Sentence #,Word,Tag
Sentence: 1,Famotidine,B-Chemical
Sentence: 1,-,O
Sentence: 1,associated,O
Sentence: 1,delirium,B-Disease
Sentence: 1,.,O
Sentence: 1,A,O
Sentence: 1,series,O
Sentence: 1,of,O
Sentence: 1,six,O
Sentence: 1,cases,O
Sentence: 1,.,O
Sentence: 2,Famotidine,B-Chemical
Sentence: 2,is,O
Sentence: 2,a,O
Sentence: 2,histamine,O
Sentence: 2,H2,O
Sentence: 2,-,O
Sentence: 2,receptor,O
Sentence: 2,antagonist,O
Sentence: 2,used,O
Sentence: 2,in,O
Sentence: 2,inpatient,O
Sentence: 2,settings,O
Sentence: 2,for,O
Sentence: 2,prevention,O
Sentence: 2,of,O
Sentence: 2,stress,O
Sentence: 2,ulcers,B-Disease
Sentence: 2,and,O
Sentence: 2,is,O
Sentence: 2,showing,O
Sentence: 2,increasing,O
Sentence: 2,popularity,O
Sentence: 2,because,O
Sentence: 2,of,O
Sentence: 2,its,O
Sentence: 2,low,O
Sentence: 2,cost,O
Sentence: 2,.,O
Sentence: 2,Although,O
Sentence: 2,all,O
Sentence: 2,of,O
Sentence: 2,the,O
Sentence: 2,currently,O
Sentence: 2,available,O
Sentence: 2,H2,O
Sentence: 2,-,O
Sentence: 2,receptor,O
Sentence: 2,antagonists,O
Sentence: 2,have,O
Sentence: 2,shown,O
Sentence: 2,the,O
Sentence: 2,propensity,O
Sentence: 2,to,O
Sentence: 2,cause,O
Sentence: 2,delirium,B-Disease
Sentence: 2,",",O
Sentence: 2,only,O
Sentence: 2,two,O
Sentence: 2,previously,O
Sentence: 2,reported,O
Sentence: 2,cases,O
Sentence: 2,have,O
Sentence: 2,been,O
Sentence: 2,associated,O
Sentence: 2,with,O
Sentence: 2,famotidine,B-Chemical
Sentence: 2,.,O
Sentence: 2,The,O
Sentence: 2,authors,O
Sentence: 2,report,O
Sentence: 2,on,O
Sentence: 2,six,O
Sentence: 2,cases,O
Sentence: 2,of,O
Sentence: 2,famotidine,B-Chemical
Sentence: 2,-,O
Sentence: 2,associated,O
Sentence: 2,delirium,B-Disease
Sentence: 2,in,O
Sentence: 2,hospitalized,O
Sentence: 2,patients,O
Sentence: 2,who,O
Sentence: 2,cleared,O
Sentence: 2,completely,O
Sentence: 2,upon,O
Sentence: 2,removal,O
Sentence: 2,of,O
Sentence: 2,famotidine,B-Chemical
Sentence: 2,.,O
Sentence: 2,The,O
Sentence: 2,pharmacokinetics,O
Sentence: 2,of,O
Sentence: 2,famotidine,B-Chemical
Sentence: 2,are,O
Sentence: 2,reviewed,O
Sentence: 2,",",O
Sentence: 2,with,O
Sentence: 2,no,O
Sentence: 2,change,O
Sentence: 2,in,O
Sentence: 2,its,O
Sentence: 2,metabolism,O
Sentence: 2,in,O
Sentence: 2,the,O
Sentence: 2,elderly,O
Sentence: 2,population,O
Sentence: 2,seen,O
Sentence: 2,.,O
Sentence: 2,The,O
Sentence: 2,implications,O
Sentence: 2,of,O
Sentence: 2,using,O
Sentence: 2,famotidine,B-Chemical
Sentence: 2,in,O
Sentence: 2,elderly,O
Sentence: 2,persons,O
Sentence: 2,are,O
Sentence: 2,discussed,O
Sentence: 2,.,O
Sentence: 3,Indomethacin,B-Chemical
Sentence: 3,induced,O
Sentence: 3,hypotension,B-Disease
Sentence: 3,in,O
Sentence: 3,sodium,B-Chemical
Sentence: 3,and,O
Sentence: 3,volume,O
Sentence: 3,depleted,O
Sentence: 3,rats,O
Sentence: 3,.,O
Sentence: 4,After,O
Sentence: 4,a,O
Sentence: 4,single,O
Sentence: 4,oral,O
Sentence: 4,dose,O
Sentence: 4,of,O
Sentence: 4,4,O
Sentence: 4,mg,O
Sentence: 4,/,O
Sentence: 4,kg,O
Sentence: 4,indomethacin,B-Chemical
Sentence: 4,(,O
Sentence: 4,IDM,B-Chemical
Sentence: 4,),O
Sentence: 4,to,O
Sentence: 4,sodium,B-Chemical
Sentence: 4,and,O
Sentence: 4,volume,O
Sentence: 4,depleted,O
Sentence: 4,rats,O
Sentence: 4,plasma,O
Sentence: 4,renin,O
Sentence: 4,activity,O
Sentence: 4,(,O
Sentence: 4,PRA,O
Sentence: 4,),O
Sentence: 4,and,O
Sentence: 4,systolic,O
Sentence: 4,blood,O
Sentence: 4,pressure,O
Sentence: 4,fell,O
Sentence: 4,significantly,O
Sentence: 4,within,O
Sentence: 4,four,O
Sentence: 4,hours,O
Sentence: 4,.,O
Sentence: 4,In,O
Sentence: 4,sodium,B-Chemical
Sentence: 4,repleted,O
Sentence: 4,animals,O
Sentence: 4,indomethacin,B-Chemical
Sentence: 4,did,O
Sentence: 4,not,O
Sentence: 4,change,O
Sentence: 4,systolic,O
Sentence: 4,blood,O
Sentence: 4,pressure,O
Sentence: 4,(,O
Sentence: 4,BP,O
Sentence: 4,),O
Sentence: 4,although,O
Sentence: 4,plasma,O
Sentence: 4,renin,O
Sentence: 4,activity,O
Sentence: 4,was,O
Sentence: 4,decreased,O
Sentence: 4,.,O
Sentence: 4,Thus,O
Sentence: 4,",",O
Sentence: 4,indomethacin,B-Chemical
Sentence: 4,by,O
Sentence: 4,inhibition,O
Sentence: 4,of,O
Sentence: 4,prostaglandin,B-Chemical
Sentence: 4,synthesis,O
Sentence: 4,may,O
Sentence: 4,diminish,O
Sentence: 4,the,O
Sentence: 4,blood,O
Sentence: 4,pressure,O
Sentence: 4,maintaining,O
Sentence: 4,effect,O
Sentence: 4,of,O
Sentence: 4,the,O
Sentence: 4,stimulated,O
Sentence: 4,renin,O
Sentence: 4,-,O
Sentence: 4,angiotensin,B-Chemical
Sentence: 4,system,O
Sentence: 4,in,O
Sentence: 4,sodium,B-Chemical
Sentence: 4,and,O
Sentence: 4,volume,O
Sentence: 4,depletion,O
Sentence: 4,.,O
Sentence: 5,Late,O
Sentence: 5,-,O
Sentence: 5,onset,O
Sentence: 5,scleroderma,B-Disease
Sentence: 5,renal,I-Disease
Sentence: 5,crisis,I-Disease
Sentence: 5,induced,O
Sentence: 5,by,O
Sentence: 5,tacrolimus,B-Chemical
Sentence: 5,and,O
Sentence: 5,prednisolone,B-Chemical
Sentence: 5,:,O
Sentence: 5,a,O
Sentence: 5,case,O
Sentence: 5,report,O
Sentence: 5,.,O
Sentence: 6,Scleroderma,B-Disease
Sentence: 6,renal,I-Disease
Sentence: 6,crisis,I-Disease
Sentence: 6,(,O
Sentence: 6,SRC,B-Disease
Sentence: 6,),O
Sentence: 6,is,O
Sentence: 6,a,O
Sentence: 6,rare,O
Sentence: 6,complication,O
Sentence: 6,of,O
Sentence: 6,systemic,B-Disease
Sentence: 6,sclerosis,I-Disease
Sentence: 6,(,O
Sentence: 6,SSc,B-Disease
Sentence: 6,),O
Sentence: 6,but,O
Sentence: 6,can,O
Sentence: 6,be,O
Sentence: 6,severe,O
Sentence: 6,enough,O
Sentence: 6,to,O
Sentence: 6,require,O
Sentence: 6,temporary,O
Sentence: 6,or,O
Sentence: 6,permanent,O
Sentence: 6,renal,O
Sentence: 6,replacement,O
Sentence: 6,therapy,O
Sentence: 6,.,O
Sentence: 6,Moderate,O
Sentence: 6,to,O
Sentence: 6,high,O
Sentence: 6,dose,O
Sentence: 6,corticosteroid,B-Chemical
Sentence: 6,use,O
Sentence: 6,is,O
Sentence: 6,recognized,O
Sentence: 6,as,O
Sentence: 6,a,O
Sentence: 6,major,O
Sentence: 6,risk,O
Sentence: 6,factor,O
Sentence: 6,for,O
Sentence: 6,SRC,B-Disease
Sentence: 6,.,O
Sentence: 6,Furthermore,O
Sentence: 6,",",O
Sentence: 6,there,O
Sentence: 6,have,O
Sentence: 6,been,O
Sentence: 6,reports,O
Sentence: 6,of,O
Sentence: 6,thrombotic,B-Disease
Sentence: 6,microangiopathy,I-Disease
Sentence: 6,precipitated,O
Sentence: 6,by,O
Sentence: 6,cyclosporine,B-Chemical
Sentence: 6,in,O
Sentence: 6,patients,O
Sentence: 6,with,O
Sentence: 6,SSc,B-Disease
Sentence: 6,.,O
Sentence: 6,In,O
Sentence: 6,this,O
Sentence: 6,article,O
Sentence: 6,",",O
Sentence: 6,we,O
Sentence: 6,report,O
Sentence: 6,a,O
Sentence: 6,patient,O
Sentence: 6,with,O
Sentence: 6,SRC,B-Disease
Sentence: 6,induced,O
Sentence: 6,by,O
Sentence: 6,tacrolimus,B-Chemical
Sentence: 6,and,O
Sentence: 6,corticosteroids,B-Chemical
Sentence: 6,.,O
Sentence: 6,The,O
Sentence: 6,aim,O
Sentence: 6,of,O
Sentence: 6,this,O
Sentence: 6,work,O
Sentence: 6,is,O
Sentence: 6,to,O
Sentence: 6,call,O
Sentence: 6,attention,O
Sentence: 6,to,O
Sentence: 6,the,O
Sentence: 6,risk,O
Sentence: 6,of,O
Sentence: 6,tacrolimus,B-Chemical
Sentence: 6,use,O
Sentence: 6,in,O
Sentence: 6,patients,O
Sentence: 6,with,O
Sentence: 6,SSc,B-Disease
Sentence: 6,.,O
Sentence: 7,The,O
Sentence: 7,risk,O
Sentence: 7,and,O
Sentence: 7,associated,O
Sentence: 7,factors,O
Sentence: 7,of,O
Sentence: 7,methamphetamine,B-Chemical
Sentence: 7,psychosis,B-Disease
Sentence: 7,in,O
Sentence: 7,methamphetamine,B-Chemical
Sentence: 7,-,O
Sentence: 7,dependent,O
Sentence: 7,patients,O
Sentence: 7,in,O
Sentence: 7,Malaysia,O
Sentence: 7,.,O
Sentence: 8,OBJECTIVE,O
Sentence: 8,:,O
Sentence: 8,The,O
Sentence: 8,objective,O
Sentence: 8,of,O
Sentence: 8,this,O
Sentence: 8,study,O
Sentence: 8,was,O
Sentence: 8,to,O
Sentence: 8,determine,O
Sentence: 8,the,O
Sentence: 8,risk,O
Sentence: 8,of,O
Sentence: 8,lifetime,O
Sentence: 8,and,O
Sentence: 8,current,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,-,O
Sentence: 8,induced,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,in,O
Sentence: 8,patients,O
Sentence: 8,with,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,dependence,O
Sentence: 8,.,O
Sentence: 8,The,O
Sentence: 8,association,O
Sentence: 8,between,O
Sentence: 8,psychiatric,O
Sentence: 8,co,O
Sentence: 8,-,O
Sentence: 8,morbidity,O
Sentence: 8,and,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,-,O
Sentence: 8,induced,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,was,O
Sentence: 8,also,O
Sentence: 8,studied,O
Sentence: 8,.,O
Sentence: 8,METHODS,O
Sentence: 8,:,O
Sentence: 8,This,O
Sentence: 8,was,O
Sentence: 8,a,O
Sentence: 8,cross,O
Sentence: 8,-,O
Sentence: 8,sectional,O
Sentence: 8,study,O
Sentence: 8,conducted,O
Sentence: 8,concurrently,O
Sentence: 8,at,O
Sentence: 8,a,O
Sentence: 8,teaching,O
Sentence: 8,hospital,O
Sentence: 8,and,O
Sentence: 8,a,O
Sentence: 8,drug,O
Sentence: 8,rehabilitation,O
Sentence: 8,center,O
Sentence: 8,in,O
Sentence: 8,Malaysia,O
Sentence: 8,.,O
Sentence: 8,Patients,O
Sentence: 8,with,O
Sentence: 8,the,O
Sentence: 8,diagnosis,O
Sentence: 8,of,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,based,O
Sentence: 8,on,O
Sentence: 8,DSM,O
Sentence: 8,-,O
Sentence: 8,IV,O
Sentence: 8,were,O
Sentence: 8,interviewed,O
Sentence: 8,using,O
Sentence: 8,the,O
Sentence: 8,Mini,O
Sentence: 8,International,O
Sentence: 8,Neuropsychiatric,O
Sentence: 8,Interview,O
Sentence: 8,(,O
Sentence: 8,M.I.N.I,O
Sentence: 8,.,O
Sentence: 8,),O
Sentence: 8,for,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,-,O
Sentence: 8,induced,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,and,O
Sentence: 8,other,O
Sentence: 8,Axis,O
Sentence: 8,I,O
Sentence: 8,psychiatric,B-Disease
Sentence: 8,disorders,I-Disease
Sentence: 8,.,O
Sentence: 8,The,O
Sentence: 8,information,O
Sentence: 8,on,O
Sentence: 8,sociodemographic,O
Sentence: 8,background,O
Sentence: 8,and,O
Sentence: 8,drug,O
Sentence: 8,use,O
Sentence: 8,history,O
Sentence: 8,was,O
Sentence: 8,obtained,O
Sentence: 8,from,O
Sentence: 8,interview,O
Sentence: 8,or,O
Sentence: 8,medical,O
Sentence: 8,records,O
Sentence: 8,.,O
Sentence: 8,RESULTS,O
Sentence: 8,:,O
Sentence: 8,Of,O
Sentence: 8,292,O
Sentence: 8,subjects,O
Sentence: 8,",",O
Sentence: 8,47.9,O
Sentence: 8,%,O
Sentence: 8,of,O
Sentence: 8,the,O
Sentence: 8,subjects,O
Sentence: 8,had,O
Sentence: 8,a,O
Sentence: 8,past,O
Sentence: 8,history,O
Sentence: 8,of,O
Sentence: 8,psychotic,B-Disease
Sentence: 8,symptoms,I-Disease
Sentence: 8,and,O
Sentence: 8,13.0,O
Sentence: 8,%,O
Sentence: 8,of,O
Sentence: 8,the,O
Sentence: 8,patients,O
Sentence: 8,were,O
Sentence: 8,having,O
Sentence: 8,current,O
Sentence: 8,psychotic,B-Disease
Sentence: 8,symptoms,I-Disease
Sentence: 8,.,O
Sentence: 8,Co,O
Sentence: 8,-,O
Sentence: 8,morbid,O
Sentence: 8,major,O
Sentence: 8,depressive,B-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,(,O
Sentence: 8,OR,O
Sentence: 8,=,O
Sentence: 8,7.18,O
Sentence: 8,",",O
Sentence: 8,95,O
Sentence: 8,CI,O
Sentence: 8,=,O
Sentence: 8,2.612,O
Sentence: 8,-,O
Sentence: 8,19.708,O
Sentence: 8,),O
Sentence: 8,",",O
Sentence: 8,bipolar,B-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,(,O
Sentence: 8,OR,O
Sentence: 8,=,O
Sentence: 8,13.807,O
Sentence: 8,",",O
Sentence: 8,95,O
Sentence: 8,CI,O
Sentence: 8,=,O
Sentence: 8,5.194,O
Sentence: 8,-,O
Sentence: 8,36.706,O
Sentence: 8,),O
Sentence: 8,",",O
Sentence: 8,antisocial,B-Disease
Sentence: 8,personality,I-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,(,O
Sentence: 8,OR,O
Sentence: 8,=,O
Sentence: 8,12.619,O
Sentence: 8,",",O
Sentence: 8,95,O
Sentence: 8,CI,O
Sentence: 8,=,O
Sentence: 8,6.702,O
Sentence: 8,-,O
Sentence: 8,23.759,O
Sentence: 8,),O
Sentence: 8,and,O
Sentence: 8,heavy,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,uses,O
Sentence: 8,were,O
Sentence: 8,significantly,O
Sentence: 8,associated,O
Sentence: 8,with,O
Sentence: 8,lifetime,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,-,O
Sentence: 8,induced,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,after,O
Sentence: 8,adjusted,O
Sentence: 8,for,O
Sentence: 8,other,O
Sentence: 8,factors,O
Sentence: 8,.,O
Sentence: 8,Major,B-Disease
Sentence: 8,depressive,I-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,(,O
Sentence: 8,OR,O
Sentence: 8,=,O
Sentence: 8,2.870,O
Sentence: 8,",",O
Sentence: 8,CI,O
Sentence: 8,=,O
Sentence: 8,1.154,O
Sentence: 8,-,O
Sentence: 8,7.142,O
Sentence: 8,),O
Sentence: 8,and,O
Sentence: 8,antisocial,B-Disease
Sentence: 8,personality,I-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,(,O
Sentence: 8,OR,O
Sentence: 8,=,O
Sentence: 8,3.299,O
Sentence: 8,",",O
Sentence: 8,95,O
Sentence: 8,CI,O
Sentence: 8,=,O
Sentence: 8,1.375,O
Sentence: 8,-,O
Sentence: 8,7.914,O
Sentence: 8,),O
Sentence: 8,were,O
Sentence: 8,the,O
Sentence: 8,only,O
Sentence: 8,factors,O
Sentence: 8,associated,O
Sentence: 8,with,O
Sentence: 8,current,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,.,O
Sentence: 8,CONCLUSION,O
Sentence: 8,:,O
Sentence: 8,There,O
Sentence: 8,was,O
Sentence: 8,a,O
Sentence: 8,high,O
Sentence: 8,risk,O
Sentence: 8,of,O
Sentence: 8,psychosis,B-Disease
Sentence: 8,in,O
Sentence: 8,patients,O
Sentence: 8,with,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,dependence,O
Sentence: 8,.,O
Sentence: 8,It,O
Sentence: 8,was,O
Sentence: 8,associated,O
Sentence: 8,with,O
Sentence: 8,co,O
Sentence: 8,-,O
Sentence: 8,morbid,O
Sentence: 8,affective,B-Disease
Sentence: 8,disorder,I-Disease
Sentence: 8,",",O
Sentence: 8,antisocial,B-Disease
Sentence: 8,personality,I-Disease
Sentence: 8,",",O
Sentence: 8,and,O
Sentence: 8,heavy,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,use,O
Sentence: 8,.,O
Sentence: 8,It,O
Sentence: 8,is,O
Sentence: 8,recommended,O
Sentence: 8,that,O
Sentence: 8,all,O
Sentence: 8,cases,O
Sentence: 8,of,O
Sentence: 8,methamphetamine,B-Chemical
Sentence: 8,dependence,O
Sentence: 8,should,O
Sentence: 8,be,O
Sentence: 8,screened,O
Sentence: 8,for,O
Sentence: 8,psychotic,B-Disease
Sentence: 8,symptoms,I-Disease
Sentence: 8,.,O
Sentence: 9,Cerebellar,O
Sentence: 9,sensory,O
Sentence: 9,processing,O
Sentence: 9,alterations,O
Sentence: 9,impact,O
Sentence: 9,motor,O
Sentence: 9,cortical,O
Sentence: 9,plasticity,O
Sentence: 9,in,O
Sentence: 9,Parkinson,B-Disease
Sentence: 9,'s,I-Disease
Sentence: 9,disease,I-Disease
Sentence: 9,:,O
Sentence: 9,clues,O
Sentence: 9,from,O
Sentence: 9,dyskinetic,B-Disease
Sentence: 9,patients,O
Sentence: 9,.,O
Sentence: 10,The,O
Sentence: 10,plasticity,O
Sentence: 10,of,O
Sentence: 10,primary,O
Sentence: 10,motor,O
Sentence: 10,cortex,O
Sentence: 10,(,O
Sentence: 10,M1,O
Sentence: 10,),O
Sentence: 10,in,O
Sentence: 10,patients,O
Sentence: 10,with,O
Sentence: 10,Parkinson,B-Disease
Sentence: 10,'s,I-Disease
Sentence: 10,disease,I-Disease
Sentence: 10,(,O
Sentence: 10,PD,B-Disease
Sentence: 10,),O
Sentence: 10,and,O
Sentence: 10,levodopa,B-Chemical
Sentence: 10,-,O
Sentence: 10,induced,O
Sentence: 10,dyskinesias,B-Disease
Sentence: 10,(,O
Sentence: 10,LIDs,B-Disease
Sentence: 10,),O
Sentence: 10,is,O
Sentence: 10,severely,O
Sentence: 10,impaired,O
Sentence: 10,.,O
Sentence: 10,We,O
Sentence: 10,recently,O
Sentence: 10,reported,O
Sentence: 10,in,O
Sentence: 10,young,O
Sentence: 10,healthy,O
Sentence: 10,subjects,O
Sentence: 10,that,O
Sentence: 10,inhibitory,O
Sentence: 10,cerebellar,O
Sentence: 10,stimulation,O
Sentence: 10,enhanced,O
Sentence: 10,the,O
Sentence: 10,sensorimotor,O
Sentence: 10,plasticity,O
Sentence: 10,of,O
Sentence: 10,M1,O
Sentence: 10,that,O
Sentence: 10,was,O
Sentence: 10,induced,O
Sentence: 10,by,O
Sentence: 10,paired,O
Sentence: 10,associative,O
Sentence: 10,stimulation,O
Sentence: 10,(,O
Sentence: 10,PAS,O
Sentence: 10,),O
Sentence: 10,.,O
Sentence: 10,This,O
Sentence: 10,study,O
Sentence: 10,demonstrates,O
Sentence: 10,that,O
Sentence: 10,the,O
Sentence: 10,deficient,O
Sentence: 10,sensorimotor,O
Sentence: 10,M1,O
Sentence: 10,plasticity,O
Sentence: 10,in,O
Sentence: 10,16,O
Sentence: 10,patients,O
Sentence: 10,with,O
Sentence: 10,LIDs,B-Disease
Sentence: 10,could,O
Sentence: 10,be,O
Sentence: 10,reinstated,O
Sentence: 10,by,O
Sentence: 10,a,O
Sentence: 10,single,O
Sentence: 10,session,O
Sentence: 10,of,O
Sentence: 10,real,O
Sentence: 10,inhibitory,O
Sentence: 10,cerebellar,O
Sentence: 10,stimulation,O
Sentence: 10,but,O
Sentence: 10,not,O
Sentence: 10,sham,O
Sentence: 10,stimulation,O
Sentence: 10,.,O
Sentence: 10,This,O
Sentence: 10,was,O
Sentence: 10,evident,O
Sentence: 10,only,O
Sentence: 10,when,O
Sentence: 10,a,O
Sentence: 10,sensory,O
Sentence: 10,component,O
Sentence: 10,was,O
Sentence: 10,involved,O
Sentence: 10,in,O
Sentence: 10,the,O
Sentence: 10,induction,O
Sentence: 10,of,O
Sentence: 10,plasticity,O
Sentence: 10,",",O
Sentence: 10,indicating,O
Sentence: 10,that,O
Sentence: 10,cerebellar,O
Sentence: 10,sensory,O
Sentence: 10,processing,O
Sentence: 10,function,O
Sentence: 10,is,O
Sentence: 10,involved,O
Sentence: 10,in,O
Sentence: 10,the,O
Sentence: 10,resurgence,O
Sentence: 10,of,O
Sentence: 10,M1,O
Sentence: 10,plasticity,O
Sentence: 10,.,O
Sentence: 10,The,O
Sentence: 10,benefit,O
Sentence: 10,of,O
Sentence: 10,inhibitory,O
Sentence: 10,cerebellar,O
Sentence: 10,stimulation,O
Sentence: 10,on,O
Sentence: 10,LIDs,B-Disease
Sentence: 10,is,O
Sentence: 10,known,O
Sentence: 10,.,O
Sentence: 10,To,O
Sentence: 10,explore,O
Sentence: 10,whether,O
Sentence: 10,this,O
Sentence: 10,benefit,O
Sentence: 10,is,O
Sentence: 10,linked,O
Sentence: 10,to,O
Sentence: 10,the,O
Sentence: 10,restoration,O
Sentence: 10,of,O
Sentence: 10,sensorimotor,O
Sentence: 10,plasticity,O
Sentence: 10,of,O
Sentence: 10,M1,O
Sentence: 10,",",O
Sentence: 10,we,O
Sentence: 10,conducted,O
Sentence: 10,an,O
Sentence: 10,additional,O
Sentence: 10,study,O
Sentence: 10,looking,O
Sentence: 10,at,O
Sentence: 10,changes,O
Sentence: 10,in,O
Sentence: 10,LIDs,B-Disease
Sentence: 10,and,O
Sentence: 10,PAS,O
Sentence: 10,-,O
Sentence: 10,induced,O
Sentence: 10,plasticity,O
Sentence: 10,after,O
Sentence: 10,10,O
Sentence: 10,sessions,O
Sentence: 10,of,O
Sentence: 10,either,O
Sentence: 10,bilateral,O
Sentence: 10,",",O
Sentence: 10,real,O
Sentence: 10,inhibitory,O
Sentence: 10,cerebellar,O
Sentence: 10,stimulation,O
Sentence: 10,or,O
Sentence: 10,sham,O
Sentence: 10,stimulation,O
Sentence: 10,.,O
Sentence: 10,Only,O
Sentence: 10,real,O
Sentence: 10,and,O
Sentence: 10,not,O
Sentence: 10,sham,O
Sentence: 10,stimulation,O
Sentence: 10,had,O
Sentence: 10,an,O
Sentence: 10,antidyskinetic,O
Sentence: 10,effect,O
Sentence: 10,and,O
Sentence: 10,it,O
Sentence: 10,was,O
Sentence: 10,paralleled,O
Sentence: 10,by,O
Sentence: 10,a,O
Sentence: 10,resurgence,O
Sentence: 10,in,O
Sentence: 10,the,O
Sentence: 10,sensorimotor,O
Sentence: 10,plasticity,O
Sentence: 10,of,O
Sentence: 10,M1,O
Sentence: 10,.,O
Sentence: 10,These,O
Sentence: 10,results,O
Sentence: 10,suggest,O
Sentence: 10,that,O
Sentence: 10,alterations,O
Sentence: 10,in,O
Sentence: 10,cerebellar,O
Sentence: 10,sensory,O
Sentence: 10,processing,O
Sentence: 10,function,O
Sentence: 10,",",O
Sentence: 10,occurring,O
Sentence: 10,secondary,O
Sentence: 10,to,O
Sentence: 10,abnormal,O
Sentence: 10,basal,O
Sentence: 10,ganglia,O
Sentence: 10,signals,O
Sentence: 10,reaching,O
Sentence: 10,it,O
Sentence: 10,",",O
Sentence: 10,may,O
Sentence: 10,be,O
Sentence: 10,an,O
Sentence: 10,important,O
Sentence: 10,element,O
Sentence: 10,contributing,O
Sentence: 10,to,O
Sentence: 10,the,O
Sentence: 10,maladaptive,O
Sentence: 10,sensorimotor,O
Sentence: 10,plasticity,O
Sentence: 10,of,O
Sentence: 10,M1,O
Sentence: 10,and,O
Sentence: 10,the,O
Sentence: 10,emergence,O
Sentence: 10,of,O
Sentence: 10,abnormal,B-Disease
Sentence: 10,involuntary,I-Disease
Sentence: 10,movements,I-Disease
Sentence: 10,.,O
Sentence: 11,The,O
Sentence: 11,function,O
Sentence: 11,of,O
Sentence: 11,P2X3,O
Sentence: 11,receptor,O
Sentence: 11,and,O
Sentence: 11,NK1,O
Sentence: 11,receptor,O
Sentence: 11,antagonists,O
Sentence: 11,on,O
Sentence: 11,cyclophosphamide,B-Chemical
Sentence: 11,-,O
Sentence: 11,induced,O
Sentence: 11,cystitis,B-Disease
Sentence: 11,in,O
Sentence: 11,rats,O
Sentence: 11,.,O
Sentence: 12,PURPOSE,O
Sentence: 12,:,O
Sentence: 12,The,O
Sentence: 12,purpose,O
Sentence: 12,of,O
Sentence: 12,the,O
Sentence: 12,study,O
Sentence: 12,is,O
Sentence: 12,to,O
Sentence: 12,explore,O
Sentence: 12,the,O
Sentence: 12,function,O
Sentence: 12,of,O
Sentence: 12,P2X3,O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptors,O
Sentence: 12,antagonists,O
Sentence: 12,on,O
Sentence: 12,cyclophosphamide,B-Chemical
Sentence: 12,(,O
Sentence: 12,CYP,B-Chemical
Sentence: 12,),O
Sentence: 12,,O
Sentence: 12,-,O
Sentence: 12,induced,O
Sentence: 12,cystitis,B-Disease
Sentence: 12,in,O
Sentence: 12,rats,O
Sentence: 12,.,O
Sentence: 12,METHODS,O
Sentence: 12,:,O
Sentence: 12,Sixty,O
Sentence: 12,female,O
Sentence: 12,Sprague,O
Sentence: 12,-,O
Sentence: 12,Dawley,O
Sentence: 12,(,O
Sentence: 12,SD,O
Sentence: 12,),O
Sentence: 12,rats,O
Sentence: 12,were,O
Sentence: 12,randomly,O
Sentence: 12,divided,O
Sentence: 12,into,O
Sentence: 12,three,O
Sentence: 12,groups,O
Sentence: 12,.,O
Sentence: 12,The,O
Sentence: 12,rats,O
Sentence: 12,in,O
Sentence: 12,the,O
Sentence: 12,control,O
Sentence: 12,group,O
Sentence: 12,were,O
Sentence: 12,intraperitoneally,O
Sentence: 12,(,O
Sentence: 12,i.p,O
Sentence: 12,.,O
Sentence: 12,),O
Sentence: 12,injected,O
Sentence: 12,with,O
Sentence: 12,0.9,O
Sentence: 12,%,O
Sentence: 12,saline,O
Sentence: 12,(,O
Sentence: 12,4,O
Sentence: 12,ml,O
Sentence: 12,/,O
Sentence: 12,kg,O
Sentence: 12,),O
Sentence: 12,;,O
Sentence: 12,the,O
Sentence: 12,rats,O
Sentence: 12,in,O
Sentence: 12,the,O
Sentence: 12,model,O
Sentence: 12,group,O
Sentence: 12,were,O
Sentence: 12,i.p,O
Sentence: 12,.,O
Sentence: 12,injected,O
Sentence: 12,with,O
Sentence: 12,CYP,B-Chemical
Sentence: 12,(,O
Sentence: 12,150,O
Sentence: 12,mg,O
Sentence: 12,/,O
Sentence: 12,kg,O
Sentence: 12,),O
Sentence: 12,;,O
Sentence: 12,and,O
Sentence: 12,the,O
Sentence: 12,rats,O
Sentence: 12,in,O
Sentence: 12,the,O
Sentence: 12,intervention,O
Sentence: 12,group,O
Sentence: 12,were,O
Sentence: 12,i.p,O
Sentence: 12,.,O
Sentence: 12,injected,O
Sentence: 12,with,O
Sentence: 12,CYP,B-Chemical
Sentence: 12,with,O
Sentence: 12,subsequently,O
Sentence: 12,perfusion,O
Sentence: 12,of,O
Sentence: 12,bladder,O
Sentence: 12,with,O
Sentence: 12,P2X3,O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptors,O
Sentence: 12,',O
Sentence: 12,antagonists,O
Sentence: 12,",",O
Sentence: 12,Suramin,B-Chemical
Sentence: 12,and,O
Sentence: 12,GR,B-Chemical
Sentence: 12,82334,I-Chemical
Sentence: 12,.,O
Sentence: 12,Spontaneous,O
Sentence: 12,pain,B-Disease
Sentence: 12,behaviors,O
Sentence: 12,following,O
Sentence: 12,the,O
Sentence: 12,administration,O
Sentence: 12,of,O
Sentence: 12,CYP,B-Chemical
Sentence: 12,were,O
Sentence: 12,observed,O
Sentence: 12,.,O
Sentence: 12,Urodynamic,O
Sentence: 12,parameters,O
Sentence: 12,",",O
Sentence: 12,bladder,O
Sentence: 12,pressure,O
Sentence: 12,-,O
Sentence: 12,volume,O
Sentence: 12,curve,O
Sentence: 12,",",O
Sentence: 12,maximum,O
Sentence: 12,voiding,O
Sentence: 12,pressure,O
Sentence: 12,(,O
Sentence: 12,MVP,O
Sentence: 12,),O
Sentence: 12,",",O
Sentence: 12,and,O
Sentence: 12,maximum,O
Sentence: 12,cystometric,O
Sentence: 12,capacity,O
Sentence: 12,(,O
Sentence: 12,MCC,O
Sentence: 12,),O
Sentence: 12,",",O
Sentence: 12,were,O
Sentence: 12,recorded,O
Sentence: 12,.,O
Sentence: 12,Pathological,O
Sentence: 12,changes,O
Sentence: 12,in,O
Sentence: 12,bladder,O
Sentence: 12,tissue,O
Sentence: 12,were,O
Sentence: 12,observed,O
Sentence: 12,.,O
Sentence: 12,Immunofluorescence,O
Sentence: 12,was,O
Sentence: 12,used,O
Sentence: 12,to,O
Sentence: 12,detect,O
Sentence: 12,the,O
Sentence: 12,expression,O
Sentence: 12,of,O
Sentence: 12,P2X3,O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptors,O
Sentence: 12,in,O
Sentence: 12,bladder,O
Sentence: 12,.,O
Sentence: 12,RESULTS,O
Sentence: 12,:,O
Sentence: 12,Cyclophosphamide,B-Chemical
Sentence: 12,treatment,O
Sentence: 12,increased,O
Sentence: 12,the,O
Sentence: 12,spontaneous,O
Sentence: 12,pain,B-Disease
Sentence: 12,behaviors,O
Sentence: 12,scores,O
Sentence: 12,.,O
Sentence: 12,The,O
Sentence: 12,incidence,O
Sentence: 12,of,O
Sentence: 12,bladder,O
Sentence: 12,instability,O
Sentence: 12,during,O
Sentence: 12,urine,O
Sentence: 12,storage,O
Sentence: 12,period,O
Sentence: 12,of,O
Sentence: 12,model,O
Sentence: 12,group,O
Sentence: 12,was,O
Sentence: 12,significantly,O
Sentence: 12,higher,O
Sentence: 12,than,O
Sentence: 12,intervention,O
Sentence: 12,group,O
Sentence: 12,(,O
Sentence: 12,X,O
Sentence: 12,(,O
Sentence: 12,2,O
Sentence: 12,),O
Sentence: 12,,O
Sentence: 12,=,O
Sentence: 12,,O
Sentence: 12,7.619,O
Sentence: 12,",",O
Sentence: 12,P,O
Sentence: 12,,O
Sentence: 12,=,O
Sentence: 12,,O
Sentence: 12,0.007,O
Sentence: 12,),O
Sentence: 12,and,O
Sentence: 12,control,O
Sentence: 12,group,O
Sentence: 12,(,O
Sentence: 12,X,O
Sentence: 12,(,O
Sentence: 12,2,O
Sentence: 12,),O
Sentence: 12,,O
Sentence: 12,=,O
Sentence: 12,,O
Sentence: 12,13.755,O
Sentence: 12,",",O
Sentence: 12,P,O
Sentence: 12,,O
Sentence: 12,=,O
Sentence: 12,,O
Sentence: 12,0.000,O
Sentence: 12,),O
Sentence: 12,.,O
Sentence: 12,MCC,O
Sentence: 12,in,O
Sentence: 12,the,O
Sentence: 12,model,O
Sentence: 12,group,O
Sentence: 12,was,O
Sentence: 12,lower,O
Sentence: 12,than,O
Sentence: 12,the,O
Sentence: 12,control,O
Sentence: 12,and,O
Sentence: 12,intervention,O
Sentence: 12,groups,O
Sentence: 12,(,O
Sentence: 12,P,O
Sentence: 12,,O
Sentence: 12,<,O
Sentence: 12,,O
Sentence: 12,0.01,O
Sentence: 12,),O
Sentence: 12,.,O
Sentence: 12,Histological,O
Sentence: 12,changes,O
Sentence: 12,evident,O
Sentence: 12,in,O
Sentence: 12,model,O
Sentence: 12,and,O
Sentence: 12,intervention,O
Sentence: 12,groups,O
Sentence: 12,rats,O
Sentence: 12,',O
Sentence: 12,bladder,O
Sentence: 12,included,O
Sentence: 12,edema,B-Disease
Sentence: 12,",",O
Sentence: 12,vasodilation,O
Sentence: 12,",",O
Sentence: 12,and,O
Sentence: 12,infiltration,O
Sentence: 12,of,O
Sentence: 12,inflammatory,O
Sentence: 12,cells,O
Sentence: 12,.,O
Sentence: 12,In,O
Sentence: 12,model,O
Sentence: 12,group,O
Sentence: 12,",",O
Sentence: 12,the,O
Sentence: 12,expression,O
Sentence: 12,of,O
Sentence: 12,P2X3,O
Sentence: 12,receptor,O
Sentence: 12,increased,O
Sentence: 12,in,O
Sentence: 12,urothelium,O
Sentence: 12,and,O
Sentence: 12,suburothelium,O
Sentence: 12,",",O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptor,O
Sentence: 12,increased,O
Sentence: 12,in,O
Sentence: 12,suburothelium,O
Sentence: 12,",",O
Sentence: 12,while,O
Sentence: 12,the,O
Sentence: 12,expression,O
Sentence: 12,of,O
Sentence: 12,them,O
Sentence: 12,in,O
Sentence: 12,intervention,O
Sentence: 12,group,O
Sentence: 12,was,O
Sentence: 12,lower,O
Sentence: 12,.,O
Sentence: 12,CONCLUSIONS,O
Sentence: 12,:,O
Sentence: 12,In,O
Sentence: 12,CYP,B-Chemical
Sentence: 12,-,O
Sentence: 12,induced,O
Sentence: 12,cystitis,B-Disease
Sentence: 12,",",O
Sentence: 12,the,O
Sentence: 12,expression,O
Sentence: 12,of,O
Sentence: 12,P2X3,O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptors,O
Sentence: 12,increased,O
Sentence: 12,in,O
Sentence: 12,urothelium,O
Sentence: 12,and,O
Sentence: 12,/,O
Sentence: 12,or,O
Sentence: 12,suburothelium,O
Sentence: 12,.,O
Sentence: 12,Perfusion,O
Sentence: 12,of,O
Sentence: 12,bladder,O
Sentence: 12,with,O
Sentence: 12,P2X3,O
Sentence: 12,and,O
Sentence: 12,NK1,O
Sentence: 12,receptors,O
Sentence: 12,antagonists,O
Sentence: 12,ameliorated,O
Sentence: 12,the,O
Sentence: 12,bladder,O
Sentence: 12,function,O
Sentence: 12,.,O
Sentence: 13,Acute,O
Sentence: 13,hepatitis,B-Disease
Sentence: 13,associated,O
Sentence: 13,with,O
Sentence: 13,clopidogrel,B-Chemical
Sentence: 13,:,O
Sentence: 13,a,O
Sentence: 13,case,O
Sentence: 13,report,O
Sentence: 13,and,O
Sentence: 13,review,O
Sentence: 13,of,O
Sentence: 13,the,O
Sentence: 13,literature,O
Sentence: 13,.,O
Sentence: 14,Drug,O
Sentence: 14,-,O
Sentence: 14,induced,O
Sentence: 14,hepatotoxicity,B-Disease
Sentence: 14,is,O
Sentence: 14,a,O
Sentence: 14,common,O
Sentence: 14,cause,O
Sentence: 14,of,O
Sentence: 14,acute,O
Sentence: 14,hepatitis,B-Disease
Sentence: 14,",",O
Sentence: 14,and,O
Sentence: 14,the,O
Sentence: 14,recognition,O
Sentence: 14,of,O
Sentence: 14,the,O
Sentence: 14,responsible,O
Sentence: 14,drug,O
Sentence: 14,may,O
Sentence: 14,be,O
Sentence: 14,difficult,O
Sentence: 14,.,O
Sentence: 14,We,O
Sentence: 14,describe,O
Sentence: 14,a,O
Sentence: 14,case,O
Sentence: 14,of,O
Sentence: 14,clopidogrel,B-Chemical
Sentence: 14,-,O
Sentence: 14,related,O
Sentence: 14,acute,O
Sentence: 14,hepatitis,B-Disease
Sentence: 14,.,O
Sentence: 14,The,O
Sentence: 14,diagnosis,O
Sentence: 14,is,O
Sentence: 14,strongly,O
Sentence: 14,suggested,O
Sentence: 14,by,O
Sentence: 14,an,O
Sentence: 14,accurate,O
Sentence: 14,medical,O
Sentence: 14,history,O
Sentence: 14,and,O
Sentence: 14,liver,O
Sentence: 14,biopsy,O
Sentence: 14,.,O
Sentence: 14,Reports,O
Sentence: 14,about,O
Sentence: 14,cases,O
Sentence: 14,of,O
Sentence: 14,hepatotoxicity,B-Disease
Sentence: 14,due,O
Sentence: 14,to,O
Sentence: 14,clopidogrel,B-Chemical
Sentence: 14,are,O
Sentence: 14,increasing,O
Sentence: 14,in,O
Sentence: 14,the,O
Sentence: 14,last,O
Sentence: 14,few,O
Sentence: 14,years,O
Sentence: 14,",",O
Sentence: 14,after,O
Sentence: 14,the,O
Sentence: 14,increased,O
Sentence: 14,use,O
Sentence: 14,of,O
Sentence: 14,this,O
Sentence: 14,drug,O
Sentence: 14,.,O
Sentence: 14,In,O
Sentence: 14,conclusion,O
Sentence: 14,",",O
Sentence: 14,we,O
Sentence: 14,believe,O
Sentence: 14,that,O
Sentence: 14,physicians,O
Sentence: 14,should,O
Sentence: 14,carefully,O
Sentence: 14,consider,O
Sentence: 14,the,O
Sentence: 14,risk,O
Sentence: 14,of,O
Sentence: 14,drug,O
Sentence: 14,-,O
Sentence: 14,induced,O
Sentence: 14,hepatic,B-Disease
Sentence: 14,injury,I-Disease
Sentence: 14,when,O
Sentence: 14,clopidogrel,B-Chemical
Sentence: 14,is,O
Sentence: 14,prescribed,O
Sentence: 14,.,O
Sentence: 15,Bortezomib,B-Chemical
Sentence: 15,and,O
Sentence: 15,dexamethasone,B-Chemical
Sentence: 15,as,O
Sentence: 15,salvage,O
Sentence: 15,therapy,O
Sentence: 15,in,O
Sentence: 15,patients,O
Sentence: 15,with,O
Sentence: 15,relapsed,O
Sentence: 15,/,O
Sentence: 15,refractory,O
Sentence: 15,multiple,B-Disease
Sentence: 15,myeloma,I-Disease
Sentence: 15,:,O
Sentence: 15,analysis,O
Sentence: 15,of,O
Sentence: 15,long,O
Sentence: 15,-,O
Sentence: 15,term,O
Sentence: 15,clinical,O
Sentence: 15,outcomes,O
Sentence: 15,.,O
Sentence: 16,Bortezomib,B-Chemical
Sentence: 16,(,O
Sentence: 16,bort,B-Chemical
Sentence: 16,),O
Sentence: 16,,O
Sentence: 16,-,O
Sentence: 16,dexamethasone,B-Chemical
Sentence: 16,(,O
Sentence: 16,dex,B-Chemical
Sentence: 16,),O
Sentence: 16,is,O
Sentence: 16,an,O
Sentence: 16,effective,O
Sentence: 16,therapy,O
Sentence: 16,for,O
Sentence: 16,relapsed,O
Sentence: 16,/,O
Sentence: 16,refractory,O
Sentence: 16,(,O
Sentence: 16,R,O
Sentence: 16,/,O
Sentence: 16,R,O
Sentence: 16,),O
Sentence: 16,multiple,B-Disease
Sentence: 16,myeloma,I-Disease
Sentence: 16,(,O
Sentence: 16,MM,B-Disease
Sentence: 16,),O
Sentence: 16,.,O
Sentence: 16,This,O
Sentence: 16,retrospective,O
Sentence: 16,study,O
Sentence: 16,investigated,O
Sentence: 16,the,O
Sentence: 16,combination,O
Sentence: 16,of,O
Sentence: 16,bort,B-Chemical
Sentence: 16,(,O
Sentence: 16,1.3,O
Sentence: 16,mg,O
Sentence: 16,/,O
Sentence: 16,m,O
Sentence: 16,(,O
Sentence: 16,2,O
Sentence: 16,),O
Sentence: 16,on,O
Sentence: 16,days,O
Sentence: 16,1,O
Sentence: 16,",",O
Sentence: 16,4,O
Sentence: 16,",",O
Sentence: 16,8,O
Sentence: 16,",",O
Sentence: 16,and,O
Sentence: 16,11,O
Sentence: 16,every,O
Sentence: 16,3,O
Sentence: 16,weeks,O
Sentence: 16,),O
Sentence: 16,and,O
Sentence: 16,dex,B-Chemical
Sentence: 16,(,O
Sentence: 16,20,O
Sentence: 16,mg,O
Sentence: 16,on,O
Sentence: 16,the,O
Sentence: 16,day,O
Sentence: 16,of,O
Sentence: 16,and,O
Sentence: 16,the,O
Sentence: 16,day,O
Sentence: 16,after,O
Sentence: 16,bort,B-Chemical
Sentence: 16,),O
Sentence: 16,as,O
Sentence: 16,salvage,O
Sentence: 16,treatment,O
Sentence: 16,in,O
Sentence: 16,85,O
Sentence: 16,patients,O
Sentence: 16,with,O
Sentence: 16,R,O
Sentence: 16,/,O
Sentence: 16,R,O
Sentence: 16,MM,B-Disease
Sentence: 16,after,O
Sentence: 16,prior,O
Sentence: 16,autologous,O
Sentence: 16,stem,O
Sentence: 16,cell,O
Sentence: 16,transplantation,O
Sentence: 16,or,O
Sentence: 16,conventional,O
Sentence: 16,chemotherapy,O
Sentence: 16,.,O
Sentence: 16,The,O
Sentence: 16,median,O
Sentence: 16,number,O
Sentence: 16,of,O
Sentence: 16,prior,O
Sentence: 16,lines,O
Sentence: 16,of,O
Sentence: 16,therapy,O
Sentence: 16,was,O
Sentence: 16,2,O
Sentence: 16,.,O
Sentence: 16,Eighty,O
Sentence: 16,-,O
Sentence: 16,seven,O
Sentence: 16,percent,O
Sentence: 16,of,O
Sentence: 16,the,O
Sentence: 16,patients,O
Sentence: 16,had,O
Sentence: 16,received,O
Sentence: 16,immunomodulatory,O
Sentence: 16,drugs,O
Sentence: 16,included,O
Sentence: 16,in,O
Sentence: 16,some,O
Sentence: 16,line,O
Sentence: 16,of,O
Sentence: 16,therapy,O
Sentence: 16,before,O
Sentence: 16,bort,B-Chemical
Sentence: 16,-,O
Sentence: 16,dex,B-Chemical
Sentence: 16,.,O
Sentence: 16,The,O
Sentence: 16,median,O
Sentence: 16,number,O
Sentence: 16,of,O
Sentence: 16,bort,B-Chemical
Sentence: 16,-,O
Sentence: 16,dex,B-Chemical
Sentence: 16,cycles,O
Sentence: 16,was,O
Sentence: 16,6,O
Sentence: 16,",",O
Sentence: 16,up,O
Sentence: 16,to,O
Sentence: 16,a,O
Sentence: 16,maximum,O
Sentence: 16,of,O
Sentence: 16,12,O
Sentence: 16,cycles,O
Sentence: 16,.,O
Sentence: 16,On,O
Sentence: 16,an,O
Sentence: 16,intention,O
Sentence: 16,-,O
Sentence: 16,to,O
Sentence: 16,-,O
Sentence: 16,treat,O
Sentence: 16,basis,O
Sentence: 16,",",O
Sentence: 16,55,O
Sentence: 16,%,O
Sentence: 16,of,O
Sentence: 16,the,O
Sentence: 16,patients,O
Sentence: 16,achieved,O
Sentence: 16,at,O
Sentence: 16,least,O
Sentence: 16,partial,O
Sentence: 16,response,O
Sentence: 16,",",O
Sentence: 16,including,O
Sentence: 16,19,O
Sentence: 16,%,O
Sentence: 16,CR,O
Sentence: 16,and,O
Sentence: 16,35,O
Sentence: 16,%,O
Sentence: 16,achieved,O
Sentence: 16,at,O
Sentence: 16,least,O
Sentence: 16,very,O
Sentence: 16,good,O
Sentence: 16,partial,O
Sentence: 16,response,O
Sentence: 16,.,O
Sentence: 16,Median,O
Sentence: 16,durations,O
Sentence: 16,of,O
Sentence: 16,response,O
Sentence: 16,",",O
Sentence: 16,time,O
Sentence: 16,to,O
Sentence: 16,next,O
Sentence: 16,therapy,O
Sentence: 16,and,O
Sentence: 16,treatment,O
Sentence: 16,-,O
Sentence: 16,free,O
Sentence: 16,interval,O
Sentence: 16,were,O
Sentence: 16,8,O
Sentence: 16,",",O
Sentence: 16,11.2,O
Sentence: 16,",",O
Sentence: 16,and,O
Sentence: 16,5.1,O
Sentence: 16,months,O
Sentence: 16,",",O
Sentence: 16,respectively,O
Sentence: 16,.,O
Sentence: 16,The,O
Sentence: 16,most,O
Sentence: 16,relevant,O
Sentence: 16,adverse,O
Sentence: 16,event,O
Sentence: 16,was,O
Sentence: 16,peripheral,B-Disease
Sentence: 16,neuropathy,I-Disease
Sentence: 16,",",O
Sentence: 16,which,O
Sentence: 16,occurred,O
Sentence: 16,in,O
Sentence: 16,78,O
Sentence: 16,%,O
Sentence: 16,of,O
Sentence: 16,the,O
Sentence: 16,patients,O
Sentence: 16,(,O
Sentence: 16,grade,O
Sentence: 16,II,O
Sentence: 16,",",O
Sentence: 16,38,O
Sentence: 16,%,O
Sentence: 16,;,O
Sentence: 16,grade,O
Sentence: 16,III,O
Sentence: 16,",",O
Sentence: 16,21,O
Sentence: 16,%,O
Sentence: 16,),O
Sentence: 16,and,O
Sentence: 16,led,O
Sentence: 16,to,O
Sentence: 16,treatment,O
Sentence: 16,discontinuation,O
Sentence: 16,in,O
Sentence: 16,6,O
Sentence: 16,%,O
Sentence: 16,.,O
Sentence: 16,With,O
Sentence: 16,a,O
Sentence: 16,median,O
Sentence: 16,follow,O
Sentence: 16,up,O
Sentence: 16,of,O
Sentence: 16,22,O
Sentence: 16,months,O
Sentence: 16,",",O
Sentence: 16,median,O
Sentence: 16,time,O
Sentence: 16,to,O
Sentence: 16,progression,O
Sentence: 16,",",O
Sentence: 16,progression,O
Sentence: 16,-,O
Sentence: 16,free,O
Sentence: 16,survival,O
Sentence: 16,(,O
Sentence: 16,PFS,O
Sentence: 16,),O
Sentence: 16,and,O
Sentence: 16,overall,O
Sentence: 16,survival,O
Sentence: 16,(,O
Sentence: 16,OS,O
Sentence: 16,),O
Sentence: 16,were,O
Sentence: 16,8.9,O
Sentence: 16,",",O
Sentence: 16,8.7,O
Sentence: 16,",",O
Sentence: 16,and,O
Sentence: 16,22,O
Sentence: 16,months,O
Sentence: 16,",",O
Sentence: 16,respectively,O
Sentence: 16,.,O
Sentence: 16,Prolonged,O
Sentence: 16,PFS,O
Sentence: 16,and,O
Sentence: 16,OS,O
Sentence: 16,were,O
Sentence: 16,observed,O
Sentence: 16,in,O
Sentence: 16,patients,O
Sentence: 16,achieving,O
Sentence: 16,CR,O
Sentence: 16,and,O
Sentence: 16,receiving,O
Sentence: 16,bort,B-Chemical
Sentence: 16,-,O
Sentence: 16,dex,B-Chemical
Sentence: 16,a,O
Sentence: 16,single,O
Sentence: 16,line,O
Sentence: 16,of,O
Sentence: 16,prior,O
Sentence: 16,therapy,O
Sentence: 16,.,O
Sentence: 16,Bort,B-Chemical
Sentence: 16,-,O
Sentence: 16,dex,B-Chemical
Sentence: 16,was,O
Sentence: 16,an,O
Sentence: 16,effective,O
Sentence: 16,salvage,O
Sentence: 16,treatment,O
Sentence: 16,for,O
Sentence: 16,MM,B-Disease
Sentence: 16,patients,O
Sentence: 16,",",O
Sentence: 16,particularly,O
Sentence: 16,for,O
Sentence: 16,those,O
Sentence: 16,in,O
Sentence: 16,first,O
Sentence: 16,relapse,O
Sentence: 16,.,O
Sentence: 17,Pubertal,O
Sentence: 17,exposure,O
Sentence: 17,to,O
Sentence: 17,Bisphenol,B-Chemical
Sentence: 17,A,I-Chemical
Sentence: 17,increases,O
Sentence: 17,anxiety,B-Disease
Sentence: 17,-,O
Sentence: 17,like,O
Sentence: 17,behavior,O
Sentence: 17,and,O
Sentence: 17,decreases,O
Sentence: 17,acetylcholinesterase,O
Sentence: 17,activity,O
Sentence: 17,of,O
Sentence: 17,hippocampus,O
Sentence: 17,in,O
Sentence: 17,adult,O
Sentence: 17,male,O
Sentence: 17,mice,O
Sentence: 17,.,O
Sentence: 18,The,O
Sentence: 18,negative,O
Sentence: 18,effects,O
Sentence: 18,of,O
Sentence: 18,Bisphenol,B-Chemical
Sentence: 18,A,I-Chemical
Sentence: 18,(,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,),O
Sentence: 18,on,O
Sentence: 18,neurodevelopment,O
Sentence: 18,and,O
Sentence: 18,behaviors,O
Sentence: 18,have,O
Sentence: 18,been,O
Sentence: 18,well,O
Sentence: 18,established,O
Sentence: 18,.,O
Sentence: 18,Acetylcholinesterase,O
Sentence: 18,(,O
Sentence: 18,AChE,O
Sentence: 18,),O
Sentence: 18,is,O
Sentence: 18,a,O
Sentence: 18,regulatory,O
Sentence: 18,enzyme,O
Sentence: 18,which,O
Sentence: 18,is,O
Sentence: 18,involved,O
Sentence: 18,in,O
Sentence: 18,anxiety,B-Disease
Sentence: 18,-,O
Sentence: 18,like,O
Sentence: 18,behavior,O
Sentence: 18,.,O
Sentence: 18,This,O
Sentence: 18,study,O
Sentence: 18,investigated,O
Sentence: 18,behavioral,O
Sentence: 18,phenotypes,O
Sentence: 18,and,O
Sentence: 18,AChE,O
Sentence: 18,activity,O
Sentence: 18,in,O
Sentence: 18,male,O
Sentence: 18,mice,O
Sentence: 18,following,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,exposure,O
Sentence: 18,during,O
Sentence: 18,puberty,O
Sentence: 18,.,O
Sentence: 18,On,O
Sentence: 18,postnatal,O
Sentence: 18,day,O
Sentence: 18,(,O
Sentence: 18,PND,O
Sentence: 18,),O
Sentence: 18,35,O
Sentence: 18,",",O
Sentence: 18,male,O
Sentence: 18,mice,O
Sentence: 18,were,O
Sentence: 18,exposed,O
Sentence: 18,to,O
Sentence: 18,50mg,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,/,O
Sentence: 18,kg,O
Sentence: 18,diet,O
Sentence: 18,per,O
Sentence: 18,day,O
Sentence: 18,for,O
Sentence: 18,a,O
Sentence: 18,period,O
Sentence: 18,of,O
Sentence: 18,35,O
Sentence: 18,days,O
Sentence: 18,.,O
Sentence: 18,On,O
Sentence: 18,PND71,O
Sentence: 18,",",O
Sentence: 18,a,O
Sentence: 18,behavioral,O
Sentence: 18,assay,O
Sentence: 18,was,O
Sentence: 18,performed,O
Sentence: 18,using,O
Sentence: 18,the,O
Sentence: 18,elevated,O
Sentence: 18,plus,O
Sentence: 18,maze,O
Sentence: 18,(,O
Sentence: 18,EPM,O
Sentence: 18,),O
Sentence: 18,and,O
Sentence: 18,the,O
Sentence: 18,light,O
Sentence: 18,/,O
Sentence: 18,dark,O
Sentence: 18,test,O
Sentence: 18,.,O
Sentence: 18,In,O
Sentence: 18,addition,O
Sentence: 18,",",O
Sentence: 18,AChE,O
Sentence: 18,activity,O
Sentence: 18,was,O
Sentence: 18,measured,O
Sentence: 18,in,O
Sentence: 18,the,O
Sentence: 18,prefrontal,O
Sentence: 18,cortex,O
Sentence: 18,",",O
Sentence: 18,hypothalamus,O
Sentence: 18,",",O
Sentence: 18,cerebellum,O
Sentence: 18,and,O
Sentence: 18,hippocampus,O
Sentence: 18,.,O
Sentence: 18,Results,O
Sentence: 18,from,O
Sentence: 18,our,O
Sentence: 18,behavioral,O
Sentence: 18,phenotyping,O
Sentence: 18,indicated,O
Sentence: 18,that,O
Sentence: 18,anxiety,B-Disease
Sentence: 18,-,O
Sentence: 18,like,O
Sentence: 18,behavior,O
Sentence: 18,was,O
Sentence: 18,increased,O
Sentence: 18,in,O
Sentence: 18,mice,O
Sentence: 18,exposed,O
Sentence: 18,to,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,.,O
Sentence: 18,AChE,O
Sentence: 18,activity,O
Sentence: 18,was,O
Sentence: 18,significantly,O
Sentence: 18,decreased,O
Sentence: 18,in,O
Sentence: 18,the,O
Sentence: 18,hippocampus,O
Sentence: 18,of,O
Sentence: 18,mice,O
Sentence: 18,with,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,compared,O
Sentence: 18,to,O
Sentence: 18,control,O
Sentence: 18,mice,O
Sentence: 18,",",O
Sentence: 18,whereas,O
Sentence: 18,no,O
Sentence: 18,difference,O
Sentence: 18,was,O
Sentence: 18,found,O
Sentence: 18,in,O
Sentence: 18,the,O
Sentence: 18,prefrontal,O
Sentence: 18,cortex,O
Sentence: 18,",",O
Sentence: 18,hypothalamus,O
Sentence: 18,and,O
Sentence: 18,cerebellum,O
Sentence: 18,.,O
Sentence: 18,Our,O
Sentence: 18,findings,O
Sentence: 18,showed,O
Sentence: 18,that,O
Sentence: 18,pubertal,O
Sentence: 18,BPA,B-Chemical
Sentence: 18,exposure,O
Sentence: 18,increased,O
Sentence: 18,anxiety,B-Disease
Sentence: 18,-,O
Sentence: 18,like,O
Sentence: 18,behavior,O
Sentence: 18,",",O
Sentence: 18,which,O
Sentence: 18,may,O
Sentence: 18,be,O
Sentence: 18,associated,O
Sentence: 18,with,O
Sentence: 18,decreased,O
Sentence: 18,AChE,O
Sentence: 18,activity,O
Sentence: 18,of,O
Sentence: 18,the,O
Sentence: 18,hippocampus,O
Sentence: 18,in,O
Sentence: 18,adult,O
Sentence: 18,male,O
Sentence: 18,mice,O
Sentence: 18,.,O
Sentence: 18,Further,O
Sentence: 18,studies,O
Sentence: 18,are,O
Sentence: 18,necessary,O
Sentence: 18,to,O
Sentence: 18,investigate,O
Sentence: 18,the,O
Sentence: 18,cholinergic,O
Sentence: 18,signaling,O
Sentence: 18,of,O
Sentence: 18,the,O
Sentence: 18,hippocampus,O
Sentence: 18,in,O
Sentence: 18,PBE,O
Sentence: 18,induced,O
Sentence: 18,anxiety,B-Disease
Sentence: 18,-,O
Sentence: 18,like,O
Sentence: 18,behaviors,O
Sentence: 18,.,O
Sentence: 19,Biochemical,O
Sentence: 19,effects,O
Sentence: 19,of,O
Sentence: 19,Solidago,O
Sentence: 19,virgaurea,O
Sentence: 19,extract,O
Sentence: 19,on,O
Sentence: 19,experimental,O
Sentence: 19,cardiotoxicity,O
Sentence: 19,.,O
Sentence: 20,Cardiovascular,B-Disease
Sentence: 20,diseases,I-Disease
Sentence: 20,(,O
Sentence: 20,CVDs,B-Disease
Sentence: 20,),O
Sentence: 20,are,O
Sentence: 20,the,O
Sentence: 20,major,O
Sentence: 20,health,O
Sentence: 20,problem,O
Sentence: 20,of,O
Sentence: 20,advanced,O
Sentence: 20,as,O
Sentence: 20,well,O
Sentence: 20,as,O
Sentence: 20,developing,O
Sentence: 20,countries,O
Sentence: 20,of,O
Sentence: 20,the,O
Sentence: 20,world,O
Sentence: 20,.,O
Sentence: 20,The,O
Sentence: 20,aim,O
Sentence: 20,of,O
Sentence: 20,the,O
Sentence: 20,present,O
Sentence: 20,study,O
Sentence: 20,was,O
Sentence: 20,to,O
Sentence: 20,investigate,O
Sentence: 20,the,O
Sentence: 20,protective,O
Sentence: 20,effect,O
Sentence: 20,of,O
Sentence: 20,the,O
Sentence: 20,Solidago,O
Sentence: 20,virgaurea,O
Sentence: 20,extract,O
Sentence: 20,on,O
Sentence: 20,isoproterenol,B-Chemical
Sentence: 20,-,O
Sentence: 20,induced,O
Sentence: 20,cardiotoxicity,B-Disease
Sentence: 20,in,O
Sentence: 20,rats,O
Sentence: 20,.,O
Sentence: 20,The,O
Sentence: 20,subcutaneous,O
Sentence: 20,injection,O
Sentence: 20,of,O
Sentence: 20,isoproterenol,B-Chemical
Sentence: 20,(,O
Sentence: 20,30,O
Sentence: 20,mg,O
Sentence: 20,/,O
Sentence: 20,kg,O
Sentence: 20,),O
Sentence: 20,into,O
Sentence: 20,rats,O
Sentence: 20,twice,O
Sentence: 20,at,O
Sentence: 20,an,O
Sentence: 20,interval,O
Sentence: 20,of,O
Sentence: 20,24,O
Sentence: 20,h,O
Sentence: 20,",",O
Sentence: 20,for,O
Sentence: 20,two,O
Sentence: 20,consecutive,O
Sentence: 20,days,O
Sentence: 20,",",O
Sentence: 20,led,O
Sentence: 20,to,O
Sentence: 20,a,O
Sentence: 20,significant,O
Sentence: 20,increase,O
Sentence: 20,in,O
Sentence: 20,serum,O
Sentence: 20,lactate,B-Chemical
Sentence: 20,dehydrogenase,O
Sentence: 20,",",O
Sentence: 20,creatine,B-Chemical
Sentence: 20,phosphokinase,O
Sentence: 20,",",O
Sentence: 20,alanine,B-Chemical
Sentence: 20,transaminase,O
Sentence: 20,",",O
Sentence: 20,aspartate,B-Chemical
Sentence: 20,transaminase,O
Sentence: 20,",",O
Sentence: 20,and,O
Sentence: 20,angiotensin,B-Chemical
Sentence: 20,-,O
Sentence: 20,converting,O
Sentence: 20,enzyme,O
Sentence: 20,activities,O
Sentence: 20,",",O
Sentence: 20,total,O
Sentence: 20,cholesterol,B-Chemical
Sentence: 20,",",O
Sentence: 20,triglycerides,B-Chemical
Sentence: 20,",",O
Sentence: 20,free,O
Sentence: 20,serum,O
Sentence: 20,fatty,B-Chemical
Sentence: 20,acid,I-Chemical
Sentence: 20,",",O
Sentence: 20,cardiac,O
Sentence: 20,tissue,O
Sentence: 20,malondialdehyde,B-Chemical
Sentence: 20,(,O
Sentence: 20,MDA,B-Chemical
Sentence: 20,),O
Sentence: 20,",",O
Sentence: 20,and,O
Sentence: 20,nitric,B-Chemical
Sentence: 20,oxide,I-Chemical
Sentence: 20,levels,O
Sentence: 20,and,O
Sentence: 20,a,O
Sentence: 20,significant,O
Sentence: 20,decrease,O
Sentence: 20,in,O
Sentence: 20,levels,O
Sentence: 20,of,O
Sentence: 20,glutathione,B-Chemical
Sentence: 20,and,O
Sentence: 20,superoxide,B-Chemical
Sentence: 20,dismutase,O
Sentence: 20,in,O
Sentence: 20,cardiac,O
Sentence: 20,tissue,O
Sentence: 20,as,O
Sentence: 20,compared,O
Sentence: 20,to,O
Sentence: 20,the,O
Sentence: 20,normal,O
Sentence: 20,control,O
Sentence: 20,group,O
Sentence: 20,(,O
Sentence: 20,P,O
Sentence: 20,,O
Sentence: 20,<,O
Sentence: 20,,O
Sentence: 20,0.05,O
Sentence: 20,),O
Sentence: 20,.,O
Sentence: 20,Pretreatment,O
Sentence: 20,with,O
Sentence: 20,S.,O
Sentence: 20,virgaurea,O
Sentence: 20,extract,O
Sentence: 20,for,O
Sentence: 20,5,O
Sentence: 20,weeks,O
Sentence: 20,at,O
Sentence: 20,a,O
Sentence: 20,dose,O
Sentence: 20,of,O
Sentence: 20,250,O
Sentence: 20,mg,O
Sentence: 20,/,O
Sentence: 20,kg,O
Sentence: 20,followed,O
Sentence: 20,by,O
Sentence: 20,isoproterenol,B-Chemical
Sentence: 20,injection,O
Sentence: 20,significantly,O
Sentence: 20,prevented,O
Sentence: 20,the,O
Sentence: 20,observed,O
Sentence: 20,alterations,O
Sentence: 20,.,O
Sentence: 20,Captopril,B-Chemical
Sentence: 20,(,O
Sentence: 20,50,O
Sentence: 20,mg,O
Sentence: 20,/,O
Sentence: 20,kg,O
Sentence: 20,/,O
Sentence: 20,day,O
Sentence: 20,",",O
Sentence: 20,given,O
Sentence: 20,orally,O
Sentence: 20,),O
Sentence: 20,",",O
Sentence: 20,an,O
Sentence: 20,inhibitor,O
Sentence: 20,of,O
Sentence: 20,angiotensin,B-Chemical
Sentence: 20,-,O
Sentence: 20,converting,O
Sentence: 20,enzyme,O
Sentence: 20,used,O
Sentence: 20,as,O
Sentence: 20,a,O
Sentence: 20,standard,O
Sentence: 20,cardioprotective,O
Sentence: 20,drug,O
Sentence: 20,",",O
Sentence: 20,was,O
Sentence: 20,used,O
Sentence: 20,as,O
Sentence: 20,a,O
Sentence: 20,positive,O
Sentence: 20,control,O
Sentence: 20,in,O
Sentence: 20,this,O
Sentence: 20,study,O
Sentence: 20,.,O
Sentence: 20,The,O
Sentence: 20,data,O
Sentence: 20,of,O
Sentence: 20,the,O
Sentence: 20,present,O
Sentence: 20,study,O
Sentence: 20,suggest,O
Sentence: 20,that,O
Sentence: 20,S.,O
Sentence: 20,virgaurea,O
Sentence: 20,extract,O
Sentence: 20,exerts,O
Sentence: 20,its,O
Sentence: 20,protective,O
Sentence: 20,effect,O
Sentence: 20,by,O
Sentence: 20,decreasing,O
Sentence: 20,MDA,B-Chemical
Sentence: 20,level,O
Sentence: 20,and,O
Sentence: 20,increasing,O
Sentence: 20,the,O
Sentence: 20,antioxidant,O
Sentence: 20,status,O
Sentence: 20,in,O
Sentence: 20,isoproterenol,B-Chemical
Sentence: 20,-,O
Sentence: 20,treated,O
Sentence: 20,rats,O
Sentence: 20,.,O
Sentence: 20,The,O
Sentence: 20,study,O
Sentence: 20,emphasizes,O
Sentence: 20,the,O
Sentence: 20,beneficial,O
Sentence: 20,action,O
Sentence: 20,of,O
Sentence: 20,S.,O
Sentence: 20,virgaurea,O
Sentence: 20,extract,O
Sentence: 20,as,O
Sentence: 20,a,O
Sentence: 20,cardioprotective,O
Sentence: 20,agent,O
Sentence: 20,.,O
Sentence: 21,``,O
Sentence: 21,Real,O
Sentence: 21,-,O
Sentence: 21,world,O
Sentence: 21,'',O
Sentence: 21,data,O
Sentence: 21,on,O
Sentence: 21,the,O
Sentence: 21,efficacy,O
Sentence: 21,and,O
Sentence: 21,safety,O
Sentence: 21,of,O
Sentence: 21,lenalidomide,B-Chemical
Sentence: 21,and,O
Sentence: 21,dexamethasone,B-Chemical
Sentence: 21,in,O
Sentence: 21,patients,O
Sentence: 21,with,O
Sentence: 21,relapsed,O
Sentence: 21,/,O
Sentence: 21,refractory,O
Sentence: 21,multiple,B-Disease
Sentence: 21,myeloma,I-Disease
Sentence: 21,who,O
Sentence: 21,were,O
Sentence: 21,treated,O
Sentence: 21,according,O
Sentence: 21,to,O
Sentence: 21,the,O
Sentence: 21,standard,O
Sentence: 21,clinical,O
Sentence: 21,practice,O
Sentence: 21,:,O
Sentence: 21,a,O
Sentence: 21,study,O
Sentence: 21,of,O
Sentence: 21,the,O
Sentence: 21,Greek,O
Sentence: 21,Myeloma,B-Disease
Sentence: 21,Study,O
Sentence: 21,Group,O
Sentence: 21,.,O
Sentence: 22,Lenalidomide,B-Chemical
Sentence: 22,and,O
Sentence: 22,dexamethasone,B-Chemical
Sentence: 22,(,O
Sentence: 22,RD,B-Chemical
Sentence: 22,),O
Sentence: 22,is,O
Sentence: 22,a,O
Sentence: 22,standard,O
Sentence: 22,of,O
Sentence: 22,care,O
Sentence: 22,for,O
Sentence: 22,relapsed,O
Sentence: 22,/,O
Sentence: 22,refractory,O
Sentence: 22,multiple,B-Disease
Sentence: 22,myeloma,I-Disease
Sentence: 22,(,O
Sentence: 22,RRMM,B-Disease
Sentence: 22,),O
Sentence: 22,",",O
Sentence: 22,but,O
Sentence: 22,there,O
Sentence: 22,is,O
Sentence: 22,limited,O
Sentence: 22,published,O
Sentence: 22,data,O
Sentence: 22,on,O
Sentence: 22,its,O
Sentence: 22,efficacy,O
Sentence: 22,and,O
Sentence: 22,safety,O
Sentence: 22,in,O
Sentence: 22,the,O
Sentence: 22,``,O
Sentence: 22,real,O
Sentence: 22,world,O
Sentence: 22,'',O
Sentence: 22,(,O
Sentence: 22,RW,O
Sentence: 22,),O
Sentence: 22,",",O
Sentence: 22,according,O
Sentence: 22,to,O
Sentence: 22,the,O
Sentence: 22,International,O
Sentence: 22,Society,O
Sentence: 22,of,O
Sentence: 22,Pharmacoeconomics,O
Sentence: 22,and,O
Sentence: 22,Outcomes,O
Sentence: 22,Research,O
Sentence: 22,definition,O
Sentence: 22,.,O
Sentence: 22,We,O
Sentence: 22,studied,O
Sentence: 22,212,O
Sentence: 22,RRMM,B-Disease
Sentence: 22,patients,O
Sentence: 22,who,O
Sentence: 22,received,O
Sentence: 22,RD,B-Chemical
Sentence: 22,in,O
Sentence: 22,RW,O
Sentence: 22,.,O
Sentence: 22,Objective,O
Sentence: 22,response,O
Sentence: 22,(,O
Sentence: 22,,O
Sentence: 22,>,O
Sentence: 22,,O
Sentence: 22,PR,O
Sentence: 22,(,O
Sentence: 22,partial,O
Sentence: 22,response,O
Sentence: 22,),O
Sentence: 22,),O
Sentence: 22,rate,O
Sentence: 22,was,O
Sentence: 22,77.4,O
Sentence: 22,%,O
Sentence: 22,(,O
Sentence: 22,complete,O
Sentence: 22,response,O
Sentence: 22,(,O
Sentence: 22,CR,O
Sentence: 22,),O
Sentence: 22,",",O
Sentence: 22,20.2,O
Sentence: 22,%,O
Sentence: 22,),O
Sentence: 22,.,O
Sentence: 22,Median,O
Sentence: 22,time,O
Sentence: 22,to,O
Sentence: 22,first,O
Sentence: 22,and,O
Sentence: 22,best,O
Sentence: 22,response,O
Sentence: 22,was,O
Sentence: 22,2,O
Sentence: 22,and,O
Sentence: 22,5,O
Sentence: 22,months,O
Sentence: 22,",",O
Sentence: 22,respectively,O
Sentence: 22,.,O
Sentence: 22,Median,O
Sentence: 22,time,O
Sentence: 22,to,O
Sentence: 22,CR,O
Sentence: 22,when,O
Sentence: 22,RD,B-Chemical
Sentence: 22,was,O
Sentence: 22,given,O
Sentence: 22,as,O
Sentence: 22,2nd,O
Sentence: 22,or,O
Sentence: 22,,O
Sentence: 22,>,O
Sentence: 22,,O
Sentence: 22,2,O
Sentence: 22,(,O
Sentence: 22,nd,O
Sentence: 22,),O
Sentence: 22,,O
Sentence: 22,-,O
Sentence: 22,line,O
Sentence: 22,treatment,O
Sentence: 22,at,O
Sentence: 22,4,O
Sentence: 22,and,O
Sentence: 22,11,O
Sentence: 22,months,O
Sentence: 22,",",O
Sentence: 22,respectively,O
Sentence: 22,.,O
Sentence: 22,Quality,O
Sentence: 22,of,O
Sentence: 22,response,O
Sentence: 22,was,O
Sentence: 22,independent,O
Sentence: 22,of,O
Sentence: 22,previous,O
Sentence: 22,lines,O
Sentence: 22,of,O
Sentence: 22,therapies,O
Sentence: 22,or,O
Sentence: 22,previous,O
Sentence: 22,exposure,O
Sentence: 22,to,O
Sentence: 22,thalidomide,B-Chemical
Sentence: 22,or,O
Sentence: 22,bortezomib,B-Chemical
Sentence: 22,.,O
Sentence: 22,Median,O
Sentence: 22,duration,O
Sentence: 22,of,O
Sentence: 22,response,O
Sentence: 22,was,O
Sentence: 22,34.4,O
Sentence: 22,months,O
Sentence: 22,",",O
Sentence: 22,and,O
Sentence: 22,it,O
Sentence: 22,was,O
Sentence: 22,higher,O
Sentence: 22,in,O
Sentence: 22,patients,O
Sentence: 22,who,O
Sentence: 22,received,O
Sentence: 22,RD,B-Chemical
Sentence: 22,until,O
Sentence: 22,progression,O
Sentence: 22,(,O
Sentence: 22,not,O
Sentence: 22,reached,O
Sentence: 22,versus,O
Sentence: 22,19,O
Sentence: 22,months,O
Sentence: 22,",",O
Sentence: 22,p,O
Sentence: 22,,O
Sentence: 22,<,O
Sentence: 22,,O
Sentence: 22,0.001,O
Sentence: 22,),O
Sentence: 22,.,O
Sentence: 22,Improvement,O
Sentence: 22,of,O
Sentence: 22,humoral,O
Sentence: 22,immunity,O
Sentence: 22,occurred,O
Sentence: 22,in,O
Sentence: 22,60,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,responders,O
Sentence: 22,(,O
Sentence: 22,p,O
Sentence: 22,,O
Sentence: 22,<,O
Sentence: 22,,O
Sentence: 22,0.001,O
Sentence: 22,),O
Sentence: 22,and,O
Sentence: 22,in,O
Sentence: 22,the,O
Sentence: 22,majority,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,who,O
Sentence: 22,achieved,O
Sentence: 22,stable,O
Sentence: 22,disease,O
Sentence: 22,.,O
Sentence: 22,Adverse,O
Sentence: 22,events,O
Sentence: 22,were,O
Sentence: 22,reported,O
Sentence: 22,in,O
Sentence: 22,68.9,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,(,O
Sentence: 22,myelosuppression,B-Disease
Sentence: 22,in,O
Sentence: 22,49.4,O
Sentence: 22,%,O
Sentence: 22,),O
Sentence: 22,and,O
Sentence: 22,12.7,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,needed,O
Sentence: 22,hospitalization,O
Sentence: 22,.,O
Sentence: 22,Peripheral,B-Disease
Sentence: 22,neuropathy,I-Disease
Sentence: 22,was,O
Sentence: 22,observed,O
Sentence: 22,only,O
Sentence: 22,in,O
Sentence: 22,2.5,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,and,O
Sentence: 22,deep,B-Disease
Sentence: 22,vein,I-Disease
Sentence: 22,thrombosis,I-Disease
Sentence: 22,in,O
Sentence: 22,5.7,O
Sentence: 22,%,O
Sentence: 22,.,O
Sentence: 22,Dose,O
Sentence: 22,reductions,O
Sentence: 22,were,O
Sentence: 22,needed,O
Sentence: 22,in,O
Sentence: 22,31,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,and,O
Sentence: 22,permanent,O
Sentence: 22,discontinuation,O
Sentence: 22,in,O
Sentence: 22,38.9,O
Sentence: 22,%,O
Sentence: 22,.,O
Sentence: 22,Median,O
Sentence: 22,time,O
Sentence: 22,to,O
Sentence: 22,treatment,O
Sentence: 22,discontinuation,O
Sentence: 22,was,O
Sentence: 22,16.8,O
Sentence: 22,months,O
Sentence: 22,.,O
Sentence: 22,Performance,O
Sentence: 22,status,O
Sentence: 22,(,O
Sentence: 22,PS,O
Sentence: 22,),O
Sentence: 22,and,O
Sentence: 22,initial,O
Sentence: 22,lenalidomide,B-Chemical
Sentence: 22,dose,O
Sentence: 22,predicted,O
Sentence: 22,for,O
Sentence: 22,treatment,O
Sentence: 22,discontinuation,O
Sentence: 22,.,O
Sentence: 22,Extra,O
Sentence: 22,-,O
Sentence: 22,medullary,O
Sentence: 22,relapses,O
Sentence: 22,occurred,O
Sentence: 22,in,O
Sentence: 22,3.8,O
Sentence: 22,%,O
Sentence: 22,of,O
Sentence: 22,patients,O
Sentence: 22,.,O
Sentence: 22,Our,O
Sentence: 22,study,O
Sentence: 22,confirms,O
Sentence: 22,that,O
Sentence: 22,RD,B-Chemical
Sentence: 22,is,O
Sentence: 22,effective,O
Sentence: 22,and,O
Sentence: 22,safe,O
Sentence: 22,in,O
Sentence: 22,RRMM,B-Disease
Sentence: 22,in,O
Sentence: 22,the,O
Sentence: 22,RW,O
Sentence: 22,;,O
Sentence: 22,it,O
Sentence: 22,produces,O
Sentence: 22,durable,O
Sentence: 22,responses,O
Sentence: 22,especially,O
Sentence: 22,in,O
Sentence: 22,patients,O
Sentence: 22,who,O
Sentence: 22,continue,O
Sentence: 22,on,O
Sentence: 22,treatment,O
Sentence: 22,till,O
Sentence: 22,progression,O
Sentence: 22,and,O
Sentence: 22,improves,O
Sentence: 22,humoral,O
Sentence: 22,immunity,O
Sentence: 22,even,O
Sentence: 22,in,O
Sentence: 22,patients,O
Sentence: 22,with,O
Sentence: 22,stable,O
Sentence: 22,disease,O
Sentence: 22,.,O
Sentence: 23,The,O
Sentence: 23,cytogenetic,O
Sentence: 23,action,O
Sentence: 23,of,O
Sentence: 23,ifosfamide,B-Chemical
Sentence: 23,",",O
Sentence: 23,mesna,B-Chemical
Sentence: 23,",",O
Sentence: 23,and,O
Sentence: 23,their,O
Sentence: 23,combination,O
Sentence: 23,on,O
Sentence: 23,peripheral,O
Sentence: 23,rabbit,O
Sentence: 23,lymphocytes,O
Sentence: 23,:,O
Sentence: 23,an,O
Sentence: 23,in,O
Sentence: 23,vivo,O
Sentence: 23,/,O
Sentence: 23,in,O
Sentence: 23,vitro,O
Sentence: 23,cytogenetic,O
Sentence: 23,study,O
Sentence: 23,.,O
Sentence: 24,Ifosfamide,B-Chemical
Sentence: 24,(,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,),O
Sentence: 24,is,O
Sentence: 24,an,O
Sentence: 24,alkylating,O
Sentence: 24,nitrogen,B-Chemical
Sentence: 24,mustard,O
Sentence: 24,",",O
Sentence: 24,administrated,O
Sentence: 24,as,O
Sentence: 24,an,O
Sentence: 24,antineoplasmic,O
Sentence: 24,agent,O
Sentence: 24,.,O
Sentence: 24,It,O
Sentence: 24,is,O
Sentence: 24,characterized,O
Sentence: 24,by,O
Sentence: 24,its,O
Sentence: 24,intense,O
Sentence: 24,urotoxic,O
Sentence: 24,action,O
Sentence: 24,",",O
Sentence: 24,leading,O
Sentence: 24,to,O
Sentence: 24,hemorrhagic,B-Disease
Sentence: 24,cystitis,B-Disease
Sentence: 24,.,O
Sentence: 24,This,O
Sentence: 24,side,O
Sentence: 24,effect,O
Sentence: 24,of,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,raises,O
Sentence: 24,the,O
Sentence: 24,requirement,O
Sentence: 24,for,O
Sentence: 24,the,O
Sentence: 24,co,O
Sentence: 24,-,O
Sentence: 24,administration,O
Sentence: 24,with,O
Sentence: 24,sodium,O
Sentence: 24,2,O
Sentence: 24,-,O
Sentence: 24,sulfanylethanesulfonate,O
Sentence: 24,(,O
Sentence: 24,Mesna,B-Chemical
Sentence: 24,),O
Sentence: 24,aiming,O
Sentence: 24,to,O
Sentence: 24,avoid,O
Sentence: 24,or,O
Sentence: 24,minimize,O
Sentence: 24,this,O
Sentence: 24,effect,O
Sentence: 24,.,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,and,O
Sentence: 24,Mesna,B-Chemical
Sentence: 24,were,O
Sentence: 24,administrated,O
Sentence: 24,separately,O
Sentence: 24,on,O
Sentence: 24,rabbit,O
Sentence: 24,'s,O
Sentence: 24,lymphocytes,O
Sentence: 24,in,O
Sentence: 24,vivo,O
Sentence: 24,",",O
Sentence: 24,which,O
Sentence: 24,were,O
Sentence: 24,later,O
Sentence: 24,developed,O
Sentence: 24,in,O
Sentence: 24,vitro,O
Sentence: 24,.,O
Sentence: 24,Cytogenetic,O
Sentence: 24,markers,O
Sentence: 24,for,O
Sentence: 24,sister,O
Sentence: 24,chromatid,O
Sentence: 24,exchanges,O
Sentence: 24,(,O
Sentence: 24,SCEs,O
Sentence: 24,),O
Sentence: 24,",",O
Sentence: 24,proliferation,O
Sentence: 24,rate,O
Sentence: 24,index,O
Sentence: 24,(,O
Sentence: 24,PRI,O
Sentence: 24,),O
Sentence: 24,and,O
Sentence: 24,Mitotic,O
Sentence: 24,Index,O
Sentence: 24,were,O
Sentence: 24,recorded,O
Sentence: 24,.,O
Sentence: 24,Mesna,B-Chemical
Sentence: 24,'s,O
Sentence: 24,action,O
Sentence: 24,",",O
Sentence: 24,in,O
Sentence: 24,conjunction,O
Sentence: 24,with,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,reduces,O
Sentence: 24,the,O
Sentence: 24,frequency,O
Sentence: 24,of,O
Sentence: 24,SCEs,O
Sentence: 24,",",O
Sentence: 24,in,O
Sentence: 24,comparison,O
Sentence: 24,with,O
Sentence: 24,the,O
Sentence: 24,SCEs,O
Sentence: 24,recordings,O
Sentence: 24,obtained,O
Sentence: 24,when,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,is,O
Sentence: 24,administered,O
Sentence: 24,alone,O
Sentence: 24,.,O
Sentence: 24,In,O
Sentence: 24,addition,O
Sentence: 24,to,O
Sentence: 24,this,O
Sentence: 24,",",O
Sentence: 24,when,O
Sentence: 24,high,O
Sentence: 24,concentrations,O
Sentence: 24,of,O
Sentence: 24,Mesna,B-Chemical
Sentence: 24,were,O
Sentence: 24,administered,O
Sentence: 24,alone,O
Sentence: 24,significant,O
Sentence: 24,reductions,O
Sentence: 24,of,O
Sentence: 24,the,O
Sentence: 24,PRI,O
Sentence: 24,were,O
Sentence: 24,noted,O
Sentence: 24,",",O
Sentence: 24,than,O
Sentence: 24,with,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,acting,O
Sentence: 24,at,O
Sentence: 24,the,O
Sentence: 24,same,O
Sentence: 24,concentration,O
Sentence: 24,on,O
Sentence: 24,the,O
Sentence: 24,lymphocytes,O
Sentence: 24,.,O
Sentence: 24,Mesna,B-Chemical
Sentence: 24,significantly,O
Sentence: 24,reduces,O
Sentence: 24,IFO,B-Chemical
Sentence: 24,'s,O
Sentence: 24,genotoxicity,B-Disease
Sentence: 24,",",O
Sentence: 24,while,O
Sentence: 24,when,O
Sentence: 24,administered,O
Sentence: 24,in,O
Sentence: 24,high,O
Sentence: 24,concentrations,O
Sentence: 24,it,O
Sentence: 24,acts,O
Sentence: 24,in,O
Sentence: 24,an,O
Sentence: 24,inhibitory,O
Sentence: 24,fashion,O
Sentence: 24,on,O
Sentence: 24,the,O
Sentence: 24,cytostatic,O
Sentence: 24,action,O
Sentence: 24,of,O
Sentence: 24,the,O
Sentence: 24,drug,O
Sentence: 24,.,O
Sentence: 25,Risk,O
Sentence: 25,factors,O
Sentence: 25,and,O
Sentence: 25,predictors,O
Sentence: 25,of,O
Sentence: 25,levodopa,B-Chemical
Sentence: 25,-,O
Sentence: 25,induced,O
Sentence: 25,dyskinesia,B-Disease
Sentence: 25,among,O
Sentence: 25,multiethnic,O
Sentence: 25,Malaysians,O
Sentence: 25,with,O
Sentence: 25,Parkinson,B-Disease
Sentence: 25,'s,I-Disease
Sentence: 25,disease,I-Disease
Sentence: 25,.,O
Sentence: 26,Chronic,O
Sentence: 26,pulsatile,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,for,O
Sentence: 26,Parkinson,B-Disease
Sentence: 26,'s,I-Disease
Sentence: 26,disease,I-Disease
Sentence: 26,(,O
Sentence: 26,PD,B-Disease
Sentence: 26,),O
Sentence: 26,leads,O
Sentence: 26,to,O
Sentence: 26,the,O
Sentence: 26,development,O
Sentence: 26,of,O
Sentence: 26,motor,O
Sentence: 26,fluctuations,O
Sentence: 26,and,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,.,O
Sentence: 26,We,O
Sentence: 26,studied,O
Sentence: 26,the,O
Sentence: 26,prevalence,O
Sentence: 26,and,O
Sentence: 26,predictors,O
Sentence: 26,of,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,-,O
Sentence: 26,induced,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,among,O
Sentence: 26,multiethnic,O
Sentence: 26,Malaysian,O
Sentence: 26,patients,O
Sentence: 26,with,O
Sentence: 26,PD,B-Disease
Sentence: 26,.,O
Sentence: 26,METHODS,O
Sentence: 26,:,O
Sentence: 26,This,O
Sentence: 26,is,O
Sentence: 26,a,O
Sentence: 26,cross,O
Sentence: 26,-,O
Sentence: 26,sectional,O
Sentence: 26,study,O
Sentence: 26,involving,O
Sentence: 26,95,O
Sentence: 26,patients,O
Sentence: 26,with,O
Sentence: 26,PD,B-Disease
Sentence: 26,on,O
Sentence: 26,uninterrupted,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,for,O
Sentence: 26,at,O
Sentence: 26,least,O
Sentence: 26,6,O
Sentence: 26,months,O
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,instrument,O
Sentence: 26,used,O
Sentence: 26,was,O
Sentence: 26,the,O
Sentence: 26,UPDRS,O
Sentence: 26,questionnaires,O
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,predictors,O
Sentence: 26,of,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,were,O
Sentence: 26,determined,O
Sentence: 26,using,O
Sentence: 26,multivariate,O
Sentence: 26,logistic,O
Sentence: 26,regression,O
Sentence: 26,analysis,O
Sentence: 26,.,O
Sentence: 26,RESULTS,O
Sentence: 26,:,O
Sentence: 26,The,O
Sentence: 26,mean,O
Sentence: 26,age,O
Sentence: 26,was,O
Sentence: 26,65.6,O
Sentence: 26,+,O
Sentence: 26,8.5,O
Sentence: 26,years,O
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,mean,O
Sentence: 26,onset,O
Sentence: 26,age,O
Sentence: 26,was,O
Sentence: 26,58.5,O
Sentence: 26,+,O
Sentence: 26,9.8,O
Sentence: 26,years,O
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,median,O
Sentence: 26,disease,O
Sentence: 26,duration,O
Sentence: 26,was,O
Sentence: 26,6,O
Sentence: 26,(,O
Sentence: 26,7,O
Sentence: 26,),O
Sentence: 26,years,O
Sentence: 26,.,O
Sentence: 26,Dyskinesia,B-Disease
Sentence: 26,was,O
Sentence: 26,present,O
Sentence: 26,in,O
Sentence: 26,44,O
Sentence: 26,%,O
Sentence: 26,(,O
Sentence: 26,n,O
Sentence: 26,,O
Sentence: 26,=,O
Sentence: 26,,O
Sentence: 26,42,O
Sentence: 26,),O
Sentence: 26,with,O
Sentence: 26,median,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,of,O
Sentence: 26,3,O
Sentence: 26,years,O
Sentence: 26,.,O
Sentence: 26,There,O
Sentence: 26,were,O
Sentence: 26,64.3,O
Sentence: 26,%,O
Sentence: 26,Chinese,O
Sentence: 26,",",O
Sentence: 26,31,O
Sentence: 26,%,O
Sentence: 26,Malays,O
Sentence: 26,",",O
Sentence: 26,and,O
Sentence: 26,3.7,O
Sentence: 26,%,O
Sentence: 26,Indians,O
Sentence: 26,and,O
Sentence: 26,other,O
Sentence: 26,ethnic,O
Sentence: 26,groups,O
Sentence: 26,.,O
Sentence: 26,Eighty,O
Sentence: 26,-,O
Sentence: 26,one,O
Sentence: 26,percent,O
Sentence: 26,of,O
Sentence: 26,patients,O
Sentence: 26,with,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,had,O
Sentence: 26,clinical,O
Sentence: 26,fluctuations,O
Sentence: 26,.,O
Sentence: 26,Patients,O
Sentence: 26,with,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,had,O
Sentence: 26,lower,O
Sentence: 26,onset,O
Sentence: 26,age,O
Sentence: 26,(,O
Sentence: 26,p,O
Sentence: 26,,O
Sentence: 26,<,O
Sentence: 26,,O
Sentence: 26,0.001,O
Sentence: 26,),O
Sentence: 26,",",O
Sentence: 26,longer,O
Sentence: 26,duration,O
Sentence: 26,of,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,(,O
Sentence: 26,p,O
Sentence: 26,,O
Sentence: 26,<,O
Sentence: 26,,O
Sentence: 26,0.001,O
Sentence: 26,),O
Sentence: 26,",",O
Sentence: 26,longer,O
Sentence: 26,disease,O
Sentence: 26,duration,O
Sentence: 26,(,O
Sentence: 26,p,O
Sentence: 26,,O
Sentence: 26,<,O
Sentence: 26,,O
Sentence: 26,0.001,O
Sentence: 26,),O
Sentence: 26,",",O
Sentence: 26,higher,O
Sentence: 26,total,O
Sentence: 26,daily,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,dose,O
Sentence: 26,(,O
Sentence: 26,p,O
Sentence: 26,,O
Sentence: 26,<,O
Sentence: 26,,O
Sentence: 26,0.001,O
Sentence: 26,),O
Sentence: 26,",",O
Sentence: 26,and,O
Sentence: 26,higher,O
Sentence: 26,total,O
Sentence: 26,UPDRS,O
Sentence: 26,scores,O
Sentence: 26,(,O
Sentence: 26,p,O
Sentence: 26,,O
Sentence: 26,=,O
Sentence: 26,,O
Sentence: 26,0.005,O
Sentence: 26,),O
Sentence: 26,than,O
Sentence: 26,patients,O
Sentence: 26,without,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,three,O
Sentence: 26,significant,O
Sentence: 26,predictors,O
Sentence: 26,of,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,were,O
Sentence: 26,duration,O
Sentence: 26,of,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,",",O
Sentence: 26,onset,O
Sentence: 26,age,O
Sentence: 26,",",O
Sentence: 26,and,O
Sentence: 26,total,O
Sentence: 26,daily,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,dose,O
Sentence: 26,.,O
Sentence: 26,CONCLUSIONS,O
Sentence: 26,:,O
Sentence: 26,The,O
Sentence: 26,prevalence,O
Sentence: 26,of,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,-,O
Sentence: 26,induced,O
Sentence: 26,dyskinesia,B-Disease
Sentence: 26,in,O
Sentence: 26,our,O
Sentence: 26,patients,O
Sentence: 26,was,O
Sentence: 26,44,O
Sentence: 26,%,O
Sentence: 26,.,O
Sentence: 26,The,O
Sentence: 26,most,O
Sentence: 26,significant,O
Sentence: 26,predictors,O
Sentence: 26,were,O
Sentence: 26,duration,O
Sentence: 26,of,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,therapy,O
Sentence: 26,",",O
Sentence: 26,total,O
Sentence: 26,daily,O
Sentence: 26,levodopa,B-Chemical
Sentence: 26,dose,O
Sentence: 26,",",O
Sentence: 26,and,O
Sentence: 26,onset,O
Sentence: 26,age,O
Sentence: 26,.,O
Sentence: 27,An,O
Sentence: 27,unexpected,O
Sentence: 27,diagnosis,O
Sentence: 27,in,O
Sentence: 27,a,O
Sentence: 27,renal,O
Sentence: 27,-,O
Sentence: 27,transplant,O
Sentence: 27,patient,O
Sentence: 27,with,O
Sentence: 27,proteinuria,B-Disease
Sentence: 27,treated,O
Sentence: 27,with,O
Sentence: 27,everolimus,B-Chemical
Sentence: 27,:,O
Sentence: 27,AL,B-Disease
Sentence: 27,amyloidosis,B-Disease
Sentence: 27,.,O
Sentence: 28,Proteinuria,B-Disease
Sentence: 28,is,O
Sentence: 28,an,O
Sentence: 28,expected,O
Sentence: 28,complication,O
Sentence: 28,in,O
Sentence: 28,transplant,O
Sentence: 28,patients,O
Sentence: 28,treated,O
Sentence: 28,with,O
Sentence: 28,mammalian,O
Sentence: 28,target,O
Sentence: 28,of,O
Sentence: 28,rapamycin,B-Chemical
Sentence: 28,inhibitors,O
Sentence: 28,(,O
Sentence: 28,mTOR,O
Sentence: 28,-,O
Sentence: 28,i,O
Sentence: 28,),O
Sentence: 28,.,O
Sentence: 28,However,O
Sentence: 28,",",O
Sentence: 28,clinical,O
Sentence: 28,suspicion,O
Sentence: 28,should,O
Sentence: 28,always,O
Sentence: 28,be,O
Sentence: 28,supported,O
Sentence: 28,by,O
Sentence: 28,histological,O
Sentence: 28,evidence,O
Sentence: 28,in,O
Sentence: 28,order,O
Sentence: 28,to,O
Sentence: 28,investigate,O
Sentence: 28,potential,O
Sentence: 28,alternate,O
Sentence: 28,diagnoses,O
Sentence: 28,such,O
Sentence: 28,as,O
Sentence: 28,acute,O
Sentence: 28,or,O
Sentence: 28,chronic,O
Sentence: 28,rejection,O
Sentence: 28,",",O
Sentence: 28,interstitial,O
Sentence: 28,fibrosis,B-Disease
Sentence: 28,and,O
Sentence: 28,tubular,O
Sentence: 28,atrophy,B-Disease
Sentence: 28,",",O
Sentence: 28,or,O
Sentence: 28,recurrent,O
Sentence: 28,or,O
Sentence: 28,de,O
Sentence: 28,novo,O
Sentence: 28,glomerulopathy,B-Disease
Sentence: 28,.,O
Sentence: 28,In,O
Sentence: 28,this,O
Sentence: 28,case,O
Sentence: 28,we,O
Sentence: 28,report,O
Sentence: 28,the,O
Sentence: 28,unexpected,O
Sentence: 28,diagnosis,O
Sentence: 28,of,O
Sentence: 28,amyloidosis,B-Disease
Sentence: 28,in,O
Sentence: 28,a,O
Sentence: 28,renal,O
Sentence: 28,-,O
Sentence: 28,transplant,O
Sentence: 28,patient,O
Sentence: 28,with,O
Sentence: 28,pre,O
Sentence: 28,-,O
Sentence: 28,transplant,O
Sentence: 28,monoclonal,O
Sentence: 28,gammapathy,O
Sentence: 28,of,O
Sentence: 28,undetermined,O
Sentence: 28,significance,O
Sentence: 28,who,O
Sentence: 28,developed,O
Sentence: 28,proteinuria,B-Disease
Sentence: 28,after,O
Sentence: 28,conversion,O
Sentence: 28,from,O
Sentence: 28,tacrolimus,B-Chemical
Sentence: 28,to,O
Sentence: 28,everolimus,B-Chemical
Sentence: 28,.,O
Sentence: 29,An,O
Sentence: 29,investigation,O
Sentence: 29,of,O
Sentence: 29,the,O
Sentence: 29,pattern,O
Sentence: 29,of,O
Sentence: 29,kidney,B-Disease
Sentence: 29,injury,I-Disease
Sentence: 29,in,O
Sentence: 29,HIV,O
Sentence: 29,-,O
Sentence: 29,positive,O
Sentence: 29,persons,O
Sentence: 29,exposed,O
Sentence: 29,to,O
Sentence: 29,tenofovir,B-Chemical
Sentence: 29,disoproxil,I-Chemical
Sentence: 29,fumarate,I-Chemical
Sentence: 29,:,O
Sentence: 29,an,O
Sentence: 29,examination,O
Sentence: 29,of,O
Sentence: 29,a,O
Sentence: 29,large,O
Sentence: 29,population,O
Sentence: 29,database,O
Sentence: 29,(,O
Sentence: 29,MHRA,O
Sentence: 29,database,O
Sentence: 29,),O
Sentence: 29,.,O
Sentence: 30,The,O
Sentence: 30,potential,O
Sentence: 30,for,O
Sentence: 30,tenofovir,B-Chemical
Sentence: 30,to,O
Sentence: 30,cause,O
Sentence: 30,a,O
Sentence: 30,range,O
Sentence: 30,of,O
Sentence: 30,kidney,O
Sentence: 30,syndromes,O
Sentence: 30,has,O
Sentence: 30,been,O
Sentence: 30,established,O
Sentence: 30,from,O
Sentence: 30,mechanistic,O
Sentence: 30,and,O
Sentence: 30,randomised,O
Sentence: 30,clinical,O
Sentence: 30,trials,O
Sentence: 30,.,O
Sentence: 30,However,O
Sentence: 30,",",O
Sentence: 30,the,O
Sentence: 30,exact,O
Sentence: 30,pattern,O
Sentence: 30,of,O
Sentence: 30,kidney,O
Sentence: 30,involvement,O
Sentence: 30,is,O
Sentence: 30,still,O
Sentence: 30,uncertain,O
Sentence: 30,.,O
Sentence: 30,We,O
Sentence: 30,undertook,O
Sentence: 30,a,O
Sentence: 30,descriptive,O
Sentence: 30,analysis,O
Sentence: 30,of,O
Sentence: 30,Yellow,O
Sentence: 30,Card,O
Sentence: 30,records,O
Sentence: 30,of,O
Sentence: 30,407,O
Sentence: 30,HIV,O
Sentence: 30,-,O
Sentence: 30,positive,O
Sentence: 30,persons,O
Sentence: 30,taking,O
Sentence: 30,tenofovir,B-Chemical
Sentence: 30,disoproxil,I-Chemical
Sentence: 30,fumarate,I-Chemical
Sentence: 30,(,O
Sentence: 30,TDF,B-Chemical
Sentence: 30,),O
Sentence: 30,as,O
Sentence: 30,part,O
Sentence: 30,of,O
Sentence: 30,their,O
Sentence: 30,antiretroviral,O
Sentence: 30,therapy,O
Sentence: 30,regimen,O
Sentence: 30,and,O
Sentence: 30,submitted,O
Sentence: 30,to,O
Sentence: 30,the,O
Sentence: 30,Medicines,O
Sentence: 30,and,O
Sentence: 30,Healthcare,O
Sentence: 30,Products,O
Sentence: 30,Regulatory,O
Sentence: 30,Agency,O
Sentence: 30,(,O
Sentence: 30,MHRA,O
Sentence: 30,),O
Sentence: 30,with,O
Sentence: 30,suspected,O
Sentence: 30,kidney,O
Sentence: 30,adverse,O
Sentence: 30,effects,O
Sentence: 30,.,O
Sentence: 30,Reports,O
Sentence: 30,that,O
Sentence: 30,satisfy,O
Sentence: 30,defined,O
Sentence: 30,criteria,O
Sentence: 30,were,O
Sentence: 30,classified,O
Sentence: 30,as,O
Sentence: 30,acute,B-Disease
Sentence: 30,kidney,I-Disease
Sentence: 30,injury,I-Disease
Sentence: 30,",",O
Sentence: 30,kidney,B-Disease
Sentence: 30,tubular,I-Disease
Sentence: 30,dysfunction,I-Disease
Sentence: 30,and,O
Sentence: 30,Fanconi,B-Disease
Sentence: 30,syndrome,I-Disease
Sentence: 30,.,O
Sentence: 30,Of,O
Sentence: 30,the,O
Sentence: 30,407,O
Sentence: 30,Yellow,O
Sentence: 30,Card,O
Sentence: 30,records,O
Sentence: 30,analysed,O
Sentence: 30,",",O
Sentence: 30,106,O
Sentence: 30,satisfied,O
Sentence: 30,criteria,O
Sentence: 30,for,O
Sentence: 30,TDF,B-Chemical
Sentence: 30,-,O
Sentence: 30,related,O
Sentence: 30,kidney,B-Disease
Sentence: 30,disease,I-Disease
Sentence: 30,",",O
Sentence: 30,of,O
Sentence: 30,which,O
Sentence: 30,53,O
Sentence: 30,(,O
Sentence: 30,50,O
Sentence: 30,%,O
Sentence: 30,),O
Sentence: 30,had,O
Sentence: 30,features,O
Sentence: 30,of,O
Sentence: 30,kidney,B-Disease
Sentence: 30,tubular,I-Disease
Sentence: 30,dysfunction,I-Disease
Sentence: 30,",",O
Sentence: 30,35,O
Sentence: 30,(,O
Sentence: 30,33,O
Sentence: 30,%,O
Sentence: 30,),O
Sentence: 30,were,O
Sentence: 30,found,O
Sentence: 30,to,O
Sentence: 30,have,O
Sentence: 30,features,O
Sentence: 30,of,O
Sentence: 30,glomerular,B-Disease
Sentence: 30,dysfunction,I-Disease
Sentence: 30,and,O
Sentence: 30,18,O
Sentence: 30,(,O
Sentence: 30,17,O
Sentence: 30,%,O
Sentence: 30,),O
Sentence: 30,had,O
Sentence: 30,Fanconi,B-Disease
Sentence: 30,syndrome,I-Disease
Sentence: 30,.,O
Sentence: 30,The,O
Sentence: 30,median,O
Sentence: 30,TDF,B-Chemical
Sentence: 30,exposure,O
Sentence: 30,was,O
Sentence: 30,316,O
Sentence: 30,days,O
Sentence: 30,(,O
Sentence: 30,interquartile,O
Sentence: 30,range,O
Sentence: 30,120,O
Sentence: 30,-,O
Sentence: 30,740,O
Sentence: 30,),O
Sentence: 30,.,O
Sentence: 30,The,O
Sentence: 30,incidence,O
Sentence: 30,of,O
Sentence: 30,hospitalisation,O
Sentence: 30,for,O
Sentence: 30,TDF,B-Chemical
Sentence: 30,kidney,O
Sentence: 30,adverse,O
Sentence: 30,effects,O
Sentence: 30,was,O
Sentence: 30,high,O
Sentence: 30,",",O
Sentence: 30,particularly,O
Sentence: 30,amongst,O
Sentence: 30,patients,O
Sentence: 30,with,O
Sentence: 30,features,O
Sentence: 30,of,O
Sentence: 30,Fanconi,B-Disease
Sentence: 30,syndrome,I-Disease
Sentence: 30,.,O
Sentence: 30,The,O
Sentence: 30,pattern,O
Sentence: 30,of,O
Sentence: 30,kidney,O
Sentence: 30,syndromes,O
Sentence: 30,in,O
Sentence: 30,this,O
Sentence: 30,population,O
Sentence: 30,series,O
Sentence: 30,mirrors,O
Sentence: 30,that,O
Sentence: 30,reported,O
Sentence: 30,in,O
Sentence: 30,randomised,O
Sentence: 30,clinical,O
Sentence: 30,trials,O
Sentence: 30,.,O
Sentence: 30,Cessation,O
Sentence: 30,of,O
Sentence: 30,TDF,B-Chemical
Sentence: 30,was,O
Sentence: 30,associated,O
Sentence: 30,with,O
Sentence: 30,complete,O
Sentence: 30,restoration,O
Sentence: 30,of,O
Sentence: 30,kidney,O
Sentence: 30,function,O
Sentence: 30,in,O
Sentence: 30,up,O
Sentence: 30,half,O
Sentence: 30,of,O
Sentence: 30,the,O
Sentence: 30,patients,O
Sentence: 30,in,O
Sentence: 30,this,O
Sentence: 30,report,O
Sentence: 30,.,O
Sentence: 31,Incidence,O
Sentence: 31,of,O
Sentence: 31,postoperative,O
Sentence: 31,delirium,O
Sentence: 31,is,O
Sentence: 31,high,O
Sentence: 31,even,O
Sentence: 31,in,O
Sentence: 31,a,O
Sentence: 31,population,O
Sentence: 31,without,O
Sentence: 31,known,O
Sentence: 31,risk,O
Sentence: 31,factors,O
Sentence: 31,.,O
Sentence: 32,PURPOSE,O
Sentence: 32,:,O
Sentence: 32,Postoperative,B-Disease
Sentence: 32,delirium,B-Disease
Sentence: 32,is,O
Sentence: 32,a,O
Sentence: 32,recognized,O
Sentence: 32,complication,O
Sentence: 32,in,O
Sentence: 32,populations,O
Sentence: 32,at,O
Sentence: 32,risk,O
Sentence: 32,.,O
Sentence: 32,The,O
Sentence: 32,aim,O
Sentence: 32,of,O
Sentence: 32,this,O
Sentence: 32,study,O
Sentence: 32,is,O
Sentence: 32,to,O
Sentence: 32,assess,O
Sentence: 32,the,O
Sentence: 32,prevalence,O
Sentence: 32,of,O
Sentence: 32,early,O
Sentence: 32,postoperative,B-Disease
Sentence: 32,delirium,I-Disease
Sentence: 32,in,O
Sentence: 32,a,O
Sentence: 32,population,O
Sentence: 32,without,O
Sentence: 32,known,O
Sentence: 32,risk,O
Sentence: 32,factors,O
Sentence: 32,admitted,O
Sentence: 32,to,O
Sentence: 32,the,O
Sentence: 32,ICU,O
Sentence: 32,for,O
Sentence: 32,postoperative,O
Sentence: 32,monitoring,O
Sentence: 32,after,O
Sentence: 32,elective,O
Sentence: 32,major,O
Sentence: 32,surgery,O
Sentence: 32,.,O
Sentence: 32,The,O
Sentence: 32,secondary,O
Sentence: 32,outcome,O
Sentence: 32,investigated,O
Sentence: 32,is,O
Sentence: 32,to,O
Sentence: 32,identify,O
Sentence: 32,eventual,O
Sentence: 32,independent,O
Sentence: 32,risk,O
Sentence: 32,factors,O
Sentence: 32,among,O
Sentence: 32,demographic,O
Sentence: 32,data,O
Sentence: 32,and,O
Sentence: 32,anesthetic,O
Sentence: 32,drugs,O
Sentence: 32,used,O
Sentence: 32,.,O
Sentence: 32,METHODS,O
Sentence: 32,:,O
Sentence: 32,An,O
Sentence: 32,observational,O
Sentence: 32,",",O
Sentence: 32,prospective,O
Sentence: 32,study,O
Sentence: 32,was,O
Sentence: 32,conducted,O
Sentence: 32,on,O
Sentence: 32,a,O
Sentence: 32,consecutive,O
Sentence: 32,cohort,O
Sentence: 32,of,O
Sentence: 32,patients,O
Sentence: 32,admitted,O
Sentence: 32,to,O
Sentence: 32,our,O
Sentence: 32,ICU,O
Sentence: 32,within,O
Sentence: 32,and,O
Sentence: 32,for,O
Sentence: 32,at,O
Sentence: 32,least,O
Sentence: 32,24,O
Sentence: 32,h,O
Sentence: 32,after,O
Sentence: 32,major,O
Sentence: 32,surgical,O
Sentence: 32,procedures,O
Sentence: 32,.,O
Sentence: 32,Exclusion,O
Sentence: 32,criteria,O
Sentence: 32,were,O
Sentence: 32,any,O
Sentence: 32,preexisting,O
Sentence: 32,predisposing,O
Sentence: 32,factor,O
Sentence: 32,for,O
Sentence: 32,delirium,B-Disease
Sentence: 32,or,O
Sentence: 32,other,O
Sentence: 32,potentially,O
Sentence: 32,confounding,O
Sentence: 32,neurological,B-Disease
Sentence: 32,dysfunctions,I-Disease
Sentence: 32,.,O
Sentence: 32,Patients,O
Sentence: 32,were,O
Sentence: 32,assessed,O
Sentence: 32,daily,O
Sentence: 32,using,O
Sentence: 32,the,O
Sentence: 32,confusion,B-Disease
Sentence: 32,assessment,O
Sentence: 32,method,O
Sentence: 32,for,O
Sentence: 32,the,O
Sentence: 32,ICU,O
Sentence: 32,scale,O
Sentence: 32,for,O
Sentence: 32,3,O
Sentence: 32,days,O
Sentence: 32,after,O
Sentence: 32,the,O
Sentence: 32,surgical,O
Sentence: 32,procedure,O
Sentence: 32,.,O
Sentence: 32,Early,O
Sentence: 32,postoperative,B-Disease
Sentence: 32,delirium,I-Disease
Sentence: 32,incidence,O
Sentence: 32,risk,O
Sentence: 32,factors,O
Sentence: 32,were,O
Sentence: 32,then,O
Sentence: 32,assessed,O
Sentence: 32,through,O
Sentence: 32,three,O
Sentence: 32,different,O
Sentence: 32,multiple,O
Sentence: 32,regression,O
Sentence: 32,models,O
Sentence: 32,.,O
Sentence: 32,RESULTS,O
Sentence: 32,:,O
Sentence: 32,According,O
Sentence: 32,to,O
Sentence: 32,the,O
Sentence: 32,confusion,B-Disease
Sentence: 32,assessment,O
Sentence: 32,method,O
Sentence: 32,for,O
Sentence: 32,the,O
Sentence: 32,ICU,O
Sentence: 32,scale,O
Sentence: 32,",",O
Sentence: 32,28,O
Sentence: 32,%,O
Sentence: 32,of,O
Sentence: 32,patients,O
Sentence: 32,were,O
Sentence: 32,diagnosed,O
Sentence: 32,with,O
Sentence: 32,early,O
Sentence: 32,postoperative,B-Disease
Sentence: 32,delirium,I-Disease
Sentence: 32,.,O
Sentence: 32,The,O
Sentence: 32,use,O
Sentence: 32,of,O
Sentence: 32,thiopentone,B-Chemical
Sentence: 32,was,O
Sentence: 32,significantly,O
Sentence: 32,associated,O
Sentence: 32,with,O
Sentence: 32,an,O
Sentence: 32,eight,O
Sentence: 32,-,O
Sentence: 32,fold,O
Sentence: 32,-,O
Sentence: 32,higher,O
Sentence: 32,risk,O
Sentence: 32,for,O
Sentence: 32,delirium,B-Disease
Sentence: 32,compared,O
Sentence: 32,to,O
Sentence: 32,propofol,B-Chemical
Sentence: 32,(,O
Sentence: 32,57.1,O
Sentence: 32,%,O
Sentence: 32,vs.,O
Sentence: 32,7.1,O
Sentence: 32,%,O
Sentence: 32,",",O
Sentence: 32,RR,O
Sentence: 32,,O
Sentence: 32,=,O
Sentence: 32,,O
Sentence: 32,8.0,O
Sentence: 32,",",O
Sentence: 32,X2,O
Sentence: 32,,O
Sentence: 32,=,O
Sentence: 32,,O
Sentence: 32,4.256,O
Sentence: 32,;,O
Sentence: 32,df,O
Sentence: 32,,O
Sentence: 32,=,O
Sentence: 32,,O
Sentence: 32,1,O
Sentence: 32,;,O
Sentence: 32,0.05,O
Sentence: 32,,O
Sentence: 32,<,O
Sentence: 32,,O
Sentence: 32,p,O
Sentence: 32,,O
Sentence: 32,<,O
Sentence: 32,,O
Sentence: 32,0.02,O
Sentence: 32,),O
Sentence: 32,.,O
Sentence: 32,CONCLUSION,O
Sentence: 32,:,O
Sentence: 32,In,O
Sentence: 32,this,O
Sentence: 32,study,O
Sentence: 32,early,O
Sentence: 32,postoperative,B-Disease
Sentence: 32,delirium,I-Disease
Sentence: 32,was,O
Sentence: 32,found,O
Sentence: 32,to,O
Sentence: 32,be,O
Sentence: 32,a,O
Sentence: 32,very,O
Sentence: 32,common,O
Sentence: 32,complication,O
Sentence: 32,after,O
Sentence: 32,major,O
Sentence: 32,surgery,O
Sentence: 32,",",O
Sentence: 32,even,O
Sentence: 32,in,O
Sentence: 32,a,O
Sentence: 32,population,O
Sentence: 32,without,O
Sentence: 32,known,O
Sentence: 32,risk,O
Sentence: 32,factors,O
Sentence: 32,.,O
Sentence: 32,Thiopentone,B-Chemical
Sentence: 32,was,O
Sentence: 32,independently,O
Sentence: 32,associated,O
Sentence: 32,with,O
Sentence: 32,an,O
Sentence: 32,increase,O
Sentence: 32,in,O
Sentence: 32,its,O
Sentence: 32,relative,O
Sentence: 32,risk,O
Sentence: 32,.,O
Sentence: 33,A,O
Sentence: 33,single,O
Sentence: 33,neurotoxic,B-Disease
Sentence: 33,dose,O
Sentence: 33,of,O
Sentence: 33,methamphetamine,B-Chemical
Sentence: 33,induces,O
Sentence: 33,a,O
Sentence: 33,long,O
Sentence: 33,-,O
Sentence: 33,lasting,O
Sentence: 33,depressive,B-Disease
Sentence: 33,-,O
Sentence: 33,like,O
Sentence: 33,behaviour,O
Sentence: 33,in,O
Sentence: 33,mice,O
Sentence: 33,.,O
Sentence: 34,Methamphetamine,B-Chemical
Sentence: 34,(,O
Sentence: 34,METH,B-Chemical
Sentence: 34,),O
Sentence: 34,triggers,O
Sentence: 34,a,O
Sentence: 34,disruption,O
Sentence: 34,of,O
Sentence: 34,the,O
Sentence: 34,monoaminergic,O
Sentence: 34,system,O
Sentence: 34,and,O
Sentence: 34,METH,B-Chemical
Sentence: 34,abuse,O
Sentence: 34,leads,O
Sentence: 34,to,O
Sentence: 34,negative,O
Sentence: 34,emotional,O
Sentence: 34,states,O
Sentence: 34,including,O
Sentence: 34,depressive,B-Disease
Sentence: 34,symptoms,I-Disease
Sentence: 34,during,O
Sentence: 34,drug,O
Sentence: 34,withdrawal,O
Sentence: 34,.,O
Sentence: 34,However,O
Sentence: 34,",",O
Sentence: 34,it,O
Sentence: 34,is,O
Sentence: 34,currently,O
Sentence: 34,unknown,O
Sentence: 34,if,O
Sentence: 34,the,O
Sentence: 34,acute,O
Sentence: 34,toxic,O
Sentence: 34,dosage,O
Sentence: 34,of,O
Sentence: 34,METH,B-Chemical
Sentence: 34,also,O
Sentence: 34,causes,O
Sentence: 34,a,O
Sentence: 34,long,O
Sentence: 34,-,O
Sentence: 34,lasting,O
Sentence: 34,depressive,B-Disease
Sentence: 34,phenotype,O
Sentence: 34,and,O
Sentence: 34,persistent,O
Sentence: 34,monoaminergic,O
Sentence: 34,deficits,O
Sentence: 34,.,O
Sentence: 34,Thus,O
Sentence: 34,",",O
Sentence: 34,we,O
Sentence: 34,now,O
Sentence: 34,assessed,O
Sentence: 34,the,O
Sentence: 34,depressive,B-Disease
Sentence: 34,-,O
Sentence: 34,like,O
Sentence: 34,behaviour,O
Sentence: 34,in,O
Sentence: 34,mice,O
Sentence: 34,at,O
Sentence: 34,early,O
Sentence: 34,and,O
Sentence: 34,long,O
Sentence: 34,-,O
Sentence: 34,term,O
Sentence: 34,periods,O
Sentence: 34,following,O
Sentence: 34,a,O
Sentence: 34,single,O
Sentence: 34,high,O
Sentence: 34,METH,B-Chemical
Sentence: 34,dose,O
Sentence: 34,(,O
Sentence: 34,30,O
Sentence: 34,mg,O
Sentence: 34,/,O
Sentence: 34,kg,O
Sentence: 34,",",O
Sentence: 34,i.p.,O
Sentence: 34,),O
Sentence: 34,.,O
Sentence: 34,METH,B-Chemical
Sentence: 34,did,O
Sentence: 34,not,O
Sentence: 34,alter,O
Sentence: 34,the,O
Sentence: 34,motor,O
Sentence: 34,function,O
Sentence: 34,and,O
Sentence: 34,procedural,O
Sentence: 34,memory,O
Sentence: 34,of,O
Sentence: 34,mice,O
Sentence: 34,as,O
Sentence: 34,assessed,O
Sentence: 34,by,O
Sentence: 34,swimming,O
Sentence: 34,speed,O
Sentence: 34,and,O
Sentence: 34,escape,O
Sentence: 34,latency,O
Sentence: 34,to,O
Sentence: 34,find,O
Sentence: 34,the,O
Sentence: 34,platform,O
Sentence: 34,in,O
Sentence: 34,a,O
Sentence: 34,cued,O
Sentence: 34,version,O
Sentence: 34,of,O
Sentence: 34,the,O
Sentence: 34,water,O
Sentence: 34,maze,O
Sentence: 34,task,O
Sentence: 34,.,O
Sentence: 34,However,O
Sentence: 34,",",O
Sentence: 34,METH,B-Chemical
Sentence: 34,significantly,O
Sentence: 34,increased,O
Sentence: 34,the,O
Sentence: 34,immobility,O
Sentence: 34,time,O
Sentence: 34,in,O
Sentence: 34,the,O
Sentence: 34,tail,O
Sentence: 34,suspension,O
Sentence: 34,test,O
Sentence: 34,at,O
Sentence: 34,3,O
Sentence: 34,and,O
Sentence: 34,49,O
Sentence: 34,days,O
Sentence: 34,post,O
Sentence: 34,-,O
Sentence: 34,administration,O
Sentence: 34,.,O
Sentence: 34,This,O
Sentence: 34,depressive,B-Disease
Sentence: 34,-,O
Sentence: 34,like,O
Sentence: 34,profile,O
Sentence: 34,induced,O
Sentence: 34,by,O
Sentence: 34,METH,B-Chemical
Sentence: 34,was,O
Sentence: 34,accompanied,O
Sentence: 34,by,O
Sentence: 34,a,O
Sentence: 34,marked,O
Sentence: 34,depletion,O
Sentence: 34,of,O
Sentence: 34,frontostriatal,O
Sentence: 34,dopaminergic,O
Sentence: 34,and,O
Sentence: 34,serotonergic,O
Sentence: 34,neurotransmission,O
Sentence: 34,",",O
Sentence: 34,indicated,O
Sentence: 34,by,O
Sentence: 34,a,O
Sentence: 34,reduction,O
Sentence: 34,in,O
Sentence: 34,the,O
Sentence: 34,levels,O
Sentence: 34,of,O
Sentence: 34,dopamine,B-Chemical
Sentence: 34,",",O
Sentence: 34,DOPAC,B-Chemical
Sentence: 34,and,O
Sentence: 34,HVA,B-Chemical
Sentence: 34,",",O
Sentence: 34,tyrosine,B-Chemical
Sentence: 34,hydroxylase,O
Sentence: 34,and,O
Sentence: 34,serotonin,B-Chemical
Sentence: 34,",",O
Sentence: 34,observed,O
Sentence: 34,at,O
Sentence: 34,both,O
Sentence: 34,3,O
Sentence: 34,and,O
Sentence: 34,49,O
Sentence: 34,days,O
Sentence: 34,post,O
Sentence: 34,-,O
Sentence: 34,administration,O
Sentence: 34,.,O
Sentence: 34,In,O
Sentence: 34,parallel,O
Sentence: 34,",",O
Sentence: 34,another,O
Sentence: 34,neurochemical,O
Sentence: 34,feature,O
Sentence: 34,of,O
Sentence: 34,depression,B-Disease
Sentence: 34,,O
Sentence: 34,-,O
Sentence: 34,,O
Sentence: 34,-,O
Sentence: 34,,O
Sentence: 34,astroglial,O
Sentence: 34,dysfunction,O
Sentence: 34,,O
Sentence: 34,-,O
Sentence: 34,,O
Sentence: 34,-,O
Sentence: 34,,O
Sentence: 34,was,O
Sentence: 34,unaffected,O
Sentence: 34,in,O
Sentence: 34,the,O
Sentence: 34,cortex,O
Sentence: 34,and,O
Sentence: 34,the,O
Sentence: 34,striatal,O
Sentence: 34,levels,O
Sentence: 34,of,O
Sentence: 34,the,O
Sentence: 34,astrocytic,O
Sentence: 34,protein,O
Sentence: 34,marker,O
Sentence: 34,",",O
Sentence: 34,glial,O
Sentence: 34,fibrillary,O
Sentence: 34,acidic,O
Sentence: 34,protein,O
Sentence: 34,",",O
Sentence: 34,were,O
Sentence: 34,only,O
Sentence: 34,transiently,O
Sentence: 34,increased,O
Sentence: 34,at,O
Sentence: 34,3,O
Sentence: 34,days,O
Sentence: 34,.,O
Sentence: 34,These,O
Sentence: 34,findings,O
Sentence: 34,demonstrate,O
Sentence: 34,for,O
Sentence: 34,the,O
Sentence: 34,first,O
Sentence: 34,time,O
Sentence: 34,that,O
Sentence: 34,a,O
Sentence: 34,single,O
Sentence: 34,high,O
Sentence: 34,dose,O
Sentence: 34,of,O
Sentence: 34,METH,B-Chemical
Sentence: 34,induces,O
Sentence: 34,long,O
Sentence: 34,-,O
Sentence: 34,lasting,O
Sentence: 34,depressive,B-Disease
Sentence: 34,-,O
Sentence: 34,like,O
Sentence: 34,behaviour,O
Sentence: 34,in,O
Sentence: 34,mice,O
Sentence: 34,associated,O
Sentence: 34,with,O
Sentence: 34,a,O
Sentence: 34,persistent,O
Sentence: 34,disruption,O
Sentence: 34,of,O
Sentence: 34,frontostriatal,O
Sentence: 34,dopaminergic,O
Sentence: 34,and,O
Sentence: 34,serotonergic,O
Sentence: 34,homoeostasis,O
Sentence: 34,.,O
Sentence: 35,Linezolid,B-Chemical
Sentence: 35,-,O
Sentence: 35,induced,O
Sentence: 35,optic,B-Disease
Sentence: 35,neuropathy,I-Disease
Sentence: 35,.,O
Sentence: 36,Many,O
Sentence: 36,systemic,O
Sentence: 36,antimicrobials,O
Sentence: 36,have,O
Sentence: 36,been,O
Sentence: 36,implicated,O
Sentence: 36,to,O
Sentence: 36,cause,O
Sentence: 36,ocular,O
Sentence: 36,adverse,O
Sentence: 36,effects,O
Sentence: 36,.,O
Sentence: 36,This,O
Sentence: 36,is,O
Sentence: 36,especially,O
Sentence: 36,relevant,O
Sentence: 36,in,O
Sentence: 36,multidrug,O
Sentence: 36,therapy,O
Sentence: 36,where,O
Sentence: 36,more,O
Sentence: 36,than,O
Sentence: 36,one,O
Sentence: 36,drug,O
Sentence: 36,can,O
Sentence: 36,cause,O
Sentence: 36,a,O
Sentence: 36,similar,O
Sentence: 36,ocular,O
Sentence: 36,adverse,O
Sentence: 36,effect,O
Sentence: 36,.,O
Sentence: 36,We,O
Sentence: 36,describe,O
Sentence: 36,a,O
Sentence: 36,case,O
Sentence: 36,of,O
Sentence: 36,progressive,O
Sentence: 36,loss,B-Disease
Sentence: 36,of,I-Disease
Sentence: 36,vision,I-Disease
Sentence: 36,associated,O
Sentence: 36,with,O
Sentence: 36,linezolid,B-Chemical
Sentence: 36,therapy,O
Sentence: 36,.,O
Sentence: 36,A,O
Sentence: 36,45,O
Sentence: 36,-,O
Sentence: 36,year,O
Sentence: 36,-,O
Sentence: 36,old,O
Sentence: 36,male,O
Sentence: 36,patient,O
Sentence: 36,who,O
Sentence: 36,was,O
Sentence: 36,on,O
Sentence: 36,treatment,O
Sentence: 36,with,O
Sentence: 36,multiple,O
Sentence: 36,second,O
Sentence: 36,-,O
Sentence: 36,line,O
Sentence: 36,anti,O
Sentence: 36,-,O
Sentence: 36,tuberculous,O
Sentence: 36,drugs,O
Sentence: 36,including,O
Sentence: 36,linezolid,B-Chemical
Sentence: 36,and,O
Sentence: 36,ethambutol,B-Chemical
Sentence: 36,for,O
Sentence: 36,extensively,O
Sentence: 36,drug,O
Sentence: 36,-,O
Sentence: 36,resistant,O
Sentence: 36,tuberculosis,O
Sentence: 36,(,O
Sentence: 36,XDR,O
Sentence: 36,-,O
Sentence: 36,TB,O
Sentence: 36,),O
Sentence: 36,presented,O
Sentence: 36,to,O
Sentence: 36,us,O
Sentence: 36,with,O
Sentence: 36,painless,O
Sentence: 36,progressive,O
Sentence: 36,loss,B-Disease
Sentence: 36,of,I-Disease
Sentence: 36,vision,I-Disease
Sentence: 36,in,O
Sentence: 36,both,O
Sentence: 36,eyes,O
Sentence: 36,.,O
Sentence: 36,Color,O
Sentence: 36,vision,O
Sentence: 36,was,O
Sentence: 36,defective,O
Sentence: 36,and,O
Sentence: 36,fundus,O
Sentence: 36,examination,O
Sentence: 36,revealed,O
Sentence: 36,optic,B-Disease
Sentence: 36,disc,I-Disease
Sentence: 36,edema,I-Disease
Sentence: 36,in,O
Sentence: 36,both,O
Sentence: 36,eyes,O
Sentence: 36,.,O
Sentence: 36,Ethambutol,B-Chemical
Sentence: 36,-,O
Sentence: 36,induced,O
Sentence: 36,toxic,B-Disease
Sentence: 36,optic,I-Disease
Sentence: 36,neuropathy,I-Disease
Sentence: 36,was,O
Sentence: 36,suspected,O
Sentence: 36,and,O
Sentence: 36,tablet,O
Sentence: 36,ethambutol,B-Chemical
Sentence: 36,was,O
Sentence: 36,withdrawn,O
Sentence: 36,.,O
Sentence: 36,Deterioration,B-Disease
Sentence: 36,of,I-Disease
Sentence: 36,vision,I-Disease
Sentence: 36,occurred,O
Sentence: 36,despite,O
Sentence: 36,withdrawal,O
Sentence: 36,of,O
Sentence: 36,ethambutol,B-Chemical
Sentence: 36,.,O
Sentence: 36,Discontinuation,O
Sentence: 36,of,O
Sentence: 36,linezolid,B-Chemical
Sentence: 36,resulted,O
Sentence: 36,in,O
Sentence: 36,marked,O
Sentence: 36,improvement,O
Sentence: 36,of,O
Sentence: 36,vision,O
Sentence: 36,.,O
Sentence: 36,Our,O
Sentence: 36,report,O
Sentence: 36,emphasizes,O
Sentence: 36,the,O
Sentence: 36,need,O
Sentence: 36,for,O
Sentence: 36,monitoring,O
Sentence: 36,of,O
Sentence: 36,visual,O
Sentence: 36,function,O
Sentence: 36,in,O
Sentence: 36,patients,O
Sentence: 36,on,O
Sentence: 36,long,O
Sentence: 36,-,O
Sentence: 36,term,O
Sentence: 36,linezolid,B-Chemical
Sentence: 36,treatment,O
Sentence: 36,.,O
Sentence: 37,Resuscitation,O
Sentence: 37,with,O
Sentence: 37,lipid,O
Sentence: 37,",",O
Sentence: 37,epinephrine,B-Chemical
Sentence: 37,",",O
Sentence: 37,or,O
Sentence: 37,both,O
Sentence: 37,in,O
Sentence: 37,levobupivacaine,B-Chemical
Sentence: 37,-,O
Sentence: 37,induced,O
Sentence: 37,cardiac,B-Disease
Sentence: 37,toxicity,I-Disease
Sentence: 37,in,O
Sentence: 37,newborn,O
Sentence: 37,piglets,O
Sentence: 37,.,O
Sentence: 38,BACKGROUND,O
Sentence: 38,:,O
Sentence: 38,The,O
Sentence: 38,optimal,O
Sentence: 38,dosing,O
Sentence: 38,regimens,O
Sentence: 38,of,O
Sentence: 38,lipid,O
Sentence: 38,emulsion,O
Sentence: 38,",",O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,",",O
Sentence: 38,or,O
Sentence: 38,both,O
Sentence: 38,are,O
Sentence: 38,not,O
Sentence: 38,yet,O
Sentence: 38,determined,O
Sentence: 38,in,O
Sentence: 38,neonates,O
Sentence: 38,in,O
Sentence: 38,cases,O
Sentence: 38,of,O
Sentence: 38,local,O
Sentence: 38,anaesthetic,O
Sentence: 38,systemic,O
Sentence: 38,toxicity,B-Disease
Sentence: 38,(,O
Sentence: 38,LAST,O
Sentence: 38,),O
Sentence: 38,.,O
Sentence: 38,METHODS,O
Sentence: 38,:,O
Sentence: 38,Newborn,O
Sentence: 38,piglets,O
Sentence: 38,received,O
Sentence: 38,levobupivacaine,B-Chemical
Sentence: 38,until,O
Sentence: 38,cardiovascular,B-Disease
Sentence: 38,collapse,I-Disease
Sentence: 38,occurred,O
Sentence: 38,.,O
Sentence: 38,Standard,O
Sentence: 38,cardiopulmonary,O
Sentence: 38,resuscitation,O
Sentence: 38,was,O
Sentence: 38,started,O
Sentence: 38,and,O
Sentence: 38,electrocardiogram,O
Sentence: 38,(,O
Sentence: 38,ECG,O
Sentence: 38,),O
Sentence: 38,was,O
Sentence: 38,monitored,O
Sentence: 38,for,O
Sentence: 38,ventricular,B-Disease
Sentence: 38,tachycardia,I-Disease
Sentence: 38,",",O
Sentence: 38,fibrillation,B-Disease
Sentence: 38,",",O
Sentence: 38,or,O
Sentence: 38,QRS,O
Sentence: 38,prolongation,O
Sentence: 38,.,O
Sentence: 38,Piglets,O
Sentence: 38,were,O
Sentence: 38,then,O
Sentence: 38,randomly,O
Sentence: 38,allocated,O
Sentence: 38,to,O
Sentence: 38,four,O
Sentence: 38,groups,O
Sentence: 38,:,O
Sentence: 38,control,O
Sentence: 38,(,O
Sentence: 38,saline,O
Sentence: 38,),O
Sentence: 38,",",O
Sentence: 38,Intralipid,O
Sentence: 38,(,O
Sentence: 38,),O
Sentence: 38,alone,O
Sentence: 38,",",O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,alone,O
Sentence: 38,",",O
Sentence: 38,or,O
Sentence: 38,a,O
Sentence: 38,combination,O
Sentence: 38,of,O
Sentence: 38,Intralipd,O
Sentence: 38,plus,O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,.,O
Sentence: 38,Resuscitation,O
Sentence: 38,continued,O
Sentence: 38,for,O
Sentence: 38,30,O
Sentence: 38,min,O
Sentence: 38,or,O
Sentence: 38,until,O
Sentence: 38,there,O
Sentence: 38,was,O
Sentence: 38,a,O
Sentence: 38,return,O
Sentence: 38,of,O
Sentence: 38,spontaneous,O
Sentence: 38,circulation,O
Sentence: 38,(,O
Sentence: 38,ROSC,O
Sentence: 38,),O
Sentence: 38,accompanied,O
Sentence: 38,by,O
Sentence: 38,a,O
Sentence: 38,mean,O
Sentence: 38,arterial,O
Sentence: 38,pressure,O
Sentence: 38,at,O
Sentence: 38,or,O
Sentence: 38,superior,O
Sentence: 38,to,O
Sentence: 38,the,O
Sentence: 38,baseline,O
Sentence: 38,pressure,O
Sentence: 38,and,O
Sentence: 38,normal,O
Sentence: 38,sinus,O
Sentence: 38,rhythm,O
Sentence: 38,for,O
Sentence: 38,a,O
Sentence: 38,period,O
Sentence: 38,of,O
Sentence: 38,30,O
Sentence: 38,min,O
Sentence: 38,.,O
Sentence: 38,RESULTS,O
Sentence: 38,:,O
Sentence: 38,ROSC,O
Sentence: 38,was,O
Sentence: 38,achieved,O
Sentence: 38,in,O
Sentence: 38,only,O
Sentence: 38,one,O
Sentence: 38,of,O
Sentence: 38,the,O
Sentence: 38,control,O
Sentence: 38,piglets,O
Sentence: 38,compared,O
Sentence: 38,with,O
Sentence: 38,most,O
Sentence: 38,of,O
Sentence: 38,the,O
Sentence: 38,treated,O
Sentence: 38,piglets,O
Sentence: 38,.,O
Sentence: 38,Mortality,O
Sentence: 38,was,O
Sentence: 38,not,O
Sentence: 38,significantly,O
Sentence: 38,different,O
Sentence: 38,between,O
Sentence: 38,the,O
Sentence: 38,three,O
Sentence: 38,treatment,O
Sentence: 38,groups,O
Sentence: 38,",",O
Sentence: 38,but,O
Sentence: 38,was,O
Sentence: 38,significantly,O
Sentence: 38,lower,O
Sentence: 38,in,O
Sentence: 38,all,O
Sentence: 38,the,O
Sentence: 38,treatment,O
Sentence: 38,groups,O
Sentence: 38,compared,O
Sentence: 38,with,O
Sentence: 38,control,O
Sentence: 38,.,O
Sentence: 38,The,O
Sentence: 38,number,O
Sentence: 38,of,O
Sentence: 38,ECG,O
Sentence: 38,abnormalities,O
Sentence: 38,was,O
Sentence: 38,zero,O
Sentence: 38,in,O
Sentence: 38,the,O
Sentence: 38,Intralipid,O
Sentence: 38,only,O
Sentence: 38,group,O
Sentence: 38,",",O
Sentence: 38,but,O
Sentence: 38,14,O
Sentence: 38,and,O
Sentence: 38,17,O
Sentence: 38,",",O
Sentence: 38,respectively,O
Sentence: 38,",",O
Sentence: 38,in,O
Sentence: 38,the,O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,and,O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,plus,O
Sentence: 38,lipid,O
Sentence: 38,groups,O
Sentence: 38,(,O
Sentence: 38,p,O
Sentence: 38,,O
Sentence: 38,<,O
Sentence: 38,,O
Sentence: 38,0.05,O
Sentence: 38,),O
Sentence: 38,.,O
Sentence: 38,CONCLUSIONS,O
Sentence: 38,:,O
Sentence: 38,Lipid,O
Sentence: 38,emulsion,O
Sentence: 38,with,O
Sentence: 38,or,O
Sentence: 38,without,O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,",",O
Sentence: 38,or,O
Sentence: 38,epinephrine,B-Chemical
Sentence: 38,alone,O
Sentence: 38,were,O
Sentence: 38,equally,O
Sentence: 38,effective,O
Sentence: 38,in,O
Sentence: 38,achieving,O
Sentence: 38,a,O
Sentence: 38,return,O
Sentence: 38,to,O
Sentence: 38,spontaneous,O
Sentence: 38,circulation,O
Sentence: 38,in,O
Sentence: 38,this,O
Sentence: 38,model,O
Sentence: 38,of,O
Sentence: 38,LAST,O
Sentence: 38,.,O
Sentence: 38,Epinephrine,B-Chemical
Sentence: 38,alone,O
Sentence: 38,or,O
Sentence: 38,in,O
Sentence: 38,combination,O
Sentence: 38,with,O
Sentence: 38,lipid,O
Sentence: 38,was,O
Sentence: 38,associated,O
Sentence: 38,with,O
Sentence: 38,an,O
Sentence: 38,increased,O
Sentence: 38,number,O
Sentence: 38,of,O
Sentence: 38,ECG,O
Sentence: 38,abnormalities,O
Sentence: 38,compared,O
Sentence: 38,with,O
Sentence: 38,lipid,O
Sentence: 38,emulsion,O
Sentence: 38,alone,O
Sentence: 38,.,O
Sentence: 39,Incidence,O
Sentence: 39,of,O
Sentence: 39,heparin,B-Chemical
Sentence: 39,-,O
Sentence: 39,induced,O
Sentence: 39,thrombocytopenia,B-Disease
Sentence: 39,type,I-Disease
Sentence: 39,II,I-Disease
Sentence: 39,and,O
Sentence: 39,postoperative,O
Sentence: 39,recovery,O
Sentence: 39,of,O
Sentence: 39,platelet,O
Sentence: 39,count,O
Sentence: 39,in,O
Sentence: 39,liver,O
Sentence: 39,graft,O
Sentence: 39,recipients,O
Sentence: 39,:,O
Sentence: 39,a,O
Sentence: 39,retrospective,O
Sentence: 39,cohort,O
Sentence: 39,analysis,O
Sentence: 39,.,O
Sentence: 40,BACKGROUND,O
Sentence: 40,:,O
Sentence: 40,Thrombocytopenia,B-Disease
Sentence: 40,in,O
Sentence: 40,patients,O
Sentence: 40,with,O
Sentence: 40,end,O
Sentence: 40,-,O
Sentence: 40,stage,O
Sentence: 40,liver,O
Sentence: 40,disease,O
Sentence: 40,is,O
Sentence: 40,a,O
Sentence: 40,common,O
Sentence: 40,disorder,O
Sentence: 40,caused,O
Sentence: 40,mainly,O
Sentence: 40,by,O
Sentence: 40,portal,B-Disease
Sentence: 40,hypertension,I-Disease
Sentence: 40,",",O
Sentence: 40,low,O
Sentence: 40,levels,O
Sentence: 40,of,O
Sentence: 40,thrombopoetin,O
Sentence: 40,",",O
Sentence: 40,and,O
Sentence: 40,endotoxemia,B-Disease
Sentence: 40,.,O
Sentence: 40,The,O
Sentence: 40,impact,O
Sentence: 40,of,O
Sentence: 40,immune,O
Sentence: 40,-,O
Sentence: 40,mediated,O
Sentence: 40,heparin,B-Chemical
Sentence: 40,-,O
Sentence: 40,induced,O
Sentence: 40,thrombocytopenia,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,(,O
Sentence: 40,HIT,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,),O
Sentence: 40,as,O
Sentence: 40,a,O
Sentence: 40,cause,O
Sentence: 40,of,O
Sentence: 40,thrombocytopenia,B-Disease
Sentence: 40,after,O
Sentence: 40,liver,O
Sentence: 40,transplantation,O
Sentence: 40,is,O
Sentence: 40,not,O
Sentence: 40,yet,O
Sentence: 40,understood,O
Sentence: 40,",",O
Sentence: 40,with,O
Sentence: 40,few,O
Sentence: 40,literature,O
Sentence: 40,citations,O
Sentence: 40,reporting,O
Sentence: 40,contradictory,O
Sentence: 40,results,O
Sentence: 40,.,O
Sentence: 40,The,O
Sentence: 40,aim,O
Sentence: 40,of,O
Sentence: 40,our,O
Sentence: 40,study,O
Sentence: 40,was,O
Sentence: 40,to,O
Sentence: 40,demonstrate,O
Sentence: 40,the,O
Sentence: 40,perioperative,O
Sentence: 40,course,O
Sentence: 40,of,O
Sentence: 40,thrombocytopenia,B-Disease
Sentence: 40,after,O
Sentence: 40,liver,O
Sentence: 40,transplantation,O
Sentence: 40,and,O
Sentence: 40,determine,O
Sentence: 40,the,O
Sentence: 40,occurrence,O
Sentence: 40,of,O
Sentence: 40,clinical,O
Sentence: 40,HIT,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,.,O
Sentence: 40,METHOD,O
Sentence: 40,:,O
Sentence: 40,We,O
Sentence: 40,retrospectively,O
Sentence: 40,evaluated,O
Sentence: 40,the,O
Sentence: 40,medical,O
Sentence: 40,records,O
Sentence: 40,of,O
Sentence: 40,205,O
Sentence: 40,consecutive,O
Sentence: 40,adult,O
Sentence: 40,patients,O
Sentence: 40,who,O
Sentence: 40,underwent,O
Sentence: 40,full,O
Sentence: 40,-,O
Sentence: 40,size,O
Sentence: 40,liver,O
Sentence: 40,transplantation,O
Sentence: 40,between,O
Sentence: 40,January,O
Sentence: 40,2006,O
Sentence: 40,and,O
Sentence: 40,December,O
Sentence: 40,2010,O
Sentence: 40,due,O
Sentence: 40,to,O
Sentence: 40,end,O
Sentence: 40,-,O
Sentence: 40,stage,O
Sentence: 40,or,O
Sentence: 40,malignant,B-Disease
Sentence: 40,liver,I-Disease
Sentence: 40,disease,I-Disease
Sentence: 40,.,O
Sentence: 40,Preoperative,O
Sentence: 40,platelet,O
Sentence: 40,count,O
Sentence: 40,",",O
Sentence: 40,postoperative,O
Sentence: 40,course,O
Sentence: 40,of,O
Sentence: 40,platelets,O
Sentence: 40,",",O
Sentence: 40,and,O
Sentence: 40,clinical,O
Sentence: 40,signs,O
Sentence: 40,of,O
Sentence: 40,HIT,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,were,O
Sentence: 40,analyzed,O
Sentence: 40,.,O
Sentence: 40,RESULTS,O
Sentence: 40,:,O
Sentence: 40,A,O
Sentence: 40,total,O
Sentence: 40,of,O
Sentence: 40,155,O
Sentence: 40,(,O
Sentence: 40,75.6,O
Sentence: 40,%,O
Sentence: 40,),O
Sentence: 40,of,O
Sentence: 40,205,O
Sentence: 40,patients,O
Sentence: 40,had,O
Sentence: 40,thrombocytopenia,B-Disease
Sentence: 40,before,O
Sentence: 40,transplantation,O
Sentence: 40,",",O
Sentence: 40,significantly,O
Sentence: 40,influenced,O
Sentence: 40,by,O
Sentence: 40,Model,O
Sentence: 40,of,O
Sentence: 40,End,O
Sentence: 40,-,O
Sentence: 40,Stage,O
Sentence: 40,Liver,O
Sentence: 40,Disease,O
Sentence: 40,score,O
Sentence: 40,and,O
Sentence: 40,liver,B-Disease
Sentence: 40,cirrhosis,I-Disease
Sentence: 40,.,O
Sentence: 40,The,O
Sentence: 40,platelet,O
Sentence: 40,count,O
Sentence: 40,exceeded,O
Sentence: 40,"100,000",O
Sentence: 40,/,O
Sentence: 40,uL,O
Sentence: 40,in,O
Sentence: 40,most,O
Sentence: 40,of,O
Sentence: 40,the,O
Sentence: 40,patients,O
Sentence: 40,(,O
Sentence: 40,n,O
Sentence: 40,,O
Sentence: 40,=,O
Sentence: 40,,O
Sentence: 40,193,O
Sentence: 40,),O
Sentence: 40,at,O
Sentence: 40,a,O
Sentence: 40,medium,O
Sentence: 40,of,O
Sentence: 40,7,O
Sentence: 40,d.,O
Sentence: 40,Regarding,O
Sentence: 40,HIT,B-Disease
Sentence: 40,II,I-Disease
Sentence: 40,",",O
Sentence: 40,there,O
Sentence: 40,were,O
Sentence: 40,four,O
Sentence: 40,(,O
Sentence: 40,1.95,O
Sentence: 40,%,O
Sentence: 40,),O
Sentence: 40,patients,O
Sentence: 40,with,O
Sentence: 40,a,O
Sentence: 40,background,O
Sentence: 40,of,O
Sentence: 40,HIT,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,.,O
Sentence: 40,CONCLUSIONS,O
Sentence: 40,:,O
Sentence: 40,The,O
Sentence: 40,incidence,O
Sentence: 40,of,O
Sentence: 40,HIT,B-Disease
Sentence: 40,in,O
Sentence: 40,patients,O
Sentence: 40,with,O
Sentence: 40,end,O
Sentence: 40,-,O
Sentence: 40,stage,O
Sentence: 40,hepatic,O
Sentence: 40,failure,O
Sentence: 40,is,O
Sentence: 40,",",O
Sentence: 40,with,O
Sentence: 40,about,O
Sentence: 40,1.95,O
Sentence: 40,%,O
Sentence: 40,",",O
Sentence: 40,rare,O
Sentence: 40,.,O
Sentence: 40,For,O
Sentence: 40,further,O
Sentence: 40,reduction,O
Sentence: 40,of,O
Sentence: 40,HIT,B-Disease
Sentence: 40,type,I-Disease
Sentence: 40,II,I-Disease
Sentence: 40,",",O
Sentence: 40,the,O
Sentence: 40,use,O
Sentence: 40,of,O
Sentence: 40,intravenous,O
Sentence: 40,heparin,B-Chemical
Sentence: 40,should,O
Sentence: 40,be,O
Sentence: 40,avoided,O
Sentence: 40,and,O
Sentence: 40,the,O
Sentence: 40,prophylactic,O
Sentence: 40,anticoagulation,O
Sentence: 40,should,O
Sentence: 40,be,O
Sentence: 40,performed,O
Sentence: 40,with,O
Sentence: 40,low,O
Sentence: 40,-,O
Sentence: 40,molecular,O
Sentence: 40,-,O
Sentence: 40,weight,O
Sentence: 40,heparin,B-Chemical
Sentence: 40,after,O
Sentence: 40,normalization,O
Sentence: 40,of,O
Sentence: 40,platelet,O
Sentence: 40,count,O
Sentence: 40,.,O
Sentence: 41,Takotsubo,B-Disease
Sentence: 41,syndrome,I-Disease
Sentence: 41,(,O
Sentence: 41,or,O
Sentence: 41,apical,B-Disease
Sentence: 41,ballooning,I-Disease
Sentence: 41,syndrome,I-Disease
Sentence: 41,),O
Sentence: 41,secondary,O
Sentence: 41,to,O
Sentence: 41,Zolmitriptan,B-Chemical
Sentence: 41,.,O
Sentence: 42,Takotsubo,B-Disease
Sentence: 42,syndrome,I-Disease
Sentence: 42,(,O
Sentence: 42,TS,B-Disease
Sentence: 42,),O
Sentence: 42,",",O
Sentence: 42,also,O
Sentence: 42,known,O
Sentence: 42,as,O
Sentence: 42,broken,B-Disease
Sentence: 42,heart,I-Disease
Sentence: 42,syndrome,I-Disease
Sentence: 42,",",O
Sentence: 42,is,O
Sentence: 42,characterized,O
Sentence: 42,by,O
Sentence: 42,left,O
Sentence: 42,ventricle,O
Sentence: 42,apical,O
Sentence: 42,ballooning,O
Sentence: 42,with,O
Sentence: 42,elevated,O
Sentence: 42,cardiac,O
Sentence: 42,biomarkers,O
Sentence: 42,and,O
Sentence: 42,electrocardiographic,O
Sentence: 42,changes,O
Sentence: 42,suggestive,O
Sentence: 42,of,O
Sentence: 42,an,O
Sentence: 42,acute,B-Disease
Sentence: 42,coronary,I-Disease
Sentence: 42,syndrome,I-Disease
Sentence: 42,(,O
Sentence: 42,ie,O
Sentence: 42,",",O
Sentence: 42,ST,O
Sentence: 42,-,O
Sentence: 42,segment,O
Sentence: 42,elevation,O
Sentence: 42,",",O
Sentence: 42,T,O
Sentence: 42,wave,O
Sentence: 42,inversions,O
Sentence: 42,",",O
Sentence: 42,and,O
Sentence: 42,pathologic,O
Sentence: 42,Q,O
Sentence: 42,waves,O
Sentence: 42,),O
Sentence: 42,.,O
Sentence: 42,We,O
Sentence: 42,report,O
Sentence: 42,a,O
Sentence: 42,case,O
Sentence: 42,of,O
Sentence: 42,54,O
Sentence: 42,-,O
Sentence: 42,year,O
Sentence: 42,-,O
Sentence: 42,old,O
Sentence: 42,woman,O
Sentence: 42,with,O
Sentence: 42,medical,O
Sentence: 42,history,O
Sentence: 42,of,O
Sentence: 42,mitral,B-Disease
Sentence: 42,valve,I-Disease
Sentence: 42,prolapse,I-Disease
Sentence: 42,and,O
Sentence: 42,migraines,B-Disease
Sentence: 42,",",O
Sentence: 42,who,O
Sentence: 42,was,O
Sentence: 42,admitted,O
Sentence: 42,to,O
Sentence: 42,the,O
Sentence: 42,hospital,O
Sentence: 42,for,O
Sentence: 42,substernal,O
Sentence: 42,chest,B-Disease
Sentence: 42,pain,I-Disease
Sentence: 42,and,O
Sentence: 42,electrocardiogram,O
Sentence: 42,demonstrated,O
Sentence: 42,1,O
Sentence: 42,/,O
Sentence: 42,2,O
Sentence: 42,mm,O
Sentence: 42,ST,O
Sentence: 42,-,O
Sentence: 42,segment,O
Sentence: 42,elevation,O
Sentence: 42,in,O
Sentence: 42,leads,O
Sentence: 42,II,O
Sentence: 42,",",O
Sentence: 42,III,O
Sentence: 42,",",O
Sentence: 42,aVF,O
Sentence: 42,",",O
Sentence: 42,V5,O
Sentence: 42,",",O
Sentence: 42,and,O
Sentence: 42,V6,O
Sentence: 42,and,O
Sentence: 42,positive,O
Sentence: 42,troponin,O
Sentence: 42,I.,O
Sentence: 42,Emergent,O
Sentence: 42,coronary,O
Sentence: 42,angiogram,O
Sentence: 42,revealed,O
Sentence: 42,normal,O
Sentence: 42,coronary,O
Sentence: 42,arteries,O
Sentence: 42,with,O
Sentence: 42,moderately,O
Sentence: 42,reduced,O
Sentence: 42,left,O
Sentence: 42,ventricular,O
Sentence: 42,ejection,O
Sentence: 42,fraction,O
Sentence: 42,with,O
Sentence: 42,wall,O
Sentence: 42,motion,O
Sentence: 42,abnormalities,O
Sentence: 42,consistent,O
Sentence: 42,with,O
Sentence: 42,TS,B-Disease
Sentence: 42,.,O
Sentence: 42,Detailed,O
Sentence: 42,history,O
Sentence: 42,obtained,O
Sentence: 42,retrospectively,O
Sentence: 42,revealed,O
Sentence: 42,that,O
Sentence: 42,the,O
Sentence: 42,patient,O
Sentence: 42,took,O
Sentence: 42,zolmitriptan,B-Chemical
Sentence: 42,sparingly,O
Sentence: 42,only,O
Sentence: 42,when,O
Sentence: 42,she,O
Sentence: 42,had,O
Sentence: 42,migraines,B-Disease
Sentence: 42,.,O
Sentence: 42,But,O
Sentence: 42,before,O
Sentence: 42,this,O
Sentence: 42,event,O
Sentence: 42,",",O
Sentence: 42,she,O
Sentence: 42,was,O
Sentence: 42,taking,O
Sentence: 42,zolmitriptan,B-Chemical
Sentence: 42,2,O
Sentence: 42,-,O
Sentence: 42,3,O
Sentence: 42,times,O
Sentence: 42,daily,O
Sentence: 42,for,O
Sentence: 42,several,O
Sentence: 42,days,O
Sentence: 42,because,O
Sentence: 42,of,O
Sentence: 42,a,O
Sentence: 42,persistent,O
Sentence: 42,migraine,B-Disease
Sentence: 42,headache,I-Disease
Sentence: 42,.,O
Sentence: 42,She,O
Sentence: 42,otherwise,O
Sentence: 42,reported,O
Sentence: 42,that,O
Sentence: 42,she,O
Sentence: 42,is,O
Sentence: 42,quite,O
Sentence: 42,active,O
Sentence: 42,",",O
Sentence: 42,rides,O
Sentence: 42,horses,O
Sentence: 42,",",O
Sentence: 42,and,O
Sentence: 42,does,O
Sentence: 42,show,O
Sentence: 42,jumping,O
Sentence: 42,without,O
Sentence: 42,any,O
Sentence: 42,limitations,O
Sentence: 42,in,O
Sentence: 42,her,O
Sentence: 42,physical,O
Sentence: 42,activity,O
Sentence: 42,.,O
Sentence: 42,There,O
Sentence: 42,was,O
Sentence: 42,no,O
Sentence: 42,evidence,O
Sentence: 42,of,O
Sentence: 42,any,O
Sentence: 42,recent,O
Sentence: 42,stress,O
Sentence: 42,or,O
Sentence: 42,status,B-Disease
Sentence: 42,migrainosus,I-Disease
Sentence: 42,.,O
Sentence: 42,Extensive,O
Sentence: 42,literature,O
Sentence: 42,search,O
Sentence: 42,revealed,O
Sentence: 42,multiple,O
Sentence: 42,cases,O
Sentence: 42,of,O
Sentence: 42,coronary,B-Disease
Sentence: 42,artery,I-Disease
Sentence: 42,vasospasm,I-Disease
Sentence: 42,secondary,O
Sentence: 42,to,O
Sentence: 42,zolmitriptan,B-Chemical
Sentence: 42,",",O
Sentence: 42,but,O
Sentence: 42,none,O
Sentence: 42,of,O
Sentence: 42,the,O
Sentence: 42,cases,O
Sentence: 42,were,O
Sentence: 42,associated,O
Sentence: 42,with,O
Sentence: 42,TS,B-Disease
Sentence: 42,.,O
Sentence: 43,Depression,B-Disease
Sentence: 43,",",O
Sentence: 43,impulsiveness,B-Disease
Sentence: 43,",",O
Sentence: 43,sleep,O
Sentence: 43,",",O
Sentence: 43,and,O
Sentence: 43,memory,O
Sentence: 43,in,O
Sentence: 43,past,O
Sentence: 43,and,O
Sentence: 43,present,O
Sentence: 43,polydrug,O
Sentence: 43,users,O
Sentence: 43,of,O
Sentence: 43,"3,4",O
Sentence: 43,-,O
Sentence: 43,methylenedioxymethamphetamine,O
Sentence: 43,(,O
Sentence: 43,MDMA,B-Chemical
Sentence: 43,",",O
Sentence: 43,ecstasy,B-Chemical
Sentence: 43,),O
Sentence: 43,.,O
Sentence: 44,RATIONALE,O
Sentence: 44,:,O
Sentence: 44,Ecstasy,B-Chemical
Sentence: 44,(,O
Sentence: 44,"3,4",O
Sentence: 44,-,O
Sentence: 44,methylenedioxymethamphetamine,O
Sentence: 44,",",O
Sentence: 44,MDMA,B-Chemical
Sentence: 44,),O
Sentence: 44,is,O
Sentence: 44,a,O
Sentence: 44,worldwide,O
Sentence: 44,recreational,O
Sentence: 44,drug,O
Sentence: 44,of,O
Sentence: 44,abuse,O
Sentence: 44,.,O
Sentence: 44,Unfortunately,O
Sentence: 44,",",O
Sentence: 44,the,O
Sentence: 44,results,O
Sentence: 44,from,O
Sentence: 44,human,O
Sentence: 44,research,O
Sentence: 44,investigating,O
Sentence: 44,its,O
Sentence: 44,psychological,O
Sentence: 44,effects,O
Sentence: 44,have,O
Sentence: 44,been,O
Sentence: 44,inconsistent,O
Sentence: 44,.,O
Sentence: 44,OBJECTIVES,O
Sentence: 44,:,O
Sentence: 44,The,O
Sentence: 44,present,O
Sentence: 44,study,O
Sentence: 44,aimed,O
Sentence: 44,to,O
Sentence: 44,be,O
Sentence: 44,the,O
Sentence: 44,largest,O
Sentence: 44,to,O
Sentence: 44,date,O
Sentence: 44,in,O
Sentence: 44,sample,O
Sentence: 44,size,O
Sentence: 44,and,O
Sentence: 44,5HT,O
Sentence: 44,-,O
Sentence: 44,related,O
Sentence: 44,behaviors,O
Sentence: 44,;,O
Sentence: 44,the,O
Sentence: 44,first,O
Sentence: 44,to,O
Sentence: 44,compare,O
Sentence: 44,present,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,users,O
Sentence: 44,with,O
Sentence: 44,past,O
Sentence: 44,users,O
Sentence: 44,after,O
Sentence: 44,an,O
Sentence: 44,abstinence,O
Sentence: 44,of,O
Sentence: 44,4,O
Sentence: 44,or,O
Sentence: 44,more,O
Sentence: 44,years,O
Sentence: 44,",",O
Sentence: 44,and,O
Sentence: 44,the,O
Sentence: 44,first,O
Sentence: 44,to,O
Sentence: 44,include,O
Sentence: 44,robust,O
Sentence: 44,controls,O
Sentence: 44,for,O
Sentence: 44,other,O
Sentence: 44,recreational,O
Sentence: 44,substances,O
Sentence: 44,.,O
Sentence: 44,METHODS,O
Sentence: 44,:,O
Sentence: 44,A,O
Sentence: 44,sample,O
Sentence: 44,of,O
Sentence: 44,997,O
Sentence: 44,participants,O
Sentence: 44,(,O
Sentence: 44,52,O
Sentence: 44,%,O
Sentence: 44,male,O
Sentence: 44,),O
Sentence: 44,was,O
Sentence: 44,recruited,O
Sentence: 44,to,O
Sentence: 44,four,O
Sentence: 44,control,O
Sentence: 44,groups,O
Sentence: 44,(,O
Sentence: 44,non,O
Sentence: 44,-,O
Sentence: 44,drug,O
Sentence: 44,(,O
Sentence: 44,ND,O
Sentence: 44,),O
Sentence: 44,",",O
Sentence: 44,alcohol,B-Chemical
Sentence: 44,/,O
Sentence: 44,nicotine,B-Chemical
Sentence: 44,(,O
Sentence: 44,AN,B-Chemical
Sentence: 44,),O
Sentence: 44,",",O
Sentence: 44,cannabis,B-Chemical
Sentence: 44,/,O
Sentence: 44,alcohol,B-Chemical
Sentence: 44,/,O
Sentence: 44,nicotine,B-Chemical
Sentence: 44,(,O
Sentence: 44,CAN,B-Chemical
Sentence: 44,),O
Sentence: 44,",",O
Sentence: 44,non,O
Sentence: 44,-,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,polydrug,O
Sentence: 44,(,O
Sentence: 44,PD,O
Sentence: 44,),O
Sentence: 44,),O
Sentence: 44,",",O
Sentence: 44,and,O
Sentence: 44,two,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,polydrug,O
Sentence: 44,groups,O
Sentence: 44,(,O
Sentence: 44,present,O
Sentence: 44,(,O
Sentence: 44,MDMA,B-Chemical
Sentence: 44,),O
Sentence: 44,and,O
Sentence: 44,past,O
Sentence: 44,users,O
Sentence: 44,(,O
Sentence: 44,EX,O
Sentence: 44,-,O
Sentence: 44,MDMA,B-Chemical
Sentence: 44,),O
Sentence: 44,.,O
Sentence: 44,Participants,O
Sentence: 44,completed,O
Sentence: 44,a,O
Sentence: 44,drug,O
Sentence: 44,history,O
Sentence: 44,questionnaire,O
Sentence: 44,",",O
Sentence: 44,Beck,O
Sentence: 44,Depression,B-Disease
Sentence: 44,Inventory,O
Sentence: 44,",",O
Sentence: 44,Barratt,O
Sentence: 44,Impulsiveness,B-Disease
Sentence: 44,Scale,O
Sentence: 44,",",O
Sentence: 44,Pittsburgh,O
Sentence: 44,Sleep,O
Sentence: 44,Quality,O
Sentence: 44,Index,O
Sentence: 44,",",O
Sentence: 44,and,O
Sentence: 44,Wechsler,O
Sentence: 44,Memory,O
Sentence: 44,Scale,O
Sentence: 44,-,O
Sentence: 44,Revised,O
Sentence: 44,which,O
Sentence: 44,",",O
Sentence: 44,in,O
Sentence: 44,total,O
Sentence: 44,",",O
Sentence: 44,provided,O
Sentence: 44,13,O
Sentence: 44,psychometric,O
Sentence: 44,measures,O
Sentence: 44,.,O
Sentence: 44,RESULTS,O
Sentence: 44,:,O
Sentence: 44,While,O
Sentence: 44,the,O
Sentence: 44,CAN,B-Chemical
Sentence: 44,and,O
Sentence: 44,PD,O
Sentence: 44,groups,O
Sentence: 44,tended,O
Sentence: 44,to,O
Sentence: 44,record,O
Sentence: 44,greater,O
Sentence: 44,deficits,O
Sentence: 44,than,O
Sentence: 44,the,O
Sentence: 44,non,O
Sentence: 44,-,O
Sentence: 44,drug,O
Sentence: 44,controls,O
Sentence: 44,",",O
Sentence: 44,the,O
Sentence: 44,MDMA,B-Chemical
Sentence: 44,and,O
Sentence: 44,EX,O
Sentence: 44,-,O
Sentence: 44,MDMA,B-Chemical
Sentence: 44,groups,O
Sentence: 44,recorded,O
Sentence: 44,greater,O
Sentence: 44,deficits,O
Sentence: 44,than,O
Sentence: 44,all,O
Sentence: 44,the,O
Sentence: 44,control,O
Sentence: 44,groups,O
Sentence: 44,on,O
Sentence: 44,ten,O
Sentence: 44,of,O
Sentence: 44,the,O
Sentence: 44,13,O
Sentence: 44,psychometric,O
Sentence: 44,measures,O
Sentence: 44,.,O
Sentence: 44,Strikingly,O
Sentence: 44,",",O
Sentence: 44,despite,O
Sentence: 44,prolonged,O
Sentence: 44,abstinence,O
Sentence: 44,(,O
Sentence: 44,mean,O
Sentence: 44,",",O
Sentence: 44,4.98,O
Sentence: 44,;,O
Sentence: 44,range,O
Sentence: 44,",",O
Sentence: 44,4,O
Sentence: 44,-,O
Sentence: 44,9,O
Sentence: 44,years,O
Sentence: 44,),O
Sentence: 44,",",O
Sentence: 44,past,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,users,O
Sentence: 44,showed,O
Sentence: 44,few,O
Sentence: 44,signs,O
Sentence: 44,of,O
Sentence: 44,recovery,O
Sentence: 44,.,O
Sentence: 44,Compared,O
Sentence: 44,with,O
Sentence: 44,present,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,users,O
Sentence: 44,",",O
Sentence: 44,the,O
Sentence: 44,past,O
Sentence: 44,users,O
Sentence: 44,showed,O
Sentence: 44,no,O
Sentence: 44,change,O
Sentence: 44,for,O
Sentence: 44,ten,O
Sentence: 44,measures,O
Sentence: 44,",",O
Sentence: 44,increased,O
Sentence: 44,impairment,O
Sentence: 44,for,O
Sentence: 44,two,O
Sentence: 44,measures,O
Sentence: 44,",",O
Sentence: 44,and,O
Sentence: 44,improvement,O
Sentence: 44,on,O
Sentence: 44,just,O
Sentence: 44,one,O
Sentence: 44,measure,O
Sentence: 44,.,O
Sentence: 44,CONCLUSIONS,O
Sentence: 44,:,O
Sentence: 44,Given,O
Sentence: 44,this,O
Sentence: 44,record,O
Sentence: 44,of,O
Sentence: 44,impaired,B-Disease
Sentence: 44,memory,I-Disease
Sentence: 44,and,O
Sentence: 44,clinically,O
Sentence: 44,significant,O
Sentence: 44,levels,O
Sentence: 44,of,O
Sentence: 44,depression,B-Disease
Sentence: 44,",",O
Sentence: 44,impulsiveness,B-Disease
Sentence: 44,",",O
Sentence: 44,and,O
Sentence: 44,sleep,B-Disease
Sentence: 44,disturbance,I-Disease
Sentence: 44,",",O
Sentence: 44,the,O
Sentence: 44,prognosis,O
Sentence: 44,for,O
Sentence: 44,the,O
Sentence: 44,current,O
Sentence: 44,generation,O
Sentence: 44,of,O
Sentence: 44,ecstasy,B-Chemical
Sentence: 44,users,O
Sentence: 44,is,O
Sentence: 44,a,O
Sentence: 44,major,O
Sentence: 44,cause,O
Sentence: 44,for,O
Sentence: 44,concern,O
Sentence: 44,.,O
Sentence: 45,Association,O
Sentence: 45,of,O
Sentence: 45,common,O
Sentence: 45,genetic,O
Sentence: 45,variants,O
Sentence: 45,of,O
Sentence: 45,HOMER1,O
Sentence: 45,gene,O
Sentence: 45,with,O
Sentence: 45,levodopa,B-Chemical
Sentence: 45,adverse,O
Sentence: 45,effects,O
Sentence: 45,in,O
Sentence: 45,Parkinson,B-Disease
Sentence: 45,'s,I-Disease
Sentence: 45,disease,I-Disease
Sentence: 45,patients,O
Sentence: 45,.,O
Sentence: 46,Levodopa,B-Chemical
Sentence: 46,is,O
Sentence: 46,the,O
Sentence: 46,most,O
Sentence: 46,effective,O
Sentence: 46,symptomatic,O
Sentence: 46,therapy,O
Sentence: 46,for,O
Sentence: 46,Parkinson,B-Disease
Sentence: 46,'s,I-Disease
Sentence: 46,disease,I-Disease
Sentence: 46,",",O
Sentence: 46,but,O
Sentence: 46,its,O
Sentence: 46,chronic,O
Sentence: 46,use,O
Sentence: 46,could,O
Sentence: 46,lead,O
Sentence: 46,to,O
Sentence: 46,chronic,O
Sentence: 46,adverse,O
Sentence: 46,outcomes,O
Sentence: 46,",",O
Sentence: 46,such,O
Sentence: 46,as,O
Sentence: 46,motor,O
Sentence: 46,fluctuations,O
Sentence: 46,",",O
Sentence: 46,dyskinesia,B-Disease
Sentence: 46,and,O
Sentence: 46,visual,B-Disease
Sentence: 46,hallucinations,I-Disease
Sentence: 46,.,O
Sentence: 46,HOMER1,O
Sentence: 46,is,O
Sentence: 46,a,O
Sentence: 46,protein,O
Sentence: 46,with,O
Sentence: 46,pivotal,O
Sentence: 46,function,O
Sentence: 46,in,O
Sentence: 46,glutamate,B-Chemical
Sentence: 46,transmission,O
Sentence: 46,",",O
Sentence: 46,which,O
Sentence: 46,has,O
Sentence: 46,been,O
Sentence: 46,related,O
Sentence: 46,to,O
Sentence: 46,the,O
Sentence: 46,pathogenesis,O
Sentence: 46,of,O
Sentence: 46,these,O
Sentence: 46,complications,O
Sentence: 46,.,O
Sentence: 46,This,O
Sentence: 46,study,O
Sentence: 46,investigates,O
Sentence: 46,whether,O
Sentence: 46,polymorphisms,O
Sentence: 46,in,O
Sentence: 46,the,O
Sentence: 46,HOMER1,O
Sentence: 46,gene,O
Sentence: 46,promoter,O
Sentence: 46,region,O
Sentence: 46,are,O
Sentence: 46,associated,O
Sentence: 46,with,O
Sentence: 46,the,O
Sentence: 46,occurrence,O
Sentence: 46,of,O
Sentence: 46,the,O
Sentence: 46,chronic,O
Sentence: 46,complications,O
Sentence: 46,of,O
Sentence: 46,levodopa,B-Chemical
Sentence: 46,therapy,O
Sentence: 46,.,O
Sentence: 46,A,O
Sentence: 46,total,O
Sentence: 46,of,O
Sentence: 46,205,O
Sentence: 46,patients,O
Sentence: 46,with,O
Sentence: 46,idiopathic,B-Disease
Sentence: 46,Parkinson,I-Disease
Sentence: 46,'s,I-Disease
Sentence: 46,disease,I-Disease
Sentence: 46,were,O
Sentence: 46,investigated,O
Sentence: 46,.,O
Sentence: 46,Patients,O
Sentence: 46,were,O
Sentence: 46,genotyped,O
Sentence: 46,for,O
Sentence: 46,rs4704559,O
Sentence: 46,",",O
Sentence: 46,rs10942891,O
Sentence: 46,and,O
Sentence: 46,rs4704560,O
Sentence: 46,by,O
Sentence: 46,allelic,O
Sentence: 46,discrimination,O
Sentence: 46,with,O
Sentence: 46,Taqman,O
Sentence: 46,assays,O
Sentence: 46,.,O
Sentence: 46,The,O
Sentence: 46,rs4704559,O
Sentence: 46,G,O
Sentence: 46,allele,O
Sentence: 46,was,O
Sentence: 46,associated,O
Sentence: 46,with,O
Sentence: 46,a,O
Sentence: 46,lower,O
Sentence: 46,prevalence,O
Sentence: 46,of,O
Sentence: 46,dyskinesia,B-Disease
Sentence: 46,(,O
Sentence: 46,prevalence,O
Sentence: 46,ratio,O
Sentence: 46,(,O
Sentence: 46,PR,O
Sentence: 46,),O
Sentence: 46,,O
Sentence: 46,=,O
Sentence: 46,0.615,O
Sentence: 46,",",O
Sentence: 46,95,O
Sentence: 46,%,O
Sentence: 46,confidence,O
Sentence: 46,interval,O
Sentence: 46,(,O
Sentence: 46,CI,O
Sentence: 46,),O
Sentence: 46,0.426,O
Sentence: 46,-,O
Sentence: 46,0.887,O
Sentence: 46,",",O
Sentence: 46,P,O
Sentence: 46,=,O
Sentence: 46,0.009,O
Sentence: 46,),O
Sentence: 46,and,O
Sentence: 46,visual,B-Disease
Sentence: 46,hallucinations,I-Disease
Sentence: 46,(,O
Sentence: 46,PR,O
Sentence: 46,=,O
Sentence: 46,0.515,O
Sentence: 46,",",O
Sentence: 46,95,O
Sentence: 46,%,O
Sentence: 46,CI,O
Sentence: 46,0.295,O
Sentence: 46,-,O
Sentence: 46,0.899,O
Sentence: 46,",",O
Sentence: 46,P,O
Sentence: 46,=,O
Sentence: 46,0.020,O
Sentence: 46,),O
Sentence: 46,.,O
Sentence: 46,Our,O
Sentence: 46,data,O
Sentence: 46,suggest,O
Sentence: 46,that,O
Sentence: 46,HOMER1,O
Sentence: 46,rs4704559,O
Sentence: 46,G,O
Sentence: 46,allele,O
Sentence: 46,has,O
Sentence: 46,a,O
Sentence: 46,protective,O
Sentence: 46,role,O
Sentence: 46,for,O
Sentence: 46,the,O
Sentence: 46,development,O
Sentence: 46,of,O
Sentence: 46,levodopa,B-Chemical
Sentence: 46,adverse,O
Sentence: 46,effects,O
Sentence: 46,.,O
Sentence: 47,Crocin,B-Chemical
Sentence: 47,improves,O
Sentence: 47,lipid,O
Sentence: 47,dysregulation,O
Sentence: 47,in,O
Sentence: 47,subacute,O
Sentence: 47,diazinon,B-Chemical
Sentence: 47,exposure,O
Sentence: 47,through,O
Sentence: 47,ERK1,O
Sentence: 47,/,O
Sentence: 47,2,O
Sentence: 47,pathway,O
Sentence: 47,in,O
Sentence: 47,rat,O
Sentence: 47,liver,O
Sentence: 47,.,O
Sentence: 48,INTRODUCTION,O
Sentence: 48,:,O
Sentence: 48,Diazinon,B-Chemical
Sentence: 48,Yis,O
Sentence: 48,one,O
Sentence: 48,of,O
Sentence: 48,the,O
Sentence: 48,most,O
Sentence: 48,broadly,O
Sentence: 48,used,O
Sentence: 48,organophosphorus,B-Chemical
Sentence: 48,insecticides,O
Sentence: 48,in,O
Sentence: 48,agriculture,O
Sentence: 48,.,O
Sentence: 48,It,O
Sentence: 48,has,O
Sentence: 48,been,O
Sentence: 48,shown,O
Sentence: 48,that,O
Sentence: 48,exposure,O
Sentence: 48,to,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,may,O
Sentence: 48,interfere,O
Sentence: 48,with,O
Sentence: 48,lipid,O
Sentence: 48,metabolism,O
Sentence: 48,.,O
Sentence: 48,Moreover,O
Sentence: 48,",",O
Sentence: 48,the,O
Sentence: 48,hypolipidemic,O
Sentence: 48,effect,O
Sentence: 48,of,O
Sentence: 48,crocin,B-Chemical
Sentence: 48,has,O
Sentence: 48,been,O
Sentence: 48,established,O
Sentence: 48,.,O
Sentence: 48,Earlier,O
Sentence: 48,studies,O
Sentence: 48,revealed,O
Sentence: 48,the,O
Sentence: 48,major,O
Sentence: 48,role,O
Sentence: 48,of,O
Sentence: 48,Extracellular,O
Sentence: 48,signal,O
Sentence: 48,-,O
Sentence: 48,regulated,O
Sentence: 48,kinase,O
Sentence: 48,(,O
Sentence: 48,ERK,O
Sentence: 48,),O
Sentence: 48,pathways,O
Sentence: 48,in,O
Sentence: 48,low,O
Sentence: 48,-,O
Sentence: 48,density,O
Sentence: 48,lipoprotein,O
Sentence: 48,receptor,O
Sentence: 48,(,O
Sentence: 48,LDLr,O
Sentence: 48,),O
Sentence: 48,expression,O
Sentence: 48,.,O
Sentence: 48,The,O
Sentence: 48,aim,O
Sentence: 48,of,O
Sentence: 48,this,O
Sentence: 48,study,O
Sentence: 48,was,O
Sentence: 48,to,O
Sentence: 48,evaluate,O
Sentence: 48,changes,O
Sentence: 48,in,O
Sentence: 48,the,O
Sentence: 48,regulation,O
Sentence: 48,of,O
Sentence: 48,lipid,O
Sentence: 48,metabolism,O
Sentence: 48,",",O
Sentence: 48,ERK,O
Sentence: 48,and,O
Sentence: 48,LDLr,O
Sentence: 48,expression,O
Sentence: 48,in,O
Sentence: 48,the,O
Sentence: 48,liver,O
Sentence: 48,of,O
Sentence: 48,rats,O
Sentence: 48,exposed,O
Sentence: 48,to,O
Sentence: 48,subacute,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,.,O
Sentence: 48,Furthermore,O
Sentence: 48,ameliorating,O
Sentence: 48,effect,O
Sentence: 48,of,O
Sentence: 48,crocin,B-Chemical
Sentence: 48,on,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,induced,O
Sentence: 48,disturbed,O
Sentence: 48,cholesterol,B-Chemical
Sentence: 48,homeostasis,O
Sentence: 48,was,O
Sentence: 48,studied,O
Sentence: 48,.,O
Sentence: 48,METHODS,O
Sentence: 48,:,O
Sentence: 48,24,O
Sentence: 48,Rats,O
Sentence: 48,were,O
Sentence: 48,divided,O
Sentence: 48,into,O
Sentence: 48,4,O
Sentence: 48,groups,O
Sentence: 48,and,O
Sentence: 48,received,O
Sentence: 48,following,O
Sentence: 48,treatments,O
Sentence: 48,for,O
Sentence: 48,4,O
Sentence: 48,weeks,O
Sentence: 48,;,O
Sentence: 48,Corn,O
Sentence: 48,oil,O
Sentence: 48,(,O
Sentence: 48,control,O
Sentence: 48,),O
Sentence: 48,",",O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,(,O
Sentence: 48,15mg,O
Sentence: 48,/,O
Sentence: 48,kg,O
Sentence: 48,per,O
Sentence: 48,day,O
Sentence: 48,",",O
Sentence: 48,orally,O
Sentence: 48,),O
Sentence: 48,and,O
Sentence: 48,crocin,B-Chemical
Sentence: 48,(,O
Sentence: 48,12.5,O
Sentence: 48,and,O
Sentence: 48,25mg,O
Sentence: 48,/,O
Sentence: 48,kg,O
Sentence: 48,per,O
Sentence: 48,day,O
Sentence: 48,",",O
Sentence: 48,intraperitoneally,O
Sentence: 48,),O
Sentence: 48,in,O
Sentence: 48,combination,O
Sentence: 48,with,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,(,O
Sentence: 48,15,O
Sentence: 48,mg,O
Sentence: 48,/,O
Sentence: 48,kg,O
Sentence: 48,),O
Sentence: 48,.,O
Sentence: 48,The,O
Sentence: 48,levels,O
Sentence: 48,of,O
Sentence: 48,cholesterol,B-Chemical
Sentence: 48,",",O
Sentence: 48,triglyceride,B-Chemical
Sentence: 48,and,O
Sentence: 48,LDL,O
Sentence: 48,in,O
Sentence: 48,blood,O
Sentence: 48,of,O
Sentence: 48,rats,O
Sentence: 48,were,O
Sentence: 48,analyzed,O
Sentence: 48,.,O
Sentence: 48,Moreover,O
Sentence: 48,mRNA,O
Sentence: 48,levels,O
Sentence: 48,of,O
Sentence: 48,LDLr,O
Sentence: 48,and,O
Sentence: 48,ERK1,O
Sentence: 48,/,O
Sentence: 48,2,O
Sentence: 48,as,O
Sentence: 48,well,O
Sentence: 48,as,O
Sentence: 48,protein,O
Sentence: 48,levels,O
Sentence: 48,of,O
Sentence: 48,total,O
Sentence: 48,and,O
Sentence: 48,activated,O
Sentence: 48,forms,O
Sentence: 48,of,O
Sentence: 48,ERK1,O
Sentence: 48,/,O
Sentence: 48,2,O
Sentence: 48,in,O
Sentence: 48,rat,O
Sentence: 48,liver,O
Sentence: 48,were,O
Sentence: 48,evaluated,O
Sentence: 48,by,O
Sentence: 48,Western,O
Sentence: 48,blotting,O
Sentence: 48,and,O
Sentence: 48,quantitative,O
Sentence: 48,real,O
Sentence: 48,time,O
Sentence: 48,polymerase,O
Sentence: 48,chain,O
Sentence: 48,reaction,O
Sentence: 48,analysis,O
Sentence: 48,.,O
Sentence: 48,RESULTS,O
Sentence: 48,:,O
Sentence: 48,Our,O
Sentence: 48,data,O
Sentence: 48,showed,O
Sentence: 48,that,O
Sentence: 48,subacute,O
Sentence: 48,exposure,O
Sentence: 48,to,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,significantly,O
Sentence: 48,increased,O
Sentence: 48,concentrations,O
Sentence: 48,of,O
Sentence: 48,cholesterol,B-Chemical
Sentence: 48,",",O
Sentence: 48,triglyceride,B-Chemical
Sentence: 48,and,O
Sentence: 48,LDL,O
Sentence: 48,.,O
Sentence: 48,Moreover,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,decreased,O
Sentence: 48,ERK1,O
Sentence: 48,/,O
Sentence: 48,2,O
Sentence: 48,protein,O
Sentence: 48,phosphorylation,O
Sentence: 48,and,O
Sentence: 48,LDLr,O
Sentence: 48,transcript,O
Sentence: 48,.,O
Sentence: 48,Crocin,B-Chemical
Sentence: 48,reduced,O
Sentence: 48,inhibition,O
Sentence: 48,of,O
Sentence: 48,ERK,O
Sentence: 48,activation,O
Sentence: 48,and,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,-,O
Sentence: 48,induced,O
Sentence: 48,hyperlipemia,B-Disease
Sentence: 48,and,O
Sentence: 48,increased,O
Sentence: 48,levels,O
Sentence: 48,of,O
Sentence: 48,LDLr,O
Sentence: 48,transcript,O
Sentence: 48,.,O
Sentence: 48,CONCLUSIONS,O
Sentence: 48,:,O
Sentence: 48,Crocin,B-Chemical
Sentence: 48,may,O
Sentence: 48,be,O
Sentence: 48,considered,O
Sentence: 48,as,O
Sentence: 48,a,O
Sentence: 48,novel,O
Sentence: 48,protective,O
Sentence: 48,agent,O
Sentence: 48,in,O
Sentence: 48,diazinon,B-Chemical
Sentence: 48,-,O
Sentence: 48,induced,O
Sentence: 48,hyperlipemia,B-Disease
Sentence: 48,through,O
Sentence: 48,modulating,O
Sentence: 48,of,O
Sentence: 48,ERK,O
Sentence: 48,pathway,O
Sentence: 48,and,O
Sentence: 48,increase,O
Sentence: 48,of,O
Sentence: 48,LDLr,O
Sentence: 48,expression,O
Sentence: 48,.,O
Sentence: 49,GEM,B-Chemical
Sentence: 49,-,O
Sentence: 49,P,O
Sentence: 49,chemotherapy,O
Sentence: 49,is,O
Sentence: 49,active,O
Sentence: 49,in,O
Sentence: 49,the,O
Sentence: 49,treatment,O
Sentence: 49,of,O
Sentence: 49,relapsed,O
Sentence: 49,Hodgkin,B-Disease
Sentence: 49,lymphoma,I-Disease
Sentence: 49,.,O
Sentence: 50,Hodgkin,B-Disease
Sentence: 50,lymphoma,I-Disease
Sentence: 50,(,O
Sentence: 50,HL,B-Disease
Sentence: 50,),O
Sentence: 50,is,O
Sentence: 50,a,O
Sentence: 50,relatively,O
Sentence: 50,chemosensitive,O
Sentence: 50,malignancy,B-Disease
Sentence: 50,.,O
Sentence: 50,However,O
Sentence: 50,",",O
Sentence: 50,for,O
Sentence: 50,those,O
Sentence: 50,who,O
Sentence: 50,relapse,O
Sentence: 50,",",O
Sentence: 50,high,O
Sentence: 50,-,O
Sentence: 50,dose,O
Sentence: 50,chemotherapy,O
Sentence: 50,with,O
Sentence: 50,autologous,O
Sentence: 50,stem,O
Sentence: 50,cell,O
Sentence: 50,transplant,O
Sentence: 50,is,O
Sentence: 50,the,O
Sentence: 50,treatment,O
Sentence: 50,of,O
Sentence: 50,choice,O
Sentence: 50,which,O
Sentence: 50,relies,O
Sentence: 50,on,O
Sentence: 50,adequate,O
Sentence: 50,disease,O
Sentence: 50,control,O
Sentence: 50,with,O
Sentence: 50,salvage,O
Sentence: 50,chemotherapy,O
Sentence: 50,.,O
Sentence: 50,Regimens,O
Sentence: 50,commonly,O
Sentence: 50,used,O
Sentence: 50,often,O
Sentence: 50,require,O
Sentence: 50,inpatient,O
Sentence: 50,administration,O
Sentence: 50,and,O
Sentence: 50,can,O
Sentence: 50,be,O
Sentence: 50,difficult,O
Sentence: 50,to,O
Sentence: 50,deliver,O
Sentence: 50,due,O
Sentence: 50,to,O
Sentence: 50,toxicity,B-Disease
Sentence: 50,.,O
Sentence: 50,Gemcitabine,B-Chemical
Sentence: 50,and,O
Sentence: 50,cisplatin,B-Chemical
Sentence: 50,have,O
Sentence: 50,activity,O
Sentence: 50,in,O
Sentence: 50,HL,B-Disease
Sentence: 50,",",O
Sentence: 50,non,O
Sentence: 50,-,O
Sentence: 50,overlapping,O
Sentence: 50,toxicity,B-Disease
Sentence: 50,with,O
Sentence: 50,first,O
Sentence: 50,-,O
Sentence: 50,line,O
Sentence: 50,chemotherapeutics,O
Sentence: 50,",",O
Sentence: 50,and,O
Sentence: 50,may,O
Sentence: 50,be,O
Sentence: 50,delivered,O
Sentence: 50,in,O
Sentence: 50,an,O
Sentence: 50,outpatient,O
Sentence: 50,setting,O
Sentence: 50,.,O
Sentence: 50,In,O
Sentence: 50,this,O
Sentence: 50,retrospective,O
Sentence: 50,single,O
Sentence: 50,-,O
Sentence: 50,centre,O
Sentence: 50,analysis,O
Sentence: 50,",",O
Sentence: 50,patients,O
Sentence: 50,with,O
Sentence: 50,relapsed,O
Sentence: 50,or,O
Sentence: 50,refractory,O
Sentence: 50,HL,B-Disease
Sentence: 50,treated,O
Sentence: 50,with,O
Sentence: 50,gemcitabine,B-Chemical
Sentence: 50,"1,000",O
Sentence: 50,mg,O
Sentence: 50,/,O
Sentence: 50,m,O
Sentence: 50,(,O
Sentence: 50,2,O
Sentence: 50,),O
Sentence: 50,day,O
Sentence: 50,(,O
Sentence: 50,D,O
Sentence: 50,),O
Sentence: 50,1,O
Sentence: 50,",",O
Sentence: 50,D8,O
Sentence: 50,and,O
Sentence: 50,D15,O
Sentence: 50,;,O
Sentence: 50,methylprednisolone,B-Chemical
Sentence: 50,"1,000",O
Sentence: 50,mg,O
Sentence: 50,D1,O
Sentence: 50,-,O
Sentence: 50,5,O
Sentence: 50,;,O
Sentence: 50,and,O
Sentence: 50,cisplatin,B-Chemical
Sentence: 50,100,O
Sentence: 50,mg,O
Sentence: 50,/,O
Sentence: 50,m,O
Sentence: 50,(,O
Sentence: 50,2,O
Sentence: 50,),O
Sentence: 50,D15,O
Sentence: 50,",",O
Sentence: 50,every,O
Sentence: 50,28,O
Sentence: 50,days,O
Sentence: 50,(,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,),O
Sentence: 50,were,O
Sentence: 50,included,O
Sentence: 50,.,O
Sentence: 50,Demographic,O
Sentence: 50,",",O
Sentence: 50,survival,O
Sentence: 50,",",O
Sentence: 50,response,O
Sentence: 50,and,O
Sentence: 50,toxicity,B-Disease
Sentence: 50,data,O
Sentence: 50,were,O
Sentence: 50,recorded,O
Sentence: 50,.,O
Sentence: 50,Forty,O
Sentence: 50,-,O
Sentence: 50,one,O
Sentence: 50,eligible,O
Sentence: 50,patients,O
Sentence: 50,were,O
Sentence: 50,identified,O
Sentence: 50,:,O
Sentence: 50,median,O
Sentence: 50,age,O
Sentence: 50,27,O
Sentence: 50,.,O
Sentence: 50,One,O
Sentence: 50,hundred,O
Sentence: 50,and,O
Sentence: 50,twenty,O
Sentence: 50,-,O
Sentence: 50,two,O
Sentence: 50,cycles,O
Sentence: 50,of,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,were,O
Sentence: 50,administered,O
Sentence: 50,in,O
Sentence: 50,total,O
Sentence: 50,(,O
Sentence: 50,median,O
Sentence: 50,3,O
Sentence: 50,cycles,O
Sentence: 50,;,O
Sentence: 50,range,O
Sentence: 50,1,O
Sentence: 50,-,O
Sentence: 50,6,O
Sentence: 50,),O
Sentence: 50,.,O
Sentence: 50,Twenty,O
Sentence: 50,of,O
Sentence: 50,41,O
Sentence: 50,(,O
Sentence: 50,48,O
Sentence: 50,%,O
Sentence: 50,),O
Sentence: 50,patients,O
Sentence: 50,received,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,as,O
Sentence: 50,second,O
Sentence: 50,-,O
Sentence: 50,line,O
Sentence: 50,treatment,O
Sentence: 50,and,O
Sentence: 50,11,O
Sentence: 50,/,O
Sentence: 50,41,O
Sentence: 50,(,O
Sentence: 50,27,O
Sentence: 50,%,O
Sentence: 50,),O
Sentence: 50,as,O
Sentence: 50,third,O
Sentence: 50,-,O
Sentence: 50,line,O
Sentence: 50,therapy,O
Sentence: 50,.,O
Sentence: 50,Overall,O
Sentence: 50,response,O
Sentence: 50,rate,O
Sentence: 50,(,O
Sentence: 50,ORR,O
Sentence: 50,),O
Sentence: 50,to,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,in,O
Sentence: 50,the,O
Sentence: 50,entire,O
Sentence: 50,cohort,O
Sentence: 50,was,O
Sentence: 50,80,O
Sentence: 50,%,O
Sentence: 50,(,O
Sentence: 50,complete,O
Sentence: 50,response,O
Sentence: 50,(,O
Sentence: 50,CR,O
Sentence: 50,),O
Sentence: 50,37,O
Sentence: 50,%,O
Sentence: 50,",",O
Sentence: 50,partial,O
Sentence: 50,response,O
Sentence: 50,44,O
Sentence: 50,%,O
Sentence: 50,),O
Sentence: 50,with,O
Sentence: 50,14,O
Sentence: 50,/,O
Sentence: 50,15,O
Sentence: 50,CR,O
Sentence: 50,confirmed,O
Sentence: 50,as,O
Sentence: 50,a,O
Sentence: 50,metabolic,O
Sentence: 50,CR,O
Sentence: 50,on,O
Sentence: 50,PET,O
Sentence: 50,and,O
Sentence: 50,ORR,O
Sentence: 50,of,O
Sentence: 50,85,O
Sentence: 50,%,O
Sentence: 50,in,O
Sentence: 50,the,O
Sentence: 50,20,O
Sentence: 50,second,O
Sentence: 50,-,O
Sentence: 50,line,O
Sentence: 50,patients,O
Sentence: 50,.,O
Sentence: 50,The,O
Sentence: 50,most,O
Sentence: 50,common,O
Sentence: 50,grade,O
Sentence: 50,3,O
Sentence: 50,/,O
Sentence: 50,4,O
Sentence: 50,toxicities,B-Disease
Sentence: 50,were,O
Sentence: 50,haematological,O
Sentence: 50,:,O
Sentence: 50,neutropenia,B-Disease
Sentence: 50,54,O
Sentence: 50,%,O
Sentence: 50,and,O
Sentence: 50,thrombocytopenia,B-Disease
Sentence: 50,51,O
Sentence: 50,%,O
Sentence: 50,.,O
Sentence: 50,Median,O
Sentence: 50,follow,O
Sentence: 50,-,O
Sentence: 50,up,O
Sentence: 50,from,O
Sentence: 50,the,O
Sentence: 50,start,O
Sentence: 50,of,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,was,O
Sentence: 50,4.5,O
Sentence: 50,years,O
Sentence: 50,.,O
Sentence: 50,Following,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,",",O
Sentence: 50,5,O
Sentence: 50,-,O
Sentence: 50,year,O
Sentence: 50,progression,O
Sentence: 50,-,O
Sentence: 50,free,O
Sentence: 50,survival,O
Sentence: 50,was,O
Sentence: 50,46,O
Sentence: 50,%,O
Sentence: 50,(,O
Sentence: 50,95,O
Sentence: 50,%,O
Sentence: 50,confidence,O
Sentence: 50,interval,O
Sentence: 50,(,O
Sentence: 50,CI,O
Sentence: 50,),O
Sentence: 50,",",O
Sentence: 50,30,O
Sentence: 50,-,O
Sentence: 50,62,O
Sentence: 50,%,O
Sentence: 50,),O
Sentence: 50,and,O
Sentence: 50,5,O
Sentence: 50,-,O
Sentence: 50,year,O
Sentence: 50,overall,O
Sentence: 50,survival,O
Sentence: 50,was,O
Sentence: 50,59,O
Sentence: 50,%,O
Sentence: 50,(,O
Sentence: 50,95,O
Sentence: 50,%,O
Sentence: 50,CI,O
Sentence: 50,",",O
Sentence: 50,43,O
Sentence: 50,-,O
Sentence: 50,74,O
Sentence: 50,%,O
Sentence: 50,),O
Sentence: 50,.,O
Sentence: 50,Fourteen,O
Sentence: 50,of,O
Sentence: 50,41,O
Sentence: 50,patients,O
Sentence: 50,proceeded,O
Sentence: 50,directly,O
Sentence: 50,to,O
Sentence: 50,autologous,O
Sentence: 50,transplant,O
Sentence: 50,.,O
Sentence: 50,GEM,B-Chemical
Sentence: 50,-,O
Sentence: 50,P,O
Sentence: 50,is,O
Sentence: 50,a,O
Sentence: 50,salvage,O
Sentence: 50,chemotherapy,O
Sentence: 50,with,O
Sentence: 50,relatively,O
Sentence: 50,high,O
Sentence: 50,response,O
Sentence: 50,rates,O
Sentence: 50,",",O
Sentence: 50,leading,O
Sentence: 50,to,O
Sentence: 50,successful,O
Sentence: 50,transplantation,O
Sentence: 50,in,O
Sentence: 50,appropriate,O
Sentence: 50,patients,O
Sentence: 50,",",O
Sentence: 50,in,O
Sentence: 50,the,O
Sentence: 50,treatment,O
Sentence: 50,of,O
Sentence: 50,relapsed,O
Sentence: 50,or,O
Sentence: 50,refractory,O
Sentence: 50,HL,B-Disease
Sentence: 50,.,O
Sentence: 51,Basal,O
Sentence: 51,functioning,O
Sentence: 51,of,O
Sentence: 51,the,O
Sentence: 51,hypothalamic,O
Sentence: 51,-,O
Sentence: 51,pituitary,O
Sentence: 51,-,O
Sentence: 51,adrenal,O
Sentence: 51,(,O
Sentence: 51,HPA,O
Sentence: 51,),O
Sentence: 51,axis,O
Sentence: 51,and,O
Sentence: 51,psychological,O
Sentence: 51,distress,O
Sentence: 51,in,O
Sentence: 51,recreational,O
Sentence: 51,ecstasy,O
Sentence: 51,polydrug,O
Sentence: 51,users,O
Sentence: 51,.,O
Sentence: 52,RATIONALE,O
Sentence: 52,:,O
Sentence: 52,Ecstasy,B-Chemical
Sentence: 52,(,O
Sentence: 52,MDMA,B-Chemical
Sentence: 52,),O
Sentence: 52,is,O
Sentence: 52,a,O
Sentence: 52,psychostimulant,O
Sentence: 52,drug,O
Sentence: 52,which,O
Sentence: 52,is,O
Sentence: 52,increasingly,O
Sentence: 52,associated,O
Sentence: 52,with,O
Sentence: 52,psychobiological,B-Disease
Sentence: 52,dysfunction,I-Disease
Sentence: 52,.,O
Sentence: 52,While,O
Sentence: 52,some,O
Sentence: 52,recent,O
Sentence: 52,studies,O
Sentence: 52,suggest,O
Sentence: 52,acute,O
Sentence: 52,changes,O
Sentence: 52,in,O
Sentence: 52,neuroendocrine,O
Sentence: 52,function,O
Sentence: 52,",",O
Sentence: 52,less,O
Sentence: 52,is,O
Sentence: 52,known,O
Sentence: 52,about,O
Sentence: 52,long,O
Sentence: 52,-,O
Sentence: 52,term,O
Sentence: 52,changes,O
Sentence: 52,in,O
Sentence: 52,HPA,O
Sentence: 52,functionality,O
Sentence: 52,in,O
Sentence: 52,recreational,O
Sentence: 52,users,O
Sentence: 52,.,O
Sentence: 52,OBJECTIVES,O
Sentence: 52,:,O
Sentence: 52,The,O
Sentence: 52,current,O
Sentence: 52,study,O
Sentence: 52,is,O
Sentence: 52,the,O
Sentence: 52,first,O
Sentence: 52,to,O
Sentence: 52,explore,O
Sentence: 52,the,O
Sentence: 52,effects,O
Sentence: 52,of,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,-,O
Sentence: 52,polydrug,O
Sentence: 52,use,O
Sentence: 52,on,O
Sentence: 52,psychological,O
Sentence: 52,distress,O
Sentence: 52,and,O
Sentence: 52,basal,O
Sentence: 52,functioning,O
Sentence: 52,of,O
Sentence: 52,the,O
Sentence: 52,HPA,O
Sentence: 52,axis,O
Sentence: 52,through,O
Sentence: 52,assessing,O
Sentence: 52,the,O
Sentence: 52,secretion,O
Sentence: 52,of,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,across,O
Sentence: 52,the,O
Sentence: 52,diurnal,O
Sentence: 52,period,O
Sentence: 52,.,O
Sentence: 52,METHOD,O
Sentence: 52,:,O
Sentence: 52,Seventy,O
Sentence: 52,-,O
Sentence: 52,six,O
Sentence: 52,participants,O
Sentence: 52,(,O
Sentence: 52,21,O
Sentence: 52,nonusers,O
Sentence: 52,",",O
Sentence: 52,29,O
Sentence: 52,light,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,-,O
Sentence: 52,polydrug,O
Sentence: 52,users,O
Sentence: 52,",",O
Sentence: 52,26,O
Sentence: 52,heavy,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,-,O
Sentence: 52,polydrug,O
Sentence: 52,users,O
Sentence: 52,),O
Sentence: 52,completed,O
Sentence: 52,a,O
Sentence: 52,substance,O
Sentence: 52,use,O
Sentence: 52,inventory,O
Sentence: 52,and,O
Sentence: 52,measures,O
Sentence: 52,of,O
Sentence: 52,psychological,O
Sentence: 52,distress,O
Sentence: 52,at,O
Sentence: 52,baseline,O
Sentence: 52,",",O
Sentence: 52,then,O
Sentence: 52,two,O
Sentence: 52,consecutive,O
Sentence: 52,days,O
Sentence: 52,of,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,sampling,O
Sentence: 52,(,O
Sentence: 52,on,O
Sentence: 52,awakening,O
Sentence: 52,",",O
Sentence: 52,30,O
Sentence: 52,min,O
Sentence: 52,post,O
Sentence: 52,awakening,O
Sentence: 52,",",O
Sentence: 52,between,O
Sentence: 52,1400,O
Sentence: 52,and,O
Sentence: 52,1600,O
Sentence: 52,hours,O
Sentence: 52,and,O
Sentence: 52,pre,O
Sentence: 52,bedtime,O
Sentence: 52,),O
Sentence: 52,.,O
Sentence: 52,On,O
Sentence: 52,day,O
Sentence: 52,2,O
Sentence: 52,",",O
Sentence: 52,participants,O
Sentence: 52,also,O
Sentence: 52,attended,O
Sentence: 52,the,O
Sentence: 52,laboratory,O
Sentence: 52,to,O
Sentence: 52,complete,O
Sentence: 52,a,O
Sentence: 52,20,O
Sentence: 52,-,O
Sentence: 52,min,O
Sentence: 52,multitasking,O
Sentence: 52,stressor,O
Sentence: 52,.,O
Sentence: 52,RESULTS,O
Sentence: 52,:,O
Sentence: 52,Both,O
Sentence: 52,user,O
Sentence: 52,groups,O
Sentence: 52,exhibited,O
Sentence: 52,significantly,O
Sentence: 52,greater,O
Sentence: 52,levels,O
Sentence: 52,of,O
Sentence: 52,anxiety,B-Disease
Sentence: 52,and,O
Sentence: 52,depression,B-Disease
Sentence: 52,than,O
Sentence: 52,nonusers,O
Sentence: 52,.,O
Sentence: 52,On,O
Sentence: 52,day,O
Sentence: 52,1,O
Sentence: 52,",",O
Sentence: 52,all,O
Sentence: 52,participants,O
Sentence: 52,exhibited,O
Sentence: 52,a,O
Sentence: 52,typical,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,profile,O
Sentence: 52,",",O
Sentence: 52,though,O
Sentence: 52,light,O
Sentence: 52,users,O
Sentence: 52,had,O
Sentence: 52,significantly,O
Sentence: 52,elevated,O
Sentence: 52,levels,O
Sentence: 52,pre,O
Sentence: 52,-,O
Sentence: 52,bed,O
Sentence: 52,.,O
Sentence: 52,On,O
Sentence: 52,day,O
Sentence: 52,2,O
Sentence: 52,",",O
Sentence: 52,heavy,O
Sentence: 52,users,O
Sentence: 52,demonstrated,O
Sentence: 52,elevated,O
Sentence: 52,levels,O
Sentence: 52,upon,O
Sentence: 52,awakening,O
Sentence: 52,and,O
Sentence: 52,all,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,-,O
Sentence: 52,polydrug,O
Sentence: 52,users,O
Sentence: 52,demonstrated,O
Sentence: 52,elevated,O
Sentence: 52,pre,O
Sentence: 52,-,O
Sentence: 52,bed,O
Sentence: 52,levels,O
Sentence: 52,compared,O
Sentence: 52,to,O
Sentence: 52,non,O
Sentence: 52,-,O
Sentence: 52,users,O
Sentence: 52,.,O
Sentence: 52,Significant,O
Sentence: 52,between,O
Sentence: 52,group,O
Sentence: 52,differences,O
Sentence: 52,were,O
Sentence: 52,also,O
Sentence: 52,observed,O
Sentence: 52,in,O
Sentence: 52,afternoon,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,levels,O
Sentence: 52,and,O
Sentence: 52,in,O
Sentence: 52,overall,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,secretion,O
Sentence: 52,across,O
Sentence: 52,the,O
Sentence: 52,day,O
Sentence: 52,.,O
Sentence: 52,CONCLUSIONS,O
Sentence: 52,:,O
Sentence: 52,The,O
Sentence: 52,increases,O
Sentence: 52,in,O
Sentence: 52,anxiety,B-Disease
Sentence: 52,and,O
Sentence: 52,depression,B-Disease
Sentence: 52,are,O
Sentence: 52,in,O
Sentence: 52,line,O
Sentence: 52,with,O
Sentence: 52,previous,O
Sentence: 52,observations,O
Sentence: 52,in,O
Sentence: 52,recreational,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,-,O
Sentence: 52,polydrug,O
Sentence: 52,users,O
Sentence: 52,.,O
Sentence: 52,Dysregulated,O
Sentence: 52,diurnal,O
Sentence: 52,cortisol,B-Chemical
Sentence: 52,may,O
Sentence: 52,be,O
Sentence: 52,indicative,O
Sentence: 52,of,O
Sentence: 52,inappropriate,O
Sentence: 52,anticipation,O
Sentence: 52,of,O
Sentence: 52,forthcoming,O
Sentence: 52,demands,O
Sentence: 52,and,O
Sentence: 52,hypersecretion,O
Sentence: 52,may,O
Sentence: 52,lead,O
Sentence: 52,to,O
Sentence: 52,the,O
Sentence: 52,increased,O
Sentence: 52,psychological,O
Sentence: 52,and,O
Sentence: 52,physical,O
Sentence: 52,morbidity,O
Sentence: 52,associated,O
Sentence: 52,with,O
Sentence: 52,heavy,O
Sentence: 52,recreational,O
Sentence: 52,use,O
Sentence: 52,of,O
Sentence: 52,ecstasy,B-Chemical
Sentence: 52,.,O
Sentence: 53,Ifosfamide,B-Chemical
Sentence: 53,related,O
Sentence: 53,encephalopathy,B-Disease
Sentence: 53,:,O
Sentence: 53,the,O
Sentence: 53,need,O
Sentence: 53,for,O
Sentence: 53,a,O
Sentence: 53,timely,O
Sentence: 53,EEG,O
Sentence: 53,evaluation,O
Sentence: 53,.,O
Sentence: 54,BACKGROUND,O
Sentence: 54,:,O
Sentence: 54,Ifosfamide,B-Chemical
Sentence: 54,is,O
Sentence: 54,an,O
Sentence: 54,alkylating,O
Sentence: 54,agent,O
Sentence: 54,useful,O
Sentence: 54,in,O
Sentence: 54,the,O
Sentence: 54,treatment,O
Sentence: 54,of,O
Sentence: 54,a,O
Sentence: 54,wide,O
Sentence: 54,range,O
Sentence: 54,of,O
Sentence: 54,cancers,B-Disease
Sentence: 54,including,O
Sentence: 54,sarcomas,B-Disease
Sentence: 54,",",O
Sentence: 54,lymphoma,B-Disease
Sentence: 54,",",O
Sentence: 54,gynecologic,B-Disease
Sentence: 54,and,I-Disease
Sentence: 54,testicular,I-Disease
Sentence: 54,cancers,I-Disease
Sentence: 54,.,O
Sentence: 54,Encephalopathy,B-Disease
Sentence: 54,has,O
Sentence: 54,been,O
Sentence: 54,reported,O
Sentence: 54,in,O
Sentence: 54,10,O
Sentence: 54,-,O
Sentence: 54,40,O
Sentence: 54,%,O
Sentence: 54,of,O
Sentence: 54,patients,O
Sentence: 54,receiving,O
Sentence: 54,high,O
Sentence: 54,-,O
Sentence: 54,dose,O
Sentence: 54,IV,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,.,O
Sentence: 54,OBJECTIVE,O
Sentence: 54,:,O
Sentence: 54,To,O
Sentence: 54,highlight,O
Sentence: 54,the,O
Sentence: 54,role,O
Sentence: 54,of,O
Sentence: 54,electroencephalogram,O
Sentence: 54,(,O
Sentence: 54,EEG,O
Sentence: 54,),O
Sentence: 54,in,O
Sentence: 54,the,O
Sentence: 54,early,O
Sentence: 54,detection,O
Sentence: 54,and,O
Sentence: 54,management,O
Sentence: 54,of,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,related,O
Sentence: 54,encephalopathy,B-Disease
Sentence: 54,.,O
Sentence: 54,METHODS,O
Sentence: 54,:,O
Sentence: 54,Retrospective,O
Sentence: 54,chart,O
Sentence: 54,review,O
Sentence: 54,including,O
Sentence: 54,clinical,O
Sentence: 54,data,O
Sentence: 54,and,O
Sentence: 54,EEG,O
Sentence: 54,recordings,O
Sentence: 54,was,O
Sentence: 54,done,O
Sentence: 54,on,O
Sentence: 54,five,O
Sentence: 54,patients,O
Sentence: 54,",",O
Sentence: 54,admitted,O
Sentence: 54,to,O
Sentence: 54,MD,O
Sentence: 54,Anderson,O
Sentence: 54,Cancer,B-Disease
Sentence: 54,Center,O
Sentence: 54,between,O
Sentence: 54,years,O
Sentence: 54,2009,O
Sentence: 54,and,O
Sentence: 54,2012,O
Sentence: 54,",",O
Sentence: 54,who,O
Sentence: 54,developed,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,related,O
Sentence: 54,acute,O
Sentence: 54,encephalopathy,B-Disease
Sentence: 54,.,O
Sentence: 54,RESULTS,O
Sentence: 54,:,O
Sentence: 54,All,O
Sentence: 54,five,O
Sentence: 54,patients,O
Sentence: 54,experienced,O
Sentence: 54,symptoms,O
Sentence: 54,of,O
Sentence: 54,encephalopathy,B-Disease
Sentence: 54,soon,O
Sentence: 54,after,O
Sentence: 54,(,O
Sentence: 54,within,O
Sentence: 54,12,O
Sentence: 54,h,O
Sentence: 54,-,O
Sentence: 54,2,O
Sentence: 54,days,O
Sentence: 54,),O
Sentence: 54,receiving,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,.,O
Sentence: 54,Two,O
Sentence: 54,patients,O
Sentence: 54,developed,O
Sentence: 54,generalized,O
Sentence: 54,convulsions,B-Disease
Sentence: 54,while,O
Sentence: 54,one,O
Sentence: 54,patient,O
Sentence: 54,developed,O
Sentence: 54,continuous,O
Sentence: 54,non,O
Sentence: 54,-,O
Sentence: 54,convulsive,O
Sentence: 54,status,O
Sentence: 54,epilepticus,O
Sentence: 54,(,O
Sentence: 54,NCSE,B-Disease
Sentence: 54,),O
Sentence: 54,that,O
Sentence: 54,required,O
Sentence: 54,ICU,O
Sentence: 54,admission,O
Sentence: 54,and,O
Sentence: 54,intubation,O
Sentence: 54,.,O
Sentence: 54,Initial,O
Sentence: 54,EEG,O
Sentence: 54,showed,O
Sentence: 54,epileptiform,O
Sentence: 54,discharges,O
Sentence: 54,in,O
Sentence: 54,three,O
Sentence: 54,patients,O
Sentence: 54,;,O
Sentence: 54,run,O
Sentence: 54,of,O
Sentence: 54,triphasic,O
Sentence: 54,waves,O
Sentence: 54,in,O
Sentence: 54,one,O
Sentence: 54,patient,O
Sentence: 54,and,O
Sentence: 54,moderate,O
Sentence: 54,degree,O
Sentence: 54,diffuse,O
Sentence: 54,generalized,O
Sentence: 54,slowing,O
Sentence: 54,.,O
Sentence: 54,Mixed,O
Sentence: 54,pattern,O
Sentence: 54,with,O
Sentence: 54,the,O
Sentence: 54,presence,O
Sentence: 54,of,O
Sentence: 54,both,O
Sentence: 54,sharps,O
Sentence: 54,and,O
Sentence: 54,triphasic,O
Sentence: 54,waves,O
Sentence: 54,were,O
Sentence: 54,also,O
Sentence: 54,noted,O
Sentence: 54,.,O
Sentence: 54,Repeat,O
Sentence: 54,EEGs,O
Sentence: 54,within,O
Sentence: 54,24_h,O
Sentence: 54,of,O
Sentence: 54,symptom,O
Sentence: 54,onset,O
Sentence: 54,showed,O
Sentence: 54,marked,O
Sentence: 54,improvement,O
Sentence: 54,that,O
Sentence: 54,was,O
Sentence: 54,correlated,O
Sentence: 54,with,O
Sentence: 54,clinical,O
Sentence: 54,improvement,O
Sentence: 54,.,O
Sentence: 54,CONCLUSIONS,O
Sentence: 54,:,O
Sentence: 54,Severity,O
Sentence: 54,of,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,related,O
Sentence: 54,encephalopathy,B-Disease
Sentence: 54,correlates,O
Sentence: 54,with,O
Sentence: 54,EEG,O
Sentence: 54,changes,O
Sentence: 54,.,O
Sentence: 54,We,O
Sentence: 54,suggest,O
Sentence: 54,a,O
Sentence: 54,timely,O
Sentence: 54,EEG,O
Sentence: 54,evaluation,O
Sentence: 54,for,O
Sentence: 54,patients,O
Sentence: 54,receiving,O
Sentence: 54,ifosfamide,B-Chemical
Sentence: 54,who,O
Sentence: 54,develop,O
Sentence: 54,features,O
Sentence: 54,of,O
Sentence: 54,encephalopathy,B-Disease
Sentence: 54,.,O
Sentence: 55,Incidence,O
Sentence: 55,of,O
Sentence: 55,contrast,B-Chemical
Sentence: 55,-,O
Sentence: 55,induced,O
Sentence: 55,nephropathy,B-Disease
Sentence: 55,in,O
Sentence: 55,hospitalised,O
Sentence: 55,patients,O
Sentence: 55,with,O
Sentence: 55,cancer,B-Disease
Sentence: 55,.,O
Sentence: 56,OBJECTIVES,O
Sentence: 56,:,O
Sentence: 56,To,O
Sentence: 56,determine,O
Sentence: 56,the,O
Sentence: 56,frequency,O
Sentence: 56,of,O
Sentence: 56,and,O
Sentence: 56,possible,O
Sentence: 56,factors,O
Sentence: 56,related,O
Sentence: 56,to,O
Sentence: 56,contrast,B-Chemical
Sentence: 56,-,O
Sentence: 56,induced,O
Sentence: 56,nephropathy,B-Disease
Sentence: 56,(,O
Sentence: 56,CIN,O
Sentence: 56,),O
Sentence: 56,in,O
Sentence: 56,hospitalised,O
Sentence: 56,patients,O
Sentence: 56,with,O
Sentence: 56,cancer,B-Disease
Sentence: 56,.,O
Sentence: 56,METHODS,O
Sentence: 56,:,O
Sentence: 56,Ninety,O
Sentence: 56,adult,O
Sentence: 56,patients,O
Sentence: 56,were,O
Sentence: 56,enrolled,O
Sentence: 56,.,O
Sentence: 56,Patients,O
Sentence: 56,with,O
Sentence: 56,risk,O
Sentence: 56,factors,O
Sentence: 56,for,O
Sentence: 56,acute,B-Disease
Sentence: 56,renal,I-Disease
Sentence: 56,failure,I-Disease
Sentence: 56,were,O
Sentence: 56,excluded,O
Sentence: 56,.,O
Sentence: 56,Blood,O
Sentence: 56,samples,O
Sentence: 56,were,O
Sentence: 56,examined,O
Sentence: 56,the,O
Sentence: 56,day,O
Sentence: 56,before,O
Sentence: 56,contrast,B-Chemical
Sentence: 56,-,O
Sentence: 56,enhanced,O
Sentence: 56,computed,O
Sentence: 56,tomography,O
Sentence: 56,(,O
Sentence: 56,CT,O
Sentence: 56,),O
Sentence: 56,and,O
Sentence: 56,serially,O
Sentence: 56,for,O
Sentence: 56,3,O
Sentence: 56,days,O
Sentence: 56,thereafter,O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,was,O
Sentence: 56,defined,O
Sentence: 56,as,O
Sentence: 56,an,O
Sentence: 56,increase,O
Sentence: 56,in,O
Sentence: 56,serum,O
Sentence: 56,creatinine,B-Chemical
Sentence: 56,(,O
Sentence: 56,Cr,B-Chemical
Sentence: 56,),O
Sentence: 56,of,O
Sentence: 56,0.5,O
Sentence: 56,mg,O
Sentence: 56,/,O
Sentence: 56,dl,O
Sentence: 56,or,O
Sentence: 56,more,O
Sentence: 56,",",O
Sentence: 56,or,O
Sentence: 56,elevation,O
Sentence: 56,of,O
Sentence: 56,Cr,B-Chemical
Sentence: 56,to,O
Sentence: 56,25,O
Sentence: 56,%,O
Sentence: 56,over,O
Sentence: 56,baseline,O
Sentence: 56,.,O
Sentence: 56,Relationships,O
Sentence: 56,between,O
Sentence: 56,CIN,O
Sentence: 56,and,O
Sentence: 56,possible,O
Sentence: 56,risk,O
Sentence: 56,factors,O
Sentence: 56,were,O
Sentence: 56,investigated,O
Sentence: 56,.,O
Sentence: 56,RESULTS,O
Sentence: 56,:,O
Sentence: 56,CIN,O
Sentence: 56,was,O
Sentence: 56,detected,O
Sentence: 56,in,O
Sentence: 56,18,O
Sentence: 56,/,O
Sentence: 56,90,O
Sentence: 56,(,O
Sentence: 56,20,O
Sentence: 56,%,O
Sentence: 56,),O
Sentence: 56,patients,O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,developed,O
Sentence: 56,in,O
Sentence: 56,25.5,O
Sentence: 56,%,O
Sentence: 56,patients,O
Sentence: 56,who,O
Sentence: 56,underwent,O
Sentence: 56,chemotherapy,O
Sentence: 56,and,O
Sentence: 56,in,O
Sentence: 56,11,O
Sentence: 56,%,O
Sentence: 56,patients,O
Sentence: 56,who,O
Sentence: 56,did,O
Sentence: 56,not,O
Sentence: 56,(,O
Sentence: 56,P,O
Sentence: 56,,O
Sentence: 56,=,O
Sentence: 56,,O
Sentence: 56,0.1,O
Sentence: 56,),O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,more,O
Sentence: 56,frequently,O
Sentence: 56,developed,O
Sentence: 56,in,O
Sentence: 56,patients,O
Sentence: 56,who,O
Sentence: 56,had,O
Sentence: 56,undergone,O
Sentence: 56,CT,O
Sentence: 56,within,O
Sentence: 56,45,O
Sentence: 56,days,O
Sentence: 56,after,O
Sentence: 56,the,O
Sentence: 56,last,O
Sentence: 56,chemotherapy,O
Sentence: 56,(,O
Sentence: 56,P,O
Sentence: 56,,O
Sentence: 56,=,O
Sentence: 56,,O
Sentence: 56,0.005,O
Sentence: 56,),O
Sentence: 56,;,O
Sentence: 56,it,O
Sentence: 56,was,O
Sentence: 56,also,O
Sentence: 56,an,O
Sentence: 56,independent,O
Sentence: 56,risk,O
Sentence: 56,factor,O
Sentence: 56,(,O
Sentence: 56,P,O
Sentence: 56,,O
Sentence: 56,=,O
Sentence: 56,,O
Sentence: 56,0.017,O
Sentence: 56,),O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,was,O
Sentence: 56,significantly,O
Sentence: 56,more,O
Sentence: 56,after,O
Sentence: 56,treatment,O
Sentence: 56,with,O
Sentence: 56,bevacizumab,B-Chemical
Sentence: 56,/,O
Sentence: 56,irinotecan,B-Chemical
Sentence: 56,(,O
Sentence: 56,P,O
Sentence: 56,,O
Sentence: 56,=,O
Sentence: 56,,O
Sentence: 56,0.021,O
Sentence: 56,),O
Sentence: 56,and,O
Sentence: 56,in,O
Sentence: 56,patients,O
Sentence: 56,with,O
Sentence: 56,hypertension,B-Disease
Sentence: 56,(,O
Sentence: 56,P,O
Sentence: 56,,O
Sentence: 56,=,O
Sentence: 56,,O
Sentence: 56,0.044,O
Sentence: 56,),O
Sentence: 56,.,O
Sentence: 56,CONCLUSIONS,O
Sentence: 56,:,O
Sentence: 56,The,O
Sentence: 56,incidence,O
Sentence: 56,of,O
Sentence: 56,CIN,O
Sentence: 56,after,O
Sentence: 56,CT,O
Sentence: 56,in,O
Sentence: 56,hospitalised,O
Sentence: 56,oncological,O
Sentence: 56,patients,O
Sentence: 56,was,O
Sentence: 56,20,O
Sentence: 56,%,O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,developed,O
Sentence: 56,4.5,O
Sentence: 56,-,O
Sentence: 56,times,O
Sentence: 56,more,O
Sentence: 56,frequently,O
Sentence: 56,in,O
Sentence: 56,patients,O
Sentence: 56,with,O
Sentence: 56,cancer,B-Disease
Sentence: 56,who,O
Sentence: 56,had,O
Sentence: 56,undergone,O
Sentence: 56,recent,O
Sentence: 56,chemotherapy,O
Sentence: 56,.,O
Sentence: 56,Hypertension,B-Disease
Sentence: 56,and,O
Sentence: 56,the,O
Sentence: 56,combination,O
Sentence: 56,of,O
Sentence: 56,bevacizumab,B-Chemical
Sentence: 56,/,O
Sentence: 56,irinotecan,B-Chemical
Sentence: 56,may,O
Sentence: 56,be,O
Sentence: 56,additional,O
Sentence: 56,risk,O
Sentence: 56,factors,O
Sentence: 56,for,O
Sentence: 56,CIN,O
Sentence: 56,development,O
Sentence: 56,.,O
Sentence: 56,KEY,O
Sentence: 56,POINTS,O
Sentence: 56,:,O
Sentence: 56,.,O
Sentence: 56,Contrast,B-Chemical
Sentence: 56,-,O
Sentence: 56,induced,O
Sentence: 56,nephropathy,B-Disease
Sentence: 56,(,O
Sentence: 56,CIN,O
Sentence: 56,),O
Sentence: 56,is,O
Sentence: 56,a,O
Sentence: 56,concern,O
Sentence: 56,for,O
Sentence: 56,oncological,O
Sentence: 56,patients,O
Sentence: 56,undergoing,O
Sentence: 56,CT.,O
Sentence: 56,.,O
Sentence: 56,CIN,O
Sentence: 56,occurs,O
Sentence: 56,more,O
Sentence: 56,often,O
Sentence: 56,when,O
Sentence: 56,CT,O
Sentence: 56,is,O
Sentence: 56,performed,O
Sentence: 56,,O
Sentence: 56,<,O
Sentence: 56,,O
Sentence: 56,45,O
Sentence: 56,days,O
Sentence: 56,after,O
Sentence: 56,chemotherapy,O
Sentence: 56,.,O
Sentence: 56,.,O
Sentence: 56,Hypertension,B-Disease
Sentence: 56,and,O
Sentence: 56,treatment,O
Sentence: 56,with,O
Sentence: 56,bevacizumab,B-Chemical
Sentence: 56,appear,O
Sentence: 56,to,O
Sentence: 56,be,O
Sentence: 56,additional,O
Sentence: 56,risk,O
Sentence: 56,factors,O
Sentence: 56,.,O
Sentence: 57,Syndrome,B-Disease
Sentence: 57,of,I-Disease
Sentence: 57,inappropriate,I-Disease
Sentence: 57,antidiuretic,I-Disease
Sentence: 57,hormone,I-Disease
Sentence: 57,secretion,O
Sentence: 57,associated,O
Sentence: 57,with,O
Sentence: 57,desvenlafaxine,B-Chemical
Sentence: 57,.,O
Sentence: 58,OBJECTIVE,O
Sentence: 58,:,O
Sentence: 58,To,O
Sentence: 58,report,O
Sentence: 58,a,O
Sentence: 58,case,O
Sentence: 58,of,O
Sentence: 58,syndrome,O
Sentence: 58,of,O
Sentence: 58,inappropriate,O
Sentence: 58,anti,O
Sentence: 58,-,O
Sentence: 58,diuretic,O
Sentence: 58,hormone,O
Sentence: 58,(,O
Sentence: 58,SIADH,B-Disease
Sentence: 58,),O
Sentence: 58,secretion,O
Sentence: 58,associated,O
Sentence: 58,with,O
Sentence: 58,desvenlafaxine,B-Chemical
Sentence: 58,.,O
Sentence: 58,CASE,O
Sentence: 58,SUMMARY,O
Sentence: 58,:,O
Sentence: 58,A,O
Sentence: 58,57,O
Sentence: 58,-,O
Sentence: 58,year,O
Sentence: 58,old,O
Sentence: 58,female,O
Sentence: 58,with,O
Sentence: 58,hyponatraemia,B-Disease
Sentence: 58,.,O
Sentence: 58,Her,O
Sentence: 58,medications,O
Sentence: 58,included,O
Sentence: 58,desvenlafaxine,B-Chemical
Sentence: 58,",",O
Sentence: 58,and,O
Sentence: 58,symptoms,O
Sentence: 58,included,O
Sentence: 58,nausea,B-Disease
Sentence: 58,",",O
Sentence: 58,anxiety,B-Disease
Sentence: 58,and,O
Sentence: 58,confusion,B-Disease
Sentence: 58,.,O
Sentence: 58,The,O
Sentence: 58,serum,O
Sentence: 58,sodium,B-Chemical
Sentence: 58,at,O
Sentence: 58,this,O
Sentence: 58,time,O
Sentence: 58,was,O
Sentence: 58,120,O
Sentence: 58,mmol,O
Sentence: 58,/,O
Sentence: 58,L,O
Sentence: 58,",",O
Sentence: 58,serum,O
Sentence: 58,osmolality,O
Sentence: 58,was,O
Sentence: 58,263,O
Sentence: 58,mosmol,O
Sentence: 58,/,O
Sentence: 58,kg,O
Sentence: 58,",",O
Sentence: 58,urine,O
Sentence: 58,osmolality,O
Sentence: 58,410,O
Sentence: 58,mosmol,O
Sentence: 58,/,O
Sentence: 58,kg,O
Sentence: 58,and,O
Sentence: 58,urine,O
Sentence: 58,sodium,B-Chemical
Sentence: 58,63,O
Sentence: 58,mmol,O
Sentence: 58,/,O
Sentence: 58,L,O
Sentence: 58,",",O
Sentence: 58,consistent,O
Sentence: 58,with,O
Sentence: 58,a,O
Sentence: 58,diagnosis,O
Sentence: 58,of,O
Sentence: 58,SIADH,B-Disease
Sentence: 58,.,O
Sentence: 58,Desvenlafaxine,B-Chemical
Sentence: 58,was,O
Sentence: 58,ceased,O
Sentence: 58,and,O
Sentence: 58,fluid,O
Sentence: 58,restriction,O
Sentence: 58,implemented,O
Sentence: 58,.,O
Sentence: 58,After,O
Sentence: 58,4,O
Sentence: 58,days,O
Sentence: 58,the,O
Sentence: 58,sodium,B-Chemical
Sentence: 58,increased,O
Sentence: 58,to,O
Sentence: 58,128,O
Sentence: 58,mmol,O
Sentence: 58,/,O
Sentence: 58,L,O
Sentence: 58,and,O
Sentence: 58,fluid,O
Sentence: 58,restriction,O
Sentence: 58,was,O
Sentence: 58,relaxed,O
Sentence: 58,.,O
Sentence: 58,During,O
Sentence: 58,her,O
Sentence: 58,further,O
Sentence: 58,3,O
Sentence: 58,weeks,O
Sentence: 58,inpatient,O
Sentence: 58,admission,O
Sentence: 58,the,O
Sentence: 58,serum,O
Sentence: 58,sodium,B-Chemical
Sentence: 58,ranged,O
Sentence: 58,from,O
Sentence: 58,134,O
Sentence: 58,to,O
Sentence: 58,137,O
Sentence: 58,mmol,O
Sentence: 58,/,O
Sentence: 58,L,O
Sentence: 58,during,O
Sentence: 58,treatment,O
Sentence: 58,with,O
Sentence: 58,mirtazapine,B-Chemical
Sentence: 58,.,O
Sentence: 58,DISCUSSION,O
Sentence: 58,:,O
Sentence: 58,SIADH,B-Disease
Sentence: 58,has,O
Sentence: 58,been,O
Sentence: 58,widely,O
Sentence: 58,reported,O
Sentence: 58,with,O
Sentence: 58,a,O
Sentence: 58,range,O
Sentence: 58,of,O
Sentence: 58,antidepressants,O
Sentence: 58,.,O
Sentence: 58,This,O
Sentence: 58,case,O
Sentence: 58,report,O
Sentence: 58,suggests,O
Sentence: 58,that,O
Sentence: 58,desvenlafaxine,B-Chemical
Sentence: 58,might,O
Sentence: 58,cause,O
Sentence: 58,clinically,O
Sentence: 58,significant,O
Sentence: 58,hyponatremia,B-Disease
Sentence: 58,.,O
Sentence: 58,CONCLUSIONS,O
Sentence: 58,:,O
Sentence: 58,Clinicians,O
Sentence: 58,should,O
Sentence: 58,be,O
Sentence: 58,aware,O
Sentence: 58,of,O
Sentence: 58,the,O
Sentence: 58,potential,O
Sentence: 58,for,O
Sentence: 58,antidepressants,O
Sentence: 58,to,O
Sentence: 58,cause,O
Sentence: 58,hyponatremia,B-Disease
Sentence: 58,",",O
Sentence: 58,and,O
Sentence: 58,take,O
Sentence: 58,appropriate,O
Sentence: 58,corrective,O
Sentence: 58,action,O
Sentence: 58,where,O
Sentence: 58,necessary,O
Sentence: 58,.,O
Sentence: 59,Oxidative,O
Sentence: 59,stress,O
Sentence: 59,on,O
Sentence: 59,cardiotoxicity,B-Disease
Sentence: 59,after,O
Sentence: 59,treatment,O
Sentence: 59,with,O
Sentence: 59,single,O
Sentence: 59,and,O
Sentence: 59,multiple,O
Sentence: 59,doses,O
Sentence: 59,of,O
Sentence: 59,doxorubicin,B-Chemical
Sentence: 59,.,O
Sentence: 60,The,O
Sentence: 60,mechanism,O
Sentence: 60,of,O
Sentence: 60,doxorubicin,B-Chemical
Sentence: 60,(,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,),O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,induced,O
Sentence: 60,cardiotoxicity,B-Disease
Sentence: 60,remains,O
Sentence: 60,controversial,O
Sentence: 60,.,O
Sentence: 60,Wistar,O
Sentence: 60,rats,O
Sentence: 60,(,O
Sentence: 60,n,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,66,O
Sentence: 60,),O
Sentence: 60,received,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,injections,O
Sentence: 60,intraperitoneally,O
Sentence: 60,and,O
Sentence: 60,were,O
Sentence: 60,randomly,O
Sentence: 60,assigned,O
Sentence: 60,to,O
Sentence: 60,2,O
Sentence: 60,experimental,O
Sentence: 60,protocols,O
Sentence: 60,:,O
Sentence: 60,(,O
Sentence: 60,1,O
Sentence: 60,),O
Sentence: 60,rats,O
Sentence: 60,were,O
Sentence: 60,killed,O
Sentence: 60,before,O
Sentence: 60,(,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,24,O
Sentence: 60,h,O
Sentence: 60,",",O
Sentence: 60,n,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,8,O
Sentence: 60,),O
Sentence: 60,and,O
Sentence: 60,24,O
Sentence: 60,h,O
Sentence: 60,after,O
Sentence: 60,(,O
Sentence: 60,+24,O
Sentence: 60,h,O
Sentence: 60,",",O
Sentence: 60,n,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,8,O
Sentence: 60,),O
Sentence: 60,a,O
Sentence: 60,single,O
Sentence: 60,dose,O
Sentence: 60,of,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,(,O
Sentence: 60,4,O
Sentence: 60,mg,O
Sentence: 60,/,O
Sentence: 60,kg,O
Sentence: 60,body,O
Sentence: 60,weight,O
Sentence: 60,),O
Sentence: 60,to,O
Sentence: 60,determine,O
Sentence: 60,the,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,acute,O
Sentence: 60,effect,O
Sentence: 60,and,O
Sentence: 60,(,O
Sentence: 60,2,O
Sentence: 60,),O
Sentence: 60,rats,O
Sentence: 60,(,O
Sentence: 60,n,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,58,O
Sentence: 60,),O
Sentence: 60,received,O
Sentence: 60,4,O
Sentence: 60,injections,O
Sentence: 60,of,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,(,O
Sentence: 60,4,O
Sentence: 60,mg,O
Sentence: 60,/,O
Sentence: 60,kg,O
Sentence: 60,body,O
Sentence: 60,weight,O
Sentence: 60,/,O
Sentence: 60,week,O
Sentence: 60,),O
Sentence: 60,and,O
Sentence: 60,were,O
Sentence: 60,killed,O
Sentence: 60,before,O
Sentence: 60,the,O
Sentence: 60,first,O
Sentence: 60,injection,O
Sentence: 60,(,O
Sentence: 60,M0,O
Sentence: 60,),O
Sentence: 60,and,O
Sentence: 60,1,O
Sentence: 60,week,O
Sentence: 60,after,O
Sentence: 60,each,O
Sentence: 60,injection,O
Sentence: 60,(,O
Sentence: 60,M1,O
Sentence: 60,",",O
Sentence: 60,M2,O
Sentence: 60,",",O
Sentence: 60,M3,O
Sentence: 60,",",O
Sentence: 60,and,O
Sentence: 60,M4,O
Sentence: 60,),O
Sentence: 60,to,O
Sentence: 60,determine,O
Sentence: 60,the,O
Sentence: 60,chronological,O
Sentence: 60,effects,O
Sentence: 60,.,O
Sentence: 60,Animals,O
Sentence: 60,used,O
Sentence: 60,at,O
Sentence: 60,M0,O
Sentence: 60,(,O
Sentence: 60,n,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,8,O
Sentence: 60,),O
Sentence: 60,were,O
Sentence: 60,also,O
Sentence: 60,used,O
Sentence: 60,at,O
Sentence: 60,moment,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,24,O
Sentence: 60,h,O
Sentence: 60,of,O
Sentence: 60,acute,O
Sentence: 60,study,O
Sentence: 60,.,O
Sentence: 60,Cardiac,O
Sentence: 60,total,O
Sentence: 60,antioxidant,O
Sentence: 60,performance,O
Sentence: 60,(,O
Sentence: 60,TAP,O
Sentence: 60,),O
Sentence: 60,",",O
Sentence: 60,DNA,O
Sentence: 60,damage,O
Sentence: 60,",",O
Sentence: 60,and,O
Sentence: 60,morphology,O
Sentence: 60,analyses,O
Sentence: 60,were,O
Sentence: 60,carried,O
Sentence: 60,out,O
Sentence: 60,at,O
Sentence: 60,each,O
Sentence: 60,time,O
Sentence: 60,point,O
Sentence: 60,.,O
Sentence: 60,Single,O
Sentence: 60,dose,O
Sentence: 60,of,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,was,O
Sentence: 60,associated,O
Sentence: 60,with,O
Sentence: 60,increased,O
Sentence: 60,cardiac,B-Disease
Sentence: 60,disarrangement,I-Disease
Sentence: 60,",",O
Sentence: 60,necrosis,B-Disease
Sentence: 60,",",O
Sentence: 60,and,O
Sentence: 60,DNA,O
Sentence: 60,damage,O
Sentence: 60,(,O
Sentence: 60,strand,O
Sentence: 60,breaks,O
Sentence: 60,(,O
Sentence: 60,SBs,O
Sentence: 60,),O
Sentence: 60,and,O
Sentence: 60,oxidized,O
Sentence: 60,pyrimidines,O
Sentence: 60,),O
Sentence: 60,and,O
Sentence: 60,decreased,O
Sentence: 60,TAP,O
Sentence: 60,.,O
Sentence: 60,The,O
Sentence: 60,chronological,O
Sentence: 60,study,O
Sentence: 60,showed,O
Sentence: 60,an,O
Sentence: 60,effect,O
Sentence: 60,of,O
Sentence: 60,a,O
Sentence: 60,cumulative,O
Sentence: 60,dose,O
Sentence: 60,on,O
Sentence: 60,body,O
Sentence: 60,weight,O
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,0.99,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.011,O
Sentence: 60,),O
Sentence: 60,",",O
Sentence: 60,necrosis,B-Disease
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,1.00,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.004,O
Sentence: 60,),O
Sentence: 60,",",O
Sentence: 60,TAP,O
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.95,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.049,O
Sentence: 60,),O
Sentence: 60,",",O
Sentence: 60,and,O
Sentence: 60,DNA,O
Sentence: 60,SBs,O
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,0.95,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.049,O
Sentence: 60,),O
Sentence: 60,.,O
Sentence: 60,DNA,O
Sentence: 60,SBs,O
Sentence: 60,damage,O
Sentence: 60,was,O
Sentence: 60,negatively,O
Sentence: 60,associated,O
Sentence: 60,with,O
Sentence: 60,TAP,O
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,0.98,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.018,O
Sentence: 60,),O
Sentence: 60,",",O
Sentence: 60,and,O
Sentence: 60,necrosis,B-Disease
Sentence: 60,(,O
Sentence: 60,R,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,,O
Sentence: 60,-,O
Sentence: 60,0.97,O
Sentence: 60,",",O
Sentence: 60,p,O
Sentence: 60,,O
Sentence: 60,=,O
Sentence: 60,,O
Sentence: 60,0.027,O
Sentence: 60,),O
Sentence: 60,.,O
Sentence: 60,Our,O
Sentence: 60,results,O
Sentence: 60,suggest,O
Sentence: 60,that,O
Sentence: 60,oxidative,O
Sentence: 60,damage,O
Sentence: 60,is,O
Sentence: 60,associated,O
Sentence: 60,with,O
Sentence: 60,acute,O
Sentence: 60,cardiotoxicity,B-Disease
Sentence: 60,induced,O
Sentence: 60,by,O
Sentence: 60,a,O
Sentence: 60,single,O
Sentence: 60,dose,O
Sentence: 60,of,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,only,O
Sentence: 60,.,O
Sentence: 60,Increased,O
Sentence: 60,resistance,O
Sentence: 60,to,O
Sentence: 60,the,O
Sentence: 60,oxidative,O
Sentence: 60,stress,O
Sentence: 60,is,O
Sentence: 60,plausible,O
Sentence: 60,for,O
Sentence: 60,the,O
Sentence: 60,multiple,O
Sentence: 60,dose,O
Sentence: 60,of,O
Sentence: 60,DOX,B-Chemical
Sentence: 60,.,O
Sentence: 60,Thus,O
Sentence: 60,",",O
Sentence: 60,different,O
Sentence: 60,mechanisms,O
Sentence: 60,may,O
Sentence: 60,be,O
Sentence: 60,involved,O
Sentence: 60,in,O
Sentence: 60,acute,O
Sentence: 60,toxicity,B-Disease
Sentence: 60,versus,O
Sentence: 60,chronic,O
Sentence: 60,toxicity,B-Disease
Sentence: 60,.,O
Sentence: 61,Tacrolimus,B-Chemical
Sentence: 61,-,O
Sentence: 61,related,O
Sentence: 61,seizure,B-Disease
Sentence: 61,after,O
Sentence: 61,pediatric,O
Sentence: 61,liver,O
Sentence: 61,transplantation,O
Sentence: 61,,O
Sentence: 61,-,O
Sentence: 61,,O
Sentence: 61,-,O
Sentence: 61,,O
Sentence: 61,a,O
Sentence: 61,single,O
Sentence: 61,-,O
Sentence: 61,center,O
Sentence: 61,experience,O
Sentence: 61,.,O
Sentence: 62,To,O
Sentence: 62,identify,O
Sentence: 62,the,O
Sentence: 62,risk,O
Sentence: 62,factors,O
Sentence: 62,for,O
Sentence: 62,new,O
Sentence: 62,-,O
Sentence: 62,onset,O
Sentence: 62,seizures,B-Disease
Sentence: 62,after,O
Sentence: 62,pediatric,O
Sentence: 62,LT,O
Sentence: 62,and,O
Sentence: 62,to,O
Sentence: 62,assess,O
Sentence: 62,their,O
Sentence: 62,clinical,O
Sentence: 62,implications,O
Sentence: 62,and,O
Sentence: 62,long,O
Sentence: 62,-,O
Sentence: 62,term,O
Sentence: 62,prognosis,O
Sentence: 62,.,O
Sentence: 62,The,O
Sentence: 62,clinical,O
Sentence: 62,and,O
Sentence: 62,laboratory,O
Sentence: 62,data,O
Sentence: 62,of,O
Sentence: 62,27,O
Sentence: 62,consecutive,O
Sentence: 62,children,O
Sentence: 62,who,O
Sentence: 62,underwent,O
Sentence: 62,LT,O
Sentence: 62,from,O
Sentence: 62,January,O
Sentence: 62,2007,O
Sentence: 62,to,O
Sentence: 62,December,O
Sentence: 62,2010,O
Sentence: 62,in,O
Sentence: 62,our,O
Sentence: 62,center,O
Sentence: 62,were,O
Sentence: 62,analyzed,O
Sentence: 62,retrospectively,O
Sentence: 62,.,O
Sentence: 62,Patients,O
Sentence: 62,were,O
Sentence: 62,divided,O
Sentence: 62,into,O
Sentence: 62,seizures,B-Disease
Sentence: 62,group,O
Sentence: 62,and,O
Sentence: 62,a,O
Sentence: 62,non,O
Sentence: 62,-,O
Sentence: 62,seizures,B-Disease
Sentence: 62,group,O
Sentence: 62,.,O
Sentence: 62,Pre,O
Sentence: 62,-,O
Sentence: 62,operative,O
Sentence: 62,",",O
Sentence: 62,intra,O
Sentence: 62,-,O
Sentence: 62,operative,O
Sentence: 62,",",O
Sentence: 62,and,O
Sentence: 62,post,O
Sentence: 62,-,O
Sentence: 62,operative,O
Sentence: 62,data,O
Sentence: 62,were,O
Sentence: 62,collected,O
Sentence: 62,.,O
Sentence: 62,Seizures,B-Disease
Sentence: 62,occurred,O
Sentence: 62,in,O
Sentence: 62,four,O
Sentence: 62,children,O
Sentence: 62,",",O
Sentence: 62,an,O
Sentence: 62,incidence,O
Sentence: 62,of,O
Sentence: 62,14.8,O
Sentence: 62,%,O
Sentence: 62,.,O
Sentence: 62,All,O
Sentence: 62,exhibited,O
Sentence: 62,generalized,O
Sentence: 62,tonic,O
Sentence: 62,-,O
Sentence: 62,clonic,O
Sentence: 62,seizures,B-Disease
Sentence: 62,within,O
Sentence: 62,the,O
Sentence: 62,first,O
Sentence: 62,two,O
Sentence: 62,wk,O
Sentence: 62,after,O
Sentence: 62,LT.,O
Sentence: 62,Univariate,O
Sentence: 62,analysis,O
Sentence: 62,showed,O
Sentence: 62,that,O
Sentence: 62,the,O
Sentence: 62,risk,O
Sentence: 62,factors,O
Sentence: 62,associated,O
Sentence: 62,with,O
Sentence: 62,seizures,B-Disease
Sentence: 62,after,O
Sentence: 62,pediatric,O
Sentence: 62,LT,O
Sentence: 62,included,O
Sentence: 62,gender,O
Sentence: 62,",",O
Sentence: 62,pediatric,O
Sentence: 62,end,O
Sentence: 62,-,O
Sentence: 62,stage,O
Sentence: 62,liver,O
Sentence: 62,disease,O
Sentence: 62,score,O
Sentence: 62,before,O
Sentence: 62,surgery,O
Sentence: 62,",",O
Sentence: 62,Child,O
Sentence: 62,-,O
Sentence: 62,Pugh,O
Sentence: 62,score,O
Sentence: 62,before,O
Sentence: 62,surgery,O
Sentence: 62,",",O
Sentence: 62,serum,O
Sentence: 62,total,O
Sentence: 62,bilirubin,B-Chemical
Sentence: 62,after,O
Sentence: 62,surgery,O
Sentence: 62,",",O
Sentence: 62,and,O
Sentence: 62,trough,O
Sentence: 62,TAC,B-Chemical
Sentence: 62,level,O
Sentence: 62,.,O
Sentence: 62,Multivariate,O
Sentence: 62,analysis,O
Sentence: 62,showed,O
Sentence: 62,that,O
Sentence: 62,trough,O
Sentence: 62,TAC,B-Chemical
Sentence: 62,level,O
Sentence: 62,was,O
Sentence: 62,the,O
Sentence: 62,only,O
Sentence: 62,independent,O
Sentence: 62,risk,O
Sentence: 62,factor,O
Sentence: 62,associated,O
Sentence: 62,with,O
Sentence: 62,the,O
Sentence: 62,seizures,B-Disease
Sentence: 62,.,O
Sentence: 62,All,O
Sentence: 62,children,O
Sentence: 62,who,O
Sentence: 62,experienced,O
Sentence: 62,seizures,B-Disease
Sentence: 62,survived,O
Sentence: 62,with,O
Sentence: 62,good,O
Sentence: 62,graft,O
Sentence: 62,function,O
Sentence: 62,and,O
Sentence: 62,remained,O
Sentence: 62,seizure,B-Disease
Sentence: 62,-,O
Sentence: 62,free,O
Sentence: 62,without,O
Sentence: 62,anti,O
Sentence: 62,-,O
Sentence: 62,epileptic,B-Disease
Sentence: 62,drugs,O
Sentence: 62,over,O
Sentence: 62,a,O
Sentence: 62,mean,O
Sentence: 62,follow,O
Sentence: 62,-,O
Sentence: 62,up,O
Sentence: 62,period,O
Sentence: 62,of,O
Sentence: 62,33.7,O
Sentence: 62,+,O
Sentence: 62,14.6,O
Sentence: 62,months,O
Sentence: 62,.,O
Sentence: 62,High,O
Sentence: 62,trough,O
Sentence: 62,TAC,B-Chemical
Sentence: 62,level,O
Sentence: 62,was,O
Sentence: 62,the,O
Sentence: 62,predominant,O
Sentence: 62,factor,O
Sentence: 62,that,O
Sentence: 62,contributed,O
Sentence: 62,to,O
Sentence: 62,seizures,B-Disease
Sentence: 62,in,O
Sentence: 62,the,O
Sentence: 62,early,O
Sentence: 62,post,O
Sentence: 62,-,O
Sentence: 62,operative,O
Sentence: 62,period,O
Sentence: 62,after,O
Sentence: 62,pediatric,O
Sentence: 62,LT.,O
Sentence: 62,High,O
Sentence: 62,PELD,O
Sentence: 62,and,O
Sentence: 62,Child,O
Sentence: 62,-,O
Sentence: 62,Pugh,O
Sentence: 62,scores,O
Sentence: 62,before,O
Sentence: 62,LT,O
Sentence: 62,and,O
Sentence: 62,high,O
Sentence: 62,post,O
Sentence: 62,-,O
Sentence: 62,operative,O
Sentence: 62,serum,O
Sentence: 62,Tbil,O
Sentence: 62,may,O
Sentence: 62,be,O
Sentence: 62,contributory,O
Sentence: 62,risk,O
Sentence: 62,factors,O
Sentence: 62,for,O
Sentence: 62,TAC,B-Chemical
Sentence: 62,-,O
Sentence: 62,related,O
Sentence: 62,seizures,B-Disease
Sentence: 62,.,O
Sentence: 63,The,O
Sentence: 63,flavonoid,B-Chemical
Sentence: 63,apigenin,B-Chemical
Sentence: 63,delays,O
Sentence: 63,forgetting,O
Sentence: 63,of,O
Sentence: 63,passive,O
Sentence: 63,avoidance,O
Sentence: 63,conditioning,O
Sentence: 63,in,O
Sentence: 63,rats,O
Sentence: 63,.,O
Sentence: 64,The,O
Sentence: 64,present,O
Sentence: 64,experiments,O
Sentence: 64,were,O
Sentence: 64,performed,O
Sentence: 64,to,O
Sentence: 64,study,O
Sentence: 64,the,O
Sentence: 64,effect,O
Sentence: 64,of,O
Sentence: 64,the,O
Sentence: 64,flavonoid,B-Chemical
Sentence: 64,apigenin,B-Chemical
Sentence: 64,(,O
Sentence: 64,20,O
Sentence: 64,mg,O
Sentence: 64,/,O
Sentence: 64,kg,O
Sentence: 64,intraperitoneally,O
Sentence: 64,(,O
Sentence: 64,i.p,O
Sentence: 64,.,O
Sentence: 64,),O
Sentence: 64,",",O
Sentence: 64,1,O
Sentence: 64,h,O
Sentence: 64,before,O
Sentence: 64,acquisition,O
Sentence: 64,),O
Sentence: 64,",",O
Sentence: 64,on,O
Sentence: 64,24,O
Sentence: 64,h,O
Sentence: 64,retention,O
Sentence: 64,performance,O
Sentence: 64,and,O
Sentence: 64,forgetting,O
Sentence: 64,of,O
Sentence: 64,a,O
Sentence: 64,step,O
Sentence: 64,-,O
Sentence: 64,through,O
Sentence: 64,passive,O
Sentence: 64,avoidance,O
Sentence: 64,task,O
Sentence: 64,",",O
Sentence: 64,in,O
Sentence: 64,young,O
Sentence: 64,male,O
Sentence: 64,Wistar,O
Sentence: 64,rats,O
Sentence: 64,.,O
Sentence: 64,There,O
Sentence: 64,were,O
Sentence: 64,no,O
Sentence: 64,differences,O
Sentence: 64,between,O
Sentence: 64,saline,O
Sentence: 64,-,O
Sentence: 64,,O
Sentence: 64,and,O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,-,O
Sentence: 64,treated,O
Sentence: 64,groups,O
Sentence: 64,in,O
Sentence: 64,the,O
Sentence: 64,24,O
Sentence: 64,h,O
Sentence: 64,retention,O
Sentence: 64,trial,O
Sentence: 64,.,O
Sentence: 64,Furthermore,O
Sentence: 64,",",O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,did,O
Sentence: 64,not,O
Sentence: 64,prevent,O
Sentence: 64,the,O
Sentence: 64,amnesia,B-Disease
Sentence: 64,induced,O
Sentence: 64,by,O
Sentence: 64,scopolamine,B-Chemical
Sentence: 64,(,O
Sentence: 64,1mg,O
Sentence: 64,/,O
Sentence: 64,kg,O
Sentence: 64,",",O
Sentence: 64,i.p.,O
Sentence: 64,",",O
Sentence: 64,30,O
Sentence: 64,min,O
Sentence: 64,before,O
Sentence: 64,the,O
Sentence: 64,acquisition,O
Sentence: 64,),O
Sentence: 64,.,O
Sentence: 64,The,O
Sentence: 64,saline,O
Sentence: 64,-,O
Sentence: 64,,O
Sentence: 64,and,O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,-,O
Sentence: 64,treated,O
Sentence: 64,rats,O
Sentence: 64,that,O
Sentence: 64,did,O
Sentence: 64,not,O
Sentence: 64,step,O
Sentence: 64,through,O
Sentence: 64,into,O
Sentence: 64,the,O
Sentence: 64,dark,O
Sentence: 64,compartment,O
Sentence: 64,during,O
Sentence: 64,the,O
Sentence: 64,cut,O
Sentence: 64,-,O
Sentence: 64,off,O
Sentence: 64,time,O
Sentence: 64,(,O
Sentence: 64,540,O
Sentence: 64,s,O
Sentence: 64,),O
Sentence: 64,were,O
Sentence: 64,retested,O
Sentence: 64,weekly,O
Sentence: 64,for,O
Sentence: 64,up,O
Sentence: 64,to,O
Sentence: 64,eight,O
Sentence: 64,weeks,O
Sentence: 64,.,O
Sentence: 64,In,O
Sentence: 64,the,O
Sentence: 64,saline,O
Sentence: 64,treated,O
Sentence: 64,group,O
Sentence: 64,",",O
Sentence: 64,the,O
Sentence: 64,first,O
Sentence: 64,significant,O
Sentence: 64,decline,O
Sentence: 64,in,O
Sentence: 64,passive,O
Sentence: 64,avoidance,O
Sentence: 64,response,O
Sentence: 64,was,O
Sentence: 64,observed,O
Sentence: 64,at,O
Sentence: 64,four,O
Sentence: 64,weeks,O
Sentence: 64,",",O
Sentence: 64,and,O
Sentence: 64,complete,O
Sentence: 64,memory,B-Disease
Sentence: 64,loss,I-Disease
Sentence: 64,was,O
Sentence: 64,found,O
Sentence: 64,five,O
Sentence: 64,weeks,O
Sentence: 64,after,O
Sentence: 64,the,O
Sentence: 64,acquisition,O
Sentence: 64,of,O
Sentence: 64,the,O
Sentence: 64,passive,O
Sentence: 64,avoidance,O
Sentence: 64,task,O
Sentence: 64,.,O
Sentence: 64,At,O
Sentence: 64,the,O
Sentence: 64,end,O
Sentence: 64,of,O
Sentence: 64,the,O
Sentence: 64,experimental,O
Sentence: 64,period,O
Sentence: 64,",",O
Sentence: 64,60,O
Sentence: 64,%,O
Sentence: 64,of,O
Sentence: 64,the,O
Sentence: 64,animals,O
Sentence: 64,treated,O
Sentence: 64,with,O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,still,O
Sentence: 64,did,O
Sentence: 64,not,O
Sentence: 64,step,O
Sentence: 64,through,O
Sentence: 64,.,O
Sentence: 64,These,O
Sentence: 64,data,O
Sentence: 64,suggest,O
Sentence: 64,that,O
Sentence: 64,1,O
Sentence: 64,),O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,delays,O
Sentence: 64,the,O
Sentence: 64,long,O
Sentence: 64,-,O
Sentence: 64,term,O
Sentence: 64,forgetting,O
Sentence: 64,but,O
Sentence: 64,did,O
Sentence: 64,not,O
Sentence: 64,modulate,O
Sentence: 64,the,O
Sentence: 64,24,O
Sentence: 64,h,O
Sentence: 64,retention,O
Sentence: 64,of,O
Sentence: 64,fear,O
Sentence: 64,memory,O
Sentence: 64,and,O
Sentence: 64,2,O
Sentence: 64,),O
Sentence: 64,the,O
Sentence: 64,obtained,O
Sentence: 64,beneficial,O
Sentence: 64,effect,O
Sentence: 64,of,O
Sentence: 64,apigenin,B-Chemical
Sentence: 64,on,O
Sentence: 64,the,O
Sentence: 64,passive,O
Sentence: 64,avoidance,O
Sentence: 64,conditioning,O
Sentence: 64,is,O
Sentence: 64,mediated,O
Sentence: 64,by,O
Sentence: 64,mechanisms,O
Sentence: 64,that,O
Sentence: 64,do,O
Sentence: 64,not,O
Sentence: 64,implicate,O
Sentence: 64,its,O
Sentence: 64,action,O
Sentence: 64,on,O
Sentence: 64,the,O
Sentence: 64,muscarinic,O
Sentence: 64,cholinergic,O
Sentence: 64,system,O
Sentence: 64,.,O
Sentence: 65,Cholecystokinin,O
Sentence: 65,-,O
Sentence: 65,octapeptide,O
Sentence: 65,restored,O
Sentence: 65,morphine,B-Chemical
Sentence: 65,-,O
Sentence: 65,induced,O
Sentence: 65,hippocampal,O
Sentence: 65,long,O
Sentence: 65,-,O
Sentence: 65,term,O
Sentence: 65,potentiation,O
Sentence: 65,impairment,O
Sentence: 65,in,O
Sentence: 65,rats,O
Sentence: 65,.,O
Sentence: 66,Cholecystokinin,O
Sentence: 66,-,O
Sentence: 66,octapeptide,O
Sentence: 66,(,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,),O
Sentence: 66,",",O
Sentence: 66,which,O
Sentence: 66,is,O
Sentence: 66,a,O
Sentence: 66,typical,O
Sentence: 66,brain,O
Sentence: 66,-,O
Sentence: 66,gut,O
Sentence: 66,peptide,O
Sentence: 66,",",O
Sentence: 66,exerts,O
Sentence: 66,a,O
Sentence: 66,wide,O
Sentence: 66,range,O
Sentence: 66,of,O
Sentence: 66,biological,O
Sentence: 66,activities,O
Sentence: 66,on,O
Sentence: 66,the,O
Sentence: 66,central,O
Sentence: 66,nervous,O
Sentence: 66,system,O
Sentence: 66,.,O
Sentence: 66,We,O
Sentence: 66,have,O
Sentence: 66,previously,O
Sentence: 66,reported,O
Sentence: 66,that,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,significantly,O
Sentence: 66,alleviated,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,-,O
Sentence: 66,induced,O
Sentence: 66,amnesia,B-Disease
Sentence: 66,and,O
Sentence: 66,reversed,O
Sentence: 66,spine,O
Sentence: 66,density,O
Sentence: 66,decreases,O
Sentence: 66,in,O
Sentence: 66,the,O
Sentence: 66,CA1,O
Sentence: 66,region,O
Sentence: 66,of,O
Sentence: 66,the,O
Sentence: 66,hippocampus,O
Sentence: 66,in,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,-,O
Sentence: 66,treated,O
Sentence: 66,animals,O
Sentence: 66,.,O
Sentence: 66,Here,O
Sentence: 66,",",O
Sentence: 66,we,O
Sentence: 66,investigated,O
Sentence: 66,the,O
Sentence: 66,effects,O
Sentence: 66,of,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,on,O
Sentence: 66,long,O
Sentence: 66,-,O
Sentence: 66,term,O
Sentence: 66,potentiation,O
Sentence: 66,(,O
Sentence: 66,LTP,O
Sentence: 66,),O
Sentence: 66,in,O
Sentence: 66,the,O
Sentence: 66,lateral,O
Sentence: 66,perforant,O
Sentence: 66,path,O
Sentence: 66,(,O
Sentence: 66,LPP,O
Sentence: 66,),O
Sentence: 66,,O
Sentence: 66,-,O
Sentence: 66,granule,O
Sentence: 66,cell,O
Sentence: 66,synapse,O
Sentence: 66,of,O
Sentence: 66,rat,O
Sentence: 66,dentate,O
Sentence: 66,gyrus,O
Sentence: 66,(,O
Sentence: 66,DG,O
Sentence: 66,),O
Sentence: 66,in,O
Sentence: 66,acute,O
Sentence: 66,saline,O
Sentence: 66,or,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,-,O
Sentence: 66,treated,O
Sentence: 66,rats,O
Sentence: 66,.,O
Sentence: 66,Population,O
Sentence: 66,spikes,O
Sentence: 66,(,O
Sentence: 66,PS,O
Sentence: 66,),O
Sentence: 66,",",O
Sentence: 66,which,O
Sentence: 66,were,O
Sentence: 66,evoked,O
Sentence: 66,by,O
Sentence: 66,stimulation,O
Sentence: 66,of,O
Sentence: 66,the,O
Sentence: 66,LPP,O
Sentence: 66,",",O
Sentence: 66,were,O
Sentence: 66,recorded,O
Sentence: 66,in,O
Sentence: 66,the,O
Sentence: 66,DG,O
Sentence: 66,region,O
Sentence: 66,.,O
Sentence: 66,Acute,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,(,O
Sentence: 66,30mg,O
Sentence: 66,/,O
Sentence: 66,kg,O
Sentence: 66,",",O
Sentence: 66,s.c.,O
Sentence: 66,),O
Sentence: 66,treatment,O
Sentence: 66,significantly,O
Sentence: 66,attenuated,O
Sentence: 66,hippocampal,O
Sentence: 66,LTP,O
Sentence: 66,and,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,(,O
Sentence: 66,1ug,O
Sentence: 66,",",O
Sentence: 66,i.c.v,O
Sentence: 66,.,O
Sentence: 66,),O
Sentence: 66,restored,O
Sentence: 66,the,O
Sentence: 66,amplitude,O
Sentence: 66,of,O
Sentence: 66,PS,O
Sentence: 66,that,O
Sentence: 66,was,O
Sentence: 66,attenuated,O
Sentence: 66,by,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,injection,O
Sentence: 66,.,O
Sentence: 66,Furthermore,O
Sentence: 66,",",O
Sentence: 66,microinjection,O
Sentence: 66,of,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,(,O
Sentence: 66,0.1,O
Sentence: 66,and,O
Sentence: 66,1ug,O
Sentence: 66,",",O
Sentence: 66,i.c.v,O
Sentence: 66,.,O
Sentence: 66,),O
Sentence: 66,also,O
Sentence: 66,significantly,O
Sentence: 66,augmented,O
Sentence: 66,hippocampal,O
Sentence: 66,LTP,O
Sentence: 66,in,O
Sentence: 66,saline,O
Sentence: 66,-,O
Sentence: 66,treated,O
Sentence: 66,(,O
Sentence: 66,1ml,O
Sentence: 66,/,O
Sentence: 66,kg,O
Sentence: 66,",",O
Sentence: 66,s.c.,O
Sentence: 66,),O
Sentence: 66,rats,O
Sentence: 66,.,O
Sentence: 66,Pre,O
Sentence: 66,-,O
Sentence: 66,treatment,O
Sentence: 66,of,O
Sentence: 66,the,O
Sentence: 66,CCK2,O
Sentence: 66,receptor,O
Sentence: 66,antagonist,O
Sentence: 66,L,O
Sentence: 66,-,O
Sentence: 66,"365,260",O
Sentence: 66,(,O
Sentence: 66,10ug,O
Sentence: 66,",",O
Sentence: 66,i.c.v,O
Sentence: 66,),O
Sentence: 66,reversed,O
Sentence: 66,the,O
Sentence: 66,effects,O
Sentence: 66,of,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,",",O
Sentence: 66,but,O
Sentence: 66,the,O
Sentence: 66,CCK1,O
Sentence: 66,receptor,O
Sentence: 66,antagonist,O
Sentence: 66,L,O
Sentence: 66,-,O
Sentence: 66,"364,718",O
Sentence: 66,(,O
Sentence: 66,10ug,O
Sentence: 66,",",O
Sentence: 66,i.c.v,O
Sentence: 66,),O
Sentence: 66,did,O
Sentence: 66,not,O
Sentence: 66,.,O
Sentence: 66,The,O
Sentence: 66,present,O
Sentence: 66,results,O
Sentence: 66,demonstrate,O
Sentence: 66,that,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,attenuates,O
Sentence: 66,the,O
Sentence: 66,effect,O
Sentence: 66,of,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,on,O
Sentence: 66,hippocampal,O
Sentence: 66,LTP,O
Sentence: 66,through,O
Sentence: 66,CCK2,O
Sentence: 66,receptors,O
Sentence: 66,and,O
Sentence: 66,suggest,O
Sentence: 66,an,O
Sentence: 66,ameliorative,O
Sentence: 66,function,O
Sentence: 66,of,O
Sentence: 66,CCK,O
Sentence: 66,-,O
Sentence: 66,8,O
Sentence: 66,on,O
Sentence: 66,morphine,B-Chemical
Sentence: 66,-,O
Sentence: 66,induced,O
Sentence: 66,memory,B-Disease
Sentence: 66,impairment,I-Disease
Sentence: 66,.,O
Sentence: 67,Glial,O
Sentence: 67,activation,O
Sentence: 67,and,O
Sentence: 67,post,O
Sentence: 67,-,O
Sentence: 67,synaptic,O
Sentence: 67,neurotoxicity,B-Disease
Sentence: 67,:,O
Sentence: 67,the,O
Sentence: 67,key,O
Sentence: 67,events,O
Sentence: 67,in,O
Sentence: 67,Streptozotocin,B-Chemical
Sentence: 67,(,O
Sentence: 67,ICV,O
Sentence: 67,),O
Sentence: 67,induced,O
Sentence: 67,memory,B-Disease
Sentence: 67,impairment,I-Disease
Sentence: 67,in,O
Sentence: 67,rats,O
Sentence: 67,.,O
Sentence: 68,In,O
Sentence: 68,the,O
Sentence: 68,present,O
Sentence: 68,study,O
Sentence: 68,the,O
Sentence: 68,role,O
Sentence: 68,of,O
Sentence: 68,glial,O
Sentence: 68,activation,O
Sentence: 68,and,O
Sentence: 68,post,O
Sentence: 68,synaptic,O
Sentence: 68,toxicity,B-Disease
Sentence: 68,in,O
Sentence: 68,ICV,O
Sentence: 68,Streptozotocin,B-Chemical
Sentence: 68,(,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,),O
Sentence: 68,induced,O
Sentence: 68,memory,B-Disease
Sentence: 68,impaired,I-Disease
Sentence: 68,rats,O
Sentence: 68,was,O
Sentence: 68,explored,O
Sentence: 68,.,O
Sentence: 68,In,O
Sentence: 68,experiment,O
Sentence: 68,set,O
Sentence: 68,up,O
Sentence: 68,1,O
Sentence: 68,:,O
Sentence: 68,Memory,B-Disease
Sentence: 68,deficit,I-Disease
Sentence: 68,was,O
Sentence: 68,found,O
Sentence: 68,in,O
Sentence: 68,Morris,O
Sentence: 68,water,O
Sentence: 68,maze,O
Sentence: 68,test,O
Sentence: 68,on,O
Sentence: 68,14,O
Sentence: 68,-,O
Sentence: 68,16,O
Sentence: 68,days,O
Sentence: 68,after,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,(,O
Sentence: 68,ICV,O
Sentence: 68,;,O
Sentence: 68,3mg,O
Sentence: 68,/,O
Sentence: 68,Kg,O
Sentence: 68,),O
Sentence: 68,administration,O
Sentence: 68,.,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,causes,O
Sentence: 68,increased,O
Sentence: 68,expression,O
Sentence: 68,of,O
Sentence: 68,GFAP,O
Sentence: 68,",",O
Sentence: 68,CD11b,O
Sentence: 68,and,O
Sentence: 68,TNF,O
Sentence: 68,-,O
Sentence: 68,a,O
Sentence: 68,indicating,O
Sentence: 68,glial,O
Sentence: 68,activation,O
Sentence: 68,and,O
Sentence: 68,neuroinflammation,B-Disease
Sentence: 68,.,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,also,O
Sentence: 68,significantly,O
Sentence: 68,increased,O
Sentence: 68,the,O
Sentence: 68,level,O
Sentence: 68,of,O
Sentence: 68,ROS,O
Sentence: 68,",",O
Sentence: 68,nitrite,B-Chemical
Sentence: 68,",",O
Sentence: 68,Ca,B-Chemical
Sentence: 68,(,O
Sentence: 68,2+,O
Sentence: 68,),O
Sentence: 68,and,O
Sentence: 68,reduced,O
Sentence: 68,the,O
Sentence: 68,mitochondrial,O
Sentence: 68,activity,O
Sentence: 68,in,O
Sentence: 68,synaptosomal,O
Sentence: 68,preparation,O
Sentence: 68,illustrating,O
Sentence: 68,free,O
Sentence: 68,radical,O
Sentence: 68,generation,O
Sentence: 68,and,O
Sentence: 68,excitotoxicity,B-Disease
Sentence: 68,.,O
Sentence: 68,Increased,O
Sentence: 68,expression,O
Sentence: 68,and,O
Sentence: 68,activity,O
Sentence: 68,of,O
Sentence: 68,Caspase,O
Sentence: 68,-,O
Sentence: 68,3,O
Sentence: 68,was,O
Sentence: 68,also,O
Sentence: 68,observed,O
Sentence: 68,in,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,treated,O
Sentence: 68,rat,O
Sentence: 68,which,O
Sentence: 68,specify,O
Sentence: 68,apoptotic,O
Sentence: 68,cell,O
Sentence: 68,death,O
Sentence: 68,in,O
Sentence: 68,hippocampus,O
Sentence: 68,and,O
Sentence: 68,cortex,O
Sentence: 68,.,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,treatment,O
Sentence: 68,showed,O
Sentence: 68,decrease,O
Sentence: 68,expression,O
Sentence: 68,of,O
Sentence: 68,post,O
Sentence: 68,synaptic,O
Sentence: 68,markers,O
Sentence: 68,CaMKIIa,O
Sentence: 68,and,O
Sentence: 68,PSD,O
Sentence: 68,-,O
Sentence: 68,95,O
Sentence: 68,",",O
Sentence: 68,while,O
Sentence: 68,",",O
Sentence: 68,expression,O
Sentence: 68,of,O
Sentence: 68,pre,O
Sentence: 68,synaptic,O
Sentence: 68,markers,O
Sentence: 68,(,O
Sentence: 68,synaptophysin,O
Sentence: 68,and,O
Sentence: 68,SNAP,O
Sentence: 68,-,O
Sentence: 68,25,O
Sentence: 68,),O
Sentence: 68,remains,O
Sentence: 68,unaltered,O
Sentence: 68,indicating,O
Sentence: 68,selective,O
Sentence: 68,post,O
Sentence: 68,synaptic,O
Sentence: 68,neurotoxicity,B-Disease
Sentence: 68,.,O
Sentence: 68,Oral,O
Sentence: 68,treatment,O
Sentence: 68,with,O
Sentence: 68,Memantine,B-Chemical
Sentence: 68,(,O
Sentence: 68,10mg,O
Sentence: 68,/,O
Sentence: 68,kg,O
Sentence: 68,),O
Sentence: 68,and,O
Sentence: 68,Ibuprofen,B-Chemical
Sentence: 68,(,O
Sentence: 68,50,O
Sentence: 68,mg,O
Sentence: 68,/,O
Sentence: 68,kg,O
Sentence: 68,),O
Sentence: 68,daily,O
Sentence: 68,for,O
Sentence: 68,13,O
Sentence: 68,days,O
Sentence: 68,attenuated,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,induced,O
Sentence: 68,glial,O
Sentence: 68,activation,O
Sentence: 68,",",O
Sentence: 68,apoptotic,O
Sentence: 68,cell,O
Sentence: 68,death,O
Sentence: 68,and,O
Sentence: 68,post,O
Sentence: 68,synaptic,O
Sentence: 68,neurotoxicity,B-Disease
Sentence: 68,in,O
Sentence: 68,rat,O
Sentence: 68,brain,O
Sentence: 68,.,O
Sentence: 68,Further,O
Sentence: 68,",",O
Sentence: 68,in,O
Sentence: 68,experiment,O
Sentence: 68,set,O
Sentence: 68,up,O
Sentence: 68,2,O
Sentence: 68,:,O
Sentence: 68,where,O
Sentence: 68,memory,O
Sentence: 68,function,O
Sentence: 68,was,O
Sentence: 68,not,O
Sentence: 68,affected,O
Sentence: 68,i.e,O
Sentence: 68,.,O
Sentence: 68,7,O
Sentence: 68,-,O
Sentence: 68,9,O
Sentence: 68,days,O
Sentence: 68,after,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,treatment,O
Sentence: 68,.,O
Sentence: 68,The,O
Sentence: 68,level,O
Sentence: 68,of,O
Sentence: 68,GFAP,O
Sentence: 68,",",O
Sentence: 68,CD11b,O
Sentence: 68,",",O
Sentence: 68,TNF,O
Sentence: 68,-,O
Sentence: 68,a,O
Sentence: 68,",",O
Sentence: 68,ROS,O
Sentence: 68,and,O
Sentence: 68,nitrite,B-Chemical
Sentence: 68,levels,O
Sentence: 68,were,O
Sentence: 68,increased,O
Sentence: 68,.,O
Sentence: 68,On,O
Sentence: 68,the,O
Sentence: 68,other,O
Sentence: 68,hand,O
Sentence: 68,",",O
Sentence: 68,apoptotic,O
Sentence: 68,marker,O
Sentence: 68,",",O
Sentence: 68,synaptic,O
Sentence: 68,markers,O
Sentence: 68,",",O
Sentence: 68,mitochondrial,O
Sentence: 68,activity,O
Sentence: 68,and,O
Sentence: 68,Ca,B-Chemical
Sentence: 68,(,O
Sentence: 68,2+,O
Sentence: 68,),O
Sentence: 68,levels,O
Sentence: 68,remained,O
Sentence: 68,unaffected,O
Sentence: 68,.,O
Sentence: 68,Collective,O
Sentence: 68,data,O
Sentence: 68,indicates,O
Sentence: 68,that,O
Sentence: 68,neuroinflammatory,B-Disease
Sentence: 68,process,O
Sentence: 68,and,O
Sentence: 68,oxidative,O
Sentence: 68,stress,O
Sentence: 68,occurs,O
Sentence: 68,earlier,O
Sentence: 68,to,O
Sentence: 68,apoptosis,O
Sentence: 68,and,O
Sentence: 68,does,O
Sentence: 68,not,O
Sentence: 68,affect,O
Sentence: 68,memory,O
Sentence: 68,function,O
Sentence: 68,.,O
Sentence: 68,Present,O
Sentence: 68,study,O
Sentence: 68,clearly,O
Sentence: 68,suggests,O
Sentence: 68,that,O
Sentence: 68,glial,O
Sentence: 68,activation,O
Sentence: 68,and,O
Sentence: 68,post,O
Sentence: 68,synaptic,O
Sentence: 68,neurotoxicity,B-Disease
Sentence: 68,are,O
Sentence: 68,the,O
Sentence: 68,key,O
Sentence: 68,factors,O
Sentence: 68,in,O
Sentence: 68,STZ,B-Chemical
Sentence: 68,induced,O
Sentence: 68,memory,B-Disease
Sentence: 68,impairment,I-Disease
Sentence: 68,and,O
Sentence: 68,neuronal,O
Sentence: 68,cell,O
Sentence: 68,death,O
Sentence: 68,.,O
Sentence: 69,Comparison,O
Sentence: 69,of,O
Sentence: 69,effects,O
Sentence: 69,of,O
Sentence: 69,isotonic,O
Sentence: 69,sodium,B-Chemical
Sentence: 69,chloride,I-Chemical
Sentence: 69,with,O
Sentence: 69,diltiazem,B-Chemical
Sentence: 69,in,O
Sentence: 69,prevention,O
Sentence: 69,of,O
Sentence: 69,contrast,B-Chemical
Sentence: 69,-,O
Sentence: 69,induced,O
Sentence: 69,nephropathy,B-Disease
Sentence: 69,.,O
Sentence: 70,INTRODUCTION,O
Sentence: 70,AND,O
Sentence: 70,OBJECTIVE,O
Sentence: 70,:,O
Sentence: 70,Contrast,B-Chemical
Sentence: 70,-,O
Sentence: 70,induced,O
Sentence: 70,nephropathy,B-Disease
Sentence: 70,(,O
Sentence: 70,CIN,O
Sentence: 70,),O
Sentence: 70,significantly,O
Sentence: 70,increases,O
Sentence: 70,the,O
Sentence: 70,morbidity,O
Sentence: 70,and,O
Sentence: 70,mortality,O
Sentence: 70,of,O
Sentence: 70,patients,O
Sentence: 70,.,O
Sentence: 70,The,O
Sentence: 70,aim,O
Sentence: 70,of,O
Sentence: 70,this,O
Sentence: 70,study,O
Sentence: 70,is,O
Sentence: 70,to,O
Sentence: 70,investigate,O
Sentence: 70,and,O
Sentence: 70,compare,O
Sentence: 70,the,O
Sentence: 70,protective,O
Sentence: 70,effects,O
Sentence: 70,of,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,with,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,bicarbonate,I-Chemical
Sentence: 70,infusion,O
Sentence: 70,and,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,infusion,O
Sentence: 70,with,O
Sentence: 70,diltiazem,B-Chemical
Sentence: 70,",",O
Sentence: 70,a,O
Sentence: 70,calcium,B-Chemical
Sentence: 70,channel,O
Sentence: 70,blocker,O
Sentence: 70,",",O
Sentence: 70,in,O
Sentence: 70,preventing,O
Sentence: 70,CIN,O
Sentence: 70,.,O
Sentence: 70,MATERIALS,O
Sentence: 70,AND,O
Sentence: 70,METHODS,O
Sentence: 70,:,O
Sentence: 70,Our,O
Sentence: 70,study,O
Sentence: 70,included,O
Sentence: 70,patients,O
Sentence: 70,who,O
Sentence: 70,were,O
Sentence: 70,administered,O
Sentence: 70,30,O
Sentence: 70,-,O
Sentence: 70,60,O
Sentence: 70,mL,O
Sentence: 70,of,O
Sentence: 70,iodinated,O
Sentence: 70,contrast,B-Chemical
Sentence: 70,agent,O
Sentence: 70,for,O
Sentence: 70,percutaneous,O
Sentence: 70,coronary,O
Sentence: 70,angiography,O
Sentence: 70,(,O
Sentence: 70,PCAG,O
Sentence: 70,),O
Sentence: 70,",",O
Sentence: 70,all,O
Sentence: 70,with,O
Sentence: 70,creatinine,B-Chemical
Sentence: 70,values,O
Sentence: 70,between,O
Sentence: 70,1.1,O
Sentence: 70,and,O
Sentence: 70,3.1,O
Sentence: 70,mg,O
Sentence: 70,/,O
Sentence: 70,dL,O
Sentence: 70,.,O
Sentence: 70,Patients,O
Sentence: 70,were,O
Sentence: 70,divided,O
Sentence: 70,into,O
Sentence: 70,three,O
Sentence: 70,groups,O
Sentence: 70,and,O
Sentence: 70,each,O
Sentence: 70,group,O
Sentence: 70,had,O
Sentence: 70,20,O
Sentence: 70,patients,O
Sentence: 70,.,O
Sentence: 70,The,O
Sentence: 70,first,O
Sentence: 70,group,O
Sentence: 70,of,O
Sentence: 70,patients,O
Sentence: 70,was,O
Sentence: 70,administered,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,;,O
Sentence: 70,the,O
Sentence: 70,second,O
Sentence: 70,group,O
Sentence: 70,was,O
Sentence: 70,administered,O
Sentence: 70,a,O
Sentence: 70,solution,O
Sentence: 70,that,O
Sentence: 70,of,O
Sentence: 70,5,O
Sentence: 70,%,O
Sentence: 70,dextrose,B-Chemical
Sentence: 70,and,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,bicarbonate,I-Chemical
Sentence: 70,",",O
Sentence: 70,while,O
Sentence: 70,the,O
Sentence: 70,third,O
Sentence: 70,group,O
Sentence: 70,was,O
Sentence: 70,administered,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,before,O
Sentence: 70,and,O
Sentence: 70,after,O
Sentence: 70,the,O
Sentence: 70,contrast,B-Chemical
Sentence: 70,injection,O
Sentence: 70,.,O
Sentence: 70,The,O
Sentence: 70,third,O
Sentence: 70,group,O
Sentence: 70,received,O
Sentence: 70,an,O
Sentence: 70,additional,O
Sentence: 70,injection,O
Sentence: 70,of,O
Sentence: 70,diltiazem,B-Chemical
Sentence: 70,the,O
Sentence: 70,day,O
Sentence: 70,before,O
Sentence: 70,and,O
Sentence: 70,first,O
Sentence: 70,2,O
Sentence: 70,days,O
Sentence: 70,after,O
Sentence: 70,the,O
Sentence: 70,contrast,B-Chemical
Sentence: 70,injection,O
Sentence: 70,.,O
Sentence: 70,All,O
Sentence: 70,of,O
Sentence: 70,the,O
Sentence: 70,patients,O
Sentence: 70,',O
Sentence: 70,plasma,O
Sentence: 70,blood,B-Chemical
Sentence: 70,urea,I-Chemical
Sentence: 70,nitrogen,I-Chemical
Sentence: 70,(,O
Sentence: 70,BUN,B-Chemical
Sentence: 70,),O
Sentence: 70,and,O
Sentence: 70,creatinine,B-Chemical
Sentence: 70,levels,O
Sentence: 70,were,O
Sentence: 70,measured,O
Sentence: 70,on,O
Sentence: 70,the,O
Sentence: 70,second,O
Sentence: 70,and,O
Sentence: 70,seventh,O
Sentence: 70,day,O
Sentence: 70,after,O
Sentence: 70,the,O
Sentence: 70,administration,O
Sentence: 70,of,O
Sentence: 70,intravenous,O
Sentence: 70,contrast,B-Chemical
Sentence: 70,material,O
Sentence: 70,.,O
Sentence: 70,RESULTS,O
Sentence: 70,:,O
Sentence: 70,The,O
Sentence: 70,basal,O
Sentence: 70,creatinine,B-Chemical
Sentence: 70,levels,O
Sentence: 70,were,O
Sentence: 70,similar,O
Sentence: 70,for,O
Sentence: 70,all,O
Sentence: 70,three,O
Sentence: 70,groups,O
Sentence: 70,(,O
Sentence: 70,p,O
Sentence: 70,,O
Sentence: 70,>,O
Sentence: 70,,O
Sentence: 70,0.05,O
Sentence: 70,),O
Sentence: 70,.,O
Sentence: 70,Among,O
Sentence: 70,a,O
Sentence: 70,total,O
Sentence: 70,of,O
Sentence: 70,60,O
Sentence: 70,patients,O
Sentence: 70,included,O
Sentence: 70,in,O
Sentence: 70,the,O
Sentence: 70,study,O
Sentence: 70,",",O
Sentence: 70,16,O
Sentence: 70,patients,O
Sentence: 70,developed,O
Sentence: 70,acute,B-Disease
Sentence: 70,renal,I-Disease
Sentence: 70,failure,I-Disease
Sentence: 70,(,O
Sentence: 70,ARF,B-Disease
Sentence: 70,),O
Sentence: 70,on,O
Sentence: 70,the,O
Sentence: 70,second,O
Sentence: 70,day,O
Sentence: 70,after,O
Sentence: 70,contrast,B-Chemical
Sentence: 70,material,O
Sentence: 70,was,O
Sentence: 70,injected,O
Sentence: 70,(,O
Sentence: 70,26.6,O
Sentence: 70,%,O
Sentence: 70,),O
Sentence: 70,.,O
Sentence: 70,The,O
Sentence: 70,number,O
Sentence: 70,of,O
Sentence: 70,patients,O
Sentence: 70,who,O
Sentence: 70,developed,O
Sentence: 70,ARF,B-Disease
Sentence: 70,on,O
Sentence: 70,the,O
Sentence: 70,second,O
Sentence: 70,day,O
Sentence: 70,after,O
Sentence: 70,the,O
Sentence: 70,injection,O
Sentence: 70,in,O
Sentence: 70,the,O
Sentence: 70,first,O
Sentence: 70,group,O
Sentence: 70,was,O
Sentence: 70,five,O
Sentence: 70,(,O
Sentence: 70,25,O
Sentence: 70,%,O
Sentence: 70,),O
Sentence: 70,",",O
Sentence: 70,in,O
Sentence: 70,the,O
Sentence: 70,second,O
Sentence: 70,group,O
Sentence: 70,was,O
Sentence: 70,six,O
Sentence: 70,(,O
Sentence: 70,30,O
Sentence: 70,%,O
Sentence: 70,),O
Sentence: 70,and,O
Sentence: 70,the,O
Sentence: 70,third,O
Sentence: 70,group,O
Sentence: 70,was,O
Sentence: 70,five,O
Sentence: 70,(,O
Sentence: 70,25,O
Sentence: 70,%,O
Sentence: 70,),O
Sentence: 70,(,O
Sentence: 70,p,O
Sentence: 70,,O
Sentence: 70,>,O
Sentence: 70,,O
Sentence: 70,0.05,O
Sentence: 70,),O
Sentence: 70,.,O
Sentence: 70,CONCLUSION,O
Sentence: 70,:,O
Sentence: 70,There,O
Sentence: 70,was,O
Sentence: 70,no,O
Sentence: 70,significant,O
Sentence: 70,difference,O
Sentence: 70,between,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,",",O
Sentence: 70,sodium,B-Chemical
Sentence: 70,bicarbonate,I-Chemical
Sentence: 70,and,O
Sentence: 70,isotonic,O
Sentence: 70,sodium,B-Chemical
Sentence: 70,chloride,I-Chemical
Sentence: 70,with,O
Sentence: 70,diltiazem,B-Chemical
Sentence: 70,application,O
Sentence: 70,in,O
Sentence: 70,prevention,O
Sentence: 70,of,O
Sentence: 70,CIN,O
Sentence: 70,.,O
Sentence: 71,Neurocognitive,O
Sentence: 71,and,O
Sentence: 71,neuroradiologic,O
Sentence: 71,central,O
Sentence: 71,nervous,O
Sentence: 71,system,O
Sentence: 71,late,O
Sentence: 71,effects,O
Sentence: 71,in,O
Sentence: 71,children,O
Sentence: 71,treated,O
Sentence: 71,on,O
Sentence: 71,Pediatric,O
Sentence: 71,Oncology,O
Sentence: 71,Group,O
Sentence: 71,(,O
Sentence: 71,POG,O
Sentence: 71,),O
Sentence: 71,P9605,O
Sentence: 71,(,O
Sentence: 71,standard,O
Sentence: 71,risk,O
Sentence: 71,),O
Sentence: 71,and,O
Sentence: 71,P9201,O
Sentence: 71,(,O
Sentence: 71,lesser,O
Sentence: 71,risk,O
Sentence: 71,),O
Sentence: 71,acute,B-Disease
Sentence: 71,lymphoblastic,I-Disease
Sentence: 71,leukemia,I-Disease
Sentence: 71,protocols,O
Sentence: 71,(,O
Sentence: 71,ACCL0131,O
Sentence: 71,),O
Sentence: 71,:,O
Sentence: 71,a,O
Sentence: 71,methotrexate,B-Chemical
Sentence: 71,consequence,O
Sentence: 71,?,O
Sentence: 71,A,O
Sentence: 71,report,O
Sentence: 71,from,O
Sentence: 71,the,O
Sentence: 71,Children,O
Sentence: 71,'s,O
Sentence: 71,Oncology,O
Sentence: 71,Group,O
Sentence: 71,.,O
Sentence: 72,Concerns,O
Sentence: 72,about,O
Sentence: 72,long,O
Sentence: 72,-,O
Sentence: 72,term,O
Sentence: 72,methotrexate,B-Chemical
Sentence: 72,(,O
Sentence: 72,MTX,B-Chemical
Sentence: 72,),O
Sentence: 72,neurotoxicity,B-Disease
Sentence: 72,in,O
Sentence: 72,the,O
Sentence: 72,1990s,O
Sentence: 72,led,O
Sentence: 72,to,O
Sentence: 72,modifications,O
Sentence: 72,in,O
Sentence: 72,intrathecal,O
Sentence: 72,(,O
Sentence: 72,IT,O
Sentence: 72,),O
Sentence: 72,therapy,O
Sentence: 72,",",O
Sentence: 72,leucovorin,O
Sentence: 72,rescue,O
Sentence: 72,",",O
Sentence: 72,and,O
Sentence: 72,frequency,O
Sentence: 72,of,O
Sentence: 72,systemic,O
Sentence: 72,MTX,B-Chemical
Sentence: 72,administration,O
Sentence: 72,in,O
Sentence: 72,children,O
Sentence: 72,with,O
Sentence: 72,acute,B-Disease
Sentence: 72,lymphoblastic,I-Disease
Sentence: 72,leukemia,B-Disease
Sentence: 72,.,O
Sentence: 72,In,O
Sentence: 72,this,O
Sentence: 72,study,O
Sentence: 72,",",O
Sentence: 72,neurocognitive,O
Sentence: 72,outcomes,O
Sentence: 72,and,O
Sentence: 72,neuroradiologic,O
Sentence: 72,evidence,O
Sentence: 72,of,O
Sentence: 72,leukoencephalopathy,B-Disease
Sentence: 72,were,O
Sentence: 72,compared,O
Sentence: 72,in,O
Sentence: 72,children,O
Sentence: 72,treated,O
Sentence: 72,with,O
Sentence: 72,intense,O
Sentence: 72,central,O
Sentence: 72,nervous,O
Sentence: 72,system,O
Sentence: 72,(,O
Sentence: 72,CNS,O
Sentence: 72,),O
Sentence: 72,,O
Sentence: 72,-,O
Sentence: 72,directed,O
Sentence: 72,therapy,O
Sentence: 72,(,O
Sentence: 72,P9605,O
Sentence: 72,),O
Sentence: 72,versus,O
Sentence: 72,those,O
Sentence: 72,receiving,O
Sentence: 72,fewer,O
Sentence: 72,CNS,O
Sentence: 72,-,O
Sentence: 72,directed,O
Sentence: 72,treatment,O
Sentence: 72,days,O
Sentence: 72,during,O
Sentence: 72,intensive,O
Sentence: 72,consolidation,O
Sentence: 72,(,O
Sentence: 72,P9201,O
Sentence: 72,),O
Sentence: 72,.,O
Sentence: 72,A,O
Sentence: 72,total,O
Sentence: 72,of,O
Sentence: 72,66,O
Sentence: 72,children,O
Sentence: 72,from,O
Sentence: 72,16,O
Sentence: 72,Pediatric,O
Sentence: 72,Oncology,O
Sentence: 72,Group,O
Sentence: 72,institutions,O
Sentence: 72,with,O
Sentence: 72,``,O
Sentence: 72,standard,O
Sentence: 72,-,O
Sentence: 72,risk,O
Sentence: 72,'',O
Sentence: 72,acute,B-Disease
Sentence: 72,lymphoblastic,I-Disease
Sentence: 72,leukemia,B-Disease
Sentence: 72,",",O
Sentence: 72,1.00,O
Sentence: 72,to,O
Sentence: 72,9.99,O
Sentence: 72,years,O
Sentence: 72,at,O
Sentence: 72,diagnosis,O
Sentence: 72,",",O
Sentence: 72,without,O
Sentence: 72,evidence,O
Sentence: 72,of,O
Sentence: 72,CNS,O
Sentence: 72,leukemia,B-Disease
Sentence: 72,at,O
Sentence: 72,diagnosis,O
Sentence: 72,were,O
Sentence: 72,enrolled,O
Sentence: 72,on,O
Sentence: 72,ACCL0131,O
Sentence: 72,:,O
Sentence: 72,28,O
Sentence: 72,from,O
Sentence: 72,P9201,O
Sentence: 72,and,O
Sentence: 72,38,O
Sentence: 72,from,O
Sentence: 72,P9605,O
Sentence: 72,.,O
Sentence: 72,Magnetic,O
Sentence: 72,resonance,O
Sentence: 72,imaging,O
Sentence: 72,scans,O
Sentence: 72,and,O
Sentence: 72,standard,O
Sentence: 72,neuropsychological,O
Sentence: 72,tests,O
Sentence: 72,were,O
Sentence: 72,performed,O
Sentence: 72,,O
Sentence: 72,>,O
Sentence: 72,,O
Sentence: 72,2.6,O
Sentence: 72,years,O
Sentence: 72,after,O
Sentence: 72,the,O
Sentence: 72,end,O
Sentence: 72,of,O
Sentence: 72,treatment,O
Sentence: 72,.,O
Sentence: 72,Significantly,O
Sentence: 72,more,O
Sentence: 72,P9605,O
Sentence: 72,patients,O
Sentence: 72,developed,O
Sentence: 72,leukoencephalopathy,B-Disease
Sentence: 72,compared,O
Sentence: 72,with,O
Sentence: 72,P9201,O
Sentence: 72,patients,O
Sentence: 72,(,O
Sentence: 72,68,O
Sentence: 72,%,O
Sentence: 72,",",O
Sentence: 72,95,O
Sentence: 72,%,O
Sentence: 72,confidence,O
Sentence: 72,interval,O
Sentence: 72,49,O
Sentence: 72,%,O
Sentence: 72,,O
Sentence: 72,-,O
Sentence: 72,83,O
Sentence: 72,%,O
Sentence: 72,vs.,O
Sentence: 72,22,O
Sentence: 72,%,O
Sentence: 72,",",O
Sentence: 72,95,O
Sentence: 72,%,O
Sentence: 72,confidence,O
Sentence: 72,interval,O
Sentence: 72,5,O
Sentence: 72,%,O
Sentence: 72,,O
Sentence: 72,-,O
Sentence: 72,44,O
Sentence: 72,%,O
Sentence: 72,;,O
Sentence: 72,P,O
Sentence: 72,=,O
Sentence: 72,0.001,O
Sentence: 72,),O
Sentence: 72,identified,O
Sentence: 72,as,O
Sentence: 72,late,O
Sentence: 72,as,O
Sentence: 72,7.7,O
Sentence: 72,years,O
Sentence: 72,after,O
Sentence: 72,the,O
Sentence: 72,end,O
Sentence: 72,of,O
Sentence: 72,treatment,O
Sentence: 72,.,O
Sentence: 72,Overall,O
Sentence: 72,",",O
Sentence: 72,40,O
Sentence: 72,%,O
Sentence: 72,of,O
Sentence: 72,patients,O
Sentence: 72,scored,O
Sentence: 72,,O
Sentence: 72,<,O
Sentence: 72,,O
Sentence: 72,85,O
Sentence: 72,on,O
Sentence: 72,either,O
Sentence: 72,Verbal,O
Sentence: 72,or,O
Sentence: 72,Performance,O
Sentence: 72,IQ,O
Sentence: 72,.,O
Sentence: 72,Children,O
Sentence: 72,on,O
Sentence: 72,both,O
Sentence: 72,studies,O
Sentence: 72,had,O
Sentence: 72,significant,O
Sentence: 72,attention,B-Disease
Sentence: 72,problems,I-Disease
Sentence: 72,",",O
Sentence: 72,but,O
Sentence: 72,P9605,O
Sentence: 72,children,O
Sentence: 72,scored,O
Sentence: 72,below,O
Sentence: 72,average,O
Sentence: 72,on,O
Sentence: 72,more,O
Sentence: 72,neurocognitive,O
Sentence: 72,measures,O
Sentence: 72,than,O
Sentence: 72,those,O
Sentence: 72,treated,O
Sentence: 72,on,O
Sentence: 72,P9201,O
Sentence: 72,(,O
Sentence: 72,82,O
Sentence: 72,%,O
Sentence: 72,",",O
Sentence: 72,14,O
Sentence: 72,/,O
Sentence: 72,17,O
Sentence: 72,measures,O
Sentence: 72,vs.,O
Sentence: 72,24,O
Sentence: 72,%,O
Sentence: 72,",",O
Sentence: 72,4,O
Sentence: 72,/,O
Sentence: 72,17,O
Sentence: 72,measures,O
Sentence: 72,),O
Sentence: 72,.,O
Sentence: 72,This,O
Sentence: 72,supports,O
Sentence: 72,ongoing,O
Sentence: 72,concerns,O
Sentence: 72,about,O
Sentence: 72,intensive,O
Sentence: 72,MTX,B-Chemical
Sentence: 72,exposure,O
Sentence: 72,as,O
Sentence: 72,a,O
Sentence: 72,major,O
Sentence: 72,contributor,O
Sentence: 72,to,O
Sentence: 72,CNS,O
Sentence: 72,late,O
Sentence: 72,effects,O
Sentence: 72,.,O
Sentence: 73,Tranexamic,B-Chemical
Sentence: 73,acid,I-Chemical
Sentence: 73,overdosage,O
Sentence: 73,-,O
Sentence: 73,induced,O
Sentence: 73,generalized,O
Sentence: 73,seizure,B-Disease
Sentence: 73,in,O
Sentence: 73,renal,B-Disease
Sentence: 73,failure,I-Disease
Sentence: 73,.,O
Sentence: 74,We,O
Sentence: 74,report,O
Sentence: 74,a,O
Sentence: 74,45,O
Sentence: 74,-,O
Sentence: 74,year,O
Sentence: 74,-,O
Sentence: 74,old,O
Sentence: 74,lady,O
Sentence: 74,with,O
Sentence: 74,chronic,B-Disease
Sentence: 74,kidney,I-Disease
Sentence: 74,disease,I-Disease
Sentence: 74,stage,O
Sentence: 74,4,O
Sentence: 74,due,O
Sentence: 74,to,O
Sentence: 74,chronic,O
Sentence: 74,tubulointerstial,B-Disease
Sentence: 74,disease,I-Disease
Sentence: 74,.,O
Sentence: 74,She,O
Sentence: 74,was,O
Sentence: 74,admitted,O
Sentence: 74,to,O
Sentence: 74,our,O
Sentence: 74,center,O
Sentence: 74,for,O
Sentence: 74,severe,O
Sentence: 74,anemia,B-Disease
Sentence: 74,due,O
Sentence: 74,to,O
Sentence: 74,menorrhagia,B-Disease
Sentence: 74,and,O
Sentence: 74,deterioration,B-Disease
Sentence: 74,of,I-Disease
Sentence: 74,renal,I-Disease
Sentence: 74,function,I-Disease
Sentence: 74,.,O
Sentence: 74,She,O
Sentence: 74,was,O
Sentence: 74,infused,O
Sentence: 74,three,O
Sentence: 74,units,O
Sentence: 74,of,O
Sentence: 74,packed,O
Sentence: 74,cells,O
Sentence: 74,during,O
Sentence: 74,a,O
Sentence: 74,session,O
Sentence: 74,of,O
Sentence: 74,hemodialysis,O
Sentence: 74,.,O
Sentence: 74,Tranexamic,B-Chemical
Sentence: 74,acid,I-Chemical
Sentence: 74,(,O
Sentence: 74,TNA,B-Chemical
Sentence: 74,),O
Sentence: 74,1,O
Sentence: 74,g,O
Sentence: 74,8,O
Sentence: 74,-,O
Sentence: 74,hourly,O
Sentence: 74,was,O
Sentence: 74,administered,O
Sentence: 74,to,O
Sentence: 74,her,O
Sentence: 74,to,O
Sentence: 74,control,O
Sentence: 74,bleeding,B-Disease
Sentence: 74,per,O
Sentence: 74,vaginum,O
Sentence: 74,.,O
Sentence: 74,Two,O
Sentence: 74,hours,O
Sentence: 74,after,O
Sentence: 74,the,O
Sentence: 74,sixth,O
Sentence: 74,dose,O
Sentence: 74,of,O
Sentence: 74,TNA,B-Chemical
Sentence: 74,",",O
Sentence: 74,she,O
Sentence: 74,had,O
Sentence: 74,an,O
Sentence: 74,episode,O
Sentence: 74,of,O
Sentence: 74,generalized,O
Sentence: 74,tonic,B-Disease
Sentence: 74,clonic,I-Disease
Sentence: 74,convulsions,B-Disease
Sentence: 74,.,O
Sentence: 74,TNA,B-Chemical
Sentence: 74,was,O
Sentence: 74,discontinued,O
Sentence: 74,.,O
Sentence: 74,Investigations,O
Sentence: 74,of,O
Sentence: 74,the,O
Sentence: 74,patient,O
Sentence: 74,revealed,O
Sentence: 74,no,O
Sentence: 74,biochemical,O
Sentence: 74,or,O
Sentence: 74,structural,O
Sentence: 74,central,O
Sentence: 74,nervous,B-Disease
Sentence: 74,system,I-Disease
Sentence: 74,abnormalities,I-Disease
Sentence: 74,that,O
Sentence: 74,could,O
Sentence: 74,have,O
Sentence: 74,provoked,O
Sentence: 74,the,O
Sentence: 74,convulsions,B-Disease
Sentence: 74,.,O
Sentence: 74,She,O
Sentence: 74,did,O
Sentence: 74,not,O
Sentence: 74,require,O
Sentence: 74,any,O
Sentence: 74,further,O
Sentence: 74,dialytic,O
Sentence: 74,support,O
Sentence: 74,.,O
Sentence: 74,She,O
Sentence: 74,had,O
Sentence: 74,no,O
Sentence: 74,further,O
Sentence: 74,episodes,O
Sentence: 74,of,O
Sentence: 74,convulsion,B-Disease
Sentence: 74,till,O
Sentence: 74,dis,O
Sentence: 74,-,O
Sentence: 74,charge,O
Sentence: 74,and,O
Sentence: 74,during,O
Sentence: 74,the,O
Sentence: 74,two,O
Sentence: 74,months,O
Sentence: 74,of,O
Sentence: 74,follow,O
Sentence: 74,-,O
Sentence: 74,up,O
Sentence: 74,.,O
Sentence: 74,Thus,O
Sentence: 74,",",O
Sentence: 74,the,O
Sentence: 74,precipitating,O
Sentence: 74,cause,O
Sentence: 74,of,O
Sentence: 74,convulsions,B-Disease
Sentence: 74,was,O
Sentence: 74,believed,O
Sentence: 74,to,O
Sentence: 74,be,O
Sentence: 74,an,O
Sentence: 74,overdose,B-Disease
Sentence: 74,of,O
Sentence: 74,TNA,B-Chemical
Sentence: 74,.,O
Sentence: 75,Pre,O
Sentence: 75,-,O
Sentence: 75,treatment,O
Sentence: 75,of,O
Sentence: 75,bupivacaine,B-Chemical
Sentence: 75,-,O
Sentence: 75,induced,O
Sentence: 75,cardiovascular,B-Disease
Sentence: 75,depression,I-Disease
Sentence: 75,using,O
Sentence: 75,different,O
Sentence: 75,lipid,O
Sentence: 75,formulations,O
Sentence: 75,of,O
Sentence: 75,propofol,B-Chemical
Sentence: 75,.,O
Sentence: 76,BACKGROUND,O
Sentence: 76,:,O
Sentence: 76,Pre,O
Sentence: 76,-,O
Sentence: 76,treatment,O
Sentence: 76,with,O
Sentence: 76,lipid,O
Sentence: 76,emulsions,O
Sentence: 76,has,O
Sentence: 76,been,O
Sentence: 76,shown,O
Sentence: 76,to,O
Sentence: 76,increase,O
Sentence: 76,lethal,O
Sentence: 76,doses,O
Sentence: 76,of,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,",",O
Sentence: 76,and,O
Sentence: 76,the,O
Sentence: 76,lipid,O
Sentence: 76,content,O
Sentence: 76,of,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,may,O
Sentence: 76,alleviate,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,-,O
Sentence: 76,induced,O
Sentence: 76,cardiotoxicity,B-Disease
Sentence: 76,.,O
Sentence: 76,The,O
Sentence: 76,aim,O
Sentence: 76,of,O
Sentence: 76,this,O
Sentence: 76,study,O
Sentence: 76,is,O
Sentence: 76,to,O
Sentence: 76,investigate,O
Sentence: 76,the,O
Sentence: 76,effects,O
Sentence: 76,of,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,intralipid,O
Sentence: 76,or,O
Sentence: 76,medialipid,O
Sentence: 76,emulsions,O
Sentence: 76,on,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,-,O
Sentence: 76,induced,O
Sentence: 76,cardiotoxicity,B-Disease
Sentence: 76,.,O
Sentence: 76,METHODS,O
Sentence: 76,:,O
Sentence: 76,Rats,O
Sentence: 76,were,O
Sentence: 76,anaesthetised,O
Sentence: 76,with,O
Sentence: 76,ketamine,B-Chemical
Sentence: 76,and,O
Sentence: 76,were,O
Sentence: 76,given,O
Sentence: 76,0.5,O
Sentence: 76,mg,O
Sentence: 76,/,O
Sentence: 76,kg,O
Sentence: 76,/,O
Sentence: 76,min,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,intralipid,O
Sentence: 76,(,O
Sentence: 76,Group,O
Sentence: 76,P,O
Sentence: 76,),O
Sentence: 76,",",O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,medialipid,O
Sentence: 76,(,O
Sentence: 76,Group,O
Sentence: 76,L,O
Sentence: 76,),O
Sentence: 76,",",O
Sentence: 76,or,O
Sentence: 76,saline,O
Sentence: 76,(,O
Sentence: 76,Group,O
Sentence: 76,C,O
Sentence: 76,),O
Sentence: 76,over,O
Sentence: 76,20,O
Sentence: 76,min,O
Sentence: 76,.,O
Sentence: 76,Thereafter,O
Sentence: 76,",",O
Sentence: 76,2,O
Sentence: 76,mg,O
Sentence: 76,/,O
Sentence: 76,kg,O
Sentence: 76,/,O
Sentence: 76,min,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,0.5,O
Sentence: 76,%,O
Sentence: 76,was,O
Sentence: 76,infused,O
Sentence: 76,.,O
Sentence: 76,We,O
Sentence: 76,recorded,O
Sentence: 76,time,O
Sentence: 76,to,O
Sentence: 76,first,O
Sentence: 76,dysrhythmia,B-Disease
Sentence: 76,occurrence,O
Sentence: 76,",",O
Sentence: 76,respective,O
Sentence: 76,times,O
Sentence: 76,to,O
Sentence: 76,25,O
Sentence: 76,%,O
Sentence: 76,and,O
Sentence: 76,50,O
Sentence: 76,%,O
Sentence: 76,reduction,O
Sentence: 76,of,O
Sentence: 76,the,O
Sentence: 76,heart,O
Sentence: 76,rate,O
Sentence: 76,(,O
Sentence: 76,HR,O
Sentence: 76,),O
Sentence: 76,and,O
Sentence: 76,mean,O
Sentence: 76,arterial,O
Sentence: 76,pressure,O
Sentence: 76,",",O
Sentence: 76,and,O
Sentence: 76,time,O
Sentence: 76,to,O
Sentence: 76,asystole,B-Disease
Sentence: 76,and,O
Sentence: 76,total,O
Sentence: 76,amount,O
Sentence: 76,of,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,consumption,O
Sentence: 76,.,O
Sentence: 76,Blood,O
Sentence: 76,and,O
Sentence: 76,tissue,O
Sentence: 76,samples,O
Sentence: 76,were,O
Sentence: 76,collected,O
Sentence: 76,following,O
Sentence: 76,asystole,B-Disease
Sentence: 76,.,O
Sentence: 76,RESULTS,O
Sentence: 76,:,O
Sentence: 76,The,O
Sentence: 76,time,O
Sentence: 76,to,O
Sentence: 76,first,O
Sentence: 76,dysrhythmia,B-Disease
Sentence: 76,occurrence,O
Sentence: 76,",",O
Sentence: 76,time,O
Sentence: 76,to,O
Sentence: 76,25,O
Sentence: 76,%,O
Sentence: 76,and,O
Sentence: 76,50,O
Sentence: 76,%,O
Sentence: 76,reductions,O
Sentence: 76,in,O
Sentence: 76,HR,O
Sentence: 76,",",O
Sentence: 76,and,O
Sentence: 76,time,O
Sentence: 76,to,O
Sentence: 76,asystole,B-Disease
Sentence: 76,were,O
Sentence: 76,longer,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,P,O
Sentence: 76,than,O
Sentence: 76,the,O
Sentence: 76,other,O
Sentence: 76,groups,O
Sentence: 76,.,O
Sentence: 76,The,O
Sentence: 76,cumulative,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,dose,O
Sentence: 76,given,O
Sentence: 76,at,O
Sentence: 76,those,O
Sentence: 76,time,O
Sentence: 76,points,O
Sentence: 76,was,O
Sentence: 76,higher,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,P.,O
Sentence: 76,Plasma,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,levels,O
Sentence: 76,were,O
Sentence: 76,significantly,O
Sentence: 76,lower,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,P,O
Sentence: 76,than,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,C.,O
Sentence: 76,Bupivacaine,B-Chemical
Sentence: 76,levels,O
Sentence: 76,in,O
Sentence: 76,the,O
Sentence: 76,brain,O
Sentence: 76,and,O
Sentence: 76,heart,O
Sentence: 76,were,O
Sentence: 76,significantly,O
Sentence: 76,lower,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,P,O
Sentence: 76,and,O
Sentence: 76,Group,O
Sentence: 76,L,O
Sentence: 76,than,O
Sentence: 76,in,O
Sentence: 76,Group,O
Sentence: 76,C.,O
Sentence: 76,CONCLUSION,O
Sentence: 76,:,O
Sentence: 76,We,O
Sentence: 76,conclude,O
Sentence: 76,that,O
Sentence: 76,pre,O
Sentence: 76,-,O
Sentence: 76,treatment,O
Sentence: 76,with,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,intralipid,O
Sentence: 76,",",O
Sentence: 76,compared,O
Sentence: 76,with,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,medialipid,O
Sentence: 76,or,O
Sentence: 76,saline,O
Sentence: 76,",",O
Sentence: 76,delayed,O
Sentence: 76,the,O
Sentence: 76,onset,O
Sentence: 76,of,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,-,O
Sentence: 76,induced,O
Sentence: 76,cardiotoxic,B-Disease
Sentence: 76,effects,O
Sentence: 76,as,O
Sentence: 76,well,O
Sentence: 76,as,O
Sentence: 76,reduced,O
Sentence: 76,plasma,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,levels,O
Sentence: 76,.,O
Sentence: 76,Further,O
Sentence: 76,studies,O
Sentence: 76,are,O
Sentence: 76,needed,O
Sentence: 76,to,O
Sentence: 76,explore,O
Sentence: 76,tissue,O
Sentence: 76,bupivacaine,B-Chemical
Sentence: 76,levels,O
Sentence: 76,of,O
Sentence: 76,propofol,B-Chemical
Sentence: 76,in,O
Sentence: 76,medialipid,O
Sentence: 76,and,O
Sentence: 76,adapt,O
Sentence: 76,these,O
Sentence: 76,results,O
Sentence: 76,to,O
Sentence: 76,clinical,O
Sentence: 76,practice,O
Sentence: 76,.,O
Sentence: 77,Drug,O
Sentence: 77,-,O
Sentence: 77,Induced,O
Sentence: 77,Acute,O
Sentence: 77,Liver,O
Sentence: 77,Injury,O
Sentence: 77,Within,O
Sentence: 77,12,O
Sentence: 77,Hours,O
Sentence: 77,After,O
Sentence: 77,Fluvastatin,B-Chemical
Sentence: 77,Therapy,O
Sentence: 77,.,O
Sentence: 78,Although,O
Sentence: 78,statins,B-Chemical
Sentence: 78,are,O
Sentence: 78,generally,O
Sentence: 78,well,O
Sentence: 78,-,O
Sentence: 78,tolerated,O
Sentence: 78,drugs,O
Sentence: 78,",",O
Sentence: 78,recent,O
Sentence: 78,cases,O
Sentence: 78,of,O
Sentence: 78,drug,O
Sentence: 78,-,O
Sentence: 78,induced,O
Sentence: 78,liver,O
Sentence: 78,injury,O
Sentence: 78,associated,O
Sentence: 78,with,O
Sentence: 78,their,O
Sentence: 78,use,O
Sentence: 78,have,O
Sentence: 78,been,O
Sentence: 78,reported,O
Sentence: 78,.,O
Sentence: 78,A,O
Sentence: 78,52,O
Sentence: 78,-,O
Sentence: 78,year,O
Sentence: 78,-,O
Sentence: 78,old,O
Sentence: 78,Chinese,O
Sentence: 78,man,O
Sentence: 78,reported,O
Sentence: 78,with,O
Sentence: 78,liver,B-Disease
Sentence: 78,damage,I-Disease
Sentence: 78,",",O
Sentence: 78,which,O
Sentence: 78,appeared,O
Sentence: 78,12,O
Sentence: 78,hours,O
Sentence: 78,after,O
Sentence: 78,beginning,O
Sentence: 78,treatment,O
Sentence: 78,with,O
Sentence: 78,fluvastatin,B-Chemical
Sentence: 78,.,O
Sentence: 78,Patient,O
Sentence: 78,presented,O
Sentence: 78,with,O
Sentence: 78,complaints,O
Sentence: 78,of,O
Sentence: 78,increasing,O
Sentence: 78,nausea,B-Disease
Sentence: 78,",",O
Sentence: 78,anorexia,B-Disease
Sentence: 78,",",O
Sentence: 78,and,O
Sentence: 78,upper,O
Sentence: 78,abdominal,B-Disease
Sentence: 78,pain,I-Disease
Sentence: 78,.,O
Sentence: 78,His,O
Sentence: 78,laboratory,O
Sentence: 78,values,O
Sentence: 78,showed,O
Sentence: 78,elevated,O
Sentence: 78,creatine,B-Chemical
Sentence: 78,kinase,O
Sentence: 78,and,O
Sentence: 78,transaminases,O
Sentence: 78,.,O
Sentence: 78,Testing,O
Sentence: 78,for,O
Sentence: 78,autoantibodies,O
Sentence: 78,was,O
Sentence: 78,also,O
Sentence: 78,negative,O
Sentence: 78,.,O
Sentence: 78,The,O
Sentence: 78,liver,O
Sentence: 78,biochemistries,O
Sentence: 78,eventually,O
Sentence: 78,normalized,O
Sentence: 78,within,O
Sentence: 78,3,O
Sentence: 78,weeks,O
Sentence: 78,of,O
Sentence: 78,stopping,O
Sentence: 78,the,O
Sentence: 78,fluvastatin,B-Chemical
Sentence: 78,.,O
Sentence: 78,Therefore,O
Sentence: 78,",",O
Sentence: 78,when,O
Sentence: 78,prescribing,O
Sentence: 78,statins,B-Chemical
Sentence: 78,",",O
Sentence: 78,the,O
Sentence: 78,possibility,O
Sentence: 78,of,O
Sentence: 78,hepatic,B-Disease
Sentence: 78,damage,I-Disease
Sentence: 78,should,O
Sentence: 78,be,O
Sentence: 78,taken,O
Sentence: 78,into,O
Sentence: 78,account,O
Sentence: 78,.,O
Sentence: 79,Fluconazole,B-Chemical
Sentence: 79,associated,O
Sentence: 79,agranulocytosis,B-Disease
Sentence: 79,and,O
Sentence: 79,thrombocytopenia,B-Disease
Sentence: 79,.,O
Sentence: 80,CASE,O
Sentence: 80,:,O
Sentence: 80,We,O
Sentence: 80,describe,O
Sentence: 80,a,O
Sentence: 80,second,O
Sentence: 80,case,O
Sentence: 80,of,O
Sentence: 80,fluconazole,B-Chemical
Sentence: 80,associated,O
Sentence: 80,agranulocytosis,B-Disease
Sentence: 80,with,O
Sentence: 80,thrombocytopenia,B-Disease
Sentence: 80,and,O
Sentence: 80,recovery,O
Sentence: 80,upon,O
Sentence: 80,discontinuation,O
Sentence: 80,of,O
Sentence: 80,therapy,O
Sentence: 80,.,O
Sentence: 80,The,O
Sentence: 80,patient,O
Sentence: 80,began,O
Sentence: 80,to,O
Sentence: 80,have,O
Sentence: 80,changes,O
Sentence: 80,in,O
Sentence: 80,white,O
Sentence: 80,blood,O
Sentence: 80,cells,O
Sentence: 80,and,O
Sentence: 80,platelets,O
Sentence: 80,within,O
Sentence: 80,48,O
Sentence: 80,h,O
Sentence: 80,of,O
Sentence: 80,administration,O
Sentence: 80,of,O
Sentence: 80,fluconazole,B-Chemical
Sentence: 80,and,O
Sentence: 80,began,O
Sentence: 80,to,O
Sentence: 80,recover,O
Sentence: 80,with,O
Sentence: 80,48,O
Sentence: 80,h,O
Sentence: 80,of,O
Sentence: 80,discontinuation,O
Sentence: 80,.,O
Sentence: 80,This,O
Sentence: 80,case,O
Sentence: 80,highlights,O
Sentence: 80,that,O
Sentence: 80,drug,O
Sentence: 80,-,O
Sentence: 80,induced,O
Sentence: 80,blood,B-Disease
Sentence: 80,dyscrasias,I-Disease
Sentence: 80,can,O
Sentence: 80,occur,O
Sentence: 80,unexpectedly,O
Sentence: 80,as,O
Sentence: 80,a,O
Sentence: 80,result,O
Sentence: 80,of,O
Sentence: 80,treatment,O
Sentence: 80,with,O
Sentence: 80,a,O
Sentence: 80,commonly,O
Sentence: 80,used,O
Sentence: 80,drug,O
Sentence: 80,thought,O
Sentence: 80,to,O
Sentence: 80,be,O
Sentence: 80,``,O
Sentence: 80,safe,O
Sentence: 80,'',O
Sentence: 80,.,O
Sentence: 80,CONCLUSION,O
Sentence: 80,:,O
Sentence: 80,According,O
Sentence: 80,to,O
Sentence: 80,Naranjo,O
Sentence: 80,'s,O
Sentence: 80,algorithm,O
Sentence: 80,the,O
Sentence: 80,likelihood,O
Sentence: 80,that,O
Sentence: 80,our,O
Sentence: 80,patient,O
Sentence: 80,'s,O
Sentence: 80,agranulocytosis,B-Disease
Sentence: 80,and,O
Sentence: 80,thrombocytopenia,B-Disease
Sentence: 80,occurred,O
Sentence: 80,as,O
Sentence: 80,a,O
Sentence: 80,result,O
Sentence: 80,of,O
Sentence: 80,therapy,O
Sentence: 80,with,O
Sentence: 80,fluconazole,B-Chemical
Sentence: 80,is,O
Sentence: 80,probable,O
Sentence: 80,",",O
Sentence: 80,with,O
Sentence: 80,a,O
Sentence: 80,total,O
Sentence: 80,of,O
Sentence: 80,six,O
Sentence: 80,points,O
Sentence: 80,.,O
Sentence: 80,We,O
Sentence: 80,feel,O
Sentence: 80,that,O
Sentence: 80,the,O
Sentence: 80,weight,O
Sentence: 80,of,O
Sentence: 80,the,O
Sentence: 80,overall,O
Sentence: 80,evidence,O
Sentence: 80,of,O
Sentence: 80,this,O
Sentence: 80,evidence,O
Sentence: 80,is,O
Sentence: 80,strong,O
Sentence: 80,.,O
Sentence: 80,In,O
Sentence: 80,particular,O
Sentence: 80,the,O
Sentence: 80,temporal,O
Sentence: 80,relationship,O
Sentence: 80,of,O
Sentence: 80,bone,B-Disease
Sentence: 80,marrow,I-Disease
Sentence: 80,suppression,I-Disease
Sentence: 80,to,O
Sentence: 80,the,O
Sentence: 80,initiation,O
Sentence: 80,of,O
Sentence: 80,fluconazole,B-Chemical
Sentence: 80,and,O
Sentence: 80,the,O
Sentence: 80,abatement,O
Sentence: 80,of,O
Sentence: 80,symptoms,O
Sentence: 80,that,O
Sentence: 80,rapidly,O
Sentence: 80,reversed,O
Sentence: 80,immediately,O
Sentence: 80,following,O
Sentence: 80,discontinuation,O
Sentence: 80,.,O
Sentence: 81,Two,O
Sentence: 81,-,O
Sentence: 81,dimensional,O
Sentence: 81,speckle,O
Sentence: 81,tracking,O
Sentence: 81,echocardiography,O
Sentence: 81,combined,O
Sentence: 81,with,O
Sentence: 81,high,O
Sentence: 81,-,O
Sentence: 81,sensitive,O
Sentence: 81,cardiac,O
Sentence: 81,troponin,O
Sentence: 81,T,O
Sentence: 81,in,O
Sentence: 81,early,O
Sentence: 81,detection,O
Sentence: 81,and,O
Sentence: 81,prediction,O
Sentence: 81,of,O
Sentence: 81,cardiotoxicity,B-Disease
Sentence: 81,during,O
Sentence: 81,epirubicine,B-Chemical
Sentence: 81,-,O
Sentence: 81,based,O
Sentence: 81,chemotherapy,O
Sentence: 81,.,O
Sentence: 82,AIMS,O
Sentence: 82,:,O
Sentence: 82,To,O
Sentence: 82,investigate,O
Sentence: 82,whether,O
Sentence: 82,alterations,O
Sentence: 82,of,O
Sentence: 82,myocardial,B-Disease
Sentence: 82,strain,I-Disease
Sentence: 82,and,O
Sentence: 82,high,O
Sentence: 82,-,O
Sentence: 82,sensitive,O
Sentence: 82,cardiac,O
Sentence: 82,troponin,O
Sentence: 82,T,O
Sentence: 82,(,O
Sentence: 82,cTnT,O
Sentence: 82,),O
Sentence: 82,could,O
Sentence: 82,predict,O
Sentence: 82,future,O
Sentence: 82,cardiac,B-Disease
Sentence: 82,dysfunction,I-Disease
Sentence: 82,in,O
Sentence: 82,patients,O
Sentence: 82,after,O
Sentence: 82,epirubicin,B-Chemical
Sentence: 82,exposure,O
Sentence: 82,.,O
Sentence: 82,METHODS,O
Sentence: 82,:,O
Sentence: 82,Seventy,O
Sentence: 82,-,O
Sentence: 82,five,O
Sentence: 82,patients,O
Sentence: 82,with,O
Sentence: 82,non,O
Sentence: 82,-,O
Sentence: 82,Hodgkin,O
Sentence: 82,lymphoma,O
Sentence: 82,treated,O
Sentence: 82,with,O
Sentence: 82,epirubicin,B-Chemical
Sentence: 82,were,O
Sentence: 82,studied,O
Sentence: 82,.,O
Sentence: 82,Blood,O
Sentence: 82,collection,O
Sentence: 82,and,O
Sentence: 82,echocardiography,O
Sentence: 82,were,O
Sentence: 82,performed,O
Sentence: 82,at,O
Sentence: 82,baseline,O
Sentence: 82,",",O
Sentence: 82,1,O
Sentence: 82,day,O
Sentence: 82,after,O
Sentence: 82,the,O
Sentence: 82,third,O
Sentence: 82,cycle,O
Sentence: 82,",",O
Sentence: 82,and,O
Sentence: 82,1,O
Sentence: 82,day,O
Sentence: 82,after,O
Sentence: 82,completion,O
Sentence: 82,of,O
Sentence: 82,chemotherapy,O
Sentence: 82,.,O
Sentence: 82,Patients,O
Sentence: 82,were,O
Sentence: 82,studied,O
Sentence: 82,using,O
Sentence: 82,echocardiography,O
Sentence: 82,during,O
Sentence: 82,follow,O
Sentence: 82,-,O
Sentence: 82,up,O
Sentence: 82,.,O
Sentence: 82,Global,O
Sentence: 82,longitudinal,O
Sentence: 82,(,O
Sentence: 82,GLS,O
Sentence: 82,),O
Sentence: 82,",",O
Sentence: 82,circumferential,O
Sentence: 82,(,O
Sentence: 82,GCS,O
Sentence: 82,),O
Sentence: 82,",",O
Sentence: 82,and,O
Sentence: 82,radial,O
Sentence: 82,strain,O
Sentence: 82,(,O
Sentence: 82,GRS,O
Sentence: 82,),O
Sentence: 82,were,O
Sentence: 82,calculated,O
Sentence: 82,using,O
Sentence: 82,speckle,O
Sentence: 82,tracking,O
Sentence: 82,echocardiography,O
Sentence: 82,.,O
Sentence: 82,Left,O
Sentence: 82,ventricular,O
Sentence: 82,ejection,O
Sentence: 82,fraction,O
Sentence: 82,was,O
Sentence: 82,analysed,O
Sentence: 82,by,O
Sentence: 82,real,O
Sentence: 82,-,O
Sentence: 82,time,O
Sentence: 82,3D,O
Sentence: 82,echocardiography,O
Sentence: 82,.,O
Sentence: 82,Cardiotoxicity,B-Disease
Sentence: 82,was,O
Sentence: 82,defined,O
Sentence: 82,as,O
Sentence: 82,a,O
Sentence: 82,reduction,O
Sentence: 82,of,O
Sentence: 82,the,O
Sentence: 82,LVEF,O
Sentence: 82,of,O
Sentence: 82,,O
Sentence: 82,>,O
Sentence: 82,,O
Sentence: 82,5,O
Sentence: 82,%,O
Sentence: 82,to,O
Sentence: 82,,O
Sentence: 82,<,O
Sentence: 82,,O
Sentence: 82,55,O
Sentence: 82,%,O
Sentence: 82,with,O
Sentence: 82,symptoms,O
Sentence: 82,of,O
Sentence: 82,heart,B-Disease
Sentence: 82,failure,I-Disease
Sentence: 82,or,O
Sentence: 82,an,O
Sentence: 82,asymptomatic,O
Sentence: 82,reduction,O
Sentence: 82,of,O
Sentence: 82,the,O
Sentence: 82,LVEF,O
Sentence: 82,of,O
Sentence: 82,,O
Sentence: 82,>,O
Sentence: 82,,O
Sentence: 82,10,O
Sentence: 82,%,O
Sentence: 82,to,O
Sentence: 82,,O
Sentence: 82,<,O
Sentence: 82,,O
Sentence: 82,55,O
Sentence: 82,%,O
Sentence: 82,.,O
Sentence: 82,RESULTS,O
Sentence: 82,:,O
Sentence: 82,Fourteen,O
Sentence: 82,patients,O
Sentence: 82,(,O
Sentence: 82,18.67,O
Sentence: 82,%,O
Sentence: 82,),O
Sentence: 82,developed,O
Sentence: 82,cardiotoxicity,B-Disease
Sentence: 82,after,O
Sentence: 82,treatment,O
Sentence: 82,.,O
Sentence: 82,GLS,O
Sentence: 82,(,O
Sentence: 82,,O
Sentence: 82,-,O
Sentence: 82,18.48,O
Sentence: 82,+,O
Sentence: 82,1.72,O
Sentence: 82,%,O
Sentence: 82,vs.,O
Sentence: 82,,O
Sentence: 82,-,O
Sentence: 82,15.96,O
Sentence: 82,+,O
Sentence: 82,1.6,O
Sentence: 82,%,O
Sentence: 82,),O
Sentence: 82,",",O
Sentence: 82,GCS,O
Sentence: 82,(,O
Sentence: 82,,O
Sentence: 82,-,O
Sentence: 82,20.93,O
Sentence: 82,+,O
Sentence: 82,2.86,O
Sentence: 82,%,O
Sentence: 82,vs.,O
Sentence: 82,,O
Sentence: 82,-,O
Sentence: 82,19.20,O
Sentence: 82,+,O
Sentence: 82,3.21,O
Sentence: 82,%,O
Sentence: 82,),O
Sentence: 82,",",O
Sentence: 82,and,O
Sentence: 82,GRS,O
Sentence: 82,(,O
Sentence: 82,39.23,O
Sentence: 82,+,O
Sentence: 82,6.44,O
Sentence: 82,%,O
Sentence: 82,vs.,O
Sentence: 82,34.98,O
Sentence: 82,+,O
Sentence: 82,6.2,O
Sentence: 82,%,O
Sentence: 82,),O
Sentence: 82,were,O
Sentence: 82,markedly,O
Sentence: 82,reduced,O
Sentence: 82,and,O
Sentence: 82,cTnT,O
Sentence: 82,was,O
Sentence: 82,elevated,O
Sentence: 82,from,O
Sentence: 82,0.0010,O
Sentence: 82,+,O
Sentence: 82,0.0020,O
Sentence: 82,to,O
Sentence: 82,0.0073,O
Sentence: 82,+,O
Sentence: 82,0.0038,O
Sentence: 82,ng,O
Sentence: 82,/,O
Sentence: 82,mL,O
Sentence: 82,(,O
Sentence: 82,P,O
Sentence: 82,all,O
Sentence: 82,,O
Sentence: 82,<,O
Sentence: 82,,O
Sentence: 82,0.01,O
Sentence: 82,),O
Sentence: 82,at,O
Sentence: 82,the,O
Sentence: 82,completion,O
Sentence: 82,of,O
Sentence: 82,chemotherapy,O
Sentence: 82,compared,O
Sentence: 82,with,O
Sentence: 82,baseline,O
Sentence: 82,values,O
Sentence: 82,.,O
Sentence: 82,A,O
Sentence: 82,,O
Sentence: 82,>,O
Sentence: 82,,O
Sentence: 82,15.9,O
Sentence: 82,%,O
Sentence: 82,decrease,O
Sentence: 82,in,O
Sentence: 82,GLS,O
Sentence: 82,[,O
Sentence: 82,sensitivity,O
Sentence: 82,",",O
Sentence: 82,86,O
Sentence: 82,%,O
Sentence: 82,;,O
Sentence: 82,specificity,O
Sentence: 82,",",O
Sentence: 82,75,O
Sentence: 82,%,O
Sentence: 82,;,O
Sentence: 82,area,O
Sentence: 82,under,O
Sentence: 82,the,O
Sentence: 82,curve,O
Sentence: 82,(,O
Sentence: 82,AUC,O
Sentence: 82,),O
Sentence: 82,,O
Sentence: 82,=,O
Sentence: 82,,O
Sentence: 82,0.815,O
Sentence: 82,;,O
Sentence: 82,P,O
Sentence: 82,,O
Sentence: 82,=,O
Sentence: 82,,O
Sentence: 82,0.001,O
Sentence: 82,],O
Sentence: 82,and,O
Sentence: 82,a,O
Sentence: 82,,O
Sentence: 82,>,O
Sentence: 82,,O
Sentence: 82,0.004,O
Sentence: 82,ng,O
Sentence: 82,/,O
Sentence: 82,mL,O
Sentence: 82,elevation,O
Sentence: 82,in,O
Sentence: 82,cTnT,O
Sentence: 82,(,O
Sentence: 82,sensitivity,O
Sentence: 82,",",O
Sentence: 82,79,O
Sentence: 82,%,O
Sentence: 82,;,O
Sentence: 82,specificity,O
Sentence: 82,",",O
Sentence: 82,64,O
Sentence: 82,%,O
Sentence: 82,;,O
Sentence: 82,AUC,O
Sentence: 82,,O
Sentence: 82,=,O
Sentence: 82,,O
Sentence: 82,0.757,O
Sentence: 82,;,O
Sentence: 82,P,O
Sentence: 82,,O
Sentence: 82,=,O
Sentence: 82,,O
Sentence: 82,0.005,O
Sentence: 82,),O
Sentence: 82,from,O
Sentence: 82,baseline,O
Sentence: 82,to,O
Sentence: 82,the,O
Sentence: 82,third,O
Sentence: 82,cycle,O
Sentence: 82,of,O
Sentence: 82,chemotherapy,O
Sentence: 82,predicted,O
Sentence: 82,later,O
Sentence: 82,cardiotoxicity,B-Disease
Sentence: 82,.,O
Sentence: 82,The,O
Sentence: 82,decrease,O
Sentence: 82,in,O
Sentence: 82,GLS,O
Sentence: 82,remained,O
Sentence: 82,the,O
Sentence: 82,only,O
Sentence: 82,independent,O
Sentence: 82,predictor,O
Sentence: 82,of,O
Sentence: 82,cardiotoxicity,B-Disease
Sentence: 82,(,O
Sentence: 82,P,O
Sentence: 82,,O
Sentence: 82,=,O
Sentence: 82,,O
Sentence: 82,0.000,O
Sentence: 82,),O
Sentence: 82,.,O
Sentence: 82,CONCLUSIONS,O
Sentence: 82,:,O
Sentence: 82,GLS,O
Sentence: 82,combined,O
Sentence: 82,with,O
Sentence: 82,cTnT,O
Sentence: 82,may,O
Sentence: 82,provide,O
Sentence: 82,a,O
Sentence: 82,reliable,O
Sentence: 82,and,O
Sentence: 82,non,O
Sentence: 82,-,O
Sentence: 82,invasive,O
Sentence: 82,method,O
Sentence: 82,to,O
Sentence: 82,predict,O
Sentence: 82,cardiac,B-Disease
Sentence: 82,dysfunction,I-Disease
Sentence: 82,in,O
Sentence: 82,patients,O
Sentence: 82,receiving,O
Sentence: 82,anthracycline,B-Chemical
Sentence: 82,-,O
Sentence: 82,based,O
Sentence: 82,chemotherapy,O
Sentence: 82,.,O
Sentence: 83,Prevention,O
Sentence: 83,of,O
Sentence: 83,etomidate,B-Chemical
Sentence: 83,-,O
Sentence: 83,induced,O
Sentence: 83,myoclonus,B-Disease
Sentence: 83,:,O
Sentence: 83,which,O
Sentence: 83,is,O
Sentence: 83,superior,O
Sentence: 83,:,O
Sentence: 83,Fentanyl,B-Chemical
Sentence: 83,",",O
Sentence: 83,midazolam,B-Chemical
Sentence: 83,",",O
Sentence: 83,or,O
Sentence: 83,a,O
Sentence: 83,combination,O
Sentence: 83,?,O
Sentence: 83,A,O
Sentence: 83,Retrospective,O
Sentence: 83,comparative,O
Sentence: 83,study,O
Sentence: 83,.,O
Sentence: 84,BACKGROUND,O
Sentence: 84,:,O
Sentence: 84,In,O
Sentence: 84,this,O
Sentence: 84,retrospective,O
Sentence: 84,comparative,O
Sentence: 84,study,O
Sentence: 84,",",O
Sentence: 84,we,O
Sentence: 84,aimed,O
Sentence: 84,to,O
Sentence: 84,compare,O
Sentence: 84,the,O
Sentence: 84,effectiveness,O
Sentence: 84,of,O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,",",O
Sentence: 84,midazolam,B-Chemical
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,a,O
Sentence: 84,combination,O
Sentence: 84,of,O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,and,O
Sentence: 84,midazolam,B-Chemical
Sentence: 84,to,O
Sentence: 84,prevent,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,-,O
Sentence: 84,induced,O
Sentence: 84,myoclonus,B-Disease
Sentence: 84,.,O
Sentence: 84,MATERIAL,O
Sentence: 84,AND,O
Sentence: 84,METHODS,O
Sentence: 84,:,O
Sentence: 84,This,O
Sentence: 84,study,O
Sentence: 84,was,O
Sentence: 84,performed,O
Sentence: 84,based,O
Sentence: 84,on,O
Sentence: 84,anesthesia,O
Sentence: 84,records,O
Sentence: 84,.,O
Sentence: 84,Depending,O
Sentence: 84,on,O
Sentence: 84,the,O
Sentence: 84,drugs,O
Sentence: 84,that,O
Sentence: 84,would,O
Sentence: 84,be,O
Sentence: 84,given,O
Sentence: 84,before,O
Sentence: 84,the,O
Sentence: 84,induction,O
Sentence: 84,of,O
Sentence: 84,anesthesia,O
Sentence: 84,with,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,",",O
Sentence: 84,the,O
Sentence: 84,patients,O
Sentence: 84,were,O
Sentence: 84,separated,O
Sentence: 84,into,O
Sentence: 84,4,O
Sentence: 84,groups,O
Sentence: 84,:,O
Sentence: 84,no,O
Sentence: 84,pretreatment,O
Sentence: 84,(,O
Sentence: 84,Group,O
Sentence: 84,NP,O
Sentence: 84,),O
Sentence: 84,",",O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,1,O
Sentence: 84,ug.kg,O
Sentence: 84,-,O
Sentence: 84,1,O
Sentence: 84,(,O
Sentence: 84,Group,O
Sentence: 84,F,O
Sentence: 84,),O
Sentence: 84,",",O
Sentence: 84,midazolam,B-Chemical
Sentence: 84,0.03,O
Sentence: 84,mg.kg,O
Sentence: 84,-,O
Sentence: 84,1,O
Sentence: 84,(,O
Sentence: 84,Group,O
Sentence: 84,M,O
Sentence: 84,),O
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,midazolam,B-Chemical
Sentence: 84,0.015,O
Sentence: 84,mg.kg,O
Sentence: 84,-,O
Sentence: 84,1,O
Sentence: 84,+,O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,0.5,O
Sentence: 84,ug.kg,O
Sentence: 84,-,O
Sentence: 84,1,O
Sentence: 84,(,O
Sentence: 84,Group,O
Sentence: 84,FM,O
Sentence: 84,),O
Sentence: 84,.,O
Sentence: 84,Patients,O
Sentence: 84,who,O
Sentence: 84,received,O
Sentence: 84,the,O
Sentence: 84,same,O
Sentence: 84,anesthetic,O
Sentence: 84,procedure,O
Sentence: 84,were,O
Sentence: 84,selected,O
Sentence: 84,:,O
Sentence: 84,2,O
Sentence: 84,minutes,O
Sentence: 84,after,O
Sentence: 84,intravenous,O
Sentence: 84,injections,O
Sentence: 84,of,O
Sentence: 84,the,O
Sentence: 84,pretreatment,O
Sentence: 84,drugs,O
Sentence: 84,",",O
Sentence: 84,anesthesia,O
Sentence: 84,is,O
Sentence: 84,induced,O
Sentence: 84,with,O
Sentence: 84,0.3,O
Sentence: 84,mg.kg,O
Sentence: 84,-,O
Sentence: 84,1,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,injected,O
Sentence: 84,intravenously,O
Sentence: 84,over,O
Sentence: 84,a,O
Sentence: 84,period,O
Sentence: 84,of,O
Sentence: 84,20,O
Sentence: 84,-,O
Sentence: 84,30,O
Sentence: 84,seconds,O
Sentence: 84,.,O
Sentence: 84,Myoclonic,B-Disease
Sentence: 84,movements,I-Disease
Sentence: 84,are,O
Sentence: 84,evaluated,O
Sentence: 84,",",O
Sentence: 84,which,O
Sentence: 84,were,O
Sentence: 84,observed,O
Sentence: 84,and,O
Sentence: 84,graded,O
Sentence: 84,according,O
Sentence: 84,to,O
Sentence: 84,clinical,O
Sentence: 84,severity,O
Sentence: 84,during,O
Sentence: 84,the,O
Sentence: 84,2,O
Sentence: 84,minutes,O
Sentence: 84,after,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,injection,O
Sentence: 84,.,O
Sentence: 84,The,O
Sentence: 84,severity,O
Sentence: 84,of,O
Sentence: 84,pain,B-Disease
Sentence: 84,due,O
Sentence: 84,to,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,injection,O
Sentence: 84,",",O
Sentence: 84,mean,O
Sentence: 84,arterial,O
Sentence: 84,pressure,O
Sentence: 84,",",O
Sentence: 84,heart,O
Sentence: 84,rate,O
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,adverse,O
Sentence: 84,effects,O
Sentence: 84,were,O
Sentence: 84,also,O
Sentence: 84,evaluated,O
Sentence: 84,.,O
Sentence: 84,RESULTS,O
Sentence: 84,:,O
Sentence: 84,Study,O
Sentence: 84,results,O
Sentence: 84,showed,O
Sentence: 84,that,O
Sentence: 84,myoclonus,B-Disease
Sentence: 84,incidence,O
Sentence: 84,was,O
Sentence: 84,85,O
Sentence: 84,%,O
Sentence: 84,",",O
Sentence: 84,40,O
Sentence: 84,%,O
Sentence: 84,",",O
Sentence: 84,70,O
Sentence: 84,%,O
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,25,O
Sentence: 84,%,O
Sentence: 84,in,O
Sentence: 84,Group,O
Sentence: 84,NP,O
Sentence: 84,",",O
Sentence: 84,Group,O
Sentence: 84,F,O
Sentence: 84,",",O
Sentence: 84,Group,O
Sentence: 84,M,O
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,Group,O
Sentence: 84,FM,O
Sentence: 84,",",O
Sentence: 84,respectively,O
Sentence: 84,",",O
Sentence: 84,and,O
Sentence: 84,were,O
Sentence: 84,significantly,O
Sentence: 84,lower,O
Sentence: 84,in,O
Sentence: 84,Group,O
Sentence: 84,F,O
Sentence: 84,and,O
Sentence: 84,Group,O
Sentence: 84,FM,O
Sentence: 84,.,O
Sentence: 84,CONCLUSIONS,O
Sentence: 84,:,O
Sentence: 84,We,O
Sentence: 84,conclude,O
Sentence: 84,that,O
Sentence: 84,pretreatment,O
Sentence: 84,with,O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,or,O
Sentence: 84,combination,O
Sentence: 84,of,O
Sentence: 84,fentanyl,B-Chemical
Sentence: 84,and,O
Sentence: 84,midazolam,B-Chemical
Sentence: 84,was,O
Sentence: 84,effective,O
Sentence: 84,in,O
Sentence: 84,preventing,O
Sentence: 84,etomidate,B-Chemical
Sentence: 84,-,O
Sentence: 84,induced,O
Sentence: 84,myoclonus,B-Disease
Sentence: 84,.,O
Sentence: 85,Cholestatic,B-Disease
Sentence: 85,presentation,O
Sentence: 85,of,O
Sentence: 85,yellow,O
Sentence: 85,phosphorus,B-Chemical
Sentence: 85,poisoning,B-Disease
Sentence: 85,.,O
Sentence: 86,Yellow,O
Sentence: 86,phosphorus,B-Chemical
Sentence: 86,",",O
Sentence: 86,a,O
Sentence: 86,component,O
Sentence: 86,of,O
Sentence: 86,certain,O
Sentence: 86,pesticide,O
Sentence: 86,pastes,O
Sentence: 86,and,O
Sentence: 86,fireworks,O
Sentence: 86,",",O
Sentence: 86,is,O
Sentence: 86,well,O
Sentence: 86,known,O
Sentence: 86,to,O
Sentence: 86,cause,O
Sentence: 86,hepatotoxicity,B-Disease
Sentence: 86,.,O
Sentence: 86,Poisoning,B-Disease
Sentence: 86,with,O
Sentence: 86,yellow,O
Sentence: 86,phosphorus,B-Chemical
Sentence: 86,classically,O
Sentence: 86,manifests,O
Sentence: 86,with,O
Sentence: 86,acute,B-Disease
Sentence: 86,hepatitis,I-Disease
Sentence: 86,leading,O
Sentence: 86,to,O
Sentence: 86,acute,B-Disease
Sentence: 86,liver,I-Disease
Sentence: 86,failure,I-Disease
Sentence: 86,which,O
Sentence: 86,may,O
Sentence: 86,need,O
Sentence: 86,liver,O
Sentence: 86,transplantation,O
Sentence: 86,.,O
Sentence: 86,We,O
Sentence: 86,present,O
Sentence: 86,a,O
Sentence: 86,case,O
Sentence: 86,of,O
Sentence: 86,yellow,O
Sentence: 86,phosphorus,B-Chemical
Sentence: 86,poisoning,B-Disease
Sentence: 86,in,O
Sentence: 86,which,O
Sentence: 86,a,O
Sentence: 86,patient,O
Sentence: 86,presented,O
Sentence: 86,with,O
Sentence: 86,florid,O
Sentence: 86,clinical,O
Sentence: 86,features,O
Sentence: 86,of,O
Sentence: 86,cholestasis,B-Disease
Sentence: 86,highlighting,O
Sentence: 86,the,O
Sentence: 86,fact,O
Sentence: 86,that,O
Sentence: 86,cholestasis,B-Disease
Sentence: 86,can,O
Sentence: 86,rarely,O
Sentence: 86,be,O
Sentence: 86,a,O
Sentence: 86,presenting,O
Sentence: 86,feature,O
Sentence: 86,of,O
Sentence: 86,yellow,O
Sentence: 86,phosphorus,B-Chemical
Sentence: 86,hepatotoxicity,B-Disease
Sentence: 86,.,O
Sentence: 87,Vasovagal,B-Disease
Sentence: 87,syncope,I-Disease
Sentence: 87,and,O
Sentence: 87,severe,O
Sentence: 87,bradycardia,B-Disease
Sentence: 87,following,O
Sentence: 87,intranasal,O
Sentence: 87,dexmedetomidine,B-Chemical
Sentence: 87,for,O
Sentence: 87,pediatric,O
Sentence: 87,procedural,O
Sentence: 87,sedation,O
Sentence: 87,.,O
Sentence: 88,We,O
Sentence: 88,report,O
Sentence: 88,syncope,B-Disease
Sentence: 88,and,O
Sentence: 88,bradycardia,B-Disease
Sentence: 88,in,O
Sentence: 88,an,O
Sentence: 88,11,O
Sentence: 88,-,O
Sentence: 88,year,O
Sentence: 88,-,O
Sentence: 88,old,O
Sentence: 88,girl,O
Sentence: 88,following,O
Sentence: 88,administration,O
Sentence: 88,of,O
Sentence: 88,intranasal,O
Sentence: 88,dexmedetomidine,B-Chemical
Sentence: 88,for,O
Sentence: 88,sedation,O
Sentence: 88,for,O
Sentence: 88,a,O
Sentence: 88,voiding,O
Sentence: 88,cystourethrogram,O
Sentence: 88,.,O
Sentence: 88,Following,O
Sentence: 88,successful,O
Sentence: 88,completion,O
Sentence: 88,of,O
Sentence: 88,VCUG,O
Sentence: 88,and,O
Sentence: 88,a,O
Sentence: 88,60,O
Sentence: 88,-,O
Sentence: 88,min,O
Sentence: 88,recovery,O
Sentence: 88,period,O
Sentence: 88,",",O
Sentence: 88,the,O
Sentence: 88,patient,O
Sentence: 88,'s,O
Sentence: 88,level,O
Sentence: 88,of,O
Sentence: 88,consciousness,O
Sentence: 88,and,O
Sentence: 88,vital,O
Sentence: 88,signs,O
Sentence: 88,returned,O
Sentence: 88,to,O
Sentence: 88,presedation,O
Sentence: 88,levels,O
Sentence: 88,.,O
Sentence: 88,Upon,O
Sentence: 88,leaving,O
Sentence: 88,the,O
Sentence: 88,sedation,O
Sentence: 88,area,O
Sentence: 88,",",O
Sentence: 88,the,O
Sentence: 88,patient,O
Sentence: 88,collapsed,O
Sentence: 88,",",O
Sentence: 88,with,O
Sentence: 88,no,O
Sentence: 88,apparent,O
Sentence: 88,inciting,O
Sentence: 88,event,O
Sentence: 88,.,O
Sentence: 88,The,O
Sentence: 88,patient,O
Sentence: 88,quickly,O
Sentence: 88,regained,O
Sentence: 88,consciousness,O
Sentence: 88,and,O
Sentence: 88,no,O
Sentence: 88,injury,O
Sentence: 88,occurred,O
Sentence: 88,.,O
Sentence: 88,The,O
Sentence: 88,primary,O
Sentence: 88,abnormality,O
Sentence: 88,found,O
Sentence: 88,was,O
Sentence: 88,persistent,O
Sentence: 88,bradycardia,B-Disease
Sentence: 88,",",O
Sentence: 88,and,O
Sentence: 88,she,O
Sentence: 88,was,O
Sentence: 88,admitted,O
Sentence: 88,to,O
Sentence: 88,the,O
Sentence: 88,hospital,O
Sentence: 88,for,O
Sentence: 88,telemetric,O
Sentence: 88,observation,O
Sentence: 88,.,O
Sentence: 88,The,O
Sentence: 88,bradycardia,B-Disease
Sentence: 88,lasted,O
Sentence: 88,~2,O
Sentence: 88,h,O
Sentence: 88,",",O
Sentence: 88,and,O
Sentence: 88,further,O
Sentence: 88,cardiac,O
Sentence: 88,workup,O
Sentence: 88,revealed,O
Sentence: 88,no,O
Sentence: 88,underlying,O
Sentence: 88,abnormality,O
Sentence: 88,.,O
Sentence: 88,Unanticipated,O
Sentence: 88,and,O
Sentence: 88,previously,O
Sentence: 88,unreported,O
Sentence: 88,outcomes,O
Sentence: 88,may,O
Sentence: 88,be,O
Sentence: 88,witnessed,O
Sentence: 88,as,O
Sentence: 88,we,O
Sentence: 88,expand,O
Sentence: 88,the,O
Sentence: 88,use,O
Sentence: 88,of,O
Sentence: 88,certain,O
Sentence: 88,sedatives,O
Sentence: 88,to,O
Sentence: 88,alternative,O
Sentence: 88,routes,O
Sentence: 88,of,O
Sentence: 88,administration,O
Sentence: 88,.,O
Sentence: 89,Paradoxical,O
Sentence: 89,severe,O
Sentence: 89,agitation,B-Disease
Sentence: 89,induced,O
Sentence: 89,by,O
Sentence: 89,add,O
Sentence: 89,-,O
Sentence: 89,on,O
Sentence: 89,high,O
Sentence: 89,-,O
Sentence: 89,doses,O
Sentence: 89,quetiapine,B-Chemical
Sentence: 89,in,O
Sentence: 89,schizo,O
Sentence: 89,-,O
Sentence: 89,affective,O
Sentence: 89,disorder,O
Sentence: 89,.,O
Sentence: 90,We,O
Sentence: 90,report,O
Sentence: 90,the,O
Sentence: 90,case,O
Sentence: 90,of,O
Sentence: 90,a,O
Sentence: 90,35,O
Sentence: 90,-,O
Sentence: 90,year,O
Sentence: 90,-,O
Sentence: 90,old,O
Sentence: 90,patient,O
Sentence: 90,suffering,O
Sentence: 90,from,O
Sentence: 90,schizo,O
Sentence: 90,-,O
Sentence: 90,affective,O
Sentence: 90,disorder,O
Sentence: 90,since,O
Sentence: 90,the,O
Sentence: 90,age,O
Sentence: 90,of,O
Sentence: 90,19,O
Sentence: 90,years,O
Sentence: 90,",",O
Sentence: 90,treated,O
Sentence: 90,by,O
Sentence: 90,a,O
Sentence: 90,combination,O
Sentence: 90,of,O
Sentence: 90,first,O
Sentence: 90,-,O
Sentence: 90,generation,O
Sentence: 90,antipsychotics,O
Sentence: 90,",",O
Sentence: 90,zuclopenthixol,B-Chemical
Sentence: 90,(,O
Sentence: 90,100,O
Sentence: 90,mg,O
Sentence: 90,/,O
Sentence: 90,day,O
Sentence: 90,),O
Sentence: 90,and,O
Sentence: 90,lithium,B-Chemical
Sentence: 90,(,O
Sentence: 90,1200,O
Sentence: 90,mg,O
Sentence: 90,/,O
Sentence: 90,day,O
Sentence: 90,),O
Sentence: 90,(,O
Sentence: 90,serum,O
Sentence: 90,lithium,B-Chemical
Sentence: 90,=,O
Sentence: 90,0.85,O
Sentence: 90,mEq,O
Sentence: 90,/,O
Sentence: 90,l,O
Sentence: 90,),O
Sentence: 90,.,O
Sentence: 90,This,O
Sentence: 90,patient,O
Sentence: 90,had,O
Sentence: 90,no,O
Sentence: 90,associated,O
Sentence: 90,personality,B-Disease
Sentence: 90,disorder,I-Disease
Sentence: 90,(,O
Sentence: 90,particularly,O
Sentence: 90,no,O
Sentence: 90,antisocial,B-Disease
Sentence: 90,disorder,I-Disease
Sentence: 90,),O
Sentence: 90,and,O
Sentence: 90,no,O
Sentence: 90,substance,B-Disease
Sentence: 90,abuse,I-Disease
Sentence: 90,disorder,I-Disease
Sentence: 90,.,O
Sentence: 90,Within,O
Sentence: 90,the,O
Sentence: 90,48,O
Sentence: 90,h,O
Sentence: 90,following,O
Sentence: 90,the,O
Sentence: 90,gradual,O
Sentence: 90,introduction,O
Sentence: 90,of,O
Sentence: 90,quetiapine,B-Chemical
Sentence: 90,(,O
Sentence: 90,up,O
Sentence: 90,to,O
Sentence: 90,600,O
Sentence: 90,mg,O
Sentence: 90,/,O
Sentence: 90,day,O
Sentence: 90,),O
Sentence: 90,",",O
Sentence: 90,the,O
Sentence: 90,patient,O
Sentence: 90,presented,O
Sentence: 90,severe,O
Sentence: 90,agitation,B-Disease
Sentence: 90,without,O
Sentence: 90,an,O
Sentence: 90,environmental,O
Sentence: 90,explanation,O
Sentence: 90,",",O
Sentence: 90,contrasting,O
Sentence: 90,with,O
Sentence: 90,the,O
Sentence: 90,absence,O
Sentence: 90,of,O
Sentence: 90,a,O
Sentence: 90,history,O
Sentence: 90,of,O
Sentence: 90,aggressiveness,B-Disease
Sentence: 90,or,O
Sentence: 90,personality,B-Disease
Sentence: 90,disorder,I-Disease
Sentence: 90,.,O
Sentence: 90,The,O
Sentence: 90,diagnoses,O
Sentence: 90,of,O
Sentence: 90,manic,B-Disease
Sentence: 90,shift,O
Sentence: 90,and,O
Sentence: 90,akathisia,B-Disease
Sentence: 90,were,O
Sentence: 90,dismissed,O
Sentence: 90,.,O
Sentence: 90,The,O
Sentence: 90,withdrawal,O
Sentence: 90,and,O
Sentence: 90,the,O
Sentence: 90,gradual,O
Sentence: 90,reintroduction,O
Sentence: 90,of,O
Sentence: 90,quetiapine,B-Chemical
Sentence: 90,2,O
Sentence: 90,weeks,O
Sentence: 90,later,O
Sentence: 90,",",O
Sentence: 90,which,O
Sentence: 90,led,O
Sentence: 90,to,O
Sentence: 90,another,O
Sentence: 90,severe,O
Sentence: 90,agitation,B-Disease
Sentence: 90,",",O
Sentence: 90,enabled,O
Sentence: 90,us,O
Sentence: 90,to,O
Sentence: 90,attribute,O
Sentence: 90,the,O
Sentence: 90,agitation,B-Disease
Sentence: 90,specifically,O
Sentence: 90,to,O
Sentence: 90,quetiapine,B-Chemical
Sentence: 90,.,O
Sentence: 91,Antioxidant,O
Sentence: 91,effects,O
Sentence: 91,of,O
Sentence: 91,bovine,O
Sentence: 91,lactoferrin,O
Sentence: 91,on,O
Sentence: 91,dexamethasone,B-Chemical
Sentence: 91,-,O
Sentence: 91,induced,O
Sentence: 91,hypertension,B-Disease
Sentence: 91,in,O
Sentence: 91,rat,O
Sentence: 91,.,O
Sentence: 92,Dexamethasone,B-Chemical
Sentence: 92,-,O
Sentence: 92,,O
Sentence: 92,(,O
Sentence: 92,Dex,B-Chemical
Sentence: 92,-,O
Sentence: 92,,O
Sentence: 92,),O
Sentence: 92,induced,O
Sentence: 92,hypertension,B-Disease
Sentence: 92,is,O
Sentence: 92,associated,O
Sentence: 92,with,O
Sentence: 92,enhanced,O
Sentence: 92,oxidative,O
Sentence: 92,stress,O
Sentence: 92,.,O
Sentence: 92,Lactoferrin,O
Sentence: 92,(,O
Sentence: 92,LF,O
Sentence: 92,),O
Sentence: 92,is,O
Sentence: 92,an,O
Sentence: 92,iron,B-Chemical
Sentence: 92,-,O
Sentence: 92,binding,O
Sentence: 92,glycoprotein,O
Sentence: 92,with,O
Sentence: 92,antihypertensive,O
Sentence: 92,properties,O
Sentence: 92,.,O
Sentence: 92,In,O
Sentence: 92,this,O
Sentence: 92,study,O
Sentence: 92,",",O
Sentence: 92,we,O
Sentence: 92,investigated,O
Sentence: 92,the,O
Sentence: 92,effect,O
Sentence: 92,of,O
Sentence: 92,chronic,O
Sentence: 92,administration,O
Sentence: 92,of,O
Sentence: 92,LF,O
Sentence: 92,on,O
Sentence: 92,oxidative,O
Sentence: 92,stress,O
Sentence: 92,and,O
Sentence: 92,hypertension,B-Disease
Sentence: 92,upon,O
Sentence: 92,Dex,B-Chemical
Sentence: 92,administration,O
Sentence: 92,.,O
Sentence: 92,Male,O
Sentence: 92,Wistar,O
Sentence: 92,rats,O
Sentence: 92,were,O
Sentence: 92,treated,O
Sentence: 92,by,O
Sentence: 92,Dex,B-Chemical
Sentence: 92,(,O
Sentence: 92,30,O
Sentence: 92,u,O
Sentence: 92,g,O
Sentence: 92,/,O
Sentence: 92,kg,O
Sentence: 92,/,O
Sentence: 92,day,O
Sentence: 92,subcutaneously,O
Sentence: 92,),O
Sentence: 92,or,O
Sentence: 92,saline,O
Sentence: 92,for,O
Sentence: 92,14,O
Sentence: 92,days,O
Sentence: 92,.,O
Sentence: 92,Oral,O
Sentence: 92,bovine,O
Sentence: 92,LF,O
Sentence: 92,(,O
Sentence: 92,30,O
Sentence: 92,",",O
Sentence: 92,100,O
Sentence: 92,",",O
Sentence: 92,300,O
Sentence: 92,mg,O
Sentence: 92,/,O
Sentence: 92,kg,O
Sentence: 92,),O
Sentence: 92,was,O
Sentence: 92,given,O
Sentence: 92,from,O
Sentence: 92,day,O
Sentence: 92,8,O
Sentence: 92,to,O
Sentence: 92,14,O
Sentence: 92,in,O
Sentence: 92,a,O
Sentence: 92,reversal,O
Sentence: 92,study,O
Sentence: 92,.,O
Sentence: 92,In,O
Sentence: 92,a,O
Sentence: 92,prevention,O
Sentence: 92,study,O
Sentence: 92,",",O
Sentence: 92,rats,O
Sentence: 92,received,O
Sentence: 92,4,O
Sentence: 92,days,O
Sentence: 92,of,O
Sentence: 92,LF,O
Sentence: 92,treatment,O
Sentence: 92,followed,O
Sentence: 92,by,O
Sentence: 92,Dex,B-Chemical
Sentence: 92,and,O
Sentence: 92,continued,O
Sentence: 92,during,O
Sentence: 92,the,O
Sentence: 92,test,O
Sentence: 92,period,O
Sentence: 92,.,O
Sentence: 92,Systolic,O
Sentence: 92,blood,O
Sentence: 92,pressure,O
Sentence: 92,(,O
Sentence: 92,SBP,O
Sentence: 92,),O
Sentence: 92,was,O
Sentence: 92,measured,O
Sentence: 92,using,O
Sentence: 92,tail,O
Sentence: 92,-,O
Sentence: 92,cuff,O
Sentence: 92,method,O
Sentence: 92,.,O
Sentence: 92,Thymus,O
Sentence: 92,weight,O
Sentence: 92,was,O
Sentence: 92,used,O
Sentence: 92,as,O
Sentence: 92,a,O
Sentence: 92,marker,O
Sentence: 92,of,O
Sentence: 92,glucocorticoid,O
Sentence: 92,activity,O
Sentence: 92,.,O
Sentence: 92,Plasma,O
Sentence: 92,hydrogen,B-Chemical
Sentence: 92,peroxide,I-Chemical
Sentence: 92,(,O
Sentence: 92,H2O2,B-Chemical
Sentence: 92,),O
Sentence: 92,concentration,O
Sentence: 92,and,O
Sentence: 92,ferric,O
Sentence: 92,reducing,O
Sentence: 92,antioxidant,O
Sentence: 92,power,O
Sentence: 92,(,O
Sentence: 92,FRAP,O
Sentence: 92,),O
Sentence: 92,value,O
Sentence: 92,were,O
Sentence: 92,determined,O
Sentence: 92,.,O
Sentence: 92,Dexamethasone,B-Chemical
Sentence: 92,significantly,O
Sentence: 92,increased,O
Sentence: 92,SBP,O
Sentence: 92,and,O
Sentence: 92,plasma,O
Sentence: 92,H2O2,B-Chemical
Sentence: 92,level,O
Sentence: 92,and,O
Sentence: 92,decreased,O
Sentence: 92,thymus,O
Sentence: 92,and,O
Sentence: 92,body,O
Sentence: 92,weights,O
Sentence: 92,.,O
Sentence: 92,LF,O
Sentence: 92,lowered,O
Sentence: 92,(,O
Sentence: 92,P,O
Sentence: 92,,O
Sentence: 92,<,O
Sentence: 92,,O
Sentence: 92,0.01,O
Sentence: 92,),O
Sentence: 92,and,O
Sentence: 92,dose,O
Sentence: 92,dependently,O
Sentence: 92,prevented,O
Sentence: 92,(,O
Sentence: 92,P,O
Sentence: 92,,O
Sentence: 92,<,O
Sentence: 92,,O
Sentence: 92,0.001,O
Sentence: 92,),O
Sentence: 92,Dex,B-Chemical
Sentence: 92,-,O
Sentence: 92,induced,O
Sentence: 92,hypertension,B-Disease
Sentence: 92,.,O
Sentence: 92,LF,O
Sentence: 92,prevented,O
Sentence: 92,body,O
Sentence: 92,weight,B-Disease
Sentence: 92,loss,I-Disease
Sentence: 92,and,O
Sentence: 92,significantly,O
Sentence: 92,reduced,O
Sentence: 92,the,O
Sentence: 92,elevated,O
Sentence: 92,plasma,O
Sentence: 92,H2O2,B-Chemical
Sentence: 92,and,O
Sentence: 92,increased,O
Sentence: 92,FRAP,O
Sentence: 92,values,O
Sentence: 92,.,O
Sentence: 92,Chronic,O
Sentence: 92,administration,O
Sentence: 92,of,O
Sentence: 92,LF,O
Sentence: 92,strongly,O
Sentence: 92,reduced,O
Sentence: 92,the,O
Sentence: 92,blood,O
Sentence: 92,pressure,O
Sentence: 92,and,O
Sentence: 92,production,O
Sentence: 92,of,O
Sentence: 92,ROS,O
Sentence: 92,and,O
Sentence: 92,improved,O
Sentence: 92,antioxidant,O
Sentence: 92,capacity,O
Sentence: 92,in,O
Sentence: 92,Dex,B-Chemical
Sentence: 92,-,O
Sentence: 92,induced,O
Sentence: 92,hypertension,B-Disease
Sentence: 92,",",O
Sentence: 92,suggesting,O
Sentence: 92,the,O
Sentence: 92,role,O
Sentence: 92,of,O
Sentence: 92,inhibition,O
Sentence: 92,of,O
Sentence: 92,oxidative,O
Sentence: 92,stress,O
Sentence: 92,as,O
Sentence: 92,another,O
Sentence: 92,mechanism,O
Sentence: 92,of,O
Sentence: 92,antihypertensive,O
Sentence: 92,action,O
Sentence: 92,of,O
Sentence: 92,LF,O
Sentence: 92,.,O
Sentence: 93,The,O
Sentence: 93,association,O
Sentence: 93,between,O
Sentence: 93,tranexamic,B-Chemical
Sentence: 93,acid,I-Chemical
Sentence: 93,and,O
Sentence: 93,convulsive,B-Disease
Sentence: 93,seizures,B-Disease
Sentence: 93,after,O
Sentence: 93,cardiac,O
Sentence: 93,surgery,O
Sentence: 93,:,O
Sentence: 93,a,O
Sentence: 93,multivariate,O
Sentence: 93,analysis,O
Sentence: 93,in,O
Sentence: 93,11,O
Sentence: 93,529,O
Sentence: 93,patients,O
Sentence: 93,.,O
Sentence: 94,Because,O
Sentence: 94,of,O
Sentence: 94,a,O
Sentence: 94,lack,O
Sentence: 94,of,O
Sentence: 94,contemporary,O
Sentence: 94,data,O
Sentence: 94,regarding,O
Sentence: 94,seizures,B-Disease
Sentence: 94,after,O
Sentence: 94,cardiac,O
Sentence: 94,surgery,O
Sentence: 94,",",O
Sentence: 94,we,O
Sentence: 94,undertook,O
Sentence: 94,a,O
Sentence: 94,retrospective,O
Sentence: 94,analysis,O
Sentence: 94,of,O
Sentence: 94,prospectively,O
Sentence: 94,collected,O
Sentence: 94,data,O
Sentence: 94,from,O
Sentence: 94,11,O
Sentence: 94,529,O
Sentence: 94,patients,O
Sentence: 94,in,O
Sentence: 94,whom,O
Sentence: 94,cardiopulmonary,O
Sentence: 94,bypass,O
Sentence: 94,was,O
Sentence: 94,used,O
Sentence: 94,from,O
Sentence: 94,January,O
Sentence: 94,2004,O
Sentence: 94,to,O
Sentence: 94,December,O
Sentence: 94,2010,O
Sentence: 94,.,O
Sentence: 94,A,O
Sentence: 94,convulsive,B-Disease
Sentence: 94,seizure,B-Disease
Sentence: 94,was,O
Sentence: 94,defined,O
Sentence: 94,as,O
Sentence: 94,a,O
Sentence: 94,transient,O
Sentence: 94,episode,O
Sentence: 94,of,O
Sentence: 94,disturbed,O
Sentence: 94,brain,O
Sentence: 94,function,O
Sentence: 94,characterised,O
Sentence: 94,by,O
Sentence: 94,abnormal,B-Disease
Sentence: 94,involuntary,I-Disease
Sentence: 94,motor,I-Disease
Sentence: 94,movements,I-Disease
Sentence: 94,.,O
Sentence: 94,Multivariate,O
Sentence: 94,regression,O
Sentence: 94,analysis,O
Sentence: 94,was,O
Sentence: 94,performed,O
Sentence: 94,to,O
Sentence: 94,identify,O
Sentence: 94,independent,O
Sentence: 94,predictors,O
Sentence: 94,of,O
Sentence: 94,postoperative,O
Sentence: 94,seizures,B-Disease
Sentence: 94,.,O
Sentence: 94,A,O
Sentence: 94,total,O
Sentence: 94,of,O
Sentence: 94,100,O
Sentence: 94,(,O
Sentence: 94,0.9,O
Sentence: 94,%,O
Sentence: 94,),O
Sentence: 94,patients,O
Sentence: 94,developed,O
Sentence: 94,postoperative,O
Sentence: 94,convulsive,B-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,.,O
Sentence: 94,Generalised,B-Disease
Sentence: 94,and,I-Disease
Sentence: 94,focal,I-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,were,O
Sentence: 94,identified,O
Sentence: 94,in,O
Sentence: 94,68,O
Sentence: 94,and,O
Sentence: 94,32,O
Sentence: 94,patients,O
Sentence: 94,",",O
Sentence: 94,respectively,O
Sentence: 94,.,O
Sentence: 94,The,O
Sentence: 94,median,O
Sentence: 94,(,O
Sentence: 94,IQR,O
Sentence: 94,[,O
Sentence: 94,range,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,time,O
Sentence: 94,after,O
Sentence: 94,surgery,O
Sentence: 94,when,O
Sentence: 94,the,O
Sentence: 94,seizure,B-Disease
Sentence: 94,occurred,O
Sentence: 94,was,O
Sentence: 94,7,O
Sentence: 94,(,O
Sentence: 94,6,O
Sentence: 94,-,O
Sentence: 94,12,O
Sentence: 94,[,O
Sentence: 94,1,O
Sentence: 94,-,O
Sentence: 94,216,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,h,O
Sentence: 94,and,O
Sentence: 94,8,O
Sentence: 94,(,O
Sentence: 94,6,O
Sentence: 94,-,O
Sentence: 94,11,O
Sentence: 94,[,O
Sentence: 94,4,O
Sentence: 94,-,O
Sentence: 94,18,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,h,O
Sentence: 94,",",O
Sentence: 94,respectively,O
Sentence: 94,.,O
Sentence: 94,Epileptiform,O
Sentence: 94,findings,O
Sentence: 94,on,O
Sentence: 94,electroencephalography,O
Sentence: 94,were,O
Sentence: 94,seen,O
Sentence: 94,in,O
Sentence: 94,19,O
Sentence: 94,patients,O
Sentence: 94,.,O
Sentence: 94,Independent,O
Sentence: 94,predictors,O
Sentence: 94,of,O
Sentence: 94,postoperative,O
Sentence: 94,seizures,B-Disease
Sentence: 94,included,O
Sentence: 94,age,O
Sentence: 94,",",O
Sentence: 94,female,O
Sentence: 94,sex,O
Sentence: 94,",",O
Sentence: 94,redo,O
Sentence: 94,cardiac,O
Sentence: 94,surgery,O
Sentence: 94,",",O
Sentence: 94,calcification,O
Sentence: 94,of,O
Sentence: 94,ascending,O
Sentence: 94,aorta,O
Sentence: 94,",",O
Sentence: 94,congestive,B-Disease
Sentence: 94,heart,I-Disease
Sentence: 94,failure,I-Disease
Sentence: 94,",",O
Sentence: 94,deep,O
Sentence: 94,hypothermic,B-Disease
Sentence: 94,circulatory,O
Sentence: 94,arrest,O
Sentence: 94,",",O
Sentence: 94,duration,O
Sentence: 94,of,O
Sentence: 94,aortic,O
Sentence: 94,cross,O
Sentence: 94,-,O
Sentence: 94,clamp,O
Sentence: 94,and,O
Sentence: 94,tranexamic,B-Chemical
Sentence: 94,acid,I-Chemical
Sentence: 94,.,O
Sentence: 94,When,O
Sentence: 94,tested,O
Sentence: 94,in,O
Sentence: 94,a,O
Sentence: 94,multivariate,O
Sentence: 94,regression,O
Sentence: 94,analysis,O
Sentence: 94,",",O
Sentence: 94,tranexamic,B-Chemical
Sentence: 94,acid,I-Chemical
Sentence: 94,was,O
Sentence: 94,a,O
Sentence: 94,strong,O
Sentence: 94,independent,O
Sentence: 94,predictor,O
Sentence: 94,of,O
Sentence: 94,seizures,B-Disease
Sentence: 94,(,O
Sentence: 94,OR,O
Sentence: 94,14.3,O
Sentence: 94,",",O
Sentence: 94,95,O
Sentence: 94,%,O
Sentence: 94,CI,O
Sentence: 94,5.5,O
Sentence: 94,-,O
Sentence: 94,36.7,O
Sentence: 94,;,O
Sentence: 94,p,O
Sentence: 94,,O
Sentence: 94,<,O
Sentence: 94,,O
Sentence: 94,0.001,O
Sentence: 94,),O
Sentence: 94,.,O
Sentence: 94,Patients,O
Sentence: 94,with,O
Sentence: 94,convulsive,B-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,had,O
Sentence: 94,2.5,O
Sentence: 94,times,O
Sentence: 94,higher,O
Sentence: 94,in,O
Sentence: 94,-,O
Sentence: 94,hospital,O
Sentence: 94,mortality,O
Sentence: 94,rates,O
Sentence: 94,and,O
Sentence: 94,twice,O
Sentence: 94,the,O
Sentence: 94,length,O
Sentence: 94,of,O
Sentence: 94,hospital,O
Sentence: 94,stay,O
Sentence: 94,compared,O
Sentence: 94,with,O
Sentence: 94,patients,O
Sentence: 94,without,O
Sentence: 94,convulsive,B-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,.,O
Sentence: 94,Mean,O
Sentence: 94,(,O
Sentence: 94,IQR,O
Sentence: 94,[,O
Sentence: 94,range,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,length,O
Sentence: 94,of,O
Sentence: 94,stay,O
Sentence: 94,in,O
Sentence: 94,the,O
Sentence: 94,intensive,O
Sentence: 94,care,O
Sentence: 94,unit,O
Sentence: 94,was,O
Sentence: 94,115,O
Sentence: 94,(,O
Sentence: 94,49,O
Sentence: 94,-,O
Sentence: 94,228,O
Sentence: 94,[,O
Sentence: 94,32,O
Sentence: 94,-,O
Sentence: 94,481,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,h,O
Sentence: 94,in,O
Sentence: 94,patients,O
Sentence: 94,with,O
Sentence: 94,convulsive,B-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,compared,O
Sentence: 94,with,O
Sentence: 94,26,O
Sentence: 94,(,O
Sentence: 94,22,O
Sentence: 94,-,O
Sentence: 94,69,O
Sentence: 94,[,O
Sentence: 94,14,O
Sentence: 94,-,O
Sentence: 94,1080,O
Sentence: 94,],O
Sentence: 94,),O
Sentence: 94,h,O
Sentence: 94,in,O
Sentence: 94,patients,O
Sentence: 94,without,O
Sentence: 94,seizures,B-Disease
Sentence: 94,(,O
Sentence: 94,p,O
Sentence: 94,,O
Sentence: 94,<,O
Sentence: 94,,O
Sentence: 94,0.001,O
Sentence: 94,),O
Sentence: 94,.,O
Sentence: 94,Convulsive,B-Disease
Sentence: 94,seizures,B-Disease
Sentence: 94,are,O
Sentence: 94,a,O
Sentence: 94,serious,O
Sentence: 94,postoperative,B-Disease
Sentence: 94,complication,I-Disease
Sentence: 94,after,O
Sentence: 94,cardiac,O
Sentence: 94,surgery,O
Sentence: 94,.,O
Sentence: 94,As,O
Sentence: 94,tranexamic,B-Chemical
Sentence: 94,acid,I-Chemical
Sentence: 94,is,O
Sentence: 94,the,O
Sentence: 94,only,O
Sentence: 94,modifiable,O
Sentence: 94,factor,O
Sentence: 94,",",O
Sentence: 94,its,O
Sentence: 94,administration,O
Sentence: 94,",",O
Sentence: 94,particularly,O
Sentence: 94,in,O
Sentence: 94,doses,O
Sentence: 94,exceeding,O
Sentence: 94,80,O
Sentence: 94,mg.kg,O
Sentence: 94,(,O
Sentence: 94,,O
Sentence: 94,-,O
Sentence: 94,1,O
Sentence: 94,),O
Sentence: 94,",",O
Sentence: 94,should,O
Sentence: 94,be,O
Sentence: 94,weighed,O
Sentence: 94,against,O
Sentence: 94,the,O
Sentence: 94,risk,O
Sentence: 94,of,O
Sentence: 94,postoperative,O
Sentence: 94,seizures,B-Disease
Sentence: 94,.,O
Sentence: 95,Dysfunctional,B-Disease
Sentence: 95,overnight,I-Disease
Sentence: 95,memory,I-Disease
Sentence: 95,consolidation,O
Sentence: 95,in,O
Sentence: 95,ecstasy,B-Chemical
Sentence: 95,users,O
Sentence: 95,.,O
Sentence: 96,Sleep,O
Sentence: 96,plays,O
Sentence: 96,an,O
Sentence: 96,important,O
Sentence: 96,role,O
Sentence: 96,in,O
Sentence: 96,the,O
Sentence: 96,consolidation,O
Sentence: 96,and,O
Sentence: 96,integration,O
Sentence: 96,of,O
Sentence: 96,memory,O
Sentence: 96,in,O
Sentence: 96,a,O
Sentence: 96,process,O
Sentence: 96,called,O
Sentence: 96,overnight,O
Sentence: 96,memory,O
Sentence: 96,consolidation,O
Sentence: 96,.,O
Sentence: 96,Previous,O
Sentence: 96,studies,O
Sentence: 96,indicate,O
Sentence: 96,that,O
Sentence: 96,ecstasy,B-Chemical
Sentence: 96,users,O
Sentence: 96,have,O
Sentence: 96,marked,O
Sentence: 96,and,O
Sentence: 96,persistent,O
Sentence: 96,neurocognitive,O
Sentence: 96,and,O
Sentence: 96,sleep,O
Sentence: 96,-,O
Sentence: 96,related,O
Sentence: 96,impairments,O
Sentence: 96,.,O
Sentence: 96,We,O
Sentence: 96,extend,O
Sentence: 96,past,O
Sentence: 96,research,O
Sentence: 96,by,O
Sentence: 96,examining,O
Sentence: 96,overnight,O
Sentence: 96,memory,O
Sentence: 96,consolidation,O
Sentence: 96,among,O
Sentence: 96,regular,O
Sentence: 96,ecstasy,B-Chemical
Sentence: 96,users,O
Sentence: 96,(,O
Sentence: 96,n,O
Sentence: 96,=,O
Sentence: 96,12,O
Sentence: 96,),O
Sentence: 96,and,O
Sentence: 96,drug,O
Sentence: 96,naive,O
Sentence: 96,healthy,O
Sentence: 96,controls,O
Sentence: 96,(,O
Sentence: 96,n,O
Sentence: 96,=,O
Sentence: 96,26,O
Sentence: 96,),O
Sentence: 96,.,O
Sentence: 96,Memory,O
Sentence: 96,recall,O
Sentence: 96,of,O
Sentence: 96,word,O
Sentence: 96,pairs,O
Sentence: 96,was,O
Sentence: 96,evaluated,O
Sentence: 96,before,O
Sentence: 96,and,O
Sentence: 96,after,O
Sentence: 96,a,O
Sentence: 96,period,O
Sentence: 96,of,O
Sentence: 96,sleep,O
Sentence: 96,",",O
Sentence: 96,with,O
Sentence: 96,and,O
Sentence: 96,without,O
Sentence: 96,interference,O
Sentence: 96,prior,O
Sentence: 96,to,O
Sentence: 96,testing,O
Sentence: 96,.,O
Sentence: 96,In,O
Sentence: 96,addition,O
Sentence: 96,",",O
Sentence: 96,we,O
Sentence: 96,assessed,O
Sentence: 96,neurocognitive,O
Sentence: 96,performances,O
Sentence: 96,across,O
Sentence: 96,tasks,O
Sentence: 96,of,O
Sentence: 96,learning,O
Sentence: 96,",",O
Sentence: 96,memory,O
Sentence: 96,and,O
Sentence: 96,executive,O
Sentence: 96,functioning,O
Sentence: 96,.,O
Sentence: 96,Ecstasy,B-Chemical
Sentence: 96,users,O
Sentence: 96,demonstrated,O
Sentence: 96,impaired,B-Disease
Sentence: 96,overnight,I-Disease
Sentence: 96,memory,I-Disease
Sentence: 96,consolidation,O
Sentence: 96,",",O
Sentence: 96,a,O
Sentence: 96,finding,O
Sentence: 96,that,O
Sentence: 96,was,O
Sentence: 96,more,O
Sentence: 96,pronounced,O
Sentence: 96,following,O
Sentence: 96,associative,O
Sentence: 96,interference,O
Sentence: 96,.,O
Sentence: 96,Additionally,O
Sentence: 96,",",O
Sentence: 96,ecstasy,B-Chemical
Sentence: 96,users,O
Sentence: 96,demonstrated,O
Sentence: 96,impairments,O
Sentence: 96,on,O
Sentence: 96,tasks,O
Sentence: 96,recruiting,O
Sentence: 96,frontostriatal,O
Sentence: 96,and,O
Sentence: 96,hippocampal,O
Sentence: 96,neural,O
Sentence: 96,circuitry,O
Sentence: 96,",",O
Sentence: 96,in,O
Sentence: 96,the,O
Sentence: 96,domains,O
Sentence: 96,of,O
Sentence: 96,proactive,O
Sentence: 96,interference,O
Sentence: 96,memory,O
Sentence: 96,",",O
Sentence: 96,long,O
Sentence: 96,-,O
Sentence: 96,term,O
Sentence: 96,memory,O
Sentence: 96,",",O
Sentence: 96,encoding,O
Sentence: 96,",",O
Sentence: 96,working,O
Sentence: 96,memory,O
Sentence: 96,and,O
Sentence: 96,complex,O
Sentence: 96,planning,O
Sentence: 96,.,O
Sentence: 96,We,O
Sentence: 96,suggest,O
Sentence: 96,that,O
Sentence: 96,ecstasy,B-Chemical
Sentence: 96,-,O
Sentence: 96,associated,O
Sentence: 96,dysfunction,O
Sentence: 96,in,O
Sentence: 96,fronto,O
Sentence: 96,-,O
Sentence: 96,temporal,O
Sentence: 96,circuitry,O
Sentence: 96,may,O
Sentence: 96,underlie,O
Sentence: 96,overnight,O
Sentence: 96,consolidation,O
Sentence: 96,memory,B-Disease
Sentence: 96,impairments,I-Disease
Sentence: 96,in,O
Sentence: 96,regular,O
Sentence: 96,ecstasy,B-Chemical
Sentence: 96,users,O
Sentence: 96,.,O
Sentence: 97,Normoammonemic,O
Sentence: 97,encephalopathy,B-Disease
Sentence: 97,:,O
Sentence: 97,solely,O
Sentence: 97,valproate,B-Chemical
Sentence: 97,induced,O
Sentence: 97,or,O
Sentence: 97,multiple,O
Sentence: 97,mechanisms,O
Sentence: 97,?,O
Sentence: 98,A,O
Sentence: 98,77,O
Sentence: 98,-,O
Sentence: 98,year,O
Sentence: 98,-,O
Sentence: 98,old,O
Sentence: 98,woman,O
Sentence: 98,presented,O
Sentence: 98,with,O
Sentence: 98,subacute,O
Sentence: 98,onset,O
Sentence: 98,progressive,O
Sentence: 98,confusion,B-Disease
Sentence: 98,",",O
Sentence: 98,aggression,B-Disease
Sentence: 98,",",O
Sentence: 98,auditory,B-Disease
Sentence: 98,hallucinations,I-Disease
Sentence: 98,and,O
Sentence: 98,delusions,B-Disease
Sentence: 98,.,O
Sentence: 98,In,O
Sentence: 98,the,O
Sentence: 98,preceding,O
Sentence: 98,months,O
Sentence: 98,",",O
Sentence: 98,the,O
Sentence: 98,patient,O
Sentence: 98,had,O
Sentence: 98,a,O
Sentence: 98,number,O
Sentence: 98,of,O
Sentence: 98,admissions,O
Sentence: 98,with,O
Sentence: 98,transient,O
Sentence: 98,unilateral,O
Sentence: 98,hemiparesis,B-Disease
Sentence: 98,with,O
Sentence: 98,facial,O
Sentence: 98,droop,O
Sentence: 98,",",O
Sentence: 98,and,O
Sentence: 98,had,O
Sentence: 98,been,O
Sentence: 98,started,O
Sentence: 98,on,O
Sentence: 98,valproate,B-Chemical
Sentence: 98,for,O
Sentence: 98,presumed,O
Sentence: 98,hemiplegic,B-Disease
Sentence: 98,migraine,I-Disease
Sentence: 98,.,O
Sentence: 98,Valproate,B-Chemical
Sentence: 98,was,O
Sentence: 98,withdrawn,O
Sentence: 98,soon,O
Sentence: 98,after,O
Sentence: 98,admission,O
Sentence: 98,and,O
Sentence: 98,her,O
Sentence: 98,cognitive,O
Sentence: 98,abilities,O
Sentence: 98,have,O
Sentence: 98,gradually,O
Sentence: 98,improved,O
Sentence: 98,over,O
Sentence: 98,3,O
Sentence: 98,months,O
Sentence: 98,of,O
Sentence: 98,follow,O
Sentence: 98,-,O
Sentence: 98,up,O
Sentence: 98,.,O
Sentence: 98,Valproate,B-Chemical
Sentence: 98,levels,O
Sentence: 98,taken,O
Sentence: 98,prior,O
Sentence: 98,to,O
Sentence: 98,withdrawal,O
Sentence: 98,were,O
Sentence: 98,subtherapeutic,O
Sentence: 98,and,O
Sentence: 98,the,O
Sentence: 98,patient,O
Sentence: 98,was,O
Sentence: 98,normoammonaemic,O
Sentence: 98,.,O
Sentence: 98,EEG,O
Sentence: 98,undertaken,O
Sentence: 98,during,O
Sentence: 98,inpatient,O
Sentence: 98,stay,O
Sentence: 98,showed,O
Sentence: 98,changes,O
Sentence: 98,consistent,O
Sentence: 98,with,O
Sentence: 98,encephalopathy,B-Disease
Sentence: 98,",",O
Sentence: 98,and,O
Sentence: 98,low,O
Sentence: 98,titre,O
Sentence: 98,N,O
Sentence: 98,-,O
Sentence: 98,methyl,O
Sentence: 98,-,O
Sentence: 98,D,O
Sentence: 98,-,O
Sentence: 98,aspartate,O
Sentence: 98,(,O
Sentence: 98,NMDA,B-Chemical
Sentence: 98,),O
Sentence: 98,receptor,O
Sentence: 98,antibodies,O
Sentence: 98,were,O
Sentence: 98,present,O
Sentence: 98,in,O
Sentence: 98,this,O
Sentence: 98,patient,O
Sentence: 98,.,O
Sentence: 98,The,O
Sentence: 98,possible,O
Sentence: 98,aetiologies,O
Sentence: 98,of,O
Sentence: 98,valproate,B-Chemical
Sentence: 98,-,O
Sentence: 98,induced,O
Sentence: 98,encephalopathy,B-Disease
Sentence: 98,and,O
Sentence: 98,NMDA,B-Chemical
Sentence: 98,receptor,O
Sentence: 98,-,O
Sentence: 98,associated,O
Sentence: 98,encephalitis,B-Disease
Sentence: 98,present,O
Sentence: 98,a,O
Sentence: 98,diagnostic,O
Sentence: 98,dilemma,O
Sentence: 98,.,O
Sentence: 98,We,O
Sentence: 98,present,O
Sentence: 98,a,O
Sentence: 98,putative,O
Sentence: 98,combinatorial,O
Sentence: 98,hypothesis,O
Sentence: 98,to,O
Sentence: 98,explain,O
Sentence: 98,this,O
Sentence: 98,patient,O
Sentence: 98,'s,O
Sentence: 98,symptoms,O
Sentence: 98,.,O
Sentence: 99,Cerebellar,B-Disease
Sentence: 99,and,I-Disease
Sentence: 99,oculomotor,B-Disease
Sentence: 99,dysfunction,I-Disease
Sentence: 99,induced,O
Sentence: 99,by,O
Sentence: 99,rapid,O
Sentence: 99,infusion,O
Sentence: 99,of,O
Sentence: 99,pethidine,B-Chemical
Sentence: 99,.,O
Sentence: 100,Pethidine,B-Chemical
Sentence: 100,is,O
Sentence: 100,an,O
Sentence: 100,opioid,O
Sentence: 100,that,O
Sentence: 100,gains,O
Sentence: 100,its,O
Sentence: 100,popularity,O
Sentence: 100,for,O
Sentence: 100,the,O
Sentence: 100,effective,O
Sentence: 100,pain,B-Disease
Sentence: 100,control,O
Sentence: 100,through,O
Sentence: 100,acting,O
Sentence: 100,on,O
Sentence: 100,the,O
Sentence: 100,opioid,O
Sentence: 100,-,O
Sentence: 100,receptors,O
Sentence: 100,.,O
Sentence: 100,However,O
Sentence: 100,",",O
Sentence: 100,rapid,O
Sentence: 100,pain,B-Disease
Sentence: 100,relief,O
Sentence: 100,sometimes,O
Sentence: 100,brings,O
Sentence: 100,about,O
Sentence: 100,unfavourable,O
Sentence: 100,side,O
Sentence: 100,effects,O
Sentence: 100,that,O
Sentence: 100,largely,O
Sentence: 100,limit,O
Sentence: 100,its,O
Sentence: 100,clinical,O
Sentence: 100,utility,O
Sentence: 100,.,O
Sentence: 100,Common,O
Sentence: 100,side,O
Sentence: 100,effects,O
Sentence: 100,include,O
Sentence: 100,nausea,B-Disease
Sentence: 100,",",O
Sentence: 100,vomiting,B-Disease
Sentence: 100,and,O
Sentence: 100,hypotension,B-Disease
Sentence: 100,.,O
Sentence: 100,In,O
Sentence: 100,patients,O
Sentence: 100,with,O
Sentence: 100,impaired,B-Disease
Sentence: 100,renal,I-Disease
Sentence: 100,and,I-Disease
Sentence: 100,liver,I-Disease
Sentence: 100,function,I-Disease
Sentence: 100,",",O
Sentence: 100,and,O
Sentence: 100,those,O
Sentence: 100,who,O
Sentence: 100,need,O
Sentence: 100,long,O
Sentence: 100,-,O
Sentence: 100,term,O
Sentence: 100,pain,B-Disease
Sentence: 100,control,O
Sentence: 100,",",O
Sentence: 100,pethidine,B-Chemical
Sentence: 100,may,O
Sentence: 100,cause,O
Sentence: 100,excitatory,O
Sentence: 100,central,O
Sentence: 100,nervous,O
Sentence: 100,system,O
Sentence: 100,(,O
Sentence: 100,CNS,O
Sentence: 100,),O
Sentence: 100,effects,O
Sentence: 100,through,O
Sentence: 100,its,O
Sentence: 100,neurotoxic,B-Disease
Sentence: 100,metabolite,O
Sentence: 100,",",O
Sentence: 100,norpethidine,B-Chemical
Sentence: 100,",",O
Sentence: 100,resulting,O
Sentence: 100,in,O
Sentence: 100,irritability,B-Disease
Sentence: 100,and,O
Sentence: 100,seizure,B-Disease
Sentence: 100,attack,O
Sentence: 100,.,O
Sentence: 100,On,O
Sentence: 100,the,O
Sentence: 100,contrary,O
Sentence: 100,",",O
Sentence: 100,though,O
Sentence: 100,not,O
Sentence: 100,clinically,O
Sentence: 100,apparent,O
Sentence: 100,",",O
Sentence: 100,pethidine,B-Chemical
Sentence: 100,potentially,O
Sentence: 100,causes,O
Sentence: 100,inhibitory,O
Sentence: 100,impacts,O
Sentence: 100,on,O
Sentence: 100,the,O
Sentence: 100,CNS,O
Sentence: 100,and,O
Sentence: 100,impairs,O
Sentence: 100,normal,O
Sentence: 100,cerebellar,O
Sentence: 100,and,O
Sentence: 100,oculomotor,O
Sentence: 100,function,O
Sentence: 100,in,O
Sentence: 100,the,O
Sentence: 100,short,O
Sentence: 100,term,O
Sentence: 100,.,O
Sentence: 100,In,O
Sentence: 100,this,O
Sentence: 100,case,O
Sentence: 100,report,O
Sentence: 100,",",O
Sentence: 100,we,O
Sentence: 100,highlight,O
Sentence: 100,opioid,O
Sentence: 100,'s,O
Sentence: 100,inhibitory,O
Sentence: 100,side,O
Sentence: 100,effects,O
Sentence: 100,on,O
Sentence: 100,the,O
Sentence: 100,cerebellar,O
Sentence: 100,structure,O
Sentence: 100,that,O
Sentence: 100,causes,O
Sentence: 100,dysmetria,B-Disease
Sentence: 100,",",O
Sentence: 100,dysarthria,B-Disease
Sentence: 100,",",O
Sentence: 100,reduced,O
Sentence: 100,smooth,O
Sentence: 100,pursuit,O
Sentence: 100,gain,O
Sentence: 100,and,O
Sentence: 100,decreased,O
Sentence: 100,saccadic,O
Sentence: 100,velocity,O
Sentence: 100,.,O
Sentence: 101,Baboon,B-Disease
Sentence: 101,syndrome,I-Disease
Sentence: 101,induced,O
Sentence: 101,by,O
Sentence: 101,ketoconazole,B-Chemical
Sentence: 101,.,O
Sentence: 102,A,O
Sentence: 102,27,O
Sentence: 102,-,O
Sentence: 102,year,O
Sentence: 102,-,O
Sentence: 102,old,O
Sentence: 102,male,O
Sentence: 102,patient,O
Sentence: 102,presented,O
Sentence: 102,with,O
Sentence: 102,a,O
Sentence: 102,maculopapular,B-Disease
Sentence: 102,eruption,I-Disease
Sentence: 102,on,O
Sentence: 102,the,O
Sentence: 102,flexural,O
Sentence: 102,areas,O
Sentence: 102,and,O
Sentence: 102,buttocks,O
Sentence: 102,after,O
Sentence: 102,using,O
Sentence: 102,oral,O
Sentence: 102,ketoconazole,B-Chemical
Sentence: 102,.,O
Sentence: 102,The,O
Sentence: 102,patient,O
Sentence: 102,was,O
Sentence: 102,diagnosed,O
Sentence: 102,with,O
Sentence: 102,drug,O
Sentence: 102,-,O
Sentence: 102,induced,O
Sentence: 102,baboon,B-Disease
Sentence: 102,syndrome,I-Disease
Sentence: 102,based,O
Sentence: 102,on,O
Sentence: 102,his,O
Sentence: 102,history,O
Sentence: 102,",",O
Sentence: 102,which,O
Sentence: 102,included,O
Sentence: 102,prior,O
Sentence: 102,sensitivity,O
Sentence: 102,to,O
Sentence: 102,topical,O
Sentence: 102,ketoconazole,B-Chemical
Sentence: 102,",",O
Sentence: 102,a,O
Sentence: 102,physical,O
Sentence: 102,examination,O
Sentence: 102,",",O
Sentence: 102,and,O
Sentence: 102,histopathological,O
Sentence: 102,findings,O
Sentence: 102,.,O
Sentence: 102,Baboon,B-Disease
Sentence: 102,syndrome,I-Disease
Sentence: 102,is,O
Sentence: 102,a,O
Sentence: 102,drug,O
Sentence: 102,-,O
Sentence: 102,,O
Sentence: 102,or,O
Sentence: 102,contact,O
Sentence: 102,allergen,O
Sentence: 102,-,O
Sentence: 102,related,O
Sentence: 102,maculopapular,B-Disease
Sentence: 102,eruption,I-Disease
Sentence: 102,that,O
Sentence: 102,typically,O
Sentence: 102,involves,O
Sentence: 102,the,O
Sentence: 102,flexural,O
Sentence: 102,and,O
Sentence: 102,gluteal,O
Sentence: 102,areas,O
Sentence: 102,.,O
Sentence: 102,To,O
Sentence: 102,the,O
Sentence: 102,best,O
Sentence: 102,of,O
Sentence: 102,our,O
Sentence: 102,knowledge,O
Sentence: 102,",",O
Sentence: 102,this,O
Sentence: 102,is,O
Sentence: 102,the,O
Sentence: 102,first,O
Sentence: 102,reported,O
Sentence: 102,case,O
Sentence: 102,of,O
Sentence: 102,ketoconazole,B-Chemical
Sentence: 102,-,O
Sentence: 102,induced,O
Sentence: 102,baboon,B-Disease
Sentence: 102,syndrome,I-Disease
Sentence: 102,in,O
Sentence: 102,the,O
Sentence: 102,English,O
Sentence: 102,literature,O
Sentence: 102,.,O
Sentence: 103,A,O
Sentence: 103,Case,O
Sentence: 103,of,O
Sentence: 103,Sudden,B-Disease
Sentence: 103,Cardiac,I-Disease
Sentence: 103,Death,I-Disease
Sentence: 103,due,O
Sentence: 103,to,O
Sentence: 103,Pilsicainide,B-Chemical
Sentence: 103,-,O
Sentence: 103,Induced,O
Sentence: 103,Torsades,B-Disease
Sentence: 103,de,I-Disease
Sentence: 103,Pointes,I-Disease
Sentence: 103,.,O
Sentence: 104,An,O
Sentence: 104,84,O
Sentence: 104,-,O
Sentence: 104,year,O
Sentence: 104,-,O
Sentence: 104,old,O
Sentence: 104,male,O
Sentence: 104,received,O
Sentence: 104,oral,O
Sentence: 104,pilsicainide,B-Chemical
Sentence: 104,",",O
Sentence: 104,a,O
Sentence: 104,pure,O
Sentence: 104,sodium,B-Chemical
Sentence: 104,channel,O
Sentence: 104,blocker,O
Sentence: 104,with,O
Sentence: 104,slow,O
Sentence: 104,recovery,O
Sentence: 104,kinetics,O
Sentence: 104,",",O
Sentence: 104,to,O
Sentence: 104,convert,O
Sentence: 104,his,O
Sentence: 104,paroxysmal,O
Sentence: 104,atrial,B-Disease
Sentence: 104,fibrillation,I-Disease
Sentence: 104,to,O
Sentence: 104,a,O
Sentence: 104,sinus,O
Sentence: 104,rhythm,O
Sentence: 104,;,O
Sentence: 104,the,O
Sentence: 104,patient,O
Sentence: 104,developed,O
Sentence: 104,sudden,B-Disease
Sentence: 104,cardiac,I-Disease
Sentence: 104,death,I-Disease
Sentence: 104,two,O
Sentence: 104,days,O
Sentence: 104,later,O
Sentence: 104,.,O
Sentence: 104,The,O
Sentence: 104,Holter,O
Sentence: 104,electrocardiogram,O
Sentence: 104,",",O
Sentence: 104,which,O
Sentence: 104,was,O
Sentence: 104,worn,O
Sentence: 104,by,O
Sentence: 104,chance,O
Sentence: 104,",",O
Sentence: 104,revealed,O
Sentence: 104,torsade,B-Disease
Sentence: 104,de,I-Disease
Sentence: 104,pointes,I-Disease
Sentence: 104,with,O
Sentence: 104,gradually,O
Sentence: 104,prolonged,O
Sentence: 104,QT,O
Sentence: 104,intervals,O
Sentence: 104,.,O
Sentence: 104,This,O
Sentence: 104,drug,O
Sentence: 104,is,O
Sentence: 104,rapidly,O
Sentence: 104,absorbed,O
Sentence: 104,from,O
Sentence: 104,the,O
Sentence: 104,gastrointestinal,O
Sentence: 104,tract,O
Sentence: 104,",",O
Sentence: 104,and,O
Sentence: 104,most,O
Sentence: 104,of,O
Sentence: 104,it,O
Sentence: 104,is,O
Sentence: 104,excreted,O
Sentence: 104,from,O
Sentence: 104,the,O
Sentence: 104,kidney,O
Sentence: 104,.,O
Sentence: 104,Although,O
Sentence: 104,the,O
Sentence: 104,patient,O
Sentence: 104,'s,O
Sentence: 104,renal,O
Sentence: 104,function,O
Sentence: 104,was,O
Sentence: 104,not,O
Sentence: 104,highly,O
Sentence: 104,impaired,O
Sentence: 104,and,O
Sentence: 104,the,O
Sentence: 104,dose,O
Sentence: 104,of,O
Sentence: 104,pilsicainide,B-Chemical
Sentence: 104,was,O
Sentence: 104,low,O
Sentence: 104,",",O
Sentence: 104,the,O
Sentence: 104,plasma,O
Sentence: 104,concentration,O
Sentence: 104,of,O
Sentence: 104,pilsicainide,B-Chemical
Sentence: 104,may,O
Sentence: 104,have,O
Sentence: 104,been,O
Sentence: 104,high,O
Sentence: 104,",",O
Sentence: 104,which,O
Sentence: 104,can,O
Sentence: 104,produce,O
Sentence: 104,torsades,B-Disease
Sentence: 104,de,I-Disease
Sentence: 104,pointes,I-Disease
Sentence: 104,in,O
Sentence: 104,the,O
Sentence: 104,octogenarian,O
Sentence: 104,.,O
Sentence: 104,Although,O
Sentence: 104,the,O
Sentence: 104,oral,O
Sentence: 104,administration,O
Sentence: 104,of,O
Sentence: 104,class,O
Sentence: 104,IC,O
Sentence: 104,drugs,O
Sentence: 104,",",O
Sentence: 104,including,O
Sentence: 104,pilsicainide,B-Chemical
Sentence: 104,",",O
Sentence: 104,is,O
Sentence: 104,effective,O
Sentence: 104,to,O
Sentence: 104,terminate,O
Sentence: 104,atrial,B-Disease
Sentence: 104,fibrillation,I-Disease
Sentence: 104,",",O
Sentence: 104,careful,O
Sentence: 104,consideration,O
Sentence: 104,must,O
Sentence: 104,be,O
Sentence: 104,taken,O
Sentence: 104,before,O
Sentence: 104,giving,O
Sentence: 104,these,O
Sentence: 104,drugs,O
Sentence: 104,to,O
Sentence: 104,octogenarians,O
Sentence: 104,.,O
Sentence: 105,All,O
Sentence: 105,-,O
Sentence: 105,trans,O
Sentence: 105,retinoic,O
Sentence: 105,acid,O
Sentence: 105,-,O
Sentence: 105,induced,O
Sentence: 105,inflammatory,O
Sentence: 105,myositis,B-Disease
Sentence: 105,in,O
Sentence: 105,a,O
Sentence: 105,patient,O
Sentence: 105,with,O
Sentence: 105,acute,B-Disease
Sentence: 105,promyelocytic,I-Disease
Sentence: 105,leukemia,I-Disease
Sentence: 105,.,O
Sentence: 106,All,O
Sentence: 106,-,O
Sentence: 106,trans,O
Sentence: 106,retinoic,O
Sentence: 106,acid,O
Sentence: 106,(,O
Sentence: 106,ATRA,B-Chemical
Sentence: 106,),O
Sentence: 106,",",O
Sentence: 106,a,O
Sentence: 106,component,O
Sentence: 106,of,O
Sentence: 106,standard,O
Sentence: 106,therapy,O
Sentence: 106,for,O
Sentence: 106,acute,B-Disease
Sentence: 106,promyelocytic,I-Disease
Sentence: 106,leukemia,I-Disease
Sentence: 106,(,O
Sentence: 106,APL,B-Disease
Sentence: 106,),O
Sentence: 106,",",O
Sentence: 106,is,O
Sentence: 106,associated,O
Sentence: 106,with,O
Sentence: 106,potentially,O
Sentence: 106,serious,O
Sentence: 106,but,O
Sentence: 106,treatable,O
Sentence: 106,adverse,O
Sentence: 106,effects,O
Sentence: 106,involving,O
Sentence: 106,numerous,O
Sentence: 106,organ,O
Sentence: 106,systems,O
Sentence: 106,",",O
Sentence: 106,including,O
Sentence: 106,rare,O
Sentence: 106,skeletal,O
Sentence: 106,muscle,O
Sentence: 106,involvement,O
Sentence: 106,.,O
Sentence: 106,Only,O
Sentence: 106,a,O
Sentence: 106,handful,O
Sentence: 106,of,O
Sentence: 106,cases,O
Sentence: 106,of,O
Sentence: 106,ATRA,B-Chemical
Sentence: 106,-,O
Sentence: 106,induced,O
Sentence: 106,myositis,B-Disease
Sentence: 106,in,O
Sentence: 106,children,O
Sentence: 106,have,O
Sentence: 106,been,O
Sentence: 106,reported,O
Sentence: 106,",",O
Sentence: 106,and,O
Sentence: 106,none,O
Sentence: 106,in,O
Sentence: 106,the,O
Sentence: 106,radiology,O
Sentence: 106,literature,O
Sentence: 106,.,O
Sentence: 106,We,O
Sentence: 106,present,O
Sentence: 106,such,O
Sentence: 106,a,O
Sentence: 106,case,O
Sentence: 106,in,O
Sentence: 106,a,O
Sentence: 106,15,O
Sentence: 106,-,O
Sentence: 106,year,O
Sentence: 106,-,O
Sentence: 106,old,O
Sentence: 106,boy,O
Sentence: 106,with,O
Sentence: 106,APL,B-Disease
Sentence: 106,",",O
Sentence: 106,where,O
Sentence: 106,recognition,O
Sentence: 106,of,O
Sentence: 106,imaging,O
Sentence: 106,findings,O
Sentence: 106,played,O
Sentence: 106,a,O
Sentence: 106,crucial,O
Sentence: 106,role,O
Sentence: 106,in,O
Sentence: 106,making,O
Sentence: 106,the,O
Sentence: 106,diagnosis,O
Sentence: 106,and,O
Sentence: 106,facilitated,O
Sentence: 106,prompt,O
Sentence: 106,",",O
Sentence: 106,effective,O
Sentence: 106,treatment,O
Sentence: 106,.,O
Sentence: 107,Tolerability,O
Sentence: 107,of,O
Sentence: 107,lomustine,B-Chemical
Sentence: 107,in,O
Sentence: 107,combination,O
Sentence: 107,with,O
Sentence: 107,cyclophosphamide,B-Chemical
Sentence: 107,in,O
Sentence: 107,dogs,O
Sentence: 107,with,O
Sentence: 107,lymphoma,B-Disease
Sentence: 107,.,O
Sentence: 108,This,O
Sentence: 108,retrospective,O
Sentence: 108,study,O
Sentence: 108,describes,O
Sentence: 108,toxicity,B-Disease
Sentence: 108,associated,O
Sentence: 108,with,O
Sentence: 108,a,O
Sentence: 108,protocol,O
Sentence: 108,of,O
Sentence: 108,lomustine,B-Chemical
Sentence: 108,(,O
Sentence: 108,CCNU,B-Chemical
Sentence: 108,),O
Sentence: 108,and,O
Sentence: 108,cyclophosphamide,B-Chemical
Sentence: 108,(,O
Sentence: 108,CTX,B-Chemical
Sentence: 108,),O
Sentence: 108,in,O
Sentence: 108,dogs,O
Sentence: 108,with,O
Sentence: 108,lymphoma,B-Disease
Sentence: 108,.,O
Sentence: 108,CCNU,B-Chemical
Sentence: 108,was,O
Sentence: 108,administered,O
Sentence: 108,per,O
Sentence: 108,os,O
Sentence: 108,(,O
Sentence: 108,PO,O
Sentence: 108,),O
Sentence: 108,at,O
Sentence: 108,a,O
Sentence: 108,targeted,O
Sentence: 108,dosage,O
Sentence: 108,of,O
Sentence: 108,60,O
Sentence: 108,mg,O
Sentence: 108,/,O
Sentence: 108,m,O
Sentence: 108,(,O
Sentence: 108,2,O
Sentence: 108,),O
Sentence: 108,body,O
Sentence: 108,surface,O
Sentence: 108,area,O
Sentence: 108,on,O
Sentence: 108,day,O
Sentence: 108,0,O
Sentence: 108,",",O
Sentence: 108,CTX,B-Chemical
Sentence: 108,was,O
Sentence: 108,administered,O
Sentence: 108,PO,O
Sentence: 108,at,O
Sentence: 108,a,O
Sentence: 108,targeted,O
Sentence: 108,dosage,O
Sentence: 108,of,O
Sentence: 108,250,O
Sentence: 108,mg,O
Sentence: 108,/,O
Sentence: 108,m,O
Sentence: 108,(,O
Sentence: 108,2,O
Sentence: 108,),O
Sentence: 108,divided,O
Sentence: 108,over,O
Sentence: 108,days,O
Sentence: 108,0,O
Sentence: 108,through,O
Sentence: 108,4,O
Sentence: 108,",",O
Sentence: 108,and,O
Sentence: 108,all,O
Sentence: 108,dogs,O
Sentence: 108,received,O
Sentence: 108,prophylactic,O
Sentence: 108,antibiotics,O
Sentence: 108,.,O
Sentence: 108,Ninety,O
Sentence: 108,treatments,O
Sentence: 108,were,O
Sentence: 108,given,O
Sentence: 108,to,O
Sentence: 108,the,O
Sentence: 108,57,O
Sentence: 108,dogs,O
Sentence: 108,included,O
Sentence: 108,in,O
Sentence: 108,the,O
Sentence: 108,study,O
Sentence: 108,.,O
Sentence: 108,Neutropenia,B-Disease
Sentence: 108,was,O
Sentence: 108,the,O
Sentence: 108,principal,O
Sentence: 108,toxic,O
Sentence: 108,effect,O
Sentence: 108,",",O
Sentence: 108,and,O
Sentence: 108,the,O
Sentence: 108,overall,O
Sentence: 108,frequency,O
Sentence: 108,of,O
Sentence: 108,grade,O
Sentence: 108,4,O
Sentence: 108,neutropenia,B-Disease
Sentence: 108,after,O
Sentence: 108,the,O
Sentence: 108,first,O
Sentence: 108,treatment,O
Sentence: 108,of,O
Sentence: 108,CCNU,B-Chemical
Sentence: 108,/,O
Sentence: 108,CTX,B-Chemical
Sentence: 108,was,O
Sentence: 108,30,O
Sentence: 108,%,O
Sentence: 108,(,O
Sentence: 108,95,O
Sentence: 108,%,O
Sentence: 108,confidence,O
Sentence: 108,interval,O
Sentence: 108,",",O
Sentence: 108,19,O
Sentence: 108,-,O
Sentence: 108,43,O
Sentence: 108,%,O
Sentence: 108,),O
Sentence: 108,.,O
Sentence: 108,The,O
Sentence: 108,mean,O
Sentence: 108,body,O
Sentence: 108,weight,O
Sentence: 108,of,O
Sentence: 108,dogs,O
Sentence: 108,with,O
Sentence: 108,grade,O
Sentence: 108,4,O
Sentence: 108,neutropenia,B-Disease
Sentence: 108,(,O
Sentence: 108,19.7,O
Sentence: 108,kg,O
Sentence: 108,+,O
Sentence: 108,13.4,O
Sentence: 108,kg,O
Sentence: 108,),O
Sentence: 108,was,O
Sentence: 108,significantly,O
Sentence: 108,less,O
Sentence: 108,than,O
Sentence: 108,the,O
Sentence: 108,mean,O
Sentence: 108,body,O
Sentence: 108,weight,O
Sentence: 108,of,O
Sentence: 108,dogs,O
Sentence: 108,that,O
Sentence: 108,did,O
Sentence: 108,not,O
Sentence: 108,develop,O
Sentence: 108,grade,O
Sentence: 108,4,O
Sentence: 108,neutropenia,B-Disease
Sentence: 108,(,O
Sentence: 108,31.7,O
Sentence: 108,kg,O
Sentence: 108,+,O
Sentence: 108,12.4,O
Sentence: 108,kg,O
Sentence: 108,;,O
Sentence: 108,P,O
Sentence: 108,,O
Sentence: 108,=,O
Sentence: 108,,O
Sentence: 108,.005,O
Sentence: 108,),O
Sentence: 108,.,O
Sentence: 108,One,O
Sentence: 108,dog,O
Sentence: 108,(,O
Sentence: 108,3,O
Sentence: 108,%,O
Sentence: 108,),O
Sentence: 108,developed,O
Sentence: 108,hematologic,O
Sentence: 108,changes,O
Sentence: 108,suggestive,O
Sentence: 108,of,O
Sentence: 108,hepatotoxicity,B-Disease
Sentence: 108,.,O
Sentence: 108,No,O
Sentence: 108,dogs,O
Sentence: 108,had,O
Sentence: 108,evidence,O
Sentence: 108,of,O
Sentence: 108,either,O
Sentence: 108,renal,B-Disease
Sentence: 108,toxicity,I-Disease
Sentence: 108,or,O
Sentence: 108,hemorrhagic,B-Disease
Sentence: 108,cystitis,B-Disease
Sentence: 108,.,O
Sentence: 108,Adverse,O
Sentence: 108,gastrointestinal,O
Sentence: 108,effects,O
Sentence: 108,were,O
Sentence: 108,uncommon,O
Sentence: 108,.,O
Sentence: 108,On,O
Sentence: 108,the,O
Sentence: 108,basis,O
Sentence: 108,of,O
Sentence: 108,the,O
Sentence: 108,findings,O
Sentence: 108,reported,O
Sentence: 108,herein,O
Sentence: 108,",",O
Sentence: 108,a,O
Sentence: 108,dose,O
Sentence: 108,of,O
Sentence: 108,60,O
Sentence: 108,mg,O
Sentence: 108,/,O
Sentence: 108,m,O
Sentence: 108,(,O
Sentence: 108,2,O
Sentence: 108,),O
Sentence: 108,of,O
Sentence: 108,CCNU,B-Chemical
Sentence: 108,combined,O
Sentence: 108,with,O
Sentence: 108,250,O
Sentence: 108,mg,O
Sentence: 108,/,O
Sentence: 108,m,O
Sentence: 108,(,O
Sentence: 108,2,O
Sentence: 108,),O
Sentence: 108,of,O
Sentence: 108,CTX,B-Chemical
Sentence: 108,(,O
Sentence: 108,divided,O
Sentence: 108,over,O
Sentence: 108,5,O
Sentence: 108,days,O
Sentence: 108,),O
Sentence: 108,q,O
Sentence: 108,4,O
Sentence: 108,wk,O
Sentence: 108,is,O
Sentence: 108,tolerable,O
Sentence: 108,in,O
Sentence: 108,tumor,B-Disease
Sentence: 108,-,O
Sentence: 108,bearing,O
Sentence: 108,dogs,O
Sentence: 108,.,O
Sentence: 109,Nelarabine,B-Chemical
Sentence: 109,neurotoxicity,B-Disease
Sentence: 109,with,O
Sentence: 109,concurrent,O
Sentence: 109,intrathecal,O
Sentence: 109,chemotherapy,O
Sentence: 109,:,O
Sentence: 109,Case,O
Sentence: 109,report,O
Sentence: 109,and,O
Sentence: 109,review,O
Sentence: 109,of,O
Sentence: 109,literature,O
Sentence: 109,.,O
Sentence: 110,Severe,O
Sentence: 110,nelarabine,B-Chemical
Sentence: 110,neurotoxicity,B-Disease
Sentence: 110,in,O
Sentence: 110,a,O
Sentence: 110,patient,O
Sentence: 110,who,O
Sentence: 110,received,O
Sentence: 110,concurrent,O
Sentence: 110,intrathecal,O
Sentence: 110,(,O
Sentence: 110,IT,O
Sentence: 110,),O
Sentence: 110,chemotherapy,O
Sentence: 110,is,O
Sentence: 110,reported,O
Sentence: 110,.,O
Sentence: 110,A,O
Sentence: 110,37,O
Sentence: 110,-,O
Sentence: 110,year,O
Sentence: 110,-,O
Sentence: 110,old,O
Sentence: 110,Caucasian,O
Sentence: 110,woman,O
Sentence: 110,with,O
Sentence: 110,a,O
Sentence: 110,history,O
Sentence: 110,of,O
Sentence: 110,T,O
Sentence: 110,-,O
Sentence: 110,cell,O
Sentence: 110,lymphoblastic,O
Sentence: 110,lymphoma,O
Sentence: 110,was,O
Sentence: 110,admitted,O
Sentence: 110,for,O
Sentence: 110,relapsed,O
Sentence: 110,disease,O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,was,O
Sentence: 110,originally,O
Sentence: 110,treated,O
Sentence: 110,with,O
Sentence: 110,induction,O
Sentence: 110,chemotherapy,O
Sentence: 110,followed,O
Sentence: 110,by,O
Sentence: 110,an,O
Sentence: 110,autologous,O
Sentence: 110,transplant,O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,developed,O
Sentence: 110,relapsed,O
Sentence: 110,disease,O
Sentence: 110,10,O
Sentence: 110,months,O
Sentence: 110,later,O
Sentence: 110,with,O
Sentence: 110,leukemic,B-Disease
Sentence: 110,involvement,O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,was,O
Sentence: 110,re,O
Sentence: 110,-,O
Sentence: 110,induced,O
Sentence: 110,with,O
Sentence: 110,nelarabine,B-Chemical
Sentence: 110,1500,O
Sentence: 110,mg,O
Sentence: 110,/,O
Sentence: 110,m,O
Sentence: 110,(,O
Sentence: 110,2,O
Sentence: 110,),O
Sentence: 110,on,O
Sentence: 110,days,O
Sentence: 110,1,O
Sentence: 110,",",O
Sentence: 110,3,O
Sentence: 110,",",O
Sentence: 110,and,O
Sentence: 110,5,O
Sentence: 110,with,O
Sentence: 110,1,O
Sentence: 110,dose,O
Sentence: 110,of,O
Sentence: 110,IT,O
Sentence: 110,cytarabine,B-Chemical
Sentence: 110,100,O
Sentence: 110,mg,O
Sentence: 110,on,O
Sentence: 110,day,O
Sentence: 110,2,O
Sentence: 110,as,O
Sentence: 110,central,O
Sentence: 110,nervous,O
Sentence: 110,system,O
Sentence: 110,(,O
Sentence: 110,CNS,O
Sentence: 110,),O
Sentence: 110,prophylaxis,O
Sentence: 110,.,O
Sentence: 110,At,O
Sentence: 110,the,O
Sentence: 110,time,O
Sentence: 110,of,O
Sentence: 110,treatment,O
Sentence: 110,",",O
Sentence: 110,she,O
Sentence: 110,was,O
Sentence: 110,on,O
Sentence: 110,continuous,O
Sentence: 110,renal,O
Sentence: 110,replacement,O
Sentence: 110,therapy,O
Sentence: 110,due,O
Sentence: 110,to,O
Sentence: 110,sequelae,O
Sentence: 110,of,O
Sentence: 110,tumor,B-Disease
Sentence: 110,lysis,I-Disease
Sentence: 110,syndrome,I-Disease
Sentence: 110,(,O
Sentence: 110,TLS,B-Disease
Sentence: 110,),O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,tolerated,O
Sentence: 110,therapy,O
Sentence: 110,well,O
Sentence: 110,",",O
Sentence: 110,entered,O
Sentence: 110,a,O
Sentence: 110,complete,O
Sentence: 110,remission,O
Sentence: 110,",",O
Sentence: 110,and,O
Sentence: 110,recovered,O
Sentence: 110,her,O
Sentence: 110,renal,O
Sentence: 110,function,O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,received,O
Sentence: 110,a,O
Sentence: 110,second,O
Sentence: 110,cycle,O
Sentence: 110,of,O
Sentence: 110,nelarabine,B-Chemical
Sentence: 110,without,O
Sentence: 110,additional,O
Sentence: 110,IT,O
Sentence: 110,prophylaxis,O
Sentence: 110,one,O
Sentence: 110,month,O
Sentence: 110,later,O
Sentence: 110,.,O
Sentence: 110,A,O
Sentence: 110,week,O
Sentence: 110,after,O
Sentence: 110,this,O
Sentence: 110,second,O
Sentence: 110,cycle,O
Sentence: 110,",",O
Sentence: 110,she,O
Sentence: 110,noted,O
Sentence: 110,numbness,O
Sentence: 110,in,O
Sentence: 110,her,O
Sentence: 110,lower,O
Sentence: 110,extremities,O
Sentence: 110,.,O
Sentence: 110,Predominantly,O
Sentence: 110,sensory,O
Sentence: 110,",",O
Sentence: 110,though,O
Sentence: 110,also,O
Sentence: 110,motor,O
Sentence: 110,and,O
Sentence: 110,autonomic,O
Sentence: 110,",",O
Sentence: 110,peripheral,B-Disease
Sentence: 110,neuropathy,B-Disease
Sentence: 110,started,O
Sentence: 110,in,O
Sentence: 110,her,O
Sentence: 110,feet,O
Sentence: 110,",",O
Sentence: 110,ascended,O
Sentence: 110,proximally,O
Sentence: 110,to,O
Sentence: 110,the,O
Sentence: 110,mid,O
Sentence: 110,-,O
Sentence: 110,thoracic,O
Sentence: 110,region,O
Sentence: 110,",",O
Sentence: 110,and,O
Sentence: 110,eventually,O
Sentence: 110,included,O
Sentence: 110,her,O
Sentence: 110,distal,O
Sentence: 110,upper,O
Sentence: 110,extremities,O
Sentence: 110,.,O
Sentence: 110,A,O
Sentence: 110,magnetic,O
Sentence: 110,resonance,O
Sentence: 110,imaging,O
Sentence: 110,(,O
Sentence: 110,MRI,O
Sentence: 110,),O
Sentence: 110,of,O
Sentence: 110,her,O
Sentence: 110,spine,O
Sentence: 110,demonstrated,O
Sentence: 110,changes,O
Sentence: 110,from,O
Sentence: 110,C2,O
Sentence: 110,to,O
Sentence: 110,C6,O
Sentence: 110,consistent,O
Sentence: 110,with,O
Sentence: 110,subacute,O
Sentence: 110,combined,O
Sentence: 110,degeneration,O
Sentence: 110,.,O
Sentence: 110,Nelarabine,B-Chemical
Sentence: 110,was,O
Sentence: 110,felt,O
Sentence: 110,to,O
Sentence: 110,be,O
Sentence: 110,the,O
Sentence: 110,cause,O
Sentence: 110,of,O
Sentence: 110,her,O
Sentence: 110,symptoms,O
Sentence: 110,.,O
Sentence: 110,Her,O
Sentence: 110,neuropathy,B-Disease
Sentence: 110,stabilized,O
Sentence: 110,and,O
Sentence: 110,showed,O
Sentence: 110,slight,O
Sentence: 110,improvement,O
Sentence: 110,and,O
Sentence: 110,ultimately,O
Sentence: 110,received,O
Sentence: 110,an,O
Sentence: 110,unrelated,O
Sentence: 110,",",O
Sentence: 110,reduced,O
Sentence: 110,-,O
Sentence: 110,intensity,O
Sentence: 110,allogeneic,O
Sentence: 110,transplant,O
Sentence: 110,while,O
Sentence: 110,in,O
Sentence: 110,complete,O
Sentence: 110,remission,O
Sentence: 110,",",O
Sentence: 110,but,O
Sentence: 110,relapsed,O
Sentence: 110,disease,O
Sentence: 110,10,O
Sentence: 110,weeks,O
Sentence: 110,later,O
Sentence: 110,.,O
Sentence: 110,She,O
Sentence: 110,is,O
Sentence: 110,currently,O
Sentence: 110,being,O
Sentence: 110,treated,O
Sentence: 110,with,O
Sentence: 110,best,O
Sentence: 110,supportive,O
Sentence: 110,care,O
Sentence: 110,.,O
Sentence: 110,To,O
Sentence: 110,our,O
Sentence: 110,knowledge,O
Sentence: 110,",",O
Sentence: 110,this,O
Sentence: 110,is,O
Sentence: 110,the,O
Sentence: 110,first,O
Sentence: 110,published,O
Sentence: 110,case,O
Sentence: 110,report,O
Sentence: 110,of,O
Sentence: 110,severe,O
Sentence: 110,neurotoxicity,B-Disease
Sentence: 110,caused,O
Sentence: 110,by,O
Sentence: 110,nelarabine,B-Chemical
Sentence: 110,in,O
Sentence: 110,a,O
Sentence: 110,patient,O
Sentence: 110,who,O
Sentence: 110,received,O
Sentence: 110,concurrent,O
Sentence: 110,IT,O
Sentence: 110,chemotherapy,O
Sentence: 110,.,O
Sentence: 111,Valproate,B-Chemical
Sentence: 111,-,O
Sentence: 111,induced,O
Sentence: 111,hyperammonemic,B-Disease
Sentence: 111,encephalopathy,B-Disease
Sentence: 111,in,O
Sentence: 111,a,O
Sentence: 111,renal,O
Sentence: 111,transplanted,O
Sentence: 111,patient,O
Sentence: 111,.,O
Sentence: 112,Neurological,B-Disease
Sentence: 112,complications,I-Disease
Sentence: 112,after,O
Sentence: 112,renal,O
Sentence: 112,transplantation,O
Sentence: 112,constitute,O
Sentence: 112,an,O
Sentence: 112,important,O
Sentence: 112,cause,O
Sentence: 112,of,O
Sentence: 112,morbidity,O
Sentence: 112,and,O
Sentence: 112,mortality,O
Sentence: 112,.,O
Sentence: 112,Their,O
Sentence: 112,differential,O
Sentence: 112,diagnosis,O
Sentence: 112,is,O
Sentence: 112,difficult,O
Sentence: 112,and,O
Sentence: 112,essential,O
Sentence: 112,for,O
Sentence: 112,subsequent,O
Sentence: 112,patient,O
Sentence: 112,'s,O
Sentence: 112,management,O
Sentence: 112,.,O
Sentence: 112,Valproate,B-Chemical
Sentence: 112,-,O
Sentence: 112,induced,O
Sentence: 112,hyperammonemic,B-Disease
Sentence: 112,encephalopathy,B-Disease
Sentence: 112,is,O
Sentence: 112,an,O
Sentence: 112,uncommon,O
Sentence: 112,but,O
Sentence: 112,serious,O
Sentence: 112,effect,O
Sentence: 112,of,O
Sentence: 112,valproate,B-Chemical
Sentence: 112,treatment,O
Sentence: 112,.,O
Sentence: 112,Here,O
Sentence: 112,",",O
Sentence: 112,we,O
Sentence: 112,describe,O
Sentence: 112,the,O
Sentence: 112,case,O
Sentence: 112,of,O
Sentence: 112,a,O
Sentence: 112,15,O
Sentence: 112,-,O
Sentence: 112,year,O
Sentence: 112,-,O
Sentence: 112,old,O
Sentence: 112,girl,O
Sentence: 112,who,O
Sentence: 112,was,O
Sentence: 112,on,O
Sentence: 112,a,O
Sentence: 112,long,O
Sentence: 112,-,O
Sentence: 112,term,O
Sentence: 112,therapy,O
Sentence: 112,with,O
Sentence: 112,valproate,B-Chemical
Sentence: 112,due,O
Sentence: 112,to,O
Sentence: 112,epilepsy,B-Disease
Sentence: 112,and,O
Sentence: 112,revealed,O
Sentence: 112,impaired,B-Disease
Sentence: 112,consciousness,I-Disease
Sentence: 112,with,O
Sentence: 112,hyperammonemia,B-Disease
Sentence: 112,12,O
Sentence: 112,days,O
Sentence: 112,after,O
Sentence: 112,renal,O
Sentence: 112,transplantation,O
Sentence: 112,.,O
Sentence: 112,After,O
Sentence: 112,withdraw,O
Sentence: 112,of,O
Sentence: 112,valproate,B-Chemical
Sentence: 112,",",O
Sentence: 112,patients,O
Sentence: 112,',O
Sentence: 112,symptoms,O
Sentence: 112,resolved,O
Sentence: 112,within,O
Sentence: 112,24,O
Sentence: 112,h.,O
Sentence: 112,Clinicians,O
Sentence: 112,should,O
Sentence: 112,increase,O
Sentence: 112,their,O
Sentence: 112,awareness,O
Sentence: 112,for,O
Sentence: 112,potential,O
Sentence: 112,complication,O
Sentence: 112,of,O
Sentence: 112,valproate,B-Chemical
Sentence: 112,",",O
Sentence: 112,especially,O
Sentence: 112,in,O
Sentence: 112,transplanted,O
Sentence: 112,patients,O
Sentence: 112,.,O
Sentence: 113,Necrotising,B-Disease
Sentence: 113,fasciitis,I-Disease
Sentence: 113,after,O
Sentence: 113,bortezomib,B-Chemical
Sentence: 113,and,O
Sentence: 113,dexamethasone,B-Chemical
Sentence: 113,-,O
Sentence: 113,containing,O
Sentence: 113,regimen,O
Sentence: 113,in,O
Sentence: 113,an,O
Sentence: 113,elderly,O
Sentence: 113,patient,O
Sentence: 113,of,O
Sentence: 113,Waldenstrom,B-Disease
Sentence: 113,macroglobulinaemia,I-Disease
Sentence: 113,.,O
Sentence: 114,Bortezomib,B-Chemical
Sentence: 114,and,O
Sentence: 114,high,O
Sentence: 114,-,O
Sentence: 114,dose,O
Sentence: 114,dexamethasone,B-Chemical
Sentence: 114,-,O
Sentence: 114,containing,O
Sentence: 114,regimens,O
Sentence: 114,are,O
Sentence: 114,considered,O
Sentence: 114,to,O
Sentence: 114,be,O
Sentence: 114,generally,O
Sentence: 114,tolerable,O
Sentence: 114,with,O
Sentence: 114,few,O
Sentence: 114,severe,O
Sentence: 114,bacterial,B-Disease
Sentence: 114,infections,I-Disease
Sentence: 114,in,O
Sentence: 114,patients,O
Sentence: 114,with,O
Sentence: 114,B,O
Sentence: 114,-,O
Sentence: 114,cell,O
Sentence: 114,malignancies,B-Disease
Sentence: 114,.,O
Sentence: 114,However,O
Sentence: 114,",",O
Sentence: 114,information,O
Sentence: 114,is,O
Sentence: 114,limited,O
Sentence: 114,concerning,O
Sentence: 114,the,O
Sentence: 114,safety,O
Sentence: 114,of,O
Sentence: 114,the,O
Sentence: 114,regimen,O
Sentence: 114,in,O
Sentence: 114,elderly,O
Sentence: 114,patients,O
Sentence: 114,.,O
Sentence: 114,We,O
Sentence: 114,report,O
Sentence: 114,a,O
Sentence: 114,case,O
Sentence: 114,of,O
Sentence: 114,a,O
Sentence: 114,76,O
Sentence: 114,-,O
Sentence: 114,year,O
Sentence: 114,-,O
Sentence: 114,old,O
Sentence: 114,man,O
Sentence: 114,with,O
Sentence: 114,Waldenstrom,B-Disease
Sentence: 114,macroglobulinaemia,I-Disease
Sentence: 114,who,O
Sentence: 114,suffered,O
Sentence: 114,necrotising,B-Disease
Sentence: 114,fasciitis,I-Disease
Sentence: 114,without,O
Sentence: 114,neutropenia,B-Disease
Sentence: 114,after,O
Sentence: 114,the,O
Sentence: 114,combination,O
Sentence: 114,treatment,O
Sentence: 114,with,O
Sentence: 114,bortezomib,B-Chemical
Sentence: 114,",",O
Sentence: 114,high,O
Sentence: 114,-,O
Sentence: 114,dose,O
Sentence: 114,dexamethasone,B-Chemical
Sentence: 114,and,O
Sentence: 114,rituximab,O
Sentence: 114,.,O
Sentence: 114,Despite,O
Sentence: 114,immediate,O
Sentence: 114,intravenous,O
Sentence: 114,antimicrobial,O
Sentence: 114,therapy,O
Sentence: 114,",",O
Sentence: 114,he,O
Sentence: 114,succumbed,O
Sentence: 114,23,O
Sentence: 114,h,O
Sentence: 114,after,O
Sentence: 114,the,O
Sentence: 114,onset,O
Sentence: 114,.,O
Sentence: 114,Physicians,O
Sentence: 114,should,O
Sentence: 114,recognise,O
Sentence: 114,the,O
Sentence: 114,possibility,O
Sentence: 114,of,O
Sentence: 114,fatal,O
Sentence: 114,bacterial,B-Disease
Sentence: 114,infections,I-Disease
Sentence: 114,related,O
Sentence: 114,to,O
Sentence: 114,bortezomib,B-Chemical
Sentence: 114,plus,O
Sentence: 114,high,O
Sentence: 114,-,O
Sentence: 114,dose,O
Sentence: 114,dexamethasone,B-Chemical
Sentence: 114,in,O
Sentence: 114,elderly,O
Sentence: 114,patients,O
Sentence: 114,",",O
Sentence: 114,and,O
Sentence: 114,we,O
Sentence: 114,believe,O
Sentence: 114,this,O
Sentence: 114,case,O
Sentence: 114,warrants,O
Sentence: 114,further,O
Sentence: 114,investigation,O
Sentence: 114,.,O
Sentence: 115,An,O
Sentence: 115,integrated,O
Sentence: 115,characterization,O
Sentence: 115,of,O
Sentence: 115,serological,O
Sentence: 115,",",O
Sentence: 115,pathological,O
Sentence: 115,",",O
Sentence: 115,and,O
Sentence: 115,functional,O
Sentence: 115,events,O
Sentence: 115,in,O
Sentence: 115,doxorubicin,B-Chemical
Sentence: 115,-,O
Sentence: 115,induced,O
Sentence: 115,cardiotoxicity,B-Disease
Sentence: 115,.,O
Sentence: 116,Many,O
Sentence: 116,efficacious,O
Sentence: 116,cancer,B-Disease
Sentence: 116,treatments,O
Sentence: 116,cause,O
Sentence: 116,significant,O
Sentence: 116,cardiac,O
Sentence: 116,morbidity,O
Sentence: 116,",",O
Sentence: 116,yet,O
Sentence: 116,biomarkers,O
Sentence: 116,or,O
Sentence: 116,functional,O
Sentence: 116,indices,O
Sentence: 116,of,O
Sentence: 116,early,O
Sentence: 116,damage,O
Sentence: 116,",",O
Sentence: 116,which,O
Sentence: 116,would,O
Sentence: 116,allow,O
Sentence: 116,monitoring,O
Sentence: 116,and,O
Sentence: 116,intervention,O
Sentence: 116,",",O
Sentence: 116,are,O
Sentence: 116,lacking,O
Sentence: 116,.,O
Sentence: 116,In,O
Sentence: 116,this,O
Sentence: 116,study,O
Sentence: 116,",",O
Sentence: 116,we,O
Sentence: 116,have,O
Sentence: 116,utilized,O
Sentence: 116,a,O
Sentence: 116,rat,O
Sentence: 116,model,O
Sentence: 116,of,O
Sentence: 116,progressive,O
Sentence: 116,doxorubicin,B-Chemical
Sentence: 116,(,O
Sentence: 116,DOX,B-Chemical
Sentence: 116,),O
Sentence: 116,,O
Sentence: 116,-,O
Sentence: 116,induced,O
Sentence: 116,cardiomyopathy,B-Disease
Sentence: 116,",",O
Sentence: 116,applying,O
Sentence: 116,multiple,O
Sentence: 116,approaches,O
Sentence: 116,",",O
Sentence: 116,including,O
Sentence: 116,cardiac,O
Sentence: 116,magnetic,O
Sentence: 116,resonance,O
Sentence: 116,imaging,O
Sentence: 116,(,O
Sentence: 116,MRI,O
Sentence: 116,),O
Sentence: 116,",",O
Sentence: 116,to,O
Sentence: 116,provide,O
Sentence: 116,the,O
Sentence: 116,most,O
Sentence: 116,comprehensive,O
Sentence: 116,characterization,O
Sentence: 116,to,O
Sentence: 116,date,O
Sentence: 116,of,O
Sentence: 116,the,O
Sentence: 116,timecourse,O
Sentence: 116,of,O
Sentence: 116,serological,O
Sentence: 116,",",O
Sentence: 116,pathological,O
Sentence: 116,",",O
Sentence: 116,and,O
Sentence: 116,functional,O
Sentence: 116,events,O
Sentence: 116,underlying,O
Sentence: 116,this,O
Sentence: 116,toxicity,B-Disease
Sentence: 116,.,O
Sentence: 116,Hannover,O
Sentence: 116,Wistar,O
Sentence: 116,rats,O
Sentence: 116,were,O
Sentence: 116,dosed,O
Sentence: 116,with,O
Sentence: 116,1.25,O
Sentence: 116,mg,O
Sentence: 116,/,O
Sentence: 116,kg,O
Sentence: 116,DOX,B-Chemical
Sentence: 116,weekly,O
Sentence: 116,for,O
Sentence: 116,8,O
Sentence: 116,weeks,O
Sentence: 116,followed,O
Sentence: 116,by,O
Sentence: 116,a,O
Sentence: 116,4,O
Sentence: 116,week,O
Sentence: 116,off,O
Sentence: 116,-,O
Sentence: 116,dosing,O
Sentence: 116,``,O
Sentence: 116,recovery,O
Sentence: 116,'',O
Sentence: 116,period,O
Sentence: 116,.,O
Sentence: 116,Electron,O
Sentence: 116,microscopy,O
Sentence: 116,of,O
Sentence: 116,the,O
Sentence: 116,myocardium,O
Sentence: 116,revealed,O
Sentence: 116,subcellular,B-Disease
Sentence: 116,degeneration,I-Disease
Sentence: 116,and,O
Sentence: 116,marked,O
Sentence: 116,mitochondrial,O
Sentence: 116,changes,O
Sentence: 116,after,O
Sentence: 116,a,O
Sentence: 116,single,O
Sentence: 116,dose,O
Sentence: 116,.,O
Sentence: 116,Histopathological,O
Sentence: 116,analysis,O
Sentence: 116,revealed,O
Sentence: 116,progressive,O
Sentence: 116,cardiomyocyte,B-Disease
Sentence: 116,degeneration,I-Disease
Sentence: 116,",",O
Sentence: 116,hypertrophy,B-Disease
Sentence: 116,/,O
Sentence: 116,cytomegaly,O
Sentence: 116,",",O
Sentence: 116,and,O
Sentence: 116,extensive,O
Sentence: 116,vacuolation,O
Sentence: 116,after,O
Sentence: 116,two,O
Sentence: 116,doses,O
Sentence: 116,.,O
Sentence: 116,Extensive,O
Sentence: 116,replacement,O
Sentence: 116,fibrosis,B-Disease
Sentence: 116,(,O
Sentence: 116,quantified,O
Sentence: 116,by,O
Sentence: 116,Sirius,O
Sentence: 116,red,O
Sentence: 116,staining,O
Sentence: 116,),O
Sentence: 116,developed,O
Sentence: 116,during,O
Sentence: 116,the,O
Sentence: 116,off,O
Sentence: 116,-,O
Sentence: 116,dosing,O
Sentence: 116,period,O
Sentence: 116,.,O
Sentence: 116,Functional,O
Sentence: 116,indices,O
Sentence: 116,assessed,O
Sentence: 116,by,O
Sentence: 116,cardiac,O
Sentence: 116,MRI,O
Sentence: 116,(,O
Sentence: 116,including,O
Sentence: 116,left,O
Sentence: 116,ventricular,O
Sentence: 116,ejection,O
Sentence: 116,fraction,O
Sentence: 116,(,O
Sentence: 116,LVEF,O
Sentence: 116,),O
Sentence: 116,",",O
Sentence: 116,cardiac,O
Sentence: 116,output,O
Sentence: 116,",",O
Sentence: 116,and,O
Sentence: 116,E,O
Sentence: 116,/,O
Sentence: 116,A,O
Sentence: 116,ratio,O
Sentence: 116,),O
Sentence: 116,declined,O
Sentence: 116,progressively,O
Sentence: 116,",",O
Sentence: 116,reaching,O
Sentence: 116,statistical,O
Sentence: 116,significance,O
Sentence: 116,after,O
Sentence: 116,two,O
Sentence: 116,doses,O
Sentence: 116,and,O
Sentence: 116,culminating,O
Sentence: 116,in,O
Sentence: 116,``,O
Sentence: 116,clinical,O
Sentence: 116,'',O
Sentence: 116,LV,B-Disease
Sentence: 116,dysfunction,I-Disease
Sentence: 116,by,O
Sentence: 116,12,O
Sentence: 116,weeks,O
Sentence: 116,.,O
Sentence: 116,Significant,O
Sentence: 116,increases,O
Sentence: 116,in,O
Sentence: 116,peak,O
Sentence: 116,myocardial,O
Sentence: 116,contrast,O
Sentence: 116,enhancement,O
Sentence: 116,and,O
Sentence: 116,serological,O
Sentence: 116,cardiac,O
Sentence: 116,troponin,O
Sentence: 116,I,O
Sentence: 116,(,O
Sentence: 116,cTnI,O
Sentence: 116,),O
Sentence: 116,emerged,O
Sentence: 116,after,O
Sentence: 116,eight,O
Sentence: 116,doses,O
Sentence: 116,",",O
Sentence: 116,importantly,O
Sentence: 116,preceding,O
Sentence: 116,the,O
Sentence: 116,LVEF,O
Sentence: 116,decline,O
Sentence: 116,to,O
Sentence: 116,,O
Sentence: 116,<,O
Sentence: 116,,O
Sentence: 116,50,O
Sentence: 116,%,O
Sentence: 116,.,O
Sentence: 116,Troponin,O
Sentence: 116,I,O
Sentence: 116,levels,O
Sentence: 116,positively,O
Sentence: 116,correlated,O
Sentence: 116,with,O
Sentence: 116,delayed,O
Sentence: 116,and,O
Sentence: 116,peak,O
Sentence: 116,gadolinium,B-Chemical
Sentence: 116,contrast,O
Sentence: 116,enhancement,O
Sentence: 116,",",O
Sentence: 116,histopathological,O
Sentence: 116,grading,O
Sentence: 116,",",O
Sentence: 116,and,O
Sentence: 116,diastolic,B-Disease
Sentence: 116,dysfunction,I-Disease
Sentence: 116,.,O
Sentence: 116,In,O
Sentence: 116,summary,O
Sentence: 116,",",O
Sentence: 116,subcellular,O
Sentence: 116,cardiomyocyte,B-Disease
Sentence: 116,degeneration,I-Disease
Sentence: 116,was,O
Sentence: 116,the,O
Sentence: 116,earliest,O
Sentence: 116,marker,O
Sentence: 116,",",O
Sentence: 116,followed,O
Sentence: 116,by,O
Sentence: 116,progressive,O
Sentence: 116,functional,O
Sentence: 116,decline,O
Sentence: 116,and,O
Sentence: 116,histopathological,O
Sentence: 116,manifestations,O
Sentence: 116,.,O
Sentence: 116,Myocardial,O
Sentence: 116,contrast,O
Sentence: 116,enhancement,O
Sentence: 116,and,O
Sentence: 116,elevations,O
Sentence: 116,in,O
Sentence: 116,cTnI,O
Sentence: 116,occurred,O
Sentence: 116,later,O
Sentence: 116,.,O
Sentence: 116,However,O
Sentence: 116,",",O
Sentence: 116,all,O
Sentence: 116,indices,O
Sentence: 116,predated,O
Sentence: 116,``,O
Sentence: 116,clinical,O
Sentence: 116,'',O
Sentence: 116,LV,B-Disease
Sentence: 116,dysfunction,I-Disease
Sentence: 116,and,O
Sentence: 116,thus,O
Sentence: 116,warrant,O
Sentence: 116,further,O
Sentence: 116,evaluation,O
Sentence: 116,as,O
Sentence: 116,predictive,O
Sentence: 116,biomarkers,O
Sentence: 116,.,O
Sentence: 117,Intradermal,O
Sentence: 117,glutamate,B-Chemical
Sentence: 117,and,O
Sentence: 117,capsaicin,B-Chemical
Sentence: 117,injections,O
Sentence: 117,:,O
Sentence: 117,intra,O
Sentence: 117,-,O
Sentence: 117,,O
Sentence: 117,and,O
Sentence: 117,interindividual,O
Sentence: 117,variability,O
Sentence: 117,of,O
Sentence: 117,provoked,O
Sentence: 117,hyperalgesia,B-Disease
Sentence: 117,and,O
Sentence: 117,allodynia,B-Disease
Sentence: 117,.,O
Sentence: 118,Intradermal,O
Sentence: 118,injections,O
Sentence: 118,of,O
Sentence: 118,glutamate,B-Chemical
Sentence: 118,and,O
Sentence: 118,capsaicin,B-Chemical
Sentence: 118,are,O
Sentence: 118,attractive,O
Sentence: 118,to,O
Sentence: 118,use,O
Sentence: 118,in,O
Sentence: 118,human,O
Sentence: 118,experimental,O
Sentence: 118,pain,B-Disease
Sentence: 118,models,O
Sentence: 118,because,O
Sentence: 118,hyperalgesia,B-Disease
Sentence: 118,and,O
Sentence: 118,allodynia,B-Disease
Sentence: 118,mimic,O
Sentence: 118,isolated,O
Sentence: 118,aspects,O
Sentence: 118,of,O
Sentence: 118,clinical,O
Sentence: 118,pain,B-Disease
Sentence: 118,disorders,I-Disease
Sentence: 118,.,O
Sentence: 118,The,O
Sentence: 118,aim,O
Sentence: 118,of,O
Sentence: 118,the,O
Sentence: 118,present,O
Sentence: 118,study,O
Sentence: 118,was,O
Sentence: 118,to,O
Sentence: 118,investigate,O
Sentence: 118,the,O
Sentence: 118,reproducibility,O
Sentence: 118,of,O
Sentence: 118,these,O
Sentence: 118,models,O
Sentence: 118,.,O
Sentence: 118,Twenty,O
Sentence: 118,healthy,O
Sentence: 118,male,O
Sentence: 118,volunteers,O
Sentence: 118,(,O
Sentence: 118,mean,O
Sentence: 118,age,O
Sentence: 118,24,O
Sentence: 118,years,O
Sentence: 118,;,O
Sentence: 118,range,O
Sentence: 118,18,O
Sentence: 118,-,O
Sentence: 118,38,O
Sentence: 118,years,O
Sentence: 118,),O
Sentence: 118,received,O
Sentence: 118,intradermal,O
Sentence: 118,injections,O
Sentence: 118,of,O
Sentence: 118,glutamate,B-Chemical
Sentence: 118,and,O
Sentence: 118,capsaicin,B-Chemical
Sentence: 118,in,O
Sentence: 118,the,O
Sentence: 118,volar,O
Sentence: 118,forearm,O
Sentence: 118,.,O
Sentence: 118,Magnitudes,O
Sentence: 118,of,O
Sentence: 118,secondary,O
Sentence: 118,pinprick,O
Sentence: 118,hyperalgesia,B-Disease
Sentence: 118,and,O
Sentence: 118,brush,O
Sentence: 118,-,O
Sentence: 118,evoked,O
Sentence: 118,allodynia,B-Disease
Sentence: 118,were,O
Sentence: 118,investigated,O
Sentence: 118,using,O
Sentence: 118,von,O
Sentence: 118,Frey,O
Sentence: 118,filaments,O
Sentence: 118,(,O
Sentence: 118,gauges,O
Sentence: 118,10,O
Sentence: 118,",",O
Sentence: 118,15,O
Sentence: 118,",",O
Sentence: 118,60,O
Sentence: 118,and,O
Sentence: 118,100,O
Sentence: 118,g,O
Sentence: 118,),O
Sentence: 118,and,O
Sentence: 118,brush,O
Sentence: 118,strokes,O
Sentence: 118,.,O
Sentence: 118,Areas,O
Sentence: 118,of,O
Sentence: 118,secondary,B-Disease
Sentence: 118,hyperalgesia,I-Disease
Sentence: 118,and,O
Sentence: 118,allodynia,B-Disease
Sentence: 118,were,O
Sentence: 118,quantified,O
Sentence: 118,immediately,O
Sentence: 118,after,O
Sentence: 118,injection,O
Sentence: 118,and,O
Sentence: 118,after,O
Sentence: 118,15,O
Sentence: 118,",",O
Sentence: 118,30,O
Sentence: 118,and,O
Sentence: 118,60,O
Sentence: 118,min,O
Sentence: 118,.,O
Sentence: 118,Two,O
Sentence: 118,identical,O
Sentence: 118,experiments,O
Sentence: 118,separated,O
Sentence: 118,by,O
Sentence: 118,at,O
Sentence: 118,least,O
Sentence: 118,7,O
Sentence: 118,days,O
Sentence: 118,were,O
Sentence: 118,performed,O
Sentence: 118,.,O
Sentence: 118,Reproducibility,O
Sentence: 118,across,O
Sentence: 118,and,O
Sentence: 118,within,O
Sentence: 118,volunteers,O
Sentence: 118,(,O
Sentence: 118,inter,O
Sentence: 118,-,O
Sentence: 118,,O
Sentence: 118,and,O
Sentence: 118,intra,O
Sentence: 118,-,O
Sentence: 118,individual,O
Sentence: 118,variation,O
Sentence: 118,",",O
Sentence: 118,respectively,O
Sentence: 118,),O
Sentence: 118,was,O
Sentence: 118,assessed,O
Sentence: 118,using,O
Sentence: 118,intraclass,O
Sentence: 118,correlation,O
Sentence: 118,coefficient,O
Sentence: 118,(,O
Sentence: 118,ICC,O
Sentence: 118,),O
Sentence: 118,and,O
Sentence: 118,coefficient,O
Sentence: 118,of,O
Sentence: 118,variation,O
Sentence: 118,(,O
Sentence: 118,CV,O
Sentence: 118,),O
Sentence: 118,.,O
Sentence: 118,Secondary,O
Sentence: 118,pinprick,O
Sentence: 118,hyperalgesia,B-Disease
Sentence: 118,was,O
Sentence: 118,observed,O
Sentence: 118,as,O
Sentence: 118,a,O
Sentence: 118,marked,O
Sentence: 118,increase,O
Sentence: 118,in,O
Sentence: 118,the,O
Sentence: 118,visual,O
Sentence: 118,analogue,O
Sentence: 118,scale,O
Sentence: 118,(,O
Sentence: 118,VAS,O
Sentence: 118,),O
Sentence: 118,response,O
Sentence: 118,to,O
Sentence: 118,von,O
Sentence: 118,Frey,O
Sentence: 118,gauges,O
Sentence: 118,60,O
Sentence: 118,and,O
Sentence: 118,100,O
Sentence: 118,g,O
Sentence: 118,(,O
Sentence: 118,P,O
Sentence: 118,,O
Sentence: 118,<,O
Sentence: 118,,O
Sentence: 118,0.001,O
Sentence: 118,),O
Sentence: 118,after,O
Sentence: 118,glutamate,B-Chemical
Sentence: 118,injection,O
Sentence: 118,.,O
Sentence: 118,For,O
Sentence: 118,capsaicin,B-Chemical
Sentence: 118,",",O
Sentence: 118,secondary,O
Sentence: 118,pinprick,O
Sentence: 118,hyperalgesia,B-Disease
Sentence: 118,was,O
Sentence: 118,detected,O
Sentence: 118,with,O
Sentence: 118,all,O
Sentence: 118,von,O
Sentence: 118,Frey,O
Sentence: 118,gauges,O
Sentence: 118,(,O
Sentence: 118,P,O
Sentence: 118,,O
Sentence: 118,<,O
Sentence: 118,,O
Sentence: 118,0.001,O
Sentence: 118,),O
Sentence: 118,.,O
Sentence: 118,Glutamate,B-Chemical
Sentence: 118,evoked,O
Sentence: 118,reproducible,O
Sentence: 118,VAS,O
Sentence: 118,response,O
Sentence: 118,to,O
Sentence: 118,all,O
Sentence: 118,von,O
Sentence: 118,Frey,O
Sentence: 118,gauges,O
Sentence: 118,(,O
Sentence: 118,ICC,O
Sentence: 118,,O
Sentence: 118,>,O
Sentence: 118,,O
Sentence: 118,0.60,O
Sentence: 118,),O
Sentence: 118,and,O
Sentence: 118,brush,O
Sentence: 118,strokes,O
Sentence: 118,(,O
Sentence: 118,ICC,O
Sentence: 118,,O
Sentence: 118,>,O
Sentence: 118,,O
Sentence: 118,0.83,O
Sentence: 118,),O
Sentence: 118,.,O
Sentence: 118,Capsaicin,B-Chemical
Sentence: 118,injection,O
Sentence: 118,was,O
Sentence: 118,reproducible,O
Sentence: 118,for,O
Sentence: 118,secondary,B-Disease
Sentence: 118,hyperalgesia,I-Disease
Sentence: 118,(,O
Sentence: 118,ICC,O
Sentence: 118,,O
Sentence: 118,>,O
Sentence: 118,,O
Sentence: 118,0.70,O
Sentence: 118,),O
Sentence: 118,and,O
Sentence: 118,allodynia,B-Disease
Sentence: 118,(,O
Sentence: 118,ICC,O
Sentence: 118,,O
Sentence: 118,>,O
Sentence: 118,,O
Sentence: 118,0.71,O
Sentence: 118,),O
Sentence: 118,.,O
Sentence: 118,Intra,O
Sentence: 118,-,O
Sentence: 118,individual,O
Sentence: 118,variability,O
Sentence: 118,was,O
Sentence: 118,generally,O
Sentence: 118,lower,O
Sentence: 118,for,O
Sentence: 118,the,O
Sentence: 118,VAS,O
Sentence: 118,response,O
Sentence: 118,to,O
Sentence: 118,von,O
Sentence: 118,Frey,O
Sentence: 118,and,O
Sentence: 118,brush,O
Sentence: 118,compared,O
Sentence: 118,with,O
Sentence: 118,areas,O
Sentence: 118,of,O
Sentence: 118,secondary,B-Disease
Sentence: 118,hyperalgesia,I-Disease
Sentence: 118,and,O
Sentence: 118,allodynia,B-Disease
Sentence: 118,.,O
Sentence: 118,In,O
Sentence: 118,conclusion,O
Sentence: 118,",",O
Sentence: 118,glutamate,B-Chemical
Sentence: 118,and,O
Sentence: 118,capsaicin,B-Chemical
Sentence: 118,yield,O
Sentence: 118,reproducible,O
Sentence: 118,hyperalgesic,B-Disease
Sentence: 118,and,O
Sentence: 118,allodynic,B-Disease
Sentence: 118,responses,O
Sentence: 118,",",O
Sentence: 118,and,O
Sentence: 118,the,O
Sentence: 118,present,O
Sentence: 118,model,O
Sentence: 118,is,O
Sentence: 118,well,O
Sentence: 118,suited,O
Sentence: 118,for,O
Sentence: 118,basic,O
Sentence: 118,research,O
Sentence: 118,",",O
Sentence: 118,as,O
Sentence: 118,well,O
Sentence: 118,as,O
Sentence: 118,for,O
Sentence: 118,assessing,O
Sentence: 118,the,O
Sentence: 118,modulation,O
Sentence: 118,of,O
Sentence: 118,central,O
Sentence: 118,phenomena,O
Sentence: 118,.,O
Sentence: 119,Ocular,O
Sentence: 119,-,O
Sentence: 119,specific,O
Sentence: 119,ER,O
Sentence: 119,stress,O
Sentence: 119,reduction,O
Sentence: 119,rescues,O
Sentence: 119,glaucoma,B-Disease
Sentence: 119,in,O
Sentence: 119,murine,O
Sentence: 119,glucocorticoid,O
Sentence: 119,-,O
Sentence: 119,induced,O
Sentence: 119,glaucoma,B-Disease
Sentence: 119,.,O
Sentence: 120,Administration,O
Sentence: 120,of,O
Sentence: 120,glucocorticoids,O
Sentence: 120,induces,O
Sentence: 120,ocular,B-Disease
Sentence: 120,hypertension,I-Disease
Sentence: 120,in,O
Sentence: 120,some,O
Sentence: 120,patients,O
Sentence: 120,.,O
Sentence: 120,If,O
Sentence: 120,untreated,O
Sentence: 120,",",O
Sentence: 120,these,O
Sentence: 120,patients,O
Sentence: 120,can,O
Sentence: 120,develop,O
Sentence: 120,a,O
Sentence: 120,secondary,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,that,O
Sentence: 120,resembles,O
Sentence: 120,primary,O
Sentence: 120,open,O
Sentence: 120,-,O
Sentence: 120,angle,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,(,O
Sentence: 120,POAG,B-Disease
Sentence: 120,),O
Sentence: 120,.,O
Sentence: 120,The,O
Sentence: 120,underlying,O
Sentence: 120,pathology,O
Sentence: 120,of,O
Sentence: 120,glucocorticoid,O
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,is,O
Sentence: 120,not,O
Sentence: 120,fully,O
Sentence: 120,understood,O
Sentence: 120,",",O
Sentence: 120,due,O
Sentence: 120,in,O
Sentence: 120,part,O
Sentence: 120,to,O
Sentence: 120,lack,O
Sentence: 120,of,O
Sentence: 120,an,O
Sentence: 120,appropriate,O
Sentence: 120,animal,O
Sentence: 120,model,O
Sentence: 120,.,O
Sentence: 120,Here,O
Sentence: 120,",",O
Sentence: 120,we,O
Sentence: 120,developed,O
Sentence: 120,a,O
Sentence: 120,murine,O
Sentence: 120,model,O
Sentence: 120,of,O
Sentence: 120,glucocorticoid,O
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,that,O
Sentence: 120,exhibits,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,features,O
Sentence: 120,that,O
Sentence: 120,are,O
Sentence: 120,observed,O
Sentence: 120,in,O
Sentence: 120,patients,O
Sentence: 120,.,O
Sentence: 120,Treatment,O
Sentence: 120,of,O
Sentence: 120,WT,O
Sentence: 120,mice,O
Sentence: 120,with,O
Sentence: 120,topical,O
Sentence: 120,ocular,O
Sentence: 120,0.1,O
Sentence: 120,%,O
Sentence: 120,dexamethasone,B-Chemical
Sentence: 120,led,O
Sentence: 120,to,O
Sentence: 120,elevation,O
Sentence: 120,of,O
Sentence: 120,intraocular,O
Sentence: 120,pressure,O
Sentence: 120,(,O
Sentence: 120,IOP,O
Sentence: 120,),O
Sentence: 120,",",O
Sentence: 120,functional,O
Sentence: 120,and,O
Sentence: 120,structural,O
Sentence: 120,loss,O
Sentence: 120,of,O
Sentence: 120,retinal,B-Disease
Sentence: 120,ganglion,I-Disease
Sentence: 120,cells,O
Sentence: 120,",",O
Sentence: 120,and,O
Sentence: 120,axonal,B-Disease
Sentence: 120,degeneration,I-Disease
Sentence: 120,",",O
Sentence: 120,resembling,O
Sentence: 120,glucocorticoid,O
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,in,O
Sentence: 120,human,O
Sentence: 120,patients,O
Sentence: 120,.,O
Sentence: 120,Furthermore,O
Sentence: 120,",",O
Sentence: 120,dexamethasone,B-Chemical
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,ocular,B-Disease
Sentence: 120,hypertension,I-Disease
Sentence: 120,was,O
Sentence: 120,associated,O
Sentence: 120,with,O
Sentence: 120,chronic,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,of,O
Sentence: 120,the,O
Sentence: 120,trabecular,O
Sentence: 120,meshwork,O
Sentence: 120,(,O
Sentence: 120,TM,O
Sentence: 120,),O
Sentence: 120,.,O
Sentence: 120,Similar,O
Sentence: 120,to,O
Sentence: 120,patients,O
Sentence: 120,",",O
Sentence: 120,withdrawal,O
Sentence: 120,of,O
Sentence: 120,dexamethasone,B-Chemical
Sentence: 120,treatment,O
Sentence: 120,reduced,O
Sentence: 120,elevated,O
Sentence: 120,IOP,O
Sentence: 120,and,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,in,O
Sentence: 120,this,O
Sentence: 120,animal,O
Sentence: 120,model,O
Sentence: 120,.,O
Sentence: 120,Dexamethasone,B-Chemical
Sentence: 120,induced,O
Sentence: 120,the,O
Sentence: 120,transcriptional,O
Sentence: 120,factor,O
Sentence: 120,CHOP,O
Sentence: 120,",",O
Sentence: 120,a,O
Sentence: 120,marker,O
Sentence: 120,for,O
Sentence: 120,chronic,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,",",O
Sentence: 120,in,O
Sentence: 120,the,O
Sentence: 120,anterior,O
Sentence: 120,segment,O
Sentence: 120,tissues,O
Sentence: 120,",",O
Sentence: 120,and,O
Sentence: 120,Chop,O
Sentence: 120,deletion,O
Sentence: 120,reduced,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,in,O
Sentence: 120,these,O
Sentence: 120,tissues,O
Sentence: 120,and,O
Sentence: 120,prevented,O
Sentence: 120,dexamethasone,B-Chemical
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,ocular,B-Disease
Sentence: 120,hypertension,I-Disease
Sentence: 120,.,O
Sentence: 120,Furthermore,O
Sentence: 120,",",O
Sentence: 120,reduction,O
Sentence: 120,of,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,in,O
Sentence: 120,the,O
Sentence: 120,TM,O
Sentence: 120,with,O
Sentence: 120,sodium,O
Sentence: 120,4,O
Sentence: 120,-,O
Sentence: 120,phenylbutyrate,O
Sentence: 120,prevented,O
Sentence: 120,dexamethasone,B-Chemical
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,ocular,B-Disease
Sentence: 120,hypertension,I-Disease
Sentence: 120,in,O
Sentence: 120,WT,O
Sentence: 120,mice,O
Sentence: 120,.,O
Sentence: 120,Our,O
Sentence: 120,data,O
Sentence: 120,indicate,O
Sentence: 120,that,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,contributes,O
Sentence: 120,to,O
Sentence: 120,glucocorticoid,O
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,ocular,B-Disease
Sentence: 120,hypertension,I-Disease
Sentence: 120,and,O
Sentence: 120,suggest,O
Sentence: 120,that,O
Sentence: 120,reducing,O
Sentence: 120,ER,O
Sentence: 120,stress,O
Sentence: 120,has,O
Sentence: 120,potential,O
Sentence: 120,as,O
Sentence: 120,a,O
Sentence: 120,therapeutic,O
Sentence: 120,strategy,O
Sentence: 120,for,O
Sentence: 120,treating,O
Sentence: 120,glucocorticoid,O
Sentence: 120,-,O
Sentence: 120,induced,O
Sentence: 120,glaucoma,B-Disease
Sentence: 120,.,O
Sentence: 121,Effects,O
Sentence: 121,of,O
Sentence: 121,ginsenosides,B-Chemical
Sentence: 121,on,O
Sentence: 121,opioid,O
Sentence: 121,-,O
Sentence: 121,induced,O
Sentence: 121,hyperalgesia,B-Disease
Sentence: 121,in,O
Sentence: 121,mice,O
Sentence: 121,.,O
Sentence: 122,Opioid,O
Sentence: 122,-,O
Sentence: 122,induced,O
Sentence: 122,hyperalgesia,B-Disease
Sentence: 122,(,O
Sentence: 122,OIH,B-Disease
Sentence: 122,),O
Sentence: 122,is,O
Sentence: 122,characterized,O
Sentence: 122,by,O
Sentence: 122,nociceptive,O
Sentence: 122,sensitization,O
Sentence: 122,caused,O
Sentence: 122,by,O
Sentence: 122,the,O
Sentence: 122,cessation,O
Sentence: 122,of,O
Sentence: 122,chronic,O
Sentence: 122,opioid,O
Sentence: 122,use,O
Sentence: 122,.,O
Sentence: 122,OIH,B-Disease
Sentence: 122,can,O
Sentence: 122,limit,O
Sentence: 122,the,O
Sentence: 122,clinical,O
Sentence: 122,use,O
Sentence: 122,of,O
Sentence: 122,opioid,O
Sentence: 122,analgesics,O
Sentence: 122,and,O
Sentence: 122,complicate,O
Sentence: 122,withdrawal,O
Sentence: 122,from,O
Sentence: 122,opioid,B-Disease
Sentence: 122,addiction,I-Disease
Sentence: 122,.,O
Sentence: 122,In,O
Sentence: 122,this,O
Sentence: 122,study,O
Sentence: 122,",",O
Sentence: 122,we,O
Sentence: 122,investigated,O
Sentence: 122,the,O
Sentence: 122,effects,O
Sentence: 122,of,O
Sentence: 122,Re,B-Chemical
Sentence: 122,",",I-Chemical
Sentence: 122,Rg1,B-Chemical
Sentence: 122,",",I-Chemical
Sentence: 122,and,I-Chemical
Sentence: 122,Rb1,B-Chemical
Sentence: 122,ginsenosides,I-Chemical
Sentence: 122,",",O
Sentence: 122,the,O
Sentence: 122,bioactive,O
Sentence: 122,components,O
Sentence: 122,of,O
Sentence: 122,ginseng,O
Sentence: 122,",",O
Sentence: 122,on,O
Sentence: 122,OIH,B-Disease
Sentence: 122,.,O
Sentence: 122,OIH,B-Disease
Sentence: 122,was,O
Sentence: 122,achieved,O
Sentence: 122,in,O
Sentence: 122,mice,O
Sentence: 122,after,O
Sentence: 122,subcutaneous,O
Sentence: 122,administration,O
Sentence: 122,of,O
Sentence: 122,morphine,B-Chemical
Sentence: 122,for,O
Sentence: 122,7,O
Sentence: 122,consecutive,O
Sentence: 122,days,O
Sentence: 122,three,O
Sentence: 122,times,O
Sentence: 122,per,O
Sentence: 122,day,O
Sentence: 122,.,O
Sentence: 122,During,O
Sentence: 122,withdrawal,O
Sentence: 122,(,O
Sentence: 122,days,O
Sentence: 122,8,O
Sentence: 122,and,O
Sentence: 122,9,O
Sentence: 122,),O
Sentence: 122,",",O
Sentence: 122,these,O
Sentence: 122,mice,O
Sentence: 122,were,O
Sentence: 122,administered,O
Sentence: 122,Re,B-Chemical
Sentence: 122,",",O
Sentence: 122,Rg1,B-Chemical
Sentence: 122,",",O
Sentence: 122,or,O
Sentence: 122,Rb1,B-Chemical
Sentence: 122,intragastrically,O
Sentence: 122,two,O
Sentence: 122,times,O
Sentence: 122,per,O
Sentence: 122,day,O
Sentence: 122,.,O
Sentence: 122,On,O
Sentence: 122,the,O
Sentence: 122,test,O
Sentence: 122,day,O
Sentence: 122,(,O
Sentence: 122,day,O
Sentence: 122,10,O
Sentence: 122,),O
Sentence: 122,",",O
Sentence: 122,mice,O
Sentence: 122,were,O
Sentence: 122,subjected,O
Sentence: 122,to,O
Sentence: 122,the,O
Sentence: 122,thermal,O
Sentence: 122,sensitivity,O
Sentence: 122,test,O
Sentence: 122,and,O
Sentence: 122,the,O
Sentence: 122,acetic,B-Chemical
Sentence: 122,acid,I-Chemical
Sentence: 122,-,O
Sentence: 122,induced,O
Sentence: 122,writhing,O
Sentence: 122,test,O
Sentence: 122,.,O
Sentence: 122,Re,B-Chemical
Sentence: 122,(,O
Sentence: 122,300,O
Sentence: 122,mg,O
Sentence: 122,/,O
Sentence: 122,kg,O
Sentence: 122,),O
Sentence: 122,inhibited,O
Sentence: 122,OIH,B-Disease
Sentence: 122,in,O
Sentence: 122,both,O
Sentence: 122,the,O
Sentence: 122,thermal,O
Sentence: 122,sensitivity,O
Sentence: 122,test,O
Sentence: 122,and,O
Sentence: 122,the,O
Sentence: 122,acetic,B-Chemical
Sentence: 122,acid,I-Chemical
Sentence: 122,-,O
Sentence: 122,induced,O
Sentence: 122,writhing,O
Sentence: 122,test,O
Sentence: 122,.,O
Sentence: 122,However,O
Sentence: 122,",",O
Sentence: 122,the,O
Sentence: 122,Rg1,B-Chemical
Sentence: 122,and,I-Chemical
Sentence: 122,Rb1,B-Chemical
Sentence: 122,ginsenosides,I-Chemical
Sentence: 122,failed,O
Sentence: 122,to,O
Sentence: 122,prevent,O
Sentence: 122,OIH,B-Disease
Sentence: 122,in,O
Sentence: 122,either,O
Sentence: 122,test,O
Sentence: 122,.,O
Sentence: 122,Furthermore,O
Sentence: 122,",",O
Sentence: 122,Rg1,B-Chemical
Sentence: 122,showed,O
Sentence: 122,a,O
Sentence: 122,tendency,O
Sentence: 122,to,O
Sentence: 122,aggravate,O
Sentence: 122,OIH,B-Disease
Sentence: 122,in,O
Sentence: 122,the,O
Sentence: 122,acetic,B-Chemical
Sentence: 122,acid,I-Chemical
Sentence: 122,-,O
Sentence: 122,induced,O
Sentence: 122,writhing,O
Sentence: 122,test,O
Sentence: 122,.,O
Sentence: 122,Our,O
Sentence: 122,data,O
Sentence: 122,suggested,O
Sentence: 122,that,O
Sentence: 122,the,O
Sentence: 122,ginsenoside,B-Chemical
Sentence: 122,Re,I-Chemical
Sentence: 122,",",O
Sentence: 122,but,O
Sentence: 122,not,O
Sentence: 122,Rg1,B-Chemical
Sentence: 122,or,O
Sentence: 122,Rb1,B-Chemical
Sentence: 122,",",O
Sentence: 122,may,O
Sentence: 122,contribute,O
Sentence: 122,toward,O
Sentence: 122,reversal,O
Sentence: 122,of,O
Sentence: 122,OIH,B-Disease
Sentence: 122,.,O
Sentence: 123,A,O
Sentence: 123,comparison,O
Sentence: 123,of,O
Sentence: 123,severe,O
Sentence: 123,hemodynamic,O
Sentence: 123,disturbances,O
Sentence: 123,between,O
Sentence: 123,dexmedetomidine,B-Chemical
Sentence: 123,and,O
Sentence: 123,propofol,B-Chemical
Sentence: 123,for,O
Sentence: 123,sedation,O
Sentence: 123,in,O
Sentence: 123,neurocritical,O
Sentence: 123,care,O
Sentence: 123,patients,O
Sentence: 123,.,O
Sentence: 124,OBJECTIVE,O
Sentence: 124,:,O
Sentence: 124,Dexmedetomidine,B-Chemical
Sentence: 124,and,O
Sentence: 124,propofol,B-Chemical
Sentence: 124,are,O
Sentence: 124,commonly,O
Sentence: 124,used,O
Sentence: 124,sedatives,O
Sentence: 124,in,O
Sentence: 124,neurocritical,O
Sentence: 124,care,O
Sentence: 124,as,O
Sentence: 124,they,O
Sentence: 124,allow,O
Sentence: 124,for,O
Sentence: 124,frequent,O
Sentence: 124,neurologic,O
Sentence: 124,examinations,O
Sentence: 124,.,O
Sentence: 124,However,O
Sentence: 124,",",O
Sentence: 124,both,O
Sentence: 124,agents,O
Sentence: 124,are,O
Sentence: 124,associated,O
Sentence: 124,with,O
Sentence: 124,significant,O
Sentence: 124,hemodynamic,O
Sentence: 124,side,O
Sentence: 124,effects,O
Sentence: 124,.,O
Sentence: 124,The,O
Sentence: 124,primary,O
Sentence: 124,objective,O
Sentence: 124,of,O
Sentence: 124,this,O
Sentence: 124,study,O
Sentence: 124,is,O
Sentence: 124,to,O
Sentence: 124,compare,O
Sentence: 124,the,O
Sentence: 124,prevalence,O
Sentence: 124,of,O
Sentence: 124,severe,O
Sentence: 124,hemodynamic,O
Sentence: 124,effects,O
Sentence: 124,in,O
Sentence: 124,neurocritical,O
Sentence: 124,care,O
Sentence: 124,patients,O
Sentence: 124,receiving,O
Sentence: 124,dexmedetomidine,B-Chemical
Sentence: 124,and,O
Sentence: 124,propofol,B-Chemical
Sentence: 124,.,O
Sentence: 124,DESIGN,O
Sentence: 124,:,O
Sentence: 124,Multicenter,O
Sentence: 124,",",O
Sentence: 124,retrospective,O
Sentence: 124,",",O
Sentence: 124,propensity,O
Sentence: 124,-,O
Sentence: 124,matched,O
Sentence: 124,cohort,O
Sentence: 124,study,O
Sentence: 124,.,O
Sentence: 124,SETTING,O
Sentence: 124,:,O
Sentence: 124,Neurocritical,O
Sentence: 124,care,O
Sentence: 124,units,O
Sentence: 124,at,O
Sentence: 124,two,O
Sentence: 124,academic,O
Sentence: 124,medical,O
Sentence: 124,centers,O
Sentence: 124,with,O
Sentence: 124,dedicated,O
Sentence: 124,neurocritical,O
Sentence: 124,care,O
Sentence: 124,teams,O
Sentence: 124,and,O
Sentence: 124,board,O
Sentence: 124,-,O
Sentence: 124,certified,O
Sentence: 124,neurointensivists,O
Sentence: 124,.,O
Sentence: 124,PATIENTS,O
Sentence: 124,:,O
Sentence: 124,Neurocritical,O
Sentence: 124,care,O
Sentence: 124,patients,O
Sentence: 124,admitted,O
Sentence: 124,between,O
Sentence: 124,July,O
Sentence: 124,2009,O
Sentence: 124,and,O
Sentence: 124,September,O
Sentence: 124,2012,O
Sentence: 124,were,O
Sentence: 124,evaluated,O
Sentence: 124,and,O
Sentence: 124,then,O
Sentence: 124,matched,O
Sentence: 124,1:1,O
Sentence: 124,based,O
Sentence: 124,on,O
Sentence: 124,propensity,O
Sentence: 124,scoring,O
Sentence: 124,of,O
Sentence: 124,baseline,O
Sentence: 124,characteristics,O
Sentence: 124,.,O
Sentence: 124,INTERVENTIONS,O
Sentence: 124,:,O
Sentence: 124,Continuous,O
Sentence: 124,sedation,O
Sentence: 124,with,O
Sentence: 124,dexmedetomidine,B-Chemical
Sentence: 124,or,O
Sentence: 124,propofol,B-Chemical
Sentence: 124,.,O
Sentence: 124,MEASUREMENTS,O
Sentence: 124,AND,O
Sentence: 124,MAIN,O
Sentence: 124,RESULTS,O
Sentence: 124,:,O
Sentence: 124,A,O
Sentence: 124,total,O
Sentence: 124,of,O
Sentence: 124,342,O
Sentence: 124,patients,O
Sentence: 124,(,O
Sentence: 124,105,O
Sentence: 124,dexmedetomidine,B-Chemical
Sentence: 124,and,O
Sentence: 124,237,O
Sentence: 124,propofol,B-Chemical
Sentence: 124,),O
Sentence: 124,were,O
Sentence: 124,included,O
Sentence: 124,in,O
Sentence: 124,the,O
Sentence: 124,analysis,O
Sentence: 124,",",O
Sentence: 124,with,O
Sentence: 124,190,O
Sentence: 124,matched,O
Sentence: 124,(,O
Sentence: 124,95,O
Sentence: 124,in,O
Sentence: 124,each,O
Sentence: 124,group,O
Sentence: 124,),O
Sentence: 124,by,O
Sentence: 124,propensity,O
Sentence: 124,score,O
Sentence: 124,.,O
Sentence: 124,The,O
Sentence: 124,primary,O
Sentence: 124,outcome,O
Sentence: 124,of,O
Sentence: 124,this,O
Sentence: 124,study,O
Sentence: 124,was,O
Sentence: 124,a,O
Sentence: 124,composite,O
Sentence: 124,of,O
Sentence: 124,severe,O
Sentence: 124,hypotension,B-Disease
Sentence: 124,(,O
Sentence: 124,mean,O
Sentence: 124,arterial,O
Sentence: 124,pressure,O
Sentence: 124,,O
Sentence: 124,<,O
Sentence: 124,,O
Sentence: 124,60,O
Sentence: 124,mm,O
Sentence: 124,Hg,O
Sentence: 124,),O
Sentence: 124,and,O
Sentence: 124,bradycardia,B-Disease
Sentence: 124,(,O
Sentence: 124,heart,O
Sentence: 124,rate,O
Sentence: 124,,O
Sentence: 124,<,O
Sentence: 124,,O
Sentence: 124,50,O
Sentence: 124,beats,O
Sentence: 124,/,O
Sentence: 124,min,O
Sentence: 124,),O
Sentence: 124,during,O
Sentence: 124,sedative,O
Sentence: 124,infusion,O
Sentence: 124,.,O
Sentence: 124,No,O
Sentence: 124,difference,O
Sentence: 124,in,O
Sentence: 124,the,O
Sentence: 124,primary,O
Sentence: 124,composite,O
Sentence: 124,outcome,O
Sentence: 124,in,O
Sentence: 124,both,O
Sentence: 124,the,O
Sentence: 124,unmatched,O
Sentence: 124,(,O
Sentence: 124,30,O
Sentence: 124,%,O
Sentence: 124,vs,O
Sentence: 124,30,O
Sentence: 124,%,O
Sentence: 124,",",O
Sentence: 124,p,O
Sentence: 124,,O
Sentence: 124,=,O
Sentence: 124,,O
Sentence: 124,0.94,O
Sentence: 124,),O
Sentence: 124,or,O
Sentence: 124,matched,O
Sentence: 124,cohorts,O
Sentence: 124,(,O
Sentence: 124,28,O
Sentence: 124,%,O
Sentence: 124,vs,O
Sentence: 124,34,O
Sentence: 124,%,O
Sentence: 124,",",O
Sentence: 124,p,O
Sentence: 124,,O
Sentence: 124,=,O
Sentence: 124,,O
Sentence: 124,0.35,O
Sentence: 124,),O
Sentence: 124,could,O
Sentence: 124,be,O
Sentence: 124,found,O
Sentence: 124,.,O
Sentence: 124,When,O
Sentence: 124,analyzed,O
Sentence: 124,separately,O
Sentence: 124,",",O
Sentence: 124,no,O
Sentence: 124,differences,O
Sentence: 124,could,O
Sentence: 124,be,O
Sentence: 124,found,O
Sentence: 124,in,O
Sentence: 124,the,O
Sentence: 124,prevalence,O
Sentence: 124,of,O
Sentence: 124,severe,O
Sentence: 124,hypotension,B-Disease
Sentence: 124,or,O
Sentence: 124,bradycardia,B-Disease
Sentence: 124,in,O
Sentence: 124,either,O
Sentence: 124,the,O
Sentence: 124,unmatched,O
Sentence: 124,or,O
Sentence: 124,matched,O
Sentence: 124,cohorts,O
Sentence: 124,.,O
Sentence: 124,CONCLUSIONS,O
Sentence: 124,:,O
Sentence: 124,Severe,O
Sentence: 124,hypotension,B-Disease
Sentence: 124,and,O
Sentence: 124,bradycardia,B-Disease
Sentence: 124,occur,O
Sentence: 124,at,O
Sentence: 124,similar,O
Sentence: 124,prevalence,O
Sentence: 124,in,O
Sentence: 124,neurocritical,O
Sentence: 124,care,O
Sentence: 124,patients,O
Sentence: 124,who,O
Sentence: 124,receive,O
Sentence: 124,dexmedetomidine,B-Chemical
Sentence: 124,or,O
Sentence: 124,propofol,B-Chemical
Sentence: 124,.,O
Sentence: 124,Providers,O
Sentence: 124,should,O
Sentence: 124,similarly,O
Sentence: 124,consider,O
Sentence: 124,the,O
Sentence: 124,likelihood,O
Sentence: 124,of,O
Sentence: 124,hypotension,B-Disease
Sentence: 124,or,O
Sentence: 124,bradycardia,B-Disease
Sentence: 124,before,O
Sentence: 124,starting,O
Sentence: 124,either,O
Sentence: 124,sedative,O
Sentence: 124,.,O
Sentence: 125,Hydroxytyrosol,B-Chemical
Sentence: 125,ameliorates,O
Sentence: 125,oxidative,O
Sentence: 125,stress,O
Sentence: 125,and,O
Sentence: 125,mitochondrial,B-Disease
Sentence: 125,dysfunction,I-Disease
Sentence: 125,in,O
Sentence: 125,doxorubicin,B-Chemical
Sentence: 125,-,O
Sentence: 125,induced,O
Sentence: 125,cardiotoxicity,B-Disease
Sentence: 125,in,O
Sentence: 125,rats,O
Sentence: 125,with,O
Sentence: 125,breast,B-Disease
Sentence: 125,cancer,I-Disease
Sentence: 125,.,O
Sentence: 126,Oxidative,O
Sentence: 126,stress,O
Sentence: 126,is,O
Sentence: 126,involved,O
Sentence: 126,in,O
Sentence: 126,several,O
Sentence: 126,processes,O
Sentence: 126,including,O
Sentence: 126,cancer,B-Disease
Sentence: 126,",",O
Sentence: 126,aging,O
Sentence: 126,and,O
Sentence: 126,cardiovascular,B-Disease
Sentence: 126,disease,I-Disease
Sentence: 126,",",O
Sentence: 126,and,O
Sentence: 126,has,O
Sentence: 126,been,O
Sentence: 126,shown,O
Sentence: 126,to,O
Sentence: 126,potentiate,O
Sentence: 126,the,O
Sentence: 126,therapeutic,O
Sentence: 126,effect,O
Sentence: 126,of,O
Sentence: 126,drugs,O
Sentence: 126,such,O
Sentence: 126,as,O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,.,O
Sentence: 126,Doxorubicin,B-Chemical
Sentence: 126,causes,O
Sentence: 126,significant,O
Sentence: 126,cardiotoxicity,B-Disease
Sentence: 126,characterized,O
Sentence: 126,by,O
Sentence: 126,marked,O
Sentence: 126,increases,O
Sentence: 126,in,O
Sentence: 126,oxidative,O
Sentence: 126,stress,O
Sentence: 126,and,O
Sentence: 126,mitochondrial,B-Disease
Sentence: 126,dysfunction,I-Disease
Sentence: 126,.,O
Sentence: 126,Herein,O
Sentence: 126,",",O
Sentence: 126,we,O
Sentence: 126,investigate,O
Sentence: 126,whether,O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,-,O
Sentence: 126,associated,O
Sentence: 126,chronic,O
Sentence: 126,cardiac,B-Disease
Sentence: 126,toxicity,I-Disease
Sentence: 126,can,O
Sentence: 126,be,O
Sentence: 126,ameliorated,O
Sentence: 126,with,O
Sentence: 126,the,O
Sentence: 126,antioxidant,O
Sentence: 126,hydroxytyrosol,B-Chemical
Sentence: 126,in,O
Sentence: 126,rats,O
Sentence: 126,with,O
Sentence: 126,breast,B-Disease
Sentence: 126,cancer,I-Disease
Sentence: 126,.,O
Sentence: 126,Thirty,O
Sentence: 126,-,O
Sentence: 126,six,O
Sentence: 126,rats,O
Sentence: 126,bearing,O
Sentence: 126,breast,B-Disease
Sentence: 126,tumors,I-Disease
Sentence: 126,induced,O
Sentence: 126,chemically,O
Sentence: 126,were,O
Sentence: 126,divided,O
Sentence: 126,into,O
Sentence: 126,4,O
Sentence: 126,groups,O
Sentence: 126,:,O
Sentence: 126,control,O
Sentence: 126,",",O
Sentence: 126,hydroxytyrosol,B-Chemical
Sentence: 126,(,O
Sentence: 126,0.5mg,O
Sentence: 126,/,O
Sentence: 126,kg,O
Sentence: 126,",",O
Sentence: 126,5days,O
Sentence: 126,/,O
Sentence: 126,week,O
Sentence: 126,),O
Sentence: 126,",",O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,(,O
Sentence: 126,1mg,O
Sentence: 126,/,O
Sentence: 126,kg,O
Sentence: 126,/,O
Sentence: 126,week,O
Sentence: 126,),O
Sentence: 126,",",O
Sentence: 126,and,O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,plus,O
Sentence: 126,hydroxytyrosol,B-Chemical
Sentence: 126,.,O
Sentence: 126,Cardiac,B-Disease
Sentence: 126,disturbances,I-Disease
Sentence: 126,at,O
Sentence: 126,the,O
Sentence: 126,cellular,O
Sentence: 126,and,O
Sentence: 126,mitochondrial,O
Sentence: 126,level,O
Sentence: 126,",",O
Sentence: 126,mitochondrial,O
Sentence: 126,electron,O
Sentence: 126,transport,O
Sentence: 126,chain,O
Sentence: 126,complexes,O
Sentence: 126,I,O
Sentence: 126,-,O
Sentence: 126,IV,O
Sentence: 126,and,O
Sentence: 126,apoptosis,O
Sentence: 126,-,O
Sentence: 126,inducing,O
Sentence: 126,factor,O
Sentence: 126,",",O
Sentence: 126,and,O
Sentence: 126,oxidative,O
Sentence: 126,stress,O
Sentence: 126,markers,O
Sentence: 126,have,O
Sentence: 126,been,O
Sentence: 126,analyzed,O
Sentence: 126,.,O
Sentence: 126,Hydroxytyrosol,B-Chemical
Sentence: 126,improved,O
Sentence: 126,the,O
Sentence: 126,cardiac,B-Disease
Sentence: 126,disturbances,I-Disease
Sentence: 126,enhanced,O
Sentence: 126,by,O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,by,O
Sentence: 126,significantly,O
Sentence: 126,reducing,O
Sentence: 126,the,O
Sentence: 126,percentage,O
Sentence: 126,of,O
Sentence: 126,altered,O
Sentence: 126,mitochondria,O
Sentence: 126,and,O
Sentence: 126,oxidative,O
Sentence: 126,damage,O
Sentence: 126,.,O
Sentence: 126,These,O
Sentence: 126,results,O
Sentence: 126,suggest,O
Sentence: 126,that,O
Sentence: 126,hydroxytyrosol,B-Chemical
Sentence: 126,improve,O
Sentence: 126,the,O
Sentence: 126,mitochondrial,O
Sentence: 126,electron,O
Sentence: 126,transport,O
Sentence: 126,chain,O
Sentence: 126,.,O
Sentence: 126,This,O
Sentence: 126,study,O
Sentence: 126,demonstrates,O
Sentence: 126,that,O
Sentence: 126,hydroxytyrosol,B-Chemical
Sentence: 126,protect,O
Sentence: 126,rat,O
Sentence: 126,heart,B-Disease
Sentence: 126,damage,I-Disease
Sentence: 126,provoked,O
Sentence: 126,by,O
Sentence: 126,doxorubicin,B-Chemical
Sentence: 126,decreasing,O
Sentence: 126,oxidative,O
Sentence: 126,damage,O
Sentence: 126,and,O
Sentence: 126,mitochondrial,O
Sentence: 126,alterations,O
Sentence: 126,.,O
Sentence: 127,Amiodarone,B-Chemical
Sentence: 127,-,O
Sentence: 127,induced,O
Sentence: 127,myxoedema,B-Disease
Sentence: 127,coma,B-Disease
Sentence: 127,.,O
Sentence: 128,A,O
Sentence: 128,62,O
Sentence: 128,-,O
Sentence: 128,year,O
Sentence: 128,-,O
Sentence: 128,old,O
Sentence: 128,man,O
Sentence: 128,was,O
Sentence: 128,found,O
Sentence: 128,to,O
Sentence: 128,have,O
Sentence: 128,bradycardia,B-Disease
Sentence: 128,",",O
Sentence: 128,hypothermia,B-Disease
Sentence: 128,and,O
Sentence: 128,respiratory,B-Disease
Sentence: 128,failure,I-Disease
Sentence: 128,3,O
Sentence: 128,weeks,O
Sentence: 128,after,O
Sentence: 128,initiation,O
Sentence: 128,of,O
Sentence: 128,amiodarone,B-Chemical
Sentence: 128,therapy,O
Sentence: 128,for,O
Sentence: 128,atrial,B-Disease
Sentence: 128,fibrillation,I-Disease
Sentence: 128,.,O
Sentence: 128,Thyroid,O
Sentence: 128,-,O
Sentence: 128,stimulating,O
Sentence: 128,hormone,O
Sentence: 128,was,O
Sentence: 128,found,O
Sentence: 128,to,O
Sentence: 128,be,O
Sentence: 128,168,O
Sentence: 128,uIU,O
Sentence: 128,/,O
Sentence: 128,mL,O
Sentence: 128,(,O
Sentence: 128,nl,O
Sentence: 128,.,O
Sentence: 128,0.3,O
Sentence: 128,-,O
Sentence: 128,5,O
Sentence: 128,uIU,O
Sentence: 128,/,O
Sentence: 128,mL,O
Sentence: 128,),O
Sentence: 128,and,O
Sentence: 128,free,O
Sentence: 128,thyroxine,B-Chemical
Sentence: 128,(,O
Sentence: 128,FT4,O
Sentence: 128,),O
Sentence: 128,was,O
Sentence: 128,,O
Sentence: 128,<,O
Sentence: 128,,O
Sentence: 128,0.2,O
Sentence: 128,ng,O
Sentence: 128,/,O
Sentence: 128,dL,O
Sentence: 128,(,O
Sentence: 128,nl,O
Sentence: 128,.,O
Sentence: 128,0.8,O
Sentence: 128,-,O
Sentence: 128,1.8,O
Sentence: 128,ng,O
Sentence: 128,/,O
Sentence: 128,dL,O
Sentence: 128,),O
Sentence: 128,.,O
Sentence: 128,He,O
Sentence: 128,received,O
Sentence: 128,intravenous,O
Sentence: 128,fluids,O
Sentence: 128,",",O
Sentence: 128,vasopressor,O
Sentence: 128,therapy,O
Sentence: 128,and,O
Sentence: 128,stress,O
Sentence: 128,dose,O
Sentence: 128,steroids,B-Chemical
Sentence: 128,;,O
Sentence: 128,he,O
Sentence: 128,was,O
Sentence: 128,intubated,O
Sentence: 128,and,O
Sentence: 128,admitted,O
Sentence: 128,to,O
Sentence: 128,the,O
Sentence: 128,intensive,O
Sentence: 128,care,O
Sentence: 128,unit,O
Sentence: 128,.,O
Sentence: 128,He,O
Sentence: 128,received,O
Sentence: 128,500,O
Sentence: 128,ug,O
Sentence: 128,of,O
Sentence: 128,intravenous,O
Sentence: 128,levothyroxine,B-Chemical
Sentence: 128,in,O
Sentence: 128,the,O
Sentence: 128,first,O
Sentence: 128,18,O
Sentence: 128,h,O
Sentence: 128,of,O
Sentence: 128,therapy,O
Sentence: 128,",",O
Sentence: 128,and,O
Sentence: 128,150,O
Sentence: 128,ug,O
Sentence: 128,intravenous,O
Sentence: 128,daily,O
Sentence: 128,thereafter,O
Sentence: 128,.,O
Sentence: 128,Haemodynamic,O
Sentence: 128,improvement,O
Sentence: 128,",",O
Sentence: 128,along,O
Sentence: 128,with,O
Sentence: 128,complete,O
Sentence: 128,recovery,O
Sentence: 128,of,O
Sentence: 128,mental,O
Sentence: 128,status,O
Sentence: 128,",",O
Sentence: 128,occurred,O
Sentence: 128,after,O
Sentence: 128,48,O
Sentence: 128,h.,O
Sentence: 128,Twelve,O
Sentence: 128,hours,O
Sentence: 128,after,O
Sentence: 128,the,O
Sentence: 128,initiation,O
Sentence: 128,of,O
Sentence: 128,therapy,O
Sentence: 128,",",O
Sentence: 128,FT4,O
Sentence: 128,was,O
Sentence: 128,0.96,O
Sentence: 128,ng,O
Sentence: 128,/,O
Sentence: 128,dL,O
Sentence: 128,.,O
Sentence: 128,The,O
Sentence: 128,patient,O
Sentence: 128,was,O
Sentence: 128,maintained,O
Sentence: 128,on,O
Sentence: 128,levothyroxine,B-Chemical
Sentence: 128,175,O
Sentence: 128,(,O
Sentence: 128,g,O
Sentence: 128,POorally,O
Sentence: 128,daily,O
Sentence: 128,.,O
Sentence: 128,A,O
Sentence: 128,thyroid,O
Sentence: 128,ultrasound,O
Sentence: 128,showed,O
Sentence: 128,diffuse,O
Sentence: 128,heterogeneity,O
Sentence: 128,.,O
Sentence: 128,The,O
Sentence: 128,24,O
Sentence: 128,hour,O
Sentence: 128,excretion,O
Sentence: 128,of,O
Sentence: 128,iodine,B-Chemical
Sentence: 128,was,O
Sentence: 128,3657,O
Sentence: 128,(,O
Sentence: 128,mcg,O
Sentence: 128,(,O
Sentence: 128,25,O
Sentence: 128,-,O
Sentence: 128,756,O
Sentence: 128,(,O
Sentence: 128,mcg,O
Sentence: 128,),O
Sentence: 128,.,O
Sentence: 128,The,O
Sentence: 128,only,O
Sentence: 128,two,O
Sentence: 128,cases,O
Sentence: 128,of,O
Sentence: 128,amiodarone,B-Chemical
Sentence: 128,-,O
Sentence: 128,induced,O
Sentence: 128,myxoedema,B-Disease
Sentence: 128,coma,B-Disease
Sentence: 128,in,O
Sentence: 128,the,O
Sentence: 128,literature,O
Sentence: 128,report,O
Sentence: 128,patient,O
Sentence: 128,death,O
Sentence: 128,despite,O
Sentence: 128,supportive,O
Sentence: 128,therapy,O
Sentence: 128,and,O
Sentence: 128,thyroid,O
Sentence: 128,hormone,O
Sentence: 128,replacement,O
Sentence: 128,.,O
Sentence: 128,This,O
Sentence: 128,case,O
Sentence: 128,represents,O
Sentence: 128,the,O
Sentence: 128,most,O
Sentence: 128,thoroughly,O
Sentence: 128,investigated,O
Sentence: 128,case,O
Sentence: 128,of,O
Sentence: 128,amiodarone,B-Chemical
Sentence: 128,-,O
Sentence: 128,induced,O
Sentence: 128,myxoedema,B-Disease
Sentence: 128,coma,B-Disease
Sentence: 128,with,O
Sentence: 128,a,O
Sentence: 128,history,O
Sentence: 128,significant,O
Sentence: 128,for,O
Sentence: 128,subclinical,O
Sentence: 128,thyroid,B-Disease
Sentence: 128,disease,I-Disease
Sentence: 128,.,O
Sentence: 129,Use,O
Sentence: 129,of,O
Sentence: 129,argatroban,B-Chemical
Sentence: 129,and,O
Sentence: 129,catheter,O
Sentence: 129,-,O
Sentence: 129,directed,O
Sentence: 129,thrombolysis,B-Disease
Sentence: 129,with,O
Sentence: 129,alteplase,O
Sentence: 129,in,O
Sentence: 129,an,O
Sentence: 129,oncology,O
Sentence: 129,patient,O
Sentence: 129,with,O
Sentence: 129,heparin,B-Chemical
Sentence: 129,-,O
Sentence: 129,induced,O
Sentence: 129,thrombocytopenia,B-Disease
Sentence: 129,with,O
Sentence: 129,thrombosis,B-Disease
Sentence: 129,.,O
Sentence: 130,PURPOSE,O
Sentence: 130,:,O
Sentence: 130,The,O
Sentence: 130,case,O
Sentence: 130,of,O
Sentence: 130,an,O
Sentence: 130,oncology,O
Sentence: 130,patient,O
Sentence: 130,who,O
Sentence: 130,developed,O
Sentence: 130,heparin,B-Chemical
Sentence: 130,-,O
Sentence: 130,induced,O
Sentence: 130,thrombocytopenia,B-Disease
Sentence: 130,with,O
Sentence: 130,thrombosis,B-Disease
Sentence: 130,(,O
Sentence: 130,HITT,B-Disease
Sentence: 130,),O
Sentence: 130,and,O
Sentence: 130,was,O
Sentence: 130,treated,O
Sentence: 130,with,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,plus,O
Sentence: 130,catheter,O
Sentence: 130,-,O
Sentence: 130,directed,O
Sentence: 130,thrombolysis,B-Disease
Sentence: 130,(,O
Sentence: 130,CDT,O
Sentence: 130,),O
Sentence: 130,with,O
Sentence: 130,alteplase,O
Sentence: 130,is,O
Sentence: 130,presented,O
Sentence: 130,.,O
Sentence: 130,SUMMARY,O
Sentence: 130,:,O
Sentence: 130,A,O
Sentence: 130,63,O
Sentence: 130,-,O
Sentence: 130,year,O
Sentence: 130,-,O
Sentence: 130,old,O
Sentence: 130,Caucasian,O
Sentence: 130,man,O
Sentence: 130,with,O
Sentence: 130,renal,O
Sentence: 130,amyloidosis,B-Disease
Sentence: 130,undergoing,O
Sentence: 130,peripheral,O
Sentence: 130,blood,O
Sentence: 130,stem,O
Sentence: 130,cell,O
Sentence: 130,collection,O
Sentence: 130,for,O
Sentence: 130,an,O
Sentence: 130,autologous,O
Sentence: 130,stem,O
Sentence: 130,cell,O
Sentence: 130,transplant,O
Sentence: 130,developed,O
Sentence: 130,extensive,O
Sentence: 130,bilateral,O
Sentence: 130,upper,O
Sentence: 130,-,O
Sentence: 130,extremity,O
Sentence: 130,deep,O
Sentence: 130,venous,O
Sentence: 130,thrombosis,B-Disease
Sentence: 130,(,O
Sentence: 130,DVT,B-Disease
Sentence: 130,),O
Sentence: 130,and,O
Sentence: 130,pulmonary,B-Disease
Sentence: 130,embolism,I-Disease
Sentence: 130,secondary,O
Sentence: 130,to,O
Sentence: 130,heparin,B-Chemical
Sentence: 130,-,O
Sentence: 130,induced,O
Sentence: 130,thrombocytopenia,B-Disease
Sentence: 130,.,O
Sentence: 130,A,O
Sentence: 130,continuous,O
Sentence: 130,i.v,O
Sentence: 130,.,O
Sentence: 130,infusion,O
Sentence: 130,of,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,was,O
Sentence: 130,initiated,O
Sentence: 130,",",O
Sentence: 130,and,O
Sentence: 130,the,O
Sentence: 130,patient,O
Sentence: 130,was,O
Sentence: 130,managed,O
Sentence: 130,on,O
Sentence: 130,the,O
Sentence: 130,general,O
Sentence: 130,medical,O
Sentence: 130,floor,O
Sentence: 130,.,O
Sentence: 130,After,O
Sentence: 130,one,O
Sentence: 130,week,O
Sentence: 130,of,O
Sentence: 130,therapy,O
Sentence: 130,",",O
Sentence: 130,he,O
Sentence: 130,was,O
Sentence: 130,transferred,O
Sentence: 130,to,O
Sentence: 130,the,O
Sentence: 130,intensive,O
Sentence: 130,care,O
Sentence: 130,unit,O
Sentence: 130,with,O
Sentence: 130,cardiopulmonary,O
Sentence: 130,compromise,O
Sentence: 130,related,O
Sentence: 130,to,O
Sentence: 130,superior,B-Disease
Sentence: 130,vena,I-Disease
Sentence: 130,cava,I-Disease
Sentence: 130,(,I-Disease
Sentence: 130,SVC,I-Disease
Sentence: 130,),I-Disease
Sentence: 130,syndrome,I-Disease
Sentence: 130,.,O
Sentence: 130,A,O
Sentence: 130,percutaneous,O
Sentence: 130,mechanical,O
Sentence: 130,thrombectomy,O
Sentence: 130,and,O
Sentence: 130,CDT,O
Sentence: 130,with,O
Sentence: 130,alteplase,O
Sentence: 130,were,O
Sentence: 130,attempted,O
Sentence: 130,",",O
Sentence: 130,but,O
Sentence: 130,the,O
Sentence: 130,procedure,O
Sentence: 130,was,O
Sentence: 130,aborted,O
Sentence: 130,due,O
Sentence: 130,to,O
Sentence: 130,epistaxis,B-Disease
Sentence: 130,.,O
Sentence: 130,The,O
Sentence: 130,epistaxis,B-Disease
Sentence: 130,resolved,O
Sentence: 130,the,O
Sentence: 130,next,O
Sentence: 130,day,O
Sentence: 130,",",O
Sentence: 130,and,O
Sentence: 130,the,O
Sentence: 130,patient,O
Sentence: 130,was,O
Sentence: 130,restarted,O
Sentence: 130,on,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,.,O
Sentence: 130,A,O
Sentence: 130,second,O
Sentence: 130,percutaneous,O
Sentence: 130,mechanical,O
Sentence: 130,thrombectomy,O
Sentence: 130,was,O
Sentence: 130,performed,O
Sentence: 130,six,O
Sentence: 130,days,O
Sentence: 130,later,O
Sentence: 130,and,O
Sentence: 130,resulted,O
Sentence: 130,in,O
Sentence: 130,partial,O
Sentence: 130,revascularization,O
Sentence: 130,of,O
Sentence: 130,the,O
Sentence: 130,SVC,O
Sentence: 130,and,O
Sentence: 130,central,O
Sentence: 130,veins,O
Sentence: 130,.,O
Sentence: 130,Postthrombectomy,O
Sentence: 130,continuous,O
Sentence: 130,CDT,O
Sentence: 130,with,O
Sentence: 130,alteplase,O
Sentence: 130,was,O
Sentence: 130,commenced,O
Sentence: 130,while,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,was,O
Sentence: 130,withheld,O
Sentence: 130,",",O
Sentence: 130,and,O
Sentence: 130,complete,O
Sentence: 130,patency,O
Sentence: 130,of,O
Sentence: 130,the,O
Sentence: 130,SVC,O
Sentence: 130,and,O
Sentence: 130,central,O
Sentence: 130,veins,O
Sentence: 130,was,O
Sentence: 130,achieved,O
Sentence: 130,after,O
Sentence: 130,three,O
Sentence: 130,days,O
Sentence: 130,of,O
Sentence: 130,therapy,O
Sentence: 130,.,O
Sentence: 130,Alteplase,O
Sentence: 130,was,O
Sentence: 130,discontinued,O
Sentence: 130,",",O
Sentence: 130,and,O
Sentence: 130,the,O
Sentence: 130,patient,O
Sentence: 130,was,O
Sentence: 130,reinitiated,O
Sentence: 130,on,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,;,O
Sentence: 130,ultimately,O
Sentence: 130,",",O
Sentence: 130,he,O
Sentence: 130,was,O
Sentence: 130,transitioned,O
Sentence: 130,to,O
Sentence: 130,warfarin,B-Chemical
Sentence: 130,for,O
Sentence: 130,long,O
Sentence: 130,-,O
Sentence: 130,term,O
Sentence: 130,anticoagulation,O
Sentence: 130,.,O
Sentence: 130,Although,O
Sentence: 130,the,O
Sentence: 130,patient,O
Sentence: 130,recovered,O
Sentence: 130,",",O
Sentence: 130,he,O
Sentence: 130,experienced,O
Sentence: 130,permanent,O
Sentence: 130,vision,B-Disease
Sentence: 130,and,I-Disease
Sentence: 130,hearing,B-Disease
Sentence: 130,loss,I-Disease
Sentence: 130,",",O
Sentence: 130,as,O
Sentence: 130,well,O
Sentence: 130,as,O
Sentence: 130,end,O
Sentence: 130,-,O
Sentence: 130,stage,O
Sentence: 130,renal,O
Sentence: 130,disease,O
Sentence: 130,.,O
Sentence: 130,CONCLUSION,O
Sentence: 130,:,O
Sentence: 130,A,O
Sentence: 130,63,O
Sentence: 130,-,O
Sentence: 130,year,O
Sentence: 130,-,O
Sentence: 130,old,O
Sentence: 130,man,O
Sentence: 130,with,O
Sentence: 130,renal,O
Sentence: 130,amyloidosis,B-Disease
Sentence: 130,and,O
Sentence: 130,SVC,B-Disease
Sentence: 130,syndrome,I-Disease
Sentence: 130,secondary,O
Sentence: 130,to,O
Sentence: 130,HITT,B-Disease
Sentence: 130,was,O
Sentence: 130,successfully,O
Sentence: 130,treated,O
Sentence: 130,with,O
Sentence: 130,argatroban,B-Chemical
Sentence: 130,and,O
Sentence: 130,CDT,O
Sentence: 130,with,O
Sentence: 130,alteplase,O
Sentence: 130,.,O
Sentence: 131,Effects,O
Sentence: 131,of,O
Sentence: 131,dehydroepiandrosterone,B-Chemical
Sentence: 131,in,O
Sentence: 131,amphetamine,B-Chemical
Sentence: 131,-,O
Sentence: 131,induced,O
Sentence: 131,schizophrenia,B-Disease
Sentence: 131,models,O
Sentence: 131,in,O
Sentence: 131,mice,O
Sentence: 131,.,O
Sentence: 132,OBJECTIVE,O
Sentence: 132,:,O
Sentence: 132,To,O
Sentence: 132,examine,O
Sentence: 132,the,O
Sentence: 132,effects,O
Sentence: 132,of,O
Sentence: 132,dehydroepiandrosterone,B-Chemical
Sentence: 132,(,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,),O
Sentence: 132,on,O
Sentence: 132,animal,O
Sentence: 132,models,O
Sentence: 132,of,O
Sentence: 132,schizophrenia,B-Disease
Sentence: 132,.,O
Sentence: 132,METHODS,O
Sentence: 132,:,O
Sentence: 132,Seventy,O
Sentence: 132,Swiss,O
Sentence: 132,albino,O
Sentence: 132,female,O
Sentence: 132,mice,O
Sentence: 132,(,O
Sentence: 132,25,O
Sentence: 132,-,O
Sentence: 132,35,O
Sentence: 132,g,O
Sentence: 132,),O
Sentence: 132,were,O
Sentence: 132,divided,O
Sentence: 132,into,O
Sentence: 132,4,O
Sentence: 132,groups,O
Sentence: 132,:,O
Sentence: 132,amphetamine,B-Chemical
Sentence: 132,-,O
Sentence: 132,free,O
Sentence: 132,(,O
Sentence: 132,control,O
Sentence: 132,),O
Sentence: 132,",",O
Sentence: 132,amphetamine,B-Chemical
Sentence: 132,",",O
Sentence: 132,50,O
Sentence: 132,",",O
Sentence: 132,and,O
Sentence: 132,100,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,.,O
Sentence: 132,The,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,was,O
Sentence: 132,administered,O
Sentence: 132,intraperitoneally,O
Sentence: 132,(,O
Sentence: 132,ip,O
Sentence: 132,),O
Sentence: 132,for,O
Sentence: 132,5,O
Sentence: 132,days,O
Sentence: 132,.,O
Sentence: 132,Amphetamine,B-Chemical
Sentence: 132,(,O
Sentence: 132,3,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,ip,O
Sentence: 132,),O
Sentence: 132,induced,O
Sentence: 132,hyper,B-Disease
Sentence: 132,locomotion,O
Sentence: 132,",",O
Sentence: 132,apomorphine,B-Chemical
Sentence: 132,(,O
Sentence: 132,1.5,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,subcutaneously,O
Sentence: 132,[,O
Sentence: 132,sc,O
Sentence: 132,],O
Sentence: 132,),O
Sentence: 132,induced,O
Sentence: 132,climbing,O
Sentence: 132,",",O
Sentence: 132,and,O
Sentence: 132,haloperidol,B-Chemical
Sentence: 132,(,O
Sentence: 132,1.5,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,sc,O
Sentence: 132,),O
Sentence: 132,induced,O
Sentence: 132,catalepsy,B-Disease
Sentence: 132,tests,O
Sentence: 132,were,O
Sentence: 132,used,O
Sentence: 132,as,O
Sentence: 132,animal,O
Sentence: 132,models,O
Sentence: 132,of,O
Sentence: 132,schizophrenia,B-Disease
Sentence: 132,.,O
Sentence: 132,The,O
Sentence: 132,study,O
Sentence: 132,was,O
Sentence: 132,conducted,O
Sentence: 132,at,O
Sentence: 132,the,O
Sentence: 132,Animal,O
Sentence: 132,Experiment,O
Sentence: 132,Laboratories,O
Sentence: 132,",",O
Sentence: 132,Department,O
Sentence: 132,of,O
Sentence: 132,Pharmacology,O
Sentence: 132,",",O
Sentence: 132,Medical,O
Sentence: 132,School,O
Sentence: 132,",",O
Sentence: 132,Eskisehir,O
Sentence: 132,Osmangazi,O
Sentence: 132,University,O
Sentence: 132,",",O
Sentence: 132,Eskisehir,O
Sentence: 132,",",O
Sentence: 132,Turkey,O
Sentence: 132,between,O
Sentence: 132,March,O
Sentence: 132,and,O
Sentence: 132,May,O
Sentence: 132,2012,O
Sentence: 132,.,O
Sentence: 132,Statistical,O
Sentence: 132,analysis,O
Sentence: 132,was,O
Sentence: 132,carried,O
Sentence: 132,out,O
Sentence: 132,using,O
Sentence: 132,Kruskal,O
Sentence: 132,-,O
Sentence: 132,Wallis,O
Sentence: 132,test,O
Sentence: 132,for,O
Sentence: 132,hyper,B-Disease
Sentence: 132,locomotion,O
Sentence: 132,",",O
Sentence: 132,and,O
Sentence: 132,one,O
Sentence: 132,-,O
Sentence: 132,way,O
Sentence: 132,ANOVA,O
Sentence: 132,for,O
Sentence: 132,climbing,O
Sentence: 132,and,O
Sentence: 132,catalepsy,B-Disease
Sentence: 132,tests,O
Sentence: 132,.,O
Sentence: 132,RESULTS,O
Sentence: 132,:,O
Sentence: 132,In,O
Sentence: 132,the,O
Sentence: 132,amphetamine,B-Chemical
Sentence: 132,-,O
Sentence: 132,induced,O
Sentence: 132,locomotion,O
Sentence: 132,test,O
Sentence: 132,",",O
Sentence: 132,there,O
Sentence: 132,were,O
Sentence: 132,significant,O
Sentence: 132,increases,O
Sentence: 132,in,O
Sentence: 132,all,O
Sentence: 132,movements,O
Sentence: 132,compared,O
Sentence: 132,with,O
Sentence: 132,the,O
Sentence: 132,amphetamine,B-Chemical
Sentence: 132,-,O
Sentence: 132,free,O
Sentence: 132,group,O
Sentence: 132,.,O
Sentence: 132,Both,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,50,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,(,O
Sentence: 132,p,O
Sentence: 132,,O
Sentence: 132,<,O
Sentence: 132,,O
Sentence: 132,0.05,O
Sentence: 132,),O
Sentence: 132,",",O
Sentence: 132,and,O
Sentence: 132,100,O
Sentence: 132,mg,O
Sentence: 132,/,O
Sentence: 132,kg,O
Sentence: 132,(,O
Sentence: 132,p,O
Sentence: 132,,O
Sentence: 132,<,O
Sentence: 132,,O
Sentence: 132,0.01,O
Sentence: 132,),O
Sentence: 132,significantly,O
Sentence: 132,decreased,O
Sentence: 132,all,O
Sentence: 132,movements,O
Sentence: 132,compared,O
Sentence: 132,with,O
Sentence: 132,the,O
Sentence: 132,amphetamine,B-Chemical
Sentence: 132,-,O
Sentence: 132,induced,O
Sentence: 132,locomotion,O
Sentence: 132,group,O
Sentence: 132,.,O
Sentence: 132,There,O
Sentence: 132,was,O
Sentence: 132,a,O
Sentence: 132,significant,O
Sentence: 132,difference,O
Sentence: 132,between,O
Sentence: 132,groups,O
Sentence: 132,in,O
Sentence: 132,the,O
Sentence: 132,haloperidol,B-Chemical
Sentence: 132,-,O
Sentence: 132,induced,O
Sentence: 132,catalepsy,B-Disease
Sentence: 132,test,O
Sentence: 132,(,O
Sentence: 132,p,O
Sentence: 132,,O
Sentence: 132,<,O
Sentence: 132,,O
Sentence: 132,0.05,O
Sentence: 132,),O
Sentence: 132,.,O
Sentence: 132,There,O
Sentence: 132,was,O
Sentence: 132,no,O
Sentence: 132,significant,O
Sentence: 132,difference,O
Sentence: 132,between,O
Sentence: 132,groups,O
Sentence: 132,in,O
Sentence: 132,terms,O
Sentence: 132,of,O
Sentence: 132,total,O
Sentence: 132,climbing,O
Sentence: 132,time,O
Sentence: 132,in,O
Sentence: 132,the,O
Sentence: 132,apomorphine,B-Chemical
Sentence: 132,-,O
Sentence: 132,induced,O
Sentence: 132,climbing,O
Sentence: 132,test,O
Sentence: 132,(,O
Sentence: 132,p,O
Sentence: 132,,O
Sentence: 132,>,O
Sentence: 132,,O
Sentence: 132,0.05,O
Sentence: 132,),O
Sentence: 132,.,O
Sentence: 132,CONCLUSION,O
Sentence: 132,:,O
Sentence: 132,We,O
Sentence: 132,observed,O
Sentence: 132,that,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,reduced,O
Sentence: 132,locomotor,O
Sentence: 132,activity,O
Sentence: 132,and,O
Sentence: 132,increased,O
Sentence: 132,catalepsy,B-Disease
Sentence: 132,at,O
Sentence: 132,both,O
Sentence: 132,doses,O
Sentence: 132,",",O
Sentence: 132,while,O
Sentence: 132,it,O
Sentence: 132,had,O
Sentence: 132,no,O
Sentence: 132,effect,O
Sentence: 132,on,O
Sentence: 132,climbing,O
Sentence: 132,behavior,O
Sentence: 132,.,O
Sentence: 132,We,O
Sentence: 132,suggest,O
Sentence: 132,that,O
Sentence: 132,DHEA,B-Chemical
Sentence: 132,displays,O
Sentence: 132,typical,O
Sentence: 132,neuroleptic,O
Sentence: 132,-,O
Sentence: 132,like,O
Sentence: 132,effects,O
Sentence: 132,",",O
Sentence: 132,and,O
Sentence: 132,may,O
Sentence: 132,be,O
Sentence: 132,used,O
Sentence: 132,in,O
Sentence: 132,the,O
Sentence: 132,treatment,O
Sentence: 132,of,O
Sentence: 132,schizophrenia,B-Disease
Sentence: 132,.,O
Sentence: 133,Availability,O
Sentence: 133,of,O
Sentence: 133,human,O
Sentence: 133,induced,O
Sentence: 133,pluripotent,O
Sentence: 133,stem,O
Sentence: 133,cell,O
Sentence: 133,-,O
Sentence: 133,derived,O
Sentence: 133,cardiomyocytes,O
Sentence: 133,in,O
Sentence: 133,assessment,O
Sentence: 133,of,O
Sentence: 133,drug,O
Sentence: 133,potential,O
Sentence: 133,for,O
Sentence: 133,QT,O
Sentence: 133,prolongation,O
Sentence: 133,.,O
Sentence: 134,Field,O
Sentence: 134,potential,O
Sentence: 134,duration,O
Sentence: 134,(,O
Sentence: 134,FPD,O
Sentence: 134,),O
Sentence: 134,in,O
Sentence: 134,human,O
Sentence: 134,-,O
Sentence: 134,induced,O
Sentence: 134,pluripotent,O
Sentence: 134,stem,O
Sentence: 134,cell,O
Sentence: 134,-,O
Sentence: 134,derived,O
Sentence: 134,cardiomyocytes,O
Sentence: 134,(,O
Sentence: 134,hiPS,O
Sentence: 134,-,O
Sentence: 134,CMs,O
Sentence: 134,),O
Sentence: 134,",",O
Sentence: 134,which,O
Sentence: 134,can,O
Sentence: 134,express,O
Sentence: 134,QT,O
Sentence: 134,interval,O
Sentence: 134,in,O
Sentence: 134,an,O
Sentence: 134,electrocardiogram,O
Sentence: 134,",",O
Sentence: 134,is,O
Sentence: 134,reported,O
Sentence: 134,to,O
Sentence: 134,be,O
Sentence: 134,a,O
Sentence: 134,useful,O
Sentence: 134,tool,O
Sentence: 134,to,O
Sentence: 134,predict,O
Sentence: 134,K,B-Chemical
Sentence: 134,(,O
Sentence: 134,+,O
Sentence: 134,),O
Sentence: 134,channel,O
Sentence: 134,and,O
Sentence: 134,Ca,B-Chemical
Sentence: 134,(,O
Sentence: 134,2+,O
Sentence: 134,),O
Sentence: 134,channel,O
Sentence: 134,blocker,O
Sentence: 134,effects,O
Sentence: 134,on,O
Sentence: 134,QT,O
Sentence: 134,interval,O
Sentence: 134,.,O
Sentence: 134,However,O
Sentence: 134,",",O
Sentence: 134,there,O
Sentence: 134,is,O
Sentence: 134,no,O
Sentence: 134,report,O
Sentence: 134,showing,O
Sentence: 134,that,O
Sentence: 134,this,O
Sentence: 134,technique,O
Sentence: 134,can,O
Sentence: 134,be,O
Sentence: 134,used,O
Sentence: 134,to,O
Sentence: 134,predict,O
Sentence: 134,multichannel,O
Sentence: 134,blocker,O
Sentence: 134,potential,O
Sentence: 134,for,O
Sentence: 134,QT,B-Disease
Sentence: 134,prolongation,I-Disease
Sentence: 134,.,O
Sentence: 134,The,O
Sentence: 134,aim,O
Sentence: 134,of,O
Sentence: 134,this,O
Sentence: 134,study,O
Sentence: 134,is,O
Sentence: 134,to,O
Sentence: 134,show,O
Sentence: 134,that,O
Sentence: 134,FPD,O
Sentence: 134,from,O
Sentence: 134,MEA,O
Sentence: 134,(,O
Sentence: 134,Multielectrode,O
Sentence: 134,array,O
Sentence: 134,),O
Sentence: 134,of,O
Sentence: 134,hiPS,O
Sentence: 134,-,O
Sentence: 134,CMs,O
Sentence: 134,can,O
Sentence: 134,detect,O
Sentence: 134,QT,B-Disease
Sentence: 134,prolongation,I-Disease
Sentence: 134,induced,O
Sentence: 134,by,O
Sentence: 134,multichannel,O
Sentence: 134,blockers,O
Sentence: 134,.,O
Sentence: 134,hiPS,O
Sentence: 134,-,O
Sentence: 134,CMs,O
Sentence: 134,were,O
Sentence: 134,seeded,O
Sentence: 134,onto,O
Sentence: 134,MEA,O
Sentence: 134,and,O
Sentence: 134,FPD,O
Sentence: 134,was,O
Sentence: 134,measured,O
Sentence: 134,for,O
Sentence: 134,2min,O
Sentence: 134,every,O
Sentence: 134,10min,O
Sentence: 134,for,O
Sentence: 134,30min,O
Sentence: 134,after,O
Sentence: 134,drug,O
Sentence: 134,exposure,O
Sentence: 134,for,O
Sentence: 134,the,O
Sentence: 134,vehicle,O
Sentence: 134,and,O
Sentence: 134,each,O
Sentence: 134,drug,O
Sentence: 134,concentration,O
Sentence: 134,.,O
Sentence: 134,IKr,O
Sentence: 134,and,O
Sentence: 134,IKs,O
Sentence: 134,blockers,O
Sentence: 134,concentration,O
Sentence: 134,-,O
Sentence: 134,dependently,O
Sentence: 134,prolonged,O
Sentence: 134,corrected,O
Sentence: 134,FPD,O
Sentence: 134,(,O
Sentence: 134,FPDc,O
Sentence: 134,),O
Sentence: 134,",",O
Sentence: 134,whereas,O
Sentence: 134,Ca,B-Chemical
Sentence: 134,(,O
Sentence: 134,2+,O
Sentence: 134,),O
Sentence: 134,channel,O
Sentence: 134,blockers,O
Sentence: 134,concentration,O
Sentence: 134,-,O
Sentence: 134,dependently,O
Sentence: 134,shortened,O
Sentence: 134,FPDc,O
Sentence: 134,.,O
Sentence: 134,Also,O
Sentence: 134,",",O
Sentence: 134,the,O
Sentence: 134,multichannel,O
Sentence: 134,blockers,O
Sentence: 134,Amiodarone,B-Chemical
Sentence: 134,",",O
Sentence: 134,Paroxetine,B-Chemical
Sentence: 134,",",O
Sentence: 134,Terfenadine,B-Chemical
Sentence: 134,and,O
Sentence: 134,Citalopram,B-Chemical
Sentence: 134,prolonged,O
Sentence: 134,FPDc,O
Sentence: 134,in,O
Sentence: 134,a,O
Sentence: 134,concentration,O
Sentence: 134,dependent,O
Sentence: 134,manner,O
Sentence: 134,.,O
Sentence: 134,Finally,O
Sentence: 134,",",O
Sentence: 134,the,O
Sentence: 134,IKr,O
Sentence: 134,blockers,O
Sentence: 134,",",O
Sentence: 134,Terfenadine,B-Chemical
Sentence: 134,and,O
Sentence: 134,Citalopram,B-Chemical
Sentence: 134,",",O
Sentence: 134,which,O
Sentence: 134,are,O
Sentence: 134,reported,O
Sentence: 134,to,O
Sentence: 134,cause,O
Sentence: 134,Torsade,B-Disease
Sentence: 134,de,I-Disease
Sentence: 134,Pointes,I-Disease
Sentence: 134,(,O
Sentence: 134,TdP,B-Disease
Sentence: 134,),O
Sentence: 134,in,O
Sentence: 134,clinical,O
Sentence: 134,practice,O
Sentence: 134,",",O
Sentence: 134,produced,O
Sentence: 134,early,O
Sentence: 134,afterdepolarization,O
Sentence: 134,(,O
Sentence: 134,EAD,O
Sentence: 134,),O
Sentence: 134,.,O
Sentence: 134,hiPS,O
Sentence: 134,-,O
Sentence: 134,CMs,O
Sentence: 134,using,O
Sentence: 134,MEA,O
Sentence: 134,system,O
Sentence: 134,and,O
Sentence: 134,FPDc,O
Sentence: 134,can,O
Sentence: 134,predict,O
Sentence: 134,the,O
Sentence: 134,effects,O
Sentence: 134,of,O
Sentence: 134,drug,O
Sentence: 134,candidates,O
Sentence: 134,on,O
Sentence: 134,QT,O
Sentence: 134,interval,O
Sentence: 134,.,O
Sentence: 134,This,O
Sentence: 134,study,O
Sentence: 134,also,O
Sentence: 134,shows,O
Sentence: 134,that,O
Sentence: 134,this,O
Sentence: 134,assay,O
Sentence: 134,can,O
Sentence: 134,help,O
Sentence: 134,detect,O
Sentence: 134,EAD,O
Sentence: 134,for,O
Sentence: 134,drugs,O
Sentence: 134,with,O
Sentence: 134,TdP,B-Disease
Sentence: 134,potential,O
Sentence: 134,.,O
Sentence: 135,Dermal,O
Sentence: 135,developmental,O
Sentence: 135,toxicity,O
Sentence: 135,of,O
Sentence: 135,N,O
Sentence: 135,-,O
Sentence: 135,phenylimide,O
Sentence: 135,herbicides,O
Sentence: 135,in,O
Sentence: 135,rats,O
Sentence: 135,.,O
Sentence: 136,BACKGROUND,O
Sentence: 136,:,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,53482,O
Sentence: 136,and,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,23121,O
Sentence: 136,are,O
Sentence: 136,N,O
Sentence: 136,-,O
Sentence: 136,phenylimide,O
Sentence: 136,herbicides,O
Sentence: 136,and,O
Sentence: 136,produced,O
Sentence: 136,embryolethality,B-Disease
Sentence: 136,",",O
Sentence: 136,teratogenicity,B-Disease
Sentence: 136,(,O
Sentence: 136,mainly,O
Sentence: 136,ventricular,B-Disease
Sentence: 136,septal,I-Disease
Sentence: 136,defects,I-Disease
Sentence: 136,and,O
Sentence: 136,wavy,O
Sentence: 136,ribs,O
Sentence: 136,),O
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,growth,B-Disease
Sentence: 136,retardation,I-Disease
Sentence: 136,in,O
Sentence: 136,rats,O
Sentence: 136,in,O
Sentence: 136,conventional,O
Sentence: 136,oral,O
Sentence: 136,developmental,O
Sentence: 136,toxicity,B-Disease
Sentence: 136,studies,O
Sentence: 136,.,O
Sentence: 136,Our,O
Sentence: 136,objective,O
Sentence: 136,in,O
Sentence: 136,this,O
Sentence: 136,study,O
Sentence: 136,was,O
Sentence: 136,to,O
Sentence: 136,investigate,O
Sentence: 136,whether,O
Sentence: 136,the,O
Sentence: 136,compounds,O
Sentence: 136,induce,O
Sentence: 136,developmental,O
Sentence: 136,toxicity,B-Disease
Sentence: 136,via,O
Sentence: 136,the,O
Sentence: 136,dermal,O
Sentence: 136,route,O
Sentence: 136,",",O
Sentence: 136,which,O
Sentence: 136,is,O
Sentence: 136,more,O
Sentence: 136,relevant,O
Sentence: 136,to,O
Sentence: 136,occupational,O
Sentence: 136,exposure,O
Sentence: 136,",",O
Sentence: 136,hence,O
Sentence: 136,better,O
Sentence: 136,addressing,O
Sentence: 136,human,O
Sentence: 136,health,O
Sentence: 136,risks,O
Sentence: 136,.,O
Sentence: 136,METHODS,O
Sentence: 136,:,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,53482,O
Sentence: 136,was,O
Sentence: 136,administered,O
Sentence: 136,dermally,O
Sentence: 136,to,O
Sentence: 136,rats,O
Sentence: 136,at,O
Sentence: 136,30,O
Sentence: 136,",",O
Sentence: 136,100,O
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,300,O
Sentence: 136,mg,O
Sentence: 136,/,O
Sentence: 136,kg,O
Sentence: 136,during,O
Sentence: 136,organogenesis,O
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,23121,O
Sentence: 136,was,O
Sentence: 136,administered,O
Sentence: 136,at,O
Sentence: 136,200,O
Sentence: 136,",",O
Sentence: 136,400,O
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,800,O
Sentence: 136,mg,O
Sentence: 136,/,O
Sentence: 136,kg,O
Sentence: 136,(,O
Sentence: 136,the,O
Sentence: 136,maximum,O
Sentence: 136,applicable,O
Sentence: 136,dose,O
Sentence: 136,level,O
Sentence: 136,),O
Sentence: 136,.,O
Sentence: 136,Fetuses,O
Sentence: 136,were,O
Sentence: 136,obtained,O
Sentence: 136,by,O
Sentence: 136,a,O
Sentence: 136,Cesarean,O
Sentence: 136,section,O
Sentence: 136,and,O
Sentence: 136,examined,O
Sentence: 136,for,O
Sentence: 136,external,O
Sentence: 136,",",O
Sentence: 136,visceral,O
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,skeletal,O
Sentence: 136,alterations,O
Sentence: 136,.,O
Sentence: 136,RESULTS,O
Sentence: 136,:,O
Sentence: 136,Dermal,O
Sentence: 136,exposure,O
Sentence: 136,of,O
Sentence: 136,rats,O
Sentence: 136,to,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,53482,O
Sentence: 136,at,O
Sentence: 136,300,O
Sentence: 136,mg,O
Sentence: 136,/,O
Sentence: 136,kg,O
Sentence: 136,produced,O
Sentence: 136,patterns,O
Sentence: 136,of,O
Sentence: 136,developmental,O
Sentence: 136,toxicity,B-Disease
Sentence: 136,similar,O
Sentence: 136,to,O
Sentence: 136,those,O
Sentence: 136,resulting,O
Sentence: 136,from,O
Sentence: 136,oral,O
Sentence: 136,exposure,O
Sentence: 136,.,O
Sentence: 136,Toxicity,B-Disease
Sentence: 136,included,O
Sentence: 136,embryolethality,B-Disease
Sentence: 136,",",O
Sentence: 136,teratogenicity,B-Disease
Sentence: 136,",",O
Sentence: 136,and,O
Sentence: 136,growth,B-Disease
Sentence: 136,retardation,I-Disease
Sentence: 136,.,O
Sentence: 136,Dermal,O
Sentence: 136,administration,O
Sentence: 136,of,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,23121,O
Sentence: 136,at,O
Sentence: 136,800,O
Sentence: 136,mg,O
Sentence: 136,/,O
Sentence: 136,kg,O
Sentence: 136,resulted,O
Sentence: 136,in,O
Sentence: 136,an,O
Sentence: 136,increased,O
Sentence: 136,incidence,O
Sentence: 136,of,O
Sentence: 136,embryonic,B-Disease
Sentence: 136,death,I-Disease
Sentence: 136,and,O
Sentence: 136,ventricular,B-Disease
Sentence: 136,septal,I-Disease
Sentence: 136,defect,I-Disease
Sentence: 136,",",O
Sentence: 136,but,O
Sentence: 136,retarded,O
Sentence: 136,fetal,O
Sentence: 136,growth,O
Sentence: 136,was,O
Sentence: 136,not,O
Sentence: 136,observed,O
Sentence: 136,as,O
Sentence: 136,it,O
Sentence: 136,was,O
Sentence: 136,following,O
Sentence: 136,oral,O
Sentence: 136,exposure,O
Sentence: 136,to,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,23121,O
Sentence: 136,.,O
Sentence: 136,CONCLUSIONS,O
Sentence: 136,:,O
Sentence: 136,Based,O
Sentence: 136,on,O
Sentence: 136,the,O
Sentence: 136,results,O
Sentence: 136,",",O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,53482,O
Sentence: 136,and,O
Sentence: 136,S,O
Sentence: 136,-,O
Sentence: 136,23121,O
Sentence: 136,were,O
Sentence: 136,teratogenic,B-Disease
Sentence: 136,when,O
Sentence: 136,administered,O
Sentence: 136,dermally,O
Sentence: 136,to,O
Sentence: 136,pregnant,O
Sentence: 136,rats,O
Sentence: 136,as,O
Sentence: 136,were,O
Sentence: 136,the,O
Sentence: 136,compounds,O
Sentence: 136,administered,O
Sentence: 136,orally,O
Sentence: 136,.,O
Sentence: 136,Thus,O
Sentence: 136,",",O
Sentence: 136,investigation,O
Sentence: 136,of,O
Sentence: 136,the,O
Sentence: 136,mechanism,O
Sentence: 136,and,O
Sentence: 136,its,O
Sentence: 136,human,O
Sentence: 136,relevancy,O
Sentence: 136,become,O
Sentence: 136,more,O
Sentence: 136,important,O
Sentence: 136,.,O
Sentence: 137,Rates,O
Sentence: 137,of,O
Sentence: 137,Renal,B-Disease
Sentence: 137,Toxicity,I-Disease
Sentence: 137,in,O
Sentence: 137,Cancer,B-Disease
Sentence: 137,Patients,O
Sentence: 137,Receiving,O
Sentence: 137,Cisplatin,B-Chemical
Sentence: 137,With,O
Sentence: 137,and,O
Sentence: 137,Without,O
Sentence: 137,Mannitol,B-Chemical
Sentence: 137,.,O
Sentence: 138,BACKGROUND,O
Sentence: 138,:,O
Sentence: 138,Cisplatin,B-Chemical
Sentence: 138,is,O
Sentence: 138,a,O
Sentence: 138,widely,O
Sentence: 138,used,O
Sentence: 138,antineoplastic,O
Sentence: 138,.,O
Sentence: 138,One,O
Sentence: 138,of,O
Sentence: 138,the,O
Sentence: 138,major,O
Sentence: 138,complications,O
Sentence: 138,of,O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,use,O
Sentence: 138,is,O
Sentence: 138,dose,O
Sentence: 138,-,O
Sentence: 138,limiting,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,.,O
Sentence: 138,There,O
Sentence: 138,are,O
Sentence: 138,many,O
Sentence: 138,strategies,O
Sentence: 138,to,O
Sentence: 138,prevent,O
Sentence: 138,this,O
Sentence: 138,toxicity,B-Disease
Sentence: 138,",",O
Sentence: 138,including,O
Sentence: 138,the,O
Sentence: 138,use,O
Sentence: 138,of,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,as,O
Sentence: 138,a,O
Sentence: 138,nephroprotectant,O
Sentence: 138,in,O
Sentence: 138,combination,O
Sentence: 138,with,O
Sentence: 138,hydration,O
Sentence: 138,.,O
Sentence: 138,OBJECTIVE,O
Sentence: 138,:,O
Sentence: 138,We,O
Sentence: 138,aimed,O
Sentence: 138,to,O
Sentence: 138,evaluate,O
Sentence: 138,the,O
Sentence: 138,rates,O
Sentence: 138,of,O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,-,O
Sentence: 138,induced,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,in,O
Sentence: 138,cancer,B-Disease
Sentence: 138,patients,O
Sentence: 138,receiving,O
Sentence: 138,single,O
Sentence: 138,-,O
Sentence: 138,agent,O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,with,O
Sentence: 138,and,O
Sentence: 138,without,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,.,O
Sentence: 138,METHODS,O
Sentence: 138,:,O
Sentence: 138,This,O
Sentence: 138,single,O
Sentence: 138,-,O
Sentence: 138,center,O
Sentence: 138,retrospective,O
Sentence: 138,analysis,O
Sentence: 138,was,O
Sentence: 138,a,O
Sentence: 138,quasi,O
Sentence: 138,experiment,O
Sentence: 138,created,O
Sentence: 138,by,O
Sentence: 138,the,O
Sentence: 138,national,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,shortage,O
Sentence: 138,.,O
Sentence: 138,Data,O
Sentence: 138,were,O
Sentence: 138,collected,O
Sentence: 138,on,O
Sentence: 138,adult,O
Sentence: 138,cancer,B-Disease
Sentence: 138,patients,O
Sentence: 138,receiving,O
Sentence: 138,single,O
Sentence: 138,-,O
Sentence: 138,agent,O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,as,O
Sentence: 138,an,O
Sentence: 138,outpatient,O
Sentence: 138,from,O
Sentence: 138,January,O
Sentence: 138,2011,O
Sentence: 138,to,O
Sentence: 138,September,O
Sentence: 138,2012,O
Sentence: 138,.,O
Sentence: 138,The,O
Sentence: 138,primary,O
Sentence: 138,outcome,O
Sentence: 138,was,O
Sentence: 138,acute,B-Disease
Sentence: 138,kidney,I-Disease
Sentence: 138,injury,I-Disease
Sentence: 138,(,O
Sentence: 138,AKI,B-Disease
Sentence: 138,),O
Sentence: 138,.,O
Sentence: 138,RESULTS,O
Sentence: 138,:,O
Sentence: 138,We,O
Sentence: 138,evaluated,O
Sentence: 138,143,O
Sentence: 138,patients,O
Sentence: 138,who,O
Sentence: 138,received,O
Sentence: 138,single,O
Sentence: 138,-,O
Sentence: 138,agent,O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,;,O
Sentence: 138,97.2,O
Sentence: 138,%,O
Sentence: 138,of,O
Sentence: 138,patients,O
Sentence: 138,had,O
Sentence: 138,head,B-Disease
Sentence: 138,and,I-Disease
Sentence: 138,neck,I-Disease
Sentence: 138,cancer,I-Disease
Sentence: 138,as,O
Sentence: 138,their,O
Sentence: 138,primary,O
Sentence: 138,malignancy,B-Disease
Sentence: 138,.,O
Sentence: 138,Patients,O
Sentence: 138,who,O
Sentence: 138,did,O
Sentence: 138,not,O
Sentence: 138,receive,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,were,O
Sentence: 138,more,O
Sentence: 138,likely,O
Sentence: 138,to,O
Sentence: 138,develop,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,:,O
Sentence: 138,odds,O
Sentence: 138,ratio,O
Sentence: 138,[,O
Sentence: 138,OR,O
Sentence: 138,],O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,2.646,O
Sentence: 138,(,O
Sentence: 138,95,O
Sentence: 138,%,O
Sentence: 138,CI,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,1.008,O
Sentence: 138,",",O
Sentence: 138,6.944,O
Sentence: 138,;,O
Sentence: 138,P,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,0.048,O
Sentence: 138,),O
Sentence: 138,.,O
Sentence: 138,Patients,O
Sentence: 138,who,O
Sentence: 138,received,O
Sentence: 138,the,O
Sentence: 138,100,O
Sentence: 138,mg,O
Sentence: 138,/,O
Sentence: 138,m,O
Sentence: 138,(,O
Sentence: 138,2,O
Sentence: 138,),O
Sentence: 138,dosing,O
Sentence: 138,and,O
Sentence: 138,patients,O
Sentence: 138,who,O
Sentence: 138,had,O
Sentence: 138,a,O
Sentence: 138,history,O
Sentence: 138,of,O
Sentence: 138,hypertension,B-Disease
Sentence: 138,also,O
Sentence: 138,had,O
Sentence: 138,a,O
Sentence: 138,higher,O
Sentence: 138,likelihood,O
Sentence: 138,of,O
Sentence: 138,developing,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,:,O
Sentence: 138,OR,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,11.494,O
Sentence: 138,(,O
Sentence: 138,95,O
Sentence: 138,%,O
Sentence: 138,CI,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,4.149,O
Sentence: 138,",",O
Sentence: 138,32.258,O
Sentence: 138,;,O
Sentence: 138,P,O
Sentence: 138,,O
Sentence: 138,<,O
Sentence: 138,,O
Sentence: 138,0.0001,O
Sentence: 138,),O
Sentence: 138,and,O
Sentence: 138,OR,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,3.219,O
Sentence: 138,(,O
Sentence: 138,95,O
Sentence: 138,%,O
Sentence: 138,CI,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,1.228,O
Sentence: 138,",",O
Sentence: 138,8.439,O
Sentence: 138,;,O
Sentence: 138,P,O
Sentence: 138,,O
Sentence: 138,=,O
Sentence: 138,,O
Sentence: 138,0.017,O
Sentence: 138,),O
Sentence: 138,",",O
Sentence: 138,respectively,O
Sentence: 138,.,O
Sentence: 138,CONCLUSIONS,O
Sentence: 138,:,O
Sentence: 138,When,O
Sentence: 138,limited,O
Sentence: 138,quantities,O
Sentence: 138,of,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,are,O
Sentence: 138,available,O
Sentence: 138,",",O
Sentence: 138,it,O
Sentence: 138,should,O
Sentence: 138,preferentially,O
Sentence: 138,be,O
Sentence: 138,given,O
Sentence: 138,to,O
Sentence: 138,patients,O
Sentence: 138,at,O
Sentence: 138,particularly,O
Sentence: 138,high,O
Sentence: 138,risk,O
Sentence: 138,of,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,.,O
Sentence: 138,Our,O
Sentence: 138,analysis,O
Sentence: 138,suggests,O
Sentence: 138,that,O
Sentence: 138,those,O
Sentence: 138,patients,O
Sentence: 138,receiving,O
Sentence: 138,the,O
Sentence: 138,dosing,O
Sentence: 138,schedule,O
Sentence: 138,of,O
Sentence: 138,100,O
Sentence: 138,mg,O
Sentence: 138,/,O
Sentence: 138,m,O
Sentence: 138,(,O
Sentence: 138,2,O
Sentence: 138,),O
Sentence: 138,cisplatin,B-Chemical
Sentence: 138,every,O
Sentence: 138,3,O
Sentence: 138,weeks,O
Sentence: 138,and,O
Sentence: 138,those,O
Sentence: 138,with,O
Sentence: 138,hypertension,B-Disease
Sentence: 138,are,O
Sentence: 138,at,O
Sentence: 138,the,O
Sentence: 138,greatest,O
Sentence: 138,risk,O
Sentence: 138,of,O
Sentence: 138,nephrotoxicity,B-Disease
Sentence: 138,and,O
Sentence: 138,would,O
Sentence: 138,benefit,O
Sentence: 138,from,O
Sentence: 138,the,O
Sentence: 138,addition,O
Sentence: 138,of,O
Sentence: 138,mannitol,B-Chemical
Sentence: 138,.,O
Sentence: 139,Metformin,B-Chemical
Sentence: 139,protects,O
Sentence: 139,against,O
Sentence: 139,seizures,B-Disease
Sentence: 139,",",O
Sentence: 139,learning,B-Disease
Sentence: 139,and,I-Disease
Sentence: 139,memory,B-Disease
Sentence: 139,impairments,I-Disease
Sentence: 139,and,O
Sentence: 139,oxidative,O
Sentence: 139,damage,O
Sentence: 139,induced,O
Sentence: 139,by,O
Sentence: 139,pentylenetetrazole,B-Chemical
Sentence: 139,-,O
Sentence: 139,induced,O
Sentence: 139,kindling,O
Sentence: 139,in,O
Sentence: 139,mice,O
Sentence: 139,.,O
Sentence: 140,Cognitive,B-Disease
Sentence: 140,impairment,I-Disease
Sentence: 140,",",O
Sentence: 140,the,O
Sentence: 140,most,O
Sentence: 140,common,O
Sentence: 140,and,O
Sentence: 140,severe,O
Sentence: 140,comorbidity,O
Sentence: 140,of,O
Sentence: 140,epilepsy,B-Disease
Sentence: 140,",",O
Sentence: 140,greatly,O
Sentence: 140,diminishes,O
Sentence: 140,the,O
Sentence: 140,quality,O
Sentence: 140,of,O
Sentence: 140,life,O
Sentence: 140,.,O
Sentence: 140,However,O
Sentence: 140,",",O
Sentence: 140,current,O
Sentence: 140,therapeutic,O
Sentence: 140,interventions,O
Sentence: 140,for,O
Sentence: 140,epilepsy,B-Disease
Sentence: 140,can,O
Sentence: 140,also,O
Sentence: 140,cause,O
Sentence: 140,untoward,O
Sentence: 140,cognitive,O
Sentence: 140,effects,O
Sentence: 140,.,O
Sentence: 140,Thus,O
Sentence: 140,",",O
Sentence: 140,there,O
Sentence: 140,is,O
Sentence: 140,an,O
Sentence: 140,urgent,O
Sentence: 140,need,O
Sentence: 140,for,O
Sentence: 140,new,O
Sentence: 140,kinds,O
Sentence: 140,of,O
Sentence: 140,agents,O
Sentence: 140,targeting,O
Sentence: 140,both,O
Sentence: 140,seizures,B-Disease
Sentence: 140,and,O
Sentence: 140,cognition,B-Disease
Sentence: 140,deficits,I-Disease
Sentence: 140,.,O
Sentence: 140,Oxidative,O
Sentence: 140,stress,O
Sentence: 140,is,O
Sentence: 140,considered,O
Sentence: 140,to,O
Sentence: 140,play,O
Sentence: 140,an,O
Sentence: 140,important,O
Sentence: 140,role,O
Sentence: 140,in,O
Sentence: 140,epileptogenesis,O
Sentence: 140,and,O
Sentence: 140,cognitive,B-Disease
Sentence: 140,deficits,I-Disease
Sentence: 140,",",O
Sentence: 140,and,O
Sentence: 140,antioxidants,O
Sentence: 140,have,O
Sentence: 140,a,O
Sentence: 140,putative,O
Sentence: 140,antiepileptic,O
Sentence: 140,potential,O
Sentence: 140,.,O
Sentence: 140,Metformin,B-Chemical
Sentence: 140,",",O
Sentence: 140,the,O
Sentence: 140,most,O
Sentence: 140,commonly,O
Sentence: 140,prescribed,O
Sentence: 140,antidiabetic,O
Sentence: 140,oral,O
Sentence: 140,drug,O
Sentence: 140,",",O
Sentence: 140,has,O
Sentence: 140,antioxidant,O
Sentence: 140,properties,O
Sentence: 140,.,O
Sentence: 140,This,O
Sentence: 140,study,O
Sentence: 140,was,O
Sentence: 140,designed,O
Sentence: 140,to,O
Sentence: 140,evaluate,O
Sentence: 140,the,O
Sentence: 140,ameliorative,O
Sentence: 140,effects,O
Sentence: 140,of,O
Sentence: 140,metformin,B-Chemical
Sentence: 140,on,O
Sentence: 140,seizures,B-Disease
Sentence: 140,",",O
Sentence: 140,cognitive,B-Disease
Sentence: 140,impairment,I-Disease
Sentence: 140,and,O
Sentence: 140,brain,O
Sentence: 140,oxidative,O
Sentence: 140,stress,O
Sentence: 140,markers,O
Sentence: 140,observed,O
Sentence: 140,in,O
Sentence: 140,pentylenetetrazole,B-Chemical
Sentence: 140,-,O
Sentence: 140,induced,O
Sentence: 140,kindling,O
Sentence: 140,animals,O
Sentence: 140,.,O
Sentence: 140,Male,O
Sentence: 140,C57BL,O
Sentence: 140,/,O
Sentence: 140,6,O
Sentence: 140,mice,O
Sentence: 140,were,O
Sentence: 140,administered,O
Sentence: 140,with,O
Sentence: 140,subconvulsive,O
Sentence: 140,dose,O
Sentence: 140,of,O
Sentence: 140,pentylenetetrazole,B-Chemical
Sentence: 140,(,O
Sentence: 140,37,O
Sentence: 140,mg,O
Sentence: 140,/,O
Sentence: 140,kg,O
Sentence: 140,",",O
Sentence: 140,i.p,O
Sentence: 140,.,O
Sentence: 140,),O
Sentence: 140,every,O
Sentence: 140,other,O
Sentence: 140,day,O
Sentence: 140,for,O
Sentence: 140,14,O
Sentence: 140,injections,O
Sentence: 140,.,O
Sentence: 140,Metformin,B-Chemical
Sentence: 140,was,O
Sentence: 140,injected,O
Sentence: 140,intraperitoneally,O
Sentence: 140,in,O
Sentence: 140,dose,O
Sentence: 140,of,O
Sentence: 140,200mg,O
Sentence: 140,/,O
Sentence: 140,kg,O
Sentence: 140,along,O
Sentence: 140,with,O
Sentence: 140,alternate,O
Sentence: 140,-,O
Sentence: 140,day,O
Sentence: 140,PTZ,B-Chemical
Sentence: 140,.,O
Sentence: 140,We,O
Sentence: 140,found,O
Sentence: 140,that,O
Sentence: 140,metformin,B-Chemical
Sentence: 140,suppressed,O
Sentence: 140,the,O
Sentence: 140,progression,O
Sentence: 140,of,O
Sentence: 140,kindling,O
Sentence: 140,",",O
Sentence: 140,ameliorated,O
Sentence: 140,the,O
Sentence: 140,cognitive,B-Disease
Sentence: 140,impairment,I-Disease
Sentence: 140,and,O
Sentence: 140,decreased,O
Sentence: 140,brain,O
Sentence: 140,oxidative,O
Sentence: 140,stress,O
Sentence: 140,.,O
Sentence: 140,Thus,O
Sentence: 140,the,O
Sentence: 140,present,O
Sentence: 140,study,O
Sentence: 140,concluded,O
Sentence: 140,that,O
Sentence: 140,metformin,B-Chemical
Sentence: 140,may,O
Sentence: 140,be,O
Sentence: 140,a,O
Sentence: 140,potential,O
Sentence: 140,agent,O
Sentence: 140,for,O
Sentence: 140,the,O
Sentence: 140,treatment,O
Sentence: 140,of,O
Sentence: 140,epilepsy,B-Disease
Sentence: 140,as,O
Sentence: 140,well,O
Sentence: 140,as,O
Sentence: 140,a,O
Sentence: 140,protective,O
Sentence: 140,medicine,O
Sentence: 140,against,O
Sentence: 140,cognitive,B-Disease
Sentence: 140,impairment,I-Disease
Sentence: 140,induced,O
Sentence: 140,by,O
Sentence: 140,seizures,B-Disease
Sentence: 140,.,O
Sentence: 141,P53,O
Sentence: 141,inhibition,O
Sentence: 141,exacerbates,O
Sentence: 141,late,O
Sentence: 141,-,O
Sentence: 141,stage,O
Sentence: 141,anthracycline,B-Chemical
Sentence: 141,cardiotoxicity,B-Disease
Sentence: 141,.,O
Sentence: 142,AIMS,O
Sentence: 142,:,O
Sentence: 142,Doxorubicin,B-Chemical
Sentence: 142,(,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,),O
Sentence: 142,is,O
Sentence: 142,an,O
Sentence: 142,effective,O
Sentence: 142,anti,O
Sentence: 142,-,O
Sentence: 142,cancer,B-Disease
Sentence: 142,therapeutic,O
Sentence: 142,",",O
Sentence: 142,but,O
Sentence: 142,is,O
Sentence: 142,associated,O
Sentence: 142,with,O
Sentence: 142,both,O
Sentence: 142,acute,O
Sentence: 142,and,O
Sentence: 142,late,O
Sentence: 142,-,O
Sentence: 142,stage,O
Sentence: 142,cardiotoxicity,B-Disease
Sentence: 142,.,O
Sentence: 142,Children,O
Sentence: 142,are,O
Sentence: 142,particularly,O
Sentence: 142,sensitive,O
Sentence: 142,to,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,-,O
Sentence: 142,induced,O
Sentence: 142,heart,B-Disease
Sentence: 142,failure,I-Disease
Sentence: 142,.,O
Sentence: 142,Here,O
Sentence: 142,",",O
Sentence: 142,the,O
Sentence: 142,impact,O
Sentence: 142,of,O
Sentence: 142,p53,O
Sentence: 142,inhibition,O
Sentence: 142,on,O
Sentence: 142,acute,O
Sentence: 142,vs.,O
Sentence: 142,late,O
Sentence: 142,-,O
Sentence: 142,stage,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,cardiotoxicity,B-Disease
Sentence: 142,was,O
Sentence: 142,examined,O
Sentence: 142,in,O
Sentence: 142,a,O
Sentence: 142,juvenile,O
Sentence: 142,model,O
Sentence: 142,.,O
Sentence: 142,METHODS,O
Sentence: 142,AND,O
Sentence: 142,RESULTS,O
Sentence: 142,:,O
Sentence: 142,Two,O
Sentence: 142,-,O
Sentence: 142,week,O
Sentence: 142,-,O
Sentence: 142,old,O
Sentence: 142,MHC,O
Sentence: 142,-,O
Sentence: 142,CB7,O
Sentence: 142,mice,O
Sentence: 142,(,O
Sentence: 142,which,O
Sentence: 142,express,O
Sentence: 142,dominant,O
Sentence: 142,-,O
Sentence: 142,interfering,O
Sentence: 142,p53,O
Sentence: 142,in,O
Sentence: 142,cardiomyocytes,O
Sentence: 142,),O
Sentence: 142,and,O
Sentence: 142,their,O
Sentence: 142,non,O
Sentence: 142,-,O
Sentence: 142,transgenic,O
Sentence: 142,(,O
Sentence: 142,NON,O
Sentence: 142,-,O
Sentence: 142,TXG,O
Sentence: 142,),O
Sentence: 142,littermates,O
Sentence: 142,received,O
Sentence: 142,weekly,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,injections,O
Sentence: 142,for,O
Sentence: 142,5,O
Sentence: 142,weeks,O
Sentence: 142,(,O
Sentence: 142,25,O
Sentence: 142,mg,O
Sentence: 142,/,O
Sentence: 142,kg,O
Sentence: 142,cumulative,O
Sentence: 142,dose,O
Sentence: 142,),O
Sentence: 142,.,O
Sentence: 142,One,O
Sentence: 142,week,O
Sentence: 142,after,O
Sentence: 142,the,O
Sentence: 142,last,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,treatment,O
Sentence: 142,(,O
Sentence: 142,acute,O
Sentence: 142,stage,O
Sentence: 142,),O
Sentence: 142,",",O
Sentence: 142,MHC,O
Sentence: 142,-,O
Sentence: 142,CB7,O
Sentence: 142,mice,O
Sentence: 142,exhibited,O
Sentence: 142,improved,O
Sentence: 142,cardiac,O
Sentence: 142,function,O
Sentence: 142,and,O
Sentence: 142,lower,O
Sentence: 142,levels,O
Sentence: 142,of,O
Sentence: 142,cardiomyocyte,O
Sentence: 142,apoptosis,O
Sentence: 142,when,O
Sentence: 142,compared,O
Sentence: 142,with,O
Sentence: 142,the,O
Sentence: 142,NON,O
Sentence: 142,-,O
Sentence: 142,TXG,O
Sentence: 142,mice,O
Sentence: 142,.,O
Sentence: 142,Surprisingly,O
Sentence: 142,",",O
Sentence: 142,by,O
Sentence: 142,13,O
Sentence: 142,weeks,O
Sentence: 142,following,O
Sentence: 142,the,O
Sentence: 142,last,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,treatment,O
Sentence: 142,(,O
Sentence: 142,late,O
Sentence: 142,stage,O
Sentence: 142,),O
Sentence: 142,",",O
Sentence: 142,MHC,O
Sentence: 142,-,O
Sentence: 142,CB7,O
Sentence: 142,exhibited,O
Sentence: 142,a,O
Sentence: 142,progressive,O
Sentence: 142,decrease,O
Sentence: 142,in,O
Sentence: 142,cardiac,O
Sentence: 142,function,O
Sentence: 142,and,O
Sentence: 142,higher,O
Sentence: 142,rates,O
Sentence: 142,of,O
Sentence: 142,cardiomyocyte,O
Sentence: 142,apoptosis,O
Sentence: 142,when,O
Sentence: 142,compared,O
Sentence: 142,with,O
Sentence: 142,NON,O
Sentence: 142,-,O
Sentence: 142,TXG,O
Sentence: 142,mice,O
Sentence: 142,.,O
Sentence: 142,p53,O
Sentence: 142,inhibition,O
Sentence: 142,blocked,O
Sentence: 142,transient,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,-,O
Sentence: 142,induced,O
Sentence: 142,STAT3,O
Sentence: 142,activation,O
Sentence: 142,in,O
Sentence: 142,MHC,O
Sentence: 142,-,O
Sentence: 142,CB7,O
Sentence: 142,mice,O
Sentence: 142,",",O
Sentence: 142,which,O
Sentence: 142,was,O
Sentence: 142,associated,O
Sentence: 142,with,O
Sentence: 142,enhanced,O
Sentence: 142,induction,O
Sentence: 142,of,O
Sentence: 142,the,O
Sentence: 142,DNA,O
Sentence: 142,repair,O
Sentence: 142,proteins,O
Sentence: 142,Ku70,O
Sentence: 142,and,O
Sentence: 142,Ku80,O
Sentence: 142,.,O
Sentence: 142,Mice,O
Sentence: 142,with,O
Sentence: 142,cardiomyocyte,O
Sentence: 142,-,O
Sentence: 142,restricted,O
Sentence: 142,deletion,O
Sentence: 142,of,O
Sentence: 142,STAT3,O
Sentence: 142,exhibited,O
Sentence: 142,worse,O
Sentence: 142,cardiac,O
Sentence: 142,function,O
Sentence: 142,",",O
Sentence: 142,higher,O
Sentence: 142,levels,O
Sentence: 142,of,O
Sentence: 142,cardiomyocyte,O
Sentence: 142,apoptosis,O
Sentence: 142,",",O
Sentence: 142,and,O
Sentence: 142,a,O
Sentence: 142,greater,O
Sentence: 142,induction,O
Sentence: 142,of,O
Sentence: 142,Ku70,O
Sentence: 142,and,O
Sentence: 142,Ku80,O
Sentence: 142,in,O
Sentence: 142,response,O
Sentence: 142,to,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,treatment,O
Sentence: 142,during,O
Sentence: 142,the,O
Sentence: 142,acute,O
Sentence: 142,stage,O
Sentence: 142,when,O
Sentence: 142,compared,O
Sentence: 142,with,O
Sentence: 142,control,O
Sentence: 142,animals,O
Sentence: 142,.,O
Sentence: 142,CONCLUSION,O
Sentence: 142,:,O
Sentence: 142,These,O
Sentence: 142,data,O
Sentence: 142,support,O
Sentence: 142,a,O
Sentence: 142,model,O
Sentence: 142,wherein,O
Sentence: 142,a,O
Sentence: 142,p53,O
Sentence: 142,-,O
Sentence: 142,dependent,O
Sentence: 142,cardioprotective,O
Sentence: 142,pathway,O
Sentence: 142,",",O
Sentence: 142,mediated,O
Sentence: 142,via,O
Sentence: 142,STAT3,O
Sentence: 142,activation,O
Sentence: 142,",",O
Sentence: 142,mitigates,O
Sentence: 142,DOX,B-Chemical
Sentence: 142,-,O
Sentence: 142,induced,O
Sentence: 142,myocardial,O
Sentence: 142,stress,O
Sentence: 142,during,O
Sentence: 142,drug,O
Sentence: 142,delivery,O
Sentence: 142,.,O
Sentence: 142,Furthermore,O
Sentence: 142,",",O
Sentence: 142,these,O
Sentence: 142,data,O
Sentence: 142,suggest,O
Sentence: 142,an,O
Sentence: 142,explanation,O
Sentence: 142,as,O
Sentence: 142,to,O
Sentence: 142,how,O
Sentence: 142,p53,O
Sentence: 142,inhibition,O
Sentence: 142,can,O
Sentence: 142,result,O
Sentence: 142,in,O
Sentence: 142,cardioprotection,O
Sentence: 142,during,O
Sentence: 142,drug,O
Sentence: 142,treatment,O
Sentence: 142,and,O
Sentence: 142,",",O
Sentence: 142,paradoxically,O
Sentence: 142,",",O
Sentence: 142,enhanced,O
Sentence: 142,cardiotoxicity,B-Disease
Sentence: 142,long,O
Sentence: 142,after,O
Sentence: 142,the,O
Sentence: 142,cessation,O
Sentence: 142,of,O
Sentence: 142,drug,O
Sentence: 142,treatment,O
Sentence: 142,.,O
Sentence: 143,Metronidazole,B-Chemical
Sentence: 143,-,O
Sentence: 143,induced,O
Sentence: 143,encephalopathy,B-Disease
Sentence: 143,:,O
Sentence: 143,an,O
Sentence: 143,uncommon,O
Sentence: 143,scenario,O
Sentence: 143,.,O
Sentence: 144,Metronidazole,B-Chemical
Sentence: 144,can,O
Sentence: 144,produce,O
Sentence: 144,neurological,O
Sentence: 144,complications,O
Sentence: 144,although,O
Sentence: 144,it,O
Sentence: 144,is,O
Sentence: 144,not,O
Sentence: 144,a,O
Sentence: 144,common,O
Sentence: 144,scenario,O
Sentence: 144,.,O
Sentence: 144,We,O
Sentence: 144,present,O
Sentence: 144,a,O
Sentence: 144,case,O
Sentence: 144,where,O
Sentence: 144,a,O
Sentence: 144,patient,O
Sentence: 144,developed,O
Sentence: 144,features,O
Sentence: 144,of,O
Sentence: 144,encephalopathy,B-Disease
Sentence: 144,following,O
Sentence: 144,prolonged,O
Sentence: 144,metronidazole,B-Chemical
Sentence: 144,intake,O
Sentence: 144,.,O
Sentence: 144,Magnetic,O
Sentence: 144,resonance,O
Sentence: 144,imaging,O
Sentence: 144,(,O
Sentence: 144,MRI,O
Sentence: 144,),O
Sentence: 144,brain,O
Sentence: 144,showed,O
Sentence: 144,abnormal,O
Sentence: 144,signal,O
Sentence: 144,intensity,O
Sentence: 144,involving,O
Sentence: 144,both,O
Sentence: 144,dentate,O
Sentence: 144,nuclei,O
Sentence: 144,of,O
Sentence: 144,cerebellum,O
Sentence: 144,and,O
Sentence: 144,splenium,O
Sentence: 144,of,O
Sentence: 144,corpus,O
Sentence: 144,callosum,O
Sentence: 144,.,O
Sentence: 144,The,O
Sentence: 144,diagnosis,O
Sentence: 144,of,O
Sentence: 144,metronidazole,B-Chemical
Sentence: 144,toxicity,B-Disease
Sentence: 144,was,O
Sentence: 144,made,O
Sentence: 144,by,O
Sentence: 144,the,O
Sentence: 144,MRI,O
Sentence: 144,findings,O
Sentence: 144,and,O
Sentence: 144,supported,O
Sentence: 144,clinically,O
Sentence: 144,.,O
Sentence: 145,Aconitine,B-Chemical
Sentence: 145,-,O
Sentence: 145,induced,O
Sentence: 145,Ca2+,O
Sentence: 145,overload,O
Sentence: 145,causes,O
Sentence: 145,arrhythmia,B-Disease
Sentence: 145,and,O
Sentence: 145,triggers,O
Sentence: 145,apoptosis,O
Sentence: 145,through,O
Sentence: 145,p38,O
Sentence: 145,MAPK,O
Sentence: 145,signaling,O
Sentence: 145,pathway,O
Sentence: 145,in,O
Sentence: 145,rats,O
Sentence: 145,.,O
Sentence: 146,Aconitine,B-Chemical
Sentence: 146,is,O
Sentence: 146,a,O
Sentence: 146,major,O
Sentence: 146,bioactive,O
Sentence: 146,diterpenoid,O
Sentence: 146,alkaloid,O
Sentence: 146,with,O
Sentence: 146,high,O
Sentence: 146,content,O
Sentence: 146,derived,O
Sentence: 146,from,O
Sentence: 146,herbal,O
Sentence: 146,aconitum,O
Sentence: 146,plants,O
Sentence: 146,.,O
Sentence: 146,Emerging,O
Sentence: 146,evidence,O
Sentence: 146,indicates,O
Sentence: 146,that,O
Sentence: 146,voltage,O
Sentence: 146,-,O
Sentence: 146,dependent,O
Sentence: 146,Na,B-Chemical
Sentence: 146,(,O
Sentence: 146,+,O
Sentence: 146,),O
Sentence: 146,channels,O
Sentence: 146,have,O
Sentence: 146,pivotal,O
Sentence: 146,roles,O
Sentence: 146,in,O
Sentence: 146,the,O
Sentence: 146,cardiotoxicity,B-Disease
Sentence: 146,of,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,.,O
Sentence: 146,However,O
Sentence: 146,",",O
Sentence: 146,no,O
Sentence: 146,reports,O
Sentence: 146,are,O
Sentence: 146,available,O
Sentence: 146,on,O
Sentence: 146,the,O
Sentence: 146,role,O
Sentence: 146,of,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,in,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,poisoning,B-Disease
Sentence: 146,.,O
Sentence: 146,In,O
Sentence: 146,this,O
Sentence: 146,study,O
Sentence: 146,",",O
Sentence: 146,we,O
Sentence: 146,explored,O
Sentence: 146,the,O
Sentence: 146,importance,O
Sentence: 146,of,O
Sentence: 146,pathological,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,signaling,O
Sentence: 146,in,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,poisoning,B-Disease
Sentence: 146,in,O
Sentence: 146,vitro,O
Sentence: 146,and,O
Sentence: 146,in,O
Sentence: 146,vivo,O
Sentence: 146,.,O
Sentence: 146,We,O
Sentence: 146,found,O
Sentence: 146,that,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,overload,O
Sentence: 146,lead,O
Sentence: 146,to,O
Sentence: 146,accelerated,O
Sentence: 146,beating,O
Sentence: 146,rhythm,O
Sentence: 146,in,O
Sentence: 146,adult,O
Sentence: 146,rat,O
Sentence: 146,ventricular,O
Sentence: 146,myocytes,O
Sentence: 146,and,O
Sentence: 146,caused,O
Sentence: 146,arrhythmia,B-Disease
Sentence: 146,in,O
Sentence: 146,conscious,O
Sentence: 146,freely,O
Sentence: 146,moving,O
Sentence: 146,rats,O
Sentence: 146,.,O
Sentence: 146,To,O
Sentence: 146,investigate,O
Sentence: 146,effects,O
Sentence: 146,of,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,on,O
Sentence: 146,myocardial,B-Disease
Sentence: 146,injury,I-Disease
Sentence: 146,",",O
Sentence: 146,we,O
Sentence: 146,performed,O
Sentence: 146,cytotoxicity,B-Disease
Sentence: 146,assay,O
Sentence: 146,in,O
Sentence: 146,neonatal,O
Sentence: 146,rat,O
Sentence: 146,ventricular,O
Sentence: 146,myocytes,O
Sentence: 146,(,O
Sentence: 146,NRVMs,O
Sentence: 146,),O
Sentence: 146,",",O
Sentence: 146,as,O
Sentence: 146,well,O
Sentence: 146,as,O
Sentence: 146,measured,O
Sentence: 146,lactate,B-Chemical
Sentence: 146,dehydrogenase,O
Sentence: 146,level,O
Sentence: 146,in,O
Sentence: 146,the,O
Sentence: 146,culture,O
Sentence: 146,medium,O
Sentence: 146,of,O
Sentence: 146,NRVMs,O
Sentence: 146,and,O
Sentence: 146,activities,O
Sentence: 146,of,O
Sentence: 146,serum,O
Sentence: 146,cardiac,O
Sentence: 146,enzymes,O
Sentence: 146,in,O
Sentence: 146,rats,O
Sentence: 146,.,O
Sentence: 146,The,O
Sentence: 146,results,O
Sentence: 146,showed,O
Sentence: 146,that,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,resulted,O
Sentence: 146,in,O
Sentence: 146,myocardial,B-Disease
Sentence: 146,injury,I-Disease
Sentence: 146,and,O
Sentence: 146,reduced,O
Sentence: 146,NRVMs,O
Sentence: 146,viability,O
Sentence: 146,dose,O
Sentence: 146,-,O
Sentence: 146,dependently,O
Sentence: 146,.,O
Sentence: 146,To,O
Sentence: 146,confirm,O
Sentence: 146,the,O
Sentence: 146,pro,O
Sentence: 146,-,O
Sentence: 146,apoptotic,O
Sentence: 146,effects,O
Sentence: 146,",",O
Sentence: 146,we,O
Sentence: 146,performed,O
Sentence: 146,flow,O
Sentence: 146,cytometric,O
Sentence: 146,detection,O
Sentence: 146,",",O
Sentence: 146,cardiac,O
Sentence: 146,histology,O
Sentence: 146,",",O
Sentence: 146,transmission,O
Sentence: 146,electron,O
Sentence: 146,microscopy,O
Sentence: 146,and,O
Sentence: 146,terminal,O
Sentence: 146,deoxynucleotidyl,O
Sentence: 146,transferase,O
Sentence: 146,-,O
Sentence: 146,mediated,O
Sentence: 146,dUTP,B-Chemical
Sentence: 146,-,O
Sentence: 146,biotin,B-Chemical
Sentence: 146,nick,O
Sentence: 146,end,O
Sentence: 146,labeling,O
Sentence: 146,assay,O
Sentence: 146,.,O
Sentence: 146,The,O
Sentence: 146,results,O
Sentence: 146,showed,O
Sentence: 146,that,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,stimulated,O
Sentence: 146,apoptosis,O
Sentence: 146,time,O
Sentence: 146,-,O
Sentence: 146,dependently,O
Sentence: 146,.,O
Sentence: 146,The,O
Sentence: 146,expression,O
Sentence: 146,analysis,O
Sentence: 146,of,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,handling,O
Sentence: 146,proteins,O
Sentence: 146,demonstrated,O
Sentence: 146,that,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,promoted,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,overload,O
Sentence: 146,through,O
Sentence: 146,the,O
Sentence: 146,expression,O
Sentence: 146,regulation,O
Sentence: 146,of,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,handling,O
Sentence: 146,proteins,O
Sentence: 146,.,O
Sentence: 146,The,O
Sentence: 146,expression,O
Sentence: 146,analysis,O
Sentence: 146,of,O
Sentence: 146,apoptosis,O
Sentence: 146,-,O
Sentence: 146,related,O
Sentence: 146,proteins,O
Sentence: 146,revealed,O
Sentence: 146,that,O
Sentence: 146,pro,O
Sentence: 146,-,O
Sentence: 146,apoptotic,O
Sentence: 146,protein,O
Sentence: 146,expression,O
Sentence: 146,was,O
Sentence: 146,upregulated,O
Sentence: 146,",",O
Sentence: 146,and,O
Sentence: 146,anti,O
Sentence: 146,-,O
Sentence: 146,apoptotic,O
Sentence: 146,protein,O
Sentence: 146,BCL,O
Sentence: 146,-,O
Sentence: 146,2,O
Sentence: 146,expression,O
Sentence: 146,was,O
Sentence: 146,downregulated,O
Sentence: 146,.,O
Sentence: 146,Furthermore,O
Sentence: 146,",",O
Sentence: 146,increased,O
Sentence: 146,phosphorylation,O
Sentence: 146,of,O
Sentence: 146,MAPK,O
Sentence: 146,family,O
Sentence: 146,members,O
Sentence: 146,",",O
Sentence: 146,especially,O
Sentence: 146,the,O
Sentence: 146,P,O
Sentence: 146,-,O
Sentence: 146,P38,O
Sentence: 146,/,O
Sentence: 146,P38,O
Sentence: 146,ratio,O
Sentence: 146,was,O
Sentence: 146,found,O
Sentence: 146,in,O
Sentence: 146,cardiac,O
Sentence: 146,tissues,O
Sentence: 146,.,O
Sentence: 146,Hence,O
Sentence: 146,",",O
Sentence: 146,our,O
Sentence: 146,results,O
Sentence: 146,suggest,O
Sentence: 146,that,O
Sentence: 146,aconitine,B-Chemical
Sentence: 146,significantly,O
Sentence: 146,aggravates,O
Sentence: 146,Ca,B-Chemical
Sentence: 146,(,O
Sentence: 146,2+,O
Sentence: 146,),O
Sentence: 146,overload,O
Sentence: 146,and,O
Sentence: 146,causes,O
Sentence: 146,arrhythmia,B-Disease
Sentence: 146,and,O
Sentence: 146,finally,O
Sentence: 146,promotes,O
Sentence: 146,apoptotic,O
Sentence: 146,development,O
Sentence: 146,via,O
Sentence: 146,phosphorylation,O
Sentence: 146,of,O
Sentence: 146,P38,O
Sentence: 146,mitogen,O
Sentence: 146,-,O
Sentence: 146,activated,O
Sentence: 146,protein,O
Sentence: 146,kinase,O
Sentence: 146,.,O
Sentence: 147,Chronic,O
Sentence: 147,treatment,O
Sentence: 147,with,O
Sentence: 147,metformin,B-Chemical
Sentence: 147,suppresses,O
Sentence: 147,toll,O
Sentence: 147,-,O
Sentence: 147,like,O
Sentence: 147,receptor,O
Sentence: 147,4,O
Sentence: 147,signaling,O
Sentence: 147,and,O
Sentence: 147,attenuates,O
Sentence: 147,left,B-Disease
Sentence: 147,ventricular,I-Disease
Sentence: 147,dysfunction,I-Disease
Sentence: 147,following,O
Sentence: 147,myocardial,B-Disease
Sentence: 147,infarction,I-Disease
Sentence: 147,.,O
Sentence: 148,Acute,O
Sentence: 148,treatment,O
Sentence: 148,with,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,has,O
Sentence: 148,a,O
Sentence: 148,protective,O
Sentence: 148,effect,O
Sentence: 148,in,O
Sentence: 148,myocardial,B-Disease
Sentence: 148,infarction,I-Disease
Sentence: 148,by,O
Sentence: 148,suppression,O
Sentence: 148,of,O
Sentence: 148,inflammatory,O
Sentence: 148,responses,O
Sentence: 148,due,O
Sentence: 148,to,O
Sentence: 148,activation,O
Sentence: 148,of,O
Sentence: 148,AMP,B-Chemical
Sentence: 148,-,O
Sentence: 148,activated,O
Sentence: 148,protein,O
Sentence: 148,kinase,O
Sentence: 148,(,O
Sentence: 148,AMPK,O
Sentence: 148,),O
Sentence: 148,.,O
Sentence: 148,In,O
Sentence: 148,the,O
Sentence: 148,present,O
Sentence: 148,study,O
Sentence: 148,",",O
Sentence: 148,the,O
Sentence: 148,effect,O
Sentence: 148,of,O
Sentence: 148,chronic,O
Sentence: 148,pre,O
Sentence: 148,-,O
Sentence: 148,treatment,O
Sentence: 148,with,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,on,O
Sentence: 148,cardiac,B-Disease
Sentence: 148,dysfunction,I-Disease
Sentence: 148,and,O
Sentence: 148,toll,O
Sentence: 148,-,O
Sentence: 148,like,O
Sentence: 148,receptor,O
Sentence: 148,4,O
Sentence: 148,(,O
Sentence: 148,TLR4,O
Sentence: 148,),O
Sentence: 148,activities,O
Sentence: 148,following,O
Sentence: 148,myocardial,B-Disease
Sentence: 148,infarction,I-Disease
Sentence: 148,and,O
Sentence: 148,their,O
Sentence: 148,relation,O
Sentence: 148,with,O
Sentence: 148,AMPK,O
Sentence: 148,were,O
Sentence: 148,assessed,O
Sentence: 148,.,O
Sentence: 148,Male,O
Sentence: 148,Wistar,O
Sentence: 148,rats,O
Sentence: 148,were,O
Sentence: 148,randomly,O
Sentence: 148,assigned,O
Sentence: 148,to,O
Sentence: 148,one,O
Sentence: 148,of,O
Sentence: 148,5,O
Sentence: 148,groups,O
Sentence: 148,(,O
Sentence: 148,n,O
Sentence: 148,=,O
Sentence: 148,6,O
Sentence: 148,),O
Sentence: 148,:,O
Sentence: 148,normal,O
Sentence: 148,control,O
Sentence: 148,and,O
Sentence: 148,groups,O
Sentence: 148,were,O
Sentence: 148,injected,O
Sentence: 148,isoproterenol,B-Chemical
Sentence: 148,after,O
Sentence: 148,chronic,O
Sentence: 148,pre,O
Sentence: 148,-,O
Sentence: 148,treatment,O
Sentence: 148,with,O
Sentence: 148,0,O
Sentence: 148,",",O
Sentence: 148,25,O
Sentence: 148,",",O
Sentence: 148,50,O
Sentence: 148,",",O
Sentence: 148,or,O
Sentence: 148,100mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,of,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,twice,O
Sentence: 148,daily,O
Sentence: 148,for,O
Sentence: 148,14,O
Sentence: 148,days,O
Sentence: 148,.,O
Sentence: 148,Isoproterenol,B-Chemical
Sentence: 148,(,O
Sentence: 148,100mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,),O
Sentence: 148,was,O
Sentence: 148,injected,O
Sentence: 148,subcutaneously,O
Sentence: 148,on,O
Sentence: 148,the,O
Sentence: 148,13th,O
Sentence: 148,and,O
Sentence: 148,14th,O
Sentence: 148,days,O
Sentence: 148,to,O
Sentence: 148,induce,O
Sentence: 148,acute,B-Disease
Sentence: 148,myocardial,B-Disease
Sentence: 148,infarction,I-Disease
Sentence: 148,.,O
Sentence: 148,Isoproterenol,B-Chemical
Sentence: 148,alone,O
Sentence: 148,decreased,O
Sentence: 148,left,O
Sentence: 148,ventricular,O
Sentence: 148,systolic,O
Sentence: 148,pressure,O
Sentence: 148,and,O
Sentence: 148,myocardial,O
Sentence: 148,contractility,O
Sentence: 148,indexed,O
Sentence: 148,as,O
Sentence: 148,LVdp,O
Sentence: 148,/,O
Sentence: 148,dtmax,O
Sentence: 148,and,O
Sentence: 148,LVdp,O
Sentence: 148,/,O
Sentence: 148,dtmin,O
Sentence: 148,.,O
Sentence: 148,The,O
Sentence: 148,left,B-Disease
Sentence: 148,ventricular,I-Disease
Sentence: 148,dysfunction,I-Disease
Sentence: 148,was,O
Sentence: 148,significantly,O
Sentence: 148,lower,O
Sentence: 148,in,O
Sentence: 148,the,O
Sentence: 148,groups,O
Sentence: 148,treated,O
Sentence: 148,with,O
Sentence: 148,25,O
Sentence: 148,and,O
Sentence: 148,50mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,of,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,.,O
Sentence: 148,Metfromin,O
Sentence: 148,markedly,O
Sentence: 148,lowered,O
Sentence: 148,isoproterenol,B-Chemical
Sentence: 148,-,O
Sentence: 148,induced,O
Sentence: 148,elevation,O
Sentence: 148,in,O
Sentence: 148,the,O
Sentence: 148,levels,O
Sentence: 148,of,O
Sentence: 148,TLR4,O
Sentence: 148,mRNA,O
Sentence: 148,",",O
Sentence: 148,myeloid,O
Sentence: 148,differentiation,O
Sentence: 148,protein,O
Sentence: 148,88,O
Sentence: 148,(,O
Sentence: 148,MyD88,O
Sentence: 148,),O
Sentence: 148,",",O
Sentence: 148,tumor,B-Disease
Sentence: 148,necrosis,B-Disease
Sentence: 148,factor,O
Sentence: 148,-,O
Sentence: 148,alpha,O
Sentence: 148,(,O
Sentence: 148,TNF,O
Sentence: 148,-,O
Sentence: 148,a,O
Sentence: 148,),O
Sentence: 148,",",O
Sentence: 148,and,O
Sentence: 148,interleukin,O
Sentence: 148,6,O
Sentence: 148,(,O
Sentence: 148,IL,O
Sentence: 148,-,O
Sentence: 148,6,O
Sentence: 148,),O
Sentence: 148,in,O
Sentence: 148,the,O
Sentence: 148,heart,O
Sentence: 148,tissues,O
Sentence: 148,.,O
Sentence: 148,Similar,O
Sentence: 148,changes,O
Sentence: 148,were,O
Sentence: 148,also,O
Sentence: 148,seen,O
Sentence: 148,in,O
Sentence: 148,the,O
Sentence: 148,serum,O
Sentence: 148,levels,O
Sentence: 148,of,O
Sentence: 148,TNF,O
Sentence: 148,-,O
Sentence: 148,a,O
Sentence: 148,and,O
Sentence: 148,IL,O
Sentence: 148,-,O
Sentence: 148,6,O
Sentence: 148,.,O
Sentence: 148,However,O
Sentence: 148,",",O
Sentence: 148,the,O
Sentence: 148,lower,O
Sentence: 148,doses,O
Sentence: 148,of,O
Sentence: 148,25,O
Sentence: 148,and,O
Sentence: 148,50mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,were,O
Sentence: 148,more,O
Sentence: 148,effective,O
Sentence: 148,than,O
Sentence: 148,100mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,.,O
Sentence: 148,Phosphorylated,O
Sentence: 148,AMPKa,O
Sentence: 148,(,O
Sentence: 148,p,O
Sentence: 148,-,O
Sentence: 148,AMPK,O
Sentence: 148,),O
Sentence: 148,in,O
Sentence: 148,the,O
Sentence: 148,myocardium,O
Sentence: 148,was,O
Sentence: 148,significantly,O
Sentence: 148,elevated,O
Sentence: 148,by,O
Sentence: 148,25mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,of,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,",",O
Sentence: 148,slightly,O
Sentence: 148,by,O
Sentence: 148,50mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,",",O
Sentence: 148,but,O
Sentence: 148,not,O
Sentence: 148,by,O
Sentence: 148,100mg,O
Sentence: 148,/,O
Sentence: 148,kg,O
Sentence: 148,.,O
Sentence: 148,Chronic,O
Sentence: 148,pre,O
Sentence: 148,-,O
Sentence: 148,treatment,O
Sentence: 148,with,O
Sentence: 148,metformin,B-Chemical
Sentence: 148,reduces,O
Sentence: 148,post,O
Sentence: 148,-,O
Sentence: 148,myocardial,B-Disease
Sentence: 148,infarction,I-Disease
Sentence: 148,cardiac,B-Disease
Sentence: 148,dysfunction,I-Disease
Sentence: 148,and,O
Sentence: 148,suppresses,O
Sentence: 148,inflammatory,O
Sentence: 148,responses,O
Sentence: 148,",",O
Sentence: 148,possibly,O
Sentence: 148,through,O
Sentence: 148,inhibition,O
Sentence: 148,of,O
Sentence: 148,TLR4,O
Sentence: 148,activities,O
Sentence: 148,.,O
Sentence: 148,This,O
Sentence: 148,mechanism,O
Sentence: 148,can,O
Sentence: 148,be,O
Sentence: 148,considered,O
Sentence: 148,as,O
Sentence: 148,a,O
Sentence: 148,target,O
Sentence: 148,to,O
Sentence: 148,protect,O
Sentence: 148,infarcted,O
Sentence: 148,myocardium,O
Sentence: 148,.,O
Sentence: 149,Neuroleptic,B-Disease
Sentence: 149,malignant,I-Disease
Sentence: 149,syndrome,I-Disease
Sentence: 149,induced,O
Sentence: 149,by,O
Sentence: 149,combination,O
Sentence: 149,therapy,O
Sentence: 149,with,O
Sentence: 149,tetrabenazine,B-Chemical
Sentence: 149,and,O
Sentence: 149,tiapride,B-Chemical
Sentence: 149,in,O
Sentence: 149,a,O
Sentence: 149,Japanese,O
Sentence: 149,patient,O
Sentence: 149,with,O
Sentence: 149,Huntington,B-Disease
Sentence: 149,'s,I-Disease
Sentence: 149,disease,I-Disease
Sentence: 149,at,O
Sentence: 149,the,O
Sentence: 149,terminal,O
Sentence: 149,stage,O
Sentence: 149,of,O
Sentence: 149,recurrent,O
Sentence: 149,breast,B-Disease
Sentence: 149,cancer,I-Disease
Sentence: 149,.,O
Sentence: 150,We,O
Sentence: 150,herein,O
Sentence: 150,describe,O
Sentence: 150,the,O
Sentence: 150,case,O
Sentence: 150,of,O
Sentence: 150,an,O
Sentence: 150,81,O
Sentence: 150,-,O
Sentence: 150,year,O
Sentence: 150,-,O
Sentence: 150,old,O
Sentence: 150,Japanese,O
Sentence: 150,woman,O
Sentence: 150,with,O
Sentence: 150,neuroleptic,B-Disease
Sentence: 150,malignant,I-Disease
Sentence: 150,syndrome,I-Disease
Sentence: 150,that,O
Sentence: 150,occurred,O
Sentence: 150,36,O
Sentence: 150,days,O
Sentence: 150,after,O
Sentence: 150,the,O
Sentence: 150,initiation,O
Sentence: 150,of,O
Sentence: 150,combination,O
Sentence: 150,therapy,O
Sentence: 150,with,O
Sentence: 150,tiapride,B-Chemical
Sentence: 150,(,O
Sentence: 150,75,O
Sentence: 150,mg,O
Sentence: 150,/,O
Sentence: 150,day,O
Sentence: 150,),O
Sentence: 150,and,O
Sentence: 150,tetrabenazine,B-Chemical
Sentence: 150,(,O
Sentence: 150,12.5,O
Sentence: 150,mg,O
Sentence: 150,/,O
Sentence: 150,day,O
Sentence: 150,),O
Sentence: 150,for,O
Sentence: 150,Huntington,B-Disease
Sentence: 150,'s,I-Disease
Sentence: 150,disease,I-Disease
Sentence: 150,.,O
Sentence: 150,The,O
Sentence: 150,patient,O
Sentence: 150,had,O
Sentence: 150,been,O
Sentence: 150,treated,O
Sentence: 150,with,O
Sentence: 150,tiapride,B-Chemical
Sentence: 150,or,O
Sentence: 150,tetrabenazine,B-Chemical
Sentence: 150,alone,O
Sentence: 150,without,O
Sentence: 150,any,O
Sentence: 150,adverse,O
Sentence: 150,effects,O
Sentence: 150,before,O
Sentence: 150,the,O
Sentence: 150,administration,O
Sentence: 150,of,O
Sentence: 150,the,O
Sentence: 150,combination,O
Sentence: 150,therapy,O
Sentence: 150,.,O
Sentence: 150,She,O
Sentence: 150,also,O
Sentence: 150,had,O
Sentence: 150,advanced,O
Sentence: 150,breast,B-Disease
Sentence: 150,cancer,I-Disease
Sentence: 150,when,O
Sentence: 150,the,O
Sentence: 150,combination,O
Sentence: 150,therapy,O
Sentence: 150,was,O
Sentence: 150,initiated,O
Sentence: 150,.,O
Sentence: 150,To,O
Sentence: 150,the,O
Sentence: 150,best,O
Sentence: 150,of,O
Sentence: 150,our,O
Sentence: 150,knowledge,O
Sentence: 150,",",O
Sentence: 150,the,O
Sentence: 150,occurrence,O
Sentence: 150,of,O
Sentence: 150,neuroleptic,B-Disease
Sentence: 150,malignant,I-Disease
Sentence: 150,syndrome,I-Disease
Sentence: 150,due,O
Sentence: 150,to,O
Sentence: 150,combination,O
Sentence: 150,therapy,O
Sentence: 150,with,O
Sentence: 150,tetrabenazine,B-Chemical
Sentence: 150,and,O
Sentence: 150,tiapride,B-Chemical
Sentence: 150,has,O
Sentence: 150,not,O
Sentence: 150,been,O
Sentence: 150,previously,O
Sentence: 150,reported,O
Sentence: 150,.,O
Sentence: 150,Tetrabenazine,B-Chemical
Sentence: 150,should,O
Sentence: 150,be,O
Sentence: 150,administered,O
Sentence: 150,very,O
Sentence: 150,carefully,O
Sentence: 150,in,O
Sentence: 150,combination,O
Sentence: 150,with,O
Sentence: 150,other,O
Sentence: 150,neuroleptic,B-Chemical
Sentence: 150,drugs,I-Chemical
Sentence: 150,",",O
Sentence: 150,particularly,O
Sentence: 150,in,O
Sentence: 150,patients,O
Sentence: 150,with,O
Sentence: 150,a,O
Sentence: 150,worsening,O
Sentence: 150,general,O
Sentence: 150,condition,O
Sentence: 150,.,O
Sentence: 151,A,O
Sentence: 151,metoprolol,B-Chemical
Sentence: 151,-,O
Sentence: 151,terbinafine,B-Chemical
Sentence: 151,combination,O
Sentence: 151,induced,O
Sentence: 151,bradycardia,B-Disease
Sentence: 151,.,O
Sentence: 152,To,O
Sentence: 152,report,O
Sentence: 152,a,O
Sentence: 152,sinus,B-Disease
Sentence: 152,bradycardia,I-Disease
Sentence: 152,induced,O
Sentence: 152,by,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,and,O
Sentence: 152,terbinafine,B-Chemical
Sentence: 152,drug,O
Sentence: 152,-,O
Sentence: 152,drug,O
Sentence: 152,interaction,O
Sentence: 152,and,O
Sentence: 152,its,O
Sentence: 152,management,O
Sentence: 152,.,O
Sentence: 152,A,O
Sentence: 152,63,O
Sentence: 152,year,O
Sentence: 152,-,O
Sentence: 152,old,O
Sentence: 152,Caucasian,O
Sentence: 152,man,O
Sentence: 152,on,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,200,O
Sentence: 152,mg,O
Sentence: 152,/,O
Sentence: 152,day,O
Sentence: 152,for,O
Sentence: 152,stable,O
Sentence: 152,coronary,B-Disease
Sentence: 152,artery,I-Disease
Sentence: 152,disease,I-Disease
Sentence: 152,was,O
Sentence: 152,prescribed,O
Sentence: 152,a,O
Sentence: 152,90,O
Sentence: 152,-,O
Sentence: 152,day,O
Sentence: 152,course,O
Sentence: 152,of,O
Sentence: 152,oral,O
Sentence: 152,terbinafine,B-Chemical
Sentence: 152,250,O
Sentence: 152,mg,O
Sentence: 152,/,O
Sentence: 152,day,O
Sentence: 152,for,O
Sentence: 152,onychomycosis,B-Disease
Sentence: 152,.,O
Sentence: 152,On,O
Sentence: 152,the,O
Sentence: 152,49th,O
Sentence: 152,day,O
Sentence: 152,of,O
Sentence: 152,terbinafine,B-Chemical
Sentence: 152,therapy,O
Sentence: 152,",",O
Sentence: 152,he,O
Sentence: 152,was,O
Sentence: 152,brought,O
Sentence: 152,to,O
Sentence: 152,the,O
Sentence: 152,emergency,O
Sentence: 152,room,O
Sentence: 152,for,O
Sentence: 152,a,O
Sentence: 152,decrease,O
Sentence: 152,of,O
Sentence: 152,his,O
Sentence: 152,global,O
Sentence: 152,health,O
Sentence: 152,status,O
Sentence: 152,",",O
Sentence: 152,confusion,B-Disease
Sentence: 152,and,O
Sentence: 152,falls,O
Sentence: 152,.,O
Sentence: 152,The,O
Sentence: 152,electrocardiogram,O
Sentence: 152,revealed,O
Sentence: 152,a,O
Sentence: 152,37,O
Sentence: 152,beats,O
Sentence: 152,/,O
Sentence: 152,min,O
Sentence: 152,sinus,B-Disease
Sentence: 152,bradycardia,I-Disease
Sentence: 152,.,O
Sentence: 152,A,O
Sentence: 152,score,O
Sentence: 152,of,O
Sentence: 152,7,O
Sentence: 152,on,O
Sentence: 152,the,O
Sentence: 152,Naranjo,O
Sentence: 152,adverse,B-Disease
Sentence: 152,drug,I-Disease
Sentence: 152,reaction,I-Disease
Sentence: 152,probability,O
Sentence: 152,scale,O
Sentence: 152,indicates,O
Sentence: 152,a,O
Sentence: 152,probable,O
Sentence: 152,relationship,O
Sentence: 152,between,O
Sentence: 152,the,O
Sentence: 152,patient,O
Sentence: 152,'s,O
Sentence: 152,sinus,B-Disease
Sentence: 152,bradycardia,I-Disease
Sentence: 152,and,O
Sentence: 152,the,O
Sentence: 152,drug,O
Sentence: 152,interaction,O
Sentence: 152,between,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,and,O
Sentence: 152,terbinafine,B-Chemical
Sentence: 152,.,O
Sentence: 152,The,O
Sentence: 152,heart,O
Sentence: 152,rate,O
Sentence: 152,ameliorated,O
Sentence: 152,first,O
Sentence: 152,with,O
Sentence: 152,a,O
Sentence: 152,decrease,O
Sentence: 152,in,O
Sentence: 152,the,O
Sentence: 152,dose,O
Sentence: 152,of,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,.,O
Sentence: 152,It,O
Sentence: 152,was,O
Sentence: 152,subsequently,O
Sentence: 152,changed,O
Sentence: 152,to,O
Sentence: 152,bisoprolol,B-Chemical
Sentence: 152,and,O
Sentence: 152,the,O
Sentence: 152,heart,O
Sentence: 152,rate,O
Sentence: 152,remained,O
Sentence: 152,normal,O
Sentence: 152,.,O
Sentence: 152,By,O
Sentence: 152,inhibiting,O
Sentence: 152,the,O
Sentence: 152,cytochrome,O
Sentence: 152,P450,O
Sentence: 152,2D6,O
Sentence: 152,",",O
Sentence: 152,terbinafine,B-Chemical
Sentence: 152,had,O
Sentence: 152,decreased,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,'s,O
Sentence: 152,clearance,O
Sentence: 152,",",O
Sentence: 152,leading,O
Sentence: 152,in,O
Sentence: 152,metoprolol,B-Chemical
Sentence: 152,accumulation,O
Sentence: 152,which,O
Sentence: 152,has,O
Sentence: 152,resulted,O
Sentence: 152,in,O
Sentence: 152,clinically,O
Sentence: 152,significant,O
Sentence: 152,sinus,B-Disease
Sentence: 152,bradycardia,I-Disease
Sentence: 152,.,O
Sentence: 153,Optochiasmatic,O
Sentence: 153,and,O
Sentence: 153,peripheral,B-Disease
Sentence: 153,neuropathy,I-Disease
Sentence: 153,due,O
Sentence: 153,to,O
Sentence: 153,ethambutol,B-Chemical
Sentence: 153,overtreatment,O
Sentence: 153,.,O
Sentence: 154,Ethambutol,B-Chemical
Sentence: 154,is,O
Sentence: 154,known,O
Sentence: 154,to,O
Sentence: 154,cause,O
Sentence: 154,optic,B-Disease
Sentence: 154,neuropathy,I-Disease
Sentence: 154,and,O
Sentence: 154,",",O
Sentence: 154,more,O
Sentence: 154,rarely,O
Sentence: 154,",",O
Sentence: 154,axonal,O
Sentence: 154,polyneuropathy,B-Disease
Sentence: 154,.,O
Sentence: 154,We,O
Sentence: 154,characterize,O
Sentence: 154,the,O
Sentence: 154,clinical,O
Sentence: 154,",",O
Sentence: 154,neurophysiological,O
Sentence: 154,",",O
Sentence: 154,and,O
Sentence: 154,neuroimaging,O
Sentence: 154,findings,O
Sentence: 154,in,O
Sentence: 154,a,O
Sentence: 154,72,O
Sentence: 154,-,O
Sentence: 154,year,O
Sentence: 154,-,O
Sentence: 154,old,O
Sentence: 154,man,O
Sentence: 154,who,O
Sentence: 154,developed,O
Sentence: 154,visual,B-Disease
Sentence: 154,loss,I-Disease
Sentence: 154,and,O
Sentence: 154,paresthesias,B-Disease
Sentence: 154,after,O
Sentence: 154,11,O
Sentence: 154,weeks,O
Sentence: 154,of,O
Sentence: 154,exposure,O
Sentence: 154,to,O
Sentence: 154,a,O
Sentence: 154,supratherapeutic,O
Sentence: 154,dose,O
Sentence: 154,of,O
Sentence: 154,ethambutol,B-Chemical
Sentence: 154,.,O
Sentence: 154,This,O
Sentence: 154,case,O
Sentence: 154,demonstrates,O
Sentence: 154,the,O
Sentence: 154,selective,O
Sentence: 154,vulnerability,O
Sentence: 154,of,O
Sentence: 154,the,O
Sentence: 154,anterior,O
Sentence: 154,visual,O
Sentence: 154,pathways,O
Sentence: 154,and,O
Sentence: 154,peripheral,O
Sentence: 154,nerves,O
Sentence: 154,to,O
Sentence: 154,ethambutol,B-Chemical
Sentence: 154,toxicity,B-Disease
Sentence: 154,.,O
Sentence: 155,Testosterone,B-Chemical
Sentence: 155,ameliorates,O
Sentence: 155,streptozotocin,B-Chemical
Sentence: 155,-,O
Sentence: 155,induced,O
Sentence: 155,memory,B-Disease
Sentence: 155,impairment,I-Disease
Sentence: 155,in,O
Sentence: 155,male,O
Sentence: 155,rats,O
Sentence: 155,.,O
Sentence: 156,AIM,O
Sentence: 156,:,O
Sentence: 156,To,O
Sentence: 156,study,O
Sentence: 156,the,O
Sentence: 156,effects,O
Sentence: 156,of,O
Sentence: 156,testosterone,B-Chemical
Sentence: 156,on,O
Sentence: 156,streptozotocin,B-Chemical
Sentence: 156,(,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,),O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,induced,O
Sentence: 156,memory,B-Disease
Sentence: 156,impairment,I-Disease
Sentence: 156,in,O
Sentence: 156,male,O
Sentence: 156,rats,O
Sentence: 156,.,O
Sentence: 156,METHODS,O
Sentence: 156,:,O
Sentence: 156,Adult,O
Sentence: 156,male,O
Sentence: 156,Wistar,O
Sentence: 156,rats,O
Sentence: 156,were,O
Sentence: 156,intracerebroventricularly,O
Sentence: 156,(,O
Sentence: 156,icv,O
Sentence: 156,),O
Sentence: 156,infused,O
Sentence: 156,with,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,(,O
Sentence: 156,750,O
Sentence: 156,ug,O
Sentence: 156,),O
Sentence: 156,on,O
Sentence: 156,d,O
Sentence: 156,1,O
Sentence: 156,and,O
Sentence: 156,d,O
Sentence: 156,3,O
Sentence: 156,",",O
Sentence: 156,and,O
Sentence: 156,a,O
Sentence: 156,passive,O
Sentence: 156,avoidance,O
Sentence: 156,task,O
Sentence: 156,was,O
Sentence: 156,assessed,O
Sentence: 156,2,O
Sentence: 156,weeks,O
Sentence: 156,after,O
Sentence: 156,the,O
Sentence: 156,first,O
Sentence: 156,injection,O
Sentence: 156,of,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,.,O
Sentence: 156,Castration,O
Sentence: 156,surgery,O
Sentence: 156,was,O
Sentence: 156,performed,O
Sentence: 156,in,O
Sentence: 156,another,O
Sentence: 156,group,O
Sentence: 156,of,O
Sentence: 156,rats,O
Sentence: 156,",",O
Sentence: 156,and,O
Sentence: 156,the,O
Sentence: 156,passive,O
Sentence: 156,avoidance,O
Sentence: 156,task,O
Sentence: 156,was,O
Sentence: 156,assessed,O
Sentence: 156,4,O
Sentence: 156,weeks,O
Sentence: 156,after,O
Sentence: 156,the,O
Sentence: 156,operation,O
Sentence: 156,.,O
Sentence: 156,Testosterone,B-Chemical
Sentence: 156,(,O
Sentence: 156,1,O
Sentence: 156,mg.kg,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,.d,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,sc,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,the,O
Sentence: 156,androgen,B-Chemical
Sentence: 156,receptor,O
Sentence: 156,antagonist,O
Sentence: 156,flutamide,B-Chemical
Sentence: 156,(,O
Sentence: 156,10,O
Sentence: 156,mg.kg,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,.d,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,ip,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,the,O
Sentence: 156,estrogen,B-Chemical
Sentence: 156,receptor,O
Sentence: 156,antagonist,O
Sentence: 156,tamoxifen,B-Chemical
Sentence: 156,(,O
Sentence: 156,1,O
Sentence: 156,mg.kg,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,.d,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,ip,O
Sentence: 156,),O
Sentence: 156,or,O
Sentence: 156,the,O
Sentence: 156,aromatase,O
Sentence: 156,inhibitor,O
Sentence: 156,letrozole,B-Chemical
Sentence: 156,(,O
Sentence: 156,4,O
Sentence: 156,mg.kg,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,.d,O
Sentence: 156,(,O
Sentence: 156,,O
Sentence: 156,-,O
Sentence: 156,1,O
Sentence: 156,),O
Sentence: 156,",",O
Sentence: 156,ip,O
Sentence: 156,),O
Sentence: 156,were,O
Sentence: 156,administered,O
Sentence: 156,for,O
Sentence: 156,6,O
Sentence: 156,d,O
Sentence: 156,after,O
Sentence: 156,the,O
Sentence: 156,first,O
Sentence: 156,injection,O
Sentence: 156,of,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,.,O
Sentence: 156,RESULTS,O
Sentence: 156,:,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,administration,O
Sentence: 156,and,O
Sentence: 156,castration,O
Sentence: 156,markedly,O
Sentence: 156,decreased,O
Sentence: 156,both,O
Sentence: 156,STL1,O
Sentence: 156,(,O
Sentence: 156,the,O
Sentence: 156,short,O
Sentence: 156,memory,O
Sentence: 156,),O
Sentence: 156,and,O
Sentence: 156,STL2,O
Sentence: 156,(,O
Sentence: 156,the,O
Sentence: 156,long,O
Sentence: 156,memory,O
Sentence: 156,),O
Sentence: 156,in,O
Sentence: 156,passive,O
Sentence: 156,avoidance,O
Sentence: 156,tests,O
Sentence: 156,.,O
Sentence: 156,Testosterone,B-Chemical
Sentence: 156,replacement,O
Sentence: 156,almost,O
Sentence: 156,restored,O
Sentence: 156,the,O
Sentence: 156,STL1,O
Sentence: 156,and,O
Sentence: 156,STL2,O
Sentence: 156,in,O
Sentence: 156,castrated,O
Sentence: 156,rats,O
Sentence: 156,",",O
Sentence: 156,and,O
Sentence: 156,significantly,O
Sentence: 156,prolonged,O
Sentence: 156,the,O
Sentence: 156,STL1,O
Sentence: 156,and,O
Sentence: 156,STL2,O
Sentence: 156,in,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,-,O
Sentence: 156,treated,O
Sentence: 156,rats,O
Sentence: 156,.,O
Sentence: 156,Administration,O
Sentence: 156,of,O
Sentence: 156,flutamide,B-Chemical
Sentence: 156,",",O
Sentence: 156,letrozole,B-Chemical
Sentence: 156,or,O
Sentence: 156,tamoxifen,B-Chemical
Sentence: 156,significantly,O
Sentence: 156,impaired,B-Disease
Sentence: 156,the,I-Disease
Sentence: 156,memory,I-Disease
Sentence: 156,in,O
Sentence: 156,intact,O
Sentence: 156,rats,O
Sentence: 156,",",O
Sentence: 156,and,O
Sentence: 156,significantly,O
Sentence: 156,attenuated,O
Sentence: 156,the,O
Sentence: 156,testosterone,B-Chemical
Sentence: 156,replacement,O
Sentence: 156,in,O
Sentence: 156,improving,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,-,O
Sentence: 156,,O
Sentence: 156,and,O
Sentence: 156,castration,O
Sentence: 156,-,O
Sentence: 156,induced,O
Sentence: 156,memory,B-Disease
Sentence: 156,impairment,I-Disease
Sentence: 156,.,O
Sentence: 156,CONCLUSION,O
Sentence: 156,:,O
Sentence: 156,Testosterone,B-Chemical
Sentence: 156,administration,O
Sentence: 156,ameliorates,O
Sentence: 156,STZ,B-Chemical
Sentence: 156,-,O
Sentence: 156,,O
Sentence: 156,and,O
Sentence: 156,castration,O
Sentence: 156,-,O
Sentence: 156,induced,O
Sentence: 156,memory,B-Disease
Sentence: 156,impairment,I-Disease
Sentence: 156,in,O
Sentence: 156,male,O
Sentence: 156,Wistar,O
Sentence: 156,rats,O
Sentence: 156,.,O
Sentence: 157,Behavioral,O
Sentence: 157,and,O
Sentence: 157,neurochemical,O
Sentence: 157,studies,O
Sentence: 157,in,O
Sentence: 157,mice,O
Sentence: 157,pretreated,O
Sentence: 157,with,O
Sentence: 157,garcinielliptone,B-Chemical
Sentence: 157,FC,I-Chemical
Sentence: 157,in,O
Sentence: 157,pilocarpine,B-Chemical
Sentence: 157,-,O
Sentence: 157,induced,O
Sentence: 157,seizures,B-Disease
Sentence: 157,.,O
Sentence: 158,Garcinielliptone,B-Chemical
Sentence: 158,FC,I-Chemical
Sentence: 158,(,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,),O
Sentence: 158,isolated,O
Sentence: 158,from,O
Sentence: 158,hexanic,O
Sentence: 158,fraction,O
Sentence: 158,seed,O
Sentence: 158,extract,O
Sentence: 158,of,O
Sentence: 158,species,O
Sentence: 158,Platonia,O
Sentence: 158,insignis,O
Sentence: 158,Mart,O
Sentence: 158,.,O
Sentence: 158,It,O
Sentence: 158,is,O
Sentence: 158,widely,O
Sentence: 158,used,O
Sentence: 158,in,O
Sentence: 158,folk,O
Sentence: 158,medicine,O
Sentence: 158,to,O
Sentence: 158,treat,O
Sentence: 158,skin,B-Disease
Sentence: 158,diseases,I-Disease
Sentence: 158,in,O
Sentence: 158,both,O
Sentence: 158,humans,O
Sentence: 158,and,O
Sentence: 158,animals,O
Sentence: 158,as,O
Sentence: 158,well,O
Sentence: 158,as,O
Sentence: 158,the,O
Sentence: 158,seed,O
Sentence: 158,decoction,O
Sentence: 158,has,O
Sentence: 158,been,O
Sentence: 158,used,O
Sentence: 158,to,O
Sentence: 158,treat,O
Sentence: 158,diarrheas,B-Disease
Sentence: 158,and,O
Sentence: 158,inflammatory,B-Disease
Sentence: 158,diseases,I-Disease
Sentence: 158,.,O
Sentence: 158,However,O
Sentence: 158,",",O
Sentence: 158,there,O
Sentence: 158,is,O
Sentence: 158,no,O
Sentence: 158,research,O
Sentence: 158,on,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,effects,O
Sentence: 158,in,O
Sentence: 158,the,O
Sentence: 158,central,O
Sentence: 158,nervous,O
Sentence: 158,system,O
Sentence: 158,of,O
Sentence: 158,rodents,O
Sentence: 158,.,O
Sentence: 158,The,O
Sentence: 158,present,O
Sentence: 158,study,O
Sentence: 158,aimed,O
Sentence: 158,to,O
Sentence: 158,evaluate,O
Sentence: 158,the,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,effects,O
Sentence: 158,at,O
Sentence: 158,doses,O
Sentence: 158,of,O
Sentence: 158,25,O
Sentence: 158,",",O
Sentence: 158,50,O
Sentence: 158,or,O
Sentence: 158,75,O
Sentence: 158,mg,O
Sentence: 158,/,O
Sentence: 158,kg,O
Sentence: 158,on,O
Sentence: 158,seizure,B-Disease
Sentence: 158,parameters,O
Sentence: 158,to,O
Sentence: 158,determine,O
Sentence: 158,their,O
Sentence: 158,anticonvulsant,O
Sentence: 158,activity,O
Sentence: 158,and,O
Sentence: 158,its,O
Sentence: 158,effects,O
Sentence: 158,on,O
Sentence: 158,amino,B-Chemical
Sentence: 158,acid,I-Chemical
Sentence: 158,(,O
Sentence: 158,r,O
Sentence: 158,-,O
Sentence: 158,aminobutyric,O
Sentence: 158,acid,O
Sentence: 158,(,O
Sentence: 158,GABA,B-Chemical
Sentence: 158,),O
Sentence: 158,",",O
Sentence: 158,glutamine,B-Chemical
Sentence: 158,",",O
Sentence: 158,aspartate,B-Chemical
Sentence: 158,and,O
Sentence: 158,glutathione,B-Chemical
Sentence: 158,),O
Sentence: 158,levels,O
Sentence: 158,as,O
Sentence: 158,well,O
Sentence: 158,as,O
Sentence: 158,on,O
Sentence: 158,acetylcholinesterase,O
Sentence: 158,(,O
Sentence: 158,AChE,O
Sentence: 158,),O
Sentence: 158,activity,O
Sentence: 158,in,O
Sentence: 158,mice,O
Sentence: 158,hippocampus,O
Sentence: 158,after,O
Sentence: 158,seizures,B-Disease
Sentence: 158,.,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,produced,O
Sentence: 158,an,O
Sentence: 158,increased,O
Sentence: 158,latency,O
Sentence: 158,to,O
Sentence: 158,first,O
Sentence: 158,seizure,B-Disease
Sentence: 158,",",O
Sentence: 158,at,O
Sentence: 158,doses,O
Sentence: 158,25mg,O
Sentence: 158,/,O
Sentence: 158,kg,O
Sentence: 158,(,O
Sentence: 158,20.12,O
Sentence: 158,+,O
Sentence: 158,2.20,O
Sentence: 158,min,O
Sentence: 158,),O
Sentence: 158,",",O
Sentence: 158,50mg,O
Sentence: 158,/,O
Sentence: 158,kg,O
Sentence: 158,(,O
Sentence: 158,20.95,O
Sentence: 158,+,O
Sentence: 158,2.21,O
Sentence: 158,min,O
Sentence: 158,),O
Sentence: 158,or,O
Sentence: 158,75,O
Sentence: 158,mg,O
Sentence: 158,/,O
Sentence: 158,kg,O
Sentence: 158,(,O
Sentence: 158,23.43,O
Sentence: 158,+,O
Sentence: 158,1.99,O
Sentence: 158,min,O
Sentence: 158,),O
Sentence: 158,when,O
Sentence: 158,compared,O
Sentence: 158,with,O
Sentence: 158,seized,O
Sentence: 158,mice,O
Sentence: 158,.,O
Sentence: 158,In,O
Sentence: 158,addition,O
Sentence: 158,",",O
Sentence: 158,GABA,B-Chemical
Sentence: 158,content,O
Sentence: 158,of,O
Sentence: 158,mice,O
Sentence: 158,hippocampus,O
Sentence: 158,treated,O
Sentence: 158,with,O
Sentence: 158,GFC75,O
Sentence: 158,plus,O
Sentence: 158,P400,O
Sentence: 158,showed,O
Sentence: 158,an,O
Sentence: 158,increase,O
Sentence: 158,of,O
Sentence: 158,46.90,O
Sentence: 158,%,O
Sentence: 158,when,O
Sentence: 158,compared,O
Sentence: 158,with,O
Sentence: 158,seized,O
Sentence: 158,mice,O
Sentence: 158,.,O
Sentence: 158,In,O
Sentence: 158,aspartate,B-Chemical
Sentence: 158,",",O
Sentence: 158,glutamine,B-Chemical
Sentence: 158,and,O
Sentence: 158,glutamate,B-Chemical
Sentence: 158,levels,O
Sentence: 158,detected,O
Sentence: 158,a,O
Sentence: 158,decrease,O
Sentence: 158,of,O
Sentence: 158,5.21,O
Sentence: 158,%,O
Sentence: 158,",",O
Sentence: 158,13.55,O
Sentence: 158,%,O
Sentence: 158,and,O
Sentence: 158,21.80,O
Sentence: 158,%,O
Sentence: 158,",",O
Sentence: 158,respectively,O
Sentence: 158,in,O
Sentence: 158,mice,O
Sentence: 158,hippocampus,O
Sentence: 158,treated,O
Sentence: 158,with,O
Sentence: 158,GFC75,O
Sentence: 158,plus,O
Sentence: 158,P400,O
Sentence: 158,when,O
Sentence: 158,compared,O
Sentence: 158,with,O
Sentence: 158,seized,O
Sentence: 158,mice,O
Sentence: 158,.,O
Sentence: 158,Hippocampus,O
Sentence: 158,mice,O
Sentence: 158,treated,O
Sentence: 158,with,O
Sentence: 158,GFC75,O
Sentence: 158,plus,O
Sentence: 158,P400,O
Sentence: 158,showed,O
Sentence: 158,an,O
Sentence: 158,increase,O
Sentence: 158,in,O
Sentence: 158,AChE,O
Sentence: 158,activity,O
Sentence: 158,(,O
Sentence: 158,63.30,O
Sentence: 158,%,O
Sentence: 158,),O
Sentence: 158,when,O
Sentence: 158,compared,O
Sentence: 158,with,O
Sentence: 158,seized,O
Sentence: 158,mice,O
Sentence: 158,.,O
Sentence: 158,The,O
Sentence: 158,results,O
Sentence: 158,indicate,O
Sentence: 158,that,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,can,O
Sentence: 158,exert,O
Sentence: 158,anticonvulsant,O
Sentence: 158,activity,O
Sentence: 158,and,O
Sentence: 158,reduce,O
Sentence: 158,the,O
Sentence: 158,frequency,O
Sentence: 158,of,O
Sentence: 158,installation,O
Sentence: 158,of,O
Sentence: 158,pilocarpine,B-Chemical
Sentence: 158,-,O
Sentence: 158,induced,O
Sentence: 158,status,B-Disease
Sentence: 158,epilepticus,I-Disease
Sentence: 158,",",O
Sentence: 158,as,O
Sentence: 158,demonstrated,O
Sentence: 158,by,O
Sentence: 158,increase,O
Sentence: 158,in,O
Sentence: 158,latency,O
Sentence: 158,to,O
Sentence: 158,first,O
Sentence: 158,seizure,B-Disease
Sentence: 158,and,O
Sentence: 158,decrease,O
Sentence: 158,in,O
Sentence: 158,mortality,O
Sentence: 158,rate,O
Sentence: 158,of,O
Sentence: 158,animals,O
Sentence: 158,.,O
Sentence: 158,In,O
Sentence: 158,conclusion,O
Sentence: 158,",",O
Sentence: 158,our,O
Sentence: 158,data,O
Sentence: 158,suggest,O
Sentence: 158,that,O
Sentence: 158,GFC,B-Chemical
Sentence: 158,may,O
Sentence: 158,influence,O
Sentence: 158,in,O
Sentence: 158,epileptogenesis,O
Sentence: 158,and,O
Sentence: 158,promote,O
Sentence: 158,anticonvulsant,O
Sentence: 158,actions,O
Sentence: 158,in,O
Sentence: 158,pilocarpine,B-Chemical
Sentence: 158,model,O
Sentence: 158,by,O
Sentence: 158,modulating,O
Sentence: 158,the,O
Sentence: 158,GABA,B-Chemical
Sentence: 158,and,O
Sentence: 158,glutamate,B-Chemical
Sentence: 158,contents,O
Sentence: 158,and,O
Sentence: 158,of,O
Sentence: 158,AChE,O
Sentence: 158,activity,O
Sentence: 158,in,O
Sentence: 158,seized,O
Sentence: 158,mice,O
Sentence: 158,hippocampus,O
Sentence: 158,.,O
Sentence: 158,This,O
Sentence: 158,compound,O
Sentence: 158,may,O
Sentence: 158,be,O
Sentence: 158,useful,O
Sentence: 158,to,O
Sentence: 158,produce,O
Sentence: 158,neuronal,O
Sentence: 158,protection,O
Sentence: 158,and,O
Sentence: 158,it,O
Sentence: 158,can,O
Sentence: 158,be,O
Sentence: 158,considered,O
Sentence: 158,as,O
Sentence: 158,an,O
Sentence: 158,anticonvulsant,O
Sentence: 158,agent,O
Sentence: 158,.,O
Sentence: 159,Standard,O
Sentence: 159,operating,O
Sentence: 159,procedures,O
Sentence: 159,for,O
Sentence: 159,antibiotic,O
Sentence: 159,therapy,O
Sentence: 159,and,O
Sentence: 159,the,O
Sentence: 159,occurrence,O
Sentence: 159,of,O
Sentence: 159,acute,O
Sentence: 159,kidney,O
Sentence: 159,injury,O
Sentence: 159,:,O
Sentence: 159,a,O
Sentence: 159,prospective,O
Sentence: 159,",",O
Sentence: 159,clinical,O
Sentence: 159,",",O
Sentence: 159,non,O
Sentence: 159,-,O
Sentence: 159,interventional,O
Sentence: 159,",",O
Sentence: 159,observational,O
Sentence: 159,study,O
Sentence: 159,.,O
Sentence: 160,INTRODUCTION,O
Sentence: 160,:,O
Sentence: 160,Acute,B-Disease
Sentence: 160,kidney,I-Disease
Sentence: 160,injury,I-Disease
Sentence: 160,(,O
Sentence: 160,AKI,B-Disease
Sentence: 160,),O
Sentence: 160,occurs,O
Sentence: 160,in,O
Sentence: 160,7,O
Sentence: 160,%,O
Sentence: 160,of,O
Sentence: 160,hospitalized,O
Sentence: 160,and,O
Sentence: 160,66,O
Sentence: 160,%,O
Sentence: 160,of,O
Sentence: 160,Intensive,O
Sentence: 160,Care,O
Sentence: 160,Unit,O
Sentence: 160,(,O
Sentence: 160,ICU,O
Sentence: 160,),O
Sentence: 160,patients,O
Sentence: 160,.,O
Sentence: 160,It,O
Sentence: 160,increases,O
Sentence: 160,mortality,O
Sentence: 160,",",O
Sentence: 160,hospital,O
Sentence: 160,length,O
Sentence: 160,of,O
Sentence: 160,stay,O
Sentence: 160,",",O
Sentence: 160,and,O
Sentence: 160,costs,O
Sentence: 160,.,O
Sentence: 160,The,O
Sentence: 160,aim,O
Sentence: 160,of,O
Sentence: 160,this,O
Sentence: 160,study,O
Sentence: 160,was,O
Sentence: 160,to,O
Sentence: 160,investigate,O
Sentence: 160,",",O
Sentence: 160,whether,O
Sentence: 160,there,O
Sentence: 160,is,O
Sentence: 160,an,O
Sentence: 160,association,O
Sentence: 160,between,O
Sentence: 160,adherence,O
Sentence: 160,to,O
Sentence: 160,guidelines,O
Sentence: 160,(,O
Sentence: 160,standard,O
Sentence: 160,operating,O
Sentence: 160,procedures,O
Sentence: 160,(,O
Sentence: 160,SOP,O
Sentence: 160,),O
Sentence: 160,),O
Sentence: 160,for,O
Sentence: 160,potentially,O
Sentence: 160,nephrotoxic,B-Disease
Sentence: 160,antibiotics,O
Sentence: 160,and,O
Sentence: 160,the,O
Sentence: 160,occurrence,O
Sentence: 160,of,O
Sentence: 160,AKI,B-Disease
Sentence: 160,.,O
Sentence: 160,METHODS,O
Sentence: 160,:,O
Sentence: 160,This,O
Sentence: 160,study,O
Sentence: 160,was,O
Sentence: 160,carried,O
Sentence: 160,out,O
Sentence: 160,as,O
Sentence: 160,a,O
Sentence: 160,prospective,O
Sentence: 160,",",O
Sentence: 160,clinical,O
Sentence: 160,",",O
Sentence: 160,non,O
Sentence: 160,-,O
Sentence: 160,interventional,O
Sentence: 160,",",O
Sentence: 160,observational,O
Sentence: 160,study,O
Sentence: 160,.,O
Sentence: 160,Data,O
Sentence: 160,collection,O
Sentence: 160,was,O
Sentence: 160,performed,O
Sentence: 160,over,O
Sentence: 160,a,O
Sentence: 160,total,O
Sentence: 160,of,O
Sentence: 160,170,O
Sentence: 160,days,O
Sentence: 160,in,O
Sentence: 160,three,O
Sentence: 160,ICUs,O
Sentence: 160,at,O
Sentence: 160,Charite,O
Sentence: 160,,O
Sentence: 160,-,O
Sentence: 160,,O
Sentence: 160,Universitaetsmedizin,O
Sentence: 160,Berlin,O
Sentence: 160,.,O
Sentence: 160,A,O
Sentence: 160,total,O
Sentence: 160,of,O
Sentence: 160,675,O
Sentence: 160,patients,O
Sentence: 160,were,O
Sentence: 160,included,O
Sentence: 160,;,O
Sentence: 160,163,O
Sentence: 160,of,O
Sentence: 160,these,O
Sentence: 160,had,O
Sentence: 160,therapy,O
Sentence: 160,with,O
Sentence: 160,vancomycin,B-Chemical
Sentence: 160,",",O
Sentence: 160,gentamicin,B-Chemical
Sentence: 160,",",O
Sentence: 160,or,O
Sentence: 160,tobramycin,B-Chemical
Sentence: 160,;,O
Sentence: 160,were,O
Sentence: 160,,O
Sentence: 160,>,O
Sentence: 160,,O
Sentence: 160,18,O
Sentence: 160,years,O
Sentence: 160,;,O
Sentence: 160,and,O
Sentence: 160,treated,O
Sentence: 160,in,O
Sentence: 160,the,O
Sentence: 160,ICU,O
Sentence: 160,for,O
Sentence: 160,,O
Sentence: 160,>,O
Sentence: 160,,O
Sentence: 160,24,O
Sentence: 160,hours,O
Sentence: 160,.,O
Sentence: 160,Patients,O
Sentence: 160,with,O
Sentence: 160,an,O
Sentence: 160,adherence,O
Sentence: 160,to,O
Sentence: 160,SOP,O
Sentence: 160,,O
Sentence: 160,>,O
Sentence: 160,,O
Sentence: 160,70,O
Sentence: 160,%,O
Sentence: 160,were,O
Sentence: 160,classified,O
Sentence: 160,into,O
Sentence: 160,the,O
Sentence: 160,high,O
Sentence: 160,adherence,O
Sentence: 160,group,O
Sentence: 160,(,O
Sentence: 160,HAG,O
Sentence: 160,),O
Sentence: 160,and,O
Sentence: 160,patients,O
Sentence: 160,with,O
Sentence: 160,an,O
Sentence: 160,adherence,O
Sentence: 160,of,O
Sentence: 160,,O
Sentence: 160,<,O
Sentence: 160,,O
Sentence: 160,70,O
Sentence: 160,%,O
Sentence: 160,into,O
Sentence: 160,the,O
Sentence: 160,low,O
Sentence: 160,adherence,O
Sentence: 160,group,O
Sentence: 160,(,O
Sentence: 160,LAG,O
Sentence: 160,),O
Sentence: 160,.,O
Sentence: 160,AKI,B-Disease
Sentence: 160,was,O
Sentence: 160,defined,O
Sentence: 160,according,O
Sentence: 160,to,O
Sentence: 160,RIFLE,O
Sentence: 160,criteria,O
Sentence: 160,.,O
Sentence: 160,Adherence,O
Sentence: 160,to,O
Sentence: 160,SOPs,O
Sentence: 160,was,O
Sentence: 160,evaluated,O
Sentence: 160,by,O
Sentence: 160,retrospective,O
Sentence: 160,expert,O
Sentence: 160,audit,O
Sentence: 160,.,O
Sentence: 160,Development,O
Sentence: 160,of,O
Sentence: 160,AKI,B-Disease
Sentence: 160,was,O
Sentence: 160,compared,O
Sentence: 160,between,O
Sentence: 160,groups,O
Sentence: 160,with,O
Sentence: 160,exact,O
Sentence: 160,Chi2,O
Sentence: 160,-,O
Sentence: 160,test,O
Sentence: 160,and,O
Sentence: 160,multivariate,O
Sentence: 160,logistic,O
Sentence: 160,regression,O
Sentence: 160,analysis,O
Sentence: 160,(,O
Sentence: 160,two,O
Sentence: 160,-,O
Sentence: 160,sided,O
Sentence: 160,P,O
Sentence: 160,,O
Sentence: 160,<,O
Sentence: 160,,O
Sentence: 160,0.05,O
Sentence: 160,),O
Sentence: 160,.,O
Sentence: 160,RESULTS,O
Sentence: 160,:,O
Sentence: 160,LAG,O
Sentence: 160,consisted,O
Sentence: 160,of,O
Sentence: 160,75,O
Sentence: 160,patients,O
Sentence: 160,(,O
Sentence: 160,46,O
Sentence: 160,%,O
Sentence: 160,),O
Sentence: 160,versus,O
Sentence: 160,88,O
Sentence: 160,HAG,O
Sentence: 160,patients,O
Sentence: 160,(,O
Sentence: 160,54,O
Sentence: 160,%,O
Sentence: 160,),O
Sentence: 160,.,O
Sentence: 160,AKI,B-Disease
Sentence: 160,occurred,O
Sentence: 160,significantly,O
Sentence: 160,more,O
Sentence: 160,often,O
Sentence: 160,in,O
Sentence: 160,LAG,O
Sentence: 160,with,O
Sentence: 160,36,O
Sentence: 160,%,O
Sentence: 160,versus,O
Sentence: 160,21,O
Sentence: 160,%,O
Sentence: 160,in,O
Sentence: 160,HAG,O
Sentence: 160,(,O
Sentence: 160,P,O
Sentence: 160,,O
Sentence: 160,=,O
Sentence: 160,,O
Sentence: 160,0.035,O
Sentence: 160,),O
Sentence: 160,.,O
Sentence: 160,Basic,O
Sentence: 160,characteristics,O
Sentence: 160,were,O
Sentence: 160,comparable,O
Sentence: 160,",",O
Sentence: 160,except,O
Sentence: 160,an,O
Sentence: 160,increased,O
Sentence: 160,rate,O
Sentence: 160,of,O
Sentence: 160,soft,O
Sentence: 160,tissue,O
Sentence: 160,infections,B-Disease
Sentence: 160,in,O
Sentence: 160,LAG,O
Sentence: 160,.,O
Sentence: 160,Multivariate,O
Sentence: 160,analysis,O
Sentence: 160,revealed,O
Sentence: 160,an,O
Sentence: 160,odds,O
Sentence: 160,ratio,O
Sentence: 160,of,O
Sentence: 160,2.5,O
Sentence: 160,-,O
Sentence: 160,fold,O
Sentence: 160,for,O
Sentence: 160,LAG,O
Sentence: 160,to,O
Sentence: 160,develop,O
Sentence: 160,AKI,B-Disease
Sentence: 160,compared,O
Sentence: 160,with,O
Sentence: 160,HAG,O
Sentence: 160,(,O
Sentence: 160,95,O
Sentence: 160,%,O
Sentence: 160,confidence,O
Sentence: 160,interval,O
Sentence: 160,1.195,O
Sentence: 160,to,O
Sentence: 160,5.124,O
Sentence: 160,",",O
Sentence: 160,P,O
Sentence: 160,,O
Sentence: 160,=,O
Sentence: 160,,O
Sentence: 160,0.039,O
Sentence: 160,),O
Sentence: 160,.,O
Sentence: 160,CONCLUSION,O
Sentence: 160,:,O
Sentence: 160,Low,O
Sentence: 160,adherence,O
Sentence: 160,to,O
Sentence: 160,SOPs,O
Sentence: 160,for,O
Sentence: 160,potentially,O
Sentence: 160,nephrotoxic,B-Disease
Sentence: 160,antibiotics,O
Sentence: 160,was,O
Sentence: 160,associated,O
Sentence: 160,with,O
Sentence: 160,a,O
Sentence: 160,higher,O
Sentence: 160,occurrence,O
Sentence: 160,of,O
Sentence: 160,AKI,B-Disease
Sentence: 160,.,O
Sentence: 160,TRIAL,O
Sentence: 160,REGISTRATION,O
Sentence: 160,:,O
Sentence: 160,Current,O
Sentence: 160,Controlled,O
Sentence: 160,Trials,O
Sentence: 160,ISRCTN54598675,O
Sentence: 160,.,O
Sentence: 160,Registered,O
Sentence: 160,17,O
Sentence: 160,August,O
Sentence: 160,2007,O
Sentence: 160,.,O
Sentence: 161,Rhabdomyolysis,B-Disease
Sentence: 161,in,O
Sentence: 161,a,O
Sentence: 161,hepatitis,B-Disease
Sentence: 161,C,I-Disease
Sentence: 161,virus,I-Disease
Sentence: 161,infected,I-Disease
Sentence: 161,patient,O
Sentence: 161,treated,O
Sentence: 161,with,O
Sentence: 161,telaprevir,B-Chemical
Sentence: 161,and,O
Sentence: 161,simvastatin,B-Chemical
Sentence: 161,.,O
Sentence: 162,A,O
Sentence: 162,46,O
Sentence: 162,-,O
Sentence: 162,year,O
Sentence: 162,old,O
Sentence: 162,man,O
Sentence: 162,with,O
Sentence: 162,a,O
Sentence: 162,chronic,O
Sentence: 162,hepatitis,B-Disease
Sentence: 162,C,I-Disease
Sentence: 162,virus,I-Disease
Sentence: 162,infection,I-Disease
Sentence: 162,received,O
Sentence: 162,triple,O
Sentence: 162,therapy,O
Sentence: 162,with,O
Sentence: 162,ribavirin,B-Chemical
Sentence: 162,",",O
Sentence: 162,pegylated,B-Chemical
Sentence: 162,interferon,I-Chemical
Sentence: 162,and,O
Sentence: 162,telaprevir,B-Chemical
Sentence: 162,.,O
Sentence: 162,The,O
Sentence: 162,patient,O
Sentence: 162,also,O
Sentence: 162,received,O
Sentence: 162,simvastatin,B-Chemical
Sentence: 162,.,O
Sentence: 162,One,O
Sentence: 162,month,O
Sentence: 162,after,O
Sentence: 162,starting,O
Sentence: 162,the,O
Sentence: 162,antiviral,O
Sentence: 162,therapy,O
Sentence: 162,",",O
Sentence: 162,the,O
Sentence: 162,patient,O
Sentence: 162,was,O
Sentence: 162,admitted,O
Sentence: 162,to,O
Sentence: 162,the,O
Sentence: 162,hospital,O
Sentence: 162,because,O
Sentence: 162,he,O
Sentence: 162,developed,O
Sentence: 162,rhabdomyolysis,B-Disease
Sentence: 162,.,O
Sentence: 162,At,O
Sentence: 162,admission,O
Sentence: 162,simvastatin,B-Chemical
Sentence: 162,and,O
Sentence: 162,all,O
Sentence: 162,antiviral,O
Sentence: 162,drugs,O
Sentence: 162,were,O
Sentence: 162,discontinued,O
Sentence: 162,because,O
Sentence: 162,toxicity,B-Disease
Sentence: 162,due,O
Sentence: 162,to,O
Sentence: 162,a,O
Sentence: 162,drug,O
Sentence: 162,-,O
Sentence: 162,drug,O
Sentence: 162,interaction,O
Sentence: 162,was,O
Sentence: 162,suspected,O
Sentence: 162,.,O
Sentence: 162,The,O
Sentence: 162,creatine,B-Chemical
Sentence: 162,kinase,O
Sentence: 162,peaked,O
Sentence: 162,at,O
Sentence: 162,"62,246",O
Sentence: 162,IU,O
Sentence: 162,/,O
Sentence: 162,L,O
Sentence: 162,and,O
Sentence: 162,the,O
Sentence: 162,patient,O
Sentence: 162,was,O
Sentence: 162,treated,O
Sentence: 162,with,O
Sentence: 162,intravenous,O
Sentence: 162,normal,O
Sentence: 162,saline,O
Sentence: 162,.,O
Sentence: 162,The,O
Sentence: 162,patient,O
Sentence: 162,'s,O
Sentence: 162,renal,O
Sentence: 162,function,O
Sentence: 162,remained,O
Sentence: 162,unaffected,O
Sentence: 162,.,O
Sentence: 162,Fourteen,O
Sentence: 162,days,O
Sentence: 162,after,O
Sentence: 162,hospitalization,O
Sentence: 162,",",O
Sentence: 162,creatine,B-Chemical
Sentence: 162,kinase,O
Sentence: 162,level,O
Sentence: 162,had,O
Sentence: 162,returned,O
Sentence: 162,to,O
Sentence: 162,230,O
Sentence: 162,IU,O
Sentence: 162,/,O
Sentence: 162,L,O
Sentence: 162,and,O
Sentence: 162,the,O
Sentence: 162,patient,O
Sentence: 162,was,O
Sentence: 162,discharged,O
Sentence: 162,.,O
Sentence: 162,Telaprevir,B-Chemical
Sentence: 162,was,O
Sentence: 162,considered,O
Sentence: 162,the,O
Sentence: 162,probable,O
Sentence: 162,causative,O
Sentence: 162,agent,O
Sentence: 162,of,O
Sentence: 162,an,O
Sentence: 162,interaction,O
Sentence: 162,with,O
Sentence: 162,simvastatin,B-Chemical
Sentence: 162,according,O
Sentence: 162,to,O
Sentence: 162,the,O
Sentence: 162,Drug,O
Sentence: 162,Interaction,O
Sentence: 162,Probability,O
Sentence: 162,Scale,O
Sentence: 162,.,O
Sentence: 162,The,O
Sentence: 162,interaction,O
Sentence: 162,is,O
Sentence: 162,due,O
Sentence: 162,to,O
Sentence: 162,inhibition,O
Sentence: 162,of,O
Sentence: 162,CYP3A4,O
Sentence: 162,-,O
Sentence: 162,mediated,O
Sentence: 162,simvastatin,B-Chemical
Sentence: 162,clearance,O
Sentence: 162,.,O
Sentence: 162,Simvastatin,B-Chemical
Sentence: 162,plasma,O
Sentence: 162,concentration,O
Sentence: 162,increased,O
Sentence: 162,30,O
Sentence: 162,times,O
Sentence: 162,in,O
Sentence: 162,this,O
Sentence: 162,patient,O
Sentence: 162,and,O
Sentence: 162,statin,B-Chemical
Sentence: 162,induced,O
Sentence: 162,muscle,B-Disease
Sentence: 162,toxicity,I-Disease
Sentence: 162,is,O
Sentence: 162,related,O
Sentence: 162,to,O
Sentence: 162,the,O
Sentence: 162,concentration,O
Sentence: 162,of,O
Sentence: 162,the,O
Sentence: 162,statin,B-Chemical
Sentence: 162,in,O
Sentence: 162,blood,O
Sentence: 162,.,O
Sentence: 162,In,O
Sentence: 162,conclusion,O
Sentence: 162,",",O
Sentence: 162,with,O
Sentence: 162,this,O
Sentence: 162,case,O
Sentence: 162,we,O
Sentence: 162,illustrate,O
Sentence: 162,that,O
Sentence: 162,telaprevir,B-Chemical
Sentence: 162,as,O
Sentence: 162,well,O
Sentence: 162,as,O
Sentence: 162,statins,B-Chemical
Sentence: 162,are,O
Sentence: 162,susceptible,O
Sentence: 162,to,O
Sentence: 162,clinical,O
Sentence: 162,relevant,O
Sentence: 162,drug,O
Sentence: 162,-,O
Sentence: 162,drug,O
Sentence: 162,interactions,O
Sentence: 162,.,O
Sentence: 163,Combination,O
Sentence: 163,of,O
Sentence: 163,bortezomib,B-Chemical
Sentence: 163,",",O
Sentence: 163,thalidomide,B-Chemical
Sentence: 163,",",O
Sentence: 163,and,O
Sentence: 163,dexamethasone,B-Chemical
Sentence: 163,(,O
Sentence: 163,VTD,O
Sentence: 163,),O
Sentence: 163,as,O
Sentence: 163,a,O
Sentence: 163,consolidation,O
Sentence: 163,therapy,O
Sentence: 163,after,O
Sentence: 163,autologous,O
Sentence: 163,stem,O
Sentence: 163,cell,O
Sentence: 163,transplantation,O
Sentence: 163,for,O
Sentence: 163,symptomatic,O
Sentence: 163,multiple,B-Disease
Sentence: 163,myeloma,I-Disease
Sentence: 163,in,O
Sentence: 163,Japanese,O
Sentence: 163,patients,O
Sentence: 163,.,O
Sentence: 164,Consolidation,O
Sentence: 164,therapy,O
Sentence: 164,for,O
Sentence: 164,patients,O
Sentence: 164,with,O
Sentence: 164,multiple,B-Disease
Sentence: 164,myeloma,I-Disease
Sentence: 164,(,O
Sentence: 164,MM,B-Disease
Sentence: 164,),O
Sentence: 164,has,O
Sentence: 164,been,O
Sentence: 164,widely,O
Sentence: 164,adopted,O
Sentence: 164,to,O
Sentence: 164,improve,O
Sentence: 164,treatment,O
Sentence: 164,response,O
Sentence: 164,following,O
Sentence: 164,autologous,O
Sentence: 164,stem,O
Sentence: 164,cell,O
Sentence: 164,transplantation,O
Sentence: 164,.,O
Sentence: 164,In,O
Sentence: 164,this,O
Sentence: 164,study,O
Sentence: 164,",",O
Sentence: 164,we,O
Sentence: 164,retrospectively,O
Sentence: 164,analyzed,O
Sentence: 164,the,O
Sentence: 164,safety,O
Sentence: 164,and,O
Sentence: 164,efficacy,O
Sentence: 164,of,O
Sentence: 164,combination,O
Sentence: 164,regimen,O
Sentence: 164,of,O
Sentence: 164,bortezomib,B-Chemical
Sentence: 164,",",O
Sentence: 164,thalidomide,B-Chemical
Sentence: 164,",",O
Sentence: 164,and,O
Sentence: 164,dexamethasone,B-Chemical
Sentence: 164,(,O
Sentence: 164,VTD,O
Sentence: 164,),O
Sentence: 164,as,O
Sentence: 164,consolidation,O
Sentence: 164,therapy,O
Sentence: 164,in,O
Sentence: 164,24,O
Sentence: 164,Japanese,O
Sentence: 164,patients,O
Sentence: 164,with,O
Sentence: 164,newly,O
Sentence: 164,diagnosed,O
Sentence: 164,MM,B-Disease
Sentence: 164,.,O
Sentence: 164,VTD,O
Sentence: 164,consisted,O
Sentence: 164,of,O
Sentence: 164,bortezomib,B-Chemical
Sentence: 164,at,O
Sentence: 164,a,O
Sentence: 164,dose,O
Sentence: 164,of,O
Sentence: 164,1.3,O
Sentence: 164,mg,O
Sentence: 164,/,O
Sentence: 164,m,O
Sentence: 164,(,O
Sentence: 164,2,O
Sentence: 164,),O
Sentence: 164,and,O
Sentence: 164,dexamethasone,B-Chemical
Sentence: 164,at,O
Sentence: 164,a,O
Sentence: 164,dose,O
Sentence: 164,of,O
Sentence: 164,40,O
Sentence: 164,mg,O
Sentence: 164,/,O
Sentence: 164,day,O
Sentence: 164,on,O
Sentence: 164,days,O
Sentence: 164,1,O
Sentence: 164,",",O
Sentence: 164,8,O
Sentence: 164,",",O
Sentence: 164,15,O
Sentence: 164,",",O
Sentence: 164,and,O
Sentence: 164,22,O
Sentence: 164,of,O
Sentence: 164,a,O
Sentence: 164,35,O
Sentence: 164,-,O
Sentence: 164,day,O
Sentence: 164,cycle,O
Sentence: 164,",",O
Sentence: 164,with,O
Sentence: 164,daily,O
Sentence: 164,oral,O
Sentence: 164,thalidomide,B-Chemical
Sentence: 164,at,O
Sentence: 164,a,O
Sentence: 164,dose,O
Sentence: 164,of,O
Sentence: 164,100,O
Sentence: 164,mg,O
Sentence: 164,/,O
Sentence: 164,day,O
Sentence: 164,.,O
Sentence: 164,Grade,O
Sentence: 164,3,O
Sentence: 164,-,O
Sentence: 164,4,O
Sentence: 164,neutropenia,B-Disease
Sentence: 164,and,O
Sentence: 164,thrombocytopenia,B-Disease
Sentence: 164,were,O
Sentence: 164,documented,O
Sentence: 164,in,O
Sentence: 164,four,O
Sentence: 164,and,O
Sentence: 164,three,O
Sentence: 164,patients,O
Sentence: 164,(,O
Sentence: 164,17,O
Sentence: 164,and,O
Sentence: 164,13,O
Sentence: 164,%,O
Sentence: 164,),O
Sentence: 164,",",O
Sentence: 164,respectively,O
Sentence: 164,",",O
Sentence: 164,but,O
Sentence: 164,drug,O
Sentence: 164,dose,O
Sentence: 164,reduction,O
Sentence: 164,due,O
Sentence: 164,to,O
Sentence: 164,cytopenia,B-Disease
Sentence: 164,was,O
Sentence: 164,not,O
Sentence: 164,required,O
Sentence: 164,in,O
Sentence: 164,any,O
Sentence: 164,case,O
Sentence: 164,.,O
Sentence: 164,Peripheral,B-Disease
Sentence: 164,neuropathy,I-Disease
Sentence: 164,was,O
Sentence: 164,common,O
Sentence: 164,(,O
Sentence: 164,63,O
Sentence: 164,%,O
Sentence: 164,),O
Sentence: 164,",",O
Sentence: 164,but,O
Sentence: 164,severe,O
Sentence: 164,grade,O
Sentence: 164,3,O
Sentence: 164,-,O
Sentence: 164,4,O
Sentence: 164,peripheral,B-Disease
Sentence: 164,neuropathy,I-Disease
Sentence: 164,was,O
Sentence: 164,not,O
Sentence: 164,observed,O
Sentence: 164,.,O
Sentence: 164,Very,O
Sentence: 164,good,O
Sentence: 164,partial,O
Sentence: 164,response,O
Sentence: 164,or,O
Sentence: 164,better,O
Sentence: 164,response,O
Sentence: 164,(,O
Sentence: 164,,O
Sentence: 164,>,O
Sentence: 164,,O
Sentence: 164,VGPR,O
Sentence: 164,),O
Sentence: 164,rates,O
Sentence: 164,before,O
Sentence: 164,and,O
Sentence: 164,after,O
Sentence: 164,consolidation,O
Sentence: 164,therapy,O
Sentence: 164,were,O
Sentence: 164,54,O
Sentence: 164,and,O
Sentence: 164,79,O
Sentence: 164,%,O
Sentence: 164,",",O
Sentence: 164,respectively,O
Sentence: 164,.,O
Sentence: 164,Patients,O
Sentence: 164,had,O
Sentence: 164,a,O
Sentence: 164,significant,O
Sentence: 164,probability,O
Sentence: 164,of,O
Sentence: 164,improving,O
Sentence: 164,from,O
Sentence: 164,,O
Sentence: 164,<,O
Sentence: 164,,O
Sentence: 164,VGPR,O
Sentence: 164,before,O
Sentence: 164,consolidation,O
Sentence: 164,therapy,O
Sentence: 164,to,O
Sentence: 164,,O
Sentence: 164,>,O
Sentence: 164,,O
Sentence: 164,VGPR,O
Sentence: 164,after,O
Sentence: 164,consolidation,O
Sentence: 164,therapy,O
Sentence: 164,(,O
Sentence: 164,p,O
Sentence: 164,,O
Sentence: 164,=,O
Sentence: 164,,O
Sentence: 164,0.041,O
Sentence: 164,),O
Sentence: 164,.,O
Sentence: 164,The,O
Sentence: 164,VTD,O
Sentence: 164,regimen,O
Sentence: 164,may,O
Sentence: 164,be,O
Sentence: 164,safe,O
Sentence: 164,and,O
Sentence: 164,effective,O
Sentence: 164,as,O
Sentence: 164,a,O
Sentence: 164,consolidation,O
Sentence: 164,therapy,O
Sentence: 164,in,O
Sentence: 164,the,O
Sentence: 164,treatment,O
Sentence: 164,of,O
Sentence: 164,MM,B-Disease
Sentence: 164,in,O
Sentence: 164,Japanese,O
Sentence: 164,population,O
Sentence: 164,.,O
Sentence: 165,Conversion,O
Sentence: 165,to,O
Sentence: 165,sirolimus,B-Chemical
Sentence: 165,ameliorates,O
Sentence: 165,cyclosporine,B-Chemical
Sentence: 165,-,O
Sentence: 165,induced,O
Sentence: 165,nephropathy,B-Disease
Sentence: 165,in,O
Sentence: 165,the,O
Sentence: 165,rat,O
Sentence: 165,:,O
Sentence: 165,focus,O
Sentence: 165,on,O
Sentence: 165,serum,O
Sentence: 165,",",O
Sentence: 165,urine,O
Sentence: 165,",",O
Sentence: 165,gene,O
Sentence: 165,",",O
Sentence: 165,and,O
Sentence: 165,protein,O
Sentence: 165,renal,O
Sentence: 165,expression,O
Sentence: 165,biomarkers,O
Sentence: 165,.,O
Sentence: 166,Protocols,O
Sentence: 166,of,O
Sentence: 166,conversion,O
Sentence: 166,from,O
Sentence: 166,cyclosporin,B-Chemical
Sentence: 166,A,I-Chemical
Sentence: 166,(,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,),O
Sentence: 166,to,O
Sentence: 166,sirolimus,B-Chemical
Sentence: 166,(,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,),O
Sentence: 166,have,O
Sentence: 166,been,O
Sentence: 166,widely,O
Sentence: 166,used,O
Sentence: 166,in,O
Sentence: 166,immunotherapy,O
Sentence: 166,after,O
Sentence: 166,transplantation,O
Sentence: 166,to,O
Sentence: 166,prevent,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,-,O
Sentence: 166,induced,O
Sentence: 166,nephropathy,B-Disease
Sentence: 166,",",O
Sentence: 166,but,O
Sentence: 166,the,O
Sentence: 166,molecular,O
Sentence: 166,mechanisms,O
Sentence: 166,underlying,O
Sentence: 166,these,O
Sentence: 166,protocols,O
Sentence: 166,remain,O
Sentence: 166,nuclear,O
Sentence: 166,.,O
Sentence: 166,This,O
Sentence: 166,study,O
Sentence: 166,aimed,O
Sentence: 166,to,O
Sentence: 166,identify,O
Sentence: 166,the,O
Sentence: 166,molecular,O
Sentence: 166,pathways,O
Sentence: 166,and,O
Sentence: 166,putative,O
Sentence: 166,biomarkers,O
Sentence: 166,of,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,-,O
Sentence: 166,to,O
Sentence: 166,-,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,conversion,O
Sentence: 166,in,O
Sentence: 166,a,O
Sentence: 166,rat,O
Sentence: 166,model,O
Sentence: 166,.,O
Sentence: 166,Four,O
Sentence: 166,animal,O
Sentence: 166,groups,O
Sentence: 166,(,O
Sentence: 166,n,O
Sentence: 166,,O
Sentence: 166,=,O
Sentence: 166,,O
Sentence: 166,6,O
Sentence: 166,),O
Sentence: 166,were,O
Sentence: 166,tested,O
Sentence: 166,during,O
Sentence: 166,9,O
Sentence: 166,weeks,O
Sentence: 166,:,O
Sentence: 166,control,O
Sentence: 166,",",O
Sentence: 166,CsA,B-Chemical
Sentence: 166,",",O
Sentence: 166,SRL,B-Chemical
Sentence: 166,",",O
Sentence: 166,and,O
Sentence: 166,conversion,O
Sentence: 166,(,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,for,O
Sentence: 166,3,O
Sentence: 166,weeks,O
Sentence: 166,followed,O
Sentence: 166,by,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,for,O
Sentence: 166,6,O
Sentence: 166,weeks,O
Sentence: 166,),O
Sentence: 166,.,O
Sentence: 166,Classical,O
Sentence: 166,and,O
Sentence: 166,emergent,O
Sentence: 166,serum,O
Sentence: 166,",",O
Sentence: 166,urinary,O
Sentence: 166,",",O
Sentence: 166,and,O
Sentence: 166,kidney,O
Sentence: 166,tissue,O
Sentence: 166,(,O
Sentence: 166,gene,O
Sentence: 166,and,O
Sentence: 166,protein,O
Sentence: 166,expression,O
Sentence: 166,),O
Sentence: 166,markers,O
Sentence: 166,were,O
Sentence: 166,assessed,O
Sentence: 166,.,O
Sentence: 166,Renal,B-Disease
Sentence: 166,lesions,I-Disease
Sentence: 166,were,O
Sentence: 166,analyzed,O
Sentence: 166,in,O
Sentence: 166,hematoxylin,B-Chemical
Sentence: 166,and,O
Sentence: 166,eosin,B-Chemical
Sentence: 166,",",O
Sentence: 166,periodic,O
Sentence: 166,acid,O
Sentence: 166,-,O
Sentence: 166,Schiff,O
Sentence: 166,",",O
Sentence: 166,and,O
Sentence: 166,Masson,O
Sentence: 166,'s,O
Sentence: 166,trichrome,O
Sentence: 166,stains,O
Sentence: 166,.,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,-,O
Sentence: 166,treated,O
Sentence: 166,rats,O
Sentence: 166,presented,O
Sentence: 166,proteinuria,B-Disease
Sentence: 166,and,O
Sentence: 166,NGAL,O
Sentence: 166,(,O
Sentence: 166,serum,O
Sentence: 166,and,O
Sentence: 166,urinary,O
Sentence: 166,),O
Sentence: 166,as,O
Sentence: 166,the,O
Sentence: 166,best,O
Sentence: 166,markers,O
Sentence: 166,of,O
Sentence: 166,renal,B-Disease
Sentence: 166,impairment,I-Disease
Sentence: 166,.,O
Sentence: 166,Short,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,treatment,O
Sentence: 166,presented,O
Sentence: 166,slight,O
Sentence: 166,or,O
Sentence: 166,even,O
Sentence: 166,absent,O
Sentence: 166,kidney,B-Disease
Sentence: 166,lesions,I-Disease
Sentence: 166,and,O
Sentence: 166,TGF,O
Sentence: 166,-,O
Sentence: 166,b,O
Sentence: 166,",",O
Sentence: 166,NF,O
Sentence: 166,-,O
Sentence: 166,,O
Sentence: 166,kb,O
Sentence: 166,",",O
Sentence: 166,mTOR,O
Sentence: 166,",",O
Sentence: 166,PCNA,O
Sentence: 166,",",O
Sentence: 166,TP53,O
Sentence: 166,",",O
Sentence: 166,KIM,O
Sentence: 166,-,O
Sentence: 166,1,O
Sentence: 166,",",O
Sentence: 166,and,O
Sentence: 166,CTGF,O
Sentence: 166,as,O
Sentence: 166,relevant,O
Sentence: 166,gene,O
Sentence: 166,and,O
Sentence: 166,protein,O
Sentence: 166,changes,O
Sentence: 166,.,O
Sentence: 166,Prolonged,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,exposure,O
Sentence: 166,aggravated,O
Sentence: 166,renal,B-Disease
Sentence: 166,damage,I-Disease
Sentence: 166,",",O
Sentence: 166,without,O
Sentence: 166,clear,O
Sentence: 166,changes,O
Sentence: 166,on,O
Sentence: 166,the,O
Sentence: 166,traditional,O
Sentence: 166,markers,O
Sentence: 166,",",O
Sentence: 166,but,O
Sentence: 166,with,O
Sentence: 166,changes,O
Sentence: 166,in,O
Sentence: 166,serums,O
Sentence: 166,TGF,O
Sentence: 166,-,O
Sentence: 166,,O
Sentence: 166,b,O
Sentence: 166,and,O
Sentence: 166,IL,O
Sentence: 166,-,O
Sentence: 166,7,O
Sentence: 166,",",O
Sentence: 166,TBARs,O
Sentence: 166,clearance,O
Sentence: 166,",",O
Sentence: 166,and,O
Sentence: 166,kidney,O
Sentence: 166,TGF,O
Sentence: 166,-,O
Sentence: 166,b,O
Sentence: 166,and,O
Sentence: 166,mTOR,O
Sentence: 166,.,O
Sentence: 166,Conversion,O
Sentence: 166,to,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,prevented,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,-,O
Sentence: 166,induced,O
Sentence: 166,renal,B-Disease
Sentence: 166,damage,I-Disease
Sentence: 166,evolution,O
Sentence: 166,(,O
Sentence: 166,absent,O
Sentence: 166,/,O
Sentence: 166,mild,O
Sentence: 166,grade,O
Sentence: 166,lesions,O
Sentence: 166,),O
Sentence: 166,",",O
Sentence: 166,while,O
Sentence: 166,NGAL,O
Sentence: 166,(,O
Sentence: 166,serum,O
Sentence: 166,versus,O
Sentence: 166,urine,O
Sentence: 166,),O
Sentence: 166,seems,O
Sentence: 166,to,O
Sentence: 166,be,O
Sentence: 166,a,O
Sentence: 166,feasible,O
Sentence: 166,biomarker,O
Sentence: 166,of,O
Sentence: 166,CsA,B-Chemical
Sentence: 166,replacement,O
Sentence: 166,to,O
Sentence: 166,SRL,B-Chemical
Sentence: 166,.,O
Sentence: 167,Kinin,O
Sentence: 167,B2,O
Sentence: 167,receptor,O
Sentence: 167,deletion,O
Sentence: 167,and,O
Sentence: 167,blockage,O
Sentence: 167,ameliorates,O
Sentence: 167,cisplatin,B-Chemical
Sentence: 167,-,O
Sentence: 167,induced,O
Sentence: 167,acute,B-Disease
Sentence: 167,renal,I-Disease
Sentence: 167,injury,I-Disease
Sentence: 167,.,O
Sentence: 168,Cisplatin,B-Chemical
Sentence: 168,treatment,O
Sentence: 168,has,O
Sentence: 168,been,O
Sentence: 168,adopted,O
Sentence: 168,in,O
Sentence: 168,some,O
Sentence: 168,chemotherapies,O
Sentence: 168,;,O
Sentence: 168,however,O
Sentence: 168,",",O
Sentence: 168,this,O
Sentence: 168,drug,O
Sentence: 168,can,O
Sentence: 168,induce,O
Sentence: 168,acute,B-Disease
Sentence: 168,kidney,I-Disease
Sentence: 168,injury,I-Disease
Sentence: 168,due,O
Sentence: 168,its,O
Sentence: 168,ability,O
Sentence: 168,to,O
Sentence: 168,negatively,O
Sentence: 168,affect,O
Sentence: 168,renal,O
Sentence: 168,function,O
Sentence: 168,",",O
Sentence: 168,augment,O
Sentence: 168,serum,O
Sentence: 168,levels,O
Sentence: 168,of,O
Sentence: 168,creatinine,B-Chemical
Sentence: 168,and,O
Sentence: 168,urea,B-Chemical
Sentence: 168,",",O
Sentence: 168,increase,O
Sentence: 168,the,O
Sentence: 168,acute,B-Disease
Sentence: 168,tubular,I-Disease
Sentence: 168,necrosis,I-Disease
Sentence: 168,score,O
Sentence: 168,and,O
Sentence: 168,up,O
Sentence: 168,-,O
Sentence: 168,regulate,O
Sentence: 168,cytokines,O
Sentence: 168,(,O
Sentence: 168,e.g.,O
Sentence: 168,",",O
Sentence: 168,IL,O
Sentence: 168,-,O
Sentence: 168,1b,O
Sentence: 168,and,O
Sentence: 168,TNF,O
Sentence: 168,-,O
Sentence: 168,a,O
Sentence: 168,),O
Sentence: 168,.,O
Sentence: 168,The,O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,has,O
Sentence: 168,been,O
Sentence: 168,associated,O
Sentence: 168,with,O
Sentence: 168,the,O
Sentence: 168,inflammation,B-Disease
Sentence: 168,process,O
Sentence: 168,",",O
Sentence: 168,as,O
Sentence: 168,well,O
Sentence: 168,as,O
Sentence: 168,the,O
Sentence: 168,regulation,O
Sentence: 168,of,O
Sentence: 168,cytokine,O
Sentence: 168,expression,O
Sentence: 168,",",O
Sentence: 168,and,O
Sentence: 168,its,O
Sentence: 168,deletion,O
Sentence: 168,resulted,O
Sentence: 168,in,O
Sentence: 168,an,O
Sentence: 168,improvement,O
Sentence: 168,in,O
Sentence: 168,the,O
Sentence: 168,diabetic,B-Disease
Sentence: 168,nephropathy,I-Disease
Sentence: 168,status,O
Sentence: 168,.,O
Sentence: 168,To,O
Sentence: 168,examine,O
Sentence: 168,the,O
Sentence: 168,role,O
Sentence: 168,of,O
Sentence: 168,the,O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,in,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,-,O
Sentence: 168,induced,O
Sentence: 168,acute,B-Disease
Sentence: 168,kidney,I-Disease
Sentence: 168,injury,I-Disease
Sentence: 168,",",O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,knockout,O
Sentence: 168,mice,O
Sentence: 168,were,O
Sentence: 168,challenged,O
Sentence: 168,with,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,.,O
Sentence: 168,Additionally,O
Sentence: 168,",",O
Sentence: 168,WT,O
Sentence: 168,mice,O
Sentence: 168,were,O
Sentence: 168,treated,O
Sentence: 168,with,O
Sentence: 168,a,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,antagonist,O
Sentence: 168,after,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,administration,O
Sentence: 168,.,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,-,O
Sentence: 168,deficient,O
Sentence: 168,mice,O
Sentence: 168,were,O
Sentence: 168,less,O
Sentence: 168,sensitive,O
Sentence: 168,to,O
Sentence: 168,this,O
Sentence: 168,drug,O
Sentence: 168,than,O
Sentence: 168,the,O
Sentence: 168,WT,O
Sentence: 168,mice,O
Sentence: 168,",",O
Sentence: 168,as,O
Sentence: 168,shown,O
Sentence: 168,by,O
Sentence: 168,reduced,O
Sentence: 168,weight,B-Disease
Sentence: 168,loss,I-Disease
Sentence: 168,",",O
Sentence: 168,better,O
Sentence: 168,preservation,O
Sentence: 168,of,O
Sentence: 168,kidney,O
Sentence: 168,function,O
Sentence: 168,",",O
Sentence: 168,down,O
Sentence: 168,regulation,O
Sentence: 168,of,O
Sentence: 168,inflammatory,O
Sentence: 168,cytokines,O
Sentence: 168,and,O
Sentence: 168,less,O
Sentence: 168,acute,B-Disease
Sentence: 168,tubular,I-Disease
Sentence: 168,necrosis,I-Disease
Sentence: 168,.,O
Sentence: 168,Moreover,O
Sentence: 168,",",O
Sentence: 168,treatment,O
Sentence: 168,with,O
Sentence: 168,the,O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,antagonist,O
Sentence: 168,effectively,O
Sentence: 168,reduced,O
Sentence: 168,the,O
Sentence: 168,levels,O
Sentence: 168,of,O
Sentence: 168,serum,O
Sentence: 168,creatinine,B-Chemical
Sentence: 168,and,O
Sentence: 168,blood,O
Sentence: 168,urea,B-Chemical
Sentence: 168,after,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,administration,O
Sentence: 168,.,O
Sentence: 168,Thus,O
Sentence: 168,",",O
Sentence: 168,our,O
Sentence: 168,data,O
Sentence: 168,suggest,O
Sentence: 168,that,O
Sentence: 168,the,O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,is,O
Sentence: 168,involved,O
Sentence: 168,in,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,-,O
Sentence: 168,induced,O
Sentence: 168,acute,B-Disease
Sentence: 168,kidney,I-Disease
Sentence: 168,injury,I-Disease
Sentence: 168,by,O
Sentence: 168,mediating,O
Sentence: 168,the,O
Sentence: 168,necrotic,B-Disease
Sentence: 168,process,O
Sentence: 168,and,O
Sentence: 168,the,O
Sentence: 168,expression,O
Sentence: 168,of,O
Sentence: 168,inflammatory,O
Sentence: 168,cytokines,O
Sentence: 168,",",O
Sentence: 168,thus,O
Sentence: 168,resulting,O
Sentence: 168,in,O
Sentence: 168,declined,O
Sentence: 168,renal,O
Sentence: 168,function,O
Sentence: 168,.,O
Sentence: 168,These,O
Sentence: 168,results,O
Sentence: 168,highlight,O
Sentence: 168,the,O
Sentence: 168,kinin,O
Sentence: 168,B2,O
Sentence: 168,receptor,O
Sentence: 168,antagonist,O
Sentence: 168,treatment,O
Sentence: 168,in,O
Sentence: 168,amelioration,O
Sentence: 168,of,O
Sentence: 168,nephrotoxicity,B-Disease
Sentence: 168,induced,O
Sentence: 168,by,O
Sentence: 168,cisplatin,B-Chemical
Sentence: 168,therapy,O
Sentence: 168,.,O
Sentence: 169,Safety,O
Sentence: 169,and,O
Sentence: 169,efficacy,O
Sentence: 169,of,O
Sentence: 169,fluocinolone,B-Chemical
Sentence: 169,acetonide,I-Chemical
Sentence: 169,intravitreal,O
Sentence: 169,implant,O
Sentence: 169,(,O
Sentence: 169,0.59,O
Sentence: 169,mg,O
Sentence: 169,),O
Sentence: 169,in,O
Sentence: 169,birdshot,B-Disease
Sentence: 169,retinochoroidopathy,I-Disease
Sentence: 169,.,O
Sentence: 170,PURPOSE,O
Sentence: 170,:,O
Sentence: 170,To,O
Sentence: 170,report,O
Sentence: 170,the,O
Sentence: 170,treatment,O
Sentence: 170,outcomes,O
Sentence: 170,of,O
Sentence: 170,the,O
Sentence: 170,fluocinolone,B-Chemical
Sentence: 170,acetonide,I-Chemical
Sentence: 170,intravitreal,O
Sentence: 170,implant,O
Sentence: 170,(,O
Sentence: 170,0.59,O
Sentence: 170,mg,O
Sentence: 170,),O
Sentence: 170,in,O
Sentence: 170,patients,O
Sentence: 170,with,O
Sentence: 170,birdshot,B-Disease
Sentence: 170,retinochoroidopathy,I-Disease
Sentence: 170,whose,O
Sentence: 170,disease,O
Sentence: 170,is,O
Sentence: 170,refractory,O
Sentence: 170,or,O
Sentence: 170,intolerant,O
Sentence: 170,to,O
Sentence: 170,conventional,O
Sentence: 170,immunomodulatory,O
Sentence: 170,therapy,O
Sentence: 170,.,O
Sentence: 170,METHODS,O
Sentence: 170,:,O
Sentence: 170,A,O
Sentence: 170,retrospective,O
Sentence: 170,case,O
Sentence: 170,series,O
Sentence: 170,involving,O
Sentence: 170,11,O
Sentence: 170,birdshot,B-Disease
Sentence: 170,retinochoroidopathy,I-Disease
Sentence: 170,patients,O
Sentence: 170,(,O
Sentence: 170,11,O
Sentence: 170,eyes,O
Sentence: 170,),O
Sentence: 170,.,O
Sentence: 170,Eleven,O
Sentence: 170,patients,O
Sentence: 170,(,O
Sentence: 170,11,O
Sentence: 170,eyes,O
Sentence: 170,),O
Sentence: 170,underwent,O
Sentence: 170,surgery,O
Sentence: 170,for,O
Sentence: 170,fluocinolone,B-Chemical
Sentence: 170,acetonide,I-Chemical
Sentence: 170,implant,O
Sentence: 170,(,O
Sentence: 170,0.59,O
Sentence: 170,mg,O
Sentence: 170,),O
Sentence: 170,.,O
Sentence: 170,Treatment,O
Sentence: 170,outcomes,O
Sentence: 170,of,O
Sentence: 170,interest,O
Sentence: 170,were,O
Sentence: 170,noted,O
Sentence: 170,at,O
Sentence: 170,baseline,O
Sentence: 170,",",O
Sentence: 170,before,O
Sentence: 170,fluocinolone,B-Chemical
Sentence: 170,acetonide,I-Chemical
Sentence: 170,implant,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,then,O
Sentence: 170,at,O
Sentence: 170,6,O
Sentence: 170,months,O
Sentence: 170,",",O
Sentence: 170,1,O
Sentence: 170,year,O
Sentence: 170,",",O
Sentence: 170,2,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,beyond,O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,.,O
Sentence: 170,Disease,O
Sentence: 170,activity,O
Sentence: 170,markers,O
Sentence: 170,",",O
Sentence: 170,including,O
Sentence: 170,signs,O
Sentence: 170,of,O
Sentence: 170,ocular,O
Sentence: 170,inflammation,B-Disease
Sentence: 170,",",O
Sentence: 170,evidence,O
Sentence: 170,of,O
Sentence: 170,retinal,B-Disease
Sentence: 170,vasculitis,B-Disease
Sentence: 170,",",O
Sentence: 170,Swedish,O
Sentence: 170,interactive,O
Sentence: 170,threshold,O
Sentence: 170,algorithm,O
Sentence: 170,-,O
Sentence: 170,short,O
Sentence: 170,wavelength,O
Sentence: 170,automated,O
Sentence: 170,perimetry,O
Sentence: 170,Humphrey,O
Sentence: 170,visual,O
Sentence: 170,field,O
Sentence: 170,analysis,O
Sentence: 170,",",O
Sentence: 170,electroretinographic,O
Sentence: 170,parameters,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,optical,O
Sentence: 170,coherence,O
Sentence: 170,tomography,O
Sentence: 170,were,O
Sentence: 170,recorded,O
Sentence: 170,.,O
Sentence: 170,Data,O
Sentence: 170,on,O
Sentence: 170,occurrence,O
Sentence: 170,of,O
Sentence: 170,cataract,B-Disease
Sentence: 170,and,O
Sentence: 170,raised,B-Disease
Sentence: 170,intraocular,I-Disease
Sentence: 170,pressure,I-Disease
Sentence: 170,were,O
Sentence: 170,collected,O
Sentence: 170,in,O
Sentence: 170,all,O
Sentence: 170,eyes,O
Sentence: 170,.,O
Sentence: 170,RESULTS,O
Sentence: 170,:,O
Sentence: 170,Intraocular,O
Sentence: 170,inflammation,B-Disease
Sentence: 170,was,O
Sentence: 170,present,O
Sentence: 170,in,O
Sentence: 170,54.5,O
Sentence: 170,",",O
Sentence: 170,9.9,O
Sentence: 170,",",O
Sentence: 170,11.1,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,0,O
Sentence: 170,%,O
Sentence: 170,of,O
Sentence: 170,patients,O
Sentence: 170,at,O
Sentence: 170,baseline,O
Sentence: 170,",",O
Sentence: 170,6,O
Sentence: 170,months,O
Sentence: 170,",",O
Sentence: 170,1,O
Sentence: 170,year,O
Sentence: 170,",",O
Sentence: 170,2,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,beyond,O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,after,O
Sentence: 170,receiving,O
Sentence: 170,the,O
Sentence: 170,implant,O
Sentence: 170,",",O
Sentence: 170,respectively,O
Sentence: 170,.,O
Sentence: 170,Active,O
Sentence: 170,vasculitis,B-Disease
Sentence: 170,was,O
Sentence: 170,noted,O
Sentence: 170,in,O
Sentence: 170,36.3,O
Sentence: 170,%,O
Sentence: 170,patients,O
Sentence: 170,at,O
Sentence: 170,baseline,O
Sentence: 170,and,O
Sentence: 170,0,O
Sentence: 170,%,O
Sentence: 170,at,O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,of,O
Sentence: 170,follow,O
Sentence: 170,-,O
Sentence: 170,up,O
Sentence: 170,.,O
Sentence: 170,More,O
Sentence: 170,than,O
Sentence: 170,20,O
Sentence: 170,%,O
Sentence: 170,(,O
Sentence: 170,47.61,O
Sentence: 170,-,O
Sentence: 170,67.2,O
Sentence: 170,%,O
Sentence: 170,),O
Sentence: 170,reduction,O
Sentence: 170,in,O
Sentence: 170,central,O
Sentence: 170,retinal,O
Sentence: 170,thickness,O
Sentence: 170,was,O
Sentence: 170,noted,O
Sentence: 170,in,O
Sentence: 170,all,O
Sentence: 170,patients,O
Sentence: 170,with,O
Sentence: 170,cystoid,B-Disease
Sentence: 170,macular,I-Disease
Sentence: 170,edema,I-Disease
Sentence: 170,at,O
Sentence: 170,6,O
Sentence: 170,months,O
Sentence: 170,",",O
Sentence: 170,1,O
Sentence: 170,year,O
Sentence: 170,",",O
Sentence: 170,2,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,postimplant,O
Sentence: 170,.,O
Sentence: 170,At,O
Sentence: 170,baseline,O
Sentence: 170,",",O
Sentence: 170,54.5,O
Sentence: 170,%,O
Sentence: 170,patients,O
Sentence: 170,were,O
Sentence: 170,on,O
Sentence: 170,immunomodulatory,O
Sentence: 170,agents,O
Sentence: 170,.,O
Sentence: 170,This,O
Sentence: 170,percentage,O
Sentence: 170,decreased,O
Sentence: 170,to,O
Sentence: 170,45.45,O
Sentence: 170,",",O
Sentence: 170,44.4,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,14.28,O
Sentence: 170,%,O
Sentence: 170,at,O
Sentence: 170,1,O
Sentence: 170,year,O
Sentence: 170,",",O
Sentence: 170,2,O
Sentence: 170,years,O
Sentence: 170,",",O
Sentence: 170,and,O
Sentence: 170,3,O
Sentence: 170,years,O
Sentence: 170,postimplant,O
Sentence: 170,",",O
Sentence: 170,respectively,O
Sentence: 170,.,O
Sentence: 170,Adverse,O
Sentence: 170,events,O
Sentence: 170,included,O
Sentence: 170,increased,B-Disease
Sentence: 170,intraocular,I-Disease
Sentence: 170,pressure,I-Disease
Sentence: 170,(,O
Sentence: 170,54.5,O
Sentence: 170,%,O
Sentence: 170,),O
Sentence: 170,and,O
Sentence: 170,cataract,B-Disease
Sentence: 170,formation,O
Sentence: 170,(,O
Sentence: 170,100,O
Sentence: 170,%,O
Sentence: 170,),O
Sentence: 170,.,O
Sentence: 170,CONCLUSION,O
Sentence: 170,:,O
Sentence: 170,The,O
Sentence: 170,data,O
Sentence: 170,suggest,O
Sentence: 170,that,O
Sentence: 170,fluocinolone,B-Chemical
Sentence: 170,acetonide,I-Chemical
Sentence: 170,implant,O
Sentence: 170,(,O
Sentence: 170,0.59,O
Sentence: 170,mg,O
Sentence: 170,),O
Sentence: 170,helps,O
Sentence: 170,to,O
Sentence: 170,control,O
Sentence: 170,inflammation,B-Disease
Sentence: 170,in,O
Sentence: 170,otherwise,O
Sentence: 170,treatment,O
Sentence: 170,-,O
Sentence: 170,refractory,O
Sentence: 170,cases,O
Sentence: 170,of,O
Sentence: 170,birdshot,B-Disease
Sentence: 170,retinochoroidopathy,I-Disease
Sentence: 170,.,O
Sentence: 170,It,O
Sentence: 170,is,O
Sentence: 170,associated,O
Sentence: 170,with,O
Sentence: 170,significant,O
Sentence: 170,side,O
Sentence: 170,effects,O
Sentence: 170,of,O
Sentence: 170,cataract,B-Disease
Sentence: 170,and,O
Sentence: 170,ocular,B-Disease
Sentence: 170,hypertension,I-Disease
Sentence: 170,requiring,O
Sentence: 170,treatment,O
Sentence: 170,.,O
Sentence: 171,Optimal,O
Sentence: 171,precurarizing,O
Sentence: 171,dose,O
Sentence: 171,of,O
Sentence: 171,rocuronium,B-Chemical
Sentence: 171,to,O
Sentence: 171,decrease,O
Sentence: 171,fasciculation,B-Disease
Sentence: 171,and,O
Sentence: 171,myalgia,B-Disease
Sentence: 171,following,O
Sentence: 171,succinylcholine,B-Chemical
Sentence: 171,administration,O
Sentence: 171,.,O
Sentence: 172,BACKGROUND,O
Sentence: 172,:,O
Sentence: 172,Succinylcholine,B-Chemical
Sentence: 172,commonly,O
Sentence: 172,produces,O
Sentence: 172,frequent,O
Sentence: 172,adverse,O
Sentence: 172,effects,O
Sentence: 172,",",O
Sentence: 172,including,O
Sentence: 172,muscle,B-Disease
Sentence: 172,fasciculation,B-Disease
Sentence: 172,and,O
Sentence: 172,myalgia,B-Disease
Sentence: 172,.,O
Sentence: 172,The,O
Sentence: 172,current,O
Sentence: 172,study,O
Sentence: 172,identified,O
Sentence: 172,the,O
Sentence: 172,optimal,O
Sentence: 172,dose,O
Sentence: 172,of,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,to,O
Sentence: 172,prevent,O
Sentence: 172,succinylcholine,B-Chemical
Sentence: 172,-,O
Sentence: 172,induced,O
Sentence: 172,fasciculation,B-Disease
Sentence: 172,and,O
Sentence: 172,myalgia,B-Disease
Sentence: 172,and,O
Sentence: 172,evaluated,O
Sentence: 172,the,O
Sentence: 172,influence,O
Sentence: 172,of,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,on,O
Sentence: 172,the,O
Sentence: 172,speed,O
Sentence: 172,of,O
Sentence: 172,onset,O
Sentence: 172,produced,O
Sentence: 172,by,O
Sentence: 172,succinylcholine,B-Chemical
Sentence: 172,.,O
Sentence: 172,METHODS,O
Sentence: 172,:,O
Sentence: 172,This,O
Sentence: 172,randomized,O
Sentence: 172,",",O
Sentence: 172,double,O
Sentence: 172,-,O
Sentence: 172,blinded,O
Sentence: 172,study,O
Sentence: 172,was,O
Sentence: 172,conducted,O
Sentence: 172,in,O
Sentence: 172,100,O
Sentence: 172,patients,O
Sentence: 172,randomly,O
Sentence: 172,allocated,O
Sentence: 172,into,O
Sentence: 172,five,O
Sentence: 172,groups,O
Sentence: 172,of,O
Sentence: 172,20,O
Sentence: 172,patients,O
Sentence: 172,each,O
Sentence: 172,.,O
Sentence: 172,Patients,O
Sentence: 172,were,O
Sentence: 172,randomized,O
Sentence: 172,to,O
Sentence: 172,receive,O
Sentence: 172,0.02,O
Sentence: 172,",",O
Sentence: 172,0.03,O
Sentence: 172,",",O
Sentence: 172,0.04,O
Sentence: 172,",",O
Sentence: 172,0.05,O
Sentence: 172,and,O
Sentence: 172,0.06,O
Sentence: 172,mg,O
Sentence: 172,/,O
Sentence: 172,kg,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,as,O
Sentence: 172,a,O
Sentence: 172,precurarizing,O
Sentence: 172,dose,O
Sentence: 172,.,O
Sentence: 172,Neuromuscular,O
Sentence: 172,monitoring,O
Sentence: 172,after,O
Sentence: 172,each,O
Sentence: 172,precurarizing,O
Sentence: 172,dose,O
Sentence: 172,was,O
Sentence: 172,recorded,O
Sentence: 172,from,O
Sentence: 172,the,O
Sentence: 172,adductor,O
Sentence: 172,pollicis,O
Sentence: 172,muscle,O
Sentence: 172,using,O
Sentence: 172,acceleromyography,O
Sentence: 172,with,O
Sentence: 172,train,O
Sentence: 172,-,O
Sentence: 172,of,O
Sentence: 172,-,O
Sentence: 172,four,O
Sentence: 172,stimulation,O
Sentence: 172,of,O
Sentence: 172,the,O
Sentence: 172,ulnar,O
Sentence: 172,nerve,O
Sentence: 172,.,O
Sentence: 172,All,O
Sentence: 172,patients,O
Sentence: 172,received,O
Sentence: 172,succinylcholine,B-Chemical
Sentence: 172,1.5,O
Sentence: 172,mg,O
Sentence: 172,/,O
Sentence: 172,kg,O
Sentence: 172,at,O
Sentence: 172,2,O
Sentence: 172,minutes,O
Sentence: 172,after,O
Sentence: 172,the,O
Sentence: 172,precurarization,O
Sentence: 172,",",O
Sentence: 172,and,O
Sentence: 172,were,O
Sentence: 172,assessed,O
Sentence: 172,the,O
Sentence: 172,incidence,O
Sentence: 172,and,O
Sentence: 172,severity,O
Sentence: 172,of,O
Sentence: 172,fasciculations,B-Disease
Sentence: 172,",",O
Sentence: 172,while,O
Sentence: 172,myalgia,B-Disease
Sentence: 172,was,O
Sentence: 172,assessed,O
Sentence: 172,at,O
Sentence: 172,24,O
Sentence: 172,hours,O
Sentence: 172,after,O
Sentence: 172,surgery,O
Sentence: 172,.,O
Sentence: 172,RESULTS,O
Sentence: 172,:,O
Sentence: 172,The,O
Sentence: 172,incidence,O
Sentence: 172,and,O
Sentence: 172,severity,O
Sentence: 172,of,O
Sentence: 172,visible,O
Sentence: 172,muscle,B-Disease
Sentence: 172,fasciculation,B-Disease
Sentence: 172,was,O
Sentence: 172,significantly,O
Sentence: 172,less,O
Sentence: 172,with,O
Sentence: 172,increasing,O
Sentence: 172,the,O
Sentence: 172,amount,O
Sentence: 172,of,O
Sentence: 172,precurarizing,O
Sentence: 172,dose,O
Sentence: 172,of,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,(,O
Sentence: 172,P,O
Sentence: 172,,O
Sentence: 172,<,O
Sentence: 172,,O
Sentence: 172,0.001,O
Sentence: 172,),O
Sentence: 172,.,O
Sentence: 172,Those,O
Sentence: 172,of,O
Sentence: 172,myalgia,B-Disease
Sentence: 172,tend,O
Sentence: 172,to,O
Sentence: 172,decrease,O
Sentence: 172,according,O
Sentence: 172,to,O
Sentence: 172,increasing,O
Sentence: 172,the,O
Sentence: 172,amount,O
Sentence: 172,of,O
Sentence: 172,precurarizing,O
Sentence: 172,dose,O
Sentence: 172,of,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,",",O
Sentence: 172,but,O
Sentence: 172,there,O
Sentence: 172,was,O
Sentence: 172,no,O
Sentence: 172,significance,O
Sentence: 172,(,O
Sentence: 172,P,O
Sentence: 172,,O
Sentence: 172,=,O
Sentence: 172,,O
Sentence: 172,0.072,O
Sentence: 172,),O
Sentence: 172,.,O
Sentence: 172,The,O
Sentence: 172,onset,O
Sentence: 172,time,O
Sentence: 172,of,O
Sentence: 172,succinylcholine,B-Chemical
Sentence: 172,was,O
Sentence: 172,significantly,O
Sentence: 172,longer,O
Sentence: 172,with,O
Sentence: 172,increasing,O
Sentence: 172,the,O
Sentence: 172,amount,O
Sentence: 172,of,O
Sentence: 172,precurarizing,O
Sentence: 172,dose,O
Sentence: 172,of,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,(,O
Sentence: 172,P,O
Sentence: 172,,O
Sentence: 172,<,O
Sentence: 172,,O
Sentence: 172,0.001,O
Sentence: 172,),O
Sentence: 172,.,O
Sentence: 172,CONCLUSIONS,O
Sentence: 172,:,O
Sentence: 172,Precurarization,O
Sentence: 172,with,O
Sentence: 172,0.04,O
Sentence: 172,mg,O
Sentence: 172,/,O
Sentence: 172,kg,O
Sentence: 172,rocuronium,B-Chemical
Sentence: 172,was,O
Sentence: 172,the,O
Sentence: 172,optimal,O
Sentence: 172,dose,O
Sentence: 172,considering,O
Sentence: 172,the,O
Sentence: 172,reduction,O
Sentence: 172,in,O
Sentence: 172,the,O
Sentence: 172,incidence,O
Sentence: 172,and,O
Sentence: 172,severity,O
Sentence: 172,of,O
Sentence: 172,fasciculation,B-Disease
Sentence: 172,and,O
Sentence: 172,myalgia,B-Disease
Sentence: 172,with,O
Sentence: 172,acceptable,O
Sentence: 172,onset,O
Sentence: 172,time,O
Sentence: 172,",",O
Sentence: 172,and,O
Sentence: 172,the,O
Sentence: 172,safe,O
Sentence: 172,and,O
Sentence: 172,effective,O
Sentence: 172,precurarization,O
Sentence: 172,.,O
Sentence: 173,Absence,O
Sentence: 173,of,O
Sentence: 173,PKC,O
Sentence: 173,-,O
Sentence: 173,alpha,O
Sentence: 173,attenuates,O
Sentence: 173,lithium,B-Chemical
Sentence: 173,-,O
Sentence: 173,induced,O
Sentence: 173,nephrogenic,B-Disease
Sentence: 173,diabetes,I-Disease
Sentence: 173,insipidus,I-Disease
Sentence: 173,.,O
Sentence: 174,Lithium,B-Chemical
Sentence: 174,",",O
Sentence: 174,an,O
Sentence: 174,effective,O
Sentence: 174,antipsychotic,O
Sentence: 174,",",O
Sentence: 174,induces,O
Sentence: 174,nephrogenic,B-Disease
Sentence: 174,diabetes,I-Disease
Sentence: 174,insipidus,I-Disease
Sentence: 174,(,O
Sentence: 174,NDI,B-Disease
Sentence: 174,),O
Sentence: 174,in,O
Sentence: 174,40,O
Sentence: 174,%,O
Sentence: 174,of,O
Sentence: 174,patients,O
Sentence: 174,.,O
Sentence: 174,The,O
Sentence: 174,decreased,O
Sentence: 174,capacity,O
Sentence: 174,to,O
Sentence: 174,concentrate,O
Sentence: 174,urine,O
Sentence: 174,is,O
Sentence: 174,likely,O
Sentence: 174,due,O
Sentence: 174,to,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,acutely,O
Sentence: 174,disrupting,O
Sentence: 174,the,O
Sentence: 174,cAMP,B-Chemical
Sentence: 174,pathway,O
Sentence: 174,and,O
Sentence: 174,chronically,O
Sentence: 174,reducing,O
Sentence: 174,urea,B-Chemical
Sentence: 174,transporter,O
Sentence: 174,(,O
Sentence: 174,UT,O
Sentence: 174,-,O
Sentence: 174,A1,O
Sentence: 174,),O
Sentence: 174,and,O
Sentence: 174,water,O
Sentence: 174,channel,O
Sentence: 174,(,O
Sentence: 174,AQP2,O
Sentence: 174,),O
Sentence: 174,expression,O
Sentence: 174,in,O
Sentence: 174,the,O
Sentence: 174,inner,O
Sentence: 174,medulla,O
Sentence: 174,.,O
Sentence: 174,Targeting,O
Sentence: 174,an,O
Sentence: 174,alternative,O
Sentence: 174,signaling,O
Sentence: 174,pathway,O
Sentence: 174,",",O
Sentence: 174,such,O
Sentence: 174,as,O
Sentence: 174,PKC,O
Sentence: 174,-,O
Sentence: 174,mediated,O
Sentence: 174,signaling,O
Sentence: 174,",",O
Sentence: 174,may,O
Sentence: 174,be,O
Sentence: 174,an,O
Sentence: 174,effective,O
Sentence: 174,method,O
Sentence: 174,of,O
Sentence: 174,treating,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,induced,O
Sentence: 174,polyuria,B-Disease
Sentence: 174,.,O
Sentence: 174,PKC,O
Sentence: 174,-,O
Sentence: 174,alpha,O
Sentence: 174,null,O
Sentence: 174,mice,O
Sentence: 174,(,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,),O
Sentence: 174,and,O
Sentence: 174,strain,O
Sentence: 174,-,O
Sentence: 174,matched,O
Sentence: 174,wild,O
Sentence: 174,type,O
Sentence: 174,(,O
Sentence: 174,WT,O
Sentence: 174,),O
Sentence: 174,controls,O
Sentence: 174,were,O
Sentence: 174,treated,O
Sentence: 174,with,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,for,O
Sentence: 174,0,O
Sentence: 174,",",O
Sentence: 174,3,O
Sentence: 174,or,O
Sentence: 174,5,O
Sentence: 174,days,O
Sentence: 174,.,O
Sentence: 174,WT,O
Sentence: 174,mice,O
Sentence: 174,had,O
Sentence: 174,increased,O
Sentence: 174,urine,O
Sentence: 174,output,O
Sentence: 174,and,O
Sentence: 174,lowered,O
Sentence: 174,urine,O
Sentence: 174,osmolality,O
Sentence: 174,after,O
Sentence: 174,3,O
Sentence: 174,and,O
Sentence: 174,5,O
Sentence: 174,days,O
Sentence: 174,of,O
Sentence: 174,treatment,O
Sentence: 174,whereas,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,mice,O
Sentence: 174,had,O
Sentence: 174,no,O
Sentence: 174,change,O
Sentence: 174,in,O
Sentence: 174,urine,O
Sentence: 174,output,O
Sentence: 174,or,O
Sentence: 174,concentration,O
Sentence: 174,.,O
Sentence: 174,Western,O
Sentence: 174,blot,O
Sentence: 174,analysis,O
Sentence: 174,revealed,O
Sentence: 174,that,O
Sentence: 174,AQP2,O
Sentence: 174,expression,O
Sentence: 174,in,O
Sentence: 174,medullary,O
Sentence: 174,tissues,O
Sentence: 174,was,O
Sentence: 174,lowered,O
Sentence: 174,after,O
Sentence: 174,3,O
Sentence: 174,and,O
Sentence: 174,5,O
Sentence: 174,days,O
Sentence: 174,in,O
Sentence: 174,WT,O
Sentence: 174,mice,O
Sentence: 174,;,O
Sentence: 174,however,O
Sentence: 174,",",O
Sentence: 174,AQP2,O
Sentence: 174,was,O
Sentence: 174,unchanged,O
Sentence: 174,in,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,.,O
Sentence: 174,Similar,O
Sentence: 174,results,O
Sentence: 174,were,O
Sentence: 174,observed,O
Sentence: 174,with,O
Sentence: 174,UT,O
Sentence: 174,-,O
Sentence: 174,A1,O
Sentence: 174,expression,O
Sentence: 174,.,O
Sentence: 174,Animals,O
Sentence: 174,were,O
Sentence: 174,also,O
Sentence: 174,treated,O
Sentence: 174,with,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,for,O
Sentence: 174,6,O
Sentence: 174,weeks,O
Sentence: 174,.,O
Sentence: 174,Lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,treated,O
Sentence: 174,WT,O
Sentence: 174,mice,O
Sentence: 174,had,O
Sentence: 174,19,O
Sentence: 174,-,O
Sentence: 174,fold,O
Sentence: 174,increased,O
Sentence: 174,urine,O
Sentence: 174,output,O
Sentence: 174,whereas,O
Sentence: 174,treated,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,animals,O
Sentence: 174,had,O
Sentence: 174,a,O
Sentence: 174,4,O
Sentence: 174,-,O
Sentence: 174,fold,O
Sentence: 174,increase,O
Sentence: 174,in,O
Sentence: 174,output,O
Sentence: 174,.,O
Sentence: 174,AQP2,O
Sentence: 174,and,O
Sentence: 174,UT,O
Sentence: 174,-,O
Sentence: 174,A1,O
Sentence: 174,expression,O
Sentence: 174,was,O
Sentence: 174,lowered,O
Sentence: 174,in,O
Sentence: 174,6,O
Sentence: 174,week,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,treated,O
Sentence: 174,WT,O
Sentence: 174,animals,O
Sentence: 174,whereas,O
Sentence: 174,in,O
Sentence: 174,treated,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,mice,O
Sentence: 174,",",O
Sentence: 174,AQP2,O
Sentence: 174,was,O
Sentence: 174,only,O
Sentence: 174,reduced,O
Sentence: 174,by,O
Sentence: 174,2,O
Sentence: 174,-,O
Sentence: 174,fold,O
Sentence: 174,and,O
Sentence: 174,UT,O
Sentence: 174,-,O
Sentence: 174,A1,O
Sentence: 174,expression,O
Sentence: 174,was,O
Sentence: 174,unaffected,O
Sentence: 174,.,O
Sentence: 174,Urinary,O
Sentence: 174,sodium,B-Chemical
Sentence: 174,",",O
Sentence: 174,potassium,B-Chemical
Sentence: 174,and,O
Sentence: 174,calcium,B-Chemical
Sentence: 174,were,O
Sentence: 174,elevated,O
Sentence: 174,in,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,fed,O
Sentence: 174,WT,O
Sentence: 174,but,O
Sentence: 174,not,O
Sentence: 174,in,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,fed,O
Sentence: 174,PKCa,O
Sentence: 174,KO,O
Sentence: 174,mice,O
Sentence: 174,.,O
Sentence: 174,Our,O
Sentence: 174,data,O
Sentence: 174,show,O
Sentence: 174,that,O
Sentence: 174,ablation,O
Sentence: 174,of,O
Sentence: 174,PKCa,O
Sentence: 174,preserves,O
Sentence: 174,AQP2,O
Sentence: 174,and,O
Sentence: 174,UT,O
Sentence: 174,-,O
Sentence: 174,A1,O
Sentence: 174,protein,O
Sentence: 174,expression,O
Sentence: 174,and,O
Sentence: 174,localization,O
Sentence: 174,in,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,-,O
Sentence: 174,induced,O
Sentence: 174,NDI,B-Disease
Sentence: 174,",",O
Sentence: 174,and,O
Sentence: 174,prevents,O
Sentence: 174,the,O
Sentence: 174,development,O
Sentence: 174,of,O
Sentence: 174,the,O
Sentence: 174,severe,O
Sentence: 174,polyuria,B-Disease
Sentence: 174,associated,O
Sentence: 174,with,O
Sentence: 174,lithium,B-Chemical
Sentence: 174,therapy,O
Sentence: 174,.,O
Sentence: 175,Is,O
Sentence: 175,Dysguesia,B-Disease
Sentence: 175,Going,O
Sentence: 175,to,O
Sentence: 175,be,O
Sentence: 175,a,O
Sentence: 175,Rare,O
Sentence: 175,or,O
Sentence: 175,a,O
Sentence: 175,Common,O
Sentence: 175,Side,O
Sentence: 175,-,O
Sentence: 175,effect,O
Sentence: 175,of,O
Sentence: 175,Amlodipine,B-Chemical
Sentence: 175,?,O
Sentence: 176,A,O
Sentence: 176,very,O
Sentence: 176,rare,O
Sentence: 176,side,O
Sentence: 176,-,O
Sentence: 176,effect,O
Sentence: 176,of,O
Sentence: 176,amlodipine,B-Chemical
Sentence: 176,is,O
Sentence: 176,dysguesia,B-Disease
Sentence: 176,.,O
Sentence: 176,A,O
Sentence: 176,review,O
Sentence: 176,of,O
Sentence: 176,the,O
Sentence: 176,literature,O
Sentence: 176,produced,O
Sentence: 176,only,O
Sentence: 176,one,O
Sentence: 176,case,O
Sentence: 176,.,O
Sentence: 176,We,O
Sentence: 176,report,O
Sentence: 176,a,O
Sentence: 176,case,O
Sentence: 176,about,O
Sentence: 176,a,O
Sentence: 176,female,O
Sentence: 176,with,O
Sentence: 176,essential,O
Sentence: 176,hypertension,B-Disease
Sentence: 176,on,O
Sentence: 176,drug,O
Sentence: 176,treatment,O
Sentence: 176,with,O
Sentence: 176,amlodipine,B-Chemical
Sentence: 176,developed,O
Sentence: 176,loss,B-Disease
Sentence: 176,of,I-Disease
Sentence: 176,taste,I-Disease
Sentence: 176,sensation,I-Disease
Sentence: 176,.,O
Sentence: 176,Condition,O
Sentence: 176,moderately,O
Sentence: 176,improved,O
Sentence: 176,on,O
Sentence: 176,stoppage,O
Sentence: 176,of,O
Sentence: 176,the,O
Sentence: 176,drug,O
Sentence: 176,for,O
Sentence: 176,25,O
Sentence: 176,days,O
Sentence: 176,.,O
Sentence: 176,We,O
Sentence: 176,conclude,O
Sentence: 176,that,O
Sentence: 176,amlodipine,B-Chemical
Sentence: 176,can,O
Sentence: 176,cause,O
Sentence: 176,dysguesia,B-Disease
Sentence: 176,.,O
Sentence: 176,Here,O
Sentence: 176,",",O
Sentence: 176,we,O
Sentence: 176,describe,O
Sentence: 176,the,O
Sentence: 176,clinical,O
Sentence: 176,presentation,O
Sentence: 176,and,O
Sentence: 176,review,O
Sentence: 176,the,O
Sentence: 176,relevant,O
Sentence: 176,literature,O
Sentence: 176,on,O
Sentence: 176,amlodipine,B-Chemical
Sentence: 176,and,O
Sentence: 176,dysguesia,B-Disease
Sentence: 176,.,O
Sentence: 177,Rhabdomyolysis,B-Disease
Sentence: 177,in,O
Sentence: 177,association,O
Sentence: 177,with,O
Sentence: 177,simvastatin,B-Chemical
Sentence: 177,and,O
Sentence: 177,dosage,O
Sentence: 177,increment,O
Sentence: 177,in,O
Sentence: 177,clarithromycin,B-Chemical
Sentence: 177,.,O
Sentence: 178,Clarithromycin,B-Chemical
Sentence: 178,is,O
Sentence: 178,the,O
Sentence: 178,most,O
Sentence: 178,documented,O
Sentence: 178,cytochrome,O
Sentence: 178,P450,O
Sentence: 178,3A4,O
Sentence: 178,(,O
Sentence: 178,CYP3A4,O
Sentence: 178,),O
Sentence: 178,inhibitor,O
Sentence: 178,to,O
Sentence: 178,cause,O
Sentence: 178,an,O
Sentence: 178,adverse,O
Sentence: 178,interaction,O
Sentence: 178,with,O
Sentence: 178,simvastatin,B-Chemical
Sentence: 178,.,O
Sentence: 178,This,O
Sentence: 178,particular,O
Sentence: 178,case,O
Sentence: 178,is,O
Sentence: 178,of,O
Sentence: 178,interest,O
Sentence: 178,as,O
Sentence: 178,rhabdomyolysis,B-Disease
Sentence: 178,only,O
Sentence: 178,occurred,O
Sentence: 178,after,O
Sentence: 178,an,O
Sentence: 178,increase,O
Sentence: 178,in,O
Sentence: 178,the,O
Sentence: 178,dose,O
Sentence: 178,of,O
Sentence: 178,clarithromycin,B-Chemical
Sentence: 178,.,O
Sentence: 178,The,O
Sentence: 178,patient,O
Sentence: 178,developed,O
Sentence: 178,raised,O
Sentence: 178,cardiac,O
Sentence: 178,biomarkers,O
Sentence: 178,without,O
Sentence: 178,any,O
Sentence: 178,obvious,O
Sentence: 178,cardiac,O
Sentence: 178,issues,O
Sentence: 178,",",O
Sentence: 178,a,O
Sentence: 178,phenomenon,O
Sentence: 178,that,O
Sentence: 178,has,O
Sentence: 178,been,O
Sentence: 178,linked,O
Sentence: 178,to,O
Sentence: 178,rhabdomyolysis,B-Disease
Sentence: 178,previously,O
Sentence: 178,.,O
Sentence: 178,To,O
Sentence: 178,date,O
Sentence: 178,",",O
Sentence: 178,there,O
Sentence: 178,has,O
Sentence: 178,been,O
Sentence: 178,no,O
Sentence: 178,reported,O
Sentence: 178,effect,O
Sentence: 178,of,O
Sentence: 178,rhabdomyolysis,B-Disease
Sentence: 178,on,O
Sentence: 178,the,O
Sentence: 178,structure,O
Sentence: 178,and,O
Sentence: 178,function,O
Sentence: 178,of,O
Sentence: 178,cardiac,O
Sentence: 178,muscle,O
Sentence: 178,.,O
Sentence: 178,Clinicians,O
Sentence: 178,need,O
Sentence: 178,to,O
Sentence: 178,be,O
Sentence: 178,aware,O
Sentence: 178,of,O
Sentence: 178,prescribing,O
Sentence: 178,concomitant,O
Sentence: 178,medications,O
Sentence: 178,that,O
Sentence: 178,increase,O
Sentence: 178,the,O
Sentence: 178,risk,O
Sentence: 178,of,O
Sentence: 178,myopathy,B-Disease
Sentence: 178,or,O
Sentence: 178,inhibit,O
Sentence: 178,the,O
Sentence: 178,CYP3A4,O
Sentence: 178,enzyme,O
Sentence: 178,.,O
Sentence: 178,Our,O
Sentence: 178,case,O
Sentence: 178,suggests,O
Sentence: 178,that,O
Sentence: 178,troponin,O
Sentence: 178,elevation,O
Sentence: 178,could,O
Sentence: 178,be,O
Sentence: 178,associated,O
Sentence: 178,with,O
Sentence: 178,statin,B-Chemical
Sentence: 178,induced,O
Sentence: 178,rhabdomyolysis,B-Disease
Sentence: 178,",",O
Sentence: 178,which,O
Sentence: 178,may,O
Sentence: 178,warrant,O
Sentence: 178,further,O
Sentence: 178,studies,O
Sentence: 178,.,O
Sentence: 179,Characterization,O
Sentence: 179,of,O
Sentence: 179,a,O
Sentence: 179,novel,O
Sentence: 179,BCHE,O
Sentence: 179,``,O
Sentence: 179,silent,O
Sentence: 179,'',O
Sentence: 179,allele,O
Sentence: 179,:,O
Sentence: 179,point,O
Sentence: 179,mutation,O
Sentence: 179,(,O
Sentence: 179,p.Val204Asp,O
Sentence: 179,),O
Sentence: 179,causes,O
Sentence: 179,loss,O
Sentence: 179,of,O
Sentence: 179,activity,O
Sentence: 179,and,O
Sentence: 179,prolonged,O
Sentence: 179,apnea,B-Disease
Sentence: 179,with,O
Sentence: 179,suxamethonium,B-Chemical
Sentence: 179,.,O
Sentence: 180,Butyrylcholinesterase,B-Disease
Sentence: 180,deficiency,I-Disease
Sentence: 180,is,O
Sentence: 180,characterized,O
Sentence: 180,by,O
Sentence: 180,prolonged,O
Sentence: 180,apnea,B-Disease
Sentence: 180,after,O
Sentence: 180,the,O
Sentence: 180,use,O
Sentence: 180,of,O
Sentence: 180,muscle,O
Sentence: 180,relaxants,O
Sentence: 180,(,O
Sentence: 180,suxamethonium,B-Chemical
Sentence: 180,or,O
Sentence: 180,mivacurium,B-Chemical
Sentence: 180,),O
Sentence: 180,in,O
Sentence: 180,patients,O
Sentence: 180,who,O
Sentence: 180,have,O
Sentence: 180,mutations,O
Sentence: 180,in,O
Sentence: 180,the,O
Sentence: 180,BCHE,O
Sentence: 180,gene,O
Sentence: 180,.,O
Sentence: 180,Here,O
Sentence: 180,",",O
Sentence: 180,we,O
Sentence: 180,report,O
Sentence: 180,a,O
Sentence: 180,case,O
Sentence: 180,of,O
Sentence: 180,prolonged,O
Sentence: 180,neuromuscular,O
Sentence: 180,block,O
Sentence: 180,after,O
Sentence: 180,administration,O
Sentence: 180,of,O
Sentence: 180,suxamethonium,B-Chemical
Sentence: 180,leading,O
Sentence: 180,to,O
Sentence: 180,the,O
Sentence: 180,discovery,O
Sentence: 180,of,O
Sentence: 180,a,O
Sentence: 180,novel,O
Sentence: 180,BCHE,O
Sentence: 180,variant,O
Sentence: 180,(,O
Sentence: 180,c.695T,O
Sentence: 180,,O
Sentence: 180,>,O
Sentence: 180,,O
Sentence: 180,A,O
Sentence: 180,",",O
Sentence: 180,p.Val204Asp,O
Sentence: 180,),O
Sentence: 180,.,O
Sentence: 180,Inhibition,O
Sentence: 180,studies,O
Sentence: 180,",",O
Sentence: 180,kinetic,O
Sentence: 180,analysis,O
Sentence: 180,and,O
Sentence: 180,molecular,O
Sentence: 180,dynamics,O
Sentence: 180,were,O
Sentence: 180,undertaken,O
Sentence: 180,to,O
Sentence: 180,understand,O
Sentence: 180,how,O
Sentence: 180,this,O
Sentence: 180,mutation,O
Sentence: 180,disrupts,O
Sentence: 180,the,O
Sentence: 180,catalytic,O
Sentence: 180,triad,O
Sentence: 180,and,O
Sentence: 180,determines,O
Sentence: 180,a,O
Sentence: 180,``,O
Sentence: 180,silent,O
Sentence: 180,'',O
Sentence: 180,phenotype,O
Sentence: 180,.,O
Sentence: 180,Low,O
Sentence: 180,activity,O
Sentence: 180,of,O
Sentence: 180,patient,O
Sentence: 180,plasma,O
Sentence: 180,butyrylcholinesterase,O
Sentence: 180,with,O
Sentence: 180,butyrylthiocholine,B-Chemical
Sentence: 180,(,O
Sentence: 180,BTC,B-Chemical
Sentence: 180,),O
Sentence: 180,and,O
Sentence: 180,benzoylcholine,B-Chemical
Sentence: 180,",",O
Sentence: 180,and,O
Sentence: 180,values,O
Sentence: 180,of,O
Sentence: 180,dibucaine,B-Chemical
Sentence: 180,and,O
Sentence: 180,fluoride,B-Chemical
Sentence: 180,numbers,O
Sentence: 180,fit,O
Sentence: 180,with,O
Sentence: 180,heterozygous,O
Sentence: 180,atypical,O
Sentence: 180,silent,O
Sentence: 180,genotype,O
Sentence: 180,.,O
Sentence: 180,Electrophoretic,O
Sentence: 180,analysis,O
Sentence: 180,of,O
Sentence: 180,plasma,O
Sentence: 180,BChE,O
Sentence: 180,of,O
Sentence: 180,the,O
Sentence: 180,proband,O
Sentence: 180,and,O
Sentence: 180,his,O
Sentence: 180,mother,O
Sentence: 180,showed,O
Sentence: 180,that,O
Sentence: 180,patient,O
Sentence: 180,has,O
Sentence: 180,a,O
Sentence: 180,reduced,O
Sentence: 180,amount,O
Sentence: 180,of,O
Sentence: 180,tetrameric,O
Sentence: 180,enzyme,O
Sentence: 180,in,O
Sentence: 180,plasma,O
Sentence: 180,and,O
Sentence: 180,that,O
Sentence: 180,minor,O
Sentence: 180,fast,O
Sentence: 180,-,O
Sentence: 180,moving,O
Sentence: 180,BChE,O
Sentence: 180,components,O
Sentence: 180,:,O
Sentence: 180,monomer,O
Sentence: 180,",",O
Sentence: 180,dimer,O
Sentence: 180,",",O
Sentence: 180,and,O
Sentence: 180,monomer,O
Sentence: 180,-,O
Sentence: 180,albumin,O
Sentence: 180,conjugate,O
Sentence: 180,are,O
Sentence: 180,missing,O
Sentence: 180,.,O
Sentence: 180,Kinetic,O
Sentence: 180,analysis,O
Sentence: 180,showed,O
Sentence: 180,that,O
Sentence: 180,the,O
Sentence: 180,p.Val204Asp,O
Sentence: 180,/,O
Sentence: 180,p.Asp70Gly,O
Sentence: 180,-,O
Sentence: 180,p.Ala539Thr,O
Sentence: 180,BChE,O
Sentence: 180,displays,O
Sentence: 180,a,O
Sentence: 180,pure,O
Sentence: 180,Michaelian,O
Sentence: 180,behavior,O
Sentence: 180,with,O
Sentence: 180,BTC,B-Chemical
Sentence: 180,as,O
Sentence: 180,the,O
Sentence: 180,substrate,O
Sentence: 180,.,O
Sentence: 180,Both,O
Sentence: 180,catalytic,O
Sentence: 180,parameters,O
Sentence: 180,Km,O
Sentence: 180,,O
Sentence: 180,=,O
Sentence: 180,,O
Sentence: 180,265,O
Sentence: 180,uM,O
Sentence: 180,for,O
Sentence: 180,BTC,B-Chemical
Sentence: 180,",",O
Sentence: 180,two,O
Sentence: 180,times,O
Sentence: 180,higher,O
Sentence: 180,than,O
Sentence: 180,that,O
Sentence: 180,of,O
Sentence: 180,the,O
Sentence: 180,atypical,O
Sentence: 180,enzyme,O
Sentence: 180,",",O
Sentence: 180,and,O
Sentence: 180,a,O
Sentence: 180,low,O
Sentence: 180,Vmax,O
Sentence: 180,are,O
Sentence: 180,consistent,O
Sentence: 180,with,O
Sentence: 180,the,O
Sentence: 180,absence,O
Sentence: 180,of,O
Sentence: 180,activity,O
Sentence: 180,against,O
Sentence: 180,suxamethonium,B-Chemical
Sentence: 180,.,O
Sentence: 180,Molecular,O
Sentence: 180,dynamic,O
Sentence: 180,(,O
Sentence: 180,MD,O
Sentence: 180,),O
Sentence: 180,simulations,O
Sentence: 180,showed,O
Sentence: 180,that,O
Sentence: 180,the,O
Sentence: 180,overall,O
Sentence: 180,effect,O
Sentence: 180,of,O
Sentence: 180,the,O
Sentence: 180,mutation,O
Sentence: 180,p.Val204Asp,O
Sentence: 180,is,O
Sentence: 180,disruption,O
Sentence: 180,of,O
Sentence: 180,hydrogen,B-Chemical
Sentence: 180,bonding,O
Sentence: 180,between,O
Sentence: 180,Gln223,O
Sentence: 180,and,O
Sentence: 180,Glu441,O
Sentence: 180,",",O
Sentence: 180,leading,O
Sentence: 180,Ser198,O
Sentence: 180,and,O
Sentence: 180,His438,O
Sentence: 180,to,O
Sentence: 180,move,O
Sentence: 180,away,O
Sentence: 180,from,O
Sentence: 180,each,O
Sentence: 180,other,O
Sentence: 180,with,O
Sentence: 180,subsequent,O
Sentence: 180,disruption,O
Sentence: 180,of,O
Sentence: 180,the,O
Sentence: 180,catalytic,O
Sentence: 180,triad,O
Sentence: 180,functionality,O
Sentence: 180,regardless,O
Sentence: 180,of,O
Sentence: 180,the,O
Sentence: 180,type,O
Sentence: 180,of,O
Sentence: 180,substrate,O
Sentence: 180,.,O
Sentence: 180,MD,O
Sentence: 180,also,O
Sentence: 180,showed,O
Sentence: 180,that,O
Sentence: 180,the,O
Sentence: 180,enzyme,O
Sentence: 180,volume,O
Sentence: 180,is,O
Sentence: 180,increased,O
Sentence: 180,",",O
Sentence: 180,suggesting,O
Sentence: 180,a,O
Sentence: 180,pre,O
Sentence: 180,-,O
Sentence: 180,denaturation,O
Sentence: 180,state,O
Sentence: 180,.,O
Sentence: 180,This,O
Sentence: 180,fits,O
Sentence: 180,with,O
Sentence: 180,the,O
Sentence: 180,reduced,O
Sentence: 180,concentration,O
Sentence: 180,of,O
Sentence: 180,p.Ala204Asp,O
Sentence: 180,/,O
Sentence: 180,p.Asp70Gly,O
Sentence: 180,-,O
Sentence: 180,p.Ala539Thr,O
Sentence: 180,tetrameric,O
Sentence: 180,enzyme,O
Sentence: 180,in,O
Sentence: 180,the,O
Sentence: 180,plasma,O
Sentence: 180,and,O
Sentence: 180,non,O
Sentence: 180,-,O
Sentence: 180,detectable,O
Sentence: 180,fast,O
Sentence: 180,moving,O
Sentence: 180,-,O
Sentence: 180,bands,O
Sentence: 180,on,O
Sentence: 180,electrophoresis,O
Sentence: 180,gels,O
Sentence: 180,.,O
Sentence: 181,Delayed,O
Sentence: 181,anemia,B-Disease
Sentence: 181,after,O
Sentence: 181,treatment,O
Sentence: 181,with,O
Sentence: 181,injectable,O
Sentence: 181,artesunate,B-Chemical
Sentence: 181,in,O
Sentence: 181,the,O
Sentence: 181,Democratic,O
Sentence: 181,Republic,O
Sentence: 181,of,O
Sentence: 181,the,O
Sentence: 181,Congo,O
Sentence: 181,:,O
Sentence: 181,a,O
Sentence: 181,manageable,O
Sentence: 181,issue,O
Sentence: 181,.,O
Sentence: 182,Cases,O
Sentence: 182,of,O
Sentence: 182,delayed,O
Sentence: 182,hemolytic,B-Disease
Sentence: 182,anemia,B-Disease
Sentence: 182,have,O
Sentence: 182,been,O
Sentence: 182,described,O
Sentence: 182,after,O
Sentence: 182,treatment,O
Sentence: 182,with,O
Sentence: 182,injectable,O
Sentence: 182,artesunate,B-Chemical
Sentence: 182,",",O
Sentence: 182,the,O
Sentence: 182,current,O
Sentence: 182,World,O
Sentence: 182,Health,O
Sentence: 182,Organization,O
Sentence: 182,(,O
Sentence: 182,WHO,O
Sentence: 182,),O
Sentence: 182,,O
Sentence: 182,-,O
Sentence: 182,recommended,O
Sentence: 182,first,O
Sentence: 182,-,O
Sentence: 182,line,O
Sentence: 182,drug,O
Sentence: 182,for,O
Sentence: 182,the,O
Sentence: 182,treatment,O
Sentence: 182,of,O
Sentence: 182,severe,O
Sentence: 182,malaria,B-Disease
Sentence: 182,.,O
Sentence: 182,A,O
Sentence: 182,total,O
Sentence: 182,of,O
Sentence: 182,350,O
Sentence: 182,patients,O
Sentence: 182,(,O
Sentence: 182,215,O
Sentence: 182,[,O
Sentence: 182,61.4,O
Sentence: 182,%,O
Sentence: 182,],O
Sentence: 182,,O
Sentence: 182,<,O
Sentence: 182,,O
Sentence: 182,5,O
Sentence: 182,years,O
Sentence: 182,of,O
Sentence: 182,age,O
Sentence: 182,and,O
Sentence: 182,135,O
Sentence: 182,[,O
Sentence: 182,38.6,O
Sentence: 182,%,O
Sentence: 182,],O
Sentence: 182,,O
Sentence: 182,>,O
Sentence: 182,,O
Sentence: 182,5,O
Sentence: 182,years,O
Sentence: 182,of,O
Sentence: 182,age,O
Sentence: 182,),O
Sentence: 182,were,O
Sentence: 182,followed,O
Sentence: 182,-,O
Sentence: 182,up,O
Sentence: 182,after,O
Sentence: 182,treatment,O
Sentence: 182,with,O
Sentence: 182,injectable,O
Sentence: 182,artesunate,B-Chemical
Sentence: 182,for,O
Sentence: 182,severe,O
Sentence: 182,malaria,B-Disease
Sentence: 182,in,O
Sentence: 182,hospitals,O
Sentence: 182,and,O
Sentence: 182,health,O
Sentence: 182,centers,O
Sentence: 182,of,O
Sentence: 182,the,O
Sentence: 182,Democratic,O
Sentence: 182,Republic,O
Sentence: 182,of,O
Sentence: 182,the,O
Sentence: 182,Congo,O
Sentence: 182,.,O
Sentence: 182,Complete,O
Sentence: 182,series,O
Sentence: 182,of,O
Sentence: 182,hemoglobin,O
Sentence: 182,(,O
Sentence: 182,Hb,O
Sentence: 182,),O
Sentence: 182,measurements,O
Sentence: 182,were,O
Sentence: 182,available,O
Sentence: 182,for,O
Sentence: 182,201,O
Sentence: 182,patients,O
Sentence: 182,.,O
Sentence: 182,A,O
Sentence: 182,decrease,O
Sentence: 182,in,O
Sentence: 182,Hb,O
Sentence: 182,levels,O
Sentence: 182,between,O
Sentence: 182,2,O
Sentence: 182,and,O
Sentence: 182,5,O
Sentence: 182,g,O
Sentence: 182,/,O
Sentence: 182,dL,O
Sentence: 182,was,O
Sentence: 182,detected,O
Sentence: 182,in,O
Sentence: 182,23,O
Sentence: 182,(,O
Sentence: 182,11.4,O
Sentence: 182,%,O
Sentence: 182,),O
Sentence: 182,patients,O
Sentence: 182,during,O
Sentence: 182,the,O
Sentence: 182,follow,O
Sentence: 182,-,O
Sentence: 182,up,O
Sentence: 182,period,O
Sentence: 182,.,O
Sentence: 182,For,O
Sentence: 182,five,O
Sentence: 182,patients,O
Sentence: 182,",",O
Sentence: 182,Hb,O
Sentence: 182,levels,O
Sentence: 182,decreased,O
Sentence: 182,below,O
Sentence: 182,5,O
Sentence: 182,g,O
Sentence: 182,/,O
Sentence: 182,dL,O
Sentence: 182,during,O
Sentence: 182,at,O
Sentence: 182,least,O
Sentence: 182,one,O
Sentence: 182,follow,O
Sentence: 182,-,O
Sentence: 182,up,O
Sentence: 182,visit,O
Sentence: 182,.,O
Sentence: 182,All,O
Sentence: 182,cases,O
Sentence: 182,of,O
Sentence: 182,delayed,O
Sentence: 182,anemia,B-Disease
Sentence: 182,were,O
Sentence: 182,clinically,O
Sentence: 182,manageable,O
Sentence: 182,and,O
Sentence: 182,resolved,O
Sentence: 182,within,O
Sentence: 182,one,O
Sentence: 182,month,O
Sentence: 182,.,O
Sentence: 183,Regulation,O
Sentence: 183,of,O
Sentence: 183,signal,O
Sentence: 183,transducer,O
Sentence: 183,and,O
Sentence: 183,activator,O
Sentence: 183,of,O
Sentence: 183,transcription,O
Sentence: 183,3,O
Sentence: 183,and,O
Sentence: 183,apoptotic,O
Sentence: 183,pathways,O
Sentence: 183,by,O
Sentence: 183,betaine,B-Chemical
Sentence: 183,attenuates,O
Sentence: 183,isoproterenol,B-Chemical
Sentence: 183,-,O
Sentence: 183,induced,O
Sentence: 183,acute,O
Sentence: 183,myocardial,B-Disease
Sentence: 183,injury,I-Disease
Sentence: 183,in,O
Sentence: 183,rats,O
Sentence: 183,.,O
Sentence: 184,The,O
Sentence: 184,present,O
Sentence: 184,study,O
Sentence: 184,was,O
Sentence: 184,designed,O
Sentence: 184,to,O
Sentence: 184,investigate,O
Sentence: 184,the,O
Sentence: 184,cardioprotective,O
Sentence: 184,effects,O
Sentence: 184,of,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,on,O
Sentence: 184,acute,O
Sentence: 184,myocardial,B-Disease
Sentence: 184,ischemia,I-Disease
Sentence: 184,induced,O
Sentence: 184,experimentally,O
Sentence: 184,in,O
Sentence: 184,rats,O
Sentence: 184,focusing,O
Sentence: 184,on,O
Sentence: 184,regulation,O
Sentence: 184,of,O
Sentence: 184,signal,O
Sentence: 184,transducer,O
Sentence: 184,and,O
Sentence: 184,activator,O
Sentence: 184,of,O
Sentence: 184,transcription,O
Sentence: 184,3,O
Sentence: 184,(,O
Sentence: 184,STAT3,O
Sentence: 184,),O
Sentence: 184,and,O
Sentence: 184,apoptotic,O
Sentence: 184,pathways,O
Sentence: 184,as,O
Sentence: 184,the,O
Sentence: 184,potential,O
Sentence: 184,mechanism,O
Sentence: 184,underlying,O
Sentence: 184,the,O
Sentence: 184,drug,O
Sentence: 184,effect,O
Sentence: 184,.,O
Sentence: 184,Male,O
Sentence: 184,Sprague,O
Sentence: 184,Dawley,O
Sentence: 184,rats,O
Sentence: 184,were,O
Sentence: 184,treated,O
Sentence: 184,with,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,(,O
Sentence: 184,100,O
Sentence: 184,",",O
Sentence: 184,200,O
Sentence: 184,",",O
Sentence: 184,and,O
Sentence: 184,400,O
Sentence: 184,mg,O
Sentence: 184,/,O
Sentence: 184,kg,O
Sentence: 184,),O
Sentence: 184,orally,O
Sentence: 184,for,O
Sentence: 184,40,O
Sentence: 184,days,O
Sentence: 184,.,O
Sentence: 184,Acute,O
Sentence: 184,myocardial,B-Disease
Sentence: 184,ischemic,I-Disease
Sentence: 184,injury,I-Disease
Sentence: 184,was,O
Sentence: 184,induced,O
Sentence: 184,in,O
Sentence: 184,rats,O
Sentence: 184,by,O
Sentence: 184,subcutaneous,O
Sentence: 184,injection,O
Sentence: 184,of,O
Sentence: 184,isoproterenol,B-Chemical
Sentence: 184,(,O
Sentence: 184,85,O
Sentence: 184,mg,O
Sentence: 184,/,O
Sentence: 184,kg,O
Sentence: 184,),O
Sentence: 184,",",O
Sentence: 184,for,O
Sentence: 184,two,O
Sentence: 184,consecutive,O
Sentence: 184,days,O
Sentence: 184,.,O
Sentence: 184,Serum,O
Sentence: 184,cardiac,O
Sentence: 184,marker,O
Sentence: 184,enzyme,O
Sentence: 184,",",O
Sentence: 184,histopathological,O
Sentence: 184,variables,O
Sentence: 184,and,O
Sentence: 184,expression,O
Sentence: 184,of,O
Sentence: 184,protein,O
Sentence: 184,levels,O
Sentence: 184,were,O
Sentence: 184,analyzed,O
Sentence: 184,.,O
Sentence: 184,Oral,O
Sentence: 184,administration,O
Sentence: 184,of,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,(,O
Sentence: 184,200,O
Sentence: 184,and,O
Sentence: 184,400,O
Sentence: 184,mg,O
Sentence: 184,/,O
Sentence: 184,kg,O
Sentence: 184,),O
Sentence: 184,significantly,O
Sentence: 184,reduced,O
Sentence: 184,the,O
Sentence: 184,level,O
Sentence: 184,of,O
Sentence: 184,cardiac,O
Sentence: 184,marker,O
Sentence: 184,enzyme,O
Sentence: 184,in,O
Sentence: 184,the,O
Sentence: 184,serum,O
Sentence: 184,and,O
Sentence: 184,prevented,O
Sentence: 184,left,O
Sentence: 184,ventricular,B-Disease
Sentence: 184,remodeling,I-Disease
Sentence: 184,.,O
Sentence: 184,Western,O
Sentence: 184,blot,O
Sentence: 184,analysis,O
Sentence: 184,showed,O
Sentence: 184,that,O
Sentence: 184,isoproterenol,B-Chemical
Sentence: 184,-,O
Sentence: 184,induced,O
Sentence: 184,phosphorylation,O
Sentence: 184,of,O
Sentence: 184,STAT3,O
Sentence: 184,was,O
Sentence: 184,maintained,O
Sentence: 184,or,O
Sentence: 184,further,O
Sentence: 184,enhanced,O
Sentence: 184,by,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,treatment,O
Sentence: 184,in,O
Sentence: 184,myocardium,O
Sentence: 184,.,O
Sentence: 184,Furthermore,O
Sentence: 184,",",O
Sentence: 184,betaine,B-Chemical
Sentence: 184,(,O
Sentence: 184,200,O
Sentence: 184,and,O
Sentence: 184,400,O
Sentence: 184,mg,O
Sentence: 184,/,O
Sentence: 184,kg,O
Sentence: 184,),O
Sentence: 184,treatment,O
Sentence: 184,increased,O
Sentence: 184,the,O
Sentence: 184,ventricular,O
Sentence: 184,expression,O
Sentence: 184,of,O
Sentence: 184,Bcl,O
Sentence: 184,-,O
Sentence: 184,2,O
Sentence: 184,and,O
Sentence: 184,reduced,O
Sentence: 184,the,O
Sentence: 184,level,O
Sentence: 184,of,O
Sentence: 184,Bax,O
Sentence: 184,",",O
Sentence: 184,therefore,O
Sentence: 184,causing,O
Sentence: 184,a,O
Sentence: 184,significant,O
Sentence: 184,increase,O
Sentence: 184,in,O
Sentence: 184,the,O
Sentence: 184,ratio,O
Sentence: 184,of,O
Sentence: 184,Bcl,O
Sentence: 184,-,O
Sentence: 184,2,O
Sentence: 184,/,O
Sentence: 184,Bax,O
Sentence: 184,.,O
Sentence: 184,The,O
Sentence: 184,protective,O
Sentence: 184,role,O
Sentence: 184,of,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,on,O
Sentence: 184,myocardial,B-Disease
Sentence: 184,damage,I-Disease
Sentence: 184,was,O
Sentence: 184,further,O
Sentence: 184,confirmed,O
Sentence: 184,by,O
Sentence: 184,histopathological,O
Sentence: 184,examination,O
Sentence: 184,.,O
Sentence: 184,In,O
Sentence: 184,summary,O
Sentence: 184,",",O
Sentence: 184,our,O
Sentence: 184,results,O
Sentence: 184,showed,O
Sentence: 184,that,O
Sentence: 184,betaine,B-Chemical
Sentence: 184,pretreatment,O
Sentence: 184,attenuated,O
Sentence: 184,isoproterenol,B-Chemical
Sentence: 184,-,O
Sentence: 184,induced,O
Sentence: 184,acute,O
Sentence: 184,myocardial,B-Disease
Sentence: 184,ischemia,I-Disease
Sentence: 184,via,O
Sentence: 184,the,O
Sentence: 184,regulation,O
Sentence: 184,of,O
Sentence: 184,STAT3,O
Sentence: 184,and,O
Sentence: 184,apoptotic,O
Sentence: 184,pathways,O
Sentence: 184,.,O
Sentence: 185,Quetiapine,B-Chemical
Sentence: 185,-,O
Sentence: 185,induced,O
Sentence: 185,neutropenia,B-Disease
Sentence: 185,in,O
Sentence: 185,a,O
Sentence: 185,bipolar,B-Disease
Sentence: 185,patient,O
Sentence: 185,with,O
Sentence: 185,hepatocellular,B-Disease
Sentence: 185,carcinoma,I-Disease
Sentence: 185,.,O
Sentence: 186,OBJECTIVE,O
Sentence: 186,:,O
Sentence: 186,Quetiapine,B-Chemical
Sentence: 186,is,O
Sentence: 186,a,O
Sentence: 186,dibenzothiazepine,O
Sentence: 186,derivative,O
Sentence: 186,",",O
Sentence: 186,similar,O
Sentence: 186,to,O
Sentence: 186,clozapine,B-Chemical
Sentence: 186,",",O
Sentence: 186,which,O
Sentence: 186,has,O
Sentence: 186,the,O
Sentence: 186,highest,O
Sentence: 186,risk,O
Sentence: 186,of,O
Sentence: 186,causing,O
Sentence: 186,blood,B-Disease
Sentence: 186,dyscrasias,I-Disease
Sentence: 186,",",O
Sentence: 186,especially,O
Sentence: 186,neutropenia,B-Disease
Sentence: 186,.,O
Sentence: 186,There,O
Sentence: 186,are,O
Sentence: 186,some,O
Sentence: 186,case,O
Sentence: 186,reports,O
Sentence: 186,about,O
Sentence: 186,this,O
Sentence: 186,side,O
Sentence: 186,effect,O
Sentence: 186,of,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,",",O
Sentence: 186,but,O
Sentence: 186,possible,O
Sentence: 186,risk,O
Sentence: 186,factors,O
Sentence: 186,are,O
Sentence: 186,seldom,O
Sentence: 186,discussed,O
Sentence: 186,and,O
Sentence: 186,identified,O
Sentence: 186,.,O
Sentence: 186,A,O
Sentence: 186,case,O
Sentence: 186,of,O
Sentence: 186,a,O
Sentence: 186,patient,O
Sentence: 186,with,O
Sentence: 186,hepatocellular,B-Disease
Sentence: 186,carcinoma,I-Disease
Sentence: 186,that,O
Sentence: 186,developed,O
Sentence: 186,neutropenia,B-Disease
Sentence: 186,after,O
Sentence: 186,treatment,O
Sentence: 186,with,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,is,O
Sentence: 186,described,O
Sentence: 186,here,O
Sentence: 186,.,O
Sentence: 186,CASE,O
Sentence: 186,REPORT,O
Sentence: 186,:,O
Sentence: 186,A,O
Sentence: 186,62,O
Sentence: 186,-,O
Sentence: 186,year,O
Sentence: 186,-,O
Sentence: 186,old,O
Sentence: 186,Taiwanese,O
Sentence: 186,widow,O
Sentence: 186,with,O
Sentence: 186,bipolar,B-Disease
Sentence: 186,disorder,I-Disease
Sentence: 186,was,O
Sentence: 186,diagnosed,O
Sentence: 186,with,O
Sentence: 186,hepatocellular,B-Disease
Sentence: 186,carcinoma,I-Disease
Sentence: 186,at,O
Sentence: 186,age,O
Sentence: 186,60,O
Sentence: 186,.,O
Sentence: 186,She,O
Sentence: 186,developed,O
Sentence: 186,leucopenia,B-Disease
Sentence: 186,after,O
Sentence: 186,being,O
Sentence: 186,treated,O
Sentence: 186,with,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,.,O
Sentence: 186,After,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,was,O
Sentence: 186,discontinued,O
Sentence: 186,",",O
Sentence: 186,her,O
Sentence: 186,white,O
Sentence: 186,blood,O
Sentence: 186,cell,O
Sentence: 186,count,O
Sentence: 186,returned,O
Sentence: 186,to,O
Sentence: 186,normal,O
Sentence: 186,.,O
Sentence: 186,CONCLUSIONS,O
Sentence: 186,:,O
Sentence: 186,Although,O
Sentence: 186,neutropenia,B-Disease
Sentence: 186,is,O
Sentence: 186,not,O
Sentence: 186,a,O
Sentence: 186,common,O
Sentence: 186,side,O
Sentence: 186,effect,O
Sentence: 186,of,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,",",O
Sentence: 186,physicians,O
Sentence: 186,should,O
Sentence: 186,be,O
Sentence: 186,cautious,O
Sentence: 186,about,O
Sentence: 186,its,O
Sentence: 186,presentation,O
Sentence: 186,and,O
Sentence: 186,associated,O
Sentence: 186,risk,O
Sentence: 186,factors,O
Sentence: 186,.,O
Sentence: 186,Hepatic,B-Disease
Sentence: 186,dysfunction,I-Disease
Sentence: 186,may,O
Sentence: 186,be,O
Sentence: 186,one,O
Sentence: 186,of,O
Sentence: 186,the,O
Sentence: 186,possible,O
Sentence: 186,risk,O
Sentence: 186,factors,O
Sentence: 186,",",O
Sentence: 186,and,O
Sentence: 186,concomitant,O
Sentence: 186,fever,B-Disease
Sentence: 186,may,O
Sentence: 186,be,O
Sentence: 186,a,O
Sentence: 186,diagnostic,O
Sentence: 186,marker,O
Sentence: 186,for,O
Sentence: 186,adverse,O
Sentence: 186,reaction,O
Sentence: 186,to,O
Sentence: 186,quetiapine,B-Chemical
Sentence: 186,.,O
Sentence: 187,Lateral,O
Sentence: 187,antebrachial,O
Sentence: 187,cutaneous,O
Sentence: 187,neuropathy,B-Disease
Sentence: 187,after,O
Sentence: 187,steroid,B-Chemical
Sentence: 187,injection,O
Sentence: 187,at,O
Sentence: 187,lateral,O
Sentence: 187,epicondyle,O
Sentence: 187,.,O
Sentence: 188,BACKGROUND,O
Sentence: 188,AND,O
Sentence: 188,OBJECTIVES,O
Sentence: 188,:,O
Sentence: 188,This,O
Sentence: 188,report,O
Sentence: 188,aimed,O
Sentence: 188,to,O
Sentence: 188,present,O
Sentence: 188,a,O
Sentence: 188,case,O
Sentence: 188,of,O
Sentence: 188,lateral,O
Sentence: 188,antebrachial,O
Sentence: 188,cutaneous,O
Sentence: 188,neuropathy,B-Disease
Sentence: 188,(,O
Sentence: 188,LACNP,O
Sentence: 188,),O
Sentence: 188,that,O
Sentence: 188,occurred,O
Sentence: 188,after,O
Sentence: 188,a,O
Sentence: 188,steroid,B-Chemical
Sentence: 188,injection,O
Sentence: 188,in,O
Sentence: 188,the,O
Sentence: 188,lateral,O
Sentence: 188,epicondyle,O
Sentence: 188,to,O
Sentence: 188,treat,O
Sentence: 188,lateral,B-Disease
Sentence: 188,epicondylitis,I-Disease
Sentence: 188,in,O
Sentence: 188,a,O
Sentence: 188,40,O
Sentence: 188,-,O
Sentence: 188,year,O
Sentence: 188,-,O
Sentence: 188,old,O
Sentence: 188,woman,O
Sentence: 188,.,O
Sentence: 188,MATERIAL,O
Sentence: 188,AND,O
Sentence: 188,METHOD,O
Sentence: 188,:,O
Sentence: 188,A,O
Sentence: 188,40,O
Sentence: 188,-,O
Sentence: 188,year,O
Sentence: 188,-,O
Sentence: 188,old,O
Sentence: 188,woman,O
Sentence: 188,presented,O
Sentence: 188,with,O
Sentence: 188,decreased,O
Sentence: 188,sensation,O
Sentence: 188,and,O
Sentence: 188,paresthesia,B-Disease
Sentence: 188,over,O
Sentence: 188,her,O
Sentence: 188,right,O
Sentence: 188,lateral,O
Sentence: 188,forearm,O
Sentence: 188,;,O
Sentence: 188,the,O
Sentence: 188,paresthesia,B-Disease
Sentence: 188,had,O
Sentence: 188,occurred,O
Sentence: 188,after,O
Sentence: 188,a,O
Sentence: 188,steroid,B-Chemical
Sentence: 188,injection,O
Sentence: 188,in,O
Sentence: 188,the,O
Sentence: 188,right,O
Sentence: 188,lateral,O
Sentence: 188,epicondyle,O
Sentence: 188,3,O
Sentence: 188,months,O
Sentence: 188,before,O
Sentence: 188,.,O
Sentence: 188,Her,O
Sentence: 188,sensation,O
Sentence: 188,of,O
Sentence: 188,light,O
Sentence: 188,touch,O
Sentence: 188,and,O
Sentence: 188,pain,B-Disease
Sentence: 188,was,O
Sentence: 188,diminished,O
Sentence: 188,over,O
Sentence: 188,the,O
Sentence: 188,lateral,O
Sentence: 188,side,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,right,O
Sentence: 188,forearm,O
Sentence: 188,and,O
Sentence: 188,wrist,O
Sentence: 188,area,O
Sentence: 188,.,O
Sentence: 188,RESULTS,O
Sentence: 188,:,O
Sentence: 188,The,O
Sentence: 188,sensory,O
Sentence: 188,action,O
Sentence: 188,potential,O
Sentence: 188,amplitude,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,right,O
Sentence: 188,lateral,O
Sentence: 188,antebrachial,O
Sentence: 188,cutaneous,O
Sentence: 188,nerve,O
Sentence: 188,(,O
Sentence: 188,LACN,O
Sentence: 188,),O
Sentence: 188,(,O
Sentence: 188,6.2,O
Sentence: 188,uV,O
Sentence: 188,),O
Sentence: 188,was,O
Sentence: 188,lower,O
Sentence: 188,than,O
Sentence: 188,that,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,left,O
Sentence: 188,(,O
Sentence: 188,13.1,O
Sentence: 188,uV,O
Sentence: 188,),O
Sentence: 188,.,O
Sentence: 188,The,O
Sentence: 188,difference,O
Sentence: 188,of,O
Sentence: 188,amplitude,O
Sentence: 188,between,O
Sentence: 188,both,O
Sentence: 188,sides,O
Sentence: 188,was,O
Sentence: 188,significant,O
Sentence: 188,because,O
Sentence: 188,there,O
Sentence: 188,was,O
Sentence: 188,more,O
Sentence: 188,than,O
Sentence: 188,a,O
Sentence: 188,50,O
Sentence: 188,%,O
Sentence: 188,reduction,O
Sentence: 188,.,O
Sentence: 188,She,O
Sentence: 188,was,O
Sentence: 188,diagnosed,O
Sentence: 188,with,O
Sentence: 188,right,O
Sentence: 188,LACNP,O
Sentence: 188,(,O
Sentence: 188,mainly,O
Sentence: 188,axonal,O
Sentence: 188,involvement,O
Sentence: 188,),O
Sentence: 188,on,O
Sentence: 188,the,O
Sentence: 188,basis,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,clinical,O
Sentence: 188,manifestation,O
Sentence: 188,and,O
Sentence: 188,the,O
Sentence: 188,electrodiagnostic,O
Sentence: 188,findings,O
Sentence: 188,.,O
Sentence: 188,Her,O
Sentence: 188,symptoms,O
Sentence: 188,improved,O
Sentence: 188,through,O
Sentence: 188,physical,O
Sentence: 188,therapy,O
Sentence: 188,but,O
Sentence: 188,persisted,O
Sentence: 188,to,O
Sentence: 188,some,O
Sentence: 188,degree,O
Sentence: 188,.,O
Sentence: 188,CONCLUSION,O
Sentence: 188,:,O
Sentence: 188,This,O
Sentence: 188,report,O
Sentence: 188,describes,O
Sentence: 188,the,O
Sentence: 188,case,O
Sentence: 188,of,O
Sentence: 188,a,O
Sentence: 188,woman,O
Sentence: 188,with,O
Sentence: 188,LACNP,O
Sentence: 188,that,O
Sentence: 188,developed,O
Sentence: 188,after,O
Sentence: 188,a,O
Sentence: 188,steroid,B-Chemical
Sentence: 188,injection,O
Sentence: 188,for,O
Sentence: 188,the,O
Sentence: 188,treatment,O
Sentence: 188,of,O
Sentence: 188,lateral,B-Disease
Sentence: 188,epicondylitis,I-Disease
Sentence: 188,.,O
Sentence: 188,An,O
Sentence: 188,electrodiagnostic,O
Sentence: 188,study,O
Sentence: 188,",",O
Sentence: 188,including,O
Sentence: 188,a,O
Sentence: 188,nerve,O
Sentence: 188,conduction,O
Sentence: 188,study,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,LACN,O
Sentence: 188,",",O
Sentence: 188,was,O
Sentence: 188,helpful,O
Sentence: 188,to,O
Sentence: 188,diagnose,O
Sentence: 188,right,O
Sentence: 188,LACNP,O
Sentence: 188,and,O
Sentence: 188,to,O
Sentence: 188,find,O
Sentence: 188,the,O
Sentence: 188,passage,O
Sentence: 188,of,O
Sentence: 188,the,O
Sentence: 188,LACN,O
Sentence: 188,on,O
Sentence: 188,the,O
Sentence: 188,lateral,O
Sentence: 188,epicondyle,O
Sentence: 188,.,O
Sentence: 189,Curcumin,B-Chemical
Sentence: 189,prevents,O
Sentence: 189,maleate,B-Chemical
Sentence: 189,-,O
Sentence: 189,induced,O
Sentence: 189,nephrotoxicity,B-Disease
Sentence: 189,:,O
Sentence: 189,relation,O
Sentence: 189,to,O
Sentence: 189,hemodynamic,O
Sentence: 189,alterations,O
Sentence: 189,",",O
Sentence: 189,oxidative,O
Sentence: 189,stress,O
Sentence: 189,",",O
Sentence: 189,mitochondrial,O
Sentence: 189,oxygen,B-Chemical
Sentence: 189,consumption,O
Sentence: 189,and,O
Sentence: 189,activity,O
Sentence: 189,of,O
Sentence: 189,respiratory,O
Sentence: 189,complex,O
Sentence: 189,I,O
Sentence: 189,.,O
Sentence: 190,The,O
Sentence: 190,potential,O
Sentence: 190,protective,O
Sentence: 190,effect,O
Sentence: 190,of,O
Sentence: 190,the,O
Sentence: 190,dietary,O
Sentence: 190,antioxidant,O
Sentence: 190,curcumin,B-Chemical
Sentence: 190,(,O
Sentence: 190,120,O
Sentence: 190,mg,O
Sentence: 190,/,O
Sentence: 190,Kg,O
Sentence: 190,/,O
Sentence: 190,day,O
Sentence: 190,for,O
Sentence: 190,6,O
Sentence: 190,days,O
Sentence: 190,),O
Sentence: 190,against,O
Sentence: 190,the,O
Sentence: 190,renal,B-Disease
Sentence: 190,injury,I-Disease
Sentence: 190,induced,O
Sentence: 190,by,O
Sentence: 190,maleate,B-Chemical
Sentence: 190,was,O
Sentence: 190,evaluated,O
Sentence: 190,.,O
Sentence: 190,Tubular,O
Sentence: 190,proteinuria,B-Disease
Sentence: 190,and,O
Sentence: 190,oxidative,O
Sentence: 190,stress,O
Sentence: 190,were,O
Sentence: 190,induced,O
Sentence: 190,by,O
Sentence: 190,a,O
Sentence: 190,single,O
Sentence: 190,injection,O
Sentence: 190,of,O
Sentence: 190,maleate,B-Chemical
Sentence: 190,(,O
Sentence: 190,400,O
Sentence: 190,mg,O
Sentence: 190,/,O
Sentence: 190,kg,O
Sentence: 190,),O
Sentence: 190,in,O
Sentence: 190,rats,O
Sentence: 190,.,O
Sentence: 190,Maleate,B-Chemical
Sentence: 190,-,O
Sentence: 190,induced,O
Sentence: 190,renal,B-Disease
Sentence: 190,injury,I-Disease
Sentence: 190,included,O
Sentence: 190,increase,O
Sentence: 190,in,O
Sentence: 190,renal,O
Sentence: 190,vascular,O
Sentence: 190,resistance,O
Sentence: 190,and,O
Sentence: 190,in,O
Sentence: 190,the,O
Sentence: 190,urinary,O
Sentence: 190,excretion,O
Sentence: 190,of,O
Sentence: 190,total,O
Sentence: 190,protein,O
Sentence: 190,",",O
Sentence: 190,glucose,B-Chemical
Sentence: 190,",",O
Sentence: 190,sodium,B-Chemical
Sentence: 190,",",O
Sentence: 190,neutrophil,O
Sentence: 190,gelatinase,O
Sentence: 190,-,O
Sentence: 190,associated,O
Sentence: 190,lipocalin,O
Sentence: 190,(,O
Sentence: 190,NGAL,O
Sentence: 190,),O
Sentence: 190,and,O
Sentence: 190,N,O
Sentence: 190,-,O
Sentence: 190,acetyl,O
Sentence: 190,b,O
Sentence: 190,-,O
Sentence: 190,D,O
Sentence: 190,-,O
Sentence: 190,glucosaminidase,O
Sentence: 190,(,O
Sentence: 190,NAG,O
Sentence: 190,),O
Sentence: 190,",",O
Sentence: 190,upregulation,O
Sentence: 190,of,O
Sentence: 190,kidney,B-Disease
Sentence: 190,injury,I-Disease
Sentence: 190,molecule,O
Sentence: 190,(,O
Sentence: 190,KIM,O
Sentence: 190,),O
Sentence: 190,,O
Sentence: 190,-,O
Sentence: 190,1,O
Sentence: 190,",",O
Sentence: 190,decrease,O
Sentence: 190,in,O
Sentence: 190,renal,O
Sentence: 190,blood,O
Sentence: 190,flow,O
Sentence: 190,and,O
Sentence: 190,claudin,O
Sentence: 190,-,O
Sentence: 190,2,O
Sentence: 190,expression,O
Sentence: 190,besides,O
Sentence: 190,of,O
Sentence: 190,necrosis,B-Disease
Sentence: 190,and,O
Sentence: 190,apoptosis,O
Sentence: 190,of,O
Sentence: 190,tubular,O
Sentence: 190,cells,O
Sentence: 190,on,O
Sentence: 190,24,O
Sentence: 190,h.,O
Sentence: 190,Oxidative,O
Sentence: 190,stress,O
Sentence: 190,was,O
Sentence: 190,determined,O
Sentence: 190,by,O
Sentence: 190,measuring,O
Sentence: 190,the,O
Sentence: 190,oxidation,O
Sentence: 190,of,O
Sentence: 190,lipids,O
Sentence: 190,and,O
Sentence: 190,proteins,O
Sentence: 190,and,O
Sentence: 190,diminution,O
Sentence: 190,in,O
Sentence: 190,renal,O
Sentence: 190,Nrf2,O
Sentence: 190,levels,O
Sentence: 190,.,O
Sentence: 190,Studies,O
Sentence: 190,were,O
Sentence: 190,also,O
Sentence: 190,conducted,O
Sentence: 190,in,O
Sentence: 190,renal,O
Sentence: 190,epithelial,O
Sentence: 190,LLC,O
Sentence: 190,-,O
Sentence: 190,PK1,O
Sentence: 190,cells,O
Sentence: 190,and,O
Sentence: 190,in,O
Sentence: 190,mitochondria,O
Sentence: 190,isolated,O
Sentence: 190,from,O
Sentence: 190,kidneys,O
Sentence: 190,of,O
Sentence: 190,all,O
Sentence: 190,the,O
Sentence: 190,experimental,O
Sentence: 190,groups,O
Sentence: 190,.,O
Sentence: 190,Maleate,B-Chemical
Sentence: 190,induced,O
Sentence: 190,cell,O
Sentence: 190,damage,O
Sentence: 190,and,O
Sentence: 190,reactive,O
Sentence: 190,oxygen,B-Chemical
Sentence: 190,species,O
Sentence: 190,(,O
Sentence: 190,ROS,O
Sentence: 190,),O
Sentence: 190,production,O
Sentence: 190,in,O
Sentence: 190,LLC,O
Sentence: 190,-,O
Sentence: 190,PK1,O
Sentence: 190,cells,O
Sentence: 190,in,O
Sentence: 190,culture,O
Sentence: 190,.,O
Sentence: 190,In,O
Sentence: 190,addition,O
Sentence: 190,",",O
Sentence: 190,maleate,B-Chemical
Sentence: 190,treatment,O
Sentence: 190,reduced,O
Sentence: 190,oxygen,B-Chemical
Sentence: 190,consumption,O
Sentence: 190,in,O
Sentence: 190,ADP,B-Chemical
Sentence: 190,-,O
Sentence: 190,stimulated,O
Sentence: 190,mitochondria,O
Sentence: 190,and,O
Sentence: 190,diminished,O
Sentence: 190,respiratory,O
Sentence: 190,control,O
Sentence: 190,index,O
Sentence: 190,when,O
Sentence: 190,using,O
Sentence: 190,malate,B-Chemical
Sentence: 190,/,O
Sentence: 190,glutamate,B-Chemical
Sentence: 190,as,O
Sentence: 190,substrate,O
Sentence: 190,.,O
Sentence: 190,The,O
Sentence: 190,activities,O
Sentence: 190,of,O
Sentence: 190,both,O
Sentence: 190,complex,O
Sentence: 190,I,O
Sentence: 190,and,O
Sentence: 190,aconitase,O
Sentence: 190,were,O
Sentence: 190,also,O
Sentence: 190,diminished,O
Sentence: 190,.,O
Sentence: 190,All,O
Sentence: 190,the,O
Sentence: 190,above,O
Sentence: 190,-,O
Sentence: 190,described,O
Sentence: 190,alterations,O
Sentence: 190,were,O
Sentence: 190,prevented,O
Sentence: 190,by,O
Sentence: 190,curcumin,B-Chemical
Sentence: 190,.,O
Sentence: 190,It,O
Sentence: 190,is,O
Sentence: 190,concluded,O
Sentence: 190,that,O
Sentence: 190,curcumin,B-Chemical
Sentence: 190,is,O
Sentence: 190,able,O
Sentence: 190,to,O
Sentence: 190,attenuate,O
Sentence: 190,in,O
Sentence: 190,vivo,O
Sentence: 190,maleate,B-Chemical
Sentence: 190,-,O
Sentence: 190,induced,O
Sentence: 190,nephropathy,B-Disease
Sentence: 190,and,O
Sentence: 190,in,O
Sentence: 190,vitro,O
Sentence: 190,cell,O
Sentence: 190,damage,O
Sentence: 190,.,O
Sentence: 190,The,O
Sentence: 190,in,O
Sentence: 190,vivo,O
Sentence: 190,protection,O
Sentence: 190,was,O
Sentence: 190,associated,O
Sentence: 190,to,O
Sentence: 190,the,O
Sentence: 190,prevention,O
Sentence: 190,of,O
Sentence: 190,oxidative,O
Sentence: 190,stress,O
Sentence: 190,and,O
Sentence: 190,preservation,O
Sentence: 190,of,O
Sentence: 190,mitochondrial,O
Sentence: 190,oxygen,B-Chemical
Sentence: 190,consumption,O
Sentence: 190,and,O
Sentence: 190,activity,O
Sentence: 190,of,O
Sentence: 190,respiratory,O
Sentence: 190,complex,O
Sentence: 190,I,O
Sentence: 190,",",O
Sentence: 190,and,O
Sentence: 190,the,O
Sentence: 190,in,O
Sentence: 190,vitro,O
Sentence: 190,protection,O
Sentence: 190,was,O
Sentence: 190,associated,O
Sentence: 190,to,O
Sentence: 190,the,O
Sentence: 190,prevention,O
Sentence: 190,of,O
Sentence: 190,ROS,O
Sentence: 190,production,O
Sentence: 190,.,O
Sentence: 191,Incidence,O
Sentence: 191,of,O
Sentence: 191,solid,O
Sentence: 191,tumours,B-Disease
Sentence: 191,among,O
Sentence: 191,pesticide,O
Sentence: 191,applicators,O
Sentence: 191,exposed,O
Sentence: 191,to,O
Sentence: 191,the,O
Sentence: 191,organophosphate,B-Chemical
Sentence: 191,insecticide,O
Sentence: 191,diazinon,B-Chemical
Sentence: 191,in,O
Sentence: 191,the,O
Sentence: 191,Agricultural,O
Sentence: 191,Health,O
Sentence: 191,Study,O
Sentence: 191,:,O
Sentence: 191,an,O
Sentence: 191,updated,O
Sentence: 191,analysis,O
Sentence: 191,.,O
Sentence: 192,OBJECTIVE,O
Sentence: 192,:,O
Sentence: 192,Diazinon,B-Chemical
Sentence: 192,",",O
Sentence: 192,a,O
Sentence: 192,common,O
Sentence: 192,organophosphate,B-Chemical
Sentence: 192,insecticide,O
Sentence: 192,with,O
Sentence: 192,genotoxic,O
Sentence: 192,properties,O
Sentence: 192,",",O
Sentence: 192,was,O
Sentence: 192,previously,O
Sentence: 192,associated,O
Sentence: 192,with,O
Sentence: 192,lung,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,in,O
Sentence: 192,the,O
Sentence: 192,Agricultural,O
Sentence: 192,Health,O
Sentence: 192,Study,O
Sentence: 192,(,O
Sentence: 192,AHS,O
Sentence: 192,),O
Sentence: 192,cohort,O
Sentence: 192,",",O
Sentence: 192,but,O
Sentence: 192,few,O
Sentence: 192,other,O
Sentence: 192,epidemiological,O
Sentence: 192,studies,O
Sentence: 192,have,O
Sentence: 192,examined,O
Sentence: 192,diazinon,B-Chemical
Sentence: 192,-,O
Sentence: 192,associated,O
Sentence: 192,cancer,B-Disease
Sentence: 192,risk,O
Sentence: 192,.,O
Sentence: 192,We,O
Sentence: 192,used,O
Sentence: 192,updated,O
Sentence: 192,diazinon,B-Chemical
Sentence: 192,exposure,O
Sentence: 192,and,O
Sentence: 192,cancer,B-Disease
Sentence: 192,incidence,O
Sentence: 192,information,O
Sentence: 192,to,O
Sentence: 192,evaluate,O
Sentence: 192,solid,O
Sentence: 192,tumour,B-Disease
Sentence: 192,risk,O
Sentence: 192,in,O
Sentence: 192,the,O
Sentence: 192,AHS,O
Sentence: 192,.,O
Sentence: 192,METHODS,O
Sentence: 192,:,O
Sentence: 192,Male,O
Sentence: 192,pesticide,O
Sentence: 192,applicators,O
Sentence: 192,in,O
Sentence: 192,Iowa,O
Sentence: 192,and,O
Sentence: 192,North,O
Sentence: 192,Carolina,O
Sentence: 192,reported,O
Sentence: 192,lifetime,O
Sentence: 192,diazinon,B-Chemical
Sentence: 192,use,O
Sentence: 192,at,O
Sentence: 192,enrolment,O
Sentence: 192,(,O
Sentence: 192,1993,O
Sentence: 192,-,O
Sentence: 192,1997,O
Sentence: 192,),O
Sentence: 192,and,O
Sentence: 192,follow,O
Sentence: 192,-,O
Sentence: 192,up,O
Sentence: 192,(,O
Sentence: 192,1998,O
Sentence: 192,-,O
Sentence: 192,2005,O
Sentence: 192,),O
Sentence: 192,;,O
Sentence: 192,cancer,B-Disease
Sentence: 192,incidence,O
Sentence: 192,was,O
Sentence: 192,assessed,O
Sentence: 192,through,O
Sentence: 192,2010,O
Sentence: 192,(,O
Sentence: 192,North,O
Sentence: 192,Carolina,O
Sentence: 192,),O
Sentence: 192,,O
Sentence: 192,/,O
Sentence: 192,2011,O
Sentence: 192,(,O
Sentence: 192,Iowa,O
Sentence: 192,),O
Sentence: 192,.,O
Sentence: 192,Among,O
Sentence: 192,applicators,O
Sentence: 192,with,O
Sentence: 192,usage,O
Sentence: 192,information,O
Sentence: 192,sufficient,O
Sentence: 192,to,O
Sentence: 192,evaluate,O
Sentence: 192,exposure,O
Sentence: 192,-,O
Sentence: 192,response,O
Sentence: 192,patterns,O
Sentence: 192,",",O
Sentence: 192,we,O
Sentence: 192,used,O
Sentence: 192,Poisson,O
Sentence: 192,regression,O
Sentence: 192,to,O
Sentence: 192,estimate,O
Sentence: 192,adjusted,O
Sentence: 192,rate,O
Sentence: 192,ratios,O
Sentence: 192,(,O
Sentence: 192,RRs,O
Sentence: 192,),O
Sentence: 192,and,O
Sentence: 192,95,O
Sentence: 192,%,O
Sentence: 192,CI,O
Sentence: 192,for,O
Sentence: 192,cancer,B-Disease
Sentence: 192,sites,O
Sentence: 192,with,O
Sentence: 192,,O
Sentence: 192,>,O
Sentence: 192,,O
Sentence: 192,10,O
Sentence: 192,exposed,O
Sentence: 192,cases,O
Sentence: 192,for,O
Sentence: 192,both,O
Sentence: 192,lifetime,O
Sentence: 192,(,O
Sentence: 192,LT,O
Sentence: 192,),O
Sentence: 192,exposure,O
Sentence: 192,days,O
Sentence: 192,and,O
Sentence: 192,intensity,O
Sentence: 192,-,O
Sentence: 192,weighted,O
Sentence: 192,(,O
Sentence: 192,IW,O
Sentence: 192,),O
Sentence: 192,lifetime,O
Sentence: 192,exposure,O
Sentence: 192,days,O
Sentence: 192,(,O
Sentence: 192,accounting,O
Sentence: 192,for,O
Sentence: 192,factors,O
Sentence: 192,impacting,O
Sentence: 192,exposure,O
Sentence: 192,),O
Sentence: 192,.,O
Sentence: 192,RESULTS,O
Sentence: 192,:,O
Sentence: 192,We,O
Sentence: 192,observed,O
Sentence: 192,elevated,O
Sentence: 192,lung,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,risks,O
Sentence: 192,(,O
Sentence: 192,N,O
Sentence: 192,=,O
Sentence: 192,283,O
Sentence: 192,),O
Sentence: 192,among,O
Sentence: 192,applicators,O
Sentence: 192,with,O
Sentence: 192,the,O
Sentence: 192,greatest,O
Sentence: 192,number,O
Sentence: 192,of,O
Sentence: 192,LT,O
Sentence: 192,(,O
Sentence: 192,RR,O
Sentence: 192,=,O
Sentence: 192,1.60,O
Sentence: 192,;,O
Sentence: 192,95,O
Sentence: 192,%,O
Sentence: 192,CI,O
Sentence: 192,1.11,O
Sentence: 192,to,O
Sentence: 192,2.31,O
Sentence: 192,;,O
Sentence: 192,Ptrend,O
Sentence: 192,=,O
Sentence: 192,0.02,O
Sentence: 192,),O
Sentence: 192,and,O
Sentence: 192,IW,O
Sentence: 192,days,O
Sentence: 192,of,O
Sentence: 192,diazinon,B-Chemical
Sentence: 192,use,O
Sentence: 192,(,O
Sentence: 192,RR,O
Sentence: 192,=,O
Sentence: 192,1.41,O
Sentence: 192,;,O
Sentence: 192,95,O
Sentence: 192,%,O
Sentence: 192,CI,O
Sentence: 192,0.98,O
Sentence: 192,to,O
Sentence: 192,2.04,O
Sentence: 192,;,O
Sentence: 192,Ptrend,O
Sentence: 192,=,O
Sentence: 192,0.08,O
Sentence: 192,),O
Sentence: 192,.,O
Sentence: 192,Kidney,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,(,O
Sentence: 192,N,O
Sentence: 192,=,O
Sentence: 192,94,O
Sentence: 192,),O
Sentence: 192,risks,O
Sentence: 192,were,O
Sentence: 192,non,O
Sentence: 192,-,O
Sentence: 192,significantly,O
Sentence: 192,elevated,O
Sentence: 192,(,O
Sentence: 192,RRLT,O
Sentence: 192,days,O
Sentence: 192,=,O
Sentence: 192,1.77,O
Sentence: 192,;,O
Sentence: 192,95,O
Sentence: 192,%,O
Sentence: 192,CI,O
Sentence: 192,0.90,O
Sentence: 192,to,O
Sentence: 192,3.51,O
Sentence: 192,;,O
Sentence: 192,Ptrend,O
Sentence: 192,=,O
Sentence: 192,0.09,O
Sentence: 192,;,O
Sentence: 192,RRIW,O
Sentence: 192,days,O
Sentence: 192,1.37,O
Sentence: 192,;,O
Sentence: 192,95,O
Sentence: 192,%,O
Sentence: 192,CI,O
Sentence: 192,0.64,O
Sentence: 192,to,O
Sentence: 192,2.92,O
Sentence: 192,;,O
Sentence: 192,Ptrend,O
Sentence: 192,=,O
Sentence: 192,0.50,O
Sentence: 192,),O
Sentence: 192,",",O
Sentence: 192,as,O
Sentence: 192,were,O
Sentence: 192,risks,O
Sentence: 192,for,O
Sentence: 192,aggressive,O
Sentence: 192,prostate,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,(,O
Sentence: 192,N,O
Sentence: 192,=,O
Sentence: 192,656,O
Sentence: 192,),O
Sentence: 192,.,O
Sentence: 192,CONCLUSIONS,O
Sentence: 192,:,O
Sentence: 192,Our,O
Sentence: 192,updated,O
Sentence: 192,evaluation,O
Sentence: 192,of,O
Sentence: 192,diazinon,B-Chemical
Sentence: 192,provides,O
Sentence: 192,additional,O
Sentence: 192,evidence,O
Sentence: 192,of,O
Sentence: 192,an,O
Sentence: 192,association,O
Sentence: 192,with,O
Sentence: 192,lung,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,risk,O
Sentence: 192,.,O
Sentence: 192,Newly,O
Sentence: 192,identified,O
Sentence: 192,links,O
Sentence: 192,to,O
Sentence: 192,kidney,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,and,O
Sentence: 192,associations,O
Sentence: 192,with,O
Sentence: 192,aggressive,O
Sentence: 192,prostate,B-Disease
Sentence: 192,cancer,I-Disease
Sentence: 192,require,O
Sentence: 192,further,O
Sentence: 192,evaluation,O
Sentence: 192,.,O
Sentence: 193,Associations,O
Sentence: 193,of,O
Sentence: 193,Ozone,B-Chemical
Sentence: 193,and,O
Sentence: 193,PM2.5,O
Sentence: 193,Concentrations,O
Sentence: 193,With,O
Sentence: 193,Parkinson,B-Disease
Sentence: 193,'s,I-Disease
Sentence: 193,Disease,I-Disease
Sentence: 193,Among,O
Sentence: 193,Participants,O
Sentence: 193,in,O
Sentence: 193,the,O
Sentence: 193,Agricultural,O
Sentence: 193,Health,O
Sentence: 193,Study,O
Sentence: 193,.,O
Sentence: 194,OBJECTIVE,O
Sentence: 194,:,O
Sentence: 194,This,O
Sentence: 194,study,O
Sentence: 194,describes,O
Sentence: 194,associations,O
Sentence: 194,of,O
Sentence: 194,ozone,B-Chemical
Sentence: 194,and,O
Sentence: 194,fine,O
Sentence: 194,particulate,B-Chemical
Sentence: 194,matter,I-Chemical
Sentence: 194,with,O
Sentence: 194,Parkinson,B-Disease
Sentence: 194,'s,I-Disease
Sentence: 194,disease,I-Disease
Sentence: 194,observed,O
Sentence: 194,among,O
Sentence: 194,farmers,O
Sentence: 194,in,O
Sentence: 194,North,O
Sentence: 194,Carolina,O
Sentence: 194,and,O
Sentence: 194,Iowa,O
Sentence: 194,.,O
Sentence: 194,METHODS,O
Sentence: 194,:,O
Sentence: 194,We,O
Sentence: 194,used,O
Sentence: 194,logistic,O
Sentence: 194,regression,O
Sentence: 194,to,O
Sentence: 194,determine,O
Sentence: 194,the,O
Sentence: 194,associations,O
Sentence: 194,of,O
Sentence: 194,these,O
Sentence: 194,pollutants,O
Sentence: 194,with,O
Sentence: 194,self,O
Sentence: 194,-,O
Sentence: 194,reported,O
Sentence: 194,",",O
Sentence: 194,doctor,O
Sentence: 194,-,O
Sentence: 194,diagnosed,O
Sentence: 194,Parkinson,B-Disease
Sentence: 194,'s,I-Disease
Sentence: 194,disease,I-Disease
Sentence: 194,.,O
Sentence: 194,Daily,O
Sentence: 194,predicted,O
Sentence: 194,pollutant,O
Sentence: 194,concentrations,O
Sentence: 194,were,O
Sentence: 194,used,O
Sentence: 194,to,O
Sentence: 194,derive,O
Sentence: 194,surrogates,O
Sentence: 194,of,O
Sentence: 194,long,O
Sentence: 194,-,O
Sentence: 194,term,O
Sentence: 194,exposure,O
Sentence: 194,and,O
Sentence: 194,link,O
Sentence: 194,them,O
Sentence: 194,to,O
Sentence: 194,study,O
Sentence: 194,participants,O
Sentence: 194,',O
Sentence: 194,geocoded,O
Sentence: 194,addresses,O
Sentence: 194,.,O
Sentence: 194,RESULTS,O
Sentence: 194,:,O
Sentence: 194,We,O
Sentence: 194,observed,O
Sentence: 194,positive,O
Sentence: 194,associations,O
Sentence: 194,of,O
Sentence: 194,Parkinson,B-Disease
Sentence: 194,'s,I-Disease
Sentence: 194,disease,I-Disease
Sentence: 194,with,O
Sentence: 194,ozone,B-Chemical
Sentence: 194,(,O
Sentence: 194,odds,O
Sentence: 194,ratio,O
Sentence: 194,,O
Sentence: 194,=,O
Sentence: 194,,O
Sentence: 194,1.39,O
Sentence: 194,;,O
Sentence: 194,95,O
Sentence: 194,%,O
Sentence: 194,CI,O
Sentence: 194,:,O
Sentence: 194,0.98,O
Sentence: 194,to,O
Sentence: 194,1.98,O
Sentence: 194,),O
Sentence: 194,and,O
Sentence: 194,fine,O
Sentence: 194,particulate,B-Chemical
Sentence: 194,matter,I-Chemical
Sentence: 194,(,O
Sentence: 194,odds,O
Sentence: 194,ratio,O
Sentence: 194,,O
Sentence: 194,=,O
Sentence: 194,,O
Sentence: 194,1.34,O
Sentence: 194,;,O
Sentence: 194,95,O
Sentence: 194,%,O
Sentence: 194,CI,O
Sentence: 194,:,O
Sentence: 194,0.93,O
Sentence: 194,to,O
Sentence: 194,1.93,O
Sentence: 194,),O
Sentence: 194,in,O
Sentence: 194,North,O
Sentence: 194,Carolina,O
Sentence: 194,but,O
Sentence: 194,not,O
Sentence: 194,in,O
Sentence: 194,Iowa,O
Sentence: 194,.,O
Sentence: 194,CONCLUSIONS,O
Sentence: 194,:,O
Sentence: 194,The,O
Sentence: 194,plausibility,O
Sentence: 194,of,O
Sentence: 194,an,O
Sentence: 194,effect,O
Sentence: 194,of,O
Sentence: 194,ambient,O
Sentence: 194,concentrations,O
Sentence: 194,of,O
Sentence: 194,these,O
Sentence: 194,pollutants,O
Sentence: 194,on,O
Sentence: 194,Parkinson,B-Disease
Sentence: 194,'s,I-Disease
Sentence: 194,disease,I-Disease
Sentence: 194,risk,O
Sentence: 194,is,O
Sentence: 194,supported,O
Sentence: 194,by,O
Sentence: 194,experimental,O
Sentence: 194,data,O
Sentence: 194,demonstrating,O
Sentence: 194,damage,O
Sentence: 194,to,O
Sentence: 194,dopaminergic,O
Sentence: 194,neurons,O
Sentence: 194,at,O
Sentence: 194,relevant,O
Sentence: 194,concentrations,O
Sentence: 194,.,O
Sentence: 194,Additional,O
Sentence: 194,studies,O
Sentence: 194,are,O
Sentence: 194,needed,O
Sentence: 194,to,O
Sentence: 194,address,O
Sentence: 194,uncertainties,O
Sentence: 194,related,O
Sentence: 194,to,O
Sentence: 194,confounding,O
Sentence: 194,and,O
Sentence: 194,to,O
Sentence: 194,examine,O
Sentence: 194,temporal,O
Sentence: 194,aspects,O
Sentence: 194,of,O
Sentence: 194,the,O
Sentence: 194,associations,O
Sentence: 194,we,O
Sentence: 194,observed,O
Sentence: 194,.,O
Sentence: 195,Low,O
Sentence: 195,functional,O
Sentence: 195,programming,O
Sentence: 195,of,O
Sentence: 195,renal,O
Sentence: 195,AT2R,O
Sentence: 195,mediates,O
Sentence: 195,the,O
Sentence: 195,developmental,O
Sentence: 195,origin,O
Sentence: 195,of,O
Sentence: 195,glomerulosclerosis,B-Disease
Sentence: 195,in,O
Sentence: 195,adult,O
Sentence: 195,offspring,O
Sentence: 195,induced,O
Sentence: 195,by,O
Sentence: 195,prenatal,O
Sentence: 195,caffeine,B-Chemical
Sentence: 195,exposure,O
Sentence: 195,.,O
Sentence: 196,UNASSIGNED,O
Sentence: 196,:,O
Sentence: 196,Our,O
Sentence: 196,previous,O
Sentence: 196,study,O
Sentence: 196,has,O
Sentence: 196,indicated,O
Sentence: 196,that,O
Sentence: 196,prenatal,O
Sentence: 196,caffeine,B-Chemical
Sentence: 196,exposure,O
Sentence: 196,(,O
Sentence: 196,PCE,O
Sentence: 196,),O
Sentence: 196,could,O
Sentence: 196,induce,O
Sentence: 196,intrauterine,B-Disease
Sentence: 196,growth,I-Disease
Sentence: 196,retardation,I-Disease
Sentence: 196,(,O
Sentence: 196,IUGR,B-Disease
Sentence: 196,),O
Sentence: 196,of,O
Sentence: 196,offspring,O
Sentence: 196,.,O
Sentence: 196,Recent,O
Sentence: 196,research,O
Sentence: 196,suggested,O
Sentence: 196,that,O
Sentence: 196,IUGR,B-Disease
Sentence: 196,is,O
Sentence: 196,a,O
Sentence: 196,risk,O
Sentence: 196,factor,O
Sentence: 196,for,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,.,O
Sentence: 196,However,O
Sentence: 196,",",O
Sentence: 196,whether,O
Sentence: 196,PCE,O
Sentence: 196,could,O
Sentence: 196,induce,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,and,O
Sentence: 196,its,O
Sentence: 196,underlying,O
Sentence: 196,mechanisms,O
Sentence: 196,remain,O
Sentence: 196,unknown,O
Sentence: 196,.,O
Sentence: 196,This,O
Sentence: 196,study,O
Sentence: 196,aimed,O
Sentence: 196,to,O
Sentence: 196,demonstrate,O
Sentence: 196,the,O
Sentence: 196,induction,O
Sentence: 196,to,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,in,O
Sentence: 196,adult,O
Sentence: 196,offspring,O
Sentence: 196,by,O
Sentence: 196,PCE,O
Sentence: 196,and,O
Sentence: 196,its,O
Sentence: 196,intrauterine,O
Sentence: 196,programming,O
Sentence: 196,mechanisms,O
Sentence: 196,.,O
Sentence: 196,A,O
Sentence: 196,rat,O
Sentence: 196,model,O
Sentence: 196,of,O
Sentence: 196,IUGR,B-Disease
Sentence: 196,was,O
Sentence: 196,established,O
Sentence: 196,by,O
Sentence: 196,PCE,O
Sentence: 196,",",O
Sentence: 196,male,O
Sentence: 196,fetuses,O
Sentence: 196,and,O
Sentence: 196,adult,O
Sentence: 196,offspring,O
Sentence: 196,at,O
Sentence: 196,the,O
Sentence: 196,age,O
Sentence: 196,of,O
Sentence: 196,postnatal,O
Sentence: 196,week,O
Sentence: 196,24,O
Sentence: 196,were,O
Sentence: 196,euthanized,O
Sentence: 196,.,O
Sentence: 196,The,O
Sentence: 196,results,O
Sentence: 196,revealed,O
Sentence: 196,that,O
Sentence: 196,the,O
Sentence: 196,adult,O
Sentence: 196,offspring,O
Sentence: 196,kidneys,O
Sentence: 196,in,O
Sentence: 196,the,O
Sentence: 196,PCE,O
Sentence: 196,group,O
Sentence: 196,exhibited,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,as,O
Sentence: 196,well,O
Sentence: 196,as,O
Sentence: 196,interstitial,B-Disease
Sentence: 196,fibrosis,I-Disease
Sentence: 196,",",O
Sentence: 196,accompanied,O
Sentence: 196,by,O
Sentence: 196,elevated,O
Sentence: 196,levels,O
Sentence: 196,of,O
Sentence: 196,serum,O
Sentence: 196,creatinine,B-Chemical
Sentence: 196,and,O
Sentence: 196,urine,O
Sentence: 196,protein,O
Sentence: 196,.,O
Sentence: 196,Renal,O
Sentence: 196,angiotensin,B-Chemical
Sentence: 196,II,I-Chemical
Sentence: 196,receptor,O
Sentence: 196,type,O
Sentence: 196,2,O
Sentence: 196,(,O
Sentence: 196,AT2R,O
Sentence: 196,),O
Sentence: 196,gene,O
Sentence: 196,expression,O
Sentence: 196,in,O
Sentence: 196,adult,O
Sentence: 196,offspring,O
Sentence: 196,was,O
Sentence: 196,reduced,O
Sentence: 196,by,O
Sentence: 196,PCE,O
Sentence: 196,",",O
Sentence: 196,whereas,O
Sentence: 196,the,O
Sentence: 196,renal,O
Sentence: 196,angiotensin,B-Chemical
Sentence: 196,II,I-Chemical
Sentence: 196,receptor,O
Sentence: 196,type,O
Sentence: 196,1a,O
Sentence: 196,(,O
Sentence: 196,AT1aR,O
Sentence: 196,),O
Sentence: 196,,O
Sentence: 196,/,O
Sentence: 196,AT2R,O
Sentence: 196,expression,O
Sentence: 196,ratio,O
Sentence: 196,was,O
Sentence: 196,increased,O
Sentence: 196,.,O
Sentence: 196,The,O
Sentence: 196,fetal,O
Sentence: 196,kidneys,O
Sentence: 196,in,O
Sentence: 196,the,O
Sentence: 196,PCE,O
Sentence: 196,group,O
Sentence: 196,displayed,O
Sentence: 196,an,O
Sentence: 196,enlarged,O
Sentence: 196,Bowman,O
Sentence: 196,'s,O
Sentence: 196,space,O
Sentence: 196,and,O
Sentence: 196,a,O
Sentence: 196,shrunken,O
Sentence: 196,glomerular,O
Sentence: 196,tuft,O
Sentence: 196,",",O
Sentence: 196,accompanied,O
Sentence: 196,by,O
Sentence: 196,a,O
Sentence: 196,reduced,O
Sentence: 196,cortex,O
Sentence: 196,width,O
Sentence: 196,and,O
Sentence: 196,an,O
Sentence: 196,increase,O
Sentence: 196,in,O
Sentence: 196,the,O
Sentence: 196,nephrogenic,O
Sentence: 196,zone,O
Sentence: 196,/,O
Sentence: 196,cortical,O
Sentence: 196,zone,O
Sentence: 196,ratio,O
Sentence: 196,.,O
Sentence: 196,Observation,O
Sentence: 196,by,O
Sentence: 196,electronic,O
Sentence: 196,microscope,O
Sentence: 196,revealed,O
Sentence: 196,structural,O
Sentence: 196,damage,O
Sentence: 196,of,O
Sentence: 196,podocytes,O
Sentence: 196,;,O
Sentence: 196,the,O
Sentence: 196,reduced,O
Sentence: 196,expression,O
Sentence: 196,level,O
Sentence: 196,of,O
Sentence: 196,podocyte,O
Sentence: 196,marker,O
Sentence: 196,genes,O
Sentence: 196,",",O
Sentence: 196,nephrin,O
Sentence: 196,and,O
Sentence: 196,podocin,O
Sentence: 196,",",O
Sentence: 196,was,O
Sentence: 196,also,O
Sentence: 196,detected,O
Sentence: 196,by,O
Sentence: 196,q,O
Sentence: 196,-,O
Sentence: 196,PCR,O
Sentence: 196,.,O
Sentence: 196,Moreover,O
Sentence: 196,",",O
Sentence: 196,AT2R,O
Sentence: 196,gene,O
Sentence: 196,and,O
Sentence: 196,protein,O
Sentence: 196,expressions,O
Sentence: 196,in,O
Sentence: 196,fetal,O
Sentence: 196,kidneys,O
Sentence: 196,were,O
Sentence: 196,inhibited,O
Sentence: 196,by,O
Sentence: 196,PCE,O
Sentence: 196,",",O
Sentence: 196,associated,O
Sentence: 196,with,O
Sentence: 196,the,O
Sentence: 196,repression,O
Sentence: 196,of,O
Sentence: 196,the,O
Sentence: 196,gene,O
Sentence: 196,expression,O
Sentence: 196,of,O
Sentence: 196,glial,O
Sentence: 196,-,O
Sentence: 196,cell,O
Sentence: 196,-,O
Sentence: 196,line,O
Sentence: 196,-,O
Sentence: 196,derived,O
Sentence: 196,neurotrophic,O
Sentence: 196,factor,O
Sentence: 196,(,O
Sentence: 196,GDNF,O
Sentence: 196,),O
Sentence: 196,,O
Sentence: 196,/,O
Sentence: 196,tyrosine,B-Chemical
Sentence: 196,kinase,O
Sentence: 196,receptor,O
Sentence: 196,(,O
Sentence: 196,c,O
Sentence: 196,-,O
Sentence: 196,Ret,O
Sentence: 196,),O
Sentence: 196,signaling,O
Sentence: 196,pathway,O
Sentence: 196,.,O
Sentence: 196,These,O
Sentence: 196,results,O
Sentence: 196,demonstrated,O
Sentence: 196,that,O
Sentence: 196,PCE,O
Sentence: 196,could,O
Sentence: 196,induce,O
Sentence: 196,dysplasia,B-Disease
Sentence: 196,of,I-Disease
Sentence: 196,fetal,I-Disease
Sentence: 196,kidneys,I-Disease
Sentence: 196,as,O
Sentence: 196,well,O
Sentence: 196,as,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,of,O
Sentence: 196,adult,O
Sentence: 196,offspring,O
Sentence: 196,",",O
Sentence: 196,and,O
Sentence: 196,the,O
Sentence: 196,low,O
Sentence: 196,functional,O
Sentence: 196,programming,O
Sentence: 196,of,O
Sentence: 196,renal,O
Sentence: 196,AT2R,O
Sentence: 196,might,O
Sentence: 196,mediate,O
Sentence: 196,the,O
Sentence: 196,developmental,O
Sentence: 196,origin,O
Sentence: 196,of,O
Sentence: 196,adult,O
Sentence: 196,glomerulosclerosis,B-Disease
Sentence: 196,.,O
Sentence: 197,"1,3",O
Sentence: 197,-,O
Sentence: 197,Butadiene,O
Sentence: 197,",",O
Sentence: 197,CML,B-Disease
Sentence: 197,and,O
Sentence: 197,the,O
Sentence: 197,t,O
Sentence: 197,(,O
Sentence: 197,9:22,O
Sentence: 197,),O
Sentence: 197,translocation,O
Sentence: 197,:,O
Sentence: 197,A,O
Sentence: 197,reality,O
Sentence: 197,check,O
Sentence: 197,.,O
Sentence: 198,UNASSIGNED,O
Sentence: 198,:,O
Sentence: 198,Epidemiological,O
Sentence: 198,studies,O
Sentence: 198,of,O
Sentence: 198,"1,3",O
Sentence: 198,-,O
Sentence: 198,butadiene,O
Sentence: 198,have,O
Sentence: 198,suggest,O
Sentence: 198,that,O
Sentence: 198,exposures,O
Sentence: 198,to,O
Sentence: 198,humans,O
Sentence: 198,are,O
Sentence: 198,associated,O
Sentence: 198,with,O
Sentence: 198,chronic,B-Disease
Sentence: 198,myeloid,I-Disease
Sentence: 198,leukemia,I-Disease
Sentence: 198,(,O
Sentence: 198,CML,B-Disease
Sentence: 198,),O
Sentence: 198,.,O
Sentence: 198,CML,B-Disease
Sentence: 198,has,O
Sentence: 198,a,O
Sentence: 198,well,O
Sentence: 198,-,O
Sentence: 198,documented,O
Sentence: 198,association,O
Sentence: 198,with,O
Sentence: 198,ionizing,O
Sentence: 198,radiation,O
Sentence: 198,",",O
Sentence: 198,but,O
Sentence: 198,reports,O
Sentence: 198,of,O
Sentence: 198,associations,O
Sentence: 198,with,O
Sentence: 198,chemical,O
Sentence: 198,exposures,O
Sentence: 198,have,O
Sentence: 198,been,O
Sentence: 198,questioned,O
Sentence: 198,.,O
Sentence: 198,Ionizing,O
Sentence: 198,radiation,O
Sentence: 198,is,O
Sentence: 198,capable,O
Sentence: 198,of,O
Sentence: 198,inducing,O
Sentence: 198,the,O
Sentence: 198,requisite,O
Sentence: 198,CML,B-Disease
Sentence: 198,-,O
Sentence: 198,associated,O
Sentence: 198,t,O
Sentence: 198,(,O
Sentence: 198,9:22,O
Sentence: 198,),O
Sentence: 198,translocation,O
Sentence: 198,(,O
Sentence: 198,Philadelphia,B-Disease
Sentence: 198,chromosome,I-Disease
Sentence: 198,),O
Sentence: 198,in,O
Sentence: 198,appropriate,O
Sentence: 198,cells,O
Sentence: 198,in,O
Sentence: 198,vitro,O
Sentence: 198,but,O
Sentence: 198,",",O
Sentence: 198,thus,O
Sentence: 198,far,O
Sentence: 198,",",O
Sentence: 198,chemicals,O
Sentence: 198,have,O
Sentence: 198,not,O
Sentence: 198,shown,O
Sentence: 198,this,O
Sentence: 198,capacity,O
Sentence: 198,.,O
Sentence: 198,We,O
Sentence: 198,have,O
Sentence: 198,proposed,O
Sentence: 198,that,O
Sentence: 198,"1,3",O
Sentence: 198,-,O
Sentence: 198,butadiene,O
Sentence: 198,metabolites,O
Sentence: 198,be,O
Sentence: 198,so,O
Sentence: 198,tested,O
Sentence: 198,as,O
Sentence: 198,a,O
Sentence: 198,reality,O
Sentence: 198,check,O
Sentence: 198,on,O
Sentence: 198,the,O
Sentence: 198,epidemiological,O
Sentence: 198,reports,O
Sentence: 198,.,O
Sentence: 198,In,O
Sentence: 198,order,O
Sentence: 198,to,O
Sentence: 198,conduct,O
Sentence: 198,reliable,O
Sentence: 198,testing,O
Sentence: 198,in,O
Sentence: 198,this,O
Sentence: 198,regard,O
Sentence: 198,",",O
Sentence: 198,it,O
Sentence: 198,is,O
Sentence: 198,essential,O
Sentence: 198,that,O
Sentence: 198,a,O
Sentence: 198,positive,O
Sentence: 198,control,O
Sentence: 198,for,O
Sentence: 198,induction,O
Sentence: 198,be,O
Sentence: 198,available,O
Sentence: 198,.,O
Sentence: 198,We,O
Sentence: 198,have,O
Sentence: 198,used,O
Sentence: 198,ionizing,O
Sentence: 198,radiation,O
Sentence: 198,to,O
Sentence: 198,develop,O
Sentence: 198,such,O
Sentence: 198,a,O
Sentence: 198,control,O
Sentence: 198,.,O
Sentence: 198,Results,O
Sentence: 198,described,O
Sentence: 198,here,O
Sentence: 198,demonstrate,O
Sentence: 198,that,O
Sentence: 198,this,O
Sentence: 198,agent,O
Sentence: 198,does,O
Sentence: 198,in,O
Sentence: 198,fact,O
Sentence: 198,induce,O
Sentence: 198,pathogenic,O
Sentence: 198,t,O
Sentence: 198,(,O
Sentence: 198,9:22,O
Sentence: 198,),O
Sentence: 198,translocations,O
Sentence: 198,in,O
Sentence: 198,a,O
Sentence: 198,human,O
Sentence: 198,myeloid,O
Sentence: 198,cell,O
Sentence: 198,line,O
Sentence: 198,in,O
Sentence: 198,vitro,O
Sentence: 198,",",O
Sentence: 198,but,O
Sentence: 198,does,O
Sentence: 198,so,O
Sentence: 198,at,O
Sentence: 198,low,O
Sentence: 198,frequencies,O
Sentence: 198,.,O
Sentence: 198,Conditions,O
Sentence: 198,that,O
Sentence: 198,will,O
Sentence: 198,be,O
Sentence: 198,required,O
Sentence: 198,for,O
Sentence: 198,studies,O
Sentence: 198,of,O
Sentence: 198,"1,3",O
Sentence: 198,-,O
Sentence: 198,butadiene,O
Sentence: 198,are,O
Sentence: 198,discussed,O
Sentence: 198,.,O
Sentence: 199,Cancer,B-Disease
Sentence: 199,incidence,O
Sentence: 199,and,O
Sentence: 199,metolachlor,B-Chemical
Sentence: 199,use,O
Sentence: 199,in,O
Sentence: 199,the,O
Sentence: 199,Agricultural,O
Sentence: 199,Health,O
Sentence: 199,Study,O
Sentence: 199,:,O
Sentence: 199,An,O
Sentence: 199,update,O
Sentence: 199,.,O
Sentence: 200,UNASSIGNED,O
Sentence: 200,:,O
Sentence: 200,Metolachlor,B-Chemical
Sentence: 200,",",O
Sentence: 200,a,O
Sentence: 200,widely,O
Sentence: 200,used,O
Sentence: 200,herbicide,O
Sentence: 200,",",O
Sentence: 200,is,O
Sentence: 200,classified,O
Sentence: 200,as,O
Sentence: 200,a,O
Sentence: 200,Group,O
Sentence: 200,C,O
Sentence: 200,carcinogen,O
Sentence: 200,by,O
Sentence: 200,the,O
Sentence: 200,U.S.,O
Sentence: 200,Environmental,O
Sentence: 200,Protection,O
Sentence: 200,Agency,O
Sentence: 200,based,O
Sentence: 200,on,O
Sentence: 200,increased,O
Sentence: 200,liver,B-Disease
Sentence: 200,neoplasms,I-Disease
Sentence: 200,in,O
Sentence: 200,female,O
Sentence: 200,rats,O
Sentence: 200,.,O
Sentence: 200,Epidemiologic,O
Sentence: 200,studies,O
Sentence: 200,of,O
Sentence: 200,the,O
Sentence: 200,health,O
Sentence: 200,effects,O
Sentence: 200,of,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,have,O
Sentence: 200,been,O
Sentence: 200,limited,O
Sentence: 200,.,O
Sentence: 200,The,O
Sentence: 200,Agricultural,O
Sentence: 200,Health,O
Sentence: 200,Study,O
Sentence: 200,(,O
Sentence: 200,AHS,O
Sentence: 200,),O
Sentence: 200,is,O
Sentence: 200,a,O
Sentence: 200,prospective,O
Sentence: 200,cohort,O
Sentence: 200,study,O
Sentence: 200,including,O
Sentence: 200,licensed,O
Sentence: 200,private,O
Sentence: 200,and,O
Sentence: 200,commercial,O
Sentence: 200,pesticide,O
Sentence: 200,applicators,O
Sentence: 200,in,O
Sentence: 200,Iowa,O
Sentence: 200,and,O
Sentence: 200,North,O
Sentence: 200,Carolina,O
Sentence: 200,enrolled,O
Sentence: 200,1993,O
Sentence: 200,-,O
Sentence: 200,1997,O
Sentence: 200,.,O
Sentence: 200,We,O
Sentence: 200,evaluated,O
Sentence: 200,cancer,B-Disease
Sentence: 200,incidence,O
Sentence: 200,through,O
Sentence: 200,2010,O
Sentence: 200,/,O
Sentence: 200,2011,O
Sentence: 200,(,O
Sentence: 200,NC,O
Sentence: 200,/,O
Sentence: 200,IA,O
Sentence: 200,),O
Sentence: 200,for,O
Sentence: 200,"49,616",O
Sentence: 200,applicators,O
Sentence: 200,",",O
Sentence: 200,53,O
Sentence: 200,%,O
Sentence: 200,of,O
Sentence: 200,whom,O
Sentence: 200,reported,O
Sentence: 200,ever,O
Sentence: 200,using,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,.,O
Sentence: 200,We,O
Sentence: 200,used,O
Sentence: 200,Poisson,O
Sentence: 200,regression,O
Sentence: 200,to,O
Sentence: 200,evaluate,O
Sentence: 200,relations,O
Sentence: 200,between,O
Sentence: 200,two,O
Sentence: 200,metrics,O
Sentence: 200,of,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,use,O
Sentence: 200,(,O
Sentence: 200,lifetime,O
Sentence: 200,days,O
Sentence: 200,",",O
Sentence: 200,intensity,O
Sentence: 200,-,O
Sentence: 200,weighted,O
Sentence: 200,lifetime,O
Sentence: 200,days,O
Sentence: 200,),O
Sentence: 200,and,O
Sentence: 200,cancer,B-Disease
Sentence: 200,incidence,O
Sentence: 200,.,O
Sentence: 200,We,O
Sentence: 200,saw,O
Sentence: 200,no,O
Sentence: 200,association,O
Sentence: 200,between,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,use,O
Sentence: 200,and,O
Sentence: 200,incidence,O
Sentence: 200,of,O
Sentence: 200,all,O
Sentence: 200,cancers,B-Disease
Sentence: 200,combined,O
Sentence: 200,(,O
Sentence: 200,n,O
Sentence: 200,,O
Sentence: 200,=,O
Sentence: 200,,O
Sentence: 200,"5,701",O
Sentence: 200,with,O
Sentence: 200,a,O
Sentence: 200,5,O
Sentence: 200,-,O
Sentence: 200,year,O
Sentence: 200,lag,O
Sentence: 200,),O
Sentence: 200,or,O
Sentence: 200,most,O
Sentence: 200,site,O
Sentence: 200,-,O
Sentence: 200,specific,O
Sentence: 200,cancers,B-Disease
Sentence: 200,.,O
Sentence: 200,For,O
Sentence: 200,liver,B-Disease
Sentence: 200,cancer,I-Disease
Sentence: 200,",",O
Sentence: 200,in,O
Sentence: 200,analyses,O
Sentence: 200,restricted,O
Sentence: 200,to,O
Sentence: 200,exposed,O
Sentence: 200,workers,O
Sentence: 200,",",O
Sentence: 200,elevations,O
Sentence: 200,observed,O
Sentence: 200,at,O
Sentence: 200,higher,O
Sentence: 200,categories,O
Sentence: 200,of,O
Sentence: 200,use,O
Sentence: 200,were,O
Sentence: 200,not,O
Sentence: 200,statistically,O
Sentence: 200,significant,O
Sentence: 200,.,O
Sentence: 200,However,O
Sentence: 200,",",O
Sentence: 200,trends,O
Sentence: 200,for,O
Sentence: 200,both,O
Sentence: 200,lifetime,O
Sentence: 200,and,O
Sentence: 200,intensity,O
Sentence: 200,-,O
Sentence: 200,weighted,O
Sentence: 200,lifetime,O
Sentence: 200,days,O
Sentence: 200,of,O
Sentence: 200,metolachor,B-Chemical
Sentence: 200,use,O
Sentence: 200,were,O
Sentence: 200,positive,O
Sentence: 200,and,O
Sentence: 200,statistically,O
Sentence: 200,significant,O
Sentence: 200,with,O
Sentence: 200,an,O
Sentence: 200,unexposed,O
Sentence: 200,reference,O
Sentence: 200,group,O
Sentence: 200,.,O
Sentence: 200,A,O
Sentence: 200,similar,O
Sentence: 200,pattern,O
Sentence: 200,was,O
Sentence: 200,observed,O
Sentence: 200,for,O
Sentence: 200,follicular,B-Disease
Sentence: 200,cell,I-Disease
Sentence: 200,lymphoma,B-Disease
Sentence: 200,",",O
Sentence: 200,but,O
Sentence: 200,no,O
Sentence: 200,other,O
Sentence: 200,lymphoma,B-Disease
Sentence: 200,subtypes,O
Sentence: 200,.,O
Sentence: 200,An,O
Sentence: 200,earlier,O
Sentence: 200,suggestion,O
Sentence: 200,of,O
Sentence: 200,increased,O
Sentence: 200,lung,B-Disease
Sentence: 200,cancer,I-Disease
Sentence: 200,risk,O
Sentence: 200,at,O
Sentence: 200,high,O
Sentence: 200,levels,O
Sentence: 200,of,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,use,O
Sentence: 200,in,O
Sentence: 200,this,O
Sentence: 200,cohort,O
Sentence: 200,was,O
Sentence: 200,not,O
Sentence: 200,confirmed,O
Sentence: 200,in,O
Sentence: 200,this,O
Sentence: 200,update,O
Sentence: 200,.,O
Sentence: 200,This,O
Sentence: 200,suggestion,O
Sentence: 200,of,O
Sentence: 200,an,O
Sentence: 200,association,O
Sentence: 200,between,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,and,O
Sentence: 200,liver,B-Disease
Sentence: 200,cancer,I-Disease
Sentence: 200,among,O
Sentence: 200,pesticide,O
Sentence: 200,applicators,O
Sentence: 200,is,O
Sentence: 200,a,O
Sentence: 200,novel,O
Sentence: 200,finding,O
Sentence: 200,and,O
Sentence: 200,echoes,O
Sentence: 200,observation,O
Sentence: 200,of,O
Sentence: 200,increased,O
Sentence: 200,liver,B-Disease
Sentence: 200,neoplasms,I-Disease
Sentence: 200,in,O
Sentence: 200,some,O
Sentence: 200,animal,O
Sentence: 200,studies,O
Sentence: 200,.,O
Sentence: 200,However,O
Sentence: 200,",",O
Sentence: 200,our,O
Sentence: 200,findings,O
Sentence: 200,for,O
Sentence: 200,both,O
Sentence: 200,liver,B-Disease
Sentence: 200,cancer,I-Disease
Sentence: 200,and,O
Sentence: 200,follicular,B-Disease
Sentence: 200,cell,I-Disease
Sentence: 200,lymphoma,B-Disease
Sentence: 200,warrant,O
Sentence: 200,follow,O
Sentence: 200,-,O
Sentence: 200,up,O
Sentence: 200,to,O
Sentence: 200,better,O
Sentence: 200,differentiate,O
Sentence: 200,effects,O
Sentence: 200,of,O
Sentence: 200,metolachlor,B-Chemical
Sentence: 200,use,O
Sentence: 200,from,O
Sentence: 200,other,O
Sentence: 200,factors,O
Sentence: 200,.,O
Sentence: 201,Mechanisms,O
Sentence: 201,Underlying,O
Sentence: 201,Latent,O
Sentence: 201,Disease,O
Sentence: 201,Risk,O
Sentence: 201,Associated,O
Sentence: 201,with,O
Sentence: 201,Early,O
Sentence: 201,-,O
Sentence: 201,Life,O
Sentence: 201,Arsenic,O
Sentence: 201,Exposure,O
Sentence: 201,:,O
Sentence: 201,Current,O
Sentence: 201,Research,O
Sentence: 201,Trends,O
Sentence: 201,and,O
Sentence: 201,Scientific,O
Sentence: 201,Gaps,O
Sentence: 201,.,O
Sentence: 202,BACKGROUND,O
Sentence: 202,:,O
Sentence: 202,Millions,O
Sentence: 202,of,O
Sentence: 202,individuals,O
Sentence: 202,worldwide,O
Sentence: 202,",",O
Sentence: 202,particularly,O
Sentence: 202,those,O
Sentence: 202,living,O
Sentence: 202,in,O
Sentence: 202,rural,O
Sentence: 202,and,O
Sentence: 202,developing,O
Sentence: 202,areas,O
Sentence: 202,",",O
Sentence: 202,are,O
Sentence: 202,exposed,O
Sentence: 202,to,O
Sentence: 202,harmful,O
Sentence: 202,levels,O
Sentence: 202,of,O
Sentence: 202,inorganic,B-Chemical
Sentence: 202,arsenic,I-Chemical
Sentence: 202,(,O
Sentence: 202,iAs,B-Chemical
Sentence: 202,),O
Sentence: 202,in,O
Sentence: 202,their,O
Sentence: 202,drinking,O
Sentence: 202,water,O
Sentence: 202,.,O
Sentence: 202,Inorganic,B-Chemical
Sentence: 202,As,I-Chemical
Sentence: 202,exposure,O
Sentence: 202,during,O
Sentence: 202,key,O
Sentence: 202,developmental,O
Sentence: 202,periods,O
Sentence: 202,is,O
Sentence: 202,associated,O
Sentence: 202,with,O
Sentence: 202,a,O
Sentence: 202,variety,O
Sentence: 202,of,O
Sentence: 202,adverse,O
Sentence: 202,health,O
Sentence: 202,effects,O
Sentence: 202,including,O
Sentence: 202,those,O
Sentence: 202,that,O
Sentence: 202,are,O
Sentence: 202,evident,O
Sentence: 202,in,O
Sentence: 202,adulthood,O
Sentence: 202,.,O
Sentence: 202,There,O
Sentence: 202,is,O
Sentence: 202,considerable,O
Sentence: 202,interest,O
Sentence: 202,in,O
Sentence: 202,identifying,O
Sentence: 202,the,O
Sentence: 202,molecular,O
Sentence: 202,mechanisms,O
Sentence: 202,that,O
Sentence: 202,relate,O
Sentence: 202,early,O
Sentence: 202,-,O
Sentence: 202,life,O
Sentence: 202,iAs,B-Chemical
Sentence: 202,exposure,O
Sentence: 202,to,O
Sentence: 202,the,O
Sentence: 202,development,O
Sentence: 202,of,O
Sentence: 202,these,O
Sentence: 202,latent,O
Sentence: 202,diseases,O
Sentence: 202,",",O
Sentence: 202,particularly,O
Sentence: 202,in,O
Sentence: 202,relationship,O
Sentence: 202,to,O
Sentence: 202,cancer,B-Disease
Sentence: 202,.,O
Sentence: 202,OBJECTIVES,O
Sentence: 202,:,O
Sentence: 202,This,O
Sentence: 202,work,O
Sentence: 202,summarizes,O
Sentence: 202,research,O
Sentence: 202,on,O
Sentence: 202,the,O
Sentence: 202,molecular,O
Sentence: 202,mechanisms,O
Sentence: 202,that,O
Sentence: 202,underlie,O
Sentence: 202,the,O
Sentence: 202,increased,O
Sentence: 202,risk,O
Sentence: 202,of,O
Sentence: 202,cancer,B-Disease
Sentence: 202,development,O
Sentence: 202,in,O
Sentence: 202,adulthood,O
Sentence: 202,that,O
Sentence: 202,is,O
Sentence: 202,associated,O
Sentence: 202,with,O
Sentence: 202,early,O
Sentence: 202,-,O
Sentence: 202,life,O
Sentence: 202,iAs,B-Chemical
Sentence: 202,exposure,O
Sentence: 202,.,O
Sentence: 202,DISCUSSION,O
Sentence: 202,:,O
Sentence: 202,Epigenetic,O
Sentence: 202,reprogramming,O
Sentence: 202,that,O
Sentence: 202,imparts,O
Sentence: 202,functional,O
Sentence: 202,changes,O
Sentence: 202,in,O
Sentence: 202,gene,O
Sentence: 202,expression,O
Sentence: 202,",",O
Sentence: 202,the,O
Sentence: 202,development,O
Sentence: 202,of,O
Sentence: 202,cancer,B-Disease
Sentence: 202,stem,O
Sentence: 202,cells,O
Sentence: 202,",",O
Sentence: 202,and,O
Sentence: 202,immunomodulation,O
Sentence: 202,are,O
Sentence: 202,plausible,O
Sentence: 202,underlying,O
Sentence: 202,mechanisms,O
Sentence: 202,by,O
Sentence: 202,which,O
Sentence: 202,early,O
Sentence: 202,-,O
Sentence: 202,life,O
Sentence: 202,iAs,B-Chemical
Sentence: 202,exposure,O
Sentence: 202,elicits,O
Sentence: 202,latent,O
Sentence: 202,carcinogenic,O
Sentence: 202,effects,O
Sentence: 202,.,O
Sentence: 202,CONCLUSIONS,O
Sentence: 202,:,O
Sentence: 202,Evidence,O
Sentence: 202,is,O
Sentence: 202,mounting,O
Sentence: 202,that,O
Sentence: 202,relates,O
Sentence: 202,early,O
Sentence: 202,-,O
Sentence: 202,life,O
Sentence: 202,iAs,B-Chemical
Sentence: 202,exposure,O
Sentence: 202,and,O
Sentence: 202,cancer,B-Disease
Sentence: 202,development,O
Sentence: 202,later,O
Sentence: 202,in,O
Sentence: 202,life,O
Sentence: 202,.,O
Sentence: 202,Future,O
Sentence: 202,research,O
Sentence: 202,should,O
Sentence: 202,include,O
Sentence: 202,animal,O
Sentence: 202,studies,O
Sentence: 202,that,O
Sentence: 202,address,O
Sentence: 202,mechanistic,O
Sentence: 202,hypotheses,O
Sentence: 202,and,O
Sentence: 202,studies,O
Sentence: 202,of,O
Sentence: 202,human,O
Sentence: 202,populations,O
Sentence: 202,that,O
Sentence: 202,integrate,O
Sentence: 202,early,O
Sentence: 202,-,O
Sentence: 202,life,O
Sentence: 202,exposure,O
Sentence: 202,",",O
Sentence: 202,molecular,O
Sentence: 202,alterations,O
Sentence: 202,",",O
Sentence: 202,and,O
Sentence: 202,latent,O
Sentence: 202,disease,O
Sentence: 202,outcomes,O
Sentence: 202,.,O
Sentence: 203,On,O
Sentence: 203,the,O
Sentence: 203,antiarrhythmic,O
Sentence: 203,activity,O
Sentence: 203,of,O
Sentence: 203,one,O
Sentence: 203,N,O
Sentence: 203,-,O
Sentence: 203,substituted,O
Sentence: 203,piperazine,B-Chemical
Sentence: 203,derivative,O
Sentence: 203,of,O
Sentence: 203,trans,O
Sentence: 203,-,O
Sentence: 203,2,O
Sentence: 203,-,O
Sentence: 203,amino,O
Sentence: 203,-,O
Sentence: 203,3,O
Sentence: 203,-,O
Sentence: 203,hydroxy,O
Sentence: 203,-,O
Sentence: 203,1,O
Sentence: 203,",",O
Sentence: 203,2,O
Sentence: 203,",",O
Sentence: 203,3,O
Sentence: 203,",",O
Sentence: 203,4,O
Sentence: 203,-,O
Sentence: 203,tetrahydroanaphthalene,O
Sentence: 203,.,O
Sentence: 204,The,O
Sentence: 204,antiarrhythmic,O
Sentence: 204,activity,O
Sentence: 204,of,O
Sentence: 204,the,O
Sentence: 204,compound,O
Sentence: 204,N,O
Sentence: 204,-,O
Sentence: 204,,O
Sentence: 204,(,O
Sentence: 204,trans,O
Sentence: 204,-,O
Sentence: 204,3,O
Sentence: 204,-,O
Sentence: 204,hydroxy,O
Sentence: 204,-,O
Sentence: 204,"1,2,3,4",O
Sentence: 204,-,O
Sentence: 204,tetrahydro,O
Sentence: 204,-,O
Sentence: 204,2,O
Sentence: 204,-,O
Sentence: 204,naphthyl,O
Sentence: 204,),O
Sentence: 204,,O
Sentence: 204,-,O
Sentence: 204,N,O
Sentence: 204,-,O
Sentence: 204,,O
Sentence: 204,(,O
Sentence: 204,3,O
Sentence: 204,-,O
Sentence: 204,oxo,O
Sentence: 204,-,O
Sentence: 204,3,O
Sentence: 204,-,O
Sentence: 204,phenyl,O
Sentence: 204,-,O
Sentence: 204,2,O
Sentence: 204,-,O
Sentence: 204,methylpropyl,O
Sentence: 204,),O
Sentence: 204,,O
Sentence: 204,-,O
Sentence: 204,piperazine,O
Sentence: 204,hydrochloride,O
Sentence: 204,",",O
Sentence: 204,referred,O
Sentence: 204,to,O
Sentence: 204,as,O
Sentence: 204,P11,B-Chemical
Sentence: 204,",",O
Sentence: 204,is,O
Sentence: 204,studied,O
Sentence: 204,on,O
Sentence: 204,anaesthesized,O
Sentence: 204,cats,O
Sentence: 204,and,O
Sentence: 204,Wistar,O
Sentence: 204,albino,O
Sentence: 204,rats,O
Sentence: 204,",",O
Sentence: 204,as,O
Sentence: 204,well,O
Sentence: 204,as,O
Sentence: 204,on,O
Sentence: 204,non,O
Sentence: 204,-,O
Sentence: 204,anaesthesized,O
Sentence: 204,rabbits,O
Sentence: 204,.,O
Sentence: 204,Four,O
Sentence: 204,types,O
Sentence: 204,of,O
Sentence: 204,experimental,O
Sentence: 204,arrhythmia,B-Disease
Sentence: 204,are,O
Sentence: 204,used,O
Sentence: 204,,O
Sentence: 204,-,O
Sentence: 204,,O
Sentence: 204,-,O
Sentence: 204,,O
Sentence: 204,with,O
Sentence: 204,BaCl2,B-Chemical
Sentence: 204,",",O
Sentence: 204,with,O
Sentence: 204,chloroform,B-Chemical
Sentence: 204,-,O
Sentence: 204,adrenaline,B-Chemical
Sentence: 204,",",O
Sentence: 204,with,O
Sentence: 204,strophantine,B-Chemical
Sentence: 204,G,I-Chemical
Sentence: 204,and,O
Sentence: 204,with,O
Sentence: 204,aconitine,B-Chemical
Sentence: 204,.,O
Sentence: 204,The,O
Sentence: 204,compound,O
Sentence: 204,P11,B-Chemical
Sentence: 204,is,O
Sentence: 204,introduced,O
Sentence: 204,in,O
Sentence: 204,doses,O
Sentence: 204,of,O
Sentence: 204,0.25,O
Sentence: 204,and,O
Sentence: 204,0.50,O
Sentence: 204,mg,O
Sentence: 204,/,O
Sentence: 204,kg,O
Sentence: 204,intravenously,O
Sentence: 204,and,O
Sentence: 204,10,O
Sentence: 204,mg,O
Sentence: 204,/,O
Sentence: 204,kg,O
Sentence: 204,orally,O
Sentence: 204,.,O
Sentence: 204,The,O
Sentence: 204,compound,O
Sentence: 204,manifests,O
Sentence: 204,antiarrhythmic,O
Sentence: 204,activity,O
Sentence: 204,in,O
Sentence: 204,all,O
Sentence: 204,models,O
Sentence: 204,of,O
Sentence: 204,experimental,O
Sentence: 204,arrhythmia,B-Disease
Sentence: 204,used,O
Sentence: 204,",",O
Sentence: 204,causing,O
Sentence: 204,greatest,O
Sentence: 204,inhibition,O
Sentence: 204,on,O
Sentence: 204,the,O
Sentence: 204,arrhythmia,B-Disease
Sentence: 204,induced,O
Sentence: 204,by,O
Sentence: 204,chloroform,B-Chemical
Sentence: 204,-,O
Sentence: 204,adrenaline,B-Chemical
Sentence: 204,(,O
Sentence: 204,in,O
Sentence: 204,90,O
Sentence: 204,per,O
Sentence: 204,cent,O
Sentence: 204,),O
Sentence: 204,and,O
Sentence: 204,with,O
Sentence: 204,BaCl2,B-Chemical
Sentence: 204,(,O
Sentence: 204,in,O
Sentence: 204,84,O
Sentence: 204,per,O
Sentence: 204,cent,O
Sentence: 204,),O
Sentence: 204,.,O
Sentence: 204,The,O
Sentence: 204,results,O
Sentence: 204,obtained,O
Sentence: 204,are,O
Sentence: 204,associated,O
Sentence: 204,with,O
Sentence: 204,the,O
Sentence: 204,beta,O
Sentence: 204,-,O
Sentence: 204,adrenoblocking,O
Sentence: 204,and,O
Sentence: 204,with,O
Sentence: 204,the,O
Sentence: 204,membrane,O
Sentence: 204,-,O
Sentence: 204,stabilizing,O
Sentence: 204,action,O
Sentence: 204,of,O
Sentence: 204,the,O
Sentence: 204,compound,O
Sentence: 204,.,O
Sentence: 205,Experimental,O
Sentence: 205,progressive,O
Sentence: 205,muscular,O
Sentence: 205,dystrophy,O
Sentence: 205,and,O
Sentence: 205,its,O
Sentence: 205,treatment,O
Sentence: 205,with,O
Sentence: 205,high,O
Sentence: 205,doses,O
Sentence: 205,anabolizing,O
Sentence: 205,agents,O
Sentence: 205,.,O
Sentence: 206,We,O
Sentence: 206,are,O
Sentence: 206,still,O
Sentence: 206,a,O
Sentence: 206,long,O
Sentence: 206,way,O
Sentence: 206,from,O
Sentence: 206,discovering,O
Sentence: 206,an,O
Sentence: 206,unequivocal,O
Sentence: 206,pathogenetic,O
Sentence: 206,interpretation,O
Sentence: 206,of,O
Sentence: 206,progressive,O
Sentence: 206,muscular,B-Disease
Sentence: 206,dystrophy,I-Disease
Sentence: 206,in,O
Sentence: 206,man,O
Sentence: 206,.,O
Sentence: 206,Noteworthy,O
Sentence: 206,efforts,O
Sentence: 206,have,O
Sentence: 206,been,O
Sentence: 206,made,O
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,experimental,O
Sentence: 206,field,O
Sentence: 206,;,O
Sentence: 206,a,O
Sentence: 206,recessive,O
Sentence: 206,autosomic,O
Sentence: 206,form,O
Sentence: 206,found,O
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,mouse,O
Sentence: 206,seems,O
Sentence: 206,to,O
Sentence: 206,bear,O
Sentence: 206,the,O
Sentence: 206,closest,O
Sentence: 206,resemblance,O
Sentence: 206,to,O
Sentence: 206,the,O
Sentence: 206,human,O
Sentence: 206,form,O
Sentence: 206,from,O
Sentence: 206,the,O
Sentence: 206,genetic,O
Sentence: 206,point,O
Sentence: 206,of,O
Sentence: 206,view,O
Sentence: 206,.,O
Sentence: 206,Myopathy,B-Disease
Sentence: 206,due,O
Sentence: 206,to,O
Sentence: 206,lack,O
Sentence: 206,of,O
Sentence: 206,vitamin,B-Chemical
Sentence: 206,E,I-Chemical
Sentence: 206,and,O
Sentence: 206,myopathy,B-Disease
Sentence: 206,induced,O
Sentence: 206,by,O
Sentence: 206,certain,O
Sentence: 206,viruses,O
Sentence: 206,have,O
Sentence: 206,much,O
Sentence: 206,in,O
Sentence: 206,common,O
Sentence: 206,anatomically,O
Sentence: 206,and,O
Sentence: 206,pathologically,O
Sentence: 206,with,O
Sentence: 206,the,O
Sentence: 206,human,O
Sentence: 206,form,O
Sentence: 206,.,O
Sentence: 206,The,O
Sentence: 206,authors,O
Sentence: 206,induced,O
Sentence: 206,myodystrophy,B-Disease
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,rat,O
Sentence: 206,by,O
Sentence: 206,giving,O
Sentence: 206,it,O
Sentence: 206,a,O
Sentence: 206,diet,O
Sentence: 206,lacking,O
Sentence: 206,in,O
Sentence: 206,vitamin,O
Sentence: 206,E.,O
Sentence: 206,The,O
Sentence: 206,pharmacological,O
Sentence: 206,characteristics,O
Sentence: 206,of,O
Sentence: 206,vitamin,B-Chemical
Sentence: 206,E,I-Chemical
Sentence: 206,and,O
Sentence: 206,the,O
Sentence: 206,degenerative,O
Sentence: 206,changes,O
Sentence: 206,brought,O
Sentence: 206,about,O
Sentence: 206,by,O
Sentence: 206,its,O
Sentence: 206,deficiency,O
Sentence: 206,",",O
Sentence: 206,especially,O
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,muscles,O
Sentence: 206,",",O
Sentence: 206,are,O
Sentence: 206,illustrated,O
Sentence: 206,.,O
Sentence: 206,It,O
Sentence: 206,is,O
Sentence: 206,thus,O
Sentence: 206,confirmed,O
Sentence: 206,that,O
Sentence: 206,the,O
Sentence: 206,histological,O
Sentence: 206,characteristics,O
Sentence: 206,of,O
Sentence: 206,myopathic,B-Disease
Sentence: 206,rat,O
Sentence: 206,muscle,O
Sentence: 206,induced,O
Sentence: 206,experimentally,O
Sentence: 206,are,O
Sentence: 206,extraordinarily,O
Sentence: 206,similar,O
Sentence: 206,to,O
Sentence: 206,those,O
Sentence: 206,of,O
Sentence: 206,human,O
Sentence: 206,myopathy,B-Disease
Sentence: 206,as,O
Sentence: 206,confirmed,O
Sentence: 206,during,O
Sentence: 206,biopsies,O
Sentence: 206,performed,O
Sentence: 206,at,O
Sentence: 206,the,O
Sentence: 206,Orthopaedic,O
Sentence: 206,Traumatological,O
Sentence: 206,Centre,O
Sentence: 206,",",O
Sentence: 206,Florence,O
Sentence: 206,.,O
Sentence: 206,The,O
Sentence: 206,encouraging,O
Sentence: 206,results,O
Sentence: 206,obtained,O
Sentence: 206,in,O
Sentence: 206,various,O
Sentence: 206,authoratative,O
Sentence: 206,departments,O
Sentence: 206,in,O
Sentence: 206,myopathic,B-Disease
Sentence: 206,patients,O
Sentence: 206,by,O
Sentence: 206,using,O
Sentence: 206,anabolizing,O
Sentence: 206,steroids,B-Chemical
Sentence: 206,have,O
Sentence: 206,encouraged,O
Sentence: 206,the,O
Sentence: 206,authors,O
Sentence: 206,to,O
Sentence: 206,investigate,O
Sentence: 206,the,O
Sentence: 206,beneficial,O
Sentence: 206,effects,O
Sentence: 206,of,O
Sentence: 206,one,O
Sentence: 206,anabolizing,O
Sentence: 206,agent,O
Sentence: 206,(,O
Sentence: 206,Dianabol,B-Chemical
Sentence: 206,",",O
Sentence: 206,CIBA,B-Chemical
Sentence: 206,),O
Sentence: 206,at,O
Sentence: 206,high,O
Sentence: 206,doses,O
Sentence: 206,in,O
Sentence: 206,rats,O
Sentence: 206,rendered,O
Sentence: 206,myopathic,B-Disease
Sentence: 206,by,O
Sentence: 206,a,O
Sentence: 206,diet,O
Sentence: 206,deficient,O
Sentence: 206,in,O
Sentence: 206,vitamin,O
Sentence: 206,E.,O
Sentence: 206,In,O
Sentence: 206,this,O
Sentence: 206,way,O
Sentence: 206,they,O
Sentence: 206,obtained,O
Sentence: 206,appreciable,O
Sentence: 206,changes,O
Sentence: 206,in,O
Sentence: 206,body,O
Sentence: 206,weight,O
Sentence: 206,(,O
Sentence: 206,increased,O
Sentence: 206,from,O
Sentence: 206,50,O
Sentence: 206,to,O
Sentence: 206,70,O
Sentence: 206,g,O
Sentence: 206,after,O
Sentence: 206,forty,O
Sentence: 206,days,O
Sentence: 206,at,O
Sentence: 206,a,O
Sentence: 206,dose,O
Sentence: 206,of,O
Sentence: 206,5,O
Sentence: 206,mg,O
Sentence: 206,per,O
Sentence: 206,day,O
Sentence: 206,of,O
Sentence: 206,anabolizing,O
Sentence: 206,agent,O
Sentence: 206,),O
Sentence: 206,",",O
Sentence: 206,but,O
Sentence: 206,most,O
Sentence: 206,of,O
Sentence: 206,all,O
Sentence: 206,they,O
Sentence: 206,found,O
Sentence: 206,histological,O
Sentence: 206,changes,O
Sentence: 206,due,O
Sentence: 206,to,O
Sentence: 206,``,O
Sentence: 206,regenerative,O
Sentence: 206,'',O
Sentence: 206,changes,O
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,muscle,O
Sentence: 206,tissue,O
Sentence: 206,",",O
Sentence: 206,which,O
Sentence: 206,however,O
Sentence: 206,maintained,O
Sentence: 206,its,O
Sentence: 206,myopathic,B-Disease
Sentence: 206,characteristics,O
Sentence: 206,in,O
Sentence: 206,the,O
Sentence: 206,control,O
Sentence: 206,animals,O
Sentence: 206,that,O
Sentence: 206,were,O
Sentence: 206,not,O
Sentence: 206,treated,O
Sentence: 206,with,O
Sentence: 206,the,O
Sentence: 206,anabolizing,O
Sentence: 206,agent,O
Sentence: 206,.,O
Sentence: 206,The,O
Sentence: 206,authors,O
Sentence: 206,conclude,O
Sentence: 206,by,O
Sentence: 206,affirming,O
Sentence: 206,the,O
Sentence: 206,undoubted,O
Sentence: 206,efficacy,O
Sentence: 206,of,O
Sentence: 206,the,O
Sentence: 206,anabolizing,O
Sentence: 206,steroids,B-Chemical
Sentence: 206,in,O
Sentence: 206,experimental,O
Sentence: 206,myopathic,B-Disease
Sentence: 206,disease,I-Disease
Sentence: 206,",",O
Sentence: 206,but,O
Sentence: 206,they,O
Sentence: 206,have,O
Sentence: 206,reservations,O
Sentence: 206,as,O
Sentence: 206,to,O
Sentence: 206,the,O
Sentence: 206,transfer,O
Sentence: 206,of,O
Sentence: 206,the,O
Sentence: 206,results,O
Sentence: 206,into,O
Sentence: 206,the,O
Sentence: 206,human,O
Sentence: 206,field,O
Sentence: 206,",",O
Sentence: 206,where,O
Sentence: 206,high,O
Sentence: 206,dosage,O
Sentence: 206,can,O
Sentence: 206,not,O
Sentence: 206,be,O
Sentence: 206,carried,O
Sentence: 206,out,O
Sentence: 206,continuously,O
Sentence: 206,because,O
Sentence: 206,of,O
Sentence: 206,the,O
Sentence: 206,effects,O
Sentence: 206,of,O
Sentence: 206,the,O
Sentence: 206,drug,O
Sentence: 206,on,O
Sentence: 206,virility,O
Sentence: 206,;,O
Sentence: 206,because,O
Sentence: 206,the,O
Sentence: 206,tissue,O
Sentence: 206,injury,O
Sentence: 206,too,O
Sentence: 206,often,O
Sentence: 206,occurs,O
Sentence: 206,at,O
Sentence: 206,an,O
Sentence: 206,irreversible,O
Sentence: 206,stage,O
Sentence: 206,vis,O
Sentence: 206,-,O
Sentence: 206,a,O
Sentence: 206,-,O
Sentence: 206,vis,O
Sentence: 206,the,O
Sentence: 206,``,O
Sentence: 206,regeneration,O
Sentence: 206,'',O
Sentence: 206,of,O
Sentence: 206,the,O
Sentence: 206,muscle,O
Sentence: 206,tissue,O
Sentence: 206,;,O
Sentence: 206,and,O
Sentence: 206,finally,O
Sentence: 206,because,O
Sentence: 206,the,O
Sentence: 206,dystrophic,O
Sentence: 206,injurious,O
Sentence: 206,agent,O
Sentence: 206,is,O
Sentence: 206,certainly,O
Sentence: 206,not,O
Sentence: 206,the,O
Sentence: 206,lack,O
Sentence: 206,of,O
Sentence: 206,vitamin,B-Chemical
Sentence: 206,E,I-Chemical
Sentence: 206,but,O
Sentence: 206,something,O
Sentence: 206,as,O
Sentence: 206,yet,O
Sentence: 206,unknown,O
Sentence: 206,.,O
Sentence: 207,Fetal,O
Sentence: 207,risks,O
Sentence: 207,due,O
Sentence: 207,to,O
Sentence: 207,warfarin,O
Sentence: 207,therapy,O
Sentence: 207,during,O
Sentence: 207,pregnancy,O
Sentence: 207,.,O
Sentence: 208,Two,O
Sentence: 208,mothers,O
Sentence: 208,with,O
Sentence: 208,heart,O
Sentence: 208,valve,O
Sentence: 208,prosthesis,O
Sentence: 208,were,O
Sentence: 208,treated,O
Sentence: 208,with,O
Sentence: 208,warfarin,B-Chemical
Sentence: 208,during,O
Sentence: 208,pregnancy,O
Sentence: 208,.,O
Sentence: 208,In,O
Sentence: 208,the,O
Sentence: 208,first,O
Sentence: 208,case,O
Sentence: 208,a,O
Sentence: 208,caesarean,O
Sentence: 208,section,O
Sentence: 208,was,O
Sentence: 208,done,O
Sentence: 208,one,O
Sentence: 208,week,O
Sentence: 208,after,O
Sentence: 208,replacement,O
Sentence: 208,of,O
Sentence: 208,warfarin,B-Chemical
Sentence: 208,with,O
Sentence: 208,heparin,B-Chemical
Sentence: 208,.,O
Sentence: 208,The,O
Sentence: 208,baby,O
Sentence: 208,died,O
Sentence: 208,of,O
Sentence: 208,cerebral,B-Disease
Sentence: 208,and,I-Disease
Sentence: 208,pulmonary,B-Disease
Sentence: 208,hemorrhage,B-Disease
Sentence: 208,.,O
Sentence: 208,The,O
Sentence: 208,second,O
Sentence: 208,mother,O
Sentence: 208,had,O
Sentence: 208,a,O
Sentence: 208,male,O
Sentence: 208,infant,O
Sentence: 208,by,O
Sentence: 208,caesarean,O
Sentence: 208,section,O
Sentence: 208,.,O
Sentence: 208,The,O
Sentence: 208,baby,O
Sentence: 208,showed,O
Sentence: 208,warfarin,B-Chemical
Sentence: 208,-,O
Sentence: 208,induced,O
Sentence: 208,embryopathy,B-Disease
Sentence: 208,with,O
Sentence: 208,nasal,B-Disease
Sentence: 208,hypoplasia,I-Disease
Sentence: 208,and,O
Sentence: 208,stippled,B-Disease
Sentence: 208,epiphyses,I-Disease
Sentence: 208,(,O
Sentence: 208,chondrodysplasia,B-Disease
Sentence: 208,punctata,I-Disease
Sentence: 208,),O
Sentence: 208,.,O
Sentence: 208,Nasal,B-Disease
Sentence: 208,hypoplasia,I-Disease
Sentence: 208,with,O
Sentence: 208,or,O
Sentence: 208,without,O
Sentence: 208,stippled,B-Disease
Sentence: 208,epiphyses,I-Disease
Sentence: 208,has,O
Sentence: 208,now,O
Sentence: 208,been,O
Sentence: 208,reported,O
Sentence: 208,in,O
Sentence: 208,11,O
Sentence: 208,infants,O
Sentence: 208,born,O
Sentence: 208,to,O
Sentence: 208,mothers,O
Sentence: 208,treated,O
Sentence: 208,with,O
Sentence: 208,warfarin,B-Chemical
Sentence: 208,during,O
Sentence: 208,the,O
Sentence: 208,first,O
Sentence: 208,trimester,O
Sentence: 208,",",O
Sentence: 208,and,O
Sentence: 208,a,O
Sentence: 208,causal,O
Sentence: 208,association,O
Sentence: 208,is,O
Sentence: 208,probable,O
Sentence: 208,.,O
Sentence: 208,In,O
Sentence: 208,view,O
Sentence: 208,of,O
Sentence: 208,the,O
Sentence: 208,risks,O
Sentence: 208,to,O
Sentence: 208,both,O
Sentence: 208,mother,O
Sentence: 208,and,O
Sentence: 208,fetus,O
Sentence: 208,in,O
Sentence: 208,women,O
Sentence: 208,with,O
Sentence: 208,prosthetic,O
Sentence: 208,cardiac,O
Sentence: 208,valves,O
Sentence: 208,it,O
Sentence: 208,is,O
Sentence: 208,recommended,O
Sentence: 208,that,O
Sentence: 208,therapeutic,O
Sentence: 208,abortion,O
Sentence: 208,be,O
Sentence: 208,advised,O
Sentence: 208,as,O
Sentence: 208,the,O
Sentence: 208,first,O
Sentence: 208,alternative,O
Sentence: 208,.,O
Sentence: 209,Isradipine,B-Chemical
Sentence: 209,treatment,O
Sentence: 209,for,O
Sentence: 209,hypertension,B-Disease
Sentence: 209,in,O
Sentence: 209,general,O
Sentence: 209,practice,O
Sentence: 209,in,O
Sentence: 209,Hong,O
Sentence: 209,Kong,O
Sentence: 209,.,O
Sentence: 210,A,O
Sentence: 210,6,O
Sentence: 210,-,O
Sentence: 210,week,O
Sentence: 210,open,O
Sentence: 210,study,O
Sentence: 210,of,O
Sentence: 210,the,O
Sentence: 210,introduction,O
Sentence: 210,of,O
Sentence: 210,isradipine,B-Chemical
Sentence: 210,treatment,O
Sentence: 210,was,O
Sentence: 210,conducted,O
Sentence: 210,in,O
Sentence: 210,general,O
Sentence: 210,practice,O
Sentence: 210,in,O
Sentence: 210,Hong,O
Sentence: 210,Kong,O
Sentence: 210,.,O
Sentence: 210,303,O
Sentence: 210,Chinese,O
Sentence: 210,patients,O
Sentence: 210,with,O
Sentence: 210,mild,O
Sentence: 210,to,O
Sentence: 210,moderate,O
Sentence: 210,hypertension,B-Disease
Sentence: 210,entered,O
Sentence: 210,the,O
Sentence: 210,study,O
Sentence: 210,.,O
Sentence: 210,Side,O
Sentence: 210,effects,O
Sentence: 210,were,O
Sentence: 210,reported,O
Sentence: 210,in,O
Sentence: 210,21,O
Sentence: 210,%,O
Sentence: 210,of,O
Sentence: 210,patients,O
Sentence: 210,and,O
Sentence: 210,caused,O
Sentence: 210,withdrawal,O
Sentence: 210,from,O
Sentence: 210,the,O
Sentence: 210,study,O
Sentence: 210,in,O
Sentence: 210,3,O
Sentence: 210,patients,O
Sentence: 210,.,O
Sentence: 210,The,O
Sentence: 210,main,O
Sentence: 210,side,O
Sentence: 210,-,O
Sentence: 210,effects,O
Sentence: 210,were,O
Sentence: 210,headache,B-Disease
Sentence: 210,",",O
Sentence: 210,dizziness,B-Disease
Sentence: 210,",",O
Sentence: 210,palpitation,B-Disease
Sentence: 210,and,O
Sentence: 210,flushing,B-Disease
Sentence: 210,and,O
Sentence: 210,these,O
Sentence: 210,were,O
Sentence: 210,not,O
Sentence: 210,more,O
Sentence: 210,frequent,O
Sentence: 210,than,O
Sentence: 210,reported,O
Sentence: 210,in,O
Sentence: 210,other,O
Sentence: 210,studies,O
Sentence: 210,with,O
Sentence: 210,isradipine,B-Chemical
Sentence: 210,or,O
Sentence: 210,with,O
Sentence: 210,placebo,O
Sentence: 210,.,O
Sentence: 210,Supine,O
Sentence: 210,blood,O
Sentence: 210,pressure,O
Sentence: 210,was,O
Sentence: 210,reduced,O
Sentence: 210,(,O
Sentence: 210,P,O
Sentence: 210,less,O
Sentence: 210,than,O
Sentence: 210,0.01,O
Sentence: 210,),O
Sentence: 210,from,O
Sentence: 210,170,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,20,O
Sentence: 210,/,O
Sentence: 210,102,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,6,O
Sentence: 210,mmHg,O
Sentence: 210,to,O
Sentence: 210,153,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,19,O
Sentence: 210,/,O
Sentence: 210,92,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,8,O
Sentence: 210,",",O
Sentence: 210,147,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,18,O
Sentence: 210,/,O
Sentence: 210,88,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,7,O
Sentence: 210,and,O
Sentence: 210,144,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,14,O
Sentence: 210,/,O
Sentence: 210,87,O
Sentence: 210,+,O
Sentence: 210,/,O
Sentence: 210,,O
Sentence: 210,-,O
Sentence: 210,,O
Sentence: 210,6,O
Sentence: 210,mmHg,O
Sentence: 210,at,O
Sentence: 210,2,O
Sentence: 210,",",O
Sentence: 210,4,O
Sentence: 210,and,O
Sentence: 210,6,O
Sentence: 210,weeks,O
Sentence: 210,respectively,O
Sentence: 210,in,O
Sentence: 210,evaluable,O
Sentence: 210,patients,O
Sentence: 210,.,O
Sentence: 210,Similar,O
Sentence: 210,reductions,O
Sentence: 210,occurred,O
Sentence: 210,in,O
Sentence: 210,standing,O
Sentence: 210,blood,O
Sentence: 210,pressure,O
Sentence: 210,and,O
Sentence: 210,there,O
Sentence: 210,was,O
Sentence: 210,no,O
Sentence: 210,evidence,O
Sentence: 210,of,O
Sentence: 210,postural,B-Disease
Sentence: 210,hypotension,I-Disease
Sentence: 210,.,O
Sentence: 210,Normalization,O
Sentence: 210,and,O
Sentence: 210,responder,O
Sentence: 210,rates,O
Sentence: 210,at,O
Sentence: 210,6,O
Sentence: 210,weeks,O
Sentence: 210,were,O
Sentence: 210,86,O
Sentence: 210,%,O
Sentence: 210,and,O
Sentence: 210,69,O
Sentence: 210,%,O
Sentence: 210,respectively,O
Sentence: 210,.,O
Sentence: 210,Dosage,O
Sentence: 210,was,O
Sentence: 210,increased,O
Sentence: 210,from,O
Sentence: 210,2.5,O
Sentence: 210,mg,O
Sentence: 210,b.d,O
Sentence: 210,.,O
Sentence: 210,to,O
Sentence: 210,5,O
Sentence: 210,mg,O
Sentence: 210,b.d,O
Sentence: 210,.,O
Sentence: 210,at,O
Sentence: 210,4,O
Sentence: 210,weeks,O
Sentence: 210,in,O
Sentence: 210,patients,O
Sentence: 210,with,O
Sentence: 210,diastolic,O
Sentence: 210,blood,O
Sentence: 210,pressure,O
Sentence: 210,greater,O
Sentence: 210,than,O
Sentence: 210,90,O
Sentence: 210,mmHg,O
Sentence: 210,and,O
Sentence: 210,their,O
Sentence: 210,further,O
Sentence: 210,response,O
Sentence: 210,was,O
Sentence: 210,greater,O
Sentence: 210,than,O
Sentence: 210,those,O
Sentence: 210,remaining,O
Sentence: 210,on,O
Sentence: 210,2.5,O
Sentence: 210,mg,O
Sentence: 210,b.d,O
Sentence: 210,.,O
Sentence: 211,Tachyphylaxis,O
Sentence: 211,to,O
Sentence: 211,systemic,O
Sentence: 211,but,O
Sentence: 211,not,O
Sentence: 211,to,O
Sentence: 211,airway,O
Sentence: 211,responses,O
Sentence: 211,during,O
Sentence: 211,prolonged,O
Sentence: 211,therapy,O
Sentence: 211,with,O
Sentence: 211,high,O
Sentence: 211,dose,O
Sentence: 211,inhaled,O
Sentence: 211,salbutamol,B-Chemical
Sentence: 211,in,O
Sentence: 211,asthmatics,B-Disease
Sentence: 211,.,O
Sentence: 212,High,O
Sentence: 212,doses,O
Sentence: 212,of,O
Sentence: 212,inhaled,O
Sentence: 212,salbutamol,B-Chemical
Sentence: 212,produce,O
Sentence: 212,substantial,O
Sentence: 212,improvements,O
Sentence: 212,in,O
Sentence: 212,airway,O
Sentence: 212,response,O
Sentence: 212,in,O
Sentence: 212,patients,O
Sentence: 212,with,O
Sentence: 212,asthma,B-Disease
Sentence: 212,",",O
Sentence: 212,and,O
Sentence: 212,are,O
Sentence: 212,associated,O
Sentence: 212,with,O
Sentence: 212,dose,O
Sentence: 212,-,O
Sentence: 212,dependent,O
Sentence: 212,systemic,O
Sentence: 212,beta,O
Sentence: 212,-,O
Sentence: 212,adrenoceptor,O
Sentence: 212,responses,O
Sentence: 212,.,O
Sentence: 212,The,O
Sentence: 212,purpose,O
Sentence: 212,of,O
Sentence: 212,the,O
Sentence: 212,present,O
Sentence: 212,study,O
Sentence: 212,was,O
Sentence: 212,to,O
Sentence: 212,investigate,O
Sentence: 212,whether,O
Sentence: 212,tachyphylaxis,O
Sentence: 212,occurs,O
Sentence: 212,during,O
Sentence: 212,prolonged,O
Sentence: 212,treatment,O
Sentence: 212,with,O
Sentence: 212,high,O
Sentence: 212,dose,O
Sentence: 212,inhaled,O
Sentence: 212,salbutamol,B-Chemical
Sentence: 212,.,O
Sentence: 212,Twelve,O
Sentence: 212,asthmatic,B-Disease
Sentence: 212,patients,O
Sentence: 212,(,O
Sentence: 212,FEV1,O
Sentence: 212,",",O
Sentence: 212,81,O
Sentence: 212,+,O
Sentence: 212,/,O
Sentence: 212,,O
Sentence: 212,-,O
Sentence: 212,,O
Sentence: 212,4,O
Sentence: 212,%,O
Sentence: 212,predicted,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,requiring,O
Sentence: 212,only,O
Sentence: 212,occasional,O
Sentence: 212,inhaled,O
Sentence: 212,beta,O
Sentence: 212,-,O
Sentence: 212,agonists,O
Sentence: 212,as,O
Sentence: 212,their,O
Sentence: 212,sole,O
Sentence: 212,therapy,O
Sentence: 212,",",O
Sentence: 212,were,O
Sentence: 212,given,O
Sentence: 212,a,O
Sentence: 212,14,O
Sentence: 212,-,O
Sentence: 212,day,O
Sentence: 212,treatment,O
Sentence: 212,with,O
Sentence: 212,high,O
Sentence: 212,dose,O
Sentence: 212,inhaled,O
Sentence: 212,salbutamol,B-Chemical
Sentence: 212,(,O
Sentence: 212,HDS,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,"4,000",O
Sentence: 212,micrograms,O
Sentence: 212,daily,O
Sentence: 212,",",O
Sentence: 212,low,O
Sentence: 212,dose,O
Sentence: 212,inhaled,O
Sentence: 212,salbutamol,B-Chemical
Sentence: 212,(,O
Sentence: 212,LDS,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,800,O
Sentence: 212,micrograms,O
Sentence: 212,daily,O
Sentence: 212,",",O
Sentence: 212,or,O
Sentence: 212,placebo,O
Sentence: 212,(,O
Sentence: 212,PI,O
Sentence: 212,),O
Sentence: 212,by,O
Sentence: 212,metered,O
Sentence: 212,-,O
Sentence: 212,dose,O
Sentence: 212,inhaler,O
Sentence: 212,in,O
Sentence: 212,a,O
Sentence: 212,double,O
Sentence: 212,-,O
Sentence: 212,blind,O
Sentence: 212,",",O
Sentence: 212,randomized,O
Sentence: 212,crossover,O
Sentence: 212,design,O
Sentence: 212,.,O
Sentence: 212,During,O
Sentence: 212,the,O
Sentence: 212,14,O
Sentence: 212,-,O
Sentence: 212,day,O
Sentence: 212,run,O
Sentence: 212,-,O
Sentence: 212,in,O
Sentence: 212,and,O
Sentence: 212,during,O
Sentence: 212,washout,O
Sentence: 212,periods,O
Sentence: 212,",",O
Sentence: 212,inhaled,O
Sentence: 212,beta,O
Sentence: 212,-,O
Sentence: 212,agonists,O
Sentence: 212,were,O
Sentence: 212,withheld,O
Sentence: 212,and,O
Sentence: 212,ipratropium,B-Chemical
Sentence: 212,bromide,I-Chemical
Sentence: 212,was,O
Sentence: 212,substituted,O
Sentence: 212,for,O
Sentence: 212,rescue,O
Sentence: 212,purposes,O
Sentence: 212,.,O
Sentence: 212,At,O
Sentence: 212,the,O
Sentence: 212,end,O
Sentence: 212,of,O
Sentence: 212,each,O
Sentence: 212,14,O
Sentence: 212,-,O
Sentence: 212,day,O
Sentence: 212,treatment,O
Sentence: 212,",",O
Sentence: 212,a,O
Sentence: 212,dose,O
Sentence: 212,-,O
Sentence: 212,response,O
Sentence: 212,curve,O
Sentence: 212,(,O
Sentence: 212,DRC,O
Sentence: 212,),O
Sentence: 212,was,O
Sentence: 212,performed,O
Sentence: 212,",",O
Sentence: 212,and,O
Sentence: 212,airway,O
Sentence: 212,(,O
Sentence: 212,FEV1,O
Sentence: 212,",",O
Sentence: 212,FEF25,O
Sentence: 212,-,O
Sentence: 212,75,O
Sentence: 212,),O
Sentence: 212,chronotropic,O
Sentence: 212,(,O
Sentence: 212,HR,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,tremor,B-Disease
Sentence: 212,",",O
Sentence: 212,and,O
Sentence: 212,metabolic,O
Sentence: 212,(,O
Sentence: 212,K,B-Chemical
Sentence: 212,",",O
Sentence: 212,Glu,B-Chemical
Sentence: 212,),O
Sentence: 212,responses,O
Sentence: 212,were,O
Sentence: 212,measured,O
Sentence: 212,at,O
Sentence: 212,each,O
Sentence: 212,step,O
Sentence: 212,(,O
Sentence: 212,from,O
Sentence: 212,100,O
Sentence: 212,to,O
Sentence: 212,"4,000",O
Sentence: 212,micrograms,O
Sentence: 212,),O
Sentence: 212,.,O
Sentence: 212,Treatment,O
Sentence: 212,had,O
Sentence: 212,no,O
Sentence: 212,significant,O
Sentence: 212,effect,O
Sentence: 212,on,O
Sentence: 212,baseline,O
Sentence: 212,values,O
Sentence: 212,.,O
Sentence: 212,There,O
Sentence: 212,were,O
Sentence: 212,dose,O
Sentence: 212,-,O
Sentence: 212,dependent,O
Sentence: 212,increases,O
Sentence: 212,in,O
Sentence: 212,FEV1,O
Sentence: 212,and,O
Sentence: 212,FEF25,O
Sentence: 212,-,O
Sentence: 212,75,O
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,and,O
Sentence: 212,pretreatment,O
Sentence: 212,with,O
Sentence: 212,HDS,O
Sentence: 212,did,O
Sentence: 212,not,O
Sentence: 212,displace,O
Sentence: 212,the,O
Sentence: 212,DRC,O
Sentence: 212,to,O
Sentence: 212,the,O
Sentence: 212,right,O
Sentence: 212,.,O
Sentence: 212,DRC,O
Sentence: 212,for,O
Sentence: 212,HR,O
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,K,B-Chemical
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,and,O
Sentence: 212,Glu,B-Chemical
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.005,O
Sentence: 212,),O
Sentence: 212,were,O
Sentence: 212,attenuated,O
Sentence: 212,after,O
Sentence: 212,treatment,O
Sentence: 212,with,O
Sentence: 212,HDS,O
Sentence: 212,compared,O
Sentence: 212,with,O
Sentence: 212,PI,O
Sentence: 212,.,O
Sentence: 212,There,O
Sentence: 212,were,O
Sentence: 212,also,O
Sentence: 212,differences,O
Sentence: 212,between,O
Sentence: 212,HDS,O
Sentence: 212,and,O
Sentence: 212,LDS,O
Sentence: 212,for,O
Sentence: 212,HR,O
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,and,O
Sentence: 212,Glu,B-Chemical
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.05,O
Sentence: 212,),O
Sentence: 212,responses,O
Sentence: 212,.,O
Sentence: 212,Frequency,O
Sentence: 212,and,O
Sentence: 212,severity,O
Sentence: 212,of,O
Sentence: 212,subjective,O
Sentence: 212,adverse,O
Sentence: 212,effects,O
Sentence: 212,were,O
Sentence: 212,also,O
Sentence: 212,reduced,O
Sentence: 212,after,O
Sentence: 212,HDS,O
Sentence: 212,:,O
Sentence: 212,tremor,B-Disease
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,",",O
Sentence: 212,palpitations,B-Disease
Sentence: 212,(,O
Sentence: 212,p,O
Sentence: 212,less,O
Sentence: 212,than,O
Sentence: 212,0.001,O
Sentence: 212,),O
Sentence: 212,.,O
Sentence: 212,(,O
Sentence: 212,ABSTRACT,O
Sentence: 212,TRUNCATED,O
Sentence: 212,AT,O
Sentence: 212,250,O
Sentence: 212,WORDS,O
Sentence: 212,),O
Sentence: 213,Increased,O
Sentence: 213,anxiogenic,O
Sentence: 213,effects,O
Sentence: 213,of,O
Sentence: 213,caffeine,B-Chemical
Sentence: 213,in,O
Sentence: 213,panic,B-Disease
Sentence: 213,disorders,I-Disease
Sentence: 213,.,O
Sentence: 214,The,O
Sentence: 214,effects,O
Sentence: 214,of,O
Sentence: 214,oral,O
Sentence: 214,administration,O
Sentence: 214,of,O
Sentence: 214,caffeine,B-Chemical
Sentence: 214,(,O
Sentence: 214,10,O
Sentence: 214,mg,O
Sentence: 214,/,O
Sentence: 214,kg,O
Sentence: 214,),O
Sentence: 214,on,O
Sentence: 214,behavioral,O
Sentence: 214,ratings,O
Sentence: 214,",",O
Sentence: 214,somatic,O
Sentence: 214,symptoms,O
Sentence: 214,",",O
Sentence: 214,blood,O
Sentence: 214,pressure,O
Sentence: 214,and,O
Sentence: 214,plasma,O
Sentence: 214,levels,O
Sentence: 214,of,O
Sentence: 214,3,O
Sentence: 214,-,O
Sentence: 214,methoxy,O
Sentence: 214,-,O
Sentence: 214,4,O
Sentence: 214,-,O
Sentence: 214,hydroxyphenethyleneglycol,O
Sentence: 214,(,O
Sentence: 214,MHPG,B-Chemical
Sentence: 214,),O
Sentence: 214,and,O
Sentence: 214,cortisol,B-Chemical
Sentence: 214,were,O
Sentence: 214,determined,O
Sentence: 214,in,O
Sentence: 214,17,O
Sentence: 214,healthy,O
Sentence: 214,subjects,O
Sentence: 214,and,O
Sentence: 214,21,O
Sentence: 214,patients,O
Sentence: 214,meeting,O
Sentence: 214,DSM,O
Sentence: 214,-,O
Sentence: 214,III,O
Sentence: 214,criteria,O
Sentence: 214,for,O
Sentence: 214,agoraphobia,B-Disease
Sentence: 214,with,O
Sentence: 214,panic,B-Disease
Sentence: 214,attacks,I-Disease
Sentence: 214,or,O
Sentence: 214,panic,B-Disease
Sentence: 214,disorder,I-Disease
Sentence: 214,.,O
Sentence: 214,Caffeine,B-Chemical
Sentence: 214,produced,O
Sentence: 214,significantly,O
Sentence: 214,greater,O
Sentence: 214,increases,O
Sentence: 214,in,O
Sentence: 214,subject,O
Sentence: 214,-,O
Sentence: 214,rated,O
Sentence: 214,anxiety,B-Disease
Sentence: 214,",",O
Sentence: 214,nervousness,O
Sentence: 214,",",O
Sentence: 214,fear,O
Sentence: 214,",",O
Sentence: 214,nausea,B-Disease
Sentence: 214,",",O
Sentence: 214,palpitations,B-Disease
Sentence: 214,",",O
Sentence: 214,restlessness,B-Disease
Sentence: 214,",",O
Sentence: 214,and,O
Sentence: 214,tremors,B-Disease
Sentence: 214,in,O
Sentence: 214,the,O
Sentence: 214,patients,O
Sentence: 214,compared,O
Sentence: 214,with,O
Sentence: 214,healthy,O
Sentence: 214,subjects,O
Sentence: 214,.,O
Sentence: 214,In,O
Sentence: 214,the,O
Sentence: 214,patients,O
Sentence: 214,",",O
Sentence: 214,but,O
Sentence: 214,not,O
Sentence: 214,the,O
Sentence: 214,healthy,O
Sentence: 214,subjects,O
Sentence: 214,",",O
Sentence: 214,these,O
Sentence: 214,symptoms,O
Sentence: 214,were,O
Sentence: 214,significantly,O
Sentence: 214,correlated,O
Sentence: 214,with,O
Sentence: 214,plasma,O
Sentence: 214,caffeine,B-Chemical
Sentence: 214,levels,O
Sentence: 214,.,O
Sentence: 214,Seventy,O
Sentence: 214,-,O
Sentence: 214,one,O
Sentence: 214,percent,O
Sentence: 214,of,O
Sentence: 214,the,O
Sentence: 214,patients,O
Sentence: 214,reported,O
Sentence: 214,that,O
Sentence: 214,the,O
Sentence: 214,behavioral,O
Sentence: 214,effects,O
Sentence: 214,of,O
Sentence: 214,caffeine,B-Chemical
Sentence: 214,were,O
Sentence: 214,similar,O
Sentence: 214,to,O
Sentence: 214,those,O
Sentence: 214,experienced,O
Sentence: 214,during,O
Sentence: 214,panic,B-Disease
Sentence: 214,attacks,I-Disease
Sentence: 214,.,O
Sentence: 214,Caffeine,B-Chemical
Sentence: 214,did,O
Sentence: 214,not,O
Sentence: 214,alter,O
Sentence: 214,plasma,O
Sentence: 214,MHPG,B-Chemical
Sentence: 214,levels,O
Sentence: 214,in,O
Sentence: 214,either,O
Sentence: 214,the,O
Sentence: 214,healthy,O
Sentence: 214,subjects,O
Sentence: 214,or,O
Sentence: 214,patients,O
Sentence: 214,.,O
Sentence: 214,Caffeine,B-Chemical
Sentence: 214,increased,O
Sentence: 214,plasma,O
Sentence: 214,cortisol,B-Chemical
Sentence: 214,levels,O
Sentence: 214,equally,O
Sentence: 214,in,O
Sentence: 214,the,O
Sentence: 214,patient,O
Sentence: 214,and,O
Sentence: 214,healthy,O
Sentence: 214,groups,O
Sentence: 214,.,O
Sentence: 214,Because,O
Sentence: 214,caffeine,B-Chemical
Sentence: 214,is,O
Sentence: 214,an,O
Sentence: 214,adenosine,B-Chemical
Sentence: 214,receptor,O
Sentence: 214,antagonist,O
Sentence: 214,",",O
Sentence: 214,these,O
Sentence: 214,results,O
Sentence: 214,suggest,O
Sentence: 214,that,O
Sentence: 214,some,O
Sentence: 214,panic,B-Disease
Sentence: 214,disorder,I-Disease
Sentence: 214,patients,O
Sentence: 214,may,O
Sentence: 214,have,O
Sentence: 214,abnormalities,B-Disease
Sentence: 214,in,I-Disease
Sentence: 214,neuronal,I-Disease
Sentence: 214,systems,I-Disease
Sentence: 214,involving,O
Sentence: 214,adenosine,B-Chemical
Sentence: 214,.,O
Sentence: 214,Patients,O
Sentence: 214,with,O
Sentence: 214,anxiety,B-Disease
Sentence: 214,disorders,I-Disease
Sentence: 214,may,O
Sentence: 214,benefit,O
Sentence: 214,by,O
Sentence: 214,avoiding,O
Sentence: 214,caffeine,B-Chemical
Sentence: 214,-,O
Sentence: 214,containing,O
Sentence: 214,foods,O
Sentence: 214,and,O
Sentence: 214,beverages,O
Sentence: 214,.,O
Sentence: 215,Human,O
Sentence: 215,and,O
Sentence: 215,canine,O
Sentence: 215,ventricular,O
Sentence: 215,vasoactive,O
Sentence: 215,intestinal,O
Sentence: 215,polypeptide,O
Sentence: 215,:,O
Sentence: 215,decrease,O
Sentence: 215,with,O
Sentence: 215,heart,O
Sentence: 215,failure,O
Sentence: 215,.,O
Sentence: 216,Vasoactive,O
Sentence: 216,intestinal,O
Sentence: 216,polypeptide,O
Sentence: 216,(,O
Sentence: 216,VIP,O
Sentence: 216,),O
Sentence: 216,is,O
Sentence: 216,a,O
Sentence: 216,systemic,O
Sentence: 216,and,O
Sentence: 216,coronary,O
Sentence: 216,vasodilator,O
Sentence: 216,that,O
Sentence: 216,may,O
Sentence: 216,have,O
Sentence: 216,positive,O
Sentence: 216,inotropic,O
Sentence: 216,properties,O
Sentence: 216,.,O
Sentence: 216,Myocardial,O
Sentence: 216,levels,O
Sentence: 216,of,O
Sentence: 216,VIP,O
Sentence: 216,were,O
Sentence: 216,assayed,O
Sentence: 216,before,O
Sentence: 216,and,O
Sentence: 216,after,O
Sentence: 216,the,O
Sentence: 216,development,O
Sentence: 216,of,O
Sentence: 216,heart,B-Disease
Sentence: 216,failure,I-Disease
Sentence: 216,in,O
Sentence: 216,two,O
Sentence: 216,canine,O
Sentence: 216,models,O
Sentence: 216,.,O
Sentence: 216,In,O
Sentence: 216,the,O
Sentence: 216,first,O
Sentence: 216,",",O
Sentence: 216,cobalt,B-Chemical
Sentence: 216,cardiomyopathy,B-Disease
Sentence: 216,was,O
Sentence: 216,induced,O
Sentence: 216,in,O
Sentence: 216,eight,O
Sentence: 216,dogs,O
Sentence: 216,;,O
Sentence: 216,VIP,O
Sentence: 216,(,O
Sentence: 216,by,O
Sentence: 216,radioimmunoassay,O
Sentence: 216,),O
Sentence: 216,decreased,O
Sentence: 216,from,O
Sentence: 216,35,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,11,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,(,O
Sentence: 216,mean,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,SD,O
Sentence: 216,),O
Sentence: 216,to,O
Sentence: 216,5,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,4,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,(,O
Sentence: 216,P,O
Sentence: 216,less,O
Sentence: 216,than,O
Sentence: 216,0.05,O
Sentence: 216,),O
Sentence: 216,.,O
Sentence: 216,In,O
Sentence: 216,six,O
Sentence: 216,dogs,O
Sentence: 216,with,O
Sentence: 216,doxorubicin,B-Chemical
Sentence: 216,-,O
Sentence: 216,induced,O
Sentence: 216,heart,B-Disease
Sentence: 216,failure,I-Disease
Sentence: 216,",",O
Sentence: 216,VIP,O
Sentence: 216,decreased,O
Sentence: 216,from,O
Sentence: 216,31,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,7,O
Sentence: 216,to,O
Sentence: 216,11,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,4,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,(,O
Sentence: 216,P,O
Sentence: 216,less,O
Sentence: 216,than,O
Sentence: 216,0.05,O
Sentence: 216,),O
Sentence: 216,.,O
Sentence: 216,In,O
Sentence: 216,addition,O
Sentence: 216,",",O
Sentence: 216,VIP,O
Sentence: 216,content,O
Sentence: 216,of,O
Sentence: 216,left,O
Sentence: 216,ventricular,O
Sentence: 216,muscle,O
Sentence: 216,of,O
Sentence: 216,resected,O
Sentence: 216,failing,O
Sentence: 216,hearts,O
Sentence: 216,in,O
Sentence: 216,10,O
Sentence: 216,patients,O
Sentence: 216,receiving,O
Sentence: 216,a,O
Sentence: 216,heart,O
Sentence: 216,transplant,O
Sentence: 216,was,O
Sentence: 216,compared,O
Sentence: 216,with,O
Sentence: 216,the,O
Sentence: 216,papillary,O
Sentence: 216,muscles,O
Sentence: 216,in,O
Sentence: 216,14,O
Sentence: 216,patients,O
Sentence: 216,(,O
Sentence: 216,five,O
Sentence: 216,with,O
Sentence: 216,rheumatic,B-Disease
Sentence: 216,disease,I-Disease
Sentence: 216,",",O
Sentence: 216,nine,O
Sentence: 216,with,O
Sentence: 216,myxomatous,B-Disease
Sentence: 216,degeneration,I-Disease
Sentence: 216,),O
Sentence: 216,receiving,O
Sentence: 216,mitral,O
Sentence: 216,valve,O
Sentence: 216,prostheses,O
Sentence: 216,.,O
Sentence: 216,The,O
Sentence: 216,lowest,O
Sentence: 216,myocardial,O
Sentence: 216,VIP,O
Sentence: 216,concentration,O
Sentence: 216,was,O
Sentence: 216,found,O
Sentence: 216,in,O
Sentence: 216,the,O
Sentence: 216,hearts,O
Sentence: 216,of,O
Sentence: 216,patients,O
Sentence: 216,with,O
Sentence: 216,coronary,B-Disease
Sentence: 216,disease,I-Disease
Sentence: 216,(,O
Sentence: 216,one,O
Sentence: 216,patient,O
Sentence: 216,receiving,O
Sentence: 216,a,O
Sentence: 216,transplant,O
Sentence: 216,and,O
Sentence: 216,three,O
Sentence: 216,receiving,O
Sentence: 216,mitral,O
Sentence: 216,prostheses,O
Sentence: 216,),O
Sentence: 216,(,O
Sentence: 216,6.3,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,1.9,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,),O
Sentence: 216,.,O
Sentence: 216,The,O
Sentence: 216,other,O
Sentence: 216,patients,O
Sentence: 216,undergoing,O
Sentence: 216,transplantation,O
Sentence: 216,had,O
Sentence: 216,an,O
Sentence: 216,average,O
Sentence: 216,ejection,O
Sentence: 216,fraction,O
Sentence: 216,of,O
Sentence: 216,17,O
Sentence: 216,%,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,6,O
Sentence: 216,%,O
Sentence: 216,and,O
Sentence: 216,a,O
Sentence: 216,VIP,O
Sentence: 216,level,O
Sentence: 216,of,O
Sentence: 216,8.8,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,3.9,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,.,O
Sentence: 216,The,O
Sentence: 216,hearts,O
Sentence: 216,without,O
Sentence: 216,coronary,B-Disease
Sentence: 216,artery,I-Disease
Sentence: 216,disease,I-Disease
Sentence: 216,(,O
Sentence: 216,average,O
Sentence: 216,ejection,O
Sentence: 216,fraction,O
Sentence: 216,of,O
Sentence: 216,this,O
Sentence: 216,group,O
Sentence: 216,62,O
Sentence: 216,%,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,10,O
Sentence: 216,%,O
Sentence: 216,),O
Sentence: 216,had,O
Sentence: 216,a,O
Sentence: 216,VIP,O
Sentence: 216,concentration,O
Sentence: 216,of,O
Sentence: 216,14.1,O
Sentence: 216,+,O
Sentence: 216,/,O
Sentence: 216,,O
Sentence: 216,-,O
Sentence: 216,,O
Sentence: 216,7.9,O
Sentence: 216,pg,O
Sentence: 216,/,O
Sentence: 216,mg,O
Sentence: 216,protein,O
Sentence: 216,",",O
Sentence: 216,and,O
Sentence: 216,this,O
Sentence: 216,was,O
Sentence: 216,greater,O
Sentence: 216,than,O
Sentence: 216,in,O
Sentence: 216,hearts,O
Sentence: 216,of,O
Sentence: 216,the,O
Sentence: 216,patients,O
Sentence: 216,with,O
Sentence: 216,coronary,B-Disease
Sentence: 216,disease,I-Disease
Sentence: 216,and,O
Sentence: 216,the,O
Sentence: 216,hearts,O
Sentence: 216,of,O
Sentence: 216,patients,O
Sentence: 216,receiving,O
Sentence: 216,a,O
Sentence: 216,transplant,O
Sentence: 216,(,O
Sentence: 216,P,O
Sentence: 216,less,O
Sentence: 216,than,O
Sentence: 216,0.05,O
Sentence: 216,),O
Sentence: 216,.,O
Sentence: 216,Myocardial,O
Sentence: 216,catecholamines,B-Chemical
Sentence: 216,were,O
Sentence: 216,also,O
Sentence: 216,determined,O
Sentence: 216,in,O
Sentence: 216,14,O
Sentence: 216,subjects,O
Sentence: 216,;,O
Sentence: 216,a,O
Sentence: 216,weak,O
Sentence: 216,correlation,O
Sentence: 216,(,O
Sentence: 216,r,O
Sentence: 216,,O
Sentence: 216,=,O
Sentence: 216,,O
Sentence: 216,0.57,O
Sentence: 216,",",O
Sentence: 216,P,O
Sentence: 216,less,O
Sentence: 216,than,O
Sentence: 216,0.05,O
Sentence: 216,),O
Sentence: 216,between,O
Sentence: 216,the,O
Sentence: 216,tissue,O
Sentence: 216,concentrations,O
Sentence: 216,of,O
Sentence: 216,VIP,O
Sentence: 216,and,O
Sentence: 216,norepinephrine,B-Chemical
Sentence: 216,was,O
Sentence: 216,noted,O
Sentence: 216,.,O
Sentence: 216,(,O
Sentence: 216,ABSTRACT,O
Sentence: 216,TRUNCATED,O
Sentence: 216,AT,O
Sentence: 216,250,O
Sentence: 216,WORDS,O
Sentence: 216,),O
Sentence: 217,Interstrain,O
Sentence: 217,variation,O
Sentence: 217,in,O
Sentence: 217,acute,O
Sentence: 217,toxic,O
Sentence: 217,response,O
Sentence: 217,to,O
Sentence: 217,caffeine,O
Sentence: 217,among,O
Sentence: 217,inbred,O
Sentence: 217,mice,O
Sentence: 217,.,O
Sentence: 218,Acute,O
Sentence: 218,toxic,O
Sentence: 218,dosage,O
Sentence: 218,-,O
Sentence: 218,dependent,O
Sentence: 218,behavioral,O
Sentence: 218,effects,O
Sentence: 218,of,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,were,O
Sentence: 218,compared,O
Sentence: 218,in,O
Sentence: 218,adult,O
Sentence: 218,males,O
Sentence: 218,from,O
Sentence: 218,seven,O
Sentence: 218,inbred,O
Sentence: 218,mouse,O
Sentence: 218,strains,O
Sentence: 218,(,O
Sentence: 218,A,O
Sentence: 218,/,O
Sentence: 218,J,O
Sentence: 218,",",O
Sentence: 218,BALB,O
Sentence: 218,/,O
Sentence: 218,cJ,O
Sentence: 218,",",O
Sentence: 218,CBA,O
Sentence: 218,/,O
Sentence: 218,J,O
Sentence: 218,",",O
Sentence: 218,C3H,O
Sentence: 218,/,O
Sentence: 218,HeJ,O
Sentence: 218,",",O
Sentence: 218,C57BL,O
Sentence: 218,/,O
Sentence: 218,6J,O
Sentence: 218,",",O
Sentence: 218,DBA,O
Sentence: 218,/,O
Sentence: 218,2J,O
Sentence: 218,",",O
Sentence: 218,SWR,O
Sentence: 218,/,O
Sentence: 218,J,O
Sentence: 218,),O
Sentence: 218,.,O
Sentence: 218,C57BL,O
Sentence: 218,/,O
Sentence: 218,6J,O
Sentence: 218,",",O
Sentence: 218,chosen,O
Sentence: 218,as,O
Sentence: 218,a,O
Sentence: 218,``,O
Sentence: 218,prototypic,O
Sentence: 218,'',O
Sentence: 218,mouse,O
Sentence: 218,strain,O
Sentence: 218,",",O
Sentence: 218,was,O
Sentence: 218,used,O
Sentence: 218,to,O
Sentence: 218,determine,O
Sentence: 218,behavioral,O
Sentence: 218,responses,O
Sentence: 218,to,O
Sentence: 218,a,O
Sentence: 218,broad,O
Sentence: 218,range,O
Sentence: 218,(,O
Sentence: 218,5,O
Sentence: 218,-,O
Sentence: 218,500,O
Sentence: 218,mg,O
Sentence: 218,/,O
Sentence: 218,kg,O
Sentence: 218,),O
Sentence: 218,of,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,doses,O
Sentence: 218,.,O
Sentence: 218,Five,O
Sentence: 218,phenotypic,O
Sentence: 218,characteristics,O
Sentence: 218,,O
Sentence: 218,-,O
Sentence: 218,,O
Sentence: 218,-,O
Sentence: 218,,O
Sentence: 218,locomotor,O
Sentence: 218,activity,O
Sentence: 218,",",O
Sentence: 218,righting,O
Sentence: 218,ability,O
Sentence: 218,",",O
Sentence: 218,clonic,B-Disease
Sentence: 218,seizure,I-Disease
Sentence: 218,induction,O
Sentence: 218,",",O
Sentence: 218,stress,O
Sentence: 218,-,O
Sentence: 218,induced,O
Sentence: 218,lethality,O
Sentence: 218,",",O
Sentence: 218,death,O
Sentence: 218,without,O
Sentence: 218,external,O
Sentence: 218,stress,O
Sentence: 218,,O
Sentence: 218,-,O
Sentence: 218,,O
Sentence: 218,-,O
Sentence: 218,,O
Sentence: 218,were,O
Sentence: 218,scored,O
Sentence: 218,at,O
Sentence: 218,various,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,doses,O
Sentence: 218,in,O
Sentence: 218,drug,O
Sentence: 218,-,O
Sentence: 218,naive,O
Sentence: 218,animals,O
Sentence: 218,under,O
Sentence: 218,empirically,O
Sentence: 218,optimized,O
Sentence: 218,",",O
Sentence: 218,rigidly,O
Sentence: 218,constant,O
Sentence: 218,experimental,O
Sentence: 218,conditions,O
Sentence: 218,.,O
Sentence: 218,Mice,O
Sentence: 218,(,O
Sentence: 218,n,O
Sentence: 218,,O
Sentence: 218,=,O
Sentence: 218,,O
Sentence: 218,12,O
Sentence: 218,for,O
Sentence: 218,each,O
Sentence: 218,point,O
Sentence: 218,),O
Sentence: 218,received,O
Sentence: 218,single,O
Sentence: 218,IP,O
Sentence: 218,injections,O
Sentence: 218,of,O
Sentence: 218,a,O
Sentence: 218,fixed,O
Sentence: 218,volume,O
Sentence: 218,/,O
Sentence: 218,g,O
Sentence: 218,body,O
Sentence: 218,weight,O
Sentence: 218,of,O
Sentence: 218,physiological,O
Sentence: 218,saline,O
Sentence: 218,carrier,O
Sentence: 218,with,O
Sentence: 218,or,O
Sentence: 218,without,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,in,O
Sentence: 218,doses,O
Sentence: 218,ranging,O
Sentence: 218,from,O
Sentence: 218,125,O
Sentence: 218,-,O
Sentence: 218,500,O
Sentence: 218,mg,O
Sentence: 218,/,O
Sentence: 218,kg,O
Sentence: 218,.,O
Sentence: 218,Loss,O
Sentence: 218,of,O
Sentence: 218,righting,O
Sentence: 218,ability,O
Sentence: 218,was,O
Sentence: 218,scored,O
Sentence: 218,at,O
Sentence: 218,1,O
Sentence: 218,",",O
Sentence: 218,3,O
Sentence: 218,",",O
Sentence: 218,5,O
Sentence: 218,min,O
Sentence: 218,post,O
Sentence: 218,dosing,O
Sentence: 218,and,O
Sentence: 218,at,O
Sentence: 218,5,O
Sentence: 218,min,O
Sentence: 218,intervals,O
Sentence: 218,thereafter,O
Sentence: 218,for,O
Sentence: 218,20,O
Sentence: 218,min,O
Sentence: 218,.,O
Sentence: 218,In,O
Sentence: 218,the,O
Sentence: 218,same,O
Sentence: 218,animals,O
Sentence: 218,the,O
Sentence: 218,occurrence,O
Sentence: 218,of,O
Sentence: 218,clonic,B-Disease
Sentence: 218,seizures,I-Disease
Sentence: 218,was,O
Sentence: 218,scored,O
Sentence: 218,as,O
Sentence: 218,to,O
Sentence: 218,time,O
Sentence: 218,of,O
Sentence: 218,onset,O
Sentence: 218,and,O
Sentence: 218,severity,O
Sentence: 218,for,O
Sentence: 218,20,O
Sentence: 218,min,O
Sentence: 218,after,O
Sentence: 218,drug,O
Sentence: 218,administration,O
Sentence: 218,.,O
Sentence: 218,When,O
Sentence: 218,these,O
Sentence: 218,proceeded,O
Sentence: 218,to,O
Sentence: 218,tonic,B-Disease
Sentence: 218,seizures,I-Disease
Sentence: 218,",",O
Sentence: 218,death,O
Sentence: 218,occurred,O
Sentence: 218,in,O
Sentence: 218,less,O
Sentence: 218,than,O
Sentence: 218,20,O
Sentence: 218,min,O
Sentence: 218,.,O
Sentence: 218,Animals,O
Sentence: 218,surviving,O
Sentence: 218,for,O
Sentence: 218,20,O
Sentence: 218,min,O
Sentence: 218,were,O
Sentence: 218,immediately,O
Sentence: 218,stressed,O
Sentence: 218,by,O
Sentence: 218,a,O
Sentence: 218,swim,O
Sentence: 218,test,O
Sentence: 218,in,O
Sentence: 218,25,O
Sentence: 218,degrees,O
Sentence: 218,C,O
Sentence: 218,water,O
Sentence: 218,",",O
Sentence: 218,and,O
Sentence: 218,death,O
Sentence: 218,-,O
Sentence: 218,producing,O
Sentence: 218,tonic,B-Disease
Sentence: 218,seizures,I-Disease
Sentence: 218,were,O
Sentence: 218,scored,O
Sentence: 218,for,O
Sentence: 218,2,O
Sentence: 218,min,O
Sentence: 218,.,O
Sentence: 218,In,O
Sentence: 218,other,O
Sentence: 218,animals,O
Sentence: 218,locomotor,O
Sentence: 218,activity,O
Sentence: 218,was,O
Sentence: 218,measured,O
Sentence: 218,15,O
Sentence: 218,or,O
Sentence: 218,60,O
Sentence: 218,min,O
Sentence: 218,after,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,administration,O
Sentence: 218,.,O
Sentence: 218,By,O
Sentence: 218,any,O
Sentence: 218,single,O
Sentence: 218,behavioral,O
Sentence: 218,criterion,O
Sentence: 218,or,O
Sentence: 218,a,O
Sentence: 218,combination,O
Sentence: 218,of,O
Sentence: 218,these,O
Sentence: 218,criteria,O
Sentence: 218,",",O
Sentence: 218,marked,O
Sentence: 218,differences,O
Sentence: 218,in,O
Sentence: 218,response,O
Sentence: 218,to,O
Sentence: 218,toxic,O
Sentence: 218,caffeine,B-Chemical
Sentence: 218,doses,O
Sentence: 218,were,O
Sentence: 218,observed,O
Sentence: 218,between,O
Sentence: 218,strains,O
Sentence: 218,.,O
Sentence: 218,These,O
Sentence: 218,results,O
Sentence: 218,indicate,O
Sentence: 218,that,O
Sentence: 218,behavioral,O
Sentence: 218,toxicity,B-Disease
Sentence: 218,testing,O
Sentence: 218,of,O
Sentence: 218,alkylxanthines,B-Chemical
Sentence: 218,in,O
Sentence: 218,a,O
Sentence: 218,single,O
Sentence: 218,mouse,O
Sentence: 218,strain,O
Sentence: 218,may,O
Sentence: 218,be,O
Sentence: 218,misleading,O
Sentence: 218,and,O
Sentence: 218,suggest,O
Sentence: 218,that,O
Sentence: 218,toxic,O
Sentence: 218,responses,O
Sentence: 218,of,O
Sentence: 218,the,O
Sentence: 218,central,O
Sentence: 218,nervous,O
Sentence: 218,system,O
Sentence: 218,to,O
Sentence: 218,this,O
Sentence: 218,class,O
Sentence: 218,of,O
Sentence: 218,compounds,O
Sentence: 218,are,O
Sentence: 218,genetically,O
Sentence: 218,influenced,O
Sentence: 218,in,O
Sentence: 218,mammals,O
Sentence: 218,.,O
Sentence: 219,Invasive,O
Sentence: 219,carcinoma,B-Disease
Sentence: 219,of,I-Disease
Sentence: 219,the,I-Disease
Sentence: 219,renal,I-Disease
Sentence: 219,pelvis,I-Disease
Sentence: 219,following,O
Sentence: 219,cyclophosphamide,B-Chemical
Sentence: 219,therapy,O
Sentence: 219,for,O
Sentence: 219,nonmalignant,O
Sentence: 219,disease,O
Sentence: 219,.,O
Sentence: 220,A,O
Sentence: 220,47,O
Sentence: 220,-,O
Sentence: 220,year,O
Sentence: 220,-,O
Sentence: 220,old,O
Sentence: 220,woman,O
Sentence: 220,with,O
Sentence: 220,right,O
Sentence: 220,hydroureteronephrosis,B-Disease
Sentence: 220,due,O
Sentence: 220,to,O
Sentence: 220,ureterovesical,O
Sentence: 220,junction,O
Sentence: 220,obstruction,O
Sentence: 220,had,O
Sentence: 220,gross,O
Sentence: 220,hematuria,B-Disease
Sentence: 220,after,O
Sentence: 220,being,O
Sentence: 220,treated,O
Sentence: 220,for,O
Sentence: 220,five,O
Sentence: 220,years,O
Sentence: 220,wtih,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,for,O
Sentence: 220,cerebral,B-Disease
Sentence: 220,vasculitis,I-Disease
Sentence: 220,.,O
Sentence: 220,A,O
Sentence: 220,right,O
Sentence: 220,nephroureterectomy,O
Sentence: 220,was,O
Sentence: 220,required,O
Sentence: 220,for,O
Sentence: 220,control,O
Sentence: 220,of,O
Sentence: 220,bleeding,B-Disease
Sentence: 220,.,O
Sentence: 220,The,O
Sentence: 220,pathology,O
Sentence: 220,specimen,O
Sentence: 220,contained,O
Sentence: 220,clinically,O
Sentence: 220,occult,O
Sentence: 220,invasive,O
Sentence: 220,carcinoma,B-Disease
Sentence: 220,of,I-Disease
Sentence: 220,the,I-Disease
Sentence: 220,renal,I-Disease
Sentence: 220,pelvis,I-Disease
Sentence: 220,.,O
Sentence: 220,Although,O
Sentence: 220,the,O
Sentence: 220,ability,O
Sentence: 220,of,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,to,O
Sentence: 220,cause,O
Sentence: 220,hemorrhagic,B-Disease
Sentence: 220,cystitis,B-Disease
Sentence: 220,and,O
Sentence: 220,urine,O
Sentence: 220,cytologic,O
Sentence: 220,abnormalities,O
Sentence: 220,indistinguishable,O
Sentence: 220,from,O
Sentence: 220,high,O
Sentence: 220,grade,O
Sentence: 220,carcinoma,B-Disease
Sentence: 220,is,O
Sentence: 220,well,O
Sentence: 220,known,O
Sentence: 220,",",O
Sentence: 220,it,O
Sentence: 220,is,O
Sentence: 220,less,O
Sentence: 220,widely,O
Sentence: 220,appreciated,O
Sentence: 220,that,O
Sentence: 220,it,O
Sentence: 220,is,O
Sentence: 220,also,O
Sentence: 220,associated,O
Sentence: 220,with,O
Sentence: 220,carcinoma,B-Disease
Sentence: 220,of,I-Disease
Sentence: 220,the,I-Disease
Sentence: 220,urinary,I-Disease
Sentence: 220,tract,I-Disease
Sentence: 220,.,O
Sentence: 220,Twenty,O
Sentence: 220,carcinomas,B-Disease
Sentence: 220,of,I-Disease
Sentence: 220,the,I-Disease
Sentence: 220,urinary,I-Disease
Sentence: 220,bladder,I-Disease
Sentence: 220,and,O
Sentence: 220,one,O
Sentence: 220,carcinoma,B-Disease
Sentence: 220,of,I-Disease
Sentence: 220,the,I-Disease
Sentence: 220,prostate,I-Disease
Sentence: 220,have,O
Sentence: 220,been,O
Sentence: 220,reported,O
Sentence: 220,in,O
Sentence: 220,association,O
Sentence: 220,with,O
Sentence: 220,its,O
Sentence: 220,use,O
Sentence: 220,.,O
Sentence: 220,The,O
Sentence: 220,present,O
Sentence: 220,case,O
Sentence: 220,is,O
Sentence: 220,the,O
Sentence: 220,first,O
Sentence: 220,carcinoma,B-Disease
Sentence: 220,of,I-Disease
Sentence: 220,the,I-Disease
Sentence: 220,renal,I-Disease
Sentence: 220,pelvis,I-Disease
Sentence: 220,reported,O
Sentence: 220,in,O
Sentence: 220,association,O
Sentence: 220,with,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,treatment,O
Sentence: 220,.,O
Sentence: 220,It,O
Sentence: 220,is,O
Sentence: 220,the,O
Sentence: 220,third,O
Sentence: 220,urinary,B-Disease
Sentence: 220,tract,I-Disease
Sentence: 220,cancer,I-Disease
Sentence: 220,reported,O
Sentence: 220,in,O
Sentence: 220,association,O
Sentence: 220,with,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,treatment,O
Sentence: 220,for,O
Sentence: 220,nonmalignant,O
Sentence: 220,disease,O
Sentence: 220,.,O
Sentence: 220,The,O
Sentence: 220,association,O
Sentence: 220,of,O
Sentence: 220,the,O
Sentence: 220,tumor,B-Disease
Sentence: 220,with,O
Sentence: 220,preexisting,O
Sentence: 220,hydroureteronephrosis,B-Disease
Sentence: 220,suggests,O
Sentence: 220,that,O
Sentence: 220,stasis,O
Sentence: 220,prolonged,O
Sentence: 220,and,O
Sentence: 220,intensified,O
Sentence: 220,exposure,O
Sentence: 220,of,O
Sentence: 220,upper,O
Sentence: 220,urinary,O
Sentence: 220,tract,O
Sentence: 220,epithelium,O
Sentence: 220,to,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,.,O
Sentence: 220,Patients,O
Sentence: 220,who,O
Sentence: 220,are,O
Sentence: 220,candidates,O
Sentence: 220,for,O
Sentence: 220,long,O
Sentence: 220,-,O
Sentence: 220,term,O
Sentence: 220,cyclophosphamide,B-Chemical
Sentence: 220,treatment,O
Sentence: 220,should,O
Sentence: 220,be,O
Sentence: 220,routinely,O
Sentence: 220,evaluated,O
Sentence: 220,for,O
Sentence: 220,obstructive,B-Disease
Sentence: 220,uropathy,I-Disease
Sentence: 220,.,O
Sentence: 221,Ascending,O
Sentence: 221,dose,O
Sentence: 221,tolerance,O
Sentence: 221,study,O
Sentence: 221,of,O
Sentence: 221,intramuscular,O
Sentence: 221,carbetocin,O
Sentence: 221,administered,O
Sentence: 221,after,O
Sentence: 221,normal,O
Sentence: 221,vaginal,O
Sentence: 221,birth,O
Sentence: 221,.,O
Sentence: 222,OBJECTIVE,O
Sentence: 222,:,O
Sentence: 222,To,O
Sentence: 222,determine,O
Sentence: 222,the,O
Sentence: 222,maximum,O
Sentence: 222,tolerated,O
Sentence: 222,dose,O
Sentence: 222,(,O
Sentence: 222,MTD,O
Sentence: 222,),O
Sentence: 222,of,O
Sentence: 222,carbetocin,B-Chemical
Sentence: 222,(,O
Sentence: 222,a,O
Sentence: 222,long,O
Sentence: 222,-,O
Sentence: 222,acting,O
Sentence: 222,synthetic,O
Sentence: 222,analogue,O
Sentence: 222,of,O
Sentence: 222,oxytocin,B-Chemical
Sentence: 222,),O
Sentence: 222,",",O
Sentence: 222,when,O
Sentence: 222,administered,O
Sentence: 222,immediately,O
Sentence: 222,after,O
Sentence: 222,vaginal,O
Sentence: 222,delivery,O
Sentence: 222,at,O
Sentence: 222,term,O
Sentence: 222,.,O
Sentence: 222,MATERIALS,O
Sentence: 222,AND,O
Sentence: 222,METHODS,O
Sentence: 222,:,O
Sentence: 222,Carbetocin,B-Chemical
Sentence: 222,was,O
Sentence: 222,given,O
Sentence: 222,as,O
Sentence: 222,an,O
Sentence: 222,intramuscular,O
Sentence: 222,injection,O
Sentence: 222,immediately,O
Sentence: 222,after,O
Sentence: 222,the,O
Sentence: 222,birth,O
Sentence: 222,of,O
Sentence: 222,the,O
Sentence: 222,infant,O
Sentence: 222,in,O
Sentence: 222,45,O
Sentence: 222,healthy,O
Sentence: 222,women,O
Sentence: 222,with,O
Sentence: 222,normal,O
Sentence: 222,singleton,O
Sentence: 222,pregnancies,O
Sentence: 222,who,O
Sentence: 222,delivered,O
Sentence: 222,vaginally,O
Sentence: 222,at,O
Sentence: 222,term,O
Sentence: 222,.,O
Sentence: 222,Dosage,O
Sentence: 222,groups,O
Sentence: 222,of,O
Sentence: 222,15,O
Sentence: 222,",",O
Sentence: 222,30,O
Sentence: 222,",",O
Sentence: 222,50,O
Sentence: 222,",",O
Sentence: 222,75,O
Sentence: 222,",",O
Sentence: 222,100,O
Sentence: 222,",",O
Sentence: 222,125,O
Sentence: 222,",",O
Sentence: 222,150,O
Sentence: 222,",",O
Sentence: 222,175,O
Sentence: 222,or,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,carbetocin,B-Chemical
Sentence: 222,were,O
Sentence: 222,assigned,O
Sentence: 222,to,O
Sentence: 222,blocks,O
Sentence: 222,of,O
Sentence: 222,three,O
Sentence: 222,women,O
Sentence: 222,according,O
Sentence: 222,to,O
Sentence: 222,the,O
Sentence: 222,continual,O
Sentence: 222,reassessment,O
Sentence: 222,method,O
Sentence: 222,(,O
Sentence: 222,CRM,O
Sentence: 222,),O
Sentence: 222,.,O
Sentence: 222,RESULTS,O
Sentence: 222,:,O
Sentence: 222,All,O
Sentence: 222,dosage,O
Sentence: 222,groups,O
Sentence: 222,consisted,O
Sentence: 222,of,O
Sentence: 222,three,O
Sentence: 222,women,O
Sentence: 222,",",O
Sentence: 222,except,O
Sentence: 222,those,O
Sentence: 222,with,O
Sentence: 222,100,O
Sentence: 222,microg,O
Sentence: 222,(,O
Sentence: 222,n,O
Sentence: 222,=,O
Sentence: 222,6,O
Sentence: 222,),O
Sentence: 222,and,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,(,O
Sentence: 222,n,O
Sentence: 222,=,O
Sentence: 222,18,O
Sentence: 222,),O
Sentence: 222,.,O
Sentence: 222,Recorded,O
Sentence: 222,were,O
Sentence: 222,dose,O
Sentence: 222,-,O
Sentence: 222,limiting,O
Sentence: 222,adverse,O
Sentence: 222,events,O
Sentence: 222,:,O
Sentence: 222,hyper,O
Sentence: 222,-,O
Sentence: 222,,O
Sentence: 222,or,O
Sentence: 222,hypotension,O
Sentence: 222,(,O
Sentence: 222,three,O
Sentence: 222,),O
Sentence: 222,",",O
Sentence: 222,severe,O
Sentence: 222,abdominal,B-Disease
Sentence: 222,pain,I-Disease
Sentence: 222,(,O
Sentence: 222,0,O
Sentence: 222,),O
Sentence: 222,",",O
Sentence: 222,vomiting,B-Disease
Sentence: 222,(,O
Sentence: 222,0,O
Sentence: 222,),O
Sentence: 222,and,O
Sentence: 222,retained,B-Disease
Sentence: 222,placenta,I-Disease
Sentence: 222,(,O
Sentence: 222,four,O
Sentence: 222,),O
Sentence: 222,.,O
Sentence: 222,Serious,O
Sentence: 222,adverse,O
Sentence: 222,events,O
Sentence: 222,occurred,O
Sentence: 222,in,O
Sentence: 222,seven,O
Sentence: 222,women,O
Sentence: 222,:,O
Sentence: 222,six,O
Sentence: 222,cases,O
Sentence: 222,with,O
Sentence: 222,blood,B-Disease
Sentence: 222,loss,I-Disease
Sentence: 222,,O
Sentence: 222,>,O
Sentence: 222,,O
Sentence: 222,or,O
Sentence: 222,,O
Sentence: 222,=,O
Sentence: 222,,O
Sentence: 222,1000,O
Sentence: 222,ml,O
Sentence: 222,",",O
Sentence: 222,four,O
Sentence: 222,cases,O
Sentence: 222,of,O
Sentence: 222,manual,O
Sentence: 222,placenta,O
Sentence: 222,removal,O
Sentence: 222,",",O
Sentence: 222,five,O
Sentence: 222,cases,O
Sentence: 222,of,O
Sentence: 222,additional,O
Sentence: 222,oxytocics,O
Sentence: 222,administration,O
Sentence: 222,and,O
Sentence: 222,five,O
Sentence: 222,cases,O
Sentence: 222,of,O
Sentence: 222,blood,O
Sentence: 222,transfusion,O
Sentence: 222,.,O
Sentence: 222,Maximum,O
Sentence: 222,blood,B-Disease
Sentence: 222,loss,I-Disease
Sentence: 222,was,O
Sentence: 222,greatest,O
Sentence: 222,at,O
Sentence: 222,the,O
Sentence: 222,upper,O
Sentence: 222,and,O
Sentence: 222,lower,O
Sentence: 222,dose,O
Sentence: 222,levels,O
Sentence: 222,",",O
Sentence: 222,and,O
Sentence: 222,lowest,O
Sentence: 222,in,O
Sentence: 222,the,O
Sentence: 222,70,O
Sentence: 222,-,O
Sentence: 222,125,O
Sentence: 222,microg,O
Sentence: 222,dose,O
Sentence: 222,range,O
Sentence: 222,.,O
Sentence: 222,Four,O
Sentence: 222,out,O
Sentence: 222,of,O
Sentence: 222,six,O
Sentence: 222,cases,O
Sentence: 222,with,O
Sentence: 222,blood,B-Disease
Sentence: 222,loss,I-Disease
Sentence: 222,,O
Sentence: 222,>,O
Sentence: 222,,O
Sentence: 222,or,O
Sentence: 222,,O
Sentence: 222,=,O
Sentence: 222,,O
Sentence: 222,1000,O
Sentence: 222,ml,O
Sentence: 222,occurred,O
Sentence: 222,in,O
Sentence: 222,the,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,group,O
Sentence: 222,.,O
Sentence: 222,The,O
Sentence: 222,majority,O
Sentence: 222,of,O
Sentence: 222,additional,O
Sentence: 222,administration,O
Sentence: 222,of,O
Sentence: 222,oxytocics,O
Sentence: 222,(,O
Sentence: 222,4,O
Sentence: 222,/,O
Sentence: 222,5,O
Sentence: 222,),O
Sentence: 222,and,O
Sentence: 222,blood,O
Sentence: 222,transfusion,O
Sentence: 222,(,O
Sentence: 222,3,O
Sentence: 222,/,O
Sentence: 222,5,O
Sentence: 222,),O
Sentence: 222,occurred,O
Sentence: 222,in,O
Sentence: 222,the,O
Sentence: 222,dose,O
Sentence: 222,groups,O
Sentence: 222,of,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,.,O
Sentence: 222,All,O
Sentence: 222,retained,O
Sentence: 222,placentae,O
Sentence: 222,were,O
Sentence: 222,found,O
Sentence: 222,in,O
Sentence: 222,the,O
Sentence: 222,group,O
Sentence: 222,of,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,.,O
Sentence: 222,CONCLUSION,O
Sentence: 222,:,O
Sentence: 222,The,O
Sentence: 222,MTD,O
Sentence: 222,was,O
Sentence: 222,calculated,O
Sentence: 222,to,O
Sentence: 222,be,O
Sentence: 222,at,O
Sentence: 222,200,O
Sentence: 222,microg,O
Sentence: 222,carbetocin,B-Chemical
Sentence: 222,.,O
Sentence: 223,A,O
Sentence: 223,pilot,O
Sentence: 223,study,O
Sentence: 223,to,O
Sentence: 223,assess,O
Sentence: 223,the,O
Sentence: 223,safety,O
Sentence: 223,of,O
Sentence: 223,dobutamine,B-Chemical
Sentence: 223,stress,O
Sentence: 223,echocardiography,O
Sentence: 223,in,O
Sentence: 223,the,O
Sentence: 223,emergency,O
Sentence: 223,department,O
Sentence: 223,evaluation,O
Sentence: 223,of,O
Sentence: 223,cocaine,B-Chemical
Sentence: 223,-,O
Sentence: 223,associated,O
Sentence: 223,chest,B-Disease
Sentence: 223,pain,I-Disease
Sentence: 223,.,O
Sentence: 224,STUDY,O
Sentence: 224,OBJECTIVE,O
Sentence: 224,:,O
Sentence: 224,Chest,B-Disease
Sentence: 224,pain,I-Disease
Sentence: 224,in,O
Sentence: 224,the,O
Sentence: 224,setting,O
Sentence: 224,of,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,use,O
Sentence: 224,poses,O
Sentence: 224,a,O
Sentence: 224,diagnostic,O
Sentence: 224,dilemma,O
Sentence: 224,.,O
Sentence: 224,Dobutamine,B-Chemical
Sentence: 224,stress,O
Sentence: 224,echocardiography,O
Sentence: 224,(,O
Sentence: 224,DSE,O
Sentence: 224,),O
Sentence: 224,is,O
Sentence: 224,a,O
Sentence: 224,widely,O
Sentence: 224,available,O
Sentence: 224,and,O
Sentence: 224,sensitive,O
Sentence: 224,test,O
Sentence: 224,for,O
Sentence: 224,evaluating,O
Sentence: 224,cardiac,O
Sentence: 224,ischemia,B-Disease
Sentence: 224,.,O
Sentence: 224,Because,O
Sentence: 224,of,O
Sentence: 224,the,O
Sentence: 224,theoretical,O
Sentence: 224,concern,O
Sentence: 224,regarding,O
Sentence: 224,administration,O
Sentence: 224,of,O
Sentence: 224,dobutamine,B-Chemical
Sentence: 224,in,O
Sentence: 224,the,O
Sentence: 224,setting,O
Sentence: 224,of,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,use,O
Sentence: 224,",",O
Sentence: 224,we,O
Sentence: 224,conducted,O
Sentence: 224,a,O
Sentence: 224,pilot,O
Sentence: 224,study,O
Sentence: 224,to,O
Sentence: 224,assess,O
Sentence: 224,the,O
Sentence: 224,safety,O
Sentence: 224,of,O
Sentence: 224,DSE,O
Sentence: 224,in,O
Sentence: 224,emergency,O
Sentence: 224,department,O
Sentence: 224,patients,O
Sentence: 224,with,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,-,O
Sentence: 224,associated,O
Sentence: 224,chest,B-Disease
Sentence: 224,pain,I-Disease
Sentence: 224,.,O
Sentence: 224,METHODS,O
Sentence: 224,:,O
Sentence: 224,A,O
Sentence: 224,prospective,O
Sentence: 224,case,O
Sentence: 224,series,O
Sentence: 224,was,O
Sentence: 224,conducted,O
Sentence: 224,in,O
Sentence: 224,the,O
Sentence: 224,intensive,O
Sentence: 224,diagnostic,O
Sentence: 224,and,O
Sentence: 224,treatment,O
Sentence: 224,unit,O
Sentence: 224,in,O
Sentence: 224,the,O
Sentence: 224,ED,O
Sentence: 224,of,O
Sentence: 224,an,O
Sentence: 224,urban,O
Sentence: 224,tertiary,O
Sentence: 224,-,O
Sentence: 224,care,O
Sentence: 224,teaching,O
Sentence: 224,hospital,O
Sentence: 224,.,O
Sentence: 224,Patients,O
Sentence: 224,were,O
Sentence: 224,eligible,O
Sentence: 224,for,O
Sentence: 224,DSE,O
Sentence: 224,if,O
Sentence: 224,they,O
Sentence: 224,had,O
Sentence: 224,used,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,within,O
Sentence: 224,24,O
Sentence: 224,hours,O
Sentence: 224,preceding,O
Sentence: 224,the,O
Sentence: 224,onset,O
Sentence: 224,of,O
Sentence: 224,chest,B-Disease
Sentence: 224,pain,I-Disease
Sentence: 224,and,O
Sentence: 224,had,O
Sentence: 224,a,O
Sentence: 224,normal,O
Sentence: 224,ECG,O
Sentence: 224,and,O
Sentence: 224,tropinin,O
Sentence: 224,I,O
Sentence: 224,level,O
Sentence: 224,.,O
Sentence: 224,Patients,O
Sentence: 224,exhibiting,O
Sentence: 224,signs,O
Sentence: 224,of,O
Sentence: 224,continuing,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,toxicity,B-Disease
Sentence: 224,were,O
Sentence: 224,excluded,O
Sentence: 224,from,O
Sentence: 224,the,O
Sentence: 224,study,O
Sentence: 224,.,O
Sentence: 224,All,O
Sentence: 224,patients,O
Sentence: 224,were,O
Sentence: 224,admitted,O
Sentence: 224,to,O
Sentence: 224,the,O
Sentence: 224,hospital,O
Sentence: 224,for,O
Sentence: 224,serial,O
Sentence: 224,testing,O
Sentence: 224,after,O
Sentence: 224,the,O
Sentence: 224,DSE,O
Sentence: 224,testing,O
Sentence: 224,in,O
Sentence: 224,the,O
Sentence: 224,intensive,O
Sentence: 224,diagnostic,O
Sentence: 224,and,O
Sentence: 224,treatment,O
Sentence: 224,unit,O
Sentence: 224,.,O
Sentence: 224,RESULTS,O
Sentence: 224,:,O
Sentence: 224,Twenty,O
Sentence: 224,-,O
Sentence: 224,four,O
Sentence: 224,patients,O
Sentence: 224,were,O
Sentence: 224,enrolled,O
Sentence: 224,.,O
Sentence: 224,Two,O
Sentence: 224,patients,O
Sentence: 224,had,O
Sentence: 224,inadequate,O
Sentence: 224,resting,O
Sentence: 224,images,O
Sentence: 224,",",O
Sentence: 224,one,O
Sentence: 224,DSE,O
Sentence: 224,was,O
Sentence: 224,terminated,O
Sentence: 224,because,O
Sentence: 224,of,O
Sentence: 224,inferior,O
Sentence: 224,hypokinesis,B-Disease
Sentence: 224,",",O
Sentence: 224,another,O
Sentence: 224,DSE,O
Sentence: 224,was,O
Sentence: 224,terminated,O
Sentence: 224,because,O
Sentence: 224,of,O
Sentence: 224,a,O
Sentence: 224,rate,O
Sentence: 224,-,O
Sentence: 224,related,O
Sentence: 224,atrial,O
Sentence: 224,conduction,O
Sentence: 224,deficit,O
Sentence: 224,",",O
Sentence: 224,and,O
Sentence: 224,1,O
Sentence: 224,patient,O
Sentence: 224,did,O
Sentence: 224,not,O
Sentence: 224,reach,O
Sentence: 224,the,O
Sentence: 224,target,O
Sentence: 224,heart,O
Sentence: 224,rate,O
Sentence: 224,.,O
Sentence: 224,Thus,O
Sentence: 224,",",O
Sentence: 224,19,O
Sentence: 224,patients,O
Sentence: 224,completed,O
Sentence: 224,a,O
Sentence: 224,DSE,O
Sentence: 224,and,O
Sentence: 224,reached,O
Sentence: 224,their,O
Sentence: 224,target,O
Sentence: 224,heart,O
Sentence: 224,rates,O
Sentence: 224,.,O
Sentence: 224,None,O
Sentence: 224,of,O
Sentence: 224,the,O
Sentence: 224,patients,O
Sentence: 224,experienced,O
Sentence: 224,signs,O
Sentence: 224,of,O
Sentence: 224,exaggerated,O
Sentence: 224,adrenergic,O
Sentence: 224,response,O
Sentence: 224,",",O
Sentence: 224,which,O
Sentence: 224,was,O
Sentence: 224,defined,O
Sentence: 224,as,O
Sentence: 224,a,O
Sentence: 224,systolic,O
Sentence: 224,blood,O
Sentence: 224,pressure,O
Sentence: 224,of,O
Sentence: 224,greater,O
Sentence: 224,than,O
Sentence: 224,200,O
Sentence: 224,mm,O
Sentence: 224,Hg,O
Sentence: 224,or,O
Sentence: 224,the,O
Sentence: 224,occurrence,O
Sentence: 224,of,O
Sentence: 224,tachydysrhythmias,B-Disease
Sentence: 224,(,O
Sentence: 224,excluding,O
Sentence: 224,sinus,B-Disease
Sentence: 224,tachycardia,I-Disease
Sentence: 224,),O
Sentence: 224,.,O
Sentence: 224,Further,O
Sentence: 224,suggesting,O
Sentence: 224,lack,O
Sentence: 224,of,O
Sentence: 224,exaggerated,O
Sentence: 224,adrenergic,O
Sentence: 224,response,O
Sentence: 224,",",O
Sentence: 224,13,O
Sentence: 224,(,O
Sentence: 224,65,O
Sentence: 224,%,O
Sentence: 224,),O
Sentence: 224,of,O
Sentence: 224,20,O
Sentence: 224,patients,O
Sentence: 224,required,O
Sentence: 224,supplemental,O
Sentence: 224,atropine,B-Chemical
Sentence: 224,to,O
Sentence: 224,reach,O
Sentence: 224,their,O
Sentence: 224,target,O
Sentence: 224,heart,O
Sentence: 224,rates,O
Sentence: 224,.,O
Sentence: 224,CONCLUSION,O
Sentence: 224,:,O
Sentence: 224,No,O
Sentence: 224,exaggerated,O
Sentence: 224,adrenergic,O
Sentence: 224,response,O
Sentence: 224,was,O
Sentence: 224,detected,O
Sentence: 224,when,O
Sentence: 224,dobutamine,B-Chemical
Sentence: 224,was,O
Sentence: 224,administered,O
Sentence: 224,to,O
Sentence: 224,patients,O
Sentence: 224,with,O
Sentence: 224,cocaine,B-Chemical
Sentence: 224,-,O
Sentence: 224,related,O
Sentence: 224,chest,B-Disease
Sentence: 224,pain,I-Disease
Sentence: 224,.,O
Sentence: 225,Amiodarone,B-Chemical
Sentence: 225,-,O
Sentence: 225,induced,O
Sentence: 225,torsade,B-Disease
Sentence: 225,de,I-Disease
Sentence: 225,pointes,I-Disease
Sentence: 225,during,O
Sentence: 225,bladder,O
Sentence: 225,irrigation,O
Sentence: 225,:,O
Sentence: 225,an,O
Sentence: 225,unusual,O
Sentence: 225,presentation,O
Sentence: 225,,O
Sentence: 225,-,O
Sentence: 225,,O
Sentence: 225,-,O
Sentence: 225,,O
Sentence: 225,a,O
Sentence: 225,case,O
Sentence: 225,report,O
Sentence: 225,.,O
Sentence: 226,The,O
Sentence: 226,authors,O
Sentence: 226,present,O
Sentence: 226,a,O
Sentence: 226,case,O
Sentence: 226,of,O
Sentence: 226,early,O
Sentence: 226,(,O
Sentence: 226,within,O
Sentence: 226,4,O
Sentence: 226,days,O
Sentence: 226,),O
Sentence: 226,development,O
Sentence: 226,of,O
Sentence: 226,torsade,B-Disease
Sentence: 226,de,I-Disease
Sentence: 226,pointes,I-Disease
Sentence: 226,(,O
Sentence: 226,TdP,B-Disease
Sentence: 226,),O
Sentence: 226,associated,O
Sentence: 226,with,O
Sentence: 226,oral,O
Sentence: 226,amiodarone,B-Chemical
Sentence: 226,therapy,O
Sentence: 226,.,O
Sentence: 226,Consistent,O
Sentence: 226,with,O
Sentence: 226,other,O
Sentence: 226,reports,O
Sentence: 226,this,O
Sentence: 226,case,O
Sentence: 226,of,O
Sentence: 226,TdP,B-Disease
Sentence: 226,occurred,O
Sentence: 226,in,O
Sentence: 226,the,O
Sentence: 226,context,O
Sentence: 226,of,O
Sentence: 226,multiple,O
Sentence: 226,exacerbating,O
Sentence: 226,factors,O
Sentence: 226,including,O
Sentence: 226,hypokalemia,B-Disease
Sentence: 226,and,O
Sentence: 226,digoxin,B-Chemical
Sentence: 226,excess,O
Sentence: 226,.,O
Sentence: 226,Transient,O
Sentence: 226,prolongation,O
Sentence: 226,of,O
Sentence: 226,the,O
Sentence: 226,QT,O
Sentence: 226,during,O
Sentence: 226,bladder,O
Sentence: 226,irrigation,O
Sentence: 226,prompted,O
Sentence: 226,the,O
Sentence: 226,episode,O
Sentence: 226,of,O
Sentence: 226,TdP,B-Disease
Sentence: 226,.,O
Sentence: 226,It,O
Sentence: 226,is,O
Sentence: 226,well,O
Sentence: 226,known,O
Sentence: 226,that,O
Sentence: 226,bradycardia,B-Disease
Sentence: 226,exacerbates,O
Sentence: 226,acquired,O
Sentence: 226,TdP,B-Disease
Sentence: 226,.,O
Sentence: 226,The,O
Sentence: 226,authors,O
Sentence: 226,speculate,O
Sentence: 226,that,O
Sentence: 226,the,O
Sentence: 226,increased,O
Sentence: 226,vagal,O
Sentence: 226,tone,O
Sentence: 226,during,O
Sentence: 226,bladder,O
Sentence: 226,irrigation,O
Sentence: 226,",",O
Sentence: 226,a,O
Sentence: 226,vagal,O
Sentence: 226,maneuver,O
Sentence: 226,",",O
Sentence: 226,in,O
Sentence: 226,the,O
Sentence: 226,context,O
Sentence: 226,of,O
Sentence: 226,amiodarone,B-Chemical
Sentence: 226,therapy,O
Sentence: 226,resulted,O
Sentence: 226,in,O
Sentence: 226,amiodarone,B-Chemical
Sentence: 226,-,O
Sentence: 226,induced,O
Sentence: 226,proarrhythmia,B-Disease
Sentence: 226,.,O
Sentence: 226,In,O
Sentence: 226,the,O
Sentence: 226,absence,O
Sentence: 226,of,O
Sentence: 226,amiodarone,B-Chemical
Sentence: 226,therapy,O
Sentence: 226,",",O
Sentence: 226,a,O
Sentence: 226,second,O
Sentence: 226,bladder,O
Sentence: 226,irrigation,O
Sentence: 226,did,O
Sentence: 226,not,O
Sentence: 226,induce,O
Sentence: 226,TdP,B-Disease
Sentence: 226,despite,O
Sentence: 226,hypokalemia,B-Disease
Sentence: 226,and,O
Sentence: 226,hypomagnesemia,B-Disease
Sentence: 226,.,O
Sentence: 227,Acute,B-Disease
Sentence: 227,renal,I-Disease
Sentence: 227,insufficiency,I-Disease
Sentence: 227,after,O
Sentence: 227,high,O
Sentence: 227,-,O
Sentence: 227,dose,O
Sentence: 227,melphalan,B-Chemical
Sentence: 227,in,O
Sentence: 227,patients,O
Sentence: 227,with,O
Sentence: 227,primary,B-Disease
Sentence: 227,systemic,I-Disease
Sentence: 227,amyloidosis,I-Disease
Sentence: 227,during,O
Sentence: 227,stem,O
Sentence: 227,cell,O
Sentence: 227,transplantation,O
Sentence: 227,.,O
Sentence: 228,BACKGROUND,O
Sentence: 228,:,O
Sentence: 228,Patients,O
Sentence: 228,with,O
Sentence: 228,primary,B-Disease
Sentence: 228,systemic,I-Disease
Sentence: 228,amyloidosis,I-Disease
Sentence: 228,(,O
Sentence: 228,AL,B-Disease
Sentence: 228,),O
Sentence: 228,have,O
Sentence: 228,a,O
Sentence: 228,poor,O
Sentence: 228,prognosis,O
Sentence: 228,.,O
Sentence: 228,Median,O
Sentence: 228,survival,O
Sentence: 228,time,O
Sentence: 228,from,O
Sentence: 228,standard,O
Sentence: 228,treatments,O
Sentence: 228,is,O
Sentence: 228,only,O
Sentence: 228,17,O
Sentence: 228,months,O
Sentence: 228,.,O
Sentence: 228,High,O
Sentence: 228,-,O
Sentence: 228,dose,O
Sentence: 228,intravenous,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,followed,O
Sentence: 228,by,O
Sentence: 228,peripheral,O
Sentence: 228,blood,O
Sentence: 228,stem,O
Sentence: 228,cell,O
Sentence: 228,transplant,O
Sentence: 228,(,O
Sentence: 228,PBSCT,O
Sentence: 228,),O
Sentence: 228,appears,O
Sentence: 228,to,O
Sentence: 228,be,O
Sentence: 228,the,O
Sentence: 228,most,O
Sentence: 228,promising,O
Sentence: 228,therapy,O
Sentence: 228,",",O
Sentence: 228,but,O
Sentence: 228,treatment,O
Sentence: 228,mortality,O
Sentence: 228,can,O
Sentence: 228,be,O
Sentence: 228,high,O
Sentence: 228,.,O
Sentence: 228,The,O
Sentence: 228,authors,O
Sentence: 228,have,O
Sentence: 228,noted,O
Sentence: 228,the,O
Sentence: 228,development,O
Sentence: 228,of,O
Sentence: 228,acute,B-Disease
Sentence: 228,renal,I-Disease
Sentence: 228,insufficiency,I-Disease
Sentence: 228,immediately,O
Sentence: 228,after,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,conditioning,O
Sentence: 228,.,O
Sentence: 228,This,O
Sentence: 228,study,O
Sentence: 228,was,O
Sentence: 228,undertaken,O
Sentence: 228,to,O
Sentence: 228,further,O
Sentence: 228,examine,O
Sentence: 228,its,O
Sentence: 228,risk,O
Sentence: 228,factors,O
Sentence: 228,and,O
Sentence: 228,impact,O
Sentence: 228,on,O
Sentence: 228,posttransplant,O
Sentence: 228,mortality,O
Sentence: 228,.,O
Sentence: 228,METHODS,O
Sentence: 228,:,O
Sentence: 228,Consecutive,O
Sentence: 228,AL,B-Disease
Sentence: 228,patients,O
Sentence: 228,who,O
Sentence: 228,underwent,O
Sentence: 228,PBSCT,O
Sentence: 228,were,O
Sentence: 228,studied,O
Sentence: 228,retrospectively,O
Sentence: 228,.,O
Sentence: 228,Acute,B-Disease
Sentence: 228,renal,I-Disease
Sentence: 228,insufficiency,I-Disease
Sentence: 228,(,O
Sentence: 228,ARI,B-Disease
Sentence: 228,),O
Sentence: 228,after,O
Sentence: 228,high,O
Sentence: 228,-,O
Sentence: 228,dose,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,was,O
Sentence: 228,defined,O
Sentence: 228,by,O
Sentence: 228,a,O
Sentence: 228,minimum,O
Sentence: 228,increase,O
Sentence: 228,of,O
Sentence: 228,0.5,O
Sentence: 228,mg,O
Sentence: 228,/,O
Sentence: 228,dL,O
Sentence: 228,(,O
Sentence: 228,44,O
Sentence: 228,micromol,O
Sentence: 228,/,O
Sentence: 228,L,O
Sentence: 228,),O
Sentence: 228,in,O
Sentence: 228,the,O
Sentence: 228,serum,O
Sentence: 228,creatinine,B-Chemical
Sentence: 228,level,O
Sentence: 228,that,O
Sentence: 228,is,O
Sentence: 228,greater,O
Sentence: 228,than,O
Sentence: 228,50,O
Sentence: 228,%,O
Sentence: 228,of,O
Sentence: 228,baseline,O
Sentence: 228,immediately,O
Sentence: 228,after,O
Sentence: 228,conditioning,O
Sentence: 228,.,O
Sentence: 228,Urine,O
Sentence: 228,sediment,O
Sentence: 228,score,O
Sentence: 228,was,O
Sentence: 228,the,O
Sentence: 228,sum,O
Sentence: 228,of,O
Sentence: 228,the,O
Sentence: 228,individual,O
Sentence: 228,types,O
Sentence: 228,of,O
Sentence: 228,sediment,O
Sentence: 228,identified,O
Sentence: 228,on,O
Sentence: 228,urine,O
Sentence: 228,microscopy,O
Sentence: 228,.,O
Sentence: 228,RESULTS,O
Sentence: 228,:,O
Sentence: 228,Of,O
Sentence: 228,the,O
Sentence: 228,80,O
Sentence: 228,patients,O
Sentence: 228,studied,O
Sentence: 228,",",O
Sentence: 228,ARI,B-Disease
Sentence: 228,developed,O
Sentence: 228,in,O
Sentence: 228,18.8,O
Sentence: 228,%,O
Sentence: 228,of,O
Sentence: 228,the,O
Sentence: 228,patients,O
Sentence: 228,after,O
Sentence: 228,high,O
Sentence: 228,-,O
Sentence: 228,dose,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,.,O
Sentence: 228,Univariate,O
Sentence: 228,analysis,O
Sentence: 228,identified,O
Sentence: 228,age,O
Sentence: 228,",",O
Sentence: 228,hypoalbuminemia,B-Disease
Sentence: 228,",",O
Sentence: 228,heavy,O
Sentence: 228,proteinuria,B-Disease
Sentence: 228,",",O
Sentence: 228,diuretic,O
Sentence: 228,use,O
Sentence: 228,",",O
Sentence: 228,and,O
Sentence: 228,urine,O
Sentence: 228,sediment,O
Sentence: 228,score,O
Sentence: 228,(,O
Sentence: 228,,O
Sentence: 228,>,O
Sentence: 228,,O
Sentence: 228,3,O
Sentence: 228,),O
Sentence: 228,as,O
Sentence: 228,risk,O
Sentence: 228,factors,O
Sentence: 228,.,O
Sentence: 228,Age,O
Sentence: 228,and,O
Sentence: 228,urine,O
Sentence: 228,sediment,O
Sentence: 228,score,O
Sentence: 228,remained,O
Sentence: 228,independently,O
Sentence: 228,significant,O
Sentence: 228,risk,O
Sentence: 228,factors,O
Sentence: 228,in,O
Sentence: 228,the,O
Sentence: 228,multivariate,O
Sentence: 228,analysis,O
Sentence: 228,.,O
Sentence: 228,Patients,O
Sentence: 228,who,O
Sentence: 228,had,O
Sentence: 228,ARI,B-Disease
Sentence: 228,after,O
Sentence: 228,high,O
Sentence: 228,-,O
Sentence: 228,dose,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,underwent,O
Sentence: 228,dialysis,O
Sentence: 228,more,O
Sentence: 228,often,O
Sentence: 228,(,O
Sentence: 228,P,O
Sentence: 228,,O
Sentence: 228,=,O
Sentence: 228,,O
Sentence: 228,0.007,O
Sentence: 228,),O
Sentence: 228,",",O
Sentence: 228,and,O
Sentence: 228,had,O
Sentence: 228,a,O
Sentence: 228,worse,O
Sentence: 228,1,O
Sentence: 228,-,O
Sentence: 228,year,O
Sentence: 228,survival,O
Sentence: 228,(,O
Sentence: 228,P,O
Sentence: 228,,O
Sentence: 228,=,O
Sentence: 228,,O
Sentence: 228,0.03,O
Sentence: 228,),O
Sentence: 228,.,O
Sentence: 228,CONCLUSION,O
Sentence: 228,:,O
Sentence: 228,The,O
Sentence: 228,timing,O
Sentence: 228,of,O
Sentence: 228,renal,B-Disease
Sentence: 228,injury,I-Disease
Sentence: 228,strongly,O
Sentence: 228,suggests,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,as,O
Sentence: 228,the,O
Sentence: 228,causative,O
Sentence: 228,agent,O
Sentence: 228,.,O
Sentence: 228,Ongoing,O
Sentence: 228,tubular,B-Disease
Sentence: 228,injury,I-Disease
Sentence: 228,may,O
Sentence: 228,be,O
Sentence: 228,a,O
Sentence: 228,prerequisite,O
Sentence: 228,for,O
Sentence: 228,renal,B-Disease
Sentence: 228,injury,I-Disease
Sentence: 228,by,O
Sentence: 228,melphalan,B-Chemical
Sentence: 228,as,O
Sentence: 228,evidenced,O
Sentence: 228,by,O
Sentence: 228,the,O
Sentence: 228,active,O
Sentence: 228,urinary,O
Sentence: 228,sediment,O
Sentence: 228,.,O
Sentence: 228,Development,O
Sentence: 228,of,O
Sentence: 228,ARI,B-Disease
Sentence: 228,adversely,O
Sentence: 228,affected,O
Sentence: 228,the,O
Sentence: 228,outcome,O
Sentence: 228,after,O
Sentence: 228,PBSCT,O
Sentence: 228,.,O
Sentence: 228,Effective,O
Sentence: 228,preventive,O
Sentence: 228,measures,O
Sentence: 228,may,O
Sentence: 228,help,O
Sentence: 228,decrease,O
Sentence: 228,the,O
Sentence: 228,treatment,O
Sentence: 228,mortality,O
Sentence: 228,of,O
Sentence: 228,PBSCT,O
Sentence: 228,in,O
Sentence: 228,AL,B-Disease
Sentence: 228,patients,O
Sentence: 228,.,O
Sentence: 229,Impaired,B-Disease
Sentence: 229,fear,I-Disease
Sentence: 229,recognition,I-Disease
Sentence: 229,in,O
Sentence: 229,regular,O
Sentence: 229,recreational,O
Sentence: 229,cocaine,B-Chemical
Sentence: 229,users,O
Sentence: 229,.,O
Sentence: 230,INTRODUCTION,O
Sentence: 230,:,O
Sentence: 230,The,O
Sentence: 230,ability,O
Sentence: 230,to,O
Sentence: 230,read,O
Sentence: 230,facial,O
Sentence: 230,expressions,O
Sentence: 230,is,O
Sentence: 230,essential,O
Sentence: 230,for,O
Sentence: 230,normal,O
Sentence: 230,human,O
Sentence: 230,social,O
Sentence: 230,interaction,O
Sentence: 230,.,O
Sentence: 230,The,O
Sentence: 230,aim,O
Sentence: 230,of,O
Sentence: 230,the,O
Sentence: 230,present,O
Sentence: 230,study,O
Sentence: 230,was,O
Sentence: 230,to,O
Sentence: 230,conduct,O
Sentence: 230,the,O
Sentence: 230,first,O
Sentence: 230,investigation,O
Sentence: 230,of,O
Sentence: 230,facial,O
Sentence: 230,expression,O
Sentence: 230,recognition,O
Sentence: 230,performance,O
Sentence: 230,in,O
Sentence: 230,recreational,O
Sentence: 230,cocaine,B-Chemical
Sentence: 230,users,O
Sentence: 230,.,O
Sentence: 230,MATERIALS,O
Sentence: 230,AND,O
Sentence: 230,METHODS,O
Sentence: 230,:,O
Sentence: 230,Three,O
Sentence: 230,groups,O
Sentence: 230,",",O
Sentence: 230,comprised,O
Sentence: 230,of,O
Sentence: 230,21,O
Sentence: 230,cocaine,B-Chemical
Sentence: 230,naive,O
Sentence: 230,participants,O
Sentence: 230,(,O
Sentence: 230,CN,O
Sentence: 230,),O
Sentence: 230,",",O
Sentence: 230,30,O
Sentence: 230,occasional,O
Sentence: 230,cocaine,B-Chemical
Sentence: 230,(,O
Sentence: 230,OC,O
Sentence: 230,),O
Sentence: 230,",",O
Sentence: 230,and,O
Sentence: 230,48,O
Sentence: 230,regular,O
Sentence: 230,recreational,O
Sentence: 230,cocaine,B-Chemical
Sentence: 230,(,O
Sentence: 230,RC,O
Sentence: 230,),O
Sentence: 230,users,O
Sentence: 230,",",O
Sentence: 230,were,O
Sentence: 230,compared,O
Sentence: 230,.,O
Sentence: 230,An,O
Sentence: 230,emotional,O
Sentence: 230,facial,O
Sentence: 230,expression,O
Sentence: 230,(,O
Sentence: 230,EFE,O
Sentence: 230,),O
Sentence: 230,task,O
Sentence: 230,consisting,O
Sentence: 230,of,O
Sentence: 230,a,O
Sentence: 230,male,O
Sentence: 230,and,O
Sentence: 230,female,O
Sentence: 230,face,O
Sentence: 230,expressing,O
Sentence: 230,six,O
Sentence: 230,basic,O
Sentence: 230,emotions,O
Sentence: 230,(,O
Sentence: 230,happiness,O
Sentence: 230,",",O
Sentence: 230,surprise,O
Sentence: 230,",",O
Sentence: 230,sadness,O
Sentence: 230,",",O
Sentence: 230,anger,O
Sentence: 230,",",O
Sentence: 230,fear,O
Sentence: 230,",",O
Sentence: 230,and,O
Sentence: 230,disgust,O
Sentence: 230,),O
Sentence: 230,was,O
Sentence: 230,administered,O
Sentence: 230,.,O
Sentence: 230,Mean,O
Sentence: 230,percent,O
Sentence: 230,accuracy,O
Sentence: 230,and,O
Sentence: 230,latencies,O
Sentence: 230,for,O
Sentence: 230,correct,O
Sentence: 230,responses,O
Sentence: 230,across,O
Sentence: 230,eight,O
Sentence: 230,presentations,O
Sentence: 230,of,O
Sentence: 230,each,O
Sentence: 230,basic,O
Sentence: 230,emotion,O
Sentence: 230,were,O
Sentence: 230,derived,O
Sentence: 230,.,O
Sentence: 230,Participants,O
Sentence: 230,were,O
Sentence: 230,also,O
Sentence: 230,assessed,O
Sentence: 230,with,O
Sentence: 230,the,O
Sentence: 230,``,O
Sentence: 230,Eyes,O
Sentence: 230,task,O
Sentence: 230,'',O
Sentence: 230,to,O
Sentence: 230,investigate,O
Sentence: 230,their,O
Sentence: 230,ability,O
Sentence: 230,to,O
Sentence: 230,recognize,O
Sentence: 230,more,O
Sentence: 230,complex,O
Sentence: 230,emotional,O
Sentence: 230,states,O
Sentence: 230,and,O
Sentence: 230,the,O
Sentence: 230,Symptom,O
Sentence: 230,CheckList,O
Sentence: 230,-,O
Sentence: 230,90,O
Sentence: 230,-,O
Sentence: 230,Revised,O
Sentence: 230,to,O
Sentence: 230,measure,O
Sentence: 230,psychopathology,O
Sentence: 230,.,O
Sentence: 230,RESULTS,O
Sentence: 230,:,O
Sentence: 230,There,O
Sentence: 230,were,O
Sentence: 230,no,O
Sentence: 230,group,O
Sentence: 230,differences,O
Sentence: 230,in,O
Sentence: 230,psychopathology,O
Sentence: 230,or,O
Sentence: 230,``,O
Sentence: 230,eyes,O
Sentence: 230,task,O
Sentence: 230,'',O
Sentence: 230,performance,O
Sentence: 230,",",O
Sentence: 230,but,O
Sentence: 230,the,O
Sentence: 230,RC,O
Sentence: 230,group,O
Sentence: 230,",",O
Sentence: 230,who,O
Sentence: 230,otherwise,O
Sentence: 230,had,O
Sentence: 230,similar,O
Sentence: 230,illicit,O
Sentence: 230,substance,O
Sentence: 230,use,O
Sentence: 230,histories,O
Sentence: 230,to,O
Sentence: 230,the,O
Sentence: 230,OC,O
Sentence: 230,group,O
Sentence: 230,",",O
Sentence: 230,exhibited,O
Sentence: 230,impaired,B-Disease
Sentence: 230,fear,I-Disease
Sentence: 230,recognition,I-Disease
Sentence: 230,accuracy,O
Sentence: 230,compared,O
Sentence: 230,to,O
Sentence: 230,the,O
Sentence: 230,OC,O
Sentence: 230,and,O
Sentence: 230,CN,O
Sentence: 230,groups,O
Sentence: 230,.,O
Sentence: 230,The,O
Sentence: 230,RC,O
Sentence: 230,group,O
Sentence: 230,also,O
Sentence: 230,correctly,O
Sentence: 230,identified,O
Sentence: 230,anger,O
Sentence: 230,",",O
Sentence: 230,fear,O
Sentence: 230,",",O
Sentence: 230,happiness,O
Sentence: 230,",",O
Sentence: 230,and,O
Sentence: 230,surprise,O
Sentence: 230,",",O
Sentence: 230,more,O
Sentence: 230,slowly,O
Sentence: 230,than,O
Sentence: 230,CN,O
Sentence: 230,",",O
Sentence: 230,but,O
Sentence: 230,not,O
Sentence: 230,OC,O
Sentence: 230,participants,O
Sentence: 230,.,O
Sentence: 230,The,O
Sentence: 230,OC,O
Sentence: 230,group,O
Sentence: 230,was,O
Sentence: 230,slower,O
Sentence: 230,than,O
Sentence: 230,CN,O
Sentence: 230,when,O
Sentence: 230,correctly,O
Sentence: 230,identifying,O
Sentence: 230,disgust,O
Sentence: 230,.,O
Sentence: 230,The,O
Sentence: 230,selective,O
Sentence: 230,deficit,B-Disease
Sentence: 230,in,I-Disease
Sentence: 230,fear,I-Disease
Sentence: 230,recognition,I-Disease
Sentence: 230,accuracy,O
Sentence: 230,manifested,O
Sentence: 230,by,O
Sentence: 230,the,O
Sentence: 230,RC,O
Sentence: 230,group,O
Sentence: 230,can,O
Sentence: 230,not,O
Sentence: 230,be,O
Sentence: 230,explained,O
Sentence: 230,by,O
Sentence: 230,the,O
Sentence: 230,subacute,O
Sentence: 230,effects,O
Sentence: 230,of,O
Sentence: 230,cocaine,B-Chemical
Sentence: 230,",",O
Sentence: 230,or,O
Sentence: 230,ecstasy,B-Chemical
Sentence: 230,",",O
Sentence: 230,because,O
Sentence: 230,recent,O
Sentence: 230,and,O
Sentence: 230,less,O
Sentence: 230,recent,O
Sentence: 230,users,O
Sentence: 230,of,O
Sentence: 230,these,O
Sentence: 230,drugs,O
Sentence: 230,within,O
Sentence: 230,this,O
Sentence: 230,group,O
Sentence: 230,were,O
Sentence: 230,similarly,O
Sentence: 230,impaired,O
Sentence: 230,.,O
Sentence: 230,Possible,O
Sentence: 230,parallels,O
Sentence: 230,between,O
Sentence: 230,RC,O
Sentence: 230,users,O
Sentence: 230,and,O
Sentence: 230,psychopaths,B-Disease
Sentence: 230,with,O
Sentence: 230,respect,O
Sentence: 230,to,O
Sentence: 230,impaired,B-Disease
Sentence: 230,fear,I-Disease
Sentence: 230,recognition,I-Disease
Sentence: 230,",",O
Sentence: 230,amygdala,B-Disease
Sentence: 230,dysfunction,I-Disease
Sentence: 230,",",O
Sentence: 230,and,O
Sentence: 230,etiology,O
Sentence: 230,are,O
Sentence: 230,discussed,O
Sentence: 230,.,O
Sentence: 231,Corneal,B-Disease
Sentence: 231,ulcers,I-Disease
Sentence: 231,associated,O
Sentence: 231,with,O
Sentence: 231,aerosolized,O
Sentence: 231,crack,B-Chemical
Sentence: 231,cocaine,I-Chemical
Sentence: 231,use,O
Sentence: 231,.,O
Sentence: 232,PURPOSE,O
Sentence: 232,:,O
Sentence: 232,We,O
Sentence: 232,report,O
Sentence: 232,4,O
Sentence: 232,cases,O
Sentence: 232,of,O
Sentence: 232,corneal,B-Disease
Sentence: 232,ulcers,I-Disease
Sentence: 232,associated,O
Sentence: 232,with,O
Sentence: 232,drug,B-Disease
Sentence: 232,abuse,I-Disease
Sentence: 232,.,O
Sentence: 232,The,O
Sentence: 232,pathogenesis,O
Sentence: 232,of,O
Sentence: 232,these,O
Sentence: 232,ulcers,B-Disease
Sentence: 232,and,O
Sentence: 232,management,O
Sentence: 232,of,O
Sentence: 232,these,O
Sentence: 232,patients,O
Sentence: 232,are,O
Sentence: 232,also,O
Sentence: 232,reviewed,O
Sentence: 232,.,O
Sentence: 232,METHODS,O
Sentence: 232,:,O
Sentence: 232,Review,O
Sentence: 232,of,O
Sentence: 232,all,O
Sentence: 232,cases,O
Sentence: 232,of,O
Sentence: 232,corneal,B-Disease
Sentence: 232,ulcers,I-Disease
Sentence: 232,associated,O
Sentence: 232,with,O
Sentence: 232,drug,B-Disease
Sentence: 232,abuse,I-Disease
Sentence: 232,seen,O
Sentence: 232,at,O
Sentence: 232,our,O
Sentence: 232,institution,O
Sentence: 232,from,O
Sentence: 232,July,O
Sentence: 232,2006,O
Sentence: 232,to,O
Sentence: 232,December,O
Sentence: 232,2006,O
Sentence: 232,.,O
Sentence: 232,RESULTS,O
Sentence: 232,:,O
Sentence: 232,Four,O
Sentence: 232,patients,O
Sentence: 232,with,O
Sentence: 232,corneal,B-Disease
Sentence: 232,ulcers,I-Disease
Sentence: 232,associated,O
Sentence: 232,with,O
Sentence: 232,crack,B-Chemical
Sentence: 232,cocaine,I-Chemical
Sentence: 232,use,O
Sentence: 232,were,O
Sentence: 232,reviewed,O
Sentence: 232,.,O
Sentence: 232,All,O
Sentence: 232,corneal,B-Disease
Sentence: 232,ulcers,I-Disease
Sentence: 232,were,O
Sentence: 232,cultured,O
Sentence: 232,",",O
Sentence: 232,and,O
Sentence: 232,the,O
Sentence: 232,patients,O
Sentence: 232,were,O
Sentence: 232,admitted,O
Sentence: 232,to,O
Sentence: 232,the,O
Sentence: 232,hospital,O
Sentence: 232,for,O
Sentence: 232,intensive,O
Sentence: 232,topical,O
Sentence: 232,antibiotic,O
Sentence: 232,treatment,O
Sentence: 232,.,O
Sentence: 232,Each,O
Sentence: 232,patient,O
Sentence: 232,received,O
Sentence: 232,comprehensive,O
Sentence: 232,health,O
Sentence: 232,care,O
Sentence: 232,",",O
Sentence: 232,including,O
Sentence: 232,medical,O
Sentence: 232,and,O
Sentence: 232,substance,B-Disease
Sentence: 232,abuse,I-Disease
Sentence: 232,consultations,O
Sentence: 232,.,O
Sentence: 232,Streptococcal,O
Sentence: 232,organisms,O
Sentence: 232,were,O
Sentence: 232,found,O
Sentence: 232,in,O
Sentence: 232,3,O
Sentence: 232,cases,O
Sentence: 232,and,O
Sentence: 232,Capnocytophaga,O
Sentence: 232,and,O
Sentence: 232,Brevibacterium,O
Sentence: 232,casei,O
Sentence: 232,in,O
Sentence: 232,1,O
Sentence: 232,patient,O
Sentence: 232,.,O
Sentence: 232,The,O
Sentence: 232,infections,B-Disease
Sentence: 232,responded,O
Sentence: 232,to,O
Sentence: 232,antibiotic,O
Sentence: 232,treatment,O
Sentence: 232,.,O
Sentence: 232,Two,O
Sentence: 232,patients,O
Sentence: 232,needed,O
Sentence: 232,a,O
Sentence: 232,lateral,O
Sentence: 232,tarsorrhaphy,O
Sentence: 232,for,O
Sentence: 232,persistent,O
Sentence: 232,epithelial,B-Disease
Sentence: 232,defects,I-Disease
Sentence: 232,.,O
Sentence: 232,CONCLUSIONS,O
Sentence: 232,:,O
Sentence: 232,Aerosolized,O
Sentence: 232,crack,B-Chemical
Sentence: 232,cocaine,I-Chemical
Sentence: 232,use,O
Sentence: 232,can,O
Sentence: 232,be,O
Sentence: 232,associated,O
Sentence: 232,with,O
Sentence: 232,the,O
Sentence: 232,development,O
Sentence: 232,of,O
Sentence: 232,corneal,B-Disease
Sentence: 232,ulcers,I-Disease
Sentence: 232,.,O
Sentence: 232,Drug,B-Disease
Sentence: 232,abuse,I-Disease
Sentence: 232,provides,O
Sentence: 232,additional,O
Sentence: 232,challenges,O
Sentence: 232,for,O
Sentence: 232,management,O
Sentence: 232,.,O
Sentence: 232,Not,O
Sentence: 232,only,O
Sentence: 232,treatment,O
Sentence: 232,of,O
Sentence: 232,their,O
Sentence: 232,infections,B-Disease
Sentence: 232,but,O
Sentence: 232,also,O
Sentence: 232,the,O
Sentence: 232,overall,O
Sentence: 232,poor,O
Sentence: 232,health,O
Sentence: 232,of,O
Sentence: 232,the,O
Sentence: 232,patients,O
Sentence: 232,and,O
Sentence: 232,increased,O
Sentence: 232,risk,O
Sentence: 232,of,O
Sentence: 232,noncompliance,O
Sentence: 232,need,O
Sentence: 232,to,O
Sentence: 232,be,O
Sentence: 232,addressed,O
Sentence: 232,.,O
Sentence: 232,Comprehensive,O
Sentence: 232,care,O
Sentence: 232,may,O
Sentence: 232,provide,O
Sentence: 232,the,O
Sentence: 232,patient,O
Sentence: 232,the,O
Sentence: 232,opportunity,O
Sentence: 232,to,O
Sentence: 232,discontinue,O
Sentence: 232,their,O
Sentence: 232,substance,B-Disease
Sentence: 232,abuse,I-Disease
Sentence: 232,",",O
Sentence: 232,improve,O
Sentence: 232,their,O
Sentence: 232,overall,O
Sentence: 232,health,O
Sentence: 232,",",O
Sentence: 232,and,O
Sentence: 232,prevent,O
Sentence: 232,future,O
Sentence: 232,corneal,O
Sentence: 232,complications,O
Sentence: 232,.,O
Sentence: 233,Levetiracetam,B-Chemical
Sentence: 233,as,O
Sentence: 233,an,O
Sentence: 233,adjunct,O
Sentence: 233,to,O
Sentence: 233,phenobarbital,B-Chemical
Sentence: 233,treatment,O
Sentence: 233,in,O
Sentence: 233,cats,O
Sentence: 233,with,O
Sentence: 233,suspected,O
Sentence: 233,idiopathic,B-Disease
Sentence: 233,epilepsy,I-Disease
Sentence: 233,.,O
Sentence: 234,OBJECTIVE,O
Sentence: 234,:,O
Sentence: 234,To,O
Sentence: 234,assess,O
Sentence: 234,pharmacokinetics,O
Sentence: 234,",",O
Sentence: 234,efficacy,O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,tolerability,O
Sentence: 234,of,O
Sentence: 234,oral,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,administered,O
Sentence: 234,as,O
Sentence: 234,an,O
Sentence: 234,adjunct,O
Sentence: 234,to,O
Sentence: 234,phenobarbital,B-Chemical
Sentence: 234,treatment,O
Sentence: 234,in,O
Sentence: 234,cats,O
Sentence: 234,with,O
Sentence: 234,poorly,O
Sentence: 234,controlled,O
Sentence: 234,suspected,O
Sentence: 234,idiopathic,B-Disease
Sentence: 234,epilepsy,I-Disease
Sentence: 234,.,O
Sentence: 234,DESIGN,O
Sentence: 234,-,O
Sentence: 234,Open,O
Sentence: 234,-,O
Sentence: 234,label,O
Sentence: 234,",",O
Sentence: 234,noncomparative,O
Sentence: 234,clinical,O
Sentence: 234,trial,O
Sentence: 234,.,O
Sentence: 234,ANIMALS,O
Sentence: 234,:,O
Sentence: 234,12,O
Sentence: 234,cats,O
Sentence: 234,suspected,O
Sentence: 234,to,O
Sentence: 234,have,O
Sentence: 234,idiopathic,B-Disease
Sentence: 234,epilepsy,I-Disease
Sentence: 234,that,O
Sentence: 234,was,O
Sentence: 234,poorly,O
Sentence: 234,controlled,O
Sentence: 234,with,O
Sentence: 234,phenobarbital,B-Chemical
Sentence: 234,or,O
Sentence: 234,that,O
Sentence: 234,had,O
Sentence: 234,unacceptable,O
Sentence: 234,adverse,O
Sentence: 234,effects,O
Sentence: 234,when,O
Sentence: 234,treated,O
Sentence: 234,with,O
Sentence: 234,phenobarbital,B-Chemical
Sentence: 234,.,O
Sentence: 234,PROCEDURES,O
Sentence: 234,:,O
Sentence: 234,Cats,O
Sentence: 234,were,O
Sentence: 234,treated,O
Sentence: 234,with,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,(,O
Sentence: 234,20,O
Sentence: 234,mg,O
Sentence: 234,/,O
Sentence: 234,kg,O
Sentence: 234,[,O
Sentence: 234,9.1,O
Sentence: 234,mg,O
Sentence: 234,/,O
Sentence: 234,lb,O
Sentence: 234,],O
Sentence: 234,",",O
Sentence: 234,PO,O
Sentence: 234,",",O
Sentence: 234,q,O
Sentence: 234,8,O
Sentence: 234,h,O
Sentence: 234,),O
Sentence: 234,.,O
Sentence: 234,After,O
Sentence: 234,a,O
Sentence: 234,minimum,O
Sentence: 234,of,O
Sentence: 234,1,O
Sentence: 234,week,O
Sentence: 234,of,O
Sentence: 234,treatment,O
Sentence: 234,",",O
Sentence: 234,serum,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,concentrations,O
Sentence: 234,were,O
Sentence: 234,measured,O
Sentence: 234,before,O
Sentence: 234,and,O
Sentence: 234,2,O
Sentence: 234,",",O
Sentence: 234,4,O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,6,O
Sentence: 234,hours,O
Sentence: 234,after,O
Sentence: 234,drug,O
Sentence: 234,administration,O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,maximum,O
Sentence: 234,and,O
Sentence: 234,minimum,O
Sentence: 234,serum,O
Sentence: 234,concentrations,O
Sentence: 234,and,O
Sentence: 234,elimination,O
Sentence: 234,half,O
Sentence: 234,-,O
Sentence: 234,life,O
Sentence: 234,were,O
Sentence: 234,calculated,O
Sentence: 234,.,O
Sentence: 234,Seizure,B-Disease
Sentence: 234,frequencies,O
Sentence: 234,before,O
Sentence: 234,and,O
Sentence: 234,after,O
Sentence: 234,initiation,O
Sentence: 234,of,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,treatment,O
Sentence: 234,were,O
Sentence: 234,compared,O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,adverse,O
Sentence: 234,effects,O
Sentence: 234,were,O
Sentence: 234,recorded,O
Sentence: 234,.,O
Sentence: 234,RESULTS,O
Sentence: 234,:,O
Sentence: 234,Median,O
Sentence: 234,maximum,O
Sentence: 234,serum,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,concentration,O
Sentence: 234,was,O
Sentence: 234,25.5,O
Sentence: 234,microg,O
Sentence: 234,/,O
Sentence: 234,mL,O
Sentence: 234,",",O
Sentence: 234,median,O
Sentence: 234,minimum,O
Sentence: 234,serum,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,concentration,O
Sentence: 234,was,O
Sentence: 234,8.3,O
Sentence: 234,microg,O
Sentence: 234,/,O
Sentence: 234,mL,O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,median,O
Sentence: 234,elimination,O
Sentence: 234,half,O
Sentence: 234,-,O
Sentence: 234,life,O
Sentence: 234,was,O
Sentence: 234,2.9,O
Sentence: 234,hours,O
Sentence: 234,.,O
Sentence: 234,Median,O
Sentence: 234,seizure,B-Disease
Sentence: 234,frequency,O
Sentence: 234,prior,O
Sentence: 234,to,O
Sentence: 234,treatment,O
Sentence: 234,with,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,(,O
Sentence: 234,2.1,O
Sentence: 234,seizures,B-Disease
Sentence: 234,/,O
Sentence: 234,mo,O
Sentence: 234,),O
Sentence: 234,was,O
Sentence: 234,significantly,O
Sentence: 234,higher,O
Sentence: 234,than,O
Sentence: 234,median,O
Sentence: 234,seizure,B-Disease
Sentence: 234,frequency,O
Sentence: 234,after,O
Sentence: 234,initiation,O
Sentence: 234,of,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,treatment,O
Sentence: 234,(,O
Sentence: 234,0.42,O
Sentence: 234,seizures,B-Disease
Sentence: 234,/,O
Sentence: 234,mo,O
Sentence: 234,),O
Sentence: 234,",",O
Sentence: 234,and,O
Sentence: 234,7,O
Sentence: 234,of,O
Sentence: 234,10,O
Sentence: 234,cats,O
Sentence: 234,were,O
Sentence: 234,classified,O
Sentence: 234,as,O
Sentence: 234,having,O
Sentence: 234,responded,O
Sentence: 234,to,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,treatment,O
Sentence: 234,(,O
Sentence: 234,ie,O
Sentence: 234,",",O
Sentence: 234,reduction,O
Sentence: 234,in,O
Sentence: 234,seizure,B-Disease
Sentence: 234,frequency,O
Sentence: 234,of,O
Sentence: 234,,O
Sentence: 234,>,O
Sentence: 234,,O
Sentence: 234,or,O
Sentence: 234,=,O
Sentence: 234,50,O
Sentence: 234,%,O
Sentence: 234,),O
Sentence: 234,.,O
Sentence: 234,Two,O
Sentence: 234,cats,O
Sentence: 234,had,O
Sentence: 234,transient,O
Sentence: 234,lethargy,B-Disease
Sentence: 234,and,O
Sentence: 234,inappetence,B-Disease
Sentence: 234,.,O
Sentence: 234,CONCLUSIONS,O
Sentence: 234,AND,O
Sentence: 234,CLINICAL,O
Sentence: 234,RELEVANCE,O
Sentence: 234,:,O
Sentence: 234,Results,O
Sentence: 234,suggested,O
Sentence: 234,that,O
Sentence: 234,levetiracetam,B-Chemical
Sentence: 234,is,O
Sentence: 234,well,O
Sentence: 234,tolerated,O
Sentence: 234,in,O
Sentence: 234,cats,O
Sentence: 234,and,O
Sentence: 234,may,O
Sentence: 234,be,O
Sentence: 234,useful,O
Sentence: 234,as,O
Sentence: 234,an,O
Sentence: 234,adjunct,O
Sentence: 234,to,O
Sentence: 234,phenobarbital,B-Chemical
Sentence: 234,treatment,O
Sentence: 234,in,O
Sentence: 234,cats,O
Sentence: 234,with,O
Sentence: 234,idiopathic,B-Disease
Sentence: 234,epilepsy,I-Disease
Sentence: 234,.,O
Sentence: 235,Bilateral,O
Sentence: 235,haemorrhagic,B-Disease
Sentence: 235,infarction,B-Disease
Sentence: 235,of,I-Disease
Sentence: 235,the,I-Disease
Sentence: 235,globus,I-Disease
Sentence: 235,pallidus,I-Disease
Sentence: 235,after,O
Sentence: 235,cocaine,B-Chemical
Sentence: 235,and,O
Sentence: 235,alcohol,B-Chemical
Sentence: 235,intoxication,O
Sentence: 235,.,O
Sentence: 236,Cocaine,B-Chemical
Sentence: 236,is,O
Sentence: 236,a,O
Sentence: 236,risk,O
Sentence: 236,factor,O
Sentence: 236,for,O
Sentence: 236,both,O
Sentence: 236,ischemic,B-Disease
Sentence: 236,and,I-Disease
Sentence: 236,haemorrhagic,B-Disease
Sentence: 236,stroke,I-Disease
Sentence: 236,.,O
Sentence: 236,We,O
Sentence: 236,present,O
Sentence: 236,the,O
Sentence: 236,case,O
Sentence: 236,of,O
Sentence: 236,a,O
Sentence: 236,31,O
Sentence: 236,-,O
Sentence: 236,year,O
Sentence: 236,-,O
Sentence: 236,old,O
Sentence: 236,man,O
Sentence: 236,with,O
Sentence: 236,bilateral,O
Sentence: 236,ischemia,B-Disease
Sentence: 236,of,I-Disease
Sentence: 236,the,I-Disease
Sentence: 236,globus,I-Disease
Sentence: 236,pallidus,I-Disease
Sentence: 236,after,O
Sentence: 236,excessive,O
Sentence: 236,alcohol,B-Chemical
Sentence: 236,and,O
Sentence: 236,intranasal,O
Sentence: 236,cocaine,B-Chemical
Sentence: 236,use,O
Sentence: 236,.,O
Sentence: 236,Drug,O
Sentence: 236,-,O
Sentence: 236,related,O
Sentence: 236,globus,B-Disease
Sentence: 236,pallidus,I-Disease
Sentence: 236,infarctions,I-Disease
Sentence: 236,are,O
Sentence: 236,most,O
Sentence: 236,often,O
Sentence: 236,associated,O
Sentence: 236,with,O
Sentence: 236,heroin,B-Chemical
Sentence: 236,.,O
Sentence: 236,Bilateral,O
Sentence: 236,basal,B-Disease
Sentence: 236,ganglia,I-Disease
Sentence: 236,infarcts,I-Disease
Sentence: 236,after,O
Sentence: 236,the,O
Sentence: 236,use,O
Sentence: 236,of,O
Sentence: 236,cocaine,B-Chemical
Sentence: 236,",",O
Sentence: 236,without,O
Sentence: 236,concurrent,O
Sentence: 236,heroin,B-Chemical
Sentence: 236,use,O
Sentence: 236,",",O
Sentence: 236,have,O
Sentence: 236,never,O
Sentence: 236,been,O
Sentence: 236,reported,O
Sentence: 236,.,O
Sentence: 236,In,O
Sentence: 236,our,O
Sentence: 236,patient,O
Sentence: 236,",",O
Sentence: 236,transient,O
Sentence: 236,cardiac,B-Disease
Sentence: 236,arrhythmia,I-Disease
Sentence: 236,or,O
Sentence: 236,respiratory,B-Disease
Sentence: 236,dysfunction,I-Disease
Sentence: 236,related,O
Sentence: 236,to,O
Sentence: 236,cocaine,B-Chemical
Sentence: 236,and,O
Sentence: 236,/,O
Sentence: 236,or,O
Sentence: 236,ethanol,B-Chemical
Sentence: 236,use,O
Sentence: 236,were,O
Sentence: 236,the,O
Sentence: 236,most,O
Sentence: 236,likely,O
Sentence: 236,causes,O
Sentence: 236,of,O
Sentence: 236,cerebral,B-Disease
Sentence: 236,hypoperfusion,I-Disease
Sentence: 236,.,O
Sentence: 237,Acute,B-Disease
Sentence: 237,renal,I-Disease
Sentence: 237,failure,I-Disease
Sentence: 237,after,O
Sentence: 237,high,O
Sentence: 237,-,O
Sentence: 237,dose,O
Sentence: 237,methotrexate,B-Chemical
Sentence: 237,therapy,O
Sentence: 237,in,O
Sentence: 237,a,O
Sentence: 237,patient,O
Sentence: 237,with,O
Sentence: 237,ileostomy,O
Sentence: 237,.,O
Sentence: 238,High,O
Sentence: 238,-,O
Sentence: 238,dose,O
Sentence: 238,methotrexate,B-Chemical
Sentence: 238,(,O
Sentence: 238,HD,O
Sentence: 238,-,O
Sentence: 238,MTX,B-Chemical
Sentence: 238,),O
Sentence: 238,is,O
Sentence: 238,an,O
Sentence: 238,important,O
Sentence: 238,treatment,O
Sentence: 238,for,O
Sentence: 238,Burkitt,B-Disease
Sentence: 238,lymphoma,I-Disease
Sentence: 238,",",O
Sentence: 238,but,O
Sentence: 238,can,O
Sentence: 238,cause,O
Sentence: 238,hepatic,B-Disease
Sentence: 238,and,I-Disease
Sentence: 238,renal,B-Disease
Sentence: 238,toxicity,I-Disease
Sentence: 238,when,O
Sentence: 238,its,O
Sentence: 238,clearance,O
Sentence: 238,is,O
Sentence: 238,delayed,O
Sentence: 238,.,O
Sentence: 238,We,O
Sentence: 238,report,O
Sentence: 238,a,O
Sentence: 238,case,O
Sentence: 238,of,O
Sentence: 238,acute,B-Disease
Sentence: 238,renal,I-Disease
Sentence: 238,failure,I-Disease
Sentence: 238,after,O
Sentence: 238,HD,O
Sentence: 238,-,O
Sentence: 238,MTX,B-Chemical
Sentence: 238,therapy,O
Sentence: 238,in,O
Sentence: 238,a,O
Sentence: 238,patient,O
Sentence: 238,with,O
Sentence: 238,ileostomy,O
Sentence: 238,",",O
Sentence: 238,The,O
Sentence: 238,patient,O
Sentence: 238,was,O
Sentence: 238,a,O
Sentence: 238,3,O
Sentence: 238,-,O
Sentence: 238,year,O
Sentence: 238,-,O
Sentence: 238,old,O
Sentence: 238,boy,O
Sentence: 238,who,O
Sentence: 238,had,O
Sentence: 238,received,O
Sentence: 238,a,O
Sentence: 238,living,O
Sentence: 238,-,O
Sentence: 238,related,O
Sentence: 238,liver,O
Sentence: 238,transplantation,O
Sentence: 238,for,O
Sentence: 238,congenital,O
Sentence: 238,biliary,B-Disease
Sentence: 238,atresia,I-Disease
Sentence: 238,.,O
Sentence: 238,At,O
Sentence: 238,day,O
Sentence: 238,833,O
Sentence: 238,after,O
Sentence: 238,the,O
Sentence: 238,transplantation,O
Sentence: 238,",",O
Sentence: 238,he,O
Sentence: 238,was,O
Sentence: 238,diagnosed,O
Sentence: 238,with,O
Sentence: 238,PTLD,B-Disease
Sentence: 238,(,O
Sentence: 238,post,O
Sentence: 238,-,O
Sentence: 238,transplantation,O
Sentence: 238,lymphoproliferative,O
Sentence: 238,disorder,O
Sentence: 238,",",O
Sentence: 238,Burkitt,O
Sentence: 238,-,O
Sentence: 238,type,O
Sentence: 238,malignant,O
Sentence: 238,lymphoma,O
Sentence: 238,),O
Sentence: 238,.,O
Sentence: 238,During,O
Sentence: 238,induction,O
Sentence: 238,therapy,O
Sentence: 238,",",O
Sentence: 238,he,O
Sentence: 238,suffered,O
Sentence: 238,ileal,O
Sentence: 238,perforation,O
Sentence: 238,and,O
Sentence: 238,ileostomy,O
Sentence: 238,was,O
Sentence: 238,performed,O
Sentence: 238,.,O
Sentence: 238,Subsequent,O
Sentence: 238,HD,O
Sentence: 238,-,O
Sentence: 238,MTX,B-Chemical
Sentence: 238,therapy,O
Sentence: 238,caused,O
Sentence: 238,acute,B-Disease
Sentence: 238,renal,I-Disease
Sentence: 238,failure,I-Disease
Sentence: 238,that,O
Sentence: 238,required,O
Sentence: 238,continuous,O
Sentence: 238,hemodialysis,O
Sentence: 238,.,O
Sentence: 238,We,O
Sentence: 238,supposed,O
Sentence: 238,that,O
Sentence: 238,intravascular,O
Sentence: 238,hypovolemia,B-Disease
Sentence: 238,due,O
Sentence: 238,to,O
Sentence: 238,substantial,O
Sentence: 238,drainage,O
Sentence: 238,from,O
Sentence: 238,the,O
Sentence: 238,ileostoma,O
Sentence: 238,caused,O
Sentence: 238,acute,B-Disease
Sentence: 238,prerenal,I-Disease
Sentence: 238,failure,I-Disease
Sentence: 238,.,O
Sentence: 238,After,O
Sentence: 238,recovery,O
Sentence: 238,of,O
Sentence: 238,his,O
Sentence: 238,renal,O
Sentence: 238,function,O
Sentence: 238,",",O
Sentence: 238,we,O
Sentence: 238,could,O
Sentence: 238,safely,O
Sentence: 238,treat,O
Sentence: 238,the,O
Sentence: 238,patient,O
Sentence: 238,with,O
Sentence: 238,HD,O
Sentence: 238,-,O
Sentence: 238,MTX,B-Chemical
Sentence: 238,therapy,O
Sentence: 238,by,O
Sentence: 238,controlling,O
Sentence: 238,drainage,O
Sentence: 238,from,O
Sentence: 238,ileostoma,O
Sentence: 238,with,O
Sentence: 238,total,O
Sentence: 238,parenteral,O
Sentence: 238,nutrition,O
Sentence: 238,.,O
Sentence: 239,Antithrombotic,O
Sentence: 239,drug,O
Sentence: 239,use,O
Sentence: 239,",",O
Sentence: 239,cerebral,B-Disease
Sentence: 239,microbleeds,I-Disease
Sentence: 239,",",O
Sentence: 239,and,O
Sentence: 239,intracerebral,B-Disease
Sentence: 239,hemorrhage,I-Disease
Sentence: 239,:,O
Sentence: 239,a,O
Sentence: 239,systematic,O
Sentence: 239,review,O
Sentence: 239,of,O
Sentence: 239,published,O
Sentence: 239,and,O
Sentence: 239,unpublished,O
Sentence: 239,studies,O
Sentence: 239,.,O
Sentence: 240,BACKGROUND,O
Sentence: 240,AND,O
Sentence: 240,PURPOSE,O
Sentence: 240,:,O
Sentence: 240,Cerebral,B-Disease
Sentence: 240,microbleeds,I-Disease
Sentence: 240,(,O
Sentence: 240,MB,B-Disease
Sentence: 240,),O
Sentence: 240,are,O
Sentence: 240,potential,O
Sentence: 240,risk,O
Sentence: 240,factors,O
Sentence: 240,for,O
Sentence: 240,intracerebral,B-Disease
Sentence: 240,hemorrhage,I-Disease
Sentence: 240,(,O
Sentence: 240,ICH,B-Disease
Sentence: 240,),O
Sentence: 240,",",O
Sentence: 240,but,O
Sentence: 240,it,O
Sentence: 240,is,O
Sentence: 240,unclear,O
Sentence: 240,if,O
Sentence: 240,they,O
Sentence: 240,are,O
Sentence: 240,a,O
Sentence: 240,contraindication,O
Sentence: 240,to,O
Sentence: 240,using,O
Sentence: 240,antithrombotic,O
Sentence: 240,drugs,O
Sentence: 240,.,O
Sentence: 240,Insights,O
Sentence: 240,could,O
Sentence: 240,be,O
Sentence: 240,gained,O
Sentence: 240,by,O
Sentence: 240,pooling,O
Sentence: 240,data,O
Sentence: 240,on,O
Sentence: 240,MB,B-Disease
Sentence: 240,frequency,O
Sentence: 240,stratified,O
Sentence: 240,by,O
Sentence: 240,antithrombotic,O
Sentence: 240,use,O
Sentence: 240,in,O
Sentence: 240,cohorts,O
Sentence: 240,with,O
Sentence: 240,ICH,B-Disease
Sentence: 240,and,O
Sentence: 240,ischemic,B-Disease
Sentence: 240,stroke,B-Disease
Sentence: 240,(,O
Sentence: 240,IS,B-Disease
Sentence: 240,),O
Sentence: 240,,O
Sentence: 240,/,O
Sentence: 240,transient,B-Disease
Sentence: 240,ischemic,B-Disease
Sentence: 240,attack,I-Disease
Sentence: 240,(,O
Sentence: 240,TIA,B-Disease
Sentence: 240,),O
Sentence: 240,.,O
Sentence: 240,METHODS,O
Sentence: 240,:,O
Sentence: 240,We,O
Sentence: 240,performed,O
Sentence: 240,a,O
Sentence: 240,systematic,O
Sentence: 240,review,O
Sentence: 240,of,O
Sentence: 240,published,O
Sentence: 240,and,O
Sentence: 240,unpublished,O
Sentence: 240,data,O
Sentence: 240,from,O
Sentence: 240,cohorts,O
Sentence: 240,with,O
Sentence: 240,stroke,B-Disease
Sentence: 240,or,O
Sentence: 240,TIA,B-Disease
Sentence: 240,to,O
Sentence: 240,compare,O
Sentence: 240,the,O
Sentence: 240,presence,O
Sentence: 240,of,O
Sentence: 240,MB,B-Disease
Sentence: 240,in,O
Sentence: 240,:,O
Sentence: 240,(,O
Sentence: 240,1,O
Sentence: 240,),O
Sentence: 240,antithrombotic,O
Sentence: 240,users,O
Sentence: 240,vs,O
Sentence: 240,nonantithrombotic,O
Sentence: 240,users,O
Sentence: 240,with,O
Sentence: 240,ICH,B-Disease
Sentence: 240,;,O
Sentence: 240,(,O
Sentence: 240,2,O
Sentence: 240,),O
Sentence: 240,antithrombotic,O
Sentence: 240,users,O
Sentence: 240,vs,O
Sentence: 240,nonusers,O
Sentence: 240,with,O
Sentence: 240,IS,B-Disease
Sentence: 240,/,O
Sentence: 240,TIA,B-Disease
Sentence: 240,;,O
Sentence: 240,and,O
Sentence: 240,(,O
Sentence: 240,3,O
Sentence: 240,),O
Sentence: 240,ICH,B-Disease
Sentence: 240,vs,O
Sentence: 240,ischemic,B-Disease
Sentence: 240,events,O
Sentence: 240,stratified,O
Sentence: 240,by,O
Sentence: 240,antithrombotic,O
Sentence: 240,use,O
Sentence: 240,.,O
Sentence: 240,We,O
Sentence: 240,also,O
Sentence: 240,analyzed,O
Sentence: 240,published,O
Sentence: 240,and,O
Sentence: 240,unpublished,O
Sentence: 240,follow,O
Sentence: 240,-,O
Sentence: 240,up,O
Sentence: 240,data,O
Sentence: 240,to,O
Sentence: 240,determine,O
Sentence: 240,the,O
Sentence: 240,risk,O
Sentence: 240,of,O
Sentence: 240,ICH,B-Disease
Sentence: 240,in,O
Sentence: 240,antithrombotic,O
Sentence: 240,users,O
Sentence: 240,with,O
Sentence: 240,MB,B-Disease
Sentence: 240,.,O
Sentence: 240,RESULTS,O
Sentence: 240,:,O
Sentence: 240,In,O
Sentence: 240,a,O
Sentence: 240,pooled,O
Sentence: 240,analysis,O
Sentence: 240,of,O
Sentence: 240,1460,O
Sentence: 240,ICH,B-Disease
Sentence: 240,and,O
Sentence: 240,3817,O
Sentence: 240,IS,B-Disease
Sentence: 240,/,O
Sentence: 240,TIA,B-Disease
Sentence: 240,",",O
Sentence: 240,MB,B-Disease
Sentence: 240,were,O
Sentence: 240,more,O
Sentence: 240,frequent,O
Sentence: 240,in,O
Sentence: 240,ICH,B-Disease
Sentence: 240,vs,O
Sentence: 240,IS,B-Disease
Sentence: 240,/,O
Sentence: 240,TIA,B-Disease
Sentence: 240,in,O
Sentence: 240,all,O
Sentence: 240,treatment,O
Sentence: 240,groups,O
Sentence: 240,",",O
Sentence: 240,but,O
Sentence: 240,the,O
Sentence: 240,excess,O
Sentence: 240,increased,O
Sentence: 240,from,O
Sentence: 240,2.8,O
Sentence: 240,(,O
Sentence: 240,odds,O
Sentence: 240,ratio,O
Sentence: 240,;,O
Sentence: 240,range,O
Sentence: 240,",",O
Sentence: 240,2.3,O
Sentence: 240,-,O
Sentence: 240,3.5,O
Sentence: 240,),O
Sentence: 240,in,O
Sentence: 240,nonantithrombotic,O
Sentence: 240,users,O
Sentence: 240,to,O
Sentence: 240,5.7,O
Sentence: 240,(,O
Sentence: 240,range,O
Sentence: 240,",",O
Sentence: 240,3.4,O
Sentence: 240,-,O
Sentence: 240,9.7,O
Sentence: 240,),O
Sentence: 240,in,O
Sentence: 240,antiplatelet,O
Sentence: 240,users,O
Sentence: 240,and,O
Sentence: 240,8.0,O
Sentence: 240,(,O
Sentence: 240,range,O
Sentence: 240,",",O
Sentence: 240,3.5,O
Sentence: 240,-,O
Sentence: 240,17.8,O
Sentence: 240,),O
Sentence: 240,in,O
Sentence: 240,warfarin,B-Chemical
Sentence: 240,users,O
Sentence: 240,(,O
Sentence: 240,P,O
Sentence: 240,difference,O
Sentence: 240,=,O
Sentence: 240,0.01,O
Sentence: 240,),O
Sentence: 240,.,O
Sentence: 240,There,O
Sentence: 240,was,O
Sentence: 240,also,O
Sentence: 240,an,O
Sentence: 240,excess,O
Sentence: 240,of,O
Sentence: 240,MB,B-Disease
Sentence: 240,in,O
Sentence: 240,warfarin,B-Chemical
Sentence: 240,users,O
Sentence: 240,vs,O
Sentence: 240,nonusers,O
Sentence: 240,with,O
Sentence: 240,ICH,B-Disease
Sentence: 240,(,O
Sentence: 240,OR,O
Sentence: 240,",",O
Sentence: 240,2.7,O
Sentence: 240,;,O
Sentence: 240,95,O
Sentence: 240,%,O
Sentence: 240,CI,O
Sentence: 240,",",O
Sentence: 240,1.6,O
Sentence: 240,-,O
Sentence: 240,4.4,O
Sentence: 240,;,O
Sentence: 240,p,O
Sentence: 240,,O
Sentence: 240,<,O
Sentence: 240,,O
Sentence: 240,0.001,O
Sentence: 240,),O
Sentence: 240,but,O
Sentence: 240,none,O
Sentence: 240,in,O
Sentence: 240,warfarin,B-Chemical
Sentence: 240,users,O
Sentence: 240,with,O
Sentence: 240,IS,B-Disease
Sentence: 240,/,O
Sentence: 240,TIA,B-Disease
Sentence: 240,(,O
Sentence: 240,OR,O
Sentence: 240,",",O
Sentence: 240,1.3,O
Sentence: 240,;,O
Sentence: 240,95,O
Sentence: 240,%,O
Sentence: 240,CI,O
Sentence: 240,",",O
Sentence: 240,0.9,O
Sentence: 240,-,O
Sentence: 240,1.7,O
Sentence: 240,;,O
Sentence: 240,P,O
Sentence: 240,=,O
Sentence: 240,0.33,O
Sentence: 240,;,O
Sentence: 240,P,O
Sentence: 240,difference,O
Sentence: 240,=,O
Sentence: 240,0.01,O
Sentence: 240,),O
Sentence: 240,.,O
Sentence: 240,There,O
Sentence: 240,was,O
Sentence: 240,a,O
Sentence: 240,smaller,O
Sentence: 240,excess,O
Sentence: 240,of,O
Sentence: 240,MB,B-Disease
Sentence: 240,in,O
Sentence: 240,antiplatelet,O
Sentence: 240,users,O
Sentence: 240,vs,O
Sentence: 240,nonusers,O
Sentence: 240,with,O
Sentence: 240,ICH,B-Disease
Sentence: 240,(,O
Sentence: 240,OR,O
Sentence: 240,",",O
Sentence: 240,1.7,O
Sentence: 240,;,O
Sentence: 240,95,O
Sentence: 240,%,O
Sentence: 240,CI,O
Sentence: 240,",",O
Sentence: 240,1.3,O
Sentence: 240,-,O
Sentence: 240,2.3,O
Sentence: 240,;,O
Sentence: 240,p,O
Sentence: 240,,O
Sentence: 240,<,O
Sentence: 240,,O
Sentence: 240,0.001,O
Sentence: 240,),O
Sentence: 240,",",O
Sentence: 240,but,O
Sentence: 240,findings,O
Sentence: 240,were,O
Sentence: 240,similar,O
Sentence: 240,for,O
Sentence: 240,antiplatelet,O
Sentence: 240,users,O
Sentence: 240,with,O
Sentence: 240,IS,B-Disease
Sentence: 240,/,O
Sentence: 240,TIA,B-Disease
Sentence: 240,(,O
Sentence: 240,OR,O
Sentence: 240,",",O
Sentence: 240,1.4,O
Sentence: 240,;,O
Sentence: 240,95,O
Sentence: 240,%,O
Sentence: 240,CI,O
Sentence: 240,",",O
Sentence: 240,1.2,O
Sentence: 240,-,O
Sentence: 240,1.7,O
Sentence: 240,;,O
Sentence: 240,p,O
Sentence: 240,,O
Sentence: 240,<,O
Sentence: 240,,O
Sentence: 240,0.001,O
Sentence: 240,;,O
Sentence: 240,P,O
Sentence: 240,difference,O
Sentence: 240,=,O
Sentence: 240,0.25,O
Sentence: 240,),O
Sentence: 240,.,O
Sentence: 240,In,O
Sentence: 240,pooled,O
Sentence: 240,follow,O
Sentence: 240,-,O
Sentence: 240,up,O
Sentence: 240,data,O
Sentence: 240,for,O
Sentence: 240,768,O
Sentence: 240,antithrombotic,O
Sentence: 240,users,O
Sentence: 240,",",O
Sentence: 240,presence,O
Sentence: 240,of,O
Sentence: 240,MB,B-Disease
Sentence: 240,at,O
Sentence: 240,baseline,O
Sentence: 240,was,O
Sentence: 240,associated,O
Sentence: 240,with,O
Sentence: 240,a,O
Sentence: 240,substantially,O
Sentence: 240,increased,O
Sentence: 240,risk,O
Sentence: 240,of,O
Sentence: 240,subsequent,O
Sentence: 240,ICH,B-Disease
Sentence: 240,(,O
Sentence: 240,OR,O
Sentence: 240,",",O
Sentence: 240,12.1,O
Sentence: 240,;,O
Sentence: 240,95,O
Sentence: 240,%,O
Sentence: 240,CI,O
Sentence: 240,",",O
Sentence: 240,3.4,O
Sentence: 240,-,O
Sentence: 240,42.5,O
Sentence: 240,;,O
Sentence: 240,p,O
Sentence: 240,,O
Sentence: 240,<,O
Sentence: 240,,O
Sentence: 240,0.001,O
Sentence: 240,),O
Sentence: 240,.,O
Sentence: 240,CONCLUSIONS,O
Sentence: 240,:,O
Sentence: 240,The,O
Sentence: 240,excess,O
Sentence: 240,of,O
Sentence: 240,MB,B-Disease
Sentence: 240,in,O
Sentence: 240,warfarin,B-Chemical
Sentence: 240,users,O
Sentence: 240,with,O
Sentence: 240,ICH,B-Disease
Sentence: 240,compared,O
Sentence: 240,to,O
Sentence: 240,other,O
Sentence: 240,groups,O
Sentence: 240,suggests,O
Sentence: 240,that,O
Sentence: 240,MB,B-Disease
Sentence: 240,increase,O
Sentence: 240,the,O
Sentence: 240,risk,O
Sentence: 240,of,O
Sentence: 240,warfarin,B-Chemical
Sentence: 240,-,O
Sentence: 240,associated,O
Sentence: 240,ICH,B-Disease
Sentence: 240,.,O
Sentence: 240,Limited,O
Sentence: 240,prospective,O
Sentence: 240,data,O
Sentence: 240,corroborate,O
Sentence: 240,these,O
Sentence: 240,findings,O
Sentence: 240,",",O
Sentence: 240,but,O
Sentence: 240,larger,O
Sentence: 240,prospective,O
Sentence: 240,studies,O
Sentence: 240,are,O
Sentence: 240,urgently,O
Sentence: 240,required,O
Sentence: 240,.,O
Sentence: 241,Verapamil,B-Chemical
Sentence: 241,stimulation,O
Sentence: 241,test,O
Sentence: 241,in,O
Sentence: 241,hyperprolactinemia,B-Disease
Sentence: 241,:,O
Sentence: 241,loss,O
Sentence: 241,of,O
Sentence: 241,prolactin,O
Sentence: 241,response,O
Sentence: 241,in,O
Sentence: 241,anatomic,O
Sentence: 241,or,O
Sentence: 241,functional,O
Sentence: 241,stalk,O
Sentence: 241,effect,O
Sentence: 241,.,O
Sentence: 242,AIM,O
Sentence: 242,:,O
Sentence: 242,Verapamil,B-Chemical
Sentence: 242,stimulation,O
Sentence: 242,test,O
Sentence: 242,was,O
Sentence: 242,previously,O
Sentence: 242,investigated,O
Sentence: 242,as,O
Sentence: 242,a,O
Sentence: 242,tool,O
Sentence: 242,for,O
Sentence: 242,differential,O
Sentence: 242,diagnosis,O
Sentence: 242,of,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,",",O
Sentence: 242,but,O
Sentence: 242,with,O
Sentence: 242,conflicting,O
Sentence: 242,results,O
Sentence: 242,.,O
Sentence: 242,Macroprolactinemia,B-Disease
Sentence: 242,was,O
Sentence: 242,never,O
Sentence: 242,considered,O
Sentence: 242,in,O
Sentence: 242,those,O
Sentence: 242,previous,O
Sentence: 242,studies,O
Sentence: 242,.,O
Sentence: 242,Here,O
Sentence: 242,",",O
Sentence: 242,we,O
Sentence: 242,aimed,O
Sentence: 242,to,O
Sentence: 242,re,O
Sentence: 242,-,O
Sentence: 242,investigate,O
Sentence: 242,the,O
Sentence: 242,diagnostic,O
Sentence: 242,value,O
Sentence: 242,of,O
Sentence: 242,verapamil,B-Chemical
Sentence: 242,in,O
Sentence: 242,a,O
Sentence: 242,population,O
Sentence: 242,who,O
Sentence: 242,were,O
Sentence: 242,all,O
Sentence: 242,screened,O
Sentence: 242,for,O
Sentence: 242,macroprolactinemia,B-Disease
Sentence: 242,.,O
Sentence: 242,Prolactin,O
Sentence: 242,responses,O
Sentence: 242,to,O
Sentence: 242,verapamil,B-Chemical
Sentence: 242,in,O
Sentence: 242,65,O
Sentence: 242,female,O
Sentence: 242,patients,O
Sentence: 242,(,O
Sentence: 242,age,O
Sentence: 242,:,O
Sentence: 242,29.9,O
Sentence: 242,+,O
Sentence: 242,/,O
Sentence: 242,,O
Sentence: 242,-,O
Sentence: 242,,O
Sentence: 242,8.1,O
Sentence: 242,years,O
Sentence: 242,),O
Sentence: 242,with,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,were,O
Sentence: 242,tested,O
Sentence: 242,in,O
Sentence: 242,a,O
Sentence: 242,descriptive,O
Sentence: 242,",",O
Sentence: 242,matched,O
Sentence: 242,case,O
Sentence: 242,-,O
Sentence: 242,control,O
Sentence: 242,study,O
Sentence: 242,.,O
Sentence: 242,METHODS,O
Sentence: 242,:,O
Sentence: 242,Verapamil,B-Chemical
Sentence: 242,80,O
Sentence: 242,mg,O
Sentence: 242,",",O
Sentence: 242,p.o,O
Sentence: 242,.,O
Sentence: 242,was,O
Sentence: 242,administered,O
Sentence: 242,",",O
Sentence: 242,and,O
Sentence: 242,then,O
Sentence: 242,PRL,O
Sentence: 242,levels,O
Sentence: 242,were,O
Sentence: 242,measured,O
Sentence: 242,at,O
Sentence: 242,8th,O
Sentence: 242,and,O
Sentence: 242,16th,O
Sentence: 242,hours,O
Sentence: 242,",",O
Sentence: 242,by,O
Sentence: 242,immunometric,O
Sentence: 242,chemiluminescence,O
Sentence: 242,.,O
Sentence: 242,Verapamil,B-Chemical
Sentence: 242,responsiveness,O
Sentence: 242,was,O
Sentence: 242,determined,O
Sentence: 242,by,O
Sentence: 242,peak,O
Sentence: 242,percent,O
Sentence: 242,change,O
Sentence: 242,in,O
Sentence: 242,basal,O
Sentence: 242,prolactin,O
Sentence: 242,levels,O
Sentence: 242,(,O
Sentence: 242,PRL,O
Sentence: 242,),O
Sentence: 242,.,O
Sentence: 242,RESULTS,O
Sentence: 242,:,O
Sentence: 242,Verapamil,B-Chemical
Sentence: 242,significantly,O
Sentence: 242,increased,O
Sentence: 242,PRL,O
Sentence: 242,levels,O
Sentence: 242,in,O
Sentence: 242,healthy,O
Sentence: 242,controls,O
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,8,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,183,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,",",O
Sentence: 242,macroprolactinoma,B-Disease
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,8,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,7,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,",",O
Sentence: 242,microprolactinoma,B-Disease
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,19,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,21,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,",",O
Sentence: 242,macroprolactinemia,B-Disease
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,23,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,126,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,",",O
Sentence: 242,but,O
Sentence: 242,not,O
Sentence: 242,in,O
Sentence: 242,pseudoprolactinoma,B-Disease
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,8,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,0.8,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,",",O
Sentence: 242,and,O
Sentence: 242,risperidone,B-Chemical
Sentence: 242,-,O
Sentence: 242,induced,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,(,O
Sentence: 242,N.,O
Sentence: 242,7,O
Sentence: 242,",",O
Sentence: 242,PRL,O
Sentence: 242,:,O
Sentence: 242,3,O
Sentence: 242,%,O
Sentence: 242,),O
Sentence: 242,.,O
Sentence: 242,ROC,O
Sentence: 242,curve,O
Sentence: 242,analysis,O
Sentence: 242,revealed,O
Sentence: 242,that,O
Sentence: 242,unresponsiveness,O
Sentence: 242,to,O
Sentence: 242,verapamil,B-Chemical
Sentence: 242,defined,O
Sentence: 242,as,O
Sentence: 242,PRL,O
Sentence: 242,,O
Sentence: 242,<,O
Sentence: 242,,O
Sentence: 242,7,O
Sentence: 242,%,O
Sentence: 242,",",O
Sentence: 242,discriminated,O
Sentence: 242,anatomical,O
Sentence: 242,or,O
Sentence: 242,functional,O
Sentence: 242,stalk,O
Sentence: 242,effect,O
Sentence: 242,(,O
Sentence: 242,sensitivity,O
Sentence: 242,:,O
Sentence: 242,74,O
Sentence: 242,%,O
Sentence: 242,",",O
Sentence: 242,specificity,O
Sentence: 242,:,O
Sentence: 242,73,O
Sentence: 242,%,O
Sentence: 242,",",O
Sentence: 242,AUC,O
Sentence: 242,:,O
Sentence: 242,0.855+,O
Sentence: 242,/,O
Sentence: 242,,O
Sentence: 242,-,O
Sentence: 242,0.04,O
Sentence: 242,",",O
Sentence: 242,P,O
Sentence: 242,,O
Sentence: 242,<,O
Sentence: 242,,O
Sentence: 242,0.001,O
Sentence: 242,",",O
Sentence: 242,CI,O
Sentence: 242,:,O
Sentence: 242,0.768,O
Sentence: 242,-,O
Sentence: 242,0.942,O
Sentence: 242,),O
Sentence: 242,associated,O
Sentence: 242,with,O
Sentence: 242,pseudoprolactinoma,B-Disease
Sentence: 242,or,O
Sentence: 242,risperidone,B-Chemical
Sentence: 242,-,O
Sentence: 242,induced,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,",",O
Sentence: 242,respectively,O
Sentence: 242,.,O
Sentence: 242,CONCLUSION,O
Sentence: 242,:,O
Sentence: 242,Verapamil,B-Chemical
Sentence: 242,responsiveness,O
Sentence: 242,is,O
Sentence: 242,not,O
Sentence: 242,a,O
Sentence: 242,reliable,O
Sentence: 242,finding,O
Sentence: 242,for,O
Sentence: 242,the,O
Sentence: 242,differential,O
Sentence: 242,diagnosis,O
Sentence: 242,of,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,.,O
Sentence: 242,However,O
Sentence: 242,",",O
Sentence: 242,verapamil,B-Chemical
Sentence: 242,unresponsiveness,O
Sentence: 242,discriminates,O
Sentence: 242,stalk,O
Sentence: 242,effect,O
Sentence: 242,(,O
Sentence: 242,i.e.,O
Sentence: 242,",",O
Sentence: 242,anatomically,O
Sentence: 242,or,O
Sentence: 242,functionally,O
Sentence: 242,inhibited,O
Sentence: 242,dopaminergic,O
Sentence: 242,tonus,O
Sentence: 242,),O
Sentence: 242,from,O
Sentence: 242,other,O
Sentence: 242,causes,O
Sentence: 242,of,O
Sentence: 242,hyperprolactinemia,B-Disease
Sentence: 242,with,O
Sentence: 242,varying,O
Sentence: 242,degrees,O
Sentence: 242,of,O
Sentence: 242,responsiveness,O
Sentence: 242,.,O
Sentence: 243,Central,O
Sentence: 243,action,O
Sentence: 243,of,O
Sentence: 243,narcotic,O
Sentence: 243,analgesics,O
Sentence: 243,.,O
Sentence: 243,Part,O
Sentence: 243,IV,O
Sentence: 243,.,O
Sentence: 243,Noradrenergic,O
Sentence: 243,influences,O
Sentence: 243,on,O
Sentence: 243,the,O
Sentence: 243,activity,O
Sentence: 243,of,O
Sentence: 243,analgesics,O
Sentence: 243,in,O
Sentence: 243,rats,O
Sentence: 243,.,O
Sentence: 244,The,O
Sentence: 244,effect,O
Sentence: 244,of,O
Sentence: 244,clonidine,B-Chemical
Sentence: 244,",",O
Sentence: 244,naphazoline,B-Chemical
Sentence: 244,and,O
Sentence: 244,xylometazoline,B-Chemical
Sentence: 244,on,O
Sentence: 244,analgesia,O
Sentence: 244,induced,O
Sentence: 244,by,O
Sentence: 244,morphine,B-Chemical
Sentence: 244,",",O
Sentence: 244,codeine,B-Chemical
Sentence: 244,",",O
Sentence: 244,fentanyl,B-Chemical
Sentence: 244,and,O
Sentence: 244,pentazocine,B-Chemical
Sentence: 244,",",O
Sentence: 244,and,O
Sentence: 244,on,O
Sentence: 244,cataleptic,B-Disease
Sentence: 244,effect,O
Sentence: 244,of,O
Sentence: 244,morphine,B-Chemical
Sentence: 244,",",O
Sentence: 244,codine,B-Chemical
Sentence: 244,and,O
Sentence: 244,fentanyl,B-Chemical
Sentence: 244,was,O
Sentence: 244,studied,O
Sentence: 244,in,O
Sentence: 244,rats,O
Sentence: 244,.,O
Sentence: 244,The,O
Sentence: 244,biochemical,O
Sentence: 244,assays,O
Sentence: 244,on,O
Sentence: 244,the,O
Sentence: 244,influence,O
Sentence: 244,of,O
Sentence: 244,four,O
Sentence: 244,analgesics,O
Sentence: 244,on,O
Sentence: 244,the,O
Sentence: 244,brain,O
Sentence: 244,concentration,O
Sentence: 244,and,O
Sentence: 244,turnover,O
Sentence: 244,of,O
Sentence: 244,noradrenaline,B-Chemical
Sentence: 244,(,O
Sentence: 244,NA,B-Chemical
Sentence: 244,),O
Sentence: 244,were,O
Sentence: 244,also,O
Sentence: 244,performed,O
Sentence: 244,.,O
Sentence: 244,It,O
Sentence: 244,was,O
Sentence: 244,found,O
Sentence: 244,that,O
Sentence: 244,three,O
Sentence: 244,drugs,O
Sentence: 244,stimulating,O
Sentence: 244,central,O
Sentence: 244,NA,B-Chemical
Sentence: 244,receptors,O
Sentence: 244,failed,O
Sentence: 244,to,O
Sentence: 244,affect,O
Sentence: 244,the,O
Sentence: 244,analgesic,O
Sentence: 244,ED50,O
Sentence: 244,of,O
Sentence: 244,all,O
Sentence: 244,antinociceptive,O
Sentence: 244,agents,O
Sentence: 244,and,O
Sentence: 244,they,O
Sentence: 244,enhanced,O
Sentence: 244,catalepsy,B-Disease
Sentence: 244,induced,O
Sentence: 244,by,O
Sentence: 244,morphine,B-Chemical
Sentence: 244,and,O
Sentence: 244,fentanyl,B-Chemical
Sentence: 244,.,O
Sentence: 244,Codeine,B-Chemical
Sentence: 244,catalepsy,B-Disease
Sentence: 244,was,O
Sentence: 244,increased,O
Sentence: 244,by,O
Sentence: 244,clonidine,B-Chemical
Sentence: 244,and,O
Sentence: 244,decreased,O
Sentence: 244,by,O
Sentence: 244,naphazoline,B-Chemical
Sentence: 244,and,O
Sentence: 244,xylometazoline,B-Chemical
Sentence: 244,.,O
Sentence: 244,The,O
Sentence: 244,brain,O
Sentence: 244,concentration,O
Sentence: 244,of,O
Sentence: 244,NA,B-Chemical
Sentence: 244,was,O
Sentence: 244,not,O
Sentence: 244,changed,O
Sentence: 244,by,O
Sentence: 244,morphine,B-Chemical
Sentence: 244,and,O
Sentence: 244,fentanyl,B-Chemical
Sentence: 244,",",O
Sentence: 244,but,O
Sentence: 244,one,O
Sentence: 244,of,O
Sentence: 244,the,O
Sentence: 244,doses,O
Sentence: 244,of,O
Sentence: 244,codeine,B-Chemical
Sentence: 244,(,O
Sentence: 244,45,O
Sentence: 244,mg,O
Sentence: 244,/,O
Sentence: 244,kg,O
Sentence: 244,),O
Sentence: 244,slightly,O
Sentence: 244,enhanced,O
Sentence: 244,it,O
Sentence: 244,.,O
Sentence: 244,Pentazocine,B-Chemical
Sentence: 244,dose,O
Sentence: 244,-,O
Sentence: 244,dependently,O
Sentence: 244,decreased,O
Sentence: 244,the,O
Sentence: 244,brain,O
Sentence: 244,level,O
Sentence: 244,of,O
Sentence: 244,NA,B-Chemical
Sentence: 244,.,O
Sentence: 244,The,O
Sentence: 244,rate,O
Sentence: 244,of,O
Sentence: 244,NA,B-Chemical
Sentence: 244,turnover,O
Sentence: 244,was,O
Sentence: 244,not,O
Sentence: 244,altered,O
Sentence: 244,by,O
Sentence: 244,analgesics,O
Sentence: 244,except,O
Sentence: 244,for,O
Sentence: 244,the,O
Sentence: 244,higher,O
Sentence: 244,dose,O
Sentence: 244,of,O
Sentence: 244,fentanyl,B-Chemical
Sentence: 244,(,O
Sentence: 244,0.2,O
Sentence: 244,mg,O
Sentence: 244,/,O
Sentence: 244,kg,O
Sentence: 244,),O
Sentence: 244,following,O
Sentence: 244,which,O
Sentence: 244,the,O
Sentence: 244,disappearance,O
Sentence: 244,of,O
Sentence: 244,NA,B-Chemical
Sentence: 244,from,O
Sentence: 244,the,O
Sentence: 244,brain,O
Sentence: 244,was,O
Sentence: 244,diminished,O
Sentence: 244,.,O
Sentence: 244,The,O
Sentence: 244,results,O
Sentence: 244,are,O
Sentence: 244,discussed,O
Sentence: 244,in,O
Sentence: 244,the,O
Sentence: 244,light,O
Sentence: 244,of,O
Sentence: 244,various,O
Sentence: 244,and,O
Sentence: 244,non,O
Sentence: 244,-,O
Sentence: 244,uniform,O
Sentence: 244,data,O
Sentence: 244,from,O
Sentence: 244,the,O
Sentence: 244,literature,O
Sentence: 244,.,O
Sentence: 244,It,O
Sentence: 244,is,O
Sentence: 244,suggested,O
Sentence: 244,that,O
Sentence: 244,in,O
Sentence: 244,rats,O
Sentence: 244,the,O
Sentence: 244,brain,O
Sentence: 244,NA,B-Chemical
Sentence: 244,plays,O
Sentence: 244,a,O
Sentence: 244,less,O
Sentence: 244,important,O
Sentence: 244,function,O
Sentence: 244,than,O
Sentence: 244,the,O
Sentence: 244,other,O
Sentence: 244,monoamines,B-Chemical
Sentence: 244,in,O
Sentence: 244,the,O
Sentence: 244,behavioural,O
Sentence: 244,activity,O
Sentence: 244,of,O
Sentence: 244,potent,O
Sentence: 244,analgesics,O
Sentence: 244,.,O
Sentence: 245,Modification,O
Sentence: 245,by,O
Sentence: 245,propranolol,B-Chemical
Sentence: 245,of,O
Sentence: 245,cardiovascular,O
Sentence: 245,effects,O
Sentence: 245,of,O
Sentence: 245,induced,O
Sentence: 245,hypoglycaemia,B-Disease
Sentence: 245,.,O
Sentence: 246,The,O
Sentence: 246,cardiovascular,O
Sentence: 246,effects,O
Sentence: 246,of,O
Sentence: 246,hypoglycaemia,B-Disease
Sentence: 246,",",O
Sentence: 246,with,O
Sentence: 246,and,O
Sentence: 246,without,O
Sentence: 246,beta,O
Sentence: 246,-,O
Sentence: 246,blockade,O
Sentence: 246,",",O
Sentence: 246,were,O
Sentence: 246,compared,O
Sentence: 246,in,O
Sentence: 246,fourteen,O
Sentence: 246,healthy,O
Sentence: 246,men,O
Sentence: 246,.,O
Sentence: 246,Eight,O
Sentence: 246,received,O
Sentence: 246,insulin,O
Sentence: 246,alone,O
Sentence: 246,",",O
Sentence: 246,and,O
Sentence: 246,eight,O
Sentence: 246,",",O
Sentence: 246,including,O
Sentence: 246,two,O
Sentence: 246,of,O
Sentence: 246,the,O
Sentence: 246,original,O
Sentence: 246,insulin,O
Sentence: 246,-,O
Sentence: 246,only,O
Sentence: 246,group,O
Sentence: 246,",",O
Sentence: 246,were,O
Sentence: 246,given,O
Sentence: 246,propranolol,B-Chemical
Sentence: 246,and,O
Sentence: 246,insulin,O
Sentence: 246,.,O
Sentence: 246,In,O
Sentence: 246,the,O
Sentence: 246,insulin,O
Sentence: 246,-,O
Sentence: 246,group,O
Sentence: 246,the,O
Sentence: 246,period,O
Sentence: 246,of,O
Sentence: 246,hypoglycaemia,B-Disease
Sentence: 246,was,O
Sentence: 246,associated,O
Sentence: 246,with,O
Sentence: 246,an,O
Sentence: 246,increase,O
Sentence: 246,in,O
Sentence: 246,heart,O
Sentence: 246,-,O
Sentence: 246,rate,O
Sentence: 246,and,O
Sentence: 246,a,O
Sentence: 246,fall,O
Sentence: 246,in,O
Sentence: 246,diastolic,O
Sentence: 246,blood,O
Sentence: 246,-,O
Sentence: 246,pressure,O
Sentence: 246,.,O
Sentence: 246,In,O
Sentence: 246,the,O
Sentence: 246,propranolol,B-Chemical
Sentence: 246,-,O
Sentence: 246,insulin,O
Sentence: 246,group,O
Sentence: 246,there,O
Sentence: 246,was,O
Sentence: 246,a,O
Sentence: 246,significant,O
Sentence: 246,fall,O
Sentence: 246,in,O
Sentence: 246,heart,O
Sentence: 246,-,O
Sentence: 246,rate,O
Sentence: 246,in,O
Sentence: 246,most,O
Sentence: 246,subjects,O
Sentence: 246,and,O
Sentence: 246,an,O
Sentence: 246,increase,O
Sentence: 246,in,O
Sentence: 246,diastolic,O
Sentence: 246,pressure,O
Sentence: 246,.,O
Sentence: 246,Typical,O
Sentence: 246,S,O
Sentence: 246,-,O
Sentence: 246,T,O
Sentence: 246,/,O
Sentence: 246,T,O
Sentence: 246,changes,O
Sentence: 246,occurred,O
Sentence: 246,in,O
Sentence: 246,the,O
Sentence: 246,insulin,O
Sentence: 246,-,O
Sentence: 246,group,O
Sentence: 246,but,O
Sentence: 246,in,O
Sentence: 246,none,O
Sentence: 246,of,O
Sentence: 246,the,O
Sentence: 246,propranolol,B-Chemical
Sentence: 246,-,O
Sentence: 246,insulin,O
Sentence: 246,group,O
Sentence: 246,.,O
Sentence: 246,Hypertension,B-Disease
Sentence: 246,in,O
Sentence: 246,diabetics,B-Disease
Sentence: 246,prone,O
Sentence: 246,to,O
Sentence: 246,hypoglycaemia,B-Disease
Sentence: 246,attacks,O
Sentence: 246,should,O
Sentence: 246,not,O
Sentence: 246,be,O
Sentence: 246,treated,O
Sentence: 246,with,O
Sentence: 246,beta,O
Sentence: 246,-,O
Sentence: 246,blockers,O
Sentence: 246,because,O
Sentence: 246,these,O
Sentence: 246,drugs,O
Sentence: 246,may,O
Sentence: 246,cause,O
Sentence: 246,a,O
Sentence: 246,sharp,O
Sentence: 246,rise,O
Sentence: 246,in,O
Sentence: 246,blood,O
Sentence: 246,-,O
Sentence: 246,pressure,O
Sentence: 246,in,O
Sentence: 246,such,O
Sentence: 246,patients,O
Sentence: 246,.,O
Sentence: 247,Prevention,O
Sentence: 247,and,O
Sentence: 247,treatment,O
Sentence: 247,of,O
Sentence: 247,endometrial,B-Disease
Sentence: 247,disease,I-Disease
Sentence: 247,in,O
Sentence: 247,climacteric,O
Sentence: 247,women,O
Sentence: 247,receiving,O
Sentence: 247,oestrogen,B-Chemical
Sentence: 247,therapy,O
Sentence: 247,.,O
Sentence: 248,The,O
Sentence: 248,treatment,O
Sentence: 248,regimens,O
Sentence: 248,are,O
Sentence: 248,described,O
Sentence: 248,in,O
Sentence: 248,74,O
Sentence: 248,patients,O
Sentence: 248,with,O
Sentence: 248,endometrial,B-Disease
Sentence: 248,disease,I-Disease
Sentence: 248,among,O
Sentence: 248,850,O
Sentence: 248,climacteric,O
Sentence: 248,women,O
Sentence: 248,receiving,O
Sentence: 248,oestrogen,B-Chemical
Sentence: 248,therapy,O
Sentence: 248,.,O
Sentence: 248,Cystic,O
Sentence: 248,hyperplasia,B-Disease
Sentence: 248,was,O
Sentence: 248,associated,O
Sentence: 248,with,O
Sentence: 248,unopposed,O
Sentence: 248,oestrogen,B-Chemical
Sentence: 248,therapy,O
Sentence: 248,without,O
Sentence: 248,progestagen,B-Chemical
Sentence: 248,.,O
Sentence: 248,Two,O
Sentence: 248,courses,O
Sentence: 248,of,O
Sentence: 248,21,O
Sentence: 248,days,O
Sentence: 248,of,O
Sentence: 248,5,O
Sentence: 248,mg,O
Sentence: 248,norethisterone,B-Chemical
Sentence: 248,daily,O
Sentence: 248,caused,O
Sentence: 248,reversion,O
Sentence: 248,to,O
Sentence: 248,normal,O
Sentence: 248,in,O
Sentence: 248,all,O
Sentence: 248,57,O
Sentence: 248,cases,O
Sentence: 248,of,O
Sentence: 248,cystic,O
Sentence: 248,hyperplasia,B-Disease
Sentence: 248,and,O
Sentence: 248,6,O
Sentence: 248,of,O
Sentence: 248,the,O
Sentence: 248,8,O
Sentence: 248,cases,O
Sentence: 248,of,O
Sentence: 248,atypical,O
Sentence: 248,hyperplasia,B-Disease
Sentence: 248,.,O
Sentence: 248,4,O
Sentence: 248,cases,O
Sentence: 248,of,O
Sentence: 248,endometrial,B-Disease
Sentence: 248,carcinoma,B-Disease
Sentence: 248,referred,O
Sentence: 248,from,O
Sentence: 248,elsewhere,O
Sentence: 248,demonstrated,O
Sentence: 248,the,O
Sentence: 248,problems,O
Sentence: 248,of,O
Sentence: 248,inappropriate,O
Sentence: 248,and,O
Sentence: 248,unsupervised,O
Sentence: 248,unopposed,O
Sentence: 248,oestrogen,B-Chemical
Sentence: 248,therapy,O
Sentence: 248,and,O
Sentence: 248,the,O
Sentence: 248,difficulty,O
Sentence: 248,in,O
Sentence: 248,distinguishing,O
Sentence: 248,severe,O
Sentence: 248,hyperplasia,B-Disease
Sentence: 248,from,O
Sentence: 248,malignancy,B-Disease
Sentence: 248,.,O
Sentence: 248,Cyclical,O
Sentence: 248,low,O
Sentence: 248,-,O
Sentence: 248,dose,O
Sentence: 248,oestrogen,B-Chemical
Sentence: 248,therapy,O
Sentence: 248,with,O
Sentence: 248,7,O
Sentence: 248,,O
Sentence: 248,-,O
Sentence: 248,,O
Sentence: 248,-,O
Sentence: 248,,O
Sentence: 248,13,O
Sentence: 248,days,O
Sentence: 248,of,O
Sentence: 248,progestagen,B-Chemical
Sentence: 248,does,O
Sentence: 248,not,O
Sentence: 248,seem,O
Sentence: 248,to,O
Sentence: 248,increase,O
Sentence: 248,the,O
Sentence: 248,risk,O
Sentence: 248,of,O
Sentence: 248,endometrial,B-Disease
Sentence: 248,hyperplasia,I-Disease
Sentence: 248,or,O
Sentence: 248,carcinoma,B-Disease
Sentence: 248,.,O
Sentence: 249,Pure,B-Disease
Sentence: 249,red,I-Disease
Sentence: 249,cell,I-Disease
Sentence: 249,aplasia,I-Disease
Sentence: 249,",",O
Sentence: 249,toxic,B-Disease
Sentence: 249,dermatitis,I-Disease
Sentence: 249,and,O
Sentence: 249,lymphadenopathy,B-Disease
Sentence: 249,in,O
Sentence: 249,a,O
Sentence: 249,patient,O
Sentence: 249,taking,O
Sentence: 249,diphenylhydantoin,B-Chemical
Sentence: 249,.,O
Sentence: 250,A,O
Sentence: 250,patient,O
Sentence: 250,taking,O
Sentence: 250,diphenylhydantoin,B-Chemical
Sentence: 250,for,O
Sentence: 250,3,O
Sentence: 250,weeks,O
Sentence: 250,developed,O
Sentence: 250,a,O
Sentence: 250,generalized,O
Sentence: 250,skin,B-Disease
Sentence: 250,rash,I-Disease
Sentence: 250,",",O
Sentence: 250,lymphadenopathy,B-Disease
Sentence: 250,and,O
Sentence: 250,pure,B-Disease
Sentence: 250,red,I-Disease
Sentence: 250,cell,I-Disease
Sentence: 250,aplasia,I-Disease
Sentence: 250,.,O
Sentence: 250,After,O
Sentence: 250,withdrawal,O
Sentence: 250,of,O
Sentence: 250,the,O
Sentence: 250,pharmacon,O
Sentence: 250,all,O
Sentence: 250,symptoms,O
Sentence: 250,disappeared,O
Sentence: 250,spontaneously,O
Sentence: 250,.,O
Sentence: 250,Skin,B-Disease
Sentence: 250,rash,I-Disease
Sentence: 250,is,O
Sentence: 250,a,O
Sentence: 250,well,O
Sentence: 250,-,O
Sentence: 250,known,O
Sentence: 250,complication,O
Sentence: 250,of,O
Sentence: 250,diphenylhydantoin,B-Chemical
Sentence: 250,treatment,O
Sentence: 250,as,O
Sentence: 250,is,O
Sentence: 250,benign,O
Sentence: 250,and,O
Sentence: 250,malignant,O
Sentence: 250,lymphadenopathy,B-Disease
Sentence: 250,.,O
Sentence: 250,Pure,B-Disease
Sentence: 250,red,I-Disease
Sentence: 250,cell,I-Disease
Sentence: 250,aplasia,I-Disease
Sentence: 250,associated,O
Sentence: 250,with,O
Sentence: 250,diphenylhydantoin,B-Chemical
Sentence: 250,medication,O
Sentence: 250,has,O
Sentence: 250,been,O
Sentence: 250,reported,O
Sentence: 250,in,O
Sentence: 250,3,O
Sentence: 250,patients,O
Sentence: 250,.,O
Sentence: 250,The,O
Sentence: 250,exact,O
Sentence: 250,mechanism,O
Sentence: 250,by,O
Sentence: 250,which,O
Sentence: 250,diphenylhydantoin,B-Chemical
Sentence: 250,exerts,O
Sentence: 250,its,O
Sentence: 250,toxic,O
Sentence: 250,effects,O
Sentence: 250,is,O
Sentence: 250,not,O
Sentence: 250,known,O
Sentence: 250,.,O
Sentence: 250,In,O
Sentence: 250,this,O
Sentence: 250,patient,O
Sentence: 250,the,O
Sentence: 250,time,O
Sentence: 250,relation,O
Sentence: 250,between,O
Sentence: 250,the,O
Sentence: 250,ingestion,O
Sentence: 250,of,O
Sentence: 250,diphenylhydantoin,B-Chemical
Sentence: 250,and,O
Sentence: 250,the,O
Sentence: 250,occurrence,O
Sentence: 250,of,O
Sentence: 250,the,O
Sentence: 250,skin,B-Disease
Sentence: 250,rash,I-Disease
Sentence: 250,",",O
Sentence: 250,lymphadenopathy,B-Disease
Sentence: 250,and,O
Sentence: 250,pure,B-Disease
Sentence: 250,red,I-Disease
Sentence: 250,cell,I-Disease
Sentence: 250,aplasia,I-Disease
Sentence: 250,is,O
Sentence: 250,very,O
Sentence: 250,suggestive,O
Sentence: 250,of,O
Sentence: 250,a,O
Sentence: 250,direct,O
Sentence: 250,connection,O
Sentence: 250,.,O
Sentence: 251,Continuous,O
Sentence: 251,infusion,O
Sentence: 251,tobramycin,B-Chemical
Sentence: 251,combined,O
Sentence: 251,with,O
Sentence: 251,carbenicillin,B-Chemical
Sentence: 251,for,O
Sentence: 251,infections,B-Disease
Sentence: 251,in,O
Sentence: 251,cancer,B-Disease
Sentence: 251,patients,O
Sentence: 251,.,O
Sentence: 252,The,O
Sentence: 252,cure,O
Sentence: 252,rate,O
Sentence: 252,of,O
Sentence: 252,infections,B-Disease
Sentence: 252,in,O
Sentence: 252,cancer,B-Disease
Sentence: 252,patients,O
Sentence: 252,is,O
Sentence: 252,adversely,O
Sentence: 252,affected,O
Sentence: 252,by,O
Sentence: 252,neutropenia,B-Disease
Sentence: 252,(,O
Sentence: 252,less,O
Sentence: 252,than,O
Sentence: 252,"1,000",O
Sentence: 252,/,O
Sentence: 252,mm3,O
Sentence: 252,),O
Sentence: 252,.,O
Sentence: 252,In,O
Sentence: 252,particular,O
Sentence: 252,",",O
Sentence: 252,patients,O
Sentence: 252,with,O
Sentence: 252,severe,O
Sentence: 252,neutropenia,B-Disease
Sentence: 252,(,O
Sentence: 252,less,O
Sentence: 252,than,O
Sentence: 252,100,O
Sentence: 252,/,O
Sentence: 252,mm3,O
Sentence: 252,),O
Sentence: 252,have,O
Sentence: 252,shown,O
Sentence: 252,a,O
Sentence: 252,poor,O
Sentence: 252,response,O
Sentence: 252,to,O
Sentence: 252,antibiotics,O
Sentence: 252,.,O
Sentence: 252,To,O
Sentence: 252,overcome,O
Sentence: 252,the,O
Sentence: 252,adverse,O
Sentence: 252,effects,O
Sentence: 252,of,O
Sentence: 252,neutropenia,B-Disease
Sentence: 252,",",O
Sentence: 252,tobramycin,B-Chemical
Sentence: 252,was,O
Sentence: 252,given,O
Sentence: 252,by,O
Sentence: 252,continuous,O
Sentence: 252,infusion,O
Sentence: 252,and,O
Sentence: 252,combined,O
Sentence: 252,with,O
Sentence: 252,intermittent,O
Sentence: 252,carbenicillin,B-Chemical
Sentence: 252,.,O
Sentence: 252,Tobramycin,B-Chemical
Sentence: 252,was,O
Sentence: 252,given,O
Sentence: 252,to,O
Sentence: 252,a,O
Sentence: 252,total,O
Sentence: 252,daily,O
Sentence: 252,dose,O
Sentence: 252,of,O
Sentence: 252,300,O
Sentence: 252,mg,O
Sentence: 252,/,O
Sentence: 252,m2,O
Sentence: 252,and,O
Sentence: 252,carbenicillin,B-Chemical
Sentence: 252,was,O
Sentence: 252,given,O
Sentence: 252,at,O
Sentence: 252,a,O
Sentence: 252,dose,O
Sentence: 252,of,O
Sentence: 252,5,O
Sentence: 252,gm,O
Sentence: 252,every,O
Sentence: 252,four,O
Sentence: 252,hours,O
Sentence: 252,.,O
Sentence: 252,There,O
Sentence: 252,were,O
Sentence: 252,125,O
Sentence: 252,infectious,O
Sentence: 252,episodes,O
Sentence: 252,in,O
Sentence: 252,116,O
Sentence: 252,cancer,B-Disease
Sentence: 252,patients,O
Sentence: 252,receiving,O
Sentence: 252,myelosuppressive,O
Sentence: 252,chemotherapy,O
Sentence: 252,.,O
Sentence: 252,The,O
Sentence: 252,overall,O
Sentence: 252,cure,O
Sentence: 252,rate,O
Sentence: 252,was,O
Sentence: 252,70,O
Sentence: 252,%,O
Sentence: 252,.,O
Sentence: 252,Pneumonia,B-Disease
Sentence: 252,was,O
Sentence: 252,the,O
Sentence: 252,most,O
Sentence: 252,common,O
Sentence: 252,infection,B-Disease
Sentence: 252,and,O
Sentence: 252,61,O
Sentence: 252,%,O
Sentence: 252,of,O
Sentence: 252,59,O
Sentence: 252,episodes,O
Sentence: 252,were,O
Sentence: 252,cured,O
Sentence: 252,.,O
Sentence: 252,Gram,O
Sentence: 252,-,O
Sentence: 252,negative,O
Sentence: 252,bacilli,O
Sentence: 252,were,O
Sentence: 252,the,O
Sentence: 252,most,O
Sentence: 252,common,O
Sentence: 252,causative,O
Sentence: 252,organisms,O
Sentence: 252,and,O
Sentence: 252,69,O
Sentence: 252,%,O
Sentence: 252,of,O
Sentence: 252,these,O
Sentence: 252,infections,B-Disease
Sentence: 252,were,O
Sentence: 252,cured,O
Sentence: 252,.,O
Sentence: 252,The,O
Sentence: 252,most,O
Sentence: 252,common,O
Sentence: 252,pathogen,O
Sentence: 252,was,O
Sentence: 252,Klebsiella,O
Sentence: 252,pneumoniae,B-Disease
Sentence: 252,and,O
Sentence: 252,this,O
Sentence: 252,",",O
Sentence: 252,together,O
Sentence: 252,with,O
Sentence: 252,Escherichia,O
Sentence: 252,coli,O
Sentence: 252,and,O
Sentence: 252,Pseudomonas,O
Sentence: 252,aeruginosa,O
Sentence: 252,",",O
Sentence: 252,accounted,O
Sentence: 252,for,O
Sentence: 252,74,O
Sentence: 252,%,O
Sentence: 252,of,O
Sentence: 252,all,O
Sentence: 252,gram,O
Sentence: 252,-,O
Sentence: 252,negative,O
Sentence: 252,bacillary,O
Sentence: 252,infections,B-Disease
Sentence: 252,.,O
Sentence: 252,Response,O
Sentence: 252,was,O
Sentence: 252,not,O
Sentence: 252,influenced,O
Sentence: 252,by,O
Sentence: 252,the,O
Sentence: 252,initial,O
Sentence: 252,neutrophil,O
Sentence: 252,count,O
Sentence: 252,",",O
Sentence: 252,with,O
Sentence: 252,a,O
Sentence: 252,62,O
Sentence: 252,%,O
Sentence: 252,cure,O
Sentence: 252,rate,O
Sentence: 252,for,O
Sentence: 252,39,O
Sentence: 252,episodes,O
Sentence: 252,associated,O
Sentence: 252,with,O
Sentence: 252,severe,O
Sentence: 252,neutropenia,B-Disease
Sentence: 252,.,O
Sentence: 252,However,O
Sentence: 252,",",O
Sentence: 252,failure,O
Sentence: 252,of,O
Sentence: 252,the,O
Sentence: 252,neutrophil,O
Sentence: 252,count,O
Sentence: 252,to,O
Sentence: 252,increase,O
Sentence: 252,during,O
Sentence: 252,therapy,O
Sentence: 252,adversely,O
Sentence: 252,affected,O
Sentence: 252,response,O
Sentence: 252,.,O
Sentence: 252,Azotemia,B-Disease
Sentence: 252,was,O
Sentence: 252,the,O
Sentence: 252,major,O
Sentence: 252,side,O
Sentence: 252,effect,O
Sentence: 252,recognized,O
Sentence: 252,",",O
Sentence: 252,and,O
Sentence: 252,it,O
Sentence: 252,occurred,O
Sentence: 252,in,O
Sentence: 252,11,O
Sentence: 252,%,O
Sentence: 252,of,O
Sentence: 252,episodes,O
Sentence: 252,.,O
Sentence: 252,Major,O
Sentence: 252,azotemia,B-Disease
Sentence: 252,(,O
Sentence: 252,serum,O
Sentence: 252,creatinine,B-Chemical
Sentence: 252,greater,O
Sentence: 252,than,O
Sentence: 252,2.5,O
Sentence: 252,mg,O
Sentence: 252,/,O
Sentence: 252,dl,O
Sentence: 252,or,O
Sentence: 252,BUN,O
Sentence: 252,greater,O
Sentence: 252,than,O
Sentence: 252,50,O
Sentence: 252,mg,O
Sentence: 252,/,O
Sentence: 252,dl,O
Sentence: 252,),O
Sentence: 252,occurred,O
Sentence: 252,in,O
Sentence: 252,only,O
Sentence: 252,2,O
Sentence: 252,%,O
Sentence: 252,.,O
Sentence: 252,Azotemia,B-Disease
Sentence: 252,was,O
Sentence: 252,not,O
Sentence: 252,related,O
Sentence: 252,to,O
Sentence: 252,duration,O
Sentence: 252,of,O
Sentence: 252,therapy,O
Sentence: 252,or,O
Sentence: 252,serum,O
Sentence: 252,tobramycin,B-Chemical
Sentence: 252,concentration,O
Sentence: 252,.,O
Sentence: 252,This,O
Sentence: 252,antibiotic,O
Sentence: 252,regimen,O
Sentence: 252,showed,O
Sentence: 252,both,O
Sentence: 252,therapeutic,O
Sentence: 252,efficacy,O
Sentence: 252,and,O
Sentence: 252,acceptable,O
Sentence: 252,renal,B-Disease
Sentence: 252,toxicity,I-Disease
Sentence: 252,for,O
Sentence: 252,these,O
Sentence: 252,patients,O
Sentence: 252,.,O
Sentence: 253,Recurrent,O
Sentence: 253,subarachnoid,B-Disease
Sentence: 253,hemorrhage,I-Disease
Sentence: 253,associated,O
Sentence: 253,with,O
Sentence: 253,aminocaproic,B-Chemical
Sentence: 253,acid,I-Chemical
Sentence: 253,therapy,O
Sentence: 253,and,O
Sentence: 253,acute,B-Disease
Sentence: 253,renal,I-Disease
Sentence: 253,artery,I-Disease
Sentence: 253,thrombosis,I-Disease
Sentence: 253,.,O
Sentence: 253,Case,O
Sentence: 253,report,O
Sentence: 253,.,O
Sentence: 254,Epsilon,B-Chemical
Sentence: 254,aminocaproic,I-Chemical
Sentence: 254,acid,I-Chemical
Sentence: 254,(,O
Sentence: 254,EACA,B-Chemical
Sentence: 254,),O
Sentence: 254,has,O
Sentence: 254,been,O
Sentence: 254,used,O
Sentence: 254,to,O
Sentence: 254,prevent,O
Sentence: 254,rebleeding,O
Sentence: 254,in,O
Sentence: 254,patients,O
Sentence: 254,with,O
Sentence: 254,subarachnoid,B-Disease
Sentence: 254,hemorrhage,I-Disease
Sentence: 254,(,O
Sentence: 254,SAH,B-Disease
Sentence: 254,),O
Sentence: 254,.,O
Sentence: 254,Although,O
Sentence: 254,this,O
Sentence: 254,agent,O
Sentence: 254,does,O
Sentence: 254,decrease,O
Sentence: 254,the,O
Sentence: 254,frequency,O
Sentence: 254,of,O
Sentence: 254,rebleeding,O
Sentence: 254,",",O
Sentence: 254,several,O
Sentence: 254,reports,O
Sentence: 254,have,O
Sentence: 254,described,O
Sentence: 254,thrombotic,B-Disease
Sentence: 254,complications,O
Sentence: 254,of,O
Sentence: 254,EACA,B-Chemical
Sentence: 254,therapy,O
Sentence: 254,.,O
Sentence: 254,These,O
Sentence: 254,complications,O
Sentence: 254,have,O
Sentence: 254,included,O
Sentence: 254,clinical,O
Sentence: 254,deterioration,O
Sentence: 254,and,O
Sentence: 254,intracranial,B-Disease
Sentence: 254,vascular,I-Disease
Sentence: 254,thrombosis,I-Disease
Sentence: 254,in,O
Sentence: 254,patients,O
Sentence: 254,with,O
Sentence: 254,SAH,B-Disease
Sentence: 254,",",O
Sentence: 254,arteriolar,O
Sentence: 254,and,O
Sentence: 254,capillary,O
Sentence: 254,fibrin,O
Sentence: 254,thrombi,B-Disease
Sentence: 254,in,O
Sentence: 254,patients,O
Sentence: 254,with,O
Sentence: 254,fibrinolytic,O
Sentence: 254,syndromes,O
Sentence: 254,treated,O
Sentence: 254,with,O
Sentence: 254,EACA,B-Chemical
Sentence: 254,",",O
Sentence: 254,or,O
Sentence: 254,other,O
Sentence: 254,thromboembolic,B-Disease
Sentence: 254,phenomena,I-Disease
Sentence: 254,.,O
Sentence: 254,Since,O
Sentence: 254,intravascular,O
Sentence: 254,fibrin,O
Sentence: 254,thrombi,B-Disease
Sentence: 254,are,O
Sentence: 254,often,O
Sentence: 254,observed,O
Sentence: 254,in,O
Sentence: 254,patients,O
Sentence: 254,with,O
Sentence: 254,fibrinolytic,O
Sentence: 254,disorders,O
Sentence: 254,",",O
Sentence: 254,EACA,B-Chemical
Sentence: 254,should,O
Sentence: 254,not,O
Sentence: 254,be,O
Sentence: 254,implicated,O
Sentence: 254,in,O
Sentence: 254,the,O
Sentence: 254,pathogenesis,O
Sentence: 254,of,O
Sentence: 254,fibrin,O
Sentence: 254,thrombi,B-Disease
Sentence: 254,in,O
Sentence: 254,patients,O
Sentence: 254,with,O
Sentence: 254,disseminated,B-Disease
Sentence: 254,intravascular,I-Disease
Sentence: 254,coagulation,I-Disease
Sentence: 254,or,O
Sentence: 254,other,O
Sentence: 254,``,O
Sentence: 254,consumption,B-Disease
Sentence: 254,coagulopathies,I-Disease
Sentence: 254,.,O
Sentence: 254,'',O
Sentence: 254,This,O
Sentence: 254,report,O
Sentence: 254,describes,O
Sentence: 254,subtotal,O
Sentence: 254,infarction,B-Disease
Sentence: 254,of,O
Sentence: 254,the,O
Sentence: 254,kidney,O
Sentence: 254,due,O
Sentence: 254,to,O
Sentence: 254,thrombosis,B-Disease
Sentence: 254,of,I-Disease
Sentence: 254,a,I-Disease
Sentence: 254,normal,I-Disease
Sentence: 254,renal,I-Disease
Sentence: 254,artery,I-Disease
Sentence: 254,.,O
Sentence: 254,This,O
Sentence: 254,occlusion,O
Sentence: 254,occurred,O
Sentence: 254,after,O
Sentence: 254,EACA,B-Chemical
Sentence: 254,therapy,O
Sentence: 254,in,O
Sentence: 254,a,O
Sentence: 254,patient,O
Sentence: 254,with,O
Sentence: 254,SAH,B-Disease
Sentence: 254,and,O
Sentence: 254,histopathological,O
Sentence: 254,documentation,O
Sentence: 254,of,O
Sentence: 254,recurrent,O
Sentence: 254,SAH,B-Disease
Sentence: 254,.,O
Sentence: 254,The,O
Sentence: 254,corresponding,O
Sentence: 254,clinical,O
Sentence: 254,event,O
Sentence: 254,was,O
Sentence: 254,characterized,O
Sentence: 254,by,O
Sentence: 254,marked,O
Sentence: 254,hypertension,B-Disease
Sentence: 254,and,O
Sentence: 254,abrupt,O
Sentence: 254,neurological,O
Sentence: 254,deterioration,O
Sentence: 254,.,O
Sentence: 255,Long,O
Sentence: 255,-,O
Sentence: 255,term,O
Sentence: 255,propranolol,O
Sentence: 255,therapy,O
Sentence: 255,in,O
Sentence: 255,pregnancy,O
Sentence: 255,:,O
Sentence: 255,maternal,O
Sentence: 255,and,O
Sentence: 255,fetal,O
Sentence: 255,outcome,O
Sentence: 255,.,O
Sentence: 256,Propranolol,B-Chemical
Sentence: 256,",",O
Sentence: 256,a,O
Sentence: 256,beta,O
Sentence: 256,-,O
Sentence: 256,adrenergic,O
Sentence: 256,blocking,O
Sentence: 256,agent,O
Sentence: 256,",",O
Sentence: 256,has,O
Sentence: 256,found,O
Sentence: 256,an,O
Sentence: 256,important,O
Sentence: 256,position,O
Sentence: 256,in,O
Sentence: 256,the,O
Sentence: 256,practice,O
Sentence: 256,of,O
Sentence: 256,medicine,O
Sentence: 256,.,O
Sentence: 256,Its,O
Sentence: 256,use,O
Sentence: 256,in,O
Sentence: 256,pregnancy,O
Sentence: 256,",",O
Sentence: 256,however,O
Sentence: 256,",",O
Sentence: 256,is,O
Sentence: 256,an,O
Sentence: 256,open,O
Sentence: 256,question,O
Sentence: 256,as,O
Sentence: 256,a,O
Sentence: 256,number,O
Sentence: 256,of,O
Sentence: 256,detrimental,O
Sentence: 256,side,O
Sentence: 256,effects,O
Sentence: 256,have,O
Sentence: 256,been,O
Sentence: 256,reported,O
Sentence: 256,in,O
Sentence: 256,the,O
Sentence: 256,fetus,O
Sentence: 256,and,O
Sentence: 256,neonate,O
Sentence: 256,.,O
Sentence: 256,Ten,O
Sentence: 256,patients,O
Sentence: 256,and,O
Sentence: 256,12,O
Sentence: 256,pregnancies,O
Sentence: 256,are,O
Sentence: 256,reported,O
Sentence: 256,where,O
Sentence: 256,chronic,O
Sentence: 256,propranolol,B-Chemical
Sentence: 256,has,O
Sentence: 256,been,O
Sentence: 256,administered,O
Sentence: 256,.,O
Sentence: 256,Five,O
Sentence: 256,patients,O
Sentence: 256,with,O
Sentence: 256,serial,O
Sentence: 256,pregnancies,O
Sentence: 256,with,O
Sentence: 256,and,O
Sentence: 256,without,O
Sentence: 256,propranolol,B-Chemical
Sentence: 256,therapy,O
Sentence: 256,are,O
Sentence: 256,also,O
Sentence: 256,examined,O
Sentence: 256,.,O
Sentence: 256,Maternal,O
Sentence: 256,",",O
Sentence: 256,fetal,O
Sentence: 256,",",O
Sentence: 256,and,O
Sentence: 256,neonatal,O
Sentence: 256,complications,O
Sentence: 256,are,O
Sentence: 256,examined,O
Sentence: 256,.,O
Sentence: 256,An,O
Sentence: 256,attempt,O
Sentence: 256,is,O
Sentence: 256,made,O
Sentence: 256,to,O
Sentence: 256,differentiate,O
Sentence: 256,drug,O
Sentence: 256,-,O
Sentence: 256,related,O
Sentence: 256,complications,O
Sentence: 256,from,O
Sentence: 256,maternal,O
Sentence: 256,disease,O
Sentence: 256,,O
Sentence: 256,-,O
Sentence: 256,,O
Sentence: 256,-,O
Sentence: 256,,O
Sentence: 256,related,O
Sentence: 256,complications,O
Sentence: 256,.,O
Sentence: 256,We,O
Sentence: 256,conclude,O
Sentence: 256,that,O
Sentence: 256,previously,O
Sentence: 256,reported,O
Sentence: 256,hypoglycemia,B-Disease
Sentence: 256,",",O
Sentence: 256,hyperbilirubinemia,B-Disease
Sentence: 256,",",O
Sentence: 256,polycythemia,B-Disease
Sentence: 256,",",O
Sentence: 256,neonatal,B-Disease
Sentence: 256,apnea,I-Disease
Sentence: 256,",",O
Sentence: 256,and,O
Sentence: 256,bradycardia,B-Disease
Sentence: 256,are,O
Sentence: 256,not,O
Sentence: 256,invariable,O
Sentence: 256,and,O
Sentence: 256,can,O
Sentence: 256,not,O
Sentence: 256,be,O
Sentence: 256,statistically,O
Sentence: 256,correlated,O
Sentence: 256,with,O
Sentence: 256,chronic,O
Sentence: 256,propranolol,B-Chemical
Sentence: 256,therapy,O
Sentence: 256,.,O
Sentence: 256,Growth,B-Disease
Sentence: 256,retardation,I-Disease
Sentence: 256,",",O
Sentence: 256,however,O
Sentence: 256,",",O
Sentence: 256,appears,O
Sentence: 256,to,O
Sentence: 256,be,O
Sentence: 256,significant,O
Sentence: 256,in,O
Sentence: 256,both,O
Sentence: 256,of,O
Sentence: 256,our,O
Sentence: 256,series,O
Sentence: 256,.,O
Sentence: 257,Use,O
Sentence: 257,of,O
Sentence: 257,propranolol,B-Chemical
Sentence: 257,in,O
Sentence: 257,the,O
Sentence: 257,treatment,O
Sentence: 257,of,O
Sentence: 257,idiopathic,B-Disease
Sentence: 257,orthostatic,I-Disease
Sentence: 257,hypotension,I-Disease
Sentence: 257,.,O
Sentence: 258,Five,O
Sentence: 258,patients,O
Sentence: 258,with,O
Sentence: 258,idiopathic,B-Disease
Sentence: 258,orthostatic,I-Disease
Sentence: 258,hypotension,I-Disease
Sentence: 258,who,O
Sentence: 258,had,O
Sentence: 258,physiologic,O
Sentence: 258,and,O
Sentence: 258,biochemical,O
Sentence: 258,evidence,O
Sentence: 258,of,O
Sentence: 258,severe,O
Sentence: 258,autonomic,O
Sentence: 258,dysfunction,O
Sentence: 258,were,O
Sentence: 258,included,O
Sentence: 258,in,O
Sentence: 258,the,O
Sentence: 258,study,O
Sentence: 258,.,O
Sentence: 258,They,O
Sentence: 258,all,O
Sentence: 258,exhibited,O
Sentence: 258,markedly,O
Sentence: 258,reduced,O
Sentence: 258,plasma,O
Sentence: 258,catecholamines,B-Chemical
Sentence: 258,and,O
Sentence: 258,plasma,O
Sentence: 258,renin,O
Sentence: 258,activity,O
Sentence: 258,in,O
Sentence: 258,both,O
Sentence: 258,recumbent,O
Sentence: 258,and,O
Sentence: 258,upright,O
Sentence: 258,positions,O
Sentence: 258,and,O
Sentence: 258,had,O
Sentence: 258,marked,O
Sentence: 258,hypersensitivity,B-Disease
Sentence: 258,to,O
Sentence: 258,the,O
Sentence: 258,pressor,O
Sentence: 258,effects,O
Sentence: 258,of,O
Sentence: 258,infused,O
Sentence: 258,norepinephrine,B-Chemical
Sentence: 258,.,O
Sentence: 258,Treatment,O
Sentence: 258,with,O
Sentence: 258,propanolol,B-Chemical
Sentence: 258,administered,O
Sentence: 258,intravenously,O
Sentence: 258,(,O
Sentence: 258,1,O
Sentence: 258,-,O
Sentence: 258,5,O
Sentence: 258,mg,O
Sentence: 258,),O
Sentence: 258,produced,O
Sentence: 258,increases,O
Sentence: 258,in,O
Sentence: 258,supine,O
Sentence: 258,and,O
Sentence: 258,upright,O
Sentence: 258,blood,O
Sentence: 258,pressure,O
Sentence: 258,in,O
Sentence: 258,4,O
Sentence: 258,of,O
Sentence: 258,the,O
Sentence: 258,5,O
Sentence: 258,individuals,O
Sentence: 258,with,O
Sentence: 258,rises,O
Sentence: 258,ranging,O
Sentence: 258,from,O
Sentence: 258,11,O
Sentence: 258,/,O
Sentence: 258,6,O
Sentence: 258,to,O
Sentence: 258,22,O
Sentence: 258,/,O
Sentence: 258,11,O
Sentence: 258,mmHg,O
Sentence: 258,.,O
Sentence: 258,Chronic,O
Sentence: 258,oral,O
Sentence: 258,administration,O
Sentence: 258,of,O
Sentence: 258,propranolol,B-Chemical
Sentence: 258,(,O
Sentence: 258,40,O
Sentence: 258,-,O
Sentence: 258,160,O
Sentence: 258,mg,O
Sentence: 258,/,O
Sentence: 258,day,O
Sentence: 258,),O
Sentence: 258,also,O
Sentence: 258,elevated,O
Sentence: 258,the,O
Sentence: 258,blood,O
Sentence: 258,pressures,O
Sentence: 258,of,O
Sentence: 258,these,O
Sentence: 258,individuals,O
Sentence: 258,with,O
Sentence: 258,increases,O
Sentence: 258,in,O
Sentence: 258,the,O
Sentence: 258,order,O
Sentence: 258,of,O
Sentence: 258,20,O
Sentence: 258,-,O
Sentence: 258,35,O
Sentence: 258,/,O
Sentence: 258,15,O
Sentence: 258,-,O
Sentence: 258,25,O
Sentence: 258,mmg,O
Sentence: 258,being,O
Sentence: 258,observed,O
Sentence: 258,.,O
Sentence: 258,In,O
Sentence: 258,1,O
Sentence: 258,patient,O
Sentence: 258,",",O
Sentence: 258,marked,O
Sentence: 258,hypertension,B-Disease
Sentence: 258,was,O
Sentence: 258,induced,O
Sentence: 258,by,O
Sentence: 258,propranolol,B-Chemical
Sentence: 258,and,O
Sentence: 258,the,O
Sentence: 258,drug,O
Sentence: 258,had,O
Sentence: 258,to,O
Sentence: 258,be,O
Sentence: 258,withdrawn,O
Sentence: 258,.,O
Sentence: 258,It,O
Sentence: 258,otherwise,O
Sentence: 258,was,O
Sentence: 258,well,O
Sentence: 258,tolerated,O
Sentence: 258,and,O
Sentence: 258,no,O
Sentence: 258,important,O
Sentence: 258,side,O
Sentence: 258,effects,O
Sentence: 258,were,O
Sentence: 258,observed,O
Sentence: 258,.,O
Sentence: 258,Treatment,O
Sentence: 258,has,O
Sentence: 258,been,O
Sentence: 258,continued,O
Sentence: 258,in,O
Sentence: 258,3,O
Sentence: 258,individuals,O
Sentence: 258,for,O
Sentence: 258,6,O
Sentence: 258,-,O
Sentence: 258,13,O
Sentence: 258,months,O
Sentence: 258,with,O
Sentence: 258,persistence,O
Sentence: 258,of,O
Sentence: 258,the,O
Sentence: 258,pressor,O
Sentence: 258,effect,O
Sentence: 258,",",O
Sentence: 258,although,O
Sentence: 258,there,O
Sentence: 258,appears,O
Sentence: 258,to,O
Sentence: 258,have,O
Sentence: 258,been,O
Sentence: 258,some,O
Sentence: 258,decrease,O
Sentence: 258,in,O
Sentence: 258,the,O
Sentence: 258,degree,O
Sentence: 258,of,O
Sentence: 258,response,O
Sentence: 258,with,O
Sentence: 258,time,O
Sentence: 258,.,O
Sentence: 258,Hemodynamic,O
Sentence: 258,measurements,O
Sentence: 258,in,O
Sentence: 258,1,O
Sentence: 258,of,O
Sentence: 258,the,O
Sentence: 258,patients,O
Sentence: 258,demonstrated,O
Sentence: 258,an,O
Sentence: 258,increase,O
Sentence: 258,in,O
Sentence: 258,total,O
Sentence: 258,peripheral,O
Sentence: 258,resistance,O
Sentence: 258,and,O
Sentence: 258,essentially,O
Sentence: 258,no,O
Sentence: 258,change,O
Sentence: 258,in,O
Sentence: 258,cardiac,O
Sentence: 258,output,O
Sentence: 258,following,O
Sentence: 258,propranolol,B-Chemical
Sentence: 258,therapy,O
Sentence: 258,.,O
Sentence: 258,The,O
Sentence: 258,studies,O
Sentence: 258,suggest,O
Sentence: 258,that,O
Sentence: 258,propranolol,B-Chemical
Sentence: 258,is,O
Sentence: 258,a,O
Sentence: 258,useful,O
Sentence: 258,drug,O
Sentence: 258,in,O
Sentence: 258,selected,O
Sentence: 258,patients,O
Sentence: 258,with,O
Sentence: 258,severe,O
Sentence: 258,idiopathic,B-Disease
Sentence: 258,orthostatic,I-Disease
Sentence: 258,hypotension,I-Disease
Sentence: 258,.,O
Sentence: 259,Total,O
Sentence: 259,intravenous,O
Sentence: 259,anesthesia,O
Sentence: 259,with,O
Sentence: 259,etomidate,O
Sentence: 259,.,O
Sentence: 259,III,O
Sentence: 259,.,O
Sentence: 259,Some,O
Sentence: 259,observations,O
Sentence: 259,in,O
Sentence: 259,adults,O
Sentence: 259,.,O
Sentence: 260,An,O
Sentence: 260,investigation,O
Sentence: 260,was,O
Sentence: 260,undertaken,O
Sentence: 260,to,O
Sentence: 260,determine,O
Sentence: 260,the,O
Sentence: 260,dosage,O
Sentence: 260,of,O
Sentence: 260,etomidate,B-Chemical
Sentence: 260,required,O
Sentence: 260,to,O
Sentence: 260,maintain,O
Sentence: 260,sleep,O
Sentence: 260,in,O
Sentence: 260,adults,O
Sentence: 260,undergoing,O
Sentence: 260,surgery,O
Sentence: 260,under,O
Sentence: 260,regional,O
Sentence: 260,local,O
Sentence: 260,anesthesia,O
Sentence: 260,.,O
Sentence: 260,Premedication,O
Sentence: 260,of,O
Sentence: 260,diazepam,B-Chemical
Sentence: 260,10,O
Sentence: 260,mg,O
Sentence: 260,and,O
Sentence: 260,atropine,B-Chemical
Sentence: 260,0.5,O
Sentence: 260,mg,O
Sentence: 260,was,O
Sentence: 260,given,O
Sentence: 260,",",O
Sentence: 260,and,O
Sentence: 260,sleep,O
Sentence: 260,was,O
Sentence: 260,induced,O
Sentence: 260,and,O
Sentence: 260,maintained,O
Sentence: 260,by,O
Sentence: 260,intermittent,O
Sentence: 260,intravenous,O
Sentence: 260,injections,O
Sentence: 260,of,O
Sentence: 260,etomidate,B-Chemical
Sentence: 260,0.1,O
Sentence: 260,/,O
Sentence: 260,mg,O
Sentence: 260,/,O
Sentence: 260,kg,O
Sentence: 260,",",O
Sentence: 260,given,O
Sentence: 260,whenever,O
Sentence: 260,the,O
Sentence: 260,patient,O
Sentence: 260,would,O
Sentence: 260,open,O
Sentence: 260,his,O
Sentence: 260,eyes,O
Sentence: 260,on,O
Sentence: 260,request,O
Sentence: 260,.,O
Sentence: 260,A,O
Sentence: 260,mean,O
Sentence: 260,overall,O
Sentence: 260,dose,O
Sentence: 260,of,O
Sentence: 260,etomidate,B-Chemical
Sentence: 260,17.4,O
Sentence: 260,microgram,O
Sentence: 260,/,O
Sentence: 260,kg,O
Sentence: 260,/,O
Sentence: 260,min,O
Sentence: 260,.,O
Sentence: 260,was,O
Sentence: 260,required,O
Sentence: 260,to,O
Sentence: 260,maintain,O
Sentence: 260,sleep,O
Sentence: 260,",",O
Sentence: 260,but,O
Sentence: 260,great,O
Sentence: 260,individual,O
Sentence: 260,variation,O
Sentence: 260,occurred,O
Sentence: 260,",",O
Sentence: 260,with,O
Sentence: 260,older,O
Sentence: 260,patients,O
Sentence: 260,requiring,O
Sentence: 260,less,O
Sentence: 260,drug,O
Sentence: 260,.,O
Sentence: 260,The,O
Sentence: 260,investigation,O
Sentence: 260,was,O
Sentence: 260,discontinued,O
Sentence: 260,after,O
Sentence: 260,18,O
Sentence: 260,patients,O
Sentence: 260,because,O
Sentence: 260,of,O
Sentence: 260,the,O
Sentence: 260,frequency,O
Sentence: 260,and,O
Sentence: 260,intensity,O
Sentence: 260,of,O
Sentence: 260,side,O
Sentence: 260,-,O
Sentence: 260,effects,O
Sentence: 260,",",O
Sentence: 260,particularly,O
Sentence: 260,pain,B-Disease
Sentence: 260,and,O
Sentence: 260,myoclonia,B-Disease
Sentence: 260,",",O
Sentence: 260,which,O
Sentence: 260,caused,O
Sentence: 260,the,O
Sentence: 260,technique,O
Sentence: 260,to,O
Sentence: 260,be,O
Sentence: 260,abandoned,O
Sentence: 260,in,O
Sentence: 260,two,O
Sentence: 260,cases,O
Sentence: 260,.,O
Sentence: 260,It,O
Sentence: 260,is,O
Sentence: 260,considered,O
Sentence: 260,unlikely,O
Sentence: 260,that,O
Sentence: 260,etomidate,B-Chemical
Sentence: 260,will,O
Sentence: 260,prove,O
Sentence: 260,to,O
Sentence: 260,be,O
Sentence: 260,the,O
Sentence: 260,hypnotic,O
Sentence: 260,of,O
Sentence: 260,choice,O
Sentence: 260,for,O
Sentence: 260,a,O
Sentence: 260,totally,O
Sentence: 260,intravenous,O
Sentence: 260,anesthetic,O
Sentence: 260,technique,O
Sentence: 260,in,O
Sentence: 260,adults,O
Sentence: 260,because,O
Sentence: 260,of,O
Sentence: 260,the,O
Sentence: 260,high,O
Sentence: 260,incidence,O
Sentence: 260,of,O
Sentence: 260,myoclonia,B-Disease
Sentence: 260,after,O
Sentence: 260,prolonged,O
Sentence: 260,administration,O
Sentence: 260,.,O
Sentence: 260,In,O
Sentence: 260,several,O
Sentence: 260,patients,O
Sentence: 260,uncontrollable,O
Sentence: 260,muscle,O
Sentence: 260,movements,O
Sentence: 260,persisted,O
Sentence: 260,for,O
Sentence: 260,many,O
Sentence: 260,minutes,O
Sentence: 260,after,O
Sentence: 260,complete,O
Sentence: 260,recovery,O
Sentence: 260,of,O
Sentence: 260,consciousness,O
Sentence: 260,.,O
Sentence: 261,A,O
Sentence: 261,method,O
Sentence: 261,for,O
Sentence: 261,the,O
Sentence: 261,measurement,O
Sentence: 261,of,O
Sentence: 261,tremor,O
Sentence: 261,",",O
Sentence: 261,and,O
Sentence: 261,a,O
Sentence: 261,comparison,O
Sentence: 261,of,O
Sentence: 261,the,O
Sentence: 261,effects,O
Sentence: 261,of,O
Sentence: 261,tocolytic,O
Sentence: 261,beta,O
Sentence: 261,-,O
Sentence: 261,mimetics,O
Sentence: 261,.,O
Sentence: 262,A,O
Sentence: 262,method,O
Sentence: 262,permitting,O
Sentence: 262,measurement,O
Sentence: 262,of,O
Sentence: 262,finger,O
Sentence: 262,tremor,B-Disease
Sentence: 262,as,O
Sentence: 262,a,O
Sentence: 262,displacement,O
Sentence: 262,-,O
Sentence: 262,time,O
Sentence: 262,curve,O
Sentence: 262,is,O
Sentence: 262,described,O
Sentence: 262,",",O
Sentence: 262,using,O
Sentence: 262,a,O
Sentence: 262,test,O
Sentence: 262,system,O
Sentence: 262,with,O
Sentence: 262,simple,O
Sentence: 262,amplitude,O
Sentence: 262,calibration,O
Sentence: 262,.,O
Sentence: 262,The,O
Sentence: 262,coordinates,O
Sentence: 262,of,O
Sentence: 262,the,O
Sentence: 262,inversion,O
Sentence: 262,points,O
Sentence: 262,of,O
Sentence: 262,the,O
Sentence: 262,displacement,O
Sentence: 262,-,O
Sentence: 262,time,O
Sentence: 262,curves,O
Sentence: 262,were,O
Sentence: 262,transferred,O
Sentence: 262,through,O
Sentence: 262,graphical,O
Sentence: 262,input,O
Sentence: 262,equipment,O
Sentence: 262,to,O
Sentence: 262,punched,O
Sentence: 262,tape,O
Sentence: 262,.,O
Sentence: 262,By,O
Sentence: 262,means,O
Sentence: 262,of,O
Sentence: 262,a,O
Sentence: 262,computer,O
Sentence: 262,program,O
Sentence: 262,",",O
Sentence: 262,periods,O
Sentence: 262,and,O
Sentence: 262,amplitudes,O
Sentence: 262,of,O
Sentence: 262,tremor,B-Disease
Sentence: 262,oscillations,O
Sentence: 262,were,O
Sentence: 262,calculated,O
Sentence: 262,and,O
Sentence: 262,classified,O
Sentence: 262,.,O
Sentence: 262,The,O
Sentence: 262,event,O
Sentence: 262,frequency,O
Sentence: 262,for,O
Sentence: 262,each,O
Sentence: 262,class,O
Sentence: 262,of,O
Sentence: 262,periods,O
Sentence: 262,and,O
Sentence: 262,amplitudes,O
Sentence: 262,was,O
Sentence: 262,determined,O
Sentence: 262,.,O
Sentence: 262,The,O
Sentence: 262,actions,O
Sentence: 262,of,O
Sentence: 262,fenoterol,O
Sentence: 262,-,O
Sentence: 262,hydrobromide,O
Sentence: 262,",",O
Sentence: 262,ritodrin,O
Sentence: 262,-,O
Sentence: 262,HCl,O
Sentence: 262,and,O
Sentence: 262,placebo,O
Sentence: 262,given,O
Sentence: 262,to,O
Sentence: 262,10,O
Sentence: 262,healthy,O
Sentence: 262,subjects,O
Sentence: 262,by,O
Sentence: 262,intravenous,O
Sentence: 262,infusion,O
Sentence: 262,in,O
Sentence: 262,a,O
Sentence: 262,double,O
Sentence: 262,-,O
Sentence: 262,blind,O
Sentence: 262,crossover,O
Sentence: 262,study,O
Sentence: 262,were,O
Sentence: 262,tested,O
Sentence: 262,by,O
Sentence: 262,this,O
Sentence: 262,method,O
Sentence: 262,.,O
Sentence: 262,At,O
Sentence: 262,therapeutic,O
Sentence: 262,doses,O
Sentence: 262,both,O
Sentence: 262,substances,O
Sentence: 262,raised,O
Sentence: 262,the,O
Sentence: 262,mean,O
Sentence: 262,tremor,B-Disease
Sentence: 262,amplitude,O
Sentence: 262,to,O
Sentence: 262,about,O
Sentence: 262,three,O
Sentence: 262,times,O
Sentence: 262,the,O
Sentence: 262,control,O
Sentence: 262,level,O
Sentence: 262,.,O
Sentence: 262,At,O
Sentence: 262,the,O
Sentence: 262,same,O
Sentence: 262,time,O
Sentence: 262,",",O
Sentence: 262,the,O
Sentence: 262,mean,O
Sentence: 262,period,O
Sentence: 262,within,O
Sentence: 262,each,O
Sentence: 262,class,O
Sentence: 262,of,O
Sentence: 262,amplitudes,O
Sentence: 262,shortened,O
Sentence: 262,by,O
Sentence: 262,10,O
Sentence: 262,,O
Sentence: 262,-,O
Sentence: 262,,O
Sentence: 262,-,O
Sentence: 262,,O
Sentence: 262,20,O
Sentence: 262,ms,O
Sentence: 262,",",O
Sentence: 262,whereas,O
Sentence: 262,the,O
Sentence: 262,mean,O
Sentence: 262,periods,O
Sentence: 262,calculated,O
Sentence: 262,from,O
Sentence: 262,all,O
Sentence: 262,oscillations,O
Sentence: 262,together,O
Sentence: 262,did,O
Sentence: 262,not,O
Sentence: 262,change,O
Sentence: 262,significantly,O
Sentence: 262,.,O
Sentence: 262,After,O
Sentence: 262,the,O
Sentence: 262,end,O
Sentence: 262,of,O
Sentence: 262,fenoterol,O
Sentence: 262,-,O
Sentence: 262,hydrobromide,O
Sentence: 262,infusion,O
Sentence: 262,",",O
Sentence: 262,tremor,B-Disease
Sentence: 262,amplitudes,O
Sentence: 262,decreased,O
Sentence: 262,significantly,O
Sentence: 262,faster,O
Sentence: 262,than,O
Sentence: 262,those,O
Sentence: 262,following,O
Sentence: 262,ritodrin,O
Sentence: 262,-,O
Sentence: 262,HCl,O
Sentence: 262,infusion,O
Sentence: 262,.,O
Sentence: 263,Bilateral,O
Sentence: 263,retinal,B-Disease
Sentence: 263,artery,I-Disease
Sentence: 263,and,I-Disease
Sentence: 263,choriocapillaris,I-Disease
Sentence: 263,occlusion,I-Disease
Sentence: 263,following,O
Sentence: 263,the,O
Sentence: 263,injection,O
Sentence: 263,of,O
Sentence: 263,long,O
Sentence: 263,-,O
Sentence: 263,acting,O
Sentence: 263,corticosteroid,B-Chemical
Sentence: 263,suspensions,O
Sentence: 263,in,O
Sentence: 263,combination,O
Sentence: 263,with,O
Sentence: 263,other,O
Sentence: 263,drugs,O
Sentence: 263,:,O
Sentence: 263,I,O
Sentence: 263,.,O
Sentence: 263,Clinical,O
Sentence: 263,studies,O
Sentence: 263,.,O
Sentence: 264,Two,O
Sentence: 264,well,O
Sentence: 264,-,O
Sentence: 264,documented,O
Sentence: 264,cases,O
Sentence: 264,of,O
Sentence: 264,bilateral,O
Sentence: 264,retinal,B-Disease
Sentence: 264,artery,I-Disease
Sentence: 264,and,I-Disease
Sentence: 264,choriocapillaris,I-Disease
Sentence: 264,occlusions,I-Disease
Sentence: 264,with,O
Sentence: 264,blindness,B-Disease
Sentence: 264,following,O
Sentence: 264,head,O
Sentence: 264,and,O
Sentence: 264,neck,O
Sentence: 264,soft,O
Sentence: 264,-,O
Sentence: 264,tissue,O
Sentence: 264,injection,O
Sentence: 264,with,O
Sentence: 264,methylprednisolone,B-Chemical
Sentence: 264,acetate,I-Chemical
Sentence: 264,in,O
Sentence: 264,combination,O
Sentence: 264,with,O
Sentence: 264,lidocaine,B-Chemical
Sentence: 264,",",O
Sentence: 264,epinephrine,B-Chemical
Sentence: 264,",",O
Sentence: 264,or,O
Sentence: 264,penicillin,B-Chemical
Sentence: 264,are,O
Sentence: 264,reported,O
Sentence: 264,.,O
Sentence: 264,One,O
Sentence: 264,case,O
Sentence: 264,had,O
Sentence: 264,only,O
Sentence: 264,a,O
Sentence: 264,unilateral,O
Sentence: 264,injection,O
Sentence: 264,.,O
Sentence: 264,The,O
Sentence: 264,acute,O
Sentence: 264,observations,O
Sentence: 264,included,O
Sentence: 264,hazy,O
Sentence: 264,sensorium,O
Sentence: 264,",",O
Sentence: 264,superior,O
Sentence: 264,gaze,O
Sentence: 264,palsy,B-Disease
Sentence: 264,",",O
Sentence: 264,pupillary,B-Disease
Sentence: 264,abnormalities,I-Disease
Sentence: 264,",",O
Sentence: 264,and,O
Sentence: 264,conjunctival,O
Sentence: 264,hemorrhages,B-Disease
Sentence: 264,with,O
Sentence: 264,edema,B-Disease
Sentence: 264,.,O
Sentence: 264,Follow,O
Sentence: 264,-,O
Sentence: 264,up,O
Sentence: 264,changes,O
Sentence: 264,showed,O
Sentence: 264,marked,O
Sentence: 264,visual,B-Disease
Sentence: 264,loss,I-Disease
Sentence: 264,",",O
Sentence: 264,constricted,O
Sentence: 264,visual,O
Sentence: 264,fields,O
Sentence: 264,",",O
Sentence: 264,optic,O
Sentence: 264,nerve,O
Sentence: 264,pallor,O
Sentence: 264,",",O
Sentence: 264,vascular,O
Sentence: 264,attenuation,O
Sentence: 264,",",O
Sentence: 264,and,O
Sentence: 264,chorioretinal,B-Disease
Sentence: 264,atrophy,I-Disease
Sentence: 264,.,O
Sentence: 264,The,O
Sentence: 264,literature,O
Sentence: 264,is,O
Sentence: 264,reviewed,O
Sentence: 264,",",O
Sentence: 264,and,O
Sentence: 264,possible,O
Sentence: 264,causes,O
Sentence: 264,are,O
Sentence: 264,discussed,O
Sentence: 264,.,O
Sentence: 265,Cephalothin,B-Chemical
Sentence: 265,-,O
Sentence: 265,induced,O
Sentence: 265,immune,O
Sentence: 265,hemolytic,B-Disease
Sentence: 265,anemia,I-Disease
Sentence: 265,.,O
Sentence: 266,A,O
Sentence: 266,patient,O
Sentence: 266,with,O
Sentence: 266,renal,B-Disease
Sentence: 266,disease,I-Disease
Sentence: 266,developed,O
Sentence: 266,Coombs,O
Sentence: 266,-,O
Sentence: 266,positive,O
Sentence: 266,hemolytic,B-Disease
Sentence: 266,anemia,I-Disease
Sentence: 266,while,O
Sentence: 266,receiving,O
Sentence: 266,cephalothin,B-Chemical
Sentence: 266,therapy,O
Sentence: 266,.,O
Sentence: 266,An,O
Sentence: 266,anti,O
Sentence: 266,-,O
Sentence: 266,cephalothin,B-Chemical
Sentence: 266,IgG,O
Sentence: 266,antibody,O
Sentence: 266,was,O
Sentence: 266,detected,O
Sentence: 266,in,O
Sentence: 266,the,O
Sentence: 266,patient,O
Sentence: 266,'s,O
Sentence: 266,serum,O
Sentence: 266,and,O
Sentence: 266,in,O
Sentence: 266,the,O
Sentence: 266,eluates,O
Sentence: 266,from,O
Sentence: 266,her,O
Sentence: 266,erythrocytes,O
Sentence: 266,.,O
Sentence: 266,In,O
Sentence: 266,addition,O
Sentence: 266,",",O
Sentence: 266,nonimmunologic,O
Sentence: 266,binding,O
Sentence: 266,of,O
Sentence: 266,normal,O
Sentence: 266,and,O
Sentence: 266,patient,O
Sentence: 266,'s,O
Sentence: 266,serum,O
Sentence: 266,proteins,O
Sentence: 266,to,O
Sentence: 266,her,O
Sentence: 266,own,O
Sentence: 266,and,O
Sentence: 266,cephalothin,B-Chemical
Sentence: 266,-,O
Sentence: 266,coated,O
Sentence: 266,normal,O
Sentence: 266,red,O
Sentence: 266,cells,O
Sentence: 266,was,O
Sentence: 266,demonstrated,O
Sentence: 266,.,O
Sentence: 266,Skin,O
Sentence: 266,tests,O
Sentence: 266,and,O
Sentence: 266,in,O
Sentence: 266,vitro,O
Sentence: 266,lymphocyte,O
Sentence: 266,stimulation,O
Sentence: 266,revealed,O
Sentence: 266,that,O
Sentence: 266,the,O
Sentence: 266,patient,O
Sentence: 266,was,O
Sentence: 266,sensitized,O
Sentence: 266,to,O
Sentence: 266,cephalothin,B-Chemical
Sentence: 266,and,O
Sentence: 266,also,O
Sentence: 266,to,O
Sentence: 266,ampicillin,B-Chemical
Sentence: 266,.,O
Sentence: 266,Careful,O
Sentence: 266,investigation,O
Sentence: 266,of,O
Sentence: 266,drug,O
Sentence: 266,-,O
Sentence: 266,induced,O
Sentence: 266,hemolytic,B-Disease
Sentence: 266,anemias,I-Disease
Sentence: 266,reveals,O
Sentence: 266,the,O
Sentence: 266,complexity,O
Sentence: 266,of,O
Sentence: 266,the,O
Sentence: 266,immune,O
Sentence: 266,mechanisms,O
Sentence: 266,involved,O
Sentence: 266,.,O
Sentence: 267,Kaliuretic,O
Sentence: 267,effect,O
Sentence: 267,of,O
Sentence: 267,L,O
Sentence: 267,-,O
Sentence: 267,dopa,O
Sentence: 267,treatment,O
Sentence: 267,in,O
Sentence: 267,parkinsonian,B-Disease
Sentence: 267,patients,O
Sentence: 267,.,O
Sentence: 268,Hypokalemia,B-Disease
Sentence: 268,",",O
Sentence: 268,sometimes,O
Sentence: 268,severe,O
Sentence: 268,",",O
Sentence: 268,was,O
Sentence: 268,observed,O
Sentence: 268,in,O
Sentence: 268,some,O
Sentence: 268,L,O
Sentence: 268,-,O
Sentence: 268,dopa,O
Sentence: 268,-,O
Sentence: 268,treated,O
Sentence: 268,parkinsonian,B-Disease
Sentence: 268,patients,O
Sentence: 268,.,O
Sentence: 268,The,O
Sentence: 268,influence,O
Sentence: 268,of,O
Sentence: 268,L,O
Sentence: 268,-,O
Sentence: 268,dopa,O
Sentence: 268,on,O
Sentence: 268,the,O
Sentence: 268,renal,O
Sentence: 268,excretion,O
Sentence: 268,of,O
Sentence: 268,potassium,B-Chemical
Sentence: 268,was,O
Sentence: 268,studied,O
Sentence: 268,in,O
Sentence: 268,3,O
Sentence: 268,patients,O
Sentence: 268,with,O
Sentence: 268,hypokalemia,B-Disease
Sentence: 268,and,O
Sentence: 268,in,O
Sentence: 268,5,O
Sentence: 268,normokalemic,O
Sentence: 268,patients,O
Sentence: 268,by,O
Sentence: 268,determination,O
Sentence: 268,of,O
Sentence: 268,renal,O
Sentence: 268,plasma,O
Sentence: 268,flow,O
Sentence: 268,",",O
Sentence: 268,glomerular,O
Sentence: 268,filtration,O
Sentence: 268,rate,O
Sentence: 268,",",O
Sentence: 268,plasma,O
Sentence: 268,concentration,O
Sentence: 268,of,O
Sentence: 268,potassium,B-Chemical
Sentence: 268,and,O
Sentence: 268,sodium,B-Chemical
Sentence: 268,as,O
Sentence: 268,well,O
Sentence: 268,as,O
Sentence: 268,urinary,O
Sentence: 268,excretion,O
Sentence: 268,of,O
Sentence: 268,potassium,B-Chemical
Sentence: 268,",",O
Sentence: 268,sodium,B-Chemical
Sentence: 268,and,O
Sentence: 268,aldosterone,B-Chemical
Sentence: 268,.,O
Sentence: 268,L,O
Sentence: 268,-,O
Sentence: 268,Dopa,O
Sentence: 268,intake,O
Sentence: 268,was,O
Sentence: 268,found,O
Sentence: 268,to,O
Sentence: 268,cause,O
Sentence: 268,an,O
Sentence: 268,increased,O
Sentence: 268,excretion,O
Sentence: 268,of,O
Sentence: 268,potassium,B-Chemical
Sentence: 268,",",O
Sentence: 268,and,O
Sentence: 268,sometimes,O
Sentence: 268,also,O
Sentence: 268,of,O
Sentence: 268,sodium,B-Chemical
Sentence: 268,",",O
Sentence: 268,in,O
Sentence: 268,the,O
Sentence: 268,hypokalemic,O
Sentence: 268,but,O
Sentence: 268,not,O
Sentence: 268,in,O
Sentence: 268,the,O
Sentence: 268,normokalemic,O
Sentence: 268,patients,O
Sentence: 268,.,O
Sentence: 268,This,O
Sentence: 268,effect,O
Sentence: 268,on,O
Sentence: 268,the,O
Sentence: 268,renal,O
Sentence: 268,function,O
Sentence: 268,could,O
Sentence: 268,be,O
Sentence: 268,prohibited,O
Sentence: 268,by,O
Sentence: 268,the,O
Sentence: 268,administration,O
Sentence: 268,of,O
Sentence: 268,a,O
Sentence: 268,peripheral,O
Sentence: 268,dopa,O
Sentence: 268,decarbodylase,O
Sentence: 268,inhibitor,O
Sentence: 268,.,O
Sentence: 268,It,O
Sentence: 268,is,O
Sentence: 268,not,O
Sentence: 268,known,O
Sentence: 268,why,O
Sentence: 268,this,O
Sentence: 268,effect,O
Sentence: 268,occurred,O
Sentence: 268,in,O
Sentence: 268,some,O
Sentence: 268,individuals,O
Sentence: 268,but,O
Sentence: 268,not,O
Sentence: 268,in,O
Sentence: 268,others,O
Sentence: 268,",",O
Sentence: 268,but,O
Sentence: 268,our,O
Sentence: 268,results,O
Sentence: 268,indicate,O
Sentence: 268,a,O
Sentence: 268,correlation,O
Sentence: 268,between,O
Sentence: 268,aldosterone,B-Chemical
Sentence: 268,production,O
Sentence: 268,and,O
Sentence: 268,this,O
Sentence: 268,renal,O
Sentence: 268,effect,O
Sentence: 268,of,O
Sentence: 268,L,O
Sentence: 268,-,O
Sentence: 268,dopa,O
Sentence: 268,.,O
Sentence: 269,Phenytoin,B-Chemical
Sentence: 269,encephalopathy,B-Disease
Sentence: 269,as,O
Sentence: 269,probable,O
Sentence: 269,idiosyncratic,O
Sentence: 269,reaction,O
Sentence: 269,:,O
Sentence: 269,case,O
Sentence: 269,report,O
Sentence: 269,.,O
Sentence: 270,A,O
Sentence: 270,case,O
Sentence: 270,of,O
Sentence: 270,phenytoin,B-Chemical
Sentence: 270,(,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,),O
Sentence: 270,encephalopathy,B-Disease
Sentence: 270,with,O
Sentence: 270,increasing,O
Sentence: 270,seizures,B-Disease
Sentence: 270,and,O
Sentence: 270,EEG,O
Sentence: 270,and,O
Sentence: 270,mental,O
Sentence: 270,changes,O
Sentence: 270,is,O
Sentence: 270,described,O
Sentence: 270,.,O
Sentence: 270,Despite,O
Sentence: 270,adequate,O
Sentence: 270,oral,O
Sentence: 270,dosage,O
Sentence: 270,of,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,(,O
Sentence: 270,5,O
Sentence: 270,mg,O
Sentence: 270,/,O
Sentence: 270,kg,O
Sentence: 270,/,O
Sentence: 270,daily,O
Sentence: 270,),O
Sentence: 270,the,O
Sentence: 270,plasma,O
Sentence: 270,level,O
Sentence: 270,was,O
Sentence: 270,very,O
Sentence: 270,low,O
Sentence: 270,(,O
Sentence: 270,2.8,O
Sentence: 270,microgramg,O
Sentence: 270,/,O
Sentence: 270,ml,O
Sentence: 270,),O
Sentence: 270,.,O
Sentence: 270,The,O
Sentence: 270,encephalopathy,B-Disease
Sentence: 270,was,O
Sentence: 270,probably,O
Sentence: 270,an,O
Sentence: 270,idiosyncratic,O
Sentence: 270,and,O
Sentence: 270,not,O
Sentence: 270,toxic,O
Sentence: 270,or,O
Sentence: 270,allergic,O
Sentence: 270,reaction,O
Sentence: 270,.,O
Sentence: 270,In,O
Sentence: 270,fact,O
Sentence: 270,the,O
Sentence: 270,concentration,O
Sentence: 270,of,O
Sentence: 270,free,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,was,O
Sentence: 270,normal,O
Sentence: 270,",",O
Sentence: 270,the,O
Sentence: 270,patient,O
Sentence: 270,presented,O
Sentence: 270,a,O
Sentence: 270,retarded,O
Sentence: 270,morbilliform,O
Sentence: 270,rash,B-Disease
Sentence: 270,during,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,treatment,O
Sentence: 270,",",O
Sentence: 270,the,O
Sentence: 270,protidogram,O
Sentence: 270,was,O
Sentence: 270,normal,O
Sentence: 270,",",O
Sentence: 270,and,O
Sentence: 270,an,O
Sentence: 270,intradermic,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,injection,O
Sentence: 270,had,O
Sentence: 270,no,O
Sentence: 270,local,O
Sentence: 270,effect,O
Sentence: 270,.,O
Sentence: 270,The,O
Sentence: 270,authors,O
Sentence: 270,conclude,O
Sentence: 270,that,O
Sentence: 270,in,O
Sentence: 270,a,O
Sentence: 270,patient,O
Sentence: 270,starting,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,treatment,O
Sentence: 270,an,O
Sentence: 270,unexpected,O
Sentence: 270,increase,O
Sentence: 270,in,O
Sentence: 270,seizures,B-Disease
Sentence: 270,",",O
Sentence: 270,with,O
Sentence: 270,EEG,O
Sentence: 270,and,O
Sentence: 270,mental,O
Sentence: 270,changes,O
Sentence: 270,occurring,O
Sentence: 270,simultaneously,O
Sentence: 270,",",O
Sentence: 270,should,O
Sentence: 270,alert,O
Sentence: 270,the,O
Sentence: 270,physician,O
Sentence: 270,to,O
Sentence: 270,the,O
Sentence: 270,possible,O
Sentence: 270,need,O
Sentence: 270,for,O
Sentence: 270,eliminating,O
Sentence: 270,DPH,B-Chemical
Sentence: 270,from,O
Sentence: 270,the,O
Sentence: 270,therapeutic,O
Sentence: 270,regimen,O
Sentence: 270,",",O
Sentence: 270,even,O
Sentence: 270,if,O
Sentence: 270,plasma,O
Sentence: 270,concentrations,O
Sentence: 270,are,O
Sentence: 270,low,O
Sentence: 270,.,O
Sentence: 271,Effects,O
Sentence: 271,of,O
Sentence: 271,exercise,O
Sentence: 271,on,O
Sentence: 271,the,O
Sentence: 271,severity,O
Sentence: 271,of,O
Sentence: 271,isoproterenol,B-Chemical
Sentence: 271,-,O
Sentence: 271,induced,O
Sentence: 271,myocardial,B-Disease
Sentence: 271,infarction,I-Disease
Sentence: 271,.,O
Sentence: 272,The,O
Sentence: 272,effect,O
Sentence: 272,of,O
Sentence: 272,exercise,O
Sentence: 272,on,O
Sentence: 272,the,O
Sentence: 272,severity,O
Sentence: 272,of,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,-,O
Sentence: 272,induced,O
Sentence: 272,myocardial,B-Disease
Sentence: 272,infarction,B-Disease
Sentence: 272,was,O
Sentence: 272,studied,O
Sentence: 272,in,O
Sentence: 272,male,O
Sentence: 272,rats,O
Sentence: 272,.,O
Sentence: 272,Ninety,O
Sentence: 272,-,O
Sentence: 272,three,O
Sentence: 272,rats,O
Sentence: 272,were,O
Sentence: 272,randomly,O
Sentence: 272,divided,O
Sentence: 272,into,O
Sentence: 272,three,O
Sentence: 272,groups,O
Sentence: 272,.,O
Sentence: 272,The,O
Sentence: 272,exercise,O
Sentence: 272,-,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,(,O
Sentence: 272,E,O
Sentence: 272,-,O
Sentence: 272,1,O
Sentence: 272,),O
Sentence: 272,and,O
Sentence: 272,exercise,O
Sentence: 272,control,O
Sentence: 272,(,O
Sentence: 272,EC,O
Sentence: 272,),O
Sentence: 272,groups,O
Sentence: 272,exercised,O
Sentence: 272,daily,O
Sentence: 272,for,O
Sentence: 272,thirty,O
Sentence: 272,days,O
Sentence: 272,on,O
Sentence: 272,a,O
Sentence: 272,treadmill,O
Sentence: 272,at,O
Sentence: 272,1,O
Sentence: 272,mph,O
Sentence: 272,",",O
Sentence: 272,2,O
Sentence: 272,%,O
Sentence: 272,grade,O
Sentence: 272,while,O
Sentence: 272,animals,O
Sentence: 272,of,O
Sentence: 272,the,O
Sentence: 272,sedentary,O
Sentence: 272,-,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,(,O
Sentence: 272,S,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,),O
Sentence: 272,group,O
Sentence: 272,remained,O
Sentence: 272,sedentary,O
Sentence: 272,.,O
Sentence: 272,Eight,O
Sentence: 272,animals,O
Sentence: 272,were,O
Sentence: 272,assigned,O
Sentence: 272,to,O
Sentence: 272,the,O
Sentence: 272,sedentary,O
Sentence: 272,control,O
Sentence: 272,(,O
Sentence: 272,SC,O
Sentence: 272,),O
Sentence: 272,group,O
Sentence: 272,which,O
Sentence: 272,remained,O
Sentence: 272,sedentary,O
Sentence: 272,throughout,O
Sentence: 272,the,O
Sentence: 272,experimental,O
Sentence: 272,period,O
Sentence: 272,.,O
Sentence: 272,Forty,O
Sentence: 272,-,O
Sentence: 272,eight,O
Sentence: 272,hours,O
Sentence: 272,after,O
Sentence: 272,the,O
Sentence: 272,final,O
Sentence: 272,exercise,O
Sentence: 272,period,O
Sentence: 272,",",O
Sentence: 272,S,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,and,O
Sentence: 272,E,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,animals,O
Sentence: 272,received,O
Sentence: 272,a,O
Sentence: 272,single,O
Sentence: 272,subcutaneous,O
Sentence: 272,injection,O
Sentence: 272,of,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,(,O
Sentence: 272,250,O
Sentence: 272,mg,O
Sentence: 272,/,O
Sentence: 272,kg,O
Sentence: 272,body,O
Sentence: 272,weight,O
Sentence: 272,),O
Sentence: 272,.,O
Sentence: 272,Animals,O
Sentence: 272,of,O
Sentence: 272,the,O
Sentence: 272,S,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,group,O
Sentence: 272,exhibited,O
Sentence: 272,significantly,O
Sentence: 272,(,O
Sentence: 272,Pp,O
Sentence: 272,less,O
Sentence: 272,than,O
Sentence: 272,0.05,O
Sentence: 272,),O
Sentence: 272,greater,O
Sentence: 272,mortality,O
Sentence: 272,from,O
Sentence: 272,the,O
Sentence: 272,effects,O
Sentence: 272,of,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,than,O
Sentence: 272,animals,O
Sentence: 272,of,O
Sentence: 272,the,O
Sentence: 272,E,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,group,O
Sentence: 272,.,O
Sentence: 272,Serum,O
Sentence: 272,CPK,O
Sentence: 272,activity,O
Sentence: 272,for,O
Sentence: 272,E,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,animals,O
Sentence: 272,was,O
Sentence: 272,significantly,O
Sentence: 272,(,O
Sentence: 272,p,O
Sentence: 272,less,O
Sentence: 272,than,O
Sentence: 272,0.05,O
Sentence: 272,),O
Sentence: 272,greater,O
Sentence: 272,than,O
Sentence: 272,for,O
Sentence: 272,animals,O
Sentence: 272,in,O
Sentence: 272,the,O
Sentence: 272,S,O
Sentence: 272,-,O
Sentence: 272,I,O
Sentence: 272,and,O
Sentence: 272,EC,O
Sentence: 272,groups,O
Sentence: 272,twenty,O
Sentence: 272,hours,O
Sentence: 272,following,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,injection,O
Sentence: 272,.,O
Sentence: 272,No,O
Sentence: 272,statistically,O
Sentence: 272,significant,O
Sentence: 272,differences,O
Sentence: 272,were,O
Sentence: 272,observed,O
Sentence: 272,between,O
Sentence: 272,the,O
Sentence: 272,two,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,treated,O
Sentence: 272,groups,O
Sentence: 272,for,O
Sentence: 272,severity,O
Sentence: 272,of,O
Sentence: 272,the,O
Sentence: 272,induced,O
Sentence: 272,lesions,O
Sentence: 272,",",O
Sentence: 272,changes,O
Sentence: 272,in,O
Sentence: 272,heart,O
Sentence: 272,weight,O
Sentence: 272,",",O
Sentence: 272,or,O
Sentence: 272,heart,O
Sentence: 272,weight,O
Sentence: 272,to,O
Sentence: 272,body,O
Sentence: 272,weight,O
Sentence: 272,ratios,O
Sentence: 272,.,O
Sentence: 272,The,O
Sentence: 272,results,O
Sentence: 272,indicated,O
Sentence: 272,that,O
Sentence: 272,exercise,O
Sentence: 272,reduced,O
Sentence: 272,the,O
Sentence: 272,mortality,O
Sentence: 272,associated,O
Sentence: 272,with,O
Sentence: 272,the,O
Sentence: 272,effects,O
Sentence: 272,of,O
Sentence: 272,large,O
Sentence: 272,dosages,O
Sentence: 272,of,O
Sentence: 272,isoproterenol,B-Chemical
Sentence: 272,but,O
Sentence: 272,had,O
Sentence: 272,little,O
Sentence: 272,on,O
Sentence: 272,the,O
Sentence: 272,severity,O
Sentence: 272,of,O
Sentence: 272,the,O
Sentence: 272,infarction,B-Disease
Sentence: 272,.,O
Sentence: 273,Effect,O
Sentence: 273,of,O
Sentence: 273,D,O
Sentence: 273,-,O
Sentence: 273,Glucarates,O
Sentence: 273,on,O
Sentence: 273,basic,O
Sentence: 273,antibiotic,O
Sentence: 273,-,O
Sentence: 273,induced,O
Sentence: 273,renal,B-Disease
Sentence: 273,damage,I-Disease
Sentence: 273,in,O
Sentence: 273,rats,O
Sentence: 273,.,O
Sentence: 274,Dehydrated,B-Disease
Sentence: 274,rats,O
Sentence: 274,regularly,O
Sentence: 274,develop,O
Sentence: 274,acute,B-Disease
Sentence: 274,renal,B-Disease
Sentence: 274,failure,I-Disease
Sentence: 274,following,O
Sentence: 274,single,O
Sentence: 274,injection,O
Sentence: 274,of,O
Sentence: 274,aminoglycoside,B-Chemical
Sentence: 274,antibiotics,O
Sentence: 274,combined,O
Sentence: 274,with,O
Sentence: 274,dextran,O
Sentence: 274,or,O
Sentence: 274,of,O
Sentence: 274,antibiotics,O
Sentence: 274,only,O
Sentence: 274,.,O
Sentence: 274,Oral,O
Sentence: 274,administration,O
Sentence: 274,of,O
Sentence: 274,"2,5",O
Sentence: 274,-,O
Sentence: 274,di,O
Sentence: 274,-,O
Sentence: 274,O,O
Sentence: 274,-,O
Sentence: 274,acetyl,O
Sentence: 274,-,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,glucaro,O
Sentence: 274,-,O
Sentence: 274,"1,4",O
Sentence: 274,-,O
Sentence: 274,"6,3",O
Sentence: 274,-,O
Sentence: 274,dilactone,O
Sentence: 274,protected,O
Sentence: 274,rats,O
Sentence: 274,against,O
Sentence: 274,renal,B-Disease
Sentence: 274,failure,I-Disease
Sentence: 274,induced,O
Sentence: 274,by,O
Sentence: 274,kanamycin,B-Chemical
Sentence: 274,-,O
Sentence: 274,dextran,O
Sentence: 274,.,O
Sentence: 274,The,O
Sentence: 274,protective,O
Sentence: 274,effect,O
Sentence: 274,was,O
Sentence: 274,prevalent,O
Sentence: 274,among,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,glucarates,O
Sentence: 274,",",O
Sentence: 274,and,O
Sentence: 274,also,O
Sentence: 274,to,O
Sentence: 274,other,O
Sentence: 274,saccharic,B-Chemical
Sentence: 274,acid,I-Chemical
Sentence: 274,",",O
Sentence: 274,hexauronic,B-Chemical
Sentence: 274,acids,I-Chemical
Sentence: 274,and,O
Sentence: 274,hexaaldonic,B-Chemical
Sentence: 274,acids,I-Chemical
Sentence: 274,",",O
Sentence: 274,although,O
Sentence: 274,to,O
Sentence: 274,a,O
Sentence: 274,lesser,O
Sentence: 274,degree,O
Sentence: 274,",",O
Sentence: 274,but,O
Sentence: 274,not,O
Sentence: 274,to,O
Sentence: 274,a,O
Sentence: 274,hexaaldose,O
Sentence: 274,",",O
Sentence: 274,sugar,B-Chemical
Sentence: 274,alcohols,I-Chemical
Sentence: 274,",",O
Sentence: 274,substances,O
Sentence: 274,inthe,O
Sentence: 274,TCA,B-Chemical
Sentence: 274,cycle,O
Sentence: 274,and,O
Sentence: 274,other,O
Sentence: 274,acidic,O
Sentence: 274,compounds,O
Sentence: 274,.,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,Glucarates,O
Sentence: 274,were,O
Sentence: 274,effective,O
Sentence: 274,against,O
Sentence: 274,renal,B-Disease
Sentence: 274,damage,I-Disease
Sentence: 274,induced,O
Sentence: 274,by,O
Sentence: 274,peptide,O
Sentence: 274,antibiotics,O
Sentence: 274,as,O
Sentence: 274,well,O
Sentence: 274,as,O
Sentence: 274,various,O
Sentence: 274,aminoglycoside,B-Chemical
Sentence: 274,antibitocis,O
Sentence: 274,.,O
Sentence: 274,Dose,O
Sentence: 274,-,O
Sentence: 274,responses,O
Sentence: 274,were,O
Sentence: 274,observed,O
Sentence: 274,in,O
Sentence: 274,the,O
Sentence: 274,protective,O
Sentence: 274,effect,O
Sentence: 274,of,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,Glucarates,O
Sentence: 274,.,O
Sentence: 274,With,O
Sentence: 274,a,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,glucarate,O
Sentence: 274,of,O
Sentence: 274,a,O
Sentence: 274,fixed,O
Sentence: 274,size,O
Sentence: 274,of,O
Sentence: 274,dose,O
Sentence: 274,",",O
Sentence: 274,approximately,O
Sentence: 274,the,O
Sentence: 274,same,O
Sentence: 274,degree,O
Sentence: 274,of,O
Sentence: 274,protection,O
Sentence: 274,was,O
Sentence: 274,obtained,O
Sentence: 274,against,O
Sentence: 274,renal,B-Disease
Sentence: 274,damages,I-Disease
Sentence: 274,induced,O
Sentence: 274,by,O
Sentence: 274,different,O
Sentence: 274,basic,O
Sentence: 274,antibiotics,O
Sentence: 274,despite,O
Sentence: 274,large,O
Sentence: 274,disparities,O
Sentence: 274,in,O
Sentence: 274,administration,O
Sentence: 274,doses,O
Sentence: 274,of,O
Sentence: 274,different,O
Sentence: 274,antibiotics,O
Sentence: 274,.,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,Glucarates,O
Sentence: 274,had,O
Sentence: 274,the,O
Sentence: 274,ability,O
Sentence: 274,to,O
Sentence: 274,prevent,O
Sentence: 274,renal,B-Disease
Sentence: 274,damage,I-Disease
Sentence: 274,but,O
Sentence: 274,not,O
Sentence: 274,to,O
Sentence: 274,cure,O
Sentence: 274,it,O
Sentence: 274,.,O
Sentence: 274,Rats,O
Sentence: 274,excreted,O
Sentence: 274,acidic,O
Sentence: 274,urine,O
Sentence: 274,when,O
Sentence: 274,they,O
Sentence: 274,were,O
Sentence: 274,spared,O
Sentence: 274,from,O
Sentence: 274,renal,B-Disease
Sentence: 274,lesions,I-Disease
Sentence: 274,by,O
Sentence: 274,monosaccharides,B-Chemical
Sentence: 274,.,O
Sentence: 274,The,O
Sentence: 274,reduction,O
Sentence: 274,effect,O
Sentence: 274,of,O
Sentence: 274,D,O
Sentence: 274,-,O
Sentence: 274,glucarates,O
Sentence: 274,against,O
Sentence: 274,nephrotoxicity,B-Disease
Sentence: 274,of,O
Sentence: 274,basic,O
Sentence: 274,antibiotics,O
Sentence: 274,was,O
Sentence: 274,discussed,O
Sentence: 274,.,O
Sentence: 275,Paraplegia,B-Disease
Sentence: 275,following,O
Sentence: 275,intrathecal,O
Sentence: 275,methotrexate,B-Chemical
Sentence: 275,:,O
Sentence: 275,report,O
Sentence: 275,of,O
Sentence: 275,a,O
Sentence: 275,case,O
Sentence: 275,and,O
Sentence: 275,review,O
Sentence: 275,of,O
Sentence: 275,the,O
Sentence: 275,literature,O
Sentence: 275,.,O
Sentence: 276,A,O
Sentence: 276,patient,O
Sentence: 276,who,O
Sentence: 276,developed,O
Sentence: 276,paraplegia,B-Disease
Sentence: 276,following,O
Sentence: 276,the,O
Sentence: 276,intrathecal,O
Sentence: 276,instillation,O
Sentence: 276,of,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,is,O
Sentence: 276,discribed,O
Sentence: 276,.,O
Sentence: 276,The,O
Sentence: 276,ten,O
Sentence: 276,previously,O
Sentence: 276,reported,O
Sentence: 276,cases,O
Sentence: 276,of,O
Sentence: 276,this,O
Sentence: 276,unusual,O
Sentence: 276,complication,O
Sentence: 276,are,O
Sentence: 276,reviewed,O
Sentence: 276,.,O
Sentence: 276,The,O
Sentence: 276,following,O
Sentence: 276,factors,O
Sentence: 276,appear,O
Sentence: 276,to,O
Sentence: 276,predispose,O
Sentence: 276,to,O
Sentence: 276,the,O
Sentence: 276,development,O
Sentence: 276,of,O
Sentence: 276,this,O
Sentence: 276,complication,O
Sentence: 276,:,O
Sentence: 276,abnormal,O
Sentence: 276,cerebrospinal,O
Sentence: 276,dynamics,O
Sentence: 276,related,O
Sentence: 276,to,O
Sentence: 276,the,O
Sentence: 276,presence,O
Sentence: 276,of,O
Sentence: 276,central,B-Disease
Sentence: 276,nervous,I-Disease
Sentence: 276,system,I-Disease
Sentence: 276,leukemia,I-Disease
Sentence: 276,",",O
Sentence: 276,and,O
Sentence: 276,epidural,O
Sentence: 276,cerebrospinal,O
Sentence: 276,leakage,O
Sentence: 276,;,O
Sentence: 276,elevated,O
Sentence: 276,cerebrospinal,O
Sentence: 276,fluid,O
Sentence: 276,methothexate,B-Chemical
Sentence: 276,concentration,O
Sentence: 276,related,O
Sentence: 276,to,O
Sentence: 276,abnormal,O
Sentence: 276,cerebrospinal,O
Sentence: 276,fluid,O
Sentence: 276,dynamics,O
Sentence: 276,and,O
Sentence: 276,to,O
Sentence: 276,inappropriately,O
Sentence: 276,high,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,doses,O
Sentence: 276,based,O
Sentence: 276,on,O
Sentence: 276,body,O
Sentence: 276,surface,O
Sentence: 276,area,O
Sentence: 276,calculations,O
Sentence: 276,in,O
Sentence: 276,older,O
Sentence: 276,children,O
Sentence: 276,and,O
Sentence: 276,adults,O
Sentence: 276,;,O
Sentence: 276,the,O
Sentence: 276,presence,O
Sentence: 276,of,O
Sentence: 276,neurotoxic,B-Disease
Sentence: 276,preservatives,O
Sentence: 276,in,O
Sentence: 276,commercially,O
Sentence: 276,available,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,preparations,O
Sentence: 276,and,O
Sentence: 276,diluents,O
Sentence: 276,;,O
Sentence: 276,and,O
Sentence: 276,the,O
Sentence: 276,use,O
Sentence: 276,of,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,diluents,O
Sentence: 276,of,O
Sentence: 276,unphysiologic,O
Sentence: 276,pH,O
Sentence: 276,",",O
Sentence: 276,ionic,O
Sentence: 276,content,O
Sentence: 276,and,O
Sentence: 276,osmolarity,O
Sentence: 276,.,O
Sentence: 276,The,O
Sentence: 276,role,O
Sentence: 276,of,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,contaminants,O
Sentence: 276,",",O
Sentence: 276,local,O
Sentence: 276,folate,B-Disease
Sentence: 276,deficiency,I-Disease
Sentence: 276,",",O
Sentence: 276,and,O
Sentence: 276,cranial,O
Sentence: 276,irradiation,O
Sentence: 276,in,O
Sentence: 276,the,O
Sentence: 276,pathogenesis,O
Sentence: 276,of,O
Sentence: 276,intrathecal,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,toxicity,B-Disease
Sentence: 276,is,O
Sentence: 276,unclear,O
Sentence: 276,.,O
Sentence: 276,The,O
Sentence: 276,incidence,O
Sentence: 276,of,O
Sentence: 276,neurotoxicity,B-Disease
Sentence: 276,may,O
Sentence: 276,be,O
Sentence: 276,reduced,O
Sentence: 276,by,O
Sentence: 276,employing,O
Sentence: 276,lower,O
Sentence: 276,doses,O
Sentence: 276,of,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,in,O
Sentence: 276,the,O
Sentence: 276,presence,O
Sentence: 276,of,O
Sentence: 276,central,B-Disease
Sentence: 276,nervous,I-Disease
Sentence: 276,system,I-Disease
Sentence: 276,leukemia,I-Disease
Sentence: 276,",",O
Sentence: 276,in,O
Sentence: 276,older,O
Sentence: 276,children,O
Sentence: 276,and,O
Sentence: 276,adults,O
Sentence: 276,",",O
Sentence: 276,and,O
Sentence: 276,in,O
Sentence: 276,the,O
Sentence: 276,presence,O
Sentence: 276,of,O
Sentence: 276,epidural,O
Sentence: 276,leakage,O
Sentence: 276,.,O
Sentence: 276,Only,O
Sentence: 276,preservative,O
Sentence: 276,-,O
Sentence: 276,free,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,in,O
Sentence: 276,Elliott,O
Sentence: 276,'s,O
Sentence: 276,B,O
Sentence: 276,Solution,O
Sentence: 276,at,O
Sentence: 276,a,O
Sentence: 276,concentration,O
Sentence: 276,of,O
Sentence: 276,not,O
Sentence: 276,more,O
Sentence: 276,than,O
Sentence: 276,1,O
Sentence: 276,mg,O
Sentence: 276,/,O
Sentence: 276,ml,O
Sentence: 276,should,O
Sentence: 276,be,O
Sentence: 276,used,O
Sentence: 276,for,O
Sentence: 276,intrathecal,O
Sentence: 276,administration,O
Sentence: 276,.,O
Sentence: 276,Periodic,O
Sentence: 276,monitoring,O
Sentence: 276,of,O
Sentence: 276,cerebruspinal,O
Sentence: 276,fluid,O
Sentence: 276,methotrexate,B-Chemical
Sentence: 276,levels,O
Sentence: 276,may,O
Sentence: 276,be,O
Sentence: 276,predictive,O
Sentence: 276,of,O
Sentence: 276,the,O
Sentence: 276,development,O
Sentence: 276,of,O
Sentence: 276,serious,O
Sentence: 276,neurotoxicity,B-Disease
Sentence: 276,.,O
Sentence: 277,Centrally,O
Sentence: 277,mediated,O
Sentence: 277,cardiovascular,O
Sentence: 277,effects,O
Sentence: 277,of,O
Sentence: 277,intracisternal,O
Sentence: 277,application,O
Sentence: 277,of,O
Sentence: 277,carbachol,O
Sentence: 277,in,O
Sentence: 277,anesthetized,O
Sentence: 277,rats,O
Sentence: 277,.,O
Sentence: 278,The,O
Sentence: 278,pressor,O
Sentence: 278,response,O
Sentence: 278,to,O
Sentence: 278,the,O
Sentence: 278,intracisternal,O
Sentence: 278,(,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,),O
Sentence: 278,injection,O
Sentence: 278,of,O
Sentence: 278,carbachol,B-Chemical
Sentence: 278,(,O
Sentence: 278,1,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,in,O
Sentence: 278,anesthetized,O
Sentence: 278,rats,O
Sentence: 278,was,O
Sentence: 278,analyzed,O
Sentence: 278,.,O
Sentence: 278,This,O
Sentence: 278,response,O
Sentence: 278,was,O
Sentence: 278,significantly,O
Sentence: 278,reduced,O
Sentence: 278,by,O
Sentence: 278,the,O
Sentence: 278,intravenous,O
Sentence: 278,(,O
Sentence: 278,i.v,O
Sentence: 278,.,O
Sentence: 278,),O
Sentence: 278,injection,O
Sentence: 278,of,O
Sentence: 278,guanethidine,B-Chemical
Sentence: 278,(,O
Sentence: 278,5,O
Sentence: 278,mg,O
Sentence: 278,),O
Sentence: 278,",",O
Sentence: 278,hexamethonium,B-Chemical
Sentence: 278,(,O
Sentence: 278,10,O
Sentence: 278,mg,O
Sentence: 278,),O
Sentence: 278,or,O
Sentence: 278,phentolamine,B-Chemical
Sentence: 278,(,O
Sentence: 278,5,O
Sentence: 278,mg,O
Sentence: 278,),O
Sentence: 278,",",O
Sentence: 278,and,O
Sentence: 278,conversely,O
Sentence: 278,",",O
Sentence: 278,potentiated,O
Sentence: 278,by,O
Sentence: 278,i.v,O
Sentence: 278,.,O
Sentence: 278,desmethylimipramine,B-Chemical
Sentence: 278,(,O
Sentence: 278,0.3,O
Sentence: 278,mg,O
Sentence: 278,),O
Sentence: 278,",",O
Sentence: 278,while,O
Sentence: 278,propranolol,B-Chemical
Sentence: 278,(,O
Sentence: 278,0.5,O
Sentence: 278,mg,O
Sentence: 278,),O
Sentence: 278,i.v,O
Sentence: 278,.,O
Sentence: 278,selectively,O
Sentence: 278,inhibited,O
Sentence: 278,the,O
Sentence: 278,enlargement,B-Disease
Sentence: 278,of,I-Disease
Sentence: 278,pulse,I-Disease
Sentence: 278,pressure,I-Disease
Sentence: 278,and,O
Sentence: 278,the,O
Sentence: 278,tachycardia,B-Disease
Sentence: 278,following,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,carbachol,B-Chemical
Sentence: 278,(,O
Sentence: 278,1,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,.,O
Sentence: 278,On,O
Sentence: 278,the,O
Sentence: 278,other,O
Sentence: 278,hand,O
Sentence: 278,",",O
Sentence: 278,the,O
Sentence: 278,pressor,O
Sentence: 278,response,O
Sentence: 278,to,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,carbachol,B-Chemical
Sentence: 278,(,O
Sentence: 278,1,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,was,O
Sentence: 278,almost,O
Sentence: 278,completely,O
Sentence: 278,blocked,O
Sentence: 278,by,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,atropine,B-Chemical
Sentence: 278,(,O
Sentence: 278,3,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,or,O
Sentence: 278,hexamethonium,B-Chemical
Sentence: 278,(,O
Sentence: 278,500,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,",",O
Sentence: 278,and,O
Sentence: 278,significantly,O
Sentence: 278,reduced,O
Sentence: 278,by,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,chlorpromazine,B-Chemical
Sentence: 278,(,O
Sentence: 278,50,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,but,O
Sentence: 278,significantly,O
Sentence: 278,potentiated,O
Sentence: 278,by,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,desmethylimipramine,B-Chemical
Sentence: 278,(,O
Sentence: 278,30,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,.,O
Sentence: 278,The,O
Sentence: 278,pressor,O
Sentence: 278,response,O
Sentence: 278,to,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,carbachol,B-Chemical
Sentence: 278,(,O
Sentence: 278,1,O
Sentence: 278,mug,O
Sentence: 278,),O
Sentence: 278,remained,O
Sentence: 278,unchanged,O
Sentence: 278,after,O
Sentence: 278,sectioning,O
Sentence: 278,of,O
Sentence: 278,the,O
Sentence: 278,bilateral,O
Sentence: 278,cervical,O
Sentence: 278,vagal,O
Sentence: 278,nerves,O
Sentence: 278,but,O
Sentence: 278,disappeared,O
Sentence: 278,after,O
Sentence: 278,sectioning,O
Sentence: 278,of,O
Sentence: 278,the,O
Sentence: 278,spinal,O
Sentence: 278,cord,O
Sentence: 278,(,O
Sentence: 278,C7,O
Sentence: 278,-,O
Sentence: 278,C8,O
Sentence: 278,),O
Sentence: 278,.,O
Sentence: 278,From,O
Sentence: 278,the,O
Sentence: 278,above,O
Sentence: 278,result,O
Sentence: 278,it,O
Sentence: 278,is,O
Sentence: 278,suggested,O
Sentence: 278,that,O
Sentence: 278,the,O
Sentence: 278,pressor,O
Sentence: 278,response,O
Sentence: 278,to,O
Sentence: 278,i.c,O
Sentence: 278,.,O
Sentence: 278,carbachol,B-Chemical
Sentence: 278,ortral,O
Sentence: 278,and,O
Sentence: 278,peripheral,O
Sentence: 278,adrenergic,O
Sentence: 278,mechanisms,O
Sentence: 278,",",O
Sentence: 278,and,O
Sentence: 278,that,O
Sentence: 278,the,O
Sentence: 278,sympathetic,O
Sentence: 278,trunk,O
Sentence: 278,is,O
Sentence: 278,the,O
Sentence: 278,main,O
Sentence: 278,pathway,O
Sentence: 278,.,O
Sentence: 279,Hyperglycemic,B-Disease
Sentence: 279,effect,O
Sentence: 279,of,O
Sentence: 279,amino,B-Chemical
Sentence: 279,compounds,O
Sentence: 279,structurally,O
Sentence: 279,related,O
Sentence: 279,to,O
Sentence: 279,caproate,B-Chemical
Sentence: 279,in,O
Sentence: 279,rats,O
Sentence: 279,.,O
Sentence: 280,The,O
Sentence: 280,chronic,O
Sentence: 280,feeding,O
Sentence: 280,of,O
Sentence: 280,small,O
Sentence: 280,amounts,O
Sentence: 280,(,O
Sentence: 280,0.3,O
Sentence: 280,-,O
Sentence: 280,3,O
Sentence: 280,%,O
Sentence: 280,of,O
Sentence: 280,diet,O
Sentence: 280,weight,O
Sentence: 280,),O
Sentence: 280,of,O
Sentence: 280,certain,O
Sentence: 280,amino,B-Chemical
Sentence: 280,derivatives,O
Sentence: 280,of,O
Sentence: 280,caproate,B-Chemical
Sentence: 280,resulted,O
Sentence: 280,in,O
Sentence: 280,hyperglycemia,B-Disease
Sentence: 280,",",O
Sentence: 280,an,O
Sentence: 280,elevated,O
Sentence: 280,glucose,B-Chemical
Sentence: 280,tolerance,O
Sentence: 280,curve,O
Sentence: 280,and,O
Sentence: 280,",",O
Sentence: 280,occasionally,O
Sentence: 280,",",O
Sentence: 280,glucosuria,B-Disease
Sentence: 280,.,O
Sentence: 280,Effective,O
Sentence: 280,compounds,O
Sentence: 280,included,O
Sentence: 280,norleucine,B-Chemical
Sentence: 280,",",O
Sentence: 280,norvaline,B-Chemical
Sentence: 280,",",O
Sentence: 280,glutamate,B-Chemical
Sentence: 280,",",O
Sentence: 280,epsilon,O
Sentence: 280,-,O
Sentence: 280,aminocaproate,O
Sentence: 280,",",O
Sentence: 280,methionine,B-Chemical
Sentence: 280,",",O
Sentence: 280,and,O
Sentence: 280,leucine,B-Chemical
Sentence: 280,.,O
Sentence: 281,Fatty,B-Disease
Sentence: 281,liver,I-Disease
Sentence: 281,induced,O
Sentence: 281,by,O
Sentence: 281,tetracycline,B-Chemical
Sentence: 281,in,O
Sentence: 281,the,O
Sentence: 281,rat,O
Sentence: 281,.,O
Sentence: 281,Dose,O
Sentence: 281,-,O
Sentence: 281,response,O
Sentence: 281,relationships,O
Sentence: 281,and,O
Sentence: 281,effect,O
Sentence: 281,of,O
Sentence: 281,sex,O
Sentence: 281,.,O
Sentence: 282,Dose,O
Sentence: 282,-,O
Sentence: 282,response,O
Sentence: 282,relationships,O
Sentence: 282,",",O
Sentence: 282,biochemical,O
Sentence: 282,mechanisms,O
Sentence: 282,",",O
Sentence: 282,and,O
Sentence: 282,sex,O
Sentence: 282,differences,O
Sentence: 282,in,O
Sentence: 282,the,O
Sentence: 282,experimental,O
Sentence: 282,fatty,B-Disease
Sentence: 282,liver,I-Disease
Sentence: 282,induced,O
Sentence: 282,by,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,were,O
Sentence: 282,studied,O
Sentence: 282,in,O
Sentence: 282,the,O
Sentence: 282,intact,O
Sentence: 282,rat,O
Sentence: 282,and,O
Sentence: 282,with,O
Sentence: 282,the,O
Sentence: 282,isolated,O
Sentence: 282,perfused,O
Sentence: 282,rat,O
Sentence: 282,liver,O
Sentence: 282,in,O
Sentence: 282,vitro,O
Sentence: 282,.,O
Sentence: 282,In,O
Sentence: 282,the,O
Sentence: 282,intact,O
Sentence: 282,male,O
Sentence: 282,and,O
Sentence: 282,female,O
Sentence: 282,rat,O
Sentence: 282,",",O
Sentence: 282,no,O
Sentence: 282,direct,O
Sentence: 282,relationship,O
Sentence: 282,was,O
Sentence: 282,observed,O
Sentence: 282,between,O
Sentence: 282,dose,O
Sentence: 282,of,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,and,O
Sentence: 282,hepatic,O
Sentence: 282,accumulation,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,.,O
Sentence: 282,With,O
Sentence: 282,provision,O
Sentence: 282,of,O
Sentence: 282,adequate,O
Sentence: 282,oleic,B-Chemical
Sentence: 282,acid,I-Chemical
Sentence: 282,as,O
Sentence: 282,a,O
Sentence: 282,substrate,O
Sentence: 282,for,O
Sentence: 282,the,O
Sentence: 282,isolated,O
Sentence: 282,perfused,O
Sentence: 282,liver,O
Sentence: 282,",",O
Sentence: 282,a,O
Sentence: 282,direct,O
Sentence: 282,relationship,O
Sentence: 282,was,O
Sentence: 282,observed,O
Sentence: 282,between,O
Sentence: 282,dose,O
Sentence: 282,of,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,and,O
Sentence: 282,both,O
Sentence: 282,accumulation,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,in,O
Sentence: 282,the,O
Sentence: 282,liver,O
Sentence: 282,and,O
Sentence: 282,depression,B-Disease
Sentence: 282,of,O
Sentence: 282,output,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,by,O
Sentence: 282,livers,O
Sentence: 282,from,O
Sentence: 282,male,O
Sentence: 282,and,O
Sentence: 282,female,O
Sentence: 282,rats,O
Sentence: 282,.,O
Sentence: 282,Marked,O
Sentence: 282,differences,O
Sentence: 282,were,O
Sentence: 282,observed,O
Sentence: 282,between,O
Sentence: 282,female,O
Sentence: 282,and,O
Sentence: 282,male,O
Sentence: 282,rats,O
Sentence: 282,with,O
Sentence: 282,regard,O
Sentence: 282,to,O
Sentence: 282,base,O
Sentence: 282,line,O
Sentence: 282,(,O
Sentence: 282,control,O
Sentence: 282,),O
Sentence: 282,hepatic,O
Sentence: 282,concentration,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,and,O
Sentence: 282,output,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,.,O
Sentence: 282,Accumulation,O
Sentence: 282,of,O
Sentence: 282,hepatic,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,",",O
Sentence: 282,as,O
Sentence: 282,a,O
Sentence: 282,per,O
Sentence: 282,cent,O
Sentence: 282,of,O
Sentence: 282,control,O
Sentence: 282,values,O
Sentence: 282,",",O
Sentence: 282,in,O
Sentence: 282,response,O
Sentence: 282,to,O
Sentence: 282,graded,O
Sentence: 282,doses,O
Sentence: 282,of,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,",",O
Sentence: 282,did,O
Sentence: 282,not,O
Sentence: 282,differ,O
Sentence: 282,significantly,O
Sentence: 282,between,O
Sentence: 282,male,O
Sentence: 282,",",O
Sentence: 282,female,O
Sentence: 282,and,O
Sentence: 282,pregnant,O
Sentence: 282,rat,O
Sentence: 282,livers,O
Sentence: 282,.,O
Sentence: 282,However,O
Sentence: 282,",",O
Sentence: 282,livers,O
Sentence: 282,from,O
Sentence: 282,female,O
Sentence: 282,",",O
Sentence: 282,and,O
Sentence: 282,especially,O
Sentence: 282,pregnant,O
Sentence: 282,female,O
Sentence: 282,rats,O
Sentence: 282,",",O
Sentence: 282,were,O
Sentence: 282,strikingly,O
Sentence: 282,resistant,O
Sentence: 282,to,O
Sentence: 282,the,O
Sentence: 282,effects,O
Sentence: 282,of,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,on,O
Sentence: 282,depression,B-Disease
Sentence: 282,of,O
Sentence: 282,output,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,under,O
Sentence: 282,these,O
Sentence: 282,experimental,O
Sentence: 282,conditions,O
Sentence: 282,.,O
Sentence: 282,These,O
Sentence: 282,differences,O
Sentence: 282,between,O
Sentence: 282,the,O
Sentence: 282,sexes,O
Sentence: 282,could,O
Sentence: 282,not,O
Sentence: 282,be,O
Sentence: 282,related,O
Sentence: 282,to,O
Sentence: 282,altered,O
Sentence: 282,disposition,O
Sentence: 282,of,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,or,O
Sentence: 282,altered,O
Sentence: 282,uptake,O
Sentence: 282,of,O
Sentence: 282,oleic,B-Chemical
Sentence: 282,acid,I-Chemical
Sentence: 282,.,O
Sentence: 282,Depressed,O
Sentence: 282,hepatic,O
Sentence: 282,secretion,O
Sentence: 282,of,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,accounted,O
Sentence: 282,only,O
Sentence: 282,for,O
Sentence: 282,30,O
Sentence: 282,to,O
Sentence: 282,50,O
Sentence: 282,%,O
Sentence: 282,of,O
Sentence: 282,accumulated,O
Sentence: 282,hepatic,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,",",O
Sentence: 282,indicating,O
Sentence: 282,that,O
Sentence: 282,additional,O
Sentence: 282,mechanisms,O
Sentence: 282,must,O
Sentence: 282,be,O
Sentence: 282,involved,O
Sentence: 282,in,O
Sentence: 282,the,O
Sentence: 282,production,O
Sentence: 282,of,O
Sentence: 282,the,O
Sentence: 282,triglyceride,B-Chemical
Sentence: 282,-,O
Sentence: 282,rich,O
Sentence: 282,fatty,B-Disease
Sentence: 282,liver,I-Disease
Sentence: 282,in,O
Sentence: 282,response,O
Sentence: 282,to,O
Sentence: 282,tetracycline,B-Chemical
Sentence: 282,.,O
Sentence: 283,Fatal,O
Sentence: 283,myeloencephalopathy,B-Disease
Sentence: 283,due,O
Sentence: 283,to,O
Sentence: 283,intrathecal,O
Sentence: 283,vincristine,B-Chemical
Sentence: 283,administration,O
Sentence: 283,.,O
Sentence: 284,Vincristine,B-Chemical
Sentence: 284,was,O
Sentence: 284,accidentally,O
Sentence: 284,given,O
Sentence: 284,intrathecally,O
Sentence: 284,to,O
Sentence: 284,a,O
Sentence: 284,child,O
Sentence: 284,with,O
Sentence: 284,leukaemia,B-Disease
Sentence: 284,",",O
Sentence: 284,producing,O
Sentence: 284,sensory,B-Disease
Sentence: 284,and,I-Disease
Sentence: 284,motor,I-Disease
Sentence: 284,dysfunction,I-Disease
Sentence: 284,followed,O
Sentence: 284,by,O
Sentence: 284,encephalopathy,B-Disease
Sentence: 284,and,O
Sentence: 284,death,O
Sentence: 284,.,O
Sentence: 284,Separate,O
Sentence: 284,times,O
Sentence: 284,for,O
Sentence: 284,administering,O
Sentence: 284,vincristine,B-Chemical
Sentence: 284,and,O
Sentence: 284,intrathecal,O
Sentence: 284,therapy,O
Sentence: 284,is,O
Sentence: 284,recommended,O
Sentence: 284,.,O
Sentence: 285,Progesterone,B-Chemical
Sentence: 285,potentiation,O
Sentence: 285,of,O
Sentence: 285,bupivacaine,B-Chemical
Sentence: 285,arrhythmogenicity,O
Sentence: 285,in,O
Sentence: 285,pentobarbital,B-Chemical
Sentence: 285,-,O
Sentence: 285,anesthetized,O
Sentence: 285,rats,O
Sentence: 285,and,O
Sentence: 285,beating,O
Sentence: 285,rat,O
Sentence: 285,heart,O
Sentence: 285,cell,O
Sentence: 285,cultures,O
Sentence: 285,.,O
Sentence: 286,The,O
Sentence: 286,effects,O
Sentence: 286,of,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,treatment,O
Sentence: 286,on,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,arrhythmogenicity,O
Sentence: 286,in,O
Sentence: 286,beating,O
Sentence: 286,rat,O
Sentence: 286,heart,O
Sentence: 286,myocyte,O
Sentence: 286,cultures,O
Sentence: 286,and,O
Sentence: 286,on,O
Sentence: 286,anesthetized,O
Sentence: 286,rats,O
Sentence: 286,were,O
Sentence: 286,determined,O
Sentence: 286,.,O
Sentence: 286,After,O
Sentence: 286,determining,O
Sentence: 286,the,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,AD50,O
Sentence: 286,(,O
Sentence: 286,the,O
Sentence: 286,concentration,O
Sentence: 286,of,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,that,O
Sentence: 286,caused,O
Sentence: 286,50,O
Sentence: 286,%,O
Sentence: 286,of,O
Sentence: 286,all,O
Sentence: 286,beating,O
Sentence: 286,rat,O
Sentence: 286,heart,O
Sentence: 286,myocyte,O
Sentence: 286,cultures,O
Sentence: 286,to,O
Sentence: 286,become,O
Sentence: 286,arrhythmic,B-Disease
Sentence: 286,),O
Sentence: 286,",",O
Sentence: 286,we,O
Sentence: 286,determined,O
Sentence: 286,the,O
Sentence: 286,effect,O
Sentence: 286,of,O
Sentence: 286,1,O
Sentence: 286,-,O
Sentence: 286,hour,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,HCl,B-Chemical
Sentence: 286,exposure,O
Sentence: 286,on,O
Sentence: 286,myocyte,O
Sentence: 286,contractile,O
Sentence: 286,rhythm,O
Sentence: 286,.,O
Sentence: 286,Each,O
Sentence: 286,concentration,O
Sentence: 286,of,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,(,O
Sentence: 286,6.25,O
Sentence: 286,",",O
Sentence: 286,12.5,O
Sentence: 286,",",O
Sentence: 286,25,O
Sentence: 286,",",O
Sentence: 286,and,O
Sentence: 286,50,O
Sentence: 286,micrograms,O
Sentence: 286,/,O
Sentence: 286,ml,O
Sentence: 286,),O
Sentence: 286,caused,O
Sentence: 286,a,O
Sentence: 286,significant,O
Sentence: 286,and,O
Sentence: 286,concentration,O
Sentence: 286,-,O
Sentence: 286,dependent,O
Sentence: 286,reduction,O
Sentence: 286,in,O
Sentence: 286,the,O
Sentence: 286,AD50,O
Sentence: 286,for,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,.,O
Sentence: 286,Estradiol,B-Chemical
Sentence: 286,treatment,O
Sentence: 286,also,O
Sentence: 286,increased,O
Sentence: 286,the,O
Sentence: 286,arrhythmogenicity,O
Sentence: 286,of,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,in,O
Sentence: 286,myocyte,O
Sentence: 286,cultures,O
Sentence: 286,",",O
Sentence: 286,but,O
Sentence: 286,was,O
Sentence: 286,only,O
Sentence: 286,one,O
Sentence: 286,fourth,O
Sentence: 286,as,O
Sentence: 286,potent,O
Sentence: 286,as,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,.,O
Sentence: 286,Neither,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,nor,O
Sentence: 286,estradiol,B-Chemical
Sentence: 286,effects,O
Sentence: 286,on,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,arrhythmogenicity,O
Sentence: 286,were,O
Sentence: 286,potentiated,O
Sentence: 286,by,O
Sentence: 286,epinephrine,B-Chemical
Sentence: 286,.,O
Sentence: 286,Chronic,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,pretreatment,O
Sentence: 286,(,O
Sentence: 286,5,O
Sentence: 286,mg,O
Sentence: 286,/,O
Sentence: 286,kg,O
Sentence: 286,/,O
Sentence: 286,day,O
Sentence: 286,for,O
Sentence: 286,21,O
Sentence: 286,days,O
Sentence: 286,),O
Sentence: 286,caused,O
Sentence: 286,a,O
Sentence: 286,significant,O
Sentence: 286,increase,O
Sentence: 286,in,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,arrhythmogenicity,O
Sentence: 286,in,O
Sentence: 286,intact,O
Sentence: 286,pentobarbital,B-Chemical
Sentence: 286,-,O
Sentence: 286,anesthetized,O
Sentence: 286,rats,O
Sentence: 286,.,O
Sentence: 286,There,O
Sentence: 286,was,O
Sentence: 286,a,O
Sentence: 286,significant,O
Sentence: 286,decrease,O
Sentence: 286,in,O
Sentence: 286,the,O
Sentence: 286,time,O
Sentence: 286,to,O
Sentence: 286,onset,O
Sentence: 286,of,O
Sentence: 286,arrhythmia,B-Disease
Sentence: 286,as,O
Sentence: 286,compared,O
Sentence: 286,with,O
Sentence: 286,control,O
Sentence: 286,nonprogesterone,O
Sentence: 286,-,O
Sentence: 286,treated,O
Sentence: 286,rats,O
Sentence: 286,(,O
Sentence: 286,6.2,O
Sentence: 286,+,O
Sentence: 286,/,O
Sentence: 286,,O
Sentence: 286,-,O
Sentence: 286,,O
Sentence: 286,1.3,O
Sentence: 286,vs.,O
Sentence: 286,30.8,O
Sentence: 286,+,O
Sentence: 286,/,O
Sentence: 286,,O
Sentence: 286,-,O
Sentence: 286,,O
Sentence: 286,2.5,O
Sentence: 286,min,O
Sentence: 286,",",O
Sentence: 286,mean,O
Sentence: 286,+,O
Sentence: 286,/,O
Sentence: 286,,O
Sentence: 286,-,O
Sentence: 286,,O
Sentence: 286,SE,O
Sentence: 286,),O
Sentence: 286,.,O
Sentence: 286,The,O
Sentence: 286,results,O
Sentence: 286,of,O
Sentence: 286,this,O
Sentence: 286,study,O
Sentence: 286,indicate,O
Sentence: 286,that,O
Sentence: 286,progesterone,B-Chemical
Sentence: 286,can,O
Sentence: 286,potentiate,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,arrhythmogenicity,O
Sentence: 286,both,O
Sentence: 286,in,O
Sentence: 286,vivo,O
Sentence: 286,and,O
Sentence: 286,in,O
Sentence: 286,vitro,O
Sentence: 286,.,O
Sentence: 286,Potentiation,O
Sentence: 286,of,O
Sentence: 286,bupivacaine,B-Chemical
Sentence: 286,arrhythmia,B-Disease
Sentence: 286,in,O
Sentence: 286,myocyte,O
Sentence: 286,cultures,O
Sentence: 286,suggests,O
Sentence: 286,that,O
Sentence: 286,this,O
Sentence: 286,effect,O
Sentence: 286,is,O
Sentence: 286,at,O
Sentence: 286,least,O
Sentence: 286,partly,O
Sentence: 286,mediated,O
Sentence: 286,at,O
Sentence: 286,the,O
Sentence: 286,myocyte,O
Sentence: 286,level,O
Sentence: 286,.,O
Sentence: 287,Acute,B-Disease
Sentence: 287,renal,I-Disease
Sentence: 287,failure,I-Disease
Sentence: 287,occurring,O
Sentence: 287,during,O
Sentence: 287,intravenous,O
Sentence: 287,desferrioxamine,B-Chemical
Sentence: 287,therapy,O
Sentence: 287,:,O
Sentence: 287,recovery,O
Sentence: 287,after,O
Sentence: 287,haemodialysis,O
Sentence: 287,.,O
Sentence: 288,A,O
Sentence: 288,patient,O
Sentence: 288,with,O
Sentence: 288,transfusion,O
Sentence: 288,-,O
Sentence: 288,dependent,O
Sentence: 288,thalassemia,B-Disease
Sentence: 288,was,O
Sentence: 288,undergoing,O
Sentence: 288,home,O
Sentence: 288,intravenous,O
Sentence: 288,desferrioxamine,B-Chemical
Sentence: 288,(,O
Sentence: 288,DFX,B-Chemical
Sentence: 288,),O
Sentence: 288,treatment,O
Sentence: 288,by,O
Sentence: 288,means,O
Sentence: 288,of,O
Sentence: 288,a,O
Sentence: 288,totally,O
Sentence: 288,implanted,O
Sentence: 288,system,O
Sentence: 288,because,O
Sentence: 288,of,O
Sentence: 288,his,O
Sentence: 288,poor,O
Sentence: 288,compliance,O
Sentence: 288,with,O
Sentence: 288,the,O
Sentence: 288,nightly,O
Sentence: 288,subcutaneous,O
Sentence: 288,therapy,O
Sentence: 288,.,O
Sentence: 288,Due,O
Sentence: 288,to,O
Sentence: 288,an,O
Sentence: 288,accidental,O
Sentence: 288,malfunctioning,O
Sentence: 288,of,O
Sentence: 288,the,O
Sentence: 288,infusion,O
Sentence: 288,pump,O
Sentence: 288,",",O
Sentence: 288,the,O
Sentence: 288,patient,O
Sentence: 288,was,O
Sentence: 288,inadvertently,O
Sentence: 288,administered,O
Sentence: 288,a,O
Sentence: 288,toxic,O
Sentence: 288,dosage,O
Sentence: 288,of,O
Sentence: 288,the,O
Sentence: 288,drug,O
Sentence: 288,which,O
Sentence: 288,caused,O
Sentence: 288,renal,B-Disease
Sentence: 288,insufficiency,I-Disease
Sentence: 288,.,O
Sentence: 288,Given,O
Sentence: 288,the,O
Sentence: 288,progressive,O
Sentence: 288,deterioration,O
Sentence: 288,of,O
Sentence: 288,the,O
Sentence: 288,symptoms,O
Sentence: 288,and,O
Sentence: 288,of,O
Sentence: 288,the,O
Sentence: 288,laboratory,O
Sentence: 288,values,O
Sentence: 288,",",O
Sentence: 288,despite,O
Sentence: 288,adequate,O
Sentence: 288,medical,O
Sentence: 288,treatment,O
Sentence: 288,",",O
Sentence: 288,a,O
Sentence: 288,decision,O
Sentence: 288,was,O
Sentence: 288,made,O
Sentence: 288,to,O
Sentence: 288,introduce,O
Sentence: 288,haemodialytical,O
Sentence: 288,therapy,O
Sentence: 288,in,O
Sentence: 288,order,O
Sentence: 288,to,O
Sentence: 288,remove,O
Sentence: 288,the,O
Sentence: 288,drug,O
Sentence: 288,and,O
Sentence: 288,therapy,O
Sentence: 288,reduce,O
Sentence: 288,the,O
Sentence: 288,nephrotoxicity,B-Disease
Sentence: 288,.,O
Sentence: 288,From,O
Sentence: 288,the,O
Sentence: 288,results,O
Sentence: 288,obtained,O
Sentence: 288,",",O
Sentence: 288,haemodialysis,O
Sentence: 288,can,O
Sentence: 288,therefore,O
Sentence: 288,be,O
Sentence: 288,suggested,O
Sentence: 288,as,O
Sentence: 288,a,O
Sentence: 288,useful,O
Sentence: 288,therapy,O
Sentence: 288,in,O
Sentence: 288,rare,O
Sentence: 288,cases,O
Sentence: 288,of,O
Sentence: 288,progressive,O
Sentence: 288,acute,B-Disease
Sentence: 288,renal,I-Disease
Sentence: 288,failure,I-Disease
Sentence: 288,caused,O
Sentence: 288,by,O
Sentence: 288,desferrioxamine,B-Chemical
Sentence: 288,.,O
Sentence: 289,Neuroleptic,B-Chemical
Sentence: 289,-,O
Sentence: 289,associated,O
Sentence: 289,hyperprolactinemia,B-Disease
Sentence: 289,.,O
Sentence: 289,Can,O
Sentence: 289,it,O
Sentence: 289,be,O
Sentence: 289,treated,O
Sentence: 289,with,O
Sentence: 289,bromocriptine,B-Chemical
Sentence: 289,?,O
Sentence: 290,Six,O
Sentence: 290,stable,O
Sentence: 290,psychiatric,O
Sentence: 290,outpatients,O
Sentence: 290,with,O
Sentence: 290,hyperprolactinemia,B-Disease
Sentence: 290,and,O
Sentence: 290,amenorrhea,B-Disease
Sentence: 290,/,O
Sentence: 290,oligomenorrhea,B-Disease
Sentence: 290,associated,O
Sentence: 290,with,O
Sentence: 290,their,O
Sentence: 290,neuroleptic,B-Chemical
Sentence: 290,medications,I-Chemical
Sentence: 290,were,O
Sentence: 290,treated,O
Sentence: 290,with,O
Sentence: 290,bromocriptine,B-Chemical
Sentence: 290,.,O
Sentence: 290,Daily,O
Sentence: 290,dosages,O
Sentence: 290,of,O
Sentence: 290,5,O
Sentence: 290,-,O
Sentence: 290,10,O
Sentence: 290,mg,O
Sentence: 290,corrected,O
Sentence: 290,the,O
Sentence: 290,hyperprolactinemia,B-Disease
Sentence: 290,and,O
Sentence: 290,restored,O
Sentence: 290,menstruation,O
Sentence: 290,in,O
Sentence: 290,four,O
Sentence: 290,of,O
Sentence: 290,the,O
Sentence: 290,six,O
Sentence: 290,patients,O
Sentence: 290,.,O
Sentence: 290,One,O
Sentence: 290,woman,O
Sentence: 290,",",O
Sentence: 290,however,O
Sentence: 290,",",O
Sentence: 290,developed,O
Sentence: 290,worsened,O
Sentence: 290,psychiatric,B-Disease
Sentence: 290,symptoms,I-Disease
Sentence: 290,while,O
Sentence: 290,taking,O
Sentence: 290,bromocriptine,B-Chemical
Sentence: 290,",",O
Sentence: 290,and,O
Sentence: 290,it,O
Sentence: 290,was,O
Sentence: 290,discontinued,O
Sentence: 290,.,O
Sentence: 290,Thus,O
Sentence: 290,",",O
Sentence: 290,three,O
Sentence: 290,of,O
Sentence: 290,six,O
Sentence: 290,patients,O
Sentence: 290,had,O
Sentence: 290,their,O
Sentence: 290,menstrual,O
Sentence: 290,irregularity,O
Sentence: 290,successfully,O
Sentence: 290,corrected,O
Sentence: 290,with,O
Sentence: 290,bromocriptine,B-Chemical
Sentence: 290,.,O
Sentence: 290,This,O
Sentence: 290,suggests,O
Sentence: 290,that,O
Sentence: 290,bromocriptine,B-Chemical
Sentence: 290,should,O
Sentence: 290,be,O
Sentence: 290,further,O
Sentence: 290,evaluated,O
Sentence: 290,as,O
Sentence: 290,potential,O
Sentence: 290,therapy,O
Sentence: 290,for,O
Sentence: 290,neuroleptic,B-Chemical
Sentence: 290,-,O
Sentence: 290,associated,O
Sentence: 290,hyperprolactinemia,B-Disease
Sentence: 290,and,O
Sentence: 290,amenorrhea,B-Disease
Sentence: 290,/,O
Sentence: 290,galactorrhea,B-Disease
Sentence: 290,.,O
Sentence: 291,Ethacrynic,B-Chemical
Sentence: 291,acid,I-Chemical
Sentence: 291,-,O
Sentence: 291,induced,O
Sentence: 291,convulsions,B-Disease
Sentence: 291,and,O
Sentence: 291,brain,O
Sentence: 291,neurotransmitters,O
Sentence: 291,in,O
Sentence: 291,mice,O
Sentence: 291,.,O
Sentence: 292,Intracerebroventricular,O
Sentence: 292,injection,O
Sentence: 292,of,O
Sentence: 292,ethacrynic,B-Chemical
Sentence: 292,acid,I-Chemical
Sentence: 292,(,O
Sentence: 292,50,O
Sentence: 292,%,O
Sentence: 292,convulsive,B-Disease
Sentence: 292,dose,O
Sentence: 292,;,O
Sentence: 292,50,O
Sentence: 292,micrograms,O
Sentence: 292,/,O
Sentence: 292,mouse,O
Sentence: 292,),O
Sentence: 292,accelerated,O
Sentence: 292,the,O
Sentence: 292,synthesis,O
Sentence: 292,/,O
Sentence: 292,turnover,O
Sentence: 292,of,O
Sentence: 292,5,O
Sentence: 292,-,O
Sentence: 292,hydroxytryptamine,O
Sentence: 292,(,O
Sentence: 292,5,O
Sentence: 292,-,O
Sentence: 292,HT,O
Sentence: 292,),O
Sentence: 292,but,O
Sentence: 292,suppressed,O
Sentence: 292,the,O
Sentence: 292,synthesis,O
Sentence: 292,of,O
Sentence: 292,gamma,O
Sentence: 292,-,O
Sentence: 292,aminobutyric,O
Sentence: 292,acid,O
Sentence: 292,and,O
Sentence: 292,acetylcholine,B-Chemical
Sentence: 292,in,O
Sentence: 292,mouse,O
Sentence: 292,brain,O
Sentence: 292,.,O
Sentence: 292,These,O
Sentence: 292,effects,O
Sentence: 292,were,O
Sentence: 292,completely,O
Sentence: 292,antagonized,O
Sentence: 292,by,O
Sentence: 292,pretreatment,O
Sentence: 292,with,O
Sentence: 292,a,O
Sentence: 292,glutamate,B-Chemical
Sentence: 292,/,O
Sentence: 292,N,O
Sentence: 292,-,O
Sentence: 292,methyl,O
Sentence: 292,-,O
Sentence: 292,D,O
Sentence: 292,-,O
Sentence: 292,aspartate,O
Sentence: 292,antagonist,O
Sentence: 292,",",O
Sentence: 292,aminophosphonovaleric,B-Chemical
Sentence: 292,acid,I-Chemical
Sentence: 292,.,O
Sentence: 292,In,O
Sentence: 292,ethacrynic,B-Chemical
Sentence: 292,acid,I-Chemical
Sentence: 292,-,O
Sentence: 292,induced,O
Sentence: 292,convulsions,B-Disease
Sentence: 292,",",O
Sentence: 292,these,O
Sentence: 292,neurotransmitter,O
Sentence: 292,systems,O
Sentence: 292,may,O
Sentence: 292,be,O
Sentence: 292,differentially,O
Sentence: 292,modulated,O
Sentence: 292,",",O
Sentence: 292,probably,O
Sentence: 292,through,O
Sentence: 292,activation,O
Sentence: 292,of,O
Sentence: 292,glutaminergic,O
Sentence: 292,neurons,O
Sentence: 292,in,O
Sentence: 292,the,O
Sentence: 292,brain,O
Sentence: 292,.,O
Sentence: 293,Pharmacology,O
Sentence: 293,of,O
Sentence: 293,gamma,O
Sentence: 293,-,O
Sentence: 293,aminobutyric,O
Sentence: 293,acidA,O
Sentence: 293,receptor,O
Sentence: 293,complex,O
Sentence: 293,after,O
Sentence: 293,the,O
Sentence: 293,in,O
Sentence: 293,vivo,O
Sentence: 293,administration,O
Sentence: 293,of,O
Sentence: 293,the,O
Sentence: 293,anxioselective,O
Sentence: 293,and,O
Sentence: 293,anticonvulsant,O
Sentence: 293,beta,O
Sentence: 293,-,O
Sentence: 293,carboline,O
Sentence: 293,derivative,O
Sentence: 293,abecarnil,B-Chemical
Sentence: 293,.,O
Sentence: 294,In,O
Sentence: 294,rodents,O
Sentence: 294,",",O
Sentence: 294,the,O
Sentence: 294,effect,O
Sentence: 294,of,O
Sentence: 294,the,O
Sentence: 294,beta,O
Sentence: 294,-,O
Sentence: 294,carboline,O
Sentence: 294,derivative,O
Sentence: 294,isopropyl,O
Sentence: 294,-,O
Sentence: 294,6,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,benzyloxy,O
Sentence: 294,-,O
Sentence: 294,4,O
Sentence: 294,-,O
Sentence: 294,methoxymethyl,O
Sentence: 294,-,O
Sentence: 294,beta,O
Sentence: 294,-,O
Sentence: 294,carboline,O
Sentence: 294,-,O
Sentence: 294,3,O
Sentence: 294,-,O
Sentence: 294,carboxylate,O
Sentence: 294,(,O
Sentence: 294,abecarrnil,B-Chemical
Sentence: 294,),O
Sentence: 294,",",O
Sentence: 294,a,O
Sentence: 294,new,O
Sentence: 294,ligand,O
Sentence: 294,for,O
Sentence: 294,benzodiazepine,B-Chemical
Sentence: 294,receptors,O
Sentence: 294,possessing,O
Sentence: 294,anxiolytic,O
Sentence: 294,and,O
Sentence: 294,anticonvulsant,O
Sentence: 294,properties,O
Sentence: 294,",",O
Sentence: 294,was,O
Sentence: 294,evaluated,O
Sentence: 294,on,O
Sentence: 294,the,O
Sentence: 294,function,O
Sentence: 294,of,O
Sentence: 294,central,O
Sentence: 294,gamma,O
Sentence: 294,-,O
Sentence: 294,aminobutyric,O
Sentence: 294,acid,O
Sentence: 294,(,O
Sentence: 294,GABA,B-Chemical
Sentence: 294,),O
Sentence: 294,A,O
Sentence: 294,receptor,O
Sentence: 294,complex,O
Sentence: 294,",",O
Sentence: 294,both,O
Sentence: 294,in,O
Sentence: 294,vitro,O
Sentence: 294,and,O
Sentence: 294,in,O
Sentence: 294,vivo,O
Sentence: 294,.,O
Sentence: 294,Added,O
Sentence: 294,in,O
Sentence: 294,vitro,O
Sentence: 294,to,O
Sentence: 294,rat,O
Sentence: 294,cortical,O
Sentence: 294,membrane,O
Sentence: 294,preparation,O
Sentence: 294,",",O
Sentence: 294,abecarnil,B-Chemical
Sentence: 294,increased,O
Sentence: 294,[,O
Sentence: 294,3H,O
Sentence: 294,],O
Sentence: 294,GABA,B-Chemical
Sentence: 294,binding,O
Sentence: 294,",",O
Sentence: 294,enhanced,O
Sentence: 294,muscimol,B-Chemical
Sentence: 294,-,O
Sentence: 294,stimulated,O
Sentence: 294,36Cl,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,uptake,O
Sentence: 294,and,O
Sentence: 294,reduced,O
Sentence: 294,the,O
Sentence: 294,binding,O
Sentence: 294,of,O
Sentence: 294,t,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,[,O
Sentence: 294,35S,O
Sentence: 294,],O
Sentence: 294,butylbicyclophosphorothionate,O
Sentence: 294,(,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,),O
Sentence: 294,.,O
Sentence: 294,These,O
Sentence: 294,effects,O
Sentence: 294,were,O
Sentence: 294,similar,O
Sentence: 294,to,O
Sentence: 294,those,O
Sentence: 294,induced,O
Sentence: 294,by,O
Sentence: 294,diazepam,B-Chemical
Sentence: 294,",",O
Sentence: 294,whereas,O
Sentence: 294,the,O
Sentence: 294,partial,O
Sentence: 294,agonist,O
Sentence: 294,Ro,O
Sentence: 294,16,O
Sentence: 294,-,O
Sentence: 294,6028,O
Sentence: 294,(,O
Sentence: 294,tert,O
Sentence: 294,-,O
Sentence: 294,butyl,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,(,O
Sentence: 294,S,O
Sentence: 294,),O
Sentence: 294,,O
Sentence: 294,-,O
Sentence: 294,8,O
Sentence: 294,-,O
Sentence: 294,bromo,O
Sentence: 294,-,O
Sentence: 294,"11,12,13,13a",O
Sentence: 294,-,O
Sentence: 294,tetrahydro,O
Sentence: 294,-,O
Sentence: 294,9,O
Sentence: 294,-,O
Sentence: 294,oxo,O
Sentence: 294,-,O
Sentence: 294,9H,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,imidazo,O
Sentence: 294,[,O
Sentence: 294,"1,5",O
Sentence: 294,-,O
Sentence: 294,a,O
Sentence: 294,],O
Sentence: 294,,O
Sentence: 294,-,O
Sentence: 294,pyrrolo,O
Sentence: 294,-,O
Sentence: 294,,O
Sentence: 294,[,O
Sentence: 294,"2,1",O
Sentence: 294,-,O
Sentence: 294,c,O
Sentence: 294,],O
Sentence: 294,[,O
Sentence: 294,"1,4",O
Sentence: 294,],O
Sentence: 294,benzodiazepine,B-Chemical
Sentence: 294,-,O
Sentence: 294,1,O
Sentence: 294,-,O
Sentence: 294,carboxylate,O
Sentence: 294,),O
Sentence: 294,showed,O
Sentence: 294,very,O
Sentence: 294,weak,O
Sentence: 294,efficacy,O
Sentence: 294,in,O
Sentence: 294,these,O
Sentence: 294,biochemical,O
Sentence: 294,tests,O
Sentence: 294,.,O
Sentence: 294,After,O
Sentence: 294,i.p,O
Sentence: 294,.,O
Sentence: 294,injection,O
Sentence: 294,to,O
Sentence: 294,rats,O
Sentence: 294,",",O
Sentence: 294,abecarnil,B-Chemical
Sentence: 294,and,O
Sentence: 294,diazepam,B-Chemical
Sentence: 294,decreased,O
Sentence: 294,in,O
Sentence: 294,a,O
Sentence: 294,time,O
Sentence: 294,-,O
Sentence: 294,dependent,O
Sentence: 294,and,O
Sentence: 294,dose,O
Sentence: 294,-,O
Sentence: 294,related,O
Sentence: 294,(,O
Sentence: 294,0.25,O
Sentence: 294,-,O
Sentence: 294,20,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,i.p,O
Sentence: 294,.,O
Sentence: 294,),O
Sentence: 294,manner,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,measured,O
Sentence: 294,ex,O
Sentence: 294,vivo,O
Sentence: 294,in,O
Sentence: 294,the,O
Sentence: 294,cerebral,O
Sentence: 294,cortex,O
Sentence: 294,.,O
Sentence: 294,Moreover,O
Sentence: 294,",",O
Sentence: 294,both,O
Sentence: 294,drugs,O
Sentence: 294,at,O
Sentence: 294,the,O
Sentence: 294,dose,O
Sentence: 294,of,O
Sentence: 294,0.5,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,antagonized,O
Sentence: 294,completely,O
Sentence: 294,the,O
Sentence: 294,convulsant,O
Sentence: 294,activity,O
Sentence: 294,and,O
Sentence: 294,the,O
Sentence: 294,increase,O
Sentence: 294,of,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,induced,O
Sentence: 294,by,O
Sentence: 294,isoniazide,B-Chemical
Sentence: 294,(,O
Sentence: 294,350,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,s.c.,O
Sentence: 294,),O
Sentence: 294,as,O
Sentence: 294,well,O
Sentence: 294,as,O
Sentence: 294,the,O
Sentence: 294,increase,O
Sentence: 294,of,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,induced,O
Sentence: 294,by,O
Sentence: 294,foot,O
Sentence: 294,-,O
Sentence: 294,shock,O
Sentence: 294,stress,O
Sentence: 294,.,O
Sentence: 294,To,O
Sentence: 294,better,O
Sentence: 294,correlate,O
Sentence: 294,the,O
Sentence: 294,biochemical,O
Sentence: 294,and,O
Sentence: 294,the,O
Sentence: 294,pharmacological,O
Sentence: 294,effects,O
Sentence: 294,",",O
Sentence: 294,we,O
Sentence: 294,studied,O
Sentence: 294,the,O
Sentence: 294,action,O
Sentence: 294,of,O
Sentence: 294,abecarnil,B-Chemical
Sentence: 294,on,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,",",O
Sentence: 294,exploratory,O
Sentence: 294,motility,O
Sentence: 294,and,O
Sentence: 294,on,O
Sentence: 294,isoniazid,B-Chemical
Sentence: 294,-,O
Sentence: 294,induced,O
Sentence: 294,biochemical,O
Sentence: 294,and,O
Sentence: 294,pharmacological,O
Sentence: 294,effects,O
Sentence: 294,in,O
Sentence: 294,mice,O
Sentence: 294,.,O
Sentence: 294,In,O
Sentence: 294,these,O
Sentence: 294,animals,O
Sentence: 294,",",O
Sentence: 294,abecarnil,B-Chemical
Sentence: 294,produced,O
Sentence: 294,a,O
Sentence: 294,paralleled,O
Sentence: 294,dose,O
Sentence: 294,-,O
Sentence: 294,dependent,O
Sentence: 294,(,O
Sentence: 294,0.05,O
Sentence: 294,-,O
Sentence: 294,1,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,i.p,O
Sentence: 294,.,O
Sentence: 294,),O
Sentence: 294,reduction,O
Sentence: 294,of,O
Sentence: 294,both,O
Sentence: 294,motor,O
Sentence: 294,behavior,O
Sentence: 294,and,O
Sentence: 294,cortical,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,.,O
Sentence: 294,Moreover,O
Sentence: 294,",",O
Sentence: 294,0.05,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,of,O
Sentence: 294,this,O
Sentence: 294,beta,O
Sentence: 294,-,O
Sentence: 294,carboline,O
Sentence: 294,reduced,O
Sentence: 294,markedly,O
Sentence: 294,the,O
Sentence: 294,increase,O
Sentence: 294,of,O
Sentence: 294,[,B-Chemical
Sentence: 294,35S,I-Chemical
Sentence: 294,],I-Chemical
Sentence: 294,TBPS,I-Chemical
Sentence: 294,binding,O
Sentence: 294,and,O
Sentence: 294,the,O
Sentence: 294,convulsions,B-Disease
Sentence: 294,induced,O
Sentence: 294,by,O
Sentence: 294,isoniazid,B-Chemical
Sentence: 294,(,O
Sentence: 294,200,O
Sentence: 294,mg,O
Sentence: 294,/,O
Sentence: 294,kg,O
Sentence: 294,s.c.,O
Sentence: 294,),O
Sentence: 294,.,O
Sentence: 294,(,O
Sentence: 294,ABSTRACT,O
Sentence: 294,TRUNCATED,O
Sentence: 294,AT,O
Sentence: 294,250,O
Sentence: 294,WORDS,O
Sentence: 294,),O
Sentence: 295,Recurrent,O
Sentence: 295,myocardial,B-Disease
Sentence: 295,infarction,I-Disease
Sentence: 295,in,O
Sentence: 295,a,O
Sentence: 295,postpartum,O
Sentence: 295,patient,O
Sentence: 295,receiving,O
Sentence: 295,bromocriptine,B-Chemical
Sentence: 295,.,O
Sentence: 296,Myocardial,B-Disease
Sentence: 296,infarction,I-Disease
Sentence: 296,in,O
Sentence: 296,puerperium,O
Sentence: 296,is,O
Sentence: 296,infrequently,O
Sentence: 296,reported,O
Sentence: 296,.,O
Sentence: 296,Spasm,B-Disease
Sentence: 296,",",O
Sentence: 296,coronary,O
Sentence: 296,dissection,O
Sentence: 296,",",O
Sentence: 296,or,O
Sentence: 296,atheromatous,O
Sentence: 296,etiology,O
Sentence: 296,has,O
Sentence: 296,been,O
Sentence: 296,described,O
Sentence: 296,.,O
Sentence: 296,Bromocriptine,B-Chemical
Sentence: 296,has,O
Sentence: 296,been,O
Sentence: 296,implicated,O
Sentence: 296,in,O
Sentence: 296,several,O
Sentence: 296,previous,O
Sentence: 296,case,O
Sentence: 296,reports,O
Sentence: 296,of,O
Sentence: 296,myocardial,B-Disease
Sentence: 296,infarction,I-Disease
Sentence: 296,in,O
Sentence: 296,the,O
Sentence: 296,puerperium,O
Sentence: 296,.,O
Sentence: 296,Our,O
Sentence: 296,case,O
Sentence: 296,(,O
Sentence: 296,including,O
Sentence: 296,an,O
Sentence: 296,inadvertent,O
Sentence: 296,rechallenge,O
Sentence: 296,),O
Sentence: 296,suggests,O
Sentence: 296,such,O
Sentence: 296,a,O
Sentence: 296,relationship,O
Sentence: 296,.,O
Sentence: 296,Although,O
Sentence: 296,generally,O
Sentence: 296,regarded,O
Sentence: 296,as,O
Sentence: 296,``,O
Sentence: 296,safe,O
Sentence: 296,",",O
Sentence: 296,'',O
Sentence: 296,possible,O
Sentence: 296,serious,O
Sentence: 296,cardiac,O
Sentence: 296,effects,O
Sentence: 296,of,O
Sentence: 296,bromocriptine,B-Chemical
Sentence: 296,should,O
Sentence: 296,be,O
Sentence: 296,acknowledged,O
Sentence: 296,.,O
Sentence: 297,Asterixis,B-Disease
Sentence: 297,induced,O
Sentence: 297,by,O
Sentence: 297,carbamazepine,B-Chemical
Sentence: 297,therapy,O
Sentence: 297,.,O
Sentence: 298,There,O
Sentence: 298,are,O
Sentence: 298,very,O
Sentence: 298,few,O
Sentence: 298,reports,O
Sentence: 298,about,O
Sentence: 298,asterixis,B-Disease
Sentence: 298,as,O
Sentence: 298,a,O
Sentence: 298,side,O
Sentence: 298,effect,O
Sentence: 298,of,O
Sentence: 298,treatment,O
Sentence: 298,with,O
Sentence: 298,psychopharmacologic,O
Sentence: 298,agents,O
Sentence: 298,.,O
Sentence: 298,In,O
Sentence: 298,this,O
Sentence: 298,report,O
Sentence: 298,we,O
Sentence: 298,present,O
Sentence: 298,four,O
Sentence: 298,patients,O
Sentence: 298,treated,O
Sentence: 298,with,O
Sentence: 298,a,O
Sentence: 298,combination,O
Sentence: 298,of,O
Sentence: 298,different,O
Sentence: 298,psychotropic,O
Sentence: 298,drugs,O
Sentence: 298,",",O
Sentence: 298,in,O
Sentence: 298,whom,O
Sentence: 298,asterixis,B-Disease
Sentence: 298,was,O
Sentence: 298,triggered,O
Sentence: 298,either,O
Sentence: 298,by,O
Sentence: 298,adding,O
Sentence: 298,carbamazepine,B-Chemical
Sentence: 298,(,O
Sentence: 298,CBZ,B-Chemical
Sentence: 298,),O
Sentence: 298,to,O
Sentence: 298,a,O
Sentence: 298,treatment,O
Sentence: 298,regimen,O
Sentence: 298,",",O
Sentence: 298,or,O
Sentence: 298,by,O
Sentence: 298,increasing,O
Sentence: 298,its,O
Sentence: 298,dosage,O
Sentence: 298,.,O
Sentence: 298,Neither,O
Sentence: 298,dosage,O
Sentence: 298,nor,O
Sentence: 298,serum,O
Sentence: 298,levels,O
Sentence: 298,of,O
Sentence: 298,CBZ,B-Chemical
Sentence: 298,were,O
Sentence: 298,in,O
Sentence: 298,a,O
Sentence: 298,higher,O
Sentence: 298,range,O
Sentence: 298,.,O
Sentence: 298,We,O
Sentence: 298,consider,O
Sentence: 298,asterixis,B-Disease
Sentence: 298,to,O
Sentence: 298,be,O
Sentence: 298,an,O
Sentence: 298,easily,O
Sentence: 298,overlooked,O
Sentence: 298,sign,O
Sentence: 298,of,O
Sentence: 298,neurotoxicity,B-Disease
Sentence: 298,",",O
Sentence: 298,which,O
Sentence: 298,may,O
Sentence: 298,occur,O
Sentence: 298,even,O
Sentence: 298,at,O
Sentence: 298,low,O
Sentence: 298,or,O
Sentence: 298,moderate,O
Sentence: 298,dosage,O
Sentence: 298,levels,O
Sentence: 298,",",O
Sentence: 298,if,O
Sentence: 298,certain,O
Sentence: 298,drugs,O
Sentence: 298,as,O
Sentence: 298,lithium,B-Chemical
Sentence: 298,or,O
Sentence: 298,clozapine,B-Chemical
Sentence: 298,are,O
Sentence: 298,used,O
Sentence: 298,in,O
Sentence: 298,combination,O
Sentence: 298,with,O
Sentence: 298,CBZ,B-Chemical
Sentence: 298,.,O
Sentence: 299,Pharmacodynamics,O
Sentence: 299,of,O
Sentence: 299,the,O
Sentence: 299,hypotensive,B-Disease
Sentence: 299,effect,O
Sentence: 299,of,O
Sentence: 299,levodopa,B-Chemical
Sentence: 299,in,O
Sentence: 299,parkinsonian,B-Disease
Sentence: 299,patients,O
Sentence: 299,.,O
Sentence: 300,Blood,O
Sentence: 300,pressure,O
Sentence: 300,effects,O
Sentence: 300,of,O
Sentence: 300,i.v,O
Sentence: 300,.,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,were,O
Sentence: 300,examined,O
Sentence: 300,in,O
Sentence: 300,parkinsonian,B-Disease
Sentence: 300,patients,O
Sentence: 300,with,O
Sentence: 300,stable,O
Sentence: 300,and,O
Sentence: 300,fluctuating,O
Sentence: 300,responses,O
Sentence: 300,to,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,.,O
Sentence: 300,The,O
Sentence: 300,magnitude,O
Sentence: 300,of,O
Sentence: 300,the,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,effect,O
Sentence: 300,of,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,was,O
Sentence: 300,concentration,O
Sentence: 300,dependent,O
Sentence: 300,and,O
Sentence: 300,was,O
Sentence: 300,fit,O
Sentence: 300,to,O
Sentence: 300,an,O
Sentence: 300,Emax,O
Sentence: 300,model,O
Sentence: 300,in,O
Sentence: 300,fluctuating,O
Sentence: 300,responders,O
Sentence: 300,.,O
Sentence: 300,Stable,O
Sentence: 300,responders,O
Sentence: 300,demonstrated,O
Sentence: 300,a,O
Sentence: 300,small,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,response,O
Sentence: 300,.,O
Sentence: 300,Baseline,O
Sentence: 300,blood,O
Sentence: 300,pressures,O
Sentence: 300,were,O
Sentence: 300,higher,O
Sentence: 300,in,O
Sentence: 300,fluctuating,O
Sentence: 300,patients,O
Sentence: 300,;,O
Sentence: 300,a,O
Sentence: 300,higher,O
Sentence: 300,baseline,O
Sentence: 300,blood,O
Sentence: 300,pressure,O
Sentence: 300,correlated,O
Sentence: 300,with,O
Sentence: 300,greater,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,effects,O
Sentence: 300,.,O
Sentence: 300,Antiparkinsonian,O
Sentence: 300,effects,O
Sentence: 300,of,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,temporally,O
Sentence: 300,correlated,O
Sentence: 300,with,O
Sentence: 300,blood,O
Sentence: 300,pressure,O
Sentence: 300,changes,O
Sentence: 300,.,O
Sentence: 300,Phenylalanine,B-Chemical
Sentence: 300,",",O
Sentence: 300,a,O
Sentence: 300,large,O
Sentence: 300,neutral,O
Sentence: 300,amino,B-Chemical
Sentence: 300,acid,I-Chemical
Sentence: 300,(,O
Sentence: 300,LNAA,O
Sentence: 300,),O
Sentence: 300,competing,O
Sentence: 300,with,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,for,O
Sentence: 300,transport,O
Sentence: 300,across,O
Sentence: 300,the,O
Sentence: 300,blood,O
Sentence: 300,-,O
Sentence: 300,brain,O
Sentence: 300,barrier,O
Sentence: 300,",",O
Sentence: 300,reduced,O
Sentence: 300,the,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,and,O
Sentence: 300,antiparkinsonian,O
Sentence: 300,effects,O
Sentence: 300,of,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,.,O
Sentence: 300,We,O
Sentence: 300,conclude,O
Sentence: 300,that,O
Sentence: 300,levodopa,B-Chemical
Sentence: 300,has,O
Sentence: 300,a,O
Sentence: 300,central,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,action,O
Sentence: 300,that,O
Sentence: 300,parallels,O
Sentence: 300,the,O
Sentence: 300,motor,O
Sentence: 300,effects,O
Sentence: 300,in,O
Sentence: 300,fluctuating,O
Sentence: 300,patients,O
Sentence: 300,.,O
Sentence: 300,The,O
Sentence: 300,hypotensive,B-Disease
Sentence: 300,effect,O
Sentence: 300,appears,O
Sentence: 300,to,O
Sentence: 300,be,O
Sentence: 300,related,O
Sentence: 300,to,O
Sentence: 300,the,O
Sentence: 300,higher,O
Sentence: 300,baseline,O
Sentence: 300,blood,O
Sentence: 300,pressure,O
Sentence: 300,we,O
Sentence: 300,observed,O
Sentence: 300,in,O
Sentence: 300,fluctuating,O
Sentence: 300,patients,O
Sentence: 300,relative,O
Sentence: 300,to,O
Sentence: 300,stable,O
Sentence: 300,patients,O
Sentence: 300,.,O
Sentence: 301,Syndrome,B-Disease
Sentence: 301,of,I-Disease
Sentence: 301,inappropriate,I-Disease
Sentence: 301,secretion,I-Disease
Sentence: 301,of,I-Disease
Sentence: 301,antidiuretic,I-Disease
Sentence: 301,hormone,I-Disease
Sentence: 301,after,O
Sentence: 301,infusional,O
Sentence: 301,vincristine,B-Chemical
Sentence: 301,.,O
Sentence: 302,A,O
Sentence: 302,77,O
Sentence: 302,-,O
Sentence: 302,year,O
Sentence: 302,-,O
Sentence: 302,old,O
Sentence: 302,woman,O
Sentence: 302,with,O
Sentence: 302,refractory,O
Sentence: 302,multiple,B-Disease
Sentence: 302,myeloma,I-Disease
Sentence: 302,was,O
Sentence: 302,treated,O
Sentence: 302,with,O
Sentence: 302,a,O
Sentence: 302,4,O
Sentence: 302,-,O
Sentence: 302,day,O
Sentence: 302,continuous,O
Sentence: 302,intravenous,O
Sentence: 302,infusion,O
Sentence: 302,of,O
Sentence: 302,vincristine,B-Chemical
Sentence: 302,and,O
Sentence: 302,doxorubicin,B-Chemical
Sentence: 302,and,O
Sentence: 302,4,O
Sentence: 302,days,O
Sentence: 302,of,O
Sentence: 302,oral,O
Sentence: 302,dexamethasone,B-Chemical
Sentence: 302,.,O
Sentence: 302,Nine,O
Sentence: 302,days,O
Sentence: 302,after,O
Sentence: 302,her,O
Sentence: 302,second,O
Sentence: 302,cycle,O
Sentence: 302,she,O
Sentence: 302,presented,O
Sentence: 302,with,O
Sentence: 302,lethargy,B-Disease
Sentence: 302,and,O
Sentence: 302,weakness,B-Disease
Sentence: 302,associated,O
Sentence: 302,with,O
Sentence: 302,hyponatremia,B-Disease
Sentence: 302,.,O
Sentence: 302,Evaluation,O
Sentence: 302,revealed,O
Sentence: 302,the,O
Sentence: 302,syndrome,B-Disease
Sentence: 302,of,I-Disease
Sentence: 302,inappropriate,I-Disease
Sentence: 302,secretion,I-Disease
Sentence: 302,of,I-Disease
Sentence: 302,antidiuretic,I-Disease
Sentence: 302,hormone,I-Disease
Sentence: 302,",",O
Sentence: 302,which,O
Sentence: 302,was,O
Sentence: 302,attributed,O
Sentence: 302,to,O
Sentence: 302,the,O
Sentence: 302,vincristine,B-Chemical
Sentence: 302,infusion,O
Sentence: 302,.,O
Sentence: 302,After,O
Sentence: 302,normal,O
Sentence: 302,serum,O
Sentence: 302,sodium,B-Chemical
Sentence: 302,levels,O
Sentence: 302,returned,O
Sentence: 302,",",O
Sentence: 302,further,O
Sentence: 302,doxorubicin,B-Chemical
Sentence: 302,and,O
Sentence: 302,dexamethasone,B-Chemical
Sentence: 302,chemotherapy,O
Sentence: 302,without,O
Sentence: 302,vincristine,B-Chemical
Sentence: 302,did,O
Sentence: 302,not,O
Sentence: 302,produce,O
Sentence: 302,this,O
Sentence: 302,complication,O
Sentence: 302,.,O
Sentence: 303,Heart,O
Sentence: 303,failure,O
Sentence: 303,:,O
Sentence: 303,to,O
Sentence: 303,digitalise,O
Sentence: 303,or,O
Sentence: 303,not,O
Sentence: 303,?,O
Sentence: 303,The,O
Sentence: 303,view,O
Sentence: 303,against,O
Sentence: 303,.,O
Sentence: 304,Despite,O
Sentence: 304,extensive,O
Sentence: 304,clinical,O
Sentence: 304,experience,O
Sentence: 304,the,O
Sentence: 304,role,O
Sentence: 304,of,O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,is,O
Sentence: 304,still,O
Sentence: 304,not,O
Sentence: 304,well,O
Sentence: 304,defined,O
Sentence: 304,.,O
Sentence: 304,In,O
Sentence: 304,patients,O
Sentence: 304,with,O
Sentence: 304,atrial,B-Disease
Sentence: 304,fibrillation,I-Disease
Sentence: 304,digoxin,B-Chemical
Sentence: 304,is,O
Sentence: 304,beneficial,O
Sentence: 304,for,O
Sentence: 304,ventricular,O
Sentence: 304,rate,O
Sentence: 304,control,O
Sentence: 304,.,O
Sentence: 304,For,O
Sentence: 304,patients,O
Sentence: 304,in,O
Sentence: 304,sinus,O
Sentence: 304,rhythm,O
Sentence: 304,and,O
Sentence: 304,heart,B-Disease
Sentence: 304,failure,I-Disease
Sentence: 304,the,O
Sentence: 304,situation,O
Sentence: 304,is,O
Sentence: 304,less,O
Sentence: 304,clear,O
Sentence: 304,.,O
Sentence: 304,Digoxin,B-Chemical
Sentence: 304,has,O
Sentence: 304,a,O
Sentence: 304,narrow,O
Sentence: 304,therapeutic,O
Sentence: 304,:,O
Sentence: 304,toxic,O
Sentence: 304,ratio,O
Sentence: 304,and,O
Sentence: 304,concentrations,O
Sentence: 304,are,O
Sentence: 304,affected,O
Sentence: 304,by,O
Sentence: 304,a,O
Sentence: 304,number,O
Sentence: 304,of,O
Sentence: 304,drugs,O
Sentence: 304,.,O
Sentence: 304,Also,O
Sentence: 304,",",O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,has,O
Sentence: 304,undesirable,O
Sentence: 304,effects,O
Sentence: 304,such,O
Sentence: 304,as,O
Sentence: 304,increasing,O
Sentence: 304,peripheral,O
Sentence: 304,resistance,O
Sentence: 304,and,O
Sentence: 304,myocardial,O
Sentence: 304,demands,O
Sentence: 304,",",O
Sentence: 304,and,O
Sentence: 304,causing,O
Sentence: 304,arrhythmias,B-Disease
Sentence: 304,.,O
Sentence: 304,There,O
Sentence: 304,is,O
Sentence: 304,a,O
Sentence: 304,paucity,O
Sentence: 304,of,O
Sentence: 304,data,O
Sentence: 304,from,O
Sentence: 304,well,O
Sentence: 304,-,O
Sentence: 304,designed,O
Sentence: 304,trials,O
Sentence: 304,.,O
Sentence: 304,The,O
Sentence: 304,trials,O
Sentence: 304,that,O
Sentence: 304,are,O
Sentence: 304,available,O
Sentence: 304,are,O
Sentence: 304,generally,O
Sentence: 304,small,O
Sentence: 304,with,O
Sentence: 304,limitations,O
Sentence: 304,in,O
Sentence: 304,design,O
Sentence: 304,and,O
Sentence: 304,these,O
Sentence: 304,show,O
Sentence: 304,variation,O
Sentence: 304,in,O
Sentence: 304,patient,O
Sentence: 304,benefit,O
Sentence: 304,.,O
Sentence: 304,More,O
Sentence: 304,convincing,O
Sentence: 304,evidence,O
Sentence: 304,is,O
Sentence: 304,required,O
Sentence: 304,showing,O
Sentence: 304,that,O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,improves,O
Sentence: 304,symptoms,O
Sentence: 304,or,O
Sentence: 304,exercise,O
Sentence: 304,capacity,O
Sentence: 304,.,O
Sentence: 304,Furthermore,O
Sentence: 304,",",O
Sentence: 304,no,O
Sentence: 304,trial,O
Sentence: 304,has,O
Sentence: 304,had,O
Sentence: 304,sufficient,O
Sentence: 304,power,O
Sentence: 304,to,O
Sentence: 304,evaluate,O
Sentence: 304,mortality,O
Sentence: 304,.,O
Sentence: 304,Pooled,O
Sentence: 304,analysis,O
Sentence: 304,of,O
Sentence: 304,the,O
Sentence: 304,effects,O
Sentence: 304,of,O
Sentence: 304,other,O
Sentence: 304,inotropic,O
Sentence: 304,drugs,O
Sentence: 304,shows,O
Sentence: 304,an,O
Sentence: 304,excess,O
Sentence: 304,mortality,O
Sentence: 304,and,O
Sentence: 304,there,O
Sentence: 304,is,O
Sentence: 304,a,O
Sentence: 304,possibility,O
Sentence: 304,that,O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,may,O
Sentence: 304,increase,O
Sentence: 304,mortality,O
Sentence: 304,after,O
Sentence: 304,myocardial,B-Disease
Sentence: 304,infarction,I-Disease
Sentence: 304,(,O
Sentence: 304,MI,B-Disease
Sentence: 304,),O
Sentence: 304,.,O
Sentence: 304,Angiotensin,B-Chemical
Sentence: 304,-,O
Sentence: 304,converting,O
Sentence: 304,enzyme,O
Sentence: 304,(,O
Sentence: 304,ACE,O
Sentence: 304,),O
Sentence: 304,inhibitors,O
Sentence: 304,should,O
Sentence: 304,be,O
Sentence: 304,used,O
Sentence: 304,first,O
Sentence: 304,as,O
Sentence: 304,they,O
Sentence: 304,are,O
Sentence: 304,safer,O
Sentence: 304,",",O
Sentence: 304,do,O
Sentence: 304,not,O
Sentence: 304,require,O
Sentence: 304,blood,O
Sentence: 304,level,O
Sentence: 304,monitoring,O
Sentence: 304,",",O
Sentence: 304,modify,O
Sentence: 304,progression,O
Sentence: 304,of,O
Sentence: 304,disease,O
Sentence: 304,",",O
Sentence: 304,relieve,O
Sentence: 304,symptoms,O
Sentence: 304,",",O
Sentence: 304,improve,O
Sentence: 304,exercise,O
Sentence: 304,tolerance,O
Sentence: 304,and,O
Sentence: 304,reduce,O
Sentence: 304,mortality,O
Sentence: 304,.,O
Sentence: 304,Caution,O
Sentence: 304,should,O
Sentence: 304,be,O
Sentence: 304,exercised,O
Sentence: 304,in,O
Sentence: 304,using,O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,until,O
Sentence: 304,large,O
Sentence: 304,mortality,O
Sentence: 304,trials,O
Sentence: 304,are,O
Sentence: 304,completed,O
Sentence: 304,showing,O
Sentence: 304,either,O
Sentence: 304,benefit,O
Sentence: 304,or,O
Sentence: 304,harm,O
Sentence: 304,.,O
Sentence: 304,Until,O
Sentence: 304,then,O
Sentence: 304,digoxin,B-Chemical
Sentence: 304,should,O
Sentence: 304,be,O
Sentence: 304,considered,O
Sentence: 304,a,O
Sentence: 304,third,O
Sentence: 304,-,O
Sentence: 304,line,O
Sentence: 304,therapy,O
Sentence: 304,.,O
Sentence: 305,Intravascular,O
Sentence: 305,hemolysis,B-Disease
Sentence: 305,and,O
Sentence: 305,acute,B-Disease
Sentence: 305,renal,I-Disease
Sentence: 305,failure,I-Disease
Sentence: 305,following,O
Sentence: 305,intermittent,O
Sentence: 305,rifampin,B-Chemical
Sentence: 305,therapy,O
Sentence: 305,.,O
Sentence: 306,Renal,B-Disease
Sentence: 306,failure,I-Disease
Sentence: 306,is,O
Sentence: 306,a,O
Sentence: 306,rare,O
Sentence: 306,complication,O
Sentence: 306,associated,O
Sentence: 306,with,O
Sentence: 306,the,O
Sentence: 306,use,O
Sentence: 306,of,O
Sentence: 306,rifampin,B-Chemical
Sentence: 306,.,O
Sentence: 306,Intravascular,O
Sentence: 306,hemolysis,B-Disease
Sentence: 306,leading,O
Sentence: 306,to,O
Sentence: 306,acute,B-Disease
Sentence: 306,renal,I-Disease
Sentence: 306,failure,I-Disease
Sentence: 306,following,O
Sentence: 306,rifampin,B-Chemical
Sentence: 306,therapy,O
Sentence: 306,is,O
Sentence: 306,extremely,O
Sentence: 306,rare,O
Sentence: 306,.,O
Sentence: 306,Two,O
Sentence: 306,patients,O
Sentence: 306,with,O
Sentence: 306,leprosy,B-Disease
Sentence: 306,who,O
Sentence: 306,developed,O
Sentence: 306,hemolysis,B-Disease
Sentence: 306,and,O
Sentence: 306,acute,B-Disease
Sentence: 306,renal,I-Disease
Sentence: 306,failure,I-Disease
Sentence: 306,following,O
Sentence: 306,rifampin,B-Chemical
Sentence: 306,are,O
Sentence: 306,reported,O
Sentence: 306,.,O
Sentence: 307,Zidovudine,B-Chemical
Sentence: 307,-,O
Sentence: 307,induced,O
Sentence: 307,hepatitis,B-Disease
Sentence: 307,.,O
Sentence: 308,A,O
Sentence: 308,case,O
Sentence: 308,of,O
Sentence: 308,acute,O
Sentence: 308,hepatitis,B-Disease
Sentence: 308,induced,O
Sentence: 308,by,O
Sentence: 308,zidovudine,B-Chemical
Sentence: 308,in,O
Sentence: 308,a,O
Sentence: 308,38,O
Sentence: 308,-,O
Sentence: 308,year,O
Sentence: 308,-,O
Sentence: 308,old,O
Sentence: 308,patient,O
Sentence: 308,with,O
Sentence: 308,AIDS,B-Disease
Sentence: 308,is,O
Sentence: 308,presented,O
Sentence: 308,.,O
Sentence: 308,The,O
Sentence: 308,mechanism,O
Sentence: 308,whereby,O
Sentence: 308,the,O
Sentence: 308,hepatitis,B-Disease
Sentence: 308,was,O
Sentence: 308,induced,O
Sentence: 308,is,O
Sentence: 308,not,O
Sentence: 308,known,O
Sentence: 308,.,O
Sentence: 308,However,O
Sentence: 308,",",O
Sentence: 308,the,O
Sentence: 308,patient,O
Sentence: 308,tolerated,O
Sentence: 308,well,O
Sentence: 308,an,O
Sentence: 308,alternative,O
Sentence: 308,reverse,O
Sentence: 308,transcriptase,O
Sentence: 308,inhibitor,O
Sentence: 308,",",O
Sentence: 308,2,B-Chemical
Sentence: 308,',I-Chemical
Sentence: 308,3,I-Chemical
Sentence: 308,',I-Chemical
Sentence: 308,dideoxyinosine,I-Chemical
Sentence: 308,.,O
Sentence: 308,Physicians,O
Sentence: 308,caring,O
Sentence: 308,for,O
Sentence: 308,patients,O
Sentence: 308,with,O
Sentence: 308,AIDS,B-Disease
Sentence: 308,should,O
Sentence: 308,be,O
Sentence: 308,aware,O
Sentence: 308,of,O
Sentence: 308,this,O
Sentence: 308,hitherto,O
Sentence: 308,rarely,O
Sentence: 308,reported,O
Sentence: 308,complication,O
Sentence: 308,.,O
Sentence: 309,Thoracic,B-Disease
Sentence: 309,hematomyelia,I-Disease
Sentence: 309,secondary,O
Sentence: 309,to,O
Sentence: 309,coumadin,B-Chemical
Sentence: 309,anticoagulant,O
Sentence: 309,therapy,O
Sentence: 309,:,O
Sentence: 309,a,O
Sentence: 309,case,O
Sentence: 309,report,O
Sentence: 309,.,O
Sentence: 310,A,O
Sentence: 310,case,O
Sentence: 310,of,O
Sentence: 310,thoracic,O
Sentence: 310,hematomyelia,O
Sentence: 310,secondary,O
Sentence: 310,to,O
Sentence: 310,anticoagulant,O
Sentence: 310,therapy,O
Sentence: 310,is,O
Sentence: 310,presented,O
Sentence: 310,.,O
Sentence: 310,Clinical,O
Sentence: 310,features,O
Sentence: 310,",",O
Sentence: 310,similar,O
Sentence: 310,to,O
Sentence: 310,2,O
Sentence: 310,other,O
Sentence: 310,previously,O
Sentence: 310,reported,O
Sentence: 310,cases,O
Sentence: 310,",",O
Sentence: 310,are,O
Sentence: 310,discussed,O
Sentence: 310,.,O
Sentence: 310,A,O
Sentence: 310,high,O
Sentence: 310,index,O
Sentence: 310,of,O
Sentence: 310,suspicion,O
Sentence: 310,may,O
Sentence: 310,lead,O
Sentence: 310,to,O
Sentence: 310,a,O
Sentence: 310,quick,O
Sentence: 310,diagnostic,O
Sentence: 310,procedure,O
Sentence: 310,and,O
Sentence: 310,successful,O
Sentence: 310,decompressive,O
Sentence: 310,surgery,O
Sentence: 310,.,O
Sentence: 311,Mania,B-Disease
Sentence: 311,associated,O
Sentence: 311,with,O
Sentence: 311,fluoxetine,B-Chemical
Sentence: 311,treatment,O
Sentence: 311,in,O
Sentence: 311,adolescents,O
Sentence: 311,.,O
Sentence: 312,Fluoxetine,B-Chemical
Sentence: 312,",",O
Sentence: 312,a,O
Sentence: 312,selective,O
Sentence: 312,serotonin,B-Chemical
Sentence: 312,reuptake,O
Sentence: 312,inhibitor,O
Sentence: 312,",",O
Sentence: 312,is,O
Sentence: 312,gaining,O
Sentence: 312,increased,O
Sentence: 312,acceptance,O
Sentence: 312,in,O
Sentence: 312,the,O
Sentence: 312,treatment,O
Sentence: 312,of,O
Sentence: 312,adolescent,O
Sentence: 312,depression,B-Disease
Sentence: 312,.,O
Sentence: 312,Generally,O
Sentence: 312,safe,O
Sentence: 312,and,O
Sentence: 312,well,O
Sentence: 312,tolerated,O
Sentence: 312,by,O
Sentence: 312,adults,O
Sentence: 312,",",O
Sentence: 312,fluoxetine,B-Chemical
Sentence: 312,has,O
Sentence: 312,been,O
Sentence: 312,reported,O
Sentence: 312,to,O
Sentence: 312,induce,O
Sentence: 312,mania,B-Disease
Sentence: 312,.,O
Sentence: 312,The,O
Sentence: 312,cases,O
Sentence: 312,of,O
Sentence: 312,five,O
Sentence: 312,depressed,B-Disease
Sentence: 312,adolescents,O
Sentence: 312,",",O
Sentence: 312,14,O
Sentence: 312,-,O
Sentence: 312,16,O
Sentence: 312,years,O
Sentence: 312,of,O
Sentence: 312,age,O
Sentence: 312,",",O
Sentence: 312,who,O
Sentence: 312,developed,O
Sentence: 312,mania,B-Disease
Sentence: 312,during,O
Sentence: 312,pharmacotherapy,O
Sentence: 312,with,O
Sentence: 312,fluoxetine,B-Chemical
Sentence: 312,",",O
Sentence: 312,are,O
Sentence: 312,reported,O
Sentence: 312,here,O
Sentence: 312,.,O
Sentence: 312,Apparent,O
Sentence: 312,risk,O
Sentence: 312,factors,O
Sentence: 312,for,O
Sentence: 312,the,O
Sentence: 312,development,O
Sentence: 312,of,O
Sentence: 312,mania,B-Disease
Sentence: 312,or,O
Sentence: 312,hypomania,B-Disease
Sentence: 312,during,O
Sentence: 312,fluoxetine,B-Chemical
Sentence: 312,pharmacotherapy,O
Sentence: 312,in,O
Sentence: 312,this,O
Sentence: 312,population,O
Sentence: 312,were,O
Sentence: 312,the,O
Sentence: 312,combination,O
Sentence: 312,of,O
Sentence: 312,attention,O
Sentence: 312,-,O
Sentence: 312,deficit,O
Sentence: 312,hyperactivity,O
Sentence: 312,disorder,O
Sentence: 312,and,O
Sentence: 312,affective,O
Sentence: 312,instability,O
Sentence: 312,;,O
Sentence: 312,major,O
Sentence: 312,depression,B-Disease
Sentence: 312,with,O
Sentence: 312,psychotic,B-Disease
Sentence: 312,features,O
Sentence: 312,;,O
Sentence: 312,a,O
Sentence: 312,family,O
Sentence: 312,history,O
Sentence: 312,of,O
Sentence: 312,affective,B-Disease
Sentence: 312,disorder,I-Disease
Sentence: 312,",",O
Sentence: 312,especially,O
Sentence: 312,bipolar,B-Disease
Sentence: 312,disorder,I-Disease
Sentence: 312,;,O
Sentence: 312,and,O
Sentence: 312,a,O
Sentence: 312,diagnosis,O
Sentence: 312,of,O
Sentence: 312,bipolar,B-Disease
Sentence: 312,disorder,I-Disease
Sentence: 312,.,O
Sentence: 312,Further,O
Sentence: 312,study,O
Sentence: 312,is,O
Sentence: 312,needed,O
Sentence: 312,to,O
Sentence: 312,determine,O
Sentence: 312,the,O
Sentence: 312,optimal,O
Sentence: 312,dosage,O
Sentence: 312,and,O
Sentence: 312,to,O
Sentence: 312,identify,O
Sentence: 312,risk,O
Sentence: 312,factors,O
Sentence: 312,that,O
Sentence: 312,increase,O
Sentence: 312,individual,O
Sentence: 312,vulnerability,O
Sentence: 312,to,O
Sentence: 312,fluoxetine,B-Chemical
Sentence: 312,induced,O
Sentence: 312,mania,B-Disease
Sentence: 312,in,O
Sentence: 312,adolescents,O
Sentence: 312,.,O
Sentence: 313,Gemfibrozil,B-Chemical
Sentence: 313,-,O
Sentence: 313,lovastatin,B-Chemical
Sentence: 313,therapy,O
Sentence: 313,for,O
Sentence: 313,primary,O
Sentence: 313,hyperlipoproteinemias,B-Disease
Sentence: 313,.,O
Sentence: 314,The,O
Sentence: 314,specific,O
Sentence: 314,aim,O
Sentence: 314,of,O
Sentence: 314,this,O
Sentence: 314,retrospective,O
Sentence: 314,",",O
Sentence: 314,observational,O
Sentence: 314,study,O
Sentence: 314,was,O
Sentence: 314,to,O
Sentence: 314,assess,O
Sentence: 314,safety,O
Sentence: 314,and,O
Sentence: 314,efficacy,O
Sentence: 314,of,O
Sentence: 314,long,O
Sentence: 314,-,O
Sentence: 314,term,O
Sentence: 314,(,O
Sentence: 314,21,O
Sentence: 314,months,O
Sentence: 314,/,O
Sentence: 314,patient,O
Sentence: 314,),O
Sentence: 314,",",O
Sentence: 314,open,O
Sentence: 314,-,O
Sentence: 314,label,O
Sentence: 314,",",O
Sentence: 314,gemfibrozil,B-Chemical
Sentence: 314,-,O
Sentence: 314,lovastatin,B-Chemical
Sentence: 314,treatment,O
Sentence: 314,in,O
Sentence: 314,80,O
Sentence: 314,patients,O
Sentence: 314,with,O
Sentence: 314,primary,O
Sentence: 314,mixed,O
Sentence: 314,hyperlipidemia,B-Disease
Sentence: 314,(,O
Sentence: 314,68,O
Sentence: 314,%,O
Sentence: 314,of,O
Sentence: 314,whom,O
Sentence: 314,had,O
Sentence: 314,atherosclerotic,B-Disease
Sentence: 314,vascular,I-Disease
Sentence: 314,disease,I-Disease
Sentence: 314,),O
Sentence: 314,.,O
Sentence: 314,Because,O
Sentence: 314,ideal,O
Sentence: 314,lipid,O
Sentence: 314,targets,O
Sentence: 314,were,O
Sentence: 314,not,O
Sentence: 314,reached,O
Sentence: 314,(,O
Sentence: 314,low,O
Sentence: 314,-,O
Sentence: 314,density,O
Sentence: 314,lipoprotein,O
Sentence: 314,(,O
Sentence: 314,LDL,O
Sentence: 314,),O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,less,O
Sentence: 314,than,O
Sentence: 314,130,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,",",O
Sentence: 314,high,O
Sentence: 314,-,O
Sentence: 314,density,O
Sentence: 314,lipoprotein,O
Sentence: 314,(,O
Sentence: 314,HDL,O
Sentence: 314,),O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,greater,O
Sentence: 314,than,O
Sentence: 314,35,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,",",O
Sentence: 314,or,O
Sentence: 314,total,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,/,O
Sentence: 314,HDL,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,less,O
Sentence: 314,than,O
Sentence: 314,4.5,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,),O
Sentence: 314,with,O
Sentence: 314,diet,O
Sentence: 314,plus,O
Sentence: 314,a,O
Sentence: 314,single,O
Sentence: 314,drug,O
Sentence: 314,",",O
Sentence: 314,gemfibrozil,B-Chemical
Sentence: 314,(,O
Sentence: 314,1.2,O
Sentence: 314,g,O
Sentence: 314,/,O
Sentence: 314,day,O
Sentence: 314,),O
Sentence: 314,,O
Sentence: 314,-,O
Sentence: 314,lovastatin,B-Chemical
Sentence: 314,(,O
Sentence: 314,primarily,O
Sentence: 314,20,O
Sentence: 314,or,O
Sentence: 314,40,O
Sentence: 314,mg,O
Sentence: 314,),O
Sentence: 314,treatment,O
Sentence: 314,was,O
Sentence: 314,given,O
Sentence: 314,.,O
Sentence: 314,Follow,O
Sentence: 314,-,O
Sentence: 314,up,O
Sentence: 314,visits,O
Sentence: 314,were,O
Sentence: 314,scheduled,O
Sentence: 314,with,O
Sentence: 314,2,O
Sentence: 314,-,O
Sentence: 314,drug,O
Sentence: 314,therapy,O
Sentence: 314,every,O
Sentence: 314,6,O
Sentence: 314,to,O
Sentence: 314,8,O
Sentence: 314,weeks,O
Sentence: 314,",",O
Sentence: 314,an,O
Sentence: 314,average,O
Sentence: 314,of,O
Sentence: 314,10.3,O
Sentence: 314,visits,O
Sentence: 314,per,O
Sentence: 314,patient,O
Sentence: 314,",",O
Sentence: 314,with,O
Sentence: 314,741,O
Sentence: 314,batteries,O
Sentence: 314,of,O
Sentence: 314,6,O
Sentence: 314,liver,O
Sentence: 314,function,O
Sentence: 314,tests,O
Sentence: 314,and,O
Sentence: 314,714,O
Sentence: 314,creatine,B-Chemical
Sentence: 314,phosphokinase,O
Sentence: 314,levels,O
Sentence: 314,measured,O
Sentence: 314,.,O
Sentence: 314,Only,O
Sentence: 314,1,O
Sentence: 314,of,O
Sentence: 314,the,O
Sentence: 314,"4,446",O
Sentence: 314,liver,O
Sentence: 314,function,O
Sentence: 314,tests,O
Sentence: 314,(,O
Sentence: 314,0.02,O
Sentence: 314,%,O
Sentence: 314,),O
Sentence: 314,",",O
Sentence: 314,a,O
Sentence: 314,gamma,O
Sentence: 314,glutamyl,O
Sentence: 314,transferase,O
Sentence: 314,",",O
Sentence: 314,was,O
Sentence: 314,greater,O
Sentence: 314,than,O
Sentence: 314,or,O
Sentence: 314,equal,O
Sentence: 314,to,O
Sentence: 314,3,O
Sentence: 314,times,O
Sentence: 314,the,O
Sentence: 314,upper,O
Sentence: 314,normal,O
Sentence: 314,limit,O
Sentence: 314,.,O
Sentence: 314,Of,O
Sentence: 314,the,O
Sentence: 314,714,O
Sentence: 314,creatine,B-Chemical
Sentence: 314,phosphokinase,O
Sentence: 314,levels,O
Sentence: 314,",",O
Sentence: 314,9,O
Sentence: 314,%,O
Sentence: 314,were,O
Sentence: 314,high,O
Sentence: 314,;,O
Sentence: 314,only,O
Sentence: 314,1,O
Sentence: 314,(,O
Sentence: 314,0.1,O
Sentence: 314,%,O
Sentence: 314,),O
Sentence: 314,was,O
Sentence: 314,greater,O
Sentence: 314,than,O
Sentence: 314,or,O
Sentence: 314,equal,O
Sentence: 314,to,O
Sentence: 314,3,O
Sentence: 314,times,O
Sentence: 314,the,O
Sentence: 314,upper,O
Sentence: 314,normal,O
Sentence: 314,limit,O
Sentence: 314,.,O
Sentence: 314,With,O
Sentence: 314,2,O
Sentence: 314,-,O
Sentence: 314,drug,O
Sentence: 314,therapy,O
Sentence: 314,",",O
Sentence: 314,mean,O
Sentence: 314,total,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,decreased,O
Sentence: 314,22,O
Sentence: 314,%,O
Sentence: 314,from,O
Sentence: 314,255,O
Sentence: 314,to,O
Sentence: 314,200,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,",",O
Sentence: 314,triglyceride,B-Chemical
Sentence: 314,levels,O
Sentence: 314,decreased,O
Sentence: 314,35,O
Sentence: 314,%,O
Sentence: 314,from,O
Sentence: 314,236,O
Sentence: 314,to,O
Sentence: 314,154,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,",",O
Sentence: 314,LDL,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,decreased,O
Sentence: 314,26,O
Sentence: 314,%,O
Sentence: 314,from,O
Sentence: 314,176,O
Sentence: 314,to,O
Sentence: 314,131,O
Sentence: 314,mg,O
Sentence: 314,/,O
Sentence: 314,dl,O
Sentence: 314,",",O
Sentence: 314,and,O
Sentence: 314,the,O
Sentence: 314,total,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,/,O
Sentence: 314,HDL,O
Sentence: 314,cholesterol,B-Chemical
Sentence: 314,ratio,O
Sentence: 314,decreased,O
Sentence: 314,24,O
Sentence: 314,%,O
Sentence: 314,from,O
Sentence: 314,7.1,O
Sentence: 314,to,O
Sentence: 314,5.4,O
Sentence: 314,",",O
Sentence: 314,all,O
Sentence: 314,p,O
Sentence: 314,less,O
Sentence: 314,than,O
Sentence: 314,or,O
Sentence: 314,equal,O
Sentence: 314,to,O
Sentence: 314,0.0001,O
Sentence: 314,.,O
Sentence: 314,Myositis,B-Disease
Sentence: 314,",",O
Sentence: 314,attributable,O
Sentence: 314,to,O
Sentence: 314,the,O
Sentence: 314,drug,O
Sentence: 314,combination,O
Sentence: 314,and,O
Sentence: 314,symptomatic,O
Sentence: 314,enough,O
Sentence: 314,to,O
Sentence: 314,discontinue,O
Sentence: 314,it,O
Sentence: 314,",",O
Sentence: 314,occurred,O
Sentence: 314,in,O
Sentence: 314,3,O
Sentence: 314,%,O
Sentence: 314,of,O
Sentence: 314,patients,O
Sentence: 314,",",O
Sentence: 314,and,O
Sentence: 314,in,O
Sentence: 314,1,O
Sentence: 314,%,O
Sentence: 314,with,O
Sentence: 314,concurrent,O
Sentence: 314,high,O
Sentence: 314,creatine,B-Chemical
Sentence: 314,phosphokinase,O
Sentence: 314,(,O
Sentence: 314,769,O
Sentence: 314,U,O
Sentence: 314,/,O
Sentence: 314,liter,O
Sentence: 314,),O
Sentence: 314,;,O
Sentence: 314,no,O
Sentence: 314,patients,O
Sentence: 314,had,O
Sentence: 314,rhabdomyolysis,B-Disease
Sentence: 314,or,O
Sentence: 314,myoglobinuria,B-Disease
Sentence: 314,.,O
Sentence: 314,(,O
Sentence: 314,ABSTRACT,O
Sentence: 314,TRUNCATED,O
Sentence: 314,AT,O
Sentence: 314,250,O
Sentence: 314,WORDS,O
Sentence: 314,),O
Sentence: 315,Hepatocellular,B-Disease
Sentence: 315,carcinoma,I-Disease
Sentence: 315,in,O
Sentence: 315,Fanconi,B-Disease
Sentence: 315,'s,I-Disease
Sentence: 315,anemia,I-Disease
Sentence: 315,treated,O
Sentence: 315,with,O
Sentence: 315,androgen,B-Chemical
Sentence: 315,and,O
Sentence: 315,corticosteroid,B-Chemical
Sentence: 315,.,O
Sentence: 316,The,O
Sentence: 316,case,O
Sentence: 316,of,O
Sentence: 316,an,O
Sentence: 316,11,O
Sentence: 316,-,O
Sentence: 316,year,O
Sentence: 316,-,O
Sentence: 316,old,O
Sentence: 316,boy,O
Sentence: 316,is,O
Sentence: 316,reported,O
Sentence: 316,who,O
Sentence: 316,was,O
Sentence: 316,known,O
Sentence: 316,to,O
Sentence: 316,have,O
Sentence: 316,Fanconi,B-Disease
Sentence: 316,'s,I-Disease
Sentence: 316,anemia,I-Disease
Sentence: 316,for,O
Sentence: 316,3,O
Sentence: 316,years,O
Sentence: 316,and,O
Sentence: 316,was,O
Sentence: 316,treated,O
Sentence: 316,with,O
Sentence: 316,androgens,B-Chemical
Sentence: 316,",",O
Sentence: 316,corticosteroids,B-Chemical
Sentence: 316,and,O
Sentence: 316,transfusions,O
Sentence: 316,.,O
Sentence: 316,Two,O
Sentence: 316,weeks,O
Sentence: 316,before,O
Sentence: 316,his,O
Sentence: 316,death,O
Sentence: 316,he,O
Sentence: 316,was,O
Sentence: 316,readmitted,O
Sentence: 316,because,O
Sentence: 316,of,O
Sentence: 316,aplastic,O
Sentence: 316,crisis,O
Sentence: 316,with,O
Sentence: 316,septicemia,B-Disease
Sentence: 316,and,O
Sentence: 316,marked,O
Sentence: 316,abnormalities,O
Sentence: 316,in,O
Sentence: 316,liver,O
Sentence: 316,function,O
Sentence: 316,and,O
Sentence: 316,died,O
Sentence: 316,of,O
Sentence: 316,hemorrhagic,B-Disease
Sentence: 316,bronchopneumonia,I-Disease
Sentence: 316,.,O
Sentence: 316,At,O
Sentence: 316,autopsy,O
Sentence: 316,peliosis,B-Disease
Sentence: 316,and,O
Sentence: 316,multiple,O
Sentence: 316,hepatic,B-Disease
Sentence: 316,tumors,I-Disease
Sentence: 316,were,O
Sentence: 316,found,O
Sentence: 316,which,O
Sentence: 316,histologically,O
Sentence: 316,proved,O
Sentence: 316,to,O
Sentence: 316,be,O
Sentence: 316,well,O
Sentence: 316,-,O
Sentence: 316,differentiated,O
Sentence: 316,hepatocellular,B-Disease
Sentence: 316,carcinoma,I-Disease
Sentence: 316,.,O
Sentence: 316,This,O
Sentence: 316,case,O
Sentence: 316,contributes,O
Sentence: 316,to,O
Sentence: 316,the,O
Sentence: 316,previous,O
Sentence: 316,observations,O
Sentence: 316,that,O
Sentence: 316,non,O
Sentence: 316,-,O
Sentence: 316,metastasizing,O
Sentence: 316,hepatic,B-Disease
Sentence: 316,neoplasms,I-Disease
Sentence: 316,and,O
Sentence: 316,peliosis,B-Disease
Sentence: 316,can,O
Sentence: 316,develop,O
Sentence: 316,in,O
Sentence: 316,patients,O
Sentence: 316,with,O
Sentence: 316,androgen,B-Chemical
Sentence: 316,-,O
Sentence: 316,,O
Sentence: 316,and,O
Sentence: 316,corticosteroid,B-Chemical
Sentence: 316,-,O
Sentence: 316,treated,O
Sentence: 316,Fanconi,B-Disease
Sentence: 316,'s,I-Disease
Sentence: 316,anemia,I-Disease
Sentence: 316,.,O
Sentence: 317,Chronic,O
Sentence: 317,lesion,O
Sentence: 317,of,O
Sentence: 317,rostral,O
Sentence: 317,ventrolateral,O
Sentence: 317,medulla,O
Sentence: 317,in,O
Sentence: 317,spontaneously,O
Sentence: 317,hypertensive,O
Sentence: 317,rats,O
Sentence: 317,.,O
Sentence: 318,We,O
Sentence: 318,studied,O
Sentence: 318,the,O
Sentence: 318,effects,O
Sentence: 318,of,O
Sentence: 318,chronic,O
Sentence: 318,selective,O
Sentence: 318,neuronal,O
Sentence: 318,lesion,O
Sentence: 318,of,O
Sentence: 318,rostral,O
Sentence: 318,ventrolateral,O
Sentence: 318,medulla,O
Sentence: 318,on,O
Sentence: 318,mean,O
Sentence: 318,arterial,O
Sentence: 318,pressure,O
Sentence: 318,",",O
Sentence: 318,heart,O
Sentence: 318,rate,O
Sentence: 318,",",O
Sentence: 318,and,O
Sentence: 318,neurogenic,O
Sentence: 318,tone,O
Sentence: 318,in,O
Sentence: 318,conscious,O
Sentence: 318,",",O
Sentence: 318,unrestrained,O
Sentence: 318,spontaneously,O
Sentence: 318,hypertensive,B-Disease
Sentence: 318,rats,O
Sentence: 318,.,O
Sentence: 318,The,O
Sentence: 318,lesions,O
Sentence: 318,were,O
Sentence: 318,placed,O
Sentence: 318,via,O
Sentence: 318,bilateral,O
Sentence: 318,microinjections,O
Sentence: 318,of,O
Sentence: 318,30,O
Sentence: 318,nmol,O
Sentence: 318,/,O
Sentence: 318,200,O
Sentence: 318,nl,O
Sentence: 318,N,O
Sentence: 318,-,O
Sentence: 318,methyl,O
Sentence: 318,-,O
Sentence: 318,D,O
Sentence: 318,-,O
Sentence: 318,aspartic,O
Sentence: 318,acid,O
Sentence: 318,.,O
Sentence: 318,The,O
Sentence: 318,restimulation,O
Sentence: 318,of,O
Sentence: 318,this,O
Sentence: 318,area,O
Sentence: 318,with,O
Sentence: 318,N,O
Sentence: 318,-,O
Sentence: 318,methyl,O
Sentence: 318,-,O
Sentence: 318,D,O
Sentence: 318,-,O
Sentence: 318,aspartic,O
Sentence: 318,acid,O
Sentence: 318,15,O
Sentence: 318,days,O
Sentence: 318,postlesion,O
Sentence: 318,failed,O
Sentence: 318,to,O
Sentence: 318,produce,O
Sentence: 318,a,O
Sentence: 318,pressor,O
Sentence: 318,response,O
Sentence: 318,.,O
Sentence: 318,One,O
Sentence: 318,day,O
Sentence: 318,postlesion,O
Sentence: 318,",",O
Sentence: 318,the,O
Sentence: 318,resting,O
Sentence: 318,mean,O
Sentence: 318,arterial,O
Sentence: 318,pressure,O
Sentence: 318,was,O
Sentence: 318,significantly,O
Sentence: 318,decreased,O
Sentence: 318,in,O
Sentence: 318,lesioned,O
Sentence: 318,rats,O
Sentence: 318,when,O
Sentence: 318,compared,O
Sentence: 318,with,O
Sentence: 318,sham,O
Sentence: 318,rats,O
Sentence: 318,(,O
Sentence: 318,100,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,7,O
Sentence: 318,versus,O
Sentence: 318,173,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,4,O
Sentence: 318,mm,O
Sentence: 318,Hg,O
Sentence: 318,",",O
Sentence: 318,p,O
Sentence: 318,less,O
Sentence: 318,than,O
Sentence: 318,0.05,O
Sentence: 318,),O
Sentence: 318,.,O
Sentence: 318,Fifteen,O
Sentence: 318,days,O
Sentence: 318,later,O
Sentence: 318,",",O
Sentence: 318,the,O
Sentence: 318,lesioned,O
Sentence: 318,group,O
Sentence: 318,still,O
Sentence: 318,showed,O
Sentence: 318,values,O
Sentence: 318,significantly,O
Sentence: 318,lower,O
Sentence: 318,than,O
Sentence: 318,the,O
Sentence: 318,sham,O
Sentence: 318,group,O
Sentence: 318,(,O
Sentence: 318,150,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,6,O
Sentence: 318,versus,O
Sentence: 318,167,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,5,O
Sentence: 318,mm,O
Sentence: 318,Hg,O
Sentence: 318,",",O
Sentence: 318,p,O
Sentence: 318,less,O
Sentence: 318,than,O
Sentence: 318,0.05,O
Sentence: 318,),O
Sentence: 318,.,O
Sentence: 318,No,O
Sentence: 318,significant,O
Sentence: 318,heart,O
Sentence: 318,rate,O
Sentence: 318,differences,O
Sentence: 318,were,O
Sentence: 318,observed,O
Sentence: 318,between,O
Sentence: 318,the,O
Sentence: 318,sham,O
Sentence: 318,and,O
Sentence: 318,lesioned,O
Sentence: 318,groups,O
Sentence: 318,.,O
Sentence: 318,The,O
Sentence: 318,ganglionic,O
Sentence: 318,blocker,O
Sentence: 318,trimethaphan,B-Chemical
Sentence: 318,(,O
Sentence: 318,5,O
Sentence: 318,mg,O
Sentence: 318,/,O
Sentence: 318,kg,O
Sentence: 318,i.v,O
Sentence: 318,.,O
Sentence: 318,),O
Sentence: 318,caused,O
Sentence: 318,similar,O
Sentence: 318,reductions,O
Sentence: 318,in,O
Sentence: 318,mean,O
Sentence: 318,arterial,O
Sentence: 318,pressure,O
Sentence: 318,in,O
Sentence: 318,both,O
Sentence: 318,lesioned,O
Sentence: 318,and,O
Sentence: 318,sham,O
Sentence: 318,groups,O
Sentence: 318,.,O
Sentence: 318,The,O
Sentence: 318,trimethaphan,B-Chemical
Sentence: 318,-,O
Sentence: 318,induced,O
Sentence: 318,hypotension,B-Disease
Sentence: 318,was,O
Sentence: 318,accompanied,O
Sentence: 318,by,O
Sentence: 318,a,O
Sentence: 318,significant,O
Sentence: 318,bradycardia,B-Disease
Sentence: 318,in,O
Sentence: 318,lesioned,O
Sentence: 318,rats,O
Sentence: 318,(,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,32,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,13,O
Sentence: 318,beats,O
Sentence: 318,per,O
Sentence: 318,minute,O
Sentence: 318,),O
Sentence: 318,but,O
Sentence: 318,a,O
Sentence: 318,tachycardia,B-Disease
Sentence: 318,in,O
Sentence: 318,sham,O
Sentence: 318,rats,O
Sentence: 318,(,O
Sentence: 318,+33,O
Sentence: 318,+,O
Sentence: 318,/,O
Sentence: 318,,O
Sentence: 318,-,O
Sentence: 318,,O
Sentence: 318,12,O
Sentence: 318,beats,O
Sentence: 318,per,O
Sentence: 318,minute,O
Sentence: 318,),O
Sentence: 318,1,O
Sentence: 318,day,O
Sentence: 318,postlesion,O
Sentence: 318,.,O
Sentence: 318,Therefore,O
Sentence: 318,",",O
Sentence: 318,rostral,O
Sentence: 318,ventrolateral,O
Sentence: 318,medulla,O
Sentence: 318,neurons,O
Sentence: 318,appear,O
Sentence: 318,to,O
Sentence: 318,play,O
Sentence: 318,a,O
Sentence: 318,significant,O
Sentence: 318,role,O
Sentence: 318,in,O
Sentence: 318,maintaining,O
Sentence: 318,hypertension,B-Disease
Sentence: 318,in,O
Sentence: 318,conscious,O
Sentence: 318,spontaneously,O
Sentence: 318,hypertensive,B-Disease
Sentence: 318,rats,O
Sentence: 318,.,O
Sentence: 318,Spinal,O
Sentence: 318,or,O
Sentence: 318,suprabulbar,O
Sentence: 318,structures,O
Sentence: 318,could,O
Sentence: 318,be,O
Sentence: 318,responsible,O
Sentence: 318,for,O
Sentence: 318,the,O
Sentence: 318,gradual,O
Sentence: 318,recovery,O
Sentence: 318,of,O
Sentence: 318,the,O
Sentence: 318,hypertension,B-Disease
Sentence: 318,in,O
Sentence: 318,the,O
Sentence: 318,lesioned,O
Sentence: 318,rats,O
Sentence: 318,.,O
Sentence: 319,Damage,B-Disease
Sentence: 319,of,I-Disease
Sentence: 319,substantia,I-Disease
Sentence: 319,nigra,I-Disease
Sentence: 319,pars,I-Disease
Sentence: 319,reticulata,I-Disease
Sentence: 319,during,O
Sentence: 319,pilocarpine,B-Chemical
Sentence: 319,-,O
Sentence: 319,induced,O
Sentence: 319,status,B-Disease
Sentence: 319,epilepticus,I-Disease
Sentence: 319,in,O
Sentence: 319,the,O
Sentence: 319,rat,O
Sentence: 319,:,O
Sentence: 319,immunohistochemical,O
Sentence: 319,study,O
Sentence: 319,of,O
Sentence: 319,neurons,O
Sentence: 319,",",O
Sentence: 319,astrocytes,O
Sentence: 319,and,O
Sentence: 319,serum,O
Sentence: 319,-,O
Sentence: 319,protein,O
Sentence: 319,extravasation,O
Sentence: 319,.,O
Sentence: 320,The,O
Sentence: 320,substantia,O
Sentence: 320,nigra,O
Sentence: 320,has,O
Sentence: 320,a,O
Sentence: 320,gating,O
Sentence: 320,function,O
Sentence: 320,controlling,O
Sentence: 320,the,O
Sentence: 320,spread,O
Sentence: 320,of,O
Sentence: 320,epileptic,B-Disease
Sentence: 320,seizure,I-Disease
Sentence: 320,activity,O
Sentence: 320,.,O
Sentence: 320,Additionally,O
Sentence: 320,",",O
Sentence: 320,in,O
Sentence: 320,models,O
Sentence: 320,of,O
Sentence: 320,prolonged,B-Disease
Sentence: 320,status,B-Disease
Sentence: 320,epilepticus,I-Disease
Sentence: 320,the,O
Sentence: 320,pars,O
Sentence: 320,reticulata,O
Sentence: 320,of,O
Sentence: 320,substantia,O
Sentence: 320,nigra,O
Sentence: 320,(,O
Sentence: 320,SNR,O
Sentence: 320,),O
Sentence: 320,suffers,O
Sentence: 320,from,O
Sentence: 320,a,O
Sentence: 320,massive,O
Sentence: 320,lesion,O
Sentence: 320,which,O
Sentence: 320,may,O
Sentence: 320,arise,O
Sentence: 320,from,O
Sentence: 320,a,O
Sentence: 320,massive,O
Sentence: 320,metabolic,B-Disease
Sentence: 320,derangement,I-Disease
Sentence: 320,and,O
Sentence: 320,hyperexcitation,O
Sentence: 320,developing,O
Sentence: 320,in,O
Sentence: 320,the,O
Sentence: 320,activated,O
Sentence: 320,SNR,O
Sentence: 320,.,O
Sentence: 320,In,O
Sentence: 320,this,O
Sentence: 320,study,O
Sentence: 320,",",O
Sentence: 320,status,B-Disease
Sentence: 320,epilepticus,I-Disease
Sentence: 320,was,O
Sentence: 320,induced,O
Sentence: 320,by,O
Sentence: 320,systemic,O
Sentence: 320,injection,O
Sentence: 320,of,O
Sentence: 320,pilocarpine,B-Chemical
Sentence: 320,in,O
Sentence: 320,rats,O
Sentence: 320,.,O
Sentence: 320,The,O
Sentence: 320,neuropathology,O
Sentence: 320,of,O
Sentence: 320,SNR,O
Sentence: 320,was,O
Sentence: 320,investigated,O
Sentence: 320,using,O
Sentence: 320,immunohistochemical,O
Sentence: 320,techniques,O
Sentence: 320,with,O
Sentence: 320,the,O
Sentence: 320,major,O
Sentence: 320,emphasis,O
Sentence: 320,on,O
Sentence: 320,the,O
Sentence: 320,time,O
Sentence: 320,-,O
Sentence: 320,course,O
Sentence: 320,of,O
Sentence: 320,changes,O
Sentence: 320,in,O
Sentence: 320,neurons,O
Sentence: 320,and,O
Sentence: 320,astrocytes,O
Sentence: 320,.,O
Sentence: 320,Animals,O
Sentence: 320,surviving,O
Sentence: 320,20,O
Sentence: 320,",",O
Sentence: 320,30,O
Sentence: 320,",",O
Sentence: 320,40,O
Sentence: 320,",",O
Sentence: 320,60,O
Sentence: 320,min,O
Sentence: 320,",",O
Sentence: 320,2,O
Sentence: 320,",",O
Sentence: 320,3,O
Sentence: 320,",",O
Sentence: 320,6,O
Sentence: 320,hours,O
Sentence: 320,",",O
Sentence: 320,1,O
Sentence: 320,",",O
Sentence: 320,2,O
Sentence: 320,",",O
Sentence: 320,and,O
Sentence: 320,3,O
Sentence: 320,days,O
Sentence: 320,after,O
Sentence: 320,induction,O
Sentence: 320,of,O
Sentence: 320,status,B-Disease
Sentence: 320,epilepticus,I-Disease
Sentence: 320,were,O
Sentence: 320,perfusion,O
Sentence: 320,-,O
Sentence: 320,fixed,O
Sentence: 320,",",O
Sentence: 320,and,O
Sentence: 320,brains,O
Sentence: 320,processed,O
Sentence: 320,for,O
Sentence: 320,immunohistochemical,O
Sentence: 320,staining,O
Sentence: 320,of,O
Sentence: 320,SNR,O
Sentence: 320,.,O
Sentence: 320,Nissl,O
Sentence: 320,-,O
Sentence: 320,staining,O
Sentence: 320,and,O
Sentence: 320,antibodies,O
Sentence: 320,against,O
Sentence: 320,the,O
Sentence: 320,neuron,O
Sentence: 320,-,O
Sentence: 320,specific,O
Sentence: 320,calcium,B-Chemical
Sentence: 320,-,O
Sentence: 320,binding,O
Sentence: 320,protein,O
Sentence: 320,",",O
Sentence: 320,parvalbumin,O
Sentence: 320,",",O
Sentence: 320,served,O
Sentence: 320,to,O
Sentence: 320,detect,O
Sentence: 320,neuronal,B-Disease
Sentence: 320,damage,I-Disease
Sentence: 320,in,O
Sentence: 320,SNR,O
Sentence: 320,.,O
Sentence: 320,Antibodies,O
Sentence: 320,against,O
Sentence: 320,the,O
Sentence: 320,astroglia,O
Sentence: 320,-,O
Sentence: 320,specific,O
Sentence: 320,cytoskeletal,O
Sentence: 320,protein,O
Sentence: 320,",",O
Sentence: 320,glial,O
Sentence: 320,fibrillary,O
Sentence: 320,acidic,O
Sentence: 320,protein,O
Sentence: 320,(,O
Sentence: 320,GFAP,O
Sentence: 320,),O
Sentence: 320,",",O
Sentence: 320,and,O
Sentence: 320,against,O
Sentence: 320,the,O
Sentence: 320,glial,O
Sentence: 320,calcium,B-Chemical
Sentence: 320,-,O
Sentence: 320,binding,O
Sentence: 320,protein,O
Sentence: 320,",",O
Sentence: 320,S,O
Sentence: 320,-,O
Sentence: 320,100,O
Sentence: 320,protein,O
Sentence: 320,",",O
Sentence: 320,were,O
Sentence: 320,used,O
Sentence: 320,to,O
Sentence: 320,assess,O
Sentence: 320,the,O
Sentence: 320,status,O
Sentence: 320,of,O
Sentence: 320,astrocytes,O
Sentence: 320,.,O
Sentence: 320,Immunohistochemical,O
Sentence: 320,staining,O
Sentence: 320,for,O
Sentence: 320,serum,O
Sentence: 320,-,O
Sentence: 320,albumin,O
Sentence: 320,and,O
Sentence: 320,immunoglobulins,O
Sentence: 320,in,O
Sentence: 320,brain,O
Sentence: 320,tissue,O
Sentence: 320,was,O
Sentence: 320,taken,O
Sentence: 320,as,O
Sentence: 320,indicator,O
Sentence: 320,of,O
Sentence: 320,blood,O
Sentence: 320,-,O
Sentence: 320,brain,O
Sentence: 320,barrier,O
Sentence: 320,disturbances,O
Sentence: 320,and,O
Sentence: 320,vasogenic,B-Disease
Sentence: 320,edema,I-Disease
Sentence: 320,formation,O
Sentence: 320,.,O
Sentence: 320,Immunohistochemical,O
Sentence: 320,staining,O
Sentence: 320,indicated,O
Sentence: 320,loss,O
Sentence: 320,of,O
Sentence: 320,GFAP,O
Sentence: 320,-,O
Sentence: 320,staining,O
Sentence: 320,already,O
Sentence: 320,at,O
Sentence: 320,30,O
Sentence: 320,min,O
Sentence: 320,after,O
Sentence: 320,induction,O
Sentence: 320,of,O
Sentence: 320,seizures,B-Disease
Sentence: 320,in,O
Sentence: 320,an,O
Sentence: 320,oval,O
Sentence: 320,focus,O
Sentence: 320,situated,O
Sentence: 320,in,O
Sentence: 320,the,O
Sentence: 320,center,O
Sentence: 320,of,O
Sentence: 320,SNR,O
Sentence: 320,while,O
Sentence: 320,sparing,O
Sentence: 320,medial,O
Sentence: 320,and,O
Sentence: 320,lateral,O
Sentence: 320,aspects,O
Sentence: 320,.,O
Sentence: 320,At,O
Sentence: 320,1,O
Sentence: 320,h,O
Sentence: 320,there,O
Sentence: 320,was,O
Sentence: 320,additional,O
Sentence: 320,vacuolation,O
Sentence: 320,in,O
Sentence: 320,S,O
Sentence: 320,-,O
Sentence: 320,100,O
Sentence: 320,protein,O
Sentence: 320,staining,O
Sentence: 320,.,O
Sentence: 320,By,O
Sentence: 320,2,O
Sentence: 320,hours,O
Sentence: 320,",",O
Sentence: 320,parvalbumin,O
Sentence: 320,-,O
Sentence: 320,staining,O
Sentence: 320,changed,O
Sentence: 320,in,O
Sentence: 320,the,O
Sentence: 320,central,O
Sentence: 320,SNR,O
Sentence: 320,indicating,O
Sentence: 320,neuronal,B-Disease
Sentence: 320,damage,I-Disease
Sentence: 320,",",O
Sentence: 320,and,O
Sentence: 320,Nissl,O
Sentence: 320,-,O
Sentence: 320,staining,O
Sentence: 320,visualized,O
Sentence: 320,some,O
Sentence: 320,neuronal,O
Sentence: 320,distortion,O
Sentence: 320,.,O
Sentence: 320,Staining,O
Sentence: 320,for,O
Sentence: 320,serum,O
Sentence: 320,-,O
Sentence: 320,proteins,O
Sentence: 320,occurred,O
Sentence: 320,in,O
Sentence: 320,a,O
Sentence: 320,patchy,O
Sentence: 320,manner,O
Sentence: 320,throughout,O
Sentence: 320,the,O
Sentence: 320,forebrain,O
Sentence: 320,during,O
Sentence: 320,the,O
Sentence: 320,first,O
Sentence: 320,hours,O
Sentence: 320,.,O
Sentence: 320,By,O
Sentence: 320,6,O
Sentence: 320,h,O
Sentence: 320,",",O
Sentence: 320,vasogenic,B-Disease
Sentence: 320,edema,I-Disease
Sentence: 320,covered,O
Sentence: 320,the,O
Sentence: 320,lesioned,B-Disease
Sentence: 320,SNR,I-Disease
Sentence: 320,.,O
Sentence: 320,By,O
Sentence: 320,24,O
Sentence: 320,h,O
Sentence: 320,",",O
Sentence: 320,glial,O
Sentence: 320,and,O
Sentence: 320,neuronal,O
Sentence: 320,markers,O
Sentence: 320,indicated,O
Sentence: 320,a,O
Sentence: 320,massive,O
Sentence: 320,lesion,O
Sentence: 320,in,O
Sentence: 320,the,O
Sentence: 320,center,O
Sentence: 320,of,O
Sentence: 320,SNR,O
Sentence: 320,.,O
Sentence: 320,By,O
Sentence: 320,48,O
Sentence: 320,-,O
Sentence: 320,72,O
Sentence: 320,h,O
Sentence: 320,",",O
Sentence: 320,astrocytes,O
Sentence: 320,surrounding,O
Sentence: 320,the,O
Sentence: 320,lesion,O
Sentence: 320,increased,O
Sentence: 320,in,O
Sentence: 320,size,O
Sentence: 320,",",O
Sentence: 320,and,O
Sentence: 320,polymorphic,O
Sentence: 320,phagocytotic,O
Sentence: 320,cells,O
Sentence: 320,invaded,O
Sentence: 320,the,O
Sentence: 320,damaged,O
Sentence: 320,area,O
Sentence: 320,.,O
Sentence: 320,In,O
Sentence: 320,a,O
Sentence: 320,further,O
Sentence: 320,group,O
Sentence: 320,of,O
Sentence: 320,animals,O
Sentence: 320,surviving,O
Sentence: 320,1,O
Sentence: 320,to,O
Sentence: 320,5,O
Sentence: 320,days,O
Sentence: 320,",",O
Sentence: 320,conventional,O
Sentence: 320,paraffin,O
Sentence: 320,-,O
Sentence: 320,sections,O
Sentence: 320,confirmed,O
Sentence: 320,the,O
Sentence: 320,neuronal,O
Sentence: 320,and,O
Sentence: 320,glial,O
Sentence: 320,damage,B-Disease
Sentence: 320,of,I-Disease
Sentence: 320,SNR,I-Disease
Sentence: 320,.,O
Sentence: 320,Additional,O
Sentence: 320,pathology,O
Sentence: 320,of,O
Sentence: 320,similar,O
Sentence: 320,quality,O
Sentence: 320,was,O
Sentence: 320,found,O
Sentence: 320,in,O
Sentence: 320,the,O
Sentence: 320,globus,O
Sentence: 320,pallidus,O
Sentence: 320,.,O
Sentence: 320,Since,O
Sentence: 320,astrocytes,O
Sentence: 320,were,O
Sentence: 320,always,O
Sentence: 320,damaged,O
Sentence: 320,in,O
Sentence: 320,parallel,O
Sentence: 320,with,O
Sentence: 320,neurons,O
Sentence: 320,in,O
Sentence: 320,SNR,O
Sentence: 320,it,O
Sentence: 320,is,O
Sentence: 320,proposed,O
Sentence: 320,that,O
Sentence: 320,the,O
Sentence: 320,anatomical,O
Sentence: 320,and,O
Sentence: 320,functional,O
Sentence: 320,interrelationship,O
Sentence: 320,between,O
Sentence: 320,neurons,O
Sentence: 320,and,O
Sentence: 320,astrocytes,O
Sentence: 320,is,O
Sentence: 320,particularly,O
Sentence: 320,tight,O
Sentence: 320,in,O
Sentence: 320,SNR,O
Sentence: 320,.,O
Sentence: 320,Both,O
Sentence: 320,cell,O
Sentence: 320,elements,O
Sentence: 320,may,O
Sentence: 320,suffer,O
Sentence: 320,in,O
Sentence: 320,common,O
Sentence: 320,from,O
Sentence: 320,metabolic,O
Sentence: 320,disturbance,O
Sentence: 320,and,O
Sentence: 320,neurotransmitter,B-Disease
Sentence: 320,dysfunction,I-Disease
Sentence: 320,as,O
Sentence: 320,occur,O
Sentence: 320,during,O
Sentence: 320,massive,O
Sentence: 320,status,B-Disease
Sentence: 320,epilepticus,I-Disease
Sentence: 320,.,O
Sentence: 321,Reduced,O
Sentence: 321,cardiotoxicity,B-Disease
Sentence: 321,of,O
Sentence: 321,doxorubicin,B-Chemical
Sentence: 321,given,O
Sentence: 321,in,O
Sentence: 321,the,O
Sentence: 321,form,O
Sentence: 321,of,O
Sentence: 321,N,O
Sentence: 321,-,O
Sentence: 321,,O
Sentence: 321,(,O
Sentence: 321,2,O
Sentence: 321,-,O
Sentence: 321,hydroxypropyl,O
Sentence: 321,),O
Sentence: 321,methacrylamide,O
Sentence: 321,conjugates,O
Sentence: 321,:,O
Sentence: 321,and,O
Sentence: 321,experimental,O
Sentence: 321,study,O
Sentence: 321,in,O
Sentence: 321,the,O
Sentence: 321,rat,O
Sentence: 321,.,O
Sentence: 322,A,O
Sentence: 322,rat,O
Sentence: 322,model,O
Sentence: 322,was,O
Sentence: 322,used,O
Sentence: 322,to,O
Sentence: 322,evaluate,O
Sentence: 322,the,O
Sentence: 322,general,O
Sentence: 322,acute,O
Sentence: 322,toxicity,B-Disease
Sentence: 322,and,O
Sentence: 322,the,O
Sentence: 322,late,O
Sentence: 322,cardiotoxicity,B-Disease
Sentence: 322,of,O
Sentence: 322,4,O
Sentence: 322,mg,O
Sentence: 322,/,O
Sentence: 322,kg,O
Sentence: 322,doxorubicin,B-Chemical
Sentence: 322,(,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,),O
Sentence: 322,given,O
Sentence: 322,either,O
Sentence: 322,as,O
Sentence: 322,free,O
Sentence: 322,drug,O
Sentence: 322,or,O
Sentence: 322,in,O
Sentence: 322,the,O
Sentence: 322,form,O
Sentence: 322,of,O
Sentence: 322,three,O
Sentence: 322,N,O
Sentence: 322,-,O
Sentence: 322,,O
Sentence: 322,(,O
Sentence: 322,2,O
Sentence: 322,-,O
Sentence: 322,hydroxypropyl,O
Sentence: 322,),O
Sentence: 322,methacrylamide,O
Sentence: 322,(,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,),O
Sentence: 322,copolymer,O
Sentence: 322,conjugates,O
Sentence: 322,.,O
Sentence: 322,In,O
Sentence: 322,these,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymers,O
Sentence: 322,",",O
Sentence: 322,DOX,B-Chemical
Sentence: 322,was,O
Sentence: 322,covalently,O
Sentence: 322,bound,O
Sentence: 322,via,O
Sentence: 322,peptide,O
Sentence: 322,linkages,O
Sentence: 322,that,O
Sentence: 322,were,O
Sentence: 322,either,O
Sentence: 322,non,O
Sentence: 322,-,O
Sentence: 322,biodegradable,O
Sentence: 322,(,O
Sentence: 322,Gly,O
Sentence: 322,-,O
Sentence: 322,Gly,O
Sentence: 322,),O
Sentence: 322,or,O
Sentence: 322,degradable,O
Sentence: 322,by,O
Sentence: 322,lysosomal,O
Sentence: 322,proteinases,O
Sentence: 322,(,O
Sentence: 322,Gly,O
Sentence: 322,-,O
Sentence: 322,Phe,O
Sentence: 322,-,O
Sentence: 322,Leu,O
Sentence: 322,-,O
Sentence: 322,Gly,O
Sentence: 322,),O
Sentence: 322,.,O
Sentence: 322,In,O
Sentence: 322,addition,O
Sentence: 322,",",O
Sentence: 322,one,O
Sentence: 322,biodegradable,O
Sentence: 322,conjugate,O
Sentence: 322,containing,O
Sentence: 322,galactosamine,B-Chemical
Sentence: 322,was,O
Sentence: 322,used,O
Sentence: 322,;,O
Sentence: 322,this,O
Sentence: 322,residue,O
Sentence: 322,was,O
Sentence: 322,targeted,O
Sentence: 322,to,O
Sentence: 322,the,O
Sentence: 322,liver,O
Sentence: 322,.,O
Sentence: 322,Over,O
Sentence: 322,the,O
Sentence: 322,first,O
Sentence: 322,3,O
Sentence: 322,weeks,O
Sentence: 322,after,O
Sentence: 322,the,O
Sentence: 322,i.v,O
Sentence: 322,.,O
Sentence: 322,administration,O
Sentence: 322,of,O
Sentence: 322,free,O
Sentence: 322,and,O
Sentence: 322,polymer,O
Sentence: 322,-,O
Sentence: 322,bound,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,",",O
Sentence: 322,all,O
Sentence: 322,animals,O
Sentence: 322,showed,O
Sentence: 322,a,O
Sentence: 322,transient,O
Sentence: 322,reduction,O
Sentence: 322,in,O
Sentence: 322,body,O
Sentence: 322,weight,O
Sentence: 322,.,O
Sentence: 322,However,O
Sentence: 322,",",O
Sentence: 322,the,O
Sentence: 322,maximal,O
Sentence: 322,reduction,O
Sentence: 322,in,O
Sentence: 322,body,O
Sentence: 322,weight,O
Sentence: 322,seen,O
Sentence: 322,in,O
Sentence: 322,animals,O
Sentence: 322,that,O
Sentence: 322,received,O
Sentence: 322,polymer,O
Sentence: 322,-,O
Sentence: 322,bound,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,(,O
Sentence: 322,4,O
Sentence: 322,mg,O
Sentence: 322,/,O
Sentence: 322,kg,O
Sentence: 322,),O
Sentence: 322,was,O
Sentence: 322,significantly,O
Sentence: 322,lower,O
Sentence: 322,than,O
Sentence: 322,that,O
Sentence: 322,observed,O
Sentence: 322,in,O
Sentence: 322,those,O
Sentence: 322,that,O
Sentence: 322,received,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,(,O
Sentence: 322,4,O
Sentence: 322,mg,O
Sentence: 322,/,O
Sentence: 322,kg,O
Sentence: 322,),O
Sentence: 322,or,O
Sentence: 322,a,O
Sentence: 322,mixture,O
Sentence: 322,of,O
Sentence: 322,the,O
Sentence: 322,unmodified,O
Sentence: 322,parent,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymer,O
Sentence: 322,and,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,(,O
Sentence: 322,4,O
Sentence: 322,mg,O
Sentence: 322,/,O
Sentence: 322,kg,O
Sentence: 322,;,O
Sentence: 322,P,O
Sentence: 322,less,O
Sentence: 322,than,O
Sentence: 322,0.01,O
Sentence: 322,),O
Sentence: 322,.,O
Sentence: 322,Throughout,O
Sentence: 322,the,O
Sentence: 322,study,O
Sentence: 322,(,O
Sentence: 322,20,O
Sentence: 322,weeks,O
Sentence: 322,),O
Sentence: 322,",",O
Sentence: 322,deaths,O
Sentence: 322,related,O
Sentence: 322,to,O
Sentence: 322,cardiotoxicity,B-Disease
Sentence: 322,were,O
Sentence: 322,observed,O
Sentence: 322,only,O
Sentence: 322,in,O
Sentence: 322,animals,O
Sentence: 322,that,O
Sentence: 322,received,O
Sentence: 322,either,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,or,O
Sentence: 322,the,O
Sentence: 322,mixture,O
Sentence: 322,of,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymer,O
Sentence: 322,and,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,;,O
Sentence: 322,in,O
Sentence: 322,these,O
Sentence: 322,cases,O
Sentence: 322,",",O
Sentence: 322,histological,O
Sentence: 322,investigations,O
Sentence: 322,revealed,O
Sentence: 322,marked,O
Sentence: 322,changes,O
Sentence: 322,in,O
Sentence: 322,the,O
Sentence: 322,heart,O
Sentence: 322,that,O
Sentence: 322,were,O
Sentence: 322,consistent,O
Sentence: 322,with,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,-,O
Sentence: 322,induced,O
Sentence: 322,cardiotoxicity,B-Disease
Sentence: 322,.,O
Sentence: 322,Sequential,O
Sentence: 322,measurements,O
Sentence: 322,of,O
Sentence: 322,cardiac,O
Sentence: 322,output,O
Sentence: 322,in,O
Sentence: 322,surviving,O
Sentence: 322,animals,O
Sentence: 322,that,O
Sentence: 322,received,O
Sentence: 322,either,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,or,O
Sentence: 322,the,O
Sentence: 322,mixture,O
Sentence: 322,of,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymer,O
Sentence: 322,and,O
Sentence: 322,free,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,showed,O
Sentence: 322,a,O
Sentence: 322,reduction,O
Sentence: 322,of,O
Sentence: 322,approximately,O
Sentence: 322,30,O
Sentence: 322,%,O
Sentence: 322,in,O
Sentence: 322,function,O
Sentence: 322,beginning,O
Sentence: 322,at,O
Sentence: 322,the,O
Sentence: 322,4th,O
Sentence: 322,week,O
Sentence: 322,after,O
Sentence: 322,drug,O
Sentence: 322,administration,O
Sentence: 322,.,O
Sentence: 322,The,O
Sentence: 322,heart,O
Sentence: 322,rate,O
Sentence: 322,in,O
Sentence: 322,these,O
Sentence: 322,animals,O
Sentence: 322,was,O
Sentence: 322,approximately,O
Sentence: 322,12,O
Sentence: 322,%,O
Sentence: 322,lower,O
Sentence: 322,than,O
Sentence: 322,that,O
Sentence: 322,measured,O
Sentence: 322,in,O
Sentence: 322,age,O
Sentence: 322,-,O
Sentence: 322,matched,O
Sentence: 322,control,O
Sentence: 322,rats,O
Sentence: 322,(,O
Sentence: 322,P,O
Sentence: 322,less,O
Sentence: 322,than,O
Sentence: 322,0.05,O
Sentence: 322,),O
Sentence: 322,.,O
Sentence: 322,Animals,O
Sentence: 322,that,O
Sentence: 322,were,O
Sentence: 322,given,O
Sentence: 322,the,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymer,O
Sentence: 322,conjugates,O
Sentence: 322,containing,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,exhibited,O
Sentence: 322,no,O
Sentence: 322,significant,O
Sentence: 322,change,O
Sentence: 322,in,O
Sentence: 322,cardiac,O
Sentence: 322,output,O
Sentence: 322,throughout,O
Sentence: 322,the,O
Sentence: 322,study,O
Sentence: 322,(,O
Sentence: 322,P,O
Sentence: 322,less,O
Sentence: 322,than,O
Sentence: 322,0.05,O
Sentence: 322,),O
Sentence: 322,.,O
Sentence: 322,In,O
Sentence: 322,addition,O
Sentence: 322,",",O
Sentence: 322,no,O
Sentence: 322,significant,O
Sentence: 322,histological,O
Sentence: 322,change,O
Sentence: 322,was,O
Sentence: 322,observed,O
Sentence: 322,in,O
Sentence: 322,the,O
Sentence: 322,heart,O
Sentence: 322,of,O
Sentence: 322,animals,O
Sentence: 322,that,O
Sentence: 322,received,O
Sentence: 322,DOX,B-Chemical
Sentence: 322,in,O
Sentence: 322,the,O
Sentence: 322,form,O
Sentence: 322,of,O
Sentence: 322,HPMA,B-Chemical
Sentence: 322,copolymer,O
Sentence: 322,conjugates,O
Sentence: 322,and,O
Sentence: 322,were,O
Sentence: 322,killed,O
Sentence: 322,at,O
Sentence: 322,the,O
Sentence: 322,end,O
Sentence: 322,of,O
Sentence: 322,the,O
Sentence: 322,study,O
Sentence: 322,.,O
Sentence: 322,However,O
Sentence: 322,",",O
Sentence: 322,these,O
Sentence: 322,animals,O
Sentence: 322,had,O
Sentence: 322,shown,O
Sentence: 322,a,O
Sentence: 322,significant,O
Sentence: 322,increase,O
Sentence: 322,in,O
Sentence: 322,heart,O
Sentence: 322,rate,O
Sentence: 322,beginning,O
Sentence: 322,at,O
Sentence: 322,8,O
Sentence: 322,weeks,O
Sentence: 322,after,O
Sentence: 322,drug,O
Sentence: 322,administration,O
Sentence: 322,(,O
Sentence: 322,P,O
Sentence: 322,less,O
Sentence: 322,than,O
Sentence: 322,0.01,O
Sentence: 322,),O
Sentence: 322,.,O
Sentence: 322,(,O
Sentence: 322,ABSTRACT,O
Sentence: 322,TRUNCATED,O
Sentence: 322,AT,O
Sentence: 322,400,O
Sentence: 322,WORDS,O
Sentence: 322,),O
Sentence: 323,Topical,O
Sentence: 323,0.025,O
Sentence: 323,%,O
Sentence: 323,capsaicin,B-Chemical
Sentence: 323,in,O
Sentence: 323,chronic,O
Sentence: 323,post,O
Sentence: 323,-,O
Sentence: 323,herpetic,O
Sentence: 323,neuralgia,O
Sentence: 323,:,O
Sentence: 323,efficacy,O
Sentence: 323,",",O
Sentence: 323,predictors,O
Sentence: 323,of,O
Sentence: 323,response,O
Sentence: 323,and,O
Sentence: 323,long,O
Sentence: 323,-,O
Sentence: 323,term,O
Sentence: 323,course,O
Sentence: 323,.,O
Sentence: 324,In,O
Sentence: 324,order,O
Sentence: 324,to,O
Sentence: 324,evaluate,O
Sentence: 324,the,O
Sentence: 324,efficacy,O
Sentence: 324,",",O
Sentence: 324,time,O
Sentence: 324,-,O
Sentence: 324,course,O
Sentence: 324,of,O
Sentence: 324,action,O
Sentence: 324,and,O
Sentence: 324,predictors,O
Sentence: 324,of,O
Sentence: 324,response,O
Sentence: 324,to,O
Sentence: 324,topical,O
Sentence: 324,capsaicin,B-Chemical
Sentence: 324,",",O
Sentence: 324,39,O
Sentence: 324,patients,O
Sentence: 324,with,O
Sentence: 324,chronic,O
Sentence: 324,post,O
Sentence: 324,-,O
Sentence: 324,herpetic,O
Sentence: 324,neuralgia,O
Sentence: 324,(,O
Sentence: 324,PHN,B-Disease
Sentence: 324,),O
Sentence: 324,",",O
Sentence: 324,median,O
Sentence: 324,duration,O
Sentence: 324,24,O
Sentence: 324,months,O
Sentence: 324,",",O
Sentence: 324,were,O
Sentence: 324,treated,O
Sentence: 324,with,O
Sentence: 324,0.025,O
Sentence: 324,%,O
Sentence: 324,capsaicin,B-Chemical
Sentence: 324,cream,O
Sentence: 324,for,O
Sentence: 324,8,O
Sentence: 324,weeks,O
Sentence: 324,.,O
Sentence: 324,During,O
Sentence: 324,therapy,O
Sentence: 324,the,O
Sentence: 324,patients,O
Sentence: 324,rated,O
Sentence: 324,their,O
Sentence: 324,pain,B-Disease
Sentence: 324,on,O
Sentence: 324,a,O
Sentence: 324,visual,O
Sentence: 324,analogue,O
Sentence: 324,scale,O
Sentence: 324,(,O
Sentence: 324,VAS,O
Sentence: 324,),O
Sentence: 324,and,O
Sentence: 324,a,O
Sentence: 324,verbal,O
Sentence: 324,outcome,O
Sentence: 324,scale,O
Sentence: 324,.,O
Sentence: 324,A,O
Sentence: 324,follow,O
Sentence: 324,-,O
Sentence: 324,up,O
Sentence: 324,investigation,O
Sentence: 324,was,O
Sentence: 324,performed,O
Sentence: 324,10,O
Sentence: 324,-,O
Sentence: 324,12,O
Sentence: 324,months,O
Sentence: 324,after,O
Sentence: 324,study,O
Sentence: 324,onset,O
Sentence: 324,on,O
Sentence: 324,the,O
Sentence: 324,patients,O
Sentence: 324,who,O
Sentence: 324,had,O
Sentence: 324,improved,O
Sentence: 324,.,O
Sentence: 324,Nineteen,O
Sentence: 324,patients,O
Sentence: 324,(,O
Sentence: 324,48.7,O
Sentence: 324,%,O
Sentence: 324,),O
Sentence: 324,substantially,O
Sentence: 324,improved,O
Sentence: 324,after,O
Sentence: 324,the,O
Sentence: 324,8,O
Sentence: 324,-,O
Sentence: 324,week,O
Sentence: 324,trial,O
Sentence: 324,;,O
Sentence: 324,5,O
Sentence: 324,(,O
Sentence: 324,12.8,O
Sentence: 324,%,O
Sentence: 324,),O
Sentence: 324,discontinued,O
Sentence: 324,therapy,O
Sentence: 324,due,O
Sentence: 324,to,O
Sentence: 324,side,O
Sentence: 324,-,O
Sentence: 324,effects,O
Sentence: 324,such,O
Sentence: 324,as,O
Sentence: 324,intolerable,O
Sentence: 324,capsaicin,B-Chemical
Sentence: 324,-,O
Sentence: 324,induced,O
Sentence: 324,burning,O
Sentence: 324,sensations,O
Sentence: 324,(,O
Sentence: 324,4,O
Sentence: 324,),O
Sentence: 324,or,O
Sentence: 324,mastitis,B-Disease
Sentence: 324,(,O
Sentence: 324,1,O
Sentence: 324,),O
Sentence: 324,;,O
Sentence: 324,15,O
Sentence: 324,(,O
Sentence: 324,38.5,O
Sentence: 324,%,O
Sentence: 324,),O
Sentence: 324,reported,O
Sentence: 324,no,O
Sentence: 324,benefit,O
Sentence: 324,.,O
Sentence: 324,The,O
Sentence: 324,decrease,O
Sentence: 324,in,O
Sentence: 324,VAS,O
Sentence: 324,ratings,O
Sentence: 324,was,O
Sentence: 324,significant,O
Sentence: 324,after,O
Sentence: 324,2,O
Sentence: 324,weeks,O
Sentence: 324,of,O
Sentence: 324,continuous,O
Sentence: 324,application,O
Sentence: 324,.,O
Sentence: 324,Of,O
Sentence: 324,the,O
Sentence: 324,responders,O
Sentence: 324,72.2,O
Sentence: 324,%,O
Sentence: 324,were,O
Sentence: 324,still,O
Sentence: 324,improved,O
Sentence: 324,at,O
Sentence: 324,the,O
Sentence: 324,follow,O
Sentence: 324,-,O
Sentence: 324,up,O
Sentence: 324,;,O
Sentence: 324,only,O
Sentence: 324,one,O
Sentence: 324,-,O
Sentence: 324,third,O
Sentence: 324,of,O
Sentence: 324,them,O
Sentence: 324,had,O
Sentence: 324,continued,O
Sentence: 324,application,O
Sentence: 324,irregularly,O
Sentence: 324,.,O
Sentence: 324,Treatment,O
Sentence: 324,effect,O
Sentence: 324,was,O
Sentence: 324,not,O
Sentence: 324,dependent,O
Sentence: 324,on,O
Sentence: 324,patient,O
Sentence: 324,'s,O
Sentence: 324,age,O
Sentence: 324,",",O
Sentence: 324,duration,O
Sentence: 324,or,O
Sentence: 324,localization,O
Sentence: 324,of,O
Sentence: 324,PHN,B-Disease
Sentence: 324,(,O
Sentence: 324,trigeminal,O
Sentence: 324,involvement,O
Sentence: 324,was,O
Sentence: 324,excluded,O
Sentence: 324,),O
Sentence: 324,",",O
Sentence: 324,sensory,B-Disease
Sentence: 324,disturbance,I-Disease
Sentence: 324,or,O
Sentence: 324,pain,B-Disease
Sentence: 324,character,O
Sentence: 324,.,O
Sentence: 324,Treatment,O
Sentence: 324,response,O
Sentence: 324,was,O
Sentence: 324,not,O
Sentence: 324,correlated,O
Sentence: 324,with,O
Sentence: 324,the,O
Sentence: 324,incidence,O
Sentence: 324,",",O
Sentence: 324,time,O
Sentence: 324,-,O
Sentence: 324,course,O
Sentence: 324,or,O
Sentence: 324,severity,O
Sentence: 324,of,O
Sentence: 324,capsaicin,B-Chemical
Sentence: 324,-,O
Sentence: 324,induced,O
Sentence: 324,burning,O
Sentence: 324,.,O
Sentence: 324,If,O
Sentence: 324,confirmed,O
Sentence: 324,in,O
Sentence: 324,controlled,O
Sentence: 324,trials,O
Sentence: 324,",",O
Sentence: 324,the,O
Sentence: 324,long,O
Sentence: 324,-,O
Sentence: 324,term,O
Sentence: 324,results,O
Sentence: 324,of,O
Sentence: 324,this,O
Sentence: 324,open,O
Sentence: 324,",",O
Sentence: 324,non,O
Sentence: 324,-,O
Sentence: 324,randomized,O
Sentence: 324,study,O
Sentence: 324,might,O
Sentence: 324,indicate,O
Sentence: 324,that,O
Sentence: 324,the,O
Sentence: 324,analgesic,O
Sentence: 324,effect,O
Sentence: 324,of,O
Sentence: 324,capsaicin,B-Chemical
Sentence: 324,in,O
Sentence: 324,PHN,B-Disease
Sentence: 324,is,O
Sentence: 324,mediated,O
Sentence: 324,by,O
Sentence: 324,both,O
Sentence: 324,interference,O
Sentence: 324,with,O
Sentence: 324,neuropeptide,O
Sentence: 324,metabolism,O
Sentence: 324,and,O
Sentence: 324,morphological,O
Sentence: 324,changes,O
Sentence: 324,(,O
Sentence: 324,perhaps,O
Sentence: 324,degeneration,O
Sentence: 324,),O
Sentence: 324,of,O
Sentence: 324,nociceptive,O
Sentence: 324,afferents,O
Sentence: 324,.,O
Sentence: 325,Serotonin,B-Chemical
Sentence: 325,reuptake,O
Sentence: 325,inhibitors,O
Sentence: 325,",",O
Sentence: 325,paranoia,B-Disease
Sentence: 325,",",O
Sentence: 325,and,O
Sentence: 325,the,O
Sentence: 325,ventral,O
Sentence: 325,basal,O
Sentence: 325,ganglia,O
Sentence: 325,.,O
Sentence: 326,Antidepressants,O
Sentence: 326,have,O
Sentence: 326,previously,O
Sentence: 326,been,O
Sentence: 326,associated,O
Sentence: 326,with,O
Sentence: 326,paranoid,B-Disease
Sentence: 326,reactions,O
Sentence: 326,in,O
Sentence: 326,psychiatric,O
Sentence: 326,patients,O
Sentence: 326,.,O
Sentence: 326,Five,O
Sentence: 326,cases,O
Sentence: 326,of,O
Sentence: 326,paranoid,B-Disease
Sentence: 326,exacerbation,O
Sentence: 326,with,O
Sentence: 326,the,O
Sentence: 326,serotonin,B-Chemical
Sentence: 326,reuptake,O
Sentence: 326,inhibitors,O
Sentence: 326,fluoxetine,B-Chemical
Sentence: 326,and,O
Sentence: 326,amitriptyline,B-Chemical
Sentence: 326,are,O
Sentence: 326,reported,O
Sentence: 326,here,O
Sentence: 326,.,O
Sentence: 326,Elements,O
Sentence: 326,common,O
Sentence: 326,to,O
Sentence: 326,these,O
Sentence: 326,cases,O
Sentence: 326,included,O
Sentence: 326,a,O
Sentence: 326,history,O
Sentence: 326,of,O
Sentence: 326,paranoid,B-Disease
Sentence: 326,symptomatology,O
Sentence: 326,and,O
Sentence: 326,the,O
Sentence: 326,concomitant,O
Sentence: 326,occurrence,O
Sentence: 326,of,O
Sentence: 326,depressive,B-Disease
Sentence: 326,and,I-Disease
Sentence: 326,psychotic,B-Disease
Sentence: 326,symptoms,I-Disease
Sentence: 326,.,O
Sentence: 326,Complicated,O
Sentence: 326,depressive,B-Disease
Sentence: 326,disorders,I-Disease
Sentence: 326,(,O
Sentence: 326,including,O
Sentence: 326,atypicality,O
Sentence: 326,of,O
Sentence: 326,course,O
Sentence: 326,and,O
Sentence: 326,symptomatology,O
Sentence: 326,",",O
Sentence: 326,chronicity,O
Sentence: 326,",",O
Sentence: 326,psychosis,B-Disease
Sentence: 326,",",O
Sentence: 326,bipolarity,O
Sentence: 326,",",O
Sentence: 326,and,O
Sentence: 326,secondary,O
Sentence: 326,onset,O
Sentence: 326,in,O
Sentence: 326,the,O
Sentence: 326,course,O
Sentence: 326,of,O
Sentence: 326,a,O
Sentence: 326,primary,O
Sentence: 326,psychosis,B-Disease
Sentence: 326,),O
Sentence: 326,may,O
Sentence: 326,present,O
Sentence: 326,particular,O
Sentence: 326,vulnerability,O
Sentence: 326,to,O
Sentence: 326,paranoid,B-Disease
Sentence: 326,exacerbations,O
Sentence: 326,associated,O
Sentence: 326,with,O
Sentence: 326,serotonin,B-Chemical
Sentence: 326,reuptake,O
Sentence: 326,inhibitors,O
Sentence: 326,.,O
Sentence: 326,Although,O
Sentence: 326,the,O
Sentence: 326,pharmacology,O
Sentence: 326,and,O
Sentence: 326,neurobiology,O
Sentence: 326,of,O
Sentence: 326,paranoia,B-Disease
Sentence: 326,remain,O
Sentence: 326,cryptic,O
Sentence: 326,",",O
Sentence: 326,several,O
Sentence: 326,mechanisms,O
Sentence: 326,",",O
Sentence: 326,including,O
Sentence: 326,5HT3,O
Sentence: 326,receptor,O
Sentence: 326,-,O
Sentence: 326,mediated,O
Sentence: 326,dopamine,B-Chemical
Sentence: 326,release,O
Sentence: 326,",",O
Sentence: 326,beta,O
Sentence: 326,-,O
Sentence: 326,noradrenergic,O
Sentence: 326,receptor,O
Sentence: 326,downregulation,O
Sentence: 326,",",O
Sentence: 326,or,O
Sentence: 326,GABAB,O
Sentence: 326,receptor,O
Sentence: 326,upregulation,O
Sentence: 326,acting,O
Sentence: 326,in,O
Sentence: 326,the,O
Sentence: 326,vicinity,O
Sentence: 326,of,O
Sentence: 326,the,O
Sentence: 326,ventral,O
Sentence: 326,basal,O
Sentence: 326,ganglia,O
Sentence: 326,(,O
Sentence: 326,possibly,O
Sentence: 326,in,O
Sentence: 326,lateral,O
Sentence: 326,orbitofrontal,O
Sentence: 326,or,O
Sentence: 326,anterior,O
Sentence: 326,cingulate,O
Sentence: 326,circuits,O
Sentence: 326,),O
Sentence: 326,",",O
Sentence: 326,might,O
Sentence: 326,apply,O
Sentence: 326,to,O
Sentence: 326,this,O
Sentence: 326,phenomenon,O
Sentence: 326,.,O
Sentence: 326,These,O
Sentence: 326,cases,O
Sentence: 326,call,O
Sentence: 326,attention,O
Sentence: 326,to,O
Sentence: 326,possible,O
Sentence: 326,paranoid,B-Disease
Sentence: 326,exacerbations,O
Sentence: 326,with,O
Sentence: 326,serotonin,B-Chemical
Sentence: 326,reuptake,O
Sentence: 326,blockers,O
Sentence: 326,in,O
Sentence: 326,select,O
Sentence: 326,patients,O
Sentence: 326,and,O
Sentence: 326,raise,O
Sentence: 326,neurobiological,O
Sentence: 326,considerations,O
Sentence: 326,regarding,O
Sentence: 326,paranoia,B-Disease
Sentence: 326,.,O
Sentence: 327,Five,O
Sentence: 327,cases,O
Sentence: 327,of,O
Sentence: 327,encephalitis,B-Disease
Sentence: 327,during,O
Sentence: 327,treatment,O
Sentence: 327,of,O
Sentence: 327,loiasis,B-Disease
Sentence: 327,with,O
Sentence: 327,diethylcarbamazine,B-Chemical
Sentence: 327,.,O
Sentence: 328,Five,O
Sentence: 328,cases,O
Sentence: 328,of,O
Sentence: 328,encephalitis,B-Disease
Sentence: 328,following,O
Sentence: 328,treatment,O
Sentence: 328,with,O
Sentence: 328,diethylcarbamazine,B-Chemical
Sentence: 328,(,O
Sentence: 328,DEC,B-Chemical
Sentence: 328,),O
Sentence: 328,were,O
Sentence: 328,observed,O
Sentence: 328,in,O
Sentence: 328,Congolese,O
Sentence: 328,patients,O
Sentence: 328,with,O
Sentence: 328,Loa,O
Sentence: 328,loa,O
Sentence: 328,filariasis,B-Disease
Sentence: 328,.,O
Sentence: 328,Two,O
Sentence: 328,cases,O
Sentence: 328,had,O
Sentence: 328,a,O
Sentence: 328,fatal,O
Sentence: 328,outcome,O
Sentence: 328,and,O
Sentence: 328,one,O
Sentence: 328,resulted,O
Sentence: 328,in,O
Sentence: 328,severe,O
Sentence: 328,sequelae,O
Sentence: 328,.,O
Sentence: 328,The,O
Sentence: 328,notable,O
Sentence: 328,fact,O
Sentence: 328,was,O
Sentence: 328,that,O
Sentence: 328,this,O
Sentence: 328,complication,O
Sentence: 328,occurred,O
Sentence: 328,in,O
Sentence: 328,three,O
Sentence: 328,patients,O
Sentence: 328,hospitalized,O
Sentence: 328,before,O
Sentence: 328,treatment,O
Sentence: 328,began,O
Sentence: 328,",",O
Sentence: 328,with,O
Sentence: 328,whom,O
Sentence: 328,particularly,O
Sentence: 328,strict,O
Sentence: 328,therapeutic,O
Sentence: 328,precautions,O
Sentence: 328,were,O
Sentence: 328,taken,O
Sentence: 328,",",O
Sentence: 328,i.e.,O
Sentence: 328,",",O
Sentence: 328,initial,O
Sentence: 328,dose,O
Sentence: 328,less,O
Sentence: 328,than,O
Sentence: 328,10,O
Sentence: 328,mg,O
Sentence: 328,of,O
Sentence: 328,DEC,B-Chemical
Sentence: 328,",",O
Sentence: 328,very,O
Sentence: 328,gradual,O
Sentence: 328,dose,O
Sentence: 328,increases,O
Sentence: 328,",",O
Sentence: 328,and,O
Sentence: 328,associated,O
Sentence: 328,anti,O
Sentence: 328,-,O
Sentence: 328,allergic,O
Sentence: 328,treatment,O
Sentence: 328,.,O
Sentence: 328,This,O
Sentence: 328,type,O
Sentence: 328,of,O
Sentence: 328,drug,O
Sentence: 328,-,O
Sentence: 328,induced,O
Sentence: 328,complication,O
Sentence: 328,may,O
Sentence: 328,not,O
Sentence: 328,be,O
Sentence: 328,that,O
Sentence: 328,uncommon,O
Sentence: 328,in,O
Sentence: 328,highly,O
Sentence: 328,endemic,O
Sentence: 328,regions,O
Sentence: 328,.,O
Sentence: 328,It,O
Sentence: 328,occurs,O
Sentence: 328,primarily,O
Sentence: 328,",",O
Sentence: 328,but,O
Sentence: 328,not,O
Sentence: 328,exclusively,O
Sentence: 328,",",O
Sentence: 328,in,O
Sentence: 328,subjects,O
Sentence: 328,presenting,O
Sentence: 328,with,O
Sentence: 328,a,O
Sentence: 328,high,O
Sentence: 328,microfilarial,O
Sentence: 328,load,O
Sentence: 328,.,O
Sentence: 328,The,O
Sentence: 328,relationship,O
Sentence: 328,between,O
Sentence: 328,the,O
Sentence: 328,occurrence,O
Sentence: 328,of,O
Sentence: 328,encephalitis,B-Disease
Sentence: 328,and,O
Sentence: 328,the,O
Sentence: 328,decrease,O
Sentence: 328,in,O
Sentence: 328,microfilaremia,B-Disease
Sentence: 328,is,O
Sentence: 328,evident,O
Sentence: 328,.,O
Sentence: 328,The,O
Sentence: 328,pathophysiological,O
Sentence: 328,mechanisms,O
Sentence: 328,are,O
Sentence: 328,discussed,O
Sentence: 328,in,O
Sentence: 328,the,O
Sentence: 328,light,O
Sentence: 328,of,O
Sentence: 328,these,O
Sentence: 328,observations,O
Sentence: 328,and,O
Sentence: 328,the,O
Sentence: 328,few,O
Sentence: 328,other,O
Sentence: 328,comments,O
Sentence: 328,on,O
Sentence: 328,this,O
Sentence: 328,subject,O
Sentence: 328,published,O
Sentence: 328,in,O
Sentence: 328,the,O
Sentence: 328,literature,O
Sentence: 328,.,O
Sentence: 329,Delirium,B-Disease
Sentence: 329,in,O
Sentence: 329,an,O
Sentence: 329,elderly,O
Sentence: 329,woman,O
Sentence: 329,possibly,O
Sentence: 329,associated,O
Sentence: 329,with,O
Sentence: 329,administration,O
Sentence: 329,of,O
Sentence: 329,misoprostol,B-Chemical
Sentence: 329,.,O
Sentence: 330,Misoprostol,B-Chemical
Sentence: 330,has,O
Sentence: 330,been,O
Sentence: 330,associated,O
Sentence: 330,with,O
Sentence: 330,adverse,O
Sentence: 330,reactions,O
Sentence: 330,",",O
Sentence: 330,including,O
Sentence: 330,gastrointestinal,O
Sentence: 330,symptoms,O
Sentence: 330,",",O
Sentence: 330,gynecologic,O
Sentence: 330,problems,O
Sentence: 330,",",O
Sentence: 330,and,O
Sentence: 330,headache,B-Disease
Sentence: 330,.,O
Sentence: 330,Changes,O
Sentence: 330,in,O
Sentence: 330,mental,O
Sentence: 330,status,O
Sentence: 330,",",O
Sentence: 330,however,O
Sentence: 330,",",O
Sentence: 330,have,O
Sentence: 330,not,O
Sentence: 330,been,O
Sentence: 330,reported,O
Sentence: 330,.,O
Sentence: 330,We,O
Sentence: 330,present,O
Sentence: 330,a,O
Sentence: 330,case,O
Sentence: 330,in,O
Sentence: 330,which,O
Sentence: 330,an,O
Sentence: 330,89,O
Sentence: 330,-,O
Sentence: 330,year,O
Sentence: 330,-,O
Sentence: 330,old,O
Sentence: 330,woman,O
Sentence: 330,in,O
Sentence: 330,a,O
Sentence: 330,long,O
Sentence: 330,-,O
Sentence: 330,term,O
Sentence: 330,care,O
Sentence: 330,facility,O
Sentence: 330,became,O
Sentence: 330,confused,O
Sentence: 330,after,O
Sentence: 330,the,O
Sentence: 330,initiation,O
Sentence: 330,of,O
Sentence: 330,misoprostol,B-Chemical
Sentence: 330,therapy,O
Sentence: 330,.,O
Sentence: 330,The,O
Sentence: 330,patient,O
Sentence: 330,'s,O
Sentence: 330,change,O
Sentence: 330,in,O
Sentence: 330,mental,O
Sentence: 330,status,O
Sentence: 330,was,O
Sentence: 330,first,O
Sentence: 330,reported,O
Sentence: 330,nine,O
Sentence: 330,days,O
Sentence: 330,after,O
Sentence: 330,the,O
Sentence: 330,initiation,O
Sentence: 330,of,O
Sentence: 330,therapy,O
Sentence: 330,.,O
Sentence: 330,Her,O
Sentence: 330,delirium,B-Disease
Sentence: 330,significantly,O
Sentence: 330,improved,O
Sentence: 330,after,O
Sentence: 330,misoprostol,B-Chemical
Sentence: 330,was,O
Sentence: 330,discontinued,O
Sentence: 330,and,O
Sentence: 330,her,O
Sentence: 330,mental,O
Sentence: 330,status,O
Sentence: 330,returned,O
Sentence: 330,to,O
Sentence: 330,normal,O
Sentence: 330,within,O
Sentence: 330,a,O
Sentence: 330,week,O
Sentence: 330,.,O
Sentence: 330,Because,O
Sentence: 330,no,O
Sentence: 330,other,O
Sentence: 330,factors,O
Sentence: 330,related,O
Sentence: 330,to,O
Sentence: 330,this,O
Sentence: 330,patient,O
Sentence: 330,changed,O
Sentence: 330,significantly,O
Sentence: 330,",",O
Sentence: 330,the,O
Sentence: 330,delirium,B-Disease
Sentence: 330,experienced,O
Sentence: 330,by,O
Sentence: 330,this,O
Sentence: 330,patient,O
Sentence: 330,possibly,O
Sentence: 330,resulted,O
Sentence: 330,from,O
Sentence: 330,misoprostol,B-Chemical
Sentence: 330,therapy,O
Sentence: 330,.,O
Sentence: 331,Hepatocellular,O
Sentence: 331,oxidant,O
Sentence: 331,stress,O
Sentence: 331,following,O
Sentence: 331,intestinal,O
Sentence: 331,ischemia,B-Disease
Sentence: 331,-,O
Sentence: 331,reperfusion,B-Disease
Sentence: 331,injury,I-Disease
Sentence: 331,.,O
Sentence: 332,Reperfusion,O
Sentence: 332,of,O
Sentence: 332,ischemic,B-Disease
Sentence: 332,intestine,O
Sentence: 332,results,O
Sentence: 332,in,O
Sentence: 332,acute,O
Sentence: 332,liver,B-Disease
Sentence: 332,dysfunction,I-Disease
Sentence: 332,characterized,O
Sentence: 332,by,O
Sentence: 332,hepatocellular,O
Sentence: 332,enzyme,O
Sentence: 332,release,O
Sentence: 332,into,O
Sentence: 332,plasma,O
Sentence: 332,",",O
Sentence: 332,reduction,O
Sentence: 332,in,O
Sentence: 332,bile,O
Sentence: 332,flow,O
Sentence: 332,rate,O
Sentence: 332,",",O
Sentence: 332,and,O
Sentence: 332,neutrophil,O
Sentence: 332,sequestration,O
Sentence: 332,within,O
Sentence: 332,the,O
Sentence: 332,liver,O
Sentence: 332,.,O
Sentence: 332,The,O
Sentence: 332,pathophysiology,O
Sentence: 332,underlying,O
Sentence: 332,this,O
Sentence: 332,acute,O
Sentence: 332,hepatic,B-Disease
Sentence: 332,injury,I-Disease
Sentence: 332,is,O
Sentence: 332,unknown,O
Sentence: 332,.,O
Sentence: 332,This,O
Sentence: 332,study,O
Sentence: 332,was,O
Sentence: 332,undertaken,O
Sentence: 332,to,O
Sentence: 332,determine,O
Sentence: 332,whether,O
Sentence: 332,oxidants,O
Sentence: 332,are,O
Sentence: 332,associated,O
Sentence: 332,with,O
Sentence: 332,the,O
Sentence: 332,hepatic,B-Disease
Sentence: 332,injury,I-Disease
Sentence: 332,and,O
Sentence: 332,to,O
Sentence: 332,determine,O
Sentence: 332,the,O
Sentence: 332,relative,O
Sentence: 332,value,O
Sentence: 332,of,O
Sentence: 332,several,O
Sentence: 332,indirect,O
Sentence: 332,methods,O
Sentence: 332,of,O
Sentence: 332,assessing,O
Sentence: 332,oxidant,O
Sentence: 332,exposure,O
Sentence: 332,in,O
Sentence: 332,vivo,O
Sentence: 332,.,O
Sentence: 332,Rats,O
Sentence: 332,were,O
Sentence: 332,subjected,O
Sentence: 332,to,O
Sentence: 332,a,O
Sentence: 332,standardized,O
Sentence: 332,intestinal,O
Sentence: 332,ischemia,B-Disease
Sentence: 332,-,O
Sentence: 332,reperfusion,B-Disease
Sentence: 332,injury,I-Disease
Sentence: 332,.,O
Sentence: 332,Hepatic,O
Sentence: 332,tissue,O
Sentence: 332,was,O
Sentence: 332,assayed,O
Sentence: 332,for,O
Sentence: 332,lipid,O
Sentence: 332,peroxidation,O
Sentence: 332,products,O
Sentence: 332,and,O
Sentence: 332,oxidized,B-Chemical
Sentence: 332,and,I-Chemical
Sentence: 332,reduced,B-Chemical
Sentence: 332,glutathione,B-Chemical
Sentence: 332,.,O
Sentence: 332,There,O
Sentence: 332,was,O
Sentence: 332,no,O
Sentence: 332,change,O
Sentence: 332,in,O
Sentence: 332,hepatic,O
Sentence: 332,tissue,O
Sentence: 332,total,O
Sentence: 332,glutathione,B-Chemical
Sentence: 332,following,O
Sentence: 332,intestinal,O
Sentence: 332,ischemia,B-Disease
Sentence: 332,-,O
Sentence: 332,reperfusion,B-Disease
Sentence: 332,injury,I-Disease
Sentence: 332,.,O
Sentence: 332,Oxidized,B-Chemical
Sentence: 332,glutathione,I-Chemical
Sentence: 332,(,O
Sentence: 332,GSSG,B-Chemical
Sentence: 332,),O
Sentence: 332,increased,O
Sentence: 332,significantly,O
Sentence: 332,following,O
Sentence: 332,30,O
Sentence: 332,and,O
Sentence: 332,60,O
Sentence: 332,min,O
Sentence: 332,of,O
Sentence: 332,reperfusion,O
Sentence: 332,.,O
Sentence: 332,There,O
Sentence: 332,was,O
Sentence: 332,no,O
Sentence: 332,increase,O
Sentence: 332,in,O
Sentence: 332,any,O
Sentence: 332,of,O
Sentence: 332,the,O
Sentence: 332,products,O
Sentence: 332,of,O
Sentence: 332,lipid,O
Sentence: 332,peroxidation,O
Sentence: 332,associated,O
Sentence: 332,with,O
Sentence: 332,this,O
Sentence: 332,injury,O
Sentence: 332,.,O
Sentence: 332,An,O
Sentence: 332,increase,O
Sentence: 332,in,O
Sentence: 332,GSSG,B-Chemical
Sentence: 332,within,O
Sentence: 332,hepatic,O
Sentence: 332,tissue,O
Sentence: 332,during,O
Sentence: 332,intestinal,O
Sentence: 332,reperfusion,O
Sentence: 332,suggests,O
Sentence: 332,exposure,O
Sentence: 332,of,O
Sentence: 332,hepatocytes,O
Sentence: 332,to,O
Sentence: 332,an,O
Sentence: 332,oxidant,O
Sentence: 332,stress,O
Sentence: 332,.,O
Sentence: 332,The,O
Sentence: 332,lack,O
Sentence: 332,of,O
Sentence: 332,a,O
Sentence: 332,significant,O
Sentence: 332,increase,O
Sentence: 332,in,O
Sentence: 332,products,O
Sentence: 332,of,O
Sentence: 332,lipid,O
Sentence: 332,peroxidation,O
Sentence: 332,suggests,O
Sentence: 332,that,O
Sentence: 332,the,O
Sentence: 332,oxidant,O
Sentence: 332,stress,O
Sentence: 332,is,O
Sentence: 332,of,O
Sentence: 332,insufficient,O
Sentence: 332,magnitude,O
Sentence: 332,to,O
Sentence: 332,result,O
Sentence: 332,in,O
Sentence: 332,irreversible,O
Sentence: 332,injury,O
Sentence: 332,to,O
Sentence: 332,hepatocyte,O
Sentence: 332,cell,O
Sentence: 332,membranes,O
Sentence: 332,.,O
Sentence: 332,These,O
Sentence: 332,data,O
Sentence: 332,also,O
Sentence: 332,suggest,O
Sentence: 332,that,O
Sentence: 332,the,O
Sentence: 332,measurement,O
Sentence: 332,of,O
Sentence: 332,tissue,O
Sentence: 332,GSSG,B-Chemical
Sentence: 332,may,O
Sentence: 332,be,O
Sentence: 332,a,O
Sentence: 332,more,O
Sentence: 332,sensitive,O
Sentence: 332,indicator,O
Sentence: 332,of,O
Sentence: 332,oxidant,O
Sentence: 332,stress,O
Sentence: 332,than,O
Sentence: 332,measurement,O
Sentence: 332,of,O
Sentence: 332,products,O
Sentence: 332,of,O
Sentence: 332,lipid,O
Sentence: 332,peroxidation,O
Sentence: 332,.,O
Sentence: 333,Diphenhydramine,B-Chemical
Sentence: 333,prevents,O
Sentence: 333,the,O
Sentence: 333,haemodynamic,O
Sentence: 333,changes,O
Sentence: 333,of,O
Sentence: 333,cimetidine,B-Chemical
Sentence: 333,in,O
Sentence: 333,ICU,O
Sentence: 333,patients,O
Sentence: 333,.,O
Sentence: 334,Cimetidine,B-Chemical
Sentence: 334,",",O
Sentence: 334,a,O
Sentence: 334,histamine,B-Chemical
Sentence: 334,2,O
Sentence: 334,(,O
Sentence: 334,H2,O
Sentence: 334,),O
Sentence: 334,antagonist,O
Sentence: 334,",",O
Sentence: 334,produces,O
Sentence: 334,a,O
Sentence: 334,decrease,O
Sentence: 334,in,O
Sentence: 334,arterial,O
Sentence: 334,pressure,O
Sentence: 334,due,O
Sentence: 334,to,O
Sentence: 334,vasodilatation,O
Sentence: 334,",",O
Sentence: 334,especially,O
Sentence: 334,in,O
Sentence: 334,critically,O
Sentence: 334,ill,O
Sentence: 334,patients,O
Sentence: 334,.,O
Sentence: 334,This,O
Sentence: 334,may,O
Sentence: 334,be,O
Sentence: 334,because,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,acts,O
Sentence: 334,as,O
Sentence: 334,a,O
Sentence: 334,histamine,B-Chemical
Sentence: 334,agonist,O
Sentence: 334,.,O
Sentence: 334,We,O
Sentence: 334,",",O
Sentence: 334,therefore,O
Sentence: 334,",",O
Sentence: 334,investigated,O
Sentence: 334,the,O
Sentence: 334,effects,O
Sentence: 334,of,O
Sentence: 334,the,O
Sentence: 334,histamine,B-Chemical
Sentence: 334,1,O
Sentence: 334,(,O
Sentence: 334,H1,O
Sentence: 334,),O
Sentence: 334,receptor,O
Sentence: 334,antagonist,O
Sentence: 334,",",O
Sentence: 334,diphenhydramine,B-Chemical
Sentence: 334,",",O
Sentence: 334,on,O
Sentence: 334,the,O
Sentence: 334,haemodynamic,O
Sentence: 334,changes,O
Sentence: 334,observed,O
Sentence: 334,after,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,in,O
Sentence: 334,ICU,O
Sentence: 334,patients,O
Sentence: 334,.,O
Sentence: 334,Each,O
Sentence: 334,patient,O
Sentence: 334,was,O
Sentence: 334,studied,O
Sentence: 334,on,O
Sentence: 334,two,O
Sentence: 334,separate,O
Sentence: 334,days,O
Sentence: 334,.,O
Sentence: 334,In,O
Sentence: 334,a,O
Sentence: 334,random,O
Sentence: 334,fashion,O
Sentence: 334,",",O
Sentence: 334,they,O
Sentence: 334,received,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,200,O
Sentence: 334,mg,O
Sentence: 334,iv,O
Sentence: 334,on,O
Sentence: 334,one,O
Sentence: 334,day,O
Sentence: 334,",",O
Sentence: 334,and,O
Sentence: 334,on,O
Sentence: 334,the,O
Sentence: 334,other,O
Sentence: 334,",",O
Sentence: 334,a,O
Sentence: 334,pretreatment,O
Sentence: 334,of,O
Sentence: 334,diphenhydramine,B-Chemical
Sentence: 334,40,O
Sentence: 334,mg,O
Sentence: 334,iv,O
Sentence: 334,with,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,200,O
Sentence: 334,mg,O
Sentence: 334,iv,O
Sentence: 334,.,O
Sentence: 334,In,O
Sentence: 334,the,O
Sentence: 334,non,O
Sentence: 334,-,O
Sentence: 334,pretreatment,O
Sentence: 334,group,O
Sentence: 334,",",O
Sentence: 334,mean,O
Sentence: 334,arterial,O
Sentence: 334,pressure,O
Sentence: 334,(,O
Sentence: 334,MAP,O
Sentence: 334,),O
Sentence: 334,decreased,O
Sentence: 334,from,O
Sentence: 334,107.4,O
Sentence: 334,+,O
Sentence: 334,/,O
Sentence: 334,,O
Sentence: 334,-,O
Sentence: 334,,O
Sentence: 334,8.4,O
Sentence: 334,mmHg,O
Sentence: 334,to,O
Sentence: 334,86.7,O
Sentence: 334,+,O
Sentence: 334,/,O
Sentence: 334,,O
Sentence: 334,-,O
Sentence: 334,,O
Sentence: 334,11.4,O
Sentence: 334,mmHg,O
Sentence: 334,(,O
Sentence: 334,P,O
Sentence: 334,less,O
Sentence: 334,than,O
Sentence: 334,0.01,O
Sentence: 334,),O
Sentence: 334,two,O
Sentence: 334,minutes,O
Sentence: 334,after,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,.,O
Sentence: 334,Also,O
Sentence: 334,",",O
Sentence: 334,systemic,O
Sentence: 334,vascular,O
Sentence: 334,resistance,O
Sentence: 334,(,O
Sentence: 334,SVR,O
Sentence: 334,),O
Sentence: 334,decreased,O
Sentence: 334,during,O
Sentence: 334,the,O
Sentence: 334,eight,O
Sentence: 334,-,O
Sentence: 334,minute,O
Sentence: 334,observation,O
Sentence: 334,period,O
Sentence: 334,(,O
Sentence: 334,P,O
Sentence: 334,less,O
Sentence: 334,than,O
Sentence: 334,0.01,O
Sentence: 334,),O
Sentence: 334,.,O
Sentence: 334,In,O
Sentence: 334,contrast,O
Sentence: 334,",",O
Sentence: 334,in,O
Sentence: 334,the,O
Sentence: 334,pretreatment,O
Sentence: 334,group,O
Sentence: 334,",",O
Sentence: 334,little,O
Sentence: 334,haemodynamic,O
Sentence: 334,change,O
Sentence: 334,was,O
Sentence: 334,seen,O
Sentence: 334,.,O
Sentence: 334,We,O
Sentence: 334,conclude,O
Sentence: 334,that,O
Sentence: 334,an,O
Sentence: 334,H1,O
Sentence: 334,antagonist,O
Sentence: 334,may,O
Sentence: 334,be,O
Sentence: 334,useful,O
Sentence: 334,in,O
Sentence: 334,preventing,O
Sentence: 334,hypotension,B-Disease
Sentence: 334,caused,O
Sentence: 334,by,O
Sentence: 334,iv,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,",",O
Sentence: 334,since,O
Sentence: 334,the,O
Sentence: 334,vasodilating,O
Sentence: 334,activity,O
Sentence: 334,of,O
Sentence: 334,cimetidine,B-Chemical
Sentence: 334,is,O
Sentence: 334,mediated,O
Sentence: 334,",",O
Sentence: 334,in,O
Sentence: 334,part,O
Sentence: 334,",",O
Sentence: 334,through,O
Sentence: 334,the,O
Sentence: 334,H1,O
Sentence: 334,receptor,O
Sentence: 334,.,O
Sentence: 335,Acute,B-Disease
Sentence: 335,renal,I-Disease
Sentence: 335,failure,I-Disease
Sentence: 335,due,O
Sentence: 335,to,O
Sentence: 335,rifampicin,B-Chemical
Sentence: 335,.,O
Sentence: 336,A,O
Sentence: 336,23,O
Sentence: 336,-,O
Sentence: 336,year,O
Sentence: 336,-,O
Sentence: 336,old,O
Sentence: 336,male,O
Sentence: 336,patient,O
Sentence: 336,with,O
Sentence: 336,bacteriologically,O
Sentence: 336,proven,O
Sentence: 336,pulmonary,B-Disease
Sentence: 336,tuberculosis,I-Disease
Sentence: 336,was,O
Sentence: 336,treated,O
Sentence: 336,with,O
Sentence: 336,the,O
Sentence: 336,various,O
Sentence: 336,regimens,O
Sentence: 336,of,O
Sentence: 336,antituberculosis,O
Sentence: 336,drugs,O
Sentence: 336,for,O
Sentence: 336,nearly,O
Sentence: 336,15,O
Sentence: 336,months,O
Sentence: 336,.,O
Sentence: 336,Rifampicin,B-Chemical
Sentence: 336,was,O
Sentence: 336,administered,O
Sentence: 336,thrice,O
Sentence: 336,as,O
Sentence: 336,one,O
Sentence: 336,of,O
Sentence: 336,the,O
Sentence: 336,3,O
Sentence: 336,-,O
Sentence: 336,4,O
Sentence: 336,drug,O
Sentence: 336,regimen,O
Sentence: 336,and,O
Sentence: 336,each,O
Sentence: 336,time,O
Sentence: 336,he,O
Sentence: 336,developed,O
Sentence: 336,untoward,O
Sentence: 336,side,O
Sentence: 336,effects,O
Sentence: 336,like,O
Sentence: 336,nausea,B-Disease
Sentence: 336,",",O
Sentence: 336,vomiting,B-Disease
Sentence: 336,and,O
Sentence: 336,fever,B-Disease
Sentence: 336,with,O
Sentence: 336,chills,O
Sentence: 336,and,O
Sentence: 336,rigors,O
Sentence: 336,.,O
Sentence: 336,The,O
Sentence: 336,last,O
Sentence: 336,such,O
Sentence: 336,episode,O
Sentence: 336,was,O
Sentence: 336,of,O
Sentence: 336,acute,O
Sentence: 336,renal,O
Sentence: 336,failure,O
Sentence: 336,at,O
Sentence: 336,which,O
Sentence: 336,stage,O
Sentence: 336,the,O
Sentence: 336,patient,O
Sentence: 336,was,O
Sentence: 336,seen,O
Sentence: 336,by,O
Sentence: 336,the,O
Sentence: 336,authors,O
Sentence: 336,of,O
Sentence: 336,this,O
Sentence: 336,report,O
Sentence: 336,.,O
Sentence: 336,The,O
Sentence: 336,patient,O
Sentence: 336,",",O
Sentence: 336,however,O
Sentence: 336,",",O
Sentence: 336,made,O
Sentence: 336,a,O
Sentence: 336,full,O
Sentence: 336,recovery,O
Sentence: 336,.,O
Sentence: 337,Severe,O
Sentence: 337,polyneuropathy,B-Disease
Sentence: 337,and,O
Sentence: 337,motor,O
Sentence: 337,loss,O
Sentence: 337,after,O
Sentence: 337,intrathecal,O
Sentence: 337,thiotepa,B-Chemical
Sentence: 337,combination,O
Sentence: 337,chemotherapy,O
Sentence: 337,:,O
Sentence: 337,description,O
Sentence: 337,of,O
Sentence: 337,two,O
Sentence: 337,cases,O
Sentence: 337,.,O
Sentence: 338,Two,O
Sentence: 338,cases,O
Sentence: 338,of,O
Sentence: 338,severe,O
Sentence: 338,delayed,O
Sentence: 338,neurologic,B-Disease
Sentence: 338,toxicity,I-Disease
Sentence: 338,related,O
Sentence: 338,to,O
Sentence: 338,the,O
Sentence: 338,administration,O
Sentence: 338,of,O
Sentence: 338,intrathecal,O
Sentence: 338,(,O
Sentence: 338,IT,O
Sentence: 338,),O
Sentence: 338,combination,O
Sentence: 338,chemotherapy,O
Sentence: 338,including,O
Sentence: 338,thiotepa,B-Chemical
Sentence: 338,(,O
Sentence: 338,TSPA,B-Chemical
Sentence: 338,),O
Sentence: 338,are,O
Sentence: 338,presented,O
Sentence: 338,.,O
Sentence: 338,Both,O
Sentence: 338,cases,O
Sentence: 338,developed,O
Sentence: 338,axonal,B-Disease
Sentence: 338,neuropathy,I-Disease
Sentence: 338,with,O
Sentence: 338,motor,O
Sentence: 338,predominance,O
Sentence: 338,in,O
Sentence: 338,the,O
Sentence: 338,lower,O
Sentence: 338,extremities,O
Sentence: 338,1,O
Sentence: 338,and,O
Sentence: 338,6,O
Sentence: 338,months,O
Sentence: 338,after,O
Sentence: 338,IT,O
Sentence: 338,chemotherapy,O
Sentence: 338,was,O
Sentence: 338,administered,O
Sentence: 338,.,O
Sentence: 338,Neurologic,B-Disease
Sentence: 338,toxicities,I-Disease
Sentence: 338,have,O
Sentence: 338,been,O
Sentence: 338,described,O
Sentence: 338,with,O
Sentence: 338,IT,O
Sentence: 338,-,O
Sentence: 338,methotrexate,B-Chemical
Sentence: 338,",",O
Sentence: 338,IT,O
Sentence: 338,-,O
Sentence: 338,cytosine,B-Chemical
Sentence: 338,arabinoside,I-Chemical
Sentence: 338,and,O
Sentence: 338,IT,O
Sentence: 338,-,O
Sentence: 338,TSPA,B-Chemical
Sentence: 338,.,O
Sentence: 338,To,O
Sentence: 338,our,O
Sentence: 338,knowledge,O
Sentence: 338,",",O
Sentence: 338,however,O
Sentence: 338,",",O
Sentence: 338,axonal,B-Disease
Sentence: 338,neuropathy,I-Disease
Sentence: 338,following,O
Sentence: 338,administration,O
Sentence: 338,of,O
Sentence: 338,these,O
Sentence: 338,three,O
Sentence: 338,agents,O
Sentence: 338,has,O
Sentence: 338,not,O
Sentence: 338,been,O
Sentence: 338,previously,O
Sentence: 338,described,O
Sentence: 338,.,O
Sentence: 338,In,O
Sentence: 338,spite,O
Sentence: 338,of,O
Sentence: 338,the,O
Sentence: 338,fact,O
Sentence: 338,that,O
Sentence: 338,TSPA,B-Chemical
Sentence: 338,is,O
Sentence: 338,a,O
Sentence: 338,useful,O
Sentence: 338,IT,O
Sentence: 338,agent,O
Sentence: 338,",",O
Sentence: 338,its,O
Sentence: 338,combination,O
Sentence: 338,with,O
Sentence: 338,MTX,B-Chemical
Sentence: 338,",",O
Sentence: 338,ara,O
Sentence: 338,-,O
Sentence: 338,C,O
Sentence: 338,and,O
Sentence: 338,radiotherapy,O
Sentence: 338,could,O
Sentence: 338,cause,O
Sentence: 338,severe,O
Sentence: 338,neurotoxicity,B-Disease
Sentence: 338,.,O
Sentence: 338,This,O
Sentence: 338,unexpected,O
Sentence: 338,complication,O
Sentence: 338,indicates,O
Sentence: 338,the,O
Sentence: 338,need,O
Sentence: 338,for,O
Sentence: 338,further,O
Sentence: 338,toxicology,O
Sentence: 338,research,O
Sentence: 338,on,O
Sentence: 338,IT,O
Sentence: 338,-,O
Sentence: 338,TSPA,B-Chemical
Sentence: 338,.,O
Sentence: 339,Effects,O
Sentence: 339,of,O
Sentence: 339,cromakalim,B-Chemical
Sentence: 339,and,O
Sentence: 339,pinacidil,B-Chemical
Sentence: 339,on,O
Sentence: 339,large,O
Sentence: 339,epicardial,O
Sentence: 339,and,O
Sentence: 339,small,O
Sentence: 339,coronary,O
Sentence: 339,arteries,O
Sentence: 339,in,O
Sentence: 339,conscious,O
Sentence: 339,dogs,O
Sentence: 339,.,O
Sentence: 340,The,O
Sentence: 340,effects,O
Sentence: 340,of,O
Sentence: 340,i.v,O
Sentence: 340,.,O
Sentence: 340,bolus,O
Sentence: 340,administration,O
Sentence: 340,of,O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,(,O
Sentence: 340,1,O
Sentence: 340,-,O
Sentence: 340,10,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,and,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,(,O
Sentence: 340,3,O
Sentence: 340,-,O
Sentence: 340,100,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,on,O
Sentence: 340,large,O
Sentence: 340,(,O
Sentence: 340,circumflex,O
Sentence: 340,artery,O
Sentence: 340,),O
Sentence: 340,and,O
Sentence: 340,small,O
Sentence: 340,coronary,O
Sentence: 340,arteries,O
Sentence: 340,and,O
Sentence: 340,on,O
Sentence: 340,systemic,O
Sentence: 340,hemodynamics,O
Sentence: 340,were,O
Sentence: 340,investigated,O
Sentence: 340,in,O
Sentence: 340,chronically,O
Sentence: 340,instrumented,O
Sentence: 340,conscious,O
Sentence: 340,dogs,O
Sentence: 340,and,O
Sentence: 340,compared,O
Sentence: 340,to,O
Sentence: 340,those,O
Sentence: 340,of,O
Sentence: 340,nitroglycerin,B-Chemical
Sentence: 340,(,O
Sentence: 340,0.03,O
Sentence: 340,-,O
Sentence: 340,10,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,.,O
Sentence: 340,Nitroglycerin,B-Chemical
Sentence: 340,",",O
Sentence: 340,up,O
Sentence: 340,to,O
Sentence: 340,0.3,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,",",O
Sentence: 340,selectively,O
Sentence: 340,increased,O
Sentence: 340,circumflex,O
Sentence: 340,artery,O
Sentence: 340,diameter,O
Sentence: 340,(,O
Sentence: 340,CxAD,O
Sentence: 340,),O
Sentence: 340,without,O
Sentence: 340,simultaneously,O
Sentence: 340,affecting,O
Sentence: 340,any,O
Sentence: 340,other,O
Sentence: 340,cardiac,O
Sentence: 340,or,O
Sentence: 340,systemic,O
Sentence: 340,hemodynamic,O
Sentence: 340,parameter,O
Sentence: 340,.,O
Sentence: 340,In,O
Sentence: 340,contrast,O
Sentence: 340,",",O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,and,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,at,O
Sentence: 340,all,O
Sentence: 340,doses,O
Sentence: 340,and,O
Sentence: 340,nitroglycerin,B-Chemical
Sentence: 340,at,O
Sentence: 340,doses,O
Sentence: 340,higher,O
Sentence: 340,than,O
Sentence: 340,0.3,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,simultaneously,O
Sentence: 340,and,O
Sentence: 340,dose,O
Sentence: 340,-,O
Sentence: 340,dependently,O
Sentence: 340,increased,O
Sentence: 340,CxAD,O
Sentence: 340,",",O
Sentence: 340,coronary,O
Sentence: 340,blood,O
Sentence: 340,flow,O
Sentence: 340,and,O
Sentence: 340,heart,O
Sentence: 340,rate,O
Sentence: 340,and,O
Sentence: 340,decreased,O
Sentence: 340,coronary,O
Sentence: 340,vascular,O
Sentence: 340,resistance,O
Sentence: 340,and,O
Sentence: 340,aortic,O
Sentence: 340,pressure,O
Sentence: 340,.,O
Sentence: 340,Cromakalim,B-Chemical
Sentence: 340,was,O
Sentence: 340,approximately,O
Sentence: 340,8,O
Sentence: 340,-,O
Sentence: 340,,O
Sentence: 340,to,O
Sentence: 340,9.5,O
Sentence: 340,-,O
Sentence: 340,fold,O
Sentence: 340,more,O
Sentence: 340,potent,O
Sentence: 340,than,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,in,O
Sentence: 340,increasing,O
Sentence: 340,CxAD,O
Sentence: 340,.,O
Sentence: 340,Vasodilation,O
Sentence: 340,of,O
Sentence: 340,large,O
Sentence: 340,and,O
Sentence: 340,small,O
Sentence: 340,coronary,O
Sentence: 340,vessels,O
Sentence: 340,and,O
Sentence: 340,hypotension,B-Disease
Sentence: 340,induced,O
Sentence: 340,by,O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,and,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,were,O
Sentence: 340,not,O
Sentence: 340,affected,O
Sentence: 340,by,O
Sentence: 340,prior,O
Sentence: 340,combined,O
Sentence: 340,beta,B-Chemical
Sentence: 340,adrenergic,I-Chemical
Sentence: 340,and,I-Chemical
Sentence: 340,muscarinic,B-Chemical
Sentence: 340,receptors,I-Chemical
Sentence: 340,blockade,I-Chemical
Sentence: 340,but,O
Sentence: 340,drug,O
Sentence: 340,-,O
Sentence: 340,induced,O
Sentence: 340,tachycardia,B-Disease
Sentence: 340,was,O
Sentence: 340,abolished,O
Sentence: 340,.,O
Sentence: 340,When,O
Sentence: 340,circumflex,O
Sentence: 340,artery,O
Sentence: 340,blood,O
Sentence: 340,flow,O
Sentence: 340,was,O
Sentence: 340,maintained,O
Sentence: 340,constant,O
Sentence: 340,",",O
Sentence: 340,the,O
Sentence: 340,increases,O
Sentence: 340,in,O
Sentence: 340,CxAD,O
Sentence: 340,induced,O
Sentence: 340,by,O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,(,O
Sentence: 340,10,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,",",O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,(,O
Sentence: 340,30,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,and,O
Sentence: 340,nitroglycerin,B-Chemical
Sentence: 340,(,O
Sentence: 340,10,O
Sentence: 340,micrograms,O
Sentence: 340,/,O
Sentence: 340,kg,O
Sentence: 340,),O
Sentence: 340,were,O
Sentence: 340,reduced,O
Sentence: 340,by,O
Sentence: 340,68,O
Sentence: 340,+,O
Sentence: 340,/,O
Sentence: 340,,O
Sentence: 340,-,O
Sentence: 340,,O
Sentence: 340,7,O
Sentence: 340,",",O
Sentence: 340,54,O
Sentence: 340,+,O
Sentence: 340,/,O
Sentence: 340,,O
Sentence: 340,-,O
Sentence: 340,,O
Sentence: 340,9,O
Sentence: 340,and,O
Sentence: 340,1,O
Sentence: 340,+,O
Sentence: 340,/,O
Sentence: 340,,O
Sentence: 340,-,O
Sentence: 340,,O
Sentence: 340,1,O
Sentence: 340,%,O
Sentence: 340,",",O
Sentence: 340,respectively,O
Sentence: 340,.,O
Sentence: 340,Thus,O
Sentence: 340,",",O
Sentence: 340,whereas,O
Sentence: 340,nitroglycerin,B-Chemical
Sentence: 340,preferentially,O
Sentence: 340,and,O
Sentence: 340,flow,O
Sentence: 340,-,O
Sentence: 340,independently,O
Sentence: 340,dilates,O
Sentence: 340,large,O
Sentence: 340,coronary,O
Sentence: 340,arteries,O
Sentence: 340,",",O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,and,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,dilate,O
Sentence: 340,both,O
Sentence: 340,large,O
Sentence: 340,and,O
Sentence: 340,small,O
Sentence: 340,coronary,O
Sentence: 340,arteries,O
Sentence: 340,and,O
Sentence: 340,this,O
Sentence: 340,effect,O
Sentence: 340,is,O
Sentence: 340,not,O
Sentence: 340,dependent,O
Sentence: 340,upon,O
Sentence: 340,the,O
Sentence: 340,simultaneous,O
Sentence: 340,beta,O
Sentence: 340,adrenoceptors,O
Sentence: 340,-,O
Sentence: 340,mediated,O
Sentence: 340,rise,O
Sentence: 340,in,O
Sentence: 340,myocardial,O
Sentence: 340,metabolic,O
Sentence: 340,demand,O
Sentence: 340,.,O
Sentence: 340,Finally,O
Sentence: 340,",",O
Sentence: 340,two,O
Sentence: 340,mechanisms,O
Sentence: 340,at,O
Sentence: 340,least,O
Sentence: 340,",",O
Sentence: 340,direct,O
Sentence: 340,vasodilation,O
Sentence: 340,and,O
Sentence: 340,flow,O
Sentence: 340,dependency,O
Sentence: 340,",",O
Sentence: 340,are,O
Sentence: 340,involved,O
Sentence: 340,in,O
Sentence: 340,the,O
Sentence: 340,cromakalim,B-Chemical
Sentence: 340,-,O
Sentence: 340,,O
Sentence: 340,and,O
Sentence: 340,pinacidil,B-Chemical
Sentence: 340,-,O
Sentence: 340,induced,O
Sentence: 340,increase,O
Sentence: 340,in,O
Sentence: 340,CxAD,O
Sentence: 340,.,O
Sentence: 341,Mefenamic,B-Chemical
Sentence: 341,acid,I-Chemical
Sentence: 341,-,O
Sentence: 341,induced,O
Sentence: 341,neutropenia,B-Disease
Sentence: 341,and,O
Sentence: 341,renal,B-Disease
Sentence: 341,failure,I-Disease
Sentence: 341,in,O
Sentence: 341,elderly,O
Sentence: 341,females,O
Sentence: 341,with,O
Sentence: 341,hypothyroidism,B-Disease
Sentence: 341,.,O
Sentence: 342,We,O
Sentence: 342,report,O
Sentence: 342,mefenamic,B-Chemical
Sentence: 342,acid,I-Chemical
Sentence: 342,-,O
Sentence: 342,induced,O
Sentence: 342,non,O
Sentence: 342,-,O
Sentence: 342,oliguric,O
Sentence: 342,renal,B-Disease
Sentence: 342,failure,I-Disease
Sentence: 342,and,O
Sentence: 342,severe,O
Sentence: 342,neutropenia,B-Disease
Sentence: 342,occurring,O
Sentence: 342,simultaneously,O
Sentence: 342,in,O
Sentence: 342,two,O
Sentence: 342,elderly,O
Sentence: 342,females,O
Sentence: 342,.,O
Sentence: 342,The,O
Sentence: 342,neutropenia,B-Disease
Sentence: 342,was,O
Sentence: 342,due,O
Sentence: 342,to,O
Sentence: 342,maturation,O
Sentence: 342,arrest,O
Sentence: 342,of,O
Sentence: 342,the,O
Sentence: 342,myeloid,O
Sentence: 342,series,O
Sentence: 342,in,O
Sentence: 342,one,O
Sentence: 342,patient,O
Sentence: 342,.,O
Sentence: 342,Both,O
Sentence: 342,patients,O
Sentence: 342,were,O
Sentence: 342,also,O
Sentence: 342,hypothyroid,B-Disease
Sentence: 342,",",O
Sentence: 342,but,O
Sentence: 342,it,O
Sentence: 342,is,O
Sentence: 342,not,O
Sentence: 342,clear,O
Sentence: 342,whether,O
Sentence: 342,this,O
Sentence: 342,was,O
Sentence: 342,a,O
Sentence: 342,predisposing,O
Sentence: 342,factor,O
Sentence: 342,to,O
Sentence: 342,the,O
Sentence: 342,development,O
Sentence: 342,of,O
Sentence: 342,these,O
Sentence: 342,adverse,O
Sentence: 342,reactions,O
Sentence: 342,.,O
Sentence: 342,However,O
Sentence: 342,",",O
Sentence: 342,it,O
Sentence: 342,would,O
Sentence: 342,seem,O
Sentence: 342,prudent,O
Sentence: 342,not,O
Sentence: 342,to,O
Sentence: 342,use,O
Sentence: 342,mefenamic,B-Chemical
Sentence: 342,acid,I-Chemical
Sentence: 342,in,O
Sentence: 342,hypothyroid,B-Disease
Sentence: 342,patients,O
Sentence: 342,until,O
Sentence: 342,the,O
Sentence: 342,hypothyroidism,B-Disease
Sentence: 342,has,O
Sentence: 342,been,O
Sentence: 342,corrected,O
Sentence: 342,.,O
Sentence: 343,Etiology,O
Sentence: 343,of,O
Sentence: 343,hypercalcemia,B-Disease
Sentence: 343,in,O
Sentence: 343,hemodialysis,O
Sentence: 343,patients,O
Sentence: 343,on,O
Sentence: 343,calcium,B-Chemical
Sentence: 343,carbonate,I-Chemical
Sentence: 343,therapy,O
Sentence: 343,.,O
Sentence: 344,Fourteen,O
Sentence: 344,of,O
Sentence: 344,39,O
Sentence: 344,dialysis,O
Sentence: 344,patients,O
Sentence: 344,(,O
Sentence: 344,36,O
Sentence: 344,%,O
Sentence: 344,),O
Sentence: 344,became,O
Sentence: 344,hypercalcemic,B-Disease
Sentence: 344,after,O
Sentence: 344,switching,O
Sentence: 344,to,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,carbonate,I-Chemical
Sentence: 344,as,O
Sentence: 344,their,O
Sentence: 344,principal,O
Sentence: 344,phosphate,B-Chemical
Sentence: 344,binder,O
Sentence: 344,.,O
Sentence: 344,In,O
Sentence: 344,order,O
Sentence: 344,to,O
Sentence: 344,identify,O
Sentence: 344,risk,O
Sentence: 344,factors,O
Sentence: 344,associated,O
Sentence: 344,with,O
Sentence: 344,the,O
Sentence: 344,development,O
Sentence: 344,of,O
Sentence: 344,hypercalcemia,B-Disease
Sentence: 344,",",O
Sentence: 344,indirect,O
Sentence: 344,parameters,O
Sentence: 344,of,O
Sentence: 344,intestinal,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,reabsorption,O
Sentence: 344,and,O
Sentence: 344,bone,O
Sentence: 344,turnover,O
Sentence: 344,rate,O
Sentence: 344,in,O
Sentence: 344,these,O
Sentence: 344,14,O
Sentence: 344,patients,O
Sentence: 344,were,O
Sentence: 344,compared,O
Sentence: 344,with,O
Sentence: 344,results,O
Sentence: 344,in,O
Sentence: 344,14,O
Sentence: 344,eucalcemic,O
Sentence: 344,patients,O
Sentence: 344,matched,O
Sentence: 344,for,O
Sentence: 344,age,O
Sentence: 344,",",O
Sentence: 344,sex,O
Sentence: 344,",",O
Sentence: 344,length,O
Sentence: 344,of,O
Sentence: 344,time,O
Sentence: 344,on,O
Sentence: 344,dialysis,O
Sentence: 344,",",O
Sentence: 344,and,O
Sentence: 344,etiology,O
Sentence: 344,of,O
Sentence: 344,renal,B-Disease
Sentence: 344,disease,I-Disease
Sentence: 344,.,O
Sentence: 344,In,O
Sentence: 344,addition,O
Sentence: 344,to,O
Sentence: 344,experiencing,O
Sentence: 344,hypercalcemic,B-Disease
Sentence: 344,episodes,O
Sentence: 344,with,O
Sentence: 344,peak,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,values,O
Sentence: 344,of,O
Sentence: 344,2.7,O
Sentence: 344,to,O
Sentence: 344,3.8,O
Sentence: 344,mmol,O
Sentence: 344,/,O
Sentence: 344,L,O
Sentence: 344,(,O
Sentence: 344,10.7,O
Sentence: 344,to,O
Sentence: 344,15.0,O
Sentence: 344,mg,O
Sentence: 344,/,O
Sentence: 344,dL,O
Sentence: 344,),O
Sentence: 344,",",O
Sentence: 344,patients,O
Sentence: 344,in,O
Sentence: 344,the,O
Sentence: 344,hypercalcemic,B-Disease
Sentence: 344,group,O
Sentence: 344,exhibited,O
Sentence: 344,a,O
Sentence: 344,significant,O
Sentence: 344,increase,O
Sentence: 344,in,O
Sentence: 344,the,O
Sentence: 344,mean,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,concentration,O
Sentence: 344,obtained,O
Sentence: 344,during,O
Sentence: 344,6,O
Sentence: 344,months,O
Sentence: 344,before,O
Sentence: 344,the,O
Sentence: 344,switch,O
Sentence: 344,",",O
Sentence: 344,compared,O
Sentence: 344,with,O
Sentence: 344,the,O
Sentence: 344,mean,O
Sentence: 344,value,O
Sentence: 344,obtained,O
Sentence: 344,during,O
Sentence: 344,the,O
Sentence: 344,7,O
Sentence: 344,months,O
Sentence: 344,of,O
Sentence: 344,observation,O
Sentence: 344,after,O
Sentence: 344,the,O
Sentence: 344,switch,O
Sentence: 344,(,O
Sentence: 344,2.4,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.03,O
Sentence: 344,to,O
Sentence: 344,2.5,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.03,O
Sentence: 344,mmol,O
Sentence: 344,/,O
Sentence: 344,L,O
Sentence: 344,[,O
Sentence: 344,9.7,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.2,O
Sentence: 344,to,O
Sentence: 344,10.2,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.1,O
Sentence: 344,mg,O
Sentence: 344,/,O
Sentence: 344,dL,O
Sentence: 344,],O
Sentence: 344,",",O
Sentence: 344,P,O
Sentence: 344,,O
Sentence: 344,=,O
Sentence: 344,,O
Sentence: 344,0.006,O
Sentence: 344,),O
Sentence: 344,.,O
Sentence: 344,In,O
Sentence: 344,contrast,O
Sentence: 344,",",O
Sentence: 344,eucalcemic,O
Sentence: 344,patients,O
Sentence: 344,exhibited,O
Sentence: 344,no,O
Sentence: 344,change,O
Sentence: 344,in,O
Sentence: 344,mean,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,values,O
Sentence: 344,over,O
Sentence: 344,the,O
Sentence: 344,same,O
Sentence: 344,time,O
Sentence: 344,period,O
Sentence: 344,(,O
Sentence: 344,2.3,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.05,O
Sentence: 344,to,O
Sentence: 344,2.3,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.05,O
Sentence: 344,mmol,O
Sentence: 344,/,O
Sentence: 344,L,O
Sentence: 344,[,O
Sentence: 344,9.2,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.2,O
Sentence: 344,to,O
Sentence: 344,9.2,O
Sentence: 344,+,O
Sentence: 344,/,O
Sentence: 344,,O
Sentence: 344,-,O
Sentence: 344,,O
Sentence: 344,0.2,O
Sentence: 344,mg,O
Sentence: 344,/,O
Sentence: 344,dL,O
Sentence: 344,],O
Sentence: 344,),O
Sentence: 344,.,O
Sentence: 344,CaCO3,B-Chemical
Sentence: 344,dosage,O
Sentence: 344,",",O
Sentence: 344,calculated,O
Sentence: 344,dietary,O
Sentence: 344,calcium,B-Chemical
Sentence: 344,intake,O
Sentence: 344,",",O
Sentence: 344,and,O
Sentence: 344,circulating,O
Sentence: 344,levels,O
Sentence: 344,of,O
Sentence: 344,vitamin,B-Chemical
Sentence: 344,D,I-Chemical
Sentence: 344,metabolites,O
Sentence: 344,were,O
Sentence: 344,similar,O
Sentence: 344,in,O
Sentence: 344,both,O
Sentence: 344,groups,O
Sentence: 344,.,O
Sentence: 344,Physical,O
Sentence: 344,activity,O
Sentence: 344,index,O
Sentence: 344,and,O
Sentence: 344,predialysis,O
Sentence: 344,serum,O
Sentence: 344,bicarbonate,B-Chemical
Sentence: 344,levels,O
Sentence: 344,also,O
Sentence: 344,were,O
Sentence: 344,similar,O
Sentence: 344,in,O
Sentence: 344,both,O
Sentence: 344,groups,O
Sentence: 344,.,O
Sentence: 344,However,O
Sentence: 344,",",O
Sentence: 344,there,O
Sentence: 344,was,O
Sentence: 344,a,O
Sentence: 344,significant,O
Sentence: 344,difference,O
Sentence: 344,in,O
Sentence: 344,parameters,O
Sentence: 344,reflecting,O
Sentence: 344,bone,O
Sentence: 344,turnover,O
Sentence: 344,rates,O
Sentence: 344,between,O
Sentence: 344,groups,O
Sentence: 344,.,O
Sentence: 344,(,O
Sentence: 344,ABSTRACT,O
Sentence: 344,TRUNCATED,O
Sentence: 344,AT,O
Sentence: 344,250,O
Sentence: 344,WORDS,O
Sentence: 344,),O
Sentence: 345,Methyldopa,B-Chemical
Sentence: 345,-,O
Sentence: 345,induced,O
Sentence: 345,hemolytic,B-Disease
Sentence: 345,anemia,I-Disease
Sentence: 345,in,O
Sentence: 345,a,O
Sentence: 345,15,O
Sentence: 345,year,O
Sentence: 345,old,O
Sentence: 345,presenting,O
Sentence: 345,as,O
Sentence: 345,near,O
Sentence: 345,-,O
Sentence: 345,syncope,B-Disease
Sentence: 345,.,O
Sentence: 346,Methyldopa,B-Chemical
Sentence: 346,is,O
Sentence: 346,an,O
Sentence: 346,antihypertensive,O
Sentence: 346,medication,O
Sentence: 346,which,O
Sentence: 346,is,O
Sentence: 346,available,O
Sentence: 346,generically,O
Sentence: 346,and,O
Sentence: 346,under,O
Sentence: 346,the,O
Sentence: 346,trade,O
Sentence: 346,name,O
Sentence: 346,Aldomet,B-Chemical
Sentence: 346,that,O
Sentence: 346,is,O
Sentence: 346,widely,O
Sentence: 346,prescribed,O
Sentence: 346,in,O
Sentence: 346,the,O
Sentence: 346,adult,O
Sentence: 346,population,O
Sentence: 346,and,O
Sentence: 346,infrequently,O
Sentence: 346,used,O
Sentence: 346,in,O
Sentence: 346,children,O
Sentence: 346,.,O
Sentence: 346,Methyldopa,B-Chemical
Sentence: 346,causes,O
Sentence: 346,an,O
Sentence: 346,autoimmune,B-Disease
Sentence: 346,hemolytic,B-Disease
Sentence: 346,anemia,I-Disease
Sentence: 346,in,O
Sentence: 346,a,O
Sentence: 346,small,O
Sentence: 346,percentage,O
Sentence: 346,of,O
Sentence: 346,patients,O
Sentence: 346,who,O
Sentence: 346,take,O
Sentence: 346,the,O
Sentence: 346,drug,O
Sentence: 346,.,O
Sentence: 346,We,O
Sentence: 346,report,O
Sentence: 346,a,O
Sentence: 346,case,O
Sentence: 346,of,O
Sentence: 346,methyldopa,B-Chemical
Sentence: 346,-,O
Sentence: 346,induced,O
Sentence: 346,hemolytic,B-Disease
Sentence: 346,anemia,I-Disease
Sentence: 346,in,O
Sentence: 346,a,O
Sentence: 346,15,O
Sentence: 346,-,O
Sentence: 346,year,O
Sentence: 346,-,O
Sentence: 346,old,O
Sentence: 346,boy,O
Sentence: 346,who,O
Sentence: 346,presented,O
Sentence: 346,to,O
Sentence: 346,the,O
Sentence: 346,emergency,B-Disease
Sentence: 346,department,I-Disease
Sentence: 346,with,O
Sentence: 346,near,O
Sentence: 346,-,O
Sentence: 346,syncope,B-Disease
Sentence: 346,.,O
Sentence: 346,The,O
Sentence: 346,boy,O
Sentence: 346,had,O
Sentence: 346,been,O
Sentence: 346,treated,O
Sentence: 346,with,O
Sentence: 346,intravenous,O
Sentence: 346,methyldopa,B-Chemical
Sentence: 346,during,O
Sentence: 346,a,O
Sentence: 346,trauma,B-Disease
Sentence: 346,admission,O
Sentence: 346,seven,O
Sentence: 346,weeks,O
Sentence: 346,prior,O
Sentence: 346,to,O
Sentence: 346,presentation,O
Sentence: 346,.,O
Sentence: 346,Evaluation,O
Sentence: 346,revealed,O
Sentence: 346,a,O
Sentence: 346,hemoglobin,O
Sentence: 346,of,O
Sentence: 346,three,O
Sentence: 346,grams,O
Sentence: 346,",",O
Sentence: 346,3+,O
Sentence: 346,Coombs,O
Sentence: 346,',O
Sentence: 346,test,O
Sentence: 346,with,O
Sentence: 346,polyspecific,O
Sentence: 346,anti,O
Sentence: 346,-,O
Sentence: 346,human,O
Sentence: 346,globulin,O
Sentence: 346,and,O
Sentence: 346,monospecific,O
Sentence: 346,IgG,O
Sentence: 346,reagents,O
Sentence: 346,",",O
Sentence: 346,and,O
Sentence: 346,a,O
Sentence: 346,warm,O
Sentence: 346,reacting,O
Sentence: 346,autoantibody,O
Sentence: 346,.,O
Sentence: 346,Transfusion,O
Sentence: 346,and,O
Sentence: 346,corticosteroid,B-Chemical
Sentence: 346,therapy,O
Sentence: 346,resulted,O
Sentence: 346,in,O
Sentence: 346,a,O
Sentence: 346,complete,O
Sentence: 346,recovery,O
Sentence: 346,of,O
Sentence: 346,the,O
Sentence: 346,patient,O
Sentence: 346,.,O
Sentence: 346,Emergency,O
Sentence: 346,physicians,O
Sentence: 346,treating,O
Sentence: 346,children,O
Sentence: 346,must,O
Sentence: 346,be,O
Sentence: 346,aware,O
Sentence: 346,of,O
Sentence: 346,this,O
Sentence: 346,syndrome,O
Sentence: 346,in,O
Sentence: 346,order,O
Sentence: 346,to,O
Sentence: 346,diagnose,O
Sentence: 346,and,O
Sentence: 346,treat,O
Sentence: 346,it,O
Sentence: 346,correctly,O
Sentence: 346,.,O
Sentence: 346,A,O
Sentence: 346,brief,O
Sentence: 346,review,O
Sentence: 346,of,O
Sentence: 346,autoimmune,O
Sentence: 346,and,O
Sentence: 346,drug,O
Sentence: 346,-,O
Sentence: 346,induced,O
Sentence: 346,hemolytic,B-Disease
Sentence: 346,anemias,I-Disease
Sentence: 346,is,O
Sentence: 346,provided,O
Sentence: 346,.,O
Sentence: 347,The,O
Sentence: 347,long,O
Sentence: 347,-,O
Sentence: 347,term,O
Sentence: 347,safety,O
Sentence: 347,of,O
Sentence: 347,danazol,B-Chemical
Sentence: 347,in,O
Sentence: 347,women,O
Sentence: 347,with,O
Sentence: 347,hereditary,B-Disease
Sentence: 347,angioedema,I-Disease
Sentence: 347,.,O
Sentence: 348,Although,O
Sentence: 348,the,O
Sentence: 348,short,O
Sentence: 348,-,O
Sentence: 348,term,O
Sentence: 348,safety,O
Sentence: 348,(,O
Sentence: 348,less,O
Sentence: 348,than,O
Sentence: 348,or,O
Sentence: 348,equal,O
Sentence: 348,to,O
Sentence: 348,6,O
Sentence: 348,months,O
Sentence: 348,),O
Sentence: 348,of,O
Sentence: 348,danazol,B-Chemical
Sentence: 348,has,O
Sentence: 348,been,O
Sentence: 348,established,O
Sentence: 348,in,O
Sentence: 348,a,O
Sentence: 348,variety,O
Sentence: 348,of,O
Sentence: 348,settings,O
Sentence: 348,",",O
Sentence: 348,no,O
Sentence: 348,information,O
Sentence: 348,exists,O
Sentence: 348,as,O
Sentence: 348,to,O
Sentence: 348,its,O
Sentence: 348,long,O
Sentence: 348,-,O
Sentence: 348,term,O
Sentence: 348,safety,O
Sentence: 348,.,O
Sentence: 348,We,O
Sentence: 348,therefore,O
Sentence: 348,investigated,O
Sentence: 348,the,O
Sentence: 348,long,O
Sentence: 348,-,O
Sentence: 348,term,O
Sentence: 348,safety,O
Sentence: 348,of,O
Sentence: 348,danazol,B-Chemical
Sentence: 348,by,O
Sentence: 348,performing,O
Sentence: 348,a,O
Sentence: 348,retrospective,O
Sentence: 348,chart,O
Sentence: 348,review,O
Sentence: 348,of,O
Sentence: 348,60,O
Sentence: 348,female,O
Sentence: 348,patients,O
Sentence: 348,with,O
Sentence: 348,hereditary,B-Disease
Sentence: 348,angioedema,I-Disease
Sentence: 348,treated,O
Sentence: 348,with,O
Sentence: 348,danazol,B-Chemical
Sentence: 348,for,O
Sentence: 348,a,O
Sentence: 348,continuous,O
Sentence: 348,period,O
Sentence: 348,of,O
Sentence: 348,6,O
Sentence: 348,months,O
Sentence: 348,or,O
Sentence: 348,longer,O
Sentence: 348,.,O
Sentence: 348,The,O
Sentence: 348,mean,O
Sentence: 348,age,O
Sentence: 348,of,O
Sentence: 348,the,O
Sentence: 348,patients,O
Sentence: 348,was,O
Sentence: 348,35.2,O
Sentence: 348,years,O
Sentence: 348,and,O
Sentence: 348,the,O
Sentence: 348,mean,O
Sentence: 348,duration,O
Sentence: 348,of,O
Sentence: 348,therapy,O
Sentence: 348,was,O
Sentence: 348,59.7,O
Sentence: 348,months,O
Sentence: 348,.,O
Sentence: 348,Virtually,O
Sentence: 348,all,O
Sentence: 348,patients,O
Sentence: 348,experienced,O
Sentence: 348,one,O
Sentence: 348,or,O
Sentence: 348,more,O
Sentence: 348,adverse,O
Sentence: 348,reactions,O
Sentence: 348,.,O
Sentence: 348,Menstrual,B-Disease
Sentence: 348,abnormalities,I-Disease
Sentence: 348,(,O
Sentence: 348,79,O
Sentence: 348,%,O
Sentence: 348,),O
Sentence: 348,",",O
Sentence: 348,weight,B-Disease
Sentence: 348,gain,I-Disease
Sentence: 348,(,O
Sentence: 348,60,O
Sentence: 348,%,O
Sentence: 348,),O
Sentence: 348,",",O
Sentence: 348,muscle,B-Disease
Sentence: 348,cramps,I-Disease
Sentence: 348,/,O
Sentence: 348,myalgias,B-Disease
Sentence: 348,(,O
Sentence: 348,40,O
Sentence: 348,%,O
Sentence: 348,),O
Sentence: 348,",",O
Sentence: 348,and,O
Sentence: 348,transaminase,O
Sentence: 348,elevations,O
Sentence: 348,(,O
Sentence: 348,40,O
Sentence: 348,%,O
Sentence: 348,),O
Sentence: 348,were,O
Sentence: 348,the,O
Sentence: 348,most,O
Sentence: 348,common,O
Sentence: 348,adverse,O
Sentence: 348,reactions,O
Sentence: 348,.,O
Sentence: 348,The,O
Sentence: 348,drug,O
Sentence: 348,was,O
Sentence: 348,discontinued,O
Sentence: 348,due,O
Sentence: 348,to,O
Sentence: 348,adverse,O
Sentence: 348,reactions,O
Sentence: 348,in,O
Sentence: 348,8,O
Sentence: 348,patients,O
Sentence: 348,.,O
Sentence: 348,No,O
Sentence: 348,patient,O
Sentence: 348,has,O
Sentence: 348,died,O
Sentence: 348,or,O
Sentence: 348,suffered,O
Sentence: 348,any,O
Sentence: 348,apparent,O
Sentence: 348,long,O
Sentence: 348,-,O
Sentence: 348,term,O
Sentence: 348,sequelae,O
Sentence: 348,that,O
Sentence: 348,were,O
Sentence: 348,directly,O
Sentence: 348,attributable,O
Sentence: 348,to,O
Sentence: 348,the,O
Sentence: 348,drug,O
Sentence: 348,.,O
Sentence: 348,We,O
Sentence: 348,conclude,O
Sentence: 348,that,O
Sentence: 348,",",O
Sentence: 348,despite,O
Sentence: 348,a,O
Sentence: 348,relatively,O
Sentence: 348,high,O
Sentence: 348,incidence,O
Sentence: 348,of,O
Sentence: 348,adverse,O
Sentence: 348,reactions,O
Sentence: 348,",",O
Sentence: 348,danazol,B-Chemical
Sentence: 348,has,O
Sentence: 348,proven,O
Sentence: 348,to,O
Sentence: 348,be,O
Sentence: 348,remarkably,O
Sentence: 348,safe,O
Sentence: 348,over,O
Sentence: 348,the,O
Sentence: 348,long,O
Sentence: 348,-,O
Sentence: 348,term,O
Sentence: 348,in,O
Sentence: 348,this,O
Sentence: 348,group,O
Sentence: 348,of,O
Sentence: 348,patients,O
Sentence: 348,.,O
Sentence: 349,Patient,O
Sentence: 349,tolerance,O
Sentence: 349,study,O
Sentence: 349,of,O
Sentence: 349,topical,O
Sentence: 349,chlorhexidine,B-Chemical
Sentence: 349,diphosphanilate,I-Chemical
Sentence: 349,:,O
Sentence: 349,a,O
Sentence: 349,new,O
Sentence: 349,topical,O
Sentence: 349,agent,O
Sentence: 349,for,O
Sentence: 349,burns,B-Disease
Sentence: 349,.,O
Sentence: 350,Effective,O
Sentence: 350,topical,O
Sentence: 350,antimicrobial,O
Sentence: 350,agents,O
Sentence: 350,decrease,O
Sentence: 350,infection,B-Disease
Sentence: 350,and,O
Sentence: 350,mortality,O
Sentence: 350,in,O
Sentence: 350,burn,B-Disease
Sentence: 350,patients,O
Sentence: 350,.,O
Sentence: 350,Chlorhexidine,B-Chemical
Sentence: 350,phosphanilate,I-Chemical
Sentence: 350,(,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,),O
Sentence: 350,",",O
Sentence: 350,a,O
Sentence: 350,new,O
Sentence: 350,broad,O
Sentence: 350,-,O
Sentence: 350,spectrum,O
Sentence: 350,antimicrobial,O
Sentence: 350,agent,O
Sentence: 350,",",O
Sentence: 350,has,O
Sentence: 350,been,O
Sentence: 350,evaluated,O
Sentence: 350,as,O
Sentence: 350,a,O
Sentence: 350,topical,O
Sentence: 350,burn,B-Disease
Sentence: 350,wound,O
Sentence: 350,dressing,O
Sentence: 350,in,O
Sentence: 350,cream,O
Sentence: 350,form,O
Sentence: 350,",",O
Sentence: 350,but,O
Sentence: 350,preliminary,O
Sentence: 350,clinical,O
Sentence: 350,trials,O
Sentence: 350,reported,O
Sentence: 350,that,O
Sentence: 350,it,O
Sentence: 350,was,O
Sentence: 350,painful,O
Sentence: 350,upon,O
Sentence: 350,application,O
Sentence: 350,.,O
Sentence: 350,This,O
Sentence: 350,study,O
Sentence: 350,compared,O
Sentence: 350,various,O
Sentence: 350,concentrations,O
Sentence: 350,of,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,to,O
Sentence: 350,determine,O
Sentence: 350,if,O
Sentence: 350,a,O
Sentence: 350,tolerable,O
Sentence: 350,concentration,O
Sentence: 350,could,O
Sentence: 350,be,O
Sentence: 350,identified,O
Sentence: 350,with,O
Sentence: 350,retention,O
Sentence: 350,of,O
Sentence: 350,antimicrobial,O
Sentence: 350,efficacy,O
Sentence: 350,.,O
Sentence: 350,Twenty,O
Sentence: 350,-,O
Sentence: 350,nine,O
Sentence: 350,burn,B-Disease
Sentence: 350,patients,O
Sentence: 350,",",O
Sentence: 350,each,O
Sentence: 350,with,O
Sentence: 350,two,O
Sentence: 350,similar,O
Sentence: 350,burns,B-Disease
Sentence: 350,which,O
Sentence: 350,could,O
Sentence: 350,be,O
Sentence: 350,separately,O
Sentence: 350,treated,O
Sentence: 350,",",O
Sentence: 350,were,O
Sentence: 350,given,O
Sentence: 350,pairs,O
Sentence: 350,of,O
Sentence: 350,treatments,O
Sentence: 350,at,O
Sentence: 350,successive,O
Sentence: 350,12,O
Sentence: 350,-,O
Sentence: 350,h,O
Sentence: 350,intervals,O
Sentence: 350,over,O
Sentence: 350,a,O
Sentence: 350,3,O
Sentence: 350,-,O
Sentence: 350,day,O
Sentence: 350,period,O
Sentence: 350,.,O
Sentence: 350,One,O
Sentence: 350,burn,B-Disease
Sentence: 350,site,O
Sentence: 350,was,O
Sentence: 350,treated,O
Sentence: 350,with,O
Sentence: 350,each,O
Sentence: 350,of,O
Sentence: 350,four,O
Sentence: 350,different,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,concentrations,O
Sentence: 350,",",O
Sentence: 350,from,O
Sentence: 350,0.25,O
Sentence: 350,per,O
Sentence: 350,cent,O
Sentence: 350,to,O
Sentence: 350,2,O
Sentence: 350,per,O
Sentence: 350,cent,O
Sentence: 350,",",O
Sentence: 350,their,O
Sentence: 350,vehicle,O
Sentence: 350,",",O
Sentence: 350,and,O
Sentence: 350,1,O
Sentence: 350,per,O
Sentence: 350,cent,O
Sentence: 350,silver,B-Chemical
Sentence: 350,sulphadiazine,I-Chemical
Sentence: 350,(,O
Sentence: 350,AgSD,B-Chemical
Sentence: 350,),O
Sentence: 350,cream,O
Sentence: 350,",",O
Sentence: 350,an,O
Sentence: 350,antimicrobial,O
Sentence: 350,agent,O
Sentence: 350,frequently,O
Sentence: 350,used,O
Sentence: 350,for,O
Sentence: 350,topical,O
Sentence: 350,treatment,O
Sentence: 350,of,O
Sentence: 350,burn,B-Disease
Sentence: 350,wounds,O
Sentence: 350,.,O
Sentence: 350,The,O
Sentence: 350,other,O
Sentence: 350,site,O
Sentence: 350,was,O
Sentence: 350,always,O
Sentence: 350,treated,O
Sentence: 350,with,O
Sentence: 350,AgSD,B-Chemical
Sentence: 350,cream,O
Sentence: 350,.,O
Sentence: 350,There,O
Sentence: 350,was,O
Sentence: 350,a,O
Sentence: 350,direct,O
Sentence: 350,relationship,O
Sentence: 350,between,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,concentration,O
Sentence: 350,and,O
Sentence: 350,patients,O
Sentence: 350,',O
Sentence: 350,ratings,O
Sentence: 350,of,O
Sentence: 350,pain,B-Disease
Sentence: 350,on,O
Sentence: 350,an,O
Sentence: 350,analogue,O
Sentence: 350,scale,O
Sentence: 350,.,O
Sentence: 350,The,O
Sentence: 350,0.25,O
Sentence: 350,per,O
Sentence: 350,cent,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,cream,O
Sentence: 350,was,O
Sentence: 350,closest,O
Sentence: 350,to,O
Sentence: 350,AgSD,B-Chemical
Sentence: 350,in,O
Sentence: 350,pain,B-Disease
Sentence: 350,tolerance,O
Sentence: 350,;,O
Sentence: 350,however,O
Sentence: 350,",",O
Sentence: 350,none,O
Sentence: 350,of,O
Sentence: 350,the,O
Sentence: 350,treatments,O
Sentence: 350,differed,O
Sentence: 350,statistically,O
Sentence: 350,from,O
Sentence: 350,AgSD,B-Chemical
Sentence: 350,or,O
Sentence: 350,from,O
Sentence: 350,each,O
Sentence: 350,other,O
Sentence: 350,.,O
Sentence: 350,In,O
Sentence: 350,addition,O
Sentence: 350,",",O
Sentence: 350,ease,O
Sentence: 350,of,O
Sentence: 350,application,O
Sentence: 350,of,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,creams,O
Sentence: 350,was,O
Sentence: 350,less,O
Sentence: 350,satisfactory,O
Sentence: 350,than,O
Sentence: 350,that,O
Sentence: 350,of,O
Sentence: 350,AgSD,B-Chemical
Sentence: 350,.,O
Sentence: 350,It,O
Sentence: 350,was,O
Sentence: 350,concluded,O
Sentence: 350,that,O
Sentence: 350,formulations,O
Sentence: 350,at,O
Sentence: 350,or,O
Sentence: 350,below,O
Sentence: 350,0.5,O
Sentence: 350,per,O
Sentence: 350,cent,O
Sentence: 350,CHP,B-Chemical
Sentence: 350,may,O
Sentence: 350,prove,O
Sentence: 350,acceptable,O
Sentence: 350,for,O
Sentence: 350,wound,O
Sentence: 350,care,O
Sentence: 350,",",O
Sentence: 350,but,O
Sentence: 350,the,O
Sentence: 350,vehicle,O
Sentence: 350,system,O
Sentence: 350,needs,O
Sentence: 350,pharmaceutical,O
Sentence: 350,improvement,O
Sentence: 350,to,O
Sentence: 350,render,O
Sentence: 350,it,O
Sentence: 350,more,O
Sentence: 350,tolerable,O
Sentence: 350,and,O
Sentence: 350,easier,O
Sentence: 350,to,O
Sentence: 350,use,O
Sentence: 350,.,O
Sentence: 351,Dose,O
Sentence: 351,-,O
Sentence: 351,dependent,O
Sentence: 351,neurotoxicity,B-Disease
Sentence: 351,of,O
Sentence: 351,high,O
Sentence: 351,-,O
Sentence: 351,dose,O
Sentence: 351,busulfan,B-Chemical
Sentence: 351,in,O
Sentence: 351,children,O
Sentence: 351,:,O
Sentence: 351,a,O
Sentence: 351,clinical,O
Sentence: 351,and,O
Sentence: 351,pharmacological,O
Sentence: 351,study,O
Sentence: 351,.,O
Sentence: 352,Busulfan,B-Chemical
Sentence: 352,is,O
Sentence: 352,known,O
Sentence: 352,to,O
Sentence: 352,be,O
Sentence: 352,neurotoxic,B-Disease
Sentence: 352,in,O
Sentence: 352,animals,O
Sentence: 352,and,O
Sentence: 352,humans,O
Sentence: 352,",",O
Sentence: 352,but,O
Sentence: 352,its,O
Sentence: 352,acute,O
Sentence: 352,neurotoxicity,B-Disease
Sentence: 352,remains,O
Sentence: 352,poorly,O
Sentence: 352,characterized,O
Sentence: 352,in,O
Sentence: 352,children,O
Sentence: 352,.,O
Sentence: 352,We,O
Sentence: 352,report,O
Sentence: 352,here,O
Sentence: 352,a,O
Sentence: 352,retrospective,O
Sentence: 352,study,O
Sentence: 352,of,O
Sentence: 352,123,O
Sentence: 352,children,O
Sentence: 352,(,O
Sentence: 352,median,O
Sentence: 352,age,O
Sentence: 352,",",O
Sentence: 352,6.5,O
Sentence: 352,years,O
Sentence: 352,),O
Sentence: 352,receiving,O
Sentence: 352,high,O
Sentence: 352,-,O
Sentence: 352,dose,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,in,O
Sentence: 352,combined,O
Sentence: 352,chemotherapy,O
Sentence: 352,before,O
Sentence: 352,bone,O
Sentence: 352,marrow,O
Sentence: 352,transplantation,O
Sentence: 352,for,O
Sentence: 352,malignant,O
Sentence: 352,solid,O
Sentence: 352,tumors,B-Disease
Sentence: 352,",",O
Sentence: 352,brain,B-Disease
Sentence: 352,tumors,I-Disease
Sentence: 352,excluded,O
Sentence: 352,.,O
Sentence: 352,Busulfan,B-Chemical
Sentence: 352,was,O
Sentence: 352,given,O
Sentence: 352,p.o.,O
Sentence: 352,",",O
Sentence: 352,every,O
Sentence: 352,6,O
Sentence: 352,hours,O
Sentence: 352,for,O
Sentence: 352,16,O
Sentence: 352,doses,O
Sentence: 352,over,O
Sentence: 352,4,O
Sentence: 352,days,O
Sentence: 352,.,O
Sentence: 352,Two,O
Sentence: 352,total,O
Sentence: 352,doses,O
Sentence: 352,were,O
Sentence: 352,consecutively,O
Sentence: 352,used,O
Sentence: 352,:,O
Sentence: 352,16,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,kg,O
Sentence: 352,",",O
Sentence: 352,then,O
Sentence: 352,600,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,m2,O
Sentence: 352,.,O
Sentence: 352,The,O
Sentence: 352,dose,O
Sentence: 352,calculation,O
Sentence: 352,on,O
Sentence: 352,the,O
Sentence: 352,basis,O
Sentence: 352,of,O
Sentence: 352,body,O
Sentence: 352,surface,O
Sentence: 352,area,O
Sentence: 352,results,O
Sentence: 352,in,O
Sentence: 352,higher,O
Sentence: 352,doses,O
Sentence: 352,in,O
Sentence: 352,young,O
Sentence: 352,children,O
Sentence: 352,than,O
Sentence: 352,in,O
Sentence: 352,older,O
Sentence: 352,patients,O
Sentence: 352,(,O
Sentence: 352,16,O
Sentence: 352,to,O
Sentence: 352,28,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,kg,O
Sentence: 352,),O
Sentence: 352,.,O
Sentence: 352,Ninety,O
Sentence: 352,-,O
Sentence: 352,six,O
Sentence: 352,patients,O
Sentence: 352,were,O
Sentence: 352,not,O
Sentence: 352,given,O
Sentence: 352,anticonvulsive,O
Sentence: 352,prophylaxis,O
Sentence: 352,;,O
Sentence: 352,7,O
Sentence: 352,(,O
Sentence: 352,7.5,O
Sentence: 352,%,O
Sentence: 352,),O
Sentence: 352,developed,O
Sentence: 352,seizures,B-Disease
Sentence: 352,during,O
Sentence: 352,the,O
Sentence: 352,4,O
Sentence: 352,days,O
Sentence: 352,of,O
Sentence: 352,the,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,course,O
Sentence: 352,or,O
Sentence: 352,within,O
Sentence: 352,24,O
Sentence: 352,h,O
Sentence: 352,after,O
Sentence: 352,the,O
Sentence: 352,last,O
Sentence: 352,dosing,O
Sentence: 352,.,O
Sentence: 352,When,O
Sentence: 352,the,O
Sentence: 352,total,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,dose,O
Sentence: 352,was,O
Sentence: 352,taken,O
Sentence: 352,into,O
Sentence: 352,account,O
Sentence: 352,",",O
Sentence: 352,there,O
Sentence: 352,was,O
Sentence: 352,a,O
Sentence: 352,significant,O
Sentence: 352,difference,O
Sentence: 352,in,O
Sentence: 352,terms,O
Sentence: 352,of,O
Sentence: 352,neurotoxicity,B-Disease
Sentence: 352,incidence,O
Sentence: 352,among,O
Sentence: 352,patients,O
Sentence: 352,under,O
Sentence: 352,16,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,kg,O
Sentence: 352,(,O
Sentence: 352,1,O
Sentence: 352,of,O
Sentence: 352,57,O
Sentence: 352,",",O
Sentence: 352,1.7,O
Sentence: 352,%,O
Sentence: 352,),O
Sentence: 352,and,O
Sentence: 352,patients,O
Sentence: 352,under,O
Sentence: 352,600,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,m2,O
Sentence: 352,(,O
Sentence: 352,6,O
Sentence: 352,of,O
Sentence: 352,39,O
Sentence: 352,",",O
Sentence: 352,15.4,O
Sentence: 352,%,O
Sentence: 352,),O
Sentence: 352,(,O
Sentence: 352,P,O
Sentence: 352,less,O
Sentence: 352,than,O
Sentence: 352,0.02,O
Sentence: 352,),O
Sentence: 352,.,O
Sentence: 352,Twenty,O
Sentence: 352,-,O
Sentence: 352,seven,O
Sentence: 352,patients,O
Sentence: 352,were,O
Sentence: 352,given,O
Sentence: 352,a,O
Sentence: 352,600,O
Sentence: 352,-,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,m2,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,total,O
Sentence: 352,dose,O
Sentence: 352,with,O
Sentence: 352,continuous,O
Sentence: 352,i.v,O
Sentence: 352,.,O
Sentence: 352,infusion,O
Sentence: 352,of,O
Sentence: 352,clonazepam,B-Chemical
Sentence: 352,;,O
Sentence: 352,none,O
Sentence: 352,had,O
Sentence: 352,any,O
Sentence: 352,neurological,B-Disease
Sentence: 352,symptoms,I-Disease
Sentence: 352,.,O
Sentence: 352,Busulfan,B-Chemical
Sentence: 352,levels,O
Sentence: 352,were,O
Sentence: 352,measured,O
Sentence: 352,by,O
Sentence: 352,a,O
Sentence: 352,gas,O
Sentence: 352,chromatographic,O
Sentence: 352,-,O
Sentence: 352,mass,O
Sentence: 352,spectrometry,O
Sentence: 352,assay,O
Sentence: 352,in,O
Sentence: 352,the,O
Sentence: 352,plasma,O
Sentence: 352,and,O
Sentence: 352,cerebrospinal,O
Sentence: 352,fluid,O
Sentence: 352,of,O
Sentence: 352,9,O
Sentence: 352,children,O
Sentence: 352,without,O
Sentence: 352,central,B-Disease
Sentence: 352,nervous,I-Disease
Sentence: 352,system,I-Disease
Sentence: 352,disease,I-Disease
Sentence: 352,under,O
Sentence: 352,600,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,m2,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,with,O
Sentence: 352,clonazepam,B-Chemical
Sentence: 352,:,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,cerebrospinal,O
Sentence: 352,fluid,O
Sentence: 352,:,O
Sentence: 352,plasma,O
Sentence: 352,ratio,O
Sentence: 352,was,O
Sentence: 352,1.39,O
Sentence: 352,.,O
Sentence: 352,This,O
Sentence: 352,was,O
Sentence: 352,significantly,O
Sentence: 352,different,O
Sentence: 352,(,O
Sentence: 352,P,O
Sentence: 352,less,O
Sentence: 352,than,O
Sentence: 352,0.02,O
Sentence: 352,),O
Sentence: 352,from,O
Sentence: 352,the,O
Sentence: 352,cerebrospinal,O
Sentence: 352,fluid,O
Sentence: 352,:,O
Sentence: 352,plasma,O
Sentence: 352,ratio,O
Sentence: 352,previously,O
Sentence: 352,defined,O
Sentence: 352,in,O
Sentence: 352,children,O
Sentence: 352,receiving,O
Sentence: 352,a,O
Sentence: 352,16,O
Sentence: 352,-,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,kg,O
Sentence: 352,total,O
Sentence: 352,dose,O
Sentence: 352,of,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,.,O
Sentence: 352,This,O
Sentence: 352,study,O
Sentence: 352,shows,O
Sentence: 352,that,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,neurotoxicity,B-Disease
Sentence: 352,is,O
Sentence: 352,dose,O
Sentence: 352,-,O
Sentence: 352,dependent,O
Sentence: 352,in,O
Sentence: 352,children,O
Sentence: 352,and,O
Sentence: 352,efficiently,O
Sentence: 352,prevented,O
Sentence: 352,by,O
Sentence: 352,clonazepam,B-Chemical
Sentence: 352,.,O
Sentence: 352,A,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,dose,O
Sentence: 352,calculated,O
Sentence: 352,on,O
Sentence: 352,the,O
Sentence: 352,basis,O
Sentence: 352,of,O
Sentence: 352,body,O
Sentence: 352,surface,O
Sentence: 352,area,O
Sentence: 352,",",O
Sentence: 352,resulting,O
Sentence: 352,in,O
Sentence: 352,higher,O
Sentence: 352,doses,O
Sentence: 352,in,O
Sentence: 352,young,O
Sentence: 352,children,O
Sentence: 352,",",O
Sentence: 352,was,O
Sentence: 352,followed,O
Sentence: 352,by,O
Sentence: 352,increased,O
Sentence: 352,neurotoxicity,B-Disease
Sentence: 352,",",O
Sentence: 352,close,O
Sentence: 352,to,O
Sentence: 352,neurotoxicity,B-Disease
Sentence: 352,incidence,O
Sentence: 352,observed,O
Sentence: 352,in,O
Sentence: 352,adults,O
Sentence: 352,.,O
Sentence: 352,Since,O
Sentence: 352,plasma,O
Sentence: 352,pharmacokinetic,O
Sentence: 352,studies,O
Sentence: 352,showed,O
Sentence: 352,a,O
Sentence: 352,faster,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,clearance,O
Sentence: 352,in,O
Sentence: 352,children,O
Sentence: 352,than,O
Sentence: 352,in,O
Sentence: 352,adults,O
Sentence: 352,",",O
Sentence: 352,this,O
Sentence: 352,new,O
Sentence: 352,dose,O
Sentence: 352,may,O
Sentence: 352,approximate,O
Sentence: 352,more,O
Sentence: 352,closely,O
Sentence: 352,the,O
Sentence: 352,adult,O
Sentence: 352,systemic,O
Sentence: 352,exposure,O
Sentence: 352,obtained,O
Sentence: 352,after,O
Sentence: 352,the,O
Sentence: 352,usual,O
Sentence: 352,16,O
Sentence: 352,-,O
Sentence: 352,mg,O
Sentence: 352,/,O
Sentence: 352,kg,O
Sentence: 352,total,O
Sentence: 352,dose,O
Sentence: 352,",",O
Sentence: 352,with,O
Sentence: 352,potential,O
Sentence: 352,inferences,O
Sentence: 352,in,O
Sentence: 352,terms,O
Sentence: 352,of,O
Sentence: 352,anticancer,O
Sentence: 352,or,O
Sentence: 352,myeloablative,O
Sentence: 352,effects,O
Sentence: 352,.,O
Sentence: 352,The,O
Sentence: 352,busulfan,B-Chemical
Sentence: 352,dose,O
Sentence: 352,in,O
Sentence: 352,children,O
Sentence: 352,and,O
Sentence: 352,infants,O
Sentence: 352,undergoing,O
Sentence: 352,bone,O
Sentence: 352,marrow,O
Sentence: 352,transplantation,O
Sentence: 352,should,O
Sentence: 352,be,O
Sentence: 352,reconsidered,O
Sentence: 352,on,O
Sentence: 352,the,O
Sentence: 352,basis,O
Sentence: 352,of,O
Sentence: 352,pharmacokinetic,O
Sentence: 352,studies,O
Sentence: 352,.,O
Sentence: 353,Histamine,B-Chemical
Sentence: 353,antagonists,O
Sentence: 353,and,O
Sentence: 353,d,O
Sentence: 353,-,O
Sentence: 353,tubocurarine,O
Sentence: 353,-,O
Sentence: 353,induced,O
Sentence: 353,hypotension,B-Disease
Sentence: 353,in,O
Sentence: 353,cardiac,O
Sentence: 353,surgical,O
Sentence: 353,patients,O
Sentence: 353,.,O
Sentence: 354,Hemodynamic,O
Sentence: 354,effects,O
Sentence: 354,and,O
Sentence: 354,histamine,B-Chemical
Sentence: 354,release,O
Sentence: 354,by,O
Sentence: 354,bolus,O
Sentence: 354,injection,O
Sentence: 354,of,O
Sentence: 354,0.35,O
Sentence: 354,mg,O
Sentence: 354,/,O
Sentence: 354,kg,O
Sentence: 354,of,O
Sentence: 354,d,O
Sentence: 354,-,O
Sentence: 354,tubocurarine,O
Sentence: 354,were,O
Sentence: 354,studied,O
Sentence: 354,in,O
Sentence: 354,24,O
Sentence: 354,patients,O
Sentence: 354,.,O
Sentence: 354,H1,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,and,O
Sentence: 354,H2,O
Sentence: 354,-,O
Sentence: 354,histamine,B-Chemical
Sentence: 354,antagonists,O
Sentence: 354,or,O
Sentence: 354,placebo,O
Sentence: 354,were,O
Sentence: 354,given,O
Sentence: 354,before,O
Sentence: 354,dosing,O
Sentence: 354,with,O
Sentence: 354,d,O
Sentence: 354,-,O
Sentence: 354,tubocurarine,O
Sentence: 354,in,O
Sentence: 354,a,O
Sentence: 354,randomized,O
Sentence: 354,double,O
Sentence: 354,-,O
Sentence: 354,blind,O
Sentence: 354,fashion,O
Sentence: 354,to,O
Sentence: 354,four,O
Sentence: 354,groups,O
Sentence: 354,:,O
Sentence: 354,group,O
Sentence: 354,1,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,placebo,O
Sentence: 354,;,O
Sentence: 354,group,O
Sentence: 354,2,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,cimetidine,B-Chemical
Sentence: 354,",",O
Sentence: 354,4,O
Sentence: 354,mg,O
Sentence: 354,/,O
Sentence: 354,kg,O
Sentence: 354,",",O
Sentence: 354,plus,O
Sentence: 354,placebo,O
Sentence: 354,;,O
Sentence: 354,group,O
Sentence: 354,3,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,chlorpheniramine,B-Chemical
Sentence: 354,",",O
Sentence: 354,0.1,O
Sentence: 354,mg,O
Sentence: 354,/,O
Sentence: 354,kg,O
Sentence: 354,",",O
Sentence: 354,plus,O
Sentence: 354,placebo,O
Sentence: 354,;,O
Sentence: 354,and,O
Sentence: 354,group,O
Sentence: 354,4,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,cimetidine,B-Chemical
Sentence: 354,plus,O
Sentence: 354,chlorpheniramine,B-Chemical
Sentence: 354,.,O
Sentence: 354,Histamine,B-Chemical
Sentence: 354,release,O
Sentence: 354,occurred,O
Sentence: 354,in,O
Sentence: 354,most,O
Sentence: 354,patients,O
Sentence: 354,",",O
Sentence: 354,the,O
Sentence: 354,highest,O
Sentence: 354,level,O
Sentence: 354,2,O
Sentence: 354,minutes,O
Sentence: 354,after,O
Sentence: 354,d,O
Sentence: 354,-,O
Sentence: 354,tubocurarine,O
Sentence: 354,dosing,O
Sentence: 354,.,O
Sentence: 354,Group,O
Sentence: 354,1,O
Sentence: 354,had,O
Sentence: 354,a,O
Sentence: 354,moderate,O
Sentence: 354,negative,O
Sentence: 354,correlation,O
Sentence: 354,between,O
Sentence: 354,plasma,O
Sentence: 354,histamine,B-Chemical
Sentence: 354,change,O
Sentence: 354,and,O
Sentence: 354,systemic,O
Sentence: 354,vascular,O
Sentence: 354,resistance,O
Sentence: 354,(,O
Sentence: 354,r,O
Sentence: 354,,O
Sentence: 354,=,O
Sentence: 354,,O
Sentence: 354,0.58,O
Sentence: 354,;,O
Sentence: 354,P,O
Sentence: 354,less,O
Sentence: 354,than,O
Sentence: 354,0.05,O
Sentence: 354,),O
Sentence: 354,not,O
Sentence: 354,present,O
Sentence: 354,in,O
Sentence: 354,group,O
Sentence: 354,4,O
Sentence: 354,.,O
Sentence: 354,Prior,O
Sentence: 354,dosing,O
Sentence: 354,with,O
Sentence: 354,antagonists,O
Sentence: 354,partially,O
Sentence: 354,prevented,O
Sentence: 354,the,O
Sentence: 354,fall,O
Sentence: 354,in,O
Sentence: 354,systemic,O
Sentence: 354,vascular,O
Sentence: 354,resistance,O
Sentence: 354,.,O
Sentence: 354,These,O
Sentence: 354,data,O
Sentence: 354,demonstrate,O
Sentence: 354,that,O
Sentence: 354,the,O
Sentence: 354,hemodynamic,O
Sentence: 354,changes,O
Sentence: 354,associated,O
Sentence: 354,with,O
Sentence: 354,d,O
Sentence: 354,-,O
Sentence: 354,tubocurarine,O
Sentence: 354,dosing,O
Sentence: 354,are,O
Sentence: 354,only,O
Sentence: 354,partially,O
Sentence: 354,explained,O
Sentence: 354,by,O
Sentence: 354,histamine,B-Chemical
Sentence: 354,release,O
Sentence: 354,.,O
Sentence: 354,Thus,O
Sentence: 354,prior,O
Sentence: 354,dosing,O
Sentence: 354,with,O
Sentence: 354,H1,O
Sentence: 354,-,O
Sentence: 354,,O
Sentence: 354,and,O
Sentence: 354,H2,O
Sentence: 354,-,O
Sentence: 354,antagonists,O
Sentence: 354,provides,O
Sentence: 354,only,O
Sentence: 354,partial,O
Sentence: 354,protection,O
Sentence: 354,.,O
Sentence: 355,Convulsant,O
Sentence: 355,effect,O
Sentence: 355,of,O
Sentence: 355,lindane,B-Chemical
Sentence: 355,and,O
Sentence: 355,regional,O
Sentence: 355,brain,O
Sentence: 355,concentration,O
Sentence: 355,of,O
Sentence: 355,GABA,B-Chemical
Sentence: 355,and,O
Sentence: 355,dopamine,B-Chemical
Sentence: 355,.,O
Sentence: 356,Lindane,B-Chemical
Sentence: 356,(,O
Sentence: 356,gamma,O
Sentence: 356,-,O
Sentence: 356,hexachlorocyclohexane,O
Sentence: 356,),O
Sentence: 356,is,O
Sentence: 356,an,O
Sentence: 356,organochlorine,O
Sentence: 356,insecticide,O
Sentence: 356,with,O
Sentence: 356,known,O
Sentence: 356,neurotoxic,B-Disease
Sentence: 356,effects,O
Sentence: 356,.,O
Sentence: 356,Its,O
Sentence: 356,mechanism,O
Sentence: 356,of,O
Sentence: 356,action,O
Sentence: 356,is,O
Sentence: 356,not,O
Sentence: 356,well,O
Sentence: 356,understood,O
Sentence: 356,although,O
Sentence: 356,it,O
Sentence: 356,has,O
Sentence: 356,been,O
Sentence: 356,proposed,O
Sentence: 356,that,O
Sentence: 356,lindane,B-Chemical
Sentence: 356,acts,O
Sentence: 356,as,O
Sentence: 356,a,O
Sentence: 356,non,O
Sentence: 356,-,O
Sentence: 356,competitive,O
Sentence: 356,antagonist,O
Sentence: 356,at,O
Sentence: 356,the,O
Sentence: 356,gamma,O
Sentence: 356,-,O
Sentence: 356,aminobutyric,O
Sentence: 356,acid,O
Sentence: 356,(,O
Sentence: 356,GABA,B-Chemical
Sentence: 356,),O
Sentence: 356,,O
Sentence: 356,-,O
Sentence: 356,A,O
Sentence: 356,receptor,O
Sentence: 356,.,O
Sentence: 356,We,O
Sentence: 356,studied,O
Sentence: 356,the,O
Sentence: 356,effect,O
Sentence: 356,of,O
Sentence: 356,lindane,B-Chemical
Sentence: 356,(,O
Sentence: 356,150,O
Sentence: 356,mg,O
Sentence: 356,/,O
Sentence: 356,kg,O
Sentence: 356,),O
Sentence: 356,on,O
Sentence: 356,the,O
Sentence: 356,GABAergic,O
Sentence: 356,and,O
Sentence: 356,dopaminergic,O
Sentence: 356,systems,O
Sentence: 356,by,O
Sentence: 356,measuring,O
Sentence: 356,the,O
Sentence: 356,concentration,O
Sentence: 356,of,O
Sentence: 356,GABA,B-Chemical
Sentence: 356,",",O
Sentence: 356,dopamine,B-Chemical
Sentence: 356,and,O
Sentence: 356,its,O
Sentence: 356,metabolites,O
Sentence: 356,in,O
Sentence: 356,7,O
Sentence: 356,brain,O
Sentence: 356,areas,O
Sentence: 356,at,O
Sentence: 356,the,O
Sentence: 356,onset,O
Sentence: 356,of,O
Sentence: 356,seizures,B-Disease
Sentence: 356,.,O
Sentence: 356,All,O
Sentence: 356,animals,O
Sentence: 356,suffered,O
Sentence: 356,tonic,O
Sentence: 356,convulsions,B-Disease
Sentence: 356,at,O
Sentence: 356,18.3,O
Sentence: 356,+,O
Sentence: 356,/,O
Sentence: 356,,O
Sentence: 356,-,O
Sentence: 356,,O
Sentence: 356,1.4,O
Sentence: 356,min,O
Sentence: 356,after,O
Sentence: 356,lindane,B-Chemical
Sentence: 356,administration,O
Sentence: 356,.,O
Sentence: 356,The,O
Sentence: 356,concentration,O
Sentence: 356,of,O
Sentence: 356,GABA,B-Chemical
Sentence: 356,was,O
Sentence: 356,only,O
Sentence: 356,slightly,O
Sentence: 356,but,O
Sentence: 356,significantly,O
Sentence: 356,decreased,O
Sentence: 356,in,O
Sentence: 356,the,O
Sentence: 356,colliculi,O
Sentence: 356,without,O
Sentence: 356,modifications,O
Sentence: 356,in,O
Sentence: 356,the,O
Sentence: 356,other,O
Sentence: 356,areas,O
Sentence: 356,.,O
Sentence: 356,The,O
Sentence: 356,concentration,O
Sentence: 356,of,O
Sentence: 356,dopamine,B-Chemical
Sentence: 356,was,O
Sentence: 356,increased,O
Sentence: 356,in,O
Sentence: 356,the,O
Sentence: 356,mesencephalon,O
Sentence: 356,and,O
Sentence: 356,that,O
Sentence: 356,of,O
Sentence: 356,its,O
Sentence: 356,metabolite,O
Sentence: 356,DOPAC,B-Chemical
Sentence: 356,was,O
Sentence: 356,also,O
Sentence: 356,increased,O
Sentence: 356,in,O
Sentence: 356,the,O
Sentence: 356,mesencephalon,O
Sentence: 356,and,O
Sentence: 356,the,O
Sentence: 356,striatum,O
Sentence: 356,.,O
Sentence: 357,Unusual,O
Sentence: 357,complications,O
Sentence: 357,of,O
Sentence: 357,antithyroid,O
Sentence: 357,drug,O
Sentence: 357,therapy,O
Sentence: 357,:,O
Sentence: 357,four,O
Sentence: 357,case,O
Sentence: 357,reports,O
Sentence: 357,and,O
Sentence: 357,review,O
Sentence: 357,of,O
Sentence: 357,literature,O
Sentence: 357,.,O
Sentence: 358,Two,O
Sentence: 358,cases,O
Sentence: 358,of,O
Sentence: 358,propylthiouracil,B-Chemical
Sentence: 358,-,O
Sentence: 358,associated,O
Sentence: 358,acute,O
Sentence: 358,hepatitis,B-Disease
Sentence: 358,",",O
Sentence: 358,one,O
Sentence: 358,case,O
Sentence: 358,of,O
Sentence: 358,fatal,O
Sentence: 358,methimazole,B-Chemical
Sentence: 358,-,O
Sentence: 358,associated,O
Sentence: 358,hepatocellular,B-Disease
Sentence: 358,necrosis,I-Disease
Sentence: 358,and,O
Sentence: 358,one,O
Sentence: 358,case,O
Sentence: 358,of,O
Sentence: 358,propylthiouracil,B-Chemical
Sentence: 358,-,O
Sentence: 358,associated,O
Sentence: 358,lupus,O
Sentence: 358,-,O
Sentence: 358,like,O
Sentence: 358,syndrome,O
Sentence: 358,are,O
Sentence: 358,described,O
Sentence: 358,.,O
Sentence: 358,The,O
Sentence: 358,literature,O
Sentence: 358,related,O
Sentence: 358,to,O
Sentence: 358,antithyroid,O
Sentence: 358,drug,O
Sentence: 358,side,O
Sentence: 358,effects,O
Sentence: 358,and,O
Sentence: 358,the,O
Sentence: 358,mechanisms,O
Sentence: 358,for,O
Sentence: 358,their,O
Sentence: 358,occurrence,O
Sentence: 358,are,O
Sentence: 358,reviewed,O
Sentence: 358,and,O
Sentence: 358,the,O
Sentence: 358,efficacy,O
Sentence: 358,and,O
Sentence: 358,complications,O
Sentence: 358,of,O
Sentence: 358,thyroidectomy,O
Sentence: 358,and,O
Sentence: 358,radioiodine,O
Sentence: 358,compared,O
Sentence: 358,to,O
Sentence: 358,those,O
Sentence: 358,of,O
Sentence: 358,antithyroid,O
Sentence: 358,drugs,O
Sentence: 358,.,O
Sentence: 358,It,O
Sentence: 358,is,O
Sentence: 358,concluded,O
Sentence: 358,that,O
Sentence: 358,in,O
Sentence: 358,most,O
Sentence: 358,circumstances,O
Sentence: 358,131I,O
Sentence: 358,is,O
Sentence: 358,the,O
Sentence: 358,therapy,O
Sentence: 358,of,O
Sentence: 358,choice,O
Sentence: 358,for,O
Sentence: 358,hyperthyroidism,B-Disease
Sentence: 358,.,O
Sentence: 359,Anticonvulsant,O
Sentence: 359,actions,O
Sentence: 359,of,O
Sentence: 359,MK,O
Sentence: 359,-,O
Sentence: 359,801,O
Sentence: 359,on,O
Sentence: 359,the,O
Sentence: 359,lithium,B-Chemical
Sentence: 359,-,O
Sentence: 359,pilocarpine,B-Chemical
Sentence: 359,model,O
Sentence: 359,of,O
Sentence: 359,status,B-Disease
Sentence: 359,epilepticus,I-Disease
Sentence: 359,in,O
Sentence: 359,rats,O
Sentence: 359,.,O
Sentence: 360,MK,O
Sentence: 360,-,O
Sentence: 360,801,O
Sentence: 360,",",O
Sentence: 360,a,O
Sentence: 360,noncompetitive,O
Sentence: 360,N,O
Sentence: 360,-,O
Sentence: 360,methyl,O
Sentence: 360,-,O
Sentence: 360,D,O
Sentence: 360,-,O
Sentence: 360,aspartate,O
Sentence: 360,(,O
Sentence: 360,NMDA,B-Chemical
Sentence: 360,),O
Sentence: 360,receptor,O
Sentence: 360,antagonist,O
Sentence: 360,",",O
Sentence: 360,was,O
Sentence: 360,tested,O
Sentence: 360,for,O
Sentence: 360,anticonvulsant,O
Sentence: 360,effects,O
Sentence: 360,in,O
Sentence: 360,rats,O
Sentence: 360,using,O
Sentence: 360,two,O
Sentence: 360,seizure,B-Disease
Sentence: 360,models,O
Sentence: 360,",",O
Sentence: 360,coadministration,O
Sentence: 360,of,O
Sentence: 360,lithium,B-Chemical
Sentence: 360,and,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,and,O
Sentence: 360,administration,O
Sentence: 360,of,O
Sentence: 360,a,O
Sentence: 360,high,O
Sentence: 360,dose,O
Sentence: 360,of,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,alone,O
Sentence: 360,.,O
Sentence: 360,Three,O
Sentence: 360,major,O
Sentence: 360,results,O
Sentence: 360,are,O
Sentence: 360,reported,O
Sentence: 360,.,O
Sentence: 360,First,O
Sentence: 360,",",O
Sentence: 360,pretreatment,O
Sentence: 360,with,O
Sentence: 360,MK,O
Sentence: 360,-,O
Sentence: 360,801,O
Sentence: 360,produced,O
Sentence: 360,an,O
Sentence: 360,effective,O
Sentence: 360,and,O
Sentence: 360,dose,O
Sentence: 360,-,O
Sentence: 360,dependent,O
Sentence: 360,anticonvulsant,O
Sentence: 360,action,O
Sentence: 360,with,O
Sentence: 360,the,O
Sentence: 360,lithium,B-Chemical
Sentence: 360,-,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,model,O
Sentence: 360,but,O
Sentence: 360,not,O
Sentence: 360,with,O
Sentence: 360,rats,O
Sentence: 360,treated,O
Sentence: 360,with,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,alone,O
Sentence: 360,",",O
Sentence: 360,suggesting,O
Sentence: 360,that,O
Sentence: 360,different,O
Sentence: 360,biochemical,O
Sentence: 360,mechanisms,O
Sentence: 360,control,O
Sentence: 360,seizures,B-Disease
Sentence: 360,in,O
Sentence: 360,these,O
Sentence: 360,two,O
Sentence: 360,models,O
Sentence: 360,.,O
Sentence: 360,Second,O
Sentence: 360,",",O
Sentence: 360,the,O
Sentence: 360,anticonvulsant,O
Sentence: 360,effect,O
Sentence: 360,of,O
Sentence: 360,MK,O
Sentence: 360,-,O
Sentence: 360,801,O
Sentence: 360,in,O
Sentence: 360,the,O
Sentence: 360,lithium,B-Chemical
Sentence: 360,-,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,model,O
Sentence: 360,only,O
Sentence: 360,occurred,O
Sentence: 360,after,O
Sentence: 360,initial,O
Sentence: 360,periods,O
Sentence: 360,of,O
Sentence: 360,seizure,B-Disease
Sentence: 360,activity,O
Sentence: 360,.,O
Sentence: 360,This,O
Sentence: 360,observation,O
Sentence: 360,is,O
Sentence: 360,suggested,O
Sentence: 360,to,O
Sentence: 360,be,O
Sentence: 360,an,O
Sentence: 360,in,O
Sentence: 360,vivo,O
Sentence: 360,demonstration,O
Sentence: 360,of,O
Sentence: 360,the,O
Sentence: 360,conclusion,O
Sentence: 360,derived,O
Sentence: 360,from,O
Sentence: 360,in,O
Sentence: 360,vitro,O
Sentence: 360,experiments,O
Sentence: 360,that,O
Sentence: 360,MK,O
Sentence: 360,-,O
Sentence: 360,801,O
Sentence: 360,binding,O
Sentence: 360,requires,O
Sentence: 360,agonist,O
Sentence: 360,-,O
Sentence: 360,induced,O
Sentence: 360,opening,O
Sentence: 360,of,O
Sentence: 360,the,O
Sentence: 360,channel,O
Sentence: 360,sites,O
Sentence: 360,of,O
Sentence: 360,the,O
Sentence: 360,NMDA,B-Chemical
Sentence: 360,receptor,O
Sentence: 360,.,O
Sentence: 360,Third,O
Sentence: 360,",",O
Sentence: 360,although,O
Sentence: 360,it,O
Sentence: 360,is,O
Sentence: 360,relatively,O
Sentence: 360,easy,O
Sentence: 360,to,O
Sentence: 360,block,O
Sentence: 360,seizures,B-Disease
Sentence: 360,induced,O
Sentence: 360,by,O
Sentence: 360,lithium,B-Chemical
Sentence: 360,and,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,by,O
Sentence: 360,administration,O
Sentence: 360,of,O
Sentence: 360,anticonvulsants,O
Sentence: 360,prior,O
Sentence: 360,to,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,",",O
Sentence: 360,it,O
Sentence: 360,is,O
Sentence: 360,more,O
Sentence: 360,difficult,O
Sentence: 360,to,O
Sentence: 360,terminate,O
Sentence: 360,ongoing,O
Sentence: 360,status,B-Disease
Sentence: 360,epilepticus,I-Disease
Sentence: 360,and,O
Sentence: 360,block,O
Sentence: 360,the,O
Sentence: 360,lethality,O
Sentence: 360,of,O
Sentence: 360,the,O
Sentence: 360,seizures,B-Disease
Sentence: 360,.,O
Sentence: 360,Administration,O
Sentence: 360,of,O
Sentence: 360,MK,O
Sentence: 360,-,O
Sentence: 360,801,O
Sentence: 360,30,O
Sentence: 360,or,O
Sentence: 360,60,O
Sentence: 360,min,O
Sentence: 360,after,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,",",O
Sentence: 360,i.e.,O
Sentence: 360,",",O
Sentence: 360,during,O
Sentence: 360,status,B-Disease
Sentence: 360,epilepticus,I-Disease
Sentence: 360,",",O
Sentence: 360,gradually,O
Sentence: 360,reduced,O
Sentence: 360,electrical,O
Sentence: 360,and,O
Sentence: 360,behavioral,O
Sentence: 360,seizure,B-Disease
Sentence: 360,activity,O
Sentence: 360,and,O
Sentence: 360,greatly,O
Sentence: 360,enhanced,O
Sentence: 360,the,O
Sentence: 360,survival,O
Sentence: 360,rate,O
Sentence: 360,.,O
Sentence: 360,These,O
Sentence: 360,results,O
Sentence: 360,suggest,O
Sentence: 360,that,O
Sentence: 360,activation,O
Sentence: 360,of,O
Sentence: 360,NMDA,B-Chemical
Sentence: 360,receptors,O
Sentence: 360,plays,O
Sentence: 360,an,O
Sentence: 360,important,O
Sentence: 360,role,O
Sentence: 360,in,O
Sentence: 360,status,B-Disease
Sentence: 360,epilepticus,I-Disease
Sentence: 360,and,O
Sentence: 360,brain,B-Disease
Sentence: 360,damage,I-Disease
Sentence: 360,in,O
Sentence: 360,the,O
Sentence: 360,lithium,B-Chemical
Sentence: 360,-,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,model,O
Sentence: 360,.,O
Sentence: 360,This,O
Sentence: 360,was,O
Sentence: 360,further,O
Sentence: 360,supported,O
Sentence: 360,by,O
Sentence: 360,results,O
Sentence: 360,showing,O
Sentence: 360,that,O
Sentence: 360,nonconvulsive,O
Sentence: 360,doses,O
Sentence: 360,of,O
Sentence: 360,NMDA,B-Chemical
Sentence: 360,and,O
Sentence: 360,pilocarpine,B-Chemical
Sentence: 360,were,O
Sentence: 360,synergistic,O
Sentence: 360,",",O
Sentence: 360,resulting,O
Sentence: 360,in,O
Sentence: 360,status,B-Disease
Sentence: 360,epilepticus,I-Disease
Sentence: 360,and,O
Sentence: 360,subsequent,O
Sentence: 360,mortality,O
Sentence: 360,.,O
Sentence: 361,Nifedipine,B-Chemical
Sentence: 361,induced,O
Sentence: 361,bradycardia,B-Disease
Sentence: 361,in,O
Sentence: 361,a,O
Sentence: 361,patient,O
Sentence: 361,with,O
Sentence: 361,autonomic,B-Disease
Sentence: 361,neuropathy,I-Disease
Sentence: 361,.,O
Sentence: 362,An,O
Sentence: 362,80,O
Sentence: 362,year,O
Sentence: 362,old,O
Sentence: 362,diabetic,B-Disease
Sentence: 362,male,O
Sentence: 362,with,O
Sentence: 362,evidence,O
Sentence: 362,of,O
Sentence: 362,peripheral,B-Disease
Sentence: 362,and,I-Disease
Sentence: 362,autonomic,B-Disease
Sentence: 362,neuropathy,I-Disease
Sentence: 362,was,O
Sentence: 362,admitted,O
Sentence: 362,with,O
Sentence: 362,chest,B-Disease
Sentence: 362,pain,I-Disease
Sentence: 362,.,O
Sentence: 362,He,O
Sentence: 362,was,O
Sentence: 362,found,O
Sentence: 362,to,O
Sentence: 362,have,O
Sentence: 362,atrial,B-Disease
Sentence: 362,flutter,I-Disease
Sentence: 362,at,O
Sentence: 362,a,O
Sentence: 362,ventricular,O
Sentence: 362,rate,O
Sentence: 362,of,O
Sentence: 362,70,O
Sentence: 362,/,O
Sentence: 362,min,O
Sentence: 362,which,O
Sentence: 362,slowed,O
Sentence: 362,down,O
Sentence: 362,to,O
Sentence: 362,30,O
Sentence: 362,-,O
Sentence: 362,40,O
Sentence: 362,/,O
Sentence: 362,min,O
Sentence: 362,when,O
Sentence: 362,nifedipine,B-Chemical
Sentence: 362,(,O
Sentence: 362,60,O
Sentence: 362,mg,O
Sentence: 362,),O
Sentence: 362,in,O
Sentence: 362,3,O
Sentence: 362,divided,O
Sentence: 362,doses,O
Sentence: 362,",",O
Sentence: 362,during,O
Sentence: 362,which,O
Sentence: 362,he,O
Sentence: 362,was,O
Sentence: 362,paced,O
Sentence: 362,at,O
Sentence: 362,a,O
Sentence: 362,rate,O
Sentence: 362,of,O
Sentence: 362,70,O
Sentence: 362,/,O
Sentence: 362,min,O
Sentence: 362,.,O
Sentence: 362,This,O
Sentence: 362,is,O
Sentence: 362,inconsistent,O
Sentence: 362,with,O
Sentence: 362,the,O
Sentence: 362,well,O
Sentence: 362,-,O
Sentence: 362,established,O
Sentence: 362,finding,O
Sentence: 362,that,O
Sentence: 362,nifedipine,B-Chemical
Sentence: 362,induces,O
Sentence: 362,tachycardia,B-Disease
Sentence: 362,in,O
Sentence: 362,normally,O
Sentence: 362,innervated,O
Sentence: 362,hearts,O
Sentence: 362,.,O
Sentence: 362,However,O
Sentence: 362,",",O
Sentence: 362,in,O
Sentence: 362,hearts,O
Sentence: 362,deprived,O
Sentence: 362,of,O
Sentence: 362,compensatory,O
Sentence: 362,sympathetic,O
Sentence: 362,drive,O
Sentence: 362,",",O
Sentence: 362,it,O
Sentence: 362,may,O
Sentence: 362,lead,O
Sentence: 362,to,O
Sentence: 362,bradycardia,B-Disease
Sentence: 362,.,O
Sentence: 363,The,O
Sentence: 363,effect,O
Sentence: 363,of,O
Sentence: 363,haloperidol,B-Chemical
Sentence: 363,in,O
Sentence: 363,cocaine,B-Chemical
Sentence: 363,and,O
Sentence: 363,amphetamine,B-Chemical
Sentence: 363,intoxication,O
Sentence: 363,.,O
Sentence: 364,The,O
Sentence: 364,effectiveness,O
Sentence: 364,of,O
Sentence: 364,haloperidol,B-Chemical
Sentence: 364,pretreatment,O
Sentence: 364,in,O
Sentence: 364,preventing,O
Sentence: 364,the,O
Sentence: 364,toxic,O
Sentence: 364,effects,O
Sentence: 364,of,O
Sentence: 364,high,O
Sentence: 364,doses,O
Sentence: 364,of,O
Sentence: 364,amphetamine,B-Chemical
Sentence: 364,and,O
Sentence: 364,cocaine,B-Chemical
Sentence: 364,was,O
Sentence: 364,studied,O
Sentence: 364,in,O
Sentence: 364,rats,O
Sentence: 364,.,O
Sentence: 364,In,O
Sentence: 364,this,O
Sentence: 364,model,O
Sentence: 364,",",O
Sentence: 364,toxic,O
Sentence: 364,effects,O
Sentence: 364,were,O
Sentence: 364,induced,O
Sentence: 364,by,O
Sentence: 364,intraperitoneal,O
Sentence: 364,(,O
Sentence: 364,i.p,O
Sentence: 364,.,O
Sentence: 364,),O
Sentence: 364,injection,O
Sentence: 364,of,O
Sentence: 364,amphetamine,B-Chemical
Sentence: 364,75,O
Sentence: 364,mg,O
Sentence: 364,/,O
Sentence: 364,kg,O
Sentence: 364,(,O
Sentence: 364,100,O
Sentence: 364,%,O
Sentence: 364,death,O
Sentence: 364,rate,O
Sentence: 364,),O
Sentence: 364,or,O
Sentence: 364,cocaine,B-Chemical
Sentence: 364,70,O
Sentence: 364,mg,O
Sentence: 364,/,O
Sentence: 364,kg,O
Sentence: 364,(,O
Sentence: 364,82,O
Sentence: 364,%,O
Sentence: 364,death,O
Sentence: 364,rate,O
Sentence: 364,),O
Sentence: 364,.,O
Sentence: 364,Haloperidol,B-Chemical
Sentence: 364,failed,O
Sentence: 364,to,O
Sentence: 364,prevent,O
Sentence: 364,amphetamine,B-Chemical
Sentence: 364,-,O
Sentence: 364,induced,O
Sentence: 364,seizures,B-Disease
Sentence: 364,",",O
Sentence: 364,but,O
Sentence: 364,did,O
Sentence: 364,lower,O
Sentence: 364,the,O
Sentence: 364,mortality,O
Sentence: 364,rate,O
Sentence: 364,at,O
Sentence: 364,most,O
Sentence: 364,doses,O
Sentence: 364,tested,O
Sentence: 364,.,O
Sentence: 364,Haloperidol,B-Chemical
Sentence: 364,decreased,O
Sentence: 364,the,O
Sentence: 364,incidence,O
Sentence: 364,of,O
Sentence: 364,cocaine,B-Chemical
Sentence: 364,-,O
Sentence: 364,induced,O
Sentence: 364,seizures,B-Disease
Sentence: 364,at,O
Sentence: 364,the,O
Sentence: 364,two,O
Sentence: 364,highest,O
Sentence: 364,doses,O
Sentence: 364,",",O
Sentence: 364,but,O
Sentence: 364,the,O
Sentence: 364,lowering,O
Sentence: 364,of,O
Sentence: 364,the,O
Sentence: 364,mortality,O
Sentence: 364,rate,O
Sentence: 364,did,O
Sentence: 364,not,O
Sentence: 364,reach,O
Sentence: 364,statistical,O
Sentence: 364,significance,O
Sentence: 364,at,O
Sentence: 364,any,O
Sentence: 364,dose,O
Sentence: 364,.,O
Sentence: 364,These,O
Sentence: 364,data,O
Sentence: 364,suggest,O
Sentence: 364,a,O
Sentence: 364,protective,O
Sentence: 364,role,O
Sentence: 364,for,O
Sentence: 364,the,O
Sentence: 364,central,O
Sentence: 364,dopamine,B-Chemical
Sentence: 364,blocker,O
Sentence: 364,haloperidol,B-Chemical
Sentence: 364,against,O
Sentence: 364,death,O
Sentence: 364,from,O
Sentence: 364,high,O
Sentence: 364,-,O
Sentence: 364,dose,O
Sentence: 364,amphetamine,B-Chemical
Sentence: 364,exposure,O
Sentence: 364,without,O
Sentence: 364,reducing,O
Sentence: 364,the,O
Sentence: 364,incidence,O
Sentence: 364,of,O
Sentence: 364,seizures,B-Disease
Sentence: 364,.,O
Sentence: 364,In,O
Sentence: 364,contrast,O
Sentence: 364,",",O
Sentence: 364,haloperidol,B-Chemical
Sentence: 364,demonstrated,O
Sentence: 364,an,O
Sentence: 364,ability,O
Sentence: 364,to,O
Sentence: 364,reduce,O
Sentence: 364,cocaine,B-Chemical
Sentence: 364,-,O
Sentence: 364,induced,O
Sentence: 364,seizures,B-Disease
Sentence: 364,without,O
Sentence: 364,significantly,O
Sentence: 364,reducing,O
Sentence: 364,mortality,O
Sentence: 364,.,O
Sentence: 365,Autoradiographic,O
Sentence: 365,evidence,O
Sentence: 365,of,O
Sentence: 365,estrogen,B-Chemical
Sentence: 365,binding,O
Sentence: 365,sites,O
Sentence: 365,in,O
Sentence: 365,nuclei,O
Sentence: 365,of,O
Sentence: 365,diethylstilbesterol,B-Chemical
Sentence: 365,induced,O
Sentence: 365,hamster,O
Sentence: 365,renal,B-Disease
Sentence: 365,carcinomas,I-Disease
Sentence: 365,.,O
Sentence: 366,Estrogen,B-Chemical
Sentence: 366,binding,O
Sentence: 366,sites,O
Sentence: 366,were,O
Sentence: 366,demonstrated,O
Sentence: 366,by,O
Sentence: 366,autoradiography,O
Sentence: 366,in,O
Sentence: 366,one,O
Sentence: 366,transplantable,O
Sentence: 366,and,O
Sentence: 366,five,O
Sentence: 366,primary,O
Sentence: 366,diethylstilbesterol,B-Chemical
Sentence: 366,induced,O
Sentence: 366,renal,B-Disease
Sentence: 366,carcinomas,I-Disease
Sentence: 366,in,O
Sentence: 366,three,O
Sentence: 366,hamsters,O
Sentence: 366,.,O
Sentence: 366,Radiolabelling,O
Sentence: 366,",",O
Sentence: 366,following,O
Sentence: 366,the,O
Sentence: 366,in,O
Sentence: 366,vivo,O
Sentence: 366,injection,O
Sentence: 366,of,O
Sentence: 366,3H,O
Sentence: 366,-,O
Sentence: 366,17,O
Sentence: 366,beta,O
Sentence: 366,estradiol,B-Chemical
Sentence: 366,",",O
Sentence: 366,was,O
Sentence: 366,increased,O
Sentence: 366,only,O
Sentence: 366,over,O
Sentence: 366,the,O
Sentence: 366,nuclei,O
Sentence: 366,of,O
Sentence: 366,tumor,B-Disease
Sentence: 366,cells,O
Sentence: 366,;,O
Sentence: 366,stereologic,O
Sentence: 366,analysis,O
Sentence: 366,revealed,O
Sentence: 366,a,O
Sentence: 366,4.5,O
Sentence: 366,-,O
Sentence: 366,,O
Sentence: 366,to,O
Sentence: 366,6.7,O
Sentence: 366,-,O
Sentence: 366,times,O
Sentence: 366,higher,O
Sentence: 366,concentration,O
Sentence: 366,of,O
Sentence: 366,reduced,O
Sentence: 366,silver,B-Chemical
Sentence: 366,grains,O
Sentence: 366,over,O
Sentence: 366,nuclei,O
Sentence: 366,than,O
Sentence: 366,cytoplasm,O
Sentence: 366,of,O
Sentence: 366,these,O
Sentence: 366,cells,O
Sentence: 366,.,O
Sentence: 366,Despite,O
Sentence: 366,rapid,O
Sentence: 366,tubular,O
Sentence: 366,excretion,O
Sentence: 366,of,O
Sentence: 366,estradiol,B-Chemical
Sentence: 366,which,O
Sentence: 366,peaked,O
Sentence: 366,in,O
Sentence: 366,less,O
Sentence: 366,than,O
Sentence: 366,1,O
Sentence: 366,h,O
Sentence: 366,",",O
Sentence: 366,the,O
Sentence: 366,normal,O
Sentence: 366,cells,O
Sentence: 366,did,O
Sentence: 366,not,O
Sentence: 366,appear,O
Sentence: 366,to,O
Sentence: 366,bind,O
Sentence: 366,the,O
Sentence: 366,ligand,O
Sentence: 366,.,O
Sentence: 366,This,O
Sentence: 366,is,O
Sentence: 366,the,O
Sentence: 366,first,O
Sentence: 366,published,O
Sentence: 366,report,O
Sentence: 366,documenting,O
Sentence: 366,the,O
Sentence: 366,preferential,O
Sentence: 366,in,O
Sentence: 366,vivo,O
Sentence: 366,binding,O
Sentence: 366,of,O
Sentence: 366,estrogen,B-Chemical
Sentence: 366,to,O
Sentence: 366,nuclei,O
Sentence: 366,of,O
Sentence: 366,cells,O
Sentence: 366,in,O
Sentence: 366,estrogen,B-Chemical
Sentence: 366,induced,O
Sentence: 366,hamster,O
Sentence: 366,renal,B-Disease
Sentence: 366,carcinomas,I-Disease
Sentence: 366,.,O
Sentence: 367,Bradycardia,B-Disease
Sentence: 367,due,O
Sentence: 367,to,O
Sentence: 367,biperiden,B-Chemical
Sentence: 367,.,O
Sentence: 368,In,O
Sentence: 368,a,O
Sentence: 368,38,O
Sentence: 368,-,O
Sentence: 368,year,O
Sentence: 368,-,O
Sentence: 368,old,O
Sentence: 368,male,O
Sentence: 368,patient,O
Sentence: 368,suffering,O
Sentence: 368,from,O
Sentence: 368,a,O
Sentence: 368,severe,O
Sentence: 368,postzosteric,B-Disease
Sentence: 368,trigeminal,B-Disease
Sentence: 368,neuralgia,I-Disease
Sentence: 368,",",O
Sentence: 368,intravenous,O
Sentence: 368,application,O
Sentence: 368,of,O
Sentence: 368,10,O
Sentence: 368,mg,O
Sentence: 368,biperiden,B-Chemical
Sentence: 368,lactate,I-Chemical
Sentence: 368,led,O
Sentence: 368,to,O
Sentence: 368,a,O
Sentence: 368,long,O
Sentence: 368,-,O
Sentence: 368,lasting,O
Sentence: 368,paradoxical,O
Sentence: 368,reaction,O
Sentence: 368,characterized,O
Sentence: 368,by,O
Sentence: 368,considerable,O
Sentence: 368,bradycardia,B-Disease
Sentence: 368,",",O
Sentence: 368,dysarthria,B-Disease
Sentence: 368,",",O
Sentence: 368,and,O
Sentence: 368,dysphagia,B-Disease
Sentence: 368,.,O
Sentence: 368,The,O
Sentence: 368,heart,O
Sentence: 368,rate,O
Sentence: 368,was,O
Sentence: 368,back,O
Sentence: 368,to,O
Sentence: 368,normal,O
Sentence: 368,within,O
Sentence: 368,12,O
Sentence: 368,hours,O
Sentence: 368,upon,O
Sentence: 368,administration,O
Sentence: 368,of,O
Sentence: 368,orciprenaline,B-Chemical
Sentence: 368,under,O
Sentence: 368,cardiac,O
Sentence: 368,monitoring,O
Sentence: 368,in,O
Sentence: 368,an,O
Sentence: 368,intensive,O
Sentence: 368,care,O
Sentence: 368,unit,O
Sentence: 368,.,O
Sentence: 368,Bradycardia,B-Disease
Sentence: 368,induced,O
Sentence: 368,by,O
Sentence: 368,biperiden,B-Chemical
Sentence: 368,is,O
Sentence: 368,attributed,O
Sentence: 368,to,O
Sentence: 368,the,O
Sentence: 368,speed,O
Sentence: 368,of,O
Sentence: 368,injection,O
Sentence: 368,and,O
Sentence: 368,to,O
Sentence: 368,a,O
Sentence: 368,dose,O
Sentence: 368,-,O
Sentence: 368,related,O
Sentence: 368,dual,O
Sentence: 368,effect,O
Sentence: 368,of,O
Sentence: 368,atropine,B-Chemical
Sentence: 368,-,O
Sentence: 368,like,O
Sentence: 368,drugs,O
Sentence: 368,on,O
Sentence: 368,muscarine,B-Chemical
Sentence: 368,receptors,O
Sentence: 368,.,O
Sentence: 369,Deliberate,O
Sentence: 369,hypotension,B-Disease
Sentence: 369,induced,O
Sentence: 369,by,O
Sentence: 369,labetalol,B-Chemical
Sentence: 369,with,O
Sentence: 369,halothane,B-Chemical
Sentence: 369,",",O
Sentence: 369,enflurane,B-Chemical
Sentence: 369,or,O
Sentence: 369,isoflurane,B-Chemical
Sentence: 369,for,O
Sentence: 369,middle,O
Sentence: 369,-,O
Sentence: 369,ear,O
Sentence: 369,surgery,O
Sentence: 369,.,O
Sentence: 370,The,O
Sentence: 370,feasibility,O
Sentence: 370,of,O
Sentence: 370,using,O
Sentence: 370,labetalol,B-Chemical
Sentence: 370,",",O
Sentence: 370,an,O
Sentence: 370,alpha,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,and,O
Sentence: 370,beta,O
Sentence: 370,-,O
Sentence: 370,adrenergic,O
Sentence: 370,blocking,O
Sentence: 370,agent,O
Sentence: 370,",",O
Sentence: 370,as,O
Sentence: 370,a,O
Sentence: 370,hypotensive,B-Disease
Sentence: 370,agent,O
Sentence: 370,in,O
Sentence: 370,combination,O
Sentence: 370,with,O
Sentence: 370,inhalation,O
Sentence: 370,anaesthetics,O
Sentence: 370,(,O
Sentence: 370,halothane,B-Chemical
Sentence: 370,",",O
Sentence: 370,enflurane,B-Chemical
Sentence: 370,or,O
Sentence: 370,isoflurane,B-Chemical
Sentence: 370,),O
Sentence: 370,was,O
Sentence: 370,studied,O
Sentence: 370,in,O
Sentence: 370,23,O
Sentence: 370,adult,O
Sentence: 370,patients,O
Sentence: 370,undergoing,O
Sentence: 370,middle,O
Sentence: 370,-,O
Sentence: 370,ear,O
Sentence: 370,surgery,O
Sentence: 370,.,O
Sentence: 370,The,O
Sentence: 370,mean,O
Sentence: 370,arterial,O
Sentence: 370,pressure,O
Sentence: 370,was,O
Sentence: 370,decreased,O
Sentence: 370,from,O
Sentence: 370,86,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,5,O
Sentence: 370,(,O
Sentence: 370,s.e,O
Sentence: 370,.,O
Sentence: 370,mean,O
Sentence: 370,),O
Sentence: 370,mmHg,O
Sentence: 370,to,O
Sentence: 370,52,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,1,O
Sentence: 370,mmHg,O
Sentence: 370,(,O
Sentence: 370,11.5,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.7,O
Sentence: 370,to,O
Sentence: 370,6.9,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.1,O
Sentence: 370,kPa,O
Sentence: 370,),O
Sentence: 370,for,O
Sentence: 370,98,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,10,O
Sentence: 370,min,O
Sentence: 370,in,O
Sentence: 370,the,O
Sentence: 370,halothane,B-Chemical
Sentence: 370,(,O
Sentence: 370,H,B-Chemical
Sentence: 370,),O
Sentence: 370,group,O
Sentence: 370,",",O
Sentence: 370,from,O
Sentence: 370,79,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,5,O
Sentence: 370,to,O
Sentence: 370,53,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,1,O
Sentence: 370,mmHg,O
Sentence: 370,(,O
Sentence: 370,10.5,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.7,O
Sentence: 370,to,O
Sentence: 370,7.1,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.1,O
Sentence: 370,kPa,O
Sentence: 370,),O
Sentence: 370,for,O
Sentence: 370,129,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,11,O
Sentence: 370,min,O
Sentence: 370,in,O
Sentence: 370,the,O
Sentence: 370,enflurane,B-Chemical
Sentence: 370,(,O
Sentence: 370,E,B-Chemical
Sentence: 370,),O
Sentence: 370,group,O
Sentence: 370,",",O
Sentence: 370,and,O
Sentence: 370,from,O
Sentence: 370,80,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,4,O
Sentence: 370,to,O
Sentence: 370,49,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,1,O
Sentence: 370,mmHg,O
Sentence: 370,(,O
Sentence: 370,10.7,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.5,O
Sentence: 370,to,O
Sentence: 370,6.5,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.1,O
Sentence: 370,kPa,O
Sentence: 370,),O
Sentence: 370,for,O
Sentence: 370,135,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,15,O
Sentence: 370,min,O
Sentence: 370,in,O
Sentence: 370,the,O
Sentence: 370,isoflurane,B-Chemical
Sentence: 370,(,O
Sentence: 370,I,B-Chemical
Sentence: 370,),O
Sentence: 370,group,O
Sentence: 370,.,O
Sentence: 370,The,O
Sentence: 370,mean,O
Sentence: 370,H,B-Chemical
Sentence: 370,concentration,O
Sentence: 370,during,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,in,O
Sentence: 370,the,O
Sentence: 370,inspiratory,O
Sentence: 370,gas,O
Sentence: 370,was,O
Sentence: 370,0.7,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.1,O
Sentence: 370,vol,O
Sentence: 370,%,O
Sentence: 370,",",O
Sentence: 370,the,O
Sentence: 370,mean,O
Sentence: 370,E,B-Chemical
Sentence: 370,concentration,O
Sentence: 370,1.6,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.2,O
Sentence: 370,vol,O
Sentence: 370,%,O
Sentence: 370,",",O
Sentence: 370,and,O
Sentence: 370,the,O
Sentence: 370,mean,O
Sentence: 370,I,B-Chemical
Sentence: 370,concentration,O
Sentence: 370,1.0,O
Sentence: 370,+,O
Sentence: 370,/,O
Sentence: 370,,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,0.1,O
Sentence: 370,vol,O
Sentence: 370,%,O
Sentence: 370,.,O
Sentence: 370,In,O
Sentence: 370,addition,O
Sentence: 370,",",O
Sentence: 370,the,O
Sentence: 370,patients,O
Sentence: 370,received,O
Sentence: 370,fentanyl,B-Chemical
Sentence: 370,and,O
Sentence: 370,d,O
Sentence: 370,-,O
Sentence: 370,tubocurarine,O
Sentence: 370,.,O
Sentence: 370,The,O
Sentence: 370,initial,O
Sentence: 370,dose,O
Sentence: 370,of,O
Sentence: 370,labetalol,B-Chemical
Sentence: 370,for,O
Sentence: 370,lowering,O
Sentence: 370,blood,O
Sentence: 370,pressure,O
Sentence: 370,was,O
Sentence: 370,similar,O
Sentence: 370,",",O
Sentence: 370,0.52,O
Sentence: 370,-,O
Sentence: 370,0.59,O
Sentence: 370,mg,O
Sentence: 370,/,O
Sentence: 370,kg,O
Sentence: 370,",",O
Sentence: 370,in,O
Sentence: 370,all,O
Sentence: 370,the,O
Sentence: 370,groups,O
Sentence: 370,.,O
Sentence: 370,During,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,",",O
Sentence: 370,the,O
Sentence: 370,heart,O
Sentence: 370,rate,O
Sentence: 370,was,O
Sentence: 370,stable,O
Sentence: 370,without,O
Sentence: 370,tachy,O
Sentence: 370,-,O
Sentence: 370,,O
Sentence: 370,or,O
Sentence: 370,bradycardia,O
Sentence: 370,.,O
Sentence: 370,The,O
Sentence: 370,operating,O
Sentence: 370,conditions,O
Sentence: 370,regarding,O
Sentence: 370,bleeding,B-Disease
Sentence: 370,were,O
Sentence: 370,estimated,O
Sentence: 370,in,O
Sentence: 370,a,O
Sentence: 370,double,O
Sentence: 370,-,O
Sentence: 370,blind,O
Sentence: 370,manner,O
Sentence: 370,",",O
Sentence: 370,and,O
Sentence: 370,did,O
Sentence: 370,not,O
Sentence: 370,differ,O
Sentence: 370,significantly,O
Sentence: 370,between,O
Sentence: 370,the,O
Sentence: 370,groups,O
Sentence: 370,.,O
Sentence: 370,During,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,",",O
Sentence: 370,the,O
Sentence: 370,serum,O
Sentence: 370,creatinine,B-Chemical
Sentence: 370,concentration,O
Sentence: 370,rose,O
Sentence: 370,significantly,O
Sentence: 370,in,O
Sentence: 370,all,O
Sentence: 370,groups,O
Sentence: 370,from,O
Sentence: 370,the,O
Sentence: 370,values,O
Sentence: 370,before,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,and,O
Sentence: 370,returned,O
Sentence: 370,postoperatively,O
Sentence: 370,to,O
Sentence: 370,the,O
Sentence: 370,initial,O
Sentence: 370,level,O
Sentence: 370,in,O
Sentence: 370,the,O
Sentence: 370,other,O
Sentence: 370,groups,O
Sentence: 370,",",O
Sentence: 370,except,O
Sentence: 370,the,O
Sentence: 370,isoflurane,B-Chemical
Sentence: 370,group,O
Sentence: 370,.,O
Sentence: 370,After,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,there,O
Sentence: 370,was,O
Sentence: 370,no,O
Sentence: 370,rebound,O
Sentence: 370,phenomenon,O
Sentence: 370,in,O
Sentence: 370,either,O
Sentence: 370,blood,O
Sentence: 370,pressure,O
Sentence: 370,or,O
Sentence: 370,heart,O
Sentence: 370,rate,O
Sentence: 370,.,O
Sentence: 370,These,O
Sentence: 370,results,O
Sentence: 370,indicate,O
Sentence: 370,that,O
Sentence: 370,labetalol,B-Chemical
Sentence: 370,induces,O
Sentence: 370,easily,O
Sentence: 370,adjustable,O
Sentence: 370,hypotension,B-Disease
Sentence: 370,without,O
Sentence: 370,compensatory,O
Sentence: 370,tachycardia,B-Disease
Sentence: 370,and,O
Sentence: 370,rebound,O
Sentence: 370,hypertension,B-Disease
Sentence: 370,.,O
Sentence: 371,Convulsion,B-Disease
Sentence: 371,following,O
Sentence: 371,intravenous,O
Sentence: 371,fluorescein,B-Chemical
Sentence: 371,angiography,O
Sentence: 371,.,O
Sentence: 372,Tonic,O
Sentence: 372,-,O
Sentence: 372,clonic,O
Sentence: 372,seizures,O
Sentence: 372,followed,O
Sentence: 372,intravenous,O
Sentence: 372,fluorescein,B-Chemical
Sentence: 372,injection,O
Sentence: 372,for,O
Sentence: 372,fundus,O
Sentence: 372,angiography,O
Sentence: 372,in,O
Sentence: 372,a,O
Sentence: 372,47,O
Sentence: 372,-,O
Sentence: 372,year,O
Sentence: 372,-,O
Sentence: 372,old,O
Sentence: 372,male,O
Sentence: 372,.,O
Sentence: 372,Despite,O
Sentence: 372,precautions,O
Sentence: 372,this,O
Sentence: 372,adverse,O
Sentence: 372,reaction,O
Sentence: 372,recurred,O
Sentence: 372,on,O
Sentence: 372,re,O
Sentence: 372,-,O
Sentence: 372,exposure,O
Sentence: 372,to,O
Sentence: 372,intravenous,O
Sentence: 372,fluorescein,B-Chemical
Sentence: 372,.,O
Sentence: 373,Pharmacology,O
Sentence: 373,of,O
Sentence: 373,ACC,O
Sentence: 373,-,O
Sentence: 373,9653,O
Sentence: 373,(,O
Sentence: 373,phenytoin,B-Chemical
Sentence: 373,prodrug,O
Sentence: 373,),O
Sentence: 373,.,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,",",O
Sentence: 374,the,O
Sentence: 374,disodium,B-Chemical
Sentence: 374,phosphate,I-Chemical
Sentence: 374,ester,I-Chemical
Sentence: 374,of,O
Sentence: 374,3,O
Sentence: 374,-,O
Sentence: 374,hydroxymethyl,O
Sentence: 374,-,O
Sentence: 374,"5,5",O
Sentence: 374,-,O
Sentence: 374,diphenylhydantoin,O
Sentence: 374,",",O
Sentence: 374,is,O
Sentence: 374,a,O
Sentence: 374,prodrug,O
Sentence: 374,of,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,with,O
Sentence: 374,advantageous,O
Sentence: 374,physicochemical,O
Sentence: 374,properties,O
Sentence: 374,.,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,is,O
Sentence: 374,rapidly,O
Sentence: 374,converted,O
Sentence: 374,enzymatically,O
Sentence: 374,to,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,in,O
Sentence: 374,vivo,O
Sentence: 374,.,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,and,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,have,O
Sentence: 374,equivalent,O
Sentence: 374,anticonvulsant,O
Sentence: 374,activity,O
Sentence: 374,against,O
Sentence: 374,seizures,B-Disease
Sentence: 374,induced,O
Sentence: 374,by,O
Sentence: 374,maximal,O
Sentence: 374,electroshock,O
Sentence: 374,(,O
Sentence: 374,MES,O
Sentence: 374,),O
Sentence: 374,in,O
Sentence: 374,mice,O
Sentence: 374,following,O
Sentence: 374,i.p.,O
Sentence: 374,",",O
Sentence: 374,oral,O
Sentence: 374,",",O
Sentence: 374,or,O
Sentence: 374,i.v,O
Sentence: 374,.,O
Sentence: 374,administration,O
Sentence: 374,.,O
Sentence: 374,The,O
Sentence: 374,ED50,O
Sentence: 374,doses,O
Sentence: 374,were,O
Sentence: 374,16,O
Sentence: 374,mg,O
Sentence: 374,/,O
Sentence: 374,kg,O
Sentence: 374,for,O
Sentence: 374,i.v,O
Sentence: 374,.,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,and,O
Sentence: 374,8,O
Sentence: 374,mg,O
Sentence: 374,/,O
Sentence: 374,kg,O
Sentence: 374,for,O
Sentence: 374,i.v,O
Sentence: 374,.,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,.,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,and,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,have,O
Sentence: 374,similar,O
Sentence: 374,antiarrhythmic,O
Sentence: 374,activity,O
Sentence: 374,against,O
Sentence: 374,ouabain,B-Chemical
Sentence: 374,-,O
Sentence: 374,induced,O
Sentence: 374,ventricular,B-Disease
Sentence: 374,tachycardia,I-Disease
Sentence: 374,in,O
Sentence: 374,anesthetized,O
Sentence: 374,dogs,O
Sentence: 374,.,O
Sentence: 374,The,O
Sentence: 374,total,O
Sentence: 374,doses,O
Sentence: 374,of,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,or,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,necessary,O
Sentence: 374,to,O
Sentence: 374,convert,O
Sentence: 374,the,O
Sentence: 374,arrhythmia,B-Disease
Sentence: 374,to,O
Sentence: 374,a,O
Sentence: 374,normal,O
Sentence: 374,sinus,O
Sentence: 374,rhythm,O
Sentence: 374,were,O
Sentence: 374,24,O
Sentence: 374,+,O
Sentence: 374,/,O
Sentence: 374,,O
Sentence: 374,-,O
Sentence: 374,,O
Sentence: 374,6,O
Sentence: 374,and,O
Sentence: 374,14,O
Sentence: 374,+,O
Sentence: 374,/,O
Sentence: 374,,O
Sentence: 374,-,O
Sentence: 374,,O
Sentence: 374,3,O
Sentence: 374,mg,O
Sentence: 374,/,O
Sentence: 374,kg,O
Sentence: 374,",",O
Sentence: 374,respectively,O
Sentence: 374,.,O
Sentence: 374,Only,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,displayed,O
Sentence: 374,in,O
Sentence: 374,vitro,O
Sentence: 374,antiarrhythmic,O
Sentence: 374,activity,O
Sentence: 374,against,O
Sentence: 374,strophanthidin,B-Chemical
Sentence: 374,-,O
Sentence: 374,induced,O
Sentence: 374,arrhythmias,B-Disease
Sentence: 374,in,O
Sentence: 374,guinea,O
Sentence: 374,pig,O
Sentence: 374,right,O
Sentence: 374,atria,O
Sentence: 374,.,O
Sentence: 374,In,O
Sentence: 374,anesthetized,O
Sentence: 374,dogs,O
Sentence: 374,",",O
Sentence: 374,a,O
Sentence: 374,high,O
Sentence: 374,dose,O
Sentence: 374,of,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,(,O
Sentence: 374,31,O
Sentence: 374,mg,O
Sentence: 374,/,O
Sentence: 374,kg,O
Sentence: 374,),O
Sentence: 374,was,O
Sentence: 374,infused,O
Sentence: 374,over,O
Sentence: 374,15,O
Sentence: 374,",",O
Sentence: 374,20,O
Sentence: 374,",",O
Sentence: 374,and,O
Sentence: 374,30,O
Sentence: 374,min,O
Sentence: 374,and,O
Sentence: 374,the,O
Sentence: 374,responses,O
Sentence: 374,were,O
Sentence: 374,compared,O
Sentence: 374,to,O
Sentence: 374,an,O
Sentence: 374,equimolar,O
Sentence: 374,dose,O
Sentence: 374,of,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,(,O
Sentence: 374,21,O
Sentence: 374,mg,O
Sentence: 374,/,O
Sentence: 374,kg,O
Sentence: 374,),O
Sentence: 374,.,O
Sentence: 374,The,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,and,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,treatments,O
Sentence: 374,produced,O
Sentence: 374,similar,O
Sentence: 374,marked,O
Sentence: 374,reductions,O
Sentence: 374,in,O
Sentence: 374,diastolic,O
Sentence: 374,blood,O
Sentence: 374,pressure,O
Sentence: 374,and,O
Sentence: 374,contractile,O
Sentence: 374,force,O
Sentence: 374,(,O
Sentence: 374,LVdP,O
Sentence: 374,/,O
Sentence: 374,dt,O
Sentence: 374,),O
Sentence: 374,.,O
Sentence: 374,The,O
Sentence: 374,maximum,O
Sentence: 374,effects,O
Sentence: 374,of,O
Sentence: 374,each,O
Sentence: 374,treatment,O
Sentence: 374,occurred,O
Sentence: 374,at,O
Sentence: 374,the,O
Sentence: 374,time,O
Sentence: 374,of,O
Sentence: 374,maximum,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,levels,O
Sentence: 374,.,O
Sentence: 374,Acute,O
Sentence: 374,toxicity,B-Disease
Sentence: 374,studies,O
Sentence: 374,of,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,and,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,were,O
Sentence: 374,carried,O
Sentence: 374,out,O
Sentence: 374,in,O
Sentence: 374,mice,O
Sentence: 374,",",O
Sentence: 374,rats,O
Sentence: 374,",",O
Sentence: 374,rabbits,O
Sentence: 374,",",O
Sentence: 374,and,O
Sentence: 374,dogs,O
Sentence: 374,by,O
Sentence: 374,i.v.,O
Sentence: 374,",",O
Sentence: 374,i.m.,O
Sentence: 374,",",O
Sentence: 374,and,O
Sentence: 374,i.p,O
Sentence: 374,.,O
Sentence: 374,routes,O
Sentence: 374,of,O
Sentence: 374,administration,O
Sentence: 374,.,O
Sentence: 374,The,O
Sentence: 374,systemic,O
Sentence: 374,toxic,O
Sentence: 374,signs,O
Sentence: 374,of,O
Sentence: 374,both,O
Sentence: 374,agents,O
Sentence: 374,were,O
Sentence: 374,similar,O
Sentence: 374,and,O
Sentence: 374,occurred,O
Sentence: 374,at,O
Sentence: 374,approximately,O
Sentence: 374,equivalent,O
Sentence: 374,doses,O
Sentence: 374,.,O
Sentence: 374,Importantly,O
Sentence: 374,",",O
Sentence: 374,the,O
Sentence: 374,local,O
Sentence: 374,irritation,O
Sentence: 374,of,O
Sentence: 374,ACC,O
Sentence: 374,-,O
Sentence: 374,9653,O
Sentence: 374,was,O
Sentence: 374,markedly,O
Sentence: 374,less,O
Sentence: 374,than,O
Sentence: 374,phenytoin,B-Chemical
Sentence: 374,sodium,I-Chemical
Sentence: 374,following,O
Sentence: 374,i.m,O
Sentence: 374,.,O
Sentence: 374,administration,O
Sentence: 374,.,O
Sentence: 374,(,O
Sentence: 374,ABSTRACT,O
Sentence: 374,TRUNCATED,O
Sentence: 374,AT,O
Sentence: 374,250,O
Sentence: 374,WORDS,O
Sentence: 374,),O
Sentence: 375,Phenytoin,B-Chemical
Sentence: 375,induced,O
Sentence: 375,fatal,O
Sentence: 375,hepatic,B-Disease
Sentence: 375,injury,I-Disease
Sentence: 375,.,O
Sentence: 376,A,O
Sentence: 376,61,O
Sentence: 376,year,O
Sentence: 376,old,O
Sentence: 376,female,O
Sentence: 376,developed,O
Sentence: 376,fatal,O
Sentence: 376,hepatic,B-Disease
Sentence: 376,failure,I-Disease
Sentence: 376,after,O
Sentence: 376,phenytoin,B-Chemical
Sentence: 376,administration,O
Sentence: 376,.,O
Sentence: 376,A,O
Sentence: 376,typical,O
Sentence: 376,multisystem,O
Sentence: 376,clinical,O
Sentence: 376,pattern,O
Sentence: 376,precedes,O
Sentence: 376,the,O
Sentence: 376,manifestations,O
Sentence: 376,of,O
Sentence: 376,hepatic,B-Disease
Sentence: 376,injury,I-Disease
Sentence: 376,.,O
Sentence: 376,The,O
Sentence: 376,hematologic,O
Sentence: 376,",",O
Sentence: 376,biochemical,O
Sentence: 376,and,O
Sentence: 376,pathologic,O
Sentence: 376,features,O
Sentence: 376,indicate,O
Sentence: 376,a,O
Sentence: 376,mixed,O
Sentence: 376,hepatocellular,B-Disease
Sentence: 376,damage,I-Disease
Sentence: 376,due,O
Sentence: 376,to,O
Sentence: 376,drug,B-Disease
Sentence: 376,hypersensitivity,I-Disease
Sentence: 376,.,O
Sentence: 376,In,O
Sentence: 376,a,O
Sentence: 376,patient,O
Sentence: 376,receiving,O
Sentence: 376,phenytoin,B-Chemical
Sentence: 376,who,O
Sentence: 376,presents,O
Sentence: 376,a,O
Sentence: 376,viral,O
Sentence: 376,-,O
Sentence: 376,like,O
Sentence: 376,illness,O
Sentence: 376,",",O
Sentence: 376,early,O
Sentence: 376,recognition,O
Sentence: 376,and,O
Sentence: 376,discontinuation,O
Sentence: 376,of,O
Sentence: 376,the,O
Sentence: 376,drug,O
Sentence: 376,are,O
Sentence: 376,mandatory,O
Sentence: 376,.,O
Sentence: 377,Treatment,O
Sentence: 377,of,O
Sentence: 377,lethal,O
Sentence: 377,pertussis,B-Chemical
Sentence: 377,vaccine,I-Chemical
Sentence: 377,reaction,O
Sentence: 377,with,O
Sentence: 377,histamine,B-Chemical
Sentence: 377,H1,O
Sentence: 377,antagonists,O
Sentence: 377,.,O
Sentence: 378,We,O
Sentence: 378,studied,O
Sentence: 378,mortality,O
Sentence: 378,after,O
Sentence: 378,pertussis,B-Disease
Sentence: 378,immunization,O
Sentence: 378,in,O
Sentence: 378,the,O
Sentence: 378,mouse,O
Sentence: 378,.,O
Sentence: 378,Without,O
Sentence: 378,treatment,O
Sentence: 378,",",O
Sentence: 378,73,O
Sentence: 378,of,O
Sentence: 378,92,O
Sentence: 378,animals,O
Sentence: 378,(,O
Sentence: 378,80,O
Sentence: 378,%,O
Sentence: 378,),O
Sentence: 378,died,O
Sentence: 378,after,O
Sentence: 378,injection,O
Sentence: 378,of,O
Sentence: 378,bovine,O
Sentence: 378,serum,O
Sentence: 378,albumin,O
Sentence: 378,(,O
Sentence: 378,BSA,O
Sentence: 378,),O
Sentence: 378,on,O
Sentence: 378,day,O
Sentence: 378,+7,O
Sentence: 378,of,O
Sentence: 378,pertussis,B-Disease
Sentence: 378,immunization,O
Sentence: 378,.,O
Sentence: 378,After,O
Sentence: 378,pretreatment,O
Sentence: 378,with,O
Sentence: 378,3,O
Sentence: 378,mg,O
Sentence: 378,of,O
Sentence: 378,cyproheptadine,B-Chemical
Sentence: 378,",",O
Sentence: 378,2,O
Sentence: 378,mg,O
Sentence: 378,mianserin,B-Chemical
Sentence: 378,",",O
Sentence: 378,or,O
Sentence: 378,2,O
Sentence: 378,mg,O
Sentence: 378,chlorpheniramine,B-Chemical
Sentence: 378,",",O
Sentence: 378,only,O
Sentence: 378,5,O
Sentence: 378,of,O
Sentence: 378,105,O
Sentence: 378,animals,O
Sentence: 378,(,O
Sentence: 378,5,O
Sentence: 378,%,O
Sentence: 378,),O
Sentence: 378,died,O
Sentence: 378,after,O
Sentence: 378,receiving,O
Sentence: 378,BSA,O
Sentence: 378,on,O
Sentence: 378,day,O
Sentence: 378,+7,O
Sentence: 378,(,O
Sentence: 378,p,O
Sentence: 378,less,O
Sentence: 378,than,O
Sentence: 378,0.001,O
Sentence: 378,),O
Sentence: 378,.,O
Sentence: 378,Blockade,O
Sentence: 378,of,O
Sentence: 378,histamine,B-Chemical
Sentence: 378,H1,O
Sentence: 378,receptors,O
Sentence: 378,may,O
Sentence: 378,reduce,O
Sentence: 378,mortality,O
Sentence: 378,in,O
Sentence: 378,pertussis,B-Disease
Sentence: 378,immunization,O
Sentence: 378,-,O
Sentence: 378,induced,O
Sentence: 378,encephalopathy,B-Disease
Sentence: 378,in,O
Sentence: 378,mice,O
Sentence: 378,.,O
Sentence: 379,Support,O
Sentence: 379,for,O
Sentence: 379,adrenaline,B-Chemical
Sentence: 379,-,O
Sentence: 379,hypertension,B-Disease
Sentence: 379,hypothesis,O
Sentence: 379,:,O
Sentence: 379,18,O
Sentence: 379,hour,O
Sentence: 379,pressor,O
Sentence: 379,effect,O
Sentence: 379,after,O
Sentence: 379,6,O
Sentence: 379,hours,O
Sentence: 379,adrenaline,B-Chemical
Sentence: 379,infusion,O
Sentence: 379,.,O
Sentence: 380,In,O
Sentence: 380,a,O
Sentence: 380,double,O
Sentence: 380,blind,O
Sentence: 380,",",O
Sentence: 380,crossover,O
Sentence: 380,study,O
Sentence: 380,6,O
Sentence: 380,h,O
Sentence: 380,infusions,O
Sentence: 380,of,O
Sentence: 380,adrenaline,B-Chemical
Sentence: 380,(,O
Sentence: 380,15,O
Sentence: 380,ng,O
Sentence: 380,/,O
Sentence: 380,kg,O
Sentence: 380,/,O
Sentence: 380,min,O
Sentence: 380,;,O
Sentence: 380,1,O
Sentence: 380,ng,O
Sentence: 380,,O
Sentence: 380,=,O
Sentence: 380,,O
Sentence: 380,5.458,O
Sentence: 380,pmol,O
Sentence: 380,),O
Sentence: 380,",",O
Sentence: 380,noradrenaline,B-Chemical
Sentence: 380,(,O
Sentence: 380,30,O
Sentence: 380,ng,O
Sentence: 380,/,O
Sentence: 380,kg,O
Sentence: 380,/,O
Sentence: 380,min,O
Sentence: 380,;,O
Sentence: 380,1,O
Sentence: 380,ng,O
Sentence: 380,,O
Sentence: 380,=,O
Sentence: 380,,O
Sentence: 380,5.911,O
Sentence: 380,pmol,O
Sentence: 380,),O
Sentence: 380,",",O
Sentence: 380,and,O
Sentence: 380,a,O
Sentence: 380,5,O
Sentence: 380,%,O
Sentence: 380,dextrose,B-Chemical
Sentence: 380,solution,O
Sentence: 380,(,O
Sentence: 380,5.4,O
Sentence: 380,ml,O
Sentence: 380,/,O
Sentence: 380,h,O
Sentence: 380,),O
Sentence: 380,",",O
Sentence: 380,were,O
Sentence: 380,given,O
Sentence: 380,to,O
Sentence: 380,ten,O
Sentence: 380,healthy,O
Sentence: 380,volunteers,O
Sentence: 380,in,O
Sentence: 380,random,O
Sentence: 380,order,O
Sentence: 380,2,O
Sentence: 380,weeks,O
Sentence: 380,apart,O
Sentence: 380,.,O
Sentence: 380,By,O
Sentence: 380,means,O
Sentence: 380,of,O
Sentence: 380,intra,O
Sentence: 380,-,O
Sentence: 380,arterial,O
Sentence: 380,ambulatory,O
Sentence: 380,monitoring,O
Sentence: 380,the,O
Sentence: 380,haemodynamic,O
Sentence: 380,effects,O
Sentence: 380,were,O
Sentence: 380,followed,O
Sentence: 380,for,O
Sentence: 380,18,O
Sentence: 380,h,O
Sentence: 380,after,O
Sentence: 380,the,O
Sentence: 380,infusions,O
Sentence: 380,were,O
Sentence: 380,stopped,O
Sentence: 380,.,O
Sentence: 380,Adrenaline,B-Chemical
Sentence: 380,",",O
Sentence: 380,but,O
Sentence: 380,not,O
Sentence: 380,noradrenaline,B-Chemical
Sentence: 380,",",O
Sentence: 380,caused,O
Sentence: 380,a,O
Sentence: 380,delayed,O
Sentence: 380,and,O
Sentence: 380,protracted,O
Sentence: 380,pressor,O
Sentence: 380,effect,O
Sentence: 380,.,O
Sentence: 380,Over,O
Sentence: 380,the,O
Sentence: 380,total,O
Sentence: 380,postinfusion,O
Sentence: 380,period,O
Sentence: 380,systolic,O
Sentence: 380,and,O
Sentence: 380,diastolic,O
Sentence: 380,arterial,O
Sentence: 380,pressure,O
Sentence: 380,were,O
Sentence: 380,6,O
Sentence: 380,(,O
Sentence: 380,SEM,O
Sentence: 380,2,O
Sentence: 380,),O
Sentence: 380,%,O
Sentence: 380,and,O
Sentence: 380,7,O
Sentence: 380,(,O
Sentence: 380,2,O
Sentence: 380,),O
Sentence: 380,%,O
Sentence: 380,",",O
Sentence: 380,respectively,O
Sentence: 380,",",O
Sentence: 380,higher,O
Sentence: 380,than,O
Sentence: 380,after,O
Sentence: 380,dextrose,B-Chemical
Sentence: 380,infusion,O
Sentence: 380,(,O
Sentence: 380,ANOVA,O
Sentence: 380,",",O
Sentence: 380,p,O
Sentence: 380,less,O
Sentence: 380,than,O
Sentence: 380,0.001,O
Sentence: 380,),O
Sentence: 380,.,O
Sentence: 380,Thus,O
Sentence: 380,",",O
Sentence: 380,``,O
Sentence: 380,stress,O
Sentence: 380,'',O
Sentence: 380,levels,O
Sentence: 380,of,O
Sentence: 380,adrenaline,B-Chemical
Sentence: 380,(,O
Sentence: 380,230,O
Sentence: 380,pg,O
Sentence: 380,/,O
Sentence: 380,ml,O
Sentence: 380,),O
Sentence: 380,for,O
Sentence: 380,6,O
Sentence: 380,h,O
Sentence: 380,cause,O
Sentence: 380,a,O
Sentence: 380,delayed,O
Sentence: 380,and,O
Sentence: 380,protracted,O
Sentence: 380,pressor,O
Sentence: 380,effect,O
Sentence: 380,.,O
Sentence: 380,These,O
Sentence: 380,findings,O
Sentence: 380,are,O
Sentence: 380,strong,O
Sentence: 380,support,O
Sentence: 380,for,O
Sentence: 380,the,O
Sentence: 380,adrenaline,B-Chemical
Sentence: 380,-,O
Sentence: 380,hypertension,B-Disease
Sentence: 380,hypothesis,O
Sentence: 380,in,O
Sentence: 380,man,O
Sentence: 380,.,O
Sentence: 381,Effect,O
Sentence: 381,of,O
Sentence: 381,alkylxanthines,B-Chemical
Sentence: 381,on,O
Sentence: 381,gentamicin,B-Chemical
Sentence: 381,-,O
Sentence: 381,induced,O
Sentence: 381,acute,B-Disease
Sentence: 381,renal,I-Disease
Sentence: 381,failure,I-Disease
Sentence: 381,in,O
Sentence: 381,the,O
Sentence: 381,rat,O
Sentence: 381,.,O
Sentence: 382,Adenosine,B-Chemical
Sentence: 382,antagonists,O
Sentence: 382,have,O
Sentence: 382,been,O
Sentence: 382,previously,O
Sentence: 382,shown,O
Sentence: 382,to,O
Sentence: 382,be,O
Sentence: 382,of,O
Sentence: 382,benefit,O
Sentence: 382,in,O
Sentence: 382,some,O
Sentence: 382,ischaemic,B-Disease
Sentence: 382,and,O
Sentence: 382,nephrotoxic,B-Disease
Sentence: 382,models,O
Sentence: 382,of,O
Sentence: 382,acute,B-Disease
Sentence: 382,renal,I-Disease
Sentence: 382,failure,I-Disease
Sentence: 382,(,O
Sentence: 382,ARF,B-Disease
Sentence: 382,),O
Sentence: 382,.,O
Sentence: 382,In,O
Sentence: 382,the,O
Sentence: 382,present,O
Sentence: 382,study,O
Sentence: 382,",",O
Sentence: 382,the,O
Sentence: 382,effects,O
Sentence: 382,of,O
Sentence: 382,three,O
Sentence: 382,alkylxanthines,B-Chemical
Sentence: 382,with,O
Sentence: 382,different,O
Sentence: 382,potencies,O
Sentence: 382,as,O
Sentence: 382,adenosine,B-Chemical
Sentence: 382,antagonists,O
Sentence: 382,8,O
Sentence: 382,-,O
Sentence: 382,phenyltheophylline,O
Sentence: 382,",",O
Sentence: 382,theophylline,B-Chemical
Sentence: 382,and,O
Sentence: 382,enprofylline,B-Chemical
Sentence: 382,",",O
Sentence: 382,were,O
Sentence: 382,examined,O
Sentence: 382,in,O
Sentence: 382,rats,O
Sentence: 382,developing,O
Sentence: 382,acute,B-Disease
Sentence: 382,renal,I-Disease
Sentence: 382,failure,I-Disease
Sentence: 382,after,O
Sentence: 382,4,O
Sentence: 382,daily,O
Sentence: 382,injections,O
Sentence: 382,of,O
Sentence: 382,gentamicin,B-Chemical
Sentence: 382,(,O
Sentence: 382,200,O
Sentence: 382,mg,O
Sentence: 382,kg,O
Sentence: 382,-,O
Sentence: 382,1,O
Sentence: 382,),O
Sentence: 382,.,O
Sentence: 382,Renal,O
Sentence: 382,function,O
Sentence: 382,was,O
Sentence: 382,assessed,O
Sentence: 382,by,O
Sentence: 382,biochemical,O
Sentence: 382,(,O
Sentence: 382,plasma,O
Sentence: 382,urea,B-Chemical
Sentence: 382,and,O
Sentence: 382,creatinine,B-Chemical
Sentence: 382,),O
Sentence: 382,",",O
Sentence: 382,functional,O
Sentence: 382,(,O
Sentence: 382,urine,O
Sentence: 382,analysis,O
Sentence: 382,and,O
Sentence: 382,[,O
Sentence: 382,3H,O
Sentence: 382,],O
Sentence: 382,inulin,O
Sentence: 382,and,O
Sentence: 382,[,O
Sentence: 382,14C,O
Sentence: 382,],O
Sentence: 382,p,O
Sentence: 382,-,O
Sentence: 382,aminohippuric,O
Sentence: 382,acid,O
Sentence: 382,clearances,O
Sentence: 382,),O
Sentence: 382,and,O
Sentence: 382,morphological,O
Sentence: 382,(,O
Sentence: 382,degree,O
Sentence: 382,of,O
Sentence: 382,necrosis,B-Disease
Sentence: 382,),O
Sentence: 382,indices,O
Sentence: 382,.,O
Sentence: 382,The,O
Sentence: 382,various,O
Sentence: 382,drug,O
Sentence: 382,treatments,O
Sentence: 382,produced,O
Sentence: 382,improvements,O
Sentence: 382,in,O
Sentence: 382,some,O
Sentence: 382,",",O
Sentence: 382,but,O
Sentence: 382,not,O
Sentence: 382,all,O
Sentence: 382,",",O
Sentence: 382,measurements,O
Sentence: 382,of,O
Sentence: 382,renal,O
Sentence: 382,function,O
Sentence: 382,.,O
Sentence: 382,However,O
Sentence: 382,",",O
Sentence: 382,any,O
Sentence: 382,improvement,O
Sentence: 382,produced,O
Sentence: 382,by,O
Sentence: 382,drug,O
Sentence: 382,treatment,O
Sentence: 382,was,O
Sentence: 382,largely,O
Sentence: 382,a,O
Sentence: 382,result,O
Sentence: 382,of,O
Sentence: 382,a,O
Sentence: 382,beneficial,O
Sentence: 382,effect,O
Sentence: 382,exerted,O
Sentence: 382,by,O
Sentence: 382,its,O
Sentence: 382,vehicle,O
Sentence: 382,(,O
Sentence: 382,polyethylene,B-Chemical
Sentence: 382,glycol,I-Chemical
Sentence: 382,and,O
Sentence: 382,NaOH,B-Chemical
Sentence: 382,),O
Sentence: 382,.,O
Sentence: 382,The,O
Sentence: 382,lack,O
Sentence: 382,of,O
Sentence: 382,any,O
Sentence: 382,consistent,O
Sentence: 382,protective,O
Sentence: 382,effect,O
Sentence: 382,noted,O
Sentence: 382,with,O
Sentence: 382,the,O
Sentence: 382,alkylxanthines,B-Chemical
Sentence: 382,tested,O
Sentence: 382,in,O
Sentence: 382,the,O
Sentence: 382,present,O
Sentence: 382,study,O
Sentence: 382,indicates,O
Sentence: 382,that,O
Sentence: 382,adenosine,B-Chemical
Sentence: 382,plays,O
Sentence: 382,little,O
Sentence: 382,",",O
Sentence: 382,if,O
Sentence: 382,any,O
Sentence: 382,",",O
Sentence: 382,pathophysiological,O
Sentence: 382,role,O
Sentence: 382,in,O
Sentence: 382,gentamicin,B-Chemical
Sentence: 382,-,O
Sentence: 382,induced,O
Sentence: 382,ARF,B-Disease
Sentence: 382,.,O
Sentence: 383,Adverse,O
Sentence: 383,ocular,O
Sentence: 383,reactions,O
Sentence: 383,possibly,O
Sentence: 383,associated,O
Sentence: 383,with,O
Sentence: 383,isotretinoin,O
Sentence: 383,.,O
Sentence: 384,A,O
Sentence: 384,total,O
Sentence: 384,of,O
Sentence: 384,261,O
Sentence: 384,adverse,O
Sentence: 384,ocular,O
Sentence: 384,reactions,O
Sentence: 384,occurred,O
Sentence: 384,in,O
Sentence: 384,237,O
Sentence: 384,patients,O
Sentence: 384,who,O
Sentence: 384,received,O
Sentence: 384,isotretinoin,B-Chemical
Sentence: 384,",",O
Sentence: 384,a,O
Sentence: 384,commonly,O
Sentence: 384,used,O
Sentence: 384,drug,O
Sentence: 384,in,O
Sentence: 384,the,O
Sentence: 384,treatment,O
Sentence: 384,of,O
Sentence: 384,severe,O
Sentence: 384,cystic,O
Sentence: 384,acne,B-Disease
Sentence: 384,.,O
Sentence: 384,Blepharoconjunctivitis,B-Disease
Sentence: 384,",",O
Sentence: 384,subjective,O
Sentence: 384,complaints,O
Sentence: 384,of,O
Sentence: 384,dry,B-Disease
Sentence: 384,eyes,I-Disease
Sentence: 384,",",O
Sentence: 384,blurred,B-Disease
Sentence: 384,vision,I-Disease
Sentence: 384,",",O
Sentence: 384,contact,O
Sentence: 384,lens,O
Sentence: 384,intolerance,O
Sentence: 384,",",O
Sentence: 384,and,O
Sentence: 384,photodermatitis,B-Disease
Sentence: 384,are,O
Sentence: 384,reversible,O
Sentence: 384,side,O
Sentence: 384,effects,O
Sentence: 384,.,O
Sentence: 384,More,O
Sentence: 384,serious,O
Sentence: 384,ocular,O
Sentence: 384,adverse,O
Sentence: 384,reactions,O
Sentence: 384,include,O
Sentence: 384,papilledema,B-Disease
Sentence: 384,",",O
Sentence: 384,pseudotumor,B-Disease
Sentence: 384,cerebri,I-Disease
Sentence: 384,",",O
Sentence: 384,and,O
Sentence: 384,white,O
Sentence: 384,or,O
Sentence: 384,gray,O
Sentence: 384,subepithelial,O
Sentence: 384,corneal,B-Disease
Sentence: 384,opacities,I-Disease
Sentence: 384,;,O
Sentence: 384,all,O
Sentence: 384,of,O
Sentence: 384,these,O
Sentence: 384,are,O
Sentence: 384,reversible,O
Sentence: 384,if,O
Sentence: 384,the,O
Sentence: 384,drug,O
Sentence: 384,is,O
Sentence: 384,discontinued,O
Sentence: 384,.,O
Sentence: 384,Reported,O
Sentence: 384,cases,O
Sentence: 384,of,O
Sentence: 384,decreased,O
Sentence: 384,dark,O
Sentence: 384,adaptation,O
Sentence: 384,are,O
Sentence: 384,under,O
Sentence: 384,investigation,O
Sentence: 384,.,O
Sentence: 384,Isotretinoin,B-Chemical
Sentence: 384,is,O
Sentence: 384,contraindicated,O
Sentence: 384,in,O
Sentence: 384,pregnancy,O
Sentence: 384,because,O
Sentence: 384,of,O
Sentence: 384,the,O
Sentence: 384,many,O
Sentence: 384,reported,O
Sentence: 384,congenital,B-Disease
Sentence: 384,abnormalities,I-Disease
Sentence: 384,after,O
Sentence: 384,maternal,O
Sentence: 384,use,O
Sentence: 384,(,O
Sentence: 384,including,O
Sentence: 384,microphthalmos,B-Disease
Sentence: 384,",",O
Sentence: 384,orbital,O
Sentence: 384,hypertelorism,B-Disease
Sentence: 384,",",O
Sentence: 384,and,O
Sentence: 384,optic,B-Disease
Sentence: 384,nerve,I-Disease
Sentence: 384,hypoplasia,I-Disease
Sentence: 384,),O
Sentence: 384,.,O
Sentence: 385,Procaterol,B-Chemical
Sentence: 385,and,O
Sentence: 385,terbutaline,B-Chemical
Sentence: 385,in,O
Sentence: 385,bronchial,B-Disease
Sentence: 385,asthma,I-Disease
Sentence: 385,.,O
Sentence: 385,A,O
Sentence: 385,double,O
Sentence: 385,-,O
Sentence: 385,blind,O
Sentence: 385,",",O
Sentence: 385,placebo,O
Sentence: 385,-,O
Sentence: 385,controlled,O
Sentence: 385,",",O
Sentence: 385,cross,O
Sentence: 385,-,O
Sentence: 385,over,O
Sentence: 385,study,O
Sentence: 385,.,O
Sentence: 386,Procaterol,B-Chemical
Sentence: 386,",",O
Sentence: 386,a,O
Sentence: 386,new,O
Sentence: 386,beta,O
Sentence: 386,-,O
Sentence: 386,2,O
Sentence: 386,adrenoceptor,O
Sentence: 386,stimulant,O
Sentence: 386,",",O
Sentence: 386,was,O
Sentence: 386,studied,O
Sentence: 386,in,O
Sentence: 386,a,O
Sentence: 386,double,O
Sentence: 386,-,O
Sentence: 386,blind,O
Sentence: 386,",",O
Sentence: 386,placebo,O
Sentence: 386,-,O
Sentence: 386,controlled,O
Sentence: 386,",",O
Sentence: 386,cross,O
Sentence: 386,-,O
Sentence: 386,over,O
Sentence: 386,trial,O
Sentence: 386,in,O
Sentence: 386,patients,O
Sentence: 386,with,O
Sentence: 386,bronchial,B-Disease
Sentence: 386,asthma,I-Disease
Sentence: 386,.,O
Sentence: 386,Oral,O
Sentence: 386,procaterol,B-Chemical
Sentence: 386,50,O
Sentence: 386,micrograms,O
Sentence: 386,b.d.,O
Sentence: 386,",",O
Sentence: 386,procaterol,B-Chemical
Sentence: 386,100,O
Sentence: 386,micrograms,O
Sentence: 386,b.d.,O
Sentence: 386,",",O
Sentence: 386,and,O
Sentence: 386,terbutaline,B-Chemical
Sentence: 386,5,O
Sentence: 386,mg,O
Sentence: 386,t.i.d.,O
Sentence: 386,",",O
Sentence: 386,were,O
Sentence: 386,compared,O
Sentence: 386,when,O
Sentence: 386,given,O
Sentence: 386,randomly,O
Sentence: 386,in,O
Sentence: 386,1,O
Sentence: 386,-,O
Sentence: 386,week,O
Sentence: 386,treatment,O
Sentence: 386,periods,O
Sentence: 386,.,O
Sentence: 386,The,O
Sentence: 386,best,O
Sentence: 386,clinical,O
Sentence: 386,effect,O
Sentence: 386,was,O
Sentence: 386,found,O
Sentence: 386,with,O
Sentence: 386,terbutaline,B-Chemical
Sentence: 386,.,O
Sentence: 386,Both,O
Sentence: 386,anti,O
Sentence: 386,-,O
Sentence: 386,asthmatic,B-Disease
Sentence: 386,and,O
Sentence: 386,tremorgenic,B-Disease
Sentence: 386,effects,O
Sentence: 386,of,O
Sentence: 386,procaterol,B-Chemical
Sentence: 386,were,O
Sentence: 386,dose,O
Sentence: 386,-,O
Sentence: 386,related,O
Sentence: 386,.,O
Sentence: 386,Procaterol,B-Chemical
Sentence: 386,appeared,O
Sentence: 386,effective,O
Sentence: 386,in,O
Sentence: 386,the,O
Sentence: 386,doses,O
Sentence: 386,tested,O
Sentence: 386,",",O
Sentence: 386,and,O
Sentence: 386,a,O
Sentence: 386,twice,O
Sentence: 386,daily,O
Sentence: 386,regimen,O
Sentence: 386,would,O
Sentence: 386,appear,O
Sentence: 386,to,O
Sentence: 386,be,O
Sentence: 386,suitable,O
Sentence: 386,with,O
Sentence: 386,this,O
Sentence: 386,drug,O
Sentence: 386,.,O
Sentence: 387,Subacute,O
Sentence: 387,effects,O
Sentence: 387,of,O
Sentence: 387,propranolol,B-Chemical
Sentence: 387,and,O
Sentence: 387,B,O
Sentence: 387,24,O
Sentence: 387,/,O
Sentence: 387,76,O
Sentence: 387,on,O
Sentence: 387,isoproterenol,B-Chemical
Sentence: 387,-,O
Sentence: 387,induced,O
Sentence: 387,rat,O
Sentence: 387,heart,B-Disease
Sentence: 387,hypertrophy,I-Disease
Sentence: 387,in,O
Sentence: 387,correlation,O
Sentence: 387,with,O
Sentence: 387,blood,O
Sentence: 387,pressure,O
Sentence: 387,.,O
Sentence: 388,We,O
Sentence: 388,compared,O
Sentence: 388,the,O
Sentence: 388,potential,O
Sentence: 388,beta,O
Sentence: 388,-,O
Sentence: 388,receptor,O
Sentence: 388,blocker,O
Sentence: 388,",",O
Sentence: 388,B,O
Sentence: 388,24,O
Sentence: 388,/,O
Sentence: 388,76,O
Sentence: 388,i.e,O
Sentence: 388,.,O
Sentence: 388,1,O
Sentence: 388,-,O
Sentence: 388,,O
Sentence: 388,(,O
Sentence: 388,"2,4",O
Sentence: 388,-,O
Sentence: 388,dichlorophenoxy,O
Sentence: 388,),O
Sentence: 388,,O
Sentence: 388,-,O
Sentence: 388,3,O
Sentence: 388,[,O
Sentence: 388,2,O
Sentence: 388,-,O
Sentence: 388,"3,4",O
Sentence: 388,-,O
Sentence: 388,dimethoxyphenyl,O
Sentence: 388,),O
Sentence: 388,ethanolamino,O
Sentence: 388,],O
Sentence: 388,,O
Sentence: 388,-,O
Sentence: 388,prop,O
Sentence: 388,an,O
Sentence: 388,-,O
Sentence: 388,2,O
Sentence: 388,-,O
Sentence: 388,ol,O
Sentence: 388,",",O
Sentence: 388,which,O
Sentence: 388,is,O
Sentence: 388,characterized,O
Sentence: 388,by,O
Sentence: 388,beta,O
Sentence: 388,1,O
Sentence: 388,-,O
Sentence: 388,adrenoceptor,O
Sentence: 388,blocking,O
Sentence: 388,and,O
Sentence: 388,beta,O
Sentence: 388,2,O
Sentence: 388,-,O
Sentence: 388,adrenoceptor,O
Sentence: 388,stimulating,O
Sentence: 388,properties,O
Sentence: 388,with,O
Sentence: 388,propranolol,B-Chemical
Sentence: 388,.,O
Sentence: 388,The,O
Sentence: 388,studies,O
Sentence: 388,were,O
Sentence: 388,performed,O
Sentence: 388,using,O
Sentence: 388,an,O
Sentence: 388,experimental,O
Sentence: 388,model,O
Sentence: 388,of,O
Sentence: 388,isoproterenol,B-Chemical
Sentence: 388,-,O
Sentence: 388,induced,O
Sentence: 388,heart,B-Disease
Sentence: 388,hypertrophy,I-Disease
Sentence: 388,in,O
Sentence: 388,rats,O
Sentence: 388,.,O
Sentence: 388,A,O
Sentence: 388,correlation,O
Sentence: 388,of,O
Sentence: 388,the,O
Sentence: 388,blood,O
Sentence: 388,pressure,O
Sentence: 388,was,O
Sentence: 388,neither,O
Sentence: 388,found,O
Sentence: 388,in,O
Sentence: 388,the,O
Sentence: 388,development,O
Sentence: 388,nor,O
Sentence: 388,in,O
Sentence: 388,the,O
Sentence: 388,attempt,O
Sentence: 388,to,O
Sentence: 388,suppress,O
Sentence: 388,the,O
Sentence: 388,development,O
Sentence: 388,of,O
Sentence: 388,heart,B-Disease
Sentence: 388,hypertrophy,I-Disease
Sentence: 388,with,O
Sentence: 388,the,O
Sentence: 388,two,O
Sentence: 388,beta,O
Sentence: 388,-,O
Sentence: 388,receptor,O
Sentence: 388,blockers,O
Sentence: 388,.,O
Sentence: 388,Both,O
Sentence: 388,beta,O
Sentence: 388,-,O
Sentence: 388,blockers,O
Sentence: 388,influenced,O
Sentence: 388,the,O
Sentence: 388,development,O
Sentence: 388,of,O
Sentence: 388,hypertrophy,B-Disease
Sentence: 388,to,O
Sentence: 388,a,O
Sentence: 388,different,O
Sentence: 388,",",O
Sentence: 388,but,O
Sentence: 388,not,O
Sentence: 388,reproducible,O
Sentence: 388,extent,O
Sentence: 388,.,O
Sentence: 388,It,O
Sentence: 388,was,O
Sentence: 388,possible,O
Sentence: 388,to,O
Sentence: 388,suppress,O
Sentence: 388,the,O
Sentence: 388,increased,O
Sentence: 388,ornithine,B-Chemical
Sentence: 388,decarboxylase,O
Sentence: 388,activity,O
Sentence: 388,with,O
Sentence: 388,both,O
Sentence: 388,beta,O
Sentence: 388,-,O
Sentence: 388,blockers,O
Sentence: 388,in,O
Sentence: 388,hypertrophied,B-Disease
Sentence: 388,hearts,I-Disease
Sentence: 388,",",O
Sentence: 388,but,O
Sentence: 388,there,O
Sentence: 388,was,O
Sentence: 388,no,O
Sentence: 388,effect,O
Sentence: 388,on,O
Sentence: 388,the,O
Sentence: 388,heart,O
Sentence: 388,mass,O
Sentence: 388,.,O
Sentence: 388,Neither,O
Sentence: 388,propranolol,B-Chemical
Sentence: 388,nor,O
Sentence: 388,B,O
Sentence: 388,24,O
Sentence: 388,/,O
Sentence: 388,76,O
Sentence: 388,could,O
Sentence: 388,stop,O
Sentence: 388,the,O
Sentence: 388,changes,O
Sentence: 388,in,O
Sentence: 388,the,O
Sentence: 388,characteristic,O
Sentence: 388,myosin,O
Sentence: 388,isoenzyme,O
Sentence: 388,pattern,O
Sentence: 388,of,O
Sentence: 388,the,O
Sentence: 388,hypertrophied,B-Disease
Sentence: 388,rat,O
Sentence: 388,heart,O
Sentence: 388,.,O
Sentence: 388,Thus,O
Sentence: 388,",",O
Sentence: 388,the,O
Sentence: 388,investigations,O
Sentence: 388,did,O
Sentence: 388,not,O
Sentence: 388,provide,O
Sentence: 388,any,O
Sentence: 388,evidence,O
Sentence: 388,that,O
Sentence: 388,the,O
Sentence: 388,beta,O
Sentence: 388,-,O
Sentence: 388,receptor,O
Sentence: 388,blockers,O
Sentence: 388,propranolol,B-Chemical
Sentence: 388,and,O
Sentence: 388,B,O
Sentence: 388,24,O
Sentence: 388,/,O
Sentence: 388,76,O
Sentence: 388,have,O
Sentence: 388,the,O
Sentence: 388,potency,O
Sentence: 388,to,O
Sentence: 388,prevent,O
Sentence: 388,isoproterenol,B-Chemical
Sentence: 388,from,O
Sentence: 388,producing,O
Sentence: 388,heart,B-Disease
Sentence: 388,hypertrophy,I-Disease
Sentence: 388,.,O
Sentence: 389,Comparison,O
Sentence: 389,of,O
Sentence: 389,the,O
Sentence: 389,effect,O
Sentence: 389,of,O
Sentence: 389,oxitropium,B-Chemical
Sentence: 389,bromide,I-Chemical
Sentence: 389,and,O
Sentence: 389,of,O
Sentence: 389,slow,O
Sentence: 389,-,O
Sentence: 389,release,O
Sentence: 389,theophylline,B-Chemical
Sentence: 389,on,O
Sentence: 389,nocturnal,O
Sentence: 389,asthma,B-Disease
Sentence: 389,.,O
Sentence: 390,The,O
Sentence: 390,effects,O
Sentence: 390,of,O
Sentence: 390,a,O
Sentence: 390,new,O
Sentence: 390,inhaled,O
Sentence: 390,antimuscarinic,O
Sentence: 390,drug,O
Sentence: 390,",",O
Sentence: 390,oxitropium,B-Chemical
Sentence: 390,bromide,I-Chemical
Sentence: 390,",",O
Sentence: 390,and,O
Sentence: 390,of,O
Sentence: 390,a,O
Sentence: 390,slow,O
Sentence: 390,-,O
Sentence: 390,release,O
Sentence: 390,theophylline,B-Chemical
Sentence: 390,preparation,O
Sentence: 390,upon,O
Sentence: 390,nocturnal,O
Sentence: 390,asthma,B-Disease
Sentence: 390,were,O
Sentence: 390,compared,O
Sentence: 390,in,O
Sentence: 390,a,O
Sentence: 390,placebo,O
Sentence: 390,-,O
Sentence: 390,controlled,O
Sentence: 390,double,O
Sentence: 390,-,O
Sentence: 390,blind,O
Sentence: 390,study,O
Sentence: 390,.,O
Sentence: 390,Two,O
Sentence: 390,samples,O
Sentence: 390,were,O
Sentence: 390,studied,O
Sentence: 390,:,O
Sentence: 390,12,O
Sentence: 390,patients,O
Sentence: 390,received,O
Sentence: 390,oxitropium,B-Chemical
Sentence: 390,at,O
Sentence: 390,600,O
Sentence: 390,micrograms,O
Sentence: 390,(,O
Sentence: 390,6,O
Sentence: 390,subjects,O
Sentence: 390,),O
Sentence: 390,or,O
Sentence: 390,at,O
Sentence: 390,400,O
Sentence: 390,micrograms,O
Sentence: 390,t.i.d,O
Sentence: 390,.,O
Sentence: 390,(,O
Sentence: 390,6,O
Sentence: 390,subjects,O
Sentence: 390,),O
Sentence: 390,whereas,O
Sentence: 390,11,O
Sentence: 390,received,O
Sentence: 390,theophylline,B-Chemical
Sentence: 390,at,O
Sentence: 390,300,O
Sentence: 390,mg,O
Sentence: 390,b.i.d,O
Sentence: 390,.,O
Sentence: 390,Morning,O
Sentence: 390,dipping,O
Sentence: 390,",",O
Sentence: 390,assessed,O
Sentence: 390,by,O
Sentence: 390,the,O
Sentence: 390,fall,O
Sentence: 390,in,O
Sentence: 390,peak,O
Sentence: 390,flow,O
Sentence: 390,overnight,O
Sentence: 390,",",O
Sentence: 390,was,O
Sentence: 390,significantly,O
Sentence: 390,reduced,O
Sentence: 390,in,O
Sentence: 390,the,O
Sentence: 390,periods,O
Sentence: 390,when,O
Sentence: 390,either,O
Sentence: 390,active,O
Sentence: 390,drug,O
Sentence: 390,was,O
Sentence: 390,taken,O
Sentence: 390,",",O
Sentence: 390,whereas,O
Sentence: 390,no,O
Sentence: 390,difference,O
Sentence: 390,was,O
Sentence: 390,noticed,O
Sentence: 390,during,O
Sentence: 390,the,O
Sentence: 390,placebo,O
Sentence: 390,administration,O
Sentence: 390,.,O
Sentence: 390,No,O
Sentence: 390,significant,O
Sentence: 390,difference,O
Sentence: 390,was,O
Sentence: 390,noticed,O
Sentence: 390,between,O
Sentence: 390,results,O
Sentence: 390,obtained,O
Sentence: 390,with,O
Sentence: 390,either,O
Sentence: 390,active,O
Sentence: 390,drug,O
Sentence: 390,",",O
Sentence: 390,as,O
Sentence: 390,well,O
Sentence: 390,as,O
Sentence: 390,with,O
Sentence: 390,either,O
Sentence: 390,dosage,O
Sentence: 390,of,O
Sentence: 390,oxitropium,B-Chemical
Sentence: 390,.,O
Sentence: 390,No,O
Sentence: 390,subject,O
Sentence: 390,reported,O
Sentence: 390,side,O
Sentence: 390,effects,O
Sentence: 390,of,O
Sentence: 390,oxitropium,B-Chemical
Sentence: 390,",",O
Sentence: 390,as,O
Sentence: 390,compared,O
Sentence: 390,to,O
Sentence: 390,three,O
Sentence: 390,subjects,O
Sentence: 390,reporting,O
Sentence: 390,nausea,B-Disease
Sentence: 390,",",O
Sentence: 390,vomiting,B-Disease
Sentence: 390,and,O
Sentence: 390,tremors,B-Disease
Sentence: 390,after,O
Sentence: 390,theophylline,B-Chemical
Sentence: 390,.,O
Sentence: 390,Oxitropium,B-Chemical
Sentence: 390,proves,O
Sentence: 390,to,O
Sentence: 390,be,O
Sentence: 390,a,O
Sentence: 390,valuable,O
Sentence: 390,alternative,O
Sentence: 390,to,O
Sentence: 390,theophylline,B-Chemical
Sentence: 390,in,O
Sentence: 390,nocturnal,O
Sentence: 390,asthma,B-Disease
Sentence: 390,",",O
Sentence: 390,since,O
Sentence: 390,it,O
Sentence: 390,is,O
Sentence: 390,equally,O
Sentence: 390,potent,O
Sentence: 390,",",O
Sentence: 390,safer,O
Sentence: 390,and,O
Sentence: 390,does,O
Sentence: 390,not,O
Sentence: 390,require,O
Sentence: 390,the,O
Sentence: 390,titration,O
Sentence: 390,of,O
Sentence: 390,dosage,O
Sentence: 390,.,O
Sentence: 391,Penicillin,B-Chemical
Sentence: 391,anaphylaxis,B-Disease
Sentence: 391,.,O
Sentence: 392,A,O
Sentence: 392,case,O
Sentence: 392,of,O
Sentence: 392,oral,O
Sentence: 392,penicillin,B-Chemical
Sentence: 392,anaphylaxis,B-Disease
Sentence: 392,is,O
Sentence: 392,described,O
Sentence: 392,",",O
Sentence: 392,and,O
Sentence: 392,the,O
Sentence: 392,terminology,O
Sentence: 392,",",O
Sentence: 392,occurrence,O
Sentence: 392,",",O
Sentence: 392,clinical,O
Sentence: 392,manifestations,O
Sentence: 392,",",O
Sentence: 392,pathogenesis,O
Sentence: 392,",",O
Sentence: 392,prevention,O
Sentence: 392,",",O
Sentence: 392,and,O
Sentence: 392,treatment,O
Sentence: 392,of,O
Sentence: 392,anaphylaxis,B-Disease
Sentence: 392,are,O
Sentence: 392,reviewed,O
Sentence: 392,.,O
Sentence: 392,Emergency,O
Sentence: 392,physicians,O
Sentence: 392,should,O
Sentence: 392,be,O
Sentence: 392,aware,O
Sentence: 392,of,O
Sentence: 392,oral,O
Sentence: 392,penicillin,B-Chemical
Sentence: 392,anaphylaxis,B-Disease
Sentence: 392,in,O
Sentence: 392,order,O
Sentence: 392,to,O
Sentence: 392,prevent,O
Sentence: 392,its,O
Sentence: 392,occurrence,O
Sentence: 392,by,O
Sentence: 392,prescribing,O
Sentence: 392,the,O
Sentence: 392,antibiotic,O
Sentence: 392,judiciously,O
Sentence: 392,and,O
Sentence: 392,knowledgeably,O
Sentence: 392,and,O
Sentence: 392,to,O
Sentence: 392,offer,O
Sentence: 392,optimal,O
Sentence: 392,medical,O
Sentence: 392,therapy,O
Sentence: 392,once,O
Sentence: 392,this,O
Sentence: 392,life,O
Sentence: 392,-,O
Sentence: 392,threatening,O
Sentence: 392,reaction,O
Sentence: 392,has,O
Sentence: 392,begun,O
Sentence: 392,.,O
Sentence: 393,Reversible,O
Sentence: 393,valproic,B-Chemical
Sentence: 393,acid,I-Chemical
Sentence: 393,-,O
Sentence: 393,induced,O
Sentence: 393,dementia,B-Disease
Sentence: 393,:,O
Sentence: 393,a,O
Sentence: 393,case,O
Sentence: 393,report,O
Sentence: 393,.,O
Sentence: 394,Reversible,O
Sentence: 394,valproic,B-Chemical
Sentence: 394,acid,I-Chemical
Sentence: 394,-,O
Sentence: 394,induced,O
Sentence: 394,dementia,B-Disease
Sentence: 394,was,O
Sentence: 394,documented,O
Sentence: 394,in,O
Sentence: 394,a,O
Sentence: 394,21,O
Sentence: 394,-,O
Sentence: 394,year,O
Sentence: 394,-,O
Sentence: 394,old,O
Sentence: 394,man,O
Sentence: 394,with,O
Sentence: 394,epilepsy,B-Disease
Sentence: 394,who,O
Sentence: 394,had,O
Sentence: 394,a,O
Sentence: 394,3,O
Sentence: 394,-,O
Sentence: 394,year,O
Sentence: 394,history,O
Sentence: 394,of,O
Sentence: 394,insidious,O
Sentence: 394,progressive,O
Sentence: 394,decline,O
Sentence: 394,in,O
Sentence: 394,global,O
Sentence: 394,cognitive,O
Sentence: 394,abilities,O
Sentence: 394,documented,O
Sentence: 394,by,O
Sentence: 394,serial,O
Sentence: 394,neuropsychological,O
Sentence: 394,studies,O
Sentence: 394,.,O
Sentence: 394,Repeat,O
Sentence: 394,neuropsychological,O
Sentence: 394,testing,O
Sentence: 394,7,O
Sentence: 394,weeks,O
Sentence: 394,after,O
Sentence: 394,discontinuation,O
Sentence: 394,of,O
Sentence: 394,the,O
Sentence: 394,drug,O
Sentence: 394,revealed,O
Sentence: 394,dramatic,O
Sentence: 394,improvement,O
Sentence: 394,in,O
Sentence: 394,IQ,O
Sentence: 394,",",O
Sentence: 394,memory,O
Sentence: 394,",",O
Sentence: 394,naming,O
Sentence: 394,",",O
Sentence: 394,and,O
Sentence: 394,other,O
Sentence: 394,tasks,O
Sentence: 394,commensurate,O
Sentence: 394,with,O
Sentence: 394,clinical,O
Sentence: 394,recovery,O
Sentence: 394,in,O
Sentence: 394,his,O
Sentence: 394,intellectual,O
Sentence: 394,capacity,O
Sentence: 394,.,O
Sentence: 394,Possible,O
Sentence: 394,pathophysiological,O
Sentence: 394,mechanisms,O
Sentence: 394,which,O
Sentence: 394,may,O
Sentence: 394,have,O
Sentence: 394,been,O
Sentence: 394,operative,O
Sentence: 394,in,O
Sentence: 394,this,O
Sentence: 394,case,O
Sentence: 394,include,O
Sentence: 394,:,O
Sentence: 394,a,O
Sentence: 394,direct,O
Sentence: 394,central,O
Sentence: 394,nervous,O
Sentence: 394,system,O
Sentence: 394,(,O
Sentence: 394,CNS,O
Sentence: 394,),O
Sentence: 394,toxic,O
Sentence: 394,effect,O
Sentence: 394,of,O
Sentence: 394,valproic,B-Chemical
Sentence: 394,acid,I-Chemical
Sentence: 394,;,O
Sentence: 394,a,O
Sentence: 394,paradoxical,O
Sentence: 394,epileptogenic,O
Sentence: 394,effect,O
Sentence: 394,secondary,O
Sentence: 394,to,O
Sentence: 394,the,O
Sentence: 394,drug,O
Sentence: 394,;,O
Sentence: 394,and,O
Sentence: 394,an,O
Sentence: 394,indirect,O
Sentence: 394,CNS,O
Sentence: 394,toxic,O
Sentence: 394,effect,O
Sentence: 394,mediated,O
Sentence: 394,through,O
Sentence: 394,valproic,B-Chemical
Sentence: 394,acid,I-Chemical
Sentence: 394,-,O
Sentence: 394,induced,O
Sentence: 394,hyperammonemia,B-Disease
Sentence: 394,.,O
Sentence: 395,Reversal,O
Sentence: 395,of,O
Sentence: 395,scopolamine,B-Chemical
Sentence: 395,-,O
Sentence: 395,induced,O
Sentence: 395,amnesia,B-Disease
Sentence: 395,of,O
Sentence: 395,passive,O
Sentence: 395,avoidance,O
Sentence: 395,by,O
Sentence: 395,pre,O
Sentence: 395,-,O
Sentence: 395,,O
Sentence: 395,and,O
Sentence: 395,post,O
Sentence: 395,-,O
Sentence: 395,training,O
Sentence: 395,naloxone,B-Chemical
Sentence: 395,.,O
Sentence: 396,In,O
Sentence: 396,a,O
Sentence: 396,series,O
Sentence: 396,of,O
Sentence: 396,five,O
Sentence: 396,experiments,O
Sentence: 396,",",O
Sentence: 396,the,O
Sentence: 396,modulating,O
Sentence: 396,role,O
Sentence: 396,of,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,on,O
Sentence: 396,a,O
Sentence: 396,scopolamine,B-Chemical
Sentence: 396,-,O
Sentence: 396,induced,O
Sentence: 396,retention,B-Disease
Sentence: 396,deficit,I-Disease
Sentence: 396,in,O
Sentence: 396,a,O
Sentence: 396,passive,O
Sentence: 396,avoidance,O
Sentence: 396,paradigm,O
Sentence: 396,was,O
Sentence: 396,investigated,O
Sentence: 396,in,O
Sentence: 396,mice,O
Sentence: 396,.,O
Sentence: 396,Scopolamine,B-Chemical
Sentence: 396,",",O
Sentence: 396,but,O
Sentence: 396,not,O
Sentence: 396,methyl,B-Chemical
Sentence: 396,scopolamine,B-Chemical
Sentence: 396,(,O
Sentence: 396,1,O
Sentence: 396,and,O
Sentence: 396,3,O
Sentence: 396,mg,O
Sentence: 396,/,O
Sentence: 396,kg,O
Sentence: 396,),O
Sentence: 396,",",O
Sentence: 396,induced,O
Sentence: 396,an,O
Sentence: 396,amnesia,B-Disease
Sentence: 396,as,O
Sentence: 396,measured,O
Sentence: 396,by,O
Sentence: 396,latency,O
Sentence: 396,and,O
Sentence: 396,duration,O
Sentence: 396,parameters,O
Sentence: 396,.,O
Sentence: 396,Naloxone,B-Chemical
Sentence: 396,(,O
Sentence: 396,0.3,O
Sentence: 396,",",O
Sentence: 396,1,O
Sentence: 396,",",O
Sentence: 396,3,O
Sentence: 396,",",O
Sentence: 396,and,O
Sentence: 396,10,O
Sentence: 396,mg,O
Sentence: 396,/,O
Sentence: 396,kg,O
Sentence: 396,),O
Sentence: 396,injected,O
Sentence: 396,prior,O
Sentence: 396,to,O
Sentence: 396,training,O
Sentence: 396,attenuated,O
Sentence: 396,the,O
Sentence: 396,retention,B-Disease
Sentence: 396,deficit,I-Disease
Sentence: 396,with,O
Sentence: 396,a,O
Sentence: 396,peak,O
Sentence: 396,of,O
Sentence: 396,activity,O
Sentence: 396,at,O
Sentence: 396,3,O
Sentence: 396,mg,O
Sentence: 396,/,O
Sentence: 396,kg,O
Sentence: 396,.,O
Sentence: 396,The,O
Sentence: 396,effect,O
Sentence: 396,of,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,could,O
Sentence: 396,be,O
Sentence: 396,antagonized,O
Sentence: 396,with,O
Sentence: 396,morphine,B-Chemical
Sentence: 396,(,O
Sentence: 396,1,O
Sentence: 396,",",O
Sentence: 396,3,O
Sentence: 396,",",O
Sentence: 396,and,O
Sentence: 396,10,O
Sentence: 396,mg,O
Sentence: 396,/,O
Sentence: 396,kg,O
Sentence: 396,),O
Sentence: 396,",",O
Sentence: 396,demonstrating,O
Sentence: 396,the,O
Sentence: 396,opioid,O
Sentence: 396,specificity,O
Sentence: 396,of,O
Sentence: 396,the,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,effect,O
Sentence: 396,.,O
Sentence: 396,Post,O
Sentence: 396,-,O
Sentence: 396,training,O
Sentence: 396,administration,O
Sentence: 396,of,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,(,O
Sentence: 396,3,O
Sentence: 396,mg,O
Sentence: 396,/,O
Sentence: 396,kg,O
Sentence: 396,),O
Sentence: 396,as,O
Sentence: 396,a,O
Sentence: 396,single,O
Sentence: 396,or,O
Sentence: 396,as,O
Sentence: 396,a,O
Sentence: 396,split,O
Sentence: 396,dose,O
Sentence: 396,also,O
Sentence: 396,attenuated,O
Sentence: 396,the,O
Sentence: 396,scopolamine,B-Chemical
Sentence: 396,-,O
Sentence: 396,induced,O
Sentence: 396,amnesia,B-Disease
Sentence: 396,.,O
Sentence: 396,Control,O
Sentence: 396,experiments,O
Sentence: 396,indicated,O
Sentence: 396,that,O
Sentence: 396,neither,O
Sentence: 396,an,O
Sentence: 396,increase,O
Sentence: 396,in,O
Sentence: 396,pain,B-Disease
Sentence: 396,sensitivity,O
Sentence: 396,(,O
Sentence: 396,pre,O
Sentence: 396,-,O
Sentence: 396,training,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,),O
Sentence: 396,nor,O
Sentence: 396,an,O
Sentence: 396,induced,O
Sentence: 396,aversive,O
Sentence: 396,state,O
Sentence: 396,(,O
Sentence: 396,post,O
Sentence: 396,-,O
Sentence: 396,training,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,),O
Sentence: 396,appear,O
Sentence: 396,to,O
Sentence: 396,be,O
Sentence: 396,responsible,O
Sentence: 396,for,O
Sentence: 396,the,O
Sentence: 396,influence,O
Sentence: 396,of,O
Sentence: 396,naloxone,B-Chemical
Sentence: 396,on,O
Sentence: 396,the,O
Sentence: 396,scopolamine,B-Chemical
Sentence: 396,-,O
Sentence: 396,induced,O
Sentence: 396,retention,B-Disease
Sentence: 396,deficit,I-Disease
Sentence: 396,.,O
Sentence: 396,These,O
Sentence: 396,results,O
Sentence: 396,extend,O
Sentence: 396,previous,O
Sentence: 396,findings,O
Sentence: 396,implicating,O
Sentence: 396,a,O
Sentence: 396,cholinergic,O
Sentence: 396,-,O
Sentence: 396,opioid,O
Sentence: 396,interaction,O
Sentence: 396,in,O
Sentence: 396,memory,O
Sentence: 396,processes,O
Sentence: 396,.,O
Sentence: 396,A,O
Sentence: 396,possible,O
Sentence: 396,mechanism,O
Sentence: 396,for,O
Sentence: 396,this,O
Sentence: 396,interaction,O
Sentence: 396,involving,O
Sentence: 396,the,O
Sentence: 396,septo,O
Sentence: 396,-,O
Sentence: 396,hippocampal,O
Sentence: 396,cholinergic,O
Sentence: 396,pathway,O
Sentence: 396,is,O
Sentence: 396,discussed,O
Sentence: 396,.,O
Sentence: 397,Electron,O
Sentence: 397,microscopic,O
Sentence: 397,investigations,O
Sentence: 397,of,O
Sentence: 397,the,O
Sentence: 397,cyclophosphamide,B-Chemical
Sentence: 397,-,O
Sentence: 397,induced,O
Sentence: 397,lesions,B-Disease
Sentence: 397,of,I-Disease
Sentence: 397,the,I-Disease
Sentence: 397,urinary,I-Disease
Sentence: 397,bladder,I-Disease
Sentence: 397,of,O
Sentence: 397,the,O
Sentence: 397,rat,O
Sentence: 397,and,O
Sentence: 397,their,O
Sentence: 397,prevention,O
Sentence: 397,by,O
Sentence: 397,mesna,B-Chemical
Sentence: 397,.,O
Sentence: 398,Fully,O
Sentence: 398,developed,O
Sentence: 398,cyclophosphamide,B-Chemical
Sentence: 398,-,O
Sentence: 398,induced,O
Sentence: 398,cystitis,B-Disease
Sentence: 398,is,O
Sentence: 398,characterized,O
Sentence: 398,by,O
Sentence: 398,nearly,O
Sentence: 398,complete,O
Sentence: 398,detachment,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,urothelium,O
Sentence: 398,",",O
Sentence: 398,severe,O
Sentence: 398,submucosal,O
Sentence: 398,edema,B-Disease
Sentence: 398,owing,O
Sentence: 398,to,O
Sentence: 398,damage,O
Sentence: 398,to,O
Sentence: 398,the,O
Sentence: 398,microvascular,O
Sentence: 398,bed,O
Sentence: 398,and,O
Sentence: 398,focal,O
Sentence: 398,muscle,O
Sentence: 398,necroses,B-Disease
Sentence: 398,.,O
Sentence: 398,The,O
Sentence: 398,initial,O
Sentence: 398,response,O
Sentence: 398,to,O
Sentence: 398,the,O
Sentence: 398,primary,O
Sentence: 398,attack,O
Sentence: 398,by,O
Sentence: 398,the,O
Sentence: 398,cyclophosphamide,B-Chemical
Sentence: 398,metabolites,O
Sentence: 398,seems,O
Sentence: 398,to,O
Sentence: 398,be,O
Sentence: 398,fragmentation,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,luminal,B-Chemical
Sentence: 398,membrane,O
Sentence: 398,.,O
Sentence: 398,This,O
Sentence: 398,damages,O
Sentence: 398,the,O
Sentence: 398,cellular,O
Sentence: 398,barrier,O
Sentence: 398,against,O
Sentence: 398,the,O
Sentence: 398,hypertonic,O
Sentence: 398,urine,O
Sentence: 398,.,O
Sentence: 398,Subsequent,O
Sentence: 398,breaks,O
Sentence: 398,in,O
Sentence: 398,the,O
Sentence: 398,lateral,O
Sentence: 398,cell,O
Sentence: 398,membranes,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,superficial,O
Sentence: 398,cells,O
Sentence: 398,and,O
Sentence: 398,in,O
Sentence: 398,all,O
Sentence: 398,the,O
Sentence: 398,plasma,O
Sentence: 398,membranes,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,intermediate,O
Sentence: 398,and,O
Sentence: 398,basal,O
Sentence: 398,cells,O
Sentence: 398,",",O
Sentence: 398,intercellular,O
Sentence: 398,and,O
Sentence: 398,intracellular,O
Sentence: 398,edema,B-Disease
Sentence: 398,and,O
Sentence: 398,disintegration,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,desmosomes,O
Sentence: 398,and,O
Sentence: 398,hemidesmosomes,O
Sentence: 398,lead,O
Sentence: 398,to,O
Sentence: 398,progressive,O
Sentence: 398,degeneration,O
Sentence: 398,and,O
Sentence: 398,detachment,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,epithelial,O
Sentence: 398,cells,O
Sentence: 398,with,O
Sentence: 398,exposure,O
Sentence: 398,and,O
Sentence: 398,splitting,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,basal,O
Sentence: 398,membrane,O
Sentence: 398,.,O
Sentence: 398,The,O
Sentence: 398,morphological,O
Sentence: 398,changes,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,endothelial,O
Sentence: 398,cells,O
Sentence: 398,",",O
Sentence: 398,which,O
Sentence: 398,become,O
Sentence: 398,more,O
Sentence: 398,pronounced,O
Sentence: 398,in,O
Sentence: 398,the,O
Sentence: 398,later,O
Sentence: 398,stages,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,experiment,O
Sentence: 398,",",O
Sentence: 398,the,O
Sentence: 398,involvement,O
Sentence: 398,of,O
Sentence: 398,blood,O
Sentence: 398,vessels,O
Sentence: 398,regardless,O
Sentence: 398,of,O
Sentence: 398,their,O
Sentence: 398,diameter,O
Sentence: 398,and,O
Sentence: 398,the,O
Sentence: 398,location,O
Sentence: 398,-,O
Sentence: 398,dependent,O
Sentence: 398,extent,O
Sentence: 398,of,O
Sentence: 398,the,O
Sentence: 398,damage,O
Sentence: 398,indicate,O
Sentence: 398,a,O
Sentence: 398,direct,O
Sentence: 398,type,O
Sentence: 398,of,O
Sentence: 398,damage,O
Sentence: 398,which,O
Sentence: 398,is,O
Sentence: 398,preceded,O
Sentence: 398,by,O
Sentence: 398,a,O
Sentence: 398,mediator,O
Sentence: 398,-,O
Sentence: 398,induced,O
Sentence: 398,increase,O
Sentence: 398,in,O
Sentence: 398,permeability,O
Sentence: 398,",",O
Sentence: 398,the,O
Sentence: 398,morphological,O
Sentence: 398,correlate,O
Sentence: 398,of,O
Sentence: 398,which,O
Sentence: 398,is,O
Sentence: 398,the,O
Sentence: 398,formation,O
Sentence: 398,of,O
Sentence: 398,gaps,O
Sentence: 398,in,O
Sentence: 398,the,O
Sentence: 398,interendothelial,O
Sentence: 398,cell,O
Sentence: 398,connections,O
Sentence: 398,on,O
Sentence: 398,the,O
Sentence: 398,venules,O
Sentence: 398,.,O
Sentence: 398,These,O
Sentence: 398,changes,O
Sentence: 398,can,O
Sentence: 398,be,O
Sentence: 398,effectively,O
Sentence: 398,prevented,O
Sentence: 398,by,O
Sentence: 398,mesna,B-Chemical
Sentence: 398,.,O
Sentence: 398,The,O
Sentence: 398,only,O
Sentence: 398,sign,O
Sentence: 398,of,O
Sentence: 398,a,O
Sentence: 398,possible,O
Sentence: 398,involvement,O
Sentence: 398,is,O
Sentence: 398,the,O
Sentence: 398,increase,O
Sentence: 398,in,O
Sentence: 398,the,O
Sentence: 398,number,O
Sentence: 398,of,O
Sentence: 398,specific,O
Sentence: 398,granules,O
Sentence: 398,with,O
Sentence: 398,a,O
Sentence: 398,presumed,O
Sentence: 398,lysosomal,O
Sentence: 398,function,O
Sentence: 398,in,O
Sentence: 398,the,O
Sentence: 398,superficial,O
Sentence: 398,cells,O
Sentence: 398,.,O
Sentence: 399,Increase,O
Sentence: 399,in,O
Sentence: 399,intragastric,O
Sentence: 399,pressure,O
Sentence: 399,during,O
Sentence: 399,suxamethonium,B-Chemical
Sentence: 399,-,O
Sentence: 399,induced,O
Sentence: 399,muscle,B-Disease
Sentence: 399,fasciculations,I-Disease
Sentence: 399,in,O
Sentence: 399,children,O
Sentence: 399,:,O
Sentence: 399,inhibition,O
Sentence: 399,by,O
Sentence: 399,alfentanil,B-Chemical
Sentence: 399,.,O
Sentence: 400,Changes,O
Sentence: 400,in,O
Sentence: 400,intragastric,O
Sentence: 400,pressure,O
Sentence: 400,after,O
Sentence: 400,the,O
Sentence: 400,administration,O
Sentence: 400,of,O
Sentence: 400,suxamethonium,B-Chemical
Sentence: 400,1.5,O
Sentence: 400,mg,O
Sentence: 400,kg,O
Sentence: 400,-,O
Sentence: 400,1,O
Sentence: 400,i.v,O
Sentence: 400,.,O
Sentence: 400,were,O
Sentence: 400,studied,O
Sentence: 400,in,O
Sentence: 400,32,O
Sentence: 400,children,O
Sentence: 400,(,O
Sentence: 400,mean,O
Sentence: 400,age,O
Sentence: 400,6.9,O
Sentence: 400,yr,O
Sentence: 400,),O
Sentence: 400,pretreated,O
Sentence: 400,with,O
Sentence: 400,either,O
Sentence: 400,physiological,O
Sentence: 400,saline,O
Sentence: 400,or,O
Sentence: 400,alfentanil,B-Chemical
Sentence: 400,50,O
Sentence: 400,micrograms,O
Sentence: 400,kg,O
Sentence: 400,-,O
Sentence: 400,1,O
Sentence: 400,.,O
Sentence: 400,Anaesthesia,O
Sentence: 400,was,O
Sentence: 400,induced,O
Sentence: 400,with,O
Sentence: 400,thiopentone,B-Chemical
Sentence: 400,5,O
Sentence: 400,mg,O
Sentence: 400,kg,O
Sentence: 400,-,O
Sentence: 400,1,O
Sentence: 400,.,O
Sentence: 400,The,O
Sentence: 400,incidence,O
Sentence: 400,and,O
Sentence: 400,intensity,O
Sentence: 400,of,O
Sentence: 400,muscle,B-Disease
Sentence: 400,fasciculations,I-Disease
Sentence: 400,caused,O
Sentence: 400,by,O
Sentence: 400,suxamethonium,B-Chemical
Sentence: 400,were,O
Sentence: 400,significantly,O
Sentence: 400,greater,O
Sentence: 400,in,O
Sentence: 400,the,O
Sentence: 400,control,O
Sentence: 400,than,O
Sentence: 400,in,O
Sentence: 400,the,O
Sentence: 400,alfentanil,B-Chemical
Sentence: 400,group,O
Sentence: 400,.,O
Sentence: 400,The,O
Sentence: 400,intragastric,O
Sentence: 400,pressure,O
Sentence: 400,during,O
Sentence: 400,muscle,B-Disease
Sentence: 400,fasciculations,I-Disease
Sentence: 400,was,O
Sentence: 400,significantly,O
Sentence: 400,higher,O
Sentence: 400,in,O
Sentence: 400,the,O
Sentence: 400,control,O
Sentence: 400,group,O
Sentence: 400,(,O
Sentence: 400,16,O
Sentence: 400,+,O
Sentence: 400,/,O
Sentence: 400,,O
Sentence: 400,-,O
Sentence: 400,,O
Sentence: 400,0.7,O
Sentence: 400,(,O
Sentence: 400,SEM,O
Sentence: 400,),O
Sentence: 400,cm,O
Sentence: 400,H2O,B-Chemical
Sentence: 400,),O
Sentence: 400,than,O
Sentence: 400,in,O
Sentence: 400,the,O
Sentence: 400,alfentanil,B-Chemical
Sentence: 400,group,O
Sentence: 400,(,O
Sentence: 400,7.7,O
Sentence: 400,+,O
Sentence: 400,/,O
Sentence: 400,,O
Sentence: 400,-,O
Sentence: 400,,O
Sentence: 400,1.5,O
Sentence: 400,(,O
Sentence: 400,SEM,O
Sentence: 400,),O
Sentence: 400,cm,O
Sentence: 400,H2O,B-Chemical
Sentence: 400,),O
Sentence: 400,.,O
Sentence: 400,The,O
Sentence: 400,increase,O
Sentence: 400,in,O
Sentence: 400,intragastric,O
Sentence: 400,pressure,O
Sentence: 400,was,O
Sentence: 400,directly,O
Sentence: 400,related,O
Sentence: 400,to,O
Sentence: 400,the,O
Sentence: 400,intensity,O
Sentence: 400,of,O
Sentence: 400,muscle,B-Disease
Sentence: 400,fasciculations,I-Disease
Sentence: 400,(,O
Sentence: 400,regression,O
Sentence: 400,line,O
Sentence: 400,:,O
Sentence: 400,y,O
Sentence: 400,,O
Sentence: 400,=,O
Sentence: 400,,O
Sentence: 400,0.5,O
Sentence: 400,+,O
Sentence: 400,4.78x,O
Sentence: 400,with,O
Sentence: 400,r,O
Sentence: 400,of,O
Sentence: 400,0.78,O
Sentence: 400,),O
Sentence: 400,.,O
Sentence: 400,It,O
Sentence: 400,is,O
Sentence: 400,concluded,O
Sentence: 400,that,O
Sentence: 400,intragastric,O
Sentence: 400,pressure,O
Sentence: 400,increases,O
Sentence: 400,significantly,O
Sentence: 400,during,O
Sentence: 400,muscle,B-Disease
Sentence: 400,fasciculations,I-Disease
Sentence: 400,caused,O
Sentence: 400,by,O
Sentence: 400,suxamethonium,B-Chemical
Sentence: 400,in,O
Sentence: 400,healthy,O
Sentence: 400,children,O
Sentence: 400,.,O
Sentence: 400,Alfentanil,B-Chemical
Sentence: 400,50,O
Sentence: 400,micrograms,O
Sentence: 400,kg,O
Sentence: 400,-,O
Sentence: 400,1,O
Sentence: 400,effectively,O
Sentence: 400,inhibits,O
Sentence: 400,the,O
Sentence: 400,incidence,O
Sentence: 400,and,O
Sentence: 400,intensity,O
Sentence: 400,of,O
Sentence: 400,suxamethonium,B-Chemical
Sentence: 400,-,O
Sentence: 400,induced,O
Sentence: 400,muscle,B-Disease
Sentence: 400,fasciculations,I-Disease
Sentence: 400,;,O
Sentence: 400,moreover,O
Sentence: 400,",",O
Sentence: 400,intragastric,O
Sentence: 400,pressure,O
Sentence: 400,remains,O
Sentence: 400,at,O
Sentence: 400,its,O
Sentence: 400,control,O
Sentence: 400,value,O
Sentence: 400,.,O
Sentence: 401,Acute,O
Sentence: 401,insulin,O
Sentence: 401,treatment,O
Sentence: 401,normalizes,O
Sentence: 401,the,O
Sentence: 401,resistance,O
Sentence: 401,to,O
Sentence: 401,the,O
Sentence: 401,cardiotoxic,B-Disease
Sentence: 401,effect,O
Sentence: 401,of,O
Sentence: 401,isoproterenol,B-Chemical
Sentence: 401,in,O
Sentence: 401,streptozotocin,B-Chemical
Sentence: 401,diabetic,B-Disease
Sentence: 401,rats,O
Sentence: 401,.,O
Sentence: 401,A,O
Sentence: 401,morphometric,O
Sentence: 401,study,O
Sentence: 401,of,O
Sentence: 401,isoproterenol,B-Chemical
Sentence: 401,induced,O
Sentence: 401,myocardial,O
Sentence: 401,fibrosis,B-Disease
Sentence: 401,.,O
Sentence: 402,The,O
Sentence: 402,acute,O
Sentence: 402,effect,O
Sentence: 402,of,O
Sentence: 402,insulin,O
Sentence: 402,treatment,O
Sentence: 402,on,O
Sentence: 402,the,O
Sentence: 402,earlier,O
Sentence: 402,reported,O
Sentence: 402,protective,O
Sentence: 402,effect,O
Sentence: 402,of,O
Sentence: 402,streptozotocin,B-Chemical
Sentence: 402,diabetes,B-Disease
Sentence: 402,against,O
Sentence: 402,the,O
Sentence: 402,cardiotoxic,B-Disease
Sentence: 402,effect,O
Sentence: 402,of,O
Sentence: 402,high,O
Sentence: 402,doses,O
Sentence: 402,of,O
Sentence: 402,isoproterenol,B-Chemical
Sentence: 402,(,O
Sentence: 402,ISO,B-Chemical
Sentence: 402,),O
Sentence: 402,was,O
Sentence: 402,investigated,O
Sentence: 402,in,O
Sentence: 402,rats,O
Sentence: 402,.,O
Sentence: 402,Thirty,O
Sentence: 402,to,O
Sentence: 402,135,O
Sentence: 402,min,O
Sentence: 402,after,O
Sentence: 402,the,O
Sentence: 402,injection,O
Sentence: 402,of,O
Sentence: 402,crystalline,O
Sentence: 402,insulin,O
Sentence: 402,",",O
Sentence: 402,ISO,B-Chemical
Sentence: 402,was,O
Sentence: 402,given,O
Sentence: 402,subcutaneously,O
Sentence: 402,and,O
Sentence: 402,when,O
Sentence: 402,ISO,B-Chemical
Sentence: 402,induced,O
Sentence: 402,fibrosis,B-Disease
Sentence: 402,in,O
Sentence: 402,the,O
Sentence: 402,myocardium,O
Sentence: 402,was,O
Sentence: 402,morphometrically,O
Sentence: 402,analyzed,O
Sentence: 402,7,O
Sentence: 402,days,O
Sentence: 402,later,O
Sentence: 402,",",O
Sentence: 402,a,O
Sentence: 402,highly,O
Sentence: 402,significant,O
Sentence: 402,correlation,O
Sentence: 402,(,O
Sentence: 402,r,O
Sentence: 402,,O
Sentence: 402,=,O
Sentence: 402,,O
Sentence: 402,0.83,O
Sentence: 402,",",O
Sentence: 402,2,O
Sentence: 402,p,O
Sentence: 402,,O
Sentence: 402,=,O
Sentence: 402,,O
Sentence: 402,0.006,O
Sentence: 402,),O
Sentence: 402,to,O
Sentence: 402,the,O
Sentence: 402,slope,O
Sentence: 402,of,O
Sentence: 402,the,O
Sentence: 402,fall,O
Sentence: 402,in,O
Sentence: 402,blood,O
Sentence: 402,glucose,B-Chemical
Sentence: 402,after,O
Sentence: 402,insulin,O
Sentence: 402,treatment,O
Sentence: 402,appeared,O
Sentence: 402,.,O
Sentence: 402,The,O
Sentence: 402,myocardial,O
Sentence: 402,content,O
Sentence: 402,of,O
Sentence: 402,catecholamines,B-Chemical
Sentence: 402,was,O
Sentence: 402,estimated,O
Sentence: 402,in,O
Sentence: 402,these,O
Sentence: 402,8,O
Sentence: 402,day,O
Sentence: 402,diabetic,B-Disease
Sentence: 402,rats,O
Sentence: 402,.,O
Sentence: 402,The,O
Sentence: 402,norepinephrine,B-Chemical
Sentence: 402,content,O
Sentence: 402,was,O
Sentence: 402,significantly,O
Sentence: 402,increased,O
Sentence: 402,while,O
Sentence: 402,epinephrine,B-Chemical
Sentence: 402,remained,O
Sentence: 402,unchanged,O
Sentence: 402,.,O
Sentence: 402,An,O
Sentence: 402,enhanced,O
Sentence: 402,sympathetic,O
Sentence: 402,nervous,O
Sentence: 402,system,O
Sentence: 402,activity,O
Sentence: 402,with,O
Sentence: 402,a,O
Sentence: 402,consequent,O
Sentence: 402,down,O
Sentence: 402,regulation,O
Sentence: 402,of,O
Sentence: 402,the,O
Sentence: 402,myocardial,O
Sentence: 402,beta,O
Sentence: 402,-,O
Sentence: 402,adrenergic,O
Sentence: 402,receptors,O
Sentence: 402,could,O
Sentence: 402,",",O
Sentence: 402,therefore,O
Sentence: 402,",",O
Sentence: 402,explain,O
Sentence: 402,this,O
Sentence: 402,catecholamine,B-Chemical
Sentence: 402,resistance,O
Sentence: 402,.,O
Sentence: 402,The,O
Sentence: 402,rapid,O
Sentence: 402,reversion,O
Sentence: 402,after,O
Sentence: 402,insulin,O
Sentence: 402,treatment,O
Sentence: 402,excludes,O
Sentence: 402,the,O
Sentence: 402,possibility,O
Sentence: 402,that,O
Sentence: 402,streptozotocin,B-Chemical
Sentence: 402,in,O
Sentence: 402,itself,O
Sentence: 402,causes,O
Sentence: 402,the,O
Sentence: 402,ISO,B-Chemical
Sentence: 402,resistance,O
Sentence: 402,and,O
Sentence: 402,points,O
Sentence: 402,towards,O
Sentence: 402,a,O
Sentence: 402,direct,O
Sentence: 402,insulin,O
Sentence: 402,effect,O
Sentence: 402,on,O
Sentence: 402,myocardial,O
Sentence: 402,catecholamine,B-Chemical
Sentence: 402,sensitivity,O
Sentence: 402,in,O
Sentence: 402,diabetic,B-Disease
Sentence: 402,rats,O
Sentence: 402,.,O
Sentence: 402,The,O
Sentence: 402,phenomenon,O
Sentence: 402,described,O
Sentence: 402,might,O
Sentence: 402,elucidate,O
Sentence: 402,pathogenetic,O
Sentence: 402,mechanisms,O
Sentence: 402,behind,O
Sentence: 402,toxic,O
Sentence: 402,myocardial,O
Sentence: 402,cell,O
Sentence: 402,degeneration,O
Sentence: 402,and,O
Sentence: 402,may,O
Sentence: 402,possibly,O
Sentence: 402,have,O
Sentence: 402,relevance,O
Sentence: 402,for,O
Sentence: 402,acute,O
Sentence: 402,cardiovascular,O
Sentence: 402,complications,O
Sentence: 402,in,O
Sentence: 402,diabetic,B-Disease
Sentence: 402,patients,O
Sentence: 402,.,O
Sentence: 403,Differential,O
Sentence: 403,effects,O
Sentence: 403,of,O
Sentence: 403,non,O
Sentence: 403,-,O
Sentence: 403,steroidal,O
Sentence: 403,anti,O
Sentence: 403,-,O
Sentence: 403,inflammatory,O
Sentence: 403,drugs,O
Sentence: 403,on,O
Sentence: 403,seizures,B-Disease
Sentence: 403,produced,O
Sentence: 403,by,O
Sentence: 403,pilocarpine,B-Chemical
Sentence: 403,in,O
Sentence: 403,rats,O
Sentence: 403,.,O
Sentence: 404,The,O
Sentence: 404,muscarinic,O
Sentence: 404,cholinergic,O
Sentence: 404,agonist,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,induces,O
Sentence: 404,in,O
Sentence: 404,rats,O
Sentence: 404,seizures,B-Disease
Sentence: 404,and,O
Sentence: 404,status,B-Disease
Sentence: 404,epilepticus,I-Disease
Sentence: 404,followed,O
Sentence: 404,by,O
Sentence: 404,widespread,O
Sentence: 404,damage,O
Sentence: 404,to,O
Sentence: 404,the,O
Sentence: 404,forebrain,O
Sentence: 404,.,O
Sentence: 404,The,O
Sentence: 404,present,O
Sentence: 404,study,O
Sentence: 404,was,O
Sentence: 404,designed,O
Sentence: 404,to,O
Sentence: 404,investigate,O
Sentence: 404,the,O
Sentence: 404,effect,O
Sentence: 404,of,O
Sentence: 404,5,O
Sentence: 404,non,O
Sentence: 404,-,O
Sentence: 404,steroidal,O
Sentence: 404,anti,O
Sentence: 404,-,O
Sentence: 404,inflammatory,O
Sentence: 404,drugs,O
Sentence: 404,",",O
Sentence: 404,sodium,B-Chemical
Sentence: 404,salicylate,I-Chemical
Sentence: 404,",",O
Sentence: 404,phenylbutazone,B-Chemical
Sentence: 404,",",O
Sentence: 404,indomethacin,B-Chemical
Sentence: 404,",",O
Sentence: 404,ibuprofen,B-Chemical
Sentence: 404,and,O
Sentence: 404,mefenamic,B-Chemical
Sentence: 404,acid,I-Chemical
Sentence: 404,",",O
Sentence: 404,on,O
Sentence: 404,seizures,B-Disease
Sentence: 404,produced,O
Sentence: 404,by,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,.,O
Sentence: 404,Pretreatment,O
Sentence: 404,of,O
Sentence: 404,rats,O
Sentence: 404,with,O
Sentence: 404,sodium,B-Chemical
Sentence: 404,salicylate,I-Chemical
Sentence: 404,",",O
Sentence: 404,ED50,O
Sentence: 404,103,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,(,O
Sentence: 404,60,O
Sentence: 404,-,O
Sentence: 404,174,O
Sentence: 404,),O
Sentence: 404,",",O
Sentence: 404,and,O
Sentence: 404,phenylbutazone,B-Chemical
Sentence: 404,",",O
Sentence: 404,59,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,(,O
Sentence: 404,50,O
Sentence: 404,-,O
Sentence: 404,70,O
Sentence: 404,),O
Sentence: 404,converted,O
Sentence: 404,the,O
Sentence: 404,non,O
Sentence: 404,-,O
Sentence: 404,convulsant,O
Sentence: 404,dose,O
Sentence: 404,of,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,",",O
Sentence: 404,200,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,",",O
Sentence: 404,to,O
Sentence: 404,a,O
Sentence: 404,convulsant,O
Sentence: 404,one,O
Sentence: 404,.,O
Sentence: 404,Indomethacin,B-Chemical
Sentence: 404,",",O
Sentence: 404,1,O
Sentence: 404,-,O
Sentence: 404,10,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,",",O
Sentence: 404,and,O
Sentence: 404,ibuprofen,B-Chemical
Sentence: 404,",",O
Sentence: 404,10,O
Sentence: 404,-,O
Sentence: 404,100,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,",",O
Sentence: 404,failed,O
Sentence: 404,to,O
Sentence: 404,modulate,O
Sentence: 404,seizures,B-Disease
Sentence: 404,produced,O
Sentence: 404,by,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,.,O
Sentence: 404,Mefenamic,B-Chemical
Sentence: 404,acid,I-Chemical
Sentence: 404,",",O
Sentence: 404,26,O
Sentence: 404,(,O
Sentence: 404,22,O
Sentence: 404,-,O
Sentence: 404,30,O
Sentence: 404,),O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,",",O
Sentence: 404,prevented,O
Sentence: 404,seizures,B-Disease
Sentence: 404,and,O
Sentence: 404,protected,O
Sentence: 404,rats,O
Sentence: 404,from,O
Sentence: 404,seizure,B-Disease
Sentence: 404,-,O
Sentence: 404,related,O
Sentence: 404,brain,B-Disease
Sentence: 404,damage,I-Disease
Sentence: 404,induced,O
Sentence: 404,by,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,",",O
Sentence: 404,380,O
Sentence: 404,mg,O
Sentence: 404,/,O
Sentence: 404,kg,O
Sentence: 404,.,O
Sentence: 404,These,O
Sentence: 404,results,O
Sentence: 404,indicate,O
Sentence: 404,that,O
Sentence: 404,non,O
Sentence: 404,-,O
Sentence: 404,steroidal,O
Sentence: 404,anti,O
Sentence: 404,-,O
Sentence: 404,inflammatory,O
Sentence: 404,drugs,O
Sentence: 404,differentially,O
Sentence: 404,modulate,O
Sentence: 404,the,O
Sentence: 404,threshold,O
Sentence: 404,for,O
Sentence: 404,pilocarpine,B-Chemical
Sentence: 404,-,O
Sentence: 404,induced,O
Sentence: 404,seizures,B-Disease
Sentence: 404,.,O
Sentence: 405,Acute,B-Disease
Sentence: 405,neurologic,I-Disease
Sentence: 405,dysfunction,I-Disease
Sentence: 405,after,O
Sentence: 405,high,O
Sentence: 405,-,O
Sentence: 405,dose,O
Sentence: 405,etoposide,B-Chemical
Sentence: 405,therapy,O
Sentence: 405,for,O
Sentence: 405,malignant,B-Disease
Sentence: 405,glioma,I-Disease
Sentence: 405,.,O
Sentence: 406,Etoposide,B-Chemical
Sentence: 406,(,O
Sentence: 406,VP,O
Sentence: 406,-,O
Sentence: 406,16,O
Sentence: 406,-,O
Sentence: 406,213,O
Sentence: 406,),O
Sentence: 406,has,O
Sentence: 406,been,O
Sentence: 406,used,O
Sentence: 406,in,O
Sentence: 406,the,O
Sentence: 406,treatment,O
Sentence: 406,of,O
Sentence: 406,many,O
Sentence: 406,solid,O
Sentence: 406,tumors,B-Disease
Sentence: 406,and,O
Sentence: 406,hematologic,B-Disease
Sentence: 406,malignancies,I-Disease
Sentence: 406,.,O
Sentence: 406,When,O
Sentence: 406,used,O
Sentence: 406,in,O
Sentence: 406,high,O
Sentence: 406,doses,O
Sentence: 406,and,O
Sentence: 406,in,O
Sentence: 406,conjunction,O
Sentence: 406,with,O
Sentence: 406,autologous,O
Sentence: 406,bone,O
Sentence: 406,marrow,O
Sentence: 406,transplantation,O
Sentence: 406,",",O
Sentence: 406,this,O
Sentence: 406,agent,O
Sentence: 406,has,O
Sentence: 406,activity,O
Sentence: 406,against,O
Sentence: 406,several,O
Sentence: 406,treatment,O
Sentence: 406,-,O
Sentence: 406,resistant,O
Sentence: 406,cancers,B-Disease
Sentence: 406,including,O
Sentence: 406,malignant,B-Disease
Sentence: 406,glioma,I-Disease
Sentence: 406,.,O
Sentence: 406,In,O
Sentence: 406,six,O
Sentence: 406,of,O
Sentence: 406,eight,O
Sentence: 406,patients,O
Sentence: 406,(,O
Sentence: 406,75,O
Sentence: 406,%,O
Sentence: 406,),O
Sentence: 406,who,O
Sentence: 406,we,O
Sentence: 406,treated,O
Sentence: 406,for,O
Sentence: 406,recurrent,O
Sentence: 406,or,O
Sentence: 406,resistant,O
Sentence: 406,glioma,B-Disease
Sentence: 406,",",O
Sentence: 406,sudden,O
Sentence: 406,severe,O
Sentence: 406,neurologic,B-Disease
Sentence: 406,deterioration,I-Disease
Sentence: 406,occurred,O
Sentence: 406,.,O
Sentence: 406,This,O
Sentence: 406,developed,O
Sentence: 406,a,O
Sentence: 406,median,O
Sentence: 406,of,O
Sentence: 406,9,O
Sentence: 406,days,O
Sentence: 406,after,O
Sentence: 406,initiation,O
Sentence: 406,of,O
Sentence: 406,high,O
Sentence: 406,-,O
Sentence: 406,dose,O
Sentence: 406,etoposide,B-Chemical
Sentence: 406,therapy,O
Sentence: 406,.,O
Sentence: 406,Significant,O
Sentence: 406,clinical,O
Sentence: 406,manifestations,O
Sentence: 406,have,O
Sentence: 406,included,O
Sentence: 406,confusion,B-Disease
Sentence: 406,",",O
Sentence: 406,papilledema,B-Disease
Sentence: 406,",",O
Sentence: 406,somnolence,B-Disease
Sentence: 406,",",O
Sentence: 406,exacerbation,O
Sentence: 406,of,O
Sentence: 406,motor,B-Disease
Sentence: 406,deficits,I-Disease
Sentence: 406,",",O
Sentence: 406,and,O
Sentence: 406,sharp,O
Sentence: 406,increase,O
Sentence: 406,in,O
Sentence: 406,seizure,B-Disease
Sentence: 406,activity,O
Sentence: 406,.,O
Sentence: 406,These,O
Sentence: 406,abnormalities,O
Sentence: 406,resolved,O
Sentence: 406,rapidly,O
Sentence: 406,after,O
Sentence: 406,initiation,O
Sentence: 406,of,O
Sentence: 406,high,O
Sentence: 406,-,O
Sentence: 406,dose,O
Sentence: 406,intravenous,O
Sentence: 406,dexamethasone,B-Chemical
Sentence: 406,therapy,O
Sentence: 406,.,O
Sentence: 406,In,O
Sentence: 406,all,O
Sentence: 406,patients,O
Sentence: 406,",",O
Sentence: 406,computerized,O
Sentence: 406,tomographic,O
Sentence: 406,(,O
Sentence: 406,CT,O
Sentence: 406,),O
Sentence: 406,brain,O
Sentence: 406,scans,O
Sentence: 406,demonstrated,O
Sentence: 406,stability,O
Sentence: 406,in,O
Sentence: 406,tumor,B-Disease
Sentence: 406,size,O
Sentence: 406,and,O
Sentence: 406,peritumor,O
Sentence: 406,edema,B-Disease
Sentence: 406,when,O
Sentence: 406,compared,O
Sentence: 406,with,O
Sentence: 406,pretransplant,O
Sentence: 406,scans,O
Sentence: 406,.,O
Sentence: 406,This,O
Sentence: 406,complication,O
Sentence: 406,appears,O
Sentence: 406,to,O
Sentence: 406,represent,O
Sentence: 406,a,O
Sentence: 406,significant,O
Sentence: 406,new,O
Sentence: 406,toxicity,B-Disease
Sentence: 406,of,O
Sentence: 406,high,O
Sentence: 406,-,O
Sentence: 406,dose,O
Sentence: 406,etoposide,B-Chemical
Sentence: 406,therapy,O
Sentence: 406,for,O
Sentence: 406,malignant,B-Disease
Sentence: 406,glioma,I-Disease
Sentence: 406,.,O
Sentence: 407,Progressive,O
Sentence: 407,bile,B-Disease
Sentence: 407,duct,I-Disease
Sentence: 407,injury,I-Disease
Sentence: 407,after,O
Sentence: 407,thiabendazole,B-Chemical
Sentence: 407,administration,O
Sentence: 407,.,O
Sentence: 408,A,O
Sentence: 408,27,O
Sentence: 408,-,O
Sentence: 408,yr,O
Sentence: 408,-,O
Sentence: 408,old,O
Sentence: 408,man,O
Sentence: 408,developed,O
Sentence: 408,jaundice,B-Disease
Sentence: 408,2,O
Sentence: 408,wk,O
Sentence: 408,after,O
Sentence: 408,exposure,O
Sentence: 408,to,O
Sentence: 408,thiabendazole,B-Chemical
Sentence: 408,.,O
Sentence: 408,Cholestasis,B-Disease
Sentence: 408,persisted,O
Sentence: 408,for,O
Sentence: 408,3,O
Sentence: 408,yr,O
Sentence: 408,",",O
Sentence: 408,at,O
Sentence: 408,which,O
Sentence: 408,time,O
Sentence: 408,a,O
Sentence: 408,liver,O
Sentence: 408,transplant,O
Sentence: 408,was,O
Sentence: 408,performed,O
Sentence: 408,.,O
Sentence: 408,Two,O
Sentence: 408,liver,O
Sentence: 408,biopsy,O
Sentence: 408,specimens,O
Sentence: 408,and,O
Sentence: 408,the,O
Sentence: 408,hepatectomy,O
Sentence: 408,specimen,O
Sentence: 408,were,O
Sentence: 408,remarkable,O
Sentence: 408,for,O
Sentence: 408,almost,O
Sentence: 408,complete,O
Sentence: 408,disappearance,O
Sentence: 408,of,O
Sentence: 408,interlobular,O
Sentence: 408,bile,O
Sentence: 408,ducts,O
Sentence: 408,.,O
Sentence: 408,Prominent,O
Sentence: 408,fibrosis,B-Disease
Sentence: 408,and,O
Sentence: 408,hepatocellular,O
Sentence: 408,regeneration,O
Sentence: 408,were,O
Sentence: 408,also,O
Sentence: 408,present,O
Sentence: 408,;,O
Sentence: 408,however,O
Sentence: 408,",",O
Sentence: 408,the,O
Sentence: 408,lobular,O
Sentence: 408,architecture,O
Sentence: 408,was,O
Sentence: 408,preserved,O
Sentence: 408,.,O
Sentence: 408,This,O
Sentence: 408,case,O
Sentence: 408,represents,O
Sentence: 408,an,O
Sentence: 408,example,O
Sentence: 408,of,O
Sentence: 408,``,O
Sentence: 408,idiosyncratic,O
Sentence: 408,'',O
Sentence: 408,drug,O
Sentence: 408,-,O
Sentence: 408,induced,O
Sentence: 408,liver,O
Sentence: 408,damage,O
Sentence: 408,in,O
Sentence: 408,which,O
Sentence: 408,the,O
Sentence: 408,primary,O
Sentence: 408,target,O
Sentence: 408,of,O
Sentence: 408,injury,O
Sentence: 408,is,O
Sentence: 408,the,O
Sentence: 408,bile,O
Sentence: 408,duct,O
Sentence: 408,.,O
Sentence: 408,An,O
Sentence: 408,autoimmune,O
Sentence: 408,pathogenesis,O
Sentence: 408,of,O
Sentence: 408,the,O
Sentence: 408,bile,B-Disease
Sentence: 408,duct,I-Disease
Sentence: 408,destruction,I-Disease
Sentence: 408,is,O
Sentence: 408,suggested,O
Sentence: 408,.,O
Sentence: 409,Differential,O
Sentence: 409,effects,O
Sentence: 409,of,O
Sentence: 409,"1,4",O
Sentence: 409,-,O
Sentence: 409,dihydropyridine,O
Sentence: 409,calcium,B-Chemical
Sentence: 409,channel,I-Chemical
Sentence: 409,blockers,I-Chemical
Sentence: 409,:,O
Sentence: 409,therapeutic,O
Sentence: 409,implications,O
Sentence: 409,.,O
Sentence: 410,Increasing,O
Sentence: 410,recognition,O
Sentence: 410,of,O
Sentence: 410,the,O
Sentence: 410,importance,O
Sentence: 410,of,O
Sentence: 410,calcium,B-Chemical
Sentence: 410,in,O
Sentence: 410,the,O
Sentence: 410,pathogenesis,O
Sentence: 410,of,O
Sentence: 410,cardiovascular,B-Disease
Sentence: 410,disease,I-Disease
Sentence: 410,has,O
Sentence: 410,stimulated,O
Sentence: 410,research,O
Sentence: 410,into,O
Sentence: 410,the,O
Sentence: 410,use,O
Sentence: 410,of,O
Sentence: 410,calcium,B-Chemical
Sentence: 410,channel,I-Chemical
Sentence: 410,blocking,I-Chemical
Sentence: 410,agents,I-Chemical
Sentence: 410,for,O
Sentence: 410,treatment,O
Sentence: 410,of,O
Sentence: 410,a,O
Sentence: 410,variety,O
Sentence: 410,of,O
Sentence: 410,cardiovascular,B-Disease
Sentence: 410,diseases,I-Disease
Sentence: 410,.,O
Sentence: 410,The,O
Sentence: 410,favorable,O
Sentence: 410,efficacy,O
Sentence: 410,and,O
Sentence: 410,tolerability,O
Sentence: 410,profiles,O
Sentence: 410,of,O
Sentence: 410,these,O
Sentence: 410,agents,O
Sentence: 410,make,O
Sentence: 410,them,O
Sentence: 410,attractive,O
Sentence: 410,therapeutic,O
Sentence: 410,modalities,O
Sentence: 410,.,O
Sentence: 410,Clinical,O
Sentence: 410,applications,O
Sentence: 410,of,O
Sentence: 410,calcium,B-Chemical
Sentence: 410,channel,I-Chemical
Sentence: 410,blockers,I-Chemical
Sentence: 410,parallel,O
Sentence: 410,their,O
Sentence: 410,tissue,O
Sentence: 410,selectivity,O
Sentence: 410,.,O
Sentence: 410,In,O
Sentence: 410,contrast,O
Sentence: 410,to,O
Sentence: 410,verapamil,B-Chemical
Sentence: 410,and,O
Sentence: 410,diltiazem,B-Chemical
Sentence: 410,",",O
Sentence: 410,which,O
Sentence: 410,are,O
Sentence: 410,roughly,O
Sentence: 410,equipotent,O
Sentence: 410,in,O
Sentence: 410,their,O
Sentence: 410,actions,O
Sentence: 410,on,O
Sentence: 410,the,O
Sentence: 410,heart,O
Sentence: 410,and,O
Sentence: 410,vascular,O
Sentence: 410,smooth,O
Sentence: 410,muscle,O
Sentence: 410,",",O
Sentence: 410,the,O
Sentence: 410,dihydropyridine,B-Chemical
Sentence: 410,calcium,B-Chemical
Sentence: 410,channel,I-Chemical
Sentence: 410,blockers,I-Chemical
Sentence: 410,are,O
Sentence: 410,a,O
Sentence: 410,group,O
Sentence: 410,of,O
Sentence: 410,potent,O
Sentence: 410,peripheral,O
Sentence: 410,vasodilator,O
Sentence: 410,agents,O
Sentence: 410,that,O
Sentence: 410,exert,O
Sentence: 410,minimal,O
Sentence: 410,electrophysiologic,O
Sentence: 410,effects,O
Sentence: 410,on,O
Sentence: 410,cardiac,O
Sentence: 410,nodal,O
Sentence: 410,or,O
Sentence: 410,conduction,O
Sentence: 410,tissue,O
Sentence: 410,.,O
Sentence: 410,As,O
Sentence: 410,the,O
Sentence: 410,first,O
Sentence: 410,dihydropyridine,B-Chemical
Sentence: 410,available,O
Sentence: 410,for,O
Sentence: 410,use,O
Sentence: 410,in,O
Sentence: 410,the,O
Sentence: 410,United,O
Sentence: 410,States,O
Sentence: 410,",",O
Sentence: 410,nifedipine,B-Chemical
Sentence: 410,controls,O
Sentence: 410,angina,B-Disease
Sentence: 410,and,O
Sentence: 410,hypertension,B-Disease
Sentence: 410,with,O
Sentence: 410,minimal,O
Sentence: 410,depression,O
Sentence: 410,of,O
Sentence: 410,cardiac,O
Sentence: 410,function,O
Sentence: 410,.,O
Sentence: 410,Additional,O
Sentence: 410,members,O
Sentence: 410,of,O
Sentence: 410,this,O
Sentence: 410,group,O
Sentence: 410,of,O
Sentence: 410,calcium,B-Chemical
Sentence: 410,channel,I-Chemical
Sentence: 410,blockers,I-Chemical
Sentence: 410,have,O
Sentence: 410,been,O
Sentence: 410,studied,O
Sentence: 410,for,O
Sentence: 410,a,O
Sentence: 410,variety,O
Sentence: 410,of,O
Sentence: 410,indications,O
Sentence: 410,for,O
Sentence: 410,which,O
Sentence: 410,they,O
Sentence: 410,may,O
Sentence: 410,offer,O
Sentence: 410,advantages,O
Sentence: 410,over,O
Sentence: 410,current,O
Sentence: 410,therapy,O
Sentence: 410,.,O
Sentence: 410,Once,O
Sentence: 410,or,O
Sentence: 410,twice,O
Sentence: 410,daily,O
Sentence: 410,dosage,O
Sentence: 410,possible,O
Sentence: 410,with,O
Sentence: 410,nitrendipine,B-Chemical
Sentence: 410,and,O
Sentence: 410,nisoldipine,B-Chemical
Sentence: 410,offers,O
Sentence: 410,a,O
Sentence: 410,convenient,O
Sentence: 410,administration,O
Sentence: 410,schedule,O
Sentence: 410,",",O
Sentence: 410,which,O
Sentence: 410,encourages,O
Sentence: 410,patient,O
Sentence: 410,compliance,O
Sentence: 410,in,O
Sentence: 410,long,O
Sentence: 410,-,O
Sentence: 410,term,O
Sentence: 410,therapy,O
Sentence: 410,of,O
Sentence: 410,hypertension,B-Disease
Sentence: 410,.,O
Sentence: 410,The,O
Sentence: 410,coronary,O
Sentence: 410,vasodilating,O
Sentence: 410,properties,O
Sentence: 410,of,O
Sentence: 410,nisoldipine,B-Chemical
Sentence: 410,have,O
Sentence: 410,led,O
Sentence: 410,to,O
Sentence: 410,the,O
Sentence: 410,investigation,O
Sentence: 410,of,O
Sentence: 410,this,O
Sentence: 410,agent,O
Sentence: 410,for,O
Sentence: 410,use,O
Sentence: 410,in,O
Sentence: 410,angina,B-Disease
Sentence: 410,.,O
Sentence: 410,Selectivity,O
Sentence: 410,for,O
Sentence: 410,the,O
Sentence: 410,cerebrovascular,O
Sentence: 410,bed,O
Sentence: 410,makes,O
Sentence: 410,nimodipine,B-Chemical
Sentence: 410,potentially,O
Sentence: 410,useful,O
Sentence: 410,in,O
Sentence: 410,the,O
Sentence: 410,treatment,O
Sentence: 410,of,O
Sentence: 410,subarachnoid,B-Disease
Sentence: 410,hemorrhage,I-Disease
Sentence: 410,",",O
Sentence: 410,migraine,B-Disease
Sentence: 410,headache,B-Disease
Sentence: 410,",",O
Sentence: 410,dementia,B-Disease
Sentence: 410,",",O
Sentence: 410,and,O
Sentence: 410,stroke,B-Disease
Sentence: 410,.,O
Sentence: 410,In,O
Sentence: 410,general,O
Sentence: 410,",",O
Sentence: 410,the,O
Sentence: 410,dihydropyridine,B-Chemical
Sentence: 410,calcium,B-Chemical
Sentence: 410,channel,I-Chemical
Sentence: 410,blockers,I-Chemical
Sentence: 410,are,O
Sentence: 410,usually,O
Sentence: 410,well,O
Sentence: 410,tolerated,O
Sentence: 410,",",O
Sentence: 410,with,O
Sentence: 410,headache,B-Disease
Sentence: 410,",",O
Sentence: 410,facial,O
Sentence: 410,flushing,B-Disease
Sentence: 410,",",O
Sentence: 410,palpitations,B-Disease
Sentence: 410,",",O
Sentence: 410,edema,B-Disease
Sentence: 410,",",O
Sentence: 410,nausea,B-Disease
Sentence: 410,",",O
Sentence: 410,anorexia,B-Disease
Sentence: 410,",",O
Sentence: 410,and,O
Sentence: 410,dizziness,B-Disease
Sentence: 410,being,O
Sentence: 410,the,O
Sentence: 410,more,O
Sentence: 410,common,O
Sentence: 410,adverse,O
Sentence: 410,effects,O
Sentence: 410,.,O
Sentence: 411,The,O
Sentence: 411,enhancement,O
Sentence: 411,of,O
Sentence: 411,aminonucleoside,B-Chemical
Sentence: 411,nephrosis,B-Disease
Sentence: 411,by,O
Sentence: 411,the,O
Sentence: 411,co,O
Sentence: 411,-,O
Sentence: 411,administration,O
Sentence: 411,of,O
Sentence: 411,protamine,O
Sentence: 411,.,O
Sentence: 412,An,O
Sentence: 412,experimental,O
Sentence: 412,model,O
Sentence: 412,of,O
Sentence: 412,focal,B-Disease
Sentence: 412,segmental,I-Disease
Sentence: 412,glomerular,I-Disease
Sentence: 412,sclerosis,I-Disease
Sentence: 412,(,O
Sentence: 412,FSGS,B-Disease
Sentence: 412,),O
Sentence: 412,was,O
Sentence: 412,developed,O
Sentence: 412,in,O
Sentence: 412,rats,O
Sentence: 412,by,O
Sentence: 412,the,O
Sentence: 412,combined,O
Sentence: 412,administration,O
Sentence: 412,of,O
Sentence: 412,puromycin,O
Sentence: 412,-,O
Sentence: 412,aminonucleoside,O
Sentence: 412,(,O
Sentence: 412,AMNS,B-Chemical
Sentence: 412,),O
Sentence: 412,and,O
Sentence: 412,protamine,B-Chemical
Sentence: 412,sulfate,I-Chemical
Sentence: 412,(,O
Sentence: 412,PS,B-Chemical
Sentence: 412,),O
Sentence: 412,.,O
Sentence: 412,Male,O
Sentence: 412,Sprague,O
Sentence: 412,-,O
Sentence: 412,Dawley,O
Sentence: 412,rats,O
Sentence: 412,",",O
Sentence: 412,uninephrectomized,O
Sentence: 412,three,O
Sentence: 412,weeks,O
Sentence: 412,before,O
Sentence: 412,",",O
Sentence: 412,received,O
Sentence: 412,daily,O
Sentence: 412,injections,O
Sentence: 412,of,O
Sentence: 412,subcutaneous,O
Sentence: 412,AMNS,B-Chemical
Sentence: 412,(,O
Sentence: 412,1,O
Sentence: 412,mg,O
Sentence: 412,/,O
Sentence: 412,100,O
Sentence: 412,g,O
Sentence: 412,body,O
Sentence: 412,wt,O
Sentence: 412,),O
Sentence: 412,and,O
Sentence: 412,intravenous,O
Sentence: 412,PS,B-Chemical
Sentence: 412,(,O
Sentence: 412,2,O
Sentence: 412,separated,O
Sentence: 412,doses,O
Sentence: 412,of,O
Sentence: 412,2.5,O
Sentence: 412,mg,O
Sentence: 412,/,O
Sentence: 412,100,O
Sentence: 412,g,O
Sentence: 412,body,O
Sentence: 412,wt,O
Sentence: 412,),O
Sentence: 412,for,O
Sentence: 412,four,O
Sentence: 412,days,O
Sentence: 412,.,O
Sentence: 412,The,O
Sentence: 412,series,O
Sentence: 412,of,O
Sentence: 412,injections,O
Sentence: 412,were,O
Sentence: 412,repeated,O
Sentence: 412,another,O
Sentence: 412,three,O
Sentence: 412,times,O
Sentence: 412,at,O
Sentence: 412,10,O
Sentence: 412,day,O
Sentence: 412,intervals,O
Sentence: 412,.,O
Sentence: 412,The,O
Sentence: 412,animals,O
Sentence: 412,were,O
Sentence: 412,sacrificed,O
Sentence: 412,on,O
Sentence: 412,days,O
Sentence: 412,24,O
Sentence: 412,",",O
Sentence: 412,52,O
Sentence: 412,",",O
Sentence: 412,and,O
Sentence: 412,80,O
Sentence: 412,.,O
Sentence: 412,They,O
Sentence: 412,developed,O
Sentence: 412,nephrotic,B-Disease
Sentence: 412,syndrome,I-Disease
Sentence: 412,and,O
Sentence: 412,finally,O
Sentence: 412,renal,B-Disease
Sentence: 412,failure,I-Disease
Sentence: 412,.,O
Sentence: 412,The,O
Sentence: 412,time,O
Sentence: 412,-,O
Sentence: 412,course,O
Sentence: 412,curve,O
Sentence: 412,of,O
Sentence: 412,creatinine,B-Chemical
Sentence: 412,clearance,O
Sentence: 412,dropped,O
Sentence: 412,and,O
Sentence: 412,showed,O
Sentence: 412,significant,O
Sentence: 412,difference,O
Sentence: 412,(,O
Sentence: 412,P,O
Sentence: 412,less,O
Sentence: 412,than,O
Sentence: 412,0.01,O
Sentence: 412,),O
Sentence: 412,from,O
Sentence: 412,that,O
Sentence: 412,of,O
Sentence: 412,each,O
Sentence: 412,control,O
Sentence: 412,group,O
Sentence: 412,",",O
Sentence: 412,such,O
Sentence: 412,as,O
Sentence: 412,",",O
Sentence: 412,AMNS,B-Chemical
Sentence: 412,alone,O
Sentence: 412,",",O
Sentence: 412,PS,B-Chemical
Sentence: 412,alone,O
Sentence: 412,or,O
Sentence: 412,saline,O
Sentence: 412,injected,O
Sentence: 412,.,O
Sentence: 412,Their,O
Sentence: 412,glomeruli,O
Sentence: 412,showed,O
Sentence: 412,changes,O
Sentence: 412,of,O
Sentence: 412,progressive,O
Sentence: 412,FSGS,B-Disease
Sentence: 412,.,O
Sentence: 412,The,O
Sentence: 412,ultrastructural,O
Sentence: 412,studies,O
Sentence: 412,in,O
Sentence: 412,the,O
Sentence: 412,initial,O
Sentence: 412,stage,O
Sentence: 412,revealed,O
Sentence: 412,significant,O
Sentence: 412,lack,O
Sentence: 412,of,O
Sentence: 412,particles,O
Sentence: 412,of,O
Sentence: 412,perfused,O
Sentence: 412,ruthenium,B-Chemical
Sentence: 412,red,O
Sentence: 412,on,O
Sentence: 412,the,O
Sentence: 412,lamina,O
Sentence: 412,rara,O
Sentence: 412,externa,O
Sentence: 412,and,O
Sentence: 412,marked,O
Sentence: 412,changes,O
Sentence: 412,in,O
Sentence: 412,epithelial,O
Sentence: 412,cell,O
Sentence: 412,cytoplasm,O
Sentence: 412,.,O
Sentence: 412,Therefore,O
Sentence: 412,",",O
Sentence: 412,it,O
Sentence: 412,is,O
Sentence: 412,suggested,O
Sentence: 412,that,O
Sentence: 412,the,O
Sentence: 412,administration,O
Sentence: 412,of,O
Sentence: 412,PS,B-Chemical
Sentence: 412,enhances,O
Sentence: 412,the,O
Sentence: 412,toxicity,B-Disease
Sentence: 412,of,O
Sentence: 412,AMNS,B-Chemical
Sentence: 412,on,O
Sentence: 412,the,O
Sentence: 412,glomerulus,O
Sentence: 412,and,O
Sentence: 412,readily,O
Sentence: 412,produces,O
Sentence: 412,progressive,O
Sentence: 412,FSGS,B-Disease
Sentence: 412,in,O
Sentence: 412,rats,O
Sentence: 412,resulting,O
Sentence: 412,in,O
Sentence: 412,the,O
Sentence: 412,end,O
Sentence: 412,-,O
Sentence: 412,stage,O
Sentence: 412,renal,O
Sentence: 412,disease,O
Sentence: 412,.,O
Sentence: 413,Theophylline,B-Chemical
Sentence: 413,neurotoxicity,B-Disease
Sentence: 413,in,O
Sentence: 413,pregnant,O
Sentence: 413,rats,O
Sentence: 413,.,O
Sentence: 414,The,O
Sentence: 414,purpose,O
Sentence: 414,of,O
Sentence: 414,this,O
Sentence: 414,investigation,O
Sentence: 414,was,O
Sentence: 414,to,O
Sentence: 414,determine,O
Sentence: 414,whether,O
Sentence: 414,the,O
Sentence: 414,neurotoxicity,B-Disease
Sentence: 414,of,O
Sentence: 414,theophylline,B-Chemical
Sentence: 414,is,O
Sentence: 414,altered,O
Sentence: 414,in,O
Sentence: 414,advanced,O
Sentence: 414,pregnancy,O
Sentence: 414,.,O
Sentence: 414,Sprague,O
Sentence: 414,-,O
Sentence: 414,Dawley,O
Sentence: 414,rats,O
Sentence: 414,that,O
Sentence: 414,were,O
Sentence: 414,20,O
Sentence: 414,days,O
Sentence: 414,pregnant,O
Sentence: 414,and,O
Sentence: 414,nonpregnant,O
Sentence: 414,rats,O
Sentence: 414,of,O
Sentence: 414,the,O
Sentence: 414,same,O
Sentence: 414,age,O
Sentence: 414,and,O
Sentence: 414,strain,O
Sentence: 414,received,O
Sentence: 414,infusions,O
Sentence: 414,of,O
Sentence: 414,aminophylline,B-Chemical
Sentence: 414,until,O
Sentence: 414,onset,O
Sentence: 414,of,O
Sentence: 414,maximal,O
Sentence: 414,seizures,B-Disease
Sentence: 414,which,O
Sentence: 414,occurred,O
Sentence: 414,after,O
Sentence: 414,28,O
Sentence: 414,and,O
Sentence: 414,30,O
Sentence: 414,minutes,O
Sentence: 414,respectively,O
Sentence: 414,.,O
Sentence: 414,Theophylline,B-Chemical
Sentence: 414,concentrations,O
Sentence: 414,at,O
Sentence: 414,this,O
Sentence: 414,endpoint,O
Sentence: 414,in,O
Sentence: 414,serum,O
Sentence: 414,(,O
Sentence: 414,total,O
Sentence: 414,),O
Sentence: 414,and,O
Sentence: 414,CSF,O
Sentence: 414,were,O
Sentence: 414,similar,O
Sentence: 414,but,O
Sentence: 414,serum,O
Sentence: 414,(,O
Sentence: 414,free,O
Sentence: 414,),O
Sentence: 414,and,O
Sentence: 414,brain,O
Sentence: 414,concentrations,O
Sentence: 414,were,O
Sentence: 414,slightly,O
Sentence: 414,different,O
Sentence: 414,in,O
Sentence: 414,pregnant,O
Sentence: 414,rats,O
Sentence: 414,.,O
Sentence: 414,Theophylline,B-Chemical
Sentence: 414,serum,O
Sentence: 414,protein,O
Sentence: 414,binding,O
Sentence: 414,determined,O
Sentence: 414,by,O
Sentence: 414,equilibrium,O
Sentence: 414,dialysis,O
Sentence: 414,was,O
Sentence: 414,lower,O
Sentence: 414,in,O
Sentence: 414,pregnant,O
Sentence: 414,rats,O
Sentence: 414,.,O
Sentence: 414,Fetal,O
Sentence: 414,serum,O
Sentence: 414,concentrations,O
Sentence: 414,at,O
Sentence: 414,onset,O
Sentence: 414,of,O
Sentence: 414,seizures,B-Disease
Sentence: 414,in,O
Sentence: 414,the,O
Sentence: 414,mother,O
Sentence: 414,were,O
Sentence: 414,similar,O
Sentence: 414,to,O
Sentence: 414,maternal,O
Sentence: 414,brain,O
Sentence: 414,and,O
Sentence: 414,CSF,O
Sentence: 414,concentrations,O
Sentence: 414,and,O
Sentence: 414,correlated,O
Sentence: 414,significantly,O
Sentence: 414,with,O
Sentence: 414,the,O
Sentence: 414,former,O
Sentence: 414,.,O
Sentence: 414,It,O
Sentence: 414,is,O
Sentence: 414,concluded,O
Sentence: 414,that,O
Sentence: 414,advanced,O
Sentence: 414,pregnancy,O
Sentence: 414,has,O
Sentence: 414,a,O
Sentence: 414,negligible,O
Sentence: 414,effect,O
Sentence: 414,on,O
Sentence: 414,the,O
Sentence: 414,neurotoxic,B-Disease
Sentence: 414,response,O
Sentence: 414,to,O
Sentence: 414,theophylline,B-Chemical
Sentence: 414,in,O
Sentence: 414,rats,O
Sentence: 414,.,O
Sentence: 415,Hyperkalemia,B-Disease
Sentence: 415,induced,O
Sentence: 415,by,O
Sentence: 415,indomethacin,B-Chemical
Sentence: 415,and,O
Sentence: 415,naproxen,B-Chemical
Sentence: 415,and,O
Sentence: 415,reversed,O
Sentence: 415,by,O
Sentence: 415,fludrocortisone,B-Chemical
Sentence: 415,.,O
Sentence: 416,We,O
Sentence: 416,have,O
Sentence: 416,described,O
Sentence: 416,a,O
Sentence: 416,patient,O
Sentence: 416,with,O
Sentence: 416,severe,O
Sentence: 416,rheumatoid,B-Disease
Sentence: 416,arthritis,I-Disease
Sentence: 416,and,O
Sentence: 416,a,O
Sentence: 416,history,O
Sentence: 416,of,O
Sentence: 416,mefenamic,B-Chemical
Sentence: 416,acid,I-Chemical
Sentence: 416,nephropathy,B-Disease
Sentence: 416,in,O
Sentence: 416,whom,O
Sentence: 416,hyperkalemia,B-Disease
Sentence: 416,and,O
Sentence: 416,inappropriate,O
Sentence: 416,hypoaldosteronism,B-Disease
Sentence: 416,were,O
Sentence: 416,caused,O
Sentence: 416,by,O
Sentence: 416,both,O
Sentence: 416,indomethacin,B-Chemical
Sentence: 416,and,O
Sentence: 416,naproxen,B-Chemical
Sentence: 416,",",O
Sentence: 416,without,O
Sentence: 416,major,O
Sentence: 416,decline,O
Sentence: 416,in,O
Sentence: 416,renal,O
Sentence: 416,function,O
Sentence: 416,.,O
Sentence: 416,It,O
Sentence: 416,is,O
Sentence: 416,likely,O
Sentence: 416,that,O
Sentence: 416,preexisting,O
Sentence: 416,renal,B-Disease
Sentence: 416,disease,I-Disease
Sentence: 416,predisposed,O
Sentence: 416,this,O
Sentence: 416,patient,O
Sentence: 416,to,O
Sentence: 416,type,B-Disease
Sentence: 416,IV,I-Disease
Sentence: 416,renal,I-Disease
Sentence: 416,tubular,I-Disease
Sentence: 416,acidosis,I-Disease
Sentence: 416,with,O
Sentence: 416,prostaglandin,B-Chemical
Sentence: 416,synthetase,O
Sentence: 416,inhibitors,O
Sentence: 416,.,O
Sentence: 416,Because,O
Sentence: 416,he,O
Sentence: 416,was,O
Sentence: 416,unable,O
Sentence: 416,to,O
Sentence: 416,discontinue,O
Sentence: 416,nonsteroidal,O
Sentence: 416,anti,O
Sentence: 416,-,O
Sentence: 416,inflammatory,O
Sentence: 416,drug,O
Sentence: 416,therapy,O
Sentence: 416,",",O
Sentence: 416,fludrocortisone,B-Chemical
Sentence: 416,was,O
Sentence: 416,added,O
Sentence: 416,",",O
Sentence: 416,correcting,O
Sentence: 416,the,O
Sentence: 416,hyperkalemia,B-Disease
Sentence: 416,and,O
Sentence: 416,allowing,O
Sentence: 416,indomethacin,B-Chemical
Sentence: 416,therapy,O
Sentence: 416,to,O
Sentence: 416,be,O
Sentence: 416,continued,O
Sentence: 416,safely,O
Sentence: 416,.,O
Sentence: 417,Hypotension,B-Disease
Sentence: 417,as,O
Sentence: 417,a,O
Sentence: 417,manifestation,O
Sentence: 417,of,O
Sentence: 417,cardiotoxicity,B-Disease
Sentence: 417,in,O
Sentence: 417,three,O
Sentence: 417,patients,O
Sentence: 417,receiving,O
Sentence: 417,cisplatin,B-Chemical
Sentence: 417,and,O
Sentence: 417,5,O
Sentence: 417,-,O
Sentence: 417,fluorouracil,O
Sentence: 417,.,O
Sentence: 418,Cardiac,O
Sentence: 418,symptoms,O
Sentence: 418,",",O
Sentence: 418,including,O
Sentence: 418,hypotension,B-Disease
Sentence: 418,",",O
Sentence: 418,developed,O
Sentence: 418,in,O
Sentence: 418,three,O
Sentence: 418,patients,O
Sentence: 418,with,O
Sentence: 418,advanced,O
Sentence: 418,colorectal,B-Disease
Sentence: 418,carcinoma,I-Disease
Sentence: 418,while,O
Sentence: 418,being,O
Sentence: 418,treated,O
Sentence: 418,with,O
Sentence: 418,cisplatin,B-Chemical
Sentence: 418,(,O
Sentence: 418,CDDP,B-Chemical
Sentence: 418,),O
Sentence: 418,and,O
Sentence: 418,5,O
Sentence: 418,-,O
Sentence: 418,fluorouracil,O
Sentence: 418,(,O
Sentence: 418,5,O
Sentence: 418,-,O
Sentence: 418,FU,O
Sentence: 418,),O
Sentence: 418,.,O
Sentence: 418,In,O
Sentence: 418,two,O
Sentence: 418,patients,O
Sentence: 418,",",O
Sentence: 418,hypotension,B-Disease
Sentence: 418,was,O
Sentence: 418,associated,O
Sentence: 418,with,O
Sentence: 418,severe,O
Sentence: 418,left,B-Disease
Sentence: 418,ventricular,I-Disease
Sentence: 418,dysfunction,I-Disease
Sentence: 418,.,O
Sentence: 418,All,O
Sentence: 418,three,O
Sentence: 418,patients,O
Sentence: 418,required,O
Sentence: 418,therapy,O
Sentence: 418,discontinuation,O
Sentence: 418,.,O
Sentence: 418,Cardiac,O
Sentence: 418,enzymes,O
Sentence: 418,remained,O
Sentence: 418,normal,O
Sentence: 418,despite,O
Sentence: 418,transient,O
Sentence: 418,electrocardiographic,O
Sentence: 418,(,O
Sentence: 418,EKG,O
Sentence: 418,),O
Sentence: 418,changes,O
Sentence: 418,.,O
Sentence: 418,The,O
Sentence: 418,presentation,O
Sentence: 418,and,O
Sentence: 418,cardiac,O
Sentence: 418,evaluation,O
Sentence: 418,(,O
Sentence: 418,hemodynamic,O
Sentence: 418,",",O
Sentence: 418,echocardiographic,O
Sentence: 418,",",O
Sentence: 418,and,O
Sentence: 418,scintigraphic,O
Sentence: 418,),O
Sentence: 418,of,O
Sentence: 418,these,O
Sentence: 418,patients,O
Sentence: 418,suggest,O
Sentence: 418,new,O
Sentence: 418,manifestations,O
Sentence: 418,of,O
Sentence: 418,5,O
Sentence: 418,-,O
Sentence: 418,FU,O
Sentence: 418,cardiotoxicity,B-Disease
Sentence: 418,that,O
Sentence: 418,may,O
Sentence: 418,be,O
Sentence: 418,influenced,O
Sentence: 418,by,O
Sentence: 418,CDDP,B-Chemical
Sentence: 418,.,O
Sentence: 418,The,O
Sentence: 418,possible,O
Sentence: 418,pathophysiologic,O
Sentence: 418,mechanisms,O
Sentence: 418,are,O
Sentence: 418,discussed,O
Sentence: 418,.,O
Sentence: 419,Fatal,O
Sentence: 419,aplastic,B-Disease
Sentence: 419,anemia,I-Disease
Sentence: 419,in,O
Sentence: 419,a,O
Sentence: 419,patient,O
Sentence: 419,treated,O
Sentence: 419,with,O
Sentence: 419,carbamazepine,B-Chemical
Sentence: 419,.,O
Sentence: 420,A,O
Sentence: 420,case,O
Sentence: 420,of,O
Sentence: 420,fatal,O
Sentence: 420,aplastic,B-Disease
Sentence: 420,anemia,I-Disease
Sentence: 420,due,O
Sentence: 420,to,O
Sentence: 420,carbamazepine,B-Chemical
Sentence: 420,treatment,O
Sentence: 420,in,O
Sentence: 420,an,O
Sentence: 420,epileptic,B-Disease
Sentence: 420,woman,O
Sentence: 420,is,O
Sentence: 420,reported,O
Sentence: 420,.,O
Sentence: 420,Despite,O
Sentence: 420,concerns,O
Sentence: 420,of,O
Sentence: 420,fatal,O
Sentence: 420,bone,B-Disease
Sentence: 420,marrow,I-Disease
Sentence: 420,toxicity,I-Disease
Sentence: 420,due,O
Sentence: 420,to,O
Sentence: 420,carbamazepine,B-Chemical
Sentence: 420,",",O
Sentence: 420,this,O
Sentence: 420,is,O
Sentence: 420,only,O
Sentence: 420,the,O
Sentence: 420,fourth,O
Sentence: 420,documented,O
Sentence: 420,and,O
Sentence: 420,published,O
Sentence: 420,report,O
Sentence: 420,.,O
Sentence: 420,Carbamazepine,B-Chemical
Sentence: 420,is,O
Sentence: 420,a,O
Sentence: 420,safe,O
Sentence: 420,drug,O
Sentence: 420,",",O
Sentence: 420,but,O
Sentence: 420,physicians,O
Sentence: 420,and,O
Sentence: 420,patients,O
Sentence: 420,should,O
Sentence: 420,be,O
Sentence: 420,aware,O
Sentence: 420,of,O
Sentence: 420,the,O
Sentence: 420,exceedingly,O
Sentence: 420,rare,O
Sentence: 420,but,O
Sentence: 420,potentially,O
Sentence: 420,fatal,O
Sentence: 420,side,O
Sentence: 420,effects,O
Sentence: 420,",",O
Sentence: 420,better,O
Sentence: 420,prevented,O
Sentence: 420,by,O
Sentence: 420,clinical,O
Sentence: 420,than,O
Sentence: 420,by,O
Sentence: 420,laboratory,O
Sentence: 420,monitoring,O
Sentence: 420,.,O
Sentence: 421,Participation,O
Sentence: 421,of,O
Sentence: 421,a,O
Sentence: 421,bulbospinal,O
Sentence: 421,serotonergic,O
Sentence: 421,pathway,O
Sentence: 421,in,O
Sentence: 421,the,O
Sentence: 421,rat,O
Sentence: 421,brain,O
Sentence: 421,in,O
Sentence: 421,clonidine,B-Chemical
Sentence: 421,-,O
Sentence: 421,induced,O
Sentence: 421,hypotension,B-Disease
Sentence: 421,and,O
Sentence: 421,bradycardia,B-Disease
Sentence: 421,.,O
Sentence: 422,The,O
Sentence: 422,effects,O
Sentence: 422,of,O
Sentence: 422,microinjection,O
Sentence: 422,of,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,(,O
Sentence: 422,1,O
Sentence: 422,-,O
Sentence: 422,10,O
Sentence: 422,micrograms,O
Sentence: 422,in,O
Sentence: 422,1,O
Sentence: 422,microliter,O
Sentence: 422,),O
Sentence: 422,into,O
Sentence: 422,a,O
Sentence: 422,region,O
Sentence: 422,adjacent,O
Sentence: 422,to,O
Sentence: 422,the,O
Sentence: 422,ventrolateral,O
Sentence: 422,surface,O
Sentence: 422,of,O
Sentence: 422,the,O
Sentence: 422,medulla,O
Sentence: 422,oblongata,O
Sentence: 422,on,O
Sentence: 422,cardiovascular,O
Sentence: 422,function,O
Sentence: 422,were,O
Sentence: 422,assessed,O
Sentence: 422,in,O
Sentence: 422,urethane,B-Chemical
Sentence: 422,-,O
Sentence: 422,anesthetized,O
Sentence: 422,rats,O
Sentence: 422,.,O
Sentence: 422,Intramedullary,O
Sentence: 422,administration,O
Sentence: 422,of,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,",",O
Sentence: 422,but,O
Sentence: 422,not,O
Sentence: 422,saline,O
Sentence: 422,vehicle,O
Sentence: 422,",",O
Sentence: 422,caused,O
Sentence: 422,a,O
Sentence: 422,dose,O
Sentence: 422,-,O
Sentence: 422,dependent,O
Sentence: 422,decrease,O
Sentence: 422,in,O
Sentence: 422,both,O
Sentence: 422,the,O
Sentence: 422,mean,O
Sentence: 422,arterial,O
Sentence: 422,pressure,O
Sentence: 422,and,O
Sentence: 422,the,O
Sentence: 422,heart,O
Sentence: 422,rate,O
Sentence: 422,.,O
Sentence: 422,The,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,-,O
Sentence: 422,induced,O
Sentence: 422,hypotension,B-Disease
Sentence: 422,was,O
Sentence: 422,antagonized,O
Sentence: 422,by,O
Sentence: 422,prior,O
Sentence: 422,spinal,O
Sentence: 422,transection,O
Sentence: 422,",",O
Sentence: 422,but,O
Sentence: 422,not,O
Sentence: 422,bilateral,O
Sentence: 422,vagotomy,O
Sentence: 422,.,O
Sentence: 422,On,O
Sentence: 422,the,O
Sentence: 422,other,O
Sentence: 422,hand,O
Sentence: 422,",",O
Sentence: 422,the,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,-,O
Sentence: 422,induced,O
Sentence: 422,bradycardia,B-Disease
Sentence: 422,was,O
Sentence: 422,antagonized,O
Sentence: 422,by,O
Sentence: 422,prior,O
Sentence: 422,bilateral,O
Sentence: 422,vagotomy,O
Sentence: 422,",",O
Sentence: 422,but,O
Sentence: 422,not,O
Sentence: 422,spinal,O
Sentence: 422,transection,O
Sentence: 422,.,O
Sentence: 422,Furthermore,O
Sentence: 422,",",O
Sentence: 422,selective,O
Sentence: 422,destruction,O
Sentence: 422,of,O
Sentence: 422,the,O
Sentence: 422,spinal,O
Sentence: 422,5,O
Sentence: 422,-,O
Sentence: 422,HT,O
Sentence: 422,nerves,O
Sentence: 422,",",O
Sentence: 422,produced,O
Sentence: 422,by,O
Sentence: 422,bilateral,O
Sentence: 422,spinal,O
Sentence: 422,injection,O
Sentence: 422,of,O
Sentence: 422,"5,7",O
Sentence: 422,-,O
Sentence: 422,dihydroxytryptamine,O
Sentence: 422,",",O
Sentence: 422,reduced,O
Sentence: 422,the,O
Sentence: 422,magnitude,O
Sentence: 422,of,O
Sentence: 422,the,O
Sentence: 422,vasodepressor,O
Sentence: 422,or,O
Sentence: 422,the,O
Sentence: 422,bradycardiac,B-Disease
Sentence: 422,responses,O
Sentence: 422,to,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,microinjected,O
Sentence: 422,into,O
Sentence: 422,the,O
Sentence: 422,area,O
Sentence: 422,near,O
Sentence: 422,the,O
Sentence: 422,ventrolateral,O
Sentence: 422,surface,O
Sentence: 422,of,O
Sentence: 422,the,O
Sentence: 422,medulla,O
Sentence: 422,oblongata,O
Sentence: 422,in,O
Sentence: 422,rats,O
Sentence: 422,.,O
Sentence: 422,The,O
Sentence: 422,data,O
Sentence: 422,indicate,O
Sentence: 422,that,O
Sentence: 422,a,O
Sentence: 422,bulbospinal,O
Sentence: 422,serotonergic,O
Sentence: 422,pathway,O
Sentence: 422,is,O
Sentence: 422,involved,O
Sentence: 422,in,O
Sentence: 422,development,O
Sentence: 422,of,O
Sentence: 422,clonidine,B-Chemical
Sentence: 422,-,O
Sentence: 422,induced,O
Sentence: 422,hypotension,B-Disease
Sentence: 422,and,O
Sentence: 422,bradycardia,B-Disease
Sentence: 422,.,O
Sentence: 422,The,O
Sentence: 422,induced,O
Sentence: 422,hypotension,B-Disease
Sentence: 422,is,O
Sentence: 422,brought,O
Sentence: 422,about,O
Sentence: 422,by,O
Sentence: 422,a,O
Sentence: 422,decrease,O
Sentence: 422,in,O
Sentence: 422,sympathetic,O
Sentence: 422,efferent,O
Sentence: 422,activity,O
Sentence: 422,",",O
Sentence: 422,whereas,O
Sentence: 422,the,O
Sentence: 422,induced,O
Sentence: 422,bradycardia,B-Disease
Sentence: 422,was,O
Sentence: 422,due,O
Sentence: 422,to,O
Sentence: 422,an,O
Sentence: 422,increase,O
Sentence: 422,in,O
Sentence: 422,vagal,O
Sentence: 422,efferent,O
Sentence: 422,activity,O
Sentence: 422,.,O
Sentence: 423,Hypertension,B-Disease
Sentence: 423,in,O
Sentence: 423,neuroblastoma,B-Disease
Sentence: 423,induced,O
Sentence: 423,by,O
Sentence: 423,imipramine,B-Chemical
Sentence: 423,.,O
Sentence: 424,Hypertension,B-Disease
Sentence: 424,is,O
Sentence: 424,a,O
Sentence: 424,well,O
Sentence: 424,-,O
Sentence: 424,known,O
Sentence: 424,finding,O
Sentence: 424,in,O
Sentence: 424,some,O
Sentence: 424,patients,O
Sentence: 424,with,O
Sentence: 424,neuroblastoma,B-Disease
Sentence: 424,.,O
Sentence: 424,However,O
Sentence: 424,",",O
Sentence: 424,it,O
Sentence: 424,has,O
Sentence: 424,not,O
Sentence: 424,previously,O
Sentence: 424,been,O
Sentence: 424,described,O
Sentence: 424,in,O
Sentence: 424,association,O
Sentence: 424,with,O
Sentence: 424,the,O
Sentence: 424,use,O
Sentence: 424,of,O
Sentence: 424,Imipramine,B-Chemical
Sentence: 424,.,O
Sentence: 424,We,O
Sentence: 424,report,O
Sentence: 424,the,O
Sentence: 424,occurrence,O
Sentence: 424,of,O
Sentence: 424,severe,O
Sentence: 424,hypertension,B-Disease
Sentence: 424,(,O
Sentence: 424,blood,O
Sentence: 424,pressure,O
Sentence: 424,190,O
Sentence: 424,/,O
Sentence: 424,160,O
Sentence: 424,),O
Sentence: 424,in,O
Sentence: 424,a,O
Sentence: 424,4,O
Sentence: 424,-,O
Sentence: 424,year,O
Sentence: 424,-,O
Sentence: 424,old,O
Sentence: 424,girl,O
Sentence: 424,with,O
Sentence: 424,neuroblastoma,B-Disease
Sentence: 424,who,O
Sentence: 424,was,O
Sentence: 424,given,O
Sentence: 424,Imipramine,B-Chemical
Sentence: 424,to,O
Sentence: 424,control,O
Sentence: 424,a,O
Sentence: 424,behavior,B-Disease
Sentence: 424,disorder,I-Disease
Sentence: 424,.,O
Sentence: 424,It,O
Sentence: 424,was,O
Sentence: 424,determined,O
Sentence: 424,later,O
Sentence: 424,that,O
Sentence: 424,this,O
Sentence: 424,patient,O
Sentence: 424,'s,O
Sentence: 424,tumor,B-Disease
Sentence: 424,was,O
Sentence: 424,recurring,O
Sentence: 424,at,O
Sentence: 424,the,O
Sentence: 424,time,O
Sentence: 424,of,O
Sentence: 424,her,O
Sentence: 424,hypertensive,B-Disease
Sentence: 424,episode,O
Sentence: 424,.,O
Sentence: 424,Since,O
Sentence: 424,she,O
Sentence: 424,had,O
Sentence: 424,no,O
Sentence: 424,blood,O
Sentence: 424,pressure,O
Sentence: 424,elevation,O
Sentence: 424,at,O
Sentence: 424,initial,O
Sentence: 424,diagnosis,O
Sentence: 424,and,O
Sentence: 424,none,O
Sentence: 424,following,O
Sentence: 424,discontinuation,O
Sentence: 424,of,O
Sentence: 424,the,O
Sentence: 424,Imipramine,B-Chemical
Sentence: 424,(,O
Sentence: 424,when,O
Sentence: 424,she,O
Sentence: 424,was,O
Sentence: 424,in,O
Sentence: 424,florid,O
Sentence: 424,relapse,O
Sentence: 424,),O
Sentence: 424,",",O
Sentence: 424,we,O
Sentence: 424,believe,O
Sentence: 424,that,O
Sentence: 424,this,O
Sentence: 424,drug,O
Sentence: 424,rather,O
Sentence: 424,than,O
Sentence: 424,her,O
Sentence: 424,underlying,O
Sentence: 424,disease,O
Sentence: 424,alone,O
Sentence: 424,caused,O
Sentence: 424,her,O
Sentence: 424,hypertension,B-Disease
Sentence: 424,.,O
Sentence: 424,The,O
Sentence: 424,mechanism,O
Sentence: 424,for,O
Sentence: 424,this,O
Sentence: 424,reaction,O
Sentence: 424,is,O
Sentence: 424,believed,O
Sentence: 424,to,O
Sentence: 424,be,O
Sentence: 424,increased,O
Sentence: 424,levels,O
Sentence: 424,of,O
Sentence: 424,vasoactive,O
Sentence: 424,catecholamines,B-Chemical
Sentence: 424,due,O
Sentence: 424,to,O
Sentence: 424,interference,O
Sentence: 424,of,O
Sentence: 424,their,O
Sentence: 424,physiologic,O
Sentence: 424,inactivation,O
Sentence: 424,by,O
Sentence: 424,Imipramine,B-Chemical
Sentence: 424,.,O
Sentence: 424,From,O
Sentence: 424,this,O
Sentence: 424,experience,O
Sentence: 424,",",O
Sentence: 424,we,O
Sentence: 424,urge,O
Sentence: 424,extreme,O
Sentence: 424,caution,O
Sentence: 424,in,O
Sentence: 424,the,O
Sentence: 424,use,O
Sentence: 424,of,O
Sentence: 424,tricyclic,O
Sentence: 424,antidepressants,O
Sentence: 424,in,O
Sentence: 424,children,O
Sentence: 424,with,O
Sentence: 424,active,O
Sentence: 424,neuroblastoma,B-Disease
Sentence: 424,.,O
Sentence: 425,Rechallenge,O
Sentence: 425,of,O
Sentence: 425,patients,O
Sentence: 425,who,O
Sentence: 425,developed,O
Sentence: 425,oral,B-Disease
Sentence: 425,candidiasis,I-Disease
Sentence: 425,or,O
Sentence: 425,hoarseness,B-Disease
Sentence: 425,with,O
Sentence: 425,beclomethasone,B-Chemical
Sentence: 425,dipropionate,I-Chemical
Sentence: 425,.,O
Sentence: 426,Of,O
Sentence: 426,158,O
Sentence: 426,asthmatic,B-Disease
Sentence: 426,patients,O
Sentence: 426,who,O
Sentence: 426,were,O
Sentence: 426,placed,O
Sentence: 426,on,O
Sentence: 426,inhaled,O
Sentence: 426,beclomethasone,B-Chemical
Sentence: 426,",",O
Sentence: 426,15,O
Sentence: 426,(,O
Sentence: 426,9.5,O
Sentence: 426,%,O
Sentence: 426,),O
Sentence: 426,developed,O
Sentence: 426,either,O
Sentence: 426,hoarseness,B-Disease
Sentence: 426,(,O
Sentence: 426,8,O
Sentence: 426,),O
Sentence: 426,",",O
Sentence: 426,oral,O
Sentence: 426,thrush,B-Disease
Sentence: 426,(,O
Sentence: 426,6,O
Sentence: 426,),O
Sentence: 426,",",O
Sentence: 426,or,O
Sentence: 426,both,O
Sentence: 426,(,O
Sentence: 426,1,O
Sentence: 426,),O
Sentence: 426,.,O
Sentence: 426,When,O
Sentence: 426,their,O
Sentence: 426,adverse,O
Sentence: 426,reactions,O
Sentence: 426,subsided,O
Sentence: 426,",",O
Sentence: 426,seven,O
Sentence: 426,of,O
Sentence: 426,these,O
Sentence: 426,15,O
Sentence: 426,patients,O
Sentence: 426,were,O
Sentence: 426,rechallenged,O
Sentence: 426,with,O
Sentence: 426,inhaled,O
Sentence: 426,beclomethasone,B-Chemical
Sentence: 426,.,O
Sentence: 426,These,O
Sentence: 426,included,O
Sentence: 426,five,O
Sentence: 426,cases,O
Sentence: 426,who,O
Sentence: 426,developed,O
Sentence: 426,hoarseness,B-Disease
Sentence: 426,and,O
Sentence: 426,three,O
Sentence: 426,who,O
Sentence: 426,developed,O
Sentence: 426,Candidiasis,B-Disease
Sentence: 426,.,O
Sentence: 426,One,O
Sentence: 426,patient,O
Sentence: 426,had,O
Sentence: 426,both,O
Sentence: 426,.,O
Sentence: 426,Oral,O
Sentence: 426,thrush,B-Disease
Sentence: 426,did,O
Sentence: 426,not,O
Sentence: 426,recur,O
Sentence: 426,",",O
Sentence: 426,but,O
Sentence: 426,60,O
Sentence: 426,%,O
Sentence: 426,(,O
Sentence: 426,3,O
Sentence: 426,/,O
Sentence: 426,5,O
Sentence: 426,),O
Sentence: 426,of,O
Sentence: 426,patients,O
Sentence: 426,with,O
Sentence: 426,hoarseness,B-Disease
Sentence: 426,had,O
Sentence: 426,recurrence,O
Sentence: 426,.,O
Sentence: 426,We,O
Sentence: 426,conclude,O
Sentence: 426,that,O
Sentence: 426,patients,O
Sentence: 426,may,O
Sentence: 426,be,O
Sentence: 426,restarted,O
Sentence: 426,on,O
Sentence: 426,inhaled,O
Sentence: 426,beclomethasone,B-Chemical
Sentence: 426,when,O
Sentence: 426,clinically,O
Sentence: 426,indicated,O
Sentence: 426,;,O
Sentence: 426,however,O
Sentence: 426,",",O
Sentence: 426,because,O
Sentence: 426,of,O
Sentence: 426,the,O
Sentence: 426,high,O
Sentence: 426,recurrence,O
Sentence: 426,rate,O
Sentence: 426,",",O
Sentence: 426,patients,O
Sentence: 426,who,O
Sentence: 426,develop,O
Sentence: 426,hoarseness,B-Disease
Sentence: 426,should,O
Sentence: 426,not,O
Sentence: 426,be,O
Sentence: 426,re,O
Sentence: 426,-,O
Sentence: 426,challenged,O
Sentence: 426,.,O
Sentence: 426,Concomitant,O
Sentence: 426,use,O
Sentence: 426,of,O
Sentence: 426,oral,O
Sentence: 426,prednisone,B-Chemical
Sentence: 426,and,O
Sentence: 426,topical,O
Sentence: 426,beclomethasone,B-Chemical
Sentence: 426,may,O
Sentence: 426,increase,O
Sentence: 426,the,O
Sentence: 426,risk,O
Sentence: 426,of,O
Sentence: 426,developing,O
Sentence: 426,hoarseness,B-Disease
Sentence: 426,or,O
Sentence: 426,candidiasis,B-Disease
Sentence: 426,.,O
Sentence: 427,Cyclophosphamide,B-Chemical
Sentence: 427,cardiotoxicity,B-Disease
Sentence: 427,:,O
Sentence: 427,an,O
Sentence: 427,analysis,O
Sentence: 427,of,O
Sentence: 427,dosing,O
Sentence: 427,as,O
Sentence: 427,a,O
Sentence: 427,risk,O
Sentence: 427,factor,O
Sentence: 427,.,O
Sentence: 428,Patients,O
Sentence: 428,who,O
Sentence: 428,undergo,O
Sentence: 428,bone,O
Sentence: 428,marrow,O
Sentence: 428,transplantation,O
Sentence: 428,are,O
Sentence: 428,generally,O
Sentence: 428,immunosuppressed,O
Sentence: 428,with,O
Sentence: 428,a,O
Sentence: 428,dose,O
Sentence: 428,of,O
Sentence: 428,cyclophosphamide,B-Chemical
Sentence: 428,(,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,),O
Sentence: 428,which,O
Sentence: 428,is,O
Sentence: 428,usually,O
Sentence: 428,calculated,O
Sentence: 428,based,O
Sentence: 428,on,O
Sentence: 428,the,O
Sentence: 428,patient,O
Sentence: 428,'s,O
Sentence: 428,weight,O
Sentence: 428,.,O
Sentence: 428,At,O
Sentence: 428,these,O
Sentence: 428,high,O
Sentence: 428,doses,O
Sentence: 428,of,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,",",O
Sentence: 428,serious,O
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,may,O
Sentence: 428,occur,O
Sentence: 428,",",O
Sentence: 428,but,O
Sentence: 428,definitive,O
Sentence: 428,risk,O
Sentence: 428,factors,O
Sentence: 428,for,O
Sentence: 428,the,O
Sentence: 428,development,O
Sentence: 428,of,O
Sentence: 428,such,O
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,have,O
Sentence: 428,not,O
Sentence: 428,been,O
Sentence: 428,described,O
Sentence: 428,.,O
Sentence: 428,Since,O
Sentence: 428,chemotherapeutic,O
Sentence: 428,agent,O
Sentence: 428,toxicity,B-Disease
Sentence: 428,generally,O
Sentence: 428,correlates,O
Sentence: 428,with,O
Sentence: 428,dose,O
Sentence: 428,per,O
Sentence: 428,body,O
Sentence: 428,surface,O
Sentence: 428,area,O
Sentence: 428,",",O
Sentence: 428,we,O
Sentence: 428,retrospectively,O
Sentence: 428,calculated,O
Sentence: 428,the,O
Sentence: 428,dose,O
Sentence: 428,of,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,in,O
Sentence: 428,patients,O
Sentence: 428,transplanted,O
Sentence: 428,at,O
Sentence: 428,our,O
Sentence: 428,institution,O
Sentence: 428,to,O
Sentence: 428,determine,O
Sentence: 428,whether,O
Sentence: 428,the,O
Sentence: 428,incidence,O
Sentence: 428,of,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,correlated,O
Sentence: 428,with,O
Sentence: 428,the,O
Sentence: 428,dose,O
Sentence: 428,per,O
Sentence: 428,body,O
Sentence: 428,surface,O
Sentence: 428,area,O
Sentence: 428,.,O
Sentence: 428,Eighty,O
Sentence: 428,patients,O
Sentence: 428,who,O
Sentence: 428,were,O
Sentence: 428,to,O
Sentence: 428,receive,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,50,O
Sentence: 428,mg,O
Sentence: 428,/,O
Sentence: 428,kg,O
Sentence: 428,/,O
Sentence: 428,d,O
Sentence: 428,for,O
Sentence: 428,four,O
Sentence: 428,days,O
Sentence: 428,as,O
Sentence: 428,preparation,O
Sentence: 428,for,O
Sentence: 428,marrow,O
Sentence: 428,grafting,O
Sentence: 428,underwent,O
Sentence: 428,a,O
Sentence: 428,total,O
Sentence: 428,of,O
Sentence: 428,84,O
Sentence: 428,transplants,O
Sentence: 428,for,O
Sentence: 428,aplastic,B-Disease
Sentence: 428,anemia,I-Disease
Sentence: 428,",",O
Sentence: 428,Wiskott,O
Sentence: 428,-,O
Sentence: 428,Aldrich,O
Sentence: 428,syndrome,O
Sentence: 428,",",O
Sentence: 428,or,O
Sentence: 428,severe,B-Disease
Sentence: 428,combined,I-Disease
Sentence: 428,immunodeficiency,I-Disease
Sentence: 428,syndrome,I-Disease
Sentence: 428,.,O
Sentence: 428,Fourteen,O
Sentence: 428,of,O
Sentence: 428,84,O
Sentence: 428,(,O
Sentence: 428,17,O
Sentence: 428,%,O
Sentence: 428,),O
Sentence: 428,patients,O
Sentence: 428,had,O
Sentence: 428,symptoms,O
Sentence: 428,and,O
Sentence: 428,signs,O
Sentence: 428,consistent,O
Sentence: 428,with,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,within,O
Sentence: 428,ten,O
Sentence: 428,days,O
Sentence: 428,of,O
Sentence: 428,receiving,O
Sentence: 428,1,O
Sentence: 428,to,O
Sentence: 428,4,O
Sentence: 428,doses,O
Sentence: 428,of,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,.,O
Sentence: 428,Six,O
Sentence: 428,of,O
Sentence: 428,the,O
Sentence: 428,14,O
Sentence: 428,patients,O
Sentence: 428,died,O
Sentence: 428,with,O
Sentence: 428,congestive,B-Disease
Sentence: 428,heart,I-Disease
Sentence: 428,failure,I-Disease
Sentence: 428,.,O
Sentence: 428,The,O
Sentence: 428,dose,O
Sentence: 428,of,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,per,O
Sentence: 428,body,O
Sentence: 428,surface,O
Sentence: 428,area,O
Sentence: 428,was,O
Sentence: 428,calculated,O
Sentence: 428,for,O
Sentence: 428,all,O
Sentence: 428,patients,O
Sentence: 428,and,O
Sentence: 428,the,O
Sentence: 428,patients,O
Sentence: 428,were,O
Sentence: 428,divided,O
Sentence: 428,into,O
Sentence: 428,two,O
Sentence: 428,groups,O
Sentence: 428,based,O
Sentence: 428,on,O
Sentence: 428,daily,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,dose,O
Sentence: 428,:,O
Sentence: 428,Group,O
Sentence: 428,1,O
Sentence: 428,",",O
Sentence: 428,CYA,B-Chemical
Sentence: 428,less,O
Sentence: 428,than,O
Sentence: 428,or,O
Sentence: 428,equal,O
Sentence: 428,to,O
Sentence: 428,1.55,O
Sentence: 428,g,O
Sentence: 428,/,O
Sentence: 428,m2,O
Sentence: 428,/,O
Sentence: 428,d,O
Sentence: 428,;,O
Sentence: 428,Group,O
Sentence: 428,2,O
Sentence: 428,",",O
Sentence: 428,CYA,B-Chemical
Sentence: 428,greater,O
Sentence: 428,than,O
Sentence: 428,1.55,O
Sentence: 428,g,O
Sentence: 428,/,O
Sentence: 428,m2,O
Sentence: 428,/,O
Sentence: 428,d,O
Sentence: 428,.,O
Sentence: 428,Cardiotoxicity,B-Disease
Sentence: 428,that,O
Sentence: 428,was,O
Sentence: 428,thought,O
Sentence: 428,to,O
Sentence: 428,be,O
Sentence: 428,related,O
Sentence: 428,to,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,occurred,O
Sentence: 428,in,O
Sentence: 428,1,O
Sentence: 428,/,O
Sentence: 428,32,O
Sentence: 428,(,O
Sentence: 428,3,O
Sentence: 428,%,O
Sentence: 428,),O
Sentence: 428,of,O
Sentence: 428,patients,O
Sentence: 428,in,O
Sentence: 428,Group,O
Sentence: 428,1,O
Sentence: 428,and,O
Sentence: 428,in,O
Sentence: 428,13,O
Sentence: 428,/,O
Sentence: 428,52,O
Sentence: 428,(,O
Sentence: 428,25,O
Sentence: 428,%,O
Sentence: 428,),O
Sentence: 428,patients,O
Sentence: 428,in,O
Sentence: 428,Group,O
Sentence: 428,2,O
Sentence: 428,(,O
Sentence: 428,P,O
Sentence: 428,less,O
Sentence: 428,than,O
Sentence: 428,0.025,O
Sentence: 428,),O
Sentence: 428,.,O
Sentence: 428,Congestive,B-Disease
Sentence: 428,heart,I-Disease
Sentence: 428,failure,I-Disease
Sentence: 428,caused,O
Sentence: 428,or,O
Sentence: 428,contributed,O
Sentence: 428,to,O
Sentence: 428,death,O
Sentence: 428,in,O
Sentence: 428,0,O
Sentence: 428,/,O
Sentence: 428,32,O
Sentence: 428,patients,O
Sentence: 428,in,O
Sentence: 428,Group,O
Sentence: 428,1,O
Sentence: 428,v,O
Sentence: 428,6,O
Sentence: 428,/,O
Sentence: 428,52,O
Sentence: 428,(,O
Sentence: 428,12,O
Sentence: 428,%,O
Sentence: 428,),O
Sentence: 428,of,O
Sentence: 428,patients,O
Sentence: 428,in,O
Sentence: 428,Group,O
Sentence: 428,2,O
Sentence: 428,(,O
Sentence: 428,P,O
Sentence: 428,less,O
Sentence: 428,than,O
Sentence: 428,0.25,O
Sentence: 428,),O
Sentence: 428,.,O
Sentence: 428,There,O
Sentence: 428,was,O
Sentence: 428,no,O
Sentence: 428,difference,O
Sentence: 428,in,O
Sentence: 428,the,O
Sentence: 428,rate,O
Sentence: 428,of,O
Sentence: 428,engraftment,O
Sentence: 428,of,O
Sentence: 428,evaluable,O
Sentence: 428,patients,O
Sentence: 428,in,O
Sentence: 428,the,O
Sentence: 428,two,O
Sentence: 428,groups,O
Sentence: 428,(,O
Sentence: 428,P,O
Sentence: 428,greater,O
Sentence: 428,than,O
Sentence: 428,0.5,O
Sentence: 428,),O
Sentence: 428,.,O
Sentence: 428,We,O
Sentence: 428,conclude,O
Sentence: 428,that,O
Sentence: 428,the,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,correlates,O
Sentence: 428,with,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,dosage,O
Sentence: 428,as,O
Sentence: 428,calculated,O
Sentence: 428,by,O
Sentence: 428,body,O
Sentence: 428,surface,O
Sentence: 428,area,O
Sentence: 428,",",O
Sentence: 428,and,O
Sentence: 428,that,O
Sentence: 428,patients,O
Sentence: 428,with,O
Sentence: 428,aplastic,B-Disease
Sentence: 428,anemia,I-Disease
Sentence: 428,and,O
Sentence: 428,immunodeficiencies,B-Disease
Sentence: 428,can,O
Sentence: 428,be,O
Sentence: 428,effectively,O
Sentence: 428,prepared,O
Sentence: 428,for,O
Sentence: 428,bone,O
Sentence: 428,marrow,O
Sentence: 428,grafting,O
Sentence: 428,at,O
Sentence: 428,a,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,dose,O
Sentence: 428,of,O
Sentence: 428,1.55,O
Sentence: 428,g,O
Sentence: 428,/,O
Sentence: 428,m2,O
Sentence: 428,/,O
Sentence: 428,d,O
Sentence: 428,for,O
Sentence: 428,four,O
Sentence: 428,days,O
Sentence: 428,with,O
Sentence: 428,a,O
Sentence: 428,lower,O
Sentence: 428,incidence,O
Sentence: 428,of,O
Sentence: 428,cardiotoxicity,B-Disease
Sentence: 428,than,O
Sentence: 428,patients,O
Sentence: 428,whose,O
Sentence: 428,CYA,B-Chemical
Sentence: 428,dosage,O
Sentence: 428,is,O
Sentence: 428,calculated,O
Sentence: 428,based,O
Sentence: 428,on,O
Sentence: 428,weight,O
Sentence: 428,.,O
Sentence: 428,This,O
Sentence: 428,study,O
Sentence: 428,reaffirms,O
Sentence: 428,the,O
Sentence: 428,principle,O
Sentence: 428,that,O
Sentence: 428,drug,O
Sentence: 428,toxicity,B-Disease
Sentence: 428,correlates,O
Sentence: 428,with,O
Sentence: 428,dose,O
Sentence: 428,per,O
Sentence: 428,body,O
Sentence: 428,surface,O
Sentence: 428,area,O
Sentence: 428,.,O
Sentence: 429,Studies,O
Sentence: 429,of,O
Sentence: 429,risk,O
Sentence: 429,factors,O
Sentence: 429,for,O
Sentence: 429,aminoglycoside,B-Chemical
Sentence: 429,nephrotoxicity,B-Disease
Sentence: 429,.,O
Sentence: 430,The,O
Sentence: 430,epidemiology,O
Sentence: 430,of,O
Sentence: 430,aminoglycoside,B-Chemical
Sentence: 430,-,O
Sentence: 430,induced,O
Sentence: 430,nephrotoxicity,B-Disease
Sentence: 430,is,O
Sentence: 430,not,O
Sentence: 430,fully,O
Sentence: 430,understood,O
Sentence: 430,.,O
Sentence: 430,Experimental,O
Sentence: 430,studies,O
Sentence: 430,in,O
Sentence: 430,healthy,O
Sentence: 430,human,O
Sentence: 430,volunteers,O
Sentence: 430,indicate,O
Sentence: 430,aminoglycosides,B-Chemical
Sentence: 430,cause,O
Sentence: 430,proximal,O
Sentence: 430,tubular,O
Sentence: 430,damage,O
Sentence: 430,in,O
Sentence: 430,most,O
Sentence: 430,patients,O
Sentence: 430,",",O
Sentence: 430,but,O
Sentence: 430,rarely,O
Sentence: 430,",",O
Sentence: 430,if,O
Sentence: 430,ever,O
Sentence: 430,",",O
Sentence: 430,cause,O
Sentence: 430,glomerular,B-Disease
Sentence: 430,or,I-Disease
Sentence: 430,tubular,I-Disease
Sentence: 430,dysfunction,I-Disease
Sentence: 430,.,O
Sentence: 430,Clinical,O
Sentence: 430,trials,O
Sentence: 430,of,O
Sentence: 430,aminoglycosides,B-Chemical
Sentence: 430,in,O
Sentence: 430,seriously,O
Sentence: 430,ill,O
Sentence: 430,patients,O
Sentence: 430,indicate,O
Sentence: 430,that,O
Sentence: 430,the,O
Sentence: 430,relative,O
Sentence: 430,risk,O
Sentence: 430,for,O
Sentence: 430,developing,O
Sentence: 430,acute,B-Disease
Sentence: 430,renal,I-Disease
Sentence: 430,failure,I-Disease
Sentence: 430,during,O
Sentence: 430,therapy,O
Sentence: 430,ranges,O
Sentence: 430,from,O
Sentence: 430,8,O
Sentence: 430,to,O
Sentence: 430,10,O
Sentence: 430,and,O
Sentence: 430,that,O
Sentence: 430,the,O
Sentence: 430,attributable,O
Sentence: 430,risk,O
Sentence: 430,is,O
Sentence: 430,70,O
Sentence: 430,%,O
Sentence: 430,to,O
Sentence: 430,80,O
Sentence: 430,%,O
Sentence: 430,.,O
Sentence: 430,Further,O
Sentence: 430,analysis,O
Sentence: 430,of,O
Sentence: 430,these,O
Sentence: 430,data,O
Sentence: 430,suggests,O
Sentence: 430,that,O
Sentence: 430,the,O
Sentence: 430,duration,O
Sentence: 430,of,O
Sentence: 430,therapy,O
Sentence: 430,",",O
Sentence: 430,plasma,O
Sentence: 430,aminoglycoside,B-Chemical
Sentence: 430,levels,O
Sentence: 430,",",O
Sentence: 430,liver,B-Disease
Sentence: 430,disease,I-Disease
Sentence: 430,",",O
Sentence: 430,advanced,O
Sentence: 430,age,O
Sentence: 430,",",O
Sentence: 430,high,O
Sentence: 430,initial,O
Sentence: 430,estimated,O
Sentence: 430,creatinine,B-Chemical
Sentence: 430,clearance,O
Sentence: 430,and,O
Sentence: 430,",",O
Sentence: 430,possibly,O
Sentence: 430,",",O
Sentence: 430,female,O
Sentence: 430,gender,O
Sentence: 430,all,O
Sentence: 430,increase,O
Sentence: 430,the,O
Sentence: 430,risk,O
Sentence: 430,for,O
Sentence: 430,nephrotoxicity,B-Disease
Sentence: 430,.,O
Sentence: 430,Other,O
Sentence: 430,causes,O
Sentence: 430,of,O
Sentence: 430,acute,B-Disease
Sentence: 430,renal,I-Disease
Sentence: 430,failure,I-Disease
Sentence: 430,",",O
Sentence: 430,such,O
Sentence: 430,as,O
Sentence: 430,shock,B-Disease
Sentence: 430,",",O
Sentence: 430,appear,O
Sentence: 430,to,O
Sentence: 430,have,O
Sentence: 430,an,O
Sentence: 430,additive,O
Sentence: 430,effect,O
Sentence: 430,.,O
Sentence: 430,Predictive,O
Sentence: 430,models,O
Sentence: 430,have,O
Sentence: 430,been,O
Sentence: 430,developed,O
Sentence: 430,from,O
Sentence: 430,these,O
Sentence: 430,analyses,O
Sentence: 430,that,O
Sentence: 430,should,O
Sentence: 430,be,O
Sentence: 430,useful,O
Sentence: 430,for,O
Sentence: 430,identifying,O
Sentence: 430,patients,O
Sentence: 430,at,O
Sentence: 430,high,O
Sentence: 430,risk,O
Sentence: 430,.,O
Sentence: 430,These,O
Sentence: 430,models,O
Sentence: 430,may,O
Sentence: 430,also,O
Sentence: 430,be,O
Sentence: 430,useful,O
Sentence: 430,in,O
Sentence: 430,developing,O
Sentence: 430,insights,O
Sentence: 430,into,O
Sentence: 430,the,O
Sentence: 430,pathophysiology,O
Sentence: 430,of,O
Sentence: 430,aminoglycoside,B-Chemical
Sentence: 430,-,O
Sentence: 430,induced,O
Sentence: 430,nephrotoxicity,B-Disease
Sentence: 430,.,O
Sentence: 431,Flurothyl,B-Chemical
Sentence: 431,seizure,B-Disease
Sentence: 431,thresholds,O
Sentence: 431,in,O
Sentence: 431,mice,O
Sentence: 431,treated,O
Sentence: 431,neonatally,O
Sentence: 431,with,O
Sentence: 431,a,O
Sentence: 431,single,O
Sentence: 431,injection,O
Sentence: 431,of,O
Sentence: 431,monosodium,B-Chemical
Sentence: 431,glutamate,I-Chemical
Sentence: 431,(,O
Sentence: 431,MSG,B-Chemical
Sentence: 431,),O
Sentence: 431,:,O
Sentence: 431,evaluation,O
Sentence: 431,of,O
Sentence: 431,experimental,O
Sentence: 431,parameters,O
Sentence: 431,in,O
Sentence: 431,flurothyl,B-Chemical
Sentence: 431,seizure,B-Disease
Sentence: 431,testing,O
Sentence: 431,.,O
Sentence: 432,Monosodium,B-Chemical
Sentence: 432,glutamate,I-Chemical
Sentence: 432,(,O
Sentence: 432,MSG,B-Chemical
Sentence: 432,),O
Sentence: 432,administration,O
Sentence: 432,to,O
Sentence: 432,neonatal,O
Sentence: 432,rodents,O
Sentence: 432,produces,O
Sentence: 432,convulsions,B-Disease
Sentence: 432,and,O
Sentence: 432,results,O
Sentence: 432,in,O
Sentence: 432,numerous,O
Sentence: 432,biochemical,O
Sentence: 432,and,O
Sentence: 432,behavioral,O
Sentence: 432,deficits,O
Sentence: 432,.,O
Sentence: 432,These,O
Sentence: 432,studies,O
Sentence: 432,were,O
Sentence: 432,undertaken,O
Sentence: 432,to,O
Sentence: 432,determine,O
Sentence: 432,if,O
Sentence: 432,neonatal,O
Sentence: 432,administration,O
Sentence: 432,of,O
Sentence: 432,MSG,B-Chemical
Sentence: 432,produced,O
Sentence: 432,permanent,O
Sentence: 432,alterations,O
Sentence: 432,in,O
Sentence: 432,seizure,B-Disease
Sentence: 432,susceptibility,O
Sentence: 432,",",O
Sentence: 432,since,O
Sentence: 432,previous,O
Sentence: 432,investigations,O
Sentence: 432,were,O
Sentence: 432,inconclusive,O
Sentence: 432,.,O
Sentence: 432,A,O
Sentence: 432,flurothyl,B-Chemical
Sentence: 432,ether,B-Chemical
Sentence: 432,seizure,B-Disease
Sentence: 432,screening,O
Sentence: 432,technique,O
Sentence: 432,was,O
Sentence: 432,used,O
Sentence: 432,to,O
Sentence: 432,evaluate,O
Sentence: 432,seizure,B-Disease
Sentence: 432,susceptibility,O
Sentence: 432,in,O
Sentence: 432,adult,O
Sentence: 432,mice,O
Sentence: 432,that,O
Sentence: 432,received,O
Sentence: 432,neonatal,O
Sentence: 432,injections,O
Sentence: 432,of,O
Sentence: 432,MSG,B-Chemical
Sentence: 432,(,O
Sentence: 432,4,O
Sentence: 432,mg,O
Sentence: 432,/,O
Sentence: 432,g,O
Sentence: 432,and,O
Sentence: 432,1,O
Sentence: 432,mg,O
Sentence: 432,/,O
Sentence: 432,g,O
Sentence: 432,),O
Sentence: 432,.,O
Sentence: 432,MSG,B-Chemical
Sentence: 432,treatment,O
Sentence: 432,resulted,O
Sentence: 432,in,O
Sentence: 432,significant,O
Sentence: 432,reductions,O
Sentence: 432,in,O
Sentence: 432,whole,O
Sentence: 432,brain,O
Sentence: 432,weight,O
Sentence: 432,but,O
Sentence: 432,did,O
Sentence: 432,not,O
Sentence: 432,alter,O
Sentence: 432,seizure,B-Disease
Sentence: 432,threshold,O
Sentence: 432,.,O
Sentence: 432,A,O
Sentence: 432,naloxone,B-Chemical
Sentence: 432,(,O
Sentence: 432,5,O
Sentence: 432,mg,O
Sentence: 432,/,O
Sentence: 432,kg,O
Sentence: 432,),O
Sentence: 432,challenge,O
Sentence: 432,was,O
Sentence: 432,also,O
Sentence: 432,ineffective,O
Sentence: 432,in,O
Sentence: 432,altering,O
Sentence: 432,the,O
Sentence: 432,seizure,B-Disease
Sentence: 432,thresholds,O
Sentence: 432,of,O
Sentence: 432,either,O
Sentence: 432,control,O
Sentence: 432,of,O
Sentence: 432,MSG,B-Chemical
Sentence: 432,-,O
Sentence: 432,treated,O
Sentence: 432,mice,O
Sentence: 432,.,O
Sentence: 432,Flurothyl,B-Chemical
Sentence: 432,ether,B-Chemical
Sentence: 432,produced,O
Sentence: 432,hypothermia,B-Disease
Sentence: 432,which,O
Sentence: 432,was,O
Sentence: 432,correlated,O
Sentence: 432,with,O
Sentence: 432,the,O
Sentence: 432,duration,O
Sentence: 432,of,O
Sentence: 432,flurothyl,B-Chemical
Sentence: 432,exposure,O
Sentence: 432,;,O
Sentence: 432,however,O
Sentence: 432,",",O
Sentence: 432,the,O
Sentence: 432,relationship,O
Sentence: 432,of,O
Sentence: 432,hypothermia,B-Disease
Sentence: 432,to,O
Sentence: 432,seizure,B-Disease
Sentence: 432,induction,O
Sentence: 432,was,O
Sentence: 432,unclear,O
Sentence: 432,.,O
Sentence: 432,Flurothyl,B-Chemical
Sentence: 432,seizure,B-Disease
Sentence: 432,testing,O
Sentence: 432,proved,O
Sentence: 432,to,O
Sentence: 432,be,O
Sentence: 432,a,O
Sentence: 432,rapid,O
Sentence: 432,and,O
Sentence: 432,reliable,O
Sentence: 432,technique,O
Sentence: 432,with,O
Sentence: 432,which,O
Sentence: 432,to,O
Sentence: 432,evaluate,O
Sentence: 432,seizure,B-Disease
Sentence: 432,susceptibility,O
Sentence: 432,.,O
Sentence: 433,Susceptibility,O
Sentence: 433,to,O
Sentence: 433,seizures,B-Disease
Sentence: 433,produced,O
Sentence: 433,by,O
Sentence: 433,pilocarpine,B-Chemical
Sentence: 433,in,O
Sentence: 433,rats,O
Sentence: 433,after,O
Sentence: 433,microinjection,O
Sentence: 433,of,O
Sentence: 433,isoniazid,B-Chemical
Sentence: 433,or,O
Sentence: 433,gamma,O
Sentence: 433,-,O
Sentence: 433,vinyl,O
Sentence: 433,-,O
Sentence: 433,GABA,O
Sentence: 433,into,O
Sentence: 433,the,O
Sentence: 433,substantia,O
Sentence: 433,nigra,O
Sentence: 433,.,O
Sentence: 434,Pilocarpine,B-Chemical
Sentence: 434,",",O
Sentence: 434,given,O
Sentence: 434,intraperitoneally,O
Sentence: 434,to,O
Sentence: 434,rats,O
Sentence: 434,",",O
Sentence: 434,reproduces,O
Sentence: 434,the,O
Sentence: 434,neuropathological,O
Sentence: 434,sequelae,O
Sentence: 434,of,O
Sentence: 434,temporal,B-Disease
Sentence: 434,lobe,I-Disease
Sentence: 434,epilepsy,I-Disease
Sentence: 434,and,O
Sentence: 434,provides,O
Sentence: 434,a,O
Sentence: 434,relevant,O
Sentence: 434,animal,O
Sentence: 434,model,O
Sentence: 434,for,O
Sentence: 434,studying,O
Sentence: 434,mechanisms,O
Sentence: 434,of,O
Sentence: 434,buildup,O
Sentence: 434,of,O
Sentence: 434,convulsive,B-Disease
Sentence: 434,activity,O
Sentence: 434,and,O
Sentence: 434,pathways,O
Sentence: 434,operative,O
Sentence: 434,in,O
Sentence: 434,the,O
Sentence: 434,generalization,O
Sentence: 434,and,O
Sentence: 434,propagation,O
Sentence: 434,of,O
Sentence: 434,seizures,B-Disease
Sentence: 434,within,O
Sentence: 434,the,O
Sentence: 434,forebrain,O
Sentence: 434,.,O
Sentence: 434,In,O
Sentence: 434,the,O
Sentence: 434,present,O
Sentence: 434,study,O
Sentence: 434,",",O
Sentence: 434,the,O
Sentence: 434,effects,O
Sentence: 434,of,O
Sentence: 434,manipulating,O
Sentence: 434,the,O
Sentence: 434,activity,O
Sentence: 434,of,O
Sentence: 434,the,O
Sentence: 434,gamma,O
Sentence: 434,-,O
Sentence: 434,aminobutyric,O
Sentence: 434,acid,O
Sentence: 434,(,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,),O
Sentence: 434,,O
Sentence: 434,-,O
Sentence: 434,mediated,O
Sentence: 434,synaptic,O
Sentence: 434,inhibition,O
Sentence: 434,within,O
Sentence: 434,the,O
Sentence: 434,substantia,O
Sentence: 434,nigra,O
Sentence: 434,on,O
Sentence: 434,seizures,B-Disease
Sentence: 434,produced,O
Sentence: 434,by,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,in,O
Sentence: 434,rats,O
Sentence: 434,",",O
Sentence: 434,were,O
Sentence: 434,investigated,O
Sentence: 434,.,O
Sentence: 434,In,O
Sentence: 434,animals,O
Sentence: 434,pretreated,O
Sentence: 434,with,O
Sentence: 434,microinjections,O
Sentence: 434,of,O
Sentence: 434,isoniazid,B-Chemical
Sentence: 434,",",O
Sentence: 434,150,O
Sentence: 434,micrograms,O
Sentence: 434,",",O
Sentence: 434,an,O
Sentence: 434,inhibitor,O
Sentence: 434,of,O
Sentence: 434,activity,O
Sentence: 434,of,O
Sentence: 434,the,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,-,O
Sentence: 434,synthesizing,O
Sentence: 434,enzyme,O
Sentence: 434,",",O
Sentence: 434,L,O
Sentence: 434,-,O
Sentence: 434,glutamic,O
Sentence: 434,acid,O
Sentence: 434,decarboxylase,O
Sentence: 434,",",O
Sentence: 434,into,O
Sentence: 434,the,O
Sentence: 434,substantia,O
Sentence: 434,nigra,O
Sentence: 434,pars,O
Sentence: 434,reticulata,O
Sentence: 434,(,O
Sentence: 434,SNR,O
Sentence: 434,),O
Sentence: 434,",",O
Sentence: 434,bilaterally,O
Sentence: 434,",",O
Sentence: 434,non,O
Sentence: 434,-,O
Sentence: 434,convulsant,O
Sentence: 434,doses,O
Sentence: 434,of,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,",",O
Sentence: 434,100,O
Sentence: 434,and,O
Sentence: 434,200,O
Sentence: 434,mg,O
Sentence: 434,/,O
Sentence: 434,kg,O
Sentence: 434,",",O
Sentence: 434,resulted,O
Sentence: 434,in,O
Sentence: 434,severe,O
Sentence: 434,motor,O
Sentence: 434,limbic,O
Sentence: 434,seizures,B-Disease
Sentence: 434,and,O
Sentence: 434,status,B-Disease
Sentence: 434,epilepticus,I-Disease
Sentence: 434,.,O
Sentence: 434,Electroencephalographic,O
Sentence: 434,and,O
Sentence: 434,behavioral,O
Sentence: 434,monitoring,O
Sentence: 434,revealed,O
Sentence: 434,a,O
Sentence: 434,profound,O
Sentence: 434,reduction,O
Sentence: 434,of,O
Sentence: 434,the,O
Sentence: 434,threshold,O
Sentence: 434,for,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,-,O
Sentence: 434,induced,O
Sentence: 434,convulsions,B-Disease
Sentence: 434,.,O
Sentence: 434,Morphological,O
Sentence: 434,analysis,O
Sentence: 434,of,O
Sentence: 434,frontal,O
Sentence: 434,forebrain,O
Sentence: 434,sections,O
Sentence: 434,with,O
Sentence: 434,light,O
Sentence: 434,microscopy,O
Sentence: 434,revealed,O
Sentence: 434,seizure,B-Disease
Sentence: 434,-,O
Sentence: 434,related,O
Sentence: 434,damage,O
Sentence: 434,to,O
Sentence: 434,the,O
Sentence: 434,hippocampal,O
Sentence: 434,formation,O
Sentence: 434,",",O
Sentence: 434,thalamus,O
Sentence: 434,",",O
Sentence: 434,amygdala,O
Sentence: 434,",",O
Sentence: 434,olfactory,O
Sentence: 434,cortex,O
Sentence: 434,",",O
Sentence: 434,substantia,O
Sentence: 434,nigra,O
Sentence: 434,and,O
Sentence: 434,neocortex,O
Sentence: 434,",",O
Sentence: 434,which,O
Sentence: 434,is,O
Sentence: 434,typically,O
Sentence: 434,observed,O
Sentence: 434,with,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,in,O
Sentence: 434,doses,O
Sentence: 434,exceeding,O
Sentence: 434,350,O
Sentence: 434,mg,O
Sentence: 434,/,O
Sentence: 434,kg,O
Sentence: 434,.,O
Sentence: 434,Bilateral,O
Sentence: 434,intrastriatal,O
Sentence: 434,injections,O
Sentence: 434,of,O
Sentence: 434,isoniazid,B-Chemical
Sentence: 434,did,O
Sentence: 434,not,O
Sentence: 434,augment,O
Sentence: 434,seizures,B-Disease
Sentence: 434,produced,O
Sentence: 434,by,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,",",O
Sentence: 434,200,O
Sentence: 434,mg,O
Sentence: 434,/,O
Sentence: 434,kg,O
Sentence: 434,.,O
Sentence: 434,Application,O
Sentence: 434,of,O
Sentence: 434,an,O
Sentence: 434,irreversible,O
Sentence: 434,inhibitor,O
Sentence: 434,of,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,transaminase,O
Sentence: 434,",",O
Sentence: 434,gamma,O
Sentence: 434,-,O
Sentence: 434,vinyl,O
Sentence: 434,-,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,(,O
Sentence: 434,D,O
Sentence: 434,",",O
Sentence: 434,L,O
Sentence: 434,-,O
Sentence: 434,4,O
Sentence: 434,-,O
Sentence: 434,amino,O
Sentence: 434,-,O
Sentence: 434,hex,O
Sentence: 434,-,O
Sentence: 434,5,O
Sentence: 434,-,O
Sentence: 434,enoic,O
Sentence: 434,acid,O
Sentence: 434,),O
Sentence: 434,",",O
Sentence: 434,5,O
Sentence: 434,micrograms,O
Sentence: 434,",",O
Sentence: 434,into,O
Sentence: 434,the,O
Sentence: 434,SNR,O
Sentence: 434,",",O
Sentence: 434,bilaterally,O
Sentence: 434,",",O
Sentence: 434,suppressed,O
Sentence: 434,the,O
Sentence: 434,appearance,O
Sentence: 434,of,O
Sentence: 434,electrographic,O
Sentence: 434,and,O
Sentence: 434,behavioral,O
Sentence: 434,seizures,B-Disease
Sentence: 434,produced,O
Sentence: 434,by,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,",",O
Sentence: 434,380,O
Sentence: 434,mg,O
Sentence: 434,/,O
Sentence: 434,kg,O
Sentence: 434,.,O
Sentence: 434,This,O
Sentence: 434,treatment,O
Sentence: 434,was,O
Sentence: 434,also,O
Sentence: 434,sufficient,O
Sentence: 434,to,O
Sentence: 434,protect,O
Sentence: 434,animals,O
Sentence: 434,from,O
Sentence: 434,the,O
Sentence: 434,occurrence,O
Sentence: 434,of,O
Sentence: 434,brain,B-Disease
Sentence: 434,damage,I-Disease
Sentence: 434,.,O
Sentence: 434,Microinjections,O
Sentence: 434,of,O
Sentence: 434,gamma,O
Sentence: 434,-,O
Sentence: 434,vinyl,O
Sentence: 434,-,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,",",O
Sentence: 434,5,O
Sentence: 434,micrograms,O
Sentence: 434,",",O
Sentence: 434,into,O
Sentence: 434,the,O
Sentence: 434,dorsal,O
Sentence: 434,striatum,O
Sentence: 434,",",O
Sentence: 434,bilaterally,O
Sentence: 434,",",O
Sentence: 434,failed,O
Sentence: 434,to,O
Sentence: 434,prevent,O
Sentence: 434,the,O
Sentence: 434,development,O
Sentence: 434,of,O
Sentence: 434,convulsions,B-Disease
Sentence: 434,produced,O
Sentence: 434,by,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,",",O
Sentence: 434,380,O
Sentence: 434,mg,O
Sentence: 434,/,O
Sentence: 434,kg,O
Sentence: 434,.,O
Sentence: 434,The,O
Sentence: 434,results,O
Sentence: 434,demonstrate,O
Sentence: 434,that,O
Sentence: 434,the,O
Sentence: 434,threshold,O
Sentence: 434,for,O
Sentence: 434,pilocarpine,B-Chemical
Sentence: 434,-,O
Sentence: 434,induced,O
Sentence: 434,seizures,B-Disease
Sentence: 434,in,O
Sentence: 434,rats,O
Sentence: 434,is,O
Sentence: 434,subjected,O
Sentence: 434,to,O
Sentence: 434,the,O
Sentence: 434,regulation,O
Sentence: 434,of,O
Sentence: 434,the,O
Sentence: 434,GABA,B-Chemical
Sentence: 434,-,O
Sentence: 434,mediated,O
Sentence: 434,synaptic,O
Sentence: 434,inhibition,O
Sentence: 434,within,O
Sentence: 434,the,O
Sentence: 434,substantia,O
Sentence: 434,nigra,O
Sentence: 434,.,O
Sentence: 435,Non,O
Sentence: 435,-,O
Sentence: 435,invasive,O
Sentence: 435,detection,O
Sentence: 435,of,O
Sentence: 435,coronary,B-Disease
Sentence: 435,artery,I-Disease
Sentence: 435,disease,I-Disease
Sentence: 435,by,O
Sentence: 435,body,O
Sentence: 435,surface,O
Sentence: 435,electrocardiographic,O
Sentence: 435,mapping,O
Sentence: 435,after,O
Sentence: 435,dipyridamole,B-Chemical
Sentence: 435,infusion,O
Sentence: 435,.,O
Sentence: 436,Electrocardiographic,O
Sentence: 436,changes,O
Sentence: 436,after,O
Sentence: 436,dipyridamole,B-Chemical
Sentence: 436,infusion,O
Sentence: 436,(,O
Sentence: 436,0.568,O
Sentence: 436,mg,O
Sentence: 436,/,O
Sentence: 436,kg,O
Sentence: 436,/,O
Sentence: 436,4,O
Sentence: 436,min,O
Sentence: 436,),O
Sentence: 436,were,O
Sentence: 436,studied,O
Sentence: 436,in,O
Sentence: 436,41,O
Sentence: 436,patients,O
Sentence: 436,with,O
Sentence: 436,coronary,B-Disease
Sentence: 436,artery,I-Disease
Sentence: 436,disease,I-Disease
Sentence: 436,and,O
Sentence: 436,compared,O
Sentence: 436,with,O
Sentence: 436,those,O
Sentence: 436,after,O
Sentence: 436,submaximal,O
Sentence: 436,treadmill,O
Sentence: 436,exercise,O
Sentence: 436,by,O
Sentence: 436,use,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,body,O
Sentence: 436,surface,O
Sentence: 436,mapping,O
Sentence: 436,technique,O
Sentence: 436,.,O
Sentence: 436,Patients,O
Sentence: 436,were,O
Sentence: 436,divided,O
Sentence: 436,into,O
Sentence: 436,three,O
Sentence: 436,groups,O
Sentence: 436,;,O
Sentence: 436,19,O
Sentence: 436,patients,O
Sentence: 436,without,O
Sentence: 436,myocardial,B-Disease
Sentence: 436,infarction,I-Disease
Sentence: 436,(,O
Sentence: 436,non,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,),O
Sentence: 436,",",O
Sentence: 436,14,O
Sentence: 436,with,O
Sentence: 436,anterior,B-Disease
Sentence: 436,infarction,I-Disease
Sentence: 436,(,O
Sentence: 436,ANT,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,),O
Sentence: 436,and,O
Sentence: 436,eight,O
Sentence: 436,with,O
Sentence: 436,inferior,B-Disease
Sentence: 436,infarction,I-Disease
Sentence: 436,(,O
Sentence: 436,INF,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,),O
Sentence: 436,.,O
Sentence: 436,Eighty,O
Sentence: 436,-,O
Sentence: 436,seven,O
Sentence: 436,unipolar,O
Sentence: 436,electrocardiograms,O
Sentence: 436,(,O
Sentence: 436,ECGs,O
Sentence: 436,),O
Sentence: 436,distributed,O
Sentence: 436,over,O
Sentence: 436,the,O
Sentence: 436,entire,O
Sentence: 436,thoracic,O
Sentence: 436,surface,O
Sentence: 436,were,O
Sentence: 436,simultaneously,O
Sentence: 436,recorded,O
Sentence: 436,.,O
Sentence: 436,After,O
Sentence: 436,dipyridamole,B-Chemical
Sentence: 436,",",O
Sentence: 436,ischemic,B-Disease
Sentence: 436,ST,O
Sentence: 436,-,O
Sentence: 436,segment,O
Sentence: 436,depression,B-Disease
Sentence: 436,(,O
Sentence: 436,0.05,O
Sentence: 436,mV,O
Sentence: 436,or,O
Sentence: 436,more,O
Sentence: 436,),O
Sentence: 436,was,O
Sentence: 436,observed,O
Sentence: 436,in,O
Sentence: 436,84,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,non,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,",",O
Sentence: 436,29,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,ANT,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,",",O
Sentence: 436,63,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,INF,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,and,O
Sentence: 436,61,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,total,O
Sentence: 436,population,O
Sentence: 436,.,O
Sentence: 436,Exercise,O
Sentence: 436,-,O
Sentence: 436,induced,O
Sentence: 436,ST,O
Sentence: 436,depression,B-Disease
Sentence: 436,was,O
Sentence: 436,observed,O
Sentence: 436,in,O
Sentence: 436,84,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,non,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,",",O
Sentence: 436,43,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,ANT,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,",",O
Sentence: 436,38,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,INF,O
Sentence: 436,-,O
Sentence: 436,MI,B-Disease
Sentence: 436,group,O
Sentence: 436,and,O
Sentence: 436,61,O
Sentence: 436,%,O
Sentence: 436,of,O
Sentence: 436,the,O
Sentence: 436,total,O
Sentence: 436,.,O
Sentence: 436,For,O
Sentence: 436,individual,O
Sentence: 436,patients,O
Sentence: 436,",",O
Sentence: 436,there,O
Sentence: 436,were,O
Sentence: 436,no,O
Sentence: 436,obvious,O
Sentence: 436,differences,O
Sentence: 436,between,O
Sentence: 436,the,O
Sentence: 436,body,O
Sentence: 436,surface,O
Sentence: 436,distribution,O
Sentence: 436,of,O
Sentence: 436,ST,O
Sentence: 436,depression,B-Disease
Sentence: 436,in,O
Sentence: 436,both,O
Sentence: 436,tests,O
Sentence: 436,.,O
Sentence: 436,The,O
Sentence: 436,increase,O
Sentence: 436,in,O
Sentence: 436,pressure,O
Sentence: 436,rate,O
Sentence: 436,product,O
Sentence: 436,after,O
Sentence: 436,dipyridamole,B-Chemical
Sentence: 436,was,O
Sentence: 436,significantly,O
Sentence: 436,less,O
Sentence: 436,than,O
Sentence: 436,that,O
Sentence: 436,during,O
Sentence: 436,the,O
Sentence: 436,treadmill,O
Sentence: 436,exercise,O
Sentence: 436,.,O
Sentence: 436,The,O
Sentence: 436,data,O
Sentence: 436,suggest,O
Sentence: 436,that,O
Sentence: 436,the,O
Sentence: 436,dipyridamole,B-Chemical
Sentence: 436,-,O
Sentence: 436,induced,O
Sentence: 436,myocardial,B-Disease
Sentence: 436,ischemia,I-Disease
Sentence: 436,is,O
Sentence: 436,caused,O
Sentence: 436,by,O
Sentence: 436,the,O
Sentence: 436,inhomogenous,O
Sentence: 436,distribution,O
Sentence: 436,of,O
Sentence: 436,myocardial,O
Sentence: 436,blood,O
Sentence: 436,flow,O
Sentence: 436,.,O
Sentence: 436,We,O
Sentence: 436,conclude,O
Sentence: 436,that,O
Sentence: 436,the,O
Sentence: 436,dipyridamole,B-Chemical
Sentence: 436,ECG,O
Sentence: 436,test,O
Sentence: 436,is,O
Sentence: 436,as,O
Sentence: 436,useful,O
Sentence: 436,as,O
Sentence: 436,the,O
Sentence: 436,exercise,O
Sentence: 436,ECG,O
Sentence: 436,test,O
Sentence: 436,for,O
Sentence: 436,the,O
Sentence: 436,assessment,O
Sentence: 436,of,O
Sentence: 436,coronary,B-Disease
Sentence: 436,artery,I-Disease
Sentence: 436,disease,I-Disease
Sentence: 436,.,O
Sentence: 437,Bradycardia,B-Disease
Sentence: 437,after,O
Sentence: 437,high,O
Sentence: 437,-,O
Sentence: 437,dose,O
Sentence: 437,intravenous,O
Sentence: 437,methylprednisolone,B-Chemical
Sentence: 437,therapy,O
Sentence: 437,.,O
Sentence: 438,In,O
Sentence: 438,5,O
Sentence: 438,consecutive,O
Sentence: 438,patients,O
Sentence: 438,with,O
Sentence: 438,rheumatoid,B-Disease
Sentence: 438,arthritis,I-Disease
Sentence: 438,who,O
Sentence: 438,received,O
Sentence: 438,intravenous,O
Sentence: 438,high,O
Sentence: 438,-,O
Sentence: 438,dose,O
Sentence: 438,methylprednisolone,B-Chemical
Sentence: 438,(,O
Sentence: 438,MP,B-Chemical
Sentence: 438,),O
Sentence: 438,therapy,O
Sentence: 438,(,O
Sentence: 438,1,O
Sentence: 438,g,O
Sentence: 438,daily,O
Sentence: 438,for,O
Sentence: 438,2,O
Sentence: 438,or,O
Sentence: 438,3,O
Sentence: 438,consecutive,O
Sentence: 438,days,O
Sentence: 438,),O
Sentence: 438,",",O
Sentence: 438,a,O
Sentence: 438,decline,O
Sentence: 438,in,O
Sentence: 438,pulse,O
Sentence: 438,rate,O
Sentence: 438,was,O
Sentence: 438,observed,O
Sentence: 438,",",O
Sentence: 438,most,O
Sentence: 438,pronounced,O
Sentence: 438,on,O
Sentence: 438,day,O
Sentence: 438,4,O
Sentence: 438,.,O
Sentence: 438,In,O
Sentence: 438,one,O
Sentence: 438,of,O
Sentence: 438,the,O
Sentence: 438,5,O
Sentence: 438,patients,O
Sentence: 438,the,O
Sentence: 438,bradycardia,B-Disease
Sentence: 438,was,O
Sentence: 438,associated,O
Sentence: 438,with,O
Sentence: 438,complaints,O
Sentence: 438,of,O
Sentence: 438,substernal,O
Sentence: 438,pressure,O
Sentence: 438,.,O
Sentence: 438,Reversal,O
Sentence: 438,to,O
Sentence: 438,normal,O
Sentence: 438,heart,O
Sentence: 438,rate,O
Sentence: 438,was,O
Sentence: 438,found,O
Sentence: 438,on,O
Sentence: 438,day,O
Sentence: 438,7,O
Sentence: 438,.,O
Sentence: 438,Electrocardiographic,O
Sentence: 438,registrations,O
Sentence: 438,showed,O
Sentence: 438,sinus,B-Disease
Sentence: 438,bradycardia,I-Disease
Sentence: 438,in,O
Sentence: 438,all,O
Sentence: 438,cases,O
Sentence: 438,.,O
Sentence: 438,No,O
Sentence: 438,significant,O
Sentence: 438,changes,O
Sentence: 438,in,O
Sentence: 438,plasma,O
Sentence: 438,concentrations,O
Sentence: 438,of,O
Sentence: 438,electrolytes,O
Sentence: 438,were,O
Sentence: 438,found,O
Sentence: 438,.,O
Sentence: 438,Careful,O
Sentence: 438,observation,O
Sentence: 438,of,O
Sentence: 438,patients,O
Sentence: 438,receiving,O
Sentence: 438,high,O
Sentence: 438,-,O
Sentence: 438,dose,O
Sentence: 438,MP,B-Chemical
Sentence: 438,is,O
Sentence: 438,recommended,O
Sentence: 438,.,O
Sentence: 438,High,O
Sentence: 438,-,O
Sentence: 438,dose,O
Sentence: 438,MP,B-Chemical
Sentence: 438,may,O
Sentence: 438,be,O
Sentence: 438,contraindicated,O
Sentence: 438,in,O
Sentence: 438,patients,O
Sentence: 438,with,O
Sentence: 438,known,O
Sentence: 438,heart,B-Disease
Sentence: 438,disease,I-Disease
Sentence: 438,.,O
Sentence: 439,Two,O
Sentence: 439,cases,O
Sentence: 439,of,O
Sentence: 439,downbeat,B-Disease
Sentence: 439,nystagmus,I-Disease
Sentence: 439,and,O
Sentence: 439,oscillopsia,B-Disease
Sentence: 439,associated,O
Sentence: 439,with,O
Sentence: 439,carbamazepine,B-Chemical
Sentence: 439,.,O
Sentence: 440,Downbeat,B-Disease
Sentence: 440,nystagmus,B-Disease
Sentence: 440,is,O
Sentence: 440,often,O
Sentence: 440,associated,O
Sentence: 440,with,O
Sentence: 440,structural,O
Sentence: 440,lesions,O
Sentence: 440,at,O
Sentence: 440,the,O
Sentence: 440,craniocervical,O
Sentence: 440,junction,O
Sentence: 440,",",O
Sentence: 440,but,O
Sentence: 440,has,O
Sentence: 440,occasionally,O
Sentence: 440,been,O
Sentence: 440,reported,O
Sentence: 440,as,O
Sentence: 440,a,O
Sentence: 440,manifestation,O
Sentence: 440,of,O
Sentence: 440,metabolic,O
Sentence: 440,imbalance,O
Sentence: 440,or,O
Sentence: 440,drug,O
Sentence: 440,intoxication,O
Sentence: 440,.,O
Sentence: 440,We,O
Sentence: 440,recorded,O
Sentence: 440,the,O
Sentence: 440,eye,O
Sentence: 440,movements,O
Sentence: 440,of,O
Sentence: 440,two,O
Sentence: 440,patients,O
Sentence: 440,with,O
Sentence: 440,reversible,O
Sentence: 440,downbeat,B-Disease
Sentence: 440,nystagmus,I-Disease
Sentence: 440,related,O
Sentence: 440,to,O
Sentence: 440,carbamazepine,B-Chemical
Sentence: 440,therapy,O
Sentence: 440,.,O
Sentence: 440,The,O
Sentence: 440,nystagmus,B-Disease
Sentence: 440,of,O
Sentence: 440,both,O
Sentence: 440,patients,O
Sentence: 440,resolved,O
Sentence: 440,after,O
Sentence: 440,reduction,O
Sentence: 440,of,O
Sentence: 440,the,O
Sentence: 440,serum,O
Sentence: 440,carbamazepine,B-Chemical
Sentence: 440,levels,O
Sentence: 440,.,O
Sentence: 440,Neuroradiologic,O
Sentence: 440,investigations,O
Sentence: 440,including,O
Sentence: 440,magnetic,O
Sentence: 440,resonance,O
Sentence: 440,imaging,O
Sentence: 440,scans,O
Sentence: 440,in,O
Sentence: 440,both,O
Sentence: 440,patients,O
Sentence: 440,showed,O
Sentence: 440,no,O
Sentence: 440,evidence,O
Sentence: 440,of,O
Sentence: 440,intracranial,O
Sentence: 440,abnormality,O
Sentence: 440,.,O
Sentence: 440,In,O
Sentence: 440,patients,O
Sentence: 440,with,O
Sentence: 440,downbeat,B-Disease
Sentence: 440,nystagmus,I-Disease
Sentence: 440,who,O
Sentence: 440,are,O
Sentence: 440,taking,O
Sentence: 440,anticonvulsant,O
Sentence: 440,medications,O
Sentence: 440,",",O
Sentence: 440,consideration,O
Sentence: 440,should,O
Sentence: 440,be,O
Sentence: 440,given,O
Sentence: 440,to,O
Sentence: 440,reduction,O
Sentence: 440,in,O
Sentence: 440,dose,O
Sentence: 440,before,O
Sentence: 440,further,O
Sentence: 440,investigation,O
Sentence: 440,is,O
Sentence: 440,undertaken,O
Sentence: 440,.,O
Sentence: 441,Improvement,O
Sentence: 441,by,O
Sentence: 441,denopamine,B-Chemical
Sentence: 441,(,O
Sentence: 441,TA,O
Sentence: 441,-,O
Sentence: 441,064,O
Sentence: 441,),O
Sentence: 441,of,O
Sentence: 441,pentobarbital,B-Chemical
Sentence: 441,-,O
Sentence: 441,induced,O
Sentence: 441,cardiac,B-Disease
Sentence: 441,failure,I-Disease
Sentence: 441,in,O
Sentence: 441,the,O
Sentence: 441,dog,O
Sentence: 441,heart,O
Sentence: 441,-,O
Sentence: 441,lung,O
Sentence: 441,preparation,O
Sentence: 441,.,O
Sentence: 442,The,O
Sentence: 442,efficacy,O
Sentence: 442,of,O
Sentence: 442,denopamine,B-Chemical
Sentence: 442,",",O
Sentence: 442,an,O
Sentence: 442,orally,O
Sentence: 442,active,O
Sentence: 442,beta,O
Sentence: 442,1,O
Sentence: 442,-,O
Sentence: 442,adrenoceptor,O
Sentence: 442,agonist,O
Sentence: 442,",",O
Sentence: 442,in,O
Sentence: 442,improving,O
Sentence: 442,cardiac,B-Disease
Sentence: 442,failure,I-Disease
Sentence: 442,was,O
Sentence: 442,assessed,O
Sentence: 442,in,O
Sentence: 442,dog,O
Sentence: 442,heart,O
Sentence: 442,-,O
Sentence: 442,lung,O
Sentence: 442,preparations,O
Sentence: 442,.,O
Sentence: 442,Cardiac,O
Sentence: 442,functions,O
Sentence: 442,depressed,O
Sentence: 442,by,O
Sentence: 442,pentobarbital,B-Chemical
Sentence: 442,(,O
Sentence: 442,118,O
Sentence: 442,+,O
Sentence: 442,/,O
Sentence: 442,,O
Sentence: 442,-,O
Sentence: 442,,O
Sentence: 442,28,O
Sentence: 442,mg,O
Sentence: 442,;,O
Sentence: 442,mean,O
Sentence: 442,value,O
Sentence: 442,+,O
Sentence: 442,/,O
Sentence: 442,,O
Sentence: 442,-,O
Sentence: 442,,O
Sentence: 442,SD,O
Sentence: 442,),O
Sentence: 442,such,O
Sentence: 442,that,O
Sentence: 442,cardiac,O
Sentence: 442,output,O
Sentence: 442,and,O
Sentence: 442,maximum,O
Sentence: 442,rate,O
Sentence: 442,of,O
Sentence: 442,rise,O
Sentence: 442,of,O
Sentence: 442,left,O
Sentence: 442,ventricular,O
Sentence: 442,pressure,O
Sentence: 442,(,O
Sentence: 442,LV,O
Sentence: 442,dP,O
Sentence: 442,/,O
Sentence: 442,dt,O
Sentence: 442,max,O
Sentence: 442,),O
Sentence: 442,had,O
Sentence: 442,been,O
Sentence: 442,reduced,O
Sentence: 442,by,O
Sentence: 442,about,O
Sentence: 442,35,O
Sentence: 442,%,O
Sentence: 442,and,O
Sentence: 442,26,O
Sentence: 442,%,O
Sentence: 442,of,O
Sentence: 442,the,O
Sentence: 442,respective,O
Sentence: 442,controls,O
Sentence: 442,were,O
Sentence: 442,improved,O
Sentence: 442,by,O
Sentence: 442,denopamine,B-Chemical
Sentence: 442,(,O
Sentence: 442,10,O
Sentence: 442,-,O
Sentence: 442,300,O
Sentence: 442,micrograms,O
Sentence: 442,),O
Sentence: 442,in,O
Sentence: 442,a,O
Sentence: 442,dose,O
Sentence: 442,-,O
Sentence: 442,dependent,O
Sentence: 442,manner,O
Sentence: 442,.,O
Sentence: 442,With,O
Sentence: 442,100,O
Sentence: 442,micrograms,O
Sentence: 442,denopamine,B-Chemical
Sentence: 442,",",O
Sentence: 442,almost,O
Sentence: 442,complete,O
Sentence: 442,restoration,O
Sentence: 442,of,O
Sentence: 442,cardiac,O
Sentence: 442,performance,O
Sentence: 442,was,O
Sentence: 442,attained,O
Sentence: 442,",",O
Sentence: 442,associated,O
Sentence: 442,with,O
Sentence: 442,a,O
Sentence: 442,slight,O
Sentence: 442,increase,O
Sentence: 442,in,O
Sentence: 442,heart,O
Sentence: 442,rate,O
Sentence: 442,.,O
Sentence: 442,No,O
Sentence: 442,arrhythmias,B-Disease
Sentence: 442,were,O
Sentence: 442,induced,O
Sentence: 442,by,O
Sentence: 442,these,O
Sentence: 442,doses,O
Sentence: 442,of,O
Sentence: 442,denopamine,B-Chemical
Sentence: 442,.,O
Sentence: 442,The,O
Sentence: 442,results,O
Sentence: 442,warrant,O
Sentence: 442,clinical,O
Sentence: 442,trials,O
Sentence: 442,of,O
Sentence: 442,denopamine,B-Chemical
Sentence: 442,in,O
Sentence: 442,the,O
Sentence: 442,treatment,O
Sentence: 442,of,O
Sentence: 442,cardiac,B-Disease
Sentence: 442,failure,I-Disease
Sentence: 442,.,O
Sentence: 443,Clonazepam,B-Chemical
Sentence: 443,monotherapy,O
Sentence: 443,for,O
Sentence: 443,epilepsy,B-Disease
Sentence: 443,in,O
Sentence: 443,childhood,O
Sentence: 443,.,O
Sentence: 444,Sixty,O
Sentence: 444,patients,O
Sentence: 444,(,O
Sentence: 444,age,O
Sentence: 444,-,O
Sentence: 444,range,O
Sentence: 444,one,O
Sentence: 444,month,O
Sentence: 444,to,O
Sentence: 444,14,O
Sentence: 444,years,O
Sentence: 444,),O
Sentence: 444,with,O
Sentence: 444,other,O
Sentence: 444,types,O
Sentence: 444,of,O
Sentence: 444,epilepsy,B-Disease
Sentence: 444,than,O
Sentence: 444,infantile,B-Disease
Sentence: 444,spasms,I-Disease
Sentence: 444,were,O
Sentence: 444,treated,O
Sentence: 444,with,O
Sentence: 444,clonazepam,B-Chemical
Sentence: 444,.,O
Sentence: 444,Disappearance,O
Sentence: 444,of,O
Sentence: 444,seizures,B-Disease
Sentence: 444,and,O
Sentence: 444,normalization,O
Sentence: 444,of,O
Sentence: 444,abnormal,O
Sentence: 444,EEG,O
Sentence: 444,with,O
Sentence: 444,disappearance,O
Sentence: 444,of,O
Sentence: 444,seizures,B-Disease
Sentence: 444,were,O
Sentence: 444,recognized,O
Sentence: 444,in,O
Sentence: 444,77,O
Sentence: 444,%,O
Sentence: 444,and,O
Sentence: 444,50,O
Sentence: 444,%,O
Sentence: 444,",",O
Sentence: 444,respectively,O
Sentence: 444,.,O
Sentence: 444,Seizures,B-Disease
Sentence: 444,disappeared,O
Sentence: 444,in,O
Sentence: 444,71,O
Sentence: 444,%,O
Sentence: 444,of,O
Sentence: 444,the,O
Sentence: 444,patients,O
Sentence: 444,with,O
Sentence: 444,generalized,O
Sentence: 444,seizures,B-Disease
Sentence: 444,and,O
Sentence: 444,89,O
Sentence: 444,%,O
Sentence: 444,of,O
Sentence: 444,partial,O
Sentence: 444,seizures,B-Disease
Sentence: 444,.,O
Sentence: 444,Improvement,O
Sentence: 444,of,O
Sentence: 444,abnormal,O
Sentence: 444,EEG,O
Sentence: 444,was,O
Sentence: 444,noticed,O
Sentence: 444,in,O
Sentence: 444,76,O
Sentence: 444,%,O
Sentence: 444,of,O
Sentence: 444,diffuse,O
Sentence: 444,paroxysms,O
Sentence: 444,and,O
Sentence: 444,in,O
Sentence: 444,67,O
Sentence: 444,%,O
Sentence: 444,of,O
Sentence: 444,focal,O
Sentence: 444,paroxysms,O
Sentence: 444,.,O
Sentence: 444,In,O
Sentence: 444,excellent,O
Sentence: 444,cases,O
Sentence: 444,",",O
Sentence: 444,mean,O
Sentence: 444,effective,O
Sentence: 444,dosages,O
Sentence: 444,were,O
Sentence: 444,0.086,O
Sentence: 444,+,O
Sentence: 444,/,O
Sentence: 444,,O
Sentence: 444,-,O
Sentence: 444,,O
Sentence: 444,0.021,O
Sentence: 444,mg,O
Sentence: 444,/,O
Sentence: 444,kg,O
Sentence: 444,/,O
Sentence: 444,day,O
Sentence: 444,in,O
Sentence: 444,infants,O
Sentence: 444,and,O
Sentence: 444,0.057,O
Sentence: 444,+,O
Sentence: 444,/,O
Sentence: 444,,O
Sentence: 444,-,O
Sentence: 444,,O
Sentence: 444,0.022,O
Sentence: 444,mg,O
Sentence: 444,/,O
Sentence: 444,kg,O
Sentence: 444,/,O
Sentence: 444,day,O
Sentence: 444,in,O
Sentence: 444,schoolchildren,O
Sentence: 444,",",O
Sentence: 444,this,O
Sentence: 444,difference,O
Sentence: 444,was,O
Sentence: 444,statistically,O
Sentence: 444,significant,O
Sentence: 444,(,O
Sentence: 444,p,O
Sentence: 444,less,O
Sentence: 444,than,O
Sentence: 444,0.005,O
Sentence: 444,),O
Sentence: 444,.,O
Sentence: 444,The,O
Sentence: 444,incidence,O
Sentence: 444,of,O
Sentence: 444,side,O
Sentence: 444,effects,O
Sentence: 444,such,O
Sentence: 444,as,O
Sentence: 444,drowsiness,B-Disease
Sentence: 444,and,O
Sentence: 444,ataxia,B-Disease
Sentence: 444,was,O
Sentence: 444,only,O
Sentence: 444,5,O
Sentence: 444,%,O
Sentence: 444,.,O
Sentence: 445,Postmarketing,O
Sentence: 445,study,O
Sentence: 445,of,O
Sentence: 445,timolol,B-Chemical
Sentence: 445,-,O
Sentence: 445,hydrochlorothiazide,B-Chemical
Sentence: 445,antihypertensive,O
Sentence: 445,therapy,O
Sentence: 445,.,O
Sentence: 446,A,O
Sentence: 446,postmarketing,O
Sentence: 446,surveillance,O
Sentence: 446,study,O
Sentence: 446,was,O
Sentence: 446,conducted,O
Sentence: 446,to,O
Sentence: 446,determine,O
Sentence: 446,the,O
Sentence: 446,safety,O
Sentence: 446,and,O
Sentence: 446,efficacy,O
Sentence: 446,of,O
Sentence: 446,a,O
Sentence: 446,fixed,O
Sentence: 446,-,O
Sentence: 446,ratio,O
Sentence: 446,combination,O
Sentence: 446,containing,O
Sentence: 446,10,O
Sentence: 446,mg,O
Sentence: 446,of,O
Sentence: 446,timolol,B-Chemical
Sentence: 446,maleate,I-Chemical
Sentence: 446,and,O
Sentence: 446,25,O
Sentence: 446,mg,O
Sentence: 446,of,O
Sentence: 446,hydrochlorothiazide,B-Chemical
Sentence: 446,",",O
Sentence: 446,administered,O
Sentence: 446,twice,O
Sentence: 446,daily,O
Sentence: 446,for,O
Sentence: 446,one,O
Sentence: 446,month,O
Sentence: 446,to,O
Sentence: 446,hypertensive,B-Disease
Sentence: 446,patients,O
Sentence: 446,.,O
Sentence: 446,Data,O
Sentence: 446,on,O
Sentence: 446,"9,037",O
Sentence: 446,patients,O
Sentence: 446,were,O
Sentence: 446,collected,O
Sentence: 446,by,O
Sentence: 446,"1,455",O
Sentence: 446,participating,O
Sentence: 446,physicians,O
Sentence: 446,.,O
Sentence: 446,Mean,O
Sentence: 446,systolic,O
Sentence: 446,blood,O
Sentence: 446,pressure,O
Sentence: 446,decreased,O
Sentence: 446,25,O
Sentence: 446,mmHg,O
Sentence: 446,and,O
Sentence: 446,mean,O
Sentence: 446,diastolic,O
Sentence: 446,blood,O
Sentence: 446,pressure,O
Sentence: 446,declined,O
Sentence: 446,15,O
Sentence: 446,mmHg,O
Sentence: 446,after,O
Sentence: 446,one,O
Sentence: 446,month,O
Sentence: 446,of,O
Sentence: 446,timolol,B-Chemical
Sentence: 446,-,O
Sentence: 446,hydrochlorothiazide,B-Chemical
Sentence: 446,therapy,O
Sentence: 446,(,O
Sentence: 446,P,O
Sentence: 446,less,O
Sentence: 446,than,O
Sentence: 446,0.01,O
Sentence: 446,",",O
Sentence: 446,both,O
Sentence: 446,comparisons,O
Sentence: 446,),O
Sentence: 446,.,O
Sentence: 446,Age,O
Sentence: 446,",",O
Sentence: 446,race,O
Sentence: 446,",",O
Sentence: 446,and,O
Sentence: 446,sex,O
Sentence: 446,appeared,O
Sentence: 446,to,O
Sentence: 446,have,O
Sentence: 446,no,O
Sentence: 446,influence,O
Sentence: 446,on,O
Sentence: 446,the,O
Sentence: 446,decrease,O
Sentence: 446,in,O
Sentence: 446,blood,O
Sentence: 446,pressure,O
Sentence: 446,.,O
Sentence: 446,The,O
Sentence: 446,antihypertensive,O
Sentence: 446,effect,O
Sentence: 446,of,O
Sentence: 446,the,O
Sentence: 446,drug,O
Sentence: 446,was,O
Sentence: 446,greater,O
Sentence: 446,in,O
Sentence: 446,patients,O
Sentence: 446,with,O
Sentence: 446,more,O
Sentence: 446,severe,O
Sentence: 446,hypertension,B-Disease
Sentence: 446,.,O
Sentence: 446,Overall,O
Sentence: 446,",",O
Sentence: 446,"1,453",O
Sentence: 446,patients,O
Sentence: 446,experienced,O
Sentence: 446,a,O
Sentence: 446,total,O
Sentence: 446,of,O
Sentence: 446,"2,658",O
Sentence: 446,adverse,O
Sentence: 446,events,O
Sentence: 446,",",O
Sentence: 446,the,O
Sentence: 446,most,O
Sentence: 446,common,O
Sentence: 446,being,O
Sentence: 446,fatigue,B-Disease
Sentence: 446,",",O
Sentence: 446,dizziness,B-Disease
Sentence: 446,",",O
Sentence: 446,and,O
Sentence: 446,weakness,B-Disease
Sentence: 446,.,O
Sentence: 446,Treatment,O
Sentence: 446,in,O
Sentence: 446,590,O
Sentence: 446,patients,O
Sentence: 446,was,O
Sentence: 446,discontinued,O
Sentence: 446,because,O
Sentence: 446,of,O
Sentence: 446,adverse,O
Sentence: 446,events,O
Sentence: 446,.,O
Sentence: 447,Salicylate,B-Chemical
Sentence: 447,nephropathy,B-Disease
Sentence: 447,in,O
Sentence: 447,the,O
Sentence: 447,Gunn,O
Sentence: 447,rat,O
Sentence: 447,:,O
Sentence: 447,potential,O
Sentence: 447,role,O
Sentence: 447,of,O
Sentence: 447,prostaglandins,B-Chemical
Sentence: 447,.,O
Sentence: 448,We,O
Sentence: 448,examined,O
Sentence: 448,the,O
Sentence: 448,potential,O
Sentence: 448,role,O
Sentence: 448,of,O
Sentence: 448,prostaglandins,B-Chemical
Sentence: 448,in,O
Sentence: 448,the,O
Sentence: 448,development,O
Sentence: 448,of,O
Sentence: 448,analgesic,O
Sentence: 448,nephropathy,B-Disease
Sentence: 448,in,O
Sentence: 448,the,O
Sentence: 448,Gunn,O
Sentence: 448,strain,O
Sentence: 448,of,O
Sentence: 448,rat,O
Sentence: 448,.,O
Sentence: 448,The,O
Sentence: 448,homozygous,O
Sentence: 448,Gunn,O
Sentence: 448,rats,O
Sentence: 448,have,O
Sentence: 448,unconjugated,O
Sentence: 448,hyperbilirubinemia,B-Disease
Sentence: 448,due,O
Sentence: 448,to,O
Sentence: 448,the,O
Sentence: 448,absence,O
Sentence: 448,of,O
Sentence: 448,glucuronyl,B-Chemical
Sentence: 448,transferase,O
Sentence: 448,",",O
Sentence: 448,leading,O
Sentence: 448,to,O
Sentence: 448,marked,O
Sentence: 448,bilirubin,B-Chemical
Sentence: 448,deposition,O
Sentence: 448,in,O
Sentence: 448,renal,O
Sentence: 448,medulla,O
Sentence: 448,and,O
Sentence: 448,papilla,O
Sentence: 448,.,O
Sentence: 448,These,O
Sentence: 448,rats,O
Sentence: 448,are,O
Sentence: 448,also,O
Sentence: 448,highly,O
Sentence: 448,susceptible,O
Sentence: 448,to,O
Sentence: 448,develop,O
Sentence: 448,papillary,B-Disease
Sentence: 448,necrosis,I-Disease
Sentence: 448,with,O
Sentence: 448,analgesic,O
Sentence: 448,administration,O
Sentence: 448,.,O
Sentence: 448,We,O
Sentence: 448,used,O
Sentence: 448,homozygous,O
Sentence: 448,(,O
Sentence: 448,jj,O
Sentence: 448,),O
Sentence: 448,and,O
Sentence: 448,phenotypically,O
Sentence: 448,normal,O
Sentence: 448,heterozygous,O
Sentence: 448,(,O
Sentence: 448,jJ,O
Sentence: 448,),O
Sentence: 448,animals,O
Sentence: 448,.,O
Sentence: 448,Four,O
Sentence: 448,groups,O
Sentence: 448,of,O
Sentence: 448,rats,O
Sentence: 448,(,O
Sentence: 448,n,O
Sentence: 448,,O
Sentence: 448,=,O
Sentence: 448,,O
Sentence: 448,7,O
Sentence: 448,),O
Sentence: 448,were,O
Sentence: 448,studied,O
Sentence: 448,:,O
Sentence: 448,jj,O
Sentence: 448,and,O
Sentence: 448,jJ,O
Sentence: 448,rats,O
Sentence: 448,treated,O
Sentence: 448,either,O
Sentence: 448,with,O
Sentence: 448,aspirin,B-Chemical
Sentence: 448,300,O
Sentence: 448,mg,O
Sentence: 448,/,O
Sentence: 448,kg,O
Sentence: 448,every,O
Sentence: 448,other,O
Sentence: 448,day,O
Sentence: 448,or,O
Sentence: 448,sham,O
Sentence: 448,-,O
Sentence: 448,treated,O
Sentence: 448,.,O
Sentence: 448,After,O
Sentence: 448,one,O
Sentence: 448,week,O
Sentence: 448,",",O
Sentence: 448,slices,O
Sentence: 448,of,O
Sentence: 448,cortex,O
Sentence: 448,",",O
Sentence: 448,outer,O
Sentence: 448,and,O
Sentence: 448,inner,O
Sentence: 448,medulla,O
Sentence: 448,from,O
Sentence: 448,one,O
Sentence: 448,kidney,O
Sentence: 448,were,O
Sentence: 448,incubated,O
Sentence: 448,in,O
Sentence: 448,buffer,O
Sentence: 448,and,O
Sentence: 448,prostaglandin,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,was,O
Sentence: 448,determined,O
Sentence: 448,by,O
Sentence: 448,radioimmunoassay,O
Sentence: 448,.,O
Sentence: 448,The,O
Sentence: 448,other,O
Sentence: 448,kidney,O
Sentence: 448,was,O
Sentence: 448,examined,O
Sentence: 448,histologically,O
Sentence: 448,.,O
Sentence: 448,A,O
Sentence: 448,marked,O
Sentence: 448,corticomedullary,O
Sentence: 448,gradient,O
Sentence: 448,of,O
Sentence: 448,prostaglandin,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,was,O
Sentence: 448,observed,O
Sentence: 448,in,O
Sentence: 448,all,O
Sentence: 448,groups,O
Sentence: 448,.,O
Sentence: 448,PGE2,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,was,O
Sentence: 448,significantly,O
Sentence: 448,higher,O
Sentence: 448,in,O
Sentence: 448,outer,O
Sentence: 448,medulla,O
Sentence: 448,",",O
Sentence: 448,but,O
Sentence: 448,not,O
Sentence: 448,cortex,O
Sentence: 448,or,O
Sentence: 448,inner,O
Sentence: 448,medulla,O
Sentence: 448,",",O
Sentence: 448,of,O
Sentence: 448,jj,O
Sentence: 448,(,O
Sentence: 448,38,O
Sentence: 448,+,O
Sentence: 448,/,O
Sentence: 448,,O
Sentence: 448,-,O
Sentence: 448,,O
Sentence: 448,6,O
Sentence: 448,ng,O
Sentence: 448,/,O
Sentence: 448,mg,O
Sentence: 448,prot,O
Sentence: 448,),O
Sentence: 448,than,O
Sentence: 448,jJ,O
Sentence: 448,rats,O
Sentence: 448,(,O
Sentence: 448,15,O
Sentence: 448,+,O
Sentence: 448,/,O
Sentence: 448,,O
Sentence: 448,-,O
Sentence: 448,,O
Sentence: 448,3,O
Sentence: 448,),O
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.01,O
Sentence: 448,),O
Sentence: 448,.,O
Sentence: 448,Aspirin,B-Chemical
Sentence: 448,treatment,O
Sentence: 448,reduced,O
Sentence: 448,PGE2,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,in,O
Sentence: 448,all,O
Sentence: 448,regions,O
Sentence: 448,",",O
Sentence: 448,but,O
Sentence: 448,outer,O
Sentence: 448,medullary,O
Sentence: 448,PGE2,B-Chemical
Sentence: 448,remained,O
Sentence: 448,higher,O
Sentence: 448,in,O
Sentence: 448,jj,O
Sentence: 448,(,O
Sentence: 448,18,O
Sentence: 448,+,O
Sentence: 448,/,O
Sentence: 448,,O
Sentence: 448,-,O
Sentence: 448,,O
Sentence: 448,3,O
Sentence: 448,),O
Sentence: 448,than,O
Sentence: 448,jJ,O
Sentence: 448,rats,O
Sentence: 448,(,O
Sentence: 448,9,O
Sentence: 448,+,O
Sentence: 448,/,O
Sentence: 448,,O
Sentence: 448,-,O
Sentence: 448,,O
Sentence: 448,2,O
Sentence: 448,),O
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.05,O
Sentence: 448,),O
Sentence: 448,.,O
Sentence: 448,PGF2,B-Chemical
Sentence: 448,alpha,I-Chemical
Sentence: 448,was,O
Sentence: 448,also,O
Sentence: 448,significantly,O
Sentence: 448,higher,O
Sentence: 448,in,O
Sentence: 448,the,O
Sentence: 448,outer,O
Sentence: 448,medulla,O
Sentence: 448,of,O
Sentence: 448,jj,O
Sentence: 448,rats,O
Sentence: 448,with,O
Sentence: 448,and,O
Sentence: 448,without,O
Sentence: 448,aspirin,B-Chemical
Sentence: 448,administration,O
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.05,O
Sentence: 448,),O
Sentence: 448,.,O
Sentence: 448,The,O
Sentence: 448,changes,O
Sentence: 448,in,O
Sentence: 448,renal,O
Sentence: 448,prostaglandin,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,were,O
Sentence: 448,accompanied,O
Sentence: 448,by,O
Sentence: 448,evidence,O
Sentence: 448,of,O
Sentence: 448,renal,B-Disease
Sentence: 448,damage,I-Disease
Sentence: 448,in,O
Sentence: 448,aspirin,B-Chemical
Sentence: 448,-,O
Sentence: 448,treated,O
Sentence: 448,jj,O
Sentence: 448,but,O
Sentence: 448,not,O
Sentence: 448,jJ,O
Sentence: 448,rats,O
Sentence: 448,as,O
Sentence: 448,evidenced,O
Sentence: 448,by,O
Sentence: 448,:,O
Sentence: 448,increased,O
Sentence: 448,incidence,O
Sentence: 448,and,O
Sentence: 448,severity,O
Sentence: 448,of,O
Sentence: 448,hematuria,B-Disease
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.01,O
Sentence: 448,),O
Sentence: 448,;,O
Sentence: 448,increased,O
Sentence: 448,serum,O
Sentence: 448,creatinine,B-Chemical
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.05,O
Sentence: 448,),O
Sentence: 448,;,O
Sentence: 448,and,O
Sentence: 448,increase,O
Sentence: 448,in,O
Sentence: 448,outer,O
Sentence: 448,medullary,O
Sentence: 448,histopathologic,O
Sentence: 448,lesions,O
Sentence: 448,(,O
Sentence: 448,p,O
Sentence: 448,less,O
Sentence: 448,than,O
Sentence: 448,0.005,O
Sentence: 448,compared,O
Sentence: 448,to,O
Sentence: 448,either,O
Sentence: 448,sham,O
Sentence: 448,-,O
Sentence: 448,treated,O
Sentence: 448,jj,O
Sentence: 448,or,O
Sentence: 448,aspirin,B-Chemical
Sentence: 448,-,O
Sentence: 448,treated,O
Sentence: 448,jJ,O
Sentence: 448,),O
Sentence: 448,.,O
Sentence: 448,These,O
Sentence: 448,results,O
Sentence: 448,suggest,O
Sentence: 448,that,O
Sentence: 448,enhanced,O
Sentence: 448,prostaglandin,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,contributes,O
Sentence: 448,to,O
Sentence: 448,maintenance,O
Sentence: 448,of,O
Sentence: 448,renal,O
Sentence: 448,function,O
Sentence: 448,and,O
Sentence: 448,morphological,O
Sentence: 448,integrity,O
Sentence: 448,",",O
Sentence: 448,and,O
Sentence: 448,that,O
Sentence: 448,inhibition,O
Sentence: 448,of,O
Sentence: 448,prostaglandin,B-Chemical
Sentence: 448,synthesis,O
Sentence: 448,may,O
Sentence: 448,lead,O
Sentence: 448,to,O
Sentence: 448,pathological,B-Disease
Sentence: 448,renal,I-Disease
Sentence: 448,medullary,I-Disease
Sentence: 448,lesions,I-Disease
Sentence: 448,and,O
Sentence: 448,deterioration,B-Disease
Sentence: 448,of,I-Disease
Sentence: 448,renal,I-Disease
Sentence: 448,function,I-Disease
Sentence: 448,.,O
Sentence: 449,Prophylactic,O
Sentence: 449,lidocaine,B-Chemical
Sentence: 449,in,O
Sentence: 449,the,O
Sentence: 449,early,O
Sentence: 449,phase,O
Sentence: 449,of,O
Sentence: 449,suspected,O
Sentence: 449,myocardial,B-Disease
Sentence: 449,infarction,I-Disease
Sentence: 449,.,O
Sentence: 450,Four,O
Sentence: 450,hundred,O
Sentence: 450,two,O
Sentence: 450,patients,O
Sentence: 450,with,O
Sentence: 450,suspected,O
Sentence: 450,myocardial,B-Disease
Sentence: 450,infarction,I-Disease
Sentence: 450,seen,O
Sentence: 450,within,O
Sentence: 450,6,O
Sentence: 450,hours,O
Sentence: 450,of,O
Sentence: 450,the,O
Sentence: 450,onset,O
Sentence: 450,of,O
Sentence: 450,symptoms,O
Sentence: 450,entered,O
Sentence: 450,a,O
Sentence: 450,double,O
Sentence: 450,-,O
Sentence: 450,blind,O
Sentence: 450,randomized,O
Sentence: 450,trial,O
Sentence: 450,of,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,vs,O
Sentence: 450,placebo,O
Sentence: 450,.,O
Sentence: 450,During,O
Sentence: 450,the,O
Sentence: 450,1,O
Sentence: 450,hour,O
Sentence: 450,after,O
Sentence: 450,administration,O
Sentence: 450,of,O
Sentence: 450,the,O
Sentence: 450,drug,O
Sentence: 450,the,O
Sentence: 450,incidence,O
Sentence: 450,of,O
Sentence: 450,ventricular,B-Disease
Sentence: 450,fibrillation,I-Disease
Sentence: 450,or,O
Sentence: 450,sustained,O
Sentence: 450,ventricular,B-Disease
Sentence: 450,tachycardia,I-Disease
Sentence: 450,among,O
Sentence: 450,the,O
Sentence: 450,204,O
Sentence: 450,patients,O
Sentence: 450,with,O
Sentence: 450,acute,O
Sentence: 450,myocardial,B-Disease
Sentence: 450,infarction,I-Disease
Sentence: 450,was,O
Sentence: 450,low,O
Sentence: 450,",",O
Sentence: 450,1.5,O
Sentence: 450,%,O
Sentence: 450,.,O
Sentence: 450,Lidocaine,B-Chemical
Sentence: 450,",",O
Sentence: 450,given,O
Sentence: 450,in,O
Sentence: 450,a,O
Sentence: 450,300,O
Sentence: 450,mg,O
Sentence: 450,dose,O
Sentence: 450,intramuscularly,O
Sentence: 450,followed,O
Sentence: 450,by,O
Sentence: 450,100,O
Sentence: 450,mg,O
Sentence: 450,intravenously,O
Sentence: 450,",",O
Sentence: 450,did,O
Sentence: 450,not,O
Sentence: 450,prevent,O
Sentence: 450,sustained,O
Sentence: 450,ventricular,B-Disease
Sentence: 450,tachycardia,I-Disease
Sentence: 450,",",O
Sentence: 450,although,O
Sentence: 450,there,O
Sentence: 450,was,O
Sentence: 450,a,O
Sentence: 450,significant,O
Sentence: 450,reduction,O
Sentence: 450,in,O
Sentence: 450,the,O
Sentence: 450,number,O
Sentence: 450,of,O
Sentence: 450,patients,O
Sentence: 450,with,O
Sentence: 450,warning,O
Sentence: 450,arrhythmias,B-Disease
Sentence: 450,between,O
Sentence: 450,15,O
Sentence: 450,and,O
Sentence: 450,45,O
Sentence: 450,minutes,O
Sentence: 450,after,O
Sentence: 450,the,O
Sentence: 450,administration,O
Sentence: 450,of,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,(,O
Sentence: 450,p,O
Sentence: 450,less,O
Sentence: 450,than,O
Sentence: 450,0.05,O
Sentence: 450,),O
Sentence: 450,.,O
Sentence: 450,The,O
Sentence: 450,average,O
Sentence: 450,plasma,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,level,O
Sentence: 450,10,O
Sentence: 450,minutes,O
Sentence: 450,after,O
Sentence: 450,administration,O
Sentence: 450,for,O
Sentence: 450,patients,O
Sentence: 450,without,O
Sentence: 450,a,O
Sentence: 450,myocardial,B-Disease
Sentence: 450,infarction,I-Disease
Sentence: 450,was,O
Sentence: 450,significantly,O
Sentence: 450,higher,O
Sentence: 450,than,O
Sentence: 450,that,O
Sentence: 450,for,O
Sentence: 450,patients,O
Sentence: 450,with,O
Sentence: 450,an,O
Sentence: 450,acute,O
Sentence: 450,infarction,B-Disease
Sentence: 450,.,O
Sentence: 450,The,O
Sentence: 450,mean,O
Sentence: 450,plasma,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,level,O
Sentence: 450,of,O
Sentence: 450,patients,O
Sentence: 450,on,O
Sentence: 450,beta,O
Sentence: 450,-,O
Sentence: 450,blocking,O
Sentence: 450,agents,O
Sentence: 450,was,O
Sentence: 450,no,O
Sentence: 450,different,O
Sentence: 450,from,O
Sentence: 450,that,O
Sentence: 450,in,O
Sentence: 450,patients,O
Sentence: 450,not,O
Sentence: 450,on,O
Sentence: 450,beta,O
Sentence: 450,blocking,O
Sentence: 450,agents,O
Sentence: 450,.,O
Sentence: 450,During,O
Sentence: 450,the,O
Sentence: 450,1,O
Sentence: 450,-,O
Sentence: 450,hour,O
Sentence: 450,study,O
Sentence: 450,period,O
Sentence: 450,",",O
Sentence: 450,the,O
Sentence: 450,incidence,O
Sentence: 450,of,O
Sentence: 450,central,O
Sentence: 450,nervous,O
Sentence: 450,system,O
Sentence: 450,side,O
Sentence: 450,effects,O
Sentence: 450,was,O
Sentence: 450,significantly,O
Sentence: 450,greater,O
Sentence: 450,in,O
Sentence: 450,the,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,group,O
Sentence: 450,",",O
Sentence: 450,hypotension,B-Disease
Sentence: 450,occurred,O
Sentence: 450,in,O
Sentence: 450,11,O
Sentence: 450,patients,O
Sentence: 450,",",O
Sentence: 450,nine,O
Sentence: 450,of,O
Sentence: 450,whom,O
Sentence: 450,had,O
Sentence: 450,received,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,",",O
Sentence: 450,and,O
Sentence: 450,four,O
Sentence: 450,patients,O
Sentence: 450,died,O
Sentence: 450,from,O
Sentence: 450,asystole,B-Disease
Sentence: 450,",",O
Sentence: 450,three,O
Sentence: 450,of,O
Sentence: 450,whom,O
Sentence: 450,had,O
Sentence: 450,had,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,.,O
Sentence: 450,We,O
Sentence: 450,can,O
Sentence: 450,not,O
Sentence: 450,advocate,O
Sentence: 450,the,O
Sentence: 450,administration,O
Sentence: 450,of,O
Sentence: 450,lidocaine,B-Chemical
Sentence: 450,prophylactically,O
Sentence: 450,in,O
Sentence: 450,the,O
Sentence: 450,early,O
Sentence: 450,hours,O
Sentence: 450,of,O
Sentence: 450,suspected,O
Sentence: 450,myocardial,B-Disease
Sentence: 450,infarction,I-Disease
Sentence: 450,.,O
Sentence: 451,Evidence,O
Sentence: 451,for,O
Sentence: 451,a,O
Sentence: 451,cholinergic,O
Sentence: 451,role,O
Sentence: 451,in,O
Sentence: 451,haloperidol,B-Chemical
Sentence: 451,-,O
Sentence: 451,induced,O
Sentence: 451,catalepsy,B-Disease
Sentence: 451,.,O
Sentence: 452,Experiments,O
Sentence: 452,in,O
Sentence: 452,mice,O
Sentence: 452,tested,O
Sentence: 452,previous,O
Sentence: 452,evidence,O
Sentence: 452,that,O
Sentence: 452,activation,O
Sentence: 452,of,O
Sentence: 452,cholinergic,O
Sentence: 452,systems,O
Sentence: 452,promotes,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,and,O
Sentence: 452,that,O
Sentence: 452,cholinergic,O
Sentence: 452,mechanisms,O
Sentence: 452,need,O
Sentence: 452,to,O
Sentence: 452,be,O
Sentence: 452,intact,O
Sentence: 452,for,O
Sentence: 452,full,O
Sentence: 452,expression,O
Sentence: 452,of,O
Sentence: 452,neuroleptic,B-Chemical
Sentence: 452,-,O
Sentence: 452,induced,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,.,O
Sentence: 452,Large,O
Sentence: 452,doses,O
Sentence: 452,of,O
Sentence: 452,the,O
Sentence: 452,cholinomimetic,O
Sentence: 452,",",O
Sentence: 452,pilocarpine,B-Chemical
Sentence: 452,",",O
Sentence: 452,could,O
Sentence: 452,induce,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,when,O
Sentence: 452,peripheral,O
Sentence: 452,cholinergic,O
Sentence: 452,receptors,O
Sentence: 452,were,O
Sentence: 452,blocked,O
Sentence: 452,.,O
Sentence: 452,Low,O
Sentence: 452,doses,O
Sentence: 452,of,O
Sentence: 452,pilocarpine,B-Chemical
Sentence: 452,caused,O
Sentence: 452,a,O
Sentence: 452,pronounced,O
Sentence: 452,enhancement,O
Sentence: 452,of,O
Sentence: 452,the,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,that,O
Sentence: 452,was,O
Sentence: 452,induced,O
Sentence: 452,by,O
Sentence: 452,the,O
Sentence: 452,dopaminergic,O
Sentence: 452,blocker,O
Sentence: 452,",",O
Sentence: 452,haloperidol,B-Chemical
Sentence: 452,.,O
Sentence: 452,A,O
Sentence: 452,muscarinic,O
Sentence: 452,receptor,O
Sentence: 452,blocker,O
Sentence: 452,",",O
Sentence: 452,atropine,B-Chemical
Sentence: 452,",",O
Sentence: 452,disrupted,O
Sentence: 452,haloperidol,B-Chemical
Sentence: 452,-,O
Sentence: 452,induced,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,.,O
Sentence: 452,Intracranial,O
Sentence: 452,injection,O
Sentence: 452,of,O
Sentence: 452,an,O
Sentence: 452,acetylcholine,B-Chemical
Sentence: 452,-,O
Sentence: 452,synthesis,O
Sentence: 452,inhibitor,O
Sentence: 452,",",O
Sentence: 452,hemicholinium,B-Chemical
Sentence: 452,",",O
Sentence: 452,prevented,O
Sentence: 452,the,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,that,O
Sentence: 452,is,O
Sentence: 452,usually,O
Sentence: 452,induced,O
Sentence: 452,by,O
Sentence: 452,haloperidol,B-Chemical
Sentence: 452,.,O
Sentence: 452,These,O
Sentence: 452,findings,O
Sentence: 452,suggest,O
Sentence: 452,the,O
Sentence: 452,hypothesis,O
Sentence: 452,that,O
Sentence: 452,the,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,that,O
Sentence: 452,is,O
Sentence: 452,produced,O
Sentence: 452,by,O
Sentence: 452,neuroleptics,B-Chemical
Sentence: 452,such,O
Sentence: 452,as,O
Sentence: 452,haloperidol,B-Chemical
Sentence: 452,is,O
Sentence: 452,actually,O
Sentence: 452,mediated,O
Sentence: 452,by,O
Sentence: 452,intrinsic,O
Sentence: 452,central,O
Sentence: 452,cholinergic,O
Sentence: 452,systems,O
Sentence: 452,.,O
Sentence: 452,Alternatively,O
Sentence: 452,",",O
Sentence: 452,activation,O
Sentence: 452,of,O
Sentence: 452,central,O
Sentence: 452,cholinergic,O
Sentence: 452,systems,O
Sentence: 452,could,O
Sentence: 452,promote,O
Sentence: 452,catalepsy,B-Disease
Sentence: 452,by,O
Sentence: 452,suppression,O
Sentence: 452,of,O
Sentence: 452,dopaminergic,O
Sentence: 452,systems,O
Sentence: 452,.,O
Sentence: 453,Cardiovascular,B-Disease
Sentence: 453,dysfunction,I-Disease
Sentence: 453,and,O
Sentence: 453,hypersensitivity,B-Disease
Sentence: 453,to,O
Sentence: 453,sodium,B-Chemical
Sentence: 453,pentobarbital,I-Chemical
Sentence: 453,induced,O
Sentence: 453,by,O
Sentence: 453,chronic,O
Sentence: 453,barium,B-Chemical
Sentence: 453,chloride,I-Chemical
Sentence: 453,ingestion,O
Sentence: 453,.,O
Sentence: 454,Barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,supplemented,O
Sentence: 454,Long,O
Sentence: 454,-,O
Sentence: 454,Evans,O
Sentence: 454,hooded,O
Sentence: 454,rats,O
Sentence: 454,were,O
Sentence: 454,characterized,O
Sentence: 454,by,O
Sentence: 454,a,O
Sentence: 454,persistent,O
Sentence: 454,hypertension,B-Disease
Sentence: 454,that,O
Sentence: 454,was,O
Sentence: 454,evident,O
Sentence: 454,after,O
Sentence: 454,1,O
Sentence: 454,month,O
Sentence: 454,of,O
Sentence: 454,barium,B-Chemical
Sentence: 454,(,O
Sentence: 454,100,O
Sentence: 454,micrograms,O
Sentence: 454,/,O
Sentence: 454,ml,O
Sentence: 454,mineral,O
Sentence: 454,fortified,O
Sentence: 454,water,O
Sentence: 454,),O
Sentence: 454,treatment,O
Sentence: 454,.,O
Sentence: 454,Analysis,O
Sentence: 454,of,O
Sentence: 454,in,O
Sentence: 454,vivo,O
Sentence: 454,myocardial,O
Sentence: 454,excitability,O
Sentence: 454,",",O
Sentence: 454,contractility,O
Sentence: 454,",",O
Sentence: 454,and,O
Sentence: 454,metabolic,O
Sentence: 454,characteristics,O
Sentence: 454,at,O
Sentence: 454,16,O
Sentence: 454,months,O
Sentence: 454,revealed,O
Sentence: 454,other,O
Sentence: 454,significant,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,induced,O
Sentence: 454,disturbances,B-Disease
Sentence: 454,within,I-Disease
Sentence: 454,the,I-Disease
Sentence: 454,cardiovascular,I-Disease
Sentence: 454,system,I-Disease
Sentence: 454,.,O
Sentence: 454,The,O
Sentence: 454,most,O
Sentence: 454,distinctive,O
Sentence: 454,aspect,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,barium,B-Chemical
Sentence: 454,effect,O
Sentence: 454,was,O
Sentence: 454,a,O
Sentence: 454,demonstrated,O
Sentence: 454,hypersensitivity,B-Disease
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,cardiovascular,O
Sentence: 454,system,O
Sentence: 454,to,O
Sentence: 454,sodium,B-Chemical
Sentence: 454,pentobarbital,I-Chemical
Sentence: 454,.,O
Sentence: 454,Under,O
Sentence: 454,barbiturate,B-Chemical
Sentence: 454,anesthesia,O
Sentence: 454,",",O
Sentence: 454,virtually,O
Sentence: 454,all,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,myocardial,O
Sentence: 454,contractile,O
Sentence: 454,indices,O
Sentence: 454,were,O
Sentence: 454,depressed,O
Sentence: 454,significantly,O
Sentence: 454,in,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,exposed,O
Sentence: 454,rats,O
Sentence: 454,relative,O
Sentence: 454,to,O
Sentence: 454,the,O
Sentence: 454,corresponding,O
Sentence: 454,control,O
Sentence: 454,-,O
Sentence: 454,fed,O
Sentence: 454,rats,O
Sentence: 454,.,O
Sentence: 454,The,O
Sentence: 454,lack,O
Sentence: 454,of,O
Sentence: 454,a,O
Sentence: 454,similar,O
Sentence: 454,response,O
Sentence: 454,to,O
Sentence: 454,ketamine,B-Chemical
Sentence: 454,and,O
Sentence: 454,xylazine,B-Chemical
Sentence: 454,anesthesia,O
Sentence: 454,revealed,O
Sentence: 454,that,O
Sentence: 454,the,O
Sentence: 454,cardiovascular,O
Sentence: 454,actions,O
Sentence: 454,of,O
Sentence: 454,sodium,B-Chemical
Sentence: 454,pentobarbital,I-Chemical
Sentence: 454,in,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,treated,O
Sentence: 454,rats,O
Sentence: 454,were,O
Sentence: 454,linked,O
Sentence: 454,specifically,O
Sentence: 454,to,O
Sentence: 454,this,O
Sentence: 454,anesthetic,O
Sentence: 454,",",O
Sentence: 454,and,O
Sentence: 454,were,O
Sentence: 454,not,O
Sentence: 454,representative,O
Sentence: 454,of,O
Sentence: 454,a,O
Sentence: 454,generalized,O
Sentence: 454,anesthetic,O
Sentence: 454,response,O
Sentence: 454,.,O
Sentence: 454,Other,O
Sentence: 454,myocardial,O
Sentence: 454,pathophysiologic,O
Sentence: 454,and,O
Sentence: 454,metabolic,O
Sentence: 454,changes,O
Sentence: 454,induced,O
Sentence: 454,by,O
Sentence: 454,barium,B-Chemical
Sentence: 454,were,O
Sentence: 454,manifest,O
Sentence: 454,",",O
Sentence: 454,irrespective,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,anesthetic,O
Sentence: 454,employed,O
Sentence: 454,.,O
Sentence: 454,The,O
Sentence: 454,contractile,O
Sentence: 454,element,O
Sentence: 454,shortening,O
Sentence: 454,velocity,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,cardiac,O
Sentence: 454,muscle,O
Sentence: 454,fibers,O
Sentence: 454,was,O
Sentence: 454,significantly,O
Sentence: 454,slower,O
Sentence: 454,in,O
Sentence: 454,both,O
Sentence: 454,groups,O
Sentence: 454,of,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,treated,O
Sentence: 454,rats,O
Sentence: 454,relative,O
Sentence: 454,to,O
Sentence: 454,the,O
Sentence: 454,control,O
Sentence: 454,groups,O
Sentence: 454,",",O
Sentence: 454,irrespective,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,anesthetic,O
Sentence: 454,regimen,O
Sentence: 454,.,O
Sentence: 454,Similarly,O
Sentence: 454,",",O
Sentence: 454,significant,O
Sentence: 454,disturbances,O
Sentence: 454,in,O
Sentence: 454,myocardial,O
Sentence: 454,energy,O
Sentence: 454,metabolism,O
Sentence: 454,were,O
Sentence: 454,detected,O
Sentence: 454,in,O
Sentence: 454,the,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,exposed,O
Sentence: 454,rats,O
Sentence: 454,which,O
Sentence: 454,were,O
Sentence: 454,consistent,O
Sentence: 454,with,O
Sentence: 454,the,O
Sentence: 454,reduced,O
Sentence: 454,contractile,O
Sentence: 454,element,O
Sentence: 454,shortening,O
Sentence: 454,velocity,O
Sentence: 454,.,O
Sentence: 454,In,O
Sentence: 454,addition,O
Sentence: 454,",",O
Sentence: 454,the,O
Sentence: 454,excitability,O
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,cardiac,O
Sentence: 454,conduction,O
Sentence: 454,system,O
Sentence: 454,was,O
Sentence: 454,depressed,O
Sentence: 454,preferentially,O
Sentence: 454,in,O
Sentence: 454,the,O
Sentence: 454,atrioventricular,O
Sentence: 454,nodal,O
Sentence: 454,region,O
Sentence: 454,of,O
Sentence: 454,hearts,O
Sentence: 454,from,O
Sentence: 454,barium,B-Chemical
Sentence: 454,-,O
Sentence: 454,exposed,O
Sentence: 454,rats,O
Sentence: 454,.,O
Sentence: 454,Overall,O
Sentence: 454,",",O
Sentence: 454,the,O
Sentence: 454,altered,O
Sentence: 454,cardiac,O
Sentence: 454,contractility,O
Sentence: 454,and,O
Sentence: 454,excitability,O
Sentence: 454,characteristics,O
Sentence: 454,",",O
Sentence: 454,the,O
Sentence: 454,myocardial,O
Sentence: 454,metabolic,B-Disease
Sentence: 454,disturbances,I-Disease
Sentence: 454,",",O
Sentence: 454,and,O
Sentence: 454,the,O
Sentence: 454,hypersensitivity,B-Disease
Sentence: 454,of,O
Sentence: 454,the,O
Sentence: 454,cardiovascular,O
Sentence: 454,system,O
Sentence: 454,to,O
Sentence: 454,sodium,B-Chemical
Sentence: 454,pentobarbital,I-Chemical
Sentence: 454,suggest,O
Sentence: 454,the,O
Sentence: 454,existence,O
Sentence: 454,of,O
Sentence: 454,a,O
Sentence: 454,heretofore,O
Sentence: 454,undescribed,O
Sentence: 454,cardiomyopathic,B-Disease
Sentence: 454,disorder,I-Disease
Sentence: 454,induced,O
Sentence: 454,by,O
Sentence: 454,chronic,O
Sentence: 454,barium,B-Chemical
Sentence: 454,exposure,O
Sentence: 454,.,O
Sentence: 454,These,O
Sentence: 454,experimental,O
Sentence: 454,findings,O
Sentence: 454,represent,O
Sentence: 454,the,O
Sentence: 454,first,O
Sentence: 454,indication,O
Sentence: 454,that,O
Sentence: 454,life,O
Sentence: 454,-,O
Sentence: 454,long,O
Sentence: 454,barium,B-Chemical
Sentence: 454,ingestion,O
Sentence: 454,may,O
Sentence: 454,have,O
Sentence: 454,significant,O
Sentence: 454,adverse,O
Sentence: 454,effects,O
Sentence: 454,on,O
Sentence: 454,the,O
Sentence: 454,mammalian,O
Sentence: 454,cardiovascular,O
Sentence: 454,system,O
Sentence: 454,.,O
Sentence: 455,Propranolol,B-Chemical
Sentence: 455,antagonism,O
Sentence: 455,of,O
Sentence: 455,phenylpropanolamine,B-Chemical
Sentence: 455,-,O
Sentence: 455,induced,O
Sentence: 455,hypertension,B-Disease
Sentence: 455,.,O
Sentence: 456,Phenylpropanolamine,B-Chemical
Sentence: 456,(,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,),O
Sentence: 456,overdose,B-Disease
Sentence: 456,can,O
Sentence: 456,cause,O
Sentence: 456,severe,O
Sentence: 456,hypertension,B-Disease
Sentence: 456,",",O
Sentence: 456,intracerebral,B-Disease
Sentence: 456,hemorrhage,I-Disease
Sentence: 456,",",O
Sentence: 456,and,O
Sentence: 456,death,O
Sentence: 456,.,O
Sentence: 456,We,O
Sentence: 456,studied,O
Sentence: 456,the,O
Sentence: 456,efficacy,O
Sentence: 456,and,O
Sentence: 456,safety,O
Sentence: 456,of,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,in,O
Sentence: 456,the,O
Sentence: 456,treatment,O
Sentence: 456,of,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,-,O
Sentence: 456,induced,O
Sentence: 456,hypertension,B-Disease
Sentence: 456,.,O
Sentence: 456,Subjects,O
Sentence: 456,received,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,either,O
Sentence: 456,by,O
Sentence: 456,mouth,O
Sentence: 456,for,O
Sentence: 456,48,O
Sentence: 456,hours,O
Sentence: 456,before,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,or,O
Sentence: 456,as,O
Sentence: 456,a,O
Sentence: 456,rapid,O
Sentence: 456,intravenous,O
Sentence: 456,infusion,O
Sentence: 456,after,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,.,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,",",O
Sentence: 456,75,O
Sentence: 456,mg,O
Sentence: 456,alone,O
Sentence: 456,",",O
Sentence: 456,increased,O
Sentence: 456,blood,O
Sentence: 456,pressure,O
Sentence: 456,(,O
Sentence: 456,31,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,14,O
Sentence: 456,mm,O
Sentence: 456,Hg,O
Sentence: 456,systolic,O
Sentence: 456,",",O
Sentence: 456,20,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,5,O
Sentence: 456,mm,O
Sentence: 456,Hg,O
Sentence: 456,diastolic,O
Sentence: 456,),O
Sentence: 456,",",O
Sentence: 456,and,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,pretreatment,O
Sentence: 456,antagonized,O
Sentence: 456,this,O
Sentence: 456,increase,O
Sentence: 456,(,O
Sentence: 456,12,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,10,O
Sentence: 456,mm,O
Sentence: 456,Hg,O
Sentence: 456,systolic,O
Sentence: 456,",",O
Sentence: 456,10,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,7,O
Sentence: 456,mm,O
Sentence: 456,Hg,O
Sentence: 456,diastolic,O
Sentence: 456,),O
Sentence: 456,.,O
Sentence: 456,Intravenous,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,after,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,also,O
Sentence: 456,decreased,O
Sentence: 456,blood,O
Sentence: 456,pressure,O
Sentence: 456,.,O
Sentence: 456,Left,O
Sentence: 456,ventricular,O
Sentence: 456,function,O
Sentence: 456,(,O
Sentence: 456,assessed,O
Sentence: 456,by,O
Sentence: 456,echocardiography,O
Sentence: 456,),O
Sentence: 456,showed,O
Sentence: 456,that,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,increased,O
Sentence: 456,the,O
Sentence: 456,stroke,B-Disease
Sentence: 456,volume,O
Sentence: 456,30,O
Sentence: 456,%,O
Sentence: 456,(,O
Sentence: 456,from,O
Sentence: 456,62.5,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,20.9,O
Sentence: 456,to,O
Sentence: 456,80.8,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,22.4,O
Sentence: 456,ml,O
Sentence: 456,),O
Sentence: 456,",",O
Sentence: 456,the,O
Sentence: 456,ejection,O
Sentence: 456,fraction,O
Sentence: 456,9,O
Sentence: 456,%,O
Sentence: 456,(,O
Sentence: 456,from,O
Sentence: 456,64,O
Sentence: 456,%,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,10,O
Sentence: 456,%,O
Sentence: 456,to,O
Sentence: 456,70,O
Sentence: 456,%,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,7,O
Sentence: 456,%,O
Sentence: 456,),O
Sentence: 456,",",O
Sentence: 456,and,O
Sentence: 456,cardiac,O
Sentence: 456,output,O
Sentence: 456,14,O
Sentence: 456,%,O
Sentence: 456,(,O
Sentence: 456,from,O
Sentence: 456,3.6,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,0.6,O
Sentence: 456,to,O
Sentence: 456,4.1,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,1.0,O
Sentence: 456,L,O
Sentence: 456,/,O
Sentence: 456,min,O
Sentence: 456,),O
Sentence: 456,.,O
Sentence: 456,Intravenous,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,reversed,O
Sentence: 456,these,O
Sentence: 456,effects,O
Sentence: 456,.,O
Sentence: 456,Systemic,O
Sentence: 456,vascular,O
Sentence: 456,resistance,O
Sentence: 456,was,O
Sentence: 456,increased,O
Sentence: 456,by,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,28,O
Sentence: 456,%,O
Sentence: 456,(,O
Sentence: 456,from,O
Sentence: 456,1710,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,200,O
Sentence: 456,to,O
Sentence: 456,2190,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,700,O
Sentence: 456,dyne,O
Sentence: 456,X,O
Sentence: 456,sec,O
Sentence: 456,/,O
Sentence: 456,cm5,O
Sentence: 456,),O
Sentence: 456,and,O
Sentence: 456,was,O
Sentence: 456,further,O
Sentence: 456,increased,O
Sentence: 456,by,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,22,O
Sentence: 456,%,O
Sentence: 456,(,O
Sentence: 456,to,O
Sentence: 456,2660,O
Sentence: 456,+,O
Sentence: 456,/,O
Sentence: 456,,O
Sentence: 456,-,O
Sentence: 456,,O
Sentence: 456,1200,O
Sentence: 456,dyne,O
Sentence: 456,X,O
Sentence: 456,sec,O
Sentence: 456,/,O
Sentence: 456,cm5,O
Sentence: 456,),O
Sentence: 456,.,O
Sentence: 456,We,O
Sentence: 456,conclude,O
Sentence: 456,that,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,increases,O
Sentence: 456,blood,O
Sentence: 456,pressure,O
Sentence: 456,by,O
Sentence: 456,increasing,O
Sentence: 456,systemic,O
Sentence: 456,vascular,O
Sentence: 456,resistance,O
Sentence: 456,and,O
Sentence: 456,cardiac,O
Sentence: 456,output,O
Sentence: 456,",",O
Sentence: 456,and,O
Sentence: 456,that,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,antagonizes,O
Sentence: 456,this,O
Sentence: 456,increase,O
Sentence: 456,by,O
Sentence: 456,reversing,O
Sentence: 456,the,O
Sentence: 456,effect,O
Sentence: 456,of,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,on,O
Sentence: 456,cardiac,O
Sentence: 456,output,O
Sentence: 456,.,O
Sentence: 456,That,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,antagonizes,O
Sentence: 456,the,O
Sentence: 456,pressor,O
Sentence: 456,effect,O
Sentence: 456,of,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,is,O
Sentence: 456,in,O
Sentence: 456,contrast,O
Sentence: 456,to,O
Sentence: 456,the,O
Sentence: 456,interaction,O
Sentence: 456,in,O
Sentence: 456,which,O
Sentence: 456,propranolol,B-Chemical
Sentence: 456,enhances,O
Sentence: 456,the,O
Sentence: 456,pressor,O
Sentence: 456,effect,O
Sentence: 456,of,O
Sentence: 456,norepinephrine,B-Chemical
Sentence: 456,.,O
Sentence: 456,This,O
Sentence: 456,is,O
Sentence: 456,probably,O
Sentence: 456,because,O
Sentence: 456,PPA,B-Chemical
Sentence: 456,has,O
Sentence: 456,less,O
Sentence: 456,beta,O
Sentence: 456,2,O
Sentence: 456,activity,O
Sentence: 456,than,O
Sentence: 456,does,O
Sentence: 456,norepinephrine,B-Chemical
Sentence: 456,.,O
Sentence: 457,Mesangial,O
Sentence: 457,function,O
Sentence: 457,and,O
Sentence: 457,glomerular,B-Disease
Sentence: 457,sclerosis,I-Disease
Sentence: 457,in,O
Sentence: 457,rats,O
Sentence: 457,with,O
Sentence: 457,aminonucleoside,B-Chemical
Sentence: 457,nephrosis,B-Disease
Sentence: 457,.,O
Sentence: 458,The,O
Sentence: 458,possible,O
Sentence: 458,relationship,O
Sentence: 458,between,O
Sentence: 458,mesangial,B-Disease
Sentence: 458,dysfunction,I-Disease
Sentence: 458,and,O
Sentence: 458,development,O
Sentence: 458,of,O
Sentence: 458,glomerular,B-Disease
Sentence: 458,sclerosis,I-Disease
Sentence: 458,was,O
Sentence: 458,studied,O
Sentence: 458,in,O
Sentence: 458,the,O
Sentence: 458,puromycin,B-Chemical
Sentence: 458,aminonucleoside,I-Chemical
Sentence: 458,(,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,),O
Sentence: 458,model,O
Sentence: 458,.,O
Sentence: 458,Five,O
Sentence: 458,male,O
Sentence: 458,Wistar,O
Sentence: 458,rats,O
Sentence: 458,received,O
Sentence: 458,repeated,O
Sentence: 458,subcutaneous,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,injections,O
Sentence: 458,;,O
Sentence: 458,five,O
Sentence: 458,controls,O
Sentence: 458,received,O
Sentence: 458,saline,O
Sentence: 458,only,O
Sentence: 458,.,O
Sentence: 458,After,O
Sentence: 458,4,O
Sentence: 458,weeks,O
Sentence: 458,the,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,rats,O
Sentence: 458,were,O
Sentence: 458,severely,O
Sentence: 458,proteinuric,B-Disease
Sentence: 458,(,O
Sentence: 458,190,O
Sentence: 458,+,O
Sentence: 458,/,O
Sentence: 458,,O
Sentence: 458,-,O
Sentence: 458,,O
Sentence: 458,80,O
Sentence: 458,mg,O
Sentence: 458,/,O
Sentence: 458,24,O
Sentence: 458,hr,O
Sentence: 458,),O
Sentence: 458,",",O
Sentence: 458,and,O
Sentence: 458,all,O
Sentence: 458,rats,O
Sentence: 458,were,O
Sentence: 458,given,O
Sentence: 458,colloidal,O
Sentence: 458,carbon,B-Chemical
Sentence: 458,(,O
Sentence: 458,CC,O
Sentence: 458,),O
Sentence: 458,intravenously,O
Sentence: 458,.,O
Sentence: 458,At,O
Sentence: 458,5,O
Sentence: 458,months,O
Sentence: 458,glomerular,B-Disease
Sentence: 458,sclerosis,I-Disease
Sentence: 458,was,O
Sentence: 458,found,O
Sentence: 458,in,O
Sentence: 458,7.6,O
Sentence: 458,+,O
Sentence: 458,/,O
Sentence: 458,,O
Sentence: 458,-,O
Sentence: 458,,O
Sentence: 458,3.4,O
Sentence: 458,%,O
Sentence: 458,of,O
Sentence: 458,the,O
Sentence: 458,glomeruli,O
Sentence: 458,of,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,rats,O
Sentence: 458,;,O
Sentence: 458,glomeruli,O
Sentence: 458,of,O
Sentence: 458,the,O
Sentence: 458,controls,O
Sentence: 458,were,O
Sentence: 458,normal,O
Sentence: 458,.,O
Sentence: 458,Glomeruli,O
Sentence: 458,of,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,rats,O
Sentence: 458,contained,O
Sentence: 458,significantly,O
Sentence: 458,more,O
Sentence: 458,CC,O
Sentence: 458,than,O
Sentence: 458,glomeruli,O
Sentence: 458,of,O
Sentence: 458,controls,O
Sentence: 458,.,O
Sentence: 458,Glomeruli,O
Sentence: 458,with,O
Sentence: 458,sclerosis,B-Disease
Sentence: 458,contained,O
Sentence: 458,significantly,O
Sentence: 458,more,O
Sentence: 458,CC,O
Sentence: 458,than,O
Sentence: 458,non,O
Sentence: 458,-,O
Sentence: 458,sclerotic,O
Sentence: 458,glomeruli,O
Sentence: 458,in,O
Sentence: 458,the,O
Sentence: 458,same,O
Sentence: 458,kidneys,O
Sentence: 458,.,O
Sentence: 458,CC,O
Sentence: 458,was,O
Sentence: 458,preferentially,O
Sentence: 458,localized,O
Sentence: 458,within,O
Sentence: 458,the,O
Sentence: 458,sclerotic,O
Sentence: 458,areas,O
Sentence: 458,of,O
Sentence: 458,the,O
Sentence: 458,affected,O
Sentence: 458,glomeruli,O
Sentence: 458,.,O
Sentence: 458,Since,O
Sentence: 458,mesangial,O
Sentence: 458,CC,O
Sentence: 458,clearance,O
Sentence: 458,from,O
Sentence: 458,the,O
Sentence: 458,mesangium,O
Sentence: 458,did,O
Sentence: 458,not,O
Sentence: 458,change,O
Sentence: 458,during,O
Sentence: 458,chronic,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,treatment,O
Sentence: 458,",",O
Sentence: 458,we,O
Sentence: 458,conclude,O
Sentence: 458,that,O
Sentence: 458,this,O
Sentence: 458,preferential,O
Sentence: 458,CC,O
Sentence: 458,localization,O
Sentence: 458,within,O
Sentence: 458,the,O
Sentence: 458,lesions,O
Sentence: 458,is,O
Sentence: 458,caused,O
Sentence: 458,by,O
Sentence: 458,an,O
Sentence: 458,increased,O
Sentence: 458,CC,O
Sentence: 458,uptake,O
Sentence: 458,shortly,O
Sentence: 458,after,O
Sentence: 458,injection,O
Sentence: 458,in,O
Sentence: 458,apparent,O
Sentence: 458,vulnerable,O
Sentence: 458,areas,O
Sentence: 458,where,O
Sentence: 458,sclerosis,B-Disease
Sentence: 458,will,O
Sentence: 458,develop,O
Sentence: 458,subsequently,O
Sentence: 458,.,O
Sentence: 458,Cluster,O
Sentence: 458,analysis,O
Sentence: 458,showed,O
Sentence: 458,a,O
Sentence: 458,random,O
Sentence: 458,distribution,O
Sentence: 458,of,O
Sentence: 458,lesions,O
Sentence: 458,in,O
Sentence: 458,the,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,glomeruli,O
Sentence: 458,in,O
Sentence: 458,concordance,O
Sentence: 458,with,O
Sentence: 458,the,O
Sentence: 458,random,O
Sentence: 458,localization,O
Sentence: 458,of,O
Sentence: 458,mesangial,O
Sentence: 458,areas,O
Sentence: 458,with,O
Sentence: 458,dysfunction,O
Sentence: 458,in,O
Sentence: 458,this,O
Sentence: 458,model,O
Sentence: 458,.,O
Sentence: 458,Similar,O
Sentence: 458,to,O
Sentence: 458,the,O
Sentence: 458,remnant,O
Sentence: 458,kidney,O
Sentence: 458,model,O
Sentence: 458,in,O
Sentence: 458,PAN,B-Chemical
Sentence: 458,nephrosis,B-Disease
Sentence: 458,the,O
Sentence: 458,development,O
Sentence: 458,of,O
Sentence: 458,glomerular,B-Disease
Sentence: 458,sclerosis,I-Disease
Sentence: 458,may,O
Sentence: 458,be,O
Sentence: 458,related,O
Sentence: 458,to,O
Sentence: 458,``,O
Sentence: 458,mesangial,O
Sentence: 458,overloading,O
Sentence: 458,.,O
Sentence: 458,'',O
Sentence: 459,Relationship,O
Sentence: 459,between,O
Sentence: 459,nicotine,B-Chemical
Sentence: 459,-,O
Sentence: 459,induced,O
Sentence: 459,seizures,B-Disease
Sentence: 459,and,O
Sentence: 459,hippocampal,O
Sentence: 459,nicotinic,O
Sentence: 459,receptors,O
Sentence: 459,.,O
Sentence: 460,A,O
Sentence: 460,controversy,O
Sentence: 460,has,O
Sentence: 460,existed,O
Sentence: 460,for,O
Sentence: 460,several,O
Sentence: 460,years,O
Sentence: 460,concerning,O
Sentence: 460,the,O
Sentence: 460,physiological,O
Sentence: 460,relevance,O
Sentence: 460,of,O
Sentence: 460,the,O
Sentence: 460,nicotinic,O
Sentence: 460,receptor,O
Sentence: 460,measured,O
Sentence: 460,by,O
Sentence: 460,alpha,O
Sentence: 460,-,O
Sentence: 460,bungarotoxin,O
Sentence: 460,binding,O
Sentence: 460,.,O
Sentence: 460,Using,O
Sentence: 460,mice,O
Sentence: 460,derived,O
Sentence: 460,from,O
Sentence: 460,a,O
Sentence: 460,classical,O
Sentence: 460,F2,O
Sentence: 460,and,O
Sentence: 460,backcross,O
Sentence: 460,genetic,O
Sentence: 460,design,O
Sentence: 460,",",O
Sentence: 460,a,O
Sentence: 460,relationship,O
Sentence: 460,between,O
Sentence: 460,nicotine,B-Chemical
Sentence: 460,-,O
Sentence: 460,induced,O
Sentence: 460,seizures,B-Disease
Sentence: 460,and,O
Sentence: 460,alpha,O
Sentence: 460,-,O
Sentence: 460,bungarotoxin,O
Sentence: 460,nicotinic,O
Sentence: 460,receptor,O
Sentence: 460,concentration,O
Sentence: 460,was,O
Sentence: 460,found,O
Sentence: 460,.,O
Sentence: 460,Mice,O
Sentence: 460,sensitive,O
Sentence: 460,to,O
Sentence: 460,the,O
Sentence: 460,convulsant,O
Sentence: 460,effects,O
Sentence: 460,of,O
Sentence: 460,nicotine,B-Chemical
Sentence: 460,had,O
Sentence: 460,greater,O
Sentence: 460,alpha,O
Sentence: 460,-,O
Sentence: 460,bungarotoxin,O
Sentence: 460,binding,O
Sentence: 460,in,O
Sentence: 460,the,O
Sentence: 460,hippocampus,O
Sentence: 460,than,O
Sentence: 460,seizure,B-Disease
Sentence: 460,insensitive,O
Sentence: 460,mice,O
Sentence: 460,.,O
Sentence: 460,The,O
Sentence: 460,binding,O
Sentence: 460,sites,O
Sentence: 460,from,O
Sentence: 460,seizure,B-Disease
Sentence: 460,sensitive,O
Sentence: 460,and,O
Sentence: 460,resistant,O
Sentence: 460,mice,O
Sentence: 460,were,O
Sentence: 460,equally,O
Sentence: 460,affected,O
Sentence: 460,by,O
Sentence: 460,treatment,O
Sentence: 460,with,O
Sentence: 460,dithiothreitol,B-Chemical
Sentence: 460,",",O
Sentence: 460,trypsin,O
Sentence: 460,or,O
Sentence: 460,heat,O
Sentence: 460,.,O
Sentence: 460,Thus,O
Sentence: 460,it,O
Sentence: 460,appears,O
Sentence: 460,that,O
Sentence: 460,the,O
Sentence: 460,difference,O
Sentence: 460,between,O
Sentence: 460,seizure,B-Disease
Sentence: 460,sensitive,O
Sentence: 460,and,O
Sentence: 460,insensitive,O
Sentence: 460,animals,O
Sentence: 460,may,O
Sentence: 460,be,O
Sentence: 460,due,O
Sentence: 460,to,O
Sentence: 460,a,O
Sentence: 460,difference,O
Sentence: 460,in,O
Sentence: 460,hippocampal,O
Sentence: 460,nicotinic,O
Sentence: 460,receptor,O
Sentence: 460,concentration,O
Sentence: 460,as,O
Sentence: 460,measured,O
Sentence: 460,with,O
Sentence: 460,alpha,O
Sentence: 460,-,O
Sentence: 460,bungarotoxin,O
Sentence: 460,binding,O
Sentence: 460,.,O
Sentence: 461,The,O
Sentence: 461,role,O
Sentence: 461,of,O
Sentence: 461,p,O
Sentence: 461,-,O
Sentence: 461,aminophenol,O
Sentence: 461,in,O
Sentence: 461,acetaminophen,B-Chemical
Sentence: 461,-,O
Sentence: 461,induced,O
Sentence: 461,nephrotoxicity,B-Disease
Sentence: 461,:,O
Sentence: 461,effect,O
Sentence: 461,of,O
Sentence: 461,bis,O
Sentence: 461,(,O
Sentence: 461,p,O
Sentence: 461,-,O
Sentence: 461,nitrophenyl,O
Sentence: 461,),O
Sentence: 461,phosphate,O
Sentence: 461,on,O
Sentence: 461,acetaminophen,B-Chemical
Sentence: 461,and,O
Sentence: 461,p,O
Sentence: 461,-,O
Sentence: 461,aminophenol,O
Sentence: 461,nephrotoxicity,B-Disease
Sentence: 461,and,O
Sentence: 461,metabolism,O
Sentence: 461,in,O
Sentence: 461,Fischer,O
Sentence: 461,344,O
Sentence: 461,rats,O
Sentence: 461,.,O
Sentence: 462,Acetaminophen,B-Chemical
Sentence: 462,(,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,),O
Sentence: 462,produces,O
Sentence: 462,proximal,O
Sentence: 462,tubular,B-Disease
Sentence: 462,necrosis,I-Disease
Sentence: 462,in,O
Sentence: 462,Fischer,O
Sentence: 462,344,O
Sentence: 462,(,O
Sentence: 462,F344,O
Sentence: 462,),O
Sentence: 462,rats,O
Sentence: 462,.,O
Sentence: 462,Recently,O
Sentence: 462,",",O
Sentence: 462,p,O
Sentence: 462,-,O
Sentence: 462,aminophenol,O
Sentence: 462,(,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,),O
Sentence: 462,",",O
Sentence: 462,a,O
Sentence: 462,known,O
Sentence: 462,potent,O
Sentence: 462,nephrotoxicant,O
Sentence: 462,",",O
Sentence: 462,was,O
Sentence: 462,identified,O
Sentence: 462,as,O
Sentence: 462,a,O
Sentence: 462,metabolite,O
Sentence: 462,of,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,in,O
Sentence: 462,F344,O
Sentence: 462,rats,O
Sentence: 462,.,O
Sentence: 462,The,O
Sentence: 462,purpose,O
Sentence: 462,of,O
Sentence: 462,this,O
Sentence: 462,study,O
Sentence: 462,was,O
Sentence: 462,to,O
Sentence: 462,determine,O
Sentence: 462,if,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,formation,O
Sentence: 462,is,O
Sentence: 462,a,O
Sentence: 462,requisite,O
Sentence: 462,step,O
Sentence: 462,in,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,-,O
Sentence: 462,induced,O
Sentence: 462,nephrotoxicity,B-Disease
Sentence: 462,.,O
Sentence: 462,Therefore,O
Sentence: 462,",",O
Sentence: 462,the,O
Sentence: 462,effect,O
Sentence: 462,of,O
Sentence: 462,bis,O
Sentence: 462,(,O
Sentence: 462,p,O
Sentence: 462,-,O
Sentence: 462,nitrophenyl,O
Sentence: 462,),O
Sentence: 462,phosphate,O
Sentence: 462,(,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,),O
Sentence: 462,",",O
Sentence: 462,an,O
Sentence: 462,acylamidase,O
Sentence: 462,inhibitor,O
Sentence: 462,",",O
Sentence: 462,on,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,and,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,nephrotoxicity,B-Disease
Sentence: 462,and,O
Sentence: 462,metabolism,O
Sentence: 462,was,O
Sentence: 462,determined,O
Sentence: 462,.,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,(,O
Sentence: 462,1,O
Sentence: 462,to,O
Sentence: 462,8,O
Sentence: 462,mM,O
Sentence: 462,),O
Sentence: 462,reduced,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,deacetylation,O
Sentence: 462,and,O
Sentence: 462,covalent,O
Sentence: 462,binding,O
Sentence: 462,in,O
Sentence: 462,F344,O
Sentence: 462,renal,O
Sentence: 462,cortical,O
Sentence: 462,homogenates,O
Sentence: 462,in,O
Sentence: 462,a,O
Sentence: 462,concentration,O
Sentence: 462,-,O
Sentence: 462,dependent,O
Sentence: 462,manner,O
Sentence: 462,.,O
Sentence: 462,Pretreatment,O
Sentence: 462,of,O
Sentence: 462,animals,O
Sentence: 462,with,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,prior,O
Sentence: 462,to,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,or,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,administration,O
Sentence: 462,resulted,O
Sentence: 462,in,O
Sentence: 462,marked,O
Sentence: 462,reduction,O
Sentence: 462,of,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,(,O
Sentence: 462,900,O
Sentence: 462,mg,O
Sentence: 462,/,O
Sentence: 462,kg,O
Sentence: 462,),O
Sentence: 462,nephrotoxicity,B-Disease
Sentence: 462,but,O
Sentence: 462,not,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,nephrotoxicity,B-Disease
Sentence: 462,.,O
Sentence: 462,This,O
Sentence: 462,result,O
Sentence: 462,was,O
Sentence: 462,not,O
Sentence: 462,due,O
Sentence: 462,to,O
Sentence: 462,altered,O
Sentence: 462,disposition,O
Sentence: 462,of,O
Sentence: 462,either,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,or,O
Sentence: 462,acetylated,O
Sentence: 462,metabolites,O
Sentence: 462,in,O
Sentence: 462,plasma,O
Sentence: 462,or,O
Sentence: 462,renal,O
Sentence: 462,cortical,O
Sentence: 462,and,O
Sentence: 462,hepatic,O
Sentence: 462,tissue,O
Sentence: 462,.,O
Sentence: 462,Rather,O
Sentence: 462,",",O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,pretreatment,O
Sentence: 462,reduced,O
Sentence: 462,the,O
Sentence: 462,fraction,O
Sentence: 462,of,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,excreted,O
Sentence: 462,as,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,by,O
Sentence: 462,64,O
Sentence: 462,and,O
Sentence: 462,75,O
Sentence: 462,%,O
Sentence: 462,after,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,doses,O
Sentence: 462,of,O
Sentence: 462,750,O
Sentence: 462,and,O
Sentence: 462,900,O
Sentence: 462,mg,O
Sentence: 462,/,O
Sentence: 462,kg,O
Sentence: 462,.,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,did,O
Sentence: 462,not,O
Sentence: 462,alter,O
Sentence: 462,the,O
Sentence: 462,excretion,O
Sentence: 462,of,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,or,O
Sentence: 462,any,O
Sentence: 462,of,O
Sentence: 462,its,O
Sentence: 462,non,O
Sentence: 462,-,O
Sentence: 462,deacetylated,O
Sentence: 462,metabolites,O
Sentence: 462,nor,O
Sentence: 462,did,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,alter,O
Sentence: 462,excretion,O
Sentence: 462,of,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,or,O
Sentence: 462,its,O
Sentence: 462,metabolites,O
Sentence: 462,after,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,doses,O
Sentence: 462,of,O
Sentence: 462,150,O
Sentence: 462,and,O
Sentence: 462,300,O
Sentence: 462,mg,O
Sentence: 462,/,O
Sentence: 462,kg,O
Sentence: 462,.,O
Sentence: 462,Therefore,O
Sentence: 462,",",O
Sentence: 462,the,O
Sentence: 462,BNPP,B-Chemical
Sentence: 462,-,O
Sentence: 462,induced,O
Sentence: 462,reduction,O
Sentence: 462,in,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,-,O
Sentence: 462,induced,O
Sentence: 462,nephrotoxicity,B-Disease
Sentence: 462,appears,O
Sentence: 462,to,O
Sentence: 462,be,O
Sentence: 462,due,O
Sentence: 462,to,O
Sentence: 462,inhibition,O
Sentence: 462,of,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,deacetylation,O
Sentence: 462,.,O
Sentence: 462,It,O
Sentence: 462,is,O
Sentence: 462,concluded,O
Sentence: 462,that,O
Sentence: 462,PAP,B-Chemical
Sentence: 462,formation,O
Sentence: 462,",",O
Sentence: 462,in,O
Sentence: 462,vivo,O
Sentence: 462,",",O
Sentence: 462,accounts,O
Sentence: 462,",",O
Sentence: 462,at,O
Sentence: 462,least,O
Sentence: 462,in,O
Sentence: 462,part,O
Sentence: 462,",",O
Sentence: 462,for,O
Sentence: 462,APAP,B-Chemical
Sentence: 462,-,O
Sentence: 462,induced,O
Sentence: 462,renal,B-Disease
Sentence: 462,tubular,I-Disease
Sentence: 462,necrosis,I-Disease
Sentence: 462,.,O
Sentence: 463,Morphine,B-Chemical
Sentence: 463,-,O
Sentence: 463,induced,O
Sentence: 463,seizures,B-Disease
Sentence: 463,in,O
Sentence: 463,newborn,O
Sentence: 463,infants,O
Sentence: 463,.,O
Sentence: 464,Two,O
Sentence: 464,neonates,O
Sentence: 464,suffered,O
Sentence: 464,from,O
Sentence: 464,generalized,O
Sentence: 464,seizures,B-Disease
Sentence: 464,during,O
Sentence: 464,the,O
Sentence: 464,course,O
Sentence: 464,of,O
Sentence: 464,intravenous,O
Sentence: 464,morphine,B-Chemical
Sentence: 464,sulfate,I-Chemical
Sentence: 464,for,O
Sentence: 464,post,O
Sentence: 464,-,O
Sentence: 464,operative,O
Sentence: 464,analgesia,O
Sentence: 464,.,O
Sentence: 464,They,O
Sentence: 464,received,O
Sentence: 464,morphine,B-Chemical
Sentence: 464,in,O
Sentence: 464,doses,O
Sentence: 464,of,O
Sentence: 464,32,O
Sentence: 464,micrograms,O
Sentence: 464,/,O
Sentence: 464,kg,O
Sentence: 464,/,O
Sentence: 464,hr,O
Sentence: 464,and,O
Sentence: 464,40,O
Sentence: 464,micrograms,O
Sentence: 464,/,O
Sentence: 464,kg,O
Sentence: 464,/,O
Sentence: 464,hr,O
Sentence: 464,larger,O
Sentence: 464,than,O
Sentence: 464,a,O
Sentence: 464,group,O
Sentence: 464,of,O
Sentence: 464,10,O
Sentence: 464,neonates,O
Sentence: 464,who,O
Sentence: 464,received,O
Sentence: 464,6,O
Sentence: 464,-,O
Sentence: 464,24,O
Sentence: 464,micrograms,O
Sentence: 464,/,O
Sentence: 464,kg,O
Sentence: 464,/,O
Sentence: 464,hr,O
Sentence: 464,and,O
Sentence: 464,had,O
Sentence: 464,no,O
Sentence: 464,seizures,B-Disease
Sentence: 464,.,O
Sentence: 464,Plasma,O
Sentence: 464,concentrations,O
Sentence: 464,of,O
Sentence: 464,morphine,B-Chemical
Sentence: 464,in,O
Sentence: 464,these,O
Sentence: 464,neonates,O
Sentence: 464,was,O
Sentence: 464,excessive,O
Sentence: 464,(,O
Sentence: 464,60,O
Sentence: 464,and,O
Sentence: 464,90,O
Sentence: 464,mg,O
Sentence: 464,/,O
Sentence: 464,ml,O
Sentence: 464,),O
Sentence: 464,.,O
Sentence: 464,Other,O
Sentence: 464,known,O
Sentence: 464,reasons,O
Sentence: 464,for,O
Sentence: 464,seizures,B-Disease
Sentence: 464,were,O
Sentence: 464,ruled,O
Sentence: 464,out,O
Sentence: 464,and,O
Sentence: 464,the,O
Sentence: 464,convulsions,B-Disease
Sentence: 464,stopped,O
Sentence: 464,a,O
Sentence: 464,few,O
Sentence: 464,hours,O
Sentence: 464,after,O
Sentence: 464,cessation,O
Sentence: 464,of,O
Sentence: 464,morphine,B-Chemical
Sentence: 464,and,O
Sentence: 464,did,O
Sentence: 464,not,O
Sentence: 464,reoccur,O
Sentence: 464,in,O
Sentence: 464,the,O
Sentence: 464,subsequent,O
Sentence: 464,8,O
Sentence: 464,months,O
Sentence: 464,.,O
Sentence: 464,It,O
Sentence: 464,is,O
Sentence: 464,suggested,O
Sentence: 464,that,O
Sentence: 464,post,O
Sentence: 464,-,O
Sentence: 464,operative,O
Sentence: 464,intravenous,O
Sentence: 464,morphine,B-Chemical
Sentence: 464,should,O
Sentence: 464,not,O
Sentence: 464,exceed,O
Sentence: 464,20,O
Sentence: 464,micrograms,O
Sentence: 464,/,O
Sentence: 464,kg,O
Sentence: 464,/,O
Sentence: 464,ml,O
Sentence: 464,in,O
Sentence: 464,neonates,O
Sentence: 464,.,O
Sentence: 465,Effect,O
Sentence: 465,of,O
Sentence: 465,vincristine,B-Chemical
Sentence: 465,sulfate,I-Chemical
Sentence: 465,on,O
Sentence: 465,Pseudomonas,B-Disease
Sentence: 465,infections,I-Disease
Sentence: 465,in,O
Sentence: 465,monkeys,O
Sentence: 465,.,O
Sentence: 466,In,O
Sentence: 466,rhesus,O
Sentence: 466,monkeys,O
Sentence: 466,",",O
Sentence: 466,intravenous,O
Sentence: 466,challenge,O
Sentence: 466,with,O
Sentence: 466,0.6,O
Sentence: 466,x,O
Sentence: 466,10,O
Sentence: 466,(,O
Sentence: 466,10,O
Sentence: 466,),O
Sentence: 466,to,O
Sentence: 466,2.2,O
Sentence: 466,x,O
Sentence: 466,10,O
Sentence: 466,(,O
Sentence: 466,10,O
Sentence: 466,),O
Sentence: 466,Pseudomonas,O
Sentence: 466,aeruginosa,O
Sentence: 466,organisms,O
Sentence: 466,caused,O
Sentence: 466,acute,O
Sentence: 466,illness,O
Sentence: 466,of,O
Sentence: 466,4,O
Sentence: 466,to,O
Sentence: 466,5,O
Sentence: 466,days,O
Sentence: 466,',O
Sentence: 466,duration,O
Sentence: 466,with,O
Sentence: 466,spontaneous,O
Sentence: 466,recovery,O
Sentence: 466,in,O
Sentence: 466,13,O
Sentence: 466,of,O
Sentence: 466,15,O
Sentence: 466,monkeys,O
Sentence: 466,;,O
Sentence: 466,blood,O
Sentence: 466,cultures,O
Sentence: 466,became,O
Sentence: 466,negative,O
Sentence: 466,3,O
Sentence: 466,to,O
Sentence: 466,17,O
Sentence: 466,days,O
Sentence: 466,after,O
Sentence: 466,challenge,O
Sentence: 466,.,O
Sentence: 466,Leukocytosis,B-Disease
Sentence: 466,was,O
Sentence: 466,observed,O
Sentence: 466,in,O
Sentence: 466,all,O
Sentence: 466,monkeys,O
Sentence: 466,.,O
Sentence: 466,Intravenous,O
Sentence: 466,or,O
Sentence: 466,intratracheal,O
Sentence: 466,inoculation,O
Sentence: 466,of,O
Sentence: 466,2.0,O
Sentence: 466,to,O
Sentence: 466,2.5,O
Sentence: 466,mg,O
Sentence: 466,of,O
Sentence: 466,vincristine,B-Chemical
Sentence: 466,sulfate,I-Chemical
Sentence: 466,was,O
Sentence: 466,followed,O
Sentence: 466,by,O
Sentence: 466,leukopenia,B-Disease
Sentence: 466,in,O
Sentence: 466,4,O
Sentence: 466,to,O
Sentence: 466,5,O
Sentence: 466,days,O
Sentence: 466,.,O
Sentence: 466,Intravenous,O
Sentence: 466,inoculation,O
Sentence: 466,of,O
Sentence: 466,4.2,O
Sentence: 466,x,O
Sentence: 466,10,O
Sentence: 466,(,O
Sentence: 466,10,O
Sentence: 466,),O
Sentence: 466,to,O
Sentence: 466,7.8,O
Sentence: 466,x,O
Sentence: 466,10,O
Sentence: 466,(,O
Sentence: 466,10,O
Sentence: 466,),O
Sentence: 466,pyocin,O
Sentence: 466,type,O
Sentence: 466,6,O
Sentence: 466,Pseudomonas,O
Sentence: 466,organisms,O
Sentence: 466,in,O
Sentence: 466,monkeys,O
Sentence: 466,given,O
Sentence: 466,vincristine,B-Chemical
Sentence: 466,sulfate,I-Chemical
Sentence: 466,4,O
Sentence: 466,days,O
Sentence: 466,previously,O
Sentence: 466,resulted,O
Sentence: 466,in,O
Sentence: 466,fatal,O
Sentence: 466,infection,B-Disease
Sentence: 466,in,O
Sentence: 466,11,O
Sentence: 466,of,O
Sentence: 466,14,O
Sentence: 466,monkeys,O
Sentence: 466,",",O
Sentence: 466,whereas,O
Sentence: 466,none,O
Sentence: 466,of,O
Sentence: 466,four,O
Sentence: 466,receiving,O
Sentence: 466,Pseudomonas,O
Sentence: 466,alone,O
Sentence: 466,died,O
Sentence: 466,.,O
Sentence: 466,These,O
Sentence: 466,studies,O
Sentence: 466,suggest,O
Sentence: 466,that,O
Sentence: 466,an,O
Sentence: 466,antimetabolite,O
Sentence: 466,-,O
Sentence: 466,induced,O
Sentence: 466,leukopenia,B-Disease
Sentence: 466,predisposes,O
Sentence: 466,to,O
Sentence: 466,severe,O
Sentence: 466,Pseudomonas,O
Sentence: 466,sepsis,B-Disease
Sentence: 466,and,O
Sentence: 466,that,O
Sentence: 466,such,O
Sentence: 466,monkeys,O
Sentence: 466,may,O
Sentence: 466,serve,O
Sentence: 466,as,O
Sentence: 466,a,O
Sentence: 466,biological,O
Sentence: 466,model,O
Sentence: 466,for,O
Sentence: 466,study,O
Sentence: 466,of,O
Sentence: 466,comparative,O
Sentence: 466,efficacy,O
Sentence: 466,of,O
Sentence: 466,antimicrobial,O
Sentence: 466,agents,O
Sentence: 466,.,O
Sentence: 467,Central,O
Sentence: 467,excitatory,O
Sentence: 467,actions,O
Sentence: 467,of,O
Sentence: 467,flurazepam,O
Sentence: 467,.,O
Sentence: 468,Toxic,O
Sentence: 468,actions,O
Sentence: 468,of,O
Sentence: 468,flurazepam,B-Chemical
Sentence: 468,(,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,),O
Sentence: 468,were,O
Sentence: 468,studied,O
Sentence: 468,in,O
Sentence: 468,cats,O
Sentence: 468,",",O
Sentence: 468,mice,O
Sentence: 468,and,O
Sentence: 468,rats,O
Sentence: 468,.,O
Sentence: 468,High,O
Sentence: 468,doses,O
Sentence: 468,caused,O
Sentence: 468,an,O
Sentence: 468,apparent,O
Sentence: 468,central,O
Sentence: 468,excitation,O
Sentence: 468,",",O
Sentence: 468,most,O
Sentence: 468,clearly,O
Sentence: 468,seen,O
Sentence: 468,as,O
Sentence: 468,clonic,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,",",O
Sentence: 468,superimposed,O
Sentence: 468,on,O
Sentence: 468,general,O
Sentence: 468,depression,B-Disease
Sentence: 468,.,O
Sentence: 468,Following,O
Sentence: 468,a,O
Sentence: 468,lethal,O
Sentence: 468,dose,O
Sentence: 468,",",O
Sentence: 468,death,O
Sentence: 468,was,O
Sentence: 468,always,O
Sentence: 468,associated,O
Sentence: 468,with,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,.,O
Sentence: 468,Comparing,O
Sentence: 468,the,O
Sentence: 468,relative,O
Sentence: 468,sensitivity,O
Sentence: 468,to,O
Sentence: 468,central,O
Sentence: 468,depression,B-Disease
Sentence: 468,and,O
Sentence: 468,excitation,O
Sentence: 468,revealed,O
Sentence: 468,that,O
Sentence: 468,rats,O
Sentence: 468,were,O
Sentence: 468,least,O
Sentence: 468,likely,O
Sentence: 468,to,O
Sentence: 468,have,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,at,O
Sentence: 468,doses,O
Sentence: 468,that,O
Sentence: 468,did,O
Sentence: 468,not,O
Sentence: 468,first,O
Sentence: 468,cause,O
Sentence: 468,loss,B-Disease
Sentence: 468,of,I-Disease
Sentence: 468,consciousness,I-Disease
Sentence: 468,",",O
Sentence: 468,while,O
Sentence: 468,cats,O
Sentence: 468,most,O
Sentence: 468,clearly,O
Sentence: 468,showed,O
Sentence: 468,marked,O
Sentence: 468,central,O
Sentence: 468,excitatory,O
Sentence: 468,actions,O
Sentence: 468,.,O
Sentence: 468,Signs,O
Sentence: 468,of,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,toxocity,B-Disease
Sentence: 468,in,O
Sentence: 468,cats,O
Sentence: 468,included,O
Sentence: 468,excessive,O
Sentence: 468,salivation,B-Disease
Sentence: 468,",",O
Sentence: 468,extreme,O
Sentence: 468,apprehensive,O
Sentence: 468,behavior,O
Sentence: 468,",",O
Sentence: 468,retching,O
Sentence: 468,",",O
Sentence: 468,muscle,B-Disease
Sentence: 468,tremors,I-Disease
Sentence: 468,and,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,.,O
Sentence: 468,An,O
Sentence: 468,interaction,O
Sentence: 468,between,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,and,O
Sentence: 468,pentylenetetrazol,B-Chemical
Sentence: 468,(,O
Sentence: 468,PTZ,B-Chemical
Sentence: 468,),O
Sentence: 468,was,O
Sentence: 468,shown,O
Sentence: 468,by,O
Sentence: 468,pretreating,O
Sentence: 468,mice,O
Sentence: 468,with,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,before,O
Sentence: 468,PTZ,B-Chemical
Sentence: 468,challenge,O
Sentence: 468,.,O
Sentence: 468,As,O
Sentence: 468,a,O
Sentence: 468,function,O
Sentence: 468,of,O
Sentence: 468,dose,O
Sentence: 468,",",O
Sentence: 468,FZP,B-Chemical
Sentence: 468,first,O
Sentence: 468,protected,O
Sentence: 468,against,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,and,O
Sentence: 468,death,O
Sentence: 468,.,O
Sentence: 468,At,O
Sentence: 468,higher,O
Sentence: 468,doses,O
Sentence: 468,",",O
Sentence: 468,however,O
Sentence: 468,",",O
Sentence: 468,convulsions,B-Disease
Sentence: 468,again,O
Sentence: 468,emerged,O
Sentence: 468,.,O
Sentence: 468,These,O
Sentence: 468,doses,O
Sentence: 468,of,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,were,O
Sentence: 468,lower,O
Sentence: 468,than,O
Sentence: 468,those,O
Sentence: 468,that,O
Sentence: 468,would,O
Sentence: 468,alone,O
Sentence: 468,cause,O
Sentence: 468,convulsions,B-Disease
Sentence: 468,.,O
Sentence: 468,These,O
Sentence: 468,results,O
Sentence: 468,may,O
Sentence: 468,be,O
Sentence: 468,relevant,O
Sentence: 468,to,O
Sentence: 468,the,O
Sentence: 468,use,O
Sentence: 468,of,O
Sentence: 468,FZP,B-Chemical
Sentence: 468,in,O
Sentence: 468,clinical,O
Sentence: 468,situations,O
Sentence: 468,in,O
Sentence: 468,which,O
Sentence: 468,there,O
Sentence: 468,is,O
Sentence: 468,increased,O
Sentence: 468,neural,O
Sentence: 468,excitability,O
Sentence: 468,",",O
Sentence: 468,such,O
Sentence: 468,as,O
Sentence: 468,epilepsy,B-Disease
Sentence: 468,or,O
Sentence: 468,sedative,O
Sentence: 468,-,O
Sentence: 468,hypnotic,O
Sentence: 468,drug,O
Sentence: 468,withdrawal,O
Sentence: 468,.,O
Sentence: 469,Evidence,O
Sentence: 469,for,O
Sentence: 469,cardiac,O
Sentence: 469,beta,O
Sentence: 469,2,O
Sentence: 469,-,O
Sentence: 469,adrenoceptors,O
Sentence: 469,in,O
Sentence: 469,man,O
Sentence: 469,.,O
Sentence: 470,We,O
Sentence: 470,compared,O
Sentence: 470,the,O
Sentence: 470,effects,O
Sentence: 470,of,O
Sentence: 470,single,O
Sentence: 470,doses,O
Sentence: 470,of,O
Sentence: 470,50,O
Sentence: 470,mg,O
Sentence: 470,atenolol,B-Chemical
Sentence: 470,(,O
Sentence: 470,cardioselective,O
Sentence: 470,),O
Sentence: 470,",",O
Sentence: 470,40,O
Sentence: 470,mg,O
Sentence: 470,propranolol,B-Chemical
Sentence: 470,(,O
Sentence: 470,nonselective,O
Sentence: 470,),O
Sentence: 470,",",O
Sentence: 470,and,O
Sentence: 470,placebo,O
Sentence: 470,on,O
Sentence: 470,both,O
Sentence: 470,exercise,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,and,O
Sentence: 470,isoproterenol,B-Chemical
Sentence: 470,-,O
Sentence: 470,induced,O
Sentence: 470,tachycardia,B-Disease
Sentence: 470,in,O
Sentence: 470,two,O
Sentence: 470,experiments,O
Sentence: 470,involving,O
Sentence: 470,nine,O
Sentence: 470,normal,O
Sentence: 470,subjects,O
Sentence: 470,.,O
Sentence: 470,Maximal,O
Sentence: 470,exercise,O
Sentence: 470,heart,O
Sentence: 470,rate,O
Sentence: 470,was,O
Sentence: 470,reduced,O
Sentence: 470,from,O
Sentence: 470,187,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,4,O
Sentence: 470,(,O
Sentence: 470,SEM,O
Sentence: 470,),O
Sentence: 470,after,O
Sentence: 470,placebo,O
Sentence: 470,to,O
Sentence: 470,146,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,7,O
Sentence: 470,bpm,O
Sentence: 470,after,O
Sentence: 470,atenolol,B-Chemical
Sentence: 470,and,O
Sentence: 470,138,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,6,O
Sentence: 470,bpm,O
Sentence: 470,after,O
Sentence: 470,propranolol,B-Chemical
Sentence: 470,",",O
Sentence: 470,but,O
Sentence: 470,there,O
Sentence: 470,were,O
Sentence: 470,no,O
Sentence: 470,differences,O
Sentence: 470,between,O
Sentence: 470,the,O
Sentence: 470,drugs,O
Sentence: 470,.,O
Sentence: 470,The,O
Sentence: 470,effects,O
Sentence: 470,on,O
Sentence: 470,isoproterenol,B-Chemical
Sentence: 470,tachycardia,B-Disease
Sentence: 470,were,O
Sentence: 470,determined,O
Sentence: 470,before,O
Sentence: 470,and,O
Sentence: 470,after,O
Sentence: 470,atropine,B-Chemical
Sentence: 470,(,O
Sentence: 470,0.04,O
Sentence: 470,mg,O
Sentence: 470,/,O
Sentence: 470,kg,O
Sentence: 470,IV,O
Sentence: 470,),O
Sentence: 470,.,O
Sentence: 470,Isoproterenol,B-Chemical
Sentence: 470,sensitivity,O
Sentence: 470,was,O
Sentence: 470,determined,O
Sentence: 470,as,O
Sentence: 470,the,O
Sentence: 470,intravenous,O
Sentence: 470,dose,O
Sentence: 470,that,O
Sentence: 470,increased,O
Sentence: 470,heart,O
Sentence: 470,rate,O
Sentence: 470,by,O
Sentence: 470,25,O
Sentence: 470,bpm,O
Sentence: 470,(,O
Sentence: 470,CD25,O
Sentence: 470,),O
Sentence: 470,and,O
Sentence: 470,this,O
Sentence: 470,was,O
Sentence: 470,increased,O
Sentence: 470,from,O
Sentence: 470,1.8,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,0.3,O
Sentence: 470,micrograms,O
Sentence: 470,after,O
Sentence: 470,placebo,O
Sentence: 470,to,O
Sentence: 470,38.9,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,8.3,O
Sentence: 470,micrograms,O
Sentence: 470,after,O
Sentence: 470,propranolol,B-Chemical
Sentence: 470,and,O
Sentence: 470,8.3,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,1.7,O
Sentence: 470,micrograms,O
Sentence: 470,after,O
Sentence: 470,atenolol,B-Chemical
Sentence: 470,.,O
Sentence: 470,The,O
Sentence: 470,difference,O
Sentence: 470,in,O
Sentence: 470,the,O
Sentence: 470,effects,O
Sentence: 470,of,O
Sentence: 470,the,O
Sentence: 470,two,O
Sentence: 470,was,O
Sentence: 470,significant,O
Sentence: 470,.,O
Sentence: 470,After,O
Sentence: 470,atropine,B-Chemical
Sentence: 470,the,O
Sentence: 470,CD25,O
Sentence: 470,was,O
Sentence: 470,unchanged,O
Sentence: 470,after,O
Sentence: 470,placebo,O
Sentence: 470,(,O
Sentence: 470,2.3,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,0.3,O
Sentence: 470,micrograms,O
Sentence: 470,),O
Sentence: 470,and,O
Sentence: 470,atenolol,B-Chemical
Sentence: 470,(,O
Sentence: 470,7.7,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,1.3,O
Sentence: 470,micrograms,O
Sentence: 470,),O
Sentence: 470,;,O
Sentence: 470,it,O
Sentence: 470,was,O
Sentence: 470,reduced,O
Sentence: 470,after,O
Sentence: 470,propranolol,B-Chemical
Sentence: 470,(,O
Sentence: 470,24.8,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,5.0,O
Sentence: 470,micrograms,O
Sentence: 470,),O
Sentence: 470,",",O
Sentence: 470,but,O
Sentence: 470,remained,O
Sentence: 470,different,O
Sentence: 470,from,O
Sentence: 470,atenolol,B-Chemical
Sentence: 470,.,O
Sentence: 470,This,O
Sentence: 470,change,O
Sentence: 470,with,O
Sentence: 470,propranolol,B-Chemical
Sentence: 470,sensitivity,O
Sentence: 470,was,O
Sentence: 470,calculated,O
Sentence: 470,as,O
Sentence: 470,the,O
Sentence: 470,apparent,O
Sentence: 470,Ka,O
Sentence: 470,",",O
Sentence: 470,this,O
Sentence: 470,was,O
Sentence: 470,unchanged,O
Sentence: 470,by,O
Sentence: 470,atropine,B-Chemical
Sentence: 470,(,O
Sentence: 470,11.7,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,2.1,O
Sentence: 470,and,O
Sentence: 470,10.1,O
Sentence: 470,+,O
Sentence: 470,/,O
Sentence: 470,,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,2.5,O
Sentence: 470,ml,O
Sentence: 470,/,O
Sentence: 470,ng,O
Sentence: 470,),O
Sentence: 470,.,O
Sentence: 470,These,O
Sentence: 470,data,O
Sentence: 470,are,O
Sentence: 470,consistent,O
Sentence: 470,with,O
Sentence: 470,the,O
Sentence: 470,hypothesis,O
Sentence: 470,that,O
Sentence: 470,exercise,O
Sentence: 470,-,O
Sentence: 470,induced,O
Sentence: 470,tachycardia,B-Disease
Sentence: 470,results,O
Sentence: 470,largely,O
Sentence: 470,from,O
Sentence: 470,beta,O
Sentence: 470,1,O
Sentence: 470,-,O
Sentence: 470,receptor,O
Sentence: 470,activation,O
Sentence: 470,that,O
Sentence: 470,is,O
Sentence: 470,blocked,O
Sentence: 470,by,O
Sentence: 470,both,O
Sentence: 470,cardioselective,O
Sentence: 470,and,O
Sentence: 470,nonselective,O
Sentence: 470,drugs,O
Sentence: 470,",",O
Sentence: 470,whereas,O
Sentence: 470,isoproterenol,B-Chemical
Sentence: 470,activates,O
Sentence: 470,both,O
Sentence: 470,beta,O
Sentence: 470,1,O
Sentence: 470,-,O
Sentence: 470,,O
Sentence: 470,and,O
Sentence: 470,beta,O
Sentence: 470,2,O
Sentence: 470,-,O
Sentence: 470,receptors,O
Sentence: 470,so,O
Sentence: 470,that,O
Sentence: 470,after,O
Sentence: 470,cardioselective,O
Sentence: 470,blockade,O
Sentence: 470,there,O
Sentence: 470,remains,O
Sentence: 470,a,O
Sentence: 470,beta,O
Sentence: 470,2,O
Sentence: 470,-,O
Sentence: 470,component,O
Sentence: 470,that,O
Sentence: 470,can,O
Sentence: 470,be,O
Sentence: 470,blocked,O
Sentence: 470,with,O
Sentence: 470,a,O
Sentence: 470,nonselective,O
Sentence: 470,drug,O
Sentence: 470,.,O
Sentence: 470,While,O
Sentence: 470,there,O
Sentence: 470,appear,O
Sentence: 470,to,O
Sentence: 470,be,O
Sentence: 470,beta,O
Sentence: 470,2,O
Sentence: 470,-,O
Sentence: 470,receptors,O
Sentence: 470,in,O
Sentence: 470,the,O
Sentence: 470,human,O
Sentence: 470,heart,O
Sentence: 470,",",O
Sentence: 470,their,O
Sentence: 470,physiologic,O
Sentence: 470,or,O
Sentence: 470,pathologic,O
Sentence: 470,roles,O
Sentence: 470,remain,O
Sentence: 470,to,O
Sentence: 470,be,O
Sentence: 470,defined,O
Sentence: 470,.,O
Sentence: 471,Hormones,O
Sentence: 471,and,O
Sentence: 471,risk,O
Sentence: 471,of,O
Sentence: 471,breast,O
Sentence: 471,cancer,O
Sentence: 471,.,O
Sentence: 472,This,O
Sentence: 472,paper,O
Sentence: 472,reports,O
Sentence: 472,the,O
Sentence: 472,results,O
Sentence: 472,of,O
Sentence: 472,a,O
Sentence: 472,study,O
Sentence: 472,of,O
Sentence: 472,50,O
Sentence: 472,menopausal,O
Sentence: 472,women,O
Sentence: 472,receiving,O
Sentence: 472,hormonal,O
Sentence: 472,replacement,O
Sentence: 472,therapy,O
Sentence: 472,.,O
Sentence: 472,The,O
Sentence: 472,majority,O
Sentence: 472,(,O
Sentence: 472,29,O
Sentence: 472,),O
Sentence: 472,had,O
Sentence: 472,surgical,O
Sentence: 472,menopause,O
Sentence: 472,;,O
Sentence: 472,their,O
Sentence: 472,mean,O
Sentence: 472,age,O
Sentence: 472,was,O
Sentence: 472,45.7,O
Sentence: 472,years,O
Sentence: 472,.,O
Sentence: 472,It,O
Sentence: 472,was,O
Sentence: 472,hypothesized,O
Sentence: 472,that,O
Sentence: 472,progestins,B-Chemical
Sentence: 472,could,O
Sentence: 472,equilibrate,O
Sentence: 472,the,O
Sentence: 472,effects,O
Sentence: 472,of,O
Sentence: 472,the,O
Sentence: 472,estrogenic,O
Sentence: 472,stimulation,O
Sentence: 472,on,O
Sentence: 472,the,O
Sentence: 472,mammary,O
Sentence: 472,and,O
Sentence: 472,endometrial,O
Sentence: 472,target,O
Sentence: 472,tissues,O
Sentence: 472,of,O
Sentence: 472,women,O
Sentence: 472,on,O
Sentence: 472,hormonal,O
Sentence: 472,replacement,O
Sentence: 472,therapy,O
Sentence: 472,.,O
Sentence: 472,The,O
Sentence: 472,treatment,O
Sentence: 472,schedule,O
Sentence: 472,consisted,O
Sentence: 472,of,O
Sentence: 472,conjugated,B-Chemical
Sentence: 472,estrogens,I-Chemical
Sentence: 472,(,O
Sentence: 472,Premarin,B-Chemical
Sentence: 472,),O
Sentence: 472,1.25,O
Sentence: 472,mg,O
Sentence: 472,/,O
Sentence: 472,day,O
Sentence: 472,for,O
Sentence: 472,21,O
Sentence: 472,days,O
Sentence: 472,and,O
Sentence: 472,Medroxyprogesterone,B-Chemical
Sentence: 472,acetate,I-Chemical
Sentence: 472,10,O
Sentence: 472,mg,O
Sentence: 472,/,O
Sentence: 472,day,O
Sentence: 472,for,O
Sentence: 472,10,O
Sentence: 472,days,O
Sentence: 472,in,O
Sentence: 472,each,O
Sentence: 472,month,O
Sentence: 472,.,O
Sentence: 472,The,O
Sentence: 472,mean,O
Sentence: 472,treatment,O
Sentence: 472,period,O
Sentence: 472,was,O
Sentence: 472,18,O
Sentence: 472,months,O
Sentence: 472,.,O
Sentence: 472,During,O
Sentence: 472,the,O
Sentence: 472,follow,O
Sentence: 472,-,O
Sentence: 472,up,O
Sentence: 472,period,O
Sentence: 472,",",O
Sentence: 472,attention,O
Sentence: 472,was,O
Sentence: 472,paid,O
Sentence: 472,to,O
Sentence: 472,breast,O
Sentence: 472,modifications,O
Sentence: 472,as,O
Sentence: 472,evidenced,O
Sentence: 472,by,O
Sentence: 472,symptomatology,O
Sentence: 472,",",O
Sentence: 472,physical,O
Sentence: 472,examination,O
Sentence: 472,",",O
Sentence: 472,and,O
Sentence: 472,plate,O
Sentence: 472,thermography,O
Sentence: 472,.,O
Sentence: 472,Mastodynia,B-Disease
Sentence: 472,was,O
Sentence: 472,reported,O
Sentence: 472,by,O
Sentence: 472,21,O
Sentence: 472,patients,O
Sentence: 472,",",O
Sentence: 472,and,O
Sentence: 472,physical,O
Sentence: 472,examination,O
Sentence: 472,revealed,O
Sentence: 472,a,O
Sentence: 472,light,O
Sentence: 472,increase,O
Sentence: 472,in,O
Sentence: 472,breast,O
Sentence: 472,firmness,O
Sentence: 472,in,O
Sentence: 472,12,O
Sentence: 472,women,O
Sentence: 472,and,O
Sentence: 472,a,O
Sentence: 472,moderate,O
Sentence: 472,increase,O
Sentence: 472,in,O
Sentence: 472,breast,O
Sentence: 472,nodularity,O
Sentence: 472,in,O
Sentence: 472,2,O
Sentence: 472,women,O
Sentence: 472,.,O
Sentence: 472,Themography,O
Sentence: 472,confirmed,O
Sentence: 472,the,O
Sentence: 472,existence,O
Sentence: 472,of,O
Sentence: 472,an,O
Sentence: 472,excessive,O
Sentence: 472,breast,O
Sentence: 472,stimulation,O
Sentence: 472,in,O
Sentence: 472,1,O
Sentence: 472,women,O
Sentence: 472,who,O
Sentence: 472,complained,O
Sentence: 472,of,O
Sentence: 472,moderate,O
Sentence: 472,mastodynia,B-Disease
Sentence: 472,and,O
Sentence: 472,in,O
Sentence: 472,5,O
Sentence: 472,of,O
Sentence: 472,the,O
Sentence: 472,7,O
Sentence: 472,women,O
Sentence: 472,who,O
Sentence: 472,complained,O
Sentence: 472,of,O
Sentence: 472,severe,O
Sentence: 472,mastodynia,B-Disease
Sentence: 472,.,O
Sentence: 472,Normalization,O
Sentence: 472,was,O
Sentence: 472,obtained,O
Sentence: 472,by,O
Sentence: 472,halving,O
Sentence: 472,the,O
Sentence: 472,estrogen,B-Chemical
Sentence: 472,dose,O
Sentence: 472,.,O
Sentence: 472,These,O
Sentence: 472,results,O
Sentence: 472,suggest,O
Sentence: 472,that,O
Sentence: 472,hormonal,O
Sentence: 472,replacement,O
Sentence: 472,therapy,O
Sentence: 472,can,O
Sentence: 472,be,O
Sentence: 472,safely,O
Sentence: 472,prescribed,O
Sentence: 472,if,O
Sentence: 472,the,O
Sentence: 472,following,O
Sentence: 472,criteria,O
Sentence: 472,are,O
Sentence: 472,satisfied,O
Sentence: 472,:,O
Sentence: 472,1,O
Sentence: 472,),O
Sentence: 472,preliminary,O
Sentence: 472,evaluation,O
Sentence: 472,of,O
Sentence: 472,patients,O
Sentence: 472,from,O
Sentence: 472,a,O
Sentence: 472,clinical,O
Sentence: 472,",",O
Sentence: 472,metabolic,O
Sentence: 472,",",O
Sentence: 472,cytologic,O
Sentence: 472,",",O
Sentence: 472,and,O
Sentence: 472,mammographic,O
Sentence: 472,perspective,O
Sentence: 472,;,O
Sentence: 472,2,O
Sentence: 472,),O
Sentence: 472,cyclic,O
Sentence: 472,treatment,O
Sentence: 472,schedule,O
Sentence: 472,",",O
Sentence: 472,with,O
Sentence: 472,a,O
Sentence: 472,progestative,O
Sentence: 472,phase,O
Sentence: 472,of,O
Sentence: 472,10,O
Sentence: 472,days,O
Sentence: 472,;,O
Sentence: 472,and,O
Sentence: 472,3,O
Sentence: 472,),O
Sentence: 472,periodic,O
Sentence: 472,complete,O
Sentence: 472,follow,O
Sentence: 472,-,O
Sentence: 472,up,O
Sentence: 472,",",O
Sentence: 472,with,O
Sentence: 472,accurate,O
Sentence: 472,thermographic,O
Sentence: 472,evaluation,O
Sentence: 472,of,O
Sentence: 472,the,O
Sentence: 472,breast,O
Sentence: 472,target,O
Sentence: 472,tissues,O
Sentence: 472,.,O
Sentence: 473,Early,O
Sentence: 473,infections,B-Disease
Sentence: 473,in,O
Sentence: 473,kidney,O
Sentence: 473,",",O
Sentence: 473,heart,O
Sentence: 473,",",O
Sentence: 473,and,O
Sentence: 473,liver,O
Sentence: 473,transplant,O
Sentence: 473,recipients,O
Sentence: 473,on,O
Sentence: 473,cyclosporine,B-Chemical
Sentence: 473,.,O
Sentence: 474,Eighty,O
Sentence: 474,-,O
Sentence: 474,one,O
Sentence: 474,renal,O
Sentence: 474,",",O
Sentence: 474,seventeen,O
Sentence: 474,heart,O
Sentence: 474,",",O
Sentence: 474,and,O
Sentence: 474,twenty,O
Sentence: 474,-,O
Sentence: 474,four,O
Sentence: 474,liver,O
Sentence: 474,transplant,O
Sentence: 474,patients,O
Sentence: 474,were,O
Sentence: 474,followed,O
Sentence: 474,for,O
Sentence: 474,infection,B-Disease
Sentence: 474,.,O
Sentence: 474,Seventeen,O
Sentence: 474,renal,O
Sentence: 474,patients,O
Sentence: 474,received,O
Sentence: 474,azathioprine,B-Chemical
Sentence: 474,(,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,),O
Sentence: 474,and,O
Sentence: 474,prednisone,B-Chemical
Sentence: 474,as,O
Sentence: 474,part,O
Sentence: 474,of,O
Sentence: 474,a,O
Sentence: 474,randomized,O
Sentence: 474,trial,O
Sentence: 474,of,O
Sentence: 474,immunosuppression,O
Sentence: 474,with,O
Sentence: 474,21,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,-,O
Sentence: 474,and,O
Sentence: 474,-,O
Sentence: 474,prednisone,B-Chemical
Sentence: 474,-,O
Sentence: 474,treated,O
Sentence: 474,renal,O
Sentence: 474,transplant,O
Sentence: 474,patients,O
Sentence: 474,.,O
Sentence: 474,All,O
Sentence: 474,others,O
Sentence: 474,received,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,and,O
Sentence: 474,prednisone,B-Chemical
Sentence: 474,.,O
Sentence: 474,The,O
Sentence: 474,randomized,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,patients,O
Sentence: 474,had,O
Sentence: 474,more,O
Sentence: 474,overall,O
Sentence: 474,infections,B-Disease
Sentence: 474,(,O
Sentence: 474,P,O
Sentence: 474,less,O
Sentence: 474,than,O
Sentence: 474,0.05,O
Sentence: 474,),O
Sentence: 474,and,O
Sentence: 474,more,O
Sentence: 474,nonviral,O
Sentence: 474,infections,B-Disease
Sentence: 474,(,O
Sentence: 474,P,O
Sentence: 474,less,O
Sentence: 474,than,O
Sentence: 474,0.02,O
Sentence: 474,),O
Sentence: 474,than,O
Sentence: 474,the,O
Sentence: 474,randomized,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,patients,O
Sentence: 474,.,O
Sentence: 474,Heart,O
Sentence: 474,and,O
Sentence: 474,liver,O
Sentence: 474,patients,O
Sentence: 474,had,O
Sentence: 474,more,O
Sentence: 474,infections,B-Disease
Sentence: 474,than,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,renal,O
Sentence: 474,patients,O
Sentence: 474,but,O
Sentence: 474,fewer,O
Sentence: 474,infections,B-Disease
Sentence: 474,than,O
Sentence: 474,the,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,renal,O
Sentence: 474,patients,O
Sentence: 474,.,O
Sentence: 474,There,O
Sentence: 474,were,O
Sentence: 474,no,O
Sentence: 474,infectious,O
Sentence: 474,deaths,O
Sentence: 474,in,O
Sentence: 474,renal,O
Sentence: 474,transplant,O
Sentence: 474,patients,O
Sentence: 474,on,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,or,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,",",O
Sentence: 474,but,O
Sentence: 474,infection,B-Disease
Sentence: 474,played,O
Sentence: 474,a,O
Sentence: 474,major,O
Sentence: 474,role,O
Sentence: 474,in,O
Sentence: 474,3,O
Sentence: 474,out,O
Sentence: 474,of,O
Sentence: 474,6,O
Sentence: 474,cardiac,O
Sentence: 474,transplant,O
Sentence: 474,deaths,O
Sentence: 474,and,O
Sentence: 474,in,O
Sentence: 474,8,O
Sentence: 474,out,O
Sentence: 474,of,O
Sentence: 474,9,O
Sentence: 474,liver,O
Sentence: 474,transplant,O
Sentence: 474,deaths,O
Sentence: 474,.,O
Sentence: 474,Renal,O
Sentence: 474,patients,O
Sentence: 474,on,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,had,O
Sentence: 474,the,O
Sentence: 474,fewest,O
Sentence: 474,bacteremias,B-Disease
Sentence: 474,.,O
Sentence: 474,Analysis,O
Sentence: 474,of,O
Sentence: 474,site,O
Sentence: 474,of,O
Sentence: 474,infection,B-Disease
Sentence: 474,showed,O
Sentence: 474,a,O
Sentence: 474,preponderance,O
Sentence: 474,of,O
Sentence: 474,abdominal,B-Disease
Sentence: 474,infections,B-Disease
Sentence: 474,in,O
Sentence: 474,liver,O
Sentence: 474,patients,O
Sentence: 474,",",O
Sentence: 474,intrathoracic,O
Sentence: 474,infections,B-Disease
Sentence: 474,in,O
Sentence: 474,heart,O
Sentence: 474,patients,O
Sentence: 474,",",O
Sentence: 474,and,O
Sentence: 474,urinary,B-Disease
Sentence: 474,tract,I-Disease
Sentence: 474,infections,B-Disease
Sentence: 474,in,O
Sentence: 474,renal,O
Sentence: 474,patients,O
Sentence: 474,.,O
Sentence: 474,Pulmonary,O
Sentence: 474,infections,B-Disease
Sentence: 474,were,O
Sentence: 474,less,O
Sentence: 474,common,O
Sentence: 474,in,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,-,O
Sentence: 474,treated,O
Sentence: 474,renal,O
Sentence: 474,patients,O
Sentence: 474,than,O
Sentence: 474,in,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,-,O
Sentence: 474,treated,O
Sentence: 474,patients,O
Sentence: 474,(,O
Sentence: 474,P,O
Sentence: 474,less,O
Sentence: 474,than,O
Sentence: 474,0.05,O
Sentence: 474,),O
Sentence: 474,.,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,patients,O
Sentence: 474,had,O
Sentence: 474,significantly,O
Sentence: 474,more,O
Sentence: 474,staphylococcal,B-Disease
Sentence: 474,infections,I-Disease
Sentence: 474,than,O
Sentence: 474,all,O
Sentence: 474,other,O
Sentence: 474,transplant,O
Sentence: 474,groups,O
Sentence: 474,(,O
Sentence: 474,P,O
Sentence: 474,less,O
Sentence: 474,than,O
Sentence: 474,0.005,O
Sentence: 474,),O
Sentence: 474,",",O
Sentence: 474,and,O
Sentence: 474,systemic,O
Sentence: 474,fungal,B-Disease
Sentence: 474,infections,I-Disease
Sentence: 474,occurred,O
Sentence: 474,only,O
Sentence: 474,in,O
Sentence: 474,the,O
Sentence: 474,liver,O
Sentence: 474,transplant,O
Sentence: 474,group,O
Sentence: 474,.,O
Sentence: 474,Cytomegalovirus,O
Sentence: 474,(,O
Sentence: 474,CMV,O
Sentence: 474,),O
Sentence: 474,shedding,O
Sentence: 474,or,O
Sentence: 474,serological,O
Sentence: 474,rises,O
Sentence: 474,in,O
Sentence: 474,antibody,O
Sentence: 474,titer,O
Sentence: 474,",",O
Sentence: 474,or,O
Sentence: 474,both,O
Sentence: 474,occurred,O
Sentence: 474,in,O
Sentence: 474,78,O
Sentence: 474,%,O
Sentence: 474,of,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,patients,O
Sentence: 474,and,O
Sentence: 474,76,O
Sentence: 474,%,O
Sentence: 474,of,O
Sentence: 474,Aza,B-Chemical
Sentence: 474,patients,O
Sentence: 474,.,O
Sentence: 474,Of,O
Sentence: 474,the,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,patients,O
Sentence: 474,",",O
Sentence: 474,15,O
Sentence: 474,%,O
Sentence: 474,had,O
Sentence: 474,symptoms,O
Sentence: 474,related,O
Sentence: 474,to,O
Sentence: 474,CMV,B-Disease
Sentence: 474,infection,I-Disease
Sentence: 474,.,O
Sentence: 474,Serological,O
Sentence: 474,evidence,O
Sentence: 474,for,O
Sentence: 474,Epstein,B-Disease
Sentence: 474,Barr,I-Disease
Sentence: 474,Virus,I-Disease
Sentence: 474,infection,I-Disease
Sentence: 474,was,O
Sentence: 474,found,O
Sentence: 474,in,O
Sentence: 474,20,O
Sentence: 474,%,O
Sentence: 474,of,O
Sentence: 474,65,O
Sentence: 474,cyclosporine,B-Chemical
Sentence: 474,patients,O
Sentence: 474,studied,O
Sentence: 474,.,O
Sentence: 474,Three,O
Sentence: 474,had,O
Sentence: 474,associated,O
Sentence: 474,symptoms,O
Sentence: 474,",",O
Sentence: 474,and,O
Sentence: 474,one,O
Sentence: 474,developed,O
Sentence: 474,a,O
Sentence: 474,lymphoma,B-Disease
Sentence: 474,.,O
Sentence: 475,Structure,O
Sentence: 475,-,O
Sentence: 475,activity,O
Sentence: 475,and,O
Sentence: 475,dose,O
Sentence: 475,-,O
Sentence: 475,effect,O
Sentence: 475,relationships,O
Sentence: 475,of,O
Sentence: 475,the,O
Sentence: 475,antagonism,O
Sentence: 475,of,O
Sentence: 475,picrotoxin,B-Chemical
Sentence: 475,-,O
Sentence: 475,induced,O
Sentence: 475,seizures,B-Disease
Sentence: 475,by,O
Sentence: 475,cholecystokinin,B-Chemical
Sentence: 475,",",O
Sentence: 475,fragments,O
Sentence: 475,and,O
Sentence: 475,analogues,O
Sentence: 475,of,O
Sentence: 475,cholecystokinin,B-Chemical
Sentence: 475,in,O
Sentence: 475,mice,O
Sentence: 475,.,O
Sentence: 476,Intraperitoneal,O
Sentence: 476,administration,O
Sentence: 476,of,O
Sentence: 476,cholecystokinin,B-Chemical
Sentence: 476,octapeptide,I-Chemical
Sentence: 476,sulphate,O
Sentence: 476,ester,O
Sentence: 476,(,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,),O
Sentence: 476,and,O
Sentence: 476,nonsulphated,O
Sentence: 476,cholecystokinin,B-Chemical
Sentence: 476,octapeptide,I-Chemical
Sentence: 476,(,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,NS,O
Sentence: 476,),O
Sentence: 476,enhanced,O
Sentence: 476,the,O
Sentence: 476,latency,O
Sentence: 476,of,O
Sentence: 476,seizures,B-Disease
Sentence: 476,induced,O
Sentence: 476,by,O
Sentence: 476,picrotoxin,B-Chemical
Sentence: 476,in,O
Sentence: 476,mice,O
Sentence: 476,.,O
Sentence: 476,Experiments,O
Sentence: 476,with,O
Sentence: 476,N,O
Sentence: 476,-,O
Sentence: 476,,O
Sentence: 476,and,O
Sentence: 476,C,O
Sentence: 476,-,O
Sentence: 476,terminal,O
Sentence: 476,fragments,O
Sentence: 476,revealed,O
Sentence: 476,that,O
Sentence: 476,the,O
Sentence: 476,C,O
Sentence: 476,-,O
Sentence: 476,terminal,O
Sentence: 476,tetrapeptide,O
Sentence: 476,(,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,5,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,),O
Sentence: 476,was,O
Sentence: 476,the,O
Sentence: 476,active,O
Sentence: 476,centre,O
Sentence: 476,of,O
Sentence: 476,the,O
Sentence: 476,CCK,O
Sentence: 476,octapeptide,O
Sentence: 476,molecule,O
Sentence: 476,.,O
Sentence: 476,The,O
Sentence: 476,analogues,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,and,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,NS,O
Sentence: 476,(,O
Sentence: 476,dose,O
Sentence: 476,range,O
Sentence: 476,0.2,O
Sentence: 476,-,O
Sentence: 476,6.4,O
Sentence: 476,mumol,O
Sentence: 476,/,O
Sentence: 476,kg,O
Sentence: 476,),O
Sentence: 476,and,O
Sentence: 476,caerulein,B-Chemical
Sentence: 476,dose,O
Sentence: 476,range,O
Sentence: 476,0.1,O
Sentence: 476,-,O
Sentence: 476,0.8,O
Sentence: 476,mumol,O
Sentence: 476,/,O
Sentence: 476,kg,O
Sentence: 476,),O
Sentence: 476,showed,O
Sentence: 476,bell,O
Sentence: 476,-,O
Sentence: 476,shaped,O
Sentence: 476,dose,O
Sentence: 476,-,O
Sentence: 476,effect,O
Sentence: 476,curves,O
Sentence: 476,",",O
Sentence: 476,with,O
Sentence: 476,the,O
Sentence: 476,greatest,O
Sentence: 476,maximum,O
Sentence: 476,inhibition,O
Sentence: 476,for,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,NS,O
Sentence: 476,.,O
Sentence: 476,The,O
Sentence: 476,peptide,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,5,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,had,O
Sentence: 476,weak,O
Sentence: 476,anticonvulsant,O
Sentence: 476,activity,O
Sentence: 476,in,O
Sentence: 476,comparison,O
Sentence: 476,to,O
Sentence: 476,the,O
Sentence: 476,octapeptides,O
Sentence: 476,",",O
Sentence: 476,3.2,O
Sentence: 476,mumol,O
Sentence: 476,/,O
Sentence: 476,kg,O
Sentence: 476,and,O
Sentence: 476,larger,O
Sentence: 476,doses,O
Sentence: 476,of,O
Sentence: 476,the,O
Sentence: 476,reference,O
Sentence: 476,drug,O
Sentence: 476,",",O
Sentence: 476,diazepam,B-Chemical
Sentence: 476,",",O
Sentence: 476,totally,O
Sentence: 476,prevented,O
Sentence: 476,picrotoxin,B-Chemical
Sentence: 476,-,O
Sentence: 476,induced,O
Sentence: 476,seizures,B-Disease
Sentence: 476,and,O
Sentence: 476,mortality,O
Sentence: 476,.,O
Sentence: 476,The,O
Sentence: 476,maximum,O
Sentence: 476,effect,O
Sentence: 476,of,O
Sentence: 476,the,O
Sentence: 476,peptides,O
Sentence: 476,tested,O
Sentence: 476,was,O
Sentence: 476,less,O
Sentence: 476,than,O
Sentence: 476,that,O
Sentence: 476,of,O
Sentence: 476,diazepam,B-Chemical
Sentence: 476,.,O
Sentence: 476,Experiments,O
Sentence: 476,with,O
Sentence: 476,analogues,O
Sentence: 476,and,O
Sentence: 476,derivatives,O
Sentence: 476,of,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,5,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,demonstrated,O
Sentence: 476,that,O
Sentence: 476,the,O
Sentence: 476,effectiveness,O
Sentence: 476,of,O
Sentence: 476,the,O
Sentence: 476,beta,O
Sentence: 476,-,O
Sentence: 476,alanyl,O
Sentence: 476,derivatives,O
Sentence: 476,of,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,5,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,were,O
Sentence: 476,enhanced,O
Sentence: 476,and,O
Sentence: 476,that,O
Sentence: 476,they,O
Sentence: 476,were,O
Sentence: 476,equipotent,O
Sentence: 476,with,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,.,O
Sentence: 476,Of,O
Sentence: 476,the,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,2,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,analogues,O
Sentence: 476,",",O
Sentence: 476,Ser,O
Sentence: 476,(,O
Sentence: 476,SO3H,O
Sentence: 476,),O
Sentence: 476,7,O
Sentence: 476,-,O
Sentence: 476,Ac,O
Sentence: 476,-,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,2,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,and,O
Sentence: 476,Thr,O
Sentence: 476,(,O
Sentence: 476,SO3H,O
Sentence: 476,),O
Sentence: 476,7,O
Sentence: 476,-,O
Sentence: 476,Ac,O
Sentence: 476,-,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,2,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,and,O
Sentence: 476,Hyp,O
Sentence: 476,(,O
Sentence: 476,SO3H,O
Sentence: 476,),O
Sentence: 476,,O
Sentence: 476,-,O
Sentence: 476,Ac,O
Sentence: 476,-,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,2,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,were,O
Sentence: 476,slightly,O
Sentence: 476,more,O
Sentence: 476,active,O
Sentence: 476,than,O
Sentence: 476,CCK,O
Sentence: 476,-,O
Sentence: 476,8,O
Sentence: 476,-,O
Sentence: 476,SE,O
Sentence: 476,.,O
Sentence: 477,Vasopressin,B-Chemical
Sentence: 477,as,O
Sentence: 477,a,O
Sentence: 477,possible,O
Sentence: 477,contributor,O
Sentence: 477,to,O
Sentence: 477,hypertension,B-Disease
Sentence: 477,.,O
Sentence: 478,The,O
Sentence: 478,role,O
Sentence: 478,of,O
Sentence: 478,vasopressin,B-Chemical
Sentence: 478,as,O
Sentence: 478,a,O
Sentence: 478,pressor,O
Sentence: 478,agent,O
Sentence: 478,to,O
Sentence: 478,the,O
Sentence: 478,hypertensive,B-Disease
Sentence: 478,process,O
Sentence: 478,was,O
Sentence: 478,examined,O
Sentence: 478,.,O
Sentence: 478,Vasopressin,B-Chemical
Sentence: 478,plays,O
Sentence: 478,a,O
Sentence: 478,major,O
Sentence: 478,role,O
Sentence: 478,in,O
Sentence: 478,the,O
Sentence: 478,pathogenesis,O
Sentence: 478,of,O
Sentence: 478,DOCA,B-Chemical
Sentence: 478,-,O
Sentence: 478,salt,O
Sentence: 478,hypertension,B-Disease
Sentence: 478,",",O
Sentence: 478,since,O
Sentence: 478,the,O
Sentence: 478,elevation,O
Sentence: 478,of,O
Sentence: 478,blood,O
Sentence: 478,pressure,O
Sentence: 478,was,O
Sentence: 478,not,O
Sentence: 478,substantial,O
Sentence: 478,in,O
Sentence: 478,the,O
Sentence: 478,rats,O
Sentence: 478,with,O
Sentence: 478,lithium,B-Chemical
Sentence: 478,-,O
Sentence: 478,treated,O
Sentence: 478,diabetes,B-Disease
Sentence: 478,insipidus,I-Disease
Sentence: 478,after,O
Sentence: 478,DOCA,B-Chemical
Sentence: 478,-,O
Sentence: 478,salt,O
Sentence: 478,treatment,O
Sentence: 478,.,O
Sentence: 478,Administration,O
Sentence: 478,of,O
Sentence: 478,DDAVP,B-Chemical
Sentence: 478,which,O
Sentence: 478,has,O
Sentence: 478,antidiuretic,O
Sentence: 478,action,O
Sentence: 478,but,O
Sentence: 478,minimal,O
Sentence: 478,vasopressor,O
Sentence: 478,effect,O
Sentence: 478,failed,O
Sentence: 478,to,O
Sentence: 478,increase,O
Sentence: 478,blood,O
Sentence: 478,pressure,O
Sentence: 478,to,O
Sentence: 478,the,O
Sentence: 478,levels,O
Sentence: 478,observed,O
Sentence: 478,after,O
Sentence: 478,administration,O
Sentence: 478,of,O
Sentence: 478,AVP,O
Sentence: 478,.,O
Sentence: 478,Furthermore,O
Sentence: 478,",",O
Sentence: 478,the,O
Sentence: 478,pressor,O
Sentence: 478,action,O
Sentence: 478,of,O
Sentence: 478,vasopressin,B-Chemical
Sentence: 478,appears,O
Sentence: 478,to,O
Sentence: 478,be,O
Sentence: 478,important,O
Sentence: 478,in,O
Sentence: 478,the,O
Sentence: 478,development,O
Sentence: 478,of,O
Sentence: 478,this,O
Sentence: 478,model,O
Sentence: 478,of,O
Sentence: 478,hypertension,B-Disease
Sentence: 478,",",O
Sentence: 478,since,O
Sentence: 478,the,O
Sentence: 478,enhanced,O
Sentence: 478,pressor,O
Sentence: 478,responsiveness,O
Sentence: 478,to,O
Sentence: 478,the,O
Sentence: 478,hormone,O
Sentence: 478,was,O
Sentence: 478,observed,O
Sentence: 478,in,O
Sentence: 478,the,O
Sentence: 478,initial,O
Sentence: 478,stage,O
Sentence: 478,of,O
Sentence: 478,hypertension,B-Disease
Sentence: 478,.,O
Sentence: 478,Increased,O
Sentence: 478,secretion,O
Sentence: 478,of,O
Sentence: 478,vasopressin,B-Chemical
Sentence: 478,from,O
Sentence: 478,neurohypophysis,O
Sentence: 478,also,O
Sentence: 478,promotes,O
Sentence: 478,the,O
Sentence: 478,function,O
Sentence: 478,of,O
Sentence: 478,the,O
Sentence: 478,hormone,O
Sentence: 478,as,O
Sentence: 478,a,O
Sentence: 478,pathogenetic,O
Sentence: 478,factor,O
Sentence: 478,in,O
Sentence: 478,hypertension,B-Disease
Sentence: 478,.,O
Sentence: 478,An,O
Sentence: 478,unproportional,O
Sentence: 478,release,O
Sentence: 478,of,O
Sentence: 478,vasopressin,B-Chemical
Sentence: 478,compared,O
Sentence: 478,to,O
Sentence: 478,plasma,O
Sentence: 478,osmolality,O
Sentence: 478,may,O
Sentence: 478,be,O
Sentence: 478,induced,O
Sentence: 478,by,O
Sentence: 478,the,O
Sentence: 478,absence,O
Sentence: 478,of,O
Sentence: 478,an,O
Sentence: 478,adjusting,O
Sentence: 478,control,O
Sentence: 478,of,O
Sentence: 478,angiotensin,B-Chemical
Sentence: 478,II,O
Sentence: 478,forming,O
Sentence: 478,and,O
Sentence: 478,receptor,O
Sentence: 478,binding,O
Sentence: 478,capacity,O
Sentence: 478,for,O
Sentence: 478,sodium,B-Chemical
Sentence: 478,balance,O
Sentence: 478,in,O
Sentence: 478,the,O
Sentence: 478,brain,O
Sentence: 478,.,O
Sentence: 478,However,O
Sentence: 478,",",O
Sentence: 478,the,O
Sentence: 478,role,O
Sentence: 478,of,O
Sentence: 478,vasopressin,B-Chemical
Sentence: 478,remains,O
Sentence: 478,to,O
Sentence: 478,be,O
Sentence: 478,determined,O
Sentence: 478,in,O
Sentence: 478,human,O
Sentence: 478,essential,O
Sentence: 478,hypertension,B-Disease
Sentence: 478,.,O
Sentence: 479,Toxic,B-Disease
Sentence: 479,hepatitis,I-Disease
Sentence: 479,induced,O
Sentence: 479,by,O
Sentence: 479,disulfiram,B-Chemical
Sentence: 479,in,O
Sentence: 479,a,O
Sentence: 479,non,O
Sentence: 479,-,O
Sentence: 479,alcoholic,O
Sentence: 479,.,O
Sentence: 480,A,O
Sentence: 480,reversible,O
Sentence: 480,toxic,B-Disease
Sentence: 480,liver,I-Disease
Sentence: 480,damage,I-Disease
Sentence: 480,was,O
Sentence: 480,observed,O
Sentence: 480,in,O
Sentence: 480,a,O
Sentence: 480,non,O
Sentence: 480,-,O
Sentence: 480,alcoholic,O
Sentence: 480,woman,O
Sentence: 480,treated,O
Sentence: 480,with,O
Sentence: 480,disulfiram,B-Chemical
Sentence: 480,.,O
Sentence: 480,The,O
Sentence: 480,causative,O
Sentence: 480,relationship,O
Sentence: 480,was,O
Sentence: 480,proven,O
Sentence: 480,by,O
Sentence: 480,challenge,O
Sentence: 480,.,O
Sentence: 481,Atrial,B-Disease
Sentence: 481,thrombosis,I-Disease
Sentence: 481,involving,O
Sentence: 481,the,O
Sentence: 481,heart,O
Sentence: 481,of,O
Sentence: 481,F,O
Sentence: 481,-,O
Sentence: 481,344,O
Sentence: 481,rats,O
Sentence: 481,ingesting,O
Sentence: 481,quinacrine,B-Chemical
Sentence: 481,hydrochloride,I-Chemical
Sentence: 481,.,O
Sentence: 482,Quinacrine,B-Chemical
Sentence: 482,hydrochloride,I-Chemical
Sentence: 482,is,O
Sentence: 482,toxic,O
Sentence: 482,for,O
Sentence: 482,the,O
Sentence: 482,heart,O
Sentence: 482,of,O
Sentence: 482,F,O
Sentence: 482,-,O
Sentence: 482,344,O
Sentence: 482,rats,O
Sentence: 482,.,O
Sentence: 482,Rats,O
Sentence: 482,treated,O
Sentence: 482,with,O
Sentence: 482,500,O
Sentence: 482,ppm,O
Sentence: 482,quinacrine,B-Chemical
Sentence: 482,hydrochloride,I-Chemical
Sentence: 482,in,O
Sentence: 482,the,O
Sentence: 482,diet,O
Sentence: 482,all,O
Sentence: 482,developed,O
Sentence: 482,a,O
Sentence: 482,high,O
Sentence: 482,incidence,O
Sentence: 482,of,O
Sentence: 482,left,O
Sentence: 482,atrial,B-Disease
Sentence: 482,thrombosis,I-Disease
Sentence: 482,.,O
Sentence: 482,The,O
Sentence: 482,lesion,O
Sentence: 482,was,O
Sentence: 482,associated,O
Sentence: 482,with,O
Sentence: 482,cardiac,B-Disease
Sentence: 482,hypertrophy,I-Disease
Sentence: 482,and,O
Sentence: 482,dilatation,O
Sentence: 482,and,O
Sentence: 482,focal,O
Sentence: 482,myocardial,B-Disease
Sentence: 482,degeneration,I-Disease
Sentence: 482,.,O
Sentence: 482,Rats,O
Sentence: 482,died,O
Sentence: 482,from,O
Sentence: 482,cardiac,B-Disease
Sentence: 482,hypertrophy,I-Disease
Sentence: 482,with,O
Sentence: 482,severe,O
Sentence: 482,acute,O
Sentence: 482,and,O
Sentence: 482,chronic,O
Sentence: 482,congestion,O
Sentence: 482,of,O
Sentence: 482,the,O
Sentence: 482,lungs,O
Sentence: 482,",",O
Sentence: 482,liver,O
Sentence: 482,",",O
Sentence: 482,and,O
Sentence: 482,other,O
Sentence: 482,organs,O
Sentence: 482,.,O
Sentence: 482,Seventy,O
Sentence: 482,percent,O
Sentence: 482,of,O
Sentence: 482,rats,O
Sentence: 482,given,O
Sentence: 482,250,O
Sentence: 482,ppm,O
Sentence: 482,quinacrine,B-Chemical
Sentence: 482,hydrochloride,I-Chemical
Sentence: 482,and,O
Sentence: 482,"1,000",O
Sentence: 482,ppm,O
Sentence: 482,sodium,B-Chemical
Sentence: 482,nitrite,I-Chemical
Sentence: 482,simultaneously,O
Sentence: 482,in,O
Sentence: 482,the,O
Sentence: 482,diet,O
Sentence: 482,had,O
Sentence: 482,thrombosis,B-Disease
Sentence: 482,of,O
Sentence: 482,the,O
Sentence: 482,atria,O
Sentence: 482,of,O
Sentence: 482,the,O
Sentence: 482,heart,O
Sentence: 482,",",O
Sentence: 482,while,O
Sentence: 482,untreated,O
Sentence: 482,control,O
Sentence: 482,rats,O
Sentence: 482,in,O
Sentence: 482,this,O
Sentence: 482,laboratory,O
Sentence: 482,did,O
Sentence: 482,not,O
Sentence: 482,have,O
Sentence: 482,atrial,B-Disease
Sentence: 482,thrombosis,I-Disease
Sentence: 482,.,O
Sentence: 482,Sodium,B-Chemical
Sentence: 482,nitrite,I-Chemical
Sentence: 482,in,O
Sentence: 482,combination,O
Sentence: 482,with,O
Sentence: 482,quinacrine,B-Chemical
Sentence: 482,hydrochloride,I-Chemical
Sentence: 482,appeared,O
Sentence: 482,to,O
Sentence: 482,have,O
Sentence: 482,no,O
Sentence: 482,additional,O
Sentence: 482,effect,O
Sentence: 482,.,O
Sentence: 483,Alternating,B-Disease
Sentence: 483,sinus,I-Disease
Sentence: 483,rhythm,I-Disease
Sentence: 483,and,O
Sentence: 483,intermittent,O
Sentence: 483,sinoatrial,B-Disease
Sentence: 483,block,I-Disease
Sentence: 483,induced,O
Sentence: 483,by,O
Sentence: 483,propranolol,B-Chemical
Sentence: 483,.,O
Sentence: 484,Alternating,B-Disease
Sentence: 484,sinus,I-Disease
Sentence: 484,rhythm,I-Disease
Sentence: 484,and,O
Sentence: 484,intermittent,O
Sentence: 484,sinoatrial,O
Sentence: 484,(,O
Sentence: 484,S,O
Sentence: 484,-,O
Sentence: 484,A,O
Sentence: 484,),O
Sentence: 484,block,O
Sentence: 484,was,O
Sentence: 484,observed,O
Sentence: 484,in,O
Sentence: 484,a,O
Sentence: 484,57,O
Sentence: 484,-,O
Sentence: 484,year,O
Sentence: 484,-,O
Sentence: 484,old,O
Sentence: 484,woman,O
Sentence: 484,",",O
Sentence: 484,under,O
Sentence: 484,treatment,O
Sentence: 484,for,O
Sentence: 484,angina,B-Disease
Sentence: 484,with,O
Sentence: 484,80,O
Sentence: 484,mg,O
Sentence: 484,propranolol,B-Chemical
Sentence: 484,daily,O
Sentence: 484,.,O
Sentence: 484,The,O
Sentence: 484,electrocardiogram,O
Sentence: 484,showed,O
Sentence: 484,alternation,O
Sentence: 484,of,O
Sentence: 484,long,O
Sentence: 484,and,O
Sentence: 484,short,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,and,O
Sentence: 484,occasional,O
Sentence: 484,pauses,O
Sentence: 484,.,O
Sentence: 484,These,O
Sentence: 484,pauses,O
Sentence: 484,were,O
Sentence: 484,always,O
Sentence: 484,preceded,O
Sentence: 484,by,O
Sentence: 484,the,O
Sentence: 484,short,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,and,O
Sentence: 484,were,O
Sentence: 484,usually,O
Sentence: 484,followed,O
Sentence: 484,by,O
Sentence: 484,one,O
Sentence: 484,or,O
Sentence: 484,two,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,of,O
Sentence: 484,0.92,O
Sentence: 484,-,O
Sentence: 484,0.95,O
Sentence: 484,s,O
Sentence: 484,representing,O
Sentence: 484,the,O
Sentence: 484,basic,O
Sentence: 484,sinus,O
Sentence: 484,cycle,O
Sentence: 484,.,O
Sentence: 484,Following,O
Sentence: 484,these,O
Sentence: 484,basic,O
Sentence: 484,sinus,O
Sentence: 484,cycles,O
Sentence: 484,",",O
Sentence: 484,alternating,B-Disease
Sentence: 484,rhythm,I-Disease
Sentence: 484,started,O
Sentence: 484,with,O
Sentence: 484,the,O
Sentence: 484,longer,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,interval,O
Sentence: 484,.,O
Sentence: 484,The,O
Sentence: 484,long,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,ranged,O
Sentence: 484,between,O
Sentence: 484,1.04,O
Sentence: 484,-,O
Sentence: 484,1.12,O
Sentence: 484,s,O
Sentence: 484,and,O
Sentence: 484,the,O
Sentence: 484,short,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,between,O
Sentence: 484,0.80,O
Sentence: 484,-,O
Sentence: 484,0.84,O
Sentence: 484,s,O
Sentence: 484,",",O
Sentence: 484,respectively,O
Sentence: 484,.,O
Sentence: 484,The,O
Sentence: 484,duration,O
Sentence: 484,of,O
Sentence: 484,the,O
Sentence: 484,pauses,O
Sentence: 484,were,O
Sentence: 484,equal,O
Sentence: 484,or,O
Sentence: 484,almost,O
Sentence: 484,equal,O
Sentence: 484,to,O
Sentence: 484,one,O
Sentence: 484,short,O
Sentence: 484,plus,O
Sentence: 484,one,O
Sentence: 484,long,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,interval,O
Sentence: 484,or,O
Sentence: 484,to,O
Sentence: 484,twice,O
Sentence: 484,the,O
Sentence: 484,basic,O
Sentence: 484,sinus,O
Sentence: 484,cycle,O
Sentence: 484,.,O
Sentence: 484,In,O
Sentence: 484,one,O
Sentence: 484,recording,O
Sentence: 484,a,O
Sentence: 484,short,O
Sentence: 484,period,O
Sentence: 484,of,O
Sentence: 484,regular,O
Sentence: 484,sinus,O
Sentence: 484,rhythm,O
Sentence: 484,with,O
Sentence: 484,intermittent,O
Sentence: 484,2,O
Sentence: 484,/,O
Sentence: 484,1,O
Sentence: 484,S,O
Sentence: 484,-,O
Sentence: 484,A,O
Sentence: 484,block,O
Sentence: 484,was,O
Sentence: 484,observed,O
Sentence: 484,.,O
Sentence: 484,This,O
Sentence: 484,short,O
Sentence: 484,period,O
Sentence: 484,of,O
Sentence: 484,sinus,O
Sentence: 484,rhythm,O
Sentence: 484,was,O
Sentence: 484,interrupted,O
Sentence: 484,by,O
Sentence: 484,sudden,O
Sentence: 484,prolongation,O
Sentence: 484,of,O
Sentence: 484,the,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,interval,O
Sentence: 484,starting,O
Sentence: 484,the,O
Sentence: 484,alternative,O
Sentence: 484,rhythm,O
Sentence: 484,.,O
Sentence: 484,There,O
Sentence: 484,were,O
Sentence: 484,small,O
Sentence: 484,changes,O
Sentence: 484,in,O
Sentence: 484,the,O
Sentence: 484,shape,O
Sentence: 484,of,O
Sentence: 484,the,O
Sentence: 484,P,O
Sentence: 484,waves,O
Sentence: 484,and,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,R,O
Sentence: 484,intervals,O
Sentence: 484,.,O
Sentence: 484,S,O
Sentence: 484,-,O
Sentence: 484,A,O
Sentence: 484,conduction,O
Sentence: 484,through,O
Sentence: 484,two,O
Sentence: 484,pathways,O
Sentence: 484,",",O
Sentence: 484,the,O
Sentence: 484,first,O
Sentence: 484,with,O
Sentence: 484,2,O
Sentence: 484,/,O
Sentence: 484,1,O
Sentence: 484,block,O
Sentence: 484,the,O
Sentence: 484,second,O
Sentence: 484,having,O
Sentence: 484,0.12,O
Sentence: 484,-,O
Sentence: 484,0.14,O
Sentence: 484,s,O
Sentence: 484,longer,O
Sentence: 484,conduction,O
Sentence: 484,time,O
Sentence: 484,and,O
Sentence: 484,with,O
Sentence: 484,occasional,O
Sentence: 484,2,O
Sentence: 484,/,O
Sentence: 484,1,O
Sentence: 484,block,O
Sentence: 484,was,O
Sentence: 484,proposed,O
Sentence: 484,for,O
Sentence: 484,the,O
Sentence: 484,explanation,O
Sentence: 484,of,O
Sentence: 484,the,O
Sentence: 484,alternating,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,interval,O
Sentence: 484,and,O
Sentence: 484,other,O
Sentence: 484,electrocardiographic,O
Sentence: 484,features,O
Sentence: 484,seen,O
Sentence: 484,.,O
Sentence: 484,Atropine,B-Chemical
Sentence: 484,1,O
Sentence: 484,mg,O
Sentence: 484,given,O
Sentence: 484,intravenously,O
Sentence: 484,resulted,O
Sentence: 484,in,O
Sentence: 484,shortening,O
Sentence: 484,of,O
Sentence: 484,all,O
Sentence: 484,P,O
Sentence: 484,-,O
Sentence: 484,P,O
Sentence: 484,intervals,O
Sentence: 484,without,O
Sentence: 484,changing,O
Sentence: 484,the,O
Sentence: 484,rhythm,O
Sentence: 484,.,O
Sentence: 484,The,O
Sentence: 484,abnormal,O
Sentence: 484,rhythm,O
Sentence: 484,disappeared,O
Sentence: 484,with,O
Sentence: 484,the,O
Sentence: 484,withdrawal,O
Sentence: 484,of,O
Sentence: 484,propranolol,B-Chemical
Sentence: 484,and,O
Sentence: 484,when,O
Sentence: 484,the,O
Sentence: 484,drug,O
Sentence: 484,was,O
Sentence: 484,restarted,O
Sentence: 484,a,O
Sentence: 484,2,O
Sentence: 484,/,O
Sentence: 484,1,O
Sentence: 484,S,O
Sentence: 484,-,O
Sentence: 484,A,O
Sentence: 484,block,O
Sentence: 484,was,O
Sentence: 484,seen,O
Sentence: 484,.,O
Sentence: 484,This,O
Sentence: 484,was,O
Sentence: 484,accepted,O
Sentence: 484,as,O
Sentence: 484,evidence,O
Sentence: 484,for,O
Sentence: 484,propranolol,B-Chemical
Sentence: 484,being,O
Sentence: 484,the,O
Sentence: 484,cause,O
Sentence: 484,of,O
Sentence: 484,this,O
Sentence: 484,conduction,B-Disease
Sentence: 484,disorder,I-Disease
Sentence: 484,.,O
Sentence: 485,Antitumor,O
Sentence: 485,effect,O
Sentence: 485,",",O
Sentence: 485,cardiotoxicity,B-Disease
Sentence: 485,",",O
Sentence: 485,and,O
Sentence: 485,nephrotoxicity,B-Disease
Sentence: 485,of,O
Sentence: 485,doxorubicin,B-Chemical
Sentence: 485,in,O
Sentence: 485,the,O
Sentence: 485,IgM,O
Sentence: 485,solid,O
Sentence: 485,immunocytoma,B-Disease
Sentence: 485,-,O
Sentence: 485,bearing,O
Sentence: 485,LOU,O
Sentence: 485,/,O
Sentence: 485,M,O
Sentence: 485,/,O
Sentence: 485,WSL,O
Sentence: 485,rat,O
Sentence: 485,.,O
Sentence: 486,Antitumor,O
Sentence: 486,activity,O
Sentence: 486,",",O
Sentence: 486,cardiotoxicity,B-Disease
Sentence: 486,",",O
Sentence: 486,and,O
Sentence: 486,nephrotoxicity,B-Disease
Sentence: 486,induced,O
Sentence: 486,by,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,were,O
Sentence: 486,studied,O
Sentence: 486,in,O
Sentence: 486,LOU,O
Sentence: 486,/,O
Sentence: 486,M,O
Sentence: 486,/,O
Sentence: 486,WSL,O
Sentence: 486,inbred,O
Sentence: 486,rats,O
Sentence: 486,each,O
Sentence: 486,bearing,O
Sentence: 486,a,O
Sentence: 486,transplantable,O
Sentence: 486,solid,O
Sentence: 486,IgM,O
Sentence: 486,immunocytoma,B-Disease
Sentence: 486,.,O
Sentence: 486,Animals,O
Sentence: 486,with,O
Sentence: 486,a,O
Sentence: 486,tumor,B-Disease
Sentence: 486,(,O
Sentence: 486,diameter,O
Sentence: 486,",",O
Sentence: 486,15.8,O
Sentence: 486,+,O
Sentence: 486,/,O
Sentence: 486,,O
Sentence: 486,-,O
Sentence: 486,,O
Sentence: 486,3.3,O
Sentence: 486,mm,O
Sentence: 486,),O
Sentence: 486,were,O
Sentence: 486,treated,O
Sentence: 486,with,O
Sentence: 486,iv,O
Sentence: 486,injections,O
Sentence: 486,of,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,on,O
Sentence: 486,5,O
Sentence: 486,consecutive,O
Sentence: 486,days,O
Sentence: 486,",",O
Sentence: 486,followed,O
Sentence: 486,by,O
Sentence: 486,1,O
Sentence: 486,weekly,O
Sentence: 486,injection,O
Sentence: 486,for,O
Sentence: 486,7,O
Sentence: 486,weeks,O
Sentence: 486,(,O
Sentence: 486,dose,O
Sentence: 486,range,O
Sentence: 486,",",O
Sentence: 486,0.015,O
Sentence: 486,-,O
Sentence: 486,4.0,O
Sentence: 486,mg,O
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,body,O
Sentence: 486,wt,O
Sentence: 486,),O
Sentence: 486,.,O
Sentence: 486,Tumor,B-Disease
Sentence: 486,regression,O
Sentence: 486,was,O
Sentence: 486,observed,O
Sentence: 486,with,O
Sentence: 486,0.5,O
Sentence: 486,mg,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,.,O
Sentence: 486,Complete,O
Sentence: 486,disappearance,O
Sentence: 486,of,O
Sentence: 486,the,O
Sentence: 486,tumor,B-Disease
Sentence: 486,was,O
Sentence: 486,induced,O
Sentence: 486,with,O
Sentence: 486,1.0,O
Sentence: 486,mg,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,.,O
Sentence: 486,Histologic,O
Sentence: 486,evidence,O
Sentence: 486,of,O
Sentence: 486,cardiotoxicity,B-Disease
Sentence: 486,scored,O
Sentence: 486,as,O
Sentence: 486,grade,O
Sentence: 486,III,O
Sentence: 486,was,O
Sentence: 486,only,O
Sentence: 486,observed,O
Sentence: 486,at,O
Sentence: 486,a,O
Sentence: 486,dose,O
Sentence: 486,of,O
Sentence: 486,1.0,O
Sentence: 486,mg,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,.,O
Sentence: 486,Light,O
Sentence: 486,microscopic,O
Sentence: 486,evidence,O
Sentence: 486,of,O
Sentence: 486,renal,B-Disease
Sentence: 486,damage,I-Disease
Sentence: 486,was,O
Sentence: 486,seen,O
Sentence: 486,above,O
Sentence: 486,a,O
Sentence: 486,dose,O
Sentence: 486,of,O
Sentence: 486,0.5,O
Sentence: 486,mg,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,",",O
Sentence: 486,which,O
Sentence: 486,resulted,O
Sentence: 486,in,O
Sentence: 486,albuminuria,B-Disease
Sentence: 486,and,O
Sentence: 486,very,O
Sentence: 486,low,O
Sentence: 486,serum,O
Sentence: 486,albumin,O
Sentence: 486,levels,O
Sentence: 486,.,O
Sentence: 486,In,O
Sentence: 486,the,O
Sentence: 486,group,O
Sentence: 486,that,O
Sentence: 486,received,O
Sentence: 486,1.0,O
Sentence: 486,mg,O
Sentence: 486,doxorubicin,B-Chemical
Sentence: 486,/,O
Sentence: 486,kg,O
Sentence: 486,",",O
Sentence: 486,the,O
Sentence: 486,serum,O
Sentence: 486,albumin,O
Sentence: 486,level,O
Sentence: 486,decreased,O
Sentence: 486,from,O
Sentence: 486,33.6,O
Sentence: 486,+,O
Sentence: 486,/,O
Sentence: 486,,O
Sentence: 486,-,O
Sentence: 486,,O
Sentence: 486,4.1,O
Sentence: 486,to,O
Sentence: 486,1.5,O
Sentence: 486,+,O
Sentence: 486,/,O
Sentence: 486,,O
Sentence: 486,-,O
Sentence: 486,,O
Sentence: 486,0.5,O
Sentence: 486,g,O
Sentence: 486,/,O
Sentence: 486,liter,O
Sentence: 486,.,O
Sentence: 486,Ascites,B-Disease
Sentence: 486,and,O
Sentence: 486,hydrothorax,B-Disease
Sentence: 486,were,O
Sentence: 486,observed,O
Sentence: 486,simultaneously,O
Sentence: 486,.,O
Sentence: 486,The,O
Sentence: 486,same,O
Sentence: 486,experiments,O
Sentence: 486,were,O
Sentence: 486,performed,O
Sentence: 486,with,O
Sentence: 486,non,O
Sentence: 486,-,O
Sentence: 486,tumor,B-Disease
Sentence: 486,-,O
Sentence: 486,bearing,O
Sentence: 486,rats,O
Sentence: 486,",",O
Sentence: 486,in,O
Sentence: 486,which,O
Sentence: 486,no,O
Sentence: 486,major,O
Sentence: 486,differences,O
Sentence: 486,were,O
Sentence: 486,observed,O
Sentence: 486,.,O
Sentence: 486,In,O
Sentence: 486,conclusion,O
Sentence: 486,",",O
Sentence: 486,antitumor,O
Sentence: 486,activity,O
Sentence: 486,",",O
Sentence: 486,cardiotoxicity,B-Disease
Sentence: 486,",",O
Sentence: 486,and,O
Sentence: 486,nephrotoxicity,B-Disease
Sentence: 486,were,O
Sentence: 486,studied,O
Sentence: 486,simultaneously,O
Sentence: 486,in,O
Sentence: 486,the,O
Sentence: 486,same,O
Sentence: 486,LOU,O
Sentence: 486,/,O
Sentence: 486,M,O
Sentence: 486,/,O
Sentence: 486,WSL,O
Sentence: 486,rat,O
Sentence: 486,.,O
Sentence: 486,Albuminuria,B-Disease
Sentence: 486,due,O
Sentence: 486,to,O
Sentence: 486,renal,B-Disease
Sentence: 486,damage,I-Disease
Sentence: 486,led,O
Sentence: 486,to,O
Sentence: 486,extremely,O
Sentence: 486,low,O
Sentence: 486,serum,O
Sentence: 486,albumin,O
Sentence: 486,levels,O
Sentence: 486,",",O
Sentence: 486,so,O
Sentence: 486,ascites,B-Disease
Sentence: 486,and,O
Sentence: 486,hydrothorax,B-Disease
Sentence: 486,were,O
Sentence: 486,not,O
Sentence: 486,necessarily,O
Sentence: 486,a,O
Sentence: 486,consequence,O
Sentence: 486,of,O
Sentence: 486,the,O
Sentence: 486,observed,O
Sentence: 486,cardiomyopathy,B-Disease
Sentence: 486,.,O
Sentence: 487,Intraoperative,O
Sentence: 487,bradycardia,B-Disease
Sentence: 487,and,O
Sentence: 487,hypotension,B-Disease
Sentence: 487,associated,O
Sentence: 487,with,O
Sentence: 487,timolol,B-Chemical
Sentence: 487,and,O
Sentence: 487,pilocarpine,B-Chemical
Sentence: 487,eye,O
Sentence: 487,drops,O
Sentence: 487,.,O
Sentence: 488,A,O
Sentence: 488,69,O
Sentence: 488,-,O
Sentence: 488,yr,O
Sentence: 488,-,O
Sentence: 488,old,O
Sentence: 488,man,O
Sentence: 488,",",O
Sentence: 488,who,O
Sentence: 488,was,O
Sentence: 488,concurrently,O
Sentence: 488,being,O
Sentence: 488,treated,O
Sentence: 488,with,O
Sentence: 488,pilocarpine,B-Chemical
Sentence: 488,nitrate,I-Chemical
Sentence: 488,and,O
Sentence: 488,timolol,B-Chemical
Sentence: 488,maleate,I-Chemical
Sentence: 488,eye,O
Sentence: 488,drops,O
Sentence: 488,",",O
Sentence: 488,developed,O
Sentence: 488,a,O
Sentence: 488,bradycardia,B-Disease
Sentence: 488,and,O
Sentence: 488,became,O
Sentence: 488,hypotensive,B-Disease
Sentence: 488,during,O
Sentence: 488,halothane,B-Chemical
Sentence: 488,anaesthesia,O
Sentence: 488,.,O
Sentence: 488,Both,O
Sentence: 488,timolol,B-Chemical
Sentence: 488,and,O
Sentence: 488,pilocarpine,B-Chemical
Sentence: 488,were,O
Sentence: 488,subsequently,O
Sentence: 488,identified,O
Sentence: 488,in,O
Sentence: 488,a,O
Sentence: 488,24,O
Sentence: 488,-,O
Sentence: 488,h,O
Sentence: 488,collection,O
Sentence: 488,of,O
Sentence: 488,urine,O
Sentence: 488,.,O
Sentence: 488,Timolol,B-Chemical
Sentence: 488,(,O
Sentence: 488,but,O
Sentence: 488,not,O
Sentence: 488,pilocarpine,B-Chemical
Sentence: 488,),O
Sentence: 488,was,O
Sentence: 488,detected,O
Sentence: 488,in,O
Sentence: 488,a,O
Sentence: 488,sample,O
Sentence: 488,of,O
Sentence: 488,plasma,O
Sentence: 488,removed,O
Sentence: 488,during,O
Sentence: 488,surgery,O
Sentence: 488,;,O
Sentence: 488,the,O
Sentence: 488,plasma,O
Sentence: 488,concentration,O
Sentence: 488,of,O
Sentence: 488,timolol,B-Chemical
Sentence: 488,(,O
Sentence: 488,2.6,O
Sentence: 488,ng,O
Sentence: 488,ml,O
Sentence: 488,-,O
Sentence: 488,1,O
Sentence: 488,),O
Sentence: 488,was,O
Sentence: 488,consistent,O
Sentence: 488,with,O
Sentence: 488,partial,O
Sentence: 488,beta,O
Sentence: 488,-,O
Sentence: 488,adrenoceptor,O
Sentence: 488,blockade,O
Sentence: 488,.,O
Sentence: 488,It,O
Sentence: 488,is,O
Sentence: 488,postulated,O
Sentence: 488,that,O
Sentence: 488,this,O
Sentence: 488,action,O
Sentence: 488,may,O
Sentence: 488,have,O
Sentence: 488,been,O
Sentence: 488,enhanced,O
Sentence: 488,during,O
Sentence: 488,halothane,B-Chemical
Sentence: 488,anaesthesia,O
Sentence: 488,with,O
Sentence: 488,resultant,O
Sentence: 488,bradycardia,B-Disease
Sentence: 488,and,O
Sentence: 488,hypotension,B-Disease
Sentence: 488,.,O
Sentence: 488,Pilocarpine,B-Chemical
Sentence: 488,may,O
Sentence: 488,have,O
Sentence: 488,had,O
Sentence: 488,a,O
Sentence: 488,contributory,O
Sentence: 488,effect,O
Sentence: 488,.,O
Sentence: 489,Succinylcholine,B-Chemical
Sentence: 489,apnoea,B-Disease
Sentence: 489,:,O
Sentence: 489,attempted,O
Sentence: 489,reversal,O
Sentence: 489,with,O
Sentence: 489,anticholinesterases,O
Sentence: 489,.,O
Sentence: 490,Anticholinesterases,O
Sentence: 490,were,O
Sentence: 490,administered,O
Sentence: 490,in,O
Sentence: 490,an,O
Sentence: 490,attempt,O
Sentence: 490,to,O
Sentence: 490,antagonize,O
Sentence: 490,prolonged,O
Sentence: 490,neuromuscular,B-Disease
Sentence: 490,blockade,I-Disease
Sentence: 490,following,O
Sentence: 490,the,O
Sentence: 490,administration,O
Sentence: 490,of,O
Sentence: 490,succinylcholine,B-Chemical
Sentence: 490,in,O
Sentence: 490,a,O
Sentence: 490,patient,O
Sentence: 490,later,O
Sentence: 490,found,O
Sentence: 490,to,O
Sentence: 490,be,O
Sentence: 490,homozygous,O
Sentence: 490,for,O
Sentence: 490,atypical,O
Sentence: 490,plasma,O
Sentence: 490,cholinesterase,O
Sentence: 490,.,O
Sentence: 490,Edrophonium,B-Chemical
Sentence: 490,10,O
Sentence: 490,mg,O
Sentence: 490,",",O
Sentence: 490,given,O
Sentence: 490,74,O
Sentence: 490,min,O
Sentence: 490,after,O
Sentence: 490,succinylcholine,B-Chemical
Sentence: 490,",",O
Sentence: 490,when,O
Sentence: 490,train,O
Sentence: 490,-,O
Sentence: 490,of,O
Sentence: 490,-,O
Sentence: 490,four,O
Sentence: 490,stimulation,O
Sentence: 490,was,O
Sentence: 490,characteristic,O
Sentence: 490,of,O
Sentence: 490,phase,O
Sentence: 490,II,O
Sentence: 490,block,O
Sentence: 490,",",O
Sentence: 490,produced,O
Sentence: 490,partial,O
Sentence: 490,antagonism,O
Sentence: 490,which,O
Sentence: 490,was,O
Sentence: 490,not,O
Sentence: 490,sustained,O
Sentence: 490,.,O
Sentence: 490,Repeated,O
Sentence: 490,doses,O
Sentence: 490,of,O
Sentence: 490,edrophonium,B-Chemical
Sentence: 490,to,O
Sentence: 490,70,O
Sentence: 490,mg,O
Sentence: 490,and,O
Sentence: 490,neostigmine,B-Chemical
Sentence: 490,to,O
Sentence: 490,2.5,O
Sentence: 490,mg,O
Sentence: 490,did,O
Sentence: 490,not,O
Sentence: 490,antagonize,O
Sentence: 490,or,O
Sentence: 490,augment,O
Sentence: 490,the,O
Sentence: 490,block,O
Sentence: 490,.,O
Sentence: 490,Spontaneous,O
Sentence: 490,respiration,O
Sentence: 490,recommenced,O
Sentence: 490,200,O
Sentence: 490,min,O
Sentence: 490,after,O
Sentence: 490,succinylcholine,B-Chemical
Sentence: 490,administration,O
Sentence: 490,.,O
Sentence: 490,It,O
Sentence: 490,is,O
Sentence: 490,concluded,O
Sentence: 490,that,O
Sentence: 490,anticholinesterases,O
Sentence: 490,are,O
Sentence: 490,only,O
Sentence: 490,partially,O
Sentence: 490,effective,O
Sentence: 490,in,O
Sentence: 490,restoring,O
Sentence: 490,neuromuscular,O
Sentence: 490,function,O
Sentence: 490,in,O
Sentence: 490,succinylcholine,B-Chemical
Sentence: 490,apnoea,B-Disease
Sentence: 490,despite,O
Sentence: 490,muscle,O
Sentence: 490,twitch,O
Sentence: 490,activity,O
Sentence: 490,typical,O
Sentence: 490,of,O
Sentence: 490,phase,O
Sentence: 490,II,O
Sentence: 490,block,O
Sentence: 490,.,O
Sentence: 491,Effect,O
Sentence: 491,of,O
Sentence: 491,doxorubicin,B-Chemical
Sentence: 491,on,O
Sentence: 491,[,O
Sentence: 491,omega,O
Sentence: 491,-,O
Sentence: 491,I,O
Sentence: 491,-,O
Sentence: 491,131,O
Sentence: 491,],O
Sentence: 491,heptadecanoic,O
Sentence: 491,acid,O
Sentence: 491,myocardial,O
Sentence: 491,scintigraphy,O
Sentence: 491,and,O
Sentence: 491,echocardiography,O
Sentence: 491,in,O
Sentence: 491,dogs,O
Sentence: 491,.,O
Sentence: 492,The,O
Sentence: 492,effects,O
Sentence: 492,of,O
Sentence: 492,serial,O
Sentence: 492,treatment,O
Sentence: 492,with,O
Sentence: 492,doxorubicin,B-Chemical
Sentence: 492,on,O
Sentence: 492,dynamic,O
Sentence: 492,myocardial,O
Sentence: 492,scintigraphy,O
Sentence: 492,with,O
Sentence: 492,[,O
Sentence: 492,omega,O
Sentence: 492,-,O
Sentence: 492,I,O
Sentence: 492,-,O
Sentence: 492,131,O
Sentence: 492,],O
Sentence: 492,heptadecanoic,O
Sentence: 492,acid,O
Sentence: 492,(,O
Sentence: 492,I,O
Sentence: 492,-,O
Sentence: 492,131,O
Sentence: 492,HA,O
Sentence: 492,),O
Sentence: 492,",",O
Sentence: 492,and,O
Sentence: 492,on,O
Sentence: 492,global,O
Sentence: 492,left,O
Sentence: 492,-,O
Sentence: 492,ventricular,O
Sentence: 492,function,O
Sentence: 492,determined,O
Sentence: 492,echocardiographically,O
Sentence: 492,",",O
Sentence: 492,were,O
Sentence: 492,studied,O
Sentence: 492,in,O
Sentence: 492,a,O
Sentence: 492,group,O
Sentence: 492,of,O
Sentence: 492,nine,O
Sentence: 492,mongrel,O
Sentence: 492,dogs,O
Sentence: 492,.,O
Sentence: 492,Total,O
Sentence: 492,extractable,O
Sentence: 492,myocardial,O
Sentence: 492,lipid,O
Sentence: 492,was,O
Sentence: 492,compared,O
Sentence: 492,postmortem,O
Sentence: 492,between,O
Sentence: 492,a,O
Sentence: 492,group,O
Sentence: 492,of,O
Sentence: 492,control,O
Sentence: 492,dogs,O
Sentence: 492,and,O
Sentence: 492,doxorubicin,B-Chemical
Sentence: 492,-,O
Sentence: 492,treated,O
Sentence: 492,dogs,O
Sentence: 492,.,O
Sentence: 492,A,O
Sentence: 492,significant,O
Sentence: 492,and,O
Sentence: 492,then,O
Sentence: 492,progressive,O
Sentence: 492,fall,O
Sentence: 492,in,O
Sentence: 492,global,O
Sentence: 492,LV,O
Sentence: 492,function,O
Sentence: 492,was,O
Sentence: 492,observed,O
Sentence: 492,at,O
Sentence: 492,a,O
Sentence: 492,cumulative,O
Sentence: 492,doxorubicin,B-Chemical
Sentence: 492,dose,O
Sentence: 492,of,O
Sentence: 492,4,O
Sentence: 492,mg,O
Sentence: 492,/,O
Sentence: 492,kg,O
Sentence: 492,.,O
Sentence: 492,A,O
Sentence: 492,significant,O
Sentence: 492,increase,O
Sentence: 492,in,O
Sentence: 492,the,O
Sentence: 492,myocardial,O
Sentence: 492,t1,O
Sentence: 492,/,O
Sentence: 492,2,O
Sentence: 492,of,O
Sentence: 492,the,O
Sentence: 492,I,O
Sentence: 492,-,O
Sentence: 492,131,O
Sentence: 492,HA,O
Sentence: 492,was,O
Sentence: 492,observed,O
Sentence: 492,only,O
Sentence: 492,at,O
Sentence: 492,a,O
Sentence: 492,higher,O
Sentence: 492,cumulative,O
Sentence: 492,dose,O
Sentence: 492,",",O
Sentence: 492,10,O
Sentence: 492,mg,O
Sentence: 492,/,O
Sentence: 492,kg,O
Sentence: 492,.,O
Sentence: 492,No,O
Sentence: 492,significant,O
Sentence: 492,alteration,O
Sentence: 492,in,O
Sentence: 492,total,O
Sentence: 492,extractable,O
Sentence: 492,myocardial,O
Sentence: 492,lipids,O
Sentence: 492,was,O
Sentence: 492,observed,O
Sentence: 492,between,O
Sentence: 492,control,O
Sentence: 492,dogs,O
Sentence: 492,and,O
Sentence: 492,those,O
Sentence: 492,treated,O
Sentence: 492,with,O
Sentence: 492,doxorubicin,B-Chemical
Sentence: 492,.,O
Sentence: 492,Our,O
Sentence: 492,findings,O
Sentence: 492,suggest,O
Sentence: 492,that,O
Sentence: 492,the,O
Sentence: 492,changes,O
Sentence: 492,leading,O
Sentence: 492,to,O
Sentence: 492,an,O
Sentence: 492,alteration,O
Sentence: 492,of,O
Sentence: 492,myocardial,O
Sentence: 492,dynamic,O
Sentence: 492,imaging,O
Sentence: 492,with,O
Sentence: 492,I,O
Sentence: 492,-,O
Sentence: 492,131,O
Sentence: 492,HA,O
Sentence: 492,are,O
Sentence: 492,not,O
Sentence: 492,the,O
Sentence: 492,initiating,O
Sentence: 492,factor,O
Sentence: 492,in,O
Sentence: 492,doxorubicin,B-Chemical
Sentence: 492,cardiotoxicity,B-Disease
Sentence: 492,.,O
Sentence: 493,Hemodynamics,O
Sentence: 493,and,O
Sentence: 493,myocardial,O
Sentence: 493,metabolism,O
Sentence: 493,under,O
Sentence: 493,deliberate,O
Sentence: 493,hypotension,O
Sentence: 493,.,O
Sentence: 493,An,O
Sentence: 493,experimental,O
Sentence: 493,study,O
Sentence: 493,in,O
Sentence: 493,dogs,O
Sentence: 493,.,O
Sentence: 494,Coronary,O
Sentence: 494,blood,O
Sentence: 494,flow,O
Sentence: 494,",",O
Sentence: 494,cardiac,O
Sentence: 494,work,O
Sentence: 494,and,O
Sentence: 494,metabolism,O
Sentence: 494,were,O
Sentence: 494,studied,O
Sentence: 494,in,O
Sentence: 494,dogs,O
Sentence: 494,under,O
Sentence: 494,sodium,B-Chemical
Sentence: 494,nitroprusside,B-Chemical
Sentence: 494,(,O
Sentence: 494,SNP,B-Chemical
Sentence: 494,),O
Sentence: 494,and,O
Sentence: 494,trimetaphan,B-Chemical
Sentence: 494,(,O
Sentence: 494,TMP,B-Chemical
Sentence: 494,),O
Sentence: 494,deliberate,O
Sentence: 494,hypotension,B-Disease
Sentence: 494,(,O
Sentence: 494,20,O
Sentence: 494,%,O
Sentence: 494,and,O
Sentence: 494,40,O
Sentence: 494,%,O
Sentence: 494,mean,O
Sentence: 494,pressure,O
Sentence: 494,decrease,O
Sentence: 494,from,O
Sentence: 494,baseline,O
Sentence: 494,),O
Sentence: 494,.,O
Sentence: 494,Regarding,O
Sentence: 494,the,O
Sentence: 494,effects,O
Sentence: 494,of,O
Sentence: 494,drug,O
Sentence: 494,-,O
Sentence: 494,induced,O
Sentence: 494,hypotension,B-Disease
Sentence: 494,on,O
Sentence: 494,coronary,O
Sentence: 494,blood,O
Sentence: 494,flow,O
Sentence: 494,",",O
Sentence: 494,aortic,O
Sentence: 494,and,O
Sentence: 494,coronary,O
Sentence: 494,sinus,O
Sentence: 494,metabolic,O
Sentence: 494,data,O
Sentence: 494,(,O
Sentence: 494,pH,O
Sentence: 494,",",O
Sentence: 494,pO2,O
Sentence: 494,",",O
Sentence: 494,pCO2,O
Sentence: 494,),O
Sentence: 494,we,O
Sentence: 494,could,O
Sentence: 494,confirm,O
Sentence: 494,that,O
Sentence: 494,nitroprusside,B-Chemical
Sentence: 494,hypotension,B-Disease
Sentence: 494,could,O
Sentence: 494,be,O
Sentence: 494,safely,O
Sentence: 494,used,O
Sentence: 494,to,O
Sentence: 494,30,O
Sentence: 494,%,O
Sentence: 494,mean,O
Sentence: 494,blood,O
Sentence: 494,pressure,O
Sentence: 494,decrease,O
Sentence: 494,from,O
Sentence: 494,control,O
Sentence: 494,",",O
Sentence: 494,trimetaphan,B-Chemical
Sentence: 494,hypotension,B-Disease
Sentence: 494,to,O
Sentence: 494,20,O
Sentence: 494,%,O
Sentence: 494,mean,O
Sentence: 494,blood,O
Sentence: 494,pressure,O
Sentence: 494,decrease,O
Sentence: 494,.,O
Sentence: 494,Cardiac,O
Sentence: 494,work,O
Sentence: 494,was,O
Sentence: 494,significantly,O
Sentence: 494,reduced,O
Sentence: 494,during,O
Sentence: 494,SNP,B-Chemical
Sentence: 494,hypotension,B-Disease
Sentence: 494,.,O
Sentence: 494,Myocardial,O
Sentence: 494,O2,B-Chemical
Sentence: 494,consumption,O
Sentence: 494,and,O
Sentence: 494,O2,B-Chemical
Sentence: 494,availability,O
Sentence: 494,were,O
Sentence: 494,directly,O
Sentence: 494,dependent,O
Sentence: 494,on,O
Sentence: 494,the,O
Sentence: 494,coronary,O
Sentence: 494,perfusion,O
Sentence: 494,.,O
Sentence: 494,Careful,O
Sentence: 494,invasive,O
Sentence: 494,monitoring,O
Sentence: 494,of,O
Sentence: 494,the,O
Sentence: 494,blood,O
Sentence: 494,pressure,O
Sentence: 494,",",O
Sentence: 494,blood,O
Sentence: 494,gases,O
Sentence: 494,and,O
Sentence: 494,of,O
Sentence: 494,the,O
Sentence: 494,ECG,O
Sentence: 494,ST,O
Sentence: 494,-,O
Sentence: 494,T,O
Sentence: 494,segment,O
Sentence: 494,is,O
Sentence: 494,mandatory,O
Sentence: 494,.,O
Sentence: 495,Evidence,O
Sentence: 495,for,O
Sentence: 495,a,O
Sentence: 495,selective,O
Sentence: 495,brain,O
Sentence: 495,noradrenergic,O
Sentence: 495,involvement,O
Sentence: 495,in,O
Sentence: 495,the,O
Sentence: 495,locomotor,O
Sentence: 495,stimulant,O
Sentence: 495,effects,O
Sentence: 495,of,O
Sentence: 495,amphetamine,O
Sentence: 495,in,O
Sentence: 495,the,O
Sentence: 495,rat,O
Sentence: 495,.,O
Sentence: 496,Male,O
Sentence: 496,rats,O
Sentence: 496,received,O
Sentence: 496,the,O
Sentence: 496,noradrenaline,B-Chemical
Sentence: 496,neurotoxin,O
Sentence: 496,DSP4,B-Chemical
Sentence: 496,(,O
Sentence: 496,50,O
Sentence: 496,mg,O
Sentence: 496,/,O
Sentence: 496,kg,O
Sentence: 496,),O
Sentence: 496,7,O
Sentence: 496,days,O
Sentence: 496,prior,O
Sentence: 496,to,O
Sentence: 496,injection,O
Sentence: 496,of,O
Sentence: 496,D,O
Sentence: 496,-,O
Sentence: 496,amphetamine,B-Chemical
Sentence: 496,(,O
Sentence: 496,10,O
Sentence: 496,or,O
Sentence: 496,40,O
Sentence: 496,mumol,O
Sentence: 496,/,O
Sentence: 496,kg,O
Sentence: 496,i.p.,O
Sentence: 496,),O
Sentence: 496,.,O
Sentence: 496,The,O
Sentence: 496,hyperactivity,B-Disease
Sentence: 496,induced,O
Sentence: 496,by,O
Sentence: 496,D,O
Sentence: 496,-,O
Sentence: 496,amphetamine,B-Chemical
Sentence: 496,(,O
Sentence: 496,10,O
Sentence: 496,mumol,O
Sentence: 496,/,O
Sentence: 496,kg,O
Sentence: 496,),O
Sentence: 496,was,O
Sentence: 496,significantly,O
Sentence: 496,reduced,O
Sentence: 496,by,O
Sentence: 496,DSP4,B-Chemical
Sentence: 496,pretreatment,O
Sentence: 496,.,O
Sentence: 496,However,O
Sentence: 496,",",O
Sentence: 496,the,O
Sentence: 496,increased,O
Sentence: 496,rearings,O
Sentence: 496,and,O
Sentence: 496,the,O
Sentence: 496,amphetamine,B-Chemical
Sentence: 496,-,O
Sentence: 496,induced,O
Sentence: 496,stereotypies,B-Disease
Sentence: 496,were,O
Sentence: 496,not,O
Sentence: 496,blocked,O
Sentence: 496,by,O
Sentence: 496,pretreatment,O
Sentence: 496,with,O
Sentence: 496,DSP4,B-Chemical
Sentence: 496,.,O
Sentence: 496,The,O
Sentence: 496,reduction,O
Sentence: 496,of,O
Sentence: 496,amphetamine,B-Chemical
Sentence: 496,hyperactivity,B-Disease
Sentence: 496,induced,O
Sentence: 496,by,O
Sentence: 496,DSP4,B-Chemical
Sentence: 496,was,O
Sentence: 496,blocked,O
Sentence: 496,by,O
Sentence: 496,pretreatment,O
Sentence: 496,with,O
Sentence: 496,the,O
Sentence: 496,noradrenaline,B-Chemical
Sentence: 496,-,O
Sentence: 496,uptake,O
Sentence: 496,blocking,O
Sentence: 496,agent,O
Sentence: 496,",",O
Sentence: 496,desipramine,B-Chemical
Sentence: 496,",",O
Sentence: 496,which,O
Sentence: 496,prevents,O
Sentence: 496,the,O
Sentence: 496,neurotoxic,B-Disease
Sentence: 496,action,O
Sentence: 496,of,O
Sentence: 496,DSP4,B-Chemical
Sentence: 496,.,O
Sentence: 496,The,O
Sentence: 496,present,O
Sentence: 496,results,O
Sentence: 496,suggest,O
Sentence: 496,a,O
Sentence: 496,selective,O
Sentence: 496,involvement,O
Sentence: 496,of,O
Sentence: 496,central,O
Sentence: 496,noradrenergic,O
Sentence: 496,neurones,O
Sentence: 496,in,O
Sentence: 496,the,O
Sentence: 496,locomotor,O
Sentence: 496,stimulant,O
Sentence: 496,effect,O
Sentence: 496,of,O
Sentence: 496,amphetamine,B-Chemical
Sentence: 496,in,O
Sentence: 496,the,O
Sentence: 496,rat,O
Sentence: 496,.,O
Sentence: 497,Accelerated,B-Disease
Sentence: 497,junctional,I-Disease
Sentence: 497,rhythms,I-Disease
Sentence: 497,during,O
Sentence: 497,oral,O
Sentence: 497,verapamil,B-Chemical
Sentence: 497,therapy,O
Sentence: 497,.,O
Sentence: 498,This,O
Sentence: 498,study,O
Sentence: 498,examined,O
Sentence: 498,the,O
Sentence: 498,frequency,O
Sentence: 498,of,O
Sentence: 498,atrioventricular,O
Sentence: 498,(,O
Sentence: 498,AV,O
Sentence: 498,),O
Sentence: 498,dissociation,O
Sentence: 498,and,O
Sentence: 498,accelerated,B-Disease
Sentence: 498,junctional,I-Disease
Sentence: 498,rhythms,I-Disease
Sentence: 498,in,O
Sentence: 498,59,O
Sentence: 498,patients,O
Sentence: 498,receiving,O
Sentence: 498,oral,O
Sentence: 498,verapamil,B-Chemical
Sentence: 498,.,O
Sentence: 498,Accelerated,B-Disease
Sentence: 498,junctional,I-Disease
Sentence: 498,rhythms,I-Disease
Sentence: 498,and,O
Sentence: 498,AV,O
Sentence: 498,dissociation,O
Sentence: 498,were,O
Sentence: 498,frequent,O
Sentence: 498,in,O
Sentence: 498,patients,O
Sentence: 498,with,O
Sentence: 498,supraventricular,B-Disease
Sentence: 498,tachyarrhythmias,I-Disease
Sentence: 498,",",O
Sentence: 498,particularly,O
Sentence: 498,AV,O
Sentence: 498,nodal,O
Sentence: 498,reentry,O
Sentence: 498,.,O
Sentence: 498,Verapamil,B-Chemical
Sentence: 498,administration,O
Sentence: 498,to,O
Sentence: 498,these,O
Sentence: 498,patients,O
Sentence: 498,led,O
Sentence: 498,to,O
Sentence: 498,an,O
Sentence: 498,asymptomatic,O
Sentence: 498,increase,O
Sentence: 498,in,O
Sentence: 498,activity,O
Sentence: 498,of,O
Sentence: 498,these,O
Sentence: 498,junctional,O
Sentence: 498,pacemakers,O
Sentence: 498,.,O
Sentence: 498,In,O
Sentence: 498,patients,O
Sentence: 498,with,O
Sentence: 498,various,O
Sentence: 498,chest,B-Disease
Sentence: 498,pain,I-Disease
Sentence: 498,syndromes,O
Sentence: 498,",",O
Sentence: 498,verapamil,B-Chemical
Sentence: 498,neither,O
Sentence: 498,increased,O
Sentence: 498,the,O
Sentence: 498,frequency,O
Sentence: 498,of,O
Sentence: 498,junctional,O
Sentence: 498,rhythms,O
Sentence: 498,nor,O
Sentence: 498,suppressed,O
Sentence: 498,their,O
Sentence: 498,role,O
Sentence: 498,as,O
Sentence: 498,escape,O
Sentence: 498,rhythms,O
Sentence: 498,under,O
Sentence: 498,physiologically,O
Sentence: 498,appropriate,O
Sentence: 498,circumstances,O
Sentence: 498,.,O
Sentence: 499,Treatment,O
Sentence: 499,of,O
Sentence: 499,ovarian,B-Disease
Sentence: 499,cancer,I-Disease
Sentence: 499,with,O
Sentence: 499,a,O
Sentence: 499,combination,O
Sentence: 499,of,O
Sentence: 499,cis,O
Sentence: 499,-,O
Sentence: 499,platinum,O
Sentence: 499,",",O
Sentence: 499,adriamycin,B-Chemical
Sentence: 499,",",O
Sentence: 499,cyclophosphamide,B-Chemical
Sentence: 499,and,O
Sentence: 499,hexamethylmelamine,B-Chemical
Sentence: 499,.,O
Sentence: 500,During,O
Sentence: 500,the,O
Sentence: 500,last,O
Sentence: 500,2,O
Sentence: 500,1,O
Sentence: 500,/,O
Sentence: 500,2,O
Sentence: 500,years,O
Sentence: 500,",",O
Sentence: 500,38,O
Sentence: 500,patients,O
Sentence: 500,with,O
Sentence: 500,ovarian,B-Disease
Sentence: 500,cancer,I-Disease
Sentence: 500,were,O
Sentence: 500,treated,O
Sentence: 500,with,O
Sentence: 500,a,O
Sentence: 500,combination,O
Sentence: 500,of,O
Sentence: 500,cisplatinum,B-Chemical
Sentence: 500,(,O
Sentence: 500,CPDD,B-Chemical
Sentence: 500,),O
Sentence: 500,",",O
Sentence: 500,50,O
Sentence: 500,mg,O
Sentence: 500,/,O
Sentence: 500,m2,O
Sentence: 500,",",O
Sentence: 500,adriamycin,B-Chemical
Sentence: 500,",",O
Sentence: 500,30,O
Sentence: 500,mg,O
Sentence: 500,/,O
Sentence: 500,m2,O
Sentence: 500,",",O
Sentence: 500,cyclophosphamide,B-Chemical
Sentence: 500,",",O
Sentence: 500,300,O
Sentence: 500,mg,O
Sentence: 500,/,O
Sentence: 500,m2,O
Sentence: 500,",",O
Sentence: 500,on,O
Sentence: 500,day,O
Sentence: 500,1,O
Sentence: 500,;,O
Sentence: 500,and,O
Sentence: 500,hexamethylmelamine,B-Chemical
Sentence: 500,(,O
Sentence: 500,HMM,B-Chemical
Sentence: 500,),O
Sentence: 500,",",O
Sentence: 500,6,O
Sentence: 500,mg,O
Sentence: 500,/,O
Sentence: 500,kg,O
Sentence: 500,daily,O
Sentence: 500,",",O
Sentence: 500,for,O
Sentence: 500,14,O
Sentence: 500,days,O
Sentence: 500,.,O
Sentence: 500,Each,O
Sentence: 500,course,O
Sentence: 500,was,O
Sentence: 500,repeated,O
Sentence: 500,monthly,O
Sentence: 500,.,O
Sentence: 500,2,O
Sentence: 500,patients,O
Sentence: 500,had,O
Sentence: 500,stage,O
Sentence: 500,II,O
Sentence: 500,",",O
Sentence: 500,14,O
Sentence: 500,stage,O
Sentence: 500,III,O
Sentence: 500,and,O
Sentence: 500,22,O
Sentence: 500,stage,O
Sentence: 500,IV,O
Sentence: 500,disease,O
Sentence: 500,.,O
Sentence: 500,14,O
Sentence: 500,of,O
Sentence: 500,the,O
Sentence: 500,38,O
Sentence: 500,patients,O
Sentence: 500,were,O
Sentence: 500,previously,O
Sentence: 500,treated,O
Sentence: 500,with,O
Sentence: 500,chemotherapy,O
Sentence: 500,",",O
Sentence: 500,1,O
Sentence: 500,with,O
Sentence: 500,radiation,O
Sentence: 500,",",O
Sentence: 500,6,O
Sentence: 500,with,O
Sentence: 500,both,O
Sentence: 500,chemotherapy,O
Sentence: 500,and,O
Sentence: 500,radiation,O
Sentence: 500,",",O
Sentence: 500,and,O
Sentence: 500,17,O
Sentence: 500,did,O
Sentence: 500,not,O
Sentence: 500,have,O
Sentence: 500,any,O
Sentence: 500,treatment,O
Sentence: 500,before,O
Sentence: 500,CPDD,B-Chemical
Sentence: 500,combination,O
Sentence: 500,.,O
Sentence: 500,31,O
Sentence: 500,of,O
Sentence: 500,the,O
Sentence: 500,38,O
Sentence: 500,cases,O
Sentence: 500,(,O
Sentence: 500,81.5,O
Sentence: 500,%,O
Sentence: 500,),O
Sentence: 500,demonstrated,O
Sentence: 500,objective,O
Sentence: 500,responses,O
Sentence: 500,lasting,O
Sentence: 500,for,O
Sentence: 500,2,O
Sentence: 500,months,O
Sentence: 500,or,O
Sentence: 500,more,O
Sentence: 500,.,O
Sentence: 500,These,O
Sentence: 500,responses,O
Sentence: 500,were,O
Sentence: 500,partial,O
Sentence: 500,in,O
Sentence: 500,19,O
Sentence: 500,and,O
Sentence: 500,complete,O
Sentence: 500,in,O
Sentence: 500,12,O
Sentence: 500,cases,O
Sentence: 500,.,O
Sentence: 500,Hematologic,B-Disease
Sentence: 500,toxicity,I-Disease
Sentence: 500,was,O
Sentence: 500,moderate,O
Sentence: 500,and,O
Sentence: 500,with,O
Sentence: 500,reversible,O
Sentence: 500,anemia,B-Disease
Sentence: 500,developing,O
Sentence: 500,in,O
Sentence: 500,71,O
Sentence: 500,%,O
Sentence: 500,of,O
Sentence: 500,patients,O
Sentence: 500,.,O
Sentence: 500,Gastrointestinal,O
Sentence: 500,side,O
Sentence: 500,effects,O
Sentence: 500,from,O
Sentence: 500,CPDD,B-Chemical
Sentence: 500,were,O
Sentence: 500,universal,O
Sentence: 500,.,O
Sentence: 500,HMM,B-Chemical
Sentence: 500,gastrointestinal,B-Disease
Sentence: 500,toxicity,I-Disease
Sentence: 500,necessitated,O
Sentence: 500,discontinuation,O
Sentence: 500,of,O
Sentence: 500,the,O
Sentence: 500,drug,O
Sentence: 500,in,O
Sentence: 500,5,O
Sentence: 500,patients,O
Sentence: 500,.,O
Sentence: 500,Severe,O
Sentence: 500,nephrotoxicity,B-Disease
Sentence: 500,was,O
Sentence: 500,observed,O
Sentence: 500,in,O
Sentence: 500,2,O
Sentence: 500,patients,O
Sentence: 500,but,O
Sentence: 500,was,O
Sentence: 500,reversible,O
Sentence: 500,.,O
Sentence: 500,There,O
Sentence: 500,were,O
Sentence: 500,no,O
Sentence: 500,drug,O
Sentence: 500,-,O
Sentence: 500,related,O
Sentence: 500,deaths,O
Sentence: 500,.,O
Sentence: 501,Nontraumatic,O
Sentence: 501,dissecting,O
Sentence: 501,aneurysm,O
Sentence: 501,of,O
Sentence: 501,the,O
Sentence: 501,basilar,O
Sentence: 501,artery,O
Sentence: 501,.,O
Sentence: 502,A,O
Sentence: 502,case,O
Sentence: 502,of,O
Sentence: 502,nontraumatic,O
Sentence: 502,dissecting,B-Disease
Sentence: 502,aneurysm,I-Disease
Sentence: 502,of,O
Sentence: 502,the,O
Sentence: 502,basilar,O
Sentence: 502,artery,O
Sentence: 502,in,O
Sentence: 502,association,O
Sentence: 502,with,O
Sentence: 502,hypertension,B-Disease
Sentence: 502,",",O
Sentence: 502,smoke,O
Sentence: 502,",",O
Sentence: 502,and,O
Sentence: 502,oral,B-Chemical
Sentence: 502,contraceptives,I-Chemical
Sentence: 502,is,O
Sentence: 502,reported,O
Sentence: 502,in,O
Sentence: 502,a,O
Sentence: 502,young,O
Sentence: 502,female,O
Sentence: 502,patient,O
Sentence: 502,with,O
Sentence: 502,a,O
Sentence: 502,locked,O
Sentence: 502,-,O
Sentence: 502,in,O
Sentence: 502,syndrome,O
Sentence: 502,.,O
Sentence: 503,Propylthiouracil,B-Chemical
Sentence: 503,-,O
Sentence: 503,induced,O
Sentence: 503,hepatic,B-Disease
Sentence: 503,damage,I-Disease
Sentence: 503,.,O
Sentence: 504,Two,O
Sentence: 504,cases,O
Sentence: 504,of,O
Sentence: 504,propylthiouracil,B-Chemical
Sentence: 504,-,O
Sentence: 504,induced,O
Sentence: 504,liver,B-Disease
Sentence: 504,damage,I-Disease
Sentence: 504,have,O
Sentence: 504,been,O
Sentence: 504,observed,O
Sentence: 504,.,O
Sentence: 504,The,O
Sentence: 504,first,O
Sentence: 504,case,O
Sentence: 504,is,O
Sentence: 504,of,O
Sentence: 504,an,O
Sentence: 504,acute,O
Sentence: 504,type,O
Sentence: 504,of,O
Sentence: 504,damage,O
Sentence: 504,",",O
Sentence: 504,proven,O
Sentence: 504,by,O
Sentence: 504,rechallenge,O
Sentence: 504,;,O
Sentence: 504,the,O
Sentence: 504,second,O
Sentence: 504,presents,O
Sentence: 504,a,O
Sentence: 504,clinical,O
Sentence: 504,and,O
Sentence: 504,histologic,O
Sentence: 504,picture,O
Sentence: 504,resembling,O
Sentence: 504,chronic,B-Disease
Sentence: 504,active,I-Disease
Sentence: 504,hepatitis,I-Disease
Sentence: 504,",",O
Sentence: 504,with,O
Sentence: 504,spontaneous,O
Sentence: 504,remission,O
Sentence: 504,.,O
Sentence: 505,Studies,O
Sentence: 505,on,O
Sentence: 505,the,O
Sentence: 505,bradycardia,B-Disease
Sentence: 505,induced,O
Sentence: 505,by,O
Sentence: 505,bepridil,B-Chemical
Sentence: 505,.,O
Sentence: 506,Bepridil,B-Chemical
Sentence: 506,",",O
Sentence: 506,a,O
Sentence: 506,novel,O
Sentence: 506,active,O
Sentence: 506,compound,O
Sentence: 506,for,O
Sentence: 506,prophylactic,O
Sentence: 506,treatment,O
Sentence: 506,of,O
Sentence: 506,anginal,B-Disease
Sentence: 506,attacks,I-Disease
Sentence: 506,",",O
Sentence: 506,induced,O
Sentence: 506,persistent,O
Sentence: 506,bradycardia,B-Disease
Sentence: 506,and,O
Sentence: 506,a,O
Sentence: 506,non,O
Sentence: 506,-,O
Sentence: 506,specific,O
Sentence: 506,anti,O
Sentence: 506,-,O
Sentence: 506,tachycardial,B-Disease
Sentence: 506,effect,O
Sentence: 506,",",O
Sentence: 506,the,O
Sentence: 506,mechanisms,O
Sentence: 506,of,O
Sentence: 506,which,O
Sentence: 506,were,O
Sentence: 506,investigated,O
Sentence: 506,in,O
Sentence: 506,vitro,O
Sentence: 506,and,O
Sentence: 506,in,O
Sentence: 506,vivo,O
Sentence: 506,.,O
Sentence: 506,In,O
Sentence: 506,vitro,O
Sentence: 506,perfusion,O
Sentence: 506,of,O
Sentence: 506,bepridil,B-Chemical
Sentence: 506,in,O
Sentence: 506,the,O
Sentence: 506,life,O
Sentence: 506,-,O
Sentence: 506,support,O
Sentence: 506,medium,O
Sentence: 506,for,O
Sentence: 506,isolated,O
Sentence: 506,sino,O
Sentence: 506,-,O
Sentence: 506,atrial,O
Sentence: 506,tissue,O
Sentence: 506,from,O
Sentence: 506,rabbit,O
Sentence: 506,heart,O
Sentence: 506,",",O
Sentence: 506,caused,O
Sentence: 506,a,O
Sentence: 506,reduction,O
Sentence: 506,in,O
Sentence: 506,action,O
Sentence: 506,potential,O
Sentence: 506,(,O
Sentence: 506,AP,O
Sentence: 506,),O
Sentence: 506,spike,O
Sentence: 506,frequency,O
Sentence: 506,(,O
Sentence: 506,recorded,O
Sentence: 506,by,O
Sentence: 506,KCl,B-Chemical
Sentence: 506,microelectrodes,O
Sentence: 506,),O
Sentence: 506,starting,O
Sentence: 506,at,O
Sentence: 506,doses,O
Sentence: 506,of,O
Sentence: 506,5,O
Sentence: 506,X,O
Sentence: 506,10,O
Sentence: 506,(,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,6,O
Sentence: 506,),O
Sentence: 506,M.,O
Sentence: 506,This,O
Sentence: 506,effect,O
Sentence: 506,was,O
Sentence: 506,dose,O
Sentence: 506,-,O
Sentence: 506,dependent,O
Sentence: 506,up,O
Sentence: 506,to,O
Sentence: 506,concentrations,O
Sentence: 506,of,O
Sentence: 506,5,O
Sentence: 506,X,O
Sentence: 506,10,O
Sentence: 506,(,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,5,O
Sentence: 506,),O
Sentence: 506,M,O
Sentence: 506,",",O
Sentence: 506,whereupon,O
Sentence: 506,blockade,O
Sentence: 506,of,O
Sentence: 506,sinus,O
Sentence: 506,activity,O
Sentence: 506,set,O
Sentence: 506,in,O
Sentence: 506,.,O
Sentence: 506,Bepridil,B-Chemical
Sentence: 506,at,O
Sentence: 506,a,O
Sentence: 506,dose,O
Sentence: 506,of,O
Sentence: 506,5,O
Sentence: 506,X,O
Sentence: 506,10,O
Sentence: 506,(,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,6,O
Sentence: 506,),O
Sentence: 506,M,O
Sentence: 506,",",O
Sentence: 506,induced,O
Sentence: 506,a,O
Sentence: 506,concomitant,O
Sentence: 506,reduction,O
Sentence: 506,in,O
Sentence: 506,AP,O
Sentence: 506,amplitude,O
Sentence: 506,(,O
Sentence: 506,falling,O
Sentence: 506,from,O
Sentence: 506,71,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,8,O
Sentence: 506,mV,O
Sentence: 506,to,O
Sentence: 506,47,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,6,O
Sentence: 506,mV,O
Sentence: 506,),O
Sentence: 506,",",O
Sentence: 506,maximum,O
Sentence: 506,systolic,O
Sentence: 506,depolarization,O
Sentence: 506,velocity,O
Sentence: 506,(,O
Sentence: 506,phase,O
Sentence: 506,0,O
Sentence: 506,),O
Sentence: 506,which,O
Sentence: 506,fell,O
Sentence: 506,from,O
Sentence: 506,1.85,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,0.35,O
Sentence: 506,V,O
Sentence: 506,/,O
Sentence: 506,s,O
Sentence: 506,to,O
Sentence: 506,0.84,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,0.28,O
Sentence: 506,V,O
Sentence: 506,/,O
Sentence: 506,s,O
Sentence: 506,",",O
Sentence: 506,together,O
Sentence: 506,with,O
Sentence: 506,maximum,O
Sentence: 506,diastolic,O
Sentence: 506,depolarization,O
Sentence: 506,velocity,O
Sentence: 506,(,O
Sentence: 506,phase,O
Sentence: 506,4,O
Sentence: 506,),O
Sentence: 506,which,O
Sentence: 506,fell,O
Sentence: 506,from,O
Sentence: 506,38,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,3,O
Sentence: 506,mV,O
Sentence: 506,/,O
Sentence: 506,s,O
Sentence: 506,to,O
Sentence: 506,24,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,5,O
Sentence: 506,mV,O
Sentence: 506,/,O
Sentence: 506,s,O
Sentence: 506,.,O
Sentence: 506,In,O
Sentence: 506,vivo,O
Sentence: 506,injection,O
Sentence: 506,of,O
Sentence: 506,bepridil,B-Chemical
Sentence: 506,at,O
Sentence: 506,a,O
Sentence: 506,dose,O
Sentence: 506,of,O
Sentence: 506,5,O
Sentence: 506,mg,O
Sentence: 506,/,O
Sentence: 506,kg,O
Sentence: 506,(,O
Sentence: 506,i.v,O
Sentence: 506,.,O
Sentence: 506,),O
Sentence: 506,into,O
Sentence: 506,6,O
Sentence: 506,anaesthetized,O
Sentence: 506,dogs,O
Sentence: 506,which,O
Sentence: 506,had,O
Sentence: 506,undergone,O
Sentence: 506,ablation,O
Sentence: 506,of,O
Sentence: 506,all,O
Sentence: 506,the,O
Sentence: 506,extrinsic,O
Sentence: 506,cardiac,O
Sentence: 506,afferent,O
Sentence: 506,nerve,O
Sentence: 506,supply,O
Sentence: 506,",",O
Sentence: 506,together,O
Sentence: 506,with,O
Sentence: 506,a,O
Sentence: 506,bilateral,O
Sentence: 506,medullo,O
Sentence: 506,-,O
Sentence: 506,adrenalectomy,O
Sentence: 506,",",O
Sentence: 506,caused,O
Sentence: 506,a,O
Sentence: 506,marked,O
Sentence: 506,reduction,O
Sentence: 506,in,O
Sentence: 506,heart,O
Sentence: 506,rate,O
Sentence: 506,which,O
Sentence: 506,fell,O
Sentence: 506,from,O
Sentence: 506,98.7,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,4.2,O
Sentence: 506,beats,O
Sentence: 506,/,O
Sentence: 506,min,O
Sentence: 506,to,O
Sentence: 506,76,O
Sentence: 506,+,O
Sentence: 506,/,O
Sentence: 506,,O
Sentence: 506,-,O
Sentence: 506,,O
Sentence: 506,5.3,O
Sentence: 506,beats,O
Sentence: 506,/,O
Sentence: 506,min,O
Sentence: 506,sustained,O
Sentence: 506,for,O
Sentence: 506,more,O
Sentence: 506,than,O
Sentence: 506,45,O
Sentence: 506,min,O
Sentence: 506,.,O
Sentence: 506,It,O
Sentence: 506,is,O
Sentence: 506,concluded,O
Sentence: 506,that,O
Sentence: 506,bepridil,B-Chemical
Sentence: 506,reduces,O
Sentence: 506,heart,O
Sentence: 506,rate,O
Sentence: 506,by,O
Sentence: 506,acting,O
Sentence: 506,directly,O
Sentence: 506,on,O
Sentence: 506,the,O
Sentence: 506,sinus,O
Sentence: 506,node,O
Sentence: 506,.,O
Sentence: 506,This,O
Sentence: 506,effect,O
Sentence: 506,",",O
Sentence: 506,which,O
Sentence: 506,results,O
Sentence: 506,in,O
Sentence: 506,a,O
Sentence: 506,flattening,O
Sentence: 506,of,O
Sentence: 506,the,O
Sentence: 506,phase,O
Sentence: 506,0,O
Sentence: 506,and,O
Sentence: 506,phase,O
Sentence: 506,4,O
Sentence: 506,slope,O
Sentence: 506,",",O
Sentence: 506,together,O
Sentence: 506,with,O
Sentence: 506,a,O
Sentence: 506,longer,O
Sentence: 506,AP,O
Sentence: 506,duration,O
Sentence: 506,",",O
Sentence: 506,may,O
Sentence: 506,be,O
Sentence: 506,due,O
Sentence: 506,to,O
Sentence: 506,an,O
Sentence: 506,increase,O
Sentence: 506,in,O
Sentence: 506,the,O
Sentence: 506,time,O
Sentence: 506,constants,O
Sentence: 506,of,O
Sentence: 506,slow,O
Sentence: 506,inward,O
Sentence: 506,ionic,O
Sentence: 506,currents,O
Sentence: 506,(,O
Sentence: 506,already,O
Sentence: 506,demonstrated,O
Sentence: 506,elsewhere,O
Sentence: 506,),O
Sentence: 506,",",O
Sentence: 506,but,O
Sentence: 506,also,O
Sentence: 506,to,O
Sentence: 506,an,O
Sentence: 506,increased,O
Sentence: 506,time,O
Sentence: 506,constant,O
Sentence: 506,for,O
Sentence: 506,deactivation,O
Sentence: 506,of,O
Sentence: 506,the,O
Sentence: 506,outward,O
Sentence: 506,potassium,B-Chemical
Sentence: 506,current,O
Sentence: 506,(,O
Sentence: 506,Ip,O
Sentence: 506,),O
Sentence: 506,.,O
Sentence: 507,Hepatitis,B-Disease
Sentence: 507,and,O
Sentence: 507,renal,B-Disease
Sentence: 507,tubular,I-Disease
Sentence: 507,acidosis,I-Disease
Sentence: 507,after,O
Sentence: 507,anesthesia,O
Sentence: 507,with,O
Sentence: 507,methoxyflurane,B-Chemical
Sentence: 507,.,O
Sentence: 508,A,O
Sentence: 508,69,O
Sentence: 508,-,O
Sentence: 508,year,O
Sentence: 508,-,O
Sentence: 508,old,O
Sentence: 508,man,O
Sentence: 508,operated,O
Sentence: 508,for,O
Sentence: 508,acute,B-Disease
Sentence: 508,cholecystitis,I-Disease
Sentence: 508,under,O
Sentence: 508,methoxyflurane,B-Chemical
Sentence: 508,anesthesia,O
Sentence: 508,developed,O
Sentence: 508,postoperatively,O
Sentence: 508,a,O
Sentence: 508,hepatic,B-Disease
Sentence: 508,insufficiency,I-Disease
Sentence: 508,syndrome,I-Disease
Sentence: 508,and,O
Sentence: 508,renal,B-Disease
Sentence: 508,tubular,I-Disease
Sentence: 508,acidosis,I-Disease
Sentence: 508,.,O
Sentence: 508,Massive,O
Sentence: 508,bleeding,B-Disease
Sentence: 508,appeared,O
Sentence: 508,during,O
Sentence: 508,surgery,O
Sentence: 508,which,O
Sentence: 508,lasted,O
Sentence: 508,for,O
Sentence: 508,six,O
Sentence: 508,hours,O
Sentence: 508,.,O
Sentence: 508,Postoperative,O
Sentence: 508,evolution,O
Sentence: 508,under,O
Sentence: 508,supportive,O
Sentence: 508,therapy,O
Sentence: 508,was,O
Sentence: 508,favourable,O
Sentence: 508,.,O
Sentence: 508,Complete,O
Sentence: 508,recovery,O
Sentence: 508,was,O
Sentence: 508,confirmed,O
Sentence: 508,by,O
Sentence: 508,repeated,O
Sentence: 508,controls,O
Sentence: 508,performed,O
Sentence: 508,over,O
Sentence: 508,a,O
Sentence: 508,period,O
Sentence: 508,of,O
Sentence: 508,one,O
Sentence: 508,year,O
Sentence: 508,after,O
Sentence: 508,surgery,O
Sentence: 508,.,O
Sentence: 509,Pituitary,O
Sentence: 509,response,O
Sentence: 509,to,O
Sentence: 509,luteinizing,O
Sentence: 509,hormone,O
Sentence: 509,-,O
Sentence: 509,releasing,O
Sentence: 509,hormone,O
Sentence: 509,during,O
Sentence: 509,haloperidol,B-Chemical
Sentence: 509,-,O
Sentence: 509,induced,O
Sentence: 509,hyperprolactinemia,B-Disease
Sentence: 509,.,O
Sentence: 510,The,O
Sentence: 510,effects,O
Sentence: 510,of,O
Sentence: 510,a,O
Sentence: 510,6,O
Sentence: 510,-,O
Sentence: 510,hour,O
Sentence: 510,infusion,O
Sentence: 510,with,O
Sentence: 510,haloperidol,B-Chemical
Sentence: 510,on,O
Sentence: 510,serum,O
Sentence: 510,prolactin,O
Sentence: 510,and,O
Sentence: 510,luteinizing,O
Sentence: 510,hormone,O
Sentence: 510,(,O
Sentence: 510,LH,O
Sentence: 510,),O
Sentence: 510,levels,O
Sentence: 510,was,O
Sentence: 510,studied,O
Sentence: 510,in,O
Sentence: 510,a,O
Sentence: 510,group,O
Sentence: 510,of,O
Sentence: 510,male,O
Sentence: 510,subjects,O
Sentence: 510,.,O
Sentence: 510,Five,O
Sentence: 510,hours,O
Sentence: 510,after,O
Sentence: 510,starting,O
Sentence: 510,the,O
Sentence: 510,infusions,O
Sentence: 510,",",O
Sentence: 510,a,O
Sentence: 510,study,O
Sentence: 510,of,O
Sentence: 510,the,O
Sentence: 510,pituitary,O
Sentence: 510,responses,O
Sentence: 510,to,O
Sentence: 510,LH,O
Sentence: 510,-,O
Sentence: 510,releasing,O
Sentence: 510,hormone,O
Sentence: 510,(,O
Sentence: 510,LH,O
Sentence: 510,-,O
Sentence: 510,RH,O
Sentence: 510,),O
Sentence: 510,was,O
Sentence: 510,carried,O
Sentence: 510,out,O
Sentence: 510,.,O
Sentence: 510,Control,O
Sentence: 510,patients,O
Sentence: 510,received,O
Sentence: 510,infusions,O
Sentence: 510,of,O
Sentence: 510,0.9,O
Sentence: 510,%,O
Sentence: 510,NaCl,B-Chemical
Sentence: 510,solution,O
Sentence: 510,.,O
Sentence: 510,During,O
Sentence: 510,the,O
Sentence: 510,course,O
Sentence: 510,of,O
Sentence: 510,haloperidol,B-Chemical
Sentence: 510,infusions,O
Sentence: 510,",",O
Sentence: 510,significant,O
Sentence: 510,hyperprolactinemia,B-Disease
Sentence: 510,was,O
Sentence: 510,found,O
Sentence: 510,",",O
Sentence: 510,together,O
Sentence: 510,with,O
Sentence: 510,an,O
Sentence: 510,abolished,O
Sentence: 510,pituitary,O
Sentence: 510,response,O
Sentence: 510,to,O
Sentence: 510,LH,O
Sentence: 510,-,O
Sentence: 510,RH,O
Sentence: 510,",",O
Sentence: 510,as,O
Sentence: 510,compared,O
Sentence: 510,with,O
Sentence: 510,responses,O
Sentence: 510,of,O
Sentence: 510,control,O
Sentence: 510,subjects,O
Sentence: 510,.,O
Sentence: 511,Antirifampicin,O
Sentence: 511,antibodies,O
Sentence: 511,in,O
Sentence: 511,acute,O
Sentence: 511,rifampicin,B-Chemical
Sentence: 511,-,O
Sentence: 511,associated,O
Sentence: 511,renal,B-Disease
Sentence: 511,failure,I-Disease
Sentence: 511,.,O
Sentence: 512,5,O
Sentence: 512,patients,O
Sentence: 512,with,O
Sentence: 512,acute,B-Disease
Sentence: 512,renal,I-Disease
Sentence: 512,failure,I-Disease
Sentence: 512,(,O
Sentence: 512,3,O
Sentence: 512,with,O
Sentence: 512,thrombopenia,B-Disease
Sentence: 512,and,O
Sentence: 512,hemolysis,B-Disease
Sentence: 512,),O
Sentence: 512,induced,O
Sentence: 512,by,O
Sentence: 512,the,O
Sentence: 512,reintroduction,O
Sentence: 512,of,O
Sentence: 512,rifampicin,B-Chemical
Sentence: 512,are,O
Sentence: 512,described,O
Sentence: 512,.,O
Sentence: 512,No,O
Sentence: 512,correlation,O
Sentence: 512,was,O
Sentence: 512,found,O
Sentence: 512,between,O
Sentence: 512,the,O
Sentence: 512,severity,O
Sentence: 512,of,O
Sentence: 512,clinical,O
Sentence: 512,manifestations,O
Sentence: 512,and,O
Sentence: 512,the,O
Sentence: 512,total,O
Sentence: 512,dose,O
Sentence: 512,taken,O
Sentence: 512,by,O
Sentence: 512,the,O
Sentence: 512,patients,O
Sentence: 512,.,O
Sentence: 512,In,O
Sentence: 512,all,O
Sentence: 512,but,O
Sentence: 512,1,O
Sentence: 512,patient,O
Sentence: 512,",",O
Sentence: 512,antirifampicin,O
Sentence: 512,antibodies,O
Sentence: 512,were,O
Sentence: 512,detected,O
Sentence: 512,.,O
Sentence: 512,Antibodies,O
Sentence: 512,suggested,O
Sentence: 512,to,O
Sentence: 512,be,O
Sentence: 512,of,O
Sentence: 512,the,O
Sentence: 512,IgM,O
Sentence: 512,class,O
Sentence: 512,were,O
Sentence: 512,detected,O
Sentence: 512,in,O
Sentence: 512,all,O
Sentence: 512,3,O
Sentence: 512,patients,O
Sentence: 512,with,O
Sentence: 512,hematological,B-Disease
Sentence: 512,disorders,I-Disease
Sentence: 512,.,O
Sentence: 512,The,O
Sentence: 512,pattern,O
Sentence: 512,of,O
Sentence: 512,non,O
Sentence: 512,-,O
Sentence: 512,specific,O
Sentence: 512,acute,B-Disease
Sentence: 512,tubular,I-Disease
Sentence: 512,necrosis,I-Disease
Sentence: 512,found,O
Sentence: 512,in,O
Sentence: 512,the,O
Sentence: 512,2,O
Sentence: 512,biopsied,O
Sentence: 512,patients,O
Sentence: 512,",",O
Sentence: 512,indistinguishable,O
Sentence: 512,from,O
Sentence: 512,that,O
Sentence: 512,of,O
Sentence: 512,ischemic,O
Sentence: 512,origin,O
Sentence: 512,",",O
Sentence: 512,raised,O
Sentence: 512,the,O
Sentence: 512,possibility,O
Sentence: 512,of,O
Sentence: 512,a,O
Sentence: 512,vascular,O
Sentence: 512,-,O
Sentence: 512,mediated,O
Sentence: 512,damage,O
Sentence: 512,.,O
Sentence: 512,In,O
Sentence: 512,3,O
Sentence: 512,patients,O
Sentence: 512,",",O
Sentence: 512,the,O
Sentence: 512,possibility,O
Sentence: 512,of,O
Sentence: 512,a,O
Sentence: 512,triggering,O
Sentence: 512,immunoallergic,O
Sentence: 512,mechanism,O
Sentence: 512,is,O
Sentence: 512,discussed,O
Sentence: 512,.,O
Sentence: 513,Cardiovascular,O
Sentence: 513,effects,O
Sentence: 513,of,O
Sentence: 513,hypotension,B-Disease
Sentence: 513,induced,O
Sentence: 513,by,O
Sentence: 513,adenosine,B-Chemical
Sentence: 513,triphosphate,I-Chemical
Sentence: 513,and,O
Sentence: 513,sodium,B-Chemical
Sentence: 513,nitroprusside,I-Chemical
Sentence: 513,on,O
Sentence: 513,dogs,O
Sentence: 513,with,O
Sentence: 513,denervated,O
Sentence: 513,hearts,O
Sentence: 513,.,O
Sentence: 514,Adenosine,B-Chemical
Sentence: 514,triphosphate,I-Chemical
Sentence: 514,(,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,),O
Sentence: 514,and,O
Sentence: 514,sodium,B-Chemical
Sentence: 514,nitroprusside,I-Chemical
Sentence: 514,(,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,),O
Sentence: 514,are,O
Sentence: 514,administered,O
Sentence: 514,to,O
Sentence: 514,patients,O
Sentence: 514,to,O
Sentence: 514,induce,O
Sentence: 514,and,O
Sentence: 514,control,O
Sentence: 514,hypotension,B-Disease
Sentence: 514,during,O
Sentence: 514,anesthesia,O
Sentence: 514,.,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,is,O
Sentence: 514,authorized,O
Sentence: 514,for,O
Sentence: 514,clinical,O
Sentence: 514,use,O
Sentence: 514,in,O
Sentence: 514,USA,O
Sentence: 514,and,O
Sentence: 514,UK,O
Sentence: 514,",",O
Sentence: 514,and,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,is,O
Sentence: 514,clinically,O
Sentence: 514,used,O
Sentence: 514,in,O
Sentence: 514,other,O
Sentence: 514,countries,O
Sentence: 514,such,O
Sentence: 514,as,O
Sentence: 514,Japan,O
Sentence: 514,.,O
Sentence: 514,We,O
Sentence: 514,investigated,O
Sentence: 514,how,O
Sentence: 514,these,O
Sentence: 514,two,O
Sentence: 514,drugs,O
Sentence: 514,act,O
Sentence: 514,on,O
Sentence: 514,the,O
Sentence: 514,cardiovascular,O
Sentence: 514,systems,O
Sentence: 514,of,O
Sentence: 514,20,O
Sentence: 514,dogs,O
Sentence: 514,whose,O
Sentence: 514,hearts,O
Sentence: 514,had,O
Sentence: 514,been,O
Sentence: 514,denervated,O
Sentence: 514,by,O
Sentence: 514,a,O
Sentence: 514,procedure,O
Sentence: 514,we,O
Sentence: 514,had,O
Sentence: 514,devised,O
Sentence: 514,.,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,(,O
Sentence: 514,10,O
Sentence: 514,dogs,O
Sentence: 514,),O
Sentence: 514,or,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,(,O
Sentence: 514,10,O
Sentence: 514,dogs,O
Sentence: 514,),O
Sentence: 514,was,O
Sentence: 514,administered,O
Sentence: 514,to,O
Sentence: 514,reduce,O
Sentence: 514,mean,O
Sentence: 514,arterial,O
Sentence: 514,pressure,O
Sentence: 514,by,O
Sentence: 514,30,O
Sentence: 514,%,O
Sentence: 514,to,O
Sentence: 514,70,O
Sentence: 514,%,O
Sentence: 514,of,O
Sentence: 514,control,O
Sentence: 514,.,O
Sentence: 514,Before,O
Sentence: 514,",",O
Sentence: 514,during,O
Sentence: 514,and,O
Sentence: 514,after,O
Sentence: 514,induced,O
Sentence: 514,hypotension,B-Disease
Sentence: 514,",",O
Sentence: 514,we,O
Sentence: 514,measured,O
Sentence: 514,major,O
Sentence: 514,cardiovascular,O
Sentence: 514,parameters,O
Sentence: 514,.,O
Sentence: 514,Hypotension,B-Disease
Sentence: 514,induced,O
Sentence: 514,by,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,was,O
Sentence: 514,accompanied,O
Sentence: 514,by,O
Sentence: 514,significant,O
Sentence: 514,decreases,O
Sentence: 514,in,O
Sentence: 514,mean,O
Sentence: 514,pulmonary,O
Sentence: 514,arterial,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,central,O
Sentence: 514,venous,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,left,O
Sentence: 514,ventricular,O
Sentence: 514,end,O
Sentence: 514,-,O
Sentence: 514,diastolic,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,total,O
Sentence: 514,peripheral,O
Sentence: 514,resistance,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,rate,O
Sentence: 514,pressure,O
Sentence: 514,product,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,total,O
Sentence: 514,body,O
Sentence: 514,oxygen,B-Chemical
Sentence: 514,consumption,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.05,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,and,O
Sentence: 514,heart,O
Sentence: 514,rate,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,;,O
Sentence: 514,all,O
Sentence: 514,these,O
Sentence: 514,variables,O
Sentence: 514,returned,O
Sentence: 514,normal,O
Sentence: 514,within,O
Sentence: 514,30,O
Sentence: 514,min,O
Sentence: 514,after,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,was,O
Sentence: 514,stopped,O
Sentence: 514,.,O
Sentence: 514,Cardiac,O
Sentence: 514,output,O
Sentence: 514,did,O
Sentence: 514,not,O
Sentence: 514,change,O
Sentence: 514,.,O
Sentence: 514,During,O
Sentence: 514,hypotension,B-Disease
Sentence: 514,produced,O
Sentence: 514,by,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,similar,O
Sentence: 514,decreases,O
Sentence: 514,were,O
Sentence: 514,observed,O
Sentence: 514,in,O
Sentence: 514,mean,O
Sentence: 514,pulmonary,O
Sentence: 514,arterial,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.01,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,central,O
Sentence: 514,venous,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,left,O
Sentence: 514,ventricular,O
Sentence: 514,end,O
Sentence: 514,-,O
Sentence: 514,diastolic,O
Sentence: 514,pressure,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.01,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,total,O
Sentence: 514,peripheral,O
Sentence: 514,resistance,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,rate,O
Sentence: 514,pressure,O
Sentence: 514,product,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,and,O
Sentence: 514,oxygen,B-Chemical
Sentence: 514,content,O
Sentence: 514,difference,O
Sentence: 514,between,O
Sentence: 514,arterial,O
Sentence: 514,and,O
Sentence: 514,mixed,O
Sentence: 514,venous,O
Sentence: 514,blood,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.05,O
Sentence: 514,),O
Sentence: 514,",",O
Sentence: 514,while,O
Sentence: 514,heart,O
Sentence: 514,rate,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.001,O
Sentence: 514,),O
Sentence: 514,and,O
Sentence: 514,cardiac,O
Sentence: 514,output,O
Sentence: 514,(,O
Sentence: 514,p,O
Sentence: 514,less,O
Sentence: 514,than,O
Sentence: 514,0.05,O
Sentence: 514,),O
Sentence: 514,were,O
Sentence: 514,increased,O
Sentence: 514,.,O
Sentence: 514,Recoveries,O
Sentence: 514,of,O
Sentence: 514,heart,O
Sentence: 514,rate,O
Sentence: 514,and,O
Sentence: 514,left,O
Sentence: 514,ventricular,O
Sentence: 514,end,O
Sentence: 514,-,O
Sentence: 514,diastolic,O
Sentence: 514,pressure,O
Sentence: 514,were,O
Sentence: 514,not,O
Sentence: 514,shown,O
Sentence: 514,within,O
Sentence: 514,60,O
Sentence: 514,min,O
Sentence: 514,after,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,had,O
Sentence: 514,been,O
Sentence: 514,stopped,O
Sentence: 514,.,O
Sentence: 514,Both,O
Sentence: 514,ATP,B-Chemical
Sentence: 514,and,O
Sentence: 514,SNP,B-Chemical
Sentence: 514,should,O
Sentence: 514,act,O
Sentence: 514,on,O
Sentence: 514,the,O
Sentence: 514,pacemaker,O
Sentence: 514,tissue,O
Sentence: 514,of,O
Sentence: 514,the,O
Sentence: 514,heart,O
Sentence: 514,.,O
Sentence: 515,Comparative,O
Sentence: 515,study,O
Sentence: 515,:,O
Sentence: 515,Endografine,B-Chemical
Sentence: 515,(,O
Sentence: 515,diatrizoate,B-Chemical
Sentence: 515,),O
Sentence: 515,",",O
Sentence: 515,Vasurix,B-Chemical
Sentence: 515,polyvidone,I-Chemical
Sentence: 515,(,O
Sentence: 515,acetrizoate,B-Chemical
Sentence: 515,),O
Sentence: 515,",",O
Sentence: 515,Dimer,O
Sentence: 515,-,O
Sentence: 515,X,O
Sentence: 515,(,O
Sentence: 515,iocarmate,B-Chemical
Sentence: 515,),O
Sentence: 515,and,O
Sentence: 515,Hexabrix,B-Chemical
Sentence: 515,(,O
Sentence: 515,ioxaglate,B-Chemical
Sentence: 515,),O
Sentence: 515,in,O
Sentence: 515,hysterosalpingography,O
Sentence: 515,.,O
Sentence: 516,Side,O
Sentence: 516,effects,O
Sentence: 516,of,O
Sentence: 516,hysterosalpingography,O
Sentence: 516,with,O
Sentence: 516,Dimer,O
Sentence: 516,-,O
Sentence: 516,X,O
Sentence: 516,",",O
Sentence: 516,Hexabrix,B-Chemical
Sentence: 516,",",O
Sentence: 516,Vasurix,B-Chemical
Sentence: 516,polyvidone,I-Chemical
Sentence: 516,and,O
Sentence: 516,Endografine,B-Chemical
Sentence: 516,in,O
Sentence: 516,142,O
Sentence: 516,consecutive,O
Sentence: 516,patients,O
Sentence: 516,",",O
Sentence: 516,receiving,O
Sentence: 516,one,O
Sentence: 516,of,O
Sentence: 516,the,O
Sentence: 516,four,O
Sentence: 516,tested,O
Sentence: 516,media,O
Sentence: 516,were,O
Sentence: 516,evaluated,O
Sentence: 516,from,O
Sentence: 516,replies,O
Sentence: 516,to,O
Sentence: 516,postal,O
Sentence: 516,questionnaires,O
Sentence: 516,.,O
Sentence: 516,The,O
Sentence: 516,Dimer,O
Sentence: 516,-,O
Sentence: 516,X,O
Sentence: 516,group,O
Sentence: 516,had,O
Sentence: 516,a,O
Sentence: 516,higher,O
Sentence: 516,incidence,O
Sentence: 516,of,O
Sentence: 516,nausea,B-Disease
Sentence: 516,and,O
Sentence: 516,dizziness,B-Disease
Sentence: 516,.,O
Sentence: 516,The,O
Sentence: 516,Endografine,B-Chemical
Sentence: 516,group,O
Sentence: 516,had,O
Sentence: 516,a,O
Sentence: 516,higher,O
Sentence: 516,incidence,O
Sentence: 516,of,O
Sentence: 516,abdominal,B-Disease
Sentence: 516,pain,I-Disease
Sentence: 516,.,O
Sentence: 516,These,O
Sentence: 516,differences,O
Sentence: 516,occur,O
Sentence: 516,especially,O
Sentence: 516,in,O
Sentence: 516,the,O
Sentence: 516,age,O
Sentence: 516,groups,O
Sentence: 516,under,O
Sentence: 516,30,O
Sentence: 516,years,O
Sentence: 516,.,O
Sentence: 516,Hexabrix,B-Chemical
Sentence: 516,and,O
Sentence: 516,Vasurix,B-Chemical
Sentence: 516,polyvidone,I-Chemical
Sentence: 516,are,O
Sentence: 516,considered,O
Sentence: 516,the,O
Sentence: 516,best,O
Sentence: 516,contrast,B-Chemical
Sentence: 516,media,I-Chemical
Sentence: 516,for,O
Sentence: 516,hysterosalpingography,O
Sentence: 516,and,O
Sentence: 516,perhaps,O
Sentence: 516,because,O
Sentence: 516,of,O
Sentence: 516,its,O
Sentence: 516,low,O
Sentence: 516,toxicity,B-Disease
Sentence: 516,Hexabrix,B-Chemical
Sentence: 516,should,O
Sentence: 516,be,O
Sentence: 516,preferred,O
Sentence: 516,.,O
Sentence: 517,Post,O
Sentence: 517,-,O
Sentence: 517,suxamethonium,B-Chemical
Sentence: 517,pains,B-Disease
Sentence: 517,in,O
Sentence: 517,Nigerian,O
Sentence: 517,surgical,O
Sentence: 517,patients,O
Sentence: 517,.,O
Sentence: 518,Contrary,O
Sentence: 518,to,O
Sentence: 518,an,O
Sentence: 518,earlier,O
Sentence: 518,report,O
Sentence: 518,by,O
Sentence: 518,Coxon,O
Sentence: 518,",",O
Sentence: 518,scoline,B-Chemical
Sentence: 518,pain,B-Disease
Sentence: 518,occurs,O
Sentence: 518,in,O
Sentence: 518,African,O
Sentence: 518,negroes,O
Sentence: 518,.,O
Sentence: 518,Its,O
Sentence: 518,incidence,O
Sentence: 518,was,O
Sentence: 518,determined,O
Sentence: 518,in,O
Sentence: 518,a,O
Sentence: 518,prospective,O
Sentence: 518,study,O
Sentence: 518,involving,O
Sentence: 518,a,O
Sentence: 518,total,O
Sentence: 518,of,O
Sentence: 518,100,O
Sentence: 518,Nigerian,O
Sentence: 518,patients,O
Sentence: 518,(,O
Sentence: 518,50,O
Sentence: 518,out,O
Sentence: 518,-,O
Sentence: 518,patients,O
Sentence: 518,and,O
Sentence: 518,50,O
Sentence: 518,in,O
Sentence: 518,-,O
Sentence: 518,patients,O
Sentence: 518,),O
Sentence: 518,.,O
Sentence: 518,About,O
Sentence: 518,62,O
Sentence: 518,%,O
Sentence: 518,of,O
Sentence: 518,the,O
Sentence: 518,out,O
Sentence: 518,-,O
Sentence: 518,patients,O
Sentence: 518,developed,O
Sentence: 518,scoline,B-Chemical
Sentence: 518,pain,B-Disease
Sentence: 518,as,O
Sentence: 518,compared,O
Sentence: 518,with,O
Sentence: 518,about,O
Sentence: 518,26,O
Sentence: 518,%,O
Sentence: 518,among,O
Sentence: 518,the,O
Sentence: 518,in,O
Sentence: 518,-,O
Sentence: 518,patients,O
Sentence: 518,.,O
Sentence: 518,The,O
Sentence: 518,abolition,O
Sentence: 518,of,O
Sentence: 518,muscle,O
Sentence: 518,fasciculations,B-Disease
Sentence: 518,(,O
Sentence: 518,by,O
Sentence: 518,0.075mg,O
Sentence: 518,/,O
Sentence: 518,kg,O
Sentence: 518,dose,O
Sentence: 518,of,O
Sentence: 518,Fazadinium,B-Chemical
Sentence: 518,),O
Sentence: 518,did,O
Sentence: 518,not,O
Sentence: 518,influence,O
Sentence: 518,the,O
Sentence: 518,occurrence,O
Sentence: 518,of,O
Sentence: 518,scoline,B-Chemical
Sentence: 518,pain,B-Disease
Sentence: 518,.,O
Sentence: 518,Neither,O
Sentence: 518,the,O
Sentence: 518,type,O
Sentence: 518,of,O
Sentence: 518,induction,O
Sentence: 518,agent,O
Sentence: 518,(,O
Sentence: 518,Althesin,B-Chemical
Sentence: 518,or,O
Sentence: 518,Thiopentone,B-Chemical
Sentence: 518,),O
Sentence: 518,nor,O
Sentence: 518,the,O
Sentence: 518,salt,O
Sentence: 518,preparation,O
Sentence: 518,of,O
Sentence: 518,suxamethonium,B-Chemical
Sentence: 518,used,O
Sentence: 518,(,O
Sentence: 518,chloride,B-Chemical
Sentence: 518,or,O
Sentence: 518,bromide,B-Chemical
Sentence: 518,),O
Sentence: 518,",",O
Sentence: 518,affected,O
Sentence: 518,the,O
Sentence: 518,incidence,O
Sentence: 518,of,O
Sentence: 518,scoline,B-Chemical
Sentence: 518,pain,B-Disease
Sentence: 518,.,O
Sentence: 519,Medial,O
Sentence: 519,changes,O
Sentence: 519,in,O
Sentence: 519,arterial,O
Sentence: 519,spasm,B-Disease
Sentence: 519,induced,O
Sentence: 519,by,O
Sentence: 519,L,O
Sentence: 519,-,O
Sentence: 519,norepinephrine,O
Sentence: 519,.,O
Sentence: 520,In,O
Sentence: 520,normal,O
Sentence: 520,rats,O
Sentence: 520,",",O
Sentence: 520,the,O
Sentence: 520,media,O
Sentence: 520,of,O
Sentence: 520,small,O
Sentence: 520,arteries,O
Sentence: 520,(,O
Sentence: 520,0.4,O
Sentence: 520,,O
Sentence: 520,-,O
Sentence: 520,,O
Sentence: 520,-,O
Sentence: 520,,O
Sentence: 520,0.2,O
Sentence: 520,mm,O
Sentence: 520,in,O
Sentence: 520,diameter,O
Sentence: 520,),O
Sentence: 520,previously,O
Sentence: 520,was,O
Sentence: 520,shown,O
Sentence: 520,to,O
Sentence: 520,contain,O
Sentence: 520,intracellular,O
Sentence: 520,vacuoles,O
Sentence: 520,",",O
Sentence: 520,identified,O
Sentence: 520,ultrastructurally,O
Sentence: 520,as,O
Sentence: 520,herniations,O
Sentence: 520,of,O
Sentence: 520,one,O
Sentence: 520,smooth,O
Sentence: 520,muscle,O
Sentence: 520,cell,O
Sentence: 520,into,O
Sentence: 520,another,O
Sentence: 520,.,O
Sentence: 520,The,O
Sentence: 520,hypothesis,O
Sentence: 520,that,O
Sentence: 520,intense,O
Sentence: 520,vasoconstriction,O
Sentence: 520,would,O
Sentence: 520,increase,O
Sentence: 520,the,O
Sentence: 520,number,O
Sentence: 520,of,O
Sentence: 520,such,O
Sentence: 520,vacuoles,O
Sentence: 520,has,O
Sentence: 520,been,O
Sentence: 520,tested,O
Sentence: 520,.,O
Sentence: 520,In,O
Sentence: 520,the,O
Sentence: 520,media,O
Sentence: 520,of,O
Sentence: 520,the,O
Sentence: 520,saphenous,O
Sentence: 520,artery,O
Sentence: 520,and,O
Sentence: 520,its,O
Sentence: 520,distal,O
Sentence: 520,branch,O
Sentence: 520,",",O
Sentence: 520,vasoconstriction,O
Sentence: 520,induced,O
Sentence: 520,by,O
Sentence: 520,L,O
Sentence: 520,-,O
Sentence: 520,norepinephrine,O
Sentence: 520,produced,O
Sentence: 520,many,O
Sentence: 520,cell,O
Sentence: 520,-,O
Sentence: 520,to,O
Sentence: 520,-,O
Sentence: 520,cell,O
Sentence: 520,hernias,B-Disease
Sentence: 520,within,O
Sentence: 520,15,O
Sentence: 520,minutes,O
Sentence: 520,.,O
Sentence: 520,At,O
Sentence: 520,1,O
Sentence: 520,day,O
Sentence: 520,their,O
Sentence: 520,number,O
Sentence: 520,was,O
Sentence: 520,reduced,O
Sentence: 520,to,O
Sentence: 520,about,O
Sentence: 520,1,O
Sentence: 520,/,O
Sentence: 520,10,O
Sentence: 520,of,O
Sentence: 520,the,O
Sentence: 520,original,O
Sentence: 520,number,O
Sentence: 520,.,O
Sentence: 520,By,O
Sentence: 520,7,O
Sentence: 520,days,O
Sentence: 520,the,O
Sentence: 520,vessel,O
Sentence: 520,was,O
Sentence: 520,almost,O
Sentence: 520,restored,O
Sentence: 520,to,O
Sentence: 520,normal,O
Sentence: 520,.,O
Sentence: 520,Triple,O
Sentence: 520,stimulation,O
Sentence: 520,over,O
Sentence: 520,1,O
Sentence: 520,day,O
Sentence: 520,induced,O
Sentence: 520,more,O
Sentence: 520,severe,O
Sentence: 520,changes,O
Sentence: 520,in,O
Sentence: 520,the,O
Sentence: 520,media,O
Sentence: 520,.,O
Sentence: 520,These,O
Sentence: 520,findings,O
Sentence: 520,suggest,O
Sentence: 520,that,O
Sentence: 520,smooth,O
Sentence: 520,muscle,O
Sentence: 520,cells,O
Sentence: 520,are,O
Sentence: 520,susceptible,O
Sentence: 520,to,O
Sentence: 520,damage,O
Sentence: 520,in,O
Sentence: 520,the,O
Sentence: 520,course,O
Sentence: 520,of,O
Sentence: 520,their,O
Sentence: 520,specific,O
Sentence: 520,function,O
Sentence: 520,.,O
Sentence: 520,The,O
Sentence: 520,experimental,O
Sentence: 520,data,O
Sentence: 520,are,O
Sentence: 520,discussed,O
Sentence: 520,in,O
Sentence: 520,relation,O
Sentence: 520,to,O
Sentence: 520,medial,O
Sentence: 520,changes,O
Sentence: 520,observed,O
Sentence: 520,in,O
Sentence: 520,other,O
Sentence: 520,instances,O
Sentence: 520,of,O
Sentence: 520,arterial,O
Sentence: 520,spasm,B-Disease
Sentence: 520,.,O
Sentence: 520,Endothelial,O
Sentence: 520,changes,O
Sentence: 520,that,O
Sentence: 520,developed,O
Sentence: 520,in,O
Sentence: 520,the,O
Sentence: 520,same,O
Sentence: 520,experimental,O
Sentence: 520,model,O
Sentence: 520,were,O
Sentence: 520,described,O
Sentence: 520,in,O
Sentence: 520,a,O
Sentence: 520,previous,O
Sentence: 520,paper,O
Sentence: 520,.,O
Sentence: 521,Abnormalities,O
Sentence: 521,of,O
Sentence: 521,the,O
Sentence: 521,pupil,O
Sentence: 521,and,O
Sentence: 521,visual,O
Sentence: 521,-,O
Sentence: 521,evoked,O
Sentence: 521,potential,O
Sentence: 521,in,O
Sentence: 521,quinine,B-Chemical
Sentence: 521,amblyopia,B-Disease
Sentence: 521,.,O
Sentence: 522,Total,O
Sentence: 522,blindness,B-Disease
Sentence: 522,with,O
Sentence: 522,a,O
Sentence: 522,transient,O
Sentence: 522,tonic,B-Disease
Sentence: 522,pupillary,I-Disease
Sentence: 522,response,O
Sentence: 522,",",O
Sentence: 522,denervation,O
Sentence: 522,supersensitivity,O
Sentence: 522,",",O
Sentence: 522,and,O
Sentence: 522,abnormal,O
Sentence: 522,visual,O
Sentence: 522,-,O
Sentence: 522,evoked,O
Sentence: 522,potentials,O
Sentence: 522,developed,O
Sentence: 522,in,O
Sentence: 522,a,O
Sentence: 522,54,O
Sentence: 522,-,O
Sentence: 522,year,O
Sentence: 522,-,O
Sentence: 522,old,O
Sentence: 522,man,O
Sentence: 522,after,O
Sentence: 522,the,O
Sentence: 522,use,O
Sentence: 522,of,O
Sentence: 522,quinine,B-Chemical
Sentence: 522,sulfate,I-Chemical
Sentence: 522,for,O
Sentence: 522,leg,B-Disease
Sentence: 522,cramps,I-Disease
Sentence: 522,.,O
Sentence: 522,He,O
Sentence: 522,later,O
Sentence: 522,recovered,O
Sentence: 522,normal,O
Sentence: 522,visual,O
Sentence: 522,acuity,O
Sentence: 522,.,O
Sentence: 522,A,O
Sentence: 522,transient,O
Sentence: 522,tonic,B-Disease
Sentence: 522,pupillary,I-Disease
Sentence: 522,response,O
Sentence: 522,",",O
Sentence: 522,denervation,O
Sentence: 522,supersensitivity,O
Sentence: 522,",",O
Sentence: 522,and,O
Sentence: 522,abnormal,O
Sentence: 522,visual,O
Sentence: 522,-,O
Sentence: 522,evoked,O
Sentence: 522,potentials,O
Sentence: 522,in,O
Sentence: 522,quinine,B-Chemical
Sentence: 522,toxicity,B-Disease
Sentence: 522,",",O
Sentence: 522,to,O
Sentence: 522,our,O
Sentence: 522,knowledge,O
Sentence: 522,",",O
Sentence: 522,have,O
Sentence: 522,not,O
Sentence: 522,been,O
Sentence: 522,previously,O
Sentence: 522,reported,O
Sentence: 522,.,O
Sentence: 523,Suxamethonium,B-Chemical
Sentence: 523,-,O
Sentence: 523,induced,O
Sentence: 523,jaw,B-Disease
Sentence: 523,stiffness,I-Disease
Sentence: 523,and,O
Sentence: 523,myalgia,B-Disease
Sentence: 523,associated,O
Sentence: 523,with,O
Sentence: 523,atypical,O
Sentence: 523,cholinesterase,O
Sentence: 523,:,O
Sentence: 523,case,O
Sentence: 523,report,O
Sentence: 523,.,O
Sentence: 524,An,O
Sentence: 524,11,O
Sentence: 524,-,O
Sentence: 524,year,O
Sentence: 524,-,O
Sentence: 524,old,O
Sentence: 524,boy,O
Sentence: 524,was,O
Sentence: 524,given,O
Sentence: 524,halothane,B-Chemical
Sentence: 524,",",O
Sentence: 524,nitrous,B-Chemical
Sentence: 524,oxide,I-Chemical
Sentence: 524,and,O
Sentence: 524,oxygen,B-Chemical
Sentence: 524,",",O
Sentence: 524,pancuronium,B-Chemical
Sentence: 524,0.4,O
Sentence: 524,mg,O
Sentence: 524,and,O
Sentence: 524,suxamethonium,B-Chemical
Sentence: 524,100,O
Sentence: 524,mg,O
Sentence: 524,for,O
Sentence: 524,induction,O
Sentence: 524,of,O
Sentence: 524,anaesthesia,O
Sentence: 524,.,O
Sentence: 524,In,O
Sentence: 524,response,O
Sentence: 524,to,O
Sentence: 524,this,O
Sentence: 524,a,O
Sentence: 524,marked,O
Sentence: 524,jaw,B-Disease
Sentence: 524,stiffness,I-Disease
Sentence: 524,occurred,O
Sentence: 524,which,O
Sentence: 524,lasted,O
Sentence: 524,for,O
Sentence: 524,two,O
Sentence: 524,minutes,O
Sentence: 524,and,O
Sentence: 524,the,O
Sentence: 524,anaesthesia,O
Sentence: 524,were,O
Sentence: 524,terminated,O
Sentence: 524,.,O
Sentence: 524,Four,O
Sentence: 524,hours,O
Sentence: 524,of,O
Sentence: 524,apnoea,B-Disease
Sentence: 524,ensued,O
Sentence: 524,and,O
Sentence: 524,he,O
Sentence: 524,suffered,O
Sentence: 524,generalized,O
Sentence: 524,severe,O
Sentence: 524,myalgia,B-Disease
Sentence: 524,lasting,O
Sentence: 524,for,O
Sentence: 524,one,O
Sentence: 524,week,O
Sentence: 524,.,O
Sentence: 524,He,O
Sentence: 524,was,O
Sentence: 524,found,O
Sentence: 524,to,O
Sentence: 524,have,O
Sentence: 524,atypical,O
Sentence: 524,plasma,O
Sentence: 524,cholinesterase,O
Sentence: 524,with,O
Sentence: 524,a,O
Sentence: 524,dibucaine,B-Chemical
Sentence: 524,number,O
Sentence: 524,of,O
Sentence: 524,12,O
Sentence: 524,",",O
Sentence: 524,indicating,O
Sentence: 524,homozygocity,O
Sentence: 524,.,O
Sentence: 524,This,O
Sentence: 524,was,O
Sentence: 524,verified,O
Sentence: 524,by,O
Sentence: 524,study,O
Sentence: 524,of,O
Sentence: 524,the,O
Sentence: 524,family,O
Sentence: 524,.,O
Sentence: 524,The,O
Sentence: 524,case,O
Sentence: 524,shows,O
Sentence: 524,that,O
Sentence: 524,prolonged,B-Disease
Sentence: 524,jaw,I-Disease
Sentence: 524,rigidity,I-Disease
Sentence: 524,and,O
Sentence: 524,myalgia,B-Disease
Sentence: 524,may,O
Sentence: 524,occur,O
Sentence: 524,after,O
Sentence: 524,suxamethonium,B-Chemical
Sentence: 524,in,O
Sentence: 524,patients,O
Sentence: 524,with,O
Sentence: 524,atypical,O
Sentence: 524,cholinesterase,O
Sentence: 524,despite,O
Sentence: 524,pretreatment,O
Sentence: 524,with,O
Sentence: 524,pancuronium,B-Chemical
Sentence: 524,.,O
Sentence: 525,Indomethacin,B-Chemical
Sentence: 525,-,O
Sentence: 525,induced,O
Sentence: 525,hyperkalemia,B-Disease
Sentence: 525,in,O
Sentence: 525,three,O
Sentence: 525,patients,O
Sentence: 525,with,O
Sentence: 525,gouty,B-Disease
Sentence: 525,arthritis,I-Disease
Sentence: 525,.,O
Sentence: 526,We,O
Sentence: 526,describe,O
Sentence: 526,three,O
Sentence: 526,patients,O
Sentence: 526,in,O
Sentence: 526,whom,O
Sentence: 526,severe,O
Sentence: 526,",",O
Sentence: 526,life,O
Sentence: 526,-,O
Sentence: 526,threatening,O
Sentence: 526,hyperkalemia,B-Disease
Sentence: 526,and,O
Sentence: 526,renal,B-Disease
Sentence: 526,insufficiency,I-Disease
Sentence: 526,developed,O
Sentence: 526,after,O
Sentence: 526,treatment,O
Sentence: 526,of,O
Sentence: 526,acute,O
Sentence: 526,gouty,B-Disease
Sentence: 526,arthritis,I-Disease
Sentence: 526,with,O
Sentence: 526,indomethacin,B-Chemical
Sentence: 526,.,O
Sentence: 526,This,O
Sentence: 526,complication,O
Sentence: 526,may,O
Sentence: 526,result,O
Sentence: 526,from,O
Sentence: 526,an,O
Sentence: 526,inhibition,O
Sentence: 526,of,O
Sentence: 526,prostaglandin,B-Chemical
Sentence: 526,synthesis,O
Sentence: 526,and,O
Sentence: 526,consequent,O
Sentence: 526,hyporeninemic,B-Disease
Sentence: 526,hypoaidosteronism,I-Disease
Sentence: 526,.,O
Sentence: 526,Careful,O
Sentence: 526,attention,O
Sentence: 526,to,O
Sentence: 526,renal,O
Sentence: 526,function,O
Sentence: 526,and,O
Sentence: 526,potassium,B-Chemical
Sentence: 526,balance,O
Sentence: 526,in,O
Sentence: 526,patients,O
Sentence: 526,receiving,O
Sentence: 526,indomethacin,B-Chemical
Sentence: 526,or,O
Sentence: 526,other,O
Sentence: 526,nonsteroidal,O
Sentence: 526,anti,O
Sentence: 526,-,O
Sentence: 526,inflammatory,O
Sentence: 526,agents,O
Sentence: 526,",",O
Sentence: 526,particularly,O
Sentence: 526,in,O
Sentence: 526,those,O
Sentence: 526,patients,O
Sentence: 526,with,O
Sentence: 526,diabetes,B-Disease
Sentence: 526,mellitus,I-Disease
Sentence: 526,or,O
Sentence: 526,preexisting,O
Sentence: 526,renal,B-Disease
Sentence: 526,disease,I-Disease
Sentence: 526,",",O
Sentence: 526,will,O
Sentence: 526,help,O
Sentence: 526,prevent,O
Sentence: 526,this,O
Sentence: 526,potentially,O
Sentence: 526,serious,O
Sentence: 526,complication,O
Sentence: 526,.,O
Sentence: 527,Etomidate,O
Sentence: 527,:,O
Sentence: 527,a,O
Sentence: 527,foreshortened,O
Sentence: 527,clinical,O
Sentence: 527,trial,O
Sentence: 527,.,O
Sentence: 528,A,O
Sentence: 528,clinical,O
Sentence: 528,evaluation,O
Sentence: 528,of,O
Sentence: 528,etomidate,B-Chemical
Sentence: 528,for,O
Sentence: 528,outpatient,O
Sentence: 528,cystoscopy,O
Sentence: 528,was,O
Sentence: 528,embarked,O
Sentence: 528,upon,O
Sentence: 528,.,O
Sentence: 528,Unpremedicated,O
Sentence: 528,patients,O
Sentence: 528,were,O
Sentence: 528,given,O
Sentence: 528,fentanyl,B-Chemical
Sentence: 528,1,O
Sentence: 528,microgram,O
Sentence: 528,/,O
Sentence: 528,kg,O
Sentence: 528,followed,O
Sentence: 528,by,O
Sentence: 528,etomidate,B-Chemical
Sentence: 528,0.3,O
Sentence: 528,mg,O
Sentence: 528,/,O
Sentence: 528,kg,O
Sentence: 528,.,O
Sentence: 528,Anaesthesia,O
Sentence: 528,was,O
Sentence: 528,maintained,O
Sentence: 528,with,O
Sentence: 528,intermittent,O
Sentence: 528,etomidate,B-Chemical
Sentence: 528,in,O
Sentence: 528,2,O
Sentence: 528,-,O
Sentence: 528,4,O
Sentence: 528,mg,O
Sentence: 528,doses,O
Sentence: 528,.,O
Sentence: 528,Patients,O
Sentence: 528,were,O
Sentence: 528,interviewed,O
Sentence: 528,personally,O
Sentence: 528,later,O
Sentence: 528,the,O
Sentence: 528,same,O
Sentence: 528,day,O
Sentence: 528,",",O
Sentence: 528,and,O
Sentence: 528,by,O
Sentence: 528,questionnaire,O
Sentence: 528,three,O
Sentence: 528,to,O
Sentence: 528,four,O
Sentence: 528,weeks,O
Sentence: 528,later,O
Sentence: 528,.,O
Sentence: 528,The,O
Sentence: 528,trial,O
Sentence: 528,was,O
Sentence: 528,discontinued,O
Sentence: 528,after,O
Sentence: 528,20,O
Sentence: 528,cases,O
Sentence: 528,because,O
Sentence: 528,of,O
Sentence: 528,an,O
Sentence: 528,unacceptable,O
Sentence: 528,incidence,O
Sentence: 528,of,O
Sentence: 528,side,O
Sentence: 528,effects,O
Sentence: 528,.,O
Sentence: 528,Venous,O
Sentence: 528,pain,B-Disease
Sentence: 528,occurred,O
Sentence: 528,in,O
Sentence: 528,68,O
Sentence: 528,%,O
Sentence: 528,of,O
Sentence: 528,patients,O
Sentence: 528,and,O
Sentence: 528,50,O
Sentence: 528,%,O
Sentence: 528,had,O
Sentence: 528,redness,O
Sentence: 528,",",O
Sentence: 528,pain,B-Disease
Sentence: 528,or,O
Sentence: 528,swelling,B-Disease
Sentence: 528,related,O
Sentence: 528,to,O
Sentence: 528,the,O
Sentence: 528,injection,O
Sentence: 528,site,O
Sentence: 528,",",O
Sentence: 528,in,O
Sentence: 528,some,O
Sentence: 528,cases,O
Sentence: 528,lasting,O
Sentence: 528,up,O
Sentence: 528,to,O
Sentence: 528,three,O
Sentence: 528,weeks,O
Sentence: 528,after,O
Sentence: 528,anaesthesia,O
Sentence: 528,.,O
Sentence: 528,Skeletal,O
Sentence: 528,movements,O
Sentence: 528,occurred,O
Sentence: 528,in,O
Sentence: 528,50,O
Sentence: 528,%,O
Sentence: 528,of,O
Sentence: 528,patients,O
Sentence: 528,;,O
Sentence: 528,30,O
Sentence: 528,%,O
Sentence: 528,experienced,O
Sentence: 528,respiratory,B-Disease
Sentence: 528,upset,I-Disease
Sentence: 528,",",O
Sentence: 528,one,O
Sentence: 528,sufficiently,O
Sentence: 528,severe,O
Sentence: 528,to,O
Sentence: 528,necessitate,O
Sentence: 528,abandoning,O
Sentence: 528,the,O
Sentence: 528,technique,O
Sentence: 528,.,O
Sentence: 528,Nausea,B-Disease
Sentence: 528,and,O
Sentence: 528,vomiting,B-Disease
Sentence: 528,occurred,O
Sentence: 528,in,O
Sentence: 528,40,O
Sentence: 528,%,O
Sentence: 528,and,O
Sentence: 528,25,O
Sentence: 528,%,O
Sentence: 528,had,O
Sentence: 528,disturbing,O
Sentence: 528,emergence,O
Sentence: 528,psychoses,B-Disease
Sentence: 528,.,O
Sentence: 529,Levodopa,B-Chemical
Sentence: 529,-,O
Sentence: 529,induced,O
Sentence: 529,dyskinesias,B-Disease
Sentence: 529,are,O
Sentence: 529,improved,O
Sentence: 529,by,O
Sentence: 529,fluoxetine,B-Chemical
Sentence: 529,.,O
Sentence: 530,We,O
Sentence: 530,evaluated,O
Sentence: 530,the,O
Sentence: 530,severity,O
Sentence: 530,of,O
Sentence: 530,motor,B-Disease
Sentence: 530,disability,I-Disease
Sentence: 530,and,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,in,O
Sentence: 530,seven,O
Sentence: 530,levodopa,B-Chemical
Sentence: 530,-,O
Sentence: 530,responsive,O
Sentence: 530,patients,O
Sentence: 530,with,O
Sentence: 530,Parkinson,B-Disease
Sentence: 530,'s,I-Disease
Sentence: 530,disease,I-Disease
Sentence: 530,after,O
Sentence: 530,an,O
Sentence: 530,acute,O
Sentence: 530,challenge,O
Sentence: 530,with,O
Sentence: 530,the,O
Sentence: 530,mixed,O
Sentence: 530,dopamine,B-Chemical
Sentence: 530,agonist,O
Sentence: 530,",",O
Sentence: 530,apomorphine,B-Chemical
Sentence: 530,",",O
Sentence: 530,before,O
Sentence: 530,and,O
Sentence: 530,after,O
Sentence: 530,the,O
Sentence: 530,administration,O
Sentence: 530,of,O
Sentence: 530,fluoxetine,B-Chemical
Sentence: 530,(,O
Sentence: 530,20,O
Sentence: 530,mg,O
Sentence: 530,twice,O
Sentence: 530,per,O
Sentence: 530,day,O
Sentence: 530,),O
Sentence: 530,for,O
Sentence: 530,11,O
Sentence: 530,+,O
Sentence: 530,/,O
Sentence: 530,,O
Sentence: 530,-,O
Sentence: 530,,O
Sentence: 530,1,O
Sentence: 530,days,O
Sentence: 530,.,O
Sentence: 530,After,O
Sentence: 530,fluoxetine,B-Chemical
Sentence: 530,treatment,O
Sentence: 530,",",O
Sentence: 530,there,O
Sentence: 530,was,O
Sentence: 530,a,O
Sentence: 530,significant,O
Sentence: 530,47,O
Sentence: 530,%,O
Sentence: 530,improvement,O
Sentence: 530,(,O
Sentence: 530,p,O
Sentence: 530,,O
Sentence: 530,<,O
Sentence: 530,,O
Sentence: 530,0.05,O
Sentence: 530,),O
Sentence: 530,of,O
Sentence: 530,apomorphine,B-Chemical
Sentence: 530,-,O
Sentence: 530,induced,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,without,O
Sentence: 530,modification,O
Sentence: 530,of,O
Sentence: 530,parkinsonian,B-Disease
Sentence: 530,motor,B-Disease
Sentence: 530,disability,I-Disease
Sentence: 530,.,O
Sentence: 530,The,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,were,O
Sentence: 530,reduced,O
Sentence: 530,predominantly,O
Sentence: 530,in,O
Sentence: 530,the,O
Sentence: 530,lower,O
Sentence: 530,limbs,O
Sentence: 530,during,O
Sentence: 530,the,O
Sentence: 530,onset,O
Sentence: 530,and,O
Sentence: 530,disappearance,O
Sentence: 530,of,O
Sentence: 530,dystonic,B-Disease
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,(,O
Sentence: 530,onset,O
Sentence: 530,-,O
Sentence: 530,,O
Sentence: 530,and,O
Sentence: 530,end,O
Sentence: 530,-,O
Sentence: 530,of,O
Sentence: 530,-,O
Sentence: 530,dose,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,),O
Sentence: 530,and,O
Sentence: 530,in,O
Sentence: 530,the,O
Sentence: 530,upper,O
Sentence: 530,limbs,O
Sentence: 530,during,O
Sentence: 530,choreic,B-Disease
Sentence: 530,mid,O
Sentence: 530,-,O
Sentence: 530,dose,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,.,O
Sentence: 530,The,O
Sentence: 530,results,O
Sentence: 530,suggest,O
Sentence: 530,that,O
Sentence: 530,increased,O
Sentence: 530,brain,O
Sentence: 530,serotoninergic,O
Sentence: 530,transmission,O
Sentence: 530,with,O
Sentence: 530,fluoxetine,B-Chemical
Sentence: 530,may,O
Sentence: 530,reduce,O
Sentence: 530,levodopa,B-Chemical
Sentence: 530,-,O
Sentence: 530,,O
Sentence: 530,or,O
Sentence: 530,dopamine,B-Chemical
Sentence: 530,agonist,O
Sentence: 530,-,O
Sentence: 530,induced,O
Sentence: 530,dyskinesias,B-Disease
Sentence: 530,without,O
Sentence: 530,aggravating,O
Sentence: 530,parkinsonian,B-Disease
Sentence: 530,motor,B-Disease
Sentence: 530,disability,I-Disease
Sentence: 530,.,O
Sentence: 531,A,O
Sentence: 531,large,O
Sentence: 531,population,O
Sentence: 531,-,O
Sentence: 531,based,O
Sentence: 531,follow,O
Sentence: 531,-,O
Sentence: 531,up,O
Sentence: 531,study,O
Sentence: 531,of,O
Sentence: 531,trimethoprim,B-Chemical
Sentence: 531,-,O
Sentence: 531,sulfamethoxazole,O
Sentence: 531,",",O
Sentence: 531,trimethoprim,B-Chemical
Sentence: 531,",",O
Sentence: 531,and,O
Sentence: 531,cephalexin,B-Chemical
Sentence: 531,for,O
Sentence: 531,uncommon,O
Sentence: 531,serious,O
Sentence: 531,drug,B-Disease
Sentence: 531,toxicity,I-Disease
Sentence: 531,.,O
Sentence: 532,We,O
Sentence: 532,conducted,O
Sentence: 532,a,O
Sentence: 532,population,O
Sentence: 532,-,O
Sentence: 532,based,O
Sentence: 532,45,O
Sentence: 532,-,O
Sentence: 532,day,O
Sentence: 532,follow,O
Sentence: 532,-,O
Sentence: 532,up,O
Sentence: 532,study,O
Sentence: 532,of,O
Sentence: 532,"232,390",O
Sentence: 532,people,O
Sentence: 532,who,O
Sentence: 532,were,O
Sentence: 532,prescribed,O
Sentence: 532,trimethoprim,B-Chemical
Sentence: 532,-,O
Sentence: 532,sulfamethoxazole,O
Sentence: 532,(,O
Sentence: 532,TMP,O
Sentence: 532,-,O
Sentence: 532,SMZ,O
Sentence: 532,),O
Sentence: 532,",",O
Sentence: 532,"266,951",O
Sentence: 532,prescribed,O
Sentence: 532,trimethoprim,B-Chemical
Sentence: 532,alone,O
Sentence: 532,",",O
Sentence: 532,and,O
Sentence: 532,"196,397",O
Sentence: 532,prescribed,O
Sentence: 532,cephalexin,B-Chemical
Sentence: 532,",",O
Sentence: 532,to,O
Sentence: 532,estimate,O
Sentence: 532,the,O
Sentence: 532,risk,O
Sentence: 532,of,O
Sentence: 532,serious,O
Sentence: 532,liver,B-Disease
Sentence: 532,",",I-Disease
Sentence: 532,blood,I-Disease
Sentence: 532,",",I-Disease
Sentence: 532,skin,I-Disease
Sentence: 532,",",I-Disease
Sentence: 532,and,I-Disease
Sentence: 532,renal,B-Disease
Sentence: 532,disorders,I-Disease
Sentence: 532,resulting,O
Sentence: 532,in,O
Sentence: 532,referral,O
Sentence: 532,or,O
Sentence: 532,hospitalization,O
Sentence: 532,associated,O
Sentence: 532,with,O
Sentence: 532,these,O
Sentence: 532,drugs,O
Sentence: 532,.,O
Sentence: 532,The,O
Sentence: 532,results,O
Sentence: 532,were,O
Sentence: 532,based,O
Sentence: 532,on,O
Sentence: 532,information,O
Sentence: 532,recorded,O
Sentence: 532,on,O
Sentence: 532,office,O
Sentence: 532,computers,O
Sentence: 532,by,O
Sentence: 532,selected,O
Sentence: 532,general,O
Sentence: 532,practitioners,O
Sentence: 532,in,O
Sentence: 532,the,O
Sentence: 532,United,O
Sentence: 532,Kingdom,O
Sentence: 532,",",O
Sentence: 532,together,O
Sentence: 532,with,O
Sentence: 532,a,O
Sentence: 532,review,O
Sentence: 532,of,O
Sentence: 532,clinical,O
Sentence: 532,records,O
Sentence: 532,.,O
Sentence: 532,The,O
Sentence: 532,risk,O
Sentence: 532,of,O
Sentence: 532,clinically,O
Sentence: 532,important,O
Sentence: 532,idiopathic,O
Sentence: 532,liver,B-Disease
Sentence: 532,disease,I-Disease
Sentence: 532,was,O
Sentence: 532,similar,O
Sentence: 532,for,O
Sentence: 532,persons,O
Sentence: 532,prescribed,O
Sentence: 532,TMP,O
Sentence: 532,-,O
Sentence: 532,SMZ,O
Sentence: 532,(,O
Sentence: 532,5.2,O
Sentence: 532,/,O
Sentence: 532,"100,000",O
Sentence: 532,),O
Sentence: 532,and,O
Sentence: 532,those,O
Sentence: 532,prescribed,O
Sentence: 532,trimethoprim,B-Chemical
Sentence: 532,alone,O
Sentence: 532,(,O
Sentence: 532,3.8,O
Sentence: 532,/,O
Sentence: 532,"100,000",O
Sentence: 532,),O
Sentence: 532,.,O
Sentence: 532,The,O
Sentence: 532,risk,O
Sentence: 532,for,O
Sentence: 532,those,O
Sentence: 532,prescribed,O
Sentence: 532,cephalexin,B-Chemical
Sentence: 532,was,O
Sentence: 532,somewhat,O
Sentence: 532,lower,O
Sentence: 532,(,O
Sentence: 532,2.0,O
Sentence: 532,/,O
Sentence: 532,"100,000",O
Sentence: 532,),O
Sentence: 532,.,O
Sentence: 532,Only,O
Sentence: 532,five,O
Sentence: 532,patients,O
Sentence: 532,experienced,O
Sentence: 532,blood,B-Disease
Sentence: 532,disorders,I-Disease
Sentence: 532,",",O
Sentence: 532,one,O
Sentence: 532,of,O
Sentence: 532,whom,O
Sentence: 532,was,O
Sentence: 532,exposed,O
Sentence: 532,to,O
Sentence: 532,TMP,O
Sentence: 532,-,O
Sentence: 532,SMZ,O
Sentence: 532,;,O
Sentence: 532,of,O
Sentence: 532,seven,O
Sentence: 532,with,O
Sentence: 532,erythema,B-Disease
Sentence: 532,multiforme,I-Disease
Sentence: 532,and,O
Sentence: 532,Stevens,O
Sentence: 532,-,O
Sentence: 532,Johnson,O
Sentence: 532,syndrome,O
Sentence: 532,",",O
Sentence: 532,four,O
Sentence: 532,were,O
Sentence: 532,exposed,O
Sentence: 532,to,O
Sentence: 532,TMP,O
Sentence: 532,-,O
Sentence: 532,SMZ,O
Sentence: 532,.,O
Sentence: 532,The,O
Sentence: 532,one,O
Sentence: 532,case,O
Sentence: 532,of,O
Sentence: 532,toxic,B-Disease
Sentence: 532,epidermal,I-Disease
Sentence: 532,necrolysis,I-Disease
Sentence: 532,occurred,O
Sentence: 532,in,O
Sentence: 532,a,O
Sentence: 532,patient,O
Sentence: 532,who,O
Sentence: 532,took,O
Sentence: 532,cephalexin,B-Chemical
Sentence: 532,.,O
Sentence: 532,Finally,O
Sentence: 532,",",O
Sentence: 532,only,O
Sentence: 532,five,O
Sentence: 532,cases,O
Sentence: 532,of,O
Sentence: 532,acute,O
Sentence: 532,parenchymal,O
Sentence: 532,renal,B-Disease
Sentence: 532,disease,I-Disease
Sentence: 532,occurred,O
Sentence: 532,",",O
Sentence: 532,none,O
Sentence: 532,likely,O
Sentence: 532,to,O
Sentence: 532,be,O
Sentence: 532,caused,O
Sentence: 532,by,O
Sentence: 532,a,O
Sentence: 532,study,O
Sentence: 532,drug,O
Sentence: 532,.,O
Sentence: 532,We,O
Sentence: 532,conclude,O
Sentence: 532,that,O
Sentence: 532,the,O
Sentence: 532,risk,O
Sentence: 532,of,O
Sentence: 532,the,O
Sentence: 532,serious,O
Sentence: 532,diseases,O
Sentence: 532,studied,O
Sentence: 532,is,O
Sentence: 532,small,O
Sentence: 532,for,O
Sentence: 532,the,O
Sentence: 532,three,O
Sentence: 532,agents,O
Sentence: 532,",",O
Sentence: 532,and,O
Sentence: 532,compares,O
Sentence: 532,reasonably,O
Sentence: 532,with,O
Sentence: 532,the,O
Sentence: 532,risk,O
Sentence: 532,for,O
Sentence: 532,many,O
Sentence: 532,other,O
Sentence: 532,antibiotics,O
Sentence: 532,.,O
Sentence: 533,Clinical,O
Sentence: 533,safety,O
Sentence: 533,of,O
Sentence: 533,lidocaine,B-Chemical
Sentence: 533,in,O
Sentence: 533,patients,O
Sentence: 533,with,O
Sentence: 533,cocaine,B-Chemical
Sentence: 533,-,O
Sentence: 533,associated,O
Sentence: 533,myocardial,B-Disease
Sentence: 533,infarction,I-Disease
Sentence: 533,.,O
Sentence: 534,STUDY,O
Sentence: 534,OBJECTIVE,O
Sentence: 534,:,O
Sentence: 534,To,O
Sentence: 534,evaluate,O
Sentence: 534,the,O
Sentence: 534,safety,O
Sentence: 534,of,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,in,O
Sentence: 534,the,O
Sentence: 534,setting,O
Sentence: 534,of,O
Sentence: 534,cocaine,B-Chemical
Sentence: 534,-,O
Sentence: 534,induced,O
Sentence: 534,myocardial,B-Disease
Sentence: 534,infarction,I-Disease
Sentence: 534,(,O
Sentence: 534,MI,B-Disease
Sentence: 534,),O
Sentence: 534,.,O
Sentence: 534,DESIGN,O
Sentence: 534,:,O
Sentence: 534,A,O
Sentence: 534,retrospective,O
Sentence: 534,",",O
Sentence: 534,multicenter,O
Sentence: 534,study,O
Sentence: 534,.,O
Sentence: 534,SETTING,O
Sentence: 534,:,O
Sentence: 534,Twenty,O
Sentence: 534,-,O
Sentence: 534,nine,O
Sentence: 534,university,O
Sentence: 534,",",O
Sentence: 534,university,O
Sentence: 534,-,O
Sentence: 534,affiliated,O
Sentence: 534,",",O
Sentence: 534,or,O
Sentence: 534,community,O
Sentence: 534,hospitals,O
Sentence: 534,during,O
Sentence: 534,a,O
Sentence: 534,6,O
Sentence: 534,-,O
Sentence: 534,year,O
Sentence: 534,period,O
Sentence: 534,(,O
Sentence: 534,total,O
Sentence: 534,of,O
Sentence: 534,117,O
Sentence: 534,cumulative,O
Sentence: 534,hospital,O
Sentence: 534,-,O
Sentence: 534,years,O
Sentence: 534,),O
Sentence: 534,.,O
Sentence: 534,PARTICIPANTS,O
Sentence: 534,:,O
Sentence: 534,Patients,O
Sentence: 534,with,O
Sentence: 534,cocaine,B-Chemical
Sentence: 534,-,O
Sentence: 534,associated,O
Sentence: 534,MI,B-Disease
Sentence: 534,who,O
Sentence: 534,received,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,in,O
Sentence: 534,the,O
Sentence: 534,emergency,O
Sentence: 534,department,O
Sentence: 534,.,O
Sentence: 534,RESULTS,O
Sentence: 534,:,O
Sentence: 534,Of,O
Sentence: 534,29,O
Sentence: 534,patients,O
Sentence: 534,who,O
Sentence: 534,received,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,in,O
Sentence: 534,the,O
Sentence: 534,setting,O
Sentence: 534,of,O
Sentence: 534,cocaine,B-Chemical
Sentence: 534,-,O
Sentence: 534,associated,O
Sentence: 534,MI,B-Disease
Sentence: 534,",",O
Sentence: 534,no,O
Sentence: 534,patient,O
Sentence: 534,died,O
Sentence: 534,;,O
Sentence: 534,exhibited,O
Sentence: 534,bradydysrhythmias,B-Disease
Sentence: 534,",",O
Sentence: 534,ventricular,B-Disease
Sentence: 534,tachycardia,I-Disease
Sentence: 534,",",O
Sentence: 534,or,O
Sentence: 534,ventricular,B-Disease
Sentence: 534,fibrillation,I-Disease
Sentence: 534,;,O
Sentence: 534,or,O
Sentence: 534,experienced,O
Sentence: 534,seizures,B-Disease
Sentence: 534,after,O
Sentence: 534,administration,O
Sentence: 534,of,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,(,O
Sentence: 534,95,O
Sentence: 534,%,O
Sentence: 534,confidence,O
Sentence: 534,interval,O
Sentence: 534,",",O
Sentence: 534,0,O
Sentence: 534,%,O
Sentence: 534,to,O
Sentence: 534,11,O
Sentence: 534,%,O
Sentence: 534,),O
Sentence: 534,.,O
Sentence: 534,CONCLUSION,O
Sentence: 534,:,O
Sentence: 534,Despite,O
Sentence: 534,theoretical,O
Sentence: 534,concerns,O
Sentence: 534,that,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,may,O
Sentence: 534,enhance,O
Sentence: 534,cocaine,B-Chemical
Sentence: 534,toxicity,B-Disease
Sentence: 534,",",O
Sentence: 534,the,O
Sentence: 534,use,O
Sentence: 534,of,O
Sentence: 534,lidocaine,B-Chemical
Sentence: 534,in,O
Sentence: 534,patients,O
Sentence: 534,with,O
Sentence: 534,cocaine,B-Chemical
Sentence: 534,-,O
Sentence: 534,associated,O
Sentence: 534,MI,B-Disease
Sentence: 534,was,O
Sentence: 534,not,O
Sentence: 534,associated,O
Sentence: 534,with,O
Sentence: 534,significant,O
Sentence: 534,cardiovascular,B-Disease
Sentence: 534,or,I-Disease
Sentence: 534,central,B-Disease
Sentence: 534,nervous,I-Disease
Sentence: 534,system,I-Disease
Sentence: 534,toxicity,I-Disease
Sentence: 534,.,O
Sentence: 535,Paclitaxel,B-Chemical
Sentence: 535,3,O
Sentence: 535,-,O
Sentence: 535,hour,O
Sentence: 535,infusion,O
Sentence: 535,given,O
Sentence: 535,alone,O
Sentence: 535,and,O
Sentence: 535,combined,O
Sentence: 535,with,O
Sentence: 535,carboplatin,B-Chemical
Sentence: 535,:,O
Sentence: 535,preliminary,O
Sentence: 535,results,O
Sentence: 535,of,O
Sentence: 535,dose,O
Sentence: 535,-,O
Sentence: 535,escalation,O
Sentence: 535,trials,O
Sentence: 535,.,O
Sentence: 536,Paclitaxel,B-Chemical
Sentence: 536,(,O
Sentence: 536,Taxol,B-Chemical
Sentence: 536,;,O
Sentence: 536,Bristol,O
Sentence: 536,-,O
Sentence: 536,Myers,O
Sentence: 536,Squibb,O
Sentence: 536,Company,O
Sentence: 536,",",O
Sentence: 536,Princeton,O
Sentence: 536,",",O
Sentence: 536,NJ,O
Sentence: 536,),O
Sentence: 536,by,O
Sentence: 536,3,O
Sentence: 536,-,O
Sentence: 536,hour,O
Sentence: 536,infusion,O
Sentence: 536,was,O
Sentence: 536,combined,O
Sentence: 536,with,O
Sentence: 536,carboplatin,B-Chemical
Sentence: 536,in,O
Sentence: 536,a,O
Sentence: 536,phase,O
Sentence: 536,I,O
Sentence: 536,/,O
Sentence: 536,II,O
Sentence: 536,study,O
Sentence: 536,directed,O
Sentence: 536,to,O
Sentence: 536,patients,O
Sentence: 536,with,O
Sentence: 536,non,O
Sentence: 536,-,O
Sentence: 536,small,O
Sentence: 536,cell,O
Sentence: 536,lung,O
Sentence: 536,cancer,O
Sentence: 536,.,O
Sentence: 536,Carboplatin,B-Chemical
Sentence: 536,was,O
Sentence: 536,given,O
Sentence: 536,at,O
Sentence: 536,a,O
Sentence: 536,fixed,O
Sentence: 536,target,O
Sentence: 536,area,O
Sentence: 536,under,O
Sentence: 536,the,O
Sentence: 536,concentration,O
Sentence: 536,-,O
Sentence: 536,time,O
Sentence: 536,curve,O
Sentence: 536,of,O
Sentence: 536,6.0,O
Sentence: 536,by,O
Sentence: 536,the,O
Sentence: 536,Calvert,O
Sentence: 536,formula,O
Sentence: 536,",",O
Sentence: 536,whereas,O
Sentence: 536,paclitaxel,B-Chemical
Sentence: 536,was,O
Sentence: 536,escalated,O
Sentence: 536,in,O
Sentence: 536,patient,O
Sentence: 536,cohorts,O
Sentence: 536,from,O
Sentence: 536,150,O
Sentence: 536,mg,O
Sentence: 536,/,O
Sentence: 536,m2,O
Sentence: 536,(,O
Sentence: 536,dose,O
Sentence: 536,level,O
Sentence: 536,I,O
Sentence: 536,),O
Sentence: 536,to,O
Sentence: 536,175,O
Sentence: 536,",",O
Sentence: 536,200,O
Sentence: 536,",",O
Sentence: 536,225,O
Sentence: 536,",",O
Sentence: 536,and,O
Sentence: 536,250,O
Sentence: 536,mg,O
Sentence: 536,/,O
Sentence: 536,m2,O
Sentence: 536,.,O
Sentence: 536,The,O
Sentence: 536,225,O
Sentence: 536,mg,O
Sentence: 536,/,O
Sentence: 536,m2,O
Sentence: 536,level,O
Sentence: 536,was,O
Sentence: 536,expanded,O
Sentence: 536,for,O
Sentence: 536,the,O
Sentence: 536,phase,O
Sentence: 536,II,O
Sentence: 536,study,O
Sentence: 536,since,O
Sentence: 536,the,O
Sentence: 536,highest,O
Sentence: 536,level,O
Sentence: 536,achieved,O
Sentence: 536,(,O
Sentence: 536,250,O
Sentence: 536,mg,O
Sentence: 536,/,O
Sentence: 536,m2,O
Sentence: 536,),O
Sentence: 536,required,O
Sentence: 536,modification,O
Sentence: 536,because,O
Sentence: 536,of,O
Sentence: 536,nonhematologic,O
Sentence: 536,toxicities,B-Disease
Sentence: 536,(,O
Sentence: 536,arthralgia,B-Disease
Sentence: 536,and,O
Sentence: 536,sensory,B-Disease
Sentence: 536,neuropathy,I-Disease
Sentence: 536,),O
Sentence: 536,.,O
Sentence: 536,Therapeutic,O
Sentence: 536,effects,O
Sentence: 536,were,O
Sentence: 536,noted,O
Sentence: 536,at,O
Sentence: 536,all,O
Sentence: 536,dose,O
Sentence: 536,levels,O
Sentence: 536,",",O
Sentence: 536,with,O
Sentence: 536,objective,O
Sentence: 536,responses,O
Sentence: 536,in,O
Sentence: 536,17,O
Sentence: 536,(,O
Sentence: 536,two,O
Sentence: 536,complete,O
Sentence: 536,and,O
Sentence: 536,15,O
Sentence: 536,partial,O
Sentence: 536,regressions,O
Sentence: 536,),O
Sentence: 536,of,O
Sentence: 536,41,O
Sentence: 536,previously,O
Sentence: 536,untreated,O
Sentence: 536,patients,O
Sentence: 536,.,O
Sentence: 536,Toxicities,B-Disease
Sentence: 536,were,O
Sentence: 536,compared,O
Sentence: 536,with,O
Sentence: 536,a,O
Sentence: 536,cohort,O
Sentence: 536,of,O
Sentence: 536,patients,O
Sentence: 536,in,O
Sentence: 536,a,O
Sentence: 536,phase,O
Sentence: 536,I,O
Sentence: 536,trial,O
Sentence: 536,of,O
Sentence: 536,paclitaxel,B-Chemical
Sentence: 536,alone,O
Sentence: 536,at,O
Sentence: 536,identical,O
Sentence: 536,dose,O
Sentence: 536,levels,O
Sentence: 536,.,O
Sentence: 536,Carboplatin,B-Chemical
Sentence: 536,did,O
Sentence: 536,not,O
Sentence: 536,appear,O
Sentence: 536,to,O
Sentence: 536,add,O
Sentence: 536,to,O
Sentence: 536,the,O
Sentence: 536,hematologic,B-Disease
Sentence: 536,toxicities,I-Disease
Sentence: 536,observed,O
Sentence: 536,",",O
Sentence: 536,and,O
Sentence: 536,the,O
Sentence: 536,paclitaxel,B-Chemical
Sentence: 536,/,O
Sentence: 536,carboplatin,B-Chemical
Sentence: 536,combination,O
Sentence: 536,could,O
Sentence: 536,be,O
Sentence: 536,dosed,O
Sentence: 536,every,O
Sentence: 536,3,O
Sentence: 536,weeks,O
Sentence: 536,.,O
Sentence: 537,The,O
Sentence: 537,dose,O
Sentence: 537,-,O
Sentence: 537,dependent,O
Sentence: 537,effect,O
Sentence: 537,of,O
Sentence: 537,misoprostol,B-Chemical
Sentence: 537,on,O
Sentence: 537,indomethacin,B-Chemical
Sentence: 537,-,O
Sentence: 537,induced,O
Sentence: 537,renal,B-Disease
Sentence: 537,dysfunction,I-Disease
Sentence: 537,in,O
Sentence: 537,well,O
Sentence: 537,compensated,O
Sentence: 537,cirrhosis,B-Disease
Sentence: 537,.,O
Sentence: 538,Misoprostol,B-Chemical
Sentence: 538,(,O
Sentence: 538,200,O
Sentence: 538,micrograms,O
Sentence: 538,),O
Sentence: 538,has,O
Sentence: 538,been,O
Sentence: 538,shown,O
Sentence: 538,to,O
Sentence: 538,acutely,O
Sentence: 538,counteract,O
Sentence: 538,the,O
Sentence: 538,indomethacin,B-Chemical
Sentence: 538,-,O
Sentence: 538,induced,O
Sentence: 538,renal,B-Disease
Sentence: 538,dysfunction,I-Disease
Sentence: 538,in,O
Sentence: 538,well,O
Sentence: 538,compensated,O
Sentence: 538,cirrhotic,B-Disease
Sentence: 538,patients,O
Sentence: 538,.,O
Sentence: 538,The,O
Sentence: 538,aim,O
Sentence: 538,of,O
Sentence: 538,this,O
Sentence: 538,study,O
Sentence: 538,was,O
Sentence: 538,to,O
Sentence: 538,determine,O
Sentence: 538,if,O
Sentence: 538,the,O
Sentence: 538,prophylactic,O
Sentence: 538,value,O
Sentence: 538,of,O
Sentence: 538,misoprostol,B-Chemical
Sentence: 538,was,O
Sentence: 538,dose,O
Sentence: 538,-,O
Sentence: 538,dependent,O
Sentence: 538,.,O
Sentence: 538,Parameters,O
Sentence: 538,of,O
Sentence: 538,renal,O
Sentence: 538,hemodynamics,O
Sentence: 538,and,O
Sentence: 538,tubular,O
Sentence: 538,sodium,B-Chemical
Sentence: 538,and,O
Sentence: 538,water,O
Sentence: 538,handling,O
Sentence: 538,were,O
Sentence: 538,assessed,O
Sentence: 538,by,O
Sentence: 538,clearance,O
Sentence: 538,techniques,O
Sentence: 538,in,O
Sentence: 538,26,O
Sentence: 538,well,O
Sentence: 538,compensated,O
Sentence: 538,cirrhotic,B-Disease
Sentence: 538,patients,O
Sentence: 538,before,O
Sentence: 538,and,O
Sentence: 538,after,O
Sentence: 538,an,O
Sentence: 538,oral,O
Sentence: 538,combination,O
Sentence: 538,of,O
Sentence: 538,50,O
Sentence: 538,mg,O
Sentence: 538,of,O
Sentence: 538,indomethacin,B-Chemical
Sentence: 538,and,O
Sentence: 538,various,O
Sentence: 538,doses,O
Sentence: 538,of,O
Sentence: 538,misoprostol,B-Chemical
Sentence: 538,.,O
Sentence: 538,The,O
Sentence: 538,200,O
Sentence: 538,-,O
Sentence: 538,micrograms,O
Sentence: 538,dose,O
Sentence: 538,was,O
Sentence: 538,able,O
Sentence: 538,to,O
Sentence: 538,totally,O
Sentence: 538,abolish,O
Sentence: 538,the,O
Sentence: 538,deleterious,O
Sentence: 538,renal,O
Sentence: 538,effects,O
Sentence: 538,of,O
Sentence: 538,indomethacin,B-Chemical
Sentence: 538,",",O
Sentence: 538,whereas,O
Sentence: 538,the,O
Sentence: 538,800,O
Sentence: 538,-,O
Sentence: 538,micrograms,O
Sentence: 538,dose,O
Sentence: 538,resulted,O
Sentence: 538,in,O
Sentence: 538,significant,O
Sentence: 538,worsening,O
Sentence: 538,of,O
Sentence: 538,renal,O
Sentence: 538,hemodynamics,O
Sentence: 538,and,O
Sentence: 538,sodium,B-Chemical
Sentence: 538,retention,O
Sentence: 538,.,O
Sentence: 538,These,O
Sentence: 538,changes,O
Sentence: 538,were,O
Sentence: 538,maximal,O
Sentence: 538,in,O
Sentence: 538,the,O
Sentence: 538,hour,O
Sentence: 538,immediately,O
Sentence: 538,after,O
Sentence: 538,medications,O
Sentence: 538,and,O
Sentence: 538,slowly,O
Sentence: 538,returned,O
Sentence: 538,toward,O
Sentence: 538,base,O
Sentence: 538,-,O
Sentence: 538,line,O
Sentence: 538,levels,O
Sentence: 538,thereafter,O
Sentence: 538,.,O
Sentence: 538,These,O
Sentence: 538,results,O
Sentence: 538,suggest,O
Sentence: 538,that,O
Sentence: 538,the,O
Sentence: 538,renal,O
Sentence: 538,protective,O
Sentence: 538,effects,O
Sentence: 538,of,O
Sentence: 538,misoprostol,B-Chemical
Sentence: 538,is,O
Sentence: 538,dose,O
Sentence: 538,-,O
Sentence: 538,dependent,O
Sentence: 538,.,O
Sentence: 538,However,O
Sentence: 538,",",O
Sentence: 538,until,O
Sentence: 538,this,O
Sentence: 538,apparent,O
Sentence: 538,ability,O
Sentence: 538,of,O
Sentence: 538,200,O
Sentence: 538,micrograms,O
Sentence: 538,of,O
Sentence: 538,misoprostol,B-Chemical
Sentence: 538,to,O
Sentence: 538,prevent,O
Sentence: 538,the,O
Sentence: 538,adverse,O
Sentence: 538,effects,O
Sentence: 538,of,O
Sentence: 538,indomethacin,B-Chemical
Sentence: 538,on,O
Sentence: 538,renal,O
Sentence: 538,function,O
Sentence: 538,is,O
Sentence: 538,confirmed,O
Sentence: 538,with,O
Sentence: 538,chronic,O
Sentence: 538,frequent,O
Sentence: 538,dosing,O
Sentence: 538,",",O
Sentence: 538,it,O
Sentence: 538,would,O
Sentence: 538,be,O
Sentence: 538,prudent,O
Sentence: 538,to,O
Sentence: 538,avoid,O
Sentence: 538,nonsteroidal,O
Sentence: 538,anti,O
Sentence: 538,-,O
Sentence: 538,inflammatory,O
Sentence: 538,therapy,O
Sentence: 538,in,O
Sentence: 538,patients,O
Sentence: 538,with,O
Sentence: 538,cirrhosis,B-Disease
Sentence: 538,.,O
Sentence: 539,Increased,O
Sentence: 539,frequency,O
Sentence: 539,and,O
Sentence: 539,severity,O
Sentence: 539,of,O
Sentence: 539,angio,O
Sentence: 539,-,O
Sentence: 539,oedema,O
Sentence: 539,related,O
Sentence: 539,to,O
Sentence: 539,long,O
Sentence: 539,-,O
Sentence: 539,term,O
Sentence: 539,therapy,O
Sentence: 539,with,O
Sentence: 539,angiotensin,O
Sentence: 539,-,O
Sentence: 539,converting,O
Sentence: 539,enzyme,O
Sentence: 539,inhibitor,O
Sentence: 539,in,O
Sentence: 539,two,O
Sentence: 539,patients,O
Sentence: 539,.,O
Sentence: 540,Adverse,O
Sentence: 540,reactions,O
Sentence: 540,to,O
Sentence: 540,drugs,O
Sentence: 540,are,O
Sentence: 540,well,O
Sentence: 540,recognized,O
Sentence: 540,as,O
Sentence: 540,a,O
Sentence: 540,cause,O
Sentence: 540,of,O
Sentence: 540,acute,O
Sentence: 540,or,O
Sentence: 540,chronic,O
Sentence: 540,urticaria,B-Disease
Sentence: 540,",",O
Sentence: 540,and,O
Sentence: 540,angio,O
Sentence: 540,-,O
Sentence: 540,oedema,O
Sentence: 540,.,O
Sentence: 540,Angiotensin,O
Sentence: 540,-,O
Sentence: 540,converting,O
Sentence: 540,enzyme,O
Sentence: 540,(,O
Sentence: 540,ACE,O
Sentence: 540,),O
Sentence: 540,inhibitors,O
Sentence: 540,",",O
Sentence: 540,used,O
Sentence: 540,to,O
Sentence: 540,treat,O
Sentence: 540,hypertension,B-Disease
Sentence: 540,and,O
Sentence: 540,congestive,B-Disease
Sentence: 540,heart,I-Disease
Sentence: 540,failure,I-Disease
Sentence: 540,",",O
Sentence: 540,were,O
Sentence: 540,introduced,O
Sentence: 540,in,O
Sentence: 540,Europe,O
Sentence: 540,in,O
Sentence: 540,the,O
Sentence: 540,middle,O
Sentence: 540,of,O
Sentence: 540,the,O
Sentence: 540,eighties,O
Sentence: 540,",",O
Sentence: 540,and,O
Sentence: 540,the,O
Sentence: 540,use,O
Sentence: 540,of,O
Sentence: 540,these,O
Sentence: 540,drugs,O
Sentence: 540,has,O
Sentence: 540,increased,O
Sentence: 540,progressively,O
Sentence: 540,.,O
Sentence: 540,Soon,O
Sentence: 540,after,O
Sentence: 540,the,O
Sentence: 540,introduction,O
Sentence: 540,of,O
Sentence: 540,ACE,B-Chemical
Sentence: 540,inhibitors,I-Chemical
Sentence: 540,",",O
Sentence: 540,acute,O
Sentence: 540,bouts,O
Sentence: 540,of,O
Sentence: 540,angio,O
Sentence: 540,-,O
Sentence: 540,oedema,O
Sentence: 540,were,O
Sentence: 540,reported,O
Sentence: 540,in,O
Sentence: 540,association,O
Sentence: 540,with,O
Sentence: 540,the,O
Sentence: 540,use,O
Sentence: 540,of,O
Sentence: 540,these,O
Sentence: 540,drugs,O
Sentence: 540,.,O
Sentence: 540,We,O
Sentence: 540,wish,O
Sentence: 540,to,O
Sentence: 540,draw,O
Sentence: 540,attention,O
Sentence: 540,to,O
Sentence: 540,the,O
Sentence: 540,possibility,O
Sentence: 540,of,O
Sentence: 540,adverse,O
Sentence: 540,reactions,O
Sentence: 540,to,O
Sentence: 540,ACE,B-Chemical
Sentence: 540,inhibitors,I-Chemical
Sentence: 540,after,O
Sentence: 540,long,O
Sentence: 540,-,O
Sentence: 540,term,O
Sentence: 540,use,O
Sentence: 540,and,O
Sentence: 540,in,O
Sentence: 540,patients,O
Sentence: 540,with,O
Sentence: 540,pre,O
Sentence: 540,-,O
Sentence: 540,existing,O
Sentence: 540,angio,O
Sentence: 540,-,O
Sentence: 540,oedema,O
Sentence: 540,.,O
Sentence: 541,Myoclonus,B-Disease
Sentence: 541,associated,O
Sentence: 541,with,O
Sentence: 541,lorazepam,B-Chemical
Sentence: 541,therapy,O
Sentence: 541,in,O
Sentence: 541,very,O
Sentence: 541,-,O
Sentence: 541,low,O
Sentence: 541,-,O
Sentence: 541,birth,O
Sentence: 541,-,O
Sentence: 541,weight,O
Sentence: 541,infants,O
Sentence: 541,.,O
Sentence: 542,Lorazepam,B-Chemical
Sentence: 542,is,O
Sentence: 542,being,O
Sentence: 542,used,O
Sentence: 542,with,O
Sentence: 542,increasing,O
Sentence: 542,frequency,O
Sentence: 542,as,O
Sentence: 542,a,O
Sentence: 542,sedative,O
Sentence: 542,in,O
Sentence: 542,the,O
Sentence: 542,newborn,O
Sentence: 542,and,O
Sentence: 542,the,O
Sentence: 542,young,O
Sentence: 542,infant,O
Sentence: 542,.,O
Sentence: 542,Concern,O
Sentence: 542,has,O
Sentence: 542,been,O
Sentence: 542,raised,O
Sentence: 542,with,O
Sentence: 542,regard,O
Sentence: 542,to,O
Sentence: 542,the,O
Sentence: 542,safety,O
Sentence: 542,of,O
Sentence: 542,lorazepam,B-Chemical
Sentence: 542,in,O
Sentence: 542,this,O
Sentence: 542,age,O
Sentence: 542,group,O
Sentence: 542,",",O
Sentence: 542,especially,O
Sentence: 542,in,O
Sentence: 542,very,O
Sentence: 542,-,O
Sentence: 542,low,O
Sentence: 542,-,O
Sentence: 542,birth,O
Sentence: 542,-,O
Sentence: 542,weight,O
Sentence: 542,(,O
Sentence: 542,VLBW,O
Sentence: 542,;,O
Sentence: 542,,O
Sentence: 542,<,O
Sentence: 542,,O
Sentence: 542,"1,500",O
Sentence: 542,g,O
Sentence: 542,),O
Sentence: 542,infants,O
Sentence: 542,.,O
Sentence: 542,Three,O
Sentence: 542,young,O
Sentence: 542,infants,O
Sentence: 542,",",O
Sentence: 542,all,O
Sentence: 542,of,O
Sentence: 542,birth,O
Sentence: 542,weight,O
Sentence: 542,,O
Sentence: 542,<,O
Sentence: 542,,O
Sentence: 542,"1,500",O
Sentence: 542,g,O
Sentence: 542,",",O
Sentence: 542,experienced,O
Sentence: 542,myoclonus,B-Disease
Sentence: 542,following,O
Sentence: 542,the,O
Sentence: 542,intravenous,O
Sentence: 542,administration,O
Sentence: 542,of,O
Sentence: 542,lorazepam,B-Chemical
Sentence: 542,.,O
Sentence: 542,The,O
Sentence: 542,potential,O
Sentence: 542,neurotoxic,B-Disease
Sentence: 542,effects,O
Sentence: 542,of,O
Sentence: 542,the,O
Sentence: 542,drug,O
Sentence: 542,(,O
Sentence: 542,and,O
Sentence: 542,its,O
Sentence: 542,vehicle,O
Sentence: 542,),O
Sentence: 542,in,O
Sentence: 542,this,O
Sentence: 542,population,O
Sentence: 542,are,O
Sentence: 542,discussed,O
Sentence: 542,.,O
Sentence: 542,Injectable,O
Sentence: 542,lorazepam,B-Chemical
Sentence: 542,should,O
Sentence: 542,be,O
Sentence: 542,used,O
Sentence: 542,with,O
Sentence: 542,caution,O
Sentence: 542,in,O
Sentence: 542,VLBW,O
Sentence: 542,infants,O
Sentence: 542,.,O
Sentence: 543,Transvenous,O
Sentence: 543,right,O
Sentence: 543,ventricular,O
Sentence: 543,pacing,O
Sentence: 543,during,O
Sentence: 543,cardiopulmonary,O
Sentence: 543,resuscitation,O
Sentence: 543,of,O
Sentence: 543,pediatric,O
Sentence: 543,patients,O
Sentence: 543,with,O
Sentence: 543,acute,O
Sentence: 543,cardiomyopathy,O
Sentence: 543,.,O
Sentence: 544,We,O
Sentence: 544,describe,O
Sentence: 544,the,O
Sentence: 544,cardiopulmonary,O
Sentence: 544,resuscitation,O
Sentence: 544,efforts,O
Sentence: 544,on,O
Sentence: 544,five,O
Sentence: 544,patients,O
Sentence: 544,who,O
Sentence: 544,presented,O
Sentence: 544,in,O
Sentence: 544,acute,O
Sentence: 544,circulatory,B-Disease
Sentence: 544,failure,I-Disease
Sentence: 544,from,O
Sentence: 544,myocardial,B-Disease
Sentence: 544,dysfunction,I-Disease
Sentence: 544,.,O
Sentence: 544,Three,O
Sentence: 544,patients,O
Sentence: 544,had,O
Sentence: 544,acute,O
Sentence: 544,viral,O
Sentence: 544,myocarditis,B-Disease
Sentence: 544,",",O
Sentence: 544,one,O
Sentence: 544,had,O
Sentence: 544,a,O
Sentence: 544,carbamazepine,B-Chemical
Sentence: 544,-,O
Sentence: 544,induced,O
Sentence: 544,acute,O
Sentence: 544,eosinophilic,B-Disease
Sentence: 544,myocarditis,B-Disease
Sentence: 544,",",O
Sentence: 544,and,O
Sentence: 544,one,O
Sentence: 544,had,O
Sentence: 544,cardiac,O
Sentence: 544,hemosiderosis,O
Sentence: 544,resulting,O
Sentence: 544,in,O
Sentence: 544,acute,O
Sentence: 544,cardiogenic,B-Disease
Sentence: 544,shock,I-Disease
Sentence: 544,.,O
Sentence: 544,All,O
Sentence: 544,patients,O
Sentence: 544,were,O
Sentence: 544,continuously,O
Sentence: 544,monitored,O
Sentence: 544,with,O
Sentence: 544,central,O
Sentence: 544,venous,O
Sentence: 544,and,O
Sentence: 544,arterial,O
Sentence: 544,catheters,O
Sentence: 544,in,O
Sentence: 544,addition,O
Sentence: 544,to,O
Sentence: 544,routine,O
Sentence: 544,noninvasive,O
Sentence: 544,monitoring,O
Sentence: 544,.,O
Sentence: 544,An,O
Sentence: 544,introducer,O
Sentence: 544,sheath,O
Sentence: 544,",",O
Sentence: 544,a,O
Sentence: 544,pacemaker,O
Sentence: 544,",",O
Sentence: 544,and,O
Sentence: 544,sterile,O
Sentence: 544,pacing,O
Sentence: 544,wires,O
Sentence: 544,were,O
Sentence: 544,made,O
Sentence: 544,readily,O
Sentence: 544,available,O
Sentence: 544,for,O
Sentence: 544,the,O
Sentence: 544,patients,O
Sentence: 544,",",O
Sentence: 544,should,O
Sentence: 544,the,O
Sentence: 544,need,O
Sentence: 544,arise,O
Sentence: 544,to,O
Sentence: 544,terminate,O
Sentence: 544,resistant,O
Sentence: 544,cardiac,O
Sentence: 544,dysrhythmias,B-Disease
Sentence: 544,.,O
Sentence: 544,All,O
Sentence: 544,patients,O
Sentence: 544,developed,O
Sentence: 544,cardiocirculatory,O
Sentence: 544,arrest,O
Sentence: 544,associated,O
Sentence: 544,with,O
Sentence: 544,extreme,O
Sentence: 544,hypotension,B-Disease
Sentence: 544,and,O
Sentence: 544,dysrhythmias,B-Disease
Sentence: 544,within,O
Sentence: 544,the,O
Sentence: 544,first,O
Sentence: 544,48,O
Sentence: 544,hours,O
Sentence: 544,of,O
Sentence: 544,their,O
Sentence: 544,admission,O
Sentence: 544,to,O
Sentence: 544,the,O
Sentence: 544,pediatric,O
Sentence: 544,intensive,O
Sentence: 544,care,O
Sentence: 544,unit,O
Sentence: 544,(,O
Sentence: 544,PICU,O
Sentence: 544,),O
Sentence: 544,.,O
Sentence: 544,Right,O
Sentence: 544,ventricular,O
Sentence: 544,pacemaker,O
Sentence: 544,wires,O
Sentence: 544,were,O
Sentence: 544,inserted,O
Sentence: 544,in,O
Sentence: 544,all,O
Sentence: 544,of,O
Sentence: 544,them,O
Sentence: 544,during,O
Sentence: 544,cardiopulmonary,O
Sentence: 544,resuscitation,O
Sentence: 544,(,O
Sentence: 544,CPR,O
Sentence: 544,),O
Sentence: 544,.,O
Sentence: 544,In,O
Sentence: 544,four,O
Sentence: 544,patients,O
Sentence: 544,",",O
Sentence: 544,cardiac,O
Sentence: 544,pacing,O
Sentence: 544,was,O
Sentence: 544,used,O
Sentence: 544,",",O
Sentence: 544,resulting,O
Sentence: 544,in,O
Sentence: 544,a,O
Sentence: 544,temporary,O
Sentence: 544,captured,O
Sentence: 544,rhythm,O
Sentence: 544,and,O
Sentence: 544,restoration,O
Sentence: 544,of,O
Sentence: 544,their,O
Sentence: 544,cardiac,O
Sentence: 544,output,O
Sentence: 544,.,O
Sentence: 544,These,O
Sentence: 544,patients,O
Sentence: 544,had,O
Sentence: 544,a,O
Sentence: 544,second,O
Sentence: 544,event,O
Sentence: 544,of,O
Sentence: 544,cardiac,B-Disease
Sentence: 544,arrest,I-Disease
Sentence: 544,",",O
Sentence: 544,resulting,O
Sentence: 544,in,O
Sentence: 544,death,O
Sentence: 544,",",O
Sentence: 544,within,O
Sentence: 544,10,O
Sentence: 544,to,O
Sentence: 544,60,O
Sentence: 544,minutes,O
Sentence: 544,.,O
Sentence: 544,In,O
Sentence: 544,one,O
Sentence: 544,patient,O
Sentence: 544,",",O
Sentence: 544,cardiac,O
Sentence: 544,pacing,O
Sentence: 544,was,O
Sentence: 544,not,O
Sentence: 544,used,O
Sentence: 544,",",O
Sentence: 544,because,O
Sentence: 544,he,O
Sentence: 544,converted,O
Sentence: 544,to,O
Sentence: 544,normal,O
Sentence: 544,sinus,O
Sentence: 544,rhythm,O
Sentence: 544,by,O
Sentence: 544,electrical,O
Sentence: 544,defibrillation,O
Sentence: 544,within,O
Sentence: 544,three,O
Sentence: 544,minutes,O
Sentence: 544,of,O
Sentence: 544,initiating,O
Sentence: 544,CPR,O
Sentence: 544,.,O
Sentence: 544,We,O
Sentence: 544,conclude,O
Sentence: 544,that,O
Sentence: 544,cardiac,O
Sentence: 544,pacing,O
Sentence: 544,during,O
Sentence: 544,resuscitative,O
Sentence: 544,efforts,O
Sentence: 544,in,O
Sentence: 544,pediatric,O
Sentence: 544,patients,O
Sentence: 544,suffering,O
Sentence: 544,from,O
Sentence: 544,acute,O
Sentence: 544,myocardial,B-Disease
Sentence: 544,dysfunction,I-Disease
Sentence: 544,may,O
Sentence: 544,not,O
Sentence: 544,have,O
Sentence: 544,long,O
Sentence: 544,-,O
Sentence: 544,term,O
Sentence: 544,value,O
Sentence: 544,in,O
Sentence: 544,and,O
Sentence: 544,of,O
Sentence: 544,itself,O
Sentence: 544,;,O
Sentence: 544,however,O
Sentence: 544,",",O
Sentence: 544,if,O
Sentence: 544,temporary,O
Sentence: 544,hemodynamic,O
Sentence: 544,stability,O
Sentence: 544,is,O
Sentence: 544,achieved,O
Sentence: 544,by,O
Sentence: 544,this,O
Sentence: 544,procedure,O
Sentence: 544,",",O
Sentence: 544,it,O
Sentence: 544,may,O
Sentence: 544,provide,O
Sentence: 544,additional,O
Sentence: 544,time,O
Sentence: 544,needed,O
Sentence: 544,to,O
Sentence: 544,institute,O
Sentence: 544,other,O
Sentence: 544,therapeutic,O
Sentence: 544,modalities,O
Sentence: 544,.,O
Sentence: 545,Efficacy,O
Sentence: 545,and,O
Sentence: 545,safety,O
Sentence: 545,of,O
Sentence: 545,granisetron,B-Chemical
Sentence: 545,",",O
Sentence: 545,a,O
Sentence: 545,selective,O
Sentence: 545,5,O
Sentence: 545,-,O
Sentence: 545,hydroxytryptamine,O
Sentence: 545,-,O
Sentence: 545,3,O
Sentence: 545,receptor,O
Sentence: 545,antagonist,O
Sentence: 545,",",O
Sentence: 545,in,O
Sentence: 545,the,O
Sentence: 545,prevention,O
Sentence: 545,of,O
Sentence: 545,nausea,B-Disease
Sentence: 545,and,O
Sentence: 545,vomiting,B-Disease
Sentence: 545,induced,O
Sentence: 545,by,O
Sentence: 545,high,O
Sentence: 545,-,O
Sentence: 545,dose,O
Sentence: 545,cisplatin,B-Chemical
Sentence: 545,.,O
Sentence: 546,PURPOSE,O
Sentence: 546,:,O
Sentence: 546,To,O
Sentence: 546,assess,O
Sentence: 546,the,O
Sentence: 546,antiemetic,O
Sentence: 546,effects,O
Sentence: 546,and,O
Sentence: 546,safety,O
Sentence: 546,profile,O
Sentence: 546,of,O
Sentence: 546,four,O
Sentence: 546,different,O
Sentence: 546,doses,O
Sentence: 546,of,O
Sentence: 546,granisetron,B-Chemical
Sentence: 546,(,O
Sentence: 546,Kytril,B-Chemical
Sentence: 546,;,O
Sentence: 546,SmithKline,O
Sentence: 546,Beecham,O
Sentence: 546,Pharmaceuticals,O
Sentence: 546,",",O
Sentence: 546,Philadelphia,O
Sentence: 546,",",O
Sentence: 546,PA,O
Sentence: 546,),O
Sentence: 546,when,O
Sentence: 546,administered,O
Sentence: 546,as,O
Sentence: 546,a,O
Sentence: 546,single,O
Sentence: 546,intravenous,O
Sentence: 546,(,O
Sentence: 546,IV,O
Sentence: 546,),O
Sentence: 546,dose,O
Sentence: 546,for,O
Sentence: 546,prophylaxis,O
Sentence: 546,of,O
Sentence: 546,cisplatin,B-Chemical
Sentence: 546,-,O
Sentence: 546,induced,O
Sentence: 546,nausea,B-Disease
Sentence: 546,and,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,.,O
Sentence: 546,PATIENTS,O
Sentence: 546,AND,O
Sentence: 546,METHODS,O
Sentence: 546,:,O
Sentence: 546,One,O
Sentence: 546,hundred,O
Sentence: 546,eighty,O
Sentence: 546,-,O
Sentence: 546,four,O
Sentence: 546,chemotherapy,O
Sentence: 546,-,O
Sentence: 546,naive,O
Sentence: 546,patients,O
Sentence: 546,receiving,O
Sentence: 546,high,O
Sentence: 546,-,O
Sentence: 546,dose,O
Sentence: 546,cisplatin,B-Chemical
Sentence: 546,(,O
Sentence: 546,81,O
Sentence: 546,to,O
Sentence: 546,120,O
Sentence: 546,mg,O
Sentence: 546,/,O
Sentence: 546,m2,O
Sentence: 546,),O
Sentence: 546,were,O
Sentence: 546,randomized,O
Sentence: 546,to,O
Sentence: 546,receive,O
Sentence: 546,one,O
Sentence: 546,of,O
Sentence: 546,four,O
Sentence: 546,granisetron,B-Chemical
Sentence: 546,doses,O
Sentence: 546,(,O
Sentence: 546,5,O
Sentence: 546,",",O
Sentence: 546,10,O
Sentence: 546,",",O
Sentence: 546,20,O
Sentence: 546,",",O
Sentence: 546,or,O
Sentence: 546,40,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,),O
Sentence: 546,administered,O
Sentence: 546,before,O
Sentence: 546,chemotherapy,O
Sentence: 546,.,O
Sentence: 546,Patients,O
Sentence: 546,were,O
Sentence: 546,observed,O
Sentence: 546,on,O
Sentence: 546,an,O
Sentence: 546,inpatient,O
Sentence: 546,basis,O
Sentence: 546,for,O
Sentence: 546,18,O
Sentence: 546,to,O
Sentence: 546,24,O
Sentence: 546,hours,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,vital,O
Sentence: 546,signs,O
Sentence: 546,",",O
Sentence: 546,nausea,B-Disease
Sentence: 546,",",O
Sentence: 546,vomiting,B-Disease
Sentence: 546,",",O
Sentence: 546,retching,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,appetite,O
Sentence: 546,were,O
Sentence: 546,assessed,O
Sentence: 546,.,O
Sentence: 546,Safety,O
Sentence: 546,analyses,O
Sentence: 546,included,O
Sentence: 546,incidence,O
Sentence: 546,of,O
Sentence: 546,adverse,O
Sentence: 546,experiences,O
Sentence: 546,and,O
Sentence: 546,laboratory,O
Sentence: 546,parameter,O
Sentence: 546,changes,O
Sentence: 546,.,O
Sentence: 546,RESULTS,O
Sentence: 546,:,O
Sentence: 546,After,O
Sentence: 546,granisetron,B-Chemical
Sentence: 546,doses,O
Sentence: 546,of,O
Sentence: 546,5,O
Sentence: 546,",",O
Sentence: 546,10,O
Sentence: 546,",",O
Sentence: 546,20,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,40,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,",",O
Sentence: 546,a,O
Sentence: 546,major,O
Sentence: 546,response,O
Sentence: 546,(,O
Sentence: 546,,O
Sentence: 546,<,O
Sentence: 546,,O
Sentence: 546,or,O
Sentence: 546,,O
Sentence: 546,=,O
Sentence: 546,,O
Sentence: 546,two,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,or,O
Sentence: 546,retching,O
Sentence: 546,episodes,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,no,O
Sentence: 546,antiemetic,O
Sentence: 546,rescue,O
Sentence: 546,),O
Sentence: 546,was,O
Sentence: 546,recorded,O
Sentence: 546,in,O
Sentence: 546,23,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,57,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,58,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,60,O
Sentence: 546,%,O
Sentence: 546,of,O
Sentence: 546,patients,O
Sentence: 546,",",O
Sentence: 546,respectively,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,a,O
Sentence: 546,complete,O
Sentence: 546,response,O
Sentence: 546,(,O
Sentence: 546,no,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,or,O
Sentence: 546,retching,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,no,O
Sentence: 546,antiemetic,O
Sentence: 546,rescue,O
Sentence: 546,),O
Sentence: 546,in,O
Sentence: 546,18,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,41,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,40,O
Sentence: 546,%,O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,47,O
Sentence: 546,%,O
Sentence: 546,of,O
Sentence: 546,patients,O
Sentence: 546,",",O
Sentence: 546,respectively,O
Sentence: 546,.,O
Sentence: 546,There,O
Sentence: 546,was,O
Sentence: 546,a,O
Sentence: 546,statistically,O
Sentence: 546,longer,O
Sentence: 546,time,O
Sentence: 546,to,O
Sentence: 546,first,O
Sentence: 546,episode,O
Sentence: 546,of,O
Sentence: 546,nausea,B-Disease
Sentence: 546,(,O
Sentence: 546,P,O
Sentence: 546,,O
Sentence: 546,=,O
Sentence: 546,,O
Sentence: 546,.0015,O
Sentence: 546,),O
Sentence: 546,and,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,(,O
Sentence: 546,P,O
Sentence: 546,,O
Sentence: 546,=,O
Sentence: 546,,O
Sentence: 546,.0001,O
Sentence: 546,),O
Sentence: 546,",",O
Sentence: 546,and,O
Sentence: 546,fewer,O
Sentence: 546,patients,O
Sentence: 546,were,O
Sentence: 546,administered,O
Sentence: 546,additional,O
Sentence: 546,antiemetic,O
Sentence: 546,medication,O
Sentence: 546,in,O
Sentence: 546,the,O
Sentence: 546,10,O
Sentence: 546,-,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,dosing,O
Sentence: 546,groups,O
Sentence: 546,than,O
Sentence: 546,in,O
Sentence: 546,the,O
Sentence: 546,5,O
Sentence: 546,-,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,dosing,O
Sentence: 546,group,O
Sentence: 546,.,O
Sentence: 546,As,O
Sentence: 546,granisetron,B-Chemical
Sentence: 546,dose,O
Sentence: 546,increased,O
Sentence: 546,",",O
Sentence: 546,appetite,O
Sentence: 546,return,O
Sentence: 546,increased,O
Sentence: 546,(,O
Sentence: 546,P,O
Sentence: 546,,O
Sentence: 546,=,O
Sentence: 546,,O
Sentence: 546,.040,O
Sentence: 546,),O
Sentence: 546,.,O
Sentence: 546,Headache,B-Disease
Sentence: 546,was,O
Sentence: 546,the,O
Sentence: 546,most,O
Sentence: 546,frequently,O
Sentence: 546,reported,O
Sentence: 546,adverse,O
Sentence: 546,event,O
Sentence: 546,(,O
Sentence: 546,20,O
Sentence: 546,%,O
Sentence: 546,),O
Sentence: 546,.,O
Sentence: 546,CONCLUSION,O
Sentence: 546,:,O
Sentence: 546,A,O
Sentence: 546,single,O
Sentence: 546,10,O
Sentence: 546,-,O
Sentence: 546,,O
Sentence: 546,",",O
Sentence: 546,20,O
Sentence: 546,-,O
Sentence: 546,,O
Sentence: 546,",",O
Sentence: 546,or,O
Sentence: 546,40,O
Sentence: 546,-,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,dose,O
Sentence: 546,of,O
Sentence: 546,granisetron,B-Chemical
Sentence: 546,was,O
Sentence: 546,effective,O
Sentence: 546,in,O
Sentence: 546,controlling,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,in,O
Sentence: 546,57,O
Sentence: 546,%,O
Sentence: 546,to,O
Sentence: 546,60,O
Sentence: 546,%,O
Sentence: 546,of,O
Sentence: 546,patients,O
Sentence: 546,who,O
Sentence: 546,received,O
Sentence: 546,cisplatin,B-Chemical
Sentence: 546,at,O
Sentence: 546,doses,O
Sentence: 546,greater,O
Sentence: 546,than,O
Sentence: 546,81,O
Sentence: 546,mg,O
Sentence: 546,/,O
Sentence: 546,m2,O
Sentence: 546,and,O
Sentence: 546,totally,O
Sentence: 546,prevented,O
Sentence: 546,vomiting,B-Disease
Sentence: 546,in,O
Sentence: 546,40,O
Sentence: 546,%,O
Sentence: 546,to,O
Sentence: 546,47,O
Sentence: 546,%,O
Sentence: 546,of,O
Sentence: 546,patients,O
Sentence: 546,.,O
Sentence: 546,There,O
Sentence: 546,were,O
Sentence: 546,no,O
Sentence: 546,statistically,O
Sentence: 546,significant,O
Sentence: 546,differences,O
Sentence: 546,in,O
Sentence: 546,efficacy,O
Sentence: 546,between,O
Sentence: 546,the,O
Sentence: 546,10,O
Sentence: 546,-,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,dose,O
Sentence: 546,and,O
Sentence: 546,the,O
Sentence: 546,20,O
Sentence: 546,-,O
Sentence: 546,,O
Sentence: 546,and,O
Sentence: 546,40,O
Sentence: 546,-,O
Sentence: 546,micrograms,O
Sentence: 546,/,O
Sentence: 546,kg,O
Sentence: 546,doses,O
Sentence: 546,.,O
Sentence: 546,Granisetron,B-Chemical
Sentence: 546,was,O
Sentence: 546,well,O
Sentence: 546,tolerated,O
Sentence: 546,at,O
Sentence: 546,all,O
Sentence: 546,doses,O
Sentence: 546,.,O
Sentence: 547,Adverse,O
Sentence: 547,interaction,O
Sentence: 547,between,O
Sentence: 547,clonidine,B-Chemical
Sentence: 547,and,O
Sentence: 547,verapamil,B-Chemical
Sentence: 547,.,O
Sentence: 548,OBJECTIVE,O
Sentence: 548,:,O
Sentence: 548,To,O
Sentence: 548,report,O
Sentence: 548,two,O
Sentence: 548,cases,O
Sentence: 548,of,O
Sentence: 548,a,O
Sentence: 548,possible,O
Sentence: 548,adverse,O
Sentence: 548,interaction,O
Sentence: 548,between,O
Sentence: 548,clonidine,B-Chemical
Sentence: 548,and,O
Sentence: 548,verapamil,B-Chemical
Sentence: 548,resulting,O
Sentence: 548,in,O
Sentence: 548,atrioventricular,B-Disease
Sentence: 548,(,I-Disease
Sentence: 548,AV,I-Disease
Sentence: 548,),I-Disease
Sentence: 548,block,I-Disease
Sentence: 548,in,O
Sentence: 548,both,O
Sentence: 548,patients,O
Sentence: 548,and,O
Sentence: 548,severe,O
Sentence: 548,hypotension,B-Disease
Sentence: 548,in,O
Sentence: 548,one,O
Sentence: 548,patient,O
Sentence: 548,.,O
Sentence: 548,CASE,O
Sentence: 548,SUMMARIES,O
Sentence: 548,:,O
Sentence: 548,A,O
Sentence: 548,54,O
Sentence: 548,-,O
Sentence: 548,year,O
Sentence: 548,-,O
Sentence: 548,old,O
Sentence: 548,woman,O
Sentence: 548,with,O
Sentence: 548,hyperaldosteronism,B-Disease
Sentence: 548,was,O
Sentence: 548,treated,O
Sentence: 548,with,O
Sentence: 548,verapamil,B-Chemical
Sentence: 548,480,O
Sentence: 548,mg,O
Sentence: 548,/,O
Sentence: 548,d,O
Sentence: 548,and,O
Sentence: 548,spironolactone,B-Chemical
Sentence: 548,100,O
Sentence: 548,mg,O
Sentence: 548,/,O
Sentence: 548,d,O
Sentence: 548,.,O
Sentence: 548,After,O
Sentence: 548,the,O
Sentence: 548,addition,O
Sentence: 548,of,O
Sentence: 548,a,O
Sentence: 548,minimal,O
Sentence: 548,dose,O
Sentence: 548,of,O
Sentence: 548,clonidine,B-Chemical
Sentence: 548,(,O
Sentence: 548,0.15,O
Sentence: 548,mg,O
Sentence: 548,bid,O
Sentence: 548,),O
Sentence: 548,",",O
Sentence: 548,she,O
Sentence: 548,developed,O
Sentence: 548,complete,O
Sentence: 548,AV,B-Disease
Sentence: 548,block,I-Disease
Sentence: 548,and,O
Sentence: 548,severe,O
Sentence: 548,hypotension,B-Disease
Sentence: 548,",",O
Sentence: 548,which,O
Sentence: 548,resolved,O
Sentence: 548,upon,O
Sentence: 548,cessation,O
Sentence: 548,of,O
Sentence: 548,all,O
Sentence: 548,medications,O
Sentence: 548,.,O
Sentence: 548,A,O
Sentence: 548,65,O
Sentence: 548,-,O
Sentence: 548,year,O
Sentence: 548,-,O
Sentence: 548,old,O
Sentence: 548,woman,O
Sentence: 548,was,O
Sentence: 548,treated,O
Sentence: 548,with,O
Sentence: 548,extended,O
Sentence: 548,-,O
Sentence: 548,release,O
Sentence: 548,verapamil,B-Chemical
Sentence: 548,240,O
Sentence: 548,mg,O
Sentence: 548,/,O
Sentence: 548,d,O
Sentence: 548,.,O
Sentence: 548,After,O
Sentence: 548,the,O
Sentence: 548,addition,O
Sentence: 548,of,O
Sentence: 548,clonidine,B-Chemical
Sentence: 548,0.15,O
Sentence: 548,mg,O
Sentence: 548,bid,O
Sentence: 548,she,O
Sentence: 548,developed,O
Sentence: 548,complete,O
Sentence: 548,AV,B-Disease
Sentence: 548,block,I-Disease
Sentence: 548,",",O
Sentence: 548,which,O
Sentence: 548,resolved,O
Sentence: 548,after,O
Sentence: 548,all,O
Sentence: 548,therapy,O
Sentence: 548,was,O
Sentence: 548,stopped,O
Sentence: 548,.,O
Sentence: 548,DISCUSSION,O
Sentence: 548,:,O
Sentence: 548,An,O
Sentence: 548,adverse,O
Sentence: 548,interaction,O
Sentence: 548,between,O
Sentence: 548,clonidine,B-Chemical
Sentence: 548,and,O
Sentence: 548,verapamil,B-Chemical
Sentence: 548,has,O
Sentence: 548,not,O
Sentence: 548,been,O
Sentence: 548,reported,O
Sentence: 548,previously,O
Sentence: 548,.,O
Sentence: 548,We,O
Sentence: 548,describe,O
Sentence: 548,two,O
Sentence: 548,such,O
Sentence: 548,cases,O
Sentence: 548,and,O
Sentence: 548,discuss,O
Sentence: 548,the,O
Sentence: 548,various,O
Sentence: 548,mechanisms,O
Sentence: 548,that,O
Sentence: 548,might,O
Sentence: 548,cause,O
Sentence: 548,such,O
Sentence: 548,an,O
Sentence: 548,interaction,O
Sentence: 548,.,O
Sentence: 548,Clinicians,O
Sentence: 548,should,O
Sentence: 548,be,O
Sentence: 548,acquainted,O
Sentence: 548,with,O
Sentence: 548,this,O
Sentence: 548,possibly,O
Sentence: 548,fatal,O
Sentence: 548,interaction,O
Sentence: 548,between,O
Sentence: 548,two,O
Sentence: 548,commonly,O
Sentence: 548,used,O
Sentence: 548,antihypertensive,O
Sentence: 548,drugs,O
Sentence: 548,.,O
Sentence: 548,CONCLUSIONS,O
Sentence: 548,:,O
Sentence: 548,Caution,O
Sentence: 548,is,O
Sentence: 548,recommended,O
Sentence: 548,in,O
Sentence: 548,combining,O
Sentence: 548,clonidine,B-Chemical
Sentence: 548,and,O
Sentence: 548,verapamil,B-Chemical
Sentence: 548,therapy,O
Sentence: 548,",",O
Sentence: 548,even,O
Sentence: 548,in,O
Sentence: 548,patients,O
Sentence: 548,who,O
Sentence: 548,do,O
Sentence: 548,not,O
Sentence: 548,have,O
Sentence: 548,sinus,O
Sentence: 548,or,O
Sentence: 548,AV,O
Sentence: 548,node,O
Sentence: 548,dysfunction,O
Sentence: 548,.,O
Sentence: 548,The,O
Sentence: 548,two,O
Sentence: 548,drugs,O
Sentence: 548,may,O
Sentence: 548,act,O
Sentence: 548,synergistically,O
Sentence: 548,on,O
Sentence: 548,both,O
Sentence: 548,the,O
Sentence: 548,AV,O
Sentence: 548,node,O
Sentence: 548,and,O
Sentence: 548,the,O
Sentence: 548,peripheral,O
Sentence: 548,circulation,O
Sentence: 548,.,O
Sentence: 549,Pharmacological,O
Sentence: 549,studies,O
Sentence: 549,on,O
Sentence: 549,a,O
Sentence: 549,new,O
Sentence: 549,dihydrothienopyridine,B-Chemical
Sentence: 549,calcium,I-Chemical
Sentence: 549,antagonist,O
Sentence: 549,",",O
Sentence: 549,S,O
Sentence: 549,-,O
Sentence: 549,312,O
Sentence: 549,-,O
Sentence: 549,d.,O
Sentence: 549,5th,O
Sentence: 549,communication,O
Sentence: 549,:,O
Sentence: 549,anticonvulsant,O
Sentence: 549,effects,O
Sentence: 549,in,O
Sentence: 549,mice,O
Sentence: 549,.,O
Sentence: 550,S,O
Sentence: 550,-,O
Sentence: 550,312,O
Sentence: 550,",",O
Sentence: 550,S,O
Sentence: 550,-,O
Sentence: 550,312,O
Sentence: 550,-,O
Sentence: 550,d,O
Sentence: 550,",",O
Sentence: 550,but,O
Sentence: 550,not,O
Sentence: 550,S,O
Sentence: 550,-,O
Sentence: 550,312,O
Sentence: 550,-,O
Sentence: 550,l,O
Sentence: 550,",",O
Sentence: 550,L,O
Sentence: 550,-,O
Sentence: 550,type,O
Sentence: 550,calcium,B-Chemical
Sentence: 550,channel,O
Sentence: 550,antagonists,O
Sentence: 550,",",O
Sentence: 550,showed,O
Sentence: 550,anticonvulsant,O
Sentence: 550,effects,O
Sentence: 550,on,O
Sentence: 550,the,O
Sentence: 550,audiogenic,B-Disease
Sentence: 550,tonic,I-Disease
Sentence: 550,convulsions,B-Disease
Sentence: 550,in,O
Sentence: 550,DBA,O
Sentence: 550,/,O
Sentence: 550,2,O
Sentence: 550,mice,O
Sentence: 550,;,O
Sentence: 550,and,O
Sentence: 550,their,O
Sentence: 550,ED50,O
Sentence: 550,values,O
Sentence: 550,were,O
Sentence: 550,18.4,O
Sentence: 550,(,O
Sentence: 550,12.8,O
Sentence: 550,-,O
Sentence: 550,27.1,O
Sentence: 550,),O
Sentence: 550,mg,O
Sentence: 550,/,O
Sentence: 550,kg,O
Sentence: 550,",",O
Sentence: 550,p.o,O
Sentence: 550,.,O
Sentence: 550,and,O
Sentence: 550,15.0,O
Sentence: 550,(,O
Sentence: 550,10.2,O
Sentence: 550,-,O
Sentence: 550,23.7,O
Sentence: 550,),O
Sentence: 550,mg,O
Sentence: 550,/,O
Sentence: 550,kg,O
Sentence: 550,",",O
Sentence: 550,p.o.,O
Sentence: 550,",",O
Sentence: 550,respectively,O
Sentence: 550,",",O
Sentence: 550,while,O
Sentence: 550,that,O
Sentence: 550,of,O
Sentence: 550,flunarizine,B-Chemical
Sentence: 550,was,O
Sentence: 550,34.0,O
Sentence: 550,(,O
Sentence: 550,26.0,O
Sentence: 550,-,O
Sentence: 550,44.8,O
Sentence: 550,),O
Sentence: 550,mg,O
Sentence: 550,/,O
Sentence: 550,kg,O
Sentence: 550,",",O
Sentence: 550,p.o,O
Sentence: 550,.,O
Sentence: 550,Although,O
Sentence: 550,moderate,O
Sentence: 550,anticonvulsant,O
Sentence: 550,effects,O
Sentence: 550,of,O
Sentence: 550,S,O
Sentence: 550,-,O
Sentence: 550,312,O
Sentence: 550,-,O
Sentence: 550,d,O
Sentence: 550,in,O
Sentence: 550,higher,O
Sentence: 550,doses,O
Sentence: 550,were,O
Sentence: 550,observed,O
Sentence: 550,against,O
Sentence: 550,the,O
Sentence: 550,clonic,O
Sentence: 550,convulsions,B-Disease
Sentence: 550,induced,O
Sentence: 550,by,O
Sentence: 550,pentylenetetrazole,B-Chemical
Sentence: 550,(,O
Sentence: 550,85,O
Sentence: 550,mg,O
Sentence: 550,/,O
Sentence: 550,kg,O
Sentence: 550,",",O
Sentence: 550,s.c.,O
Sentence: 550,),O
Sentence: 550,or,O
Sentence: 550,bemegride,B-Chemical
Sentence: 550,(,O
Sentence: 550,40,O
Sentence: 550,mg,O
Sentence: 550,/,O
Sentence: 550,kg,O
Sentence: 550,",",O
Sentence: 550,s.c.,O
Sentence: 550,),O
Sentence: 550,",",O
Sentence: 550,no,O
Sentence: 550,effects,O
Sentence: 550,were,O
Sentence: 550,observed,O
Sentence: 550,in,O
Sentence: 550,convulsions,B-Disease
Sentence: 550,induced,O
Sentence: 550,by,O
Sentence: 550,N,O
Sentence: 550,-,O
Sentence: 550,methyl,O
Sentence: 550,-,O
Sentence: 550,D,O
Sentence: 550,-,O
Sentence: 550,aspartate,O
Sentence: 550,",",O
Sentence: 550,picrotoxin,B-Chemical
Sentence: 550,",",O
Sentence: 550,or,O
Sentence: 550,electroshock,O
Sentence: 550,in,O
Sentence: 550,Slc,O
Sentence: 550,:,O
Sentence: 550,ddY,O
Sentence: 550,mice,O
Sentence: 550,.,O
Sentence: 550,S,O
Sentence: 550,-,O
Sentence: 550,312,O
Sentence: 550,-,O
Sentence: 550,d,O
Sentence: 550,may,O
Sentence: 550,be,O
Sentence: 550,useful,O
Sentence: 550,in,O
Sentence: 550,the,O
Sentence: 550,therapy,O
Sentence: 550,of,O
Sentence: 550,certain,O
Sentence: 550,types,O
Sentence: 550,of,O
Sentence: 550,human,O
Sentence: 550,epilepsy,B-Disease
Sentence: 550,.,O
Sentence: 551,Transmural,O
Sentence: 551,myocardial,B-Disease
Sentence: 551,infarction,I-Disease
Sentence: 551,with,O
Sentence: 551,sumatriptan,B-Chemical
Sentence: 551,.,O
Sentence: 552,For,O
Sentence: 552,sumatriptan,B-Chemical
Sentence: 552,",",O
Sentence: 552,tightness,O
Sentence: 552,in,O
Sentence: 552,the,O
Sentence: 552,chest,O
Sentence: 552,caused,O
Sentence: 552,by,O
Sentence: 552,an,O
Sentence: 552,unknown,O
Sentence: 552,mechanism,O
Sentence: 552,has,O
Sentence: 552,been,O
Sentence: 552,reported,O
Sentence: 552,in,O
Sentence: 552,3,O
Sentence: 552,-,O
Sentence: 552,5,O
Sentence: 552,%,O
Sentence: 552,of,O
Sentence: 552,users,O
Sentence: 552,.,O
Sentence: 552,We,O
Sentence: 552,describe,O
Sentence: 552,a,O
Sentence: 552,47,O
Sentence: 552,-,O
Sentence: 552,year,O
Sentence: 552,-,O
Sentence: 552,old,O
Sentence: 552,woman,O
Sentence: 552,with,O
Sentence: 552,an,O
Sentence: 552,acute,O
Sentence: 552,myocardial,B-Disease
Sentence: 552,infarction,I-Disease
Sentence: 552,after,O
Sentence: 552,administration,O
Sentence: 552,of,O
Sentence: 552,sumatriptan,B-Chemical
Sentence: 552,6,O
Sentence: 552,mg,O
Sentence: 552,subcutaneously,O
Sentence: 552,for,O
Sentence: 552,cluster,B-Disease
Sentence: 552,headache,I-Disease
Sentence: 552,.,O
Sentence: 552,The,O
Sentence: 552,patient,O
Sentence: 552,had,O
Sentence: 552,no,O
Sentence: 552,history,O
Sentence: 552,of,O
Sentence: 552,underlying,O
Sentence: 552,ischaemic,B-Disease
Sentence: 552,heart,I-Disease
Sentence: 552,disease,I-Disease
Sentence: 552,or,O
Sentence: 552,Prinzmetal,B-Disease
Sentence: 552,'s,I-Disease
Sentence: 552,angina,I-Disease
Sentence: 552,.,O
Sentence: 552,She,O
Sentence: 552,recovered,O
Sentence: 552,without,O
Sentence: 552,complications,O
Sentence: 552,.,O
Sentence: 553,Flumazenil,B-Chemical
Sentence: 553,induces,O
Sentence: 553,seizures,B-Disease
Sentence: 553,and,O
Sentence: 553,death,O
Sentence: 553,in,O
Sentence: 553,mixed,O
Sentence: 553,cocaine,B-Chemical
Sentence: 553,-,O
Sentence: 553,diazepam,B-Chemical
Sentence: 553,intoxications,O
Sentence: 553,.,O
Sentence: 554,STUDY,O
Sentence: 554,HYPOTHESIS,O
Sentence: 554,:,O
Sentence: 554,Administration,O
Sentence: 554,of,O
Sentence: 554,the,O
Sentence: 554,benzodiazepine,B-Chemical
Sentence: 554,antagonist,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,may,O
Sentence: 554,unmask,O
Sentence: 554,seizures,B-Disease
Sentence: 554,in,O
Sentence: 554,mixed,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,-,O
Sentence: 554,benzodiazepine,B-Chemical
Sentence: 554,intoxication,O
Sentence: 554,.,O
Sentence: 554,DESIGN,O
Sentence: 554,:,O
Sentence: 554,Male,O
Sentence: 554,Sprague,O
Sentence: 554,-,O
Sentence: 554,Dawley,O
Sentence: 554,rats,O
Sentence: 554,received,O
Sentence: 554,100,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,IP,O
Sentence: 554,alone,O
Sentence: 554,",",O
Sentence: 554,5,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,alone,O
Sentence: 554,",",O
Sentence: 554,or,O
Sentence: 554,a,O
Sentence: 554,combination,O
Sentence: 554,of,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,and,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,.,O
Sentence: 554,Three,O
Sentence: 554,minutes,O
Sentence: 554,later,O
Sentence: 554,",",O
Sentence: 554,groups,O
Sentence: 554,were,O
Sentence: 554,challenged,O
Sentence: 554,with,O
Sentence: 554,vehicle,O
Sentence: 554,or,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,5,O
Sentence: 554,or,O
Sentence: 554,10,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,IP,O
Sentence: 554,.,O
Sentence: 554,Animal,O
Sentence: 554,behavior,O
Sentence: 554,",",O
Sentence: 554,seizures,B-Disease
Sentence: 554,(,O
Sentence: 554,time,O
Sentence: 554,to,O
Sentence: 554,and,O
Sentence: 554,incidence,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,death,O
Sentence: 554,(,O
Sentence: 554,time,O
Sentence: 554,to,O
Sentence: 554,and,O
Sentence: 554,incidence,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,and,O
Sentence: 554,cortical,O
Sentence: 554,EEG,O
Sentence: 554,tracings,O
Sentence: 554,were,O
Sentence: 554,recorded,O
Sentence: 554,.,O
Sentence: 554,INTERVENTIONS,O
Sentence: 554,:,O
Sentence: 554,Administration,O
Sentence: 554,of,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,to,O
Sentence: 554,animals,O
Sentence: 554,after,O
Sentence: 554,they,O
Sentence: 554,had,O
Sentence: 554,received,O
Sentence: 554,a,O
Sentence: 554,combination,O
Sentence: 554,dose,O
Sentence: 554,of,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,and,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,.,O
Sentence: 554,RESULTS,O
Sentence: 554,:,O
Sentence: 554,In,O
Sentence: 554,group,O
Sentence: 554,1,O
Sentence: 554,",",O
Sentence: 554,animals,O
Sentence: 554,received,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,followed,O
Sentence: 554,by,O
Sentence: 554,vehicle,O
Sentence: 554,.,O
Sentence: 554,This,O
Sentence: 554,resulted,O
Sentence: 554,in,O
Sentence: 554,100,O
Sentence: 554,%,O
Sentence: 554,developing,O
Sentence: 554,seizures,B-Disease
Sentence: 554,and,O
Sentence: 554,death,O
Sentence: 554,.,O
Sentence: 554,Group,O
Sentence: 554,2,O
Sentence: 554,received,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,alone,O
Sentence: 554,followed,O
Sentence: 554,by,O
Sentence: 554,vehicle,O
Sentence: 554,.,O
Sentence: 554,Animals,O
Sentence: 554,became,O
Sentence: 554,somnolent,O
Sentence: 554,and,O
Sentence: 554,none,O
Sentence: 554,died,O
Sentence: 554,.,O
Sentence: 554,Group,O
Sentence: 554,3,O
Sentence: 554,received,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,followed,O
Sentence: 554,by,O
Sentence: 554,5,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,.,O
Sentence: 554,Animals,O
Sentence: 554,became,O
Sentence: 554,somnolent,O
Sentence: 554,after,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,and,O
Sentence: 554,then,O
Sentence: 554,active,O
Sentence: 554,after,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,administration,O
Sentence: 554,.,O
Sentence: 554,In,O
Sentence: 554,group,O
Sentence: 554,4,O
Sentence: 554,",",O
Sentence: 554,a,O
Sentence: 554,combination,O
Sentence: 554,of,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,and,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,was,O
Sentence: 554,administered,O
Sentence: 554,simultaneously,O
Sentence: 554,.,O
Sentence: 554,This,O
Sentence: 554,resulted,O
Sentence: 554,in,O
Sentence: 554,no,O
Sentence: 554,overt,O
Sentence: 554,or,O
Sentence: 554,EEG,O
Sentence: 554,-,O
Sentence: 554,detectable,O
Sentence: 554,seizures,B-Disease
Sentence: 554,and,O
Sentence: 554,a,O
Sentence: 554,50,O
Sentence: 554,%,O
Sentence: 554,incidence,O
Sentence: 554,of,O
Sentence: 554,death,O
Sentence: 554,.,O
Sentence: 554,Group,O
Sentence: 554,5,O
Sentence: 554,received,O
Sentence: 554,a,O
Sentence: 554,similar,O
Sentence: 554,combination,O
Sentence: 554,of,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,and,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,",",O
Sentence: 554,followed,O
Sentence: 554,later,O
Sentence: 554,by,O
Sentence: 554,5,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,.,O
Sentence: 554,This,O
Sentence: 554,resulted,O
Sentence: 554,in,O
Sentence: 554,an,O
Sentence: 554,increased,O
Sentence: 554,incidence,O
Sentence: 554,of,O
Sentence: 554,seizures,B-Disease
Sentence: 554,",",O
Sentence: 554,90,O
Sentence: 554,%,O
Sentence: 554,(,O
Sentence: 554,P,O
Sentence: 554,,O
Sentence: 554,<,O
Sentence: 554,,O
Sentence: 554,.01,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,and,O
Sentence: 554,death,O
Sentence: 554,",",O
Sentence: 554,100,O
Sentence: 554,%,O
Sentence: 554,(,O
Sentence: 554,P,O
Sentence: 554,,O
Sentence: 554,<,O
Sentence: 554,,O
Sentence: 554,or,O
Sentence: 554,,O
Sentence: 554,=,O
Sentence: 554,,O
Sentence: 554,.01,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,compared,O
Sentence: 554,with,O
Sentence: 554,group,O
Sentence: 554,4,O
Sentence: 554,.,O
Sentence: 554,Group,O
Sentence: 554,6,O
Sentence: 554,received,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,and,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,followed,O
Sentence: 554,by,O
Sentence: 554,10,O
Sentence: 554,mg,O
Sentence: 554,/,O
Sentence: 554,kg,O
Sentence: 554,flumazenil,B-Chemical
Sentence: 554,.,O
Sentence: 554,This,O
Sentence: 554,also,O
Sentence: 554,resulted,O
Sentence: 554,in,O
Sentence: 554,an,O
Sentence: 554,increased,O
Sentence: 554,incidence,O
Sentence: 554,of,O
Sentence: 554,seizures,B-Disease
Sentence: 554,",",O
Sentence: 554,90,O
Sentence: 554,%,O
Sentence: 554,(,O
Sentence: 554,P,O
Sentence: 554,,O
Sentence: 554,<,O
Sentence: 554,,O
Sentence: 554,or,O
Sentence: 554,,O
Sentence: 554,=,O
Sentence: 554,,O
Sentence: 554,.01,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,and,O
Sentence: 554,death,O
Sentence: 554,",",O
Sentence: 554,90,O
Sentence: 554,%,O
Sentence: 554,(,O
Sentence: 554,P,O
Sentence: 554,,O
Sentence: 554,<,O
Sentence: 554,,O
Sentence: 554,or,O
Sentence: 554,,O
Sentence: 554,=,O
Sentence: 554,,O
Sentence: 554,.05,O
Sentence: 554,),O
Sentence: 554,",",O
Sentence: 554,compared,O
Sentence: 554,with,O
Sentence: 554,group,O
Sentence: 554,4,O
Sentence: 554,.,O
Sentence: 554,CONCLUSION,O
Sentence: 554,:,O
Sentence: 554,Flumazenil,B-Chemical
Sentence: 554,can,O
Sentence: 554,unmask,O
Sentence: 554,seizures,B-Disease
Sentence: 554,and,O
Sentence: 554,increase,O
Sentence: 554,the,O
Sentence: 554,incidence,O
Sentence: 554,of,O
Sentence: 554,death,O
Sentence: 554,in,O
Sentence: 554,a,O
Sentence: 554,model,O
Sentence: 554,of,O
Sentence: 554,combined,O
Sentence: 554,cocaine,B-Chemical
Sentence: 554,-,O
Sentence: 554,diazepam,B-Chemical
Sentence: 554,intoxications,O
Sentence: 554,.,O
Sentence: 555,Mechanisms,O
Sentence: 555,for,O
Sentence: 555,protective,O
Sentence: 555,effects,O
Sentence: 555,of,O
Sentence: 555,free,O
Sentence: 555,radical,O
Sentence: 555,scavengers,O
Sentence: 555,on,O
Sentence: 555,gentamicin,B-Chemical
Sentence: 555,-,O
Sentence: 555,mediated,O
Sentence: 555,nephropathy,B-Disease
Sentence: 555,in,O
Sentence: 555,rats,O
Sentence: 555,.,O
Sentence: 556,Studies,O
Sentence: 556,were,O
Sentence: 556,performed,O
Sentence: 556,to,O
Sentence: 556,examine,O
Sentence: 556,the,O
Sentence: 556,mechanisms,O
Sentence: 556,for,O
Sentence: 556,the,O
Sentence: 556,protective,O
Sentence: 556,effects,O
Sentence: 556,of,O
Sentence: 556,free,O
Sentence: 556,radical,O
Sentence: 556,scavengers,O
Sentence: 556,on,O
Sentence: 556,gentamicin,B-Chemical
Sentence: 556,(,O
Sentence: 556,GM,B-Chemical
Sentence: 556,),O
Sentence: 556,,O
Sentence: 556,-,O
Sentence: 556,mediated,O
Sentence: 556,nephropathy,B-Disease
Sentence: 556,.,O
Sentence: 556,Administration,O
Sentence: 556,of,O
Sentence: 556,GM,B-Chemical
Sentence: 556,at,O
Sentence: 556,40,O
Sentence: 556,mg,O
Sentence: 556,/,O
Sentence: 556,kg,O
Sentence: 556,sc,O
Sentence: 556,for,O
Sentence: 556,13,O
Sentence: 556,days,O
Sentence: 556,to,O
Sentence: 556,rats,O
Sentence: 556,induced,O
Sentence: 556,a,O
Sentence: 556,significant,O
Sentence: 556,reduction,O
Sentence: 556,in,O
Sentence: 556,renal,O
Sentence: 556,blood,O
Sentence: 556,flow,O
Sentence: 556,(,O
Sentence: 556,RBF,O
Sentence: 556,),O
Sentence: 556,and,O
Sentence: 556,inulin,O
Sentence: 556,clearance,O
Sentence: 556,(,O
Sentence: 556,CIn,O
Sentence: 556,),O
Sentence: 556,as,O
Sentence: 556,well,O
Sentence: 556,as,O
Sentence: 556,marked,O
Sentence: 556,tubular,B-Disease
Sentence: 556,damage,I-Disease
Sentence: 556,.,O
Sentence: 556,A,O
Sentence: 556,significant,O
Sentence: 556,reduction,O
Sentence: 556,in,O
Sentence: 556,urinary,O
Sentence: 556,guanosine,O
Sentence: 556,"3',5'",O
Sentence: 556,-,O
Sentence: 556,cyclic,O
Sentence: 556,monophosphate,O
Sentence: 556,(,O
Sentence: 556,cGMP,B-Chemical
Sentence: 556,),O
Sentence: 556,excretion,O
Sentence: 556,and,O
Sentence: 556,a,O
Sentence: 556,significant,O
Sentence: 556,increase,O
Sentence: 556,in,O
Sentence: 556,renal,O
Sentence: 556,cortical,O
Sentence: 556,renin,O
Sentence: 556,and,O
Sentence: 556,endothelin,O
Sentence: 556,-,O
Sentence: 556,1,O
Sentence: 556,contents,O
Sentence: 556,were,O
Sentence: 556,also,O
Sentence: 556,observed,O
Sentence: 556,in,O
Sentence: 556,GM,B-Chemical
Sentence: 556,-,O
Sentence: 556,mediated,O
Sentence: 556,nephropathy,B-Disease
Sentence: 556,.,O
Sentence: 556,Superoxide,B-Chemical
Sentence: 556,dismutase,O
Sentence: 556,(,O
Sentence: 556,SOD,O
Sentence: 556,),O
Sentence: 556,or,O
Sentence: 556,dimethylthiourea,B-Chemical
Sentence: 556,(,O
Sentence: 556,DMTU,B-Chemical
Sentence: 556,),O
Sentence: 556,significantly,O
Sentence: 556,lessened,O
Sentence: 556,the,O
Sentence: 556,GM,B-Chemical
Sentence: 556,-,O
Sentence: 556,induced,O
Sentence: 556,decrement,O
Sentence: 556,in,O
Sentence: 556,CIn,O
Sentence: 556,.,O
Sentence: 556,The,O
Sentence: 556,SOD,O
Sentence: 556,-,O
Sentence: 556,induced,O
Sentence: 556,increase,O
Sentence: 556,in,O
Sentence: 556,glomerular,O
Sentence: 556,filtration,O
Sentence: 556,rate,O
Sentence: 556,was,O
Sentence: 556,associated,O
Sentence: 556,with,O
Sentence: 556,a,O
Sentence: 556,marked,O
Sentence: 556,improvement,O
Sentence: 556,in,O
Sentence: 556,RBF,O
Sentence: 556,",",O
Sentence: 556,an,O
Sentence: 556,increase,O
Sentence: 556,in,O
Sentence: 556,urinary,O
Sentence: 556,cGMP,B-Chemical
Sentence: 556,excretion,O
Sentence: 556,",",O
Sentence: 556,and,O
Sentence: 556,a,O
Sentence: 556,decrease,O
Sentence: 556,in,O
Sentence: 556,renal,O
Sentence: 556,renin,O
Sentence: 556,and,O
Sentence: 556,endothelin,O
Sentence: 556,-,O
Sentence: 556,1,O
Sentence: 556,content,O
Sentence: 556,.,O
Sentence: 556,SOD,O
Sentence: 556,did,O
Sentence: 556,not,O
Sentence: 556,attenuate,O
Sentence: 556,the,O
Sentence: 556,tubular,B-Disease
Sentence: 556,damage,I-Disease
Sentence: 556,.,O
Sentence: 556,In,O
Sentence: 556,contrast,O
Sentence: 556,",",O
Sentence: 556,DMTU,B-Chemical
Sentence: 556,significantly,O
Sentence: 556,reduced,O
Sentence: 556,the,O
Sentence: 556,tubular,B-Disease
Sentence: 556,damage,I-Disease
Sentence: 556,and,O
Sentence: 556,lipid,O
Sentence: 556,peroxidation,O
Sentence: 556,",",O
Sentence: 556,but,O
Sentence: 556,it,O
Sentence: 556,did,O
Sentence: 556,not,O
Sentence: 556,affect,O
Sentence: 556,renal,O
Sentence: 556,hemodynamics,O
Sentence: 556,and,O
Sentence: 556,vasoactive,O
Sentence: 556,substances,O
Sentence: 556,.,O
Sentence: 556,Neither,O
Sentence: 556,SOD,O
Sentence: 556,nor,O
Sentence: 556,DMTU,B-Chemical
Sentence: 556,affected,O
Sentence: 556,the,O
Sentence: 556,renal,O
Sentence: 556,cortical,O
Sentence: 556,GM,B-Chemical
Sentence: 556,content,O
Sentence: 556,in,O
Sentence: 556,GM,B-Chemical
Sentence: 556,-,O
Sentence: 556,treated,O
Sentence: 556,rats,O
Sentence: 556,.,O
Sentence: 556,These,O
Sentence: 556,results,O
Sentence: 556,suggest,O
Sentence: 556,that,O
Sentence: 556,1,O
Sentence: 556,),O
Sentence: 556,both,O
Sentence: 556,SOD,O
Sentence: 556,and,O
Sentence: 556,DMTU,B-Chemical
Sentence: 556,have,O
Sentence: 556,protective,O
Sentence: 556,effects,O
Sentence: 556,on,O
Sentence: 556,GM,B-Chemical
Sentence: 556,-,O
Sentence: 556,mediated,O
Sentence: 556,nephropathy,B-Disease
Sentence: 556,",",O
Sentence: 556,2,O
Sentence: 556,),O
Sentence: 556,the,O
Sentence: 556,mechanisms,O
Sentence: 556,for,O
Sentence: 556,the,O
Sentence: 556,protective,O
Sentence: 556,effects,O
Sentence: 556,differ,O
Sentence: 556,for,O
Sentence: 556,SOD,O
Sentence: 556,and,O
Sentence: 556,DMTU,B-Chemical
Sentence: 556,",",O
Sentence: 556,and,O
Sentence: 556,3,O
Sentence: 556,),O
Sentence: 556,superoxide,B-Chemical
Sentence: 556,anions,O
Sentence: 556,play,O
Sentence: 556,a,O
Sentence: 556,critical,O
Sentence: 556,role,O
Sentence: 556,in,O
Sentence: 556,GM,B-Chemical
Sentence: 556,-,O
Sentence: 556,induced,O
Sentence: 556,renal,O
Sentence: 556,vasoconstriction,O
Sentence: 556,.,O
Sentence: 557,Assessment,O
Sentence: 557,of,O
Sentence: 557,cardiomyocyte,O
Sentence: 557,DNA,O
Sentence: 557,synthesis,O
Sentence: 557,during,O
Sentence: 557,hypertrophy,O
Sentence: 557,in,O
Sentence: 557,adult,O
Sentence: 557,mice,O
Sentence: 557,.,O
Sentence: 558,The,O
Sentence: 558,ability,O
Sentence: 558,of,O
Sentence: 558,cardiomyocytes,O
Sentence: 558,to,O
Sentence: 558,synthesize,O
Sentence: 558,DNA,O
Sentence: 558,in,O
Sentence: 558,response,O
Sentence: 558,to,O
Sentence: 558,experimentally,O
Sentence: 558,induced,O
Sentence: 558,cardiac,B-Disease
Sentence: 558,hypertrophy,I-Disease
Sentence: 558,was,O
Sentence: 558,assessed,O
Sentence: 558,in,O
Sentence: 558,adult,O
Sentence: 558,mice,O
Sentence: 558,.,O
Sentence: 558,Isoproterenol,B-Chemical
Sentence: 558,delivered,O
Sentence: 558,by,O
Sentence: 558,osmotic,O
Sentence: 558,minipump,O
Sentence: 558,implantation,O
Sentence: 558,in,O
Sentence: 558,adult,O
Sentence: 558,C3Heb,O
Sentence: 558,/,O
Sentence: 558,FeJ,O
Sentence: 558,mice,O
Sentence: 558,resulted,O
Sentence: 558,in,O
Sentence: 558,a,O
Sentence: 558,46,O
Sentence: 558,%,O
Sentence: 558,increase,O
Sentence: 558,in,O
Sentence: 558,heart,O
Sentence: 558,weight,O
Sentence: 558,and,O
Sentence: 558,a,O
Sentence: 558,19.3,O
Sentence: 558,%,O
Sentence: 558,increase,O
Sentence: 558,in,O
Sentence: 558,cardiomyocyte,O
Sentence: 558,area,O
Sentence: 558,.,O
Sentence: 558,No,O
Sentence: 558,DNA,O
Sentence: 558,synthesis,O
Sentence: 558,",",O
Sentence: 558,as,O
Sentence: 558,assessed,O
Sentence: 558,by,O
Sentence: 558,autoradiographic,O
Sentence: 558,analysis,O
Sentence: 558,of,O
Sentence: 558,isolated,O
Sentence: 558,cardiomyocytes,O
Sentence: 558,",",O
Sentence: 558,was,O
Sentence: 558,observed,O
Sentence: 558,in,O
Sentence: 558,control,O
Sentence: 558,or,O
Sentence: 558,hypertrophic,B-Disease
Sentence: 558,hearts,I-Disease
Sentence: 558,.,O
Sentence: 558,A,O
Sentence: 558,survey,O
Sentence: 558,of,O
Sentence: 558,15,O
Sentence: 558,independent,O
Sentence: 558,inbred,O
Sentence: 558,strains,O
Sentence: 558,of,O
Sentence: 558,mice,O
Sentence: 558,revealed,O
Sentence: 558,that,O
Sentence: 558,ventricular,O
Sentence: 558,cardiomyocyte,O
Sentence: 558,nuclear,O
Sentence: 558,number,O
Sentence: 558,ranged,O
Sentence: 558,from,O
Sentence: 558,3,O
Sentence: 558,to,O
Sentence: 558,13,O
Sentence: 558,%,O
Sentence: 558,mononucleate,O
Sentence: 558,",",O
Sentence: 558,suggesting,O
Sentence: 558,that,O
Sentence: 558,cardiomyocyte,O
Sentence: 558,terminal,O
Sentence: 558,differentiation,O
Sentence: 558,is,O
Sentence: 558,influenced,O
Sentence: 558,directly,O
Sentence: 558,or,O
Sentence: 558,indirectly,O
Sentence: 558,by,O
Sentence: 558,genetic,O
Sentence: 558,background,O
Sentence: 558,.,O
Sentence: 558,To,O
Sentence: 558,determine,O
Sentence: 558,whether,O
Sentence: 558,the,O
Sentence: 558,capacity,O
Sentence: 558,for,O
Sentence: 558,reactive,O
Sentence: 558,DNA,O
Sentence: 558,synthesis,O
Sentence: 558,was,O
Sentence: 558,also,O
Sentence: 558,subject,O
Sentence: 558,to,O
Sentence: 558,genetic,O
Sentence: 558,regulation,O
Sentence: 558,",",O
Sentence: 558,cardiac,B-Disease
Sentence: 558,hypertrophy,I-Disease
Sentence: 558,was,O
Sentence: 558,induced,O
Sentence: 558,in,O
Sentence: 558,the,O
Sentence: 558,strains,O
Sentence: 558,of,O
Sentence: 558,mice,O
Sentence: 558,comprising,O
Sentence: 558,the,O
Sentence: 558,extremes,O
Sentence: 558,of,O
Sentence: 558,the,O
Sentence: 558,nuclear,O
Sentence: 558,number,O
Sentence: 558,survey,O
Sentence: 558,.,O
Sentence: 558,These,O
Sentence: 558,data,O
Sentence: 558,indicate,O
Sentence: 558,that,O
Sentence: 558,adult,O
Sentence: 558,mouse,O
Sentence: 558,atrial,O
Sentence: 558,and,O
Sentence: 558,ventricular,O
Sentence: 558,cardiomyocytes,O
Sentence: 558,do,O
Sentence: 558,not,O
Sentence: 558,synthesize,O
Sentence: 558,DNA,O
Sentence: 558,in,O
Sentence: 558,response,O
Sentence: 558,to,O
Sentence: 558,isoproterenol,B-Chemical
Sentence: 558,-,O
Sentence: 558,induced,O
Sentence: 558,cardiac,B-Disease
Sentence: 558,hypertrophy,I-Disease
Sentence: 558,.,O
Sentence: 559,Central,O
Sentence: 559,cardiovascular,O
Sentence: 559,effects,O
Sentence: 559,of,O
Sentence: 559,AVP,B-Chemical
Sentence: 559,and,O
Sentence: 559,ANP,O
Sentence: 559,in,O
Sentence: 559,normotensive,O
Sentence: 559,and,O
Sentence: 559,spontaneously,O
Sentence: 559,hypertensive,B-Disease
Sentence: 559,rats,O
Sentence: 559,.,O
Sentence: 560,The,O
Sentence: 560,purpose,O
Sentence: 560,of,O
Sentence: 560,the,O
Sentence: 560,present,O
Sentence: 560,study,O
Sentence: 560,was,O
Sentence: 560,to,O
Sentence: 560,compare,O
Sentence: 560,influence,O
Sentence: 560,of,O
Sentence: 560,central,O
Sentence: 560,arginine,B-Chemical
Sentence: 560,vasopressin,I-Chemical
Sentence: 560,(,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,),O
Sentence: 560,and,O
Sentence: 560,of,O
Sentence: 560,atrial,O
Sentence: 560,natriuretic,O
Sentence: 560,peptide,O
Sentence: 560,(,O
Sentence: 560,ANP,O
Sentence: 560,),O
Sentence: 560,on,O
Sentence: 560,control,O
Sentence: 560,of,O
Sentence: 560,arterial,O
Sentence: 560,blood,O
Sentence: 560,pressure,O
Sentence: 560,(,O
Sentence: 560,MAP,O
Sentence: 560,),O
Sentence: 560,and,O
Sentence: 560,heart,O
Sentence: 560,rate,O
Sentence: 560,(,O
Sentence: 560,HR,O
Sentence: 560,),O
Sentence: 560,in,O
Sentence: 560,normotensive,O
Sentence: 560,(,O
Sentence: 560,WKY,O
Sentence: 560,),O
Sentence: 560,and,O
Sentence: 560,spontaneously,O
Sentence: 560,hypertensive,B-Disease
Sentence: 560,(,O
Sentence: 560,SHR,O
Sentence: 560,),O
Sentence: 560,rats,O
Sentence: 560,.,O
Sentence: 560,Three,O
Sentence: 560,series,O
Sentence: 560,of,O
Sentence: 560,experiments,O
Sentence: 560,were,O
Sentence: 560,performed,O
Sentence: 560,on,O
Sentence: 560,30,O
Sentence: 560,WKY,O
Sentence: 560,and,O
Sentence: 560,30,O
Sentence: 560,SHR,O
Sentence: 560,",",O
Sentence: 560,chronically,O
Sentence: 560,instrumented,O
Sentence: 560,with,O
Sentence: 560,guide,O
Sentence: 560,tubes,O
Sentence: 560,in,O
Sentence: 560,the,O
Sentence: 560,lateral,O
Sentence: 560,ventricle,O
Sentence: 560,(,O
Sentence: 560,LV,O
Sentence: 560,),O
Sentence: 560,and,O
Sentence: 560,arterial,O
Sentence: 560,and,O
Sentence: 560,venous,O
Sentence: 560,catheters,O
Sentence: 560,.,O
Sentence: 560,MAP,O
Sentence: 560,and,O
Sentence: 560,HR,O
Sentence: 560,were,O
Sentence: 560,monitored,O
Sentence: 560,before,O
Sentence: 560,and,O
Sentence: 560,after,O
Sentence: 560,i.v,O
Sentence: 560,.,O
Sentence: 560,injections,O
Sentence: 560,of,O
Sentence: 560,either,O
Sentence: 560,vehicle,O
Sentence: 560,or,O
Sentence: 560,1,O
Sentence: 560,",",O
Sentence: 560,10,O
Sentence: 560,and,O
Sentence: 560,50,O
Sentence: 560,ng,O
Sentence: 560,of,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,and,O
Sentence: 560,25,O
Sentence: 560,",",O
Sentence: 560,125,O
Sentence: 560,and,O
Sentence: 560,500,O
Sentence: 560,ng,O
Sentence: 560,of,O
Sentence: 560,ANP,O
Sentence: 560,.,O
Sentence: 560,Sensitivity,O
Sentence: 560,of,O
Sentence: 560,cardiac,O
Sentence: 560,component,O
Sentence: 560,of,O
Sentence: 560,baroreflex,O
Sentence: 560,(,O
Sentence: 560,CCB,O
Sentence: 560,),O
Sentence: 560,",",O
Sentence: 560,expressed,O
Sentence: 560,as,O
Sentence: 560,a,O
Sentence: 560,slope,O
Sentence: 560,of,O
Sentence: 560,the,O
Sentence: 560,regression,O
Sentence: 560,line,O
Sentence: 560,was,O
Sentence: 560,determined,O
Sentence: 560,from,O
Sentence: 560,relationships,O
Sentence: 560,between,O
Sentence: 560,systolic,O
Sentence: 560,arterial,O
Sentence: 560,pressure,O
Sentence: 560,(,O
Sentence: 560,SAP,O
Sentence: 560,),O
Sentence: 560,and,O
Sentence: 560,HR,O
Sentence: 560,period,O
Sentence: 560,(,O
Sentence: 560,HRp,O
Sentence: 560,),O
Sentence: 560,during,O
Sentence: 560,phenylephrine,B-Chemical
Sentence: 560,(,O
Sentence: 560,Phe,B-Chemical
Sentence: 560,),O
Sentence: 560,,O
Sentence: 560,-,O
Sentence: 560,induced,O
Sentence: 560,hypertension,B-Disease
Sentence: 560,and,O
Sentence: 560,sodium,B-Chemical
Sentence: 560,nitroprusside,I-Chemical
Sentence: 560,(,O
Sentence: 560,SN,B-Chemical
Sentence: 560,),O
Sentence: 560,,O
Sentence: 560,-,O
Sentence: 560,induced,O
Sentence: 560,hypotension,B-Disease
Sentence: 560,.,O
Sentence: 560,CCB,O
Sentence: 560,was,O
Sentence: 560,measured,O
Sentence: 560,before,O
Sentence: 560,and,O
Sentence: 560,after,O
Sentence: 560,administration,O
Sentence: 560,of,O
Sentence: 560,either,O
Sentence: 560,vehicle,O
Sentence: 560,",",O
Sentence: 560,AVP,B-Chemical
Sentence: 560,",",O
Sentence: 560,ANP,O
Sentence: 560,",",O
Sentence: 560,or,O
Sentence: 560,both,O
Sentence: 560,peptides,O
Sentence: 560,together,O
Sentence: 560,.,O
Sentence: 560,Increases,O
Sentence: 560,of,O
Sentence: 560,MAP,O
Sentence: 560,occurred,O
Sentence: 560,after,O
Sentence: 560,LV,O
Sentence: 560,administration,O
Sentence: 560,of,O
Sentence: 560,1,O
Sentence: 560,",",O
Sentence: 560,10,O
Sentence: 560,and,O
Sentence: 560,50,O
Sentence: 560,ng,O
Sentence: 560,of,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,in,O
Sentence: 560,WKY,O
Sentence: 560,and,O
Sentence: 560,of,O
Sentence: 560,10,O
Sentence: 560,and,O
Sentence: 560,50,O
Sentence: 560,ng,O
Sentence: 560,in,O
Sentence: 560,SHR,O
Sentence: 560,.,O
Sentence: 560,ANP,O
Sentence: 560,did,O
Sentence: 560,not,O
Sentence: 560,cause,O
Sentence: 560,significant,O
Sentence: 560,changes,O
Sentence: 560,in,O
Sentence: 560,MAP,O
Sentence: 560,in,O
Sentence: 560,both,O
Sentence: 560,strains,O
Sentence: 560,as,O
Sentence: 560,compared,O
Sentence: 560,to,O
Sentence: 560,vehicle,O
Sentence: 560,",",O
Sentence: 560,but,O
Sentence: 560,it,O
Sentence: 560,abolished,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,-,O
Sentence: 560,induced,O
Sentence: 560,MAP,O
Sentence: 560,increase,O
Sentence: 560,in,O
Sentence: 560,WKY,O
Sentence: 560,and,O
Sentence: 560,SHR,O
Sentence: 560,.,O
Sentence: 560,CCB,O
Sentence: 560,was,O
Sentence: 560,reduced,O
Sentence: 560,in,O
Sentence: 560,WKY,O
Sentence: 560,and,O
Sentence: 560,SHR,O
Sentence: 560,after,O
Sentence: 560,LV,O
Sentence: 560,administration,O
Sentence: 560,of,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,during,O
Sentence: 560,SN,B-Chemical
Sentence: 560,-,O
Sentence: 560,induced,O
Sentence: 560,hypotension,B-Disease
Sentence: 560,.,O
Sentence: 560,In,O
Sentence: 560,SHR,O
Sentence: 560,but,O
Sentence: 560,not,O
Sentence: 560,in,O
Sentence: 560,WKY,O
Sentence: 560,administration,O
Sentence: 560,of,O
Sentence: 560,ANP,O
Sentence: 560,",",O
Sentence: 560,AVP,B-Chemical
Sentence: 560,and,O
Sentence: 560,ANP,O
Sentence: 560,+,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,decreased,O
Sentence: 560,CCB,O
Sentence: 560,during,O
Sentence: 560,Phe,B-Chemical
Sentence: 560,-,O
Sentence: 560,induced,O
Sentence: 560,MAP,O
Sentence: 560,elevation,O
Sentence: 560,.,O
Sentence: 560,The,O
Sentence: 560,results,O
Sentence: 560,indicate,O
Sentence: 560,that,O
Sentence: 560,centrally,O
Sentence: 560,applied,O
Sentence: 560,AVP,B-Chemical
Sentence: 560,and,O
Sentence: 560,ANP,O
Sentence: 560,exert,O
Sentence: 560,differential,O
Sentence: 560,effects,O
Sentence: 560,on,O
Sentence: 560,blood,O
Sentence: 560,pressure,O
Sentence: 560,and,O
Sentence: 560,baroreflex,O
Sentence: 560,control,O
Sentence: 560,of,O
Sentence: 560,heart,O
Sentence: 560,rate,O
Sentence: 560,in,O
Sentence: 560,WKY,O
Sentence: 560,and,O
Sentence: 560,SHR,O
Sentence: 560,and,O
Sentence: 560,suggest,O
Sentence: 560,interaction,O
Sentence: 560,of,O
Sentence: 560,these,O
Sentence: 560,two,O
Sentence: 560,peptides,O
Sentence: 560,in,O
Sentence: 560,blood,O
Sentence: 560,pressure,O
Sentence: 560,regulation,O
Sentence: 560,at,O
Sentence: 560,the,O
Sentence: 560,level,O
Sentence: 560,of,O
Sentence: 560,central,O
Sentence: 560,nervous,O
Sentence: 560,system,O
Sentence: 560,.,O
Sentence: 561,Cutaneous,O
Sentence: 561,exposure,O
Sentence: 561,to,O
Sentence: 561,warfarin,B-Chemical
Sentence: 561,-,O
Sentence: 561,like,O
Sentence: 561,anticoagulant,O
Sentence: 561,causing,O
Sentence: 561,an,O
Sentence: 561,intracerebral,B-Disease
Sentence: 561,hemorrhage,I-Disease
Sentence: 561,:,O
Sentence: 561,a,O
Sentence: 561,case,O
Sentence: 561,report,O
Sentence: 561,.,O
Sentence: 562,A,O
Sentence: 562,case,O
Sentence: 562,of,O
Sentence: 562,intercerebral,O
Sentence: 562,hematoma,B-Disease
Sentence: 562,due,O
Sentence: 562,to,O
Sentence: 562,warfarin,B-Chemical
Sentence: 562,-,O
Sentence: 562,induced,O
Sentence: 562,coagulopathy,B-Disease
Sentence: 562,is,O
Sentence: 562,presented,O
Sentence: 562,.,O
Sentence: 562,The,O
Sentence: 562,39,O
Sentence: 562,-,O
Sentence: 562,year,O
Sentence: 562,-,O
Sentence: 562,old,O
Sentence: 562,woman,O
Sentence: 562,had,O
Sentence: 562,spread,O
Sentence: 562,a,O
Sentence: 562,warfarin,B-Chemical
Sentence: 562,-,O
Sentence: 562,type,O
Sentence: 562,rat,O
Sentence: 562,poison,O
Sentence: 562,around,O
Sentence: 562,her,O
Sentence: 562,house,O
Sentence: 562,weekly,O
Sentence: 562,using,O
Sentence: 562,her,O
Sentence: 562,bare,O
Sentence: 562,hands,O
Sentence: 562,",",O
Sentence: 562,with,O
Sentence: 562,no,O
Sentence: 562,washing,O
Sentence: 562,post,O
Sentence: 562,application,O
Sentence: 562,.,O
Sentence: 562,Percutaneous,O
Sentence: 562,absorption,O
Sentence: 562,of,O
Sentence: 562,warfarin,B-Chemical
Sentence: 562,causing,O
Sentence: 562,coagulopathy,B-Disease
Sentence: 562,",",O
Sentence: 562,reported,O
Sentence: 562,three,O
Sentence: 562,times,O
Sentence: 562,in,O
Sentence: 562,the,O
Sentence: 562,past,O
Sentence: 562,",",O
Sentence: 562,is,O
Sentence: 562,a,O
Sentence: 562,significant,O
Sentence: 562,risk,O
Sentence: 562,if,O
Sentence: 562,protective,O
Sentence: 562,measures,O
Sentence: 562,",",O
Sentence: 562,such,O
Sentence: 562,as,O
Sentence: 562,gloves,O
Sentence: 562,",",O
Sentence: 562,are,O
Sentence: 562,not,O
Sentence: 562,used,O
Sentence: 562,.,O
Sentence: 562,An,O
Sentence: 562,adverse,O
Sentence: 562,drug,O
Sentence: 562,interaction,O
Sentence: 562,with,O
Sentence: 562,piroxicam,B-Chemical
Sentence: 562,",",O
Sentence: 562,which,O
Sentence: 562,she,O
Sentence: 562,took,O
Sentence: 562,occasionally,O
Sentence: 562,",",O
Sentence: 562,may,O
Sentence: 562,have,O
Sentence: 562,exacerbated,O
Sentence: 562,the,O
Sentence: 562,coagulopathy,B-Disease
Sentence: 562,.,O
Sentence: 563,Pediatric,O
Sentence: 563,heart,O
Sentence: 563,transplantation,O
Sentence: 563,without,O
Sentence: 563,chronic,O
Sentence: 563,maintenance,O
Sentence: 563,steroids,O
Sentence: 563,.,O
Sentence: 564,From,O
Sentence: 564,1986,O
Sentence: 564,to,O
Sentence: 564,February,O
Sentence: 564,1993,O
Sentence: 564,",",O
Sentence: 564,40,O
Sentence: 564,children,O
Sentence: 564,aged,O
Sentence: 564,2,O
Sentence: 564,months,O
Sentence: 564,to,O
Sentence: 564,18,O
Sentence: 564,years,O
Sentence: 564,(,O
Sentence: 564,average,O
Sentence: 564,age,O
Sentence: 564,10.4,O
Sentence: 564,+,O
Sentence: 564,/,O
Sentence: 564,,O
Sentence: 564,-,O
Sentence: 564,,O
Sentence: 564,5.8,O
Sentence: 564,years,O
Sentence: 564,),O
Sentence: 564,underwent,O
Sentence: 564,heart,O
Sentence: 564,transplantation,O
Sentence: 564,.,O
Sentence: 564,Indications,O
Sentence: 564,for,O
Sentence: 564,transplantation,O
Sentence: 564,were,O
Sentence: 564,idiopathic,B-Disease
Sentence: 564,cardiomyopathy,B-Disease
Sentence: 564,(,O
Sentence: 564,52,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,",",O
Sentence: 564,congenital,B-Disease
Sentence: 564,heart,I-Disease
Sentence: 564,disease,I-Disease
Sentence: 564,(,O
Sentence: 564,35,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,with,O
Sentence: 564,and,O
Sentence: 564,without,O
Sentence: 564,prior,O
Sentence: 564,repair,O
Sentence: 564,(,O
Sentence: 564,71,O
Sentence: 564,%,O
Sentence: 564,and,O
Sentence: 564,29,O
Sentence: 564,%,O
Sentence: 564,",",O
Sentence: 564,respectively,O
Sentence: 564,),O
Sentence: 564,",",O
Sentence: 564,hypertrophic,B-Disease
Sentence: 564,cardiomyopathy,B-Disease
Sentence: 564,(,O
Sentence: 564,5,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,",",O
Sentence: 564,valvular,B-Disease
Sentence: 564,heart,I-Disease
Sentence: 564,disease,I-Disease
Sentence: 564,(,O
Sentence: 564,3,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,",",O
Sentence: 564,and,O
Sentence: 564,doxorubicin,B-Chemical
Sentence: 564,cardiomyopathy,B-Disease
Sentence: 564,(,O
Sentence: 564,5,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,.,O
Sentence: 564,Patients,O
Sentence: 564,were,O
Sentence: 564,managed,O
Sentence: 564,with,O
Sentence: 564,cyclosporine,B-Chemical
Sentence: 564,and,O
Sentence: 564,azathioprine,B-Chemical
Sentence: 564,.,O
Sentence: 564,No,O
Sentence: 564,prophylaxis,O
Sentence: 564,with,O
Sentence: 564,antilymphocyte,O
Sentence: 564,globulin,O
Sentence: 564,was,O
Sentence: 564,used,O
Sentence: 564,.,O
Sentence: 564,Steroids,B-Chemical
Sentence: 564,were,O
Sentence: 564,given,O
Sentence: 564,to,O
Sentence: 564,39,O
Sentence: 564,%,O
Sentence: 564,of,O
Sentence: 564,patients,O
Sentence: 564,for,O
Sentence: 564,refractory,O
Sentence: 564,rejection,O
Sentence: 564,",",O
Sentence: 564,but,O
Sentence: 564,weaning,O
Sentence: 564,was,O
Sentence: 564,always,O
Sentence: 564,attempted,O
Sentence: 564,and,O
Sentence: 564,generally,O
Sentence: 564,successful,O
Sentence: 564,(,O
Sentence: 564,64,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,.,O
Sentence: 564,Five,O
Sentence: 564,patients,O
Sentence: 564,(,O
Sentence: 564,14,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,received,O
Sentence: 564,maintenance,O
Sentence: 564,steroids,B-Chemical
Sentence: 564,.,O
Sentence: 564,Four,O
Sentence: 564,patients,O
Sentence: 564,died,O
Sentence: 564,in,O
Sentence: 564,the,O
Sentence: 564,perioperative,O
Sentence: 564,period,O
Sentence: 564,and,O
Sentence: 564,one,O
Sentence: 564,died,O
Sentence: 564,4,O
Sentence: 564,months,O
Sentence: 564,later,O
Sentence: 564,.,O
Sentence: 564,There,O
Sentence: 564,have,O
Sentence: 564,been,O
Sentence: 564,no,O
Sentence: 564,deaths,O
Sentence: 564,related,O
Sentence: 564,to,O
Sentence: 564,rejection,O
Sentence: 564,or,O
Sentence: 564,infection,B-Disease
Sentence: 564,.,O
Sentence: 564,Average,O
Sentence: 564,follow,O
Sentence: 564,-,O
Sentence: 564,up,O
Sentence: 564,was,O
Sentence: 564,36,O
Sentence: 564,+,O
Sentence: 564,/,O
Sentence: 564,,O
Sentence: 564,-,O
Sentence: 564,,O
Sentence: 564,19,O
Sentence: 564,months,O
Sentence: 564,(,O
Sentence: 564,range,O
Sentence: 564,1,O
Sentence: 564,to,O
Sentence: 564,65,O
Sentence: 564,months,O
Sentence: 564,),O
Sentence: 564,.,O
Sentence: 564,Cumulative,O
Sentence: 564,survival,O
Sentence: 564,is,O
Sentence: 564,88,O
Sentence: 564,%,O
Sentence: 564,at,O
Sentence: 564,5,O
Sentence: 564,years,O
Sentence: 564,.,O
Sentence: 564,In,O
Sentence: 564,patients,O
Sentence: 564,less,O
Sentence: 564,than,O
Sentence: 564,7,O
Sentence: 564,years,O
Sentence: 564,of,O
Sentence: 564,age,O
Sentence: 564,",",O
Sentence: 564,rejection,O
Sentence: 564,was,O
Sentence: 564,monitored,O
Sentence: 564,noninvasively,O
Sentence: 564,.,O
Sentence: 564,In,O
Sentence: 564,the,O
Sentence: 564,first,O
Sentence: 564,postoperative,O
Sentence: 564,month,O
Sentence: 564,",",O
Sentence: 564,89,O
Sentence: 564,%,O
Sentence: 564,of,O
Sentence: 564,patients,O
Sentence: 564,were,O
Sentence: 564,treated,O
Sentence: 564,for,O
Sentence: 564,rejection,O
Sentence: 564,.,O
Sentence: 564,Freedom,O
Sentence: 564,from,O
Sentence: 564,serious,O
Sentence: 564,infections,B-Disease
Sentence: 564,was,O
Sentence: 564,83,O
Sentence: 564,%,O
Sentence: 564,at,O
Sentence: 564,1,O
Sentence: 564,month,O
Sentence: 564,and,O
Sentence: 564,65,O
Sentence: 564,%,O
Sentence: 564,at,O
Sentence: 564,1,O
Sentence: 564,year,O
Sentence: 564,.,O
Sentence: 564,Cytomegalovirus,B-Disease
Sentence: 564,infections,I-Disease
Sentence: 564,were,O
Sentence: 564,treated,O
Sentence: 564,successfully,O
Sentence: 564,with,O
Sentence: 564,ganciclovir,B-Chemical
Sentence: 564,in,O
Sentence: 564,11,O
Sentence: 564,patients,O
Sentence: 564,.,O
Sentence: 564,No,O
Sentence: 564,impairment,O
Sentence: 564,of,O
Sentence: 564,growth,O
Sentence: 564,was,O
Sentence: 564,observed,O
Sentence: 564,in,O
Sentence: 564,children,O
Sentence: 564,who,O
Sentence: 564,underwent,O
Sentence: 564,transplantation,O
Sentence: 564,compared,O
Sentence: 564,with,O
Sentence: 564,a,O
Sentence: 564,control,O
Sentence: 564,population,O
Sentence: 564,.,O
Sentence: 564,Twenty,O
Sentence: 564,-,O
Sentence: 564,one,O
Sentence: 564,patients,O
Sentence: 564,(,O
Sentence: 564,60,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,have,O
Sentence: 564,undergone,O
Sentence: 564,annual,O
Sentence: 564,catheterizations,O
Sentence: 564,and,O
Sentence: 564,no,O
Sentence: 564,sign,O
Sentence: 564,of,O
Sentence: 564,graft,O
Sentence: 564,atherosclerosis,B-Disease
Sentence: 564,has,O
Sentence: 564,been,O
Sentence: 564,observed,O
Sentence: 564,.,O
Sentence: 564,Seizures,B-Disease
Sentence: 564,occurred,O
Sentence: 564,in,O
Sentence: 564,five,O
Sentence: 564,patients,O
Sentence: 564,(,O
Sentence: 564,14,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,and,O
Sentence: 564,hypertension,B-Disease
Sentence: 564,was,O
Sentence: 564,treated,O
Sentence: 564,in,O
Sentence: 564,10,O
Sentence: 564,patients,O
Sentence: 564,(,O
Sentence: 564,28,O
Sentence: 564,%,O
Sentence: 564,),O
Sentence: 564,.,O
Sentence: 564,No,O
Sentence: 564,patient,O
Sentence: 564,was,O
Sentence: 564,disabled,O
Sentence: 564,and,O
Sentence: 564,no,O
Sentence: 564,lymphoproliferative,B-Disease
Sentence: 564,disorder,I-Disease
Sentence: 564,was,O
Sentence: 564,observed,O
Sentence: 564,.,O
Sentence: 564,(,O
Sentence: 564,ABSTRACT,O
Sentence: 564,TRUNCATED,O
Sentence: 564,AT,O
Sentence: 564,250,O
Sentence: 564,WORDS,O
Sentence: 564,),O
Sentence: 565,Delirium,B-Disease
Sentence: 565,during,O
Sentence: 565,fluoxetine,B-Chemical
Sentence: 565,treatment,O
Sentence: 565,.,O
Sentence: 565,A,O
Sentence: 565,case,O
Sentence: 565,report,O
Sentence: 565,.,O
Sentence: 566,The,O
Sentence: 566,correlation,O
Sentence: 566,between,O
Sentence: 566,high,O
Sentence: 566,serum,O
Sentence: 566,tricyclic,O
Sentence: 566,antidepressant,O
Sentence: 566,concentrations,O
Sentence: 566,and,O
Sentence: 566,central,O
Sentence: 566,nervous,O
Sentence: 566,system,O
Sentence: 566,side,O
Sentence: 566,effects,O
Sentence: 566,has,O
Sentence: 566,been,O
Sentence: 566,well,O
Sentence: 566,established,O
Sentence: 566,.,O
Sentence: 566,Only,O
Sentence: 566,a,O
Sentence: 566,few,O
Sentence: 566,reports,O
Sentence: 566,exist,O
Sentence: 566,",",O
Sentence: 566,however,O
Sentence: 566,",",O
Sentence: 566,on,O
Sentence: 566,the,O
Sentence: 566,relationship,O
Sentence: 566,between,O
Sentence: 566,the,O
Sentence: 566,serum,O
Sentence: 566,concentrations,O
Sentence: 566,of,O
Sentence: 566,selective,O
Sentence: 566,serotonin,B-Chemical
Sentence: 566,reuptake,O
Sentence: 566,inhibitors,O
Sentence: 566,(,O
Sentence: 566,SSRIs,O
Sentence: 566,),O
Sentence: 566,and,O
Sentence: 566,their,O
Sentence: 566,toxic,O
Sentence: 566,effects,O
Sentence: 566,.,O
Sentence: 566,In,O
Sentence: 566,some,O
Sentence: 566,cases,O
Sentence: 566,",",O
Sentence: 566,a,O
Sentence: 566,high,O
Sentence: 566,serum,O
Sentence: 566,concentration,O
Sentence: 566,of,O
Sentence: 566,citalopram,B-Chemical
Sentence: 566,(,O
Sentence: 566,,O
Sentence: 566,>,O
Sentence: 566,,O
Sentence: 566,600,O
Sentence: 566,nmol,O
Sentence: 566,/,O
Sentence: 566,L,O
Sentence: 566,),O
Sentence: 566,in,O
Sentence: 566,elderly,O
Sentence: 566,patients,O
Sentence: 566,has,O
Sentence: 566,been,O
Sentence: 566,associated,O
Sentence: 566,with,O
Sentence: 566,increased,O
Sentence: 566,somnolence,B-Disease
Sentence: 566,and,O
Sentence: 566,movement,B-Disease
Sentence: 566,difficulties,I-Disease
Sentence: 566,.,O
Sentence: 566,Widespread,O
Sentence: 566,cognitive,B-Disease
Sentence: 566,disorders,I-Disease
Sentence: 566,",",O
Sentence: 566,such,O
Sentence: 566,as,O
Sentence: 566,delirium,B-Disease
Sentence: 566,",",O
Sentence: 566,have,O
Sentence: 566,not,O
Sentence: 566,been,O
Sentence: 566,previously,O
Sentence: 566,linked,O
Sentence: 566,with,O
Sentence: 566,high,O
Sentence: 566,blood,O
Sentence: 566,levels,O
Sentence: 566,of,O
Sentence: 566,SSRIs,O
Sentence: 566,.,O
Sentence: 566,In,O
Sentence: 566,this,O
Sentence: 566,report,O
Sentence: 566,",",O
Sentence: 566,we,O
Sentence: 566,describe,O
Sentence: 566,a,O
Sentence: 566,patient,O
Sentence: 566,with,O
Sentence: 566,acute,O
Sentence: 566,hyperkinetic,B-Disease
Sentence: 566,delirium,B-Disease
Sentence: 566,connected,O
Sentence: 566,with,O
Sentence: 566,a,O
Sentence: 566,high,O
Sentence: 566,serum,O
Sentence: 566,total,O
Sentence: 566,fluoxetine,B-Chemical
Sentence: 566,(,O
Sentence: 566,fluoxetine,B-Chemical
Sentence: 566,plus,O
Sentence: 566,desmethylfluoxetine,B-Chemical
Sentence: 566,),O
Sentence: 566,concentration,O
Sentence: 566,.,O
Sentence: 567,Pulmonary,B-Disease
Sentence: 567,edema,I-Disease
Sentence: 567,and,O
Sentence: 567,shock,B-Disease
Sentence: 567,after,O
Sentence: 567,high,O
Sentence: 567,-,O
Sentence: 567,dose,O
Sentence: 567,aracytine,O
Sentence: 567,-,O
Sentence: 567,C,O
Sentence: 567,for,O
Sentence: 567,lymphoma,B-Disease
Sentence: 567,;,O
Sentence: 567,possible,O
Sentence: 567,role,O
Sentence: 567,of,O
Sentence: 567,TNF,O
Sentence: 567,-,O
Sentence: 567,alpha,O
Sentence: 567,and,O
Sentence: 567,PAF,O
Sentence: 567,.,O
Sentence: 568,Four,O
Sentence: 568,out,O
Sentence: 568,of,O
Sentence: 568,23,O
Sentence: 568,consecutive,O
Sentence: 568,patients,O
Sentence: 568,treated,O
Sentence: 568,with,O
Sentence: 568,high,O
Sentence: 568,-,O
Sentence: 568,dose,O
Sentence: 568,Ara,O
Sentence: 568,-,O
Sentence: 568,C,O
Sentence: 568,for,O
Sentence: 568,lymphomas,B-Disease
Sentence: 568,in,O
Sentence: 568,our,O
Sentence: 568,institution,O
Sentence: 568,developed,O
Sentence: 568,a,O
Sentence: 568,strikingly,O
Sentence: 568,similar,O
Sentence: 568,syndrome,O
Sentence: 568,during,O
Sentence: 568,the,O
Sentence: 568,perfusion,O
Sentence: 568,.,O
Sentence: 568,It,O
Sentence: 568,was,O
Sentence: 568,characterized,O
Sentence: 568,by,O
Sentence: 568,the,O
Sentence: 568,onset,O
Sentence: 568,of,O
Sentence: 568,fever,B-Disease
Sentence: 568,",",O
Sentence: 568,diarrhea,B-Disease
Sentence: 568,",",O
Sentence: 568,shock,B-Disease
Sentence: 568,",",O
Sentence: 568,pulmonary,B-Disease
Sentence: 568,edema,I-Disease
Sentence: 568,",",O
Sentence: 568,acute,B-Disease
Sentence: 568,renal,I-Disease
Sentence: 568,failure,I-Disease
Sentence: 568,",",O
Sentence: 568,metabolic,B-Disease
Sentence: 568,acidosis,I-Disease
Sentence: 568,",",O
Sentence: 568,weight,B-Disease
Sentence: 568,gain,I-Disease
Sentence: 568,and,O
Sentence: 568,leukocytosis,B-Disease
Sentence: 568,.,O
Sentence: 568,Thorough,O
Sentence: 568,bacteriological,O
Sentence: 568,screening,O
Sentence: 568,failed,O
Sentence: 568,to,O
Sentence: 568,provide,O
Sentence: 568,evidence,O
Sentence: 568,of,O
Sentence: 568,infection,B-Disease
Sentence: 568,.,O
Sentence: 568,Sequential,O
Sentence: 568,biological,O
Sentence: 568,assays,O
Sentence: 568,of,O
Sentence: 568,IL,O
Sentence: 568,-,O
Sentence: 568,1,O
Sentence: 568,",",O
Sentence: 568,IL,O
Sentence: 568,-,O
Sentence: 568,2,O
Sentence: 568,",",O
Sentence: 568,TNF,O
Sentence: 568,and,O
Sentence: 568,PAF,O
Sentence: 568,were,O
Sentence: 568,performed,O
Sentence: 568,during,O
Sentence: 568,Ara,O
Sentence: 568,-,O
Sentence: 568,C,O
Sentence: 568,infusion,O
Sentence: 568,to,O
Sentence: 568,ten,O
Sentence: 568,patients,O
Sentence: 568,",",O
Sentence: 568,including,O
Sentence: 568,the,O
Sentence: 568,four,O
Sentence: 568,who,O
Sentence: 568,developed,O
Sentence: 568,the,O
Sentence: 568,syndrome,O
Sentence: 568,.,O
Sentence: 568,TNF,O
Sentence: 568,and,O
Sentence: 568,PAF,O
Sentence: 568,activity,O
Sentence: 568,was,O
Sentence: 568,found,O
Sentence: 568,in,O
Sentence: 568,the,O
Sentence: 568,serum,O
Sentence: 568,of,O
Sentence: 568,respectively,O
Sentence: 568,two,O
Sentence: 568,and,O
Sentence: 568,four,O
Sentence: 568,of,O
Sentence: 568,the,O
Sentence: 568,cases,O
Sentence: 568,",",O
Sentence: 568,but,O
Sentence: 568,not,O
Sentence: 568,in,O
Sentence: 568,the,O
Sentence: 568,six,O
Sentence: 568,controls,O
Sentence: 568,.,O
Sentence: 568,As,O
Sentence: 568,TNF,O
Sentence: 568,and,O
Sentence: 568,PAF,O
Sentence: 568,are,O
Sentence: 568,thought,O
Sentence: 568,to,O
Sentence: 568,be,O
Sentence: 568,involved,O
Sentence: 568,in,O
Sentence: 568,the,O
Sentence: 568,development,O
Sentence: 568,of,O
Sentence: 568,septic,O
Sentence: 568,shock,B-Disease
Sentence: 568,and,O
Sentence: 568,adult,B-Disease
Sentence: 568,respiratory,I-Disease
Sentence: 568,distress,I-Disease
Sentence: 568,syndrome,I-Disease
Sentence: 568,",",O
Sentence: 568,we,O
Sentence: 568,hypothesize,O
Sentence: 568,that,O
Sentence: 568,high,O
Sentence: 568,-,O
Sentence: 568,dose,O
Sentence: 568,Ara,O
Sentence: 568,-,O
Sentence: 568,C,O
Sentence: 568,may,O
Sentence: 568,be,O
Sentence: 568,associated,O
Sentence: 568,with,O
Sentence: 568,cytokine,O
Sentence: 568,release,O
Sentence: 568,.,O
Sentence: 569,Protective,O
Sentence: 569,effect,O
Sentence: 569,of,O
Sentence: 569,clentiazem,B-Chemical
Sentence: 569,against,O
Sentence: 569,epinephrine,B-Chemical
Sentence: 569,-,O
Sentence: 569,induced,O
Sentence: 569,cardiac,B-Disease
Sentence: 569,injury,I-Disease
Sentence: 569,in,O
Sentence: 569,rats,O
Sentence: 569,.,O
Sentence: 570,We,O
Sentence: 570,investigated,O
Sentence: 570,the,O
Sentence: 570,effects,O
Sentence: 570,of,O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,",",O
Sentence: 570,a,O
Sentence: 570,"1,5",O
Sentence: 570,-,O
Sentence: 570,benzothiazepine,O
Sentence: 570,calcium,B-Chemical
Sentence: 570,antagonist,O
Sentence: 570,",",O
Sentence: 570,on,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,induced,O
Sentence: 570,cardiomyopathy,B-Disease
Sentence: 570,in,O
Sentence: 570,rats,O
Sentence: 570,.,O
Sentence: 570,With,O
Sentence: 570,2,O
Sentence: 570,-,O
Sentence: 570,week,O
Sentence: 570,chronic,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,infusion,O
Sentence: 570,",",O
Sentence: 570,16,O
Sentence: 570,of,O
Sentence: 570,30,O
Sentence: 570,rats,O
Sentence: 570,died,O
Sentence: 570,within,O
Sentence: 570,4,O
Sentence: 570,days,O
Sentence: 570,",",O
Sentence: 570,and,O
Sentence: 570,severe,O
Sentence: 570,ischemic,B-Disease
Sentence: 570,lesions,I-Disease
Sentence: 570,and,O
Sentence: 570,fibrosis,B-Disease
Sentence: 570,of,O
Sentence: 570,the,O
Sentence: 570,left,O
Sentence: 570,ventricles,O
Sentence: 570,were,O
Sentence: 570,observed,O
Sentence: 570,.,O
Sentence: 570,In,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,treated,O
Sentence: 570,rats,O
Sentence: 570,",",O
Sentence: 570,left,O
Sentence: 570,atrial,O
Sentence: 570,and,O
Sentence: 570,left,O
Sentence: 570,ventricular,O
Sentence: 570,papillary,O
Sentence: 570,muscle,O
Sentence: 570,contractile,O
Sentence: 570,responses,O
Sentence: 570,to,O
Sentence: 570,isoproterenol,B-Chemical
Sentence: 570,were,O
Sentence: 570,reduced,O
Sentence: 570,",",O
Sentence: 570,but,O
Sentence: 570,responses,O
Sentence: 570,to,O
Sentence: 570,calcium,B-Chemical
Sentence: 570,were,O
Sentence: 570,normal,O
Sentence: 570,or,O
Sentence: 570,enhanced,O
Sentence: 570,compared,O
Sentence: 570,to,O
Sentence: 570,controls,O
Sentence: 570,.,O
Sentence: 570,Left,O
Sentence: 570,ventricular,O
Sentence: 570,alpha,O
Sentence: 570,and,O
Sentence: 570,beta,O
Sentence: 570,adrenoceptor,O
Sentence: 570,densities,O
Sentence: 570,were,O
Sentence: 570,also,O
Sentence: 570,reduced,O
Sentence: 570,compared,O
Sentence: 570,to,O
Sentence: 570,controls,O
Sentence: 570,.,O
Sentence: 570,Treatment,O
Sentence: 570,with,O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,prevented,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,induced,O
Sentence: 570,death,O
Sentence: 570,(,O
Sentence: 570,P,O
Sentence: 570,,O
Sentence: 570,<,O
Sentence: 570,,O
Sentence: 570,.05,O
Sentence: 570,),O
Sentence: 570,",",O
Sentence: 570,and,O
Sentence: 570,attenuated,O
Sentence: 570,the,O
Sentence: 570,ventricular,O
Sentence: 570,ischemic,B-Disease
Sentence: 570,lesions,I-Disease
Sentence: 570,and,O
Sentence: 570,fibrosis,B-Disease
Sentence: 570,",",O
Sentence: 570,in,O
Sentence: 570,a,O
Sentence: 570,dose,O
Sentence: 570,-,O
Sentence: 570,dependent,O
Sentence: 570,manner,O
Sentence: 570,.,O
Sentence: 570,Left,O
Sentence: 570,atrial,O
Sentence: 570,and,O
Sentence: 570,left,O
Sentence: 570,ventricular,O
Sentence: 570,papillary,O
Sentence: 570,muscle,O
Sentence: 570,contractile,O
Sentence: 570,responses,O
Sentence: 570,to,O
Sentence: 570,isoproterenol,B-Chemical
Sentence: 570,were,O
Sentence: 570,reduced,O
Sentence: 570,compared,O
Sentence: 570,to,O
Sentence: 570,controls,O
Sentence: 570,in,O
Sentence: 570,groups,O
Sentence: 570,treated,O
Sentence: 570,with,O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,alone,O
Sentence: 570,",",O
Sentence: 570,but,O
Sentence: 570,combined,O
Sentence: 570,with,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,",",O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,restored,O
Sentence: 570,left,O
Sentence: 570,atrial,O
Sentence: 570,responses,O
Sentence: 570,and,O
Sentence: 570,enhanced,O
Sentence: 570,left,O
Sentence: 570,ventricular,O
Sentence: 570,papillary,O
Sentence: 570,responses,O
Sentence: 570,to,O
Sentence: 570,isoproterenol,B-Chemical
Sentence: 570,.,O
Sentence: 570,On,O
Sentence: 570,the,O
Sentence: 570,other,O
Sentence: 570,hand,O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,did,O
Sentence: 570,not,O
Sentence: 570,prevent,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,induced,O
Sentence: 570,down,O
Sentence: 570,-,O
Sentence: 570,regulation,O
Sentence: 570,of,O
Sentence: 570,alpha,O
Sentence: 570,and,O
Sentence: 570,beta,O
Sentence: 570,adrenoceptors,O
Sentence: 570,.,O
Sentence: 570,Interestingly,O
Sentence: 570,",",O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,",",O
Sentence: 570,infused,O
Sentence: 570,alone,O
Sentence: 570,",",O
Sentence: 570,resulted,O
Sentence: 570,in,O
Sentence: 570,decreased,O
Sentence: 570,adrenergic,O
Sentence: 570,receptor,O
Sentence: 570,densities,O
Sentence: 570,in,O
Sentence: 570,the,O
Sentence: 570,left,O
Sentence: 570,ventricle,O
Sentence: 570,.,O
Sentence: 570,Clentiazem,B-Chemical
Sentence: 570,also,O
Sentence: 570,did,O
Sentence: 570,not,O
Sentence: 570,prevent,O
Sentence: 570,the,O
Sentence: 570,enhanced,O
Sentence: 570,responses,O
Sentence: 570,to,O
Sentence: 570,calcium,B-Chemical
Sentence: 570,seen,O
Sentence: 570,in,O
Sentence: 570,the,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,treated,O
Sentence: 570,animals,O
Sentence: 570,",",O
Sentence: 570,although,O
Sentence: 570,the,O
Sentence: 570,high,O
Sentence: 570,dose,O
Sentence: 570,of,O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,partially,O
Sentence: 570,attenuated,O
Sentence: 570,the,O
Sentence: 570,maximal,O
Sentence: 570,response,O
Sentence: 570,to,O
Sentence: 570,calcium,B-Chemical
Sentence: 570,compared,O
Sentence: 570,to,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,treated,O
Sentence: 570,animals,O
Sentence: 570,.,O
Sentence: 570,In,O
Sentence: 570,conclusion,O
Sentence: 570,",",O
Sentence: 570,clentiazem,B-Chemical
Sentence: 570,attenuated,O
Sentence: 570,epinephrine,B-Chemical
Sentence: 570,-,O
Sentence: 570,induced,O
Sentence: 570,cardiac,B-Disease
Sentence: 570,injury,I-Disease
Sentence: 570,",",O
Sentence: 570,possibly,O
Sentence: 570,through,O
Sentence: 570,its,O
Sentence: 570,effect,O
Sentence: 570,on,O
Sentence: 570,the,O
Sentence: 570,adrenergic,O
Sentence: 570,pathway,O
Sentence: 570,.,O
Sentence: 571,Cocaine,B-Chemical
Sentence: 571,induced,O
Sentence: 571,myocardial,B-Disease
Sentence: 571,ischemia,I-Disease
Sentence: 571,.,O
Sentence: 572,We,O
Sentence: 572,report,O
Sentence: 572,a,O
Sentence: 572,case,O
Sentence: 572,of,O
Sentence: 572,myocardial,B-Disease
Sentence: 572,ischemia,B-Disease
Sentence: 572,induced,O
Sentence: 572,by,O
Sentence: 572,cocaine,B-Chemical
Sentence: 572,.,O
Sentence: 572,The,O
Sentence: 572,ischemia,B-Disease
Sentence: 572,probably,O
Sentence: 572,induced,O
Sentence: 572,by,O
Sentence: 572,coronary,B-Disease
Sentence: 572,artery,I-Disease
Sentence: 572,spasm,I-Disease
Sentence: 572,was,O
Sentence: 572,reversed,O
Sentence: 572,by,O
Sentence: 572,nitroglycerin,B-Chemical
Sentence: 572,and,O
Sentence: 572,calcium,B-Chemical
Sentence: 572,blocking,O
Sentence: 572,agents,O
Sentence: 572,.,O
Sentence: 573,Doxorubicin,B-Chemical
Sentence: 573,-,O
Sentence: 573,induced,O
Sentence: 573,cardiotoxicity,B-Disease
Sentence: 573,monitored,O
Sentence: 573,by,O
Sentence: 573,ECG,O
Sentence: 573,in,O
Sentence: 573,freely,O
Sentence: 573,moving,O
Sentence: 573,mice,O
Sentence: 573,.,O
Sentence: 573,A,O
Sentence: 573,new,O
Sentence: 573,model,O
Sentence: 573,to,O
Sentence: 573,test,O
Sentence: 573,potential,O
Sentence: 573,protectors,O
Sentence: 573,.,O
Sentence: 574,In,O
Sentence: 574,laboratory,O
Sentence: 574,animals,O
Sentence: 574,",",O
Sentence: 574,histology,O
Sentence: 574,is,O
Sentence: 574,most,O
Sentence: 574,commonly,O
Sentence: 574,used,O
Sentence: 574,to,O
Sentence: 574,study,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,-,O
Sentence: 574,induced,O
Sentence: 574,cardiotoxicity,B-Disease
Sentence: 574,.,O
Sentence: 574,However,O
Sentence: 574,",",O
Sentence: 574,for,O
Sentence: 574,monitoring,O
Sentence: 574,during,O
Sentence: 574,treatment,O
Sentence: 574,",",O
Sentence: 574,large,O
Sentence: 574,numbers,O
Sentence: 574,of,O
Sentence: 574,animals,O
Sentence: 574,are,O
Sentence: 574,needed,O
Sentence: 574,.,O
Sentence: 574,Recently,O
Sentence: 574,we,O
Sentence: 574,developed,O
Sentence: 574,a,O
Sentence: 574,new,O
Sentence: 574,method,O
Sentence: 574,to,O
Sentence: 574,measure,O
Sentence: 574,ECG,O
Sentence: 574,values,O
Sentence: 574,in,O
Sentence: 574,freely,O
Sentence: 574,moving,O
Sentence: 574,mice,O
Sentence: 574,by,O
Sentence: 574,telemetry,O
Sentence: 574,.,O
Sentence: 574,With,O
Sentence: 574,this,O
Sentence: 574,model,O
Sentence: 574,we,O
Sentence: 574,investigated,O
Sentence: 574,the,O
Sentence: 574,effect,O
Sentence: 574,of,O
Sentence: 574,chronic,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,administration,O
Sentence: 574,on,O
Sentence: 574,the,O
Sentence: 574,ECG,O
Sentence: 574,of,O
Sentence: 574,freely,O
Sentence: 574,moving,O
Sentence: 574,BALB,O
Sentence: 574,/,O
Sentence: 574,c,O
Sentence: 574,mice,O
Sentence: 574,and,O
Sentence: 574,the,O
Sentence: 574,efficacy,O
Sentence: 574,of,O
Sentence: 574,ICRF,O
Sentence: 574,-,O
Sentence: 574,187,O
Sentence: 574,as,O
Sentence: 574,a,O
Sentence: 574,protective,O
Sentence: 574,agent,O
Sentence: 574,.,O
Sentence: 574,The,O
Sentence: 574,ST,O
Sentence: 574,interval,O
Sentence: 574,significantly,O
Sentence: 574,widened,O
Sentence: 574,from,O
Sentence: 574,15.0,O
Sentence: 574,+,O
Sentence: 574,/,O
Sentence: 574,,O
Sentence: 574,-,O
Sentence: 574,,O
Sentence: 574,1.5,O
Sentence: 574,to,O
Sentence: 574,56.8,O
Sentence: 574,+,O
Sentence: 574,/,O
Sentence: 574,,O
Sentence: 574,-,O
Sentence: 574,,O
Sentence: 574,11.8,O
Sentence: 574,ms,O
Sentence: 574,in,O
Sentence: 574,week,O
Sentence: 574,10,O
Sentence: 574,(,O
Sentence: 574,7,O
Sentence: 574,weekly,O
Sentence: 574,doses,O
Sentence: 574,of,O
Sentence: 574,4,O
Sentence: 574,mg,O
Sentence: 574,/,O
Sentence: 574,kg,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,given,O
Sentence: 574,i.v,O
Sentence: 574,.,O
Sentence: 574,plus,O
Sentence: 574,3,O
Sentence: 574,weeks,O
Sentence: 574,of,O
Sentence: 574,observation,O
Sentence: 574,),O
Sentence: 574,.,O
Sentence: 574,The,O
Sentence: 574,ECG,O
Sentence: 574,of,O
Sentence: 574,the,O
Sentence: 574,control,O
Sentence: 574,animals,O
Sentence: 574,did,O
Sentence: 574,not,O
Sentence: 574,change,O
Sentence: 574,during,O
Sentence: 574,the,O
Sentence: 574,entire,O
Sentence: 574,study,O
Sentence: 574,.,O
Sentence: 574,After,O
Sentence: 574,sacrifice,O
Sentence: 574,the,O
Sentence: 574,hearts,O
Sentence: 574,of,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,-,O
Sentence: 574,treated,O
Sentence: 574,animals,O
Sentence: 574,were,O
Sentence: 574,enlarged,O
Sentence: 574,and,O
Sentence: 574,the,O
Sentence: 574,atria,O
Sentence: 574,were,O
Sentence: 574,hypertrophic,B-Disease
Sentence: 574,.,O
Sentence: 574,As,O
Sentence: 574,this,O
Sentence: 574,schedule,O
Sentence: 574,exerted,O
Sentence: 574,more,O
Sentence: 574,toxicity,B-Disease
Sentence: 574,than,O
Sentence: 574,needed,O
Sentence: 574,to,O
Sentence: 574,investigate,O
Sentence: 574,protective,O
Sentence: 574,agents,O
Sentence: 574,",",O
Sentence: 574,the,O
Sentence: 574,protection,O
Sentence: 574,of,O
Sentence: 574,ICRF,O
Sentence: 574,-,O
Sentence: 574,187,O
Sentence: 574,was,O
Sentence: 574,determined,O
Sentence: 574,using,O
Sentence: 574,a,O
Sentence: 574,dose,O
Sentence: 574,schedule,O
Sentence: 574,with,O
Sentence: 574,lower,O
Sentence: 574,general,O
Sentence: 574,toxicity,B-Disease
Sentence: 574,(,O
Sentence: 574,6,O
Sentence: 574,weekly,O
Sentence: 574,doses,O
Sentence: 574,of,O
Sentence: 574,4,O
Sentence: 574,mg,O
Sentence: 574,/,O
Sentence: 574,kg,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,given,O
Sentence: 574,i.v,O
Sentence: 574,.,O
Sentence: 574,plus,O
Sentence: 574,2,O
Sentence: 574,weeks,O
Sentence: 574,of,O
Sentence: 574,observation,O
Sentence: 574,),O
Sentence: 574,.,O
Sentence: 574,On,O
Sentence: 574,this,O
Sentence: 574,schedule,O
Sentence: 574,",",O
Sentence: 574,the,O
Sentence: 574,animals,O
Sentence: 574,',O
Sentence: 574,hearts,O
Sentence: 574,appeared,O
Sentence: 574,normal,O
Sentence: 574,after,O
Sentence: 574,sacrifice,O
Sentence: 574,and,O
Sentence: 574,ICRF,O
Sentence: 574,-,O
Sentence: 574,187,O
Sentence: 574,(,O
Sentence: 574,50,O
Sentence: 574,mg,O
Sentence: 574,/,O
Sentence: 574,kg,O
Sentence: 574,given,O
Sentence: 574,i.p,O
Sentence: 574,.,O
Sentence: 574,1,O
Sentence: 574,h,O
Sentence: 574,before,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,),O
Sentence: 574,provided,O
Sentence: 574,almost,O
Sentence: 574,full,O
Sentence: 574,protection,O
Sentence: 574,.,O
Sentence: 574,These,O
Sentence: 574,data,O
Sentence: 574,were,O
Sentence: 574,confirmed,O
Sentence: 574,by,O
Sentence: 574,histology,O
Sentence: 574,.,O
Sentence: 574,The,O
Sentence: 574,results,O
Sentence: 574,indicate,O
Sentence: 574,that,O
Sentence: 574,this,O
Sentence: 574,new,O
Sentence: 574,model,O
Sentence: 574,is,O
Sentence: 574,very,O
Sentence: 574,sensitive,O
Sentence: 574,and,O
Sentence: 574,enables,O
Sentence: 574,monitoring,O
Sentence: 574,of,O
Sentence: 574,the,O
Sentence: 574,development,O
Sentence: 574,of,O
Sentence: 574,cardiotoxicity,B-Disease
Sentence: 574,with,O
Sentence: 574,time,O
Sentence: 574,.,O
Sentence: 574,These,O
Sentence: 574,findings,O
Sentence: 574,result,O
Sentence: 574,in,O
Sentence: 574,a,O
Sentence: 574,model,O
Sentence: 574,that,O
Sentence: 574,allows,O
Sentence: 574,the,O
Sentence: 574,testing,O
Sentence: 574,of,O
Sentence: 574,protectors,O
Sentence: 574,against,O
Sentence: 574,doxorubicin,B-Chemical
Sentence: 574,-,O
Sentence: 574,induced,O
Sentence: 574,cardiotoxicity,B-Disease
Sentence: 574,as,O
Sentence: 574,demonstrated,O
Sentence: 574,by,O
Sentence: 574,the,O
Sentence: 574,protection,O
Sentence: 574,provided,O
Sentence: 574,by,O
Sentence: 574,ICRF,O
Sentence: 574,-,O
Sentence: 574,187,O
Sentence: 574,.,O
Sentence: 575,Epinephrine,B-Chemical
Sentence: 575,dysrhythmogenicity,O
Sentence: 575,is,O
Sentence: 575,not,O
Sentence: 575,enhanced,O
Sentence: 575,by,O
Sentence: 575,subtoxic,O
Sentence: 575,bupivacaine,B-Chemical
Sentence: 575,in,O
Sentence: 575,dogs,O
Sentence: 575,.,O
Sentence: 576,Since,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,and,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,may,O
Sentence: 576,both,O
Sentence: 576,precipitate,O
Sentence: 576,dysrhythmias,B-Disease
Sentence: 576,",",O
Sentence: 576,circulating,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,during,O
Sentence: 576,regional,O
Sentence: 576,anesthesia,O
Sentence: 576,could,O
Sentence: 576,potentiate,O
Sentence: 576,dysrhythmogenic,O
Sentence: 576,effects,O
Sentence: 576,of,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,.,O
Sentence: 576,We,O
Sentence: 576,therefore,O
Sentence: 576,examined,O
Sentence: 576,whether,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,alters,O
Sentence: 576,the,O
Sentence: 576,dysrhythmogenicity,O
Sentence: 576,of,O
Sentence: 576,subsequent,O
Sentence: 576,administration,O
Sentence: 576,of,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,in,O
Sentence: 576,conscious,O
Sentence: 576,",",O
Sentence: 576,healthy,O
Sentence: 576,dogs,O
Sentence: 576,and,O
Sentence: 576,in,O
Sentence: 576,anesthetized,O
Sentence: 576,dogs,O
Sentence: 576,with,O
Sentence: 576,myocardial,B-Disease
Sentence: 576,infarction,I-Disease
Sentence: 576,.,O
Sentence: 576,Forty,O
Sentence: 576,-,O
Sentence: 576,one,O
Sentence: 576,conscious,O
Sentence: 576,dogs,O
Sentence: 576,received,O
Sentence: 576,10,O
Sentence: 576,micrograms.kg,O
Sentence: 576,-,O
Sentence: 576,1.min,O
Sentence: 576,-,O
Sentence: 576,1,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,.,O
Sentence: 576,Seventeen,O
Sentence: 576,animals,O
Sentence: 576,responded,O
Sentence: 576,with,O
Sentence: 576,ventricular,B-Disease
Sentence: 576,tachycardia,I-Disease
Sentence: 576,(,O
Sentence: 576,VT,B-Disease
Sentence: 576,),O
Sentence: 576,within,O
Sentence: 576,3,O
Sentence: 576,min,O
Sentence: 576,.,O
Sentence: 576,After,O
Sentence: 576,3,O
Sentence: 576,h,O
Sentence: 576,",",O
Sentence: 576,these,O
Sentence: 576,responders,O
Sentence: 576,randomly,O
Sentence: 576,received,O
Sentence: 576,1,O
Sentence: 576,or,O
Sentence: 576,2,O
Sentence: 576,mg,O
Sentence: 576,/,O
Sentence: 576,kg,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,or,O
Sentence: 576,saline,O
Sentence: 576,over,O
Sentence: 576,5,O
Sentence: 576,min,O
Sentence: 576,",",O
Sentence: 576,followed,O
Sentence: 576,by,O
Sentence: 576,10,O
Sentence: 576,micrograms.kg,O
Sentence: 576,-,O
Sentence: 576,1.min,O
Sentence: 576,-,O
Sentence: 576,1,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,.,O
Sentence: 576,In,O
Sentence: 576,the,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,groups,O
Sentence: 576,",",O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,caused,O
Sentence: 576,fewer,O
Sentence: 576,prodysrhythmic,O
Sentence: 576,effects,O
Sentence: 576,than,O
Sentence: 576,without,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,.,O
Sentence: 576,VT,B-Disease
Sentence: 576,appeared,O
Sentence: 576,in,O
Sentence: 576,fewer,O
Sentence: 576,dogs,O
Sentence: 576,and,O
Sentence: 576,at,O
Sentence: 576,a,O
Sentence: 576,later,O
Sentence: 576,time,O
Sentence: 576,",",O
Sentence: 576,and,O
Sentence: 576,there,O
Sentence: 576,were,O
Sentence: 576,more,O
Sentence: 576,sinoatrial,O
Sentence: 576,beats,O
Sentence: 576,and,O
Sentence: 576,less,O
Sentence: 576,ectopies,O
Sentence: 576,.,O
Sentence: 576,Epinephrine,B-Chemical
Sentence: 576,shortened,O
Sentence: 576,QT,O
Sentence: 576,less,O
Sentence: 576,after,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,than,O
Sentence: 576,in,O
Sentence: 576,control,O
Sentence: 576,animals,O
Sentence: 576,.,O
Sentence: 576,One,O
Sentence: 576,day,O
Sentence: 576,after,O
Sentence: 576,experimental,O
Sentence: 576,myocardial,B-Disease
Sentence: 576,infarction,I-Disease
Sentence: 576,",",O
Sentence: 576,six,O
Sentence: 576,additional,O
Sentence: 576,halothane,B-Chemical
Sentence: 576,-,O
Sentence: 576,anesthetized,O
Sentence: 576,dogs,O
Sentence: 576,received,O
Sentence: 576,4,O
Sentence: 576,micrograms.kg,O
Sentence: 576,-,O
Sentence: 576,1.min,O
Sentence: 576,-,O
Sentence: 576,1,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,until,O
Sentence: 576,VT,B-Disease
Sentence: 576,appeared,O
Sentence: 576,.,O
Sentence: 576,After,O
Sentence: 576,45,O
Sentence: 576,min,O
Sentence: 576,",",O
Sentence: 576,1,O
Sentence: 576,mg,O
Sentence: 576,/,O
Sentence: 576,kg,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,was,O
Sentence: 576,injected,O
Sentence: 576,over,O
Sentence: 576,5,O
Sentence: 576,min,O
Sentence: 576,",",O
Sentence: 576,again,O
Sentence: 576,followed,O
Sentence: 576,by,O
Sentence: 576,4,O
Sentence: 576,micrograms.kg,O
Sentence: 576,-,O
Sentence: 576,1.min,O
Sentence: 576,-,O
Sentence: 576,1,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,.,O
Sentence: 576,In,O
Sentence: 576,these,O
Sentence: 576,dogs,O
Sentence: 576,",",O
Sentence: 576,the,O
Sentence: 576,prodysrhythmic,O
Sentence: 576,response,O
Sentence: 576,to,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,was,O
Sentence: 576,also,O
Sentence: 576,mitigated,O
Sentence: 576,by,O
Sentence: 576,preceding,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,.,O
Sentence: 576,Bupivacaine,B-Chemical
Sentence: 576,antagonizes,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,dysrhythmogenicity,O
Sentence: 576,in,O
Sentence: 576,conscious,O
Sentence: 576,dogs,O
Sentence: 576,susceptible,O
Sentence: 576,to,O
Sentence: 576,VT,B-Disease
Sentence: 576,and,O
Sentence: 576,in,O
Sentence: 576,anesthetized,O
Sentence: 576,dogs,O
Sentence: 576,with,O
Sentence: 576,spontaneous,O
Sentence: 576,postinfarct,O
Sentence: 576,dysrhythmias,B-Disease
Sentence: 576,.,O
Sentence: 576,There,O
Sentence: 576,is,O
Sentence: 576,no,O
Sentence: 576,evidence,O
Sentence: 576,that,O
Sentence: 576,systemic,O
Sentence: 576,subtoxic,O
Sentence: 576,bupivacaine,B-Chemical
Sentence: 576,administration,O
Sentence: 576,enhances,O
Sentence: 576,the,O
Sentence: 576,dysrhythmogenicity,O
Sentence: 576,of,O
Sentence: 576,subsequent,O
Sentence: 576,epinephrine,B-Chemical
Sentence: 576,.,O
Sentence: 577,Milk,O
Sentence: 577,-,O
Sentence: 577,alkali,O
Sentence: 577,syndrome,O
Sentence: 577,induced,O
Sentence: 577,by,O
Sentence: 577,"1,25",B-Chemical
Sentence: 577,(,I-Chemical
Sentence: 577,OH,I-Chemical
Sentence: 577,),I-Chemical
Sentence: 577,2D,I-Chemical
Sentence: 577,in,O
Sentence: 577,a,O
Sentence: 577,patient,O
Sentence: 577,with,O
Sentence: 577,hypoparathyroidism,B-Disease
Sentence: 577,.,O
Sentence: 578,Milk,O
Sentence: 578,-,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,syndrome,O
Sentence: 578,was,O
Sentence: 578,first,O
Sentence: 578,described,O
Sentence: 578,70,O
Sentence: 578,years,O
Sentence: 578,ago,O
Sentence: 578,in,O
Sentence: 578,the,O
Sentence: 578,context,O
Sentence: 578,of,O
Sentence: 578,the,O
Sentence: 578,treatment,O
Sentence: 578,of,O
Sentence: 578,peptic,B-Disease
Sentence: 578,ulcer,B-Disease
Sentence: 578,disease,I-Disease
Sentence: 578,with,O
Sentence: 578,large,O
Sentence: 578,amounts,O
Sentence: 578,of,O
Sentence: 578,calcium,B-Chemical
Sentence: 578,and,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,.,O
Sentence: 578,Although,O
Sentence: 578,with,O
Sentence: 578,current,O
Sentence: 578,ulcer,B-Disease
Sentence: 578,therapy,O
Sentence: 578,(,O
Sentence: 578,H,O
Sentence: 578,-,O
Sentence: 578,2,O
Sentence: 578,blockers,O
Sentence: 578,",",O
Sentence: 578,omeprazole,B-Chemical
Sentence: 578,",",O
Sentence: 578,and,O
Sentence: 578,sucralfate,B-Chemical
Sentence: 578,),O
Sentence: 578,",",O
Sentence: 578,the,O
Sentence: 578,frequency,O
Sentence: 578,of,O
Sentence: 578,milk,O
Sentence: 578,-,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,syndrome,O
Sentence: 578,has,O
Sentence: 578,decreased,O
Sentence: 578,significantly,O
Sentence: 578,",",O
Sentence: 578,the,O
Sentence: 578,classic,O
Sentence: 578,triad,O
Sentence: 578,of,O
Sentence: 578,hypercalcemia,B-Disease
Sentence: 578,",",O
Sentence: 578,alkalosis,B-Disease
Sentence: 578,",",O
Sentence: 578,and,O
Sentence: 578,renal,B-Disease
Sentence: 578,impairment,I-Disease
Sentence: 578,remains,O
Sentence: 578,the,O
Sentence: 578,hallmark,O
Sentence: 578,of,O
Sentence: 578,the,O
Sentence: 578,syndrome,O
Sentence: 578,.,O
Sentence: 578,Milk,O
Sentence: 578,-,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,syndrome,O
Sentence: 578,can,O
Sentence: 578,present,O
Sentence: 578,serious,O
Sentence: 578,and,O
Sentence: 578,occasionally,O
Sentence: 578,life,O
Sentence: 578,-,O
Sentence: 578,threatening,O
Sentence: 578,illness,O
Sentence: 578,unless,O
Sentence: 578,diagnosed,O
Sentence: 578,and,O
Sentence: 578,treated,O
Sentence: 578,appropriately,O
Sentence: 578,.,O
Sentence: 578,This,O
Sentence: 578,article,O
Sentence: 578,presents,O
Sentence: 578,a,O
Sentence: 578,patient,O
Sentence: 578,with,O
Sentence: 578,hypoparathyroidism,B-Disease
Sentence: 578,who,O
Sentence: 578,was,O
Sentence: 578,treated,O
Sentence: 578,with,O
Sentence: 578,calcium,B-Chemical
Sentence: 578,carbonate,I-Chemical
Sentence: 578,and,O
Sentence: 578,calcitriol,B-Chemical
Sentence: 578,resulting,O
Sentence: 578,in,O
Sentence: 578,two,O
Sentence: 578,admissions,O
Sentence: 578,to,O
Sentence: 578,the,O
Sentence: 578,hospital,O
Sentence: 578,for,O
Sentence: 578,milk,O
Sentence: 578,-,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,syndrome,O
Sentence: 578,.,O
Sentence: 578,The,O
Sentence: 578,patient,O
Sentence: 578,was,O
Sentence: 578,successfully,O
Sentence: 578,treated,O
Sentence: 578,with,O
Sentence: 578,intravenous,O
Sentence: 578,pamidronate,B-Chemical
Sentence: 578,on,O
Sentence: 578,his,O
Sentence: 578,first,O
Sentence: 578,admission,O
Sentence: 578,and,O
Sentence: 578,with,O
Sentence: 578,hydrocortisone,B-Chemical
Sentence: 578,on,O
Sentence: 578,the,O
Sentence: 578,second,O
Sentence: 578,.,O
Sentence: 578,This,O
Sentence: 578,illustrates,O
Sentence: 578,intravenous,O
Sentence: 578,pamidronate,B-Chemical
Sentence: 578,as,O
Sentence: 578,a,O
Sentence: 578,valuable,O
Sentence: 578,therapeutic,O
Sentence: 578,tool,O
Sentence: 578,when,O
Sentence: 578,milk,O
Sentence: 578,-,O
Sentence: 578,alkali,B-Chemical
Sentence: 578,syndrome,O
Sentence: 578,presents,O
Sentence: 578,as,O
Sentence: 578,hypercalcemic,B-Disease
Sentence: 578,emergency,I-Disease
Sentence: 578,.,O
Sentence: 579,Encephalopathy,B-Disease
Sentence: 579,during,O
Sentence: 579,amitriptyline,B-Chemical
Sentence: 579,therapy,O
Sentence: 579,:,O
Sentence: 579,are,O
Sentence: 579,neuroleptic,B-Disease
Sentence: 579,malignant,I-Disease
Sentence: 579,syndrome,I-Disease
Sentence: 579,and,O
Sentence: 579,serotonin,B-Disease
Sentence: 579,syndrome,I-Disease
Sentence: 579,spectrum,O
Sentence: 579,disorders,O
Sentence: 579,?,O
Sentence: 580,This,O
Sentence: 580,report,O
Sentence: 580,describes,O
Sentence: 580,a,O
Sentence: 580,case,O
Sentence: 580,of,O
Sentence: 580,encephalopathy,B-Disease
Sentence: 580,developed,O
Sentence: 580,in,O
Sentence: 580,the,O
Sentence: 580,course,O
Sentence: 580,of,O
Sentence: 580,amitriptyline,B-Chemical
Sentence: 580,therapy,O
Sentence: 580,",",O
Sentence: 580,during,O
Sentence: 580,a,O
Sentence: 580,remission,O
Sentence: 580,of,O
Sentence: 580,unipolar,B-Disease
Sentence: 580,depression,I-Disease
Sentence: 580,.,O
Sentence: 580,This,O
Sentence: 580,patient,O
Sentence: 580,could,O
Sentence: 580,have,O
Sentence: 580,been,O
Sentence: 580,diagnosed,O
Sentence: 580,as,O
Sentence: 580,having,O
Sentence: 580,either,O
Sentence: 580,neuroleptic,B-Disease
Sentence: 580,malignant,I-Disease
Sentence: 580,syndrome,I-Disease
Sentence: 580,(,O
Sentence: 580,NMS,B-Disease
Sentence: 580,),O
Sentence: 580,or,O
Sentence: 580,serotonin,B-Chemical
Sentence: 580,syndrome,I-Disease
Sentence: 580,(,O
Sentence: 580,SS,B-Disease
Sentence: 580,),O
Sentence: 580,.,O
Sentence: 580,The,O
Sentence: 580,major,O
Sentence: 580,determinant,O
Sentence: 580,of,O
Sentence: 580,the,O
Sentence: 580,symptoms,O
Sentence: 580,may,O
Sentence: 580,have,O
Sentence: 580,been,O
Sentence: 580,dopamine,B-Chemical
Sentence: 580,/,O
Sentence: 580,serotonin,B-Chemical
Sentence: 580,imbalance,O
Sentence: 580,in,O
Sentence: 580,the,O
Sentence: 580,central,O
Sentence: 580,nervous,O
Sentence: 580,system,O
Sentence: 580,.,O
Sentence: 580,The,O
Sentence: 580,NMS,B-Disease
Sentence: 580,-,O
Sentence: 580,like,O
Sentence: 580,encephalopathy,B-Disease
Sentence: 580,that,O
Sentence: 580,develops,O
Sentence: 580,in,O
Sentence: 580,association,O
Sentence: 580,with,O
Sentence: 580,the,O
Sentence: 580,use,O
Sentence: 580,of,O
Sentence: 580,antidepressants,O
Sentence: 580,indicates,O
Sentence: 580,that,O
Sentence: 580,NMS,B-Disease
Sentence: 580,and,O
Sentence: 580,SS,B-Disease
Sentence: 580,are,O
Sentence: 580,spectrum,O
Sentence: 580,disorders,O
Sentence: 580,induced,O
Sentence: 580,by,O
Sentence: 580,drugs,O
Sentence: 580,with,O
Sentence: 580,both,O
Sentence: 580,antidopaminergic,O
Sentence: 580,and,O
Sentence: 580,serotonergic,O
Sentence: 580,effects,O
Sentence: 580,.,O
Sentence: 581,Genetic,O
Sentence: 581,separation,O
Sentence: 581,of,O
Sentence: 581,tumor,B-Disease
Sentence: 581,growth,O
Sentence: 581,and,O
Sentence: 581,hemorrhagic,B-Disease
Sentence: 581,phenotypes,O
Sentence: 581,in,O
Sentence: 581,an,O
Sentence: 581,estrogen,B-Chemical
Sentence: 581,-,O
Sentence: 581,induced,O
Sentence: 581,tumor,B-Disease
Sentence: 581,.,O
Sentence: 582,Chronic,O
Sentence: 582,administration,O
Sentence: 582,of,O
Sentence: 582,estrogen,B-Chemical
Sentence: 582,to,O
Sentence: 582,the,O
Sentence: 582,Fischer,O
Sentence: 582,344,O
Sentence: 582,(,O
Sentence: 582,F344,O
Sentence: 582,),O
Sentence: 582,rat,O
Sentence: 582,induces,O
Sentence: 582,growth,O
Sentence: 582,of,O
Sentence: 582,large,O
Sentence: 582,",",O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,pituitary,B-Disease
Sentence: 582,tumors,B-Disease
Sentence: 582,.,O
Sentence: 582,Ten,O
Sentence: 582,weeks,O
Sentence: 582,of,O
Sentence: 582,diethylstilbestrol,B-Chemical
Sentence: 582,(,O
Sentence: 582,DES,B-Chemical
Sentence: 582,),O
Sentence: 582,treatment,O
Sentence: 582,caused,O
Sentence: 582,female,O
Sentence: 582,F344,O
Sentence: 582,rat,O
Sentence: 582,pituitaries,O
Sentence: 582,to,O
Sentence: 582,grow,O
Sentence: 582,to,O
Sentence: 582,an,O
Sentence: 582,average,O
Sentence: 582,of,O
Sentence: 582,109.2,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,6.3,O
Sentence: 582,mg,O
Sentence: 582,(,O
Sentence: 582,mean,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,SE,O
Sentence: 582,),O
Sentence: 582,versus,O
Sentence: 582,11.3,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,1.4,O
Sentence: 582,mg,O
Sentence: 582,for,O
Sentence: 582,untreated,O
Sentence: 582,rats,O
Sentence: 582,",",O
Sentence: 582,and,O
Sentence: 582,to,O
Sentence: 582,become,O
Sentence: 582,highly,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,.,O
Sentence: 582,The,O
Sentence: 582,same,O
Sentence: 582,DES,B-Chemical
Sentence: 582,treatment,O
Sentence: 582,produced,O
Sentence: 582,no,O
Sentence: 582,significant,O
Sentence: 582,growth,O
Sentence: 582,(,O
Sentence: 582,8.9,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,0.5,O
Sentence: 582,mg,O
Sentence: 582,for,O
Sentence: 582,treated,O
Sentence: 582,females,O
Sentence: 582,versus,O
Sentence: 582,8.7,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,1.1,O
Sentence: 582,for,O
Sentence: 582,untreated,O
Sentence: 582,females,O
Sentence: 582,),O
Sentence: 582,or,O
Sentence: 582,morphological,O
Sentence: 582,changes,O
Sentence: 582,in,O
Sentence: 582,Brown,O
Sentence: 582,Norway,O
Sentence: 582,(,O
Sentence: 582,BN,O
Sentence: 582,),O
Sentence: 582,rat,O
Sentence: 582,pituitaries,O
Sentence: 582,.,O
Sentence: 582,An,O
Sentence: 582,F1,O
Sentence: 582,hybrid,O
Sentence: 582,of,O
Sentence: 582,F344,O
Sentence: 582,and,O
Sentence: 582,BN,O
Sentence: 582,exhibited,O
Sentence: 582,significant,O
Sentence: 582,pituitary,O
Sentence: 582,growth,O
Sentence: 582,after,O
Sentence: 582,10,O
Sentence: 582,weeks,O
Sentence: 582,of,O
Sentence: 582,DES,B-Chemical
Sentence: 582,treatment,O
Sentence: 582,with,O
Sentence: 582,an,O
Sentence: 582,average,O
Sentence: 582,mass,O
Sentence: 582,of,O
Sentence: 582,26.3,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,0.7,O
Sentence: 582,mg,O
Sentence: 582,compared,O
Sentence: 582,with,O
Sentence: 582,8.6,O
Sentence: 582,+,O
Sentence: 582,/,O
Sentence: 582,,O
Sentence: 582,-,O
Sentence: 582,,O
Sentence: 582,0.9,O
Sentence: 582,mg,O
Sentence: 582,for,O
Sentence: 582,untreated,O
Sentence: 582,rats,O
Sentence: 582,.,O
Sentence: 582,Surprisingly,O
Sentence: 582,",",O
Sentence: 582,the,O
Sentence: 582,F1,O
Sentence: 582,hybrid,O
Sentence: 582,tumors,B-Disease
Sentence: 582,were,O
Sentence: 582,not,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,and,O
Sentence: 582,had,O
Sentence: 582,hemoglobin,O
Sentence: 582,content,O
Sentence: 582,and,O
Sentence: 582,outward,O
Sentence: 582,appearance,O
Sentence: 582,identical,O
Sentence: 582,to,O
Sentence: 582,that,O
Sentence: 582,of,O
Sentence: 582,BN,O
Sentence: 582,.,O
Sentence: 582,Expression,O
Sentence: 582,of,O
Sentence: 582,both,O
Sentence: 582,growth,O
Sentence: 582,and,O
Sentence: 582,morphological,O
Sentence: 582,changes,O
Sentence: 582,is,O
Sentence: 582,due,O
Sentence: 582,to,O
Sentence: 582,multiple,O
Sentence: 582,genes,O
Sentence: 582,.,O
Sentence: 582,However,O
Sentence: 582,",",O
Sentence: 582,while,O
Sentence: 582,DES,B-Chemical
Sentence: 582,-,O
Sentence: 582,induced,O
Sentence: 582,pituitary,O
Sentence: 582,growth,O
Sentence: 582,exhibited,O
Sentence: 582,quantitative,O
Sentence: 582,",",O
Sentence: 582,additive,O
Sentence: 582,inheritance,O
Sentence: 582,",",O
Sentence: 582,the,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,phenotype,O
Sentence: 582,exhibited,O
Sentence: 582,recessive,O
Sentence: 582,",",O
Sentence: 582,epistatic,O
Sentence: 582,inheritance,O
Sentence: 582,.,O
Sentence: 582,Only,O
Sentence: 582,5,O
Sentence: 582,of,O
Sentence: 582,the,O
Sentence: 582,160,O
Sentence: 582,F2,O
Sentence: 582,pituitaries,O
Sentence: 582,exhibited,O
Sentence: 582,the,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,phenotype,O
Sentence: 582,;,O
Sentence: 582,36,O
Sentence: 582,of,O
Sentence: 582,the,O
Sentence: 582,160,O
Sentence: 582,F2,O
Sentence: 582,pituitaries,O
Sentence: 582,were,O
Sentence: 582,in,O
Sentence: 582,the,O
Sentence: 582,F344,O
Sentence: 582,range,O
Sentence: 582,of,O
Sentence: 582,mass,O
Sentence: 582,",",O
Sentence: 582,but,O
Sentence: 582,31,O
Sentence: 582,of,O
Sentence: 582,these,O
Sentence: 582,were,O
Sentence: 582,not,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,",",O
Sentence: 582,indicating,O
Sentence: 582,that,O
Sentence: 582,the,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,phenotype,O
Sentence: 582,is,O
Sentence: 582,not,O
Sentence: 582,merely,O
Sentence: 582,a,O
Sentence: 582,consequence,O
Sentence: 582,of,O
Sentence: 582,extensive,O
Sentence: 582,growth,O
Sentence: 582,.,O
Sentence: 582,The,O
Sentence: 582,hemorrhagic,B-Disease
Sentence: 582,F2,O
Sentence: 582,pituitaries,O
Sentence: 582,were,O
Sentence: 582,all,O
Sentence: 582,among,O
Sentence: 582,the,O
Sentence: 582,most,O
Sentence: 582,massive,O
Sentence: 582,",",O
Sentence: 582,indicating,O
Sentence: 582,that,O
Sentence: 582,some,O
Sentence: 582,of,O
Sentence: 582,the,O
Sentence: 582,genes,O
Sentence: 582,regulate,O
Sentence: 582,both,O
Sentence: 582,phenotypes,O
Sentence: 582,.,O
Sentence: 583,Increased,O
Sentence: 583,expression,O
Sentence: 583,of,O
Sentence: 583,neuronal,O
Sentence: 583,nitric,B-Chemical
Sentence: 583,oxide,I-Chemical
Sentence: 583,synthase,O
Sentence: 583,in,O
Sentence: 583,bladder,O
Sentence: 583,afferent,O
Sentence: 583,pathways,O
Sentence: 583,following,O
Sentence: 583,chronic,O
Sentence: 583,bladder,B-Disease
Sentence: 583,irritation,I-Disease
Sentence: 583,.,O
Sentence: 584,Immunocytochemical,O
Sentence: 584,techniques,O
Sentence: 584,were,O
Sentence: 584,used,O
Sentence: 584,to,O
Sentence: 584,examine,O
Sentence: 584,alterations,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,expression,O
Sentence: 584,of,O
Sentence: 584,neuronal,O
Sentence: 584,nitric,B-Chemical
Sentence: 584,oxide,I-Chemical
Sentence: 584,synthase,O
Sentence: 584,(,O
Sentence: 584,NOS,O
Sentence: 584,),O
Sentence: 584,in,O
Sentence: 584,bladder,O
Sentence: 584,pathways,O
Sentence: 584,following,O
Sentence: 584,acute,O
Sentence: 584,and,O
Sentence: 584,chronic,O
Sentence: 584,irritation,B-Disease
Sentence: 584,of,I-Disease
Sentence: 584,the,I-Disease
Sentence: 584,urinary,I-Disease
Sentence: 584,tract,I-Disease
Sentence: 584,of,O
Sentence: 584,the,O
Sentence: 584,rat,O
Sentence: 584,.,O
Sentence: 584,Chemical,O
Sentence: 584,cystitis,B-Disease
Sentence: 584,was,O
Sentence: 584,induced,O
Sentence: 584,by,O
Sentence: 584,cyclophosphamide,B-Chemical
Sentence: 584,(,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,),O
Sentence: 584,which,O
Sentence: 584,is,O
Sentence: 584,metabolized,O
Sentence: 584,to,O
Sentence: 584,acrolein,B-Chemical
Sentence: 584,",",O
Sentence: 584,an,O
Sentence: 584,irritant,O
Sentence: 584,eliminated,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,urine,O
Sentence: 584,.,O
Sentence: 584,Injection,O
Sentence: 584,of,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,(,O
Sentence: 584,n,O
Sentence: 584,,O
Sentence: 584,=,O
Sentence: 584,,O
Sentence: 584,10,O
Sentence: 584,",",O
Sentence: 584,75,O
Sentence: 584,mg,O
Sentence: 584,/,O
Sentence: 584,kg,O
Sentence: 584,",",O
Sentence: 584,i.p,O
Sentence: 584,.,O
Sentence: 584,),O
Sentence: 584,2,O
Sentence: 584,hours,O
Sentence: 584,prior,O
Sentence: 584,to,O
Sentence: 584,perfusion,O
Sentence: 584,(,O
Sentence: 584,acute,O
Sentence: 584,treatment,O
Sentence: 584,),O
Sentence: 584,of,O
Sentence: 584,the,O
Sentence: 584,animals,O
Sentence: 584,increased,O
Sentence: 584,Fos,O
Sentence: 584,-,O
Sentence: 584,immunoreactivity,O
Sentence: 584,(,O
Sentence: 584,IR,O
Sentence: 584,),O
Sentence: 584,in,O
Sentence: 584,neurons,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,dorsal,O
Sentence: 584,commissure,O
Sentence: 584,",",O
Sentence: 584,dorsal,O
Sentence: 584,horn,O
Sentence: 584,",",O
Sentence: 584,and,O
Sentence: 584,autonomic,O
Sentence: 584,regions,O
Sentence: 584,of,O
Sentence: 584,spinal,O
Sentence: 584,segments,O
Sentence: 584,(,O
Sentence: 584,L1,O
Sentence: 584,-,O
Sentence: 584,L2,O
Sentence: 584,and,O
Sentence: 584,L6,O
Sentence: 584,-,O
Sentence: 584,S1,O
Sentence: 584,),O
Sentence: 584,which,O
Sentence: 584,receive,O
Sentence: 584,afferent,O
Sentence: 584,inputs,O
Sentence: 584,from,O
Sentence: 584,the,O
Sentence: 584,bladder,O
Sentence: 584,",",O
Sentence: 584,urethra,O
Sentence: 584,",",O
Sentence: 584,and,O
Sentence: 584,ureter,O
Sentence: 584,.,O
Sentence: 584,Fos,O
Sentence: 584,-,O
Sentence: 584,IR,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,spinal,O
Sentence: 584,cord,O
Sentence: 584,was,O
Sentence: 584,not,O
Sentence: 584,changed,O
Sentence: 584,in,O
Sentence: 584,rats,O
Sentence: 584,receiving,O
Sentence: 584,chronic,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,treatment,O
Sentence: 584,(,O
Sentence: 584,n,O
Sentence: 584,,O
Sentence: 584,=,O
Sentence: 584,,O
Sentence: 584,15,O
Sentence: 584,",",O
Sentence: 584,75,O
Sentence: 584,mg,O
Sentence: 584,/,O
Sentence: 584,kg,O
Sentence: 584,",",O
Sentence: 584,i.p.,O
Sentence: 584,",",O
Sentence: 584,every,O
Sentence: 584,3rd,O
Sentence: 584,day,O
Sentence: 584,for,O
Sentence: 584,2,O
Sentence: 584,weeks,O
Sentence: 584,),O
Sentence: 584,.,O
Sentence: 584,In,O
Sentence: 584,control,O
Sentence: 584,animals,O
Sentence: 584,and,O
Sentence: 584,in,O
Sentence: 584,animals,O
Sentence: 584,treated,O
Sentence: 584,acutely,O
Sentence: 584,with,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,",",O
Sentence: 584,only,O
Sentence: 584,small,O
Sentence: 584,numbers,O
Sentence: 584,of,O
Sentence: 584,NOS,O
Sentence: 584,-,O
Sentence: 584,IR,O
Sentence: 584,cells,O
Sentence: 584,(,O
Sentence: 584,0.5,O
Sentence: 584,-,O
Sentence: 584,0.7,O
Sentence: 584,cell,O
Sentence: 584,profiles,O
Sentence: 584,/,O
Sentence: 584,sections,O
Sentence: 584,),O
Sentence: 584,were,O
Sentence: 584,detected,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,L6,O
Sentence: 584,-,O
Sentence: 584,S1,O
Sentence: 584,dorsal,O
Sentence: 584,root,O
Sentence: 584,ganglia,O
Sentence: 584,(,O
Sentence: 584,DRG,O
Sentence: 584,),O
Sentence: 584,.,O
Sentence: 584,Chronic,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,administration,O
Sentence: 584,significantly,O
Sentence: 584,(,O
Sentence: 584,P,O
Sentence: 584,,O
Sentence: 584,<,O
Sentence: 584,,O
Sentence: 584,or,O
Sentence: 584,,O
Sentence: 584,=,O
Sentence: 584,,O
Sentence: 584,.002,O
Sentence: 584,),O
Sentence: 584,increased,O
Sentence: 584,bladder,O
Sentence: 584,weight,O
Sentence: 584,by,O
Sentence: 584,60,O
Sentence: 584,%,O
Sentence: 584,and,O
Sentence: 584,increased,O
Sentence: 584,(,O
Sentence: 584,7,O
Sentence: 584,-,O
Sentence: 584,,O
Sentence: 584,to,O
Sentence: 584,11,O
Sentence: 584,-,O
Sentence: 584,fold,O
Sentence: 584,),O
Sentence: 584,the,O
Sentence: 584,numbers,O
Sentence: 584,of,O
Sentence: 584,NOS,O
Sentence: 584,-,O
Sentence: 584,immunoreactive,O
Sentence: 584,(,O
Sentence: 584,IR,O
Sentence: 584,),O
Sentence: 584,afferent,O
Sentence: 584,neurons,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,L6,O
Sentence: 584,-,O
Sentence: 584,S1,O
Sentence: 584,DRG,O
Sentence: 584,.,O
Sentence: 584,A,O
Sentence: 584,small,O
Sentence: 584,increase,O
Sentence: 584,(,O
Sentence: 584,1.5,O
Sentence: 584,-,O
Sentence: 584,fold,O
Sentence: 584,),O
Sentence: 584,also,O
Sentence: 584,occurred,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,L1,O
Sentence: 584,DRG,O
Sentence: 584,",",O
Sentence: 584,but,O
Sentence: 584,no,O
Sentence: 584,change,O
Sentence: 584,was,O
Sentence: 584,detected,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,L2,O
Sentence: 584,and,O
Sentence: 584,L5,O
Sentence: 584,DRG,O
Sentence: 584,.,O
Sentence: 584,Bladder,O
Sentence: 584,afferent,O
Sentence: 584,cells,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,L6,O
Sentence: 584,-,O
Sentence: 584,S1,O
Sentence: 584,DRG,O
Sentence: 584,labeled,O
Sentence: 584,by,O
Sentence: 584,Fluorogold,O
Sentence: 584,(,O
Sentence: 584,40,O
Sentence: 584,microliters,O
Sentence: 584,),O
Sentence: 584,injected,O
Sentence: 584,into,O
Sentence: 584,the,O
Sentence: 584,bladder,O
Sentence: 584,wall,O
Sentence: 584,did,O
Sentence: 584,not,O
Sentence: 584,exhibit,O
Sentence: 584,NOS,O
Sentence: 584,-,O
Sentence: 584,IR,O
Sentence: 584,in,O
Sentence: 584,control,O
Sentence: 584,animals,O
Sentence: 584,;,O
Sentence: 584,however,O
Sentence: 584,",",O
Sentence: 584,following,O
Sentence: 584,chronic,O
Sentence: 584,CYP,B-Chemical
Sentence: 584,administration,O
Sentence: 584,",",O
Sentence: 584,a,O
Sentence: 584,significant,O
Sentence: 584,percentage,O
Sentence: 584,of,O
Sentence: 584,bladder,O
Sentence: 584,afferent,O
Sentence: 584,neurons,O
Sentence: 584,were,O
Sentence: 584,NOS,O
Sentence: 584,-,O
Sentence: 584,IR,O
Sentence: 584,:,O
Sentence: 584,L6,O
Sentence: 584,(,O
Sentence: 584,19.8,O
Sentence: 584,+,O
Sentence: 584,/,O
Sentence: 584,,O
Sentence: 584,-,O
Sentence: 584,,O
Sentence: 584,4.6,O
Sentence: 584,%,O
Sentence: 584,),O
Sentence: 584,and,O
Sentence: 584,S1,O
Sentence: 584,(,O
Sentence: 584,25.3,O
Sentence: 584,+,O
Sentence: 584,/,O
Sentence: 584,,O
Sentence: 584,-,O
Sentence: 584,,O
Sentence: 584,2.9,O
Sentence: 584,%,O
Sentence: 584,),O
Sentence: 584,.,O
Sentence: 584,These,O
Sentence: 584,results,O
Sentence: 584,indicate,O
Sentence: 584,that,O
Sentence: 584,neuronal,O
Sentence: 584,gene,O
Sentence: 584,expression,O
Sentence: 584,in,O
Sentence: 584,visceral,O
Sentence: 584,sensory,O
Sentence: 584,pathways,O
Sentence: 584,can,O
Sentence: 584,be,O
Sentence: 584,upregulated,O
Sentence: 584,by,O
Sentence: 584,chemical,O
Sentence: 584,irritation,O
Sentence: 584,of,O
Sentence: 584,afferent,O
Sentence: 584,receptors,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,urinary,O
Sentence: 584,tract,O
Sentence: 584,and,O
Sentence: 584,/,O
Sentence: 584,or,O
Sentence: 584,that,O
Sentence: 584,pathological,O
Sentence: 584,changes,O
Sentence: 584,in,O
Sentence: 584,the,O
Sentence: 584,urinary,O
Sentence: 584,tract,O
Sentence: 584,can,O
Sentence: 584,initiate,O
Sentence: 584,chemical,O
Sentence: 584,signals,O
Sentence: 584,that,O
Sentence: 584,alter,O
Sentence: 584,the,O
Sentence: 584,chemical,O
Sentence: 584,properties,O
Sentence: 584,of,O
Sentence: 584,visceral,O
Sentence: 584,afferent,O
Sentence: 584,neurons,O
Sentence: 584,.,O
Sentence: 585,Effects,O
Sentence: 585,of,O
Sentence: 585,a,O
Sentence: 585,new,O
Sentence: 585,calcium,B-Chemical
Sentence: 585,antagonist,O
Sentence: 585,",",O
Sentence: 585,CD,O
Sentence: 585,-,O
Sentence: 585,832,O
Sentence: 585,",",O
Sentence: 585,on,O
Sentence: 585,isoproterenol,B-Chemical
Sentence: 585,-,O
Sentence: 585,induced,O
Sentence: 585,myocardial,B-Disease
Sentence: 585,ischemia,I-Disease
Sentence: 585,in,O
Sentence: 585,dogs,O
Sentence: 585,with,O
Sentence: 585,partial,O
Sentence: 585,coronary,B-Disease
Sentence: 585,stenosis,I-Disease
Sentence: 585,.,O
Sentence: 586,Effects,O
Sentence: 586,of,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,on,O
Sentence: 586,isoproterenol,B-Chemical
Sentence: 586,(,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,),O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,induced,O
Sentence: 586,myocardial,B-Disease
Sentence: 586,ischemia,I-Disease
Sentence: 586,were,O
Sentence: 586,studied,O
Sentence: 586,in,O
Sentence: 586,dogs,O
Sentence: 586,with,O
Sentence: 586,partial,O
Sentence: 586,coronary,B-Disease
Sentence: 586,stenosis,B-Disease
Sentence: 586,of,O
Sentence: 586,the,O
Sentence: 586,left,O
Sentence: 586,circumflex,O
Sentence: 586,coronary,O
Sentence: 586,artery,O
Sentence: 586,and,O
Sentence: 586,findings,O
Sentence: 586,were,O
Sentence: 586,compared,O
Sentence: 586,with,O
Sentence: 586,those,O
Sentence: 586,for,O
Sentence: 586,nifedipine,B-Chemical
Sentence: 586,or,O
Sentence: 586,diltiazem,B-Chemical
Sentence: 586,.,O
Sentence: 586,In,O
Sentence: 586,the,O
Sentence: 586,presence,O
Sentence: 586,of,O
Sentence: 586,coronary,B-Disease
Sentence: 586,artery,I-Disease
Sentence: 586,stenosis,B-Disease
Sentence: 586,",",O
Sentence: 586,3,O
Sentence: 586,-,O
Sentence: 586,min,O
Sentence: 586,periods,O
Sentence: 586,of,O
Sentence: 586,intracoronary,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,(,O
Sentence: 586,10,O
Sentence: 586,ng,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,),O
Sentence: 586,increased,O
Sentence: 586,heart,O
Sentence: 586,rate,O
Sentence: 586,and,O
Sentence: 586,maximal,O
Sentence: 586,rate,O
Sentence: 586,of,O
Sentence: 586,left,O
Sentence: 586,ventricular,O
Sentence: 586,pressure,O
Sentence: 586,rise,O
Sentence: 586,",",O
Sentence: 586,which,O
Sentence: 586,resulted,O
Sentence: 586,in,O
Sentence: 586,a,O
Sentence: 586,decrease,O
Sentence: 586,in,O
Sentence: 586,percentage,O
Sentence: 586,segmental,O
Sentence: 586,shortening,O
Sentence: 586,and,O
Sentence: 586,ST,O
Sentence: 586,-,O
Sentence: 586,segment,O
Sentence: 586,elevation,O
Sentence: 586,of,O
Sentence: 586,the,O
Sentence: 586,epicardial,O
Sentence: 586,electrocardiogram,O
Sentence: 586,.,O
Sentence: 586,After,O
Sentence: 586,the,O
Sentence: 586,control,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,with,O
Sentence: 586,stenosis,B-Disease
Sentence: 586,was,O
Sentence: 586,performed,O
Sentence: 586,",",O
Sentence: 586,equihypotensive,O
Sentence: 586,doses,O
Sentence: 586,of,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,(,O
Sentence: 586,3,O
Sentence: 586,and,O
Sentence: 586,10,O
Sentence: 586,micrograms,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,",",O
Sentence: 586,n,O
Sentence: 586,,O
Sentence: 586,=,O
Sentence: 586,,O
Sentence: 586,7,O
Sentence: 586,),O
Sentence: 586,",",O
Sentence: 586,nifedipine,B-Chemical
Sentence: 586,(,O
Sentence: 586,1,O
Sentence: 586,and,O
Sentence: 586,3,O
Sentence: 586,micrograms,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,",",O
Sentence: 586,n,O
Sentence: 586,,O
Sentence: 586,=,O
Sentence: 586,,O
Sentence: 586,9,O
Sentence: 586,),O
Sentence: 586,or,O
Sentence: 586,diltiazem,B-Chemical
Sentence: 586,(,O
Sentence: 586,10,O
Sentence: 586,and,O
Sentence: 586,30,O
Sentence: 586,micrograms,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,",",O
Sentence: 586,n,O
Sentence: 586,,O
Sentence: 586,=,O
Sentence: 586,,O
Sentence: 586,7,O
Sentence: 586,),O
Sentence: 586,were,O
Sentence: 586,infused,O
Sentence: 586,5,O
Sentence: 586,min,O
Sentence: 586,before,O
Sentence: 586,and,O
Sentence: 586,during,O
Sentence: 586,the,O
Sentence: 586,second,O
Sentence: 586,and,O
Sentence: 586,third,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,.,O
Sentence: 586,Both,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,and,O
Sentence: 586,diltiazem,B-Chemical
Sentence: 586,",",O
Sentence: 586,but,O
Sentence: 586,not,O
Sentence: 586,nifedipine,B-Chemical
Sentence: 586,",",O
Sentence: 586,significantly,O
Sentence: 586,reduced,O
Sentence: 586,the,O
Sentence: 586,increase,O
Sentence: 586,in,O
Sentence: 586,heart,O
Sentence: 586,rate,O
Sentence: 586,induced,O
Sentence: 586,by,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,.,O
Sentence: 586,In,O
Sentence: 586,contrast,O
Sentence: 586,to,O
Sentence: 586,nifedipine,B-Chemical
Sentence: 586,",",O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,(,O
Sentence: 586,10,O
Sentence: 586,micrograms,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,),O
Sentence: 586,prevented,O
Sentence: 586,the,O
Sentence: 586,decrease,O
Sentence: 586,in,O
Sentence: 586,percentage,O
Sentence: 586,segmental,O
Sentence: 586,shortening,O
Sentence: 586,from,O
Sentence: 586,32,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,12,O
Sentence: 586,%,O
Sentence: 586,to,O
Sentence: 586,115,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,26,O
Sentence: 586,%,O
Sentence: 586,of,O
Sentence: 586,the,O
Sentence: 586,control,O
Sentence: 586,value,O
Sentence: 586,(,O
Sentence: 586,P,O
Sentence: 586,,O
Sentence: 586,<,O
Sentence: 586,,O
Sentence: 586,.01,O
Sentence: 586,),O
Sentence: 586,and,O
Sentence: 586,ST,O
Sentence: 586,-,O
Sentence: 586,segment,O
Sentence: 586,elevation,O
Sentence: 586,from,O
Sentence: 586,5.6,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,1.0,O
Sentence: 586,mV,O
Sentence: 586,to,O
Sentence: 586,1.6,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,1.3,O
Sentence: 586,mV,O
Sentence: 586,(,O
Sentence: 586,P,O
Sentence: 586,,O
Sentence: 586,<,O
Sentence: 586,,O
Sentence: 586,.01,O
Sentence: 586,),O
Sentence: 586,at,O
Sentence: 586,3,O
Sentence: 586,min,O
Sentence: 586,after,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,with,O
Sentence: 586,stenosis,B-Disease
Sentence: 586,.,O
Sentence: 586,Diltiazem,B-Chemical
Sentence: 586,(,O
Sentence: 586,30,O
Sentence: 586,micrograms,O
Sentence: 586,/,O
Sentence: 586,kg,O
Sentence: 586,/,O
Sentence: 586,min,O
Sentence: 586,),O
Sentence: 586,also,O
Sentence: 586,prevented,O
Sentence: 586,the,O
Sentence: 586,decrease,O
Sentence: 586,in,O
Sentence: 586,percentage,O
Sentence: 586,segmental,O
Sentence: 586,shortening,O
Sentence: 586,from,O
Sentence: 586,34,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,14,O
Sentence: 586,%,O
Sentence: 586,to,O
Sentence: 586,63,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,18,O
Sentence: 586,%,O
Sentence: 586,of,O
Sentence: 586,the,O
Sentence: 586,control,O
Sentence: 586,value,O
Sentence: 586,(,O
Sentence: 586,P,O
Sentence: 586,,O
Sentence: 586,<,O
Sentence: 586,,O
Sentence: 586,.05,O
Sentence: 586,),O
Sentence: 586,and,O
Sentence: 586,ST,O
Sentence: 586,-,O
Sentence: 586,segment,O
Sentence: 586,elevation,O
Sentence: 586,from,O
Sentence: 586,4.7,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,0.7,O
Sentence: 586,mV,O
Sentence: 586,to,O
Sentence: 586,2.1,O
Sentence: 586,+,O
Sentence: 586,/,O
Sentence: 586,,O
Sentence: 586,-,O
Sentence: 586,,O
Sentence: 586,0.7,O
Sentence: 586,mV,O
Sentence: 586,(,O
Sentence: 586,P,O
Sentence: 586,,O
Sentence: 586,<,O
Sentence: 586,,O
Sentence: 586,.01,O
Sentence: 586,),O
Sentence: 586,at,O
Sentence: 586,3,O
Sentence: 586,min,O
Sentence: 586,after,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,with,O
Sentence: 586,stenosis,B-Disease
Sentence: 586,.,O
Sentence: 586,These,O
Sentence: 586,data,O
Sentence: 586,show,O
Sentence: 586,that,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,improves,O
Sentence: 586,myocardial,B-Disease
Sentence: 586,ischemia,I-Disease
Sentence: 586,during,O
Sentence: 586,ISO,B-Chemical
Sentence: 586,infusion,O
Sentence: 586,with,O
Sentence: 586,stenosis,B-Disease
Sentence: 586,and,O
Sentence: 586,suggest,O
Sentence: 586,that,O
Sentence: 586,the,O
Sentence: 586,negative,O
Sentence: 586,chronotropic,O
Sentence: 586,property,O
Sentence: 586,of,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,plays,O
Sentence: 586,a,O
Sentence: 586,major,O
Sentence: 586,role,O
Sentence: 586,in,O
Sentence: 586,the,O
Sentence: 586,beneficial,O
Sentence: 586,effects,O
Sentence: 586,of,O
Sentence: 586,CD,O
Sentence: 586,-,O
Sentence: 586,832,O
Sentence: 586,.,O
Sentence: 587,The,O
Sentence: 587,effect,O
Sentence: 587,of,O
Sentence: 587,recombinant,O
Sentence: 587,human,O
Sentence: 587,insulin,O
Sentence: 587,-,O
Sentence: 587,like,O
Sentence: 587,growth,O
Sentence: 587,factor,O
Sentence: 587,-,O
Sentence: 587,I,O
Sentence: 587,on,O
Sentence: 587,chronic,O
Sentence: 587,puromycin,B-Chemical
Sentence: 587,aminonucleoside,I-Chemical
Sentence: 587,nephropathy,B-Disease
Sentence: 587,in,O
Sentence: 587,rats,O
Sentence: 587,.,O
Sentence: 588,We,O
Sentence: 588,recently,O
Sentence: 588,demonstrated,O
Sentence: 588,that,O
Sentence: 588,recombinant,O
Sentence: 588,hGH,O
Sentence: 588,exacerbates,O
Sentence: 588,renal,O
Sentence: 588,functional,O
Sentence: 588,and,O
Sentence: 588,structural,O
Sentence: 588,injury,O
Sentence: 588,in,O
Sentence: 588,chronic,O
Sentence: 588,puromycin,B-Chemical
Sentence: 588,aminonucleoside,I-Chemical
Sentence: 588,(,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,),O
Sentence: 588,nephropathy,B-Disease
Sentence: 588,",",O
Sentence: 588,an,O
Sentence: 588,experimental,O
Sentence: 588,model,O
Sentence: 588,of,O
Sentence: 588,glomerular,B-Disease
Sentence: 588,disease,I-Disease
Sentence: 588,.,O
Sentence: 588,Therefore,O
Sentence: 588,",",O
Sentence: 588,we,O
Sentence: 588,examined,O
Sentence: 588,whether,O
Sentence: 588,recombinant,O
Sentence: 588,human,O
Sentence: 588,(,O
Sentence: 588,rh,O
Sentence: 588,),O
Sentence: 588,IGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,is,O
Sentence: 588,a,O
Sentence: 588,safer,O
Sentence: 588,alternative,O
Sentence: 588,for,O
Sentence: 588,the,O
Sentence: 588,treatment,O
Sentence: 588,of,O
Sentence: 588,growth,B-Disease
Sentence: 588,failure,I-Disease
Sentence: 588,in,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,chronic,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,nephropathy,B-Disease
Sentence: 588,.,O
Sentence: 588,The,O
Sentence: 588,glomerulopathy,B-Disease
Sentence: 588,was,O
Sentence: 588,induced,O
Sentence: 588,by,O
Sentence: 588,seven,O
Sentence: 588,serial,O
Sentence: 588,injections,O
Sentence: 588,of,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,over,O
Sentence: 588,12,O
Sentence: 588,wk,O
Sentence: 588,.,O
Sentence: 588,Experimental,O
Sentence: 588,animals,O
Sentence: 588,(,O
Sentence: 588,n,O
Sentence: 588,,O
Sentence: 588,=,O
Sentence: 588,,O
Sentence: 588,6,O
Sentence: 588,),O
Sentence: 588,received,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,",",O
Sentence: 588,400,O
Sentence: 588,micrograms,O
Sentence: 588,/,O
Sentence: 588,d,O
Sentence: 588,",",O
Sentence: 588,whereas,O
Sentence: 588,control,O
Sentence: 588,rats,O
Sentence: 588,(,O
Sentence: 588,n,O
Sentence: 588,,O
Sentence: 588,=,O
Sentence: 588,,O
Sentence: 588,6,O
Sentence: 588,),O
Sentence: 588,received,O
Sentence: 588,the,O
Sentence: 588,vehicle,O
Sentence: 588,.,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,improved,O
Sentence: 588,weight,O
Sentence: 588,gain,O
Sentence: 588,by,O
Sentence: 588,14,O
Sentence: 588,%,O
Sentence: 588,(,O
Sentence: 588,p,O
Sentence: 588,,O
Sentence: 588,<,O
Sentence: 588,,O
Sentence: 588,0.05,O
Sentence: 588,),O
Sentence: 588,",",O
Sentence: 588,without,O
Sentence: 588,altering,O
Sentence: 588,hematocrit,O
Sentence: 588,or,O
Sentence: 588,blood,O
Sentence: 588,pressure,O
Sentence: 588,in,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,renal,B-Disease
Sentence: 588,disease,I-Disease
Sentence: 588,.,O
Sentence: 588,Urinary,O
Sentence: 588,protein,O
Sentence: 588,excretion,O
Sentence: 588,was,O
Sentence: 588,unaltered,O
Sentence: 588,by,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,treatment,O
Sentence: 588,in,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,chronic,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,nephropathy,B-Disease
Sentence: 588,.,O
Sentence: 588,After,O
Sentence: 588,12,O
Sentence: 588,wk,O
Sentence: 588,",",O
Sentence: 588,the,O
Sentence: 588,inulin,O
Sentence: 588,clearance,O
Sentence: 588,was,O
Sentence: 588,higher,O
Sentence: 588,in,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,-,O
Sentence: 588,treated,O
Sentence: 588,rats,O
Sentence: 588,",",O
Sentence: 588,0.48,O
Sentence: 588,+,O
Sentence: 588,/,O
Sentence: 588,,O
Sentence: 588,-,O
Sentence: 588,,O
Sentence: 588,0.08,O
Sentence: 588,versus,O
Sentence: 588,0.24,O
Sentence: 588,+,O
Sentence: 588,/,O
Sentence: 588,,O
Sentence: 588,-,O
Sentence: 588,,O
Sentence: 588,0.06,O
Sentence: 588,mL,O
Sentence: 588,/,O
Sentence: 588,min,O
Sentence: 588,/,O
Sentence: 588,100,O
Sentence: 588,g,O
Sentence: 588,of,O
Sentence: 588,body,O
Sentence: 588,weight,O
Sentence: 588,in,O
Sentence: 588,untreated,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,nephropathy,B-Disease
Sentence: 588,animals,O
Sentence: 588,",",O
Sentence: 588,p,O
Sentence: 588,,O
Sentence: 588,<,O
Sentence: 588,,O
Sentence: 588,0.05,O
Sentence: 588,.,O
Sentence: 588,The,O
Sentence: 588,improvement,O
Sentence: 588,in,O
Sentence: 588,GFR,O
Sentence: 588,was,O
Sentence: 588,not,O
Sentence: 588,associated,O
Sentence: 588,with,O
Sentence: 588,enhanced,O
Sentence: 588,glomerular,B-Disease
Sentence: 588,hypertrophy,I-Disease
Sentence: 588,or,O
Sentence: 588,increased,O
Sentence: 588,segmental,O
Sentence: 588,glomerulosclerosis,B-Disease
Sentence: 588,",",O
Sentence: 588,tubulointerstitial,B-Disease
Sentence: 588,injury,I-Disease
Sentence: 588,",",O
Sentence: 588,or,O
Sentence: 588,renal,O
Sentence: 588,cortical,O
Sentence: 588,malondialdehyde,B-Chemical
Sentence: 588,content,O
Sentence: 588,.,O
Sentence: 588,In,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,nephropathy,B-Disease
Sentence: 588,",",O
Sentence: 588,administration,O
Sentence: 588,of,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,increased,O
Sentence: 588,IGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,and,O
Sentence: 588,GH,O
Sentence: 588,receptor,O
Sentence: 588,gene,O
Sentence: 588,expression,O
Sentence: 588,",",O
Sentence: 588,without,O
Sentence: 588,altering,O
Sentence: 588,the,O
Sentence: 588,steady,O
Sentence: 588,state,O
Sentence: 588,level,O
Sentence: 588,of,O
Sentence: 588,IGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,receptor,O
Sentence: 588,mRNA,O
Sentence: 588,.,O
Sentence: 588,In,O
Sentence: 588,normal,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,intact,O
Sentence: 588,kidneys,O
Sentence: 588,",",O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,administration,O
Sentence: 588,(,O
Sentence: 588,n,O
Sentence: 588,,O
Sentence: 588,=,O
Sentence: 588,,O
Sentence: 588,4,O
Sentence: 588,),O
Sentence: 588,did,O
Sentence: 588,not,O
Sentence: 588,alter,O
Sentence: 588,weight,O
Sentence: 588,gain,O
Sentence: 588,",",O
Sentence: 588,blood,O
Sentence: 588,pressure,O
Sentence: 588,",",O
Sentence: 588,proteinuria,B-Disease
Sentence: 588,",",O
Sentence: 588,GFR,O
Sentence: 588,",",O
Sentence: 588,glomerular,O
Sentence: 588,planar,O
Sentence: 588,area,O
Sentence: 588,",",O
Sentence: 588,renal,O
Sentence: 588,cortical,O
Sentence: 588,malondialdehyde,B-Chemical
Sentence: 588,content,O
Sentence: 588,",",O
Sentence: 588,or,O
Sentence: 588,glomerular,O
Sentence: 588,or,O
Sentence: 588,tubulointerstitial,B-Disease
Sentence: 588,damage,I-Disease
Sentence: 588,",",O
Sentence: 588,compared,O
Sentence: 588,with,O
Sentence: 588,untreated,O
Sentence: 588,animals,O
Sentence: 588,(,O
Sentence: 588,n,O
Sentence: 588,,O
Sentence: 588,=,O
Sentence: 588,,O
Sentence: 588,4,O
Sentence: 588,),O
Sentence: 588,.,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,treatment,O
Sentence: 588,reduced,O
Sentence: 588,the,O
Sentence: 588,steady,O
Sentence: 588,state,O
Sentence: 588,renal,O
Sentence: 588,IGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,mRNA,O
Sentence: 588,level,O
Sentence: 588,but,O
Sentence: 588,did,O
Sentence: 588,not,O
Sentence: 588,modify,O
Sentence: 588,gene,O
Sentence: 588,expression,O
Sentence: 588,of,O
Sentence: 588,the,O
Sentence: 588,IGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,or,O
Sentence: 588,GH,O
Sentence: 588,receptors,O
Sentence: 588,.,O
Sentence: 588,We,O
Sentence: 588,conclude,O
Sentence: 588,that,O
Sentence: 588,:,O
Sentence: 588,1,O
Sentence: 588,),O
Sentence: 588,administration,O
Sentence: 588,of,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,improves,O
Sentence: 588,growth,O
Sentence: 588,and,O
Sentence: 588,GFR,O
Sentence: 588,in,O
Sentence: 588,rats,O
Sentence: 588,with,O
Sentence: 588,chronic,O
Sentence: 588,PAN,B-Chemical
Sentence: 588,nephropathy,B-Disease
Sentence: 588,and,O
Sentence: 588,2,O
Sentence: 588,),O
Sentence: 588,unlike,O
Sentence: 588,rhGH,O
Sentence: 588,",",O
Sentence: 588,long,O
Sentence: 588,-,O
Sentence: 588,term,O
Sentence: 588,use,O
Sentence: 588,of,O
Sentence: 588,rhIGF,O
Sentence: 588,-,O
Sentence: 588,I,O
Sentence: 588,does,O
Sentence: 588,not,O
Sentence: 588,worsen,O
Sentence: 588,renal,O
Sentence: 588,functional,O
Sentence: 588,and,O
Sentence: 588,structural,O
Sentence: 588,injury,O
Sentence: 588,in,O
Sentence: 588,this,O
Sentence: 588,disease,O
Sentence: 588,model,O
Sentence: 588,.,O
Sentence: 589,Nefiracetam,B-Chemical
Sentence: 589,(,O
Sentence: 589,DM,O
Sentence: 589,-,O
Sentence: 589,9384,O
Sentence: 589,),O
Sentence: 589,reverses,O
Sentence: 589,apomorphine,B-Chemical
Sentence: 589,-,O
Sentence: 589,induced,O
Sentence: 589,amnesia,B-Disease
Sentence: 589,of,O
Sentence: 589,a,O
Sentence: 589,passive,O
Sentence: 589,avoidance,O
Sentence: 589,response,O
Sentence: 589,:,O
Sentence: 589,delayed,O
Sentence: 589,emergence,O
Sentence: 589,of,O
Sentence: 589,the,O
Sentence: 589,memory,O
Sentence: 589,retention,O
Sentence: 589,effects,O
Sentence: 589,.,O
Sentence: 590,Nefiracetam,B-Chemical
Sentence: 590,is,O
Sentence: 590,a,O
Sentence: 590,novel,O
Sentence: 590,pyrrolidone,B-Chemical
Sentence: 590,derivative,O
Sentence: 590,which,O
Sentence: 590,attenuates,O
Sentence: 590,scopolamine,B-Chemical
Sentence: 590,-,O
Sentence: 590,induced,O
Sentence: 590,learning,O
Sentence: 590,and,O
Sentence: 590,post,O
Sentence: 590,-,O
Sentence: 590,training,O
Sentence: 590,consolidation,O
Sentence: 590,deficits,O
Sentence: 590,.,O
Sentence: 590,Given,O
Sentence: 590,that,O
Sentence: 590,apomorphine,B-Chemical
Sentence: 590,inhibits,O
Sentence: 590,passive,O
Sentence: 590,avoidance,O
Sentence: 590,retention,O
Sentence: 590,when,O
Sentence: 590,given,O
Sentence: 590,during,O
Sentence: 590,training,O
Sentence: 590,or,O
Sentence: 590,in,O
Sentence: 590,a,O
Sentence: 590,defined,O
Sentence: 590,10,O
Sentence: 590,-,O
Sentence: 590,12h,O
Sentence: 590,post,O
Sentence: 590,-,O
Sentence: 590,training,O
Sentence: 590,period,O
Sentence: 590,",",O
Sentence: 590,we,O
Sentence: 590,evaluated,O
Sentence: 590,the,O
Sentence: 590,ability,O
Sentence: 590,of,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,to,O
Sentence: 590,attenuate,O
Sentence: 590,amnesia,B-Disease
Sentence: 590,induced,O
Sentence: 590,by,O
Sentence: 590,dopaminergic,O
Sentence: 590,agonism,O
Sentence: 590,.,O
Sentence: 590,A,O
Sentence: 590,step,O
Sentence: 590,-,O
Sentence: 590,down,O
Sentence: 590,passive,O
Sentence: 590,avoidance,O
Sentence: 590,paradigm,O
Sentence: 590,was,O
Sentence: 590,employed,O
Sentence: 590,and,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,(,O
Sentence: 590,3,O
Sentence: 590,mg,O
Sentence: 590,/,O
Sentence: 590,kg,O
Sentence: 590,),O
Sentence: 590,and,O
Sentence: 590,apomorphine,B-Chemical
Sentence: 590,(,O
Sentence: 590,0.5,O
Sentence: 590,mg,O
Sentence: 590,/,O
Sentence: 590,kg,O
Sentence: 590,),O
Sentence: 590,were,O
Sentence: 590,given,O
Sentence: 590,alone,O
Sentence: 590,or,O
Sentence: 590,in,O
Sentence: 590,combination,O
Sentence: 590,during,O
Sentence: 590,training,O
Sentence: 590,and,O
Sentence: 590,at,O
Sentence: 590,the,O
Sentence: 590,10,O
Sentence: 590,-,O
Sentence: 590,12h,O
Sentence: 590,post,O
Sentence: 590,-,O
Sentence: 590,training,O
Sentence: 590,period,O
Sentence: 590,of,O
Sentence: 590,consolidation,O
Sentence: 590,.,O
Sentence: 590,Co,O
Sentence: 590,-,O
Sentence: 590,administration,O
Sentence: 590,of,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,and,O
Sentence: 590,apomorphine,B-Chemical
Sentence: 590,during,O
Sentence: 590,training,O
Sentence: 590,or,O
Sentence: 590,10h,O
Sentence: 590,thereafter,O
Sentence: 590,produced,O
Sentence: 590,no,O
Sentence: 590,significant,O
Sentence: 590,anti,O
Sentence: 590,-,O
Sentence: 590,amnesic,O
Sentence: 590,effect,O
Sentence: 590,.,O
Sentence: 590,However,O
Sentence: 590,",",O
Sentence: 590,administration,O
Sentence: 590,of,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,during,O
Sentence: 590,training,O
Sentence: 590,completely,O
Sentence: 590,reversed,O
Sentence: 590,the,O
Sentence: 590,amnesia,B-Disease
Sentence: 590,induced,O
Sentence: 590,by,O
Sentence: 590,apomorphine,B-Chemical
Sentence: 590,at,O
Sentence: 590,the,O
Sentence: 590,10h,O
Sentence: 590,post,O
Sentence: 590,-,O
Sentence: 590,training,O
Sentence: 590,time,O
Sentence: 590,and,O
Sentence: 590,the,O
Sentence: 590,converse,O
Sentence: 590,was,O
Sentence: 590,also,O
Sentence: 590,true,O
Sentence: 590,.,O
Sentence: 590,These,O
Sentence: 590,effects,O
Sentence: 590,were,O
Sentence: 590,not,O
Sentence: 590,mediated,O
Sentence: 590,by,O
Sentence: 590,a,O
Sentence: 590,dopaminergic,O
Sentence: 590,mechanism,O
Sentence: 590,as,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,",",O
Sentence: 590,at,O
Sentence: 590,millimolar,O
Sentence: 590,concentrations,O
Sentence: 590,",",O
Sentence: 590,failed,O
Sentence: 590,to,O
Sentence: 590,displace,O
Sentence: 590,either,O
Sentence: 590,[,O
Sentence: 590,3H,O
Sentence: 590,],O
Sentence: 590,SCH,B-Chemical
Sentence: 590,23390,I-Chemical
Sentence: 590,or,O
Sentence: 590,[,O
Sentence: 590,3H,O
Sentence: 590,],O
Sentence: 590,spiperone,B-Chemical
Sentence: 590,binding,O
Sentence: 590,from,O
Sentence: 590,D1,O
Sentence: 590,or,O
Sentence: 590,D2,O
Sentence: 590,dopamine,B-Chemical
Sentence: 590,receptor,O
Sentence: 590,subtypes,O
Sentence: 590,",",O
Sentence: 590,respectively,O
Sentence: 590,.,O
Sentence: 590,It,O
Sentence: 590,is,O
Sentence: 590,suggested,O
Sentence: 590,that,O
Sentence: 590,nefiracetam,B-Chemical
Sentence: 590,augments,O
Sentence: 590,molecular,O
Sentence: 590,processes,O
Sentence: 590,in,O
Sentence: 590,the,O
Sentence: 590,early,O
Sentence: 590,stages,O
Sentence: 590,of,O
Sentence: 590,events,O
Sentence: 590,which,O
Sentence: 590,ultimately,O
Sentence: 590,lead,O
Sentence: 590,to,O
Sentence: 590,consolidation,O
Sentence: 590,of,O
Sentence: 590,memory,O
Sentence: 590,.,O
Sentence: 591,Human,O
Sentence: 591,corticotropin,B-Chemical
Sentence: 591,-,O
Sentence: 591,releasing,O
Sentence: 591,hormone,O
Sentence: 591,and,O
Sentence: 591,thyrotropin,B-Chemical
Sentence: 591,-,O
Sentence: 591,releasing,O
Sentence: 591,hormone,O
Sentence: 591,modulate,O
Sentence: 591,the,O
Sentence: 591,hypercapnic,B-Disease
Sentence: 591,ventilatory,O
Sentence: 591,response,O
Sentence: 591,in,O
Sentence: 591,humans,O
Sentence: 591,.,O
Sentence: 592,Human,O
Sentence: 592,corticotropin,B-Chemical
Sentence: 592,-,O
Sentence: 592,releasing,O
Sentence: 592,hormone,O
Sentence: 592,(,O
Sentence: 592,hCRH,O
Sentence: 592,),O
Sentence: 592,and,O
Sentence: 592,thyrotropin,B-Chemical
Sentence: 592,-,O
Sentence: 592,releasing,O
Sentence: 592,hormone,O
Sentence: 592,(,O
Sentence: 592,TRH,O
Sentence: 592,),O
Sentence: 592,are,O
Sentence: 592,known,O
Sentence: 592,to,O
Sentence: 592,stimulate,O
Sentence: 592,ventilation,O
Sentence: 592,after,O
Sentence: 592,i.v,O
Sentence: 592,.,O
Sentence: 592,administration,O
Sentence: 592,in,O
Sentence: 592,humans,O
Sentence: 592,.,O
Sentence: 592,In,O
Sentence: 592,a,O
Sentence: 592,placebo,O
Sentence: 592,-,O
Sentence: 592,controlled,O
Sentence: 592,",",O
Sentence: 592,single,O
Sentence: 592,-,O
Sentence: 592,blind,O
Sentence: 592,study,O
Sentence: 592,we,O
Sentence: 592,aimed,O
Sentence: 592,to,O
Sentence: 592,clarify,O
Sentence: 592,if,O
Sentence: 592,both,O
Sentence: 592,peptides,O
Sentence: 592,act,O
Sentence: 592,by,O
Sentence: 592,altering,O
Sentence: 592,central,O
Sentence: 592,chemosensitivity,O
Sentence: 592,.,O
Sentence: 592,Two,O
Sentence: 592,subsequent,O
Sentence: 592,CO2,B-Chemical
Sentence: 592,-,O
Sentence: 592,rebreathing,O
Sentence: 592,tests,O
Sentence: 592,were,O
Sentence: 592,performed,O
Sentence: 592,in,O
Sentence: 592,healthy,O
Sentence: 592,young,O
Sentence: 592,volunteers,O
Sentence: 592,.,O
Sentence: 592,During,O
Sentence: 592,the,O
Sentence: 592,first,O
Sentence: 592,test,O
Sentence: 592,0.9,O
Sentence: 592,%,O
Sentence: 592,NaCl,B-Chemical
Sentence: 592,was,O
Sentence: 592,given,O
Sentence: 592,i.v,O
Sentence: 592,.,O
Sentence: 592,;,O
Sentence: 592,during,O
Sentence: 592,the,O
Sentence: 592,second,O
Sentence: 592,test,O
Sentence: 592,200,O
Sentence: 592,micrograms,O
Sentence: 592,of,O
Sentence: 592,hCRH,O
Sentence: 592,(,O
Sentence: 592,n,O
Sentence: 592,,O
Sentence: 592,=,O
Sentence: 592,,O
Sentence: 592,12,O
Sentence: 592,),O
Sentence: 592,or,O
Sentence: 592,400,O
Sentence: 592,micrograms,O
Sentence: 592,of,O
Sentence: 592,TRH,O
Sentence: 592,(,O
Sentence: 592,n,O
Sentence: 592,,O
Sentence: 592,=,O
Sentence: 592,,O
Sentence: 592,6,O
Sentence: 592,),O
Sentence: 592,was,O
Sentence: 592,administered,O
Sentence: 592,i.v,O
Sentence: 592,.,O
Sentence: 592,Nine,O
Sentence: 592,subjects,O
Sentence: 592,received,O
Sentence: 592,0.9,O
Sentence: 592,%,O
Sentence: 592,NaCl,B-Chemical
Sentence: 592,i.v,O
Sentence: 592,.,O
Sentence: 592,during,O
Sentence: 592,both,O
Sentence: 592,rebreathing,O
Sentence: 592,manoeuvres,O
Sentence: 592,.,O
Sentence: 592,The,O
Sentence: 592,CO2,B-Chemical
Sentence: 592,-,O
Sentence: 592,response,O
Sentence: 592,curves,O
Sentence: 592,for,O
Sentence: 592,the,O
Sentence: 592,two,O
Sentence: 592,tests,O
Sentence: 592,were,O
Sentence: 592,compared,O
Sentence: 592,within,O
Sentence: 592,the,O
Sentence: 592,same,O
Sentence: 592,subject,O
Sentence: 592,.,O
Sentence: 592,In,O
Sentence: 592,the,O
Sentence: 592,hCRH,O
Sentence: 592,group,O
Sentence: 592,a,O
Sentence: 592,marked,O
Sentence: 592,parallel,O
Sentence: 592,shift,O
Sentence: 592,of,O
Sentence: 592,the,O
Sentence: 592,CO2,B-Chemical
Sentence: 592,-,O
Sentence: 592,response,O
Sentence: 592,curve,O
Sentence: 592,to,O
Sentence: 592,the,O
Sentence: 592,left,O
Sentence: 592,was,O
Sentence: 592,observed,O
Sentence: 592,after,O
Sentence: 592,hCRH,O
Sentence: 592,(,O
Sentence: 592,P,O
Sentence: 592,,O
Sentence: 592,<,O
Sentence: 592,,O
Sentence: 592,0.01,O
Sentence: 592,),O
Sentence: 592,.,O
Sentence: 592,The,O
Sentence: 592,same,O
Sentence: 592,effect,O
Sentence: 592,occurred,O
Sentence: 592,following,O
Sentence: 592,TRH,O
Sentence: 592,but,O
Sentence: 592,was,O
Sentence: 592,less,O
Sentence: 592,striking,O
Sentence: 592,(,O
Sentence: 592,P,O
Sentence: 592,,O
Sentence: 592,=,O
Sentence: 592,,O
Sentence: 592,0.05,O
Sentence: 592,),O
Sentence: 592,.,O
Sentence: 592,hCRH,O
Sentence: 592,and,O
Sentence: 592,TRH,O
Sentence: 592,caused,O
Sentence: 592,a,O
Sentence: 592,reduction,O
Sentence: 592,in,O
Sentence: 592,the,O
Sentence: 592,CO2,B-Chemical
Sentence: 592,threshold,O
Sentence: 592,.,O
Sentence: 592,The,O
Sentence: 592,CO2,B-Chemical
Sentence: 592,-,O
Sentence: 592,response,O
Sentence: 592,curves,O
Sentence: 592,in,O
Sentence: 592,the,O
Sentence: 592,control,O
Sentence: 592,group,O
Sentence: 592,were,O
Sentence: 592,nearly,O
Sentence: 592,identical,O
Sentence: 592,.,O
Sentence: 592,The,O
Sentence: 592,results,O
Sentence: 592,indicate,O
Sentence: 592,an,O
Sentence: 592,additive,O
Sentence: 592,effect,O
Sentence: 592,of,O
Sentence: 592,both,O
Sentence: 592,releasing,O
Sentence: 592,hormones,O
Sentence: 592,on,O
Sentence: 592,the,O
Sentence: 592,hypercapnic,B-Disease
Sentence: 592,ventilatory,O
Sentence: 592,response,O
Sentence: 592,in,O
Sentence: 592,humans,O
Sentence: 592,",",O
Sentence: 592,presumably,O
Sentence: 592,independent,O
Sentence: 592,of,O
Sentence: 592,central,O
Sentence: 592,chemosensitivity,O
Sentence: 592,.,O
Sentence: 593,Lamivudine,B-Chemical
Sentence: 593,is,O
Sentence: 593,effective,O
Sentence: 593,in,O
Sentence: 593,suppressing,O
Sentence: 593,hepatitis,B-Disease
Sentence: 593,B,I-Disease
Sentence: 593,virus,O
Sentence: 593,DNA,O
Sentence: 593,in,O
Sentence: 593,Chinese,O
Sentence: 593,hepatitis,B-Chemical
Sentence: 593,B,I-Chemical
Sentence: 593,surface,I-Chemical
Sentence: 593,antigen,I-Chemical
Sentence: 593,carriers,O
Sentence: 593,:,O
Sentence: 593,a,O
Sentence: 593,placebo,O
Sentence: 593,-,O
Sentence: 593,controlled,O
Sentence: 593,trial,O
Sentence: 593,.,O
Sentence: 594,Lamivudine,B-Chemical
Sentence: 594,is,O
Sentence: 594,a,O
Sentence: 594,novel,O
Sentence: 594,"2',3'",O
Sentence: 594,-,O
Sentence: 594,dideoxy,O
Sentence: 594,cytosine,O
Sentence: 594,analogue,O
Sentence: 594,that,O
Sentence: 594,has,O
Sentence: 594,potent,O
Sentence: 594,inhibitory,O
Sentence: 594,effects,O
Sentence: 594,on,O
Sentence: 594,hepatitis,B-Disease
Sentence: 594,B,I-Disease
Sentence: 594,virus,O
Sentence: 594,replication,O
Sentence: 594,in,O
Sentence: 594,vitro,O
Sentence: 594,and,O
Sentence: 594,in,O
Sentence: 594,vivo,O
Sentence: 594,.,O
Sentence: 594,We,O
Sentence: 594,performed,O
Sentence: 594,a,O
Sentence: 594,single,O
Sentence: 594,-,O
Sentence: 594,blind,O
Sentence: 594,",",O
Sentence: 594,placebo,O
Sentence: 594,-,O
Sentence: 594,controlled,O
Sentence: 594,study,O
Sentence: 594,to,O
Sentence: 594,assess,O
Sentence: 594,its,O
Sentence: 594,effectiveness,O
Sentence: 594,and,O
Sentence: 594,safety,O
Sentence: 594,in,O
Sentence: 594,Chinese,O
Sentence: 594,hepatitis,B-Disease
Sentence: 594,B,I-Disease
Sentence: 594,surface,I-Chemical
Sentence: 594,antigen,I-Chemical
Sentence: 594,(,O
Sentence: 594,HBsAg,B-Chemical
Sentence: 594,),O
Sentence: 594,carriers,O
Sentence: 594,.,O
Sentence: 594,Forty,O
Sentence: 594,-,O
Sentence: 594,two,O
Sentence: 594,Chinese,O
Sentence: 594,HBsAg,B-Chemical
Sentence: 594,carriers,O
Sentence: 594,were,O
Sentence: 594,randomized,O
Sentence: 594,to,O
Sentence: 594,receive,O
Sentence: 594,placebo,O
Sentence: 594,(,O
Sentence: 594,6,O
Sentence: 594,patients,O
Sentence: 594,),O
Sentence: 594,or,O
Sentence: 594,lamivudine,B-Chemical
Sentence: 594,orally,O
Sentence: 594,in,O
Sentence: 594,dosages,O
Sentence: 594,of,O
Sentence: 594,25,O
Sentence: 594,mg,O
Sentence: 594,",",O
Sentence: 594,100,O
Sentence: 594,mg,O
Sentence: 594,",",O
Sentence: 594,or,O
Sentence: 594,300,O
Sentence: 594,mg,O
Sentence: 594,daily,O
Sentence: 594,(,O
Sentence: 594,12,O
Sentence: 594,patients,O
Sentence: 594,for,O
Sentence: 594,each,O
Sentence: 594,dosage,O
Sentence: 594,),O
Sentence: 594,.,O
Sentence: 594,The,O
Sentence: 594,drug,O
Sentence: 594,was,O
Sentence: 594,given,O
Sentence: 594,for,O
Sentence: 594,4,O
Sentence: 594,weeks,O
Sentence: 594,.,O
Sentence: 594,The,O
Sentence: 594,patients,O
Sentence: 594,were,O
Sentence: 594,closely,O
Sentence: 594,monitored,O
Sentence: 594,clinically,O
Sentence: 594,",",O
Sentence: 594,biochemically,O
Sentence: 594,",",O
Sentence: 594,and,O
Sentence: 594,serologically,O
Sentence: 594,up,O
Sentence: 594,to,O
Sentence: 594,4,O
Sentence: 594,weeks,O
Sentence: 594,after,O
Sentence: 594,drug,O
Sentence: 594,treatment,O
Sentence: 594,.,O
Sentence: 594,All,O
Sentence: 594,36,O
Sentence: 594,patients,O
Sentence: 594,receiving,O
Sentence: 594,lamivudine,B-Chemical
Sentence: 594,had,O
Sentence: 594,a,O
Sentence: 594,decrease,O
Sentence: 594,in,O
Sentence: 594,hepatitis,B-Disease
Sentence: 594,B,I-Disease
Sentence: 594,virus,O
Sentence: 594,(,O
Sentence: 594,HBV,O
Sentence: 594,),O
Sentence: 594,DNA,O
Sentence: 594,values,O
Sentence: 594,of,O
Sentence: 594,,O
Sentence: 594,>,O
Sentence: 594,,O
Sentence: 594,90,O
Sentence: 594,%,O
Sentence: 594,(,O
Sentence: 594,P,O
Sentence: 594,,O
Sentence: 594,<,O
Sentence: 594,,O
Sentence: 594,.001,O
Sentence: 594,compared,O
Sentence: 594,with,O
Sentence: 594,placebo,O
Sentence: 594,),O
Sentence: 594,.,O
Sentence: 594,Although,O
Sentence: 594,25,O
Sentence: 594,mg,O
Sentence: 594,of,O
Sentence: 594,lamivudine,B-Chemical
Sentence: 594,was,O
Sentence: 594,slightly,O
Sentence: 594,less,O
Sentence: 594,effective,O
Sentence: 594,than,O
Sentence: 594,100,O
Sentence: 594,mg,O
Sentence: 594,(,O
Sentence: 594,P,O
Sentence: 594,,O
Sentence: 594,=,O
Sentence: 594,,O
Sentence: 594,.011,O
Sentence: 594,),O
Sentence: 594,and,O
Sentence: 594,300,O
Sentence: 594,mg,O
Sentence: 594,(,O
Sentence: 594,P,O
Sentence: 594,,O
Sentence: 594,=,O
Sentence: 594,,O
Sentence: 594,.005,O
Sentence: 594,),O
Sentence: 594,",",O
Sentence: 594,it,O
Sentence: 594,still,O
Sentence: 594,induced,O
Sentence: 594,94,O
Sentence: 594,%,O
Sentence: 594,suppression,O
Sentence: 594,of,O
Sentence: 594,HBV,O
Sentence: 594,DNA,O
Sentence: 594,after,O
Sentence: 594,the,O
Sentence: 594,fourth,O
Sentence: 594,week,O
Sentence: 594,of,O
Sentence: 594,therapy,O
Sentence: 594,.,O
Sentence: 594,HBV,O
Sentence: 594,DNA,O
Sentence: 594,values,O
Sentence: 594,returned,O
Sentence: 594,to,O
Sentence: 594,pretreatment,O
Sentence: 594,levels,O
Sentence: 594,within,O
Sentence: 594,4,O
Sentence: 594,weeks,O
Sentence: 594,of,O
Sentence: 594,cessation,O
Sentence: 594,of,O
Sentence: 594,therapy,O
Sentence: 594,.,O
Sentence: 594,There,O
Sentence: 594,was,O
Sentence: 594,no,O
Sentence: 594,change,O
Sentence: 594,in,O
Sentence: 594,the,O
Sentence: 594,hepatitis,B-Disease
Sentence: 594,B,I-Disease
Sentence: 594,e,O
Sentence: 594,antigen,O
Sentence: 594,status,O
Sentence: 594,or,O
Sentence: 594,in,O
Sentence: 594,aminotransferase,O
Sentence: 594,levels,O
Sentence: 594,.,O
Sentence: 594,No,O
Sentence: 594,serious,O
Sentence: 594,adverse,O
Sentence: 594,events,O
Sentence: 594,were,O
Sentence: 594,observed,O
Sentence: 594,.,O
Sentence: 594,In,O
Sentence: 594,conclusion,O
Sentence: 594,",",O
Sentence: 594,a,O
Sentence: 594,4,O
Sentence: 594,-,O
Sentence: 594,week,O
Sentence: 594,course,O
Sentence: 594,of,O
Sentence: 594,lamivudine,B-Chemical
Sentence: 594,was,O
Sentence: 594,safe,O
Sentence: 594,and,O
Sentence: 594,effective,O
Sentence: 594,in,O
Sentence: 594,suppression,O
Sentence: 594,of,O
Sentence: 594,HBV,O
Sentence: 594,DNA,O
Sentence: 594,in,O
Sentence: 594,Chinese,O
Sentence: 594,HBsAg,B-Chemical
Sentence: 594,carriers,O
Sentence: 594,.,O
Sentence: 594,The,O
Sentence: 594,suppression,O
Sentence: 594,was,O
Sentence: 594,,O
Sentence: 594,>,O
Sentence: 594,,O
Sentence: 594,90,O
Sentence: 594,%,O
Sentence: 594,but,O
Sentence: 594,reversible,O
Sentence: 594,.,O
Sentence: 594,Studies,O
Sentence: 594,with,O
Sentence: 594,long,O
Sentence: 594,-,O
Sentence: 594,term,O
Sentence: 594,lamivudine,B-Chemical
Sentence: 594,administration,O
Sentence: 594,should,O
Sentence: 594,be,O
Sentence: 594,performed,O
Sentence: 594,to,O
Sentence: 594,determine,O
Sentence: 594,if,O
Sentence: 594,prolonged,O
Sentence: 594,suppression,O
Sentence: 594,of,O
Sentence: 594,HBV,O
Sentence: 594,DNA,O
Sentence: 594,can,O
Sentence: 594,be,O
Sentence: 594,achieved,O
Sentence: 594,.,O
Sentence: 595,Population,O
Sentence: 595,-,O
Sentence: 595,based,O
Sentence: 595,study,O
Sentence: 595,of,O
Sentence: 595,risk,O
Sentence: 595,of,O
Sentence: 595,venous,B-Disease
Sentence: 595,thromboembolism,I-Disease
Sentence: 595,associated,O
Sentence: 595,with,O
Sentence: 595,various,O
Sentence: 595,oral,B-Chemical
Sentence: 595,contraceptives,I-Chemical
Sentence: 595,.,O
Sentence: 596,BACKGROUND,O
Sentence: 596,:,O
Sentence: 596,Four,O
Sentence: 596,studies,O
Sentence: 596,published,O
Sentence: 596,since,O
Sentence: 596,December,O
Sentence: 596,",",O
Sentence: 596,1995,O
Sentence: 596,",",O
Sentence: 596,reported,O
Sentence: 596,that,O
Sentence: 596,the,O
Sentence: 596,incidence,O
Sentence: 596,of,O
Sentence: 596,venous,B-Disease
Sentence: 596,thromboembolism,I-Disease
Sentence: 596,(,O
Sentence: 596,VTE,B-Disease
Sentence: 596,),O
Sentence: 596,was,O
Sentence: 596,higher,O
Sentence: 596,in,O
Sentence: 596,women,O
Sentence: 596,who,O
Sentence: 596,used,O
Sentence: 596,oral,B-Chemical
Sentence: 596,contraceptives,I-Chemical
Sentence: 596,(,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,),O
Sentence: 596,containing,O
Sentence: 596,the,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,progestagens,B-Chemical
Sentence: 596,gestodene,B-Chemical
Sentence: 596,or,O
Sentence: 596,desogestrel,B-Chemical
Sentence: 596,than,O
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,containing,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,progestagens,B-Chemical
Sentence: 596,.,O
Sentence: 596,However,O
Sentence: 596,",",O
Sentence: 596,confounding,O
Sentence: 596,and,O
Sentence: 596,bias,O
Sentence: 596,in,O
Sentence: 596,the,O
Sentence: 596,design,O
Sentence: 596,of,O
Sentence: 596,these,O
Sentence: 596,studies,O
Sentence: 596,may,O
Sentence: 596,have,O
Sentence: 596,affected,O
Sentence: 596,the,O
Sentence: 596,findings,O
Sentence: 596,.,O
Sentence: 596,The,O
Sentence: 596,aim,O
Sentence: 596,of,O
Sentence: 596,our,O
Sentence: 596,study,O
Sentence: 596,was,O
Sentence: 596,to,O
Sentence: 596,re,O
Sentence: 596,-,O
Sentence: 596,examine,O
Sentence: 596,the,O
Sentence: 596,association,O
Sentence: 596,between,O
Sentence: 596,risk,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,and,O
Sentence: 596,OC,B-Chemical
Sentence: 596,use,O
Sentence: 596,with,O
Sentence: 596,a,O
Sentence: 596,different,O
Sentence: 596,study,O
Sentence: 596,design,O
Sentence: 596,and,O
Sentence: 596,analysis,O
Sentence: 596,to,O
Sentence: 596,avoid,O
Sentence: 596,some,O
Sentence: 596,of,O
Sentence: 596,the,O
Sentence: 596,bias,O
Sentence: 596,and,O
Sentence: 596,confounding,O
Sentence: 596,of,O
Sentence: 596,the,O
Sentence: 596,earlier,O
Sentence: 596,studies,O
Sentence: 596,.,O
Sentence: 596,METHODS,O
Sentence: 596,:,O
Sentence: 596,We,O
Sentence: 596,used,O
Sentence: 596,computer,O
Sentence: 596,records,O
Sentence: 596,of,O
Sentence: 596,patients,O
Sentence: 596,from,O
Sentence: 596,143,O
Sentence: 596,general,O
Sentence: 596,practices,O
Sentence: 596,in,O
Sentence: 596,the,O
Sentence: 596,UK,O
Sentence: 596,.,O
Sentence: 596,The,O
Sentence: 596,study,O
Sentence: 596,was,O
Sentence: 596,based,O
Sentence: 596,on,O
Sentence: 596,the,O
Sentence: 596,medical,O
Sentence: 596,records,O
Sentence: 596,of,O
Sentence: 596,about,O
Sentence: 596,"540,000",O
Sentence: 596,women,O
Sentence: 596,born,O
Sentence: 596,between,O
Sentence: 596,1941,O
Sentence: 596,and,O
Sentence: 596,1981,O
Sentence: 596,.,O
Sentence: 596,All,O
Sentence: 596,women,O
Sentence: 596,who,O
Sentence: 596,had,O
Sentence: 596,a,O
Sentence: 596,recorded,O
Sentence: 596,diagnosis,O
Sentence: 596,of,O
Sentence: 596,deep,O
Sentence: 596,-,O
Sentence: 596,vein,O
Sentence: 596,thrombosis,B-Disease
Sentence: 596,",",O
Sentence: 596,venous,B-Disease
Sentence: 596,thrombosis,I-Disease
Sentence: 596,not,O
Sentence: 596,otherwise,O
Sentence: 596,specified,O
Sentence: 596,",",O
Sentence: 596,or,O
Sentence: 596,pulmonary,O
Sentence: 596,embolus,O
Sentence: 596,during,O
Sentence: 596,the,O
Sentence: 596,study,O
Sentence: 596,period,O
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,who,O
Sentence: 596,had,O
Sentence: 596,been,O
Sentence: 596,treated,O
Sentence: 596,with,O
Sentence: 596,an,O
Sentence: 596,anticoagulant,O
Sentence: 596,were,O
Sentence: 596,identified,O
Sentence: 596,as,O
Sentence: 596,potential,O
Sentence: 596,cases,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,.,O
Sentence: 596,We,O
Sentence: 596,did,O
Sentence: 596,a,O
Sentence: 596,cohort,O
Sentence: 596,analysis,O
Sentence: 596,to,O
Sentence: 596,estimate,O
Sentence: 596,and,O
Sentence: 596,compare,O
Sentence: 596,incidence,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,the,O
Sentence: 596,main,O
Sentence: 596,OC,B-Chemical
Sentence: 596,preparations,O
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,a,O
Sentence: 596,nested,O
Sentence: 596,case,O
Sentence: 596,-,O
Sentence: 596,control,O
Sentence: 596,study,O
Sentence: 596,to,O
Sentence: 596,calculate,O
Sentence: 596,the,O
Sentence: 596,odds,O
Sentence: 596,ratios,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,associated,O
Sentence: 596,with,O
Sentence: 596,use,O
Sentence: 596,of,O
Sentence: 596,different,O
Sentence: 596,types,O
Sentence: 596,of,O
Sentence: 596,OC,B-Chemical
Sentence: 596,",",O
Sentence: 596,after,O
Sentence: 596,adjustment,O
Sentence: 596,for,O
Sentence: 596,potential,O
Sentence: 596,confounding,O
Sentence: 596,factors,O
Sentence: 596,.,O
Sentence: 596,In,O
Sentence: 596,the,O
Sentence: 596,case,O
Sentence: 596,-,O
Sentence: 596,control,O
Sentence: 596,study,O
Sentence: 596,",",O
Sentence: 596,we,O
Sentence: 596,matched,O
Sentence: 596,cases,O
Sentence: 596,to,O
Sentence: 596,controls,O
Sentence: 596,by,O
Sentence: 596,exact,O
Sentence: 596,year,O
Sentence: 596,of,O
Sentence: 596,birth,O
Sentence: 596,",",O
Sentence: 596,practice,O
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,current,O
Sentence: 596,use,O
Sentence: 596,of,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,.,O
Sentence: 596,We,O
Sentence: 596,used,O
Sentence: 596,a,O
Sentence: 596,multiple,O
Sentence: 596,logistic,O
Sentence: 596,regression,O
Sentence: 596,model,O
Sentence: 596,that,O
Sentence: 596,included,O
Sentence: 596,body,O
Sentence: 596,-,O
Sentence: 596,mass,O
Sentence: 596,index,O
Sentence: 596,",",O
Sentence: 596,number,O
Sentence: 596,of,O
Sentence: 596,cycles,O
Sentence: 596,",",O
Sentence: 596,change,O
Sentence: 596,in,O
Sentence: 596,type,O
Sentence: 596,of,O
Sentence: 596,OC,B-Chemical
Sentence: 596,prescribed,O
Sentence: 596,within,O
Sentence: 596,3,O
Sentence: 596,months,O
Sentence: 596,of,O
Sentence: 596,the,O
Sentence: 596,event,O
Sentence: 596,",",O
Sentence: 596,previous,O
Sentence: 596,pregnancy,O
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,concurrent,O
Sentence: 596,disease,O
Sentence: 596,.,O
Sentence: 596,FINDINGS,O
Sentence: 596,:,O
Sentence: 596,85,O
Sentence: 596,women,O
Sentence: 596,met,O
Sentence: 596,the,O
Sentence: 596,inclusion,O
Sentence: 596,criteria,O
Sentence: 596,for,O
Sentence: 596,VTE,B-Disease
Sentence: 596,",",O
Sentence: 596,two,O
Sentence: 596,of,O
Sentence: 596,whom,O
Sentence: 596,were,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,progestagen,B-Chemical
Sentence: 596,-,O
Sentence: 596,only,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,.,O
Sentence: 596,Of,O
Sentence: 596,the,O
Sentence: 596,83,O
Sentence: 596,cases,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,associated,O
Sentence: 596,with,O
Sentence: 596,use,O
Sentence: 596,of,O
Sentence: 596,combined,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,",",O
Sentence: 596,43,O
Sentence: 596,were,O
Sentence: 596,recorded,O
Sentence: 596,as,O
Sentence: 596,deep,O
Sentence: 596,-,O
Sentence: 596,vein,O
Sentence: 596,thrombosis,B-Disease
Sentence: 596,",",O
Sentence: 596,35,O
Sentence: 596,as,O
Sentence: 596,pulmonary,O
Sentence: 596,thrombosis,B-Disease
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,five,O
Sentence: 596,as,O
Sentence: 596,venous,B-Disease
Sentence: 596,thrombosis,I-Disease
Sentence: 596,not,O
Sentence: 596,otherwise,O
Sentence: 596,specified,O
Sentence: 596,.,O
Sentence: 596,The,O
Sentence: 596,crude,O
Sentence: 596,rate,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,per,O
Sentence: 596,"10,000",O
Sentence: 596,woman,O
Sentence: 596,-,O
Sentence: 596,years,O
Sentence: 596,was,O
Sentence: 596,4.10,O
Sentence: 596,in,O
Sentence: 596,current,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,any,O
Sentence: 596,OC,B-Chemical
Sentence: 596,",",O
Sentence: 596,3.10,O
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,4.96,O
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,preparations,O
Sentence: 596,.,O
Sentence: 596,After,O
Sentence: 596,adjustment,O
Sentence: 596,for,O
Sentence: 596,age,O
Sentence: 596,",",O
Sentence: 596,the,O
Sentence: 596,rate,O
Sentence: 596,ratio,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,relative,O
Sentence: 596,to,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,was,O
Sentence: 596,1.68,O
Sentence: 596,(,O
Sentence: 596,95,O
Sentence: 596,%,O
Sentence: 596,CI,O
Sentence: 596,1.04,O
Sentence: 596,-,O
Sentence: 596,2.75,O
Sentence: 596,),O
Sentence: 596,.,O
Sentence: 596,Logistic,O
Sentence: 596,regression,O
Sentence: 596,showed,O
Sentence: 596,no,O
Sentence: 596,significant,O
Sentence: 596,difference,O
Sentence: 596,in,O
Sentence: 596,the,O
Sentence: 596,risk,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,between,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,and,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,.,O
Sentence: 596,Among,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,progestagens,B-Chemical
Sentence: 596,",",O
Sentence: 596,the,O
Sentence: 596,risk,O
Sentence: 596,of,O
Sentence: 596,VTE,B-Disease
Sentence: 596,was,O
Sentence: 596,higher,O
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,desogestrel,B-Chemical
Sentence: 596,with,O
Sentence: 596,20,O
Sentence: 596,g,O
Sentence: 596,ethinyloestradiol,B-Chemical
Sentence: 596,than,O
Sentence: 596,in,O
Sentence: 596,users,O
Sentence: 596,of,O
Sentence: 596,gestodene,B-Chemical
Sentence: 596,or,O
Sentence: 596,desogestrel,B-Chemical
Sentence: 596,with,O
Sentence: 596,30,O
Sentence: 596,g,O
Sentence: 596,ethinyloestradiol,B-Chemical
Sentence: 596,.,O
Sentence: 596,With,O
Sentence: 596,all,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,as,O
Sentence: 596,the,O
Sentence: 596,reference,O
Sentence: 596,",",O
Sentence: 596,the,O
Sentence: 596,odds,O
Sentence: 596,ratios,O
Sentence: 596,for,O
Sentence: 596,VTE,B-Disease
Sentence: 596,were,O
Sentence: 596,3.49,O
Sentence: 596,(,O
Sentence: 596,1.21,O
Sentence: 596,-,O
Sentence: 596,10.12,O
Sentence: 596,),O
Sentence: 596,for,O
Sentence: 596,desogestrel,B-Chemical
Sentence: 596,plus,O
Sentence: 596,20,O
Sentence: 596,g,O
Sentence: 596,ethinyloestradiol,B-Chemical
Sentence: 596,and,O
Sentence: 596,1.18,O
Sentence: 596,(,O
Sentence: 596,0.66,O
Sentence: 596,-,O
Sentence: 596,2.17,O
Sentence: 596,),O
Sentence: 596,for,O
Sentence: 596,the,O
Sentence: 596,other,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,progestagens,B-Chemical
Sentence: 596,.,O
Sentence: 596,INTERPRETATION,O
Sentence: 596,:,O
Sentence: 596,The,O
Sentence: 596,previously,O
Sentence: 596,reported,O
Sentence: 596,increase,O
Sentence: 596,in,O
Sentence: 596,odds,O
Sentence: 596,ratio,O
Sentence: 596,associated,O
Sentence: 596,with,O
Sentence: 596,third,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,OCs,B-Chemical
Sentence: 596,when,O
Sentence: 596,compared,O
Sentence: 596,with,O
Sentence: 596,second,O
Sentence: 596,-,O
Sentence: 596,generation,O
Sentence: 596,products,O
Sentence: 596,is,O
Sentence: 596,likely,O
Sentence: 596,to,O
Sentence: 596,have,O
Sentence: 596,been,O
Sentence: 596,the,O
Sentence: 596,result,O
Sentence: 596,of,O
Sentence: 596,residual,O
Sentence: 596,confounding,O
Sentence: 596,by,O
Sentence: 596,age,O
Sentence: 596,.,O
Sentence: 596,The,O
Sentence: 596,increased,O
Sentence: 596,odds,O
Sentence: 596,ratio,O
Sentence: 596,associated,O
Sentence: 596,with,O
Sentence: 596,products,O
Sentence: 596,containing,O
Sentence: 596,20,O
Sentence: 596,micrograms,O
Sentence: 596,ethinyloestradiol,B-Chemical
Sentence: 596,and,O
Sentence: 596,desogestrel,B-Chemical
Sentence: 596,compared,O
Sentence: 596,with,O
Sentence: 596,the,O
Sentence: 596,30,O
Sentence: 596,micrograms,O
Sentence: 596,product,O
Sentence: 596,is,O
Sentence: 596,biologically,O
Sentence: 596,implausible,O
Sentence: 596,",",O
Sentence: 596,and,O
Sentence: 596,is,O
Sentence: 596,likely,O
Sentence: 596,to,O
Sentence: 596,be,O
Sentence: 596,the,O
Sentence: 596,result,O
Sentence: 596,of,O
Sentence: 596,preferential,O
Sentence: 596,prescribing,O
Sentence: 596,and,O
Sentence: 596,",",O
Sentence: 596,thus,O
Sentence: 596,",",O
Sentence: 596,confounding,O
Sentence: 596,.,O
Sentence: 597,MK,O
Sentence: 597,-,O
Sentence: 597,801,O
Sentence: 597,augments,O
Sentence: 597,pilocarpine,B-Chemical
Sentence: 597,-,O
Sentence: 597,induced,O
Sentence: 597,electrographic,O
Sentence: 597,seizure,B-Disease
Sentence: 597,but,O
Sentence: 597,protects,O
Sentence: 597,against,O
Sentence: 597,brain,B-Disease
Sentence: 597,damage,I-Disease
Sentence: 597,in,O
Sentence: 597,rats,O
Sentence: 597,.,O
Sentence: 598,1,O
Sentence: 598,.,O
Sentence: 598,The,O
Sentence: 598,authors,O
Sentence: 598,examined,O
Sentence: 598,the,O
Sentence: 598,anticonvulsant,O
Sentence: 598,effects,O
Sentence: 598,of,O
Sentence: 598,MK,O
Sentence: 598,-,O
Sentence: 598,801,O
Sentence: 598,on,O
Sentence: 598,the,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,-,O
Sentence: 598,induced,O
Sentence: 598,seizure,B-Disease
Sentence: 598,model,O
Sentence: 598,.,O
Sentence: 598,Intraperitoneal,O
Sentence: 598,injection,O
Sentence: 598,of,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,(,O
Sentence: 598,400,O
Sentence: 598,mg,O
Sentence: 598,/,O
Sentence: 598,kg,O
Sentence: 598,),O
Sentence: 598,induced,O
Sentence: 598,tonic,B-Disease
Sentence: 598,and,I-Disease
Sentence: 598,clonic,I-Disease
Sentence: 598,seizure,B-Disease
Sentence: 598,.,O
Sentence: 598,Scopolamine,B-Chemical
Sentence: 598,(,O
Sentence: 598,10,O
Sentence: 598,mg,O
Sentence: 598,/,O
Sentence: 598,kg,O
Sentence: 598,),O
Sentence: 598,and,O
Sentence: 598,pentobarbital,B-Chemical
Sentence: 598,(,O
Sentence: 598,5,O
Sentence: 598,mg,O
Sentence: 598,/,O
Sentence: 598,kg,O
Sentence: 598,),O
Sentence: 598,prevented,O
Sentence: 598,development,O
Sentence: 598,of,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,-,O
Sentence: 598,induced,O
Sentence: 598,behavioral,O
Sentence: 598,seizure,B-Disease
Sentence: 598,but,O
Sentence: 598,MK,O
Sentence: 598,-,O
Sentence: 598,801,O
Sentence: 598,(,O
Sentence: 598,0.5,O
Sentence: 598,mg,O
Sentence: 598,/,O
Sentence: 598,kg,O
Sentence: 598,),O
Sentence: 598,did,O
Sentence: 598,not,O
Sentence: 598,.,O
Sentence: 598,2,O
Sentence: 598,.,O
Sentence: 598,An,O
Sentence: 598,electrical,O
Sentence: 598,seizure,B-Disease
Sentence: 598,measured,O
Sentence: 598,with,O
Sentence: 598,hippocampal,O
Sentence: 598,EEG,O
Sentence: 598,appeared,O
Sentence: 598,in,O
Sentence: 598,the,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,-,O
Sentence: 598,treated,O
Sentence: 598,group,O
Sentence: 598,.,O
Sentence: 598,Scopolamine,B-Chemical
Sentence: 598,and,O
Sentence: 598,pentobarbital,B-Chemical
Sentence: 598,blocked,O
Sentence: 598,the,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,-,O
Sentence: 598,induced,O
Sentence: 598,electrographic,O
Sentence: 598,seizure,B-Disease
Sentence: 598,",",O
Sentence: 598,MK,O
Sentence: 598,-,O
Sentence: 598,801,O
Sentence: 598,treatment,O
Sentence: 598,augmented,O
Sentence: 598,the,O
Sentence: 598,electrographic,O
Sentence: 598,seizure,B-Disease
Sentence: 598,induced,O
Sentence: 598,by,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,.,O
Sentence: 598,3,O
Sentence: 598,.,O
Sentence: 598,Brain,B-Disease
Sentence: 598,damage,I-Disease
Sentence: 598,was,O
Sentence: 598,assessed,O
Sentence: 598,by,O
Sentence: 598,examining,O
Sentence: 598,the,O
Sentence: 598,hippocampus,O
Sentence: 598,microscopically,O
Sentence: 598,.,O
Sentence: 598,Pilocarpine,B-Chemical
Sentence: 598,produced,O
Sentence: 598,neuronal,B-Disease
Sentence: 598,death,I-Disease
Sentence: 598,in,O
Sentence: 598,the,O
Sentence: 598,hippocampus,O
Sentence: 598,",",O
Sentence: 598,which,O
Sentence: 598,showed,O
Sentence: 598,pyknotic,O
Sentence: 598,changes,O
Sentence: 598,.,O
Sentence: 598,Pentobarbital,B-Chemical
Sentence: 598,",",O
Sentence: 598,scopolamine,B-Chemical
Sentence: 598,and,O
Sentence: 598,MK,O
Sentence: 598,-,O
Sentence: 598,801,O
Sentence: 598,protected,O
Sentence: 598,the,O
Sentence: 598,brain,B-Disease
Sentence: 598,damage,I-Disease
Sentence: 598,by,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,",",O
Sentence: 598,though,O
Sentence: 598,in,O
Sentence: 598,the,O
Sentence: 598,MK,O
Sentence: 598,-,O
Sentence: 598,801,O
Sentence: 598,-,O
Sentence: 598,treated,O
Sentence: 598,group,O
Sentence: 598,",",O
Sentence: 598,the,O
Sentence: 598,pyramidal,O
Sentence: 598,cells,O
Sentence: 598,of,O
Sentence: 598,hippocampus,O
Sentence: 598,appeared,O
Sentence: 598,darker,O
Sentence: 598,than,O
Sentence: 598,normal,O
Sentence: 598,.,O
Sentence: 598,In,O
Sentence: 598,all,O
Sentence: 598,treatments,O
Sentence: 598,",",O
Sentence: 598,granule,O
Sentence: 598,cells,O
Sentence: 598,of,O
Sentence: 598,the,O
Sentence: 598,dentate,O
Sentence: 598,gyrus,O
Sentence: 598,were,O
Sentence: 598,not,O
Sentence: 598,affected,O
Sentence: 598,.,O
Sentence: 598,4,O
Sentence: 598,.,O
Sentence: 598,These,O
Sentence: 598,results,O
Sentence: 598,indicate,O
Sentence: 598,that,O
Sentence: 598,status,B-Disease
Sentence: 598,epilepticus,I-Disease
Sentence: 598,induced,O
Sentence: 598,by,O
Sentence: 598,pilocarpine,B-Chemical
Sentence: 598,is,O
Sentence: 598,initiated,O
Sentence: 598,by,O
Sentence: 598,cholinergic,O
Sentence: 598,overstimulation,O
Sentence: 598,and,O
Sentence: 598,propagated,O
Sentence: 598,by,O
Sentence: 598,glutamatergic,O
Sentence: 598,transmission,O
Sentence: 598,",",O
Sentence: 598,the,O
Sentence: 598,elevation,O
Sentence: 598,of,O
Sentence: 598,which,O
Sentence: 598,may,O
Sentence: 598,cause,O
Sentence: 598,brain,B-Disease
Sentence: 598,damage,I-Disease
Sentence: 598,through,O
Sentence: 598,an,O
Sentence: 598,excitatory,O
Sentence: 598,NMDA,B-Chemical
Sentence: 598,receptor,O
Sentence: 598,-,O
Sentence: 598,mediated,O
Sentence: 598,mechanism,O
Sentence: 598,.,O
Sentence: 599,Paclitaxel,B-Chemical
Sentence: 599,",",O
Sentence: 599,5,O
Sentence: 599,-,O
Sentence: 599,fluorouracil,O
Sentence: 599,",",O
Sentence: 599,and,O
Sentence: 599,folinic,B-Chemical
Sentence: 599,acid,I-Chemical
Sentence: 599,in,O
Sentence: 599,metastatic,O
Sentence: 599,breast,B-Disease
Sentence: 599,cancer,I-Disease
Sentence: 599,:,O
Sentence: 599,BRE,O
Sentence: 599,-,O
Sentence: 599,26,O
Sentence: 599,",",O
Sentence: 599,a,O
Sentence: 599,phase,O
Sentence: 599,II,O
Sentence: 599,trial,O
Sentence: 599,.,O
Sentence: 600,5,O
Sentence: 600,-,O
Sentence: 600,Fluorouracil,O
Sentence: 600,plus,O
Sentence: 600,folinic,B-Chemical
Sentence: 600,acid,I-Chemical
Sentence: 600,and,O
Sentence: 600,paclitaxel,B-Chemical
Sentence: 600,(,O
Sentence: 600,Taxol,B-Chemical
Sentence: 600,;,O
Sentence: 600,Bristol,O
Sentence: 600,-,O
Sentence: 600,Myers,O
Sentence: 600,Squibb,O
Sentence: 600,Company,O
Sentence: 600,",",O
Sentence: 600,Princeton,O
Sentence: 600,",",O
Sentence: 600,NJ,O
Sentence: 600,),O
Sentence: 600,are,O
Sentence: 600,effective,O
Sentence: 600,salvage,O
Sentence: 600,therapies,O
Sentence: 600,for,O
Sentence: 600,metastatic,O
Sentence: 600,breast,B-Disease
Sentence: 600,cancer,I-Disease
Sentence: 600,patients,O
Sentence: 600,.,O
Sentence: 600,Paclitaxel,B-Chemical
Sentence: 600,and,O
Sentence: 600,5,O
Sentence: 600,-,O
Sentence: 600,fluorouracil,O
Sentence: 600,have,O
Sentence: 600,additive,O
Sentence: 600,cytotoxicity,B-Disease
Sentence: 600,in,O
Sentence: 600,MCF,O
Sentence: 600,-,O
Sentence: 600,7,O
Sentence: 600,cell,O
Sentence: 600,lines,O
Sentence: 600,.,O
Sentence: 600,We,O
Sentence: 600,performed,O
Sentence: 600,a,O
Sentence: 600,phase,O
Sentence: 600,II,O
Sentence: 600,trial,O
Sentence: 600,of,O
Sentence: 600,paclitaxel,B-Chemical
Sentence: 600,175,O
Sentence: 600,mg,O
Sentence: 600,/,O
Sentence: 600,m2,O
Sentence: 600,over,O
Sentence: 600,3,O
Sentence: 600,hours,O
Sentence: 600,on,O
Sentence: 600,day,O
Sentence: 600,I,O
Sentence: 600,followed,O
Sentence: 600,by,O
Sentence: 600,folinic,B-Chemical
Sentence: 600,acid,I-Chemical
Sentence: 600,300,O
Sentence: 600,mg,O
Sentence: 600,over,O
Sentence: 600,1,O
Sentence: 600,hour,O
Sentence: 600,before,O
Sentence: 600,5,O
Sentence: 600,-,O
Sentence: 600,fluorouracil,O
Sentence: 600,350,O
Sentence: 600,mg,O
Sentence: 600,/,O
Sentence: 600,m2,O
Sentence: 600,on,O
Sentence: 600,days,O
Sentence: 600,1,O
Sentence: 600,to,O
Sentence: 600,3,O
Sentence: 600,every,O
Sentence: 600,28,O
Sentence: 600,days,O
Sentence: 600,(,O
Sentence: 600,TFL,O
Sentence: 600,),O
Sentence: 600,in,O
Sentence: 600,women,O
Sentence: 600,with,O
Sentence: 600,metastatic,O
Sentence: 600,breast,B-Disease
Sentence: 600,cancer,I-Disease
Sentence: 600,.,O
Sentence: 600,Analysis,O
Sentence: 600,is,O
Sentence: 600,reported,O
Sentence: 600,on,O
Sentence: 600,37,O
Sentence: 600,patients,O
Sentence: 600,with,O
Sentence: 600,a,O
Sentence: 600,minimum,O
Sentence: 600,of,O
Sentence: 600,6,O
Sentence: 600,months,O
Sentence: 600,follow,O
Sentence: 600,-,O
Sentence: 600,up,O
Sentence: 600,who,O
Sentence: 600,received,O
Sentence: 600,a,O
Sentence: 600,total,O
Sentence: 600,of,O
Sentence: 600,192,O
Sentence: 600,cycles,O
Sentence: 600,of,O
Sentence: 600,TFL,O
Sentence: 600,:,O
Sentence: 600,nine,O
Sentence: 600,cycles,O
Sentence: 600,(,O
Sentence: 600,5,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,were,O
Sentence: 600,associated,O
Sentence: 600,with,O
Sentence: 600,grade,O
Sentence: 600,3,O
Sentence: 600,/,O
Sentence: 600,4,O
Sentence: 600,neutropenia,B-Disease
Sentence: 600,requiring,O
Sentence: 600,hospitalization,O
Sentence: 600,;,O
Sentence: 600,seven,O
Sentence: 600,(,O
Sentence: 600,4,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,cycles,O
Sentence: 600,in,O
Sentence: 600,two,O
Sentence: 600,patients,O
Sentence: 600,required,O
Sentence: 600,granulocyte,O
Sentence: 600,colony,O
Sentence: 600,-,O
Sentence: 600,stimulating,O
Sentence: 600,factor,O
Sentence: 600,due,O
Sentence: 600,to,O
Sentence: 600,neutropenia,B-Disease
Sentence: 600,;,O
Sentence: 600,no,O
Sentence: 600,patient,O
Sentence: 600,required,O
Sentence: 600,platelet,O
Sentence: 600,transfusions,O
Sentence: 600,.,O
Sentence: 600,Grade,O
Sentence: 600,3,O
Sentence: 600,/,O
Sentence: 600,4,O
Sentence: 600,nonhematologic,O
Sentence: 600,toxicities,B-Disease
Sentence: 600,were,O
Sentence: 600,uncommon,O
Sentence: 600,.,O
Sentence: 600,Among,O
Sentence: 600,the,O
Sentence: 600,34,O
Sentence: 600,patients,O
Sentence: 600,evaluable,O
Sentence: 600,for,O
Sentence: 600,response,O
Sentence: 600,",",O
Sentence: 600,there,O
Sentence: 600,were,O
Sentence: 600,three,O
Sentence: 600,complete,O
Sentence: 600,responses,O
Sentence: 600,(,O
Sentence: 600,9,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,and,O
Sentence: 600,18,O
Sentence: 600,partial,O
Sentence: 600,responses,O
Sentence: 600,(,O
Sentence: 600,53,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,for,O
Sentence: 600,an,O
Sentence: 600,overall,O
Sentence: 600,response,O
Sentence: 600,rate,O
Sentence: 600,of,O
Sentence: 600,62,O
Sentence: 600,%,O
Sentence: 600,.,O
Sentence: 600,Of,O
Sentence: 600,the,O
Sentence: 600,19,O
Sentence: 600,evaluable,O
Sentence: 600,patients,O
Sentence: 600,with,O
Sentence: 600,prior,O
Sentence: 600,doxorubicin,B-Chemical
Sentence: 600,exposure,O
Sentence: 600,",",O
Sentence: 600,11,O
Sentence: 600,(,O
Sentence: 600,58,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,responded,O
Sentence: 600,compared,O
Sentence: 600,with,O
Sentence: 600,nine,O
Sentence: 600,of,O
Sentence: 600,15,O
Sentence: 600,(,O
Sentence: 600,60,O
Sentence: 600,%,O
Sentence: 600,),O
Sentence: 600,without,O
Sentence: 600,prior,O
Sentence: 600,doxorubicin,B-Chemical
Sentence: 600,.,O
Sentence: 600,Plasma,O
Sentence: 600,paclitaxel,B-Chemical
Sentence: 600,concentrations,O
Sentence: 600,were,O
Sentence: 600,measured,O
Sentence: 600,at,O
Sentence: 600,the,O
Sentence: 600,completion,O
Sentence: 600,of,O
Sentence: 600,paclitaxel,B-Chemical
Sentence: 600,infusion,O
Sentence: 600,and,O
Sentence: 600,at,O
Sentence: 600,24,O
Sentence: 600,hours,O
Sentence: 600,in,O
Sentence: 600,19,O
Sentence: 600,patients,O
Sentence: 600,.,O
Sentence: 600,TFL,O
Sentence: 600,is,O
Sentence: 600,an,O
Sentence: 600,active,O
Sentence: 600,",",O
Sentence: 600,well,O
Sentence: 600,-,O
Sentence: 600,tolerated,O
Sentence: 600,regimen,O
Sentence: 600,in,O
Sentence: 600,metastatic,O
Sentence: 600,breast,B-Disease
Sentence: 600,cancer,I-Disease
Sentence: 600,.,O
Sentence: 601,Efficacy,O
Sentence: 601,and,O
Sentence: 601,proarrhythmia,B-Disease
Sentence: 601,with,O
Sentence: 601,the,O
Sentence: 601,use,O
Sentence: 601,of,O
Sentence: 601,d,O
Sentence: 601,",",O
Sentence: 601,l,O
Sentence: 601,-,O
Sentence: 601,sotalol,O
Sentence: 601,for,O
Sentence: 601,sustained,O
Sentence: 601,ventricular,B-Disease
Sentence: 601,tachyarrhythmias,I-Disease
Sentence: 601,.,O
Sentence: 602,This,O
Sentence: 602,study,O
Sentence: 602,prospectively,O
Sentence: 602,evaluated,O
Sentence: 602,the,O
Sentence: 602,clinical,O
Sentence: 602,efficacy,O
Sentence: 602,",",O
Sentence: 602,the,O
Sentence: 602,incidence,O
Sentence: 602,of,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,the,O
Sentence: 602,presumable,O
Sentence: 602,risk,O
Sentence: 602,factors,O
Sentence: 602,for,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,in,O
Sentence: 602,patients,O
Sentence: 602,treated,O
Sentence: 602,with,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,for,O
Sentence: 602,sustained,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachyarrhythmias,I-Disease
Sentence: 602,.,O
Sentence: 602,Eighty,O
Sentence: 602,-,O
Sentence: 602,one,O
Sentence: 602,consecutive,O
Sentence: 602,patients,O
Sentence: 602,(,O
Sentence: 602,54,O
Sentence: 602,with,O
Sentence: 602,coronary,B-Disease
Sentence: 602,artery,I-Disease
Sentence: 602,disease,I-Disease
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,20,O
Sentence: 602,with,O
Sentence: 602,dilated,B-Disease
Sentence: 602,cardiomyopathy,I-Disease
Sentence: 602,),O
Sentence: 602,with,O
Sentence: 602,inducible,O
Sentence: 602,sustained,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachycardia,I-Disease
Sentence: 602,or,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,fibrillation,I-Disease
Sentence: 602,received,O
Sentence: 602,oral,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,to,O
Sentence: 602,prevent,O
Sentence: 602,induction,O
Sentence: 602,of,O
Sentence: 602,the,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachyarrhythmia,I-Disease
Sentence: 602,.,O
Sentence: 602,During,O
Sentence: 602,oral,O
Sentence: 602,loading,O
Sentence: 602,with,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,",",O
Sentence: 602,continuous,O
Sentence: 602,electrocardiographic,O
Sentence: 602,(,O
Sentence: 602,ECG,O
Sentence: 602,),O
Sentence: 602,monitoring,O
Sentence: 602,was,O
Sentence: 602,performed,O
Sentence: 602,.,O
Sentence: 602,Those,O
Sentence: 602,patients,O
Sentence: 602,in,O
Sentence: 602,whom,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,prevented,O
Sentence: 602,induction,O
Sentence: 602,of,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachycardia,I-Disease
Sentence: 602,or,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,fibrillation,I-Disease
Sentence: 602,were,O
Sentence: 602,discharged,O
Sentence: 602,with,O
Sentence: 602,the,O
Sentence: 602,drug,O
Sentence: 602,and,O
Sentence: 602,followed,O
Sentence: 602,up,O
Sentence: 602,on,O
Sentence: 602,an,O
Sentence: 602,outpatient,O
Sentence: 602,basis,O
Sentence: 602,for,O
Sentence: 602,21,O
Sentence: 602,+,O
Sentence: 602,/,O
Sentence: 602,,O
Sentence: 602,-,O
Sentence: 602,,O
Sentence: 602,18,O
Sentence: 602,months,O
Sentence: 602,.,O
Sentence: 602,Induction,O
Sentence: 602,of,O
Sentence: 602,the,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachyarrhythmia,I-Disease
Sentence: 602,was,O
Sentence: 602,prevented,O
Sentence: 602,by,O
Sentence: 602,oral,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,in,O
Sentence: 602,35,O
Sentence: 602,(,O
Sentence: 602,43,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,;,O
Sentence: 602,the,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachyarrhythmia,I-Disease
Sentence: 602,remained,O
Sentence: 602,inducible,O
Sentence: 602,in,O
Sentence: 602,40,O
Sentence: 602,(,O
Sentence: 602,49,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,;,O
Sentence: 602,and,O
Sentence: 602,two,O
Sentence: 602,(,O
Sentence: 602,2.5,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,did,O
Sentence: 602,not,O
Sentence: 602,tolerate,O
Sentence: 602,even,O
Sentence: 602,40,O
Sentence: 602,mg,O
Sentence: 602,of,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,once,O
Sentence: 602,daily,O
Sentence: 602,.,O
Sentence: 602,Four,O
Sentence: 602,(,O
Sentence: 602,5,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,had,O
Sentence: 602,from,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,during,O
Sentence: 602,the,O
Sentence: 602,initial,O
Sentence: 602,oral,O
Sentence: 602,treatment,O
Sentence: 602,with,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,.,O
Sentence: 602,Neither,O
Sentence: 602,ECG,O
Sentence: 602,[,O
Sentence: 602,sinus,O
Sentence: 602,-,O
Sentence: 602,cycle,O
Sentence: 602,length,O
Sentence: 602,(,O
Sentence: 602,SCL,O
Sentence: 602,),O
Sentence: 602,",",O
Sentence: 602,QT,O
Sentence: 602,or,O
Sentence: 602,QTc,O
Sentence: 602,interval,O
Sentence: 602,",",O
Sentence: 602,or,O
Sentence: 602,U,O
Sentence: 602,wave,O
Sentence: 602,],O
Sentence: 602,nor,O
Sentence: 602,clinical,O
Sentence: 602,parameters,O
Sentence: 602,identified,O
Sentence: 602,patients,O
Sentence: 602,at,O
Sentence: 602,risk,O
Sentence: 602,for,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,.,O
Sentence: 602,However,O
Sentence: 602,",",O
Sentence: 602,the,O
Sentence: 602,oral,O
Sentence: 602,dose,O
Sentence: 602,of,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,was,O
Sentence: 602,significantly,O
Sentence: 602,lower,O
Sentence: 602,in,O
Sentence: 602,patients,O
Sentence: 602,with,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,(,O
Sentence: 602,200,O
Sentence: 602,+,O
Sentence: 602,/,O
Sentence: 602,,O
Sentence: 602,-,O
Sentence: 602,,O
Sentence: 602,46,O
Sentence: 602,vs.,O
Sentence: 602,328,O
Sentence: 602,+,O
Sentence: 602,/,O
Sentence: 602,,O
Sentence: 602,-,O
Sentence: 602,,O
Sentence: 602,53,O
Sentence: 602,mg,O
Sentence: 602,/,O
Sentence: 602,day,O
Sentence: 602,;,O
Sentence: 602,p,O
Sentence: 602,,O
Sentence: 602,=,O
Sentence: 602,,O
Sentence: 602,0.0017,O
Sentence: 602,),O
Sentence: 602,.,O
Sentence: 602,Risk,O
Sentence: 602,factors,O
Sentence: 602,associated,O
Sentence: 602,with,O
Sentence: 602,the,O
Sentence: 602,development,O
Sentence: 602,of,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,were,O
Sentence: 602,the,O
Sentence: 602,appearance,O
Sentence: 602,of,O
Sentence: 602,an,O
Sentence: 602,U,O
Sentence: 602,wave,O
Sentence: 602,(,O
Sentence: 602,p,O
Sentence: 602,,O
Sentence: 602,=,O
Sentence: 602,,O
Sentence: 602,0.049,O
Sentence: 602,),O
Sentence: 602,",",O
Sentence: 602,female,O
Sentence: 602,gender,O
Sentence: 602,(,O
Sentence: 602,p,O
Sentence: 602,,O
Sentence: 602,=,O
Sentence: 602,,O
Sentence: 602,0.015,O
Sentence: 602,),O
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,significant,O
Sentence: 602,dose,O
Sentence: 602,-,O
Sentence: 602,corrected,O
Sentence: 602,changes,O
Sentence: 602,of,O
Sentence: 602,SCL,O
Sentence: 602,",",O
Sentence: 602,QT,O
Sentence: 602,interval,O
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,QTc,O
Sentence: 602,interval,O
Sentence: 602,(,O
Sentence: 602,p,O
Sentence: 602,,O
Sentence: 602,<,O
Sentence: 602,,O
Sentence: 602,0.05,O
Sentence: 602,),O
Sentence: 602,.,O
Sentence: 602,During,O
Sentence: 602,follow,O
Sentence: 602,-,O
Sentence: 602,up,O
Sentence: 602,",",O
Sentence: 602,seven,O
Sentence: 602,(,O
Sentence: 602,20,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,had,O
Sentence: 602,a,O
Sentence: 602,nonfatal,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachycardia,I-Disease
Sentence: 602,recurrence,O
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,two,O
Sentence: 602,(,O
Sentence: 602,6,O
Sentence: 602,%,O
Sentence: 602,),O
Sentence: 602,patients,O
Sentence: 602,died,O
Sentence: 602,suddenly,O
Sentence: 602,.,O
Sentence: 602,One,O
Sentence: 602,female,O
Sentence: 602,patient,O
Sentence: 602,with,O
Sentence: 602,stable,O
Sentence: 602,cardiac,B-Disease
Sentence: 602,disease,I-Disease
Sentence: 602,had,O
Sentence: 602,recurrent,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,after,O
Sentence: 602,2,O
Sentence: 602,years,O
Sentence: 602,of,O
Sentence: 602,successful,O
Sentence: 602,treatment,O
Sentence: 602,with,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,.,O
Sentence: 602,Torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,occurred,O
Sentence: 602,early,O
Sentence: 602,during,O
Sentence: 602,treatment,O
Sentence: 602,even,O
Sentence: 602,with,O
Sentence: 602,low,O
Sentence: 602,doses,O
Sentence: 602,of,O
Sentence: 602,oral,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,.,O
Sentence: 602,Pronounced,O
Sentence: 602,changes,O
Sentence: 602,in,O
Sentence: 602,the,O
Sentence: 602,surface,O
Sentence: 602,ECG,O
Sentence: 602,(,O
Sentence: 602,cycle,O
Sentence: 602,length,O
Sentence: 602,",",O
Sentence: 602,QT,O
Sentence: 602,",",O
Sentence: 602,and,O
Sentence: 602,QTc,O
Sentence: 602,),O
Sentence: 602,in,O
Sentence: 602,relation,O
Sentence: 602,to,O
Sentence: 602,the,O
Sentence: 602,dose,O
Sentence: 602,of,O
Sentence: 602,oral,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,might,O
Sentence: 602,identify,O
Sentence: 602,a,O
Sentence: 602,subgroup,O
Sentence: 602,of,O
Sentence: 602,patients,O
Sentence: 602,with,O
Sentence: 602,an,O
Sentence: 602,increased,O
Sentence: 602,risk,O
Sentence: 602,for,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,.,O
Sentence: 602,Other,O
Sentence: 602,ECG,O
Sentence: 602,parameters,O
Sentence: 602,before,O
Sentence: 602,the,O
Sentence: 602,application,O
Sentence: 602,of,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,did,O
Sentence: 602,not,O
Sentence: 602,identify,O
Sentence: 602,patients,O
Sentence: 602,at,O
Sentence: 602,increased,O
Sentence: 602,risk,O
Sentence: 602,for,O
Sentence: 602,torsades,B-Disease
Sentence: 602,de,I-Disease
Sentence: 602,pointes,I-Disease
Sentence: 602,.,O
Sentence: 602,Recurrence,O
Sentence: 602,rates,O
Sentence: 602,of,O
Sentence: 602,ventricular,B-Disease
Sentence: 602,tachyarrhythmias,I-Disease
Sentence: 602,are,O
Sentence: 602,high,O
Sentence: 602,despite,O
Sentence: 602,complete,O
Sentence: 602,suppression,O
Sentence: 602,of,O
Sentence: 602,the,O
Sentence: 602,arrhythmia,B-Disease
Sentence: 602,during,O
Sentence: 602,programmed,O
Sentence: 602,stimulation,O
Sentence: 602,.,O
Sentence: 602,Therefore,O
Sentence: 602,programmed,O
Sentence: 602,electrical,O
Sentence: 602,stimulation,O
Sentence: 602,in,O
Sentence: 602,the,O
Sentence: 602,case,O
Sentence: 602,of,O
Sentence: 602,d,O
Sentence: 602,",",O
Sentence: 602,l,O
Sentence: 602,-,O
Sentence: 602,sotalol,O
Sentence: 602,seems,O
Sentence: 602,to,O
Sentence: 602,be,O
Sentence: 602,of,O
Sentence: 602,limited,O
Sentence: 602,prognostic,O
Sentence: 602,value,O
Sentence: 602,.,O
Sentence: 603,Chronic,O
Sentence: 603,hyperprolactinemia,B-Disease
Sentence: 603,and,O
Sentence: 603,changes,O
Sentence: 603,in,O
Sentence: 603,dopamine,B-Chemical
Sentence: 603,neurons,O
Sentence: 603,.,O
Sentence: 604,The,O
Sentence: 604,tuberoinfundibular,O
Sentence: 604,dopaminergic,O
Sentence: 604,(,O
Sentence: 604,TIDA,O
Sentence: 604,),O
Sentence: 604,system,O
Sentence: 604,is,O
Sentence: 604,known,O
Sentence: 604,to,O
Sentence: 604,inhibit,O
Sentence: 604,prolactin,O
Sentence: 604,(,O
Sentence: 604,PRL,O
Sentence: 604,),O
Sentence: 604,secretion,O
Sentence: 604,.,O
Sentence: 604,In,O
Sentence: 604,young,O
Sentence: 604,animals,O
Sentence: 604,this,O
Sentence: 604,system,O
Sentence: 604,responds,O
Sentence: 604,to,O
Sentence: 604,acute,O
Sentence: 604,elevations,O
Sentence: 604,in,O
Sentence: 604,serum,O
Sentence: 604,PRL,O
Sentence: 604,by,O
Sentence: 604,increasing,O
Sentence: 604,its,O
Sentence: 604,activity,O
Sentence: 604,.,O
Sentence: 604,However,O
Sentence: 604,",",O
Sentence: 604,this,O
Sentence: 604,responsiveness,O
Sentence: 604,is,O
Sentence: 604,lost,O
Sentence: 604,in,O
Sentence: 604,aging,O
Sentence: 604,rats,O
Sentence: 604,with,O
Sentence: 604,chronically,O
Sentence: 604,high,O
Sentence: 604,serum,O
Sentence: 604,PRL,O
Sentence: 604,levels,O
Sentence: 604,.,O
Sentence: 604,The,O
Sentence: 604,purpose,O
Sentence: 604,of,O
Sentence: 604,this,O
Sentence: 604,study,O
Sentence: 604,was,O
Sentence: 604,to,O
Sentence: 604,induce,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,in,O
Sentence: 604,rats,O
Sentence: 604,for,O
Sentence: 604,extended,O
Sentence: 604,periods,O
Sentence: 604,of,O
Sentence: 604,time,O
Sentence: 604,and,O
Sentence: 604,examine,O
Sentence: 604,its,O
Sentence: 604,effects,O
Sentence: 604,on,O
Sentence: 604,dopaminergic,O
Sentence: 604,systems,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,brain,O
Sentence: 604,.,O
Sentence: 604,Hyperprolactinemia,B-Disease
Sentence: 604,was,O
Sentence: 604,induced,O
Sentence: 604,by,O
Sentence: 604,treatment,O
Sentence: 604,with,O
Sentence: 604,haloperidol,B-Chemical
Sentence: 604,",",O
Sentence: 604,a,O
Sentence: 604,dopamine,B-Chemical
Sentence: 604,receptor,O
Sentence: 604,antagonist,O
Sentence: 604,",",O
Sentence: 604,and,O
Sentence: 604,Palkovits,O
Sentence: 604,',O
Sentence: 604,microdissection,O
Sentence: 604,technique,O
Sentence: 604,in,O
Sentence: 604,combination,O
Sentence: 604,with,O
Sentence: 604,high,O
Sentence: 604,-,O
Sentence: 604,performance,O
Sentence: 604,liquid,O
Sentence: 604,chromatography,O
Sentence: 604,was,O
Sentence: 604,used,O
Sentence: 604,to,O
Sentence: 604,measure,O
Sentence: 604,neurotransmitter,O
Sentence: 604,concentrations,O
Sentence: 604,in,O
Sentence: 604,several,O
Sentence: 604,areas,O
Sentence: 604,of,O
Sentence: 604,the,O
Sentence: 604,brain,O
Sentence: 604,.,O
Sentence: 604,After,O
Sentence: 604,6,O
Sentence: 604,months,O
Sentence: 604,of,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,",",O
Sentence: 604,dopamine,B-Chemical
Sentence: 604,(,O
Sentence: 604,DA,B-Chemical
Sentence: 604,),O
Sentence: 604,concentrations,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,median,O
Sentence: 604,eminence,O
Sentence: 604,(,O
Sentence: 604,ME,O
Sentence: 604,),O
Sentence: 604,increased,O
Sentence: 604,by,O
Sentence: 604,84,O
Sentence: 604,%,O
Sentence: 604,over,O
Sentence: 604,the,O
Sentence: 604,control,O
Sentence: 604,group,O
Sentence: 604,.,O
Sentence: 604,Nine,O
Sentence: 604,months,O
Sentence: 604,of,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,produced,O
Sentence: 604,a,O
Sentence: 604,50,O
Sentence: 604,%,O
Sentence: 604,increase,O
Sentence: 604,in,O
Sentence: 604,DA,B-Chemical
Sentence: 604,concentrations,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,ME,O
Sentence: 604,over,O
Sentence: 604,the,O
Sentence: 604,control,O
Sentence: 604,group,O
Sentence: 604,.,O
Sentence: 604,However,O
Sentence: 604,",",O
Sentence: 604,DA,B-Chemical
Sentence: 604,response,O
Sentence: 604,was,O
Sentence: 604,lost,O
Sentence: 604,if,O
Sentence: 604,a,O
Sentence: 604,9,O
Sentence: 604,-,O
Sentence: 604,month,O
Sentence: 604,long,O
Sentence: 604,haloperidol,B-Chemical
Sentence: 604,-,O
Sentence: 604,induced,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,was,O
Sentence: 604,followed,O
Sentence: 604,by,O
Sentence: 604,a,O
Sentence: 604,1,O
Sentence: 604,1,O
Sentence: 604,/,O
Sentence: 604,2,O
Sentence: 604,month,O
Sentence: 604,-,O
Sentence: 604,long,O
Sentence: 604,extremely,O
Sentence: 604,high,O
Sentence: 604,increase,O
Sentence: 604,in,O
Sentence: 604,serum,O
Sentence: 604,PRL,O
Sentence: 604,levels,O
Sentence: 604,produced,O
Sentence: 604,by,O
Sentence: 604,implantation,O
Sentence: 604,of,O
Sentence: 604,MMQ,O
Sentence: 604,cells,O
Sentence: 604,under,O
Sentence: 604,the,O
Sentence: 604,kidney,O
Sentence: 604,capsule,O
Sentence: 604,.,O
Sentence: 604,There,O
Sentence: 604,was,O
Sentence: 604,no,O
Sentence: 604,change,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,levels,O
Sentence: 604,of,O
Sentence: 604,DA,B-Chemical
Sentence: 604,",",O
Sentence: 604,norepinephrine,B-Chemical
Sentence: 604,(,O
Sentence: 604,NE,B-Chemical
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,serotonin,B-Chemical
Sentence: 604,(,O
Sentence: 604,5,O
Sentence: 604,-,O
Sentence: 604,HT,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,or,O
Sentence: 604,their,O
Sentence: 604,metabolites,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,arcuate,O
Sentence: 604,nucleus,O
Sentence: 604,(,O
Sentence: 604,AN,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,medial,O
Sentence: 604,preoptic,O
Sentence: 604,area,O
Sentence: 604,(,O
Sentence: 604,MPA,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,caudate,O
Sentence: 604,putamen,O
Sentence: 604,(,O
Sentence: 604,CP,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,substantia,O
Sentence: 604,nigra,O
Sentence: 604,(,O
Sentence: 604,SN,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,and,O
Sentence: 604,zona,O
Sentence: 604,incerta,O
Sentence: 604,(,O
Sentence: 604,ZI,O
Sentence: 604,),O
Sentence: 604,",",O
Sentence: 604,except,O
Sentence: 604,for,O
Sentence: 604,a,O
Sentence: 604,decrease,O
Sentence: 604,in,O
Sentence: 604,5,O
Sentence: 604,-,O
Sentence: 604,hydroxyindoleacetic,O
Sentence: 604,acid,O
Sentence: 604,(,O
Sentence: 604,5,O
Sentence: 604,-,O
Sentence: 604,HIAA,O
Sentence: 604,),O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,AN,O
Sentence: 604,after,O
Sentence: 604,6,O
Sentence: 604,-,O
Sentence: 604,months,O
Sentence: 604,of,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,and,O
Sentence: 604,an,O
Sentence: 604,increase,O
Sentence: 604,in,O
Sentence: 604,DA,B-Chemical
Sentence: 604,concentrations,O
Sentence: 604,in,O
Sentence: 604,the,O
Sentence: 604,AN,O
Sentence: 604,after,O
Sentence: 604,9,O
Sentence: 604,-,O
Sentence: 604,months,O
Sentence: 604,of,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,.,O
Sentence: 604,These,O
Sentence: 604,results,O
Sentence: 604,demonstrate,O
Sentence: 604,that,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,specifically,O
Sentence: 604,affects,O
Sentence: 604,TIDA,O
Sentence: 604,neurons,O
Sentence: 604,and,O
Sentence: 604,these,O
Sentence: 604,effects,O
Sentence: 604,vary,O
Sentence: 604,",",O
Sentence: 604,depending,O
Sentence: 604,on,O
Sentence: 604,the,O
Sentence: 604,duration,O
Sentence: 604,and,O
Sentence: 604,intensity,O
Sentence: 604,of,O
Sentence: 604,hyperprolactinemia,B-Disease
Sentence: 604,.,O
Sentence: 604,The,O
Sentence: 604,age,O
Sentence: 604,-,O
Sentence: 604,related,O
Sentence: 604,decrease,O
Sentence: 604,in,O
Sentence: 604,hypothalamic,O
Sentence: 604,dopamine,B-Chemical
Sentence: 604,function,O
Sentence: 604,may,O
Sentence: 604,be,O
Sentence: 604,associated,O
Sentence: 604,with,O
Sentence: 604,increases,O
Sentence: 604,in,O
Sentence: 604,PRL,O
Sentence: 604,secretion,O
Sentence: 604,.,O
Sentence: 605,Treatment,O
Sentence: 605,-,O
Sentence: 605,related,O
Sentence: 605,disseminated,O
Sentence: 605,necrotizing,O
Sentence: 605,leukoencephalopathy,O
Sentence: 605,with,O
Sentence: 605,characteristic,O
Sentence: 605,contrast,O
Sentence: 605,enhancement,O
Sentence: 605,of,O
Sentence: 605,the,O
Sentence: 605,white,O
Sentence: 605,matter,O
Sentence: 605,.,O
Sentence: 606,This,O
Sentence: 606,report,O
Sentence: 606,describes,O
Sentence: 606,unique,O
Sentence: 606,contrast,O
Sentence: 606,enhancement,O
Sentence: 606,of,O
Sentence: 606,the,O
Sentence: 606,white,O
Sentence: 606,matter,O
Sentence: 606,on,O
Sentence: 606,T1,O
Sentence: 606,-,O
Sentence: 606,weighted,O
Sentence: 606,magnetic,O
Sentence: 606,resonance,O
Sentence: 606,images,O
Sentence: 606,of,O
Sentence: 606,two,O
Sentence: 606,patients,O
Sentence: 606,with,O
Sentence: 606,disseminated,O
Sentence: 606,necrotizing,O
Sentence: 606,leukoencephalopathy,B-Disease
Sentence: 606,",",O
Sentence: 606,which,O
Sentence: 606,developed,O
Sentence: 606,from,O
Sentence: 606,acute,B-Disease
Sentence: 606,lymphoblastic,I-Disease
Sentence: 606,leukemia,I-Disease
Sentence: 606,treated,O
Sentence: 606,with,O
Sentence: 606,high,O
Sentence: 606,-,O
Sentence: 606,dose,O
Sentence: 606,methotrexate,B-Chemical
Sentence: 606,.,O
Sentence: 606,In,O
Sentence: 606,both,O
Sentence: 606,patients,O
Sentence: 606,",",O
Sentence: 606,the,O
Sentence: 606,enhancement,O
Sentence: 606,was,O
Sentence: 606,more,O
Sentence: 606,pronounced,O
Sentence: 606,near,O
Sentence: 606,the,O
Sentence: 606,base,O
Sentence: 606,of,O
Sentence: 606,the,O
Sentence: 606,brain,O
Sentence: 606,than,O
Sentence: 606,at,O
Sentence: 606,the,O
Sentence: 606,vertex,O
Sentence: 606,.,O
Sentence: 606,Necropsy,O
Sentence: 606,of,O
Sentence: 606,the,O
Sentence: 606,first,O
Sentence: 606,case,O
Sentence: 606,revealed,O
Sentence: 606,loss,B-Disease
Sentence: 606,of,I-Disease
Sentence: 606,myelination,I-Disease
Sentence: 606,and,O
Sentence: 606,necrosis,B-Disease
Sentence: 606,of,O
Sentence: 606,the,O
Sentence: 606,white,O
Sentence: 606,matter,O
Sentence: 606,.,O
Sentence: 606,Possible,O
Sentence: 606,mechanisms,O
Sentence: 606,causing,O
Sentence: 606,such,O
Sentence: 606,a,O
Sentence: 606,leukoencephalopathy,B-Disease
Sentence: 606,are,O
Sentence: 606,discussed,O
Sentence: 606,.,O
Sentence: 607,Thrombotic,B-Disease
Sentence: 607,complications,O
Sentence: 607,in,O
Sentence: 607,acute,B-Disease
Sentence: 607,promyelocytic,I-Disease
Sentence: 607,leukemia,I-Disease
Sentence: 607,during,O
Sentence: 607,all,O
Sentence: 607,-,O
Sentence: 607,trans,O
Sentence: 607,-,O
Sentence: 607,retinoic,O
Sentence: 607,acid,O
Sentence: 607,therapy,O
Sentence: 607,.,O
Sentence: 608,A,O
Sentence: 608,case,O
Sentence: 608,of,O
Sentence: 608,acute,B-Disease
Sentence: 608,renal,I-Disease
Sentence: 608,failure,I-Disease
Sentence: 608,",",O
Sentence: 608,due,O
Sentence: 608,to,O
Sentence: 608,occlusion,B-Disease
Sentence: 608,of,I-Disease
Sentence: 608,renal,I-Disease
Sentence: 608,vessels,I-Disease
Sentence: 608,in,O
Sentence: 608,a,O
Sentence: 608,patient,O
Sentence: 608,with,O
Sentence: 608,acute,B-Disease
Sentence: 608,promyelocytic,I-Disease
Sentence: 608,leukemia,I-Disease
Sentence: 608,(,O
Sentence: 608,APL,B-Disease
Sentence: 608,),O
Sentence: 608,treated,O
Sentence: 608,with,O
Sentence: 608,all,O
Sentence: 608,-,O
Sentence: 608,trans,O
Sentence: 608,-,O
Sentence: 608,retinoic,O
Sentence: 608,acid,O
Sentence: 608,(,O
Sentence: 608,ATRA,B-Chemical
Sentence: 608,),O
Sentence: 608,and,O
Sentence: 608,tranexamic,B-Chemical
Sentence: 608,acid,I-Chemical
Sentence: 608,has,O
Sentence: 608,been,O
Sentence: 608,described,O
Sentence: 608,recently,O
Sentence: 608,.,O
Sentence: 608,We,O
Sentence: 608,report,O
Sentence: 608,a,O
Sentence: 608,case,O
Sentence: 608,of,O
Sentence: 608,acute,B-Disease
Sentence: 608,renal,I-Disease
Sentence: 608,failure,I-Disease
Sentence: 608,in,O
Sentence: 608,an,O
Sentence: 608,APL,B-Disease
Sentence: 608,patient,O
Sentence: 608,treated,O
Sentence: 608,with,O
Sentence: 608,ATRA,B-Chemical
Sentence: 608,alone,O
Sentence: 608,.,O
Sentence: 608,This,O
Sentence: 608,case,O
Sentence: 608,further,O
Sentence: 608,supports,O
Sentence: 608,the,O
Sentence: 608,concern,O
Sentence: 608,about,O
Sentence: 608,thromboembolic,B-Disease
Sentence: 608,complications,O
Sentence: 608,associated,O
Sentence: 608,with,O
Sentence: 608,ATRA,B-Chemical
Sentence: 608,therapy,O
Sentence: 608,in,O
Sentence: 608,APL,B-Disease
Sentence: 608,patients,O
Sentence: 608,.,O
Sentence: 608,The,O
Sentence: 608,patients,O
Sentence: 608,",",O
Sentence: 608,a,O
Sentence: 608,43,O
Sentence: 608,-,O
Sentence: 608,year,O
Sentence: 608,-,O
Sentence: 608,old,O
Sentence: 608,man,O
Sentence: 608,",",O
Sentence: 608,presented,O
Sentence: 608,all,O
Sentence: 608,the,O
Sentence: 608,signs,O
Sentence: 608,and,O
Sentence: 608,symptoms,O
Sentence: 608,of,O
Sentence: 608,APL,B-Disease
Sentence: 608,and,O
Sentence: 608,was,O
Sentence: 608,included,O
Sentence: 608,in,O
Sentence: 608,a,O
Sentence: 608,treatment,O
Sentence: 608,protocol,O
Sentence: 608,with,O
Sentence: 608,ATRA,B-Chemical
Sentence: 608,.,O
Sentence: 608,After,O
Sentence: 608,10,O
Sentence: 608,days,O
Sentence: 608,of,O
Sentence: 608,treatment,O
Sentence: 608,",",O
Sentence: 608,he,O
Sentence: 608,developed,O
Sentence: 608,acute,B-Disease
Sentence: 608,renal,I-Disease
Sentence: 608,failure,I-Disease
Sentence: 608,that,O
Sentence: 608,was,O
Sentence: 608,completely,O
Sentence: 608,reversible,O
Sentence: 608,after,O
Sentence: 608,complete,O
Sentence: 608,remission,O
Sentence: 608,of,O
Sentence: 608,APL,B-Disease
Sentence: 608,was,O
Sentence: 608,achieved,O
Sentence: 608,and,O
Sentence: 608,therapy,O
Sentence: 608,discontinued,O
Sentence: 608,.,O
Sentence: 608,We,O
Sentence: 608,conclude,O
Sentence: 608,that,O
Sentence: 608,ATRA,B-Chemical
Sentence: 608,is,O
Sentence: 608,a,O
Sentence: 608,valid,O
Sentence: 608,therapeutic,O
Sentence: 608,choice,O
Sentence: 608,for,O
Sentence: 608,patients,O
Sentence: 608,with,O
Sentence: 608,APL,B-Disease
Sentence: 608,",",O
Sentence: 608,although,O
Sentence: 608,the,O
Sentence: 608,procoagulant,O
Sentence: 608,tendency,O
Sentence: 608,is,O
Sentence: 608,not,O
Sentence: 608,completely,O
Sentence: 608,corrected,O
Sentence: 608,.,O
Sentence: 608,Thrombotic,B-Disease
Sentence: 608,events,O
Sentence: 608,",",O
Sentence: 608,however,O
Sentence: 608,",",O
Sentence: 608,could,O
Sentence: 608,be,O
Sentence: 608,avoided,O
Sentence: 608,by,O
Sentence: 608,using,O
Sentence: 608,low,O
Sentence: 608,-,O
Sentence: 608,dose,O
Sentence: 608,heparin,B-Chemical
Sentence: 608,.,O
Sentence: 609,Pupillary,O
Sentence: 609,changes,O
Sentence: 609,associated,O
Sentence: 609,with,O
Sentence: 609,the,O
Sentence: 609,development,O
Sentence: 609,of,O
Sentence: 609,stimulant,O
Sentence: 609,-,O
Sentence: 609,induced,O
Sentence: 609,mania,O
Sentence: 609,:,O
Sentence: 609,a,O
Sentence: 609,case,O
Sentence: 609,report,O
Sentence: 609,.,O
Sentence: 610,A,O
Sentence: 610,30,O
Sentence: 610,-,O
Sentence: 610,year,O
Sentence: 610,-,O
Sentence: 610,old,O
Sentence: 610,cocaine,B-Chemical
Sentence: 610,-,O
Sentence: 610,dependent,O
Sentence: 610,man,O
Sentence: 610,who,O
Sentence: 610,was,O
Sentence: 610,a,O
Sentence: 610,subject,O
Sentence: 610,in,O
Sentence: 610,a,O
Sentence: 610,study,O
Sentence: 610,evaluating,O
Sentence: 610,the,O
Sentence: 610,anticraving,O
Sentence: 610,efficacy,O
Sentence: 610,of,O
Sentence: 610,the,O
Sentence: 610,stimulant,O
Sentence: 610,medication,O
Sentence: 610,diethylpropion,B-Chemical
Sentence: 610,(,O
Sentence: 610,DEP,B-Chemical
Sentence: 610,),O
Sentence: 610,became,O
Sentence: 610,manic,B-Disease
Sentence: 610,during,O
Sentence: 610,his,O
Sentence: 610,second,O
Sentence: 610,week,O
Sentence: 610,on,O
Sentence: 610,the,O
Sentence: 610,study,O
Sentence: 610,drug,O
Sentence: 610,.,O
Sentence: 610,Pupillometric,O
Sentence: 610,changes,O
Sentence: 610,while,O
Sentence: 610,on,O
Sentence: 610,DEP,B-Chemical
Sentence: 610,",",O
Sentence: 610,especially,O
Sentence: 610,changes,O
Sentence: 610,in,O
Sentence: 610,the,O
Sentence: 610,total,O
Sentence: 610,power,O
Sentence: 610,of,O
Sentence: 610,pupillary,B-Disease
Sentence: 610,oscillation,I-Disease
Sentence: 610,",",O
Sentence: 610,were,O
Sentence: 610,dramatically,O
Sentence: 610,different,O
Sentence: 610,than,O
Sentence: 610,those,O
Sentence: 610,observed,O
Sentence: 610,in,O
Sentence: 610,the,O
Sentence: 610,eight,O
Sentence: 610,other,O
Sentence: 610,study,O
Sentence: 610,subjects,O
Sentence: 610,who,O
Sentence: 610,did,O
Sentence: 610,not,O
Sentence: 610,become,O
Sentence: 610,manic,B-Disease
Sentence: 610,.,O
Sentence: 610,The,O
Sentence: 610,large,O
Sentence: 610,changes,O
Sentence: 610,in,O
Sentence: 610,total,O
Sentence: 610,power,O
Sentence: 610,of,O
Sentence: 610,pupillary,B-Disease
Sentence: 610,oscillation,I-Disease
Sentence: 610,occurred,O
Sentence: 610,a,O
Sentence: 610,few,O
Sentence: 610,days,O
Sentence: 610,before,O
Sentence: 610,the,O
Sentence: 610,patient,O
Sentence: 610,became,O
Sentence: 610,fully,O
Sentence: 610,manic,B-Disease
Sentence: 610,.,O
Sentence: 610,Such,O
Sentence: 610,medication,O
Sentence: 610,-,O
Sentence: 610,associated,O
Sentence: 610,changes,O
Sentence: 610,in,O
Sentence: 610,the,O
Sentence: 610,total,O
Sentence: 610,power,O
Sentence: 610,of,O
Sentence: 610,pupillary,B-Disease
Sentence: 610,oscillation,I-Disease
Sentence: 610,might,O
Sentence: 610,be,O
Sentence: 610,of,O
Sentence: 610,utility,O
Sentence: 610,in,O
Sentence: 610,identifying,O
Sentence: 610,persons,O
Sentence: 610,at,O
Sentence: 610,risk,O
Sentence: 610,for,O
Sentence: 610,manic,B-Disease
Sentence: 610,-,O
Sentence: 610,like,O
Sentence: 610,adverse,O
Sentence: 610,effects,O
Sentence: 610,during,O
Sentence: 610,the,O
Sentence: 610,medical,O
Sentence: 610,use,O
Sentence: 610,of,O
Sentence: 610,psychomotor,O
Sentence: 610,stimulants,O
Sentence: 610,or,O
Sentence: 610,sympathomimetic,O
Sentence: 610,agents,O
Sentence: 610,.,O
Sentence: 611,The,O
Sentence: 611,negative,O
Sentence: 611,mucosal,O
Sentence: 611,potential,O
Sentence: 611,:,O
Sentence: 611,separating,O
Sentence: 611,central,O
Sentence: 611,and,O
Sentence: 611,peripheral,O
Sentence: 611,effects,O
Sentence: 611,of,O
Sentence: 611,NSAIDs,O
Sentence: 611,in,O
Sentence: 611,man,O
Sentence: 611,.,O
Sentence: 612,OBJECTIVE,O
Sentence: 612,:,O
Sentence: 612,We,O
Sentence: 612,wanted,O
Sentence: 612,to,O
Sentence: 612,test,O
Sentence: 612,whether,O
Sentence: 612,assessment,O
Sentence: 612,of,O
Sentence: 612,both,O
Sentence: 612,a,O
Sentence: 612,central,O
Sentence: 612,pain,B-Disease
Sentence: 612,-,O
Sentence: 612,related,O
Sentence: 612,signal,O
Sentence: 612,(,O
Sentence: 612,chemo,O
Sentence: 612,-,O
Sentence: 612,somatosensory,O
Sentence: 612,evoked,O
Sentence: 612,potential,O
Sentence: 612,",",O
Sentence: 612,CSSEP,O
Sentence: 612,),O
Sentence: 612,and,O
Sentence: 612,a,O
Sentence: 612,concomitantly,O
Sentence: 612,recorded,O
Sentence: 612,peripheral,O
Sentence: 612,signal,O
Sentence: 612,(,O
Sentence: 612,negative,O
Sentence: 612,mucosal,O
Sentence: 612,potential,O
Sentence: 612,",",O
Sentence: 612,NMP,O
Sentence: 612,),O
Sentence: 612,allows,O
Sentence: 612,for,O
Sentence: 612,separation,O
Sentence: 612,of,O
Sentence: 612,central,O
Sentence: 612,and,O
Sentence: 612,peripheral,O
Sentence: 612,effects,O
Sentence: 612,of,O
Sentence: 612,NSAIDs,O
Sentence: 612,.,O
Sentence: 612,For,O
Sentence: 612,this,O
Sentence: 612,purpose,O
Sentence: 612,",",O
Sentence: 612,experimental,O
Sentence: 612,conditions,O
Sentence: 612,were,O
Sentence: 612,created,O
Sentence: 612,in,O
Sentence: 612,which,O
Sentence: 612,NSAIDs,O
Sentence: 612,had,O
Sentence: 612,previously,O
Sentence: 612,been,O
Sentence: 612,observed,O
Sentence: 612,to,O
Sentence: 612,produce,O
Sentence: 612,effects,O
Sentence: 612,on,O
Sentence: 612,phasic,O
Sentence: 612,and,O
Sentence: 612,tonic,O
Sentence: 612,pain,B-Disease
Sentence: 612,by,O
Sentence: 612,either,O
Sentence: 612,central,O
Sentence: 612,or,O
Sentence: 612,peripheral,O
Sentence: 612,mechanisms,O
Sentence: 612,.,O
Sentence: 612,METHODS,O
Sentence: 612,:,O
Sentence: 612,According,O
Sentence: 612,to,O
Sentence: 612,a,O
Sentence: 612,double,O
Sentence: 612,-,O
Sentence: 612,blind,O
Sentence: 612,",",O
Sentence: 612,randomised,O
Sentence: 612,",",O
Sentence: 612,controlled,O
Sentence: 612,",",O
Sentence: 612,threefold,O
Sentence: 612,cross,O
Sentence: 612,-,O
Sentence: 612,over,O
Sentence: 612,design,O
Sentence: 612,",",O
Sentence: 612,18,O
Sentence: 612,healthy,O
Sentence: 612,subjects,O
Sentence: 612,(,O
Sentence: 612,11,O
Sentence: 612,males,O
Sentence: 612,",",O
Sentence: 612,7,O
Sentence: 612,females,O
Sentence: 612,;,O
Sentence: 612,mean,O
Sentence: 612,age,O
Sentence: 612,26,O
Sentence: 612,years,O
Sentence: 612,),O
Sentence: 612,received,O
Sentence: 612,either,O
Sentence: 612,placebo,O
Sentence: 612,",",O
Sentence: 612,400,O
Sentence: 612,mg,O
Sentence: 612,ibuprofen,B-Chemical
Sentence: 612,",",O
Sentence: 612,or,O
Sentence: 612,800,O
Sentence: 612,mg,O
Sentence: 612,ibuprofen,B-Chemical
Sentence: 612,.,O
Sentence: 612,Phasic,O
Sentence: 612,pain,B-Disease
Sentence: 612,was,O
Sentence: 612,applied,O
Sentence: 612,by,O
Sentence: 612,means,O
Sentence: 612,of,O
Sentence: 612,short,O
Sentence: 612,pulses,O
Sentence: 612,of,O
Sentence: 612,CO2,B-Chemical
Sentence: 612,to,O
Sentence: 612,the,O
Sentence: 612,nasal,O
Sentence: 612,mucosa,O
Sentence: 612,(,O
Sentence: 612,stimulus,O
Sentence: 612,duration,O
Sentence: 612,500,O
Sentence: 612,ms,O
Sentence: 612,",",O
Sentence: 612,interval,O
Sentence: 612,approximately,O
Sentence: 612,60,O
Sentence: 612,s,O
Sentence: 612,),O
Sentence: 612,",",O
Sentence: 612,and,O
Sentence: 612,tonic,O
Sentence: 612,pain,B-Disease
Sentence: 612,was,O
Sentence: 612,induced,O
Sentence: 612,in,O
Sentence: 612,the,O
Sentence: 612,nasal,O
Sentence: 612,cavity,O
Sentence: 612,by,O
Sentence: 612,means,O
Sentence: 612,of,O
Sentence: 612,dry,O
Sentence: 612,air,O
Sentence: 612,of,O
Sentence: 612,controlled,O
Sentence: 612,temperature,O
Sentence: 612,",",O
Sentence: 612,humidity,O
Sentence: 612,and,O
Sentence: 612,flow,O
Sentence: 612,rate,O
Sentence: 612,(,O
Sentence: 612,22,O
Sentence: 612,degrees,O
Sentence: 612,C,O
Sentence: 612,",",O
Sentence: 612,0,O
Sentence: 612,%,O
Sentence: 612,relative,O
Sentence: 612,humidity,O
Sentence: 612,",",O
Sentence: 612,145,O
Sentence: 612,ml.s,O
Sentence: 612,-,O
Sentence: 612,1,O
Sentence: 612,),O
Sentence: 612,.,O
Sentence: 612,Both,O
Sentence: 612,CSSEPs,O
Sentence: 612,as,O
Sentence: 612,central,O
Sentence: 612,and,O
Sentence: 612,NMPs,O
Sentence: 612,as,O
Sentence: 612,peripheral,O
Sentence: 612,correlates,O
Sentence: 612,of,O
Sentence: 612,pain,B-Disease
Sentence: 612,were,O
Sentence: 612,obtained,O
Sentence: 612,in,O
Sentence: 612,response,O
Sentence: 612,to,O
Sentence: 612,the,O
Sentence: 612,CO2,B-Chemical
Sentence: 612,stimuli,O
Sentence: 612,.,O
Sentence: 612,Additionally,O
Sentence: 612,",",O
Sentence: 612,the,O
Sentence: 612,subjects,O
Sentence: 612,rated,O
Sentence: 612,the,O
Sentence: 612,intensity,O
Sentence: 612,of,O
Sentence: 612,both,O
Sentence: 612,phasic,O
Sentence: 612,and,O
Sentence: 612,tonic,O
Sentence: 612,pain,B-Disease
Sentence: 612,by,O
Sentence: 612,means,O
Sentence: 612,of,O
Sentence: 612,visual,O
Sentence: 612,analogue,O
Sentence: 612,scales,O
Sentence: 612,.,O
Sentence: 612,RESULTS,O
Sentence: 612,:,O
Sentence: 612,As,O
Sentence: 612,described,O
Sentence: 612,earlier,O
Sentence: 612,",",O
Sentence: 612,administration,O
Sentence: 612,of,O
Sentence: 612,ibuprofen,B-Chemical
Sentence: 612,was,O
Sentence: 612,followed,O
Sentence: 612,by,O
Sentence: 612,a,O
Sentence: 612,decrease,O
Sentence: 612,in,O
Sentence: 612,tonic,O
Sentence: 612,pain,B-Disease
Sentence: 612,but,O
Sentence: 612,-,O
Sentence: 612,relative,O
Sentence: 612,to,O
Sentence: 612,placebo,O
Sentence: 612,-,O
Sentence: 612,an,O
Sentence: 612,increase,O
Sentence: 612,in,O
Sentence: 612,correlates,O
Sentence: 612,of,O
Sentence: 612,phasic,O
Sentence: 612,pain,B-Disease
Sentence: 612,",",O
Sentence: 612,indicating,O
Sentence: 612,a,O
Sentence: 612,specific,O
Sentence: 612,effect,O
Sentence: 612,of,O
Sentence: 612,ibuprofen,B-Chemical
Sentence: 612,on,O
Sentence: 612,the,O
Sentence: 612,interaction,O
Sentence: 612,between,O
Sentence: 612,the,O
Sentence: 612,pain,B-Disease
Sentence: 612,stimuli,O
Sentence: 612,under,O
Sentence: 612,these,O
Sentence: 612,special,O
Sentence: 612,experimental,O
Sentence: 612,conditions,O
Sentence: 612,.,O
Sentence: 612,Based,O
Sentence: 612,on,O
Sentence: 612,the,O
Sentence: 612,similar,O
Sentence: 612,behaviour,O
Sentence: 612,of,O
Sentence: 612,CSSEP,O
Sentence: 612,and,O
Sentence: 612,NMP,O
Sentence: 612,",",O
Sentence: 612,it,O
Sentence: 612,was,O
Sentence: 612,concluded,O
Sentence: 612,that,O
Sentence: 612,the,O
Sentence: 612,pharmacological,O
Sentence: 612,process,O
Sentence: 612,underlying,O
Sentence: 612,this,O
Sentence: 612,phenomenon,O
Sentence: 612,was,O
Sentence: 612,localised,O
Sentence: 612,in,O
Sentence: 612,the,O
Sentence: 612,periphery,O
Sentence: 612,.,O
Sentence: 612,By,O
Sentence: 612,means,O
Sentence: 612,of,O
Sentence: 612,the,O
Sentence: 612,simultaneous,O
Sentence: 612,recording,O
Sentence: 612,of,O
Sentence: 612,interrelated,O
Sentence: 612,peripheral,O
Sentence: 612,and,O
Sentence: 612,central,O
Sentence: 612,electrophysiologic,O
Sentence: 612,correlates,O
Sentence: 612,of,O
Sentence: 612,nociception,O
Sentence: 612,",",O
Sentence: 612,it,O
Sentence: 612,was,O
Sentence: 612,possible,O
Sentence: 612,to,O
Sentence: 612,separate,O
Sentence: 612,central,O
Sentence: 612,and,O
Sentence: 612,peripheral,O
Sentence: 612,effects,O
Sentence: 612,of,O
Sentence: 612,an,O
Sentence: 612,NSAID,O
Sentence: 612,.,O
Sentence: 612,The,O
Sentence: 612,major,O
Sentence: 612,advantage,O
Sentence: 612,of,O
Sentence: 612,this,O
Sentence: 612,pain,B-Disease
Sentence: 612,model,O
Sentence: 612,is,O
Sentence: 612,the,O
Sentence: 612,possibility,O
Sentence: 612,of,O
Sentence: 612,obtaining,O
Sentence: 612,peripheral,O
Sentence: 612,pain,B-Disease
Sentence: 612,-,O
Sentence: 612,related,O
Sentence: 612,activity,O
Sentence: 612,directly,O
Sentence: 612,using,O
Sentence: 612,a,O
Sentence: 612,non,O
Sentence: 612,-,O
Sentence: 612,invasive,O
Sentence: 612,technique,O
Sentence: 612,in,O
Sentence: 612,humans,O
Sentence: 612,.,O
Sentence: 613,Acute,O
Sentence: 613,severe,O
Sentence: 613,depression,B-Disease
Sentence: 613,following,O
Sentence: 613,peri,O
Sentence: 613,-,O
Sentence: 613,operative,O
Sentence: 613,ondansetron,B-Chemical
Sentence: 613,.,O
Sentence: 614,A,O
Sentence: 614,41,O
Sentence: 614,-,O
Sentence: 614,year,O
Sentence: 614,-,O
Sentence: 614,old,O
Sentence: 614,woman,O
Sentence: 614,with,O
Sentence: 614,a,O
Sentence: 614,strong,O
Sentence: 614,history,O
Sentence: 614,of,O
Sentence: 614,postoperative,B-Disease
Sentence: 614,nausea,B-Disease
Sentence: 614,and,I-Disease
Sentence: 614,vomiting,I-Disease
Sentence: 614,presented,O
Sentence: 614,for,O
Sentence: 614,abdominal,O
Sentence: 614,hysterectomy,O
Sentence: 614,3,O
Sentence: 614,months,O
Sentence: 614,after,O
Sentence: 614,a,O
Sentence: 614,previous,O
Sentence: 614,anaesthetic,O
Sentence: 614,where,O
Sentence: 614,ondansetron,B-Chemical
Sentence: 614,prophylaxis,O
Sentence: 614,had,O
Sentence: 614,been,O
Sentence: 614,used,O
Sentence: 614,.,O
Sentence: 614,She,O
Sentence: 614,had,O
Sentence: 614,developed,O
Sentence: 614,a,O
Sentence: 614,severe,O
Sentence: 614,acute,O
Sentence: 614,major,B-Disease
Sentence: 614,depression,B-Disease
Sentence: 614,disorder,I-Disease
Sentence: 614,almost,O
Sentence: 614,immediately,O
Sentence: 614,thereafter,O
Sentence: 614,",",O
Sentence: 614,possibly,O
Sentence: 614,related,O
Sentence: 614,to,O
Sentence: 614,the,O
Sentence: 614,use,O
Sentence: 614,of,O
Sentence: 614,a,O
Sentence: 614,serotonin,B-Chemical
Sentence: 614,antagonist,O
Sentence: 614,.,O
Sentence: 614,Nine,O
Sentence: 614,years,O
Sentence: 614,before,O
Sentence: 614,she,O
Sentence: 614,had,O
Sentence: 614,experienced,O
Sentence: 614,a,O
Sentence: 614,self,O
Sentence: 614,-,O
Sentence: 614,limited,O
Sentence: 614,puerperal,O
Sentence: 614,depressive,B-Disease
Sentence: 614,episode,I-Disease
Sentence: 614,.,O
Sentence: 614,Anaesthesia,O
Sentence: 614,with,O
Sentence: 614,a,O
Sentence: 614,propofol,B-Chemical
Sentence: 614,infusion,O
Sentence: 614,and,O
Sentence: 614,avoidance,O
Sentence: 614,of,O
Sentence: 614,serotonin,B-Chemical
Sentence: 614,antagonists,O
Sentence: 614,provided,O
Sentence: 614,a,O
Sentence: 614,nausea,B-Disease
Sentence: 614,-,O
Sentence: 614,free,O
Sentence: 614,postoperative,O
Sentence: 614,course,O
Sentence: 614,without,O
Sentence: 614,exacerbation,O
Sentence: 614,of,O
Sentence: 614,the,O
Sentence: 614,depression,B-Disease
Sentence: 614,disorder,I-Disease
Sentence: 614,.,O
Sentence: 615,Hypertensive,B-Disease
Sentence: 615,response,O
Sentence: 615,during,O
Sentence: 615,dobutamine,B-Chemical
Sentence: 615,stress,O
Sentence: 615,echocardiography,O
Sentence: 615,.,O
Sentence: 616,Among,O
Sentence: 616,"3,129",O
Sentence: 616,dobutamine,B-Chemical
Sentence: 616,stress,O
Sentence: 616,echocardiographic,O
Sentence: 616,studies,O
Sentence: 616,",",O
Sentence: 616,a,O
Sentence: 616,hypertensive,B-Disease
Sentence: 616,response,O
Sentence: 616,",",O
Sentence: 616,defined,O
Sentence: 616,as,O
Sentence: 616,systolic,O
Sentence: 616,blood,O
Sentence: 616,pressure,O
Sentence: 616,(,O
Sentence: 616,BP,O
Sentence: 616,),O
Sentence: 616,,O
Sentence: 616,>,O
Sentence: 616,,O
Sentence: 616,or,O
Sentence: 616,,O
Sentence: 616,=,O
Sentence: 616,,O
Sentence: 616,220,O
Sentence: 616,mm,O
Sentence: 616,Hg,O
Sentence: 616,and,O
Sentence: 616,/,O
Sentence: 616,or,O
Sentence: 616,diastolic,O
Sentence: 616,BP,O
Sentence: 616,,O
Sentence: 616,>,O
Sentence: 616,,O
Sentence: 616,or,O
Sentence: 616,,O
Sentence: 616,=,O
Sentence: 616,,O
Sentence: 616,110,O
Sentence: 616,mm,O
Sentence: 616,Hg,O
Sentence: 616,",",O
Sentence: 616,occurred,O
Sentence: 616,in,O
Sentence: 616,30,O
Sentence: 616,patients,O
Sentence: 616,(,O
Sentence: 616,1,O
Sentence: 616,%,O
Sentence: 616,),O
Sentence: 616,.,O
Sentence: 616,Patients,O
Sentence: 616,with,O
Sentence: 616,this,O
Sentence: 616,response,O
Sentence: 616,more,O
Sentence: 616,often,O
Sentence: 616,had,O
Sentence: 616,a,O
Sentence: 616,history,O
Sentence: 616,of,O
Sentence: 616,hypertension,B-Disease
Sentence: 616,and,O
Sentence: 616,had,O
Sentence: 616,higher,O
Sentence: 616,resting,O
Sentence: 616,systolic,O
Sentence: 616,and,O
Sentence: 616,diastolic,O
Sentence: 616,BP,O
Sentence: 616,before,O
Sentence: 616,dobutamine,B-Chemical
Sentence: 616,infusion,O
Sentence: 616,.,O
Sentence: 617,Continuously,O
Sentence: 617,nebulized,O
Sentence: 617,albuterol,B-Chemical
Sentence: 617,in,O
Sentence: 617,severe,O
Sentence: 617,exacerbations,O
Sentence: 617,of,O
Sentence: 617,asthma,B-Disease
Sentence: 617,in,O
Sentence: 617,adults,O
Sentence: 617,:,O
Sentence: 617,a,O
Sentence: 617,case,O
Sentence: 617,-,O
Sentence: 617,controlled,O
Sentence: 617,study,O
Sentence: 617,.,O
Sentence: 618,A,O
Sentence: 618,retrospective,O
Sentence: 618,",",O
Sentence: 618,case,O
Sentence: 618,-,O
Sentence: 618,controlled,O
Sentence: 618,analysis,O
Sentence: 618,comparing,O
Sentence: 618,patients,O
Sentence: 618,admitted,O
Sentence: 618,to,O
Sentence: 618,a,O
Sentence: 618,medical,O
Sentence: 618,intensive,O
Sentence: 618,care,O
Sentence: 618,unit,O
Sentence: 618,with,O
Sentence: 618,severe,O
Sentence: 618,exacerbations,O
Sentence: 618,of,O
Sentence: 618,asthma,B-Disease
Sentence: 618,who,O
Sentence: 618,received,O
Sentence: 618,continuously,O
Sentence: 618,nebulized,O
Sentence: 618,albuterol,B-Chemical
Sentence: 618,(,O
Sentence: 618,CNA,O
Sentence: 618,),O
Sentence: 618,versus,O
Sentence: 618,intermittent,O
Sentence: 618,albuterol,B-Chemical
Sentence: 618,(,O
Sentence: 618,INA,O
Sentence: 618,),O
Sentence: 618,treatments,O
Sentence: 618,is,O
Sentence: 618,reported,O
Sentence: 618,.,O
Sentence: 618,Forty,O
Sentence: 618,matched,O
Sentence: 618,pairs,O
Sentence: 618,of,O
Sentence: 618,patients,O
Sentence: 618,with,O
Sentence: 618,asthma,B-Disease
Sentence: 618,are,O
Sentence: 618,compared,O
Sentence: 618,.,O
Sentence: 618,CNA,O
Sentence: 618,was,O
Sentence: 618,administered,O
Sentence: 618,for,O
Sentence: 618,a,O
Sentence: 618,mean,O
Sentence: 618,of,O
Sentence: 618,11,O
Sentence: 618,+,O
Sentence: 618,/,O
Sentence: 618,,O
Sentence: 618,-,O
Sentence: 618,,O
Sentence: 618,10,O
Sentence: 618,hr,O
Sentence: 618,.,O
Sentence: 618,The,O
Sentence: 618,incidence,O
Sentence: 618,of,O
Sentence: 618,cardiac,B-Disease
Sentence: 618,dysrhythmias,I-Disease
Sentence: 618,was,O
Sentence: 618,similar,O
Sentence: 618,between,O
Sentence: 618,groups,O
Sentence: 618,.,O
Sentence: 618,Symptomatic,O
Sentence: 618,hypokalemia,B-Disease
Sentence: 618,did,O
Sentence: 618,not,O
Sentence: 618,occur,O
Sentence: 618,.,O
Sentence: 618,CNA,O
Sentence: 618,patients,O
Sentence: 618,had,O
Sentence: 618,higher,O
Sentence: 618,heart,O
Sentence: 618,rates,O
Sentence: 618,during,O
Sentence: 618,treatment,O
Sentence: 618,",",O
Sentence: 618,which,O
Sentence: 618,may,O
Sentence: 618,reflect,O
Sentence: 618,severity,O
Sentence: 618,of,O
Sentence: 618,illness,O
Sentence: 618,.,O
Sentence: 618,The,O
Sentence: 618,incidence,O
Sentence: 618,of,O
Sentence: 618,intubation,O
Sentence: 618,was,O
Sentence: 618,similar,O
Sentence: 618,.,O
Sentence: 618,We,O
Sentence: 618,conclude,O
Sentence: 618,that,O
Sentence: 618,CNA,O
Sentence: 618,and,O
Sentence: 618,INA,O
Sentence: 618,demonstrated,O
Sentence: 618,similar,O
Sentence: 618,profiles,O
Sentence: 618,with,O
Sentence: 618,regard,O
Sentence: 618,to,O
Sentence: 618,safety,O
Sentence: 618,",",O
Sentence: 618,morbidity,O
Sentence: 618,",",O
Sentence: 618,and,O
Sentence: 618,mortality,O
Sentence: 618,.,O
Sentence: 619,Hyperosmolar,B-Disease
Sentence: 619,nonketotic,I-Disease
Sentence: 619,coma,I-Disease
Sentence: 619,precipitated,O
Sentence: 619,by,O
Sentence: 619,lithium,B-Chemical
Sentence: 619,-,O
Sentence: 619,induced,O
Sentence: 619,nephrogenic,B-Disease
Sentence: 619,diabetes,I-Disease
Sentence: 619,insipidus,I-Disease
Sentence: 619,.,O
Sentence: 620,A,O
Sentence: 620,45,O
Sentence: 620,-,O
Sentence: 620,year,O
Sentence: 620,-,O
Sentence: 620,old,O
Sentence: 620,man,O
Sentence: 620,",",O
Sentence: 620,with,O
Sentence: 620,a,O
Sentence: 620,10,O
Sentence: 620,-,O
Sentence: 620,year,O
Sentence: 620,history,O
Sentence: 620,of,O
Sentence: 620,manic,B-Disease
Sentence: 620,depression,I-Disease
Sentence: 620,treated,O
Sentence: 620,with,O
Sentence: 620,lithium,B-Chemical
Sentence: 620,",",O
Sentence: 620,was,O
Sentence: 620,admitted,O
Sentence: 620,with,O
Sentence: 620,hyperosmolar,B-Disease
Sentence: 620,",",I-Disease
Sentence: 620,nonketotic,I-Disease
Sentence: 620,coma,I-Disease
Sentence: 620,.,O
Sentence: 620,He,O
Sentence: 620,gave,O
Sentence: 620,a,O
Sentence: 620,five,O
Sentence: 620,-,O
Sentence: 620,year,O
Sentence: 620,history,O
Sentence: 620,of,O
Sentence: 620,polyuria,B-Disease
Sentence: 620,and,O
Sentence: 620,polydipsia,B-Disease
Sentence: 620,",",O
Sentence: 620,during,O
Sentence: 620,which,O
Sentence: 620,time,O
Sentence: 620,urinalysis,O
Sentence: 620,had,O
Sentence: 620,been,O
Sentence: 620,negative,O
Sentence: 620,for,O
Sentence: 620,glucose,B-Chemical
Sentence: 620,.,O
Sentence: 620,After,O
Sentence: 620,recovery,O
Sentence: 620,from,O
Sentence: 620,hyperglycaemia,B-Disease
Sentence: 620,",",O
Sentence: 620,he,O
Sentence: 620,remained,O
Sentence: 620,polyuric,B-Disease
Sentence: 620,despite,O
Sentence: 620,normal,O
Sentence: 620,blood,O
Sentence: 620,glucose,B-Chemical
Sentence: 620,concentrations,O
Sentence: 620,;,O
Sentence: 620,water,O
Sentence: 620,deprivation,O
Sentence: 620,testing,O
Sentence: 620,indicated,O
Sentence: 620,nephrogenic,B-Disease
Sentence: 620,diabetes,I-Disease
Sentence: 620,insipidus,I-Disease
Sentence: 620,",",O
Sentence: 620,likely,O
Sentence: 620,to,O
Sentence: 620,be,O
Sentence: 620,lithium,B-Chemical
Sentence: 620,-,O
Sentence: 620,induced,O
Sentence: 620,.,O
Sentence: 620,We,O
Sentence: 620,hypothesize,O
Sentence: 620,that,O
Sentence: 620,when,O
Sentence: 620,this,O
Sentence: 620,man,O
Sentence: 620,developed,O
Sentence: 620,type,B-Disease
Sentence: 620,2,I-Disease
Sentence: 620,diabetes,I-Disease
Sentence: 620,",",O
Sentence: 620,chronic,O
Sentence: 620,polyuria,B-Disease
Sentence: 620,due,O
Sentence: 620,to,O
Sentence: 620,nephrogenic,B-Disease
Sentence: 620,diabetes,I-Disease
Sentence: 620,insipidus,I-Disease
Sentence: 620,was,O
Sentence: 620,sufficient,O
Sentence: 620,to,O
Sentence: 620,precipitate,O
Sentence: 620,hyperosmolar,O
Sentence: 620,dehydration,B-Disease
Sentence: 620,.,O
Sentence: 621,Effects,O
Sentence: 621,of,O
Sentence: 621,the,O
Sentence: 621,intracoronary,O
Sentence: 621,infusion,O
Sentence: 621,of,O
Sentence: 621,cocaine,O
Sentence: 621,on,O
Sentence: 621,left,O
Sentence: 621,ventricular,O
Sentence: 621,systolic,O
Sentence: 621,and,O
Sentence: 621,diastolic,O
Sentence: 621,function,O
Sentence: 621,in,O
Sentence: 621,humans,O
Sentence: 621,.,O
Sentence: 622,BACKGROUND,O
Sentence: 622,:,O
Sentence: 622,In,O
Sentence: 622,dogs,O
Sentence: 622,",",O
Sentence: 622,a,O
Sentence: 622,large,O
Sentence: 622,amount,O
Sentence: 622,of,O
Sentence: 622,intravenous,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,causes,O
Sentence: 622,a,O
Sentence: 622,profound,O
Sentence: 622,deterioration,B-Disease
Sentence: 622,of,I-Disease
Sentence: 622,left,I-Disease
Sentence: 622,ventricular,I-Disease
Sentence: 622,(,I-Disease
Sentence: 622,LV,I-Disease
Sentence: 622,),I-Disease
Sentence: 622,systolic,I-Disease
Sentence: 622,function,I-Disease
Sentence: 622,and,O
Sentence: 622,an,O
Sentence: 622,increase,O
Sentence: 622,in,O
Sentence: 622,LV,O
Sentence: 622,end,O
Sentence: 622,-,O
Sentence: 622,diastolic,O
Sentence: 622,pressure,O
Sentence: 622,.,O
Sentence: 622,This,O
Sentence: 622,study,O
Sentence: 622,was,O
Sentence: 622,done,O
Sentence: 622,to,O
Sentence: 622,assess,O
Sentence: 622,the,O
Sentence: 622,influence,O
Sentence: 622,of,O
Sentence: 622,a,O
Sentence: 622,high,O
Sentence: 622,intracoronary,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,concentration,O
Sentence: 622,on,O
Sentence: 622,LV,O
Sentence: 622,systolic,O
Sentence: 622,and,O
Sentence: 622,diastolic,O
Sentence: 622,function,O
Sentence: 622,in,O
Sentence: 622,humans,O
Sentence: 622,.,O
Sentence: 622,METHODS,O
Sentence: 622,AND,O
Sentence: 622,RESULTS,O
Sentence: 622,:,O
Sentence: 622,In,O
Sentence: 622,20,O
Sentence: 622,patients,O
Sentence: 622,(,O
Sentence: 622,14,O
Sentence: 622,men,O
Sentence: 622,and,O
Sentence: 622,6,O
Sentence: 622,women,O
Sentence: 622,aged,O
Sentence: 622,39,O
Sentence: 622,to,O
Sentence: 622,72,O
Sentence: 622,years,O
Sentence: 622,),O
Sentence: 622,referred,O
Sentence: 622,for,O
Sentence: 622,cardiac,O
Sentence: 622,catheterization,O
Sentence: 622,for,O
Sentence: 622,the,O
Sentence: 622,evaluation,O
Sentence: 622,of,O
Sentence: 622,chest,B-Disease
Sentence: 622,pain,I-Disease
Sentence: 622,",",O
Sentence: 622,we,O
Sentence: 622,measured,O
Sentence: 622,heart,O
Sentence: 622,rate,O
Sentence: 622,",",O
Sentence: 622,systemic,O
Sentence: 622,arterial,O
Sentence: 622,pressure,O
Sentence: 622,",",O
Sentence: 622,LV,O
Sentence: 622,pressure,O
Sentence: 622,and,O
Sentence: 622,its,O
Sentence: 622,first,O
Sentence: 622,derivative,O
Sentence: 622,(,O
Sentence: 622,dP,O
Sentence: 622,/,O
Sentence: 622,dt,O
Sentence: 622,),O
Sentence: 622,",",O
Sentence: 622,and,O
Sentence: 622,LV,O
Sentence: 622,volumes,O
Sentence: 622,and,O
Sentence: 622,ejection,O
Sentence: 622,fraction,O
Sentence: 622,before,O
Sentence: 622,and,O
Sentence: 622,during,O
Sentence: 622,the,O
Sentence: 622,final,O
Sentence: 622,2,O
Sentence: 622,to,O
Sentence: 622,3,O
Sentence: 622,minutes,O
Sentence: 622,of,O
Sentence: 622,a,O
Sentence: 622,15,O
Sentence: 622,-,O
Sentence: 622,minute,O
Sentence: 622,intracoronary,O
Sentence: 622,infusion,O
Sentence: 622,of,O
Sentence: 622,saline,O
Sentence: 622,(,O
Sentence: 622,n,O
Sentence: 622,=,O
Sentence: 622,10,O
Sentence: 622,",",O
Sentence: 622,control,O
Sentence: 622,subjects,O
Sentence: 622,),O
Sentence: 622,or,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,hydrochloride,I-Chemical
Sentence: 622,1,O
Sentence: 622,mg,O
Sentence: 622,/,O
Sentence: 622,min,O
Sentence: 622,(,O
Sentence: 622,n,O
Sentence: 622,=,O
Sentence: 622,10,O
Sentence: 622,),O
Sentence: 622,.,O
Sentence: 622,No,O
Sentence: 622,variable,O
Sentence: 622,changed,O
Sentence: 622,with,O
Sentence: 622,saline,O
Sentence: 622,.,O
Sentence: 622,With,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,",",O
Sentence: 622,the,O
Sentence: 622,drug,O
Sentence: 622,concentration,O
Sentence: 622,in,O
Sentence: 622,blood,O
Sentence: 622,obtained,O
Sentence: 622,from,O
Sentence: 622,the,O
Sentence: 622,coronary,O
Sentence: 622,sinus,O
Sentence: 622,was,O
Sentence: 622,3.0+,O
Sentence: 622,/,O
Sentence: 622,,O
Sentence: 622,-,O
Sentence: 622,0.4,O
Sentence: 622,(,O
Sentence: 622,mean+,O
Sentence: 622,/,O
Sentence: 622,,O
Sentence: 622,-,O
Sentence: 622,SD,O
Sentence: 622,),O
Sentence: 622,mg,O
Sentence: 622,/,O
Sentence: 622,L,O
Sentence: 622,",",O
Sentence: 622,similar,O
Sentence: 622,in,O
Sentence: 622,magnitude,O
Sentence: 622,to,O
Sentence: 622,the,O
Sentence: 622,blood,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,concentration,O
Sentence: 622,reported,O
Sentence: 622,in,O
Sentence: 622,abusers,O
Sentence: 622,dying,O
Sentence: 622,of,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,intoxication,O
Sentence: 622,.,O
Sentence: 622,Cocaine,B-Chemical
Sentence: 622,induced,O
Sentence: 622,no,O
Sentence: 622,significant,O
Sentence: 622,change,O
Sentence: 622,in,O
Sentence: 622,heart,O
Sentence: 622,rate,O
Sentence: 622,",",O
Sentence: 622,LV,O
Sentence: 622,dP,O
Sentence: 622,/,O
Sentence: 622,dt,O
Sentence: 622,(,O
Sentence: 622,positive,O
Sentence: 622,or,O
Sentence: 622,negative,O
Sentence: 622,),O
Sentence: 622,",",O
Sentence: 622,or,O
Sentence: 622,LV,O
Sentence: 622,end,O
Sentence: 622,-,O
Sentence: 622,diastolic,O
Sentence: 622,volume,O
Sentence: 622,",",O
Sentence: 622,but,O
Sentence: 622,it,O
Sentence: 622,caused,O
Sentence: 622,an,O
Sentence: 622,increase,O
Sentence: 622,in,O
Sentence: 622,systolic,O
Sentence: 622,and,O
Sentence: 622,mean,O
Sentence: 622,arterial,O
Sentence: 622,pressures,O
Sentence: 622,",",O
Sentence: 622,LV,O
Sentence: 622,end,O
Sentence: 622,-,O
Sentence: 622,diastolic,O
Sentence: 622,pressure,O
Sentence: 622,",",O
Sentence: 622,and,O
Sentence: 622,LV,O
Sentence: 622,end,O
Sentence: 622,-,O
Sentence: 622,systolic,O
Sentence: 622,volume,O
Sentence: 622,",",O
Sentence: 622,as,O
Sentence: 622,well,O
Sentence: 622,as,O
Sentence: 622,a,O
Sentence: 622,decrease,O
Sentence: 622,in,O
Sentence: 622,LV,O
Sentence: 622,ejection,O
Sentence: 622,fraction,O
Sentence: 622,.,O
Sentence: 622,CONCLUSIONS,O
Sentence: 622,:,O
Sentence: 622,In,O
Sentence: 622,humans,O
Sentence: 622,",",O
Sentence: 622,the,O
Sentence: 622,intracoronary,O
Sentence: 622,infusion,O
Sentence: 622,of,O
Sentence: 622,cocaine,B-Chemical
Sentence: 622,sufficient,O
Sentence: 622,in,O
Sentence: 622,amount,O
Sentence: 622,to,O
Sentence: 622,achieve,O
Sentence: 622,a,O
Sentence: 622,high,O
Sentence: 622,drug,O
Sentence: 622,concentration,O
Sentence: 622,in,O
Sentence: 622,coronary,O
Sentence: 622,sinus,O
Sentence: 622,blood,O
Sentence: 622,causes,O
Sentence: 622,a,O
Sentence: 622,deterioration,B-Disease
Sentence: 622,of,I-Disease
Sentence: 622,LV,I-Disease
Sentence: 622,systolic,I-Disease
Sentence: 622,and,I-Disease
Sentence: 622,diastolic,I-Disease
Sentence: 622,performance,I-Disease
Sentence: 622,.,O
Sentence: 623,Heparin,B-Chemical
Sentence: 623,-,O
Sentence: 623,induced,O
Sentence: 623,thrombocytopenia,B-Disease
Sentence: 623,",",O
Sentence: 623,paradoxical,O
Sentence: 623,thromboembolism,B-Disease
Sentence: 623,",",O
Sentence: 623,and,O
Sentence: 623,other,O
Sentence: 623,side,O
Sentence: 623,effects,O
Sentence: 623,of,O
Sentence: 623,heparin,B-Chemical
Sentence: 623,therapy,O
Sentence: 623,.,O
Sentence: 624,Although,O
Sentence: 624,several,O
Sentence: 624,new,O
Sentence: 624,anticoagulant,O
Sentence: 624,drugs,O
Sentence: 624,are,O
Sentence: 624,in,O
Sentence: 624,development,O
Sentence: 624,",",O
Sentence: 624,heparin,B-Chemical
Sentence: 624,remains,O
Sentence: 624,the,O
Sentence: 624,drug,O
Sentence: 624,of,O
Sentence: 624,choice,O
Sentence: 624,for,O
Sentence: 624,most,O
Sentence: 624,anticoagulation,O
Sentence: 624,needs,O
Sentence: 624,.,O
Sentence: 624,The,O
Sentence: 624,clinical,O
Sentence: 624,effects,O
Sentence: 624,of,O
Sentence: 624,heparin,B-Chemical
Sentence: 624,are,O
Sentence: 624,meritorious,O
Sentence: 624,",",O
Sentence: 624,but,O
Sentence: 624,side,O
Sentence: 624,effects,O
Sentence: 624,do,O
Sentence: 624,exist,O
Sentence: 624,.,O
Sentence: 624,Important,O
Sentence: 624,untoward,O
Sentence: 624,effects,O
Sentence: 624,of,O
Sentence: 624,heparin,B-Chemical
Sentence: 624,therapy,O
Sentence: 624,including,O
Sentence: 624,heparin,B-Chemical
Sentence: 624,-,O
Sentence: 624,induced,O
Sentence: 624,thrombocytopenia,B-Disease
Sentence: 624,",",O
Sentence: 624,heparin,B-Chemical
Sentence: 624,-,O
Sentence: 624,associated,O
Sentence: 624,osteoporosis,B-Disease
Sentence: 624,",",O
Sentence: 624,eosinophilia,B-Disease
Sentence: 624,",",O
Sentence: 624,skin,B-Disease
Sentence: 624,reactions,I-Disease
Sentence: 624,",",O
Sentence: 624,allergic,B-Disease
Sentence: 624,reactions,I-Disease
Sentence: 624,other,O
Sentence: 624,than,O
Sentence: 624,thrombocytopenia,B-Disease
Sentence: 624,and,O
Sentence: 624,alopecia,B-Disease
Sentence: 624,will,O
Sentence: 624,be,O
Sentence: 624,discussed,O
Sentence: 624,in,O
Sentence: 624,this,O
Sentence: 624,article,O
Sentence: 624,.,O
Sentence: 625,Nonopaque,O
Sentence: 625,crystal,O
Sentence: 625,deposition,O
Sentence: 625,causing,O
Sentence: 625,ureteric,B-Disease
Sentence: 625,obstruction,I-Disease
Sentence: 625,in,O
Sentence: 625,patients,O
Sentence: 625,with,O
Sentence: 625,HIV,O
Sentence: 625,undergoing,O
Sentence: 625,indinavir,B-Chemical
Sentence: 625,therapy,O
Sentence: 625,.,O
Sentence: 626,OBJECTIVE,O
Sentence: 626,:,O
Sentence: 626,We,O
Sentence: 626,describe,O
Sentence: 626,the,O
Sentence: 626,unique,O
Sentence: 626,CT,O
Sentence: 626,features,O
Sentence: 626,of,O
Sentence: 626,ureteric,B-Disease
Sentence: 626,calculi,I-Disease
Sentence: 626,in,O
Sentence: 626,six,O
Sentence: 626,HIV,O
Sentence: 626,-,O
Sentence: 626,infected,O
Sentence: 626,patients,O
Sentence: 626,receiving,O
Sentence: 626,indinavir,B-Chemical
Sentence: 626,",",O
Sentence: 626,the,O
Sentence: 626,most,O
Sentence: 626,commonly,O
Sentence: 626,used,O
Sentence: 626,HIV,O
Sentence: 626,protease,O
Sentence: 626,inhibitor,O
Sentence: 626,",",O
Sentence: 626,which,O
Sentence: 626,is,O
Sentence: 626,associated,O
Sentence: 626,with,O
Sentence: 626,an,O
Sentence: 626,increased,O
Sentence: 626,incidence,O
Sentence: 626,of,O
Sentence: 626,urolithiasis,B-Disease
Sentence: 626,.,O
Sentence: 626,CONCLUSION,O
Sentence: 626,:,O
Sentence: 626,Ureteric,B-Disease
Sentence: 626,obstruction,I-Disease
Sentence: 626,caused,O
Sentence: 626,by,O
Sentence: 626,precipitated,O
Sentence: 626,indinavir,B-Chemical
Sentence: 626,crystals,O
Sentence: 626,may,O
Sentence: 626,be,O
Sentence: 626,difficult,O
Sentence: 626,to,O
Sentence: 626,diagnose,O
Sentence: 626,with,O
Sentence: 626,unenhanced,O
Sentence: 626,CT,O
Sentence: 626,.,O
Sentence: 626,The,O
Sentence: 626,calculi,O
Sentence: 626,are,O
Sentence: 626,not,O
Sentence: 626,opaque,O
Sentence: 626,",",O
Sentence: 626,and,O
Sentence: 626,secondary,O
Sentence: 626,signs,O
Sentence: 626,of,O
Sentence: 626,obstruction,O
Sentence: 626,may,O
Sentence: 626,be,O
Sentence: 626,absent,O
Sentence: 626,or,O
Sentence: 626,minimal,O
Sentence: 626,and,O
Sentence: 626,should,O
Sentence: 626,be,O
Sentence: 626,sought,O
Sentence: 626,carefully,O
Sentence: 626,.,O
Sentence: 626,Images,O
Sentence: 626,may,O
Sentence: 626,need,O
Sentence: 626,to,O
Sentence: 626,be,O
Sentence: 626,obtained,O
Sentence: 626,using,O
Sentence: 626,i.v,O
Sentence: 626,.,O
Sentence: 626,contrast,O
Sentence: 626,material,O
Sentence: 626,to,O
Sentence: 626,enable,O
Sentence: 626,diagnosis,O
Sentence: 626,of,O
Sentence: 626,ureteric,B-Disease
Sentence: 626,stones,I-Disease
Sentence: 626,or,I-Disease
Sentence: 626,obstruction,I-Disease
Sentence: 626,in,O
Sentence: 626,patients,O
Sentence: 626,with,O
Sentence: 626,HIV,B-Disease
Sentence: 626,infection,I-Disease
Sentence: 626,who,O
Sentence: 626,receive,O
Sentence: 626,indinavir,B-Chemical
Sentence: 626,therapy,O
Sentence: 626,.,O
Sentence: 627,Ischemic,B-Disease
Sentence: 627,colitis,I-Disease
Sentence: 627,and,O
Sentence: 627,sumatriptan,B-Chemical
Sentence: 627,use,O
Sentence: 627,.,O
Sentence: 628,Sumatriptan,B-Chemical
Sentence: 628,succinate,I-Chemical
Sentence: 628,",",O
Sentence: 628,a,O
Sentence: 628,serotonin,B-Chemical
Sentence: 628,-,O
Sentence: 628,1,O
Sentence: 628,(,O
Sentence: 628,5,O
Sentence: 628,-,O
Sentence: 628,hydroxytryptamine,O
Sentence: 628,-,O
Sentence: 628,1,O
Sentence: 628,),O
Sentence: 628,receptor,O
Sentence: 628,agonist,O
Sentence: 628,",",O
Sentence: 628,is,O
Sentence: 628,an,O
Sentence: 628,antimigraine,O
Sentence: 628,drug,O
Sentence: 628,that,O
Sentence: 628,is,O
Sentence: 628,reported,O
Sentence: 628,to,O
Sentence: 628,act,O
Sentence: 628,by,O
Sentence: 628,selectively,O
Sentence: 628,constricting,O
Sentence: 628,intracranial,O
Sentence: 628,arteries,O
Sentence: 628,.,O
Sentence: 628,Recently,O
Sentence: 628,",",O
Sentence: 628,vasopressor,O
Sentence: 628,responses,O
Sentence: 628,that,O
Sentence: 628,are,O
Sentence: 628,distinct,O
Sentence: 628,from,O
Sentence: 628,the,O
Sentence: 628,cranial,O
Sentence: 628,circulation,O
Sentence: 628,have,O
Sentence: 628,been,O
Sentence: 628,demonstrated,O
Sentence: 628,to,O
Sentence: 628,occur,O
Sentence: 628,in,O
Sentence: 628,the,O
Sentence: 628,systemic,O
Sentence: 628,",",O
Sentence: 628,pulmonary,O
Sentence: 628,",",O
Sentence: 628,and,O
Sentence: 628,coronary,O
Sentence: 628,circulations,O
Sentence: 628,.,O
Sentence: 628,Cases,O
Sentence: 628,have,O
Sentence: 628,been,O
Sentence: 628,published,O
Sentence: 628,of,O
Sentence: 628,coronary,B-Disease
Sentence: 628,vasospasm,I-Disease
Sentence: 628,",",O
Sentence: 628,myocardial,B-Disease
Sentence: 628,ischemia,I-Disease
Sentence: 628,",",O
Sentence: 628,and,O
Sentence: 628,myocardial,B-Disease
Sentence: 628,infarction,I-Disease
Sentence: 628,occurring,O
Sentence: 628,after,O
Sentence: 628,sumatriptan,B-Chemical
Sentence: 628,use,O
Sentence: 628,.,O
Sentence: 628,We,O
Sentence: 628,report,O
Sentence: 628,on,O
Sentence: 628,the,O
Sentence: 628,development,O
Sentence: 628,of,O
Sentence: 628,8,O
Sentence: 628,serious,O
Sentence: 628,cases,O
Sentence: 628,of,O
Sentence: 628,ischemic,B-Disease
Sentence: 628,colitis,I-Disease
Sentence: 628,in,O
Sentence: 628,patients,O
Sentence: 628,with,O
Sentence: 628,migraine,B-Disease
Sentence: 628,treated,O
Sentence: 628,with,O
Sentence: 628,sumatriptan,B-Chemical
Sentence: 628,.,O
Sentence: 629,Pallidotomy,O
Sentence: 629,with,O
Sentence: 629,the,O
Sentence: 629,gamma,O
Sentence: 629,knife,O
Sentence: 629,:,O
Sentence: 629,a,O
Sentence: 629,positive,O
Sentence: 629,experience,O
Sentence: 629,.,O
Sentence: 630,51,O
Sentence: 630,patients,O
Sentence: 630,with,O
Sentence: 630,medically,O
Sentence: 630,refractory,O
Sentence: 630,Parkinson,B-Disease
Sentence: 630,'s,I-Disease
Sentence: 630,disease,I-Disease
Sentence: 630,underwent,O
Sentence: 630,stereotactic,O
Sentence: 630,posteromedial,O
Sentence: 630,pallidotomy,O
Sentence: 630,between,O
Sentence: 630,August,O
Sentence: 630,1993,O
Sentence: 630,and,O
Sentence: 630,February,O
Sentence: 630,1997,O
Sentence: 630,for,O
Sentence: 630,treatment,O
Sentence: 630,of,O
Sentence: 630,bradykinesia,B-Disease
Sentence: 630,",",O
Sentence: 630,rigidity,B-Disease
Sentence: 630,",",O
Sentence: 630,and,O
Sentence: 630,L,O
Sentence: 630,-,O
Sentence: 630,DOPA,O
Sentence: 630,-,O
Sentence: 630,induced,O
Sentence: 630,dyskinesias,B-Disease
Sentence: 630,.,O
Sentence: 630,In,O
Sentence: 630,29,O
Sentence: 630,patients,O
Sentence: 630,",",O
Sentence: 630,the,O
Sentence: 630,pallidotomies,O
Sentence: 630,were,O
Sentence: 630,performed,O
Sentence: 630,with,O
Sentence: 630,the,O
Sentence: 630,Leksell,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,and,O
Sentence: 630,in,O
Sentence: 630,22,O
Sentence: 630,they,O
Sentence: 630,were,O
Sentence: 630,performed,O
Sentence: 630,with,O
Sentence: 630,the,O
Sentence: 630,standard,O
Sentence: 630,radiofrequency,O
Sentence: 630,(,O
Sentence: 630,RF,O
Sentence: 630,),O
Sentence: 630,method,O
Sentence: 630,.,O
Sentence: 630,Clinical,O
Sentence: 630,assessment,O
Sentence: 630,as,O
Sentence: 630,well,O
Sentence: 630,as,O
Sentence: 630,blinded,O
Sentence: 630,ratings,O
Sentence: 630,of,O
Sentence: 630,Unified,O
Sentence: 630,Parkinson,B-Disease
Sentence: 630,'s,I-Disease
Sentence: 630,Disease,I-Disease
Sentence: 630,Rating,O
Sentence: 630,Scale,O
Sentence: 630,(,O
Sentence: 630,UPDRS,O
Sentence: 630,),O
Sentence: 630,scores,O
Sentence: 630,were,O
Sentence: 630,carried,O
Sentence: 630,out,O
Sentence: 630,pre,O
Sentence: 630,-,O
Sentence: 630,,O
Sentence: 630,and,O
Sentence: 630,postoperatively,O
Sentence: 630,.,O
Sentence: 630,Mean,O
Sentence: 630,follow,O
Sentence: 630,-,O
Sentence: 630,up,O
Sentence: 630,time,O
Sentence: 630,is,O
Sentence: 630,20.6,O
Sentence: 630,months,O
Sentence: 630,(,O
Sentence: 630,range,O
Sentence: 630,6,O
Sentence: 630,-,O
Sentence: 630,48,O
Sentence: 630,),O
Sentence: 630,and,O
Sentence: 630,all,O
Sentence: 630,except,O
Sentence: 630,4,O
Sentence: 630,patients,O
Sentence: 630,have,O
Sentence: 630,been,O
Sentence: 630,followed,O
Sentence: 630,more,O
Sentence: 630,than,O
Sentence: 630,one,O
Sentence: 630,year,O
Sentence: 630,.,O
Sentence: 630,85,O
Sentence: 630,percent,O
Sentence: 630,of,O
Sentence: 630,patients,O
Sentence: 630,with,O
Sentence: 630,dyskinesias,B-Disease
Sentence: 630,were,O
Sentence: 630,relieved,O
Sentence: 630,of,O
Sentence: 630,symptoms,O
Sentence: 630,",",O
Sentence: 630,regardless,O
Sentence: 630,of,O
Sentence: 630,whether,O
Sentence: 630,the,O
Sentence: 630,pallidotomies,O
Sentence: 630,were,O
Sentence: 630,performed,O
Sentence: 630,with,O
Sentence: 630,the,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,or,O
Sentence: 630,radiofrequency,O
Sentence: 630,methods,O
Sentence: 630,.,O
Sentence: 630,About,O
Sentence: 630,2,O
Sentence: 630,/,O
Sentence: 630,3,O
Sentence: 630,of,O
Sentence: 630,the,O
Sentence: 630,patients,O
Sentence: 630,in,O
Sentence: 630,both,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,and,O
Sentence: 630,radiofrequency,O
Sentence: 630,groups,O
Sentence: 630,showed,O
Sentence: 630,improvements,O
Sentence: 630,in,O
Sentence: 630,bradykinesia,B-Disease
Sentence: 630,and,O
Sentence: 630,rigidity,B-Disease
Sentence: 630,",",O
Sentence: 630,although,O
Sentence: 630,when,O
Sentence: 630,considered,O
Sentence: 630,as,O
Sentence: 630,a,O
Sentence: 630,group,O
Sentence: 630,neither,O
Sentence: 630,the,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,nor,O
Sentence: 630,the,O
Sentence: 630,radiofrequency,O
Sentence: 630,group,O
Sentence: 630,showed,O
Sentence: 630,statistically,O
Sentence: 630,significant,O
Sentence: 630,improvements,O
Sentence: 630,in,O
Sentence: 630,UPDRS,O
Sentence: 630,scores,O
Sentence: 630,.,O
Sentence: 630,One,O
Sentence: 630,patient,O
Sentence: 630,in,O
Sentence: 630,the,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,group,O
Sentence: 630,(,O
Sentence: 630,3.4,O
Sentence: 630,%,O
Sentence: 630,),O
Sentence: 630,developed,O
Sentence: 630,a,O
Sentence: 630,homonymous,B-Disease
Sentence: 630,hemianopsia,I-Disease
Sentence: 630,9,O
Sentence: 630,months,O
Sentence: 630,following,O
Sentence: 630,treatment,O
Sentence: 630,and,O
Sentence: 630,5,O
Sentence: 630,patients,O
Sentence: 630,(,O
Sentence: 630,27.7,O
Sentence: 630,%,O
Sentence: 630,),O
Sentence: 630,in,O
Sentence: 630,the,O
Sentence: 630,radiofrequency,O
Sentence: 630,group,O
Sentence: 630,became,O
Sentence: 630,transiently,O
Sentence: 630,confused,O
Sentence: 630,postoperatively,O
Sentence: 630,.,O
Sentence: 630,No,O
Sentence: 630,other,O
Sentence: 630,complications,O
Sentence: 630,were,O
Sentence: 630,seen,O
Sentence: 630,.,O
Sentence: 630,Gamma,O
Sentence: 630,Knife,O
Sentence: 630,pallidotomy,O
Sentence: 630,is,O
Sentence: 630,as,O
Sentence: 630,effective,O
Sentence: 630,as,O
Sentence: 630,radiofrequency,O
Sentence: 630,pallidotomy,O
Sentence: 630,in,O
Sentence: 630,controlling,O
Sentence: 630,certain,O
Sentence: 630,of,O
Sentence: 630,the,O
Sentence: 630,symptoms,O
Sentence: 630,of,O
Sentence: 630,Parkinson,B-Disease
Sentence: 630,'s,I-Disease
Sentence: 630,disease,I-Disease
Sentence: 630,.,O
Sentence: 630,It,O
Sentence: 630,may,O
Sentence: 630,be,O
Sentence: 630,the,O
Sentence: 630,only,O
Sentence: 630,practical,O
Sentence: 630,technique,O
Sentence: 630,available,O
Sentence: 630,in,O
Sentence: 630,certain,O
Sentence: 630,patients,O
Sentence: 630,",",O
Sentence: 630,such,O
Sentence: 630,as,O
Sentence: 630,those,O
Sentence: 630,who,O
Sentence: 630,take,O
Sentence: 630,anticoagulants,O
Sentence: 630,",",O
Sentence: 630,have,O
Sentence: 630,bleeding,B-Disease
Sentence: 630,diatheses,O
Sentence: 630,or,O
Sentence: 630,serious,O
Sentence: 630,systemic,O
Sentence: 630,medical,O
Sentence: 630,illnesses,O
Sentence: 630,.,O
Sentence: 630,It,O
Sentence: 630,is,O
Sentence: 630,a,O
Sentence: 630,viable,O
Sentence: 630,option,O
Sentence: 630,for,O
Sentence: 630,other,O
Sentence: 630,patients,O
Sentence: 630,as,O
Sentence: 630,well,O
Sentence: 630,.,O
Sentence: 631,Neuroleptic,B-Disease
Sentence: 631,malignant,I-Disease
Sentence: 631,syndrome,I-Disease
Sentence: 631,and,O
Sentence: 631,methylphenidate,B-Chemical
Sentence: 631,.,O
Sentence: 632,A,O
Sentence: 632,1,O
Sentence: 632,-,O
Sentence: 632,year,O
Sentence: 632,-,O
Sentence: 632,old,O
Sentence: 632,female,O
Sentence: 632,presented,O
Sentence: 632,with,O
Sentence: 632,neuroleptic,B-Disease
Sentence: 632,malignant,I-Disease
Sentence: 632,syndrome,I-Disease
Sentence: 632,probably,O
Sentence: 632,caused,O
Sentence: 632,by,O
Sentence: 632,methylphenidate,B-Chemical
Sentence: 632,.,O
Sentence: 632,She,O
Sentence: 632,had,O
Sentence: 632,defects,O
Sentence: 632,in,O
Sentence: 632,the,O
Sentence: 632,supratentorial,O
Sentence: 632,brain,O
Sentence: 632,including,O
Sentence: 632,the,O
Sentence: 632,basal,O
Sentence: 632,ganglia,O
Sentence: 632,and,O
Sentence: 632,the,O
Sentence: 632,striatum,O
Sentence: 632,(,O
Sentence: 632,multicystic,B-Disease
Sentence: 632,encephalomalacia,I-Disease
Sentence: 632,),O
Sentence: 632,due,O
Sentence: 632,to,O
Sentence: 632,severe,O
Sentence: 632,perinatal,O
Sentence: 632,hypoxic,O
Sentence: 632,-,O
Sentence: 632,ischemic,O
Sentence: 632,encephalopathy,O
Sentence: 632,",",O
Sentence: 632,which,O
Sentence: 632,was,O
Sentence: 632,considered,O
Sentence: 632,to,O
Sentence: 632,be,O
Sentence: 632,a,O
Sentence: 632,possible,O
Sentence: 632,predisposing,O
Sentence: 632,factor,O
Sentence: 632,causing,O
Sentence: 632,neuroleptic,B-Disease
Sentence: 632,malignant,I-Disease
Sentence: 632,syndrome,I-Disease
Sentence: 632,.,O
Sentence: 632,A,O
Sentence: 632,dopaminergic,O
Sentence: 632,blockade,O
Sentence: 632,mechanism,O
Sentence: 632,generally,O
Sentence: 632,is,O
Sentence: 632,accepted,O
Sentence: 632,as,O
Sentence: 632,the,O
Sentence: 632,pathogenesis,O
Sentence: 632,of,O
Sentence: 632,this,O
Sentence: 632,syndrome,O
Sentence: 632,.,O
Sentence: 632,However,O
Sentence: 632,",",O
Sentence: 632,methylphenidate,B-Chemical
Sentence: 632,is,O
Sentence: 632,a,O
Sentence: 632,dopamine,B-Chemical
Sentence: 632,agonist,O
Sentence: 632,via,O
Sentence: 632,the,O
Sentence: 632,inhibition,O
Sentence: 632,of,O
Sentence: 632,uptake,O
Sentence: 632,of,O
Sentence: 632,dopamine,B-Chemical
Sentence: 632,",",O
Sentence: 632,and,O
Sentence: 632,therefore,O
Sentence: 632,dopaminergic,O
Sentence: 632,systems,O
Sentence: 632,in,O
Sentence: 632,the,O
Sentence: 632,brainstem,O
Sentence: 632,(,O
Sentence: 632,mainly,O
Sentence: 632,the,O
Sentence: 632,midbrain,O
Sentence: 632,),O
Sentence: 632,and,O
Sentence: 632,the,O
Sentence: 632,spinal,O
Sentence: 632,cord,O
Sentence: 632,were,O
Sentence: 632,unlikely,O
Sentence: 632,to,O
Sentence: 632,participate,O
Sentence: 632,in,O
Sentence: 632,the,O
Sentence: 632,onset,O
Sentence: 632,of,O
Sentence: 632,this,O
Sentence: 632,syndrome,O
Sentence: 632,.,O
Sentence: 632,A,O
Sentence: 632,relative,O
Sentence: 632,gamma,O
Sentence: 632,-,O
Sentence: 632,aminobutyric,O
Sentence: 632,acid,O
Sentence: 632,-,O
Sentence: 632,ergic,O
Sentence: 632,deficiency,O
Sentence: 632,might,O
Sentence: 632,occur,O
Sentence: 632,because,O
Sentence: 632,diazepam,B-Chemical
Sentence: 632,",",O
Sentence: 632,a,O
Sentence: 632,gamma,O
Sentence: 632,-,O
Sentence: 632,aminobutyric,O
Sentence: 632,acid,O
Sentence: 632,-,O
Sentence: 632,mimetic,O
Sentence: 632,agent,O
Sentence: 632,",",O
Sentence: 632,was,O
Sentence: 632,strikingly,O
Sentence: 632,effective,O
Sentence: 632,.,O
Sentence: 632,This,O
Sentence: 632,is,O
Sentence: 632,the,O
Sentence: 632,first,O
Sentence: 632,reported,O
Sentence: 632,patient,O
Sentence: 632,with,O
Sentence: 632,neuroleptic,B-Disease
Sentence: 632,malignant,I-Disease
Sentence: 632,syndrome,I-Disease
Sentence: 632,probably,O
Sentence: 632,caused,O
Sentence: 632,by,O
Sentence: 632,methylphenidate,B-Chemical
Sentence: 632,.,O
Sentence: 633,Differential,O
Sentence: 633,effects,O
Sentence: 633,of,O
Sentence: 633,17alpha,O
Sentence: 633,-,O
Sentence: 633,ethinylestradiol,O
Sentence: 633,on,O
Sentence: 633,the,O
Sentence: 633,neutral,O
Sentence: 633,and,O
Sentence: 633,acidic,O
Sentence: 633,pathways,O
Sentence: 633,of,O
Sentence: 633,bile,B-Chemical
Sentence: 633,salt,I-Chemical
Sentence: 633,synthesis,O
Sentence: 633,in,O
Sentence: 633,the,O
Sentence: 633,rat,O
Sentence: 633,.,O
Sentence: 634,Effects,O
Sentence: 634,of,O
Sentence: 634,17alpha,O
Sentence: 634,-,O
Sentence: 634,ethinylestradiol,O
Sentence: 634,(,O
Sentence: 634,EE,B-Chemical
Sentence: 634,),O
Sentence: 634,on,O
Sentence: 634,the,O
Sentence: 634,neutral,O
Sentence: 634,and,O
Sentence: 634,acidic,O
Sentence: 634,biosynthetic,O
Sentence: 634,pathways,O
Sentence: 634,of,O
Sentence: 634,bile,B-Chemical
Sentence: 634,salt,I-Chemical
Sentence: 634,(,O
Sentence: 634,BS,B-Chemical
Sentence: 634,),O
Sentence: 634,synthesis,O
Sentence: 634,were,O
Sentence: 634,evaluated,O
Sentence: 634,in,O
Sentence: 634,rats,O
Sentence: 634,with,O
Sentence: 634,an,O
Sentence: 634,intact,O
Sentence: 634,enterohepatic,O
Sentence: 634,circulation,O
Sentence: 634,and,O
Sentence: 634,in,O
Sentence: 634,rats,O
Sentence: 634,with,O
Sentence: 634,long,O
Sentence: 634,-,O
Sentence: 634,term,O
Sentence: 634,bile,O
Sentence: 634,diversion,O
Sentence: 634,to,O
Sentence: 634,induce,O
Sentence: 634,BS,B-Chemical
Sentence: 634,synthesis,O
Sentence: 634,.,O
Sentence: 634,For,O
Sentence: 634,this,O
Sentence: 634,purpose,O
Sentence: 634,",",O
Sentence: 634,bile,B-Chemical
Sentence: 634,salt,I-Chemical
Sentence: 634,pool,O
Sentence: 634,composition,O
Sentence: 634,",",O
Sentence: 634,synthesis,O
Sentence: 634,of,O
Sentence: 634,individual,O
Sentence: 634,BS,B-Chemical
Sentence: 634,in,O
Sentence: 634,vivo,O
Sentence: 634,",",O
Sentence: 634,hepatic,O
Sentence: 634,activities,O
Sentence: 634,",",O
Sentence: 634,and,O
Sentence: 634,expression,O
Sentence: 634,levels,O
Sentence: 634,of,O
Sentence: 634,cholesterol,B-Chemical
Sentence: 634,7alpha,O
Sentence: 634,-,O
Sentence: 634,hydroxylase,O
Sentence: 634,(,O
Sentence: 634,CYP7A,O
Sentence: 634,),O
Sentence: 634,",",O
Sentence: 634,and,O
Sentence: 634,sterol,B-Chemical
Sentence: 634,27,O
Sentence: 634,-,O
Sentence: 634,hydroxylase,O
Sentence: 634,(,O
Sentence: 634,CYP27,O
Sentence: 634,),O
Sentence: 634,",",O
Sentence: 634,as,O
Sentence: 634,well,O
Sentence: 634,as,O
Sentence: 634,of,O
Sentence: 634,other,O
Sentence: 634,enzymes,O
Sentence: 634,involved,O
Sentence: 634,in,O
Sentence: 634,BS,B-Chemical
Sentence: 634,synthesis,O
Sentence: 634,",",O
Sentence: 634,were,O
Sentence: 634,analyzed,O
Sentence: 634,in,O
Sentence: 634,rats,O
Sentence: 634,treated,O
Sentence: 634,with,O
Sentence: 634,EE,B-Chemical
Sentence: 634,(,O
Sentence: 634,5,O
Sentence: 634,mg,O
Sentence: 634,/,O
Sentence: 634,kg,O
Sentence: 634,",",O
Sentence: 634,3,O
Sentence: 634,days,O
Sentence: 634,),O
Sentence: 634,or,O
Sentence: 634,its,O
Sentence: 634,vehicle,O
Sentence: 634,.,O
Sentence: 634,BS,B-Chemical
Sentence: 634,pool,O
Sentence: 634,size,O
Sentence: 634,was,O
Sentence: 634,decreased,O
Sentence: 634,by,O
Sentence: 634,27,O
Sentence: 634,%,O
Sentence: 634,but,O
Sentence: 634,total,O
Sentence: 634,BS,B-Chemical
Sentence: 634,synthesis,O
Sentence: 634,was,O
Sentence: 634,not,O
Sentence: 634,affected,O
Sentence: 634,by,O
Sentence: 634,EE,B-Chemical
Sentence: 634,in,O
Sentence: 634,intact,O
Sentence: 634,rats,O
Sentence: 634,.,O
Sentence: 634,Synthesis,O
Sentence: 634,of,O
Sentence: 634,cholate,B-Chemical
Sentence: 634,was,O
Sentence: 634,reduced,O
Sentence: 634,by,O
Sentence: 634,68,O
Sentence: 634,%,O
Sentence: 634,in,O
Sentence: 634,EE,B-Chemical
Sentence: 634,-,O
Sentence: 634,treated,O
Sentence: 634,rats,O
Sentence: 634,",",O
Sentence: 634,while,O
Sentence: 634,that,O
Sentence: 634,of,O
Sentence: 634,chenodeoxycholate,B-Chemical
Sentence: 634,was,O
Sentence: 634,increased,O
Sentence: 634,by,O
Sentence: 634,60,O
Sentence: 634,%,O
Sentence: 634,.,O
Sentence: 634,The,O
Sentence: 634,recently,O
Sentence: 634,identified,O
Sentence: 634,Delta22,O
Sentence: 634,-,O
Sentence: 634,isomer,O
Sentence: 634,of,O
Sentence: 634,beta,O
Sentence: 634,-,O
Sentence: 634,muricholate,O
Sentence: 634,contributed,O
Sentence: 634,for,O
Sentence: 634,5.4,O
Sentence: 634,%,O
Sentence: 634,and,O
Sentence: 634,18.3,O
Sentence: 634,%,O
Sentence: 634,(,O
Sentence: 634,P,O
Sentence: 634,,O
Sentence: 634,<,O
Sentence: 634,,O
Sentence: 634,0.01,O
Sentence: 634,),O
Sentence: 634,to,O
Sentence: 634,the,O
Sentence: 634,pool,O
Sentence: 634,in,O
Sentence: 634,control,O
Sentence: 634,and,O
Sentence: 634,EE,B-Chemical
Sentence: 634,-,O
Sentence: 634,treated,O
Sentence: 634,rats,O
Sentence: 634,",",O
Sentence: 634,respectively,O
Sentence: 634,",",O
Sentence: 634,but,O
Sentence: 634,could,O
Sentence: 634,not,O
Sentence: 634,be,O
Sentence: 634,detected,O
Sentence: 634,in,O
Sentence: 634,bile,O
Sentence: 634,after,O
Sentence: 634,exhaustion,O
Sentence: 634,of,O
Sentence: 634,the,O
Sentence: 634,pool,O
Sentence: 634,.,O
Sentence: 634,A,O
Sentence: 634,clear,O
Sentence: 634,reduction,O
Sentence: 634,of,O
Sentence: 634,BS,B-Chemical
Sentence: 634,synthesis,O
Sentence: 634,was,O
Sentence: 634,found,O
Sentence: 634,in,O
Sentence: 634,bile,O
Sentence: 634,-,O
Sentence: 634,diverted,O
Sentence: 634,rats,O
Sentence: 634,treated,O
Sentence: 634,with,O
Sentence: 634,EE,B-Chemical
Sentence: 634,",",O
Sentence: 634,yet,O
Sentence: 634,biliary,O
Sentence: 634,BS,B-Chemical
Sentence: 634,composition,O
Sentence: 634,was,O
Sentence: 634,only,O
Sentence: 634,minimally,O
Sentence: 634,affected,O
Sentence: 634,.,O
Sentence: 634,Activity,O
Sentence: 634,of,O
Sentence: 634,CYP7A,O
Sentence: 634,was,O
Sentence: 634,decreased,O
Sentence: 634,by,O
Sentence: 634,EE,B-Chemical
Sentence: 634,in,O
Sentence: 634,both,O
Sentence: 634,intact,O
Sentence: 634,and,O
Sentence: 634,bile,O
Sentence: 634,-,O
Sentence: 634,diverted,O
Sentence: 634,rats,O
Sentence: 634,",",O
Sentence: 634,whereas,O
Sentence: 634,the,O
Sentence: 634,activity,O
Sentence: 634,of,O
Sentence: 634,the,O
Sentence: 634,CYP27,O
Sentence: 634,was,O
Sentence: 634,not,O
Sentence: 634,affected,O
Sentence: 634,.,O
Sentence: 634,Hepatic,O
Sentence: 634,mRNA,O
Sentence: 634,levels,O
Sentence: 634,of,O
Sentence: 634,CYP7A,O
Sentence: 634,were,O
Sentence: 634,significantly,O
Sentence: 634,reduced,O
Sentence: 634,by,O
Sentence: 634,EE,B-Chemical
Sentence: 634,in,O
Sentence: 634,bile,O
Sentence: 634,-,O
Sentence: 634,diverted,O
Sentence: 634,rats,O
Sentence: 634,only,O
Sentence: 634,;,O
Sentence: 634,CYP27,O
Sentence: 634,mRNA,O
Sentence: 634,levels,O
Sentence: 634,were,O
Sentence: 634,not,O
Sentence: 634,affected,O
Sentence: 634,by,O
Sentence: 634,EE,B-Chemical
Sentence: 634,.,O
Sentence: 634,In,O
Sentence: 634,addition,O
Sentence: 634,",",O
Sentence: 634,mRNA,O
Sentence: 634,levels,O
Sentence: 634,of,O
Sentence: 634,sterol,B-Chemical
Sentence: 634,12alpha,O
Sentence: 634,-,O
Sentence: 634,hydroxylase,O
Sentence: 634,and,O
Sentence: 634,lithocholate,O
Sentence: 634,6beta,O
Sentence: 634,-,O
Sentence: 634,hydroxylase,O
Sentence: 634,were,O
Sentence: 634,increased,O
Sentence: 634,by,O
Sentence: 634,bile,O
Sentence: 634,diversion,O
Sentence: 634,and,O
Sentence: 634,suppressed,O
Sentence: 634,by,O
Sentence: 634,EE,B-Chemical
Sentence: 634,.,O
Sentence: 634,This,O
Sentence: 634,study,O
Sentence: 634,shows,O
Sentence: 634,that,O
Sentence: 634,17alpha,O
Sentence: 634,-,O
Sentence: 634,ethinylestradiol,O
Sentence: 634,(,O
Sentence: 634,EE,B-Chemical
Sentence: 634,),O
Sentence: 634,,O
Sentence: 634,-,O
Sentence: 634,induced,O
Sentence: 634,intrahepatic,B-Disease
Sentence: 634,cholestasis,I-Disease
Sentence: 634,in,O
Sentence: 634,rats,O
Sentence: 634,is,O
Sentence: 634,associated,O
Sentence: 634,with,O
Sentence: 634,selective,O
Sentence: 634,inhibition,O
Sentence: 634,of,O
Sentence: 634,the,O
Sentence: 634,neutral,O
Sentence: 634,pathway,O
Sentence: 634,of,O
Sentence: 634,bile,B-Chemical
Sentence: 634,salt,I-Chemical
Sentence: 634,(,O
Sentence: 634,BS,B-Chemical
Sentence: 634,),O
Sentence: 634,synthesis,O
Sentence: 634,.,O
Sentence: 634,Simultaneous,O
Sentence: 634,impairment,O
Sentence: 634,of,O
Sentence: 634,other,O
Sentence: 634,enzymes,O
Sentence: 634,in,O
Sentence: 634,the,O
Sentence: 634,BS,B-Chemical
Sentence: 634,biosynthetic,O
Sentence: 634,pathways,O
Sentence: 634,may,O
Sentence: 634,contribute,O
Sentence: 634,to,O
Sentence: 634,overall,O
Sentence: 634,effects,O
Sentence: 634,of,O
Sentence: 634,EE,B-Chemical
Sentence: 634,on,O
Sentence: 634,BS,B-Chemical
Sentence: 634,synthesis,O
Sentence: 634,.,O
Sentence: 635,Glibenclamide,B-Chemical
Sentence: 635,-,O
Sentence: 635,sensitive,O
Sentence: 635,hypotension,B-Disease
Sentence: 635,produced,O
Sentence: 635,by,O
Sentence: 635,helodermin,B-Chemical
Sentence: 635,assessed,O
Sentence: 635,in,O
Sentence: 635,the,O
Sentence: 635,rat,O
Sentence: 635,.,O
Sentence: 636,The,O
Sentence: 636,effects,O
Sentence: 636,of,O
Sentence: 636,helodermin,B-Chemical
Sentence: 636,",",O
Sentence: 636,a,O
Sentence: 636,basic,O
Sentence: 636,35,O
Sentence: 636,-,O
Sentence: 636,amino,B-Chemical
Sentence: 636,acid,I-Chemical
Sentence: 636,peptide,O
Sentence: 636,isolated,O
Sentence: 636,from,O
Sentence: 636,the,O
Sentence: 636,venom,O
Sentence: 636,of,O
Sentence: 636,a,O
Sentence: 636,lizard,O
Sentence: 636,salivary,O
Sentence: 636,gland,O
Sentence: 636,",",O
Sentence: 636,on,O
Sentence: 636,arterial,O
Sentence: 636,blood,O
Sentence: 636,pressure,O
Sentence: 636,and,O
Sentence: 636,heart,O
Sentence: 636,rate,O
Sentence: 636,were,O
Sentence: 636,examined,O
Sentence: 636,in,O
Sentence: 636,the,O
Sentence: 636,rat,O
Sentence: 636,",",O
Sentence: 636,focusing,O
Sentence: 636,on,O
Sentence: 636,the,O
Sentence: 636,possibility,O
Sentence: 636,that,O
Sentence: 636,activation,O
Sentence: 636,of,O
Sentence: 636,ATP,B-Chemical
Sentence: 636,sensitive,O
Sentence: 636,K+,O
Sentence: 636,(,O
Sentence: 636,K,B-Chemical
Sentence: 636,(,O
Sentence: 636,ATP,B-Chemical
Sentence: 636,),O
Sentence: 636,),O
Sentence: 636,channels,O
Sentence: 636,is,O
Sentence: 636,involved,O
Sentence: 636,in,O
Sentence: 636,the,O
Sentence: 636,responses,O
Sentence: 636,.,O
Sentence: 636,The,O
Sentence: 636,results,O
Sentence: 636,were,O
Sentence: 636,also,O
Sentence: 636,compared,O
Sentence: 636,with,O
Sentence: 636,those,O
Sentence: 636,of,O
Sentence: 636,vasoactive,O
Sentence: 636,intestinal,O
Sentence: 636,polypeptide,O
Sentence: 636,(,O
Sentence: 636,VIP,O
Sentence: 636,),O
Sentence: 636,.,O
Sentence: 636,Helodermin,B-Chemical
Sentence: 636,produced,O
Sentence: 636,hypotension,B-Disease
Sentence: 636,in,O
Sentence: 636,a,O
Sentence: 636,dose,O
Sentence: 636,-,O
Sentence: 636,dependent,O
Sentence: 636,manner,O
Sentence: 636,with,O
Sentence: 636,approximately,O
Sentence: 636,similar,O
Sentence: 636,potency,O
Sentence: 636,and,O
Sentence: 636,duration,O
Sentence: 636,to,O
Sentence: 636,VIP,O
Sentence: 636,.,O
Sentence: 636,Hypotension,B-Disease
Sentence: 636,induced,O
Sentence: 636,by,O
Sentence: 636,both,O
Sentence: 636,peptides,O
Sentence: 636,was,O
Sentence: 636,significantly,O
Sentence: 636,attenuated,O
Sentence: 636,by,O
Sentence: 636,glibenclamide,B-Chemical
Sentence: 636,",",O
Sentence: 636,which,O
Sentence: 636,abolished,O
Sentence: 636,a,O
Sentence: 636,levcromakalim,B-Chemical
Sentence: 636,-,O
Sentence: 636,produced,O
Sentence: 636,decrease,O
Sentence: 636,in,O
Sentence: 636,arterial,O
Sentence: 636,blood,O
Sentence: 636,pressure,O
Sentence: 636,.,O
Sentence: 636,Oxyhemoglobin,O
Sentence: 636,did,O
Sentence: 636,not,O
Sentence: 636,affect,O
Sentence: 636,helodermin,B-Chemical
Sentence: 636,-,O
Sentence: 636,induced,O
Sentence: 636,hypotension,B-Disease
Sentence: 636,",",O
Sentence: 636,whereas,O
Sentence: 636,it,O
Sentence: 636,shortened,O
Sentence: 636,the,O
Sentence: 636,duration,O
Sentence: 636,of,O
Sentence: 636,acetylcholine,B-Chemical
Sentence: 636,(,O
Sentence: 636,ACh,B-Chemical
Sentence: 636,),O
Sentence: 636,,O
Sentence: 636,-,O
Sentence: 636,produced,O
Sentence: 636,hypotension,B-Disease
Sentence: 636,.,O
Sentence: 636,These,O
Sentence: 636,findings,O
Sentence: 636,suggest,O
Sentence: 636,that,O
Sentence: 636,helodermin,B-Chemical
Sentence: 636,-,O
Sentence: 636,produced,O
Sentence: 636,hypotension,B-Disease
Sentence: 636,is,O
Sentence: 636,partly,O
Sentence: 636,attributable,O
Sentence: 636,to,O
Sentence: 636,the,O
Sentence: 636,activation,O
Sentence: 636,of,O
Sentence: 636,glibenclamide,B-Chemical
Sentence: 636,-,O
Sentence: 636,sensitive,O
Sentence: 636,K+,O
Sentence: 636,channels,O
Sentence: 636,(,O
Sentence: 636,K,B-Chemical
Sentence: 636,(,O
Sentence: 636,ATP,B-Chemical
Sentence: 636,),O
Sentence: 636,channels,O
Sentence: 636,),O
Sentence: 636,",",O
Sentence: 636,which,O
Sentence: 636,presumably,O
Sentence: 636,exist,O
Sentence: 636,on,O
Sentence: 636,arterial,O
Sentence: 636,smooth,O
Sentence: 636,muscle,O
Sentence: 636,cells,O
Sentence: 636,.,O
Sentence: 636,EDRF,O
Sentence: 636,(,O
Sentence: 636,endothelium,O
Sentence: 636,-,O
Sentence: 636,derived,O
Sentence: 636,relaxing,O
Sentence: 636,factor,O
Sentence: 636,),O
Sentence: 636,,O
Sentence: 636,/,O
Sentence: 636,nitric,B-Chemical
Sentence: 636,oxide,I-Chemical
Sentence: 636,does,O
Sentence: 636,not,O
Sentence: 636,seem,O
Sentence: 636,to,O
Sentence: 636,play,O
Sentence: 636,an,O
Sentence: 636,important,O
Sentence: 636,role,O
Sentence: 636,in,O
Sentence: 636,the,O
Sentence: 636,peptide,O
Sentence: 636,-,O
Sentence: 636,produced,O
Sentence: 636,hypotension,B-Disease
Sentence: 636,.,O
Sentence: 637,Long,O
Sentence: 637,-,O
Sentence: 637,term,O
Sentence: 637,efficacy,O
Sentence: 637,and,O
Sentence: 637,adverse,O
Sentence: 637,event,O
Sentence: 637,of,O
Sentence: 637,nifedipine,B-Chemical
Sentence: 637,sustained,O
Sentence: 637,-,O
Sentence: 637,release,O
Sentence: 637,tablets,O
Sentence: 637,for,O
Sentence: 637,cyclosporin,B-Chemical
Sentence: 637,A,I-Chemical
Sentence: 637,-,O
Sentence: 637,induced,O
Sentence: 637,hypertension,B-Disease
Sentence: 637,in,O
Sentence: 637,patients,O
Sentence: 637,with,O
Sentence: 637,psoriasis,B-Disease
Sentence: 637,.,O
Sentence: 638,Thirteen,O
Sentence: 638,psoriatic,B-Disease
Sentence: 638,patients,O
Sentence: 638,with,O
Sentence: 638,hypertension,B-Disease
Sentence: 638,during,O
Sentence: 638,the,O
Sentence: 638,course,O
Sentence: 638,of,O
Sentence: 638,cyclosporin,B-Chemical
Sentence: 638,A,I-Chemical
Sentence: 638,therapy,O
Sentence: 638,were,O
Sentence: 638,treated,O
Sentence: 638,for,O
Sentence: 638,25,O
Sentence: 638,months,O
Sentence: 638,with,O
Sentence: 638,a,O
Sentence: 638,calcium,B-Chemical
Sentence: 638,channel,O
Sentence: 638,blocker,O
Sentence: 638,",",O
Sentence: 638,sustained,O
Sentence: 638,-,O
Sentence: 638,release,O
Sentence: 638,nifedipine,B-Chemical
Sentence: 638,",",O
Sentence: 638,to,O
Sentence: 638,study,O
Sentence: 638,the,O
Sentence: 638,clinical,O
Sentence: 638,antihypertensive,O
Sentence: 638,effects,O
Sentence: 638,and,O
Sentence: 638,adverse,O
Sentence: 638,events,O
Sentence: 638,during,O
Sentence: 638,treatment,O
Sentence: 638,with,O
Sentence: 638,both,O
Sentence: 638,drugs,O
Sentence: 638,.,O
Sentence: 638,Seven,O
Sentence: 638,of,O
Sentence: 638,the,O
Sentence: 638,13,O
Sentence: 638,patients,O
Sentence: 638,had,O
Sentence: 638,exhibited,O
Sentence: 638,a,O
Sentence: 638,subclinical,O
Sentence: 638,hypertensive,B-Disease
Sentence: 638,state,O
Sentence: 638,before,O
Sentence: 638,cyclosporin,B-Chemical
Sentence: 638,A,I-Chemical
Sentence: 638,therapy,O
Sentence: 638,.,O
Sentence: 638,Both,O
Sentence: 638,systolic,O
Sentence: 638,and,O
Sentence: 638,diastolic,O
Sentence: 638,blood,O
Sentence: 638,pressures,O
Sentence: 638,of,O
Sentence: 638,these,O
Sentence: 638,13,O
Sentence: 638,patients,O
Sentence: 638,were,O
Sentence: 638,decreased,O
Sentence: 638,significantly,O
Sentence: 638,after,O
Sentence: 638,4,O
Sentence: 638,weeks,O
Sentence: 638,of,O
Sentence: 638,nifedipine,B-Chemical
Sentence: 638,therapy,O
Sentence: 638,",",O
Sentence: 638,and,O
Sentence: 638,blood,O
Sentence: 638,pressure,O
Sentence: 638,was,O
Sentence: 638,maintained,O
Sentence: 638,within,O
Sentence: 638,the,O
Sentence: 638,normal,O
Sentence: 638,range,O
Sentence: 638,thereafter,O
Sentence: 638,for,O
Sentence: 638,25,O
Sentence: 638,months,O
Sentence: 638,.,O
Sentence: 638,The,O
Sentence: 638,adverse,O
Sentence: 638,events,O
Sentence: 638,during,O
Sentence: 638,combined,O
Sentence: 638,therapy,O
Sentence: 638,with,O
Sentence: 638,cyclosporin,B-Chemical
Sentence: 638,A,I-Chemical
Sentence: 638,and,O
Sentence: 638,nifedipine,B-Chemical
Sentence: 638,included,O
Sentence: 638,an,O
Sentence: 638,increase,O
Sentence: 638,in,O
Sentence: 638,blood,B-Chemical
Sentence: 638,urea,I-Chemical
Sentence: 638,nitrogen,I-Chemical
Sentence: 638,levels,O
Sentence: 638,in,O
Sentence: 638,9,O
Sentence: 638,of,O
Sentence: 638,the,O
Sentence: 638,13,O
Sentence: 638,patients,O
Sentence: 638,and,O
Sentence: 638,development,O
Sentence: 638,of,O
Sentence: 638,gingival,B-Disease
Sentence: 638,hyperplasia,I-Disease
Sentence: 638,in,O
Sentence: 638,2,O
Sentence: 638,of,O
Sentence: 638,the,O
Sentence: 638,13,O
Sentence: 638,patients,O
Sentence: 638,.,O
Sentence: 638,Our,O
Sentence: 638,findings,O
Sentence: 638,indicate,O
Sentence: 638,that,O
Sentence: 638,sustained,O
Sentence: 638,-,O
Sentence: 638,release,O
Sentence: 638,nifedipine,B-Chemical
Sentence: 638,is,O
Sentence: 638,useful,O
Sentence: 638,for,O
Sentence: 638,hypertensive,B-Disease
Sentence: 638,psoriatic,B-Disease
Sentence: 638,patients,O
Sentence: 638,under,O
Sentence: 638,long,O
Sentence: 638,-,O
Sentence: 638,term,O
Sentence: 638,treatment,O
Sentence: 638,with,O
Sentence: 638,cyclosporin,B-Chemical
Sentence: 638,A,I-Chemical
Sentence: 638,",",O
Sentence: 638,but,O
Sentence: 638,that,O
Sentence: 638,these,O
Sentence: 638,patients,O
Sentence: 638,should,O
Sentence: 638,be,O
Sentence: 638,monitored,O
Sentence: 638,for,O
Sentence: 638,gingival,B-Disease
Sentence: 638,hyperplasia,I-Disease
Sentence: 638,.,O
Sentence: 639,Torsade,B-Disease
Sentence: 639,de,I-Disease
Sentence: 639,pointes,I-Disease
Sentence: 639,ventricular,B-Disease
Sentence: 639,tachycardia,I-Disease
Sentence: 639,during,O
Sentence: 639,low,O
Sentence: 639,dose,O
Sentence: 639,intermittent,O
Sentence: 639,dobutamine,B-Chemical
Sentence: 639,treatment,O
Sentence: 639,in,O
Sentence: 639,a,O
Sentence: 639,patient,O
Sentence: 639,with,O
Sentence: 639,dilated,B-Disease
Sentence: 639,cardiomyopathy,I-Disease
Sentence: 639,and,O
Sentence: 639,congestive,B-Disease
Sentence: 639,heart,I-Disease
Sentence: 639,failure,I-Disease
Sentence: 639,.,O
Sentence: 640,The,O
Sentence: 640,authors,O
Sentence: 640,describe,O
Sentence: 640,the,O
Sentence: 640,case,O
Sentence: 640,of,O
Sentence: 640,a,O
Sentence: 640,56,O
Sentence: 640,-,O
Sentence: 640,year,O
Sentence: 640,-,O
Sentence: 640,old,O
Sentence: 640,woman,O
Sentence: 640,with,O
Sentence: 640,chronic,O
Sentence: 640,",",O
Sentence: 640,severe,O
Sentence: 640,heart,B-Disease
Sentence: 640,failure,I-Disease
Sentence: 640,secondary,O
Sentence: 640,to,O
Sentence: 640,dilated,B-Disease
Sentence: 640,cardiomyopathy,I-Disease
Sentence: 640,and,O
Sentence: 640,absence,O
Sentence: 640,of,O
Sentence: 640,significant,O
Sentence: 640,ventricular,B-Disease
Sentence: 640,arrhythmias,B-Disease
Sentence: 640,who,O
Sentence: 640,developed,O
Sentence: 640,QT,B-Disease
Sentence: 640,prolongation,I-Disease
Sentence: 640,and,O
Sentence: 640,torsade,B-Disease
Sentence: 640,de,I-Disease
Sentence: 640,pointes,I-Disease
Sentence: 640,ventricular,B-Disease
Sentence: 640,tachycardia,I-Disease
Sentence: 640,during,O
Sentence: 640,one,O
Sentence: 640,cycle,O
Sentence: 640,of,O
Sentence: 640,intermittent,O
Sentence: 640,low,O
Sentence: 640,dose,O
Sentence: 640,(,O
Sentence: 640,2.5,O
Sentence: 640,mcg,O
Sentence: 640,/,O
Sentence: 640,kg,O
Sentence: 640,per,O
Sentence: 640,min,O
Sentence: 640,),O
Sentence: 640,dobutamine,B-Chemical
Sentence: 640,.,O
Sentence: 640,This,O
Sentence: 640,report,O
Sentence: 640,of,O
Sentence: 640,torsade,B-Disease
Sentence: 640,de,I-Disease
Sentence: 640,pointes,I-Disease
Sentence: 640,ventricular,B-Disease
Sentence: 640,tachycardia,I-Disease
Sentence: 640,during,O
Sentence: 640,intermittent,O
Sentence: 640,dobutamine,B-Chemical
Sentence: 640,supports,O
Sentence: 640,the,O
Sentence: 640,hypothesis,O
Sentence: 640,that,O
Sentence: 640,unpredictable,O
Sentence: 640,fatal,O
Sentence: 640,arrhythmias,B-Disease
Sentence: 640,may,O
Sentence: 640,occur,O
Sentence: 640,even,O
Sentence: 640,with,O
Sentence: 640,low,O
Sentence: 640,doses,O
Sentence: 640,and,O
Sentence: 640,in,O
Sentence: 640,patients,O
Sentence: 640,with,O
Sentence: 640,no,O
Sentence: 640,history,O
Sentence: 640,of,O
Sentence: 640,significant,O
Sentence: 640,rhythm,O
Sentence: 640,disturbances,O
Sentence: 640,.,O
Sentence: 640,The,O
Sentence: 640,mechanisms,O
Sentence: 640,of,O
Sentence: 640,proarrhythmic,O
Sentence: 640,effects,O
Sentence: 640,of,O
Sentence: 640,Dubutamine,B-Chemical
Sentence: 640,are,O
Sentence: 640,discussed,O
Sentence: 640,.,O
Sentence: 641,Positive,O
Sentence: 641,skin,O
Sentence: 641,tests,O
Sentence: 641,in,O
Sentence: 641,late,O
Sentence: 641,reactions,O
Sentence: 641,to,O
Sentence: 641,radiographic,O
Sentence: 641,contrast,O
Sentence: 641,media,O
Sentence: 641,.,O
Sentence: 642,In,O
Sentence: 642,the,O
Sentence: 642,last,O
Sentence: 642,few,O
Sentence: 642,years,O
Sentence: 642,delayed,O
Sentence: 642,reactions,O
Sentence: 642,several,O
Sentence: 642,hours,O
Sentence: 642,after,O
Sentence: 642,the,O
Sentence: 642,injection,O
Sentence: 642,of,O
Sentence: 642,radiographic,O
Sentence: 642,and,O
Sentence: 642,contrast,B-Chemical
Sentence: 642,materials,I-Chemical
Sentence: 642,(,O
Sentence: 642,PRC,B-Chemical
Sentence: 642,),O
Sentence: 642,have,O
Sentence: 642,been,O
Sentence: 642,described,O
Sentence: 642,with,O
Sentence: 642,increasing,O
Sentence: 642,frequency,O
Sentence: 642,.,O
Sentence: 642,The,O
Sentence: 642,authors,O
Sentence: 642,report,O
Sentence: 642,two,O
Sentence: 642,observations,O
Sentence: 642,on,O
Sentence: 642,patients,O
Sentence: 642,with,O
Sentence: 642,delayed,O
Sentence: 642,reactions,O
Sentence: 642,in,O
Sentence: 642,whom,O
Sentence: 642,intradermoreactions,O
Sentence: 642,(,O
Sentence: 642,IDR,O
Sentence: 642,),O
Sentence: 642,and,O
Sentence: 642,patch,O
Sentence: 642,tests,O
Sentence: 642,to,O
Sentence: 642,a,O
Sentence: 642,series,O
Sentence: 642,of,O
Sentence: 642,ionic,O
Sentence: 642,and,O
Sentence: 642,non,O
Sentence: 642,ionic,O
Sentence: 642,PRC,B-Chemical
Sentence: 642,were,O
Sentence: 642,studied,O
Sentence: 642,.,O
Sentence: 642,After,O
Sentence: 642,angiography,O
Sentence: 642,by,O
Sentence: 642,the,O
Sentence: 642,venous,O
Sentence: 642,route,O
Sentence: 642,in,O
Sentence: 642,patient,O
Sentence: 642,n,O
Sentence: 642,degree,O
Sentence: 642,1,O
Sentence: 642,a,O
Sentence: 642,biphasic,O
Sentence: 642,reaction,O
Sentence: 642,with,O
Sentence: 642,an,O
Sentence: 642,immediate,O
Sentence: 642,reaction,O
Sentence: 642,(,O
Sentence: 642,dyspnea,B-Disease
Sentence: 642,",",O
Sentence: 642,loss,B-Disease
Sentence: 642,of,I-Disease
Sentence: 642,consciousness,I-Disease
Sentence: 642,),O
Sentence: 642,and,O
Sentence: 642,delayed,O
Sentence: 642,macro,O
Sentence: 642,-,O
Sentence: 642,papular,O
Sentence: 642,rash,O
Sentence: 642,appeared,O
Sentence: 642,",",O
Sentence: 642,whilst,O
Sentence: 642,patient,O
Sentence: 642,n,O
Sentence: 642,degree,O
Sentence: 642,2,O
Sentence: 642,developed,O
Sentence: 642,a,O
Sentence: 642,generalised,O
Sentence: 642,sensation,O
Sentence: 642,of,O
Sentence: 642,heat,O
Sentence: 642,",",O
Sentence: 642,persistent,O
Sentence: 642,pain,B-Disease
Sentence: 642,at,O
Sentence: 642,the,O
Sentence: 642,site,O
Sentence: 642,of,O
Sentence: 642,injection,O
Sentence: 642,immediately,O
Sentence: 642,and,O
Sentence: 642,a,O
Sentence: 642,generalised,O
Sentence: 642,macro,O
Sentence: 642,-,O
Sentence: 642,papular,O
Sentence: 642,reaction,O
Sentence: 642,after,O
Sentence: 642,24,O
Sentence: 642,hours,O
Sentence: 642,.,O
Sentence: 642,The,O
Sentence: 642,skin,O
Sentence: 642,tests,O
Sentence: 642,revealed,O
Sentence: 642,positive,O
Sentence: 642,delayed,O
Sentence: 642,reactions,O
Sentence: 642,of,O
Sentence: 642,24,O
Sentence: 642,hours,O
Sentence: 642,and,O
Sentence: 642,48,O
Sentence: 642,hours,O
Sentence: 642,by,O
Sentence: 642,IDR,O
Sentence: 642,and,O
Sentence: 642,patch,O
Sentence: 642,tests,O
Sentence: 642,to,O
Sentence: 642,only,O
Sentence: 642,some,O
Sentence: 642,PRC,B-Chemical
Sentence: 642,with,O
Sentence: 642,common,O
Sentence: 642,chains,O
Sentence: 642,in,O
Sentence: 642,their,O
Sentence: 642,structures,O
Sentence: 642,.,O
Sentence: 642,The,O
Sentence: 642,positive,O
Sentence: 642,skin,O
Sentence: 642,tests,O
Sentence: 642,are,O
Sentence: 642,in,O
Sentence: 642,favour,O
Sentence: 642,of,O
Sentence: 642,immunological,O
Sentence: 642,reactions,O
Sentence: 642,and,O
Sentence: 642,may,O
Sentence: 642,help,O
Sentence: 642,in,O
Sentence: 642,diagnosis,O
Sentence: 642,of,O
Sentence: 642,allergy,B-Disease
Sentence: 642,in,O
Sentence: 642,the,O
Sentence: 642,patients,O
Sentence: 642,.,O
Sentence: 643,Risk,O
Sentence: 643,of,O
Sentence: 643,transient,O
Sentence: 643,hyperammonemic,B-Disease
Sentence: 643,encephalopathy,B-Disease
Sentence: 643,in,O
Sentence: 643,cancer,B-Disease
Sentence: 643,patients,O
Sentence: 643,who,O
Sentence: 643,received,O
Sentence: 643,continuous,O
Sentence: 643,infusion,O
Sentence: 643,of,O
Sentence: 643,5,O
Sentence: 643,-,O
Sentence: 643,fluorouracil,O
Sentence: 643,with,O
Sentence: 643,the,O
Sentence: 643,complication,O
Sentence: 643,of,O
Sentence: 643,dehydration,B-Disease
Sentence: 643,and,O
Sentence: 643,infection,B-Disease
Sentence: 643,.,O
Sentence: 644,From,O
Sentence: 644,1986,O
Sentence: 644,to,O
Sentence: 644,1998,O
Sentence: 644,",",O
Sentence: 644,29,O
Sentence: 644,cancer,B-Disease
Sentence: 644,patients,O
Sentence: 644,who,O
Sentence: 644,had,O
Sentence: 644,32,O
Sentence: 644,episodes,O
Sentence: 644,of,O
Sentence: 644,transient,O
Sentence: 644,hyperammonemic,B-Disease
Sentence: 644,encephalopathy,B-Disease
Sentence: 644,related,O
Sentence: 644,to,O
Sentence: 644,continuous,O
Sentence: 644,infusion,O
Sentence: 644,of,O
Sentence: 644,5,O
Sentence: 644,-,O
Sentence: 644,fluorouracil,O
Sentence: 644,(,O
Sentence: 644,5,O
Sentence: 644,-,O
Sentence: 644,FU,O
Sentence: 644,),O
Sentence: 644,were,O
Sentence: 644,identified,O
Sentence: 644,.,O
Sentence: 644,None,O
Sentence: 644,of,O
Sentence: 644,the,O
Sentence: 644,patients,O
Sentence: 644,had,O
Sentence: 644,decompensated,O
Sentence: 644,liver,B-Disease
Sentence: 644,disease,I-Disease
Sentence: 644,.,O
Sentence: 644,Onset,O
Sentence: 644,of,O
Sentence: 644,hyperammonemic,B-Disease
Sentence: 644,encephalopathy,B-Disease
Sentence: 644,varied,O
Sentence: 644,from,O
Sentence: 644,0.5,O
Sentence: 644,to,O
Sentence: 644,5,O
Sentence: 644,days,O
Sentence: 644,(,O
Sentence: 644,mean,O
Sentence: 644,:,O
Sentence: 644,2.6,O
Sentence: 644,+,O
Sentence: 644,/,O
Sentence: 644,,O
Sentence: 644,-,O
Sentence: 644,,O
Sentence: 644,1.3,O
Sentence: 644,days,O
Sentence: 644,),O
Sentence: 644,after,O
Sentence: 644,the,O
Sentence: 644,initiation,O
Sentence: 644,of,O
Sentence: 644,chemotherapy,O
Sentence: 644,.,O
Sentence: 644,Plasma,O
Sentence: 644,ammonium,B-Chemical
Sentence: 644,level,O
Sentence: 644,ranged,O
Sentence: 644,from,O
Sentence: 644,248,O
Sentence: 644,to,O
Sentence: 644,2387,O
Sentence: 644,microg,O
Sentence: 644,%,O
Sentence: 644,(,O
Sentence: 644,mean,O
Sentence: 644,:,O
Sentence: 644,626,O
Sentence: 644,+,O
Sentence: 644,/,O
Sentence: 644,,O
Sentence: 644,-,O
Sentence: 644,,O
Sentence: 644,431,O
Sentence: 644,microg,O
Sentence: 644,%,O
Sentence: 644,),O
Sentence: 644,.,O
Sentence: 644,Among,O
Sentence: 644,the,O
Sentence: 644,32,O
Sentence: 644,episodes,O
Sentence: 644,",",O
Sentence: 644,26,O
Sentence: 644,(,O
Sentence: 644,81,O
Sentence: 644,%,O
Sentence: 644,),O
Sentence: 644,had,O
Sentence: 644,various,O
Sentence: 644,degrees,O
Sentence: 644,of,O
Sentence: 644,azotemia,B-Disease
Sentence: 644,",",O
Sentence: 644,18,O
Sentence: 644,(,O
Sentence: 644,56,O
Sentence: 644,%,O
Sentence: 644,),O
Sentence: 644,occurred,O
Sentence: 644,during,O
Sentence: 644,bacterial,B-Disease
Sentence: 644,infections,I-Disease
Sentence: 644,and,O
Sentence: 644,14,O
Sentence: 644,(,O
Sentence: 644,44,O
Sentence: 644,%,O
Sentence: 644,),O
Sentence: 644,without,O
Sentence: 644,infection,B-Disease
Sentence: 644,occurred,O
Sentence: 644,during,O
Sentence: 644,periods,O
Sentence: 644,of,O
Sentence: 644,dehydration,B-Disease
Sentence: 644,.,O
Sentence: 644,Higher,O
Sentence: 644,plasma,O
Sentence: 644,ammonium,B-Chemical
Sentence: 644,levels,O
Sentence: 644,and,O
Sentence: 644,more,O
Sentence: 644,rapid,O
Sentence: 644,onset,O
Sentence: 644,of,O
Sentence: 644,hyperammonemia,B-Disease
Sentence: 644,were,O
Sentence: 644,seen,O
Sentence: 644,in,O
Sentence: 644,18,O
Sentence: 644,patients,O
Sentence: 644,with,O
Sentence: 644,bacterial,B-Disease
Sentence: 644,infections,I-Disease
Sentence: 644,(,O
Sentence: 644,p,O
Sentence: 644,=,O
Sentence: 644,0.003,O
Sentence: 644,and,O
Sentence: 644,0.0006,O
Sentence: 644,",",O
Sentence: 644,respectively,O
Sentence: 644,),O
Sentence: 644,and,O
Sentence: 644,in,O
Sentence: 644,nine,O
Sentence: 644,patients,O
Sentence: 644,receiving,O
Sentence: 644,high,O
Sentence: 644,daily,O
Sentence: 644,doses,O
Sentence: 644,(,O
Sentence: 644,2600,O
Sentence: 644,or,O
Sentence: 644,1800,O
Sentence: 644,mg,O
Sentence: 644,/,O
Sentence: 644,m2,O
Sentence: 644,),O
Sentence: 644,of,O
Sentence: 644,5,O
Sentence: 644,-,O
Sentence: 644,FU,O
Sentence: 644,(,O
Sentence: 644,p,O
Sentence: 644,=,O
Sentence: 644,0.0001,O
Sentence: 644,and,O
Sentence: 644,,O
Sentence: 644,<,O
Sentence: 644,,O
Sentence: 644,0.0001,O
Sentence: 644,",",O
Sentence: 644,respectively,O
Sentence: 644,),O
Sentence: 644,.,O
Sentence: 644,In,O
Sentence: 644,25,O
Sentence: 644,out,O
Sentence: 644,of,O
Sentence: 644,32,O
Sentence: 644,episodes,O
Sentence: 644,(,O
Sentence: 644,78,O
Sentence: 644,%,O
Sentence: 644,),O
Sentence: 644,",",O
Sentence: 644,plasma,O
Sentence: 644,ammonium,B-Chemical
Sentence: 644,levels,O
Sentence: 644,and,O
Sentence: 644,mental,O
Sentence: 644,status,O
Sentence: 644,returned,O
Sentence: 644,to,O
Sentence: 644,normal,O
Sentence: 644,within,O
Sentence: 644,2,O
Sentence: 644,days,O
Sentence: 644,after,O
Sentence: 644,adequate,O
Sentence: 644,management,O
Sentence: 644,.,O
Sentence: 644,In,O
Sentence: 644,conclusion,O
Sentence: 644,",",O
Sentence: 644,hyperammonemic,B-Disease
Sentence: 644,encephalopathy,B-Disease
Sentence: 644,can,O
Sentence: 644,occur,O
Sentence: 644,in,O
Sentence: 644,patients,O
Sentence: 644,receiving,O
Sentence: 644,continuous,O
Sentence: 644,infusion,O
Sentence: 644,of,O
Sentence: 644,5,O
Sentence: 644,-,O
Sentence: 644,FU,O
Sentence: 644,.,O
Sentence: 644,Azotemia,B-Disease
Sentence: 644,",",O
Sentence: 644,body,O
Sentence: 644,fluid,O
Sentence: 644,insufficiency,O
Sentence: 644,and,O
Sentence: 644,bacterial,B-Disease
Sentence: 644,infections,I-Disease
Sentence: 644,were,O
Sentence: 644,frequently,O
Sentence: 644,found,O
Sentence: 644,in,O
Sentence: 644,these,O
Sentence: 644,patients,O
Sentence: 644,.,O
Sentence: 644,It,O
Sentence: 644,is,O
Sentence: 644,therefore,O
Sentence: 644,important,O
Sentence: 644,to,O
Sentence: 644,recognize,O
Sentence: 644,this,O
Sentence: 644,condition,O
Sentence: 644,in,O
Sentence: 644,patients,O
Sentence: 644,receiving,O
Sentence: 644,continuous,O
Sentence: 644,infusion,O
Sentence: 644,of,O
Sentence: 644,5,O
Sentence: 644,-,O
Sentence: 644,FU,O
Sentence: 644,.,O
Sentence: 645,The,O
Sentence: 645,effects,O
Sentence: 645,of,O
Sentence: 645,quinine,B-Chemical
Sentence: 645,and,O
Sentence: 645,4,O
Sentence: 645,-,O
Sentence: 645,aminopyridine,O
Sentence: 645,on,O
Sentence: 645,conditioned,O
Sentence: 645,place,O
Sentence: 645,preference,O
Sentence: 645,and,O
Sentence: 645,changes,O
Sentence: 645,in,O
Sentence: 645,motor,O
Sentence: 645,activity,O
Sentence: 645,induced,O
Sentence: 645,by,O
Sentence: 645,morphine,B-Chemical
Sentence: 645,in,O
Sentence: 645,rats,O
Sentence: 645,.,O
Sentence: 646,1,O
Sentence: 646,.,O
Sentence: 646,The,O
Sentence: 646,effects,O
Sentence: 646,of,O
Sentence: 646,two,O
Sentence: 646,unselective,O
Sentence: 646,potassium,B-Chemical
Sentence: 646,(,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,,O
Sentence: 646,),O
Sentence: 646,channel,O
Sentence: 646,blockers,O
Sentence: 646,",",O
Sentence: 646,quinine,B-Chemical
Sentence: 646,(,O
Sentence: 646,12.5,O
Sentence: 646,",",O
Sentence: 646,25,O
Sentence: 646,and,O
Sentence: 646,50,O
Sentence: 646,mg,O
Sentence: 646,/,O
Sentence: 646,kg,O
Sentence: 646,),O
Sentence: 646,and,O
Sentence: 646,4,O
Sentence: 646,-,O
Sentence: 646,aminopyridine,O
Sentence: 646,(,O
Sentence: 646,1,O
Sentence: 646,and,O
Sentence: 646,2,O
Sentence: 646,mg,O
Sentence: 646,/,O
Sentence: 646,kg,O
Sentence: 646,),O
Sentence: 646,",",O
Sentence: 646,on,O
Sentence: 646,conditioned,O
Sentence: 646,place,O
Sentence: 646,preference,O
Sentence: 646,and,O
Sentence: 646,biphasic,O
Sentence: 646,changes,O
Sentence: 646,in,O
Sentence: 646,motor,O
Sentence: 646,activity,O
Sentence: 646,induced,O
Sentence: 646,by,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,(,O
Sentence: 646,10,O
Sentence: 646,mg,O
Sentence: 646,/,O
Sentence: 646,kg,O
Sentence: 646,),O
Sentence: 646,were,O
Sentence: 646,tested,O
Sentence: 646,in,O
Sentence: 646,Wistar,O
Sentence: 646,rats,O
Sentence: 646,.,O
Sentence: 646,Quinine,B-Chemical
Sentence: 646,is,O
Sentence: 646,known,O
Sentence: 646,to,O
Sentence: 646,block,O
Sentence: 646,voltage,O
Sentence: 646,-,O
Sentence: 646,,O
Sentence: 646,",",O
Sentence: 646,calcium,B-Chemical
Sentence: 646,-,O
Sentence: 646,,O
Sentence: 646,and,O
Sentence: 646,ATP,B-Chemical
Sentence: 646,-,O
Sentence: 646,sensitive,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channels,O
Sentence: 646,while,O
Sentence: 646,4,O
Sentence: 646,-,O
Sentence: 646,aminopyridine,O
Sentence: 646,is,O
Sentence: 646,known,O
Sentence: 646,to,O
Sentence: 646,block,O
Sentence: 646,voltage,O
Sentence: 646,-,O
Sentence: 646,sensitive,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channels,O
Sentence: 646,.,O
Sentence: 646,2,O
Sentence: 646,.,O
Sentence: 646,In,O
Sentence: 646,the,O
Sentence: 646,counterbalanced,O
Sentence: 646,method,O
Sentence: 646,",",O
Sentence: 646,quinine,B-Chemical
Sentence: 646,attenuated,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,-,O
Sentence: 646,induced,O
Sentence: 646,place,O
Sentence: 646,preference,O
Sentence: 646,",",O
Sentence: 646,whereas,O
Sentence: 646,4,O
Sentence: 646,-,O
Sentence: 646,aminopyridine,O
Sentence: 646,was,O
Sentence: 646,ineffective,O
Sentence: 646,.,O
Sentence: 646,In,O
Sentence: 646,the,O
Sentence: 646,motor,O
Sentence: 646,activity,O
Sentence: 646,test,O
Sentence: 646,measured,O
Sentence: 646,with,O
Sentence: 646,an,O
Sentence: 646,Animex,O
Sentence: 646,-,O
Sentence: 646,activity,O
Sentence: 646,meter,O
Sentence: 646,neither,O
Sentence: 646,of,O
Sentence: 646,the,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channel,O
Sentence: 646,blockers,O
Sentence: 646,affected,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,-,O
Sentence: 646,induced,O
Sentence: 646,hypoactivity,B-Disease
Sentence: 646,",",O
Sentence: 646,but,O
Sentence: 646,both,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channel,O
Sentence: 646,blockers,O
Sentence: 646,prevented,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,-,O
Sentence: 646,induced,O
Sentence: 646,secondary,O
Sentence: 646,hyperactivity,B-Disease
Sentence: 646,.,O
Sentence: 646,3,O
Sentence: 646,.,O
Sentence: 646,These,O
Sentence: 646,results,O
Sentence: 646,suggest,O
Sentence: 646,the,O
Sentence: 646,involvement,O
Sentence: 646,of,O
Sentence: 646,quinine,B-Chemical
Sentence: 646,-,O
Sentence: 646,sensitive,O
Sentence: 646,but,O
Sentence: 646,not,O
Sentence: 646,4,O
Sentence: 646,-,O
Sentence: 646,aminopyridine,O
Sentence: 646,-,O
Sentence: 646,sensitive,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channels,O
Sentence: 646,in,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,reward,O
Sentence: 646,.,O
Sentence: 646,It,O
Sentence: 646,is,O
Sentence: 646,also,O
Sentence: 646,suggested,O
Sentence: 646,that,O
Sentence: 646,the,O
Sentence: 646,blockade,O
Sentence: 646,of,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channels,O
Sentence: 646,sensitive,O
Sentence: 646,to,O
Sentence: 646,these,O
Sentence: 646,blockers,O
Sentence: 646,is,O
Sentence: 646,not,O
Sentence: 646,sufficient,O
Sentence: 646,to,O
Sentence: 646,prevent,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,-,O
Sentence: 646,induced,O
Sentence: 646,hypoactivity,B-Disease
Sentence: 646,whereas,O
Sentence: 646,morphine,B-Chemical
Sentence: 646,-,O
Sentence: 646,induced,O
Sentence: 646,hyperactivity,B-Disease
Sentence: 646,seems,O
Sentence: 646,to,O
Sentence: 646,be,O
Sentence: 646,connected,O
Sentence: 646,to,O
Sentence: 646,both,O
Sentence: 646,quinine,B-Chemical
Sentence: 646,-,O
Sentence: 646,,O
Sentence: 646,and,O
Sentence: 646,4,O
Sentence: 646,-,O
Sentence: 646,aminopyridine,O
Sentence: 646,-,O
Sentence: 646,sensitive,O
Sentence: 646,K,B-Chemical
Sentence: 646,(,O
Sentence: 646,+,O
Sentence: 646,),O
Sentence: 646,,O
Sentence: 646,-,O
Sentence: 646,channels,O
Sentence: 646,.,O
Sentence: 647,Nociceptin,B-Chemical
Sentence: 647,/,O
Sentence: 647,orphanin,B-Chemical
Sentence: 647,FQ,I-Chemical
Sentence: 647,and,O
Sentence: 647,nocistatin,B-Chemical
Sentence: 647,on,O
Sentence: 647,learning,B-Disease
Sentence: 647,and,I-Disease
Sentence: 647,memory,B-Disease
Sentence: 647,impairment,I-Disease
Sentence: 647,induced,O
Sentence: 647,by,O
Sentence: 647,scopolamine,B-Chemical
Sentence: 647,in,O
Sentence: 647,mice,O
Sentence: 647,.,O
Sentence: 648,1,O
Sentence: 648,.,O
Sentence: 648,Nociceptin,B-Chemical
Sentence: 648,",",O
Sentence: 648,also,O
Sentence: 648,known,O
Sentence: 648,as,O
Sentence: 648,orphanin,B-Chemical
Sentence: 648,FQ,I-Chemical
Sentence: 648,",",O
Sentence: 648,is,O
Sentence: 648,an,O
Sentence: 648,endogenous,O
Sentence: 648,ligand,O
Sentence: 648,for,O
Sentence: 648,the,O
Sentence: 648,orphan,O
Sentence: 648,opioid,O
Sentence: 648,receptor,O
Sentence: 648,-,O
Sentence: 648,like,O
Sentence: 648,receptor,O
Sentence: 648,1,O
Sentence: 648,(,O
Sentence: 648,ORL1,O
Sentence: 648,),O
Sentence: 648,and,O
Sentence: 648,involves,O
Sentence: 648,in,O
Sentence: 648,various,O
Sentence: 648,functions,O
Sentence: 648,in,O
Sentence: 648,the,O
Sentence: 648,central,O
Sentence: 648,nervous,O
Sentence: 648,system,O
Sentence: 648,(,O
Sentence: 648,CNS,O
Sentence: 648,),O
Sentence: 648,.,O
Sentence: 648,On,O
Sentence: 648,the,O
Sentence: 648,other,O
Sentence: 648,hand,O
Sentence: 648,",",O
Sentence: 648,nocistatin,B-Chemical
Sentence: 648,is,O
Sentence: 648,recently,O
Sentence: 648,isolated,O
Sentence: 648,from,O
Sentence: 648,the,O
Sentence: 648,same,O
Sentence: 648,precursor,O
Sentence: 648,as,O
Sentence: 648,nociceptin,B-Chemical
Sentence: 648,and,O
Sentence: 648,blocks,O
Sentence: 648,nociceptin,B-Chemical
Sentence: 648,-,O
Sentence: 648,induced,O
Sentence: 648,allodynia,B-Disease
Sentence: 648,and,O
Sentence: 648,hyperalgesia,B-Disease
Sentence: 648,.,O
Sentence: 648,2,O
Sentence: 648,.,O
Sentence: 648,Although,O
Sentence: 648,ORL1,O
Sentence: 648,receptors,O
Sentence: 648,which,O
Sentence: 648,display,O
Sentence: 648,a,O
Sentence: 648,high,O
Sentence: 648,degree,O
Sentence: 648,of,O
Sentence: 648,sequence,O
Sentence: 648,homology,O
Sentence: 648,with,O
Sentence: 648,classical,O
Sentence: 648,opioid,O
Sentence: 648,receptors,O
Sentence: 648,are,O
Sentence: 648,abundant,O
Sentence: 648,in,O
Sentence: 648,the,O
Sentence: 648,hippocampus,O
Sentence: 648,",",O
Sentence: 648,little,O
Sentence: 648,is,O
Sentence: 648,known,O
Sentence: 648,regarding,O
Sentence: 648,their,O
Sentence: 648,role,O
Sentence: 648,in,O
Sentence: 648,learning,O
Sentence: 648,and,O
Sentence: 648,memory,O
Sentence: 648,.,O
Sentence: 648,3,O
Sentence: 648,.,O
Sentence: 648,The,O
Sentence: 648,present,O
Sentence: 648,study,O
Sentence: 648,was,O
Sentence: 648,designed,O
Sentence: 648,to,O
Sentence: 648,investigate,O
Sentence: 648,whether,O
Sentence: 648,nociceptin,B-Chemical
Sentence: 648,/,O
Sentence: 648,orphanin,B-Chemical
Sentence: 648,FQ,I-Chemical
Sentence: 648,and,O
Sentence: 648,nocistatin,B-Chemical
Sentence: 648,could,O
Sentence: 648,modulate,O
Sentence: 648,impairment,B-Disease
Sentence: 648,of,I-Disease
Sentence: 648,learning,I-Disease
Sentence: 648,and,I-Disease
Sentence: 648,memory,I-Disease
Sentence: 648,induced,O
Sentence: 648,by,O
Sentence: 648,scopolamine,B-Chemical
Sentence: 648,",",O
Sentence: 648,a,O
Sentence: 648,muscarinic,O
Sentence: 648,cholinergic,O
Sentence: 648,receptor,O
Sentence: 648,antagonist,O
Sentence: 648,",",O
Sentence: 648,using,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,of,O
Sentence: 648,Y,O
Sentence: 648,-,O
Sentence: 648,maze,O
Sentence: 648,and,O
Sentence: 648,step,O
Sentence: 648,-,O
Sentence: 648,down,O
Sentence: 648,type,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,tasks,O
Sentence: 648,in,O
Sentence: 648,mice,O
Sentence: 648,.,O
Sentence: 648,4,O
Sentence: 648,.,O
Sentence: 648,While,O
Sentence: 648,nocistatin,B-Chemical
Sentence: 648,(,O
Sentence: 648,0.5,O
Sentence: 648,-,O
Sentence: 648,5.0,O
Sentence: 648,nmol,O
Sentence: 648,mouse,O
Sentence: 648,-,O
Sentence: 648,1,O
Sentence: 648,",",O
Sentence: 648,i.c.v,O
Sentence: 648,.,O
Sentence: 648,),O
Sentence: 648,administered,O
Sentence: 648,30,O
Sentence: 648,min,O
Sentence: 648,before,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,performance,O
Sentence: 648,or,O
Sentence: 648,the,O
Sentence: 648,training,O
Sentence: 648,session,O
Sentence: 648,of,O
Sentence: 648,the,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,task,O
Sentence: 648,",",O
Sentence: 648,had,O
Sentence: 648,no,O
Sentence: 648,effect,O
Sentence: 648,on,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,or,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,behaviours,O
Sentence: 648,",",O
Sentence: 648,a,O
Sentence: 648,lower,O
Sentence: 648,per,O
Sentence: 648,cent,O
Sentence: 648,alternation,O
Sentence: 648,and,O
Sentence: 648,shorter,O
Sentence: 648,median,O
Sentence: 648,step,O
Sentence: 648,-,O
Sentence: 648,down,O
Sentence: 648,latency,O
Sentence: 648,in,O
Sentence: 648,the,O
Sentence: 648,retention,O
Sentence: 648,test,O
Sentence: 648,were,O
Sentence: 648,obtained,O
Sentence: 648,in,O
Sentence: 648,nociceptin,B-Chemical
Sentence: 648,(,O
Sentence: 648,1.5,O
Sentence: 648,and,O
Sentence: 648,/,O
Sentence: 648,or,O
Sentence: 648,5.0,O
Sentence: 648,nmol,O
Sentence: 648,mouse,O
Sentence: 648,-,O
Sentence: 648,1,O
Sentence: 648,",",O
Sentence: 648,i.c.v,O
Sentence: 648,.,O
Sentence: 648,),O
Sentence: 648,,O
Sentence: 648,-,O
Sentence: 648,treated,O
Sentence: 648,normal,O
Sentence: 648,mice,O
Sentence: 648,.,O
Sentence: 648,5,O
Sentence: 648,.,O
Sentence: 648,Administration,O
Sentence: 648,of,O
Sentence: 648,nocistatin,B-Chemical
Sentence: 648,(,O
Sentence: 648,1.5,O
Sentence: 648,and,O
Sentence: 648,/,O
Sentence: 648,or,O
Sentence: 648,5.0,O
Sentence: 648,nmol,O
Sentence: 648,mouse,O
Sentence: 648,-,O
Sentence: 648,1,O
Sentence: 648,",",O
Sentence: 648,i.c.v,O
Sentence: 648,.,O
Sentence: 648,),O
Sentence: 648,30,O
Sentence: 648,min,O
Sentence: 648,before,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,performance,O
Sentence: 648,or,O
Sentence: 648,the,O
Sentence: 648,training,O
Sentence: 648,session,O
Sentence: 648,of,O
Sentence: 648,the,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,task,O
Sentence: 648,",",O
Sentence: 648,attenuated,O
Sentence: 648,the,O
Sentence: 648,scopolamine,B-Chemical
Sentence: 648,-,O
Sentence: 648,induced,O
Sentence: 648,impairment,O
Sentence: 648,of,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,and,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,behaviours,O
Sentence: 648,.,O
Sentence: 648,6,O
Sentence: 648,.,O
Sentence: 648,These,O
Sentence: 648,results,O
Sentence: 648,indicated,O
Sentence: 648,that,O
Sentence: 648,nocistatin,B-Chemical
Sentence: 648,",",O
Sentence: 648,a,O
Sentence: 648,new,O
Sentence: 648,biologically,O
Sentence: 648,active,O
Sentence: 648,peptide,O
Sentence: 648,",",O
Sentence: 648,ameliorates,O
Sentence: 648,impairments,O
Sentence: 648,of,O
Sentence: 648,spontaneous,O
Sentence: 648,alternation,O
Sentence: 648,and,O
Sentence: 648,passive,O
Sentence: 648,avoidance,O
Sentence: 648,induced,O
Sentence: 648,by,O
Sentence: 648,scopolamine,B-Chemical
Sentence: 648,",",O
Sentence: 648,and,O
Sentence: 648,suggested,O
Sentence: 648,that,O
Sentence: 648,these,O
Sentence: 648,peptides,O
Sentence: 648,play,O
Sentence: 648,opposite,O
Sentence: 648,roles,O
Sentence: 648,in,O
Sentence: 648,learning,O
Sentence: 648,and,O
Sentence: 648,memory,O
Sentence: 648,.,O
Sentence: 649,Meloxicam,B-Chemical
Sentence: 649,-,O
Sentence: 649,induced,O
Sentence: 649,liver,B-Disease
Sentence: 649,toxicity,I-Disease
Sentence: 649,.,O
Sentence: 650,We,O
Sentence: 650,report,O
Sentence: 650,the,O
Sentence: 650,case,O
Sentence: 650,of,O
Sentence: 650,a,O
Sentence: 650,female,O
Sentence: 650,patient,O
Sentence: 650,with,O
Sentence: 650,rheumatoid,B-Disease
Sentence: 650,arthritis,I-Disease
Sentence: 650,who,O
Sentence: 650,developed,O
Sentence: 650,acute,O
Sentence: 650,cytolytic,O
Sentence: 650,hepatitis,B-Disease
Sentence: 650,due,O
Sentence: 650,to,O
Sentence: 650,meloxicam,B-Chemical
Sentence: 650,.,O
Sentence: 650,Recently,O
Sentence: 650,introduced,O
Sentence: 650,in,O
Sentence: 650,Belgium,O
Sentence: 650,",",O
Sentence: 650,meloxicam,B-Chemical
Sentence: 650,is,O
Sentence: 650,the,O
Sentence: 650,first,O
Sentence: 650,nonsteroidal,O
Sentence: 650,antiinflammatory,O
Sentence: 650,drug,O
Sentence: 650,with,O
Sentence: 650,selective,O
Sentence: 650,action,O
Sentence: 650,on,O
Sentence: 650,the,O
Sentence: 650,inducible,O
Sentence: 650,form,O
Sentence: 650,of,O
Sentence: 650,cyclooxygenase,O
Sentence: 650,2,O
Sentence: 650,.,O
Sentence: 650,The,O
Sentence: 650,acute,O
Sentence: 650,cytolytic,O
Sentence: 650,hepatitis,B-Disease
Sentence: 650,occurred,O
Sentence: 650,rapidly,O
Sentence: 650,after,O
Sentence: 650,meloxicam,B-Chemical
Sentence: 650,administration,O
Sentence: 650,and,O
Sentence: 650,was,O
Sentence: 650,associated,O
Sentence: 650,with,O
Sentence: 650,the,O
Sentence: 650,development,O
Sentence: 650,of,O
Sentence: 650,antinuclear,O
Sentence: 650,antibodies,O
Sentence: 650,suggesting,O
Sentence: 650,a,O
Sentence: 650,hypersensitivity,B-Disease
Sentence: 650,mechanism,O
Sentence: 650,.,O
Sentence: 650,This,O
Sentence: 650,first,O
Sentence: 650,case,O
Sentence: 650,of,O
Sentence: 650,meloxicam,B-Chemical
Sentence: 650,related,O
Sentence: 650,liver,B-Disease
Sentence: 650,toxicity,I-Disease
Sentence: 650,demonstrates,O
Sentence: 650,the,O
Sentence: 650,potential,O
Sentence: 650,of,O
Sentence: 650,this,O
Sentence: 650,drug,O
Sentence: 650,to,O
Sentence: 650,induce,O
Sentence: 650,hepatic,B-Disease
Sentence: 650,damage,I-Disease
Sentence: 650,.,O
Sentence: 651,Induction,O
Sentence: 651,of,O
Sentence: 651,apoptosis,O
Sentence: 651,by,O
Sentence: 651,remoxipride,B-Chemical
Sentence: 651,metabolites,O
Sentence: 651,in,O
Sentence: 651,HL60,O
Sentence: 651,and,O
Sentence: 651,CD34+,O
Sentence: 651,/,O
Sentence: 651,CD19,O
Sentence: 651,-,O
Sentence: 651,,O
Sentence: 651,human,O
Sentence: 651,bone,O
Sentence: 651,marrow,O
Sentence: 651,progenitor,O
Sentence: 651,cells,O
Sentence: 651,:,O
Sentence: 651,potential,O
Sentence: 651,relevance,O
Sentence: 651,to,O
Sentence: 651,remoxipride,B-Chemical
Sentence: 651,-,O
Sentence: 651,induced,O
Sentence: 651,aplastic,B-Disease
Sentence: 651,anemia,I-Disease
Sentence: 651,.,O
Sentence: 652,The,O
Sentence: 652,antipsychotic,O
Sentence: 652,agent,O
Sentence: 652,",",O
Sentence: 652,remoxipride,B-Chemical
Sentence: 652,[,O
Sentence: 652,(,O
Sentence: 652,S,O
Sentence: 652,),O
Sentence: 652,,O
Sentence: 652,-,O
Sentence: 652,,O
Sentence: 652,(,O
Sentence: 652,,O
Sentence: 652,-,O
Sentence: 652,,O
Sentence: 652,),O
Sentence: 652,,O
Sentence: 652,-,O
Sentence: 652,3,O
Sentence: 652,-,O
Sentence: 652,bromo,O
Sentence: 652,-,O
Sentence: 652,N,O
Sentence: 652,-,O
Sentence: 652,,O
Sentence: 652,[,O
Sentence: 652,(,O
Sentence: 652,1,O
Sentence: 652,-,O
Sentence: 652,ethyl,O
Sentence: 652,-,O
Sentence: 652,2,O
Sentence: 652,-,O
Sentence: 652,pyrrolidinyl,O
Sentence: 652,),O
Sentence: 652,methyl,O
Sentence: 652,],O
Sentence: 652,,O
Sentence: 652,-,O
Sentence: 652,"2,6",O
Sentence: 652,-,O
Sentence: 652,dimethoxybenz,O
Sentence: 652,amide,O
Sentence: 652,],O
Sentence: 652,has,O
Sentence: 652,been,O
Sentence: 652,associated,O
Sentence: 652,with,O
Sentence: 652,acquired,O
Sentence: 652,aplastic,B-Disease
Sentence: 652,anemia,I-Disease
Sentence: 652,.,O
Sentence: 652,We,O
Sentence: 652,have,O
Sentence: 652,examined,O
Sentence: 652,the,O
Sentence: 652,ability,O
Sentence: 652,of,O
Sentence: 652,remoxipride,B-Chemical
Sentence: 652,",",O
Sentence: 652,three,O
Sentence: 652,pyrrolidine,B-Chemical
Sentence: 652,ring,O
Sentence: 652,metabolites,O
Sentence: 652,and,O
Sentence: 652,five,O
Sentence: 652,aromatic,O
Sentence: 652,ring,O
Sentence: 652,metabolites,O
Sentence: 652,of,O
Sentence: 652,the,O
Sentence: 652,parent,O
Sentence: 652,compound,O
Sentence: 652,to,O
Sentence: 652,induce,O
Sentence: 652,apoptosis,O
Sentence: 652,in,O
Sentence: 652,HL60,O
Sentence: 652,cells,O
Sentence: 652,and,O
Sentence: 652,human,O
Sentence: 652,bone,O
Sentence: 652,marrow,O
Sentence: 652,progenitor,O
Sentence: 652,(,O
Sentence: 652,HBMP,O
Sentence: 652,),O
Sentence: 652,cells,O
Sentence: 652,.,O
Sentence: 652,Cells,O
Sentence: 652,were,O
Sentence: 652,treated,O
Sentence: 652,for,O
Sentence: 652,0,O
Sentence: 652,-,O
Sentence: 652,24,O
Sentence: 652,h,O
Sentence: 652,with,O
Sentence: 652,each,O
Sentence: 652,compound,O
Sentence: 652,(,O
Sentence: 652,0,O
Sentence: 652,-,O
Sentence: 652,200,O
Sentence: 652,microM,O
Sentence: 652,),O
Sentence: 652,.,O
Sentence: 652,Apoptosis,O
Sentence: 652,was,O
Sentence: 652,assessed,O
Sentence: 652,by,O
Sentence: 652,fluorescence,O
Sentence: 652,microscopy,O
Sentence: 652,in,O
Sentence: 652,Hoechst,B-Chemical
Sentence: 652,33342,I-Chemical
Sentence: 652,-,O
Sentence: 652,,O
Sentence: 652,and,O
Sentence: 652,propidium,B-Chemical
Sentence: 652,iodide,I-Chemical
Sentence: 652,stained,O
Sentence: 652,cell,O
Sentence: 652,samples,O
Sentence: 652,.,O
Sentence: 652,Results,O
Sentence: 652,were,O
Sentence: 652,confirmed,O
Sentence: 652,by,O
Sentence: 652,determination,O
Sentence: 652,of,O
Sentence: 652,internucleosomal,O
Sentence: 652,DNA,O
Sentence: 652,fragmentation,O
Sentence: 652,using,O
Sentence: 652,gel,O
Sentence: 652,electrophoresis,O
Sentence: 652,for,O
Sentence: 652,HL60,O
Sentence: 652,cell,O
Sentence: 652,samples,O
Sentence: 652,and,O
Sentence: 652,terminal,O
Sentence: 652,deoxynucleotidyl,O
Sentence: 652,transferase,O
Sentence: 652,assay,O
Sentence: 652,in,O
Sentence: 652,HBMP,O
Sentence: 652,cells,O
Sentence: 652,.,O
Sentence: 652,The,O
Sentence: 652,catechol,B-Chemical
Sentence: 652,and,O
Sentence: 652,hydroquinone,B-Chemical
Sentence: 652,metabolites,O
Sentence: 652,",",O
Sentence: 652,NCQ436,B-Chemical
Sentence: 652,and,O
Sentence: 652,NCQ344,B-Chemical
Sentence: 652,",",O
Sentence: 652,induced,O
Sentence: 652,apoptosis,O
Sentence: 652,in,O
Sentence: 652,HL60,O
Sentence: 652,and,O
Sentence: 652,HBMP,O
Sentence: 652,cells,O
Sentence: 652,in,O
Sentence: 652,a,O
Sentence: 652,time,O
Sentence: 652,-,O
Sentence: 652,,O
Sentence: 652,and,O
Sentence: 652,concentration,O
Sentence: 652,dependent,O
Sentence: 652,manner,O
Sentence: 652,",",O
Sentence: 652,while,O
Sentence: 652,the,O
Sentence: 652,phenols,B-Chemical
Sentence: 652,",",O
Sentence: 652,NCR181,O
Sentence: 652,",",O
Sentence: 652,FLA873,O
Sentence: 652,",",O
Sentence: 652,and,O
Sentence: 652,FLA797,B-Chemical
Sentence: 652,",",O
Sentence: 652,and,O
Sentence: 652,the,O
Sentence: 652,derivatives,O
Sentence: 652,formed,O
Sentence: 652,by,O
Sentence: 652,oxidation,O
Sentence: 652,of,O
Sentence: 652,the,O
Sentence: 652,pyrrolidine,B-Chemical
Sentence: 652,ring,O
Sentence: 652,",",O
Sentence: 652,FLA838,O
Sentence: 652,",",O
Sentence: 652,NCM001,O
Sentence: 652,",",O
Sentence: 652,and,O
Sentence: 652,NCL118,O
Sentence: 652,",",O
Sentence: 652,had,O
Sentence: 652,no,O
Sentence: 652,effect,O
Sentence: 652,.,O
Sentence: 652,No,O
Sentence: 652,necrosis,B-Disease
Sentence: 652,was,O
Sentence: 652,observed,O
Sentence: 652,in,O
Sentence: 652,cells,O
Sentence: 652,treated,O
Sentence: 652,with,O
Sentence: 652,NCQ436,B-Chemical
Sentence: 652,but,O
Sentence: 652,NCQ344,B-Chemical
Sentence: 652,had,O
Sentence: 652,a,O
Sentence: 652,biphasic,O
Sentence: 652,effect,O
Sentence: 652,in,O
Sentence: 652,both,O
Sentence: 652,cell,O
Sentence: 652,types,O
Sentence: 652,",",O
Sentence: 652,inducing,O
Sentence: 652,apoptosis,O
Sentence: 652,at,O
Sentence: 652,lower,O
Sentence: 652,concentrations,O
Sentence: 652,and,O
Sentence: 652,necrosis,B-Disease
Sentence: 652,at,O
Sentence: 652,higher,O
Sentence: 652,concentrations,O
Sentence: 652,.,O
Sentence: 652,These,O
Sentence: 652,data,O
Sentence: 652,show,O
Sentence: 652,that,O
Sentence: 652,the,O
Sentence: 652,catechol,B-Chemical
Sentence: 652,and,O
Sentence: 652,hydroquinone,B-Chemical
Sentence: 652,metabolites,O
Sentence: 652,of,O
Sentence: 652,remoxipride,B-Chemical
Sentence: 652,have,O
Sentence: 652,direct,O
Sentence: 652,toxic,O
Sentence: 652,effects,O
Sentence: 652,in,O
Sentence: 652,HL60,O
Sentence: 652,and,O
Sentence: 652,HBMP,O
Sentence: 652,cells,O
Sentence: 652,",",O
Sentence: 652,leading,O
Sentence: 652,to,O
Sentence: 652,apoptosis,O
Sentence: 652,",",O
Sentence: 652,while,O
Sentence: 652,the,O
Sentence: 652,phenol,B-Chemical
Sentence: 652,metabolites,O
Sentence: 652,were,O
Sentence: 652,inactive,O
Sentence: 652,.,O
Sentence: 652,Similarly,O
Sentence: 652,",",O
Sentence: 652,benzene,B-Chemical
Sentence: 652,-,O
Sentence: 652,derived,O
Sentence: 652,catechol,B-Chemical
Sentence: 652,and,O
Sentence: 652,hydroquinone,B-Chemical
Sentence: 652,",",O
Sentence: 652,but,O
Sentence: 652,not,O
Sentence: 652,phenol,B-Chemical
Sentence: 652,",",O
Sentence: 652,induce,O
Sentence: 652,apoptosis,O
Sentence: 652,in,O
Sentence: 652,HBMP,O
Sentence: 652,cells,O
Sentence: 652,[,O
Sentence: 652,Moran,O
Sentence: 652,et,O
Sentence: 652,al.,O
Sentence: 652,",",O
Sentence: 652,Mol,O
Sentence: 652,.,O
Sentence: 652,Pharmacol.,O
Sentence: 652,",",O
Sentence: 652,50,O
Sentence: 652,(,O
Sentence: 652,1996,O
Sentence: 652,),O
Sentence: 652,610,O
Sentence: 652,-,O
Sentence: 652,615,O
Sentence: 652,],O
Sentence: 652,.,O
Sentence: 652,We,O
Sentence: 652,propose,O
Sentence: 652,that,O
Sentence: 652,remoxipride,B-Chemical
Sentence: 652,and,O
Sentence: 652,benzene,B-Chemical
Sentence: 652,may,O
Sentence: 652,induce,O
Sentence: 652,aplastic,B-Disease
Sentence: 652,anemia,I-Disease
Sentence: 652,via,O
Sentence: 652,production,O
Sentence: 652,of,O
Sentence: 652,similar,O
Sentence: 652,reactive,O
Sentence: 652,metabolites,O
Sentence: 652,and,O
Sentence: 652,that,O
Sentence: 652,the,O
Sentence: 652,ability,O
Sentence: 652,of,O
Sentence: 652,NCQ436,B-Chemical
Sentence: 652,and,O
Sentence: 652,NCQ344,B-Chemical
Sentence: 652,to,O
Sentence: 652,induce,O
Sentence: 652,apoptosis,O
Sentence: 652,in,O
Sentence: 652,HBMP,O
Sentence: 652,cells,O
Sentence: 652,may,O
Sentence: 652,contribute,O
Sentence: 652,to,O
Sentence: 652,the,O
Sentence: 652,mechanism,O
Sentence: 652,underlying,O
Sentence: 652,acquired,O
Sentence: 652,aplastic,B-Disease
Sentence: 652,anemia,I-Disease
Sentence: 652,that,O
Sentence: 652,has,O
Sentence: 652,been,O
Sentence: 652,associated,O
Sentence: 652,with,O
Sentence: 652,remoxipride,B-Chemical
Sentence: 652,.,O
Sentence: 653,Synthesis,O
Sentence: 653,and,O
Sentence: 653,preliminary,O
Sentence: 653,pharmacological,O
Sentence: 653,investigations,O
Sentence: 653,of,O
Sentence: 653,1,O
Sentence: 653,-,O
Sentence: 653,,O
Sentence: 653,(,O
Sentence: 653,"1,2",O
Sentence: 653,-,O
Sentence: 653,dihydro,O
Sentence: 653,-,O
Sentence: 653,2,O
Sentence: 653,-,O
Sentence: 653,acenaphthylenyl,O
Sentence: 653,),O
Sentence: 653,piperazine,O
Sentence: 653,derivatives,O
Sentence: 653,as,O
Sentence: 653,potential,O
Sentence: 653,atypical,O
Sentence: 653,antipsychotic,O
Sentence: 653,agents,O
Sentence: 653,in,O
Sentence: 653,mice,O
Sentence: 653,.,O
Sentence: 654,In,O
Sentence: 654,research,O
Sentence: 654,towards,O
Sentence: 654,the,O
Sentence: 654,development,O
Sentence: 654,of,O
Sentence: 654,new,O
Sentence: 654,atypical,O
Sentence: 654,antipsychotic,O
Sentence: 654,agents,O
Sentence: 654,",",O
Sentence: 654,one,O
Sentence: 654,strategy,O
Sentence: 654,is,O
Sentence: 654,that,O
Sentence: 654,the,O
Sentence: 654,dopaminergic,O
Sentence: 654,system,O
Sentence: 654,can,O
Sentence: 654,be,O
Sentence: 654,modulated,O
Sentence: 654,through,O
Sentence: 654,manipulation,O
Sentence: 654,of,O
Sentence: 654,the,O
Sentence: 654,serotonergic,O
Sentence: 654,system,O
Sentence: 654,.,O
Sentence: 654,The,O
Sentence: 654,synthesis,O
Sentence: 654,and,O
Sentence: 654,preliminary,O
Sentence: 654,pharmacological,O
Sentence: 654,evaluation,O
Sentence: 654,of,O
Sentence: 654,a,O
Sentence: 654,series,O
Sentence: 654,of,O
Sentence: 654,potential,O
Sentence: 654,atypical,O
Sentence: 654,antipsychotic,O
Sentence: 654,agents,O
Sentence: 654,based,O
Sentence: 654,on,O
Sentence: 654,the,O
Sentence: 654,structure,O
Sentence: 654,of,O
Sentence: 654,1,O
Sentence: 654,-,O
Sentence: 654,,O
Sentence: 654,(,O
Sentence: 654,"1,2",O
Sentence: 654,-,O
Sentence: 654,dihydro,O
Sentence: 654,-,O
Sentence: 654,2,O
Sentence: 654,-,O
Sentence: 654,acenaphthylenyl,O
Sentence: 654,),O
Sentence: 654,piperazine,O
Sentence: 654,(,O
Sentence: 654,7,O
Sentence: 654,),O
Sentence: 654,is,O
Sentence: 654,described,O
Sentence: 654,.,O
Sentence: 654,Compound,O
Sentence: 654,7e,O
Sentence: 654,",",O
Sentence: 654,5,O
Sentence: 654,-,O
Sentence: 654,,O
Sentence: 654,{,O
Sentence: 654,2,O
Sentence: 654,-,O
Sentence: 654,,O
Sentence: 654,[,O
Sentence: 654,4,O
Sentence: 654,-,O
Sentence: 654,,O
Sentence: 654,(,O
Sentence: 654,"1,2",O
Sentence: 654,-,O
Sentence: 654,dihydro,O
Sentence: 654,-,O
Sentence: 654,2,O
Sentence: 654,-,O
Sentence: 654,acenaphthylenyl,O
Sentence: 654,),O
Sentence: 654,piperazinyl,O
Sentence: 654,],O
Sentence: 654,ethyl,O
Sentence: 654,},O
Sentence: 654,,O
Sentence: 654,-,O
Sentence: 654,"2,3",O
Sentence: 654,-,O
Sentence: 654,dihy,O
Sentence: 654,dro,O
Sentence: 654,-,O
Sentence: 654,1H,O
Sentence: 654,-,O
Sentence: 654,,O
Sentence: 654,indol,O
Sentence: 654,-,O
Sentence: 654,2,O
Sentence: 654,-,O
Sentence: 654,one,O
Sentence: 654,",",O
Sentence: 654,from,O
Sentence: 654,this,O
Sentence: 654,series,O
Sentence: 654,showed,O
Sentence: 654,significant,O
Sentence: 654,affinities,O
Sentence: 654,at,O
Sentence: 654,the,O
Sentence: 654,5,O
Sentence: 654,-,O
Sentence: 654,HT1A,O
Sentence: 654,and,O
Sentence: 654,5,O
Sentence: 654,-,O
Sentence: 654,HT2A,O
Sentence: 654,receptors,O
Sentence: 654,and,O
Sentence: 654,moderate,O
Sentence: 654,affinity,O
Sentence: 654,at,O
Sentence: 654,the,O
Sentence: 654,D2,O
Sentence: 654,receptor,O
Sentence: 654,.,O
Sentence: 654,7e,O
Sentence: 654,exhibits,O
Sentence: 654,a,O
Sentence: 654,high,O
Sentence: 654,reversal,O
Sentence: 654,of,O
Sentence: 654,catalepsy,B-Disease
Sentence: 654,induced,O
Sentence: 654,by,O
Sentence: 654,haloperidol,B-Chemical
Sentence: 654,indicating,O
Sentence: 654,its,O
Sentence: 654,atypical,O
Sentence: 654,antipsychotic,O
Sentence: 654,nature,O
Sentence: 654,.,O
Sentence: 655,Sub,O
Sentence: 655,-,O
Sentence: 655,chronic,O
Sentence: 655,inhibition,O
Sentence: 655,of,O
Sentence: 655,nitric,O
Sentence: 655,-,O
Sentence: 655,oxide,O
Sentence: 655,synthesis,O
Sentence: 655,modifies,O
Sentence: 655,haloperidol,B-Chemical
Sentence: 655,-,O
Sentence: 655,induced,O
Sentence: 655,catalepsy,B-Disease
Sentence: 655,and,O
Sentence: 655,the,O
Sentence: 655,number,O
Sentence: 655,of,O
Sentence: 655,NADPH,B-Chemical
Sentence: 655,-,O
Sentence: 655,diaphorase,O
Sentence: 655,neurons,O
Sentence: 655,in,O
Sentence: 655,mice,O
Sentence: 655,.,O
Sentence: 656,RATIONALE,O
Sentence: 656,:,O
Sentence: 656,NG,O
Sentence: 656,-,O
Sentence: 656,nitro,O
Sentence: 656,-,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,arginine,O
Sentence: 656,(,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,),O
Sentence: 656,",",O
Sentence: 656,an,O
Sentence: 656,inhibitor,O
Sentence: 656,of,O
Sentence: 656,nitric,O
Sentence: 656,-,O
Sentence: 656,oxide,O
Sentence: 656,synthase,O
Sentence: 656,(,O
Sentence: 656,NOS,O
Sentence: 656,),O
Sentence: 656,",",O
Sentence: 656,induces,O
Sentence: 656,catalepsy,B-Disease
Sentence: 656,in,O
Sentence: 656,mice,O
Sentence: 656,.,O
Sentence: 656,This,O
Sentence: 656,effect,O
Sentence: 656,undergoes,O
Sentence: 656,rapid,O
Sentence: 656,tolerance,O
Sentence: 656,",",O
Sentence: 656,showing,O
Sentence: 656,a,O
Sentence: 656,significant,O
Sentence: 656,decrease,O
Sentence: 656,after,O
Sentence: 656,2,O
Sentence: 656,days,O
Sentence: 656,of,O
Sentence: 656,sub,O
Sentence: 656,-,O
Sentence: 656,chronic,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,treatment,O
Sentence: 656,.,O
Sentence: 656,Nitric,B-Chemical
Sentence: 656,oxide,I-Chemical
Sentence: 656,(,O
Sentence: 656,NO,B-Chemical
Sentence: 656,),O
Sentence: 656,has,O
Sentence: 656,been,O
Sentence: 656,shown,O
Sentence: 656,to,O
Sentence: 656,influence,O
Sentence: 656,dopaminergic,O
Sentence: 656,neurotransmission,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,striatum,O
Sentence: 656,.,O
Sentence: 656,Neuroleptic,O
Sentence: 656,drugs,O
Sentence: 656,such,O
Sentence: 656,as,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,",",O
Sentence: 656,which,O
Sentence: 656,block,O
Sentence: 656,dopamine,B-Chemical
Sentence: 656,receptors,O
Sentence: 656,",",O
Sentence: 656,also,O
Sentence: 656,cause,O
Sentence: 656,catalepsy,B-Disease
Sentence: 656,in,O
Sentence: 656,rodents,O
Sentence: 656,.,O
Sentence: 656,OBJECTIVES,O
Sentence: 656,:,O
Sentence: 656,To,O
Sentence: 656,investigate,O
Sentence: 656,the,O
Sentence: 656,effects,O
Sentence: 656,of,O
Sentence: 656,subchronic,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,treatment,O
Sentence: 656,in,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,-,O
Sentence: 656,induced,O
Sentence: 656,catalepsy,B-Disease
Sentence: 656,and,O
Sentence: 656,the,O
Sentence: 656,number,O
Sentence: 656,of,O
Sentence: 656,NOS,O
Sentence: 656,neurons,O
Sentence: 656,in,O
Sentence: 656,areas,O
Sentence: 656,related,O
Sentence: 656,to,O
Sentence: 656,motor,O
Sentence: 656,control,O
Sentence: 656,.,O
Sentence: 656,METHODS,O
Sentence: 656,:,O
Sentence: 656,Male,O
Sentence: 656,albino,O
Sentence: 656,Swiss,O
Sentence: 656,mice,O
Sentence: 656,were,O
Sentence: 656,treated,O
Sentence: 656,sub,O
Sentence: 656,-,O
Sentence: 656,chronically,O
Sentence: 656,(,O
Sentence: 656,twice,O
Sentence: 656,a,O
Sentence: 656,day,O
Sentence: 656,for,O
Sentence: 656,4,O
Sentence: 656,days,O
Sentence: 656,),O
Sentence: 656,with,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,(,O
Sentence: 656,40,O
Sentence: 656,mg,O
Sentence: 656,/,O
Sentence: 656,kg,O
Sentence: 656,i.p,O
Sentence: 656,.,O
Sentence: 656,),O
Sentence: 656,or,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,(,O
Sentence: 656,1,O
Sentence: 656,mg,O
Sentence: 656,/,O
Sentence: 656,kg,O
Sentence: 656,i.p.,O
Sentence: 656,),O
Sentence: 656,.,O
Sentence: 656,Catalepsy,B-Disease
Sentence: 656,was,O
Sentence: 656,evaluated,O
Sentence: 656,at,O
Sentence: 656,the,O
Sentence: 656,beginning,O
Sentence: 656,and,O
Sentence: 656,the,O
Sentence: 656,end,O
Sentence: 656,of,O
Sentence: 656,the,O
Sentence: 656,treatments,O
Sentence: 656,.,O
Sentence: 656,Reduced,O
Sentence: 656,nicotinamide,B-Chemical
Sentence: 656,adenine,I-Chemical
Sentence: 656,dinucleotide,I-Chemical
Sentence: 656,phosphate,I-Chemical
Sentence: 656,-,O
Sentence: 656,diaphorase,O
Sentence: 656,(,O
Sentence: 656,NADPH,B-Chemical
Sentence: 656,-,O
Sentence: 656,d,O
Sentence: 656,),O
Sentence: 656,histochemistry,O
Sentence: 656,was,O
Sentence: 656,also,O
Sentence: 656,employed,O
Sentence: 656,to,O
Sentence: 656,visualize,O
Sentence: 656,NOS,O
Sentence: 656,as,O
Sentence: 656,an,O
Sentence: 656,index,O
Sentence: 656,of,O
Sentence: 656,enzyme,O
Sentence: 656,expression,O
Sentence: 656,in,O
Sentence: 656,mice,O
Sentence: 656,brain,O
Sentence: 656,regions,O
Sentence: 656,related,O
Sentence: 656,to,O
Sentence: 656,motor,O
Sentence: 656,control,O
Sentence: 656,.,O
Sentence: 656,RESULTS,O
Sentence: 656,:,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,sub,O
Sentence: 656,-,O
Sentence: 656,chronic,O
Sentence: 656,administration,O
Sentence: 656,produced,O
Sentence: 656,tolerance,O
Sentence: 656,of,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,and,O
Sentence: 656,of,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,-,O
Sentence: 656,induced,O
Sentence: 656,catalepsy,B-Disease
Sentence: 656,.,O
Sentence: 656,It,O
Sentence: 656,also,O
Sentence: 656,induced,O
Sentence: 656,an,O
Sentence: 656,increase,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,number,O
Sentence: 656,of,O
Sentence: 656,NADPH,B-Chemical
Sentence: 656,-,O
Sentence: 656,d,O
Sentence: 656,-,O
Sentence: 656,positive,O
Sentence: 656,cells,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,dorsal,O
Sentence: 656,part,O
Sentence: 656,of,O
Sentence: 656,the,O
Sentence: 656,caudate,O
Sentence: 656,and,O
Sentence: 656,accumbens,O
Sentence: 656,nuclei,O
Sentence: 656,compared,O
Sentence: 656,with,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,and,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,pedunculopontine,O
Sentence: 656,tegmental,O
Sentence: 656,nucleus,O
Sentence: 656,compared,O
Sentence: 656,with,O
Sentence: 656,saline,O
Sentence: 656,.,O
Sentence: 656,In,O
Sentence: 656,contrast,O
Sentence: 656,",",O
Sentence: 656,there,O
Sentence: 656,was,O
Sentence: 656,a,O
Sentence: 656,decrease,O
Sentence: 656,in,O
Sentence: 656,NADPH,B-Chemical
Sentence: 656,-,O
Sentence: 656,d,O
Sentence: 656,neuron,O
Sentence: 656,number,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,substantia,O
Sentence: 656,nigra,O
Sentence: 656,",",O
Sentence: 656,pars,O
Sentence: 656,compacta,O
Sentence: 656,in,O
Sentence: 656,both,O
Sentence: 656,haloperidol,B-Chemical
Sentence: 656,-,O
Sentence: 656,treated,O
Sentence: 656,and,O
Sentence: 656,L,O
Sentence: 656,-,O
Sentence: 656,NOARG,O
Sentence: 656,-,O
Sentence: 656,treated,O
Sentence: 656,animals,O
Sentence: 656,.,O
Sentence: 656,CONCLUSIONS,O
Sentence: 656,:,O
Sentence: 656,The,O
Sentence: 656,results,O
Sentence: 656,give,O
Sentence: 656,further,O
Sentence: 656,support,O
Sentence: 656,to,O
Sentence: 656,the,O
Sentence: 656,hypothesis,O
Sentence: 656,that,O
Sentence: 656,NO,B-Chemical
Sentence: 656,plays,O
Sentence: 656,a,O
Sentence: 656,role,O
Sentence: 656,in,O
Sentence: 656,motor,O
Sentence: 656,behavior,O
Sentence: 656,control,O
Sentence: 656,and,O
Sentence: 656,suggest,O
Sentence: 656,that,O
Sentence: 656,it,O
Sentence: 656,may,O
Sentence: 656,take,O
Sentence: 656,part,O
Sentence: 656,in,O
Sentence: 656,the,O
Sentence: 656,synaptic,O
Sentence: 656,changes,O
Sentence: 656,produced,O
Sentence: 656,by,O
Sentence: 656,antipsychotic,O
Sentence: 656,treatment,O
Sentence: 656,.,O
Sentence: 657,Prolonged,O
Sentence: 657,left,B-Disease
Sentence: 657,ventricular,I-Disease
Sentence: 657,dysfunction,I-Disease
Sentence: 657,occurs,O
Sentence: 657,in,O
Sentence: 657,patients,O
Sentence: 657,with,O
Sentence: 657,coronary,B-Disease
Sentence: 657,artery,I-Disease
Sentence: 657,disease,I-Disease
Sentence: 657,after,O
Sentence: 657,both,O
Sentence: 657,dobutamine,B-Chemical
Sentence: 657,and,O
Sentence: 657,exercise,O
Sentence: 657,induced,O
Sentence: 657,myocardial,B-Disease
Sentence: 657,ischaemia,I-Disease
Sentence: 657,.,O
Sentence: 658,OBJECTIVE,O
Sentence: 658,:,O
Sentence: 658,To,O
Sentence: 658,determine,O
Sentence: 658,whether,O
Sentence: 658,pharmacological,O
Sentence: 658,stress,O
Sentence: 658,leads,O
Sentence: 658,to,O
Sentence: 658,prolonged,O
Sentence: 658,but,O
Sentence: 658,reversible,O
Sentence: 658,left,B-Disease
Sentence: 658,ventricular,I-Disease
Sentence: 658,dysfunction,I-Disease
Sentence: 658,in,O
Sentence: 658,patients,O
Sentence: 658,with,O
Sentence: 658,coronary,B-Disease
Sentence: 658,artery,I-Disease
Sentence: 658,disease,I-Disease
Sentence: 658,",",O
Sentence: 658,similar,O
Sentence: 658,to,O
Sentence: 658,that,O
Sentence: 658,seen,O
Sentence: 658,after,O
Sentence: 658,exercise,O
Sentence: 658,.,O
Sentence: 658,DESIGN,O
Sentence: 658,:,O
Sentence: 658,A,O
Sentence: 658,randomised,O
Sentence: 658,crossover,O
Sentence: 658,study,O
Sentence: 658,of,O
Sentence: 658,recovery,O
Sentence: 658,time,O
Sentence: 658,of,O
Sentence: 658,systolic,O
Sentence: 658,and,O
Sentence: 658,diastolic,O
Sentence: 658,left,O
Sentence: 658,ventricular,O
Sentence: 658,function,O
Sentence: 658,after,O
Sentence: 658,exercise,O
Sentence: 658,and,O
Sentence: 658,dobutamine,B-Chemical
Sentence: 658,induced,O
Sentence: 658,ischaemia,B-Disease
Sentence: 658,.,O
Sentence: 658,SUBJECTS,O
Sentence: 658,:,O
Sentence: 658,10,O
Sentence: 658,patients,O
Sentence: 658,with,O
Sentence: 658,stable,B-Disease
Sentence: 658,angina,I-Disease
Sentence: 658,",",O
Sentence: 658,angiographically,O
Sentence: 658,proven,O
Sentence: 658,coronary,B-Disease
Sentence: 658,artery,I-Disease
Sentence: 658,disease,I-Disease
Sentence: 658,",",O
Sentence: 658,and,O
Sentence: 658,normal,O
Sentence: 658,left,O
Sentence: 658,ventricular,O
Sentence: 658,function,O
Sentence: 658,.,O
Sentence: 658,INTERVENTIONS,O
Sentence: 658,:,O
Sentence: 658,Treadmill,O
Sentence: 658,exercise,O
Sentence: 658,and,O
Sentence: 658,dobutamine,B-Chemical
Sentence: 658,stress,O
Sentence: 658,were,O
Sentence: 658,performed,O
Sentence: 658,on,O
Sentence: 658,different,O
Sentence: 658,days,O
Sentence: 658,.,O
Sentence: 658,Quantitative,O
Sentence: 658,assessment,O
Sentence: 658,of,O
Sentence: 658,systolic,O
Sentence: 658,and,O
Sentence: 658,diastolic,O
Sentence: 658,left,O
Sentence: 658,ventricular,O
Sentence: 658,function,O
Sentence: 658,was,O
Sentence: 658,performed,O
Sentence: 658,using,O
Sentence: 658,transthoracic,O
Sentence: 658,echocardiography,O
Sentence: 658,at,O
Sentence: 658,baseline,O
Sentence: 658,and,O
Sentence: 658,at,O
Sentence: 658,regular,O
Sentence: 658,intervals,O
Sentence: 658,after,O
Sentence: 658,each,O
Sentence: 658,test,O
Sentence: 658,.,O
Sentence: 658,RESULTS,O
Sentence: 658,:,O
Sentence: 658,Both,O
Sentence: 658,forms,O
Sentence: 658,of,O
Sentence: 658,stress,O
Sentence: 658,led,O
Sentence: 658,to,O
Sentence: 658,prolonged,O
Sentence: 658,but,O
Sentence: 658,reversible,O
Sentence: 658,systolic,O
Sentence: 658,and,O
Sentence: 658,diastolic,O
Sentence: 658,dysfunction,O
Sentence: 658,.,O
Sentence: 658,There,O
Sentence: 658,was,O
Sentence: 658,no,O
Sentence: 658,difference,O
Sentence: 658,in,O
Sentence: 658,the,O
Sentence: 658,maximum,O
Sentence: 658,double,O
Sentence: 658,product,O
Sentence: 658,(,O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,=,O
Sentence: 658,,O
Sentence: 658,0.53,O
Sentence: 658,),O
Sentence: 658,or,O
Sentence: 658,ST,O
Sentence: 658,depression,B-Disease
Sentence: 658,(,O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,=,O
Sentence: 658,,O
Sentence: 658,0.63,O
Sentence: 658,),O
Sentence: 658,with,O
Sentence: 658,either,O
Sentence: 658,form,O
Sentence: 658,of,O
Sentence: 658,stress,O
Sentence: 658,.,O
Sentence: 658,After,O
Sentence: 658,exercise,O
Sentence: 658,",",O
Sentence: 658,ejection,O
Sentence: 658,fraction,O
Sentence: 658,was,O
Sentence: 658,reduced,O
Sentence: 658,at,O
Sentence: 658,15,O
Sentence: 658,and,O
Sentence: 658,30,O
Sentence: 658,minutes,O
Sentence: 658,compared,O
Sentence: 658,with,O
Sentence: 658,baseline,O
Sentence: 658,(,O
Sentence: 658,mean,O
Sentence: 658,(,O
Sentence: 658,SEM,O
Sentence: 658,),O
Sentence: 658,",",O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,5.6,O
Sentence: 658,(,O
Sentence: 658,1.5,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,",",O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0.05,O
Sentence: 658,;,O
Sentence: 658,and,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,6.1,O
Sentence: 658,(,O
Sentence: 658,2.2,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,",",O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0,O
Sentence: 658,.,O
Sentence: 658,01,O
Sentence: 658,),O
Sentence: 658,",",O
Sentence: 658,and,O
Sentence: 658,at,O
Sentence: 658,30,O
Sentence: 658,and,O
Sentence: 658,45,O
Sentence: 658,minutes,O
Sentence: 658,after,O
Sentence: 658,dobutamine,B-Chemical
Sentence: 658,(,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,10.8,O
Sentence: 658,(,O
Sentence: 658,1.8,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,and,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,5,O
Sentence: 658,.,O
Sentence: 658,5,O
Sentence: 658,(,O
Sentence: 658,1.8,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,",",O
Sentence: 658,both,O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0.01,O
Sentence: 658,),O
Sentence: 658,.,O
Sentence: 658,Regional,O
Sentence: 658,analysis,O
Sentence: 658,showed,O
Sentence: 658,a,O
Sentence: 658,reduction,O
Sentence: 658,in,O
Sentence: 658,the,O
Sentence: 658,worst,O
Sentence: 658,affected,O
Sentence: 658,segment,O
Sentence: 658,15,O
Sentence: 658,and,O
Sentence: 658,30,O
Sentence: 658,minutes,O
Sentence: 658,after,O
Sentence: 658,exercise,O
Sentence: 658,(,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,27.9,O
Sentence: 658,(,O
Sentence: 658,7.2,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,and,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,28.6,O
Sentence: 658,(,O
Sentence: 658,5.7,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,",",O
Sentence: 658,both,O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0.01,O
Sentence: 658,),O
Sentence: 658,",",O
Sentence: 658,and,O
Sentence: 658,at,O
Sentence: 658,30,O
Sentence: 658,minutes,O
Sentence: 658,after,O
Sentence: 658,dobutamine,B-Chemical
Sentence: 658,(,O
Sentence: 658,,O
Sentence: 658,-,O
Sentence: 658,32,O
Sentence: 658,(,O
Sentence: 658,5.3,O
Sentence: 658,),O
Sentence: 658,%,O
Sentence: 658,",",O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0.01,O
Sentence: 658,),O
Sentence: 658,.,O
Sentence: 658,The,O
Sentence: 658,isovolumic,O
Sentence: 658,relaxation,O
Sentence: 658,period,O
Sentence: 658,was,O
Sentence: 658,prolonged,O
Sentence: 658,45,O
Sentence: 658,minutes,O
Sentence: 658,after,O
Sentence: 658,each,O
Sentence: 658,form,O
Sentence: 658,of,O
Sentence: 658,stress,O
Sentence: 658,(,O
Sentence: 658,p,O
Sentence: 658,,O
Sentence: 658,<,O
Sentence: 658,,O
Sentence: 658,0.05,O
Sentence: 658,),O
Sentence: 658,.,O
Sentence: 658,CONCLUSIONS,O
Sentence: 658,:,O
Sentence: 658,In,O
Sentence: 658,patients,O
Sentence: 658,with,O
Sentence: 658,coronary,B-Disease
Sentence: 658,artery,I-Disease
Sentence: 658,disease,I-Disease
Sentence: 658,",",O
Sentence: 658,dobutamine,B-Chemical
Sentence: 658,induced,O
Sentence: 658,ischaemia,B-Disease
Sentence: 658,results,O
Sentence: 658,in,O
Sentence: 658,prolonged,O
Sentence: 658,reversible,O
Sentence: 658,left,B-Disease
Sentence: 658,ventricular,I-Disease
Sentence: 658,dysfunction,I-Disease
Sentence: 658,",",O
Sentence: 658,presumed,O
Sentence: 658,to,O
Sentence: 658,be,O
Sentence: 658,myocardial,B-Disease
Sentence: 658,stunning,I-Disease
Sentence: 658,",",O
Sentence: 658,similar,O
Sentence: 658,to,O
Sentence: 658,that,O
Sentence: 658,seen,O
Sentence: 658,after,O
Sentence: 658,exercise,O
Sentence: 658,.,O
Sentence: 658,Dobutamine,B-Chemical
Sentence: 658,induced,O
Sentence: 658,ischaemia,B-Disease
Sentence: 658,could,O
Sentence: 658,therefore,O
Sentence: 658,be,O
Sentence: 658,used,O
Sentence: 658,to,O
Sentence: 658,study,O
Sentence: 658,the,O
Sentence: 658,pathophysiology,O
Sentence: 658,of,O
Sentence: 658,this,O
Sentence: 658,phenomenon,O
Sentence: 658,further,O
Sentence: 658,in,O
Sentence: 658,patients,O
Sentence: 658,with,O
Sentence: 658,coronary,B-Disease
Sentence: 658,artery,I-Disease
Sentence: 658,disease,I-Disease
Sentence: 658,.,O
Sentence: 659,Anorexigens,O
Sentence: 659,and,O
Sentence: 659,pulmonary,B-Disease
Sentence: 659,hypertension,I-Disease
Sentence: 659,in,O
Sentence: 659,the,O
Sentence: 659,United,O
Sentence: 659,States,O
Sentence: 659,:,O
Sentence: 659,results,O
Sentence: 659,from,O
Sentence: 659,the,O
Sentence: 659,surveillance,O
Sentence: 659,of,O
Sentence: 659,North,O
Sentence: 659,American,O
Sentence: 659,pulmonary,B-Disease
Sentence: 659,hypertension,I-Disease
Sentence: 659,.,O
Sentence: 660,BACKGROUND,O
Sentence: 660,:,O
Sentence: 660,The,O
Sentence: 660,use,O
Sentence: 660,of,O
Sentence: 660,appetite,O
Sentence: 660,suppressants,O
Sentence: 660,in,O
Sentence: 660,Europe,O
Sentence: 660,has,O
Sentence: 660,been,O
Sentence: 660,associated,O
Sentence: 660,with,O
Sentence: 660,the,O
Sentence: 660,development,O
Sentence: 660,of,O
Sentence: 660,primary,B-Disease
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,(,O
Sentence: 660,PPH,B-Disease
Sentence: 660,),O
Sentence: 660,.,O
Sentence: 660,Recently,O
Sentence: 660,",",O
Sentence: 660,fenfluramine,B-Chemical
Sentence: 660,appetite,O
Sentence: 660,suppressants,O
Sentence: 660,became,O
Sentence: 660,widely,O
Sentence: 660,used,O
Sentence: 660,in,O
Sentence: 660,the,O
Sentence: 660,United,O
Sentence: 660,States,O
Sentence: 660,but,O
Sentence: 660,were,O
Sentence: 660,withdrawn,O
Sentence: 660,in,O
Sentence: 660,September,O
Sentence: 660,1997,O
Sentence: 660,because,O
Sentence: 660,of,O
Sentence: 660,concerns,O
Sentence: 660,over,O
Sentence: 660,adverse,O
Sentence: 660,effects,O
Sentence: 660,.,O
Sentence: 660,MATERIALS,O
Sentence: 660,AND,O
Sentence: 660,METHODS,O
Sentence: 660,:,O
Sentence: 660,We,O
Sentence: 660,conducted,O
Sentence: 660,a,O
Sentence: 660,prospective,O
Sentence: 660,surveillance,O
Sentence: 660,study,O
Sentence: 660,on,O
Sentence: 660,patients,O
Sentence: 660,diagnosed,O
Sentence: 660,with,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,at,O
Sentence: 660,12,O
Sentence: 660,large,O
Sentence: 660,referral,O
Sentence: 660,centers,O
Sentence: 660,in,O
Sentence: 660,North,O
Sentence: 660,America,O
Sentence: 660,.,O
Sentence: 660,Data,O
Sentence: 660,collected,O
Sentence: 660,on,O
Sentence: 660,patients,O
Sentence: 660,seen,O
Sentence: 660,from,O
Sentence: 660,September,O
Sentence: 660,1,O
Sentence: 660,",",O
Sentence: 660,1996,O
Sentence: 660,",",O
Sentence: 660,to,O
Sentence: 660,December,O
Sentence: 660,31,O
Sentence: 660,",",O
Sentence: 660,1997,O
Sentence: 660,",",O
Sentence: 660,included,O
Sentence: 660,the,O
Sentence: 660,cause,O
Sentence: 660,of,O
Sentence: 660,the,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,and,O
Sentence: 660,its,O
Sentence: 660,severity,O
Sentence: 660,.,O
Sentence: 660,Patients,O
Sentence: 660,with,O
Sentence: 660,no,O
Sentence: 660,identifiable,O
Sentence: 660,cause,O
Sentence: 660,of,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,were,O
Sentence: 660,classed,O
Sentence: 660,as,O
Sentence: 660,PPH,B-Disease
Sentence: 660,.,O
Sentence: 660,A,O
Sentence: 660,history,O
Sentence: 660,of,O
Sentence: 660,drug,O
Sentence: 660,exposure,O
Sentence: 660,also,O
Sentence: 660,was,O
Sentence: 660,taken,O
Sentence: 660,with,O
Sentence: 660,special,O
Sentence: 660,attention,O
Sentence: 660,on,O
Sentence: 660,the,O
Sentence: 660,use,O
Sentence: 660,of,O
Sentence: 660,antidepressants,O
Sentence: 660,",",O
Sentence: 660,anorexigens,O
Sentence: 660,",",O
Sentence: 660,and,O
Sentence: 660,amphetamines,B-Chemical
Sentence: 660,.,O
Sentence: 660,RESULTS,O
Sentence: 660,:,O
Sentence: 660,Five,O
Sentence: 660,hundred,O
Sentence: 660,seventy,O
Sentence: 660,-,O
Sentence: 660,nine,O
Sentence: 660,patients,O
Sentence: 660,were,O
Sentence: 660,studied,O
Sentence: 660,",",O
Sentence: 660,205,O
Sentence: 660,with,O
Sentence: 660,PPH,B-Disease
Sentence: 660,and,O
Sentence: 660,374,O
Sentence: 660,with,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,from,O
Sentence: 660,other,O
Sentence: 660,causes,O
Sentence: 660,(,O
Sentence: 660,secondary,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,[,O
Sentence: 660,SPH,O
Sentence: 660,],O
Sentence: 660,),O
Sentence: 660,.,O
Sentence: 660,The,O
Sentence: 660,use,O
Sentence: 660,of,O
Sentence: 660,anorexigens,O
Sentence: 660,was,O
Sentence: 660,common,O
Sentence: 660,in,O
Sentence: 660,both,O
Sentence: 660,groups,O
Sentence: 660,.,O
Sentence: 660,However,O
Sentence: 660,",",O
Sentence: 660,of,O
Sentence: 660,the,O
Sentence: 660,medications,O
Sentence: 660,surveyed,O
Sentence: 660,",",O
Sentence: 660,only,O
Sentence: 660,the,O
Sentence: 660,fenfluramines,B-Chemical
Sentence: 660,had,O
Sentence: 660,a,O
Sentence: 660,significant,O
Sentence: 660,preferential,O
Sentence: 660,association,O
Sentence: 660,with,O
Sentence: 660,PPH,B-Disease
Sentence: 660,as,O
Sentence: 660,compared,O
Sentence: 660,with,O
Sentence: 660,SPH,O
Sentence: 660,(,O
Sentence: 660,adjusted,O
Sentence: 660,odds,O
Sentence: 660,ratio,O
Sentence: 660,for,O
Sentence: 660,use,O
Sentence: 660,,O
Sentence: 660,>,O
Sentence: 660,,O
Sentence: 660,6,O
Sentence: 660,months,O
Sentence: 660,",",O
Sentence: 660,7.5,O
Sentence: 660,;,O
Sentence: 660,95,O
Sentence: 660,%,O
Sentence: 660,confidence,O
Sentence: 660,interval,O
Sentence: 660,",",O
Sentence: 660,1.7,O
Sentence: 660,to,O
Sentence: 660,32.4,O
Sentence: 660,),O
Sentence: 660,.,O
Sentence: 660,The,O
Sentence: 660,association,O
Sentence: 660,was,O
Sentence: 660,stronger,O
Sentence: 660,with,O
Sentence: 660,longer,O
Sentence: 660,duration,O
Sentence: 660,of,O
Sentence: 660,use,O
Sentence: 660,when,O
Sentence: 660,compared,O
Sentence: 660,to,O
Sentence: 660,shorter,O
Sentence: 660,duration,O
Sentence: 660,of,O
Sentence: 660,use,O
Sentence: 660,and,O
Sentence: 660,was,O
Sentence: 660,more,O
Sentence: 660,pronounced,O
Sentence: 660,in,O
Sentence: 660,recent,O
Sentence: 660,users,O
Sentence: 660,than,O
Sentence: 660,in,O
Sentence: 660,remote,O
Sentence: 660,users,O
Sentence: 660,.,O
Sentence: 660,An,O
Sentence: 660,unexpectedly,O
Sentence: 660,high,O
Sentence: 660,(,O
Sentence: 660,11.4,O
Sentence: 660,%,O
Sentence: 660,),O
Sentence: 660,number,O
Sentence: 660,of,O
Sentence: 660,patients,O
Sentence: 660,with,O
Sentence: 660,SPH,O
Sentence: 660,had,O
Sentence: 660,used,O
Sentence: 660,anorexigens,O
Sentence: 660,.,O
Sentence: 660,CONCLUSION,O
Sentence: 660,:,O
Sentence: 660,The,O
Sentence: 660,magnitude,O
Sentence: 660,of,O
Sentence: 660,the,O
Sentence: 660,association,O
Sentence: 660,with,O
Sentence: 660,PPH,B-Disease
Sentence: 660,",",O
Sentence: 660,the,O
Sentence: 660,increase,O
Sentence: 660,of,O
Sentence: 660,association,O
Sentence: 660,with,O
Sentence: 660,increasing,O
Sentence: 660,duration,O
Sentence: 660,of,O
Sentence: 660,use,O
Sentence: 660,",",O
Sentence: 660,and,O
Sentence: 660,the,O
Sentence: 660,specificity,O
Sentence: 660,for,O
Sentence: 660,fenfluramines,B-Chemical
Sentence: 660,are,O
Sentence: 660,consistent,O
Sentence: 660,with,O
Sentence: 660,previous,O
Sentence: 660,studies,O
Sentence: 660,indicating,O
Sentence: 660,that,O
Sentence: 660,fenfluramines,B-Chemical
Sentence: 660,are,O
Sentence: 660,causally,O
Sentence: 660,related,O
Sentence: 660,to,O
Sentence: 660,PPH,B-Disease
Sentence: 660,.,O
Sentence: 660,The,O
Sentence: 660,high,O
Sentence: 660,prevalence,O
Sentence: 660,of,O
Sentence: 660,anorexigen,O
Sentence: 660,use,O
Sentence: 660,in,O
Sentence: 660,patients,O
Sentence: 660,with,O
Sentence: 660,SPH,O
Sentence: 660,also,O
Sentence: 660,raises,O
Sentence: 660,the,O
Sentence: 660,possibility,O
Sentence: 660,that,O
Sentence: 660,these,O
Sentence: 660,drugs,O
Sentence: 660,precipitate,O
Sentence: 660,pulmonary,B-Disease
Sentence: 660,hypertension,I-Disease
Sentence: 660,in,O
Sentence: 660,patients,O
Sentence: 660,with,O
Sentence: 660,underlying,O
Sentence: 660,conditions,O
Sentence: 660,associated,O
Sentence: 660,with,O
Sentence: 660,SPH,O
Sentence: 660,.,O
Sentence: 661,Clinical,O
Sentence: 661,aspects,O
Sentence: 661,of,O
Sentence: 661,heparin,B-Chemical
Sentence: 661,-,O
Sentence: 661,induced,O
Sentence: 661,thrombocytopenia,B-Disease
Sentence: 661,and,O
Sentence: 661,thrombosis,B-Disease
Sentence: 661,and,O
Sentence: 661,other,O
Sentence: 661,side,O
Sentence: 661,effects,O
Sentence: 661,of,O
Sentence: 661,heparin,B-Chemical
Sentence: 661,therapy,O
Sentence: 661,.,O
Sentence: 662,Heparin,B-Chemical
Sentence: 662,",",O
Sentence: 662,first,O
Sentence: 662,used,O
Sentence: 662,to,O
Sentence: 662,prevent,O
Sentence: 662,the,O
Sentence: 662,clotting,O
Sentence: 662,of,O
Sentence: 662,blood,O
Sentence: 662,in,O
Sentence: 662,vitro,O
Sentence: 662,",",O
Sentence: 662,has,O
Sentence: 662,been,O
Sentence: 662,clinically,O
Sentence: 662,used,O
Sentence: 662,to,O
Sentence: 662,treat,O
Sentence: 662,thrombosis,B-Disease
Sentence: 662,for,O
Sentence: 662,more,O
Sentence: 662,than,O
Sentence: 662,50,O
Sentence: 662,years,O
Sentence: 662,.,O
Sentence: 662,Although,O
Sentence: 662,several,O
Sentence: 662,new,O
Sentence: 662,anticoagulant,O
Sentence: 662,drugs,O
Sentence: 662,are,O
Sentence: 662,in,O
Sentence: 662,development,O
Sentence: 662,",",O
Sentence: 662,heparin,B-Chemical
Sentence: 662,remains,O
Sentence: 662,the,O
Sentence: 662,anticoagulant,O
Sentence: 662,of,O
Sentence: 662,choice,O
Sentence: 662,to,O
Sentence: 662,treat,O
Sentence: 662,acute,O
Sentence: 662,thrombotic,B-Disease
Sentence: 662,episodes,O
Sentence: 662,.,O
Sentence: 662,The,O
Sentence: 662,clinical,O
Sentence: 662,effects,O
Sentence: 662,of,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,are,O
Sentence: 662,meritorious,O
Sentence: 662,",",O
Sentence: 662,but,O
Sentence: 662,side,O
Sentence: 662,effects,O
Sentence: 662,do,O
Sentence: 662,exist,O
Sentence: 662,.,O
Sentence: 662,Bleeding,B-Disease
Sentence: 662,is,O
Sentence: 662,the,O
Sentence: 662,primary,O
Sentence: 662,untoward,O
Sentence: 662,effect,O
Sentence: 662,of,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,.,O
Sentence: 662,Major,O
Sentence: 662,bleeding,B-Disease
Sentence: 662,is,O
Sentence: 662,of,O
Sentence: 662,primary,O
Sentence: 662,concern,O
Sentence: 662,in,O
Sentence: 662,patients,O
Sentence: 662,receiving,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,therapy,O
Sentence: 662,.,O
Sentence: 662,However,O
Sentence: 662,",",O
Sentence: 662,additional,O
Sentence: 662,important,O
Sentence: 662,untoward,O
Sentence: 662,effects,O
Sentence: 662,of,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,therapy,O
Sentence: 662,include,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,-,O
Sentence: 662,induced,O
Sentence: 662,thrombocytopenia,B-Disease
Sentence: 662,",",O
Sentence: 662,heparin,B-Chemical
Sentence: 662,-,O
Sentence: 662,associated,O
Sentence: 662,osteoporosis,B-Disease
Sentence: 662,",",O
Sentence: 662,eosinophilia,B-Disease
Sentence: 662,",",O
Sentence: 662,skin,B-Disease
Sentence: 662,reactions,I-Disease
Sentence: 662,",",O
Sentence: 662,allergic,B-Disease
Sentence: 662,reactions,I-Disease
Sentence: 662,other,O
Sentence: 662,than,O
Sentence: 662,thrombocytopenia,B-Disease
Sentence: 662,",",O
Sentence: 662,alopecia,B-Disease
Sentence: 662,",",O
Sentence: 662,transaminasemia,O
Sentence: 662,",",O
Sentence: 662,hyperkalemia,B-Disease
Sentence: 662,",",O
Sentence: 662,hypoaldosteronism,B-Disease
Sentence: 662,",",O
Sentence: 662,and,O
Sentence: 662,priapism,B-Disease
Sentence: 662,.,O
Sentence: 662,These,O
Sentence: 662,side,O
Sentence: 662,effects,O
Sentence: 662,are,O
Sentence: 662,relatively,O
Sentence: 662,rare,O
Sentence: 662,in,O
Sentence: 662,a,O
Sentence: 662,given,O
Sentence: 662,individual,O
Sentence: 662,",",O
Sentence: 662,but,O
Sentence: 662,given,O
Sentence: 662,the,O
Sentence: 662,extremely,O
Sentence: 662,widespread,O
Sentence: 662,use,O
Sentence: 662,of,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,",",O
Sentence: 662,some,O
Sentence: 662,are,O
Sentence: 662,quite,O
Sentence: 662,common,O
Sentence: 662,",",O
Sentence: 662,particularly,O
Sentence: 662,HITT,B-Disease
Sentence: 662,and,O
Sentence: 662,osteoporosis,B-Disease
Sentence: 662,.,O
Sentence: 662,Although,O
Sentence: 662,reasonable,O
Sentence: 662,incidences,O
Sentence: 662,of,O
Sentence: 662,many,O
Sentence: 662,of,O
Sentence: 662,these,O
Sentence: 662,side,O
Sentence: 662,effects,O
Sentence: 662,can,O
Sentence: 662,be,O
Sentence: 662,``,O
Sentence: 662,softly,O
Sentence: 662,'',O
Sentence: 662,deduced,O
Sentence: 662,from,O
Sentence: 662,current,O
Sentence: 662,reports,O
Sentence: 662,dealing,O
Sentence: 662,with,O
Sentence: 662,unfractionated,O
Sentence: 662,heparin,B-Chemical
Sentence: 662,",",O
Sentence: 662,at,O
Sentence: 662,present,O
Sentence: 662,the,O
Sentence: 662,incidences,O
Sentence: 662,of,O
Sentence: 662,these,O
Sentence: 662,side,O
Sentence: 662,effects,O
Sentence: 662,with,O
Sentence: 662,newer,O
Sentence: 662,low,O
Sentence: 662,molecular,O
Sentence: 662,weight,O
Sentence: 662,heparins,B-Chemical
Sentence: 662,appear,O
Sentence: 662,to,O
Sentence: 662,be,O
Sentence: 662,much,O
Sentence: 662,less,O
Sentence: 662,common,O
Sentence: 662,.,O
Sentence: 662,However,O
Sentence: 662,",",O
Sentence: 662,only,O
Sentence: 662,longer,O
Sentence: 662,experience,O
Sentence: 662,will,O
Sentence: 662,more,O
Sentence: 662,clearly,O
Sentence: 662,define,O
Sentence: 662,the,O
Sentence: 662,incidence,O
Sentence: 662,of,O
Sentence: 662,each,O
Sentence: 662,side,O
Sentence: 662,effect,O
Sentence: 662,with,O
Sentence: 662,low,O
Sentence: 662,molecular,O
Sentence: 662,weight,O
Sentence: 662,preparations,O
Sentence: 662,.,O
Sentence: 663,A,O
Sentence: 663,case,O
Sentence: 663,of,O
Sentence: 663,bilateral,O
Sentence: 663,optic,B-Disease
Sentence: 663,neuropathy,I-Disease
Sentence: 663,in,O
Sentence: 663,a,O
Sentence: 663,patient,O
Sentence: 663,on,O
Sentence: 663,tacrolimus,B-Chemical
Sentence: 663,(,O
Sentence: 663,FK506,B-Chemical
Sentence: 663,),O
Sentence: 663,therapy,O
Sentence: 663,after,O
Sentence: 663,liver,O
Sentence: 663,transplantation,O
Sentence: 663,.,O
Sentence: 664,PURPOSE,O
Sentence: 664,:,O
Sentence: 664,To,O
Sentence: 664,report,O
Sentence: 664,a,O
Sentence: 664,case,O
Sentence: 664,of,O
Sentence: 664,bilateral,O
Sentence: 664,optic,B-Disease
Sentence: 664,neuropathy,I-Disease
Sentence: 664,in,O
Sentence: 664,a,O
Sentence: 664,patient,O
Sentence: 664,receiving,O
Sentence: 664,tacrolimus,B-Chemical
Sentence: 664,(,O
Sentence: 664,FK,B-Chemical
Sentence: 664,506,I-Chemical
Sentence: 664,",",O
Sentence: 664,Prograf,O
Sentence: 664,;,O
Sentence: 664,Fujisawa,O
Sentence: 664,USA,O
Sentence: 664,",",O
Sentence: 664,Inc,O
Sentence: 664,",",O
Sentence: 664,Deerfield,O
Sentence: 664,",",O
Sentence: 664,Illinois,O
Sentence: 664,),O
Sentence: 664,for,O
Sentence: 664,immunosuppression,O
Sentence: 664,after,O
Sentence: 664,orthotropic,O
Sentence: 664,liver,O
Sentence: 664,transplantation,O
Sentence: 664,.,O
Sentence: 664,METHOD,O
Sentence: 664,:,O
Sentence: 664,Case,O
Sentence: 664,report,O
Sentence: 664,.,O
Sentence: 664,In,O
Sentence: 664,a,O
Sentence: 664,58,O
Sentence: 664,-,O
Sentence: 664,year,O
Sentence: 664,-,O
Sentence: 664,old,O
Sentence: 664,man,O
Sentence: 664,receiving,O
Sentence: 664,tacrolimus,B-Chemical
Sentence: 664,after,O
Sentence: 664,orthotropic,O
Sentence: 664,liver,O
Sentence: 664,transplantation,O
Sentence: 664,",",O
Sentence: 664,serial,O
Sentence: 664,neuro,O
Sentence: 664,-,O
Sentence: 664,ophthalmologic,O
Sentence: 664,examinations,O
Sentence: 664,and,O
Sentence: 664,laboratory,O
Sentence: 664,studies,O
Sentence: 664,were,O
Sentence: 664,performed,O
Sentence: 664,.,O
Sentence: 664,RESULTS,O
Sentence: 664,:,O
Sentence: 664,The,O
Sentence: 664,patient,O
Sentence: 664,had,O
Sentence: 664,episodic,O
Sentence: 664,deterioration,O
Sentence: 664,of,O
Sentence: 664,vision,O
Sentence: 664,in,O
Sentence: 664,both,O
Sentence: 664,eyes,O
Sentence: 664,",",O
Sentence: 664,with,O
Sentence: 664,clinical,O
Sentence: 664,features,O
Sentence: 664,resembling,O
Sentence: 664,ischemic,B-Disease
Sentence: 664,optic,I-Disease
Sentence: 664,neuropathies,I-Disease
Sentence: 664,.,O
Sentence: 664,Deterioration,B-Disease
Sentence: 664,of,I-Disease
Sentence: 664,vision,I-Disease
Sentence: 664,occurred,O
Sentence: 664,despite,O
Sentence: 664,discontinuation,O
Sentence: 664,of,O
Sentence: 664,the,O
Sentence: 664,tacrolimus,B-Chemical
Sentence: 664,.,O
Sentence: 664,CONCLUSION,O
Sentence: 664,:,O
Sentence: 664,Tacrolimus,B-Chemical
Sentence: 664,and,O
Sentence: 664,other,O
Sentence: 664,immunosuppressive,O
Sentence: 664,agents,O
Sentence: 664,may,O
Sentence: 664,be,O
Sentence: 664,associated,O
Sentence: 664,with,O
Sentence: 664,optic,B-Disease
Sentence: 664,nerve,I-Disease
Sentence: 664,toxicity,I-Disease
Sentence: 664,.,O
Sentence: 665,Hypercalcemia,B-Disease
Sentence: 665,",",O
Sentence: 665,arrhythmia,B-Disease
Sentence: 665,",",O
Sentence: 665,and,O
Sentence: 665,mood,O
Sentence: 665,stabilizers,O
Sentence: 665,.,O
Sentence: 666,Recent,O
Sentence: 666,findings,O
Sentence: 666,in,O
Sentence: 666,a,O
Sentence: 666,bipolar,B-Disease
Sentence: 666,patient,O
Sentence: 666,receiving,O
Sentence: 666,maintenance,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,therapy,O
Sentence: 666,who,O
Sentence: 666,developed,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,and,O
Sentence: 666,severe,O
Sentence: 666,bradyarrhythmia,B-Disease
Sentence: 666,prompted,O
Sentence: 666,the,O
Sentence: 666,authors,O
Sentence: 666,to,O
Sentence: 666,conduct,O
Sentence: 666,a,O
Sentence: 666,retrospective,O
Sentence: 666,study,O
Sentence: 666,of,O
Sentence: 666,bipolar,B-Disease
Sentence: 666,patients,O
Sentence: 666,with,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,-,O
Sentence: 666,associated,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,.,O
Sentence: 666,A,O
Sentence: 666,printout,O
Sentence: 666,of,O
Sentence: 666,all,O
Sentence: 666,cases,O
Sentence: 666,of,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,that,O
Sentence: 666,presented,O
Sentence: 666,during,O
Sentence: 666,a,O
Sentence: 666,1,O
Sentence: 666,-,O
Sentence: 666,year,O
Sentence: 666,period,O
Sentence: 666,was,O
Sentence: 666,generated,O
Sentence: 666,.,O
Sentence: 666,After,O
Sentence: 666,eliminating,O
Sentence: 666,spurious,O
Sentence: 666,hypercalcemias,B-Disease
Sentence: 666,or,O
Sentence: 666,those,O
Sentence: 666,associated,O
Sentence: 666,with,O
Sentence: 666,intravenous,O
Sentence: 666,fluids,O
Sentence: 666,",",O
Sentence: 666,the,O
Sentence: 666,authors,O
Sentence: 666,identified,O
Sentence: 666,18,O
Sentence: 666,non,O
Sentence: 666,-,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,-,O
Sentence: 666,treated,O
Sentence: 666,patients,O
Sentence: 666,with,O
Sentence: 666,hypercalcemias,B-Disease
Sentence: 666,related,O
Sentence: 666,to,O
Sentence: 666,malignancies,B-Disease
Sentence: 666,and,O
Sentence: 666,other,O
Sentence: 666,medical,O
Sentence: 666,conditions,O
Sentence: 666,(,O
Sentence: 666,group,O
Sentence: 666,A,O
Sentence: 666,),O
Sentence: 666,and,O
Sentence: 666,12,O
Sentence: 666,patients,O
Sentence: 666,with,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,-,O
Sentence: 666,associated,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,(,O
Sentence: 666,group,O
Sentence: 666,B,O
Sentence: 666,),O
Sentence: 666,.,O
Sentence: 666,Patients,O
Sentence: 666,in,O
Sentence: 666,group,O
Sentence: 666,B,O
Sentence: 666,were,O
Sentence: 666,not,O
Sentence: 666,comparable,O
Sentence: 666,to,O
Sentence: 666,those,O
Sentence: 666,in,O
Sentence: 666,group,O
Sentence: 666,A,O
Sentence: 666,",",O
Sentence: 666,as,O
Sentence: 666,the,O
Sentence: 666,latter,O
Sentence: 666,were,O
Sentence: 666,medically,O
Sentence: 666,compromised,O
Sentence: 666,and,O
Sentence: 666,were,O
Sentence: 666,receiving,O
Sentence: 666,multiple,O
Sentence: 666,pharmacotherapies,O
Sentence: 666,.,O
Sentence: 666,Thus,O
Sentence: 666,",",O
Sentence: 666,two,O
Sentence: 666,control,O
Sentence: 666,groups,O
Sentence: 666,were,O
Sentence: 666,generated,O
Sentence: 666,:,O
Sentence: 666,group,O
Sentence: 666,C1,O
Sentence: 666,",",O
Sentence: 666,which,O
Sentence: 666,included,O
Sentence: 666,age,O
Sentence: 666,-,O
Sentence: 666,,O
Sentence: 666,and,O
Sentence: 666,sex,O
Sentence: 666,-,O
Sentence: 666,comparable,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,-,O
Sentence: 666,treated,O
Sentence: 666,bipolar,B-Disease
Sentence: 666,normocalcemic,O
Sentence: 666,patients,O
Sentence: 666,",",O
Sentence: 666,and,O
Sentence: 666,group,O
Sentence: 666,C2,O
Sentence: 666,",",O
Sentence: 666,which,O
Sentence: 666,included,O
Sentence: 666,bipolar,B-Disease
Sentence: 666,normocalcemic,O
Sentence: 666,patients,O
Sentence: 666,treated,O
Sentence: 666,with,O
Sentence: 666,anticonvulsant,O
Sentence: 666,mood,O
Sentence: 666,stabilizers,O
Sentence: 666,.,O
Sentence: 666,The,O
Sentence: 666,electrocardiographic,O
Sentence: 666,(,O
Sentence: 666,ECG,O
Sentence: 666,),O
Sentence: 666,findings,O
Sentence: 666,for,O
Sentence: 666,patients,O
Sentence: 666,in,O
Sentence: 666,group,O
Sentence: 666,B,O
Sentence: 666,were,O
Sentence: 666,compared,O
Sentence: 666,with,O
Sentence: 666,those,O
Sentence: 666,of,O
Sentence: 666,patients,O
Sentence: 666,in,O
Sentence: 666,groups,O
Sentence: 666,C1,O
Sentence: 666,and,O
Sentence: 666,C2,O
Sentence: 666,.,O
Sentence: 666,It,O
Sentence: 666,was,O
Sentence: 666,found,O
Sentence: 666,that,O
Sentence: 666,these,O
Sentence: 666,groups,O
Sentence: 666,did,O
Sentence: 666,not,O
Sentence: 666,differ,O
Sentence: 666,in,O
Sentence: 666,their,O
Sentence: 666,overall,O
Sentence: 666,frequency,O
Sentence: 666,of,O
Sentence: 666,ECG,O
Sentence: 666,abnormalities,O
Sentence: 666,;,O
Sentence: 666,however,O
Sentence: 666,",",O
Sentence: 666,there,O
Sentence: 666,were,O
Sentence: 666,significant,O
Sentence: 666,differences,O
Sentence: 666,in,O
Sentence: 666,the,O
Sentence: 666,frequency,O
Sentence: 666,of,O
Sentence: 666,conduction,O
Sentence: 666,defects,O
Sentence: 666,.,O
Sentence: 666,Patients,O
Sentence: 666,with,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,resulting,O
Sentence: 666,from,O
Sentence: 666,medical,O
Sentence: 666,diseases,O
Sentence: 666,and,O
Sentence: 666,bipolar,B-Disease
Sentence: 666,patients,O
Sentence: 666,with,O
Sentence: 666,lithium,B-Chemical
Sentence: 666,-,O
Sentence: 666,associated,O
Sentence: 666,hypercalcemia,B-Disease
Sentence: 666,had,O
Sentence: 666,significantly,O
Sentence: 666,higher,O
Sentence: 666,frequencies,O
Sentence: 666,of,O
Sentence: 666,conduction,O
Sentence: 666,defects,O
Sentence: 666,.,O
Sentence: 666,Patients,O
Sentence: 666,in,O
Sentence: 666,group,O
Sentence: 666,A,O
Sentence: 666,had,O
Sentence: 666,significant,O
Sentence: 666,mortality,O
Sentence: 666,at,O
Sentence: 666,2,O
Sentence: 666,-,O
Sentence: 666,year,O
Sentence: 666,follow,O
Sentence: 666,-,O
Sentence: 666,up,O
Sentence: 666,(,O
Sentence: 666,28,O
Sentence: 666,%,O
Sentence: 666,),O
Sentence: 666,",",O
Sentence: 666,in,O
Sentence: 666,contrast,O
Sentence: 666,to,O
Sentence: 666,zero,O
Sentence: 666,mortality,O
Sentence: 666,in,O
Sentence: 666,the,O
Sentence: 666,other,O
Sentence: 666,three,O
Sentence: 666,groups,O
Sentence: 666,.,O
Sentence: 666,The,O
Sentence: 666,clinical,O
Sentence: 666,implications,O
Sentence: 666,of,O
Sentence: 666,these,O
Sentence: 666,findings,O
Sentence: 666,are,O
Sentence: 666,discussed,O
Sentence: 666,.,O
Sentence: 667,Attenuation,O
Sentence: 667,of,O
Sentence: 667,nephrotoxicity,B-Disease
Sentence: 667,by,O
Sentence: 667,a,O
Sentence: 667,novel,O
Sentence: 667,lipid,O
Sentence: 667,nanosphere,O
Sentence: 667,(,O
Sentence: 667,NS,O
Sentence: 667,-,O
Sentence: 667,718,O
Sentence: 667,),O
Sentence: 667,incorporating,O
Sentence: 667,amphotericin,B-Chemical
Sentence: 667,B,I-Chemical
Sentence: 667,.,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,",",O
Sentence: 668,a,O
Sentence: 668,lipid,O
Sentence: 668,nanosphere,O
Sentence: 668,incorporating,O
Sentence: 668,amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,",",O
Sentence: 668,is,O
Sentence: 668,effective,O
Sentence: 668,against,O
Sentence: 668,pathogenic,O
Sentence: 668,fungi,O
Sentence: 668,and,O
Sentence: 668,has,O
Sentence: 668,low,O
Sentence: 668,toxicity,B-Disease
Sentence: 668,.,O
Sentence: 668,We,O
Sentence: 668,compared,O
Sentence: 668,the,O
Sentence: 668,toxicity,B-Disease
Sentence: 668,of,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,with,O
Sentence: 668,that,O
Sentence: 668,of,O
Sentence: 668,Fungizone,B-Chemical
Sentence: 668,(,O
Sentence: 668,amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,-,O
Sentence: 668,sodium,O
Sentence: 668,deoxycholate,O
Sentence: 668,;,O
Sentence: 668,D,O
Sentence: 668,-,O
Sentence: 668,AmB,O
Sentence: 668,),O
Sentence: 668,in,O
Sentence: 668,vitro,O
Sentence: 668,using,O
Sentence: 668,renal,O
Sentence: 668,cell,O
Sentence: 668,cultures,O
Sentence: 668,and,O
Sentence: 668,in,O
Sentence: 668,vivo,O
Sentence: 668,by,O
Sentence: 668,biochemical,O
Sentence: 668,analysis,O
Sentence: 668,",",O
Sentence: 668,histopathological,O
Sentence: 668,study,O
Sentence: 668,of,O
Sentence: 668,the,O
Sentence: 668,kidney,O
Sentence: 668,and,O
Sentence: 668,pharmacokinetic,O
Sentence: 668,study,O
Sentence: 668,of,O
Sentence: 668,amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,following,O
Sentence: 668,intravenous,O
Sentence: 668,infusion,O
Sentence: 668,of,O
Sentence: 668,the,O
Sentence: 668,formulation,O
Sentence: 668,in,O
Sentence: 668,rats,O
Sentence: 668,.,O
Sentence: 668,Incubation,O
Sentence: 668,with,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,resulted,O
Sentence: 668,in,O
Sentence: 668,significantly,O
Sentence: 668,less,O
Sentence: 668,damage,O
Sentence: 668,of,O
Sentence: 668,cultured,O
Sentence: 668,human,O
Sentence: 668,renal,O
Sentence: 668,proximal,O
Sentence: 668,tubular,O
Sentence: 668,epithelial,O
Sentence: 668,cells,O
Sentence: 668,compared,O
Sentence: 668,with,O
Sentence: 668,D,O
Sentence: 668,-,O
Sentence: 668,AmB,O
Sentence: 668,.,O
Sentence: 668,Serum,O
Sentence: 668,blood,O
Sentence: 668,urea,B-Chemical
Sentence: 668,and,O
Sentence: 668,creatinine,B-Chemical
Sentence: 668,concentrations,O
Sentence: 668,increased,O
Sentence: 668,significantly,O
Sentence: 668,in,O
Sentence: 668,rats,O
Sentence: 668,given,O
Sentence: 668,an,O
Sentence: 668,iv,O
Sentence: 668,infusion,O
Sentence: 668,of,O
Sentence: 668,D,O
Sentence: 668,-,O
Sentence: 668,AmB,O
Sentence: 668,3,O
Sentence: 668,mg,O
Sentence: 668,/,O
Sentence: 668,kg,O
Sentence: 668,but,O
Sentence: 668,not,O
Sentence: 668,in,O
Sentence: 668,those,O
Sentence: 668,given,O
Sentence: 668,the,O
Sentence: 668,same,O
Sentence: 668,dose,O
Sentence: 668,of,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,.,O
Sentence: 668,Histopathological,O
Sentence: 668,examination,O
Sentence: 668,of,O
Sentence: 668,the,O
Sentence: 668,kidney,O
Sentence: 668,showed,O
Sentence: 668,tubular,B-Disease
Sentence: 668,necrosis,I-Disease
Sentence: 668,in,O
Sentence: 668,D,O
Sentence: 668,-,O
Sentence: 668,AmB,O
Sentence: 668,-,O
Sentence: 668,treated,O
Sentence: 668,rats,O
Sentence: 668,but,O
Sentence: 668,no,O
Sentence: 668,change,O
Sentence: 668,in,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,-,O
Sentence: 668,treated,O
Sentence: 668,rats,O
Sentence: 668,.,O
Sentence: 668,Amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,concentrations,O
Sentence: 668,in,O
Sentence: 668,the,O
Sentence: 668,kidney,O
Sentence: 668,in,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,-,O
Sentence: 668,treated,O
Sentence: 668,rats,O
Sentence: 668,were,O
Sentence: 668,higher,O
Sentence: 668,than,O
Sentence: 668,those,O
Sentence: 668,in,O
Sentence: 668,D,O
Sentence: 668,-,O
Sentence: 668,AmB,O
Sentence: 668,-,O
Sentence: 668,treated,O
Sentence: 668,rats,O
Sentence: 668,.,O
Sentence: 668,Our,O
Sentence: 668,in,O
Sentence: 668,vitro,O
Sentence: 668,and,O
Sentence: 668,in,O
Sentence: 668,vivo,O
Sentence: 668,results,O
Sentence: 668,suggest,O
Sentence: 668,that,O
Sentence: 668,incorporation,O
Sentence: 668,of,O
Sentence: 668,amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,into,O
Sentence: 668,lipid,O
Sentence: 668,nanospheres,O
Sentence: 668,of,O
Sentence: 668,NS,O
Sentence: 668,-,O
Sentence: 668,718,O
Sentence: 668,attenuates,O
Sentence: 668,the,O
Sentence: 668,nephrotoxicity,B-Disease
Sentence: 668,of,O
Sentence: 668,amphotericin,B-Chemical
Sentence: 668,B,I-Chemical
Sentence: 668,.,O
Sentence: 669,Patterns,O
Sentence: 669,of,O
Sentence: 669,sulfadiazine,B-Chemical
Sentence: 669,acute,B-Disease
Sentence: 669,nephrotoxicity,I-Disease
Sentence: 669,.,O
Sentence: 670,Sulfadiazine,B-Chemical
Sentence: 670,acute,B-Disease
Sentence: 670,nephrotoxicity,I-Disease
Sentence: 670,is,O
Sentence: 670,reviving,O
Sentence: 670,specially,O
Sentence: 670,because,O
Sentence: 670,of,O
Sentence: 670,its,O
Sentence: 670,use,O
Sentence: 670,in,O
Sentence: 670,toxoplasmosis,B-Disease
Sentence: 670,in,O
Sentence: 670,HIV,O
Sentence: 670,-,O
Sentence: 670,positive,O
Sentence: 670,patients,O
Sentence: 670,.,O
Sentence: 670,We,O
Sentence: 670,report,O
Sentence: 670,4,O
Sentence: 670,cases,O
Sentence: 670,",",O
Sentence: 670,one,O
Sentence: 670,of,O
Sentence: 670,them,O
Sentence: 670,in,O
Sentence: 670,a,O
Sentence: 670,previously,O
Sentence: 670,healthy,O
Sentence: 670,person,O
Sentence: 670,.,O
Sentence: 670,Under,O
Sentence: 670,treatment,O
Sentence: 670,with,O
Sentence: 670,sulfadiazine,B-Chemical
Sentence: 670,they,O
Sentence: 670,developed,O
Sentence: 670,oliguria,B-Disease
Sentence: 670,",",O
Sentence: 670,abdominal,B-Disease
Sentence: 670,pain,I-Disease
Sentence: 670,",",O
Sentence: 670,renal,B-Disease
Sentence: 670,failure,I-Disease
Sentence: 670,and,O
Sentence: 670,showed,O
Sentence: 670,multiple,O
Sentence: 670,radiolucent,O
Sentence: 670,renal,B-Disease
Sentence: 670,calculi,I-Disease
Sentence: 670,in,O
Sentence: 670,echography,O
Sentence: 670,.,O
Sentence: 670,All,O
Sentence: 670,patients,O
Sentence: 670,recovered,O
Sentence: 670,their,O
Sentence: 670,previous,O
Sentence: 670,normal,O
Sentence: 670,renal,O
Sentence: 670,function,O
Sentence: 670,after,O
Sentence: 670,adequate,O
Sentence: 670,hydration,O
Sentence: 670,and,O
Sentence: 670,alcalinization,O
Sentence: 670,.,O
Sentence: 670,A,O
Sentence: 670,nephrostomy,O
Sentence: 670,tube,O
Sentence: 670,had,O
Sentence: 670,to,O
Sentence: 670,be,O
Sentence: 670,placed,O
Sentence: 670,in,O
Sentence: 670,one,O
Sentence: 670,of,O
Sentence: 670,the,O
Sentence: 670,patients,O
Sentence: 670,for,O
Sentence: 670,ureteral,B-Disease
Sentence: 670,lithiasis,I-Disease
Sentence: 670,in,O
Sentence: 670,a,O
Sentence: 670,single,O
Sentence: 670,functional,O
Sentence: 670,kidney,O
Sentence: 670,.,O
Sentence: 670,None,O
Sentence: 670,of,O
Sentence: 670,them,O
Sentence: 670,needed,O
Sentence: 670,dialysis,O
Sentence: 670,or,O
Sentence: 670,a,O
Sentence: 670,renal,O
Sentence: 670,biopsy,O
Sentence: 670,because,O
Sentence: 670,of,O
Sentence: 670,a,O
Sentence: 670,typical,O
Sentence: 670,benign,O
Sentence: 670,course,O
Sentence: 670,.,O
Sentence: 670,Treatment,O
Sentence: 670,with,O
Sentence: 670,sulfadiazine,B-Chemical
Sentence: 670,requires,O
Sentence: 670,exquisite,O
Sentence: 670,control,O
Sentence: 670,of,O
Sentence: 670,renal,O
Sentence: 670,function,O
Sentence: 670,",",O
Sentence: 670,an,O
Sentence: 670,increase,O
Sentence: 670,in,O
Sentence: 670,water,O
Sentence: 670,ingestion,O
Sentence: 670,and,O
Sentence: 670,possibly,O
Sentence: 670,the,O
Sentence: 670,alcalinization,O
Sentence: 670,of,O
Sentence: 670,the,O
Sentence: 670,urine,O
Sentence: 670,.,O
Sentence: 670,We,O
Sentence: 670,communicate,O
Sentence: 670,a,O
Sentence: 670,case,O
Sentence: 670,in,O
Sentence: 670,a,O
Sentence: 670,previously,O
Sentence: 670,healthy,O
Sentence: 670,person,O
Sentence: 670,",",O
Sentence: 670,a,O
Sentence: 670,fact,O
Sentence: 670,not,O
Sentence: 670,found,O
Sentence: 670,in,O
Sentence: 670,the,O
Sentence: 670,recent,O
Sentence: 670,literature,O
Sentence: 670,.,O
Sentence: 670,Probably,O
Sentence: 670,many,O
Sentence: 670,more,O
Sentence: 670,cases,O
Sentence: 670,are,O
Sentence: 670,not,O
Sentence: 670,detected,O
Sentence: 670,.,O
Sentence: 670,We,O
Sentence: 670,think,O
Sentence: 670,that,O
Sentence: 670,a,O
Sentence: 670,prospective,O
Sentence: 670,study,O
Sentence: 670,would,O
Sentence: 670,be,O
Sentence: 670,useful,O
Sentence: 670,.,O
Sentence: 671,Downbeat,B-Disease
Sentence: 671,nystagmus,I-Disease
Sentence: 671,associated,O
Sentence: 671,with,O
Sentence: 671,intravenous,O
Sentence: 671,patient,O
Sentence: 671,-,O
Sentence: 671,controlled,O
Sentence: 671,administration,O
Sentence: 671,of,O
Sentence: 671,morphine,B-Chemical
Sentence: 671,.,O
Sentence: 672,IMPLICATIONS,O
Sentence: 672,:,O
Sentence: 672,This,O
Sentence: 672,case,O
Sentence: 672,documents,O
Sentence: 672,a,O
Sentence: 672,patient,O
Sentence: 672,who,O
Sentence: 672,developed,O
Sentence: 672,dizziness,B-Disease
Sentence: 672,with,O
Sentence: 672,downbeating,B-Disease
Sentence: 672,nystagmus,I-Disease
Sentence: 672,while,O
Sentence: 672,receiving,O
Sentence: 672,a,O
Sentence: 672,relatively,O
Sentence: 672,large,O
Sentence: 672,dose,O
Sentence: 672,of,O
Sentence: 672,IV,O
Sentence: 672,patient,O
Sentence: 672,-,O
Sentence: 672,controlled,O
Sentence: 672,analgesia,O
Sentence: 672,morphine,B-Chemical
Sentence: 672,.,O
Sentence: 672,Although,O
Sentence: 672,there,O
Sentence: 672,have,O
Sentence: 672,been,O
Sentence: 672,case,O
Sentence: 672,reports,O
Sentence: 672,of,O
Sentence: 672,epidural,O
Sentence: 672,morphine,B-Chemical
Sentence: 672,with,O
Sentence: 672,these,O
Sentence: 672,symptoms,O
Sentence: 672,and,O
Sentence: 672,signs,O
Sentence: 672,",",O
Sentence: 672,this,O
Sentence: 672,has,O
Sentence: 672,not,O
Sentence: 672,been,O
Sentence: 672,previously,O
Sentence: 672,documented,O
Sentence: 672,with,O
Sentence: 672,IV,O
Sentence: 672,or,O
Sentence: 672,patient,O
Sentence: 672,-,O
Sentence: 672,controlled,O
Sentence: 672,analgesia,O
Sentence: 672,morphine,B-Chemical
Sentence: 672,.,O
Sentence: 673,Hemodynamic,O
Sentence: 673,and,O
Sentence: 673,antiadrenergic,O
Sentence: 673,effects,O
Sentence: 673,of,O
Sentence: 673,dronedarone,B-Chemical
Sentence: 673,and,O
Sentence: 673,amiodarone,B-Chemical
Sentence: 673,in,O
Sentence: 673,animals,O
Sentence: 673,with,O
Sentence: 673,a,O
Sentence: 673,healed,O
Sentence: 673,myocardial,B-Disease
Sentence: 673,infarction,I-Disease
Sentence: 673,.,O
Sentence: 674,The,O
Sentence: 674,hemodynamic,O
Sentence: 674,and,O
Sentence: 674,antiadrenergic,O
Sentence: 674,effects,O
Sentence: 674,of,O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,",",O
Sentence: 674,a,O
Sentence: 674,noniodinated,O
Sentence: 674,compound,O
Sentence: 674,structurally,O
Sentence: 674,related,O
Sentence: 674,to,O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,",",O
Sentence: 674,were,O
Sentence: 674,compared,O
Sentence: 674,with,O
Sentence: 674,those,O
Sentence: 674,of,O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,after,O
Sentence: 674,prolonged,O
Sentence: 674,oral,O
Sentence: 674,administration,O
Sentence: 674,",",O
Sentence: 674,both,O
Sentence: 674,at,O
Sentence: 674,rest,O
Sentence: 674,and,O
Sentence: 674,during,O
Sentence: 674,sympathetic,O
Sentence: 674,stimulation,O
Sentence: 674,in,O
Sentence: 674,conscious,O
Sentence: 674,dogs,O
Sentence: 674,with,O
Sentence: 674,a,O
Sentence: 674,healed,O
Sentence: 674,myocardial,B-Disease
Sentence: 674,infarction,I-Disease
Sentence: 674,.,O
Sentence: 674,All,O
Sentence: 674,dogs,O
Sentence: 674,(,O
Sentence: 674,n,O
Sentence: 674,,O
Sentence: 674,=,O
Sentence: 674,,O
Sentence: 674,6,O
Sentence: 674,),O
Sentence: 674,randomly,O
Sentence: 674,received,O
Sentence: 674,orally,O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,(,O
Sentence: 674,10,O
Sentence: 674,and,O
Sentence: 674,30,O
Sentence: 674,mg,O
Sentence: 674,/,O
Sentence: 674,kg,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,(,O
Sentence: 674,10,O
Sentence: 674,and,O
Sentence: 674,30,O
Sentence: 674,mg,O
Sentence: 674,/,O
Sentence: 674,kg,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,and,O
Sentence: 674,placebo,O
Sentence: 674,twice,O
Sentence: 674,daily,O
Sentence: 674,for,O
Sentence: 674,7,O
Sentence: 674,days,O
Sentence: 674,",",O
Sentence: 674,with,O
Sentence: 674,a,O
Sentence: 674,3,O
Sentence: 674,-,O
Sentence: 674,week,O
Sentence: 674,washout,O
Sentence: 674,between,O
Sentence: 674,consecutive,O
Sentence: 674,treatments,O
Sentence: 674,.,O
Sentence: 674,Heart,O
Sentence: 674,rate,O
Sentence: 674,(,O
Sentence: 674,HR,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,mean,O
Sentence: 674,arterial,O
Sentence: 674,pressure,O
Sentence: 674,(,O
Sentence: 674,MBP,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,positive,O
Sentence: 674,rate,O
Sentence: 674,of,O
Sentence: 674,increase,O
Sentence: 674,of,O
Sentence: 674,left,O
Sentence: 674,ventricular,O
Sentence: 674,pressure,O
Sentence: 674,(,O
Sentence: 674,+LVdP,O
Sentence: 674,/,O
Sentence: 674,dt,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,echocardiographically,O
Sentence: 674,assessed,O
Sentence: 674,left,O
Sentence: 674,ventricular,O
Sentence: 674,ejection,O
Sentence: 674,fraction,O
Sentence: 674,(,O
Sentence: 674,LVEF,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,and,O
Sentence: 674,fractional,O
Sentence: 674,shortening,O
Sentence: 674,(,O
Sentence: 674,FS,O
Sentence: 674,),O
Sentence: 674,",",O
Sentence: 674,as,O
Sentence: 674,well,O
Sentence: 674,as,O
Sentence: 674,chronotropic,O
Sentence: 674,response,O
Sentence: 674,to,O
Sentence: 674,isoproterenol,B-Chemical
Sentence: 674,and,O
Sentence: 674,exercise,O
Sentence: 674,-,O
Sentence: 674,induced,O
Sentence: 674,sympathetic,O
Sentence: 674,stimulation,O
Sentence: 674,were,O
Sentence: 674,evaluated,O
Sentence: 674,under,O
Sentence: 674,baseline,O
Sentence: 674,and,O
Sentence: 674,posttreatment,O
Sentence: 674,conditions,O
Sentence: 674,.,O
Sentence: 674,Resting,O
Sentence: 674,values,O
Sentence: 674,of,O
Sentence: 674,LVEF,O
Sentence: 674,",",O
Sentence: 674,FS,O
Sentence: 674,",",O
Sentence: 674,+LVdP,O
Sentence: 674,/,O
Sentence: 674,dt,O
Sentence: 674,",",O
Sentence: 674,and,O
Sentence: 674,MBP,O
Sentence: 674,remained,O
Sentence: 674,unchanged,O
Sentence: 674,whatever,O
Sentence: 674,the,O
Sentence: 674,drug,O
Sentence: 674,and,O
Sentence: 674,the,O
Sentence: 674,dosing,O
Sentence: 674,regimen,O
Sentence: 674,",",O
Sentence: 674,whereas,O
Sentence: 674,resting,O
Sentence: 674,HR,O
Sentence: 674,was,O
Sentence: 674,significantly,O
Sentence: 674,and,O
Sentence: 674,dose,O
Sentence: 674,-,O
Sentence: 674,dependently,O
Sentence: 674,lowered,O
Sentence: 674,after,O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,and,O
Sentence: 674,to,O
Sentence: 674,a,O
Sentence: 674,lesser,O
Sentence: 674,extent,O
Sentence: 674,after,O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,.,O
Sentence: 674,Both,O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,and,O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,significantly,O
Sentence: 674,reduced,O
Sentence: 674,the,O
Sentence: 674,exercise,O
Sentence: 674,-,O
Sentence: 674,induced,O
Sentence: 674,tachycardia,B-Disease
Sentence: 674,and,O
Sentence: 674,",",O
Sentence: 674,at,O
Sentence: 674,the,O
Sentence: 674,highest,O
Sentence: 674,dose,O
Sentence: 674,",",O
Sentence: 674,decreased,O
Sentence: 674,the,O
Sentence: 674,isoproterenol,B-Chemical
Sentence: 674,-,O
Sentence: 674,induced,O
Sentence: 674,tachycardia,B-Disease
Sentence: 674,.,O
Sentence: 674,Thus,O
Sentence: 674,",",O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,and,O
Sentence: 674,amiodarone,B-Chemical
Sentence: 674,displayed,O
Sentence: 674,a,O
Sentence: 674,similar,O
Sentence: 674,level,O
Sentence: 674,of,O
Sentence: 674,antiadrenergic,O
Sentence: 674,effect,O
Sentence: 674,and,O
Sentence: 674,did,O
Sentence: 674,not,O
Sentence: 674,impair,O
Sentence: 674,the,O
Sentence: 674,resting,O
Sentence: 674,left,O
Sentence: 674,ventricular,O
Sentence: 674,function,O
Sentence: 674,.,O
Sentence: 674,Consequently,O
Sentence: 674,",",O
Sentence: 674,dronedarone,B-Chemical
Sentence: 674,might,O
Sentence: 674,be,O
Sentence: 674,particularly,O
Sentence: 674,suitable,O
Sentence: 674,for,O
Sentence: 674,the,O
Sentence: 674,treatment,O
Sentence: 674,and,O
Sentence: 674,prevention,O
Sentence: 674,of,O
Sentence: 674,various,O
Sentence: 674,clinical,O
Sentence: 674,arrhythmias,B-Disease
Sentence: 674,",",O
Sentence: 674,without,O
Sentence: 674,compromising,O
Sentence: 674,the,O
Sentence: 674,left,O
Sentence: 674,ventricular,O
Sentence: 674,function,O
Sentence: 674,.,O
Sentence: 675,Phase,O
Sentence: 675,2,O
Sentence: 675,trial,O
Sentence: 675,of,O
Sentence: 675,liposomal,O
Sentence: 675,doxorubicin,B-Chemical
Sentence: 675,(,O
Sentence: 675,40,O
Sentence: 675,mg,O
Sentence: 675,/,O
Sentence: 675,m,O
Sentence: 675,(,O
Sentence: 675,2,O
Sentence: 675,),O
Sentence: 675,),O
Sentence: 675,in,O
Sentence: 675,platinum,B-Chemical
Sentence: 675,/,O
Sentence: 675,paclitaxel,B-Chemical
Sentence: 675,-,O
Sentence: 675,refractory,O
Sentence: 675,ovarian,B-Disease
Sentence: 675,and,I-Disease
Sentence: 675,fallopian,B-Disease
Sentence: 675,tube,I-Disease
Sentence: 675,cancers,I-Disease
Sentence: 675,and,O
Sentence: 675,primary,O
Sentence: 675,carcinoma,B-Disease
Sentence: 675,of,I-Disease
Sentence: 675,the,I-Disease
Sentence: 675,peritoneum,I-Disease
Sentence: 675,.,O
Sentence: 676,BACKGROUND,O
Sentence: 676,:,O
Sentence: 676,Several,O
Sentence: 676,studies,O
Sentence: 676,have,O
Sentence: 676,demonstrated,O
Sentence: 676,liposomal,O
Sentence: 676,doxorubicin,B-Chemical
Sentence: 676,(,O
Sentence: 676,Doxil,B-Chemical
Sentence: 676,),O
Sentence: 676,to,O
Sentence: 676,be,O
Sentence: 676,an,O
Sentence: 676,active,O
Sentence: 676,antineoplastic,O
Sentence: 676,agent,O
Sentence: 676,in,O
Sentence: 676,platinum,B-Chemical
Sentence: 676,-,O
Sentence: 676,resistant,O
Sentence: 676,ovarian,B-Disease
Sentence: 676,cancer,I-Disease
Sentence: 676,",",O
Sentence: 676,with,O
Sentence: 676,dose,O
Sentence: 676,limiting,O
Sentence: 676,toxicity,B-Disease
Sentence: 676,of,O
Sentence: 676,the,O
Sentence: 676,standard,O
Sentence: 676,dosing,O
Sentence: 676,regimen,O
Sentence: 676,(,O
Sentence: 676,50,O
Sentence: 676,mg,O
Sentence: 676,/,O
Sentence: 676,m,O
Sentence: 676,(,O
Sentence: 676,2,O
Sentence: 676,),O
Sentence: 676,q,O
Sentence: 676,4,O
Sentence: 676,weeks,O
Sentence: 676,),O
Sentence: 676,being,O
Sentence: 676,severe,O
Sentence: 676,erythrodysesthesia,B-Disease
Sentence: 676,(,O
Sentence: 676,``,O
Sentence: 676,hand,O
Sentence: 676,-,O
Sentence: 676,foot,O
Sentence: 676,syndrome,O
Sentence: 676,'',O
Sentence: 676,),O
Sentence: 676,and,O
Sentence: 676,stomatitis,B-Disease
Sentence: 676,.,O
Sentence: 676,We,O
Sentence: 676,wished,O
Sentence: 676,to,O
Sentence: 676,develop,O
Sentence: 676,a,O
Sentence: 676,more,O
Sentence: 676,tolerable,O
Sentence: 676,liposomal,O
Sentence: 676,doxorubicin,B-Chemical
Sentence: 676,treatment,O
Sentence: 676,regimen,O
Sentence: 676,and,O
Sentence: 676,document,O
Sentence: 676,its,O
Sentence: 676,level,O
Sentence: 676,of,O
Sentence: 676,activity,O
Sentence: 676,in,O
Sentence: 676,a,O
Sentence: 676,well,O
Sentence: 676,-,O
Sentence: 676,defined,O
Sentence: 676,patient,O
Sentence: 676,population,O
Sentence: 676,with,O
Sentence: 676,platinum,B-Chemical
Sentence: 676,/,O
Sentence: 676,paclitaxel,B-Chemical
Sentence: 676,-,O
Sentence: 676,refractory,O
Sentence: 676,disease,O
Sentence: 676,.,O
Sentence: 676,METHODS,O
Sentence: 676,AND,O
Sentence: 676,MATERIALS,O
Sentence: 676,:,O
Sentence: 676,Patients,O
Sentence: 676,with,O
Sentence: 676,ovarian,B-Disease
Sentence: 676,or,I-Disease
Sentence: 676,fallopian,B-Disease
Sentence: 676,tube,I-Disease
Sentence: 676,cancers,I-Disease
Sentence: 676,or,O
Sentence: 676,primary,O
Sentence: 676,peritoneal,B-Disease
Sentence: 676,carcinoma,I-Disease
Sentence: 676,with,O
Sentence: 676,platinum,B-Chemical
Sentence: 676,/,O
Sentence: 676,paclitaxel,B-Chemical
Sentence: 676,-,O
Sentence: 676,refractory,O
Sentence: 676,disease,O
Sentence: 676,(,O
Sentence: 676,stable,O
Sentence: 676,or,O
Sentence: 676,progressive,O
Sentence: 676,disease,O
Sentence: 676,following,O
Sentence: 676,treatment,O
Sentence: 676,with,O
Sentence: 676,these,O
Sentence: 676,agents,O
Sentence: 676,or,O
Sentence: 676,previous,O
Sentence: 676,objective,O
Sentence: 676,response,O
Sentence: 676,,O
Sentence: 676,<,O
Sentence: 676,,O
Sentence: 676,3,O
Sentence: 676,months,O
Sentence: 676,in,O
Sentence: 676,duration,O
Sentence: 676,),O
Sentence: 676,were,O
Sentence: 676,treated,O
Sentence: 676,with,O
Sentence: 676,liposomal,O
Sentence: 676,doxorubicin,B-Chemical
Sentence: 676,at,O
Sentence: 676,a,O
Sentence: 676,dose,O
Sentence: 676,of,O
Sentence: 676,40,O
Sentence: 676,mg,O
Sentence: 676,/,O
Sentence: 676,m,O
Sentence: 676,(,O
Sentence: 676,2,O
Sentence: 676,),O
Sentence: 676,q,O
Sentence: 676,4,O
Sentence: 676,weeks,O
Sentence: 676,.,O
Sentence: 676,RESULTS,O
Sentence: 676,:,O
Sentence: 676,A,O
Sentence: 676,total,O
Sentence: 676,of,O
Sentence: 676,49,O
Sentence: 676,patients,O
Sentence: 676,(,O
Sentence: 676,median,O
Sentence: 676,age,O
Sentence: 676,:,O
Sentence: 676,60,O
Sentence: 676,;,O
Sentence: 676,range,O
Sentence: 676,41,O
Sentence: 676,-,O
Sentence: 676,81,O
Sentence: 676,),O
Sentence: 676,entered,O
Sentence: 676,this,O
Sentence: 676,phase,O
Sentence: 676,2,O
Sentence: 676,trial,O
Sentence: 676,.,O
Sentence: 676,The,O
Sentence: 676,median,O
Sentence: 676,number,O
Sentence: 676,of,O
Sentence: 676,prior,O
Sentence: 676,regimens,O
Sentence: 676,was,O
Sentence: 676,2,O
Sentence: 676,(,O
Sentence: 676,range,O
Sentence: 676,:,O
Sentence: 676,1,O
Sentence: 676,-,O
Sentence: 676,6,O
Sentence: 676,),O
Sentence: 676,.,O
Sentence: 676,Six,O
Sentence: 676,(,O
Sentence: 676,12,O
Sentence: 676,%,O
Sentence: 676,),O
Sentence: 676,and,O
Sentence: 676,4,O
Sentence: 676,(,O
Sentence: 676,8,O
Sentence: 676,%,O
Sentence: 676,),O
Sentence: 676,patients,O
Sentence: 676,experienced,O
Sentence: 676,grade,O
Sentence: 676,2,O
Sentence: 676,hand,O
Sentence: 676,-,O
Sentence: 676,foot,O
Sentence: 676,syndrome,O
Sentence: 676,and,O
Sentence: 676,stomatitis,B-Disease
Sentence: 676,",",O
Sentence: 676,respectively,O
Sentence: 676,(,O
Sentence: 676,no,O
Sentence: 676,episodes,O
Sentence: 676,of,O
Sentence: 676,grade,O
Sentence: 676,3,O
Sentence: 676,),O
Sentence: 676,.,O
Sentence: 676,One,O
Sentence: 676,patient,O
Sentence: 676,developed,O
Sentence: 676,grade,O
Sentence: 676,3,O
Sentence: 676,diarrhea,B-Disease
Sentence: 676,requiring,O
Sentence: 676,hospitalization,O
Sentence: 676,for,O
Sentence: 676,hydration,O
Sentence: 676,.,O
Sentence: 676,Six,O
Sentence: 676,(,O
Sentence: 676,12,O
Sentence: 676,%,O
Sentence: 676,),O
Sentence: 676,individuals,O
Sentence: 676,required,O
Sentence: 676,dose,O
Sentence: 676,reductions,O
Sentence: 676,.,O
Sentence: 676,The,O
Sentence: 676,median,O
Sentence: 676,number,O
Sentence: 676,of,O
Sentence: 676,courses,O
Sentence: 676,of,O
Sentence: 676,liposomal,O
Sentence: 676,doxorubicin,B-Chemical
Sentence: 676,administered,O
Sentence: 676,on,O
Sentence: 676,this,O
Sentence: 676,protocol,O
Sentence: 676,was,O
Sentence: 676,2,O
Sentence: 676,(,O
Sentence: 676,range,O
Sentence: 676,:,O
Sentence: 676,1,O
Sentence: 676,-,O
Sentence: 676,12,O
Sentence: 676,),O
Sentence: 676,.,O
Sentence: 676,Four,O
Sentence: 676,of,O
Sentence: 676,44,O
Sentence: 676,patients,O
Sentence: 676,(,O
Sentence: 676,9,O
Sentence: 676,%,O
Sentence: 676,),O
Sentence: 676,evaluable,O
Sentence: 676,for,O
Sentence: 676,response,O
Sentence: 676,exhibited,O
Sentence: 676,objective,O
Sentence: 676,and,O
Sentence: 676,subjective,O
Sentence: 676,evidence,O
Sentence: 676,of,O
Sentence: 676,an,O
Sentence: 676,antineoplastic,O
Sentence: 676,effect,O
Sentence: 676,of,O
Sentence: 676,therapy,O
Sentence: 676,.,O
Sentence: 676,CONCLUSION,O
Sentence: 676,:,O
Sentence: 676,This,O
Sentence: 676,modified,O
Sentence: 676,liposomal,O
Sentence: 676,doxorubicin,B-Chemical
Sentence: 676,regimen,O
Sentence: 676,results,O
Sentence: 676,in,O
Sentence: 676,less,O
Sentence: 676,toxicity,B-Disease
Sentence: 676,(,O
Sentence: 676,stomatitis,B-Disease
Sentence: 676,",",O
Sentence: 676,hand,O
Sentence: 676,-,O
Sentence: 676,foot,O
Sentence: 676,syndrome,O
Sentence: 676,),O
Sentence: 676,than,O
Sentence: 676,the,O
Sentence: 676,standard,O
Sentence: 676,FDA,O
Sentence: 676,-,O
Sentence: 676,approved,O
Sentence: 676,dose,O
Sentence: 676,schedule,O
Sentence: 676,.,O
Sentence: 676,Definite,O
Sentence: 676,",",O
Sentence: 676,although,O
Sentence: 676,limited,O
Sentence: 676,",",O
Sentence: 676,antineoplastic,O
Sentence: 676,activity,O
Sentence: 676,is,O
Sentence: 676,observed,O
Sentence: 676,in,O
Sentence: 676,patients,O
Sentence: 676,with,O
Sentence: 676,well,O
Sentence: 676,-,O
Sentence: 676,defined,O
Sentence: 676,platinum,B-Chemical
Sentence: 676,-,O
Sentence: 676,,O
Sentence: 676,and,O
Sentence: 676,paclitaxel,B-Chemical
Sentence: 676,-,O
Sentence: 676,refractory,O
Sentence: 676,ovarian,B-Disease
Sentence: 676,cancer,I-Disease
Sentence: 676,.,O
Sentence: 677,Efficacy,O
Sentence: 677,of,O
Sentence: 677,olanzapine,B-Chemical
Sentence: 677,in,O
Sentence: 677,acute,O
Sentence: 677,bipolar,B-Disease
Sentence: 677,mania,I-Disease
Sentence: 677,:,O
Sentence: 677,a,O
Sentence: 677,double,O
Sentence: 677,-,O
Sentence: 677,blind,O
Sentence: 677,",",O
Sentence: 677,placebo,O
Sentence: 677,-,O
Sentence: 677,controlled,O
Sentence: 677,study,O
Sentence: 677,.,O
Sentence: 677,The,O
Sentence: 677,Olanzipine,B-Chemical
Sentence: 677,HGGW,O
Sentence: 677,Study,O
Sentence: 677,Group,O
Sentence: 677,.,O
Sentence: 678,BACKGROUND,O
Sentence: 678,:,O
Sentence: 678,We,O
Sentence: 678,compared,O
Sentence: 678,the,O
Sentence: 678,efficacy,O
Sentence: 678,and,O
Sentence: 678,safety,O
Sentence: 678,of,O
Sentence: 678,olanzapine,B-Chemical
Sentence: 678,vs,O
Sentence: 678,placebo,O
Sentence: 678,for,O
Sentence: 678,the,O
Sentence: 678,treatment,O
Sentence: 678,of,O
Sentence: 678,acute,O
Sentence: 678,bipolar,B-Disease
Sentence: 678,mania,I-Disease
Sentence: 678,.,O
Sentence: 678,METHODS,O
Sentence: 678,:,O
Sentence: 678,Four,O
Sentence: 678,-,O
Sentence: 678,week,O
Sentence: 678,",",O
Sentence: 678,randomized,O
Sentence: 678,",",O
Sentence: 678,double,O
Sentence: 678,-,O
Sentence: 678,blind,O
Sentence: 678,",",O
Sentence: 678,parallel,O
Sentence: 678,study,O
Sentence: 678,.,O
Sentence: 678,A,O
Sentence: 678,total,O
Sentence: 678,of,O
Sentence: 678,115,O
Sentence: 678,patients,O
Sentence: 678,with,O
Sentence: 678,a,O
Sentence: 678,DSM,O
Sentence: 678,-,O
Sentence: 678,IV,O
Sentence: 678,diagnosis,O
Sentence: 678,of,O
Sentence: 678,bipolar,B-Disease
Sentence: 678,disorder,I-Disease
Sentence: 678,",",O
Sentence: 678,manic,B-Disease
Sentence: 678,or,O
Sentence: 678,mixed,O
Sentence: 678,",",O
Sentence: 678,were,O
Sentence: 678,randomized,O
Sentence: 678,to,O
Sentence: 678,olanzapine,B-Chemical
Sentence: 678,",",O
Sentence: 678,5,O
Sentence: 678,to,O
Sentence: 678,20,O
Sentence: 678,mg,O
Sentence: 678,/,O
Sentence: 678,d,O
Sentence: 678,(,O
Sentence: 678,n,O
Sentence: 678,,O
Sentence: 678,=,O
Sentence: 678,,O
Sentence: 678,55,O
Sentence: 678,),O
Sentence: 678,",",O
Sentence: 678,or,O
Sentence: 678,placebo,O
Sentence: 678,(,O
Sentence: 678,n,O
Sentence: 678,,O
Sentence: 678,=,O
Sentence: 678,,O
Sentence: 678,60,O
Sentence: 678,),O
Sentence: 678,.,O
Sentence: 678,The,O
Sentence: 678,primary,O
Sentence: 678,efficacy,O
Sentence: 678,measure,O
Sentence: 678,was,O
Sentence: 678,the,O
Sentence: 678,Young,O
Sentence: 678,-,O
Sentence: 678,Mania,B-Disease
Sentence: 678,Rating,O
Sentence: 678,Scale,O
Sentence: 678,(,O
Sentence: 678,Y,O
Sentence: 678,-,O
Sentence: 678,MRS,O
Sentence: 678,),O
Sentence: 678,total,O
Sentence: 678,score,O
Sentence: 678,.,O
Sentence: 678,Response,O
Sentence: 678,and,O
Sentence: 678,euthymia,O
Sentence: 678,were,O
Sentence: 678,defined,O
Sentence: 678,",",O
Sentence: 678,a,O
Sentence: 678,priori,O
Sentence: 678,",",O
Sentence: 678,as,O
Sentence: 678,at,O
Sentence: 678,least,O
Sentence: 678,a,O
Sentence: 678,50,O
Sentence: 678,%,O
Sentence: 678,improvement,O
Sentence: 678,from,O
Sentence: 678,baseline,O
Sentence: 678,to,O
Sentence: 678,end,O
Sentence: 678,point,O
Sentence: 678,and,O
Sentence: 678,as,O
Sentence: 678,a,O
Sentence: 678,score,O
Sentence: 678,of,O
Sentence: 678,no,O
Sentence: 678,less,O
Sentence: 678,than,O
Sentence: 678,12,O
Sentence: 678,at,O
Sentence: 678,end,O
Sentence: 678,point,O
Sentence: 678,in,O
Sentence: 678,the,O
Sentence: 678,Y,O
Sentence: 678,-,O
Sentence: 678,MRS,O
Sentence: 678,total,O
Sentence: 678,score,O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,.,O
Sentence: 678,Safety,O
Sentence: 678,was,O
Sentence: 678,assessed,O
Sentence: 678,using,O
Sentence: 678,adverse,O
Sentence: 678,events,O
Sentence: 678,",",O
Sentence: 678,Extrapyramidal,B-Disease
Sentence: 678,Symptom,I-Disease
Sentence: 678,(,O
Sentence: 678,EPS,B-Disease
Sentence: 678,),O
Sentence: 678,rating,O
Sentence: 678,scales,O
Sentence: 678,",",O
Sentence: 678,laboratory,O
Sentence: 678,values,O
Sentence: 678,",",O
Sentence: 678,electrocardiograms,O
Sentence: 678,",",O
Sentence: 678,vital,O
Sentence: 678,signs,O
Sentence: 678,",",O
Sentence: 678,and,O
Sentence: 678,weight,O
Sentence: 678,change,O
Sentence: 678,.,O
Sentence: 678,RESULTS,O
Sentence: 678,:,O
Sentence: 678,Olanzapine,B-Chemical
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,demonstrated,O
Sentence: 678,a,O
Sentence: 678,statistically,O
Sentence: 678,significant,O
Sentence: 678,greater,O
Sentence: 678,mean,O
Sentence: 678,(,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,SD,O
Sentence: 678,),O
Sentence: 678,improvement,O
Sentence: 678,in,O
Sentence: 678,Y,O
Sentence: 678,-,O
Sentence: 678,MRS,O
Sentence: 678,total,O
Sentence: 678,score,O
Sentence: 678,than,O
Sentence: 678,placebo,O
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,(,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,14.8,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,12.5,O
Sentence: 678,and,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,8.1,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,12.7,O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,;,O
Sentence: 678,p,O
Sentence: 678,,O
Sentence: 678,<,O
Sentence: 678,,O
Sentence: 678,.001,O
Sentence: 678,),O
Sentence: 678,",",O
Sentence: 678,which,O
Sentence: 678,was,O
Sentence: 678,evident,O
Sentence: 678,at,O
Sentence: 678,the,O
Sentence: 678,first,O
Sentence: 678,postbaseline,O
Sentence: 678,observation,O
Sentence: 678,1,O
Sentence: 678,week,O
Sentence: 678,after,O
Sentence: 678,randomization,O
Sentence: 678,and,O
Sentence: 678,was,O
Sentence: 678,maintained,O
Sentence: 678,throughout,O
Sentence: 678,the,O
Sentence: 678,study,O
Sentence: 678,(,O
Sentence: 678,last,O
Sentence: 678,observation,O
Sentence: 678,carried,O
Sentence: 678,forward,O
Sentence: 678,),O
Sentence: 678,.,O
Sentence: 678,Olanzapine,B-Chemical
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,demonstrated,O
Sentence: 678,a,O
Sentence: 678,higher,O
Sentence: 678,rate,O
Sentence: 678,of,O
Sentence: 678,response,O
Sentence: 678,(,O
Sentence: 678,65,O
Sentence: 678,%,O
Sentence: 678,vs,O
Sentence: 678,43,O
Sentence: 678,%,O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,;,O
Sentence: 678,P,O
Sentence: 678,,O
Sentence: 678,=,O
Sentence: 678,.02,O
Sentence: 678,),O
Sentence: 678,and,O
Sentence: 678,euthymia,O
Sentence: 678,(,O
Sentence: 678,61,O
Sentence: 678,%,O
Sentence: 678,vs,O
Sentence: 678,36,O
Sentence: 678,%,O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,;,O
Sentence: 678,P,O
Sentence: 678,,O
Sentence: 678,=,O
Sentence: 678,,O
Sentence: 678,.,O
Sentence: 678,01,O
Sentence: 678,),O
Sentence: 678,than,O
Sentence: 678,placebo,O
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,.,O
Sentence: 678,There,O
Sentence: 678,were,O
Sentence: 678,no,O
Sentence: 678,statistically,O
Sentence: 678,significant,O
Sentence: 678,differences,O
Sentence: 678,in,O
Sentence: 678,EPSs,B-Disease
Sentence: 678,between,O
Sentence: 678,groups,O
Sentence: 678,.,O
Sentence: 678,However,O
Sentence: 678,",",O
Sentence: 678,olanzapine,B-Chemical
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,had,O
Sentence: 678,a,O
Sentence: 678,statistically,O
Sentence: 678,significant,O
Sentence: 678,greater,O
Sentence: 678,mean,O
Sentence: 678,(,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,SD,O
Sentence: 678,),O
Sentence: 678,weight,B-Disease
Sentence: 678,gain,I-Disease
Sentence: 678,than,O
Sentence: 678,placebo,O
Sentence: 678,-,O
Sentence: 678,treated,O
Sentence: 678,patients,O
Sentence: 678,(,O
Sentence: 678,2.1,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,2.8,O
Sentence: 678,vs,O
Sentence: 678,0.45,O
Sentence: 678,+,O
Sentence: 678,/,O
Sentence: 678,,O
Sentence: 678,-,O
Sentence: 678,,O
Sentence: 678,2.3,O
Sentence: 678,kg,O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,),O
Sentence: 678,and,O
Sentence: 678,also,O
Sentence: 678,experienced,O
Sentence: 678,more,O
Sentence: 678,treatment,O
Sentence: 678,-,O
Sentence: 678,emergent,O
Sentence: 678,somnolence,B-Disease
Sentence: 678,(,O
Sentence: 678,21,O
Sentence: 678,patients,O
Sentence: 678,[,O
Sentence: 678,38.2,O
Sentence: 678,%,O
Sentence: 678,],O
Sentence: 678,vs,O
Sentence: 678,5,O
Sentence: 678,[,O
Sentence: 678,8.3,O
Sentence: 678,%,O
Sentence: 678,],O
Sentence: 678,",",O
Sentence: 678,respectively,O
Sentence: 678,),O
Sentence: 678,.,O
Sentence: 678,CONCLUSION,O
Sentence: 678,:,O
Sentence: 678,Olanzapine,B-Chemical
Sentence: 678,demonstrated,O
Sentence: 678,greater,O
Sentence: 678,efficacy,O
Sentence: 678,than,O
Sentence: 678,placebo,O
Sentence: 678,in,O
Sentence: 678,the,O
Sentence: 678,treatment,O
Sentence: 678,of,O
Sentence: 678,acute,O
Sentence: 678,bipolar,B-Disease
Sentence: 678,mania,I-Disease
Sentence: 678,and,O
Sentence: 678,was,O
Sentence: 678,generally,O
Sentence: 678,well,O
Sentence: 678,tolerated,O
Sentence: 678,.,O
Sentence: 679,The,O
Sentence: 679,effect,O
Sentence: 679,of,O
Sentence: 679,pupil,B-Disease
Sentence: 679,dilation,I-Disease
Sentence: 679,with,O
Sentence: 679,tropicamide,B-Chemical
Sentence: 679,on,O
Sentence: 679,vision,O
Sentence: 679,and,O
Sentence: 679,driving,O
Sentence: 679,simulator,O
Sentence: 679,performance,O
Sentence: 679,.,O
Sentence: 680,PURPOSE,O
Sentence: 680,:,O
Sentence: 680,To,O
Sentence: 680,assess,O
Sentence: 680,the,O
Sentence: 680,effect,O
Sentence: 680,of,O
Sentence: 680,pupil,B-Disease
Sentence: 680,dilation,I-Disease
Sentence: 680,on,O
Sentence: 680,vision,O
Sentence: 680,and,O
Sentence: 680,driving,O
Sentence: 680,ability,O
Sentence: 680,.,O
Sentence: 680,METHODS,O
Sentence: 680,:,O
Sentence: 680,A,O
Sentence: 680,series,O
Sentence: 680,of,O
Sentence: 680,tests,O
Sentence: 680,on,O
Sentence: 680,various,O
Sentence: 680,parameters,O
Sentence: 680,of,O
Sentence: 680,visual,O
Sentence: 680,function,O
Sentence: 680,and,O
Sentence: 680,driving,O
Sentence: 680,simulator,O
Sentence: 680,performance,O
Sentence: 680,were,O
Sentence: 680,performed,O
Sentence: 680,on,O
Sentence: 680,12,O
Sentence: 680,healthy,O
Sentence: 680,drivers,O
Sentence: 680,",",O
Sentence: 680,before,O
Sentence: 680,and,O
Sentence: 680,after,O
Sentence: 680,pupil,B-Disease
Sentence: 680,dilation,I-Disease
Sentence: 680,using,O
Sentence: 680,guttae,O
Sentence: 680,tropicamide,B-Chemical
Sentence: 680,1,O
Sentence: 680,%,O
Sentence: 680,.,O
Sentence: 680,A,O
Sentence: 680,driving,O
Sentence: 680,simulator,O
Sentence: 680,(,O
Sentence: 680,Transport,O
Sentence: 680,Research,O
Sentence: 680,Laboratory,O
Sentence: 680,),O
Sentence: 680,was,O
Sentence: 680,used,O
Sentence: 680,to,O
Sentence: 680,measure,O
Sentence: 680,reaction,O
Sentence: 680,time,O
Sentence: 680,(,O
Sentence: 680,RT,O
Sentence: 680,),O
Sentence: 680,",",O
Sentence: 680,speed,O
Sentence: 680,maintenance,O
Sentence: 680,and,O
Sentence: 680,steering,O
Sentence: 680,accuracy,O
Sentence: 680,.,O
Sentence: 680,Tests,O
Sentence: 680,of,O
Sentence: 680,basic,O
Sentence: 680,visual,O
Sentence: 680,function,O
Sentence: 680,included,O
Sentence: 680,high,O
Sentence: 680,-,O
Sentence: 680,,O
Sentence: 680,and,O
Sentence: 680,low,O
Sentence: 680,-,O
Sentence: 680,contrast,O
Sentence: 680,visual,O
Sentence: 680,acuity,O
Sentence: 680,(,O
Sentence: 680,HCVA,O
Sentence: 680,and,O
Sentence: 680,LCVA,O
Sentence: 680,),O
Sentence: 680,",",O
Sentence: 680,Pelli,O
Sentence: 680,-,O
Sentence: 680,Robson,O
Sentence: 680,contrast,O
Sentence: 680,threshold,O
Sentence: 680,(,O
Sentence: 680,CT,O
Sentence: 680,),O
Sentence: 680,and,O
Sentence: 680,Goldmann,O
Sentence: 680,perimetry,O
Sentence: 680,(,O
Sentence: 680,FIELDS,O
Sentence: 680,),O
Sentence: 680,.,O
Sentence: 680,Useful,O
Sentence: 680,Field,O
Sentence: 680,of,O
Sentence: 680,View,O
Sentence: 680,(,O
Sentence: 680,UFOV,O
Sentence: 680,,O
Sentence: 680,-,O
Sentence: 680,,O
Sentence: 680,-,O
Sentence: 680,,O
Sentence: 680,a,O
Sentence: 680,test,O
Sentence: 680,of,O
Sentence: 680,visual,O
Sentence: 680,attention,O
Sentence: 680,),O
Sentence: 680,was,O
Sentence: 680,also,O
Sentence: 680,undertaken,O
Sentence: 680,.,O
Sentence: 680,The,O
Sentence: 680,mean,O
Sentence: 680,differences,O
Sentence: 680,in,O
Sentence: 680,the,O
Sentence: 680,pre,O
Sentence: 680,-,O
Sentence: 680,,O
Sentence: 680,and,O
Sentence: 680,post,O
Sentence: 680,-,O
Sentence: 680,dilatation,O
Sentence: 680,measurements,O
Sentence: 680,were,O
Sentence: 680,tested,O
Sentence: 680,for,O
Sentence: 680,statistical,O
Sentence: 680,significance,O
Sentence: 680,at,O
Sentence: 680,the,O
Sentence: 680,95,O
Sentence: 680,%,O
Sentence: 680,level,O
Sentence: 680,using,O
Sentence: 680,one,O
Sentence: 680,-,O
Sentence: 680,tail,O
Sentence: 680,paired,O
Sentence: 680,t,O
Sentence: 680,-,O
Sentence: 680,tests,O
Sentence: 680,.,O
Sentence: 680,RESULTS,O
Sentence: 680,:,O
Sentence: 680,Pupillary,B-Disease
Sentence: 680,dilation,I-Disease
Sentence: 680,resulted,O
Sentence: 680,in,O
Sentence: 680,a,O
Sentence: 680,statistically,O
Sentence: 680,significant,O
Sentence: 680,deterioration,O
Sentence: 680,in,O
Sentence: 680,CT,O
Sentence: 680,and,O
Sentence: 680,HCVA,O
Sentence: 680,only,O
Sentence: 680,.,O
Sentence: 680,Five,O
Sentence: 680,of,O
Sentence: 680,12,O
Sentence: 680,drivers,O
Sentence: 680,also,O
Sentence: 680,exhibited,O
Sentence: 680,deterioration,O
Sentence: 680,in,O
Sentence: 680,LCVA,O
Sentence: 680,",",O
Sentence: 680,CT,O
Sentence: 680,and,O
Sentence: 680,RT,O
Sentence: 680,.,O
Sentence: 680,Little,O
Sentence: 680,evidence,O
Sentence: 680,emerged,O
Sentence: 680,for,O
Sentence: 680,deterioration,O
Sentence: 680,in,O
Sentence: 680,FIELDS,O
Sentence: 680,and,O
Sentence: 680,UFOV,O
Sentence: 680,.,O
Sentence: 680,Also,O
Sentence: 680,",",O
Sentence: 680,7,O
Sentence: 680,of,O
Sentence: 680,12,O
Sentence: 680,drivers,O
Sentence: 680,appeared,O
Sentence: 680,to,O
Sentence: 680,adjust,O
Sentence: 680,their,O
Sentence: 680,driving,O
Sentence: 680,behaviour,O
Sentence: 680,by,O
Sentence: 680,reducing,O
Sentence: 680,their,O
Sentence: 680,speed,O
Sentence: 680,on,O
Sentence: 680,the,O
Sentence: 680,driving,O
Sentence: 680,simulator,O
Sentence: 680,",",O
Sentence: 680,leading,O
Sentence: 680,to,O
Sentence: 680,improved,O
Sentence: 680,steering,O
Sentence: 680,accuracy,O
Sentence: 680,.,O
Sentence: 680,CONCLUSIONS,O
Sentence: 680,:,O
Sentence: 680,Pupillary,B-Disease
Sentence: 680,dilation,I-Disease
Sentence: 680,may,O
Sentence: 680,lead,O
Sentence: 680,to,O
Sentence: 680,a,O
Sentence: 680,decrease,O
Sentence: 680,in,O
Sentence: 680,vision,O
Sentence: 680,and,O
Sentence: 680,daylight,O
Sentence: 680,driving,O
Sentence: 680,performance,O
Sentence: 680,in,O
Sentence: 680,young,O
Sentence: 680,people,O
Sentence: 680,.,O
Sentence: 680,A,O
Sentence: 680,larger,O
Sentence: 680,study,O
Sentence: 680,",",O
Sentence: 680,including,O
Sentence: 680,a,O
Sentence: 680,broader,O
Sentence: 680,spectrum,O
Sentence: 680,of,O
Sentence: 680,subjects,O
Sentence: 680,",",O
Sentence: 680,is,O
Sentence: 680,warranted,O
Sentence: 680,before,O
Sentence: 680,guidelines,O
Sentence: 680,can,O
Sentence: 680,be,O
Sentence: 680,recommended,O
Sentence: 680,.,O
Sentence: 681,A,O
Sentence: 681,case,O
Sentence: 681,of,O
Sentence: 681,isotretinoin,B-Disease
Sentence: 681,embryopathy,I-Disease
Sentence: 681,with,O
Sentence: 681,bilateral,O
Sentence: 681,anotia,B-Disease
Sentence: 681,and,O
Sentence: 681,Taussig,O
Sentence: 681,-,O
Sentence: 681,Bing,O
Sentence: 681,malformation,O
Sentence: 681,.,O
Sentence: 682,We,O
Sentence: 682,report,O
Sentence: 682,a,O
Sentence: 682,newborn,O
Sentence: 682,infant,O
Sentence: 682,with,O
Sentence: 682,multiple,O
Sentence: 682,congenital,O
Sentence: 682,anomalies,O
Sentence: 682,(,O
Sentence: 682,anotia,B-Disease
Sentence: 682,and,O
Sentence: 682,Taussig,O
Sentence: 682,-,O
Sentence: 682,Bing,O
Sentence: 682,malformation,O
Sentence: 682,),O
Sentence: 682,due,O
Sentence: 682,to,O
Sentence: 682,exposure,O
Sentence: 682,to,O
Sentence: 682,isotretinoin,B-Chemical
Sentence: 682,within,O
Sentence: 682,the,O
Sentence: 682,first,O
Sentence: 682,trimester,O
Sentence: 682,.,O
Sentence: 682,In,O
Sentence: 682,this,O
Sentence: 682,paper,O
Sentence: 682,we,O
Sentence: 682,aim,O
Sentence: 682,to,O
Sentence: 682,draw,O
Sentence: 682,to,O
Sentence: 682,the,O
Sentence: 682,fact,O
Sentence: 682,that,O
Sentence: 682,caution,O
Sentence: 682,is,O
Sentence: 682,needed,O
Sentence: 682,when,O
Sentence: 682,prescribing,O
Sentence: 682,vitamin,B-Chemical
Sentence: 682,A,I-Chemical
Sentence: 682,-,O
Sentence: 682,containing,O
Sentence: 682,drugs,O
Sentence: 682,to,O
Sentence: 682,women,O
Sentence: 682,of,O
Sentence: 682,childbearing,O
Sentence: 682,years,O
Sentence: 682,.,O
Sentence: 683,Effect,O
Sentence: 683,of,O
Sentence: 683,methoxamine,B-Chemical
Sentence: 683,on,O
Sentence: 683,maximum,O
Sentence: 683,urethral,O
Sentence: 683,pressure,O
Sentence: 683,in,O
Sentence: 683,women,O
Sentence: 683,with,O
Sentence: 683,genuine,O
Sentence: 683,stress,B-Disease
Sentence: 683,incontinence,I-Disease
Sentence: 683,:,O
Sentence: 683,a,O
Sentence: 683,placebo,O
Sentence: 683,-,O
Sentence: 683,controlled,O
Sentence: 683,",",O
Sentence: 683,double,O
Sentence: 683,-,O
Sentence: 683,blind,O
Sentence: 683,crossover,O
Sentence: 683,study,O
Sentence: 683,.,O
Sentence: 684,The,O
Sentence: 684,aim,O
Sentence: 684,of,O
Sentence: 684,the,O
Sentence: 684,study,O
Sentence: 684,was,O
Sentence: 684,to,O
Sentence: 684,evaluate,O
Sentence: 684,the,O
Sentence: 684,potential,O
Sentence: 684,role,O
Sentence: 684,for,O
Sentence: 684,a,O
Sentence: 684,selective,O
Sentence: 684,alpha1,O
Sentence: 684,-,O
Sentence: 684,adrenoceptor,O
Sentence: 684,agonist,O
Sentence: 684,in,O
Sentence: 684,the,O
Sentence: 684,treatment,O
Sentence: 684,of,O
Sentence: 684,urinary,B-Disease
Sentence: 684,stress,B-Disease
Sentence: 684,incontinence,I-Disease
Sentence: 684,.,O
Sentence: 684,A,O
Sentence: 684,randomised,O
Sentence: 684,",",O
Sentence: 684,double,O
Sentence: 684,-,O
Sentence: 684,blind,O
Sentence: 684,",",O
Sentence: 684,placebo,O
Sentence: 684,-,O
Sentence: 684,controlled,O
Sentence: 684,",",O
Sentence: 684,crossover,O
Sentence: 684,study,O
Sentence: 684,design,O
Sentence: 684,was,O
Sentence: 684,employed,O
Sentence: 684,.,O
Sentence: 684,Half,O
Sentence: 684,log,O
Sentence: 684,incremental,O
Sentence: 684,doses,O
Sentence: 684,of,O
Sentence: 684,intravenous,O
Sentence: 684,methoxamine,B-Chemical
Sentence: 684,or,O
Sentence: 684,placebo,O
Sentence: 684,(,O
Sentence: 684,saline,O
Sentence: 684,),O
Sentence: 684,were,O
Sentence: 684,administered,O
Sentence: 684,to,O
Sentence: 684,a,O
Sentence: 684,group,O
Sentence: 684,of,O
Sentence: 684,women,O
Sentence: 684,with,O
Sentence: 684,genuine,O
Sentence: 684,stress,B-Disease
Sentence: 684,incontinence,I-Disease
Sentence: 684,while,O
Sentence: 684,measuring,O
Sentence: 684,maximum,O
Sentence: 684,urethral,O
Sentence: 684,pressure,O
Sentence: 684,(,O
Sentence: 684,MUP,O
Sentence: 684,),O
Sentence: 684,",",O
Sentence: 684,blood,O
Sentence: 684,pressure,O
Sentence: 684,",",O
Sentence: 684,heart,O
Sentence: 684,rate,O
Sentence: 684,",",O
Sentence: 684,and,O
Sentence: 684,symptomatic,O
Sentence: 684,side,O
Sentence: 684,effects,O
Sentence: 684,.,O
Sentence: 684,Methoxamine,B-Chemical
Sentence: 684,evoked,O
Sentence: 684,non,O
Sentence: 684,-,O
Sentence: 684,significant,O
Sentence: 684,increases,O
Sentence: 684,in,O
Sentence: 684,MUP,O
Sentence: 684,and,O
Sentence: 684,diastolic,O
Sentence: 684,blood,O
Sentence: 684,pressure,O
Sentence: 684,but,O
Sentence: 684,caused,O
Sentence: 684,a,B-Disease
Sentence: 684,significant,I-Disease
Sentence: 684,rise,I-Disease
Sentence: 684,in,I-Disease
Sentence: 684,systolic,I-Disease
Sentence: 684,blood,I-Disease
Sentence: 684,pressure,I-Disease
Sentence: 684,and,O
Sentence: 684,significant,O
Sentence: 684,fall,O
Sentence: 684,in,O
Sentence: 684,heart,O
Sentence: 684,rate,O
Sentence: 684,at,O
Sentence: 684,maximum,O
Sentence: 684,dosage,O
Sentence: 684,.,O
Sentence: 684,Systemic,O
Sentence: 684,side,O
Sentence: 684,effects,O
Sentence: 684,including,O
Sentence: 684,piloerection,O
Sentence: 684,",",O
Sentence: 684,headache,B-Disease
Sentence: 684,",",O
Sentence: 684,and,O
Sentence: 684,cold,O
Sentence: 684,extremities,O
Sentence: 684,were,O
Sentence: 684,experienced,O
Sentence: 684,in,O
Sentence: 684,all,O
Sentence: 684,subjects,O
Sentence: 684,.,O
Sentence: 684,The,O
Sentence: 684,results,O
Sentence: 684,indicate,O
Sentence: 684,that,O
Sentence: 684,the,O
Sentence: 684,clinical,O
Sentence: 684,usefulness,O
Sentence: 684,of,O
Sentence: 684,direct,O
Sentence: 684,",",O
Sentence: 684,peripherally,O
Sentence: 684,acting,O
Sentence: 684,sub,O
Sentence: 684,-,O
Sentence: 684,type,O
Sentence: 684,-,O
Sentence: 684,selective,O
Sentence: 684,alpha1,O
Sentence: 684,-,O
Sentence: 684,adrenoceptor,O
Sentence: 684,agonists,O
Sentence: 684,in,O
Sentence: 684,the,O
Sentence: 684,medical,O
Sentence: 684,treatment,O
Sentence: 684,of,O
Sentence: 684,stress,B-Disease
Sentence: 684,incontinence,I-Disease
Sentence: 684,may,O
Sentence: 684,be,O
Sentence: 684,limited,O
Sentence: 684,by,O
Sentence: 684,associated,O
Sentence: 684,piloerection,O
Sentence: 684,and,O
Sentence: 684,cardiovascular,O
Sentence: 684,side,O
Sentence: 684,effects,O
Sentence: 684,.,O
Sentence: 685,Toleration,O
Sentence: 685,of,O
Sentence: 685,high,O
Sentence: 685,doses,O
Sentence: 685,of,O
Sentence: 685,angiotensin,O
Sentence: 685,-,O
Sentence: 685,converting,O
Sentence: 685,enzyme,O
Sentence: 685,inhibitors,O
Sentence: 685,in,O
Sentence: 685,patients,O
Sentence: 685,with,O
Sentence: 685,chronic,O
Sentence: 685,heart,B-Disease
Sentence: 685,failure,I-Disease
Sentence: 685,:,O
Sentence: 685,results,O
Sentence: 685,from,O
Sentence: 685,the,O
Sentence: 685,ATLAS,O
Sentence: 685,trial,O
Sentence: 685,.,O
Sentence: 685,The,O
Sentence: 685,Assessment,O
Sentence: 685,of,O
Sentence: 685,Treatment,O
Sentence: 685,with,O
Sentence: 685,Lisinopril,B-Chemical
Sentence: 685,and,O
Sentence: 685,Survival,O
Sentence: 685,.,O
Sentence: 686,BACKGROUND,O
Sentence: 686,:,O
Sentence: 686,Treatment,O
Sentence: 686,with,O
Sentence: 686,angiotensin,O
Sentence: 686,-,O
Sentence: 686,converting,O
Sentence: 686,enzyme,O
Sentence: 686,(,O
Sentence: 686,ACE,O
Sentence: 686,),O
Sentence: 686,inhibitors,O
Sentence: 686,reduces,O
Sentence: 686,mortality,O
Sentence: 686,and,O
Sentence: 686,morbidity,O
Sentence: 686,in,O
Sentence: 686,patients,O
Sentence: 686,with,O
Sentence: 686,chronic,O
Sentence: 686,heart,B-Disease
Sentence: 686,failure,I-Disease
Sentence: 686,(,O
Sentence: 686,CHF,B-Disease
Sentence: 686,),O
Sentence: 686,",",O
Sentence: 686,but,O
Sentence: 686,most,O
Sentence: 686,affected,O
Sentence: 686,patients,O
Sentence: 686,are,O
Sentence: 686,not,O
Sentence: 686,receiving,O
Sentence: 686,these,O
Sentence: 686,agents,O
Sentence: 686,or,O
Sentence: 686,are,O
Sentence: 686,being,O
Sentence: 686,treated,O
Sentence: 686,with,O
Sentence: 686,doses,O
Sentence: 686,lower,O
Sentence: 686,than,O
Sentence: 686,those,O
Sentence: 686,found,O
Sentence: 686,to,O
Sentence: 686,be,O
Sentence: 686,efficacious,O
Sentence: 686,in,O
Sentence: 686,trials,O
Sentence: 686,",",O
Sentence: 686,primarily,O
Sentence: 686,because,O
Sentence: 686,of,O
Sentence: 686,concerns,O
Sentence: 686,about,O
Sentence: 686,the,O
Sentence: 686,safety,O
Sentence: 686,and,O
Sentence: 686,tolerability,O
Sentence: 686,of,O
Sentence: 686,these,O
Sentence: 686,agents,O
Sentence: 686,",",O
Sentence: 686,especially,O
Sentence: 686,at,O
Sentence: 686,the,O
Sentence: 686,recommended,O
Sentence: 686,doses,O
Sentence: 686,.,O
Sentence: 686,The,O
Sentence: 686,present,O
Sentence: 686,study,O
Sentence: 686,examines,O
Sentence: 686,the,O
Sentence: 686,safety,O
Sentence: 686,and,O
Sentence: 686,tolerability,O
Sentence: 686,of,O
Sentence: 686,high,O
Sentence: 686,-,O
Sentence: 686,,O
Sentence: 686,compared,O
Sentence: 686,with,O
Sentence: 686,low,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,lisinopril,B-Chemical
Sentence: 686,in,O
Sentence: 686,CHF,B-Disease
Sentence: 686,.,O
Sentence: 686,METHODS,O
Sentence: 686,:,O
Sentence: 686,The,O
Sentence: 686,Assessment,O
Sentence: 686,of,O
Sentence: 686,Lisinopril,B-Chemical
Sentence: 686,and,O
Sentence: 686,Survival,O
Sentence: 686,study,O
Sentence: 686,was,O
Sentence: 686,a,O
Sentence: 686,multicenter,O
Sentence: 686,",",O
Sentence: 686,randomized,O
Sentence: 686,",",O
Sentence: 686,double,O
Sentence: 686,-,O
Sentence: 686,blind,O
Sentence: 686,trial,O
Sentence: 686,in,O
Sentence: 686,which,O
Sentence: 686,patients,O
Sentence: 686,with,O
Sentence: 686,or,O
Sentence: 686,without,O
Sentence: 686,previous,O
Sentence: 686,ACE,B-Chemical
Sentence: 686,inhibitor,I-Chemical
Sentence: 686,treatment,O
Sentence: 686,were,O
Sentence: 686,stabilized,O
Sentence: 686,receiving,O
Sentence: 686,medium,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,lisinopril,B-Chemical
Sentence: 686,(,O
Sentence: 686,12.5,O
Sentence: 686,or,O
Sentence: 686,15.0,O
Sentence: 686,mg,O
Sentence: 686,once,O
Sentence: 686,daily,O
Sentence: 686,[,O
Sentence: 686,OD,O
Sentence: 686,],O
Sentence: 686,),O
Sentence: 686,for,O
Sentence: 686,2,O
Sentence: 686,to,O
Sentence: 686,4,O
Sentence: 686,weeks,O
Sentence: 686,and,O
Sentence: 686,then,O
Sentence: 686,randomized,O
Sentence: 686,to,O
Sentence: 686,high,O
Sentence: 686,-,O
Sentence: 686,,O
Sentence: 686,(,O
Sentence: 686,35.0,O
Sentence: 686,or,O
Sentence: 686,32.5,O
Sentence: 686,mg,O
Sentence: 686,OD,O
Sentence: 686,),O
Sentence: 686,or,O
Sentence: 686,low,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,(,O
Sentence: 686,5.0,O
Sentence: 686,or,O
Sentence: 686,2.5,O
Sentence: 686,mg,O
Sentence: 686,OD,O
Sentence: 686,),O
Sentence: 686,groups,O
Sentence: 686,.,O
Sentence: 686,Patients,O
Sentence: 686,with,O
Sentence: 686,New,O
Sentence: 686,York,O
Sentence: 686,Heart,O
Sentence: 686,Association,O
Sentence: 686,classes,O
Sentence: 686,II,O
Sentence: 686,to,O
Sentence: 686,IV,O
Sentence: 686,CHF,B-Disease
Sentence: 686,and,O
Sentence: 686,left,O
Sentence: 686,ventricular,O
Sentence: 686,ejection,O
Sentence: 686,fractions,O
Sentence: 686,of,O
Sentence: 686,no,O
Sentence: 686,greater,O
Sentence: 686,than,O
Sentence: 686,0.30,O
Sentence: 686,(,O
Sentence: 686,n,O
Sentence: 686,,O
Sentence: 686,=,O
Sentence: 686,,O
Sentence: 686,3164,O
Sentence: 686,),O
Sentence: 686,were,O
Sentence: 686,randomized,O
Sentence: 686,and,O
Sentence: 686,followed,O
Sentence: 686,up,O
Sentence: 686,for,O
Sentence: 686,a,O
Sentence: 686,median,O
Sentence: 686,of,O
Sentence: 686,46,O
Sentence: 686,months,O
Sentence: 686,.,O
Sentence: 686,We,O
Sentence: 686,examined,O
Sentence: 686,the,O
Sentence: 686,occurrence,O
Sentence: 686,of,O
Sentence: 686,adverse,O
Sentence: 686,events,O
Sentence: 686,and,O
Sentence: 686,the,O
Sentence: 686,need,O
Sentence: 686,for,O
Sentence: 686,discontinuation,O
Sentence: 686,and,O
Sentence: 686,dose,O
Sentence: 686,reduction,O
Sentence: 686,during,O
Sentence: 686,treatment,O
Sentence: 686,",",O
Sentence: 686,with,O
Sentence: 686,a,O
Sentence: 686,focus,O
Sentence: 686,on,O
Sentence: 686,hypotension,B-Disease
Sentence: 686,and,O
Sentence: 686,renal,B-Disease
Sentence: 686,dysfunction,I-Disease
Sentence: 686,.,O
Sentence: 686,RESULTS,O
Sentence: 686,:,O
Sentence: 686,Of,O
Sentence: 686,405,O
Sentence: 686,patients,O
Sentence: 686,not,O
Sentence: 686,previously,O
Sentence: 686,receiving,O
Sentence: 686,an,O
Sentence: 686,ACE,B-Chemical
Sentence: 686,inhibitor,I-Chemical
Sentence: 686,",",O
Sentence: 686,doses,O
Sentence: 686,in,O
Sentence: 686,only,O
Sentence: 686,4.2,O
Sentence: 686,%,O
Sentence: 686,could,O
Sentence: 686,not,O
Sentence: 686,be,O
Sentence: 686,titrated,O
Sentence: 686,to,O
Sentence: 686,the,O
Sentence: 686,medium,O
Sentence: 686,doses,O
Sentence: 686,required,O
Sentence: 686,for,O
Sentence: 686,randomization,O
Sentence: 686,because,O
Sentence: 686,of,O
Sentence: 686,symptoms,O
Sentence: 686,possibly,O
Sentence: 686,related,O
Sentence: 686,to,O
Sentence: 686,hypotension,B-Disease
Sentence: 686,(,O
Sentence: 686,2.0,O
Sentence: 686,%,O
Sentence: 686,),O
Sentence: 686,or,O
Sentence: 686,because,O
Sentence: 686,of,O
Sentence: 686,renal,B-Disease
Sentence: 686,dysfunction,I-Disease
Sentence: 686,or,O
Sentence: 686,hyperkalemia,B-Disease
Sentence: 686,(,O
Sentence: 686,2.3,O
Sentence: 686,%,O
Sentence: 686,),O
Sentence: 686,.,O
Sentence: 686,Doses,O
Sentence: 686,in,O
Sentence: 686,more,O
Sentence: 686,than,O
Sentence: 686,90,O
Sentence: 686,%,O
Sentence: 686,of,O
Sentence: 686,randomized,O
Sentence: 686,patients,O
Sentence: 686,in,O
Sentence: 686,the,O
Sentence: 686,high,O
Sentence: 686,-,O
Sentence: 686,,O
Sentence: 686,and,O
Sentence: 686,low,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,groups,O
Sentence: 686,were,O
Sentence: 686,titrated,O
Sentence: 686,to,O
Sentence: 686,their,O
Sentence: 686,assigned,O
Sentence: 686,target,O
Sentence: 686,",",O
Sentence: 686,and,O
Sentence: 686,the,O
Sentence: 686,mean,O
Sentence: 686,doses,O
Sentence: 686,of,O
Sentence: 686,blinded,O
Sentence: 686,medication,O
Sentence: 686,in,O
Sentence: 686,both,O
Sentence: 686,groups,O
Sentence: 686,remained,O
Sentence: 686,similar,O
Sentence: 686,throughout,O
Sentence: 686,the,O
Sentence: 686,study,O
Sentence: 686,.,O
Sentence: 686,Withdrawals,O
Sentence: 686,occurred,O
Sentence: 686,in,O
Sentence: 686,27.1,O
Sentence: 686,%,O
Sentence: 686,of,O
Sentence: 686,the,O
Sentence: 686,high,O
Sentence: 686,-,O
Sentence: 686,,O
Sentence: 686,and,O
Sentence: 686,30.7,O
Sentence: 686,%,O
Sentence: 686,of,O
Sentence: 686,the,O
Sentence: 686,low,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,groups,O
Sentence: 686,.,O
Sentence: 686,Subgroups,O
Sentence: 686,presumed,O
Sentence: 686,to,O
Sentence: 686,be,O
Sentence: 686,at,O
Sentence: 686,higher,O
Sentence: 686,risk,O
Sentence: 686,for,O
Sentence: 686,ACE,B-Chemical
Sentence: 686,inhibitor,I-Chemical
Sentence: 686,intolerance,O
Sentence: 686,(,O
Sentence: 686,blood,O
Sentence: 686,pressure,O
Sentence: 686,",",O
Sentence: 686,,O
Sentence: 686,<,O
Sentence: 686,,O
Sentence: 686,120,O
Sentence: 686,mm,O
Sentence: 686,Hg,O
Sentence: 686,;,O
Sentence: 686,creatinine,B-Chemical
Sentence: 686,",",O
Sentence: 686,,O
Sentence: 686,>,O
Sentence: 686,,O
Sentence: 686,or,O
Sentence: 686,,O
Sentence: 686,=,O
Sentence: 686,132.6,O
Sentence: 686,micromol,O
Sentence: 686,/,O
Sentence: 686,L,O
Sentence: 686,[,O
Sentence: 686,,O
Sentence: 686,>,O
Sentence: 686,,O
Sentence: 686,or,O
Sentence: 686,,O
Sentence: 686,=,O
Sentence: 686,1.5,O
Sentence: 686,mg,O
Sentence: 686,/,O
Sentence: 686,dL,O
Sentence: 686,],O
Sentence: 686,;,O
Sentence: 686,age,O
Sentence: 686,",",O
Sentence: 686,,O
Sentence: 686,>,O
Sentence: 686,,O
Sentence: 686,or,O
Sentence: 686,,O
Sentence: 686,=,O
Sentence: 686,70,O
Sentence: 686,years,O
Sentence: 686,;,O
Sentence: 686,and,O
Sentence: 686,patients,O
Sentence: 686,with,O
Sentence: 686,diabetes,B-Disease
Sentence: 686,),O
Sentence: 686,generally,O
Sentence: 686,tolerated,O
Sentence: 686,the,O
Sentence: 686,high,O
Sentence: 686,-,O
Sentence: 686,dose,O
Sentence: 686,strategy,O
Sentence: 686,.,O
Sentence: 686,CONCLUSIONS,O
Sentence: 686,:,O
Sentence: 686,These,O
Sentence: 686,findings,O
Sentence: 686,demonstrate,O
Sentence: 686,that,O
Sentence: 686,ACE,B-Chemical
Sentence: 686,inhibitor,I-Chemical
Sentence: 686,therapy,O
Sentence: 686,in,O
Sentence: 686,most,O
Sentence: 686,patients,O
Sentence: 686,with,O
Sentence: 686,CHF,B-Disease
Sentence: 686,can,O
Sentence: 686,be,O
Sentence: 686,successfully,O
Sentence: 686,titrated,O
Sentence: 686,to,O
Sentence: 686,and,O
Sentence: 686,maintained,O
Sentence: 686,at,O
Sentence: 686,high,O
Sentence: 686,doses,O
Sentence: 686,",",O
Sentence: 686,and,O
Sentence: 686,that,O
Sentence: 686,more,O
Sentence: 686,aggressive,O
Sentence: 686,use,O
Sentence: 686,of,O
Sentence: 686,these,O
Sentence: 686,agents,O
Sentence: 686,is,O
Sentence: 686,warranted,O
Sentence: 686,.,O
Sentence: 687,Cocaine,B-Chemical
Sentence: 687,",",O
Sentence: 687,ethanol,B-Chemical
Sentence: 687,",",O
Sentence: 687,and,O
Sentence: 687,cocaethylene,B-Chemical
Sentence: 687,cardiotoxity,B-Disease
Sentence: 687,in,O
Sentence: 687,an,O
Sentence: 687,animal,O
Sentence: 687,model,O
Sentence: 687,of,O
Sentence: 687,cocaine,B-Disease
Sentence: 687,and,I-Disease
Sentence: 687,ethanol,B-Disease
Sentence: 687,abuse,I-Disease
Sentence: 687,.,O
Sentence: 688,OBJECTIVES,O
Sentence: 688,:,O
Sentence: 688,Simultaneous,O
Sentence: 688,abuse,B-Disease
Sentence: 688,of,I-Disease
Sentence: 688,cocaine,B-Chemical
Sentence: 688,and,I-Disease
Sentence: 688,ethanol,B-Chemical
Sentence: 688,affects,O
Sentence: 688,12,O
Sentence: 688,million,O
Sentence: 688,Americans,O
Sentence: 688,annually,O
Sentence: 688,.,O
Sentence: 688,In,O
Sentence: 688,combination,O
Sentence: 688,",",O
Sentence: 688,these,O
Sentence: 688,substances,O
Sentence: 688,are,O
Sentence: 688,substantially,O
Sentence: 688,more,O
Sentence: 688,toxic,O
Sentence: 688,than,O
Sentence: 688,either,O
Sentence: 688,drug,O
Sentence: 688,alone,O
Sentence: 688,.,O
Sentence: 688,Their,O
Sentence: 688,combined,O
Sentence: 688,cardiac,B-Disease
Sentence: 688,toxicity,I-Disease
Sentence: 688,may,O
Sentence: 688,be,O
Sentence: 688,due,O
Sentence: 688,to,O
Sentence: 688,independent,O
Sentence: 688,effects,O
Sentence: 688,of,O
Sentence: 688,each,O
Sentence: 688,drug,O
Sentence: 688,;,O
Sentence: 688,however,O
Sentence: 688,",",O
Sentence: 688,they,O
Sentence: 688,may,O
Sentence: 688,also,O
Sentence: 688,be,O
Sentence: 688,due,O
Sentence: 688,to,O
Sentence: 688,cocaethylene,B-Chemical
Sentence: 688,(,O
Sentence: 688,CE,B-Chemical
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,a,O
Sentence: 688,cocaine,B-Chemical
Sentence: 688,metabolite,O
Sentence: 688,formed,O
Sentence: 688,only,O
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,presence,O
Sentence: 688,of,O
Sentence: 688,ethanol,B-Chemical
Sentence: 688,.,O
Sentence: 688,The,O
Sentence: 688,purpose,O
Sentence: 688,of,O
Sentence: 688,this,O
Sentence: 688,study,O
Sentence: 688,was,O
Sentence: 688,to,O
Sentence: 688,delineate,O
Sentence: 688,the,O
Sentence: 688,role,O
Sentence: 688,of,O
Sentence: 688,CE,B-Chemical
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,combined,O
Sentence: 688,cardiotoxicity,B-Disease
Sentence: 688,of,O
Sentence: 688,cocaine,B-Chemical
Sentence: 688,and,O
Sentence: 688,ethanol,B-Chemical
Sentence: 688,in,O
Sentence: 688,a,O
Sentence: 688,model,O
Sentence: 688,simulating,O
Sentence: 688,their,O
Sentence: 688,abuse,O
Sentence: 688,.,O
Sentence: 688,METHODS,O
Sentence: 688,:,O
Sentence: 688,Twenty,O
Sentence: 688,-,O
Sentence: 688,three,O
Sentence: 688,dogs,O
Sentence: 688,were,O
Sentence: 688,randomized,O
Sentence: 688,to,O
Sentence: 688,receive,O
Sentence: 688,either,O
Sentence: 688,1,O
Sentence: 688,),O
Sentence: 688,three,O
Sentence: 688,intravenous,O
Sentence: 688,(,O
Sentence: 688,IV,O
Sentence: 688,),O
Sentence: 688,boluses,O
Sentence: 688,of,O
Sentence: 688,cocaine,B-Chemical
Sentence: 688,7.5,O
Sentence: 688,mg,O
Sentence: 688,/,O
Sentence: 688,kg,O
Sentence: 688,with,O
Sentence: 688,ethanol,B-Chemical
Sentence: 688,(,O
Sentence: 688,1,O
Sentence: 688,g,O
Sentence: 688,/,O
Sentence: 688,kg,O
Sentence: 688,),O
Sentence: 688,as,O
Sentence: 688,an,O
Sentence: 688,IV,O
Sentence: 688,infusion,O
Sentence: 688,(,O
Sentence: 688,C+E,O
Sentence: 688,",",O
Sentence: 688,n,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,8,O
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,2,O
Sentence: 688,),O
Sentence: 688,three,O
Sentence: 688,cocaine,B-Chemical
Sentence: 688,boluses,O
Sentence: 688,only,O
Sentence: 688,(,O
Sentence: 688,C,O
Sentence: 688,",",O
Sentence: 688,n,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,6,O
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,3,O
Sentence: 688,),O
Sentence: 688,ethanol,B-Chemical
Sentence: 688,infusion,O
Sentence: 688,only,O
Sentence: 688,(,O
Sentence: 688,E,O
Sentence: 688,",",O
Sentence: 688,n,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,5,O
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,or,O
Sentence: 688,4,O
Sentence: 688,),O
Sentence: 688,placebo,O
Sentence: 688,boluses,O
Sentence: 688,and,O
Sentence: 688,infusion,O
Sentence: 688,(,O
Sentence: 688,n,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,4,O
Sentence: 688,),O
Sentence: 688,.,O
Sentence: 688,Hemodynamic,O
Sentence: 688,measurements,O
Sentence: 688,",",O
Sentence: 688,electrocardiograms,O
Sentence: 688,",",O
Sentence: 688,and,O
Sentence: 688,serum,O
Sentence: 688,drug,O
Sentence: 688,concentrations,O
Sentence: 688,were,O
Sentence: 688,obtained,O
Sentence: 688,at,O
Sentence: 688,baseline,O
Sentence: 688,",",O
Sentence: 688,and,O
Sentence: 688,then,O
Sentence: 688,at,O
Sentence: 688,fixed,O
Sentence: 688,time,O
Sentence: 688,intervals,O
Sentence: 688,after,O
Sentence: 688,each,O
Sentence: 688,drug,O
Sentence: 688,was,O
Sentence: 688,administered,O
Sentence: 688,.,O
Sentence: 688,RESULTS,O
Sentence: 688,:,O
Sentence: 688,Two,O
Sentence: 688,of,O
Sentence: 688,eight,O
Sentence: 688,dogs,O
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,C+E,O
Sentence: 688,group,O
Sentence: 688,experienced,O
Sentence: 688,cardiovascular,B-Disease
Sentence: 688,collapse,I-Disease
Sentence: 688,.,O
Sentence: 688,The,O
Sentence: 688,most,O
Sentence: 688,dramatic,O
Sentence: 688,hemodynamic,O
Sentence: 688,changes,O
Sentence: 688,occurred,O
Sentence: 688,after,O
Sentence: 688,each,O
Sentence: 688,cocaine,B-Chemical
Sentence: 688,bolus,O
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,C+E,O
Sentence: 688,and,O
Sentence: 688,C,O
Sentence: 688,only,O
Sentence: 688,groups,O
Sentence: 688,;,O
Sentence: 688,however,O
Sentence: 688,",",O
Sentence: 688,persistent,O
Sentence: 688,hemodynamic,O
Sentence: 688,changes,O
Sentence: 688,occurred,O
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,C+E,O
Sentence: 688,group,O
Sentence: 688,.,O
Sentence: 688,Peak,O
Sentence: 688,CE,B-Chemical
Sentence: 688,levels,O
Sentence: 688,were,O
Sentence: 688,associated,O
Sentence: 688,with,O
Sentence: 688,a,O
Sentence: 688,45,O
Sentence: 688,%,O
Sentence: 688,(,O
Sentence: 688,SD,O
Sentence: 688,+,O
Sentence: 688,/,O
Sentence: 688,,O
Sentence: 688,-,O
Sentence: 688,,O
Sentence: 688,22,O
Sentence: 688,%,O
Sentence: 688,",",O
Sentence: 688,95,O
Sentence: 688,%,O
Sentence: 688,CI,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,22,O
Sentence: 688,%,O
Sentence: 688,to,O
Sentence: 688,69,O
Sentence: 688,%,O
Sentence: 688,),O
Sentence: 688,decrease,B-Disease
Sentence: 688,in,I-Disease
Sentence: 688,cardiac,I-Disease
Sentence: 688,output,I-Disease
Sentence: 688,(,O
Sentence: 688,p,O
Sentence: 688,,O
Sentence: 688,<,O
Sentence: 688,,O
Sentence: 688,0.05,O
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,a,O
Sentence: 688,56,O
Sentence: 688,%,O
Sentence: 688,(,O
Sentence: 688,SD,O
Sentence: 688,+,O
Sentence: 688,/,O
Sentence: 688,,O
Sentence: 688,-,O
Sentence: 688,,O
Sentence: 688,23,O
Sentence: 688,%,O
Sentence: 688,",",O
Sentence: 688,95,O
Sentence: 688,%,O
Sentence: 688,CI,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,32,O
Sentence: 688,%,O
Sentence: 688,to,O
Sentence: 688,80,O
Sentence: 688,%,O
Sentence: 688,),O
Sentence: 688,decrease,O
Sentence: 688,in,O
Sentence: 688,dP,O
Sentence: 688,/,O
Sentence: 688,dt,O
Sentence: 688,(,O
Sentence: 688,max,O
Sentence: 688,),O
Sentence: 688,(,O
Sentence: 688,p,O
Sentence: 688,,O
Sentence: 688,<,O
Sentence: 688,,O
Sentence: 688,.006,O
Sentence: 688,),O
Sentence: 688,",",O
Sentence: 688,and,O
Sentence: 688,a,O
Sentence: 688,23,O
Sentence: 688,%,O
Sentence: 688,(,O
Sentence: 688,SD,O
Sentence: 688,+,O
Sentence: 688,/,O
Sentence: 688,,O
Sentence: 688,-,O
Sentence: 688,,O
Sentence: 688,15,O
Sentence: 688,%,O
Sentence: 688,",",O
Sentence: 688,95,O
Sentence: 688,%,O
Sentence: 688,CI,O
Sentence: 688,,O
Sentence: 688,=,O
Sentence: 688,,O
Sentence: 688,7,O
Sentence: 688,%,O
Sentence: 688,to,O
Sentence: 688,49,O
Sentence: 688,%,O
Sentence: 688,),O
Sentence: 688,decrease,O
Sentence: 688,in,O
Sentence: 688,SVO,O
Sentence: 688,(,O
Sentence: 688,2,O
Sentence: 688,),O
Sentence: 688,(,O
Sentence: 688,p,O
Sentence: 688,,O
Sentence: 688,<,O
Sentence: 688,,O
Sentence: 688,0.025,O
Sentence: 688,),O
Sentence: 688,.,O
Sentence: 688,Ventricular,B-Disease
Sentence: 688,arrhythmias,I-Disease
Sentence: 688,were,O
Sentence: 688,primarily,O
Sentence: 688,observed,O
Sentence: 688,in,O
Sentence: 688,the,O
Sentence: 688,C+E,O
Sentence: 688,group,O
Sentence: 688,",",O
Sentence: 688,in,O
Sentence: 688,which,O
Sentence: 688,four,O
Sentence: 688,of,O
Sentence: 688,eight,O
Sentence: 688,dogs,O
Sentence: 688,experienced,O
Sentence: 688,ventricular,B-Disease
Sentence: 688,tachycardia,I-Disease
Sentence: 688,.,O
Sentence: 688,CONCLUSIONS,O
Sentence: 688,:,O
Sentence: 688,Cocaine,B-Chemical
Sentence: 688,and,O
Sentence: 688,ethanol,B-Chemical
Sentence: 688,in,O
Sentence: 688,combination,O
Sentence: 688,were,O
Sentence: 688,more,O
Sentence: 688,toxic,O
Sentence: 688,than,O
Sentence: 688,either,O
Sentence: 688,substance,O
Sentence: 688,alone,O
Sentence: 688,.,O
Sentence: 688,Co,O
Sentence: 688,-,O
Sentence: 688,administration,O
Sentence: 688,resulted,O
Sentence: 688,in,O
Sentence: 688,prolonged,O
Sentence: 688,cardiac,B-Disease
Sentence: 688,toxicity,I-Disease
Sentence: 688,and,O
Sentence: 688,was,O
Sentence: 688,dysrhythmogenic,O
Sentence: 688,.,O
Sentence: 688,Peak,O
Sentence: 688,serum,O
Sentence: 688,cocaethylene,B-Chemical
Sentence: 688,concentrations,O
Sentence: 688,were,O
Sentence: 688,associated,O
Sentence: 688,with,O
Sentence: 688,prolonged,O
Sentence: 688,myocardial,B-Disease
Sentence: 688,depression,I-Disease
Sentence: 688,.,O
Sentence: 689,Worsening,O
Sentence: 689,of,O
Sentence: 689,Parkinsonism,B-Disease
Sentence: 689,after,O
Sentence: 689,the,O
Sentence: 689,use,O
Sentence: 689,of,O
Sentence: 689,veralipride,B-Chemical
Sentence: 689,for,O
Sentence: 689,treatment,O
Sentence: 689,of,O
Sentence: 689,menopause,O
Sentence: 689,:,O
Sentence: 689,case,O
Sentence: 689,report,O
Sentence: 689,.,O
Sentence: 690,We,O
Sentence: 690,describe,O
Sentence: 690,a,O
Sentence: 690,female,O
Sentence: 690,patient,O
Sentence: 690,with,O
Sentence: 690,stable,O
Sentence: 690,Parkinson,B-Disease
Sentence: 690,'s,I-Disease
Sentence: 690,disease,I-Disease
Sentence: 690,who,O
Sentence: 690,has,O
Sentence: 690,shown,O
Sentence: 690,a,O
Sentence: 690,marked,O
Sentence: 690,worsening,O
Sentence: 690,of,O
Sentence: 690,her,O
Sentence: 690,motor,O
Sentence: 690,functions,O
Sentence: 690,following,O
Sentence: 690,therapy,O
Sentence: 690,of,O
Sentence: 690,menopause,O
Sentence: 690,related,O
Sentence: 690,symptoms,O
Sentence: 690,with,O
Sentence: 690,veralipride,B-Chemical
Sentence: 690,",",O
Sentence: 690,as,O
Sentence: 690,well,O
Sentence: 690,as,O
Sentence: 690,the,O
Sentence: 690,improvement,O
Sentence: 690,of,O
Sentence: 690,her,O
Sentence: 690,symptoms,O
Sentence: 690,back,O
Sentence: 690,to,O
Sentence: 690,baseline,O
Sentence: 690,after,O
Sentence: 690,discontinuation,O
Sentence: 690,of,O
Sentence: 690,the,O
Sentence: 690,drug,O
Sentence: 690,.,O
Sentence: 690,We,O
Sentence: 690,emphasize,O
Sentence: 690,the,O
Sentence: 690,anti,O
Sentence: 690,-,O
Sentence: 690,dopaminergic,O
Sentence: 690,effect,O
Sentence: 690,of,O
Sentence: 690,veralipride,B-Chemical
Sentence: 690,.,O
Sentence: 691,Viracept,B-Chemical
Sentence: 691,and,O
Sentence: 691,irregular,B-Disease
Sentence: 691,heartbeat,I-Disease
Sentence: 691,warning,O
Sentence: 691,.,O
Sentence: 692,A,O
Sentence: 692,group,O
Sentence: 692,of,O
Sentence: 692,doctors,O
Sentence: 692,in,O
Sentence: 692,Boston,O
Sentence: 692,warn,O
Sentence: 692,that,O
Sentence: 692,the,O
Sentence: 692,protease,O
Sentence: 692,inhibitor,O
Sentence: 692,Viracept,B-Chemical
Sentence: 692,may,O
Sentence: 692,cause,O
Sentence: 692,an,O
Sentence: 692,irregular,B-Disease
Sentence: 692,heart,I-Disease
Sentence: 692,beat,I-Disease
Sentence: 692,",",O
Sentence: 692,known,O
Sentence: 692,as,O
Sentence: 692,bradycardia,B-Disease
Sentence: 692,",",O
Sentence: 692,in,O
Sentence: 692,people,O
Sentence: 692,with,O
Sentence: 692,HIV,O
Sentence: 692,.,O
Sentence: 692,Bradycardia,B-Disease
Sentence: 692,occurred,O
Sentence: 692,in,O
Sentence: 692,a,O
Sentence: 692,45,O
Sentence: 692,-,O
Sentence: 692,year,O
Sentence: 692,-,O
Sentence: 692,old,O
Sentence: 692,male,O
Sentence: 692,patient,O
Sentence: 692,who,O
Sentence: 692,was,O
Sentence: 692,Viracept,B-Chemical
Sentence: 692,in,O
Sentence: 692,combination,O
Sentence: 692,with,O
Sentence: 692,other,O
Sentence: 692,anti,O
Sentence: 692,-,O
Sentence: 692,HIV,O
Sentence: 692,drugs,O
Sentence: 692,.,O
Sentence: 692,The,O
Sentence: 692,symptoms,O
Sentence: 692,ceased,O
Sentence: 692,after,O
Sentence: 692,switching,O
Sentence: 692,to,O
Sentence: 692,another,O
Sentence: 692,drug,O
Sentence: 692,combination,O
Sentence: 692,.,O
Sentence: 693,Frequency,O
Sentence: 693,of,O
Sentence: 693,appearance,O
Sentence: 693,of,O
Sentence: 693,myeloperoxidase,O
Sentence: 693,-,O
Sentence: 693,antineutrophil,O
Sentence: 693,cytoplasmic,O
Sentence: 693,antibody,O
Sentence: 693,(,O
Sentence: 693,MPO,O
Sentence: 693,-,O
Sentence: 693,ANCA,O
Sentence: 693,),O
Sentence: 693,in,O
Sentence: 693,Graves,B-Disease
Sentence: 693,',I-Disease
Sentence: 693,disease,I-Disease
Sentence: 693,patients,O
Sentence: 693,treated,O
Sentence: 693,with,O
Sentence: 693,propylthiouracil,B-Chemical
Sentence: 693,and,O
Sentence: 693,the,O
Sentence: 693,relationship,O
Sentence: 693,between,O
Sentence: 693,MPO,O
Sentence: 693,-,O
Sentence: 693,ANCA,O
Sentence: 693,and,O
Sentence: 693,clinical,O
Sentence: 693,manifestations,O
Sentence: 693,.,O
Sentence: 694,OBJECTIVE,O
Sentence: 694,:,O
Sentence: 694,Myeloperoxidase,O
Sentence: 694,antineutrophil,O
Sentence: 694,cytoplasmic,O
Sentence: 694,antibody,O
Sentence: 694,(,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,),O
Sentence: 694,,O
Sentence: 694,-,O
Sentence: 694,positive,O
Sentence: 694,vasculitis,B-Disease
Sentence: 694,has,O
Sentence: 694,been,O
Sentence: 694,reported,O
Sentence: 694,in,O
Sentence: 694,patients,O
Sentence: 694,with,O
Sentence: 694,Graves,B-Disease
Sentence: 694,',I-Disease
Sentence: 694,disease,I-Disease
Sentence: 694,who,O
Sentence: 694,were,O
Sentence: 694,treated,O
Sentence: 694,with,O
Sentence: 694,propylthiouracil,B-Chemical
Sentence: 694,(,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,),O
Sentence: 694,.,O
Sentence: 694,The,O
Sentence: 694,appearance,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,in,O
Sentence: 694,these,O
Sentence: 694,cases,O
Sentence: 694,was,O
Sentence: 694,suspected,O
Sentence: 694,of,O
Sentence: 694,being,O
Sentence: 694,related,O
Sentence: 694,to,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,because,O
Sentence: 694,the,O
Sentence: 694,titres,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,decreased,O
Sentence: 694,when,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,was,O
Sentence: 694,stopped,O
Sentence: 694,.,O
Sentence: 694,Nevertheless,O
Sentence: 694,",",O
Sentence: 694,there,O
Sentence: 694,have,O
Sentence: 694,been,O
Sentence: 694,no,O
Sentence: 694,studies,O
Sentence: 694,on,O
Sentence: 694,the,O
Sentence: 694,temporal,O
Sentence: 694,relationship,O
Sentence: 694,between,O
Sentence: 694,the,O
Sentence: 694,appearance,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,and,O
Sentence: 694,vasculitis,B-Disease
Sentence: 694,during,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,",",O
Sentence: 694,or,O
Sentence: 694,on,O
Sentence: 694,the,O
Sentence: 694,incidence,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,in,O
Sentence: 694,untreated,O
Sentence: 694,Graves,B-Disease
Sentence: 694,',I-Disease
Sentence: 694,disease,I-Disease
Sentence: 694,patients,O
Sentence: 694,.,O
Sentence: 694,Therefore,O
Sentence: 694,",",O
Sentence: 694,we,O
Sentence: 694,sought,O
Sentence: 694,to,O
Sentence: 694,address,O
Sentence: 694,these,O
Sentence: 694,parameters,O
Sentence: 694,in,O
Sentence: 694,patients,O
Sentence: 694,with,O
Sentence: 694,Graves,B-Disease
Sentence: 694,',I-Disease
Sentence: 694,disease,I-Disease
Sentence: 694,.,O
Sentence: 694,PATIENTS,O
Sentence: 694,:,O
Sentence: 694,We,O
Sentence: 694,investigated,O
Sentence: 694,102,O
Sentence: 694,untreated,O
Sentence: 694,patients,O
Sentence: 694,with,O
Sentence: 694,hyperthyroidism,B-Disease
Sentence: 694,due,O
Sentence: 694,to,O
Sentence: 694,Graves,B-Disease
Sentence: 694,',I-Disease
Sentence: 694,disease,I-Disease
Sentence: 694,for,O
Sentence: 694,the,O
Sentence: 694,presence,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,",",O
Sentence: 694,and,O
Sentence: 694,for,O
Sentence: 694,the,O
Sentence: 694,development,O
Sentence: 694,vasculitis,B-Disease
Sentence: 694,after,O
Sentence: 694,starting,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,.,O
Sentence: 694,Twenty,O
Sentence: 694,-,O
Sentence: 694,nine,O
Sentence: 694,of,O
Sentence: 694,them,O
Sentence: 694,were,O
Sentence: 694,later,O
Sentence: 694,excluded,O
Sentence: 694,because,O
Sentence: 694,of,O
Sentence: 694,adverse,O
Sentence: 694,effects,O
Sentence: 694,of,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,or,O
Sentence: 694,because,O
Sentence: 694,the,O
Sentence: 694,observation,O
Sentence: 694,period,O
Sentence: 694,was,O
Sentence: 694,less,O
Sentence: 694,than,O
Sentence: 694,3,O
Sentence: 694,months,O
Sentence: 694,.,O
Sentence: 694,The,O
Sentence: 694,remaining,O
Sentence: 694,73,O
Sentence: 694,patients,O
Sentence: 694,(,O
Sentence: 694,55,O
Sentence: 694,women,O
Sentence: 694,and,O
Sentence: 694,18,O
Sentence: 694,men,O
Sentence: 694,),O
Sentence: 694,",",O
Sentence: 694,all,O
Sentence: 694,of,O
Sentence: 694,whom,O
Sentence: 694,were,O
Sentence: 694,examined,O
Sentence: 694,for,O
Sentence: 694,more,O
Sentence: 694,than,O
Sentence: 694,3,O
Sentence: 694,months,O
Sentence: 694,",",O
Sentence: 694,were,O
Sentence: 694,adopted,O
Sentence: 694,as,O
Sentence: 694,the,O
Sentence: 694,subjects,O
Sentence: 694,of,O
Sentence: 694,the,O
Sentence: 694,investigation,O
Sentence: 694,.,O
Sentence: 694,The,O
Sentence: 694,median,O
Sentence: 694,observation,O
Sentence: 694,period,O
Sentence: 694,was,O
Sentence: 694,23.6,O
Sentence: 694,months,O
Sentence: 694,(,O
Sentence: 694,range,O
Sentence: 694,:,O
Sentence: 694,3,O
Sentence: 694,-,O
Sentence: 694,37,O
Sentence: 694,months,O
Sentence: 694,),O
Sentence: 694,.,O
Sentence: 694,MEASUREMENTS,O
Sentence: 694,:,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,was,O
Sentence: 694,measured,O
Sentence: 694,at,O
Sentence: 694,intervals,O
Sentence: 694,of,O
Sentence: 694,2,O
Sentence: 694,-,O
Sentence: 694,6,O
Sentence: 694,months,O
Sentence: 694,.,O
Sentence: 694,RESULTS,O
Sentence: 694,:,O
Sentence: 694,Before,O
Sentence: 694,treatment,O
Sentence: 694,",",O
Sentence: 694,the,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,titres,O
Sentence: 694,of,O
Sentence: 694,all,O
Sentence: 694,102,O
Sentence: 694,untreated,O
Sentence: 694,Graves,B-Disease
Sentence: 694,',I-Disease
Sentence: 694,disease,I-Disease
Sentence: 694,patients,O
Sentence: 694,were,O
Sentence: 694,within,O
Sentence: 694,the,O
Sentence: 694,reference,O
Sentence: 694,range,O
Sentence: 694,(,O
Sentence: 694,below,O
Sentence: 694,10,O
Sentence: 694,U,O
Sentence: 694,/,O
Sentence: 694,ml,O
Sentence: 694,),O
Sentence: 694,.,O
Sentence: 694,Three,O
Sentence: 694,(,O
Sentence: 694,4.1,O
Sentence: 694,%,O
Sentence: 694,),O
Sentence: 694,of,O
Sentence: 694,the,O
Sentence: 694,73,O
Sentence: 694,patients,O
Sentence: 694,were,O
Sentence: 694,positive,O
Sentence: 694,for,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,at,O
Sentence: 694,13,O
Sentence: 694,",",O
Sentence: 694,16,O
Sentence: 694,and,O
Sentence: 694,17,O
Sentence: 694,months,O
Sentence: 694,",",O
Sentence: 694,respectively,O
Sentence: 694,",",O
Sentence: 694,after,O
Sentence: 694,the,O
Sentence: 694,start,O
Sentence: 694,of,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,.,O
Sentence: 694,In,O
Sentence: 694,two,O
Sentence: 694,of,O
Sentence: 694,them,O
Sentence: 694,",",O
Sentence: 694,the,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,titres,O
Sentence: 694,transiently,O
Sentence: 694,increased,O
Sentence: 694,to,O
Sentence: 694,12.8,O
Sentence: 694,and,O
Sentence: 694,15.0,O
Sentence: 694,U,O
Sentence: 694,/,O
Sentence: 694,ml,O
Sentence: 694,",",O
Sentence: 694,respectively,O
Sentence: 694,",",O
Sentence: 694,despite,O
Sentence: 694,continued,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,",",O
Sentence: 694,but,O
Sentence: 694,no,O
Sentence: 694,vasculitic,B-Disease
Sentence: 694,disorders,I-Disease
Sentence: 694,developed,O
Sentence: 694,.,O
Sentence: 694,In,O
Sentence: 694,the,O
Sentence: 694,third,O
Sentence: 694,patient,O
Sentence: 694,",",O
Sentence: 694,the,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,titre,O
Sentence: 694,increased,O
Sentence: 694,to,O
Sentence: 694,204,O
Sentence: 694,U,O
Sentence: 694,/,O
Sentence: 694,ml,O
Sentence: 694,and,O
Sentence: 694,she,O
Sentence: 694,developed,O
Sentence: 694,a,O
Sentence: 694,higher,O
Sentence: 694,fever,B-Disease
Sentence: 694,",",O
Sentence: 694,oral,B-Disease
Sentence: 694,ulcers,I-Disease
Sentence: 694,and,O
Sentence: 694,polyarthralgia,B-Disease
Sentence: 694,",",O
Sentence: 694,but,O
Sentence: 694,the,O
Sentence: 694,symptoms,O
Sentence: 694,resolved,O
Sentence: 694,2,O
Sentence: 694,weeks,O
Sentence: 694,after,O
Sentence: 694,stopping,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,",",O
Sentence: 694,and,O
Sentence: 694,the,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,titre,O
Sentence: 694,decreased,O
Sentence: 694,to,O
Sentence: 694,20.7,O
Sentence: 694,U,O
Sentence: 694,/,O
Sentence: 694,ml,O
Sentence: 694,by,O
Sentence: 694,4,O
Sentence: 694,months,O
Sentence: 694,after,O
Sentence: 694,discontinuing,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,.,O
Sentence: 694,CONCLUSIONS,O
Sentence: 694,:,O
Sentence: 694,PTU,B-Chemical
Sentence: 694,therapy,O
Sentence: 694,may,O
Sentence: 694,be,O
Sentence: 694,related,O
Sentence: 694,to,O
Sentence: 694,the,O
Sentence: 694,appearance,O
Sentence: 694,of,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,",",O
Sentence: 694,but,O
Sentence: 694,MPO,O
Sentence: 694,-,O
Sentence: 694,ANCA,O
Sentence: 694,does,O
Sentence: 694,not,O
Sentence: 694,appear,O
Sentence: 694,to,O
Sentence: 694,be,O
Sentence: 694,closely,O
Sentence: 694,related,O
Sentence: 694,to,O
Sentence: 694,vasculitis,B-Disease
Sentence: 694,.,O
Sentence: 695,Prevalence,O
Sentence: 695,of,O
Sentence: 695,heart,B-Disease
Sentence: 695,disease,I-Disease
Sentence: 695,in,O
Sentence: 695,asymptomatic,O
Sentence: 695,chronic,O
Sentence: 695,cocaine,B-Chemical
Sentence: 695,users,O
Sentence: 695,.,O
Sentence: 696,To,O
Sentence: 696,determine,O
Sentence: 696,the,O
Sentence: 696,prevalence,O
Sentence: 696,of,O
Sentence: 696,heart,B-Disease
Sentence: 696,disease,I-Disease
Sentence: 696,in,O
Sentence: 696,outpatient,O
Sentence: 696,young,O
Sentence: 696,asymptomatic,O
Sentence: 696,chronic,O
Sentence: 696,cocaine,B-Chemical
Sentence: 696,users,O
Sentence: 696,",",O
Sentence: 696,35,O
Sentence: 696,cocaine,B-Chemical
Sentence: 696,users,O
Sentence: 696,and,O
Sentence: 696,32,O
Sentence: 696,age,O
Sentence: 696,-,O
Sentence: 696,matched,O
Sentence: 696,controls,O
Sentence: 696,underwent,O
Sentence: 696,resting,O
Sentence: 696,and,O
Sentence: 696,exercise,O
Sentence: 696,electrocardiography,O
Sentence: 696,(,O
Sentence: 696,ECG,O
Sentence: 696,),O
Sentence: 696,and,O
Sentence: 696,Doppler,O
Sentence: 696,echocardiography,O
Sentence: 696,.,O
Sentence: 696,Findings,O
Sentence: 696,consistent,O
Sentence: 696,with,O
Sentence: 696,coronary,B-Disease
Sentence: 696,artery,I-Disease
Sentence: 696,disease,I-Disease
Sentence: 696,were,O
Sentence: 696,detected,O
Sentence: 696,in,O
Sentence: 696,12,O
Sentence: 696,(,O
Sentence: 696,34,O
Sentence: 696,%,O
Sentence: 696,),O
Sentence: 696,patients,O
Sentence: 696,and,O
Sentence: 696,3,O
Sentence: 696,(,O
Sentence: 696,9,O
Sentence: 696,%,O
Sentence: 696,),O
Sentence: 696,controls,O
Sentence: 696,(,O
Sentence: 696,p,O
Sentence: 696,,O
Sentence: 696,=,O
Sentence: 696,,O
Sentence: 696,0.01,O
Sentence: 696,),O
Sentence: 696,.,O
Sentence: 696,Decreased,O
Sentence: 696,left,O
Sentence: 696,ventricular,O
Sentence: 696,systolic,O
Sentence: 696,function,O
Sentence: 696,was,O
Sentence: 696,demonstrated,O
Sentence: 696,in,O
Sentence: 696,5,O
Sentence: 696,(,O
Sentence: 696,14,O
Sentence: 696,%,O
Sentence: 696,),O
Sentence: 696,patients,O
Sentence: 696,",",O
Sentence: 696,but,O
Sentence: 696,in,O
Sentence: 696,none,O
Sentence: 696,of,O
Sentence: 696,the,O
Sentence: 696,controls,O
Sentence: 696,(,O
Sentence: 696,p,O
Sentence: 696,,O
Sentence: 696,=,O
Sentence: 696,,O
Sentence: 696,0.055,O
Sentence: 696,),O
Sentence: 696,.,O
Sentence: 696,Finally,O
Sentence: 696,",",O
Sentence: 696,resting,O
Sentence: 696,and,O
Sentence: 696,peak,O
Sentence: 696,exercise,O
Sentence: 696,abnormal,B-Disease
Sentence: 696,left,I-Disease
Sentence: 696,ventricular,I-Disease
Sentence: 696,filling,I-Disease
Sentence: 696,was,O
Sentence: 696,detected,O
Sentence: 696,in,O
Sentence: 696,38,O
Sentence: 696,and,O
Sentence: 696,35,O
Sentence: 696,%,O
Sentence: 696,of,O
Sentence: 696,patients,O
Sentence: 696,as,O
Sentence: 696,compared,O
Sentence: 696,to,O
Sentence: 696,19,O
Sentence: 696,and,O
Sentence: 696,9,O
Sentence: 696,%,O
Sentence: 696,of,O
Sentence: 696,controls,O
Sentence: 696,",",O
Sentence: 696,respectively,O
Sentence: 696,(,O
Sentence: 696,p,O
Sentence: 696,,O
Sentence: 696,=,O
Sentence: 696,,O
Sentence: 696,0.11,O
Sentence: 696,and,O
Sentence: 696,0.02,O
Sentence: 696,",",O
Sentence: 696,respectively,O
Sentence: 696,),O
Sentence: 696,.,O
Sentence: 696,We,O
Sentence: 696,conclude,O
Sentence: 696,that,O
Sentence: 696,coronary,B-Disease
Sentence: 696,artery,I-Disease
Sentence: 696,or,I-Disease
Sentence: 696,myocardial,B-Disease
Sentence: 696,disease,I-Disease
Sentence: 696,is,O
Sentence: 696,common,O
Sentence: 696,(,O
Sentence: 696,38,O
Sentence: 696,%,O
Sentence: 696,),O
Sentence: 696,in,O
Sentence: 696,young,O
Sentence: 696,asymptomatic,O
Sentence: 696,chronic,O
Sentence: 696,cocaine,B-Chemical
Sentence: 696,users,O
Sentence: 696,.,O
Sentence: 696,Therefore,O
Sentence: 696,",",O
Sentence: 696,screening,O
Sentence: 696,ECG,O
Sentence: 696,and,O
Sentence: 696,echocardiography,O
Sentence: 696,may,O
Sentence: 696,be,O
Sentence: 696,warranted,O
Sentence: 696,in,O
Sentence: 696,these,O
Sentence: 696,patients,O
Sentence: 696,.,O
Sentence: 697,Cardioprotective,O
Sentence: 697,effects,O
Sentence: 697,of,O
Sentence: 697,Picrorrhiza,O
Sentence: 697,kurroa,O
Sentence: 697,against,O
Sentence: 697,isoproterenol,O
Sentence: 697,-,O
Sentence: 697,induced,O
Sentence: 697,myocardial,O
Sentence: 697,stress,O
Sentence: 697,in,O
Sentence: 697,rats,O
Sentence: 697,.,O
Sentence: 698,The,O
Sentence: 698,cardioprotective,O
Sentence: 698,effect,O
Sentence: 698,of,O
Sentence: 698,the,O
Sentence: 698,ethanol,B-Chemical
Sentence: 698,extract,O
Sentence: 698,of,O
Sentence: 698,Picrorrhiza,O
Sentence: 698,kurroa,O
Sentence: 698,rhizomes,O
Sentence: 698,and,O
Sentence: 698,roots,O
Sentence: 698,(,O
Sentence: 698,PK,O
Sentence: 698,),O
Sentence: 698,on,O
Sentence: 698,isoproterenol,B-Chemical
Sentence: 698,-,O
Sentence: 698,induced,O
Sentence: 698,myocardial,B-Disease
Sentence: 698,infarction,I-Disease
Sentence: 698,in,O
Sentence: 698,rats,O
Sentence: 698,with,O
Sentence: 698,respect,O
Sentence: 698,to,O
Sentence: 698,lipid,O
Sentence: 698,metabolism,O
Sentence: 698,in,O
Sentence: 698,serum,O
Sentence: 698,and,O
Sentence: 698,heart,O
Sentence: 698,tissue,O
Sentence: 698,has,O
Sentence: 698,been,O
Sentence: 698,investigated,O
Sentence: 698,.,O
Sentence: 698,Oral,O
Sentence: 698,pre,O
Sentence: 698,-,O
Sentence: 698,treatment,O
Sentence: 698,with,O
Sentence: 698,PK,O
Sentence: 698,(,O
Sentence: 698,80,O
Sentence: 698,mg,O
Sentence: 698,kg,O
Sentence: 698,(,O
Sentence: 698,,O
Sentence: 698,-,O
Sentence: 698,1,O
Sentence: 698,),O
Sentence: 698,day,O
Sentence: 698,(,O
Sentence: 698,,O
Sentence: 698,-,O
Sentence: 698,1,O
Sentence: 698,),O
Sentence: 698,for,O
Sentence: 698,15,O
Sentence: 698,days,O
Sentence: 698,),O
Sentence: 698,significantly,O
Sentence: 698,prevented,O
Sentence: 698,the,O
Sentence: 698,isoproterenol,B-Chemical
Sentence: 698,-,O
Sentence: 698,induced,O
Sentence: 698,myocardial,B-Disease
Sentence: 698,infarction,I-Disease
Sentence: 698,and,O
Sentence: 698,maintained,O
Sentence: 698,the,O
Sentence: 698,rats,O
Sentence: 698,at,O
Sentence: 698,near,O
Sentence: 698,normal,O
Sentence: 698,status,O
Sentence: 698,.,O
Sentence: 699,Phase,O
Sentence: 699,2,O
Sentence: 699,early,O
Sentence: 699,afterdepolarization,O
Sentence: 699,as,O
Sentence: 699,a,O
Sentence: 699,trigger,O
Sentence: 699,of,O
Sentence: 699,polymorphic,O
Sentence: 699,ventricular,B-Disease
Sentence: 699,tachycardia,I-Disease
Sentence: 699,in,O
Sentence: 699,acquired,O
Sentence: 699,long,O
Sentence: 699,-,O
Sentence: 699,QT,O
Sentence: 699,syndrome,O
Sentence: 699,:,O
Sentence: 699,direct,O
Sentence: 699,evidence,O
Sentence: 699,from,O
Sentence: 699,intracellular,O
Sentence: 699,recordings,O
Sentence: 699,in,O
Sentence: 699,the,O
Sentence: 699,intact,O
Sentence: 699,left,O
Sentence: 699,ventricular,O
Sentence: 699,wall,O
Sentence: 699,.,O
Sentence: 700,BACKGROUND,O
Sentence: 700,:,O
Sentence: 700,This,O
Sentence: 700,study,O
Sentence: 700,examined,O
Sentence: 700,the,O
Sentence: 700,role,O
Sentence: 700,of,O
Sentence: 700,phase,O
Sentence: 700,2,O
Sentence: 700,early,O
Sentence: 700,afterdepolarization,O
Sentence: 700,(,O
Sentence: 700,EAD,O
Sentence: 700,),O
Sentence: 700,in,O
Sentence: 700,producing,O
Sentence: 700,a,O
Sentence: 700,trigger,O
Sentence: 700,to,O
Sentence: 700,initiate,O
Sentence: 700,torsade,B-Disease
Sentence: 700,de,I-Disease
Sentence: 700,pointes,I-Disease
Sentence: 700,(,O
Sentence: 700,TdP,B-Disease
Sentence: 700,),O
Sentence: 700,with,O
Sentence: 700,QT,B-Disease
Sentence: 700,prolongation,I-Disease
Sentence: 700,induced,O
Sentence: 700,by,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,sotalol,B-Chemical
Sentence: 700,and,O
Sentence: 700,azimilide,B-Chemical
Sentence: 700,.,O
Sentence: 700,The,O
Sentence: 700,contribution,O
Sentence: 700,of,O
Sentence: 700,transmural,O
Sentence: 700,dispersion,O
Sentence: 700,of,O
Sentence: 700,repolarization,O
Sentence: 700,(,O
Sentence: 700,TDR,O
Sentence: 700,),O
Sentence: 700,to,O
Sentence: 700,transmural,O
Sentence: 700,propagation,O
Sentence: 700,of,O
Sentence: 700,EAD,O
Sentence: 700,and,O
Sentence: 700,the,O
Sentence: 700,maintenance,O
Sentence: 700,of,O
Sentence: 700,TdP,B-Disease
Sentence: 700,was,O
Sentence: 700,also,O
Sentence: 700,evaluated,O
Sentence: 700,.,O
Sentence: 700,METHODS,O
Sentence: 700,AND,O
Sentence: 700,RESULTS,O
Sentence: 700,:,O
Sentence: 700,Transmembrane,O
Sentence: 700,action,O
Sentence: 700,potentials,O
Sentence: 700,from,O
Sentence: 700,epicardium,O
Sentence: 700,",",O
Sentence: 700,midmyocardium,O
Sentence: 700,",",O
Sentence: 700,and,O
Sentence: 700,endocardium,O
Sentence: 700,were,O
Sentence: 700,recorded,O
Sentence: 700,simultaneously,O
Sentence: 700,",",O
Sentence: 700,together,O
Sentence: 700,with,O
Sentence: 700,a,O
Sentence: 700,transmural,O
Sentence: 700,ECG,O
Sentence: 700,",",O
Sentence: 700,in,O
Sentence: 700,arterially,O
Sentence: 700,perfused,O
Sentence: 700,canine,O
Sentence: 700,and,O
Sentence: 700,rabbit,O
Sentence: 700,left,O
Sentence: 700,ventricular,O
Sentence: 700,preparations,O
Sentence: 700,.,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,Sotalol,B-Chemical
Sentence: 700,preferentially,O
Sentence: 700,prolonged,O
Sentence: 700,action,O
Sentence: 700,potential,O
Sentence: 700,duration,O
Sentence: 700,(,O
Sentence: 700,APD,O
Sentence: 700,),O
Sentence: 700,in,O
Sentence: 700,M,O
Sentence: 700,cells,O
Sentence: 700,dose,O
Sentence: 700,-,O
Sentence: 700,dependently,O
Sentence: 700,(,O
Sentence: 700,1,O
Sentence: 700,to,O
Sentence: 700,100,O
Sentence: 700,micromol,O
Sentence: 700,/,O
Sentence: 700,L,O
Sentence: 700,),O
Sentence: 700,",",O
Sentence: 700,leading,O
Sentence: 700,to,O
Sentence: 700,QT,B-Disease
Sentence: 700,prolongation,I-Disease
Sentence: 700,and,O
Sentence: 700,an,O
Sentence: 700,increase,O
Sentence: 700,in,O
Sentence: 700,TDR,O
Sentence: 700,.,O
Sentence: 700,Azimilide,B-Chemical
Sentence: 700,",",O
Sentence: 700,however,O
Sentence: 700,",",O
Sentence: 700,significantly,O
Sentence: 700,prolonged,O
Sentence: 700,APD,O
Sentence: 700,and,O
Sentence: 700,QT,O
Sentence: 700,interval,O
Sentence: 700,at,O
Sentence: 700,concentrations,O
Sentence: 700,from,O
Sentence: 700,0.1,O
Sentence: 700,to,O
Sentence: 700,10,O
Sentence: 700,micromol,O
Sentence: 700,/,O
Sentence: 700,L,O
Sentence: 700,but,O
Sentence: 700,shortened,O
Sentence: 700,them,O
Sentence: 700,at,O
Sentence: 700,30,O
Sentence: 700,micromol,O
Sentence: 700,/,O
Sentence: 700,L,O
Sentence: 700,.,O
Sentence: 700,Unlike,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,sotalol,B-Chemical
Sentence: 700,",",O
Sentence: 700,azimilide,B-Chemical
Sentence: 700,(,O
Sentence: 700,,O
Sentence: 700,>,O
Sentence: 700,,O
Sentence: 700,3,O
Sentence: 700,micromol,O
Sentence: 700,/,O
Sentence: 700,L,O
Sentence: 700,),O
Sentence: 700,increased,O
Sentence: 700,epicardial,O
Sentence: 700,APD,O
Sentence: 700,markedly,O
Sentence: 700,",",O
Sentence: 700,causing,O
Sentence: 700,a,O
Sentence: 700,diminished,O
Sentence: 700,TDR,O
Sentence: 700,.,O
Sentence: 700,Although,O
Sentence: 700,both,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,sotalol,B-Chemical
Sentence: 700,and,O
Sentence: 700,azimilide,B-Chemical
Sentence: 700,rarely,O
Sentence: 700,induced,O
Sentence: 700,EADs,O
Sentence: 700,in,O
Sentence: 700,canine,O
Sentence: 700,left,O
Sentence: 700,ventricles,O
Sentence: 700,",",O
Sentence: 700,they,O
Sentence: 700,produced,O
Sentence: 700,frequent,O
Sentence: 700,EADs,O
Sentence: 700,in,O
Sentence: 700,rabbits,O
Sentence: 700,",",O
Sentence: 700,in,O
Sentence: 700,which,O
Sentence: 700,more,O
Sentence: 700,pronounced,O
Sentence: 700,QT,B-Disease
Sentence: 700,prolongation,I-Disease
Sentence: 700,was,O
Sentence: 700,seen,O
Sentence: 700,.,O
Sentence: 700,An,O
Sentence: 700,increase,O
Sentence: 700,in,O
Sentence: 700,TDR,O
Sentence: 700,by,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,sotalol,B-Chemical
Sentence: 700,facilitated,O
Sentence: 700,transmural,O
Sentence: 700,propagation,O
Sentence: 700,of,O
Sentence: 700,EADs,O
Sentence: 700,that,O
Sentence: 700,initiated,O
Sentence: 700,multiple,O
Sentence: 700,episodes,O
Sentence: 700,of,O
Sentence: 700,spontaneous,O
Sentence: 700,TdP,B-Disease
Sentence: 700,in,O
Sentence: 700,3,O
Sentence: 700,of,O
Sentence: 700,6,O
Sentence: 700,rabbit,O
Sentence: 700,left,O
Sentence: 700,ventricles,O
Sentence: 700,.,O
Sentence: 700,Of,O
Sentence: 700,note,O
Sentence: 700,",",O
Sentence: 700,although,O
Sentence: 700,azimilide,B-Chemical
Sentence: 700,(,O
Sentence: 700,3,O
Sentence: 700,to,O
Sentence: 700,10,O
Sentence: 700,micromol,O
Sentence: 700,/,O
Sentence: 700,L,O
Sentence: 700,),O
Sentence: 700,increased,O
Sentence: 700,APD,O
Sentence: 700,more,O
Sentence: 700,than,O
Sentence: 700,dl,O
Sentence: 700,-,O
Sentence: 700,sotalol,B-Chemical
Sentence: 700,",",O
Sentence: 700,its,O
Sentence: 700,EADs,O
Sentence: 700,often,O
Sentence: 700,failed,O
Sentence: 700,to,O
Sentence: 700,propagate,O
Sentence: 700,transmurally,O
Sentence: 700,",",O
Sentence: 700,probably,O
Sentence: 700,because,O
Sentence: 700,of,O
Sentence: 700,a,O
Sentence: 700,diminished,O
Sentence: 700,TDR,O
Sentence: 700,.,O
Sentence: 700,CONCLUSIONS,O
Sentence: 700,:,O
Sentence: 700,This,O
Sentence: 700,study,O
Sentence: 700,provides,O
Sentence: 700,the,O
Sentence: 700,first,O
Sentence: 700,direct,O
Sentence: 700,evidence,O
Sentence: 700,from,O
Sentence: 700,intracellular,O
Sentence: 700,action,O
Sentence: 700,potential,O
Sentence: 700,recordings,O
Sentence: 700,that,O
Sentence: 700,phase,O
Sentence: 700,2,O
Sentence: 700,EAD,O
Sentence: 700,can,O
Sentence: 700,be,O
Sentence: 700,generated,O
Sentence: 700,from,O
Sentence: 700,intact,O
Sentence: 700,ventricular,O
Sentence: 700,wall,O
Sentence: 700,and,O
Sentence: 700,produce,O
Sentence: 700,a,O
Sentence: 700,trigger,O
Sentence: 700,to,O
Sentence: 700,initiate,O
Sentence: 700,the,O
Sentence: 700,onset,O
Sentence: 700,of,O
Sentence: 700,TdP,B-Disease
Sentence: 700,under,O
Sentence: 700,QT,B-Disease
Sentence: 700,prolongation,I-Disease
Sentence: 700,.,O
Sentence: 701,Prenatal,O
Sentence: 701,cocaine,B-Chemical
Sentence: 701,exposure,O
Sentence: 701,and,O
Sentence: 701,cranial,O
Sentence: 701,sonographic,O
Sentence: 701,findings,O
Sentence: 701,in,O
Sentence: 701,preterm,B-Disease
Sentence: 701,infants,I-Disease
Sentence: 701,.,O
Sentence: 702,PURPOSE,O
Sentence: 702,:,O
Sentence: 702,Prenatal,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,exposure,O
Sentence: 702,has,O
Sentence: 702,been,O
Sentence: 702,linked,O
Sentence: 702,with,O
Sentence: 702,subependymal,O
Sentence: 702,hemorrhage,B-Disease
Sentence: 702,and,O
Sentence: 702,the,O
Sentence: 702,formation,O
Sentence: 702,of,O
Sentence: 702,cysts,B-Disease
Sentence: 702,that,O
Sentence: 702,are,O
Sentence: 702,detectable,O
Sentence: 702,on,O
Sentence: 702,cranial,O
Sentence: 702,sonography,O
Sentence: 702,in,O
Sentence: 702,neonates,O
Sentence: 702,born,O
Sentence: 702,at,O
Sentence: 702,term,O
Sentence: 702,.,O
Sentence: 702,We,O
Sentence: 702,sought,O
Sentence: 702,to,O
Sentence: 702,determine,O
Sentence: 702,if,O
Sentence: 702,prenatal,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,exposure,O
Sentence: 702,increases,O
Sentence: 702,the,O
Sentence: 702,incidence,O
Sentence: 702,of,O
Sentence: 702,subependymal,B-Disease
Sentence: 702,cysts,B-Disease
Sentence: 702,in,O
Sentence: 702,preterm,B-Disease
Sentence: 702,infants,I-Disease
Sentence: 702,.,O
Sentence: 702,METHODS,O
Sentence: 702,:,O
Sentence: 702,We,O
Sentence: 702,retrospectively,O
Sentence: 702,reviewed,O
Sentence: 702,the,O
Sentence: 702,medical,O
Sentence: 702,records,O
Sentence: 702,and,O
Sentence: 702,cranial,O
Sentence: 702,sonograms,O
Sentence: 702,obtained,O
Sentence: 702,during,O
Sentence: 702,a,O
Sentence: 702,1,O
Sentence: 702,-,O
Sentence: 702,year,O
Sentence: 702,period,O
Sentence: 702,on,O
Sentence: 702,122,O
Sentence: 702,premature,O
Sentence: 702,(,O
Sentence: 702,,O
Sentence: 702,<,O
Sentence: 702,,O
Sentence: 702,36,O
Sentence: 702,weeks,O
Sentence: 702,of,O
Sentence: 702,gestation,O
Sentence: 702,),O
Sentence: 702,infants,O
Sentence: 702,.,O
Sentence: 702,Infants,O
Sentence: 702,were,O
Sentence: 702,categorized,O
Sentence: 702,into,O
Sentence: 702,1,O
Sentence: 702,of,O
Sentence: 702,2,O
Sentence: 702,groups,O
Sentence: 702,:,O
Sentence: 702,those,O
Sentence: 702,exposed,O
Sentence: 702,to,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,and,O
Sentence: 702,those,O
Sentence: 702,not,O
Sentence: 702,exposed,O
Sentence: 702,to,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,.,O
Sentence: 702,Infants,O
Sentence: 702,were,O
Sentence: 702,assigned,O
Sentence: 702,to,O
Sentence: 702,the,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,-,O
Sentence: 702,exposed,O
Sentence: 702,group,O
Sentence: 702,if,O
Sentence: 702,there,O
Sentence: 702,was,O
Sentence: 702,a,O
Sentence: 702,maternal,O
Sentence: 702,history,O
Sentence: 702,of,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,abuse,I-Disease
Sentence: 702,during,O
Sentence: 702,pregnancy,O
Sentence: 702,or,O
Sentence: 702,if,O
Sentence: 702,maternal,O
Sentence: 702,or,O
Sentence: 702,neonatal,O
Sentence: 702,urine,O
Sentence: 702,toxicology,O
Sentence: 702,results,O
Sentence: 702,were,O
Sentence: 702,positive,O
Sentence: 702,at,O
Sentence: 702,the,O
Sentence: 702,time,O
Sentence: 702,of,O
Sentence: 702,delivery,O
Sentence: 702,.,O
Sentence: 702,RESULTS,O
Sentence: 702,:,O
Sentence: 702,Five,O
Sentence: 702,of,O
Sentence: 702,the,O
Sentence: 702,122,O
Sentence: 702,infants,O
Sentence: 702,were,O
Sentence: 702,excluded,O
Sentence: 702,from,O
Sentence: 702,the,O
Sentence: 702,study,O
Sentence: 702,because,O
Sentence: 702,of,O
Sentence: 702,insufficient,O
Sentence: 702,medical,O
Sentence: 702,and,O
Sentence: 702,drug,O
Sentence: 702,histories,O
Sentence: 702,.,O
Sentence: 702,The,O
Sentence: 702,incidence,O
Sentence: 702,of,O
Sentence: 702,subependymal,B-Disease
Sentence: 702,cysts,B-Disease
Sentence: 702,in,O
Sentence: 702,the,O
Sentence: 702,117,O
Sentence: 702,remaining,O
Sentence: 702,infants,O
Sentence: 702,was,O
Sentence: 702,14,O
Sentence: 702,%,O
Sentence: 702,(,O
Sentence: 702,16,O
Sentence: 702,of,O
Sentence: 702,117,O
Sentence: 702,),O
Sentence: 702,.,O
Sentence: 702,The,O
Sentence: 702,incidence,O
Sentence: 702,of,O
Sentence: 702,subependymal,B-Disease
Sentence: 702,cysts,B-Disease
Sentence: 702,in,O
Sentence: 702,infants,O
Sentence: 702,exposed,O
Sentence: 702,to,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,prenatally,O
Sentence: 702,was,O
Sentence: 702,44,O
Sentence: 702,%,O
Sentence: 702,(,O
Sentence: 702,8,O
Sentence: 702,of,O
Sentence: 702,18,O
Sentence: 702,),O
Sentence: 702,compared,O
Sentence: 702,with,O
Sentence: 702,8,O
Sentence: 702,%,O
Sentence: 702,(,O
Sentence: 702,8,O
Sentence: 702,of,O
Sentence: 702,99,O
Sentence: 702,),O
Sentence: 702,in,O
Sentence: 702,the,O
Sentence: 702,unexposed,O
Sentence: 702,group,O
Sentence: 702,(,O
Sentence: 702,p,O
Sentence: 702,,O
Sentence: 702,<,O
Sentence: 702,,O
Sentence: 702,0.01,O
Sentence: 702,),O
Sentence: 702,.,O
Sentence: 702,CONCLUSIONS,O
Sentence: 702,:,O
Sentence: 702,We,O
Sentence: 702,found,O
Sentence: 702,an,O
Sentence: 702,increased,O
Sentence: 702,incidence,O
Sentence: 702,of,O
Sentence: 702,subependymal,B-Disease
Sentence: 702,cyst,B-Disease
Sentence: 702,formation,O
Sentence: 702,in,O
Sentence: 702,preterm,B-Disease
Sentence: 702,infants,I-Disease
Sentence: 702,who,O
Sentence: 702,were,O
Sentence: 702,exposed,O
Sentence: 702,to,O
Sentence: 702,cocaine,B-Chemical
Sentence: 702,prenatally,O
Sentence: 702,.,O
Sentence: 702,This,O
Sentence: 702,result,O
Sentence: 702,is,O
Sentence: 702,consistent,O
Sentence: 702,with,O
Sentence: 702,results,O
Sentence: 702,of,O
Sentence: 702,similar,O
Sentence: 702,studies,O
Sentence: 702,in,O
Sentence: 702,term,O
Sentence: 702,infants,O
Sentence: 702,.,O
Sentence: 703,Thalidomide,B-Chemical
Sentence: 703,neuropathy,B-Disease
Sentence: 703,in,O
Sentence: 703,patients,O
Sentence: 703,treated,O
Sentence: 703,for,O
Sentence: 703,metastatic,O
Sentence: 703,prostate,B-Disease
Sentence: 703,cancer,I-Disease
Sentence: 703,.,O
Sentence: 704,We,O
Sentence: 704,prospectively,O
Sentence: 704,evaluated,O
Sentence: 704,thalidomide,B-Chemical
Sentence: 704,-,O
Sentence: 704,induced,O
Sentence: 704,neuropathy,B-Disease
Sentence: 704,using,O
Sentence: 704,electrodiagnostic,O
Sentence: 704,studies,O
Sentence: 704,.,O
Sentence: 704,Sixty,O
Sentence: 704,-,O
Sentence: 704,seven,O
Sentence: 704,men,O
Sentence: 704,with,O
Sentence: 704,metastatic,O
Sentence: 704,androgen,B-Chemical
Sentence: 704,-,O
Sentence: 704,independent,O
Sentence: 704,prostate,B-Disease
Sentence: 704,cancer,I-Disease
Sentence: 704,in,O
Sentence: 704,an,O
Sentence: 704,open,O
Sentence: 704,-,O
Sentence: 704,label,O
Sentence: 704,trial,O
Sentence: 704,of,O
Sentence: 704,oral,O
Sentence: 704,thalidomide,B-Chemical
Sentence: 704,underwent,O
Sentence: 704,neurologic,O
Sentence: 704,examinations,O
Sentence: 704,and,O
Sentence: 704,nerve,O
Sentence: 704,conduction,O
Sentence: 704,studies,O
Sentence: 704,(,O
Sentence: 704,NCS,O
Sentence: 704,),O
Sentence: 704,prior,O
Sentence: 704,to,O
Sentence: 704,and,O
Sentence: 704,at,O
Sentence: 704,3,O
Sentence: 704,-,O
Sentence: 704,month,O
Sentence: 704,intervals,O
Sentence: 704,during,O
Sentence: 704,treatment,O
Sentence: 704,.,O
Sentence: 704,NCS,O
Sentence: 704,included,O
Sentence: 704,recording,O
Sentence: 704,of,O
Sentence: 704,sensory,O
Sentence: 704,nerve,O
Sentence: 704,action,O
Sentence: 704,potentials,O
Sentence: 704,(,O
Sentence: 704,SNAPs,O
Sentence: 704,),O
Sentence: 704,from,O
Sentence: 704,median,O
Sentence: 704,",",O
Sentence: 704,radial,O
Sentence: 704,",",O
Sentence: 704,ulnar,O
Sentence: 704,",",O
Sentence: 704,and,O
Sentence: 704,sural,O
Sentence: 704,nerves,O
Sentence: 704,.,O
Sentence: 704,SNAP,O
Sentence: 704,amplitudes,O
Sentence: 704,for,O
Sentence: 704,each,O
Sentence: 704,nerve,O
Sentence: 704,were,O
Sentence: 704,expressed,O
Sentence: 704,as,O
Sentence: 704,the,O
Sentence: 704,percentage,O
Sentence: 704,of,O
Sentence: 704,its,O
Sentence: 704,baseline,O
Sentence: 704,",",O
Sentence: 704,and,O
Sentence: 704,the,O
Sentence: 704,mean,O
Sentence: 704,of,O
Sentence: 704,the,O
Sentence: 704,four,O
Sentence: 704,was,O
Sentence: 704,termed,O
Sentence: 704,the,O
Sentence: 704,SNAP,O
Sentence: 704,index,O
Sentence: 704,.,O
Sentence: 704,A,O
Sentence: 704,40,O
Sentence: 704,%,O
Sentence: 704,decline,O
Sentence: 704,in,O
Sentence: 704,the,O
Sentence: 704,SNAP,O
Sentence: 704,index,O
Sentence: 704,was,O
Sentence: 704,considered,O
Sentence: 704,clinically,O
Sentence: 704,significant,O
Sentence: 704,.,O
Sentence: 704,Thalidomide,B-Chemical
Sentence: 704,was,O
Sentence: 704,discontinued,O
Sentence: 704,in,O
Sentence: 704,55,O
Sentence: 704,patients,O
Sentence: 704,for,O
Sentence: 704,lack,O
Sentence: 704,of,O
Sentence: 704,therapeutic,O
Sentence: 704,response,O
Sentence: 704,.,O
Sentence: 704,Of,O
Sentence: 704,67,O
Sentence: 704,patients,O
Sentence: 704,initially,O
Sentence: 704,enrolled,O
Sentence: 704,",",O
Sentence: 704,24,O
Sentence: 704,remained,O
Sentence: 704,on,O
Sentence: 704,thalidomide,B-Chemical
Sentence: 704,for,O
Sentence: 704,3,O
Sentence: 704,months,O
Sentence: 704,",",O
Sentence: 704,8,O
Sentence: 704,remained,O
Sentence: 704,at,O
Sentence: 704,6,O
Sentence: 704,months,O
Sentence: 704,",",O
Sentence: 704,and,O
Sentence: 704,3,O
Sentence: 704,remained,O
Sentence: 704,at,O
Sentence: 704,9,O
Sentence: 704,months,O
Sentence: 704,.,O
Sentence: 704,Six,O
Sentence: 704,patients,O
Sentence: 704,developed,O
Sentence: 704,neuropathy,B-Disease
Sentence: 704,.,O
Sentence: 704,Clinical,O
Sentence: 704,symptoms,O
Sentence: 704,and,O
Sentence: 704,a,O
Sentence: 704,decline,O
Sentence: 704,in,O
Sentence: 704,the,O
Sentence: 704,SNAP,O
Sentence: 704,index,O
Sentence: 704,occurred,O
Sentence: 704,concurrently,O
Sentence: 704,.,O
Sentence: 704,Older,O
Sentence: 704,age,O
Sentence: 704,and,O
Sentence: 704,cumulative,O
Sentence: 704,dose,O
Sentence: 704,were,O
Sentence: 704,possible,O
Sentence: 704,contributing,O
Sentence: 704,factors,O
Sentence: 704,.,O
Sentence: 704,Neuropathy,B-Disease
Sentence: 704,may,O
Sentence: 704,thus,O
Sentence: 704,be,O
Sentence: 704,a,O
Sentence: 704,common,O
Sentence: 704,complication,O
Sentence: 704,of,O
Sentence: 704,thalidomide,B-Chemical
Sentence: 704,in,O
Sentence: 704,older,O
Sentence: 704,patients,O
Sentence: 704,.,O
Sentence: 704,The,O
Sentence: 704,SNAP,O
Sentence: 704,index,O
Sentence: 704,can,O
Sentence: 704,be,O
Sentence: 704,used,O
Sentence: 704,to,O
Sentence: 704,monitor,O
Sentence: 704,peripheral,B-Disease
Sentence: 704,neuropathy,I-Disease
Sentence: 704,",",O
Sentence: 704,but,O
Sentence: 704,not,O
Sentence: 704,for,O
Sentence: 704,early,O
Sentence: 704,detection,O
Sentence: 704,.,O
Sentence: 705,Overexpression,O
Sentence: 705,of,O
Sentence: 705,copper,B-Chemical
Sentence: 705,/,O
Sentence: 705,zinc,B-Chemical
Sentence: 705,-,O
Sentence: 705,superoxide,B-Chemical
Sentence: 705,dismutase,O
Sentence: 705,protects,O
Sentence: 705,from,O
Sentence: 705,kanamycin,B-Chemical
Sentence: 705,-,O
Sentence: 705,induced,O
Sentence: 705,hearing,B-Disease
Sentence: 705,loss,I-Disease
Sentence: 705,.,O
Sentence: 706,The,O
Sentence: 706,participation,O
Sentence: 706,of,O
Sentence: 706,reactive,O
Sentence: 706,oxygen,B-Chemical
Sentence: 706,species,O
Sentence: 706,in,O
Sentence: 706,aminoglycoside,B-Chemical
Sentence: 706,-,O
Sentence: 706,induced,O
Sentence: 706,ototoxicity,B-Disease
Sentence: 706,has,O
Sentence: 706,been,O
Sentence: 706,deduced,O
Sentence: 706,from,O
Sentence: 706,observations,O
Sentence: 706,that,O
Sentence: 706,aminoglycoside,B-Chemical
Sentence: 706,-,O
Sentence: 706,iron,B-Chemical
Sentence: 706,complexes,O
Sentence: 706,catalyze,O
Sentence: 706,the,O
Sentence: 706,formation,O
Sentence: 706,of,O
Sentence: 706,superoxide,B-Chemical
Sentence: 706,radicals,O
Sentence: 706,in,O
Sentence: 706,vitro,O
Sentence: 706,and,O
Sentence: 706,that,O
Sentence: 706,antioxidants,O
Sentence: 706,attenuate,O
Sentence: 706,ototoxicity,B-Disease
Sentence: 706,in,O
Sentence: 706,vivo,O
Sentence: 706,.,O
Sentence: 706,We,O
Sentence: 706,therefore,O
Sentence: 706,hypothesized,O
Sentence: 706,that,O
Sentence: 706,overexpression,O
Sentence: 706,of,O
Sentence: 706,Cu,B-Chemical
Sentence: 706,/,O
Sentence: 706,Zn,B-Chemical
Sentence: 706,-,O
Sentence: 706,superoxide,B-Chemical
Sentence: 706,dismutase,O
Sentence: 706,(,O
Sentence: 706,h,O
Sentence: 706,-,O
Sentence: 706,SOD1,O
Sentence: 706,),O
Sentence: 706,should,O
Sentence: 706,protect,O
Sentence: 706,transgenic,O
Sentence: 706,mice,O
Sentence: 706,from,O
Sentence: 706,ototoxicity,B-Disease
Sentence: 706,.,O
Sentence: 706,Immunocytochemistry,O
Sentence: 706,confirmed,O
Sentence: 706,expression,O
Sentence: 706,of,O
Sentence: 706,h,O
Sentence: 706,-,O
Sentence: 706,SOD1,O
Sentence: 706,in,O
Sentence: 706,inner,O
Sentence: 706,ear,O
Sentence: 706,tissues,O
Sentence: 706,of,O
Sentence: 706,transgenic,O
Sentence: 706,C57BL,O
Sentence: 706,/,O
Sentence: 706,6,O
Sentence: 706,-,O
Sentence: 706,TgN,O
Sentence: 706,[,O
Sentence: 706,SOD1,O
Sentence: 706,],O
Sentence: 706,3Cje,O
Sentence: 706,mice,O
Sentence: 706,.,O
Sentence: 706,Transgenic,O
Sentence: 706,and,O
Sentence: 706,nontransgenic,O
Sentence: 706,littermates,O
Sentence: 706,received,O
Sentence: 706,kanamycin,B-Chemical
Sentence: 706,(,O
Sentence: 706,400,O
Sentence: 706,mg,O
Sentence: 706,/,O
Sentence: 706,kg,O
Sentence: 706,body,O
Sentence: 706,weight,O
Sentence: 706,/,O
Sentence: 706,day,O
Sentence: 706,),O
Sentence: 706,for,O
Sentence: 706,10,O
Sentence: 706,days,O
Sentence: 706,beginning,O
Sentence: 706,on,O
Sentence: 706,day,O
Sentence: 706,10,O
Sentence: 706,after,O
Sentence: 706,birth,O
Sentence: 706,.,O
Sentence: 706,Auditory,O
Sentence: 706,thresholds,O
Sentence: 706,were,O
Sentence: 706,tested,O
Sentence: 706,by,O
Sentence: 706,evoked,O
Sentence: 706,auditory,O
Sentence: 706,brain,O
Sentence: 706,stem,O
Sentence: 706,responses,O
Sentence: 706,at,O
Sentence: 706,1,O
Sentence: 706,month,O
Sentence: 706,after,O
Sentence: 706,birth,O
Sentence: 706,.,O
Sentence: 706,In,O
Sentence: 706,nontransgenic,O
Sentence: 706,animals,O
Sentence: 706,",",O
Sentence: 706,the,O
Sentence: 706,threshold,O
Sentence: 706,in,O
Sentence: 706,the,O
Sentence: 706,kanamycin,B-Chemical
Sentence: 706,-,O
Sentence: 706,treated,O
Sentence: 706,group,O
Sentence: 706,was,O
Sentence: 706,45,O
Sentence: 706,-,O
Sentence: 706,50,O
Sentence: 706,dB,O
Sentence: 706,higher,O
Sentence: 706,than,O
Sentence: 706,in,O
Sentence: 706,saline,O
Sentence: 706,-,O
Sentence: 706,injected,O
Sentence: 706,controls,O
Sentence: 706,.,O
Sentence: 706,In,O
Sentence: 706,the,O
Sentence: 706,transgenic,O
Sentence: 706,group,O
Sentence: 706,",",O
Sentence: 706,kanamycin,B-Chemical
Sentence: 706,increased,O
Sentence: 706,the,O
Sentence: 706,threshold,O
Sentence: 706,by,O
Sentence: 706,only,O
Sentence: 706,15,O
Sentence: 706,dB,O
Sentence: 706,over,O
Sentence: 706,the,O
Sentence: 706,respective,O
Sentence: 706,controls,O
Sentence: 706,.,O
Sentence: 706,The,O
Sentence: 706,effects,O
Sentence: 706,were,O
Sentence: 706,similar,O
Sentence: 706,at,O
Sentence: 706,12,O
Sentence: 706,and,O
Sentence: 706,24,O
Sentence: 706,kHz,O
Sentence: 706,.,O
Sentence: 706,The,O
Sentence: 706,protection,O
Sentence: 706,by,O
Sentence: 706,overexpression,O
Sentence: 706,of,O
Sentence: 706,superoxide,B-Chemical
Sentence: 706,dismutase,O
Sentence: 706,supports,O
Sentence: 706,the,O
Sentence: 706,hypothesis,O
Sentence: 706,that,O
Sentence: 706,oxidant,O
Sentence: 706,stress,O
Sentence: 706,plays,O
Sentence: 706,a,O
Sentence: 706,significant,O
Sentence: 706,role,O
Sentence: 706,in,O
Sentence: 706,aminoglycoside,B-Chemical
Sentence: 706,-,O
Sentence: 706,induced,O
Sentence: 706,ototoxicity,B-Disease
Sentence: 706,.,O
Sentence: 706,The,O
Sentence: 706,results,O
Sentence: 706,also,O
Sentence: 706,suggest,O
Sentence: 706,transgenic,O
Sentence: 706,animals,O
Sentence: 706,as,O
Sentence: 706,suitable,O
Sentence: 706,models,O
Sentence: 706,to,O
Sentence: 706,investigate,O
Sentence: 706,the,O
Sentence: 706,underlying,O
Sentence: 706,mechanisms,O
Sentence: 706,and,O
Sentence: 706,possible,O
Sentence: 706,strategies,O
Sentence: 706,for,O
Sentence: 706,prevention,O
Sentence: 706,.,O
Sentence: 707,Prednisone,B-Chemical
Sentence: 707,induces,O
Sentence: 707,anxiety,B-Disease
Sentence: 707,and,O
Sentence: 707,glial,O
Sentence: 707,cerebral,O
Sentence: 707,changes,O
Sentence: 707,in,O
Sentence: 707,rats,O
Sentence: 707,.,O
Sentence: 708,OBJECTIVE,O
Sentence: 708,:,O
Sentence: 708,To,O
Sentence: 708,assess,O
Sentence: 708,whether,O
Sentence: 708,prednisone,B-Chemical
Sentence: 708,(,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,),O
Sentence: 708,produces,O
Sentence: 708,anxiety,B-Disease
Sentence: 708,and,O
Sentence: 708,/,O
Sentence: 708,or,O
Sentence: 708,cerebral,O
Sentence: 708,glial,O
Sentence: 708,changes,O
Sentence: 708,in,O
Sentence: 708,rats,O
Sentence: 708,.,O
Sentence: 708,METHODS,O
Sentence: 708,:,O
Sentence: 708,Male,O
Sentence: 708,Wistar,O
Sentence: 708,rats,O
Sentence: 708,were,O
Sentence: 708,studied,O
Sentence: 708,and,O
Sentence: 708,3,O
Sentence: 708,groups,O
Sentence: 708,were,O
Sentence: 708,formed,O
Sentence: 708,(,O
Sentence: 708,8,O
Sentence: 708,rats,O
Sentence: 708,per,O
Sentence: 708,group,O
Sentence: 708,),O
Sentence: 708,.,O
Sentence: 708,The,O
Sentence: 708,moderate,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,group,O
Sentence: 708,received,O
Sentence: 708,5,O
Sentence: 708,mg,O
Sentence: 708,/,O
Sentence: 708,kg,O
Sentence: 708,/,O
Sentence: 708,day,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,released,O
Sentence: 708,from,O
Sentence: 708,a,O
Sentence: 708,subcutaneous,O
Sentence: 708,implant,O
Sentence: 708,.,O
Sentence: 708,In,O
Sentence: 708,the,O
Sentence: 708,high,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,group,O
Sentence: 708,",",O
Sentence: 708,implants,O
Sentence: 708,containing,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,equivalent,O
Sentence: 708,to,O
Sentence: 708,60,O
Sentence: 708,mg,O
Sentence: 708,/,O
Sentence: 708,kg,O
Sentence: 708,/,O
Sentence: 708,day,O
Sentence: 708,were,O
Sentence: 708,applied,O
Sentence: 708,.,O
Sentence: 708,In,O
Sentence: 708,the,O
Sentence: 708,control,O
Sentence: 708,group,O
Sentence: 708,implants,O
Sentence: 708,contained,O
Sentence: 708,no,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,.,O
Sentence: 708,Anxiety,B-Disease
Sentence: 708,was,O
Sentence: 708,assessed,O
Sentence: 708,using,O
Sentence: 708,an,O
Sentence: 708,open,O
Sentence: 708,field,O
Sentence: 708,and,O
Sentence: 708,elevated,O
Sentence: 708,plus,O
Sentence: 708,-,O
Sentence: 708,maze,O
Sentence: 708,devices,O
Sentence: 708,.,O
Sentence: 708,The,O
Sentence: 708,number,O
Sentence: 708,of,O
Sentence: 708,cells,O
Sentence: 708,and,O
Sentence: 708,cytoplasmic,O
Sentence: 708,transformation,O
Sentence: 708,of,O
Sentence: 708,astrocytes,O
Sentence: 708,and,O
Sentence: 708,microglia,O
Sentence: 708,cells,O
Sentence: 708,were,O
Sentence: 708,assessed,O
Sentence: 708,by,O
Sentence: 708,immunohistochemical,O
Sentence: 708,analyses,O
Sentence: 708,.,O
Sentence: 708,RESULTS,O
Sentence: 708,:,O
Sentence: 708,Anxiety,B-Disease
Sentence: 708,was,O
Sentence: 708,documented,O
Sentence: 708,in,O
Sentence: 708,both,O
Sentence: 708,groups,O
Sentence: 708,of,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,treated,O
Sentence: 708,rats,O
Sentence: 708,compared,O
Sentence: 708,with,O
Sentence: 708,controls,O
Sentence: 708,.,O
Sentence: 708,The,O
Sentence: 708,magnitude,O
Sentence: 708,of,O
Sentence: 708,transformation,O
Sentence: 708,of,O
Sentence: 708,the,O
Sentence: 708,microglia,O
Sentence: 708,assessed,O
Sentence: 708,by,O
Sentence: 708,the,O
Sentence: 708,number,O
Sentence: 708,of,O
Sentence: 708,intersections,O
Sentence: 708,was,O
Sentence: 708,significantly,O
Sentence: 708,higher,O
Sentence: 708,in,O
Sentence: 708,the,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,groups,O
Sentence: 708,than,O
Sentence: 708,in,O
Sentence: 708,controls,O
Sentence: 708,in,O
Sentence: 708,the,O
Sentence: 708,prefrontal,O
Sentence: 708,cortex,O
Sentence: 708,(,O
Sentence: 708,moderate,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,",",O
Sentence: 708,24.1,O
Sentence: 708,;,O
Sentence: 708,high,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,",",O
Sentence: 708,23.6,O
Sentence: 708,;,O
Sentence: 708,controls,O
Sentence: 708,18.7,O
Sentence: 708,;,O
Sentence: 708,p,O
Sentence: 708,,O
Sentence: 708,<,O
Sentence: 708,,O
Sentence: 708,0.01,O
Sentence: 708,),O
Sentence: 708,and,O
Sentence: 708,striatum,O
Sentence: 708,(,O
Sentence: 708,moderate,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,25.6,O
Sentence: 708,;,O
Sentence: 708,high,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,26.3,O
Sentence: 708,;,O
Sentence: 708,controls,O
Sentence: 708,18.9,O
Sentence: 708,;,O
Sentence: 708,p,O
Sentence: 708,,O
Sentence: 708,<,O
Sentence: 708,,O
Sentence: 708,0.01,O
Sentence: 708,),O
Sentence: 708,",",O
Sentence: 708,but,O
Sentence: 708,not,O
Sentence: 708,in,O
Sentence: 708,hippocampus,O
Sentence: 708,.,O
Sentence: 708,The,O
Sentence: 708,number,O
Sentence: 708,of,O
Sentence: 708,stained,O
Sentence: 708,microglia,O
Sentence: 708,cells,O
Sentence: 708,was,O
Sentence: 708,significantly,O
Sentence: 708,higher,O
Sentence: 708,in,O
Sentence: 708,the,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,treated,O
Sentence: 708,groups,O
Sentence: 708,in,O
Sentence: 708,the,O
Sentence: 708,prefrontal,O
Sentence: 708,cortex,O
Sentence: 708,than,O
Sentence: 708,in,O
Sentence: 708,controls,O
Sentence: 708,(,O
Sentence: 708,moderate,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,",",O
Sentence: 708,29.1,O
Sentence: 708,;,O
Sentence: 708,high,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,",",O
Sentence: 708,28.4,O
Sentence: 708,;,O
Sentence: 708,control,O
Sentence: 708,",",O
Sentence: 708,17.7,O
Sentence: 708,cells,O
Sentence: 708,per,O
Sentence: 708,field,O
Sentence: 708,;,O
Sentence: 708,p,O
Sentence: 708,,O
Sentence: 708,<,O
Sentence: 708,,O
Sentence: 708,0.01,O
Sentence: 708,),O
Sentence: 708,.,O
Sentence: 708,Stained,O
Sentence: 708,microglia,O
Sentence: 708,cells,O
Sentence: 708,were,O
Sentence: 708,significantly,O
Sentence: 708,more,O
Sentence: 708,numerous,O
Sentence: 708,striatum,O
Sentence: 708,and,O
Sentence: 708,hippocampus,O
Sentence: 708,in,O
Sentence: 708,the,O
Sentence: 708,high,O
Sentence: 708,-,O
Sentence: 708,dose,O
Sentence: 708,group,O
Sentence: 708,compared,O
Sentence: 708,to,O
Sentence: 708,controls,O
Sentence: 708,.,O
Sentence: 708,CONCLUSION,O
Sentence: 708,:,O
Sentence: 708,Subacute,O
Sentence: 708,exposure,O
Sentence: 708,to,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,induced,O
Sentence: 708,anxiety,B-Disease
Sentence: 708,and,O
Sentence: 708,reactivity,O
Sentence: 708,of,O
Sentence: 708,microglia,O
Sentence: 708,.,O
Sentence: 708,The,O
Sentence: 708,relevance,O
Sentence: 708,of,O
Sentence: 708,these,O
Sentence: 708,features,O
Sentence: 708,for,O
Sentence: 708,patients,O
Sentence: 708,using,O
Sentence: 708,PDN,B-Chemical
Sentence: 708,remains,O
Sentence: 708,to,O
Sentence: 708,be,O
Sentence: 708,elucidated,O
Sentence: 708,.,O
Sentence: 709,Phase,O
Sentence: 709,II,O
Sentence: 709,study,O
Sentence: 709,of,O
Sentence: 709,carboplatin,B-Chemical
Sentence: 709,and,O
Sentence: 709,liposomal,O
Sentence: 709,doxorubicin,B-Chemical
Sentence: 709,in,O
Sentence: 709,patients,O
Sentence: 709,with,O
Sentence: 709,recurrent,O
Sentence: 709,squamous,B-Disease
Sentence: 709,cell,I-Disease
Sentence: 709,carcinoma,B-Disease
Sentence: 709,of,I-Disease
Sentence: 709,the,I-Disease
Sentence: 709,cervix,I-Disease
Sentence: 709,.,O
Sentence: 710,BACKGROUND,O
Sentence: 710,:,O
Sentence: 710,The,O
Sentence: 710,activity,O
Sentence: 710,of,O
Sentence: 710,the,O
Sentence: 710,combination,O
Sentence: 710,of,O
Sentence: 710,carboplatin,B-Chemical
Sentence: 710,and,O
Sentence: 710,liposomal,O
Sentence: 710,doxorubicin,B-Chemical
Sentence: 710,was,O
Sentence: 710,tested,O
Sentence: 710,in,O
Sentence: 710,a,O
Sentence: 710,Phase,O
Sentence: 710,II,O
Sentence: 710,study,O
Sentence: 710,of,O
Sentence: 710,patients,O
Sentence: 710,with,O
Sentence: 710,recurrent,O
Sentence: 710,cervical,B-Disease
Sentence: 710,carcinoma,I-Disease
Sentence: 710,.,O
Sentence: 710,METHODS,O
Sentence: 710,:,O
Sentence: 710,The,O
Sentence: 710,combination,O
Sentence: 710,of,O
Sentence: 710,carboplatin,B-Chemical
Sentence: 710,(,O
Sentence: 710,area,O
Sentence: 710,under,O
Sentence: 710,the,O
Sentence: 710,concentration,O
Sentence: 710,curve,O
Sentence: 710,[,O
Sentence: 710,AUC,O
Sentence: 710,],O
Sentence: 710,",",O
Sentence: 710,5,O
Sentence: 710,),O
Sentence: 710,and,O
Sentence: 710,liposomal,O
Sentence: 710,doxorubicin,B-Chemical
Sentence: 710,(,O
Sentence: 710,Doxil,B-Chemical
Sentence: 710,;,O
Sentence: 710,starting,O
Sentence: 710,dose,O
Sentence: 710,",",O
Sentence: 710,40,O
Sentence: 710,mg,O
Sentence: 710,/,O
Sentence: 710,m,O
Sentence: 710,(,O
Sentence: 710,2,O
Sentence: 710,),O
Sentence: 710,),O
Sentence: 710,was,O
Sentence: 710,administered,O
Sentence: 710,intravenously,O
Sentence: 710,every,O
Sentence: 710,28,O
Sentence: 710,days,O
Sentence: 710,to,O
Sentence: 710,37,O
Sentence: 710,patients,O
Sentence: 710,with,O
Sentence: 710,recurrent,O
Sentence: 710,squamous,B-Disease
Sentence: 710,cell,I-Disease
Sentence: 710,cervical,B-Disease
Sentence: 710,carcinoma,I-Disease
Sentence: 710,to,O
Sentence: 710,determine,O
Sentence: 710,antitumor,O
Sentence: 710,activity,O
Sentence: 710,and,O
Sentence: 710,toxicity,B-Disease
Sentence: 710,profile,O
Sentence: 710,.,O
Sentence: 710,RESULTS,O
Sentence: 710,:,O
Sentence: 710,Twenty,O
Sentence: 710,-,O
Sentence: 710,nine,O
Sentence: 710,patients,O
Sentence: 710,were,O
Sentence: 710,assessable,O
Sentence: 710,for,O
Sentence: 710,response,O
Sentence: 710,",",O
Sentence: 710,and,O
Sentence: 710,35,O
Sentence: 710,patients,O
Sentence: 710,were,O
Sentence: 710,assessable,O
Sentence: 710,for,O
Sentence: 710,toxicity,B-Disease
Sentence: 710,.,O
Sentence: 710,The,O
Sentence: 710,overall,O
Sentence: 710,response,O
Sentence: 710,rate,O
Sentence: 710,was,O
Sentence: 710,38,O
Sentence: 710,%,O
Sentence: 710,",",O
Sentence: 710,the,O
Sentence: 710,median,O
Sentence: 710,time,O
Sentence: 710,to,O
Sentence: 710,response,O
Sentence: 710,was,O
Sentence: 710,10,O
Sentence: 710,weeks,O
Sentence: 710,",",O
Sentence: 710,the,O
Sentence: 710,median,O
Sentence: 710,duration,O
Sentence: 710,of,O
Sentence: 710,response,O
Sentence: 710,was,O
Sentence: 710,26,O
Sentence: 710,weeks,O
Sentence: 710,",",O
Sentence: 710,and,O
Sentence: 710,the,O
Sentence: 710,median,O
Sentence: 710,survival,O
Sentence: 710,was,O
Sentence: 710,37,O
Sentence: 710,weeks,O
Sentence: 710,.,O
Sentence: 710,The,O
Sentence: 710,main,O
Sentence: 710,toxic,O
Sentence: 710,effect,O
Sentence: 710,was,O
Sentence: 710,myelosuppression,B-Disease
Sentence: 710,",",O
Sentence: 710,with,O
Sentence: 710,Grade,O
Sentence: 710,3,O
Sentence: 710,and,O
Sentence: 710,4,O
Sentence: 710,neutropenia,B-Disease
Sentence: 710,in,O
Sentence: 710,16,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,anemia,B-Disease
Sentence: 710,in,O
Sentence: 710,12,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,thrombocytopenia,B-Disease
Sentence: 710,in,O
Sentence: 710,11,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,and,O
Sentence: 710,neutropenic,B-Disease
Sentence: 710,fever,B-Disease
Sentence: 710,in,O
Sentence: 710,3,O
Sentence: 710,patients,O
Sentence: 710,.,O
Sentence: 710,Four,O
Sentence: 710,patients,O
Sentence: 710,had,O
Sentence: 710,five,O
Sentence: 710,infusion,O
Sentence: 710,-,O
Sentence: 710,related,O
Sentence: 710,reactions,O
Sentence: 710,during,O
Sentence: 710,the,O
Sentence: 710,infusion,O
Sentence: 710,of,O
Sentence: 710,liposomal,O
Sentence: 710,doxorubicin,B-Chemical
Sentence: 710,",",O
Sentence: 710,leading,O
Sentence: 710,to,O
Sentence: 710,treatment,O
Sentence: 710,discontinuation,O
Sentence: 710,in,O
Sentence: 710,three,O
Sentence: 710,patients,O
Sentence: 710,.,O
Sentence: 710,Grade,O
Sentence: 710,,O
Sentence: 710,>,O
Sentence: 710,,O
Sentence: 710,or,O
Sentence: 710,,O
Sentence: 710,=,O
Sentence: 710,,O
Sentence: 710,2,O
Sentence: 710,nonhematologic,O
Sentence: 710,toxicity,B-Disease
Sentence: 710,included,O
Sentence: 710,nausea,B-Disease
Sentence: 710,in,O
Sentence: 710,17,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,emesis,B-Disease
Sentence: 710,in,O
Sentence: 710,14,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,fatigue,B-Disease
Sentence: 710,in,O
Sentence: 710,9,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,mucositis,B-Disease
Sentence: 710,and,O
Sentence: 710,/,O
Sentence: 710,or,O
Sentence: 710,stomatitis,B-Disease
Sentence: 710,in,O
Sentence: 710,8,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,constipation,B-Disease
Sentence: 710,in,O
Sentence: 710,6,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,weight,B-Disease
Sentence: 710,loss,I-Disease
Sentence: 710,in,O
Sentence: 710,5,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,hand,O
Sentence: 710,-,O
Sentence: 710,foot,O
Sentence: 710,syndrome,O
Sentence: 710,in,O
Sentence: 710,2,O
Sentence: 710,patients,O
Sentence: 710,",",O
Sentence: 710,and,O
Sentence: 710,skin,B-Disease
Sentence: 710,reactions,I-Disease
Sentence: 710,in,O
Sentence: 710,3,O
Sentence: 710,patients,O
Sentence: 710,.,O
Sentence: 710,CONCLUSIONS,O
Sentence: 710,:,O
Sentence: 710,The,O
Sentence: 710,combination,O
Sentence: 710,of,O
Sentence: 710,carboplatin,B-Chemical
Sentence: 710,and,O
Sentence: 710,liposomal,O
Sentence: 710,doxorubicin,B-Chemical
Sentence: 710,has,O
Sentence: 710,modest,O
Sentence: 710,activity,O
Sentence: 710,in,O
Sentence: 710,patients,O
Sentence: 710,with,O
Sentence: 710,recurrent,O
Sentence: 710,cervical,B-Disease
Sentence: 710,carcinoma,I-Disease
Sentence: 710,.,O
Sentence: 711,Antimicrobial,O
Sentence: 711,-,O
Sentence: 711,induced,O
Sentence: 711,mania,B-Disease
Sentence: 711,(,O
Sentence: 711,antibiomania,B-Disease
Sentence: 711,),O
Sentence: 711,:,O
Sentence: 711,a,O
Sentence: 711,review,O
Sentence: 711,of,O
Sentence: 711,spontaneous,O
Sentence: 711,reports,O
Sentence: 711,.,O
Sentence: 712,The,O
Sentence: 712,authors,O
Sentence: 712,reviewed,O
Sentence: 712,reported,O
Sentence: 712,cases,O
Sentence: 712,of,O
Sentence: 712,antibiotic,O
Sentence: 712,-,O
Sentence: 712,induced,O
Sentence: 712,manic,B-Disease
Sentence: 712,episodes,O
Sentence: 712,by,O
Sentence: 712,means,O
Sentence: 712,of,O
Sentence: 712,a,O
Sentence: 712,MEDLINE,O
Sentence: 712,and,O
Sentence: 712,PsychLit,O
Sentence: 712,search,O
Sentence: 712,for,O
Sentence: 712,reports,O
Sentence: 712,of,O
Sentence: 712,antibiotic,O
Sentence: 712,-,O
Sentence: 712,induced,O
Sentence: 712,mania,B-Disease
Sentence: 712,.,O
Sentence: 712,Unpublished,O
Sentence: 712,reports,O
Sentence: 712,were,O
Sentence: 712,requested,O
Sentence: 712,from,O
Sentence: 712,the,O
Sentence: 712,World,O
Sentence: 712,Health,O
Sentence: 712,Organization,O
Sentence: 712,(,O
Sentence: 712,WHO,O
Sentence: 712,),O
Sentence: 712,and,O
Sentence: 712,the,O
Sentence: 712,Food,O
Sentence: 712,and,O
Sentence: 712,Drug,O
Sentence: 712,Administration,O
Sentence: 712,(,O
Sentence: 712,FDA,O
Sentence: 712,),O
Sentence: 712,.,O
Sentence: 712,Twenty,O
Sentence: 712,-,O
Sentence: 712,one,O
Sentence: 712,reports,O
Sentence: 712,of,O
Sentence: 712,antimicrobial,O
Sentence: 712,-,O
Sentence: 712,induced,O
Sentence: 712,mania,B-Disease
Sentence: 712,were,O
Sentence: 712,found,O
Sentence: 712,in,O
Sentence: 712,the,O
Sentence: 712,literature,O
Sentence: 712,.,O
Sentence: 712,There,O
Sentence: 712,were,O
Sentence: 712,6,O
Sentence: 712,cases,O
Sentence: 712,implicating,O
Sentence: 712,clarithromycin,B-Chemical
Sentence: 712,",",O
Sentence: 712,13,O
Sentence: 712,implicating,O
Sentence: 712,isoniazid,B-Chemical
Sentence: 712,",",O
Sentence: 712,and,O
Sentence: 712,1,O
Sentence: 712,case,O
Sentence: 712,each,O
Sentence: 712,implicating,O
Sentence: 712,erythromycin,B-Chemical
Sentence: 712,and,O
Sentence: 712,amoxicillin,B-Chemical
Sentence: 712,.,O
Sentence: 712,The,O
Sentence: 712,WHO,O
Sentence: 712,reported,O
Sentence: 712,82,O
Sentence: 712,cases,O
Sentence: 712,.,O
Sentence: 712,Of,O
Sentence: 712,these,O
Sentence: 712,",",O
Sentence: 712,clarithromycin,B-Chemical
Sentence: 712,was,O
Sentence: 712,implicated,O
Sentence: 712,in,O
Sentence: 712,23,O
Sentence: 712,(,O
Sentence: 712,27.6,O
Sentence: 712,%,O
Sentence: 712,),O
Sentence: 712,cases,O
Sentence: 712,",",O
Sentence: 712,ciprofloxacin,B-Chemical
Sentence: 712,in,O
Sentence: 712,12,O
Sentence: 712,(,O
Sentence: 712,14.4,O
Sentence: 712,%,O
Sentence: 712,),O
Sentence: 712,cases,O
Sentence: 712,",",O
Sentence: 712,and,O
Sentence: 712,ofloxacin,B-Chemical
Sentence: 712,in,O
Sentence: 712,10,O
Sentence: 712,(,O
Sentence: 712,12,O
Sentence: 712,%,O
Sentence: 712,),O
Sentence: 712,cases,O
Sentence: 712,.,O
Sentence: 712,Cotrimoxazole,B-Chemical
Sentence: 712,",",O
Sentence: 712,metronidazole,B-Chemical
Sentence: 712,",",O
Sentence: 712,and,O
Sentence: 712,erythromycin,B-Chemical
Sentence: 712,were,O
Sentence: 712,involved,O
Sentence: 712,in,O
Sentence: 712,15,O
Sentence: 712,reported,O
Sentence: 712,manic,B-Disease
Sentence: 712,episodes,O
Sentence: 712,.,O
Sentence: 712,Cases,O
Sentence: 712,reported,O
Sentence: 712,by,O
Sentence: 712,the,O
Sentence: 712,FDA,O
Sentence: 712,showed,O
Sentence: 712,clarithromycin,B-Chemical
Sentence: 712,and,O
Sentence: 712,ciprofloxacin,B-Chemical
Sentence: 712,to,O
Sentence: 712,be,O
Sentence: 712,the,O
Sentence: 712,most,O
Sentence: 712,frequently,O
Sentence: 712,associated,O
Sentence: 712,with,O
Sentence: 712,the,O
Sentence: 712,development,O
Sentence: 712,of,O
Sentence: 712,mania,B-Disease
Sentence: 712,.,O
Sentence: 712,Statistical,O
Sentence: 712,analysis,O
Sentence: 712,of,O
Sentence: 712,the,O
Sentence: 712,data,O
Sentence: 712,would,O
Sentence: 712,not,O
Sentence: 712,have,O
Sentence: 712,demonstrated,O
Sentence: 712,a,O
Sentence: 712,significant,O
Sentence: 712,statistical,O
Sentence: 712,correlative,O
Sentence: 712,risk,O
Sentence: 712,and,O
Sentence: 712,was,O
Sentence: 712,therefore,O
Sentence: 712,not,O
Sentence: 712,undertaken,O
Sentence: 712,.,O
Sentence: 712,Patients,O
Sentence: 712,have,O
Sentence: 712,an,O
Sentence: 712,increased,O
Sentence: 712,risk,O
Sentence: 712,of,O
Sentence: 712,developing,O
Sentence: 712,mania,B-Disease
Sentence: 712,while,O
Sentence: 712,being,O
Sentence: 712,treated,O
Sentence: 712,with,O
Sentence: 712,antimicrobials,O
Sentence: 712,.,O
Sentence: 712,Although,O
Sentence: 712,this,O
Sentence: 712,is,O
Sentence: 712,not,O
Sentence: 712,a,O
Sentence: 712,statistically,O
Sentence: 712,significant,O
Sentence: 712,risk,O
Sentence: 712,",",O
Sentence: 712,physicians,O
Sentence: 712,must,O
Sentence: 712,be,O
Sentence: 712,aware,O
Sentence: 712,of,O
Sentence: 712,the,O
Sentence: 712,effect,O
Sentence: 712,and,O
Sentence: 712,reversibility,O
Sentence: 712,.,O
Sentence: 712,Further,O
Sentence: 712,research,O
Sentence: 712,clearly,O
Sentence: 712,is,O
Sentence: 712,required,O
Sentence: 712,to,O
Sentence: 712,determine,O
Sentence: 712,the,O
Sentence: 712,incidence,O
Sentence: 712,of,O
Sentence: 712,antimicrobial,O
Sentence: 712,-,O
Sentence: 712,induced,O
Sentence: 712,mania,B-Disease
Sentence: 712,",",O
Sentence: 712,the,O
Sentence: 712,relative,O
Sentence: 712,risk,O
Sentence: 712,factors,O
Sentence: 712,of,O
Sentence: 712,developing,O
Sentence: 712,an,O
Sentence: 712,antimicrobial,O
Sentence: 712,-,O
Sentence: 712,induced,O
Sentence: 712,manic,B-Disease
Sentence: 712,episode,O
Sentence: 712,among,O
Sentence: 712,various,O
Sentence: 712,demographic,O
Sentence: 712,populations,O
Sentence: 712,",",O
Sentence: 712,and,O
Sentence: 712,the,O
Sentence: 712,incidence,O
Sentence: 712,of,O
Sentence: 712,patients,O
Sentence: 712,who,O
Sentence: 712,continue,O
Sentence: 712,to,O
Sentence: 712,have,O
Sentence: 712,persistent,O
Sentence: 712,affective,O
Sentence: 712,disorders,O
Sentence: 712,once,O
Sentence: 712,the,O
Sentence: 712,initial,O
Sentence: 712,episode,O
Sentence: 712,",",O
Sentence: 712,which,O
Sentence: 712,occurs,O
Sentence: 712,while,O
Sentence: 712,the,O
Sentence: 712,patient,O
Sentence: 712,is,O
Sentence: 712,taking,O
Sentence: 712,antibiotics,O
Sentence: 712,",",O
Sentence: 712,subsides,O
Sentence: 712,.,O
Sentence: 712,The,O
Sentence: 712,authors,O
Sentence: 712,elected,O
Sentence: 712,to,O
Sentence: 712,name,O
Sentence: 712,this,O
Sentence: 712,syndrome,O
Sentence: 712,``,O
Sentence: 712,antibiomania,B-Disease
Sentence: 712,.,O
Sentence: 712,'',O
Sentence: 713,Levodopa,B-Chemical
Sentence: 713,-,O
Sentence: 713,induced,O
Sentence: 713,ocular,B-Disease
Sentence: 713,dyskinesias,I-Disease
Sentence: 713,in,O
Sentence: 713,Parkinson,B-Disease
Sentence: 713,'s,I-Disease
Sentence: 713,disease,I-Disease
Sentence: 713,.,O
Sentence: 714,Levodopa,B-Chemical
Sentence: 714,-,O
Sentence: 714,induced,O
Sentence: 714,ocular,B-Disease
Sentence: 714,dyskinesias,I-Disease
Sentence: 714,are,O
Sentence: 714,very,O
Sentence: 714,uncommon,O
Sentence: 714,.,O
Sentence: 714,Usually,O
Sentence: 714,they,O
Sentence: 714,occur,O
Sentence: 714,simultaneously,O
Sentence: 714,with,O
Sentence: 714,limb,O
Sentence: 714,peak,O
Sentence: 714,-,O
Sentence: 714,dose,O
Sentence: 714,choreatic,B-Disease
Sentence: 714,dyskinesias,I-Disease
Sentence: 714,.,O
Sentence: 714,We,O
Sentence: 714,report,O
Sentence: 714,on,O
Sentence: 714,a,O
Sentence: 714,patient,O
Sentence: 714,with,O
Sentence: 714,leftward,O
Sentence: 714,and,O
Sentence: 714,upward,O
Sentence: 714,deviations,O
Sentence: 714,of,O
Sentence: 714,gaze,O
Sentence: 714,during,O
Sentence: 714,the,O
Sentence: 714,peak,O
Sentence: 714,effect,O
Sentence: 714,of,O
Sentence: 714,levodopa,B-Chemical
Sentence: 714,",",O
Sentence: 714,and,O
Sentence: 714,hypothesize,O
Sentence: 714,that,O
Sentence: 714,a,O
Sentence: 714,severe,O
Sentence: 714,dopaminergic,O
Sentence: 714,denervation,O
Sentence: 714,in,O
Sentence: 714,the,O
Sentence: 714,caudate,O
Sentence: 714,nucleus,O
Sentence: 714,is,O
Sentence: 714,needed,O
Sentence: 714,for,O
Sentence: 714,the,O
Sentence: 714,appearance,O
Sentence: 714,of,O
Sentence: 714,these,O
Sentence: 714,levodopa,B-Chemical
Sentence: 714,-,O
Sentence: 714,induce,O
Sentence: 714,ocular,B-Disease
Sentence: 714,dyskinesias,I-Disease
Sentence: 714,.,O
Sentence: 715,A,O
Sentence: 715,comparison,O
Sentence: 715,of,O
Sentence: 715,glyceryl,B-Chemical
Sentence: 715,trinitrate,I-Chemical
Sentence: 715,with,O
Sentence: 715,diclofenac,B-Chemical
Sentence: 715,for,O
Sentence: 715,the,O
Sentence: 715,treatment,O
Sentence: 715,of,O
Sentence: 715,primary,O
Sentence: 715,dysmenorrhea,B-Disease
Sentence: 715,:,O
Sentence: 715,an,O
Sentence: 715,open,O
Sentence: 715,",",O
Sentence: 715,randomized,O
Sentence: 715,",",O
Sentence: 715,cross,O
Sentence: 715,-,O
Sentence: 715,over,O
Sentence: 715,trial,O
Sentence: 715,.,O
Sentence: 716,Primary,O
Sentence: 716,dysmenorrhea,B-Disease
Sentence: 716,is,O
Sentence: 716,a,O
Sentence: 716,syndrome,O
Sentence: 716,characterized,O
Sentence: 716,by,O
Sentence: 716,painful,O
Sentence: 716,uterine,O
Sentence: 716,contractility,O
Sentence: 716,caused,O
Sentence: 716,by,O
Sentence: 716,a,O
Sentence: 716,hypersecretion,O
Sentence: 716,of,O
Sentence: 716,endometrial,O
Sentence: 716,prostaglandins,B-Chemical
Sentence: 716,;,O
Sentence: 716,non,O
Sentence: 716,-,O
Sentence: 716,steroidal,O
Sentence: 716,anti,O
Sentence: 716,-,O
Sentence: 716,inflammatory,O
Sentence: 716,drugs,O
Sentence: 716,are,O
Sentence: 716,the,O
Sentence: 716,first,O
Sentence: 716,choice,O
Sentence: 716,for,O
Sentence: 716,its,O
Sentence: 716,treatment,O
Sentence: 716,.,O
Sentence: 716,However,O
Sentence: 716,",",O
Sentence: 716,in,O
Sentence: 716,vivo,O
Sentence: 716,and,O
Sentence: 716,in,O
Sentence: 716,vitro,O
Sentence: 716,studies,O
Sentence: 716,have,O
Sentence: 716,demonstrated,O
Sentence: 716,that,O
Sentence: 716,myometrial,O
Sentence: 716,cells,O
Sentence: 716,are,O
Sentence: 716,also,O
Sentence: 716,targets,O
Sentence: 716,of,O
Sentence: 716,the,O
Sentence: 716,relaxant,O
Sentence: 716,effects,O
Sentence: 716,of,O
Sentence: 716,nitric,B-Chemical
Sentence: 716,oxide,I-Chemical
Sentence: 716,(,O
Sentence: 716,NO,B-Chemical
Sentence: 716,),O
Sentence: 716,.,O
Sentence: 716,The,O
Sentence: 716,aim,O
Sentence: 716,of,O
Sentence: 716,the,O
Sentence: 716,present,O
Sentence: 716,study,O
Sentence: 716,was,O
Sentence: 716,to,O
Sentence: 716,determine,O
Sentence: 716,the,O
Sentence: 716,efficacy,O
Sentence: 716,of,O
Sentence: 716,glyceryl,B-Chemical
Sentence: 716,trinitrate,I-Chemical
Sentence: 716,(,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,),O
Sentence: 716,",",O
Sentence: 716,an,O
Sentence: 716,NO,B-Chemical
Sentence: 716,donor,O
Sentence: 716,",",O
Sentence: 716,in,O
Sentence: 716,the,O
Sentence: 716,resolution,O
Sentence: 716,of,O
Sentence: 716,primary,O
Sentence: 716,dysmenorrhea,B-Disease
Sentence: 716,in,O
Sentence: 716,comparison,O
Sentence: 716,with,O
Sentence: 716,diclofenac,B-Chemical
Sentence: 716,(,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,),O
Sentence: 716,.,O
Sentence: 716,A,O
Sentence: 716,total,O
Sentence: 716,of,O
Sentence: 716,24,O
Sentence: 716,patients,O
Sentence: 716,with,O
Sentence: 716,the,O
Sentence: 716,diagnosis,O
Sentence: 716,of,O
Sentence: 716,severe,O
Sentence: 716,primary,O
Sentence: 716,dysmenorrhea,B-Disease
Sentence: 716,were,O
Sentence: 716,studied,O
Sentence: 716,during,O
Sentence: 716,two,O
Sentence: 716,consecutive,O
Sentence: 716,menstrual,O
Sentence: 716,cycles,O
Sentence: 716,.,O
Sentence: 716,In,O
Sentence: 716,an,O
Sentence: 716,open,O
Sentence: 716,",",O
Sentence: 716,cross,O
Sentence: 716,-,O
Sentence: 716,over,O
Sentence: 716,",",O
Sentence: 716,controlled,O
Sentence: 716,design,O
Sentence: 716,",",O
Sentence: 716,patients,O
Sentence: 716,were,O
Sentence: 716,randomized,O
Sentence: 716,to,O
Sentence: 716,receive,O
Sentence: 716,either,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,per,O
Sentence: 716,os,O
Sentence: 716,or,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,patches,O
Sentence: 716,the,O
Sentence: 716,first,O
Sentence: 716,days,O
Sentence: 716,of,O
Sentence: 716,menses,O
Sentence: 716,",",O
Sentence: 716,when,O
Sentence: 716,menstrual,O
Sentence: 716,cramps,O
Sentence: 716,became,O
Sentence: 716,unendurable,O
Sentence: 716,.,O
Sentence: 716,In,O
Sentence: 716,the,O
Sentence: 716,subsequent,O
Sentence: 716,cycle,O
Sentence: 716,the,O
Sentence: 716,other,O
Sentence: 716,treatment,O
Sentence: 716,was,O
Sentence: 716,used,O
Sentence: 716,.,O
Sentence: 716,Patients,O
Sentence: 716,received,O
Sentence: 716,up,O
Sentence: 716,to,O
Sentence: 716,3,O
Sentence: 716,doses,O
Sentence: 716,/,O
Sentence: 716,day,O
Sentence: 716,of,O
Sentence: 716,50,O
Sentence: 716,mg,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,or,O
Sentence: 716,2.5,O
Sentence: 716,mg,O
Sentence: 716,/,O
Sentence: 716,24,O
Sentence: 716,h,O
Sentence: 716,transdermal,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,for,O
Sentence: 716,the,O
Sentence: 716,first,O
Sentence: 716,3,O
Sentence: 716,days,O
Sentence: 716,of,O
Sentence: 716,the,O
Sentence: 716,cycle,O
Sentence: 716,",",O
Sentence: 716,according,O
Sentence: 716,to,O
Sentence: 716,their,O
Sentence: 716,needs,O
Sentence: 716,.,O
Sentence: 716,The,O
Sentence: 716,participants,O
Sentence: 716,recorded,O
Sentence: 716,menstrual,O
Sentence: 716,symptoms,O
Sentence: 716,and,O
Sentence: 716,possible,O
Sentence: 716,side,O
Sentence: 716,-,O
Sentence: 716,effects,O
Sentence: 716,at,O
Sentence: 716,different,O
Sentence: 716,times,O
Sentence: 716,(,O
Sentence: 716,0,O
Sentence: 716,",",O
Sentence: 716,30,O
Sentence: 716,",",O
Sentence: 716,60,O
Sentence: 716,",",O
Sentence: 716,120,O
Sentence: 716,minutes,O
Sentence: 716,),O
Sentence: 716,after,O
Sentence: 716,the,O
Sentence: 716,first,O
Sentence: 716,dose,O
Sentence: 716,of,O
Sentence: 716,medication,O
Sentence: 716,on,O
Sentence: 716,the,O
Sentence: 716,first,O
Sentence: 716,day,O
Sentence: 716,of,O
Sentence: 716,the,O
Sentence: 716,cycle,O
Sentence: 716,",",O
Sentence: 716,with,O
Sentence: 716,both,O
Sentence: 716,drugs,O
Sentence: 716,.,O
Sentence: 716,The,O
Sentence: 716,difference,O
Sentence: 716,in,O
Sentence: 716,pain,B-Disease
Sentence: 716,intensity,O
Sentence: 716,score,O
Sentence: 716,(,O
Sentence: 716,DPI,O
Sentence: 716,),O
Sentence: 716,was,O
Sentence: 716,the,O
Sentence: 716,main,O
Sentence: 716,outcome,O
Sentence: 716,variable,O
Sentence: 716,.,O
Sentence: 716,Both,O
Sentence: 716,treatments,O
Sentence: 716,significantly,O
Sentence: 716,reduced,O
Sentence: 716,DPI,O
Sentence: 716,by,O
Sentence: 716,the,O
Sentence: 716,30th,O
Sentence: 716,minute,O
Sentence: 716,(,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,12.8,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,17.9,O
Sentence: 716,;,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,18.9,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,16.6,O
Sentence: 716,),O
Sentence: 716,.,O
Sentence: 716,However,O
Sentence: 716,",",O
Sentence: 716,DCF,B-Chemical
Sentence: 716,continued,O
Sentence: 716,to,O
Sentence: 716,be,O
Sentence: 716,effective,O
Sentence: 716,in,O
Sentence: 716,reducing,O
Sentence: 716,pelvic,B-Disease
Sentence: 716,pain,I-Disease
Sentence: 716,for,O
Sentence: 716,two,O
Sentence: 716,hours,O
Sentence: 716,",",O
Sentence: 716,whereas,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,scores,O
Sentence: 716,remained,O
Sentence: 716,more,O
Sentence: 716,or,O
Sentence: 716,less,O
Sentence: 716,stable,O
Sentence: 716,after,O
Sentence: 716,30,O
Sentence: 716,min,O
Sentence: 716,and,O
Sentence: 716,significantly,O
Sentence: 716,higher,O
Sentence: 716,than,O
Sentence: 716,those,O
Sentence: 716,for,O
Sentence: 716,DFC,O
Sentence: 716,(,O
Sentence: 716,after,O
Sentence: 716,one,O
Sentence: 716,hour,O
Sentence: 716,:,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,12.8,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,17.9,O
Sentence: 716,;,O
Sentence: 716,DFC,O
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,18.9,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,16.6,O
Sentence: 716,and,O
Sentence: 716,after,O
Sentence: 716,two,O
Sentence: 716,hours,O
Sentence: 716,:,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,23.7,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,20.5,O
Sentence: 716,;,O
Sentence: 716,DFC,O
Sentence: 716,",",O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,59.7,O
Sentence: 716,+,O
Sentence: 716,/,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,17.9,O
Sentence: 716,",",O
Sentence: 716,p,O
Sentence: 716,,O
Sentence: 716,=,O
Sentence: 716,,O
Sentence: 716,0.0001,O
Sentence: 716,),O
Sentence: 716,.,O
Sentence: 716,Low,B-Disease
Sentence: 716,back,I-Disease
Sentence: 716,pain,I-Disease
Sentence: 716,was,O
Sentence: 716,also,O
Sentence: 716,relieved,O
Sentence: 716,by,O
Sentence: 716,both,O
Sentence: 716,drugs,O
Sentence: 716,.,O
Sentence: 716,Headache,B-Disease
Sentence: 716,was,O
Sentence: 716,significantly,O
Sentence: 716,increased,O
Sentence: 716,by,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,but,O
Sentence: 716,not,O
Sentence: 716,by,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,.,O
Sentence: 716,Eight,O
Sentence: 716,patients,O
Sentence: 716,stopped,O
Sentence: 716,using,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,because,O
Sentence: 716,headache,B-Disease
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,attributed,O
Sentence: 716,to,O
Sentence: 716,its,O
Sentence: 716,use,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,-,O
Sentence: 716,,O
Sentence: 716,became,O
Sentence: 716,intolerable,O
Sentence: 716,.,O
Sentence: 716,These,O
Sentence: 716,findings,O
Sentence: 716,indicate,O
Sentence: 716,that,O
Sentence: 716,GTN,B-Chemical
Sentence: 716,has,O
Sentence: 716,a,O
Sentence: 716,reduced,O
Sentence: 716,efficacy,O
Sentence: 716,and,O
Sentence: 716,tolerability,O
Sentence: 716,by,O
Sentence: 716,comparison,O
Sentence: 716,with,O
Sentence: 716,DCF,B-Chemical
Sentence: 716,in,O
Sentence: 716,the,O
Sentence: 716,treatment,O
Sentence: 716,of,O
Sentence: 716,primary,O
Sentence: 716,dysmenorrhea,B-Disease
Sentence: 716,.,O
Sentence: 717,Temocapril,B-Chemical
Sentence: 717,",",O
Sentence: 717,a,O
Sentence: 717,long,O
Sentence: 717,-,O
Sentence: 717,acting,O
Sentence: 717,non,O
Sentence: 717,-,O
Sentence: 717,SH,O
Sentence: 717,group,O
Sentence: 717,angiotensin,B-Chemical
Sentence: 717,converting,O
Sentence: 717,enzyme,O
Sentence: 717,inhibitor,O
Sentence: 717,",",O
Sentence: 717,modulates,O
Sentence: 717,glomerular,B-Disease
Sentence: 717,injury,I-Disease
Sentence: 717,in,O
Sentence: 717,chronic,O
Sentence: 717,puromycin,B-Chemical
Sentence: 717,aminonucleoside,I-Chemical
Sentence: 717,nephrosis,B-Disease
Sentence: 717,.,O
Sentence: 718,The,O
Sentence: 718,purpose,O
Sentence: 718,of,O
Sentence: 718,the,O
Sentence: 718,present,O
Sentence: 718,study,O
Sentence: 718,was,O
Sentence: 718,to,O
Sentence: 718,determine,O
Sentence: 718,whether,O
Sentence: 718,chronic,O
Sentence: 718,administration,O
Sentence: 718,of,O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,",",O
Sentence: 718,a,O
Sentence: 718,long,O
Sentence: 718,-,O
Sentence: 718,acting,O
Sentence: 718,non,O
Sentence: 718,-,O
Sentence: 718,SH,O
Sentence: 718,group,O
Sentence: 718,angiotensin,B-Chemical
Sentence: 718,converting,O
Sentence: 718,enzyme,O
Sentence: 718,(,O
Sentence: 718,ACE,O
Sentence: 718,),O
Sentence: 718,inhibitor,O
Sentence: 718,",",O
Sentence: 718,reduced,O
Sentence: 718,proteinuria,B-Disease
Sentence: 718,",",O
Sentence: 718,inhibited,O
Sentence: 718,glomerular,O
Sentence: 718,hypertrophy,B-Disease
Sentence: 718,and,O
Sentence: 718,prevented,O
Sentence: 718,glomerulosclerosis,B-Disease
Sentence: 718,in,O
Sentence: 718,chronic,O
Sentence: 718,puromycin,B-Chemical
Sentence: 718,aminonucleoside,I-Chemical
Sentence: 718,(,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,),O
Sentence: 718,,O
Sentence: 718,-,O
Sentence: 718,,O
Sentence: 718,induced,O
Sentence: 718,nephrotic,B-Disease
Sentence: 718,rats,O
Sentence: 718,.,O
Sentence: 718,Nephrosis,B-Disease
Sentence: 718,was,O
Sentence: 718,induced,O
Sentence: 718,by,O
Sentence: 718,injection,O
Sentence: 718,of,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,(,O
Sentence: 718,15mg,O
Sentence: 718,/,O
Sentence: 718,100g,O
Sentence: 718,body,O
Sentence: 718,weight,O
Sentence: 718,),O
Sentence: 718,in,O
Sentence: 718,male,O
Sentence: 718,Sprague,O
Sentence: 718,-,O
Sentence: 718,Dawley,O
Sentence: 718,(,O
Sentence: 718,SD,O
Sentence: 718,),O
Sentence: 718,rats,O
Sentence: 718,.,O
Sentence: 718,Four,O
Sentence: 718,groups,O
Sentence: 718,were,O
Sentence: 718,used,O
Sentence: 718,",",O
Sentence: 718,i,O
Sentence: 718,),O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,group,O
Sentence: 718,(,O
Sentence: 718,14,O
Sentence: 718,),O
Sentence: 718,",",O
Sentence: 718,ii,O
Sentence: 718,),O
Sentence: 718,PAN,B-Chemical
Sentence: 718,/,O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,(,O
Sentence: 718,13,O
Sentence: 718,),O
Sentence: 718,",",O
Sentence: 718,iii,O
Sentence: 718,),O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,(,O
Sentence: 718,14,O
Sentence: 718,),O
Sentence: 718,and,O
Sentence: 718,iv,O
Sentence: 718,),O
Sentence: 718,untreated,O
Sentence: 718,controls,O
Sentence: 718,(,O
Sentence: 718,15,O
Sentence: 718,),O
Sentence: 718,.,O
Sentence: 718,Temocapril,B-Chemical
Sentence: 718,(,O
Sentence: 718,8,O
Sentence: 718,mg,O
Sentence: 718,/,O
Sentence: 718,kg,O
Sentence: 718,/,O
Sentence: 718,day,O
Sentence: 718,),O
Sentence: 718,was,O
Sentence: 718,administered,O
Sentence: 718,to,O
Sentence: 718,the,O
Sentence: 718,rats,O
Sentence: 718,which,O
Sentence: 718,were,O
Sentence: 718,killed,O
Sentence: 718,at,O
Sentence: 718,weeks,O
Sentence: 718,4,O
Sentence: 718,",",O
Sentence: 718,14,O
Sentence: 718,or,O
Sentence: 718,20,O
Sentence: 718,.,O
Sentence: 718,At,O
Sentence: 718,each,O
Sentence: 718,time,O
Sentence: 718,point,O
Sentence: 718,",",O
Sentence: 718,systolic,O
Sentence: 718,blood,O
Sentence: 718,pressure,O
Sentence: 718,(,O
Sentence: 718,BP,O
Sentence: 718,),O
Sentence: 718,",",O
Sentence: 718,urinary,O
Sentence: 718,protein,O
Sentence: 718,excretion,O
Sentence: 718,and,O
Sentence: 718,renal,O
Sentence: 718,histopathological,O
Sentence: 718,findings,O
Sentence: 718,were,O
Sentence: 718,evaluated,O
Sentence: 718,",",O
Sentence: 718,and,O
Sentence: 718,morphometric,O
Sentence: 718,image,O
Sentence: 718,analysis,O
Sentence: 718,was,O
Sentence: 718,done,O
Sentence: 718,.,O
Sentence: 718,Systolic,O
Sentence: 718,BP,O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,group,O
Sentence: 718,was,O
Sentence: 718,significantly,O
Sentence: 718,high,O
Sentence: 718,at,O
Sentence: 718,4,O
Sentence: 718,",",O
Sentence: 718,14,O
Sentence: 718,and,O
Sentence: 718,20,O
Sentence: 718,weeks,O
Sentence: 718,",",O
Sentence: 718,but,O
Sentence: 718,was,O
Sentence: 718,normal,O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,/,O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,group,O
Sentence: 718,.,O
Sentence: 718,Urinary,O
Sentence: 718,protein,O
Sentence: 718,excretion,O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,group,O
Sentence: 718,increased,O
Sentence: 718,significantly,O
Sentence: 718,",",O
Sentence: 718,peaking,O
Sentence: 718,at,O
Sentence: 718,8,O
Sentence: 718,days,O
Sentence: 718,",",O
Sentence: 718,then,O
Sentence: 718,decreased,O
Sentence: 718,at,O
Sentence: 718,4,O
Sentence: 718,weeks,O
Sentence: 718,",",O
Sentence: 718,but,O
Sentence: 718,rose,O
Sentence: 718,again,O
Sentence: 718,significantly,O
Sentence: 718,at,O
Sentence: 718,14,O
Sentence: 718,and,O
Sentence: 718,20,O
Sentence: 718,weeks,O
Sentence: 718,.,O
Sentence: 718,Temocapril,B-Chemical
Sentence: 718,did,O
Sentence: 718,not,O
Sentence: 718,attenuate,O
Sentence: 718,proteinuria,B-Disease
Sentence: 718,at,O
Sentence: 718,8,O
Sentence: 718,days,O
Sentence: 718,",",O
Sentence: 718,but,O
Sentence: 718,it,O
Sentence: 718,did,O
Sentence: 718,markedly,O
Sentence: 718,lower,O
Sentence: 718,it,O
Sentence: 718,from,O
Sentence: 718,weeks,O
Sentence: 718,4,O
Sentence: 718,to,O
Sentence: 718,20,O
Sentence: 718,.,O
Sentence: 718,The,O
Sentence: 718,glomerulosclerosis,B-Disease
Sentence: 718,index,O
Sentence: 718,(,O
Sentence: 718,GSI,O
Sentence: 718,),O
Sentence: 718,was,O
Sentence: 718,6.21,O
Sentence: 718,%,O
Sentence: 718,at,O
Sentence: 718,4,O
Sentence: 718,weeks,O
Sentence: 718,and,O
Sentence: 718,respectively,O
Sentence: 718,25.35,O
Sentence: 718,%,O
Sentence: 718,and,O
Sentence: 718,30.49,O
Sentence: 718,%,O
Sentence: 718,at,O
Sentence: 718,14,O
Sentence: 718,and,O
Sentence: 718,20,O
Sentence: 718,weeks,O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,group,O
Sentence: 718,.,O
Sentence: 718,There,O
Sentence: 718,was,O
Sentence: 718,a,O
Sentence: 718,significant,O
Sentence: 718,correlation,O
Sentence: 718,between,O
Sentence: 718,urinary,O
Sentence: 718,protein,O
Sentence: 718,excretion,O
Sentence: 718,and,O
Sentence: 718,GSI,O
Sentence: 718,(,O
Sentence: 718,r,O
Sentence: 718,,O
Sentence: 718,=,O
Sentence: 718,,O
Sentence: 718,0.808,O
Sentence: 718,",",O
Sentence: 718,p,O
Sentence: 718,,O
Sentence: 718,<,O
Sentence: 718,,O
Sentence: 718,0.0001,O
Sentence: 718,),O
Sentence: 718,.,O
Sentence: 718,The,O
Sentence: 718,ratio,O
Sentence: 718,of,O
Sentence: 718,glomerular,O
Sentence: 718,tuft,O
Sentence: 718,area,O
Sentence: 718,to,O
Sentence: 718,the,O
Sentence: 718,area,O
Sentence: 718,of,O
Sentence: 718,Bowman,O
Sentence: 718,'s,O
Sentence: 718,capsules,O
Sentence: 718,(,O
Sentence: 718,GT,O
Sentence: 718,/,O
Sentence: 718,BC,O
Sentence: 718,),O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,group,O
Sentence: 718,was,O
Sentence: 718,significantly,O
Sentence: 718,increased,O
Sentence: 718,",",O
Sentence: 718,but,O
Sentence: 718,it,O
Sentence: 718,was,O
Sentence: 718,significantly,O
Sentence: 718,lower,O
Sentence: 718,in,O
Sentence: 718,the,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,/,O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,group,O
Sentence: 718,.,O
Sentence: 718,It,O
Sentence: 718,appears,O
Sentence: 718,that,O
Sentence: 718,temocapril,B-Chemical
Sentence: 718,was,O
Sentence: 718,effective,O
Sentence: 718,in,O
Sentence: 718,retarding,O
Sentence: 718,renal,O
Sentence: 718,progression,O
Sentence: 718,and,O
Sentence: 718,protected,O
Sentence: 718,renal,O
Sentence: 718,function,O
Sentence: 718,in,O
Sentence: 718,PAN,B-Chemical
Sentence: 718,neprotic,B-Disease
Sentence: 718,rats,O
Sentence: 718,.,O
Sentence: 719,Pulmonary,B-Disease
Sentence: 719,hypertension,I-Disease
Sentence: 719,after,O
Sentence: 719,ibuprofen,B-Chemical
Sentence: 719,prophylaxis,O
Sentence: 719,in,O
Sentence: 719,very,O
Sentence: 719,preterm,O
Sentence: 719,infants,O
Sentence: 719,.,O
Sentence: 720,We,O
Sentence: 720,report,O
Sentence: 720,three,O
Sentence: 720,cases,O
Sentence: 720,of,O
Sentence: 720,severe,O
Sentence: 720,hypoxaemia,B-Disease
Sentence: 720,after,O
Sentence: 720,ibuprofen,B-Chemical
Sentence: 720,administration,O
Sentence: 720,during,O
Sentence: 720,a,O
Sentence: 720,randomised,O
Sentence: 720,controlled,O
Sentence: 720,trial,O
Sentence: 720,of,O
Sentence: 720,prophylactic,O
Sentence: 720,treatment,O
Sentence: 720,of,O
Sentence: 720,patent,B-Disease
Sentence: 720,ductus,I-Disease
Sentence: 720,arteriosus,I-Disease
Sentence: 720,with,O
Sentence: 720,ibuprofen,B-Chemical
Sentence: 720,in,O
Sentence: 720,premature,O
Sentence: 720,infants,O
Sentence: 720,born,O
Sentence: 720,at,O
Sentence: 720,less,O
Sentence: 720,than,O
Sentence: 720,28,O
Sentence: 720,weeks,O
Sentence: 720,of,O
Sentence: 720,gestation,O
Sentence: 720,.,O
Sentence: 720,Echocardiography,O
Sentence: 720,showed,O
Sentence: 720,severely,O
Sentence: 720,decreased,O
Sentence: 720,pulmonary,O
Sentence: 720,blood,O
Sentence: 720,flow,O
Sentence: 720,.,O
Sentence: 720,Hypoxaemia,B-Disease
Sentence: 720,resolved,O
Sentence: 720,quickly,O
Sentence: 720,on,O
Sentence: 720,inhaled,O
Sentence: 720,nitric,B-Chemical
Sentence: 720,oxide,I-Chemical
Sentence: 720,therapy,O
Sentence: 720,.,O
Sentence: 720,We,O
Sentence: 720,suggest,O
Sentence: 720,that,O
Sentence: 720,investigators,O
Sentence: 720,involved,O
Sentence: 720,in,O
Sentence: 720,similar,O
Sentence: 720,trials,O
Sentence: 720,pay,O
Sentence: 720,close,O
Sentence: 720,attention,O
Sentence: 720,to,O
Sentence: 720,pulmonary,O
Sentence: 720,pressure,O
Sentence: 720,if,O
Sentence: 720,hypoxaemia,B-Disease
Sentence: 720,occurs,O
Sentence: 720,after,O
Sentence: 720,prophylactic,O
Sentence: 720,administration,O
Sentence: 720,of,O
Sentence: 720,ibuprofen,B-Chemical
Sentence: 720,.,O
Sentence: 721,Hyponatremia,B-Disease
Sentence: 721,and,O
Sentence: 721,syndrome,O
Sentence: 721,of,O
Sentence: 721,inappropriate,O
Sentence: 721,anti,O
Sentence: 721,-,O
Sentence: 721,diuretic,O
Sentence: 721,hormone,O
Sentence: 721,reported,O
Sentence: 721,with,O
Sentence: 721,the,O
Sentence: 721,use,O
Sentence: 721,of,O
Sentence: 721,Vincristine,B-Chemical
Sentence: 721,:,O
Sentence: 721,an,O
Sentence: 721,over,O
Sentence: 721,-,O
Sentence: 721,representation,O
Sentence: 721,of,O
Sentence: 721,Asians,O
Sentence: 721,?,O
Sentence: 722,PURPOSE,O
Sentence: 722,:,O
Sentence: 722,This,O
Sentence: 722,retrospective,O
Sentence: 722,study,O
Sentence: 722,used,O
Sentence: 722,a,O
Sentence: 722,pharmaceutical,O
Sentence: 722,company,O
Sentence: 722,'s,O
Sentence: 722,global,O
Sentence: 722,safety,O
Sentence: 722,database,O
Sentence: 722,to,O
Sentence: 722,determine,O
Sentence: 722,the,O
Sentence: 722,reporting,O
Sentence: 722,rate,O
Sentence: 722,of,O
Sentence: 722,hyponatremia,B-Disease
Sentence: 722,and,O
Sentence: 722,/,O
Sentence: 722,or,O
Sentence: 722,syndrome,O
Sentence: 722,of,O
Sentence: 722,inappropriate,O
Sentence: 722,secretion,O
Sentence: 722,of,O
Sentence: 722,anti,O
Sentence: 722,-,O
Sentence: 722,diuretic,O
Sentence: 722,hormone,O
Sentence: 722,(,O
Sentence: 722,SIADH,B-Disease
Sentence: 722,),O
Sentence: 722,among,O
Sentence: 722,vincristine,B-Chemical
Sentence: 722,-,O
Sentence: 722,treated,O
Sentence: 722,patients,O
Sentence: 722,and,O
Sentence: 722,to,O
Sentence: 722,explore,O
Sentence: 722,the,O
Sentence: 722,possibility,O
Sentence: 722,of,O
Sentence: 722,at,O
Sentence: 722,-,O
Sentence: 722,risk,O
Sentence: 722,population,O
Sentence: 722,subgroups,O
Sentence: 722,.,O
Sentence: 722,METHOD,O
Sentence: 722,:,O
Sentence: 722,We,O
Sentence: 722,searched,O
Sentence: 722,the,O
Sentence: 722,Eli,O
Sentence: 722,Lilly,O
Sentence: 722,and,O
Sentence: 722,Company,O
Sentence: 722,'s,O
Sentence: 722,computerized,O
Sentence: 722,adverse,O
Sentence: 722,event,O
Sentence: 722,database,O
Sentence: 722,for,O
Sentence: 722,all,O
Sentence: 722,reported,O
Sentence: 722,cases,O
Sentence: 722,of,O
Sentence: 722,hyponatremia,B-Disease
Sentence: 722,and,O
Sentence: 722,/,O
Sentence: 722,or,O
Sentence: 722,SIADH,B-Disease
Sentence: 722,as,O
Sentence: 722,of,O
Sentence: 722,1,O
Sentence: 722,November,O
Sentence: 722,1999,O
Sentence: 722,that,O
Sentence: 722,had,O
Sentence: 722,been,O
Sentence: 722,reported,O
Sentence: 722,during,O
Sentence: 722,the,O
Sentence: 722,use,O
Sentence: 722,of,O
Sentence: 722,vincristine,B-Chemical
Sentence: 722,.,O
Sentence: 722,RESULTS,O
Sentence: 722,:,O
Sentence: 722,A,O
Sentence: 722,total,O
Sentence: 722,of,O
Sentence: 722,76,O
Sentence: 722,cases,O
Sentence: 722,of,O
Sentence: 722,hyponatremia,B-Disease
Sentence: 722,and,O
Sentence: 722,/,O
Sentence: 722,or,O
Sentence: 722,SIADH,B-Disease
Sentence: 722,associated,O
Sentence: 722,with,O
Sentence: 722,vincristine,B-Chemical
Sentence: 722,use,O
Sentence: 722,were,O
Sentence: 722,identified,O
Sentence: 722,.,O
Sentence: 722,The,O
Sentence: 722,overall,O
Sentence: 722,reporting,O
Sentence: 722,rate,O
Sentence: 722,was,O
Sentence: 722,estimated,O
Sentence: 722,to,O
Sentence: 722,be,O
Sentence: 722,1.3,O
Sentence: 722,/,O
Sentence: 722,"100,000",O
Sentence: 722,treated,O
Sentence: 722,patients,O
Sentence: 722,.,O
Sentence: 722,The,O
Sentence: 722,average,O
Sentence: 722,age,O
Sentence: 722,of,O
Sentence: 722,patients,O
Sentence: 722,was,O
Sentence: 722,35.6,O
Sentence: 722,+,O
Sentence: 722,/,O
Sentence: 722,,O
Sentence: 722,-,O
Sentence: 722,,O
Sentence: 722,28.3,O
Sentence: 722,years,O
Sentence: 722,",",O
Sentence: 722,and,O
Sentence: 722,62,O
Sentence: 722,%,O
Sentence: 722,were,O
Sentence: 722,males,O
Sentence: 722,.,O
Sentence: 722,Approximately,O
Sentence: 722,75,O
Sentence: 722,%,O
Sentence: 722,of,O
Sentence: 722,the,O
Sentence: 722,patients,O
Sentence: 722,were,O
Sentence: 722,receiving,O
Sentence: 722,treatment,O
Sentence: 722,for,O
Sentence: 722,leukemia,B-Disease
Sentence: 722,or,O
Sentence: 722,lymphoma,B-Disease
Sentence: 722,.,O
Sentence: 722,Among,O
Sentence: 722,the,O
Sentence: 722,39,O
Sentence: 722,reports,O
Sentence: 722,that,O
Sentence: 722,included,O
Sentence: 722,information,O
Sentence: 722,on,O
Sentence: 722,race,O
Sentence: 722,",",O
Sentence: 722,the,O
Sentence: 722,racial,O
Sentence: 722,distribution,O
Sentence: 722,was,O
Sentence: 722,:,O
Sentence: 722,1,O
Sentence: 722,Black,O
Sentence: 722,",",O
Sentence: 722,3,O
Sentence: 722,Caucasian,O
Sentence: 722,",",O
Sentence: 722,and,O
Sentence: 722,35,O
Sentence: 722,Asian,O
Sentence: 722,.,O
Sentence: 722,CONCLUSION,O
Sentence: 722,:,O
Sentence: 722,Our,O
Sentence: 722,data,O
Sentence: 722,suggest,O
Sentence: 722,that,O
Sentence: 722,Asian,O
Sentence: 722,patients,O
Sentence: 722,may,O
Sentence: 722,be,O
Sentence: 722,at,O
Sentence: 722,increased,O
Sentence: 722,risk,O
Sentence: 722,of,O
Sentence: 722,hyponatremia,B-Disease
Sentence: 722,and,O
Sentence: 722,/,O
Sentence: 722,or,O
Sentence: 722,SIADH,B-Disease
Sentence: 722,associated,O
Sentence: 722,with,O
Sentence: 722,vincristine,B-Chemical
Sentence: 722,use,O
Sentence: 722,.,O
Sentence: 722,Although,O
Sentence: 722,the,O
Sentence: 722,overall,O
Sentence: 722,reported,O
Sentence: 722,rate,O
Sentence: 722,of,O
Sentence: 722,SIADH,B-Disease
Sentence: 722,associated,O
Sentence: 722,with,O
Sentence: 722,vincristine,B-Chemical
Sentence: 722,is,O
Sentence: 722,very,O
Sentence: 722,low,O
Sentence: 722,",",O
Sentence: 722,physicians,O
Sentence: 722,caring,O
Sentence: 722,for,O
Sentence: 722,Asian,O
Sentence: 722,oncology,O
Sentence: 722,patients,O
Sentence: 722,should,O
Sentence: 722,be,O
Sentence: 722,aware,O
Sentence: 722,of,O
Sentence: 722,this,O
Sentence: 722,potential,O
Sentence: 722,serious,O
Sentence: 722,but,O
Sentence: 722,reversible,O
Sentence: 722,adverse,O
Sentence: 722,event,O
Sentence: 722,.,O
Sentence: 723,Delayed,O
Sentence: 723,toxicity,B-Disease
Sentence: 723,of,O
Sentence: 723,cyclophosphamide,B-Chemical
Sentence: 723,on,O
Sentence: 723,the,O
Sentence: 723,bladder,O
Sentence: 723,of,O
Sentence: 723,DBA,O
Sentence: 723,/,O
Sentence: 723,2,O
Sentence: 723,and,O
Sentence: 723,C57BL,O
Sentence: 723,/,O
Sentence: 723,6,O
Sentence: 723,female,O
Sentence: 723,mouse,O
Sentence: 723,.,O
Sentence: 724,The,O
Sentence: 724,present,O
Sentence: 724,study,O
Sentence: 724,describes,O
Sentence: 724,the,O
Sentence: 724,delayed,O
Sentence: 724,development,O
Sentence: 724,of,O
Sentence: 724,a,O
Sentence: 724,severe,O
Sentence: 724,bladder,O
Sentence: 724,pathology,O
Sentence: 724,in,O
Sentence: 724,a,O
Sentence: 724,susceptible,O
Sentence: 724,strain,O
Sentence: 724,of,O
Sentence: 724,mice,O
Sentence: 724,(,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,),O
Sentence: 724,but,O
Sentence: 724,not,O
Sentence: 724,in,O
Sentence: 724,a,O
Sentence: 724,resistant,O
Sentence: 724,strain,O
Sentence: 724,(,O
Sentence: 724,C57BL,O
Sentence: 724,/,O
Sentence: 724,6,O
Sentence: 724,),O
Sentence: 724,when,O
Sentence: 724,both,O
Sentence: 724,were,O
Sentence: 724,treated,O
Sentence: 724,with,O
Sentence: 724,a,O
Sentence: 724,single,O
Sentence: 724,300,O
Sentence: 724,mg,O
Sentence: 724,/,O
Sentence: 724,kg,O
Sentence: 724,dose,O
Sentence: 724,of,O
Sentence: 724,cyclophosphamide,B-Chemical
Sentence: 724,(,O
Sentence: 724,CY,B-Chemical
Sentence: 724,),O
Sentence: 724,.,O
Sentence: 724,Inbred,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,and,O
Sentence: 724,C57BL,O
Sentence: 724,/,O
Sentence: 724,6,O
Sentence: 724,female,O
Sentence: 724,mice,O
Sentence: 724,were,O
Sentence: 724,injected,O
Sentence: 724,with,O
Sentence: 724,CY,B-Chemical
Sentence: 724,",",O
Sentence: 724,and,O
Sentence: 724,the,O
Sentence: 724,effect,O
Sentence: 724,of,O
Sentence: 724,the,O
Sentence: 724,drug,O
Sentence: 724,on,O
Sentence: 724,the,O
Sentence: 724,bladder,O
Sentence: 724,was,O
Sentence: 724,assessed,O
Sentence: 724,during,O
Sentence: 724,100,O
Sentence: 724,days,O
Sentence: 724,by,O
Sentence: 724,light,O
Sentence: 724,microscopy,O
Sentence: 724,using,O
Sentence: 724,different,O
Sentence: 724,staining,O
Sentence: 724,procedures,O
Sentence: 724,",",O
Sentence: 724,and,O
Sentence: 724,after,O
Sentence: 724,30,O
Sentence: 724,days,O
Sentence: 724,by,O
Sentence: 724,conventional,O
Sentence: 724,electron,O
Sentence: 724,microscopy,O
Sentence: 724,.,O
Sentence: 724,Early,O
Sentence: 724,CY,B-Chemical
Sentence: 724,toxicity,B-Disease
Sentence: 724,caused,O
Sentence: 724,a,O
Sentence: 724,typical,O
Sentence: 724,haemorrhagic,B-Disease
Sentence: 724,cystitis,B-Disease
Sentence: 724,in,O
Sentence: 724,both,O
Sentence: 724,strains,O
Sentence: 724,that,O
Sentence: 724,was,O
Sentence: 724,completely,O
Sentence: 724,repaired,O
Sentence: 724,in,O
Sentence: 724,about,O
Sentence: 724,7,O
Sentence: 724,-,O
Sentence: 724,10,O
Sentence: 724,days,O
Sentence: 724,.,O
Sentence: 724,After,O
Sentence: 724,30,O
Sentence: 724,days,O
Sentence: 724,of,O
Sentence: 724,CY,B-Chemical
Sentence: 724,injection,O
Sentence: 724,ulcerous,O
Sentence: 724,and,O
Sentence: 724,non,O
Sentence: 724,-,O
Sentence: 724,ulcerous,O
Sentence: 724,forms,O
Sentence: 724,of,O
Sentence: 724,chronic,O
Sentence: 724,cystitis,B-Disease
Sentence: 724,appeared,O
Sentence: 724,in,O
Sentence: 724,86,O
Sentence: 724,%,O
Sentence: 724,of,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,mice,O
Sentence: 724,but,O
Sentence: 724,only,O
Sentence: 724,in,O
Sentence: 724,4,O
Sentence: 724,%,O
Sentence: 724,of,O
Sentence: 724,C57BL,O
Sentence: 724,/,O
Sentence: 724,6,O
Sentence: 724,mice,O
Sentence: 724,.,O
Sentence: 724,Delayed,O
Sentence: 724,cystitis,B-Disease
Sentence: 724,was,O
Sentence: 724,characterized,O
Sentence: 724,by,O
Sentence: 724,infiltration,O
Sentence: 724,and,O
Sentence: 724,transepithelial,O
Sentence: 724,passage,O
Sentence: 724,into,O
Sentence: 724,the,O
Sentence: 724,lumen,O
Sentence: 724,of,O
Sentence: 724,inflammatory,O
Sentence: 724,cells,O
Sentence: 724,and,O
Sentence: 724,by,O
Sentence: 724,frequent,O
Sentence: 724,exfoliation,O
Sentence: 724,of,O
Sentence: 724,the,O
Sentence: 724,urothelium,O
Sentence: 724,.,O
Sentence: 724,Mast,O
Sentence: 724,cells,O
Sentence: 724,appeared,O
Sentence: 724,in,O
Sentence: 724,the,O
Sentence: 724,connective,O
Sentence: 724,and,O
Sentence: 724,muscular,O
Sentence: 724,layers,O
Sentence: 724,of,O
Sentence: 724,the,O
Sentence: 724,bladder,O
Sentence: 724,at,O
Sentence: 724,a,O
Sentence: 724,much,O
Sentence: 724,higher,O
Sentence: 724,number,O
Sentence: 724,in,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,mice,O
Sentence: 724,than,O
Sentence: 724,in,O
Sentence: 724,C57BL,O
Sentence: 724,/,O
Sentence: 724,6,O
Sentence: 724,mice,O
Sentence: 724,or,O
Sentence: 724,untreated,O
Sentence: 724,controls,O
Sentence: 724,.,O
Sentence: 724,Electron,O
Sentence: 724,microscopy,O
Sentence: 724,disclosed,O
Sentence: 724,the,O
Sentence: 724,absence,O
Sentence: 724,of,O
Sentence: 724,the,O
Sentence: 724,typical,O
Sentence: 724,discoidal,O
Sentence: 724,vesicles,O
Sentence: 724,normally,O
Sentence: 724,present,O
Sentence: 724,in,O
Sentence: 724,the,O
Sentence: 724,cytoplasm,O
Sentence: 724,of,O
Sentence: 724,surface,O
Sentence: 724,cells,O
Sentence: 724,.,O
Sentence: 724,Instead,O
Sentence: 724,",",O
Sentence: 724,numerous,O
Sentence: 724,abnormal,O
Sentence: 724,vesicles,O
Sentence: 724,containing,O
Sentence: 724,one,O
Sentence: 724,or,O
Sentence: 724,several,O
Sentence: 724,dark,O
Sentence: 724,granules,O
Sentence: 724,were,O
Sentence: 724,observed,O
Sentence: 724,in,O
Sentence: 724,the,O
Sentence: 724,cytoplasm,O
Sentence: 724,of,O
Sentence: 724,cells,O
Sentence: 724,from,O
Sentence: 724,all,O
Sentence: 724,the,O
Sentence: 724,epithelial,O
Sentence: 724,layers,O
Sentence: 724,.,O
Sentence: 724,Delayed,O
Sentence: 724,cystitis,B-Disease
Sentence: 724,still,O
Sentence: 724,persisted,O
Sentence: 724,in,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,mice,O
Sentence: 724,100,O
Sentence: 724,days,O
Sentence: 724,after,O
Sentence: 724,treatment,O
Sentence: 724,.,O
Sentence: 724,These,O
Sentence: 724,results,O
Sentence: 724,indicate,O
Sentence: 724,that,O
Sentence: 724,delayed,O
Sentence: 724,toxicity,B-Disease
Sentence: 724,of,O
Sentence: 724,CY,B-Chemical
Sentence: 724,in,O
Sentence: 724,female,O
Sentence: 724,DBA,O
Sentence: 724,/,O
Sentence: 724,2,O
Sentence: 724,mice,O
Sentence: 724,causes,O
Sentence: 724,a,O
Sentence: 724,bladder,O
Sentence: 724,pathology,O
Sentence: 724,that,O
Sentence: 724,is,O
Sentence: 724,not,O
Sentence: 724,observed,O
Sentence: 724,in,O
Sentence: 724,C57BL,O
Sentence: 724,/,O
Sentence: 724,6,O
Sentence: 724,mice,O
Sentence: 724,.,O
Sentence: 724,This,O
Sentence: 724,pathology,O
Sentence: 724,resembles,O
Sentence: 724,interstitial,B-Disease
Sentence: 724,cystitis,I-Disease
Sentence: 724,in,O
Sentence: 724,humans,O
Sentence: 724,and,O
Sentence: 724,could,O
Sentence: 724,perhaps,O
Sentence: 724,be,O
Sentence: 724,used,O
Sentence: 724,as,O
Sentence: 724,an,O
Sentence: 724,animal,O
Sentence: 724,model,O
Sentence: 724,for,O
Sentence: 724,studies,O
Sentence: 724,on,O
Sentence: 724,the,O
Sentence: 724,disease,O
Sentence: 724,.,O
Sentence: 725,High,O
Sentence: 725,-,O
Sentence: 725,dose,O
Sentence: 725,5,O
Sentence: 725,-,O
Sentence: 725,fluorouracil,O
Sentence: 725,,O
Sentence: 725,/,O
Sentence: 725,,O
Sentence: 725,folinic,B-Chemical
Sentence: 725,acid,I-Chemical
Sentence: 725,in,O
Sentence: 725,combination,O
Sentence: 725,with,O
Sentence: 725,three,O
Sentence: 725,-,O
Sentence: 725,weekly,O
Sentence: 725,mitomycin,B-Chemical
Sentence: 725,C,I-Chemical
Sentence: 725,in,O
Sentence: 725,the,O
Sentence: 725,treatment,O
Sentence: 725,of,O
Sentence: 725,advanced,O
Sentence: 725,gastric,B-Disease
Sentence: 725,cancer,I-Disease
Sentence: 725,.,O
Sentence: 725,A,O
Sentence: 725,phase,O
Sentence: 725,II,O
Sentence: 725,study,O
Sentence: 725,.,O
Sentence: 726,BACKGROUND,O
Sentence: 726,:,O
Sentence: 726,The,O
Sentence: 726,24,O
Sentence: 726,-,O
Sentence: 726,hour,O
Sentence: 726,continuous,O
Sentence: 726,infusion,O
Sentence: 726,of,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,fluorouracil,O
Sentence: 726,(,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,FU,O
Sentence: 726,),O
Sentence: 726,and,O
Sentence: 726,folinic,B-Chemical
Sentence: 726,acid,I-Chemical
Sentence: 726,(,O
Sentence: 726,FA,B-Chemical
Sentence: 726,),O
Sentence: 726,as,O
Sentence: 726,part,O
Sentence: 726,of,O
Sentence: 726,several,O
Sentence: 726,new,O
Sentence: 726,multidrug,O
Sentence: 726,chemotherapy,O
Sentence: 726,regimens,O
Sentence: 726,in,O
Sentence: 726,advanced,O
Sentence: 726,gastric,B-Disease
Sentence: 726,cancer,I-Disease
Sentence: 726,(,O
Sentence: 726,AGC,B-Disease
Sentence: 726,),O
Sentence: 726,has,O
Sentence: 726,shown,O
Sentence: 726,to,O
Sentence: 726,be,O
Sentence: 726,effective,O
Sentence: 726,",",O
Sentence: 726,with,O
Sentence: 726,low,O
Sentence: 726,toxicity,B-Disease
Sentence: 726,.,O
Sentence: 726,In,O
Sentence: 726,a,O
Sentence: 726,previous,O
Sentence: 726,phase,O
Sentence: 726,II,O
Sentence: 726,study,O
Sentence: 726,with,O
Sentence: 726,3,O
Sentence: 726,-,O
Sentence: 726,weekly,O
Sentence: 726,bolus,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,FU,O
Sentence: 726,",",O
Sentence: 726,FA,B-Chemical
Sentence: 726,and,O
Sentence: 726,mitomycin,B-Chemical
Sentence: 726,C,I-Chemical
Sentence: 726,(,O
Sentence: 726,MMC,B-Chemical
Sentence: 726,),O
Sentence: 726,we,O
Sentence: 726,found,O
Sentence: 726,a,O
Sentence: 726,low,O
Sentence: 726,toxicity,B-Disease
Sentence: 726,rate,O
Sentence: 726,and,O
Sentence: 726,response,O
Sentence: 726,rates,O
Sentence: 726,comparable,O
Sentence: 726,to,O
Sentence: 726,those,O
Sentence: 726,of,O
Sentence: 726,regimens,O
Sentence: 726,such,O
Sentence: 726,as,O
Sentence: 726,ELF,O
Sentence: 726,",",O
Sentence: 726,FAM,O
Sentence: 726,or,O
Sentence: 726,FAMTX,O
Sentence: 726,",",O
Sentence: 726,and,O
Sentence: 726,a,O
Sentence: 726,promising,O
Sentence: 726,median,O
Sentence: 726,overall,O
Sentence: 726,survival,O
Sentence: 726,.,O
Sentence: 726,In,O
Sentence: 726,order,O
Sentence: 726,to,O
Sentence: 726,improve,O
Sentence: 726,this,O
Sentence: 726,MMC,B-Chemical
Sentence: 726,-,O
Sentence: 726,dependent,O
Sentence: 726,schedule,O
Sentence: 726,we,O
Sentence: 726,initiated,O
Sentence: 726,a,O
Sentence: 726,phase,O
Sentence: 726,II,O
Sentence: 726,study,O
Sentence: 726,with,O
Sentence: 726,high,O
Sentence: 726,-,O
Sentence: 726,dose,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,FU,O
Sentence: 726,/,O
Sentence: 726,FA,B-Chemical
Sentence: 726,and,O
Sentence: 726,3,O
Sentence: 726,-,O
Sentence: 726,weekly,O
Sentence: 726,bolus,O
Sentence: 726,MMC,B-Chemical
Sentence: 726,.,O
Sentence: 726,PATIENTS,O
Sentence: 726,AND,O
Sentence: 726,METHODS,O
Sentence: 726,:,O
Sentence: 726,From,O
Sentence: 726,February,O
Sentence: 726,",",O
Sentence: 726,1998,O
Sentence: 726,to,O
Sentence: 726,September,O
Sentence: 726,",",O
Sentence: 726,2000,O
Sentence: 726,we,O
Sentence: 726,recruited,O
Sentence: 726,33,O
Sentence: 726,patients,O
Sentence: 726,with,O
Sentence: 726,AGC,B-Disease
Sentence: 726,to,O
Sentence: 726,receive,O
Sentence: 726,weekly,O
Sentence: 726,24,O
Sentence: 726,-,O
Sentence: 726,hour,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,FU,O
Sentence: 726,"2,600",O
Sentence: 726,mg,O
Sentence: 726,/,O
Sentence: 726,m,O
Sentence: 726,(,O
Sentence: 726,2,O
Sentence: 726,),O
Sentence: 726,preceded,O
Sentence: 726,by,O
Sentence: 726,2,O
Sentence: 726,-,O
Sentence: 726,hour,O
Sentence: 726,FA,B-Chemical
Sentence: 726,500,O
Sentence: 726,mg,O
Sentence: 726,/,O
Sentence: 726,m,O
Sentence: 726,(,O
Sentence: 726,2,O
Sentence: 726,),O
Sentence: 726,for,O
Sentence: 726,6,O
Sentence: 726,weeks,O
Sentence: 726,",",O
Sentence: 726,followed,O
Sentence: 726,by,O
Sentence: 726,a,O
Sentence: 726,2,O
Sentence: 726,-,O
Sentence: 726,week,O
Sentence: 726,rest,O
Sentence: 726,period,O
Sentence: 726,.,O
Sentence: 726,Bolus,O
Sentence: 726,MMC,B-Chemical
Sentence: 726,10,O
Sentence: 726,mg,O
Sentence: 726,/,O
Sentence: 726,m,O
Sentence: 726,(,O
Sentence: 726,2,O
Sentence: 726,),O
Sentence: 726,was,O
Sentence: 726,added,O
Sentence: 726,in,O
Sentence: 726,3,O
Sentence: 726,-,O
Sentence: 726,weekly,O
Sentence: 726,intervals,O
Sentence: 726,.,O
Sentence: 726,Treatment,O
Sentence: 726,given,O
Sentence: 726,on,O
Sentence: 726,an,O
Sentence: 726,outpatient,O
Sentence: 726,basis,O
Sentence: 726,",",O
Sentence: 726,using,O
Sentence: 726,portable,O
Sentence: 726,pump,O
Sentence: 726,systems,O
Sentence: 726,",",O
Sentence: 726,was,O
Sentence: 726,repeated,O
Sentence: 726,on,O
Sentence: 726,day,O
Sentence: 726,57,O
Sentence: 726,.,O
Sentence: 726,Patients,O
Sentence: 726,',O
Sentence: 726,characteristics,O
Sentence: 726,were,O
Sentence: 726,:,O
Sentence: 726,male,O
Sentence: 726,/,O
Sentence: 726,female,O
Sentence: 726,ratio,O
Sentence: 726,20,O
Sentence: 726,/,O
Sentence: 726,13,O
Sentence: 726,;,O
Sentence: 726,median,O
Sentence: 726,age,O
Sentence: 726,57,O
Sentence: 726,(,O
Sentence: 726,27,O
Sentence: 726,-,O
Sentence: 726,75,O
Sentence: 726,),O
Sentence: 726,years,O
Sentence: 726,;,O
Sentence: 726,median,O
Sentence: 726,WHO,O
Sentence: 726,status,O
Sentence: 726,1,O
Sentence: 726,(,O
Sentence: 726,0,O
Sentence: 726,-,O
Sentence: 726,2,O
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,18,O
Sentence: 726,patients,O
Sentence: 726,had,O
Sentence: 726,a,O
Sentence: 726,primary,O
Sentence: 726,AGC,B-Disease
Sentence: 726,",",O
Sentence: 726,and,O
Sentence: 726,15,O
Sentence: 726,showed,O
Sentence: 726,a,O
Sentence: 726,relapsed,O
Sentence: 726,AGC,B-Disease
Sentence: 726,.,O
Sentence: 726,Median,O
Sentence: 726,follow,O
Sentence: 726,-,O
Sentence: 726,up,O
Sentence: 726,was,O
Sentence: 726,11.8,O
Sentence: 726,months,O
Sentence: 726,(,O
Sentence: 726,range,O
Sentence: 726,of,O
Sentence: 726,those,O
Sentence: 726,surviving,O
Sentence: 726,:,O
Sentence: 726,2.7,O
Sentence: 726,-,O
Sentence: 726,11.8,O
Sentence: 726,months,O
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,RESULTS,O
Sentence: 726,:,O
Sentence: 726,32,O
Sentence: 726,patients,O
Sentence: 726,were,O
Sentence: 726,evaluable,O
Sentence: 726,for,O
Sentence: 726,response,O
Sentence: 726,,O
Sentence: 726,-,O
Sentence: 726,,O
Sentence: 726,complete,O
Sentence: 726,remission,O
Sentence: 726,9.1,O
Sentence: 726,%,O
Sentence: 726,(,O
Sentence: 726,n,O
Sentence: 726,,O
Sentence: 726,=,O
Sentence: 726,,O
Sentence: 726,3,O
Sentence: 726,),O
Sentence: 726,",",O
Sentence: 726,partial,O
Sentence: 726,remission,O
Sentence: 726,45.5,O
Sentence: 726,%,O
Sentence: 726,(,O
Sentence: 726,n,O
Sentence: 726,,O
Sentence: 726,=,O
Sentence: 726,,O
Sentence: 726,15,O
Sentence: 726,),O
Sentence: 726,",",O
Sentence: 726,no,O
Sentence: 726,change,O
Sentence: 726,27.3,O
Sentence: 726,%,O
Sentence: 726,(,O
Sentence: 726,n,O
Sentence: 726,,O
Sentence: 726,=,O
Sentence: 726,,O
Sentence: 726,9,O
Sentence: 726,),O
Sentence: 726,",",O
Sentence: 726,progressive,O
Sentence: 726,disease,O
Sentence: 726,15.1,O
Sentence: 726,%,O
Sentence: 726,(,O
Sentence: 726,n,O
Sentence: 726,,O
Sentence: 726,=,O
Sentence: 726,,O
Sentence: 726,5,O
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,Median,O
Sentence: 726,overall,O
Sentence: 726,survival,O
Sentence: 726,time,O
Sentence: 726,was,O
Sentence: 726,10.2,O
Sentence: 726,months,O
Sentence: 726,[,O
Sentence: 726,95,O
Sentence: 726,%,O
Sentence: 726,confidence,O
Sentence: 726,interval,O
Sentence: 726,(,O
Sentence: 726,CI,O
Sentence: 726,),O
Sentence: 726,:,O
Sentence: 726,8.7,O
Sentence: 726,-,O
Sentence: 726,11.6,O
Sentence: 726,],O
Sentence: 726,",",O
Sentence: 726,and,O
Sentence: 726,median,O
Sentence: 726,progression,O
Sentence: 726,-,O
Sentence: 726,free,O
Sentence: 726,survival,O
Sentence: 726,time,O
Sentence: 726,was,O
Sentence: 726,7.6,O
Sentence: 726,months,O
Sentence: 726,(,O
Sentence: 726,95,O
Sentence: 726,%,O
Sentence: 726,CI,O
Sentence: 726,:,O
Sentence: 726,4.4,O
Sentence: 726,-,O
Sentence: 726,10.9,O
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,The,O
Sentence: 726,worst,O
Sentence: 726,toxicities,B-Disease
Sentence: 726,(,O
Sentence: 726,%,O
Sentence: 726,),O
Sentence: 726,observed,O
Sentence: 726,were,O
Sentence: 726,(,O
Sentence: 726,CTC,O
Sentence: 726,-,O
Sentence: 726,NCI,O
Sentence: 726,1,O
Sentence: 726,/,O
Sentence: 726,2,O
Sentence: 726,/,O
Sentence: 726,3,O
Sentence: 726,),O
Sentence: 726,:,O
Sentence: 726,leukopenia,B-Disease
Sentence: 726,45.5,O
Sentence: 726,/,O
Sentence: 726,18.2,O
Sentence: 726,/,O
Sentence: 726,6.1,O
Sentence: 726,",",O
Sentence: 726,thrombocytopenia,B-Disease
Sentence: 726,33.3,O
Sentence: 726,/,O
Sentence: 726,9.1,O
Sentence: 726,/,O
Sentence: 726,6.1,O
Sentence: 726,",",O
Sentence: 726,vomitus,B-Disease
Sentence: 726,24.2,O
Sentence: 726,/,O
Sentence: 726,9.1,O
Sentence: 726,/,O
Sentence: 726,0,O
Sentence: 726,",",O
Sentence: 726,diarrhea,B-Disease
Sentence: 726,36.4,O
Sentence: 726,/,O
Sentence: 726,6.1,O
Sentence: 726,/,O
Sentence: 726,3.0,O
Sentence: 726,",",O
Sentence: 726,stomatitis,B-Disease
Sentence: 726,18.2,O
Sentence: 726,/,O
Sentence: 726,9.1,O
Sentence: 726,/,O
Sentence: 726,0,O
Sentence: 726,",",O
Sentence: 726,hand,O
Sentence: 726,-,O
Sentence: 726,foot,O
Sentence: 726,syndrome,O
Sentence: 726,12.1,O
Sentence: 726,/,O
Sentence: 726,0,O
Sentence: 726,/,O
Sentence: 726,0,O
Sentence: 726,.,O
Sentence: 726,Two,O
Sentence: 726,patients,O
Sentence: 726,developed,O
Sentence: 726,hemolytic,O
Sentence: 726,-,O
Sentence: 726,uremic,O
Sentence: 726,syndrome,O
Sentence: 726,(,O
Sentence: 726,HUS,B-Disease
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,CONCLUSIONS,O
Sentence: 726,:,O
Sentence: 726,High,O
Sentence: 726,-,O
Sentence: 726,dose,O
Sentence: 726,5,O
Sentence: 726,-,O
Sentence: 726,FU,O
Sentence: 726,/,O
Sentence: 726,FA,B-Chemical
Sentence: 726,/,O
Sentence: 726,MMC,B-Chemical
Sentence: 726,is,O
Sentence: 726,an,O
Sentence: 726,effective,O
Sentence: 726,and,O
Sentence: 726,well,O
Sentence: 726,-,O
Sentence: 726,tolerated,O
Sentence: 726,outpatient,O
Sentence: 726,regimen,O
Sentence: 726,for,O
Sentence: 726,AGC,B-Disease
Sentence: 726,(,O
Sentence: 726,objective,O
Sentence: 726,response,O
Sentence: 726,rate,O
Sentence: 726,54.6,O
Sentence: 726,%,O
Sentence: 726,),O
Sentence: 726,.,O
Sentence: 726,It,O
Sentence: 726,may,O
Sentence: 726,serve,O
Sentence: 726,as,O
Sentence: 726,an,O
Sentence: 726,alternative,O
Sentence: 726,to,O
Sentence: 726,cisplatin,B-Chemical
Sentence: 726,-,O
Sentence: 726,containing,O
Sentence: 726,regimens,O
Sentence: 726,;,O
Sentence: 726,however,O
Sentence: 726,",",O
Sentence: 726,it,O
Sentence: 726,has,O
Sentence: 726,to,O
Sentence: 726,be,O
Sentence: 726,considered,O
Sentence: 726,that,O
Sentence: 726,possibly,O
Sentence: 726,HUS,B-Disease
Sentence: 726,may,O
Sentence: 726,occur,O
Sentence: 726,.,O
Sentence: 727,Persistent,O
Sentence: 727,sterile,O
Sentence: 727,leukocyturia,B-Disease
Sentence: 727,is,O
Sentence: 727,associated,O
Sentence: 727,with,O
Sentence: 727,impaired,B-Disease
Sentence: 727,renal,I-Disease
Sentence: 727,function,I-Disease
Sentence: 727,in,O
Sentence: 727,human,O
Sentence: 727,immunodeficiency,O
Sentence: 727,virus,O
Sentence: 727,type,O
Sentence: 727,1,O
Sentence: 727,-,O
Sentence: 727,infected,O
Sentence: 727,children,O
Sentence: 727,treated,O
Sentence: 727,with,O
Sentence: 727,indinavir,B-Chemical
Sentence: 727,.,O
Sentence: 728,BACKGROUND,O
Sentence: 728,:,O
Sentence: 728,Prolonged,O
Sentence: 728,administration,O
Sentence: 728,of,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,is,O
Sentence: 728,associated,O
Sentence: 728,with,O
Sentence: 728,the,O
Sentence: 728,occurrence,O
Sentence: 728,of,O
Sentence: 728,a,O
Sentence: 728,variety,O
Sentence: 728,of,O
Sentence: 728,renal,O
Sentence: 728,complications,O
Sentence: 728,in,O
Sentence: 728,adults,O
Sentence: 728,.,O
Sentence: 728,These,O
Sentence: 728,well,O
Sentence: 728,-,O
Sentence: 728,documented,O
Sentence: 728,side,O
Sentence: 728,effects,O
Sentence: 728,have,O
Sentence: 728,restricted,O
Sentence: 728,the,O
Sentence: 728,use,O
Sentence: 728,of,O
Sentence: 728,this,O
Sentence: 728,potent,O
Sentence: 728,protease,O
Sentence: 728,inhibitor,O
Sentence: 728,in,O
Sentence: 728,children,O
Sentence: 728,.,O
Sentence: 728,DESIGN,O
Sentence: 728,:,O
Sentence: 728,A,O
Sentence: 728,prospective,O
Sentence: 728,study,O
Sentence: 728,to,O
Sentence: 728,monitor,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,-,O
Sentence: 728,related,O
Sentence: 728,nephrotoxicity,B-Disease
Sentence: 728,in,O
Sentence: 728,a,O
Sentence: 728,cohort,O
Sentence: 728,of,O
Sentence: 728,30,O
Sentence: 728,human,O
Sentence: 728,immunodeficiency,O
Sentence: 728,virus,O
Sentence: 728,type,O
Sentence: 728,1,O
Sentence: 728,-,O
Sentence: 728,infected,O
Sentence: 728,children,O
Sentence: 728,treated,O
Sentence: 728,with,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,.,O
Sentence: 728,METHODS,O
Sentence: 728,:,O
Sentence: 728,Urinary,O
Sentence: 728,pH,O
Sentence: 728,",",O
Sentence: 728,albumin,O
Sentence: 728,",",O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,",",O
Sentence: 728,the,O
Sentence: 728,presence,O
Sentence: 728,of,O
Sentence: 728,erythrocytes,O
Sentence: 728,",",O
Sentence: 728,leukocytes,O
Sentence: 728,",",O
Sentence: 728,bacteria,O
Sentence: 728,and,O
Sentence: 728,crystals,O
Sentence: 728,",",O
Sentence: 728,and,O
Sentence: 728,culture,O
Sentence: 728,were,O
Sentence: 728,analyzed,O
Sentence: 728,every,O
Sentence: 728,3,O
Sentence: 728,months,O
Sentence: 728,for,O
Sentence: 728,96,O
Sentence: 728,weeks,O
Sentence: 728,.,O
Sentence: 728,Serum,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,levels,O
Sentence: 728,were,O
Sentence: 728,routinely,O
Sentence: 728,determined,O
Sentence: 728,at,O
Sentence: 728,the,O
Sentence: 728,same,O
Sentence: 728,time,O
Sentence: 728,points,O
Sentence: 728,.,O
Sentence: 728,Steady,O
Sentence: 728,-,O
Sentence: 728,state,O
Sentence: 728,pharmacokinetics,O
Sentence: 728,of,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,were,O
Sentence: 728,done,O
Sentence: 728,at,O
Sentence: 728,week,O
Sentence: 728,4,O
Sentence: 728,after,O
Sentence: 728,the,O
Sentence: 728,initiation,O
Sentence: 728,of,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,.,O
Sentence: 728,RESULTS,O
Sentence: 728,:,O
Sentence: 728,The,O
Sentence: 728,cumulative,O
Sentence: 728,incidence,O
Sentence: 728,of,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,(,O
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,or,O
Sentence: 728,,O
Sentence: 728,=,O
Sentence: 728,75,O
Sentence: 728,cells,O
Sentence: 728,/,O
Sentence: 728,,O
Sentence: 728,micro,O
Sentence: 728,L,O
Sentence: 728,in,O
Sentence: 728,at,O
Sentence: 728,least,O
Sentence: 728,2,O
Sentence: 728,consecutive,O
Sentence: 728,visits,O
Sentence: 728,),O
Sentence: 728,after,O
Sentence: 728,96,O
Sentence: 728,weeks,O
Sentence: 728,was,O
Sentence: 728,53,O
Sentence: 728,%,O
Sentence: 728,.,O
Sentence: 728,Persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,was,O
Sentence: 728,frequently,O
Sentence: 728,associated,O
Sentence: 728,with,O
Sentence: 728,a,O
Sentence: 728,mild,O
Sentence: 728,increase,O
Sentence: 728,in,O
Sentence: 728,the,O
Sentence: 728,urine,O
Sentence: 728,albumin,O
Sentence: 728,/,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,ratio,O
Sentence: 728,and,O
Sentence: 728,by,O
Sentence: 728,microscopic,O
Sentence: 728,hematuria,B-Disease
Sentence: 728,.,O
Sentence: 728,The,O
Sentence: 728,cumulative,O
Sentence: 728,incidence,O
Sentence: 728,of,O
Sentence: 728,serum,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,levels,O
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,50,O
Sentence: 728,%,O
Sentence: 728,above,O
Sentence: 728,normal,O
Sentence: 728,was,O
Sentence: 728,33,O
Sentence: 728,%,O
Sentence: 728,after,O
Sentence: 728,96,O
Sentence: 728,weeks,O
Sentence: 728,.,O
Sentence: 728,Children,O
Sentence: 728,with,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,more,O
Sentence: 728,frequently,O
Sentence: 728,had,O
Sentence: 728,serum,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,levels,O
Sentence: 728,of,O
Sentence: 728,50,O
Sentence: 728,%,O
Sentence: 728,above,O
Sentence: 728,normal,O
Sentence: 728,than,O
Sentence: 728,those,O
Sentence: 728,children,O
Sentence: 728,without,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,.,O
Sentence: 728,In,O
Sentence: 728,children,O
Sentence: 728,younger,O
Sentence: 728,than,O
Sentence: 728,5.6,O
Sentence: 728,years,O
Sentence: 728,",",O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,was,O
Sentence: 728,significantly,O
Sentence: 728,more,O
Sentence: 728,frequent,O
Sentence: 728,than,O
Sentence: 728,in,O
Sentence: 728,older,O
Sentence: 728,children,O
Sentence: 728,.,O
Sentence: 728,A,O
Sentence: 728,higher,O
Sentence: 728,cumulative,O
Sentence: 728,incidence,O
Sentence: 728,of,O
Sentence: 728,persistent,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,was,O
Sentence: 728,found,O
Sentence: 728,in,O
Sentence: 728,children,O
Sentence: 728,with,O
Sentence: 728,an,O
Sentence: 728,area,O
Sentence: 728,under,O
Sentence: 728,the,O
Sentence: 728,curve,O
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,19,O
Sentence: 728,mg,O
Sentence: 728,/,O
Sentence: 728,L,O
Sentence: 728,x,O
Sentence: 728,h,O
Sentence: 728,or,O
Sentence: 728,a,O
Sentence: 728,peak,O
Sentence: 728,serum,O
Sentence: 728,level,O
Sentence: 728,of,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,12,O
Sentence: 728,mg,O
Sentence: 728,/,O
Sentence: 728,L,O
Sentence: 728,.,O
Sentence: 728,In,O
Sentence: 728,4,O
Sentence: 728,children,O
Sentence: 728,",",O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,was,O
Sentence: 728,discontinued,O
Sentence: 728,because,O
Sentence: 728,of,O
Sentence: 728,nephrotoxicity,B-Disease
Sentence: 728,.,O
Sentence: 728,Subsequently,O
Sentence: 728,",",O
Sentence: 728,the,O
Sentence: 728,serum,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,levels,O
Sentence: 728,decreased,O
Sentence: 728,",",O
Sentence: 728,the,O
Sentence: 728,urine,O
Sentence: 728,albumin,O
Sentence: 728,/,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,ratios,O
Sentence: 728,returned,O
Sentence: 728,to,O
Sentence: 728,zero,O
Sentence: 728,",",O
Sentence: 728,and,O
Sentence: 728,the,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,disappeared,O
Sentence: 728,within,O
Sentence: 728,3,O
Sentence: 728,months,O
Sentence: 728,.,O
Sentence: 728,CONCLUSIONS,O
Sentence: 728,:,O
Sentence: 728,Children,O
Sentence: 728,treated,O
Sentence: 728,with,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,have,O
Sentence: 728,a,O
Sentence: 728,high,O
Sentence: 728,cumulative,O
Sentence: 728,incidence,O
Sentence: 728,of,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,.,O
Sentence: 728,Children,O
Sentence: 728,with,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,more,O
Sentence: 728,frequently,O
Sentence: 728,had,O
Sentence: 728,an,O
Sentence: 728,increase,O
Sentence: 728,in,O
Sentence: 728,serum,O
Sentence: 728,creatinine,B-Chemical
Sentence: 728,levels,O
Sentence: 728,of,O
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,50,O
Sentence: 728,%,O
Sentence: 728,above,O
Sentence: 728,normal,O
Sentence: 728,.,O
Sentence: 728,Younger,O
Sentence: 728,children,O
Sentence: 728,have,O
Sentence: 728,an,O
Sentence: 728,additional,O
Sentence: 728,risk,O
Sentence: 728,for,O
Sentence: 728,renal,O
Sentence: 728,complications,O
Sentence: 728,.,O
Sentence: 728,The,O
Sentence: 728,impairment,B-Disease
Sentence: 728,of,I-Disease
Sentence: 728,the,I-Disease
Sentence: 728,renal,I-Disease
Sentence: 728,function,I-Disease
Sentence: 728,in,O
Sentence: 728,these,O
Sentence: 728,children,O
Sentence: 728,occurred,O
Sentence: 728,in,O
Sentence: 728,the,O
Sentence: 728,absence,O
Sentence: 728,of,O
Sentence: 728,clinical,O
Sentence: 728,symptoms,O
Sentence: 728,of,O
Sentence: 728,nephrolithiasis,B-Disease
Sentence: 728,.,O
Sentence: 728,Indinavir,B-Chemical
Sentence: 728,-,O
Sentence: 728,associated,O
Sentence: 728,nephrotoxicity,B-Disease
Sentence: 728,must,O
Sentence: 728,be,O
Sentence: 728,monitored,O
Sentence: 728,closely,O
Sentence: 728,",",O
Sentence: 728,especially,O
Sentence: 728,in,O
Sentence: 728,children,O
Sentence: 728,with,O
Sentence: 728,risk,O
Sentence: 728,factors,O
Sentence: 728,such,O
Sentence: 728,as,O
Sentence: 728,persistent,O
Sentence: 728,sterile,O
Sentence: 728,leukocyturia,B-Disease
Sentence: 728,",",O
Sentence: 728,age,O
Sentence: 728,,O
Sentence: 728,<,O
Sentence: 728,,O
Sentence: 728,5.6,O
Sentence: 728,years,O
Sentence: 728,",",O
Sentence: 728,an,O
Sentence: 728,area,O
Sentence: 728,under,O
Sentence: 728,the,O
Sentence: 728,curve,O
Sentence: 728,of,O
Sentence: 728,indinavir,B-Chemical
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,19,O
Sentence: 728,mg,O
Sentence: 728,/,O
Sentence: 728,L,O
Sentence: 728,x,O
Sentence: 728,h,O
Sentence: 728,",",O
Sentence: 728,and,O
Sentence: 728,a,O
Sentence: 728,C,O
Sentence: 728,(,O
Sentence: 728,max,O
Sentence: 728,),O
Sentence: 728,,O
Sentence: 728,>,O
Sentence: 728,,O
Sentence: 728,12,O
Sentence: 728,mg,O
Sentence: 728,/,O
Sentence: 728,L,O
Sentence: 728,.,O
Sentence: 729,Utility,O
Sentence: 729,of,O
Sentence: 729,troponin,O
Sentence: 729,I,O
Sentence: 729,in,O
Sentence: 729,patients,O
Sentence: 729,with,O
Sentence: 729,cocaine,B-Chemical
Sentence: 729,-,O
Sentence: 729,associated,O
Sentence: 729,chest,B-Disease
Sentence: 729,pain,I-Disease
Sentence: 729,.,O
Sentence: 730,Baseline,O
Sentence: 730,electrocardiogram,O
Sentence: 730,abnormalities,O
Sentence: 730,and,O
Sentence: 730,market,O
Sentence: 730,elevations,O
Sentence: 730,not,O
Sentence: 730,associated,O
Sentence: 730,with,O
Sentence: 730,myocardial,B-Disease
Sentence: 730,necrosis,B-Disease
Sentence: 730,make,O
Sentence: 730,accurate,O
Sentence: 730,diagnosis,O
Sentence: 730,of,O
Sentence: 730,myocardial,B-Disease
Sentence: 730,infarction,I-Disease
Sentence: 730,(,O
Sentence: 730,MI,B-Disease
Sentence: 730,),O
Sentence: 730,difficult,O
Sentence: 730,in,O
Sentence: 730,patients,O
Sentence: 730,with,O
Sentence: 730,cocaine,B-Chemical
Sentence: 730,-,O
Sentence: 730,associated,O
Sentence: 730,chest,B-Disease
Sentence: 730,pain,I-Disease
Sentence: 730,.,O
Sentence: 730,Troponin,O
Sentence: 730,sampling,O
Sentence: 730,may,O
Sentence: 730,offer,O
Sentence: 730,greater,O
Sentence: 730,diagnostic,O
Sentence: 730,utility,O
Sentence: 730,in,O
Sentence: 730,these,O
Sentence: 730,patients,O
Sentence: 730,.,O
Sentence: 730,OBJECTIVE,O
Sentence: 730,:,O
Sentence: 730,To,O
Sentence: 730,assess,O
Sentence: 730,outcomes,O
Sentence: 730,based,O
Sentence: 730,on,O
Sentence: 730,troponin,O
Sentence: 730,positivity,O
Sentence: 730,in,O
Sentence: 730,patients,O
Sentence: 730,with,O
Sentence: 730,cocaine,B-Chemical
Sentence: 730,chest,B-Disease
Sentence: 730,pain,I-Disease
Sentence: 730,admitted,O
Sentence: 730,for,O
Sentence: 730,exclusion,O
Sentence: 730,of,O
Sentence: 730,MI,B-Disease
Sentence: 730,.,O
Sentence: 730,METHODS,O
Sentence: 730,:,O
Sentence: 730,Outcomes,O
Sentence: 730,were,O
Sentence: 730,examined,O
Sentence: 730,in,O
Sentence: 730,patients,O
Sentence: 730,admitted,O
Sentence: 730,for,O
Sentence: 730,possible,O
Sentence: 730,MI,B-Disease
Sentence: 730,after,O
Sentence: 730,cocaine,B-Chemical
Sentence: 730,use,O
Sentence: 730,.,O
Sentence: 730,All,O
Sentence: 730,patients,O
Sentence: 730,underwent,O
Sentence: 730,a,O
Sentence: 730,rapid,O
Sentence: 730,rule,O
Sentence: 730,-,O
Sentence: 730,in,O
Sentence: 730,protocol,O
Sentence: 730,that,O
Sentence: 730,included,O
Sentence: 730,serial,O
Sentence: 730,sampling,O
Sentence: 730,of,O
Sentence: 730,creatine,B-Chemical
Sentence: 730,kinase,O
Sentence: 730,(,O
Sentence: 730,CK,O
Sentence: 730,),O
Sentence: 730,",",O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,",",O
Sentence: 730,and,O
Sentence: 730,cardiac,O
Sentence: 730,troponin,O
Sentence: 730,I,O
Sentence: 730,(,O
Sentence: 730,cTnI,O
Sentence: 730,),O
Sentence: 730,over,O
Sentence: 730,eight,O
Sentence: 730,hours,O
Sentence: 730,.,O
Sentence: 730,Outcomes,O
Sentence: 730,included,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,MI,B-Disease
Sentence: 730,(,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,,O
Sentence: 730,>,O
Sentence: 730,,O
Sentence: 730,or,O
Sentence: 730,=,O
Sentence: 730,,O
Sentence: 730,8,O
Sentence: 730,ng,O
Sentence: 730,/,O
Sentence: 730,mL,O
Sentence: 730,with,O
Sentence: 730,a,O
Sentence: 730,relative,O
Sentence: 730,index,O
Sentence: 730,[,O
Sentence: 730,(,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,x,O
Sentence: 730,100,O
Sentence: 730,),O
Sentence: 730,,O
Sentence: 730,/,O
Sentence: 730,total,O
Sentence: 730,CK,O
Sentence: 730,],O
Sentence: 730,,O
Sentence: 730,>,O
Sentence: 730,,O
Sentence: 730,or,O
Sentence: 730,=,O
Sentence: 730,,O
Sentence: 730,4,O
Sentence: 730,",",O
Sentence: 730,cardiac,B-Disease
Sentence: 730,death,I-Disease
Sentence: 730,",",O
Sentence: 730,and,O
Sentence: 730,significant,O
Sentence: 730,coronary,B-Disease
Sentence: 730,disease,I-Disease
Sentence: 730,(,O
Sentence: 730,,O
Sentence: 730,>,O
Sentence: 730,,O
Sentence: 730,or,O
Sentence: 730,=,O
Sentence: 730,50,O
Sentence: 730,%,O
Sentence: 730,),O
Sentence: 730,.,O
Sentence: 730,RESULTS,O
Sentence: 730,:,O
Sentence: 730,Of,O
Sentence: 730,the,O
Sentence: 730,246,O
Sentence: 730,admitted,O
Sentence: 730,patients,O
Sentence: 730,",",O
Sentence: 730,34,O
Sentence: 730,(,O
Sentence: 730,14,O
Sentence: 730,%,O
Sentence: 730,),O
Sentence: 730,met,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,criteria,O
Sentence: 730,for,O
Sentence: 730,MI,B-Disease
Sentence: 730,and,O
Sentence: 730,38,O
Sentence: 730,(,O
Sentence: 730,16,O
Sentence: 730,%,O
Sentence: 730,),O
Sentence: 730,had,O
Sentence: 730,cTnI,O
Sentence: 730,elevations,O
Sentence: 730,.,O
Sentence: 730,Angiography,O
Sentence: 730,was,O
Sentence: 730,performed,O
Sentence: 730,in,O
Sentence: 730,29,O
Sentence: 730,of,O
Sentence: 730,38,O
Sentence: 730,patients,O
Sentence: 730,who,O
Sentence: 730,were,O
Sentence: 730,cTnI,O
Sentence: 730,-,O
Sentence: 730,positive,O
Sentence: 730,",",O
Sentence: 730,with,O
Sentence: 730,significant,O
Sentence: 730,disease,O
Sentence: 730,present,O
Sentence: 730,in,O
Sentence: 730,25,O
Sentence: 730,(,O
Sentence: 730,86,O
Sentence: 730,%,O
Sentence: 730,),O
Sentence: 730,.,O
Sentence: 730,Three,O
Sentence: 730,of,O
Sentence: 730,the,O
Sentence: 730,four,O
Sentence: 730,patients,O
Sentence: 730,without,O
Sentence: 730,significant,O
Sentence: 730,disease,O
Sentence: 730,who,O
Sentence: 730,had,O
Sentence: 730,cTnI,O
Sentence: 730,elevations,O
Sentence: 730,met,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,criteria,O
Sentence: 730,for,O
Sentence: 730,MI,B-Disease
Sentence: 730,",",O
Sentence: 730,and,O
Sentence: 730,the,O
Sentence: 730,other,O
Sentence: 730,had,O
Sentence: 730,a,O
Sentence: 730,peak,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,level,O
Sentence: 730,of,O
Sentence: 730,13,O
Sentence: 730,ng,O
Sentence: 730,/,O
Sentence: 730,mL,O
Sentence: 730,.,O
Sentence: 730,Sensitivities,O
Sentence: 730,",",O
Sentence: 730,specificities,O
Sentence: 730,",",O
Sentence: 730,and,O
Sentence: 730,positive,O
Sentence: 730,and,O
Sentence: 730,negative,O
Sentence: 730,likelihood,O
Sentence: 730,ratios,O
Sentence: 730,for,O
Sentence: 730,predicting,O
Sentence: 730,cardiac,B-Disease
Sentence: 730,death,I-Disease
Sentence: 730,or,O
Sentence: 730,significant,O
Sentence: 730,disease,O
Sentence: 730,were,O
Sentence: 730,high,O
Sentence: 730,for,O
Sentence: 730,both,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,MI,B-Disease
Sentence: 730,and,O
Sentence: 730,cTnI,O
Sentence: 730,and,O
Sentence: 730,were,O
Sentence: 730,not,O
Sentence: 730,significantly,O
Sentence: 730,different,O
Sentence: 730,.,O
Sentence: 730,CONCLUSIONS,O
Sentence: 730,:,O
Sentence: 730,Most,O
Sentence: 730,patients,O
Sentence: 730,with,O
Sentence: 730,cTnI,O
Sentence: 730,elevations,O
Sentence: 730,meet,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,criteria,O
Sentence: 730,for,O
Sentence: 730,MI,B-Disease
Sentence: 730,",",O
Sentence: 730,as,O
Sentence: 730,well,O
Sentence: 730,as,O
Sentence: 730,have,O
Sentence: 730,a,O
Sentence: 730,high,O
Sentence: 730,incidence,O
Sentence: 730,of,O
Sentence: 730,underlying,O
Sentence: 730,significant,O
Sentence: 730,disease,O
Sentence: 730,.,O
Sentence: 730,Troponin,O
Sentence: 730,appears,O
Sentence: 730,to,O
Sentence: 730,have,O
Sentence: 730,an,O
Sentence: 730,equivalent,O
Sentence: 730,diagnostic,O
Sentence: 730,accuracy,O
Sentence: 730,compared,O
Sentence: 730,with,O
Sentence: 730,CK,O
Sentence: 730,-,O
Sentence: 730,MB,O
Sentence: 730,for,O
Sentence: 730,diagnosing,O
Sentence: 730,necrosis,B-Disease
Sentence: 730,in,O
Sentence: 730,patients,O
Sentence: 730,with,O
Sentence: 730,cocaine,B-Chemical
Sentence: 730,-,O
Sentence: 730,associated,O
Sentence: 730,chest,B-Disease
Sentence: 730,pain,I-Disease
Sentence: 730,and,O
Sentence: 730,suspected,O
Sentence: 730,MI,B-Disease
Sentence: 730,.,O
Sentence: 731,Acute,O
Sentence: 731,interstitial,B-Disease
Sentence: 731,nephritis,I-Disease
Sentence: 731,due,O
Sentence: 731,to,O
Sentence: 731,nicergoline,B-Chemical
Sentence: 731,(,O
Sentence: 731,Sermion,B-Chemical
Sentence: 731,),O
Sentence: 731,.,O
Sentence: 732,We,O
Sentence: 732,report,O
Sentence: 732,a,O
Sentence: 732,case,O
Sentence: 732,of,O
Sentence: 732,acute,O
Sentence: 732,interstitial,B-Disease
Sentence: 732,nephritis,I-Disease
Sentence: 732,(,O
Sentence: 732,AIN,B-Disease
Sentence: 732,),O
Sentence: 732,due,O
Sentence: 732,to,O
Sentence: 732,nicergoline,B-Chemical
Sentence: 732,(,O
Sentence: 732,Sermion,B-Chemical
Sentence: 732,),O
Sentence: 732,.,O
Sentence: 732,A,O
Sentence: 732,50,O
Sentence: 732,-,O
Sentence: 732,year,O
Sentence: 732,-,O
Sentence: 732,old,O
Sentence: 732,patient,O
Sentence: 732,admitted,O
Sentence: 732,to,O
Sentence: 732,our,O
Sentence: 732,hospital,O
Sentence: 732,for,O
Sentence: 732,fever,B-Disease
Sentence: 732,and,O
Sentence: 732,acute,B-Disease
Sentence: 732,renal,B-Disease
Sentence: 732,failure,I-Disease
Sentence: 732,.,O
Sentence: 732,Before,O
Sentence: 732,admission,O
Sentence: 732,",",O
Sentence: 732,he,O
Sentence: 732,had,O
Sentence: 732,been,O
Sentence: 732,taking,O
Sentence: 732,nicergoline,B-Chemical
Sentence: 732,and,O
Sentence: 732,bendazac,B-Chemical
Sentence: 732,lysine,I-Chemical
Sentence: 732,due,O
Sentence: 732,to,O
Sentence: 732,retinal,B-Disease
Sentence: 732,vein,I-Disease
Sentence: 732,occlusion,I-Disease
Sentence: 732,at,O
Sentence: 732,ophthalmologic,O
Sentence: 732,department,O
Sentence: 732,.,O
Sentence: 732,Thereafter,O
Sentence: 732,",",O
Sentence: 732,he,O
Sentence: 732,experienced,O
Sentence: 732,intermittent,O
Sentence: 732,fever,B-Disease
Sentence: 732,and,O
Sentence: 732,skin,B-Disease
Sentence: 732,rash,I-Disease
Sentence: 732,.,O
Sentence: 732,On,O
Sentence: 732,admission,O
Sentence: 732,",",O
Sentence: 732,clinical,O
Sentence: 732,symptoms,O
Sentence: 732,(,O
Sentence: 732,i.e,O
Sentence: 732,.,O
Sentence: 732,arthralgia,B-Disease
Sentence: 732,and,O
Sentence: 732,fever,B-Disease
Sentence: 732,),O
Sentence: 732,and,O
Sentence: 732,laboratory,O
Sentence: 732,findings,O
Sentence: 732,(,O
Sentence: 732,i.e,O
Sentence: 732,.,O
Sentence: 732,eosinophilia,B-Disease
Sentence: 732,and,O
Sentence: 732,renal,B-Disease
Sentence: 732,failure,I-Disease
Sentence: 732,),O
Sentence: 732,suggested,O
Sentence: 732,AIN,B-Disease
Sentence: 732,",",O
Sentence: 732,and,O
Sentence: 732,which,O
Sentence: 732,was,O
Sentence: 732,confirmed,O
Sentence: 732,by,O
Sentence: 732,pathologic,O
Sentence: 732,findings,O
Sentence: 732,on,O
Sentence: 732,renal,O
Sentence: 732,biopsy,O
Sentence: 732,.,O
Sentence: 732,A,O
Sentence: 732,lymphocyte,O
Sentence: 732,transformation,O
Sentence: 732,test,O
Sentence: 732,demonstrated,O
Sentence: 732,a,O
Sentence: 732,positive,O
Sentence: 732,result,O
Sentence: 732,against,O
Sentence: 732,nicergoline,B-Chemical
Sentence: 732,.,O
Sentence: 732,Treatment,O
Sentence: 732,was,O
Sentence: 732,consisted,O
Sentence: 732,of,O
Sentence: 732,withdrawal,O
Sentence: 732,of,O
Sentence: 732,nicergoline,B-Chemical
Sentence: 732,and,O
Sentence: 732,intravenous,O
Sentence: 732,methylprednisolone,B-Chemical
Sentence: 732,",",O
Sentence: 732,and,O
Sentence: 732,his,O
Sentence: 732,renal,O
Sentence: 732,function,O
Sentence: 732,was,O
Sentence: 732,completely,O
Sentence: 732,recovered,O
Sentence: 732,.,O
Sentence: 732,To,O
Sentence: 732,our,O
Sentence: 732,knowledge,O
Sentence: 732,",",O
Sentence: 732,this,O
Sentence: 732,is,O
Sentence: 732,the,O
Sentence: 732,first,O
Sentence: 732,report,O
Sentence: 732,of,O
Sentence: 732,nicergoline,B-Chemical
Sentence: 732,-,O
Sentence: 732,associated,O
Sentence: 732,AIN,B-Disease
Sentence: 732,.,O
Sentence: 733,Neuroleptic,B-Disease
Sentence: 733,malignant,I-Disease
Sentence: 733,syndrome,I-Disease
Sentence: 733,complicated,O
Sentence: 733,by,O
Sentence: 733,massive,O
Sentence: 733,intestinal,O
Sentence: 733,bleeding,B-Disease
Sentence: 733,in,O
Sentence: 733,a,O
Sentence: 733,patient,O
Sentence: 733,with,O
Sentence: 733,chronic,B-Disease
Sentence: 733,renal,I-Disease
Sentence: 733,failure,I-Disease
Sentence: 733,.,O
Sentence: 734,A,O
Sentence: 734,patient,O
Sentence: 734,with,O
Sentence: 734,chronic,B-Disease
Sentence: 734,renal,I-Disease
Sentence: 734,failure,I-Disease
Sentence: 734,(,O
Sentence: 734,CRF,B-Disease
Sentence: 734,),O
Sentence: 734,developed,O
Sentence: 734,neuroleptic,B-Disease
Sentence: 734,malignant,I-Disease
Sentence: 734,syndrome,I-Disease
Sentence: 734,(,O
Sentence: 734,NMS,B-Disease
Sentence: 734,),O
Sentence: 734,after,O
Sentence: 734,administration,O
Sentence: 734,of,O
Sentence: 734,risperidone,B-Chemical
Sentence: 734,and,O
Sentence: 734,levomepromazine,B-Chemical
Sentence: 734,.,O
Sentence: 734,In,O
Sentence: 734,addition,O
Sentence: 734,to,O
Sentence: 734,the,O
Sentence: 734,typical,O
Sentence: 734,symptoms,O
Sentence: 734,of,O
Sentence: 734,NMS,B-Disease
Sentence: 734,",",O
Sentence: 734,massive,O
Sentence: 734,intestinal,O
Sentence: 734,bleeding,B-Disease
Sentence: 734,was,O
Sentence: 734,observed,O
Sentence: 734,during,O
Sentence: 734,the,O
Sentence: 734,episode,O
Sentence: 734,.,O
Sentence: 734,This,O
Sentence: 734,report,O
Sentence: 734,suggests,O
Sentence: 734,that,O
Sentence: 734,NMS,B-Disease
Sentence: 734,in,O
Sentence: 734,a,O
Sentence: 734,patient,O
Sentence: 734,with,O
Sentence: 734,CRF,B-Disease
Sentence: 734,may,O
Sentence: 734,be,O
Sentence: 734,complicated,O
Sentence: 734,by,O
Sentence: 734,intestinal,O
Sentence: 734,bleeding,B-Disease
Sentence: 734,and,O
Sentence: 734,needs,O
Sentence: 734,special,O
Sentence: 734,caution,O
Sentence: 734,for,O
Sentence: 734,this,O
Sentence: 734,complication,O
Sentence: 734,.,O
Sentence: 735,Blood,O
Sentence: 735,brain,O
Sentence: 735,barrier,O
Sentence: 735,in,O
Sentence: 735,right,O
Sentence: 735,-,O
Sentence: 735,,O
Sentence: 735,and,O
Sentence: 735,left,O
Sentence: 735,-,O
Sentence: 735,pawed,O
Sentence: 735,female,O
Sentence: 735,rats,O
Sentence: 735,assessed,O
Sentence: 735,by,O
Sentence: 735,a,O
Sentence: 735,new,O
Sentence: 735,staining,O
Sentence: 735,method,O
Sentence: 735,.,O
Sentence: 736,The,O
Sentence: 736,asymmetrical,O
Sentence: 736,breakdown,O
Sentence: 736,of,O
Sentence: 736,the,O
Sentence: 736,blood,O
Sentence: 736,-,O
Sentence: 736,brain,O
Sentence: 736,barrier,O
Sentence: 736,(,O
Sentence: 736,BBB,O
Sentence: 736,),O
Sentence: 736,was,O
Sentence: 736,studied,O
Sentence: 736,in,O
Sentence: 736,female,O
Sentence: 736,rats,O
Sentence: 736,.,O
Sentence: 736,Paw,O
Sentence: 736,preference,O
Sentence: 736,was,O
Sentence: 736,assessed,O
Sentence: 736,by,O
Sentence: 736,a,O
Sentence: 736,food,O
Sentence: 736,reaching,O
Sentence: 736,test,O
Sentence: 736,.,O
Sentence: 736,Adrenaline,B-Chemical
Sentence: 736,-,O
Sentence: 736,induced,O
Sentence: 736,hypertension,B-Disease
Sentence: 736,was,O
Sentence: 736,used,O
Sentence: 736,to,O
Sentence: 736,destroy,O
Sentence: 736,the,O
Sentence: 736,BBB,O
Sentence: 736,",",O
Sentence: 736,which,O
Sentence: 736,was,O
Sentence: 736,evaluated,O
Sentence: 736,using,O
Sentence: 736,triphenyltetrazolium,B-Chemical
Sentence: 736,(,O
Sentence: 736,TTC,B-Chemical
Sentence: 736,),O
Sentence: 736,staining,O
Sentence: 736,of,O
Sentence: 736,the,O
Sentence: 736,brain,O
Sentence: 736,slices,O
Sentence: 736,just,O
Sentence: 736,after,O
Sentence: 736,giving,O
Sentence: 736,adrenaline,B-Chemical
Sentence: 736,for,O
Sentence: 736,30,O
Sentence: 736,s.,O
Sentence: 736,In,O
Sentence: 736,normal,O
Sentence: 736,rats,O
Sentence: 736,",",O
Sentence: 736,the,O
Sentence: 736,whole,O
Sentence: 736,brain,O
Sentence: 736,sections,O
Sentence: 736,exhibited,O
Sentence: 736,complete,O
Sentence: 736,staining,O
Sentence: 736,with,O
Sentence: 736,TTC,B-Chemical
Sentence: 736,.,O
Sentence: 736,After,O
Sentence: 736,adrenaline,B-Chemical
Sentence: 736,infusion,O
Sentence: 736,for,O
Sentence: 736,30,O
Sentence: 736,s,O
Sentence: 736,",",O
Sentence: 736,there,O
Sentence: 736,were,O
Sentence: 736,large,O
Sentence: 736,unstained,O
Sentence: 736,areas,O
Sentence: 736,in,O
Sentence: 736,the,O
Sentence: 736,left,O
Sentence: 736,brain,O
Sentence: 736,in,O
Sentence: 736,right,O
Sentence: 736,-,O
Sentence: 736,pawed,O
Sentence: 736,animals,O
Sentence: 736,",",O
Sentence: 736,and,O
Sentence: 736,vice,O
Sentence: 736,versa,O
Sentence: 736,in,O
Sentence: 736,left,O
Sentence: 736,-,O
Sentence: 736,pawed,O
Sentence: 736,animals,O
Sentence: 736,.,O
Sentence: 736,Similar,O
Sentence: 736,results,O
Sentence: 736,were,O
Sentence: 736,obtained,O
Sentence: 736,in,O
Sentence: 736,seizure,B-Disease
Sentence: 736,-,O
Sentence: 736,induced,O
Sentence: 736,breakdown,O
Sentence: 736,of,O
Sentence: 736,BBB,O
Sentence: 736,.,O
Sentence: 736,These,O
Sentence: 736,results,O
Sentence: 736,were,O
Sentence: 736,explained,O
Sentence: 736,by,O
Sentence: 736,an,O
Sentence: 736,asymmetric,O
Sentence: 736,cerebral,O
Sentence: 736,blood,O
Sentence: 736,flow,O
Sentence: 736,depending,O
Sentence: 736,upon,O
Sentence: 736,the,O
Sentence: 736,paw,O
Sentence: 736,preference,O
Sentence: 736,in,O
Sentence: 736,rats,O
Sentence: 736,.,O
Sentence: 736,It,O
Sentence: 736,was,O
Sentence: 736,suggested,O
Sentence: 736,that,O
Sentence: 736,this,O
Sentence: 736,new,O
Sentence: 736,method,O
Sentence: 736,and,O
Sentence: 736,the,O
Sentence: 736,results,O
Sentence: 736,are,O
Sentence: 736,consistent,O
Sentence: 736,with,O
Sentence: 736,contralateral,O
Sentence: 736,motor,O
Sentence: 736,control,O
Sentence: 736,that,O
Sentence: 736,may,O
Sentence: 736,be,O
Sentence: 736,important,O
Sentence: 736,in,O
Sentence: 736,determining,O
Sentence: 736,the,O
Sentence: 736,dominant,O
Sentence: 736,cerebral,O
Sentence: 736,hemisphere,O
Sentence: 736,in,O
Sentence: 736,animals,O
Sentence: 736,.,O
Sentence: 737,Carvedilol,B-Chemical
Sentence: 737,protects,O
Sentence: 737,against,O
Sentence: 737,doxorubicin,B-Chemical
Sentence: 737,-,O
Sentence: 737,induced,O
Sentence: 737,mitochondrial,O
Sentence: 737,cardiomyopathy,B-Disease
Sentence: 737,.,O
Sentence: 738,Several,O
Sentence: 738,cytopathic,O
Sentence: 738,mechanisms,O
Sentence: 738,have,O
Sentence: 738,been,O
Sentence: 738,suggested,O
Sentence: 738,to,O
Sentence: 738,mediate,O
Sentence: 738,the,O
Sentence: 738,dose,O
Sentence: 738,-,O
Sentence: 738,limiting,O
Sentence: 738,cumulative,O
Sentence: 738,and,O
Sentence: 738,irreversible,O
Sentence: 738,cardiomyopathy,B-Disease
Sentence: 738,caused,O
Sentence: 738,by,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,.,O
Sentence: 738,Recent,O
Sentence: 738,evidence,O
Sentence: 738,indicates,O
Sentence: 738,that,O
Sentence: 738,oxidative,O
Sentence: 738,stress,O
Sentence: 738,and,O
Sentence: 738,mitochondrial,B-Disease
Sentence: 738,dysfunction,I-Disease
Sentence: 738,are,O
Sentence: 738,key,O
Sentence: 738,factors,O
Sentence: 738,in,O
Sentence: 738,the,O
Sentence: 738,pathogenic,O
Sentence: 738,process,O
Sentence: 738,.,O
Sentence: 738,The,O
Sentence: 738,objective,O
Sentence: 738,of,O
Sentence: 738,this,O
Sentence: 738,investigation,O
Sentence: 738,was,O
Sentence: 738,to,O
Sentence: 738,test,O
Sentence: 738,the,O
Sentence: 738,hypothesis,O
Sentence: 738,that,O
Sentence: 738,carvedilol,B-Chemical
Sentence: 738,",",O
Sentence: 738,a,O
Sentence: 738,nonselective,O
Sentence: 738,beta,O
Sentence: 738,-,O
Sentence: 738,adrenergic,O
Sentence: 738,receptor,O
Sentence: 738,antagonist,O
Sentence: 738,with,O
Sentence: 738,potent,O
Sentence: 738,antioxidant,O
Sentence: 738,properties,O
Sentence: 738,",",O
Sentence: 738,protects,O
Sentence: 738,against,O
Sentence: 738,the,O
Sentence: 738,cardiac,O
Sentence: 738,and,O
Sentence: 738,hepatic,O
Sentence: 738,mitochondrial,O
Sentence: 738,bioenergetic,O
Sentence: 738,dysfunction,O
Sentence: 738,associated,O
Sentence: 738,with,O
Sentence: 738,subchronic,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,toxicity,B-Disease
Sentence: 738,.,O
Sentence: 738,Heart,O
Sentence: 738,and,O
Sentence: 738,liver,O
Sentence: 738,mitochondria,O
Sentence: 738,were,O
Sentence: 738,isolated,O
Sentence: 738,from,O
Sentence: 738,rats,O
Sentence: 738,treated,O
Sentence: 738,for,O
Sentence: 738,7,O
Sentence: 738,weeks,O
Sentence: 738,with,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,(,O
Sentence: 738,2,O
Sentence: 738,mg,O
Sentence: 738,/,O
Sentence: 738,kg,O
Sentence: 738,sc,O
Sentence: 738,/,O
Sentence: 738,week,O
Sentence: 738,),O
Sentence: 738,",",O
Sentence: 738,carvedilol,B-Chemical
Sentence: 738,(,O
Sentence: 738,1,O
Sentence: 738,mg,O
Sentence: 738,/,O
Sentence: 738,kg,O
Sentence: 738,ip,O
Sentence: 738,/,O
Sentence: 738,week,O
Sentence: 738,),O
Sentence: 738,",",O
Sentence: 738,or,O
Sentence: 738,the,O
Sentence: 738,combination,O
Sentence: 738,of,O
Sentence: 738,the,O
Sentence: 738,two,O
Sentence: 738,drugs,O
Sentence: 738,.,O
Sentence: 738,Heart,O
Sentence: 738,mitochondria,O
Sentence: 738,isolated,O
Sentence: 738,from,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,-,O
Sentence: 738,treated,O
Sentence: 738,rats,O
Sentence: 738,exhibited,O
Sentence: 738,depressed,O
Sentence: 738,rates,O
Sentence: 738,for,O
Sentence: 738,state,O
Sentence: 738,3,O
Sentence: 738,respiration,O
Sentence: 738,(,O
Sentence: 738,336,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,26,O
Sentence: 738,versus,O
Sentence: 738,425,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,53,O
Sentence: 738,natom,O
Sentence: 738,O,O
Sentence: 738,/,O
Sentence: 738,min,O
Sentence: 738,/,O
Sentence: 738,mg,O
Sentence: 738,protein,O
Sentence: 738,),O
Sentence: 738,and,O
Sentence: 738,a,O
Sentence: 738,lower,O
Sentence: 738,respiratory,O
Sentence: 738,control,O
Sentence: 738,ratio,O
Sentence: 738,(,O
Sentence: 738,RCR,O
Sentence: 738,),O
Sentence: 738,(,O
Sentence: 738,4.3,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,0.6,O
Sentence: 738,versus,O
Sentence: 738,5.8,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,0.4,O
Sentence: 738,),O
Sentence: 738,compared,O
Sentence: 738,with,O
Sentence: 738,cardiac,O
Sentence: 738,mitochondria,O
Sentence: 738,isolated,O
Sentence: 738,from,O
Sentence: 738,saline,O
Sentence: 738,-,O
Sentence: 738,treated,O
Sentence: 738,rats,O
Sentence: 738,.,O
Sentence: 738,Mitochondrial,O
Sentence: 738,calcium,B-Chemical
Sentence: 738,-,O
Sentence: 738,loading,O
Sentence: 738,capacity,O
Sentence: 738,and,O
Sentence: 738,the,O
Sentence: 738,activity,O
Sentence: 738,of,O
Sentence: 738,NADH,O
Sentence: 738,-,O
Sentence: 738,dehydrogenase,O
Sentence: 738,were,O
Sentence: 738,also,O
Sentence: 738,suppressed,O
Sentence: 738,in,O
Sentence: 738,cardiac,O
Sentence: 738,mitochondria,O
Sentence: 738,from,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,-,O
Sentence: 738,treated,O
Sentence: 738,rats,O
Sentence: 738,.,O
Sentence: 738,Doxorubicin,B-Chemical
Sentence: 738,treatment,O
Sentence: 738,also,O
Sentence: 738,caused,O
Sentence: 738,a,O
Sentence: 738,decrease,O
Sentence: 738,in,O
Sentence: 738,RCR,O
Sentence: 738,for,O
Sentence: 738,liver,O
Sentence: 738,mitochondria,O
Sentence: 738,(,O
Sentence: 738,3.9,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,0.9,O
Sentence: 738,versus,O
Sentence: 738,5.6,O
Sentence: 738,+,O
Sentence: 738,/,O
Sentence: 738,,O
Sentence: 738,-,O
Sentence: 738,,O
Sentence: 738,0.7,O
Sentence: 738,for,O
Sentence: 738,control,O
Sentence: 738,rats,O
Sentence: 738,),O
Sentence: 738,and,O
Sentence: 738,inhibition,O
Sentence: 738,of,O
Sentence: 738,hepatic,O
Sentence: 738,cytochrome,O
Sentence: 738,oxidase,O
Sentence: 738,activity,O
Sentence: 738,.,O
Sentence: 738,Coadministration,O
Sentence: 738,of,O
Sentence: 738,carvedilol,B-Chemical
Sentence: 738,decreased,O
Sentence: 738,the,O
Sentence: 738,extent,O
Sentence: 738,of,O
Sentence: 738,cellular,O
Sentence: 738,vacuolization,O
Sentence: 738,in,O
Sentence: 738,cardiac,O
Sentence: 738,myocytes,O
Sentence: 738,and,O
Sentence: 738,prevented,O
Sentence: 738,the,O
Sentence: 738,inhibitory,O
Sentence: 738,effect,O
Sentence: 738,of,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,on,O
Sentence: 738,mitochondrial,O
Sentence: 738,respiration,O
Sentence: 738,in,O
Sentence: 738,both,O
Sentence: 738,heart,O
Sentence: 738,and,O
Sentence: 738,liver,O
Sentence: 738,.,O
Sentence: 738,Carvedilol,B-Chemical
Sentence: 738,also,O
Sentence: 738,prevented,O
Sentence: 738,the,O
Sentence: 738,decrease,O
Sentence: 738,in,O
Sentence: 738,mitochondrial,O
Sentence: 738,Ca,B-Chemical
Sentence: 738,(,O
Sentence: 738,2+,O
Sentence: 738,),O
Sentence: 738,loading,O
Sentence: 738,capacity,O
Sentence: 738,and,O
Sentence: 738,the,O
Sentence: 738,inhibition,O
Sentence: 738,of,O
Sentence: 738,the,O
Sentence: 738,respiratory,O
Sentence: 738,complexes,O
Sentence: 738,of,O
Sentence: 738,heart,O
Sentence: 738,mitochondria,O
Sentence: 738,caused,O
Sentence: 738,by,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,.,O
Sentence: 738,Carvedilol,B-Chemical
Sentence: 738,by,O
Sentence: 738,itself,O
Sentence: 738,did,O
Sentence: 738,not,O
Sentence: 738,affect,O
Sentence: 738,any,O
Sentence: 738,of,O
Sentence: 738,the,O
Sentence: 738,parameters,O
Sentence: 738,measured,O
Sentence: 738,for,O
Sentence: 738,heart,O
Sentence: 738,or,O
Sentence: 738,liver,O
Sentence: 738,mitochondria,O
Sentence: 738,.,O
Sentence: 738,It,O
Sentence: 738,is,O
Sentence: 738,concluded,O
Sentence: 738,that,O
Sentence: 738,this,O
Sentence: 738,protection,O
Sentence: 738,by,O
Sentence: 738,carvedilol,B-Chemical
Sentence: 738,against,O
Sentence: 738,both,O
Sentence: 738,the,O
Sentence: 738,structural,O
Sentence: 738,and,O
Sentence: 738,functional,O
Sentence: 738,cardiac,O
Sentence: 738,tissue,O
Sentence: 738,damage,O
Sentence: 738,may,O
Sentence: 738,afford,O
Sentence: 738,significant,O
Sentence: 738,clinical,O
Sentence: 738,advantage,O
Sentence: 738,in,O
Sentence: 738,minimizing,O
Sentence: 738,the,O
Sentence: 738,dose,O
Sentence: 738,-,O
Sentence: 738,limiting,O
Sentence: 738,mitochondrial,B-Disease
Sentence: 738,dysfunction,I-Disease
Sentence: 738,and,O
Sentence: 738,cardiomyopathy,B-Disease
Sentence: 738,that,O
Sentence: 738,accompanies,O
Sentence: 738,long,O
Sentence: 738,-,O
Sentence: 738,term,O
Sentence: 738,doxorubicin,B-Chemical
Sentence: 738,therapy,O
Sentence: 738,in,O
Sentence: 738,cancer,B-Disease
Sentence: 738,patients,O
Sentence: 738,.,O
Sentence: 739,Cocaine,B-Chemical
Sentence: 739,-,O
Sentence: 739,induced,O
Sentence: 739,hyperactivity,B-Disease
Sentence: 739,is,O
Sentence: 739,more,O
Sentence: 739,influenced,O
Sentence: 739,by,O
Sentence: 739,adenosine,B-Chemical
Sentence: 739,receptor,O
Sentence: 739,agonists,O
Sentence: 739,than,O
Sentence: 739,amphetamine,B-Chemical
Sentence: 739,-,O
Sentence: 739,induced,O
Sentence: 739,hyperactivity,B-Disease
Sentence: 739,.,O
Sentence: 740,The,O
Sentence: 740,influence,O
Sentence: 740,of,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,and,O
Sentence: 740,antagonists,O
Sentence: 740,on,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,and,O
Sentence: 740,amphetamine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,hyperactivity,B-Disease
Sentence: 740,was,O
Sentence: 740,examined,O
Sentence: 740,in,O
Sentence: 740,mice,O
Sentence: 740,.,O
Sentence: 740,All,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,significantly,O
Sentence: 740,decreased,B-Disease
Sentence: 740,the,I-Disease
Sentence: 740,locomotor,I-Disease
Sentence: 740,activity,I-Disease
Sentence: 740,in,O
Sentence: 740,mice,O
Sentence: 740,",",O
Sentence: 740,and,O
Sentence: 740,the,O
Sentence: 740,effects,O
Sentence: 740,were,O
Sentence: 740,dose,O
Sentence: 740,-,O
Sentence: 740,dependent,O
Sentence: 740,.,O
Sentence: 740,It,O
Sentence: 740,seems,O
Sentence: 740,that,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,A1,O
Sentence: 740,and,O
Sentence: 740,A2,O
Sentence: 740,receptors,O
Sentence: 740,might,O
Sentence: 740,be,O
Sentence: 740,involved,O
Sentence: 740,in,O
Sentence: 740,this,O
Sentence: 740,reaction,O
Sentence: 740,.,O
Sentence: 740,Moreover,O
Sentence: 740,",",O
Sentence: 740,all,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,:,O
Sentence: 740,2,O
Sentence: 740,-,O
Sentence: 740,p,O
Sentence: 740,-,O
Sentence: 740,,O
Sentence: 740,(,O
Sentence: 740,2,O
Sentence: 740,-,O
Sentence: 740,carboxyethyl,O
Sentence: 740,),O
Sentence: 740,phenethylamino,O
Sentence: 740,-,O
Sentence: 740,5',O
Sentence: 740,-,O
Sentence: 740,N,O
Sentence: 740,-,O
Sentence: 740,ethylcarboxamidoadenosine,O
Sentence: 740,(,O
Sentence: 740,CGS,B-Chemical
Sentence: 740,21680,I-Chemical
Sentence: 740,),O
Sentence: 740,",",O
Sentence: 740,A2A,O
Sentence: 740,receptor,O
Sentence: 740,agonist,O
Sentence: 740,",",O
Sentence: 740,N6,O
Sentence: 740,-,O
Sentence: 740,cyclopentyladenosine,O
Sentence: 740,(,O
Sentence: 740,CPA,B-Chemical
Sentence: 740,),O
Sentence: 740,",",O
Sentence: 740,A1,O
Sentence: 740,receptor,O
Sentence: 740,agonist,O
Sentence: 740,",",O
Sentence: 740,and,O
Sentence: 740,5',O
Sentence: 740,-,O
Sentence: 740,N,O
Sentence: 740,-,O
Sentence: 740,ethylcarboxamidoadenosine,O
Sentence: 740,(,O
Sentence: 740,NECA,B-Chemical
Sentence: 740,),O
Sentence: 740,",",O
Sentence: 740,A2,O
Sentence: 740,/,O
Sentence: 740,A1,O
Sentence: 740,receptor,O
Sentence: 740,agonist,O
Sentence: 740,significantly,O
Sentence: 740,and,O
Sentence: 740,dose,O
Sentence: 740,-,O
Sentence: 740,dependently,O
Sentence: 740,decreased,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,locomotor,O
Sentence: 740,activity,O
Sentence: 740,.,O
Sentence: 740,CPA,B-Chemical
Sentence: 740,reduced,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,action,O
Sentence: 740,at,O
Sentence: 740,the,O
Sentence: 740,doses,O
Sentence: 740,which,O
Sentence: 740,",",O
Sentence: 740,given,O
Sentence: 740,alone,O
Sentence: 740,",",O
Sentence: 740,did,O
Sentence: 740,not,O
Sentence: 740,influence,O
Sentence: 740,motility,O
Sentence: 740,",",O
Sentence: 740,while,O
Sentence: 740,CGS,B-Chemical
Sentence: 740,21680,I-Chemical
Sentence: 740,and,O
Sentence: 740,NECA,B-Chemical
Sentence: 740,decreased,O
Sentence: 740,the,O
Sentence: 740,action,O
Sentence: 740,of,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,at,O
Sentence: 740,the,O
Sentence: 740,doses,O
Sentence: 740,which,O
Sentence: 740,",",O
Sentence: 740,given,O
Sentence: 740,alone,O
Sentence: 740,",",O
Sentence: 740,decreased,O
Sentence: 740,locomotor,O
Sentence: 740,activity,O
Sentence: 740,in,O
Sentence: 740,animals,O
Sentence: 740,.,O
Sentence: 740,These,O
Sentence: 740,results,O
Sentence: 740,suggest,O
Sentence: 740,the,O
Sentence: 740,involvement,O
Sentence: 740,of,O
Sentence: 740,both,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptors,O
Sentence: 740,in,O
Sentence: 740,the,O
Sentence: 740,action,O
Sentence: 740,of,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,although,O
Sentence: 740,agonists,O
Sentence: 740,of,O
Sentence: 740,A1,O
Sentence: 740,receptors,O
Sentence: 740,seem,O
Sentence: 740,to,O
Sentence: 740,have,O
Sentence: 740,stronger,O
Sentence: 740,influence,O
Sentence: 740,on,O
Sentence: 740,it,O
Sentence: 740,.,O
Sentence: 740,The,O
Sentence: 740,selective,O
Sentence: 740,blockade,O
Sentence: 740,of,O
Sentence: 740,A2,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,by,O
Sentence: 740,DMPX,B-Chemical
Sentence: 740,(,O
Sentence: 740,"3,7",O
Sentence: 740,-,O
Sentence: 740,dimethyl,O
Sentence: 740,-,O
Sentence: 740,1,O
Sentence: 740,-,O
Sentence: 740,propargylxanthine,O
Sentence: 740,),O
Sentence: 740,significantly,O
Sentence: 740,enhanced,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,locomotor,O
Sentence: 740,activity,O
Sentence: 740,of,O
Sentence: 740,animals,O
Sentence: 740,.,O
Sentence: 740,Caffeine,B-Chemical
Sentence: 740,had,O
Sentence: 740,similar,O
Sentence: 740,action,O
Sentence: 740,but,O
Sentence: 740,the,O
Sentence: 740,effect,O
Sentence: 740,was,O
Sentence: 740,not,O
Sentence: 740,significant,O
Sentence: 740,.,O
Sentence: 740,CPT,B-Chemical
Sentence: 740,(,O
Sentence: 740,8,O
Sentence: 740,-,O
Sentence: 740,cyclopentyltheophylline,O
Sentence: 740,),O
Sentence: 740,,O
Sentence: 740,-,O
Sentence: 740,,O
Sentence: 740,-,O
Sentence: 740,,O
Sentence: 740,A1,O
Sentence: 740,receptor,O
Sentence: 740,antagonist,O
Sentence: 740,",",O
Sentence: 740,did,O
Sentence: 740,not,O
Sentence: 740,show,O
Sentence: 740,any,O
Sentence: 740,influence,O
Sentence: 740,in,O
Sentence: 740,this,O
Sentence: 740,test,O
Sentence: 740,.,O
Sentence: 740,Similarly,O
Sentence: 740,",",O
Sentence: 740,all,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,decreased,O
Sentence: 740,amphetamine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,hyperactivity,B-Disease
Sentence: 740,",",O
Sentence: 740,but,O
Sentence: 740,at,O
Sentence: 740,the,O
Sentence: 740,higher,O
Sentence: 740,doses,O
Sentence: 740,than,O
Sentence: 740,those,O
Sentence: 740,which,O
Sentence: 740,were,O
Sentence: 740,active,O
Sentence: 740,in,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,hyperactivity,B-Disease
Sentence: 740,.,O
Sentence: 740,The,O
Sentence: 740,selective,O
Sentence: 740,blockade,O
Sentence: 740,of,O
Sentence: 740,A2,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptors,O
Sentence: 740,(,O
Sentence: 740,DMPX,B-Chemical
Sentence: 740,),O
Sentence: 740,and,O
Sentence: 740,non,O
Sentence: 740,-,O
Sentence: 740,selective,O
Sentence: 740,blockade,O
Sentence: 740,of,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptors,O
Sentence: 740,(,O
Sentence: 740,caffeine,B-Chemical
Sentence: 740,),O
Sentence: 740,significantly,O
Sentence: 740,increased,O
Sentence: 740,the,O
Sentence: 740,action,O
Sentence: 740,of,O
Sentence: 740,amphetamine,B-Chemical
Sentence: 740,in,O
Sentence: 740,the,O
Sentence: 740,locomotor,O
Sentence: 740,activity,O
Sentence: 740,test,O
Sentence: 740,.,O
Sentence: 740,Our,O
Sentence: 740,results,O
Sentence: 740,have,O
Sentence: 740,shown,O
Sentence: 740,that,O
Sentence: 740,all,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,(,O
Sentence: 740,A1,O
Sentence: 740,and,O
Sentence: 740,A2,O
Sentence: 740,),O
Sentence: 740,reduce,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,,O
Sentence: 740,and,O
Sentence: 740,amphetamine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,locomotor,O
Sentence: 740,activity,O
Sentence: 740,and,O
Sentence: 740,indicate,O
Sentence: 740,that,O
Sentence: 740,cocaine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,hyperactivity,B-Disease
Sentence: 740,is,O
Sentence: 740,more,O
Sentence: 740,influenced,O
Sentence: 740,by,O
Sentence: 740,adenosine,B-Chemical
Sentence: 740,receptor,O
Sentence: 740,agonists,O
Sentence: 740,(,O
Sentence: 740,particularly,O
Sentence: 740,A1,O
Sentence: 740,receptors,O
Sentence: 740,),O
Sentence: 740,than,O
Sentence: 740,amphetamine,B-Chemical
Sentence: 740,-,O
Sentence: 740,induced,O
Sentence: 740,hyperactivity,B-Disease
Sentence: 740,.,O
Sentence: 741,Amiodarone,B-Chemical
Sentence: 741,and,O
Sentence: 741,the,O
Sentence: 741,risk,O
Sentence: 741,of,O
Sentence: 741,bradyarrhythmia,B-Disease
Sentence: 741,requiring,O
Sentence: 741,permanent,O
Sentence: 741,pacemaker,O
Sentence: 741,in,O
Sentence: 741,elderly,O
Sentence: 741,patients,O
Sentence: 741,with,O
Sentence: 741,atrial,B-Disease
Sentence: 741,fibrillation,I-Disease
Sentence: 741,and,O
Sentence: 741,prior,O
Sentence: 741,myocardial,B-Disease
Sentence: 741,infarction,I-Disease
Sentence: 741,.,O
Sentence: 742,OBJECTIVES,O
Sentence: 742,:,O
Sentence: 742,The,O
Sentence: 742,aim,O
Sentence: 742,of,O
Sentence: 742,this,O
Sentence: 742,study,O
Sentence: 742,was,O
Sentence: 742,to,O
Sentence: 742,determine,O
Sentence: 742,whether,O
Sentence: 742,the,O
Sentence: 742,use,O
Sentence: 742,of,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,in,O
Sentence: 742,patients,O
Sentence: 742,with,O
Sentence: 742,atrial,B-Disease
Sentence: 742,fibrillation,I-Disease
Sentence: 742,(,O
Sentence: 742,AF,B-Disease
Sentence: 742,),O
Sentence: 742,increases,O
Sentence: 742,the,O
Sentence: 742,risk,O
Sentence: 742,of,O
Sentence: 742,bradyarrhythmia,B-Disease
Sentence: 742,requiring,O
Sentence: 742,a,O
Sentence: 742,permanent,O
Sentence: 742,pacemaker,O
Sentence: 742,.,O
Sentence: 742,BACKGROUND,O
Sentence: 742,:,O
Sentence: 742,Reports,O
Sentence: 742,of,O
Sentence: 742,severe,O
Sentence: 742,bradyarrhythmia,B-Disease
Sentence: 742,during,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,therapy,O
Sentence: 742,are,O
Sentence: 742,infrequent,O
Sentence: 742,and,O
Sentence: 742,limited,O
Sentence: 742,to,O
Sentence: 742,studies,O
Sentence: 742,assessing,O
Sentence: 742,the,O
Sentence: 742,therapy,O
Sentence: 742,'s,O
Sentence: 742,use,O
Sentence: 742,in,O
Sentence: 742,the,O
Sentence: 742,management,O
Sentence: 742,of,O
Sentence: 742,patients,O
Sentence: 742,with,O
Sentence: 742,ventricular,B-Disease
Sentence: 742,arrhythmias,I-Disease
Sentence: 742,.,O
Sentence: 742,METHODS,O
Sentence: 742,:,O
Sentence: 742,A,O
Sentence: 742,study,O
Sentence: 742,cohort,O
Sentence: 742,of,O
Sentence: 742,"8,770",O
Sentence: 742,patients,O
Sentence: 742,age,O
Sentence: 742,,O
Sentence: 742,>,O
Sentence: 742,,O
Sentence: 742,or,O
Sentence: 742,,O
Sentence: 742,=,O
Sentence: 742,65,O
Sentence: 742,years,O
Sentence: 742,with,O
Sentence: 742,a,O
Sentence: 742,new,O
Sentence: 742,diagnosis,O
Sentence: 742,of,O
Sentence: 742,AF,B-Disease
Sentence: 742,was,O
Sentence: 742,identified,O
Sentence: 742,from,O
Sentence: 742,a,O
Sentence: 742,provincewide,O
Sentence: 742,database,O
Sentence: 742,of,O
Sentence: 742,Quebec,O
Sentence: 742,residents,O
Sentence: 742,with,O
Sentence: 742,a,O
Sentence: 742,myocardial,B-Disease
Sentence: 742,infarction,I-Disease
Sentence: 742,(,O
Sentence: 742,MI,B-Disease
Sentence: 742,),O
Sentence: 742,between,O
Sentence: 742,1991,O
Sentence: 742,and,O
Sentence: 742,1999,O
Sentence: 742,.,O
Sentence: 742,Using,O
Sentence: 742,a,O
Sentence: 742,nested,O
Sentence: 742,case,O
Sentence: 742,-,O
Sentence: 742,control,O
Sentence: 742,design,O
Sentence: 742,",",O
Sentence: 742,477,O
Sentence: 742,cases,O
Sentence: 742,of,O
Sentence: 742,bradyarrhythmia,B-Disease
Sentence: 742,requiring,O
Sentence: 742,a,O
Sentence: 742,permanent,O
Sentence: 742,pacemaker,O
Sentence: 742,were,O
Sentence: 742,matched,O
Sentence: 742,(,O
Sentence: 742,1:4,O
Sentence: 742,),O
Sentence: 742,to,O
Sentence: 742,"1,908",O
Sentence: 742,controls,O
Sentence: 742,.,O
Sentence: 742,Multivariable,O
Sentence: 742,logistic,O
Sentence: 742,regression,O
Sentence: 742,was,O
Sentence: 742,used,O
Sentence: 742,to,O
Sentence: 742,estimate,O
Sentence: 742,the,O
Sentence: 742,odds,O
Sentence: 742,ratio,O
Sentence: 742,(,O
Sentence: 742,OR,O
Sentence: 742,),O
Sentence: 742,of,O
Sentence: 742,pacemaker,O
Sentence: 742,insertion,O
Sentence: 742,associated,O
Sentence: 742,with,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,use,O
Sentence: 742,",",O
Sentence: 742,controlling,O
Sentence: 742,for,O
Sentence: 742,baseline,O
Sentence: 742,risk,O
Sentence: 742,factors,O
Sentence: 742,and,O
Sentence: 742,exposure,O
Sentence: 742,to,O
Sentence: 742,sotalol,B-Chemical
Sentence: 742,",",O
Sentence: 742,Class,O
Sentence: 742,I,O
Sentence: 742,antiarrhythmic,O
Sentence: 742,agents,O
Sentence: 742,",",O
Sentence: 742,beta,O
Sentence: 742,-,O
Sentence: 742,blockers,O
Sentence: 742,",",O
Sentence: 742,calcium,B-Chemical
Sentence: 742,channel,O
Sentence: 742,blockers,O
Sentence: 742,",",O
Sentence: 742,and,O
Sentence: 742,digoxin,B-Chemical
Sentence: 742,.,O
Sentence: 742,RESULTS,O
Sentence: 742,:,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,use,O
Sentence: 742,was,O
Sentence: 742,associated,O
Sentence: 742,with,O
Sentence: 742,an,O
Sentence: 742,increased,O
Sentence: 742,risk,O
Sentence: 742,of,O
Sentence: 742,pacemaker,O
Sentence: 742,insertion,O
Sentence: 742,(,O
Sentence: 742,OR,O
Sentence: 742,:,O
Sentence: 742,2.14,O
Sentence: 742,",",O
Sentence: 742,95,O
Sentence: 742,%,O
Sentence: 742,confidence,O
Sentence: 742,interval,O
Sentence: 742,[,O
Sentence: 742,CI,O
Sentence: 742,],O
Sentence: 742,:,O
Sentence: 742,1.30,O
Sentence: 742,to,O
Sentence: 742,3.54,O
Sentence: 742,),O
Sentence: 742,.,O
Sentence: 742,This,O
Sentence: 742,effect,O
Sentence: 742,was,O
Sentence: 742,modified,O
Sentence: 742,by,O
Sentence: 742,gender,O
Sentence: 742,",",O
Sentence: 742,with,O
Sentence: 742,a,O
Sentence: 742,greater,O
Sentence: 742,risk,O
Sentence: 742,in,O
Sentence: 742,women,O
Sentence: 742,versus,O
Sentence: 742,men,O
Sentence: 742,(,O
Sentence: 742,OR,O
Sentence: 742,:,O
Sentence: 742,3.86,O
Sentence: 742,",",O
Sentence: 742,95,O
Sentence: 742,%,O
Sentence: 742,CI,O
Sentence: 742,:,O
Sentence: 742,1.70,O
Sentence: 742,to,O
Sentence: 742,8.75,O
Sentence: 742,vs.,O
Sentence: 742,OR,O
Sentence: 742,:,O
Sentence: 742,1.52,O
Sentence: 742,",",O
Sentence: 742,95,O
Sentence: 742,%,O
Sentence: 742,CI,O
Sentence: 742,:,O
Sentence: 742,0.80,O
Sentence: 742,to,O
Sentence: 742,2.89,O
Sentence: 742,),O
Sentence: 742,.,O
Sentence: 742,Digoxin,B-Chemical
Sentence: 742,was,O
Sentence: 742,the,O
Sentence: 742,only,O
Sentence: 742,other,O
Sentence: 742,medication,O
Sentence: 742,associated,O
Sentence: 742,with,O
Sentence: 742,an,O
Sentence: 742,increased,O
Sentence: 742,risk,O
Sentence: 742,of,O
Sentence: 742,pacemaker,O
Sentence: 742,insertion,O
Sentence: 742,(,O
Sentence: 742,OR,O
Sentence: 742,:,O
Sentence: 742,1.78,O
Sentence: 742,",",O
Sentence: 742,95,O
Sentence: 742,%,O
Sentence: 742,CI,O
Sentence: 742,:,O
Sentence: 742,1.37,O
Sentence: 742,to,O
Sentence: 742,2.31,O
Sentence: 742,),O
Sentence: 742,.,O
Sentence: 742,CONCLUSIONS,O
Sentence: 742,:,O
Sentence: 742,This,O
Sentence: 742,study,O
Sentence: 742,suggests,O
Sentence: 742,that,O
Sentence: 742,the,O
Sentence: 742,use,O
Sentence: 742,of,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,in,O
Sentence: 742,elderly,O
Sentence: 742,patients,O
Sentence: 742,with,O
Sentence: 742,AF,B-Disease
Sentence: 742,and,O
Sentence: 742,a,O
Sentence: 742,previous,O
Sentence: 742,MI,B-Disease
Sentence: 742,increases,O
Sentence: 742,the,O
Sentence: 742,risk,O
Sentence: 742,of,O
Sentence: 742,bradyarrhythmia,B-Disease
Sentence: 742,requiring,O
Sentence: 742,a,O
Sentence: 742,permanent,O
Sentence: 742,pacemaker,O
Sentence: 742,.,O
Sentence: 742,The,O
Sentence: 742,finding,O
Sentence: 742,of,O
Sentence: 742,an,O
Sentence: 742,augmented,O
Sentence: 742,risk,O
Sentence: 742,of,O
Sentence: 742,pacemaker,O
Sentence: 742,insertion,O
Sentence: 742,in,O
Sentence: 742,elderly,O
Sentence: 742,women,O
Sentence: 742,receiving,O
Sentence: 742,amiodarone,B-Chemical
Sentence: 742,requires,O
Sentence: 742,further,O
Sentence: 742,investigation,O
Sentence: 742,.,O
Sentence: 743,Indomethacin,O
Sentence: 743,-,O
Sentence: 743,induced,O
Sentence: 743,morphologic,O
Sentence: 743,changes,O
Sentence: 743,in,O
Sentence: 743,the,O
Sentence: 743,rat,O
Sentence: 743,urinary,O
Sentence: 743,bladder,O
Sentence: 743,epithelium,O
Sentence: 743,.,O
Sentence: 744,OBJECTIVES,O
Sentence: 744,:,O
Sentence: 744,To,O
Sentence: 744,evaluate,O
Sentence: 744,the,O
Sentence: 744,morphologic,O
Sentence: 744,changes,O
Sentence: 744,in,O
Sentence: 744,rat,O
Sentence: 744,urothelium,O
Sentence: 744,induced,O
Sentence: 744,by,O
Sentence: 744,indomethacin,B-Chemical
Sentence: 744,.,O
Sentence: 744,Nonsteroidal,O
Sentence: 744,anti,O
Sentence: 744,-,O
Sentence: 744,inflammatory,O
Sentence: 744,drug,O
Sentence: 744,-,O
Sentence: 744,induced,O
Sentence: 744,cystitis,B-Disease
Sentence: 744,is,O
Sentence: 744,a,O
Sentence: 744,poorly,O
Sentence: 744,recognized,O
Sentence: 744,and,O
Sentence: 744,under,O
Sentence: 744,-,O
Sentence: 744,reported,O
Sentence: 744,condition,O
Sentence: 744,.,O
Sentence: 744,In,O
Sentence: 744,addition,O
Sentence: 744,to,O
Sentence: 744,tiaprofenic,B-Chemical
Sentence: 744,acid,I-Chemical
Sentence: 744,",",O
Sentence: 744,indomethacin,B-Chemical
Sentence: 744,has,O
Sentence: 744,been,O
Sentence: 744,reported,O
Sentence: 744,to,O
Sentence: 744,be,O
Sentence: 744,associated,O
Sentence: 744,with,O
Sentence: 744,this,O
Sentence: 744,condition,O
Sentence: 744,.,O
Sentence: 744,METHODS,O
Sentence: 744,:,O
Sentence: 744,Three,O
Sentence: 744,groups,O
Sentence: 744,were,O
Sentence: 744,established,O
Sentence: 744,:,O
Sentence: 744,a,O
Sentence: 744,control,O
Sentence: 744,group,O
Sentence: 744,(,O
Sentence: 744,n,O
Sentence: 744,,O
Sentence: 744,=,O
Sentence: 744,,O
Sentence: 744,10,O
Sentence: 744,),O
Sentence: 744,",",O
Sentence: 744,a,O
Sentence: 744,high,O
Sentence: 744,-,O
Sentence: 744,dose,O
Sentence: 744,group,O
Sentence: 744,(,O
Sentence: 744,n,O
Sentence: 744,,O
Sentence: 744,=,O
Sentence: 744,,O
Sentence: 744,10,O
Sentence: 744,),O
Sentence: 744,",",O
Sentence: 744,treated,O
Sentence: 744,with,O
Sentence: 744,one,O
Sentence: 744,intraperitoneal,O
Sentence: 744,injection,O
Sentence: 744,of,O
Sentence: 744,indomethacin,B-Chemical
Sentence: 744,20,O
Sentence: 744,mg,O
Sentence: 744,/,O
Sentence: 744,kg,O
Sentence: 744,",",O
Sentence: 744,and,O
Sentence: 744,a,O
Sentence: 744,therapeutic,O
Sentence: 744,dose,O
Sentence: 744,group,O
Sentence: 744,(,O
Sentence: 744,n,O
Sentence: 744,,O
Sentence: 744,=,O
Sentence: 744,,O
Sentence: 744,10,O
Sentence: 744,),O
Sentence: 744,in,O
Sentence: 744,which,O
Sentence: 744,oral,O
Sentence: 744,indomethacin,B-Chemical
Sentence: 744,was,O
Sentence: 744,administered,O
Sentence: 744,3.25,O
Sentence: 744,mg,O
Sentence: 744,/,O
Sentence: 744,kg,O
Sentence: 744,body,O
Sentence: 744,weight,O
Sentence: 744,daily,O
Sentence: 744,for,O
Sentence: 744,3,O
Sentence: 744,weeks,O
Sentence: 744,.,O
Sentence: 744,The,O
Sentence: 744,animals,O
Sentence: 744,were,O
Sentence: 744,then,O
Sentence: 744,killed,O
Sentence: 744,and,O
Sentence: 744,the,O
Sentence: 744,bladders,O
Sentence: 744,removed,O
Sentence: 744,for,O
Sentence: 744,light,O
Sentence: 744,and,O
Sentence: 744,electron,O
Sentence: 744,microscopic,O
Sentence: 744,studies,O
Sentence: 744,.,O
Sentence: 744,RESULTS,O
Sentence: 744,:,O
Sentence: 744,The,O
Sentence: 744,light,O
Sentence: 744,microscopic,O
Sentence: 744,findings,O
Sentence: 744,showed,O
Sentence: 744,some,O
Sentence: 744,focal,O
Sentence: 744,epithelial,O
Sentence: 744,degeneration,O
Sentence: 744,that,O
Sentence: 744,was,O
Sentence: 744,more,O
Sentence: 744,prominent,O
Sentence: 744,in,O
Sentence: 744,the,O
Sentence: 744,high,O
Sentence: 744,-,O
Sentence: 744,dose,O
Sentence: 744,group,O
Sentence: 744,.,O
Sentence: 744,When,O
Sentence: 744,compared,O
Sentence: 744,with,O
Sentence: 744,the,O
Sentence: 744,control,O
Sentence: 744,group,O
Sentence: 744,",",O
Sentence: 744,both,O
Sentence: 744,indomethacin,B-Chemical
Sentence: 744,groups,O
Sentence: 744,revealed,O
Sentence: 744,statistically,O
Sentence: 744,increased,O
Sentence: 744,numbers,O
Sentence: 744,of,O
Sentence: 744,mast,O
Sentence: 744,cells,O
Sentence: 744,in,O
Sentence: 744,the,O
Sentence: 744,mucosa,O
Sentence: 744,(,O
Sentence: 744,P,O
Sentence: 744,,O
Sentence: 744,<,O
Sentence: 744,,O
Sentence: 744,0.0001,O
Sentence: 744,),O
Sentence: 744,and,O
Sentence: 744,penetration,O
Sentence: 744,of,O
Sentence: 744,lanthanum,B-Chemical
Sentence: 744,nitrate,I-Chemical
Sentence: 744,through,O
Sentence: 744,intercellular,O
Sentence: 744,areas,O
Sentence: 744,of,O
Sentence: 744,the,O
Sentence: 744,epithelium,O
Sentence: 744,.,O
Sentence: 744,Furthermore,O
Sentence: 744,",",O
Sentence: 744,the,O
Sentence: 744,difference,O
Sentence: 744,in,O
Sentence: 744,mast,O
Sentence: 744,cell,O
Sentence: 744,counts,O
Sentence: 744,between,O
Sentence: 744,the,O
Sentence: 744,high,O
Sentence: 744,and,O
Sentence: 744,therapeutic,O
Sentence: 744,dose,O
Sentence: 744,groups,O
Sentence: 744,was,O
Sentence: 744,also,O
Sentence: 744,statistically,O
Sentence: 744,significant,O
Sentence: 744,(,O
Sentence: 744,P,O
Sentence: 744,,O
Sentence: 744,<,O
Sentence: 744,,O
Sentence: 744,0.0001,O
Sentence: 744,),O
Sentence: 744,.,O
Sentence: 744,CONCLUSIONS,O
Sentence: 744,:,O
Sentence: 744,Indomethacin,B-Chemical
Sentence: 744,resulted,O
Sentence: 744,in,O
Sentence: 744,histopathologic,O
Sentence: 744,findings,O
Sentence: 744,typical,O
Sentence: 744,of,O
Sentence: 744,interstitial,B-Disease
Sentence: 744,cystitis,B-Disease
Sentence: 744,",",O
Sentence: 744,such,O
Sentence: 744,as,O
Sentence: 744,leaky,O
Sentence: 744,bladder,O
Sentence: 744,epithelium,O
Sentence: 744,and,O
Sentence: 744,mucosal,O
Sentence: 744,mastocytosis,B-Disease
Sentence: 744,.,O
Sentence: 744,The,O
Sentence: 744,true,O
Sentence: 744,incidence,O
Sentence: 744,of,O
Sentence: 744,nonsteroidal,O
Sentence: 744,anti,O
Sentence: 744,-,O
Sentence: 744,inflammatory,O
Sentence: 744,drug,O
Sentence: 744,-,O
Sentence: 744,induced,O
Sentence: 744,cystitis,B-Disease
Sentence: 744,in,O
Sentence: 744,humans,O
Sentence: 744,must,O
Sentence: 744,be,O
Sentence: 744,clarified,O
Sentence: 744,by,O
Sentence: 744,prospective,O
Sentence: 744,clinical,O
Sentence: 744,trials,O
Sentence: 744,.,O
Sentence: 745,An,O
Sentence: 745,open,O
Sentence: 745,-,O
Sentence: 745,label,O
Sentence: 745,phase,O
Sentence: 745,II,O
Sentence: 745,study,O
Sentence: 745,of,O
Sentence: 745,low,O
Sentence: 745,-,O
Sentence: 745,dose,O
Sentence: 745,thalidomide,B-Chemical
Sentence: 745,in,O
Sentence: 745,androgen,B-Chemical
Sentence: 745,-,O
Sentence: 745,independent,O
Sentence: 745,prostate,B-Disease
Sentence: 745,cancer,I-Disease
Sentence: 745,.,O
Sentence: 746,The,O
Sentence: 746,antiangiogenic,O
Sentence: 746,effects,O
Sentence: 746,of,O
Sentence: 746,thalidomide,B-Chemical
Sentence: 746,have,O
Sentence: 746,been,O
Sentence: 746,assessed,O
Sentence: 746,in,O
Sentence: 746,clinical,O
Sentence: 746,trials,O
Sentence: 746,in,O
Sentence: 746,patients,O
Sentence: 746,with,O
Sentence: 746,various,O
Sentence: 746,solid,O
Sentence: 746,and,O
Sentence: 746,haematological,B-Disease
Sentence: 746,malignancies,I-Disease
Sentence: 746,.,O
Sentence: 746,Thalidomide,B-Chemical
Sentence: 746,blocks,O
Sentence: 746,the,O
Sentence: 746,activity,O
Sentence: 746,of,O
Sentence: 746,angiogenic,O
Sentence: 746,agents,O
Sentence: 746,including,O
Sentence: 746,bFGF,O
Sentence: 746,",",O
Sentence: 746,VEGF,O
Sentence: 746,and,O
Sentence: 746,IL,O
Sentence: 746,-,O
Sentence: 746,6,O
Sentence: 746,.,O
Sentence: 746,We,O
Sentence: 746,undertook,O
Sentence: 746,an,O
Sentence: 746,open,O
Sentence: 746,-,O
Sentence: 746,label,O
Sentence: 746,study,O
Sentence: 746,using,O
Sentence: 746,thalidomide,B-Chemical
Sentence: 746,100,O
Sentence: 746,mg,O
Sentence: 746,once,O
Sentence: 746,daily,O
Sentence: 746,for,O
Sentence: 746,up,O
Sentence: 746,to,O
Sentence: 746,6,O
Sentence: 746,months,O
Sentence: 746,in,O
Sentence: 746,20,O
Sentence: 746,men,O
Sentence: 746,with,O
Sentence: 746,androgen,B-Chemical
Sentence: 746,-,O
Sentence: 746,independent,O
Sentence: 746,prostate,B-Disease
Sentence: 746,cancer,I-Disease
Sentence: 746,.,O
Sentence: 746,The,O
Sentence: 746,mean,O
Sentence: 746,time,O
Sentence: 746,of,O
Sentence: 746,study,O
Sentence: 746,was,O
Sentence: 746,109,O
Sentence: 746,days,O
Sentence: 746,(,O
Sentence: 746,median,O
Sentence: 746,107,O
Sentence: 746,",",O
Sentence: 746,range,O
Sentence: 746,4,O
Sentence: 746,-,O
Sentence: 746,184,O
Sentence: 746,days,O
Sentence: 746,),O
Sentence: 746,.,O
Sentence: 746,Patients,O
Sentence: 746,underwent,O
Sentence: 746,regular,O
Sentence: 746,measurement,O
Sentence: 746,of,O
Sentence: 746,prostate,O
Sentence: 746,-,O
Sentence: 746,specific,O
Sentence: 746,antigen,O
Sentence: 746,(,O
Sentence: 746,PSA,O
Sentence: 746,),O
Sentence: 746,",",O
Sentence: 746,urea,B-Chemical
Sentence: 746,and,O
Sentence: 746,electrolytes,O
Sentence: 746,",",O
Sentence: 746,serum,O
Sentence: 746,bFGF,O
Sentence: 746,and,O
Sentence: 746,VEGF,O
Sentence: 746,.,O
Sentence: 746,Three,O
Sentence: 746,men,O
Sentence: 746,(,O
Sentence: 746,15,O
Sentence: 746,%,O
Sentence: 746,),O
Sentence: 746,showed,O
Sentence: 746,a,O
Sentence: 746,decline,O
Sentence: 746,in,O
Sentence: 746,serum,O
Sentence: 746,PSA,O
Sentence: 746,of,O
Sentence: 746,at,O
Sentence: 746,least,O
Sentence: 746,50,O
Sentence: 746,%,O
Sentence: 746,",",O
Sentence: 746,sustained,O
Sentence: 746,throughout,O
Sentence: 746,treatment,O
Sentence: 746,.,O
Sentence: 746,Of,O
Sentence: 746,16,O
Sentence: 746,men,O
Sentence: 746,treated,O
Sentence: 746,for,O
Sentence: 746,at,O
Sentence: 746,least,O
Sentence: 746,2,O
Sentence: 746,months,O
Sentence: 746,",",O
Sentence: 746,six,O
Sentence: 746,(,O
Sentence: 746,37.5,O
Sentence: 746,%,O
Sentence: 746,),O
Sentence: 746,showed,O
Sentence: 746,a,O
Sentence: 746,fall,O
Sentence: 746,in,O
Sentence: 746,absolute,O
Sentence: 746,PSA,O
Sentence: 746,by,O
Sentence: 746,a,O
Sentence: 746,median,O
Sentence: 746,of,O
Sentence: 746,48,O
Sentence: 746,%,O
Sentence: 746,.,O
Sentence: 746,Increasing,O
Sentence: 746,levels,O
Sentence: 746,of,O
Sentence: 746,serum,O
Sentence: 746,bFGF,O
Sentence: 746,and,O
Sentence: 746,VEGF,O
Sentence: 746,were,O
Sentence: 746,associated,O
Sentence: 746,with,O
Sentence: 746,progressive,O
Sentence: 746,disease,O
Sentence: 746,;,O
Sentence: 746,five,O
Sentence: 746,of,O
Sentence: 746,six,O
Sentence: 746,men,O
Sentence: 746,who,O
Sentence: 746,demonstrated,O
Sentence: 746,a,O
Sentence: 746,fall,O
Sentence: 746,in,O
Sentence: 746,PSA,O
Sentence: 746,also,O
Sentence: 746,showed,O
Sentence: 746,a,O
Sentence: 746,decline,O
Sentence: 746,in,O
Sentence: 746,bFGF,O
Sentence: 746,and,O
Sentence: 746,VEGF,O
Sentence: 746,levels,O
Sentence: 746,",",O
Sentence: 746,and,O
Sentence: 746,three,O
Sentence: 746,of,O
Sentence: 746,four,O
Sentence: 746,men,O
Sentence: 746,with,O
Sentence: 746,a,O
Sentence: 746,rising,O
Sentence: 746,PSA,O
Sentence: 746,showed,O
Sentence: 746,an,O
Sentence: 746,increase,O
Sentence: 746,in,O
Sentence: 746,both,O
Sentence: 746,growth,O
Sentence: 746,factors,O
Sentence: 746,.,O
Sentence: 746,Adverse,O
Sentence: 746,effects,O
Sentence: 746,included,O
Sentence: 746,constipation,B-Disease
Sentence: 746,",",O
Sentence: 746,morning,O
Sentence: 746,drowsiness,B-Disease
Sentence: 746,",",O
Sentence: 746,dizziness,B-Disease
Sentence: 746,and,O
Sentence: 746,rash,B-Disease
Sentence: 746,",",O
Sentence: 746,and,O
Sentence: 746,resulted,O
Sentence: 746,in,O
Sentence: 746,withdrawal,O
Sentence: 746,from,O
Sentence: 746,the,O
Sentence: 746,study,O
Sentence: 746,by,O
Sentence: 746,three,O
Sentence: 746,men,O
Sentence: 746,.,O
Sentence: 746,Evidence,O
Sentence: 746,of,O
Sentence: 746,peripheral,B-Disease
Sentence: 746,sensory,I-Disease
Sentence: 746,neuropathy,I-Disease
Sentence: 746,was,O
Sentence: 746,found,O
Sentence: 746,in,O
Sentence: 746,nine,O
Sentence: 746,of,O
Sentence: 746,13,O
Sentence: 746,men,O
Sentence: 746,before,O
Sentence: 746,treatment,O
Sentence: 746,.,O
Sentence: 746,In,O
Sentence: 746,the,O
Sentence: 746,seven,O
Sentence: 746,men,O
Sentence: 746,who,O
Sentence: 746,completed,O
Sentence: 746,six,O
Sentence: 746,months,O
Sentence: 746,on,O
Sentence: 746,thalidomide,B-Chemical
Sentence: 746,",",O
Sentence: 746,subclinical,O
Sentence: 746,evidence,O
Sentence: 746,of,O
Sentence: 746,peripheral,B-Disease
Sentence: 746,neuropathy,I-Disease
Sentence: 746,was,O
Sentence: 746,found,O
Sentence: 746,in,O
Sentence: 746,four,O
Sentence: 746,before,O
Sentence: 746,treatment,O
Sentence: 746,",",O
Sentence: 746,but,O
Sentence: 746,in,O
Sentence: 746,all,O
Sentence: 746,seven,O
Sentence: 746,at,O
Sentence: 746,repeat,O
Sentence: 746,testing,O
Sentence: 746,.,O
Sentence: 746,The,O
Sentence: 746,findings,O
Sentence: 746,indicate,O
Sentence: 746,that,O
Sentence: 746,thalidomide,B-Chemical
Sentence: 746,may,O
Sentence: 746,be,O
Sentence: 746,an,O
Sentence: 746,option,O
Sentence: 746,for,O
Sentence: 746,patients,O
Sentence: 746,who,O
Sentence: 746,have,O
Sentence: 746,failed,O
Sentence: 746,other,O
Sentence: 746,forms,O
Sentence: 746,of,O
Sentence: 746,therapy,O
Sentence: 746,",",O
Sentence: 746,provided,O
Sentence: 746,close,O
Sentence: 746,follow,O
Sentence: 746,-,O
Sentence: 746,up,O
Sentence: 746,is,O
Sentence: 746,maintained,O
Sentence: 746,for,O
Sentence: 746,development,O
Sentence: 746,of,O
Sentence: 746,peripheral,B-Disease
Sentence: 746,neuropathy,I-Disease
Sentence: 746,.,O
Sentence: 747,Central,B-Disease
Sentence: 747,nervous,I-Disease
Sentence: 747,system,I-Disease
Sentence: 747,toxicity,I-Disease
Sentence: 747,following,O
Sentence: 747,the,O
Sentence: 747,administration,O
Sentence: 747,of,O
Sentence: 747,levobupivacaine,B-Chemical
Sentence: 747,for,O
Sentence: 747,lumbar,O
Sentence: 747,plexus,O
Sentence: 747,block,O
Sentence: 747,:,O
Sentence: 747,A,O
Sentence: 747,report,O
Sentence: 747,of,O
Sentence: 747,two,O
Sentence: 747,cases,O
Sentence: 747,.,O
Sentence: 748,BACKGROUND,O
Sentence: 748,AND,O
Sentence: 748,OBJECTIVES,O
Sentence: 748,:,O
Sentence: 748,Central,B-Disease
Sentence: 748,nervous,I-Disease
Sentence: 748,system,I-Disease
Sentence: 748,and,I-Disease
Sentence: 748,cardiac,B-Disease
Sentence: 748,toxicity,I-Disease
Sentence: 748,following,O
Sentence: 748,the,O
Sentence: 748,administration,O
Sentence: 748,of,O
Sentence: 748,local,O
Sentence: 748,anesthetics,O
Sentence: 748,is,O
Sentence: 748,a,O
Sentence: 748,recognized,O
Sentence: 748,complication,O
Sentence: 748,of,O
Sentence: 748,regional,O
Sentence: 748,anesthesia,O
Sentence: 748,.,O
Sentence: 748,Levobupivacaine,B-Chemical
Sentence: 748,",",O
Sentence: 748,the,O
Sentence: 748,pure,O
Sentence: 748,S,O
Sentence: 748,(,O
Sentence: 748,,O
Sentence: 748,-,O
Sentence: 748,,O
Sentence: 748,),O
Sentence: 748,enantiomer,O
Sentence: 748,of,O
Sentence: 748,bupivacaine,B-Chemical
Sentence: 748,",",O
Sentence: 748,was,O
Sentence: 748,developed,O
Sentence: 748,to,O
Sentence: 748,improve,O
Sentence: 748,the,O
Sentence: 748,cardiac,O
Sentence: 748,safety,O
Sentence: 748,profile,O
Sentence: 748,of,O
Sentence: 748,bupivacaine,B-Chemical
Sentence: 748,.,O
Sentence: 748,We,O
Sentence: 748,describe,O
Sentence: 748,2,O
Sentence: 748,cases,O
Sentence: 748,of,O
Sentence: 748,grand,B-Disease
Sentence: 748,mal,I-Disease
Sentence: 748,seizures,B-Disease
Sentence: 748,following,O
Sentence: 748,accidental,O
Sentence: 748,intravascular,O
Sentence: 748,injection,O
Sentence: 748,of,O
Sentence: 748,levobupivacaine,B-Chemical
Sentence: 748,.,O
Sentence: 748,CASE,O
Sentence: 748,REPORT,O
Sentence: 748,:,O
Sentence: 748,Two,O
Sentence: 748,patients,O
Sentence: 748,presenting,O
Sentence: 748,for,O
Sentence: 748,elective,O
Sentence: 748,orthopedic,O
Sentence: 748,surgery,O
Sentence: 748,of,O
Sentence: 748,the,O
Sentence: 748,lower,O
Sentence: 748,limb,O
Sentence: 748,underwent,O
Sentence: 748,blockade,O
Sentence: 748,of,O
Sentence: 748,the,O
Sentence: 748,lumbar,O
Sentence: 748,plexus,O
Sentence: 748,via,O
Sentence: 748,the,O
Sentence: 748,posterior,O
Sentence: 748,approach,O
Sentence: 748,.,O
Sentence: 748,Immediately,O
Sentence: 748,after,O
Sentence: 748,the,O
Sentence: 748,administration,O
Sentence: 748,of,O
Sentence: 748,levobupivacaine,B-Chemical
Sentence: 748,0.5,O
Sentence: 748,%,O
Sentence: 748,with,O
Sentence: 748,epinephrine,B-Chemical
Sentence: 748,2.5,O
Sentence: 748,microgram,O
Sentence: 748,/,O
Sentence: 748,mL,O
Sentence: 748,",",O
Sentence: 748,the,O
Sentence: 748,patients,O
Sentence: 748,developed,O
Sentence: 748,grand,B-Disease
Sentence: 748,mal,I-Disease
Sentence: 748,seizures,B-Disease
Sentence: 748,",",O
Sentence: 748,despite,O
Sentence: 748,negative,O
Sentence: 748,aspiration,O
Sentence: 748,for,O
Sentence: 748,blood,O
Sentence: 748,and,O
Sentence: 748,no,O
Sentence: 748,clinical,O
Sentence: 748,signs,O
Sentence: 748,of,O
Sentence: 748,intravenous,O
Sentence: 748,epinephrine,B-Chemical
Sentence: 748,administration,O
Sentence: 748,.,O
Sentence: 748,The,O
Sentence: 748,seizures,B-Disease
Sentence: 748,were,O
Sentence: 748,successfully,O
Sentence: 748,treated,O
Sentence: 748,with,O
Sentence: 748,sodium,B-Chemical
Sentence: 748,thiopental,I-Chemical
Sentence: 748,in,O
Sentence: 748,addition,O
Sentence: 748,to,O
Sentence: 748,succinylcholine,B-Chemical
Sentence: 748,in,O
Sentence: 748,1,O
Sentence: 748,patient,O
Sentence: 748,.,O
Sentence: 748,Neither,O
Sentence: 748,patient,O
Sentence: 748,developed,O
Sentence: 748,signs,O
Sentence: 748,of,O
Sentence: 748,cardiovascular,B-Disease
Sentence: 748,toxicity,I-Disease
Sentence: 748,.,O
Sentence: 748,Both,O
Sentence: 748,patients,O
Sentence: 748,were,O
Sentence: 748,treated,O
Sentence: 748,preoperatively,O
Sentence: 748,with,O
Sentence: 748,beta,O
Sentence: 748,-,O
Sentence: 748,adrenergic,O
Sentence: 748,antagonist,O
Sentence: 748,medications,O
Sentence: 748,",",O
Sentence: 748,which,O
Sentence: 748,may,O
Sentence: 748,have,O
Sentence: 748,masked,O
Sentence: 748,the,O
Sentence: 748,cardiovascular,O
Sentence: 748,signs,O
Sentence: 748,of,O
Sentence: 748,the,O
Sentence: 748,unintentional,O
Sentence: 748,intravascular,O
Sentence: 748,administration,O
Sentence: 748,of,O
Sentence: 748,levobupivacaine,B-Chemical
Sentence: 748,with,O
Sentence: 748,epinephrine,B-Chemical
Sentence: 748,.,O
Sentence: 748,CONCLUSIONS,O
Sentence: 748,:,O
Sentence: 748,Although,O
Sentence: 748,levobupivacaine,B-Chemical
Sentence: 748,may,O
Sentence: 748,have,O
Sentence: 748,a,O
Sentence: 748,safer,O
Sentence: 748,cardiac,B-Disease
Sentence: 748,toxicity,I-Disease
Sentence: 748,profile,O
Sentence: 748,than,O
Sentence: 748,racemic,O
Sentence: 748,bupivacaine,B-Chemical
Sentence: 748,",",O
Sentence: 748,if,O
Sentence: 748,adequate,O
Sentence: 748,amounts,O
Sentence: 748,of,O
Sentence: 748,levobupivacaine,B-Chemical
Sentence: 748,reach,O
Sentence: 748,the,O
Sentence: 748,circulation,O
Sentence: 748,",",O
Sentence: 748,it,O
Sentence: 748,will,O
Sentence: 748,result,O
Sentence: 748,in,O
Sentence: 748,convulsions,B-Disease
Sentence: 748,.,O
Sentence: 748,Plasma,O
Sentence: 748,concentrations,O
Sentence: 748,sufficient,O
Sentence: 748,to,O
Sentence: 748,result,O
Sentence: 748,in,O
Sentence: 748,central,B-Disease
Sentence: 748,nervous,I-Disease
Sentence: 748,system,I-Disease
Sentence: 748,toxicity,I-Disease
Sentence: 748,did,O
Sentence: 748,not,O
Sentence: 748,produce,O
Sentence: 748,manifestations,O
Sentence: 748,of,O
Sentence: 748,cardiac,B-Disease
Sentence: 748,toxicity,I-Disease
Sentence: 748,in,O
Sentence: 748,these,O
Sentence: 748,2,O
Sentence: 748,patients,O
Sentence: 748,.,O
Sentence: 749,Anaesthetic,O
Sentence: 749,complications,O
Sentence: 749,associated,O
Sentence: 749,with,O
Sentence: 749,myotonia,B-Disease
Sentence: 749,congenita,I-Disease
Sentence: 749,:,O
Sentence: 749,case,O
Sentence: 749,study,O
Sentence: 749,and,O
Sentence: 749,comparison,O
Sentence: 749,with,O
Sentence: 749,other,O
Sentence: 749,myotonic,B-Disease
Sentence: 749,disorders,I-Disease
Sentence: 749,.,O
Sentence: 750,Myotonia,B-Disease
Sentence: 750,congenita,I-Disease
Sentence: 750,(,O
Sentence: 750,MC,B-Disease
Sentence: 750,),O
Sentence: 750,is,O
Sentence: 750,caused,O
Sentence: 750,by,O
Sentence: 750,a,O
Sentence: 750,defect,O
Sentence: 750,in,O
Sentence: 750,the,O
Sentence: 750,skeletal,O
Sentence: 750,muscle,O
Sentence: 750,chloride,B-Chemical
Sentence: 750,channel,O
Sentence: 750,function,O
Sentence: 750,",",O
Sentence: 750,which,O
Sentence: 750,may,O
Sentence: 750,cause,O
Sentence: 750,sustained,B-Disease
Sentence: 750,membrane,I-Disease
Sentence: 750,depolarisation,I-Disease
Sentence: 750,.,O
Sentence: 750,We,O
Sentence: 750,describe,O
Sentence: 750,a,O
Sentence: 750,previously,O
Sentence: 750,healthy,O
Sentence: 750,32,O
Sentence: 750,-,O
Sentence: 750,year,O
Sentence: 750,-,O
Sentence: 750,old,O
Sentence: 750,woman,O
Sentence: 750,who,O
Sentence: 750,developed,O
Sentence: 750,a,O
Sentence: 750,life,O
Sentence: 750,-,O
Sentence: 750,threatening,O
Sentence: 750,muscle,B-Disease
Sentence: 750,spasm,I-Disease
Sentence: 750,and,O
Sentence: 750,secondary,O
Sentence: 750,ventilation,O
Sentence: 750,difficulties,O
Sentence: 750,following,O
Sentence: 750,a,O
Sentence: 750,preoperative,O
Sentence: 750,injection,O
Sentence: 750,of,O
Sentence: 750,suxamethonium,B-Chemical
Sentence: 750,.,O
Sentence: 750,The,O
Sentence: 750,muscle,B-Disease
Sentence: 750,spasms,I-Disease
Sentence: 750,disappeared,O
Sentence: 750,spontaneously,O
Sentence: 750,and,O
Sentence: 750,the,O
Sentence: 750,surgery,O
Sentence: 750,proceeded,O
Sentence: 750,without,O
Sentence: 750,further,O
Sentence: 750,problems,O
Sentence: 750,.,O
Sentence: 750,When,O
Sentence: 750,subsequently,O
Sentence: 750,questioned,O
Sentence: 750,",",O
Sentence: 750,she,O
Sentence: 750,reported,O
Sentence: 750,minor,O
Sentence: 750,symptoms,O
Sentence: 750,suggesting,O
Sentence: 750,a,O
Sentence: 750,myotonic,B-Disease
Sentence: 750,condition,I-Disease
Sentence: 750,.,O
Sentence: 750,Myotonia,B-Disease
Sentence: 750,was,O
Sentence: 750,found,O
Sentence: 750,on,O
Sentence: 750,clinical,O
Sentence: 750,examination,O
Sentence: 750,and,O
Sentence: 750,EMG,O
Sentence: 750,.,O
Sentence: 750,The,O
Sentence: 750,diagnosis,O
Sentence: 750,MC,B-Disease
Sentence: 750,was,O
Sentence: 750,confirmed,O
Sentence: 750,genetically,O
Sentence: 750,.,O
Sentence: 750,Neither,O
Sentence: 750,the,O
Sentence: 750,patient,O
Sentence: 750,nor,O
Sentence: 750,the,O
Sentence: 750,anaesthetist,O
Sentence: 750,were,O
Sentence: 750,aware,O
Sentence: 750,of,O
Sentence: 750,the,O
Sentence: 750,diagnosis,O
Sentence: 750,before,O
Sentence: 750,this,O
Sentence: 750,potentially,O
Sentence: 750,lethal,O
Sentence: 750,complication,O
Sentence: 750,occurred,O
Sentence: 750,.,O
Sentence: 750,We,O
Sentence: 750,give,O
Sentence: 750,a,O
Sentence: 750,brief,O
Sentence: 750,overview,O
Sentence: 750,of,O
Sentence: 750,ion,B-Disease
Sentence: 750,channel,I-Disease
Sentence: 750,disorders,I-Disease
Sentence: 750,including,O
Sentence: 750,malignant,B-Disease
Sentence: 750,hyperthermia,I-Disease
Sentence: 750,and,O
Sentence: 750,their,O
Sentence: 750,anaesthetic,O
Sentence: 750,considerations,O
Sentence: 750,.,O
Sentence: 751,Respiratory,O
Sentence: 751,pattern,O
Sentence: 751,in,O
Sentence: 751,a,O
Sentence: 751,rat,O
Sentence: 751,model,O
Sentence: 751,of,O
Sentence: 751,epilepsy,O
Sentence: 751,.,O
Sentence: 752,PURPOSE,O
Sentence: 752,:,O
Sentence: 752,Apnea,B-Disease
Sentence: 752,is,O
Sentence: 752,known,O
Sentence: 752,to,O
Sentence: 752,occur,O
Sentence: 752,during,O
Sentence: 752,seizures,B-Disease
Sentence: 752,",",O
Sentence: 752,but,O
Sentence: 752,systematic,O
Sentence: 752,studies,O
Sentence: 752,of,O
Sentence: 752,ictal,O
Sentence: 752,respiratory,O
Sentence: 752,changes,O
Sentence: 752,in,O
Sentence: 752,adults,O
Sentence: 752,are,O
Sentence: 752,few,O
Sentence: 752,.,O
Sentence: 752,Data,O
Sentence: 752,regarding,O
Sentence: 752,respiratory,O
Sentence: 752,pattern,O
Sentence: 752,defects,O
Sentence: 752,during,O
Sentence: 752,interictal,O
Sentence: 752,periods,O
Sentence: 752,also,O
Sentence: 752,are,O
Sentence: 752,scarce,O
Sentence: 752,.,O
Sentence: 752,Here,O
Sentence: 752,we,O
Sentence: 752,sought,O
Sentence: 752,to,O
Sentence: 752,generate,O
Sentence: 752,information,O
Sentence: 752,with,O
Sentence: 752,regard,O
Sentence: 752,to,O
Sentence: 752,the,O
Sentence: 752,interictal,O
Sentence: 752,period,O
Sentence: 752,in,O
Sentence: 752,animals,O
Sentence: 752,with,O
Sentence: 752,pilocarpine,B-Chemical
Sentence: 752,-,O
Sentence: 752,induced,O
Sentence: 752,epilepsy,B-Disease
Sentence: 752,.,O
Sentence: 752,METHODS,O
Sentence: 752,:,O
Sentence: 752,Twelve,O
Sentence: 752,rats,O
Sentence: 752,(,O
Sentence: 752,six,O
Sentence: 752,chronically,O
Sentence: 752,epileptic,B-Disease
Sentence: 752,animals,O
Sentence: 752,and,O
Sentence: 752,six,O
Sentence: 752,controls,O
Sentence: 752,),O
Sentence: 752,were,O
Sentence: 752,anesthetized,O
Sentence: 752,",",O
Sentence: 752,given,O
Sentence: 752,tracheotomies,O
Sentence: 752,",",O
Sentence: 752,and,O
Sentence: 752,subjected,O
Sentence: 752,to,O
Sentence: 752,hyperventilation,B-Disease
Sentence: 752,or,O
Sentence: 752,hypoventilation,O
Sentence: 752,conditions,O
Sentence: 752,.,O
Sentence: 752,Breathing,O
Sentence: 752,movements,O
Sentence: 752,caused,O
Sentence: 752,changes,O
Sentence: 752,in,O
Sentence: 752,thoracic,O
Sentence: 752,volume,O
Sentence: 752,and,O
Sentence: 752,forced,O
Sentence: 752,air,O
Sentence: 752,to,O
Sentence: 752,flow,O
Sentence: 752,tidally,O
Sentence: 752,through,O
Sentence: 752,a,O
Sentence: 752,pneumotachograph,O
Sentence: 752,.,O
Sentence: 752,This,O
Sentence: 752,flow,O
Sentence: 752,was,O
Sentence: 752,measured,O
Sentence: 752,by,O
Sentence: 752,using,O
Sentence: 752,a,O
Sentence: 752,differential,O
Sentence: 752,pressure,O
Sentence: 752,transducer,O
Sentence: 752,",",O
Sentence: 752,passed,O
Sentence: 752,through,O
Sentence: 752,a,O
Sentence: 752,polygraph,O
Sentence: 752,",",O
Sentence: 752,and,O
Sentence: 752,from,O
Sentence: 752,this,O
Sentence: 752,to,O
Sentence: 752,a,O
Sentence: 752,computer,O
Sentence: 752,with,O
Sentence: 752,custom,O
Sentence: 752,software,O
Sentence: 752,that,O
Sentence: 752,derived,O
Sentence: 752,ventilation,O
Sentence: 752,(,O
Sentence: 752,VE,O
Sentence: 752,),O
Sentence: 752,",",O
Sentence: 752,tidal,O
Sentence: 752,volume,O
Sentence: 752,(,O
Sentence: 752,VT,O
Sentence: 752,),O
Sentence: 752,",",O
Sentence: 752,inspiratory,O
Sentence: 752,time,O
Sentence: 752,(,O
Sentence: 752,TI,O
Sentence: 752,),O
Sentence: 752,",",O
Sentence: 752,expiratory,O
Sentence: 752,time,O
Sentence: 752,(,O
Sentence: 752,TE,O
Sentence: 752,),O
Sentence: 752,",",O
Sentence: 752,breathing,O
Sentence: 752,frequency,O
Sentence: 752,(,O
Sentence: 752,f,O
Sentence: 752,),O
Sentence: 752,",",O
Sentence: 752,and,O
Sentence: 752,mean,O
Sentence: 752,inspiratory,O
Sentence: 752,flow,O
Sentence: 752,(,O
Sentence: 752,VT,O
Sentence: 752,/,O
Sentence: 752,TI,O
Sentence: 752,),O
Sentence: 752,on,O
Sentence: 752,a,O
Sentence: 752,breath,O
Sentence: 752,-,O
Sentence: 752,by,O
Sentence: 752,-,O
Sentence: 752,breath,O
Sentence: 752,basis,O
Sentence: 752,.,O
Sentence: 752,RESULTS,O
Sentence: 752,:,O
Sentence: 752,The,O
Sentence: 752,hyperventilation,B-Disease
Sentence: 752,maneuver,O
Sentence: 752,caused,O
Sentence: 752,a,O
Sentence: 752,decrease,O
Sentence: 752,in,O
Sentence: 752,spontaneous,O
Sentence: 752,ventilation,O
Sentence: 752,in,O
Sentence: 752,pilocarpine,B-Chemical
Sentence: 752,-,O
Sentence: 752,treated,O
Sentence: 752,and,O
Sentence: 752,control,O
Sentence: 752,rats,O
Sentence: 752,.,O
Sentence: 752,Although,O
Sentence: 752,VE,O
Sentence: 752,had,O
Sentence: 752,a,O
Sentence: 752,similar,O
Sentence: 752,decrease,O
Sentence: 752,in,O
Sentence: 752,both,O
Sentence: 752,groups,O
Sentence: 752,",",O
Sentence: 752,in,O
Sentence: 752,the,O
Sentence: 752,epileptic,B-Disease
Sentence: 752,group,O
Sentence: 752,",",O
Sentence: 752,the,O
Sentence: 752,decrease,O
Sentence: 752,in,O
Sentence: 752,VE,O
Sentence: 752,was,O
Sentence: 752,due,O
Sentence: 752,to,O
Sentence: 752,a,O
Sentence: 752,significant,O
Sentence: 752,(,O
Sentence: 752,p,O
Sentence: 752,,O
Sentence: 752,<,O
Sentence: 752,,O
Sentence: 752,0.05,O
Sentence: 752,),O
Sentence: 752,increase,O
Sentence: 752,in,O
Sentence: 752,TE,O
Sentence: 752,peak,O
Sentence: 752,in,O
Sentence: 752,relation,O
Sentence: 752,to,O
Sentence: 752,that,O
Sentence: 752,of,O
Sentence: 752,the,O
Sentence: 752,control,O
Sentence: 752,animals,O
Sentence: 752,.,O
Sentence: 752,The,O
Sentence: 752,hypoventilation,O
Sentence: 752,maneuver,O
Sentence: 752,led,O
Sentence: 752,to,O
Sentence: 752,an,O
Sentence: 752,increase,O
Sentence: 752,in,O
Sentence: 752,the,O
Sentence: 752,arterial,O
Sentence: 752,Paco2,O
Sentence: 752,",",O
Sentence: 752,followed,O
Sentence: 752,by,O
Sentence: 752,an,O
Sentence: 752,increase,O
Sentence: 752,in,O
Sentence: 752,VE,O
Sentence: 752,.,O
Sentence: 752,In,O
Sentence: 752,the,O
Sentence: 752,epileptic,B-Disease
Sentence: 752,group,O
Sentence: 752,",",O
Sentence: 752,the,O
Sentence: 752,increase,O
Sentence: 752,in,O
Sentence: 752,VE,O
Sentence: 752,was,O
Sentence: 752,mediated,O
Sentence: 752,by,O
Sentence: 752,a,O
Sentence: 752,significant,O
Sentence: 752,(,O
Sentence: 752,p,O
Sentence: 752,,O
Sentence: 752,<,O
Sentence: 752,,O
Sentence: 752,0.05,O
Sentence: 752,),O
Sentence: 752,decrease,O
Sentence: 752,in,O
Sentence: 752,TE,O
Sentence: 752,peak,O
Sentence: 752,compared,O
Sentence: 752,with,O
Sentence: 752,the,O
Sentence: 752,control,O
Sentence: 752,group,O
Sentence: 752,.,O
Sentence: 752,Systemic,O
Sentence: 752,application,O
Sentence: 752,of,O
Sentence: 752,KCN,O
Sentence: 752,",",O
Sentence: 752,to,O
Sentence: 752,evaluate,O
Sentence: 752,the,O
Sentence: 752,effects,O
Sentence: 752,of,O
Sentence: 752,peripheral,O
Sentence: 752,chemoreception,O
Sentence: 752,activation,O
Sentence: 752,on,O
Sentence: 752,ventilation,O
Sentence: 752,",",O
Sentence: 752,led,O
Sentence: 752,to,O
Sentence: 752,a,O
Sentence: 752,similar,O
Sentence: 752,increase,O
Sentence: 752,in,O
Sentence: 752,VE,O
Sentence: 752,for,O
Sentence: 752,both,O
Sentence: 752,groups,O
Sentence: 752,.,O
Sentence: 752,CONCLUSIONS,O
Sentence: 752,:,O
Sentence: 752,The,O
Sentence: 752,data,O
Sentence: 752,indicate,O
Sentence: 752,that,O
Sentence: 752,pilocarpine,B-Chemical
Sentence: 752,-,O
Sentence: 752,treated,O
Sentence: 752,animals,O
Sentence: 752,have,O
Sentence: 752,an,O
Sentence: 752,altered,O
Sentence: 752,ability,O
Sentence: 752,to,O
Sentence: 752,react,O
Sentence: 752,to,O
Sentence: 752,(,O
Sentence: 752,or,O
Sentence: 752,compensate,O
Sentence: 752,for,O
Sentence: 752,),O
Sentence: 752,blood,O
Sentence: 752,gas,O
Sentence: 752,changes,O
Sentence: 752,with,O
Sentence: 752,changes,O
Sentence: 752,in,O
Sentence: 752,ventilation,O
Sentence: 752,and,O
Sentence: 752,suggest,O
Sentence: 752,that,O
Sentence: 752,it,O
Sentence: 752,is,O
Sentence: 752,centrally,O
Sentence: 752,determined,O
Sentence: 752,.,O
Sentence: 752,We,O
Sentence: 752,speculate,O
Sentence: 752,on,O
Sentence: 752,the,O
Sentence: 752,possible,O
Sentence: 752,relation,O
Sentence: 752,of,O
Sentence: 752,the,O
Sentence: 752,current,O
Sentence: 752,findings,O
Sentence: 752,on,O
Sentence: 752,treating,O
Sentence: 752,different,O
Sentence: 752,epilepsy,B-Disease
Sentence: 752,-,O
Sentence: 752,associated,O
Sentence: 752,conditions,O
Sentence: 752,.,O
Sentence: 753,Increased,O
Sentence: 753,serum,O
Sentence: 753,soluble,O
Sentence: 753,Fas,O
Sentence: 753,in,O
Sentence: 753,patients,O
Sentence: 753,with,O
Sentence: 753,acute,B-Disease
Sentence: 753,liver,I-Disease
Sentence: 753,failure,I-Disease
Sentence: 753,due,O
Sentence: 753,to,O
Sentence: 753,paracetamol,B-Chemical
Sentence: 753,overdose,B-Disease
Sentence: 753,.,O
Sentence: 754,BACKGROUND,O
Sentence: 754,/,O
Sentence: 754,AIMS,O
Sentence: 754,:,O
Sentence: 754,Experimental,O
Sentence: 754,studies,O
Sentence: 754,have,O
Sentence: 754,suggested,O
Sentence: 754,that,O
Sentence: 754,apoptosis,O
Sentence: 754,via,O
Sentence: 754,the,O
Sentence: 754,Fas,O
Sentence: 754,/,O
Sentence: 754,Fas,O
Sentence: 754,Ligand,O
Sentence: 754,signaling,O
Sentence: 754,system,O
Sentence: 754,may,O
Sentence: 754,play,O
Sentence: 754,an,O
Sentence: 754,important,O
Sentence: 754,role,O
Sentence: 754,in,O
Sentence: 754,the,O
Sentence: 754,development,O
Sentence: 754,of,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,.,O
Sentence: 754,The,O
Sentence: 754,aim,O
Sentence: 754,of,O
Sentence: 754,the,O
Sentence: 754,study,O
Sentence: 754,was,O
Sentence: 754,to,O
Sentence: 754,investigate,O
Sentence: 754,the,O
Sentence: 754,soluble,O
Sentence: 754,form,O
Sentence: 754,of,O
Sentence: 754,Fas,O
Sentence: 754,in,O
Sentence: 754,patients,O
Sentence: 754,with,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,.,O
Sentence: 754,METHODOLOGY,O
Sentence: 754,:,O
Sentence: 754,Serum,O
Sentence: 754,levels,O
Sentence: 754,of,O
Sentence: 754,sFas,O
Sentence: 754,(,O
Sentence: 754,soluble,O
Sentence: 754,Fas,O
Sentence: 754,),O
Sentence: 754,were,O
Sentence: 754,measured,O
Sentence: 754,by,O
Sentence: 754,ELISA,O
Sentence: 754,in,O
Sentence: 754,24,O
Sentence: 754,patients,O
Sentence: 754,with,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,and,O
Sentence: 754,10,O
Sentence: 754,normal,O
Sentence: 754,control,O
Sentence: 754,subjects,O
Sentence: 754,.,O
Sentence: 754,Serum,O
Sentence: 754,levels,O
Sentence: 754,of,O
Sentence: 754,tumor,B-Disease
Sentence: 754,necrosis,B-Disease
Sentence: 754,factor,O
Sentence: 754,-,O
Sentence: 754,alpha,O
Sentence: 754,and,O
Sentence: 754,interferon,O
Sentence: 754,-,O
Sentence: 754,gamma,O
Sentence: 754,were,O
Sentence: 754,also,O
Sentence: 754,determined,O
Sentence: 754,by,O
Sentence: 754,ELISA,O
Sentence: 754,.,O
Sentence: 754,RESULTS,O
Sentence: 754,:,O
Sentence: 754,Serum,O
Sentence: 754,sFas,O
Sentence: 754,was,O
Sentence: 754,significantly,O
Sentence: 754,increased,O
Sentence: 754,in,O
Sentence: 754,patients,O
Sentence: 754,with,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,(,O
Sentence: 754,median,O
Sentence: 754,",",O
Sentence: 754,26.8,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,;,O
Sentence: 754,range,O
Sentence: 754,",",O
Sentence: 754,6.9,O
Sentence: 754,-,O
Sentence: 754,52.7,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,),O
Sentence: 754,compared,O
Sentence: 754,to,O
Sentence: 754,the,O
Sentence: 754,normal,O
Sentence: 754,controls,O
Sentence: 754,(,O
Sentence: 754,median,O
Sentence: 754,",",O
Sentence: 754,8.6,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,;,O
Sentence: 754,range,O
Sentence: 754,",",O
Sentence: 754,6.5,O
Sentence: 754,-,O
Sentence: 754,12.0,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,",",O
Sentence: 754,P,O
Sentence: 754,,O
Sentence: 754,<,O
Sentence: 754,,O
Sentence: 754,0.0001,O
Sentence: 754,),O
Sentence: 754,.,O
Sentence: 754,Levels,O
Sentence: 754,were,O
Sentence: 754,significantly,O
Sentence: 754,greater,O
Sentence: 754,in,O
Sentence: 754,patients,O
Sentence: 754,with,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,due,O
Sentence: 754,to,O
Sentence: 754,paracetamol,B-Chemical
Sentence: 754,overdose,B-Disease
Sentence: 754,(,O
Sentence: 754,median,O
Sentence: 754,",",O
Sentence: 754,28.7,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,;,O
Sentence: 754,range,O
Sentence: 754,",",O
Sentence: 754,12.8,O
Sentence: 754,-,O
Sentence: 754,52.7,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,",",O
Sentence: 754,n,O
Sentence: 754,,O
Sentence: 754,=,O
Sentence: 754,,O
Sentence: 754,17,O
Sentence: 754,),O
Sentence: 754,than,O
Sentence: 754,those,O
Sentence: 754,due,O
Sentence: 754,to,O
Sentence: 754,non,O
Sentence: 754,-,O
Sentence: 754,A,O
Sentence: 754,to,O
Sentence: 754,E,O
Sentence: 754,hepatitis,B-Disease
Sentence: 754,(,O
Sentence: 754,median,O
Sentence: 754,",",O
Sentence: 754,12.5,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,;,O
Sentence: 754,range,O
Sentence: 754,",",O
Sentence: 754,6.9,O
Sentence: 754,-,O
Sentence: 754,46.0,O
Sentence: 754,U,O
Sentence: 754,/,O
Sentence: 754,mL,O
Sentence: 754,",",O
Sentence: 754,n,O
Sentence: 754,,O
Sentence: 754,=,O
Sentence: 754,,O
Sentence: 754,7,O
Sentence: 754,",",O
Sentence: 754,P,O
Sentence: 754,,O
Sentence: 754,<,O
Sentence: 754,,O
Sentence: 754,0.01,O
Sentence: 754,),O
Sentence: 754,.,O
Sentence: 754,There,O
Sentence: 754,was,O
Sentence: 754,no,O
Sentence: 754,relationship,O
Sentence: 754,of,O
Sentence: 754,sFas,O
Sentence: 754,to,O
Sentence: 754,eventual,O
Sentence: 754,outcome,O
Sentence: 754,in,O
Sentence: 754,the,O
Sentence: 754,patients,O
Sentence: 754,.,O
Sentence: 754,A,O
Sentence: 754,significant,O
Sentence: 754,correlation,O
Sentence: 754,was,O
Sentence: 754,observed,O
Sentence: 754,between,O
Sentence: 754,serum,O
Sentence: 754,sFas,O
Sentence: 754,levels,O
Sentence: 754,and,O
Sentence: 754,aspartate,B-Chemical
Sentence: 754,aminotransferase,O
Sentence: 754,(,O
Sentence: 754,r,O
Sentence: 754,,O
Sentence: 754,=,O
Sentence: 754,,O
Sentence: 754,0.613,O
Sentence: 754,",",O
Sentence: 754,P,O
Sentence: 754,,O
Sentence: 754,<,O
Sentence: 754,,O
Sentence: 754,0.01,O
Sentence: 754,),O
Sentence: 754,.,O
Sentence: 754,CONCLUSIONS,O
Sentence: 754,:,O
Sentence: 754,The,O
Sentence: 754,increased,O
Sentence: 754,concentration,O
Sentence: 754,of,O
Sentence: 754,sFas,O
Sentence: 754,in,O
Sentence: 754,serum,O
Sentence: 754,of,O
Sentence: 754,patients,O
Sentence: 754,with,O
Sentence: 754,acute,B-Disease
Sentence: 754,liver,I-Disease
Sentence: 754,failure,I-Disease
Sentence: 754,may,O
Sentence: 754,reflect,O
Sentence: 754,activation,O
Sentence: 754,of,O
Sentence: 754,Fas,O
Sentence: 754,-,O
Sentence: 754,mediated,O
Sentence: 754,apoptosis,O
Sentence: 754,in,O
Sentence: 754,the,O
Sentence: 754,liver,O
Sentence: 754,and,O
Sentence: 754,this,O
Sentence: 754,together,O
Sentence: 754,with,O
Sentence: 754,increased,O
Sentence: 754,tumor,B-Disease
Sentence: 754,necrosis,B-Disease
Sentence: 754,factor,O
Sentence: 754,-,O
Sentence: 754,alpha,O
Sentence: 754,may,O
Sentence: 754,be,O
Sentence: 754,an,O
Sentence: 754,important,O
Sentence: 754,factor,O
Sentence: 754,in,O
Sentence: 754,liver,O
Sentence: 754,cell,O
Sentence: 754,loss,O
Sentence: 754,.,O
Sentence: 755,Bilateral,O
Sentence: 755,subthalamic,O
Sentence: 755,nucleus,O
Sentence: 755,stimulation,O
Sentence: 755,for,O
Sentence: 755,Parkinson,O
Sentence: 755,'s,O
Sentence: 755,disease,O
Sentence: 755,.,O
Sentence: 756,High,O
Sentence: 756,frequency,O
Sentence: 756,stimulation,O
Sentence: 756,of,O
Sentence: 756,the,O
Sentence: 756,subthalamic,O
Sentence: 756,nucleus,O
Sentence: 756,(,O
Sentence: 756,STN,O
Sentence: 756,),O
Sentence: 756,is,O
Sentence: 756,known,O
Sentence: 756,to,O
Sentence: 756,ameliorate,O
Sentence: 756,the,O
Sentence: 756,signs,O
Sentence: 756,and,O
Sentence: 756,symptoms,O
Sentence: 756,of,O
Sentence: 756,advanced,O
Sentence: 756,Parkinson,B-Disease
Sentence: 756,'s,I-Disease
Sentence: 756,disease,I-Disease
Sentence: 756,.,O
Sentence: 756,AIM,O
Sentence: 756,:,O
Sentence: 756,We,O
Sentence: 756,studied,O
Sentence: 756,the,O
Sentence: 756,effect,O
Sentence: 756,of,O
Sentence: 756,high,O
Sentence: 756,frequency,O
Sentence: 756,STN,O
Sentence: 756,stimulation,O
Sentence: 756,in,O
Sentence: 756,23,O
Sentence: 756,patients,O
Sentence: 756,.,O
Sentence: 756,METHOD,O
Sentence: 756,:,O
Sentence: 756,Twenty,O
Sentence: 756,-,O
Sentence: 756,three,O
Sentence: 756,patients,O
Sentence: 756,suffering,O
Sentence: 756,from,O
Sentence: 756,severe,O
Sentence: 756,Parkinson,B-Disease
Sentence: 756,'s,I-Disease
Sentence: 756,disease,I-Disease
Sentence: 756,(,O
Sentence: 756,Stages,O
Sentence: 756,III,O
Sentence: 756,-,O
Sentence: 756,V,O
Sentence: 756,on,O
Sentence: 756,Hoehn,O
Sentence: 756,and,O
Sentence: 756,Yahr,O
Sentence: 756,scale,O
Sentence: 756,),O
Sentence: 756,and,O
Sentence: 756,",",O
Sentence: 756,particularly,O
Sentence: 756,bradykinesia,B-Disease
Sentence: 756,",",O
Sentence: 756,rigidity,B-Disease
Sentence: 756,",",O
Sentence: 756,and,O
Sentence: 756,levodopa,B-Chemical
Sentence: 756,-,O
Sentence: 756,induced,O
Sentence: 756,dyskinesias,B-Disease
Sentence: 756,underwent,O
Sentence: 756,bilateral,O
Sentence: 756,implantation,O
Sentence: 756,of,O
Sentence: 756,electrodes,O
Sentence: 756,in,O
Sentence: 756,the,O
Sentence: 756,STN,O
Sentence: 756,.,O
Sentence: 756,Preoperative,O
Sentence: 756,and,O
Sentence: 756,postoperative,O
Sentence: 756,assessments,O
Sentence: 756,of,O
Sentence: 756,these,O
Sentence: 756,patients,O
Sentence: 756,at,O
Sentence: 756,1,O
Sentence: 756,",",O
Sentence: 756,3,O
Sentence: 756,",",O
Sentence: 756,6,O
Sentence: 756,and,O
Sentence: 756,12,O
Sentence: 756,months,O
Sentence: 756,follow,O
Sentence: 756,-,O
Sentence: 756,up,O
Sentence: 756,",",O
Sentence: 756,in,O
Sentence: 756,``,O
Sentence: 756,on,O
Sentence: 756,'',O
Sentence: 756,and,O
Sentence: 756,``,O
Sentence: 756,off,O
Sentence: 756,'',O
Sentence: 756,drug,O
Sentence: 756,conditions,O
Sentence: 756,",",O
Sentence: 756,was,O
Sentence: 756,carried,O
Sentence: 756,out,O
Sentence: 756,using,O
Sentence: 756,Unified,O
Sentence: 756,Parkinson,B-Disease
Sentence: 756,'s,I-Disease
Sentence: 756,Disease,I-Disease
Sentence: 756,Rating,O
Sentence: 756,Scale,O
Sentence: 756,",",O
Sentence: 756,Hoehn,O
Sentence: 756,and,O
Sentence: 756,Yahr,O
Sentence: 756,staging,O
Sentence: 756,",",O
Sentence: 756,England,O
Sentence: 756,activities,O
Sentence: 756,of,O
Sentence: 756,daily,O
Sentence: 756,living,O
Sentence: 756,score,O
Sentence: 756,and,O
Sentence: 756,video,O
Sentence: 756,recordings,O
Sentence: 756,.,O
Sentence: 756,RESULTS,O
Sentence: 756,:,O
Sentence: 756,After,O
Sentence: 756,one,O
Sentence: 756,year,O
Sentence: 756,of,O
Sentence: 756,electrical,O
Sentence: 756,stimulation,O
Sentence: 756,of,O
Sentence: 756,the,O
Sentence: 756,STN,O
Sentence: 756,",",O
Sentence: 756,the,O
Sentence: 756,patients,O
Sentence: 756,',O
Sentence: 756,scores,O
Sentence: 756,for,O
Sentence: 756,activities,O
Sentence: 756,of,O
Sentence: 756,daily,O
Sentence: 756,living,O
Sentence: 756,and,O
Sentence: 756,motor,O
Sentence: 756,examination,O
Sentence: 756,scores,O
Sentence: 756,(,O
Sentence: 756,Unified,O
Sentence: 756,Parkinson,B-Disease
Sentence: 756,'s,I-Disease
Sentence: 756,Disease,I-Disease
Sentence: 756,Rating,O
Sentence: 756,Scale,O
Sentence: 756,parts,O
Sentence: 756,II,O
Sentence: 756,and,O
Sentence: 756,III,O
Sentence: 756,),O
Sentence: 756,off,O
Sentence: 756,medication,O
Sentence: 756,improved,O
Sentence: 756,by,O
Sentence: 756,62,O
Sentence: 756,%,O
Sentence: 756,and,O
Sentence: 756,61,O
Sentence: 756,%,O
Sentence: 756,respectively,O
Sentence: 756,(,O
Sentence: 756,p,O
Sentence: 756,,O
Sentence: 756,<,O
Sentence: 756,,O
Sentence: 756,0.0005,O
Sentence: 756,),O
Sentence: 756,.,O
Sentence: 756,The,O
Sentence: 756,subscores,O
Sentence: 756,for,O
Sentence: 756,the,O
Sentence: 756,akinesia,B-Disease
Sentence: 756,",",O
Sentence: 756,rigidity,B-Disease
Sentence: 756,",",O
Sentence: 756,tremor,B-Disease
Sentence: 756,and,O
Sentence: 756,gait,O
Sentence: 756,also,O
Sentence: 756,improved,O
Sentence: 756,.,O
Sentence: 756,(,O
Sentence: 756,p,O
Sentence: 756,,O
Sentence: 756,<,O
Sentence: 756,,O
Sentence: 756,0.0005,O
Sentence: 756,),O
Sentence: 756,.,O
Sentence: 756,The,O
Sentence: 756,average,O
Sentence: 756,levodopa,B-Chemical
Sentence: 756,dose,O
Sentence: 756,decreased,O
Sentence: 756,from,O
Sentence: 756,813,O
Sentence: 756,mg,O
Sentence: 756,to,O
Sentence: 756,359,O
Sentence: 756,mg,O
Sentence: 756,.,O
Sentence: 756,The,O
Sentence: 756,cognitive,O
Sentence: 756,functions,O
Sentence: 756,remained,O
Sentence: 756,unchanged,O
Sentence: 756,.,O
Sentence: 756,Two,O
Sentence: 756,patients,O
Sentence: 756,developed,O
Sentence: 756,device,O
Sentence: 756,-,O
Sentence: 756,related,O
Sentence: 756,complications,O
Sentence: 756,and,O
Sentence: 756,two,O
Sentence: 756,patients,O
Sentence: 756,experienced,O
Sentence: 756,abnormal,O
Sentence: 756,weight,O
Sentence: 756,gain,O
Sentence: 756,.,O
Sentence: 756,CONCLUSION,O
Sentence: 756,:,O
Sentence: 756,Bilateral,O
Sentence: 756,subthalamic,O
Sentence: 756,nucleus,O
Sentence: 756,stimulation,O
Sentence: 756,is,O
Sentence: 756,an,O
Sentence: 756,effective,O
Sentence: 756,treatment,O
Sentence: 756,for,O
Sentence: 756,advanced,O
Sentence: 756,Parkinson,B-Disease
Sentence: 756,'s,I-Disease
Sentence: 756,disease,I-Disease
Sentence: 756,.,O
Sentence: 756,It,O
Sentence: 756,reduces,O
Sentence: 756,the,O
Sentence: 756,severity,O
Sentence: 756,of,O
Sentence: 756,``,O
Sentence: 756,off,O
Sentence: 756,'',O
Sentence: 756,phase,O
Sentence: 756,symptoms,O
Sentence: 756,",",O
Sentence: 756,improves,O
Sentence: 756,the,O
Sentence: 756,axial,O
Sentence: 756,symptoms,O
Sentence: 756,and,O
Sentence: 756,reduces,O
Sentence: 756,levodopa,B-Chemical
Sentence: 756,requirements,O
Sentence: 756,.,O
Sentence: 756,The,O
Sentence: 756,reduction,O
Sentence: 756,in,O
Sentence: 756,the,O
Sentence: 756,levodopa,B-Chemical
Sentence: 756,dose,O
Sentence: 756,is,O
Sentence: 756,useful,O
Sentence: 756,in,O
Sentence: 756,controlling,O
Sentence: 756,drug,O
Sentence: 756,-,O
Sentence: 756,induced,O
Sentence: 756,dyskinesias,B-Disease
Sentence: 756,.,O
Sentence: 757,Ocular,O
Sentence: 757,motility,O
Sentence: 757,changes,O
Sentence: 757,after,O
Sentence: 757,subtenon,O
Sentence: 757,carboplatin,B-Chemical
Sentence: 757,chemotherapy,O
Sentence: 757,for,O
Sentence: 757,retinoblastoma,B-Disease
Sentence: 757,.,O
Sentence: 758,BACKGROUND,O
Sentence: 758,:,O
Sentence: 758,Focal,O
Sentence: 758,subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,injections,O
Sentence: 758,have,O
Sentence: 758,recently,O
Sentence: 758,been,O
Sentence: 758,used,O
Sentence: 758,as,O
Sentence: 758,a,O
Sentence: 758,presumably,O
Sentence: 758,toxicity,B-Disease
Sentence: 758,-,O
Sentence: 758,free,O
Sentence: 758,adjunct,O
Sentence: 758,to,O
Sentence: 758,systemic,O
Sentence: 758,chemotherapy,O
Sentence: 758,for,O
Sentence: 758,intraocular,O
Sentence: 758,retinoblastoma,B-Disease
Sentence: 758,.,O
Sentence: 758,OBJECTIVE,O
Sentence: 758,:,O
Sentence: 758,To,O
Sentence: 758,report,O
Sentence: 758,our,O
Sentence: 758,clinical,O
Sentence: 758,experience,O
Sentence: 758,with,O
Sentence: 758,abnormal,B-Disease
Sentence: 758,ocular,I-Disease
Sentence: 758,motility,I-Disease
Sentence: 758,in,O
Sentence: 758,patients,O
Sentence: 758,treated,O
Sentence: 758,with,O
Sentence: 758,subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,chemotherapy,O
Sentence: 758,.,O
Sentence: 758,METHODS,O
Sentence: 758,:,O
Sentence: 758,We,O
Sentence: 758,noted,O
Sentence: 758,abnormal,B-Disease
Sentence: 758,ocular,I-Disease
Sentence: 758,motility,I-Disease
Sentence: 758,in,O
Sentence: 758,10,O
Sentence: 758,consecutive,O
Sentence: 758,patients,O
Sentence: 758,with,O
Sentence: 758,retinoblastoma,B-Disease
Sentence: 758,who,O
Sentence: 758,had,O
Sentence: 758,received,O
Sentence: 758,subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,.,O
Sentence: 758,During,O
Sentence: 758,ocular,O
Sentence: 758,manipulation,O
Sentence: 758,under,O
Sentence: 758,general,O
Sentence: 758,anesthesia,O
Sentence: 758,",",O
Sentence: 758,we,O
Sentence: 758,assessed,O
Sentence: 758,their,O
Sentence: 758,eyes,O
Sentence: 758,by,O
Sentence: 758,forced,O
Sentence: 758,duction,O
Sentence: 758,testing,O
Sentence: 758,",",O
Sentence: 758,comparing,O
Sentence: 758,ocular,O
Sentence: 758,motility,O
Sentence: 758,after,O
Sentence: 758,tumor,B-Disease
Sentence: 758,control,O
Sentence: 758,with,O
Sentence: 758,ocular,O
Sentence: 758,motility,O
Sentence: 758,at,O
Sentence: 758,diagnosis,O
Sentence: 758,.,O
Sentence: 758,Eyes,O
Sentence: 758,subsequently,O
Sentence: 758,enucleated,O
Sentence: 758,because,O
Sentence: 758,of,O
Sentence: 758,treatment,O
Sentence: 758,failure,O
Sentence: 758,(,O
Sentence: 758,n,O
Sentence: 758,,O
Sentence: 758,=,O
Sentence: 758,,O
Sentence: 758,4,O
Sentence: 758,),O
Sentence: 758,were,O
Sentence: 758,examined,O
Sentence: 758,histologically,O
Sentence: 758,.,O
Sentence: 758,RESULTS,O
Sentence: 758,:,O
Sentence: 758,Limitation,O
Sentence: 758,of,O
Sentence: 758,ocular,O
Sentence: 758,motility,O
Sentence: 758,was,O
Sentence: 758,detected,O
Sentence: 758,in,O
Sentence: 758,all,O
Sentence: 758,12,O
Sentence: 758,eyes,O
Sentence: 758,of,O
Sentence: 758,10,O
Sentence: 758,patients,O
Sentence: 758,treated,O
Sentence: 758,for,O
Sentence: 758,intraocular,O
Sentence: 758,retinoblastoma,B-Disease
Sentence: 758,with,O
Sentence: 758,1,O
Sentence: 758,to,O
Sentence: 758,6,O
Sentence: 758,injections,O
Sentence: 758,of,O
Sentence: 758,subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,as,O
Sentence: 758,part,O
Sentence: 758,of,O
Sentence: 758,multimodality,O
Sentence: 758,therapy,O
Sentence: 758,.,O
Sentence: 758,Histopathological,O
Sentence: 758,examination,O
Sentence: 758,revealed,O
Sentence: 758,many,O
Sentence: 758,lipophages,O
Sentence: 758,in,O
Sentence: 758,the,O
Sentence: 758,periorbital,O
Sentence: 758,fat,O
Sentence: 758,surrounding,O
Sentence: 758,the,O
Sentence: 758,optic,O
Sentence: 758,nerve,O
Sentence: 758,in,O
Sentence: 758,1,O
Sentence: 758,eye,O
Sentence: 758,",",O
Sentence: 758,indicative,O
Sentence: 758,of,O
Sentence: 758,phagocytosis,O
Sentence: 758,of,O
Sentence: 758,previously,O
Sentence: 758,existing,O
Sentence: 758,fat,O
Sentence: 758,cells,O
Sentence: 758,and,O
Sentence: 758,suggesting,O
Sentence: 758,prior,O
Sentence: 758,fat,O
Sentence: 758,necrosis,B-Disease
Sentence: 758,.,O
Sentence: 758,The,O
Sentence: 758,enucleations,O
Sentence: 758,were,O
Sentence: 758,technically,O
Sentence: 758,difficult,O
Sentence: 758,and,O
Sentence: 758,hazardous,O
Sentence: 758,for,O
Sentence: 758,globe,O
Sentence: 758,rupture,B-Disease
Sentence: 758,because,O
Sentence: 758,of,O
Sentence: 758,extensive,O
Sentence: 758,orbital,O
Sentence: 758,soft,O
Sentence: 758,tissue,O
Sentence: 758,adhesions,O
Sentence: 758,.,O
Sentence: 758,CONCLUSIONS,O
Sentence: 758,:,O
Sentence: 758,Subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,chemotherapy,O
Sentence: 758,is,O
Sentence: 758,associated,O
Sentence: 758,with,O
Sentence: 758,significant,O
Sentence: 758,fibrosis,B-Disease
Sentence: 758,of,O
Sentence: 758,orbital,O
Sentence: 758,soft,O
Sentence: 758,tissues,O
Sentence: 758,",",O
Sentence: 758,leading,O
Sentence: 758,to,O
Sentence: 758,mechanical,O
Sentence: 758,restriction,O
Sentence: 758,of,O
Sentence: 758,eye,O
Sentence: 758,movements,O
Sentence: 758,and,O
Sentence: 758,making,O
Sentence: 758,subsequent,O
Sentence: 758,enucleation,O
Sentence: 758,difficult,O
Sentence: 758,.,O
Sentence: 758,Subtenon,O
Sentence: 758,carboplatin,B-Chemical
Sentence: 758,is,O
Sentence: 758,not,O
Sentence: 758,free,O
Sentence: 758,of,O
Sentence: 758,toxicity,B-Disease
Sentence: 758,",",O
Sentence: 758,and,O
Sentence: 758,its,O
Sentence: 758,use,O
Sentence: 758,is,O
Sentence: 758,best,O
Sentence: 758,restricted,O
Sentence: 758,to,O
Sentence: 758,specific,O
Sentence: 758,indications,O
Sentence: 758,.,O
Sentence: 759,Ethambutol,B-Chemical
Sentence: 759,and,O
Sentence: 759,optic,B-Disease
Sentence: 759,neuropathy,I-Disease
Sentence: 759,.,O
Sentence: 760,PURPOSE,O
Sentence: 760,:,O
Sentence: 760,To,O
Sentence: 760,demonstrate,O
Sentence: 760,the,O
Sentence: 760,association,O
Sentence: 760,between,O
Sentence: 760,ethambutol,B-Chemical
Sentence: 760,and,O
Sentence: 760,optic,B-Disease
Sentence: 760,neuropathy,I-Disease
Sentence: 760,.,O
Sentence: 760,METHOD,O
Sentence: 760,:,O
Sentence: 760,Thirteen,O
Sentence: 760,patients,O
Sentence: 760,who,O
Sentence: 760,developed,O
Sentence: 760,optic,B-Disease
Sentence: 760,neuropathy,I-Disease
Sentence: 760,after,O
Sentence: 760,being,O
Sentence: 760,treated,O
Sentence: 760,with,O
Sentence: 760,ethambutol,B-Chemical
Sentence: 760,for,O
Sentence: 760,tuberculosis,B-Disease
Sentence: 760,of,I-Disease
Sentence: 760,the,I-Disease
Sentence: 760,lung,I-Disease
Sentence: 760,or,I-Disease
Sentence: 760,lymph,I-Disease
Sentence: 760,node,I-Disease
Sentence: 760,at,O
Sentence: 760,Siriraj,O
Sentence: 760,Hospital,O
Sentence: 760,between,O
Sentence: 760,1997,O
Sentence: 760,and,O
Sentence: 760,2001,O
Sentence: 760,were,O
Sentence: 760,retrospectively,O
Sentence: 760,reviewed,O
Sentence: 760,.,O
Sentence: 760,The,O
Sentence: 760,clinical,O
Sentence: 760,characteristics,O
Sentence: 760,and,O
Sentence: 760,initial,O
Sentence: 760,and,O
Sentence: 760,final,O
Sentence: 760,visual,O
Sentence: 760,acuity,O
Sentence: 760,were,O
Sentence: 760,analyzed,O
Sentence: 760,to,O
Sentence: 760,determine,O
Sentence: 760,visual,O
Sentence: 760,outcome,O
Sentence: 760,.,O
Sentence: 760,RESULTS,O
Sentence: 760,:,O
Sentence: 760,All,O
Sentence: 760,patients,O
Sentence: 760,had,O
Sentence: 760,optic,B-Disease
Sentence: 760,neuropathy,I-Disease
Sentence: 760,between,O
Sentence: 760,1,O
Sentence: 760,to,O
Sentence: 760,6,O
Sentence: 760,months,O
Sentence: 760,(,O
Sentence: 760,mean,O
Sentence: 760,,O
Sentence: 760,=,O
Sentence: 760,,O
Sentence: 760,2.9,O
Sentence: 760,months,O
Sentence: 760,),O
Sentence: 760,after,O
Sentence: 760,starting,O
Sentence: 760,ethambutol,B-Chemical
Sentence: 760,therapy,O
Sentence: 760,at,O
Sentence: 760,a,O
Sentence: 760,dosage,O
Sentence: 760,ranging,O
Sentence: 760,from,O
Sentence: 760,13,O
Sentence: 760,to,O
Sentence: 760,20,O
Sentence: 760,mg,O
Sentence: 760,/,O
Sentence: 760,kg,O
Sentence: 760,/,O
Sentence: 760,day,O
Sentence: 760,(,O
Sentence: 760,mean,O
Sentence: 760,,O
Sentence: 760,=,O
Sentence: 760,,O
Sentence: 760,17,O
Sentence: 760,mg,O
Sentence: 760,/,O
Sentence: 760,kg,O
Sentence: 760,/,O
Sentence: 760,day,O
Sentence: 760,),O
Sentence: 760,.,O
Sentence: 760,Seven,O
Sentence: 760,(,O
Sentence: 760,54,O
Sentence: 760,%,O
Sentence: 760,),O
Sentence: 760,of,O
Sentence: 760,the,O
Sentence: 760,13,O
Sentence: 760,patients,O
Sentence: 760,experienced,O
Sentence: 760,visual,O
Sentence: 760,recovery,O
Sentence: 760,after,O
Sentence: 760,stopping,O
Sentence: 760,the,O
Sentence: 760,drug,O
Sentence: 760,.,O
Sentence: 760,Of,O
Sentence: 760,6,O
Sentence: 760,patients,O
Sentence: 760,with,O
Sentence: 760,irreversible,O
Sentence: 760,visual,B-Disease
Sentence: 760,impairment,I-Disease
Sentence: 760,",",O
Sentence: 760,4,O
Sentence: 760,patients,O
Sentence: 760,had,O
Sentence: 760,diabetes,B-Disease
Sentence: 760,mellitus,I-Disease
Sentence: 760,",",O
Sentence: 760,glaucoma,B-Disease
Sentence: 760,and,O
Sentence: 760,a,O
Sentence: 760,history,O
Sentence: 760,of,O
Sentence: 760,heavy,O
Sentence: 760,smoking,O
Sentence: 760,.,O
Sentence: 760,CONCLUSION,O
Sentence: 760,:,O
Sentence: 760,Early,O
Sentence: 760,recognition,O
Sentence: 760,of,O
Sentence: 760,optic,B-Disease
Sentence: 760,neuropathy,I-Disease
Sentence: 760,should,O
Sentence: 760,be,O
Sentence: 760,considered,O
Sentence: 760,in,O
Sentence: 760,patients,O
Sentence: 760,with,O
Sentence: 760,ethambutol,B-Chemical
Sentence: 760,therapy,O
Sentence: 760,.,O
Sentence: 760,A,O
Sentence: 760,low,O
Sentence: 760,dose,O
Sentence: 760,and,O
Sentence: 760,prompt,O
Sentence: 760,discontinuation,O
Sentence: 760,of,O
Sentence: 760,the,O
Sentence: 760,drug,O
Sentence: 760,is,O
Sentence: 760,recommended,O
Sentence: 760,particularly,O
Sentence: 760,in,O
Sentence: 760,individuals,O
Sentence: 760,with,O
Sentence: 760,diabetes,B-Disease
Sentence: 760,mellitus,I-Disease
Sentence: 760,",",O
Sentence: 760,glaucoma,B-Disease
Sentence: 760,or,O
Sentence: 760,who,O
Sentence: 760,are,O
Sentence: 760,heavy,O
Sentence: 760,smokers,O
Sentence: 760,.,O
Sentence: 761,Treatment,O
Sentence: 761,of,O
Sentence: 761,compensatory,O
Sentence: 761,gustatory,B-Disease
Sentence: 761,hyperhidrosis,I-Disease
Sentence: 761,with,O
Sentence: 761,topical,O
Sentence: 761,glycopyrrolate,B-Chemical
Sentence: 761,.,O
Sentence: 762,Gustatory,B-Disease
Sentence: 762,hyperhidrosis,B-Disease
Sentence: 762,is,O
Sentence: 762,facial,O
Sentence: 762,sweating,B-Disease
Sentence: 762,usually,O
Sentence: 762,associated,O
Sentence: 762,with,O
Sentence: 762,the,O
Sentence: 762,eating,O
Sentence: 762,of,O
Sentence: 762,hot,O
Sentence: 762,spicy,O
Sentence: 762,food,O
Sentence: 762,or,O
Sentence: 762,even,O
Sentence: 762,smelling,O
Sentence: 762,this,O
Sentence: 762,food,O
Sentence: 762,.,O
Sentence: 762,Current,O
Sentence: 762,options,O
Sentence: 762,of,O
Sentence: 762,treatment,O
Sentence: 762,include,O
Sentence: 762,oral,O
Sentence: 762,anticholinergic,O
Sentence: 762,drugs,O
Sentence: 762,",",O
Sentence: 762,the,O
Sentence: 762,topical,O
Sentence: 762,application,O
Sentence: 762,of,O
Sentence: 762,anticholinergics,O
Sentence: 762,or,O
Sentence: 762,aluminum,B-Chemical
Sentence: 762,chloride,I-Chemical
Sentence: 762,",",O
Sentence: 762,and,O
Sentence: 762,the,O
Sentence: 762,injection,O
Sentence: 762,of,O
Sentence: 762,botulinum,O
Sentence: 762,toxin,O
Sentence: 762,.,O
Sentence: 762,Thirteen,O
Sentence: 762,patients,O
Sentence: 762,have,O
Sentence: 762,been,O
Sentence: 762,treated,O
Sentence: 762,to,O
Sentence: 762,date,O
Sentence: 762,with,O
Sentence: 762,1.5,O
Sentence: 762,%,O
Sentence: 762,or,O
Sentence: 762,2,O
Sentence: 762,%,O
Sentence: 762,topical,O
Sentence: 762,glycopyrrolate,B-Chemical
Sentence: 762,.,O
Sentence: 762,All,O
Sentence: 762,patients,O
Sentence: 762,had,O
Sentence: 762,gustatory,B-Disease
Sentence: 762,hyperhidrosis,I-Disease
Sentence: 762,",",O
Sentence: 762,which,O
Sentence: 762,interfered,O
Sentence: 762,with,O
Sentence: 762,their,O
Sentence: 762,social,O
Sentence: 762,activities,O
Sentence: 762,",",O
Sentence: 762,after,O
Sentence: 762,transthroacic,O
Sentence: 762,endoscopic,O
Sentence: 762,sympathectomy,O
Sentence: 762,",",O
Sentence: 762,and,O
Sentence: 762,which,O
Sentence: 762,was,O
Sentence: 762,associated,O
Sentence: 762,with,O
Sentence: 762,compensatory,O
Sentence: 762,focal,O
Sentence: 762,hyperhidrosis,B-Disease
Sentence: 762,.,O
Sentence: 762,After,O
Sentence: 762,applying,O
Sentence: 762,topical,O
Sentence: 762,glycopyrrolate,B-Chemical
Sentence: 762,",",O
Sentence: 762,the,O
Sentence: 762,subjective,O
Sentence: 762,effect,O
Sentence: 762,was,O
Sentence: 762,excellent,O
Sentence: 762,(,O
Sentence: 762,no,O
Sentence: 762,sweating,B-Disease
Sentence: 762,after,O
Sentence: 762,eating,O
Sentence: 762,hot,O
Sentence: 762,spicy,O
Sentence: 762,food,O
Sentence: 762,),O
Sentence: 762,in,O
Sentence: 762,10,O
Sentence: 762,patients,O
Sentence: 762,(,O
Sentence: 762,77,O
Sentence: 762,%,O
Sentence: 762,),O
Sentence: 762,",",O
Sentence: 762,and,O
Sentence: 762,fair,O
Sentence: 762,(,O
Sentence: 762,clearly,O
Sentence: 762,reduced,O
Sentence: 762,sweating,B-Disease
Sentence: 762,),O
Sentence: 762,in,O
Sentence: 762,3,O
Sentence: 762,patients,O
Sentence: 762,(,O
Sentence: 762,23,O
Sentence: 762,%,O
Sentence: 762,),O
Sentence: 762,.,O
Sentence: 762,All,O
Sentence: 762,had,O
Sentence: 762,reported,O
Sentence: 762,incidents,O
Sentence: 762,of,O
Sentence: 762,being,O
Sentence: 762,very,O
Sentence: 762,embarrassed,O
Sentence: 762,whilst,O
Sentence: 762,eating,O
Sentence: 762,hot,O
Sentence: 762,spicy,O
Sentence: 762,foods,O
Sentence: 762,.,O
Sentence: 762,Adverse,O
Sentence: 762,effects,O
Sentence: 762,included,O
Sentence: 762,a,O
Sentence: 762,mildly,O
Sentence: 762,dry,B-Disease
Sentence: 762,mouth,I-Disease
Sentence: 762,and,O
Sentence: 762,a,O
Sentence: 762,sore,B-Disease
Sentence: 762,throat,I-Disease
Sentence: 762,in,O
Sentence: 762,2,O
Sentence: 762,patients,O
Sentence: 762,(,O
Sentence: 762,2,O
Sentence: 762,%,O
Sentence: 762,glycopyrrolate,B-Chemical
Sentence: 762,),O
Sentence: 762,",",O
Sentence: 762,a,O
Sentence: 762,light,O
Sentence: 762,headache,B-Disease
Sentence: 762,in,O
Sentence: 762,1,O
Sentence: 762,patient,O
Sentence: 762,(,O
Sentence: 762,1.5,O
Sentence: 762,%,O
Sentence: 762,glycopyrrolate,B-Chemical
Sentence: 762,),O
Sentence: 762,.,O
Sentence: 762,The,O
Sentence: 762,topical,O
Sentence: 762,application,O
Sentence: 762,of,O
Sentence: 762,a,O
Sentence: 762,glycopyrrolate,B-Chemical
Sentence: 762,pad,O
Sentence: 762,appeared,O
Sentence: 762,to,O
Sentence: 762,be,O
Sentence: 762,safe,O
Sentence: 762,",",O
Sentence: 762,efficacious,O
Sentence: 762,",",O
Sentence: 762,well,O
Sentence: 762,tolerated,O
Sentence: 762,",",O
Sentence: 762,and,O
Sentence: 762,a,O
Sentence: 762,convenient,O
Sentence: 762,method,O
Sentence: 762,of,O
Sentence: 762,treatment,O
Sentence: 762,for,O
Sentence: 762,moderate,O
Sentence: 762,to,O
Sentence: 762,severe,O
Sentence: 762,symptoms,O
Sentence: 762,of,O
Sentence: 762,gustatory,B-Disease
Sentence: 762,hyperhidrosis,I-Disease
Sentence: 762,in,O
Sentence: 762,post,O
Sentence: 762,transthoracic,O
Sentence: 762,endoscopic,O
Sentence: 762,sympathectomy,O
Sentence: 762,or,O
Sentence: 762,sympathicotomy,O
Sentence: 762,patients,O
Sentence: 762,",",O
Sentence: 762,with,O
Sentence: 762,few,O
Sentence: 762,side,O
Sentence: 762,effects,O
Sentence: 762,.,O
Sentence: 763,Pharmacological,O
Sentence: 763,characteristics,O
Sentence: 763,and,O
Sentence: 763,side,O
Sentence: 763,effects,O
Sentence: 763,of,O
Sentence: 763,a,O
Sentence: 763,new,O
Sentence: 763,galenic,O
Sentence: 763,formulation,O
Sentence: 763,of,O
Sentence: 763,propofol,O
Sentence: 763,without,O
Sentence: 763,soyabean,O
Sentence: 763,oil,O
Sentence: 763,.,O
Sentence: 764,We,O
Sentence: 764,compared,O
Sentence: 764,the,O
Sentence: 764,pharmacokinetics,O
Sentence: 764,",",O
Sentence: 764,pharmacodynamics,O
Sentence: 764,and,O
Sentence: 764,safety,O
Sentence: 764,profile,O
Sentence: 764,of,O
Sentence: 764,a,O
Sentence: 764,new,O
Sentence: 764,galenic,O
Sentence: 764,formulation,O
Sentence: 764,of,O
Sentence: 764,propofol,B-Chemical
Sentence: 764,(,O
Sentence: 764,AM149,O
Sentence: 764,1,O
Sentence: 764,%,O
Sentence: 764,),O
Sentence: 764,",",O
Sentence: 764,which,O
Sentence: 764,does,O
Sentence: 764,not,O
Sentence: 764,contain,O
Sentence: 764,soyabean,O
Sentence: 764,oil,O
Sentence: 764,",",O
Sentence: 764,with,O
Sentence: 764,a,O
Sentence: 764,standard,O
Sentence: 764,formulation,O
Sentence: 764,of,O
Sentence: 764,propofol,B-Chemical
Sentence: 764,(,O
Sentence: 764,Disoprivan,B-Chemical
Sentence: 764,1,O
Sentence: 764,%,O
Sentence: 764,),O
Sentence: 764,.,O
Sentence: 764,In,O
Sentence: 764,a,O
Sentence: 764,randomised,O
Sentence: 764,",",O
Sentence: 764,double,O
Sentence: 764,-,O
Sentence: 764,blind,O
Sentence: 764,",",O
Sentence: 764,cross,O
Sentence: 764,-,O
Sentence: 764,over,O
Sentence: 764,study,O
Sentence: 764,",",O
Sentence: 764,30,O
Sentence: 764,healthy,O
Sentence: 764,volunteers,O
Sentence: 764,received,O
Sentence: 764,a,O
Sentence: 764,single,O
Sentence: 764,intravenous,O
Sentence: 764,bolus,O
Sentence: 764,injection,O
Sentence: 764,of,O
Sentence: 764,2.5,O
Sentence: 764,mg.kg,O
Sentence: 764,-,O
Sentence: 764,1,O
Sentence: 764,propofol,B-Chemical
Sentence: 764,.,O
Sentence: 764,Plasma,O
Sentence: 764,propofol,B-Chemical
Sentence: 764,levels,O
Sentence: 764,were,O
Sentence: 764,measured,O
Sentence: 764,for,O
Sentence: 764,48,O
Sentence: 764,h,O
Sentence: 764,following,O
Sentence: 764,drug,O
Sentence: 764,administration,O
Sentence: 764,and,O
Sentence: 764,evaluated,O
Sentence: 764,according,O
Sentence: 764,to,O
Sentence: 764,a,O
Sentence: 764,three,O
Sentence: 764,-,O
Sentence: 764,compartment,O
Sentence: 764,model,O
Sentence: 764,.,O
Sentence: 764,The,O
Sentence: 764,pharmacodynamic,O
Sentence: 764,parameters,O
Sentence: 764,assessed,O
Sentence: 764,included,O
Sentence: 764,induction,O
Sentence: 764,and,O
Sentence: 764,emergence,O
Sentence: 764,times,O
Sentence: 764,",",O
Sentence: 764,respiratory,O
Sentence: 764,and,O
Sentence: 764,cardiovascular,O
Sentence: 764,effects,O
Sentence: 764,",",O
Sentence: 764,and,O
Sentence: 764,pain,B-Disease
Sentence: 764,on,O
Sentence: 764,injection,O
Sentence: 764,.,O
Sentence: 764,Patients,O
Sentence: 764,were,O
Sentence: 764,monitored,O
Sentence: 764,for,O
Sentence: 764,side,O
Sentence: 764,effects,O
Sentence: 764,over,O
Sentence: 764,48,O
Sentence: 764,h.,O
Sentence: 764,Owing,O
Sentence: 764,to,O
Sentence: 764,a,O
Sentence: 764,high,O
Sentence: 764,incidence,O
Sentence: 764,of,O
Sentence: 764,thrombophlebitis,B-Disease
Sentence: 764,",",O
Sentence: 764,the,O
Sentence: 764,study,O
Sentence: 764,was,O
Sentence: 764,terminated,O
Sentence: 764,prematurely,O
Sentence: 764,and,O
Sentence: 764,only,O
Sentence: 764,the,O
Sentence: 764,data,O
Sentence: 764,of,O
Sentence: 764,the,O
Sentence: 764,two,O
Sentence: 764,parallel,O
Sentence: 764,treatment,O
Sentence: 764,groups,O
Sentence: 764,(,O
Sentence: 764,15,O
Sentence: 764,patients,O
Sentence: 764,in,O
Sentence: 764,each,O
Sentence: 764,group,O
Sentence: 764,),O
Sentence: 764,were,O
Sentence: 764,analysed,O
Sentence: 764,.,O
Sentence: 764,Plasma,O
Sentence: 764,concentrations,O
Sentence: 764,did,O
Sentence: 764,not,O
Sentence: 764,differ,O
Sentence: 764,significantly,O
Sentence: 764,between,O
Sentence: 764,the,O
Sentence: 764,two,O
Sentence: 764,formulations,O
Sentence: 764,.,O
Sentence: 764,Anaesthesia,O
Sentence: 764,induction,O
Sentence: 764,and,O
Sentence: 764,emergence,O
Sentence: 764,times,O
Sentence: 764,",",O
Sentence: 764,respiratory,O
Sentence: 764,and,O
Sentence: 764,cardiovascular,O
Sentence: 764,variables,O
Sentence: 764,showed,O
Sentence: 764,no,O
Sentence: 764,significant,O
Sentence: 764,differences,O
Sentence: 764,between,O
Sentence: 764,the,O
Sentence: 764,two,O
Sentence: 764,treatment,O
Sentence: 764,groups,O
Sentence: 764,.,O
Sentence: 764,Pain,B-Disease
Sentence: 764,on,O
Sentence: 764,injection,O
Sentence: 764,(,O
Sentence: 764,80,O
Sentence: 764,vs.,O
Sentence: 764,20,O
Sentence: 764,%,O
Sentence: 764,",",O
Sentence: 764,p,O
Sentence: 764,,O
Sentence: 764,<,O
Sentence: 764,,O
Sentence: 764,0.01,O
Sentence: 764,),O
Sentence: 764,and,O
Sentence: 764,thrombophlebitis,B-Disease
Sentence: 764,(,O
Sentence: 764,93.3,O
Sentence: 764,vs.,O
Sentence: 764,6.6,O
Sentence: 764,%,O
Sentence: 764,",",O
Sentence: 764,p,O
Sentence: 764,,O
Sentence: 764,<,O
Sentence: 764,,O
Sentence: 764,0.001,O
Sentence: 764,),O
Sentence: 764,occurred,O
Sentence: 764,more,O
Sentence: 764,frequently,O
Sentence: 764,with,O
Sentence: 764,AM149,O
Sentence: 764,than,O
Sentence: 764,with,O
Sentence: 764,Disoprivan,B-Chemical
Sentence: 764,.,O
Sentence: 764,Although,O
Sentence: 764,both,O
Sentence: 764,formulations,O
Sentence: 764,had,O
Sentence: 764,similar,O
Sentence: 764,pharmacokinetic,O
Sentence: 764,and,O
Sentence: 764,pharmacodynamic,O
Sentence: 764,profiles,O
Sentence: 764,the,O
Sentence: 764,new,O
Sentence: 764,formulation,O
Sentence: 764,is,O
Sentence: 764,not,O
Sentence: 764,suitable,O
Sentence: 764,for,O
Sentence: 764,clinical,O
Sentence: 764,use,O
Sentence: 764,due,O
Sentence: 764,to,O
Sentence: 764,the,O
Sentence: 764,high,O
Sentence: 764,incidence,O
Sentence: 764,of,O
Sentence: 764,thrombophlebitis,B-Disease
Sentence: 764,produced,O
Sentence: 764,.,O
Sentence: 765,Vinorelbine,O
Sentence: 765,-,O
Sentence: 765,related,O
Sentence: 765,cardiac,O
Sentence: 765,events,O
Sentence: 765,:,O
Sentence: 765,a,O
Sentence: 765,meta,O
Sentence: 765,-,O
Sentence: 765,analysis,O
Sentence: 765,of,O
Sentence: 765,randomized,O
Sentence: 765,clinical,O
Sentence: 765,trials,O
Sentence: 765,.,O
Sentence: 766,Several,O
Sentence: 766,cases,O
Sentence: 766,of,O
Sentence: 766,cardiac,O
Sentence: 766,adverse,O
Sentence: 766,reactions,O
Sentence: 766,related,O
Sentence: 766,to,O
Sentence: 766,vinorelbine,B-Chemical
Sentence: 766,(,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,),O
Sentence: 766,have,O
Sentence: 766,been,O
Sentence: 766,reported,O
Sentence: 766,in,O
Sentence: 766,the,O
Sentence: 766,literature,O
Sentence: 766,.,O
Sentence: 766,In,O
Sentence: 766,order,O
Sentence: 766,to,O
Sentence: 766,quantify,O
Sentence: 766,the,O
Sentence: 766,incidence,O
Sentence: 766,of,O
Sentence: 766,these,O
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,",",O
Sentence: 766,we,O
Sentence: 766,performed,O
Sentence: 766,a,O
Sentence: 766,meta,O
Sentence: 766,-,O
Sentence: 766,analysis,O
Sentence: 766,of,O
Sentence: 766,clinical,O
Sentence: 766,trials,O
Sentence: 766,comparing,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,with,O
Sentence: 766,other,O
Sentence: 766,chemotherapeutic,O
Sentence: 766,agents,O
Sentence: 766,in,O
Sentence: 766,the,O
Sentence: 766,treatment,O
Sentence: 766,of,O
Sentence: 766,various,O
Sentence: 766,malignancies,B-Disease
Sentence: 766,.,O
Sentence: 766,Randomized,O
Sentence: 766,clinical,O
Sentence: 766,trials,O
Sentence: 766,comparing,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,with,O
Sentence: 766,other,O
Sentence: 766,drugs,O
Sentence: 766,in,O
Sentence: 766,the,O
Sentence: 766,treatment,O
Sentence: 766,of,O
Sentence: 766,cancer,B-Disease
Sentence: 766,were,O
Sentence: 766,searched,O
Sentence: 766,in,O
Sentence: 766,Medline,O
Sentence: 766,",",O
Sentence: 766,Embase,O
Sentence: 766,",",O
Sentence: 766,Evidence,O
Sentence: 766,-,O
Sentence: 766,based,O
Sentence: 766,Medicine,O
Sentence: 766,Reviews,O
Sentence: 766,databases,O
Sentence: 766,and,O
Sentence: 766,the,O
Sentence: 766,Cochrane,O
Sentence: 766,library,O
Sentence: 766,from,O
Sentence: 766,1987,O
Sentence: 766,to,O
Sentence: 766,2002,O
Sentence: 766,.,O
Sentence: 766,Outcomes,O
Sentence: 766,of,O
Sentence: 766,interest,O
Sentence: 766,were,O
Sentence: 766,severe,O
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,",",O
Sentence: 766,toxic,O
Sentence: 766,deaths,O
Sentence: 766,and,O
Sentence: 766,cardiac,O
Sentence: 766,event,O
Sentence: 766,-,O
Sentence: 766,related,O
Sentence: 766,deaths,O
Sentence: 766,reported,O
Sentence: 766,in,O
Sentence: 766,each,O
Sentence: 766,publication,O
Sentence: 766,.,O
Sentence: 766,We,O
Sentence: 766,found,O
Sentence: 766,19,O
Sentence: 766,trials,O
Sentence: 766,",",O
Sentence: 766,involving,O
Sentence: 766,2441,O
Sentence: 766,patients,O
Sentence: 766,treated,O
Sentence: 766,by,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,and,O
Sentence: 766,2050,O
Sentence: 766,control,O
Sentence: 766,patients,O
Sentence: 766,.,O
Sentence: 766,The,O
Sentence: 766,incidence,O
Sentence: 766,of,O
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,with,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,was,O
Sentence: 766,1.19,O
Sentence: 766,%,O
Sentence: 766,[,O
Sentence: 766,95,O
Sentence: 766,%,O
Sentence: 766,confidence,O
Sentence: 766,interval,O
Sentence: 766,(,O
Sentence: 766,CI,O
Sentence: 766,),O
Sentence: 766,(,O
Sentence: 766,0.75,O
Sentence: 766,;,O
Sentence: 766,1.67,O
Sentence: 766,),O
Sentence: 766,],O
Sentence: 766,.,O
Sentence: 766,There,O
Sentence: 766,was,O
Sentence: 766,no,O
Sentence: 766,difference,O
Sentence: 766,in,O
Sentence: 766,the,O
Sentence: 766,risk,O
Sentence: 766,of,O
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,between,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,and,O
Sentence: 766,other,O
Sentence: 766,drugs,O
Sentence: 766,[,O
Sentence: 766,odds,O
Sentence: 766,ratio,O
Sentence: 766,:,O
Sentence: 766,0.92,O
Sentence: 766,",",O
Sentence: 766,95,O
Sentence: 766,%,O
Sentence: 766,CI,O
Sentence: 766,(,O
Sentence: 766,0.54,O
Sentence: 766,;,O
Sentence: 766,1.55,O
Sentence: 766,),O
Sentence: 766,],O
Sentence: 766,.,O
Sentence: 766,The,O
Sentence: 766,risk,O
Sentence: 766,of,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,was,O
Sentence: 766,similar,O
Sentence: 766,to,O
Sentence: 766,vindesine,B-Chemical
Sentence: 766,(,O
Sentence: 766,VDS,B-Chemical
Sentence: 766,),O
Sentence: 766,and,O
Sentence: 766,other,O
Sentence: 766,cardiotoxic,B-Disease
Sentence: 766,drugs,O
Sentence: 766,[,O
Sentence: 766,fluorouracil,B-Chemical
Sentence: 766,",",O
Sentence: 766,anthracyclines,B-Chemical
Sentence: 766,",",O
Sentence: 766,gemcitabine,B-Chemical
Sentence: 766,(,O
Sentence: 766,GEM,B-Chemical
Sentence: 766,),O
Sentence: 766,em,O
Sentence: 766,leader,O
Sentence: 766,],O
Sentence: 766,.,O
Sentence: 766,Even,O
Sentence: 766,if,O
Sentence: 766,it,O
Sentence: 766,did,O
Sentence: 766,not,O
Sentence: 766,reach,O
Sentence: 766,statistical,O
Sentence: 766,significance,O
Sentence: 766,because,O
Sentence: 766,of,O
Sentence: 766,a,O
Sentence: 766,few,O
Sentence: 766,number,O
Sentence: 766,of,O
Sentence: 766,cases,O
Sentence: 766,",",O
Sentence: 766,the,O
Sentence: 766,risk,O
Sentence: 766,was,O
Sentence: 766,lower,O
Sentence: 766,in,O
Sentence: 766,trials,O
Sentence: 766,excluding,O
Sentence: 766,patients,O
Sentence: 766,with,O
Sentence: 766,cardiac,O
Sentence: 766,history,O
Sentence: 766,",",O
Sentence: 766,and,O
Sentence: 766,seemed,O
Sentence: 766,to,O
Sentence: 766,be,O
Sentence: 766,higher,O
Sentence: 766,in,O
Sentence: 766,trials,O
Sentence: 766,including,O
Sentence: 766,patients,O
Sentence: 766,with,O
Sentence: 766,pre,O
Sentence: 766,-,O
Sentence: 766,existing,O
Sentence: 766,cardiac,B-Disease
Sentence: 766,diseases,I-Disease
Sentence: 766,.,O
Sentence: 766,Vinorelbine,B-Chemical
Sentence: 766,-,O
Sentence: 766,related,O
Sentence: 766,cardiac,O
Sentence: 766,events,O
Sentence: 766,concern,O
Sentence: 766,about,O
Sentence: 766,1,O
Sentence: 766,%,O
Sentence: 766,of,O
Sentence: 766,treated,O
Sentence: 766,patients,O
Sentence: 766,in,O
Sentence: 766,clinical,O
Sentence: 766,trials,O
Sentence: 766,.,O
Sentence: 766,However,O
Sentence: 766,",",O
Sentence: 766,the,O
Sentence: 766,risk,O
Sentence: 766,associated,O
Sentence: 766,with,O
Sentence: 766,VNR,B-Chemical
Sentence: 766,seems,O
Sentence: 766,to,O
Sentence: 766,be,O
Sentence: 766,similar,O
Sentence: 766,to,O
Sentence: 766,that,O
Sentence: 766,of,O
Sentence: 766,other,O
Sentence: 766,chemotherapeutic,O
Sentence: 766,agents,O
Sentence: 766,in,O
Sentence: 766,the,O
Sentence: 766,same,O
Sentence: 766,indications,O
Sentence: 766,.,O
Sentence: 767,MRI,O
Sentence: 767,findings,O
Sentence: 767,of,O
Sentence: 767,hypoxic,O
Sentence: 767,cortical,O
Sentence: 767,laminar,O
Sentence: 767,necrosis,B-Disease
Sentence: 767,in,O
Sentence: 767,a,O
Sentence: 767,child,O
Sentence: 767,with,O
Sentence: 767,hemolytic,B-Disease
Sentence: 767,anemia,I-Disease
Sentence: 767,crisis,O
Sentence: 767,.,O
Sentence: 768,We,O
Sentence: 768,present,O
Sentence: 768,magnetic,O
Sentence: 768,resonance,O
Sentence: 768,imaging,O
Sentence: 768,findings,O
Sentence: 768,of,O
Sentence: 768,a,O
Sentence: 768,5,O
Sentence: 768,-,O
Sentence: 768,year,O
Sentence: 768,-,O
Sentence: 768,old,O
Sentence: 768,girl,O
Sentence: 768,who,O
Sentence: 768,had,O
Sentence: 768,a,O
Sentence: 768,rapidly,O
Sentence: 768,installing,O
Sentence: 768,hemolytic,B-Disease
Sentence: 768,anemia,I-Disease
Sentence: 768,crisis,O
Sentence: 768,induced,O
Sentence: 768,by,O
Sentence: 768,trimethoprim,O
Sentence: 768,-,O
Sentence: 768,sulfomethoxazole,O
Sentence: 768,",",O
Sentence: 768,resulting,O
Sentence: 768,in,O
Sentence: 768,cerebral,B-Disease
Sentence: 768,anoxia,I-Disease
Sentence: 768,leading,O
Sentence: 768,to,O
Sentence: 768,permanent,O
Sentence: 768,damage,O
Sentence: 768,.,O
Sentence: 768,Magnetic,O
Sentence: 768,Resonance,O
Sentence: 768,imaging,O
Sentence: 768,revealed,O
Sentence: 768,cortical,O
Sentence: 768,laminar,O
Sentence: 768,necrosis,B-Disease
Sentence: 768,in,O
Sentence: 768,arterial,O
Sentence: 768,border,O
Sentence: 768,zones,O
Sentence: 768,in,O
Sentence: 768,both,O
Sentence: 768,cerebral,O
Sentence: 768,hemispheres,O
Sentence: 768,",",O
Sentence: 768,ischemic,O
Sentence: 768,changes,O
Sentence: 768,in,O
Sentence: 768,subcortical,O
Sentence: 768,white,O
Sentence: 768,matter,O
Sentence: 768,of,O
Sentence: 768,left,O
Sentence: 768,cerebral,O
Sentence: 768,hemisphere,O
Sentence: 768,",",O
Sentence: 768,and,O
Sentence: 768,in,O
Sentence: 768,the,O
Sentence: 768,left,O
Sentence: 768,putamen,O
Sentence: 768,.,O
Sentence: 768,Although,O
Sentence: 768,cortical,O
Sentence: 768,laminar,O
Sentence: 768,necrosis,B-Disease
Sentence: 768,is,O
Sentence: 768,a,O
Sentence: 768,classic,O
Sentence: 768,entity,O
Sentence: 768,in,O
Sentence: 768,adulthood,O
Sentence: 768,related,O
Sentence: 768,to,O
Sentence: 768,conditions,O
Sentence: 768,of,O
Sentence: 768,energy,O
Sentence: 768,depletions,O
Sentence: 768,",",O
Sentence: 768,there,O
Sentence: 768,are,O
Sentence: 768,few,O
Sentence: 768,reports,O
Sentence: 768,available,O
Sentence: 768,in,O
Sentence: 768,children,O
Sentence: 768,.,O
Sentence: 768,A,O
Sentence: 768,wide,O
Sentence: 768,review,O
Sentence: 768,of,O
Sentence: 768,the,O
Sentence: 768,literature,O
Sentence: 768,is,O
Sentence: 768,also,O
Sentence: 768,presented,O
Sentence: 768,.,O
Sentence: 769,The,O
Sentence: 769,natural,O
Sentence: 769,history,O
Sentence: 769,of,O
Sentence: 769,Vigabatrin,B-Chemical
Sentence: 769,associated,O
Sentence: 769,visual,B-Disease
Sentence: 769,field,I-Disease
Sentence: 769,defects,I-Disease
Sentence: 769,in,O
Sentence: 769,patients,O
Sentence: 769,electing,O
Sentence: 769,to,O
Sentence: 769,continue,O
Sentence: 769,their,O
Sentence: 769,medication,O
Sentence: 769,.,O
Sentence: 770,PURPOSE,O
Sentence: 770,:,O
Sentence: 770,To,O
Sentence: 770,determine,O
Sentence: 770,the,O
Sentence: 770,natural,O
Sentence: 770,history,O
Sentence: 770,of,O
Sentence: 770,visual,B-Disease
Sentence: 770,field,I-Disease
Sentence: 770,defects,I-Disease
Sentence: 770,in,O
Sentence: 770,a,O
Sentence: 770,group,O
Sentence: 770,of,O
Sentence: 770,patients,O
Sentence: 770,known,O
Sentence: 770,to,O
Sentence: 770,have,O
Sentence: 770,Vigabatrin,B-Chemical
Sentence: 770,-,O
Sentence: 770,associated,O
Sentence: 770,changes,O
Sentence: 770,who,O
Sentence: 770,elected,O
Sentence: 770,to,O
Sentence: 770,continue,O
Sentence: 770,the,O
Sentence: 770,medication,O
Sentence: 770,because,O
Sentence: 770,of,O
Sentence: 770,good,O
Sentence: 770,seizure,B-Disease
Sentence: 770,control,O
Sentence: 770,.,O
Sentence: 770,METHODS,O
Sentence: 770,:,O
Sentence: 770,All,O
Sentence: 770,patients,O
Sentence: 770,taking,O
Sentence: 770,Vigabatrin,B-Chemical
Sentence: 770,alone,O
Sentence: 770,or,O
Sentence: 770,in,O
Sentence: 770,combination,O
Sentence: 770,with,O
Sentence: 770,other,O
Sentence: 770,antiepileptic,O
Sentence: 770,drugs,O
Sentence: 770,for,O
Sentence: 770,at,O
Sentence: 770,least,O
Sentence: 770,5,O
Sentence: 770,years,O
Sentence: 770,(,O
Sentence: 770,range,O
Sentence: 770,5,O
Sentence: 770,-,O
Sentence: 770,12,O
Sentence: 770,years,O
Sentence: 770,),O
Sentence: 770,were,O
Sentence: 770,entered,O
Sentence: 770,into,O
Sentence: 770,a,O
Sentence: 770,visual,O
Sentence: 770,surveillance,O
Sentence: 770,programme,O
Sentence: 770,.,O
Sentence: 770,Patients,O
Sentence: 770,were,O
Sentence: 770,followed,O
Sentence: 770,up,O
Sentence: 770,at,O
Sentence: 770,6,O
Sentence: 770,-,O
Sentence: 770,monthly,O
Sentence: 770,intervals,O
Sentence: 770,for,O
Sentence: 770,not,O
Sentence: 770,less,O
Sentence: 770,than,O
Sentence: 770,18,O
Sentence: 770,months,O
Sentence: 770,(,O
Sentence: 770,range,O
Sentence: 770,18,O
Sentence: 770,-,O
Sentence: 770,43,O
Sentence: 770,months,O
Sentence: 770,),O
Sentence: 770,.,O
Sentence: 770,In,O
Sentence: 770,all,O
Sentence: 770,",",O
Sentence: 770,16,O
Sentence: 770,patients,O
Sentence: 770,with,O
Sentence: 770,unequivocal,O
Sentence: 770,defects,O
Sentence: 770,continued,O
Sentence: 770,the,O
Sentence: 770,medication,O
Sentence: 770,.,O
Sentence: 770,Following,O
Sentence: 770,already,O
Sentence: 770,published,O
Sentence: 770,methodology,O
Sentence: 770,(,O
Sentence: 770,Eye,O
Sentence: 770,2002,O
Sentence: 770,;,O
Sentence: 770,16,O
Sentence: 770,;,O
Sentence: 770,567,O
Sentence: 770,-,O
Sentence: 770,571,O
Sentence: 770,),O
Sentence: 770,monocular,O
Sentence: 770,mean,O
Sentence: 770,radial,O
Sentence: 770,degrees,O
Sentence: 770,(,O
Sentence: 770,MRDs,O
Sentence: 770,),O
Sentence: 770,to,O
Sentence: 770,the,O
Sentence: 770,I,O
Sentence: 770,/,O
Sentence: 770,4e,O
Sentence: 770,isopter,O
Sentence: 770,on,O
Sentence: 770,Goldmann,O
Sentence: 770,perimetry,O
Sentence: 770,was,O
Sentence: 770,calculated,O
Sentence: 770,for,O
Sentence: 770,the,O
Sentence: 770,right,O
Sentence: 770,eye,O
Sentence: 770,at,O
Sentence: 770,the,O
Sentence: 770,time,O
Sentence: 770,of,O
Sentence: 770,discovery,O
Sentence: 770,of,O
Sentence: 770,a,O
Sentence: 770,visual,B-Disease
Sentence: 770,field,I-Disease
Sentence: 770,defect,I-Disease
Sentence: 770,and,O
Sentence: 770,again,O
Sentence: 770,after,O
Sentence: 770,not,O
Sentence: 770,less,O
Sentence: 770,than,O
Sentence: 770,18,O
Sentence: 770,months,O
Sentence: 770,follow,O
Sentence: 770,-,O
Sentence: 770,up,O
Sentence: 770,.,O
Sentence: 770,RESULTS,O
Sentence: 770,:,O
Sentence: 770,Mean,O
Sentence: 770,right,O
Sentence: 770,eye,O
Sentence: 770,MRD,O
Sentence: 770,at,O
Sentence: 770,presentation,O
Sentence: 770,was,O
Sentence: 770,36.98,O
Sentence: 770,degrees,O
Sentence: 770,(,O
Sentence: 770,range,O
Sentence: 770,22.25,O
Sentence: 770,-,O
Sentence: 770,51.0,O
Sentence: 770,),O
Sentence: 770,",",O
Sentence: 770,compared,O
Sentence: 770,to,O
Sentence: 770,38.40,O
Sentence: 770,degrees,O
Sentence: 770,(,O
Sentence: 770,range,O
Sentence: 770,22.5,O
Sentence: 770,-,O
Sentence: 770,49.75,O
Sentence: 770,),O
Sentence: 770,after,O
Sentence: 770,follow,O
Sentence: 770,-,O
Sentence: 770,up,O
Sentence: 770,;,O
Sentence: 770,P,O
Sentence: 770,=,O
Sentence: 770,0.338,O
Sentence: 770,unpaired,O
Sentence: 770,t,O
Sentence: 770,-,O
Sentence: 770,test,O
Sentence: 770,.,O
Sentence: 770,Only,O
Sentence: 770,one,O
Sentence: 770,patient,O
Sentence: 770,demonstrated,O
Sentence: 770,a,O
Sentence: 770,deterioration,B-Disease
Sentence: 770,in,I-Disease
Sentence: 770,visual,I-Disease
Sentence: 770,field,I-Disease
Sentence: 770,during,O
Sentence: 770,the,O
Sentence: 770,study,O
Sentence: 770,period,O
Sentence: 770,and,O
Sentence: 770,discontinued,O
Sentence: 770,treatment,O
Sentence: 770,.,O
Sentence: 770,CONCLUSION,O
Sentence: 770,:,O
Sentence: 770,Established,O
Sentence: 770,visual,B-Disease
Sentence: 770,field,I-Disease
Sentence: 770,defects,I-Disease
Sentence: 770,presumed,O
Sentence: 770,to,O
Sentence: 770,be,O
Sentence: 770,due,O
Sentence: 770,to,O
Sentence: 770,Vigabatrin,B-Chemical
Sentence: 770,therapy,O
Sentence: 770,did,O
Sentence: 770,not,O
Sentence: 770,usually,O
Sentence: 770,progress,O
Sentence: 770,in,O
Sentence: 770,spite,O
Sentence: 770,of,O
Sentence: 770,continuing,O
Sentence: 770,use,O
Sentence: 770,of,O
Sentence: 770,the,O
Sentence: 770,medication,O
Sentence: 770,.,O
Sentence: 770,These,O
Sentence: 770,data,O
Sentence: 770,give,O
Sentence: 770,support,O
Sentence: 770,to,O
Sentence: 770,the,O
Sentence: 770,hypothesis,O
Sentence: 770,that,O
Sentence: 770,the,O
Sentence: 770,pathogenesis,O
Sentence: 770,of,O
Sentence: 770,Vigabatrin,B-Chemical
Sentence: 770,-,O
Sentence: 770,associated,O
Sentence: 770,visual,B-Disease
Sentence: 770,field,I-Disease
Sentence: 770,defects,I-Disease
Sentence: 770,may,O
Sentence: 770,be,O
Sentence: 770,an,O
Sentence: 770,idiosyncratic,O
Sentence: 770,adverse,O
Sentence: 770,drug,O
Sentence: 770,reaction,O
Sentence: 770,rather,O
Sentence: 770,than,O
Sentence: 770,dose,O
Sentence: 770,-,O
Sentence: 770,dependent,O
Sentence: 770,toxicity,B-Disease
Sentence: 770,.,O
Sentence: 771,Induction,O
Sentence: 771,of,O
Sentence: 771,rosaceiform,O
Sentence: 771,dermatitis,B-Disease
Sentence: 771,during,O
Sentence: 771,treatment,O
Sentence: 771,of,O
Sentence: 771,facial,B-Disease
Sentence: 771,inflammatory,I-Disease
Sentence: 771,dermatoses,I-Disease
Sentence: 771,with,O
Sentence: 771,tacrolimus,B-Chemical
Sentence: 771,ointment,O
Sentence: 771,.,O
Sentence: 772,BACKGROUND,O
Sentence: 772,:,O
Sentence: 772,Tacrolimus,B-Chemical
Sentence: 772,ointment,O
Sentence: 772,is,O
Sentence: 772,increasingly,O
Sentence: 772,used,O
Sentence: 772,for,O
Sentence: 772,anti,O
Sentence: 772,-,O
Sentence: 772,inflammatory,O
Sentence: 772,treatment,O
Sentence: 772,of,O
Sentence: 772,sensitive,O
Sentence: 772,areas,O
Sentence: 772,such,O
Sentence: 772,as,O
Sentence: 772,the,O
Sentence: 772,face,O
Sentence: 772,",",O
Sentence: 772,and,O
Sentence: 772,recent,O
Sentence: 772,observations,O
Sentence: 772,indicate,O
Sentence: 772,that,O
Sentence: 772,the,O
Sentence: 772,treatment,O
Sentence: 772,is,O
Sentence: 772,effective,O
Sentence: 772,in,O
Sentence: 772,steroid,B-Chemical
Sentence: 772,-,O
Sentence: 772,aggravated,O
Sentence: 772,rosacea,B-Disease
Sentence: 772,and,O
Sentence: 772,perioral,B-Disease
Sentence: 772,dermatitis,B-Disease
Sentence: 772,.,O
Sentence: 772,We,O
Sentence: 772,report,O
Sentence: 772,on,O
Sentence: 772,rosaceiform,O
Sentence: 772,dermatitis,B-Disease
Sentence: 772,as,O
Sentence: 772,a,O
Sentence: 772,complication,O
Sentence: 772,of,O
Sentence: 772,treatment,O
Sentence: 772,with,O
Sentence: 772,tacrolimus,B-Chemical
Sentence: 772,ointment,O
Sentence: 772,.,O
Sentence: 772,OBSERVATIONS,O
Sentence: 772,:,O
Sentence: 772,Six,O
Sentence: 772,adult,O
Sentence: 772,patients,O
Sentence: 772,with,O
Sentence: 772,inflammatory,B-Disease
Sentence: 772,facial,I-Disease
Sentence: 772,dermatoses,I-Disease
Sentence: 772,were,O
Sentence: 772,treated,O
Sentence: 772,with,O
Sentence: 772,tacrolimus,B-Chemical
Sentence: 772,ointment,O
Sentence: 772,because,O
Sentence: 772,of,O
Sentence: 772,the,O
Sentence: 772,ineffectiveness,O
Sentence: 772,of,O
Sentence: 772,standard,O
Sentence: 772,treatments,O
Sentence: 772,.,O
Sentence: 772,Within,O
Sentence: 772,2,O
Sentence: 772,to,O
Sentence: 772,3,O
Sentence: 772,weeks,O
Sentence: 772,of,O
Sentence: 772,initially,O
Sentence: 772,effective,O
Sentence: 772,and,O
Sentence: 772,well,O
Sentence: 772,-,O
Sentence: 772,tolerated,O
Sentence: 772,treatment,O
Sentence: 772,",",O
Sentence: 772,3,O
Sentence: 772,patients,O
Sentence: 772,with,O
Sentence: 772,a,O
Sentence: 772,history,O
Sentence: 772,of,O
Sentence: 772,rosacea,B-Disease
Sentence: 772,and,O
Sentence: 772,1,O
Sentence: 772,with,O
Sentence: 772,a,O
Sentence: 772,history,O
Sentence: 772,of,O
Sentence: 772,acne,B-Disease
Sentence: 772,experienced,O
Sentence: 772,sudden,O
Sentence: 772,worsening,O
Sentence: 772,with,O
Sentence: 772,pustular,O
Sentence: 772,rosaceiform,O
Sentence: 772,lesions,O
Sentence: 772,.,O
Sentence: 772,Biopsy,O
Sentence: 772,revealed,O
Sentence: 772,an,O
Sentence: 772,abundance,O
Sentence: 772,of,O
Sentence: 772,Demodex,O
Sentence: 772,mites,O
Sentence: 772,in,O
Sentence: 772,2,O
Sentence: 772,of,O
Sentence: 772,these,O
Sentence: 772,patients,O
Sentence: 772,.,O
Sentence: 772,In,O
Sentence: 772,1,O
Sentence: 772,patient,O
Sentence: 772,with,O
Sentence: 772,eyelid,O
Sentence: 772,eczema,B-Disease
Sentence: 772,",",O
Sentence: 772,rosaceiform,O
Sentence: 772,periocular,B-Disease
Sentence: 772,dermatitis,B-Disease
Sentence: 772,gradually,O
Sentence: 772,appeared,O
Sentence: 772,after,O
Sentence: 772,3,O
Sentence: 772,weeks,O
Sentence: 772,of,O
Sentence: 772,treatment,O
Sentence: 772,.,O
Sentence: 772,In,O
Sentence: 772,1,O
Sentence: 772,patient,O
Sentence: 772,with,O
Sentence: 772,atopic,B-Disease
Sentence: 772,dermatitis,B-Disease
Sentence: 772,",",O
Sentence: 772,telangiectatic,O
Sentence: 772,and,O
Sentence: 772,papular,B-Disease
Sentence: 772,rosacea,I-Disease
Sentence: 772,insidiously,O
Sentence: 772,appeared,O
Sentence: 772,after,O
Sentence: 772,5,O
Sentence: 772,months,O
Sentence: 772,of,O
Sentence: 772,treatment,O
Sentence: 772,.,O
Sentence: 772,CONCLUSIONS,O
Sentence: 772,:,O
Sentence: 772,Our,O
Sentence: 772,observations,O
Sentence: 772,suggest,O
Sentence: 772,that,O
Sentence: 772,the,O
Sentence: 772,spectrum,O
Sentence: 772,of,O
Sentence: 772,rosaceiform,O
Sentence: 772,dermatitis,B-Disease
Sentence: 772,as,O
Sentence: 772,a,O
Sentence: 772,complication,O
Sentence: 772,of,O
Sentence: 772,treatment,O
Sentence: 772,with,O
Sentence: 772,tacrolimus,B-Chemical
Sentence: 772,ointment,O
Sentence: 772,is,O
Sentence: 772,heterogeneous,O
Sentence: 772,.,O
Sentence: 772,A,O
Sentence: 772,variety,O
Sentence: 772,of,O
Sentence: 772,factors,O
Sentence: 772,",",O
Sentence: 772,such,O
Sentence: 772,as,O
Sentence: 772,vasoactive,O
Sentence: 772,properties,O
Sentence: 772,of,O
Sentence: 772,tacrolimus,B-Chemical
Sentence: 772,",",O
Sentence: 772,proliferation,O
Sentence: 772,of,O
Sentence: 772,Demodex,O
Sentence: 772,due,O
Sentence: 772,to,O
Sentence: 772,local,O
Sentence: 772,immunosuppression,O
Sentence: 772,",",O
Sentence: 772,and,O
Sentence: 772,the,O
Sentence: 772,occlusive,O
Sentence: 772,properties,O
Sentence: 772,of,O
Sentence: 772,the,O
Sentence: 772,ointment,O
Sentence: 772,",",O
Sentence: 772,may,O
Sentence: 772,be,O
Sentence: 772,involved,O
Sentence: 772,in,O
Sentence: 772,the,O
Sentence: 772,observed,O
Sentence: 772,phenomena,O
Sentence: 772,.,O
Sentence: 772,Future,O
Sentence: 772,studies,O
Sentence: 772,are,O
Sentence: 772,needed,O
Sentence: 772,to,O
Sentence: 772,identify,O
Sentence: 772,individual,O
Sentence: 772,risk,O
Sentence: 772,factors,O
Sentence: 772,.,O
Sentence: 773,Structural,O
Sentence: 773,abnormalities,O
Sentence: 773,in,O
Sentence: 773,the,O
Sentence: 773,brains,O
Sentence: 773,of,O
Sentence: 773,human,O
Sentence: 773,subjects,O
Sentence: 773,who,O
Sentence: 773,use,O
Sentence: 773,methamphetamine,O
Sentence: 773,.,O
Sentence: 774,We,O
Sentence: 774,visualize,O
Sentence: 774,",",O
Sentence: 774,for,O
Sentence: 774,the,O
Sentence: 774,first,O
Sentence: 774,time,O
Sentence: 774,",",O
Sentence: 774,the,O
Sentence: 774,profile,O
Sentence: 774,of,O
Sentence: 774,structural,B-Disease
Sentence: 774,deficits,I-Disease
Sentence: 774,in,I-Disease
Sentence: 774,the,I-Disease
Sentence: 774,human,I-Disease
Sentence: 774,brain,I-Disease
Sentence: 774,associated,O
Sentence: 774,with,O
Sentence: 774,chronic,O
Sentence: 774,methamphetamine,B-Chemical
Sentence: 774,(,O
Sentence: 774,MA,B-Chemical
Sentence: 774,),O
Sentence: 774,abuse,O
Sentence: 774,.,O
Sentence: 774,Studies,O
Sentence: 774,of,O
Sentence: 774,human,O
Sentence: 774,subjects,O
Sentence: 774,who,O
Sentence: 774,have,O
Sentence: 774,used,O
Sentence: 774,MA,B-Chemical
Sentence: 774,chronically,O
Sentence: 774,have,O
Sentence: 774,revealed,O
Sentence: 774,deficits,O
Sentence: 774,in,O
Sentence: 774,dopaminergic,O
Sentence: 774,and,O
Sentence: 774,serotonergic,O
Sentence: 774,systems,O
Sentence: 774,and,O
Sentence: 774,cerebral,O
Sentence: 774,metabolic,B-Disease
Sentence: 774,abnormalities,I-Disease
Sentence: 774,.,O
Sentence: 774,Using,O
Sentence: 774,magnetic,O
Sentence: 774,resonance,O
Sentence: 774,imaging,O
Sentence: 774,(,O
Sentence: 774,MRI,O
Sentence: 774,),O
Sentence: 774,and,O
Sentence: 774,new,O
Sentence: 774,computational,O
Sentence: 774,brain,O
Sentence: 774,-,O
Sentence: 774,mapping,O
Sentence: 774,techniques,O
Sentence: 774,",",O
Sentence: 774,we,O
Sentence: 774,determined,O
Sentence: 774,the,O
Sentence: 774,pattern,O
Sentence: 774,of,O
Sentence: 774,structural,O
Sentence: 774,brain,O
Sentence: 774,alterations,O
Sentence: 774,associated,O
Sentence: 774,with,O
Sentence: 774,chronic,O
Sentence: 774,MA,B-Chemical
Sentence: 774,abuse,O
Sentence: 774,in,O
Sentence: 774,human,O
Sentence: 774,subjects,O
Sentence: 774,and,O
Sentence: 774,related,O
Sentence: 774,these,O
Sentence: 774,deficits,O
Sentence: 774,to,O
Sentence: 774,cognitive,B-Disease
Sentence: 774,impairment,I-Disease
Sentence: 774,.,O
Sentence: 774,We,O
Sentence: 774,used,O
Sentence: 774,high,O
Sentence: 774,-,O
Sentence: 774,resolution,O
Sentence: 774,MRI,O
Sentence: 774,and,O
Sentence: 774,surface,O
Sentence: 774,-,O
Sentence: 774,based,O
Sentence: 774,computational,O
Sentence: 774,image,O
Sentence: 774,analyses,O
Sentence: 774,to,O
Sentence: 774,map,O
Sentence: 774,regional,O
Sentence: 774,abnormalities,B-Disease
Sentence: 774,in,I-Disease
Sentence: 774,the,I-Disease
Sentence: 774,cortex,I-Disease
Sentence: 774,",",I-Disease
Sentence: 774,hippocampus,I-Disease
Sentence: 774,",",I-Disease
Sentence: 774,white,I-Disease
Sentence: 774,matter,I-Disease
Sentence: 774,",",I-Disease
Sentence: 774,and,I-Disease
Sentence: 774,ventricles,I-Disease
Sentence: 774,in,O
Sentence: 774,22,O
Sentence: 774,human,O
Sentence: 774,subjects,O
Sentence: 774,who,O
Sentence: 774,used,O
Sentence: 774,MA,B-Chemical
Sentence: 774,and,O
Sentence: 774,21,O
Sentence: 774,age,O
Sentence: 774,-,O
Sentence: 774,matched,O
Sentence: 774,",",O
Sentence: 774,healthy,O
Sentence: 774,controls,O
Sentence: 774,.,O
Sentence: 774,Cortical,O
Sentence: 774,maps,O
Sentence: 774,revealed,O
Sentence: 774,severe,O
Sentence: 774,gray,O
Sentence: 774,-,O
Sentence: 774,matter,O
Sentence: 774,deficits,O
Sentence: 774,in,O
Sentence: 774,the,O
Sentence: 774,cingulate,O
Sentence: 774,",",O
Sentence: 774,limbic,O
Sentence: 774,",",O
Sentence: 774,and,O
Sentence: 774,paralimbic,O
Sentence: 774,cortices,O
Sentence: 774,of,O
Sentence: 774,MA,B-Chemical
Sentence: 774,abusers,O
Sentence: 774,(,O
Sentence: 774,averaging,O
Sentence: 774,11.3,O
Sentence: 774,%,O
Sentence: 774,below,O
Sentence: 774,control,O
Sentence: 774,;,O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,<,O
Sentence: 774,,O
Sentence: 774,0.05,O
Sentence: 774,),O
Sentence: 774,.,O
Sentence: 774,On,O
Sentence: 774,average,O
Sentence: 774,",",O
Sentence: 774,MA,B-Chemical
Sentence: 774,abusers,O
Sentence: 774,had,O
Sentence: 774,7.8,O
Sentence: 774,%,O
Sentence: 774,smaller,O
Sentence: 774,hippocampal,O
Sentence: 774,volumes,O
Sentence: 774,than,O
Sentence: 774,control,O
Sentence: 774,subjects,O
Sentence: 774,(,O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,<,O
Sentence: 774,,O
Sentence: 774,0.01,O
Sentence: 774,;,O
Sentence: 774,left,O
Sentence: 774,",",O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,=,O
Sentence: 774,,O
Sentence: 774,0.01,O
Sentence: 774,;,O
Sentence: 774,right,O
Sentence: 774,",",O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,<,O
Sentence: 774,,O
Sentence: 774,0.05,O
Sentence: 774,),O
Sentence: 774,and,O
Sentence: 774,significant,O
Sentence: 774,white,O
Sentence: 774,-,O
Sentence: 774,matter,O
Sentence: 774,hypertrophy,B-Disease
Sentence: 774,(,O
Sentence: 774,7.0,O
Sentence: 774,%,O
Sentence: 774,;,O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,<,O
Sentence: 774,,O
Sentence: 774,0.01,O
Sentence: 774,),O
Sentence: 774,.,O
Sentence: 774,Hippocampal,O
Sentence: 774,deficits,O
Sentence: 774,were,O
Sentence: 774,mapped,O
Sentence: 774,and,O
Sentence: 774,correlated,O
Sentence: 774,with,O
Sentence: 774,memory,O
Sentence: 774,performance,O
Sentence: 774,on,O
Sentence: 774,a,O
Sentence: 774,word,O
Sentence: 774,-,O
Sentence: 774,recall,O
Sentence: 774,test,O
Sentence: 774,(,O
Sentence: 774,p,O
Sentence: 774,,O
Sentence: 774,<,O
Sentence: 774,,O
Sentence: 774,0.05,O
Sentence: 774,),O
Sentence: 774,.,O
Sentence: 774,MRI,O
Sentence: 774,-,O
Sentence: 774,based,O
Sentence: 774,maps,O
Sentence: 774,suggest,O
Sentence: 774,that,O
Sentence: 774,chronic,O
Sentence: 774,methamphetamine,B-Chemical
Sentence: 774,abuse,O
Sentence: 774,causes,O
Sentence: 774,a,O
Sentence: 774,selective,O
Sentence: 774,pattern,O
Sentence: 774,of,O
Sentence: 774,cerebral,O
Sentence: 774,deterioration,O
Sentence: 774,that,O
Sentence: 774,contributes,O
Sentence: 774,to,O
Sentence: 774,impaired,B-Disease
Sentence: 774,memory,I-Disease
Sentence: 774,performance,I-Disease
Sentence: 774,.,O
Sentence: 774,MA,B-Chemical
Sentence: 774,may,O
Sentence: 774,selectively,O
Sentence: 774,damage,O
Sentence: 774,the,O
Sentence: 774,medial,O
Sentence: 774,temporal,O
Sentence: 774,lobe,O
Sentence: 774,and,O
Sentence: 774,",",O
Sentence: 774,consistent,O
Sentence: 774,with,O
Sentence: 774,metabolic,O
Sentence: 774,studies,O
Sentence: 774,",",O
Sentence: 774,the,O
Sentence: 774,cingulate,O
Sentence: 774,-,O
Sentence: 774,limbic,O
Sentence: 774,cortex,O
Sentence: 774,",",O
Sentence: 774,inducing,O
Sentence: 774,neuroadaptation,O
Sentence: 774,",",O
Sentence: 774,neuropil,O
Sentence: 774,reduction,O
Sentence: 774,",",O
Sentence: 774,or,O
Sentence: 774,cell,O
Sentence: 774,death,O
Sentence: 774,.,O
Sentence: 774,Prominent,O
Sentence: 774,white,O
Sentence: 774,-,O
Sentence: 774,matter,O
Sentence: 774,hypertrophy,B-Disease
Sentence: 774,may,O
Sentence: 774,result,O
Sentence: 774,from,O
Sentence: 774,altered,O
Sentence: 774,myelination,O
Sentence: 774,and,O
Sentence: 774,adaptive,O
Sentence: 774,glial,O
Sentence: 774,changes,O
Sentence: 774,",",O
Sentence: 774,including,O
Sentence: 774,gliosis,B-Disease
Sentence: 774,secondary,O
Sentence: 774,to,O
Sentence: 774,neuronal,B-Disease
Sentence: 774,damage,I-Disease
Sentence: 774,.,O
Sentence: 774,These,O
Sentence: 774,brain,O
Sentence: 774,substrates,O
Sentence: 774,may,O
Sentence: 774,help,O
Sentence: 774,account,O
Sentence: 774,for,O
Sentence: 774,the,O
Sentence: 774,symptoms,O
Sentence: 774,of,O
Sentence: 774,MA,B-Chemical
Sentence: 774,abuse,O
Sentence: 774,",",O
Sentence: 774,providing,O
Sentence: 774,therapeutic,O
Sentence: 774,targets,O
Sentence: 774,for,O
Sentence: 774,drug,O
Sentence: 774,-,O
Sentence: 774,induced,O
Sentence: 774,brain,B-Disease
Sentence: 774,injury,I-Disease
Sentence: 774,.,O
Sentence: 775,Disruption,O
Sentence: 775,of,O
Sentence: 775,hepatic,O
Sentence: 775,lipid,O
Sentence: 775,homeostasis,O
Sentence: 775,in,O
Sentence: 775,mice,O
Sentence: 775,after,O
Sentence: 775,amiodarone,O
Sentence: 775,treatment,O
Sentence: 775,is,O
Sentence: 775,associated,O
Sentence: 775,with,O
Sentence: 775,peroxisome,O
Sentence: 775,proliferator,O
Sentence: 775,-,O
Sentence: 775,activated,O
Sentence: 775,receptor,O
Sentence: 775,-,O
Sentence: 775,alpha,O
Sentence: 775,target,O
Sentence: 775,gene,O
Sentence: 775,activation,O
Sentence: 775,.,O
Sentence: 776,Amiodarone,B-Chemical
Sentence: 776,",",O
Sentence: 776,an,O
Sentence: 776,efficacious,O
Sentence: 776,and,O
Sentence: 776,widely,O
Sentence: 776,used,O
Sentence: 776,antiarrhythmic,O
Sentence: 776,agent,O
Sentence: 776,",",O
Sentence: 776,has,O
Sentence: 776,been,O
Sentence: 776,reported,O
Sentence: 776,to,O
Sentence: 776,cause,O
Sentence: 776,hepatotoxicity,B-Disease
Sentence: 776,in,O
Sentence: 776,some,O
Sentence: 776,patients,O
Sentence: 776,.,O
Sentence: 776,To,O
Sentence: 776,gain,O
Sentence: 776,insight,O
Sentence: 776,into,O
Sentence: 776,the,O
Sentence: 776,mechanism,O
Sentence: 776,of,O
Sentence: 776,this,O
Sentence: 776,unwanted,O
Sentence: 776,effect,O
Sentence: 776,",",O
Sentence: 776,mice,O
Sentence: 776,were,O
Sentence: 776,administered,O
Sentence: 776,various,O
Sentence: 776,doses,O
Sentence: 776,of,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,and,O
Sentence: 776,examined,O
Sentence: 776,for,O
Sentence: 776,changes,O
Sentence: 776,in,O
Sentence: 776,hepatic,O
Sentence: 776,histology,O
Sentence: 776,and,O
Sentence: 776,gene,O
Sentence: 776,regulation,O
Sentence: 776,.,O
Sentence: 776,Amiodarone,B-Chemical
Sentence: 776,induced,O
Sentence: 776,hepatomegaly,B-Disease
Sentence: 776,",",O
Sentence: 776,hepatocyte,O
Sentence: 776,microvesicular,O
Sentence: 776,lipid,O
Sentence: 776,accumulation,O
Sentence: 776,",",O
Sentence: 776,and,O
Sentence: 776,a,O
Sentence: 776,significant,O
Sentence: 776,decrease,O
Sentence: 776,in,O
Sentence: 776,serum,O
Sentence: 776,triglycerides,B-Chemical
Sentence: 776,and,O
Sentence: 776,glucose,B-Chemical
Sentence: 776,.,O
Sentence: 776,Northern,O
Sentence: 776,blot,O
Sentence: 776,analysis,O
Sentence: 776,of,O
Sentence: 776,hepatic,O
Sentence: 776,RNA,O
Sentence: 776,revealed,O
Sentence: 776,a,O
Sentence: 776,dose,O
Sentence: 776,-,O
Sentence: 776,dependent,O
Sentence: 776,increase,O
Sentence: 776,in,O
Sentence: 776,the,O
Sentence: 776,expression,O
Sentence: 776,of,O
Sentence: 776,a,O
Sentence: 776,number,O
Sentence: 776,of,O
Sentence: 776,genes,O
Sentence: 776,critical,O
Sentence: 776,for,O
Sentence: 776,fatty,B-Chemical
Sentence: 776,acid,I-Chemical
Sentence: 776,oxidation,O
Sentence: 776,",",O
Sentence: 776,lipoprotein,O
Sentence: 776,assembly,O
Sentence: 776,",",O
Sentence: 776,and,O
Sentence: 776,lipid,O
Sentence: 776,transport,O
Sentence: 776,.,O
Sentence: 776,Many,O
Sentence: 776,of,O
Sentence: 776,these,O
Sentence: 776,genes,O
Sentence: 776,are,O
Sentence: 776,regulated,O
Sentence: 776,by,O
Sentence: 776,the,O
Sentence: 776,peroxisome,O
Sentence: 776,proliferator,O
Sentence: 776,-,O
Sentence: 776,activated,O
Sentence: 776,receptor,O
Sentence: 776,-,O
Sentence: 776,alpha,O
Sentence: 776,(,O
Sentence: 776,PPARalpha,O
Sentence: 776,),O
Sentence: 776,",",O
Sentence: 776,a,O
Sentence: 776,ligand,O
Sentence: 776,-,O
Sentence: 776,activated,O
Sentence: 776,nuclear,O
Sentence: 776,hormone,O
Sentence: 776,receptor,O
Sentence: 776,transcription,O
Sentence: 776,factor,O
Sentence: 776,.,O
Sentence: 776,The,O
Sentence: 776,absence,O
Sentence: 776,of,O
Sentence: 776,induction,O
Sentence: 776,of,O
Sentence: 776,these,O
Sentence: 776,genes,O
Sentence: 776,as,O
Sentence: 776,well,O
Sentence: 776,as,O
Sentence: 776,hepatomegaly,B-Disease
Sentence: 776,in,O
Sentence: 776,PPARalpha,O
Sentence: 776,knockout,O
Sentence: 776,[,O
Sentence: 776,PPARalpha,O
Sentence: 776,-,O
Sentence: 776,,O
Sentence: 776,/,O
Sentence: 776,,O
Sentence: 776,-,O
Sentence: 776,,O
Sentence: 776,],O
Sentence: 776,mice,O
Sentence: 776,indicated,O
Sentence: 776,that,O
Sentence: 776,the,O
Sentence: 776,effects,O
Sentence: 776,of,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,were,O
Sentence: 776,dependent,O
Sentence: 776,upon,O
Sentence: 776,the,O
Sentence: 776,presence,O
Sentence: 776,of,O
Sentence: 776,a,O
Sentence: 776,functional,O
Sentence: 776,PPARalpha,O
Sentence: 776,gene,O
Sentence: 776,.,O
Sentence: 776,Compared,O
Sentence: 776,to,O
Sentence: 776,wild,O
Sentence: 776,-,O
Sentence: 776,type,O
Sentence: 776,mice,O
Sentence: 776,",",O
Sentence: 776,treatment,O
Sentence: 776,of,O
Sentence: 776,PPARalpha,O
Sentence: 776,-,O
Sentence: 776,,O
Sentence: 776,/,O
Sentence: 776,,O
Sentence: 776,-,O
Sentence: 776,,O
Sentence: 776,mice,O
Sentence: 776,with,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,resulted,O
Sentence: 776,in,O
Sentence: 776,an,O
Sentence: 776,increased,O
Sentence: 776,rate,O
Sentence: 776,and,O
Sentence: 776,extent,O
Sentence: 776,of,O
Sentence: 776,total,O
Sentence: 776,body,O
Sentence: 776,weight,B-Disease
Sentence: 776,loss,I-Disease
Sentence: 776,.,O
Sentence: 776,The,O
Sentence: 776,inability,O
Sentence: 776,of,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,to,O
Sentence: 776,directly,O
Sentence: 776,activate,O
Sentence: 776,either,O
Sentence: 776,human,O
Sentence: 776,or,O
Sentence: 776,mouse,O
Sentence: 776,PPARalpha,O
Sentence: 776,transiently,O
Sentence: 776,expressed,O
Sentence: 776,in,O
Sentence: 776,human,O
Sentence: 776,HepG2,O
Sentence: 776,hepatoma,B-Disease
Sentence: 776,cells,O
Sentence: 776,indicates,O
Sentence: 776,that,O
Sentence: 776,the,O
Sentence: 776,effects,O
Sentence: 776,of,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,on,O
Sentence: 776,the,O
Sentence: 776,function,O
Sentence: 776,of,O
Sentence: 776,this,O
Sentence: 776,receptor,O
Sentence: 776,were,O
Sentence: 776,indirect,O
Sentence: 776,.,O
Sentence: 776,Based,O
Sentence: 776,upon,O
Sentence: 776,these,O
Sentence: 776,results,O
Sentence: 776,",",O
Sentence: 776,we,O
Sentence: 776,conclude,O
Sentence: 776,that,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,disrupts,O
Sentence: 776,hepatic,O
Sentence: 776,lipid,O
Sentence: 776,homeostasis,O
Sentence: 776,and,O
Sentence: 776,that,O
Sentence: 776,the,O
Sentence: 776,increased,O
Sentence: 776,expression,O
Sentence: 776,of,O
Sentence: 776,PPARalpha,O
Sentence: 776,target,O
Sentence: 776,genes,O
Sentence: 776,is,O
Sentence: 776,secondary,O
Sentence: 776,to,O
Sentence: 776,this,O
Sentence: 776,toxic,O
Sentence: 776,effect,O
Sentence: 776,.,O
Sentence: 776,These,O
Sentence: 776,results,O
Sentence: 776,provide,O
Sentence: 776,important,O
Sentence: 776,new,O
Sentence: 776,mechanistic,O
Sentence: 776,information,O
Sentence: 776,regarding,O
Sentence: 776,the,O
Sentence: 776,hepatotoxic,B-Disease
Sentence: 776,effects,O
Sentence: 776,of,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,and,O
Sentence: 776,indicate,O
Sentence: 776,that,O
Sentence: 776,PPARalpha,O
Sentence: 776,protects,O
Sentence: 776,against,O
Sentence: 776,amiodarone,B-Chemical
Sentence: 776,-,O
Sentence: 776,induced,O
Sentence: 776,hepatotoxicity,B-Disease
Sentence: 776,.,O
Sentence: 777,Safety,O
Sentence: 777,and,O
Sentence: 777,compliance,O
Sentence: 777,with,O
Sentence: 777,once,O
Sentence: 777,-,O
Sentence: 777,daily,O
Sentence: 777,niacin,O
Sentence: 777,extended,O
Sentence: 777,-,O
Sentence: 777,release,O
Sentence: 777,/,O
Sentence: 777,lovastatin,O
Sentence: 777,as,O
Sentence: 777,initial,O
Sentence: 777,therapy,O
Sentence: 777,in,O
Sentence: 777,the,O
Sentence: 777,Impact,O
Sentence: 777,of,O
Sentence: 777,Medical,O
Sentence: 777,Subspecialty,O
Sentence: 777,on,O
Sentence: 777,Patient,O
Sentence: 777,Compliance,O
Sentence: 777,to,O
Sentence: 777,Treatment,O
Sentence: 777,(,O
Sentence: 777,IMPACT,O
Sentence: 777,),O
Sentence: 777,study,O
Sentence: 777,.,O
Sentence: 778,Niacin,O
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,is,O
Sentence: 778,a,O
Sentence: 778,new,O
Sentence: 778,combination,O
Sentence: 778,product,O
Sentence: 778,approved,O
Sentence: 778,for,O
Sentence: 778,treatment,O
Sentence: 778,of,O
Sentence: 778,primary,O
Sentence: 778,hypercholesterolemia,B-Disease
Sentence: 778,and,O
Sentence: 778,mixed,O
Sentence: 778,dyslipidemia,B-Disease
Sentence: 778,.,O
Sentence: 778,This,O
Sentence: 778,open,O
Sentence: 778,-,O
Sentence: 778,labeled,O
Sentence: 778,",",O
Sentence: 778,multicenter,O
Sentence: 778,study,O
Sentence: 778,evaluated,O
Sentence: 778,the,O
Sentence: 778,safety,O
Sentence: 778,of,O
Sentence: 778,bedtime,O
Sentence: 778,niacin,B-Chemical
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,when,O
Sentence: 778,dosed,O
Sentence: 778,as,O
Sentence: 778,initial,O
Sentence: 778,therapy,O
Sentence: 778,and,O
Sentence: 778,patient,O
Sentence: 778,compliance,O
Sentence: 778,to,O
Sentence: 778,treatment,O
Sentence: 778,in,O
Sentence: 778,various,O
Sentence: 778,clinical,O
Sentence: 778,practice,O
Sentence: 778,settings,O
Sentence: 778,.,O
Sentence: 778,A,O
Sentence: 778,total,O
Sentence: 778,of,O
Sentence: 778,"4,499",O
Sentence: 778,patients,O
Sentence: 778,with,O
Sentence: 778,dyslipidemia,B-Disease
Sentence: 778,requiring,O
Sentence: 778,drug,O
Sentence: 778,intervention,O
Sentence: 778,was,O
Sentence: 778,enrolled,O
Sentence: 778,at,O
Sentence: 778,"1,081",O
Sentence: 778,sites,O
Sentence: 778,.,O
Sentence: 778,Patients,O
Sentence: 778,were,O
Sentence: 778,treated,O
Sentence: 778,with,O
Sentence: 778,1,O
Sentence: 778,tablet,O
Sentence: 778,(,O
Sentence: 778,500,O
Sentence: 778,mg,O
Sentence: 778,of,O
Sentence: 778,niacin,B-Chemical
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,20,O
Sentence: 778,mg,O
Sentence: 778,of,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,),O
Sentence: 778,once,O
Sentence: 778,nightly,O
Sentence: 778,for,O
Sentence: 778,4,O
Sentence: 778,weeks,O
Sentence: 778,and,O
Sentence: 778,then,O
Sentence: 778,2,O
Sentence: 778,tablets,O
Sentence: 778,for,O
Sentence: 778,8,O
Sentence: 778,weeks,O
Sentence: 778,.,O
Sentence: 778,Patients,O
Sentence: 778,also,O
Sentence: 778,received,O
Sentence: 778,dietary,O
Sentence: 778,counseling,O
Sentence: 778,",",O
Sentence: 778,educational,O
Sentence: 778,materials,O
Sentence: 778,",",O
Sentence: 778,and,O
Sentence: 778,reminders,O
Sentence: 778,to,O
Sentence: 778,call,O
Sentence: 778,a,O
Sentence: 778,toll,O
Sentence: 778,-,O
Sentence: 778,free,O
Sentence: 778,number,O
Sentence: 778,that,O
Sentence: 778,provided,O
Sentence: 778,further,O
Sentence: 778,education,O
Sentence: 778,about,O
Sentence: 778,dyslipidemia,B-Disease
Sentence: 778,and,O
Sentence: 778,niacin,B-Chemical
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,.,O
Sentence: 778,Primary,O
Sentence: 778,end,O
Sentence: 778,points,O
Sentence: 778,were,O
Sentence: 778,study,O
Sentence: 778,compliance,O
Sentence: 778,",",O
Sentence: 778,increases,O
Sentence: 778,in,O
Sentence: 778,liver,O
Sentence: 778,transaminases,O
Sentence: 778,to,O
Sentence: 778,,O
Sentence: 778,>,O
Sentence: 778,,O
Sentence: 778,3,O
Sentence: 778,times,O
Sentence: 778,the,O
Sentence: 778,upper,O
Sentence: 778,limit,O
Sentence: 778,of,O
Sentence: 778,normal,O
Sentence: 778,",",O
Sentence: 778,and,O
Sentence: 778,clinical,O
Sentence: 778,myopathy,B-Disease
Sentence: 778,.,O
Sentence: 778,Final,O
Sentence: 778,study,O
Sentence: 778,status,O
Sentence: 778,was,O
Sentence: 778,available,O
Sentence: 778,for,O
Sentence: 778,"4,217",O
Sentence: 778,patients,O
Sentence: 778,(,O
Sentence: 778,94,O
Sentence: 778,%,O
Sentence: 778,),O
Sentence: 778,.,O
Sentence: 778,Compliance,O
Sentence: 778,to,O
Sentence: 778,niacin,B-Chemical
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,was,O
Sentence: 778,77,O
Sentence: 778,%,O
Sentence: 778,",",O
Sentence: 778,with,O
Sentence: 778,"3,245",O
Sentence: 778,patients,O
Sentence: 778,completing,O
Sentence: 778,the,O
Sentence: 778,study,O
Sentence: 778,.,O
Sentence: 778,Patients,O
Sentence: 778,in,O
Sentence: 778,the,O
Sentence: 778,southeast,O
Sentence: 778,and,O
Sentence: 778,those,O
Sentence: 778,enrolled,O
Sentence: 778,by,O
Sentence: 778,endocrinologists,O
Sentence: 778,had,O
Sentence: 778,the,O
Sentence: 778,lowest,O
Sentence: 778,compliance,O
Sentence: 778,and,O
Sentence: 778,highest,O
Sentence: 778,adverse,O
Sentence: 778,event,O
Sentence: 778,rates,O
Sentence: 778,.,O
Sentence: 778,Flushing,B-Disease
Sentence: 778,was,O
Sentence: 778,the,O
Sentence: 778,most,O
Sentence: 778,common,O
Sentence: 778,adverse,O
Sentence: 778,event,O
Sentence: 778,",",O
Sentence: 778,reported,O
Sentence: 778,by,O
Sentence: 778,18,O
Sentence: 778,%,O
Sentence: 778,of,O
Sentence: 778,patients,O
Sentence: 778,and,O
Sentence: 778,leading,O
Sentence: 778,to,O
Sentence: 778,discontinuation,O
Sentence: 778,by,O
Sentence: 778,6,O
Sentence: 778,%,O
Sentence: 778,.,O
Sentence: 778,Incidence,O
Sentence: 778,of,O
Sentence: 778,increased,O
Sentence: 778,aspartate,B-Chemical
Sentence: 778,aminotransferase,O
Sentence: 778,and,O
Sentence: 778,/,O
Sentence: 778,or,O
Sentence: 778,alanine,B-Chemical
Sentence: 778,aminotransferase,O
Sentence: 778,,O
Sentence: 778,>,O
Sentence: 778,,O
Sentence: 778,3,O
Sentence: 778,times,O
Sentence: 778,the,O
Sentence: 778,upper,O
Sentence: 778,limit,O
Sentence: 778,of,O
Sentence: 778,normal,O
Sentence: 778,was,O
Sentence: 778,,O
Sentence: 778,<,O
Sentence: 778,,O
Sentence: 778,0.3,O
Sentence: 778,%,O
Sentence: 778,.,O
Sentence: 778,An,O
Sentence: 778,increase,O
Sentence: 778,of,O
Sentence: 778,creatine,B-Chemical
Sentence: 778,phosphokinase,O
Sentence: 778,to,O
Sentence: 778,,O
Sentence: 778,>,O
Sentence: 778,,O
Sentence: 778,5,O
Sentence: 778,times,O
Sentence: 778,the,O
Sentence: 778,upper,O
Sentence: 778,limit,O
Sentence: 778,of,O
Sentence: 778,normal,O
Sentence: 778,occurred,O
Sentence: 778,in,O
Sentence: 778,0.24,O
Sentence: 778,%,O
Sentence: 778,of,O
Sentence: 778,patients,O
Sentence: 778,",",O
Sentence: 778,and,O
Sentence: 778,no,O
Sentence: 778,cases,O
Sentence: 778,of,O
Sentence: 778,drug,O
Sentence: 778,-,O
Sentence: 778,induced,O
Sentence: 778,myopathy,B-Disease
Sentence: 778,were,O
Sentence: 778,observed,O
Sentence: 778,.,O
Sentence: 778,Niacin,O
Sentence: 778,extended,O
Sentence: 778,-,O
Sentence: 778,release,O
Sentence: 778,/,O
Sentence: 778,lovastatin,B-Chemical
Sentence: 778,"1,000",O
Sentence: 778,/,O
Sentence: 778,40,O
Sentence: 778,mg,O
Sentence: 778,",",O
Sentence: 778,dosed,O
Sentence: 778,as,O
Sentence: 778,initial,O
Sentence: 778,therapy,O
Sentence: 778,",",O
Sentence: 778,was,O
Sentence: 778,associated,O
Sentence: 778,with,O
Sentence: 778,good,O
Sentence: 778,compliance,O
Sentence: 778,and,O
Sentence: 778,safety,O
Sentence: 778,and,O
Sentence: 778,had,O
Sentence: 778,very,O
Sentence: 778,low,O
Sentence: 778,incidences,O
Sentence: 778,of,O
Sentence: 778,increased,O
Sentence: 778,liver,O
Sentence: 778,and,O
Sentence: 778,muscle,O
Sentence: 778,enzymes,O
Sentence: 778,.,O
Sentence: 779,Protective,O
Sentence: 779,effect,O
Sentence: 779,of,O
Sentence: 779,Terminalia,B-Chemical
Sentence: 779,chebula,I-Chemical
Sentence: 779,against,O
Sentence: 779,experimental,O
Sentence: 779,myocardial,B-Disease
Sentence: 779,injury,I-Disease
Sentence: 779,induced,O
Sentence: 779,by,O
Sentence: 779,isoproterenol,B-Chemical
Sentence: 779,.,O
Sentence: 780,Cardioprotective,O
Sentence: 780,effect,O
Sentence: 780,of,O
Sentence: 780,ethanolic,B-Chemical
Sentence: 780,extract,I-Chemical
Sentence: 780,of,I-Chemical
Sentence: 780,Terminalia,I-Chemical
Sentence: 780,chebula,I-Chemical
Sentence: 780,fruits,I-Chemical
Sentence: 780,(,O
Sentence: 780,500,O
Sentence: 780,mg,O
Sentence: 780,/,O
Sentence: 780,kg,O
Sentence: 780,body,O
Sentence: 780,wt,O
Sentence: 780,),O
Sentence: 780,was,O
Sentence: 780,examined,O
Sentence: 780,in,O
Sentence: 780,isoproterenol,B-Chemical
Sentence: 780,(,O
Sentence: 780,200,O
Sentence: 780,mg,O
Sentence: 780,/,O
Sentence: 780,kg,O
Sentence: 780,body,O
Sentence: 780,wt,O
Sentence: 780,),O
Sentence: 780,induced,O
Sentence: 780,myocardial,B-Disease
Sentence: 780,damage,I-Disease
Sentence: 780,in,O
Sentence: 780,rats,O
Sentence: 780,.,O
Sentence: 780,In,O
Sentence: 780,isoproterenol,B-Chemical
Sentence: 780,administered,O
Sentence: 780,rats,O
Sentence: 780,",",O
Sentence: 780,the,O
Sentence: 780,level,O
Sentence: 780,of,O
Sentence: 780,lipid,O
Sentence: 780,peroxides,B-Chemical
Sentence: 780,increased,O
Sentence: 780,significantly,O
Sentence: 780,in,O
Sentence: 780,the,O
Sentence: 780,serum,O
Sentence: 780,and,O
Sentence: 780,heart,O
Sentence: 780,.,O
Sentence: 780,A,O
Sentence: 780,significant,O
Sentence: 780,decrease,O
Sentence: 780,was,O
Sentence: 780,observed,O
Sentence: 780,in,O
Sentence: 780,the,O
Sentence: 780,activity,O
Sentence: 780,of,O
Sentence: 780,the,O
Sentence: 780,myocardial,O
Sentence: 780,marker,O
Sentence: 780,enzymes,O
Sentence: 780,with,O
Sentence: 780,a,O
Sentence: 780,concomitant,O
Sentence: 780,increase,O
Sentence: 780,in,O
Sentence: 780,their,O
Sentence: 780,activity,O
Sentence: 780,in,O
Sentence: 780,serum,O
Sentence: 780,.,O
Sentence: 780,Histopathological,O
Sentence: 780,examination,O
Sentence: 780,was,O
Sentence: 780,carried,O
Sentence: 780,out,O
Sentence: 780,to,O
Sentence: 780,confirm,O
Sentence: 780,the,O
Sentence: 780,myocardial,O
Sentence: 780,necrosis,B-Disease
Sentence: 780,.,O
Sentence: 780,T.,B-Chemical
Sentence: 780,chebula,I-Chemical
Sentence: 780,extract,I-Chemical
Sentence: 780,pretreatment,O
Sentence: 780,was,O
Sentence: 780,found,O
Sentence: 780,to,O
Sentence: 780,ameliorate,O
Sentence: 780,the,O
Sentence: 780,effect,O
Sentence: 780,of,O
Sentence: 780,isoproterenol,B-Chemical
Sentence: 780,on,O
Sentence: 780,lipid,O
Sentence: 780,peroxide,B-Chemical
Sentence: 780,formation,O
Sentence: 780,and,O
Sentence: 780,retained,O
Sentence: 780,the,O
Sentence: 780,activities,O
Sentence: 780,of,O
Sentence: 780,the,O
Sentence: 780,diagnostic,O
Sentence: 780,marker,O
Sentence: 780,enzymes,O
Sentence: 780,.,O
Sentence: 781,A,O
Sentence: 781,case,O
Sentence: 781,of,O
Sentence: 781,postoperative,O
Sentence: 781,anxiety,B-Disease
Sentence: 781,due,O
Sentence: 781,to,O
Sentence: 781,low,O
Sentence: 781,dose,O
Sentence: 781,droperidol,B-Chemical
Sentence: 781,used,O
Sentence: 781,with,O
Sentence: 781,patient,O
Sentence: 781,-,O
Sentence: 781,controlled,O
Sentence: 781,analgesia,O
Sentence: 781,.,O
Sentence: 782,A,O
Sentence: 782,multiparous,O
Sentence: 782,woman,O
Sentence: 782,in,O
Sentence: 782,good,O
Sentence: 782,psychological,O
Sentence: 782,health,O
Sentence: 782,underwent,O
Sentence: 782,urgent,O
Sentence: 782,caesarean,O
Sentence: 782,section,O
Sentence: 782,in,O
Sentence: 782,labour,O
Sentence: 782,.,O
Sentence: 782,Postoperatively,O
Sentence: 782,",",O
Sentence: 782,she,O
Sentence: 782,was,O
Sentence: 782,given,O
Sentence: 782,a,O
Sentence: 782,patient,O
Sentence: 782,-,O
Sentence: 782,controlled,O
Sentence: 782,analgesia,O
Sentence: 782,device,O
Sentence: 782,delivering,O
Sentence: 782,boluses,O
Sentence: 782,of,O
Sentence: 782,diamorphine,B-Chemical
Sentence: 782,0.5,O
Sentence: 782,mg,O
Sentence: 782,and,O
Sentence: 782,droperidol,B-Chemical
Sentence: 782,0.025,O
Sentence: 782,mg.,O
Sentence: 782,Whilst,O
Sentence: 782,using,O
Sentence: 782,the,O
Sentence: 782,device,O
Sentence: 782,she,O
Sentence: 782,gradually,O
Sentence: 782,became,O
Sentence: 782,anxious,O
Sentence: 782,",",O
Sentence: 782,the,O
Sentence: 782,feeling,O
Sentence: 782,worsening,O
Sentence: 782,after,O
Sentence: 782,each,O
Sentence: 782,bolus,O
Sentence: 782,.,O
Sentence: 782,The,O
Sentence: 782,diagnosis,O
Sentence: 782,of,O
Sentence: 782,droperidol,B-Chemical
Sentence: 782,-,O
Sentence: 782,induced,O
Sentence: 782,psychological,B-Disease
Sentence: 782,disturbance,I-Disease
Sentence: 782,was,O
Sentence: 782,not,O
Sentence: 782,made,O
Sentence: 782,straight,O
Sentence: 782,away,O
Sentence: 782,although,O
Sentence: 782,on,O
Sentence: 782,subsequent,O
Sentence: 782,close,O
Sentence: 782,questioning,O
Sentence: 782,the,O
Sentence: 782,patient,O
Sentence: 782,gave,O
Sentence: 782,a,O
Sentence: 782,very,O
Sentence: 782,clear,O
Sentence: 782,history,O
Sentence: 782,.,O
Sentence: 782,After,O
Sentence: 782,she,O
Sentence: 782,had,O
Sentence: 782,received,O
Sentence: 782,a,O
Sentence: 782,total,O
Sentence: 782,of,O
Sentence: 782,only,O
Sentence: 782,0.9,O
Sentence: 782,mg,O
Sentence: 782,droperidol,B-Chemical
Sentence: 782,",",O
Sentence: 782,a,O
Sentence: 782,syringe,O
Sentence: 782,containing,O
Sentence: 782,diamorphine,B-Chemical
Sentence: 782,only,O
Sentence: 782,was,O
Sentence: 782,substituted,O
Sentence: 782,and,O
Sentence: 782,her,O
Sentence: 782,unease,O
Sentence: 782,resolved,O
Sentence: 782,completely,O
Sentence: 782,.,O
Sentence: 782,We,O
Sentence: 782,feel,O
Sentence: 782,that,O
Sentence: 782,",",O
Sentence: 782,although,O
Sentence: 782,the,O
Sentence: 782,dramatic,O
Sentence: 782,extrapyramidal,O
Sentence: 782,side,O
Sentence: 782,effects,O
Sentence: 782,of,O
Sentence: 782,dopaminergic,O
Sentence: 782,antiemetics,O
Sentence: 782,are,O
Sentence: 782,well,O
Sentence: 782,known,O
Sentence: 782,",",O
Sentence: 782,more,O
Sentence: 782,subtle,O
Sentence: 782,manifestations,O
Sentence: 782,may,O
Sentence: 782,easily,O
Sentence: 782,be,O
Sentence: 782,overlooked,O
Sentence: 782,.,O
Sentence: 783,Accurate,O
Sentence: 783,patient,O
Sentence: 783,history,O
Sentence: 783,contributes,O
Sentence: 783,to,O
Sentence: 783,differentiating,O
Sentence: 783,diabetes,O
Sentence: 783,insipidus,O
Sentence: 783,:,O
Sentence: 783,a,O
Sentence: 783,case,O
Sentence: 783,study,O
Sentence: 783,.,O
Sentence: 784,This,O
Sentence: 784,case,O
Sentence: 784,study,O
Sentence: 784,highlights,O
Sentence: 784,the,O
Sentence: 784,important,O
Sentence: 784,contribution,O
Sentence: 784,of,O
Sentence: 784,nursing,O
Sentence: 784,in,O
Sentence: 784,obtaining,O
Sentence: 784,an,O
Sentence: 784,accurate,O
Sentence: 784,health,O
Sentence: 784,history,O
Sentence: 784,.,O
Sentence: 784,The,O
Sentence: 784,case,O
Sentence: 784,discussed,O
Sentence: 784,herein,O
Sentence: 784,initially,O
Sentence: 784,appeared,O
Sentence: 784,to,O
Sentence: 784,be,O
Sentence: 784,neurogenic,B-Disease
Sentence: 784,diabetes,I-Disease
Sentence: 784,insipidus,I-Disease
Sentence: 784,(,O
Sentence: 784,DI,B-Disease
Sentence: 784,),O
Sentence: 784,secondary,O
Sentence: 784,to,O
Sentence: 784,a,O
Sentence: 784,traumatic,B-Disease
Sentence: 784,brain,I-Disease
Sentence: 784,injury,I-Disease
Sentence: 784,.,O
Sentence: 784,The,O
Sentence: 784,nursing,O
Sentence: 784,staff,O
Sentence: 784,",",O
Sentence: 784,by,O
Sentence: 784,reviewing,O
Sentence: 784,the,O
Sentence: 784,patient,O
Sentence: 784,'s,O
Sentence: 784,health,O
Sentence: 784,history,O
Sentence: 784,with,O
Sentence: 784,his,O
Sentence: 784,family,O
Sentence: 784,",",O
Sentence: 784,discovered,O
Sentence: 784,a,O
Sentence: 784,history,O
Sentence: 784,of,O
Sentence: 784,polydipsia,B-Disease
Sentence: 784,and,O
Sentence: 784,long,O
Sentence: 784,-,O
Sentence: 784,standing,O
Sentence: 784,lithium,B-Chemical
Sentence: 784,use,O
Sentence: 784,.,O
Sentence: 784,Lithium,B-Chemical
Sentence: 784,is,O
Sentence: 784,implicated,O
Sentence: 784,in,O
Sentence: 784,drug,O
Sentence: 784,-,O
Sentence: 784,induced,O
Sentence: 784,nephrogenic,B-Disease
Sentence: 784,DI,I-Disease
Sentence: 784,",",O
Sentence: 784,and,O
Sentence: 784,because,O
Sentence: 784,the,O
Sentence: 784,patient,O
Sentence: 784,had,O
Sentence: 784,not,O
Sentence: 784,received,O
Sentence: 784,lithium,B-Chemical
Sentence: 784,since,O
Sentence: 784,being,O
Sentence: 784,admitted,O
Sentence: 784,to,O
Sentence: 784,the,O
Sentence: 784,hospital,O
Sentence: 784,",",O
Sentence: 784,his,O
Sentence: 784,treatment,O
Sentence: 784,changed,O
Sentence: 784,to,O
Sentence: 784,focus,O
Sentence: 784,on,O
Sentence: 784,nephrogenic,B-Disease
Sentence: 784,DI,I-Disease
Sentence: 784,.,O
Sentence: 784,By,O
Sentence: 784,combining,O
Sentence: 784,information,O
Sentence: 784,from,O
Sentence: 784,the,O
Sentence: 784,patient,O
Sentence: 784,history,O
Sentence: 784,",",O
Sentence: 784,the,O
Sentence: 784,physical,O
Sentence: 784,examination,O
Sentence: 784,",",O
Sentence: 784,and,O
Sentence: 784,radiologic,O
Sentence: 784,and,O
Sentence: 784,laboratory,O
Sentence: 784,studies,O
Sentence: 784,",",O
Sentence: 784,the,O
Sentence: 784,critical,O
Sentence: 784,care,O
Sentence: 784,team,O
Sentence: 784,demonstrated,O
Sentence: 784,that,O
Sentence: 784,the,O
Sentence: 784,patient,O
Sentence: 784,had,O
Sentence: 784,been,O
Sentence: 784,self,O
Sentence: 784,-,O
Sentence: 784,treating,O
Sentence: 784,his,O
Sentence: 784,lithium,B-Chemical
Sentence: 784,-,O
Sentence: 784,induced,O
Sentence: 784,nephrogenic,B-Disease
Sentence: 784,DI,I-Disease
Sentence: 784,and,O
Sentence: 784,developed,O
Sentence: 784,neurogenic,B-Disease
Sentence: 784,DI,I-Disease
Sentence: 784,secondary,O
Sentence: 784,to,O
Sentence: 784,brain,B-Disease
Sentence: 784,trauma,I-Disease
Sentence: 784,.,O
Sentence: 784,Thus,O
Sentence: 784,successful,O
Sentence: 784,treatment,O
Sentence: 784,required,O
Sentence: 784,that,O
Sentence: 784,nephrogenic,O
Sentence: 784,and,O
Sentence: 784,neurogenic,B-Disease
Sentence: 784,DI,I-Disease
Sentence: 784,be,O
Sentence: 784,treated,O
Sentence: 784,concomitantly,O
Sentence: 784,.,O
Sentence: 785,Factors,O
Sentence: 785,contributing,O
Sentence: 785,to,O
Sentence: 785,ribavirin,B-Chemical
Sentence: 785,-,O
Sentence: 785,induced,O
Sentence: 785,anemia,B-Disease
Sentence: 785,.,O
Sentence: 786,BACKGROUND,O
Sentence: 786,AND,O
Sentence: 786,AIM,O
Sentence: 786,:,O
Sentence: 786,Interferon,B-Chemical
Sentence: 786,and,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,combination,O
Sentence: 786,therapy,O
Sentence: 786,for,O
Sentence: 786,chronic,B-Disease
Sentence: 786,hepatitis,I-Disease
Sentence: 786,C,I-Disease
Sentence: 786,produces,O
Sentence: 786,hemolytic,B-Disease
Sentence: 786,anemia,B-Disease
Sentence: 786,.,O
Sentence: 786,This,O
Sentence: 786,study,O
Sentence: 786,was,O
Sentence: 786,conducted,O
Sentence: 786,to,O
Sentence: 786,identify,O
Sentence: 786,the,O
Sentence: 786,factors,O
Sentence: 786,contributing,O
Sentence: 786,to,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,-,O
Sentence: 786,induced,O
Sentence: 786,anemia,B-Disease
Sentence: 786,.,O
Sentence: 786,METHODS,O
Sentence: 786,:,O
Sentence: 786,Eighty,O
Sentence: 786,-,O
Sentence: 786,eight,O
Sentence: 786,patients,O
Sentence: 786,with,O
Sentence: 786,chronic,B-Disease
Sentence: 786,hepatitis,I-Disease
Sentence: 786,C,I-Disease
Sentence: 786,who,O
Sentence: 786,received,O
Sentence: 786,interferon,O
Sentence: 786,-,O
Sentence: 786,alpha,O
Sentence: 786,-,O
Sentence: 786,2b,O
Sentence: 786,at,O
Sentence: 786,a,O
Sentence: 786,dose,O
Sentence: 786,of,O
Sentence: 786,6,O
Sentence: 786,MU,O
Sentence: 786,administered,O
Sentence: 786,intramuscularly,O
Sentence: 786,for,O
Sentence: 786,24,O
Sentence: 786,weeks,O
Sentence: 786,in,O
Sentence: 786,combination,O
Sentence: 786,with,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,administered,O
Sentence: 786,orally,O
Sentence: 786,at,O
Sentence: 786,a,O
Sentence: 786,dose,O
Sentence: 786,of,O
Sentence: 786,600,O
Sentence: 786,mg,O
Sentence: 786,or,O
Sentence: 786,800,O
Sentence: 786,mg,O
Sentence: 786,participated,O
Sentence: 786,in,O
Sentence: 786,the,O
Sentence: 786,study,O
Sentence: 786,.,O
Sentence: 786,A,O
Sentence: 786,hemoglobin,O
Sentence: 786,concentration,O
Sentence: 786,of,O
Sentence: 786,,O
Sentence: 786,<,O
Sentence: 786,,O
Sentence: 786,10,O
Sentence: 786,g,O
Sentence: 786,/,O
Sentence: 786,dL,O
Sentence: 786,was,O
Sentence: 786,defined,O
Sentence: 786,as,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,-,O
Sentence: 786,induced,O
Sentence: 786,anemia,B-Disease
Sentence: 786,.,O
Sentence: 786,RESULTS,O
Sentence: 786,:,O
Sentence: 786,Ribavirin,B-Chemical
Sentence: 786,-,O
Sentence: 786,induced,O
Sentence: 786,anemia,B-Disease
Sentence: 786,occurred,O
Sentence: 786,in,O
Sentence: 786,18,O
Sentence: 786,(,O
Sentence: 786,20.5,O
Sentence: 786,%,O
Sentence: 786,),O
Sentence: 786,patients,O
Sentence: 786,during,O
Sentence: 786,treatment,O
Sentence: 786,.,O
Sentence: 786,A,O
Sentence: 786,2,O
Sentence: 786,g,O
Sentence: 786,/,O
Sentence: 786,dL,O
Sentence: 786,decrease,O
Sentence: 786,in,O
Sentence: 786,hemoglobin,O
Sentence: 786,concentrations,O
Sentence: 786,in,O
Sentence: 786,patients,O
Sentence: 786,with,O
Sentence: 786,anemia,B-Disease
Sentence: 786,was,O
Sentence: 786,observed,O
Sentence: 786,at,O
Sentence: 786,week,O
Sentence: 786,2,O
Sentence: 786,after,O
Sentence: 786,the,O
Sentence: 786,start,O
Sentence: 786,of,O
Sentence: 786,treatment,O
Sentence: 786,.,O
Sentence: 786,The,O
Sentence: 786,hemoglobin,O
Sentence: 786,concentration,O
Sentence: 786,in,O
Sentence: 786,patients,O
Sentence: 786,with,O
Sentence: 786,,O
Sentence: 786,>,O
Sentence: 786,,O
Sentence: 786,or,O
Sentence: 786,,O
Sentence: 786,=,O
Sentence: 786,2,O
Sentence: 786,g,O
Sentence: 786,/,O
Sentence: 786,dL,O
Sentence: 786,decrease,O
Sentence: 786,at,O
Sentence: 786,week,O
Sentence: 786,2,O
Sentence: 786,was,O
Sentence: 786,observed,O
Sentence: 786,to,O
Sentence: 786,be,O
Sentence: 786,significantly,O
Sentence: 786,lower,O
Sentence: 786,even,O
Sentence: 786,after,O
Sentence: 786,week,O
Sentence: 786,2,O
Sentence: 786,than,O
Sentence: 786,in,O
Sentence: 786,patients,O
Sentence: 786,with,O
Sentence: 786,,O
Sentence: 786,<,O
Sentence: 786,,O
Sentence: 786,2,O
Sentence: 786,g,O
Sentence: 786,/,O
Sentence: 786,dL,O
Sentence: 786,decrease,O
Sentence: 786,(,O
Sentence: 786,P,O
Sentence: 786,,O
Sentence: 786,<,O
Sentence: 786,,O
Sentence: 786,0.01,O
Sentence: 786,),O
Sentence: 786,.,O
Sentence: 786,A,O
Sentence: 786,significant,O
Sentence: 786,relationship,O
Sentence: 786,was,O
Sentence: 786,observed,O
Sentence: 786,between,O
Sentence: 786,the,O
Sentence: 786,rate,O
Sentence: 786,of,O
Sentence: 786,reduction,O
Sentence: 786,of,O
Sentence: 786,hemoglobin,O
Sentence: 786,concentrations,O
Sentence: 786,at,O
Sentence: 786,week,O
Sentence: 786,2,O
Sentence: 786,and,O
Sentence: 786,the,O
Sentence: 786,severity,O
Sentence: 786,of,O
Sentence: 786,anemia,B-Disease
Sentence: 786,(,O
Sentence: 786,P,O
Sentence: 786,,O
Sentence: 786,<,O
Sentence: 786,,O
Sentence: 786,0.01,O
Sentence: 786,),O
Sentence: 786,.,O
Sentence: 786,Such,O
Sentence: 786,factors,O
Sentence: 786,as,O
Sentence: 786,sex,O
Sentence: 786,(,O
Sentence: 786,female,O
Sentence: 786,),O
Sentence: 786,",",O
Sentence: 786,age,O
Sentence: 786,(,O
Sentence: 786,,O
Sentence: 786,>,O
Sentence: 786,,O
Sentence: 786,or,O
Sentence: 786,,O
Sentence: 786,=,O
Sentence: 786,60,O
Sentence: 786,years,O
Sentence: 786,old,O
Sentence: 786,),O
Sentence: 786,",",O
Sentence: 786,and,O
Sentence: 786,the,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,dose,O
Sentence: 786,by,O
Sentence: 786,body,O
Sentence: 786,weight,O
Sentence: 786,(,O
Sentence: 786,12,O
Sentence: 786,mg,O
Sentence: 786,/,O
Sentence: 786,kg,O
Sentence: 786,or,O
Sentence: 786,more,O
Sentence: 786,),O
Sentence: 786,were,O
Sentence: 786,significant,O
Sentence: 786,by,O
Sentence: 786,univariate,O
Sentence: 786,analysis,O
Sentence: 786,.,O
Sentence: 786,CONCLUSIONS,O
Sentence: 786,:,O
Sentence: 786,Careful,O
Sentence: 786,administration,O
Sentence: 786,is,O
Sentence: 786,necessary,O
Sentence: 786,in,O
Sentence: 786,patients,O
Sentence: 786,,O
Sentence: 786,>,O
Sentence: 786,,O
Sentence: 786,or,O
Sentence: 786,,O
Sentence: 786,=,O
Sentence: 786,60,O
Sentence: 786,years,O
Sentence: 786,old,O
Sentence: 786,",",O
Sentence: 786,in,O
Sentence: 786,female,O
Sentence: 786,patients,O
Sentence: 786,",",O
Sentence: 786,and,O
Sentence: 786,in,O
Sentence: 786,patients,O
Sentence: 786,receiving,O
Sentence: 786,a,O
Sentence: 786,ribavirin,B-Chemical
Sentence: 786,dose,O
Sentence: 786,of,O
Sentence: 786,12,O
Sentence: 786,mg,O
Sentence: 786,/,O
Sentence: 786,kg,O
Sentence: 786,or,O
Sentence: 786,more,O
Sentence: 786,.,O
Sentence: 786,Patients,O
Sentence: 786,who,O
Sentence: 786,experience,O
Sentence: 786,a,O
Sentence: 786,fall,O
Sentence: 786,in,O
Sentence: 786,hemoglobin,O
Sentence: 786,concentrations,O
Sentence: 786,of,O
Sentence: 786,2,O
Sentence: 786,g,O
Sentence: 786,/,O
Sentence: 786,dL,O
Sentence: 786,or,O
Sentence: 786,more,O
Sentence: 786,at,O
Sentence: 786,week,O
Sentence: 786,2,O
Sentence: 786,after,O
Sentence: 786,the,O
Sentence: 786,start,O
Sentence: 786,of,O
Sentence: 786,treatment,O
Sentence: 786,should,O
Sentence: 786,be,O
Sentence: 786,monitored,O
Sentence: 786,with,O
Sentence: 786,particular,O
Sentence: 786,care,O
Sentence: 786,.,O
Sentence: 787,Oxidative,O
Sentence: 787,damage,O
Sentence: 787,precedes,O
Sentence: 787,nitrative,O
Sentence: 787,damage,O
Sentence: 787,in,O
Sentence: 787,adriamycin,B-Chemical
Sentence: 787,-,O
Sentence: 787,induced,O
Sentence: 787,cardiac,O
Sentence: 787,mitochondrial,B-Disease
Sentence: 787,injury,I-Disease
Sentence: 787,.,O
Sentence: 788,The,O
Sentence: 788,purpose,O
Sentence: 788,of,O
Sentence: 788,the,O
Sentence: 788,present,O
Sentence: 788,study,O
Sentence: 788,was,O
Sentence: 788,to,O
Sentence: 788,determine,O
Sentence: 788,if,O
Sentence: 788,elevated,O
Sentence: 788,reactive,O
Sentence: 788,oxygen,B-Chemical
Sentence: 788,(,O
Sentence: 788,ROS,O
Sentence: 788,),O
Sentence: 788,,O
Sentence: 788,/,O
Sentence: 788,nitrogen,B-Chemical
Sentence: 788,species,O
Sentence: 788,(,O
Sentence: 788,RNS,O
Sentence: 788,),O
Sentence: 788,reported,O
Sentence: 788,to,O
Sentence: 788,be,O
Sentence: 788,present,O
Sentence: 788,in,O
Sentence: 788,adriamycin,B-Chemical
Sentence: 788,(,O
Sentence: 788,ADR,B-Chemical
Sentence: 788,),O
Sentence: 788,,O
Sentence: 788,-,O
Sentence: 788,induced,O
Sentence: 788,cardiotoxicity,B-Disease
Sentence: 788,actually,O
Sentence: 788,resulted,O
Sentence: 788,in,O
Sentence: 788,cardiomyocyte,O
Sentence: 788,oxidative,O
Sentence: 788,/,O
Sentence: 788,nitrative,O
Sentence: 788,damage,O
Sentence: 788,",",O
Sentence: 788,and,O
Sentence: 788,to,O
Sentence: 788,quantitatively,O
Sentence: 788,determine,O
Sentence: 788,the,O
Sentence: 788,time,O
Sentence: 788,course,O
Sentence: 788,and,O
Sentence: 788,subcellular,O
Sentence: 788,localization,O
Sentence: 788,of,O
Sentence: 788,these,O
Sentence: 788,postulated,O
Sentence: 788,damage,O
Sentence: 788,products,O
Sentence: 788,using,O
Sentence: 788,an,O
Sentence: 788,in,O
Sentence: 788,vivo,O
Sentence: 788,approach,O
Sentence: 788,.,O
Sentence: 788,B6C3,O
Sentence: 788,mice,O
Sentence: 788,were,O
Sentence: 788,treated,O
Sentence: 788,with,O
Sentence: 788,a,O
Sentence: 788,single,O
Sentence: 788,dose,O
Sentence: 788,of,O
Sentence: 788,20,O
Sentence: 788,mg,O
Sentence: 788,/,O
Sentence: 788,kg,O
Sentence: 788,ADR,B-Chemical
Sentence: 788,.,O
Sentence: 788,Ultrastructural,O
Sentence: 788,damage,O
Sentence: 788,and,O
Sentence: 788,levels,O
Sentence: 788,of,O
Sentence: 788,4,O
Sentence: 788,-,O
Sentence: 788,hydroxy,O
Sentence: 788,-,O
Sentence: 788,2,O
Sentence: 788,-,O
Sentence: 788,nonenal,O
Sentence: 788,(,O
Sentence: 788,4HNE,B-Chemical
Sentence: 788,),O
Sentence: 788,,O
Sentence: 788,-,O
Sentence: 788,protein,O
Sentence: 788,adducts,O
Sentence: 788,and,O
Sentence: 788,3,O
Sentence: 788,-,O
Sentence: 788,nitrotyrosine,O
Sentence: 788,(,O
Sentence: 788,3NT,B-Chemical
Sentence: 788,),O
Sentence: 788,were,O
Sentence: 788,analyzed,O
Sentence: 788,.,O
Sentence: 788,Quantitative,O
Sentence: 788,ultrastructural,O
Sentence: 788,damage,O
Sentence: 788,using,O
Sentence: 788,computerized,O
Sentence: 788,image,O
Sentence: 788,techniques,O
Sentence: 788,showed,O
Sentence: 788,cardiomyocyte,O
Sentence: 788,injury,O
Sentence: 788,as,O
Sentence: 788,early,O
Sentence: 788,as,O
Sentence: 788,3,O
Sentence: 788,hours,O
Sentence: 788,",",O
Sentence: 788,with,O
Sentence: 788,mitochondria,O
Sentence: 788,being,O
Sentence: 788,the,O
Sentence: 788,most,O
Sentence: 788,extensively,O
Sentence: 788,and,O
Sentence: 788,progressively,O
Sentence: 788,injured,O
Sentence: 788,subcellular,O
Sentence: 788,organelle,O
Sentence: 788,.,O
Sentence: 788,Analysis,O
Sentence: 788,of,O
Sentence: 788,4HNE,B-Chemical
Sentence: 788,protein,O
Sentence: 788,adducts,O
Sentence: 788,by,O
Sentence: 788,immunogold,O
Sentence: 788,electron,O
Sentence: 788,microscopy,O
Sentence: 788,showed,O
Sentence: 788,appearance,O
Sentence: 788,of,O
Sentence: 788,4HNE,B-Chemical
Sentence: 788,protein,O
Sentence: 788,adducts,O
Sentence: 788,in,O
Sentence: 788,mitochondria,O
Sentence: 788,as,O
Sentence: 788,early,O
Sentence: 788,as,O
Sentence: 788,3,O
Sentence: 788,hours,O
Sentence: 788,",",O
Sentence: 788,with,O
Sentence: 788,a,O
Sentence: 788,peak,O
Sentence: 788,at,O
Sentence: 788,6,O
Sentence: 788,hours,O
Sentence: 788,and,O
Sentence: 788,subsequent,O
Sentence: 788,decline,O
Sentence: 788,at,O
Sentence: 788,24,O
Sentence: 788,hours,O
Sentence: 788,.,O
Sentence: 788,3NT,B-Chemical
Sentence: 788,levels,O
Sentence: 788,were,O
Sentence: 788,significantly,O
Sentence: 788,increased,O
Sentence: 788,in,O
Sentence: 788,all,O
Sentence: 788,subcellular,O
Sentence: 788,compartments,O
Sentence: 788,at,O
Sentence: 788,6,O
Sentence: 788,hours,O
Sentence: 788,and,O
Sentence: 788,subsequently,O
Sentence: 788,declined,O
Sentence: 788,at,O
Sentence: 788,24,O
Sentence: 788,hours,O
Sentence: 788,.,O
Sentence: 788,Our,O
Sentence: 788,data,O
Sentence: 788,showed,O
Sentence: 788,ADR,B-Chemical
Sentence: 788,induced,O
Sentence: 788,4HNE,B-Chemical
Sentence: 788,-,O
Sentence: 788,protein,O
Sentence: 788,adducts,O
Sentence: 788,in,O
Sentence: 788,mitochondria,O
Sentence: 788,at,O
Sentence: 788,the,O
Sentence: 788,same,O
Sentence: 788,time,O
Sentence: 788,point,O
Sentence: 788,as,O
Sentence: 788,when,O
Sentence: 788,mitochondrial,B-Disease
Sentence: 788,injury,I-Disease
Sentence: 788,initially,O
Sentence: 788,appeared,O
Sentence: 788,.,O
Sentence: 788,These,O
Sentence: 788,results,O
Sentence: 788,document,O
Sentence: 788,for,O
Sentence: 788,the,O
Sentence: 788,first,O
Sentence: 788,time,O
Sentence: 788,in,O
Sentence: 788,vivo,O
Sentence: 788,that,O
Sentence: 788,mitochondrial,B-Disease
Sentence: 788,oxidative,I-Disease
Sentence: 788,damage,I-Disease
Sentence: 788,precedes,O
Sentence: 788,nitrative,O
Sentence: 788,damage,O
Sentence: 788,.,O
Sentence: 788,The,O
Sentence: 788,progressive,O
Sentence: 788,nature,O
Sentence: 788,of,O
Sentence: 788,mitochondrial,B-Disease
Sentence: 788,injury,I-Disease
Sentence: 788,suggests,O
Sentence: 788,that,O
Sentence: 788,mitochondria,O
Sentence: 788,",",O
Sentence: 788,not,O
Sentence: 788,other,O
Sentence: 788,subcellular,O
Sentence: 788,organelles,O
Sentence: 788,",",O
Sentence: 788,are,O
Sentence: 788,the,O
Sentence: 788,major,O
Sentence: 788,site,O
Sentence: 788,of,O
Sentence: 788,intracellular,O
Sentence: 788,injury,O
Sentence: 788,.,O
Sentence: 789,Sotalol,B-Chemical
Sentence: 789,-,O
Sentence: 789,induced,O
Sentence: 789,coronary,B-Disease
Sentence: 789,spasm,I-Disease
Sentence: 789,in,O
Sentence: 789,a,O
Sentence: 789,patient,O
Sentence: 789,with,O
Sentence: 789,dilated,B-Disease
Sentence: 789,cardiomyopathy,I-Disease
Sentence: 789,associated,O
Sentence: 789,with,O
Sentence: 789,sustained,O
Sentence: 789,ventricular,B-Disease
Sentence: 789,tachycardia,I-Disease
Sentence: 789,.,O
Sentence: 790,A,O
Sentence: 790,54,O
Sentence: 790,-,O
Sentence: 790,year,O
Sentence: 790,-,O
Sentence: 790,old,O
Sentence: 790,man,O
Sentence: 790,with,O
Sentence: 790,severe,O
Sentence: 790,left,O
Sentence: 790,ventricular,B-Disease
Sentence: 790,dysfunction,I-Disease
Sentence: 790,due,O
Sentence: 790,to,O
Sentence: 790,dilated,B-Disease
Sentence: 790,cardiomyopathy,I-Disease
Sentence: 790,was,O
Sentence: 790,referred,O
Sentence: 790,to,O
Sentence: 790,our,O
Sentence: 790,hospital,O
Sentence: 790,for,O
Sentence: 790,symptomatic,O
Sentence: 790,incessant,O
Sentence: 790,sustained,O
Sentence: 790,ventricular,B-Disease
Sentence: 790,tachycardia,I-Disease
Sentence: 790,(,O
Sentence: 790,VT,B-Disease
Sentence: 790,),O
Sentence: 790,.,O
Sentence: 790,After,O
Sentence: 790,the,O
Sentence: 790,administration,O
Sentence: 790,of,O
Sentence: 790,nifekalant,B-Chemical
Sentence: 790,hydrochloride,I-Chemical
Sentence: 790,",",O
Sentence: 790,sustained,O
Sentence: 790,VT,B-Disease
Sentence: 790,was,O
Sentence: 790,terminated,O
Sentence: 790,.,O
Sentence: 790,An,O
Sentence: 790,alternate,O
Sentence: 790,class,O
Sentence: 790,III,O
Sentence: 790,agent,O
Sentence: 790,",",O
Sentence: 790,sotalol,B-Chemical
Sentence: 790,",",O
Sentence: 790,was,O
Sentence: 790,also,O
Sentence: 790,effective,O
Sentence: 790,for,O
Sentence: 790,the,O
Sentence: 790,prevention,O
Sentence: 790,of,O
Sentence: 790,VT,B-Disease
Sentence: 790,.,O
Sentence: 790,However,O
Sentence: 790,",",O
Sentence: 790,one,O
Sentence: 790,month,O
Sentence: 790,after,O
Sentence: 790,switching,O
Sentence: 790,over,O
Sentence: 790,nifekalant,B-Chemical
Sentence: 790,to,O
Sentence: 790,sotalol,B-Chemical
Sentence: 790,",",O
Sentence: 790,a,O
Sentence: 790,short,O
Sentence: 790,duration,O
Sentence: 790,of,O
Sentence: 790,ST,O
Sentence: 790,elevation,O
Sentence: 790,was,O
Sentence: 790,documented,O
Sentence: 790,in,O
Sentence: 790,ECG,O
Sentence: 790,monitoring,O
Sentence: 790,at,O
Sentence: 790,almost,O
Sentence: 790,the,O
Sentence: 790,same,O
Sentence: 790,time,O
Sentence: 790,for,O
Sentence: 790,three,O
Sentence: 790,consecutive,O
Sentence: 790,days,O
Sentence: 790,.,O
Sentence: 790,ST,O
Sentence: 790,elevation,O
Sentence: 790,with,O
Sentence: 790,chest,O
Sentence: 790,discomfort,O
Sentence: 790,disappeared,O
Sentence: 790,since,O
Sentence: 790,he,O
Sentence: 790,began,O
Sentence: 790,taking,O
Sentence: 790,long,O
Sentence: 790,-,O
Sentence: 790,acting,O
Sentence: 790,diltiazem,B-Chemical
Sentence: 790,.,O
Sentence: 790,Coronary,B-Disease
Sentence: 790,vasospasm,I-Disease
Sentence: 790,may,O
Sentence: 790,be,O
Sentence: 790,induced,O
Sentence: 790,by,O
Sentence: 790,the,O
Sentence: 790,non,O
Sentence: 790,-,O
Sentence: 790,selective,O
Sentence: 790,beta,O
Sentence: 790,-,O
Sentence: 790,blocking,O
Sentence: 790,properties,O
Sentence: 790,of,O
Sentence: 790,sotalol,B-Chemical
Sentence: 790,.,O
Sentence: 791,Effects,O
Sentence: 791,of,O
Sentence: 791,the,O
Sentence: 791,antidepressant,O
Sentence: 791,trazodone,B-Chemical
Sentence: 791,",",O
Sentence: 791,a,O
Sentence: 791,5,O
Sentence: 791,-,O
Sentence: 791,HT,O
Sentence: 791,2A,O
Sentence: 791,/,O
Sentence: 791,2C,O
Sentence: 791,receptor,O
Sentence: 791,antagonist,O
Sentence: 791,",",O
Sentence: 791,on,O
Sentence: 791,dopamine,B-Chemical
Sentence: 791,-,O
Sentence: 791,dependent,O
Sentence: 791,behaviors,O
Sentence: 791,in,O
Sentence: 791,rats,O
Sentence: 791,.,O
Sentence: 792,RATIONALE,O
Sentence: 792,:,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,Hydroxytryptamine,O
Sentence: 792,",",O
Sentence: 792,via,O
Sentence: 792,stimulation,O
Sentence: 792,of,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2C,O
Sentence: 792,receptors,O
Sentence: 792,",",O
Sentence: 792,exerts,O
Sentence: 792,a,O
Sentence: 792,tonic,O
Sentence: 792,inhibitory,O
Sentence: 792,influence,O
Sentence: 792,on,O
Sentence: 792,dopaminergic,O
Sentence: 792,neurotransmission,O
Sentence: 792,",",O
Sentence: 792,whereas,O
Sentence: 792,activation,O
Sentence: 792,of,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2A,O
Sentence: 792,receptors,O
Sentence: 792,enhances,O
Sentence: 792,stimulated,O
Sentence: 792,DAergic,O
Sentence: 792,neurotransmission,O
Sentence: 792,.,O
Sentence: 792,The,O
Sentence: 792,antidepressant,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,is,O
Sentence: 792,a,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2A,O
Sentence: 792,/,O
Sentence: 792,2C,O
Sentence: 792,receptor,O
Sentence: 792,antagonist,O
Sentence: 792,.,O
Sentence: 792,OBJECTIVES,O
Sentence: 792,:,O
Sentence: 792,To,O
Sentence: 792,evaluate,O
Sentence: 792,the,O
Sentence: 792,effect,O
Sentence: 792,of,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,treatment,O
Sentence: 792,on,O
Sentence: 792,behaviors,O
Sentence: 792,dependent,O
Sentence: 792,on,O
Sentence: 792,the,O
Sentence: 792,functional,O
Sentence: 792,status,O
Sentence: 792,of,O
Sentence: 792,the,O
Sentence: 792,nigrostriatal,O
Sentence: 792,DAergic,O
Sentence: 792,system,O
Sentence: 792,.,O
Sentence: 792,METHODS,O
Sentence: 792,:,O
Sentence: 792,The,O
Sentence: 792,effect,O
Sentence: 792,of,O
Sentence: 792,pretreatment,O
Sentence: 792,with,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,on,O
Sentence: 792,dexamphetamine,B-Chemical
Sentence: 792,-,O
Sentence: 792,,O
Sentence: 792,and,O
Sentence: 792,apomorphine,B-Chemical
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,oral,B-Disease
Sentence: 792,stereotypies,I-Disease
Sentence: 792,",",O
Sentence: 792,on,O
Sentence: 792,catalepsy,B-Disease
Sentence: 792,induced,O
Sentence: 792,by,O
Sentence: 792,haloperidol,B-Chemical
Sentence: 792,and,O
Sentence: 792,apomorphine,B-Chemical
Sentence: 792,(,O
Sentence: 792,0.05,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,",",O
Sentence: 792,i.p,O
Sentence: 792,.,O
Sentence: 792,),O
Sentence: 792,",",O
Sentence: 792,on,O
Sentence: 792,ergometrine,B-Chemical
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,wet,O
Sentence: 792,dog,O
Sentence: 792,shake,O
Sentence: 792,(,O
Sentence: 792,WDS,O
Sentence: 792,),O
Sentence: 792,behavior,O
Sentence: 792,and,O
Sentence: 792,fluoxetine,B-Chemical
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,penile,O
Sentence: 792,erections,O
Sentence: 792,was,O
Sentence: 792,studied,O
Sentence: 792,in,O
Sentence: 792,rats,O
Sentence: 792,.,O
Sentence: 792,We,O
Sentence: 792,also,O
Sentence: 792,investigated,O
Sentence: 792,whether,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,induces,O
Sentence: 792,catalepsy,B-Disease
Sentence: 792,in,O
Sentence: 792,rats,O
Sentence: 792,.,O
Sentence: 792,RESULTS,O
Sentence: 792,:,O
Sentence: 792,Trazodone,B-Chemical
Sentence: 792,at,O
Sentence: 792,2.5,O
Sentence: 792,-,O
Sentence: 792,20,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,i.p,O
Sentence: 792,.,O
Sentence: 792,did,O
Sentence: 792,not,O
Sentence: 792,induce,O
Sentence: 792,catalepsy,B-Disease
Sentence: 792,",",O
Sentence: 792,and,O
Sentence: 792,did,O
Sentence: 792,not,O
Sentence: 792,antagonize,O
Sentence: 792,apomorphine,B-Chemical
Sentence: 792,(,O
Sentence: 792,1.5,O
Sentence: 792,and,O
Sentence: 792,3,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,),O
Sentence: 792,stereotypy,O
Sentence: 792,and,O
Sentence: 792,apomorphine,B-Chemical
Sentence: 792,(,O
Sentence: 792,0.05,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,),O
Sentence: 792,,O
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,catalepsy,B-Disease
Sentence: 792,.,O
Sentence: 792,However,O
Sentence: 792,",",O
Sentence: 792,pretreatment,O
Sentence: 792,with,O
Sentence: 792,5,O
Sentence: 792,",",O
Sentence: 792,10,O
Sentence: 792,and,O
Sentence: 792,20,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,i.p,O
Sentence: 792,.,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,enhanced,O
Sentence: 792,dexamphetamine,B-Chemical
Sentence: 792,stereotypy,O
Sentence: 792,",",O
Sentence: 792,and,O
Sentence: 792,antagonized,O
Sentence: 792,haloperidol,B-Chemical
Sentence: 792,catalepsy,B-Disease
Sentence: 792,",",O
Sentence: 792,ergometrine,B-Chemical
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,WDS,O
Sentence: 792,behavior,O
Sentence: 792,and,O
Sentence: 792,fluoxetine,B-Chemical
Sentence: 792,-,O
Sentence: 792,induced,O
Sentence: 792,penile,O
Sentence: 792,erections,O
Sentence: 792,.,O
Sentence: 792,Trazodone,B-Chemical
Sentence: 792,at,O
Sentence: 792,30,O
Sentence: 792,",",O
Sentence: 792,40,O
Sentence: 792,and,O
Sentence: 792,50,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,i.p,O
Sentence: 792,.,O
Sentence: 792,induced,O
Sentence: 792,catalepsy,B-Disease
Sentence: 792,and,O
Sentence: 792,antagonized,O
Sentence: 792,apomorphine,B-Chemical
Sentence: 792,and,O
Sentence: 792,dexamphetamine,B-Chemical
Sentence: 792,stereotypies,O
Sentence: 792,.,O
Sentence: 792,CONCLUSIONS,O
Sentence: 792,:,O
Sentence: 792,Our,O
Sentence: 792,results,O
Sentence: 792,indicate,O
Sentence: 792,that,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,at,O
Sentence: 792,2.5,O
Sentence: 792,-,O
Sentence: 792,20,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,does,O
Sentence: 792,not,O
Sentence: 792,block,O
Sentence: 792,pre,O
Sentence: 792,-,O
Sentence: 792,,O
Sentence: 792,and,O
Sentence: 792,postsynaptic,O
Sentence: 792,striatal,O
Sentence: 792,D2,O
Sentence: 792,DA,O
Sentence: 792,receptors,O
Sentence: 792,",",O
Sentence: 792,while,O
Sentence: 792,at,O
Sentence: 792,30,O
Sentence: 792,",",O
Sentence: 792,40,O
Sentence: 792,and,O
Sentence: 792,50,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,it,O
Sentence: 792,blocks,O
Sentence: 792,postsynaptic,O
Sentence: 792,striatal,O
Sentence: 792,D2,O
Sentence: 792,DA,O
Sentence: 792,receptors,O
Sentence: 792,.,O
Sentence: 792,Furthermore,O
Sentence: 792,",",O
Sentence: 792,at,O
Sentence: 792,5,O
Sentence: 792,",",O
Sentence: 792,10,O
Sentence: 792,and,O
Sentence: 792,20,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,",",O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,blocks,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2A,O
Sentence: 792,and,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2C,O
Sentence: 792,receptors,O
Sentence: 792,.,O
Sentence: 792,We,O
Sentence: 792,suggest,O
Sentence: 792,that,O
Sentence: 792,trazodone,B-Chemical
Sentence: 792,(,O
Sentence: 792,5,O
Sentence: 792,",",O
Sentence: 792,10,O
Sentence: 792,and,O
Sentence: 792,20,O
Sentence: 792,mg,O
Sentence: 792,/,O
Sentence: 792,kg,O
Sentence: 792,),O
Sentence: 792,",",O
Sentence: 792,by,O
Sentence: 792,blocking,O
Sentence: 792,the,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,2C,O
Sentence: 792,receptors,O
Sentence: 792,",",O
Sentence: 792,releases,O
Sentence: 792,the,O
Sentence: 792,nigrostriatal,O
Sentence: 792,DAergic,O
Sentence: 792,neurons,O
Sentence: 792,from,O
Sentence: 792,tonic,O
Sentence: 792,inhibition,O
Sentence: 792,caused,O
Sentence: 792,by,O
Sentence: 792,5,O
Sentence: 792,-,O
Sentence: 792,HT,O
Sentence: 792,",",O
Sentence: 792,and,O
Sentence: 792,thereby,O
Sentence: 792,potentiates,O
Sentence: 792,dexamphetamine,B-Chemical
Sentence: 792,stereotypy,O
Sentence: 792,and,O
Sentence: 792,antagonizes,O
Sentence: 792,haloperidol,B-Chemical
Sentence: 792,catalepsy,B-Disease
Sentence: 792,.,O
Sentence: 793,Swallowing,B-Disease
Sentence: 793,abnormalities,I-Disease
Sentence: 793,and,O
Sentence: 793,dyskinesia,B-Disease
Sentence: 793,in,O
Sentence: 793,Parkinson,B-Disease
Sentence: 793,'s,I-Disease
Sentence: 793,disease,I-Disease
Sentence: 793,.,O
Sentence: 794,Gastrointestinal,B-Disease
Sentence: 794,abnormalities,I-Disease
Sentence: 794,in,O
Sentence: 794,Parkinson,B-Disease
Sentence: 794,'s,I-Disease
Sentence: 794,disease,I-Disease
Sentence: 794,(,O
Sentence: 794,PD,B-Disease
Sentence: 794,),O
Sentence: 794,have,O
Sentence: 794,been,O
Sentence: 794,known,O
Sentence: 794,for,O
Sentence: 794,almost,O
Sentence: 794,two,O
Sentence: 794,centuries,O
Sentence: 794,",",O
Sentence: 794,but,O
Sentence: 794,many,O
Sentence: 794,aspects,O
Sentence: 794,concerning,O
Sentence: 794,their,O
Sentence: 794,pathophysiology,O
Sentence: 794,have,O
Sentence: 794,not,O
Sentence: 794,been,O
Sentence: 794,completely,O
Sentence: 794,clarified,O
Sentence: 794,.,O
Sentence: 794,The,O
Sentence: 794,aim,O
Sentence: 794,of,O
Sentence: 794,this,O
Sentence: 794,study,O
Sentence: 794,was,O
Sentence: 794,to,O
Sentence: 794,characterize,O
Sentence: 794,the,O
Sentence: 794,oropharyngeal,O
Sentence: 794,dynamics,O
Sentence: 794,in,O
Sentence: 794,PD,B-Disease
Sentence: 794,patients,O
Sentence: 794,with,O
Sentence: 794,and,O
Sentence: 794,without,O
Sentence: 794,levodopa,B-Chemical
Sentence: 794,-,O
Sentence: 794,induced,O
Sentence: 794,dyskinesia,B-Disease
Sentence: 794,.,O
Sentence: 794,Fifteen,O
Sentence: 794,dyskinetic,B-Disease
Sentence: 794,",",O
Sentence: 794,12,O
Sentence: 794,nondyskinetic,O
Sentence: 794,patients,O
Sentence: 794,",",O
Sentence: 794,and,O
Sentence: 794,a,O
Sentence: 794,control,O
Sentence: 794,group,O
Sentence: 794,were,O
Sentence: 794,included,O
Sentence: 794,.,O
Sentence: 794,Patients,O
Sentence: 794,were,O
Sentence: 794,asked,O
Sentence: 794,about,O
Sentence: 794,dysphagia,B-Disease
Sentence: 794,and,O
Sentence: 794,evaluated,O
Sentence: 794,with,O
Sentence: 794,the,O
Sentence: 794,Unified,O
Sentence: 794,Parkinson,B-Disease
Sentence: 794,'s,I-Disease
Sentence: 794,Disease,I-Disease
Sentence: 794,Rating,O
Sentence: 794,Scale,O
Sentence: 794,Parts,O
Sentence: 794,II,O
Sentence: 794,and,O
Sentence: 794,III,O
Sentence: 794,and,O
Sentence: 794,the,O
Sentence: 794,Hoehn,O
Sentence: 794,and,O
Sentence: 794,Yahr,O
Sentence: 794,scale,O
Sentence: 794,.,O
Sentence: 794,Deglutition,O
Sentence: 794,was,O
Sentence: 794,assessed,O
Sentence: 794,using,O
Sentence: 794,modified,O
Sentence: 794,barium,B-Chemical
Sentence: 794,swallow,O
Sentence: 794,with,O
Sentence: 794,videofluoroscopy,O
Sentence: 794,.,O
Sentence: 794,Nondyskinetic,O
Sentence: 794,patients,O
Sentence: 794,",",O
Sentence: 794,but,O
Sentence: 794,not,O
Sentence: 794,the,O
Sentence: 794,dyskinetic,B-Disease
Sentence: 794,ones,O
Sentence: 794,",",O
Sentence: 794,showed,O
Sentence: 794,less,O
Sentence: 794,oropharyngeal,O
Sentence: 794,swallowing,O
Sentence: 794,efficiency,O
Sentence: 794,(,O
Sentence: 794,OPSE,O
Sentence: 794,),O
Sentence: 794,for,O
Sentence: 794,liquid,O
Sentence: 794,food,O
Sentence: 794,than,O
Sentence: 794,controls,O
Sentence: 794,(,O
Sentence: 794,Dunnett,O
Sentence: 794,",",O
Sentence: 794,P,O
Sentence: 794,,O
Sentence: 794,=,O
Sentence: 794,,O
Sentence: 794,0.02,O
Sentence: 794,),O
Sentence: 794,.,O
Sentence: 794,Dyskinetic,B-Disease
Sentence: 794,patients,O
Sentence: 794,tended,O
Sentence: 794,to,O
Sentence: 794,have,O
Sentence: 794,a,O
Sentence: 794,greater,O
Sentence: 794,OPSE,O
Sentence: 794,than,O
Sentence: 794,nondyskinetic,O
Sentence: 794,(,O
Sentence: 794,Dunnett,O
Sentence: 794,",",O
Sentence: 794,P,O
Sentence: 794,,O
Sentence: 794,=,O
Sentence: 794,,O
Sentence: 794,0.06,O
Sentence: 794,),O
Sentence: 794,.,O
Sentence: 794,Patients,O
Sentence: 794,who,O
Sentence: 794,were,O
Sentence: 794,using,O
Sentence: 794,a,O
Sentence: 794,higher,O
Sentence: 794,dose,O
Sentence: 794,of,O
Sentence: 794,levodopa,B-Chemical
Sentence: 794,had,O
Sentence: 794,a,O
Sentence: 794,greater,O
Sentence: 794,OPSE,O
Sentence: 794,and,O
Sentence: 794,a,O
Sentence: 794,trend,O
Sentence: 794,toward,O
Sentence: 794,a,O
Sentence: 794,smaller,O
Sentence: 794,oral,O
Sentence: 794,transit,O
Sentence: 794,time,O
Sentence: 794,(,O
Sentence: 794,Pearson,O
Sentence: 794,'s,O
Sentence: 794,correlation,O
Sentence: 794,",",O
Sentence: 794,P,O
Sentence: 794,,O
Sentence: 794,=,O
Sentence: 794,,O
Sentence: 794,0.01,O
Sentence: 794,and,O
Sentence: 794,0.08,O
Sentence: 794,",",O
Sentence: 794,respectively,O
Sentence: 794,),O
Sentence: 794,.,O
Sentence: 794,Neither,O
Sentence: 794,the,O
Sentence: 794,report,O
Sentence: 794,of,O
Sentence: 794,dysphagia,B-Disease
Sentence: 794,nor,O
Sentence: 794,any,O
Sentence: 794,of,O
Sentence: 794,the,O
Sentence: 794,PD,B-Disease
Sentence: 794,severity,O
Sentence: 794,parameters,O
Sentence: 794,correlated,O
Sentence: 794,to,O
Sentence: 794,the,O
Sentence: 794,videofluoroscopic,O
Sentence: 794,variables,O
Sentence: 794,.,O
Sentence: 794,In,O
Sentence: 794,the,O
Sentence: 794,current,O
Sentence: 794,study,O
Sentence: 794,",",O
Sentence: 794,dyskinetic,B-Disease
Sentence: 794,patients,O
Sentence: 794,performed,O
Sentence: 794,better,O
Sentence: 794,in,O
Sentence: 794,swallowing,O
Sentence: 794,function,O
Sentence: 794,",",O
Sentence: 794,which,O
Sentence: 794,could,O
Sentence: 794,be,O
Sentence: 794,explained,O
Sentence: 794,on,O
Sentence: 794,the,O
Sentence: 794,basis,O
Sentence: 794,of,O
Sentence: 794,a,O
Sentence: 794,greater,O
Sentence: 794,levodopa,B-Chemical
Sentence: 794,dose,O
Sentence: 794,.,O
Sentence: 794,Our,O
Sentence: 794,results,O
Sentence: 794,suggest,O
Sentence: 794,a,O
Sentence: 794,role,O
Sentence: 794,for,O
Sentence: 794,levodopa,B-Chemical
Sentence: 794,in,O
Sentence: 794,the,O
Sentence: 794,oral,O
Sentence: 794,phase,O
Sentence: 794,of,O
Sentence: 794,deglutition,O
Sentence: 794,and,O
Sentence: 794,confirm,O
Sentence: 794,that,O
Sentence: 794,dysphagia,B-Disease
Sentence: 794,is,O
Sentence: 794,not,O
Sentence: 794,a,O
Sentence: 794,good,O
Sentence: 794,predictor,O
Sentence: 794,of,O
Sentence: 794,deglutition,O
Sentence: 794,alterations,O
Sentence: 794,in,O
Sentence: 794,PD,B-Disease
Sentence: 794,.,O
Sentence: 795,Inhibition,O
Sentence: 795,of,O
Sentence: 795,nuclear,O
Sentence: 795,factor,O
Sentence: 795,-,O
Sentence: 795,kappaB,O
Sentence: 795,activation,O
Sentence: 795,attenuates,O
Sentence: 795,tubulointerstitial,B-Disease
Sentence: 795,nephritis,I-Disease
Sentence: 795,induced,O
Sentence: 795,by,O
Sentence: 795,gentamicin,B-Chemical
Sentence: 795,.,O
Sentence: 796,BACKGROUND,O
Sentence: 796,:,O
Sentence: 796,Animals,O
Sentence: 796,treated,O
Sentence: 796,with,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,can,O
Sentence: 796,show,O
Sentence: 796,residual,O
Sentence: 796,areas,O
Sentence: 796,of,O
Sentence: 796,interstitial,O
Sentence: 796,fibrosis,B-Disease
Sentence: 796,in,O
Sentence: 796,the,O
Sentence: 796,renal,O
Sentence: 796,cortex,O
Sentence: 796,.,O
Sentence: 796,This,O
Sentence: 796,study,O
Sentence: 796,investigated,O
Sentence: 796,the,O
Sentence: 796,expression,O
Sentence: 796,of,O
Sentence: 796,nuclear,O
Sentence: 796,factor,O
Sentence: 796,-,O
Sentence: 796,kappaB,O
Sentence: 796,(,O
Sentence: 796,NF,O
Sentence: 796,-,O
Sentence: 796,kappaB,O
Sentence: 796,),O
Sentence: 796,",",O
Sentence: 796,mitogen,O
Sentence: 796,-,O
Sentence: 796,activated,O
Sentence: 796,protein,O
Sentence: 796,(,O
Sentence: 796,MAP,O
Sentence: 796,),O
Sentence: 796,kinases,O
Sentence: 796,and,O
Sentence: 796,macrophages,O
Sentence: 796,in,O
Sentence: 796,the,O
Sentence: 796,renal,O
Sentence: 796,cortex,O
Sentence: 796,and,O
Sentence: 796,structural,O
Sentence: 796,and,O
Sentence: 796,functional,O
Sentence: 796,renal,O
Sentence: 796,changes,O
Sentence: 796,of,O
Sentence: 796,rats,O
Sentence: 796,treated,O
Sentence: 796,with,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,or,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,+,O
Sentence: 796,pyrrolidine,B-Chemical
Sentence: 796,dithiocarbamate,I-Chemical
Sentence: 796,(,O
Sentence: 796,PDTC,B-Chemical
Sentence: 796,),O
Sentence: 796,",",O
Sentence: 796,an,O
Sentence: 796,NF,O
Sentence: 796,-,O
Sentence: 796,kappaB,O
Sentence: 796,inhibitor,O
Sentence: 796,.,O
Sentence: 796,METHODS,O
Sentence: 796,:,O
Sentence: 796,38,O
Sentence: 796,female,O
Sentence: 796,Wistar,O
Sentence: 796,rats,O
Sentence: 796,were,O
Sentence: 796,injected,O
Sentence: 796,with,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,",",O
Sentence: 796,40,O
Sentence: 796,mg,O
Sentence: 796,/,O
Sentence: 796,kg,O
Sentence: 796,",",O
Sentence: 796,twice,O
Sentence: 796,a,O
Sentence: 796,day,O
Sentence: 796,for,O
Sentence: 796,9,O
Sentence: 796,days,O
Sentence: 796,",",O
Sentence: 796,38,O
Sentence: 796,with,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,+,O
Sentence: 796,PDTC,B-Chemical
Sentence: 796,",",O
Sentence: 796,and,O
Sentence: 796,28,O
Sentence: 796,with,O
Sentence: 796,0.15,O
Sentence: 796,M,O
Sentence: 796,NaCl,B-Chemical
Sentence: 796,solution,O
Sentence: 796,.,O
Sentence: 796,The,O
Sentence: 796,animals,O
Sentence: 796,were,O
Sentence: 796,killed,O
Sentence: 796,5,O
Sentence: 796,and,O
Sentence: 796,30,O
Sentence: 796,days,O
Sentence: 796,after,O
Sentence: 796,these,O
Sentence: 796,injections,O
Sentence: 796,and,O
Sentence: 796,the,O
Sentence: 796,kidneys,O
Sentence: 796,were,O
Sentence: 796,removed,O
Sentence: 796,for,O
Sentence: 796,histological,O
Sentence: 796,and,O
Sentence: 796,immunohistochemical,O
Sentence: 796,studies,O
Sentence: 796,.,O
Sentence: 796,The,O
Sentence: 796,results,O
Sentence: 796,of,O
Sentence: 796,the,O
Sentence: 796,immunohistochemical,O
Sentence: 796,studies,O
Sentence: 796,were,O
Sentence: 796,scored,O
Sentence: 796,according,O
Sentence: 796,to,O
Sentence: 796,the,O
Sentence: 796,extent,O
Sentence: 796,of,O
Sentence: 796,staining,O
Sentence: 796,.,O
Sentence: 796,The,O
Sentence: 796,fractional,O
Sentence: 796,interstitial,O
Sentence: 796,area,O
Sentence: 796,was,O
Sentence: 796,determined,O
Sentence: 796,by,O
Sentence: 796,morphometry,O
Sentence: 796,.,O
Sentence: 796,RESULTS,O
Sentence: 796,:,O
Sentence: 796,Gentamicin,B-Chemical
Sentence: 796,-,O
Sentence: 796,treated,O
Sentence: 796,rats,O
Sentence: 796,presented,O
Sentence: 796,a,O
Sentence: 796,transitory,O
Sentence: 796,increase,O
Sentence: 796,in,O
Sentence: 796,plasma,O
Sentence: 796,creatinine,B-Chemical
Sentence: 796,levels,O
Sentence: 796,.,O
Sentence: 796,Increased,O
Sentence: 796,ED,O
Sentence: 796,-,O
Sentence: 796,1,O
Sentence: 796,",",O
Sentence: 796,MAP,O
Sentence: 796,kinases,O
Sentence: 796,and,O
Sentence: 796,NF,O
Sentence: 796,-,O
Sentence: 796,kappaB,O
Sentence: 796,staining,O
Sentence: 796,were,O
Sentence: 796,also,O
Sentence: 796,observed,O
Sentence: 796,in,O
Sentence: 796,the,O
Sentence: 796,renal,O
Sentence: 796,cortex,O
Sentence: 796,from,O
Sentence: 796,all,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,-,O
Sentence: 796,treated,O
Sentence: 796,rats,O
Sentence: 796,compared,O
Sentence: 796,to,O
Sentence: 796,control,O
Sentence: 796,(,O
Sentence: 796,p,O
Sentence: 796,,O
Sentence: 796,<,O
Sentence: 796,,O
Sentence: 796,0.05,O
Sentence: 796,),O
Sentence: 796,.,O
Sentence: 796,The,O
Sentence: 796,animals,O
Sentence: 796,killed,O
Sentence: 796,on,O
Sentence: 796,day,O
Sentence: 796,30,O
Sentence: 796,also,O
Sentence: 796,presented,O
Sentence: 796,fibrosis,B-Disease
Sentence: 796,in,O
Sentence: 796,the,O
Sentence: 796,renal,O
Sentence: 796,cortex,O
Sentence: 796,despite,O
Sentence: 796,the,O
Sentence: 796,recovery,O
Sentence: 796,of,O
Sentence: 796,renal,O
Sentence: 796,function,O
Sentence: 796,.,O
Sentence: 796,Treatment,O
Sentence: 796,with,O
Sentence: 796,PDTC,B-Chemical
Sentence: 796,reduced,O
Sentence: 796,the,O
Sentence: 796,functional,O
Sentence: 796,and,O
Sentence: 796,structural,O
Sentence: 796,changes,O
Sentence: 796,induced,O
Sentence: 796,by,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,.,O
Sentence: 796,CONCLUSIONS,O
Sentence: 796,:,O
Sentence: 796,These,O
Sentence: 796,data,O
Sentence: 796,show,O
Sentence: 796,that,O
Sentence: 796,inhibition,O
Sentence: 796,of,O
Sentence: 796,NF,O
Sentence: 796,-,O
Sentence: 796,kappaB,O
Sentence: 796,activation,O
Sentence: 796,attenuates,O
Sentence: 796,tubulointerstitial,B-Disease
Sentence: 796,nephritis,I-Disease
Sentence: 796,induced,O
Sentence: 796,by,O
Sentence: 796,gentamicin,B-Chemical
Sentence: 796,.,O
Sentence: 797,Glucose,B-Chemical
Sentence: 797,metabolism,O
Sentence: 797,in,O
Sentence: 797,patients,O
Sentence: 797,with,O
Sentence: 797,schizophrenia,B-Disease
Sentence: 797,treated,O
Sentence: 797,with,O
Sentence: 797,atypical,O
Sentence: 797,antipsychotic,O
Sentence: 797,agents,O
Sentence: 797,:,O
Sentence: 797,a,O
Sentence: 797,frequently,O
Sentence: 797,sampled,O
Sentence: 797,intravenous,O
Sentence: 797,glucose,B-Chemical
Sentence: 797,tolerance,O
Sentence: 797,test,O
Sentence: 797,and,O
Sentence: 797,minimal,O
Sentence: 797,model,O
Sentence: 797,analysis,O
Sentence: 797,.,O
Sentence: 798,BACKGROUND,O
Sentence: 798,:,O
Sentence: 798,While,O
Sentence: 798,the,O
Sentence: 798,incidence,O
Sentence: 798,of,O
Sentence: 798,new,O
Sentence: 798,-,O
Sentence: 798,onset,O
Sentence: 798,diabetes,B-Disease
Sentence: 798,mellitus,I-Disease
Sentence: 798,may,O
Sentence: 798,be,O
Sentence: 798,increasing,O
Sentence: 798,in,O
Sentence: 798,patients,O
Sentence: 798,with,O
Sentence: 798,schizophrenia,B-Disease
Sentence: 798,treated,O
Sentence: 798,with,O
Sentence: 798,certain,O
Sentence: 798,atypical,O
Sentence: 798,antipsychotic,O
Sentence: 798,agents,O
Sentence: 798,",",O
Sentence: 798,it,O
Sentence: 798,remains,O
Sentence: 798,unclear,O
Sentence: 798,whether,O
Sentence: 798,atypical,O
Sentence: 798,agents,O
Sentence: 798,are,O
Sentence: 798,directly,O
Sentence: 798,affecting,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,metabolism,O
Sentence: 798,or,O
Sentence: 798,simply,O
Sentence: 798,increasing,O
Sentence: 798,known,O
Sentence: 798,risk,O
Sentence: 798,factors,O
Sentence: 798,for,O
Sentence: 798,diabetes,B-Disease
Sentence: 798,.,O
Sentence: 798,OBJECTIVE,O
Sentence: 798,:,O
Sentence: 798,To,O
Sentence: 798,study,O
Sentence: 798,the,O
Sentence: 798,2,O
Sentence: 798,drugs,O
Sentence: 798,most,O
Sentence: 798,clearly,O
Sentence: 798,implicated,O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,),O
Sentence: 798,and,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,using,O
Sentence: 798,a,O
Sentence: 798,frequently,O
Sentence: 798,sampled,O
Sentence: 798,intravenous,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,tolerance,O
Sentence: 798,test,O
Sentence: 798,.,O
Sentence: 798,DESIGN,O
Sentence: 798,:,O
Sentence: 798,A,O
Sentence: 798,cross,O
Sentence: 798,-,O
Sentence: 798,sectional,O
Sentence: 798,design,O
Sentence: 798,in,O
Sentence: 798,stable,O
Sentence: 798,",",O
Sentence: 798,treated,O
Sentence: 798,patients,O
Sentence: 798,with,O
Sentence: 798,schizophrenia,B-Disease
Sentence: 798,evaluated,O
Sentence: 798,using,O
Sentence: 798,a,O
Sentence: 798,frequently,O
Sentence: 798,sampled,O
Sentence: 798,intravenous,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,tolerance,O
Sentence: 798,test,O
Sentence: 798,and,O
Sentence: 798,the,O
Sentence: 798,Bergman,O
Sentence: 798,minimal,O
Sentence: 798,model,O
Sentence: 798,analysis,O
Sentence: 798,.,O
Sentence: 798,SETTING,O
Sentence: 798,:,O
Sentence: 798,Subjects,O
Sentence: 798,were,O
Sentence: 798,recruited,O
Sentence: 798,from,O
Sentence: 798,an,O
Sentence: 798,urban,O
Sentence: 798,community,O
Sentence: 798,mental,O
Sentence: 798,health,O
Sentence: 798,clinic,O
Sentence: 798,and,O
Sentence: 798,were,O
Sentence: 798,studied,O
Sentence: 798,at,O
Sentence: 798,a,O
Sentence: 798,general,O
Sentence: 798,clinical,O
Sentence: 798,research,O
Sentence: 798,center,O
Sentence: 798,.,O
Sentence: 798,Patients,O
Sentence: 798,Fifty,O
Sentence: 798,subjects,O
Sentence: 798,signed,O
Sentence: 798,informed,O
Sentence: 798,consent,O
Sentence: 798,and,O
Sentence: 798,41,O
Sentence: 798,underwent,O
Sentence: 798,the,O
Sentence: 798,frequently,O
Sentence: 798,sampled,O
Sentence: 798,intravenous,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,tolerance,O
Sentence: 798,test,O
Sentence: 798,.,O
Sentence: 798,Thirty,O
Sentence: 798,-,O
Sentence: 798,six,O
Sentence: 798,nonobese,O
Sentence: 798,subjects,O
Sentence: 798,with,O
Sentence: 798,schizophrenia,B-Disease
Sentence: 798,or,O
Sentence: 798,schizoaffective,B-Disease
Sentence: 798,disorder,I-Disease
Sentence: 798,",",O
Sentence: 798,matched,O
Sentence: 798,by,O
Sentence: 798,body,O
Sentence: 798,mass,O
Sentence: 798,index,O
Sentence: 798,and,O
Sentence: 798,treated,O
Sentence: 798,with,O
Sentence: 798,either,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,",",O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,",",O
Sentence: 798,or,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,",",O
Sentence: 798,were,O
Sentence: 798,included,O
Sentence: 798,in,O
Sentence: 798,the,O
Sentence: 798,analysis,O
Sentence: 798,.,O
Sentence: 798,MAIN,O
Sentence: 798,OUTCOME,O
Sentence: 798,MEASURES,O
Sentence: 798,:,O
Sentence: 798,Fasting,O
Sentence: 798,plasma,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,and,O
Sentence: 798,fasting,O
Sentence: 798,serum,O
Sentence: 798,insulin,O
Sentence: 798,levels,O
Sentence: 798,",",O
Sentence: 798,insulin,B-Disease
Sentence: 798,sensitivity,I-Disease
Sentence: 798,index,O
Sentence: 798,",",O
Sentence: 798,homeostasis,O
Sentence: 798,model,O
Sentence: 798,assessment,O
Sentence: 798,of,O
Sentence: 798,insulin,B-Disease
Sentence: 798,resistance,I-Disease
Sentence: 798,",",O
Sentence: 798,and,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,effectiveness,O
Sentence: 798,.,O
Sentence: 798,RESULTS,O
Sentence: 798,:,O
Sentence: 798,The,O
Sentence: 798,mean,O
Sentence: 798,+,O
Sentence: 798,/,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,,O
Sentence: 798,SD,O
Sentence: 798,duration,O
Sentence: 798,of,O
Sentence: 798,treatment,O
Sentence: 798,with,O
Sentence: 798,the,O
Sentence: 798,identified,O
Sentence: 798,atypical,O
Sentence: 798,antipsychotic,O
Sentence: 798,agent,O
Sentence: 798,was,O
Sentence: 798,68.3,O
Sentence: 798,+,O
Sentence: 798,/,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,,O
Sentence: 798,28.9,O
Sentence: 798,months,O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,),O
Sentence: 798,",",O
Sentence: 798,29.5,O
Sentence: 798,+,O
Sentence: 798,/,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,,O
Sentence: 798,17.5,O
Sentence: 798,months,O
Sentence: 798,(,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,),O
Sentence: 798,",",O
Sentence: 798,and,O
Sentence: 798,40.9,O
Sentence: 798,+,O
Sentence: 798,/,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,,O
Sentence: 798,33.7,O
Sentence: 798,(,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,),O
Sentence: 798,.,O
Sentence: 798,Fasting,O
Sentence: 798,serum,O
Sentence: 798,insulin,O
Sentence: 798,concentrations,O
Sentence: 798,differed,O
Sentence: 798,among,O
Sentence: 798,groups,O
Sentence: 798,(,O
Sentence: 798,F,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,3.35,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.047,O
Sentence: 798,),O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,,O
Sentence: 798,>,O
Sentence: 798,,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,,O
Sentence: 798,>,O
Sentence: 798,,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,),O
Sentence: 798,with,O
Sentence: 798,significant,O
Sentence: 798,differences,O
Sentence: 798,between,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,(,O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,2.32,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.03,O
Sentence: 798,),O
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,(,O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,2.15,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.04,O
Sentence: 798,),O
Sentence: 798,.,O
Sentence: 798,There,O
Sentence: 798,was,O
Sentence: 798,a,O
Sentence: 798,significant,O
Sentence: 798,difference,O
Sentence: 798,in,O
Sentence: 798,insulin,B-Disease
Sentence: 798,sensitivity,I-Disease
Sentence: 798,index,O
Sentence: 798,among,O
Sentence: 798,groups,O
Sentence: 798,(,O
Sentence: 798,F,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,10.66,O
Sentence: 798,;,O
Sentence: 798,p,O
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,.001,O
Sentence: 798,),O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,),O
Sentence: 798,",",O
Sentence: 798,with,O
Sentence: 798,subjects,O
Sentence: 798,who,O
Sentence: 798,received,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,exhibiting,O
Sentence: 798,significant,O
Sentence: 798,insulin,B-Disease
Sentence: 798,resistance,I-Disease
Sentence: 798,compared,O
Sentence: 798,with,O
Sentence: 798,subjects,O
Sentence: 798,who,O
Sentence: 798,were,O
Sentence: 798,treated,O
Sentence: 798,with,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,vs,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,",",O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,4.29,O
Sentence: 798,;,O
Sentence: 798,p,O
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,.001,O
Sentence: 798,;,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,vs,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,",",O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,3.62,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.001,O
Sentence: 798,[,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,.001,O
Sentence: 798,],O
Sentence: 798,),O
Sentence: 798,.,O
Sentence: 798,The,O
Sentence: 798,homeostasis,O
Sentence: 798,model,O
Sentence: 798,assessment,O
Sentence: 798,of,O
Sentence: 798,insulin,B-Disease
Sentence: 798,resistance,I-Disease
Sentence: 798,also,O
Sentence: 798,differed,O
Sentence: 798,significantly,O
Sentence: 798,among,O
Sentence: 798,groups,O
Sentence: 798,(,O
Sentence: 798,F,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,4.92,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.01,O
Sentence: 798,),O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,,O
Sentence: 798,>,O
Sentence: 798,,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,,O
Sentence: 798,>,O
Sentence: 798,,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,),O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,vs,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,",",O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,2.94,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.006,O
Sentence: 798,;,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,vs,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,",",O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,33,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,2.42,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.02,O
Sentence: 798,),O
Sentence: 798,.,O
Sentence: 798,There,O
Sentence: 798,was,O
Sentence: 798,a,O
Sentence: 798,significant,O
Sentence: 798,difference,O
Sentence: 798,among,O
Sentence: 798,groups,O
Sentence: 798,in,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,effectiveness,O
Sentence: 798,(,O
Sentence: 798,F,O
Sentence: 798,(,O
Sentence: 798,30,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,4.18,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.02,O
Sentence: 798,),O
Sentence: 798,(,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,,O
Sentence: 798,<,O
Sentence: 798,,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,),O
Sentence: 798,with,O
Sentence: 798,significant,O
Sentence: 798,differences,O
Sentence: 798,between,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,(,O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,30,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,2.59,O
Sentence: 798,;,O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.02,O
Sentence: 798,),O
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,(,O
Sentence: 798,t,O
Sentence: 798,(,O
Sentence: 798,30,O
Sentence: 798,),O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,,O
Sentence: 798,-,O
Sentence: 798,2.34,O
Sentence: 798,",",O
Sentence: 798,P,O
Sentence: 798,,O
Sentence: 798,=,O
Sentence: 798,,O
Sentence: 798,.03,O
Sentence: 798,),O
Sentence: 798,.,O
Sentence: 798,CONCLUSIONS,O
Sentence: 798,:,O
Sentence: 798,Both,O
Sentence: 798,nonobese,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,-,O
Sentence: 798,,O
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,-,O
Sentence: 798,treated,O
Sentence: 798,groups,O
Sentence: 798,displayed,O
Sentence: 798,significant,O
Sentence: 798,insulin,B-Disease
Sentence: 798,resistance,I-Disease
Sentence: 798,and,O
Sentence: 798,impairment,O
Sentence: 798,of,O
Sentence: 798,glucose,B-Chemical
Sentence: 798,effectiveness,O
Sentence: 798,compared,O
Sentence: 798,with,O
Sentence: 798,risperidone,B-Chemical
Sentence: 798,-,O
Sentence: 798,treated,O
Sentence: 798,subjects,O
Sentence: 798,.,O
Sentence: 798,Patients,O
Sentence: 798,taking,O
Sentence: 798,clozapine,B-Chemical
Sentence: 798,and,O
Sentence: 798,olanzapine,B-Chemical
Sentence: 798,must,O
Sentence: 798,be,O
Sentence: 798,examined,O
Sentence: 798,for,O
Sentence: 798,insulin,B-Disease
Sentence: 798,resistance,I-Disease
Sentence: 798,and,O
Sentence: 798,its,O
Sentence: 798,consequences,O
Sentence: 798,.,O
Sentence: 799,Focal,O
Sentence: 799,cerebral,B-Disease
Sentence: 799,ischemia,I-Disease
Sentence: 799,in,O
Sentence: 799,rats,O
Sentence: 799,:,O
Sentence: 799,effect,O
Sentence: 799,of,O
Sentence: 799,phenylephrine,B-Chemical
Sentence: 799,-,O
Sentence: 799,induced,O
Sentence: 799,hypertension,B-Disease
Sentence: 799,during,O
Sentence: 799,reperfusion,O
Sentence: 799,.,O
Sentence: 800,After,O
Sentence: 800,180,O
Sentence: 800,min,O
Sentence: 800,of,O
Sentence: 800,temporary,O
Sentence: 800,middle,B-Disease
Sentence: 800,cerebral,I-Disease
Sentence: 800,artery,I-Disease
Sentence: 800,occlusion,I-Disease
Sentence: 800,in,O
Sentence: 800,spontaneously,O
Sentence: 800,hypertensive,B-Disease
Sentence: 800,rats,O
Sentence: 800,",",O
Sentence: 800,the,O
Sentence: 800,effect,O
Sentence: 800,of,O
Sentence: 800,phenylephrine,B-Chemical
Sentence: 800,-,O
Sentence: 800,induced,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,on,O
Sentence: 800,ischemic,B-Disease
Sentence: 800,brain,B-Disease
Sentence: 800,injury,I-Disease
Sentence: 800,and,O
Sentence: 800,blood,O
Sentence: 800,-,O
Sentence: 800,brain,O
Sentence: 800,barrier,O
Sentence: 800,permeability,O
Sentence: 800,was,O
Sentence: 800,determined,O
Sentence: 800,.,O
Sentence: 800,Blood,O
Sentence: 800,pressure,O
Sentence: 800,was,O
Sentence: 800,manipulated,O
Sentence: 800,by,O
Sentence: 800,one,O
Sentence: 800,of,O
Sentence: 800,the,O
Sentence: 800,following,O
Sentence: 800,schedules,O
Sentence: 800,during,O
Sentence: 800,120,O
Sentence: 800,min,O
Sentence: 800,of,O
Sentence: 800,reperfusion,O
Sentence: 800,:,O
Sentence: 800,Control,O
Sentence: 800,",",O
Sentence: 800,normotensive,O
Sentence: 800,reperfusion,O
Sentence: 800,;,O
Sentence: 800,90,O
Sentence: 800,/,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,(,O
Sentence: 800,90,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,),O
Sentence: 800,",",O
Sentence: 800,blood,O
Sentence: 800,pressure,O
Sentence: 800,was,O
Sentence: 800,increased,O
Sentence: 800,by,O
Sentence: 800,35,O
Sentence: 800,mm,O
Sentence: 800,Hg,O
Sentence: 800,during,O
Sentence: 800,the,O
Sentence: 800,initial,O
Sentence: 800,90,O
Sentence: 800,min,O
Sentence: 800,of,O
Sentence: 800,reperfusion,O
Sentence: 800,only,O
Sentence: 800,;,O
Sentence: 800,15,O
Sentence: 800,/,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,(,O
Sentence: 800,15,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,),O
Sentence: 800,",",O
Sentence: 800,normotensive,O
Sentence: 800,reperfusion,O
Sentence: 800,for,O
Sentence: 800,30,O
Sentence: 800,min,O
Sentence: 800,followed,O
Sentence: 800,by,O
Sentence: 800,15,O
Sentence: 800,min,O
Sentence: 800,of,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,and,O
Sentence: 800,75,O
Sentence: 800,min,O
Sentence: 800,of,O
Sentence: 800,normotension,O
Sentence: 800,.,O
Sentence: 800,Part,O
Sentence: 800,A,O
Sentence: 800,",",O
Sentence: 800,for,O
Sentence: 800,eight,O
Sentence: 800,rats,O
Sentence: 800,in,O
Sentence: 800,each,O
Sentence: 800,group,O
Sentence: 800,brain,B-Disease
Sentence: 800,injury,I-Disease
Sentence: 800,was,O
Sentence: 800,evaluated,O
Sentence: 800,by,O
Sentence: 800,staining,O
Sentence: 800,tissue,O
Sentence: 800,using,O
Sentence: 800,"2,3,5",O
Sentence: 800,-,O
Sentence: 800,triphenyltetrazolium,O
Sentence: 800,chloride,O
Sentence: 800,and,O
Sentence: 800,edema,B-Disease
Sentence: 800,was,O
Sentence: 800,evaluated,O
Sentence: 800,by,O
Sentence: 800,microgravimetry,O
Sentence: 800,.,O
Sentence: 800,Part,O
Sentence: 800,B,O
Sentence: 800,",",O
Sentence: 800,for,O
Sentence: 800,eight,O
Sentence: 800,different,O
Sentence: 800,rats,O
Sentence: 800,in,O
Sentence: 800,each,O
Sentence: 800,group,O
Sentence: 800,blood,O
Sentence: 800,-,O
Sentence: 800,brain,O
Sentence: 800,barrier,O
Sentence: 800,permeability,O
Sentence: 800,was,O
Sentence: 800,evaluated,O
Sentence: 800,by,O
Sentence: 800,measuring,O
Sentence: 800,the,O
Sentence: 800,amount,O
Sentence: 800,and,O
Sentence: 800,extent,O
Sentence: 800,of,O
Sentence: 800,extravasation,O
Sentence: 800,of,O
Sentence: 800,Evans,B-Chemical
Sentence: 800,Blue,I-Chemical
Sentence: 800,dye,O
Sentence: 800,.,O
Sentence: 800,Brain,B-Disease
Sentence: 800,injury,I-Disease
Sentence: 800,(,O
Sentence: 800,percentage,O
Sentence: 800,of,O
Sentence: 800,the,O
Sentence: 800,ischemic,B-Disease
Sentence: 800,hemisphere,I-Disease
Sentence: 800,),O
Sentence: 800,was,O
Sentence: 800,less,O
Sentence: 800,in,O
Sentence: 800,the,O
Sentence: 800,15,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,16,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,6,O
Sentence: 800,",",O
Sentence: 800,mean,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,SD,O
Sentence: 800,),O
Sentence: 800,versus,O
Sentence: 800,the,O
Sentence: 800,90,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,30,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,6,O
Sentence: 800,),O
Sentence: 800,",",O
Sentence: 800,which,O
Sentence: 800,was,O
Sentence: 800,in,O
Sentence: 800,turn,O
Sentence: 800,less,O
Sentence: 800,than,O
Sentence: 800,the,O
Sentence: 800,control,O
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,42,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,5,O
Sentence: 800,),O
Sentence: 800,.,O
Sentence: 800,Specific,O
Sentence: 800,gravity,O
Sentence: 800,was,O
Sentence: 800,greater,O
Sentence: 800,in,O
Sentence: 800,the,O
Sentence: 800,15,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,1.043,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,0.002,O
Sentence: 800,),O
Sentence: 800,versus,O
Sentence: 800,the,O
Sentence: 800,90,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,(,O
Sentence: 800,1.036,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,0.003,O
Sentence: 800,),O
Sentence: 800,and,O
Sentence: 800,control,O
Sentence: 800,(,O
Sentence: 800,1.037,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,0.003,O
Sentence: 800,),O
Sentence: 800,groups,O
Sentence: 800,.,O
Sentence: 800,Evans,B-Chemical
Sentence: 800,Blue,I-Chemical
Sentence: 800,(,O
Sentence: 800,mug,O
Sentence: 800,g,O
Sentence: 800,-,O
Sentence: 800,1,O
Sentence: 800,of,O
Sentence: 800,brain,O
Sentence: 800,tissue,O
Sentence: 800,),O
Sentence: 800,was,O
Sentence: 800,greater,O
Sentence: 800,in,O
Sentence: 800,the,O
Sentence: 800,90,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,24.4,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,6.0,O
Sentence: 800,),O
Sentence: 800,versus,O
Sentence: 800,the,O
Sentence: 800,control,O
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,12.3,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,4.1,O
Sentence: 800,),O
Sentence: 800,",",O
Sentence: 800,which,O
Sentence: 800,was,O
Sentence: 800,in,O
Sentence: 800,turn,O
Sentence: 800,greater,O
Sentence: 800,than,O
Sentence: 800,the,O
Sentence: 800,15,O
Sentence: 800,/,O
Sentence: 800,HTN,B-Disease
Sentence: 800,group,O
Sentence: 800,(,O
Sentence: 800,7.3,O
Sentence: 800,+,O
Sentence: 800,/,O
Sentence: 800,,O
Sentence: 800,-,O
Sentence: 800,,O
Sentence: 800,3.2,O
Sentence: 800,),O
Sentence: 800,.,O
Sentence: 800,This,O
Sentence: 800,study,O
Sentence: 800,supports,O
Sentence: 800,a,O
Sentence: 800,hypothesis,O
Sentence: 800,that,O
Sentence: 800,during,O
Sentence: 800,reperfusion,O
Sentence: 800,",",O
Sentence: 800,a,O
Sentence: 800,short,O
Sentence: 800,interval,O
Sentence: 800,of,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,decreases,O
Sentence: 800,brain,B-Disease
Sentence: 800,injury,I-Disease
Sentence: 800,and,O
Sentence: 800,edema,B-Disease
Sentence: 800,;,O
Sentence: 800,and,O
Sentence: 800,that,O
Sentence: 800,sustained,O
Sentence: 800,hypertension,B-Disease
Sentence: 800,increases,O
Sentence: 800,the,O
Sentence: 800,risk,O
Sentence: 800,of,O
Sentence: 800,vasogenic,B-Disease
Sentence: 800,edema,I-Disease
Sentence: 800,.,O
Sentence: 801,People,O
Sentence: 801,aged,O
Sentence: 801,over,O
Sentence: 801,75,O
Sentence: 801,in,O
Sentence: 801,atrial,B-Disease
Sentence: 801,fibrillation,I-Disease
Sentence: 801,on,O
Sentence: 801,warfarin,B-Chemical
Sentence: 801,:,O
Sentence: 801,the,O
Sentence: 801,rate,O
Sentence: 801,of,O
Sentence: 801,major,O
Sentence: 801,hemorrhage,B-Disease
Sentence: 801,and,O
Sentence: 801,stroke,B-Disease
Sentence: 801,in,O
Sentence: 801,more,O
Sentence: 801,than,O
Sentence: 801,500,O
Sentence: 801,patient,O
Sentence: 801,-,O
Sentence: 801,years,O
Sentence: 801,of,O
Sentence: 801,follow,O
Sentence: 801,-,O
Sentence: 801,up,O
Sentence: 801,.,O
Sentence: 802,OBJECTIVES,O
Sentence: 802,:,O
Sentence: 802,To,O
Sentence: 802,determine,O
Sentence: 802,the,O
Sentence: 802,incidence,O
Sentence: 802,of,O
Sentence: 802,major,O
Sentence: 802,hemorrhage,B-Disease
Sentence: 802,and,O
Sentence: 802,stroke,B-Disease
Sentence: 802,in,O
Sentence: 802,people,O
Sentence: 802,aged,O
Sentence: 802,76,O
Sentence: 802,and,O
Sentence: 802,older,O
Sentence: 802,with,O
Sentence: 802,atrial,B-Disease
Sentence: 802,fibrillation,I-Disease
Sentence: 802,on,O
Sentence: 802,adjusted,O
Sentence: 802,-,O
Sentence: 802,dose,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,who,O
Sentence: 802,had,O
Sentence: 802,been,O
Sentence: 802,recently,O
Sentence: 802,been,O
Sentence: 802,admitted,O
Sentence: 802,to,O
Sentence: 802,hospital,O
Sentence: 802,.,O
Sentence: 802,DESIGN,O
Sentence: 802,:,O
Sentence: 802,A,O
Sentence: 802,retrospective,O
Sentence: 802,observational,O
Sentence: 802,cohort,O
Sentence: 802,study,O
Sentence: 802,.,O
Sentence: 802,SETTING,O
Sentence: 802,:,O
Sentence: 802,A,O
Sentence: 802,major,O
Sentence: 802,healthcare,O
Sentence: 802,network,O
Sentence: 802,involving,O
Sentence: 802,four,O
Sentence: 802,tertiary,O
Sentence: 802,hospitals,O
Sentence: 802,.,O
Sentence: 802,PARTICIPANTS,O
Sentence: 802,:,O
Sentence: 802,Two,O
Sentence: 802,hundred,O
Sentence: 802,thirty,O
Sentence: 802,-,O
Sentence: 802,five,O
Sentence: 802,patients,O
Sentence: 802,aged,O
Sentence: 802,76,O
Sentence: 802,and,O
Sentence: 802,older,O
Sentence: 802,admitted,O
Sentence: 802,to,O
Sentence: 802,a,O
Sentence: 802,major,O
Sentence: 802,healthcare,O
Sentence: 802,network,O
Sentence: 802,between,O
Sentence: 802,July,O
Sentence: 802,1,O
Sentence: 802,",",O
Sentence: 802,2001,O
Sentence: 802,",",O
Sentence: 802,and,O
Sentence: 802,June,O
Sentence: 802,30,O
Sentence: 802,",",O
Sentence: 802,2002,O
Sentence: 802,",",O
Sentence: 802,with,O
Sentence: 802,atrial,B-Disease
Sentence: 802,fibrillation,I-Disease
Sentence: 802,on,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,were,O
Sentence: 802,enrolled,O
Sentence: 802,.,O
Sentence: 802,MEASUREMENTS,O
Sentence: 802,:,O
Sentence: 802,Information,O
Sentence: 802,regarding,O
Sentence: 802,major,O
Sentence: 802,bleeding,B-Disease
Sentence: 802,episodes,O
Sentence: 802,",",O
Sentence: 802,strokes,B-Disease
Sentence: 802,",",O
Sentence: 802,and,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,use,O
Sentence: 802,was,O
Sentence: 802,obtained,O
Sentence: 802,from,O
Sentence: 802,patients,O
Sentence: 802,",",O
Sentence: 802,relatives,O
Sentence: 802,",",O
Sentence: 802,primary,O
Sentence: 802,physicians,O
Sentence: 802,",",O
Sentence: 802,and,O
Sentence: 802,medical,O
Sentence: 802,records,O
Sentence: 802,.,O
Sentence: 802,RESULTS,O
Sentence: 802,:,O
Sentence: 802,Two,O
Sentence: 802,hundred,O
Sentence: 802,twenty,O
Sentence: 802,-,O
Sentence: 802,eight,O
Sentence: 802,patients,O
Sentence: 802,(,O
Sentence: 802,42,O
Sentence: 802,%,O
Sentence: 802,men,O
Sentence: 802,),O
Sentence: 802,with,O
Sentence: 802,a,O
Sentence: 802,mean,O
Sentence: 802,age,O
Sentence: 802,of,O
Sentence: 802,81.1,O
Sentence: 802,(,O
Sentence: 802,range,O
Sentence: 802,76,O
Sentence: 802,-,O
Sentence: 802,94,O
Sentence: 802,),O
Sentence: 802,were,O
Sentence: 802,included,O
Sentence: 802,in,O
Sentence: 802,the,O
Sentence: 802,analysis,O
Sentence: 802,.,O
Sentence: 802,Total,O
Sentence: 802,follow,O
Sentence: 802,-,O
Sentence: 802,up,O
Sentence: 802,on,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,was,O
Sentence: 802,530,O
Sentence: 802,years,O
Sentence: 802,(,O
Sentence: 802,mean,O
Sentence: 802,28,O
Sentence: 802,months,O
Sentence: 802,),O
Sentence: 802,.,O
Sentence: 802,There,O
Sentence: 802,were,O
Sentence: 802,53,O
Sentence: 802,major,O
Sentence: 802,hemorrhages,B-Disease
Sentence: 802,",",O
Sentence: 802,for,O
Sentence: 802,an,O
Sentence: 802,annual,O
Sentence: 802,rate,O
Sentence: 802,of,O
Sentence: 802,10.0,O
Sentence: 802,%,O
Sentence: 802,",",O
Sentence: 802,including,O
Sentence: 802,24,O
Sentence: 802,(,O
Sentence: 802,45.3,O
Sentence: 802,%,O
Sentence: 802,),O
Sentence: 802,life,O
Sentence: 802,-,O
Sentence: 802,threatening,O
Sentence: 802,and,O
Sentence: 802,five,O
Sentence: 802,(,O
Sentence: 802,9.4,O
Sentence: 802,%,O
Sentence: 802,),O
Sentence: 802,fatal,O
Sentence: 802,bleeds,O
Sentence: 802,.,O
Sentence: 802,The,O
Sentence: 802,annual,O
Sentence: 802,stroke,B-Disease
Sentence: 802,rate,O
Sentence: 802,after,O
Sentence: 802,initiation,O
Sentence: 802,of,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,was,O
Sentence: 802,2.6,O
Sentence: 802,%,O
Sentence: 802,.,O
Sentence: 802,CONCLUSION,O
Sentence: 802,:,O
Sentence: 802,The,O
Sentence: 802,rate,O
Sentence: 802,of,O
Sentence: 802,major,O
Sentence: 802,hemorrhage,B-Disease
Sentence: 802,was,O
Sentence: 802,high,O
Sentence: 802,in,O
Sentence: 802,this,O
Sentence: 802,old,O
Sentence: 802,",",O
Sentence: 802,frail,O
Sentence: 802,group,O
Sentence: 802,",",O
Sentence: 802,but,O
Sentence: 802,excluding,O
Sentence: 802,fatalities,O
Sentence: 802,",",O
Sentence: 802,resulted,O
Sentence: 802,in,O
Sentence: 802,no,O
Sentence: 802,long,O
Sentence: 802,-,O
Sentence: 802,term,O
Sentence: 802,sequelae,O
Sentence: 802,",",O
Sentence: 802,and,O
Sentence: 802,the,O
Sentence: 802,stroke,B-Disease
Sentence: 802,rate,O
Sentence: 802,on,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,was,O
Sentence: 802,low,O
Sentence: 802,",",O
Sentence: 802,demonstrating,O
Sentence: 802,how,O
Sentence: 802,effective,O
Sentence: 802,warfarin,B-Chemical
Sentence: 802,treatment,O
Sentence: 802,is,O
Sentence: 802,.,O
Sentence: 803,Safety,O
Sentence: 803,of,O
Sentence: 803,celecoxib,B-Chemical
Sentence: 803,in,O
Sentence: 803,patients,O
Sentence: 803,with,O
Sentence: 803,adverse,O
Sentence: 803,skin,B-Disease
Sentence: 803,reactions,I-Disease
Sentence: 803,to,O
Sentence: 803,acetaminophen,B-Chemical
Sentence: 803,(,O
Sentence: 803,paracetamol,B-Chemical
Sentence: 803,),O
Sentence: 803,and,O
Sentence: 803,nimesulide,B-Chemical
Sentence: 803,associated,O
Sentence: 803,or,O
Sentence: 803,not,O
Sentence: 803,with,O
Sentence: 803,common,O
Sentence: 803,non,O
Sentence: 803,-,O
Sentence: 803,steroidal,O
Sentence: 803,anti,O
Sentence: 803,-,O
Sentence: 803,inflammatory,O
Sentence: 803,drugs,O
Sentence: 803,.,O
Sentence: 804,BACKGROUND,O
Sentence: 804,:,O
Sentence: 804,Acetaminophen,B-Chemical
Sentence: 804,(,O
Sentence: 804,paracetamol,B-Chemical
Sentence: 804,,O
Sentence: 804,-,O
Sentence: 804,,O
Sentence: 804,-,O
Sentence: 804,,O
Sentence: 804,P,B-Chemical
Sentence: 804,),O
Sentence: 804,and,O
Sentence: 804,Nimesulide,B-Chemical
Sentence: 804,(,O
Sentence: 804,N,B-Chemical
Sentence: 804,),O
Sentence: 804,are,O
Sentence: 804,widely,O
Sentence: 804,used,O
Sentence: 804,analgesic,O
Sentence: 804,-,O
Sentence: 804,antipyretic,O
Sentence: 804,/,O
Sentence: 804,anti,O
Sentence: 804,-,O
Sentence: 804,inflammatory,O
Sentence: 804,drugs,O
Sentence: 804,.,O
Sentence: 804,The,O
Sentence: 804,rate,O
Sentence: 804,of,O
Sentence: 804,adverse,O
Sentence: 804,hypersensitivity,B-Disease
Sentence: 804,reactions,O
Sentence: 804,to,O
Sentence: 804,these,O
Sentence: 804,agents,O
Sentence: 804,is,O
Sentence: 804,generally,O
Sentence: 804,low,O
Sentence: 804,.,O
Sentence: 804,On,O
Sentence: 804,the,O
Sentence: 804,contrary,O
Sentence: 804,non,O
Sentence: 804,-,O
Sentence: 804,steroidal,O
Sentence: 804,anti,O
Sentence: 804,-,O
Sentence: 804,inflammatory,O
Sentence: 804,drugs,O
Sentence: 804,(,O
Sentence: 804,NSAIDs,O
Sentence: 804,),O
Sentence: 804,are,O
Sentence: 804,commonly,O
Sentence: 804,involved,O
Sentence: 804,in,O
Sentence: 804,such,O
Sentence: 804,reactions,O
Sentence: 804,.,O
Sentence: 804,Celecoxib,B-Chemical
Sentence: 804,(,O
Sentence: 804,CE,B-Chemical
Sentence: 804,),O
Sentence: 804,is,O
Sentence: 804,a,O
Sentence: 804,novel,O
Sentence: 804,drug,O
Sentence: 804,",",O
Sentence: 804,with,O
Sentence: 804,high,O
Sentence: 804,selectivity,O
Sentence: 804,and,O
Sentence: 804,affinity,O
Sentence: 804,for,O
Sentence: 804,COX,O
Sentence: 804,-,O
Sentence: 804,2,O
Sentence: 804,enzyme,O
Sentence: 804,.,O
Sentence: 804,OBJECTIVE,O
Sentence: 804,:,O
Sentence: 804,We,O
Sentence: 804,evaluated,O
Sentence: 804,the,O
Sentence: 804,tolerability,O
Sentence: 804,of,O
Sentence: 804,CE,B-Chemical
Sentence: 804,in,O
Sentence: 804,a,O
Sentence: 804,group,O
Sentence: 804,of,O
Sentence: 804,patients,O
Sentence: 804,with,O
Sentence: 804,documented,O
Sentence: 804,history,O
Sentence: 804,of,O
Sentence: 804,adverse,O
Sentence: 804,cutaneous,B-Disease
Sentence: 804,reactions,I-Disease
Sentence: 804,to,O
Sentence: 804,P,B-Chemical
Sentence: 804,and,O
Sentence: 804,N,B-Chemical
Sentence: 804,associated,O
Sentence: 804,or,O
Sentence: 804,not,O
Sentence: 804,to,O
Sentence: 804,classic,O
Sentence: 804,NSAIDs,O
Sentence: 804,.,O
Sentence: 804,METHODS,O
Sentence: 804,:,O
Sentence: 804,We,O
Sentence: 804,studied,O
Sentence: 804,9,O
Sentence: 804,patients,O
Sentence: 804,with,O
Sentence: 804,hypersensitivity,B-Disease
Sentence: 804,to,O
Sentence: 804,P,B-Chemical
Sentence: 804,and,O
Sentence: 804,N,B-Chemical
Sentence: 804,with,O
Sentence: 804,or,O
Sentence: 804,without,O
Sentence: 804,associated,O
Sentence: 804,reactions,O
Sentence: 804,to,O
Sentence: 804,classic,O
Sentence: 804,NSAIDs,O
Sentence: 804,.,O
Sentence: 804,The,O
Sentence: 804,diagnosis,O
Sentence: 804,of,O
Sentence: 804,P,B-Chemical
Sentence: 804,and,O
Sentence: 804,N,B-Chemical
Sentence: 804,-,O
Sentence: 804,induced,O
Sentence: 804,skin,B-Disease
Sentence: 804,reactions,I-Disease
Sentence: 804,was,O
Sentence: 804,based,O
Sentence: 804,in,O
Sentence: 804,vivo,O
Sentence: 804,challenge,O
Sentence: 804,.,O
Sentence: 804,The,O
Sentence: 804,placebo,O
Sentence: 804,was,O
Sentence: 804,blindly,O
Sentence: 804,administered,O
Sentence: 804,at,O
Sentence: 804,the,O
Sentence: 804,beginning,O
Sentence: 804,of,O
Sentence: 804,each,O
Sentence: 804,challenge,O
Sentence: 804,.,O
Sentence: 804,After,O
Sentence: 804,three,O
Sentence: 804,days,O
Sentence: 804,",",O
Sentence: 804,a,O
Sentence: 804,cumulative,O
Sentence: 804,dosage,O
Sentence: 804,of,O
Sentence: 804,200,O
Sentence: 804,mg,O
Sentence: 804,of,O
Sentence: 804,CE,B-Chemical
Sentence: 804,in,O
Sentence: 804,refracted,O
Sentence: 804,doses,O
Sentence: 804,were,O
Sentence: 804,given,O
Sentence: 804,.,O
Sentence: 804,After,O
Sentence: 804,2,O
Sentence: 804,-,O
Sentence: 804,3,O
Sentence: 804,days,O
Sentence: 804,",",O
Sentence: 804,a,O
Sentence: 804,single,O
Sentence: 804,dose,O
Sentence: 804,of,O
Sentence: 804,200,O
Sentence: 804,mg,O
Sentence: 804,was,O
Sentence: 804,administered,O
Sentence: 804,.,O
Sentence: 804,All,O
Sentence: 804,patients,O
Sentence: 804,were,O
Sentence: 804,observed,O
Sentence: 804,for,O
Sentence: 804,6,O
Sentence: 804,hours,O
Sentence: 804,after,O
Sentence: 804,each,O
Sentence: 804,challenge,O
Sentence: 804,",",O
Sentence: 804,and,O
Sentence: 804,controlled,O
Sentence: 804,again,O
Sentence: 804,after,O
Sentence: 804,24,O
Sentence: 804,hours,O
Sentence: 804,to,O
Sentence: 804,exclude,O
Sentence: 804,delayed,O
Sentence: 804,reactions,O
Sentence: 804,.,O
Sentence: 804,The,O
Sentence: 804,challenge,O
Sentence: 804,was,O
Sentence: 804,considered,O
Sentence: 804,positive,O
Sentence: 804,if,O
Sentence: 804,one,O
Sentence: 804,or,O
Sentence: 804,more,O
Sentence: 804,of,O
Sentence: 804,the,O
Sentence: 804,following,O
Sentence: 804,appeared,O
Sentence: 804,:,O
Sentence: 804,erythema,B-Disease
Sentence: 804,",",O
Sentence: 804,rush,O
Sentence: 804,or,O
Sentence: 804,urticaria,B-Disease
Sentence: 804,-,O
Sentence: 804,angioedema,B-Disease
Sentence: 804,.,O
Sentence: 804,RESULTS,O
Sentence: 804,:,O
Sentence: 804,No,O
Sentence: 804,reaction,O
Sentence: 804,was,O
Sentence: 804,observed,O
Sentence: 804,with,O
Sentence: 804,placebo,O
Sentence: 804,and,O
Sentence: 804,eight,O
Sentence: 804,patients,O
Sentence: 804,(,O
Sentence: 804,88.8,O
Sentence: 804,%,O
Sentence: 804,),O
Sentence: 804,tolerated,O
Sentence: 804,CE,B-Chemical
Sentence: 804,.,O
Sentence: 804,Only,O
Sentence: 804,one,O
Sentence: 804,patient,O
Sentence: 804,developed,O
Sentence: 804,a,O
Sentence: 804,moderate,O
Sentence: 804,angioedema,B-Disease
Sentence: 804,of,O
Sentence: 804,the,O
Sentence: 804,lips,O
Sentence: 804,.,O
Sentence: 804,CONCLUSION,O
Sentence: 804,:,O
Sentence: 804,Only,O
Sentence: 804,one,O
Sentence: 804,hypersensitivity,B-Disease
Sentence: 804,reaction,O
Sentence: 804,to,O
Sentence: 804,CE,B-Chemical
Sentence: 804,was,O
Sentence: 804,documented,O
Sentence: 804,among,O
Sentence: 804,9,O
Sentence: 804,P,B-Chemical
Sentence: 804,and,O
Sentence: 804,N,B-Chemical
Sentence: 804,-,O
Sentence: 804,highly,O
Sentence: 804,NSAIDs,O
Sentence: 804,intolerant,O
Sentence: 804,patients,O
Sentence: 804,.,O
Sentence: 804,Thus,O
Sentence: 804,",",O
Sentence: 804,we,O
Sentence: 804,conclude,O
Sentence: 804,that,O
Sentence: 804,CE,B-Chemical
Sentence: 804,is,O
Sentence: 804,a,O
Sentence: 804,reasonably,O
Sentence: 804,safe,O
Sentence: 804,alternative,O
Sentence: 804,to,O
Sentence: 804,be,O
Sentence: 804,used,O
Sentence: 804,in,O
Sentence: 804,subjects,O
Sentence: 804,who,O
Sentence: 804,do,O
Sentence: 804,not,O
Sentence: 804,tolerate,O
Sentence: 804,P,B-Chemical
Sentence: 804,and,O
Sentence: 804,N,B-Chemical
Sentence: 804,.,O
Sentence: 805,Case,O
Sentence: 805,-,O
Sentence: 805,control,O
Sentence: 805,study,O
Sentence: 805,of,O
Sentence: 805,regular,O
Sentence: 805,analgesic,O
Sentence: 805,and,O
Sentence: 805,nonsteroidal,O
Sentence: 805,anti,O
Sentence: 805,-,O
Sentence: 805,inflammatory,O
Sentence: 805,use,O
Sentence: 805,and,O
Sentence: 805,end,O
Sentence: 805,-,O
Sentence: 805,stage,O
Sentence: 805,renal,O
Sentence: 805,disease,O
Sentence: 805,.,O
Sentence: 806,BACKGROUND,O
Sentence: 806,:,O
Sentence: 806,Studies,O
Sentence: 806,on,O
Sentence: 806,the,O
Sentence: 806,association,O
Sentence: 806,between,O
Sentence: 806,the,O
Sentence: 806,long,O
Sentence: 806,-,O
Sentence: 806,term,O
Sentence: 806,use,O
Sentence: 806,of,O
Sentence: 806,aspirin,B-Chemical
Sentence: 806,and,O
Sentence: 806,other,O
Sentence: 806,analgesic,O
Sentence: 806,and,O
Sentence: 806,nonsteroidal,O
Sentence: 806,anti,O
Sentence: 806,-,O
Sentence: 806,inflammatory,O
Sentence: 806,drugs,O
Sentence: 806,(,O
Sentence: 806,NSAIDs,O
Sentence: 806,),O
Sentence: 806,and,O
Sentence: 806,end,O
Sentence: 806,-,O
Sentence: 806,stage,O
Sentence: 806,renal,O
Sentence: 806,disease,O
Sentence: 806,(,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,),O
Sentence: 806,have,O
Sentence: 806,given,O
Sentence: 806,conflicting,O
Sentence: 806,results,O
Sentence: 806,.,O
Sentence: 806,In,O
Sentence: 806,order,O
Sentence: 806,to,O
Sentence: 806,examine,O
Sentence: 806,this,O
Sentence: 806,association,O
Sentence: 806,",",O
Sentence: 806,a,O
Sentence: 806,case,O
Sentence: 806,-,O
Sentence: 806,control,O
Sentence: 806,study,O
Sentence: 806,with,O
Sentence: 806,incident,O
Sentence: 806,cases,O
Sentence: 806,of,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,was,O
Sentence: 806,carried,O
Sentence: 806,out,O
Sentence: 806,.,O
Sentence: 806,METHODS,O
Sentence: 806,:,O
Sentence: 806,The,O
Sentence: 806,cases,O
Sentence: 806,were,O
Sentence: 806,all,O
Sentence: 806,patients,O
Sentence: 806,entering,O
Sentence: 806,the,O
Sentence: 806,local,O
Sentence: 806,dialysis,O
Sentence: 806,program,O
Sentence: 806,because,O
Sentence: 806,of,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,in,O
Sentence: 806,the,O
Sentence: 806,study,O
Sentence: 806,area,O
Sentence: 806,between,O
Sentence: 806,June,O
Sentence: 806,1,O
Sentence: 806,",",O
Sentence: 806,1995,O
Sentence: 806,and,O
Sentence: 806,November,O
Sentence: 806,30,O
Sentence: 806,",",O
Sentence: 806,1997,O
Sentence: 806,.,O
Sentence: 806,They,O
Sentence: 806,were,O
Sentence: 806,classified,O
Sentence: 806,according,O
Sentence: 806,to,O
Sentence: 806,the,O
Sentence: 806,underlying,O
Sentence: 806,disease,O
Sentence: 806,",",O
Sentence: 806,which,O
Sentence: 806,had,O
Sentence: 806,presumably,O
Sentence: 806,led,O
Sentence: 806,them,O
Sentence: 806,to,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,.,O
Sentence: 806,Controls,O
Sentence: 806,were,O
Sentence: 806,patients,O
Sentence: 806,admitted,O
Sentence: 806,to,O
Sentence: 806,the,O
Sentence: 806,same,O
Sentence: 806,hospitals,O
Sentence: 806,from,O
Sentence: 806,where,O
Sentence: 806,the,O
Sentence: 806,cases,O
Sentence: 806,arose,O
Sentence: 806,",",O
Sentence: 806,also,O
Sentence: 806,matched,O
Sentence: 806,by,O
Sentence: 806,age,O
Sentence: 806,and,O
Sentence: 806,sex,O
Sentence: 806,.,O
Sentence: 806,Odds,O
Sentence: 806,ratios,O
Sentence: 806,were,O
Sentence: 806,calculated,O
Sentence: 806,using,O
Sentence: 806,a,O
Sentence: 806,conditional,O
Sentence: 806,logistic,O
Sentence: 806,model,O
Sentence: 806,",",O
Sentence: 806,including,O
Sentence: 806,potential,O
Sentence: 806,confounding,O
Sentence: 806,factors,O
Sentence: 806,",",O
Sentence: 806,both,O
Sentence: 806,for,O
Sentence: 806,the,O
Sentence: 806,whole,O
Sentence: 806,study,O
Sentence: 806,population,O
Sentence: 806,and,O
Sentence: 806,for,O
Sentence: 806,the,O
Sentence: 806,various,O
Sentence: 806,underlying,O
Sentence: 806,diseases,O
Sentence: 806,.,O
Sentence: 806,RESULTS,O
Sentence: 806,:,O
Sentence: 806,Five,O
Sentence: 806,hundred,O
Sentence: 806,and,O
Sentence: 806,eighty,O
Sentence: 806,-,O
Sentence: 806,three,O
Sentence: 806,cases,O
Sentence: 806,and,O
Sentence: 806,1190,O
Sentence: 806,controls,O
Sentence: 806,were,O
Sentence: 806,included,O
Sentence: 806,in,O
Sentence: 806,the,O
Sentence: 806,analysis,O
Sentence: 806,.,O
Sentence: 806,Long,O
Sentence: 806,-,O
Sentence: 806,term,O
Sentence: 806,use,O
Sentence: 806,of,O
Sentence: 806,any,O
Sentence: 806,analgesic,O
Sentence: 806,was,O
Sentence: 806,associated,O
Sentence: 806,with,O
Sentence: 806,an,O
Sentence: 806,overall,O
Sentence: 806,odds,O
Sentence: 806,ratio,O
Sentence: 806,of,O
Sentence: 806,1.22,O
Sentence: 806,(,O
Sentence: 806,95,O
Sentence: 806,%,O
Sentence: 806,CI,O
Sentence: 806,",",O
Sentence: 806,0.89,O
Sentence: 806,-,O
Sentence: 806,1.66,O
Sentence: 806,),O
Sentence: 806,.,O
Sentence: 806,For,O
Sentence: 806,specific,O
Sentence: 806,groups,O
Sentence: 806,of,O
Sentence: 806,drugs,O
Sentence: 806,",",O
Sentence: 806,the,O
Sentence: 806,risks,O
Sentence: 806,were,O
Sentence: 806,1.56,O
Sentence: 806,(,O
Sentence: 806,1.05,O
Sentence: 806,-,O
Sentence: 806,2.30,O
Sentence: 806,),O
Sentence: 806,for,O
Sentence: 806,aspirin,B-Chemical
Sentence: 806,",",O
Sentence: 806,1.03,O
Sentence: 806,(,O
Sentence: 806,0.60,O
Sentence: 806,-,O
Sentence: 806,1.76,O
Sentence: 806,),O
Sentence: 806,for,O
Sentence: 806,pyrazolones,B-Chemical
Sentence: 806,",",O
Sentence: 806,0.80,O
Sentence: 806,(,O
Sentence: 806,0.39,O
Sentence: 806,-,O
Sentence: 806,1.63,O
Sentence: 806,),O
Sentence: 806,for,O
Sentence: 806,paracetamol,B-Chemical
Sentence: 806,",",O
Sentence: 806,and,O
Sentence: 806,0.94,O
Sentence: 806,(,O
Sentence: 806,0.57,O
Sentence: 806,-,O
Sentence: 806,1.56,O
Sentence: 806,),O
Sentence: 806,for,O
Sentence: 806,nonaspirin,O
Sentence: 806,NSAIDs,O
Sentence: 806,.,O
Sentence: 806,The,O
Sentence: 806,risk,O
Sentence: 806,of,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,associated,O
Sentence: 806,with,O
Sentence: 806,aspirin,B-Chemical
Sentence: 806,was,O
Sentence: 806,related,O
Sentence: 806,to,O
Sentence: 806,the,O
Sentence: 806,cumulated,O
Sentence: 806,dose,O
Sentence: 806,and,O
Sentence: 806,duration,O
Sentence: 806,of,O
Sentence: 806,use,O
Sentence: 806,",",O
Sentence: 806,and,O
Sentence: 806,it,O
Sentence: 806,was,O
Sentence: 806,particularly,O
Sentence: 806,high,O
Sentence: 806,among,O
Sentence: 806,the,O
Sentence: 806,subset,O
Sentence: 806,of,O
Sentence: 806,patients,O
Sentence: 806,with,O
Sentence: 806,vascular,O
Sentence: 806,nephropathy,B-Disease
Sentence: 806,as,O
Sentence: 806,underlying,O
Sentence: 806,disease,O
Sentence: 806,[,O
Sentence: 806,2.35,O
Sentence: 806,(,O
Sentence: 806,1.17,O
Sentence: 806,-,O
Sentence: 806,4.72,O
Sentence: 806,),O
Sentence: 806,],O
Sentence: 806,.,O
Sentence: 806,CONCLUSION,O
Sentence: 806,:,O
Sentence: 806,Our,O
Sentence: 806,data,O
Sentence: 806,indicate,O
Sentence: 806,that,O
Sentence: 806,long,O
Sentence: 806,-,O
Sentence: 806,term,O
Sentence: 806,use,O
Sentence: 806,of,O
Sentence: 806,nonaspirin,O
Sentence: 806,analgesic,O
Sentence: 806,drugs,O
Sentence: 806,and,O
Sentence: 806,NSAIDs,O
Sentence: 806,is,O
Sentence: 806,not,O
Sentence: 806,associated,O
Sentence: 806,with,O
Sentence: 806,an,O
Sentence: 806,increased,O
Sentence: 806,risk,O
Sentence: 806,of,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,.,O
Sentence: 806,However,O
Sentence: 806,",",O
Sentence: 806,the,O
Sentence: 806,chronic,O
Sentence: 806,use,O
Sentence: 806,of,O
Sentence: 806,aspirin,B-Chemical
Sentence: 806,may,O
Sentence: 806,increase,O
Sentence: 806,the,O
Sentence: 806,risk,O
Sentence: 806,of,O
Sentence: 806,ESRD,B-Disease
Sentence: 806,.,O
Sentence: 807,Two,O
Sentence: 807,cases,O
Sentence: 807,of,O
Sentence: 807,amisulpride,B-Chemical
Sentence: 807,overdose,B-Disease
Sentence: 807,:,O
Sentence: 807,a,O
Sentence: 807,cause,O
Sentence: 807,for,O
Sentence: 807,prolonged,B-Disease
Sentence: 807,QT,I-Disease
Sentence: 807,syndrome,I-Disease
Sentence: 807,.,O
Sentence: 808,Two,O
Sentence: 808,cases,O
Sentence: 808,of,O
Sentence: 808,deliberate,O
Sentence: 808,self,O
Sentence: 808,-,O
Sentence: 808,poisoning,B-Disease
Sentence: 808,with,O
Sentence: 808,5,O
Sentence: 808,g,O
Sentence: 808,and,O
Sentence: 808,3.6,O
Sentence: 808,g,O
Sentence: 808,of,O
Sentence: 808,amisulpride,B-Chemical
Sentence: 808,",",O
Sentence: 808,respectively,O
Sentence: 808,",",O
Sentence: 808,are,O
Sentence: 808,reported,O
Sentence: 808,.,O
Sentence: 808,In,O
Sentence: 808,both,O
Sentence: 808,cases,O
Sentence: 808,",",O
Sentence: 808,QT,B-Disease
Sentence: 808,prolongation,I-Disease
Sentence: 808,and,O
Sentence: 808,hypocalcaemia,B-Disease
Sentence: 808,were,O
Sentence: 808,noted,O
Sentence: 808,.,O
Sentence: 808,The,O
Sentence: 808,QT,B-Disease
Sentence: 808,prolongation,I-Disease
Sentence: 808,appeared,O
Sentence: 808,to,O
Sentence: 808,respond,O
Sentence: 808,to,O
Sentence: 808,administration,O
Sentence: 808,of,O
Sentence: 808,i.v,O
Sentence: 808,.,O
Sentence: 808,calcium,B-Chemical
Sentence: 808,gluconate,I-Chemical
Sentence: 808,.,O
Sentence: 809,Growth,O
Sentence: 809,-,O
Sentence: 809,associated,O
Sentence: 809,protein,O
Sentence: 809,43,O
Sentence: 809,expression,O
Sentence: 809,in,O
Sentence: 809,hippocampal,O
Sentence: 809,molecular,O
Sentence: 809,layer,O
Sentence: 809,of,O
Sentence: 809,chronic,O
Sentence: 809,epileptic,B-Disease
Sentence: 809,rats,O
Sentence: 809,treated,O
Sentence: 809,with,O
Sentence: 809,cycloheximide,B-Chemical
Sentence: 809,.,O
Sentence: 810,PURPOSE,O
Sentence: 810,:,O
Sentence: 810,GAP43,O
Sentence: 810,has,O
Sentence: 810,been,O
Sentence: 810,thought,O
Sentence: 810,to,O
Sentence: 810,be,O
Sentence: 810,linked,O
Sentence: 810,with,O
Sentence: 810,mossy,O
Sentence: 810,fiber,O
Sentence: 810,sprouting,O
Sentence: 810,(,O
Sentence: 810,MFS,O
Sentence: 810,),O
Sentence: 810,in,O
Sentence: 810,various,O
Sentence: 810,experimental,O
Sentence: 810,models,O
Sentence: 810,of,O
Sentence: 810,epilepsy,B-Disease
Sentence: 810,.,O
Sentence: 810,To,O
Sentence: 810,investigate,O
Sentence: 810,how,O
Sentence: 810,GAP43,O
Sentence: 810,expression,O
Sentence: 810,(,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,),O
Sentence: 810,correlates,O
Sentence: 810,with,O
Sentence: 810,MFS,O
Sentence: 810,",",O
Sentence: 810,we,O
Sentence: 810,assessed,O
Sentence: 810,the,O
Sentence: 810,intensity,O
Sentence: 810,(,O
Sentence: 810,densitometry,O
Sentence: 810,),O
Sentence: 810,and,O
Sentence: 810,extension,O
Sentence: 810,(,O
Sentence: 810,width,O
Sentence: 810,),O
Sentence: 810,of,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,inner,O
Sentence: 810,molecular,O
Sentence: 810,layer,O
Sentence: 810,of,O
Sentence: 810,the,O
Sentence: 810,dentate,O
Sentence: 810,gyrus,O
Sentence: 810,(,O
Sentence: 810,IML,O
Sentence: 810,),O
Sentence: 810,of,O
Sentence: 810,rats,O
Sentence: 810,subject,O
Sentence: 810,to,O
Sentence: 810,status,B-Disease
Sentence: 810,epilepticus,I-Disease
Sentence: 810,induced,O
Sentence: 810,by,O
Sentence: 810,pilocarpine,B-Chemical
Sentence: 810,(,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,),O
Sentence: 810,",",O
Sentence: 810,previously,O
Sentence: 810,injected,O
Sentence: 810,or,O
Sentence: 810,not,O
Sentence: 810,with,O
Sentence: 810,cycloheximide,B-Chemical
Sentence: 810,(,O
Sentence: 810,CHX,B-Chemical
Sentence: 810,),O
Sentence: 810,",",O
Sentence: 810,which,O
Sentence: 810,has,O
Sentence: 810,been,O
Sentence: 810,shown,O
Sentence: 810,to,O
Sentence: 810,inhibit,O
Sentence: 810,MFS,O
Sentence: 810,.,O
Sentence: 810,METHODS,O
Sentence: 810,:,O
Sentence: 810,CHX,B-Chemical
Sentence: 810,was,O
Sentence: 810,injected,O
Sentence: 810,before,O
Sentence: 810,the,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,injection,O
Sentence: 810,in,O
Sentence: 810,adult,O
Sentence: 810,Wistar,O
Sentence: 810,rats,O
Sentence: 810,.,O
Sentence: 810,The,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,group,O
Sentence: 810,was,O
Sentence: 810,injected,O
Sentence: 810,with,O
Sentence: 810,the,O
Sentence: 810,same,O
Sentence: 810,drugs,O
Sentence: 810,",",O
Sentence: 810,except,O
Sentence: 810,for,O
Sentence: 810,CHX,B-Chemical
Sentence: 810,.,O
Sentence: 810,Animals,O
Sentence: 810,were,O
Sentence: 810,killed,O
Sentence: 810,between,O
Sentence: 810,30,O
Sentence: 810,and,O
Sentence: 810,60,O
Sentence: 810,days,O
Sentence: 810,later,O
Sentence: 810,",",O
Sentence: 810,and,O
Sentence: 810,brain,O
Sentence: 810,sections,O
Sentence: 810,were,O
Sentence: 810,processed,O
Sentence: 810,for,O
Sentence: 810,GAP43,O
Sentence: 810,immunohistochemistry,O
Sentence: 810,.,O
Sentence: 810,RESULTS,O
Sentence: 810,:,O
Sentence: 810,Densitometry,O
Sentence: 810,showed,O
Sentence: 810,no,O
Sentence: 810,significant,O
Sentence: 810,difference,O
Sentence: 810,regarding,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,IML,O
Sentence: 810,between,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,",",O
Sentence: 810,CHX+Pilo,O
Sentence: 810,",",O
Sentence: 810,and,O
Sentence: 810,control,O
Sentence: 810,groups,O
Sentence: 810,.,O
Sentence: 810,However,O
Sentence: 810,",",O
Sentence: 810,the,O
Sentence: 810,results,O
Sentence: 810,of,O
Sentence: 810,the,O
Sentence: 810,width,O
Sentence: 810,of,O
Sentence: 810,the,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,band,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,IML,O
Sentence: 810,showed,O
Sentence: 810,that,O
Sentence: 810,CHX+Pilo,O
Sentence: 810,and,O
Sentence: 810,control,O
Sentence: 810,animals,O
Sentence: 810,had,O
Sentence: 810,a,O
Sentence: 810,significantly,O
Sentence: 810,larger,O
Sentence: 810,band,O
Sentence: 810,(,O
Sentence: 810,p,O
Sentence: 810,,O
Sentence: 810,=,O
Sentence: 810,,O
Sentence: 810,0.03,O
Sentence: 810,),O
Sentence: 810,as,O
Sentence: 810,compared,O
Sentence: 810,with,O
Sentence: 810,that,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,group,O
Sentence: 810,.,O
Sentence: 810,CONCLUSIONS,O
Sentence: 810,:,O
Sentence: 810,Our,O
Sentence: 810,current,O
Sentence: 810,finding,O
Sentence: 810,that,O
Sentence: 810,animals,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,CHX+Pilo,O
Sentence: 810,group,O
Sentence: 810,have,O
Sentence: 810,a,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,band,O
Sentence: 810,in,O
Sentence: 810,the,O
Sentence: 810,IML,O
Sentence: 810,",",O
Sentence: 810,similar,O
Sentence: 810,to,O
Sentence: 810,that,O
Sentence: 810,of,O
Sentence: 810,controls,O
Sentence: 810,",",O
Sentence: 810,reinforces,O
Sentence: 810,prior,O
Sentence: 810,data,O
Sentence: 810,on,O
Sentence: 810,the,O
Sentence: 810,blockade,O
Sentence: 810,of,O
Sentence: 810,MFS,O
Sentence: 810,in,O
Sentence: 810,these,O
Sentence: 810,animals,O
Sentence: 810,.,O
Sentence: 810,The,O
Sentence: 810,change,O
Sentence: 810,in,O
Sentence: 810,GAP43,O
Sentence: 810,-,O
Sentence: 810,ir,O
Sentence: 810,present,O
Sentence: 810,in,O
Sentence: 810,Pilo,B-Chemical
Sentence: 810,-,O
Sentence: 810,treated,O
Sentence: 810,animals,O
Sentence: 810,was,O
Sentence: 810,a,O
Sentence: 810,thinning,O
Sentence: 810,of,O
Sentence: 810,the,O
Sentence: 810,band,O
Sentence: 810,to,O
Sentence: 810,a,O
Sentence: 810,very,O
Sentence: 810,narrow,O
Sentence: 810,layer,O
Sentence: 810,just,O
Sentence: 810,above,O
Sentence: 810,the,O
Sentence: 810,granule,O
Sentence: 810,cell,O
Sentence: 810,layer,O
Sentence: 810,that,O
Sentence: 810,is,O
Sentence: 810,likely,O
Sentence: 810,to,O
Sentence: 810,be,O
Sentence: 810,associated,O
Sentence: 810,with,O
Sentence: 810,the,O
Sentence: 810,loss,O
Sentence: 810,of,O
Sentence: 810,hilar,O
Sentence: 810,cell,O
Sentence: 810,projections,O
Sentence: 810,that,O
Sentence: 810,express,O
Sentence: 810,GAP,O
Sentence: 810,-,O
Sentence: 810,43,O
Sentence: 810,.,O
Sentence: 811,Nicotine,B-Chemical
Sentence: 811,antagonizes,O
Sentence: 811,caffeine,B-Chemical
Sentence: 811,-,O
Sentence: 811,,O
Sentence: 811,but,O
Sentence: 811,not,O
Sentence: 811,pentylenetetrazole,B-Chemical
Sentence: 811,-,O
Sentence: 811,induced,O
Sentence: 811,anxiogenic,O
Sentence: 811,effect,O
Sentence: 811,in,O
Sentence: 811,mice,O
Sentence: 811,.,O
Sentence: 812,RATIONALE,O
Sentence: 812,:,O
Sentence: 812,Nicotine,B-Chemical
Sentence: 812,and,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,are,O
Sentence: 812,widely,O
Sentence: 812,consumed,O
Sentence: 812,licit,O
Sentence: 812,psychoactive,O
Sentence: 812,drugs,O
Sentence: 812,worldwide,O
Sentence: 812,.,O
Sentence: 812,Epidemiological,O
Sentence: 812,studies,O
Sentence: 812,showed,O
Sentence: 812,that,O
Sentence: 812,they,O
Sentence: 812,were,O
Sentence: 812,generally,O
Sentence: 812,used,O
Sentence: 812,concurrently,O
Sentence: 812,.,O
Sentence: 812,Although,O
Sentence: 812,some,O
Sentence: 812,studies,O
Sentence: 812,in,O
Sentence: 812,experimental,O
Sentence: 812,animals,O
Sentence: 812,indicate,O
Sentence: 812,clear,O
Sentence: 812,pharmacological,O
Sentence: 812,interactions,O
Sentence: 812,between,O
Sentence: 812,them,O
Sentence: 812,",",O
Sentence: 812,no,O
Sentence: 812,studies,O
Sentence: 812,have,O
Sentence: 812,shown,O
Sentence: 812,a,O
Sentence: 812,specific,O
Sentence: 812,interaction,O
Sentence: 812,on,O
Sentence: 812,anxiety,B-Disease
Sentence: 812,responses,O
Sentence: 812,.,O
Sentence: 812,OBJECTIVES,O
Sentence: 812,:,O
Sentence: 812,The,O
Sentence: 812,present,O
Sentence: 812,study,O
Sentence: 812,investigates,O
Sentence: 812,the,O
Sentence: 812,effects,O
Sentence: 812,of,O
Sentence: 812,nicotine,B-Chemical
Sentence: 812,on,O
Sentence: 812,anxiety,B-Disease
Sentence: 812,induced,O
Sentence: 812,by,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,and,O
Sentence: 812,another,O
Sentence: 812,anxiogenic,O
Sentence: 812,drug,O
Sentence: 812,",",O
Sentence: 812,pentylenetetrazole,B-Chemical
Sentence: 812,",",O
Sentence: 812,in,O
Sentence: 812,mice,O
Sentence: 812,.,O
Sentence: 812,The,O
Sentence: 812,elevated,O
Sentence: 812,plus,O
Sentence: 812,-,O
Sentence: 812,maze,O
Sentence: 812,(,O
Sentence: 812,EPM,O
Sentence: 812,),O
Sentence: 812,test,O
Sentence: 812,was,O
Sentence: 812,used,O
Sentence: 812,to,O
Sentence: 812,evaluate,O
Sentence: 812,the,O
Sentence: 812,effects,O
Sentence: 812,of,O
Sentence: 812,drugs,O
Sentence: 812,on,O
Sentence: 812,anxiety,B-Disease
Sentence: 812,.,O
Sentence: 812,METHODS,O
Sentence: 812,:,O
Sentence: 812,Adult,O
Sentence: 812,male,O
Sentence: 812,Swiss,O
Sentence: 812,Webster,O
Sentence: 812,mice,O
Sentence: 812,(,O
Sentence: 812,25,O
Sentence: 812,-,O
Sentence: 812,32,O
Sentence: 812,g,O
Sentence: 812,),O
Sentence: 812,were,O
Sentence: 812,given,O
Sentence: 812,nicotine,B-Chemical
Sentence: 812,(,O
Sentence: 812,0.05,O
Sentence: 812,-,O
Sentence: 812,0.25,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,s.c.,O
Sentence: 812,),O
Sentence: 812,or,O
Sentence: 812,saline,O
Sentence: 812,10,O
Sentence: 812,min,O
Sentence: 812,before,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,(,O
Sentence: 812,70,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,i.p,O
Sentence: 812,.,O
Sentence: 812,),O
Sentence: 812,or,O
Sentence: 812,pentylenetetrazole,B-Chemical
Sentence: 812,(,O
Sentence: 812,15,O
Sentence: 812,and,O
Sentence: 812,30,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,i.p,O
Sentence: 812,.,O
Sentence: 812,),O
Sentence: 812,injections,O
Sentence: 812,.,O
Sentence: 812,After,O
Sentence: 812,15,O
Sentence: 812,min,O
Sentence: 812,",",O
Sentence: 812,mice,O
Sentence: 812,were,O
Sentence: 812,evaluated,O
Sentence: 812,for,O
Sentence: 812,their,O
Sentence: 812,open,O
Sentence: 812,-,O
Sentence: 812,,O
Sentence: 812,and,O
Sentence: 812,closed,O
Sentence: 812,-,O
Sentence: 812,arm,O
Sentence: 812,time,O
Sentence: 812,and,O
Sentence: 812,entries,O
Sentence: 812,on,O
Sentence: 812,the,O
Sentence: 812,EPM,O
Sentence: 812,for,O
Sentence: 812,a,O
Sentence: 812,10,O
Sentence: 812,-,O
Sentence: 812,min,O
Sentence: 812,session,O
Sentence: 812,.,O
Sentence: 812,Locomotor,O
Sentence: 812,activity,O
Sentence: 812,was,O
Sentence: 812,recorded,O
Sentence: 812,for,O
Sentence: 812,individual,O
Sentence: 812,groups,O
Sentence: 812,by,O
Sentence: 812,using,O
Sentence: 812,the,O
Sentence: 812,same,O
Sentence: 812,treatment,O
Sentence: 812,protocol,O
Sentence: 812,with,O
Sentence: 812,the,O
Sentence: 812,EPM,O
Sentence: 812,test,O
Sentence: 812,.,O
Sentence: 812,RESULTS,O
Sentence: 812,:,O
Sentence: 812,Nicotine,B-Chemical
Sentence: 812,(,O
Sentence: 812,0.05,O
Sentence: 812,-,O
Sentence: 812,0.25,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,),O
Sentence: 812,itself,O
Sentence: 812,did,O
Sentence: 812,not,O
Sentence: 812,produce,O
Sentence: 812,any,O
Sentence: 812,significant,O
Sentence: 812,effect,O
Sentence: 812,in,O
Sentence: 812,the,O
Sentence: 812,EPM,O
Sentence: 812,test,O
Sentence: 812,",",O
Sentence: 812,whereas,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,(,O
Sentence: 812,70,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,),O
Sentence: 812,and,O
Sentence: 812,pentylenetetrazole,B-Chemical
Sentence: 812,(,O
Sentence: 812,30,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,),O
Sentence: 812,produced,O
Sentence: 812,an,O
Sentence: 812,anxiogenic,O
Sentence: 812,effect,O
Sentence: 812,",",O
Sentence: 812,apparent,O
Sentence: 812,with,O
Sentence: 812,decreases,O
Sentence: 812,in,O
Sentence: 812,open,O
Sentence: 812,-,O
Sentence: 812,arm,O
Sentence: 812,time,O
Sentence: 812,and,O
Sentence: 812,entry,O
Sentence: 812,.,O
Sentence: 812,Nicotine,B-Chemical
Sentence: 812,(,O
Sentence: 812,0.25,O
Sentence: 812,mg,O
Sentence: 812,/,O
Sentence: 812,kg,O
Sentence: 812,),O
Sentence: 812,pretreatment,O
Sentence: 812,blocked,O
Sentence: 812,the,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,-,O
Sentence: 812,,O
Sentence: 812,but,O
Sentence: 812,not,O
Sentence: 812,pentylenetetrazole,B-Chemical
Sentence: 812,-,O
Sentence: 812,induced,O
Sentence: 812,anxiety,B-Disease
Sentence: 812,.,O
Sentence: 812,Administration,O
Sentence: 812,of,O
Sentence: 812,each,O
Sentence: 812,drug,O
Sentence: 812,and,O
Sentence: 812,their,O
Sentence: 812,combinations,O
Sentence: 812,did,O
Sentence: 812,not,O
Sentence: 812,produce,O
Sentence: 812,any,O
Sentence: 812,effect,O
Sentence: 812,on,O
Sentence: 812,locomotor,O
Sentence: 812,activity,O
Sentence: 812,.,O
Sentence: 812,CONCLUSIONS,O
Sentence: 812,:,O
Sentence: 812,Our,O
Sentence: 812,results,O
Sentence: 812,suggest,O
Sentence: 812,that,O
Sentence: 812,the,O
Sentence: 812,antagonistic,O
Sentence: 812,effect,O
Sentence: 812,of,O
Sentence: 812,nicotine,B-Chemical
Sentence: 812,on,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,-,O
Sentence: 812,induced,O
Sentence: 812,anxiety,B-Disease
Sentence: 812,is,O
Sentence: 812,specific,O
Sentence: 812,to,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,",",O
Sentence: 812,instead,O
Sentence: 812,of,O
Sentence: 812,a,O
Sentence: 812,non,O
Sentence: 812,-,O
Sentence: 812,specific,O
Sentence: 812,anxiolytic,O
Sentence: 812,effect,O
Sentence: 812,.,O
Sentence: 812,Thus,O
Sentence: 812,",",O
Sentence: 812,it,O
Sentence: 812,may,O
Sentence: 812,extend,O
Sentence: 812,the,O
Sentence: 812,current,O
Sentence: 812,findings,O
Sentence: 812,on,O
Sentence: 812,the,O
Sentence: 812,interaction,O
Sentence: 812,between,O
Sentence: 812,nicotine,B-Chemical
Sentence: 812,and,O
Sentence: 812,caffeine,B-Chemical
Sentence: 812,.,O
Sentence: 813,Long,O
Sentence: 813,term,O
Sentence: 813,hormone,O
Sentence: 813,therapy,O
Sentence: 813,for,O
Sentence: 813,perimenopausal,O
Sentence: 813,and,O
Sentence: 813,postmenopausal,O
Sentence: 813,women,O
Sentence: 813,.,O
Sentence: 814,BACKGROUND,O
Sentence: 814,:,O
Sentence: 814,Hormone,O
Sentence: 814,therapy,O
Sentence: 814,(,O
Sentence: 814,HT,O
Sentence: 814,),O
Sentence: 814,is,O
Sentence: 814,widely,O
Sentence: 814,used,O
Sentence: 814,for,O
Sentence: 814,controlling,O
Sentence: 814,menopausal,B-Disease
Sentence: 814,symptoms,I-Disease
Sentence: 814,.,O
Sentence: 814,It,O
Sentence: 814,has,O
Sentence: 814,also,O
Sentence: 814,been,O
Sentence: 814,used,O
Sentence: 814,for,O
Sentence: 814,the,O
Sentence: 814,management,O
Sentence: 814,and,O
Sentence: 814,prevention,O
Sentence: 814,of,O
Sentence: 814,cardiovascular,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,",",O
Sentence: 814,osteoporosis,B-Disease
Sentence: 814,and,O
Sentence: 814,dementia,B-Disease
Sentence: 814,in,O
Sentence: 814,older,O
Sentence: 814,women,O
Sentence: 814,but,O
Sentence: 814,the,O
Sentence: 814,evidence,O
Sentence: 814,supporting,O
Sentence: 814,its,O
Sentence: 814,use,O
Sentence: 814,for,O
Sentence: 814,these,O
Sentence: 814,indications,O
Sentence: 814,is,O
Sentence: 814,largely,O
Sentence: 814,observational,O
Sentence: 814,.,O
Sentence: 814,OBJECTIVES,O
Sentence: 814,:,O
Sentence: 814,To,O
Sentence: 814,assess,O
Sentence: 814,the,O
Sentence: 814,effect,O
Sentence: 814,of,O
Sentence: 814,long,O
Sentence: 814,-,O
Sentence: 814,term,O
Sentence: 814,HT,O
Sentence: 814,on,O
Sentence: 814,mortality,O
Sentence: 814,",",O
Sentence: 814,heart,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,",",O
Sentence: 814,venous,B-Disease
Sentence: 814,thromboembolism,I-Disease
Sentence: 814,",",O
Sentence: 814,stroke,B-Disease
Sentence: 814,",",O
Sentence: 814,transient,B-Disease
Sentence: 814,ischaemic,I-Disease
Sentence: 814,attacks,I-Disease
Sentence: 814,",",O
Sentence: 814,breast,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,",",O
Sentence: 814,colorectal,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,",",O
Sentence: 814,ovarian,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,",",O
Sentence: 814,endometrial,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,",",O
Sentence: 814,gallbladder,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,",",O
Sentence: 814,cognitive,O
Sentence: 814,function,O
Sentence: 814,",",O
Sentence: 814,dementia,B-Disease
Sentence: 814,",",O
Sentence: 814,fractures,B-Disease
Sentence: 814,and,O
Sentence: 814,quality,O
Sentence: 814,of,O
Sentence: 814,life,O
Sentence: 814,.,O
Sentence: 814,SEARCH,O
Sentence: 814,STRATEGY,O
Sentence: 814,:,O
Sentence: 814,We,O
Sentence: 814,searched,O
Sentence: 814,the,O
Sentence: 814,following,O
Sentence: 814,databases,O
Sentence: 814,up,O
Sentence: 814,to,O
Sentence: 814,November,O
Sentence: 814,2004,O
Sentence: 814,:,O
Sentence: 814,the,O
Sentence: 814,Cochrane,O
Sentence: 814,Menstrual,O
Sentence: 814,Disorders,O
Sentence: 814,and,O
Sentence: 814,Subfertility,O
Sentence: 814,Group,O
Sentence: 814,Trials,O
Sentence: 814,Register,O
Sentence: 814,",",O
Sentence: 814,Cochrane,O
Sentence: 814,Central,O
Sentence: 814,Register,O
Sentence: 814,of,O
Sentence: 814,Controlled,O
Sentence: 814,Trials,O
Sentence: 814,(,O
Sentence: 814,CENTRAL,O
Sentence: 814,),O
Sentence: 814,",",O
Sentence: 814,MEDLINE,O
Sentence: 814,",",O
Sentence: 814,EMBASE,O
Sentence: 814,",",O
Sentence: 814,Biological,O
Sentence: 814,Abstracts,O
Sentence: 814,.,O
Sentence: 814,Relevant,O
Sentence: 814,non,O
Sentence: 814,-,O
Sentence: 814,indexed,O
Sentence: 814,journals,O
Sentence: 814,and,O
Sentence: 814,conference,O
Sentence: 814,abstracts,O
Sentence: 814,were,O
Sentence: 814,also,O
Sentence: 814,searched,O
Sentence: 814,.,O
Sentence: 814,SELECTION,O
Sentence: 814,CRITERIA,O
Sentence: 814,:,O
Sentence: 814,Randomised,O
Sentence: 814,double,O
Sentence: 814,-,O
Sentence: 814,blind,O
Sentence: 814,trials,O
Sentence: 814,of,O
Sentence: 814,HT,O
Sentence: 814,(,O
Sentence: 814,oestrogens,B-Chemical
Sentence: 814,with,O
Sentence: 814,or,O
Sentence: 814,without,O
Sentence: 814,progestogens,B-Chemical
Sentence: 814,),O
Sentence: 814,versus,O
Sentence: 814,placebo,O
Sentence: 814,",",O
Sentence: 814,taken,O
Sentence: 814,for,O
Sentence: 814,at,O
Sentence: 814,least,O
Sentence: 814,one,O
Sentence: 814,year,O
Sentence: 814,by,O
Sentence: 814,perimenopausal,O
Sentence: 814,or,O
Sentence: 814,postmenopausal,O
Sentence: 814,women,O
Sentence: 814,.,O
Sentence: 814,DATA,O
Sentence: 814,COLLECTION,O
Sentence: 814,AND,O
Sentence: 814,ANALYSIS,O
Sentence: 814,:,O
Sentence: 814,Fifteen,O
Sentence: 814,RCTs,O
Sentence: 814,were,O
Sentence: 814,included,O
Sentence: 814,.,O
Sentence: 814,Trials,O
Sentence: 814,were,O
Sentence: 814,assessed,O
Sentence: 814,for,O
Sentence: 814,quality,O
Sentence: 814,and,O
Sentence: 814,two,O
Sentence: 814,review,O
Sentence: 814,authors,O
Sentence: 814,extracted,O
Sentence: 814,data,O
Sentence: 814,independently,O
Sentence: 814,.,O
Sentence: 814,They,O
Sentence: 814,calculated,O
Sentence: 814,risk,O
Sentence: 814,ratios,O
Sentence: 814,for,O
Sentence: 814,dichotomous,O
Sentence: 814,outcomes,O
Sentence: 814,and,O
Sentence: 814,weighted,O
Sentence: 814,mean,O
Sentence: 814,differences,O
Sentence: 814,for,O
Sentence: 814,continuous,O
Sentence: 814,outcomes,O
Sentence: 814,.,O
Sentence: 814,Clinical,O
Sentence: 814,heterogeneity,O
Sentence: 814,precluded,O
Sentence: 814,meta,O
Sentence: 814,-,O
Sentence: 814,analysis,O
Sentence: 814,for,O
Sentence: 814,most,O
Sentence: 814,outcomes,O
Sentence: 814,.,O
Sentence: 814,MAIN,O
Sentence: 814,RESULTS,O
Sentence: 814,:,O
Sentence: 814,All,O
Sentence: 814,the,O
Sentence: 814,statistically,O
Sentence: 814,significant,O
Sentence: 814,results,O
Sentence: 814,were,O
Sentence: 814,derived,O
Sentence: 814,from,O
Sentence: 814,the,O
Sentence: 814,two,O
Sentence: 814,biggest,O
Sentence: 814,trials,O
Sentence: 814,.,O
Sentence: 814,In,O
Sentence: 814,relatively,O
Sentence: 814,healthy,O
Sentence: 814,women,O
Sentence: 814,",",O
Sentence: 814,combined,O
Sentence: 814,continuous,O
Sentence: 814,HT,O
Sentence: 814,significantly,O
Sentence: 814,increased,O
Sentence: 814,the,O
Sentence: 814,risk,O
Sentence: 814,of,O
Sentence: 814,venous,B-Disease
Sentence: 814,thromboembolism,I-Disease
Sentence: 814,or,O
Sentence: 814,coronary,O
Sentence: 814,event,O
Sentence: 814,(,O
Sentence: 814,after,O
Sentence: 814,one,O
Sentence: 814,year,O
Sentence: 814,'s,O
Sentence: 814,use,O
Sentence: 814,),O
Sentence: 814,",",O
Sentence: 814,stroke,B-Disease
Sentence: 814,(,O
Sentence: 814,after,O
Sentence: 814,3,O
Sentence: 814,years,O
Sentence: 814,),O
Sentence: 814,",",O
Sentence: 814,breast,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,(,O
Sentence: 814,after,O
Sentence: 814,5,O
Sentence: 814,years,O
Sentence: 814,),O
Sentence: 814,and,O
Sentence: 814,gallbladder,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,.,O
Sentence: 814,Long,O
Sentence: 814,-,O
Sentence: 814,term,O
Sentence: 814,oestrogen,B-Chemical
Sentence: 814,-,O
Sentence: 814,only,O
Sentence: 814,HT,O
Sentence: 814,also,O
Sentence: 814,significantly,O
Sentence: 814,increased,O
Sentence: 814,the,O
Sentence: 814,risk,O
Sentence: 814,of,O
Sentence: 814,stroke,B-Disease
Sentence: 814,and,O
Sentence: 814,gallbladder,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,.,O
Sentence: 814,Overall,O
Sentence: 814,",",O
Sentence: 814,the,O
Sentence: 814,only,O
Sentence: 814,statistically,O
Sentence: 814,significant,O
Sentence: 814,benefits,O
Sentence: 814,of,O
Sentence: 814,HT,O
Sentence: 814,were,O
Sentence: 814,a,O
Sentence: 814,decreased,O
Sentence: 814,incidence,O
Sentence: 814,of,O
Sentence: 814,fractures,B-Disease
Sentence: 814,and,O
Sentence: 814,colon,B-Disease
Sentence: 814,cancer,I-Disease
Sentence: 814,with,O
Sentence: 814,long,O
Sentence: 814,-,O
Sentence: 814,term,O
Sentence: 814,use,O
Sentence: 814,.,O
Sentence: 814,Among,O
Sentence: 814,relatively,O
Sentence: 814,healthy,O
Sentence: 814,women,O
Sentence: 814,over,O
Sentence: 814,65,O
Sentence: 814,years,O
Sentence: 814,taking,O
Sentence: 814,continuous,O
Sentence: 814,combined,O
Sentence: 814,HT,O
Sentence: 814,",",O
Sentence: 814,there,O
Sentence: 814,was,O
Sentence: 814,a,O
Sentence: 814,statistically,O
Sentence: 814,significant,O
Sentence: 814,increase,O
Sentence: 814,in,O
Sentence: 814,the,O
Sentence: 814,incidence,O
Sentence: 814,of,O
Sentence: 814,dementia,B-Disease
Sentence: 814,.,O
Sentence: 814,Among,O
Sentence: 814,women,O
Sentence: 814,with,O
Sentence: 814,cardiovascular,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,",",O
Sentence: 814,long,O
Sentence: 814,-,O
Sentence: 814,term,O
Sentence: 814,use,O
Sentence: 814,of,O
Sentence: 814,combined,O
Sentence: 814,continuous,O
Sentence: 814,HT,O
Sentence: 814,significantly,O
Sentence: 814,increased,O
Sentence: 814,the,O
Sentence: 814,risk,O
Sentence: 814,of,O
Sentence: 814,venous,B-Disease
Sentence: 814,thromboembolism,I-Disease
Sentence: 814,.,O
Sentence: 814,No,O
Sentence: 814,trials,O
Sentence: 814,focussed,O
Sentence: 814,specifically,O
Sentence: 814,on,O
Sentence: 814,younger,O
Sentence: 814,women,O
Sentence: 814,.,O
Sentence: 814,However,O
Sentence: 814,",",O
Sentence: 814,one,O
Sentence: 814,trial,O
Sentence: 814,analysed,O
Sentence: 814,subgroups,O
Sentence: 814,of,O
Sentence: 814,2839,O
Sentence: 814,relatively,O
Sentence: 814,healthy,O
Sentence: 814,50,O
Sentence: 814,to,O
Sentence: 814,59,O
Sentence: 814,year,O
Sentence: 814,-,O
Sentence: 814,old,O
Sentence: 814,women,O
Sentence: 814,taking,O
Sentence: 814,combined,O
Sentence: 814,continuous,O
Sentence: 814,HT,O
Sentence: 814,and,O
Sentence: 814,1637,O
Sentence: 814,taking,O
Sentence: 814,oestrogen,B-Chemical
Sentence: 814,-,O
Sentence: 814,only,O
Sentence: 814,HT,O
Sentence: 814,",",O
Sentence: 814,versus,O
Sentence: 814,similar,O
Sentence: 814,-,O
Sentence: 814,sized,O
Sentence: 814,placebo,O
Sentence: 814,groups,O
Sentence: 814,.,O
Sentence: 814,The,O
Sentence: 814,only,O
Sentence: 814,significantly,O
Sentence: 814,increased,O
Sentence: 814,risk,O
Sentence: 814,reported,O
Sentence: 814,was,O
Sentence: 814,for,O
Sentence: 814,venous,B-Disease
Sentence: 814,thromboembolism,I-Disease
Sentence: 814,in,O
Sentence: 814,women,O
Sentence: 814,taking,O
Sentence: 814,combined,O
Sentence: 814,continuous,O
Sentence: 814,HT,O
Sentence: 814,;,O
Sentence: 814,their,O
Sentence: 814,absolute,O
Sentence: 814,risk,O
Sentence: 814,remained,O
Sentence: 814,very,O
Sentence: 814,low,O
Sentence: 814,.,O
Sentence: 814,AUTHORS,O
Sentence: 814,',O
Sentence: 814,CONCLUSIONS,O
Sentence: 814,:,O
Sentence: 814,HT,O
Sentence: 814,is,O
Sentence: 814,not,O
Sentence: 814,indicated,O
Sentence: 814,for,O
Sentence: 814,the,O
Sentence: 814,routine,O
Sentence: 814,management,O
Sentence: 814,of,O
Sentence: 814,chronic,B-Disease
Sentence: 814,disease,I-Disease
Sentence: 814,.,O
Sentence: 814,We,O
Sentence: 814,need,O
Sentence: 814,more,O
Sentence: 814,evidence,O
Sentence: 814,on,O
Sentence: 814,the,O
Sentence: 814,safety,O
Sentence: 814,of,O
Sentence: 814,HT,O
Sentence: 814,for,O
Sentence: 814,menopausal,O
Sentence: 814,symptom,O
Sentence: 814,control,O
Sentence: 814,",",O
Sentence: 814,though,O
Sentence: 814,short,O
Sentence: 814,-,O
Sentence: 814,term,O
Sentence: 814,use,O
Sentence: 814,appears,O
Sentence: 814,to,O
Sentence: 814,be,O
Sentence: 814,relatively,O
Sentence: 814,safe,O
Sentence: 814,for,O
Sentence: 814,healthy,O
Sentence: 814,younger,O
Sentence: 814,women,O
Sentence: 814,.,O
Sentence: 815,Drug,O
Sentence: 815,-,O
Sentence: 815,induced,O
Sentence: 815,liver,O
Sentence: 815,injury,O
Sentence: 815,:,O
Sentence: 815,an,O
Sentence: 815,analysis,O
Sentence: 815,of,O
Sentence: 815,461,O
Sentence: 815,incidences,O
Sentence: 815,submitted,O
Sentence: 815,to,O
Sentence: 815,the,O
Sentence: 815,Spanish,O
Sentence: 815,registry,O
Sentence: 815,over,O
Sentence: 815,a,O
Sentence: 815,10,O
Sentence: 815,-,O
Sentence: 815,year,O
Sentence: 815,period,O
Sentence: 815,.,O
Sentence: 816,BACKGROUND,O
Sentence: 816,&,O
Sentence: 816,AIMS,O
Sentence: 816,:,O
Sentence: 816,Progress,O
Sentence: 816,in,O
Sentence: 816,the,O
Sentence: 816,understanding,O
Sentence: 816,of,O
Sentence: 816,susceptibility,O
Sentence: 816,factors,O
Sentence: 816,to,O
Sentence: 816,drug,O
Sentence: 816,-,O
Sentence: 816,induced,O
Sentence: 816,liver,O
Sentence: 816,injury,O
Sentence: 816,(,O
Sentence: 816,DILI,B-Disease
Sentence: 816,),O
Sentence: 816,and,O
Sentence: 816,outcome,O
Sentence: 816,predictability,O
Sentence: 816,are,O
Sentence: 816,hampered,O
Sentence: 816,by,O
Sentence: 816,the,O
Sentence: 816,lack,O
Sentence: 816,of,O
Sentence: 816,systematic,O
Sentence: 816,programs,O
Sentence: 816,to,O
Sentence: 816,detect,O
Sentence: 816,bona,O
Sentence: 816,fide,O
Sentence: 816,cases,O
Sentence: 816,.,O
Sentence: 816,METHODS,O
Sentence: 816,:,O
Sentence: 816,A,O
Sentence: 816,cooperative,O
Sentence: 816,network,O
Sentence: 816,was,O
Sentence: 816,created,O
Sentence: 816,in,O
Sentence: 816,1994,O
Sentence: 816,in,O
Sentence: 816,Spain,O
Sentence: 816,to,O
Sentence: 816,identify,O
Sentence: 816,all,O
Sentence: 816,suspicions,O
Sentence: 816,of,O
Sentence: 816,DILI,B-Disease
Sentence: 816,following,O
Sentence: 816,a,O
Sentence: 816,prospective,O
Sentence: 816,structured,O
Sentence: 816,report,O
Sentence: 816,form,O
Sentence: 816,.,O
Sentence: 816,The,O
Sentence: 816,liver,B-Disease
Sentence: 816,damage,I-Disease
Sentence: 816,was,O
Sentence: 816,characterized,O
Sentence: 816,according,O
Sentence: 816,to,O
Sentence: 816,hepatocellular,O
Sentence: 816,",",O
Sentence: 816,cholestatic,B-Disease
Sentence: 816,",",O
Sentence: 816,and,O
Sentence: 816,mixed,O
Sentence: 816,laboratory,O
Sentence: 816,criteria,O
Sentence: 816,and,O
Sentence: 816,to,O
Sentence: 816,histologic,O
Sentence: 816,criteria,O
Sentence: 816,when,O
Sentence: 816,available,O
Sentence: 816,.,O
Sentence: 816,Further,O
Sentence: 816,evaluation,O
Sentence: 816,of,O
Sentence: 816,causality,O
Sentence: 816,assessment,O
Sentence: 816,was,O
Sentence: 816,centrally,O
Sentence: 816,performed,O
Sentence: 816,.,O
Sentence: 816,RESULTS,O
Sentence: 816,:,O
Sentence: 816,Since,O
Sentence: 816,April,O
Sentence: 816,1994,O
Sentence: 816,to,O
Sentence: 816,August,O
Sentence: 816,2004,O
Sentence: 816,",",O
Sentence: 816,461,O
Sentence: 816,out,O
Sentence: 816,of,O
Sentence: 816,570,O
Sentence: 816,submitted,O
Sentence: 816,cases,O
Sentence: 816,",",O
Sentence: 816,involving,O
Sentence: 816,505,O
Sentence: 816,drugs,O
Sentence: 816,",",O
Sentence: 816,were,O
Sentence: 816,deemed,O
Sentence: 816,to,O
Sentence: 816,be,O
Sentence: 816,related,O
Sentence: 816,to,O
Sentence: 816,DILI,B-Disease
Sentence: 816,.,O
Sentence: 816,The,O
Sentence: 816,antiinfective,O
Sentence: 816,group,O
Sentence: 816,of,O
Sentence: 816,drugs,O
Sentence: 816,was,O
Sentence: 816,the,O
Sentence: 816,more,O
Sentence: 816,frequently,O
Sentence: 816,incriminated,O
Sentence: 816,",",O
Sentence: 816,amoxicillin,O
Sentence: 816,-,O
Sentence: 816,clavulanate,O
Sentence: 816,accounting,O
Sentence: 816,for,O
Sentence: 816,the,O
Sentence: 816,12.8,O
Sentence: 816,%,O
Sentence: 816,of,O
Sentence: 816,the,O
Sentence: 816,whole,O
Sentence: 816,series,O
Sentence: 816,.,O
Sentence: 816,The,O
Sentence: 816,hepatocellular,O
Sentence: 816,pattern,O
Sentence: 816,of,O
Sentence: 816,damage,O
Sentence: 816,was,O
Sentence: 816,the,O
Sentence: 816,most,O
Sentence: 816,common,O
Sentence: 816,(,O
Sentence: 816,58,O
Sentence: 816,%,O
Sentence: 816,),O
Sentence: 816,",",O
Sentence: 816,was,O
Sentence: 816,inversely,O
Sentence: 816,correlated,O
Sentence: 816,with,O
Sentence: 816,age,O
Sentence: 816,(,O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.0001,O
Sentence: 816,),O
Sentence: 816,",",O
Sentence: 816,and,O
Sentence: 816,had,O
Sentence: 816,the,O
Sentence: 816,worst,O
Sentence: 816,outcome,O
Sentence: 816,(,O
Sentence: 816,Cox,O
Sentence: 816,regression,O
Sentence: 816,",",O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.034,O
Sentence: 816,),O
Sentence: 816,.,O
Sentence: 816,Indeed,O
Sentence: 816,",",O
Sentence: 816,the,O
Sentence: 816,incidence,O
Sentence: 816,of,O
Sentence: 816,liver,O
Sentence: 816,transplantation,O
Sentence: 816,and,O
Sentence: 816,death,O
Sentence: 816,in,O
Sentence: 816,this,O
Sentence: 816,group,O
Sentence: 816,was,O
Sentence: 816,11.7,O
Sentence: 816,%,O
Sentence: 816,if,O
Sentence: 816,patients,O
Sentence: 816,had,O
Sentence: 816,jaundice,B-Disease
Sentence: 816,at,O
Sentence: 816,presentation,O
Sentence: 816,",",O
Sentence: 816,whereas,O
Sentence: 816,the,O
Sentence: 816,corresponding,O
Sentence: 816,figure,O
Sentence: 816,was,O
Sentence: 816,3.8,O
Sentence: 816,%,O
Sentence: 816,in,O
Sentence: 816,nonjaundiced,O
Sentence: 816,patients,O
Sentence: 816,(,O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.04,O
Sentence: 816,),O
Sentence: 816,.,O
Sentence: 816,Factors,O
Sentence: 816,associated,O
Sentence: 816,with,O
Sentence: 816,the,O
Sentence: 816,development,O
Sentence: 816,of,O
Sentence: 816,fulminant,B-Disease
Sentence: 816,hepatic,I-Disease
Sentence: 816,failure,I-Disease
Sentence: 816,were,O
Sentence: 816,female,O
Sentence: 816,sex,O
Sentence: 816,(,O
Sentence: 816,OR,O
Sentence: 816,,O
Sentence: 816,=,O
Sentence: 816,,O
Sentence: 816,25,O
Sentence: 816,;,O
Sentence: 816,95,O
Sentence: 816,%,O
Sentence: 816,CI,O
Sentence: 816,:,O
Sentence: 816,4.1,O
Sentence: 816,-,O
Sentence: 816,151,O
Sentence: 816,;,O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.0001,O
Sentence: 816,),O
Sentence: 816,",",O
Sentence: 816,hepatocellular,O
Sentence: 816,damage,O
Sentence: 816,(,O
Sentence: 816,OR,O
Sentence: 816,,O
Sentence: 816,=,O
Sentence: 816,,O
Sentence: 816,7.9,O
Sentence: 816,;,O
Sentence: 816,95,O
Sentence: 816,%,O
Sentence: 816,CI,O
Sentence: 816,:,O
Sentence: 816,1.6,O
Sentence: 816,-,O
Sentence: 816,37,O
Sentence: 816,;,O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.009,O
Sentence: 816,),O
Sentence: 816,",",O
Sentence: 816,and,O
Sentence: 816,higher,O
Sentence: 816,baseline,O
Sentence: 816,plasma,O
Sentence: 816,bilirubin,B-Chemical
Sentence: 816,value,O
Sentence: 816,(,O
Sentence: 816,OR,O
Sentence: 816,,O
Sentence: 816,=,O
Sentence: 816,,O
Sentence: 816,1.15,O
Sentence: 816,;,O
Sentence: 816,95,O
Sentence: 816,%,O
Sentence: 816,CI,O
Sentence: 816,:,O
Sentence: 816,1.09,O
Sentence: 816,-,O
Sentence: 816,1.22,O
Sentence: 816,;,O
Sentence: 816,P,O
Sentence: 816,,O
Sentence: 816,<,O
Sentence: 816,,O
Sentence: 816,.0001,O
Sentence: 816,),O
Sentence: 816,.,O
Sentence: 816,CONCLUSIONS,O
Sentence: 816,:,O
Sentence: 816,Patients,O
Sentence: 816,with,O
Sentence: 816,drug,O
Sentence: 816,-,O
Sentence: 816,induced,O
Sentence: 816,hepatocellular,O
Sentence: 816,jaundice,B-Disease
Sentence: 816,have,O
Sentence: 816,11.7,O
Sentence: 816,%,O
Sentence: 816,chance,O
Sentence: 816,of,O
Sentence: 816,progressing,O
Sentence: 816,to,O
Sentence: 816,death,O
Sentence: 816,or,O
Sentence: 816,transplantation,O
Sentence: 816,.,O
Sentence: 816,Amoxicillin,O
Sentence: 816,-,O
Sentence: 816,clavulanate,O
Sentence: 816,stands,O
Sentence: 816,out,O
Sentence: 816,as,O
Sentence: 816,the,O
Sentence: 816,most,O
Sentence: 816,common,O
Sentence: 816,drug,O
Sentence: 816,related,O
Sentence: 816,to,O
Sentence: 816,DILI,B-Disease
Sentence: 816,.,O
Sentence: 817,Morphological,O
Sentence: 817,evaluation,O
Sentence: 817,of,O
Sentence: 817,the,O
Sentence: 817,effect,O
Sentence: 817,of,O
Sentence: 817,d,O
Sentence: 817,-,O
Sentence: 817,ribose,O
Sentence: 817,on,O
Sentence: 817,adriamycin,B-Chemical
Sentence: 817,-,O
Sentence: 817,evoked,O
Sentence: 817,cardiotoxicity,B-Disease
Sentence: 817,in,O
Sentence: 817,rats,O
Sentence: 817,.,O
Sentence: 818,The,O
Sentence: 818,influence,O
Sentence: 818,of,O
Sentence: 818,d,O
Sentence: 818,-,O
Sentence: 818,ribose,O
Sentence: 818,on,O
Sentence: 818,adriamycin,B-Chemical
Sentence: 818,-,O
Sentence: 818,induced,O
Sentence: 818,myocardiopathy,B-Disease
Sentence: 818,in,O
Sentence: 818,rats,O
Sentence: 818,was,O
Sentence: 818,studied,O
Sentence: 818,.,O
Sentence: 818,Adriamycin,B-Chemical
Sentence: 818,in,O
Sentence: 818,the,O
Sentence: 818,cumulative,O
Sentence: 818,dose,O
Sentence: 818,of,O
Sentence: 818,25,O
Sentence: 818,mg,O
Sentence: 818,/,O
Sentence: 818,kg,O
Sentence: 818,evoked,O
Sentence: 818,fully,O
Sentence: 818,developed,O
Sentence: 818,cardiac,B-Disease
Sentence: 818,toxicity,I-Disease
Sentence: 818,.,O
Sentence: 818,D,O
Sentence: 818,-,O
Sentence: 818,ribose,O
Sentence: 818,in,O
Sentence: 818,the,O
Sentence: 818,multiple,O
Sentence: 818,doses,O
Sentence: 818,of,O
Sentence: 818,200,O
Sentence: 818,mg,O
Sentence: 818,/,O
Sentence: 818,kg,O
Sentence: 818,did,O
Sentence: 818,not,O
Sentence: 818,influence,O
Sentence: 818,ADR,B-Chemical
Sentence: 818,cardiotoxicity,B-Disease
Sentence: 818,.,O
Sentence: 819,In,O
Sentence: 819,vivo,O
Sentence: 819,evidences,O
Sentence: 819,suggesting,O
Sentence: 819,the,O
Sentence: 819,role,O
Sentence: 819,of,O
Sentence: 819,oxidative,O
Sentence: 819,stress,O
Sentence: 819,in,O
Sentence: 819,pathogenesis,O
Sentence: 819,of,O
Sentence: 819,vancomycin,B-Chemical
Sentence: 819,-,O
Sentence: 819,induced,O
Sentence: 819,nephrotoxicity,B-Disease
Sentence: 819,:,O
Sentence: 819,protection,O
Sentence: 819,by,O
Sentence: 819,erdosteine,B-Chemical
Sentence: 819,.,O
Sentence: 820,The,O
Sentence: 820,aims,O
Sentence: 820,of,O
Sentence: 820,this,O
Sentence: 820,study,O
Sentence: 820,were,O
Sentence: 820,to,O
Sentence: 820,examine,O
Sentence: 820,vancomycin,B-Chemical
Sentence: 820,(,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,),O
Sentence: 820,,O
Sentence: 820,-,O
Sentence: 820,induced,O
Sentence: 820,oxidative,O
Sentence: 820,stress,O
Sentence: 820,that,O
Sentence: 820,promotes,O
Sentence: 820,production,O
Sentence: 820,of,O
Sentence: 820,reactive,O
Sentence: 820,oxygen,B-Chemical
Sentence: 820,species,O
Sentence: 820,(,O
Sentence: 820,ROS,O
Sentence: 820,),O
Sentence: 820,and,O
Sentence: 820,to,O
Sentence: 820,investigate,O
Sentence: 820,the,O
Sentence: 820,role,O
Sentence: 820,of,O
Sentence: 820,erdosteine,B-Chemical
Sentence: 820,",",O
Sentence: 820,an,O
Sentence: 820,expectorant,O
Sentence: 820,agent,O
Sentence: 820,",",O
Sentence: 820,which,O
Sentence: 820,has,O
Sentence: 820,also,O
Sentence: 820,antioxidant,O
Sentence: 820,properties,O
Sentence: 820,",",O
Sentence: 820,on,O
Sentence: 820,kidney,O
Sentence: 820,tissue,O
Sentence: 820,against,O
Sentence: 820,the,O
Sentence: 820,possible,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,-,O
Sentence: 820,induced,O
Sentence: 820,renal,B-Disease
Sentence: 820,impairment,I-Disease
Sentence: 820,in,O
Sentence: 820,rats,O
Sentence: 820,.,O
Sentence: 820,Rats,O
Sentence: 820,were,O
Sentence: 820,divided,O
Sentence: 820,into,O
Sentence: 820,three,O
Sentence: 820,groups,O
Sentence: 820,:,O
Sentence: 820,sham,O
Sentence: 820,",",O
Sentence: 820,VCM,B-Chemical
Sentence: 820,and,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,plus,O
Sentence: 820,erdosteine,B-Chemical
Sentence: 820,.,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,was,O
Sentence: 820,administrated,O
Sentence: 820,intraperitoneally,O
Sentence: 820,(,O
Sentence: 820,i.p,O
Sentence: 820,.,O
Sentence: 820,),O
Sentence: 820,with,O
Sentence: 820,200mgkg,O
Sentence: 820,(,O
Sentence: 820,,O
Sentence: 820,-,O
Sentence: 820,1,O
Sentence: 820,),O
Sentence: 820,twice,O
Sentence: 820,daily,O
Sentence: 820,for,O
Sentence: 820,7,O
Sentence: 820,days,O
Sentence: 820,.,O
Sentence: 820,Erdosteine,B-Chemical
Sentence: 820,was,O
Sentence: 820,administered,O
Sentence: 820,orally,O
Sentence: 820,.,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,administration,O
Sentence: 820,to,O
Sentence: 820,control,O
Sentence: 820,rats,O
Sentence: 820,significantly,O
Sentence: 820,increased,O
Sentence: 820,renal,O
Sentence: 820,malondialdehyde,B-Chemical
Sentence: 820,(,O
Sentence: 820,MDA,B-Chemical
Sentence: 820,),O
Sentence: 820,and,O
Sentence: 820,urinary,O
Sentence: 820,N,O
Sentence: 820,-,O
Sentence: 820,acetyl,O
Sentence: 820,-,O
Sentence: 820,beta,O
Sentence: 820,-,O
Sentence: 820,d,O
Sentence: 820,-,O
Sentence: 820,glucosaminidase,O
Sentence: 820,(,O
Sentence: 820,NAG,O
Sentence: 820,",",O
Sentence: 820,a,O
Sentence: 820,marker,O
Sentence: 820,of,O
Sentence: 820,renal,B-Disease
Sentence: 820,tubular,I-Disease
Sentence: 820,injury,I-Disease
Sentence: 820,),O
Sentence: 820,excretion,O
Sentence: 820,but,O
Sentence: 820,decreased,O
Sentence: 820,superoxide,B-Chemical
Sentence: 820,dismutase,O
Sentence: 820,(,O
Sentence: 820,SOD,O
Sentence: 820,),O
Sentence: 820,and,O
Sentence: 820,catalase,O
Sentence: 820,(,O
Sentence: 820,CAT,O
Sentence: 820,),O
Sentence: 820,activities,O
Sentence: 820,.,O
Sentence: 820,Erdosteine,B-Chemical
Sentence: 820,administration,O
Sentence: 820,with,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,injections,O
Sentence: 820,caused,O
Sentence: 820,significantly,O
Sentence: 820,decreased,O
Sentence: 820,renal,O
Sentence: 820,MDA,B-Chemical
Sentence: 820,and,O
Sentence: 820,urinary,O
Sentence: 820,NAG,O
Sentence: 820,excretion,O
Sentence: 820,",",O
Sentence: 820,and,O
Sentence: 820,increased,O
Sentence: 820,SOD,O
Sentence: 820,activity,O
Sentence: 820,",",O
Sentence: 820,but,O
Sentence: 820,not,O
Sentence: 820,CAT,O
Sentence: 820,activity,O
Sentence: 820,in,O
Sentence: 820,renal,O
Sentence: 820,tissue,O
Sentence: 820,when,O
Sentence: 820,compared,O
Sentence: 820,with,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,alone,O
Sentence: 820,.,O
Sentence: 820,Erdosteine,B-Chemical
Sentence: 820,showed,O
Sentence: 820,histopathological,O
Sentence: 820,protection,O
Sentence: 820,against,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,-,O
Sentence: 820,induced,O
Sentence: 820,nephrotoxicity,B-Disease
Sentence: 820,.,O
Sentence: 820,There,O
Sentence: 820,were,O
Sentence: 820,a,O
Sentence: 820,significant,O
Sentence: 820,dilatation,O
Sentence: 820,of,O
Sentence: 820,tubular,O
Sentence: 820,lumens,O
Sentence: 820,",",O
Sentence: 820,extensive,O
Sentence: 820,epithelial,O
Sentence: 820,cell,O
Sentence: 820,vacuolization,O
Sentence: 820,",",O
Sentence: 820,atrophy,B-Disease
Sentence: 820,",",O
Sentence: 820,desquamation,B-Disease
Sentence: 820,",",O
Sentence: 820,and,O
Sentence: 820,necrosis,B-Disease
Sentence: 820,in,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,-,O
Sentence: 820,treated,O
Sentence: 820,rats,O
Sentence: 820,more,O
Sentence: 820,than,O
Sentence: 820,those,O
Sentence: 820,of,O
Sentence: 820,the,O
Sentence: 820,control,O
Sentence: 820,and,O
Sentence: 820,the,O
Sentence: 820,erdosteine,B-Chemical
Sentence: 820,groups,O
Sentence: 820,.,O
Sentence: 820,Erdosteine,B-Chemical
Sentence: 820,caused,O
Sentence: 820,a,O
Sentence: 820,marked,O
Sentence: 820,reduction,O
Sentence: 820,in,O
Sentence: 820,the,O
Sentence: 820,extent,O
Sentence: 820,of,O
Sentence: 820,tubular,O
Sentence: 820,damage,O
Sentence: 820,.,O
Sentence: 820,It,O
Sentence: 820,is,O
Sentence: 820,concluded,O
Sentence: 820,that,O
Sentence: 820,oxidative,O
Sentence: 820,tubular,O
Sentence: 820,damage,O
Sentence: 820,plays,O
Sentence: 820,an,O
Sentence: 820,important,O
Sentence: 820,role,O
Sentence: 820,in,O
Sentence: 820,the,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,-,O
Sentence: 820,induced,O
Sentence: 820,nephrotoxicity,B-Disease
Sentence: 820,and,O
Sentence: 820,the,O
Sentence: 820,modulation,O
Sentence: 820,of,O
Sentence: 820,oxidative,O
Sentence: 820,stress,O
Sentence: 820,with,O
Sentence: 820,erdosteine,B-Chemical
Sentence: 820,reduces,O
Sentence: 820,the,O
Sentence: 820,VCM,B-Chemical
Sentence: 820,-,O
Sentence: 820,induced,O
Sentence: 820,kidney,B-Disease
Sentence: 820,damage,I-Disease
Sentence: 820,both,O
Sentence: 820,at,O
Sentence: 820,the,O
Sentence: 820,biochemical,O
Sentence: 820,and,O
Sentence: 820,histological,O
Sentence: 820,levels,O
Sentence: 820,.,O
Sentence: 821,Does,O
Sentence: 821,domperidone,B-Chemical
Sentence: 821,potentiate,O
Sentence: 821,mirtazapine,B-Chemical
Sentence: 821,-,O
Sentence: 821,associated,O
Sentence: 821,restless,B-Disease
Sentence: 821,legs,I-Disease
Sentence: 821,syndrome,I-Disease
Sentence: 821,?,O
Sentence: 822,There,O
Sentence: 822,is,O
Sentence: 822,now,O
Sentence: 822,evidence,O
Sentence: 822,to,O
Sentence: 822,suggest,O
Sentence: 822,a,O
Sentence: 822,central,O
Sentence: 822,role,O
Sentence: 822,for,O
Sentence: 822,the,O
Sentence: 822,dopaminergic,O
Sentence: 822,system,O
Sentence: 822,in,O
Sentence: 822,restless,B-Disease
Sentence: 822,legs,I-Disease
Sentence: 822,syndrome,I-Disease
Sentence: 822,(,O
Sentence: 822,RLS,B-Disease
Sentence: 822,),O
Sentence: 822,.,O
Sentence: 822,For,O
Sentence: 822,example,O
Sentence: 822,",",O
Sentence: 822,the,O
Sentence: 822,symptoms,O
Sentence: 822,of,O
Sentence: 822,RLS,B-Disease
Sentence: 822,can,O
Sentence: 822,be,O
Sentence: 822,dramatically,O
Sentence: 822,improved,O
Sentence: 822,by,O
Sentence: 822,levodopa,B-Chemical
Sentence: 822,and,O
Sentence: 822,dopamine,B-Chemical
Sentence: 822,agonists,O
Sentence: 822,",",O
Sentence: 822,whereas,O
Sentence: 822,central,O
Sentence: 822,dopamine,B-Chemical
Sentence: 822,D2,O
Sentence: 822,receptor,O
Sentence: 822,antagonists,O
Sentence: 822,can,O
Sentence: 822,induce,O
Sentence: 822,or,O
Sentence: 822,aggravate,O
Sentence: 822,RLS,B-Disease
Sentence: 822,symptoms,O
Sentence: 822,.,O
Sentence: 822,To,O
Sentence: 822,our,O
Sentence: 822,knowledge,O
Sentence: 822,",",O
Sentence: 822,there,O
Sentence: 822,is,O
Sentence: 822,no,O
Sentence: 822,previous,O
Sentence: 822,report,O
Sentence: 822,regarding,O
Sentence: 822,whether,O
Sentence: 822,domperidone,B-Chemical
Sentence: 822,",",O
Sentence: 822,a,O
Sentence: 822,peripheral,O
Sentence: 822,dopamine,B-Chemical
Sentence: 822,D2,O
Sentence: 822,receptor,O
Sentence: 822,antagonist,O
Sentence: 822,",",O
Sentence: 822,can,O
Sentence: 822,also,O
Sentence: 822,induce,O
Sentence: 822,or,O
Sentence: 822,aggravate,O
Sentence: 822,symptoms,O
Sentence: 822,of,O
Sentence: 822,RLS,B-Disease
Sentence: 822,.,O
Sentence: 822,Mirtazapine,B-Chemical
Sentence: 822,",",O
Sentence: 822,the,O
Sentence: 822,first,O
Sentence: 822,noradrenergic,O
Sentence: 822,and,O
Sentence: 822,specific,O
Sentence: 822,serotonergic,O
Sentence: 822,antidepressant,O
Sentence: 822,(,O
Sentence: 822,NaSSA,O
Sentence: 822,),O
Sentence: 822,",",O
Sentence: 822,has,O
Sentence: 822,been,O
Sentence: 822,associated,O
Sentence: 822,with,O
Sentence: 822,RLS,B-Disease
Sentence: 822,in,O
Sentence: 822,several,O
Sentence: 822,recent,O
Sentence: 822,publications,O
Sentence: 822,.,O
Sentence: 822,The,O
Sentence: 822,authors,O
Sentence: 822,report,O
Sentence: 822,here,O
Sentence: 822,a,O
Sentence: 822,depressed,O
Sentence: 822,patient,O
Sentence: 822,comorbid,O
Sentence: 822,with,O
Sentence: 822,postprandial,B-Disease
Sentence: 822,dyspepsia,I-Disease
Sentence: 822,who,O
Sentence: 822,developed,O
Sentence: 822,RLS,B-Disease
Sentence: 822,after,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,had,O
Sentence: 822,been,O
Sentence: 822,added,O
Sentence: 822,to,O
Sentence: 822,his,O
Sentence: 822,domperidone,B-Chemical
Sentence: 822,therapy,O
Sentence: 822,.,O
Sentence: 822,Our,O
Sentence: 822,patient,O
Sentence: 822,started,O
Sentence: 822,to,O
Sentence: 822,have,O
Sentence: 822,symptoms,O
Sentence: 822,of,O
Sentence: 822,RLS,B-Disease
Sentence: 822,only,O
Sentence: 822,after,O
Sentence: 822,he,O
Sentence: 822,had,O
Sentence: 822,been,O
Sentence: 822,treated,O
Sentence: 822,with,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,",",O
Sentence: 822,and,O
Sentence: 822,his,O
Sentence: 822,RLS,B-Disease
Sentence: 822,symptoms,O
Sentence: 822,resolved,O
Sentence: 822,completely,O
Sentence: 822,upon,O
Sentence: 822,discontinuation,O
Sentence: 822,of,O
Sentence: 822,his,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,.,O
Sentence: 822,Such,O
Sentence: 822,a,O
Sentence: 822,temporal,O
Sentence: 822,relationship,O
Sentence: 822,between,O
Sentence: 822,the,O
Sentence: 822,use,O
Sentence: 822,of,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,and,O
Sentence: 822,the,O
Sentence: 822,symptoms,O
Sentence: 822,of,O
Sentence: 822,RLS,B-Disease
Sentence: 822,in,O
Sentence: 822,our,O
Sentence: 822,patient,O
Sentence: 822,did,O
Sentence: 822,not,O
Sentence: 822,support,O
Sentence: 822,a,O
Sentence: 822,potentiating,O
Sentence: 822,effect,O
Sentence: 822,of,O
Sentence: 822,domperione,B-Chemical
Sentence: 822,on,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,-,O
Sentence: 822,associated,O
Sentence: 822,RLS,B-Disease
Sentence: 822,.,O
Sentence: 822,However,O
Sentence: 822,",",O
Sentence: 822,physicians,O
Sentence: 822,should,O
Sentence: 822,be,O
Sentence: 822,aware,O
Sentence: 822,of,O
Sentence: 822,the,O
Sentence: 822,possibility,O
Sentence: 822,that,O
Sentence: 822,mirtazapine,B-Chemical
Sentence: 822,can,O
Sentence: 822,be,O
Sentence: 822,associated,O
Sentence: 822,with,O
Sentence: 822,RLS,B-Disease
Sentence: 822,in,O
Sentence: 822,some,O
Sentence: 822,individuals,O
Sentence: 822,",",O
Sentence: 822,especially,O
Sentence: 822,those,O
Sentence: 822,receiving,O
Sentence: 822,concomitant,O
Sentence: 822,dopamine,B-Chemical
Sentence: 822,D2,O
Sentence: 822,receptor,O
Sentence: 822,antagonists,O
Sentence: 822,.,O
Sentence: 823,Antiandrogenic,O
Sentence: 823,therapy,O
Sentence: 823,can,O
Sentence: 823,cause,O
Sentence: 823,coronary,O
Sentence: 823,arterial,O
Sentence: 823,disease,O
Sentence: 823,.,O
Sentence: 824,AIM,O
Sentence: 824,:,O
Sentence: 824,To,O
Sentence: 824,study,O
Sentence: 824,the,O
Sentence: 824,change,O
Sentence: 824,of,O
Sentence: 824,lipid,O
Sentence: 824,metabolism,O
Sentence: 824,by,O
Sentence: 824,antiandrogen,O
Sentence: 824,therapy,O
Sentence: 824,in,O
Sentence: 824,patients,O
Sentence: 824,with,O
Sentence: 824,prostate,B-Disease
Sentence: 824,cancer,I-Disease
Sentence: 824,.,O
Sentence: 824,MATERIALS,O
Sentence: 824,AND,O
Sentence: 824,METHODS,O
Sentence: 824,:,O
Sentence: 824,We,O
Sentence: 824,studied,O
Sentence: 824,with,O
Sentence: 824,a,O
Sentence: 824,2.5,O
Sentence: 824,years,O
Sentence: 824,follow,O
Sentence: 824,-,O
Sentence: 824,up,O
Sentence: 824,the,O
Sentence: 824,changes,O
Sentence: 824,in,O
Sentence: 824,plasma,O
Sentence: 824,cholesterols,B-Chemical
Sentence: 824,(,O
Sentence: 824,C,B-Chemical
Sentence: 824,),O
Sentence: 824,",",O
Sentence: 824,triglycerides,B-Chemical
Sentence: 824,(,O
Sentence: 824,TG,B-Chemical
Sentence: 824,),O
Sentence: 824,",",O
Sentence: 824,lipoproteins,O
Sentence: 824,(,O
Sentence: 824,LP,O
Sentence: 824,),O
Sentence: 824,",",O
Sentence: 824,and,O
Sentence: 824,apolipoproteins,O
Sentence: 824,(,O
Sentence: 824,Apo,O
Sentence: 824,),O
Sentence: 824,B,O
Sentence: 824,-,O
Sentence: 824,100,O
Sentence: 824,",",O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,I,O
Sentence: 824,",",O
Sentence: 824,and,O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,II,O
Sentence: 824,pro,O
Sentence: 824,fi,O
Sentence: 824,les,O
Sentence: 824,in,O
Sentence: 824,24,O
Sentence: 824,patients,O
Sentence: 824,of,O
Sentence: 824,mean,O
Sentence: 824,age,O
Sentence: 824,60,O
Sentence: 824,years,O
Sentence: 824,with,O
Sentence: 824,low,O
Sentence: 824,risk,O
Sentence: 824,prostate,B-Disease
Sentence: 824,cancer,I-Disease
Sentence: 824,(,O
Sentence: 824,stage,O
Sentence: 824,:,O
Sentence: 824,T1cN0M0,O
Sentence: 824,",",O
Sentence: 824,Gleason,O
Sentence: 824,score,O
Sentence: 824,:,O
Sentence: 824,2,O
Sentence: 824,-,O
Sentence: 824,5,O
Sentence: 824,),O
Sentence: 824,during,O
Sentence: 824,treatment,O
Sentence: 824,with,O
Sentence: 824,cyproterone,B-Chemical
Sentence: 824,acetate,I-Chemical
Sentence: 824,(,O
Sentence: 824,CPA,B-Chemical
Sentence: 824,),O
Sentence: 824,without,O
Sentence: 824,surgical,O
Sentence: 824,management,O
Sentence: 824,or,O
Sentence: 824,radiation,O
Sentence: 824,therapy,O
Sentence: 824,.,O
Sentence: 824,RESULTS,O
Sentence: 824,:,O
Sentence: 824,Significant,O
Sentence: 824,decreases,O
Sentence: 824,of,O
Sentence: 824,HDL,O
Sentence: 824,-,O
Sentence: 824,C,B-Chemical
Sentence: 824,",",O
Sentence: 824,Apo,O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,I,O
Sentence: 824,and,O
Sentence: 824,Apo,O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,II,O
Sentence: 824,and,O
Sentence: 824,an,O
Sentence: 824,increase,O
Sentence: 824,of,O
Sentence: 824,triglyceride,B-Chemical
Sentence: 824,levels,O
Sentence: 824,in,O
Sentence: 824,VLDL,O
Sentence: 824,were,O
Sentence: 824,induced,O
Sentence: 824,by,O
Sentence: 824,CPA,B-Chemical
Sentence: 824,.,O
Sentence: 824,After,O
Sentence: 824,a,O
Sentence: 824,period,O
Sentence: 824,of,O
Sentence: 824,2.5,O
Sentence: 824,years,O
Sentence: 824,on,O
Sentence: 824,CPA,B-Chemical
Sentence: 824,treatment,O
Sentence: 824,",",O
Sentence: 824,four,O
Sentence: 824,patients,O
Sentence: 824,out,O
Sentence: 824,of,O
Sentence: 824,twenty,O
Sentence: 824,-,O
Sentence: 824,four,O
Sentence: 824,were,O
Sentence: 824,found,O
Sentence: 824,to,O
Sentence: 824,be,O
Sentence: 824,affected,O
Sentence: 824,by,O
Sentence: 824,coronary,B-Disease
Sentence: 824,heart,I-Disease
Sentence: 824,disease,I-Disease
Sentence: 824,.,O
Sentence: 824,CONCLUSIONS,O
Sentence: 824,:,O
Sentence: 824,Ischaemic,O
Sentence: 824,coronary,B-Disease
Sentence: 824,arteriosclerosis,I-Disease
Sentence: 824,with,O
Sentence: 824,an,O
Sentence: 824,incidence,O
Sentence: 824,rate,O
Sentence: 824,of,O
Sentence: 824,16.6,O
Sentence: 824,%,O
Sentence: 824,as,O
Sentence: 824,caused,O
Sentence: 824,by,O
Sentence: 824,prolonged,O
Sentence: 824,CPA,B-Chemical
Sentence: 824,therapy,O
Sentence: 824,is,O
Sentence: 824,mediated,O
Sentence: 824,through,O
Sentence: 824,changes,O
Sentence: 824,in,O
Sentence: 824,HDL,O
Sentence: 824,cholesterol,B-Chemical
Sentence: 824,",",O
Sentence: 824,Apo,O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,I,O
Sentence: 824,and,O
Sentence: 824,Apo,O
Sentence: 824,A,O
Sentence: 824,-,O
Sentence: 824,II,O
Sentence: 824,pro,O
Sentence: 824,fi,O
Sentence: 824,les,O
Sentence: 824,",",O
Sentence: 824,other,O
Sentence: 824,than,O
Sentence: 824,the,O
Sentence: 824,well,O
Sentence: 824,-,O
Sentence: 824,known,O
Sentence: 824,hyperglyceridemic,B-Disease
Sentence: 824,effect,I-Disease
Sentence: 824,caused,O
Sentence: 824,by,O
Sentence: 824,estrogen,B-Chemical
Sentence: 824,.,O
Sentence: 825,5,O
Sentence: 825,-,O
Sentence: 825,Fluorouracil,O
Sentence: 825,cardiotoxicity,B-Disease
Sentence: 825,induced,O
Sentence: 825,by,O
Sentence: 825,alpha,O
Sentence: 825,-,O
Sentence: 825,fluoro,O
Sentence: 825,-,O
Sentence: 825,beta,O
Sentence: 825,-,O
Sentence: 825,alanine,O
Sentence: 825,.,O
Sentence: 826,Cardiotoxicity,B-Disease
Sentence: 826,is,O
Sentence: 826,a,O
Sentence: 826,rare,O
Sentence: 826,complication,O
Sentence: 826,occurring,O
Sentence: 826,during,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,fluorouracil,O
Sentence: 826,(,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,),O
Sentence: 826,treatment,O
Sentence: 826,for,O
Sentence: 826,malignancies,B-Disease
Sentence: 826,.,O
Sentence: 826,We,O
Sentence: 826,herein,O
Sentence: 826,report,O
Sentence: 826,the,O
Sentence: 826,case,O
Sentence: 826,of,O
Sentence: 826,a,O
Sentence: 826,70,O
Sentence: 826,-,O
Sentence: 826,year,O
Sentence: 826,-,O
Sentence: 826,old,O
Sentence: 826,man,O
Sentence: 826,with,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,-,O
Sentence: 826,induced,O
Sentence: 826,cardiotoxicity,B-Disease
Sentence: 826,",",O
Sentence: 826,in,O
Sentence: 826,whom,O
Sentence: 826,a,O
Sentence: 826,high,O
Sentence: 826,serum,O
Sentence: 826,level,O
Sentence: 826,of,O
Sentence: 826,alpha,O
Sentence: 826,-,O
Sentence: 826,fluoro,O
Sentence: 826,-,O
Sentence: 826,beta,O
Sentence: 826,-,O
Sentence: 826,alanine,O
Sentence: 826,(,O
Sentence: 826,FBAL,B-Chemical
Sentence: 826,),O
Sentence: 826,was,O
Sentence: 826,observed,O
Sentence: 826,.,O
Sentence: 826,The,O
Sentence: 826,patient,O
Sentence: 826,",",O
Sentence: 826,who,O
Sentence: 826,had,O
Sentence: 826,unresectable,O
Sentence: 826,colon,B-Disease
Sentence: 826,cancer,I-Disease
Sentence: 826,metastases,O
Sentence: 826,to,O
Sentence: 826,the,O
Sentence: 826,liver,O
Sentence: 826,and,O
Sentence: 826,lung,O
Sentence: 826,",",O
Sentence: 826,was,O
Sentence: 826,referred,O
Sentence: 826,to,O
Sentence: 826,us,O
Sentence: 826,for,O
Sentence: 826,chemotherapy,O
Sentence: 826,from,O
Sentence: 826,an,O
Sentence: 826,affiliated,O
Sentence: 826,hospital,O
Sentence: 826,;,O
Sentence: 826,he,O
Sentence: 826,had,O
Sentence: 826,no,O
Sentence: 826,cardiac,O
Sentence: 826,history,O
Sentence: 826,.,O
Sentence: 826,After,O
Sentence: 826,admission,O
Sentence: 826,",",O
Sentence: 826,the,O
Sentence: 826,patient,O
Sentence: 826,received,O
Sentence: 826,a,O
Sentence: 826,continuous,O
Sentence: 826,intravenous,O
Sentence: 826,infusion,O
Sentence: 826,of,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,(,O
Sentence: 826,1000,O
Sentence: 826,mg,O
Sentence: 826,/,O
Sentence: 826,day,O
Sentence: 826,),O
Sentence: 826,",",O
Sentence: 826,during,O
Sentence: 826,which,O
Sentence: 826,precordial,B-Disease
Sentence: 826,pain,I-Disease
Sentence: 826,with,O
Sentence: 826,right,B-Disease
Sentence: 826,bundle,I-Disease
Sentence: 826,branch,I-Disease
Sentence: 826,block,I-Disease
Sentence: 826,occurred,O
Sentence: 826,concomitantly,O
Sentence: 826,with,O
Sentence: 826,a,O
Sentence: 826,high,O
Sentence: 826,serum,O
Sentence: 826,FBAL,B-Chemical
Sentence: 826,concentration,O
Sentence: 826,of,O
Sentence: 826,1955,O
Sentence: 826,ng,O
Sentence: 826,/,O
Sentence: 826,ml,O
Sentence: 826,.,O
Sentence: 826,Both,O
Sentence: 826,the,O
Sentence: 826,precordial,B-Disease
Sentence: 826,pain,I-Disease
Sentence: 826,and,O
Sentence: 826,the,O
Sentence: 826,electrocardiographic,O
Sentence: 826,changes,O
Sentence: 826,disappeared,O
Sentence: 826,spontaneously,O
Sentence: 826,after,O
Sentence: 826,the,O
Sentence: 826,discontinuation,O
Sentence: 826,of,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,.,O
Sentence: 826,As,O
Sentence: 826,the,O
Sentence: 826,precordial,B-Disease
Sentence: 826,pain,I-Disease
Sentence: 826,in,O
Sentence: 826,this,O
Sentence: 826,patient,O
Sentence: 826,was,O
Sentence: 826,considered,O
Sentence: 826,to,O
Sentence: 826,have,O
Sentence: 826,been,O
Sentence: 826,due,O
Sentence: 826,to,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,-,O
Sentence: 826,induced,O
Sentence: 826,cardiotoxicity,B-Disease
Sentence: 826,",",O
Sentence: 826,the,O
Sentence: 826,administration,O
Sentence: 826,of,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,was,O
Sentence: 826,abandoned,O
Sentence: 826,.,O
Sentence: 826,Instead,O
Sentence: 826,",",O
Sentence: 826,oral,O
Sentence: 826,administration,O
Sentence: 826,of,O
Sentence: 826,S,O
Sentence: 826,-,O
Sentence: 826,1,O
Sentence: 826,(,O
Sentence: 826,a,O
Sentence: 826,derivative,O
Sentence: 826,of,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,),O
Sentence: 826,",",O
Sentence: 826,at,O
Sentence: 826,200,O
Sentence: 826,mg,O
Sentence: 826,/,O
Sentence: 826,day,O
Sentence: 826,twice,O
Sentence: 826,a,O
Sentence: 826,week,O
Sentence: 826,",",O
Sentence: 826,was,O
Sentence: 826,instituted,O
Sentence: 826,",",O
Sentence: 826,because,O
Sentence: 826,S,O
Sentence: 826,-,O
Sentence: 826,1,O
Sentence: 826,has,O
Sentence: 826,a,O
Sentence: 826,strong,O
Sentence: 826,inhibitory,O
Sentence: 826,effect,O
Sentence: 826,on,O
Sentence: 826,dihydropyrimidine,B-Chemical
Sentence: 826,dehydrogenase,O
Sentence: 826,",",O
Sentence: 826,which,O
Sentence: 826,catalyzes,O
Sentence: 826,the,O
Sentence: 826,degradative,O
Sentence: 826,of,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,into,O
Sentence: 826,FBAL,B-Chemical
Sentence: 826,.,O
Sentence: 826,The,O
Sentence: 826,serum,O
Sentence: 826,FBAL,B-Chemical
Sentence: 826,concentration,O
Sentence: 826,subsequently,O
Sentence: 826,decreased,O
Sentence: 826,to,O
Sentence: 826,352,O
Sentence: 826,ng,O
Sentence: 826,/,O
Sentence: 826,ml,O
Sentence: 826,",",O
Sentence: 826,the,O
Sentence: 826,same,O
Sentence: 826,as,O
Sentence: 826,the,O
Sentence: 826,value,O
Sentence: 826,measured,O
Sentence: 826,on,O
Sentence: 826,the,O
Sentence: 826,first,O
Sentence: 826,day,O
Sentence: 826,of,O
Sentence: 826,S,O
Sentence: 826,-,O
Sentence: 826,1,O
Sentence: 826,administration,O
Sentence: 826,.,O
Sentence: 826,Thereafter,O
Sentence: 826,",",O
Sentence: 826,no,O
Sentence: 826,cardiac,B-Disease
Sentence: 826,symptoms,I-Disease
Sentence: 826,were,O
Sentence: 826,observed,O
Sentence: 826,.,O
Sentence: 826,The,O
Sentence: 826,patient,O
Sentence: 826,achieved,O
Sentence: 826,a,O
Sentence: 826,partial,O
Sentence: 826,response,O
Sentence: 826,6,O
Sentence: 826,months,O
Sentence: 826,after,O
Sentence: 826,the,O
Sentence: 826,initiation,O
Sentence: 826,of,O
Sentence: 826,the,O
Sentence: 826,S,O
Sentence: 826,-,O
Sentence: 826,1,O
Sentence: 826,treatment,O
Sentence: 826,.,O
Sentence: 826,The,O
Sentence: 826,experience,O
Sentence: 826,of,O
Sentence: 826,this,O
Sentence: 826,case,O
Sentence: 826,",",O
Sentence: 826,together,O
Sentence: 826,with,O
Sentence: 826,a,O
Sentence: 826,review,O
Sentence: 826,of,O
Sentence: 826,the,O
Sentence: 826,literature,O
Sentence: 826,",",O
Sentence: 826,suggests,O
Sentence: 826,that,O
Sentence: 826,FBAL,B-Chemical
Sentence: 826,is,O
Sentence: 826,related,O
Sentence: 826,to,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,-,O
Sentence: 826,induced,O
Sentence: 826,cardiotoxicity,B-Disease
Sentence: 826,.,O
Sentence: 826,S,O
Sentence: 826,-,O
Sentence: 826,1,O
Sentence: 826,may,O
Sentence: 826,be,O
Sentence: 826,administered,O
Sentence: 826,safely,O
Sentence: 826,to,O
Sentence: 826,patients,O
Sentence: 826,with,O
Sentence: 826,5,O
Sentence: 826,-,O
Sentence: 826,FU,O
Sentence: 826,-,O
Sentence: 826,induced,O
Sentence: 826,cardiotoxicity,B-Disease
Sentence: 826,.,O
Sentence: 827,The,O
Sentence: 827,influence,O
Sentence: 827,of,O
Sentence: 827,the,O
Sentence: 827,time,O
Sentence: 827,interval,O
Sentence: 827,between,O
Sentence: 827,monoHER,B-Chemical
Sentence: 827,and,O
Sentence: 827,doxorubicin,B-Chemical
Sentence: 827,administration,O
Sentence: 827,on,O
Sentence: 827,the,O
Sentence: 827,protection,O
Sentence: 827,against,O
Sentence: 827,doxorubicin,B-Chemical
Sentence: 827,-,O
Sentence: 827,induced,O
Sentence: 827,cardiotoxicity,B-Disease
Sentence: 827,in,O
Sentence: 827,mice,O
Sentence: 827,.,O
Sentence: 828,PURPOSE,O
Sentence: 828,:,O
Sentence: 828,Despite,O
Sentence: 828,its,O
Sentence: 828,well,O
Sentence: 828,-,O
Sentence: 828,known,O
Sentence: 828,cardiotoxicity,B-Disease
Sentence: 828,",",O
Sentence: 828,the,O
Sentence: 828,anthracyclin,O
Sentence: 828,doxorubicin,B-Chemical
Sentence: 828,(,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,),O
Sentence: 828,continues,O
Sentence: 828,to,O
Sentence: 828,be,O
Sentence: 828,an,O
Sentence: 828,effective,O
Sentence: 828,and,O
Sentence: 828,widely,O
Sentence: 828,used,O
Sentence: 828,chemotherapeutic,O
Sentence: 828,agent,O
Sentence: 828,.,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,-,O
Sentence: 828,induced,O
Sentence: 828,cardiac,B-Disease
Sentence: 828,damage,I-Disease
Sentence: 828,presumably,O
Sentence: 828,results,O
Sentence: 828,from,O
Sentence: 828,the,O
Sentence: 828,formation,O
Sentence: 828,of,O
Sentence: 828,free,O
Sentence: 828,radicals,O
Sentence: 828,by,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,.,O
Sentence: 828,Reactive,O
Sentence: 828,oxygen,B-Chemical
Sentence: 828,species,O
Sentence: 828,particularly,O
Sentence: 828,affect,O
Sentence: 828,the,O
Sentence: 828,cardiac,O
Sentence: 828,myocytes,O
Sentence: 828,because,O
Sentence: 828,these,O
Sentence: 828,cells,O
Sentence: 828,seem,O
Sentence: 828,to,O
Sentence: 828,have,O
Sentence: 828,a,O
Sentence: 828,relatively,O
Sentence: 828,poor,O
Sentence: 828,antioxidant,O
Sentence: 828,defense,O
Sentence: 828,system,O
Sentence: 828,.,O
Sentence: 828,The,O
Sentence: 828,semisynthetic,O
Sentence: 828,flavonoid,B-Chemical
Sentence: 828,monohydroxyethylrutoside,B-Chemical
Sentence: 828,(,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,),O
Sentence: 828,showed,O
Sentence: 828,cardioprotection,O
Sentence: 828,against,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,-,O
Sentence: 828,induced,O
Sentence: 828,cardiotoxicity,B-Disease
Sentence: 828,through,O
Sentence: 828,its,O
Sentence: 828,radical,O
Sentence: 828,scavenging,O
Sentence: 828,and,O
Sentence: 828,iron,B-Chemical
Sentence: 828,chelating,O
Sentence: 828,properties,O
Sentence: 828,.,O
Sentence: 828,Because,O
Sentence: 828,of,O
Sentence: 828,the,O
Sentence: 828,relatively,O
Sentence: 828,short,O
Sentence: 828,final,O
Sentence: 828,half,O
Sentence: 828,-,O
Sentence: 828,life,O
Sentence: 828,of,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,(,O
Sentence: 828,about,O
Sentence: 828,30,O
Sentence: 828,min,O
Sentence: 828,),O
Sentence: 828,",",O
Sentence: 828,it,O
Sentence: 828,is,O
Sentence: 828,expected,O
Sentence: 828,that,O
Sentence: 828,the,O
Sentence: 828,time,O
Sentence: 828,interval,O
Sentence: 828,between,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,and,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,might,O
Sentence: 828,be,O
Sentence: 828,of,O
Sentence: 828,influence,O
Sentence: 828,on,O
Sentence: 828,the,O
Sentence: 828,cardioprotective,O
Sentence: 828,effect,O
Sentence: 828,of,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,.,O
Sentence: 828,Therefore,O
Sentence: 828,",",O
Sentence: 828,the,O
Sentence: 828,aim,O
Sentence: 828,of,O
Sentence: 828,the,O
Sentence: 828,present,O
Sentence: 828,study,O
Sentence: 828,was,O
Sentence: 828,to,O
Sentence: 828,investigate,O
Sentence: 828,this,O
Sentence: 828,possible,O
Sentence: 828,effect,O
Sentence: 828,.,O
Sentence: 828,METHODS,O
Sentence: 828,:,O
Sentence: 828,Six,O
Sentence: 828,groups,O
Sentence: 828,of,O
Sentence: 828,6,O
Sentence: 828,BALB,O
Sentence: 828,/,O
Sentence: 828,c,O
Sentence: 828,mice,O
Sentence: 828,were,O
Sentence: 828,treated,O
Sentence: 828,with,O
Sentence: 828,saline,O
Sentence: 828,",",O
Sentence: 828,DOX,B-Chemical
Sentence: 828,alone,O
Sentence: 828,or,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,(,O
Sentence: 828,4,O
Sentence: 828,mg,O
Sentence: 828,/,O
Sentence: 828,kg,O
Sentence: 828,i.v,O
Sentence: 828,.,O
Sentence: 828,),O
Sentence: 828,preceded,O
Sentence: 828,by,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,(,O
Sentence: 828,500,O
Sentence: 828,mg,O
Sentence: 828,/,O
Sentence: 828,kg,O
Sentence: 828,i.p,O
Sentence: 828,.,O
Sentence: 828,),O
Sentence: 828,with,O
Sentence: 828,an,O
Sentence: 828,interval,O
Sentence: 828,of,O
Sentence: 828,10,O
Sentence: 828,",",O
Sentence: 828,30,O
Sentence: 828,",",O
Sentence: 828,60,O
Sentence: 828,or,O
Sentence: 828,120,O
Sentence: 828,min,O
Sentence: 828,.,O
Sentence: 828,After,O
Sentence: 828,a,O
Sentence: 828,6,O
Sentence: 828,-,O
Sentence: 828,week,O
Sentence: 828,treatment,O
Sentence: 828,period,O
Sentence: 828,and,O
Sentence: 828,additional,O
Sentence: 828,observation,O
Sentence: 828,for,O
Sentence: 828,2,O
Sentence: 828,weeks,O
Sentence: 828,",",O
Sentence: 828,the,O
Sentence: 828,mice,O
Sentence: 828,were,O
Sentence: 828,sacrificed,O
Sentence: 828,.,O
Sentence: 828,Their,O
Sentence: 828,cardiac,O
Sentence: 828,tissues,O
Sentence: 828,were,O
Sentence: 828,processed,O
Sentence: 828,for,O
Sentence: 828,light,O
Sentence: 828,microscopy,O
Sentence: 828,",",O
Sentence: 828,after,O
Sentence: 828,which,O
Sentence: 828,cardiomyocyte,B-Disease
Sentence: 828,damage,I-Disease
Sentence: 828,was,O
Sentence: 828,evaluated,O
Sentence: 828,according,O
Sentence: 828,to,O
Sentence: 828,Billingham,O
Sentence: 828,(,O
Sentence: 828,in,O
Sentence: 828,Cancer,B-Disease
Sentence: 828,Treat,O
Sentence: 828,Rep,O
Sentence: 828,62,O
Sentence: 828,(,O
Sentence: 828,6,O
Sentence: 828,),O
Sentence: 828,:865,O
Sentence: 828,-,O
Sentence: 828,872,O
Sentence: 828,",",O
Sentence: 828,1978,O
Sentence: 828,),O
Sentence: 828,.,O
Sentence: 828,Microscopic,O
Sentence: 828,evaluation,O
Sentence: 828,revealed,O
Sentence: 828,that,O
Sentence: 828,treatment,O
Sentence: 828,with,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,alone,O
Sentence: 828,induced,O
Sentence: 828,significant,O
Sentence: 828,cardiac,B-Disease
Sentence: 828,damage,I-Disease
Sentence: 828,in,O
Sentence: 828,comparison,O
Sentence: 828,to,O
Sentence: 828,the,O
Sentence: 828,saline,O
Sentence: 828,control,O
Sentence: 828,group,O
Sentence: 828,(,O
Sentence: 828,p,O
Sentence: 828,,O
Sentence: 828,<,O
Sentence: 828,,O
Sentence: 828,0.001,O
Sentence: 828,),O
Sentence: 828,.,O
Sentence: 828,RESULTS,O
Sentence: 828,:,O
Sentence: 828,The,O
Sentence: 828,number,O
Sentence: 828,of,O
Sentence: 828,damaged,O
Sentence: 828,cardiomyocytes,O
Sentence: 828,was,O
Sentence: 828,9.6,O
Sentence: 828,-,O
Sentence: 828,fold,O
Sentence: 828,(,O
Sentence: 828,95,O
Sentence: 828,%,O
Sentence: 828,CI,O
Sentence: 828,4.4,O
Sentence: 828,-,O
Sentence: 828,21.0,O
Sentence: 828,),O
Sentence: 828,higher,O
Sentence: 828,in,O
Sentence: 828,mice,O
Sentence: 828,treated,O
Sentence: 828,with,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,alone,O
Sentence: 828,than,O
Sentence: 828,that,O
Sentence: 828,in,O
Sentence: 828,animals,O
Sentence: 828,of,O
Sentence: 828,the,O
Sentence: 828,control,O
Sentence: 828,group,O
Sentence: 828,.,O
Sentence: 828,The,O
Sentence: 828,ratio,O
Sentence: 828,of,O
Sentence: 828,aberrant,O
Sentence: 828,cardiomyocytes,O
Sentence: 828,in,O
Sentence: 828,mice,O
Sentence: 828,treated,O
Sentence: 828,with,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,preceded,O
Sentence: 828,by,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,and,O
Sentence: 828,those,O
Sentence: 828,in,O
Sentence: 828,mice,O
Sentence: 828,treated,O
Sentence: 828,with,O
Sentence: 828,saline,O
Sentence: 828,ranged,O
Sentence: 828,from,O
Sentence: 828,1.6,O
Sentence: 828,to,O
Sentence: 828,2.8,O
Sentence: 828,(,O
Sentence: 828,mean,O
Sentence: 828,2.2,O
Sentence: 828,",",O
Sentence: 828,95,O
Sentence: 828,%,O
Sentence: 828,CI,O
Sentence: 828,1.2,O
Sentence: 828,-,O
Sentence: 828,4.1,O
Sentence: 828,",",O
Sentence: 828,P,O
Sentence: 828,=,O
Sentence: 828,0.019,O
Sentence: 828,),O
Sentence: 828,.,O
Sentence: 828,The,O
Sentence: 828,mean,O
Sentence: 828,protective,O
Sentence: 828,effect,O
Sentence: 828,by,O
Sentence: 828,adding,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,before,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,led,O
Sentence: 828,to,O
Sentence: 828,a,O
Sentence: 828,significant,O
Sentence: 828,4.4,O
Sentence: 828,-,O
Sentence: 828,fold,O
Sentence: 828,reduction,O
Sentence: 828,(,O
Sentence: 828,p,O
Sentence: 828,,O
Sentence: 828,<,O
Sentence: 828,,O
Sentence: 828,0.001,O
Sentence: 828,",",O
Sentence: 828,95,O
Sentence: 828,%,O
Sentence: 828,CI,O
Sentence: 828,2.3,O
Sentence: 828,-,O
Sentence: 828,8.2,O
Sentence: 828,),O
Sentence: 828,of,O
Sentence: 828,abnormal,O
Sentence: 828,cardiomyocytes,O
Sentence: 828,.,O
Sentence: 828,This,O
Sentence: 828,protective,O
Sentence: 828,effect,O
Sentence: 828,did,O
Sentence: 828,not,O
Sentence: 828,depend,O
Sentence: 828,on,O
Sentence: 828,the,O
Sentence: 828,time,O
Sentence: 828,interval,O
Sentence: 828,between,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,and,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,administration,O
Sentence: 828,(,O
Sentence: 828,P,O
Sentence: 828,=,O
Sentence: 828,0.345,O
Sentence: 828,),O
Sentence: 828,.,O
Sentence: 828,CONCLUSION,O
Sentence: 828,:,O
Sentence: 828,The,O
Sentence: 828,results,O
Sentence: 828,indicate,O
Sentence: 828,that,O
Sentence: 828,in,O
Sentence: 828,an,O
Sentence: 828,outpatient,O
Sentence: 828,clinical,O
Sentence: 828,setting,O
Sentence: 828,monoHER,B-Chemical
Sentence: 828,may,O
Sentence: 828,be,O
Sentence: 828,administered,O
Sentence: 828,shortly,O
Sentence: 828,before,O
Sentence: 828,DOX,B-Chemical
Sentence: 828,.,O
Sentence: 829,Clinical,O
Sentence: 829,evaluation,O
Sentence: 829,of,O
Sentence: 829,adverse,O
Sentence: 829,effects,O
Sentence: 829,during,O
Sentence: 829,bepridil,B-Chemical
Sentence: 829,administration,O
Sentence: 829,for,O
Sentence: 829,atrial,B-Disease
Sentence: 829,fibrillation,I-Disease
Sentence: 829,and,I-Disease
Sentence: 829,flutter,I-Disease
Sentence: 829,.,O
Sentence: 830,BACKGROUND,O
Sentence: 830,:,O
Sentence: 830,Bepridil,B-Chemical
Sentence: 830,hydrochloride,I-Chemical
Sentence: 830,(,O
Sentence: 830,Bpd,B-Chemical
Sentence: 830,),O
Sentence: 830,has,O
Sentence: 830,attracted,O
Sentence: 830,attention,O
Sentence: 830,as,O
Sentence: 830,an,O
Sentence: 830,effective,O
Sentence: 830,drug,O
Sentence: 830,for,O
Sentence: 830,atrial,B-Disease
Sentence: 830,fibrillation,I-Disease
Sentence: 830,(,O
Sentence: 830,AF,B-Disease
Sentence: 830,),O
Sentence: 830,and,O
Sentence: 830,atrial,B-Disease
Sentence: 830,flutter,I-Disease
Sentence: 830,(,O
Sentence: 830,AFL,B-Disease
Sentence: 830,),O
Sentence: 830,.,O
Sentence: 830,However,O
Sentence: 830,",",O
Sentence: 830,serious,O
Sentence: 830,adverse,O
Sentence: 830,effects,O
Sentence: 830,",",O
Sentence: 830,including,O
Sentence: 830,torsade,B-Disease
Sentence: 830,de,I-Disease
Sentence: 830,pointes,I-Disease
Sentence: 830,(,O
Sentence: 830,Tdp,B-Disease
Sentence: 830,),O
Sentence: 830,",",O
Sentence: 830,have,O
Sentence: 830,been,O
Sentence: 830,reported,O
Sentence: 830,.,O
Sentence: 830,METHODS,O
Sentence: 830,AND,O
Sentence: 830,RESULTS,O
Sentence: 830,:,O
Sentence: 830,Adverse,O
Sentence: 830,effects,O
Sentence: 830,of,O
Sentence: 830,Bpd,B-Chemical
Sentence: 830,requiring,O
Sentence: 830,discontinuation,O
Sentence: 830,of,O
Sentence: 830,treatment,O
Sentence: 830,were,O
Sentence: 830,evaluated,O
Sentence: 830,.,O
Sentence: 830,Bpd,B-Chemical
Sentence: 830,was,O
Sentence: 830,administered,O
Sentence: 830,to,O
Sentence: 830,459,O
Sentence: 830,patients,O
Sentence: 830,(,O
Sentence: 830,361,O
Sentence: 830,males,O
Sentence: 830,",",O
Sentence: 830,63+,O
Sentence: 830,/,O
Sentence: 830,,O
Sentence: 830,-,O
Sentence: 830,12,O
Sentence: 830,years,O
Sentence: 830,old,O
Sentence: 830,),O
Sentence: 830,comprising,O
Sentence: 830,378,O
Sentence: 830,AF,B-Disease
Sentence: 830,and,O
Sentence: 830,81,O
Sentence: 830,AFL,B-Disease
Sentence: 830,cases,O
Sentence: 830,.,O
Sentence: 830,Mean,O
Sentence: 830,left,O
Sentence: 830,ventricular,O
Sentence: 830,ejection,O
Sentence: 830,fraction,O
Sentence: 830,and,O
Sentence: 830,atrial,O
Sentence: 830,dimension,O
Sentence: 830,(,O
Sentence: 830,LAD,O
Sentence: 830,),O
Sentence: 830,were,O
Sentence: 830,66+,O
Sentence: 830,/,O
Sentence: 830,,O
Sentence: 830,-,O
Sentence: 830,11,O
Sentence: 830,%,O
Sentence: 830,and,O
Sentence: 830,40+,O
Sentence: 830,/,O
Sentence: 830,,O
Sentence: 830,-,O
Sentence: 830,6,O
Sentence: 830,mm,O
Sentence: 830,",",O
Sentence: 830,respectively,O
Sentence: 830,.,O
Sentence: 830,Adverse,O
Sentence: 830,effects,O
Sentence: 830,were,O
Sentence: 830,observed,O
Sentence: 830,in,O
Sentence: 830,19,O
Sentence: 830,patients,O
Sentence: 830,(,O
Sentence: 830,4,O
Sentence: 830,%,O
Sentence: 830,),O
Sentence: 830,during,O
Sentence: 830,an,O
Sentence: 830,average,O
Sentence: 830,follow,O
Sentence: 830,-,O
Sentence: 830,up,O
Sentence: 830,of,O
Sentence: 830,20,O
Sentence: 830,months,O
Sentence: 830,.,O
Sentence: 830,There,O
Sentence: 830,was,O
Sentence: 830,marked,O
Sentence: 830,QT,B-Disease
Sentence: 830,prolongation,I-Disease
Sentence: 830,greater,O
Sentence: 830,than,O
Sentence: 830,0.55,O
Sentence: 830,s,O
Sentence: 830,in,O
Sentence: 830,13,O
Sentence: 830,patients,O
Sentence: 830,",",O
Sentence: 830,bradycardia,B-Disease
Sentence: 830,less,O
Sentence: 830,than,O
Sentence: 830,40,O
Sentence: 830,beats,O
Sentence: 830,/,O
Sentence: 830,min,O
Sentence: 830,in,O
Sentence: 830,6,O
Sentence: 830,patients,O
Sentence: 830,",",O
Sentence: 830,dizziness,B-Disease
Sentence: 830,and,O
Sentence: 830,general,O
Sentence: 830,fatigue,B-Disease
Sentence: 830,in,O
Sentence: 830,1,O
Sentence: 830,patient,O
Sentence: 830,each,O
Sentence: 830,.,O
Sentence: 830,In,O
Sentence: 830,4,O
Sentence: 830,of,O
Sentence: 830,13,O
Sentence: 830,patients,O
Sentence: 830,with,O
Sentence: 830,QT,B-Disease
Sentence: 830,prolongation,I-Disease
Sentence: 830,",",O
Sentence: 830,Tdp,B-Disease
Sentence: 830,occurred,O
Sentence: 830,.,O
Sentence: 830,The,O
Sentence: 830,major,O
Sentence: 830,triggering,O
Sentence: 830,factors,O
Sentence: 830,of,O
Sentence: 830,Tdp,B-Disease
Sentence: 830,were,O
Sentence: 830,hypokalemia,B-Disease
Sentence: 830,and,O
Sentence: 830,sudden,O
Sentence: 830,decrease,O
Sentence: 830,in,O
Sentence: 830,heart,O
Sentence: 830,rate,O
Sentence: 830,.,O
Sentence: 830,There,O
Sentence: 830,were,O
Sentence: 830,no,O
Sentence: 830,differences,O
Sentence: 830,in,O
Sentence: 830,the,O
Sentence: 830,clinical,O
Sentence: 830,backgrounds,O
Sentence: 830,of,O
Sentence: 830,the,O
Sentence: 830,patients,O
Sentence: 830,with,O
Sentence: 830,and,O
Sentence: 830,without,O
Sentence: 830,Tdp,B-Disease
Sentence: 830,other,O
Sentence: 830,than,O
Sentence: 830,LAD,O
Sentence: 830,and,O
Sentence: 830,age,O
Sentence: 830,",",O
Sentence: 830,which,O
Sentence: 830,were,O
Sentence: 830,larger,O
Sentence: 830,and,O
Sentence: 830,older,O
Sentence: 830,in,O
Sentence: 830,the,O
Sentence: 830,patients,O
Sentence: 830,with,O
Sentence: 830,Tdp,B-Disease
Sentence: 830,.,O
Sentence: 830,CONCLUSION,O
Sentence: 830,:,O
Sentence: 830,Careful,O
Sentence: 830,observation,O
Sentence: 830,of,O
Sentence: 830,serum,O
Sentence: 830,potassium,B-Chemical
Sentence: 830,concentration,O
Sentence: 830,and,O
Sentence: 830,the,O
Sentence: 830,ECG,O
Sentence: 830,should,O
Sentence: 830,always,O
Sentence: 830,be,O
Sentence: 830,done,O
Sentence: 830,during,O
Sentence: 830,Bpd,B-Chemical
Sentence: 830,administration,O
Sentence: 830,",",O
Sentence: 830,particularly,O
Sentence: 830,in,O
Sentence: 830,elderly,O
Sentence: 830,patients,O
Sentence: 830,.,O
Sentence: 831,Enhanced,O
Sentence: 831,isoproterenol,B-Chemical
Sentence: 831,-,O
Sentence: 831,induced,O
Sentence: 831,cardiac,B-Disease
Sentence: 831,hypertrophy,I-Disease
Sentence: 831,in,O
Sentence: 831,transgenic,O
Sentence: 831,rats,O
Sentence: 831,with,O
Sentence: 831,low,O
Sentence: 831,brain,O
Sentence: 831,angiotensinogen,O
Sentence: 831,.,O
Sentence: 832,We,O
Sentence: 832,have,O
Sentence: 832,previously,O
Sentence: 832,shown,O
Sentence: 832,that,O
Sentence: 832,a,O
Sentence: 832,permanent,O
Sentence: 832,deficiency,O
Sentence: 832,in,O
Sentence: 832,the,O
Sentence: 832,brain,O
Sentence: 832,renin,O
Sentence: 832,-,O
Sentence: 832,angiotensin,B-Chemical
Sentence: 832,system,O
Sentence: 832,(,O
Sentence: 832,RAS,O
Sentence: 832,),O
Sentence: 832,may,O
Sentence: 832,increase,O
Sentence: 832,the,O
Sentence: 832,sensitivity,O
Sentence: 832,of,O
Sentence: 832,the,O
Sentence: 832,baroreflex,O
Sentence: 832,control,O
Sentence: 832,of,O
Sentence: 832,heart,O
Sentence: 832,rate,O
Sentence: 832,.,O
Sentence: 832,In,O
Sentence: 832,this,O
Sentence: 832,study,O
Sentence: 832,we,O
Sentence: 832,aimed,O
Sentence: 832,at,O
Sentence: 832,studying,O
Sentence: 832,the,O
Sentence: 832,involvement,O
Sentence: 832,of,O
Sentence: 832,the,O
Sentence: 832,brain,O
Sentence: 832,RAS,O
Sentence: 832,in,O
Sentence: 832,the,O
Sentence: 832,cardiac,O
Sentence: 832,reactivity,O
Sentence: 832,to,O
Sentence: 832,the,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,adrenoceptor,O
Sentence: 832,(,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,AR,O
Sentence: 832,),O
Sentence: 832,agonist,O
Sentence: 832,isoproterenol,B-Chemical
Sentence: 832,(,O
Sentence: 832,Iso,B-Chemical
Sentence: 832,),O
Sentence: 832,.,O
Sentence: 832,Transgenic,O
Sentence: 832,rats,O
Sentence: 832,with,O
Sentence: 832,low,O
Sentence: 832,brain,O
Sentence: 832,angiotensinogen,O
Sentence: 832,(,O
Sentence: 832,TGR,O
Sentence: 832,),O
Sentence: 832,were,O
Sentence: 832,used,O
Sentence: 832,.,O
Sentence: 832,In,O
Sentence: 832,isolated,O
Sentence: 832,hearts,O
Sentence: 832,",",O
Sentence: 832,Iso,B-Chemical
Sentence: 832,induced,O
Sentence: 832,a,O
Sentence: 832,significantly,O
Sentence: 832,greater,O
Sentence: 832,increase,O
Sentence: 832,in,O
Sentence: 832,left,O
Sentence: 832,ventricular,O
Sentence: 832,(,O
Sentence: 832,LV,O
Sentence: 832,),O
Sentence: 832,pressure,O
Sentence: 832,and,O
Sentence: 832,maximal,O
Sentence: 832,contraction,O
Sentence: 832,(,O
Sentence: 832,+dP,O
Sentence: 832,/,O
Sentence: 832,dt,O
Sentence: 832,(,O
Sentence: 832,max,O
Sentence: 832,),O
Sentence: 832,),O
Sentence: 832,in,O
Sentence: 832,the,O
Sentence: 832,TGR,O
Sentence: 832,than,O
Sentence: 832,in,O
Sentence: 832,the,O
Sentence: 832,Sprague,O
Sentence: 832,-,O
Sentence: 832,Dawley,O
Sentence: 832,(,O
Sentence: 832,SD,O
Sentence: 832,),O
Sentence: 832,rats,O
Sentence: 832,.,O
Sentence: 832,LV,B-Disease
Sentence: 832,hypertrophy,B-Disease
Sentence: 832,induced,O
Sentence: 832,by,O
Sentence: 832,Iso,B-Chemical
Sentence: 832,treatment,O
Sentence: 832,was,O
Sentence: 832,significantly,O
Sentence: 832,higher,O
Sentence: 832,in,O
Sentence: 832,TGR,O
Sentence: 832,than,O
Sentence: 832,in,O
Sentence: 832,SD,O
Sentence: 832,rats,O
Sentence: 832,(,O
Sentence: 832,in,O
Sentence: 832,g,O
Sentence: 832,LV,O
Sentence: 832,wt,O
Sentence: 832,/,O
Sentence: 832,100,O
Sentence: 832,g,O
Sentence: 832,body,O
Sentence: 832,wt,O
Sentence: 832,",",O
Sentence: 832,0.28,O
Sentence: 832,+,O
Sentence: 832,/,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,,O
Sentence: 832,0.004,O
Sentence: 832,vs.,O
Sentence: 832,0.24,O
Sentence: 832,+,O
Sentence: 832,/,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,,O
Sentence: 832,0.004,O
Sentence: 832,",",O
Sentence: 832,respectively,O
Sentence: 832,),O
Sentence: 832,.,O
Sentence: 832,The,O
Sentence: 832,greater,O
Sentence: 832,LV,B-Disease
Sentence: 832,hypertrophy,B-Disease
Sentence: 832,in,O
Sentence: 832,TGR,O
Sentence: 832,rats,O
Sentence: 832,was,O
Sentence: 832,associated,O
Sentence: 832,with,O
Sentence: 832,more,O
Sentence: 832,pronounced,O
Sentence: 832,downregulation,O
Sentence: 832,of,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,AR,O
Sentence: 832,and,O
Sentence: 832,upregulation,O
Sentence: 832,of,O
Sentence: 832,LV,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,AR,O
Sentence: 832,kinase,O
Sentence: 832,-,O
Sentence: 832,1,O
Sentence: 832,mRNA,O
Sentence: 832,levels,O
Sentence: 832,compared,O
Sentence: 832,with,O
Sentence: 832,those,O
Sentence: 832,in,O
Sentence: 832,SD,O
Sentence: 832,rats,O
Sentence: 832,.,O
Sentence: 832,The,O
Sentence: 832,decrease,O
Sentence: 832,in,O
Sentence: 832,the,O
Sentence: 832,heart,O
Sentence: 832,rate,O
Sentence: 832,(,O
Sentence: 832,HR,O
Sentence: 832,),O
Sentence: 832,induced,O
Sentence: 832,by,O
Sentence: 832,the,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,AR,O
Sentence: 832,antagonist,O
Sentence: 832,metoprolol,B-Chemical
Sentence: 832,in,O
Sentence: 832,conscious,O
Sentence: 832,rats,O
Sentence: 832,was,O
Sentence: 832,significantly,O
Sentence: 832,attenuated,O
Sentence: 832,in,O
Sentence: 832,TGR,O
Sentence: 832,compared,O
Sentence: 832,with,O
Sentence: 832,SD,O
Sentence: 832,rats,O
Sentence: 832,(,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,9.9,O
Sentence: 832,+,O
Sentence: 832,/,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,,O
Sentence: 832,1.7,O
Sentence: 832,%,O
Sentence: 832,vs.,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,18.1,O
Sentence: 832,+,O
Sentence: 832,/,O
Sentence: 832,,O
Sentence: 832,-,O
Sentence: 832,,O
Sentence: 832,1.5,O
Sentence: 832,%,O
Sentence: 832,),O
Sentence: 832,",",O
Sentence: 832,whereas,O
Sentence: 832,the,O
Sentence: 832,effect,O
Sentence: 832,of,O
Sentence: 832,parasympathetic,O
Sentence: 832,blockade,O
Sentence: 832,by,O
Sentence: 832,atropine,B-Chemical
Sentence: 832,on,O
Sentence: 832,HR,O
Sentence: 832,was,O
Sentence: 832,similar,O
Sentence: 832,in,O
Sentence: 832,both,O
Sentence: 832,strains,O
Sentence: 832,.,O
Sentence: 832,These,O
Sentence: 832,results,O
Sentence: 832,indicate,O
Sentence: 832,that,O
Sentence: 832,TGR,O
Sentence: 832,are,O
Sentence: 832,more,O
Sentence: 832,sensitive,O
Sentence: 832,to,O
Sentence: 832,beta,O
Sentence: 832,-,O
Sentence: 832,AR,O
Sentence: 832,agonist,O
Sentence: 832,-,O
Sentence: 832,induced,O
Sentence: 832,cardiac,B-Disease
Sentence: 832,inotropic,I-Disease
Sentence: 832,response,O
Sentence: 832,and,O
Sentence: 832,hypertrophy,B-Disease
Sentence: 832,",",O
Sentence: 832,possibly,O
Sentence: 832,due,O
Sentence: 832,to,O
Sentence: 832,chronically,O
Sentence: 832,low,O
Sentence: 832,sympathetic,O
Sentence: 832,outflow,O
Sentence: 832,directed,O
Sentence: 832,to,O
Sentence: 832,the,O
Sentence: 832,heart,O
Sentence: 832,.,O
Sentence: 833,Drug,O
Sentence: 833,-,O
Sentence: 833,induced,O
Sentence: 833,long,B-Disease
Sentence: 833,QT,I-Disease
Sentence: 833,syndrome,I-Disease
Sentence: 833,in,O
Sentence: 833,injection,O
Sentence: 833,drug,O
Sentence: 833,users,O
Sentence: 833,receiving,O
Sentence: 833,methadone,B-Chemical
Sentence: 833,:,O
Sentence: 833,high,O
Sentence: 833,frequency,O
Sentence: 833,in,O
Sentence: 833,hospitalized,O
Sentence: 833,patients,O
Sentence: 833,and,O
Sentence: 833,risk,O
Sentence: 833,factors,O
Sentence: 833,.,O
Sentence: 834,BACKGROUND,O
Sentence: 834,:,O
Sentence: 834,Drug,O
Sentence: 834,-,O
Sentence: 834,induced,O
Sentence: 834,long,B-Disease
Sentence: 834,QT,I-Disease
Sentence: 834,syndrome,I-Disease
Sentence: 834,is,O
Sentence: 834,a,O
Sentence: 834,serious,O
Sentence: 834,adverse,O
Sentence: 834,drug,O
Sentence: 834,reaction,O
Sentence: 834,.,O
Sentence: 834,Methadone,B-Chemical
Sentence: 834,prolongs,O
Sentence: 834,the,O
Sentence: 834,QT,O
Sentence: 834,interval,O
Sentence: 834,in,O
Sentence: 834,vitro,O
Sentence: 834,in,O
Sentence: 834,a,O
Sentence: 834,dose,O
Sentence: 834,-,O
Sentence: 834,dependent,O
Sentence: 834,manner,O
Sentence: 834,.,O
Sentence: 834,In,O
Sentence: 834,the,O
Sentence: 834,inpatient,O
Sentence: 834,setting,O
Sentence: 834,",",O
Sentence: 834,the,O
Sentence: 834,frequency,O
Sentence: 834,of,O
Sentence: 834,QT,B-Disease
Sentence: 834,interval,I-Disease
Sentence: 834,prolongation,I-Disease
Sentence: 834,with,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,treatment,O
Sentence: 834,",",O
Sentence: 834,its,O
Sentence: 834,dose,O
Sentence: 834,dependence,O
Sentence: 834,",",O
Sentence: 834,and,O
Sentence: 834,the,O
Sentence: 834,importance,O
Sentence: 834,of,O
Sentence: 834,cofactors,O
Sentence: 834,such,O
Sentence: 834,as,O
Sentence: 834,drug,O
Sentence: 834,-,O
Sentence: 834,drug,O
Sentence: 834,interactions,O
Sentence: 834,remain,O
Sentence: 834,unknown,O
Sentence: 834,.,O
Sentence: 834,METHODS,O
Sentence: 834,:,O
Sentence: 834,We,O
Sentence: 834,performed,O
Sentence: 834,a,O
Sentence: 834,systematic,O
Sentence: 834,",",O
Sentence: 834,retrospective,O
Sentence: 834,study,O
Sentence: 834,comparing,O
Sentence: 834,active,O
Sentence: 834,or,O
Sentence: 834,former,O
Sentence: 834,intravenous,O
Sentence: 834,drug,O
Sentence: 834,users,O
Sentence: 834,receiving,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,and,O
Sentence: 834,those,O
Sentence: 834,not,O
Sentence: 834,receiving,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,among,O
Sentence: 834,all,O
Sentence: 834,patients,O
Sentence: 834,hospitalized,O
Sentence: 834,over,O
Sentence: 834,a,O
Sentence: 834,5,O
Sentence: 834,-,O
Sentence: 834,year,O
Sentence: 834,period,O
Sentence: 834,in,O
Sentence: 834,a,O
Sentence: 834,tertiary,O
Sentence: 834,care,O
Sentence: 834,hospital,O
Sentence: 834,.,O
Sentence: 834,A,O
Sentence: 834,total,O
Sentence: 834,of,O
Sentence: 834,167,O
Sentence: 834,patients,O
Sentence: 834,receiving,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,fulfilled,O
Sentence: 834,the,O
Sentence: 834,inclusion,O
Sentence: 834,criteria,O
Sentence: 834,and,O
Sentence: 834,were,O
Sentence: 834,compared,O
Sentence: 834,with,O
Sentence: 834,a,O
Sentence: 834,control,O
Sentence: 834,group,O
Sentence: 834,of,O
Sentence: 834,80,O
Sentence: 834,injection,O
Sentence: 834,drug,O
Sentence: 834,users,O
Sentence: 834,not,O
Sentence: 834,receiving,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,.,O
Sentence: 834,In,O
Sentence: 834,addition,O
Sentence: 834,to,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,dose,O
Sentence: 834,",",O
Sentence: 834,15,O
Sentence: 834,demographic,O
Sentence: 834,",",O
Sentence: 834,biological,O
Sentence: 834,",",O
Sentence: 834,and,O
Sentence: 834,pharmacological,O
Sentence: 834,variables,O
Sentence: 834,were,O
Sentence: 834,considered,O
Sentence: 834,as,O
Sentence: 834,potential,O
Sentence: 834,risk,O
Sentence: 834,factors,O
Sentence: 834,for,O
Sentence: 834,QT,B-Disease
Sentence: 834,prolongation,I-Disease
Sentence: 834,.,O
Sentence: 834,RESULTS,O
Sentence: 834,:,O
Sentence: 834,Among,O
Sentence: 834,167,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,maintenance,O
Sentence: 834,patients,O
Sentence: 834,",",O
Sentence: 834,the,O
Sentence: 834,prevalence,O
Sentence: 834,of,O
Sentence: 834,QTc,O
Sentence: 834,prolongation,O
Sentence: 834,to,O
Sentence: 834,0.50,O
Sentence: 834,second,O
Sentence: 834,(,O
Sentence: 834,(,O
Sentence: 834,1,O
Sentence: 834,/,O
Sentence: 834,2,O
Sentence: 834,),O
Sentence: 834,),O
Sentence: 834,or,O
Sentence: 834,longer,O
Sentence: 834,was,O
Sentence: 834,16.2,O
Sentence: 834,%,O
Sentence: 834,compared,O
Sentence: 834,with,O
Sentence: 834,0,O
Sentence: 834,%,O
Sentence: 834,in,O
Sentence: 834,80,O
Sentence: 834,control,O
Sentence: 834,subjects,O
Sentence: 834,.,O
Sentence: 834,Six,O
Sentence: 834,patients,O
Sentence: 834,(,O
Sentence: 834,3.6,O
Sentence: 834,%,O
Sentence: 834,),O
Sentence: 834,in,O
Sentence: 834,the,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,group,O
Sentence: 834,presented,O
Sentence: 834,torsades,B-Disease
Sentence: 834,de,I-Disease
Sentence: 834,pointes,I-Disease
Sentence: 834,.,O
Sentence: 834,QTc,O
Sentence: 834,length,O
Sentence: 834,was,O
Sentence: 834,weakly,O
Sentence: 834,but,O
Sentence: 834,significantly,O
Sentence: 834,associated,O
Sentence: 834,with,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,daily,O
Sentence: 834,dose,O
Sentence: 834,(,O
Sentence: 834,Spearman,O
Sentence: 834,rank,O
Sentence: 834,correlation,O
Sentence: 834,coefficient,O
Sentence: 834,",",O
Sentence: 834,0.20,O
Sentence: 834,;,O
Sentence: 834,p,O
Sentence: 834,,O
Sentence: 834,<,O
Sentence: 834,,O
Sentence: 834,.01,O
Sentence: 834,),O
Sentence: 834,.,O
Sentence: 834,Multivariate,O
Sentence: 834,regression,O
Sentence: 834,analysis,O
Sentence: 834,allowed,O
Sentence: 834,attribution,O
Sentence: 834,of,O
Sentence: 834,31.8,O
Sentence: 834,%,O
Sentence: 834,of,O
Sentence: 834,QTc,O
Sentence: 834,variability,O
Sentence: 834,to,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,dose,O
Sentence: 834,",",O
Sentence: 834,cytochrome,O
Sentence: 834,P,O
Sentence: 834,-,O
Sentence: 834,450,O
Sentence: 834,3A4,O
Sentence: 834,drug,O
Sentence: 834,-,O
Sentence: 834,drug,O
Sentence: 834,interactions,O
Sentence: 834,",",O
Sentence: 834,hypokalemia,B-Disease
Sentence: 834,",",O
Sentence: 834,and,O
Sentence: 834,altered,O
Sentence: 834,liver,O
Sentence: 834,function,O
Sentence: 834,.,O
Sentence: 834,CONCLUSIONS,O
Sentence: 834,:,O
Sentence: 834,QT,B-Disease
Sentence: 834,interval,I-Disease
Sentence: 834,prolongation,I-Disease
Sentence: 834,in,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,maintenance,O
Sentence: 834,patients,O
Sentence: 834,hospitalized,O
Sentence: 834,in,O
Sentence: 834,a,O
Sentence: 834,tertiary,O
Sentence: 834,care,O
Sentence: 834,center,O
Sentence: 834,is,O
Sentence: 834,a,O
Sentence: 834,frequent,O
Sentence: 834,finding,O
Sentence: 834,.,O
Sentence: 834,Methadone,B-Chemical
Sentence: 834,dose,O
Sentence: 834,",",O
Sentence: 834,presence,O
Sentence: 834,of,O
Sentence: 834,cytochrome,O
Sentence: 834,P,O
Sentence: 834,-,O
Sentence: 834,450,O
Sentence: 834,3A4,O
Sentence: 834,inhibitors,O
Sentence: 834,",",O
Sentence: 834,potassium,B-Chemical
Sentence: 834,level,O
Sentence: 834,",",O
Sentence: 834,and,O
Sentence: 834,liver,O
Sentence: 834,function,O
Sentence: 834,contribute,O
Sentence: 834,to,O
Sentence: 834,QT,B-Disease
Sentence: 834,prolongation,I-Disease
Sentence: 834,.,O
Sentence: 834,Long,B-Disease
Sentence: 834,QT,I-Disease
Sentence: 834,syndrome,I-Disease
Sentence: 834,can,O
Sentence: 834,occur,O
Sentence: 834,with,O
Sentence: 834,low,O
Sentence: 834,doses,O
Sentence: 834,of,O
Sentence: 834,methadone,B-Chemical
Sentence: 834,.,O
Sentence: 835,Mechanisms,O
Sentence: 835,of,O
Sentence: 835,hypertension,B-Disease
Sentence: 835,induced,O
Sentence: 835,by,O
Sentence: 835,nitric,B-Chemical
Sentence: 835,oxide,I-Chemical
Sentence: 835,(,O
Sentence: 835,NO,B-Chemical
Sentence: 835,),O
Sentence: 835,deficiency,O
Sentence: 835,:,O
Sentence: 835,focus,O
Sentence: 835,on,O
Sentence: 835,venous,O
Sentence: 835,function,O
Sentence: 835,.,O
Sentence: 836,Loss,O
Sentence: 836,of,O
Sentence: 836,endothelial,O
Sentence: 836,cell,O
Sentence: 836,-,O
Sentence: 836,derived,O
Sentence: 836,nitric,B-Chemical
Sentence: 836,oxide,I-Chemical
Sentence: 836,(,O
Sentence: 836,NO,B-Chemical
Sentence: 836,),O
Sentence: 836,in,O
Sentence: 836,hypertension,B-Disease
Sentence: 836,is,O
Sentence: 836,a,O
Sentence: 836,hallmark,O
Sentence: 836,of,O
Sentence: 836,arterial,B-Disease
Sentence: 836,dysfunction,I-Disease
Sentence: 836,.,O
Sentence: 836,Experimental,O
Sentence: 836,hypertension,B-Disease
Sentence: 836,created,O
Sentence: 836,by,O
Sentence: 836,the,O
Sentence: 836,removal,O
Sentence: 836,of,O
Sentence: 836,NO,B-Chemical
Sentence: 836,",",O
Sentence: 836,however,O
Sentence: 836,",",O
Sentence: 836,involves,O
Sentence: 836,mechanisms,O
Sentence: 836,in,O
Sentence: 836,addition,O
Sentence: 836,to,O
Sentence: 836,decreased,O
Sentence: 836,arterial,O
Sentence: 836,vasodilator,O
Sentence: 836,activity,O
Sentence: 836,.,O
Sentence: 836,These,O
Sentence: 836,include,O
Sentence: 836,augmented,O
Sentence: 836,endothelin,O
Sentence: 836,-,O
Sentence: 836,1,O
Sentence: 836,(,O
Sentence: 836,ET,O
Sentence: 836,-,O
Sentence: 836,1,O
Sentence: 836,),O
Sentence: 836,release,O
Sentence: 836,",",O
Sentence: 836,increased,O
Sentence: 836,sympathetic,O
Sentence: 836,nervous,O
Sentence: 836,system,O
Sentence: 836,activity,O
Sentence: 836,",",O
Sentence: 836,and,O
Sentence: 836,elevated,O
Sentence: 836,tissue,O
Sentence: 836,oxidative,O
Sentence: 836,stress,O
Sentence: 836,.,O
Sentence: 836,We,O
Sentence: 836,hypothesized,O
Sentence: 836,that,O
Sentence: 836,increased,O
Sentence: 836,venous,O
Sentence: 836,smooth,O
Sentence: 836,muscle,O
Sentence: 836,(,O
Sentence: 836,venomotor,O
Sentence: 836,),O
Sentence: 836,tone,O
Sentence: 836,plays,O
Sentence: 836,a,O
Sentence: 836,role,O
Sentence: 836,in,O
Sentence: 836,Nomega,O
Sentence: 836,-,O
Sentence: 836,nitro,O
Sentence: 836,-,O
Sentence: 836,L,O
Sentence: 836,-,O
Sentence: 836,arginine,O
Sentence: 836,(,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,),O
Sentence: 836,hypertension,B-Disease
Sentence: 836,through,O
Sentence: 836,these,O
Sentence: 836,mechanisms,O
Sentence: 836,.,O
Sentence: 836,Rats,O
Sentence: 836,were,O
Sentence: 836,treated,O
Sentence: 836,with,O
Sentence: 836,the,O
Sentence: 836,NO,B-Chemical
Sentence: 836,synthase,O
Sentence: 836,inhibitor,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,(,O
Sentence: 836,0.5,O
Sentence: 836,g,O
Sentence: 836,/,O
Sentence: 836,L,O
Sentence: 836,in,O
Sentence: 836,drinking,O
Sentence: 836,water,O
Sentence: 836,),O
Sentence: 836,for,O
Sentence: 836,2,O
Sentence: 836,weeks,O
Sentence: 836,.,O
Sentence: 836,Mean,O
Sentence: 836,arterial,O
Sentence: 836,pressure,O
Sentence: 836,of,O
Sentence: 836,conscious,O
Sentence: 836,rats,O
Sentence: 836,was,O
Sentence: 836,119,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,2,O
Sentence: 836,mm,O
Sentence: 836,Hg,O
Sentence: 836,in,O
Sentence: 836,control,O
Sentence: 836,and,O
Sentence: 836,194,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,5,O
Sentence: 836,mm,O
Sentence: 836,Hg,O
Sentence: 836,in,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,rats,O
Sentence: 836,(,O
Sentence: 836,p,O
Sentence: 836,,O
Sentence: 836,<,O
Sentence: 836,,O
Sentence: 836,0.05,O
Sentence: 836,),O
Sentence: 836,.,O
Sentence: 836,Carotid,O
Sentence: 836,arteries,O
Sentence: 836,and,O
Sentence: 836,vena,O
Sentence: 836,cava,O
Sentence: 836,were,O
Sentence: 836,removed,O
Sentence: 836,for,O
Sentence: 836,measurement,O
Sentence: 836,of,O
Sentence: 836,isometric,O
Sentence: 836,contraction,O
Sentence: 836,.,O
Sentence: 836,Maximal,O
Sentence: 836,contraction,O
Sentence: 836,to,O
Sentence: 836,norepinephrine,B-Chemical
Sentence: 836,was,O
Sentence: 836,modestly,O
Sentence: 836,reduced,O
Sentence: 836,in,O
Sentence: 836,arteries,O
Sentence: 836,from,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,compared,O
Sentence: 836,with,O
Sentence: 836,control,O
Sentence: 836,rats,O
Sentence: 836,whereas,O
Sentence: 836,the,O
Sentence: 836,maximum,O
Sentence: 836,contraction,O
Sentence: 836,to,O
Sentence: 836,ET,O
Sentence: 836,-,O
Sentence: 836,1,O
Sentence: 836,was,O
Sentence: 836,significantly,O
Sentence: 836,reduced,O
Sentence: 836,(,O
Sentence: 836,54,O
Sentence: 836,%,O
Sentence: 836,control,O
Sentence: 836,),O
Sentence: 836,.,O
Sentence: 836,Maximum,O
Sentence: 836,contraction,O
Sentence: 836,of,O
Sentence: 836,vena,O
Sentence: 836,cava,O
Sentence: 836,to,O
Sentence: 836,norepinephrine,B-Chemical
Sentence: 836,(,O
Sentence: 836,37,O
Sentence: 836,%,O
Sentence: 836,control,O
Sentence: 836,),O
Sentence: 836,also,O
Sentence: 836,was,O
Sentence: 836,reduced,O
Sentence: 836,but,O
Sentence: 836,no,O
Sentence: 836,change,O
Sentence: 836,in,O
Sentence: 836,response,O
Sentence: 836,to,O
Sentence: 836,ET,O
Sentence: 836,-,O
Sentence: 836,1,O
Sentence: 836,was,O
Sentence: 836,observed,O
Sentence: 836,.,O
Sentence: 836,Mean,O
Sentence: 836,circulatory,O
Sentence: 836,filling,O
Sentence: 836,pressure,O
Sentence: 836,",",O
Sentence: 836,an,O
Sentence: 836,in,O
Sentence: 836,vivo,O
Sentence: 836,measure,O
Sentence: 836,of,O
Sentence: 836,venomotor,O
Sentence: 836,tone,O
Sentence: 836,",",O
Sentence: 836,was,O
Sentence: 836,not,O
Sentence: 836,elevated,O
Sentence: 836,in,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,hypertension,B-Disease
Sentence: 836,at,O
Sentence: 836,1,O
Sentence: 836,or,O
Sentence: 836,2,O
Sentence: 836,weeks,O
Sentence: 836,after,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,.,O
Sentence: 836,The,O
Sentence: 836,superoxide,B-Chemical
Sentence: 836,scavenger,O
Sentence: 836,tempol,B-Chemical
Sentence: 836,(,O
Sentence: 836,30,O
Sentence: 836,",",O
Sentence: 836,100,O
Sentence: 836,",",O
Sentence: 836,and,O
Sentence: 836,300,O
Sentence: 836,micromol,O
Sentence: 836,kg,O
Sentence: 836,(,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,1,O
Sentence: 836,),O
Sentence: 836,",",O
Sentence: 836,IV,O
Sentence: 836,),O
Sentence: 836,did,O
Sentence: 836,not,O
Sentence: 836,change,O
Sentence: 836,arterial,O
Sentence: 836,pressure,O
Sentence: 836,in,O
Sentence: 836,control,O
Sentence: 836,rats,O
Sentence: 836,but,O
Sentence: 836,caused,O
Sentence: 836,a,O
Sentence: 836,dose,O
Sentence: 836,-,O
Sentence: 836,dependent,O
Sentence: 836,decrease,O
Sentence: 836,in,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,rats,O
Sentence: 836,(,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,18,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,8,O
Sentence: 836,",",O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,26,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,15,O
Sentence: 836,",",O
Sentence: 836,and,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,54,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,11,O
Sentence: 836,mm,O
Sentence: 836,Hg,O
Sentence: 836,),O
Sentence: 836,.,O
Sentence: 836,Similarly,O
Sentence: 836,",",O
Sentence: 836,ganglionic,O
Sentence: 836,blockade,O
Sentence: 836,with,O
Sentence: 836,hexamethonium,B-Chemical
Sentence: 836,caused,O
Sentence: 836,a,O
Sentence: 836,significantly,O
Sentence: 836,greater,O
Sentence: 836,fall,O
Sentence: 836,in,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,hypertensive,B-Disease
Sentence: 836,rats,O
Sentence: 836,(,O
Sentence: 836,76,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,9,O
Sentence: 836,mm,O
Sentence: 836,Hg,O
Sentence: 836,),O
Sentence: 836,compared,O
Sentence: 836,with,O
Sentence: 836,control,O
Sentence: 836,rats,O
Sentence: 836,(,O
Sentence: 836,35,O
Sentence: 836,+,O
Sentence: 836,/,O
Sentence: 836,,O
Sentence: 836,-,O
Sentence: 836,,O
Sentence: 836,10,O
Sentence: 836,mm,O
Sentence: 836,Hg,O
Sentence: 836,),O
Sentence: 836,.,O
Sentence: 836,Carotid,O
Sentence: 836,arteries,O
Sentence: 836,",",O
Sentence: 836,vena,O
Sentence: 836,cava,O
Sentence: 836,",",O
Sentence: 836,and,O
Sentence: 836,sympathetic,O
Sentence: 836,ganglia,O
Sentence: 836,from,O
Sentence: 836,LNNA,B-Chemical
Sentence: 836,rats,O
Sentence: 836,had,O
Sentence: 836,higher,O
Sentence: 836,basal,O
Sentence: 836,levels,O
Sentence: 836,of,O
Sentence: 836,superoxide,B-Chemical
Sentence: 836,compared,O
Sentence: 836,with,O
Sentence: 836,those,O
Sentence: 836,from,O
Sentence: 836,control,O
Sentence: 836,rats,O
Sentence: 836,.,O
Sentence: 836,These,O
Sentence: 836,data,O
Sentence: 836,suggest,O
Sentence: 836,that,O
Sentence: 836,while,O
Sentence: 836,NO,B-Chemical
Sentence: 836,deficiency,O
Sentence: 836,increases,O
Sentence: 836,oxidative,O
Sentence: 836,stress,O
Sentence: 836,and,O
Sentence: 836,sympathetic,O
Sentence: 836,activity,O
Sentence: 836,in,O
Sentence: 836,both,O
Sentence: 836,arterial,O
Sentence: 836,and,O
Sentence: 836,venous,O
Sentence: 836,vessels,O
Sentence: 836,",",O
Sentence: 836,the,O
Sentence: 836,impact,O
Sentence: 836,on,O
Sentence: 836,veins,O
Sentence: 836,does,O
Sentence: 836,not,O
Sentence: 836,make,O
Sentence: 836,a,O
Sentence: 836,major,O
Sentence: 836,contribution,O
Sentence: 836,to,O
Sentence: 836,this,O
Sentence: 836,form,O
Sentence: 836,of,O
Sentence: 836,hypertension,B-Disease
Sentence: 836,.,O
Sentence: 837,Association,O
Sentence: 837,of,O
Sentence: 837,DRD2,O
Sentence: 837,polymorphisms,O
Sentence: 837,and,O
Sentence: 837,chlorpromazine,B-Chemical
Sentence: 837,-,O
Sentence: 837,induced,O
Sentence: 837,extrapyramidal,B-Disease
Sentence: 837,syndrome,I-Disease
Sentence: 837,in,O
Sentence: 837,Chinese,O
Sentence: 837,schizophrenic,B-Disease
Sentence: 837,patients,O
Sentence: 837,.,O
Sentence: 838,AIM,O
Sentence: 838,:,O
Sentence: 838,Extrapyramidal,B-Disease
Sentence: 838,syndrome,I-Disease
Sentence: 838,(,O
Sentence: 838,EPS,B-Disease
Sentence: 838,),O
Sentence: 838,is,O
Sentence: 838,most,O
Sentence: 838,commonly,O
Sentence: 838,affected,O
Sentence: 838,by,O
Sentence: 838,typical,O
Sentence: 838,antipsychotic,O
Sentence: 838,drugs,O
Sentence: 838,that,O
Sentence: 838,have,O
Sentence: 838,a,O
Sentence: 838,high,O
Sentence: 838,affinity,O
Sentence: 838,with,O
Sentence: 838,the,O
Sentence: 838,D2,O
Sentence: 838,receptor,O
Sentence: 838,.,O
Sentence: 838,Recently,O
Sentence: 838,",",O
Sentence: 838,many,O
Sentence: 838,research,O
Sentence: 838,groups,O
Sentence: 838,have,O
Sentence: 838,reported,O
Sentence: 838,on,O
Sentence: 838,the,O
Sentence: 838,positive,O
Sentence: 838,relationship,O
Sentence: 838,between,O
Sentence: 838,the,O
Sentence: 838,genetic,O
Sentence: 838,variations,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,DRD2,O
Sentence: 838,gene,O
Sentence: 838,and,O
Sentence: 838,the,O
Sentence: 838,therapeutic,O
Sentence: 838,response,O
Sentence: 838,in,O
Sentence: 838,schizophrenia,B-Disease
Sentence: 838,patients,O
Sentence: 838,as,O
Sentence: 838,a,O
Sentence: 838,result,O
Sentence: 838,of,O
Sentence: 838,the,O
Sentence: 838,role,O
Sentence: 838,of,O
Sentence: 838,variations,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,receptor,O
Sentence: 838,in,O
Sentence: 838,modulating,O
Sentence: 838,receptor,O
Sentence: 838,expression,O
Sentence: 838,.,O
Sentence: 838,In,O
Sentence: 838,this,O
Sentence: 838,study,O
Sentence: 838,",",O
Sentence: 838,we,O
Sentence: 838,evaluate,O
Sentence: 838,the,O
Sentence: 838,role,O
Sentence: 838,DRD2,O
Sentence: 838,plays,O
Sentence: 838,in,O
Sentence: 838,chlorpromazine,B-Chemical
Sentence: 838,-,O
Sentence: 838,induced,O
Sentence: 838,EPS,B-Disease
Sentence: 838,in,O
Sentence: 838,schizophrenic,B-Disease
Sentence: 838,patients,O
Sentence: 838,.,O
Sentence: 838,METHODS,O
Sentence: 838,:,O
Sentence: 838,We,O
Sentence: 838,identified,O
Sentence: 838,seven,O
Sentence: 838,SNP,O
Sentence: 838,(,O
Sentence: 838,single,O
Sentence: 838,nucleotide,O
Sentence: 838,polymorphism,O
Sentence: 838,),O
Sentence: 838,(,O
Sentence: 838,,O
Sentence: 838,-,O
Sentence: 838,141Cins,O
Sentence: 838,,O
Sentence: 838,>,O
Sentence: 838,,O
Sentence: 838,del,O
Sentence: 838,",",O
Sentence: 838,TaqIB,O
Sentence: 838,",",O
Sentence: 838,TaqID,O
Sentence: 838,",",O
Sentence: 838,Ser311Cys,O
Sentence: 838,",",O
Sentence: 838,rs6275,O
Sentence: 838,",",O
Sentence: 838,rs6277,O
Sentence: 838,and,O
Sentence: 838,TaqIA,O
Sentence: 838,),O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,DRD2,O
Sentence: 838,gene,O
Sentence: 838,in,O
Sentence: 838,146,O
Sentence: 838,schizophrenic,B-Disease
Sentence: 838,inpatients,O
Sentence: 838,(,O
Sentence: 838,59,O
Sentence: 838,with,O
Sentence: 838,EPS,B-Disease
Sentence: 838,and,O
Sentence: 838,87,O
Sentence: 838,without,O
Sentence: 838,EPS,B-Disease
Sentence: 838,according,O
Sentence: 838,to,O
Sentence: 838,the,O
Sentence: 838,Simpson,O
Sentence: 838,-,O
Sentence: 838,Angus,O
Sentence: 838,Scale,O
Sentence: 838,),O
Sentence: 838,treated,O
Sentence: 838,with,O
Sentence: 838,chlorpromazine,B-Chemical
Sentence: 838,after,O
Sentence: 838,8,O
Sentence: 838,weeks,O
Sentence: 838,.,O
Sentence: 838,The,O
Sentence: 838,alleles,O
Sentence: 838,of,O
Sentence: 838,all,O
Sentence: 838,loci,O
Sentence: 838,were,O
Sentence: 838,determined,O
Sentence: 838,by,O
Sentence: 838,PCR,O
Sentence: 838,(,O
Sentence: 838,polymerase,O
Sentence: 838,chain,O
Sentence: 838,reaction,O
Sentence: 838,),O
Sentence: 838,.,O
Sentence: 838,RESULTS,O
Sentence: 838,:,O
Sentence: 838,Polymorphisms,O
Sentence: 838,TaqID,O
Sentence: 838,",",O
Sentence: 838,Ser311Cys,O
Sentence: 838,and,O
Sentence: 838,rs6277,O
Sentence: 838,were,O
Sentence: 838,not,O
Sentence: 838,polymorphic,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,population,O
Sentence: 838,recruited,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,present,O
Sentence: 838,study,O
Sentence: 838,.,O
Sentence: 838,No,O
Sentence: 838,statistical,O
Sentence: 838,significance,O
Sentence: 838,was,O
Sentence: 838,found,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,allele,O
Sentence: 838,distribution,O
Sentence: 838,of,O
Sentence: 838,,O
Sentence: 838,-,O
Sentence: 838,141Cins,O
Sentence: 838,,O
Sentence: 838,>,O
Sentence: 838,,O
Sentence: 838,del,O
Sentence: 838,",",O
Sentence: 838,TaqIB,O
Sentence: 838,",",O
Sentence: 838,rs6275,O
Sentence: 838,and,O
Sentence: 838,TaqIA,O
Sentence: 838,or,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,estimated,O
Sentence: 838,haplotypes,O
Sentence: 838,(,O
Sentence: 838,constituted,O
Sentence: 838,by,O
Sentence: 838,TaqIB,O
Sentence: 838,",",O
Sentence: 838,rs6275,O
Sentence: 838,and,O
Sentence: 838,TaqIA,O
Sentence: 838,),O
Sentence: 838,in,O
Sentence: 838,linkage,O
Sentence: 838,disequilibrium,O
Sentence: 838,between,O
Sentence: 838,the,O
Sentence: 838,two,O
Sentence: 838,groups,O
Sentence: 838,.,O
Sentence: 838,CONCLUSION,O
Sentence: 838,:,O
Sentence: 838,Our,O
Sentence: 838,results,O
Sentence: 838,did,O
Sentence: 838,not,O
Sentence: 838,lend,O
Sentence: 838,strong,O
Sentence: 838,support,O
Sentence: 838,to,O
Sentence: 838,the,O
Sentence: 838,view,O
Sentence: 838,that,O
Sentence: 838,the,O
Sentence: 838,genetic,O
Sentence: 838,variation,O
Sentence: 838,of,O
Sentence: 838,the,O
Sentence: 838,DRD2,O
Sentence: 838,gene,O
Sentence: 838,plays,O
Sentence: 838,a,O
Sentence: 838,major,O
Sentence: 838,role,O
Sentence: 838,in,O
Sentence: 838,the,O
Sentence: 838,individually,O
Sentence: 838,variable,O
Sentence: 838,adverse,O
Sentence: 838,effect,O
Sentence: 838,induced,O
Sentence: 838,by,O
Sentence: 838,chlorpromazine,B-Chemical
Sentence: 838,",",O
Sentence: 838,at,O
Sentence: 838,least,O
Sentence: 838,in,O
Sentence: 838,Chinese,O
Sentence: 838,patients,O
Sentence: 838,with,O
Sentence: 838,schizophrenia,B-Disease
Sentence: 838,.,O
Sentence: 838,Our,O
Sentence: 838,results,O
Sentence: 838,confirmed,O
Sentence: 838,a,O
Sentence: 838,previous,O
Sentence: 838,study,O
Sentence: 838,on,O
Sentence: 838,the,O
Sentence: 838,relationship,O
Sentence: 838,between,O
Sentence: 838,DRD2,O
Sentence: 838,and,O
Sentence: 838,EPS,B-Disease
Sentence: 838,in,O
Sentence: 838,Caucasians,O
Sentence: 838,.,O
Sentence: 839,Physical,O
Sentence: 839,training,O
Sentence: 839,decreases,O
Sentence: 839,susceptibility,O
Sentence: 839,to,O
Sentence: 839,subsequent,O
Sentence: 839,pilocarpine,B-Chemical
Sentence: 839,-,O
Sentence: 839,induced,O
Sentence: 839,seizures,B-Disease
Sentence: 839,in,O
Sentence: 839,the,O
Sentence: 839,rat,O
Sentence: 839,.,O
Sentence: 840,Regular,O
Sentence: 840,motor,O
Sentence: 840,activity,O
Sentence: 840,has,O
Sentence: 840,many,O
Sentence: 840,benefits,O
Sentence: 840,for,O
Sentence: 840,mental,O
Sentence: 840,and,O
Sentence: 840,physical,O
Sentence: 840,condition,O
Sentence: 840,but,O
Sentence: 840,its,O
Sentence: 840,implications,O
Sentence: 840,for,O
Sentence: 840,epilepsy,B-Disease
Sentence: 840,are,O
Sentence: 840,still,O
Sentence: 840,controversial,O
Sentence: 840,.,O
Sentence: 840,In,O
Sentence: 840,order,O
Sentence: 840,to,O
Sentence: 840,elucidate,O
Sentence: 840,this,O
Sentence: 840,problem,O
Sentence: 840,",",O
Sentence: 840,we,O
Sentence: 840,have,O
Sentence: 840,studied,O
Sentence: 840,the,O
Sentence: 840,effect,O
Sentence: 840,of,O
Sentence: 840,long,O
Sentence: 840,-,O
Sentence: 840,term,O
Sentence: 840,physical,O
Sentence: 840,activity,O
Sentence: 840,on,O
Sentence: 840,susceptibility,O
Sentence: 840,to,O
Sentence: 840,subsequent,O
Sentence: 840,seizures,B-Disease
Sentence: 840,.,O
Sentence: 840,Male,O
Sentence: 840,Wistar,O
Sentence: 840,rats,O
Sentence: 840,were,O
Sentence: 840,subjected,O
Sentence: 840,to,O
Sentence: 840,repeated,O
Sentence: 840,training,O
Sentence: 840,sessions,O
Sentence: 840,in,O
Sentence: 840,a,O
Sentence: 840,treadmill,O
Sentence: 840,and,O
Sentence: 840,swimming,O
Sentence: 840,pool,O
Sentence: 840,.,O
Sentence: 840,Thereafter,O
Sentence: 840,",",O
Sentence: 840,seizures,B-Disease
Sentence: 840,were,O
Sentence: 840,induced,O
Sentence: 840,by,O
Sentence: 840,pilocarpine,B-Chemical
Sentence: 840,injections,O
Sentence: 840,in,O
Sentence: 840,trained,O
Sentence: 840,and,O
Sentence: 840,non,O
Sentence: 840,-,O
Sentence: 840,trained,O
Sentence: 840,control,O
Sentence: 840,groups,O
Sentence: 840,.,O
Sentence: 840,During,O
Sentence: 840,the,O
Sentence: 840,acute,O
Sentence: 840,period,O
Sentence: 840,of,O
Sentence: 840,status,B-Disease
Sentence: 840,epilepticus,I-Disease
Sentence: 840,",",O
Sentence: 840,we,O
Sentence: 840,measured,O
Sentence: 840,:,O
Sentence: 840,(,O
Sentence: 840,1,O
Sentence: 840,),O
Sentence: 840,the,O
Sentence: 840,latency,O
Sentence: 840,of,O
Sentence: 840,the,O
Sentence: 840,first,O
Sentence: 840,motor,O
Sentence: 840,sign,O
Sentence: 840,",",O
Sentence: 840,(,O
Sentence: 840,2,O
Sentence: 840,),O
Sentence: 840,the,O
Sentence: 840,intensity,O
Sentence: 840,of,O
Sentence: 840,seizures,B-Disease
Sentence: 840,",",O
Sentence: 840,(,O
Sentence: 840,3,O
Sentence: 840,),O
Sentence: 840,the,O
Sentence: 840,time,O
Sentence: 840,when,O
Sentence: 840,it,O
Sentence: 840,occurred,O
Sentence: 840,within,O
Sentence: 840,the,O
Sentence: 840,6,O
Sentence: 840,-,O
Sentence: 840,h,O
Sentence: 840,observation,O
Sentence: 840,period,O
Sentence: 840,",",O
Sentence: 840,and,O
Sentence: 840,(,O
Sentence: 840,4,O
Sentence: 840,),O
Sentence: 840,the,O
Sentence: 840,time,O
Sentence: 840,when,O
Sentence: 840,the,O
Sentence: 840,acute,O
Sentence: 840,period,O
Sentence: 840,ended,O
Sentence: 840,.,O
Sentence: 840,All,O
Sentence: 840,these,O
Sentence: 840,behavioral,O
Sentence: 840,parameters,O
Sentence: 840,showed,O
Sentence: 840,statistically,O
Sentence: 840,significant,O
Sentence: 840,changes,O
Sentence: 840,suggesting,O
Sentence: 840,that,O
Sentence: 840,regular,O
Sentence: 840,physical,O
Sentence: 840,exercises,O
Sentence: 840,decrease,O
Sentence: 840,susceptibility,O
Sentence: 840,to,O
Sentence: 840,subsequently,O
Sentence: 840,induced,O
Sentence: 840,seizures,B-Disease
Sentence: 840,and,O
Sentence: 840,ameliorate,O
Sentence: 840,the,O
Sentence: 840,course,O
Sentence: 840,of,O
Sentence: 840,experimentally,O
Sentence: 840,induced,O
Sentence: 840,status,B-Disease
Sentence: 840,epilepticus,I-Disease
Sentence: 840,.,O
Sentence: 841,Tonic,O
Sentence: 841,dopaminergic,O
Sentence: 841,stimulation,O
Sentence: 841,impairs,O
Sentence: 841,associative,O
Sentence: 841,learning,O
Sentence: 841,in,O
Sentence: 841,healthy,O
Sentence: 841,subjects,O
Sentence: 841,.,O
Sentence: 842,Endogenous,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,plays,O
Sentence: 842,a,O
Sentence: 842,central,O
Sentence: 842,role,O
Sentence: 842,in,O
Sentence: 842,salience,O
Sentence: 842,coding,O
Sentence: 842,during,O
Sentence: 842,associative,O
Sentence: 842,learning,O
Sentence: 842,.,O
Sentence: 842,Administration,O
Sentence: 842,of,O
Sentence: 842,the,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,precursor,O
Sentence: 842,levodopa,B-Chemical
Sentence: 842,enhances,O
Sentence: 842,learning,O
Sentence: 842,in,O
Sentence: 842,healthy,O
Sentence: 842,subjects,O
Sentence: 842,and,O
Sentence: 842,stroke,B-Disease
Sentence: 842,patients,O
Sentence: 842,.,O
Sentence: 842,Because,O
Sentence: 842,levodopa,B-Chemical
Sentence: 842,increases,O
Sentence: 842,both,O
Sentence: 842,phasic,O
Sentence: 842,and,O
Sentence: 842,tonic,O
Sentence: 842,dopaminergic,O
Sentence: 842,neurotransmission,O
Sentence: 842,",",O
Sentence: 842,the,O
Sentence: 842,critical,O
Sentence: 842,mechanism,O
Sentence: 842,mediating,O
Sentence: 842,the,O
Sentence: 842,enhancement,O
Sentence: 842,of,O
Sentence: 842,learning,O
Sentence: 842,is,O
Sentence: 842,unresolved,O
Sentence: 842,.,O
Sentence: 842,We,O
Sentence: 842,here,O
Sentence: 842,probed,O
Sentence: 842,how,O
Sentence: 842,selective,O
Sentence: 842,tonic,O
Sentence: 842,dopaminergic,O
Sentence: 842,stimulation,O
Sentence: 842,affects,O
Sentence: 842,associative,O
Sentence: 842,learning,O
Sentence: 842,.,O
Sentence: 842,Forty,O
Sentence: 842,healthy,O
Sentence: 842,subjects,O
Sentence: 842,were,O
Sentence: 842,trained,O
Sentence: 842,in,O
Sentence: 842,a,O
Sentence: 842,novel,O
Sentence: 842,vocabulary,O
Sentence: 842,of,O
Sentence: 842,45,O
Sentence: 842,concrete,O
Sentence: 842,nouns,O
Sentence: 842,over,O
Sentence: 842,the,O
Sentence: 842,course,O
Sentence: 842,of,O
Sentence: 842,5,O
Sentence: 842,consecutive,O
Sentence: 842,training,O
Sentence: 842,days,O
Sentence: 842,in,O
Sentence: 842,a,O
Sentence: 842,prospective,O
Sentence: 842,",",O
Sentence: 842,randomized,O
Sentence: 842,",",O
Sentence: 842,double,O
Sentence: 842,-,O
Sentence: 842,blind,O
Sentence: 842,",",O
Sentence: 842,placebo,O
Sentence: 842,-,O
Sentence: 842,controlled,O
Sentence: 842,design,O
Sentence: 842,.,O
Sentence: 842,Subjects,O
Sentence: 842,received,O
Sentence: 842,the,O
Sentence: 842,tonically,O
Sentence: 842,stimulating,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,-,O
Sentence: 842,receptor,O
Sentence: 842,agonist,O
Sentence: 842,pergolide,B-Chemical
Sentence: 842,(,O
Sentence: 842,0.1,O
Sentence: 842,mg,O
Sentence: 842,),O
Sentence: 842,vs,O
Sentence: 842,placebo,O
Sentence: 842,120,O
Sentence: 842,min,O
Sentence: 842,before,O
Sentence: 842,training,O
Sentence: 842,on,O
Sentence: 842,each,O
Sentence: 842,training,O
Sentence: 842,day,O
Sentence: 842,.,O
Sentence: 842,The,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,agonist,O
Sentence: 842,significantly,O
Sentence: 842,impaired,B-Disease
Sentence: 842,novel,I-Disease
Sentence: 842,word,I-Disease
Sentence: 842,learning,I-Disease
Sentence: 842,compared,O
Sentence: 842,to,O
Sentence: 842,placebo,O
Sentence: 842,.,O
Sentence: 842,This,O
Sentence: 842,learning,O
Sentence: 842,decrement,O
Sentence: 842,persisted,O
Sentence: 842,up,O
Sentence: 842,to,O
Sentence: 842,the,O
Sentence: 842,last,O
Sentence: 842,follow,O
Sentence: 842,-,O
Sentence: 842,up,O
Sentence: 842,4,O
Sentence: 842,weeks,O
Sentence: 842,post,O
Sentence: 842,-,O
Sentence: 842,training,O
Sentence: 842,.,O
Sentence: 842,Subjects,O
Sentence: 842,treated,O
Sentence: 842,with,O
Sentence: 842,pergolide,B-Chemical
Sentence: 842,also,O
Sentence: 842,showed,O
Sentence: 842,restricted,O
Sentence: 842,emotional,O
Sentence: 842,responses,O
Sentence: 842,compared,O
Sentence: 842,to,O
Sentence: 842,the,O
Sentence: 842,PLACEBO,O
Sentence: 842,group,O
Sentence: 842,.,O
Sentence: 842,The,O
Sentence: 842,extent,O
Sentence: 842,of,O
Sentence: 842,'flattened,O
Sentence: 842,',O
Sentence: 842,affect,O
Sentence: 842,with,O
Sentence: 842,pergolide,B-Chemical
Sentence: 842,was,O
Sentence: 842,related,O
Sentence: 842,to,O
Sentence: 842,the,O
Sentence: 842,degree,O
Sentence: 842,of,O
Sentence: 842,learning,O
Sentence: 842,inhibition,O
Sentence: 842,.,O
Sentence: 842,These,O
Sentence: 842,findings,O
Sentence: 842,suggest,O
Sentence: 842,that,O
Sentence: 842,tonic,O
Sentence: 842,occupation,O
Sentence: 842,of,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,receptors,O
Sentence: 842,impairs,O
Sentence: 842,learning,O
Sentence: 842,by,O
Sentence: 842,competition,O
Sentence: 842,with,O
Sentence: 842,phasic,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,signals,O
Sentence: 842,.,O
Sentence: 842,Thus,O
Sentence: 842,",",O
Sentence: 842,phasic,O
Sentence: 842,signaling,O
Sentence: 842,seems,O
Sentence: 842,to,O
Sentence: 842,be,O
Sentence: 842,the,O
Sentence: 842,critical,O
Sentence: 842,mechanism,O
Sentence: 842,by,O
Sentence: 842,which,O
Sentence: 842,dopamine,B-Chemical
Sentence: 842,enhances,O
Sentence: 842,associative,O
Sentence: 842,learning,O
Sentence: 842,in,O
Sentence: 842,healthy,O
Sentence: 842,subjects,O
Sentence: 842,and,O
Sentence: 842,stroke,B-Disease
Sentence: 842,patients,O
Sentence: 842,.,O
Sentence: 843,Minocycline,B-Chemical
Sentence: 843,-,O
Sentence: 843,induced,O
Sentence: 843,vasculitis,B-Disease
Sentence: 843,fulfilling,O
Sentence: 843,the,O
Sentence: 843,criteria,O
Sentence: 843,of,O
Sentence: 843,polyarteritis,B-Disease
Sentence: 843,nodosa,I-Disease
Sentence: 843,.,O
Sentence: 844,A,O
Sentence: 844,47,O
Sentence: 844,-,O
Sentence: 844,year,O
Sentence: 844,-,O
Sentence: 844,old,O
Sentence: 844,man,O
Sentence: 844,who,O
Sentence: 844,had,O
Sentence: 844,been,O
Sentence: 844,taking,O
Sentence: 844,minocycline,B-Chemical
Sentence: 844,for,O
Sentence: 844,palmoplantar,B-Disease
Sentence: 844,pustulosis,I-Disease
Sentence: 844,developed,O
Sentence: 844,fever,B-Disease
Sentence: 844,",",O
Sentence: 844,myalgias,B-Disease
Sentence: 844,",",O
Sentence: 844,polyneuropathy,B-Disease
Sentence: 844,",",O
Sentence: 844,and,O
Sentence: 844,testicular,B-Disease
Sentence: 844,pain,I-Disease
Sentence: 844,",",O
Sentence: 844,with,O
Sentence: 844,elevated,O
Sentence: 844,C,O
Sentence: 844,-,O
Sentence: 844,reactive,O
Sentence: 844,protein,O
Sentence: 844,(,O
Sentence: 844,CRP,O
Sentence: 844,),O
Sentence: 844,.,O
Sentence: 844,Neither,O
Sentence: 844,myeloperoxidase,O
Sentence: 844,-,O
Sentence: 844,,O
Sentence: 844,nor,O
Sentence: 844,proteinase,O
Sentence: 844,-,O
Sentence: 844,3,O
Sentence: 844,-,O
Sentence: 844,antineutrophil,O
Sentence: 844,cytoplasmic,O
Sentence: 844,antibody,O
Sentence: 844,was,O
Sentence: 844,positive,O
Sentence: 844,.,O
Sentence: 844,These,O
Sentence: 844,manifestations,O
Sentence: 844,met,O
Sentence: 844,the,O
Sentence: 844,American,O
Sentence: 844,College,O
Sentence: 844,of,O
Sentence: 844,Rheumatology,O
Sentence: 844,1990,O
Sentence: 844,criteria,O
Sentence: 844,for,O
Sentence: 844,the,O
Sentence: 844,classification,O
Sentence: 844,of,O
Sentence: 844,polyarteritis,B-Disease
Sentence: 844,nodosa,I-Disease
Sentence: 844,.,O
Sentence: 844,Stopping,O
Sentence: 844,minocycline,B-Chemical
Sentence: 844,led,O
Sentence: 844,to,O
Sentence: 844,amelioration,O
Sentence: 844,of,O
Sentence: 844,symptoms,O
Sentence: 844,and,O
Sentence: 844,normalization,O
Sentence: 844,of,O
Sentence: 844,CRP,O
Sentence: 844,level,O
Sentence: 844,.,O
Sentence: 844,To,O
Sentence: 844,our,O
Sentence: 844,knowledge,O
Sentence: 844,",",O
Sentence: 844,this,O
Sentence: 844,is,O
Sentence: 844,the,O
Sentence: 844,second,O
Sentence: 844,case,O
Sentence: 844,of,O
Sentence: 844,minocycline,B-Chemical
Sentence: 844,-,O
Sentence: 844,induced,O
Sentence: 844,vasculitis,B-Disease
Sentence: 844,satisfying,O
Sentence: 844,the,O
Sentence: 844,criteria,O
Sentence: 844,.,O
Sentence: 844,Differential,O
Sentence: 844,diagnosis,O
Sentence: 844,for,O
Sentence: 844,drug,O
Sentence: 844,-,O
Sentence: 844,induced,O
Sentence: 844,disease,O
Sentence: 844,is,O
Sentence: 844,invaluable,O
Sentence: 844,even,O
Sentence: 844,for,O
Sentence: 844,patients,O
Sentence: 844,with,O
Sentence: 844,classical,O
Sentence: 844,polyarteritis,B-Disease
Sentence: 844,nodosa,I-Disease
Sentence: 844,.,O
Sentence: 845,Intramuscular,O
Sentence: 845,hepatitis,B-Disease
Sentence: 845,B,I-Disease
Sentence: 845,immune,O
Sentence: 845,globulin,O
Sentence: 845,combined,O
Sentence: 845,with,O
Sentence: 845,lamivudine,B-Chemical
Sentence: 845,in,O
Sentence: 845,prevention,O
Sentence: 845,of,O
Sentence: 845,hepatitis,B-Disease
Sentence: 845,B,I-Disease
Sentence: 845,recurrence,O
Sentence: 845,after,O
Sentence: 845,liver,O
Sentence: 845,transplantation,O
Sentence: 845,.,O
Sentence: 846,BACKGROUND,O
Sentence: 846,:,O
Sentence: 846,Combined,O
Sentence: 846,hepatitis,B-Disease
Sentence: 846,B,I-Disease
Sentence: 846,immune,O
Sentence: 846,globulin,O
Sentence: 846,(,O
Sentence: 846,HBIg,O
Sentence: 846,),O
Sentence: 846,and,O
Sentence: 846,lamivudine,B-Chemical
Sentence: 846,in,O
Sentence: 846,prophylaxis,O
Sentence: 846,of,O
Sentence: 846,the,O
Sentence: 846,recurrence,O
Sentence: 846,of,O
Sentence: 846,hepatitis,B-Disease
Sentence: 846,B,I-Disease
Sentence: 846,after,O
Sentence: 846,liver,O
Sentence: 846,transplantation,O
Sentence: 846,has,O
Sentence: 846,significantly,O
Sentence: 846,improved,O
Sentence: 846,the,O
Sentence: 846,survival,O
Sentence: 846,of,O
Sentence: 846,HBsAg,B-Chemical
Sentence: 846,positive,O
Sentence: 846,patients,O
Sentence: 846,.,O
Sentence: 846,This,O
Sentence: 846,study,O
Sentence: 846,was,O
Sentence: 846,undertaken,O
Sentence: 846,to,O
Sentence: 846,evaluate,O
Sentence: 846,the,O
Sentence: 846,outcomes,O
Sentence: 846,of,O
Sentence: 846,liver,O
Sentence: 846,transplantation,O
Sentence: 846,for,O
Sentence: 846,patients,O
Sentence: 846,with,O
Sentence: 846,hepatitis,B-Disease
Sentence: 846,B,I-Disease
Sentence: 846,virus,O
Sentence: 846,(,O
Sentence: 846,HBV,O
Sentence: 846,),O
Sentence: 846,.,O
Sentence: 846,METHODS,O
Sentence: 846,:,O
Sentence: 846,A,O
Sentence: 846,retrospective,O
Sentence: 846,chart,O
Sentence: 846,analysis,O
Sentence: 846,and,O
Sentence: 846,a,O
Sentence: 846,review,O
Sentence: 846,of,O
Sentence: 846,the,O
Sentence: 846,organ,O
Sentence: 846,transplant,O
Sentence: 846,database,O
Sentence: 846,identified,O
Sentence: 846,51,O
Sentence: 846,patients,O
Sentence: 846,(,O
Sentence: 846,43,O
Sentence: 846,men,O
Sentence: 846,and,O
Sentence: 846,8,O
Sentence: 846,women,O
Sentence: 846,),O
Sentence: 846,transplanted,O
Sentence: 846,for,O
Sentence: 846,benign,O
Sentence: 846,HBV,O
Sentence: 846,-,O
Sentence: 846,related,O
Sentence: 846,cirrhotic,B-Disease
Sentence: 846,diseases,I-Disease
Sentence: 846,between,O
Sentence: 846,June,O
Sentence: 846,2002,O
Sentence: 846,and,O
Sentence: 846,December,O
Sentence: 846,2004,O
Sentence: 846,who,O
Sentence: 846,had,O
Sentence: 846,survived,O
Sentence: 846,more,O
Sentence: 846,than,O
Sentence: 846,3,O
Sentence: 846,months,O
Sentence: 846,.,O
Sentence: 846,HBIg,O
Sentence: 846,was,O
Sentence: 846,administered,O
Sentence: 846,intravenously,O
Sentence: 846,during,O
Sentence: 846,the,O
Sentence: 846,first,O
Sentence: 846,week,O
Sentence: 846,and,O
Sentence: 846,intramuscularly,O
Sentence: 846,thereafter,O
Sentence: 846,.,O
Sentence: 846,RESULTS,O
Sentence: 846,:,O
Sentence: 846,At,O
Sentence: 846,a,O
Sentence: 846,median,O
Sentence: 846,follow,O
Sentence: 846,-,O
Sentence: 846,up,O
Sentence: 846,of,O
Sentence: 846,14.1,O
Sentence: 846,months,O
Sentence: 846,",",O
Sentence: 846,the,O
Sentence: 846,overall,O
Sentence: 846,recurrence,O
Sentence: 846,rate,O
Sentence: 846,in,O
Sentence: 846,the,O
Sentence: 846,51,O
Sentence: 846,patients,O
Sentence: 846,was,O
Sentence: 846,3.9,O
Sentence: 846,%,O
Sentence: 846,(,O
Sentence: 846,2,O
Sentence: 846,/,O
Sentence: 846,51,O
Sentence: 846,),O
Sentence: 846,.,O
Sentence: 846,The,O
Sentence: 846,overall,O
Sentence: 846,patient,O
Sentence: 846,survival,O
Sentence: 846,was,O
Sentence: 846,88.3,O
Sentence: 846,%,O
Sentence: 846,",",O
Sentence: 846,and,O
Sentence: 846,82.4,O
Sentence: 846,%,O
Sentence: 846,after,O
Sentence: 846,1,O
Sentence: 846,and,O
Sentence: 846,2,O
Sentence: 846,years,O
Sentence: 846,",",O
Sentence: 846,respectively,O
Sentence: 846,.,O
Sentence: 846,A,O
Sentence: 846,daily,O
Sentence: 846,oral,O
Sentence: 846,dose,O
Sentence: 846,of,O
Sentence: 846,100,O
Sentence: 846,mg,O
Sentence: 846,lamivudine,B-Chemical
Sentence: 846,for,O
Sentence: 846,2,O
Sentence: 846,weeks,O
Sentence: 846,before,O
Sentence: 846,transplantation,O
Sentence: 846,for,O
Sentence: 846,10,O
Sentence: 846,patients,O
Sentence: 846,enabled,O
Sentence: 846,57.1,O
Sentence: 846,%,O
Sentence: 846,(,O
Sentence: 846,4,O
Sentence: 846,/,O
Sentence: 846,7,O
Sentence: 846,),O
Sentence: 846,and,O
Sentence: 846,62.5,O
Sentence: 846,%,O
Sentence: 846,(,O
Sentence: 846,5,O
Sentence: 846,/,O
Sentence: 846,8,O
Sentence: 846,),O
Sentence: 846,of,O
Sentence: 846,HBV,O
Sentence: 846,-,O
Sentence: 846,DNA,O
Sentence: 846,and,O
Sentence: 846,HBeAg,B-Chemical
Sentence: 846,positive,O
Sentence: 846,patients,O
Sentence: 846,respectively,O
Sentence: 846,to,O
Sentence: 846,convert,O
Sentence: 846,to,O
Sentence: 846,be,O
Sentence: 846,negative,O
Sentence: 846,.,O
Sentence: 846,Intramuscular,O
Sentence: 846,HBIg,O
Sentence: 846,was,O
Sentence: 846,well,O
Sentence: 846,tolerated,O
Sentence: 846,in,O
Sentence: 846,all,O
Sentence: 846,patients,O
Sentence: 846,.,O
Sentence: 846,CONCLUSION,O
Sentence: 846,:,O
Sentence: 846,Lamivudine,B-Chemical
Sentence: 846,combined,O
Sentence: 846,with,O
Sentence: 846,intramuscular,O
Sentence: 846,HBIg,O
Sentence: 846,can,O
Sentence: 846,effectively,O
Sentence: 846,prevent,O
Sentence: 846,allograft,O
Sentence: 846,from,O
Sentence: 846,the,O
Sentence: 846,recurrence,O
Sentence: 846,of,O
Sentence: 846,HBV,O
Sentence: 846,after,O
Sentence: 846,liver,O
Sentence: 846,transplantation,O
Sentence: 846,.,O
Sentence: 847,Anticonvulsant,O
Sentence: 847,effect,O
Sentence: 847,of,O
Sentence: 847,eslicarbazepine,B-Chemical
Sentence: 847,acetate,I-Chemical
Sentence: 847,(,O
Sentence: 847,BIA,O
Sentence: 847,2,O
Sentence: 847,-,O
Sentence: 847,093,O
Sentence: 847,),O
Sentence: 847,on,O
Sentence: 847,seizures,B-Disease
Sentence: 847,induced,O
Sentence: 847,by,O
Sentence: 847,microperfusion,O
Sentence: 847,of,O
Sentence: 847,picrotoxin,B-Chemical
Sentence: 847,in,O
Sentence: 847,the,O
Sentence: 847,hippocampus,O
Sentence: 847,of,O
Sentence: 847,freely,O
Sentence: 847,moving,O
Sentence: 847,rats,O
Sentence: 847,.,O
Sentence: 848,Eslicarbazepine,B-Chemical
Sentence: 848,acetate,I-Chemical
Sentence: 848,(,O
Sentence: 848,BIA,O
Sentence: 848,2,O
Sentence: 848,-,O
Sentence: 848,093,O
Sentence: 848,",",O
Sentence: 848,S,O
Sentence: 848,-,O
Sentence: 848,,O
Sentence: 848,(,O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,,O
Sentence: 848,),O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,10,O
Sentence: 848,-,O
Sentence: 848,acetoxy,O
Sentence: 848,-,O
Sentence: 848,"10,11",O
Sentence: 848,-,O
Sentence: 848,dihydro,O
Sentence: 848,-,O
Sentence: 848,5H,O
Sentence: 848,-,O
Sentence: 848,dibenzo,O
Sentence: 848,/,O
Sentence: 848,b,O
Sentence: 848,",",O
Sentence: 848,f,O
Sentence: 848,/,O
Sentence: 848,azepine,O
Sentence: 848,-,O
Sentence: 848,5,O
Sentence: 848,-,O
Sentence: 848,carboxamide,O
Sentence: 848,),O
Sentence: 848,is,O
Sentence: 848,a,O
Sentence: 848,novel,O
Sentence: 848,antiepileptic,O
Sentence: 848,drug,O
Sentence: 848,",",O
Sentence: 848,now,O
Sentence: 848,in,O
Sentence: 848,Phase,O
Sentence: 848,III,O
Sentence: 848,clinical,O
Sentence: 848,trials,O
Sentence: 848,",",O
Sentence: 848,designed,O
Sentence: 848,with,O
Sentence: 848,the,O
Sentence: 848,aim,O
Sentence: 848,of,O
Sentence: 848,improving,O
Sentence: 848,efficacy,O
Sentence: 848,and,O
Sentence: 848,safety,O
Sentence: 848,in,O
Sentence: 848,comparison,O
Sentence: 848,with,O
Sentence: 848,the,O
Sentence: 848,structurally,O
Sentence: 848,related,O
Sentence: 848,drugs,O
Sentence: 848,carbamazepine,B-Chemical
Sentence: 848,(,O
Sentence: 848,CBZ,B-Chemical
Sentence: 848,),O
Sentence: 848,and,O
Sentence: 848,oxcarbazepine,B-Chemical
Sentence: 848,(,O
Sentence: 848,OXC,B-Chemical
Sentence: 848,),O
Sentence: 848,.,O
Sentence: 848,We,O
Sentence: 848,have,O
Sentence: 848,studied,O
Sentence: 848,the,O
Sentence: 848,effects,O
Sentence: 848,of,O
Sentence: 848,oral,O
Sentence: 848,treatment,O
Sentence: 848,with,O
Sentence: 848,eslicarbazepine,B-Chemical
Sentence: 848,acetate,I-Chemical
Sentence: 848,on,O
Sentence: 848,a,O
Sentence: 848,whole,O
Sentence: 848,-,O
Sentence: 848,animal,O
Sentence: 848,model,O
Sentence: 848,in,O
Sentence: 848,which,O
Sentence: 848,partial,O
Sentence: 848,seizures,B-Disease
Sentence: 848,can,O
Sentence: 848,be,O
Sentence: 848,elicited,O
Sentence: 848,repeatedly,O
Sentence: 848,on,O
Sentence: 848,different,O
Sentence: 848,days,O
Sentence: 848,without,O
Sentence: 848,changes,O
Sentence: 848,in,O
Sentence: 848,threshold,O
Sentence: 848,or,O
Sentence: 848,seizure,B-Disease
Sentence: 848,patterns,O
Sentence: 848,.,O
Sentence: 848,In,O
Sentence: 848,the,O
Sentence: 848,animals,O
Sentence: 848,treated,O
Sentence: 848,with,O
Sentence: 848,threshold,O
Sentence: 848,doses,O
Sentence: 848,of,O
Sentence: 848,picrotoxin,B-Chemical
Sentence: 848,",",O
Sentence: 848,the,O
Sentence: 848,average,O
Sentence: 848,number,O
Sentence: 848,of,O
Sentence: 848,seizures,B-Disease
Sentence: 848,was,O
Sentence: 848,2.3+,O
Sentence: 848,/,O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,1.2,O
Sentence: 848,",",O
Sentence: 848,and,O
Sentence: 848,average,O
Sentence: 848,seizure,B-Disease
Sentence: 848,duration,O
Sentence: 848,was,O
Sentence: 848,39.5+,O
Sentence: 848,/,O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,8.4s,O
Sentence: 848,.,O
Sentence: 848,Pre,O
Sentence: 848,-,O
Sentence: 848,treatment,O
Sentence: 848,with,O
Sentence: 848,a,O
Sentence: 848,dose,O
Sentence: 848,of,O
Sentence: 848,30,O
Sentence: 848,mg,O
Sentence: 848,/,O
Sentence: 848,kg,O
Sentence: 848,2h,O
Sentence: 848,before,O
Sentence: 848,picrotoxin,B-Chemical
Sentence: 848,microperfusion,O
Sentence: 848,prevented,O
Sentence: 848,seizures,B-Disease
Sentence: 848,in,O
Sentence: 848,the,O
Sentence: 848,75,O
Sentence: 848,%,O
Sentence: 848,of,O
Sentence: 848,the,O
Sentence: 848,rats,O
Sentence: 848,.,O
Sentence: 848,Lower,O
Sentence: 848,doses,O
Sentence: 848,(,O
Sentence: 848,3,O
Sentence: 848,and,O
Sentence: 848,10mg,O
Sentence: 848,/,O
Sentence: 848,kg,O
Sentence: 848,),O
Sentence: 848,did,O
Sentence: 848,not,O
Sentence: 848,suppress,O
Sentence: 848,seizures,B-Disease
Sentence: 848,",",O
Sentence: 848,however,O
Sentence: 848,",",O
Sentence: 848,after,O
Sentence: 848,administration,O
Sentence: 848,of,O
Sentence: 848,10mg,O
Sentence: 848,/,O
Sentence: 848,kg,O
Sentence: 848,",",O
Sentence: 848,significant,O
Sentence: 848,reductions,O
Sentence: 848,in,O
Sentence: 848,seizures,B-Disease
Sentence: 848,duration,O
Sentence: 848,(,O
Sentence: 848,24.3+,O
Sentence: 848,/,O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,6.8s,O
Sentence: 848,),O
Sentence: 848,and,O
Sentence: 848,seizure,B-Disease
Sentence: 848,number,O
Sentence: 848,(,O
Sentence: 848,1.6+,O
Sentence: 848,/,O
Sentence: 848,,O
Sentence: 848,-,O
Sentence: 848,0.34,O
Sentence: 848,),O
Sentence: 848,were,O
Sentence: 848,found,O
Sentence: 848,.,O
Sentence: 848,No,O
Sentence: 848,adverse,O
Sentence: 848,effects,O
Sentence: 848,of,O
Sentence: 848,eslicarbazepine,B-Chemical
Sentence: 848,acetate,I-Chemical
Sentence: 848,were,O
Sentence: 848,observed,O
Sentence: 848,in,O
Sentence: 848,the,O
Sentence: 848,behavioral,O
Sentence: 848,/,O
Sentence: 848,EEG,O
Sentence: 848,patterns,O
Sentence: 848,studied,O
Sentence: 848,",",O
Sentence: 848,including,O
Sentence: 848,sleep,O
Sentence: 848,/,O
Sentence: 848,wakefulness,O
Sentence: 848,cycle,O
Sentence: 848,",",O
Sentence: 848,at,O
Sentence: 848,the,O
Sentence: 848,doses,O
Sentence: 848,studied,O
Sentence: 848,.,O
Sentence: 849,Acute,B-Disease
Sentence: 849,renal,I-Disease
Sentence: 849,failure,I-Disease
Sentence: 849,associated,O
Sentence: 849,with,O
Sentence: 849,prolonged,O
Sentence: 849,intake,O
Sentence: 849,of,O
Sentence: 849,slimming,O
Sentence: 849,pills,O
Sentence: 849,containing,O
Sentence: 849,anthraquinones,B-Chemical
Sentence: 849,.,O
Sentence: 850,Chinese,B-Chemical
Sentence: 850,herbal,I-Chemical
Sentence: 850,medicine,O
Sentence: 850,preparations,O
Sentence: 850,are,O
Sentence: 850,widely,O
Sentence: 850,available,O
Sentence: 850,and,O
Sentence: 850,often,O
Sentence: 850,regarded,O
Sentence: 850,by,O
Sentence: 850,the,O
Sentence: 850,public,O
Sentence: 850,as,O
Sentence: 850,natural,O
Sentence: 850,and,O
Sentence: 850,safe,O
Sentence: 850,remedies,O
Sentence: 850,for,O
Sentence: 850,a,O
Sentence: 850,variety,O
Sentence: 850,of,O
Sentence: 850,medical,O
Sentence: 850,conditions,O
Sentence: 850,.,O
Sentence: 850,Nephropathy,B-Disease
Sentence: 850,caused,O
Sentence: 850,by,O
Sentence: 850,Chinese,B-Chemical
Sentence: 850,herbs,I-Chemical
Sentence: 850,has,O
Sentence: 850,previously,O
Sentence: 850,been,O
Sentence: 850,reported,O
Sentence: 850,",",O
Sentence: 850,usually,O
Sentence: 850,involving,O
Sentence: 850,the,O
Sentence: 850,use,O
Sentence: 850,of,O
Sentence: 850,aristolochic,B-Chemical
Sentence: 850,acids,I-Chemical
Sentence: 850,.,O
Sentence: 850,We,O
Sentence: 850,report,O
Sentence: 850,a,O
Sentence: 850,23,O
Sentence: 850,-,O
Sentence: 850,year,O
Sentence: 850,-,O
Sentence: 850,old,O
Sentence: 850,woman,O
Sentence: 850,who,O
Sentence: 850,developed,O
Sentence: 850,acute,B-Disease
Sentence: 850,renal,B-Disease
Sentence: 850,failure,I-Disease
Sentence: 850,following,O
Sentence: 850,prolonged,O
Sentence: 850,use,O
Sentence: 850,of,O
Sentence: 850,a,O
Sentence: 850,proprietary,O
Sentence: 850,Chinese,B-Chemical
Sentence: 850,herbal,I-Chemical
Sentence: 850,slimming,O
Sentence: 850,pill,O
Sentence: 850,that,O
Sentence: 850,contained,O
Sentence: 850,anthraquinone,B-Chemical
Sentence: 850,derivatives,O
Sentence: 850,",",O
Sentence: 850,extracted,O
Sentence: 850,from,O
Sentence: 850,Rhizoma,O
Sentence: 850,Rhei,O
Sentence: 850,(,O
Sentence: 850,rhubarb,O
Sentence: 850,),O
Sentence: 850,.,O
Sentence: 850,The,O
Sentence: 850,renal,B-Disease
Sentence: 850,injury,I-Disease
Sentence: 850,was,O
Sentence: 850,probably,O
Sentence: 850,aggravated,O
Sentence: 850,by,O
Sentence: 850,the,O
Sentence: 850,concomitant,O
Sentence: 850,intake,O
Sentence: 850,of,O
Sentence: 850,a,O
Sentence: 850,non,O
Sentence: 850,-,O
Sentence: 850,steroidal,O
Sentence: 850,anti,O
Sentence: 850,-,O
Sentence: 850,inflammatory,O
Sentence: 850,drug,O
Sentence: 850,",",O
Sentence: 850,diclofenac,B-Chemical
Sentence: 850,.,O
Sentence: 850,Renal,O
Sentence: 850,pathology,O
Sentence: 850,was,O
Sentence: 850,that,O
Sentence: 850,of,O
Sentence: 850,hypocellular,O
Sentence: 850,interstitial,O
Sentence: 850,fibrosis,B-Disease
Sentence: 850,.,O
Sentence: 850,Spontaneous,O
Sentence: 850,renal,O
Sentence: 850,recovery,O
Sentence: 850,occurred,O
Sentence: 850,upon,O
Sentence: 850,cessation,O
Sentence: 850,of,O
Sentence: 850,the,O
Sentence: 850,slimming,O
Sentence: 850,pills,O
Sentence: 850,",",O
Sentence: 850,but,O
Sentence: 850,mild,O
Sentence: 850,interstitial,O
Sentence: 850,fibrosis,B-Disease
Sentence: 850,and,O
Sentence: 850,tubular,O
Sentence: 850,atrophy,B-Disease
Sentence: 850,was,O
Sentence: 850,still,O
Sentence: 850,evident,O
Sentence: 850,histologically,O
Sentence: 850,4,O
Sentence: 850,months,O
Sentence: 850,later,O
Sentence: 850,.,O
Sentence: 850,Although,O
Sentence: 850,a,O
Sentence: 850,causal,O
Sentence: 850,relationship,O
Sentence: 850,between,O
Sentence: 850,the,O
Sentence: 850,use,O
Sentence: 850,of,O
Sentence: 850,an,O
Sentence: 850,anthraquinone,B-Chemical
Sentence: 850,-,O
Sentence: 850,containing,O
Sentence: 850,herbal,O
Sentence: 850,agent,O
Sentence: 850,and,O
Sentence: 850,renal,B-Disease
Sentence: 850,injury,I-Disease
Sentence: 850,remains,O
Sentence: 850,to,O
Sentence: 850,be,O
Sentence: 850,proven,O
Sentence: 850,",",O
Sentence: 850,phytotherapy,O
Sentence: 850,-,O
Sentence: 850,associated,O
Sentence: 850,interstitial,O
Sentence: 850,nephropathy,B-Disease
Sentence: 850,should,O
Sentence: 850,be,O
Sentence: 850,considered,O
Sentence: 850,in,O
Sentence: 850,patients,O
Sentence: 850,who,O
Sentence: 850,present,O
Sentence: 850,with,O
Sentence: 850,unexplained,O
Sentence: 850,renal,B-Disease
Sentence: 850,failure,I-Disease
Sentence: 850,.,O
Sentence: 851,Chloroacetaldehyde,B-Chemical
Sentence: 851,as,O
Sentence: 851,a,O
Sentence: 851,sulfhydryl,B-Chemical
Sentence: 851,reagent,O
Sentence: 851,:,O
Sentence: 851,the,O
Sentence: 851,role,O
Sentence: 851,of,O
Sentence: 851,critical,O
Sentence: 851,thiol,B-Chemical
Sentence: 851,groups,O
Sentence: 851,in,O
Sentence: 851,ifosfamide,B-Chemical
Sentence: 851,nephropathy,B-Disease
Sentence: 851,.,O
Sentence: 852,Chloroacetaldehyde,B-Chemical
Sentence: 852,(,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,),O
Sentence: 852,is,O
Sentence: 852,a,O
Sentence: 852,metabolite,O
Sentence: 852,of,O
Sentence: 852,the,O
Sentence: 852,alkylating,O
Sentence: 852,agent,O
Sentence: 852,ifosfamide,B-Chemical
Sentence: 852,(,O
Sentence: 852,IFO,B-Chemical
Sentence: 852,),O
Sentence: 852,and,O
Sentence: 852,putatively,O
Sentence: 852,responsible,O
Sentence: 852,for,O
Sentence: 852,renal,B-Disease
Sentence: 852,damage,I-Disease
Sentence: 852,following,O
Sentence: 852,anti,O
Sentence: 852,-,O
Sentence: 852,tumor,B-Disease
Sentence: 852,therapy,O
Sentence: 852,with,O
Sentence: 852,IFO,B-Chemical
Sentence: 852,.,O
Sentence: 852,Depletion,O
Sentence: 852,of,O
Sentence: 852,sulfhydryl,B-Chemical
Sentence: 852,(,O
Sentence: 852,SH,B-Chemical
Sentence: 852,),O
Sentence: 852,groups,O
Sentence: 852,has,O
Sentence: 852,been,O
Sentence: 852,reported,O
Sentence: 852,from,O
Sentence: 852,cell,O
Sentence: 852,culture,O
Sentence: 852,",",O
Sentence: 852,animal,O
Sentence: 852,and,O
Sentence: 852,clinical,O
Sentence: 852,studies,O
Sentence: 852,.,O
Sentence: 852,In,O
Sentence: 852,this,O
Sentence: 852,work,O
Sentence: 852,the,O
Sentence: 852,effect,O
Sentence: 852,of,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,on,O
Sentence: 852,human,O
Sentence: 852,proximal,O
Sentence: 852,tubule,O
Sentence: 852,cells,O
Sentence: 852,in,O
Sentence: 852,primary,O
Sentence: 852,culture,O
Sentence: 852,(,O
Sentence: 852,hRPTEC,O
Sentence: 852,),O
Sentence: 852,was,O
Sentence: 852,investigated,O
Sentence: 852,.,O
Sentence: 852,Toxicity,B-Disease
Sentence: 852,of,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,was,O
Sentence: 852,determined,O
Sentence: 852,by,O
Sentence: 852,protein,O
Sentence: 852,content,O
Sentence: 852,",",O
Sentence: 852,cell,O
Sentence: 852,number,O
Sentence: 852,",",O
Sentence: 852,LDH,O
Sentence: 852,release,O
Sentence: 852,",",O
Sentence: 852,trypan,B-Chemical
Sentence: 852,blue,I-Chemical
Sentence: 852,exclusion,O
Sentence: 852,assay,O
Sentence: 852,and,O
Sentence: 852,caspase,O
Sentence: 852,-,O
Sentence: 852,3,O
Sentence: 852,activity,O
Sentence: 852,.,O
Sentence: 852,Free,O
Sentence: 852,thiols,B-Chemical
Sentence: 852,were,O
Sentence: 852,measured,O
Sentence: 852,by,O
Sentence: 852,the,O
Sentence: 852,method,O
Sentence: 852,of,O
Sentence: 852,Ellman,O
Sentence: 852,.,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,reduced,O
Sentence: 852,hRPTEC,O
Sentence: 852,cell,O
Sentence: 852,number,O
Sentence: 852,and,O
Sentence: 852,protein,O
Sentence: 852,",",O
Sentence: 852,induced,O
Sentence: 852,a,O
Sentence: 852,loss,O
Sentence: 852,in,O
Sentence: 852,free,O
Sentence: 852,intracellular,O
Sentence: 852,thiols,B-Chemical
Sentence: 852,and,O
Sentence: 852,an,O
Sentence: 852,increase,O
Sentence: 852,in,O
Sentence: 852,necrosis,B-Disease
Sentence: 852,markers,O
Sentence: 852,.,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,but,O
Sentence: 852,not,O
Sentence: 852,acrolein,B-Chemical
Sentence: 852,inhibited,O
Sentence: 852,the,O
Sentence: 852,cysteine,B-Chemical
Sentence: 852,proteases,O
Sentence: 852,caspase,O
Sentence: 852,-,O
Sentence: 852,3,O
Sentence: 852,",",O
Sentence: 852,caspase,O
Sentence: 852,-,O
Sentence: 852,8,O
Sentence: 852,and,O
Sentence: 852,cathepsin,O
Sentence: 852,B.,O
Sentence: 852,Caspase,O
Sentence: 852,activation,O
Sentence: 852,by,O
Sentence: 852,cisplatin,B-Chemical
Sentence: 852,was,O
Sentence: 852,inhibited,O
Sentence: 852,by,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,.,O
Sentence: 852,In,O
Sentence: 852,cells,O
Sentence: 852,stained,O
Sentence: 852,with,O
Sentence: 852,fluorescent,O
Sentence: 852,dyes,O
Sentence: 852,targeting,O
Sentence: 852,lysosomes,O
Sentence: 852,",",O
Sentence: 852,CAA,B-Chemical
Sentence: 852,induced,O
Sentence: 852,an,O
Sentence: 852,increase,O
Sentence: 852,in,O
Sentence: 852,lysosomal,O
Sentence: 852,size,O
Sentence: 852,and,O
Sentence: 852,lysosomal,O
Sentence: 852,leakage,O
Sentence: 852,.,O
Sentence: 852,The,O
Sentence: 852,effects,O
Sentence: 852,of,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,on,O
Sentence: 852,cysteine,B-Chemical
Sentence: 852,protease,O
Sentence: 852,activities,O
Sentence: 852,and,O
Sentence: 852,thiols,B-Chemical
Sentence: 852,could,O
Sentence: 852,be,O
Sentence: 852,reproduced,O
Sentence: 852,in,O
Sentence: 852,cell,O
Sentence: 852,lysate,O
Sentence: 852,.,O
Sentence: 852,Acidification,O
Sentence: 852,",",O
Sentence: 852,which,O
Sentence: 852,slowed,O
Sentence: 852,the,O
Sentence: 852,reaction,O
Sentence: 852,of,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,with,O
Sentence: 852,thiol,B-Chemical
Sentence: 852,donors,O
Sentence: 852,",",O
Sentence: 852,could,O
Sentence: 852,also,O
Sentence: 852,attenuate,O
Sentence: 852,effects,O
Sentence: 852,of,O
Sentence: 852,CAA,B-Chemical
Sentence: 852,on,O
Sentence: 852,necrosis,B-Disease
Sentence: 852,markers,O
Sentence: 852,",",O
Sentence: 852,thiol,B-Chemical
Sentence: 852,depletion,O
Sentence: 852,and,O
Sentence: 852,cysteine,B-Chemical
Sentence: 852,protease,O
Sentence: 852,inhibition,O
Sentence: 852,in,O
Sentence: 852,living,O
Sentence: 852,cells,O
Sentence: 852,.,O
Sentence: 852,Thus,O
Sentence: 852,",",O
Sentence: 852,CAA,B-Chemical
Sentence: 852,directly,O
Sentence: 852,reacts,O
Sentence: 852,with,O
Sentence: 852,cellular,O
Sentence: 852,protein,O
Sentence: 852,and,O
Sentence: 852,non,O
Sentence: 852,-,O
Sentence: 852,protein,O
Sentence: 852,thiols,B-Chemical
Sentence: 852,",",O
Sentence: 852,mediating,O
Sentence: 852,its,O
Sentence: 852,toxicity,B-Disease
Sentence: 852,on,O
Sentence: 852,hRPTEC,O
Sentence: 852,.,O
Sentence: 852,This,O
Sentence: 852,effect,O
Sentence: 852,can,O
Sentence: 852,be,O
Sentence: 852,reduced,O
Sentence: 852,by,O
Sentence: 852,acidification,O
Sentence: 852,.,O
Sentence: 852,Therefore,O
Sentence: 852,",",O
Sentence: 852,urinary,O
Sentence: 852,acidification,O
Sentence: 852,could,O
Sentence: 852,be,O
Sentence: 852,an,O
Sentence: 852,option,O
Sentence: 852,to,O
Sentence: 852,prevent,O
Sentence: 852,IFO,B-Chemical
Sentence: 852,nephropathy,B-Disease
Sentence: 852,in,O
Sentence: 852,patients,O
Sentence: 852,.,O
Sentence: 853,Stereological,O
Sentence: 853,methods,O
Sentence: 853,reveal,O
Sentence: 853,the,O
Sentence: 853,robust,O
Sentence: 853,size,O
Sentence: 853,and,O
Sentence: 853,stability,O
Sentence: 853,of,O
Sentence: 853,ectopic,O
Sentence: 853,hilar,O
Sentence: 853,granule,O
Sentence: 853,cells,O
Sentence: 853,after,O
Sentence: 853,pilocarpine,B-Chemical
Sentence: 853,-,O
Sentence: 853,induced,O
Sentence: 853,status,B-Disease
Sentence: 853,epilepticus,I-Disease
Sentence: 853,in,O
Sentence: 853,the,O
Sentence: 853,adult,O
Sentence: 853,rat,O
Sentence: 853,.,O
Sentence: 854,Following,O
Sentence: 854,status,B-Disease
Sentence: 854,epilepticus,I-Disease
Sentence: 854,in,O
Sentence: 854,the,O
Sentence: 854,rat,O
Sentence: 854,",",O
Sentence: 854,dentate,O
Sentence: 854,granule,O
Sentence: 854,cell,O
Sentence: 854,neurogenesis,O
Sentence: 854,increases,O
Sentence: 854,greatly,O
Sentence: 854,",",O
Sentence: 854,and,O
Sentence: 854,many,O
Sentence: 854,of,O
Sentence: 854,the,O
Sentence: 854,new,O
Sentence: 854,neurons,O
Sentence: 854,appear,O
Sentence: 854,to,O
Sentence: 854,develop,O
Sentence: 854,ectopically,O
Sentence: 854,",",O
Sentence: 854,in,O
Sentence: 854,the,O
Sentence: 854,hilar,O
Sentence: 854,region,O
Sentence: 854,of,O
Sentence: 854,the,O
Sentence: 854,hippocampal,O
Sentence: 854,formation,O
Sentence: 854,.,O
Sentence: 854,It,O
Sentence: 854,has,O
Sentence: 854,been,O
Sentence: 854,suggested,O
Sentence: 854,that,O
Sentence: 854,the,O
Sentence: 854,ectopic,O
Sentence: 854,hilar,O
Sentence: 854,granule,O
Sentence: 854,cells,O
Sentence: 854,could,O
Sentence: 854,contribute,O
Sentence: 854,to,O
Sentence: 854,the,O
Sentence: 854,spontaneous,O
Sentence: 854,seizures,B-Disease
Sentence: 854,that,O
Sentence: 854,ultimately,O
Sentence: 854,develop,O
Sentence: 854,after,O
Sentence: 854,status,B-Disease
Sentence: 854,epilepticus,I-Disease
Sentence: 854,.,O
Sentence: 854,However,O
Sentence: 854,",",O
Sentence: 854,the,O
Sentence: 854,population,O
Sentence: 854,has,O
Sentence: 854,never,O
Sentence: 854,been,O
Sentence: 854,quantified,O
Sentence: 854,",",O
Sentence: 854,so,O
Sentence: 854,it,O
Sentence: 854,is,O
Sentence: 854,unclear,O
Sentence: 854,whether,O
Sentence: 854,it,O
Sentence: 854,is,O
Sentence: 854,substantial,O
Sentence: 854,enough,O
Sentence: 854,to,O
Sentence: 854,have,O
Sentence: 854,a,O
Sentence: 854,strong,O
Sentence: 854,influence,O
Sentence: 854,on,O
Sentence: 854,epileptogenesis,O
Sentence: 854,.,O
Sentence: 854,To,O
Sentence: 854,quantify,O
Sentence: 854,this,O
Sentence: 854,population,O
Sentence: 854,",",O
Sentence: 854,the,O
Sentence: 854,total,O
Sentence: 854,number,O
Sentence: 854,of,O
Sentence: 854,ectopic,O
Sentence: 854,hilar,O
Sentence: 854,granule,O
Sentence: 854,cells,O
Sentence: 854,was,O
Sentence: 854,estimated,O
Sentence: 854,using,O
Sentence: 854,unbiased,O
Sentence: 854,stereology,O
Sentence: 854,at,O
Sentence: 854,different,O
Sentence: 854,times,O
Sentence: 854,after,O
Sentence: 854,pilocarpine,B-Chemical
Sentence: 854,-,O
Sentence: 854,induced,O
Sentence: 854,status,B-Disease
Sentence: 854,epilepticus,I-Disease
Sentence: 854,.,O
Sentence: 854,The,O
Sentence: 854,number,O
Sentence: 854,of,O
Sentence: 854,hilar,O
Sentence: 854,neurons,O
Sentence: 854,immunoreactive,O
Sentence: 854,for,O
Sentence: 854,Prox,O
Sentence: 854,-,O
Sentence: 854,1,O
Sentence: 854,",",O
Sentence: 854,a,O
Sentence: 854,granule,O
Sentence: 854,-,O
Sentence: 854,cell,O
Sentence: 854,-,O
Sentence: 854,specific,O
Sentence: 854,marker,O
Sentence: 854,",",O
Sentence: 854,was,O
Sentence: 854,estimated,O
Sentence: 854,using,O
Sentence: 854,the,O
Sentence: 854,optical,O
Sentence: 854,fractionator,O
Sentence: 854,method,O
Sentence: 854,.,O
Sentence: 854,The,O
Sentence: 854,results,O
Sentence: 854,indicate,O
Sentence: 854,that,O
Sentence: 854,the,O
Sentence: 854,size,O
Sentence: 854,of,O
Sentence: 854,the,O
Sentence: 854,hilar,O
Sentence: 854,ectopic,O
Sentence: 854,granule,O
Sentence: 854,cell,O
Sentence: 854,population,O
Sentence: 854,after,O
Sentence: 854,status,B-Disease
Sentence: 854,epilepticus,I-Disease
Sentence: 854,is,O
Sentence: 854,substantial,O
Sentence: 854,",",O
Sentence: 854,and,O
Sentence: 854,stable,O
Sentence: 854,over,O
Sentence: 854,time,O
Sentence: 854,.,O
Sentence: 854,Interestingly,O
Sentence: 854,",",O
Sentence: 854,the,O
Sentence: 854,size,O
Sentence: 854,of,O
Sentence: 854,the,O
Sentence: 854,population,O
Sentence: 854,appears,O
Sentence: 854,to,O
Sentence: 854,be,O
Sentence: 854,correlated,O
Sentence: 854,with,O
Sentence: 854,the,O
Sentence: 854,frequency,O
Sentence: 854,of,O
Sentence: 854,behavioral,O
Sentence: 854,seizures,B-Disease
Sentence: 854,",",O
Sentence: 854,because,O
Sentence: 854,animals,O
Sentence: 854,with,O
Sentence: 854,more,O
Sentence: 854,ectopic,O
Sentence: 854,granule,O
Sentence: 854,cells,O
Sentence: 854,in,O
Sentence: 854,the,O
Sentence: 854,hilus,O
Sentence: 854,have,O
Sentence: 854,more,O
Sentence: 854,frequent,O
Sentence: 854,behavioral,O
Sentence: 854,seizures,B-Disease
Sentence: 854,.,O
Sentence: 854,The,O
Sentence: 854,hilar,O
Sentence: 854,ectopic,O
Sentence: 854,granule,O
Sentence: 854,cell,O
Sentence: 854,population,O
Sentence: 854,does,O
Sentence: 854,not,O
Sentence: 854,appear,O
Sentence: 854,to,O
Sentence: 854,vary,O
Sentence: 854,systematically,O
Sentence: 854,across,O
Sentence: 854,the,O
Sentence: 854,septotemporal,O
Sentence: 854,axis,O
Sentence: 854,",",O
Sentence: 854,although,O
Sentence: 854,it,O
Sentence: 854,is,O
Sentence: 854,associated,O
Sentence: 854,with,O
Sentence: 854,an,O
Sentence: 854,increase,O
Sentence: 854,in,O
Sentence: 854,volume,O
Sentence: 854,of,O
Sentence: 854,the,O
Sentence: 854,hilus,O
Sentence: 854,.,O
Sentence: 854,The,O
Sentence: 854,results,O
Sentence: 854,provide,O
Sentence: 854,new,O
Sentence: 854,insight,O
Sentence: 854,into,O
Sentence: 854,the,O
Sentence: 854,potential,O
Sentence: 854,role,O
Sentence: 854,of,O
Sentence: 854,ectopic,O
Sentence: 854,hilar,O
Sentence: 854,granule,O
Sentence: 854,cells,O
Sentence: 854,in,O
Sentence: 854,the,O
Sentence: 854,pilocarpine,B-Chemical
Sentence: 854,model,O
Sentence: 854,of,O
Sentence: 854,temporal,B-Disease
Sentence: 854,lobe,I-Disease
Sentence: 854,epilepsy,I-Disease
Sentence: 854,.,O
Sentence: 855,A,O
Sentence: 855,prospective,O
Sentence: 855,",",O
Sentence: 855,open,O
Sentence: 855,-,O
Sentence: 855,label,O
Sentence: 855,trial,O
Sentence: 855,of,O
Sentence: 855,galantamine,B-Chemical
Sentence: 855,in,O
Sentence: 855,autistic,B-Disease
Sentence: 855,disorder,I-Disease
Sentence: 855,.,O
Sentence: 856,OBJECTIVE,O
Sentence: 856,:,O
Sentence: 856,Post,O
Sentence: 856,-,O
Sentence: 856,mortem,O
Sentence: 856,studies,O
Sentence: 856,have,O
Sentence: 856,reported,O
Sentence: 856,abnormalities,O
Sentence: 856,of,O
Sentence: 856,the,O
Sentence: 856,cholinergic,O
Sentence: 856,system,O
Sentence: 856,in,O
Sentence: 856,autism,B-Disease
Sentence: 856,.,O
Sentence: 856,The,O
Sentence: 856,purpose,O
Sentence: 856,of,O
Sentence: 856,this,O
Sentence: 856,study,O
Sentence: 856,was,O
Sentence: 856,to,O
Sentence: 856,assess,O
Sentence: 856,the,O
Sentence: 856,use,O
Sentence: 856,of,O
Sentence: 856,galantamine,B-Chemical
Sentence: 856,",",O
Sentence: 856,an,O
Sentence: 856,acetylcholinesterase,O
Sentence: 856,inhibitor,O
Sentence: 856,and,O
Sentence: 856,nicotinic,O
Sentence: 856,receptor,O
Sentence: 856,modulator,O
Sentence: 856,",",O
Sentence: 856,in,O
Sentence: 856,the,O
Sentence: 856,treatment,O
Sentence: 856,of,O
Sentence: 856,interfering,O
Sentence: 856,behaviors,O
Sentence: 856,in,O
Sentence: 856,children,O
Sentence: 856,with,O
Sentence: 856,autism,B-Disease
Sentence: 856,.,O
Sentence: 856,METHODS,O
Sentence: 856,:,O
Sentence: 856,Thirteen,O
Sentence: 856,medication,O
Sentence: 856,-,O
Sentence: 856,free,O
Sentence: 856,children,O
Sentence: 856,with,O
Sentence: 856,autism,B-Disease
Sentence: 856,(,O
Sentence: 856,mean,O
Sentence: 856,age,O
Sentence: 856,",",O
Sentence: 856,8.8,O
Sentence: 856,+,O
Sentence: 856,/,O
Sentence: 856,,O
Sentence: 856,-,O
Sentence: 856,,O
Sentence: 856,3.5,O
Sentence: 856,years,O
Sentence: 856,),O
Sentence: 856,participated,O
Sentence: 856,in,O
Sentence: 856,a,O
Sentence: 856,12,O
Sentence: 856,-,O
Sentence: 856,week,O
Sentence: 856,",",O
Sentence: 856,open,O
Sentence: 856,-,O
Sentence: 856,label,O
Sentence: 856,trial,O
Sentence: 856,of,O
Sentence: 856,galantamine,B-Chemical
Sentence: 856,.,O
Sentence: 856,Patients,O
Sentence: 856,were,O
Sentence: 856,rated,O
Sentence: 856,monthly,O
Sentence: 856,by,O
Sentence: 856,parents,O
Sentence: 856,on,O
Sentence: 856,the,O
Sentence: 856,Aberrant,O
Sentence: 856,Behavior,O
Sentence: 856,Checklist,O
Sentence: 856,(,O
Sentence: 856,ABC,O
Sentence: 856,),O
Sentence: 856,and,O
Sentence: 856,the,O
Sentence: 856,Conners,O
Sentence: 856,',O
Sentence: 856,Parent,O
Sentence: 856,Rating,O
Sentence: 856,Scale,O
Sentence: 856,-,O
Sentence: 856,Revised,O
Sentence: 856,",",O
Sentence: 856,and,O
Sentence: 856,by,O
Sentence: 856,a,O
Sentence: 856,physician,O
Sentence: 856,using,O
Sentence: 856,the,O
Sentence: 856,Children,O
Sentence: 856,'s,O
Sentence: 856,Psychiatric,O
Sentence: 856,Rating,O
Sentence: 856,Scale,O
Sentence: 856,and,O
Sentence: 856,the,O
Sentence: 856,Clinical,O
Sentence: 856,Global,O
Sentence: 856,Impressions,O
Sentence: 856,scale,O
Sentence: 856,.,O
Sentence: 856,RESULTS,O
Sentence: 856,:,O
Sentence: 856,Patients,O
Sentence: 856,showed,O
Sentence: 856,a,O
Sentence: 856,significant,O
Sentence: 856,reduction,O
Sentence: 856,in,O
Sentence: 856,parent,O
Sentence: 856,-,O
Sentence: 856,rated,O
Sentence: 856,irritability,B-Disease
Sentence: 856,and,O
Sentence: 856,social,O
Sentence: 856,withdrawal,O
Sentence: 856,on,O
Sentence: 856,the,O
Sentence: 856,ABC,O
Sentence: 856,as,O
Sentence: 856,well,O
Sentence: 856,as,O
Sentence: 856,significant,O
Sentence: 856,improvements,O
Sentence: 856,in,O
Sentence: 856,emotional,O
Sentence: 856,lability,O
Sentence: 856,and,O
Sentence: 856,inattention,B-Disease
Sentence: 856,on,O
Sentence: 856,the,O
Sentence: 856,Conners,O
Sentence: 856,',O
Sentence: 856,Parent,O
Sentence: 856,Rating,O
Sentence: 856,Scale,O
Sentence: 856,,O
Sentence: 856,-,O
Sentence: 856,,O
Sentence: 856,-,O
Sentence: 856,,O
Sentence: 856,Revised,O
Sentence: 856,.,O
Sentence: 856,Similarly,O
Sentence: 856,",",O
Sentence: 856,clinician,O
Sentence: 856,ratings,O
Sentence: 856,showed,O
Sentence: 856,reductions,O
Sentence: 856,in,O
Sentence: 856,the,O
Sentence: 856,anger,O
Sentence: 856,subscale,O
Sentence: 856,of,O
Sentence: 856,the,O
Sentence: 856,Children,O
Sentence: 856,'s,O
Sentence: 856,Psychiatric,O
Sentence: 856,Rating,O
Sentence: 856,Scale,O
Sentence: 856,.,O
Sentence: 856,Eight,O
Sentence: 856,of,O
Sentence: 856,13,O
Sentence: 856,participants,O
Sentence: 856,were,O
Sentence: 856,rated,O
Sentence: 856,as,O
Sentence: 856,responders,O
Sentence: 856,on,O
Sentence: 856,the,O
Sentence: 856,basis,O
Sentence: 856,of,O
Sentence: 856,their,O
Sentence: 856,improvement,O
Sentence: 856,scores,O
Sentence: 856,on,O
Sentence: 856,the,O
Sentence: 856,Clinical,O
Sentence: 856,Global,O
Sentence: 856,Impressions,O
Sentence: 856,scale,O
Sentence: 856,.,O
Sentence: 856,Overall,O
Sentence: 856,",",O
Sentence: 856,galantamine,B-Chemical
Sentence: 856,was,O
Sentence: 856,well,O
Sentence: 856,-,O
Sentence: 856,tolerated,O
Sentence: 856,",",O
Sentence: 856,with,O
Sentence: 856,no,O
Sentence: 856,significant,O
Sentence: 856,adverse,O
Sentence: 856,effects,O
Sentence: 856,apart,O
Sentence: 856,from,O
Sentence: 856,headaches,B-Disease
Sentence: 856,in,O
Sentence: 856,one,O
Sentence: 856,patient,O
Sentence: 856,.,O
Sentence: 856,CONCLUSION,O
Sentence: 856,:,O
Sentence: 856,In,O
Sentence: 856,this,O
Sentence: 856,open,O
Sentence: 856,trial,O
Sentence: 856,",",O
Sentence: 856,galantamine,B-Chemical
Sentence: 856,was,O
Sentence: 856,well,O
Sentence: 856,-,O
Sentence: 856,tolerated,O
Sentence: 856,and,O
Sentence: 856,appeared,O
Sentence: 856,to,O
Sentence: 856,be,O
Sentence: 856,beneficial,O
Sentence: 856,for,O
Sentence: 856,the,O
Sentence: 856,treatment,O
Sentence: 856,of,O
Sentence: 856,interfering,O
Sentence: 856,behaviors,O
Sentence: 856,in,O
Sentence: 856,children,O
Sentence: 856,with,O
Sentence: 856,autism,B-Disease
Sentence: 856,",",O
Sentence: 856,particularly,O
Sentence: 856,aggression,B-Disease
Sentence: 856,",",O
Sentence: 856,behavioral,B-Disease
Sentence: 856,dyscontrol,I-Disease
Sentence: 856,",",O
Sentence: 856,and,O
Sentence: 856,inattention,B-Disease
Sentence: 856,.,O
Sentence: 856,Further,O
Sentence: 856,controlled,O
Sentence: 856,trials,O
Sentence: 856,are,O
Sentence: 856,warranted,O
Sentence: 856,.,O
Sentence: 857,Randomized,O
Sentence: 857,comparison,O
Sentence: 857,of,O
Sentence: 857,olanzapine,B-Chemical
Sentence: 857,versus,O
Sentence: 857,risperidone,B-Chemical
Sentence: 857,for,O
Sentence: 857,the,O
Sentence: 857,treatment,O
Sentence: 857,of,O
Sentence: 857,first,O
Sentence: 857,-,O
Sentence: 857,episode,O
Sentence: 857,schizophrenia,B-Disease
Sentence: 857,:,O
Sentence: 857,4,O
Sentence: 857,-,O
Sentence: 857,month,O
Sentence: 857,outcomes,O
Sentence: 857,.,O
Sentence: 858,OBJECTIVE,O
Sentence: 858,:,O
Sentence: 858,The,O
Sentence: 858,authors,O
Sentence: 858,compared,O
Sentence: 858,4,O
Sentence: 858,-,O
Sentence: 858,month,O
Sentence: 858,treatment,O
Sentence: 858,outcomes,O
Sentence: 858,for,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,versus,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,in,O
Sentence: 858,patients,O
Sentence: 858,with,O
Sentence: 858,first,O
Sentence: 858,-,O
Sentence: 858,episode,O
Sentence: 858,schizophrenia,B-Disease
Sentence: 858,spectrum,O
Sentence: 858,disorders,O
Sentence: 858,.,O
Sentence: 858,METHOD,O
Sentence: 858,:,O
Sentence: 858,One,O
Sentence: 858,hundred,O
Sentence: 858,twelve,O
Sentence: 858,subjects,O
Sentence: 858,(,O
Sentence: 858,70,O
Sentence: 858,%,O
Sentence: 858,male,O
Sentence: 858,;,O
Sentence: 858,mean,O
Sentence: 858,age,O
Sentence: 858,=,O
Sentence: 858,23.3,O
Sentence: 858,years,O
Sentence: 858,[,O
Sentence: 858,SD,O
Sentence: 858,,O
Sentence: 858,=,O
Sentence: 858,,O
Sentence: 858,5.1,O
Sentence: 858,],O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,first,O
Sentence: 858,-,O
Sentence: 858,episode,O
Sentence: 858,schizophrenia,B-Disease
Sentence: 858,(,O
Sentence: 858,75,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,",",O
Sentence: 858,schizophreniform,B-Disease
Sentence: 858,disorder,I-Disease
Sentence: 858,(,O
Sentence: 858,17,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,",",O
Sentence: 858,or,O
Sentence: 858,schizoaffective,B-Disease
Sentence: 858,disorder,I-Disease
Sentence: 858,(,O
Sentence: 858,8,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,were,O
Sentence: 858,randomly,O
Sentence: 858,assigned,O
Sentence: 858,to,O
Sentence: 858,treatment,O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,(,O
Sentence: 858,2.5,O
Sentence: 858,-,O
Sentence: 858,20,O
Sentence: 858,mg,O
Sentence: 858,/,O
Sentence: 858,day,O
Sentence: 858,),O
Sentence: 858,or,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,(,O
Sentence: 858,1,O
Sentence: 858,-,O
Sentence: 858,6,O
Sentence: 858,mg,O
Sentence: 858,/,O
Sentence: 858,day,O
Sentence: 858,),O
Sentence: 858,.,O
Sentence: 858,RESULTS,O
Sentence: 858,:,O
Sentence: 858,Response,O
Sentence: 858,rates,O
Sentence: 858,did,O
Sentence: 858,not,O
Sentence: 858,significantly,O
Sentence: 858,differ,O
Sentence: 858,between,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,(,O
Sentence: 858,43.7,O
Sentence: 858,%,O
Sentence: 858,",",O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,28.8,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,58.6,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,and,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,(,O
Sentence: 858,54.3,O
Sentence: 858,%,O
Sentence: 858,",",O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,39.9,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,68.7,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,.,O
Sentence: 858,Among,O
Sentence: 858,those,O
Sentence: 858,responding,O
Sentence: 858,to,O
Sentence: 858,treatment,O
Sentence: 858,",",O
Sentence: 858,more,O
Sentence: 858,subjects,O
Sentence: 858,in,O
Sentence: 858,the,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,group,O
Sentence: 858,(,O
Sentence: 858,40.9,O
Sentence: 858,%,O
Sentence: 858,",",O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,16.8,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,65.0,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,than,O
Sentence: 858,in,O
Sentence: 858,the,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,group,O
Sentence: 858,(,O
Sentence: 858,18.9,O
Sentence: 858,%,O
Sentence: 858,",",O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,0,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,39.2,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,had,O
Sentence: 858,subsequent,O
Sentence: 858,ratings,O
Sentence: 858,not,O
Sentence: 858,meeting,O
Sentence: 858,response,O
Sentence: 858,criteria,O
Sentence: 858,.,O
Sentence: 858,Negative,O
Sentence: 858,symptom,O
Sentence: 858,outcomes,O
Sentence: 858,and,O
Sentence: 858,measures,O
Sentence: 858,of,O
Sentence: 858,parkinsonism,B-Disease
Sentence: 858,and,O
Sentence: 858,akathisia,B-Disease
Sentence: 858,did,O
Sentence: 858,not,O
Sentence: 858,differ,O
Sentence: 858,between,O
Sentence: 858,medications,O
Sentence: 858,.,O
Sentence: 858,Extrapyramidal,B-Disease
Sentence: 858,symptom,I-Disease
Sentence: 858,severity,O
Sentence: 858,scores,O
Sentence: 858,were,O
Sentence: 858,1.4,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,1.2,O
Sentence: 858,-,O
Sentence: 858,1.6,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,and,O
Sentence: 858,1.2,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,1.0,O
Sentence: 858,-,O
Sentence: 858,1.4,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,.,O
Sentence: 858,Significantly,O
Sentence: 858,more,O
Sentence: 858,weight,B-Disease
Sentence: 858,gain,I-Disease
Sentence: 858,occurred,O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,than,O
Sentence: 858,with,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,:,O
Sentence: 858,the,O
Sentence: 858,increase,O
Sentence: 858,in,O
Sentence: 858,weight,O
Sentence: 858,at,O
Sentence: 858,4,O
Sentence: 858,months,O
Sentence: 858,relative,O
Sentence: 858,to,O
Sentence: 858,baseline,O
Sentence: 858,weight,O
Sentence: 858,was,O
Sentence: 858,17.3,O
Sentence: 858,%,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,14.2,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,20.5,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,and,O
Sentence: 858,11.3,O
Sentence: 858,%,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,8.4,O
Sentence: 858,%,O
Sentence: 858,,O
Sentence: 858,-,O
Sentence: 858,14.3,O
Sentence: 858,%,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,.,O
Sentence: 858,Body,O
Sentence: 858,mass,O
Sentence: 858,index,O
Sentence: 858,at,O
Sentence: 858,baseline,O
Sentence: 858,and,O
Sentence: 858,at,O
Sentence: 858,4,O
Sentence: 858,months,O
Sentence: 858,was,O
Sentence: 858,24.3,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,22.8,O
Sentence: 858,-,O
Sentence: 858,25.7,O
Sentence: 858,),O
Sentence: 858,versus,O
Sentence: 858,28.2,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,26.7,O
Sentence: 858,-,O
Sentence: 858,29.7,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,and,O
Sentence: 858,23.9,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,22.5,O
Sentence: 858,-,O
Sentence: 858,25.3,O
Sentence: 858,),O
Sentence: 858,versus,O
Sentence: 858,26.7,O
Sentence: 858,(,O
Sentence: 858,95,O
Sentence: 858,%,O
Sentence: 858,CI,O
Sentence: 858,=,O
Sentence: 858,25.2,O
Sentence: 858,-,O
Sentence: 858,28.2,O
Sentence: 858,),O
Sentence: 858,with,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,.,O
Sentence: 858,CONCLUSIONS,O
Sentence: 858,:,O
Sentence: 858,Clinical,O
Sentence: 858,outcomes,O
Sentence: 858,with,O
Sentence: 858,risperidone,B-Chemical
Sentence: 858,were,O
Sentence: 858,equal,O
Sentence: 858,to,O
Sentence: 858,those,O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,",",O
Sentence: 858,and,O
Sentence: 858,response,O
Sentence: 858,may,O
Sentence: 858,be,O
Sentence: 858,more,O
Sentence: 858,stable,O
Sentence: 858,.,O
Sentence: 858,Olanzapine,B-Chemical
Sentence: 858,may,O
Sentence: 858,have,O
Sentence: 858,an,O
Sentence: 858,advantage,O
Sentence: 858,for,O
Sentence: 858,motor,O
Sentence: 858,side,O
Sentence: 858,effects,O
Sentence: 858,.,O
Sentence: 858,Both,O
Sentence: 858,medications,O
Sentence: 858,caused,O
Sentence: 858,substantial,O
Sentence: 858,rapid,O
Sentence: 858,weight,B-Disease
Sentence: 858,gain,I-Disease
Sentence: 858,",",O
Sentence: 858,but,O
Sentence: 858,weight,B-Disease
Sentence: 858,gain,I-Disease
Sentence: 858,was,O
Sentence: 858,greater,O
Sentence: 858,with,O
Sentence: 858,olanzapine,B-Chemical
Sentence: 858,.,O
Sentence: 859,Early,O
Sentence: 859,paracentral,O
Sentence: 859,visual,B-Disease
Sentence: 859,field,I-Disease
Sentence: 859,loss,I-Disease
Sentence: 859,in,O
Sentence: 859,patients,O
Sentence: 859,taking,O
Sentence: 859,hydroxychloroquine,B-Chemical
Sentence: 859,.,O
Sentence: 860,OBJECTIVE,O
Sentence: 860,:,O
Sentence: 860,To,O
Sentence: 860,review,O
Sentence: 860,the,O
Sentence: 860,natural,O
Sentence: 860,history,O
Sentence: 860,and,O
Sentence: 860,ocular,O
Sentence: 860,and,O
Sentence: 860,systemic,O
Sentence: 860,adverse,O
Sentence: 860,effects,O
Sentence: 860,of,O
Sentence: 860,patients,O
Sentence: 860,taking,O
Sentence: 860,hydroxychloroquine,B-Chemical
Sentence: 860,sulfate,I-Chemical
Sentence: 860,who,O
Sentence: 860,attended,O
Sentence: 860,an,O
Sentence: 860,ophthalmic,O
Sentence: 860,screening,O
Sentence: 860,program,O
Sentence: 860,.,O
Sentence: 860,DESIGN,O
Sentence: 860,:,O
Sentence: 860,Retrospective,O
Sentence: 860,study,O
Sentence: 860,.,O
Sentence: 860,RESULTS,O
Sentence: 860,:,O
Sentence: 860,Records,O
Sentence: 860,of,O
Sentence: 860,262,O
Sentence: 860,patients,O
Sentence: 860,who,O
Sentence: 860,were,O
Sentence: 860,taking,O
Sentence: 860,hydroxychloroquine,B-Chemical
Sentence: 860,and,O
Sentence: 860,screened,O
Sentence: 860,in,O
Sentence: 860,the,O
Sentence: 860,Department,O
Sentence: 860,of,O
Sentence: 860,Ophthalmology,O
Sentence: 860,were,O
Sentence: 860,reviewed,O
Sentence: 860,.,O
Sentence: 860,Of,O
Sentence: 860,the,O
Sentence: 860,262,O
Sentence: 860,patients,O
Sentence: 860,",",O
Sentence: 860,14,O
Sentence: 860,(,O
Sentence: 860,18,O
Sentence: 860,%,O
Sentence: 860,),O
Sentence: 860,of,O
Sentence: 860,76,O
Sentence: 860,who,O
Sentence: 860,had,O
Sentence: 860,stopped,O
Sentence: 860,treatment,O
Sentence: 860,at,O
Sentence: 860,the,O
Sentence: 860,time,O
Sentence: 860,of,O
Sentence: 860,the,O
Sentence: 860,study,O
Sentence: 860,experienced,O
Sentence: 860,documented,O
Sentence: 860,adverse,O
Sentence: 860,effects,O
Sentence: 860,.,O
Sentence: 860,Systemic,O
Sentence: 860,adverse,O
Sentence: 860,effects,O
Sentence: 860,occurred,O
Sentence: 860,in,O
Sentence: 860,8,O
Sentence: 860,patients,O
Sentence: 860,(,O
Sentence: 860,10.5,O
Sentence: 860,%,O
Sentence: 860,),O
Sentence: 860,and,O
Sentence: 860,ocular,O
Sentence: 860,adverse,O
Sentence: 860,effects,O
Sentence: 860,",",O
Sentence: 860,in,O
Sentence: 860,5,O
Sentence: 860,(,O
Sentence: 860,6.5,O
Sentence: 860,%,O
Sentence: 860,),O
Sentence: 860,.,O
Sentence: 860,Thirty,O
Sentence: 860,-,O
Sentence: 860,five,O
Sentence: 860,patients,O
Sentence: 860,(,O
Sentence: 860,13.4,O
Sentence: 860,%,O
Sentence: 860,),O
Sentence: 860,had,O
Sentence: 860,visual,B-Disease
Sentence: 860,field,I-Disease
Sentence: 860,abnormalities,I-Disease
Sentence: 860,",",O
Sentence: 860,which,O
Sentence: 860,were,O
Sentence: 860,attributed,O
Sentence: 860,to,O
Sentence: 860,hydroxychloroquine,B-Chemical
Sentence: 860,treatment,O
Sentence: 860,in,O
Sentence: 860,4,O
Sentence: 860,patients,O
Sentence: 860,(,O
Sentence: 860,1.5,O
Sentence: 860,%,O
Sentence: 860,),O
Sentence: 860,.,O
Sentence: 860,Three,O
Sentence: 860,of,O
Sentence: 860,the,O
Sentence: 860,4,O
Sentence: 860,patients,O
Sentence: 860,were,O
Sentence: 860,taking,O
Sentence: 860,less,O
Sentence: 860,than,O
Sentence: 860,6.5,O
Sentence: 860,mg,O
Sentence: 860,/,O
Sentence: 860,kg,O
Sentence: 860,per,O
Sentence: 860,day,O
Sentence: 860,and,O
Sentence: 860,all,O
Sentence: 860,patients,O
Sentence: 860,had,O
Sentence: 860,normal,O
Sentence: 860,renal,O
Sentence: 860,and,O
Sentence: 860,liver,O
Sentence: 860,function,O
Sentence: 860,test,O
Sentence: 860,results,O
Sentence: 860,.,O
Sentence: 860,CONCLUSIONS,O
Sentence: 860,:,O
Sentence: 860,The,O
Sentence: 860,current,O
Sentence: 860,study,O
Sentence: 860,used,O
Sentence: 860,a,O
Sentence: 860,protocol,O
Sentence: 860,of,O
Sentence: 860,visual,O
Sentence: 860,acuity,O
Sentence: 860,and,O
Sentence: 860,color,O
Sentence: 860,vision,O
Sentence: 860,assessment,O
Sentence: 860,",",O
Sentence: 860,funduscopy,O
Sentence: 860,",",O
Sentence: 860,and,O
Sentence: 860,Humphrey,O
Sentence: 860,10,O
Sentence: 860,-,O
Sentence: 860,2,O
Sentence: 860,visual,O
Sentence: 860,field,O
Sentence: 860,testing,O
Sentence: 860,and,O
Sentence: 860,shows,O
Sentence: 860,that,O
Sentence: 860,visual,B-Disease
Sentence: 860,field,I-Disease
Sentence: 860,defects,I-Disease
Sentence: 860,appeared,O
Sentence: 860,before,O
Sentence: 860,any,O
Sentence: 860,corresponding,O
Sentence: 860,changes,O
Sentence: 860,in,O
Sentence: 860,any,O
Sentence: 860,other,O
Sentence: 860,tested,O
Sentence: 860,clinical,O
Sentence: 860,parameters,O
Sentence: 860,;,O
Sentence: 860,the,O
Sentence: 860,defects,O
Sentence: 860,were,O
Sentence: 860,reproducible,O
Sentence: 860,and,O
Sentence: 860,the,O
Sentence: 860,test,O
Sentence: 860,parameters,O
Sentence: 860,were,O
Sentence: 860,reliable,O
Sentence: 860,.,O
Sentence: 860,Patients,O
Sentence: 860,taking,O
Sentence: 860,hydroxychloroquine,B-Chemical
Sentence: 860,can,O
Sentence: 860,demonstrate,O
Sentence: 860,a,O
Sentence: 860,toxic,O
Sentence: 860,reaction,O
Sentence: 860,in,O
Sentence: 860,the,O
Sentence: 860,retina,O
Sentence: 860,despite,O
Sentence: 860,the,O
Sentence: 860,absence,O
Sentence: 860,of,O
Sentence: 860,known,O
Sentence: 860,risk,O
Sentence: 860,factors,O
Sentence: 860,.,O
Sentence: 860,Screening,O
Sentence: 860,",",O
Sentence: 860,including,O
Sentence: 860,Humphrey,O
Sentence: 860,10,O
Sentence: 860,-,O
Sentence: 860,2,O
Sentence: 860,visual,O
Sentence: 860,field,O
Sentence: 860,assessment,O
Sentence: 860,",",O
Sentence: 860,is,O
Sentence: 860,recommended,O
Sentence: 860,2,O
Sentence: 860,years,O
Sentence: 860,after,O
Sentence: 860,the,O
Sentence: 860,initial,O
Sentence: 860,baseline,O
Sentence: 860,and,O
Sentence: 860,yearly,O
Sentence: 860,thereafter,O
Sentence: 860,.,O
Sentence: 861,Peri,O
Sentence: 861,-,O
Sentence: 861,operative,O
Sentence: 861,atrioventricular,B-Disease
Sentence: 861,block,I-Disease
Sentence: 861,as,O
Sentence: 861,a,O
Sentence: 861,result,O
Sentence: 861,of,O
Sentence: 861,chemotherapy,O
Sentence: 861,with,O
Sentence: 861,epirubicin,B-Chemical
Sentence: 861,and,O
Sentence: 861,paclitaxel,B-Chemical
Sentence: 861,.,O
Sentence: 862,A,O
Sentence: 862,47,O
Sentence: 862,-,O
Sentence: 862,year,O
Sentence: 862,-,O
Sentence: 862,old,O
Sentence: 862,woman,O
Sentence: 862,presented,O
Sentence: 862,for,O
Sentence: 862,mastectomy,O
Sentence: 862,and,O
Sentence: 862,immediate,O
Sentence: 862,latissimus,O
Sentence: 862,dorsi,O
Sentence: 862,flap,O
Sentence: 862,reconstruction,O
Sentence: 862,having,O
Sentence: 862,been,O
Sentence: 862,diagnosed,O
Sentence: 862,with,O
Sentence: 862,carcinoma,B-Disease
Sentence: 862,of,I-Disease
Sentence: 862,the,I-Disease
Sentence: 862,breast,I-Disease
Sentence: 862,6,O
Sentence: 862,months,O
Sentence: 862,previously,O
Sentence: 862,.,O
Sentence: 862,In,O
Sentence: 862,the,O
Sentence: 862,preceding,O
Sentence: 862,months,O
Sentence: 862,she,O
Sentence: 862,had,O
Sentence: 862,received,O
Sentence: 862,neo,O
Sentence: 862,-,O
Sentence: 862,adjuvant,O
Sentence: 862,chemotherapy,O
Sentence: 862,with,O
Sentence: 862,epirubicin,B-Chemical
Sentence: 862,",",O
Sentence: 862,paclitaxel,B-Chemical
Sentence: 862,(,O
Sentence: 862,Taxol,B-Chemical
Sentence: 862,),O
Sentence: 862,and,O
Sentence: 862,cyclophosphamide,B-Chemical
Sentence: 862,.,O
Sentence: 862,This,O
Sentence: 862,had,O
Sentence: 862,been,O
Sentence: 862,apparently,O
Sentence: 862,uncomplicated,O
Sentence: 862,and,O
Sentence: 862,she,O
Sentence: 862,had,O
Sentence: 862,maintained,O
Sentence: 862,a,O
Sentence: 862,remarkably,O
Sentence: 862,high,O
Sentence: 862,level,O
Sentence: 862,of,O
Sentence: 862,physical,O
Sentence: 862,activity,O
Sentence: 862,.,O
Sentence: 862,She,O
Sentence: 862,was,O
Sentence: 862,found,O
Sentence: 862,to,O
Sentence: 862,be,O
Sentence: 862,bradycardic,B-Disease
Sentence: 862,at,O
Sentence: 862,pre,O
Sentence: 862,-,O
Sentence: 862,operative,O
Sentence: 862,assessment,O
Sentence: 862,but,O
Sentence: 862,had,O
Sentence: 862,no,O
Sentence: 862,cardiac,O
Sentence: 862,symptoms,O
Sentence: 862,.,O
Sentence: 862,Second,O
Sentence: 862,degree,O
Sentence: 862,Mobitz,O
Sentence: 862,type,O
Sentence: 862,II,O
Sentence: 862,atrioventricular,B-Disease
Sentence: 862,block,I-Disease
Sentence: 862,was,O
Sentence: 862,diagnosed,O
Sentence: 862,on,O
Sentence: 862,electrocardiogram,O
Sentence: 862,",",O
Sentence: 862,and,O
Sentence: 862,temporary,O
Sentence: 862,transvenous,O
Sentence: 862,ventricular,O
Sentence: 862,pacing,O
Sentence: 862,instituted,O
Sentence: 862,in,O
Sentence: 862,the,O
Sentence: 862,peri,O
Sentence: 862,-,O
Sentence: 862,operative,O
Sentence: 862,period,O
Sentence: 862,.,O
Sentence: 862,We,O
Sentence: 862,discuss,O
Sentence: 862,how,O
Sentence: 862,evidence,O
Sentence: 862,-,O
Sentence: 862,based,O
Sentence: 862,guidelines,O
Sentence: 862,would,O
Sentence: 862,not,O
Sentence: 862,have,O
Sentence: 862,been,O
Sentence: 862,helpful,O
Sentence: 862,in,O
Sentence: 862,this,O
Sentence: 862,case,O
Sentence: 862,",",O
Sentence: 862,and,O
Sentence: 862,how,O
Sentence: 862,chemotherapy,O
Sentence: 862,can,O
Sentence: 862,exhibit,O
Sentence: 862,substantial,O
Sentence: 862,cardiotoxicity,B-Disease
Sentence: 862,that,O
Sentence: 862,may,O
Sentence: 862,develop,O
Sentence: 862,over,O
Sentence: 862,many,O
Sentence: 862,years,O
Sentence: 862,.,O
Sentence: 862,We,O
Sentence: 862,suggest,O
Sentence: 862,that,O
Sentence: 862,patients,O
Sentence: 862,who,O
Sentence: 862,have,O
Sentence: 862,received,O
Sentence: 862,chemotherapy,O
Sentence: 862,at,O
Sentence: 862,any,O
Sentence: 862,time,O
Sentence: 862,should,O
Sentence: 862,have,O
Sentence: 862,a,O
Sentence: 862,pre,O
Sentence: 862,-,O
Sentence: 862,operative,O
Sentence: 862,electrocardiogram,O
Sentence: 862,even,O
Sentence: 862,if,O
Sentence: 862,they,O
Sentence: 862,are,O
Sentence: 862,asymptomatic,O
Sentence: 862,.,O
Sentence: 863,Risks,O
Sentence: 863,and,O
Sentence: 863,benefits,O
Sentence: 863,of,O
Sentence: 863,COX,O
Sentence: 863,-,O
Sentence: 863,2,O
Sentence: 863,inhibitors,O
Sentence: 863,vs,O
Sentence: 863,non,O
Sentence: 863,-,O
Sentence: 863,selective,O
Sentence: 863,NSAIDs,O
Sentence: 863,:,O
Sentence: 863,does,O
Sentence: 863,their,O
Sentence: 863,cardiovascular,O
Sentence: 863,risk,O
Sentence: 863,exceed,O
Sentence: 863,their,O
Sentence: 863,gastrointestinal,O
Sentence: 863,benefit,O
Sentence: 863,?,O
Sentence: 863,A,O
Sentence: 863,retrospective,O
Sentence: 863,cohort,O
Sentence: 863,study,O
Sentence: 863,.,O
Sentence: 864,OBJECTIVES,O
Sentence: 864,:,O
Sentence: 864,The,O
Sentence: 864,risk,O
Sentence: 864,of,O
Sentence: 864,acute,B-Disease
Sentence: 864,myocardial,I-Disease
Sentence: 864,infarction,I-Disease
Sentence: 864,(,O
Sentence: 864,AMI,B-Disease
Sentence: 864,),O
Sentence: 864,with,O
Sentence: 864,COX,O
Sentence: 864,-,O
Sentence: 864,2,O
Sentence: 864,inhibitors,O
Sentence: 864,may,O
Sentence: 864,offset,O
Sentence: 864,their,O
Sentence: 864,gastrointestinal,O
Sentence: 864,(,O
Sentence: 864,GI,O
Sentence: 864,),O
Sentence: 864,benefit,O
Sentence: 864,compared,O
Sentence: 864,with,O
Sentence: 864,non,O
Sentence: 864,-,O
Sentence: 864,selective,O
Sentence: 864,(,O
Sentence: 864,NS,O
Sentence: 864,),O
Sentence: 864,non,O
Sentence: 864,-,O
Sentence: 864,steroidal,O
Sentence: 864,anti,O
Sentence: 864,-,O
Sentence: 864,inflammatory,O
Sentence: 864,drugs,O
Sentence: 864,(,O
Sentence: 864,NSAIDs,O
Sentence: 864,),O
Sentence: 864,.,O
Sentence: 864,We,O
Sentence: 864,aimed,O
Sentence: 864,to,O
Sentence: 864,compare,O
Sentence: 864,the,O
Sentence: 864,risks,O
Sentence: 864,of,O
Sentence: 864,hospitalization,O
Sentence: 864,for,O
Sentence: 864,AMI,B-Disease
Sentence: 864,and,O
Sentence: 864,GI,B-Disease
Sentence: 864,bleeding,I-Disease
Sentence: 864,among,O
Sentence: 864,elderly,O
Sentence: 864,patients,O
Sentence: 864,using,O
Sentence: 864,COX,O
Sentence: 864,-,O
Sentence: 864,2,O
Sentence: 864,inhibitors,O
Sentence: 864,",",O
Sentence: 864,NS,O
Sentence: 864,-,O
Sentence: 864,NSAIDs,O
Sentence: 864,and,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,.,O
Sentence: 864,METHODS,O
Sentence: 864,:,O
Sentence: 864,We,O
Sentence: 864,conducted,O
Sentence: 864,a,O
Sentence: 864,retrospective,O
Sentence: 864,cohort,O
Sentence: 864,study,O
Sentence: 864,using,O
Sentence: 864,administrative,O
Sentence: 864,data,O
Sentence: 864,of,O
Sentence: 864,patients,O
Sentence: 864,,O
Sentence: 864,>,O
Sentence: 864,,O
Sentence: 864,or,O
Sentence: 864,,O
Sentence: 864,=,O
Sentence: 864,65,O
Sentence: 864,years,O
Sentence: 864,of,O
Sentence: 864,age,O
Sentence: 864,who,O
Sentence: 864,filled,O
Sentence: 864,a,O
Sentence: 864,prescription,O
Sentence: 864,for,O
Sentence: 864,NSAID,O
Sentence: 864,or,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,during,O
Sentence: 864,1999,O
Sentence: 864,-,O
Sentence: 864,2002,O
Sentence: 864,.,O
Sentence: 864,Outcomes,O
Sentence: 864,were,O
Sentence: 864,compared,O
Sentence: 864,using,O
Sentence: 864,Cox,O
Sentence: 864,regression,O
Sentence: 864,models,O
Sentence: 864,with,O
Sentence: 864,time,O
Sentence: 864,-,O
Sentence: 864,dependent,O
Sentence: 864,exposures,O
Sentence: 864,.,O
Sentence: 864,RESULTS,O
Sentence: 864,:,O
Sentence: 864,Person,O
Sentence: 864,-,O
Sentence: 864,years,O
Sentence: 864,of,O
Sentence: 864,exposure,O
Sentence: 864,among,O
Sentence: 864,non,O
Sentence: 864,-,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,were,O
Sentence: 864,:,O
Sentence: 864,"75,761",O
Sentence: 864,to,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,",",O
Sentence: 864,"42,671",O
Sentence: 864,to,O
Sentence: 864,rofecoxib,B-Chemical
Sentence: 864,"65,860",O
Sentence: 864,to,O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,",",O
Sentence: 864,and,O
Sentence: 864,"37,495",O
Sentence: 864,to,O
Sentence: 864,NS,O
Sentence: 864,-,O
Sentence: 864,NSAIDs,O
Sentence: 864,.,O
Sentence: 864,Among,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,",",O
Sentence: 864,they,O
Sentence: 864,were,O
Sentence: 864,:,O
Sentence: 864,"14,671",O
Sentence: 864,to,O
Sentence: 864,rofecoxib,B-Chemical
Sentence: 864,",",O
Sentence: 864,"22,875",O
Sentence: 864,to,O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,",",O
Sentence: 864,"9,832",O
Sentence: 864,to,O
Sentence: 864,NS,O
Sentence: 864,-,O
Sentence: 864,NSAIDs,O
Sentence: 864,and,O
Sentence: 864,"38,048",O
Sentence: 864,to,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,.,O
Sentence: 864,Among,O
Sentence: 864,non,O
Sentence: 864,-,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,",",O
Sentence: 864,the,O
Sentence: 864,adjusted,O
Sentence: 864,hazard,O
Sentence: 864,ratios,O
Sentence: 864,(,O
Sentence: 864,95,O
Sentence: 864,%,O
Sentence: 864,confidence,O
Sentence: 864,interval,O
Sentence: 864,),O
Sentence: 864,of,O
Sentence: 864,hospitalization,O
Sentence: 864,for,O
Sentence: 864,AMI,B-Disease
Sentence: 864,/,O
Sentence: 864,GI,O
Sentence: 864,vs,O
Sentence: 864,the,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,(,O
Sentence: 864,with,O
Sentence: 864,no,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,),O
Sentence: 864,group,O
Sentence: 864,were,O
Sentence: 864,:,O
Sentence: 864,rofecoxib,B-Chemical
Sentence: 864,1.27,O
Sentence: 864,(,O
Sentence: 864,1.13,O
Sentence: 864,",",O
Sentence: 864,1.42,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,0.93,O
Sentence: 864,(,O
Sentence: 864,0.83,O
Sentence: 864,",",O
Sentence: 864,1.03,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,naproxen,B-Chemical
Sentence: 864,1.59,O
Sentence: 864,(,O
Sentence: 864,1.31,O
Sentence: 864,",",O
Sentence: 864,1.93,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,diclofenac,B-Chemical
Sentence: 864,1.17,O
Sentence: 864,(,O
Sentence: 864,0.99,O
Sentence: 864,",",O
Sentence: 864,1.38,O
Sentence: 864,),O
Sentence: 864,and,O
Sentence: 864,ibuprofen,B-Chemical
Sentence: 864,1.05,O
Sentence: 864,(,O
Sentence: 864,0.74,O
Sentence: 864,",",O
Sentence: 864,1.51,O
Sentence: 864,),O
Sentence: 864,.,O
Sentence: 864,Among,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,",",O
Sentence: 864,they,O
Sentence: 864,were,O
Sentence: 864,:,O
Sentence: 864,rofecoxib,B-Chemical
Sentence: 864,1.73,O
Sentence: 864,(,O
Sentence: 864,1.52,O
Sentence: 864,",",O
Sentence: 864,1.98,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,1.34,O
Sentence: 864,(,O
Sentence: 864,1.19,O
Sentence: 864,",",O
Sentence: 864,1.52,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,ibuprofen,B-Chemical
Sentence: 864,1.51,O
Sentence: 864,(,O
Sentence: 864,0.95,O
Sentence: 864,",",O
Sentence: 864,2.41,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,diclofenac,B-Chemical
Sentence: 864,1.69,O
Sentence: 864,(,O
Sentence: 864,1.35,O
Sentence: 864,",",O
Sentence: 864,2.10,O
Sentence: 864,),O
Sentence: 864,",",O
Sentence: 864,naproxen,B-Chemical
Sentence: 864,1.35,O
Sentence: 864,(,O
Sentence: 864,0.97,O
Sentence: 864,",",O
Sentence: 864,1.88,O
Sentence: 864,),O
Sentence: 864,and,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,1.29,O
Sentence: 864,(,O
Sentence: 864,1.17,O
Sentence: 864,",",O
Sentence: 864,1.42,O
Sentence: 864,),O
Sentence: 864,.,O
Sentence: 864,CONCLUSION,O
Sentence: 864,:,O
Sentence: 864,Among,O
Sentence: 864,non,O
Sentence: 864,-,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,",",O
Sentence: 864,naproxen,B-Chemical
Sentence: 864,seemed,O
Sentence: 864,to,O
Sentence: 864,carry,O
Sentence: 864,the,O
Sentence: 864,highest,O
Sentence: 864,risk,O
Sentence: 864,for,O
Sentence: 864,AMI,B-Disease
Sentence: 864,/,O
Sentence: 864,GI,B-Disease
Sentence: 864,bleeding,I-Disease
Sentence: 864,.,O
Sentence: 864,The,O
Sentence: 864,AMI,B-Disease
Sentence: 864,/,O
Sentence: 864,GI,O
Sentence: 864,toxicity,B-Disease
Sentence: 864,of,O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,was,O
Sentence: 864,similar,O
Sentence: 864,to,O
Sentence: 864,that,O
Sentence: 864,of,O
Sentence: 864,acetaminophen,B-Chemical
Sentence: 864,and,O
Sentence: 864,seemed,O
Sentence: 864,to,O
Sentence: 864,be,O
Sentence: 864,better,O
Sentence: 864,than,O
Sentence: 864,those,O
Sentence: 864,of,O
Sentence: 864,rofecoxib,B-Chemical
Sentence: 864,and,O
Sentence: 864,NS,O
Sentence: 864,-,O
Sentence: 864,NSAIDs,O
Sentence: 864,.,O
Sentence: 864,Among,O
Sentence: 864,users,O
Sentence: 864,of,O
Sentence: 864,aspirin,B-Chemical
Sentence: 864,",",O
Sentence: 864,both,O
Sentence: 864,celecoxib,B-Chemical
Sentence: 864,and,O
Sentence: 864,naproxen,B-Chemical
Sentence: 864,seemed,O
Sentence: 864,to,O
Sentence: 864,be,O
Sentence: 864,the,O
Sentence: 864,least,O
Sentence: 864,toxic,O
Sentence: 864,.,O
Sentence: 865,Quinine,B-Chemical
Sentence: 865,-,O
Sentence: 865,induced,O
Sentence: 865,arrhythmia,B-Disease
Sentence: 865,in,O
Sentence: 865,a,O
Sentence: 865,patient,O
Sentence: 865,with,O
Sentence: 865,severe,B-Disease
Sentence: 865,malaria,I-Disease
Sentence: 865,.,O
Sentence: 866,It,O
Sentence: 866,was,O
Sentence: 866,reported,O
Sentence: 866,that,O
Sentence: 866,there,O
Sentence: 866,was,O
Sentence: 866,a,O
Sentence: 866,case,O
Sentence: 866,of,O
Sentence: 866,severe,B-Disease
Sentence: 866,malaria,B-Disease
Sentence: 866,patient,O
Sentence: 866,with,O
Sentence: 866,jaundice,B-Disease
Sentence: 866,who,O
Sentence: 866,presented,O
Sentence: 866,with,O
Sentence: 866,arrhythmia,B-Disease
Sentence: 866,(,O
Sentence: 866,premature,B-Disease
Sentence: 866,ventricular,I-Disease
Sentence: 866,contraction,I-Disease
Sentence: 866,),O
Sentence: 866,while,O
Sentence: 866,getting,O
Sentence: 866,quinine,B-Chemical
Sentence: 866,infusion,O
Sentence: 866,was,O
Sentence: 866,reported,O
Sentence: 866,.,O
Sentence: 866,A,O
Sentence: 866,man,O
Sentence: 866,",",O
Sentence: 866,25,O
Sentence: 866,years,O
Sentence: 866,old,O
Sentence: 866,",",O
Sentence: 866,was,O
Sentence: 866,admitted,O
Sentence: 866,to,O
Sentence: 866,hospital,O
Sentence: 866,with,O
Sentence: 866,high,O
Sentence: 866,fever,B-Disease
Sentence: 866,",",O
Sentence: 866,chill,B-Disease
Sentence: 866,",",O
Sentence: 866,vomiting,B-Disease
Sentence: 866,",",O
Sentence: 866,jaundice,B-Disease
Sentence: 866,.,O
Sentence: 866,The,O
Sentence: 866,patient,O
Sentence: 866,was,O
Sentence: 866,fully,O
Sentence: 866,conscious,O
Sentence: 866,",",O
Sentence: 866,blood,O
Sentence: 866,pressure,O
Sentence: 866,120,O
Sentence: 866,/,O
Sentence: 866,80,O
Sentence: 866,mmHg,O
Sentence: 866,",",O
Sentence: 866,pulse,O
Sentence: 866,rate,O
Sentence: 866,100,O
Sentence: 866,x,O
Sentence: 866,/,O
Sentence: 866,minute,O
Sentence: 866,",",O
Sentence: 866,regular,O
Sentence: 866,.,O
Sentence: 866,On,O
Sentence: 866,admission,O
Sentence: 866,",",O
Sentence: 866,laboratory,O
Sentence: 866,examination,O
Sentence: 866,showed,O
Sentence: 866,Plasmodium,O
Sentence: 866,falciparum,O
Sentence: 866,(,O
Sentence: 866,++++,O
Sentence: 866,),O
Sentence: 866,",",O
Sentence: 866,total,O
Sentence: 866,bilirubin,B-Chemical
Sentence: 866,8.25,O
Sentence: 866,mg,O
Sentence: 866,/,O
Sentence: 866,dL,O
Sentence: 866,",",O
Sentence: 866,conjugated,O
Sentence: 866,bilirubin,B-Chemical
Sentence: 866,4.36,O
Sentence: 866,mg,O
Sentence: 866,/,O
Sentence: 866,dL,O
Sentence: 866,",",O
Sentence: 866,unconjugated,O
Sentence: 866,bilirubin,B-Chemical
Sentence: 866,3.89,O
Sentence: 866,mg,O
Sentence: 866,/,O
Sentence: 866,dL,O
Sentence: 866,",",O
Sentence: 866,potassium,B-Chemical
Sentence: 866,3.52,O
Sentence: 866,meq,O
Sentence: 866,/,O
Sentence: 866,L,O
Sentence: 866,Patient,O
Sentence: 866,was,O
Sentence: 866,diagnosed,O
Sentence: 866,as,O
Sentence: 866,severe,B-Disease
Sentence: 866,malaria,B-Disease
Sentence: 866,with,O
Sentence: 866,jaundice,B-Disease
Sentence: 866,and,O
Sentence: 866,got,O
Sentence: 866,quinine,B-Chemical
Sentence: 866,infusion,O
Sentence: 866,in,O
Sentence: 866,dextrose,B-Chemical
Sentence: 866,5,O
Sentence: 866,%,O
Sentence: 866,500,O
Sentence: 866,mg,O
Sentence: 866,/,O
Sentence: 866,8,O
Sentence: 866,hour,O
Sentence: 866,.,O
Sentence: 866,On,O
Sentence: 866,the,O
Sentence: 866,second,O
Sentence: 866,day,O
Sentence: 866,the,O
Sentence: 866,patient,O
Sentence: 866,had,O
Sentence: 866,vomitus,B-Disease
Sentence: 866,",",O
Sentence: 866,diarrhea,B-Disease
Sentence: 866,",",O
Sentence: 866,tinnitus,B-Disease
Sentence: 866,",",O
Sentence: 866,loss,B-Disease
Sentence: 866,of,I-Disease
Sentence: 866,hearing,I-Disease
Sentence: 866,.,O
Sentence: 866,After,O
Sentence: 866,30,O
Sentence: 866,hours,O
Sentence: 866,of,O
Sentence: 866,quinine,B-Chemical
Sentence: 866,infusion,O
Sentence: 866,the,O
Sentence: 866,patient,O
Sentence: 866,felt,O
Sentence: 866,palpitation,B-Disease
Sentence: 866,and,O
Sentence: 866,electrocardiography,O
Sentence: 866,(,O
Sentence: 866,ECG,O
Sentence: 866,),O
Sentence: 866,recording,O
Sentence: 866,showed,O
Sentence: 866,premature,B-Disease
Sentence: 866,ventricular,I-Disease
Sentence: 866,contraction,I-Disease
Sentence: 866,(,O
Sentence: 866,PVC,B-Disease
Sentence: 866,),O
Sentence: 866,,O
Sentence: 866,>,O
Sentence: 866,,O
Sentence: 866,5,O
Sentence: 866,x,O
Sentence: 866,/,O
Sentence: 866,minute,O
Sentence: 866,",",O
Sentence: 866,trigemini,O
Sentence: 866,",",O
Sentence: 866,constant,O
Sentence: 866,type,O
Sentence: 866,,O
Sentence: 866,-,O
Sentence: 866,,O
Sentence: 866,-,O
Sentence: 866,,O
Sentence: 866,sinoatrial,B-Disease
Sentence: 866,block,I-Disease
Sentence: 866,",",O
Sentence: 866,positive,O
Sentence: 866,U,O
Sentence: 866,wave,O
Sentence: 866,.,O
Sentence: 866,He,O
Sentence: 866,was,O
Sentence: 866,treated,O
Sentence: 866,with,O
Sentence: 866,lidocaine,B-Chemical
Sentence: 866,50,O
Sentence: 866,mg,O
Sentence: 866,intravenously,O
Sentence: 866,followed,O
Sentence: 866,by,O
Sentence: 866,infusion,O
Sentence: 866,1500,O
Sentence: 866,mg,O
Sentence: 866,in,O
Sentence: 866,dextrose,B-Chemical
Sentence: 866,5,O
Sentence: 866,%,O
Sentence: 866,,O
Sentence: 866,/,O
Sentence: 866,24,O
Sentence: 866,hour,O
Sentence: 866,and,O
Sentence: 866,potassium,B-Chemical
Sentence: 866,aspartate,I-Chemical
Sentence: 866,tablet,O
Sentence: 866,.,O
Sentence: 866,Quinine,B-Chemical
Sentence: 866,infusion,O
Sentence: 866,was,O
Sentence: 866,discontinued,O
Sentence: 866,and,O
Sentence: 866,changed,O
Sentence: 866,with,O
Sentence: 866,sulfate,O
Sentence: 866,quinine,B-Chemical
Sentence: 866,tablets,O
Sentence: 866,.,O
Sentence: 866,Three,O
Sentence: 866,hours,O
Sentence: 866,later,O
Sentence: 866,the,O
Sentence: 866,patient,O
Sentence: 866,felt,O
Sentence: 866,better,O
Sentence: 866,",",O
Sentence: 866,the,O
Sentence: 866,frequency,O
Sentence: 866,of,O
Sentence: 866,PVC,B-Disease
Sentence: 866,reduced,O
Sentence: 866,to,O
Sentence: 866,4,O
Sentence: 866,,O
Sentence: 866,-,O
Sentence: 866,,O
Sentence: 866,5,O
Sentence: 866,x,O
Sentence: 866,/,O
Sentence: 866,minute,O
Sentence: 866,and,O
Sentence: 866,on,O
Sentence: 866,the,O
Sentence: 866,third,O
Sentence: 866,day,O
Sentence: 866,ECG,O
Sentence: 866,was,O
Sentence: 866,normal,O
Sentence: 866,",",O
Sentence: 866,potassium,B-Chemical
Sentence: 866,level,O
Sentence: 866,was,O
Sentence: 866,3.34,O
Sentence: 866,meq,O
Sentence: 866,/,O
Sentence: 866,L,O
Sentence: 866,.,O
Sentence: 866,He,O
Sentence: 866,was,O
Sentence: 866,discharged,O
Sentence: 866,on,O
Sentence: 866,7th,O
Sentence: 866,day,O
Sentence: 866,in,O
Sentence: 866,good,O
Sentence: 866,condition,O
Sentence: 866,.,O
Sentence: 866,Quinine,B-Chemical
Sentence: 866,",",O
Sentence: 866,like,O
Sentence: 866,quinidine,B-Chemical
Sentence: 866,",",O
Sentence: 866,is,O
Sentence: 866,a,O
Sentence: 866,chincona,O
Sentence: 866,alkaloid,O
Sentence: 866,that,O
Sentence: 866,has,O
Sentence: 866,anti,O
Sentence: 866,-,O
Sentence: 866,arrhythmic,B-Disease
Sentence: 866,property,O
Sentence: 866,",",O
Sentence: 866,although,O
Sentence: 866,it,O
Sentence: 866,also,O
Sentence: 866,pro,O
Sentence: 866,-,O
Sentence: 866,arrhythmic,B-Disease
Sentence: 866,that,O
Sentence: 866,can,O
Sentence: 866,cause,O
Sentence: 866,various,O
Sentence: 866,arrhythmias,B-Disease
Sentence: 866,",",O
Sentence: 866,including,O
Sentence: 866,severe,O
Sentence: 866,arrhythmia,B-Disease
Sentence: 866,such,O
Sentence: 866,as,O
Sentence: 866,multiple,O
Sentence: 866,PVC,B-Disease
Sentence: 866,.,O
Sentence: 866,Administration,O
Sentence: 866,of,O
Sentence: 866,parenteral,O
Sentence: 866,quinine,B-Chemical
Sentence: 866,must,O
Sentence: 866,be,O
Sentence: 866,done,O
Sentence: 866,carefully,O
Sentence: 866,and,O
Sentence: 866,with,O
Sentence: 866,good,O
Sentence: 866,observation,O
Sentence: 866,because,O
Sentence: 866,of,O
Sentence: 866,its,O
Sentence: 866,pro,O
Sentence: 866,-,O
Sentence: 866,arrhythmic,B-Disease
Sentence: 866,effect,O
Sentence: 866,",",O
Sentence: 866,especially,O
Sentence: 866,in,O
Sentence: 866,older,O
Sentence: 866,patients,O
Sentence: 866,who,O
Sentence: 866,have,O
Sentence: 866,heart,B-Disease
Sentence: 866,diseases,I-Disease
Sentence: 866,or,O
Sentence: 866,patients,O
Sentence: 866,with,O
Sentence: 866,electrolyte,B-Disease
Sentence: 866,disorder,I-Disease
Sentence: 866,(,O
Sentence: 866,hypokalemia,B-Disease
Sentence: 866,),O
Sentence: 866,which,O
Sentence: 866,frequently,O
Sentence: 866,occurs,O
Sentence: 866,due,O
Sentence: 866,to,O
Sentence: 866,vomiting,B-Disease
Sentence: 866,and,O
Sentence: 866,or,O
Sentence: 866,diarrhea,B-Disease
Sentence: 866,in,O
Sentence: 866,malaria,B-Disease
Sentence: 866,cases,O
Sentence: 866,.,O
Sentence: 867,Penicillamine,B-Chemical
Sentence: 867,-,O
Sentence: 867,related,O
Sentence: 867,lichenoid,B-Disease
Sentence: 867,dermatitis,I-Disease
Sentence: 867,and,O
Sentence: 867,utility,O
Sentence: 867,of,O
Sentence: 867,zinc,B-Chemical
Sentence: 867,acetate,I-Chemical
Sentence: 867,in,O
Sentence: 867,a,O
Sentence: 867,Wilson,B-Disease
Sentence: 867,disease,I-Disease
Sentence: 867,patient,O
Sentence: 867,with,O
Sentence: 867,hepatic,O
Sentence: 867,presentation,O
Sentence: 867,",",O
Sentence: 867,anxiety,B-Disease
Sentence: 867,and,O
Sentence: 867,SPECT,O
Sentence: 867,abnormalities,O
Sentence: 867,.,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,is,O
Sentence: 868,an,O
Sentence: 868,autosomal,O
Sentence: 868,recessive,O
Sentence: 868,disorder,O
Sentence: 868,of,O
Sentence: 868,hepatic,O
Sentence: 868,copper,B-Chemical
Sentence: 868,metabolism,O
Sentence: 868,with,O
Sentence: 868,consequent,O
Sentence: 868,copper,B-Chemical
Sentence: 868,accumulation,O
Sentence: 868,and,O
Sentence: 868,toxicity,B-Disease
Sentence: 868,in,O
Sentence: 868,many,O
Sentence: 868,tissues,O
Sentence: 868,and,O
Sentence: 868,consequent,O
Sentence: 868,hepatic,B-Disease
Sentence: 868,",",I-Disease
Sentence: 868,neurologic,I-Disease
Sentence: 868,and,I-Disease
Sentence: 868,psychiatric,B-Disease
Sentence: 868,disorders,I-Disease
Sentence: 868,.,O
Sentence: 868,We,O
Sentence: 868,report,O
Sentence: 868,a,O
Sentence: 868,case,O
Sentence: 868,of,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,with,O
Sentence: 868,chronic,B-Disease
Sentence: 868,liver,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,;,O
Sentence: 868,moreover,O
Sentence: 868,",",O
Sentence: 868,in,O
Sentence: 868,our,O
Sentence: 868,patient,O
Sentence: 868,",",O
Sentence: 868,presenting,O
Sentence: 868,also,O
Sentence: 868,with,O
Sentence: 868,high,O
Sentence: 868,levels,O
Sentence: 868,of,O
Sentence: 868,state,O
Sentence: 868,anxiety,B-Disease
Sentence: 868,without,O
Sentence: 868,depression,B-Disease
Sentence: 868,",",O
Sentence: 868,99mTc,O
Sentence: 868,-,O
Sentence: 868,ECD,O
Sentence: 868,-,O
Sentence: 868,SPECT,O
Sentence: 868,showed,O
Sentence: 868,cortical,O
Sentence: 868,hypoperfusion,O
Sentence: 868,in,O
Sentence: 868,frontal,O
Sentence: 868,lobes,O
Sentence: 868,",",O
Sentence: 868,more,O
Sentence: 868,marked,O
Sentence: 868,on,O
Sentence: 868,the,O
Sentence: 868,left,O
Sentence: 868,frontal,O
Sentence: 868,lobe,O
Sentence: 868,.,O
Sentence: 868,During,O
Sentence: 868,the,O
Sentence: 868,follow,O
Sentence: 868,-,O
Sentence: 868,up,O
Sentence: 868,of,O
Sentence: 868,our,O
Sentence: 868,patient,O
Sentence: 868,",",O
Sentence: 868,penicillamine,B-Chemical
Sentence: 868,was,O
Sentence: 868,interrupted,O
Sentence: 868,after,O
Sentence: 868,the,O
Sentence: 868,appearance,O
Sentence: 868,of,O
Sentence: 868,a,O
Sentence: 868,lichenoid,B-Disease
Sentence: 868,dermatitis,I-Disease
Sentence: 868,",",O
Sentence: 868,and,O
Sentence: 868,zinc,B-Chemical
Sentence: 868,acetate,I-Chemical
Sentence: 868,permitted,O
Sentence: 868,to,O
Sentence: 868,continue,O
Sentence: 868,the,O
Sentence: 868,successful,O
Sentence: 868,treatment,O
Sentence: 868,of,O
Sentence: 868,the,O
Sentence: 868,patient,O
Sentence: 868,without,O
Sentence: 868,side,O
Sentence: 868,-,O
Sentence: 868,effects,O
Sentence: 868,.,O
Sentence: 868,In,O
Sentence: 868,our,O
Sentence: 868,case,O
Sentence: 868,the,O
Sentence: 868,therapy,O
Sentence: 868,with,O
Sentence: 868,zinc,B-Chemical
Sentence: 868,acetate,I-Chemical
Sentence: 868,represented,O
Sentence: 868,an,O
Sentence: 868,effective,O
Sentence: 868,treatment,O
Sentence: 868,for,O
Sentence: 868,a,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,patient,O
Sentence: 868,in,O
Sentence: 868,which,O
Sentence: 868,penicillamine,B-Chemical
Sentence: 868,-,O
Sentence: 868,related,O
Sentence: 868,side,O
Sentence: 868,effects,O
Sentence: 868,appeared,O
Sentence: 868,.,O
Sentence: 868,The,O
Sentence: 868,safety,O
Sentence: 868,of,O
Sentence: 868,the,O
Sentence: 868,zinc,B-Chemical
Sentence: 868,acetate,I-Chemical
Sentence: 868,allowed,O
Sentence: 868,us,O
Sentence: 868,to,O
Sentence: 868,avoid,O
Sentence: 868,other,O
Sentence: 868,potentially,O
Sentence: 868,toxic,O
Sentence: 868,chelating,O
Sentence: 868,drugs,O
Sentence: 868,;,O
Sentence: 868,this,O
Sentence: 868,observation,O
Sentence: 868,is,O
Sentence: 868,in,O
Sentence: 868,line,O
Sentence: 868,with,O
Sentence: 868,the,O
Sentence: 868,growing,O
Sentence: 868,evidence,O
Sentence: 868,on,O
Sentence: 868,the,O
Sentence: 868,efficacy,O
Sentence: 868,of,O
Sentence: 868,the,O
Sentence: 868,drug,O
Sentence: 868,in,O
Sentence: 868,the,O
Sentence: 868,treatment,O
Sentence: 868,of,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,.,O
Sentence: 868,Since,O
Sentence: 868,most,O
Sentence: 868,of,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,penicillamine,B-Chemical
Sentence: 868,-,O
Sentence: 868,treated,O
Sentence: 868,patients,O
Sentence: 868,do,O
Sentence: 868,not,O
Sentence: 868,seem,O
Sentence: 868,to,O
Sentence: 868,develop,O
Sentence: 868,this,O
Sentence: 868,skin,B-Disease
Sentence: 868,lesion,I-Disease
Sentence: 868,",",O
Sentence: 868,it,O
Sentence: 868,could,O
Sentence: 868,be,O
Sentence: 868,conceivable,O
Sentence: 868,that,O
Sentence: 868,a,O
Sentence: 868,specific,O
Sentence: 868,genetic,O
Sentence: 868,factor,O
Sentence: 868,is,O
Sentence: 868,involved,O
Sentence: 868,in,O
Sentence: 868,drug,O
Sentence: 868,response,O
Sentence: 868,.,O
Sentence: 868,Further,O
Sentence: 868,studies,O
Sentence: 868,are,O
Sentence: 868,needed,O
Sentence: 868,for,O
Sentence: 868,a,O
Sentence: 868,better,O
Sentence: 868,clarification,O
Sentence: 868,of,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,therapy,O
Sentence: 868,",",O
Sentence: 868,and,O
Sentence: 868,in,O
Sentence: 868,particular,O
Sentence: 868,to,O
Sentence: 868,differentiate,O
Sentence: 868,specific,O
Sentence: 868,therapies,O
Sentence: 868,for,O
Sentence: 868,different,O
Sentence: 868,Wilson,B-Disease
Sentence: 868,'s,I-Disease
Sentence: 868,disease,I-Disease
Sentence: 868,phenotypes,O
Sentence: 868,.,O
Sentence: 869,A,O
Sentence: 869,dramatic,O
Sentence: 869,drop,B-Disease
Sentence: 869,in,I-Disease
Sentence: 869,blood,I-Disease
Sentence: 869,pressure,I-Disease
Sentence: 869,following,O
Sentence: 869,prehospital,O
Sentence: 869,GTN,B-Chemical
Sentence: 869,administration,O
Sentence: 869,.,O
Sentence: 870,A,O
Sentence: 870,male,O
Sentence: 870,in,O
Sentence: 870,his,O
Sentence: 870,sixties,O
Sentence: 870,with,O
Sentence: 870,no,O
Sentence: 870,history,O
Sentence: 870,of,O
Sentence: 870,cardiac,O
Sentence: 870,chest,B-Disease
Sentence: 870,pain,I-Disease
Sentence: 870,awoke,O
Sentence: 870,with,O
Sentence: 870,chest,B-Disease
Sentence: 870,pain,I-Disease
Sentence: 870,following,O
Sentence: 870,an,O
Sentence: 870,afternoon,O
Sentence: 870,sleep,O
Sentence: 870,.,O
Sentence: 870,The,O
Sentence: 870,patient,O
Sentence: 870,did,O
Sentence: 870,not,O
Sentence: 870,self,O
Sentence: 870,medicate,O
Sentence: 870,.,O
Sentence: 870,The,O
Sentence: 870,patient,O
Sentence: 870,'s,O
Sentence: 870,observations,O
Sentence: 870,were,O
Sentence: 870,within,O
Sentence: 870,normal,O
Sentence: 870,limits,O
Sentence: 870,",",O
Sentence: 870,he,O
Sentence: 870,was,O
Sentence: 870,administered,O
Sentence: 870,oxygen,B-Chemical
Sentence: 870,via,O
Sentence: 870,a,O
Sentence: 870,face,O
Sentence: 870,mask,O
Sentence: 870,and,O
Sentence: 870,glyceryl,B-Chemical
Sentence: 870,trinitrate,I-Chemical
Sentence: 870,(,O
Sentence: 870,GTN,B-Chemical
Sentence: 870,),O
Sentence: 870,.,O
Sentence: 870,Several,O
Sentence: 870,minutes,O
Sentence: 870,after,O
Sentence: 870,the,O
Sentence: 870,GTN,B-Chemical
Sentence: 870,the,O
Sentence: 870,patient,O
Sentence: 870,experienced,O
Sentence: 870,a,O
Sentence: 870,sudden,O
Sentence: 870,drop,B-Disease
Sentence: 870,in,I-Disease
Sentence: 870,blood,I-Disease
Sentence: 870,pressure,I-Disease
Sentence: 870,and,O
Sentence: 870,heart,O
Sentence: 870,rate,O
Sentence: 870,",",O
Sentence: 870,this,O
Sentence: 870,was,O
Sentence: 870,rectified,O
Sentence: 870,by,O
Sentence: 870,atropine,B-Chemical
Sentence: 870,sulphate,I-Chemical
Sentence: 870,and,O
Sentence: 870,a,O
Sentence: 870,fluid,O
Sentence: 870,challenge,O
Sentence: 870,.,O
Sentence: 870,There,O
Sentence: 870,was,O
Sentence: 870,no,O
Sentence: 870,further,O
Sentence: 870,deterioration,O
Sentence: 870,in,O
Sentence: 870,the,O
Sentence: 870,patient,O
Sentence: 870,'s,O
Sentence: 870,condition,O
Sentence: 870,during,O
Sentence: 870,transport,O
Sentence: 870,to,O
Sentence: 870,hospital,O
Sentence: 870,.,O
Sentence: 870,There,O
Sentence: 870,are,O
Sentence: 870,very,O
Sentence: 870,few,O
Sentence: 870,documented,O
Sentence: 870,case,O
Sentence: 870,like,O
Sentence: 870,this,O
Sentence: 870,in,O
Sentence: 870,the,O
Sentence: 870,prehospital,O
Sentence: 870,scientific,O
Sentence: 870,literature,O
Sentence: 870,.,O
Sentence: 870,The,O
Sentence: 870,cause,O
Sentence: 870,appears,O
Sentence: 870,to,O
Sentence: 870,be,O
Sentence: 870,the,O
Sentence: 870,Bezold,O
Sentence: 870,-,O
Sentence: 870,Jarish,O
Sentence: 870,reflex,O
Sentence: 870,",",O
Sentence: 870,stimulation,O
Sentence: 870,of,O
Sentence: 870,the,O
Sentence: 870,ventricular,O
Sentence: 870,walls,O
Sentence: 870,which,O
Sentence: 870,in,O
Sentence: 870,turn,O
Sentence: 870,decreases,O
Sentence: 870,sympathetic,O
Sentence: 870,outflow,O
Sentence: 870,from,O
Sentence: 870,the,O
Sentence: 870,vasomotor,O
Sentence: 870,centre,O
Sentence: 870,.,O
Sentence: 870,Prehospital,O
Sentence: 870,care,O
Sentence: 870,providers,O
Sentence: 870,who,O
Sentence: 870,are,O
Sentence: 870,managing,O
Sentence: 870,any,O
Sentence: 870,patient,O
Sentence: 870,with,O
Sentence: 870,a,O
Sentence: 870,syncopal,B-Disease
Sentence: 870,episode,I-Disease
Sentence: 870,that,O
Sentence: 870,fails,O
Sentence: 870,to,O
Sentence: 870,recover,O
Sentence: 870,within,O
Sentence: 870,a,O
Sentence: 870,reasonable,O
Sentence: 870,time,O
Sentence: 870,frame,O
Sentence: 870,should,O
Sentence: 870,consider,O
Sentence: 870,the,O
Sentence: 870,Bezold,O
Sentence: 870,-,O
Sentence: 870,Jarisch,O
Sentence: 870,reflex,O
Sentence: 870,as,O
Sentence: 870,the,O
Sentence: 870,cause,O
Sentence: 870,and,O
Sentence: 870,manage,O
Sentence: 870,the,O
Sentence: 870,patient,O
Sentence: 870,accordingly,O
Sentence: 870,.,O
Sentence: 871,Acute,B-Disease
Sentence: 871,encephalopathy,I-Disease
Sentence: 871,and,O
Sentence: 871,cerebral,B-Disease
Sentence: 871,vasospasm,I-Disease
Sentence: 871,after,O
Sentence: 871,multiagent,O
Sentence: 871,chemotherapy,O
Sentence: 871,including,O
Sentence: 871,PEG,O
Sentence: 871,-,O
Sentence: 871,asparaginase,O
Sentence: 871,and,O
Sentence: 871,intrathecal,O
Sentence: 871,cytarabine,B-Chemical
Sentence: 871,for,O
Sentence: 871,the,O
Sentence: 871,treatment,O
Sentence: 871,of,O
Sentence: 871,acute,B-Disease
Sentence: 871,lymphoblastic,I-Disease
Sentence: 871,leukemia,I-Disease
Sentence: 871,.,O
Sentence: 872,A,O
Sentence: 872,7,O
Sentence: 872,-,O
Sentence: 872,year,O
Sentence: 872,-,O
Sentence: 872,old,O
Sentence: 872,girl,O
Sentence: 872,with,O
Sentence: 872,an,O
Sentence: 872,unusual,O
Sentence: 872,reaction,O
Sentence: 872,to,O
Sentence: 872,induction,O
Sentence: 872,chemotherapy,O
Sentence: 872,for,O
Sentence: 872,precursor,O
Sentence: 872,B,O
Sentence: 872,-,O
Sentence: 872,cell,O
Sentence: 872,acute,B-Disease
Sentence: 872,lymphoblastic,I-Disease
Sentence: 872,leukemia,I-Disease
Sentence: 872,(,O
Sentence: 872,ALL,B-Disease
Sentence: 872,),O
Sentence: 872,is,O
Sentence: 872,described,O
Sentence: 872,.,O
Sentence: 872,The,O
Sentence: 872,patient,O
Sentence: 872,developed,O
Sentence: 872,acute,B-Disease
Sentence: 872,encephalopathy,I-Disease
Sentence: 872,evidenced,O
Sentence: 872,by,O
Sentence: 872,behavioral,O
Sentence: 872,changes,O
Sentence: 872,",",O
Sentence: 872,aphasia,B-Disease
Sentence: 872,",",O
Sentence: 872,incontinence,B-Disease
Sentence: 872,",",O
Sentence: 872,visual,B-Disease
Sentence: 872,hallucinations,I-Disease
Sentence: 872,",",O
Sentence: 872,and,O
Sentence: 872,right,O
Sentence: 872,-,O
Sentence: 872,sided,O
Sentence: 872,weakness,B-Disease
Sentence: 872,with,O
Sentence: 872,diffuse,O
Sentence: 872,cerebral,B-Disease
Sentence: 872,vasospasm,I-Disease
Sentence: 872,on,O
Sentence: 872,magnetic,O
Sentence: 872,resonance,O
Sentence: 872,angiography,O
Sentence: 872,after,O
Sentence: 872,the,O
Sentence: 872,administration,O
Sentence: 872,of,O
Sentence: 872,intrathecal,O
Sentence: 872,cytarabine,B-Chemical
Sentence: 872,.,O
Sentence: 872,Vincristine,B-Chemical
Sentence: 872,",",O
Sentence: 872,dexamethasone,B-Chemical
Sentence: 872,",",O
Sentence: 872,and,O
Sentence: 872,polyethylene,O
Sentence: 872,glycol,O
Sentence: 872,-,O
Sentence: 872,asparaginase,O
Sentence: 872,were,O
Sentence: 872,also,O
Sentence: 872,administered,O
Sentence: 872,before,O
Sentence: 872,the,O
Sentence: 872,episode,O
Sentence: 872,as,O
Sentence: 872,part,O
Sentence: 872,of,O
Sentence: 872,induction,O
Sentence: 872,therapy,O
Sentence: 872,.,O
Sentence: 872,Neurologic,O
Sentence: 872,status,O
Sentence: 872,returned,O
Sentence: 872,to,O
Sentence: 872,baseline,O
Sentence: 872,within,O
Sentence: 872,10,O
Sentence: 872,days,O
Sentence: 872,of,O
Sentence: 872,the,O
Sentence: 872,acute,O
Sentence: 872,event,O
Sentence: 872,",",O
Sentence: 872,and,O
Sentence: 872,magnetic,O
Sentence: 872,resonance,O
Sentence: 872,angiography,O
Sentence: 872,findings,O
Sentence: 872,returned,O
Sentence: 872,to,O
Sentence: 872,normal,O
Sentence: 872,4,O
Sentence: 872,months,O
Sentence: 872,later,O
Sentence: 872,.,O
Sentence: 873,Comparison,O
Sentence: 873,of,O
Sentence: 873,valsartan,B-Chemical
Sentence: 873,/,O
Sentence: 873,hydrochlorothiazide,B-Chemical
Sentence: 873,combination,O
Sentence: 873,therapy,O
Sentence: 873,at,O
Sentence: 873,doses,O
Sentence: 873,up,O
Sentence: 873,to,O
Sentence: 873,320,O
Sentence: 873,/,O
Sentence: 873,25,O
Sentence: 873,mg,O
Sentence: 873,versus,O
Sentence: 873,monotherapy,O
Sentence: 873,:,O
Sentence: 873,a,O
Sentence: 873,double,O
Sentence: 873,-,O
Sentence: 873,blind,O
Sentence: 873,",",O
Sentence: 873,placebo,O
Sentence: 873,-,O
Sentence: 873,controlled,O
Sentence: 873,study,O
Sentence: 873,followed,O
Sentence: 873,by,O
Sentence: 873,long,O
Sentence: 873,-,O
Sentence: 873,term,O
Sentence: 873,combination,O
Sentence: 873,therapy,O
Sentence: 873,in,O
Sentence: 873,hypertensive,B-Disease
Sentence: 873,adults,O
Sentence: 873,.,O
Sentence: 874,BACKGROUND,O
Sentence: 874,:,O
Sentence: 874,One,O
Sentence: 874,third,O
Sentence: 874,of,O
Sentence: 874,patients,O
Sentence: 874,treated,O
Sentence: 874,for,O
Sentence: 874,hypertension,B-Disease
Sentence: 874,attain,O
Sentence: 874,adequate,O
Sentence: 874,blood,O
Sentence: 874,pressure,O
Sentence: 874,(,O
Sentence: 874,BP,O
Sentence: 874,),O
Sentence: 874,control,O
Sentence: 874,",",O
Sentence: 874,and,O
Sentence: 874,multidrug,O
Sentence: 874,regimens,O
Sentence: 874,are,O
Sentence: 874,often,O
Sentence: 874,required,O
Sentence: 874,.,O
Sentence: 874,Given,O
Sentence: 874,the,O
Sentence: 874,lifelong,O
Sentence: 874,nature,O
Sentence: 874,of,O
Sentence: 874,hypertension,B-Disease
Sentence: 874,",",O
Sentence: 874,there,O
Sentence: 874,is,O
Sentence: 874,a,O
Sentence: 874,need,O
Sentence: 874,to,O
Sentence: 874,evaluate,O
Sentence: 874,the,O
Sentence: 874,long,O
Sentence: 874,-,O
Sentence: 874,term,O
Sentence: 874,efficacy,O
Sentence: 874,and,O
Sentence: 874,tolerability,O
Sentence: 874,of,O
Sentence: 874,higher,O
Sentence: 874,doses,O
Sentence: 874,of,O
Sentence: 874,combination,O
Sentence: 874,anti,O
Sentence: 874,-,O
Sentence: 874,hypertensive,B-Disease
Sentence: 874,therapies,O
Sentence: 874,.,O
Sentence: 874,OBJECTIVE,O
Sentence: 874,:,O
Sentence: 874,This,O
Sentence: 874,study,O
Sentence: 874,investigated,O
Sentence: 874,the,O
Sentence: 874,efficacy,O
Sentence: 874,and,O
Sentence: 874,tolerability,O
Sentence: 874,of,O
Sentence: 874,valsartan,B-Chemical
Sentence: 874,(,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,),O
Sentence: 874,or,O
Sentence: 874,hydrochlorothiazide,B-Chemical
Sentence: 874,(,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,),O
Sentence: 874,,O
Sentence: 874,-,O
Sentence: 874,monotherapy,O
Sentence: 874,and,O
Sentence: 874,higher,O
Sentence: 874,-,O
Sentence: 874,dose,O
Sentence: 874,combinations,O
Sentence: 874,in,O
Sentence: 874,patients,O
Sentence: 874,with,O
Sentence: 874,essential,B-Disease
Sentence: 874,hypertension,I-Disease
Sentence: 874,.,O
Sentence: 874,METHODS,O
Sentence: 874,:,O
Sentence: 874,The,O
Sentence: 874,first,O
Sentence: 874,part,O
Sentence: 874,of,O
Sentence: 874,this,O
Sentence: 874,study,O
Sentence: 874,was,O
Sentence: 874,an,O
Sentence: 874,8,O
Sentence: 874,-,O
Sentence: 874,week,O
Sentence: 874,",",O
Sentence: 874,multicenter,O
Sentence: 874,",",O
Sentence: 874,randomized,O
Sentence: 874,",",O
Sentence: 874,double,O
Sentence: 874,-,O
Sentence: 874,blind,O
Sentence: 874,",",O
Sentence: 874,placebo,O
Sentence: 874,controlled,O
Sentence: 874,",",O
Sentence: 874,parallel,O
Sentence: 874,-,O
Sentence: 874,group,O
Sentence: 874,trial,O
Sentence: 874,.,O
Sentence: 874,Patients,O
Sentence: 874,with,O
Sentence: 874,essential,B-Disease
Sentence: 874,hypertension,I-Disease
Sentence: 874,(,O
Sentence: 874,mean,O
Sentence: 874,sitting,O
Sentence: 874,diastolic,O
Sentence: 874,BP,O
Sentence: 874,[,O
Sentence: 874,MSDBP,O
Sentence: 874,],O
Sentence: 874,",",O
Sentence: 874,,O
Sentence: 874,>,O
Sentence: 874,,O
Sentence: 874,or,O
Sentence: 874,,O
Sentence: 874,=,O
Sentence: 874,95,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,and,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,110,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,),O
Sentence: 874,were,O
Sentence: 874,randomized,O
Sentence: 874,to,O
Sentence: 874,1,O
Sentence: 874,of,O
Sentence: 874,8,O
Sentence: 874,treatment,O
Sentence: 874,groups,O
Sentence: 874,:,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,160,O
Sentence: 874,or,O
Sentence: 874,320,O
Sentence: 874,mg,O
Sentence: 874,;,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,12.5,O
Sentence: 874,or,O
Sentence: 874,25,O
Sentence: 874,mg,O
Sentence: 874,;,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,160,O
Sentence: 874,/,O
Sentence: 874,12.5,O
Sentence: 874,",",O
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,12.5,O
Sentence: 874,",",O
Sentence: 874,or,O
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,25,O
Sentence: 874,mg,O
Sentence: 874,;,O
Sentence: 874,or,O
Sentence: 874,placebo,O
Sentence: 874,.,O
Sentence: 874,Mean,O
Sentence: 874,changes,O
Sentence: 874,in,O
Sentence: 874,MSDBP,O
Sentence: 874,and,O
Sentence: 874,mean,O
Sentence: 874,sitting,O
Sentence: 874,systolic,O
Sentence: 874,BP,O
Sentence: 874,(,O
Sentence: 874,MSSBP,O
Sentence: 874,),O
Sentence: 874,were,O
Sentence: 874,analyzed,O
Sentence: 874,at,O
Sentence: 874,the,O
Sentence: 874,8,O
Sentence: 874,-,O
Sentence: 874,week,O
Sentence: 874,core,O
Sentence: 874,study,O
Sentence: 874,end,O
Sentence: 874,point,O
Sentence: 874,.,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,12.5,O
Sentence: 874,and,O
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,25,O
Sentence: 874,mg,O
Sentence: 874,were,O
Sentence: 874,further,O
Sentence: 874,investigated,O
Sentence: 874,in,O
Sentence: 874,a,O
Sentence: 874,54,O
Sentence: 874,-,O
Sentence: 874,week,O
Sentence: 874,",",O
Sentence: 874,open,O
Sentence: 874,-,O
Sentence: 874,label,O
Sentence: 874,extension,O
Sentence: 874,.,O
Sentence: 874,Response,O
Sentence: 874,was,O
Sentence: 874,defined,O
Sentence: 874,as,O
Sentence: 874,MSDBP,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,90,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,or,O
Sentence: 874,a,O
Sentence: 874,,O
Sentence: 874,>,O
Sentence: 874,,O
Sentence: 874,or,O
Sentence: 874,,O
Sentence: 874,=,O
Sentence: 874,10,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,decrease,O
Sentence: 874,compared,O
Sentence: 874,to,O
Sentence: 874,baseline,O
Sentence: 874,.,O
Sentence: 874,Control,O
Sentence: 874,was,O
Sentence: 874,defined,O
Sentence: 874,as,O
Sentence: 874,MSDBP,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,90,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,baseline,O
Sentence: 874,.,O
Sentence: 874,Tolerability,O
Sentence: 874,was,O
Sentence: 874,assessed,O
Sentence: 874,by,O
Sentence: 874,monitoring,O
Sentence: 874,adverse,O
Sentence: 874,events,O
Sentence: 874,at,O
Sentence: 874,randomization,O
Sentence: 874,and,O
Sentence: 874,all,O
Sentence: 874,subsequent,O
Sentence: 874,study,O
Sentence: 874,visits,O
Sentence: 874,and,O
Sentence: 874,regular,O
Sentence: 874,evaluation,O
Sentence: 874,of,O
Sentence: 874,hematology,O
Sentence: 874,and,O
Sentence: 874,blood,O
Sentence: 874,chemistry,O
Sentence: 874,.,O
Sentence: 874,RESULTS,O
Sentence: 874,:,O
Sentence: 874,A,O
Sentence: 874,total,O
Sentence: 874,of,O
Sentence: 874,1346,O
Sentence: 874,patients,O
Sentence: 874,were,O
Sentence: 874,randomized,O
Sentence: 874,into,O
Sentence: 874,the,O
Sentence: 874,8,O
Sentence: 874,-,O
Sentence: 874,week,O
Sentence: 874,core,O
Sentence: 874,study,O
Sentence: 874,(,O
Sentence: 874,734,O
Sentence: 874,men,O
Sentence: 874,",",O
Sentence: 874,612,O
Sentence: 874,women,O
Sentence: 874,;,O
Sentence: 874,924,O
Sentence: 874,white,O
Sentence: 874,",",O
Sentence: 874,291,O
Sentence: 874,black,O
Sentence: 874,",",O
Sentence: 874,23,O
Sentence: 874,Asian,O
Sentence: 874,",",O
Sentence: 874,108,O
Sentence: 874,other,O
Sentence: 874,;,O
Sentence: 874,mean,O
Sentence: 874,age,O
Sentence: 874,",",O
Sentence: 874,52.7,O
Sentence: 874,years,O
Sentence: 874,;,O
Sentence: 874,mean,O
Sentence: 874,weight,O
Sentence: 874,",",O
Sentence: 874,92.6,O
Sentence: 874,kg,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,All,O
Sentence: 874,active,O
Sentence: 874,treatments,O
Sentence: 874,were,O
Sentence: 874,associated,O
Sentence: 874,with,O
Sentence: 874,significantly,O
Sentence: 874,reduced,O
Sentence: 874,MSSBP,O
Sentence: 874,and,O
Sentence: 874,MSDBP,O
Sentence: 874,during,O
Sentence: 874,the,O
Sentence: 874,core,O
Sentence: 874,8,O
Sentence: 874,-,O
Sentence: 874,week,O
Sentence: 874,study,O
Sentence: 874,",",O
Sentence: 874,with,O
Sentence: 874,each,O
Sentence: 874,monotherapy,O
Sentence: 874,significantly,O
Sentence: 874,contributing,O
Sentence: 874,to,O
Sentence: 874,the,O
Sentence: 874,overall,O
Sentence: 874,effect,O
Sentence: 874,of,O
Sentence: 874,combination,O
Sentence: 874,therapy,O
Sentence: 874,(,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,and,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,",",O
Sentence: 874,P,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,0.001,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,Each,O
Sentence: 874,combination,O
Sentence: 874,was,O
Sentence: 874,associated,O
Sentence: 874,with,O
Sentence: 874,significantly,O
Sentence: 874,greater,O
Sentence: 874,reductions,O
Sentence: 874,in,O
Sentence: 874,MSSBP,O
Sentence: 874,and,O
Sentence: 874,MSDBP,O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,the,O
Sentence: 874,monotherapies,O
Sentence: 874,and,O
Sentence: 874,placebo,O
Sentence: 874,(,O
Sentence: 874,all,O
Sentence: 874,",",O
Sentence: 874,P,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,0.001,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,The,O
Sentence: 874,mean,O
Sentence: 874,reduction,O
Sentence: 874,in,O
Sentence: 874,MSSBP,O
Sentence: 874,/,O
Sentence: 874,MSDBP,O
Sentence: 874,with,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,25,O
Sentence: 874,mg,O
Sentence: 874,was,O
Sentence: 874,24.7,O
Sentence: 874,/,O
Sentence: 874,16.6,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,",",O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,5.9,O
Sentence: 874,/,O
Sentence: 874,7.0,O
Sentence: 874,mm,O
Sentence: 874,Hg,O
Sentence: 874,with,O
Sentence: 874,placebo,O
Sentence: 874,.,O
Sentence: 874,The,O
Sentence: 874,reduction,O
Sentence: 874,in,O
Sentence: 874,MSSBP,O
Sentence: 874,was,O
Sentence: 874,significantly,O
Sentence: 874,greater,O
Sentence: 874,with,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,320,O
Sentence: 874,/,O
Sentence: 874,25,O
Sentence: 874,mg,O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,160,O
Sentence: 874,/,O
Sentence: 874,12.5,O
Sentence: 874,mg,O
Sentence: 874,(,O
Sentence: 874,P,O
Sentence: 874,,O
Sentence: 874,<,O
Sentence: 874,,O
Sentence: 874,0.002,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,Rates,O
Sentence: 874,of,O
Sentence: 874,response,O
Sentence: 874,and,O
Sentence: 874,BP,O
Sentence: 874,control,O
Sentence: 874,were,O
Sentence: 874,significantly,O
Sentence: 874,higher,O
Sentence: 874,in,O
Sentence: 874,the,O
Sentence: 874,groups,O
Sentence: 874,that,O
Sentence: 874,received,O
Sentence: 874,combination,O
Sentence: 874,treatment,O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,those,O
Sentence: 874,that,O
Sentence: 874,received,O
Sentence: 874,monotherapy,O
Sentence: 874,.,O
Sentence: 874,The,O
Sentence: 874,incidence,O
Sentence: 874,of,O
Sentence: 874,hypokalemia,B-Disease
Sentence: 874,was,O
Sentence: 874,lower,O
Sentence: 874,with,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,combinations,O
Sentence: 874,(,O
Sentence: 874,1.8,O
Sentence: 874,%,O
Sentence: 874,,O
Sentence: 874,-,O
Sentence: 874,6.1,O
Sentence: 874,%,O
Sentence: 874,),O
Sentence: 874,than,O
Sentence: 874,with,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,monotherapies,O
Sentence: 874,(,O
Sentence: 874,7.1,O
Sentence: 874,%,O
Sentence: 874,,O
Sentence: 874,-,O
Sentence: 874,13.3,O
Sentence: 874,%,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,The,O
Sentence: 874,majority,O
Sentence: 874,of,O
Sentence: 874,adverse,O
Sentence: 874,events,O
Sentence: 874,in,O
Sentence: 874,the,O
Sentence: 874,core,O
Sentence: 874,study,O
Sentence: 874,were,O
Sentence: 874,of,O
Sentence: 874,mild,O
Sentence: 874,to,O
Sentence: 874,moderate,O
Sentence: 874,severity,O
Sentence: 874,.,O
Sentence: 874,The,O
Sentence: 874,efficacy,O
Sentence: 874,and,O
Sentence: 874,tolerability,O
Sentence: 874,of,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,combinations,O
Sentence: 874,were,O
Sentence: 874,maintained,O
Sentence: 874,during,O
Sentence: 874,the,O
Sentence: 874,extension,O
Sentence: 874,(,O
Sentence: 874,797,O
Sentence: 874,patients,O
Sentence: 874,),O
Sentence: 874,.,O
Sentence: 874,CONCLUSIONS,O
Sentence: 874,:,O
Sentence: 874,In,O
Sentence: 874,this,O
Sentence: 874,study,O
Sentence: 874,population,O
Sentence: 874,",",O
Sentence: 874,combination,O
Sentence: 874,therapies,O
Sentence: 874,with,O
Sentence: 874,VAL,B-Chemical
Sentence: 874,/,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,were,O
Sentence: 874,associated,O
Sentence: 874,with,O
Sentence: 874,significantly,O
Sentence: 874,greater,O
Sentence: 874,BP,O
Sentence: 874,reductions,O
Sentence: 874,compared,O
Sentence: 874,with,O
Sentence: 874,either,O
Sentence: 874,monotherapy,O
Sentence: 874,",",O
Sentence: 874,were,O
Sentence: 874,well,O
Sentence: 874,tolerated,O
Sentence: 874,",",O
Sentence: 874,and,O
Sentence: 874,were,O
Sentence: 874,associated,O
Sentence: 874,with,O
Sentence: 874,less,O
Sentence: 874,hypokalemia,B-Disease
Sentence: 874,than,O
Sentence: 874,HCTZ,B-Chemical
Sentence: 874,alone,O
Sentence: 874,.,O
Sentence: 875,Succimer,B-Chemical
Sentence: 875,chelation,O
Sentence: 875,improves,O
Sentence: 875,learning,O
Sentence: 875,",",O
Sentence: 875,attention,O
Sentence: 875,",",O
Sentence: 875,and,O
Sentence: 875,arousal,O
Sentence: 875,regulation,O
Sentence: 875,in,O
Sentence: 875,lead,B-Chemical
Sentence: 875,-,O
Sentence: 875,exposed,O
Sentence: 875,rats,O
Sentence: 875,but,O
Sentence: 875,produces,O
Sentence: 875,lasting,O
Sentence: 875,cognitive,B-Disease
Sentence: 875,impairment,I-Disease
Sentence: 875,in,O
Sentence: 875,the,O
Sentence: 875,absence,O
Sentence: 875,of,O
Sentence: 875,lead,B-Chemical
Sentence: 875,exposure,O
Sentence: 875,.,O
Sentence: 876,BACKGROUND,O
Sentence: 876,:,O
Sentence: 876,There,O
Sentence: 876,is,O
Sentence: 876,growing,O
Sentence: 876,pressure,O
Sentence: 876,for,O
Sentence: 876,clinicians,O
Sentence: 876,to,O
Sentence: 876,prescribe,O
Sentence: 876,chelation,O
Sentence: 876,therapy,O
Sentence: 876,at,O
Sentence: 876,only,O
Sentence: 876,slightly,O
Sentence: 876,elevated,O
Sentence: 876,blood,O
Sentence: 876,lead,B-Chemical
Sentence: 876,levels,O
Sentence: 876,.,O
Sentence: 876,However,O
Sentence: 876,",",O
Sentence: 876,very,O
Sentence: 876,few,O
Sentence: 876,studies,O
Sentence: 876,have,O
Sentence: 876,evaluated,O
Sentence: 876,whether,O
Sentence: 876,chelation,O
Sentence: 876,improves,O
Sentence: 876,cognitive,O
Sentence: 876,outcomes,O
Sentence: 876,in,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,-,O
Sentence: 876,exposed,O
Sentence: 876,children,O
Sentence: 876,",",O
Sentence: 876,or,O
Sentence: 876,whether,O
Sentence: 876,these,O
Sentence: 876,agents,O
Sentence: 876,have,O
Sentence: 876,adverse,O
Sentence: 876,effects,O
Sentence: 876,that,O
Sentence: 876,may,O
Sentence: 876,affect,O
Sentence: 876,brain,O
Sentence: 876,development,O
Sentence: 876,in,O
Sentence: 876,the,O
Sentence: 876,absence,O
Sentence: 876,of,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,.,O
Sentence: 876,OBJECTIVES,O
Sentence: 876,:,O
Sentence: 876,The,O
Sentence: 876,present,O
Sentence: 876,study,O
Sentence: 876,was,O
Sentence: 876,designed,O
Sentence: 876,to,O
Sentence: 876,answer,O
Sentence: 876,these,O
Sentence: 876,questions,O
Sentence: 876,",",O
Sentence: 876,using,O
Sentence: 876,a,O
Sentence: 876,rodent,O
Sentence: 876,model,O
Sentence: 876,of,O
Sentence: 876,early,O
Sentence: 876,childhood,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,and,O
Sentence: 876,treatment,O
Sentence: 876,with,O
Sentence: 876,succimer,B-Chemical
Sentence: 876,",",O
Sentence: 876,a,O
Sentence: 876,widely,O
Sentence: 876,used,O
Sentence: 876,chelating,O
Sentence: 876,agent,O
Sentence: 876,for,O
Sentence: 876,the,O
Sentence: 876,treatment,O
Sentence: 876,of,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,poisoning,I-Disease
Sentence: 876,.,O
Sentence: 876,RESULTS,O
Sentence: 876,:,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,produced,O
Sentence: 876,lasting,O
Sentence: 876,impairments,B-Disease
Sentence: 876,in,I-Disease
Sentence: 876,learning,I-Disease
Sentence: 876,",",I-Disease
Sentence: 876,attention,I-Disease
Sentence: 876,",",I-Disease
Sentence: 876,inhibitory,I-Disease
Sentence: 876,control,I-Disease
Sentence: 876,",",I-Disease
Sentence: 876,and,I-Disease
Sentence: 876,arousal,I-Disease
Sentence: 876,regulation,I-Disease
Sentence: 876,",",O
Sentence: 876,paralleling,O
Sentence: 876,the,O
Sentence: 876,areas,O
Sentence: 876,of,O
Sentence: 876,dysfunction,O
Sentence: 876,seen,O
Sentence: 876,in,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,-,O
Sentence: 876,exposed,O
Sentence: 876,children,O
Sentence: 876,.,O
Sentence: 876,Succimer,B-Chemical
Sentence: 876,treatment,O
Sentence: 876,of,O
Sentence: 876,the,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,-,O
Sentence: 876,exposed,O
Sentence: 876,rats,O
Sentence: 876,significantly,O
Sentence: 876,improved,O
Sentence: 876,learning,O
Sentence: 876,",",O
Sentence: 876,attention,O
Sentence: 876,",",O
Sentence: 876,and,O
Sentence: 876,arousal,O
Sentence: 876,regulation,O
Sentence: 876,",",O
Sentence: 876,although,O
Sentence: 876,the,O
Sentence: 876,efficacy,O
Sentence: 876,of,O
Sentence: 876,the,O
Sentence: 876,treatment,O
Sentence: 876,varied,O
Sentence: 876,as,O
Sentence: 876,a,O
Sentence: 876,function,O
Sentence: 876,of,O
Sentence: 876,the,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,level,O
Sentence: 876,and,O
Sentence: 876,the,O
Sentence: 876,specific,O
Sentence: 876,functional,O
Sentence: 876,deficit,O
Sentence: 876,.,O
Sentence: 876,In,O
Sentence: 876,contrast,O
Sentence: 876,",",O
Sentence: 876,succimer,B-Chemical
Sentence: 876,treatment,O
Sentence: 876,of,O
Sentence: 876,rats,O
Sentence: 876,not,O
Sentence: 876,previously,O
Sentence: 876,exposed,O
Sentence: 876,to,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,produced,O
Sentence: 876,lasting,O
Sentence: 876,and,O
Sentence: 876,pervasive,O
Sentence: 876,cognitive,B-Disease
Sentence: 876,and,I-Disease
Sentence: 876,affective,B-Disease
Sentence: 876,dysfunction,I-Disease
Sentence: 876,comparable,O
Sentence: 876,in,O
Sentence: 876,magnitude,O
Sentence: 876,to,O
Sentence: 876,that,O
Sentence: 876,produced,O
Sentence: 876,by,O
Sentence: 876,the,O
Sentence: 876,higher,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,regimen,O
Sentence: 876,.,O
Sentence: 876,CONCLUSIONS,O
Sentence: 876,:,O
Sentence: 876,These,O
Sentence: 876,are,O
Sentence: 876,the,O
Sentence: 876,first,O
Sentence: 876,data,O
Sentence: 876,",",O
Sentence: 876,to,O
Sentence: 876,our,O
Sentence: 876,knowledge,O
Sentence: 876,",",O
Sentence: 876,to,O
Sentence: 876,show,O
Sentence: 876,that,O
Sentence: 876,treatment,O
Sentence: 876,with,O
Sentence: 876,any,O
Sentence: 876,chelating,O
Sentence: 876,agent,O
Sentence: 876,can,O
Sentence: 876,alleviate,O
Sentence: 876,cognitive,B-Disease
Sentence: 876,deficits,I-Disease
Sentence: 876,due,O
Sentence: 876,to,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,exposure,O
Sentence: 876,.,O
Sentence: 876,These,O
Sentence: 876,findings,O
Sentence: 876,suggest,O
Sentence: 876,that,O
Sentence: 876,it,O
Sentence: 876,may,O
Sentence: 876,be,O
Sentence: 876,possible,O
Sentence: 876,to,O
Sentence: 876,identify,O
Sentence: 876,a,O
Sentence: 876,succimer,B-Chemical
Sentence: 876,treatment,O
Sentence: 876,protocol,O
Sentence: 876,that,O
Sentence: 876,improves,O
Sentence: 876,cognitive,O
Sentence: 876,outcomes,O
Sentence: 876,in,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,-,O
Sentence: 876,exposed,O
Sentence: 876,children,O
Sentence: 876,.,O
Sentence: 876,However,O
Sentence: 876,",",O
Sentence: 876,they,O
Sentence: 876,also,O
Sentence: 876,suggest,O
Sentence: 876,that,O
Sentence: 876,succimer,B-Chemical
Sentence: 876,treatment,O
Sentence: 876,should,O
Sentence: 876,be,O
Sentence: 876,strongly,O
Sentence: 876,discouraged,O
Sentence: 876,for,O
Sentence: 876,children,O
Sentence: 876,who,O
Sentence: 876,do,O
Sentence: 876,not,O
Sentence: 876,have,O
Sentence: 876,elevated,O
Sentence: 876,tissue,O
Sentence: 876,levels,O
Sentence: 876,of,O
Sentence: 876,Pb,B-Chemical
Sentence: 876,or,O
Sentence: 876,other,O
Sentence: 876,heavy,O
Sentence: 876,metals,O
Sentence: 876,.,O
Sentence: 877,Caffeine,B-Chemical
Sentence: 877,challenge,O
Sentence: 877,test,O
Sentence: 877,in,O
Sentence: 877,panic,B-Disease
Sentence: 877,disorder,I-Disease
Sentence: 877,and,O
Sentence: 877,depression,B-Disease
Sentence: 877,with,O
Sentence: 877,panic,B-Disease
Sentence: 877,attacks,I-Disease
Sentence: 877,.,O
Sentence: 878,Our,O
Sentence: 878,aim,O
Sentence: 878,was,O
Sentence: 878,to,O
Sentence: 878,observe,O
Sentence: 878,if,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,panic,B-Disease
Sentence: 878,disorder,I-Disease
Sentence: 878,(,O
Sentence: 878,PD,B-Disease
Sentence: 878,),O
Sentence: 878,and,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,major,B-Disease
Sentence: 878,depression,I-Disease
Sentence: 878,with,O
Sentence: 878,panic,B-Disease
Sentence: 878,attacks,I-Disease
Sentence: 878,(,O
Sentence: 878,MDP,B-Disease
Sentence: 878,),O
Sentence: 878,(,O
Sentence: 878,Diagnostic,O
Sentence: 878,and,O
Sentence: 878,Statistical,O
Sentence: 878,Manual,O
Sentence: 878,of,O
Sentence: 878,Mental,B-Disease
Sentence: 878,Disorders,I-Disease
Sentence: 878,",",O
Sentence: 878,Fourth,O
Sentence: 878,Edition,O
Sentence: 878,criteria,O
Sentence: 878,),O
Sentence: 878,respond,O
Sentence: 878,in,O
Sentence: 878,a,O
Sentence: 878,similar,O
Sentence: 878,way,O
Sentence: 878,to,O
Sentence: 878,the,O
Sentence: 878,induction,O
Sentence: 878,of,O
Sentence: 878,panic,B-Disease
Sentence: 878,attacks,I-Disease
Sentence: 878,by,O
Sentence: 878,an,O
Sentence: 878,oral,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,challenge,O
Sentence: 878,test,O
Sentence: 878,.,O
Sentence: 878,We,O
Sentence: 878,randomly,O
Sentence: 878,selected,O
Sentence: 878,29,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,PD,B-Disease
Sentence: 878,",",O
Sentence: 878,27,O
Sentence: 878,with,O
Sentence: 878,MDP,B-Disease
Sentence: 878,",",O
Sentence: 878,25,O
Sentence: 878,with,O
Sentence: 878,major,B-Disease
Sentence: 878,depression,I-Disease
Sentence: 878,without,O
Sentence: 878,panic,B-Disease
Sentence: 878,attacks,I-Disease
Sentence: 878,(,O
Sentence: 878,MD,B-Disease
Sentence: 878,),O
Sentence: 878,",",O
Sentence: 878,and,O
Sentence: 878,28,O
Sentence: 878,healthy,O
Sentence: 878,volunteers,O
Sentence: 878,.,O
Sentence: 878,The,O
Sentence: 878,patients,O
Sentence: 878,had,O
Sentence: 878,no,O
Sentence: 878,psychotropic,O
Sentence: 878,drug,O
Sentence: 878,for,O
Sentence: 878,at,O
Sentence: 878,least,O
Sentence: 878,a,O
Sentence: 878,4,O
Sentence: 878,-,O
Sentence: 878,week,O
Sentence: 878,period,O
Sentence: 878,.,O
Sentence: 878,In,O
Sentence: 878,a,O
Sentence: 878,randomized,O
Sentence: 878,double,O
Sentence: 878,-,O
Sentence: 878,blind,O
Sentence: 878,experiment,O
Sentence: 878,performed,O
Sentence: 878,in,O
Sentence: 878,2,O
Sentence: 878,occasions,O
Sentence: 878,7,O
Sentence: 878,days,O
Sentence: 878,apart,O
Sentence: 878,",",O
Sentence: 878,480,O
Sentence: 878,mg,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,and,O
Sentence: 878,a,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,-,O
Sentence: 878,free,O
Sentence: 878,(,O
Sentence: 878,placebo,O
Sentence: 878,),O
Sentence: 878,solution,O
Sentence: 878,were,O
Sentence: 878,administered,O
Sentence: 878,in,O
Sentence: 878,a,O
Sentence: 878,coffee,O
Sentence: 878,form,O
Sentence: 878,and,O
Sentence: 878,anxiety,B-Disease
Sentence: 878,scales,O
Sentence: 878,were,O
Sentence: 878,applied,O
Sentence: 878,before,O
Sentence: 878,and,O
Sentence: 878,after,O
Sentence: 878,each,O
Sentence: 878,test,O
Sentence: 878,.,O
Sentence: 878,A,O
Sentence: 878,total,O
Sentence: 878,of,O
Sentence: 878,58.6,O
Sentence: 878,%,O
Sentence: 878,(,O
Sentence: 878,n,O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,17,O
Sentence: 878,),O
Sentence: 878,of,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,PD,B-Disease
Sentence: 878,",",O
Sentence: 878,44.4,O
Sentence: 878,%,O
Sentence: 878,(,O
Sentence: 878,n,O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,12,O
Sentence: 878,),O
Sentence: 878,of,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,MDP,B-Disease
Sentence: 878,",",O
Sentence: 878,12.0,O
Sentence: 878,%,O
Sentence: 878,(,O
Sentence: 878,n,O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,3,O
Sentence: 878,),O
Sentence: 878,of,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,MD,B-Disease
Sentence: 878,",",O
Sentence: 878,and,O
Sentence: 878,7.1,O
Sentence: 878,%,O
Sentence: 878,(,O
Sentence: 878,n,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,2,O
Sentence: 878,),O
Sentence: 878,of,O
Sentence: 878,control,O
Sentence: 878,subjects,O
Sentence: 878,had,O
Sentence: 878,a,O
Sentence: 878,panic,B-Disease
Sentence: 878,attack,I-Disease
Sentence: 878,after,O
Sentence: 878,the,O
Sentence: 878,480,O
Sentence: 878,-,O
Sentence: 878,mg,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,challenge,O
Sentence: 878,test,O
Sentence: 878,(,O
Sentence: 878,chi,O
Sentence: 878,(,O
Sentence: 878,2,O
Sentence: 878,),O
Sentence: 878,(,O
Sentence: 878,3,O
Sentence: 878,),O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,16.22,O
Sentence: 878,",",O
Sentence: 878,P,O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,.001,O
Sentence: 878,),O
Sentence: 878,.,O
Sentence: 878,The,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,PD,B-Disease
Sentence: 878,and,O
Sentence: 878,MDP,B-Disease
Sentence: 878,were,O
Sentence: 878,more,O
Sentence: 878,sensitive,O
Sentence: 878,to,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,than,O
Sentence: 878,were,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,MD,B-Disease
Sentence: 878,and,O
Sentence: 878,healthy,O
Sentence: 878,volunteers,O
Sentence: 878,.,O
Sentence: 878,No,O
Sentence: 878,panic,B-Disease
Sentence: 878,attack,I-Disease
Sentence: 878,was,O
Sentence: 878,observed,O
Sentence: 878,after,O
Sentence: 878,the,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,-,O
Sentence: 878,free,O
Sentence: 878,solution,O
Sentence: 878,intake,O
Sentence: 878,.,O
Sentence: 878,The,O
Sentence: 878,patients,O
Sentence: 878,with,O
Sentence: 878,MD,B-Disease
Sentence: 878,had,O
Sentence: 878,a,O
Sentence: 878,lower,O
Sentence: 878,heart,O
Sentence: 878,rate,O
Sentence: 878,response,O
Sentence: 878,to,O
Sentence: 878,the,O
Sentence: 878,test,O
Sentence: 878,than,O
Sentence: 878,all,O
Sentence: 878,the,O
Sentence: 878,other,O
Sentence: 878,groups,O
Sentence: 878,(,O
Sentence: 878,2,O
Sentence: 878,-,O
Sentence: 878,way,O
Sentence: 878,analysis,O
Sentence: 878,of,O
Sentence: 878,variance,O
Sentence: 878,",",O
Sentence: 878,group,O
Sentence: 878,by,O
Sentence: 878,time,O
Sentence: 878,interaction,O
Sentence: 878,with,O
Sentence: 878,Greenhouse,O
Sentence: 878,-,O
Sentence: 878,Geisser,O
Sentence: 878,correction,O
Sentence: 878,:,O
Sentence: 878,F,O
Sentence: 878,(,O
Sentence: 878,"3,762",O
Sentence: 878,),O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,2.85,O
Sentence: 878,",",O
Sentence: 878,P,O
Sentence: 878,,O
Sentence: 878,=,O
Sentence: 878,,O
Sentence: 878,.026,O
Sentence: 878,),O
Sentence: 878,.,O
Sentence: 878,Our,O
Sentence: 878,data,O
Sentence: 878,suggest,O
Sentence: 878,that,O
Sentence: 878,there,O
Sentence: 878,is,O
Sentence: 878,an,O
Sentence: 878,association,O
Sentence: 878,between,O
Sentence: 878,panic,B-Disease
Sentence: 878,attacks,I-Disease
Sentence: 878,",",O
Sentence: 878,no,O
Sentence: 878,matter,O
Sentence: 878,if,O
Sentence: 878,associated,O
Sentence: 878,with,O
Sentence: 878,PD,B-Disease
Sentence: 878,or,O
Sentence: 878,MDP,B-Disease
Sentence: 878,",",O
Sentence: 878,and,O
Sentence: 878,hyperreactivity,O
Sentence: 878,to,O
Sentence: 878,an,O
Sentence: 878,oral,O
Sentence: 878,caffeine,B-Chemical
Sentence: 878,challenge,O
Sentence: 878,test,O
Sentence: 878,.,O
Sentence: 879,Mitral,O
Sentence: 879,annuloplasty,O
Sentence: 879,as,O
Sentence: 879,a,O
Sentence: 879,ventricular,O
Sentence: 879,restoration,O
Sentence: 879,method,O
Sentence: 879,for,O
Sentence: 879,the,O
Sentence: 879,failing,O
Sentence: 879,left,O
Sentence: 879,ventricle,O
Sentence: 879,:,O
Sentence: 879,a,O
Sentence: 879,pilot,O
Sentence: 879,study,O
Sentence: 879,.,O
Sentence: 880,BACKGROUND,O
Sentence: 880,AND,O
Sentence: 880,AIM,O
Sentence: 880,OF,O
Sentence: 880,THE,O
Sentence: 880,STUDY,O
Sentence: 880,:,O
Sentence: 880,Undersized,O
Sentence: 880,mitral,O
Sentence: 880,annuloplasty,O
Sentence: 880,(,O
Sentence: 880,MAP,O
Sentence: 880,),O
Sentence: 880,is,O
Sentence: 880,effective,O
Sentence: 880,in,O
Sentence: 880,patients,O
Sentence: 880,with,O
Sentence: 880,dilated,B-Disease
Sentence: 880,cardiomyopathy,I-Disease
Sentence: 880,and,O
Sentence: 880,functional,O
Sentence: 880,mitral,B-Disease
Sentence: 880,regurgitation,I-Disease
Sentence: 880,(,O
Sentence: 880,MR,B-Disease
Sentence: 880,),O
Sentence: 880,since,O
Sentence: 880,",",O
Sentence: 880,as,O
Sentence: 880,well,O
Sentence: 880,as,O
Sentence: 880,addressing,O
Sentence: 880,the,O
Sentence: 880,MR,B-Disease
Sentence: 880,",",O
Sentence: 880,the,O
Sentence: 880,MAP,O
Sentence: 880,may,O
Sentence: 880,also,O
Sentence: 880,reshape,O
Sentence: 880,the,O
Sentence: 880,dilated,O
Sentence: 880,left,O
Sentence: 880,ventricular,O
Sentence: 880,(,O
Sentence: 880,LV,O
Sentence: 880,),O
Sentence: 880,base,O
Sentence: 880,.,O
Sentence: 880,However,O
Sentence: 880,",",O
Sentence: 880,the,O
Sentence: 880,direct,O
Sentence: 880,benefits,O
Sentence: 880,of,O
Sentence: 880,this,O
Sentence: 880,possible,O
Sentence: 880,reshaping,O
Sentence: 880,on,O
Sentence: 880,LV,O
Sentence: 880,function,O
Sentence: 880,in,O
Sentence: 880,the,O
Sentence: 880,absence,O
Sentence: 880,of,O
Sentence: 880,underlying,O
Sentence: 880,MR,B-Disease
Sentence: 880,remain,O
Sentence: 880,incompletely,O
Sentence: 880,understood,O
Sentence: 880,.,O
Sentence: 880,The,O
Sentence: 880,study,O
Sentence: 880,aim,O
Sentence: 880,was,O
Sentence: 880,to,O
Sentence: 880,identify,O
Sentence: 880,these,O
Sentence: 880,benefits,O
Sentence: 880,in,O
Sentence: 880,a,O
Sentence: 880,canine,O
Sentence: 880,model,O
Sentence: 880,of,O
Sentence: 880,acute,O
Sentence: 880,heart,B-Disease
Sentence: 880,failure,I-Disease
Sentence: 880,.,O
Sentence: 880,METHODS,O
Sentence: 880,:,O
Sentence: 880,Six,O
Sentence: 880,dogs,O
Sentence: 880,underwent,O
Sentence: 880,MAP,O
Sentence: 880,with,O
Sentence: 880,a,O
Sentence: 880,prosthetic,O
Sentence: 880,band,O
Sentence: 880,on,O
Sentence: 880,the,O
Sentence: 880,posterior,O
Sentence: 880,mitral,O
Sentence: 880,annulus,O
Sentence: 880,",",O
Sentence: 880,using,O
Sentence: 880,four,O
Sentence: 880,mattress,O
Sentence: 880,sutures,O
Sentence: 880,.,O
Sentence: 880,The,O
Sentence: 880,sutures,O
Sentence: 880,were,O
Sentence: 880,passed,O
Sentence: 880,individually,O
Sentence: 880,through,O
Sentence: 880,four,O
Sentence: 880,tourniquets,O
Sentence: 880,and,O
Sentence: 880,exteriorized,O
Sentence: 880,untied,O
Sentence: 880,via,O
Sentence: 880,the,O
Sentence: 880,left,O
Sentence: 880,atriotomy,O
Sentence: 880,.,O
Sentence: 880,Sonomicrometry,O
Sentence: 880,crystals,O
Sentence: 880,were,O
Sentence: 880,implanted,O
Sentence: 880,around,O
Sentence: 880,the,O
Sentence: 880,mitral,O
Sentence: 880,annulus,O
Sentence: 880,and,O
Sentence: 880,left,O
Sentence: 880,ventricle,O
Sentence: 880,to,O
Sentence: 880,measure,O
Sentence: 880,geometry,O
Sentence: 880,and,O
Sentence: 880,regional,O
Sentence: 880,function,O
Sentence: 880,.,O
Sentence: 880,Acute,O
Sentence: 880,heart,B-Disease
Sentence: 880,failure,I-Disease
Sentence: 880,was,O
Sentence: 880,induced,O
Sentence: 880,by,O
Sentence: 880,propranolol,B-Chemical
Sentence: 880,and,O
Sentence: 880,volume,O
Sentence: 880,loading,O
Sentence: 880,after,O
Sentence: 880,weaning,O
Sentence: 880,from,O
Sentence: 880,cardiopulmonary,O
Sentence: 880,bypass,O
Sentence: 880,;,O
Sentence: 880,an,O
Sentence: 880,absence,O
Sentence: 880,of,O
Sentence: 880,MR,B-Disease
Sentence: 880,was,O
Sentence: 880,confirmed,O
Sentence: 880,by,O
Sentence: 880,echocardiography,O
Sentence: 880,.,O
Sentence: 880,MAP,O
Sentence: 880,was,O
Sentence: 880,accomplished,O
Sentence: 880,by,O
Sentence: 880,cinching,O
Sentence: 880,the,O
Sentence: 880,tourniquets,O
Sentence: 880,.,O
Sentence: 880,Data,O
Sentence: 880,were,O
Sentence: 880,acquired,O
Sentence: 880,at,O
Sentence: 880,baseline,O
Sentence: 880,",",O
Sentence: 880,after,O
Sentence: 880,induction,O
Sentence: 880,of,O
Sentence: 880,acute,O
Sentence: 880,heart,B-Disease
Sentence: 880,failure,I-Disease
Sentence: 880,",",O
Sentence: 880,and,O
Sentence: 880,after,O
Sentence: 880,MAP,O
Sentence: 880,.,O
Sentence: 880,RESULTS,O
Sentence: 880,:,O
Sentence: 880,MAP,O
Sentence: 880,decreased,O
Sentence: 880,mitral,O
Sentence: 880,annular,O
Sentence: 880,dimensions,O
Sentence: 880,in,O
Sentence: 880,both,O
Sentence: 880,commissure,O
Sentence: 880,-,O
Sentence: 880,commissure,O
Sentence: 880,and,O
Sentence: 880,septal,O
Sentence: 880,-,O
Sentence: 880,lateral,O
Sentence: 880,directions,O
Sentence: 880,.,O
Sentence: 880,Concomitantly,O
Sentence: 880,",",O
Sentence: 880,the,O
Sentence: 880,diastolic,O
Sentence: 880,diameter,O
Sentence: 880,of,O
Sentence: 880,the,O
Sentence: 880,LV,O
Sentence: 880,base,O
Sentence: 880,and,O
Sentence: 880,LV,O
Sentence: 880,sphericity,O
Sentence: 880,decreased,O
Sentence: 880,(,O
Sentence: 880,i.e.,O
Sentence: 880,",",O
Sentence: 880,improved,O
Sentence: 880,),O
Sentence: 880,from,O
Sentence: 880,37.4,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,9.3,O
Sentence: 880,to,O
Sentence: 880,35.9,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,10,O
Sentence: 880,mm,O
Sentence: 880,(,O
Sentence: 880,p,O
Sentence: 880,,O
Sentence: 880,=,O
Sentence: 880,,O
Sentence: 880,0.063,O
Sentence: 880,),O
Sentence: 880,",",O
Sentence: 880,and,O
Sentence: 880,from,O
Sentence: 880,67.9,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,18.6,O
Sentence: 880,%,O
Sentence: 880,to,O
Sentence: 880,65.3,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,18.9,O
Sentence: 880,%,O
Sentence: 880,(,O
Sentence: 880,p,O
Sentence: 880,,O
Sentence: 880,=,O
Sentence: 880,,O
Sentence: 880,0.016,O
Sentence: 880,),O
Sentence: 880,",",O
Sentence: 880,respectively,O
Sentence: 880,.,O
Sentence: 880,Decreases,O
Sentence: 880,were,O
Sentence: 880,evident,O
Sentence: 880,in,O
Sentence: 880,both,O
Sentence: 880,LV,O
Sentence: 880,end,O
Sentence: 880,-,O
Sentence: 880,diastolic,O
Sentence: 880,pressure,O
Sentence: 880,(,O
Sentence: 880,from,O
Sentence: 880,17,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,7,O
Sentence: 880,to,O
Sentence: 880,15,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,6,O
Sentence: 880,mmHg,O
Sentence: 880,",",O
Sentence: 880,p,O
Sentence: 880,,O
Sentence: 880,=,O
Sentence: 880,,O
Sentence: 880,0.0480,O
Sentence: 880,and,O
Sentence: 880,Tau,O
Sentence: 880,(,O
Sentence: 880,from,O
Sentence: 880,48,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,8,O
Sentence: 880,to,O
Sentence: 880,45,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,8,O
Sentence: 880,ms,O
Sentence: 880,",",O
Sentence: 880,p,O
Sentence: 880,,O
Sentence: 880,<,O
Sentence: 880,,O
Sentence: 880,0.01,O
Sentence: 880,),O
Sentence: 880,",",O
Sentence: 880,while,O
Sentence: 880,fractional,O
Sentence: 880,shortening,O
Sentence: 880,at,O
Sentence: 880,the,O
Sentence: 880,LV,O
Sentence: 880,base,O
Sentence: 880,increased,O
Sentence: 880,from,O
Sentence: 880,7.7,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,4.5,O
Sentence: 880,%,O
Sentence: 880,to,O
Sentence: 880,9.4,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,4.5,O
Sentence: 880,%,O
Sentence: 880,(,O
Sentence: 880,p,O
Sentence: 880,,O
Sentence: 880,=,O
Sentence: 880,,O
Sentence: 880,0.045,O
Sentence: 880,),O
Sentence: 880,.,O
Sentence: 880,After,O
Sentence: 880,MAP,O
Sentence: 880,",",O
Sentence: 880,increases,O
Sentence: 880,were,O
Sentence: 880,identified,O
Sentence: 880,in,O
Sentence: 880,both,O
Sentence: 880,cardiac,O
Sentence: 880,output,O
Sentence: 880,(,O
Sentence: 880,from,O
Sentence: 880,1.54,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,0.57,O
Sentence: 880,to,O
Sentence: 880,1.65,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,0.57,O
Sentence: 880,1,O
Sentence: 880,/,O
Sentence: 880,min,O
Sentence: 880,),O
Sentence: 880,and,O
Sentence: 880,Emax,O
Sentence: 880,(,O
Sentence: 880,from,O
Sentence: 880,1.86,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,0.9,O
Sentence: 880,to,O
Sentence: 880,2.41,O
Sentence: 880,+,O
Sentence: 880,/,O
Sentence: 880,,O
Sentence: 880,-,O
Sentence: 880,,O
Sentence: 880,1.31,O
Sentence: 880,mmHg,O
Sentence: 880,/,O
Sentence: 880,ml,O
Sentence: 880,),O
Sentence: 880,.,O
Sentence: 880,CONCLUSION,O
Sentence: 880,:,O
Sentence: 880,The,O
Sentence: 880,data,O
Sentence: 880,acquired,O
Sentence: 880,suggest,O
Sentence: 880,that,O
Sentence: 880,isolated,O
Sentence: 880,MAP,O
Sentence: 880,may,O
Sentence: 880,have,O
Sentence: 880,certain,O
Sentence: 880,benefits,O
Sentence: 880,on,O
Sentence: 880,LV,O
Sentence: 880,dimension,O
Sentence: 880,/,O
Sentence: 880,function,O
Sentence: 880,in,O
Sentence: 880,acute,O
Sentence: 880,heart,B-Disease
Sentence: 880,failure,I-Disease
Sentence: 880,",",O
Sentence: 880,even,O
Sentence: 880,in,O
Sentence: 880,the,O
Sentence: 880,absence,O
Sentence: 880,of,O
Sentence: 880,MR,B-Disease
Sentence: 880,.,O
Sentence: 880,However,O
Sentence: 880,",",O
Sentence: 880,further,O
Sentence: 880,investigations,O
Sentence: 880,are,O
Sentence: 880,warranted,O
Sentence: 880,in,O
Sentence: 880,a,O
Sentence: 880,model,O
Sentence: 880,of,O
Sentence: 880,chronic,O
Sentence: 880,heart,B-Disease
Sentence: 880,failure,I-Disease
Sentence: 880,.,O
Sentence: 881,Piperacillin,O
Sentence: 881,/,O
Sentence: 881,tazobactam,O
Sentence: 881,-,O
Sentence: 881,induced,O
Sentence: 881,seizure,B-Disease
Sentence: 881,rapidly,O
Sentence: 881,reversed,O
Sentence: 881,by,O
Sentence: 881,high,O
Sentence: 881,flux,O
Sentence: 881,hemodialysis,O
Sentence: 881,in,O
Sentence: 881,a,O
Sentence: 881,patient,O
Sentence: 881,on,O
Sentence: 881,peritoneal,O
Sentence: 881,dialysis,O
Sentence: 881,.,O
Sentence: 882,Despite,O
Sentence: 882,popular,O
Sentence: 882,use,O
Sentence: 882,of,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,",",O
Sentence: 882,the,O
Sentence: 882,dire,O
Sentence: 882,neurotoxicity,B-Disease
Sentence: 882,associated,O
Sentence: 882,with,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,still,O
Sentence: 882,goes,O
Sentence: 882,unrecognized,O
Sentence: 882,",",O
Sentence: 882,leading,O
Sentence: 882,to,O
Sentence: 882,a,O
Sentence: 882,delay,O
Sentence: 882,in,O
Sentence: 882,appropriate,O
Sentence: 882,management,O
Sentence: 882,.,O
Sentence: 882,We,O
Sentence: 882,report,O
Sentence: 882,a,O
Sentence: 882,57,O
Sentence: 882,-,O
Sentence: 882,year,O
Sentence: 882,-,O
Sentence: 882,old,O
Sentence: 882,woman,O
Sentence: 882,with,O
Sentence: 882,end,O
Sentence: 882,-,O
Sentence: 882,stage,O
Sentence: 882,renal,O
Sentence: 882,disease,O
Sentence: 882,receiving,O
Sentence: 882,continuous,O
Sentence: 882,ambulatory,O
Sentence: 882,peritoneal,O
Sentence: 882,dialysis,O
Sentence: 882,(,O
Sentence: 882,CAPD,O
Sentence: 882,),O
Sentence: 882,",",O
Sentence: 882,who,O
Sentence: 882,developed,O
Sentence: 882,slurred,O
Sentence: 882,speech,O
Sentence: 882,",",O
Sentence: 882,tremor,B-Disease
Sentence: 882,",",O
Sentence: 882,bizarre,O
Sentence: 882,behavior,O
Sentence: 882,",",O
Sentence: 882,progressive,O
Sentence: 882,mental,O
Sentence: 882,confusion,B-Disease
Sentence: 882,",",O
Sentence: 882,and,O
Sentence: 882,2,O
Sentence: 882,episodes,O
Sentence: 882,of,O
Sentence: 882,generalized,O
Sentence: 882,tonic,O
Sentence: 882,-,O
Sentence: 882,clonic,O
Sentence: 882,seizure,O
Sentence: 882,(,O
Sentence: 882,GTCS,B-Disease
Sentence: 882,),O
Sentence: 882,after,O
Sentence: 882,5,O
Sentence: 882,doses,O
Sentence: 882,of,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,/,O
Sentence: 882,tazobactam,O
Sentence: 882,(,O
Sentence: 882,2,O
Sentence: 882,g,O
Sentence: 882,/,O
Sentence: 882,250,O
Sentence: 882,mg,O
Sentence: 882,),O
Sentence: 882,were,O
Sentence: 882,given,O
Sentence: 882,for,O
Sentence: 882,bronchiectasis,B-Disease
Sentence: 882,with,O
Sentence: 882,secondary,B-Disease
Sentence: 882,infection,I-Disease
Sentence: 882,.,O
Sentence: 882,The,O
Sentence: 882,laboratory,O
Sentence: 882,data,O
Sentence: 882,revealed,O
Sentence: 882,normal,O
Sentence: 882,plasma,O
Sentence: 882,electrolyte,O
Sentence: 882,and,O
Sentence: 882,ammonia,B-Chemical
Sentence: 882,levels,O
Sentence: 882,but,O
Sentence: 882,leukocytosis,B-Disease
Sentence: 882,.,O
Sentence: 882,Neurologic,O
Sentence: 882,examinations,O
Sentence: 882,showed,O
Sentence: 882,dysarthria,B-Disease
Sentence: 882,and,O
Sentence: 882,bilateral,O
Sentence: 882,Babinski,O
Sentence: 882,sign,O
Sentence: 882,.,O
Sentence: 882,Computed,O
Sentence: 882,tomography,O
Sentence: 882,of,O
Sentence: 882,brain,O
Sentence: 882,and,O
Sentence: 882,electroencephalogram,O
Sentence: 882,were,O
Sentence: 882,unremarkable,O
Sentence: 882,.,O
Sentence: 882,Despite,O
Sentence: 882,the,O
Sentence: 882,use,O
Sentence: 882,of,O
Sentence: 882,antiepileptic,O
Sentence: 882,agents,O
Sentence: 882,",",O
Sentence: 882,another,O
Sentence: 882,GTCS,B-Disease
Sentence: 882,episode,O
Sentence: 882,recurred,O
Sentence: 882,after,O
Sentence: 882,the,O
Sentence: 882,sixth,O
Sentence: 882,dose,O
Sentence: 882,of,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,/,O
Sentence: 882,tazobactam,O
Sentence: 882,.,O
Sentence: 882,Brain,O
Sentence: 882,magnetic,O
Sentence: 882,resonance,O
Sentence: 882,imaging,O
Sentence: 882,did,O
Sentence: 882,not,O
Sentence: 882,demonstrate,O
Sentence: 882,acute,O
Sentence: 882,infarction,B-Disease
Sentence: 882,and,O
Sentence: 882,organic,B-Disease
Sentence: 882,brain,I-Disease
Sentence: 882,lesions,I-Disease
Sentence: 882,.,O
Sentence: 882,Initiation,O
Sentence: 882,of,O
Sentence: 882,high,O
Sentence: 882,-,O
Sentence: 882,flux,O
Sentence: 882,hemodialysis,O
Sentence: 882,rapidly,O
Sentence: 882,reversed,O
Sentence: 882,the,O
Sentence: 882,neurologic,O
Sentence: 882,symptoms,O
Sentence: 882,within,O
Sentence: 882,4,O
Sentence: 882,hours,O
Sentence: 882,.,O
Sentence: 882,Piperacillin,B-Chemical
Sentence: 882,-,O
Sentence: 882,induced,O
Sentence: 882,encephalopathy,B-Disease
Sentence: 882,should,O
Sentence: 882,be,O
Sentence: 882,considered,O
Sentence: 882,in,O
Sentence: 882,any,O
Sentence: 882,uremic,B-Disease
Sentence: 882,patients,O
Sentence: 882,with,O
Sentence: 882,unexplained,O
Sentence: 882,neurological,O
Sentence: 882,manifestations,O
Sentence: 882,.,O
Sentence: 882,CAPD,O
Sentence: 882,is,O
Sentence: 882,inefficient,O
Sentence: 882,in,O
Sentence: 882,removing,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,",",O
Sentence: 882,whereas,O
Sentence: 882,hemodialysis,O
Sentence: 882,can,O
Sentence: 882,rapidly,O
Sentence: 882,terminate,O
Sentence: 882,the,O
Sentence: 882,piperacillin,B-Chemical
Sentence: 882,-,O
Sentence: 882,induced,O
Sentence: 882,encephalopathy,B-Disease
Sentence: 882,.,O
Sentence: 883,Frequency,O
Sentence: 883,of,O
Sentence: 883,transient,O
Sentence: 883,ipsilateral,O
Sentence: 883,vocal,O
Sentence: 883,cord,O
Sentence: 883,paralysis,O
Sentence: 883,in,O
Sentence: 883,patients,O
Sentence: 883,undergoing,O
Sentence: 883,carotid,O
Sentence: 883,endarterectomy,O
Sentence: 883,under,O
Sentence: 883,local,O
Sentence: 883,anesthesia,O
Sentence: 883,.,O
Sentence: 884,BACKGROUND,O
Sentence: 884,:,O
Sentence: 884,Especially,O
Sentence: 884,because,O
Sentence: 884,of,O
Sentence: 884,improvements,O
Sentence: 884,in,O
Sentence: 884,clinical,O
Sentence: 884,neurologic,O
Sentence: 884,monitoring,O
Sentence: 884,",",O
Sentence: 884,carotid,O
Sentence: 884,endarterectomy,O
Sentence: 884,done,O
Sentence: 884,under,O
Sentence: 884,local,O
Sentence: 884,anesthesia,O
Sentence: 884,has,O
Sentence: 884,become,O
Sentence: 884,the,O
Sentence: 884,technique,O
Sentence: 884,of,O
Sentence: 884,choice,O
Sentence: 884,in,O
Sentence: 884,several,O
Sentence: 884,centers,O
Sentence: 884,.,O
Sentence: 884,Temporary,O
Sentence: 884,ipsilateral,O
Sentence: 884,vocal,B-Disease
Sentence: 884,nerve,I-Disease
Sentence: 884,palsies,I-Disease
Sentence: 884,due,O
Sentence: 884,to,O
Sentence: 884,local,O
Sentence: 884,anesthetics,O
Sentence: 884,have,O
Sentence: 884,been,O
Sentence: 884,described,O
Sentence: 884,",",O
Sentence: 884,however,O
Sentence: 884,.,O
Sentence: 884,Such,O
Sentence: 884,complications,O
Sentence: 884,are,O
Sentence: 884,most,O
Sentence: 884,important,O
Sentence: 884,in,O
Sentence: 884,situations,O
Sentence: 884,where,O
Sentence: 884,there,O
Sentence: 884,is,O
Sentence: 884,a,O
Sentence: 884,pre,O
Sentence: 884,-,O
Sentence: 884,existing,O
Sentence: 884,contralateral,O
Sentence: 884,paralysis,B-Disease
Sentence: 884,.,O
Sentence: 884,We,O
Sentence: 884,therefore,O
Sentence: 884,examined,O
Sentence: 884,the,O
Sentence: 884,effect,O
Sentence: 884,of,O
Sentence: 884,local,O
Sentence: 884,anesthesia,O
Sentence: 884,on,O
Sentence: 884,vocal,O
Sentence: 884,cord,O
Sentence: 884,function,O
Sentence: 884,to,O
Sentence: 884,better,O
Sentence: 884,understand,O
Sentence: 884,its,O
Sentence: 884,possible,O
Sentence: 884,consequences,O
Sentence: 884,.,O
Sentence: 884,METHODS,O
Sentence: 884,:,O
Sentence: 884,This,O
Sentence: 884,prospective,O
Sentence: 884,study,O
Sentence: 884,included,O
Sentence: 884,28,O
Sentence: 884,patients,O
Sentence: 884,undergoing,O
Sentence: 884,carotid,O
Sentence: 884,endarterectomy,O
Sentence: 884,under,O
Sentence: 884,local,O
Sentence: 884,anesthesia,O
Sentence: 884,.,O
Sentence: 884,Vocal,O
Sentence: 884,cord,O
Sentence: 884,function,O
Sentence: 884,was,O
Sentence: 884,evaluated,O
Sentence: 884,before,O
Sentence: 884,",",O
Sentence: 884,during,O
Sentence: 884,",",O
Sentence: 884,and,O
Sentence: 884,after,O
Sentence: 884,surgery,O
Sentence: 884,(,O
Sentence: 884,postoperative,O
Sentence: 884,day,O
Sentence: 884,1,O
Sentence: 884,),O
Sentence: 884,using,O
Sentence: 884,flexible,O
Sentence: 884,laryngoscopy,O
Sentence: 884,.,O
Sentence: 884,Anesthesia,O
Sentence: 884,was,O
Sentence: 884,performed,O
Sentence: 884,by,O
Sentence: 884,injecting,O
Sentence: 884,20,O
Sentence: 884,to,O
Sentence: 884,40,O
Sentence: 884,mL,O
Sentence: 884,of,O
Sentence: 884,a,O
Sentence: 884,mixture,O
Sentence: 884,of,O
Sentence: 884,long,O
Sentence: 884,-,O
Sentence: 884,acting,O
Sentence: 884,(,O
Sentence: 884,ropivacaine,B-Chemical
Sentence: 884,),O
Sentence: 884,and,O
Sentence: 884,short,O
Sentence: 884,-,O
Sentence: 884,acting,O
Sentence: 884,(,O
Sentence: 884,prilocaine,B-Chemical
Sentence: 884,),O
Sentence: 884,anesthetic,O
Sentence: 884,.,O
Sentence: 884,RESULTS,O
Sentence: 884,:,O
Sentence: 884,All,O
Sentence: 884,patients,O
Sentence: 884,had,O
Sentence: 884,normal,O
Sentence: 884,vocal,O
Sentence: 884,cord,O
Sentence: 884,function,O
Sentence: 884,preoperatively,O
Sentence: 884,.,O
Sentence: 884,Twelve,O
Sentence: 884,patients,O
Sentence: 884,(,O
Sentence: 884,43,O
Sentence: 884,%,O
Sentence: 884,),O
Sentence: 884,were,O
Sentence: 884,found,O
Sentence: 884,to,O
Sentence: 884,have,O
Sentence: 884,intraoperative,O
Sentence: 884,ipsilateral,O
Sentence: 884,vocal,B-Disease
Sentence: 884,cord,I-Disease
Sentence: 884,paralysis,I-Disease
Sentence: 884,.,O
Sentence: 884,It,O
Sentence: 884,resolved,O
Sentence: 884,in,O
Sentence: 884,all,O
Sentence: 884,cases,O
Sentence: 884,,O
Sentence: 884,<,O
Sentence: 884,,O
Sentence: 884,or,O
Sentence: 884,,O
Sentence: 884,=,O
Sentence: 884,24,O
Sentence: 884,hours,O
Sentence: 884,.,O
Sentence: 884,There,O
Sentence: 884,were,O
Sentence: 884,no,O
Sentence: 884,significant,O
Sentence: 884,differences,O
Sentence: 884,in,O
Sentence: 884,operating,O
Sentence: 884,time,O
Sentence: 884,or,O
Sentence: 884,volume,O
Sentence: 884,or,O
Sentence: 884,frequency,O
Sentence: 884,of,O
Sentence: 884,anesthetic,O
Sentence: 884,administration,O
Sentence: 884,in,O
Sentence: 884,patients,O
Sentence: 884,with,O
Sentence: 884,temporary,O
Sentence: 884,vocal,B-Disease
Sentence: 884,cord,I-Disease
Sentence: 884,paralysis,I-Disease
Sentence: 884,compared,O
Sentence: 884,with,O
Sentence: 884,those,O
Sentence: 884,without,O
Sentence: 884,.,O
Sentence: 884,CONCLUSION,O
Sentence: 884,:,O
Sentence: 884,Local,O
Sentence: 884,anesthesia,O
Sentence: 884,led,O
Sentence: 884,to,O
Sentence: 884,temporary,O
Sentence: 884,ipsilateral,O
Sentence: 884,vocal,B-Disease
Sentence: 884,cord,I-Disease
Sentence: 884,paralysis,I-Disease
Sentence: 884,in,O
Sentence: 884,almost,O
Sentence: 884,half,O
Sentence: 884,of,O
Sentence: 884,these,O
Sentence: 884,patients,O
Sentence: 884,.,O
Sentence: 884,Because,O
Sentence: 884,pre,O
Sentence: 884,-,O
Sentence: 884,existing,O
Sentence: 884,paralysis,B-Disease
Sentence: 884,is,O
Sentence: 884,of,O
Sentence: 884,a,O
Sentence: 884,relevant,O
Sentence: 884,frequency,O
Sentence: 884,(,O
Sentence: 884,up,O
Sentence: 884,to,O
Sentence: 884,3,O
Sentence: 884,%,O
Sentence: 884,),O
Sentence: 884,",",O
Sentence: 884,a,O
Sentence: 884,preoperative,O
Sentence: 884,evaluation,O
Sentence: 884,of,O
Sentence: 884,vocal,O
Sentence: 884,cord,O
Sentence: 884,function,O
Sentence: 884,before,O
Sentence: 884,carotid,O
Sentence: 884,endarterectomy,O
Sentence: 884,under,O
Sentence: 884,local,O
Sentence: 884,anesthesia,O
Sentence: 884,is,O
Sentence: 884,recommended,O
Sentence: 884,to,O
Sentence: 884,avoid,O
Sentence: 884,intraoperative,O
Sentence: 884,bilateral,O
Sentence: 884,paralysis,B-Disease
Sentence: 884,.,O
Sentence: 884,In,O
Sentence: 884,patients,O
Sentence: 884,with,O
Sentence: 884,preoperative,O
Sentence: 884,contralateral,O
Sentence: 884,vocal,B-Disease
Sentence: 884,cord,I-Disease
Sentence: 884,paralysis,I-Disease
Sentence: 884,",",O
Sentence: 884,surgery,O
Sentence: 884,under,O
Sentence: 884,general,O
Sentence: 884,anesthesia,O
Sentence: 884,should,O
Sentence: 884,be,O
Sentence: 884,considered,O
Sentence: 884,.,O
Sentence: 885,Neuroprotective,O
Sentence: 885,effects,O
Sentence: 885,of,O
Sentence: 885,melatonin,B-Chemical
Sentence: 885,upon,O
Sentence: 885,the,O
Sentence: 885,offspring,O
Sentence: 885,cerebellar,O
Sentence: 885,cortex,O
Sentence: 885,in,O
Sentence: 885,the,O
Sentence: 885,rat,O
Sentence: 885,model,O
Sentence: 885,of,O
Sentence: 885,BCNU,B-Chemical
Sentence: 885,-,O
Sentence: 885,induced,O
Sentence: 885,cortical,B-Disease
Sentence: 885,dysplasia,I-Disease
Sentence: 885,.,O
Sentence: 886,Cortical,B-Disease
Sentence: 886,dysplasia,I-Disease
Sentence: 886,is,O
Sentence: 886,a,O
Sentence: 886,malformation,O
Sentence: 886,characterized,O
Sentence: 886,by,O
Sentence: 886,defects,O
Sentence: 886,in,O
Sentence: 886,proliferation,O
Sentence: 886,",",O
Sentence: 886,migration,O
Sentence: 886,and,O
Sentence: 886,maturation,O
Sentence: 886,.,O
Sentence: 886,This,O
Sentence: 886,study,O
Sentence: 886,was,O
Sentence: 886,designed,O
Sentence: 886,to,O
Sentence: 886,evaluate,O
Sentence: 886,the,O
Sentence: 886,alterations,O
Sentence: 886,in,O
Sentence: 886,offspring,O
Sentence: 886,rat,O
Sentence: 886,cerebellum,O
Sentence: 886,induced,O
Sentence: 886,by,O
Sentence: 886,maternal,O
Sentence: 886,exposure,O
Sentence: 886,to,O
Sentence: 886,carmustine,B-Chemical
Sentence: 886,-,O
Sentence: 886,,O
Sentence: 886,[,O
Sentence: 886,"1,3",O
Sentence: 886,-,O
Sentence: 886,bis,O
Sentence: 886,(,O
Sentence: 886,2,O
Sentence: 886,-,O
Sentence: 886,chloroethyl,O
Sentence: 886,),O
Sentence: 886,,O
Sentence: 886,-,O
Sentence: 886,1,O
Sentence: 886,-,O
Sentence: 886,nitrosoure,O
Sentence: 886,],O
Sentence: 886,(,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,),O
Sentence: 886,and,O
Sentence: 886,to,O
Sentence: 886,investigate,O
Sentence: 886,the,O
Sentence: 886,effects,O
Sentence: 886,of,O
Sentence: 886,exogenous,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,upon,O
Sentence: 886,cerebellar,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,induced,O
Sentence: 886,cortical,B-Disease
Sentence: 886,dysplasia,I-Disease
Sentence: 886,",",O
Sentence: 886,using,O
Sentence: 886,histological,O
Sentence: 886,and,O
Sentence: 886,biochemical,O
Sentence: 886,analyses,O
Sentence: 886,.,O
Sentence: 886,Pregnant,O
Sentence: 886,Wistar,O
Sentence: 886,rats,O
Sentence: 886,were,O
Sentence: 886,assigned,O
Sentence: 886,to,O
Sentence: 886,five,O
Sentence: 886,groups,O
Sentence: 886,:,O
Sentence: 886,intact,O
Sentence: 886,-,O
Sentence: 886,control,O
Sentence: 886,",",O
Sentence: 886,saline,O
Sentence: 886,-,O
Sentence: 886,control,O
Sentence: 886,",",O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,-,O
Sentence: 886,treated,O
Sentence: 886,",",O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,exposed,O
Sentence: 886,and,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,exposed,O
Sentence: 886,plus,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,.,O
Sentence: 886,Rats,O
Sentence: 886,were,O
Sentence: 886,exposed,O
Sentence: 886,to,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,on,O
Sentence: 886,embryonic,O
Sentence: 886,day,O
Sentence: 886,15,O
Sentence: 886,and,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,was,O
Sentence: 886,given,O
Sentence: 886,until,O
Sentence: 886,delivery,O
Sentence: 886,.,O
Sentence: 886,Immuno,O
Sentence: 886,/,O
Sentence: 886,histochemistry,O
Sentence: 886,and,O
Sentence: 886,electron,O
Sentence: 886,microscopy,O
Sentence: 886,were,O
Sentence: 886,carried,O
Sentence: 886,out,O
Sentence: 886,on,O
Sentence: 886,the,O
Sentence: 886,offspring,O
Sentence: 886,cerebellum,O
Sentence: 886,",",O
Sentence: 886,and,O
Sentence: 886,levels,O
Sentence: 886,of,O
Sentence: 886,malondialdehyde,B-Chemical
Sentence: 886,and,O
Sentence: 886,superoxide,B-Chemical
Sentence: 886,dismutase,O
Sentence: 886,were,O
Sentence: 886,determined,O
Sentence: 886,.,O
Sentence: 886,Histopathologically,O
Sentence: 886,",",O
Sentence: 886,typical,O
Sentence: 886,findings,O
Sentence: 886,were,O
Sentence: 886,observed,O
Sentence: 886,in,O
Sentence: 886,the,O
Sentence: 886,cerebella,O
Sentence: 886,from,O
Sentence: 886,the,O
Sentence: 886,control,O
Sentence: 886,groups,O
Sentence: 886,",",O
Sentence: 886,but,O
Sentence: 886,the,O
Sentence: 886,findings,O
Sentence: 886,consistent,O
Sentence: 886,with,O
Sentence: 886,early,O
Sentence: 886,embryonic,O
Sentence: 886,development,O
Sentence: 886,were,O
Sentence: 886,noted,O
Sentence: 886,in,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,exposed,O
Sentence: 886,cortical,B-Disease
Sentence: 886,dysplasia,I-Disease
Sentence: 886,group,O
Sentence: 886,.,O
Sentence: 886,There,O
Sentence: 886,was,O
Sentence: 886,a,O
Sentence: 886,marked,O
Sentence: 886,increase,O
Sentence: 886,in,O
Sentence: 886,the,O
Sentence: 886,number,O
Sentence: 886,of,O
Sentence: 886,TUNEL,O
Sentence: 886,positive,O
Sentence: 886,cells,O
Sentence: 886,and,O
Sentence: 886,nestin,O
Sentence: 886,positive,O
Sentence: 886,cells,O
Sentence: 886,in,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,exposed,O
Sentence: 886,group,O
Sentence: 886,",",O
Sentence: 886,but,O
Sentence: 886,a,O
Sentence: 886,decreased,O
Sentence: 886,immunoreactivity,O
Sentence: 886,to,O
Sentence: 886,glial,O
Sentence: 886,fibrillary,O
Sentence: 886,acidic,O
Sentence: 886,protein,O
Sentence: 886,",",O
Sentence: 886,synaptophysin,O
Sentence: 886,and,O
Sentence: 886,transforming,O
Sentence: 886,growth,O
Sentence: 886,factor,O
Sentence: 886,beta1,O
Sentence: 886,was,O
Sentence: 886,observed,O
Sentence: 886,",",O
Sentence: 886,indicating,O
Sentence: 886,a,O
Sentence: 886,delayed,O
Sentence: 886,maturation,O
Sentence: 886,",",O
Sentence: 886,and,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,significantly,O
Sentence: 886,reversed,O
Sentence: 886,these,O
Sentence: 886,changes,O
Sentence: 886,.,O
Sentence: 886,Malondialdehyde,B-Chemical
Sentence: 886,level,O
Sentence: 886,in,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,-,O
Sentence: 886,exposed,O
Sentence: 886,group,O
Sentence: 886,was,O
Sentence: 886,higher,O
Sentence: 886,than,O
Sentence: 886,those,O
Sentence: 886,in,O
Sentence: 886,control,O
Sentence: 886,groups,O
Sentence: 886,and,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,decreased,O
Sentence: 886,malondialdehyde,B-Chemical
Sentence: 886,levels,O
Sentence: 886,in,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,group,O
Sentence: 886,(,O
Sentence: 886,p,O
Sentence: 886,,O
Sentence: 886,<,O
Sentence: 886,,O
Sentence: 886,0.01,O
Sentence: 886,),O
Sentence: 886,",",O
Sentence: 886,while,O
Sentence: 886,there,O
Sentence: 886,were,O
Sentence: 886,no,O
Sentence: 886,significant,O
Sentence: 886,differences,O
Sentence: 886,in,O
Sentence: 886,the,O
Sentence: 886,superoxide,B-Chemical
Sentence: 886,dismutase,O
Sentence: 886,levels,O
Sentence: 886,between,O
Sentence: 886,these,O
Sentence: 886,groups,O
Sentence: 886,.,O
Sentence: 886,These,O
Sentence: 886,data,O
Sentence: 886,suggest,O
Sentence: 886,that,O
Sentence: 886,exposure,O
Sentence: 886,of,O
Sentence: 886,animals,O
Sentence: 886,to,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,during,O
Sentence: 886,pregnancy,O
Sentence: 886,leads,O
Sentence: 886,to,O
Sentence: 886,delayed,O
Sentence: 886,maturation,O
Sentence: 886,of,O
Sentence: 886,offspring,O
Sentence: 886,cerebellum,O
Sentence: 886,and,O
Sentence: 886,melatonin,B-Chemical
Sentence: 886,protects,O
Sentence: 886,the,O
Sentence: 886,cerebellum,O
Sentence: 886,against,O
Sentence: 886,the,O
Sentence: 886,effects,O
Sentence: 886,of,O
Sentence: 886,BCNU,B-Chemical
Sentence: 886,.,O
Sentence: 887,Myo,O
Sentence: 887,-,O
Sentence: 887,inositol,O
Sentence: 887,-,O
Sentence: 887,1,O
Sentence: 887,-,O
Sentence: 887,phosphate,O
Sentence: 887,(,O
Sentence: 887,MIP,B-Chemical
Sentence: 887,),O
Sentence: 887,synthase,O
Sentence: 887,inhibition,O
Sentence: 887,:,O
Sentence: 887,in,O
Sentence: 887,-,O
Sentence: 887,vivo,O
Sentence: 887,study,O
Sentence: 887,in,O
Sentence: 887,rats,O
Sentence: 887,.,O
Sentence: 888,Lithium,B-Chemical
Sentence: 888,and,O
Sentence: 888,valproate,B-Chemical
Sentence: 888,are,O
Sentence: 888,the,O
Sentence: 888,prototypic,O
Sentence: 888,mood,O
Sentence: 888,stabilizers,O
Sentence: 888,and,O
Sentence: 888,have,O
Sentence: 888,diverse,O
Sentence: 888,structures,O
Sentence: 888,and,O
Sentence: 888,targets,O
Sentence: 888,.,O
Sentence: 888,Both,O
Sentence: 888,drugs,O
Sentence: 888,influence,O
Sentence: 888,inositol,B-Chemical
Sentence: 888,metabolism,O
Sentence: 888,.,O
Sentence: 888,Lithium,B-Chemical
Sentence: 888,inhibits,O
Sentence: 888,IMPase,O
Sentence: 888,and,O
Sentence: 888,valproate,B-Chemical
Sentence: 888,inhibits,O
Sentence: 888,MIP,B-Chemical
Sentence: 888,synthase,O
Sentence: 888,.,O
Sentence: 888,This,O
Sentence: 888,study,O
Sentence: 888,shows,O
Sentence: 888,that,O
Sentence: 888,MIP,B-Chemical
Sentence: 888,synthase,O
Sentence: 888,inhibition,O
Sentence: 888,does,O
Sentence: 888,not,O
Sentence: 888,replicate,O
Sentence: 888,or,O
Sentence: 888,augment,O
Sentence: 888,the,O
Sentence: 888,effects,O
Sentence: 888,of,O
Sentence: 888,lithium,B-Chemical
Sentence: 888,in,O
Sentence: 888,the,O
Sentence: 888,inositol,B-Chemical
Sentence: 888,sensitive,O
Sentence: 888,pilocarpine,B-Chemical
Sentence: 888,-,O
Sentence: 888,induced,O
Sentence: 888,seizures,B-Disease
Sentence: 888,model,O
Sentence: 888,.,O
Sentence: 888,This,O
Sentence: 888,lack,O
Sentence: 888,of,O
Sentence: 888,effects,O
Sentence: 888,may,O
Sentence: 888,stem,O
Sentence: 888,from,O
Sentence: 888,the,O
Sentence: 888,low,O
Sentence: 888,contribution,O
Sentence: 888,of,O
Sentence: 888,de,O
Sentence: 888,-,O
Sentence: 888,novo,O
Sentence: 888,synthesis,O
Sentence: 888,to,O
Sentence: 888,cellular,O
Sentence: 888,inositol,B-Chemical
Sentence: 888,supply,O
Sentence: 888,or,O
Sentence: 888,to,O
Sentence: 888,the,O
Sentence: 888,inhibition,O
Sentence: 888,of,O
Sentence: 888,the,O
Sentence: 888,de,O
Sentence: 888,-,O
Sentence: 888,novo,O
Sentence: 888,synthesis,O
Sentence: 888,by,O
Sentence: 888,lithium,B-Chemical
Sentence: 888,itself,O
Sentence: 888,.,O
Sentence: 889,Non,O
Sentence: 889,-,O
Sentence: 889,steroidal,O
Sentence: 889,anti,O
Sentence: 889,-,O
Sentence: 889,inflammatory,O
Sentence: 889,drugs,O
Sentence: 889,-,O
Sentence: 889,associated,O
Sentence: 889,acute,O
Sentence: 889,interstitial,O
Sentence: 889,nephritis,O
Sentence: 889,with,O
Sentence: 889,granular,O
Sentence: 889,tubular,O
Sentence: 889,basement,O
Sentence: 889,membrane,O
Sentence: 889,deposits,O
Sentence: 889,.,O
Sentence: 890,Acute,O
Sentence: 890,tubulo,O
Sentence: 890,-,O
Sentence: 890,interstitial,O
Sentence: 890,nephritis,O
Sentence: 890,(,O
Sentence: 890,ATIN,B-Disease
Sentence: 890,),O
Sentence: 890,is,O
Sentence: 890,an,O
Sentence: 890,important,O
Sentence: 890,cause,O
Sentence: 890,of,O
Sentence: 890,acute,B-Disease
Sentence: 890,renal,I-Disease
Sentence: 890,failure,I-Disease
Sentence: 890,resulting,O
Sentence: 890,from,O
Sentence: 890,a,O
Sentence: 890,variety,O
Sentence: 890,of,O
Sentence: 890,insults,O
Sentence: 890,",",O
Sentence: 890,including,O
Sentence: 890,immune,O
Sentence: 890,complex,O
Sentence: 890,-,O
Sentence: 890,mediated,O
Sentence: 890,tubulo,O
Sentence: 890,-,O
Sentence: 890,interstitial,O
Sentence: 890,injury,O
Sentence: 890,",",O
Sentence: 890,but,O
Sentence: 890,drugs,O
Sentence: 890,such,O
Sentence: 890,as,O
Sentence: 890,non,O
Sentence: 890,-,O
Sentence: 890,steroidal,O
Sentence: 890,anti,O
Sentence: 890,-,O
Sentence: 890,inflammatory,O
Sentence: 890,drugs,O
Sentence: 890,(,O
Sentence: 890,NSAIDs,O
Sentence: 890,),O
Sentence: 890,are,O
Sentence: 890,a,O
Sentence: 890,far,O
Sentence: 890,more,O
Sentence: 890,frequent,O
Sentence: 890,cause,O
Sentence: 890,.,O
Sentence: 890,Overall,O
Sentence: 890,",",O
Sentence: 890,as,O
Sentence: 890,an,O
Sentence: 890,entity,O
Sentence: 890,",",O
Sentence: 890,ATIN,B-Disease
Sentence: 890,remains,O
Sentence: 890,under,O
Sentence: 890,-,O
Sentence: 890,diagnosed,O
Sentence: 890,",",O
Sentence: 890,as,O
Sentence: 890,symptoms,O
Sentence: 890,resolve,O
Sentence: 890,spontaneously,O
Sentence: 890,if,O
Sentence: 890,the,O
Sentence: 890,medication,O
Sentence: 890,is,O
Sentence: 890,stopped,O
Sentence: 890,.,O
Sentence: 890,We,O
Sentence: 890,report,O
Sentence: 890,on,O
Sentence: 890,a,O
Sentence: 890,14,O
Sentence: 890,-,O
Sentence: 890,year,O
Sentence: 890,-,O
Sentence: 890,old,O
Sentence: 890,boy,O
Sentence: 890,who,O
Sentence: 890,developed,O
Sentence: 890,acute,B-Disease
Sentence: 890,renal,I-Disease
Sentence: 890,failure,I-Disease
Sentence: 890,2,O
Sentence: 890,weeks,O
Sentence: 890,after,O
Sentence: 890,aortic,O
Sentence: 890,valve,O
Sentence: 890,surgery,O
Sentence: 890,.,O
Sentence: 890,He,O
Sentence: 890,was,O
Sentence: 890,put,O
Sentence: 890,on,O
Sentence: 890,aspirin,B-Chemical
Sentence: 890,following,O
Sentence: 890,surgery,O
Sentence: 890,and,O
Sentence: 890,took,O
Sentence: 890,ibuprofen,B-Chemical
Sentence: 890,for,O
Sentence: 890,fever,B-Disease
Sentence: 890,for,O
Sentence: 890,nearly,O
Sentence: 890,a,O
Sentence: 890,week,O
Sentence: 890,prior,O
Sentence: 890,to,O
Sentence: 890,presentation,O
Sentence: 890,.,O
Sentence: 890,He,O
Sentence: 890,then,O
Sentence: 890,presented,O
Sentence: 890,to,O
Sentence: 890,the,O
Sentence: 890,emergency,O
Sentence: 890,department,O
Sentence: 890,feeling,O
Sentence: 890,quite,O
Sentence: 890,ill,O
Sentence: 890,and,O
Sentence: 890,was,O
Sentence: 890,found,O
Sentence: 890,to,O
Sentence: 890,have,O
Sentence: 890,a,O
Sentence: 890,blood,B-Chemical
Sentence: 890,urea,I-Chemical
Sentence: 890,nitrogen,I-Chemical
Sentence: 890,(,O
Sentence: 890,BUN,B-Chemical
Sentence: 890,),O
Sentence: 890,concentration,O
Sentence: 890,of,O
Sentence: 890,of,O
Sentence: 890,147,O
Sentence: 890,mg,O
Sentence: 890,/,O
Sentence: 890,dl,O
Sentence: 890,",",O
Sentence: 890,creatinine,B-Chemical
Sentence: 890,of,O
Sentence: 890,15.3,O
Sentence: 890,mg,O
Sentence: 890,/,O
Sentence: 890,dl,O
Sentence: 890,and,O
Sentence: 890,serum,O
Sentence: 890,potassium,B-Chemical
Sentence: 890,of,O
Sentence: 890,8.7,O
Sentence: 890,mEq,O
Sentence: 890,/,O
Sentence: 890,l,O
Sentence: 890,.,O
Sentence: 890,Dialysis,O
Sentence: 890,was,O
Sentence: 890,immediately,O
Sentence: 890,initiated,O
Sentence: 890,.,O
Sentence: 890,A,O
Sentence: 890,kidney,O
Sentence: 890,biopsy,O
Sentence: 890,showed,O
Sentence: 890,inflammatory,O
Sentence: 890,infiltrate,O
Sentence: 890,consistent,O
Sentence: 890,with,O
Sentence: 890,ATIN,B-Disease
Sentence: 890,.,O
Sentence: 890,However,O
Sentence: 890,",",O
Sentence: 890,in,O
Sentence: 890,the,O
Sentence: 890,tubular,O
Sentence: 890,basement,O
Sentence: 890,membrane,O
Sentence: 890,(,O
Sentence: 890,TBM,O
Sentence: 890,),O
Sentence: 890,",",O
Sentence: 890,very,O
Sentence: 890,intense,O
Sentence: 890,granular,O
Sentence: 890,deposits,O
Sentence: 890,of,O
Sentence: 890,polyclonal,O
Sentence: 890,IgG,O
Sentence: 890,and,O
Sentence: 890,C3,O
Sentence: 890,were,O
Sentence: 890,noted,O
Sentence: 890,.,O
Sentence: 890,He,O
Sentence: 890,needed,O
Sentence: 890,dialysis,O
Sentence: 890,for,O
Sentence: 890,2,O
Sentence: 890,weeks,O
Sentence: 890,and,O
Sentence: 890,was,O
Sentence: 890,treated,O
Sentence: 890,successfully,O
Sentence: 890,with,O
Sentence: 890,steroids,B-Chemical
Sentence: 890,for,O
Sentence: 890,6,O
Sentence: 890,months,O
Sentence: 890,.,O
Sentence: 890,His,O
Sentence: 890,renal,O
Sentence: 890,recovery,O
Sentence: 890,and,O
Sentence: 890,disappearance,O
Sentence: 890,of,O
Sentence: 890,proteinuria,B-Disease
Sentence: 890,took,O
Sentence: 890,a,O
Sentence: 890,year,O
Sentence: 890,.,O
Sentence: 890,In,O
Sentence: 890,conclusion,O
Sentence: 890,",",O
Sentence: 890,this,O
Sentence: 890,is,O
Sentence: 890,a,O
Sentence: 890,first,O
Sentence: 890,report,O
Sentence: 890,of,O
Sentence: 890,NSAIDs,O
Sentence: 890,-,O
Sentence: 890,associated,O
Sentence: 890,ATIN,B-Disease
Sentence: 890,",",O
Sentence: 890,showing,O
Sentence: 890,deposits,O
Sentence: 890,of,O
Sentence: 890,granular,O
Sentence: 890,immune,O
Sentence: 890,complex,O
Sentence: 890,present,O
Sentence: 890,only,O
Sentence: 890,in,O
Sentence: 890,the,O
Sentence: 890,TBM,O
Sentence: 890,and,O
Sentence: 890,not,O
Sentence: 890,in,O
Sentence: 890,the,O
Sentence: 890,glomeruli,O
Sentence: 890,.,O
Sentence: 891,Rifampicin,B-Chemical
Sentence: 891,-,O
Sentence: 891,associated,O
Sentence: 891,segmental,O
Sentence: 891,necrotizing,O
Sentence: 891,glomerulonephritis,B-Disease
Sentence: 891,in,O
Sentence: 891,staphylococcal,B-Disease
Sentence: 891,endocarditis,B-Disease
Sentence: 891,.,O
Sentence: 892,Segmental,O
Sentence: 892,necrotising,O
Sentence: 892,glomerulonephritis,B-Disease
Sentence: 892,has,O
Sentence: 892,been,O
Sentence: 892,reported,O
Sentence: 892,as,O
Sentence: 892,complication,O
Sentence: 892,of,O
Sentence: 892,rifampicin,B-Chemical
Sentence: 892,therapy,O
Sentence: 892,in,O
Sentence: 892,patients,O
Sentence: 892,receiving,O
Sentence: 892,treatment,O
Sentence: 892,for,O
Sentence: 892,tuberculosis,B-Disease
Sentence: 892,.,O
Sentence: 892,Changing,O
Sentence: 892,epidemiology,O
Sentence: 892,of,O
Sentence: 892,infections,B-Disease
Sentence: 892,such,O
Sentence: 892,as,O
Sentence: 892,infective,B-Disease
Sentence: 892,endocarditis,I-Disease
Sentence: 892,(,O
Sentence: 892,IE,B-Disease
Sentence: 892,),O
Sentence: 892,has,O
Sentence: 892,led,O
Sentence: 892,to,O
Sentence: 892,an,O
Sentence: 892,increase,O
Sentence: 892,in,O
Sentence: 892,the,O
Sentence: 892,use,O
Sentence: 892,of,O
Sentence: 892,rifampicin,B-Chemical
Sentence: 892,for,O
Sentence: 892,Staphylococcal,B-Disease
Sentence: 892,infections,I-Disease
Sentence: 892,.,O
Sentence: 892,We,O
Sentence: 892,describe,O
Sentence: 892,a,O
Sentence: 892,case,O
Sentence: 892,of,O
Sentence: 892,a,O
Sentence: 892,patient,O
Sentence: 892,with,O
Sentence: 892,Staphylococcal,B-Disease
Sentence: 892,IE,B-Disease
Sentence: 892,who,O
Sentence: 892,developed,O
Sentence: 892,acute,B-Disease
Sentence: 892,renal,I-Disease
Sentence: 892,failure,I-Disease
Sentence: 892,secondary,O
Sentence: 892,to,O
Sentence: 892,a,O
Sentence: 892,segmental,O
Sentence: 892,necrotising,O
Sentence: 892,glomerulonephritis,B-Disease
Sentence: 892,while,O
Sentence: 892,being,O
Sentence: 892,treated,O
Sentence: 892,with,O
Sentence: 892,rifampicin,B-Chemical
Sentence: 892,",",O
Sentence: 892,and,O
Sentence: 892,review,O
Sentence: 892,the,O
Sentence: 892,literature,O
Sentence: 892,regarding,O
Sentence: 892,this,O
Sentence: 892,complication,O
Sentence: 892,of,O
Sentence: 892,rifampicin,B-Chemical
Sentence: 892,therapy,O
Sentence: 892,.,O
Sentence: 893,Rate,O
Sentence: 893,of,O
Sentence: 893,YMDD,O
Sentence: 893,motif,O
Sentence: 893,mutants,O
Sentence: 893,in,O
Sentence: 893,lamivudine,B-Chemical
Sentence: 893,-,O
Sentence: 893,untreated,O
Sentence: 893,Iranian,O
Sentence: 893,patients,O
Sentence: 893,with,O
Sentence: 893,chronic,B-Disease
Sentence: 893,hepatitis,I-Disease
Sentence: 893,B,I-Disease
Sentence: 893,virus,I-Disease
Sentence: 893,infection,I-Disease
Sentence: 893,.,O
Sentence: 894,BACKGROUND,O
Sentence: 894,:,O
Sentence: 894,Lamivudine,B-Chemical
Sentence: 894,is,O
Sentence: 894,used,O
Sentence: 894,for,O
Sentence: 894,the,O
Sentence: 894,treatment,O
Sentence: 894,of,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,patients,O
Sentence: 894,.,O
Sentence: 894,Recent,O
Sentence: 894,studies,O
Sentence: 894,show,O
Sentence: 894,that,O
Sentence: 894,the,O
Sentence: 894,YMDD,O
Sentence: 894,motif,O
Sentence: 894,mutants,O
Sentence: 894,(,O
Sentence: 894,resistant,O
Sentence: 894,hepatitis,B-Disease
Sentence: 894,B,I-Disease
Sentence: 894,virus,O
Sentence: 894,),O
Sentence: 894,occur,O
Sentence: 894,as,O
Sentence: 894,natural,O
Sentence: 894,genome,O
Sentence: 894,variability,O
Sentence: 894,in,O
Sentence: 894,lamivudine,B-Chemical
Sentence: 894,-,O
Sentence: 894,untreated,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,patients,O
Sentence: 894,.,O
Sentence: 894,In,O
Sentence: 894,this,O
Sentence: 894,study,O
Sentence: 894,we,O
Sentence: 894,aimed,O
Sentence: 894,to,O
Sentence: 894,determine,O
Sentence: 894,the,O
Sentence: 894,rate,O
Sentence: 894,of,O
Sentence: 894,YMDD,O
Sentence: 894,motif,O
Sentence: 894,mutants,O
Sentence: 894,in,O
Sentence: 894,lamivudine,B-Chemical
Sentence: 894,-,O
Sentence: 894,untreated,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,patients,O
Sentence: 894,in,O
Sentence: 894,Iran,O
Sentence: 894,.,O
Sentence: 894,PATIENTS,O
Sentence: 894,AND,O
Sentence: 894,METHODS,O
Sentence: 894,:,O
Sentence: 894,A,O
Sentence: 894,total,O
Sentence: 894,of,O
Sentence: 894,77,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,patients,O
Sentence: 894,who,O
Sentence: 894,had,O
Sentence: 894,not,O
Sentence: 894,been,O
Sentence: 894,treated,O
Sentence: 894,with,O
Sentence: 894,lamivudine,B-Chemical
Sentence: 894,were,O
Sentence: 894,included,O
Sentence: 894,in,O
Sentence: 894,the,O
Sentence: 894,study,O
Sentence: 894,.,O
Sentence: 894,Serum,O
Sentence: 894,samples,O
Sentence: 894,from,O
Sentence: 894,patients,O
Sentence: 894,were,O
Sentence: 894,tested,O
Sentence: 894,by,O
Sentence: 894,polymerase,O
Sentence: 894,chain,O
Sentence: 894,reaction,O
Sentence: 894,-,O
Sentence: 894,restriction,O
Sentence: 894,fragment,O
Sentence: 894,length,O
Sentence: 894,polymorphism,O
Sentence: 894,(,O
Sentence: 894,PCR,O
Sentence: 894,-,O
Sentence: 894,RFLP,O
Sentence: 894,),O
Sentence: 894,for,O
Sentence: 894,detection,O
Sentence: 894,of,O
Sentence: 894,YMDD,O
Sentence: 894,motif,O
Sentence: 894,mutants,O
Sentence: 894,.,O
Sentence: 894,All,O
Sentence: 894,patients,O
Sentence: 894,were,O
Sentence: 894,also,O
Sentence: 894,tested,O
Sentence: 894,for,O
Sentence: 894,liver,O
Sentence: 894,enzymes,O
Sentence: 894,",",O
Sentence: 894,anti,O
Sentence: 894,-,O
Sentence: 894,HCV,O
Sentence: 894,",",O
Sentence: 894,HBeAg,B-Chemical
Sentence: 894,",",O
Sentence: 894,and,O
Sentence: 894,anti,O
Sentence: 894,-,O
Sentence: 894,HBe,O
Sentence: 894,.,O
Sentence: 894,RESULTS,O
Sentence: 894,:,O
Sentence: 894,Of,O
Sentence: 894,the,O
Sentence: 894,77,O
Sentence: 894,patients,O
Sentence: 894,enrolled,O
Sentence: 894,in,O
Sentence: 894,the,O
Sentence: 894,study,O
Sentence: 894,",",O
Sentence: 894,73,O
Sentence: 894,%,O
Sentence: 894,were,O
Sentence: 894,male,O
Sentence: 894,and,O
Sentence: 894,27,O
Sentence: 894,%,O
Sentence: 894,were,O
Sentence: 894,female,O
Sentence: 894,.,O
Sentence: 894,Mean,O
Sentence: 894,ALT,O
Sentence: 894,and,O
Sentence: 894,AST,O
Sentence: 894,levels,O
Sentence: 894,were,O
Sentence: 894,124.4+,O
Sentence: 894,/,O
Sentence: 894,,O
Sentence: 894,-,O
Sentence: 894,73.4,O
Sentence: 894,and,O
Sentence: 894,103.1+,O
Sentence: 894,/,O
Sentence: 894,,O
Sentence: 894,-,O
Sentence: 894,81,O
Sentence: 894,IU,O
Sentence: 894,/,O
Sentence: 894,l,O
Sentence: 894,",",O
Sentence: 894,respectively,O
Sentence: 894,.,O
Sentence: 894,HBeAg,B-Chemical
Sentence: 894,was,O
Sentence: 894,positive,O
Sentence: 894,in,O
Sentence: 894,40,O
Sentence: 894,%,O
Sentence: 894,and,O
Sentence: 894,anti,O
Sentence: 894,-,O
Sentence: 894,HBe,O
Sentence: 894,in,O
Sentence: 894,60,O
Sentence: 894,%,O
Sentence: 894,of,O
Sentence: 894,the,O
Sentence: 894,patients,O
Sentence: 894,.,O
Sentence: 894,Anti,O
Sentence: 894,-,O
Sentence: 894,HCV,O
Sentence: 894,was,O
Sentence: 894,negative,O
Sentence: 894,in,O
Sentence: 894,all,O
Sentence: 894,of,O
Sentence: 894,them,O
Sentence: 894,.,O
Sentence: 894,YMDD,O
Sentence: 894,motif,O
Sentence: 894,mutants,O
Sentence: 894,were,O
Sentence: 894,not,O
Sentence: 894,detected,O
Sentence: 894,in,O
Sentence: 894,any,O
Sentence: 894,of,O
Sentence: 894,the,O
Sentence: 894,patients,O
Sentence: 894,despite,O
Sentence: 894,the,O
Sentence: 894,liver,O
Sentence: 894,enzyme,O
Sentence: 894,levels,O
Sentence: 894,and,O
Sentence: 894,the,O
Sentence: 894,presence,O
Sentence: 894,of,O
Sentence: 894,HBeAg,B-Chemical
Sentence: 894,or,O
Sentence: 894,anti,O
Sentence: 894,-,O
Sentence: 894,HBe,O
Sentence: 894,.,O
Sentence: 894,CONCLUSION,O
Sentence: 894,:,O
Sentence: 894,Although,O
Sentence: 894,the,O
Sentence: 894,natural,O
Sentence: 894,occurrence,O
Sentence: 894,of,O
Sentence: 894,YMDD,O
Sentence: 894,motif,O
Sentence: 894,mutants,O
Sentence: 894,in,O
Sentence: 894,lamivudine,B-Chemical
Sentence: 894,-,O
Sentence: 894,untreated,O
Sentence: 894,patients,O
Sentence: 894,with,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,has,O
Sentence: 894,been,O
Sentence: 894,reported,O
Sentence: 894,",",O
Sentence: 894,these,O
Sentence: 894,mutants,O
Sentence: 894,were,O
Sentence: 894,not,O
Sentence: 894,detected,O
Sentence: 894,in,O
Sentence: 894,Iranian,O
Sentence: 894,lamivudine,B-Chemical
Sentence: 894,-,O
Sentence: 894,untreated,O
Sentence: 894,chronic,B-Disease
Sentence: 894,hepatitis,I-Disease
Sentence: 894,B,I-Disease
Sentence: 894,patients,O
Sentence: 894,.,O
Sentence: 895,Branch,O
Sentence: 895,retinal,B-Disease
Sentence: 895,vein,I-Disease
Sentence: 895,occlusion,I-Disease
Sentence: 895,and,O
Sentence: 895,fluoxetine,B-Chemical
Sentence: 895,.,O
Sentence: 896,A,O
Sentence: 896,case,O
Sentence: 896,of,O
Sentence: 896,branch,O
Sentence: 896,retinal,B-Disease
Sentence: 896,vein,I-Disease
Sentence: 896,occlusion,I-Disease
Sentence: 896,associated,O
Sentence: 896,with,O
Sentence: 896,fluoxetine,B-Chemical
Sentence: 896,-,O
Sentence: 896,induced,O
Sentence: 896,secondary,O
Sentence: 896,hypertension,B-Disease
Sentence: 896,is,O
Sentence: 896,described,O
Sentence: 896,.,O
Sentence: 896,Although,O
Sentence: 896,an,O
Sentence: 896,infrequent,O
Sentence: 896,complication,O
Sentence: 896,of,O
Sentence: 896,selective,O
Sentence: 896,serotonin,B-Chemical
Sentence: 896,reuptake,O
Sentence: 896,inhibitor,O
Sentence: 896,therapy,O
Sentence: 896,",",O
Sentence: 896,it,O
Sentence: 896,is,O
Sentence: 896,important,O
Sentence: 896,that,O
Sentence: 896,ophthalmologists,O
Sentence: 896,are,O
Sentence: 896,aware,O
Sentence: 896,that,O
Sentence: 896,these,O
Sentence: 896,agents,O
Sentence: 896,can,O
Sentence: 896,cause,O
Sentence: 896,hypertension,B-Disease
Sentence: 896,because,O
Sentence: 896,this,O
Sentence: 896,class,O
Sentence: 896,of,O
Sentence: 896,drugs,O
Sentence: 896,is,O
Sentence: 896,widely,O
Sentence: 896,prescribed,O
Sentence: 896,.,O
Sentence: 897,The,O
Sentence: 897,differential,O
Sentence: 897,effects,O
Sentence: 897,of,O
Sentence: 897,bupivacaine,B-Chemical
Sentence: 897,and,O
Sentence: 897,lidocaine,B-Chemical
Sentence: 897,on,O
Sentence: 897,prostaglandin,B-Chemical
Sentence: 897,E2,I-Chemical
Sentence: 897,release,O
Sentence: 897,",",O
Sentence: 897,cyclooxygenase,O
Sentence: 897,gene,O
Sentence: 897,expression,O
Sentence: 897,and,O
Sentence: 897,pain,B-Disease
Sentence: 897,in,O
Sentence: 897,a,O
Sentence: 897,clinical,O
Sentence: 897,pain,B-Disease
Sentence: 897,model,O
Sentence: 897,.,O
Sentence: 898,BACKGROUND,O
Sentence: 898,:,O
Sentence: 898,In,O
Sentence: 898,addition,O
Sentence: 898,to,O
Sentence: 898,blocking,O
Sentence: 898,nociceptive,O
Sentence: 898,input,O
Sentence: 898,from,O
Sentence: 898,surgical,O
Sentence: 898,sites,O
Sentence: 898,",",O
Sentence: 898,long,O
Sentence: 898,-,O
Sentence: 898,acting,O
Sentence: 898,local,O
Sentence: 898,anesthetics,O
Sentence: 898,might,O
Sentence: 898,directly,O
Sentence: 898,modulate,O
Sentence: 898,inflammation,B-Disease
Sentence: 898,.,O
Sentence: 898,In,O
Sentence: 898,the,O
Sentence: 898,present,O
Sentence: 898,study,O
Sentence: 898,",",O
Sentence: 898,we,O
Sentence: 898,describe,O
Sentence: 898,the,O
Sentence: 898,proinflammatory,O
Sentence: 898,effects,O
Sentence: 898,of,O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,on,O
Sentence: 898,local,O
Sentence: 898,prostaglandin,B-Chemical
Sentence: 898,E2,I-Chemical
Sentence: 898,(,O
Sentence: 898,PGE2,B-Chemical
Sentence: 898,),O
Sentence: 898,production,O
Sentence: 898,and,O
Sentence: 898,cyclooxygenase,O
Sentence: 898,(,O
Sentence: 898,COX,O
Sentence: 898,),O
Sentence: 898,gene,O
Sentence: 898,expression,O
Sentence: 898,that,O
Sentence: 898,increases,O
Sentence: 898,postoperative,B-Disease
Sentence: 898,pain,B-Disease
Sentence: 898,in,O
Sentence: 898,human,O
Sentence: 898,subjects,O
Sentence: 898,.,O
Sentence: 898,METHODS,O
Sentence: 898,:,O
Sentence: 898,Subjects,O
Sentence: 898,(,O
Sentence: 898,n,O
Sentence: 898,,O
Sentence: 898,=,O
Sentence: 898,,O
Sentence: 898,114,O
Sentence: 898,),O
Sentence: 898,undergoing,O
Sentence: 898,extraction,O
Sentence: 898,of,O
Sentence: 898,impacted,O
Sentence: 898,third,O
Sentence: 898,molars,O
Sentence: 898,received,O
Sentence: 898,either,O
Sentence: 898,2,O
Sentence: 898,%,O
Sentence: 898,lidocaine,B-Chemical
Sentence: 898,or,O
Sentence: 898,0.5,O
Sentence: 898,%,O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,before,O
Sentence: 898,surgery,O
Sentence: 898,and,O
Sentence: 898,either,O
Sentence: 898,rofecoxib,B-Chemical
Sentence: 898,50,O
Sentence: 898,mg,O
Sentence: 898,or,O
Sentence: 898,placebo,O
Sentence: 898,orally,O
Sentence: 898,90,O
Sentence: 898,min,O
Sentence: 898,before,O
Sentence: 898,surgery,O
Sentence: 898,and,O
Sentence: 898,for,O
Sentence: 898,the,O
Sentence: 898,following,O
Sentence: 898,48,O
Sentence: 898,h.,O
Sentence: 898,Oral,O
Sentence: 898,mucosal,O
Sentence: 898,biopsies,O
Sentence: 898,were,O
Sentence: 898,taken,O
Sentence: 898,before,O
Sentence: 898,surgery,O
Sentence: 898,and,O
Sentence: 898,48,O
Sentence: 898,h,O
Sentence: 898,after,O
Sentence: 898,surgery,O
Sentence: 898,.,O
Sentence: 898,After,O
Sentence: 898,extraction,O
Sentence: 898,",",O
Sentence: 898,a,O
Sentence: 898,microdialysis,O
Sentence: 898,probe,O
Sentence: 898,was,O
Sentence: 898,placed,O
Sentence: 898,at,O
Sentence: 898,the,O
Sentence: 898,surgical,O
Sentence: 898,site,O
Sentence: 898,for,O
Sentence: 898,PGE2,B-Chemical
Sentence: 898,and,O
Sentence: 898,thromboxane,B-Chemical
Sentence: 898,B2,I-Chemical
Sentence: 898,(,O
Sentence: 898,TXB2,B-Chemical
Sentence: 898,),O
Sentence: 898,measurements,O
Sentence: 898,.,O
Sentence: 898,RESULTS,O
Sentence: 898,:,O
Sentence: 898,The,O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,/,O
Sentence: 898,rofecoxib,B-Chemical
Sentence: 898,group,O
Sentence: 898,reported,O
Sentence: 898,significantly,O
Sentence: 898,less,O
Sentence: 898,pain,B-Disease
Sentence: 898,",",O
Sentence: 898,as,O
Sentence: 898,assessed,O
Sentence: 898,by,O
Sentence: 898,a,O
Sentence: 898,visual,O
Sentence: 898,analog,O
Sentence: 898,scale,O
Sentence: 898,",",O
Sentence: 898,compared,O
Sentence: 898,with,O
Sentence: 898,the,O
Sentence: 898,other,O
Sentence: 898,three,O
Sentence: 898,treatment,O
Sentence: 898,groups,O
Sentence: 898,over,O
Sentence: 898,the,O
Sentence: 898,first,O
Sentence: 898,4,O
Sentence: 898,h.,O
Sentence: 898,However,O
Sentence: 898,",",O
Sentence: 898,the,O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,/,O
Sentence: 898,placebo,O
Sentence: 898,group,O
Sentence: 898,reported,O
Sentence: 898,significantly,O
Sentence: 898,more,O
Sentence: 898,pain,B-Disease
Sentence: 898,at,O
Sentence: 898,24,O
Sentence: 898,h,O
Sentence: 898,and,O
Sentence: 898,PGE2,B-Chemical
Sentence: 898,levels,O
Sentence: 898,during,O
Sentence: 898,the,O
Sentence: 898,first,O
Sentence: 898,4,O
Sentence: 898,h,O
Sentence: 898,were,O
Sentence: 898,significantly,O
Sentence: 898,higher,O
Sentence: 898,than,O
Sentence: 898,the,O
Sentence: 898,other,O
Sentence: 898,three,O
Sentence: 898,treatment,O
Sentence: 898,groups,O
Sentence: 898,.,O
Sentence: 898,Moreover,O
Sentence: 898,",",O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,significantly,O
Sentence: 898,increased,O
Sentence: 898,COX,O
Sentence: 898,-,O
Sentence: 898,2,O
Sentence: 898,gene,O
Sentence: 898,expression,O
Sentence: 898,at,O
Sentence: 898,48,O
Sentence: 898,h,O
Sentence: 898,as,O
Sentence: 898,compared,O
Sentence: 898,with,O
Sentence: 898,the,O
Sentence: 898,lidocaine,B-Chemical
Sentence: 898,/,O
Sentence: 898,placebo,O
Sentence: 898,group,O
Sentence: 898,.,O
Sentence: 898,Thromboxane,B-Chemical
Sentence: 898,levels,O
Sentence: 898,were,O
Sentence: 898,not,O
Sentence: 898,significantly,O
Sentence: 898,affected,O
Sentence: 898,by,O
Sentence: 898,any,O
Sentence: 898,of,O
Sentence: 898,the,O
Sentence: 898,treatments,O
Sentence: 898,",",O
Sentence: 898,indicating,O
Sentence: 898,that,O
Sentence: 898,the,O
Sentence: 898,effects,O
Sentence: 898,seen,O
Sentence: 898,were,O
Sentence: 898,attributable,O
Sentence: 898,to,O
Sentence: 898,inhibition,O
Sentence: 898,of,O
Sentence: 898,COX,O
Sentence: 898,-,O
Sentence: 898,2,O
Sentence: 898,",",O
Sentence: 898,but,O
Sentence: 898,not,O
Sentence: 898,COX,O
Sentence: 898,-,O
Sentence: 898,1,O
Sentence: 898,.,O
Sentence: 898,CONCLUSIONS,O
Sentence: 898,:,O
Sentence: 898,These,O
Sentence: 898,results,O
Sentence: 898,suggest,O
Sentence: 898,that,O
Sentence: 898,bupivacaine,B-Chemical
Sentence: 898,stimulates,O
Sentence: 898,COX,O
Sentence: 898,-,O
Sentence: 898,2,O
Sentence: 898,gene,O
Sentence: 898,expression,O
Sentence: 898,after,O
Sentence: 898,tissue,B-Disease
Sentence: 898,injury,I-Disease
Sentence: 898,",",O
Sentence: 898,which,O
Sentence: 898,is,O
Sentence: 898,associated,O
Sentence: 898,with,O
Sentence: 898,higher,O
Sentence: 898,PGE2,B-Chemical
Sentence: 898,production,O
Sentence: 898,and,O
Sentence: 898,pain,B-Disease
Sentence: 898,after,O
Sentence: 898,the,O
Sentence: 898,local,O
Sentence: 898,anesthetic,O
Sentence: 898,effect,O
Sentence: 898,dissipates,O
Sentence: 898,.,O
Sentence: 899,p75NTR,O
Sentence: 899,expression,O
Sentence: 899,in,O
Sentence: 899,rat,O
Sentence: 899,urinary,O
Sentence: 899,bladder,O
Sentence: 899,sensory,O
Sentence: 899,neurons,O
Sentence: 899,and,O
Sentence: 899,spinal,O
Sentence: 899,cord,O
Sentence: 899,with,O
Sentence: 899,cyclophosphamide,B-Chemical
Sentence: 899,-,O
Sentence: 899,induced,O
Sentence: 899,cystitis,B-Disease
Sentence: 899,.,O
Sentence: 900,A,O
Sentence: 900,role,O
Sentence: 900,for,O
Sentence: 900,nerve,O
Sentence: 900,growth,O
Sentence: 900,factor,O
Sentence: 900,(,O
Sentence: 900,NGF,O
Sentence: 900,),O
Sentence: 900,in,O
Sentence: 900,contributing,O
Sentence: 900,to,O
Sentence: 900,increased,O
Sentence: 900,voiding,O
Sentence: 900,frequency,O
Sentence: 900,and,O
Sentence: 900,altered,O
Sentence: 900,sensation,O
Sentence: 900,from,O
Sentence: 900,the,O
Sentence: 900,urinary,O
Sentence: 900,bladder,O
Sentence: 900,has,O
Sentence: 900,been,O
Sentence: 900,suggested,O
Sentence: 900,.,O
Sentence: 900,Previous,O
Sentence: 900,studies,O
Sentence: 900,have,O
Sentence: 900,examined,O
Sentence: 900,the,O
Sentence: 900,expression,O
Sentence: 900,and,O
Sentence: 900,regulation,O
Sentence: 900,of,O
Sentence: 900,tyrosine,B-Chemical
Sentence: 900,kinase,O
Sentence: 900,receptors,O
Sentence: 900,(,O
Sentence: 900,Trks,O
Sentence: 900,),O
Sentence: 900,in,O
Sentence: 900,micturition,O
Sentence: 900,reflexes,O
Sentence: 900,with,O
Sentence: 900,urinary,B-Disease
Sentence: 900,bladder,B-Disease
Sentence: 900,inflammation,I-Disease
Sentence: 900,.,O
Sentence: 900,The,O
Sentence: 900,present,O
Sentence: 900,studies,O
Sentence: 900,examine,O
Sentence: 900,the,O
Sentence: 900,expression,O
Sentence: 900,and,O
Sentence: 900,regulation,O
Sentence: 900,of,O
Sentence: 900,another,O
Sentence: 900,receptor,O
Sentence: 900,known,O
Sentence: 900,to,O
Sentence: 900,bind,O
Sentence: 900,NGF,O
Sentence: 900,",",O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,",",O
Sentence: 900,after,O
Sentence: 900,various,O
Sentence: 900,durations,O
Sentence: 900,of,O
Sentence: 900,bladder,B-Disease
Sentence: 900,inflammation,I-Disease
Sentence: 900,induced,O
Sentence: 900,by,O
Sentence: 900,cyclophosphamide,B-Chemical
Sentence: 900,(,O
Sentence: 900,CYP,B-Chemical
Sentence: 900,),O
Sentence: 900,.,O
Sentence: 900,CYP,B-Chemical
Sentence: 900,-,O
Sentence: 900,induced,O
Sentence: 900,cystitis,B-Disease
Sentence: 900,increased,O
Sentence: 900,(,O
Sentence: 900,P,O
Sentence: 900,,O
Sentence: 900,<,O
Sentence: 900,,O
Sentence: 900,or,O
Sentence: 900,,O
Sentence: 900,=,O
Sentence: 900,,O
Sentence: 900,0.001,O
Sentence: 900,),O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,expression,O
Sentence: 900,in,O
Sentence: 900,the,O
Sentence: 900,superficial,O
Sentence: 900,lateral,O
Sentence: 900,and,O
Sentence: 900,medial,O
Sentence: 900,dorsal,O
Sentence: 900,horn,O
Sentence: 900,in,O
Sentence: 900,L1,O
Sentence: 900,-,O
Sentence: 900,L2,O
Sentence: 900,and,O
Sentence: 900,L6,O
Sentence: 900,-,O
Sentence: 900,S1,O
Sentence: 900,spinal,O
Sentence: 900,segments,O
Sentence: 900,.,O
Sentence: 900,The,O
Sentence: 900,number,O
Sentence: 900,of,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,immunoreactive,O
Sentence: 900,(,O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,IR,O
Sentence: 900,),O
Sentence: 900,cells,O
Sentence: 900,in,O
Sentence: 900,the,O
Sentence: 900,lumbosacral,O
Sentence: 900,dorsal,O
Sentence: 900,root,O
Sentence: 900,ganglia,O
Sentence: 900,(,O
Sentence: 900,DRG,O
Sentence: 900,),O
Sentence: 900,also,O
Sentence: 900,increased,O
Sentence: 900,(,O
Sentence: 900,P,O
Sentence: 900,,O
Sentence: 900,<,O
Sentence: 900,,O
Sentence: 900,or,O
Sentence: 900,,O
Sentence: 900,=,O
Sentence: 900,,O
Sentence: 900,0.05,O
Sentence: 900,),O
Sentence: 900,with,O
Sentence: 900,CYP,B-Chemical
Sentence: 900,-,O
Sentence: 900,induced,O
Sentence: 900,cystitis,B-Disease
Sentence: 900,(,O
Sentence: 900,acute,O
Sentence: 900,",",O
Sentence: 900,intermediate,O
Sentence: 900,",",O
Sentence: 900,and,O
Sentence: 900,chronic,O
Sentence: 900,),O
Sentence: 900,.,O
Sentence: 900,Quantitative,O
Sentence: 900,",",O
Sentence: 900,real,O
Sentence: 900,-,O
Sentence: 900,time,O
Sentence: 900,polymerase,O
Sentence: 900,chain,O
Sentence: 900,reaction,O
Sentence: 900,also,O
Sentence: 900,demonstrated,O
Sentence: 900,significant,O
Sentence: 900,increases,O
Sentence: 900,(,O
Sentence: 900,P,O
Sentence: 900,,O
Sentence: 900,<,O
Sentence: 900,,O
Sentence: 900,or,O
Sentence: 900,,O
Sentence: 900,=,O
Sentence: 900,,O
Sentence: 900,0.01,O
Sentence: 900,),O
Sentence: 900,in,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,mRNA,O
Sentence: 900,in,O
Sentence: 900,DRG,O
Sentence: 900,with,O
Sentence: 900,intermediate,O
Sentence: 900,and,O
Sentence: 900,chronic,O
Sentence: 900,CYP,B-Chemical
Sentence: 900,-,O
Sentence: 900,induced,O
Sentence: 900,cystitis,B-Disease
Sentence: 900,.,O
Sentence: 900,Retrograde,O
Sentence: 900,dye,O
Sentence: 900,-,O
Sentence: 900,tracing,O
Sentence: 900,techniques,O
Sentence: 900,with,O
Sentence: 900,Fastblue,O
Sentence: 900,were,O
Sentence: 900,used,O
Sentence: 900,to,O
Sentence: 900,identify,O
Sentence: 900,presumptive,O
Sentence: 900,bladder,O
Sentence: 900,afferent,O
Sentence: 900,cells,O
Sentence: 900,in,O
Sentence: 900,the,O
Sentence: 900,lumbosacral,O
Sentence: 900,DRG,O
Sentence: 900,.,O
Sentence: 900,In,O
Sentence: 900,bladder,O
Sentence: 900,afferent,O
Sentence: 900,cells,O
Sentence: 900,in,O
Sentence: 900,DRG,O
Sentence: 900,",",O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,IR,O
Sentence: 900,was,O
Sentence: 900,also,O
Sentence: 900,increased,O
Sentence: 900,(,O
Sentence: 900,P,O
Sentence: 900,,O
Sentence: 900,<,O
Sentence: 900,,O
Sentence: 900,or,O
Sentence: 900,,O
Sentence: 900,=,O
Sentence: 900,,O
Sentence: 900,0.01,O
Sentence: 900,),O
Sentence: 900,with,O
Sentence: 900,cystitis,B-Disease
Sentence: 900,.,O
Sentence: 900,In,O
Sentence: 900,addition,O
Sentence: 900,to,O
Sentence: 900,increases,O
Sentence: 900,in,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,IR,O
Sentence: 900,in,O
Sentence: 900,DRG,O
Sentence: 900,cell,O
Sentence: 900,bodies,O
Sentence: 900,",",O
Sentence: 900,increases,O
Sentence: 900,(,O
Sentence: 900,P,O
Sentence: 900,,O
Sentence: 900,<,O
Sentence: 900,,O
Sentence: 900,or,O
Sentence: 900,,O
Sentence: 900,=,O
Sentence: 900,,O
Sentence: 900,0.001,O
Sentence: 900,),O
Sentence: 900,in,O
Sentence: 900,pericellular,O
Sentence: 900,(,O
Sentence: 900,encircling,O
Sentence: 900,DRG,O
Sentence: 900,cells,O
Sentence: 900,),O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,IR,O
Sentence: 900,in,O
Sentence: 900,DRG,O
Sentence: 900,also,O
Sentence: 900,increased,O
Sentence: 900,.,O
Sentence: 900,Confocal,O
Sentence: 900,analyses,O
Sentence: 900,demonstrated,O
Sentence: 900,that,O
Sentence: 900,pericellular,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,,O
Sentence: 900,-,O
Sentence: 900,IR,O
Sentence: 900,was,O
Sentence: 900,not,O
Sentence: 900,colocalized,O
Sentence: 900,with,O
Sentence: 900,the,O
Sentence: 900,glial,O
Sentence: 900,marker,O
Sentence: 900,",",O
Sentence: 900,glial,O
Sentence: 900,fibrillary,O
Sentence: 900,acidic,O
Sentence: 900,protein,O
Sentence: 900,(,O
Sentence: 900,GFAP,O
Sentence: 900,),O
Sentence: 900,.,O
Sentence: 900,These,O
Sentence: 900,studies,O
Sentence: 900,demonstrate,O
Sentence: 900,that,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,expression,O
Sentence: 900,in,O
Sentence: 900,micturition,O
Sentence: 900,reflexes,O
Sentence: 900,is,O
Sentence: 900,present,O
Sentence: 900,constitutively,O
Sentence: 900,and,O
Sentence: 900,modified,O
Sentence: 900,by,O
Sentence: 900,bladder,B-Disease
Sentence: 900,inflammation,I-Disease
Sentence: 900,.,O
Sentence: 900,The,O
Sentence: 900,functional,O
Sentence: 900,significance,O
Sentence: 900,of,O
Sentence: 900,p75,O
Sentence: 900,(,O
Sentence: 900,NTR,O
Sentence: 900,),O
Sentence: 900,expression,O
Sentence: 900,in,O
Sentence: 900,micturition,O
Sentence: 900,reflexes,O
Sentence: 900,remains,O
Sentence: 900,to,O
Sentence: 900,be,O
Sentence: 900,determined,O
Sentence: 900,.,O
Sentence: 901,Azathioprine,O
Sentence: 901,-,O
Sentence: 901,induced,O
Sentence: 901,suicidal,O
Sentence: 901,erythrocyte,O
Sentence: 901,death,O
Sentence: 901,.,O
Sentence: 902,BACKGROUND,O
Sentence: 902,:,O
Sentence: 902,Azathioprine,B-Chemical
Sentence: 902,is,O
Sentence: 902,widely,O
Sentence: 902,used,O
Sentence: 902,as,O
Sentence: 902,an,O
Sentence: 902,immunosuppressive,O
Sentence: 902,drug,O
Sentence: 902,.,O
Sentence: 902,The,O
Sentence: 902,side,O
Sentence: 902,effects,O
Sentence: 902,of,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,include,O
Sentence: 902,anemia,B-Disease
Sentence: 902,",",O
Sentence: 902,which,O
Sentence: 902,has,O
Sentence: 902,been,O
Sentence: 902,attributed,O
Sentence: 902,to,O
Sentence: 902,bone,O
Sentence: 902,marrow,O
Sentence: 902,suppression,O
Sentence: 902,.,O
Sentence: 902,Alternatively,O
Sentence: 902,",",O
Sentence: 902,anemia,B-Disease
Sentence: 902,could,O
Sentence: 902,result,O
Sentence: 902,from,O
Sentence: 902,accelerated,O
Sentence: 902,suicidal,O
Sentence: 902,erythrocyte,O
Sentence: 902,death,O
Sentence: 902,or,O
Sentence: 902,eryptosis,O
Sentence: 902,",",O
Sentence: 902,which,O
Sentence: 902,is,O
Sentence: 902,characterized,O
Sentence: 902,by,O
Sentence: 902,exposure,O
Sentence: 902,of,O
Sentence: 902,phosphatidylserine,B-Chemical
Sentence: 902,(,O
Sentence: 902,PS,B-Chemical
Sentence: 902,),O
Sentence: 902,at,O
Sentence: 902,the,O
Sentence: 902,erythrocyte,O
Sentence: 902,surface,O
Sentence: 902,and,O
Sentence: 902,by,O
Sentence: 902,cell,O
Sentence: 902,shrinkage,O
Sentence: 902,.,O
Sentence: 902,METHODS,O
Sentence: 902,:,O
Sentence: 902,The,O
Sentence: 902,present,O
Sentence: 902,experiments,O
Sentence: 902,explored,O
Sentence: 902,whether,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,influences,O
Sentence: 902,eryptosis,O
Sentence: 902,.,O
Sentence: 902,According,O
Sentence: 902,to,O
Sentence: 902,annexin,O
Sentence: 902,V,O
Sentence: 902,binding,O
Sentence: 902,",",O
Sentence: 902,erythrocytes,O
Sentence: 902,from,O
Sentence: 902,patients,O
Sentence: 902,indeed,O
Sentence: 902,showed,O
Sentence: 902,a,O
Sentence: 902,significant,O
Sentence: 902,increase,O
Sentence: 902,of,O
Sentence: 902,PS,B-Chemical
Sentence: 902,exposure,O
Sentence: 902,within,O
Sentence: 902,1,O
Sentence: 902,week,O
Sentence: 902,of,O
Sentence: 902,treatment,O
Sentence: 902,with,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,.,O
Sentence: 902,In,O
Sentence: 902,a,O
Sentence: 902,second,O
Sentence: 902,series,O
Sentence: 902,",",O
Sentence: 902,cytosolic,O
Sentence: 902,Ca2+,O
Sentence: 902,activity,O
Sentence: 902,(,O
Sentence: 902,Fluo3,B-Chemical
Sentence: 902,fluorescence,O
Sentence: 902,),O
Sentence: 902,",",O
Sentence: 902,cell,O
Sentence: 902,volume,O
Sentence: 902,(,O
Sentence: 902,forward,O
Sentence: 902,scatter,O
Sentence: 902,),O
Sentence: 902,",",O
Sentence: 902,and,O
Sentence: 902,PS,B-Chemical
Sentence: 902,-,O
Sentence: 902,exposure,O
Sentence: 902,(,O
Sentence: 902,annexin,O
Sentence: 902,V,O
Sentence: 902,binding,O
Sentence: 902,),O
Sentence: 902,were,O
Sentence: 902,determined,O
Sentence: 902,by,O
Sentence: 902,FACS,O
Sentence: 902,analysis,O
Sentence: 902,in,O
Sentence: 902,erythrocytes,O
Sentence: 902,from,O
Sentence: 902,healthy,O
Sentence: 902,volunteers,O
Sentence: 902,.,O
Sentence: 902,RESULTS,O
Sentence: 902,:,O
Sentence: 902,Exposure,O
Sentence: 902,to,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,(,O
Sentence: 902,,O
Sentence: 902,>,O
Sentence: 902,,O
Sentence: 902,or,O
Sentence: 902,,O
Sentence: 902,=,O
Sentence: 902,2,O
Sentence: 902,microg,O
Sentence: 902,/,O
Sentence: 902,mL,O
Sentence: 902,),O
Sentence: 902,for,O
Sentence: 902,48,O
Sentence: 902,hours,O
Sentence: 902,increased,O
Sentence: 902,cytosolic,O
Sentence: 902,Ca2+,O
Sentence: 902,activity,O
Sentence: 902,and,O
Sentence: 902,annexin,O
Sentence: 902,V,O
Sentence: 902,binding,O
Sentence: 902,and,O
Sentence: 902,decreased,O
Sentence: 902,forward,O
Sentence: 902,scatter,O
Sentence: 902,.,O
Sentence: 902,The,O
Sentence: 902,effect,O
Sentence: 902,of,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,on,O
Sentence: 902,both,O
Sentence: 902,annexin,O
Sentence: 902,V,O
Sentence: 902,binding,O
Sentence: 902,and,O
Sentence: 902,forward,O
Sentence: 902,scatter,O
Sentence: 902,was,O
Sentence: 902,significantly,O
Sentence: 902,blunted,O
Sentence: 902,in,O
Sentence: 902,the,O
Sentence: 902,nominal,O
Sentence: 902,absence,O
Sentence: 902,of,O
Sentence: 902,extracellular,O
Sentence: 902,Ca2+,O
Sentence: 902,.,O
Sentence: 902,CONCLUSIONS,O
Sentence: 902,:,O
Sentence: 902,Azathioprine,B-Chemical
Sentence: 902,triggers,O
Sentence: 902,suicidal,O
Sentence: 902,erythrocyte,O
Sentence: 902,death,O
Sentence: 902,",",O
Sentence: 902,an,O
Sentence: 902,effect,O
Sentence: 902,presumably,O
Sentence: 902,contributing,O
Sentence: 902,to,O
Sentence: 902,azathioprine,B-Chemical
Sentence: 902,-,O
Sentence: 902,induced,O
Sentence: 902,anemia,B-Disease
Sentence: 902,.,O
Sentence: 903,Clinical,O
Sentence: 903,comparison,O
Sentence: 903,of,O
Sentence: 903,cardiorespiratory,O
Sentence: 903,effects,O
Sentence: 903,during,O
Sentence: 903,unilateral,O
Sentence: 903,and,O
Sentence: 903,conventional,O
Sentence: 903,spinal,O
Sentence: 903,anaesthesia,O
Sentence: 903,.,O
Sentence: 904,BACKGROUND,O
Sentence: 904,:,O
Sentence: 904,Spinal,O
Sentence: 904,anaesthesia,O
Sentence: 904,is,O
Sentence: 904,widely,O
Sentence: 904,employed,O
Sentence: 904,in,O
Sentence: 904,clinical,O
Sentence: 904,practice,O
Sentence: 904,but,O
Sentence: 904,has,O
Sentence: 904,the,O
Sentence: 904,main,O
Sentence: 904,drawback,O
Sentence: 904,of,O
Sentence: 904,post,O
Sentence: 904,-,O
Sentence: 904,spinal,O
Sentence: 904,block,O
Sentence: 904,hypotension,B-Disease
Sentence: 904,.,O
Sentence: 904,Efforts,O
Sentence: 904,must,O
Sentence: 904,therefore,O
Sentence: 904,continue,O
Sentence: 904,to,O
Sentence: 904,be,O
Sentence: 904,made,O
Sentence: 904,to,O
Sentence: 904,obviate,O
Sentence: 904,this,O
Sentence: 904,setback,O
Sentence: 904,OBJECTIVE,O
Sentence: 904,:,O
Sentence: 904,To,O
Sentence: 904,evaluate,O
Sentence: 904,the,O
Sentence: 904,cardiovascular,O
Sentence: 904,and,O
Sentence: 904,respiratory,O
Sentence: 904,changes,O
Sentence: 904,during,O
Sentence: 904,unilateral,O
Sentence: 904,and,O
Sentence: 904,conventional,O
Sentence: 904,spinal,O
Sentence: 904,anaesthesia,O
Sentence: 904,.,O
Sentence: 904,METHODS,O
Sentence: 904,:,O
Sentence: 904,With,O
Sentence: 904,ethical,O
Sentence: 904,approval,O
Sentence: 904,",",O
Sentence: 904,we,O
Sentence: 904,studied,O
Sentence: 904,74,O
Sentence: 904,American,O
Sentence: 904,Society,O
Sentence: 904,of,O
Sentence: 904,Anesthesiologists,O
Sentence: 904,(,O
Sentence: 904,ASA,O
Sentence: 904,),O
Sentence: 904,",",O
Sentence: 904,physical,O
Sentence: 904,status,O
Sentence: 904,class,O
Sentence: 904,1,O
Sentence: 904,and,O
Sentence: 904,2,O
Sentence: 904,patients,O
Sentence: 904,scheduled,O
Sentence: 904,for,O
Sentence: 904,elective,O
Sentence: 904,unilateral,O
Sentence: 904,lower,O
Sentence: 904,limb,O
Sentence: 904,surgery,O
Sentence: 904,.,O
Sentence: 904,Patients,O
Sentence: 904,were,O
Sentence: 904,randomly,O
Sentence: 904,allocated,O
Sentence: 904,into,O
Sentence: 904,one,O
Sentence: 904,of,O
Sentence: 904,two,O
Sentence: 904,groups,O
Sentence: 904,:,O
Sentence: 904,lateral,O
Sentence: 904,and,O
Sentence: 904,conventional,O
Sentence: 904,spinal,O
Sentence: 904,anaesthesia,O
Sentence: 904,groups,O
Sentence: 904,.,O
Sentence: 904,In,O
Sentence: 904,the,O
Sentence: 904,lateral,O
Sentence: 904,position,O
Sentence: 904,with,O
Sentence: 904,operative,O
Sentence: 904,side,O
Sentence: 904,down,O
Sentence: 904,",",O
Sentence: 904,patients,O
Sentence: 904,recived,O
Sentence: 904,10,O
Sentence: 904,mg,O
Sentence: 904,(,O
Sentence: 904,2mls,O
Sentence: 904,),O
Sentence: 904,of,O
Sentence: 904,0.5,O
Sentence: 904,%,O
Sentence: 904,hyperbaric,O
Sentence: 904,bupivacaine,B-Chemical
Sentence: 904,through,O
Sentence: 904,a,O
Sentence: 904,25,O
Sentence: 904,-,O
Sentence: 904,gauge,O
Sentence: 904,spinal,O
Sentence: 904,needle,O
Sentence: 904,.,O
Sentence: 904,Patients,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,unilateral,O
Sentence: 904,group,O
Sentence: 904,were,O
Sentence: 904,maintained,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,lateral,O
Sentence: 904,position,O
Sentence: 904,for,O
Sentence: 904,15,O
Sentence: 904,minutes,O
Sentence: 904,following,O
Sentence: 904,spinal,O
Sentence: 904,injection,O
Sentence: 904,while,O
Sentence: 904,those,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,conventional,O
Sentence: 904,group,O
Sentence: 904,were,O
Sentence: 904,turned,O
Sentence: 904,supine,O
Sentence: 904,immediately,O
Sentence: 904,after,O
Sentence: 904,injection,O
Sentence: 904,.,O
Sentence: 904,Blood,O
Sentence: 904,pressure,O
Sentence: 904,",",O
Sentence: 904,heart,O
Sentence: 904,rate,O
Sentence: 904,",",O
Sentence: 904,respiratory,O
Sentence: 904,rate,O
Sentence: 904,and,O
Sentence: 904,oxygen,B-Chemical
Sentence: 904,saturation,O
Sentence: 904,were,O
Sentence: 904,monitored,O
Sentence: 904,over,O
Sentence: 904,1,O
Sentence: 904,hour,O
Sentence: 904,.,O
Sentence: 904,RESULTS,O
Sentence: 904,:,O
Sentence: 904,Three,O
Sentence: 904,patients,O
Sentence: 904,(,O
Sentence: 904,8.1,O
Sentence: 904,%,O
Sentence: 904,),O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,unilateral,O
Sentence: 904,group,O
Sentence: 904,and,O
Sentence: 904,5,O
Sentence: 904,(,O
Sentence: 904,13.5,O
Sentence: 904,%,O
Sentence: 904,),O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,conventional,O
Sentence: 904,group,O
Sentence: 904,developed,O
Sentence: 904,hypotension,B-Disease
Sentence: 904,",",O
Sentence: 904,P,O
Sentence: 904,=,O
Sentence: 904,,O
Sentence: 904,0.71,O
Sentence: 904,.,O
Sentence: 904,Four,O
Sentence: 904,(,O
Sentence: 904,10.8,O
Sentence: 904,%,O
Sentence: 904,),O
Sentence: 904,patients,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,conventional,O
Sentence: 904,group,O
Sentence: 904,and,O
Sentence: 904,1,O
Sentence: 904,(,O
Sentence: 904,2.7,O
Sentence: 904,%,O
Sentence: 904,),O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,unilateral,O
Sentence: 904,group,O
Sentence: 904,",",O
Sentence: 904,P,O
Sentence: 904,=,O
Sentence: 904,,O
Sentence: 904,0.17,O
Sentence: 904,required,O
Sentence: 904,epinephrine,B-Chemical
Sentence: 904,infusion,O
Sentence: 904,to,O
Sentence: 904,treat,O
Sentence: 904,hypotension,B-Disease
Sentence: 904,.,O
Sentence: 904,Patients,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,conventional,O
Sentence: 904,group,O
Sentence: 904,had,O
Sentence: 904,statistically,O
Sentence: 904,significant,O
Sentence: 904,greater,O
Sentence: 904,fall,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,systolic,O
Sentence: 904,blood,O
Sentence: 904,pressures,O
Sentence: 904,at,O
Sentence: 904,15,O
Sentence: 904,",",O
Sentence: 904,30,O
Sentence: 904,and,O
Sentence: 904,45,O
Sentence: 904,minutes,O
Sentence: 904,when,O
Sentence: 904,compared,O
Sentence: 904,to,O
Sentence: 904,the,O
Sentence: 904,baseline,O
Sentence: 904,(,O
Sentence: 904,P,O
Sentence: 904,=,O
Sentence: 904,,O
Sentence: 904,0.003,O
Sentence: 904,",",O
Sentence: 904,0.001,O
Sentence: 904,and,O
Sentence: 904,0.004,O
Sentence: 904,),O
Sentence: 904,.,O
Sentence: 904,The,O
Sentence: 904,mean,O
Sentence: 904,respiratory,O
Sentence: 904,rate,O
Sentence: 904,and,O
Sentence: 904,oxygen,B-Chemical
Sentence: 904,saturations,O
Sentence: 904,in,O
Sentence: 904,the,O
Sentence: 904,two,O
Sentence: 904,groups,O
Sentence: 904,were,O
Sentence: 904,similar,O
Sentence: 904,.,O
Sentence: 904,CONCLUSION,O
Sentence: 904,:,O
Sentence: 904,Compared,O
Sentence: 904,to,O
Sentence: 904,conventional,O
Sentence: 904,spinal,O
Sentence: 904,anaesthesia,O
Sentence: 904,",",O
Sentence: 904,unilateral,O
Sentence: 904,spinal,O
Sentence: 904,anaesthesia,O
Sentence: 904,was,O
Sentence: 904,associated,O
Sentence: 904,with,O
Sentence: 904,fewer,O
Sentence: 904,cardiovascular,O
Sentence: 904,perturbations,O
Sentence: 904,.,O
Sentence: 904,Also,O
Sentence: 904,",",O
Sentence: 904,the,O
Sentence: 904,type,O
Sentence: 904,of,O
Sentence: 904,spinal,O
Sentence: 904,block,O
Sentence: 904,instituted,O
Sentence: 904,affected,O
Sentence: 904,neither,O
Sentence: 904,the,O
Sentence: 904,respiratory,O
Sentence: 904,rate,O
Sentence: 904,nor,O
Sentence: 904,the,O
Sentence: 904,arterial,O
Sentence: 904,oxygen,B-Chemical
Sentence: 904,saturation,O
Sentence: 904,.,O
Sentence: 905,Spectrum,O
Sentence: 905,of,O
Sentence: 905,adverse,O
Sentence: 905,events,O
Sentence: 905,after,O
Sentence: 905,generic,O
Sentence: 905,HAART,O
Sentence: 905,in,O
Sentence: 905,southern,O
Sentence: 905,Indian,O
Sentence: 905,HIV,O
Sentence: 905,-,O
Sentence: 905,infected,O
Sentence: 905,patients,O
Sentence: 905,.,O
Sentence: 906,To,O
Sentence: 906,determine,O
Sentence: 906,the,O
Sentence: 906,incidence,O
Sentence: 906,of,O
Sentence: 906,clinically,O
Sentence: 906,significant,O
Sentence: 906,adverse,O
Sentence: 906,events,O
Sentence: 906,after,O
Sentence: 906,long,O
Sentence: 906,-,O
Sentence: 906,term,O
Sentence: 906,",",O
Sentence: 906,fixed,O
Sentence: 906,-,O
Sentence: 906,dose,O
Sentence: 906,",",O
Sentence: 906,generic,O
Sentence: 906,highly,O
Sentence: 906,active,O
Sentence: 906,antiretroviral,O
Sentence: 906,therapy,O
Sentence: 906,(,O
Sentence: 906,HAART,O
Sentence: 906,),O
Sentence: 906,use,O
Sentence: 906,among,O
Sentence: 906,HIV,O
Sentence: 906,-,O
Sentence: 906,infected,O
Sentence: 906,individuals,O
Sentence: 906,in,O
Sentence: 906,South,O
Sentence: 906,India,O
Sentence: 906,",",O
Sentence: 906,we,O
Sentence: 906,examined,O
Sentence: 906,the,O
Sentence: 906,experiences,O
Sentence: 906,of,O
Sentence: 906,3154,O
Sentence: 906,HIV,O
Sentence: 906,-,O
Sentence: 906,infected,O
Sentence: 906,individuals,O
Sentence: 906,who,O
Sentence: 906,received,O
Sentence: 906,a,O
Sentence: 906,minimum,O
Sentence: 906,of,O
Sentence: 906,3,O
Sentence: 906,months,O
Sentence: 906,of,O
Sentence: 906,generic,O
Sentence: 906,HAART,O
Sentence: 906,between,O
Sentence: 906,February,O
Sentence: 906,1996,O
Sentence: 906,and,O
Sentence: 906,December,O
Sentence: 906,2006,O
Sentence: 906,at,O
Sentence: 906,a,O
Sentence: 906,tertiary,O
Sentence: 906,HIV,O
Sentence: 906,care,O
Sentence: 906,referral,O
Sentence: 906,center,O
Sentence: 906,in,O
Sentence: 906,South,O
Sentence: 906,India,O
Sentence: 906,.,O
Sentence: 906,The,O
Sentence: 906,most,O
Sentence: 906,common,O
Sentence: 906,regimens,O
Sentence: 906,were,O
Sentence: 906,3TC,B-Chemical
Sentence: 906,+,O
Sentence: 906,d4T,B-Chemical
Sentence: 906,+,O
Sentence: 906,nevirapine,B-Chemical
Sentence: 906,(,O
Sentence: 906,NVP,B-Chemical
Sentence: 906,),O
Sentence: 906,(,O
Sentence: 906,54.8,O
Sentence: 906,%,O
Sentence: 906,),O
Sentence: 906,",",O
Sentence: 906,zidovudine,B-Chemical
Sentence: 906,(,O
Sentence: 906,AZT,B-Chemical
Sentence: 906,),O
Sentence: 906,+,O
Sentence: 906,3TC,B-Chemical
Sentence: 906,+,O
Sentence: 906,NVP,B-Chemical
Sentence: 906,(,O
Sentence: 906,14.5,O
Sentence: 906,%,O
Sentence: 906,),O
Sentence: 906,",",O
Sentence: 906,3TC,B-Chemical
Sentence: 906,+,O
Sentence: 906,d4T,B-Chemical
Sentence: 906,+,O
Sentence: 906,efavirenz,B-Chemical
Sentence: 906,(,O
Sentence: 906,EFV,B-Chemical
Sentence: 906,),O
Sentence: 906,(,O
Sentence: 906,20.1,O
Sentence: 906,%,O
Sentence: 906,),O
Sentence: 906,",",O
Sentence: 906,and,O
Sentence: 906,AZT,B-Chemical
Sentence: 906,+,O
Sentence: 906,3TC,B-Chemical
Sentence: 906,+,O
Sentence: 906,EFV,B-Chemical
Sentence: 906,(,O
Sentence: 906,5.4,O
Sentence: 906,%,O
Sentence: 906,),O
Sentence: 906,.,O
Sentence: 906,The,O
Sentence: 906,most,O
Sentence: 906,common,O
Sentence: 906,adverse,O
Sentence: 906,events,O
Sentence: 906,and,O
Sentence: 906,median,O
Sentence: 906,CD4,O
Sentence: 906,at,O
Sentence: 906,time,O
Sentence: 906,of,O
Sentence: 906,event,O
Sentence: 906,were,O
Sentence: 906,rash,B-Disease
Sentence: 906,(,O
Sentence: 906,15.2,O
Sentence: 906,%,O
Sentence: 906,;,O
Sentence: 906,CD4,O
Sentence: 906,",",O
Sentence: 906,285,O
Sentence: 906,cells,O
Sentence: 906,/,O
Sentence: 906,microL,O
Sentence: 906,),O
Sentence: 906,and,O
Sentence: 906,peripheral,B-Disease
Sentence: 906,neuropathy,I-Disease
Sentence: 906,(,O
Sentence: 906,9.0,O
Sentence: 906,%,O
Sentence: 906,and,O
Sentence: 906,348,O
Sentence: 906,cells,O
Sentence: 906,/,O
Sentence: 906,microL,O
Sentence: 906,),O
Sentence: 906,.,O
Sentence: 906,Clinically,O
Sentence: 906,significant,O
Sentence: 906,anemia,B-Disease
Sentence: 906,(,O
Sentence: 906,hemoglobin,O
Sentence: 906,,O
Sentence: 906,<,O
Sentence: 906,,O
Sentence: 906,7,O
Sentence: 906,g,O
Sentence: 906,/,O
Sentence: 906,dL,O
Sentence: 906,),O
Sentence: 906,was,O
Sentence: 906,observed,O
Sentence: 906,in,O
Sentence: 906,5.4,O
Sentence: 906,%,O
Sentence: 906,of,O
Sentence: 906,patients,O
Sentence: 906,(,O
Sentence: 906,CD4,O
Sentence: 906,",",O
Sentence: 906,165,O
Sentence: 906,cells,O
Sentence: 906,/,O
Sentence: 906,microL,O
Sentence: 906,),O
Sentence: 906,and,O
Sentence: 906,hepatitis,B-Disease
Sentence: 906,(,O
Sentence: 906,clinical,O
Sentence: 906,jaundice,B-Disease
Sentence: 906,with,O
Sentence: 906,alanine,B-Chemical
Sentence: 906,aminotransferase,O
Sentence: 906,,O
Sentence: 906,>,O
Sentence: 906,,O
Sentence: 906,5,O
Sentence: 906,times,O
Sentence: 906,upper,O
Sentence: 906,limits,O
Sentence: 906,of,O
Sentence: 906,normal,O
Sentence: 906,),O
Sentence: 906,in,O
Sentence: 906,3.5,O
Sentence: 906,%,O
Sentence: 906,of,O
Sentence: 906,patients,O
Sentence: 906,(,O
Sentence: 906,CD4,O
Sentence: 906,",",O
Sentence: 906,260,O
Sentence: 906,cells,O
Sentence: 906,/,O
Sentence: 906,microL,O
Sentence: 906,),O
Sentence: 906,.,O
Sentence: 906,Women,O
Sentence: 906,were,O
Sentence: 906,significantly,O
Sentence: 906,more,O
Sentence: 906,likely,O
Sentence: 906,to,O
Sentence: 906,experience,O
Sentence: 906,lactic,B-Disease
Sentence: 906,acidosis,I-Disease
Sentence: 906,",",O
Sentence: 906,while,O
Sentence: 906,men,O
Sentence: 906,were,O
Sentence: 906,significantly,O
Sentence: 906,more,O
Sentence: 906,likely,O
Sentence: 906,to,O
Sentence: 906,experience,O
Sentence: 906,immune,B-Disease
Sentence: 906,reconstitution,I-Disease
Sentence: 906,syndrome,I-Disease
Sentence: 906,(,O
Sentence: 906,p,O
Sentence: 906,,O
Sentence: 906,<,O
Sentence: 906,,O
Sentence: 906,0.05,O
Sentence: 906,),O
Sentence: 906,.,O
Sentence: 906,Among,O
Sentence: 906,the,O
Sentence: 906,patients,O
Sentence: 906,with,O
Sentence: 906,1,O
Sentence: 906,year,O
Sentence: 906,of,O
Sentence: 906,follow,O
Sentence: 906,-,O
Sentence: 906,up,O
Sentence: 906,",",O
Sentence: 906,NVP,B-Chemical
Sentence: 906,therapy,O
Sentence: 906,was,O
Sentence: 906,significantly,O
Sentence: 906,associated,O
Sentence: 906,with,O
Sentence: 906,developing,O
Sentence: 906,rash,B-Disease
Sentence: 906,and,O
Sentence: 906,d4T,B-Chemical
Sentence: 906,therapy,O
Sentence: 906,with,O
Sentence: 906,developing,O
Sentence: 906,peripheral,B-Disease
Sentence: 906,neuropathy,I-Disease
Sentence: 906,(,O
Sentence: 906,p,O
Sentence: 906,,O
Sentence: 906,<,O
Sentence: 906,,O
Sentence: 906,0.05,O
Sentence: 906,),O
Sentence: 906,.,O
Sentence: 906,Anemia,B-Disease
Sentence: 906,and,O
Sentence: 906,hepatitis,B-Disease
Sentence: 906,often,O
Sentence: 906,occur,O
Sentence: 906,within,O
Sentence: 906,12,O
Sentence: 906,weeks,O
Sentence: 906,of,O
Sentence: 906,initiating,O
Sentence: 906,generic,O
Sentence: 906,HAART,O
Sentence: 906,.,O
Sentence: 906,Frequent,O
Sentence: 906,and,O
Sentence: 906,early,O
Sentence: 906,monitoring,O
Sentence: 906,for,O
Sentence: 906,these,O
Sentence: 906,toxicities,B-Disease
Sentence: 906,is,O
Sentence: 906,warranted,O
Sentence: 906,in,O
Sentence: 906,developing,O
Sentence: 906,countries,O
Sentence: 906,where,O
Sentence: 906,generic,O
Sentence: 906,HAART,O
Sentence: 906,is,O
Sentence: 906,increasingly,O
Sentence: 906,available,O
Sentence: 906,.,O
Sentence: 907,Thalidomide,B-Chemical
Sentence: 907,and,O
Sentence: 907,sensory,B-Disease
Sentence: 907,neurotoxicity,I-Disease
Sentence: 907,:,O
Sentence: 907,a,O
Sentence: 907,neurophysiological,O
Sentence: 907,study,O
Sentence: 907,.,O
Sentence: 908,BACKGROUND,O
Sentence: 908,:,O
Sentence: 908,Recent,O
Sentence: 908,studies,O
Sentence: 908,confirmed,O
Sentence: 908,a,O
Sentence: 908,high,O
Sentence: 908,incidence,O
Sentence: 908,of,O
Sentence: 908,sensory,B-Disease
Sentence: 908,axonal,I-Disease
Sentence: 908,neuropathy,I-Disease
Sentence: 908,in,O
Sentence: 908,patients,O
Sentence: 908,treated,O
Sentence: 908,with,O
Sentence: 908,different,O
Sentence: 908,doses,O
Sentence: 908,of,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,.,O
Sentence: 908,The,O
Sentence: 908,study,O
Sentence: 908,'s,O
Sentence: 908,aims,O
Sentence: 908,were,O
Sentence: 908,to,O
Sentence: 908,measure,O
Sentence: 908,variations,O
Sentence: 908,in,O
Sentence: 908,sural,O
Sentence: 908,nerve,O
Sentence: 908,sensory,O
Sentence: 908,action,O
Sentence: 908,potential,O
Sentence: 908,(,O
Sentence: 908,SAP,O
Sentence: 908,),O
Sentence: 908,amplitude,O
Sentence: 908,in,O
Sentence: 908,patients,O
Sentence: 908,with,O
Sentence: 908,refractory,O
Sentence: 908,cutaneous,B-Disease
Sentence: 908,lupus,I-Disease
Sentence: 908,erythematosus,I-Disease
Sentence: 908,(,O
Sentence: 908,CLE,B-Disease
Sentence: 908,),O
Sentence: 908,treated,O
Sentence: 908,with,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,and,O
Sentence: 908,use,O
Sentence: 908,these,O
Sentence: 908,findings,O
Sentence: 908,to,O
Sentence: 908,identify,O
Sentence: 908,the,O
Sentence: 908,neurotoxic,B-Disease
Sentence: 908,potential,O
Sentence: 908,of,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,and,O
Sentence: 908,the,O
Sentence: 908,recovery,O
Sentence: 908,capacity,O
Sentence: 908,of,O
Sentence: 908,sensory,O
Sentence: 908,fibres,O
Sentence: 908,after,O
Sentence: 908,discontinuation,O
Sentence: 908,of,O
Sentence: 908,treatment,O
Sentence: 908,.,O
Sentence: 908,PATIENTS,O
Sentence: 908,AND,O
Sentence: 908,METHODS,O
Sentence: 908,:,O
Sentence: 908,Clinical,O
Sentence: 908,and,O
Sentence: 908,electrophysiological,O
Sentence: 908,data,O
Sentence: 908,in,O
Sentence: 908,12,O
Sentence: 908,female,O
Sentence: 908,patients,O
Sentence: 908,with,O
Sentence: 908,CLE,B-Disease
Sentence: 908,during,O
Sentence: 908,treatment,O
Sentence: 908,with,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,and,O
Sentence: 908,up,O
Sentence: 908,to,O
Sentence: 908,47,O
Sentence: 908,months,O
Sentence: 908,after,O
Sentence: 908,discontinuation,O
Sentence: 908,of,O
Sentence: 908,treatment,O
Sentence: 908,were,O
Sentence: 908,analysed,O
Sentence: 908,.,O
Sentence: 908,Sural,O
Sentence: 908,nerve,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,reduction,O
Sentence: 908,,O
Sentence: 908,>,O
Sentence: 908,,O
Sentence: 908,or,O
Sentence: 908,,O
Sentence: 908,=,O
Sentence: 908,40,O
Sentence: 908,%,O
Sentence: 908,was,O
Sentence: 908,the,O
Sentence: 908,criteria,O
Sentence: 908,for,O
Sentence: 908,discontinuing,O
Sentence: 908,therapy,O
Sentence: 908,.,O
Sentence: 908,RESULTS,O
Sentence: 908,:,O
Sentence: 908,During,O
Sentence: 908,treatment,O
Sentence: 908,",",O
Sentence: 908,11,O
Sentence: 908,patients,O
Sentence: 908,showed,O
Sentence: 908,a,O
Sentence: 908,reduction,O
Sentence: 908,in,O
Sentence: 908,sural,O
Sentence: 908,nerve,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,compared,O
Sentence: 908,to,O
Sentence: 908,baseline,O
Sentence: 908,values,O
Sentence: 908,(,O
Sentence: 908,9,O
Sentence: 908,with,O
Sentence: 908,a,O
Sentence: 908,reduction,O
Sentence: 908,,O
Sentence: 908,>,O
Sentence: 908,,O
Sentence: 908,or,O
Sentence: 908,,O
Sentence: 908,=,O
Sentence: 908,50,O
Sentence: 908,%,O
Sentence: 908,and,O
Sentence: 908,2,O
Sentence: 908,,O
Sentence: 908,<,O
Sentence: 908,,O
Sentence: 908,50,O
Sentence: 908,%,O
Sentence: 908,),O
Sentence: 908,.,O
Sentence: 908,One,O
Sentence: 908,patient,O
Sentence: 908,showed,O
Sentence: 908,no,O
Sentence: 908,changes,O
Sentence: 908,in,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,.,O
Sentence: 908,Five,O
Sentence: 908,patients,O
Sentence: 908,complained,O
Sentence: 908,of,O
Sentence: 908,paresthesias,B-Disease
Sentence: 908,and,O
Sentence: 908,leg,O
Sentence: 908,cramps,B-Disease
Sentence: 908,.,O
Sentence: 908,After,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,treatment,O
Sentence: 908,",",O
Sentence: 908,sural,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,recovered,O
Sentence: 908,in,O
Sentence: 908,3,O
Sentence: 908,patients,O
Sentence: 908,.,O
Sentence: 908,At,O
Sentence: 908,detection,O
Sentence: 908,of,O
Sentence: 908,reduction,O
Sentence: 908,in,O
Sentence: 908,sural,O
Sentence: 908,nerve,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,",",O
Sentence: 908,the,O
Sentence: 908,median,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,cumulative,O
Sentence: 908,dose,O
Sentence: 908,was,O
Sentence: 908,21.4,O
Sentence: 908,g.,O
Sentence: 908,The,O
Sentence: 908,threshold,O
Sentence: 908,neurotoxic,B-Disease
Sentence: 908,dosage,O
Sentence: 908,is,O
Sentence: 908,lower,O
Sentence: 908,than,O
Sentence: 908,previously,O
Sentence: 908,reported,O
Sentence: 908,.,O
Sentence: 908,CONCLUSIONS,O
Sentence: 908,:,O
Sentence: 908,Sural,O
Sentence: 908,nerve,O
Sentence: 908,SAP,O
Sentence: 908,amplitude,O
Sentence: 908,reduction,O
Sentence: 908,is,O
Sentence: 908,a,O
Sentence: 908,reliable,O
Sentence: 908,and,O
Sentence: 908,sensitive,O
Sentence: 908,marker,O
Sentence: 908,of,O
Sentence: 908,degeneration,O
Sentence: 908,and,O
Sentence: 908,recovery,O
Sentence: 908,of,O
Sentence: 908,sensory,O
Sentence: 908,fibres,O
Sentence: 908,.,O
Sentence: 908,This,O
Sentence: 908,electrophysiological,O
Sentence: 908,parameter,O
Sentence: 908,provides,O
Sentence: 908,information,O
Sentence: 908,about,O
Sentence: 908,subclinical,O
Sentence: 908,neurotoxic,B-Disease
Sentence: 908,potential,O
Sentence: 908,of,O
Sentence: 908,thalidomide,B-Chemical
Sentence: 908,but,O
Sentence: 908,is,O
Sentence: 908,not,O
Sentence: 908,helpful,O
Sentence: 908,in,O
Sentence: 908,predicting,O
Sentence: 908,the,O
Sentence: 908,appearance,O
Sentence: 908,of,O
Sentence: 908,sensory,O
Sentence: 908,symptoms,O
Sentence: 908,.,O
Sentence: 909,Amiodarone,B-Chemical
Sentence: 909,-,O
Sentence: 909,related,O
Sentence: 909,pulmonary,B-Disease
Sentence: 909,mass,I-Disease
Sentence: 909,and,O
Sentence: 909,unique,O
Sentence: 909,membranous,B-Disease
Sentence: 909,glomerulonephritis,I-Disease
Sentence: 909,in,O
Sentence: 909,a,O
Sentence: 909,patient,O
Sentence: 909,with,O
Sentence: 909,valvular,B-Disease
Sentence: 909,heart,I-Disease
Sentence: 909,disease,I-Disease
Sentence: 909,:,O
Sentence: 909,Diagnostic,O
Sentence: 909,pitfall,O
Sentence: 909,and,O
Sentence: 909,new,O
Sentence: 909,findings,O
Sentence: 909,.,O
Sentence: 910,Amiodarone,B-Chemical
Sentence: 910,is,O
Sentence: 910,an,O
Sentence: 910,anti,O
Sentence: 910,-,O
Sentence: 910,arrhythmic,B-Disease
Sentence: 910,drug,O
Sentence: 910,for,O
Sentence: 910,life,O
Sentence: 910,-,O
Sentence: 910,threatening,O
Sentence: 910,tachycardia,B-Disease
Sentence: 910,",",O
Sentence: 910,but,O
Sentence: 910,various,O
Sentence: 910,adverse,O
Sentence: 910,effects,O
Sentence: 910,have,O
Sentence: 910,been,O
Sentence: 910,reported,O
Sentence: 910,.,O
Sentence: 910,Reported,O
Sentence: 910,herein,O
Sentence: 910,is,O
Sentence: 910,an,O
Sentence: 910,autopsy,O
Sentence: 910,case,O
Sentence: 910,of,O
Sentence: 910,valvular,B-Disease
Sentence: 910,heart,I-Disease
Sentence: 910,disease,I-Disease
Sentence: 910,",",O
Sentence: 910,in,O
Sentence: 910,a,O
Sentence: 910,patient,O
Sentence: 910,who,O
Sentence: 910,developed,O
Sentence: 910,a,O
Sentence: 910,lung,B-Disease
Sentence: 910,mass,I-Disease
Sentence: 910,(,O
Sentence: 910,1.5,O
Sentence: 910,cm,O
Sentence: 910,in,O
Sentence: 910,diameter,O
Sentence: 910,),O
Sentence: 910,and,O
Sentence: 910,proteinuria,B-Disease
Sentence: 910,(,O
Sentence: 910,2.76,O
Sentence: 910,g,O
Sentence: 910,/,O
Sentence: 910,day,O
Sentence: 910,),O
Sentence: 910,after,O
Sentence: 910,treatment,O
Sentence: 910,with,O
Sentence: 910,amiodarone,B-Chemical
Sentence: 910,for,O
Sentence: 910,a,O
Sentence: 910,long,O
Sentence: 910,time,O
Sentence: 910,.,O
Sentence: 910,The,O
Sentence: 910,lung,B-Disease
Sentence: 910,mass,I-Disease
Sentence: 910,was,O
Sentence: 910,highly,O
Sentence: 910,suspected,O
Sentence: 910,to,O
Sentence: 910,be,O
Sentence: 910,lung,B-Disease
Sentence: 910,cancer,I-Disease
Sentence: 910,on,O
Sentence: 910,CT,O
Sentence: 910,and,O
Sentence: 910,positron,O
Sentence: 910,emission,O
Sentence: 910,tomography,O
Sentence: 910,",",O
Sentence: 910,but,O
Sentence: 910,histologically,O
Sentence: 910,the,O
Sentence: 910,lesion,O
Sentence: 910,was,O
Sentence: 910,composed,O
Sentence: 910,of,O
Sentence: 910,lymphoplasmacytic,O
Sentence: 910,infiltrates,O
Sentence: 910,in,O
Sentence: 910,alveolar,O
Sentence: 910,walls,O
Sentence: 910,and,O
Sentence: 910,intra,O
Sentence: 910,-,O
Sentence: 910,alveolar,O
Sentence: 910,accumulation,O
Sentence: 910,of,O
Sentence: 910,foamy,O
Sentence: 910,macrophages,O
Sentence: 910,containing,O
Sentence: 910,characteristic,O
Sentence: 910,myelinoid,O
Sentence: 910,bodies,O
Sentence: 910,",",O
Sentence: 910,indicating,O
Sentence: 910,that,O
Sentence: 910,it,O
Sentence: 910,was,O
Sentence: 910,an,O
Sentence: 910,amiodarone,B-Chemical
Sentence: 910,-,O
Sentence: 910,related,O
Sentence: 910,lesion,O
Sentence: 910,.,O
Sentence: 910,In,O
Sentence: 910,addition,O
Sentence: 910,",",O
Sentence: 910,the,O
Sentence: 910,lung,O
Sentence: 910,tissue,O
Sentence: 910,had,O
Sentence: 910,unevenly,O
Sentence: 910,distributed,O
Sentence: 910,hemosiderin,B-Disease
Sentence: 910,deposition,O
Sentence: 910,",",O
Sentence: 910,and,O
Sentence: 910,abnormally,O
Sentence: 910,tortuous,O
Sentence: 910,capillaries,O
Sentence: 910,were,O
Sentence: 910,seen,O
Sentence: 910,in,O
Sentence: 910,the,O
Sentence: 910,mass,O
Sentence: 910,and,O
Sentence: 910,in,O
Sentence: 910,heavily,O
Sentence: 910,hemosiderotic,B-Disease
Sentence: 910,lung,O
Sentence: 910,portions,O
Sentence: 910,outside,O
Sentence: 910,the,O
Sentence: 910,mass,O
Sentence: 910,.,O
Sentence: 910,In,O
Sentence: 910,the,O
Sentence: 910,kidneys,O
Sentence: 910,",",O
Sentence: 910,glomeruli,O
Sentence: 910,had,O
Sentence: 910,membrane,O
Sentence: 910,spikes,O
Sentence: 910,",",O
Sentence: 910,prominent,O
Sentence: 910,swelling,O
Sentence: 910,of,O
Sentence: 910,podocytes,O
Sentence: 910,and,O
Sentence: 910,subepithelial,O
Sentence: 910,deposits,O
Sentence: 910,",",O
Sentence: 910,which,O
Sentence: 910,were,O
Sentence: 910,sometimes,O
Sentence: 910,large,O
Sentence: 910,and,O
Sentence: 910,hump,O
Sentence: 910,-,O
Sentence: 910,like,O
Sentence: 910,.,O
Sentence: 910,Autoimmune,B-Disease
Sentence: 910,diseases,I-Disease
Sentence: 910,",",O
Sentence: 910,viral,B-Disease
Sentence: 910,hepatitis,I-Disease
Sentence: 910,",",O
Sentence: 910,malignant,O
Sentence: 910,neoplasms,B-Disease
Sentence: 910,or,O
Sentence: 910,other,O
Sentence: 910,diseases,O
Sentence: 910,with,O
Sentence: 910,a,O
Sentence: 910,known,O
Sentence: 910,relationship,O
Sentence: 910,to,O
Sentence: 910,membranous,B-Disease
Sentence: 910,glomerulonephritis,I-Disease
Sentence: 910,were,O
Sentence: 910,not,O
Sentence: 910,found,O
Sentence: 910,.,O
Sentence: 910,The,O
Sentence: 910,present,O
Sentence: 910,case,O
Sentence: 910,highlights,O
Sentence: 910,the,O
Sentence: 910,possibility,O
Sentence: 910,that,O
Sentence: 910,differential,O
Sentence: 910,diagnosis,O
Sentence: 910,between,O
Sentence: 910,an,O
Sentence: 910,amiodarone,B-Chemical
Sentence: 910,-,O
Sentence: 910,related,O
Sentence: 910,pulmonary,B-Disease
Sentence: 910,lesion,I-Disease
Sentence: 910,and,O
Sentence: 910,a,O
Sentence: 910,neoplasm,B-Disease
Sentence: 910,can,O
Sentence: 910,be,O
Sentence: 910,very,O
Sentence: 910,difficult,O
Sentence: 910,radiologically,O
Sentence: 910,",",O
Sentence: 910,and,O
Sentence: 910,suggests,O
Sentence: 910,that,O
Sentence: 910,membranous,B-Disease
Sentence: 910,glomerulonephritis,I-Disease
Sentence: 910,might,O
Sentence: 910,be,O
Sentence: 910,another,O
Sentence: 910,possible,O
Sentence: 910,complication,O
Sentence: 910,of,O
Sentence: 910,amiodarone,B-Chemical
Sentence: 910,treatment,O
Sentence: 910,.,O
Sentence: 911,Risk,O
Sentence: 911,of,O
Sentence: 911,coronary,B-Disease
Sentence: 911,artery,I-Disease
Sentence: 911,disease,I-Disease
Sentence: 911,associated,O
Sentence: 911,with,O
Sentence: 911,initial,O
Sentence: 911,sulphonylurea,B-Chemical
Sentence: 911,treatment,O
Sentence: 911,of,O
Sentence: 911,patients,O
Sentence: 911,with,O
Sentence: 911,type,B-Disease
Sentence: 911,2,I-Disease
Sentence: 911,diabetes,I-Disease
Sentence: 911,:,O
Sentence: 911,a,O
Sentence: 911,matched,O
Sentence: 911,case,O
Sentence: 911,-,O
Sentence: 911,control,O
Sentence: 911,study,O
Sentence: 911,.,O
Sentence: 912,AIMS,O
Sentence: 912,:,O
Sentence: 912,This,O
Sentence: 912,study,O
Sentence: 912,sought,O
Sentence: 912,to,O
Sentence: 912,assess,O
Sentence: 912,the,O
Sentence: 912,risk,O
Sentence: 912,of,O
Sentence: 912,developing,O
Sentence: 912,coronary,B-Disease
Sentence: 912,artery,I-Disease
Sentence: 912,disease,I-Disease
Sentence: 912,(,O
Sentence: 912,CAD,B-Disease
Sentence: 912,),O
Sentence: 912,associated,O
Sentence: 912,with,O
Sentence: 912,initial,O
Sentence: 912,treatment,O
Sentence: 912,of,O
Sentence: 912,type,B-Disease
Sentence: 912,2,I-Disease
Sentence: 912,diabetes,I-Disease
Sentence: 912,with,O
Sentence: 912,different,O
Sentence: 912,sulphonylureas,B-Chemical
Sentence: 912,.,O
Sentence: 912,METHODS,O
Sentence: 912,:,O
Sentence: 912,In,O
Sentence: 912,type,B-Disease
Sentence: 912,2,I-Disease
Sentence: 912,diabetic,I-Disease
Sentence: 912,patients,O
Sentence: 912,",",O
Sentence: 912,cases,O
Sentence: 912,who,O
Sentence: 912,developed,O
Sentence: 912,CAD,B-Disease
Sentence: 912,were,O
Sentence: 912,compared,O
Sentence: 912,retrospectively,O
Sentence: 912,with,O
Sentence: 912,controls,O
Sentence: 912,that,O
Sentence: 912,did,O
Sentence: 912,not,O
Sentence: 912,.,O
Sentence: 912,The,O
Sentence: 912,20,O
Sentence: 912,-,O
Sentence: 912,year,O
Sentence: 912,risk,O
Sentence: 912,of,O
Sentence: 912,CAD,B-Disease
Sentence: 912,at,O
Sentence: 912,diagnosis,O
Sentence: 912,of,O
Sentence: 912,diabetes,B-Disease
Sentence: 912,",",O
Sentence: 912,using,O
Sentence: 912,the,O
Sentence: 912,UKPDS,O
Sentence: 912,risk,O
Sentence: 912,engine,O
Sentence: 912,",",O
Sentence: 912,was,O
Sentence: 912,used,O
Sentence: 912,to,O
Sentence: 912,match,O
Sentence: 912,cases,O
Sentence: 912,with,O
Sentence: 912,controls,O
Sentence: 912,.,O
Sentence: 912,RESULTS,O
Sentence: 912,:,O
Sentence: 912,The,O
Sentence: 912,76,O
Sentence: 912,cases,O
Sentence: 912,of,O
Sentence: 912,CAD,B-Disease
Sentence: 912,were,O
Sentence: 912,compared,O
Sentence: 912,with,O
Sentence: 912,152,O
Sentence: 912,controls,O
Sentence: 912,.,O
Sentence: 912,The,O
Sentence: 912,hazard,O
Sentence: 912,of,O
Sentence: 912,developing,O
Sentence: 912,CAD,B-Disease
Sentence: 912,(,O
Sentence: 912,95,O
Sentence: 912,%,O
Sentence: 912,CI,O
Sentence: 912,),O
Sentence: 912,associated,O
Sentence: 912,with,O
Sentence: 912,initial,O
Sentence: 912,treatment,O
Sentence: 912,increased,O
Sentence: 912,by,O
Sentence: 912,2.4,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,1.3,O
Sentence: 912,-,O
Sentence: 912,4.3,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.004,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,glibenclamide,B-Chemical
Sentence: 912,;,O
Sentence: 912,2,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,0.9,O
Sentence: 912,-,O
Sentence: 912,4.6,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.099,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,glipizide,B-Chemical
Sentence: 912,;,O
Sentence: 912,2.9,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,1.6,O
Sentence: 912,-,O
Sentence: 912,5.1,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.000,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,either,O
Sentence: 912,",",O
Sentence: 912,and,O
Sentence: 912,was,O
Sentence: 912,unchanged,O
Sentence: 912,with,O
Sentence: 912,metformin,B-Chemical
Sentence: 912,.,O
Sentence: 912,The,O
Sentence: 912,hazard,O
Sentence: 912,decreased,O
Sentence: 912,0.3,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,0.7,O
Sentence: 912,-,O
Sentence: 912,1.7,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.385,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,glimepiride,B-Chemical
Sentence: 912,",",O
Sentence: 912,0.4,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,0.7,O
Sentence: 912,-,O
Sentence: 912,1.3,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.192,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,gliclazide,B-Chemical
Sentence: 912,",",O
Sentence: 912,and,O
Sentence: 912,0.4,O
Sentence: 912,-,O
Sentence: 912,fold,O
Sentence: 912,(,O
Sentence: 912,0.7,O
Sentence: 912,-,O
Sentence: 912,1.1,O
Sentence: 912,",",O
Sentence: 912,P,O
Sentence: 912,=,O
Sentence: 912,0.09,O
Sentence: 912,),O
Sentence: 912,with,O
Sentence: 912,either,O
Sentence: 912,.,O
Sentence: 912,CONCLUSIONS,O
Sentence: 912,:,O
Sentence: 912,Initiating,O
Sentence: 912,treatment,O
Sentence: 912,of,O
Sentence: 912,type,B-Disease
Sentence: 912,2,I-Disease
Sentence: 912,diabetes,I-Disease
Sentence: 912,with,O
Sentence: 912,glibenclamide,B-Chemical
Sentence: 912,or,O
Sentence: 912,glipizide,B-Chemical
Sentence: 912,is,O
Sentence: 912,associated,O
Sentence: 912,with,O
Sentence: 912,increased,O
Sentence: 912,risk,O
Sentence: 912,of,O
Sentence: 912,CAD,B-Disease
Sentence: 912,in,O
Sentence: 912,comparison,O
Sentence: 912,to,O
Sentence: 912,gliclazide,B-Chemical
Sentence: 912,or,O
Sentence: 912,glimepiride,B-Chemical
Sentence: 912,.,O
Sentence: 912,If,O
Sentence: 912,confirmed,O
Sentence: 912,",",O
Sentence: 912,this,O
Sentence: 912,may,O
Sentence: 912,be,O
Sentence: 912,important,O
Sentence: 912,because,O
Sentence: 912,most,O
Sentence: 912,Indian,O
Sentence: 912,patients,O
Sentence: 912,receive,O
Sentence: 912,the,O
Sentence: 912,cheaper,O
Sentence: 912,older,O
Sentence: 912,sulphonylureas,B-Chemical
Sentence: 912,",",O
Sentence: 912,and,O
Sentence: 912,present,O
Sentence: 912,guidelines,O
Sentence: 912,do,O
Sentence: 912,not,O
Sentence: 912,distinguish,O
Sentence: 912,between,O
Sentence: 912,individual,O
Sentence: 912,agents,O
Sentence: 912,.,O
Sentence: 913,Reduced,O
Sentence: 913,progression,O
Sentence: 913,of,O
Sentence: 913,adriamycin,B-Chemical
Sentence: 913,nephropathy,B-Disease
Sentence: 913,in,O
Sentence: 913,spontaneously,O
Sentence: 913,hypertensive,B-Disease
Sentence: 913,rats,O
Sentence: 913,treated,O
Sentence: 913,by,O
Sentence: 913,losartan,B-Chemical
Sentence: 913,.,O
Sentence: 914,BACKGROUND,O
Sentence: 914,:,O
Sentence: 914,The,O
Sentence: 914,aim,O
Sentence: 914,of,O
Sentence: 914,the,O
Sentence: 914,study,O
Sentence: 914,was,O
Sentence: 914,to,O
Sentence: 914,investigate,O
Sentence: 914,the,O
Sentence: 914,antihypertensive,O
Sentence: 914,effects,O
Sentence: 914,of,O
Sentence: 914,angiotensin,B-Chemical
Sentence: 914,II,I-Chemical
Sentence: 914,type,O
Sentence: 914,-,O
Sentence: 914,1,O
Sentence: 914,receptor,O
Sentence: 914,blocker,O
Sentence: 914,",",O
Sentence: 914,losartan,B-Chemical
Sentence: 914,",",O
Sentence: 914,and,O
Sentence: 914,its,O
Sentence: 914,potential,O
Sentence: 914,in,O
Sentence: 914,slowing,O
Sentence: 914,down,O
Sentence: 914,renal,B-Disease
Sentence: 914,disease,I-Disease
Sentence: 914,progression,O
Sentence: 914,in,O
Sentence: 914,spontaneously,O
Sentence: 914,hypertensive,B-Disease
Sentence: 914,rats,O
Sentence: 914,(,O
Sentence: 914,SHR,O
Sentence: 914,),O
Sentence: 914,with,O
Sentence: 914,adriamycin,B-Chemical
Sentence: 914,(,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,),O
Sentence: 914,nephropathy,B-Disease
Sentence: 914,.,O
Sentence: 914,METHODS,O
Sentence: 914,:,O
Sentence: 914,Six,O
Sentence: 914,-,O
Sentence: 914,month,O
Sentence: 914,-,O
Sentence: 914,old,O
Sentence: 914,female,O
Sentence: 914,SHR,O
Sentence: 914,were,O
Sentence: 914,randomly,O
Sentence: 914,selected,O
Sentence: 914,in,O
Sentence: 914,six,O
Sentence: 914,groups,O
Sentence: 914,.,O
Sentence: 914,Two,O
Sentence: 914,control,O
Sentence: 914,groups,O
Sentence: 914,(,O
Sentence: 914,SH,O
Sentence: 914,(,O
Sentence: 914,6,O
Sentence: 914,),O
Sentence: 914,",",O
Sentence: 914,SH,O
Sentence: 914,(,O
Sentence: 914,12,O
Sentence: 914,),O
Sentence: 914,),O
Sentence: 914,received,O
Sentence: 914,vehicle,O
Sentence: 914,.,O
Sentence: 914,Groups,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,(,O
Sentence: 914,6,O
Sentence: 914,),O
Sentence: 914,",",O
Sentence: 914,ADR+LOS,O
Sentence: 914,(,O
Sentence: 914,6,O
Sentence: 914,),O
Sentence: 914,and,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,(,O
Sentence: 914,12,O
Sentence: 914,),O
Sentence: 914,",",O
Sentence: 914,and,O
Sentence: 914,ADR+LOS,O
Sentence: 914,(,O
Sentence: 914,12,O
Sentence: 914,),O
Sentence: 914,received,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,(,O
Sentence: 914,2,O
Sentence: 914,mg,O
Sentence: 914,/,O
Sentence: 914,kg,O
Sentence: 914,/,O
Sentence: 914,b.w,O
Sentence: 914,.,O
Sentence: 914,i.v,O
Sentence: 914,.,O
Sentence: 914,),O
Sentence: 914,twice,O
Sentence: 914,in,O
Sentence: 914,a,O
Sentence: 914,3,O
Sentence: 914,-,O
Sentence: 914,week,O
Sentence: 914,interval,O
Sentence: 914,.,O
Sentence: 914,Group,O
Sentence: 914,ADR+LOS,O
Sentence: 914,(,O
Sentence: 914,6,O
Sentence: 914,),O
Sentence: 914,received,O
Sentence: 914,losartan,B-Chemical
Sentence: 914,(,O
Sentence: 914,10,O
Sentence: 914,mg,O
Sentence: 914,/,O
Sentence: 914,kg,O
Sentence: 914,/,O
Sentence: 914,b.w.,O
Sentence: 914,/,O
Sentence: 914,day,O
Sentence: 914,by,O
Sentence: 914,gavages,O
Sentence: 914,),O
Sentence: 914,for,O
Sentence: 914,6,O
Sentence: 914,weeks,O
Sentence: 914,and,O
Sentence: 914,group,O
Sentence: 914,ADR+LOS,O
Sentence: 914,(,O
Sentence: 914,12,O
Sentence: 914,),O
Sentence: 914,for,O
Sentence: 914,12,O
Sentence: 914,weeks,O
Sentence: 914,after,O
Sentence: 914,second,O
Sentence: 914,injection,O
Sentence: 914,of,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,.,O
Sentence: 914,Animals,O
Sentence: 914,were,O
Sentence: 914,killed,O
Sentence: 914,after,O
Sentence: 914,6,O
Sentence: 914,or,O
Sentence: 914,12,O
Sentence: 914,weeks,O
Sentence: 914,",",O
Sentence: 914,respectively,O
Sentence: 914,.,O
Sentence: 914,Haemodynamic,O
Sentence: 914,measurements,O
Sentence: 914,were,O
Sentence: 914,performed,O
Sentence: 914,on,O
Sentence: 914,anaesthetized,O
Sentence: 914,animals,O
Sentence: 914,",",O
Sentence: 914,blood,O
Sentence: 914,and,O
Sentence: 914,urine,O
Sentence: 914,samples,O
Sentence: 914,were,O
Sentence: 914,taken,O
Sentence: 914,for,O
Sentence: 914,biochemical,O
Sentence: 914,analysis,O
Sentence: 914,and,O
Sentence: 914,the,O
Sentence: 914,left,O
Sentence: 914,kidney,O
Sentence: 914,was,O
Sentence: 914,processed,O
Sentence: 914,for,O
Sentence: 914,morphological,O
Sentence: 914,studies,O
Sentence: 914,.,O
Sentence: 914,RESULTS,O
Sentence: 914,:,O
Sentence: 914,Short,O
Sentence: 914,-,O
Sentence: 914,term,O
Sentence: 914,losartan,B-Chemical
Sentence: 914,treatment,O
Sentence: 914,",",O
Sentence: 914,besides,O
Sentence: 914,antihypertensive,O
Sentence: 914,effect,O
Sentence: 914,",",O
Sentence: 914,improved,O
Sentence: 914,glomerular,O
Sentence: 914,filtration,O
Sentence: 914,rate,O
Sentence: 914,and,O
Sentence: 914,ameliorated,O
Sentence: 914,glomerulosclerosis,B-Disease
Sentence: 914,resulting,O
Sentence: 914,in,O
Sentence: 914,decreased,O
Sentence: 914,proteinuria,B-Disease
Sentence: 914,.,O
Sentence: 914,Prolonged,O
Sentence: 914,treatment,O
Sentence: 914,with,O
Sentence: 914,losartan,B-Chemical
Sentence: 914,showed,O
Sentence: 914,further,O
Sentence: 914,reduction,O
Sentence: 914,of,O
Sentence: 914,glomerulosclerosis,B-Disease
Sentence: 914,associated,O
Sentence: 914,with,O
Sentence: 914,reduced,O
Sentence: 914,progression,O
Sentence: 914,of,O
Sentence: 914,tubular,O
Sentence: 914,atrophy,B-Disease
Sentence: 914,and,O
Sentence: 914,interstitial,B-Disease
Sentence: 914,fibrosis,B-Disease
Sentence: 914,",",O
Sentence: 914,thus,O
Sentence: 914,preventing,O
Sentence: 914,heavy,O
Sentence: 914,proteinuria,B-Disease
Sentence: 914,and,O
Sentence: 914,chronic,B-Disease
Sentence: 914,renal,I-Disease
Sentence: 914,failure,I-Disease
Sentence: 914,.,O
Sentence: 914,Losartan,B-Chemical
Sentence: 914,reduced,O
Sentence: 914,uraemia,B-Disease
Sentence: 914,and,O
Sentence: 914,increased,O
Sentence: 914,urea,B-Chemical
Sentence: 914,clearance,O
Sentence: 914,in,O
Sentence: 914,advanced,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,nephropathy,B-Disease
Sentence: 914,in,O
Sentence: 914,SHR,O
Sentence: 914,.,O
Sentence: 914,Histological,O
Sentence: 914,examination,O
Sentence: 914,showed,O
Sentence: 914,that,O
Sentence: 914,losartan,B-Chemical
Sentence: 914,could,O
Sentence: 914,prevent,O
Sentence: 914,tubular,O
Sentence: 914,atrophy,B-Disease
Sentence: 914,",",O
Sentence: 914,interstitial,O
Sentence: 914,infiltration,O
Sentence: 914,and,O
Sentence: 914,fibrosis,B-Disease
Sentence: 914,in,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,nephropathy,B-Disease
Sentence: 914,.,O
Sentence: 914,CONCLUSION,O
Sentence: 914,:,O
Sentence: 914,Losartan,B-Chemical
Sentence: 914,reduces,O
Sentence: 914,the,O
Sentence: 914,rate,O
Sentence: 914,of,O
Sentence: 914,progression,O
Sentence: 914,of,O
Sentence: 914,ADR,B-Chemical
Sentence: 914,-,O
Sentence: 914,induced,O
Sentence: 914,focal,B-Disease
Sentence: 914,segmental,I-Disease
Sentence: 914,glomerulosclerosis,I-Disease
Sentence: 914,to,O
Sentence: 914,end,O
Sentence: 914,-,O
Sentence: 914,stage,O
Sentence: 914,renal,B-Disease
Sentence: 914,disease,I-Disease
Sentence: 914,in,O
Sentence: 914,SHR,O
Sentence: 914,.,O
Sentence: 915,The,O
Sentence: 915,risks,O
Sentence: 915,of,O
Sentence: 915,aprotinin,O
Sentence: 915,and,O
Sentence: 915,tranexamic,O
Sentence: 915,acid,O
Sentence: 915,in,O
Sentence: 915,cardiac,O
Sentence: 915,surgery,O
Sentence: 915,:,O
Sentence: 915,a,O
Sentence: 915,one,O
Sentence: 915,-,O
Sentence: 915,year,O
Sentence: 915,follow,O
Sentence: 915,-,O
Sentence: 915,up,O
Sentence: 915,of,O
Sentence: 915,1188,O
Sentence: 915,consecutive,O
Sentence: 915,patients,O
Sentence: 915,.,O
Sentence: 916,BACKGROUND,O
Sentence: 916,:,O
Sentence: 916,Our,O
Sentence: 916,aim,O
Sentence: 916,was,O
Sentence: 916,to,O
Sentence: 916,investigate,O
Sentence: 916,postoperative,O
Sentence: 916,complications,O
Sentence: 916,and,O
Sentence: 916,mortality,O
Sentence: 916,after,O
Sentence: 916,administration,O
Sentence: 916,of,O
Sentence: 916,aprotinin,O
Sentence: 916,compared,O
Sentence: 916,to,O
Sentence: 916,tranexamic,B-Chemical
Sentence: 916,acid,I-Chemical
Sentence: 916,in,O
Sentence: 916,an,O
Sentence: 916,unselected,O
Sentence: 916,",",O
Sentence: 916,consecutive,O
Sentence: 916,cohort,O
Sentence: 916,.,O
Sentence: 916,METHODS,O
Sentence: 916,:,O
Sentence: 916,Perioperative,O
Sentence: 916,data,O
Sentence: 916,from,O
Sentence: 916,consecutive,O
Sentence: 916,cardiac,O
Sentence: 916,surgery,O
Sentence: 916,patients,O
Sentence: 916,were,O
Sentence: 916,prospectively,O
Sentence: 916,collected,O
Sentence: 916,between,O
Sentence: 916,September,O
Sentence: 916,2005,O
Sentence: 916,and,O
Sentence: 916,June,O
Sentence: 916,2006,O
Sentence: 916,in,O
Sentence: 916,a,O
Sentence: 916,university,O
Sentence: 916,-,O
Sentence: 916,affiliated,O
Sentence: 916,clinic,O
Sentence: 916,(,O
Sentence: 916,n,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,1188,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,During,O
Sentence: 916,the,O
Sentence: 916,first,O
Sentence: 916,5,O
Sentence: 916,mo,O
Sentence: 916,",",O
Sentence: 916,596,O
Sentence: 916,patients,O
Sentence: 916,received,O
Sentence: 916,aprotinin,O
Sentence: 916,(,O
Sentence: 916,Group,O
Sentence: 916,A,O
Sentence: 916,),O
Sentence: 916,;,O
Sentence: 916,in,O
Sentence: 916,the,O
Sentence: 916,next,O
Sentence: 916,5,O
Sentence: 916,mo,O
Sentence: 916,",",O
Sentence: 916,592,O
Sentence: 916,patients,O
Sentence: 916,were,O
Sentence: 916,treated,O
Sentence: 916,with,O
Sentence: 916,tranexamic,B-Chemical
Sentence: 916,acid,I-Chemical
Sentence: 916,(,O
Sentence: 916,Group,O
Sentence: 916,T,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,Except,O
Sentence: 916,for,O
Sentence: 916,antifibrinolytic,O
Sentence: 916,therapy,O
Sentence: 916,",",O
Sentence: 916,the,O
Sentence: 916,anesthetic,O
Sentence: 916,and,O
Sentence: 916,surgical,O
Sentence: 916,protocols,O
Sentence: 916,remained,O
Sentence: 916,unchanged,O
Sentence: 916,.,O
Sentence: 916,RESULTS,O
Sentence: 916,:,O
Sentence: 916,The,O
Sentence: 916,pre,O
Sentence: 916,-,O
Sentence: 916,,O
Sentence: 916,and,O
Sentence: 916,intraoperative,O
Sentence: 916,variables,O
Sentence: 916,were,O
Sentence: 916,comparable,O
Sentence: 916,between,O
Sentence: 916,the,O
Sentence: 916,treatment,O
Sentence: 916,groups,O
Sentence: 916,.,O
Sentence: 916,Postoperatively,O
Sentence: 916,",",O
Sentence: 916,a,O
Sentence: 916,significantly,O
Sentence: 916,higher,O
Sentence: 916,incidence,O
Sentence: 916,of,O
Sentence: 916,seizures,B-Disease
Sentence: 916,was,O
Sentence: 916,found,O
Sentence: 916,in,O
Sentence: 916,Group,O
Sentence: 916,T,O
Sentence: 916,(,O
Sentence: 916,4.6,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,1.2,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,<,O
Sentence: 916,,O
Sentence: 916,0.001,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,This,O
Sentence: 916,difference,O
Sentence: 916,was,O
Sentence: 916,also,O
Sentence: 916,significant,O
Sentence: 916,in,O
Sentence: 916,the,O
Sentence: 916,primary,O
Sentence: 916,valve,O
Sentence: 916,surgery,O
Sentence: 916,and,O
Sentence: 916,the,O
Sentence: 916,high,O
Sentence: 916,risk,O
Sentence: 916,surgery,O
Sentence: 916,subgroups,O
Sentence: 916,(,O
Sentence: 916,7.9,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,1.2,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.003,O
Sentence: 916,;,O
Sentence: 916,7.3,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,2.4,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.035,O
Sentence: 916,",",O
Sentence: 916,respectively,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,Persistent,O
Sentence: 916,atrial,O
Sentence: 916,fibrillation,O
Sentence: 916,(,O
Sentence: 916,7.9,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,2.3,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.020,O
Sentence: 916,),O
Sentence: 916,and,O
Sentence: 916,renal,B-Disease
Sentence: 916,failure,I-Disease
Sentence: 916,(,O
Sentence: 916,9.7,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,1.7,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.002,O
Sentence: 916,),O
Sentence: 916,were,O
Sentence: 916,also,O
Sentence: 916,more,O
Sentence: 916,common,O
Sentence: 916,in,O
Sentence: 916,Group,O
Sentence: 916,T,O
Sentence: 916,",",O
Sentence: 916,in,O
Sentence: 916,the,O
Sentence: 916,primary,O
Sentence: 916,valve,O
Sentence: 916,surgery,O
Sentence: 916,subgroup,O
Sentence: 916,.,O
Sentence: 916,On,O
Sentence: 916,the,O
Sentence: 916,contrary,O
Sentence: 916,",",O
Sentence: 916,among,O
Sentence: 916,primary,O
Sentence: 916,coronary,O
Sentence: 916,artery,O
Sentence: 916,bypass,O
Sentence: 916,surgery,O
Sentence: 916,patients,O
Sentence: 916,",",O
Sentence: 916,there,O
Sentence: 916,were,O
Sentence: 916,more,O
Sentence: 916,acute,O
Sentence: 916,myocardial,B-Disease
Sentence: 916,infarctions,I-Disease
Sentence: 916,and,O
Sentence: 916,renal,B-Disease
Sentence: 916,dysfunction,I-Disease
Sentence: 916,in,O
Sentence: 916,Group,O
Sentence: 916,A,O
Sentence: 916,(,O
Sentence: 916,5.8,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,2.0,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.027,O
Sentence: 916,;,O
Sentence: 916,22.5,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,15.2,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.036,O
Sentence: 916,",",O
Sentence: 916,respectively,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,The,O
Sentence: 916,1,O
Sentence: 916,-,O
Sentence: 916,yr,O
Sentence: 916,mortality,O
Sentence: 916,was,O
Sentence: 916,significantly,O
Sentence: 916,higher,O
Sentence: 916,after,O
Sentence: 916,aprotinin,O
Sentence: 916,treatment,O
Sentence: 916,in,O
Sentence: 916,the,O
Sentence: 916,high,O
Sentence: 916,risk,O
Sentence: 916,surgery,O
Sentence: 916,group,O
Sentence: 916,(,O
Sentence: 916,17.7,O
Sentence: 916,%,O
Sentence: 916,vs,O
Sentence: 916,9.8,O
Sentence: 916,%,O
Sentence: 916,",",O
Sentence: 916,P,O
Sentence: 916,,O
Sentence: 916,=,O
Sentence: 916,,O
Sentence: 916,0.034,O
Sentence: 916,),O
Sentence: 916,.,O
Sentence: 916,CONCLUSION,O
Sentence: 916,:,O
Sentence: 916,Both,O
Sentence: 916,antifibrinolytic,O
Sentence: 916,drugs,O
Sentence: 916,bear,O
Sentence: 916,the,O
Sentence: 916,risk,O
Sentence: 916,of,O
Sentence: 916,adverse,O
Sentence: 916,outcome,O
Sentence: 916,depending,O
Sentence: 916,on,O
Sentence: 916,the,O
Sentence: 916,type,O
Sentence: 916,of,O
Sentence: 916,cardiac,O
Sentence: 916,surgery,O
Sentence: 916,.,O
Sentence: 916,Administration,O
Sentence: 916,of,O
Sentence: 916,aprotinin,O
Sentence: 916,should,O
Sentence: 916,be,O
Sentence: 916,avoided,O
Sentence: 916,in,O
Sentence: 916,coronary,O
Sentence: 916,artery,O
Sentence: 916,bypass,O
Sentence: 916,graft,O
Sentence: 916,and,O
Sentence: 916,high,O
Sentence: 916,risk,O
Sentence: 916,patients,O
Sentence: 916,",",O
Sentence: 916,whereas,O
Sentence: 916,administration,O
Sentence: 916,of,O
Sentence: 916,tranexamic,B-Chemical
Sentence: 916,acid,I-Chemical
Sentence: 916,is,O
Sentence: 916,not,O
Sentence: 916,recommended,O
Sentence: 916,in,O
Sentence: 916,valve,O
Sentence: 916,surgery,O
Sentence: 916,.,O
Sentence: 917,The,O
Sentence: 917,biological,O
Sentence: 917,properties,O
Sentence: 917,of,O
Sentence: 917,the,O
Sentence: 917,optical,O
Sentence: 917,isomers,O
Sentence: 917,of,O
Sentence: 917,propranolol,B-Chemical
Sentence: 917,and,O
Sentence: 917,their,O
Sentence: 917,effects,O
Sentence: 917,on,O
Sentence: 917,cardiac,B-Disease
Sentence: 917,arrhythmias,I-Disease
Sentence: 917,.,O
Sentence: 918,1,O
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,optical,O
Sentence: 918,isomers,O
Sentence: 918,of,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,have,O
Sentence: 918,been,O
Sentence: 918,compared,O
Sentence: 918,for,O
Sentence: 918,their,O
Sentence: 918,beta,O
Sentence: 918,-,O
Sentence: 918,blocking,O
Sentence: 918,and,O
Sentence: 918,antiarrhythmic,O
Sentence: 918,activities.2,O
Sentence: 918,.,O
Sentence: 918,In,O
Sentence: 918,blocking,O
Sentence: 918,the,O
Sentence: 918,positive,O
Sentence: 918,inotropic,O
Sentence: 918,and,O
Sentence: 918,chronotropic,O
Sentence: 918,responses,O
Sentence: 918,to,O
Sentence: 918,isoprenaline,B-Chemical
Sentence: 918,",",O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,had,O
Sentence: 918,less,O
Sentence: 918,than,O
Sentence: 918,one,O
Sentence: 918,hundredth,O
Sentence: 918,the,O
Sentence: 918,potency,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,.,O
Sentence: 918,At,O
Sentence: 918,dose,O
Sentence: 918,levels,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,which,O
Sentence: 918,attenuated,O
Sentence: 918,the,O
Sentence: 918,responses,O
Sentence: 918,to,O
Sentence: 918,isoprenaline,B-Chemical
Sentence: 918,",",O
Sentence: 918,there,O
Sentence: 918,was,O
Sentence: 918,a,O
Sentence: 918,significant,O
Sentence: 918,prolongation,O
Sentence: 918,of,O
Sentence: 918,the,O
Sentence: 918,PR,O
Sentence: 918,interval,O
Sentence: 918,of,O
Sentence: 918,the,O
Sentence: 918,electrocardiogram.3,O
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,metabolic,O
Sentence: 918,responses,O
Sentence: 918,to,O
Sentence: 918,isoprenaline,B-Chemical
Sentence: 918,in,O
Sentence: 918,dogs,O
Sentence: 918,(,O
Sentence: 918,an,O
Sentence: 918,increase,O
Sentence: 918,in,O
Sentence: 918,circulating,O
Sentence: 918,glucose,B-Chemical
Sentence: 918,",",O
Sentence: 918,lactate,B-Chemical
Sentence: 918,and,O
Sentence: 918,free,O
Sentence: 918,fatty,B-Chemical
Sentence: 918,acids,I-Chemical
Sentence: 918,),O
Sentence: 918,were,O
Sentence: 918,all,O
Sentence: 918,blocked,O
Sentence: 918,by,O
Sentence: 918,(,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,.,O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,Propranolol,B-Chemical
Sentence: 918,had,O
Sentence: 918,no,O
Sentence: 918,effect,O
Sentence: 918,on,O
Sentence: 918,fatty,B-Chemical
Sentence: 918,acid,I-Chemical
Sentence: 918,mobilization,O
Sentence: 918,but,O
Sentence: 918,significantly,O
Sentence: 918,reduced,O
Sentence: 918,the,O
Sentence: 918,increments,O
Sentence: 918,in,O
Sentence: 918,both,O
Sentence: 918,lactate,B-Chemical
Sentence: 918,and,O
Sentence: 918,glucose.4,O
Sentence: 918,.,O
Sentence: 918,Both,O
Sentence: 918,isomers,O
Sentence: 918,of,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,possessed,O
Sentence: 918,similar,O
Sentence: 918,depressant,O
Sentence: 918,potency,O
Sentence: 918,on,O
Sentence: 918,isolated,O
Sentence: 918,atrial,O
Sentence: 918,muscle,O
Sentence: 918,taken,O
Sentence: 918,from,O
Sentence: 918,guinea,O
Sentence: 918,-,O
Sentence: 918,pigs.5,O
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,isomers,O
Sentence: 918,of,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,exhibited,O
Sentence: 918,similar,O
Sentence: 918,local,O
Sentence: 918,anaesthetic,O
Sentence: 918,potencies,O
Sentence: 918,on,O
Sentence: 918,an,O
Sentence: 918,isolated,O
Sentence: 918,frog,O
Sentence: 918,nerve,O
Sentence: 918,preparation,O
Sentence: 918,at,O
Sentence: 918,a,O
Sentence: 918,level,O
Sentence: 918,approximately,O
Sentence: 918,three,O
Sentence: 918,times,O
Sentence: 918,that,O
Sentence: 918,of,O
Sentence: 918,procaine,B-Chemical
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,racemic,O
Sentence: 918,compound,O
Sentence: 918,was,O
Sentence: 918,significantly,O
Sentence: 918,less,O
Sentence: 918,potent,O
Sentence: 918,than,O
Sentence: 918,either,O
Sentence: 918,isomer.6,O
Sentence: 918,.,O
Sentence: 918,Both,O
Sentence: 918,isomers,O
Sentence: 918,of,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,were,O
Sentence: 918,capable,O
Sentence: 918,of,O
Sentence: 918,preventing,O
Sentence: 918,adrenaline,B-Chemical
Sentence: 918,-,O
Sentence: 918,induced,O
Sentence: 918,cardiac,B-Disease
Sentence: 918,arrhythmias,B-Disease
Sentence: 918,in,O
Sentence: 918,cats,O
Sentence: 918,anaesthetized,O
Sentence: 918,with,O
Sentence: 918,halothane,B-Chemical
Sentence: 918,",",O
Sentence: 918,but,O
Sentence: 918,the,O
Sentence: 918,mean,O
Sentence: 918,dose,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,was,O
Sentence: 918,0.09+,O
Sentence: 918,/,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,0.02,O
Sentence: 918,mg,O
Sentence: 918,/,O
Sentence: 918,kg,O
Sentence: 918,whereas,O
Sentence: 918,that,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,was,O
Sentence: 918,4.2+,O
Sentence: 918,/,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,1.2,O
Sentence: 918,mg,O
Sentence: 918,/,O
Sentence: 918,kg,O
Sentence: 918,.,O
Sentence: 918,At,O
Sentence: 918,the,O
Sentence: 918,effective,O
Sentence: 918,dose,O
Sentence: 918,level,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,there,O
Sentence: 918,was,O
Sentence: 918,a,O
Sentence: 918,significant,O
Sentence: 918,prolongation,O
Sentence: 918,of,O
Sentence: 918,the,O
Sentence: 918,PR,O
Sentence: 918,interval,O
Sentence: 918,of,O
Sentence: 918,the,O
Sentence: 918,electrocardiogram,O
Sentence: 918,.,O
Sentence: 918,Blockade,O
Sentence: 918,of,O
Sentence: 918,arrhythmias,B-Disease
Sentence: 918,with,O
Sentence: 918,both,O
Sentence: 918,isomers,O
Sentence: 918,was,O
Sentence: 918,surmountable,O
Sentence: 918,by,O
Sentence: 918,increasing,O
Sentence: 918,the,O
Sentence: 918,dose,O
Sentence: 918,of,O
Sentence: 918,adrenaline.7,O
Sentence: 918,.,O
Sentence: 918,Both,O
Sentence: 918,isomers,O
Sentence: 918,of,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,were,O
Sentence: 918,also,O
Sentence: 918,capable,O
Sentence: 918,of,O
Sentence: 918,reversing,O
Sentence: 918,ventricular,B-Disease
Sentence: 918,tachycardia,I-Disease
Sentence: 918,caused,O
Sentence: 918,by,O
Sentence: 918,ouabain,B-Chemical
Sentence: 918,in,O
Sentence: 918,anaesthetized,O
Sentence: 918,cats,O
Sentence: 918,and,O
Sentence: 918,dogs,O
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,dose,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,was,O
Sentence: 918,significantly,O
Sentence: 918,smaller,O
Sentence: 918,than,O
Sentence: 918,that,O
Sentence: 918,of,O
Sentence: 918,(,O
Sentence: 918,+,O
Sentence: 918,),O
Sentence: 918,,O
Sentence: 918,-,O
Sentence: 918,propranolol,B-Chemical
Sentence: 918,in,O
Sentence: 918,both,O
Sentence: 918,species,O
Sentence: 918,but,O
Sentence: 918,much,O
Sentence: 918,higher,O
Sentence: 918,than,O
Sentence: 918,that,O
Sentence: 918,required,O
Sentence: 918,to,O
Sentence: 918,produce,O
Sentence: 918,evidence,O
Sentence: 918,of,O
Sentence: 918,beta,O
Sentence: 918,-,O
Sentence: 918,blockade.8,O
Sentence: 918,.,O
Sentence: 918,The,O
Sentence: 918,implications,O
Sentence: 918,of,O
Sentence: 918,these,O
Sentence: 918,results,O
Sentence: 918,are,O
Sentence: 918,discussed,O
Sentence: 918,.,O
Sentence: 919,Topotecan,B-Chemical
Sentence: 919,in,O
Sentence: 919,combination,O
Sentence: 919,with,O
Sentence: 919,radiotherapy,O
Sentence: 919,in,O
Sentence: 919,unresectable,O
Sentence: 919,glioblastoma,B-Disease
Sentence: 919,:,O
Sentence: 919,a,O
Sentence: 919,phase,O
Sentence: 919,2,O
Sentence: 919,study,O
Sentence: 919,.,O
Sentence: 920,Improving,O
Sentence: 920,glioblastoma,B-Disease
Sentence: 920,multiforme,I-Disease
Sentence: 920,(,O
Sentence: 920,GBM,B-Disease
Sentence: 920,),O
Sentence: 920,treatment,O
Sentence: 920,with,O
Sentence: 920,radio,O
Sentence: 920,-,O
Sentence: 920,chemotherapy,O
Sentence: 920,remains,O
Sentence: 920,a,O
Sentence: 920,challenge,O
Sentence: 920,.,O
Sentence: 920,Topotecan,B-Chemical
Sentence: 920,is,O
Sentence: 920,an,O
Sentence: 920,attractive,O
Sentence: 920,option,O
Sentence: 920,as,O
Sentence: 920,it,O
Sentence: 920,exhibits,O
Sentence: 920,growth,O
Sentence: 920,inhibition,O
Sentence: 920,of,O
Sentence: 920,human,O
Sentence: 920,glioma,B-Disease
Sentence: 920,as,O
Sentence: 920,well,O
Sentence: 920,as,O
Sentence: 920,brain,O
Sentence: 920,penetration,O
Sentence: 920,.,O
Sentence: 920,The,O
Sentence: 920,present,O
Sentence: 920,study,O
Sentence: 920,assessed,O
Sentence: 920,the,O
Sentence: 920,combination,O
Sentence: 920,of,O
Sentence: 920,radiotherapy,O
Sentence: 920,(,O
Sentence: 920,60,O
Sentence: 920,Gy,O
Sentence: 920,/,O
Sentence: 920,30,O
Sentence: 920,fractions,O
Sentence: 920,/,O
Sentence: 920,40,O
Sentence: 920,days,O
Sentence: 920,),O
Sentence: 920,and,O
Sentence: 920,topotecan,B-Chemical
Sentence: 920,(,O
Sentence: 920,0.9,O
Sentence: 920,mg,O
Sentence: 920,/,O
Sentence: 920,m,O
Sentence: 920,(,O
Sentence: 920,2,O
Sentence: 920,),O
Sentence: 920,,O
Sentence: 920,/,O
Sentence: 920,day,O
Sentence: 920,on,O
Sentence: 920,days,O
Sentence: 920,1,O
Sentence: 920,-,O
Sentence: 920,5,O
Sentence: 920,on,O
Sentence: 920,weeks,O
Sentence: 920,1,O
Sentence: 920,",",O
Sentence: 920,3,O
Sentence: 920,and,O
Sentence: 920,5,O
Sentence: 920,),O
Sentence: 920,in,O
Sentence: 920,50,O
Sentence: 920,adults,O
Sentence: 920,with,O
Sentence: 920,histologically,O
Sentence: 920,proven,O
Sentence: 920,and,O
Sentence: 920,untreated,O
Sentence: 920,GBM,B-Disease
Sentence: 920,.,O
Sentence: 920,The,O
Sentence: 920,incidence,O
Sentence: 920,of,O
Sentence: 920,non,O
Sentence: 920,-,O
Sentence: 920,hematological,O
Sentence: 920,toxicities,B-Disease
Sentence: 920,was,O
Sentence: 920,low,O
Sentence: 920,and,O
Sentence: 920,grade,O
Sentence: 920,3,O
Sentence: 920,-,O
Sentence: 920,4,O
Sentence: 920,hematological,O
Sentence: 920,toxicities,B-Disease
Sentence: 920,were,O
Sentence: 920,reported,O
Sentence: 920,in,O
Sentence: 920,20,O
Sentence: 920,patients,O
Sentence: 920,(,O
Sentence: 920,mainly,O
Sentence: 920,lymphopenia,B-Disease
Sentence: 920,and,O
Sentence: 920,neutropenia,B-Disease
Sentence: 920,),O
Sentence: 920,.,O
Sentence: 920,Partial,O
Sentence: 920,response,O
Sentence: 920,and,O
Sentence: 920,stabilization,O
Sentence: 920,rates,O
Sentence: 920,were,O
Sentence: 920,2,O
Sentence: 920,%,O
Sentence: 920,and,O
Sentence: 920,32,O
Sentence: 920,%,O
Sentence: 920,",",O
Sentence: 920,respectively,O
Sentence: 920,",",O
Sentence: 920,with,O
Sentence: 920,an,O
Sentence: 920,overall,O
Sentence: 920,time,O
Sentence: 920,to,O
Sentence: 920,progression,O
Sentence: 920,of,O
Sentence: 920,12,O
Sentence: 920,weeks,O
Sentence: 920,.,O
Sentence: 920,One,O
Sentence: 920,-,O
Sentence: 920,year,O
Sentence: 920,overall,O
Sentence: 920,survival,O
Sentence: 920,(,O
Sentence: 920,OS,O
Sentence: 920,),O
Sentence: 920,rate,O
Sentence: 920,was,O
Sentence: 920,42,O
Sentence: 920,%,O
Sentence: 920,",",O
Sentence: 920,with,O
Sentence: 920,a,O
Sentence: 920,median,O
Sentence: 920,OS,O
Sentence: 920,of,O
Sentence: 920,40,O
Sentence: 920,weeks,O
Sentence: 920,.,O
Sentence: 920,Topotecan,B-Chemical
Sentence: 920,in,O
Sentence: 920,combination,O
Sentence: 920,with,O
Sentence: 920,radiotherapy,O
Sentence: 920,was,O
Sentence: 920,well,O
Sentence: 920,tolerated,O
Sentence: 920,.,O
Sentence: 920,However,O
Sentence: 920,",",O
Sentence: 920,while,O
Sentence: 920,response,O
Sentence: 920,and,O
Sentence: 920,stabilization,O
Sentence: 920,concerned,O
Sentence: 920,one,O
Sentence: 920,-,O
Sentence: 920,third,O
Sentence: 920,of,O
Sentence: 920,the,O
Sentence: 920,patients,O
Sentence: 920,",",O
Sentence: 920,the,O
Sentence: 920,study,O
Sentence: 920,did,O
Sentence: 920,not,O
Sentence: 920,show,O
Sentence: 920,increased,O
Sentence: 920,benefits,O
Sentence: 920,in,O
Sentence: 920,terms,O
Sentence: 920,of,O
Sentence: 920,survival,O
Sentence: 920,in,O
Sentence: 920,patients,O
Sentence: 920,with,O
Sentence: 920,unresectable,O
Sentence: 920,GBM,B-Disease
Sentence: 920,.,O
Sentence: 921,Long,O
Sentence: 921,-,O
Sentence: 921,term,O
Sentence: 921,lithium,B-Chemical
Sentence: 921,therapy,O
Sentence: 921,leading,O
Sentence: 921,to,O
Sentence: 921,hyperparathyroidism,B-Disease
Sentence: 921,:,O
Sentence: 921,a,O
Sentence: 921,case,O
Sentence: 921,report,O
Sentence: 921,.,O
Sentence: 922,PURPOSE,O
Sentence: 922,:,O
Sentence: 922,This,O
Sentence: 922,paper,O
Sentence: 922,reviews,O
Sentence: 922,the,O
Sentence: 922,effect,O
Sentence: 922,of,O
Sentence: 922,chronic,O
Sentence: 922,lithium,B-Chemical
Sentence: 922,therapy,O
Sentence: 922,on,O
Sentence: 922,serum,O
Sentence: 922,calcium,B-Chemical
Sentence: 922,level,O
Sentence: 922,and,O
Sentence: 922,parathyroid,O
Sentence: 922,glands,O
Sentence: 922,",",O
Sentence: 922,its,O
Sentence: 922,pathogenesis,O
Sentence: 922,",",O
Sentence: 922,and,O
Sentence: 922,treatment,O
Sentence: 922,options,O
Sentence: 922,.,O
Sentence: 922,We,O
Sentence: 922,examined,O
Sentence: 922,the,O
Sentence: 922,case,O
Sentence: 922,of,O
Sentence: 922,a,O
Sentence: 922,lithium,B-Chemical
Sentence: 922,-,O
Sentence: 922,treated,O
Sentence: 922,patient,O
Sentence: 922,who,O
Sentence: 922,had,O
Sentence: 922,recurrent,O
Sentence: 922,hypercalcemia,B-Disease
Sentence: 922,to,O
Sentence: 922,better,O
Sentence: 922,understand,O
Sentence: 922,the,O
Sentence: 922,disease,O
Sentence: 922,process,O
Sentence: 922,.,O
Sentence: 922,CONCLUSION,O
Sentence: 922,:,O
Sentence: 922,Primary,B-Disease
Sentence: 922,hyperparathyroidism,I-Disease
Sentence: 922,is,O
Sentence: 922,a,O
Sentence: 922,rare,O
Sentence: 922,but,O
Sentence: 922,potentially,O
Sentence: 922,life,O
Sentence: 922,-,O
Sentence: 922,threatening,O
Sentence: 922,side,O
Sentence: 922,effect,O
Sentence: 922,of,O
Sentence: 922,long,O
Sentence: 922,-,O
Sentence: 922,term,O
Sentence: 922,lithium,B-Chemical
Sentence: 922,therapy,O
Sentence: 922,.,O
Sentence: 922,Careful,O
Sentence: 922,patient,O
Sentence: 922,selection,O
Sentence: 922,and,O
Sentence: 922,long,O
Sentence: 922,-,O
Sentence: 922,term,O
Sentence: 922,follow,O
Sentence: 922,-,O
Sentence: 922,up,O
Sentence: 922,can,O
Sentence: 922,reduce,O
Sentence: 922,morbidity,O
Sentence: 922,.,O
Sentence: 922,PRACTICAL,O
Sentence: 922,IMPLICATIONS,O
Sentence: 922,:,O
Sentence: 922,As,O
Sentence: 922,much,O
Sentence: 922,as,O
Sentence: 922,15,O
Sentence: 922,%,O
Sentence: 922,of,O
Sentence: 922,lithium,B-Chemical
Sentence: 922,-,O
Sentence: 922,treated,O
Sentence: 922,patients,O
Sentence: 922,become,O
Sentence: 922,hypercalcemic,B-Disease
Sentence: 922,.,O
Sentence: 922,By,O
Sentence: 922,routinely,O
Sentence: 922,monitoring,O
Sentence: 922,serum,O
Sentence: 922,calcium,B-Chemical
Sentence: 922,levels,O
Sentence: 922,",",O
Sentence: 922,healthcare,O
Sentence: 922,providers,O
Sentence: 922,can,O
Sentence: 922,improve,O
Sentence: 922,the,O
Sentence: 922,quality,O
Sentence: 922,of,O
Sentence: 922,life,O
Sentence: 922,of,O
Sentence: 922,this,O
Sentence: 922,patient,O
Sentence: 922,group,O
Sentence: 922,.,O
Sentence: 923,Comparison,O
Sentence: 923,of,O
Sentence: 923,laryngeal,O
Sentence: 923,mask,O
Sentence: 923,with,O
Sentence: 923,endotracheal,O
Sentence: 923,tube,O
Sentence: 923,for,O
Sentence: 923,anesthesia,O
Sentence: 923,in,O
Sentence: 923,endoscopic,O
Sentence: 923,sinus,O
Sentence: 923,surgery,O
Sentence: 923,.,O
Sentence: 924,BACKGROUND,O
Sentence: 924,:,O
Sentence: 924,The,O
Sentence: 924,purpose,O
Sentence: 924,of,O
Sentence: 924,this,O
Sentence: 924,study,O
Sentence: 924,was,O
Sentence: 924,to,O
Sentence: 924,compare,O
Sentence: 924,surgical,O
Sentence: 924,conditions,O
Sentence: 924,",",O
Sentence: 924,including,O
Sentence: 924,the,O
Sentence: 924,amount,O
Sentence: 924,of,O
Sentence: 924,intraoperative,O
Sentence: 924,bleeding,B-Disease
Sentence: 924,as,O
Sentence: 924,well,O
Sentence: 924,as,O
Sentence: 924,intraoperative,O
Sentence: 924,blood,O
Sentence: 924,pressure,O
Sentence: 924,",",O
Sentence: 924,during,O
Sentence: 924,functional,O
Sentence: 924,endoscopic,O
Sentence: 924,sinus,O
Sentence: 924,surgery,O
Sentence: 924,(,O
Sentence: 924,FESS,O
Sentence: 924,),O
Sentence: 924,using,O
Sentence: 924,flexible,O
Sentence: 924,reinforced,O
Sentence: 924,laryngeal,O
Sentence: 924,mask,O
Sentence: 924,airway,O
Sentence: 924,(,O
Sentence: 924,FRLMA,O
Sentence: 924,),O
Sentence: 924,versus,O
Sentence: 924,endotracheal,O
Sentence: 924,tube,O
Sentence: 924,(,O
Sentence: 924,ETT,O
Sentence: 924,),O
Sentence: 924,in,O
Sentence: 924,maintaining,O
Sentence: 924,controlled,O
Sentence: 924,hypotension,B-Disease
Sentence: 924,anesthesia,O
Sentence: 924,induced,O
Sentence: 924,by,O
Sentence: 924,propofol,B-Chemical
Sentence: 924,-,O
Sentence: 924,remifentanil,B-Chemical
Sentence: 924,total,O
Sentence: 924,i.v,O
Sentence: 924,.,O
Sentence: 924,anesthesia,O
Sentence: 924,(,O
Sentence: 924,TIVA,O
Sentence: 924,),O
Sentence: 924,.,O
Sentence: 924,METHODS,O
Sentence: 924,:,O
Sentence: 924,Sixty,O
Sentence: 924,normotensive,O
Sentence: 924,American,O
Sentence: 924,Society,O
Sentence: 924,of,O
Sentence: 924,Anesthesiologists,O
Sentence: 924,I,O
Sentence: 924,-,O
Sentence: 924,II,O
Sentence: 924,adult,O
Sentence: 924,patients,O
Sentence: 924,undergoing,O
Sentence: 924,FESS,O
Sentence: 924,under,O
Sentence: 924,controlled,O
Sentence: 924,hypotension,B-Disease
Sentence: 924,anesthesia,O
Sentence: 924,caused,O
Sentence: 924,by,O
Sentence: 924,propofol,B-Chemical
Sentence: 924,-,O
Sentence: 924,remifentanil,B-Chemical
Sentence: 924,-,O
Sentence: 924,TIVA,O
Sentence: 924,were,O
Sentence: 924,randomly,O
Sentence: 924,assigned,O
Sentence: 924,into,O
Sentence: 924,two,O
Sentence: 924,groups,O
Sentence: 924,:,O
Sentence: 924,group,O
Sentence: 924,I,O
Sentence: 924,",",O
Sentence: 924,FRLMA,O
Sentence: 924,;,O
Sentence: 924,group,O
Sentence: 924,II,O
Sentence: 924,",",O
Sentence: 924,ETT,O
Sentence: 924,.,O
Sentence: 924,Hemorrhage,B-Disease
Sentence: 924,was,O
Sentence: 924,measured,O
Sentence: 924,and,O
Sentence: 924,the,O
Sentence: 924,visibility,O
Sentence: 924,of,O
Sentence: 924,the,O
Sentence: 924,operative,O
Sentence: 924,field,O
Sentence: 924,was,O
Sentence: 924,evaluated,O
Sentence: 924,according,O
Sentence: 924,to,O
Sentence: 924,a,O
Sentence: 924,six,O
Sentence: 924,-,O
Sentence: 924,point,O
Sentence: 924,scale,O
Sentence: 924,.,O
Sentence: 924,RESULTS,O
Sentence: 924,:,O
Sentence: 924,Controlled,O
Sentence: 924,hypotension,B-Disease
Sentence: 924,was,O
Sentence: 924,achieved,O
Sentence: 924,within,O
Sentence: 924,a,O
Sentence: 924,shorter,O
Sentence: 924,period,O
Sentence: 924,using,O
Sentence: 924,laryngeal,O
Sentence: 924,mask,O
Sentence: 924,using,O
Sentence: 924,lower,O
Sentence: 924,rates,O
Sentence: 924,of,O
Sentence: 924,remifentanil,B-Chemical
Sentence: 924,infusion,O
Sentence: 924,and,O
Sentence: 924,lower,O
Sentence: 924,total,O
Sentence: 924,dose,O
Sentence: 924,of,O
Sentence: 924,remifentanil,B-Chemical
Sentence: 924,.,O
Sentence: 924,CONCLUSION,O
Sentence: 924,:,O
Sentence: 924,In,O
Sentence: 924,summary,O
Sentence: 924,",",O
Sentence: 924,our,O
Sentence: 924,results,O
Sentence: 924,indicate,O
Sentence: 924,that,O
Sentence: 924,airway,O
Sentence: 924,management,O
Sentence: 924,using,O
Sentence: 924,FRLMA,O
Sentence: 924,during,O
Sentence: 924,controlled,O
Sentence: 924,hypotension,B-Disease
Sentence: 924,anesthesia,O
Sentence: 924,provided,O
Sentence: 924,better,O
Sentence: 924,surgical,O
Sentence: 924,conditions,O
Sentence: 924,in,O
Sentence: 924,terms,O
Sentence: 924,of,O
Sentence: 924,quality,O
Sentence: 924,of,O
Sentence: 924,operative,O
Sentence: 924,field,O
Sentence: 924,and,O
Sentence: 924,blood,O
Sentence: 924,loss,O
Sentence: 924,and,O
Sentence: 924,allowed,O
Sentence: 924,for,O
Sentence: 924,convenient,O
Sentence: 924,induced,O
Sentence: 924,hypotension,B-Disease
Sentence: 924,with,O
Sentence: 924,low,O
Sentence: 924,doses,O
Sentence: 924,of,O
Sentence: 924,remifentanil,B-Chemical
Sentence: 924,during,O
Sentence: 924,TIVA,O
Sentence: 924,in,O
Sentence: 924,patients,O
Sentence: 924,undergoing,O
Sentence: 924,FESS,O
Sentence: 924,.,O
Sentence: 925,Nonalcoholic,B-Disease
Sentence: 925,fatty,I-Disease
Sentence: 925,liver,I-Disease
Sentence: 925,disease,I-Disease
Sentence: 925,during,O
Sentence: 925,valproate,B-Chemical
Sentence: 925,therapy,O
Sentence: 925,.,O
Sentence: 926,Valproic,B-Chemical
Sentence: 926,acid,I-Chemical
Sentence: 926,(,O
Sentence: 926,VPA,B-Chemical
Sentence: 926,),O
Sentence: 926,is,O
Sentence: 926,effective,O
Sentence: 926,for,O
Sentence: 926,the,O
Sentence: 926,treatment,O
Sentence: 926,of,O
Sentence: 926,many,O
Sentence: 926,types,O
Sentence: 926,of,O
Sentence: 926,epilepsy,B-Disease
Sentence: 926,",",O
Sentence: 926,but,O
Sentence: 926,its,O
Sentence: 926,use,O
Sentence: 926,can,O
Sentence: 926,be,O
Sentence: 926,associated,O
Sentence: 926,with,O
Sentence: 926,an,O
Sentence: 926,increase,O
Sentence: 926,in,O
Sentence: 926,body,O
Sentence: 926,weight,O
Sentence: 926,.,O
Sentence: 926,We,O
Sentence: 926,report,O
Sentence: 926,a,O
Sentence: 926,case,O
Sentence: 926,of,O
Sentence: 926,nonalcoholic,B-Disease
Sentence: 926,fatty,I-Disease
Sentence: 926,liver,I-Disease
Sentence: 926,disease,I-Disease
Sentence: 926,(,O
Sentence: 926,NAFLD,B-Disease
Sentence: 926,),O
Sentence: 926,arising,O
Sentence: 926,in,O
Sentence: 926,a,O
Sentence: 926,child,O
Sentence: 926,who,O
Sentence: 926,developed,O
Sentence: 926,obesity,B-Disease
Sentence: 926,during,O
Sentence: 926,VPA,B-Chemical
Sentence: 926,treatment,O
Sentence: 926,.,O
Sentence: 926,Laboratory,O
Sentence: 926,data,O
Sentence: 926,revealed,O
Sentence: 926,hyperinsulinemia,B-Disease
Sentence: 926,with,O
Sentence: 926,insulin,B-Disease
Sentence: 926,resistance,I-Disease
Sentence: 926,.,O
Sentence: 926,After,O
Sentence: 926,the,O
Sentence: 926,withdrawal,O
Sentence: 926,of,O
Sentence: 926,VPA,B-Chemical
Sentence: 926,therapy,O
Sentence: 926,",",O
Sentence: 926,our,O
Sentence: 926,patient,O
Sentence: 926,showed,O
Sentence: 926,a,O
Sentence: 926,significant,O
Sentence: 926,weight,B-Disease
Sentence: 926,loss,I-Disease
Sentence: 926,",",O
Sentence: 926,a,O
Sentence: 926,decrease,O
Sentence: 926,of,O
Sentence: 926,body,O
Sentence: 926,mass,O
Sentence: 926,index,O
Sentence: 926,",",O
Sentence: 926,and,O
Sentence: 926,normalization,O
Sentence: 926,of,O
Sentence: 926,metabolic,O
Sentence: 926,and,O
Sentence: 926,endocrine,O
Sentence: 926,parameters,O
Sentence: 926,;,O
Sentence: 926,moreover,O
Sentence: 926,",",O
Sentence: 926,ultrasound,O
Sentence: 926,measurements,O
Sentence: 926,showed,O
Sentence: 926,a,O
Sentence: 926,complete,O
Sentence: 926,normalization,O
Sentence: 926,.,O
Sentence: 926,The,O
Sentence: 926,present,O
Sentence: 926,case,O
Sentence: 926,suggests,O
Sentence: 926,that,O
Sentence: 926,obesity,B-Disease
Sentence: 926,",",O
Sentence: 926,hyperinsulinemia,B-Disease
Sentence: 926,",",O
Sentence: 926,insulin,B-Disease
Sentence: 926,resistance,I-Disease
Sentence: 926,",",O
Sentence: 926,and,O
Sentence: 926,long,O
Sentence: 926,-,O
Sentence: 926,term,O
Sentence: 926,treatment,O
Sentence: 926,with,O
Sentence: 926,VPA,B-Chemical
Sentence: 926,may,O
Sentence: 926,be,O
Sentence: 926,all,O
Sentence: 926,associated,O
Sentence: 926,with,O
Sentence: 926,the,O
Sentence: 926,development,O
Sentence: 926,of,O
Sentence: 926,NAFLD,B-Disease
Sentence: 926,;,O
Sentence: 926,this,O
Sentence: 926,side,O
Sentence: 926,effect,O
Sentence: 926,is,O
Sentence: 926,reversible,O
Sentence: 926,after,O
Sentence: 926,VPA,B-Chemical
Sentence: 926,withdrawal,O
Sentence: 926,.,O
Sentence: 927,Carbimazole,B-Chemical
Sentence: 927,induced,O
Sentence: 927,ANCA,B-Disease
Sentence: 927,positive,I-Disease
Sentence: 927,vasculitis,I-Disease
Sentence: 927,.,O
Sentence: 928,Anti,O
Sentence: 928,-,O
Sentence: 928,thyroid,O
Sentence: 928,drugs,O
Sentence: 928,",",O
Sentence: 928,like,O
Sentence: 928,carbimazole,B-Chemical
Sentence: 928,and,O
Sentence: 928,propylthiouracil,B-Chemical
Sentence: 928,(,O
Sentence: 928,PTU,B-Chemical
Sentence: 928,),O
Sentence: 928,are,O
Sentence: 928,commonly,O
Sentence: 928,prescribed,O
Sentence: 928,for,O
Sentence: 928,the,O
Sentence: 928,treatment,O
Sentence: 928,of,O
Sentence: 928,hyperthyroidism,B-Disease
Sentence: 928,.,O
Sentence: 928,One,O
Sentence: 928,should,O
Sentence: 928,be,O
Sentence: 928,aware,O
Sentence: 928,of,O
Sentence: 928,the,O
Sentence: 928,side,O
Sentence: 928,effects,O
Sentence: 928,of,O
Sentence: 928,antithyroid,B-Chemical
Sentence: 928,medications,I-Chemical
Sentence: 928,.,O
Sentence: 928,Antineutrophil,O
Sentence: 928,cytoplasmic,O
Sentence: 928,antibody,O
Sentence: 928,(,O
Sentence: 928,ANCA,O
Sentence: 928,),O
Sentence: 928,,O
Sentence: 928,-,O
Sentence: 928,,O
Sentence: 928,-,O
Sentence: 928,,O
Sentence: 928,associated,O
Sentence: 928,vasculitis,B-Disease
Sentence: 928,is,O
Sentence: 928,a,O
Sentence: 928,potentially,O
Sentence: 928,life,O
Sentence: 928,-,O
Sentence: 928,threatening,O
Sentence: 928,adverse,O
Sentence: 928,effect,O
Sentence: 928,of,O
Sentence: 928,antithyroidmedications,B-Chemical
Sentence: 928,.,O
Sentence: 928,We,O
Sentence: 928,report,O
Sentence: 928,a,O
Sentence: 928,patient,O
Sentence: 928,with,O
Sentence: 928,Graves,B-Disease
Sentence: 928,',I-Disease
Sentence: 928,disease,I-Disease
Sentence: 928,who,O
Sentence: 928,developed,O
Sentence: 928,ANCA,O
Sentence: 928,positive,O
Sentence: 928,carbimazole,B-Chemical
Sentence: 928,induced,O
Sentence: 928,vasculitis,B-Disease
Sentence: 928,.,O
Sentence: 928,The,O
Sentence: 928,episode,O
Sentence: 928,was,O
Sentence: 928,characterized,O
Sentence: 928,by,O
Sentence: 928,a,O
Sentence: 928,vasculitic,B-Disease
Sentence: 928,skin,B-Disease
Sentence: 928,rash,I-Disease
Sentence: 928,associated,O
Sentence: 928,with,O
Sentence: 928,large,O
Sentence: 928,joint,O
Sentence: 928,arthritis,B-Disease
Sentence: 928,",",O
Sentence: 928,pyrexia,B-Disease
Sentence: 928,and,O
Sentence: 928,parotiditis,B-Disease
Sentence: 928,but,O
Sentence: 928,no,O
Sentence: 928,renal,O
Sentence: 928,or,O
Sentence: 928,pulmonary,O
Sentence: 928,involvement,O
Sentence: 928,.,O
Sentence: 928,He,O
Sentence: 928,was,O
Sentence: 928,referred,O
Sentence: 928,to,O
Sentence: 928,us,O
Sentence: 928,for,O
Sentence: 928,neurological,O
Sentence: 928,evaluation,O
Sentence: 928,because,O
Sentence: 928,he,O
Sentence: 928,had,O
Sentence: 928,difficulty,O
Sentence: 928,in,O
Sentence: 928,getting,O
Sentence: 928,up,O
Sentence: 928,from,O
Sentence: 928,squatting,O
Sentence: 928,position,O
Sentence: 928,and,O
Sentence: 928,was,O
Sentence: 928,suspected,O
Sentence: 928,to,O
Sentence: 928,have,O
Sentence: 928,myositis,B-Disease
Sentence: 928,.,O
Sentence: 928,Carbimazole,B-Chemical
Sentence: 928,and,O
Sentence: 928,methimazole,B-Chemical
Sentence: 928,have,O
Sentence: 928,a,O
Sentence: 928,lower,O
Sentence: 928,incidence,O
Sentence: 928,of,O
Sentence: 928,reported,O
Sentence: 928,ANCA,O
Sentence: 928,positive,O
Sentence: 928,side,O
Sentence: 928,effects,O
Sentence: 928,than,O
Sentence: 928,PUT,O
Sentence: 928,.,O
Sentence: 928,To,O
Sentence: 928,the,O
Sentence: 928,best,O
Sentence: 928,of,O
Sentence: 928,our,O
Sentence: 928,knowledge,O
Sentence: 928,this,O
Sentence: 928,is,O
Sentence: 928,the,O
Sentence: 928,first,O
Sentence: 928,ANCA,O
Sentence: 928,positive,O
Sentence: 928,carbimazole,B-Chemical
Sentence: 928,induced,O
Sentence: 928,vasculitis,B-Disease
Sentence: 928,case,O
Sentence: 928,reported,O
Sentence: 928,from,O
Sentence: 928,India,O
Sentence: 928,.,O
Sentence: 929,Aspirin,O
Sentence: 929,for,O
Sentence: 929,the,O
Sentence: 929,primary,O
Sentence: 929,prevention,O
Sentence: 929,of,O
Sentence: 929,cardiovascular,O
Sentence: 929,events,O
Sentence: 929,:,O
Sentence: 929,an,O
Sentence: 929,update,O
Sentence: 929,of,O
Sentence: 929,the,O
Sentence: 929,evidence,O
Sentence: 929,for,O
Sentence: 929,the,O
Sentence: 929,U.S.,O
Sentence: 929,Preventive,O
Sentence: 929,Services,O
Sentence: 929,Task,O
Sentence: 929,Force,O
Sentence: 929,.,O
Sentence: 930,BACKGROUND,O
Sentence: 930,:,O
Sentence: 930,Coronary,B-Disease
Sentence: 930,heart,I-Disease
Sentence: 930,disease,I-Disease
Sentence: 930,and,O
Sentence: 930,cerebrovascular,B-Disease
Sentence: 930,disease,I-Disease
Sentence: 930,are,O
Sentence: 930,leading,O
Sentence: 930,causes,O
Sentence: 930,of,O
Sentence: 930,death,O
Sentence: 930,in,O
Sentence: 930,the,O
Sentence: 930,United,O
Sentence: 930,States,O
Sentence: 930,.,O
Sentence: 930,In,O
Sentence: 930,2002,O
Sentence: 930,",",O
Sentence: 930,the,O
Sentence: 930,U.S.,O
Sentence: 930,Preventive,O
Sentence: 930,Services,O
Sentence: 930,Task,O
Sentence: 930,Force,O
Sentence: 930,(,O
Sentence: 930,USPSTF,O
Sentence: 930,),O
Sentence: 930,strongly,O
Sentence: 930,recommended,O
Sentence: 930,that,O
Sentence: 930,clinicians,O
Sentence: 930,discuss,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,with,O
Sentence: 930,adults,O
Sentence: 930,who,O
Sentence: 930,are,O
Sentence: 930,at,O
Sentence: 930,increased,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,coronary,B-Disease
Sentence: 930,heart,I-Disease
Sentence: 930,disease,I-Disease
Sentence: 930,.,O
Sentence: 930,PURPOSE,O
Sentence: 930,:,O
Sentence: 930,To,O
Sentence: 930,determine,O
Sentence: 930,the,O
Sentence: 930,benefits,O
Sentence: 930,and,O
Sentence: 930,harms,O
Sentence: 930,of,O
Sentence: 930,taking,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,for,O
Sentence: 930,the,O
Sentence: 930,primary,O
Sentence: 930,prevention,O
Sentence: 930,of,O
Sentence: 930,myocardial,B-Disease
Sentence: 930,infarctions,I-Disease
Sentence: 930,",",O
Sentence: 930,strokes,B-Disease
Sentence: 930,",",O
Sentence: 930,and,O
Sentence: 930,death,O
Sentence: 930,.,O
Sentence: 930,DATA,O
Sentence: 930,SOURCES,O
Sentence: 930,:,O
Sentence: 930,MEDLINE,O
Sentence: 930,and,O
Sentence: 930,Cochrane,O
Sentence: 930,Library,O
Sentence: 930,(,O
Sentence: 930,search,O
Sentence: 930,dates,O
Sentence: 930,",",O
Sentence: 930,1,O
Sentence: 930,January,O
Sentence: 930,2001,O
Sentence: 930,to,O
Sentence: 930,28,O
Sentence: 930,August,O
Sentence: 930,2008,O
Sentence: 930,),O
Sentence: 930,",",O
Sentence: 930,recent,O
Sentence: 930,systematic,O
Sentence: 930,reviews,O
Sentence: 930,",",O
Sentence: 930,reference,O
Sentence: 930,lists,O
Sentence: 930,of,O
Sentence: 930,retrieved,O
Sentence: 930,articles,O
Sentence: 930,",",O
Sentence: 930,and,O
Sentence: 930,suggestions,O
Sentence: 930,from,O
Sentence: 930,experts,O
Sentence: 930,.,O
Sentence: 930,STUDY,O
Sentence: 930,SELECTION,O
Sentence: 930,:,O
Sentence: 930,English,O
Sentence: 930,-,O
Sentence: 930,language,O
Sentence: 930,randomized,O
Sentence: 930,",",O
Sentence: 930,controlled,O
Sentence: 930,trials,O
Sentence: 930,(,O
Sentence: 930,RCTs,O
Sentence: 930,),O
Sentence: 930,;,O
Sentence: 930,case,O
Sentence: 930,-,O
Sentence: 930,control,O
Sentence: 930,studies,O
Sentence: 930,;,O
Sentence: 930,meta,O
Sentence: 930,-,O
Sentence: 930,analyses,O
Sentence: 930,;,O
Sentence: 930,and,O
Sentence: 930,systematic,O
Sentence: 930,reviews,O
Sentence: 930,of,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,versus,O
Sentence: 930,control,O
Sentence: 930,for,O
Sentence: 930,the,O
Sentence: 930,primary,O
Sentence: 930,prevention,O
Sentence: 930,of,O
Sentence: 930,cardiovascular,B-Disease
Sentence: 930,disease,I-Disease
Sentence: 930,(,O
Sentence: 930,CVD,B-Disease
Sentence: 930,),O
Sentence: 930,were,O
Sentence: 930,selected,O
Sentence: 930,to,O
Sentence: 930,answer,O
Sentence: 930,the,O
Sentence: 930,following,O
Sentence: 930,questions,O
Sentence: 930,:,O
Sentence: 930,Does,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,decrease,O
Sentence: 930,coronary,O
Sentence: 930,heart,O
Sentence: 930,events,O
Sentence: 930,",",O
Sentence: 930,strokes,B-Disease
Sentence: 930,",",O
Sentence: 930,death,O
Sentence: 930,from,O
Sentence: 930,coronary,O
Sentence: 930,heart,O
Sentence: 930,events,O
Sentence: 930,or,O
Sentence: 930,stroke,B-Disease
Sentence: 930,",",O
Sentence: 930,or,O
Sentence: 930,all,O
Sentence: 930,-,O
Sentence: 930,cause,O
Sentence: 930,mortality,O
Sentence: 930,in,O
Sentence: 930,adults,O
Sentence: 930,without,O
Sentence: 930,known,O
Sentence: 930,CVD,B-Disease
Sentence: 930,?,O
Sentence: 930,Does,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,increase,O
Sentence: 930,gastrointestinal,B-Disease
Sentence: 930,bleeding,B-Disease
Sentence: 930,or,O
Sentence: 930,hemorrhagic,B-Disease
Sentence: 930,strokes,B-Disease
Sentence: 930,?,O
Sentence: 930,DATA,O
Sentence: 930,EXTRACTION,O
Sentence: 930,:,O
Sentence: 930,All,O
Sentence: 930,studies,O
Sentence: 930,were,O
Sentence: 930,reviewed,O
Sentence: 930,",",O
Sentence: 930,abstracted,O
Sentence: 930,",",O
Sentence: 930,and,O
Sentence: 930,rated,O
Sentence: 930,for,O
Sentence: 930,quality,O
Sentence: 930,by,O
Sentence: 930,using,O
Sentence: 930,predefined,O
Sentence: 930,USPSTF,O
Sentence: 930,criteria,O
Sentence: 930,.,O
Sentence: 930,DATA,O
Sentence: 930,SYNTHESIS,O
Sentence: 930,:,O
Sentence: 930,New,O
Sentence: 930,evidence,O
Sentence: 930,from,O
Sentence: 930,1,O
Sentence: 930,good,O
Sentence: 930,-,O
Sentence: 930,quality,O
Sentence: 930,RCT,O
Sentence: 930,",",O
Sentence: 930,1,O
Sentence: 930,good,O
Sentence: 930,-,O
Sentence: 930,quality,O
Sentence: 930,meta,O
Sentence: 930,-,O
Sentence: 930,analysis,O
Sentence: 930,",",O
Sentence: 930,and,O
Sentence: 930,2,O
Sentence: 930,fair,O
Sentence: 930,-,O
Sentence: 930,quality,O
Sentence: 930,subanalyses,O
Sentence: 930,of,O
Sentence: 930,RCTs,O
Sentence: 930,demonstrates,O
Sentence: 930,that,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,use,O
Sentence: 930,reduces,O
Sentence: 930,the,O
Sentence: 930,number,O
Sentence: 930,of,O
Sentence: 930,CVD,B-Disease
Sentence: 930,events,O
Sentence: 930,in,O
Sentence: 930,patients,O
Sentence: 930,without,O
Sentence: 930,known,O
Sentence: 930,CVD,B-Disease
Sentence: 930,.,O
Sentence: 930,Men,O
Sentence: 930,in,O
Sentence: 930,these,O
Sentence: 930,studies,O
Sentence: 930,experienced,O
Sentence: 930,fewer,O
Sentence: 930,myocardial,B-Disease
Sentence: 930,infarctions,I-Disease
Sentence: 930,and,O
Sentence: 930,women,O
Sentence: 930,experienced,O
Sentence: 930,fewer,O
Sentence: 930,ischemic,O
Sentence: 930,strokes,B-Disease
Sentence: 930,.,O
Sentence: 930,Aspirin,B-Chemical
Sentence: 930,does,O
Sentence: 930,not,O
Sentence: 930,seem,O
Sentence: 930,to,O
Sentence: 930,affect,O
Sentence: 930,CVD,B-Disease
Sentence: 930,mortality,O
Sentence: 930,or,O
Sentence: 930,all,O
Sentence: 930,-,O
Sentence: 930,cause,O
Sentence: 930,mortality,O
Sentence: 930,in,O
Sentence: 930,either,O
Sentence: 930,men,O
Sentence: 930,or,O
Sentence: 930,women,O
Sentence: 930,.,O
Sentence: 930,The,O
Sentence: 930,use,O
Sentence: 930,of,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,for,O
Sentence: 930,primary,O
Sentence: 930,prevention,O
Sentence: 930,increases,O
Sentence: 930,the,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,major,O
Sentence: 930,bleeding,B-Disease
Sentence: 930,events,O
Sentence: 930,",",O
Sentence: 930,primarily,O
Sentence: 930,gastrointestinal,B-Disease
Sentence: 930,bleeding,B-Disease
Sentence: 930,events,O
Sentence: 930,",",O
Sentence: 930,in,O
Sentence: 930,both,O
Sentence: 930,men,O
Sentence: 930,and,O
Sentence: 930,women,O
Sentence: 930,.,O
Sentence: 930,Men,O
Sentence: 930,have,O
Sentence: 930,an,O
Sentence: 930,increased,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,hemorrhagic,B-Disease
Sentence: 930,strokes,B-Disease
Sentence: 930,with,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,use,O
Sentence: 930,.,O
Sentence: 930,A,O
Sentence: 930,new,O
Sentence: 930,RCT,O
Sentence: 930,and,O
Sentence: 930,meta,O
Sentence: 930,-,O
Sentence: 930,analysis,O
Sentence: 930,suggest,O
Sentence: 930,that,O
Sentence: 930,the,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,hemorrhagic,B-Disease
Sentence: 930,strokes,B-Disease
Sentence: 930,in,O
Sentence: 930,women,O
Sentence: 930,is,O
Sentence: 930,not,O
Sentence: 930,statistically,O
Sentence: 930,significantly,O
Sentence: 930,increased,O
Sentence: 930,.,O
Sentence: 930,LIMITATIONS,O
Sentence: 930,:,O
Sentence: 930,New,O
Sentence: 930,evidence,O
Sentence: 930,on,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,for,O
Sentence: 930,the,O
Sentence: 930,primary,O
Sentence: 930,prevention,O
Sentence: 930,of,O
Sentence: 930,CVD,B-Disease
Sentence: 930,is,O
Sentence: 930,limited,O
Sentence: 930,.,O
Sentence: 930,The,O
Sentence: 930,dose,O
Sentence: 930,of,O
Sentence: 930,aspirin,B-Chemical
Sentence: 930,used,O
Sentence: 930,in,O
Sentence: 930,the,O
Sentence: 930,RCTs,O
Sentence: 930,varied,O
Sentence: 930,",",O
Sentence: 930,which,O
Sentence: 930,prevented,O
Sentence: 930,the,O
Sentence: 930,estimation,O
Sentence: 930,of,O
Sentence: 930,the,O
Sentence: 930,most,O
Sentence: 930,appropriate,O
Sentence: 930,dose,O
Sentence: 930,for,O
Sentence: 930,primary,O
Sentence: 930,prevention,O
Sentence: 930,.,O
Sentence: 930,Several,O
Sentence: 930,of,O
Sentence: 930,the,O
Sentence: 930,RCTs,O
Sentence: 930,were,O
Sentence: 930,conducted,O
Sentence: 930,within,O
Sentence: 930,populations,O
Sentence: 930,of,O
Sentence: 930,health,O
Sentence: 930,professionals,O
Sentence: 930,",",O
Sentence: 930,which,O
Sentence: 930,potentially,O
Sentence: 930,limits,O
Sentence: 930,generalizability,O
Sentence: 930,.,O
Sentence: 930,CONCLUSION,O
Sentence: 930,:,O
Sentence: 930,Aspirin,B-Chemical
Sentence: 930,reduces,O
Sentence: 930,the,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,myocardial,B-Disease
Sentence: 930,infarction,I-Disease
Sentence: 930,in,O
Sentence: 930,men,O
Sentence: 930,and,O
Sentence: 930,strokes,B-Disease
Sentence: 930,in,O
Sentence: 930,women,O
Sentence: 930,.,O
Sentence: 930,Aspirin,B-Chemical
Sentence: 930,use,O
Sentence: 930,increases,O
Sentence: 930,the,O
Sentence: 930,risk,O
Sentence: 930,for,O
Sentence: 930,serious,O
Sentence: 930,bleeding,B-Disease
Sentence: 930,events,O
Sentence: 930,.,O
Sentence: 931,Reducing,O
Sentence: 931,harm,O
Sentence: 931,associated,O
Sentence: 931,with,O
Sentence: 931,anticoagulation,O
Sentence: 931,:,O
Sentence: 931,practical,O
Sentence: 931,considerations,O
Sentence: 931,of,O
Sentence: 931,argatroban,B-Chemical
Sentence: 931,therapy,O
Sentence: 931,in,O
Sentence: 931,heparin,B-Chemical
Sentence: 931,-,O
Sentence: 931,induced,O
Sentence: 931,thrombocytopenia,B-Disease
Sentence: 931,.,O
Sentence: 932,Argatroban,B-Chemical
Sentence: 932,is,O
Sentence: 932,a,O
Sentence: 932,hepatically,O
Sentence: 932,metabolized,O
Sentence: 932,",",O
Sentence: 932,direct,O
Sentence: 932,thrombin,O
Sentence: 932,inhibitor,O
Sentence: 932,used,O
Sentence: 932,for,O
Sentence: 932,prophylaxis,O
Sentence: 932,or,O
Sentence: 932,treatment,O
Sentence: 932,of,O
Sentence: 932,thrombosis,B-Disease
Sentence: 932,in,O
Sentence: 932,heparin,B-Chemical
Sentence: 932,-,O
Sentence: 932,induced,O
Sentence: 932,thrombocytopenia,B-Disease
Sentence: 932,(,O
Sentence: 932,HIT,B-Disease
Sentence: 932,),O
Sentence: 932,and,O
Sentence: 932,for,O
Sentence: 932,patients,O
Sentence: 932,with,O
Sentence: 932,or,O
Sentence: 932,at,O
Sentence: 932,risk,O
Sentence: 932,of,O
Sentence: 932,HIT,B-Disease
Sentence: 932,undergoing,O
Sentence: 932,percutaneous,O
Sentence: 932,coronary,O
Sentence: 932,intervention,O
Sentence: 932,(,O
Sentence: 932,PCI,O
Sentence: 932,),O
Sentence: 932,.,O
Sentence: 932,The,O
Sentence: 932,objective,O
Sentence: 932,of,O
Sentence: 932,this,O
Sentence: 932,review,O
Sentence: 932,is,O
Sentence: 932,to,O
Sentence: 932,summarize,O
Sentence: 932,practical,O
Sentence: 932,considerations,O
Sentence: 932,of,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,therapy,O
Sentence: 932,in,O
Sentence: 932,HIT,B-Disease
Sentence: 932,.,O
Sentence: 932,The,O
Sentence: 932,US,O
Sentence: 932,FDA,O
Sentence: 932,-,O
Sentence: 932,recommended,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,dose,O
Sentence: 932,in,O
Sentence: 932,HIT,B-Disease
Sentence: 932,is,O
Sentence: 932,2,O
Sentence: 932,microg,O
Sentence: 932,/,O
Sentence: 932,kg,O
Sentence: 932,/,O
Sentence: 932,min,O
Sentence: 932,(,O
Sentence: 932,reduced,O
Sentence: 932,in,O
Sentence: 932,patients,O
Sentence: 932,with,O
Sentence: 932,hepatic,B-Disease
Sentence: 932,impairment,I-Disease
Sentence: 932,and,O
Sentence: 932,in,O
Sentence: 932,paediatric,O
Sentence: 932,patients,O
Sentence: 932,),O
Sentence: 932,",",O
Sentence: 932,adjusted,O
Sentence: 932,to,O
Sentence: 932,achieve,O
Sentence: 932,activated,O
Sentence: 932,partial,O
Sentence: 932,thromboplastin,O
Sentence: 932,times,O
Sentence: 932,(,O
Sentence: 932,aPTTs,O
Sentence: 932,),O
Sentence: 932,1.5,O
Sentence: 932,-,O
Sentence: 932,3,O
Sentence: 932,times,O
Sentence: 932,baseline,O
Sentence: 932,(,O
Sentence: 932,not,O
Sentence: 932,,O
Sentence: 932,>,O
Sentence: 932,,O
Sentence: 932,100,O
Sentence: 932,seconds,O
Sentence: 932,),O
Sentence: 932,.,O
Sentence: 932,Contemporary,O
Sentence: 932,experiences,O
Sentence: 932,indicate,O
Sentence: 932,that,O
Sentence: 932,reduced,O
Sentence: 932,doses,O
Sentence: 932,are,O
Sentence: 932,also,O
Sentence: 932,needed,O
Sentence: 932,in,O
Sentence: 932,patients,O
Sentence: 932,with,O
Sentence: 932,conditions,O
Sentence: 932,associated,O
Sentence: 932,with,O
Sentence: 932,hepatic,O
Sentence: 932,hypoperfusion,O
Sentence: 932,",",O
Sentence: 932,e.g,O
Sentence: 932,.,O
Sentence: 932,heart,B-Disease
Sentence: 932,failure,I-Disease
Sentence: 932,",",O
Sentence: 932,yet,O
Sentence: 932,are,O
Sentence: 932,unnecessary,O
Sentence: 932,for,O
Sentence: 932,renal,B-Disease
Sentence: 932,dysfunction,I-Disease
Sentence: 932,",",O
Sentence: 932,adult,O
Sentence: 932,age,O
Sentence: 932,",",O
Sentence: 932,sex,O
Sentence: 932,",",O
Sentence: 932,race,O
Sentence: 932,/,O
Sentence: 932,ethnicity,O
Sentence: 932,or,O
Sentence: 932,obesity,B-Disease
Sentence: 932,.,O
Sentence: 932,Argatroban,B-Chemical
Sentence: 932,0.5,O
Sentence: 932,-,O
Sentence: 932,1.2,O
Sentence: 932,microg,O
Sentence: 932,/,O
Sentence: 932,kg,O
Sentence: 932,/,O
Sentence: 932,min,O
Sentence: 932,typically,O
Sentence: 932,supports,O
Sentence: 932,therapeutic,O
Sentence: 932,aPTTs,O
Sentence: 932,.,O
Sentence: 932,The,O
Sentence: 932,FDA,O
Sentence: 932,-,O
Sentence: 932,recommended,O
Sentence: 932,dose,O
Sentence: 932,during,O
Sentence: 932,PCI,O
Sentence: 932,is,O
Sentence: 932,25,O
Sentence: 932,microg,O
Sentence: 932,/,O
Sentence: 932,kg,O
Sentence: 932,/,O
Sentence: 932,min,O
Sentence: 932,(,O
Sentence: 932,350,O
Sentence: 932,microg,O
Sentence: 932,/,O
Sentence: 932,kg,O
Sentence: 932,initial,O
Sentence: 932,bolus,O
Sentence: 932,),O
Sentence: 932,",",O
Sentence: 932,adjusted,O
Sentence: 932,to,O
Sentence: 932,achieve,O
Sentence: 932,activated,O
Sentence: 932,clotting,O
Sentence: 932,times,O
Sentence: 932,(,O
Sentence: 932,ACTs,O
Sentence: 932,),O
Sentence: 932,of,O
Sentence: 932,300,O
Sentence: 932,-,O
Sentence: 932,450,O
Sentence: 932,sec,O
Sentence: 932,.,O
Sentence: 932,For,O
Sentence: 932,PCI,O
Sentence: 932,",",O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,has,O
Sentence: 932,not,O
Sentence: 932,been,O
Sentence: 932,investigated,O
Sentence: 932,in,O
Sentence: 932,hepatically,O
Sentence: 932,impaired,O
Sentence: 932,patients,O
Sentence: 932,;,O
Sentence: 932,dose,O
Sentence: 932,adjustment,O
Sentence: 932,is,O
Sentence: 932,unnecessary,O
Sentence: 932,for,O
Sentence: 932,adult,O
Sentence: 932,age,O
Sentence: 932,",",O
Sentence: 932,sex,O
Sentence: 932,",",O
Sentence: 932,race,O
Sentence: 932,/,O
Sentence: 932,ethnicity,O
Sentence: 932,or,O
Sentence: 932,obesity,B-Disease
Sentence: 932,",",O
Sentence: 932,and,O
Sentence: 932,lesser,O
Sentence: 932,doses,O
Sentence: 932,may,O
Sentence: 932,be,O
Sentence: 932,adequate,O
Sentence: 932,with,O
Sentence: 932,concurrent,O
Sentence: 932,glycoprotein,O
Sentence: 932,IIb,O
Sentence: 932,/,O
Sentence: 932,IIIa,O
Sentence: 932,inhibition,O
Sentence: 932,.,O
Sentence: 932,Argatroban,B-Chemical
Sentence: 932,prolongs,O
Sentence: 932,the,O
Sentence: 932,International,O
Sentence: 932,Normalized,O
Sentence: 932,Ratio,O
Sentence: 932,",",O
Sentence: 932,and,O
Sentence: 932,published,O
Sentence: 932,approaches,O
Sentence: 932,for,O
Sentence: 932,monitoring,O
Sentence: 932,the,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,-,O
Sentence: 932,to,O
Sentence: 932,-,O
Sentence: 932,warfarin,B-Chemical
Sentence: 932,transition,O
Sentence: 932,should,O
Sentence: 932,be,O
Sentence: 932,followed,O
Sentence: 932,.,O
Sentence: 932,Major,O
Sentence: 932,bleeding,B-Disease
Sentence: 932,with,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,is,O
Sentence: 932,0,O
Sentence: 932,-,O
Sentence: 932,10,O
Sentence: 932,%,O
Sentence: 932,in,O
Sentence: 932,the,O
Sentence: 932,non,O
Sentence: 932,-,O
Sentence: 932,interventional,O
Sentence: 932,setting,O
Sentence: 932,and,O
Sentence: 932,0,O
Sentence: 932,-,O
Sentence: 932,5.8,O
Sentence: 932,%,O
Sentence: 932,periprocedurally,O
Sentence: 932,.,O
Sentence: 932,Argatroban,B-Chemical
Sentence: 932,has,O
Sentence: 932,no,O
Sentence: 932,specific,O
Sentence: 932,antidote,O
Sentence: 932,",",O
Sentence: 932,and,O
Sentence: 932,if,O
Sentence: 932,excessive,O
Sentence: 932,anticoagulation,O
Sentence: 932,occurs,O
Sentence: 932,",",O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,infusion,O
Sentence: 932,should,O
Sentence: 932,be,O
Sentence: 932,stopped,O
Sentence: 932,or,O
Sentence: 932,reduced,O
Sentence: 932,.,O
Sentence: 932,Improved,O
Sentence: 932,familiarity,O
Sentence: 932,of,O
Sentence: 932,healthcare,O
Sentence: 932,professionals,O
Sentence: 932,with,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,therapy,O
Sentence: 932,in,O
Sentence: 932,HIT,B-Disease
Sentence: 932,",",O
Sentence: 932,including,O
Sentence: 932,in,O
Sentence: 932,special,O
Sentence: 932,populations,O
Sentence: 932,and,O
Sentence: 932,during,O
Sentence: 932,PCI,O
Sentence: 932,",",O
Sentence: 932,may,O
Sentence: 932,facilitate,O
Sentence: 932,reduction,O
Sentence: 932,of,O
Sentence: 932,harm,O
Sentence: 932,associated,O
Sentence: 932,with,O
Sentence: 932,HIT,B-Disease
Sentence: 932,(,O
Sentence: 932,e.g,O
Sentence: 932,.,O
Sentence: 932,fewer,O
Sentence: 932,thromboses,O
Sentence: 932,),O
Sentence: 932,or,O
Sentence: 932,its,O
Sentence: 932,treatment,O
Sentence: 932,(,O
Sentence: 932,e.g,O
Sentence: 932,.,O
Sentence: 932,fewer,O
Sentence: 932,argatroban,B-Chemical
Sentence: 932,medication,O
Sentence: 932,errors,O
Sentence: 932,),O
Sentence: 932,.,O
Sentence: 933,Rhabdomyolysis,B-Disease
Sentence: 933,and,O
Sentence: 933,brain,O
Sentence: 933,ischemic,B-Disease
Sentence: 933,stroke,I-Disease
Sentence: 933,in,O
Sentence: 933,a,O
Sentence: 933,heroin,B-Chemical
Sentence: 933,-,O
Sentence: 933,dependent,O
Sentence: 933,male,O
Sentence: 933,under,O
Sentence: 933,methadone,B-Chemical
Sentence: 933,maintenance,O
Sentence: 933,therapy,O
Sentence: 933,.,O
Sentence: 934,OBJECTIVE,O
Sentence: 934,:,O
Sentence: 934,There,O
Sentence: 934,are,O
Sentence: 934,several,O
Sentence: 934,complications,O
Sentence: 934,associated,O
Sentence: 934,with,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,abuse,I-Disease
Sentence: 934,",",O
Sentence: 934,some,O
Sentence: 934,of,O
Sentence: 934,which,O
Sentence: 934,are,O
Sentence: 934,life,O
Sentence: 934,-,O
Sentence: 934,threatening,O
Sentence: 934,.,O
Sentence: 934,Methadone,B-Chemical
Sentence: 934,may,O
Sentence: 934,aggravate,O
Sentence: 934,this,O
Sentence: 934,problem,O
Sentence: 934,.,O
Sentence: 934,METHOD,O
Sentence: 934,:,O
Sentence: 934,A,O
Sentence: 934,clinical,O
Sentence: 934,case,O
Sentence: 934,description,O
Sentence: 934,.,O
Sentence: 934,RESULTS,O
Sentence: 934,:,O
Sentence: 934,A,O
Sentence: 934,33,O
Sentence: 934,-,O
Sentence: 934,year,O
Sentence: 934,-,O
Sentence: 934,old,O
Sentence: 934,man,O
Sentence: 934,presented,O
Sentence: 934,with,O
Sentence: 934,rhabdomyolysis,B-Disease
Sentence: 934,and,O
Sentence: 934,cerebral,O
Sentence: 934,ischemic,B-Disease
Sentence: 934,stroke,B-Disease
Sentence: 934,after,O
Sentence: 934,intravenous,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,.,O
Sentence: 934,He,O
Sentence: 934,had,O
Sentence: 934,used,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,since,O
Sentence: 934,age,O
Sentence: 934,20,O
Sentence: 934,",",O
Sentence: 934,and,O
Sentence: 934,had,O
Sentence: 934,used,O
Sentence: 934,150,O
Sentence: 934,mg,O
Sentence: 934,methadone,B-Chemical
Sentence: 934,daily,O
Sentence: 934,for,O
Sentence: 934,6,O
Sentence: 934,months,O
Sentence: 934,.,O
Sentence: 934,He,O
Sentence: 934,was,O
Sentence: 934,found,O
Sentence: 934,unconsciousness,B-Disease
Sentence: 934,at,O
Sentence: 934,home,O
Sentence: 934,and,O
Sentence: 934,was,O
Sentence: 934,sent,O
Sentence: 934,to,O
Sentence: 934,our,O
Sentence: 934,hospital,O
Sentence: 934,.,O
Sentence: 934,In,O
Sentence: 934,the,O
Sentence: 934,ER,O
Sentence: 934,",",O
Sentence: 934,his,O
Sentence: 934,opiate,O
Sentence: 934,level,O
Sentence: 934,was,O
Sentence: 934,4497,O
Sentence: 934,ng,O
Sentence: 934,/,O
Sentence: 934,ml,O
Sentence: 934,.,O
Sentence: 934,In,O
Sentence: 934,the,O
Sentence: 934,ICU,O
Sentence: 934,",",O
Sentence: 934,we,O
Sentence: 934,found,O
Sentence: 934,rhabdomyolysis,B-Disease
Sentence: 934,",",O
Sentence: 934,acute,B-Disease
Sentence: 934,renal,I-Disease
Sentence: 934,failure,I-Disease
Sentence: 934,and,O
Sentence: 934,acute,O
Sentence: 934,respiratory,B-Disease
Sentence: 934,failure,I-Disease
Sentence: 934,.,O
Sentence: 934,After,O
Sentence: 934,transfer,O
Sentence: 934,to,O
Sentence: 934,an,O
Sentence: 934,internal,O
Sentence: 934,ward,O
Sentence: 934,",",O
Sentence: 934,we,O
Sentence: 934,noted,O
Sentence: 934,aphasia,B-Disease
Sentence: 934,and,O
Sentence: 934,weakness,B-Disease
Sentence: 934,of,O
Sentence: 934,his,O
Sentence: 934,left,O
Sentence: 934,limbs,O
Sentence: 934,.,O
Sentence: 934,After,O
Sentence: 934,MRI,O
Sentence: 934,",",O
Sentence: 934,we,O
Sentence: 934,found,O
Sentence: 934,cerebral,B-Disease
Sentence: 934,ischemic,I-Disease
Sentence: 934,infarction,I-Disease
Sentence: 934,.,O
Sentence: 934,CONCLUSION,O
Sentence: 934,:,O
Sentence: 934,Those,O
Sentence: 934,using,O
Sentence: 934,methadone,B-Chemical
Sentence: 934,and,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,simultaneously,O
Sentence: 934,may,O
Sentence: 934,increase,O
Sentence: 934,risk,O
Sentence: 934,of,O
Sentence: 934,rhabdomyolysis,B-Disease
Sentence: 934,and,O
Sentence: 934,ischemic,B-Disease
Sentence: 934,stroke,B-Disease
Sentence: 934,.,O
Sentence: 934,Patients,O
Sentence: 934,under,O
Sentence: 934,methadone,B-Chemical
Sentence: 934,maintenance,O
Sentence: 934,therapy,O
Sentence: 934,should,O
Sentence: 934,be,O
Sentence: 934,warned,O
Sentence: 934,regarding,O
Sentence: 934,these,O
Sentence: 934,serious,O
Sentence: 934,adverse,O
Sentence: 934,events,O
Sentence: 934,.,O
Sentence: 934,Hypotheses,O
Sentence: 934,of,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,-,O
Sentence: 934,related,O
Sentence: 934,rhabdomyolysis,B-Disease
Sentence: 934,and,O
Sentence: 934,stroke,B-Disease
Sentence: 934,in,O
Sentence: 934,heroin,B-Chemical
Sentence: 934,abusers,O
Sentence: 934,are,O
Sentence: 934,discussed,O
Sentence: 934,.,O
Sentence: 935,Increased,O
Sentence: 935,vulnerability,O
Sentence: 935,to,O
Sentence: 935,6,O
Sentence: 935,-,O
Sentence: 935,hydroxydopamine,O
Sentence: 935,lesion,O
Sentence: 935,and,O
Sentence: 935,reduced,O
Sentence: 935,development,O
Sentence: 935,of,O
Sentence: 935,dyskinesias,B-Disease
Sentence: 935,in,O
Sentence: 935,mice,O
Sentence: 935,lacking,O
Sentence: 935,CB1,O
Sentence: 935,cannabinoid,O
Sentence: 935,receptors,O
Sentence: 935,.,O
Sentence: 936,Motor,O
Sentence: 936,impairment,O
Sentence: 936,",",O
Sentence: 936,dopamine,B-Chemical
Sentence: 936,(,O
Sentence: 936,DA,B-Chemical
Sentence: 936,),O
Sentence: 936,neuronal,O
Sentence: 936,activity,O
Sentence: 936,and,O
Sentence: 936,proenkephalin,B-Chemical
Sentence: 936,(,O
Sentence: 936,PENK,B-Chemical
Sentence: 936,),O
Sentence: 936,gene,O
Sentence: 936,expression,O
Sentence: 936,in,O
Sentence: 936,the,O
Sentence: 936,caudate,O
Sentence: 936,-,O
Sentence: 936,putamen,O
Sentence: 936,(,O
Sentence: 936,CPu,O
Sentence: 936,),O
Sentence: 936,were,O
Sentence: 936,measured,O
Sentence: 936,in,O
Sentence: 936,6,O
Sentence: 936,-,O
Sentence: 936,OHDA,O
Sentence: 936,-,O
Sentence: 936,lesioned,O
Sentence: 936,and,O
Sentence: 936,treated,O
Sentence: 936,(,O
Sentence: 936,L,O
Sentence: 936,-,O
Sentence: 936,DOPA+benserazide,O
Sentence: 936,),O
Sentence: 936,CB1,O
Sentence: 936,KO,O
Sentence: 936,and,O
Sentence: 936,WT,O
Sentence: 936,mice,O
Sentence: 936,.,O
Sentence: 936,A,O
Sentence: 936,lesion,O
Sentence: 936,induced,O
Sentence: 936,by,O
Sentence: 936,6,O
Sentence: 936,-,O
Sentence: 936,OHDA,O
Sentence: 936,produced,O
Sentence: 936,more,O
Sentence: 936,severe,O
Sentence: 936,motor,O
Sentence: 936,deterioration,O
Sentence: 936,in,O
Sentence: 936,CB1,O
Sentence: 936,KO,O
Sentence: 936,mice,O
Sentence: 936,accompanied,O
Sentence: 936,by,O
Sentence: 936,more,O
Sentence: 936,loss,O
Sentence: 936,of,O
Sentence: 936,DA,B-Chemical
Sentence: 936,neurons,O
Sentence: 936,and,O
Sentence: 936,increased,O
Sentence: 936,PENK,B-Chemical
Sentence: 936,gene,O
Sentence: 936,expression,O
Sentence: 936,in,O
Sentence: 936,the,O
Sentence: 936,CPu,O
Sentence: 936,.,O
Sentence: 936,Oxidative,O
Sentence: 936,/,O
Sentence: 936,nitrosative,O
Sentence: 936,and,O
Sentence: 936,neuroinflammatory,O
Sentence: 936,parameters,O
Sentence: 936,were,O
Sentence: 936,estimated,O
Sentence: 936,in,O
Sentence: 936,the,O
Sentence: 936,CPu,O
Sentence: 936,and,O
Sentence: 936,cingulate,O
Sentence: 936,cortex,O
Sentence: 936,(,O
Sentence: 936,Cg,O
Sentence: 936,),O
Sentence: 936,.,O
Sentence: 936,CB1,O
Sentence: 936,KO,O
Sentence: 936,mice,O
Sentence: 936,exhibited,O
Sentence: 936,higher,O
Sentence: 936,MDA,B-Chemical
Sentence: 936,levels,O
Sentence: 936,and,O
Sentence: 936,iNOS,O
Sentence: 936,protein,O
Sentence: 936,expression,O
Sentence: 936,in,O
Sentence: 936,the,O
Sentence: 936,CPu,O
Sentence: 936,and,O
Sentence: 936,Cg,O
Sentence: 936,compared,O
Sentence: 936,to,O
Sentence: 936,WT,O
Sentence: 936,mice,O
Sentence: 936,.,O
Sentence: 936,Treatment,O
Sentence: 936,with,O
Sentence: 936,L,O
Sentence: 936,-,O
Sentence: 936,DOPA+benserazide,O
Sentence: 936,(,O
Sentence: 936,12,O
Sentence: 936,weeks,O
Sentence: 936,),O
Sentence: 936,resulted,O
Sentence: 936,in,O
Sentence: 936,less,O
Sentence: 936,severe,O
Sentence: 936,dyskinesias,B-Disease
Sentence: 936,in,O
Sentence: 936,CB1,O
Sentence: 936,KO,O
Sentence: 936,than,O
Sentence: 936,in,O
Sentence: 936,WT,O
Sentence: 936,mice,O
Sentence: 936,.,O
Sentence: 936,The,O
Sentence: 936,results,O
Sentence: 936,revealed,O
Sentence: 936,that,O
Sentence: 936,the,O
Sentence: 936,lack,O
Sentence: 936,of,O
Sentence: 936,cannabinoid,O
Sentence: 936,CB1,O
Sentence: 936,receptors,O
Sentence: 936,increased,O
Sentence: 936,the,O
Sentence: 936,severity,O
Sentence: 936,of,O
Sentence: 936,motor,O
Sentence: 936,impairment,O
Sentence: 936,and,O
Sentence: 936,DA,B-Chemical
Sentence: 936,lesion,O
Sentence: 936,",",O
Sentence: 936,and,O
Sentence: 936,reduced,O
Sentence: 936,L,O
Sentence: 936,-,O
Sentence: 936,DOPA,O
Sentence: 936,-,O
Sentence: 936,induced,O
Sentence: 936,dyskinesias,B-Disease
Sentence: 936,.,O
Sentence: 936,These,O
Sentence: 936,results,O
Sentence: 936,suggest,O
Sentence: 936,that,O
Sentence: 936,activation,O
Sentence: 936,of,O
Sentence: 936,CB1,O
Sentence: 936,receptors,O
Sentence: 936,offers,O
Sentence: 936,neuroprotection,O
Sentence: 936,against,O
Sentence: 936,dopaminergic,O
Sentence: 936,lesion,O
Sentence: 936,and,O
Sentence: 936,the,O
Sentence: 936,development,O
Sentence: 936,of,O
Sentence: 936,L,O
Sentence: 936,-,O
Sentence: 936,DOPA,O
Sentence: 936,-,O
Sentence: 936,induced,O
Sentence: 936,dyskinesias,B-Disease
Sentence: 936,.,O
Sentence: 937,Animal,O
Sentence: 937,model,O
Sentence: 937,of,O
Sentence: 937,mania,B-Disease
Sentence: 937,induced,O
Sentence: 937,by,O
Sentence: 937,ouabain,B-Chemical
Sentence: 937,:,O
Sentence: 937,Evidence,O
Sentence: 937,of,O
Sentence: 937,oxidative,O
Sentence: 937,stress,O
Sentence: 937,in,O
Sentence: 937,submitochondrial,O
Sentence: 937,particles,O
Sentence: 937,of,O
Sentence: 937,the,O
Sentence: 937,rat,O
Sentence: 937,brain,O
Sentence: 937,.,O
Sentence: 938,The,O
Sentence: 938,intracerebroventricular,O
Sentence: 938,(,O
Sentence: 938,ICV,O
Sentence: 938,),O
Sentence: 938,administration,O
Sentence: 938,of,O
Sentence: 938,ouabain,B-Chemical
Sentence: 938,(,O
Sentence: 938,a,O
Sentence: 938,Na,B-Chemical
Sentence: 938,(,O
Sentence: 938,+,O
Sentence: 938,),O
Sentence: 938,,O
Sentence: 938,/,O
Sentence: 938,K,B-Chemical
Sentence: 938,(,O
Sentence: 938,+,O
Sentence: 938,),O
Sentence: 938,,O
Sentence: 938,-,O
Sentence: 938,ATPase,O
Sentence: 938,inhibitor,O
Sentence: 938,),O
Sentence: 938,in,O
Sentence: 938,rats,O
Sentence: 938,has,O
Sentence: 938,been,O
Sentence: 938,suggested,O
Sentence: 938,to,O
Sentence: 938,mimic,O
Sentence: 938,some,O
Sentence: 938,symptoms,O
Sentence: 938,of,O
Sentence: 938,human,O
Sentence: 938,bipolar,B-Disease
Sentence: 938,mania,B-Disease
Sentence: 938,.,O
Sentence: 938,Clinical,O
Sentence: 938,studies,O
Sentence: 938,have,O
Sentence: 938,shown,O
Sentence: 938,that,O
Sentence: 938,bipolar,B-Disease
Sentence: 938,disorder,I-Disease
Sentence: 938,may,O
Sentence: 938,be,O
Sentence: 938,related,O
Sentence: 938,to,O
Sentence: 938,mitochondrial,B-Disease
Sentence: 938,dysfunction,I-Disease
Sentence: 938,.,O
Sentence: 938,Herein,O
Sentence: 938,",",O
Sentence: 938,we,O
Sentence: 938,investigated,O
Sentence: 938,the,O
Sentence: 938,behavioral,O
Sentence: 938,and,O
Sentence: 938,biochemical,O
Sentence: 938,effects,O
Sentence: 938,induced,O
Sentence: 938,by,O
Sentence: 938,the,O
Sentence: 938,ICV,O
Sentence: 938,administration,O
Sentence: 938,of,O
Sentence: 938,ouabain,B-Chemical
Sentence: 938,in,O
Sentence: 938,rats,O
Sentence: 938,.,O
Sentence: 938,To,O
Sentence: 938,achieve,O
Sentence: 938,this,O
Sentence: 938,aim,O
Sentence: 938,",",O
Sentence: 938,the,O
Sentence: 938,effects,O
Sentence: 938,of,O
Sentence: 938,ouabain,B-Chemical
Sentence: 938,injection,O
Sentence: 938,immediately,O
Sentence: 938,after,O
Sentence: 938,and,O
Sentence: 938,7,O
Sentence: 938,days,O
Sentence: 938,following,O
Sentence: 938,a,O
Sentence: 938,single,O
Sentence: 938,ICV,O
Sentence: 938,administration,O
Sentence: 938,(,O
Sentence: 938,at,O
Sentence: 938,concentrations,O
Sentence: 938,of,O
Sentence: 938,10,O
Sentence: 938,(,O
Sentence: 938,,O
Sentence: 938,-,O
Sentence: 938,2,O
Sentence: 938,),O
Sentence: 938,and,O
Sentence: 938,10,O
Sentence: 938,(,O
Sentence: 938,,O
Sentence: 938,-,O
Sentence: 938,3,O
Sentence: 938,),O
Sentence: 938,M,O
Sentence: 938,),O
Sentence: 938,on,O
Sentence: 938,locomotion,O
Sentence: 938,was,O
Sentence: 938,measured,O
Sentence: 938,using,O
Sentence: 938,the,O
Sentence: 938,open,O
Sentence: 938,-,O
Sentence: 938,field,O
Sentence: 938,test,O
Sentence: 938,.,O
Sentence: 938,Additionally,O
Sentence: 938,",",O
Sentence: 938,thiobarbituric,B-Chemical
Sentence: 938,acid,I-Chemical
Sentence: 938,reactive,O
Sentence: 938,substances,O
Sentence: 938,(,O
Sentence: 938,TBARSs,O
Sentence: 938,),O
Sentence: 938,and,O
Sentence: 938,superoxide,B-Chemical
Sentence: 938,production,O
Sentence: 938,were,O
Sentence: 938,measured,O
Sentence: 938,in,O
Sentence: 938,submitochondrial,O
Sentence: 938,particles,O
Sentence: 938,of,O
Sentence: 938,the,O
Sentence: 938,prefrontal,O
Sentence: 938,cortex,O
Sentence: 938,",",O
Sentence: 938,hippocampus,O
Sentence: 938,",",O
Sentence: 938,striatum,O
Sentence: 938,and,O
Sentence: 938,amygdala,O
Sentence: 938,.,O
Sentence: 938,Our,O
Sentence: 938,findings,O
Sentence: 938,demonstrated,O
Sentence: 938,that,O
Sentence: 938,ouabain,B-Chemical
Sentence: 938,at,O
Sentence: 938,10,O
Sentence: 938,(,O
Sentence: 938,,O
Sentence: 938,-,O
Sentence: 938,2,O
Sentence: 938,),O
Sentence: 938,and,O
Sentence: 938,10,O
Sentence: 938,(,O
Sentence: 938,,O
Sentence: 938,-,O
Sentence: 938,3,O
Sentence: 938,),O
Sentence: 938,M,O
Sentence: 938,induced,O
Sentence: 938,hyperlocomotion,B-Disease
Sentence: 938,in,O
Sentence: 938,rats,O
Sentence: 938,",",O
Sentence: 938,and,O
Sentence: 938,this,O
Sentence: 938,response,O
Sentence: 938,remained,O
Sentence: 938,up,O
Sentence: 938,to,O
Sentence: 938,7,O
Sentence: 938,days,O
Sentence: 938,following,O
Sentence: 938,a,O
Sentence: 938,single,O
Sentence: 938,ICV,O
Sentence: 938,injection,O
Sentence: 938,.,O
Sentence: 938,In,O
Sentence: 938,addition,O
Sentence: 938,",",O
Sentence: 938,we,O
Sentence: 938,observed,O
Sentence: 938,that,O
Sentence: 938,the,O
Sentence: 938,persistent,O
Sentence: 938,increase,O
Sentence: 938,in,O
Sentence: 938,the,O
Sentence: 938,rat,O
Sentence: 938,spontaneous,O
Sentence: 938,locomotion,O
Sentence: 938,is,O
Sentence: 938,associated,O
Sentence: 938,with,O
Sentence: 938,increased,O
Sentence: 938,TBARS,O
Sentence: 938,levels,O
Sentence: 938,and,O
Sentence: 938,superoxide,B-Chemical
Sentence: 938,generation,O
Sentence: 938,in,O
Sentence: 938,submitochondrial,O
Sentence: 938,particles,O
Sentence: 938,in,O
Sentence: 938,the,O
Sentence: 938,prefrontal,O
Sentence: 938,cortex,O
Sentence: 938,",",O
Sentence: 938,striatum,O
Sentence: 938,and,O
Sentence: 938,amygdala,O
Sentence: 938,.,O
Sentence: 938,In,O
Sentence: 938,conclusion,O
Sentence: 938,",",O
Sentence: 938,ouabain,B-Chemical
Sentence: 938,-,O
Sentence: 938,induced,O
Sentence: 938,mania,B-Disease
Sentence: 938,-,O
Sentence: 938,like,O
Sentence: 938,behavior,O
Sentence: 938,may,O
Sentence: 938,provide,O
Sentence: 938,a,O
Sentence: 938,useful,O
Sentence: 938,animal,O
Sentence: 938,model,O
Sentence: 938,to,O
Sentence: 938,test,O
Sentence: 938,the,O
Sentence: 938,hypothesis,O
Sentence: 938,of,O
Sentence: 938,the,O
Sentence: 938,involvement,O
Sentence: 938,of,O
Sentence: 938,oxidative,O
Sentence: 938,stress,O
Sentence: 938,in,O
Sentence: 938,bipolar,B-Disease
Sentence: 938,disorder,I-Disease
Sentence: 938,.,O
Sentence: 939,Intraoperative,O
Sentence: 939,dialysis,O
Sentence: 939,during,O
Sentence: 939,liver,O
Sentence: 939,transplantation,O
Sentence: 939,with,O
Sentence: 939,citrate,O
Sentence: 939,dialysate,O
Sentence: 939,.,O
Sentence: 940,Liver,O
Sentence: 940,transplantation,O
Sentence: 940,for,O
Sentence: 940,acutely,O
Sentence: 940,ill,O
Sentence: 940,patients,O
Sentence: 940,with,O
Sentence: 940,fulminant,B-Disease
Sentence: 940,liver,I-Disease
Sentence: 940,failure,I-Disease
Sentence: 940,carries,O
Sentence: 940,high,O
Sentence: 940,intraoperative,O
Sentence: 940,and,O
Sentence: 940,immediate,O
Sentence: 940,postoperative,O
Sentence: 940,risks,O
Sentence: 940,.,O
Sentence: 940,These,O
Sentence: 940,are,O
Sentence: 940,increased,O
Sentence: 940,with,O
Sentence: 940,the,O
Sentence: 940,presence,O
Sentence: 940,of,O
Sentence: 940,concomitant,O
Sentence: 940,acute,B-Disease
Sentence: 940,kidney,I-Disease
Sentence: 940,injury,I-Disease
Sentence: 940,(,O
Sentence: 940,AKI,B-Disease
Sentence: 940,),O
Sentence: 940,and,O
Sentence: 940,intraoperative,O
Sentence: 940,dialysis,O
Sentence: 940,is,O
Sentence: 940,sometimes,O
Sentence: 940,required,O
Sentence: 940,to,O
Sentence: 940,allow,O
Sentence: 940,the,O
Sentence: 940,transplant,O
Sentence: 940,to,O
Sentence: 940,proceed,O
Sentence: 940,.,O
Sentence: 940,The,O
Sentence: 940,derangements,O
Sentence: 940,in,O
Sentence: 940,the,O
Sentence: 940,procoagulant,O
Sentence: 940,and,O
Sentence: 940,anticoagulant,O
Sentence: 940,pathways,O
Sentence: 940,during,O
Sentence: 940,fulminant,B-Disease
Sentence: 940,liver,I-Disease
Sentence: 940,failure,I-Disease
Sentence: 940,can,O
Sentence: 940,lead,O
Sentence: 940,to,O
Sentence: 940,difficulties,O
Sentence: 940,with,O
Sentence: 940,anticoagulation,O
Sentence: 940,during,O
Sentence: 940,dialysis,O
Sentence: 940,",",O
Sentence: 940,especially,O
Sentence: 940,when,O
Sentence: 940,continued,O
Sentence: 940,in,O
Sentence: 940,the,O
Sentence: 940,operating,O
Sentence: 940,room,O
Sentence: 940,.,O
Sentence: 940,Systemic,O
Sentence: 940,anticoagulation,O
Sentence: 940,is,O
Sentence: 940,unsafe,O
Sentence: 940,and,O
Sentence: 940,regional,O
Sentence: 940,citrate,B-Chemical
Sentence: 940,anticoagulation,O
Sentence: 940,in,O
Sentence: 940,the,O
Sentence: 940,absence,O
Sentence: 940,of,O
Sentence: 940,a,O
Sentence: 940,functional,O
Sentence: 940,liver,O
Sentence: 940,carries,O
Sentence: 940,the,O
Sentence: 940,risk,O
Sentence: 940,of,O
Sentence: 940,citrate,B-Chemical
Sentence: 940,toxicity,B-Disease
Sentence: 940,.,O
Sentence: 940,Citrate,B-Chemical
Sentence: 940,dialysate,O
Sentence: 940,",",O
Sentence: 940,a,O
Sentence: 940,new,O
Sentence: 940,dialysate,O
Sentence: 940,with,O
Sentence: 940,citric,B-Chemical
Sentence: 940,acid,I-Chemical
Sentence: 940,can,O
Sentence: 940,be,O
Sentence: 940,used,O
Sentence: 940,for,O
Sentence: 940,anticoagulation,O
Sentence: 940,in,O
Sentence: 940,patients,O
Sentence: 940,who,O
Sentence: 940,can,O
Sentence: 940,not,O
Sentence: 940,tolerate,O
Sentence: 940,heparin,B-Chemical
Sentence: 940,or,O
Sentence: 940,regional,O
Sentence: 940,citrate,B-Chemical
Sentence: 940,.,O
Sentence: 940,We,O
Sentence: 940,report,O
Sentence: 940,a,O
Sentence: 940,case,O
Sentence: 940,of,O
Sentence: 940,a,O
Sentence: 940,40,O
Sentence: 940,-,O
Sentence: 940,year,O
Sentence: 940,-,O
Sentence: 940,old,O
Sentence: 940,female,O
Sentence: 940,with,O
Sentence: 940,acetaminophen,B-Chemical
Sentence: 940,-,O
Sentence: 940,induced,O
Sentence: 940,fulminant,B-Disease
Sentence: 940,liver,I-Disease
Sentence: 940,failure,I-Disease
Sentence: 940,with,O
Sentence: 940,associated,O
Sentence: 940,AKI,B-Disease
Sentence: 940,who,O
Sentence: 940,underwent,O
Sentence: 940,intraoperative,O
Sentence: 940,dialytic,O
Sentence: 940,support,O
Sentence: 940,during,O
Sentence: 940,liver,O
Sentence: 940,transplantation,O
Sentence: 940,anticoagulated,O
Sentence: 940,with,O
Sentence: 940,citrate,B-Chemical
Sentence: 940,dialysate,O
Sentence: 940,during,O
Sentence: 940,the,O
Sentence: 940,entire,O
Sentence: 940,procedure,O
Sentence: 940,.,O
Sentence: 940,The,O
Sentence: 940,patient,O
Sentence: 940,tolerated,O
Sentence: 940,the,O
Sentence: 940,procedure,O
Sentence: 940,well,O
Sentence: 940,without,O
Sentence: 940,any,O
Sentence: 940,signs,O
Sentence: 940,of,O
Sentence: 940,citrate,B-Chemical
Sentence: 940,toxicity,B-Disease
Sentence: 940,and,O
Sentence: 940,maintained,O
Sentence: 940,adequate,O
Sentence: 940,anticoagulation,O
Sentence: 940,for,O
Sentence: 940,patency,O
Sentence: 940,of,O
Sentence: 940,the,O
Sentence: 940,dialysis,O
Sentence: 940,circuit,O
Sentence: 940,.,O
Sentence: 940,Citrate,B-Chemical
Sentence: 940,dialysate,O
Sentence: 940,is,O
Sentence: 940,a,O
Sentence: 940,safe,O
Sentence: 940,alternative,O
Sentence: 940,for,O
Sentence: 940,intradialytic,O
Sentence: 940,support,O
Sentence: 940,of,O
Sentence: 940,liver,O
Sentence: 940,transplantation,O
Sentence: 940,in,O
Sentence: 940,fulminant,B-Disease
Sentence: 940,liver,I-Disease
Sentence: 940,failure,I-Disease
Sentence: 940,.,O
Sentence: 941,Delirium,B-Disease
Sentence: 941,in,O
Sentence: 941,a,O
Sentence: 941,patient,O
Sentence: 941,with,O
Sentence: 941,toxic,O
Sentence: 941,flecainide,B-Chemical
Sentence: 941,plasma,O
Sentence: 941,concentrations,O
Sentence: 941,:,O
Sentence: 941,the,O
Sentence: 941,role,O
Sentence: 941,of,O
Sentence: 941,a,O
Sentence: 941,pharmacokinetic,O
Sentence: 941,drug,O
Sentence: 941,interaction,O
Sentence: 941,with,O
Sentence: 941,paroxetine,B-Chemical
Sentence: 941,.,O
Sentence: 942,OBJECTIVE,O
Sentence: 942,:,O
Sentence: 942,To,O
Sentence: 942,describe,O
Sentence: 942,a,O
Sentence: 942,case,O
Sentence: 942,of,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,-,O
Sentence: 942,induced,O
Sentence: 942,delirium,B-Disease
Sentence: 942,associated,O
Sentence: 942,with,O
Sentence: 942,a,O
Sentence: 942,pharmacokinetic,O
Sentence: 942,drug,O
Sentence: 942,interaction,O
Sentence: 942,with,O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,.,O
Sentence: 942,CASE,O
Sentence: 942,SUMMARY,O
Sentence: 942,:,O
Sentence: 942,A,O
Sentence: 942,69,O
Sentence: 942,-,O
Sentence: 942,year,O
Sentence: 942,-,O
Sentence: 942,old,O
Sentence: 942,white,O
Sentence: 942,female,O
Sentence: 942,presented,O
Sentence: 942,to,O
Sentence: 942,the,O
Sentence: 942,emergency,O
Sentence: 942,department,O
Sentence: 942,with,O
Sentence: 942,a,O
Sentence: 942,history,O
Sentence: 942,of,O
Sentence: 942,confusion,B-Disease
Sentence: 942,and,O
Sentence: 942,paranoia,B-Disease
Sentence: 942,over,O
Sentence: 942,the,O
Sentence: 942,past,O
Sentence: 942,several,O
Sentence: 942,days,O
Sentence: 942,.,O
Sentence: 942,On,O
Sentence: 942,admission,O
Sentence: 942,the,O
Sentence: 942,patient,O
Sentence: 942,was,O
Sentence: 942,taking,O
Sentence: 942,carvedilol,B-Chemical
Sentence: 942,12,O
Sentence: 942,mg,O
Sentence: 942,twice,O
Sentence: 942,daily,O
Sentence: 942,",",O
Sentence: 942,warfarin,B-Chemical
Sentence: 942,2,O
Sentence: 942,mg,O
Sentence: 942,/,O
Sentence: 942,day,O
Sentence: 942,",",O
Sentence: 942,folic,B-Chemical
Sentence: 942,acid,I-Chemical
Sentence: 942,1,O
Sentence: 942,mg,O
Sentence: 942,/,O
Sentence: 942,day,O
Sentence: 942,",",O
Sentence: 942,levothyroxine,B-Chemical
Sentence: 942,100,O
Sentence: 942,microg,O
Sentence: 942,/,O
Sentence: 942,day,O
Sentence: 942,",",O
Sentence: 942,pantoprazole,B-Chemical
Sentence: 942,40,O
Sentence: 942,mg,O
Sentence: 942,/,O
Sentence: 942,day,O
Sentence: 942,",",O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,40,O
Sentence: 942,mg,O
Sentence: 942,/,O
Sentence: 942,day,O
Sentence: 942,",",O
Sentence: 942,and,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,100,O
Sentence: 942,mg,O
Sentence: 942,twice,O
Sentence: 942,daily,O
Sentence: 942,.,O
Sentence: 942,Flecainide,B-Chemical
Sentence: 942,had,O
Sentence: 942,been,O
Sentence: 942,started,O
Sentence: 942,2,O
Sentence: 942,weeks,O
Sentence: 942,prior,O
Sentence: 942,for,O
Sentence: 942,atrial,B-Disease
Sentence: 942,fibrillation,I-Disease
Sentence: 942,.,O
Sentence: 942,Laboratory,O
Sentence: 942,test,O
Sentence: 942,findings,O
Sentence: 942,on,O
Sentence: 942,admission,O
Sentence: 942,were,O
Sentence: 942,notable,O
Sentence: 942,only,O
Sentence: 942,for,O
Sentence: 942,a,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,plasma,O
Sentence: 942,concentration,O
Sentence: 942,of,O
Sentence: 942,1360,O
Sentence: 942,microg,O
Sentence: 942,/,O
Sentence: 942,L,O
Sentence: 942,(,O
Sentence: 942,reference,O
Sentence: 942,range,O
Sentence: 942,200,O
Sentence: 942,-,O
Sentence: 942,1000,O
Sentence: 942,),O
Sentence: 942,.,O
Sentence: 942,A,O
Sentence: 942,metabolic,O
Sentence: 942,drug,O
Sentence: 942,interaction,O
Sentence: 942,between,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,and,O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,",",O
Sentence: 942,which,O
Sentence: 942,the,O
Sentence: 942,patient,O
Sentence: 942,had,O
Sentence: 942,been,O
Sentence: 942,taking,O
Sentence: 942,for,O
Sentence: 942,more,O
Sentence: 942,than,O
Sentence: 942,5,O
Sentence: 942,years,O
Sentence: 942,",",O
Sentence: 942,was,O
Sentence: 942,considered,O
Sentence: 942,.,O
Sentence: 942,Paroxetine,B-Chemical
Sentence: 942,was,O
Sentence: 942,discontinued,O
Sentence: 942,and,O
Sentence: 942,the,O
Sentence: 942,dose,O
Sentence: 942,of,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,was,O
Sentence: 942,reduced,O
Sentence: 942,to,O
Sentence: 942,50,O
Sentence: 942,mg,O
Sentence: 942,twice,O
Sentence: 942,daily,O
Sentence: 942,.,O
Sentence: 942,Her,O
Sentence: 942,delirium,B-Disease
Sentence: 942,resolved,O
Sentence: 942,3,O
Sentence: 942,days,O
Sentence: 942,later,O
Sentence: 942,.,O
Sentence: 942,DISCUSSION,O
Sentence: 942,:,O
Sentence: 942,Flecainide,B-Chemical
Sentence: 942,and,O
Sentence: 942,pharmacologically,O
Sentence: 942,similar,O
Sentence: 942,agents,O
Sentence: 942,that,O
Sentence: 942,interact,O
Sentence: 942,with,O
Sentence: 942,sodium,B-Chemical
Sentence: 942,channels,O
Sentence: 942,may,O
Sentence: 942,cause,O
Sentence: 942,delirium,B-Disease
Sentence: 942,in,O
Sentence: 942,susceptible,O
Sentence: 942,patients,O
Sentence: 942,.,O
Sentence: 942,A,O
Sentence: 942,MEDLINE,O
Sentence: 942,search,O
Sentence: 942,(,O
Sentence: 942,1966,O
Sentence: 942,-,O
Sentence: 942,January,O
Sentence: 942,2009,O
Sentence: 942,),O
Sentence: 942,revealed,O
Sentence: 942,one,O
Sentence: 942,in,O
Sentence: 942,vivo,O
Sentence: 942,pharmacokinetic,O
Sentence: 942,study,O
Sentence: 942,on,O
Sentence: 942,the,O
Sentence: 942,interaction,O
Sentence: 942,between,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,",",O
Sentence: 942,a,O
Sentence: 942,CYP2D6,O
Sentence: 942,substrate,O
Sentence: 942,",",O
Sentence: 942,and,O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,",",O
Sentence: 942,a,O
Sentence: 942,CYP2D6,O
Sentence: 942,inhibitor,O
Sentence: 942,",",O
Sentence: 942,as,O
Sentence: 942,well,O
Sentence: 942,as,O
Sentence: 942,3,O
Sentence: 942,case,O
Sentence: 942,reports,O
Sentence: 942,of,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,-,O
Sentence: 942,induced,O
Sentence: 942,delirium,B-Disease
Sentence: 942,.,O
Sentence: 942,According,O
Sentence: 942,to,O
Sentence: 942,the,O
Sentence: 942,Naranjo,O
Sentence: 942,probability,O
Sentence: 942,scale,O
Sentence: 942,",",O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,was,O
Sentence: 942,the,O
Sentence: 942,probable,O
Sentence: 942,cause,O
Sentence: 942,of,O
Sentence: 942,the,O
Sentence: 942,patient,O
Sentence: 942,'s,O
Sentence: 942,delirium,B-Disease
Sentence: 942,;,O
Sentence: 942,the,O
Sentence: 942,Horn,O
Sentence: 942,Drug,O
Sentence: 942,Interaction,O
Sentence: 942,Probability,O
Sentence: 942,Scale,O
Sentence: 942,indicates,O
Sentence: 942,a,O
Sentence: 942,possible,O
Sentence: 942,pharmacokinetic,O
Sentence: 942,drug,O
Sentence: 942,interaction,O
Sentence: 942,between,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,and,O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,.,O
Sentence: 942,CONCLUSIONS,O
Sentence: 942,:,O
Sentence: 942,Supratherapeutic,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,plasma,O
Sentence: 942,concentrations,O
Sentence: 942,may,O
Sentence: 942,cause,O
Sentence: 942,delirium,B-Disease
Sentence: 942,.,O
Sentence: 942,Because,O
Sentence: 942,toxicity,B-Disease
Sentence: 942,may,O
Sentence: 942,occur,O
Sentence: 942,when,O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,is,O
Sentence: 942,prescribed,O
Sentence: 942,with,O
Sentence: 942,paroxetine,B-Chemical
Sentence: 942,and,O
Sentence: 942,other,O
Sentence: 942,potent,O
Sentence: 942,CYP2D6,O
Sentence: 942,inhibitors,O
Sentence: 942,",",O
Sentence: 942,flecainide,B-Chemical
Sentence: 942,plasma,O
Sentence: 942,concentrations,O
Sentence: 942,should,O
Sentence: 942,be,O
Sentence: 942,monitored,O
Sentence: 942,closely,O
Sentence: 942,with,O
Sentence: 942,commencement,O
Sentence: 942,of,O
Sentence: 942,CYP2D6,O
Sentence: 942,inhibitors,O
Sentence: 942,.,O
Sentence: 943,Efficacy,O
Sentence: 943,of,O
Sentence: 943,everolimus,B-Chemical
Sentence: 943,(,O
Sentence: 943,RAD001,B-Chemical
Sentence: 943,),O
Sentence: 943,in,O
Sentence: 943,patients,O
Sentence: 943,with,O
Sentence: 943,advanced,O
Sentence: 943,NSCLC,B-Disease
Sentence: 943,previously,O
Sentence: 943,treated,O
Sentence: 943,with,O
Sentence: 943,chemotherapy,O
Sentence: 943,alone,O
Sentence: 943,or,O
Sentence: 943,with,O
Sentence: 943,chemotherapy,O
Sentence: 943,and,O
Sentence: 943,EGFR,O
Sentence: 943,inhibitors,O
Sentence: 943,.,O
Sentence: 944,BACKGROUND,O
Sentence: 944,:,O
Sentence: 944,Treatment,O
Sentence: 944,options,O
Sentence: 944,are,O
Sentence: 944,scarce,O
Sentence: 944,in,O
Sentence: 944,pretreated,O
Sentence: 944,advanced,O
Sentence: 944,non,O
Sentence: 944,-,O
Sentence: 944,small,O
Sentence: 944,-,O
Sentence: 944,cell,O
Sentence: 944,lung,O
Sentence: 944,cancer,O
Sentence: 944,(,O
Sentence: 944,NSCLC,B-Disease
Sentence: 944,),O
Sentence: 944,patients,O
Sentence: 944,.,O
Sentence: 944,RAD001,B-Chemical
Sentence: 944,",",O
Sentence: 944,an,O
Sentence: 944,oral,O
Sentence: 944,inhibitor,O
Sentence: 944,of,O
Sentence: 944,the,O
Sentence: 944,mammalian,O
Sentence: 944,target,O
Sentence: 944,of,O
Sentence: 944,rapamycin,B-Chemical
Sentence: 944,(,O
Sentence: 944,mTOR,O
Sentence: 944,),O
Sentence: 944,",",O
Sentence: 944,has,O
Sentence: 944,shown,O
Sentence: 944,phase,O
Sentence: 944,I,O
Sentence: 944,efficacy,O
Sentence: 944,in,O
Sentence: 944,NSCLC,B-Disease
Sentence: 944,.,O
Sentence: 944,METHODS,O
Sentence: 944,:,O
Sentence: 944,Stage,O
Sentence: 944,IIIb,O
Sentence: 944,or,O
Sentence: 944,IV,O
Sentence: 944,NSCLC,B-Disease
Sentence: 944,patients,O
Sentence: 944,",",O
Sentence: 944,with,O
Sentence: 944,two,O
Sentence: 944,or,O
Sentence: 944,fewer,O
Sentence: 944,prior,O
Sentence: 944,chemotherapy,O
Sentence: 944,regimens,O
Sentence: 944,",",O
Sentence: 944,one,O
Sentence: 944,platinum,B-Chemical
Sentence: 944,based,O
Sentence: 944,(,O
Sentence: 944,stratum,O
Sentence: 944,1,O
Sentence: 944,),O
Sentence: 944,or,O
Sentence: 944,both,O
Sentence: 944,chemotherapy,O
Sentence: 944,and,O
Sentence: 944,epidermal,O
Sentence: 944,growth,O
Sentence: 944,factor,O
Sentence: 944,receptor,O
Sentence: 944,tyrosine,B-Chemical
Sentence: 944,kinase,O
Sentence: 944,inhibitors,O
Sentence: 944,(,O
Sentence: 944,stratum,O
Sentence: 944,2,O
Sentence: 944,),O
Sentence: 944,",",O
Sentence: 944,received,O
Sentence: 944,RAD001,B-Chemical
Sentence: 944,10,O
Sentence: 944,mg,O
Sentence: 944,/,O
Sentence: 944,day,O
Sentence: 944,until,O
Sentence: 944,progression,O
Sentence: 944,or,O
Sentence: 944,unacceptable,O
Sentence: 944,toxicity,B-Disease
Sentence: 944,.,O
Sentence: 944,Primary,O
Sentence: 944,objective,O
Sentence: 944,was,O
Sentence: 944,overall,O
Sentence: 944,response,O
Sentence: 944,rate,O
Sentence: 944,(,O
Sentence: 944,ORR,O
Sentence: 944,),O
Sentence: 944,.,O
Sentence: 944,Analyses,O
Sentence: 944,of,O
Sentence: 944,markers,O
Sentence: 944,associated,O
Sentence: 944,with,O
Sentence: 944,the,O
Sentence: 944,mTOR,O
Sentence: 944,pathway,O
Sentence: 944,were,O
Sentence: 944,carried,O
Sentence: 944,out,O
Sentence: 944,on,O
Sentence: 944,archival,O
Sentence: 944,tumor,B-Disease
Sentence: 944,from,O
Sentence: 944,a,O
Sentence: 944,subgroup,O
Sentence: 944,using,O
Sentence: 944,immunohistochemistry,O
Sentence: 944,(,O
Sentence: 944,IHC,O
Sentence: 944,),O
Sentence: 944,and,O
Sentence: 944,direct,O
Sentence: 944,mutation,O
Sentence: 944,sequencing,O
Sentence: 944,.,O
Sentence: 944,RESULTS,O
Sentence: 944,:,O
Sentence: 944,Eighty,O
Sentence: 944,-,O
Sentence: 944,five,O
Sentence: 944,patients,O
Sentence: 944,were,O
Sentence: 944,enrolled,O
Sentence: 944,",",O
Sentence: 944,42,O
Sentence: 944,in,O
Sentence: 944,stratum,O
Sentence: 944,1,O
Sentence: 944,and,O
Sentence: 944,43,O
Sentence: 944,in,O
Sentence: 944,stratum,O
Sentence: 944,.,O
Sentence: 944,ORR,O
Sentence: 944,was,O
Sentence: 944,4.7,O
Sentence: 944,%,O
Sentence: 944,(,O
Sentence: 944,7.1,O
Sentence: 944,%,O
Sentence: 944,stratum,O
Sentence: 944,1,O
Sentence: 944,;,O
Sentence: 944,2.3,O
Sentence: 944,%,O
Sentence: 944,stratum,O
Sentence: 944,2,O
Sentence: 944,),O
Sentence: 944,.,O
Sentence: 944,Overall,O
Sentence: 944,disease,O
Sentence: 944,control,O
Sentence: 944,rate,O
Sentence: 944,was,O
Sentence: 944,47.1,O
Sentence: 944,%,O
Sentence: 944,.,O
Sentence: 944,Median,O
Sentence: 944,progression,O
Sentence: 944,-,O
Sentence: 944,free,O
Sentence: 944,survivals,O
Sentence: 944,(,O
Sentence: 944,PFSs,O
Sentence: 944,),O
Sentence: 944,were,O
Sentence: 944,2.6,O
Sentence: 944,(,O
Sentence: 944,stratum,O
Sentence: 944,1,O
Sentence: 944,),O
Sentence: 944,and,O
Sentence: 944,2.7,O
Sentence: 944,months,O
Sentence: 944,(,O
Sentence: 944,stratum,O
Sentence: 944,2,O
Sentence: 944,),O
Sentence: 944,.,O
Sentence: 944,Common,O
Sentence: 944,,O
Sentence: 944,>,O
Sentence: 944,,O
Sentence: 944,or,O
Sentence: 944,,O
Sentence: 944,=,O
Sentence: 944,grade,O
Sentence: 944,3,O
Sentence: 944,events,O
Sentence: 944,were,O
Sentence: 944,fatigue,B-Disease
Sentence: 944,",",O
Sentence: 944,dyspnea,B-Disease
Sentence: 944,",",O
Sentence: 944,stomatitis,B-Disease
Sentence: 944,",",O
Sentence: 944,anemia,B-Disease
Sentence: 944,",",O
Sentence: 944,and,O
Sentence: 944,thrombocytopenia,B-Disease
Sentence: 944,.,O
Sentence: 944,Pneumonitis,B-Disease
Sentence: 944,",",O
Sentence: 944,probably,O
Sentence: 944,or,O
Sentence: 944,possibly,O
Sentence: 944,related,O
Sentence: 944,",",O
Sentence: 944,mainly,O
Sentence: 944,grade,O
Sentence: 944,1,O
Sentence: 944,/,O
Sentence: 944,2,O
Sentence: 944,",",O
Sentence: 944,occurred,O
Sentence: 944,in,O
Sentence: 944,25,O
Sentence: 944,%,O
Sentence: 944,.,O
Sentence: 944,Cox,O
Sentence: 944,regression,O
Sentence: 944,analysis,O
Sentence: 944,of,O
Sentence: 944,IHC,O
Sentence: 944,scores,O
Sentence: 944,found,O
Sentence: 944,that,O
Sentence: 944,only,O
Sentence: 944,phospho,O
Sentence: 944,AKT,O
Sentence: 944,(,O
Sentence: 944,pAKT,O
Sentence: 944,),O
Sentence: 944,was,O
Sentence: 944,a,O
Sentence: 944,significant,O
Sentence: 944,independent,O
Sentence: 944,predictor,O
Sentence: 944,of,O
Sentence: 944,worse,O
Sentence: 944,PFS,O
Sentence: 944,.,O
Sentence: 944,CONCLUSIONS,O
Sentence: 944,:,O
Sentence: 944,RAD001,B-Chemical
Sentence: 944,10,O
Sentence: 944,mg,O
Sentence: 944,/,O
Sentence: 944,day,O
Sentence: 944,was,O
Sentence: 944,well,O
Sentence: 944,tolerated,O
Sentence: 944,",",O
Sentence: 944,showing,O
Sentence: 944,modest,O
Sentence: 944,clinical,O
Sentence: 944,activity,O
Sentence: 944,in,O
Sentence: 944,pretreated,O
Sentence: 944,NSCLC,B-Disease
Sentence: 944,.,O
Sentence: 944,Evaluation,O
Sentence: 944,of,O
Sentence: 944,RAD001,B-Chemical
Sentence: 944,plus,O
Sentence: 944,standard,O
Sentence: 944,therapy,O
Sentence: 944,for,O
Sentence: 944,metastatic,O
Sentence: 944,NSCLC,B-Disease
Sentence: 944,continues,O
Sentence: 944,.,O
Sentence: 945,Posttransplant,O
Sentence: 945,anemia,B-Disease
Sentence: 945,:,O
Sentence: 945,the,O
Sentence: 945,role,O
Sentence: 945,of,O
Sentence: 945,sirolimus,B-Chemical
Sentence: 945,.,O
Sentence: 946,Posttransplant,O
Sentence: 946,anemia,B-Disease
Sentence: 946,is,O
Sentence: 946,a,O
Sentence: 946,common,O
Sentence: 946,problem,O
Sentence: 946,that,O
Sentence: 946,may,O
Sentence: 946,hinder,O
Sentence: 946,patients,O
Sentence: 946,',O
Sentence: 946,quality,O
Sentence: 946,of,O
Sentence: 946,life,O
Sentence: 946,.,O
Sentence: 946,It,O
Sentence: 946,occurs,O
Sentence: 946,in,O
Sentence: 946,12,O
Sentence: 946,to,O
Sentence: 946,76,O
Sentence: 946,%,O
Sentence: 946,of,O
Sentence: 946,patients,O
Sentence: 946,",",O
Sentence: 946,and,O
Sentence: 946,is,O
Sentence: 946,most,O
Sentence: 946,common,O
Sentence: 946,in,O
Sentence: 946,the,O
Sentence: 946,immediate,O
Sentence: 946,posttransplant,O
Sentence: 946,period,O
Sentence: 946,.,O
Sentence: 946,A,O
Sentence: 946,variety,O
Sentence: 946,of,O
Sentence: 946,factors,O
Sentence: 946,have,O
Sentence: 946,been,O
Sentence: 946,identified,O
Sentence: 946,that,O
Sentence: 946,increase,O
Sentence: 946,the,O
Sentence: 946,risk,O
Sentence: 946,of,O
Sentence: 946,posttransplant,O
Sentence: 946,anemia,B-Disease
Sentence: 946,",",O
Sentence: 946,of,O
Sentence: 946,which,O
Sentence: 946,the,O
Sentence: 946,level,O
Sentence: 946,of,O
Sentence: 946,renal,O
Sentence: 946,function,O
Sentence: 946,is,O
Sentence: 946,most,O
Sentence: 946,important,O
Sentence: 946,.,O
Sentence: 946,Sirolimus,B-Chemical
Sentence: 946,",",O
Sentence: 946,a,O
Sentence: 946,mammalian,O
Sentence: 946,target,O
Sentence: 946,of,O
Sentence: 946,rapamycin,B-Chemical
Sentence: 946,inhibitor,O
Sentence: 946,",",O
Sentence: 946,has,O
Sentence: 946,been,O
Sentence: 946,implicated,O
Sentence: 946,as,O
Sentence: 946,playing,O
Sentence: 946,a,O
Sentence: 946,special,O
Sentence: 946,role,O
Sentence: 946,in,O
Sentence: 946,posttransplant,O
Sentence: 946,anemia,B-Disease
Sentence: 946,.,O
Sentence: 946,This,O
Sentence: 946,review,O
Sentence: 946,considers,O
Sentence: 946,anemia,B-Disease
Sentence: 946,associated,O
Sentence: 946,with,O
Sentence: 946,sirolimus,B-Chemical
Sentence: 946,",",O
Sentence: 946,including,O
Sentence: 946,its,O
Sentence: 946,presentation,O
Sentence: 946,",",O
Sentence: 946,mechanisms,O
Sentence: 946,",",O
Sentence: 946,and,O
Sentence: 946,management,O
Sentence: 946,.,O
Sentence: 947,Coronary,O
Sentence: 947,computerized,O
Sentence: 947,tomography,O
Sentence: 947,angiography,O
Sentence: 947,for,O
Sentence: 947,rapid,O
Sentence: 947,discharge,O
Sentence: 947,of,O
Sentence: 947,low,O
Sentence: 947,-,O
Sentence: 947,risk,O
Sentence: 947,patients,O
Sentence: 947,with,O
Sentence: 947,cocaine,B-Chemical
Sentence: 947,-,O
Sentence: 947,associated,O
Sentence: 947,chest,B-Disease
Sentence: 947,pain,I-Disease
Sentence: 947,.,O
Sentence: 948,BACKGROUND,O
Sentence: 948,:,O
Sentence: 948,Most,O
Sentence: 948,patients,O
Sentence: 948,presenting,O
Sentence: 948,to,O
Sentence: 948,emergency,O
Sentence: 948,departments,O
Sentence: 948,(,O
Sentence: 948,EDs,O
Sentence: 948,),O
Sentence: 948,with,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,-,O
Sentence: 948,associated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,are,O
Sentence: 948,admitted,O
Sentence: 948,for,O
Sentence: 948,at,O
Sentence: 948,least,O
Sentence: 948,12,O
Sentence: 948,hours,O
Sentence: 948,and,O
Sentence: 948,receive,O
Sentence: 948,a,O
Sentence: 948,``,O
Sentence: 948,rule,O
Sentence: 948,out,O
Sentence: 948,acute,B-Disease
Sentence: 948,coronary,I-Disease
Sentence: 948,syndrome,I-Disease
Sentence: 948,'',O
Sentence: 948,protocol,O
Sentence: 948,",",O
Sentence: 948,often,O
Sentence: 948,with,O
Sentence: 948,noninvasive,O
Sentence: 948,testing,O
Sentence: 948,prior,O
Sentence: 948,to,O
Sentence: 948,discharge,O
Sentence: 948,.,O
Sentence: 948,In,O
Sentence: 948,patients,O
Sentence: 948,without,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,use,O
Sentence: 948,",",O
Sentence: 948,coronary,O
Sentence: 948,computerized,O
Sentence: 948,tomography,O
Sentence: 948,angiography,O
Sentence: 948,(,O
Sentence: 948,CTA,O
Sentence: 948,),O
Sentence: 948,has,O
Sentence: 948,been,O
Sentence: 948,shown,O
Sentence: 948,to,O
Sentence: 948,be,O
Sentence: 948,useful,O
Sentence: 948,for,O
Sentence: 948,identifying,O
Sentence: 948,a,O
Sentence: 948,group,O
Sentence: 948,of,O
Sentence: 948,patients,O
Sentence: 948,at,O
Sentence: 948,low,O
Sentence: 948,risk,O
Sentence: 948,for,O
Sentence: 948,cardiac,O
Sentence: 948,events,O
Sentence: 948,who,O
Sentence: 948,can,O
Sentence: 948,be,O
Sentence: 948,safely,O
Sentence: 948,discharged,O
Sentence: 948,.,O
Sentence: 948,It,O
Sentence: 948,is,O
Sentence: 948,unclear,O
Sentence: 948,whether,O
Sentence: 948,a,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,strategy,O
Sentence: 948,would,O
Sentence: 948,be,O
Sentence: 948,efficacious,O
Sentence: 948,in,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,-,O
Sentence: 948,associated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,",",O
Sentence: 948,as,O
Sentence: 948,coronary,B-Disease
Sentence: 948,vasospasm,I-Disease
Sentence: 948,may,O
Sentence: 948,account,O
Sentence: 948,for,O
Sentence: 948,some,O
Sentence: 948,of,O
Sentence: 948,the,O
Sentence: 948,ischemia,B-Disease
Sentence: 948,.,O
Sentence: 948,We,O
Sentence: 948,studied,O
Sentence: 948,whether,O
Sentence: 948,a,O
Sentence: 948,negative,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,in,O
Sentence: 948,patients,O
Sentence: 948,with,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,-,O
Sentence: 948,associated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,could,O
Sentence: 948,identify,O
Sentence: 948,a,O
Sentence: 948,subset,O
Sentence: 948,safe,O
Sentence: 948,for,O
Sentence: 948,discharge,O
Sentence: 948,.,O
Sentence: 948,METHODS,O
Sentence: 948,:,O
Sentence: 948,We,O
Sentence: 948,prospectively,O
Sentence: 948,evaluated,O
Sentence: 948,the,O
Sentence: 948,safety,O
Sentence: 948,of,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,for,O
Sentence: 948,low,O
Sentence: 948,-,O
Sentence: 948,risk,O
Sentence: 948,patients,O
Sentence: 948,who,O
Sentence: 948,presented,O
Sentence: 948,to,O
Sentence: 948,the,O
Sentence: 948,ED,O
Sentence: 948,with,O
Sentence: 948,cocaineassociated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,(,O
Sentence: 948,self,O
Sentence: 948,-,O
Sentence: 948,reported,O
Sentence: 948,or,O
Sentence: 948,positive,O
Sentence: 948,urine,O
Sentence: 948,test,O
Sentence: 948,),O
Sentence: 948,.,O
Sentence: 948,Consecutive,O
Sentence: 948,patients,O
Sentence: 948,received,O
Sentence: 948,either,O
Sentence: 948,immediate,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,in,O
Sentence: 948,the,O
Sentence: 948,ED,O
Sentence: 948,(,O
Sentence: 948,without,O
Sentence: 948,serial,O
Sentence: 948,markers,O
Sentence: 948,),O
Sentence: 948,or,O
Sentence: 948,underwent,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,after,O
Sentence: 948,a,O
Sentence: 948,brief,O
Sentence: 948,observation,O
Sentence: 948,period,O
Sentence: 948,with,O
Sentence: 948,serial,O
Sentence: 948,cardiac,O
Sentence: 948,marker,O
Sentence: 948,measurements,O
Sentence: 948,.,O
Sentence: 948,Patients,O
Sentence: 948,with,O
Sentence: 948,negative,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,(,O
Sentence: 948,maximal,O
Sentence: 948,stenosis,B-Disease
Sentence: 948,less,O
Sentence: 948,than,O
Sentence: 948,50,O
Sentence: 948,%,O
Sentence: 948,),O
Sentence: 948,were,O
Sentence: 948,discharged,O
Sentence: 948,.,O
Sentence: 948,The,O
Sentence: 948,main,O
Sentence: 948,outcome,O
Sentence: 948,was,O
Sentence: 948,30,O
Sentence: 948,-,O
Sentence: 948,day,O
Sentence: 948,cardiovascular,O
Sentence: 948,death,O
Sentence: 948,or,O
Sentence: 948,myocardial,B-Disease
Sentence: 948,infarction,I-Disease
Sentence: 948,.,O
Sentence: 948,RESULTS,O
Sentence: 948,:,O
Sentence: 948,A,O
Sentence: 948,total,O
Sentence: 948,of,O
Sentence: 948,59,O
Sentence: 948,patients,O
Sentence: 948,with,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,-,O
Sentence: 948,associated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,were,O
Sentence: 948,evaluated,O
Sentence: 948,.,O
Sentence: 948,Patients,O
Sentence: 948,had,O
Sentence: 948,a,O
Sentence: 948,mean,O
Sentence: 948,age,O
Sentence: 948,of,O
Sentence: 948,45.6,O
Sentence: 948,+,O
Sentence: 948,/,O
Sentence: 948,,O
Sentence: 948,-,O
Sentence: 948,,O
Sentence: 948,6.6,O
Sentence: 948,yrs,O
Sentence: 948,and,O
Sentence: 948,were,O
Sentence: 948,86,O
Sentence: 948,%,O
Sentence: 948,black,O
Sentence: 948,",",O
Sentence: 948,66,O
Sentence: 948,%,O
Sentence: 948,male,O
Sentence: 948,.,O
Sentence: 948,Seventy,O
Sentence: 948,-,O
Sentence: 948,nine,O
Sentence: 948,percent,O
Sentence: 948,had,O
Sentence: 948,a,O
Sentence: 948,normal,O
Sentence: 948,or,O
Sentence: 948,nonspecific,O
Sentence: 948,ECG,O
Sentence: 948,and,O
Sentence: 948,85,O
Sentence: 948,%,O
Sentence: 948,had,O
Sentence: 948,a,O
Sentence: 948,TIMI,O
Sentence: 948,score,O
Sentence: 948,,O
Sentence: 948,<,O
Sentence: 948,,O
Sentence: 948,2,O
Sentence: 948,.,O
Sentence: 948,Twenty,O
Sentence: 948,patients,O
Sentence: 948,received,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,immediately,O
Sentence: 948,in,O
Sentence: 948,the,O
Sentence: 948,ED,O
Sentence: 948,",",O
Sentence: 948,18,O
Sentence: 948,of,O
Sentence: 948,whom,O
Sentence: 948,were,O
Sentence: 948,discharged,O
Sentence: 948,following,O
Sentence: 948,CTA,O
Sentence: 948,(,O
Sentence: 948,90,O
Sentence: 948,%,O
Sentence: 948,),O
Sentence: 948,.,O
Sentence: 948,Thirty,O
Sentence: 948,-,O
Sentence: 948,nine,O
Sentence: 948,received,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,after,O
Sentence: 948,a,O
Sentence: 948,brief,O
Sentence: 948,observation,O
Sentence: 948,period,O
Sentence: 948,",",O
Sentence: 948,with,O
Sentence: 948,37,O
Sentence: 948,discharged,O
Sentence: 948,home,O
Sentence: 948,following,O
Sentence: 948,CTA,O
Sentence: 948,(,O
Sentence: 948,95,O
Sentence: 948,%,O
Sentence: 948,),O
Sentence: 948,.,O
Sentence: 948,Six,O
Sentence: 948,patients,O
Sentence: 948,had,O
Sentence: 948,coronary,B-Disease
Sentence: 948,stenosis,I-Disease
Sentence: 948,,O
Sentence: 948,>,O
Sentence: 948,,O
Sentence: 948,or,O
Sentence: 948,=,O
Sentence: 948,50,O
Sentence: 948,%,O
Sentence: 948,.,O
Sentence: 948,During,O
Sentence: 948,the,O
Sentence: 948,30,O
Sentence: 948,-,O
Sentence: 948,day,O
Sentence: 948,follow,O
Sentence: 948,-,O
Sentence: 948,up,O
Sentence: 948,period,O
Sentence: 948,",",O
Sentence: 948,no,O
Sentence: 948,patients,O
Sentence: 948,died,O
Sentence: 948,of,O
Sentence: 948,a,O
Sentence: 948,cardiovascular,O
Sentence: 948,event,O
Sentence: 948,(,O
Sentence: 948,0,O
Sentence: 948,%,O
Sentence: 948,;,O
Sentence: 948,95,O
Sentence: 948,%,O
Sentence: 948,CI,O
Sentence: 948,",",O
Sentence: 948,0,O
Sentence: 948,-,O
Sentence: 948,6.1,O
Sentence: 948,%,O
Sentence: 948,),O
Sentence: 948,and,O
Sentence: 948,no,O
Sentence: 948,patient,O
Sentence: 948,sustained,O
Sentence: 948,a,O
Sentence: 948,nonfatal,O
Sentence: 948,myocardial,B-Disease
Sentence: 948,infarction,I-Disease
Sentence: 948,(,O
Sentence: 948,0,O
Sentence: 948,%,O
Sentence: 948,;,O
Sentence: 948,95,O
Sentence: 948,%,O
Sentence: 948,CI,O
Sentence: 948,",",O
Sentence: 948,0,O
Sentence: 948,-,O
Sentence: 948,6.1,O
Sentence: 948,%,O
Sentence: 948,),O
Sentence: 948,.,O
Sentence: 948,CONCLUSIONS,O
Sentence: 948,:,O
Sentence: 948,Although,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,-,O
Sentence: 948,associated,O
Sentence: 948,myocardial,B-Disease
Sentence: 948,ischemia,I-Disease
Sentence: 948,can,O
Sentence: 948,result,O
Sentence: 948,from,O
Sentence: 948,coronary,O
Sentence: 948,vasoconstriction,O
Sentence: 948,",",O
Sentence: 948,patients,O
Sentence: 948,with,O
Sentence: 948,cocaine,B-Chemical
Sentence: 948,associated,O
Sentence: 948,chest,B-Disease
Sentence: 948,pain,I-Disease
Sentence: 948,",",O
Sentence: 948,a,O
Sentence: 948,non,O
Sentence: 948,-,O
Sentence: 948,ischemic,B-Disease
Sentence: 948,ECG,O
Sentence: 948,",",O
Sentence: 948,and,O
Sentence: 948,a,O
Sentence: 948,TIMI,O
Sentence: 948,risk,O
Sentence: 948,score,O
Sentence: 948,,O
Sentence: 948,<,O
Sentence: 948,,O
Sentence: 948,2,O
Sentence: 948,may,O
Sentence: 948,be,O
Sentence: 948,safely,O
Sentence: 948,discharged,O
Sentence: 948,from,O
Sentence: 948,the,O
Sentence: 948,ED,O
Sentence: 948,after,O
Sentence: 948,a,O
Sentence: 948,negative,O
Sentence: 948,coronary,O
Sentence: 948,CTA,O
Sentence: 948,with,O
Sentence: 948,a,O
Sentence: 948,low,O
Sentence: 948,risk,O
Sentence: 948,of,O
Sentence: 948,30,O
Sentence: 948,-,O
Sentence: 948,day,O
Sentence: 948,adverse,O
Sentence: 948,events,O
Sentence: 948,.,O
Sentence: 949,Late,O
Sentence: 949,fulminant,O
Sentence: 949,posterior,O
Sentence: 949,reversible,O
Sentence: 949,encephalopathy,O
Sentence: 949,syndrome,O
Sentence: 949,after,O
Sentence: 949,liver,O
Sentence: 949,transplant,O
Sentence: 949,.,O
Sentence: 950,OBJECTIVES,O
Sentence: 950,:,O
Sentence: 950,Posterior,B-Disease
Sentence: 950,leukoencephalopathy,I-Disease
Sentence: 950,due,O
Sentence: 950,to,O
Sentence: 950,calcineurin,O
Sentence: 950,-,O
Sentence: 950,inhibitor,O
Sentence: 950,-,O
Sentence: 950,related,O
Sentence: 950,neurotoxicity,B-Disease
Sentence: 950,is,O
Sentence: 950,a,O
Sentence: 950,rare,O
Sentence: 950,but,O
Sentence: 950,severe,O
Sentence: 950,complication,O
Sentence: 950,that,O
Sentence: 950,results,O
Sentence: 950,from,O
Sentence: 950,treatment,O
Sentence: 950,with,O
Sentence: 950,immunosuppressive,O
Sentence: 950,agents,O
Sentence: 950,(,O
Sentence: 950,primarily,O
Sentence: 950,those,O
Sentence: 950,administered,O
Sentence: 950,after,O
Sentence: 950,a,O
Sentence: 950,liver,O
Sentence: 950,or,O
Sentence: 950,kidney,O
Sentence: 950,transplant,O
Sentence: 950,),O
Sentence: 950,.,O
Sentence: 950,The,O
Sentence: 950,pathophysiologic,O
Sentence: 950,mechanisms,O
Sentence: 950,of,O
Sentence: 950,that,O
Sentence: 950,disorder,O
Sentence: 950,remain,O
Sentence: 950,unknown,O
Sentence: 950,.,O
Sentence: 950,CASE,O
Sentence: 950,:,O
Sentence: 950,We,O
Sentence: 950,report,O
Sentence: 950,the,O
Sentence: 950,case,O
Sentence: 950,of,O
Sentence: 950,a,O
Sentence: 950,46,O
Sentence: 950,-,O
Sentence: 950,year,O
Sentence: 950,-,O
Sentence: 950,old,O
Sentence: 950,woman,O
Sentence: 950,who,O
Sentence: 950,received,O
Sentence: 950,a,O
Sentence: 950,liver,O
Sentence: 950,transplant,O
Sentence: 950,in,O
Sentence: 950,our,O
Sentence: 950,center,O
Sentence: 950,as,O
Sentence: 950,treatment,O
Sentence: 950,for,O
Sentence: 950,alcoholic,B-Disease
Sentence: 950,cirrhosis,I-Disease
Sentence: 950,and,O
Sentence: 950,in,O
Sentence: 950,whom,O
Sentence: 950,either,O
Sentence: 950,a,O
Sentence: 950,fulminant,O
Sentence: 950,course,O
Sentence: 950,of,O
Sentence: 950,posterior,B-Disease
Sentence: 950,leukoencephalopathy,I-Disease
Sentence: 950,or,O
Sentence: 950,posterior,B-Disease
Sentence: 950,reversible,I-Disease
Sentence: 950,encephalopathy,I-Disease
Sentence: 950,syndrome,I-Disease
Sentence: 950,developed,O
Sentence: 950,110,O
Sentence: 950,days,O
Sentence: 950,after,O
Sentence: 950,transplant,O
Sentence: 950,.,O
Sentence: 950,After,O
Sentence: 950,an,O
Sentence: 950,initially,O
Sentence: 950,uneventful,O
Sentence: 950,course,O
Sentence: 950,after,O
Sentence: 950,the,O
Sentence: 950,transplant,O
Sentence: 950,",",O
Sentence: 950,the,O
Sentence: 950,patient,O
Sentence: 950,rapidly,O
Sentence: 950,fell,O
Sentence: 950,into,O
Sentence: 950,deep,O
Sentence: 950,coma,O
Sentence: 950,.,O
Sentence: 950,RESULTS,O
Sentence: 950,:,O
Sentence: 950,Cerebral,O
Sentence: 950,MRI,O
Sentence: 950,scan,O
Sentence: 950,showed,O
Sentence: 950,typical,O
Sentence: 950,signs,O
Sentence: 950,of,O
Sentence: 950,enhancement,O
Sentence: 950,in,O
Sentence: 950,the,O
Sentence: 950,pontine,O
Sentence: 950,and,O
Sentence: 950,posterior,O
Sentence: 950,regions,O
Sentence: 950,.,O
Sentence: 950,Switching,O
Sentence: 950,the,O
Sentence: 950,immunosuppressive,O
Sentence: 950,regimen,O
Sentence: 950,from,O
Sentence: 950,tacrolimus,B-Chemical
Sentence: 950,to,O
Sentence: 950,cyclosporine,B-Chemical
Sentence: 950,did,O
Sentence: 950,not,O
Sentence: 950,improve,O
Sentence: 950,the,O
Sentence: 950,clinical,O
Sentence: 950,situation,O
Sentence: 950,.,O
Sentence: 950,The,O
Sentence: 950,termination,O
Sentence: 950,of,O
Sentence: 950,treatment,O
Sentence: 950,with,O
Sentence: 950,any,O
Sentence: 950,calcineurin,O
Sentence: 950,inhibitor,O
Sentence: 950,resulted,O
Sentence: 950,in,O
Sentence: 950,a,O
Sentence: 950,complete,O
Sentence: 950,resolution,O
Sentence: 950,of,O
Sentence: 950,that,O
Sentence: 950,complication,O
Sentence: 950,.,O
Sentence: 950,CONCLUSIONS,O
Sentence: 950,:,O
Sentence: 950,Posterior,B-Disease
Sentence: 950,reversible,I-Disease
Sentence: 950,encephalopathy,I-Disease
Sentence: 950,syndrome,I-Disease
Sentence: 950,after,O
Sentence: 950,liver,O
Sentence: 950,transplant,O
Sentence: 950,is,O
Sentence: 950,rare,O
Sentence: 950,.,O
Sentence: 950,We,O
Sentence: 950,recommend,O
Sentence: 950,a,O
Sentence: 950,complete,O
Sentence: 950,cessation,O
Sentence: 950,of,O
Sentence: 950,any,O
Sentence: 950,calcineurin,O
Sentence: 950,inhibitor,O
Sentence: 950,rather,O
Sentence: 950,than,O
Sentence: 950,a,O
Sentence: 950,dose,O
Sentence: 950,reduction,O
Sentence: 950,.,O
Sentence: 951,Prolonged,O
Sentence: 951,hypothermia,B-Disease
Sentence: 951,as,O
Sentence: 951,a,O
Sentence: 951,bridge,O
Sentence: 951,to,O
Sentence: 951,recovery,O
Sentence: 951,for,O
Sentence: 951,cerebral,B-Disease
Sentence: 951,edema,I-Disease
Sentence: 951,and,O
Sentence: 951,intracranial,B-Disease
Sentence: 951,hypertension,I-Disease
Sentence: 951,associated,O
Sentence: 951,with,O
Sentence: 951,fulminant,B-Disease
Sentence: 951,hepatic,I-Disease
Sentence: 951,failure,I-Disease
Sentence: 951,.,O
Sentence: 952,BACKGROUND,O
Sentence: 952,:,O
Sentence: 952,To,O
Sentence: 952,review,O
Sentence: 952,evidence,O
Sentence: 952,-,O
Sentence: 952,based,O
Sentence: 952,treatment,O
Sentence: 952,options,O
Sentence: 952,in,O
Sentence: 952,patients,O
Sentence: 952,with,O
Sentence: 952,cerebral,B-Disease
Sentence: 952,edema,I-Disease
Sentence: 952,complicating,O
Sentence: 952,fulminant,B-Disease
Sentence: 952,hepatic,I-Disease
Sentence: 952,failure,I-Disease
Sentence: 952,(,O
Sentence: 952,FHF,B-Disease
Sentence: 952,),O
Sentence: 952,and,O
Sentence: 952,discuss,O
Sentence: 952,the,O
Sentence: 952,potential,O
Sentence: 952,applications,O
Sentence: 952,of,O
Sentence: 952,hypothermia,B-Disease
Sentence: 952,.,O
Sentence: 952,METHOD,O
Sentence: 952,:,O
Sentence: 952,Case,O
Sentence: 952,-,O
Sentence: 952,based,O
Sentence: 952,observations,O
Sentence: 952,from,O
Sentence: 952,a,O
Sentence: 952,medical,O
Sentence: 952,intensive,O
Sentence: 952,care,O
Sentence: 952,unit,O
Sentence: 952,(,O
Sentence: 952,MICU,O
Sentence: 952,),O
Sentence: 952,in,O
Sentence: 952,a,O
Sentence: 952,tertiary,O
Sentence: 952,care,O
Sentence: 952,facility,O
Sentence: 952,in,O
Sentence: 952,a,O
Sentence: 952,27,O
Sentence: 952,-,O
Sentence: 952,year,O
Sentence: 952,-,O
Sentence: 952,old,O
Sentence: 952,female,O
Sentence: 952,with,O
Sentence: 952,FHF,B-Disease
Sentence: 952,from,O
Sentence: 952,acetaminophen,B-Chemical
Sentence: 952,and,O
Sentence: 952,resultant,O
Sentence: 952,cerebral,B-Disease
Sentence: 952,edema,I-Disease
Sentence: 952,.,O
Sentence: 952,RESULTS,O
Sentence: 952,:,O
Sentence: 952,Our,O
Sentence: 952,patient,O
Sentence: 952,was,O
Sentence: 952,admitted,O
Sentence: 952,to,O
Sentence: 952,the,O
Sentence: 952,MICU,O
Sentence: 952,after,O
Sentence: 952,being,O
Sentence: 952,found,O
Sentence: 952,unresponsive,O
Sentence: 952,with,O
Sentence: 952,presumed,O
Sentence: 952,toxicity,B-Disease
Sentence: 952,from,O
Sentence: 952,acetaminophen,B-Chemical
Sentence: 952,which,O
Sentence: 952,was,O
Sentence: 952,ingested,O
Sentence: 952,over,O
Sentence: 952,a,O
Sentence: 952,2,O
Sentence: 952,-,O
Sentence: 952,day,O
Sentence: 952,period,O
Sentence: 952,.,O
Sentence: 952,The,O
Sentence: 952,patient,O
Sentence: 952,had,O
Sentence: 952,depressed,O
Sentence: 952,of,O
Sentence: 952,mental,O
Sentence: 952,status,O
Sentence: 952,lasting,O
Sentence: 952,at,O
Sentence: 952,least,O
Sentence: 952,24,O
Sentence: 952,h,O
Sentence: 952,prior,O
Sentence: 952,to,O
Sentence: 952,admission,O
Sentence: 952,.,O
Sentence: 952,Initial,O
Sentence: 952,evaluation,O
Sentence: 952,confirmed,O
Sentence: 952,FHF,B-Disease
Sentence: 952,from,O
Sentence: 952,acetaminophen,B-Chemical
Sentence: 952,and,O
Sentence: 952,cerebral,B-Disease
Sentence: 952,edema,I-Disease
Sentence: 952,.,O
Sentence: 952,The,O
Sentence: 952,patient,O
Sentence: 952,was,O
Sentence: 952,treated,O
Sentence: 952,with,O
Sentence: 952,hyperosmolar,O
Sentence: 952,therapy,O
Sentence: 952,",",O
Sentence: 952,hyperventilation,B-Disease
Sentence: 952,",",O
Sentence: 952,sedation,O
Sentence: 952,",",O
Sentence: 952,and,O
Sentence: 952,chemical,O
Sentence: 952,paralysis,B-Disease
Sentence: 952,.,O
Sentence: 952,Her,O
Sentence: 952,intracranial,O
Sentence: 952,pressure,O
Sentence: 952,remained,O
Sentence: 952,elevated,O
Sentence: 952,despite,O
Sentence: 952,maximal,O
Sentence: 952,medical,O
Sentence: 952,therapy,O
Sentence: 952,.,O
Sentence: 952,We,O
Sentence: 952,then,O
Sentence: 952,initiated,O
Sentence: 952,therapeutic,O
Sentence: 952,hypothermia,B-Disease
Sentence: 952,which,O
Sentence: 952,was,O
Sentence: 952,continued,O
Sentence: 952,for,O
Sentence: 952,5,O
Sentence: 952,days,O
Sentence: 952,.,O
Sentence: 952,At,O
Sentence: 952,re,O
Sentence: 952,-,O
Sentence: 952,warming,O
Sentence: 952,",",O
Sentence: 952,patient,O
Sentence: 952,had,O
Sentence: 952,resolution,O
Sentence: 952,of,O
Sentence: 952,her,O
Sentence: 952,cerebral,B-Disease
Sentence: 952,edema,I-Disease
Sentence: 952,and,O
Sentence: 952,intracranial,B-Disease
Sentence: 952,hypertension,I-Disease
Sentence: 952,.,O
Sentence: 952,At,O
Sentence: 952,discharge,O
Sentence: 952,",",O
Sentence: 952,she,O
Sentence: 952,had,O
Sentence: 952,complete,O
Sentence: 952,recovery,O
Sentence: 952,of,O
Sentence: 952,neurological,O
Sentence: 952,and,O
Sentence: 952,hepatic,O
Sentence: 952,functions,O
Sentence: 952,.,O
Sentence: 952,CONCLUSION,O
Sentence: 952,:,O
Sentence: 952,In,O
Sentence: 952,patients,O
Sentence: 952,with,O
Sentence: 952,FHF,B-Disease
Sentence: 952,and,O
Sentence: 952,cerebral,B-Disease
Sentence: 952,edema,I-Disease
Sentence: 952,from,O
Sentence: 952,acetaminophen,B-Chemical
Sentence: 952,overdose,B-Disease
Sentence: 952,",",O
Sentence: 952,prolonged,O
Sentence: 952,therapeutic,O
Sentence: 952,hypothermia,B-Disease
Sentence: 952,could,O
Sentence: 952,potentially,O
Sentence: 952,be,O
Sentence: 952,used,O
Sentence: 952,as,O
Sentence: 952,a,O
Sentence: 952,life,O
Sentence: 952,saving,O
Sentence: 952,therapy,O
Sentence: 952,and,O
Sentence: 952,a,O
Sentence: 952,bridge,O
Sentence: 952,to,O
Sentence: 952,hepatic,O
Sentence: 952,and,O
Sentence: 952,neurological,O
Sentence: 952,recovery,O
Sentence: 952,.,O
Sentence: 952,A,O
Sentence: 952,clinical,O
Sentence: 952,trial,O
Sentence: 952,of,O
Sentence: 952,hypothermia,B-Disease
Sentence: 952,in,O
Sentence: 952,patients,O
Sentence: 952,with,O
Sentence: 952,this,O
Sentence: 952,condition,O
Sentence: 952,is,O
Sentence: 952,warranted,O
Sentence: 952,.,O
Sentence: 953,Binasal,B-Disease
Sentence: 953,visual,I-Disease
Sentence: 953,field,I-Disease
Sentence: 953,defects,I-Disease
Sentence: 953,are,O
Sentence: 953,not,O
Sentence: 953,specific,O
Sentence: 953,to,O
Sentence: 953,vigabatrin,B-Chemical
Sentence: 953,.,O
Sentence: 954,This,O
Sentence: 954,study,O
Sentence: 954,investigated,O
Sentence: 954,the,O
Sentence: 954,visual,B-Disease
Sentence: 954,defects,I-Disease
Sentence: 954,associated,O
Sentence: 954,with,O
Sentence: 954,the,O
Sentence: 954,antiepileptic,O
Sentence: 954,drug,O
Sentence: 954,vigabatrin,B-Chemical
Sentence: 954,(,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,),O
Sentence: 954,.,O
Sentence: 954,Two,O
Sentence: 954,hundred,O
Sentence: 954,four,O
Sentence: 954,people,O
Sentence: 954,with,O
Sentence: 954,epilepsy,B-Disease
Sentence: 954,were,O
Sentence: 954,grouped,O
Sentence: 954,on,O
Sentence: 954,the,O
Sentence: 954,basis,O
Sentence: 954,of,O
Sentence: 954,antiepileptic,O
Sentence: 954,drug,O
Sentence: 954,therapy,O
Sentence: 954,(,O
Sentence: 954,current,O
Sentence: 954,",",O
Sentence: 954,previous,O
Sentence: 954,",",O
Sentence: 954,or,O
Sentence: 954,no,O
Sentence: 954,exposure,O
Sentence: 954,to,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,),O
Sentence: 954,.,O
Sentence: 954,Groups,O
Sentence: 954,were,O
Sentence: 954,matched,O
Sentence: 954,with,O
Sentence: 954,respect,O
Sentence: 954,to,O
Sentence: 954,age,O
Sentence: 954,",",O
Sentence: 954,gender,O
Sentence: 954,",",O
Sentence: 954,and,O
Sentence: 954,seizure,B-Disease
Sentence: 954,frequency,O
Sentence: 954,.,O
Sentence: 954,All,O
Sentence: 954,patients,O
Sentence: 954,underwent,O
Sentence: 954,objective,O
Sentence: 954,assessment,O
Sentence: 954,of,O
Sentence: 954,electrophysiological,O
Sentence: 954,function,O
Sentence: 954,(,O
Sentence: 954,wide,O
Sentence: 954,-,O
Sentence: 954,field,O
Sentence: 954,multifocal,O
Sentence: 954,electroretinography,O
Sentence: 954,),O
Sentence: 954,and,O
Sentence: 954,conventional,O
Sentence: 954,visual,O
Sentence: 954,field,O
Sentence: 954,testing,O
Sentence: 954,(,O
Sentence: 954,static,O
Sentence: 954,perimetry,O
Sentence: 954,),O
Sentence: 954,.,O
Sentence: 954,Bilateral,O
Sentence: 954,visual,O
Sentence: 954,field,O
Sentence: 954,constriction,O
Sentence: 954,was,O
Sentence: 954,observed,O
Sentence: 954,in,O
Sentence: 954,59,O
Sentence: 954,%,O
Sentence: 954,of,O
Sentence: 954,patients,O
Sentence: 954,currently,O
Sentence: 954,taking,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,",",O
Sentence: 954,43,O
Sentence: 954,%,O
Sentence: 954,of,O
Sentence: 954,patients,O
Sentence: 954,who,O
Sentence: 954,previously,O
Sentence: 954,took,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,",",O
Sentence: 954,and,O
Sentence: 954,24,O
Sentence: 954,%,O
Sentence: 954,of,O
Sentence: 954,patients,O
Sentence: 954,with,O
Sentence: 954,no,O
Sentence: 954,exposure,O
Sentence: 954,to,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,.,O
Sentence: 954,Assessment,O
Sentence: 954,of,O
Sentence: 954,retinal,O
Sentence: 954,function,O
Sentence: 954,revealed,O
Sentence: 954,abnormal,O
Sentence: 954,responses,O
Sentence: 954,in,O
Sentence: 954,48,O
Sentence: 954,%,O
Sentence: 954,of,O
Sentence: 954,current,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,users,O
Sentence: 954,and,O
Sentence: 954,22,O
Sentence: 954,%,O
Sentence: 954,of,O
Sentence: 954,prior,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,users,O
Sentence: 954,",",O
Sentence: 954,but,O
Sentence: 954,in,O
Sentence: 954,none,O
Sentence: 954,of,O
Sentence: 954,the,O
Sentence: 954,patients,O
Sentence: 954,without,O
Sentence: 954,previous,O
Sentence: 954,exposure,O
Sentence: 954,to,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,.,O
Sentence: 954,Bilateral,B-Disease
Sentence: 954,visual,I-Disease
Sentence: 954,field,I-Disease
Sentence: 954,abnormalities,I-Disease
Sentence: 954,are,O
Sentence: 954,common,O
Sentence: 954,in,O
Sentence: 954,the,O
Sentence: 954,treated,O
Sentence: 954,epilepsy,B-Disease
Sentence: 954,population,O
Sentence: 954,",",O
Sentence: 954,irrespective,O
Sentence: 954,of,O
Sentence: 954,drug,O
Sentence: 954,history,O
Sentence: 954,.,O
Sentence: 954,Assessment,O
Sentence: 954,by,O
Sentence: 954,conventional,O
Sentence: 954,static,O
Sentence: 954,perimetry,O
Sentence: 954,may,O
Sentence: 954,neither,O
Sentence: 954,be,O
Sentence: 954,sufficiently,O
Sentence: 954,sensitive,O
Sentence: 954,nor,O
Sentence: 954,specific,O
Sentence: 954,to,O
Sentence: 954,reliably,O
Sentence: 954,identify,O
Sentence: 954,retinal,B-Disease
Sentence: 954,toxicity,I-Disease
Sentence: 954,associated,O
Sentence: 954,with,O
Sentence: 954,VGB,B-Chemical
Sentence: 954,.,O
Sentence: 955,Smoking,O
Sentence: 955,of,O
Sentence: 955,crack,B-Chemical
Sentence: 955,cocaine,I-Chemical
Sentence: 955,as,O
Sentence: 955,a,O
Sentence: 955,risk,O
Sentence: 955,factor,O
Sentence: 955,for,O
Sentence: 955,HIV,B-Disease
Sentence: 955,infection,I-Disease
Sentence: 955,among,O
Sentence: 955,people,O
Sentence: 955,who,O
Sentence: 955,use,O
Sentence: 955,injection,O
Sentence: 955,drugs,O
Sentence: 955,.,O
Sentence: 956,BACKGROUND,O
Sentence: 956,:,O
Sentence: 956,Little,O
Sentence: 956,is,O
Sentence: 956,known,O
Sentence: 956,about,O
Sentence: 956,the,O
Sentence: 956,possible,O
Sentence: 956,role,O
Sentence: 956,that,O
Sentence: 956,smoking,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,has,O
Sentence: 956,on,O
Sentence: 956,the,O
Sentence: 956,incidence,O
Sentence: 956,of,O
Sentence: 956,HIV,B-Disease
Sentence: 956,infection,I-Disease
Sentence: 956,.,O
Sentence: 956,Given,O
Sentence: 956,the,O
Sentence: 956,increasing,O
Sentence: 956,use,O
Sentence: 956,of,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,",",O
Sentence: 956,we,O
Sentence: 956,sought,O
Sentence: 956,to,O
Sentence: 956,examine,O
Sentence: 956,whether,O
Sentence: 956,use,O
Sentence: 956,of,O
Sentence: 956,this,O
Sentence: 956,illicit,O
Sentence: 956,drug,O
Sentence: 956,has,O
Sentence: 956,become,O
Sentence: 956,a,O
Sentence: 956,risk,O
Sentence: 956,factor,O
Sentence: 956,for,O
Sentence: 956,HIV,B-Disease
Sentence: 956,infection,I-Disease
Sentence: 956,.,O
Sentence: 956,METHODS,O
Sentence: 956,:,O
Sentence: 956,We,O
Sentence: 956,included,O
Sentence: 956,data,O
Sentence: 956,from,O
Sentence: 956,people,O
Sentence: 956,participating,O
Sentence: 956,in,O
Sentence: 956,the,O
Sentence: 956,Vancouver,O
Sentence: 956,Injection,O
Sentence: 956,Drug,O
Sentence: 956,Users,O
Sentence: 956,Study,O
Sentence: 956,who,O
Sentence: 956,reported,O
Sentence: 956,injecting,O
Sentence: 956,illicit,O
Sentence: 956,drugs,O
Sentence: 956,at,O
Sentence: 956,least,O
Sentence: 956,once,O
Sentence: 956,in,O
Sentence: 956,the,O
Sentence: 956,month,O
Sentence: 956,before,O
Sentence: 956,enrolment,O
Sentence: 956,",",O
Sentence: 956,lived,O
Sentence: 956,in,O
Sentence: 956,the,O
Sentence: 956,greater,O
Sentence: 956,Vancouver,O
Sentence: 956,area,O
Sentence: 956,",",O
Sentence: 956,were,O
Sentence: 956,HIV,O
Sentence: 956,-,O
Sentence: 956,negative,O
Sentence: 956,at,O
Sentence: 956,enrolment,O
Sentence: 956,and,O
Sentence: 956,completed,O
Sentence: 956,at,O
Sentence: 956,least,O
Sentence: 956,1,O
Sentence: 956,follow,O
Sentence: 956,-,O
Sentence: 956,up,O
Sentence: 956,study,O
Sentence: 956,visit,O
Sentence: 956,.,O
Sentence: 956,To,O
Sentence: 956,determine,O
Sentence: 956,whether,O
Sentence: 956,the,O
Sentence: 956,risk,O
Sentence: 956,of,O
Sentence: 956,HIV,B-Disease
Sentence: 956,seroconversion,I-Disease
Sentence: 956,among,O
Sentence: 956,daily,O
Sentence: 956,smokers,O
Sentence: 956,of,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,changed,O
Sentence: 956,over,O
Sentence: 956,time,O
Sentence: 956,",",O
Sentence: 956,we,O
Sentence: 956,used,O
Sentence: 956,Cox,O
Sentence: 956,proportional,O
Sentence: 956,hazards,O
Sentence: 956,regression,O
Sentence: 956,and,O
Sentence: 956,divided,O
Sentence: 956,the,O
Sentence: 956,study,O
Sentence: 956,into,O
Sentence: 956,3,O
Sentence: 956,periods,O
Sentence: 956,:,O
Sentence: 956,May,O
Sentence: 956,1,O
Sentence: 956,",",O
Sentence: 956,1996,O
Sentence: 956,-,O
Sentence: 956,Nov.,O
Sentence: 956,30,O
Sentence: 956,",",O
Sentence: 956,1999,O
Sentence: 956,(,O
Sentence: 956,period,O
Sentence: 956,1,O
Sentence: 956,),O
Sentence: 956,",",O
Sentence: 956,Dec.,O
Sentence: 956,1,O
Sentence: 956,",",O
Sentence: 956,1999,O
Sentence: 956,-,O
Sentence: 956,Nov.,O
Sentence: 956,30,O
Sentence: 956,",",O
Sentence: 956,2002,O
Sentence: 956,(,O
Sentence: 956,period,O
Sentence: 956,2,O
Sentence: 956,),O
Sentence: 956,",",O
Sentence: 956,and,O
Sentence: 956,Dec.,O
Sentence: 956,1,O
Sentence: 956,",",O
Sentence: 956,2002,O
Sentence: 956,-,O
Sentence: 956,Dec.,O
Sentence: 956,30,O
Sentence: 956,",",O
Sentence: 956,2005,O
Sentence: 956,(,O
Sentence: 956,period,O
Sentence: 956,3,O
Sentence: 956,),O
Sentence: 956,.,O
Sentence: 956,RESULTS,O
Sentence: 956,:,O
Sentence: 956,Overall,O
Sentence: 956,",",O
Sentence: 956,1048,O
Sentence: 956,eligible,O
Sentence: 956,injection,O
Sentence: 956,drug,O
Sentence: 956,users,O
Sentence: 956,were,O
Sentence: 956,included,O
Sentence: 956,in,O
Sentence: 956,our,O
Sentence: 956,study,O
Sentence: 956,.,O
Sentence: 956,Of,O
Sentence: 956,these,O
Sentence: 956,",",O
Sentence: 956,137,O
Sentence: 956,acquired,O
Sentence: 956,HIV,B-Disease
Sentence: 956,infection,I-Disease
Sentence: 956,during,O
Sentence: 956,follow,O
Sentence: 956,-,O
Sentence: 956,up,O
Sentence: 956,.,O
Sentence: 956,The,O
Sentence: 956,mean,O
Sentence: 956,proportion,O
Sentence: 956,of,O
Sentence: 956,participants,O
Sentence: 956,who,O
Sentence: 956,reported,O
Sentence: 956,daily,O
Sentence: 956,smoking,O
Sentence: 956,of,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,increased,O
Sentence: 956,from,O
Sentence: 956,11.6,O
Sentence: 956,%,O
Sentence: 956,in,O
Sentence: 956,period,O
Sentence: 956,1,O
Sentence: 956,to,O
Sentence: 956,39.7,O
Sentence: 956,%,O
Sentence: 956,in,O
Sentence: 956,period,O
Sentence: 956,3,O
Sentence: 956,.,O
Sentence: 956,After,O
Sentence: 956,adjusting,O
Sentence: 956,for,O
Sentence: 956,potential,O
Sentence: 956,confounders,O
Sentence: 956,",",O
Sentence: 956,we,O
Sentence: 956,found,O
Sentence: 956,that,O
Sentence: 956,the,O
Sentence: 956,risk,O
Sentence: 956,of,O
Sentence: 956,HIV,B-Disease
Sentence: 956,seroconversion,I-Disease
Sentence: 956,among,O
Sentence: 956,participants,O
Sentence: 956,who,O
Sentence: 956,were,O
Sentence: 956,daily,O
Sentence: 956,smokers,O
Sentence: 956,of,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,increased,O
Sentence: 956,over,O
Sentence: 956,time,O
Sentence: 956,(,O
Sentence: 956,period,O
Sentence: 956,1,O
Sentence: 956,:,O
Sentence: 956,hazard,O
Sentence: 956,ratio,O
Sentence: 956,[,O
Sentence: 956,HR,O
Sentence: 956,],O
Sentence: 956,1.03,O
Sentence: 956,",",O
Sentence: 956,95,O
Sentence: 956,%,O
Sentence: 956,confidence,O
Sentence: 956,interval,O
Sentence: 956,[,O
Sentence: 956,CI,O
Sentence: 956,],O
Sentence: 956,0.57,O
Sentence: 956,-,O
Sentence: 956,1.85,O
Sentence: 956,;,O
Sentence: 956,period,O
Sentence: 956,2,O
Sentence: 956,:,O
Sentence: 956,HR,O
Sentence: 956,1.68,O
Sentence: 956,",",O
Sentence: 956,95,O
Sentence: 956,%,O
Sentence: 956,CI,O
Sentence: 956,1.01,O
Sentence: 956,-,O
Sentence: 956,2.80,O
Sentence: 956,;,O
Sentence: 956,and,O
Sentence: 956,period,O
Sentence: 956,3,O
Sentence: 956,:,O
Sentence: 956,HR,O
Sentence: 956,2.74,O
Sentence: 956,",",O
Sentence: 956,95,O
Sentence: 956,%,O
Sentence: 956,CI,O
Sentence: 956,1.06,O
Sentence: 956,-,O
Sentence: 956,7.11,O
Sentence: 956,),O
Sentence: 956,.,O
Sentence: 956,INTERPRETATION,O
Sentence: 956,:,O
Sentence: 956,Smoking,O
Sentence: 956,of,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,was,O
Sentence: 956,found,O
Sentence: 956,to,O
Sentence: 956,be,O
Sentence: 956,an,O
Sentence: 956,independent,O
Sentence: 956,risk,O
Sentence: 956,factor,O
Sentence: 956,for,O
Sentence: 956,HIV,B-Disease
Sentence: 956,seroconversion,I-Disease
Sentence: 956,among,O
Sentence: 956,people,O
Sentence: 956,who,O
Sentence: 956,were,O
Sentence: 956,injection,O
Sentence: 956,drug,O
Sentence: 956,users,O
Sentence: 956,.,O
Sentence: 956,This,O
Sentence: 956,finding,O
Sentence: 956,points,O
Sentence: 956,to,O
Sentence: 956,the,O
Sentence: 956,urgent,O
Sentence: 956,need,O
Sentence: 956,for,O
Sentence: 956,evidence,O
Sentence: 956,-,O
Sentence: 956,based,O
Sentence: 956,public,O
Sentence: 956,health,O
Sentence: 956,initiatives,O
Sentence: 956,targeted,O
Sentence: 956,at,O
Sentence: 956,people,O
Sentence: 956,who,O
Sentence: 956,smoke,O
Sentence: 956,crack,B-Chemical
Sentence: 956,cocaine,I-Chemical
Sentence: 956,.,O
Sentence: 957,Fluoxetine,B-Chemical
Sentence: 957,improves,O
Sentence: 957,the,O
Sentence: 957,memory,B-Disease
Sentence: 957,deficits,I-Disease
Sentence: 957,caused,O
Sentence: 957,by,O
Sentence: 957,the,O
Sentence: 957,chemotherapy,O
Sentence: 957,agent,O
Sentence: 957,5,O
Sentence: 957,-,O
Sentence: 957,fluorouracil,O
Sentence: 957,.,O
Sentence: 958,Cancer,B-Disease
Sentence: 958,patients,O
Sentence: 958,who,O
Sentence: 958,have,O
Sentence: 958,been,O
Sentence: 958,treated,O
Sentence: 958,with,O
Sentence: 958,systemic,O
Sentence: 958,adjuvant,O
Sentence: 958,chemotherapy,O
Sentence: 958,have,O
Sentence: 958,described,O
Sentence: 958,experiencing,O
Sentence: 958,deteriorations,O
Sentence: 958,in,O
Sentence: 958,cognition,O
Sentence: 958,.,O
Sentence: 958,A,O
Sentence: 958,widely,O
Sentence: 958,used,O
Sentence: 958,chemotherapeutic,O
Sentence: 958,agent,O
Sentence: 958,",",O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,fluorouracil,O
Sentence: 958,(,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,),O
Sentence: 958,",",O
Sentence: 958,readily,O
Sentence: 958,crosses,O
Sentence: 958,the,O
Sentence: 958,blood,O
Sentence: 958,-,O
Sentence: 958,brain,O
Sentence: 958,barrier,O
Sentence: 958,and,O
Sentence: 958,so,O
Sentence: 958,could,O
Sentence: 958,have,O
Sentence: 958,a,O
Sentence: 958,direct,O
Sentence: 958,effect,O
Sentence: 958,on,O
Sentence: 958,brain,O
Sentence: 958,function,O
Sentence: 958,.,O
Sentence: 958,In,O
Sentence: 958,particular,O
Sentence: 958,this,O
Sentence: 958,anti,O
Sentence: 958,mitotic,O
Sentence: 958,drug,O
Sentence: 958,could,O
Sentence: 958,reduce,O
Sentence: 958,cell,O
Sentence: 958,proliferation,O
Sentence: 958,in,O
Sentence: 958,the,O
Sentence: 958,neurogenic,O
Sentence: 958,regions,O
Sentence: 958,of,O
Sentence: 958,the,O
Sentence: 958,adult,O
Sentence: 958,brain,O
Sentence: 958,.,O
Sentence: 958,In,O
Sentence: 958,contrast,O
Sentence: 958,reports,O
Sentence: 958,indicate,O
Sentence: 958,that,O
Sentence: 958,hippocampal,O
Sentence: 958,dependent,O
Sentence: 958,neurogenesis,O
Sentence: 958,and,O
Sentence: 958,cognition,O
Sentence: 958,are,O
Sentence: 958,enhanced,O
Sentence: 958,by,O
Sentence: 958,the,O
Sentence: 958,SSRI,B-Chemical
Sentence: 958,antidepressant,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,.,O
Sentence: 958,In,O
Sentence: 958,this,O
Sentence: 958,investigation,O
Sentence: 958,the,O
Sentence: 958,behavioural,O
Sentence: 958,effects,O
Sentence: 958,of,O
Sentence: 958,chronic,O
Sentence: 958,(,O
Sentence: 958,two,O
Sentence: 958,week,O
Sentence: 958,),O
Sentence: 958,treatment,O
Sentence: 958,with,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,and,O
Sentence: 958,(,O
Sentence: 958,three,O
Sentence: 958,weeks,O
Sentence: 958,),O
Sentence: 958,with,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,either,O
Sentence: 958,separately,O
Sentence: 958,or,O
Sentence: 958,in,O
Sentence: 958,combination,O
Sentence: 958,with,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,were,O
Sentence: 958,tested,O
Sentence: 958,on,O
Sentence: 958,adult,O
Sentence: 958,Lister,O
Sentence: 958,hooded,O
Sentence: 958,rats,O
Sentence: 958,.,O
Sentence: 958,Behavioural,O
Sentence: 958,effects,O
Sentence: 958,were,O
Sentence: 958,tested,O
Sentence: 958,using,O
Sentence: 958,a,O
Sentence: 958,context,O
Sentence: 958,dependent,O
Sentence: 958,conditioned,O
Sentence: 958,emotional,O
Sentence: 958,response,O
Sentence: 958,test,O
Sentence: 958,(,O
Sentence: 958,CER,O
Sentence: 958,),O
Sentence: 958,which,O
Sentence: 958,showed,O
Sentence: 958,that,O
Sentence: 958,animals,O
Sentence: 958,treated,O
Sentence: 958,with,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,had,O
Sentence: 958,a,O
Sentence: 958,significant,O
Sentence: 958,reduction,O
Sentence: 958,in,O
Sentence: 958,freezing,O
Sentence: 958,time,O
Sentence: 958,compared,O
Sentence: 958,to,O
Sentence: 958,controls,O
Sentence: 958,.,O
Sentence: 958,A,O
Sentence: 958,separate,O
Sentence: 958,group,O
Sentence: 958,of,O
Sentence: 958,animals,O
Sentence: 958,was,O
Sentence: 958,tested,O
Sentence: 958,using,O
Sentence: 958,a,O
Sentence: 958,hippocampal,O
Sentence: 958,dependent,O
Sentence: 958,spatial,O
Sentence: 958,working,O
Sentence: 958,memory,O
Sentence: 958,test,O
Sentence: 958,",",O
Sentence: 958,the,O
Sentence: 958,object,O
Sentence: 958,location,O
Sentence: 958,recognition,O
Sentence: 958,test,O
Sentence: 958,(,O
Sentence: 958,OLR,O
Sentence: 958,),O
Sentence: 958,.,O
Sentence: 958,Animals,O
Sentence: 958,treated,O
Sentence: 958,only,O
Sentence: 958,with,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,showed,O
Sentence: 958,significant,O
Sentence: 958,deficits,O
Sentence: 958,in,O
Sentence: 958,their,O
Sentence: 958,ability,O
Sentence: 958,to,O
Sentence: 958,carry,O
Sentence: 958,out,O
Sentence: 958,the,O
Sentence: 958,OLR,O
Sentence: 958,task,O
Sentence: 958,but,O
Sentence: 958,co,O
Sentence: 958,administration,O
Sentence: 958,of,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,improved,O
Sentence: 958,their,O
Sentence: 958,performance,O
Sentence: 958,.,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,chemotherapy,O
Sentence: 958,caused,O
Sentence: 958,a,O
Sentence: 958,significant,O
Sentence: 958,reduction,O
Sentence: 958,in,O
Sentence: 958,the,O
Sentence: 958,number,O
Sentence: 958,of,O
Sentence: 958,proliferating,O
Sentence: 958,cells,O
Sentence: 958,in,O
Sentence: 958,the,O
Sentence: 958,sub,O
Sentence: 958,granular,O
Sentence: 958,zone,O
Sentence: 958,of,O
Sentence: 958,the,O
Sentence: 958,dentate,O
Sentence: 958,gyrus,O
Sentence: 958,compared,O
Sentence: 958,to,O
Sentence: 958,controls,O
Sentence: 958,.,O
Sentence: 958,This,O
Sentence: 958,reduction,O
Sentence: 958,was,O
Sentence: 958,eliminated,O
Sentence: 958,when,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,was,O
Sentence: 958,co,O
Sentence: 958,administered,O
Sentence: 958,with,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,.,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,on,O
Sentence: 958,its,O
Sentence: 958,own,O
Sentence: 958,had,O
Sentence: 958,no,O
Sentence: 958,effect,O
Sentence: 958,on,O
Sentence: 958,proliferating,O
Sentence: 958,cell,O
Sentence: 958,number,O
Sentence: 958,or,O
Sentence: 958,behaviour,O
Sentence: 958,.,O
Sentence: 958,These,O
Sentence: 958,findings,O
Sentence: 958,suggest,O
Sentence: 958,that,O
Sentence: 958,5,O
Sentence: 958,-,O
Sentence: 958,FU,O
Sentence: 958,can,O
Sentence: 958,negatively,O
Sentence: 958,affect,O
Sentence: 958,both,O
Sentence: 958,cell,O
Sentence: 958,proliferation,O
Sentence: 958,and,O
Sentence: 958,hippocampal,O
Sentence: 958,dependent,O
Sentence: 958,working,O
Sentence: 958,memory,O
Sentence: 958,and,O
Sentence: 958,that,O
Sentence: 958,these,O
Sentence: 958,deficits,O
Sentence: 958,can,O
Sentence: 958,be,O
Sentence: 958,reversed,O
Sentence: 958,by,O
Sentence: 958,the,O
Sentence: 958,simultaneous,O
Sentence: 958,administration,O
Sentence: 958,of,O
Sentence: 958,the,O
Sentence: 958,antidepressant,O
Sentence: 958,Fluoxetine,B-Chemical
Sentence: 958,.,O
Sentence: 959,Liver,O
Sentence: 959,-,O
Sentence: 959,specific,O
Sentence: 959,ablation,O
Sentence: 959,of,O
Sentence: 959,integrin,O
Sentence: 959,-,O
Sentence: 959,linked,O
Sentence: 959,kinase,O
Sentence: 959,in,O
Sentence: 959,mice,O
Sentence: 959,results,O
Sentence: 959,in,O
Sentence: 959,enhanced,O
Sentence: 959,and,O
Sentence: 959,prolonged,O
Sentence: 959,cell,O
Sentence: 959,proliferation,O
Sentence: 959,and,O
Sentence: 959,hepatomegaly,B-Disease
Sentence: 959,after,O
Sentence: 959,phenobarbital,B-Chemical
Sentence: 959,administration,O
Sentence: 959,.,O
Sentence: 960,We,O
Sentence: 960,have,O
Sentence: 960,recently,O
Sentence: 960,demonstrated,O
Sentence: 960,that,O
Sentence: 960,disruption,O
Sentence: 960,of,O
Sentence: 960,extracellular,O
Sentence: 960,matrix,O
Sentence: 960,(,O
Sentence: 960,ECM,O
Sentence: 960,),O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,integrin,O
Sentence: 960,signaling,O
Sentence: 960,via,O
Sentence: 960,elimination,O
Sentence: 960,of,O
Sentence: 960,integrin,O
Sentence: 960,-,O
Sentence: 960,linked,O
Sentence: 960,kinase,O
Sentence: 960,(,O
Sentence: 960,ILK,O
Sentence: 960,),O
Sentence: 960,in,O
Sentence: 960,hepatocytes,O
Sentence: 960,interferes,O
Sentence: 960,with,O
Sentence: 960,signals,O
Sentence: 960,leading,O
Sentence: 960,to,O
Sentence: 960,termination,O
Sentence: 960,of,O
Sentence: 960,liver,O
Sentence: 960,regeneration,O
Sentence: 960,.,O
Sentence: 960,This,O
Sentence: 960,study,O
Sentence: 960,investigates,O
Sentence: 960,the,O
Sentence: 960,role,O
Sentence: 960,of,O
Sentence: 960,ILK,O
Sentence: 960,in,O
Sentence: 960,liver,O
Sentence: 960,enlargement,O
Sentence: 960,induced,O
Sentence: 960,by,O
Sentence: 960,phenobarbital,B-Chemical
Sentence: 960,(,O
Sentence: 960,PB,B-Chemical
Sentence: 960,),O
Sentence: 960,.,O
Sentence: 960,Wild,O
Sentence: 960,-,O
Sentence: 960,type,O
Sentence: 960,(,O
Sentence: 960,WT,O
Sentence: 960,),O
Sentence: 960,and,O
Sentence: 960,ILK,O
Sentence: 960,:,O
Sentence: 960,liver,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,mice,O
Sentence: 960,were,O
Sentence: 960,given,O
Sentence: 960,PB,B-Chemical
Sentence: 960,(,O
Sentence: 960,0.1,O
Sentence: 960,%,O
Sentence: 960,in,O
Sentence: 960,drinking,O
Sentence: 960,water,O
Sentence: 960,),O
Sentence: 960,for,O
Sentence: 960,10,O
Sentence: 960,days,O
Sentence: 960,.,O
Sentence: 960,Livers,O
Sentence: 960,were,O
Sentence: 960,harvested,O
Sentence: 960,on,O
Sentence: 960,2,O
Sentence: 960,",",O
Sentence: 960,5,O
Sentence: 960,",",O
Sentence: 960,and,O
Sentence: 960,10,O
Sentence: 960,days,O
Sentence: 960,during,O
Sentence: 960,PB,B-Chemical
Sentence: 960,administration,O
Sentence: 960,.,O
Sentence: 960,In,O
Sentence: 960,the,O
Sentence: 960,hepatocyte,O
Sentence: 960,-,O
Sentence: 960,specific,O
Sentence: 960,ILK,O
Sentence: 960,/,O
Sentence: 960,liver,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,mice,O
Sentence: 960,",",O
Sentence: 960,the,O
Sentence: 960,liver,O
Sentence: 960,:,O
Sentence: 960,body,O
Sentence: 960,weight,O
Sentence: 960,ratio,O
Sentence: 960,was,O
Sentence: 960,more,O
Sentence: 960,than,O
Sentence: 960,double,O
Sentence: 960,as,O
Sentence: 960,compared,O
Sentence: 960,to,O
Sentence: 960,0,O
Sentence: 960,h,O
Sentence: 960,at,O
Sentence: 960,day,O
Sentence: 960,2,O
Sentence: 960,(,O
Sentence: 960,2.5,O
Sentence: 960,times,O
Sentence: 960,),O
Sentence: 960,",",O
Sentence: 960,while,O
Sentence: 960,at,O
Sentence: 960,days,O
Sentence: 960,5,O
Sentence: 960,and,O
Sentence: 960,10,O
Sentence: 960,",",O
Sentence: 960,it,O
Sentence: 960,was,O
Sentence: 960,enlarged,O
Sentence: 960,three,O
Sentence: 960,times,O
Sentence: 960,.,O
Sentence: 960,In,O
Sentence: 960,the,O
Sentence: 960,WT,O
Sentence: 960,mice,O
Sentence: 960,",",O
Sentence: 960,the,O
Sentence: 960,increase,O
Sentence: 960,was,O
Sentence: 960,as,O
Sentence: 960,expected,O
Sentence: 960,from,O
Sentence: 960,previous,O
Sentence: 960,literature,O
Sentence: 960,(,O
Sentence: 960,1.8,O
Sentence: 960,times,O
Sentence: 960,),O
Sentence: 960,and,O
Sentence: 960,seems,O
Sentence: 960,to,O
Sentence: 960,have,O
Sentence: 960,leveled,O
Sentence: 960,off,O
Sentence: 960,after,O
Sentence: 960,day,O
Sentence: 960,2,O
Sentence: 960,.,O
Sentence: 960,There,O
Sentence: 960,were,O
Sentence: 960,slightly,O
Sentence: 960,increased,O
Sentence: 960,proliferating,O
Sentence: 960,cell,O
Sentence: 960,nuclear,O
Sentence: 960,antigen,O
Sentence: 960,-,O
Sentence: 960,positive,O
Sentence: 960,cells,O
Sentence: 960,in,O
Sentence: 960,the,O
Sentence: 960,ILK,O
Sentence: 960,/,O
Sentence: 960,liver,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,animals,O
Sentence: 960,at,O
Sentence: 960,day,O
Sentence: 960,2,O
Sentence: 960,as,O
Sentence: 960,compared,O
Sentence: 960,to,O
Sentence: 960,WT,O
Sentence: 960,after,O
Sentence: 960,PB,B-Chemical
Sentence: 960,administration,O
Sentence: 960,.,O
Sentence: 960,In,O
Sentence: 960,the,O
Sentence: 960,WT,O
Sentence: 960,animals,O
Sentence: 960,",",O
Sentence: 960,the,O
Sentence: 960,proliferative,O
Sentence: 960,response,O
Sentence: 960,had,O
Sentence: 960,come,O
Sentence: 960,back,O
Sentence: 960,to,O
Sentence: 960,normal,O
Sentence: 960,by,O
Sentence: 960,days,O
Sentence: 960,5,O
Sentence: 960,and,O
Sentence: 960,10,O
Sentence: 960,.,O
Sentence: 960,Hepatocytes,O
Sentence: 960,of,O
Sentence: 960,the,O
Sentence: 960,ILK,O
Sentence: 960,/,O
Sentence: 960,liver,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,mice,O
Sentence: 960,continued,O
Sentence: 960,to,O
Sentence: 960,proliferate,O
Sentence: 960,up,O
Sentence: 960,until,O
Sentence: 960,day,O
Sentence: 960,10,O
Sentence: 960,.,O
Sentence: 960,ILK,O
Sentence: 960,/,O
Sentence: 960,liver,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,/,O
Sentence: 960,,O
Sentence: 960,-,O
Sentence: 960,,O
Sentence: 960,mice,O
Sentence: 960,also,O
Sentence: 960,showed,O
Sentence: 960,increased,O
Sentence: 960,expression,O
Sentence: 960,of,O
Sentence: 960,key,O
Sentence: 960,genes,O
Sentence: 960,involved,O
Sentence: 960,in,O
Sentence: 960,hepatocyte,O
Sentence: 960,proliferation,O
Sentence: 960,at,O
Sentence: 960,different,O
Sentence: 960,time,O
Sentence: 960,points,O
Sentence: 960,during,O
Sentence: 960,PB,B-Chemical
Sentence: 960,administration,O
Sentence: 960,.,O
Sentence: 960,In,O
Sentence: 960,summary,O
Sentence: 960,",",O
Sentence: 960,ECM,O
Sentence: 960,proteins,O
Sentence: 960,communicate,O
Sentence: 960,with,O
Sentence: 960,the,O
Sentence: 960,signaling,O
Sentence: 960,machinery,O
Sentence: 960,of,O
Sentence: 960,dividing,O
Sentence: 960,cells,O
Sentence: 960,via,O
Sentence: 960,ILK,O
Sentence: 960,to,O
Sentence: 960,regulate,O
Sentence: 960,hepatocyte,O
Sentence: 960,proliferation,O
Sentence: 960,and,O
Sentence: 960,termination,O
Sentence: 960,of,O
Sentence: 960,the,O
Sentence: 960,proliferative,O
Sentence: 960,response,O
Sentence: 960,.,O
Sentence: 960,Lack,O
Sentence: 960,of,O
Sentence: 960,ILK,O
Sentence: 960,in,O
Sentence: 960,the,O
Sentence: 960,hepatocytes,O
Sentence: 960,imparts,O
Sentence: 960,prolonged,O
Sentence: 960,proliferative,O
Sentence: 960,response,O
Sentence: 960,not,O
Sentence: 960,only,O
Sentence: 960,to,O
Sentence: 960,stimuli,O
Sentence: 960,related,O
Sentence: 960,to,O
Sentence: 960,liver,O
Sentence: 960,regeneration,O
Sentence: 960,but,O
Sentence: 960,also,O
Sentence: 960,to,O
Sentence: 960,xenobiotic,O
Sentence: 960,chemical,O
Sentence: 960,mitogens,O
Sentence: 960,",",O
Sentence: 960,such,O
Sentence: 960,as,O
Sentence: 960,PB,B-Chemical
Sentence: 960,.,O
Sentence: 961,Decreased,O
Sentence: 961,Expression,O
Sentence: 961,of,O
Sentence: 961,Na,B-Chemical
Sentence: 961,/,O
Sentence: 961,K,B-Chemical
Sentence: 961,-,O
Sentence: 961,ATPase,O
Sentence: 961,",",O
Sentence: 961,NHE3,O
Sentence: 961,",",O
Sentence: 961,NBC1,O
Sentence: 961,",",O
Sentence: 961,AQP1,O
Sentence: 961,and,O
Sentence: 961,OAT,O
Sentence: 961,in,O
Sentence: 961,Gentamicin,B-Chemical
Sentence: 961,-,O
Sentence: 961,induced,O
Sentence: 961,Nephropathy,B-Disease
Sentence: 961,.,O
Sentence: 962,The,O
Sentence: 962,present,O
Sentence: 962,study,O
Sentence: 962,was,O
Sentence: 962,aimed,O
Sentence: 962,to,O
Sentence: 962,determine,O
Sentence: 962,whether,O
Sentence: 962,there,O
Sentence: 962,is,O
Sentence: 962,an,O
Sentence: 962,altered,O
Sentence: 962,regulation,O
Sentence: 962,of,O
Sentence: 962,tubular,O
Sentence: 962,transporters,O
Sentence: 962,in,O
Sentence: 962,gentamicin,B-Chemical
Sentence: 962,-,O
Sentence: 962,induced,O
Sentence: 962,nephropathy,B-Disease
Sentence: 962,.,O
Sentence: 962,Sprague,O
Sentence: 962,-,O
Sentence: 962,Dawley,O
Sentence: 962,male,O
Sentence: 962,rats,O
Sentence: 962,(,O
Sentence: 962,200~250,O
Sentence: 962,g,O
Sentence: 962,),O
Sentence: 962,were,O
Sentence: 962,subcutaneously,O
Sentence: 962,injected,O
Sentence: 962,with,O
Sentence: 962,gentamicin,B-Chemical
Sentence: 962,(,O
Sentence: 962,100,O
Sentence: 962,mg,O
Sentence: 962,/,O
Sentence: 962,kg,O
Sentence: 962,per,O
Sentence: 962,day,O
Sentence: 962,),O
Sentence: 962,for,O
Sentence: 962,7,O
Sentence: 962,days,O
Sentence: 962,",",O
Sentence: 962,and,O
Sentence: 962,the,O
Sentence: 962,expression,O
Sentence: 962,of,O
Sentence: 962,tubular,O
Sentence: 962,transporters,O
Sentence: 962,was,O
Sentence: 962,determined,O
Sentence: 962,by,O
Sentence: 962,immunoblotting,O
Sentence: 962,and,O
Sentence: 962,immunohistochemistry,O
Sentence: 962,.,O
Sentence: 962,The,O
Sentence: 962,mRNA,O
Sentence: 962,and,O
Sentence: 962,protein,O
Sentence: 962,expression,O
Sentence: 962,of,O
Sentence: 962,OAT,O
Sentence: 962,was,O
Sentence: 962,also,O
Sentence: 962,determined,O
Sentence: 962,.,O
Sentence: 962,Gentamicin,B-Chemical
Sentence: 962,-,O
Sentence: 962,treated,O
Sentence: 962,rats,O
Sentence: 962,exhibited,O
Sentence: 962,significantly,O
Sentence: 962,decreased,O
Sentence: 962,creatinine,B-Chemical
Sentence: 962,clearance,O
Sentence: 962,along,O
Sentence: 962,with,O
Sentence: 962,increased,O
Sentence: 962,plasma,O
Sentence: 962,creatinine,B-Chemical
Sentence: 962,levels,O
Sentence: 962,.,O
Sentence: 962,Accordingly,O
Sentence: 962,",",O
Sentence: 962,the,O
Sentence: 962,fractional,O
Sentence: 962,excretion,O
Sentence: 962,of,O
Sentence: 962,sodium,B-Chemical
Sentence: 962,increased,O
Sentence: 962,.,O
Sentence: 962,Urine,O
Sentence: 962,volume,O
Sentence: 962,was,O
Sentence: 962,increased,O
Sentence: 962,",",O
Sentence: 962,while,O
Sentence: 962,urine,O
Sentence: 962,osmolality,O
Sentence: 962,and,O
Sentence: 962,free,O
Sentence: 962,water,O
Sentence: 962,reabsorption,O
Sentence: 962,were,O
Sentence: 962,decreased,O
Sentence: 962,.,O
Sentence: 962,Immunoblotting,O
Sentence: 962,and,O
Sentence: 962,immunohistochemistry,O
Sentence: 962,revealed,O
Sentence: 962,decreased,O
Sentence: 962,expression,O
Sentence: 962,of,O
Sentence: 962,Na,B-Chemical
Sentence: 962,(,O
Sentence: 962,+,O
Sentence: 962,),O
Sentence: 962,,O
Sentence: 962,/,O
Sentence: 962,K,B-Chemical
Sentence: 962,(,O
Sentence: 962,+,O
Sentence: 962,),O
Sentence: 962,,O
Sentence: 962,-,O
Sentence: 962,ATPase,O
Sentence: 962,",",O
Sentence: 962,NHE3,O
Sentence: 962,",",O
Sentence: 962,NBC1,O
Sentence: 962,",",O
Sentence: 962,and,O
Sentence: 962,AQP1,O
Sentence: 962,in,O
Sentence: 962,the,O
Sentence: 962,kidney,O
Sentence: 962,of,O
Sentence: 962,gentamicin,B-Chemical
Sentence: 962,-,O
Sentence: 962,treated,O
Sentence: 962,rats,O
Sentence: 962,.,O
Sentence: 962,The,O
Sentence: 962,expression,O
Sentence: 962,of,O
Sentence: 962,OAT1,O
Sentence: 962,and,O
Sentence: 962,OAT3,O
Sentence: 962,was,O
Sentence: 962,also,O
Sentence: 962,decreased,O
Sentence: 962,.,O
Sentence: 962,Gentamicin,B-Chemical
Sentence: 962,-,O
Sentence: 962,induced,O
Sentence: 962,nephropathy,B-Disease
Sentence: 962,may,O
Sentence: 962,at,O
Sentence: 962,least,O
Sentence: 962,in,O
Sentence: 962,part,O
Sentence: 962,be,O
Sentence: 962,causally,O
Sentence: 962,related,O
Sentence: 962,with,O
Sentence: 962,a,O
Sentence: 962,decreased,O
Sentence: 962,expression,O
Sentence: 962,of,O
Sentence: 962,Na,B-Chemical
Sentence: 962,(,O
Sentence: 962,+,O
Sentence: 962,),O
Sentence: 962,,O
Sentence: 962,/,O
Sentence: 962,K,B-Chemical
Sentence: 962,(,O
Sentence: 962,+,O
Sentence: 962,),O
Sentence: 962,,O
Sentence: 962,-,O
Sentence: 962,ATPase,O
Sentence: 962,",",O
Sentence: 962,NHE3,O
Sentence: 962,",",O
Sentence: 962,NBC1,O
Sentence: 962,",",O
Sentence: 962,AQP1,O
Sentence: 962,and,O
Sentence: 962,OAT,O
Sentence: 962,.,O
Sentence: 963,Longitudinal,O
Sentence: 963,association,O
Sentence: 963,of,O
Sentence: 963,alcohol,B-Chemical
Sentence: 963,use,O
Sentence: 963,with,O
Sentence: 963,HIV,B-Disease
Sentence: 963,disease,I-Disease
Sentence: 963,progression,O
Sentence: 963,and,O
Sentence: 963,psychological,O
Sentence: 963,health,O
Sentence: 963,of,O
Sentence: 963,women,O
Sentence: 963,with,O
Sentence: 963,HIV,O
Sentence: 963,.,O
Sentence: 964,We,O
Sentence: 964,evaluated,O
Sentence: 964,the,O
Sentence: 964,association,O
Sentence: 964,of,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,consumption,O
Sentence: 964,and,O
Sentence: 964,depression,B-Disease
Sentence: 964,",",O
Sentence: 964,and,O
Sentence: 964,their,O
Sentence: 964,effects,O
Sentence: 964,on,O
Sentence: 964,HIV,B-Disease
Sentence: 964,disease,I-Disease
Sentence: 964,progression,O
Sentence: 964,among,O
Sentence: 964,women,O
Sentence: 964,with,O
Sentence: 964,HIV,O
Sentence: 964,.,O
Sentence: 964,The,O
Sentence: 964,study,O
Sentence: 964,included,O
Sentence: 964,871,O
Sentence: 964,women,O
Sentence: 964,with,O
Sentence: 964,HIV,O
Sentence: 964,who,O
Sentence: 964,were,O
Sentence: 964,recruited,O
Sentence: 964,from,O
Sentence: 964,1993,O
Sentence: 964,-,O
Sentence: 964,1995,O
Sentence: 964,in,O
Sentence: 964,four,O
Sentence: 964,US,O
Sentence: 964,cities,O
Sentence: 964,.,O
Sentence: 964,The,O
Sentence: 964,participants,O
Sentence: 964,had,O
Sentence: 964,physical,O
Sentence: 964,examination,O
Sentence: 964,",",O
Sentence: 964,medical,O
Sentence: 964,record,O
Sentence: 964,extraction,O
Sentence: 964,",",O
Sentence: 964,and,O
Sentence: 964,venipuncture,O
Sentence: 964,",",O
Sentence: 964,CD4+T,O
Sentence: 964,-,O
Sentence: 964,cell,O
Sentence: 964,counts,O
Sentence: 964,determination,O
Sentence: 964,",",O
Sentence: 964,measurement,O
Sentence: 964,of,O
Sentence: 964,depression,B-Disease
Sentence: 964,symptoms,O
Sentence: 964,(,O
Sentence: 964,using,O
Sentence: 964,the,O
Sentence: 964,self,O
Sentence: 964,-,O
Sentence: 964,report,O
Sentence: 964,Center,O
Sentence: 964,for,O
Sentence: 964,Epidemiological,O
Sentence: 964,Studies,O
Sentence: 964,-,O
Sentence: 964,Depression,B-Disease
Sentence: 964,Scale,O
Sentence: 964,),O
Sentence: 964,",",O
Sentence: 964,and,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,use,O
Sentence: 964,assessment,O
Sentence: 964,at,O
Sentence: 964,enrollment,O
Sentence: 964,",",O
Sentence: 964,and,O
Sentence: 964,semiannually,O
Sentence: 964,until,O
Sentence: 964,March,O
Sentence: 964,2000,O
Sentence: 964,.,O
Sentence: 964,Multilevel,O
Sentence: 964,random,O
Sentence: 964,coefficient,O
Sentence: 964,ordinal,O
Sentence: 964,models,O
Sentence: 964,as,O
Sentence: 964,well,O
Sentence: 964,as,O
Sentence: 964,multilevel,O
Sentence: 964,models,O
Sentence: 964,with,O
Sentence: 964,joint,O
Sentence: 964,responses,O
Sentence: 964,were,O
Sentence: 964,used,O
Sentence: 964,in,O
Sentence: 964,the,O
Sentence: 964,analysis,O
Sentence: 964,.,O
Sentence: 964,There,O
Sentence: 964,was,O
Sentence: 964,no,O
Sentence: 964,significant,O
Sentence: 964,association,O
Sentence: 964,between,O
Sentence: 964,level,O
Sentence: 964,of,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,use,O
Sentence: 964,and,O
Sentence: 964,CD4+,O
Sentence: 964,T,O
Sentence: 964,-,O
Sentence: 964,cell,O
Sentence: 964,counts,O
Sentence: 964,.,O
Sentence: 964,When,O
Sentence: 964,participants,O
Sentence: 964,were,O
Sentence: 964,stratified,O
Sentence: 964,by,O
Sentence: 964,antiretroviral,O
Sentence: 964,therapy,O
Sentence: 964,(,O
Sentence: 964,ART,O
Sentence: 964,),O
Sentence: 964,use,O
Sentence: 964,",",O
Sentence: 964,the,O
Sentence: 964,association,O
Sentence: 964,between,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,and,O
Sentence: 964,CD4+,O
Sentence: 964,T,O
Sentence: 964,-,O
Sentence: 964,cell,O
Sentence: 964,did,O
Sentence: 964,not,O
Sentence: 964,reach,O
Sentence: 964,statistical,O
Sentence: 964,significance,O
Sentence: 964,.,O
Sentence: 964,The,O
Sentence: 964,association,O
Sentence: 964,between,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,consumption,O
Sentence: 964,and,O
Sentence: 964,depression,B-Disease
Sentence: 964,was,O
Sentence: 964,significant,O
Sentence: 964,(,O
Sentence: 964,p,O
Sentence: 964,,O
Sentence: 964,<,O
Sentence: 964,,O
Sentence: 964,0.001,O
Sentence: 964,),O
Sentence: 964,.,O
Sentence: 964,Depression,B-Disease
Sentence: 964,had,O
Sentence: 964,a,O
Sentence: 964,significant,O
Sentence: 964,negative,O
Sentence: 964,effect,O
Sentence: 964,on,O
Sentence: 964,CD4+,O
Sentence: 964,T,O
Sentence: 964,-,O
Sentence: 964,cell,O
Sentence: 964,counts,O
Sentence: 964,over,O
Sentence: 964,time,O
Sentence: 964,regardless,O
Sentence: 964,of,O
Sentence: 964,ART,O
Sentence: 964,use,O
Sentence: 964,.,O
Sentence: 964,Our,O
Sentence: 964,findings,O
Sentence: 964,suggest,O
Sentence: 964,that,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,consumption,O
Sentence: 964,has,O
Sentence: 964,a,O
Sentence: 964,direct,O
Sentence: 964,association,O
Sentence: 964,with,O
Sentence: 964,depression,B-Disease
Sentence: 964,.,O
Sentence: 964,Moreover,O
Sentence: 964,",",O
Sentence: 964,depression,B-Disease
Sentence: 964,is,O
Sentence: 964,associated,O
Sentence: 964,with,O
Sentence: 964,HIV,B-Disease
Sentence: 964,disease,I-Disease
Sentence: 964,progression,O
Sentence: 964,.,O
Sentence: 964,Our,O
Sentence: 964,findings,O
Sentence: 964,have,O
Sentence: 964,implications,O
Sentence: 964,for,O
Sentence: 964,the,O
Sentence: 964,provision,O
Sentence: 964,of,O
Sentence: 964,alcohol,B-Chemical
Sentence: 964,use,O
Sentence: 964,interventions,O
Sentence: 964,and,O
Sentence: 964,psychological,O
Sentence: 964,resources,O
Sentence: 964,to,O
Sentence: 964,improve,O
Sentence: 964,the,O
Sentence: 964,health,O
Sentence: 964,of,O
Sentence: 964,women,O
Sentence: 964,with,O
Sentence: 964,HIV,O
Sentence: 964,.,O
Sentence: 965,Chemokine,O
Sentence: 965,CCL2,O
Sentence: 965,and,O
Sentence: 965,its,O
Sentence: 965,receptor,O
Sentence: 965,CCR2,O
Sentence: 965,are,O
Sentence: 965,increased,O
Sentence: 965,in,O
Sentence: 965,the,O
Sentence: 965,hippocampus,O
Sentence: 965,following,O
Sentence: 965,pilocarpine,B-Chemical
Sentence: 965,-,O
Sentence: 965,induced,O
Sentence: 965,status,B-Disease
Sentence: 965,epilepticus,I-Disease
Sentence: 965,.,O
Sentence: 966,BACKGROUND,O
Sentence: 966,:,O
Sentence: 966,Neuroinflammation,B-Disease
Sentence: 966,occurs,O
Sentence: 966,after,O
Sentence: 966,seizures,B-Disease
Sentence: 966,and,O
Sentence: 966,is,O
Sentence: 966,implicated,O
Sentence: 966,in,O
Sentence: 966,epileptogenesis,O
Sentence: 966,.,O
Sentence: 966,CCR2,O
Sentence: 966,is,O
Sentence: 966,a,O
Sentence: 966,chemokine,O
Sentence: 966,receptor,O
Sentence: 966,for,O
Sentence: 966,CCL2,O
Sentence: 966,and,O
Sentence: 966,their,O
Sentence: 966,interaction,O
Sentence: 966,mediates,O
Sentence: 966,monocyte,O
Sentence: 966,infiltration,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,neuroinflammatory,B-Disease
Sentence: 966,cascade,O
Sentence: 966,triggered,O
Sentence: 966,in,O
Sentence: 966,different,O
Sentence: 966,brain,O
Sentence: 966,pathologies,O
Sentence: 966,.,O
Sentence: 966,In,O
Sentence: 966,this,O
Sentence: 966,work,O
Sentence: 966,CCR2,O
Sentence: 966,and,O
Sentence: 966,CCL2,O
Sentence: 966,expression,O
Sentence: 966,were,O
Sentence: 966,examined,O
Sentence: 966,following,O
Sentence: 966,status,B-Disease
Sentence: 966,epilepticus,I-Disease
Sentence: 966,(,O
Sentence: 966,SE,B-Disease
Sentence: 966,),O
Sentence: 966,induced,O
Sentence: 966,by,O
Sentence: 966,pilocarpine,B-Chemical
Sentence: 966,injection,O
Sentence: 966,.,O
Sentence: 966,METHODS,O
Sentence: 966,:,O
Sentence: 966,SE,B-Disease
Sentence: 966,was,O
Sentence: 966,induced,O
Sentence: 966,by,O
Sentence: 966,pilocarpine,B-Chemical
Sentence: 966,injection,O
Sentence: 966,.,O
Sentence: 966,Control,O
Sentence: 966,rats,O
Sentence: 966,were,O
Sentence: 966,injected,O
Sentence: 966,with,O
Sentence: 966,saline,O
Sentence: 966,instead,O
Sentence: 966,of,O
Sentence: 966,pilocarpine,B-Chemical
Sentence: 966,.,O
Sentence: 966,Five,O
Sentence: 966,days,O
Sentence: 966,after,O
Sentence: 966,SE,B-Disease
Sentence: 966,",",O
Sentence: 966,CCR2,O
Sentence: 966,staining,O
Sentence: 966,in,O
Sentence: 966,neurons,O
Sentence: 966,and,O
Sentence: 966,glial,O
Sentence: 966,cells,O
Sentence: 966,was,O
Sentence: 966,examined,O
Sentence: 966,using,O
Sentence: 966,imunohistochemical,O
Sentence: 966,analyses,O
Sentence: 966,.,O
Sentence: 966,The,O
Sentence: 966,number,O
Sentence: 966,of,O
Sentence: 966,CCR2,O
Sentence: 966,positive,O
Sentence: 966,cells,O
Sentence: 966,was,O
Sentence: 966,determined,O
Sentence: 966,using,O
Sentence: 966,stereology,O
Sentence: 966,probes,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,hippocampus,O
Sentence: 966,.,O
Sentence: 966,CCL2,O
Sentence: 966,expression,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,hippocampus,O
Sentence: 966,was,O
Sentence: 966,examined,O
Sentence: 966,by,O
Sentence: 966,molecular,O
Sentence: 966,assay,O
Sentence: 966,.,O
Sentence: 966,RESULTS,O
Sentence: 966,:,O
Sentence: 966,Increased,O
Sentence: 966,CCR2,O
Sentence: 966,was,O
Sentence: 966,observed,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,hippocampus,O
Sentence: 966,after,O
Sentence: 966,SE,B-Disease
Sentence: 966,.,O
Sentence: 966,Seizures,B-Disease
Sentence: 966,also,O
Sentence: 966,resulted,O
Sentence: 966,in,O
Sentence: 966,alterations,O
Sentence: 966,to,O
Sentence: 966,the,O
Sentence: 966,cell,O
Sentence: 966,types,O
Sentence: 966,expressing,O
Sentence: 966,CCR2,O
Sentence: 966,.,O
Sentence: 966,Increased,O
Sentence: 966,numbers,O
Sentence: 966,of,O
Sentence: 966,neurons,O
Sentence: 966,that,O
Sentence: 966,expressed,O
Sentence: 966,CCR2,O
Sentence: 966,was,O
Sentence: 966,observed,O
Sentence: 966,following,O
Sentence: 966,SE,B-Disease
Sentence: 966,.,O
Sentence: 966,Microglial,O
Sentence: 966,cells,O
Sentence: 966,were,O
Sentence: 966,more,O
Sentence: 966,closely,O
Sentence: 966,apposed,O
Sentence: 966,to,O
Sentence: 966,the,O
Sentence: 966,CCR2,O
Sentence: 966,-,O
Sentence: 966,labeled,O
Sentence: 966,cells,O
Sentence: 966,in,O
Sentence: 966,SE,B-Disease
Sentence: 966,rats,O
Sentence: 966,.,O
Sentence: 966,In,O
Sentence: 966,addition,O
Sentence: 966,",",O
Sentence: 966,rats,O
Sentence: 966,that,O
Sentence: 966,experienced,O
Sentence: 966,SE,B-Disease
Sentence: 966,exhibited,O
Sentence: 966,CCR2,O
Sentence: 966,-,O
Sentence: 966,labeling,O
Sentence: 966,in,O
Sentence: 966,populations,O
Sentence: 966,of,O
Sentence: 966,hypertrophied,B-Disease
Sentence: 966,astrocytes,O
Sentence: 966,",",O
Sentence: 966,especially,O
Sentence: 966,in,O
Sentence: 966,CA1,O
Sentence: 966,and,O
Sentence: 966,dentate,O
Sentence: 966,gyrus,O
Sentence: 966,.,O
Sentence: 966,These,O
Sentence: 966,CCR2+,O
Sentence: 966,astroctytes,O
Sentence: 966,were,O
Sentence: 966,not,O
Sentence: 966,observed,O
Sentence: 966,in,O
Sentence: 966,control,O
Sentence: 966,rats,O
Sentence: 966,.,O
Sentence: 966,Examination,O
Sentence: 966,of,O
Sentence: 966,CCL2,O
Sentence: 966,expression,O
Sentence: 966,showed,O
Sentence: 966,that,O
Sentence: 966,it,O
Sentence: 966,was,O
Sentence: 966,elevated,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,hippocampus,O
Sentence: 966,following,O
Sentence: 966,SE,B-Disease
Sentence: 966,.,O
Sentence: 966,CONCLUSION,O
Sentence: 966,:,O
Sentence: 966,The,O
Sentence: 966,data,O
Sentence: 966,show,O
Sentence: 966,that,O
Sentence: 966,CCR2,O
Sentence: 966,and,O
Sentence: 966,CCL2,O
Sentence: 966,are,O
Sentence: 966,up,O
Sentence: 966,-,O
Sentence: 966,regulated,O
Sentence: 966,in,O
Sentence: 966,the,O
Sentence: 966,hippocampus,O
Sentence: 966,after,O
Sentence: 966,pilocarpine,B-Chemical
Sentence: 966,-,O
Sentence: 966,induced,O
Sentence: 966,SE,B-Disease
Sentence: 966,.,O
Sentence: 966,Seizures,B-Disease
Sentence: 966,also,O
Sentence: 966,result,O
Sentence: 966,in,O
Sentence: 966,changes,O
Sentence: 966,to,O
Sentence: 966,CCR2,O
Sentence: 966,receptor,O
Sentence: 966,expression,O
Sentence: 966,in,O
Sentence: 966,neurons,O
Sentence: 966,and,O
Sentence: 966,astrocytes,O
Sentence: 966,.,O
Sentence: 966,These,O
Sentence: 966,changes,O
Sentence: 966,might,O
Sentence: 966,be,O
Sentence: 966,involved,O
Sentence: 966,in,O
Sentence: 966,detrimental,O
Sentence: 966,neuroplasticity,O
Sentence: 966,and,O
Sentence: 966,neuroinflammatory,B-Disease
Sentence: 966,changes,O
Sentence: 966,that,O
Sentence: 966,occur,O
Sentence: 966,following,O
Sentence: 966,seizures,B-Disease
Sentence: 966,.,O
Sentence: 967,Metallothionein,B-Chemical
Sentence: 967,induction,O
Sentence: 967,reduces,O
Sentence: 967,caspase,O
Sentence: 967,-,O
Sentence: 967,3,O
Sentence: 967,activity,O
Sentence: 967,and,O
Sentence: 967,TNFalpha,O
Sentence: 967,levels,O
Sentence: 967,with,O
Sentence: 967,preservation,O
Sentence: 967,of,O
Sentence: 967,cognitive,O
Sentence: 967,function,O
Sentence: 967,and,O
Sentence: 967,intact,O
Sentence: 967,hippocampal,O
Sentence: 967,neurons,O
Sentence: 967,in,O
Sentence: 967,carmustine,B-Chemical
Sentence: 967,-,O
Sentence: 967,treated,O
Sentence: 967,rats,O
Sentence: 967,.,O
Sentence: 968,Hippocampal,O
Sentence: 968,integrity,O
Sentence: 968,is,O
Sentence: 968,essential,O
Sentence: 968,for,O
Sentence: 968,cognitive,O
Sentence: 968,functions,O
Sentence: 968,.,O
Sentence: 968,On,O
Sentence: 968,the,O
Sentence: 968,other,O
Sentence: 968,hand,O
Sentence: 968,",",O
Sentence: 968,induction,O
Sentence: 968,of,O
Sentence: 968,metallothionein,B-Chemical
Sentence: 968,(,O
Sentence: 968,MT,B-Chemical
Sentence: 968,),O
Sentence: 968,by,O
Sentence: 968,ZnSO,B-Chemical
Sentence: 968,(,I-Chemical
Sentence: 968,4,I-Chemical
Sentence: 968,),I-Chemical
Sentence: 968,and,O
Sentence: 968,its,O
Sentence: 968,role,O
Sentence: 968,in,O
Sentence: 968,neuroprotection,O
Sentence: 968,has,O
Sentence: 968,been,O
Sentence: 968,documented,O
Sentence: 968,.,O
Sentence: 968,The,O
Sentence: 968,present,O
Sentence: 968,study,O
Sentence: 968,aimed,O
Sentence: 968,to,O
Sentence: 968,explore,O
Sentence: 968,the,O
Sentence: 968,effect,O
Sentence: 968,of,O
Sentence: 968,MT,B-Chemical
Sentence: 968,induction,O
Sentence: 968,on,O
Sentence: 968,carmustine,B-Chemical
Sentence: 968,(,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,),O
Sentence: 968,,O
Sentence: 968,-,O
Sentence: 968,induced,O
Sentence: 968,hippocampal,O
Sentence: 968,cognitive,B-Disease
Sentence: 968,dysfunction,I-Disease
Sentence: 968,in,O
Sentence: 968,rats,O
Sentence: 968,.,O
Sentence: 968,A,O
Sentence: 968,total,O
Sentence: 968,of,O
Sentence: 968,60,O
Sentence: 968,male,O
Sentence: 968,Wistar,O
Sentence: 968,albino,O
Sentence: 968,rats,O
Sentence: 968,were,O
Sentence: 968,randomly,O
Sentence: 968,divided,O
Sentence: 968,into,O
Sentence: 968,four,O
Sentence: 968,groups,O
Sentence: 968,(,O
Sentence: 968,15,O
Sentence: 968,/,O
Sentence: 968,group,O
Sentence: 968,),O
Sentence: 968,:,O
Sentence: 968,The,O
Sentence: 968,control,O
Sentence: 968,group,O
Sentence: 968,injected,O
Sentence: 968,with,O
Sentence: 968,single,O
Sentence: 968,doses,O
Sentence: 968,of,O
Sentence: 968,normal,O
Sentence: 968,saline,O
Sentence: 968,(,O
Sentence: 968,i.c.v,O
Sentence: 968,),O
Sentence: 968,followed,O
Sentence: 968,24,O
Sentence: 968,h,O
Sentence: 968,later,O
Sentence: 968,by,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,solvent,O
Sentence: 968,(,O
Sentence: 968,i.v,O
Sentence: 968,),O
Sentence: 968,.,O
Sentence: 968,The,O
Sentence: 968,second,O
Sentence: 968,group,O
Sentence: 968,administered,O
Sentence: 968,ZnSO,B-Chemical
Sentence: 968,(,I-Chemical
Sentence: 968,4,I-Chemical
Sentence: 968,),I-Chemical
Sentence: 968,(,O
Sentence: 968,0.1,O
Sentence: 968,micromol,O
Sentence: 968,/,O
Sentence: 968,10,O
Sentence: 968,microl,O
Sentence: 968,normal,O
Sentence: 968,saline,O
Sentence: 968,",",O
Sentence: 968,i.c.v,O
Sentence: 968,",",O
Sentence: 968,once,O
Sentence: 968,),O
Sentence: 968,then,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,solvent,O
Sentence: 968,(,O
Sentence: 968,i.v,O
Sentence: 968,),O
Sentence: 968,after,O
Sentence: 968,24,O
Sentence: 968,h.,O
Sentence: 968,Third,O
Sentence: 968,group,O
Sentence: 968,received,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,(,O
Sentence: 968,20,O
Sentence: 968,mg,O
Sentence: 968,/,O
Sentence: 968,kg,O
Sentence: 968,",",O
Sentence: 968,i.v,O
Sentence: 968,",",O
Sentence: 968,once,O
Sentence: 968,),O
Sentence: 968,24,O
Sentence: 968,h,O
Sentence: 968,after,O
Sentence: 968,injection,O
Sentence: 968,with,O
Sentence: 968,normal,O
Sentence: 968,saline,O
Sentence: 968,(,O
Sentence: 968,i.c.v,O
Sentence: 968,),O
Sentence: 968,.,O
Sentence: 968,Fourth,O
Sentence: 968,group,O
Sentence: 968,received,O
Sentence: 968,a,O
Sentence: 968,single,O
Sentence: 968,dose,O
Sentence: 968,of,O
Sentence: 968,ZnSO,B-Chemical
Sentence: 968,(,I-Chemical
Sentence: 968,4,I-Chemical
Sentence: 968,),I-Chemical
Sentence: 968,(,O
Sentence: 968,0.1,O
Sentence: 968,micromol,O
Sentence: 968,/,O
Sentence: 968,10,O
Sentence: 968,microl,O
Sentence: 968,normal,O
Sentence: 968,saline,O
Sentence: 968,",",O
Sentence: 968,i.c.v,O
Sentence: 968,),O
Sentence: 968,then,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,(,O
Sentence: 968,20,O
Sentence: 968,mg,O
Sentence: 968,/,O
Sentence: 968,kg,O
Sentence: 968,",",O
Sentence: 968,i.v,O
Sentence: 968,",",O
Sentence: 968,once,O
Sentence: 968,),O
Sentence: 968,after,O
Sentence: 968,24,O
Sentence: 968,h.,O
Sentence: 968,The,O
Sentence: 968,obtained,O
Sentence: 968,data,O
Sentence: 968,revealed,O
Sentence: 968,that,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,administration,O
Sentence: 968,resulted,O
Sentence: 968,in,O
Sentence: 968,deterioration,B-Disease
Sentence: 968,of,I-Disease
Sentence: 968,learning,I-Disease
Sentence: 968,and,O
Sentence: 968,short,O
Sentence: 968,-,O
Sentence: 968,term,O
Sentence: 968,memory,O
Sentence: 968,(,O
Sentence: 968,STM,O
Sentence: 968,),O
Sentence: 968,",",O
Sentence: 968,as,O
Sentence: 968,measured,O
Sentence: 968,by,O
Sentence: 968,using,O
Sentence: 968,radial,O
Sentence: 968,arm,O
Sentence: 968,water,O
Sentence: 968,maze,O
Sentence: 968,",",O
Sentence: 968,accompanied,O
Sentence: 968,with,O
Sentence: 968,decreased,O
Sentence: 968,hippocampal,O
Sentence: 968,glutathione,B-Chemical
Sentence: 968,reductase,O
Sentence: 968,(,O
Sentence: 968,GR,O
Sentence: 968,),O
Sentence: 968,activity,O
Sentence: 968,and,O
Sentence: 968,reduced,O
Sentence: 968,glutathione,B-Chemical
Sentence: 968,(,O
Sentence: 968,GSH,B-Chemical
Sentence: 968,),O
Sentence: 968,content,O
Sentence: 968,.,O
Sentence: 968,Also,O
Sentence: 968,",",O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,administration,O
Sentence: 968,increased,O
Sentence: 968,serum,O
Sentence: 968,tumor,B-Disease
Sentence: 968,necrosis,B-Disease
Sentence: 968,factor,O
Sentence: 968,-,O
Sentence: 968,alpha,O
Sentence: 968,(,O
Sentence: 968,TNFalpha,O
Sentence: 968,),O
Sentence: 968,",",O
Sentence: 968,hippocampal,O
Sentence: 968,MT,B-Chemical
Sentence: 968,and,O
Sentence: 968,malondialdehyde,B-Chemical
Sentence: 968,(,O
Sentence: 968,MDA,B-Chemical
Sentence: 968,),O
Sentence: 968,contents,O
Sentence: 968,as,O
Sentence: 968,well,O
Sentence: 968,as,O
Sentence: 968,caspase,O
Sentence: 968,-,O
Sentence: 968,3,O
Sentence: 968,activity,O
Sentence: 968,in,O
Sentence: 968,addition,O
Sentence: 968,to,O
Sentence: 968,histological,O
Sentence: 968,alterations,O
Sentence: 968,.,O
Sentence: 968,ZnSO,B-Chemical
Sentence: 968,(,I-Chemical
Sentence: 968,4,I-Chemical
Sentence: 968,),I-Chemical
Sentence: 968,pretreatment,O
Sentence: 968,counteracted,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,-,O
Sentence: 968,induced,O
Sentence: 968,inhibition,O
Sentence: 968,of,O
Sentence: 968,GR,O
Sentence: 968,and,O
Sentence: 968,depletion,O
Sentence: 968,of,O
Sentence: 968,GSH,B-Chemical
Sentence: 968,and,O
Sentence: 968,resulted,O
Sentence: 968,in,O
Sentence: 968,significant,O
Sentence: 968,reduction,O
Sentence: 968,in,O
Sentence: 968,the,O
Sentence: 968,levels,O
Sentence: 968,of,O
Sentence: 968,MDA,B-Chemical
Sentence: 968,and,O
Sentence: 968,TNFalpha,O
Sentence: 968,as,O
Sentence: 968,well,O
Sentence: 968,as,O
Sentence: 968,the,O
Sentence: 968,activity,O
Sentence: 968,of,O
Sentence: 968,caspase,O
Sentence: 968,-,O
Sentence: 968,3,O
Sentence: 968,.,O
Sentence: 968,The,O
Sentence: 968,histological,O
Sentence: 968,features,O
Sentence: 968,were,O
Sentence: 968,improved,O
Sentence: 968,in,O
Sentence: 968,hippocampus,O
Sentence: 968,of,O
Sentence: 968,rats,O
Sentence: 968,treated,O
Sentence: 968,with,O
Sentence: 968,ZnSO,B-Chemical
Sentence: 968,(,I-Chemical
Sentence: 968,4,I-Chemical
Sentence: 968,),I-Chemical
Sentence: 968,+,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,compared,O
Sentence: 968,to,O
Sentence: 968,only,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,-,O
Sentence: 968,treated,O
Sentence: 968,animals,O
Sentence: 968,.,O
Sentence: 968,In,O
Sentence: 968,conclusion,O
Sentence: 968,",",O
Sentence: 968,MT,B-Chemical
Sentence: 968,induction,O
Sentence: 968,halts,O
Sentence: 968,BCNU,B-Chemical
Sentence: 968,-,O
Sentence: 968,induced,O
Sentence: 968,hippocampal,O
Sentence: 968,toxicity,B-Disease
Sentence: 968,as,O
Sentence: 968,it,O
Sentence: 968,prevented,O
Sentence: 968,GR,O
Sentence: 968,inhibition,O
Sentence: 968,and,O
Sentence: 968,GSH,B-Chemical
Sentence: 968,depletion,O
Sentence: 968,and,O
Sentence: 968,counteracted,O
Sentence: 968,the,O
Sentence: 968,increased,O
Sentence: 968,levels,O
Sentence: 968,of,O
Sentence: 968,TNFalpha,O
Sentence: 968,",",O
Sentence: 968,MDA,B-Chemical
Sentence: 968,and,O
Sentence: 968,caspase,O
Sentence: 968,-,O
Sentence: 968,3,O
Sentence: 968,activity,O
Sentence: 968,with,O
Sentence: 968,subsequent,O
Sentence: 968,preservation,O
Sentence: 968,of,O
Sentence: 968,cognition,O
Sentence: 968,.,O
Sentence: 969,Fatal,O
Sentence: 969,carbamazepine,B-Chemical
Sentence: 969,induced,O
Sentence: 969,fulminant,B-Disease
Sentence: 969,eosinophilic,I-Disease
Sentence: 969,(,O
Sentence: 969,hypersensitivity,B-Disease
Sentence: 969,),O
Sentence: 969,myocarditis,B-Disease
Sentence: 969,:,O
Sentence: 969,emphasis,O
Sentence: 969,on,O
Sentence: 969,anatomical,O
Sentence: 969,and,O
Sentence: 969,histological,O
Sentence: 969,characteristics,O
Sentence: 969,",",O
Sentence: 969,mechanisms,O
Sentence: 969,and,O
Sentence: 969,genetics,O
Sentence: 969,of,O
Sentence: 969,drug,B-Disease
Sentence: 969,hypersensitivity,I-Disease
Sentence: 969,and,O
Sentence: 969,differential,O
Sentence: 969,diagnosis,O
Sentence: 969,.,O
Sentence: 970,The,O
Sentence: 970,most,O
Sentence: 970,severe,O
Sentence: 970,adverse,O
Sentence: 970,reactions,O
Sentence: 970,to,O
Sentence: 970,carbamazepine,B-Chemical
Sentence: 970,have,O
Sentence: 970,been,O
Sentence: 970,observed,O
Sentence: 970,in,O
Sentence: 970,the,O
Sentence: 970,haemopoietic,O
Sentence: 970,system,O
Sentence: 970,",",O
Sentence: 970,the,O
Sentence: 970,liver,O
Sentence: 970,and,O
Sentence: 970,the,O
Sentence: 970,cardiovascular,O
Sentence: 970,system,O
Sentence: 970,.,O
Sentence: 970,A,O
Sentence: 970,frequently,O
Sentence: 970,fatal,O
Sentence: 970,",",O
Sentence: 970,although,O
Sentence: 970,exceptionally,O
Sentence: 970,rare,O
Sentence: 970,side,O
Sentence: 970,effect,O
Sentence: 970,of,O
Sentence: 970,carbamazepine,B-Chemical
Sentence: 970,is,O
Sentence: 970,necrotizing,O
Sentence: 970,eosinophilic,O
Sentence: 970,(,O
Sentence: 970,hypersensitivity,B-Disease
Sentence: 970,),O
Sentence: 970,myocarditis,B-Disease
Sentence: 970,.,O
Sentence: 970,We,O
Sentence: 970,report,O
Sentence: 970,a,O
Sentence: 970,case,O
Sentence: 970,of,O
Sentence: 970,hypersensitivity,B-Disease
Sentence: 970,myocarditis,B-Disease
Sentence: 970,secondary,O
Sentence: 970,to,O
Sentence: 970,administration,O
Sentence: 970,of,O
Sentence: 970,carbamazepine,B-Chemical
Sentence: 970,.,O
Sentence: 970,Acute,O
Sentence: 970,hypersensitivity,B-Disease
Sentence: 970,myocarditis,B-Disease
Sentence: 970,was,O
Sentence: 970,not,O
Sentence: 970,suspected,O
Sentence: 970,clinically,O
Sentence: 970,",",O
Sentence: 970,and,O
Sentence: 970,the,O
Sentence: 970,diagnosis,O
Sentence: 970,was,O
Sentence: 970,made,O
Sentence: 970,post,O
Sentence: 970,-,O
Sentence: 970,mortem,O
Sentence: 970,.,O
Sentence: 970,Histology,O
Sentence: 970,revealed,O
Sentence: 970,diffuse,O
Sentence: 970,infiltration,O
Sentence: 970,of,O
Sentence: 970,the,O
Sentence: 970,myocardium,O
Sentence: 970,by,O
Sentence: 970,eosinophils,O
Sentence: 970,and,O
Sentence: 970,lymphocytes,O
Sentence: 970,with,O
Sentence: 970,myocyte,O
Sentence: 970,damage,O
Sentence: 970,.,O
Sentence: 970,Clinically,O
Sentence: 970,",",O
Sentence: 970,death,O
Sentence: 970,was,O
Sentence: 970,due,O
Sentence: 970,to,O
Sentence: 970,cardiogenic,B-Disease
Sentence: 970,shock,I-Disease
Sentence: 970,.,O
Sentence: 970,To,O
Sentence: 970,best,O
Sentence: 970,of,O
Sentence: 970,our,O
Sentence: 970,knowledge,O
Sentence: 970,this,O
Sentence: 970,is,O
Sentence: 970,the,O
Sentence: 970,second,O
Sentence: 970,case,O
Sentence: 970,of,O
Sentence: 970,fatal,O
Sentence: 970,carbamazepine,B-Chemical
Sentence: 970,induced,O
Sentence: 970,myocarditis,B-Disease
Sentence: 970,reported,O
Sentence: 970,in,O
Sentence: 970,English,O
Sentence: 970,literature,O
Sentence: 970,.,O
Sentence: 971,Neuropsychiatric,O
Sentence: 971,behaviors,O
Sentence: 971,in,O
Sentence: 971,the,O
Sentence: 971,MPTP,B-Chemical
Sentence: 971,marmoset,O
Sentence: 971,model,O
Sentence: 971,of,O
Sentence: 971,Parkinson,B-Disease
Sentence: 971,'s,I-Disease
Sentence: 971,disease,I-Disease
Sentence: 971,.,O
Sentence: 972,OBJECTIVES,O
Sentence: 972,:,O
Sentence: 972,Neuropsychiatric,O
Sentence: 972,symptoms,O
Sentence: 972,are,O
Sentence: 972,increasingly,O
Sentence: 972,recognised,O
Sentence: 972,as,O
Sentence: 972,a,O
Sentence: 972,significant,O
Sentence: 972,problem,O
Sentence: 972,in,O
Sentence: 972,patients,O
Sentence: 972,with,O
Sentence: 972,Parkinson,B-Disease
Sentence: 972,'s,I-Disease
Sentence: 972,disease,I-Disease
Sentence: 972,(,O
Sentence: 972,PD,B-Disease
Sentence: 972,),O
Sentence: 972,.,O
Sentence: 972,These,O
Sentence: 972,symptoms,O
Sentence: 972,may,O
Sentence: 972,be,O
Sentence: 972,due,O
Sentence: 972,to,O
Sentence: 972,'sensitisation,O
Sentence: 972,',O
Sentence: 972,following,O
Sentence: 972,repeated,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,treatment,O
Sentence: 972,or,O
Sentence: 972,a,O
Sentence: 972,direct,O
Sentence: 972,effect,O
Sentence: 972,of,O
Sentence: 972,dopamine,B-Chemical
Sentence: 972,on,O
Sentence: 972,the,O
Sentence: 972,disease,O
Sentence: 972,state,O
Sentence: 972,.,O
Sentence: 972,The,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,-,O
Sentence: 972,treated,O
Sentence: 972,MPTP,B-Chemical
Sentence: 972,-,O
Sentence: 972,lesioned,O
Sentence: 972,marmoset,O
Sentence: 972,was,O
Sentence: 972,used,O
Sentence: 972,as,O
Sentence: 972,a,O
Sentence: 972,model,O
Sentence: 972,of,O
Sentence: 972,neuropsychiatric,B-Disease
Sentence: 972,symptoms,I-Disease
Sentence: 972,in,O
Sentence: 972,PD,B-Disease
Sentence: 972,patients,O
Sentence: 972,.,O
Sentence: 972,Here,O
Sentence: 972,we,O
Sentence: 972,compare,O
Sentence: 972,the,O
Sentence: 972,time,O
Sentence: 972,course,O
Sentence: 972,of,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,-,O
Sentence: 972,induced,O
Sentence: 972,motor,O
Sentence: 972,fluctuations,O
Sentence: 972,and,O
Sentence: 972,neuropsychiatric,O
Sentence: 972,-,O
Sentence: 972,like,O
Sentence: 972,behaviors,O
Sentence: 972,to,O
Sentence: 972,determine,O
Sentence: 972,the,O
Sentence: 972,relationship,O
Sentence: 972,between,O
Sentence: 972,duration,O
Sentence: 972,of,O
Sentence: 972,treatment,O
Sentence: 972,and,O
Sentence: 972,onset,O
Sentence: 972,of,O
Sentence: 972,symptoms,O
Sentence: 972,.,O
Sentence: 972,METHODS,O
Sentence: 972,:,O
Sentence: 972,Marmosets,O
Sentence: 972,were,O
Sentence: 972,administered,O
Sentence: 972,1,O
Sentence: 972,-,O
Sentence: 972,methyl,O
Sentence: 972,-,O
Sentence: 972,4,O
Sentence: 972,-,O
Sentence: 972,phenyl,O
Sentence: 972,-,O
Sentence: 972,"1,2,3,6",O
Sentence: 972,-,O
Sentence: 972,tetrahydropyridine,O
Sentence: 972,(,O
Sentence: 972,2.0,O
Sentence: 972,mg,O
Sentence: 972,/,O
Sentence: 972,kg,O
Sentence: 972,s.c.,O
Sentence: 972,),O
Sentence: 972,for,O
Sentence: 972,five,O
Sentence: 972,days,O
Sentence: 972,",",O
Sentence: 972,resulting,O
Sentence: 972,in,O
Sentence: 972,stable,O
Sentence: 972,parkinsonism,B-Disease
Sentence: 972,.,O
Sentence: 972,Levodopa,B-Chemical
Sentence: 972,(,O
Sentence: 972,15,O
Sentence: 972,mg,O
Sentence: 972,/,O
Sentence: 972,kg,O
Sentence: 972,and,O
Sentence: 972,benserazide,B-Chemical
Sentence: 972,",",O
Sentence: 972,3.75,O
Sentence: 972,mg,O
Sentence: 972,/,O
Sentence: 972,kg,O
Sentence: 972,),O
Sentence: 972,p.o,O
Sentence: 972,.,O
Sentence: 972,b.i.d,O
Sentence: 972,",",O
Sentence: 972,was,O
Sentence: 972,administered,O
Sentence: 972,for,O
Sentence: 972,30,O
Sentence: 972,days,O
Sentence: 972,.,O
Sentence: 972,Animals,O
Sentence: 972,were,O
Sentence: 972,evaluated,O
Sentence: 972,for,O
Sentence: 972,parkinsonian,B-Disease
Sentence: 972,disability,I-Disease
Sentence: 972,",",O
Sentence: 972,dyskinesia,B-Disease
Sentence: 972,and,O
Sentence: 972,on,O
Sentence: 972,-,O
Sentence: 972,time,O
Sentence: 972,(,O
Sentence: 972,motor,O
Sentence: 972,fluctuations,O
Sentence: 972,),O
Sentence: 972,and,O
Sentence: 972,neuropsychiatric,O
Sentence: 972,-,O
Sentence: 972,like,O
Sentence: 972,behaviors,O
Sentence: 972,on,O
Sentence: 972,Day,O
Sentence: 972,0,O
Sentence: 972,(,O
Sentence: 972,prior,O
Sentence: 972,to,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,),O
Sentence: 972,and,O
Sentence: 972,on,O
Sentence: 972,Days,O
Sentence: 972,1,O
Sentence: 972,",",O
Sentence: 972,7,O
Sentence: 972,",",O
Sentence: 972,13,O
Sentence: 972,",",O
Sentence: 972,27,O
Sentence: 972,and,O
Sentence: 972,30,O
Sentence: 972,of,O
Sentence: 972,treatment,O
Sentence: 972,using,O
Sentence: 972,post,O
Sentence: 972,hoc,O
Sentence: 972,DVD,O
Sentence: 972,analysis,O
Sentence: 972,by,O
Sentence: 972,a,O
Sentence: 972,trained,O
Sentence: 972,rater,O
Sentence: 972,",",O
Sentence: 972,blind,O
Sentence: 972,to,O
Sentence: 972,the,O
Sentence: 972,treatment,O
Sentence: 972,day,O
Sentence: 972,.,O
Sentence: 972,RESULTS,O
Sentence: 972,:,O
Sentence: 972,The,O
Sentence: 972,neuropsychiatric,O
Sentence: 972,-,O
Sentence: 972,like,O
Sentence: 972,behavior,O
Sentence: 972,rating,O
Sentence: 972,scale,O
Sentence: 972,demonstrated,O
Sentence: 972,high,O
Sentence: 972,interrater,O
Sentence: 972,reliability,O
Sentence: 972,between,O
Sentence: 972,three,O
Sentence: 972,trained,O
Sentence: 972,raters,O
Sentence: 972,of,O
Sentence: 972,differing,O
Sentence: 972,professional,O
Sentence: 972,backgrounds,O
Sentence: 972,.,O
Sentence: 972,As,O
Sentence: 972,anticipated,O
Sentence: 972,",",O
Sentence: 972,animals,O
Sentence: 972,exhibited,O
Sentence: 972,a,O
Sentence: 972,progressive,O
Sentence: 972,increase,O
Sentence: 972,in,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,-,O
Sentence: 972,induced,O
Sentence: 972,motor,O
Sentence: 972,fluctuations,O
Sentence: 972,",",O
Sentence: 972,dyskinesia,B-Disease
Sentence: 972,and,O
Sentence: 972,wearing,O
Sentence: 972,-,O
Sentence: 972,off,O
Sentence: 972,",",O
Sentence: 972,that,O
Sentence: 972,correlated,O
Sentence: 972,with,O
Sentence: 972,the,O
Sentence: 972,duration,O
Sentence: 972,of,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,therapy,O
Sentence: 972,.,O
Sentence: 972,In,O
Sentence: 972,contrast,O
Sentence: 972,",",O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,-,O
Sentence: 972,induced,O
Sentence: 972,neuropsychiatric,O
Sentence: 972,-,O
Sentence: 972,like,O
Sentence: 972,behaviors,O
Sentence: 972,were,O
Sentence: 972,present,O
Sentence: 972,on,O
Sentence: 972,Day,O
Sentence: 972,1,O
Sentence: 972,of,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,treatment,O
Sentence: 972,and,O
Sentence: 972,their,O
Sentence: 972,severity,O
Sentence: 972,did,O
Sentence: 972,not,O
Sentence: 972,correlate,O
Sentence: 972,with,O
Sentence: 972,duration,O
Sentence: 972,of,O
Sentence: 972,treatment,O
Sentence: 972,.,O
Sentence: 972,CONCLUSIONS,O
Sentence: 972,:,O
Sentence: 972,The,O
Sentence: 972,data,O
Sentence: 972,suggest,O
Sentence: 972,that,O
Sentence: 972,neuropsychiatric,B-Disease
Sentence: 972,disorders,I-Disease
Sentence: 972,in,O
Sentence: 972,PD,B-Disease
Sentence: 972,are,O
Sentence: 972,more,O
Sentence: 972,likely,O
Sentence: 972,an,O
Sentence: 972,interaction,O
Sentence: 972,between,O
Sentence: 972,levodopa,B-Chemical
Sentence: 972,and,O
Sentence: 972,the,O
Sentence: 972,disease,O
Sentence: 972,state,O
Sentence: 972,than,O
Sentence: 972,a,O
Sentence: 972,consequence,O
Sentence: 972,of,O
Sentence: 972,sensitisation,O
Sentence: 972,to,O
Sentence: 972,repeated,O
Sentence: 972,dopaminergic,O
Sentence: 972,therapy,O
Sentence: 972,.,O
Sentence: 973,Contrast,B-Chemical
Sentence: 973,medium,I-Chemical
Sentence: 973,nephrotoxicity,B-Disease
Sentence: 973,after,O
Sentence: 973,renal,O
Sentence: 973,artery,O
Sentence: 973,and,O
Sentence: 973,coronary,O
Sentence: 973,angioplasty,O
Sentence: 973,.,O
Sentence: 974,BACKGROUND,O
Sentence: 974,:,O
Sentence: 974,Renal,B-Disease
Sentence: 974,dysfunction,I-Disease
Sentence: 974,induced,O
Sentence: 974,by,O
Sentence: 974,iodinated,O
Sentence: 974,contrast,B-Chemical
Sentence: 974,medium,I-Chemical
Sentence: 974,(,O
Sentence: 974,CM,B-Chemical
Sentence: 974,),O
Sentence: 974,administration,O
Sentence: 974,can,O
Sentence: 974,minimize,O
Sentence: 974,the,O
Sentence: 974,benefit,O
Sentence: 974,of,O
Sentence: 974,the,O
Sentence: 974,interventional,O
Sentence: 974,procedure,O
Sentence: 974,in,O
Sentence: 974,patients,O
Sentence: 974,undergoing,O
Sentence: 974,renal,O
Sentence: 974,angioplasty,O
Sentence: 974,(,O
Sentence: 974,PTRA,O
Sentence: 974,),O
Sentence: 974,.,O
Sentence: 974,PURPOSE,O
Sentence: 974,:,O
Sentence: 974,To,O
Sentence: 974,compare,O
Sentence: 974,the,O
Sentence: 974,susceptibility,O
Sentence: 974,to,O
Sentence: 974,nephrotoxic,B-Disease
Sentence: 974,effect,O
Sentence: 974,of,O
Sentence: 974,CM,B-Chemical
Sentence: 974,in,O
Sentence: 974,patients,O
Sentence: 974,undergoing,O
Sentence: 974,PTRA,O
Sentence: 974,with,O
Sentence: 974,that,O
Sentence: 974,of,O
Sentence: 974,patients,O
Sentence: 974,submitted,O
Sentence: 974,to,O
Sentence: 974,percutaneous,O
Sentence: 974,coronary,O
Sentence: 974,intervention,O
Sentence: 974,(,O
Sentence: 974,PCI,O
Sentence: 974,),O
Sentence: 974,.,O
Sentence: 974,MATERIAL,O
Sentence: 974,AND,O
Sentence: 974,METHODS,O
Sentence: 974,:,O
Sentence: 974,A,O
Sentence: 974,total,O
Sentence: 974,of,O
Sentence: 974,33,O
Sentence: 974,patients,O
Sentence: 974,successfully,O
Sentence: 974,treated,O
Sentence: 974,with,O
Sentence: 974,PTRA,O
Sentence: 974,(,O
Sentence: 974,PTRA,O
Sentence: 974,group,O
Sentence: 974,",",O
Sentence: 974,mean,O
Sentence: 974,age,O
Sentence: 974,70+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,12,O
Sentence: 974,years,O
Sentence: 974,",",O
Sentence: 974,23,O
Sentence: 974,female,O
Sentence: 974,",",O
Sentence: 974,basal,O
Sentence: 974,creatinine,B-Chemical
Sentence: 974,1.46+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.79,O
Sentence: 974,",",O
Sentence: 974,range,O
Sentence: 974,0.7,O
Sentence: 974,-,O
Sentence: 974,4.9,O
Sentence: 974,mg,O
Sentence: 974,/,O
Sentence: 974,dl,O
Sentence: 974,),O
Sentence: 974,were,O
Sentence: 974,compared,O
Sentence: 974,with,O
Sentence: 974,33,O
Sentence: 974,patients,O
Sentence: 974,undergoing,O
Sentence: 974,successful,O
Sentence: 974,PCI,O
Sentence: 974,(,O
Sentence: 974,PCI,O
Sentence: 974,group,O
Sentence: 974,),O
Sentence: 974,",",O
Sentence: 974,matched,O
Sentence: 974,for,O
Sentence: 974,basal,O
Sentence: 974,creatinine,B-Chemical
Sentence: 974,(,O
Sentence: 974,1.44+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.6,O
Sentence: 974,",",O
Sentence: 974,range,O
Sentence: 974,0.7,O
Sentence: 974,-,O
Sentence: 974,3.4,O
Sentence: 974,mg,O
Sentence: 974,/,O
Sentence: 974,dl,O
Sentence: 974,),O
Sentence: 974,",",O
Sentence: 974,gender,O
Sentence: 974,",",O
Sentence: 974,and,O
Sentence: 974,age,O
Sentence: 974,.,O
Sentence: 974,In,O
Sentence: 974,both,O
Sentence: 974,groups,O
Sentence: 974,postprocedural,O
Sentence: 974,(,O
Sentence: 974,48,O
Sentence: 974,h,O
Sentence: 974,),O
Sentence: 974,serum,O
Sentence: 974,creatinine,B-Chemical
Sentence: 974,was,O
Sentence: 974,measured,O
Sentence: 974,.,O
Sentence: 974,RESULTS,O
Sentence: 974,:,O
Sentence: 974,Postprocedural,O
Sentence: 974,creatinine,B-Chemical
Sentence: 974,level,O
Sentence: 974,decreased,O
Sentence: 974,nonsignificantly,O
Sentence: 974,in,O
Sentence: 974,the,O
Sentence: 974,PTRA,O
Sentence: 974,group,O
Sentence: 974,(,O
Sentence: 974,1.46+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.8,O
Sentence: 974,vs.,O
Sentence: 974,1.34+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.5,O
Sentence: 974,mg,O
Sentence: 974,/,O
Sentence: 974,dl,O
Sentence: 974,",",O
Sentence: 974,P,O
Sentence: 974,=,O
Sentence: 974,NS,O
Sentence: 974,),O
Sentence: 974,and,O
Sentence: 974,increased,O
Sentence: 974,significantly,O
Sentence: 974,in,O
Sentence: 974,the,O
Sentence: 974,PCI,O
Sentence: 974,group,O
Sentence: 974,(,O
Sentence: 974,1.44+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.6,O
Sentence: 974,vs.,O
Sentence: 974,1.57+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.7,O
Sentence: 974,mg,O
Sentence: 974,/,O
Sentence: 974,dl,O
Sentence: 974,",",O
Sentence: 974,p,O
Sentence: 974,,O
Sentence: 974,<,O
Sentence: 974,,O
Sentence: 974,0.02,O
Sentence: 974,),O
Sentence: 974,.,O
Sentence: 974,Changes,O
Sentence: 974,in,O
Sentence: 974,serum,O
Sentence: 974,creatinine,B-Chemical
Sentence: 974,after,O
Sentence: 974,intervention,O
Sentence: 974,(,O
Sentence: 974,after,O
Sentence: 974,-,O
Sentence: 974,before,O
Sentence: 974,),O
Sentence: 974,were,O
Sentence: 974,significantly,O
Sentence: 974,different,O
Sentence: 974,between,O
Sentence: 974,the,O
Sentence: 974,PTRA,O
Sentence: 974,and,O
Sentence: 974,PCI,O
Sentence: 974,groups,O
Sentence: 974,(,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.12+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.5,O
Sentence: 974,vs.,O
Sentence: 974,0.13+,O
Sentence: 974,/,O
Sentence: 974,,O
Sentence: 974,-,O
Sentence: 974,0.3,O
Sentence: 974,",",O
Sentence: 974,P,O
Sentence: 974,=,O
Sentence: 974,0.014,O
Sentence: 974,),O
Sentence: 974,.,O
Sentence: 974,This,O
Sentence: 974,difference,O
Sentence: 974,was,O
Sentence: 974,not,O
Sentence: 974,related,O
Sentence: 974,to,O
Sentence: 974,either,O
Sentence: 974,a,O
Sentence: 974,different,O
Sentence: 974,clinical,O
Sentence: 974,risk,O
Sentence: 974,profile,O
Sentence: 974,or,O
Sentence: 974,to,O
Sentence: 974,the,O
Sentence: 974,volume,O
Sentence: 974,of,O
Sentence: 974,CM,B-Chemical
Sentence: 974,administered,O
Sentence: 974,.,O
Sentence: 974,CONCLUSION,O
Sentence: 974,:,O
Sentence: 974,In,O
Sentence: 974,this,O
Sentence: 974,preliminary,O
Sentence: 974,study,O
Sentence: 974,patients,O
Sentence: 974,submitted,O
Sentence: 974,to,O
Sentence: 974,PTRA,O
Sentence: 974,showed,O
Sentence: 974,a,O
Sentence: 974,lower,O
Sentence: 974,susceptibility,O
Sentence: 974,to,O
Sentence: 974,renal,B-Disease
Sentence: 974,damage,I-Disease
Sentence: 974,induced,O
Sentence: 974,by,O
Sentence: 974,CM,B-Chemical
Sentence: 974,administration,O
Sentence: 974,than,O
Sentence: 974,PCI,O
Sentence: 974,patients,O
Sentence: 974,.,O
Sentence: 974,The,O
Sentence: 974,effectiveness,O
Sentence: 974,of,O
Sentence: 974,PTRA,O
Sentence: 974,on,O
Sentence: 974,renal,O
Sentence: 974,function,O
Sentence: 974,seems,O
Sentence: 974,to,O
Sentence: 974,be,O
Sentence: 974,barely,O
Sentence: 974,influenced,O
Sentence: 974,by,O
Sentence: 974,CM,B-Chemical
Sentence: 974,toxicity,B-Disease
Sentence: 974,.,O
Sentence: 975,Medical,O
Sentence: 975,and,O
Sentence: 975,psychiatric,O
Sentence: 975,outcomes,O
Sentence: 975,for,O
Sentence: 975,patients,O
Sentence: 975,transplanted,O
Sentence: 975,for,O
Sentence: 975,acetaminophen,B-Chemical
Sentence: 975,-,O
Sentence: 975,induced,O
Sentence: 975,acute,B-Disease
Sentence: 975,liver,I-Disease
Sentence: 975,failure,I-Disease
Sentence: 975,:,O
Sentence: 975,a,O
Sentence: 975,case,O
Sentence: 975,-,O
Sentence: 975,control,O
Sentence: 975,study,O
Sentence: 975,.,O
Sentence: 976,BACKGROUND,O
Sentence: 976,:,O
Sentence: 976,Acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,hepatotoxicity,B-Disease
Sentence: 976,is,O
Sentence: 976,the,O
Sentence: 976,most,O
Sentence: 976,common,O
Sentence: 976,cause,O
Sentence: 976,of,O
Sentence: 976,acute,B-Disease
Sentence: 976,liver,I-Disease
Sentence: 976,failure,I-Disease
Sentence: 976,(,O
Sentence: 976,ALF,B-Disease
Sentence: 976,),O
Sentence: 976,in,O
Sentence: 976,the,O
Sentence: 976,UK,O
Sentence: 976,.,O
Sentence: 976,Patients,O
Sentence: 976,often,O
Sentence: 976,consume,O
Sentence: 976,the,O
Sentence: 976,drug,O
Sentence: 976,with,O
Sentence: 976,suicidal,O
Sentence: 976,intent,O
Sentence: 976,or,O
Sentence: 976,with,O
Sentence: 976,a,O
Sentence: 976,background,O
Sentence: 976,of,O
Sentence: 976,substance,O
Sentence: 976,dependence,O
Sentence: 976,.,O
Sentence: 976,AIMS,O
Sentence: 976,AND,O
Sentence: 976,METHODS,O
Sentence: 976,:,O
Sentence: 976,We,O
Sentence: 976,compared,O
Sentence: 976,the,O
Sentence: 976,severity,O
Sentence: 976,of,O
Sentence: 976,pretransplant,O
Sentence: 976,illness,O
Sentence: 976,",",O
Sentence: 976,psychiatric,O
Sentence: 976,co,O
Sentence: 976,-,O
Sentence: 976,morbidity,O
Sentence: 976,",",O
Sentence: 976,medical,O
Sentence: 976,and,O
Sentence: 976,psychosocial,O
Sentence: 976,outcomes,O
Sentence: 976,of,O
Sentence: 976,all,O
Sentence: 976,patients,O
Sentence: 976,who,O
Sentence: 976,had,O
Sentence: 976,undergone,O
Sentence: 976,liver,O
Sentence: 976,transplantation,O
Sentence: 976,(,O
Sentence: 976,LT,O
Sentence: 976,),O
Sentence: 976,emergently,O
Sentence: 976,between,O
Sentence: 976,1999,O
Sentence: 976,-,O
Sentence: 976,2004,O
Sentence: 976,for,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,(,O
Sentence: 976,n,O
Sentence: 976,=,O
Sentence: 976,36,O
Sentence: 976,),O
Sentence: 976,with,O
Sentence: 976,age,O
Sentence: 976,-,O
Sentence: 976,,O
Sentence: 976,and,O
Sentence: 976,sex,O
Sentence: 976,-,O
Sentence: 976,matched,O
Sentence: 976,patients,O
Sentence: 976,undergoing,O
Sentence: 976,emergent,O
Sentence: 976,LT,O
Sentence: 976,for,O
Sentence: 976,non,O
Sentence: 976,-,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,(,O
Sentence: 976,n,O
Sentence: 976,=,O
Sentence: 976,35,O
Sentence: 976,),O
Sentence: 976,and,O
Sentence: 976,elective,O
Sentence: 976,LT,O
Sentence: 976,for,O
Sentence: 976,chronic,B-Disease
Sentence: 976,liver,I-Disease
Sentence: 976,disease,I-Disease
Sentence: 976,(,O
Sentence: 976,CLD,B-Disease
Sentence: 976,",",O
Sentence: 976,n,O
Sentence: 976,=,O
Sentence: 976,34,O
Sentence: 976,),O
Sentence: 976,.,O
Sentence: 976,RESULTS,O
Sentence: 976,:,O
Sentence: 976,Acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,patients,O
Sentence: 976,undergoing,O
Sentence: 976,LT,O
Sentence: 976,had,O
Sentence: 976,a,O
Sentence: 976,greater,O
Sentence: 976,severity,O
Sentence: 976,of,O
Sentence: 976,pre,O
Sentence: 976,-,O
Sentence: 976,LT,O
Sentence: 976,illness,O
Sentence: 976,reflected,O
Sentence: 976,by,O
Sentence: 976,higher,O
Sentence: 976,Acute,O
Sentence: 976,Physiology,O
Sentence: 976,and,O
Sentence: 976,Chronic,O
Sentence: 976,Health,O
Sentence: 976,Evaluation,O
Sentence: 976,II,O
Sentence: 976,scores,O
Sentence: 976,and,O
Sentence: 976,requirement,O
Sentence: 976,for,O
Sentence: 976,organ,O
Sentence: 976,support,O
Sentence: 976,compared,O
Sentence: 976,with,O
Sentence: 976,the,O
Sentence: 976,other,O
Sentence: 976,two,O
Sentence: 976,groups,O
Sentence: 976,.,O
Sentence: 976,Twenty,O
Sentence: 976,(,O
Sentence: 976,56,O
Sentence: 976,%,O
Sentence: 976,),O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,patients,O
Sentence: 976,had,O
Sentence: 976,a,O
Sentence: 976,formal,O
Sentence: 976,psychiatric,O
Sentence: 976,diagnosis,O
Sentence: 976,before,O
Sentence: 976,LT,O
Sentence: 976,(,O
Sentence: 976,non,O
Sentence: 976,-,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,=,O
Sentence: 976,0,O
Sentence: 976,/,O
Sentence: 976,35,O
Sentence: 976,",",O
Sentence: 976,CLD,B-Disease
Sentence: 976,=,O
Sentence: 976,2,O
Sentence: 976,/,O
Sentence: 976,34,O
Sentence: 976,;,O
Sentence: 976,p,O
Sentence: 976,,O
Sentence: 976,<,O
Sentence: 976,,O
Sentence: 976,0.01,O
Sentence: 976,for,O
Sentence: 976,all,O
Sentence: 976,),O
Sentence: 976,and,O
Sentence: 976,nine,O
Sentence: 976,(,O
Sentence: 976,25,O
Sentence: 976,%,O
Sentence: 976,),O
Sentence: 976,had,O
Sentence: 976,a,O
Sentence: 976,previous,O
Sentence: 976,suicide,O
Sentence: 976,attempt,O
Sentence: 976,.,O
Sentence: 976,During,O
Sentence: 976,follow,O
Sentence: 976,-,O
Sentence: 976,up,O
Sentence: 976,(,O
Sentence: 976,median,O
Sentence: 976,5,O
Sentence: 976,years,O
Sentence: 976,),O
Sentence: 976,",",O
Sentence: 976,there,O
Sentence: 976,were,O
Sentence: 976,no,O
Sentence: 976,significant,O
Sentence: 976,differences,O
Sentence: 976,in,O
Sentence: 976,rejection,O
Sentence: 976,(,O
Sentence: 976,acute,O
Sentence: 976,and,O
Sentence: 976,chronic,O
Sentence: 976,),O
Sentence: 976,",",O
Sentence: 976,graft,O
Sentence: 976,failure,O
Sentence: 976,or,O
Sentence: 976,survival,O
Sentence: 976,between,O
Sentence: 976,the,O
Sentence: 976,groups,O
Sentence: 976,(,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,1,O
Sentence: 976,year,O
Sentence: 976,87,O
Sentence: 976,%,O
Sentence: 976,",",O
Sentence: 976,5,O
Sentence: 976,years,O
Sentence: 976,75,O
Sentence: 976,%,O
Sentence: 976,;,O
Sentence: 976,non,O
Sentence: 976,-,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,88,O
Sentence: 976,%,O
Sentence: 976,",",O
Sentence: 976,78,O
Sentence: 976,%,O
Sentence: 976,;,O
Sentence: 976,CLD,B-Disease
Sentence: 976,93,O
Sentence: 976,%,O
Sentence: 976,",",O
Sentence: 976,82,O
Sentence: 976,%,O
Sentence: 976,:,O
Sentence: 976,P,O
Sentence: 976,,O
Sentence: 976,>,O
Sentence: 976,,O
Sentence: 976,0.6,O
Sentence: 976,log,O
Sentence: 976,rank,O
Sentence: 976,),O
Sentence: 976,.,O
Sentence: 976,Two,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,patients,O
Sentence: 976,reattempted,O
Sentence: 976,suicide,O
Sentence: 976,post,O
Sentence: 976,-,O
Sentence: 976,LT,O
Sentence: 976,(,O
Sentence: 976,one,O
Sentence: 976,died,O
Sentence: 976,8,O
Sentence: 976,years,O
Sentence: 976,post,O
Sentence: 976,-,O
Sentence: 976,LT,O
Sentence: 976,),O
Sentence: 976,.,O
Sentence: 976,CONCLUSIONS,O
Sentence: 976,:,O
Sentence: 976,Despite,O
Sentence: 976,a,O
Sentence: 976,high,O
Sentence: 976,prevalence,O
Sentence: 976,of,O
Sentence: 976,psychiatric,O
Sentence: 976,disturbance,O
Sentence: 976,",",O
Sentence: 976,outcomes,O
Sentence: 976,for,O
Sentence: 976,patients,O
Sentence: 976,transplanted,O
Sentence: 976,emergently,O
Sentence: 976,for,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,were,O
Sentence: 976,comparable,O
Sentence: 976,to,O
Sentence: 976,those,O
Sentence: 976,transplanted,O
Sentence: 976,for,O
Sentence: 976,non,O
Sentence: 976,-,O
Sentence: 976,acetaminophen,B-Chemical
Sentence: 976,-,O
Sentence: 976,induced,O
Sentence: 976,ALF,B-Disease
Sentence: 976,and,O
Sentence: 976,electively,O
Sentence: 976,for,O
Sentence: 976,CLD,B-Disease
Sentence: 976,.,O
Sentence: 976,Multidisciplinary,O
Sentence: 976,approaches,O
Sentence: 976,with,O
Sentence: 976,long,O
Sentence: 976,-,O
Sentence: 976,term,O
Sentence: 976,psychiatric,O
Sentence: 976,follow,O
Sentence: 976,-,O
Sentence: 976,up,O
Sentence: 976,may,O
Sentence: 976,contribute,O
Sentence: 976,to,O
Sentence: 976,low,O
Sentence: 976,post,O
Sentence: 976,-,O
Sentence: 976,transplant,O
Sentence: 976,suicide,O
Sentence: 976,rates,O
Sentence: 976,seen,O
Sentence: 976,and,O
Sentence: 976,low,O
Sentence: 976,rates,O
Sentence: 976,of,O
Sentence: 976,graft,O
Sentence: 976,loss,O
Sentence: 976,because,O
Sentence: 976,of,O
Sentence: 976,non,O
Sentence: 976,-,O
Sentence: 976,compliance,O
Sentence: 976,.,O
Sentence: 977,Studies,O
Sentence: 977,of,O
Sentence: 977,synergy,O
Sentence: 977,between,O
Sentence: 977,morphine,B-Chemical
Sentence: 977,and,O
Sentence: 977,a,O
Sentence: 977,novel,O
Sentence: 977,sodium,B-Chemical
Sentence: 977,channel,O
Sentence: 977,blocker,O
Sentence: 977,",",O
Sentence: 977,CNSB002,B-Chemical
Sentence: 977,",",O
Sentence: 977,in,O
Sentence: 977,rat,O
Sentence: 977,models,O
Sentence: 977,of,O
Sentence: 977,inflammatory,O
Sentence: 977,and,O
Sentence: 977,neuropathic,B-Disease
Sentence: 977,pain,I-Disease
Sentence: 977,.,O
Sentence: 978,OBJECTIVE,O
Sentence: 978,:,O
Sentence: 978,This,O
Sentence: 978,study,O
Sentence: 978,determined,O
Sentence: 978,the,O
Sentence: 978,antihyperalgesic,O
Sentence: 978,effect,O
Sentence: 978,of,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,",",O
Sentence: 978,a,O
Sentence: 978,sodium,B-Chemical
Sentence: 978,channel,O
Sentence: 978,blocker,O
Sentence: 978,with,O
Sentence: 978,antioxidant,O
Sentence: 978,properties,O
Sentence: 978,given,O
Sentence: 978,alone,O
Sentence: 978,and,O
Sentence: 978,in,O
Sentence: 978,combinations,O
Sentence: 978,with,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,in,O
Sentence: 978,rat,O
Sentence: 978,models,O
Sentence: 978,of,O
Sentence: 978,inflammatory,O
Sentence: 978,and,O
Sentence: 978,neuropathic,B-Disease
Sentence: 978,pain,B-Disease
Sentence: 978,.,O
Sentence: 978,DESIGN,O
Sentence: 978,:,O
Sentence: 978,Dose,O
Sentence: 978,response,O
Sentence: 978,curves,O
Sentence: 978,for,O
Sentence: 978,nonsedating,O
Sentence: 978,doses,O
Sentence: 978,of,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,and,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,given,O
Sentence: 978,intraperitoneally,O
Sentence: 978,alone,O
Sentence: 978,and,O
Sentence: 978,together,O
Sentence: 978,in,O
Sentence: 978,combinations,O
Sentence: 978,were,O
Sentence: 978,constructed,O
Sentence: 978,for,O
Sentence: 978,antihyperalgesic,O
Sentence: 978,effect,O
Sentence: 978,using,O
Sentence: 978,paw,O
Sentence: 978,withdrawal,O
Sentence: 978,from,O
Sentence: 978,noxious,O
Sentence: 978,heat,O
Sentence: 978,in,O
Sentence: 978,two,O
Sentence: 978,rat,O
Sentence: 978,pain,B-Disease
Sentence: 978,models,O
Sentence: 978,:,O
Sentence: 978,carrageenan,B-Chemical
Sentence: 978,-,O
Sentence: 978,induced,O
Sentence: 978,paw,O
Sentence: 978,inflammation,B-Disease
Sentence: 978,and,O
Sentence: 978,streptozotocin,B-Chemical
Sentence: 978,(,O
Sentence: 978,STZ,B-Chemical
Sentence: 978,),O
Sentence: 978,,O
Sentence: 978,-,O
Sentence: 978,induced,O
Sentence: 978,diabetic,B-Disease
Sentence: 978,neuropathy,B-Disease
Sentence: 978,.,O
Sentence: 978,RESULTS,O
Sentence: 978,:,O
Sentence: 978,The,O
Sentence: 978,maximum,O
Sentence: 978,nonsedating,O
Sentence: 978,doses,O
Sentence: 978,were,O
Sentence: 978,:,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,",",O
Sentence: 978,3.2,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,;,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,10.0,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,;,O
Sentence: 978,5.0,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,with,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,3.2,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,in,O
Sentence: 978,combination,O
Sentence: 978,.,O
Sentence: 978,The,O
Sentence: 978,doses,O
Sentence: 978,calculated,O
Sentence: 978,to,O
Sentence: 978,cause,O
Sentence: 978,50,O
Sentence: 978,%,O
Sentence: 978,reversal,O
Sentence: 978,of,O
Sentence: 978,hyperalgesia,B-Disease
Sentence: 978,(,O
Sentence: 978,ED50,O
Sentence: 978,),O
Sentence: 978,were,O
Sentence: 978,7.54,O
Sentence: 978,(,O
Sentence: 978,1.81,O
Sentence: 978,),O
Sentence: 978,and,O
Sentence: 978,4.83,O
Sentence: 978,(,O
Sentence: 978,1.54,O
Sentence: 978,),O
Sentence: 978,in,O
Sentence: 978,the,O
Sentence: 978,carrageenan,B-Chemical
Sentence: 978,model,O
Sentence: 978,and,O
Sentence: 978,44.18,O
Sentence: 978,(,O
Sentence: 978,1.37,O
Sentence: 978,),O
Sentence: 978,and,O
Sentence: 978,9.14,O
Sentence: 978,(,O
Sentence: 978,1.24,O
Sentence: 978,),O
Sentence: 978,in,O
Sentence: 978,the,O
Sentence: 978,STZ,B-Chemical
Sentence: 978,-,O
Sentence: 978,induced,O
Sentence: 978,neuropathy,B-Disease
Sentence: 978,model,O
Sentence: 978,for,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,and,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,",",O
Sentence: 978,respectively,O
Sentence: 978,(,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,;,O
Sentence: 978,mean,O
Sentence: 978,",",O
Sentence: 978,SEM,O
Sentence: 978,),O
Sentence: 978,.,O
Sentence: 978,These,O
Sentence: 978,values,O
Sentence: 978,were,O
Sentence: 978,greater,O
Sentence: 978,than,O
Sentence: 978,the,O
Sentence: 978,maximum,O
Sentence: 978,nonsedating,O
Sentence: 978,doses,O
Sentence: 978,.,O
Sentence: 978,The,O
Sentence: 978,ED50,O
Sentence: 978,values,O
Sentence: 978,for,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,when,O
Sentence: 978,given,O
Sentence: 978,in,O
Sentence: 978,combination,O
Sentence: 978,with,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,(,O
Sentence: 978,5,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,),O
Sentence: 978,were,O
Sentence: 978,less,O
Sentence: 978,than,O
Sentence: 978,the,O
Sentence: 978,maximum,O
Sentence: 978,nonsedating,O
Sentence: 978,dose,O
Sentence: 978,:,O
Sentence: 978,0.56,O
Sentence: 978,(,O
Sentence: 978,1.55,O
Sentence: 978,),O
Sentence: 978,in,O
Sentence: 978,the,O
Sentence: 978,carrageenan,B-Chemical
Sentence: 978,model,O
Sentence: 978,and,O
Sentence: 978,1.37,O
Sentence: 978,(,O
Sentence: 978,1.23,O
Sentence: 978,),O
Sentence: 978,in,O
Sentence: 978,the,O
Sentence: 978,neuropathy,B-Disease
Sentence: 978,model,O
Sentence: 978,(,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,;,O
Sentence: 978,mean,O
Sentence: 978,",",O
Sentence: 978,SEM,O
Sentence: 978,),O
Sentence: 978,.,O
Sentence: 978,The,O
Sentence: 978,antinociception,O
Sentence: 978,after,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,(,O
Sentence: 978,3.2,O
Sentence: 978,mg,O
Sentence: 978,/,O
Sentence: 978,kg,O
Sentence: 978,),O
Sentence: 978,was,O
Sentence: 978,increased,O
Sentence: 978,by,O
Sentence: 978,co,O
Sentence: 978,-,O
Sentence: 978,administration,O
Sentence: 978,with,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,from,O
Sentence: 978,28.0,O
Sentence: 978,and,O
Sentence: 978,31.7,O
Sentence: 978,%,O
Sentence: 978,to,O
Sentence: 978,114.6,O
Sentence: 978,and,O
Sentence: 978,56.9,O
Sentence: 978,%,O
Sentence: 978,reversal,O
Sentence: 978,of,O
Sentence: 978,hyperalgesia,B-Disease
Sentence: 978,in,O
Sentence: 978,the,O
Sentence: 978,inflammatory,O
Sentence: 978,and,O
Sentence: 978,neuropathic,B-Disease
Sentence: 978,models,O
Sentence: 978,",",O
Sentence: 978,respectively,O
Sentence: 978,(,O
Sentence: 978,P,O
Sentence: 978,,O
Sentence: 978,<,O
Sentence: 978,,O
Sentence: 978,0.01,O
Sentence: 978,;,O
Sentence: 978,one,O
Sentence: 978,-,O
Sentence: 978,way,O
Sentence: 978,analysis,O
Sentence: 978,of,O
Sentence: 978,variance,O
Sentence: 978,-,O
Sentence: 978,significantly,O
Sentence: 978,greater,O
Sentence: 978,than,O
Sentence: 978,either,O
Sentence: 978,drug,O
Sentence: 978,given,O
Sentence: 978,alone,O
Sentence: 978,),O
Sentence: 978,.,O
Sentence: 978,CONCLUSIONS,O
Sentence: 978,:,O
Sentence: 978,The,O
Sentence: 978,maximum,O
Sentence: 978,antihyperalgesic,O
Sentence: 978,effect,O
Sentence: 978,achievable,O
Sentence: 978,with,O
Sentence: 978,nonsedating,O
Sentence: 978,doses,O
Sentence: 978,of,O
Sentence: 978,morphine,B-Chemical
Sentence: 978,may,O
Sentence: 978,be,O
Sentence: 978,increased,O
Sentence: 978,significantly,O
Sentence: 978,when,O
Sentence: 978,the,O
Sentence: 978,drug,O
Sentence: 978,is,O
Sentence: 978,used,O
Sentence: 978,in,O
Sentence: 978,combination,O
Sentence: 978,with,O
Sentence: 978,CNSB002,B-Chemical
Sentence: 978,.,O
Sentence: 979,Heparin,B-Chemical
Sentence: 979,-,O
Sentence: 979,induced,O
Sentence: 979,thrombocytopenia,B-Disease
Sentence: 979,:,O
Sentence: 979,a,O
Sentence: 979,practical,O
Sentence: 979,review,O
Sentence: 979,.,O
Sentence: 980,Heparin,B-Chemical
Sentence: 980,-,O
Sentence: 980,induced,O
Sentence: 980,thrombocytopenia,B-Disease
Sentence: 980,(,O
Sentence: 980,HIT,B-Disease
Sentence: 980,),O
Sentence: 980,remains,O
Sentence: 980,under,O
Sentence: 980,-,O
Sentence: 980,recognized,O
Sentence: 980,despite,O
Sentence: 980,its,O
Sentence: 980,potentially,O
Sentence: 980,devastating,O
Sentence: 980,outcomes,O
Sentence: 980,.,O
Sentence: 980,It,O
Sentence: 980,begins,O
Sentence: 980,when,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,exposure,O
Sentence: 980,stimulates,O
Sentence: 980,the,O
Sentence: 980,formation,O
Sentence: 980,of,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,-,O
Sentence: 980,platelet,O
Sentence: 980,factor,O
Sentence: 980,4,O
Sentence: 980,antibodies,O
Sentence: 980,",",O
Sentence: 980,which,O
Sentence: 980,in,O
Sentence: 980,turn,O
Sentence: 980,triggers,O
Sentence: 980,the,O
Sentence: 980,release,O
Sentence: 980,of,O
Sentence: 980,procoagulant,O
Sentence: 980,platelet,O
Sentence: 980,particles,O
Sentence: 980,.,O
Sentence: 980,Thrombosis,B-Disease
Sentence: 980,and,O
Sentence: 980,thrombocytopenia,B-Disease
Sentence: 980,that,O
Sentence: 980,follow,O
Sentence: 980,comprise,O
Sentence: 980,the,O
Sentence: 980,2,O
Sentence: 980,hallmark,O
Sentence: 980,traits,O
Sentence: 980,of,O
Sentence: 980,HIT,B-Disease
Sentence: 980,",",O
Sentence: 980,with,O
Sentence: 980,the,O
Sentence: 980,former,O
Sentence: 980,largely,O
Sentence: 980,responsible,O
Sentence: 980,for,O
Sentence: 980,significant,O
Sentence: 980,vascular,O
Sentence: 980,complications,O
Sentence: 980,.,O
Sentence: 980,The,O
Sentence: 980,prevalence,O
Sentence: 980,of,O
Sentence: 980,HIT,B-Disease
Sentence: 980,varies,O
Sentence: 980,among,O
Sentence: 980,several,O
Sentence: 980,subgroups,O
Sentence: 980,",",O
Sentence: 980,with,O
Sentence: 980,greater,O
Sentence: 980,incidence,O
Sentence: 980,in,O
Sentence: 980,surgical,O
Sentence: 980,as,O
Sentence: 980,compared,O
Sentence: 980,with,O
Sentence: 980,medical,O
Sentence: 980,populations,O
Sentence: 980,.,O
Sentence: 980,HIT,B-Disease
Sentence: 980,must,O
Sentence: 980,be,O
Sentence: 980,acknowledged,O
Sentence: 980,for,O
Sentence: 980,its,O
Sentence: 980,intense,O
Sentence: 980,predilection,O
Sentence: 980,for,O
Sentence: 980,thrombosis,B-Disease
Sentence: 980,and,O
Sentence: 980,suspected,O
Sentence: 980,whenever,O
Sentence: 980,thrombosis,B-Disease
Sentence: 980,occurs,O
Sentence: 980,after,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,exposure,O
Sentence: 980,.,O
Sentence: 980,Early,O
Sentence: 980,recognition,O
Sentence: 980,that,O
Sentence: 980,incorporates,O
Sentence: 980,the,O
Sentence: 980,clinical,O
Sentence: 980,and,O
Sentence: 980,serologic,O
Sentence: 980,clues,O
Sentence: 980,is,O
Sentence: 980,paramount,O
Sentence: 980,to,O
Sentence: 980,timely,O
Sentence: 980,institution,O
Sentence: 980,of,O
Sentence: 980,treatment,O
Sentence: 980,",",O
Sentence: 980,as,O
Sentence: 980,its,O
Sentence: 980,delay,O
Sentence: 980,may,O
Sentence: 980,result,O
Sentence: 980,in,O
Sentence: 980,catastrophic,O
Sentence: 980,outcomes,O
Sentence: 980,.,O
Sentence: 980,The,O
Sentence: 980,treatment,O
Sentence: 980,of,O
Sentence: 980,HIT,B-Disease
Sentence: 980,mandates,O
Sentence: 980,an,O
Sentence: 980,immediate,O
Sentence: 980,cessation,O
Sentence: 980,of,O
Sentence: 980,all,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,exposure,O
Sentence: 980,and,O
Sentence: 980,the,O
Sentence: 980,institution,O
Sentence: 980,of,O
Sentence: 980,an,O
Sentence: 980,antithrombotic,O
Sentence: 980,therapy,O
Sentence: 980,",",O
Sentence: 980,most,O
Sentence: 980,commonly,O
Sentence: 980,using,O
Sentence: 980,a,O
Sentence: 980,direct,B-Chemical
Sentence: 980,thrombin,I-Chemical
Sentence: 980,inhibitor,I-Chemical
Sentence: 980,.,O
Sentence: 980,Current,O
Sentence: 980,``,O
Sentence: 980,diagnostic,O
Sentence: 980,'',O
Sentence: 980,tests,O
Sentence: 980,",",O
Sentence: 980,which,O
Sentence: 980,primarily,O
Sentence: 980,include,O
Sentence: 980,functional,O
Sentence: 980,and,O
Sentence: 980,antigenic,O
Sentence: 980,assays,O
Sentence: 980,",",O
Sentence: 980,have,O
Sentence: 980,more,O
Sentence: 980,of,O
Sentence: 980,a,O
Sentence: 980,confirmatory,O
Sentence: 980,than,O
Sentence: 980,diagnostic,O
Sentence: 980,role,O
Sentence: 980,in,O
Sentence: 980,the,O
Sentence: 980,management,O
Sentence: 980,of,O
Sentence: 980,HIT,B-Disease
Sentence: 980,.,O
Sentence: 980,Special,O
Sentence: 980,attention,O
Sentence: 980,must,O
Sentence: 980,be,O
Sentence: 980,paid,O
Sentence: 980,to,O
Sentence: 980,cardiac,O
Sentence: 980,patients,O
Sentence: 980,who,O
Sentence: 980,are,O
Sentence: 980,often,O
Sentence: 980,exposed,O
Sentence: 980,to,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,multiple,O
Sentence: 980,times,O
Sentence: 980,during,O
Sentence: 980,their,O
Sentence: 980,course,O
Sentence: 980,of,O
Sentence: 980,treatment,O
Sentence: 980,.,O
Sentence: 980,Direct,B-Chemical
Sentence: 980,thrombin,I-Chemical
Sentence: 980,inhibitors,I-Chemical
Sentence: 980,are,O
Sentence: 980,appropriate,O
Sentence: 980,",",O
Sentence: 980,evidence,O
Sentence: 980,-,O
Sentence: 980,based,O
Sentence: 980,alternatives,O
Sentence: 980,to,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,in,O
Sentence: 980,patients,O
Sentence: 980,with,O
Sentence: 980,a,O
Sentence: 980,history,O
Sentence: 980,of,O
Sentence: 980,HIT,B-Disease
Sentence: 980,",",O
Sentence: 980,who,O
Sentence: 980,need,O
Sentence: 980,to,O
Sentence: 980,undergo,O
Sentence: 980,percutaneous,O
Sentence: 980,coronary,O
Sentence: 980,intervention,O
Sentence: 980,.,O
Sentence: 980,As,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,remains,O
Sentence: 980,one,O
Sentence: 980,of,O
Sentence: 980,the,O
Sentence: 980,most,O
Sentence: 980,frequently,O
Sentence: 980,used,O
Sentence: 980,medications,O
Sentence: 980,today,O
Sentence: 980,with,O
Sentence: 980,potential,O
Sentence: 980,for,O
Sentence: 980,HIT,B-Disease
Sentence: 980,with,O
Sentence: 980,every,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,exposure,O
Sentence: 980,",",O
Sentence: 980,a,O
Sentence: 980,close,O
Sentence: 980,vigilance,O
Sentence: 980,of,O
Sentence: 980,platelet,O
Sentence: 980,counts,O
Sentence: 980,must,O
Sentence: 980,be,O
Sentence: 980,practiced,O
Sentence: 980,whenever,O
Sentence: 980,heparin,B-Chemical
Sentence: 980,is,O
Sentence: 980,initiated,O
Sentence: 980,.,O
Sentence: 981,Abductor,O
Sentence: 981,paralysis,B-Disease
Sentence: 981,after,O
Sentence: 981,botox,B-Chemical
Sentence: 981,injection,O
Sentence: 981,for,O
Sentence: 981,adductor,B-Disease
Sentence: 981,spasmodic,I-Disease
Sentence: 981,dysphonia,I-Disease
Sentence: 981,.,O
Sentence: 982,OBJECTIVES,O
Sentence: 982,/,O
Sentence: 982,HYPOTHESIS,O
Sentence: 982,:,O
Sentence: 982,Botulinum,O
Sentence: 982,toxin,O
Sentence: 982,(,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,),O
Sentence: 982,injections,O
Sentence: 982,into,O
Sentence: 982,the,O
Sentence: 982,thyroarytenoid,O
Sentence: 982,muscles,O
Sentence: 982,are,O
Sentence: 982,the,O
Sentence: 982,current,O
Sentence: 982,standard,O
Sentence: 982,of,O
Sentence: 982,care,O
Sentence: 982,for,O
Sentence: 982,adductor,B-Disease
Sentence: 982,spasmodic,B-Disease
Sentence: 982,dysphonia,I-Disease
Sentence: 982,(,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,),O
Sentence: 982,.,O
Sentence: 982,Reported,O
Sentence: 982,adverse,O
Sentence: 982,effects,O
Sentence: 982,include,O
Sentence: 982,a,O
Sentence: 982,period,O
Sentence: 982,of,O
Sentence: 982,breathiness,O
Sentence: 982,",",O
Sentence: 982,throat,B-Disease
Sentence: 982,pain,I-Disease
Sentence: 982,",",O
Sentence: 982,and,O
Sentence: 982,difficulty,O
Sentence: 982,with,O
Sentence: 982,swallowing,O
Sentence: 982,liquids,O
Sentence: 982,.,O
Sentence: 982,Here,O
Sentence: 982,we,O
Sentence: 982,report,O
Sentence: 982,multiple,O
Sentence: 982,cases,O
Sentence: 982,of,O
Sentence: 982,bilateral,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,following,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,injections,O
Sentence: 982,for,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,",",O
Sentence: 982,a,O
Sentence: 982,complication,O
Sentence: 982,previously,O
Sentence: 982,unreported,O
Sentence: 982,.,O
Sentence: 982,STUDY,O
Sentence: 982,DESIGN,O
Sentence: 982,:,O
Sentence: 982,Retrospective,O
Sentence: 982,case,O
Sentence: 982,series,O
Sentence: 982,.,O
Sentence: 982,METHODS,O
Sentence: 982,:,O
Sentence: 982,Patients,O
Sentence: 982,that,O
Sentence: 982,received,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,injections,O
Sentence: 982,for,O
Sentence: 982,spasmodic,B-Disease
Sentence: 982,dysphonia,I-Disease
Sentence: 982,between,O
Sentence: 982,January,O
Sentence: 982,2000,O
Sentence: 982,and,O
Sentence: 982,October,O
Sentence: 982,2009,O
Sentence: 982,were,O
Sentence: 982,evaluated,O
Sentence: 982,.,O
Sentence: 982,Patients,O
Sentence: 982,with,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,were,O
Sentence: 982,identified,O
Sentence: 982,.,O
Sentence: 982,The,O
Sentence: 982,number,O
Sentence: 982,of,O
Sentence: 982,treatments,O
Sentence: 982,received,O
Sentence: 982,and,O
Sentence: 982,adverse,O
Sentence: 982,effects,O
Sentence: 982,were,O
Sentence: 982,noted,O
Sentence: 982,.,O
Sentence: 982,For,O
Sentence: 982,patients,O
Sentence: 982,with,O
Sentence: 982,bilateral,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,",",O
Sentence: 982,age,O
Sentence: 982,",",O
Sentence: 982,sex,O
Sentence: 982,",",O
Sentence: 982,paralytic,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,dose,O
Sentence: 982,",",O
Sentence: 982,prior,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,dose,O
Sentence: 982,",",O
Sentence: 982,and,O
Sentence: 982,course,O
Sentence: 982,following,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,were,O
Sentence: 982,noted,O
Sentence: 982,.,O
Sentence: 982,RESULTS,O
Sentence: 982,:,O
Sentence: 982,From,O
Sentence: 982,a,O
Sentence: 982,database,O
Sentence: 982,of,O
Sentence: 982,452,O
Sentence: 982,patients,O
Sentence: 982,receiving,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,",",O
Sentence: 982,352,O
Sentence: 982,patients,O
Sentence: 982,had,O
Sentence: 982,been,O
Sentence: 982,diagnosed,O
Sentence: 982,with,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,.,O
Sentence: 982,Of,O
Sentence: 982,these,O
Sentence: 982,352,O
Sentence: 982,patients,O
Sentence: 982,",",O
Sentence: 982,eight,O
Sentence: 982,patients,O
Sentence: 982,suffered,O
Sentence: 982,bilateral,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,",",O
Sentence: 982,and,O
Sentence: 982,two,O
Sentence: 982,suffered,O
Sentence: 982,this,O
Sentence: 982,complication,O
Sentence: 982,twice,O
Sentence: 982,.,O
Sentence: 982,All,O
Sentence: 982,affected,O
Sentence: 982,patients,O
Sentence: 982,were,O
Sentence: 982,females,O
Sentence: 982,over,O
Sentence: 982,the,O
Sentence: 982,age,O
Sentence: 982,of,O
Sentence: 982,50,O
Sentence: 982,years,O
Sentence: 982,.,O
Sentence: 982,Most,O
Sentence: 982,patients,O
Sentence: 982,had,O
Sentence: 982,received,O
Sentence: 982,treatments,O
Sentence: 982,prior,O
Sentence: 982,to,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,and,O
Sentence: 982,continued,O
Sentence: 982,receiving,O
Sentence: 982,after,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,.,O
Sentence: 982,Seven,O
Sentence: 982,patients,O
Sentence: 982,recovered,O
Sentence: 982,after,O
Sentence: 982,a,O
Sentence: 982,brief,O
Sentence: 982,period,O
Sentence: 982,of,O
Sentence: 982,activity,O
Sentence: 982,restrictions,O
Sentence: 982,",",O
Sentence: 982,and,O
Sentence: 982,one,O
Sentence: 982,underwent,O
Sentence: 982,a,O
Sentence: 982,tracheotomy,O
Sentence: 982,.,O
Sentence: 982,The,O
Sentence: 982,incidence,O
Sentence: 982,of,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,after,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,injection,O
Sentence: 982,for,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,was,O
Sentence: 982,0.34,O
Sentence: 982,%,O
Sentence: 982,.,O
Sentence: 982,CONCLUSIONS,O
Sentence: 982,:,O
Sentence: 982,Bilateral,O
Sentence: 982,abductor,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,is,O
Sentence: 982,a,O
Sentence: 982,rare,O
Sentence: 982,complication,O
Sentence: 982,of,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,injections,O
Sentence: 982,for,O
Sentence: 982,ADSD,B-Disease
Sentence: 982,",",O
Sentence: 982,causing,O
Sentence: 982,difficulty,O
Sentence: 982,with,O
Sentence: 982,breathing,O
Sentence: 982,upon,O
Sentence: 982,exertion,O
Sentence: 982,.,O
Sentence: 982,The,O
Sentence: 982,likely,O
Sentence: 982,mechanism,O
Sentence: 982,of,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,is,O
Sentence: 982,diffusion,O
Sentence: 982,of,O
Sentence: 982,Botox,B-Chemical
Sentence: 982,around,O
Sentence: 982,the,O
Sentence: 982,muscular,O
Sentence: 982,process,O
Sentence: 982,of,O
Sentence: 982,the,O
Sentence: 982,arytenoid,O
Sentence: 982,to,O
Sentence: 982,the,O
Sentence: 982,posterior,O
Sentence: 982,cricoarytenoid,O
Sentence: 982,muscles,O
Sentence: 982,.,O
Sentence: 982,The,O
Sentence: 982,paralysis,B-Disease
Sentence: 982,is,O
Sentence: 982,temporary,O
Sentence: 982,",",O
Sentence: 982,and,O
Sentence: 982,watchful,O
Sentence: 982,waiting,O
Sentence: 982,with,O
Sentence: 982,restriction,O
Sentence: 982,of,O
Sentence: 982,activity,O
Sentence: 982,is,O
Sentence: 982,the,O
Sentence: 982,recommended,O
Sentence: 982,management,O
Sentence: 982,.,O
Sentence: 983,Mitochondrial,B-Disease
Sentence: 983,impairment,I-Disease
Sentence: 983,contributes,O
Sentence: 983,to,O
Sentence: 983,cocaine,B-Chemical
Sentence: 983,-,O
Sentence: 983,induced,O
Sentence: 983,cardiac,B-Disease
Sentence: 983,dysfunction,I-Disease
Sentence: 983,:,O
Sentence: 983,Prevention,O
Sentence: 983,by,O
Sentence: 983,the,O
Sentence: 983,targeted,O
Sentence: 983,antioxidant,O
Sentence: 983,MitoQ,B-Chemical
Sentence: 983,.,O
Sentence: 984,The,O
Sentence: 984,goal,O
Sentence: 984,of,O
Sentence: 984,this,O
Sentence: 984,study,O
Sentence: 984,was,O
Sentence: 984,to,O
Sentence: 984,assess,O
Sentence: 984,mitochondrial,O
Sentence: 984,function,O
Sentence: 984,and,O
Sentence: 984,ROS,O
Sentence: 984,production,O
Sentence: 984,in,O
Sentence: 984,an,O
Sentence: 984,experimental,O
Sentence: 984,model,O
Sentence: 984,of,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,-,O
Sentence: 984,induced,O
Sentence: 984,cardiac,B-Disease
Sentence: 984,dysfunction,I-Disease
Sentence: 984,.,O
Sentence: 984,We,O
Sentence: 984,hypothesized,O
Sentence: 984,that,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,abuse,I-Disease
Sentence: 984,may,O
Sentence: 984,lead,O
Sentence: 984,to,O
Sentence: 984,altered,O
Sentence: 984,mitochondrial,O
Sentence: 984,function,O
Sentence: 984,that,O
Sentence: 984,in,O
Sentence: 984,turn,O
Sentence: 984,may,O
Sentence: 984,cause,O
Sentence: 984,left,B-Disease
Sentence: 984,ventricular,I-Disease
Sentence: 984,dysfunction,I-Disease
Sentence: 984,.,O
Sentence: 984,Seven,O
Sentence: 984,days,O
Sentence: 984,of,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,administration,O
Sentence: 984,to,O
Sentence: 984,rats,O
Sentence: 984,led,O
Sentence: 984,to,O
Sentence: 984,an,O
Sentence: 984,increased,O
Sentence: 984,oxygen,B-Chemical
Sentence: 984,consumption,O
Sentence: 984,detected,O
Sentence: 984,in,O
Sentence: 984,cardiac,O
Sentence: 984,fibers,O
Sentence: 984,",",O
Sentence: 984,specifically,O
Sentence: 984,through,O
Sentence: 984,complex,O
Sentence: 984,I,O
Sentence: 984,and,O
Sentence: 984,complex,O
Sentence: 984,III,O
Sentence: 984,.,O
Sentence: 984,ROS,O
Sentence: 984,levels,O
Sentence: 984,were,O
Sentence: 984,increased,O
Sentence: 984,",",O
Sentence: 984,specifically,O
Sentence: 984,in,O
Sentence: 984,interfibrillar,O
Sentence: 984,mitochondria,O
Sentence: 984,.,O
Sentence: 984,In,O
Sentence: 984,parallel,O
Sentence: 984,there,O
Sentence: 984,was,O
Sentence: 984,a,O
Sentence: 984,decrease,O
Sentence: 984,in,O
Sentence: 984,ATP,B-Chemical
Sentence: 984,synthesis,O
Sentence: 984,",",O
Sentence: 984,whereas,O
Sentence: 984,no,O
Sentence: 984,difference,O
Sentence: 984,was,O
Sentence: 984,observed,O
Sentence: 984,in,O
Sentence: 984,subsarcolemmal,O
Sentence: 984,mitochondria,O
Sentence: 984,.,O
Sentence: 984,This,O
Sentence: 984,uncoupling,O
Sentence: 984,effect,O
Sentence: 984,on,O
Sentence: 984,oxidative,O
Sentence: 984,phosphorylation,O
Sentence: 984,was,O
Sentence: 984,not,O
Sentence: 984,detectable,O
Sentence: 984,after,O
Sentence: 984,short,O
Sentence: 984,-,O
Sentence: 984,term,O
Sentence: 984,exposure,O
Sentence: 984,to,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,",",O
Sentence: 984,suggesting,O
Sentence: 984,that,O
Sentence: 984,these,O
Sentence: 984,mitochondrial,B-Disease
Sentence: 984,abnormalities,I-Disease
Sentence: 984,were,O
Sentence: 984,a,O
Sentence: 984,late,O
Sentence: 984,rather,O
Sentence: 984,than,O
Sentence: 984,a,O
Sentence: 984,primary,O
Sentence: 984,event,O
Sentence: 984,in,O
Sentence: 984,the,O
Sentence: 984,pathological,O
Sentence: 984,response,O
Sentence: 984,to,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,.,O
Sentence: 984,MitoQ,B-Chemical
Sentence: 984,",",O
Sentence: 984,a,O
Sentence: 984,mitochondrial,O
Sentence: 984,-,O
Sentence: 984,targeted,O
Sentence: 984,antioxidant,O
Sentence: 984,",",O
Sentence: 984,was,O
Sentence: 984,shown,O
Sentence: 984,to,O
Sentence: 984,completely,O
Sentence: 984,prevent,O
Sentence: 984,these,O
Sentence: 984,mitochondrial,B-Disease
Sentence: 984,abnormalities,I-Disease
Sentence: 984,as,O
Sentence: 984,well,O
Sentence: 984,as,O
Sentence: 984,cardiac,B-Disease
Sentence: 984,dysfunction,I-Disease
Sentence: 984,characterized,O
Sentence: 984,here,O
Sentence: 984,by,O
Sentence: 984,a,O
Sentence: 984,diastolic,B-Disease
Sentence: 984,dysfunction,I-Disease
Sentence: 984,studied,O
Sentence: 984,with,O
Sentence: 984,a,O
Sentence: 984,conductance,O
Sentence: 984,catheter,O
Sentence: 984,to,O
Sentence: 984,obtain,O
Sentence: 984,pressure,O
Sentence: 984,-,O
Sentence: 984,volume,O
Sentence: 984,data,O
Sentence: 984,.,O
Sentence: 984,Taken,O
Sentence: 984,together,O
Sentence: 984,",",O
Sentence: 984,these,O
Sentence: 984,results,O
Sentence: 984,extend,O
Sentence: 984,previous,O
Sentence: 984,studies,O
Sentence: 984,and,O
Sentence: 984,demonstrate,O
Sentence: 984,that,O
Sentence: 984,cocaine,B-Chemical
Sentence: 984,-,O
Sentence: 984,induced,O
Sentence: 984,cardiac,B-Disease
Sentence: 984,dysfunction,I-Disease
Sentence: 984,may,O
Sentence: 984,be,O
Sentence: 984,due,O
Sentence: 984,to,O
Sentence: 984,a,O
Sentence: 984,mitochondrial,B-Disease
Sentence: 984,defect,I-Disease
Sentence: 984,.,O
Sentence: 985,Trimethoprim,B-Chemical
Sentence: 985,-,O
Sentence: 985,induced,O
Sentence: 985,immune,O
Sentence: 985,hemolytic,B-Disease
Sentence: 985,anemia,I-Disease
Sentence: 985,in,O
Sentence: 985,a,O
Sentence: 985,pediatric,O
Sentence: 985,oncology,O
Sentence: 985,patient,O
Sentence: 985,presenting,O
Sentence: 985,as,O
Sentence: 985,an,O
Sentence: 985,acute,O
Sentence: 985,hemolytic,O
Sentence: 985,transfusion,O
Sentence: 985,reaction,O
Sentence: 985,.,O
Sentence: 986,A,O
Sentence: 986,10,O
Sentence: 986,-,O
Sentence: 986,year,O
Sentence: 986,-,O
Sentence: 986,old,O
Sentence: 986,male,O
Sentence: 986,with,O
Sentence: 986,acute,B-Disease
Sentence: 986,leukemia,I-Disease
Sentence: 986,presented,O
Sentence: 986,with,O
Sentence: 986,post,O
Sentence: 986,-,O
Sentence: 986,chemotherapy,O
Sentence: 986,anemia,B-Disease
Sentence: 986,.,O
Sentence: 986,During,O
Sentence: 986,red,O
Sentence: 986,cell,O
Sentence: 986,transfusion,O
Sentence: 986,",",O
Sentence: 986,he,O
Sentence: 986,developed,O
Sentence: 986,hemoglobinuria,B-Disease
Sentence: 986,.,O
Sentence: 986,Transfusion,O
Sentence: 986,reaction,O
Sentence: 986,workup,O
Sentence: 986,was,O
Sentence: 986,negative,O
Sentence: 986,.,O
Sentence: 986,Drug,O
Sentence: 986,-,O
Sentence: 986,induced,O
Sentence: 986,immune,O
Sentence: 986,hemolytic,B-Disease
Sentence: 986,anemia,B-Disease
Sentence: 986,was,O
Sentence: 986,suspected,O
Sentence: 986,because,O
Sentence: 986,of,O
Sentence: 986,positive,O
Sentence: 986,direct,O
Sentence: 986,antiglobulin,O
Sentence: 986,test,O
Sentence: 986,",",O
Sentence: 986,negative,O
Sentence: 986,eluate,O
Sentence: 986,",",O
Sentence: 986,and,O
Sentence: 986,microspherocytes,O
Sentence: 986,on,O
Sentence: 986,smear,O
Sentence: 986,pre,O
Sentence: 986,-,O
Sentence: 986,,O
Sentence: 986,and,O
Sentence: 986,post,O
Sentence: 986,-,O
Sentence: 986,transfusion,O
Sentence: 986,.,O
Sentence: 986,Drug,O
Sentence: 986,studies,O
Sentence: 986,using,O
Sentence: 986,the,O
Sentence: 986,indirect,O
Sentence: 986,antiglobulin,O
Sentence: 986,test,O
Sentence: 986,were,O
Sentence: 986,strongly,O
Sentence: 986,positive,O
Sentence: 986,with,O
Sentence: 986,trimethoprim,B-Chemical
Sentence: 986,and,O
Sentence: 986,trimethoprim,B-Chemical
Sentence: 986,-,O
Sentence: 986,sulfamethoxazole,B-Chemical
Sentence: 986,but,O
Sentence: 986,negative,O
Sentence: 986,with,O
Sentence: 986,sulfamethoxazole,B-Chemical
Sentence: 986,.,O
Sentence: 986,The,O
Sentence: 986,patient,O
Sentence: 986,recovered,O
Sentence: 986,after,O
Sentence: 986,discontinuing,O
Sentence: 986,the,O
Sentence: 986,drug,O
Sentence: 986,",",O
Sentence: 986,with,O
Sentence: 986,no,O
Sentence: 986,recurrence,O
Sentence: 986,in,O
Sentence: 986,2,O
Sentence: 986,years,O
Sentence: 986,.,O
Sentence: 986,Other,O
Sentence: 986,causes,O
Sentence: 986,of,O
Sentence: 986,anemia,B-Disease
Sentence: 986,should,O
Sentence: 986,be,O
Sentence: 986,considered,O
Sentence: 986,in,O
Sentence: 986,patients,O
Sentence: 986,with,O
Sentence: 986,worse,O
Sentence: 986,-,O
Sentence: 986,than,O
Sentence: 986,-,O
Sentence: 986,expected,O
Sentence: 986,anemia,B-Disease
Sentence: 986,after,O
Sentence: 986,chemotherapy,O
Sentence: 986,.,O
Sentence: 986,Furthermore,O
Sentence: 986,",",O
Sentence: 986,hemolysis,B-Disease
Sentence: 986,during,O
Sentence: 986,transfusion,O
Sentence: 986,is,O
Sentence: 986,not,O
Sentence: 986,always,O
Sentence: 986,a,O
Sentence: 986,transfusion,O
Sentence: 986,reaction,O
Sentence: 986,.,O
Sentence: 987,Blockade,O
Sentence: 987,of,O
Sentence: 987,endothelial,O
Sentence: 987,-,O
Sentence: 987,mesenchymal,O
Sentence: 987,transition,O
Sentence: 987,by,O
Sentence: 987,a,O
Sentence: 987,Smad3,O
Sentence: 987,inhibitor,O
Sentence: 987,delays,O
Sentence: 987,the,O
Sentence: 987,early,O
Sentence: 987,development,O
Sentence: 987,of,O
Sentence: 987,streptozotocin,B-Chemical
Sentence: 987,-,O
Sentence: 987,induced,O
Sentence: 987,diabetic,B-Disease
Sentence: 987,nephropathy,I-Disease
Sentence: 987,.,O
Sentence: 988,OBJECTIVE,O
Sentence: 988,:,O
Sentence: 988,A,O
Sentence: 988,multicenter,O
Sentence: 988,",",O
Sentence: 988,controlled,O
Sentence: 988,trial,O
Sentence: 988,showed,O
Sentence: 988,that,O
Sentence: 988,early,O
Sentence: 988,blockade,O
Sentence: 988,of,O
Sentence: 988,the,O
Sentence: 988,renin,O
Sentence: 988,-,O
Sentence: 988,angiotensin,B-Chemical
Sentence: 988,system,O
Sentence: 988,in,O
Sentence: 988,patients,O
Sentence: 988,with,O
Sentence: 988,type,B-Disease
Sentence: 988,1,I-Disease
Sentence: 988,diabetes,B-Disease
Sentence: 988,and,O
Sentence: 988,normoalbuminuria,O
Sentence: 988,did,O
Sentence: 988,not,O
Sentence: 988,retard,O
Sentence: 988,the,O
Sentence: 988,progression,O
Sentence: 988,of,O
Sentence: 988,nephropathy,B-Disease
Sentence: 988,",",O
Sentence: 988,suggesting,O
Sentence: 988,that,O
Sentence: 988,other,O
Sentence: 988,mechanism,O
Sentence: 988,(,O
Sentence: 988,s,O
Sentence: 988,),O
Sentence: 988,are,O
Sentence: 988,involved,O
Sentence: 988,in,O
Sentence: 988,the,O
Sentence: 988,pathogenesis,O
Sentence: 988,of,O
Sentence: 988,early,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,(,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,),O
Sentence: 988,.,O
Sentence: 988,We,O
Sentence: 988,have,O
Sentence: 988,previously,O
Sentence: 988,demonstrated,O
Sentence: 988,that,O
Sentence: 988,endothelial,O
Sentence: 988,-,O
Sentence: 988,mesenchymal,O
Sentence: 988,-,O
Sentence: 988,transition,O
Sentence: 988,(,O
Sentence: 988,EndoMT,O
Sentence: 988,),O
Sentence: 988,contributes,O
Sentence: 988,to,O
Sentence: 988,the,O
Sentence: 988,early,O
Sentence: 988,development,O
Sentence: 988,of,O
Sentence: 988,renal,O
Sentence: 988,interstitial,O
Sentence: 988,fibrosis,B-Disease
Sentence: 988,independently,O
Sentence: 988,of,O
Sentence: 988,microalbuminuria,O
Sentence: 988,in,O
Sentence: 988,mice,O
Sentence: 988,with,O
Sentence: 988,streptozotocin,B-Chemical
Sentence: 988,(,O
Sentence: 988,STZ,B-Chemical
Sentence: 988,),O
Sentence: 988,,O
Sentence: 988,-,O
Sentence: 988,induced,O
Sentence: 988,diabetes,B-Disease
Sentence: 988,.,O
Sentence: 988,In,O
Sentence: 988,the,O
Sentence: 988,present,O
Sentence: 988,study,O
Sentence: 988,",",O
Sentence: 988,we,O
Sentence: 988,hypothesized,O
Sentence: 988,that,O
Sentence: 988,blocking,O
Sentence: 988,EndoMT,O
Sentence: 988,reduces,O
Sentence: 988,the,O
Sentence: 988,early,O
Sentence: 988,development,O
Sentence: 988,of,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,.,O
Sentence: 988,RESEARCH,O
Sentence: 988,DESIGN,O
Sentence: 988,AND,O
Sentence: 988,METHODS,O
Sentence: 988,:,O
Sentence: 988,EndoMT,O
Sentence: 988,was,O
Sentence: 988,induced,O
Sentence: 988,in,O
Sentence: 988,a,O
Sentence: 988,mouse,O
Sentence: 988,pancreatic,O
Sentence: 988,microvascular,O
Sentence: 988,endothelial,O
Sentence: 988,cell,O
Sentence: 988,line,O
Sentence: 988,(,O
Sentence: 988,MMEC,O
Sentence: 988,),O
Sentence: 988,in,O
Sentence: 988,the,O
Sentence: 988,presence,O
Sentence: 988,of,O
Sentence: 988,advanced,O
Sentence: 988,glycation,O
Sentence: 988,end,O
Sentence: 988,products,O
Sentence: 988,(,O
Sentence: 988,AGEs,O
Sentence: 988,),O
Sentence: 988,and,O
Sentence: 988,in,O
Sentence: 988,the,O
Sentence: 988,endothelial,O
Sentence: 988,lineage,O
Sentence: 988,-,O
Sentence: 988,traceble,O
Sentence: 988,mouse,O
Sentence: 988,line,O
Sentence: 988,Tie2,O
Sentence: 988,-,O
Sentence: 988,Cre,O
Sentence: 988,;,O
Sentence: 988,Loxp,O
Sentence: 988,-,O
Sentence: 988,EGFP,O
Sentence: 988,by,O
Sentence: 988,administration,O
Sentence: 988,of,O
Sentence: 988,AGEs,O
Sentence: 988,",",O
Sentence: 988,with,O
Sentence: 988,nonglycated,O
Sentence: 988,mouse,O
Sentence: 988,albumin,O
Sentence: 988,serving,O
Sentence: 988,as,O
Sentence: 988,a,O
Sentence: 988,control,O
Sentence: 988,.,O
Sentence: 988,Phosphorylated,O
Sentence: 988,Smad3,O
Sentence: 988,was,O
Sentence: 988,detected,O
Sentence: 988,by,O
Sentence: 988,immunoprecipitation,O
Sentence: 988,/,O
Sentence: 988,Western,O
Sentence: 988,blotting,O
Sentence: 988,and,O
Sentence: 988,confocal,O
Sentence: 988,microscopy,O
Sentence: 988,.,O
Sentence: 988,Blocking,O
Sentence: 988,studies,O
Sentence: 988,using,O
Sentence: 988,receptor,O
Sentence: 988,for,O
Sentence: 988,AGE,O
Sentence: 988,siRNA,O
Sentence: 988,and,O
Sentence: 988,a,O
Sentence: 988,specific,O
Sentence: 988,inhibitor,O
Sentence: 988,of,O
Sentence: 988,Smad3,O
Sentence: 988,(,O
Sentence: 988,SIS3,O
Sentence: 988,),O
Sentence: 988,were,O
Sentence: 988,performed,O
Sentence: 988,in,O
Sentence: 988,MMECs,O
Sentence: 988,and,O
Sentence: 988,in,O
Sentence: 988,STZ,B-Chemical
Sentence: 988,-,O
Sentence: 988,induced,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,in,O
Sentence: 988,Tie2,O
Sentence: 988,-,O
Sentence: 988,Cre,O
Sentence: 988,;,O
Sentence: 988,Loxp,O
Sentence: 988,-,O
Sentence: 988,EGFP,O
Sentence: 988,mice,O
Sentence: 988,.,O
Sentence: 988,RESULTS,O
Sentence: 988,:,O
Sentence: 988,Confocal,O
Sentence: 988,microscopy,O
Sentence: 988,and,O
Sentence: 988,real,O
Sentence: 988,-,O
Sentence: 988,time,O
Sentence: 988,PCR,O
Sentence: 988,demonstrated,O
Sentence: 988,that,O
Sentence: 988,AGEs,O
Sentence: 988,induced,O
Sentence: 988,EndoMT,O
Sentence: 988,in,O
Sentence: 988,MMECs,O
Sentence: 988,and,O
Sentence: 988,in,O
Sentence: 988,Tie2,O
Sentence: 988,-,O
Sentence: 988,Cre,O
Sentence: 988,;,O
Sentence: 988,Loxp,O
Sentence: 988,-,O
Sentence: 988,EGFP,O
Sentence: 988,mice,O
Sentence: 988,.,O
Sentence: 988,Immunoprecipitation,O
Sentence: 988,/,O
Sentence: 988,Western,O
Sentence: 988,blotting,O
Sentence: 988,showed,O
Sentence: 988,that,O
Sentence: 988,Smad3,O
Sentence: 988,was,O
Sentence: 988,activated,O
Sentence: 988,by,O
Sentence: 988,AGEs,O
Sentence: 988,but,O
Sentence: 988,was,O
Sentence: 988,inhibited,O
Sentence: 988,by,O
Sentence: 988,SIS3,O
Sentence: 988,in,O
Sentence: 988,MMECs,O
Sentence: 988,and,O
Sentence: 988,in,O
Sentence: 988,STZ,B-Chemical
Sentence: 988,-,O
Sentence: 988,induced,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,.,O
Sentence: 988,Confocal,O
Sentence: 988,microscopy,O
Sentence: 988,and,O
Sentence: 988,real,O
Sentence: 988,-,O
Sentence: 988,time,O
Sentence: 988,PCR,O
Sentence: 988,further,O
Sentence: 988,demonstrated,O
Sentence: 988,that,O
Sentence: 988,SIS3,O
Sentence: 988,abrogated,O
Sentence: 988,EndoMT,O
Sentence: 988,",",O
Sentence: 988,reduced,O
Sentence: 988,renal,O
Sentence: 988,fibrosis,B-Disease
Sentence: 988,",",O
Sentence: 988,and,O
Sentence: 988,retarded,O
Sentence: 988,progression,O
Sentence: 988,of,O
Sentence: 988,nephropathy,B-Disease
Sentence: 988,.,O
Sentence: 988,CONCLUSIONS,O
Sentence: 988,:,O
Sentence: 988,EndoMT,O
Sentence: 988,is,O
Sentence: 988,a,O
Sentence: 988,novel,O
Sentence: 988,pathway,O
Sentence: 988,leading,O
Sentence: 988,to,O
Sentence: 988,early,O
Sentence: 988,development,O
Sentence: 988,of,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,.,O
Sentence: 988,Blockade,O
Sentence: 988,of,O
Sentence: 988,EndoMT,O
Sentence: 988,by,O
Sentence: 988,SIS3,O
Sentence: 988,may,O
Sentence: 988,provide,O
Sentence: 988,a,O
Sentence: 988,new,O
Sentence: 988,strategy,O
Sentence: 988,to,O
Sentence: 988,retard,O
Sentence: 988,the,O
Sentence: 988,progression,O
Sentence: 988,of,O
Sentence: 988,diabetic,B-Disease
Sentence: 988,nephropathy,I-Disease
Sentence: 988,and,O
Sentence: 988,other,O
Sentence: 988,diabetes,B-Disease
Sentence: 988,complications,I-Disease
Sentence: 988,.,O
Sentence: 989,Cytostatic,O
Sentence: 989,and,O
Sentence: 989,anti,O
Sentence: 989,-,O
Sentence: 989,angiogenic,O
Sentence: 989,effects,O
Sentence: 989,of,O
Sentence: 989,temsirolimus,B-Chemical
Sentence: 989,in,O
Sentence: 989,refractory,O
Sentence: 989,mantle,B-Disease
Sentence: 989,cell,I-Disease
Sentence: 989,lymphoma,I-Disease
Sentence: 989,.,O
Sentence: 990,Mantle,B-Disease
Sentence: 990,cell,I-Disease
Sentence: 990,lymphoma,I-Disease
Sentence: 990,(,O
Sentence: 990,MCL,B-Disease
Sentence: 990,),O
Sentence: 990,is,O
Sentence: 990,a,O
Sentence: 990,rare,O
Sentence: 990,and,O
Sentence: 990,aggressive,O
Sentence: 990,type,O
Sentence: 990,of,O
Sentence: 990,B,O
Sentence: 990,-,O
Sentence: 990,cell,O
Sentence: 990,non,O
Sentence: 990,-,O
Sentence: 990,Hodgkin,O
Sentence: 990,'s,O
Sentence: 990,lymphoma,O
Sentence: 990,.,O
Sentence: 990,Patients,O
Sentence: 990,become,O
Sentence: 990,progressively,O
Sentence: 990,refractory,O
Sentence: 990,to,O
Sentence: 990,conventional,O
Sentence: 990,chemotherapy,O
Sentence: 990,",",O
Sentence: 990,and,O
Sentence: 990,their,O
Sentence: 990,prognosis,O
Sentence: 990,is,O
Sentence: 990,poor,O
Sentence: 990,.,O
Sentence: 990,However,O
Sentence: 990,",",O
Sentence: 990,a,O
Sentence: 990,38,O
Sentence: 990,%,O
Sentence: 990,remission,O
Sentence: 990,rate,O
Sentence: 990,has,O
Sentence: 990,been,O
Sentence: 990,recently,O
Sentence: 990,reported,O
Sentence: 990,in,O
Sentence: 990,refractory,O
Sentence: 990,MCL,B-Disease
Sentence: 990,treated,O
Sentence: 990,with,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,",",O
Sentence: 990,a,O
Sentence: 990,mTOR,O
Sentence: 990,inhibitor.Here,O
Sentence: 990,we,O
Sentence: 990,had,O
Sentence: 990,the,O
Sentence: 990,opportunity,O
Sentence: 990,to,O
Sentence: 990,study,O
Sentence: 990,a,O
Sentence: 990,case,O
Sentence: 990,of,O
Sentence: 990,refractory,O
Sentence: 990,MCL,B-Disease
Sentence: 990,who,O
Sentence: 990,had,O
Sentence: 990,tumor,B-Disease
Sentence: 990,regression,O
Sentence: 990,two,O
Sentence: 990,months,O
Sentence: 990,after,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,treatment,O
Sentence: 990,",",O
Sentence: 990,and,O
Sentence: 990,a,O
Sentence: 990,progression,O
Sentence: 990,-,O
Sentence: 990,free,O
Sentence: 990,survival,O
Sentence: 990,of,O
Sentence: 990,10,O
Sentence: 990,months,O
Sentence: 990,.,O
Sentence: 990,In,O
Sentence: 990,this,O
Sentence: 990,case,O
Sentence: 990,",",O
Sentence: 990,lymph,O
Sentence: 990,node,O
Sentence: 990,biopsies,O
Sentence: 990,were,O
Sentence: 990,performed,O
Sentence: 990,before,O
Sentence: 990,and,O
Sentence: 990,six,O
Sentence: 990,months,O
Sentence: 990,after,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,therapy,O
Sentence: 990,.,O
Sentence: 990,Comparison,O
Sentence: 990,of,O
Sentence: 990,the,O
Sentence: 990,two,O
Sentence: 990,biopsies,O
Sentence: 990,showed,O
Sentence: 990,that,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,inhibited,O
Sentence: 990,tumor,B-Disease
Sentence: 990,cell,O
Sentence: 990,proliferation,O
Sentence: 990,through,O
Sentence: 990,cell,O
Sentence: 990,cycle,O
Sentence: 990,arrest,O
Sentence: 990,",",O
Sentence: 990,but,O
Sentence: 990,did,O
Sentence: 990,not,O
Sentence: 990,induce,O
Sentence: 990,any,O
Sentence: 990,change,O
Sentence: 990,in,O
Sentence: 990,the,O
Sentence: 990,number,O
Sentence: 990,of,O
Sentence: 990,apoptotic,O
Sentence: 990,tumor,B-Disease
Sentence: 990,cells,O
Sentence: 990,.,O
Sentence: 990,Apart,O
Sentence: 990,from,O
Sentence: 990,this,O
Sentence: 990,cytostatic,O
Sentence: 990,effect,O
Sentence: 990,",",O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,had,O
Sentence: 990,an,O
Sentence: 990,antiangiogenic,O
Sentence: 990,effect,O
Sentence: 990,with,O
Sentence: 990,decrease,O
Sentence: 990,of,O
Sentence: 990,tumor,B-Disease
Sentence: 990,microvessel,O
Sentence: 990,density,O
Sentence: 990,and,O
Sentence: 990,of,O
Sentence: 990,VEGF,O
Sentence: 990,expression,O
Sentence: 990,.,O
Sentence: 990,Moreover,O
Sentence: 990,",",O
Sentence: 990,numerous,O
Sentence: 990,patchy,O
Sentence: 990,",",O
Sentence: 990,well,O
Sentence: 990,-,O
Sentence: 990,limited,O
Sentence: 990,fibrotic,O
Sentence: 990,areas,O
Sentence: 990,",",O
Sentence: 990,compatible,O
Sentence: 990,with,O
Sentence: 990,post,O
Sentence: 990,-,O
Sentence: 990,necrotic,B-Disease
Sentence: 990,tissue,O
Sentence: 990,repair,O
Sentence: 990,",",O
Sentence: 990,were,O
Sentence: 990,found,O
Sentence: 990,after,O
Sentence: 990,6,O
Sentence: 990,-,O
Sentence: 990,month,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,therapy,O
Sentence: 990,.,O
Sentence: 990,Thus,O
Sentence: 990,",",O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,reduced,O
Sentence: 990,tumor,B-Disease
Sentence: 990,burden,O
Sentence: 990,through,O
Sentence: 990,associated,O
Sentence: 990,cytostatic,O
Sentence: 990,and,O
Sentence: 990,anti,O
Sentence: 990,-,O
Sentence: 990,angiogenic,O
Sentence: 990,effects.This,O
Sentence: 990,dual,O
Sentence: 990,effect,O
Sentence: 990,of,O
Sentence: 990,temsirolimus,B-Chemical
Sentence: 990,on,O
Sentence: 990,tumor,B-Disease
Sentence: 990,tissue,O
Sentence: 990,could,O
Sentence: 990,contribute,O
Sentence: 990,to,O
Sentence: 990,its,O
Sentence: 990,recently,O
Sentence: 990,reported,O
Sentence: 990,efficiency,O
Sentence: 990,in,O
Sentence: 990,refractory,O
Sentence: 990,MCL,B-Disease
Sentence: 990,resistant,O
Sentence: 990,to,O
Sentence: 990,conventional,O
Sentence: 990,chemotherapy,O
Sentence: 990,.,O
Sentence: 991,Syncope,B-Disease
Sentence: 991,caused,O
Sentence: 991,by,O
Sentence: 991,hyperkalemia,B-Disease
Sentence: 991,during,O
Sentence: 991,use,O
Sentence: 991,of,O
Sentence: 991,a,O
Sentence: 991,combined,O
Sentence: 991,therapy,O
Sentence: 991,with,O
Sentence: 991,the,O
Sentence: 991,angiotensin,B-Chemical
Sentence: 991,-,O
Sentence: 991,converting,O
Sentence: 991,enzyme,O
Sentence: 991,inhibitor,O
Sentence: 991,and,O
Sentence: 991,spironolactone,B-Chemical
Sentence: 991,.,O
Sentence: 992,A,O
Sentence: 992,76,O
Sentence: 992,year,O
Sentence: 992,-,O
Sentence: 992,old,O
Sentence: 992,woman,O
Sentence: 992,with,O
Sentence: 992,a,O
Sentence: 992,history,O
Sentence: 992,of,O
Sentence: 992,coronary,O
Sentence: 992,artery,O
Sentence: 992,bypass,O
Sentence: 992,grafting,O
Sentence: 992,and,O
Sentence: 992,prior,O
Sentence: 992,myocardial,B-Disease
Sentence: 992,infarction,I-Disease
Sentence: 992,was,O
Sentence: 992,transferred,O
Sentence: 992,to,O
Sentence: 992,the,O
Sentence: 992,emergency,O
Sentence: 992,room,O
Sentence: 992,with,O
Sentence: 992,loss,B-Disease
Sentence: 992,of,I-Disease
Sentence: 992,consciousness,I-Disease
Sentence: 992,due,O
Sentence: 992,to,O
Sentence: 992,marked,O
Sentence: 992,bradycardia,B-Disease
Sentence: 992,caused,O
Sentence: 992,by,O
Sentence: 992,hyperkalemia,B-Disease
Sentence: 992,.,O
Sentence: 992,The,O
Sentence: 992,concentration,O
Sentence: 992,of,O
Sentence: 992,serum,O
Sentence: 992,potassium,B-Chemical
Sentence: 992,was,O
Sentence: 992,high,O
Sentence: 992,",",O
Sentence: 992,and,O
Sentence: 992,normal,O
Sentence: 992,sinus,O
Sentence: 992,rhythm,O
Sentence: 992,was,O
Sentence: 992,restored,O
Sentence: 992,after,O
Sentence: 992,correction,O
Sentence: 992,of,O
Sentence: 992,the,O
Sentence: 992,serum,O
Sentence: 992,potassium,B-Chemical
Sentence: 992,level,O
Sentence: 992,.,O
Sentence: 992,The,O
Sentence: 992,cause,O
Sentence: 992,of,O
Sentence: 992,hyperkalemia,B-Disease
Sentence: 992,was,O
Sentence: 992,considered,O
Sentence: 992,to,O
Sentence: 992,be,O
Sentence: 992,several,O
Sentence: 992,doses,O
Sentence: 992,of,O
Sentence: 992,spiranolactone,B-Chemical
Sentence: 992,",",O
Sentence: 992,an,O
Sentence: 992,aldosterone,B-Chemical
Sentence: 992,antagonist,O
Sentence: 992,",",O
Sentence: 992,in,O
Sentence: 992,addition,O
Sentence: 992,to,O
Sentence: 992,the,O
Sentence: 992,long,O
Sentence: 992,-,O
Sentence: 992,term,O
Sentence: 992,intake,O
Sentence: 992,of,O
Sentence: 992,ramipril,B-Chemical
Sentence: 992,",",O
Sentence: 992,an,O
Sentence: 992,ACE,O
Sentence: 992,inhibitor,O
Sentence: 992,.,O
Sentence: 992,This,O
Sentence: 992,case,O
Sentence: 992,is,O
Sentence: 992,a,O
Sentence: 992,good,O
Sentence: 992,example,O
Sentence: 992,of,O
Sentence: 992,electrolyte,O
Sentence: 992,imbalance,O
Sentence: 992,causing,O
Sentence: 992,acute,O
Sentence: 992,life,O
Sentence: 992,-,O
Sentence: 992,threatening,O
Sentence: 992,cardiac,O
Sentence: 992,events,O
Sentence: 992,.,O
Sentence: 992,Clinicians,O
Sentence: 992,should,O
Sentence: 992,be,O
Sentence: 992,alert,O
Sentence: 992,to,O
Sentence: 992,the,O
Sentence: 992,possibility,O
Sentence: 992,of,O
Sentence: 992,hyperkalemia,B-Disease
Sentence: 992,",",O
Sentence: 992,especially,O
Sentence: 992,in,O
Sentence: 992,elderly,O
Sentence: 992,patients,O
Sentence: 992,using,O
Sentence: 992,ACE,O
Sentence: 992,/,O
Sentence: 992,ARB,O
Sentence: 992,in,O
Sentence: 992,combination,O
Sentence: 992,with,O
Sentence: 992,potassium,B-Chemical
Sentence: 992,sparing,O
Sentence: 992,agents,O
Sentence: 992,and,O
Sentence: 992,who,O
Sentence: 992,have,O
Sentence: 992,mild,O
Sentence: 992,renal,B-Disease
Sentence: 992,disturbance,I-Disease
Sentence: 992,.,O
Sentence: 993,Diffuse,O
Sentence: 993,skeletal,O
Sentence: 993,pain,B-Disease
Sentence: 993,after,O
Sentence: 993,administration,O
Sentence: 993,of,O
Sentence: 993,alendronate,B-Chemical
Sentence: 993,.,O
Sentence: 994,BACKGROUND,O
Sentence: 994,:,O
Sentence: 994,Osteoporosis,B-Disease
Sentence: 994,is,O
Sentence: 994,caused,O
Sentence: 994,by,O
Sentence: 994,bone,O
Sentence: 994,resorption,O
Sentence: 994,in,O
Sentence: 994,excess,O
Sentence: 994,of,O
Sentence: 994,bone,O
Sentence: 994,formation,O
Sentence: 994,",",O
Sentence: 994,and,O
Sentence: 994,bisphosphonates,B-Chemical
Sentence: 994,",",O
Sentence: 994,are,O
Sentence: 994,used,O
Sentence: 994,to,O
Sentence: 994,inhibit,O
Sentence: 994,bone,O
Sentence: 994,resorption,O
Sentence: 994,.,O
Sentence: 994,Alendronate,B-Chemical
Sentence: 994,",",O
Sentence: 994,a,O
Sentence: 994,biphosphonate,B-Chemical
Sentence: 994,",",O
Sentence: 994,is,O
Sentence: 994,effective,O
Sentence: 994,for,O
Sentence: 994,both,O
Sentence: 994,the,O
Sentence: 994,treatment,O
Sentence: 994,and,O
Sentence: 994,prevention,O
Sentence: 994,of,O
Sentence: 994,osteoporosis,B-Disease
Sentence: 994,in,O
Sentence: 994,postmenopausal,O
Sentence: 994,women,O
Sentence: 994,.,O
Sentence: 994,Side,O
Sentence: 994,effects,O
Sentence: 994,are,O
Sentence: 994,relatively,O
Sentence: 994,few,O
Sentence: 994,and,O
Sentence: 994,prominently,O
Sentence: 994,gastrointestinal,O
Sentence: 994,.,O
Sentence: 994,Musculoskeletal,B-Disease
Sentence: 994,pain,B-Disease
Sentence: 994,may,O
Sentence: 994,be,O
Sentence: 994,an,O
Sentence: 994,important,O
Sentence: 994,side,O
Sentence: 994,effect,O
Sentence: 994,in,O
Sentence: 994,these,O
Sentence: 994,patients,O
Sentence: 994,.,O
Sentence: 994,We,O
Sentence: 994,presented,O
Sentence: 994,a,O
Sentence: 994,patient,O
Sentence: 994,admitted,O
Sentence: 994,to,O
Sentence: 994,our,O
Sentence: 994,out,O
Sentence: 994,-,O
Sentence: 994,patient,O
Sentence: 994,clinic,O
Sentence: 994,with,O
Sentence: 994,diffuse,O
Sentence: 994,skeletal,O
Sentence: 994,pain,B-Disease
Sentence: 994,after,O
Sentence: 994,three,O
Sentence: 994,consecutive,O
Sentence: 994,administration,O
Sentence: 994,of,O
Sentence: 994,alendronate,B-Chemical
Sentence: 994,.,O
Sentence: 994,CONCLUSION,O
Sentence: 994,:,O
Sentence: 994,We,O
Sentence: 994,conclude,O
Sentence: 994,that,O
Sentence: 994,patients,O
Sentence: 994,with,O
Sentence: 994,osteoporosis,B-Disease
Sentence: 994,can,O
Sentence: 994,report,O
Sentence: 994,pain,B-Disease
Sentence: 994,",",O
Sentence: 994,and,O
Sentence: 994,bisphosphonate,B-Chemical
Sentence: 994,-,O
Sentence: 994,related,O
Sentence: 994,pain,B-Disease
Sentence: 994,should,O
Sentence: 994,also,O
Sentence: 994,be,O
Sentence: 994,considered,O
Sentence: 994,before,O
Sentence: 994,ascribing,O
Sentence: 994,this,O
Sentence: 994,complaint,O
Sentence: 994,to,O
Sentence: 994,osteoporosis,B-Disease
Sentence: 994,.,O
Sentence: 995,Cerebrospinal,O
Sentence: 995,fluid,O
Sentence: 995,penetration,O
Sentence: 995,of,O
Sentence: 995,high,O
Sentence: 995,-,O
Sentence: 995,dose,O
Sentence: 995,daptomycin,B-Chemical
Sentence: 995,in,O
Sentence: 995,suspected,O
Sentence: 995,Staphylococcus,O
Sentence: 995,aureus,O
Sentence: 995,meningitis,B-Disease
Sentence: 995,.,O
Sentence: 996,OBJECTIVE,O
Sentence: 996,:,O
Sentence: 996,To,O
Sentence: 996,report,O
Sentence: 996,a,O
Sentence: 996,case,O
Sentence: 996,of,O
Sentence: 996,methicillin,B-Chemical
Sentence: 996,-,O
Sentence: 996,sensitive,O
Sentence: 996,Staphylococcus,O
Sentence: 996,aureus,O
Sentence: 996,(,O
Sentence: 996,MSSA,O
Sentence: 996,),O
Sentence: 996,bacteremia,B-Disease
Sentence: 996,with,O
Sentence: 996,suspected,O
Sentence: 996,MSSA,O
Sentence: 996,meningitis,B-Disease
Sentence: 996,treated,O
Sentence: 996,with,O
Sentence: 996,high,O
Sentence: 996,-,O
Sentence: 996,dose,O
Sentence: 996,daptomycin,B-Chemical
Sentence: 996,assessed,O
Sentence: 996,with,O
Sentence: 996,concurrent,O
Sentence: 996,serum,O
Sentence: 996,and,O
Sentence: 996,cerebrospinal,O
Sentence: 996,fluid,O
Sentence: 996,(,O
Sentence: 996,CSF,O
Sentence: 996,),O
Sentence: 996,concentrations,O
Sentence: 996,.,O
Sentence: 996,CASE,O
Sentence: 996,SUMMARY,O
Sentence: 996,:,O
Sentence: 996,A,O
Sentence: 996,54,O
Sentence: 996,-,O
Sentence: 996,year,O
Sentence: 996,-,O
Sentence: 996,old,O
Sentence: 996,male,O
Sentence: 996,presented,O
Sentence: 996,to,O
Sentence: 996,the,O
Sentence: 996,emergency,O
Sentence: 996,department,O
Sentence: 996,with,O
Sentence: 996,generalized,O
Sentence: 996,weakness,B-Disease
Sentence: 996,and,O
Sentence: 996,presumed,O
Sentence: 996,health,O
Sentence: 996,-,O
Sentence: 996,care,O
Sentence: 996,-,O
Sentence: 996,associated,O
Sentence: 996,pneumonia,B-Disease
Sentence: 996,shown,O
Sentence: 996,on,O
Sentence: 996,chest,O
Sentence: 996,radiograph,O
Sentence: 996,.,O
Sentence: 996,Treatment,O
Sentence: 996,was,O
Sentence: 996,empirically,O
Sentence: 996,initiated,O
Sentence: 996,with,O
Sentence: 996,vancomycin,B-Chemical
Sentence: 996,",",O
Sentence: 996,levofloxacin,B-Chemical
Sentence: 996,",",O
Sentence: 996,and,O
Sentence: 996,piperacillin,B-Chemical
Sentence: 996,/,O
Sentence: 996,tazobactam,B-Chemical
Sentence: 996,.,O
Sentence: 996,Blood,O
Sentence: 996,cultures,O
Sentence: 996,revealed,O
Sentence: 996,S.,O
Sentence: 996,aureus,O
Sentence: 996,susceptible,O
Sentence: 996,to,O
Sentence: 996,oxacillin,B-Chemical
Sentence: 996,.,O
Sentence: 996,Empiric,O
Sentence: 996,antibiotic,O
Sentence: 996,treatment,O
Sentence: 996,was,O
Sentence: 996,narrowed,O
Sentence: 996,to,O
Sentence: 996,nafcillin,B-Chemical
Sentence: 996,on,O
Sentence: 996,day,O
Sentence: 996,4,O
Sentence: 996,.,O
Sentence: 996,On,O
Sentence: 996,day,O
Sentence: 996,8,O
Sentence: 996,",",O
Sentence: 996,the,O
Sentence: 996,patient,O
Sentence: 996,developed,O
Sentence: 996,acute,B-Disease
Sentence: 996,renal,I-Disease
Sentence: 996,failure,I-Disease
Sentence: 996,(,O
Sentence: 996,serum,O
Sentence: 996,creatinine,B-Chemical
Sentence: 996,1.9,O
Sentence: 996,mg,O
Sentence: 996,/,O
Sentence: 996,dL,O
Sentence: 996,",",O
Sentence: 996,increased,O
Sentence: 996,from,O
Sentence: 996,1.2,O
Sentence: 996,mg,O
Sentence: 996,/,O
Sentence: 996,dL,O
Sentence: 996,the,O
Sentence: 996,previous,O
Sentence: 996,day,O
Sentence: 996,and,O
Sentence: 996,0.8,O
Sentence: 996,mg,O
Sentence: 996,/,O
Sentence: 996,dL,O
Sentence: 996,on,O
Sentence: 996,admission,O
Sentence: 996,),O
Sentence: 996,.,O
Sentence: 996,The,O
Sentence: 996,patient,O
Sentence: 996,'s,O
Sentence: 996,Glasgow,O
Sentence: 996,Coma,O
Sentence: 996,Score,O
Sentence: 996,was,O
Sentence: 996,3,O
Sentence: 996,",",O
Sentence: 996,with,O
Sentence: 996,normal,O
Sentence: 996,findings,O
Sentence: 996,shown,O
Sentence: 996,on,O
Sentence: 996,computed,O
Sentence: 996,tomography,O
Sentence: 996,scan,O
Sentence: 996,of,O
Sentence: 996,the,O
Sentence: 996,head,O
Sentence: 996,72,O
Sentence: 996,hours,O
Sentence: 996,following,O
Sentence: 996,an,O
Sentence: 996,episode,O
Sentence: 996,of,O
Sentence: 996,cardiac,B-Disease
Sentence: 996,arrest,I-Disease
Sentence: 996,on,O
Sentence: 996,day,O
Sentence: 996,10,O
Sentence: 996,.,O
Sentence: 996,The,O
Sentence: 996,patient,O
Sentence: 996,experienced,O
Sentence: 996,relapsing,O
Sentence: 996,MSSA,O
Sentence: 996,bacteremia,B-Disease
Sentence: 996,on,O
Sentence: 996,day,O
Sentence: 996,9,O
Sentence: 996,",",O
Sentence: 996,increasing,O
Sentence: 996,the,O
Sentence: 996,suspicion,O
Sentence: 996,for,O
Sentence: 996,a,O
Sentence: 996,central,O
Sentence: 996,nervous,O
Sentence: 996,system,O
Sentence: 996,(,O
Sentence: 996,CNS,O
Sentence: 996,),O
Sentence: 996,infection,B-Disease
Sentence: 996,.,O
Sentence: 996,Nafcillin,B-Chemical
Sentence: 996,was,O
Sentence: 996,discontinued,O
Sentence: 996,and,O
Sentence: 996,daptomycin,B-Chemical
Sentence: 996,9,O
Sentence: 996,mg,O
Sentence: 996,/,O
Sentence: 996,kg,O
Sentence: 996,daily,O
Sentence: 996,was,O
Sentence: 996,initiated,O
Sentence: 996,for,O
Sentence: 996,suspected,O
Sentence: 996,meningitis,B-Disease
Sentence: 996,and,O
Sentence: 996,was,O
Sentence: 996,continued,O
Sentence: 996,until,O
Sentence: 996,the,O
Sentence: 996,patient,O
Sentence: 996,'s,O
Sentence: 996,death,O
Sentence: 996,on,O
Sentence: 996,day,O
Sentence: 996,16,O
Sentence: 996,.,O
Sentence: 996,Daptomycin,B-Chemical
Sentence: 996,serum,O
Sentence: 996,and,O
Sentence: 996,CSF,O
Sentence: 996,trough,O
Sentence: 996,concentrations,O
Sentence: 996,were,O
Sentence: 996,11.21,O
Sentence: 996,ug,O
Sentence: 996,/,O
Sentence: 996,mL,O
Sentence: 996,and,O
Sentence: 996,0.52,O
Sentence: 996,ug,O
Sentence: 996,/,O
Sentence: 996,mL,O
Sentence: 996,",",O
Sentence: 996,respectively,O
Sentence: 996,",",O
Sentence: 996,prior,O
Sentence: 996,to,O
Sentence: 996,the,O
Sentence: 996,third,O
Sentence: 996,dose,O
Sentence: 996,.,O
Sentence: 996,Lumbar,O
Sentence: 996,puncture,O
Sentence: 996,results,O
Sentence: 996,were,O
Sentence: 996,inconclusive,O
Sentence: 996,and,O
Sentence: 996,no,O
Sentence: 996,further,O
Sentence: 996,blood,O
Sentence: 996,cultures,O
Sentence: 996,were,O
Sentence: 996,positive,O
Sentence: 996,for,O
Sentence: 996,MSSA,O
Sentence: 996,.,O
Sentence: 996,Creatine,B-Chemical
Sentence: 996,kinase,O
Sentence: 996,levels,O
Sentence: 996,were,O
Sentence: 996,normal,O
Sentence: 996,prior,O
Sentence: 996,to,O
Sentence: 996,daptomycin,B-Chemical
Sentence: 996,therapy,O
Sentence: 996,and,O
Sentence: 996,were,O
Sentence: 996,not,O
Sentence: 996,reassessed,O
Sentence: 996,.,O
Sentence: 996,DISCUSSION,O
Sentence: 996,:,O
Sentence: 996,Daptomycin,B-Chemical
Sentence: 996,was,O
Sentence: 996,initiated,O
Sentence: 996,in,O
Sentence: 996,our,O
Sentence: 996,patient,O
Sentence: 996,secondary,O
Sentence: 996,to,O
Sentence: 996,possible,O
Sentence: 996,nafcillin,B-Chemical
Sentence: 996,-,O
Sentence: 996,induced,O
Sentence: 996,acute,O
Sentence: 996,interstitial,B-Disease
Sentence: 996,nephritis,I-Disease
Sentence: 996,and,O
Sentence: 996,relapsing,O
Sentence: 996,bacteremia,B-Disease
Sentence: 996,.,O
Sentence: 996,At,O
Sentence: 996,a,O
Sentence: 996,dose,O
Sentence: 996,of,O
Sentence: 996,9,O
Sentence: 996,mg,O
Sentence: 996,/,O
Sentence: 996,kg,O
Sentence: 996,",",O
Sentence: 996,resultant,O
Sentence: 996,penetration,O
Sentence: 996,of,O
Sentence: 996,5,O
Sentence: 996,%,O
Sentence: 996,was,O
Sentence: 996,higher,O
Sentence: 996,than,O
Sentence: 996,in,O
Sentence: 996,previous,O
Sentence: 996,reports,O
Sentence: 996,",",O
Sentence: 996,more,O
Sentence: 996,consistent,O
Sentence: 996,with,O
Sentence: 996,inflamed,O
Sentence: 996,meninges,O
Sentence: 996,.,O
Sentence: 996,CONCLUSIONS,O
Sentence: 996,:,O
Sentence: 996,High,O
Sentence: 996,-,O
Sentence: 996,dose,O
Sentence: 996,daptomycin,B-Chemical
Sentence: 996,may,O
Sentence: 996,be,O
Sentence: 996,an,O
Sentence: 996,alternative,O
Sentence: 996,option,O
Sentence: 996,for,O
Sentence: 996,MSSA,O
Sentence: 996,bacteremia,B-Disease
Sentence: 996,with,O
Sentence: 996,or,O
Sentence: 996,without,O
Sentence: 996,a,O
Sentence: 996,CNS,O
Sentence: 996,source,O
Sentence: 996,in,O
Sentence: 996,patients,O
Sentence: 996,who,O
Sentence: 996,have,O
Sentence: 996,failed,O
Sentence: 996,or,O
Sentence: 996,can,O
Sentence: 996,not,O
Sentence: 996,tolerate,O
Sentence: 996,standard,O
Sentence: 996,therapy,O
Sentence: 996,.,O
Sentence: 996,Further,O
Sentence: 996,clinical,O
Sentence: 996,evaluation,O
Sentence: 996,in,O
Sentence: 996,patients,O
Sentence: 996,with,O
Sentence: 996,confirmed,O
Sentence: 996,meningitis,B-Disease
Sentence: 996,is,O
Sentence: 996,warranted,O
Sentence: 996,.,O
Sentence: 997,The,O
Sentence: 997,role,O
Sentence: 997,of,O
Sentence: 997,nitric,B-Chemical
Sentence: 997,oxide,I-Chemical
Sentence: 997,in,O
Sentence: 997,convulsions,B-Disease
Sentence: 997,induced,O
Sentence: 997,by,O
Sentence: 997,lindane,B-Chemical
Sentence: 997,in,O
Sentence: 997,rats,O
Sentence: 997,.,O
Sentence: 998,Lindane,B-Chemical
Sentence: 998,is,O
Sentence: 998,an,O
Sentence: 998,organochloride,O
Sentence: 998,pesticide,O
Sentence: 998,and,O
Sentence: 998,scabicide,O
Sentence: 998,.,O
Sentence: 998,It,O
Sentence: 998,evokes,O
Sentence: 998,convulsions,B-Disease
Sentence: 998,mainly,O
Sentence: 998,trough,O
Sentence: 998,the,O
Sentence: 998,blockage,O
Sentence: 998,of,O
Sentence: 998,GABA,B-Chemical
Sentence: 998,(,O
Sentence: 998,A,O
Sentence: 998,),O
Sentence: 998,receptors,O
Sentence: 998,.,O
Sentence: 998,Nitric,B-Chemical
Sentence: 998,oxide,I-Chemical
Sentence: 998,(,O
Sentence: 998,NO,B-Chemical
Sentence: 998,),O
Sentence: 998,",",O
Sentence: 998,gaseous,O
Sentence: 998,neurotransmitter,O
Sentence: 998,",",O
Sentence: 998,has,O
Sentence: 998,contradictor,O
Sentence: 998,role,O
Sentence: 998,in,O
Sentence: 998,epileptogenesis,O
Sentence: 998,due,O
Sentence: 998,to,O
Sentence: 998,opposite,O
Sentence: 998,effects,O
Sentence: 998,of,O
Sentence: 998,L,O
Sentence: 998,-,O
Sentence: 998,arginine,O
Sentence: 998,",",O
Sentence: 998,precursor,O
Sentence: 998,of,O
Sentence: 998,NO,B-Chemical
Sentence: 998,syntheses,O
Sentence: 998,(,O
Sentence: 998,NOS,O
Sentence: 998,),O
Sentence: 998,",",O
Sentence: 998,and,O
Sentence: 998,L,O
Sentence: 998,-,O
Sentence: 998,NAME,O
Sentence: 998,(,O
Sentence: 998,NOS,O
Sentence: 998,inhibitor,O
Sentence: 998,),O
Sentence: 998,observed,O
Sentence: 998,in,O
Sentence: 998,different,O
Sentence: 998,epilepsy,B-Disease
Sentence: 998,models,O
Sentence: 998,.,O
Sentence: 998,The,O
Sentence: 998,aim,O
Sentence: 998,of,O
Sentence: 998,the,O
Sentence: 998,current,O
Sentence: 998,study,O
Sentence: 998,was,O
Sentence: 998,to,O
Sentence: 998,determine,O
Sentence: 998,the,O
Sentence: 998,effects,O
Sentence: 998,of,O
Sentence: 998,NO,B-Chemical
Sentence: 998,on,O
Sentence: 998,the,O
Sentence: 998,behavioral,O
Sentence: 998,and,O
Sentence: 998,EEG,O
Sentence: 998,characteristics,O
Sentence: 998,of,O
Sentence: 998,lindane,B-Chemical
Sentence: 998,-,O
Sentence: 998,induced,O
Sentence: 998,epilepsy,B-Disease
Sentence: 998,in,O
Sentence: 998,male,O
Sentence: 998,Wistar,O
Sentence: 998,albino,O
Sentence: 998,rats,O
Sentence: 998,.,O
Sentence: 998,The,O
Sentence: 998,administration,O
Sentence: 998,of,O
Sentence: 998,L,O
Sentence: 998,-,O
Sentence: 998,arginine,O
Sentence: 998,(,O
Sentence: 998,600,O
Sentence: 998,",",O
Sentence: 998,800,O
Sentence: 998,and,O
Sentence: 998,1000,O
Sentence: 998,mg,O
Sentence: 998,/,O
Sentence: 998,kg,O
Sentence: 998,",",O
Sentence: 998,i.p,O
Sentence: 998,.,O
Sentence: 998,),O
Sentence: 998,in,O
Sentence: 998,dose,O
Sentence: 998,-,O
Sentence: 998,dependent,O
Sentence: 998,manner,O
Sentence: 998,significantly,O
Sentence: 998,increased,O
Sentence: 998,convulsion,B-Disease
Sentence: 998,incidence,O
Sentence: 998,and,O
Sentence: 998,severity,O
Sentence: 998,and,O
Sentence: 998,shortened,O
Sentence: 998,latency,O
Sentence: 998,time,O
Sentence: 998,to,O
Sentence: 998,first,O
Sentence: 998,convulsion,B-Disease
Sentence: 998,elicited,O
Sentence: 998,by,O
Sentence: 998,lower,O
Sentence: 998,lindane,B-Chemical
Sentence: 998,dose,O
Sentence: 998,(,O
Sentence: 998,4,O
Sentence: 998,mg,O
Sentence: 998,/,O
Sentence: 998,kg,O
Sentence: 998,",",O
Sentence: 998,i.p.,O
Sentence: 998,),O
Sentence: 998,.,O
Sentence: 998,On,O
Sentence: 998,the,O
Sentence: 998,contrary,O
Sentence: 998,",",O
Sentence: 998,pretreatment,O
Sentence: 998,with,O
Sentence: 998,L,O
Sentence: 998,-,O
Sentence: 998,NAME,O
Sentence: 998,(,O
Sentence: 998,500,O
Sentence: 998,",",O
Sentence: 998,700,O
Sentence: 998,and,O
Sentence: 998,900,O
Sentence: 998,mg,O
Sentence: 998,/,O
Sentence: 998,kg,O
Sentence: 998,",",O
Sentence: 998,i.p,O
Sentence: 998,.,O
Sentence: 998,),O
Sentence: 998,decreased,O
Sentence: 998,convulsion,B-Disease
Sentence: 998,incidence,O
Sentence: 998,and,O
Sentence: 998,severity,O
Sentence: 998,and,O
Sentence: 998,prolonged,O
Sentence: 998,latency,O
Sentence: 998,time,O
Sentence: 998,to,O
Sentence: 998,convulsion,B-Disease
Sentence: 998,following,O
Sentence: 998,injection,O
Sentence: 998,with,O
Sentence: 998,a,O
Sentence: 998,convulsive,B-Disease
Sentence: 998,dose,O
Sentence: 998,of,O
Sentence: 998,lindane,B-Chemical
Sentence: 998,(,O
Sentence: 998,8,O
Sentence: 998,mg,O
Sentence: 998,/,O
Sentence: 998,kg,O
Sentence: 998,",",O
Sentence: 998,i.p.,O
Sentence: 998,),O
Sentence: 998,.,O
Sentence: 998,EEG,O
Sentence: 998,analyses,O
Sentence: 998,showed,O
Sentence: 998,increase,O
Sentence: 998,of,O
Sentence: 998,number,O
Sentence: 998,and,O
Sentence: 998,duration,O
Sentence: 998,of,O
Sentence: 998,ictal,O
Sentence: 998,periods,O
Sentence: 998,in,O
Sentence: 998,EEG,O
Sentence: 998,of,O
Sentence: 998,rats,O
Sentence: 998,receiving,O
Sentence: 998,l,O
Sentence: 998,-,O
Sentence: 998,arginine,O
Sentence: 998,prior,O
Sentence: 998,to,O
Sentence: 998,lindane,B-Chemical
Sentence: 998,and,O
Sentence: 998,decrease,O
Sentence: 998,of,O
Sentence: 998,this,O
Sentence: 998,number,O
Sentence: 998,in,O
Sentence: 998,rats,O
Sentence: 998,pretreated,O
Sentence: 998,with,O
Sentence: 998,L,O
Sentence: 998,-,O
Sentence: 998,NAME,O
Sentence: 998,.,O
Sentence: 998,These,O
Sentence: 998,results,O
Sentence: 998,support,O
Sentence: 998,the,O
Sentence: 998,conclusion,O
Sentence: 998,that,O
Sentence: 998,NO,B-Chemical
Sentence: 998,plays,O
Sentence: 998,a,O
Sentence: 998,role,O
Sentence: 998,of,O
Sentence: 998,endogenous,O
Sentence: 998,convulsant,O
Sentence: 998,in,O
Sentence: 998,rat,O
Sentence: 998,model,O
Sentence: 998,of,O
Sentence: 998,lindane,B-Chemical
Sentence: 998,seizures,B-Disease
Sentence: 998,.,O
Sentence: 999,Long,O
Sentence: 999,-,O
Sentence: 999,term,O
Sentence: 999,oral,O
Sentence: 999,galactose,B-Chemical
Sentence: 999,treatment,O
Sentence: 999,prevents,O
Sentence: 999,cognitive,B-Disease
Sentence: 999,deficits,I-Disease
Sentence: 999,in,O
Sentence: 999,male,O
Sentence: 999,Wistar,O
Sentence: 999,rats,O
Sentence: 999,treated,O
Sentence: 999,intracerebroventricularly,O
Sentence: 999,with,O
Sentence: 999,streptozotocin,B-Chemical
Sentence: 999,.,O
Sentence: 1000,Basic,O
Sentence: 1000,and,O
Sentence: 1000,clinical,O
Sentence: 1000,research,O
Sentence: 1000,has,O
Sentence: 1000,demonstrated,O
Sentence: 1000,that,O
Sentence: 1000,dementia,B-Disease
Sentence: 1000,of,O
Sentence: 1000,sporadic,O
Sentence: 1000,Alzheimer,B-Disease
Sentence: 1000,'s,I-Disease
Sentence: 1000,disease,I-Disease
Sentence: 1000,(,O
Sentence: 1000,sAD,O
Sentence: 1000,),O
Sentence: 1000,type,O
Sentence: 1000,is,O
Sentence: 1000,associated,O
Sentence: 1000,with,O
Sentence: 1000,dysfunction,O
Sentence: 1000,of,O
Sentence: 1000,the,O
Sentence: 1000,insulin,O
Sentence: 1000,-,O
Sentence: 1000,receptor,O
Sentence: 1000,(,O
Sentence: 1000,IR,O
Sentence: 1000,),O
Sentence: 1000,system,O
Sentence: 1000,followed,O
Sentence: 1000,by,O
Sentence: 1000,decreased,O
Sentence: 1000,glucose,B-Chemical
Sentence: 1000,transport,O
Sentence: 1000,via,O
Sentence: 1000,glucose,B-Chemical
Sentence: 1000,transporter,O
Sentence: 1000,GLUT4,O
Sentence: 1000,and,O
Sentence: 1000,decreased,O
Sentence: 1000,glucose,B-Chemical
Sentence: 1000,metabolism,O
Sentence: 1000,in,O
Sentence: 1000,brain,O
Sentence: 1000,cells,O
Sentence: 1000,.,O
Sentence: 1000,An,O
Sentence: 1000,alternative,O
Sentence: 1000,source,O
Sentence: 1000,of,O
Sentence: 1000,energy,O
Sentence: 1000,is,O
Sentence: 1000,d,O
Sentence: 1000,-,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,(,O
Sentence: 1000,the,O
Sentence: 1000,C,O
Sentence: 1000,-,O
Sentence: 1000,4,O
Sentence: 1000,-,O
Sentence: 1000,epimer,O
Sentence: 1000,of,O
Sentence: 1000,d,O
Sentence: 1000,-,O
Sentence: 1000,glucose,B-Chemical
Sentence: 1000,),O
Sentence: 1000,which,O
Sentence: 1000,is,O
Sentence: 1000,transported,O
Sentence: 1000,into,O
Sentence: 1000,the,O
Sentence: 1000,brain,O
Sentence: 1000,by,O
Sentence: 1000,insulin,O
Sentence: 1000,-,O
Sentence: 1000,independent,O
Sentence: 1000,GLUT3,O
Sentence: 1000,transporter,O
Sentence: 1000,where,O
Sentence: 1000,it,O
Sentence: 1000,might,O
Sentence: 1000,be,O
Sentence: 1000,metabolized,O
Sentence: 1000,to,O
Sentence: 1000,glucose,B-Chemical
Sentence: 1000,via,O
Sentence: 1000,the,O
Sentence: 1000,Leloir,O
Sentence: 1000,pathway,O
Sentence: 1000,.,O
Sentence: 1000,Exclusively,O
Sentence: 1000,parenteral,O
Sentence: 1000,daily,O
Sentence: 1000,injections,O
Sentence: 1000,of,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,induce,O
Sentence: 1000,memory,B-Disease
Sentence: 1000,deterioration,I-Disease
Sentence: 1000,in,O
Sentence: 1000,rodents,O
Sentence: 1000,and,O
Sentence: 1000,are,O
Sentence: 1000,used,O
Sentence: 1000,to,O
Sentence: 1000,generate,O
Sentence: 1000,animal,O
Sentence: 1000,aging,O
Sentence: 1000,model,O
Sentence: 1000,",",O
Sentence: 1000,but,O
Sentence: 1000,the,O
Sentence: 1000,effects,O
Sentence: 1000,of,O
Sentence: 1000,oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,treatment,O
Sentence: 1000,on,O
Sentence: 1000,cognitive,O
Sentence: 1000,functions,O
Sentence: 1000,have,O
Sentence: 1000,never,O
Sentence: 1000,been,O
Sentence: 1000,tested,O
Sentence: 1000,.,O
Sentence: 1000,We,O
Sentence: 1000,have,O
Sentence: 1000,investigated,O
Sentence: 1000,the,O
Sentence: 1000,effects,O
Sentence: 1000,of,O
Sentence: 1000,continuous,O
Sentence: 1000,daily,O
Sentence: 1000,oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,(,O
Sentence: 1000,200,O
Sentence: 1000,mg,O
Sentence: 1000,/,O
Sentence: 1000,kg,O
Sentence: 1000,/,O
Sentence: 1000,day,O
Sentence: 1000,),O
Sentence: 1000,treatment,O
Sentence: 1000,on,O
Sentence: 1000,cognitive,B-Disease
Sentence: 1000,deficits,I-Disease
Sentence: 1000,in,O
Sentence: 1000,streptozotocin,B-Chemical
Sentence: 1000,-,O
Sentence: 1000,induced,O
Sentence: 1000,(,O
Sentence: 1000,STZ,B-Chemical
Sentence: 1000,-,O
Sentence: 1000,icv,O
Sentence: 1000,),O
Sentence: 1000,rat,O
Sentence: 1000,model,O
Sentence: 1000,of,O
Sentence: 1000,sAD,O
Sentence: 1000,",",O
Sentence: 1000,tested,O
Sentence: 1000,by,O
Sentence: 1000,Morris,O
Sentence: 1000,Water,O
Sentence: 1000,Maze,O
Sentence: 1000,and,O
Sentence: 1000,Passive,O
Sentence: 1000,Avoidance,O
Sentence: 1000,test,O
Sentence: 1000,",",O
Sentence: 1000,respectively,O
Sentence: 1000,.,O
Sentence: 1000,One,O
Sentence: 1000,month,O
Sentence: 1000,of,O
Sentence: 1000,oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,treatment,O
Sentence: 1000,initiated,O
Sentence: 1000,immediately,O
Sentence: 1000,after,O
Sentence: 1000,the,O
Sentence: 1000,STZ,B-Chemical
Sentence: 1000,-,O
Sentence: 1000,icv,O
Sentence: 1000,administration,O
Sentence: 1000,",",O
Sentence: 1000,successfully,O
Sentence: 1000,prevented,O
Sentence: 1000,development,O
Sentence: 1000,of,O
Sentence: 1000,the,O
Sentence: 1000,STZ,B-Chemical
Sentence: 1000,-,O
Sentence: 1000,icv,O
Sentence: 1000,-,O
Sentence: 1000,induced,O
Sentence: 1000,cognitive,B-Disease
Sentence: 1000,deficits,I-Disease
Sentence: 1000,.,O
Sentence: 1000,Beneficial,O
Sentence: 1000,effect,O
Sentence: 1000,of,O
Sentence: 1000,oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,was,O
Sentence: 1000,independent,O
Sentence: 1000,of,O
Sentence: 1000,the,O
Sentence: 1000,rat,O
Sentence: 1000,age,O
Sentence: 1000,and,O
Sentence: 1000,of,O
Sentence: 1000,the,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,dose,O
Sentence: 1000,ranging,O
Sentence: 1000,from,O
Sentence: 1000,100,O
Sentence: 1000,to,O
Sentence: 1000,300,O
Sentence: 1000,mg,O
Sentence: 1000,/,O
Sentence: 1000,kg,O
Sentence: 1000,/,O
Sentence: 1000,day,O
Sentence: 1000,.,O
Sentence: 1000,Additionally,O
Sentence: 1000,",",O
Sentence: 1000,oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,administration,O
Sentence: 1000,led,O
Sentence: 1000,to,O
Sentence: 1000,the,O
Sentence: 1000,appearance,O
Sentence: 1000,of,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,in,O
Sentence: 1000,the,O
Sentence: 1000,blood,O
Sentence: 1000,.,O
Sentence: 1000,The,O
Sentence: 1000,increase,O
Sentence: 1000,of,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,concentration,O
Sentence: 1000,in,O
Sentence: 1000,the,O
Sentence: 1000,cerebrospinal,O
Sentence: 1000,fluid,O
Sentence: 1000,was,O
Sentence: 1000,several,O
Sentence: 1000,times,O
Sentence: 1000,lower,O
Sentence: 1000,after,O
Sentence: 1000,oral,O
Sentence: 1000,than,O
Sentence: 1000,after,O
Sentence: 1000,parenteral,O
Sentence: 1000,administration,O
Sentence: 1000,of,O
Sentence: 1000,the,O
Sentence: 1000,same,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,dose,O
Sentence: 1000,.,O
Sentence: 1000,Oral,O
Sentence: 1000,galactose,B-Chemical
Sentence: 1000,exposure,O
Sentence: 1000,might,O
Sentence: 1000,have,O
Sentence: 1000,beneficial,O
Sentence: 1000,effects,O
Sentence: 1000,on,O
Sentence: 1000,learning,O
Sentence: 1000,and,O
Sentence: 1000,memory,O
Sentence: 1000,ability,O
Sentence: 1000,and,O
Sentence: 1000,could,O
Sentence: 1000,be,O
Sentence: 1000,worth,O
Sentence: 1000,investigating,O
Sentence: 1000,for,O
Sentence: 1000,improvement,O
Sentence: 1000,of,O
Sentence: 1000,cognitive,B-Disease
Sentence: 1000,deficits,I-Disease
Sentence: 1000,associated,O
Sentence: 1000,with,O
Sentence: 1000,glucose,B-Disease
Sentence: 1000,hypometabolism,I-Disease
Sentence: 1000,in,O
Sentence: 1000,AD,B-Disease
Sentence: 1000,.,O
